FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Kowalski, SJ
   Szadzinska, J
AF Kowalski, S. J.
   Szadzinska, J.
TI Convective-intermittent drying of cherries preceded by ultrasonic
   assisted osmotic dehydration
SO CHEMICAL ENGINEERING AND PROCESSING
LA English
DT Article
DE Intermittent drying; Cherries; Ultrasounds; Color; Water activity
ID PRODUCT QUALITY; CARROT; APPLE; PRETREATMENT; KINETICS; AIR
AB This paper presents the results of experimental studies on convective drying of cherries (Prunus cerasus L) in stationary and intermittent conditions, previously pretreated with ultrasonic assisted osmotic dehydration. The effect of a stepwise changing air temperature and osmotic pretreatment on drying kinetics and the biomaterial quality were investigated. The main aim of the studies was to find the possibly best drying conditions, by which the drying time was shortened and the product quality degradation was minimized. Except drying kinetics and total color and water activity changes, the effect of osmotic pretreatment expressed by such parameters as the Solid Gain and the Water Loss were examined. It was proved that intermittent drying of cherries preceded by ultrasonic assisted osmotic dehydration contributes to shorter drying time, better color preservation and smaller water activity. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kowalski, S. J.; Szadzinska, J.] Poznan Univ Tech, Inst Technol & Chem Engn, Dept Proc Engn, PL-60965 Poznan, Poland.
RP Kowalski, SJ (reprint author), Poznan Univ Tech, Inst Technol & Chem Engn, Dept Proc Engn, Pl Marii Sklodowskiej,Curie 2, PL-60965 Poznan, Poland.
EM Stefan.J.Kowalski@put.poznan.pl;
   Justyna.Szadzinska@doctorate.put.poznan.pl
RI Szadzinska, Justyna/R-5862-2016; Kowalski, Stefan/M-8986-2014
FU National Science Center Poland [2012/05/B/ST8/01773]
FX This work was carried out as part of a research project; No.
   2012/05/B/ST8/01773 sponsored by the National Science Center Poland.
CR Bonazzi C., 2011, MODERN DRYING TECHNO, V3, P1
   Chua KJ, 2003, BIORESOURCE TECHNOL, V90, P285, DOI 10.1016/S0960-8524(03)00133-0
   Fernandes FAN, 2009, J FOOD ENG, V90, P186, DOI 10.1016/j.jfoodeng.2008.06.021
   Frias J, 2010, J AGR FOOD CHEM, V58, P10539, DOI 10.1021/jf102797y
   Fuente-Blanco S., 2006, ULTRASON SONOCHEM, V44, P523
   Ho JC, 2002, J FOOD ENG, V51, P65, DOI 10.1016/S0260-8774(01)00038-3
   Hui Y. H., 2006, HDB FRUITS FRUIT PRO
   Jayaraman KS, 2006, HDB IND DRYING, P606
   Konopacka D, 2009, J HORTIC SCI BIOTECH, P80
   Kowalski SJ, 2013, DRY TECHNOL, V31, P1849, DOI 10.1080/07373937.2013.833518
   Kowalski SJ, 2013, J FOOD ENG, V118, P393, DOI 10.1016/j.jfoodeng.2013.04.028
   Krokida MK, 2000, DRY TECHNOL, V18, P1251, DOI 10.1080/07373930008917775
   Kumar C, 2014, J FOOD ENG, V121, P48, DOI 10.1016/j.jfoodeng.2013.08.014
   Labuza T.P., 1970, FOOD TECHNOL, V24, P546
   Labuza T.P., 1970, FOOD TECHNOL, V24, P550
   LABUZA TP, 1970, FOOD TECHNOL-CHICAGO, V24, P543
   Lewicki PP, 2006, HDB IND DRYING, P665
   Mason TJ, 2005, FOOD SCI TECHNOL-INT, P323, DOI 10.1016/B978-012676757-5/50015-3
   Moazzam R.K., 2012, PAKISTAN J FOOD SCI, V22, P71
   Nowacka M, 2012, J FOOD ENG, V113, P427, DOI 10.1016/j.jfoodeng.2012.06.013
   Ong S.P., 2010, DRYING FOODS VEGETAB, V1, P31
   Ong SP, 2012, DRY TECHNOL, V30, P1676, DOI 10.1080/07373937.2012.703741
   Pan YK, 1999, DRY TECHNOL, V17, P2323, DOI 10.1080/07373939908917686
   Pan YK, 2003, DRY TECHNOL, V21, P1101, DOI 10.1081/DRT-120021877
   Rawson A, 2011, ULTRASON SONOCHEM, V18, P1172, DOI 10.1016/j.ultsonch.2011.03.009
   Sabarez HT, 2012, DRY TECHNOL, V30, P989, DOI 10.1080/07373937.2012.677083
   Saltmarch M., 1982, Diabetes, V31, P29
   Sikorski Z.E., 2007, FOOD CHEM, V1
   Steger-Mate M., 2006, Handbook of fruits and fruit processing, P665
   Thomkapanich O, 2007, DRY TECHNOL, V25, P205, DOI 10.1080/07373930601161146
   Wang HB, 1999, J NAT PROD, V62, P294, DOI 10.1021/np980501m
   Zalewski S., 2009, FUNDAMENTALS GASTRON
NR 32
TC 19
Z9 21
U1 1
U2 28
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0255-2701
EI 1873-3204
J9 CHEM ENG PROCESS
JI Chem. Eng. Process.
PD AUG
PY 2014
VL 82
BP 65
EP 70
DI 10.1016/j.cep.2014.05.006
PG 6
WC Energy & Fuels; Engineering, Chemical
SC Energy & Fuels; Engineering
GA AO0JN
UT WOS:000340995000007
DA 2018-10-20
ER

PT J
AU Ramaraju, H
   Miller, SJ
   Kohn, DH
AF Ramaraju, Harsha
   Miller, Sharon J.
   Kohn, David H.
TI Dual-functioning phage-derived peptides encourage human bone marrow
   cell-specific attachment to mineralized biomaterials
SO CONNECTIVE TISSUE RESEARCH
LA English
DT Article
DE Binding affinity; biomimetic apatite; centrifugation assay; Langmuir
   isotherms; tissue regeneration
ID HYDROXYAPATITE; SEQUENCES
AB Cell instructive mineralized biomaterials are a promising alternative to conventional auto-, allo-, and xenograft therapies for the reconstruction of critical sized defects. Extracellular matrix proteins, peptide domains, and functional motifs demonstrating cell and mineral binding activity have been used to improve cell attachment. However, these strategies vary in their tissue regeneration outcomes due to lack of specificity to both regenerative cell populations and the material substrates. In order to mediate cell-specific interactions on apatite surfaces, we identified peptide sequences with high affinity towards apatite (VTKHLNQISQSY, VTK) and clonally derived human bone marrow stromal cells (DPIYALSWSGMA, DPI) using phage display. The primary aims of this study were to measure apatite binding affinity, human bone marrow stromal cell (hBMSC) adhesion strength, and peptide specificity to hBMSCs when the apatite and cell-specific peptides are combined into a dual-functioning peptide. To assess binding affinity to hydroxyapatite (HA), binding isotherms were constructed and peptide binding affinity (K-1) determined. HBMSC, MC3T3 and mouse dermal fibroblast (MDF) adhesion strength on biomimetic apatite functionalized with single-and dual-functioning peptide sequences were evaluated using a centrifugation assay. DPI-VTK had the highest binding strength towards hBMSCs (p<0.01). DPI-VTK, while promoting strong initial attachment to hBMSCs, did not encourage strong adhesions to MC3T3s or fibroblasts (p<0.01). Taken together, phage display is a promising strategy to identify preferential cell and material binding peptide sequences that can tether specific cell populations onto specific biomaterial chemistries.
C1 [Ramaraju, Harsha; Miller, Sharon J.; Kohn, David H.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Kohn, David H.] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
RP Kohn, DH (reprint author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, 1011 N Univ Ave,Room 2213, Ann Arbor, MI 48109 USA.
EM dhkohn@umich.edu
FU NIH [DE015411, DE13380]
FX This article was funded by NIH DE015411 and NIH DE13380. There are no
   outside contributors to the completion of this work or any known
   conflicts of interest.
CR Addison WN, 2010, BIOMATERIALS, V31, P9422, DOI 10.1016/j.biomaterials.2010.08.064
   Fujisawa R, 1997, MATRIX BIOL, V16, P21, DOI 10.1016/S0945-053X(97)90113-X
   Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200
   Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014
   McClay D. R., 2001, CURR PROTOC CELL BIO
   Segvich SJ, 2009, BIOMATERIALS, V30, P1287, DOI 10.1016/j.biomaterials.2008.11.008
   Segvich SJ, 2008, THESIS U MICHIGAN, V215
NR 7
TC 3
Z9 3
U1 0
U2 15
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0300-8207
EI 1607-8438
J9 CONNECT TISSUE RES
JI Connect. Tissue Res.
PD AUG
PY 2014
VL 55
SU 1
BP 160
EP 163
DI 10.3109/03008207.2014.923868
PG 4
WC Cell Biology; Orthopedics
SC Cell Biology; Orthopedics
GA AO3LP
UT WOS:000341231000036
PM 25158203
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Negron, L
   Lun, S
   May, BCH
AF Negron, Leonardo
   Lun, Stan
   May, Barnaby C. H.
TI Ovine forestomach matrix biomaterial is a broad spectrum inhibitor of
   matrix metalloproteinases and neutrophil elastase
SO INTERNATIONAL WOUND JOURNAL
LA English
DT Article
DE Enzyme inhibitor; Inhibition; Matrix metalloproteinase; Neutrophil
   elastase; Ovine forestomach matrix; Wound healing
ID CHRONIC WOUND FLUID; OXIDIZED REGENERATED CELLULOSE/COLLAGEN; CHRONIC
   VENOUS INSUFFICIENCY; IN-VITRO; ULCERS; PROTEASES; DRESSINGS;
   COLLAGENASE; ENVIRONMENT; EXPRESSION
AB Proteases play a critical role in the ordered remodelling of extracellular matrix (ECM) components during wound healing and tissue regeneration. However, the usually ordered proteolysis is compromised in chronic wounds due to over-expression and high concentrations of matrix metalloproteinase's (MMPs) and neutrophil elastase (NE). Ovine forestomach matrix (OFM) is a decellularised extracellular matrix-based biomaterial developed for tissue regeneration applications, including the treatment of chronic wounds, and is a heterogeneous mixture of ECM proteins and proteoglycans that retains the native structural and functional characteristics of tissue ECM. Given the diverse molecular species present in OFM, we hypothesised that OFM may contain components or fragments that inhibit MMP and NE activity. An extract of OFM was shown to be a potent inhibitor of a range of tissue MMPs (IC(50)s = 23 +/- 5 to 115 +/- 14 mu g/ml) and NE (IC50 = 157 +/- 37 mu g/ml), and was more potent than extracts prepared from a known protease modulating wound dressing. The broad spectrum activity of OFM against different classes of MMPs (i.e. collagenases, gelatinases and stromelysins) may provide a clinical advantage by more effectively addressing the protease imbalance seen in chronic wounds.
C1 [Negron, Leonardo; Lun, Stan; May, Barnaby C. H.] Mesynthes Ltd, Lower Hutt 5040, New Zealand.
RP May, BCH (reprint author), Mesynthes Ltd, Lower Hutt 5040, New Zealand.
EM barnaby.may@mesynthes.com
OI Negron, Leonardo/0000-0003-3852-3002
CR Beidler SK, 2008, WOUND REPAIR REGEN, V16, P642, DOI 10.1111/j.1524-475X.2008.00415.x
   Calne S, 2010, INT CONSENSUS ACELLU
   Cao Y, 2011, J BIOMED MATER RES A, V96A, P663, DOI 10.1002/jbm.a.33027
   Cullen B, 2002, WOUND REPAIR REGEN, V10, P16, DOI 10.1046/j.1524-475X.2002.10703.x
   Cullen B, 2002, INT J BIOCHEM CELL B, V34, P1544, DOI 10.1016/S1357-2725(02)00054-7
   Edwards JV, 2007, J BIOMED MATER RES A, V83A, P446, DOI 10.1002/jbm.a.31171
   Edwards JV, 2001, WOUND REPAIR REGEN, V9, P50, DOI 10.1046/j.1524-475x.2001.00050.x
   Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745
   Fray MJ, 2003, J MED CHEM, V46, P3514, DOI 10.1021/jm0308038
   Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/hh0302.105345
   Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024
   Grinnell F, 1996, J INVEST DERMATOL, V106, P335, DOI 10.1111/1523-1747.ep12342990
   Herouy Y, 2000, EUR J DERMATOL, V10, P173
   Irvine SM, 2011, BIOMATERIALS, V32, P6351, DOI 10.1016/j.biomaterials.2011.05.040
   Klein T, AMINO ACIDS, V41, P271
   KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6
   Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8
   Lun S, 2010, BIOMATERIALS, V31, P4517, DOI 10.1016/j.biomaterials.2010.02.025
   Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010
   NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027
   Nwomeh BC, 1999, J SURG RES, V81, P189, DOI 10.1006/jsre.1998.5495
   Rayment EA, 2008, BRIT J DERMATOL, V158, P951, DOI 10.1111/j.1365-2133.2008.08462.x
   Rayment EA, 2008, BIOMATERIALS, V29, P1785, DOI 10.1016/j.biomaterials.2007.12.043
   Rayment EA, 2009, INT J LOW EXTR WOUND, V8, P19, DOI 10.1177/1534734609331596
   Saito S, 2001, J VASC SURG, V34, P930, DOI 10.1067/mva.2001.119503
   Schonfelder U, 2005, BIOMATERIALS, V26, P6664, DOI 10.1016/j.biomaterials.2005.04.030
   Shi L, 2011, INT WOUND J, V9, P44
   Smeets R, 2008, INT WOUND J, V5, P195, DOI 10.1111/j.1742-481X.2007.00367.x
   Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4
   Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x
   Vaalamo M, 1996, BRIT J DERMATOL, V135, P52
   Vachon DJ, 2006, J BIOMED MATER RES A, V76A, P35, DOI 10.1002/jbm.a.30440
   Wiegand C, 2010, ARCH DERMATOL RES, V302, P419, DOI 10.1007/s00403-009-1011-1
   WYSOCKI AB, 1993, J INVEST DERMATOL, V101, P64, DOI 10.1111/1523-1747.ep12359590
   Xue ML, 2006, EXPERT OPIN THER TAR, V10, P143, DOI 10.1517/14728222.10.1.143
   Yager Dorne R., 1997, Wound Repair and Regeneration, V5, P23, DOI 10.1046/j.1524-475X.1997.50108.x
   Yager DR, 1999, WOUND REPAIR REGEN, V7, P433, DOI 10.1046/j.1524-475X.1999.00433.x
   Yager DR, 1996, J INVEST DERMATOL, V107, P743, DOI 10.1111/1523-1747.ep12365637
NR 38
TC 16
Z9 16
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-4801
EI 1742-481X
J9 INT WOUND J
JI Int. Wound J.
PD AUG
PY 2014
VL 11
IS 4
BP 392
EP 397
DI 10.1111/j.1742-481X.2012.01106.x
PG 6
WC Dermatology; Surgery
SC Dermatology; Surgery
GA AN5XH
UT WOS:000340665000010
PM 23116239
DA 2018-10-20
ER

PT J
AU Karlsson, J
   Sundell, G
   Thuvander, M
   Andersson, M
AF Karlsson, Johan
   Sundell, Gustav
   Thuvander, Mattias
   Andersson, Martin
TI Atomically Resolved Tissue Integration
SO NANO LETTERS
LA English
DT Article
DE Biomedical implants; osseointegration; atom probe tomography; in vivo;
   biomaterials; nanotopography
ID ATOM-PROBE TOMOGRAPHY; BONE; IMPLANTS; OSSEOINTEGRATION; BIOMATERIALS;
   INTERFACE
AB In the field of biomedical technology, a critical aspect is the ability to control and understand the integration of an implantable device in living tissue. Despite the technical advances in the development of biomaterials, the elaborate interplay encompassing materials science and biology on the atomic level is not very well understood. Within implantology, anchoring a biomaterial device into bone tissue is termed osseointegration. In the most accepted theory, osseointegration is defined as an interfacial bonding between implant and bone; however, there is lack of experimental evidence to confirm this. Here we show that atom probe tomography can be used to study the implant tissue interaction, allowing for three-dimensional atomic mapping of the interface region. Interestingly, our analyses demonstrated that direct contact between Ca atoms and the implanted titanium oxide surface is formed without the presence of a protein interlayer, which means that a pure inorganic interface is created, hence giving experimental support to the current theory of osseointegration. We foresee that this result will be of importance in the development of future biomaterials as well as in the design of in vitro evaluation techniques.
C1 [Karlsson, Johan; Andersson, Martin] Chalmers, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden.
   [Sundell, Gustav; Thuvander, Mattias] Chalmers, Dept Appl Phys, SE-41296 Gothenburg, Sweden.
RP Andersson, M (reprint author), Chalmers, Dept Chem & Biol Engn, Kemivagen 10, SE-41296 Gothenburg, Sweden.
EM martin.andersson@chalmers.se
RI Thuvander, Mattias/N-5329-2014
OI , Martin/0000-0003-1523-4697
FU Materials Area of Advance at Chalmers University of Technology
FX This work was supported by the Materials Area of Advance at Chalmers
   University of Technology. We thank N. Harmankaya, A. Palmquist, P.
   Tengvall, and M. Halvarsson for their input to this work.
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andersson M, 2005, CHEM MATER, V17, P1409, DOI 10.1021/cm0485761
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Gordon LM, 2012, ACS NANO, V6, P10667, DOI 10.1021/nn3049957
   Gordon LM, 2011, NATURE, V469, P194, DOI 10.1038/nature09686
   Grandfield K, 2013, NANOSCALE, V5, P4302, DOI 10.1039/c3nr00826f
   Harmankaya N, 2013, ACTA BIOMATER, V9, P7064, DOI 10.1016/j.actbio.2013.02.040
   Joos U, 2006, INT J ORAL MAX SURG, V35, P783, DOI 10.1016/j.ijom.2006.03.013
   Karlsson J, 2012, ACTA BIOMATER, V8, P4438, DOI 10.1016/j.actbio.2012.07.035
   Kelly TF, 2007, ANNU REV MATER RES, V37, P681, DOI 10.1146/annurev.matsci.37.052506.084239
   Kelly TF, 2009, MRS BULL, V34, P744, DOI 10.1557/mrs2009.249
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Mendes VC, 2007, BIOMATERIALS, V28, P4748, DOI 10.1016/j.biomaterials.2007.07.020
   Miller MK, 2005, ULTRAMICROSCOPY, V102, P287, DOI [10.1016/j.ultramic.2004.10.011, 10.1016/J.ULTRAMIC.2004.10.011]
   Miller MK, 2000, ATOM PROBE TOMOGRAPH
   MUNDY GR, 1994, NATURE, V367, P216, DOI 10.1038/367216a0
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Stiller K, 2013, OXID MET, V79, P227, DOI 10.1007/s11085-012-9330-6
   Thompson K, 2007, ULTRAMICROSCOPY, V107, P131, DOI 10.1016/j.ultramic.2006.06.008
   Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B
NR 24
TC 22
Z9 22
U1 0
U2 32
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
EI 1530-6992
J9 NANO LETT
JI Nano Lett.
PD AUG
PY 2014
VL 14
IS 8
BP 4220
EP 4223
DI 10.1021/nl1501564f
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AN2WH
UT WOS:000340446200004
PM 24989063
DA 2018-10-20
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Rokicki, R
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Rokicki, Ryszard
TI XPS MEASUREMENTS OF AISI 316LVM SS BIOMATERIAL TUBES AFTER
   MAGNETOELECTROPOLISHING
SO TEHNICKI VJESNIK-TECHNICAL GAZETTE
LA English
DT Article
DE magnetoelectropolishing (MEP); PREN (pitting resistance equivalent
   number); 316LVM SS tube biomaterial; XPS results comparison
ID STAINLESS-STEEL; TITANIUM BIOMATERIAL; MAGNETIC-FIELD; SURFACE
   CHARACTERIZATION; CORROSION; ALLOY; SIMS
AB XPS (X-ray Photoelectron Spectroscopy) measurements were performed on AISI 316LVM stainless steel tubes of biomaterial samples, serving for stents, after a standard electropolishing (EP), and magnetoelectropolishing (MEP). After electropolishing operations, the samples were kept in a closed foil pack for about four years. The results of XPS analysis indicate a significant difference in the measurement and calculation values, dependent on surface treatment method: EP and/or MEP. The steel surface film composition and PREN (pitting resistance equivalent number) were calculated. The highest numbers of these values were obtained on samples after MEP where both chromium compounds (Cr 2p) and molybdenum (Mo 3d) increased over three times against these values after EP treatment. The calculated PRENMEP (Fe, Cr, Mo, Mn, Ni, P, S, O) = 16,37, with PRENMEP (Fe, Cr, Mo, Mn, Ni, P, S) = 36,89, versus PRENEP (Fe, Cr, Mo, Mn, Ni, P, S, O) = 3,12, with PRENEP (Fe, Cr, Mo, Mn, Ni, P, S) = 8,53. The results obtained point to an advantageous and unusual effect of the magnetic field action during MEP.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz] Koszalin Univ Technol, Div Surface Electrochem & Technol, PL-75620 Koszalin, Poland.
   [Rokicki, Ryszard] ELECTROBRIGHT, Macungie, PA 18062 USA.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Div Surface Electrochem & Technol, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM rokosz@tu.koszalin.pl; Tadeusz.Hryniewicz@tu.koszalin.pl
CR BARON A, 2006, J ACHIEV MAT MANUF E, V18, P55
   Crist V., 2000, HDB MONOCHROMATIC XP
   Hanawa T, 2009, J ARTIF ORGANS, V12, P73, DOI 10.1007/s10047-008-0456-x
   Hryniewicz T, 2008, CORROS SCI, V50, P2676, DOI 10.1016/j.corsci.2008.06.048
   Hryniewicz T, 2008, CORROSION, V64, P660, DOI 10.5006/1.3279927
   Hryniewicz T, 2008, MATER LETT, V62, P3073, DOI 10.1016/j.matlet.2008.01.130
   Hryniewicz T, 2007, Metal Finishing, V104, P26, DOI 10.1016/S0026-0576(06)80361-2
   Hryniewicz T, 2008, SURF COAT TECH, V202, P1668, DOI 10.1016/j.surfcoat.2007.07.067
   Hryniewicz T, 2007, T I MET FINISH, V85, P325, DOI 10.1179/174591907X246537
   Hryniewicz T, 2012, APPL SURF SCI, V263, P357, DOI 10.1016/j.apsusc.2012.09.060
   Hryniewicz T, 2010, MATER CHEM PHYS, V123, P47, DOI 10.1016/j.matchemphys.2010.03.060
   Hryniewicz T, 2010, SURF COAT TECH, V204, P2583, DOI 10.1016/j.surfcoat.2010.02.005
   Hryniewicz T, 2009, SURF COAT TECH, V203, P1508, DOI 10.1016/j.surfcoat.2008.11.028
   Hryniewicz T., 2011, WORLD J ENG S1, P439
   Hryniewicz T., 2012, NAN ICCE 20 P 20 INT
   Hryniewicz T., 2009, BIOM MRS P 18 INT MA, V1244E, P21
   Hryniewicz T., 2011, TECH
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Hryniewicz T, 2012, SURF COAT TECH, V206, P4027, DOI 10.1016/j.surfcoat.2012.03.083
   Hryniewicz T, 2011, SURF COAT TECH, V205, P4228, DOI 10.1016/j.surfcoat.2011.03.024
   Hryniewicz T, 2010, MATER CHEM PHYS, V122, P169, DOI 10.1016/j.matchemphys.2010.02.055
   Hryniewicz T, 2009, MATERIALS, V2, P129, DOI 10.3390/ma2010129
   Lo KH, 2009, MAT SCI ENG R, V65, P39, DOI 10.1016/j.mser.2009.03.001
   Milewski K, 2012, KARDIOL POL, V70, P703
   Nazneen F, 2012, J SOLID STATE ELECTR, V16, P1389, DOI 10.1007/s10008-011-1539-9
   Rokicki R, 2012, T I MET FINISH, V90, P188, DOI 10.1179/0020296712Z.00000000031
   Rokicki R., 2009, US Patent, Patent No. 7632390
   Rokicki R, 2012, J MATER SCI-MATER M, V23, P2127, DOI 10.1007/s10856-012-4696-1
   Rokosz Krzysztof, 2012, Pomiary Automatyka Kontrola, V58, P460
   Rokosz K., 2012, PAK MEASUREMENT AUTO, V58, P126
   Rokosz K., 2010, CORROSION J SCI ENG, V66
   Rokosz K, 2013, INT J MATER RES, V104, P1223, DOI 10.3139/146.110984
   Rokosz K, 2012, STEEL RES INT, V83, P910, DOI 10.1002/srin.201200046
   Simka W, 2012, SURF COAT TECH, V213, P239, DOI 10.1016/j.surfcoat.2012.10.055
   Wagner C.D., 2000, HDB XRAY PHOTOELECTR
NR 35
TC 5
Z9 5
U1 0
U2 11
PU UNIV OSIJEK, TECH FAC
PI SLAVONSKI BROD
PA TRG IVANE BRLIC-MAZURANIC 2, SLAVONSKI BROD, HR-35000, CROATIA
SN 1330-3651
EI 1848-6339
J9 TEH VJESN
JI Teh. Vjesn.
PD AUG
PY 2014
VL 21
IS 4
BP 799
EP 805
PG 7
WC Engineering, Multidisciplinary
SC Engineering
GA AO3UX
UT WOS:000341262900014
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Rossi, F
   van Griensven, M
AF Rossi, Filippo
   van Griensven, Martijn
TI Polymer Functionalization as a Powerful Tool to Improve Scaffold
   Performances
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; NEURAL STEM-CELLS; FACILE SURFACE
   FUNCTIONALIZATION; TISSUE ENGINEERING APPLICATIONS; STARCH-BASED
   SCAFFOLDS; BONE REGENERATION; IN-VIVO; BIOMEDICAL APPLICATIONS;
   HYALURONIC-ACID; LIGAND DENSITY
AB To address the increasing need for improved tissue substitutes, tissue engineering seeks to create synthetic, three-dimensional scaffolds made from polymeric materials, incorporating cells and growth factors to induce new tissue formation. Materials science, in conjunction with biotechnology, can satisfy these needs by developing artificial, synthetic substitutes and organ implants. Here, scaffold ability to promote cell growth and differentiation is a key point and, in this framework, orthogonal chemistry has led the field of biomaterial science into a new area of selective, versatile and biocompatible nature. In particular, the possibility to modify and functionalize scaffolds with compounds that are able to improve mechanical properties or cell viability and improve their differentiation in a tailorable manner opens new opportunities for researchers. In this review, we seek to emphasize the recent endeavors of exploiting this versatile chemistry toward the development of new cell culture scaffolds.
C1 [Rossi, Filippo] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, I-20131 Milan, Italy.
   [van Griensven, Martijn] Tech Univ Munich, Klinikum Rechts Isar, Dept Expt Trauma Surg, Clin Trauma Surg, D-80290 Munich, Germany.
RP Rossi, F (reprint author), Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, Via Mancinelli 7, I-20131 Milan, Italy.
EM filippo.rossi@polimi.it
RI Rossi, Filippo/D-3679-2013; van Griensven, Martijn/F-5808-2012
OI Rossi, Filippo/0000-0003-2665-120X; van Griensven,
   Martijn/0000-0001-5104-9881
CR Aizawa Y., 2011, ADV MATER, V22, P4831
   Aizawa Y, 2012, BIOMATERIALS, V33, P5198, DOI 10.1016/j.biomaterials.2012.03.062
   Aizawa Y, 2012, PROG POLYM SCI, V37, P645, DOI 10.1016/j.progpolymsci.2011.11.004
   Altin H, 2010, MACROMOLECULES, V43, P3801, DOI 10.1021/ma100292w
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Armentano I, 2011, J BIOMAT SCI-POLYM E, V22, P541, DOI 10.1163/092050610X487873
   Atala A., 2008, PRINCIPLES REGENERAT
   Azagarsamy MA, 2013, ACS MACRO LETT, V2, P5, DOI 10.1021/mz300585q
   Bach LG, 2013, J COLLOID INTERF SCI, V394, P132, DOI 10.1016/j.jcis.2012.11.068
   Binder WH, 2007, MACROMOL RAPID COMM, V28, P15, DOI 10.1002/marc.200600625
   Borcard F, 2012, J MED CHEM, V55, P7988, DOI 10.1021/jm301092r
   Brandl FP, 2010, BIOMATERIALS, V31, P3957, DOI 10.1016/j.biomaterials.2010.01.128
   Breukers RD, 2010, J BIOMED MATER RES A, V95A, P256, DOI 10.1002/jbm.a.32822
   Chen G, 2013, J BIOMED MATER RES A, V101, P44, DOI 10.1002/jbm.a.34298
   Chen J, 2011, INT J NANOMED, V6, P2533, DOI 10.2147/IJN.S23688
   Cheng Q, 2013, TISSUE ENG PT A, V19, P1188, DOI [10.1089/ten.tea.2011.0725, 10.1089/ten.TEA.2011.0725]
   Chien HW, 2012, BIOMATERIALS, V33, P5706, DOI 10.1016/j.biomaterials.2012.04.031
   Choi BH, 2012, TISSUE ENG PART C-ME, V18, P71, DOI [10.1089/ten.tec.2011.0384, 10.1089/ten.TEC.2011.0384]
   Cont L, 2013, J BIOMATER APPL, V27, P707, DOI 10.1177/0885328211423792
   Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002
   de Mulder ELW, 2013, J BIOMED MATER RES A, V101, P919, DOI 10.1002/jbm.a.34389
   Deeg JA, 2011, NANO LETT, V11, P1469, DOI 10.1021/nl104079r
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Desmet T, 2012, J MATER SCI-MATER M, V23, P293, DOI 10.1007/s10856-011-4527-9
   Dorj B, 2011, MATER LETT, V65, P3559, DOI 10.1016/j.matlet.2011.07.110
   Durmaz H, 2012, POLYM CHEM-UK, V3, P825, DOI 10.1039/c1py00471a
   Dyke JC, 2012, J MATER CHEM, V22, P22888, DOI 10.1039/c2jm32466k
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Gandavarapu NR, 2013, ACTA BIOMATER, V9, P4525, DOI 10.1016/j.actbio.2012.09.007
   Gentilini C, 2012, ADV HEALTHC MATER, V1, P308, DOI 10.1002/adhm.201200036
   Ghasemi-Mobarakeh L, 2010, MAT SCI ENG C-MATER, V30, P1129, DOI 10.1016/j.msec.2010.06.004
   Gilmore L, 2013, BIOTECHNOL BIOENG, V110, P296, DOI 10.1002/bit.24598
   Gkioni K, 2010, TISSUE ENG PART B-RE, V16, P577, DOI [10.1089/ten.teb.2010.0462, 10.1089/ten.TEB.2010.0462]
   Gloria A, 2012, BIOMACROMOLECULES, V13, P3510, DOI 10.1021/bm300818y
   Gould ST, 2012, ACTA BIOMATER, V8, P3201, DOI 10.1016/j.actbio.2012.05.009
   Gumusderelioglu M, 2011, CARBOHYD RES, V346, P606, DOI 10.1016/j.carres.2010.12.007
   Hildner F, 2011, J TISSUE ENG REGEN M, V5, pE36, DOI 10.1002/term.386
   Hong JM, 2012, ACTA BIOMATER, V8, P2578, DOI 10.1016/j.actbio.2012.03.041
   Huerta-Angeles G, 2011, CARBOHYD POLYM, V84, P1293, DOI 10.1016/j.carbpol.2011.01.021
   Hume PS, 2011, BIOMATERIALS, V32, P6204, DOI 10.1016/j.biomaterials.2011.04.049
   Jaiswal AK, 2013, APPL SURF SCI, V268, P477, DOI 10.1016/j.apsusc.2012.12.152
   Jiang T, 2010, J BIOMED MATER RES A, V93A, P1193, DOI 10.1002/jbm.a.32615
   Jin GZ, 2011, NEUROSCI LETT, V501, P10, DOI 10.1016/j.neulet.2011.06.023
   Kade MJ, 2010, J POLYM SCI POL CHEM, V48, P743, DOI 10.1002/pola.23824
   Kim JH, 2013, J BIOMED MATER RES A, V101, P1447, DOI 10.1002/jbm.a.34446
   Kirschner CM, 2013, ACTA MATER, V61, P931, DOI 10.1016/j.actamat.2012.10.037
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   Lam MT, 2012, J TISSUE ENG REGEN M, V6, ps80, DOI 10.1002/term.1499
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573
   Leonor IB, 2011, J TISSUE ENG REGEN M, V5, P104, DOI 10.1002/term.294
   Li M, 2013, EUR J PHARM SCI, V48, P111, DOI 10.1016/j.ejps.2012.10.008
   Li Y, 2011, ACTA BIOMATER, V7, P751, DOI 10.1016/j.actbio.2010.09.008
   Lin CC, 2009, BIOMACROMOLECULES, V10, P2460, DOI 10.1021/bm900420f
   Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083
   Liu YX, 2010, BIOMATERIALS, V31, P1158, DOI 10.1016/j.biomaterials.2009.10.040
   Lopez-Perez PM, 2010, ACTA BIOMATER, V6, P3704, DOI 10.1016/j.actbio.2010.03.008
   Losel R., 2011, MACROMOL BIOSCI, V10, P1177
   Luo XS, 2013, BIOMATERIALS, V34, P3336, DOI 10.1016/j.biomaterials.2013.01.060
   Luo Y, 2013, CARBOHYD POLYM, V91, P419, DOI 10.1016/j.carbpol.2012.08.069
   Morelli A, 2010, MACROMOL CHEM PHYS, V211, P821, DOI 10.1002/macp.200900562
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nicolas J, 2013, CHEM SOC REV, V42, P1147, DOI 10.1039/c2cs35265f
   Odedra D, 2011, ACTA BIOMATER, V7, P3027, DOI 10.1016/j.actbio.2011.05.002
   Ossipov DA, 2010, BIOMACROMOLECULES, V11, P2247, DOI 10.1021/bm1007986
   Ouasti S, 2012, BIOMATERIALS, V33, P1120, DOI 10.1016/j.biomaterials.2011.10.009
   Panda JJ, 2010, ACS APPL MATER INTER, V2, P2839, DOI 10.1021/am1005173
   Pasqui D, 2011, MATER LETT, V65, P392, DOI 10.1016/j.matlet.2010.10.053
   Peach MS, 2012, J BIOMED NANOTECHNOL, V8, P107, DOI 10.1166/jbn.2012.1368
   Perale G, 2012, J CONTROL RELEASE, V159, P271, DOI 10.1016/j.jconrel.2011.12.025
   Pertici G., 2010, TISSUE ENG PART A, V16
   Phipps MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040831
   Rahman N, 2010, BIOMATERIALS, V31, P8262, DOI 10.1016/j.biomaterials.2010.07.040
   Raphel J, 2012, J MATER CHEM, V22, P19429, DOI 10.1039/c2jm31768k
   Richter C, 2010, BIOMED MICRODEVICES, V12, P787, DOI 10.1007/s10544-010-9433-2
   Rodrigues AI, 2012, ACTA BIOMATER, V8, P3765, DOI 10.1016/j.actbio.2012.05.025
   Perez ER, 2013, J BIOACT COMPAT POL, V28, P50, DOI 10.1177/0883911512469710
   Ronn LCB, 1999, NAT BIOTECHNOL, V17, P1000, DOI 10.1038/13697
   Rossi F, 2013, EXPERT OPIN DRUG DEL, V10, P385, DOI 10.1517/17425247.2013.751372
   Santos TC, 2010, ACTA BIOMATER, V6, P4314, DOI 10.1016/j.actbio.2010.06.020
   Santos TC, 2013, TISSUE ENG PT A, V19, P834, DOI [10.1089/ten.tea.2010.0741, 10.1089/ten.TEA.2010.0741]
   Schofer MD, 2012, J MATER SCI-MATER M, V23, P2227, DOI 10.1007/s10856-012-4697-0
   Shih H, 2013, ACS APPL MATER INTER, V5, P1673, DOI 10.1021/am302690t
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Silva NA, 2012, BIOMATERIALS, V33, P6345, DOI 10.1016/j.biomaterials.2012.05.050
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Sletten EM, 2011, ACCOUNTS CHEM RES, V44, P666, DOI 10.1021/ar200148z
   Su Y, 2012, ACTA BIOMATER, V8, P763, DOI 10.1016/j.actbio.2011.11.002
   Subramani C, 2011, ADV MATER, V23, P3165, DOI 10.1002/adma.201101292
   Tam RY, 2012, J MATER CHEM, V22, P19402, DOI 10.1039/c2jm33680d
   Tan W, 2010, IEEE T NANOBIOSCI, V9, P111, DOI 10.1109/TNB.2010.2043367
   Theato P., 2012, FUNCTIONAL POLYM POS
   Tuzlakoglu K, 2010, J BIOMED MATER RES A, V92A, P369, DOI 10.1002/jbm.a.32358
   Tyson T, 2011, MACROMOL BIOSCI, V11, P1432, DOI 10.1002/mabi.201100166
   Tzeranis DS, 2010, J R SOC INTERFACE, V7, pS649, DOI 10.1098/rsif.2010.0321.focus
   Venkatesan J, 2011, CARBOHYD POLYM, V83, P569, DOI 10.1016/j.carbpol.2010.08.019
   Vulic K, 2012, J AM CHEM SOC, V134, P882, DOI 10.1021/ja210638x
   Wang R, 2011, MACROMOLECULES, V44, P6009, DOI 10.1021/ma200824k
   Wang XQ, 2011, MACROMOL BIOSCI, V11, P100, DOI 10.1002/mabi.201000173
   Ward J, 2010, BIOMACROMOLECULES, V11, P3093, DOI 10.1021/bm100898p
   WARD MD, 1995, ANN BIOMED ENG, V23, P322, DOI 10.1007/BF02584432
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Wray LS, 2012, BIOMATERIALS, V33, P9214, DOI 10.1016/j.biomaterials.2012.09.017
   Yamanlar S, 2011, BIOMATERIALS, V32, P5590, DOI 10.1016/j.biomaterials.2011.04.030
   You ZW, 2012, ACTA BIOMATER, V8, P502, DOI 10.1016/j.actbio.2011.11.004
   Zhang HY, 2013, CARBOHYD POLYM, V93, P401, DOI 10.1016/j.carbpol.2012.12.015
NR 110
TC 15
Z9 15
U1 1
U2 33
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD AUG
PY 2014
VL 20
IS 15-16
BP 2043
EP 2051
DI 10.1089/ten.tea.2013.0367
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AN8HZ
UT WOS:000340846500002
PM 24206079
DA 2018-10-20
ER

PT J
AU Lopa, S
   Madry, H
AF Lopa, Silvia
   Madry, Henning
TI Bioinspired Scaffolds for Osteochondral Regeneration
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ARTICULAR-CARTILAGE REPAIR; HYDROXYAPATITE BIPHASIC SCAFFOLD;
   MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; COMPOSITE
   MULTILAYERED BIOMATERIAL; ENGINEERING CURRENT STRATEGIES; LARGE
   ANIMAL-MODEL; SUBCHONDRAL BONE; HYDROGEL SCAFFOLDS; DEFECT REPAIR
AB Osteochondral defects are difficult to treat because the articular cartilage and the subchondral bone have dissimilar characteristics and abilities to regenerate. Bioinspired scaffolds are designed to mimic structural and biological cues of the native osteochondral unit, supporting both cartilaginous and subchondral bone repair and the integration of the newly formed osteochondral matrix with the surrounding tissues. The aim of this review is to outline fundamental requirements and strategies for the development of biomimetic scaffolds reproducing the unique and multifaceted anatomical structure of the osteochondral unit. Recent progress in preclinical animal studies using bilayer and multilayer scaffolds, together with continuous gradient scaffolds will be discussed and placed in a translational perspective with data emerging from their clinical application to treat osteochondral defects in patients.
C1 [Lopa, Silvia] IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy.
   [Madry, Henning] Univ Saarland, Ctr Expt Orthopaed, D-66421 Homburg, Germany.
   [Madry, Henning] Univ Saarland, Dept Orthopaed Surg, Med Ctr, D-66421 Homburg, Germany.
RP Madry, H (reprint author), Univ Saarland, Ctr Expt Orthopaed, D-66421 Homburg, Germany.
EM henning.madry@uks.eu
RI Lopa, Silvia/I-6531-2016; Lopa, Silvia/G-3455-2015
OI Lopa, Silvia/0000-0003-0410-5814; Lopa, Silvia/0000-0003-0410-5814
CR Ahn JH, 2009, TISSUE ENG PT A, V15, P2595, DOI 10.1089/ten.TEA.2008.0511
   Aigner T, 2010, OSTEOARTHR CARTILAGE, V18, pS2, DOI 10.1016/j.joca.2010.07.013
   Allan KS, 2007, TISSUE ENG, V13, P167, DOI 10.1089/ten.2006.0081
   Bal BS, 2010, J BIOMED MATER RES B, V93B, P164, DOI 10.1002/jbm.b.31571
   Barber FA, 2011, ARTHROSCOPY, V27, P60, DOI 10.1016/j.arthro.2010.06.023
   Becerra J, 2010, TISSUE ENG PART B-RE, V16, P617, DOI [10.1089/ten.teb.2010.0191, 10.1089/ten.TEB.2010.0191]
   Bekkers JEJ, 2013, AM J SPORT MED, V41, P1290, DOI 10.1177/0363546513483536
   Bertoldi S, 2011, J APPL BIOMATER BIOM, V9, P165, DOI 10.5301/JABB.2011.8863
   Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn025
   Boccaccio A, 2011, INT J BIOL SCI, V7, P112, DOI 10.7150/ijbs.7.112
   Bonnet CS, 2005, RHEUMATOLOGY, V44, P7, DOI 10.1093/rheumatology/keh344
   Brittberg M, 2010, AM J SPORT MED, V38, P1259, DOI 10.1177/0363546509346395
   BROOM ND, 1982, J ANAT, V135, P65
   Cao Z, 2012, BIOTECHNOL LETT, V34, P1151, DOI 10.1007/s10529-012-0884-9
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Chen KL, 2012, TISSUE ENG PT A, V18, P1902, DOI [10.1089/ten.tea.2011.0580, 10.1089/ten.TEA.2011.0580]
   Chen T, 2013, BIOTECHNOL BIOENG, V110, P1476, DOI 10.1002/bit.24799
   Correia C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028352
   Crowley C, 2013, CURR STEM CELL RES T, V8, P243, DOI 10.2174/1574888X11308030009
   Cucchiarini M, 2013, J MOL MED, V91, P625, DOI 10.1007/s00109-012-0978-9
   Cui WD, 2011, J BIOSCI BIOENG, V111, P493, DOI 10.1016/j.jbiosc.2010.11.023
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]
   Da H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054838
   Deng TZ, 2014, J TISSUE ENG REGEN M, V8, P546, DOI 10.1002/term.1556
   Despang F, 2015, J TISSUE ENG REGEN M, V9, pE152, DOI 10.1002/term.1729
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Dormer NH, 2012, J BIOMED MATER RES A, V100A, P162, DOI 10.1002/jbm.a.33225
   Dormer NH, 2011, J ORAL MAXIL SURG, V69, pE50, DOI 10.1016/j.joms.2010.12.049
   Driesang IMK, 2000, J ORTHOPAED RES, V18, P909, DOI 10.1002/jor.1100180609
   Duan PG, 2014, J BIOMED MATER RES A, V102, P180, DOI 10.1002/jbm.a.34683
   Duda GN, 2005, J BIOMECH, V38, P843, DOI 10.1016/j.jbiomech.2004.04.034
   Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Frenkel SR, 2005, OSTEOARTHR CARTILAGE, V13, P798, DOI 10.1016/j.joca.2005.04.018
   Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187
   Getgood AMJ, 2012, KNEE, V19, P422, DOI 10.1016/j.knee.2011.03.011
   Gilbert SJ, 2009, TISSUE ENG PT A, V15, P1739, DOI 10.1089/ten.tea.2008.0361
   Goebel L, 2012, OSTEOARTHR CARTILAGE, V20, P1046, DOI 10.1016/j.joca.2012.05.010
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Ho STB, 2010, TISSUE ENG PT A, V16, P1123, DOI 10.1089/ten.TEA.2009.0471
   Hoemann CD, 2012, J KNEE SURG, V25, P85, DOI 10.1055/s-0032-1319782
   Holland TA, 2005, J BIOMED MATER RES A, V75A, P156, DOI 10.1002/jbm.a.30379
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   Hunziker EB, 2012, BONE, V51, P98, DOI 10.1016/j.bone.2012.04.004
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Hunziker EB, 2003, OSTEOARTHR CARTILAGE, V11, P320, DOI 10.1016/S1063-4584(03)00031-1
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS182
   Hunziker EB, 2009, ADV MATER, V21, P3419, DOI 10.1002/adma.200801957
   Im GI, 2010, TISSUE ENG PT A, V16, P1189, DOI [10.1089/ten.tea.2009.0540, 10.1089/ten.TEA.2009.0540]
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keeney M, 2009, TISSUE ENG PART B-RE, V15, P55, DOI 10.1089/ten.teb.2008.0388
   Khan IM, 2008, EUR CELLS MATER, V16, P26, DOI 10.22203/eCM.v016a04
   Kiss A, 2014, J TISSUE ENG REGEN M, V8, P41, DOI 10.1002/term.1495
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Kon E, 2014, KNEE SURG SPORT TR A, V22, P1452, DOI 10.1007/s00167-013-2467-2
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2010, BMC MUSCULOSKEL DIS, V11, P220
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Lajeunesse D, 2003, CURR OPIN RHEUMATOL, V15, P628, DOI 10.1097/00002281-200309000-00018
   Laschke MW, 2009, TISSUE ENG PART B-RE, V15, P455, DOI 10.1089/ten.TEB.2009.0252
   Laverty S, 2010, OSTEOARTHR CARTILAGE, V18, pS53, DOI 10.1016/j.joca.2010.05.029
   LAYTON MW, 1988, ARTHRITIS RHEUM, V31, P1400, DOI 10.1002/art.1780311109
   LINDEN B, 1976, ACTA ORTHOP SCAND, V47, P664, DOI 10.3109/17453677608988756
   Little CB, 2010, OSTEOARTHR CARTILAGE, V18, pS80, DOI 10.1016/j.joca.2010.04.016
   Lyons TJ, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-52
   Lyons TJ, 2005, J MOL HISTOL, V36, P207, DOI 10.1007/s10735-005-3283-x
   Madry H, 2011, DTSCH ARZTEBL INT, V108, P669, DOI 10.3238/arztebl.2011.0669
   Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z
   Madry H, 2010, KNEE SURG SPORT TR A, V18, P417, DOI 10.1007/s00167-010-1071-y
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Marcacci M, 2013, INJURY, V44, pS11, DOI 10.1016/S0020-1383(13)70004-4
   Marmotti A, 2012, KNEE SURG SPORT TR A, V20, P2590, DOI 10.1007/s00167-012-1920-y
   Marquass B, 2010, J ORTHOP RES, V28, P1586, DOI 10.1002/jor.21173
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Menetrey J, 2010, KNEE SURG SPORT TR A, V18, P463, DOI 10.1007/s00167-010-1053-0
   Michael JWP, 2008, INT ORTHOP, V32, P217, DOI 10.1007/s00264-006-0292-7
   Minas T, 2012, J BONE JOINT SURG BR, V94B, P141, DOI 10.1302/0301-620X.94B11.30679
   Miot S, 2012, EUR CELLS MATER, V23, P222, DOI 10.22203/eCM.v023a17
   Mohan N, 2011, TISSUE ENG PT A, V17, P2845, DOI 10.1089/ten.tea.2011.0135
   Newman AP, 1998, AM J SPORT MED, V26, P309, DOI 10.1177/03635465980260022701
   Nguyen LH, 2012, TISSUE ENG PART B-RE, V18, P363, DOI 10.1089/ten.teb.2012.0012
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   Nguyen LH, 2011, BIOMATERIALS, V32, P1327, DOI 10.1016/j.biomaterials.2010.10.009
   Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1
   Nooeaid P, 2012, J CELL MOL MED, V16, P2247, DOI 10.1111/j.1582-4934.2012.01571.x
   Nukavarapu SP, 2013, BIOTECHNOL ADV, V31, P706, DOI 10.1016/j.biotechadv.2012.11.004
   O'Shea TM, 2008, TISSUE ENG PART B-RE, V14, P447, DOI 10.1089/ten.teb.2008.0327
   Orth P, 2012, OSTEOARTHR CARTILAGE, V20, P1161, DOI 10.1016/j.joca.2012.06.008
   Orth P, 2013, EUR CELLS MATER, V25, P299, DOI 10.22203/eCM.v025a21
   Orth P, 2012, AM J SPORT MED, V40, P828, DOI 10.1177/0363546511430376
   Owen SC, 2010, J BIOMED MATER RES A, V94A, P1321, DOI 10.1002/jbm.a.32834
   Pan J, 2009, J ORTHOP RES, V27, P1347, DOI 10.1002/jor.20883
   Panseri S, 2012, J BIOMED MATER RES A, V100A, P2278, DOI 10.1002/jbm.a.34167
   Panseri S., 2011, KNEE SURG SPORTS TRA
   Panseri S, 2012, KNEE SURG SPORT TR A, V20, P1182, DOI 10.1007/s00167-011-1655-1
   Pei M, 2009, OSTEOARTHR CARTILAGE, V17, P714, DOI 10.1016/j.joca.2008.11.017
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Pulkkinen HJ, 2013, OSTEOARTHR CARTILAGE, V21, P481, DOI 10.1016/j.joca.2012.12.004
   Qi YY, 2014, KNEE SURG SPORT TR A, V22, P1424, DOI 10.1007/s00167-012-2256-3
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Re'em T, 2012, ACTA BIOMATER, V8, P3283, DOI 10.1016/j.actbio.2012.05.014
   Reddi AH, 2011, TISSUE ENG PART B-RE, V17, P301, DOI [10.1089/ten.TEB.2011.0141, 10.1089/ten.teb.2011.0141]
   Reyes R, 2014, J TISSUE ENG REGEN M, V8, P521, DOI 10.1002/term.1549
   Rivron NC, 2012, P NATL ACAD SCI USA, V109, P4413, DOI 10.1073/pnas.1117627109
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Schleicher I, 2013, J SURG RES, V183, P184, DOI 10.1016/j.jss.2012.11.036
   Schlichting K, 2008, AM J SPORT MED, V36, P2379, DOI 10.1177/0363546508322899
   Seo J, 2013, RES VET SCI, V95, P1210, DOI 10.1016/j.rvsc.2013.08.016
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shirazi R, 2009, J BIOMECH, V42, P2458, DOI 10.1016/j.jbiomech.2009.07.022
   Steinhagen J, 2001, Ortop Traumatol Rehabil, V3, P163
   Sundelacruz S, 2009, SEMIN CELL DEV BIOL, V20, P646, DOI 10.1016/j.semcdb.2009.03.017
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]
   Tampieri A, 2005, ANAL BIOANAL CHEM, V381, P568, DOI 10.1007/s00216-004-2943-0
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tampieri A, 2011, TRENDS BIOTECHNOL, V29, P526, DOI 10.1016/j.tibtech.2011.04.011
   Thorpe SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060764
   Van der Vis HM, 1998, CLIN ORTHOP RELAT R, P201
   van Dijk C Niek, 2010, Instr Course Lect, V59, P375
   van Osch GJVM, 2009, J CELL MOL MED, V13, P792, DOI 10.1111/j.1582-4934.2009.00789.x
   van Susante JLC, 1998, BIOMATERIALS, V19, P2367, DOI 10.1016/S0142-9612(98)00158-6
   Wang FY, 2009, J STRUCT BIOL, V168, P359, DOI 10.1016/j.jsb.2009.08.010
   Wise JK, 2009, TISSUE ENG PT A, V15, P913, DOI 10.1089/ten.tea.2008.0109
   Wu CT, 2011, ACTA BIOMATER, V7, P2644, DOI 10.1016/j.actbio.2011.03.009
   Yang Q, 2011, CHINESE MED J-PEKING, V124, P3930, DOI 10.3760/cma.j.issn.0366-6999.2011.23.018
   Zhang SF, 2013, ACTA BIOMATER, V9, P7236, DOI 10.1016/j.actbio.2013.04.003
   Zhang WJ, 2013, BIOMATERIALS, V34, P3184, DOI 10.1016/j.biomaterials.2013.01.008
   Zhou XZ, 2008, INT J ARTIF ORGANS, V31, P480
NR 137
TC 36
Z9 37
U1 8
U2 71
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD AUG
PY 2014
VL 20
IS 15-16
BP 2052
EP 2076
DI 10.1089/ten.tea.2013.0356
PG 25
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AN8HZ
UT WOS:000340846500003
PM 24476065
DA 2018-10-20
ER

PT J
AU Hanson, S
   D'Souza, RN
   Hematti, P
AF Hanson, Summer
   D'Souza, Rena N.
   Hematti, Peiman
TI Biomaterial-Mesenchymal Stem Cell Constructs for Immunomodulation in
   Composite Tissue Engineering
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID TOLL-LIKE RECEPTORS; SURFACE-CHEMISTRY; STROMAL CELLS; MACROPHAGE
   ACTIVATION; DIFFERENTIATION; THERAPY; SCAFFOLDS; RESPONSES;
   BIOCOMPATIBILITY; PHENOTYPE
AB Cell-based treatments are being developed as a novel approach for the treatment of many diseases in an effort to repair injured tissues and regenerate lost tissues. Interest in the potential use of multipotent progenitor or stem cells has grown significantly in recent years, specifically the use of mesenchymal stem cells (MSCs), for tissue engineering in combination with extracellular matrix-based scaffolds. An area that warrants further attention is the local or systemic host responses toward the implanted cell-biomaterial constructs. Such immunological responses could play a major role in determining the clinical efficacy of the therapeutic device or biomaterials used. MSCs, due to their unique immunomodulatory properties, hold great promise in tissue engineering as they not only directly participate in tissue repair and regeneration but also modulate the host foreign body response toward the engineered constructs. The purpose of this review was to summarize the current state of knowledge and applications of MSC-biomaterial constructs as a potential immunoregulatory tool in tissue engineering. Better understanding of the interactions between biomaterials and cells could translate to the development of clinically relevant and novel cell-based therapeutics for tissue reconstruction and regenerative medicine.
C1 [Hanson, Summer] Univ Texas MD Anderson Canc Ctr, Dept Plast Surg, Houston, TX 77030 USA.
   [D'Souza, Rena N.] Univ Utah, Sch Dent, Salt Lake City, UT USA.
   [Hematti, Peiman] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI USA.
RP Hanson, S (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Plast Surg, 1400 Pressler St,Unit 1488, Houston, TX 77030 USA.
EM sehanson@mdanderson.org
OI D'Souza, Rena/0000-0002-1505-5173
CR Altman AM, 2010, PLAST RECONSTR SURG, V126, P845, DOI 10.1097/PRS.0b013e3181e6044f
   Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890
   Baumann D.P., 2012, SEMIN PLAST SURG, V26
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Bueno EM, 2013, J CRANIOFAC SURG, V24, P256, DOI 10.1097/SCS.0b013e318275f173
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Clemens MW, 2013, PLAST RECONSTR SURG, V131, P71, DOI 10.1097/PRS.0b013e3182729e58
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   Dazzi F, 2007, CURR OPIN ONCOL, V19, P650, DOI 10.1097/CCO.0b013e3282f0e116
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Galler KM, 2012, TISSUE ENG PT A, V18, P176, DOI [10.1089/ten.tea.2011.0222, 10.1089/ten.TEA.2011.0222]
   Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959
   Hanson SE, 2011, TISSUE ENG PT A, V17, P2463, DOI [10.1089/ten.tea.2010.0716, 10.1089/ten.TEA.2010.0716]
   Hanson SE, 2013, AESTHET SURG J, V33, P888, DOI 10.1177/1090820X13496115
   Hanson SE, 2010, AESTHET SURG J, V30, P838, DOI 10.1177/1090820X10386364
   Hanson SE, 2010, PLAST RECONSTR SURG, V125, P510, DOI 10.1097/PRS.0b013e3181c722bb
   HEIMBACH D, 1988, ANN SURG, V208, P313, DOI 10.1097/00000658-198809000-00008
   Hematti P, 2012, BIOMATERIALS AND STEM CELLS IN REGENERATIVE MEDICINE, P405
   Hematti Peiman, 2008, Transplant Rev (Orlando), V22, P262, DOI 10.1016/j.trre.2008.05.002
   Hezi-Yamit A, 2009, J BIOMED MATER RES A, V90A, P133, DOI 10.1002/jbm.a.32057
   Hoogduijn MJ, 2007, STEM CELLS DEV, V16, P597, DOI 10.1089/scd.2006.0110
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   King SN, 2014, J BIOMED MATER RES A, V102, P890, DOI 10.1002/jbm.a.34746
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Lushaj EB, 2011, CYTOTHERAPY, V13, P400, DOI 10.3109/14653249.2010.529890
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   McBane JE, 2011, ACTA BIOMATER, V7, P115, DOI 10.1016/j.actbio.2010.08.014
   Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Prestwich GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004915
   Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Rudolf R, 2012, J VOICE, V26, P785, DOI 10.1016/j.jvoice.2011.11.007
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Stacey DH, 2009, TISSUE ENG PT A, V15, P3389, DOI [10.1089/ten.tea.2008.0293, 10.1089/ten.TEA.2008.0293]
   Sundaram H., 2013, PLAST RECONSTRUCT SU, V132
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Tibbitt MW, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004804
   Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563
   Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007
   Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088
   Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1
   Yoshikawa T, 2008, PLAST RECONSTR SURG, V121, P860, DOI 10.1097/01.prs.0000299922.96006.24
NR 56
TC 25
Z9 25
U1 1
U2 28
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD AUG
PY 2014
VL 20
IS 15-16
BP 2162
EP 2168
DI 10.1089/ten.tea.2013.0359
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AN8HZ
UT WOS:000340846500012
PM 25140989
DA 2018-10-20
ER

PT J
AU Florczak, A
   Mackiewicz, A
   Dams-Kozlowska, H
AF Florczak, Anna
   Mackiewicz, Andrzej
   Dams-Kozlowska, Hanna
TI Functionalized Spider Silk Spheres As Drug Carriers for Targeted Cancer
   Therapy
SO BIOMACROMOLECULES
LA English
DT Article
ID BREAST-CANCER; PROTEINS; DELIVERY; CELLS; NANOPARTICLES; MICROSPHERES;
   BIOMATERIALS; EXPRESSION; PEPTIDES; RECEPTOR
AB Bioengineered spider silk is a biomaterial that combines the properties of self-assembly, biocompatibility and biodegradability with reasonable accessibility and a simple purification procedure. Moreover, genetic engineering enables the functionalization of silk by adding the peptide coding sequences of the desired attribute. Hybrids composed of Her2 binding peptides (H2.1 or H2.2) and bioengineered silk MS1 (based on the MaSp1 sequence from N. clavipes) were designed. Bioengineered silks were expressed in a bacterial system and purified using a tag-free thermal method. The hybrid silks with N-terminal functionalization were bound more efficiently to cells that were overexpressing Her2 than those with the C-terminal fusion. Moreover, the functionalization did not impede the self-assembly property of bioengineered silk, enabling the processing of silk proteins into spheres. The binding domains were exposed on the surface of the spheres, because the functionalized particles specifically bound and internalized into Her2-overexpressing cells. The binding of the functionalized spheres to Her2-positive cells was significantly higher compared with the control sphere and Her2-negative cell binding. Silk spheres were loaded with doxorubicin and showed pH-dependent drug release. The silk spheres were not cytotoxic, unless they were loaded with the drug doxorubicin. This study indicates the ability of drug-loaded functionalized spider silk spheres to serve as a carrier for targeted cancer therapy.
C1 [Florczak, Anna; Mackiewicz, Andrzej; Dams-Kozlowska, Hanna] Poznan Univ Med Sci, Chair Med Biotechnol, PL-61866 Poznan, Poland.
   [Florczak, Anna] Adam Mickiewicz Univ, NanoBioMed Ctr, PL-61614 Poznan, Poland.
   [Mackiewicz, Andrzej] Greater Poland Canc Ctr, Dept Diagnost & Canc Immunol, PL-61866 Poznan, Poland.
   [Mackiewicz, Andrzej] BioContract, PL-61051 Poznan, Poland.
RP Dams-Kozlowska, H (reprint author), Poznan Univ Med Sci, Chair Med Biotechnol, PL-61866 Poznan, Poland.
EM hanna.dams-kozlowska@wco.pl
OI Florczak, Anna/0000-0001-5499-2824; Dams-Kozlowska,
   Hanna/0000-0003-2349-419X
FU Int Ph.D. Projects Programme of Foundation for Polish Sci within
   European Regional Development Fund
FX A.F. was supported by the International Ph.D. Projects Programme of
   Foundation for Polish Science operated within the Innovative Economy
   Operational Programme (IE OP) 2007-2013 within European Regional
   Development Fund.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656
   Dams-Kozlowska H, 2013, J BIOMED MATER RES A, V101, P456, DOI 10.1002/jbm.a.34353
   Gomes SC, 2011, BIOMATERIALS, V32, P4255, DOI 10.1016/j.biomaterials.2011.02.040
   Hedhammar M, 2010, BIOMACROMOLECULES, V11, P953, DOI 10.1021/bm9014039
   Hofer M., 2011, BIOMATERIALS, V33, P1554
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Lammel A., 2010, BIOMATERIALS, V32, P2233
   Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Maeda H, 2013, CANCER SCI, V104, P779, DOI 10.1111/cas.12152
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Numata K, 2012, MACROMOL BIOSCI, V12, P75, DOI 10.1002/mabi.201100274
   Numata K, 2011, BIOCONJUGATE CHEM, V22, P1605, DOI 10.1021/bc200170u
   Numata K, 2010, BIOMACROMOLECULES, V11, P3189, DOI 10.1021/bm101055m
   Patwardhan SV, 2006, P NATL ACAD SCI USA, V103, P9428
   Qi JN, 2010, INT J PHARMACEUT, V393, P176, DOI 10.1016/j.ijpharm.2010.03.063
   Rising A., 2010, CELL MOL LIFE SCI, V68, P169
   Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036
   Sanna V, 2014, INT J NANOMED, V9, P467, DOI 10.2147/IJN.S36654
   Sanson C, 2010, J CONTROL RELEASE, V147, P428, DOI 10.1016/j.jconrel.2010.07.123
   Seib FP, 2013, ADV HEALTHC MATER, V2, P1606, DOI 10.1002/adhm.201300034
   Shadidi Mohsen, 2003, FASEB Journal, V17, P256
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Subedi RK, 2009, EUR J PHARM SCI, V37, P508, DOI 10.1016/j.ejps.2009.04.008
   Tokareva O, 2014, ACTA BIOMATER, V10, P1612, DOI 10.1016/j.actbio.2013.08.020
   Tokareva O, 2013, MICROB BIOTECHNOL, V6, P651, DOI 10.1111/1751-7915.12081
   Urbanelli L, 2001, J MOL BIOL, V313, P965, DOI 10.1006/jmbi.2001.5111
   Wang XF, 2007, CANCER RES, V67, P3337, DOI 10.1158/0008-5472.CAN-06-2480
   Widhe M, 2013, BIOMATERIALS, V34, P8223, DOI 10.1016/j.biomaterials.2013.07.058
   Widhe M, 2012, BIOPOLYMERS, V97, P468, DOI 10.1002/bip.21715
   Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
   Yang XY, 2008, J PHYS CHEM C, V112, P17554, DOI 10.1021/jp806751k
NR 37
TC 31
Z9 31
U1 3
U2 44
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD AUG
PY 2014
VL 15
IS 8
BP 2971
EP 2981
DI 10.1021/bm500591p
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AN1MS
UT WOS:000340348600017
PM 24963985
DA 2018-10-20
ER

PT J
AU Lakes, AL
   Peyyala, R
   Ebersole, JL
   Puleo, DA
   Hilt, JZ
   Dziubla, TD
AF Lakes, Andrew L.
   Peyyala, Rebecca
   Ebersole, Jeffrey L.
   Puleo, David. A.
   Hilt, J. Zach
   Dziubla, Thomas D.
TI Synthesis and Characterization of an Antibacterial Hydrogel Containing
   Covalently Bound Vancomycin
SO BIOMACROMOLECULES
LA English
DT Article
ID CONTROLLED-RELEASE; SUSTAINED-RELEASE; LOCAL-DELIVERY; DRUG-RELEASE;
   BONE-CEMENT; PMMA BEADS; ANTIBIOTICS; OSTEOMYELITIS; INFECTION; KINETICS
AB The release of freely loaded small molecules from biomaterials often exhibits an initial burst, inhibiting the ability of these materials to match drug release with the biomaterial's degradation period. In terms of antibiotic release systems, the remaining vehicle may become a substrate for colonization by bacterial biofilms once the payload is depleted, which can become life threatening. Secondary surgeries are typically performed to remove these empty depots as a means of preventing this type of infection. To maintain the effectiveness of a locally delivered antibiotic without the drawback of a second surgery, we propose a hydrogel drug delivery system in which the drug release rate of vancomycin and degradation rate of the hydrogel are linked via covalent incorporation of vancomycin in the hydrogel backbone. This was achieved through coupling PEG based monomer with vancomycin to create poly(beta-amino ester) chemistry and verified through drug release and matrix degradation studies. Antibiotic release and material degradation were tunable via hydrophobic/hydrophilic content of the hydrogel matrix and extended up to 3 weeks in PBS sink conditions. Covalent addition of vancomycin to the hydrogel polymer backbone was verified through mass spectroscopy and HPLC peak addition, as well as radiotracing of collected HPLC fractions. Bioactivity of released vancomycin was also confirmed alongside the resulting antimicrobial activity of the reacted vancomycin releasate.
C1 [Lakes, Andrew L.; Hilt, J. Zach; Dziubla, Thomas D.] Univ Kentucky, Coll Engn, Dept Chem & Mat Engn, Lexington, KY 40506 USA.
   [Puleo, David. A.] Univ Kentucky, Coll Engn, Dept Biomed Engn, Lexington, KY 40506 USA.
   [Peyyala, Rebecca; Ebersole, Jeffrey L.] Univ Kentucky, Coll Dent, Ctr Oral Hlth Res, Lexington, KY 40506 USA.
RP Dziubla, TD (reprint author), Univ Kentucky, Coll Engn, Dept Chem & Mat Engn, Lexington, KY 40506 USA.
EM dziubla@engr.uky.edu
FU U.S. Army Medical Research Acquisition Activity [W81XWH-09-1-0461];
   IGERT/NSF [DGE-0653710]
FX This work was supported by a grant from the U.S. Army Medical Research
   Acquisition Activity (W81XWH-09-1-0461), as well as through IGERT/NSF
   (DGE-0653710). The contents herein do not necessarily represent the
   position or policy of the Government, and no official endorsement should
   be inferred. Special thanks to Mark C. Bailey and Haoyang Zhou for their
   aid and expertise in cell culture from the University of Kentucky.
CR Baral A, 2014, LANGMUIR, V30, P929, DOI 10.1021/la4043638
   Bastari K, 2014, J MATER SCI-MATER M, V25, P747, DOI 10.1007/s10856-013-5125-9
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   BISNO AL, 1995, INFECT CONT HOSP EP, V16, P648
   Brandl F, 2010, J CONTROL RELEASE, V142, P221, DOI 10.1016/j.jconrel.2009.10.030
   Brooks BD, 2014, J BIOMED MATER RES B, V102, P1074, DOI 10.1002/jbm.b.33089
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Chilukuri DM, 2005, PHARM RES, V22, P563, DOI 10.1007/s11095-005-2492-z
   Cui X, 2014, J MATER SCI-MATER M, V25, P733, DOI 10.1007/s10856-013-5122-z
   El-Husseiny M, 2011, J BONE JOINT SURG BR, V93B, P151, DOI 10.1302/0301-620X.93B2.24933
   Gao P, 2011, J ANTIBIOT, V64, P625, DOI 10.1038/ja.2011.58
   Gitelis Steven, 2002, J Orthop Surg (Hong Kong), V10, P53
   Gogia J. S., 2009, SEMIN PLAST SURG, V23
   Harth KC, 2010, J SURG RES, V163, P337, DOI 10.1016/j.jss.2010.03.065
   Hawkins AM, 2013, POLYMER, V54, P4422, DOI 10.1016/j.polymer.2013.06.010
   Hawkins AM, 2011, J APPL POLYM SCI, V122, P1420, DOI 10.1002/app.34093
   Hawkins AM, 2011, ACTA BIOMATER, V7, P1956, DOI 10.1016/j.actbio.2011.01.024
   Huang JG, 2013, MOL MED REP, V8, P1221, DOI 10.3892/mmr.2013.1624
   Justinger C, 2009, SURGERY, V146, P468
   Khodaverdi Elham, 2013, PDA J Pharm Sci Technol, V67, P135, DOI 10.5731/pdajpst.2013.00908
   Kluin OS, 2013, EXPERT OPIN DRUG DEL, V10, P341, DOI 10.1517/17425247.2013.751371
   Kuechle DK, 1991, CLIN ORTHOPAEDICS, V264, P302
   Lalidou Fani, 2014, Surg Technol Int, V24, P353
   Lawson MC, 2007, CLIN ORTHOP RELAT R, P96, DOI 10.1097/BLO.0b013e3180986706
   Lawson MC, 2009, BIOMACROMOLECULES, V10, P2221, DOI 10.1021/bm900410a
   Li B, 2010, J CONTROL RELEASE, V145, P221, DOI 10.1016/j.jconrel.2010.04.002
   Mohan YM, 2006, J APPL POLYM SCI, V101, P3202, DOI 10.1002/app.23277
   Mohanty S P, 2003, J Orthop Surg (Hong Kong), V11, P73
   Moojen DJF, 2008, J ARTHROPLASTY, V23, P1152, DOI 10.1016/j.arth.2007.08.020
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   NELSON CL, 1992, CLIN ORTHOP RELAT R, P303
   Overstreet DJ, 2013, J BIOMED MATER RES A, V101, P1437, DOI 10.1002/jbm.a.34443
   Robibaro B, 1998, J ANTIMICROB CHEMOTH, V41, P297, DOI 10.1093/jac/41.2.297
   Schnieders J, 2011, J BIOMED MATER RES B, V99B, P391, DOI 10.1002/jbm.b.31910
   Shinsako K, 2008, BIO-MED MATER ENG, V18, P377, DOI 10.3233/BME-2008-0554
   Shukla A, 2012, J CONTROL RELEASE, V157, P64, DOI 10.1016/j.jconrel.2011.09.062
   Thatiparti TR, 2010, BIOMATERIALS, V31, P2335, DOI 10.1016/j.biomaterials.2009.11.087
   Wattamwar PP, 2012, ACTA BIOMATER, V8, P2529, DOI 10.1016/j.actbio.2012.03.022
NR 38
TC 21
Z9 21
U1 4
U2 90
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD AUG
PY 2014
VL 15
IS 8
BP 3009
EP 3018
DI 10.1021/bm5006323
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AN1MS
UT WOS:000340348600021
PM 25000243
DA 2018-10-20
ER

PT J
AU Karabulut, A
   Akyer, SP
   Mete, GA
   Sahin, B
AF Karabulut, Aysun
   Akyer, Sahika Pinar
   Mete, Gulcin Abban
   Sahin, Barbaros
TI Effects of menopause, diabetes mellitus and steroid use on type I
   mesh-induced tissue reaction in a rat model
SO EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
LA English
DT Article
DE Urogynecology; Mesh reaction; Inflammation; Menopause; Diabetes mellitus
ID FOREIGN-BODY REACTION; PELVIC-SURGERY; ABDOMINAL-WALL; BIOMATERIAL;
   GRAFTS
AB Objective: To evaluate the effects of menopause, use of steroids, diabetes mellitus, and site of implantation on the tissue response to type I polypropylene mesh used in pelvic reconstructive surgery.
   Study design: Forty mature female albino rats were used in the study. Inflammatory reaction and meshtissue detachment strength were studied in 4 different animal models; control (GI), menopause (GII), steroid +.menopause (GIII), and diabetes mellitus + menopause (GIV) groups. Two pieces of 1 cm x 1 cm type I macro porous polypropylene monofilament mesh were fixed over rectus abdominis muscle on both sides of the midline, and 0.5 cm x 0.5 cm in size was placed into paravaginal area. Nine weeks later, implanted sling materials in the vaginal region and the right abdominal side were harvested with surrounding tissue for histopathologic examination, whereas the left sided meshes were used for the mechanical testing of detachment strength.
   Results: The mean detachment strengths in groups were, 595 +/- 274 g for GI, 410 +/- 161 g for GII 610 +/- 202 g for Gill, and 457 +/- 250 g for GIV (p > 0.008). Inflammatory process was more intense in menopause and DM + menopause groups for both abdominal and vaginal tissues (p < 0.008). There was no difference between control and steroid + menopause groups, and DM + menopause and menopause groups (p > 0.008). Comparison of tissue reaction caused by meshes in abdominal and vaginal area showed more intense granulocyte infiltration in abdominal region whereas more prominent inflammation and necrosis in the vaginal site (p < 0.05).
   Conclusion: The abdominal and vaginal region show differences in tissue reaction to type I mesh, and menopause was the most determining factor on the intensity of mesh induced inflammatory response. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Karabulut, Aysun] Pamukkale Univ, Sch Med, Dept Obstet & Gynecol, Denizli, Turkey.
   [Akyer, Sahika Pinar] Pamukkale Univ, Sch Med, Dept Anat, Denizli, Turkey.
   [Mete, Gulcin Abban] Pamukkale Univ, Sch Med, Dept Histol & Embryol, Denizli, Turkey.
   [Sahin, Barbaros] Pamukkale Univ, Sch Med, Anim Expt Lab, Denizli, Turkey.
RP Karabulut, A (reprint author), Onelya Merl,A-4 Yenisehir, TR-20125 Denizli, Turkey.
EM aysunkarabulut@yahoo.com
CR Al-Baghdadi O, 2009, CLIMACTERIC, V12, P91, DOI 10.1080/13697130802585576
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bazi TM, 2007, EUR UROL, V51, P1364, DOI 10.1016/j.eururo.2006.10.002
   Brandt CJ, 2011, J BIOMED MATER RES A, V99A, P335, DOI 10.1002/jbm.a.33136
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Chen CCG, 2007, CLIN OBSTET GYNECOL, V50, P383, DOI 10.1097/GRF.0b013e31804b184c
   DABROWIECKI S, 1991, EUR SURG RES, V23, P240, DOI 10.1159/000129159
   Dwyer PL, 2006, INT UROGYNECOL J, V17, pS10, DOI 10.1007/s00192-006-0103-0
   Higgins EW, 2009, AM J OBSTET GYNECOL, V201, P505
   HUNT JA, 1994, ANAL CELL PATHOL, V7, P43
   Jakus SM, 2008, OBSTET GYNECOL SURV, V63, P253, DOI 10.1097/OGX.0b013e318166fb44
   Kaelin-Gambirasio Isabelle, 2009, BMC Womens Health, V9, P28, DOI 10.1186/1472-6874-9-28
   Klinge U, 1999, EUR J SURG, V165, P665
   Krause HG, 2006, AUST NZ J OBSTET GYN, V46, P42, DOI 10.1111/j.1479-828X.2006.00513.x
   Kuhn A, 2009, EUR UROL, V56, P371, DOI 10.1016/j.eururo.2008.07.001
   Pierce LM, 2009, AM J OBSTET GYNECOL, V200, P546, DOI DOI 10.1016/J.AJ0G.2008.12.040
   Yildirim A, 2005, J UROLOGY, V174, P2037, DOI 10.1097/01.ju.0000176478.17749.07
NR 17
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-2115
EI 1872-7654
J9 EUR J OBSTET GYN R B
JI Eur. J. Obstet. Gynecol. Reprod. Biol.
PD AUG
PY 2014
VL 179
BP 27
EP 31
DI 10.1016/j.ejogrb.2014.03.024
PG 5
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AN1BR
UT WOS:000340318200006
PM 24965975
DA 2018-10-20
ER

PT J
AU Sudwilai, T
   Ng, JJ
   Boonkrai, C
   Israsena, N
   Chuangchote, S
   Supaphol, P
AF Sudwilai, Thitima
   Ng, Jun Jye
   Boonkrai, Chatikorn
   Israsena, Nipan
   Chuangchote, Surawut
   Supaphol, Pitt
TI Polypyrrole-coated electrospun poly(lactic acid) fibrous scaffold:
   effects of coating on electrical conductivity and neural cell growth
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polypyrole; poly(lactic acid); electrospinning; scaffold; nerve cell
ID ADMICELLAR POLYMERIZATION; NANOFIBER MEMBRANES; FIBERS; FABRICATION;
   POLYMERS
AB Neuronal activities play critical roles in both neurogenesis and neural regeneration. In that sense, electrically conductive and biocompatible biomaterial scaffolds can be applied in various applications of neural tissue engineering. In this study, we fabricated a novel biomaterial for neural tissue engineering applications by coating electrospun poly(lactic acid) (PLA) nanofibers with a conducting polymer, polypyrole (PPy), via admicellar polymerization. Optimal conditions for polymerization and preparation of PPy-coated electrospun PLA nanofibers were obtained by comparing results from scanning electron microscopy, X-ray photoelectron spectrometer, and surface conductivity tests. In vitro cell culture experiments showed that PPy-coated electrospun PLA fibrous scaffold is not toxic. The scaffold could support attachment and migration of neural progenitor cells. Neurons derived from progenitor exhibited long neurite outgrowth under electrical stimulation. Our study concluded that PPy-coated electrospun PLA fibers had a good biocompatibility with neural progenitor cells and may serve as a promising material for controlling progenitor cell behaviors and enhancing neural repair.
C1 [Sudwilai, Thitima; Ng, Jun Jye; Supaphol, Pitt] Ctr Excellence Petrochem & Mat Technol PETROMAT, Bangkok 10330, Thailand.
   [Boonkrai, Chatikorn; Israsena, Nipan] Chulalongkorn Univ, Stem Cell & Cell Therapy Res Unit, Fac Med, Bangkok 10330, Thailand.
   [Israsena, Nipan] Chulalongkorn Univ, Dept Pharmacol, Fac Med, Bangkok 10330, Thailand.
   [Chuangchote, Surawut] King Mongkuts Univ Technol Thonburi, Joint Grad Sch Energy & Environm, Bangkok 10140, Thailand.
   [Supaphol, Pitt] Ctr Petr Petrochem & Adv Mat, Bangkok 10330, Thailand.
RP Supaphol, P (reprint author), Ctr Excellence Petrochem & Mat Technol PETROMAT, Soi Chula 12,Phyathai Rd, Bangkok 10330, Thailand.
EM pitt.s@chula.ac.th
OI Chuangchote, Surawut/0000-0002-2145-4015
FU National Nanotechnology Center (NANOTEC) [RES_54_198_63_006]; Thailand
   Research Fund (TRF) [DBG5280015]
FX This work was supported by the National Nanotechnology Center (NANOTEC)
   research fund [RES_54_198_63_006] and the Thailand Research Fund (TRF)
   [grant number DBG5280015].
CR Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Boontharika C, 2009, POLYM INT, V59, P227
   Boschi A, 2008, FIBER POLYM, V9, P698, DOI 10.1007/s12221-008-0110-5
   Chuangchote S, 2006, J NANOSCI NANOTECHNO, V6, P125, DOI 10.1166/jnn.2006.043
   Chuangchote S, 2008, JPN J APPL PHYS, V47, P787, DOI 10.1143/JJAP.47.787
   Fine EG, 2000, PRINCIPLES TISSUE EN, P785, DOI DOI 10.1016/B978-012436630-5/50060-X
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511
   Huang YC, 2006, BIOMED ENG-APP BAS C, V18, P100, DOI 10.4015/S101623720600018X
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kim GH, 2008, APPL PHYS A-MATER, V90, P389, DOI 10.1007/s00339-007-4330-0
   Kincal D, 1998, SYNTHETIC MET, V92, P53, DOI 10.1016/S0379-6779(98)80022-2
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Li DP, 2006, J MEMBRANE SCI, V279, P354, DOI 10.1016/j.memsci.2005.12.036
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Mou CY, 2008, THIN SOLID FILMS, V516, P8752, DOI 10.1016/j.tsf.2008.06.094
   Peesan M, 2006, J BIOMAT SCI-POLYM E, V17, P547, DOI 10.1163/156856206776986251
   Piyachat C, 2009, MACROMOL CHEM PHYS, V210, P814
   Xu XY, 2006, EUR POLYM J, V42, P2081, DOI 10.1016/j.eurpolymj.2006.03.032
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yuan WL, 2002, LANGMUIR, V18, P3343, DOI 10.1021/la011349i
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 22
TC 23
Z9 25
U1 5
U2 147
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD AUG
PY 2014
VL 25
IS 12
BP 1240
EP 1252
DI 10.1080/09205063.2014.926578
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AN1UV
UT WOS:000340370200003
PM 24933469
DA 2018-10-20
ER

PT J
AU Rata, DM
   Popa, M
   Chailan, JF
   Zamfir, CL
   Peptu, CA
AF Rata, Delia Mihaela
   Popa, Marcel
   Chailan, Jean-Francois
   Zamfir, Carmen Lacramioara
   Peptu, Catalina Anisoara
TI Biomaterial properties evaluation of poly(vinyl acetate-alt-maleic
   anhydride)/chitosan nanocapsules
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Nanocapsules; Interfacial condensation; Controlled release;
   Haemocompatibility; Biocompatibility
ID VINYL ACETATE); ANHYDRIDE; NORFLOXACIN; PARTICLES; DELIVERY
AB Nanocapsules with diameter around 100 nm based on a natural polymer (chitosan) and a synthetic polymer poly(vinyl acetate-alt-maleic anhydride) [poly(MAVA)] by interfacial condensation method were prepared. The present study proposes a new type of biocompatible nanocapsules based on poly(vinyl acetate-alt-maleic anhydride-chitosan) (MCS) able to become a reliable support for inclusion and release of drugs. The spherical shape of the nanocapsules was evidenced by scanning electron microscopy. Nanocapsules presented a good Norfloxacin loading and release capacity. Haemocompatibility tests have demonstrated that the nanocapsules present a low toxicity and a good compatibility with sanguine medium. The biocompatibility properties of the nanocapsules after their intraperitoneal administration in rats were evidenced by histopathological examination of different organs (brain, liver, kidney, and lung). The results are encouraging and the nanocapsules can be used as controlled drug delivery systems.
C1 [Rata, Delia Mihaela; Popa, Marcel; Peptu, Catalina Anisoara] Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Dept Nat & Synthet Polymers, Iasi 700050, Romania.
   [Rata, Delia Mihaela] Apollonia Univ Iasi, Fac Med Dent, Iasi 700511, Romania.
   [Chailan, Jean-Francois] Univ Sud Toulon Var, Mat Polymeres Interfaces Environm Marin MAPIEM La, F-83957 La Garde, France.
   [Zamfir, Carmen Lacramioara] Grigore T Popa Univ Med & Pharm, Fac Med, Dept Morpho Funct Sci, Iasi 700115, Romania.
RP Peptu, CA (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Dept Nat & Synthet Polymers, Prof Dr Docent Dimitrie Mangeron Ave 73, Iasi 700050, Romania.
EM iureadeliamihaela@yahoo.com; marpopa2001@yahoo.fr; chailan@univ-tln.fr;
   zamfircia@yahoo.com; catipeptu@yahoo.co.uk
RI Peptu, Catalina/C-4813-2012
OI Peptu, Catalina Anisoara/0000-0002-1682-0682; Chailan, Jean
   Francois/0000-0003-0249-7965
CR Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008
   Anitha A, 2011, CARBOHYD POLYM, V83, P66, DOI 10.1016/j.carbpol.2010.07.028
   Balan V, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0730-y
   Barbas R, 2007, J THERM ANAL CALORIM, V89, P687, DOI 10.1007/s10973-006-7956-9
   Chitanu GC, 2006, REV ROUM CHIM, V51, P923
   Ciofani G, 2008, BIOMED MICRODEVICES, V10, P131, DOI 10.1007/s10544-007-9118-7
   Dhaneshwar S, 2011, CHEM PHYS LIPIDS, V164, P307, DOI 10.1016/j.chemphyslip.2011.03.006
   Dhumal SS, 2008, J MEMBRANE SCI, V325, P758, DOI 10.1016/j.memsci.2008.09.002
   Fu GD, 2011, PROG POLYM SCI, V36, P127, DOI 10.1016/j.progpolymsci.2010.07.011
   Irache JM, 2011, VET PARASITOL, V180, P47, DOI 10.1016/j.vetpar.2011.05.028
   Irfan M, 2010, IND ENG CHEM RES, V49, P1169, DOI 10.1021/ie900216r
   Iurea DM, 2013, J BIOACT COMPAT POL, V28, P368, DOI 10.1177/0883911513490336
   Jatariu AN, 2012, INT J PHARMACEUT, V436, P66, DOI 10.1016/j.ijpharm.2012.06.029
   Loh JW, 2010, TOXICOL APPL PHARM, V249, P148, DOI 10.1016/j.taap.2010.08.029
   Popa M, 2007, J BIOACT COMPAT POL, V22, P651, DOI 10.1177/0883911507084424
   Prego C, 2006, J CONTROL RELEASE, V111, P299, DOI 10.1016/j.jconrel.2005.12.015
   Rieger J, 2005, NANOTECHNOLOGIES LIF, V8, P342
   Singh MN, 2010, RES PHARM SCI, V5, P65
   Spridon D, 1997, POLYM INT, V43, P175, DOI 10.1002/(SICI)1097-0126(199706)43:2<175::AID-PI734>3.0.CO;2-I
   Sunel V, 2005, REACT FUNCT POLYM, V65, P367, DOI 10.1016/j.reactfunctpolym.2005.07.019
   Tripathi S, 2009, INT J BIOL MACROMOL, V45, P372, DOI 10.1016/j.ijbiomac.2009.07.006
   Watanabe J, 2005, COLLOID SURFACE B, V42, P141, DOI 10.1016/j.colsurfb.2005.02.005
   Zhu SF, 2009, SURF COAT TECH, V203, P1523, DOI 10.1016/j.surfcoat.2008.11.033
NR 23
TC 2
Z9 2
U1 1
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD AUG 1
PY 2014
VL 16
IS 8
AR 2569
DI 10.1007/s11051-014-2569-x
PG 10
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AN3QK
UT WOS:000340503000001
DA 2018-10-20
ER

PT J
AU Lee, H
   Noh, K
   Lee, SC
   Kwon, IK
   Han, DW
   Lee, IS
   Hwang, YS
AF Lee, Hanna
   Noh, Kwantae
   Lee, Sang Cheon
   Kwon, Il-Keun
   Han, Dong-Wook
   Lee, In-Seop
   Hwang, Yu-Shik
TI Human Hair Keratin and Its-Based Biomaterials for Biomedical
   Applications
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Review
DE Human hair; Keratin; Biomaterial; Tissue engineering; Biomedical
   Application
ID DYSTROPHIC EPIDERMOLYSIS-BULLOSA; PERIPHERAL-NERVE REPAIR;
   INTERMEDIATE-FILAMENTS; HYDROGELS SUPPORT; COLLAGEN; WOOL; EXPRESSION;
   PROTEINS; INJURY; MODEL
AB Over the past few decades, naturally derived biomaterials have been extensively used in tissue engineering and regenerative medicine owing to their biological function, structural support, excellent biocompatibility, and favorable biodegradability characteristics. Traditionally, keratin has been extracted from wool, feathers, horns, and other animal sources for industrial use, and it has also been used as a biomaterial to develop scaffolds, hydrogels, and other forms for biomedical applications. Recently, keratin extracted from human hair has emerged as a fascinating biomaterial, which as a human-derived protein, exhibits excellent biocompatibility, no immune reaction upon transplantation, good cellular interaction activity, and biodegradability. Recent development of well-defined and proficient processes for human hair keratin extraction has led to the fabrication of various types of keratin-based biomaterials, which have been employed in successful approaches for tissue regeneration. The use of human hair keratin-based biomaterials for translational biomedical applications requires better understanding of the molecular properties and biological function of keratin. This review provides a critical summary of molecular characteristics, cellular interactions, various extraction strategies, and recent advances in biomedical applications of human hair keratin that could be used to improve tissue regeneration for regenerative medicine.
C1 [Lee, Hanna; Lee, Sang Cheon; Kwon, Il-Keun; Hwang, Yu-Shik] Kyung Hee Univ, Sch Dent, Dept Maxillofacial Biomed Engn, Seoul 130701, South Korea.
   [Lee, Hanna; Lee, Sang Cheon; Kwon, Il-Keun; Hwang, Yu-Shik] Kyung Hee Univ, Sch Dent, Inst Oral Biol, Seoul 130701, South Korea.
   [Lee, Hanna] Korea Univ, Dept Food Biochem & Engn, Seoul 136713, South Korea.
   [Noh, Kwantae] Kyung Hee Univ, Sch Dent, Dept Prosthodont, Seoul 130701, South Korea.
   [Han, Dong-Wook] Pusan Natl Univ, Dept Cognomechatron Engn, Pusan 609735, South Korea.
   [Lee, In-Seop] Yonsei Univ, Inst Nat Sci, Seoul 120749, South Korea.
   [Lee, In-Seop] Yonsei Univ, Ato Scale Surface Sci Res Ctr, Seoul 120749, South Korea.
RP Lee, IS (reprint author), Yonsei Univ, Inst Nat Sci, Seoul 120749, South Korea.
EM inseop@yonsei.ac.kr; yshwang@khu.ac.kr
OI Han, Dong-Wook/0000-0001-8314-1981
FU Basic Research Program through the National Research Foundation of Korea
   (NRF) - Korea government (MEST) Republic of Korea [NRF-2013R1A1A2009706,
   2012R1A2A2A02010181, 2012R1A5A2051387]; Korea Health Industry
   Development Institute, Republic of Korea [A100208]
FX This research was supported by grants NRF-2013R1A1A2009706,
   2012R1A2A2A02010181 and 2012R1A5A2051387 from the Basic Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Korea government (MEST) Republic of Korea and by grant A100208 from
   Korea Health Industry Development Institute, Republic of Korea.
CR Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793
   Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034
   BADEN HP, 1973, BIOCHIM BIOPHYS ACTA, V322, P269, DOI 10.1016/0005-2795(73)90303-6
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Bernot KM, 2002, J INVEST DERMATOL, V119, P1137, DOI 10.1046/j.1523-1747.2002.19518.x
   BLACKBURN S, 1951, BIOCHEM J, V49, P554, DOI 10.1042/bj0490554
   Block RJ, 1939, J BIOL CHEM, V128, P181
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   Burnett LR, 2013, BIOMATERIALS, V34, P2632, DOI 10.1016/j.biomaterials.2012.12.022
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   DHOUAILLY D, 1989, EXP CELL RES, V181, P141, DOI 10.1016/0014-4827(89)90189-4
   Dias GJ, 2010, J BIOMED MATER RES A, V92A, P513, DOI 10.1002/jbm.a.32394
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   EARLAND C, 1955, BIOCHIM BIOPHYS ACTA, V17, P457, DOI 10.1016/0006-3002(55)90406-6
   FRASER RDB, 1986, P NATL ACAD SCI USA, V83, P1179, DOI 10.1073/pnas.83.5.1179
   GEISLER N, 1985, J MOL BIOL, V182, P173, DOI 10.1016/0022-2836(85)90035-X
   GILLESPIE J. M., 1960, AUSTRALIAN JOUR BIOL SCI, V13, P81
   Goddard DR, 1934, J BIOL CHEM, V106, P605
   Gupta A, 2012, J CHEM CHEM ENG, P732
   HEID HW, 1988, DIFFERENTIATION, V37, P137, DOI 10.1111/j.1432-0436.1988.tb00805.x
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Hill PS, 2011, TISSUE ENG PT A, V17, P1499, DOI 10.1089/ten.tea.2010.0184
   Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202
   Jin J, 2013, TISSUE ENG PT A, V19, P2138, DOI [10.1089/ten.TEA.2012.0575, 10.1089/ten.tea.2012.0575]
   Jones Chase B., 1943, ARCH BIOCHEM, V3, P193
   Karthikeyan R, 2007, J SCI IND RES INDIA, V66, P710
   KHAWAR SL, 1995, ELECTROPHORESIS, V16, P110, DOI 10.1002/elps.1150160120
   Kirsner RS, 2012, ADV SKIN WOUND CARE, V25, P400, DOI 10.1097/01.ASW.0000419404.44947.de
   Kirubanandan S, 2012, INT J PHARM CHEM SCI, V1, P1447
   Lin YC, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024102
   Lin YC, 2012, PLAST RECONSTR SURG, V129, P67, DOI 10.1097/PRS.0b013e3182268ae0
   LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593
   MAKAREM R, 1991, Biochemical Society Transactions, V19, p380S
   MAKAREM R, 1994, J BIOL CHEM, V269, P4005
   Masukawa Y., 2005, INT J COSMETIC SCI, V27, P191
   Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6
   Nakamura A, 2002, BIOL PHARM BULL, V25, P569, DOI 10.1248/bpb.25.569
   Narins RS, 2008, DERMATOL SURG, V34, pS31, DOI 10.1111/j.1524-4725.2008.34240.x
   O'donnell I, 2013, AUST J BIOL SCI, V17, P973
   Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381
   Park GT, 2002, NUCLEIC ACIDS RES, V30, P515, DOI 10.1093/nar/30.2.515
   Pechter PM, 2012, WOUND REPAIR REGEN, V20, P236, DOI 10.1111/j.1524-475X.2012.00768.x
   Poole AJ, 2011, J POLYM ENVIRON, V19, P995, DOI 10.1007/s10924-011-0365-6
   Reichl S, 2011, EUR J PHARM BIOPHARM, V78, P432
   Reichl S, 2011, BIOMATERIALS, V32, P3375, DOI 10.1016/j.biomaterials.2011.01.052
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Richter JR, 2011, BIOMATERIALS, V32, P7555, DOI 10.1016/j.biomaterials.2011.06.061
   Robbins C. R., 2012, CHEM PHYS BEHAV HUMA
   Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X
   Saul JM, 2011, J BIOMED MATER RES A, V98A, P544, DOI 10.1002/jbm.a.33147
   SIEGLE RJ, 1984, ARCH DERMATOL, V120, P183, DOI 10.1001/archderm.120.2.183
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Srinivasan B, 2010, J BIOMED MATER RES B, V92B, P5, DOI 10.1002/jbm.b.31483
   Stmad P, 2011, J CELL SCI, V124, P4221
   Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Than MP, 2013, J DERMATOL TREAT, V24, P290, DOI 10.3109/09546634.2011.654108
   Than Martin P, 2012, J Clin Aesthet Dermatol, V5, P31
   THOMPSON EO, 1965, AUST J BIOL SCI, V18, P1207, DOI 10.1071/BI9651207
   Toivola DM, 2000, AM J PHYSIOL-GASTR L, V279, pG1343
   Toivola DM, 2000, EXP CELL RES, V255, P156, DOI 10.1006/excr.1999.4787
   Torchinsky YM, 1981, SULFUR PROTEINS, V1
   VANDYKE ME, 2001, Patent No. 6270791
   Wang S, 2012, CELL TISSUE RES, V347, P795, DOI 10.1007/s00441-011-1295-2
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Xing ZC, 2011, INT C NAN BIOS IPCBE, V2, P120
   Yamauchi C, 2008, BIOL PHARM BULL, V31, P994, DOI 10.1248/bpb.31.994
   YU JL, 1993, J INVEST DERMATOL, V101, pS56, DOI 10.1111/1523-1747.ep12362635
   Yuan J, 2009, MACROMOL RES, V17, P850, DOI 10.1007/BF03218625
NR 71
TC 25
Z9 26
U1 3
U2 84
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD AUG
PY 2014
VL 11
IS 4
BP 255
EP 265
DI 10.1007/s13770-014-0029-4
PG 11
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA AN1MA
UT WOS:000340346800001
DA 2018-10-20
ER

PT J
AU Yan, XZ
   van den Beucken, JJJP
   Both, SK
   Yang, PS
   Jansen, JA
   Yang, F
AF Yan, Xiang-Zhen
   van den Beucken, Jeroen J. J. P.
   Both, Sanne K.
   Yang, Pi-Shan
   Jansen, John A.
   Yang, Fang
TI Biomaterial Strategies for Stem Cell Maintenance During In Vitro
   Expansion
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID TERM SELF-RENEWAL; CHEMICALLY-DEFINED CONDITIONS; MESENCHYMAL STROMAL
   CELLS; UMBILICAL-CORD BLOOD; EX-VIVO EXPANSION; HEMATOPOIETIC STEM;
   EXTRACELLULAR-MATRIX; SPHEROID FORMATION; CULTURE-SYSTEM; CLINICAL-TRIAL
AB Stem cells, having the potential for self-renewal and multilineage differentiation, are the building blocks for tissue/organ regeneration. Stem cells can be isolated from various sources but are, in general, available in too small numbers to be used directly for clinical purpose without intermediate expansion procedures in vitro. Although this in vitro expansion of undifferentiated stem cells is necessary, stem cells typically diminish their ability to self-renew and proliferate during passaging. Consequently, maintaining the stemness of stem cells has been recognized as a major challenge in stem cell-based research. This review focuses on the latest developments in maintaining the self-renewal ability of stem cells during in vitro expansion by biomaterial strategies. Further, this review highlights what should be the focus for future studies using stem cells for regenerative applications.
C1 [Yan, Xiang-Zhen; van den Beucken, Jeroen J. J. P.; Both, Sanne K.; Jansen, John A.; Yang, Fang] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   [Yan, Xiang-Zhen; Yang, Pi-Shan] Shandong Univ, Dept Stomatol, Jinan 250100, Peoples R China.
RP Yang, F (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM f.yang@dent.umcn.nl
RI van den beucken, jeroen/N-2910-2013; Jansen, John/H-8055-2014; Yang,
   Fang/E-1937-2011
OI van den beucken, jeroen/0000-0002-0301-1966; Yang,
   Fang/0000-0002-4022-7643
FU China Scholarship Council [2010622061]
FX Xiang-Zhen Yan acknowledges the China Scholarship Council for financial
   support rendered (No. 2010622061).
CR AARONSON SA, 1991, SCIENCE, V254, P1146, DOI 10.1126/science.1659742
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Baraniak PR, 2012, CELL TISSUE RES, V347, P701, DOI 10.1007/s00441-011-1215-5
   Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107
   Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284
   Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14
   Both SK, 2007, TISSUE ENG, V13, P3, DOI 10.1089/ten.2005.0513
   Bouuaert CC, 2010, GENETICA, V138, P473, DOI 10.1007/s10709-009-9391-x
   Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291
   Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001
   Celebi B, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055011
   Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1
   Chang KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018738
   Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
   Chen LY, 2012, ACTA BIOMATER, V8, P1749, DOI 10.1016/j.actbio.2012.01.002
   Chen T, 2012, NATURE, V485, P104, DOI 10.1038/nature10940
   Chen WW, 2012, STEM CELLS, V30, P2612, DOI 10.1002/stem.1240
   Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049
   Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655
   CIPOLLESCHI MG, 1993, BLOOD, V82, P2031
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Domogatskaya A, 2008, STEM CELLS, V26, P2800, DOI 10.1634/stemcells.2007-0389
   DUCH M, 1994, J VIROL, V68, P5596
   Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le
   Elliott NT, 2011, J PHARM SCI-US, V100, P59, DOI 10.1002/jps.22257
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eshghi S., 2008, STEMBOOK
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Faustman DL, 2010, INT J BIOCHEM CELL B, V42, P1576, DOI 10.1016/j.biocel.2010.06.012
   Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321
   Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003
   FLOTTE TR, 1994, AM J RESP CELL MOL, V11, P517, DOI 10.1165/ajrcmb.11.5.7946381
   Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI [10.1089/ten.tec.2009.0432, 10.1089/ten.TEC.2009.0432]
   Fu RH, 2011, CELL TRANSPLANT, V20, P37, DOI 10.3727/096368910X532756
   Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014
   Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gilbert PM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt44
   Goncalves R, 2006, EXP HEMATOL, V34, P1353, DOI 10.1016/j.exphem.2006.05.024
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hashemi SM, 2011, BIOMATERIALS, V32, P7363, DOI 10.1016/j.biomaterials.2011.06.048
   He F, 2009, TISSUE ENG PT A, V15, P3809, DOI [10.1089/ten.tea.2009.0188, 10.1089/ten.TEA.2009.0188]
   He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248
   Hsu SH, 2012, BIOMATERIALS, V33, P2642, DOI 10.1016/j.biomaterials.2011.12.032
   Huang GS, 2011, BIOMATERIALS, V32, P6929, DOI 10.1016/j.biomaterials.2011.05.092
   Huch M, 2013, REGEN MED, V8, P385, DOI 10.2217/rme.13.39
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   Irwin EE, 2011, BIOMATERIALS, V32, P6912, DOI 10.1016/j.biomaterials.2011.05.058
   Jiang XS, 2006, BIOMATERIALS, V27, P2723, DOI 10.1016/j.biomaterials.2005.12.001
   Jones MB, 2010, STEM CELLS DEV, V19, P1923, DOI 10.1089/scd.2009.0326
   Kabiri M, 2012, BIOCHEM BIOPH RES CO, V419, P142, DOI 10.1016/j.bbrc.2012.01.017
   Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105
   Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011
   Kim HT, 2013, BIOMATERIALS, V34, P1041, DOI 10.1016/j.biomaterials.2012.10.064
   Kim M, 2011, DERMATOL SURG, V37, P750, DOI 10.1111/j.1524-4725.2011.01765.x
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532
   Knight B, 2000, CURR BIOL, V10, P576, DOI 10.1016/S0960-9822(00)00486-3
   Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108
   Kolli S, 2010, STEM CELLS, V28, P597, DOI 10.1002/stem.276
   Koudstaal S, 2013, STEM CELL TRANSL MED, V2, P434, DOI 10.5966/sctm.2013-0001
   Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60
   Kruyt MC, 2004, TRANSPLANTATION, V77, P359, DOI 10.1097/01.TP.0000102550.58160.39
   Lee WY, 2009, BIOMATERIALS, V30, P5505, DOI 10.1016/j.biomaterials.2009.07.006
   Li XY, 2007, CELL TISSUE RES, V327, P607, DOI 10.1007/s00441-006-0354-6
   Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732
   Lim HL, 2011, ADV FUNCT MATER, V21, P55, DOI 10.1002/adfm.201001519
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lin H, 2012, BIOMATERIALS, V33, P4480, DOI 10.1016/j.biomaterials.2012.03.012
   Lin SJ, 2005, BIOMATERIALS, V26, P1413, DOI 10.1016/j.biomaterials.2004.05.002
   Lo Surdo J, 2012, TISSUE ENG PART C-ME, V18, P877, DOI [10.1089/ten.tec.2011.0736, 10.1089/ten.TEC.2011.0736]
   Loeser RF, 2002, BIORHEOLOGY, V39, P119
   Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617
   Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177
   Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013
   Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Markert LD, 2009, STEM CELLS DEV, V18, P1331, DOI 10.1089/scd.2009.0114
   Masthan KMK, 2013, J CLIN DIAGN RES, V7, P945, DOI 10.7860/JCDR/2013/5379.2984
   McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3
   Miyagawa Y, 2011, TISSUE ENG PT A, V17, P513, DOI 10.1089/ten.TEA.2009.0810
   Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111
   Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007
   Moroni L, 2008, J BIOMAT SCI-POLYM E, V19, P543, DOI 10.1163/156856208784089571
   Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001
   Ng AP, 2011, BLOOD, V118, P2454, DOI 10.1182/blood-2011-03-344739
   Nur E. K. A., 2006, STEM CELLS, V24, P426, DOI DOI 10.1634/STEMCELLS.2005-0170)
   Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269
   Papanikolaou E, 2010, CURR GENE THER, V10, P404, DOI 10.2174/156652310793180724
   Park Y, 2011, STEM CELLS DEV, V20, P1901, DOI 10.1089/scd.2010.0496
   Pei M, 2011, TISSUE ENG PT A, V17, P3067, DOI [10.1089/ten.TEA.2011.0158, 10.1089/ten.tea.2011.0158]
   Petersson Monika, 2013, Methods Mol Biol, V989, P45, DOI 10.1007/978-1-62703-330-5_5
   POTTEN CS, 1990, DEVELOPMENT, V110, P1001
   Pricola KL, 2009, J CELL BIOCHEM, V108, P577, DOI 10.1002/jcb.22289
   Prowse ABJ, 2010, BIOMATERIALS, V31, P8281, DOI 10.1016/j.biomaterials.2010.07.037
   Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013
   Ravari H, 2011, CYTOTHERAPY, V13, P705, DOI 10.3109/14653249.2011.553594
   Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Rickert D, 2011, CLIN ORAL IMPLAN RES, V22, P251, DOI 10.1111/j.1600-0501.2010.01981.x
   Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620
   ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378
   Safwani WKZW, 2011, BIOTECHNOL APPL BIOC, V58, P261, DOI 10.1002/bab.38
   Sagar BMM, 2006, BIOCHEM BIOPH RES CO, V350, P1000, DOI 10.1016/j.bbrc.2006.09.140
   Saha K, 2011, P NATL ACAD SCI USA, V108, P18714, DOI 10.1073/pnas.1114854108
   Saha S, 2006, J CELL PHYSIOL, V206, P126, DOI 10.1002/jcp.20441
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2
   Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9
   Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587
   Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592
   Siti-Ismail N, 2008, BIOMATERIALS, V29, P3946, DOI 10.1016/j.biomaterials.2008.04.027
   Soma Tsutomu, 2013, Methods Mol Biol, V989, P265, DOI 10.1007/978-1-62703-330-5_20
   Sun LY, 2009, BIOELECTROMAGNETICS, V30, P251, DOI 10.1002/bem.20472
   Sun Y, 2011, FASEB J, V25, P1474, DOI 10.1096/fj.10-161497
   Szablowska-Gadomska I, 2011, ACTA NEUROBIOL EXP, V71, P86
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   TONG JZ, 1994, BIOL CELL, V81, P77, DOI 10.1016/0248-4900(94)90058-2
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Trowbridge JJ, 2010, STEM CELLS, V28, P1379, DOI 10.1002/stem.457
   Underhill GH, 2007, CURR OPIN CHEM BIOL, V11, P357, DOI 10.1016/j.cbpa.2007.05.036
   van der Spoel TIG, 2012, J CELL MOL MED, V16, P2768, DOI 10.1111/j.1582-4934.2012.01594.x
   Vellenga E, 2011, BLOOD, V118, P6037, DOI 10.1182/blood-2011-07-370247
   Verma P, 2007, IN VITRO CELL DEV-AN, V43, P328, DOI 10.1007/s11626-007-9045-1
   Lopez MAV, 2011, STEM CELLS DEV, V20, P1011, DOI 10.1089/scd.2010.0355
   Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631
   Walenda G, 2012, TISSUE ENG PART C-ME, V18, P924, DOI [10.1089/ten.tec.2011.0541, 10.1089/ten.TEC.2011.0541]
   Wang WJ, 2009, BIOMATERIALS, V30, P2705, DOI 10.1016/j.biomaterials.2009.01.030
   Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Xie XY, 2011, STEM CELLS DEV, V20, P127, DOI 10.1089/scd.2009.0475
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
   Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744
   Yamashita T, 2011, CELL TRANSPLANT, V20, P883, DOI 10.3727/096368910X539092
   Yang ZJ, 2010, CARDIOVASC THER, V28, P380, DOI 10.1111/j.1755-5922.2009.00116.x
   Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103
   Yeh YC, 2010, BIOMATERIALS, V31, P6444, DOI 10.1016/j.biomaterials.2010.04.069
   Yew TL, 2011, AGING CELL, V10, P349, DOI 10.1111/j.1474-9726.2011.00676.x
   Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283
   Yoon TM, 2010, STEM CELL REV REP, V6, P425, DOI 10.1007/s12015-010-9158-x
   Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020
   Zhang JY, 2011, BIOMATERIALS, V32, P6972, DOI 10.1016/j.biomaterials.2011.05.088
NR 156
TC 10
Z9 10
U1 0
U2 18
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD AUG
PY 2014
VL 20
IS 4
BP 340
EP 354
DI 10.1089/ten.teb.2013.0349
PG 15
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AN3XK
UT WOS:000340521800011
PM 24168361
OA Green Published
DA 2018-10-20
ER

PT J
AU Dumont, CM
   Karande, P
   Thompson, DM
AF Dumont, Courtney M.
   Karande, Pankaj
   Thompson, Deanna M.
TI Rapid Assessment of Migration and Proliferation: A Novel 3D
   High-Throughput Platform for Rational and Combinatorial Screening of
   Tissue-Specific Biomaterials
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID AMYOTROPHIC-LATERAL-SCLEROSIS; SCHWANN-CELLS; STEM-CELLS; MICROARRAY;
   NERVE; DIFFERENTIATION; REGENERATION; SCAFFOLDS; CULTURE; ASSAYS
AB Designing an ideal biomaterial supportive of multicellular tissue repair is challenging, especially with a poor understanding of the synergy between constituent proteins and growth factors. A brute-force approach, based on screening all possible combinations of proteins and growth factors, is inadequate due to the prohibitively large experimental space coupled with current low-throughput screening techniques. A high-throughput screening platform based on rational and combinatorial strategies for design and testing of proteins and growth factors can significantly impact the discovery of novel tissue-specific biomaterials. Here, we report the development of a flexible high-throughput screening platform, Rapid Assessment of Migration and Proliferation (RAMP), to rapidly investigate cell viability, proliferation, and migration in response to highly miniaturized three-dimensional biomaterial cultures (4-20 mu L) with sparingly low cell densities (63-1000 cells per mu L for cell arrays; 1 mu L of 1000-10,000 cells per mu L for migration arrays). The predictions made by RAMP on the efficacy and potency of the biomaterials are in agreement with the predictions made by conventional assays but at a throughput that is at least 100-1000-fold higher. The RAMP assay is therefore a novel approach for the rapid discovery of tissue-specific biomaterials for tissue engineering and regenerative medicine.
C1 [Dumont, Courtney M.; Thompson, Deanna M.] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Karande, Pankaj] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
RP Thompson, DM (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, 110 8th St, Troy, NY 12180 USA.
EM thompd4@rpi.edu
OI Dumont, Courtney/0000-0001-8455-7188
FU National Science Foundation [CBET-1067208]
FX This work was supported by the National Science Foundation-CBET-1067208
   and was performed within the Center for Biotechnology and
   Interdisciplinary Studies. Experimental data were analyzed using
   instrumentation within the Molecular Biology CORE and Microscopy CORE
   facilities.
CR Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   ASSOULINE JG, 1989, EXP CELL RES, V182, P499, DOI 10.1016/0014-4827(89)90253-X
   Chen AA, 2010, INTEGR BIOL-UK, V2, P517, DOI 10.1039/c0ib00054j
   Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593
   Cimetta E, 2010, BIOTECHNOL PROGR, V26, P220, DOI 10.1002/btpr.300
   Dewitt DD, 2009, TISSUE ENG PT A, V15, P2785, DOI [10.1089/ten.tea.2008.0406, 10.1089/ten.TEA.2008.0406]
   Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q
   Finkelstein E. A., 2006, INCIDENCE EC BURDEN
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Glass JD, 2012, STEM CELLS, V30, P1144, DOI 10.1002/stem.1079
   Hoke A, 2010, EXP NEUROL, V223, P1, DOI 10.1016/j.expneurol.2009.12.001
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Jesuraj NJ, 2012, J NEUROSCI RES, V90, P96, DOI 10.1002/jnr.22752
   Koppes AN, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046023
   Lee MY, 2008, P NATL ACAD SCI USA, V105, P59, DOI 10.1073/pnas.0708756105
   MORRISSEY TK, 1991, J NEUROSCI, V11, P2433
   O'Connor DM, 2012, NEUROSCI LETT, V527, P78, DOI 10.1016/j.neulet.2012.04.079
   Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041
   Rosner BI, 2005, EXP NEUROL, V195, P81, DOI 10.1016/j.expneurol.2005.04.003
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Seggio AM, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046001
   Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
NR 25
TC 4
Z9 4
U1 0
U2 15
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD AUG
PY 2014
VL 20
IS 8
BP 620
EP 629
DI 10.1089/ten.tec.2013.0362
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AN3XF
UT WOS:000340521300002
PM 24256302
OA Green Published
DA 2018-10-20
ER

PT J
AU Kirmali, O
   Akin, H
   Kapdan, A
AF Kirmali, Omer
   Akin, Hakan
   Kapdan, Alper
TI Evaluation of the surface roughness of zirconia ceramics after different
   surface treatments
SO ACTA ODONTOLOGICA SCANDINAVICA
LA English
DT Article
DE Y-TZP zirconia; surface roughness; surface treatment; laser treatment
ID MICROTENSILE BOND STRENGTH; ND-YAG LASER; RESIN CEMENT; PARTICLE
   ABRASION; ROCATEC SYSTEM; DENTAL LASER; OXIDE; BIOMATERIAL; IRRADIATION;
   PORCELAIN
AB Objective. This study aimed to investigate the effects of different mechanical surface treatments of pre-sintered zirconium oxide (ZrO2) in an attempt to improve its bonding potential. Materials and methods. One hundred and twenty IPS e-max ZirCAD (Ivoclar Vivadent) pre-sintered zirconia blocks (7 mm diameter, 3 mm height) received six different surface treatments (n = 20): Group C was untreated (control); Group E was Er: YAG laser irradiated; Group N was Nd: YAG laser irradiated; Group SB was sandblasted, Group SN was sandblasted and Nd:YAG laser irradiated; and Group SE was sandblasted and Er: YAG laser irradiated. After the surface treatments, the average surface roughness (Ra, mu m) of each specimen was determined with a profilometer, then all the specimens were sintered. The surface roughness values were analysed through one-way ANOVA and Tukey's test. Changes in the morphological characteristics of ZrO2 were examined through scanning electron microscopy (SEM). Results. Sintered sandblasted, Er:YAG laser treatment, sandblasted + Er: YAG laser and sandblasted + Nd:YAG laser irradiation resulted in a rougher surface than the other treatments. Conclusion. Nd:YAG laser irradiation alone was not effective in altering the zirconia surface morphology.
C1 [Kirmali, Omer] Akdeniz Univ, Fac Dent, Dept Prosthodont, TR-07058 Antalya, Turkey.
   [Akin, Hakan] Cumhuriyet Univ, Fac Dent, Dept Prosthodont, Sivas, Turkey.
   [Kapdan, Alper] Cumhuriyet Univ, Fac Dent, Dept Restorat Dent, Sivas, Turkey.
RP Kirmali, O (reprint author), Akdeniz Univ, Fac Dent, Dept Prosthodont, TR-07058 Antalya, Turkey.
EM omerkrml@ymail.com
RI Kirmali, Omer/C-5720-2016
OI Kirmali, Omer/0000-0002-4313-344X; Akin, Hakan/0000-0002-4770-4297
CR Aboushelib Moustafa N, 2008, J Prosthodont, V17, P401, DOI 10.1111/j.1532-849X.2008.00306.x
   Ahmad I, 1998, Int J Periodontics Restorative Dent, V18, P454
   Akin H, 2011, PHOTOMED LASER SURG, V29, P797, DOI 10.1089/pho.2011.3039
   Akin H, 2012, LASER MED SCI, V27, P333, DOI 10.1007/s10103-011-0883-4
   Akyil MS, 2010, PHOTOMED LASER SURG, V28, P801, DOI 10.1089/pho.2009.2697
   Amaral R, 2006, DENT MATER, V22, P283, DOI 10.1016/j.dental.2005.04.021
   Birang R, 2007, LASER MED SCI, V22, P21, DOI 10.1007/s10103-006-0412-z
   Blatz MB, 2003, J PROSTHET DENT, V89, P268, DOI 10.1067/mpr.2003.50
   Borges GA, 2003, J PROSTHET DENT, V89, P479, DOI 10.1016/S0022-3913(03)52704-9
   Burke F J Trevor, 2002, J Adhes Dent, V4, P7
   Casucci A, 2009, J DENT, V37, P891, DOI 10.1016/j.jdent.2009.06.013
   Cavalcanti AN, 2009, OPER DENT, V34, P280, DOI 10.2341/08-80
   Cavalcanti AN, 2009, PHOTOMED LASER SURG, V27, P473, DOI 10.1089/pho.2008.2293
   Curtis AR, 2006, J DENT, V34, P195, DOI 10.1016/j.jdent.2005.06.006
   Da Silveira BL, 2005, PHOTOMED LASER SURG, V23, P543, DOI 10.1089/pho.2005.23.543
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Ersu B, 2009, J DENT, V37, P848, DOI 10.1016/j.jdent.2009.06.017
   Fischer J, 2008, DENT MATER J, V27, P448, DOI 10.4012/dmj.27.448
   Guess PC, 2010, J DENT RES, V89, P592, DOI 10.1177/0022034510363253
   Harding AB, 2012, J PROSTHODONT, V21, P346, DOI 10.1111/j.1532-849X.2012.00843.x
   Harris DM, 2002, LASER SURG MED, V30, P342, DOI 10.1002/lsm.10052
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Kim HJ, 2011, J PROSTHET DENT, V105, P315, DOI 10.1016/S0022-3913(11)60060-7
   Koutayas SO, 2009, INT J ESTHET DENT, V4, P348
   Kramer N., 2000, AM J DENT, V13, P60
   Kumbuloglu O, 2006, OPER DENT, V31, P248, DOI 10.2341/05-22
   Marcondes M, 2009, J BIOMED MATER RES B, V90B, P388, DOI 10.1002/jbm.b.31297
   Corona SAM, 2007, PHOTOMED LASER SURG, V25, P26, DOI 10.1089/pho.2006.1075
   Monaco C, 2011, J PROSTHODONT, V20, P97, DOI 10.1111/j.1532-849X.2010.00677.x
   Moon JE, 2011, DENT MATER, V27, P651, DOI 10.1016/j.dental.2011.03.005
   Noda M, 2010, DENT MATER J, V29, P536, DOI 10.4012/dmj.2009-127
   Ozcan M, 1998, QUINTESSENCE INT, V29, P713
   Ozcan M, 2007, CLIN ORAL INVEST, V13, P279
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pittayachawan P, 2009, J BIOMED MATER RES B, V88B, P366, DOI 10.1002/jbm.b.31064
   Rosenstiel SF, 1998, J PROSTHET DENT, V80, P280, DOI 10.1016/S0022-3913(98)70128-3
   SEMMELMAN JO, 1968, J AM DENT ASSOC, V76, P69, DOI 10.14219/jada.archive.1968.0017
   Shiu P, 2007, PHOTOMED LASER SURG, V25, P291, DOI 10.1089/pho.2007.2018
   Spohr AM, 2008, PHOTOMED LASER SURG, V26, P203, DOI 10.1089/pho.2007.2130
   Thompson JY, 1998, J PROSTHET DENT, V79, P378, DOI 10.1016/S0022-3913(98)70148-9
   Ural C, 2010, ACTA ODONTOL SCAND, V68, P354, DOI 10.3109/00016357.2010.514720
   Vagkopoulou T, 2009, INT J ESTHET DENT, V4, P130
   Vagopoulou T., 2009, EUR J ESTHET DENT, V4, P2
   van As Glenn, 2004, Dent Clin North Am, V48, P1017, DOI 10.1016/j.cden.2004.06.001
   Wang QQ, 2007, J ENDODONT, V33, P830, DOI 10.1016/j.joen.2007.03.017
   Wolfart M, 2007, DENT MATER, V23, P45, DOI 10.1016/j.dental.2005.11.040
NR 46
TC 13
Z9 13
U1 1
U2 15
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0001-6357
EI 1502-3850
J9 ACTA ODONTOL SCAND
JI Acta Odontol. Scand.
PD AUG
PY 2014
VL 72
IS 6
BP 432
EP 439
DI 10.3109/00016357.2013.853320
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AN0FQ
UT WOS:000340259700006
PM 24255966
DA 2018-10-20
ER

PT J
AU Rahimi, M
   Mohseni-Kouchesfehani, H
   Zarnani, AH
   Mobini, S
   Nikoo, S
   Kazemnejad, S
AF Rahimi, Maryam
   Mohseni-Kouchesfehani, Homa
   Zarnani, Amir-Hassan
   Mobini, Sahba
   Nikoo, Shohreh
   Kazemnejad, Somaieh
TI Evaluation of menstrual blood stem cells seeded in biocompatible Bombyx
   mori silk fibroin scaffold for cardiac tissue engineering
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Menstrual blood; bone marrow; stem cells; silk scaffold; cardiac tissue
   engineering
ID BONE-MARROW; IN-VITRO; CHONDROGENIC DIFFERENTIATION; DILATED
   CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; MECHANICAL-PROPERTIES;
   PROLIFERATION; BIOMATERIAL; CONSTRUCTS; ELASTOMERS
AB Recently, silk fibroin scaffolds have been introduced as novel and promising biomaterials in the field of cardiac tissue engineering. This study was designed to compare infiltration, proliferation, and cardiac differentiation potential of menstrual blood-derived stem cells (MenSCs) versus bone marrow-derived mesenchymal stem cells (BMSCs) in Bombyx mori-derived silk scaffold. Our primary data revealed that the fabricated scaffold has mechanical and physical qualities suitable for cardiac tissue engineering. The MenSCs tracking in scaffolds using immunofluorescent staining and scanning electron microscopy confirmed MenSCs attachment, penetration, and distribution within the porous scaffold matrix. Based on proliferation assay using propidium iodide DNA quantification, the significantly higher level of growth rates of both MenSCs and BMSCs was documented in scaffolds than that in two-dimensional culture (p<0.01). The expression level of TNNT2, a bona fide cardiac differentiation marker, in BMSCs differentiated on silk scaffolds was markedly higher than those cultured in two-dimensional culture indicating the improvement of cardiac differentiation in the silk scaffolds. Furthermore, differentiated MenSCs exhibited higher expression of TNNT2 compared with induced BMSCs. It seems that silk scaffold-seeded MenSCs could be viewed as a novel, safe, natural, and accessible construct for cardiac tissue engineering.
C1 [Rahimi, Maryam; Mohseni-Kouchesfehani, Homa] Kharazmi Univ, Fac Biol Sci, Dept Anim Biol, Tehran, Iran.
   [Zarnani, Amir-Hassan] Avicenna Res Inst, Nanobiotechnol Res Ctr, ACECR, Tehran, Iran.
   [Zarnani, Amir-Hassan] Iran Univ Med Sci, Immunol Res Ctr, Tehran, Iran.
   [Mobini, Sahba; Kazemnejad, Somaieh] Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran.
   [Nikoo, Shohreh] Avicenna Res Inst, Reprod Immunol Res Ctr, ACECR, Tehran, Iran.
RP Kazemnejad, S (reprint author), Avicenna Res Inst, Reprod Biotechnol Res Ctr, POB 19615-1177, Tehran, Iran.
EM s.kazemnejad@avicenna.ac.ir
RI Kazemnejad, Somaieh/O-6577-2018
OI Kazemnejad, Somaieh/0000-0003-1808-8357; Mobini,
   Sahba/0000-0003-2756-8694
FU Iranian Stem Cell Network
FX This research was supported by the Iranian Stem Cell Network grant.
CR Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Boublik J, 2005, TISSUE ENG, V11, P1122, DOI 10.1089/ten.2005.11.1122
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Chang G, 2007, EUR SPINE J, V16, P1848, DOI 10.1007/s00586-007-0364-4
   Choi YS, 2010, BIOMATERIALS, V31, P2236, DOI 10.1016/j.biomaterials.2009.11.097
   Darzi S, 2012, TISSUE ENG PT A, V18, P1720, DOI [10.1089/ten.TEA.2011.0386, 10.1089/ten.tea.2011.0386]
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002
   Haghani K, 2012, MOL CELL BIOCHEM, V361, P315, DOI 10.1007/s11010-011-1117-6
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hida N, 2008, STEM CELLS, V26, P1695, DOI 10.1634/stemcells.2007-0826
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Kazemnejad S, 2012, INT J ARTIF ORGANS, V35, P55, DOI 10.5301/ijao.5000019
   Khanjani S, 2013, J TISSUE EN IN PRESS
   Khanmohammadi M, 2012, INT J HEMATOL, V95, P484, DOI 10.1007/s12185-012-1067-0
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Martin B. M., 1994, TISSUE CULTURE TECHN, P247
   Martinez EC, 2011, J MOL CELL CARDIOL, V50, P312, DOI 10.1016/j.yjmcc.2010.08.009
   Meng XL, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-57
   Misof K, 1997, J CLIN INVEST, V100, P40, DOI 10.1172/JCI119519
   Mobini S, 2013, J BIOMED MATER RES A, V101, P2392, DOI 10.1002/jbm.a.34537
   Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Musina RA, 2008, B EXP BIOL MED+, V145, P539, DOI 10.1007/s10517-008-0136-0
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Patel AN, 2008, CELL TRANSPLANT, V17, P303, DOI 10.3727/096368908784153922
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   Piao H, 2007, BIOMATERIALS, V28, P641, DOI 10.1016/j.biomaterials.2006.09.009
   Pok S, 2013, ACTA BIOMATER, V9, P5630, DOI 10.1016/j.actbio.2012.10.032
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Silvestri A, 2013, MACROMOL BIOSCI, V13, P984, DOI 10.1002/mabi.201200483
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Watanabe S, 2006, EUR HEART J, V27, P832, DOI 10.1093/eurheartj/ehi772
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang MC, 2010, BIOMATERIALS, V31, P854, DOI 10.1016/j.biomaterials.2009.09.096
   Yang MC, 2009, BIOMATERIALS, V30, P3757, DOI 10.1016/j.biomaterials.2009.03.057
   Zhang MJ, 2009, MED HYPOTHESES, V72, P252, DOI 10.1016/j.mehy.2008.10.021
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
   Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048028
NR 49
TC 11
Z9 12
U1 0
U2 20
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD AUG
PY 2014
VL 29
IS 2
BP 199
EP 208
DI 10.1177/0885328213519835
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM8UX
UT WOS:000340154500004
PM 24445773
DA 2018-10-20
ER

PT J
AU Wang, RH
   Wang, Q
   Wang, XM
   Tian, LL
   Liu, HY
   Zhao, MM
   Peng, C
   Cai, Q
   Shi, YM
AF Wang, Ronghan
   Wang, Qiong
   Wang, Xiumei
   Tian, Lili
   Liu, Huiying
   Zhao, Miaomiao
   Peng, Ce
   Cai, Qiang
   Shi, Yunming
TI Enhancement of nano-hydroxyapatite bonding to dentin through a
   collagen/calcium dual-affinitive peptide for dentinal tubule occlusion
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Dentin hypersensitivity; hydroxyapatite; peptide; dentinal tubule
   occlusion; interface bond
ID IN-VITRO; MECHANICAL-PROPERTIES; ELECTRON-MICROSCOPY; BONE SIALOPROTEIN;
   HYPERSENSITIVITY; APATITE; BIOMATERIAL; NUCLEATION; DENTIFRICE; CRYSTALS
AB Calcium phosphate crystals, as the main component of dentin and enamel, have been widely used for the occlusion of dentinal tubules. However, the low bond strength and poor sealing effect limit their clinical practicality. In this study, a collagen/calcium dual-affinitive peptide E8DS (EEEEEEEEDSpESpSpEEDR) and nano-hydroxyapatite (nano-HAp) flocculi were developed to seal dentin tubules for reducing dentin hypersensitivity, whereas the E8DS peptides were pre-applied to improve the adhesion of occlusive hydroxyapatite coating on dentin collagen matrix for the long-lasting sealing effect and relief from hypersensitivity. Our study showed that E8DS peptides had a strong affinity with dentin collageneous matrix that almost 43.7% of initial E8DS peptides immobilized on exposed dentin samples remained detained after continuous washing by distilled water for four weeks at a rate of 1mL/min. Nano-HAp flocculi were obtained by re-neutralization of HAp-HCl solution and then brushed onto the surfaces of pre-treated human dentin disks with E8DS peptides, which showed a perfect occlusion of exposed dentinal tubules, as compared with Nano-HAp only and a commercial desensitizer, Green Or. With only around 10-min E8DS peptide pre-treatment, the occlusive mineral layers remained intact against consecutively stirred washing in phosphate-buffered saline or coke for 15min, and 6min of tooth-brushing, which implied that our E8DS peptide could comparatively improve the durability of sealant-dentin interface bonds for long-lasting dentine desensitization.
C1 [Wang, Ronghan; Wang, Qiong; Wang, Xiumei; Peng, Ce; Cai, Qiang] Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram Fine Proc, Beijing 100084, Peoples R China.
   [Tian, Lili] China Japan Friendship Hosp, Dept Stomatol, Beijing, Peoples R China.
   [Liu, Huiying; Zhao, Miaomiao] Dalian Med Univ, Sch Stomatol, Dept Oral & Maxillofacial, Dalian, Peoples R China.
   [Shi, Yunming] P&G Technol Beijing Co Ltd, Crest Res Inst, Beijing, Peoples R China.
RP Wang, XM (reprint author), Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram Fine Proc, Beijing 100084, Peoples R China.
EM wxm@mail.tsinghua.edu.cn
FU 'Twelfth Five-Year' National Technology Support Program [2012BAI17B02];
   Tsinghua University Initiative Scientific Research Program
   [20121087982]; National Natural Science Foundation of China [21371106];
   Analysis Foundation of Tsinghua University
FX This work is in part supported by 'Twelfth Five-Year' National
   Technology Support Program (2012BAI17B02), Tsinghua University
   Initiative Scientific Research Program (20121087982), National Natural
   Science Foundation of China (21371106), and the Analysis Foundation of
   Tsinghua University.
CR ABSI EG, 1987, J CLIN PERIODONTOL, V14, P280, DOI 10.1111/j.1600-051X.1987.tb01533.x
   Arcis RW, 2002, DENT MATER, V18, P49, DOI 10.1016/S0109-5641(01)00019-7
   Bartlett DW, 2011, J DENT, V39, P811, DOI 10.1016/j.jdent.2011.08.014
   Burrow MF, 1996, DENT MATER, V12, P302, DOI 10.1016/S0109-5641(96)80038-8
   Chiang YC, 2010, J DENT RES, V89, P236, DOI 10.1177/0022034509357148
   Culpepper BK, 2010, BIOMATERIALS, V31, P9586, DOI 10.1016/j.biomaterials.2010.08.020
   Fujisawa R, 1997, MATRIX BIOL, V16, P21, DOI 10.1016/S0945-053X(97)90113-X
   Garcia-Godoy A, 2010, AM J DENT, V23, P324
   Gillam DG, 1999, ENDOD DENT TRAUMATOL, V15, P198
   Hashimoto M, 2003, BIOMATERIALS, V24, P3795, DOI 10.1016/S0142-9612(03)00262-X
   He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945
   He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200
   He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059
   Israel K, 2002, DENT TODAY, V21, P42
   Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338
   Kimura Y, 2000, J CLIN PERIODONTOL, V27, P715, DOI 10.1034/j.1600-051x.2000.027010715.x
   Kinney JH, 2003, J DENT RES, V82, P957, DOI 10.1177/154405910308201204
   Lee BS, 2007, DENT MATER J, V26, P52, DOI 10.4012/dmj.26.52
   Lee SY, 2008, J ORAL REHABIL, V35, P847, DOI 10.1111/j.1365-2842.2008.01876.x
   Liu XJ, 2011, J DENT, V39, P293, DOI 10.1016/j.jdent.2010.10.016
   Markowitz K, 2008, J ORAL REHABIL, V35, P300, DOI 10.1111/j.1365-2842.2007.01798.x
   Murphy MB, 2007, BIOMACROMOLECULES, V8, P2237, DOI 10.1021/bm070121s
   Nishitani Y, 2006, J DENT RES, V85, P1016, DOI 10.1177/154405910608501108
   Olley RC, 2012, J DENT, V40, P585, DOI 10.1016/j.jdent.2012.03.008
   Petrou Irene, 2009, J Clin Dent, V20, P23
   Richard D, 2011, DENT CLIN N AM, V55, P599
   Sadek FT, 2007, J DENT RES, V86, P524, DOI 10.1177/154405910708600607
   Sadek FT, 2008, J BIOMED MATER RES A, V84A, P19, DOI 10.1002/jbm.a.31290
   Shelon CS, 2010, BRAZ DENT J, V21, P390
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Wang Q, 2011, SOFT MATTER, V7, P9673, DOI 10.1039/c1sm05018d
   Wazen RM, 2007, J HISTOCHEM CYTOCHEM, V55, P35, DOI 10.1369/jhc.6A7046.2006
   Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301
NR 35
TC 8
Z9 8
U1 4
U2 38
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD AUG
PY 2014
VL 29
IS 2
BP 268
EP 277
DI 10.1177/0885328214523057
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM8UX
UT WOS:000340154500010
PM 24505078
DA 2018-10-20
ER

PT J
AU Shindo, D
   Aizawa, S
   Akase, Z
   Tanigaki, T
   Murakami, Y
   Park, HS
AF Shindo, Daisuke
   Aizawa, Shinji
   Akase, Zentaro
   Tanigaki, Toshiaki
   Murakami, Yasukazu
   Park, Hyun Soon
TI Electron Holographic Visualization of Collective Motion of Electrons
   Through Electric Field Variation
SO MICROSCOPY AND MICROANALYSIS
LA English
DT Article
DE electron holography; charging; secondary electron; electric field
ID SCIATIC-NERVE TISSUES
AB This study demonstrates the accumulation of electron-induced secondary electrons by utilizing a simple geometrical configuration of two branches of a charged insulating biomaterial. The collective motion of these secondary electrons between the branches has been visualized by analyzing the reconstructed amplitude images obtained using in situ electron holography. In order to understand the collective motion of secondary electrons, the trajectories of these electrons around the branches have also been simulated by taking into account the electric field around the charged branches on the basis of Maxwell's equations.
C1 [Shindo, Daisuke; Akase, Zentaro; Murakami, Yasukazu] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan.
   [Shindo, Daisuke; Aizawa, Shinji; Akase, Zentaro; Tanigaki, Toshiaki; Murakami, Yasukazu; Park, Hyun Soon] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan.
RP Shindo, D (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan.
EM shindo@tagen.tohoku.ac.jp
RI Shindo, Daisuke/I-3865-2012; Park, Hyun Soon/D-3941-2013; Akase,
   Zentaro/G-8866-2012
OI Park, Hyun Soon/0000-0002-1039-7334; 
FU Japan Society for the Promotion of Science (JSPS) [25249093]
FX Sciatic nerve tissues were kindly provided by Prof. S. Ohno in
   University of Yamanashi. The authors wish to thank Dr. N. Osakabe,
   Hitachi Central Research Lab and Dr. Y. A. Ono and Dr. T. Matsuda, Japan
   Science and Technology Agency (JST) for their kind encouragement and
   useful discussions. This study was financially supported by a
   Grant-in-Aid for Scientific Research (No. 25249093) and a grant from the
   Japan Society for the Promotion of Science (JSPS) through the "Funding
   Program for World-Leading Innovative R&D on Science and Technology
   (FIRST Program)," initiated by the Council for Science and Technology
   Policy (CSTP) under the program of " Development and Application of an
   Atomic-Resolution Holography Electron Microscope."
CR Inoue M, 2012, J ELECTRON MICROSC, V61, P217, DOI 10.1093/jmicro/dfs046
   Kim JJ, 2007, NANO LETT, V7, P2243, DOI 10.1021/nl070696v
   Kim KH, 2013, MICROSC MICROANAL, V19, P54, DOI 10.1017/S1431927613012324
   Lichte H, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/1/016102
   MATTEUCCI G, 1991, J APPL PHYS, V69, P1835, DOI 10.1063/1.348970
   McCartney MR, 2007, ANNU REV MATER RES, V37, P729, DOI 10.1146/annurev.matsci.37.052506.084219
   OHNO S, 1992, VIRCHOWS ARCH B, V61, P351, DOI 10.1007/BF02890438
   Shindo D, 1998, HIGH RESOLUTION ELEC
   Shindo D, 2007, J ELECTRON MICROSC, V56, P1, DOI 10.1093/jmicro/dfl039
   Shindo D, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.104802
   Shindo D, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/18/183002
   Tonomura A., 1999, ELECT HOLOGRAPHY
   Volkl E., 1999, INTRO ELECT HOLOGRAP
NR 13
TC 2
Z9 2
U1 0
U2 15
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1431-9276
EI 1435-8115
J9 MICROSC MICROANAL
JI Microsc. microanal.
PD AUG
PY 2014
VL 20
IS 4
BP 1015
EP 1021
DI 10.1017/S1431927614000786
PG 7
WC Materials Science, Multidisciplinary; Microscopy
SC Materials Science; Microscopy
GA AN0FR
UT WOS:000340259800006
PM 24815225
DA 2018-10-20
ER

PT J
AU Sakamoto, Y
   Ochiai, H
   Ohsugi, I
   Inoue, Y
   Yoshimura, Y
   Kishi, K
AF Sakamoto, Yoshiaki
   Ochiai, Hiroko
   Ohsugi, Ikuko
   Inoue, Yoshikazu
   Yoshimura, Yoko
   Kishi, Kazuo
TI Evaluation of Antibiotic-loaded Calcium Phosphate Bone Cement in a
   Cranium-infected Experimental Model
SO NEUROLOGIA MEDICO-CHIRURGICA
LA English
DT Article
DE calcium phosphate cement; hydroxyapatite; antibiotics;
   methicillin-resistant Staphylococcus aureus (MRSA)
ID STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PYOGENES; MURINE MODEL; VANCOMYCIN;
   CEFAZOLIN; STRENGTH; THERAPY
AB Treatment of calvarial defects has remained a challenge in reconstruction surgery, especially because of infection at these sites. We produced a bactericidal biomaterial for treating infected bone defects by using calcium phosphate bone cement mixed with antibiotics. We evaluated the usefulness of this material mixed with the antibiotic vancomycin in a cranium-infected rat model. The concentration of vancomycin used was 5.0 wt%, as reported in our previous study. In order to establish the rat model, a cranium defect (diameter, 5 mm) was made that was infected with methicillin-resistant Staphylococcus aureus (MRSA). Thirty-six rats were divided into 6 groups depending on whether an autologous graft or bone cement with or without antibiotic was used for the defect. After 1 and 4 weeks, abscess formation was checked, tissue bacterial counts were determined, and pathological examination was performed. At both 1 and 4 weeks, no MRSA was detected on tissue bacterial culture or pathological examination in groups that received bone cement with antibiotics. In groups that received bone cement without antibiotic, MRSA was detected, and the bone cement had compromised and disintegrated into several slices. In conclusion, bone cement that contains antibiotics appears to be effective not only for reconstruction in cases of cranial defect, but also in terms of preventing infection.
C1 [Sakamoto, Yoshiaki; Kishi, Kazuo] Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo 1608582, Japan.
   [Ochiai, Hiroko] Tokyo Med Ctr, Natl Hosp Org, Dept Plast & Reconstruct Surg, Tokyo, Japan.
   [Ohsugi, Ikuko; Inoue, Yoshikazu; Yoshimura, Yoko] Fujita Hlth Univ, Sch Med, Dept Plast & Reconstruct Surg, Toyoake, Aichi 47011, Japan.
RP Sakamoto, Y (reprint author), Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Shinjuku Ku, 35 Shina Nomachi, Tokyo 1608582, Japan.
EM ysakamoto@z8.keio.jp
CR BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barg N, 1998, J ANTIMICROB CHEMOTH, V42, P257, DOI 10.1093/jac/42.2.257
   BOON RJ, 1987, ANTIMICROB AGENTS CH, V31, P1204, DOI 10.1128/AAC.31.8.1204
   BUNCE C, 1992, INFECT IMMUN, V60, P2636
   CARTER DR, 1978, CLIN ORTHOP RELAT R, P192
   EVANS FG, 1957, J APPL PHYSIOL, V10, P493
   Fallon MT, 1999, J SURG RES, V86, P97, DOI 10.1006/jsre.1999.5686
   GAAR E, 1994, BRIT J SURG, V81, P1309, DOI 10.1002/bjs.1800810915
   Gilardino MS, 2009, PLAST RECONSTR SURG, V123, P983, DOI 10.1097/PRS.0b013e318199f6ad
   KERNODLE DS, 1993, J INFECT DIS, V168, P152, DOI 10.1093/infdis/168.1.152
   Kisanuki O, 2007, J ORTHOP SCI, V12, P281, DOI 10.1007/s00776-007-1124-3
   Larsson S, 2010, J ORTHOP TRAUMA, V24, pS41, DOI 10.1097/BOT.0b013e3181cec472
   Levine JF, 1987, MED CLIN N AM, V71, P1134
   Lewis G, 2009, J BIOMED MATER RES B, V89B, P558, DOI 10.1002/jbm.b.31220
   Niikura T, 2007, ORTHOPEDICS, V30, P320
   Ogaard A. R., 1992, NIPH (National Institute of Public Health) Annals (Oslo), V15, P99
   Sakamoto Y, 2013, J CRANIOFAC SURG, V24, P1447, DOI 10.1097/SCS.0b013e31829972de
   Schbettler R, 2004, EUR J TRAUMA, V30, P219
   van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557
NR 19
TC 1
Z9 1
U1 1
U2 14
PU JAPAN NEUROSURGICAL SOC
PI TOKYO
PA 5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN
SN 0470-8105
EI 1349-8029
J9 NEUROL MED-CHIR
JI Neurol. Med.-Chir.
PD AUG
PY 2014
VL 54
IS 8
BP 647
EP 653
DI 10.2176/nmc.oa.2013-0295
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA AN1JL
UT WOS:000340338500009
PM 24670313
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Hagenau, A
   Suhre, MH
   Scheibel, TR
AF Hagenau, Anja
   Suhre, Michael H.
   Scheibel, Thomas R.
TI Nature as a blueprint for polymer material concepts: Protein
   fiber-reinforced composites as holdfasts of mussels
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Mussel byssus; Collagen structure; Biomimetics; Gradient materials;
   preCols; PTMP1
ID MYTILUS-EDULIS-L; CELL-ADHESION BIOMATERIAL; BYSSUS ATTACHMENT-PLAQUE;
   TRIPLE-HELICAL PEPTIDES; SPIDER DRAGLINE SILK; MECHANICAL-PROPERTIES;
   ESCHERICHIA-COLI; SEA MUSSEL; MOLECULAR-STRUCTURE; BLOCK-COPOLYMER
AB Today' demands for novel high-performance polymeric materials with precisely adjusted task-specific mechanics, durability and reliability require new concepts. This review introduces the byssus of blue mussels as a conceptual example of a natural functional proteinaceous material with gradual mechanical properties. The structure-function relationship of the involved proteins, as well as their arrangement and interplay are described in detail to gain insights into how nature deals with mechanical polymer gradients. The mussel byssus can serve as a blueprint which already led to bioinspired approaches for novel applications. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Hagenau, Anja; Suhre, Michael H.; Scheibel, Thomas R.] Univ Bayreuth, Fak Ingenieurwissensch, Lehrstuhl Biomat, D-95440 Bayreuth, Germany.
   [Scheibel, Thomas R.] Univ Bayreuth, Bayreuther Zentrum Kolloide & Grenzflachen, D-95440 Bayreuth, Germany.
   [Scheibel, Thomas R.] Univ Bayreuth, Inst Biomakromol Biomac, D-95440 Bayreuth, Germany.
   [Scheibel, Thomas R.] Univ Bayreuth, Bayreuther Zentrum Mol Biowissensch, D-95440 Bayreuth, Germany.
   [Scheibel, Thomas R.] Univ Bayreuth, Bayreuther Mat Zentrum BayMAT, D-95440 Bayreuth, Germany.
RP Scheibel, TR (reprint author), Univ Bayreuth, Fak Ingenieurwissensch, Lehrstuhl Biomat, Univ Str 30, D-95440 Bayreuth, Germany.
EM thomas.scheibel@uni-bayreuth.de
RI Scheibel, Thomas/I-1170-2014
OI Scheibel, Thomas/0000-0002-0457-2423; Suhre, Michael/0000-0002-2279-7765
FU graduate program "Material Science of Complex Interfaces" of the
   "Elitenetzwerk Bayern"; DFG [SCHE 603/7-1]
FX This work was supported by the graduate program "Material Science of
   Complex Interfaces" of the "Elitenetzwerk Bayern" (AH) and the DFG (SCHE
   603/7-1) (TS). Special thanks to Prof. Dr. Daniel Huster and Dr. Holger
   Scheidt for NMR data, Prof. Dr. Jerzy Adamski for support on the
   generation of cDNA libraries, Prof. Dr. Friedrich Kremer and Dr.
   Periklis Papadopoulos for FTIR data.
CR Aldred N, 2007, J R SOC INTERFACE, V4, P1159, DOI 10.1098/rsif.2007.1026
   Aldred N, 2006, J ROY SOC INTERFACE, V3, P37, DOI 10.1098/rsif.2005.0074
   ALLEN J A, 1976, Journal of Molluscan Studies, V42, P279
   Anderson KE, 2000, J EXP BIOL, V203, P3065
   Arnold AA, 2013, BIOMACROMOLECULES, V14, P132, DOI 10.1021/bm301493u
   BAIRATI A, 1976, CELL TISSUE RES, V166, P219
   Barrett DG, 2013, ADV FUNCT MATER, V23, P1111, DOI 10.1002/adfm.201201922
   Bauman L, 2006, DERMATOL THER, V19, P134, DOI 10.1111/j.1529-8019.2006.00067.x
   BDOLAH A, 1976, COMP BIOCHEM PHYS B, V55, P171, DOI 10.1016/0305-0491(76)90225-X
   Bell EC, 1996, J EXP BIOL, V199, P1005
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Bella J, 2006, J MOL BIOL, V362, P298, DOI 10.1016/j.jmb.2006.07.014
   BENEDICT CV, 1986, J MORPHOL, V189, P171, DOI 10.1002/jmor.1051890207
   Bertoldi K, 2007, J MATER SCI, V42, P8943, DOI 10.1007/s10853-007-1649-z
   BOBEK LA, 1988, MOL CELL BIOL, V8, P3008, DOI 10.1128/MCB.8.8.3008
   Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200
   Brazee SL, 2006, BIOL BULL-US, V211, P263, DOI 10.2307/4134548
   Brodsky B, 1995, FASEB J, V9, P1537
   Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958
   Broomell CC, 2007, J R SOC INTERFACE, V4, P19, DOI 10.1098/rsif.2006.0153
   Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434
   Carrington E, 2002, INTEGR COMP BIOL, V42, P846, DOI 10.1093/icb/42.4.846
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Cha HJ, 2009, BIOFOULING, V25, P99, DOI 10.1080/08927010802563108
   Chawla KK, 2012, COMPOSITE MAT, P542
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Choi BH, 2010, BIOMATERIALS, V31, P8980, DOI 10.1016/j.biomaterials.2010.08.027
   Choi YS, 2011, BIOFOULING, V27, P729, DOI 10.1080/08927014.2011.600830
   Claussen KU, 2013, MACROMOL BIOSCI, V13, P1396, DOI 10.1002/mabi.201300221
   Claussen KU, 2012, MACROMOL MATER ENG, V297, P938, DOI 10.1002/mame.201200032
   Claussen KU, 2012, MACROMOL RAPID COMM, V33, P206, DOI 10.1002/marc.201100620
   CONDIT CM, 1986, NATURE, V323, P178, DOI 10.1038/323178a0
   Coyne KJ, 1997, SCIENCE, V277, P1830, DOI 10.1126/science.277.5333.1830
   Coyne KJ, 2000, J EXP BIOL, V203, P1425
   CRISP DJ, 1985, J COLLOID INTERF SCI, V104, P40, DOI 10.1016/0021-9797(85)90007-4
   Cristescu R, 2005, APPL SURF SCI, V247, P217, DOI 10.1016/j.apsusc.2005.01.066
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   Danner EW, 2012, BIOCHEMISTRY-US, V51, P6511, DOI 10.1021/bi3002538
   DEVORE DP, 1984, COMP BIOCHEM PHYS B, V77, P529, DOI 10.1016/0305-0491(84)90270-0
   Doraiswamy A, 2007, MAT SCI ENG C-BIO S, V27, P409, DOI 10.1016/j.msec.2006.05.026
   Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131
   ENGEBRETSON GH, 1984, COMP BIOCHEM PHYS B, V77, P201, DOI 10.1016/0305-0491(84)90244-X
   FILPULA DR, 1990, BIOTECHNOL PROGR, V6, P171, DOI 10.1021/bp00003a001
   Fraser R. D. B., 1973, CONFORMATION FIBROUS, P344
   Fraser ROB, 1973, ALPHA HELIX, P179
   Fraser ROB, 1973, INFLUENCE COMPOSITIO, P276
   Gao CL, 2010, BIOMATERIALS, V31, P1486, DOI 10.1016/j.biomaterials.2009.11.025
   Gim Y, 2008, BIOTECHNOL PROGR, V24, P1272, DOI [10.1002/btpr.65, 10.1021/bp.65]
   Glass P, 2009, LANGMUIR, V25, P6607, DOI 10.1021/la9009114
   Goldmann AS, 2010, MACROMOL RAPID COMM, V31, P1608, DOI 10.1002/marc.201000193
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   GREEN K, 1987, CURR EYE RES, V6, P835, DOI 10.3109/02713688709034851
   Grunwald I, 2009, PHILOS T R SOC A, V367, P1727, DOI 10.1098/rsta.2009.0012
   Hagenau A, 2011, THESIS LEHRSTUHL BIO
   Hagenau A, 2011, J STRUCT BIOL, V175, P339, DOI 10.1016/j.jsb.2011.05.016
   Hagenau A, 2010, J ADHESION, V86, P10, DOI 10.1080/00218460903417701
   Hagenau A, 2009, MACROMOL BIOSCI, V9, P162, DOI 10.1002/mabi.200800271
   Hamming LM, 2008, COMPOS SCI TECHNOL, V68, P2042, DOI 10.1016/j.compscitech.2008.02.036
   Hansen DC, 1998, LANGMUIR, V14, P1139, DOI 10.1021/la970881w
   Harrington MJ, 2008, BIOMACROMOLECULES, V9, P1480, DOI 10.1021/bm8000827
   Harrington MJ, 2007, J EXP BIOL, V210, P4307, DOI 10.1242/jeb.009753
   Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044
   Harrington MJ, 2009, ADV MATER, V21, P440, DOI 10.1002/adma.200801072
   Harrington MJ, 2009, J STRUCT BIOL, V167, P47, DOI 10.1016/j.jsb.2009.03.001
   Harrington MJ, 2008, FIBROUS PROTEINS, P1
   Hassenkam T, 2004, BIOMACROMOLECULES, V5, P1351, DOI 10.1021/bm049899t
   Hayashi CY, 2001, BIOESSAYS, V23, P750, DOI 10.1002/bies.1105
   Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341
   Hellio C, 2000, BIOFOULING, V16, P235, DOI 10.1080/08927010009378448
   Holten-Andersen N, 2008, J DENT RES, V87, P701, DOI 10.1177/154405910808700808
   Holten-Andersen N, 2007, NAT MATER, V6, P669, DOI 10.1038/nmat1956
   Holten-Andersen N, 2011, P NATL ACAD SCI USA, V108, P2651, DOI 10.1073/pnas.1015862108
   Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028
   Hwang DS, 2007, J BIOTECHNOL, V127, P727, DOI 10.1016/j.jbiotec.2006.08.005
   Hwang DS, 2007, BIOMATERIALS, V28, P3560, DOI 10.1016/j.biomaterials.2007.04.039
   Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157
   Hwang DS, 2005, BIOTECHNOL PROGR, V21, P965, DOI 10.1021/bp050014e
   Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004
   Inoue K, 1996, EUR J BIOCHEM, V239, P172, DOI 10.1111/j.1432-1033.1996.0172u.x
   INOUE K, 1994, BIOL BULL, V186, P349, DOI 10.2307/1542281
   INOUE K, 1995, J BIOL CHEM, V270, P6698, DOI 10.1074/jbc.270.12.6698
   Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h
   Kang SM, 2010, ANGEW CHEM INT EDIT, V49, P9401, DOI 10.1002/anie.201004693
   Kang SM, 2009, J AM CHEM SOC, V131, P13224, DOI 10.1021/ja905183k
   Kitamura M, 1999, J POLYM SCI POL CHEM, V37, P729, DOI 10.1002/(SICI)1099-0518(19990315)37:6<729::AID-POLA8>3.3.CO;2-V
   Knight DP, 2000, INT J BIOL MACROMOL, V27, P205, DOI 10.1016/S0141-8130(00)00124-0
   Krauss S, 2013, BIOMACROMOLECULES, V14, P1520, DOI 10.1021/bm4001712
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Lee SJ, 2008, MOL CELLS, V26, P34
   Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104
   Lucas JM, 2002, J EXP BIOL, V205, P1807
   MARUMO K, 1987, J EXP ZOOL, V244, P365, DOI 10.1002/jez.1402440303
   Mayer G, 2002, EXP MECH, V42, P395, DOI 10.1007/BF02412144
   Mercer E, 1952, MAR FRESHWATER RES, V3, P199
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117
   Moeser GM, 2006, J EXP BIOL, V209, P1996, DOI 10.1242/jeb.02234
   Nagarajan V, 1999, J BIOCHEM-TOKYO, V125, P310, DOI 10.1093/oxfordjournals.jbchem.a022288
   OKUYAMA K, 1972, J MOL BIOL, V72, P571, DOI 10.1016/0022-2836(72)90175-1
   Okuyama K, 1999, P INDIAN AS-CHEM SCI, V111, P19
   Okuyama K, 2008, CONNECT TISSUE RES, V49, P299, DOI 10.1080/03008200802325110
   Olivieri MP, 2010, J ADHESION, V86, P111, DOI 10.1080/00218460903418154
   OLIVIERI MP, 1990, J ADHES SCI TECHNOL, V4, P197, DOI 10.1163/156856190X00216
   Pace CN, 1998, BIOPHYS J, V75, P422
   PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183
   Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d
   Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200
   PIKKARAINEN J, 1968, EUR J BIOCHEM, V4, P555, DOI 10.1111/j.1432-1033.1968.tb00248.x
   Platko JD, 2008, PROTEIN EXPRES PURIF, V57, P57, DOI 10.1016/j.pep.2007.08.013
   PRICE HA, 1983, J MOLLUS STUD, V49, P9, DOI 10.1093/oxfordjournals.mollus.a065695
   Pujol MM, 1972, ARCH ZOOL EXP GEN, V113, P251
   QIN XX, 1995, J EXP BIOL, V198, P633
   Qin XX, 1998, P NATL ACAD SCI USA, V95, P10517, DOI 10.1073/pnas.95.18.10517
   Qin XX, 1997, J BIOL CHEM, V272, P32623, DOI 10.1074/jbc.272.51.32623
   Raabe D, 2005, ACTA MATER, V53, P4281, DOI 10.1016/j.actamat.2005.05.027
   Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977
   RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0
   Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/nmat3115, 10.1038/NMAT3115]
   RUDALL K. M., 1955, S SOC EXP BIOL, V9, P49
   RZEPECKI LM, 1992, BIOL BULL, V183, P123, DOI 10.2307/1542413
   Sadick N, 2007, EXPERT REV MED DEVIC, V4, P559, DOI 10.1586/17434440.4.4.559
   Sagert J, 2006, BIOLOGICAL ADHESIVES, P125, DOI 10.1007/978-3-540-31049-5_7
   Sagert J, 2009, J EXP BIOL, V212, P2224, DOI 10.1242/jeb.029686
   Sai P, 2000, BURNS, V26, P54
   SALERNO AJ, 1993, APPL MICROBIOL BIOT, V39, P221
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x
   SMEATHERS JE, 1979, J MOLLUS STUD, V45, P219, DOI 10.1093/oxfordjournals.mollus.a065497
   SMYTH JD, 1954, Q J MICROSC SCI, V95, P139
   STRAUSBERG RL, 1989, ACS SYM SER, V385, P462
   Suhre MH, 2013, THESIS LEHRSTUHL BIO
   Suhre MH, 2014, ACTA CRYSTAL F UNPUB
   Suhre MH, 2014, NAT COMMUN
   Suhre MH, 2014, J STRUCT BIOL, V186, P75, DOI 10.1016/j.jsb.2014.02.013
   Sun CJ, 2005, J BIOL CHEM, V280, P39332, DOI 10.1074/jbc.M508674200
   Sun CJ, 2002, BIOMACROMOLECULES, V3, P1240, DOI 10.1021/bm0255903
   Sun CJ, 2001, BIOPHYS J, V81, P3590, DOI 10.1016/S0006-3495(01)75989-9
   Suresh S, 2001, SCIENCE, V292, P2447, DOI 10.1126/science.1059716
   TAMARIN A, 1976, J MORPHOL, V149, P199, DOI 10.1002/jmor.1051490205
   TAMARIN A, 1972, J ULTRA MOL STRUCT R, V40, P401, DOI 10.1016/S0022-5320(72)90110-4
   TAMARIN A, 1974, J MORPHOL, V142, P321, DOI 10.1002/jmor.1051420307
   TAYLOR SW, 1994, J AM CHEM SOC, V116, P10803, DOI 10.1021/ja00102a063
   Thiagranjan G, 2008, J MOL BIOL, V376, P736, DOI 10.1016/j.jmb.2007.11.075
   Vaccaro E, 2001, BIOMACROMOLECULES, V2, P906, DOI 10.1021/bm0100514
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72
   VITELLAROZUCCARELLO L, 1983, TISSUE CELL, V15, P547, DOI 10.1016/0040-8166(83)90006-X
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Waite J.H., 1992, Results and Problems in Cell Differentiation, V19, P27
   Waite JH, 2012, J EXP BIOL, V215, P873, DOI 10.1242/jeb.058925
   WAITE JH, 1980, BIOCHEM BIOPH RES CO, V96, P1554, DOI 10.1016/0006-291X(80)91351-0
   WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P
   Waite JH, 1998, MATRIX BIOL, V17, P93, DOI 10.1016/S0945-053X(98)90023-3
   Waite JH, 2004, BIOCHEMISTRY-US, V43, P7653, DOI 10.1021/bi049380h
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Waite JH, 2002, PHILOS T R SOC B, V357, P143, DOI 10.1098/rstb.2001.1025
   WAITE JH, 1983, J BIOL CHEM, V258, P2911
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   WAITE JH, 1985, J MAR BIOL ASSOC UK, V65, P359, DOI 10.1017/S0025315400050487
   WAITE JH, 1991, CHEM IND-LONDON, P607
   Wang J, 2007, BIOMATERIALS, V28, P3456, DOI 10.1016/j.biomaterials.2007.04.009
   Westwood G, 2007, MACROMOLECULES, V40, P3960, DOI 10.1021/ma0703002
   Xu CJ, 2004, J AM CHEM SOC, V126, P9938, DOI 10.1021/ja0464802
   Yamamoto H, 1996, BIOTECHNOL GENET ENG, V13, P133, DOI 10.1080/02648725.1996.10647926
   Yin M, 2009, BIOMATERIALS, V30, P2764, DOI 10.1016/j.biomaterials.2009.01.039
   Yu J, 2011, NAT CHEM BIOL, V7, P588, DOI [10.1038/NCHEMBIO.630, 10.1038/nchembio.630]
   Yu J, 2011, ADV MATER, V23, P2362, DOI 10.1002/adma.201003580
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Zhao H, 2006, J BIOL CHEM, V281, P11090, DOI 10.1074/jbc.M510792200
   Zhao H, 2006, BIOCHEMISTRY-US, V45, P14223, DOI 10.1021/bi061677n
   Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200
   Zhao H, 2009, J BIOL CHEM, V284, P23344, DOI 10.1074/jbc.M109.022517
   ZUCCARELLO LV, 1980, J ULTRA MOL STRUCT R, V73, P135, DOI 10.1016/S0022-5320(80)90119-7
NR 178
TC 22
Z9 22
U1 7
U2 111
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
EI 1873-1619
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD AUG
PY 2014
VL 39
IS 8
BP 1564
EP 1583
DI 10.1016/j.progpolymsci.2014.02.007
PG 20
WC Polymer Science
SC Polymer Science
GA AM9TM
UT WOS:000340223900004
DA 2018-10-20
ER

PT J
AU Pertici, V
   Laurin, J
   Marqueste, T
   Decherchi, P
AF Pertici, Vincent
   Laurin, Jerome
   Marqueste, Tanguy
   Decherchi, Patrick
TI Comparison of a collagen membrane versus a fibrin sealant after a
   peroneal nerve section and repair: a functional and histological study
SO ACTA NEUROCHIRURGICA
LA English
DT Article
DE Biomaterial; Peroneal function index; Kinematic analysis; Anastomosis;
   Rat
ID RAT SCIATIC-NERVE; GROWTH-FACTOR; REGENERATION; GLUE; REDUCTION;
   RECOVERY; ADHESION
AB To date, fibrin sealant is considered to be one of the most effective substitutes to prevent post-operative fibrosis and to limit neuroma formation after nerve suture. Because fibrin sealant presents a number of drawbacks, more suitable techniques should be considered. The aim of this study was to functionally and histologically compare the efficiency of a fibrin sealant to a resorbable semi-permeable porcine type I collagen membrane after a peroneal nerve lesion and repair on rats.
   Rats were divided into four groups: (1) a SHAM group (n = 10) in which surgery was performed without damaging the nerve, (2) a LESION group (n = 15) in which the nerve was cut and immediately sutured without additional treatment, (3) a MEMBRANE group (n = 30) in which a collagen membrane was wrapped around the lesion site, and (4) a GLUE group (n = 30) in which the peroneal nerve was coated by fibrin sealant. Peroneal Functional Index (PFI), kinematic analysis of locomotion, muscular atrophy, axonal regrowth, and irritant ranking score (IRS) were performed during three months post-surgery.
   Our results indicate that at the third month post-surgery, no difference in both the functional recovery and the histological measurement was observed between groups. However, no deleterious effect was observed following the use of the collagen membrane. Indeed, the porcine membrane was well-integrated into the host tissue, with no noticeable foreign body reaction at three months post-surgery.
   Our preliminary results highlight the fact that the collagen membrane could be used as an alternative to fibrin sealant in peripheral nerve repair surgery. Indeed, animals in which the collagen membrane was used to wrap the lesion site exhibited similar functional and histological results as animals in which a fibrin sealant was used to coat the lesion. The greatest advantage of this membrane is that it could be used as a drug delivery device, regulated by its degradation rate.
C1 [Pertici, Vincent; Laurin, Jerome; Marqueste, Tanguy; Decherchi, Patrick] Aix Marseille Univ, F-13288 Marseille 09, France.
   [Pertici, Vincent; Laurin, Jerome; Marqueste, Tanguy; Decherchi, Patrick] Fac Sci Sport Marseille, Parc Sci & Technol Luminy, Equipe Plasticite Syst Nerveux & Musculaire, CNRS,UMR 7287,Inst Sci Mouvement ISM Etienne Jule, F-13288 Marseille 09, France.
RP Decherchi, P (reprint author), Aix Marseille Univ, CC910,163 Ave Luminy, F-13288 Marseille 09, France.
EM patrick.decherchi@univ-amu.fr
OI DECHERCHI, Patrick/0000-0001-5639-852X
FU Association Mediterraneenne pour le Developpement des Transplantations
   (AMDT); Aix-Marseille Universite (AMU); Centre National de la Recherche
   Scientifique (CNRS)
FX This work was supported by the Association Mediterraneenne pour le
   Developpement des Transplantations (AMDT). Grants were provided from
   Aix-Marseille Universite (AMU) and the Centre National de la Recherche
   Scientifique (CNRS). Biom'Up S.A (Saint Priest, France) provided the
   Cova (TM) membrane. The authors are grateful to Violaine SEVREZ and Numa
   BASILIO for their helpful assistance in Matlab (R) programming and
   statistical analysis, respectively. We also thank Biomatech S.A
   (Chasse-sur-Rhone, France) for their excellent help in histology and
   microscopy.
CR Alluin O, 2009, BIOMATERIALS, V30, P363, DOI 10.1016/j.biomaterials.2008.09.043
   BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024
   Bel A, 2010, INTERACT CARDIOV TH, V10, P213, DOI 10.1510/icvts.2009.215251
   Dam-Hieu Phong, 2005, Neurosurgery, V56, P425, DOI 10.1227/01.NEU.0000156845.41626.E9
   de Ruiter GC, 2007, J PERIPHER NERV SYST, V12, P216, DOI 10.1111/j.1529-8027.2007.00142.x
   Dreesmann L, 2009, EUR J CELL BIOL, V88, P285, DOI 10.1016/j.ejcb.2009.01.001
   Forest P, 2007, BIO-MED MATER ENG, V17, P199
   Gagnieu CH, 2007, BIO-MED MATER ENG, V17, P9
   Gao CZ, 2008, INJURY, V39, P1414, DOI 10.1016/j.injury.2008.05.010
   Ide C, 1998, EXP NEUROL, V154, P99, DOI 10.1006/exnr.1998.6921
   Ikeda K, 2003, BRIT J PLAST SURG, V56, P342, DOI 10.1016/S0007-1226(03)00197-8
   Inaloz SS, 1997, NEUROSURG REV, V20, P250, DOI 10.1007/BF01105896
   Jackson MR, 2001, AM J SURG, V182, p1S, DOI 10.1016/S0002-9610(01)00770-X
   Jeans LA, 2007, J PLAST RECONSTR AES, V60, P1302, DOI 10.1016/j.bjps.2006.06.014
   Kanazawa R, 2010, NEUROL MED-CHIR, V50, P608, DOI 10.2176/nmc.50.608
   Kim PD, 2010, MICROSURG, V30, P392, DOI 10.1002/micr.20760
   Marcol W, 2011, MICROSURG, V31, P642, DOI 10.1002/micr.20945
   MARTINS RS, 2005, SURG NEUROL S1, V64, P10, DOI DOI 10.1016/J.SURNEU.2005.04.022
   Masmejean E, 2011, E-MEM ACAD NATL CHIR, V10, P33, DOI 10.14607/emem.2011.1.033
   Mathieu L, 2012, CHIR MAIN, V31, P311, DOI 10.1016/j.main.2012.10.167
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   MILLESI H, 1990, Annales de Chirurgie de la Main et du Membre Superieur, V9, P87, DOI 10.1016/S0753-9053(05)80485-5
   Ohsumi H, 2005, PLAST RECONSTR SURG, V116, P823, DOI 10.1097/01.prs.0000176893.44656.8e
   Ohta M, 2008, NEUROL MED-CHIR, V48, P30, DOI 10.2176/nmc.48.30
   Okui N, 2010, MUSCLE NERVE, V42, P570, DOI 10.1002/mus.21727
   Ornelas L, 2006, J RECONSTR MICROSURG, V22, P123, DOI 10.1055/s-2006-932507
   Radosevich M, 1997, VOX SANG, V72, P133, DOI 10.1046/j.1423-0410.1997.7230133.x
   Sameem M, 2011, PLAST RECONSTR SURG, V127, P2381, DOI 10.1097/PRS.0b013e3182131cf5
   SANTOS PM, 1995, J NEUROSCI METH, V61, P79, DOI 10.1016/0165-0270(95)00026-Q
   Shaffer SW, 2007, PHYS THER, V87, P193, DOI 10.2522/ptj.20060083
   Spicer PP, 2010, J CONTROL RELEASE, V148, P49, DOI 10.1016/j.jconrel.2010.06.025
   Vleggeert-Lankamp CLAM, 2007, J NEUROSURG, V107, P1168, DOI 10.3171/JNS-07/12/1168
   Xu JM, 2000, J HAND SURG-AM, V25A, P93
NR 33
TC 3
Z9 3
U1 1
U2 10
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0001-6268
EI 0942-0940
J9 ACTA NEUROCHIR
JI Acta Neurochir.
PD AUG
PY 2014
VL 156
IS 8
BP 1577
EP 1590
DI 10.1007/s00701-014-2117-6
PG 14
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA AM3BA
UT WOS:000339724900025
PM 24875612
DA 2018-10-20
ER

PT J
AU Wu, ZY
   Tang, TT
   Guo, H
   Tang, SC
   Niu, YF
   Zhang, J
   Zhang, WJ
   Ma, R
   Su, JC
   Liu, CS
   Wei, J
AF Wu, Zhaoying
   Tang, Tingting
   Guo, Han
   Tang, Songchao
   Niu, Yunfei
   Zhang, Jue
   Zhang, Wenjing
   Ma, Rui
   Su, Jiacan
   Liu, Changsheng
   Wei, Jie
TI In vitro degradability, bioactivity and cell responses to mesoporous
   magnesium silicate for the induction of bone regeneration
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE esoporous magnesium silicate; Water absorption; Degradation; Bioactive
   materials; Cytocompatibility
ID DRUG-DELIVERY; GLASS SCAFFOLDS; NANOPARTICLES; ENHANCEMENT; BIOCERAMICS;
   STABILITY; CERAMICS; CHITOSAN; RELEASE; ALLOY
AB Mesoporous magnesium silicate (m-MS) was synthesized, and the in vitro degradability, bioactivity and primary cell responses to m-MS were investigated. The results suggested that the m-MS with mesoporous channels of approximately 5 nm possessed the high specific surface area of 451.0 m(2)/g and a large specific pore volume of 0.41 cm(3)/g compared with magnesium silicate (MS) without mesopores of 75 m2/g and 0.21 cm(3)/g, respectively. The m-MS was able to absorb a large number of water, with water absorption of 74% compared with 26% for MS. The m-MS was also degradable in a Tris-HCI solution, with a weight loss ratio of 40 wt% after a 70-day immersion period. The m-MS exhibited good in vitro bioactivity, inducing apatite formation on its surfaces after soaking in simulated body fluid (SBF) at a faster rate than observed for MS. The m-MS surface clearly promoted the proliferation and differentiation of MC3T3-E1 cells, and their normal cell morphology indicated excellent cytocompatibility. This study suggested that mesoporous magnesium silicate with a high specific surface area and pore volume had suitable degradability and good bioactivity and biocompatibility, making it an excellent candidate biomaterial for the induction of bone regeneration. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Wu, Zhaoying; Tang, Songchao; Zhang, Jue; Zhang, Wenjing; Liu, Changsheng; Wei, Jie] E China Univ Sci & Technol, Minist Educ, Key Lab Ultrafine Mat, Shanghai 200237, Peoples R China.
   [Tang, Tingting; Ma, Rui] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthopaed Implants, Dept Orthopaed Surg,Sch Med, Shanghai 200011, Peoples R China.
   [Guo, Han] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai Synchrotron Radiat Facil, Shanghai 201800, Peoples R China.
   [Niu, Yunfei; Su, Jiacan] Second Mil Med Univ, Changhai Hosp, Dept Orthopaed, Shanghai 200433, Peoples R China.
RP Liu, CS (reprint author), E China Univ Sci & Technol, Minist Educ, Key Lab Ultrafine Mat, Shanghai 200237, Peoples R China.
EM biomaterbone@163.com; jiewei7860@sina.com
RI Tang, Tingting/B-1361-2013
OI Tang, Tingting/0000-0002-1670-7452
FU National Natural Science Foundation of China [81271705, 81000799,
   31100680]; Nano special program of Science and Technology Development of
   Shanghai [12nm0500400]; Key Medical Program of Science and Technology
   Development of Shanghai [12441903600]; Opening Project of Shanghai Key
   Laboratory of Orthopaedic Implants
FX This study was supported by grants from the National Natural Science
   Foundation of China (No. 81271705, 81000799 and 31100680), the Nano
   special program of Science and Technology Development of Shanghai (No.
   12nm0500400), the Key Medical Program of Science and Technology
   Development of Shanghai (No. 12441903600), and the Opening Project of
   Shanghai Key Laboratory of Orthopaedic Implants.
CR Chen ZD, 2012, COLLOID SURFACE B, V95, P274, DOI 10.1016/j.colsurfb.2012.03.012
   Dai CL, 2010, BIOMATERIALS, V31, P7620, DOI 10.1016/j.biomaterials.2010.06.049
   Delcroix GJR, 2011, BIOMATERIALS, V32, P1560, DOI 10.1016/j.biomaterials.2010.10.041
   Diba M, 2012, INT J APPL GLASS SCI, V3, P221, DOI 10.1111/j.2041-1294.2012.00095.x
   Guo Z, 2013, COLLOID SURFACE B, V101, P228, DOI 10.1016/j.colsurfb.2012.06.026
   Hong YJ, 2011, COLLOID SURFACE B, V83, P245, DOI 10.1016/j.colsurfb.2010.11.028
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077
   Kuo YC, 2011, COLLOID SURFACE B, V84, P63, DOI 10.1016/j.colsurfb.2010.12.021
   Lee S, 2011, BIOMATERIALS, V32, P9434, DOI 10.1016/j.biomaterials.2011.08.042
   Li JN, 2010, BIOMATERIALS, V31, P5782, DOI 10.1016/j.biomaterials.2010.04.023
   Liu GQ, 2013, COLLOID SURFACE B, V111, P7, DOI 10.1016/j.colsurfb.2013.05.027
   Masuda Y, 2013, COLLOID SURFACE B, V101, P26, DOI 10.1016/j.colsurfb.2012.05.037
   Misra SK, 2010, BIOMATERIALS, V31, P2806, DOI 10.1016/j.biomaterials.2009.12.045
   Moreno A.I., 2012, J NANOTECHNOL, V2012, P1687
   Moscofian ASO, 2008, MICROPOR MESOPOR MAT, V107, P113, DOI 10.1016/j.micromeso.2007.05.047
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Pan YK, 2013, COLLOID SURFACE B, V109, P1, DOI 10.1016/j.colsurfb.2013.03.026
   Ruiz-Hernandez SE, 2012, CHEM-EUR J, V18, P9828, DOI 10.1002/chem.201200966
   Salinas AJ, 2000, BIOMATERIALS, V21, P251, DOI 10.1016/S0142-9612(99)00150-7
   Salinas AJ, 2013, RSC ADV, V3, P11116, DOI 10.1039/c3ra00166k
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tabasi O, 2012, COLLOID SURFACE B, V98, P18, DOI 10.1016/j.colsurfb.2012.04.018
   Vallet-Regi M, 2012, PHILOS T R SOC A, V370, P1400, DOI 10.1098/rsta.2011.0258
   Verron E, 2010, BIOMATERIALS, V31, P7776, DOI 10.1016/j.biomaterials.2010.06.047
   Vlad MD, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/2/025006
   Volpe SL, 2013, ADV NUTR, V4, p378S, DOI 10.3945/an.112.003483
   Wang HX, 2011, COLLOID SURFACE B, V88, P254, DOI 10.1016/j.colsurfb.2011.06.040
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Wang XL, 2011, COLLOID SURFACE B, V82, P233, DOI 10.1016/j.colsurfb.2010.08.047
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu X., 2010, BIOMED MATER, V3, P1748
   Zhang W, 2011, BIOMATERIALS, V32, P2894, DOI 10.1016/j.biomaterials.2010.12.039
NR 34
TC 33
Z9 33
U1 5
U2 112
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD AUG 1
PY 2014
VL 120
BP 38
EP 46
DI 10.1016/j.colsurfb.2014.04.010
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AM3TA
UT WOS:000339774500006
PM 24905677
DA 2018-10-20
ER

PT J
AU Han, YL
   Xu, Q
   Lu, ZQ
   Wang, JY
AF Han, Yi-Long
   Xu, Qin
   Lu, Zhi-Qian
   Wang, Jin-Ye
TI Preparation of transparent zein films for cell culture applications
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Zein; Transparent; Degradation; Swelling; Cell culture
ID X-RAY-DIFFRACTION; MICROFLUIDIC DEVICES; ALPHA-ZEIN;
   PHYSICAL-PROPERTIES; FTIR SPECTROSCOPY; ACID FILMS; PROTEIN; CORN;
   BIOMATERIAL
AB In our previous studies, zein has shown good cell compatibility in both films and porous scaffolds. To use the zein film in microfluidic devices or as a cell culture substrate, swelling and excessive degradation should be avoided. Moreover, the film should be transparent. In this study, we found that the zein film could maintain good transparency even after swelling when it was treated for 20min at 121 degrees C, 100% relative humidity and 103.4 kPa, especially for the zein film without the addition of a plasticizer. Fr-IR and XRD analysis showed that the ratio of a-helix of zein structure decreased and the ratio of its beta-sheet increased. Proliferation of NIH 3T3 cells on the transparent zein film was as cytocompatible as the untreated one and the cell culture plate. The improved transparency of zein films after swelling will expand the application field of zein. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Han, Yi-Long; Xu, Qin; Wang, Jin-Ye] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200240, Peoples R China.
   [Lu, Zhi-Qian] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp Affiliated 6, Dept Cardiothorac Surg, Shanghai 200233, Peoples R China.
RP Wang, JY (reprint author), Shanghai Jiao Tong Univ, Sch Biomed Engn, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.
EM jinyewang@sjtu.edu.cn
RI Wang, Jin-Ye/H-1450-2011
FU National Natural Science Foundation of China [30870635, 31070868];
   International S&T Cooperation Program of China [2012DFA30270,
   2014DFG02330]; Shanghai Municipal Science and Technology Commission
   [13JC1403400]; Medical Engineering Cooperation Program of SJTU
   [YG2010MS69]
FX This study was supported by the National Natural Science Foundation of
   China (30870635, 31070868), the International S&T Cooperation Program of
   China (2012DFA30270, 2014DFG02330), Shanghai Municipal Science and
   Technology Commission (13JC1403400), and the Medical Engineering
   Cooperation Program of SJTU (YG2010MS69).
CR Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X
   Cabodi M, 2005, J AM CHEM SOC, V127, P13788, DOI 10.1021/ja054820t
   de Almeida CB, 2011, MACROMOL SYMP, V299-300, P20, DOI 10.1002/masy.200900082
   Domachuk P, 2010, ADV MATER, V22, P249, DOI 10.1002/adma.200900821
   Emmambux MN, 2009, J AGR FOOD CHEM, V57, P1045, DOI 10.1021/jf802672e
   Forato LA, 2003, BIOPOLYMERS, V72, P421, DOI 10.1002/bip.10481
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hu ZK, 2008, J AM CHEM SOC, V130, P14244, DOI 10.1021/ja803991n
   JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140
   Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b
   Kim S, 2008, J CEREAL SCI, V47, P1, DOI 10.1016/j.jcs.2007.08.004
   King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522
   Lai HM, 1999, J APPL POLYM SCI, V71, P1267, DOI 10.1002/(SICI)1097-4628(19990222)71:8<1267::AID-APP7>3.0.CO;2-O
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawton JW, 2004, CEREAL CHEM, V81, P1, DOI 10.1094/CCHEM.2004.81.1.1
   Lawton JW, 2002, CEREAL CHEM, V79, P1, DOI 10.1094/CCHEM.2002.79.1.1
   Lehninger AL, 2000, LEHNINGER PRINCIPLES
   Luecha J, 2011, LAB CHIP, V11, P3419, DOI 10.1039/c1lc20726a
   MAGOSHI J, 1992, J APPL POLYM SCI, V45, P2043, DOI 10.1002/app.1992.070451119
   Maran JP, 2013, CARBOHYD POLYM, V92, P1335, DOI 10.1016/j.carbpol.2012.09.069
   Matsushima N, 1997, BBA-PROTEIN STRUCT M, V1339, P14, DOI 10.1016/S0167-4838(96)00212-9
   Paguirigan A, 2006, LAB CHIP, V6, P407, DOI 10.1039/b517524k
   SCHULZ GE, 1979, PRINCIPLES PROTEIN S
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Singh N, 2009, J AGR FOOD CHEM, V57, P4334, DOI 10.1021/jf900436q
   Sun QS, 2005, BIOPOLYMERS, V78, P268, DOI 10.1002/bip.20298
   Teng WB, 2011, J PHYS CHEM B, V115, P1608, DOI 10.1021/jp109764f
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   van Midwoud PM, 2012, ANAL CHEM, V84, P3938, DOI 10.1021/ac300771z
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang Y, 2005, MACROMOL BIOSCI, V5, P1200, DOI 10.1002/mabi.200500140
   Wang YL, 2001, J AGR FOOD CHEM, V49, P3414, DOI 10.1021/jf010076u
   Wojciechowska E, 1999, J MOL STRUCT, V511, P307, DOI 10.1016/S0022-2860(99)00173-8
   Yong YH, 2004, J AGR FOOD CHEM, V52, P7094, DOI 10.1021/jf040133u
   Yoshino T, 2002, J AM OIL CHEM SOC, V79, P345, DOI 10.1007/s11746-002-0486-6
   Zhang BC, 2011, FOOD CHEM, V124, P210, DOI 10.1016/j.foodchem.2010.06.019
NR 36
TC 12
Z9 13
U1 2
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD AUG 1
PY 2014
VL 120
BP 55
EP 62
DI 10.1016/j.colsurfb.2014.04.019
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AM3TA
UT WOS:000339774500008
PM 24905679
DA 2018-10-20
ER

PT J
AU Lass, R
   Giurea, A
   Kubista, B
   Hirschl, AM
   Graninger, W
   Presterl, E
   Windhager, R
   Holinka, J
AF Lass, Richard
   Giurea, Alexander
   Kubista, Bernd
   Hirschl, Alexander M.
   Graninger, Wolfgang
   Presterl, Elisabeth
   Windhager, Reinhard
   Holinka, Johannes
TI Bacterial adherence to different components of total hip prosthesis in
   patients with prosthetic joint infection
SO INTERNATIONAL ORTHOPAEDICS
LA English
DT Article
DE Total hip prosthesis; Periprosthetic joint infection; Sonication
   culture; Microbial biofilm; Bacterial adherence; Biomaterial
ID SONICATE FLUID CULTURES; POSTOPERATIVE INFECTION; ULTRACLEAN AIR;
   ARTHROPLASTY; REPLACEMENT; DIAGNOSIS; IMPLANTS; RISK
AB Purpose The purpose of our study was to evaluate and quantify the bacterial adherence to the different components of total hip prosthesis.
   Methods The bacterial load of 80 retrieved hip components from 24 patients was evaluated by counting of colony-forming units (CFU) dislodged from component surfaces using the sonication culture method.
   Results Micro-organisms were detected in 68 of 80 explanted components. The highest bacterial load was detected on the polyethylene liners, showing a significant difference in distribution of CFU between the liner and metal components (stem and cup). Staphylococcus epidermidis was identified as the pathogen causing the highest CFU count, especially from the polyethylene liner.
   Conclusions Results of our study confirm that sonicate culture of the retrieved liners and heads, which revealed the highest bacterial loads, are reliable and sufficient for pathogen detection in the clinical diagnostic routine.
C1 [Lass, Richard; Giurea, Alexander; Kubista, Bernd; Windhager, Reinhard; Holinka, Johannes] Med Univ Vienna, Dept Orthoped Surg, A-1090 Vienna, Austria.
   [Hirschl, Alexander M.] Med Univ Vienna, Dept Clin Microbiol, A-1090 Vienna, Austria.
   [Graninger, Wolfgang] Med Univ Vienna, Dept Med 1, Div Infect Dis, A-1090 Vienna, Austria.
   [Presterl, Elisabeth] Med Univ Vienna, Clin Inst Hyg & Med Microbiol, A-1090 Vienna, Austria.
RP Lass, R (reprint author), Med Univ Vienna, Dept Orthoped Surg, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.
EM richard.lass@meduniwien.ac.at
CR Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991
   CHARNLEY J, 1969, BRIT J SURG, V56, P641, DOI 10.1002/bjs.1800560902
   Choi HR, 2012, INT ORTHOP, V36, P1609, DOI [10.1007/s00264-011-1324-5, 10.1007/s00264-012-1541-6]
   CORDERO J, 1994, J BONE JOINT SURG BR, V76B, P717
   Cordero J, 1996, INJURY, V27, P34
   Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9
   Del Gaizo DJ, 2012, CLIN ORTHOP RELAT R, V470, P395, DOI 10.1007/s11999-011-2170-x
   Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029
   Esteban J, 2008, J CLIN MICROBIOL, V46, P488, DOI 10.1128/JCM.01762-07
   Gomez-Barrena E, 2012, J ORTHOP RES, V30, P1634, DOI 10.1002/jor.22114
   Holinka J, 2012, INT J ARTIF ORGANS, V35, P735, DOI 10.5301/ijao.5000152
   Holinka J, 2011, J ORTHOP RES, V29, P617, DOI 10.1002/jor.21286
   Janz V, 2013, J ORTHOP RES, V31, P2021, DOI 10.1002/jor.22451
   Janz V, 2013, INT ORTHOP, V37, P931, DOI 10.1007/s00264-013-1853-1
   Klouche S, 2010, ORTHOP TRAUMATOL-SUR, V96, P124, DOI [10.1016/j.otsr.2009.11.004, 10.1016/j.rcot.2010.02.005]
   LIDWELL OM, 1987, ACTA ORTHOP SCAND, V58, P4, DOI 10.3109/17453678709146334
   LIDWELL OM, 1982, BRIT MED J, V285, P10, DOI 10.1136/bmj.285.6334.10
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   Phillips JE, 2006, J BONE JOINT SURG BR, V88B, P943, DOI 10.1302/0301-620X.88B7.17150
   Trampuz A, 2006, J CLIN MICROBIOL, V44, P628, DOI 10.1128/JCM.44.2.628-631.2006
   Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588
   Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 23
TC 15
Z9 15
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0341-2695
EI 1432-5195
J9 INT ORTHOP
JI Int. Orthop.
PD AUG
PY 2014
VL 38
IS 8
BP 1597
EP 1602
DI 10.1007/s00264-014-2358-2
PG 6
WC Orthopedics
SC Orthopedics
GA AM5II
UT WOS:000339890100010
PM 24817024
OA Green Published
DA 2018-10-20
ER

PT J
AU Tran, RT
   Wang, L
   Zhang, C
   Huang, MJ
   Tang, WJ
   Zhang, C
   Zhang, ZM
   Jin, DD
   Banik, B
   Brown, JL
   Xie, ZW
   Bai, XC
   Yang, J
AF Tran, Richard T.
   Wang, Liang
   Zhang, Chang
   Huang, Minjun
   Tang, Wanjin
   Zhang, Chi
   Zhang, Zhongmin
   Jin, Dadi
   Banik, Brittany
   Brown, Justin L.
   Xie, Zhiwei
   Bai, Xiaochun
   Yang, Jian
TI Synthesis and characterization of biomimetic citrate-based biodegradable
   composites
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone tissue engineering; biodegradable composites; citric acid; osterix
ID TRANSCRIPTION FACTOR OSTERIX; CITRIC-ACID; BONE-FORMATION;
   HYDROXYAPATITE COMPOSITE; ORTHOPEDIC APPLICATIONS; OCTACALCIUM
   PHOSPHATE; POLYESTER ELASTOMERS; CORTICAL BONE; IN-VITRO; POLYMER
AB Natural bone apatite crystals, which mediate the development and regulate the load-bearing function of bone, have recently been associated with strongly bound citrate molecules. However, such understanding has not been translated into bone biomaterial design and osteoblast cell culture. In this work, we have developed a new class of biodegradable, mechanically strong, and biocompatible citrate-based polymer blends (CBPBs), which offer enhanced hydroxyapatite binding to produce more biomimetic composites (CBPBHAs) for orthopedic applications. CBPBHAs consist of the newly developed osteoconductive citrate-presenting biodegradable polymers, crosslinked urethane-doped polyester and poly (octanediol citrate), which can be composited with up to 65 wt % hydroxyapatite. CBPBHA networks produced materials with a compressive strength of 116.23 +/- 5.37 MPa comparable to human cortical bone (100-230 MPa), and increased C2C12 osterix gene and alkaline phosphatase gene expression in vitro. The promising results above prompted an investigation on the role of citrate supplementation in culture medium for osteoblast culture, which showed that exogenous citrate supplemented into media accelerated the in vitro phenotype progression of MG-63 osteoblasts. After 6 weeks of implantation in a rabbit lateral femoral condyle defect model, CBPBHA composites elicited minimal fibrous tissue encapsulation and were well integrated with the surrounding bone tissues. The development of citrate-presenting CBPBHA biomaterials and preliminary studies revealing the effects of free exogenous citrate on osteoblast culture shows the potential of citrate biomaterials to bridge the gap in orthopedic biomaterial design and osteoblast cell culture in that the role of citrate molecules has previously been overlooked. (C) 2013 Wiley Periodicals, Inc.
C1 [Tran, Richard T.; Banik, Brittany; Brown, Justin L.; Xie, Zhiwei; Yang, Jian] Penn State Univ, Dept Bioengn, Mat Res Inst, Huck Inst Life Sci, University Pk, PA 16802 USA.
   [Wang, Liang; Huang, Minjun; Zhang, Zhongmin; Jin, Dadi; Bai, Xiaochun] Southern Med Univ, Acad Orthoped, Affiliated Hosp 3, Dept Orthoped, Guangzhou 510665, Guangdong, Peoples R China.
   [Wang, Liang; Huang, Minjun; Zhang, Zhongmin; Jin, Dadi; Bai, Xiaochun] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510515, Guangdong, Peoples R China.
   [Zhang, Chang] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76010 USA.
   [Tang, Wanjin; Zhang, Chi] Univ Texas SW Med Ctr Dallas, Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA.
RP Yang, J (reprint author), Penn State Univ, Dept Bioengn, Mat Res Inst, Huck Inst Life Sci, University Pk, PA 16802 USA.
EM baixc15@smu.edu.cn; jxy30@psu.edu
RI Xie, Zhiwei/M-5295-2013; Brown, Justin/N-4775-2015; Yang,
   Jian/N-1291-2014
OI Xie, Zhiwei/0000-0001-9776-8726; Brown, Justin/0000-0001-9401-6094;
   Yang, Jian/0000-0003-0695-828X
FU National Institute of Biomedical Imaging and Bioengineering (NIBIB)
   [EB012575]; National Science Foundation (NSF) CAREER award [1313553];
   National Natural Sciences Foundation of China [31228007]; Arthritis
   Foundation; Texas Scottish Rite Hospital for Children [RAP01]
FX Contract grant sponsor: National Institute of Biomedical Imaging and
   Bioengineering (NIBIB); contract grant number: R01 award EB012575;
   Contract grant sponsor: National Science Foundation (NSF) CAREER award;
   contract grant number: 1313553; Contract grant sponsor: National Natural
   Sciences Foundation of China; contract grant number: 31228007; Contract
   grant sponsor: Arthritis Foundation; Contract grant sponsor: Texas
   Scottish Rite Hospital for Children; contract grant number: RAP01
CR Ao ZM, 2006, LANGMUIR, V22, P1241, DOI 10.1021/la0516779
   Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108
   Brauer DS, 2007, J BIOMED MATER RES A, V80A, P410, DOI 10.1002/jbm.a.30902
   Chesnutt BM, 2009, J BIOMED MATER RES A, V88A, P491, DOI 10.1002/jbm.a.31878
   Childs THC, 2011, MACH SCI TECHNOL, V15, P206, DOI 10.1080/10910344.2011.580699
   Chung EJ, 2011, ACTA BIOMATER, V7, P4057, DOI 10.1016/j.actbio.2011.07.001
   Dey J, 2011, MACROMOL MATER ENG, V296, P1149, DOI 10.1002/mame.201100074
   Dey J, 2008, BIOMATERIALS, V29, P4637, DOI 10.1016/j.biomaterials.2008.08.020
   Dickens F, 1941, BIOCHEM J, V35, P1011, DOI 10.1042/bj0351011
   DIXON TF, 1952, BIOCHEM J, V52, P260, DOI 10.1042/bj0520260
   EASTOE JE, 1954, BIOCHEM J, V57, P453, DOI 10.1042/bj0570453
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   GRAYSON WL, 2009, P NATL ACAD SCI USA, V107, P3299
   HARTLES R. L., 1964, ADVANCE ORAL BIOL, V1, P225
   Hu YY, 2010, P NATL ACAD SCI USA, V107, P22425, DOI 10.1073/pnas.1009219107
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Imaizumi H, 2006, CALCIFIED TISSUE INT, V78, P45, DOI 10.1007/s00223-005-0170-0
   Jiao Y, 2012, SOFT MATTER, V8, P1499, DOI 10.1039/c1sm05786c
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   Kane RJ, 2008, J MECH BEHAV BIOMED, V1, P261, DOI 10.1016/j.jmbbm.2008.01.004
   Katti KS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034122
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Liang SL, 2010, BIOMATERIALS, V31, P8516, DOI 10.1016/j.biomaterials.2010.07.105
   Liu HN, 2010, INT J NANOMED, V5, P299
   Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Qiu HJ, 2006, BIOMATERIALS, V27, P5845, DOI 10.1016/j.biomaterials.2006.07.042
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rhee SH, 1999, BIOMATERIALS, V20, P2155, DOI 10.1016/S0142-9612(99)00118-0
   Rhee SH, 2000, J MATER SCI-MATER M, V11, P449, DOI 10.1023/A:1008992009826
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011
   SAITO M, 1994, BIOMATERIALS, V15, P156, DOI 10.1016/0142-9612(94)90266-6
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   Serrano CA, 2011, RAPID COMMUN MASS SP, V25, P1152, DOI 10.1002/rcm.4974
   Suzuki O, 2010, ACTA BIOMATER, V6, P3379, DOI 10.1016/j.actbio.2010.04.002
   Tang WJ, 2011, J BIOL CHEM, V286, P32995, DOI 10.1074/jbc.M111.244236
   Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
   Yokoyama A, 2002, BIOMATERIALS, V23, P1091, DOI 10.1016/S0142-9612(01)00221-6
   Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37
   Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107
   Zioupos P, 2008, J BIOMED MATER RES A, V86A, P627, DOI 10.1002/jbm.a.31576
NR 50
TC 14
Z9 14
U1 2
U2 52
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2014
VL 102
IS 8
BP 2521
EP 2532
DI 10.1002/jbm.a.34928
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM6HH
UT WOS:000339964300005
PM 23996976
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Karavasili, C
   Bouropoulos, N
   Kontopoulou, I
   Smith, A
   van der Merwe, SM
   Rehman, IUR
   Ahmad, Z
   Fatouros, DG
AF Karavasili, Chirstina
   Bouropoulos, Nikolaos
   Kontopoulou, Ioanna
   Smith, Ashleigh
   van der Merwe, Susanna M.
   Rehman, Ihtesham U. R.
   Ahmad, Zeeshan
   Fatouros, Dimitrios G.
TI Preparation and characterization of multiactive electrospun fibers:
   Poly-epsilon-carpolactone fibers loaded with hydroxyapatite and selected
   NSAIDs
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE electrospinning; poorly soluble drugs; hydroxyapatite;
   poly(epsilon-caprolactone); bioactive and multiactive
ID DRUG-DELIVERY SYSTEMS; CONTROLLED-RELEASE; IN-VITRO; ULTRAFINE FIBERS;
   NANOFIBERS; COMPOSITES; NANOCOMPOSITES; INDOMETHACIN; SCAFFOLDS;
   IBUPROFEN
AB Electrospun poly-epsilon-caprolactone fibers were employed as hosts for hydroxypatite and nonsteroidal anti-inflammatory drugs (NSAIDs) ibuprofen (IBU) and indomethacin (INDO) (separately). The fibers (size range between 400 and 20 mu m) were characterized by means of X-ray diffraction, differential scanning calorimetry, fourier-transform infrared spectroscopy and scanning electron microscopy. The physicochemical characterization of the fibers indicated that the drugs are associated with the fibers in an amorphous state. The release of IBU and INDO was monitored in PBS pH 7.4. A rapid release was observed for both drugs. Finally, bioactivity studies in simulated body fluid revealed the formation of hydroxyapatite, indicating that the fibers could be further utilized as materials for coupled (or multipurpose) biomedical and biomaterial engineering applications. (C) 2013 Wiley Periodicals, Inc.
C1 [Karavasili, Chirstina; Fatouros, Dimitrios G.] Aristotle Univ Thessaloniki, Dept Pharmaceut Technol, Sch Pharm, GR-54124 Thessaloniki, Greece.
   [Bouropoulos, Nikolaos; Kontopoulou, Ioanna] Univ Patras, Dept Mat Sci, Patras 26504, Greece.
   [Bouropoulos, Nikolaos] Fdn Res & Technol Hellas, Inst Chem Engn & High Temp Chem Proc, FORTH ICE HT, GR-26504 Patras, Greece.
   [Smith, Ashleigh; van der Merwe, Susanna M.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
   [Rehman, Ihtesham U. R.] Univ Sheffield, Kroto Res Inst, Dept Mat Sci & Engn, Sheffield S3 7HQ, S Yorkshire, England.
   [Ahmad, Zeeshan] De Montfort Univ, Sch Pharm, Leicester LE1 9BH, Leics, England.
RP Fatouros, DG (reprint author), Aristotle Univ Thessaloniki, Dept Pharmaceut Technol, Sch Pharm, GR-54124 Thessaloniki, Greece.
EM dfatouro@pharm.auth.gr
OI Ahmad, Zeeshan/0000-0001-8863-6211
FU Royal Society; PeReNE [Interreg-European Union (EU)]
FX Contract grant sponsor: Royal Society and PeReNE [Interreg-European
   Union (EU)]
CR Ahmad Z, 2010, MACROMOL MATER ENG, V295, P315, DOI 10.1002/mame.200900396
   Arcos D, 1997, BIOMATERIALS, V18, P1235, DOI 10.1016/S0142-9612(97)00054-9
   Bolgen N, J BIOMED MAT RES B, V81, P530
   Casper CL, 2007, BIOMACROMOLECULES, V8, P1116, DOI 10.1021/bm061003s
   de Guevara-Fernandez SL, 2003, BIOMATERIALS, V24, P4037, DOI 10.1016/S0142-9612(03)00279-5
   Elzubair A, 2006, J DENT, V34, P784, DOI 10.1016/j.jdent.2006.03.002
   Feng S, 2013, INTEGR BIOL-UK, V5, P768, DOI 10.1039/c3ib20255k
   Gan ZH, 1999, POLYMER, V40, P1961, DOI 10.1016/S0032-3861(98)00414-5
   Huang ZM, 2006, J BIOMED MATER RES A, V77A, P169, DOI 10.1002/jbm.a.30564
   Jain A, 2013, CRIT REV THER DRUG, V30, P293, DOI 10.1615/CritRevTherDrugCarrierSyst.2013006955
   Jiang HL, 2005, J CONTROL RELEASE, V108, P237, DOI 10.1016/j.jconrel.2005.08.006
   Jiang HL, 2006, J BIOMED MATER RES B, V79B, P50, DOI 10.1002/jbm.b.30510
   Jiang SC, 2001, POLYMER, V42, P3901, DOI 10.1016/S0032-3861(00)00565-6
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Kim MJ, 2013, MAT SCI ENG C-MATER, V33, P2266, DOI 10.1016/j.msec.2013.01.051
   Liu H, 2012, J BIOMAT SCI-POLYM E, V23, P251, DOI 10.1163/092050610X549171
   Liu XM, 2013, APPL SURF SCI, V273, P748, DOI 10.1016/j.apsusc.2013.02.130
   Manoochehr R, 2011, ADV ENG MATER, V13, pB296
   Miao YE, 2012, MATER CHEM PHYS, V134, P623, DOI 10.1016/j.matchemphys.2012.03.041
   OTSUKA M, 1994, J CONTROL RELEASE, V31, P111, DOI 10.1016/0168-3659(94)00007-7
   Penel G, 1997, J MATER SCI-MATER M, V8, P271, DOI 10.1023/A:1018504126866
   Ramukutty S, 2012, CRYST RES TECHNOL, V47, P31, DOI 10.1002/crat.201100394
   Steele TWJ, 2011, ACTA BIOMATER, V7, P1973, DOI 10.1016/j.actbio.2011.02.002
   Verma D, 2006, J BIOMED MATER RES A, V78A, P772, DOI 10.1002/jbm.a.30774
   Verreck G, 2003, PHARMACEUT RES, V20, P810, DOI 10.1023/A:1023450006281
   Verreck G, 2003, J CONTROL RELEASE, V92, P349, DOI 10.1016/S0168-3659(03)00342-0
   Williams GR, 2012, THER DELIV, V3, P515, DOI 10.4155/tde.12.17
   Wu M, 2009, EUR J PHARM SCI, V36, P493, DOI 10.1016/j.ejps.2008.12.001
   Xiao JW, 2009, J MATER SCI-MATER M, V20, P889, DOI 10.1007/s10856-008-3631-y
   Xie JW, 2006, PHARM RES, V23, P1817, DOI 10.1007/s11095-006-9036-z
   Xu XL, 2006, J CONTROL RELEASE, V114, P307, DOI 10.1016/j.jconrel.2006.05.031
   Zhang GC, 2012, J PHARMACEUT BIOMED, V66, P162, DOI 10.1016/j.jpba.2012.03.039
NR 33
TC 9
Z9 9
U1 1
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2014
VL 102
IS 8
BP 2583
EP 2589
DI 10.1002/jbm.a.34931
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM6HH
UT WOS:000339964300011
PM 24000194
DA 2018-10-20
ER

PT J
AU Ma, N
   Chen, YM
   Yang, BC
AF Ma Nan
   Chen Yangmei
   Yang Bangcheng
TI Magnesium metal-A potential biomaterial with antibone cancer properties
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE magnesium metal; biodegradation; H-2 releasing; free radicals
   scavenging; anti-bone cancer
ID OXIDATIVE STRESS; DEGREES-C; IN-VITRO; HYDROGEN; BIOACTIVITY; BEHAVIOR;
   CELLS; ANTIOXIDANT; RADICALS; ACID
AB Reactive oxygen plays an important role in the pathogenesis of many serious illnesses, including bony cancer. Recently, it has been suggested that hydrogen (H-2), a selective antioxidant, can effectively scavenge free radicals. Biomedical magnesium (Mg) used for bone defect repair in the surgery of bony cancer could release H-2 because of the degradation, so Mg might have the potential to prevent bony cancer from metastasis and recurrence. In this study, alkali-heat treatment method was employed to modify the surface structure of Mg metal, so as to control the degradation of Mg metal and the H-2 releasing rate. Then the released H-2 was introduced to the Fenton Reaction system to detect its effect on scavenging free radicals. The modified Mg metal was employed as the substrate for bone cancer cell culture to study the effect of the H-2 releasing on scavenging free radicals in the cells. It is found that the H-2 released from the Mg degradation could scavenge free radicals both in the Fenton Reaction system and bone cancer cells. The effect on the scavenging free radical is proportional to the rate of H-2 releasing. It suggested that Mg might be a potential material with anti-bone cancer properties. It is hopeful to both repair the bone defect and prevent bony cancer from metastasis and recurrence for the bony cancer patients by biomedical Mg metal. (C) 2013 Wiley Periodicals, Inc.
C1 [Ma Nan; Chen Yangmei; Yang Bangcheng] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
   [Ma Nan; Chen Yangmei; Yang Bangcheng] Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Yang, BC (reprint author), Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM yangbchengc@126.com
FU National Basic Research Program of China; 973 Program [2012CB933600];
   National Natural Science Foundation of China [31070848]; Key Program for
   Science & Technology Development of China [2012BAI18B04]; Research Fund
   for the Doctoral Program of Higher Education of China [20110181110064];
   Foundation of Jiangsu Collaborative Innovation Center of Biomedical
   Functional Materials, China
FX Contract grant sponsor: National Basic Research Program of China;
   contract grant number: 973 Program, 2012CB933600; Contract grant
   sponsor: National Natural Science Foundation of China; contract grant
   number: NO 31070848; Contract grant sponsor: Key Program for Science &
   Technology Development of China; contract grant number: No.
   2012BAI18B04; Contract grant sponsor: Research Fund for the Doctoral
   Program of Higher Education of China; contract grant number: No.
   20110181110064; Contract grant sponsor: Foundation of Jiangsu
   Collaborative Innovation Center of Biomedical Functional Materials,
   China
CR Al-Abdullat Y, 2001, MATER TRANS, V42, P1777, DOI 10.2320/matertrans.42.1777
   Brown NS, 2000, CANCER RES, V60, P6298
   Cekin E, 2009, J INT MED RES, V37, P325, DOI 10.1177/147323000903700206
   DOLE M, 1975, SCIENCE, V190, P152, DOI 10.1126/science.1166304
   El Kady AA, 2009, CERAM INT, V35, P2933, DOI 10.1016/j.ceramint.2009.03.042
   Han M, 2010, MOLECULES, V15, P399, DOI 10.3390/molecules15010399
   Inano H, 2002, INT J RADIAT ONCOL, V52, P212, DOI 10.1016/S0360-3016(01)02651-7
   Joshi R, 2001, FREE RADICAL BIO MED, V30, P1390, DOI 10.1016/S0891-5849(01)00543-3
   Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P316, DOI 10.1016/j.bbrc.2009.06.024
   Kannan MB, 2010, J BIOMED MATER RES A, V93A, P1050, DOI 10.1002/jbm.a.32576
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Ma CC., 1997, CHN J OIL CROP SCI, V19, P27
   Martin RI, 1997, CALCIFIED TISSUE INT, V60, P538, DOI 10.1007/s002239900277
   Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017
   Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577
   Orzolek A, 2013, REPROD BIOL, V13, P34, DOI 10.1016/j.repbio.2013.01.176
   Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076
   Russell LH, 2012, ANTICANCER RES, V32, P1595
   Saitoh Y., 2009, Experimental Oncology, V31, P156
   Sakashita T, 2010, J RADIAT RES, V51, P107, DOI 10.1269/jrr.09100
   Sigrid K, 2010, J BIOMED MATER RES B, V96B, P84
   Song YW, 2009, MAT SCI ENG C-BIO S, V29, P1039, DOI 10.1016/j.msec.2008.08.026
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Xie KL, 2010, SHOCK, V34, P90, DOI 10.1097/SHK.0b013e3181cdc4ae
NR 26
TC 6
Z9 6
U1 4
U2 42
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2014
VL 102
IS 8
BP 2644
EP 2651
DI 10.1002/jbm.a.34933
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM6HH
UT WOS:000339964300017
PM 24019294
DA 2018-10-20
ER

PT J
AU Chen, ZT
   Wu, CT
   Yuen, J
   Klein, T
   Crawford, R
   Xiao, Y
AF Chen, Zetao
   Wu, Chengtie
   Yuen, Jones
   Klein, Travis
   Crawford, Ross
   Xiao, Yin
TI Influence of osteocytes in the in vitro and in vivo beta-tricalcium
   phosphate-stimulated osteogenesis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE osteocyte; bone substitute; beta-TCP; osteogenesis
ID SIGNALING PATHWAY; IMPLANT SURFACES; MULTIPLE ROLES; BONE-FORMATION;
   CELL-LINE; EXPRESSION; DIFFERENTIATION; OSTEOBLASTS; WNT; MLO-Y4
AB Osteocytes, known to act as the main regulators of bone homeostasis, have become a major focus in the field of bone research. Bioactive ceramics have been widely used for bone regeneration. However, there are few studies about the interaction of osteocytes with bioceramics. The effects of osteocytes on the in vitro and in vivo osteogenesis of bioceramics are also unclear. The aim of this study was to investigate the role of osteocytes on the beta-tricalcium phosphate (beta-TCP) stimulated osteogenesis. It was found that osteocytes responded to the beta-TCP stimulation, leading to the release of Wnt (wingless-related MMTV integration site), which enhanced osteogenic differentiation of bone marrow stromal cells via Wnt signaling pathway. Receptor activator of nuclear factor kappa B ligand, an osteoclast inducer, was also upregulated, indicating that osteocytes would also participated in activation of osteoclasts, which played a major role in the degradation process of beta-TCP and new bone remodeling. In vivo studies further demonstrated that when the material was completely embedded by newly formed bone, the only cell contacting with the material was osteocyte. However, the material would eventually be degraded and replaced by the new bone, requiring the participation of osteoclasts and osteoblasts, which were demonstrated by using immunostaining in this study. As the only cell contacting with the material, osteocytes probably acted in a regulatory role to regulate the surrounding osteoclasts and osteoblasts. Osteocytes were also found to participate in the maturation of osteoblasts and the mineralization process of biomaterials, by upregulating E11 (podoplanin) and dentin matrix protein 1 expression. These findings indicated that osteocytes involved in bone biomaterial-mediated osteogenesis and biomaterial degradation, providing valuable insights into the mechanism of material-stimulated osteogenesis, and a novel strategy to optimize the evaluating system for the biological properties of biomaterials. (C) 2013 Wiley Periodicals, Inc.
C1 [Chen, Zetao; Yuen, Jones; Klein, Travis; Crawford, Ross; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
   [Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Wu, CT (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM chengtiewu@mail.sic.ac.cn; yin.xiao@qut.edu.au
OI Xiao, Yin/0000-0003-1785-3491; Klein, Travis/0000-0002-6669-7766;
   Crawford, Ross/0000-0001-6079-1316
FU Australian Research Council [DP120103697]; Recruitment Program of Global
   Young Talent, China; Natural Science Foundation of China [81201202,
   51061160499]
FX Contract grant sponsor: Discovery project of Australian Research
   Council; contract grant number: DP120103697; Contract grant sponsor:
   Recruitment Program of Global Young Talent, China (Dr. Wu) and Natural
   Science Foundation of China; contract grant number: 81201202 and
   51061160499
CR Bohner M, 2012, J EUR CERAM SOC, V32, P2663, DOI 10.1016/j.jeurceramsoc.2012.02.028
   Bonewald LF, 1999, J BONE MINER METAB, V17, P61, DOI 10.1007/s007740050066
   Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224
   Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320
   Boyce BF, 2009, CRIT REV EUKAR GENE, V19, P171, DOI 10.1615/CritRevEukarGeneExpr.v19.i3.10
   Chai HW, 2012, J BIOMED MATER RES A, V100A, P293, DOI 10.1002/jbm.a.33267
   Chakravorty N, 2012, ACTA BIOMATER, V8, P3516, DOI 10.1016/j.actbio.2012.05.008
   Chappard D, 2010, MICRON, V41, P321, DOI 10.1016/j.micron.2009.12.005
   DasGupta R, 1999, DEVELOPMENT, V126, P4557
   De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079
   Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603
   Gaasbeek RDA, 2005, BIOMATERIALS, V26, P6713, DOI 10.1016/j.biomaterials.2005.04.056
   Gajjeraman S, 2007, J BIOL CHEM, V282, P1193, DOI 10.1074/jbc.M604732200
   Galli C, 2010, J DENT RES, V89, P331, DOI 10.1177/0022034510363963
   Geng F, 2009, J MATER SCI TECHNOL, V25, P123
   Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006
   He G, 2003, CONNECT TISSUE RES, V44, P240, DOI 10.1080/03008200390181726
   Heinemann S, 2013, ACTA BIOMATER, V9, P4878, DOI 10.1016/j.actbio.2012.10.010
   Kalajzic I, 2013, BONE, V54, P296, DOI 10.1016/j.bone.2012.09.040
   Kamel MA, 2010, BONE, V47, P872, DOI 10.1016/j.bone.2010.08.007
   Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014
   Kogianni G, 2008, J BONE MINER RES, V23, P915, DOI 10.1359/JBMR.080207
   Lang NP, 2011, CLIN ORAL IMPLAN RES, V22, P349, DOI 10.1111/j.1600-0501.2011.02172.x
   Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]
   Liu Y, 2007, MOL ENDOCRINOL, V21, P376, DOI 10.1210/me.2006-0342
   Manduch M, 2009, PATHOL RES PRACT, V205, P353, DOI 10.1016/j.prp.2008.11.006
   Mareddy S, 2007, TISSUE ENG, V13, P819, DOI 10.1089/ten.2006.0180
   Maye P, 2004, J BIOL CHEM, V279, P24659, DOI 10.1074/jbc.M311724200
   O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942
   Pajevic PD, 2009, IBMS BONEKEY, V6, P63
   Papanicolaou SE, 2009, BIORHEOLOGY, V46, P389, DOI 10.3233/BIR-2009-0550
   Percival CJ, 2013, DEV DYNAM, V242, P909, DOI 10.1002/dvdy.23992
   Petit A, 2005, BIOMATERIALS, V26, P4416, DOI 10.1016/j.biomaterials.2004.11.019
   Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202
   Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304
   Rochefort GY, 2010, OSTEOPOROSIS INT, V21, P1457, DOI 10.1007/s00198-010-1194-5
   Rokn Ar, 2012, J Dent (Tehran), V9, P35
   Singh S, 2008, STEM CELLS DEV, V17, P245, DOI 10.1089/scd.2007.0146
   Soltanoff CS, 2009, CRIT REV EUKAR GENE, V19, P1
   Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876
   Suzuki T, 1997, J BIOMED MATER RES, V34, P507, DOI 10.1002/(SICI)1097-4636(19970315)34:4<507::AID-JBM11>3.3.CO;2-P
   Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025
   Wadhwa S, 2002, BIOCHEM BIOPH RES CO, V297, P46, DOI 10.1016/S0006-291X(02)02124-1
   Wadhwa S, 2002, J BONE MINER RES, V17, P266, DOI 10.1359/jbmr.2002.17.2.266
   Wetterwald A, 1996, BONE, V18, P125, DOI 10.1016/8756-3282(95)00457-2
   Xiong JH, 2012, J BONE MINER RES, V27, P499, DOI 10.1002/jbmr.1547
   Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593
   Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05
   Zhang ML, 2012, J MATER CHEM, V22, P21686, DOI 10.1039/c2jm34395a
   Zhang ML, 2012, J BIOMED MATER RES A, V100A, P2979, DOI 10.1002/jbm.a.34246
   Zhu DX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019595
NR 51
TC 9
Z9 10
U1 2
U2 37
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2014
VL 102
IS 8
BP 2813
EP 2823
DI 10.1002/jbm.a.34954
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM6HH
UT WOS:000339964300034
PM 24115533
DA 2018-10-20
ER

PT J
AU Bassett, DC
   Meszaros, R
   Orzol, D
   Woy, M
   Zhang, YL
   Tiedemann, K
   Wondraczek, L
   Komarova, S
   Barralet, JE
AF Bassett, David C.
   Meszaros, Robert
   Orzol, Dominik
   Woy, Michel
   Zhang, Yu Ling
   Tiedemann, Kerstin
   Wondraczek, Lothar
   Komarova, Svetlana
   Barralet, Jake E.
TI A new class of bioactive glasses: Calcium-magnesium sulfophosphates
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE sulfophosphate glass; bioglass; degradable glass; cell response;
   biocompatibility
ID SOLUBLE PHOSPHATE-GLASSES; SINUS FLOOR ELEVATION; IN-VITRO; BONE REPAIR;
   DEGRADATION; VISCOSITY; CERAMICS; SYSTEM; CELLS; ZINC
AB Low-melting ionic sulfophosphate glasses from the system P2O5-SO4-MO-Na2O (M = Zn2+, Ca2+ or Mg2+) have been previously shown by us to allow tuneable aqueous dissolution and also enable processing temperatures well below 400 degrees C. Sulfate ions are extremely safe for use in the body as decades of use of calcium sulfate bone grafts testifies and there is no known limit on their adult oral toxicity. This glass system therefore offers great potential for use as biomaterials, especially in organic-inorganic hybrid systems such as glass-polymer composites for tissue engineering or drug encapsulation and delivery applications. A compositional region was identified where stable sulfophosphates of the type P2O5-SO4-(Ca, Mg, Zn)O-Na2O can be fabricated. For these glasses, the viscosity-temperature-dependence, glass transformation temperatures (T-g) and the onset of crystallization were evaluated as the primary processing parameters. As a first step in exploring their potential as a biomaterial, in this study we examine the bioactivity of several compositions of these glasses using fibroblast, monocyte, and osteoclast cell culture models to determine cellular responses in terms of attachment, proliferation, differentiation, and toxicity. (C) 2013 Wiley Periodicals, Inc.
C1 [Bassett, David C.; Zhang, Yu Ling; Tiedemann, Kerstin; Komarova, Svetlana; Barralet, Jake E.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   [Meszaros, Robert; Orzol, Dominik; Woy, Michel; Wondraczek, Lothar] Univ Erlangen Nurnberg, Dept Mat Sci, Inst Glass & Ceram, D-91058 Erlangen, Germany.
   [Wondraczek, Lothar] Univ Jena, Otto Schott Inst, D-07743 Jena, Germany.
   [Barralet, Jake E.] Montreal Gen Hosp, Fac Med, Dept Surg, Div Orthopaed, Montreal, PQ H3G 1A4, Canada.
RP Barralet, JE (reprint author), McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
EM jake.barralet@mcgill.ca
RI Wondraczek, Lothar/A-2145-2013; Bassett, David/B-2489-2009; Tiedemann,
   one/A-9739-2016
OI Bassett, David/0000-0001-7167-2566; Barralet, jake/0000-0003-3543-6042;
   Wondraczek, Lothar/0000-0002-0747-3076
FU German Academic Exchange Service (DAAD); Canada Research Chair Program;
   Natural Sciences and Engineering Research Council of Canada
FX Contract grant sponsors: German Academic Exchange Service (DAAD); Canada
   Research Chair Program; Natural Sciences and Engineering Research
   Council of Canada
CR Abou Neel EA, 2009, J MATER CHEM, V19, P690, DOI 10.1039/b810675d
   Ahmed I, 2004, BIOMATERIALS, V25, P491, DOI 10.1016/S0142-9612(03)00546-5
   Allen DD, 2005, DRUG DEV IND PHARM, V31, P757, DOI 10.1080/03639040500216246
   Bitar M, 2004, BIOMATERIALS, V25, P2283, DOI 10.1016/j.biomaterials.2003.08.054
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Brauer DS, 2012, J NON-CRYST SOLIDS, V358, P1720, DOI 10.1016/j.jnoncrysol.2012.04.027
   Cerovic A, 2007, BIOL TRACE ELEM RES, V116, P61, DOI 10.1007/s12011-007-9016-0
   Cormack AN, 2012, PHILOS T R SOC A, V370, P1271, DOI 10.1098/rsta.2011.0371
   Da N, 2011, J NON-CRYST SOLIDS, V357, P2202, DOI 10.1016/j.jnoncrysol.2011.02.037
   Da N, 2010, J AM CERAM SOC, V93, P2171, DOI 10.1111/j.1551-2916.2010.03707.x
   Da N, 2010, OPT EXPRESS, V18, P2549, DOI 10.1364/OE.18.002549
   Detsch R, 2012, ADV ENG MATER, V14, pB38, DOI 10.1002/adem.201180068
   Franks K, 2001, BIOMATERIALS, V22, P497, DOI 10.1016/S0142-9612(00)00207-6
   Fulcher GS, 1925, J AM CERAM SOC, V8, P339, DOI 10.1111/j.1151-2916.1925.tb16731.x
   Gough JE, 2002, J BIOMED MATER RES, V59, P481, DOI 10.1002/jbm.10020
   Graham T., 1833, PHILOS T ROY SOC LON, V123, P253
   Guillon O, 2011, J EUR CERAM SOC, V31, P999, DOI 10.1016/j.jeurceramsoc.2010.12.031
   Habibovic P, 2011, ACTA BIOMATER, V7, P3013, DOI 10.1016/j.actbio.2011.03.027
   Haynes W.M., 2012, CRC HDB CHEM PHYS
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kasuga T, 2007, J CERAM SOC JPN, V115, P455, DOI 10.2109/jcersj2.115.455
   Lakhkar NJ, 2013, ADV DRUG DELIVER REV, V65, P405, DOI 10.1016/j.addr.2012.05.015
   Manolson MF, 2003, J BIOL CHEM, V278, P49271, DOI 10.1074/jbc.M309914200
   Meszaros R, 2011, GLASS TECHNOL-PART A, V52, P111
   Navarro M, 2003, J AM CERAM SOC, V86, P1345, DOI 10.1111/j.1151-2916.2003.tb03474.x
   PARKS JR, 1957, J AM CHEM SOC, V79, P4890, DOI 10.1021/ja01575a017
   Parsons AJ, 2004, J BIOMED MATER RES A, V71A, P283, DOI 10.1002/jbm.a.30161
   Reibstein S, 2012, PHYS CHEM GLASSES-B, V53, P61
   SCHEIDLER PA, 1992, BIOMED SCI INSTRUM, V28, P183
   Sirotkin S, 2012, INT J APPL GLASS SCI, V3, P44, DOI 10.1111/j.2041-1294.2011.00076.x
   Tadjoedin ES, 2002, CLIN ORAL IMPLAN RES, V13, P428, DOI 10.1034/j.1600-0501.2002.130412.x
   Tadjoedin ES, 2000, CLIN ORAL IMPLAN RES, V11, P334, DOI 10.1034/j.1600-0501.2000.011004334.x
   Tammann G, 1926, Z ANORG ALLG CHEM, V156, P245, DOI DOI 10.1002/ZAAC.19261560121
   Uo M, 1998, BIOMATERIALS, V19, P2277, DOI 10.1016/S0142-9612(98)00136-7
   Urman K, 2007, PROG POLYM SCI, V32, P1462, DOI 10.1016/j.progpolymsci.2007.07.006
   Vogel H, 1921, PHYS Z, V22, P645
   Winkel A, 2012, J AM CERAM SOC, V95, P3387, DOI 10.1111/j.1551-2916.2012.05368.x
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yamada Y, 2008, J BIOMED MATER RES A, V84A, P344, DOI 10.1002/jbm.a.31265
   Young RT, 2000, COMPOS PART B-ENG, V31, P209, DOI 10.1016/S1359-8368(99)00080-3
   Zhang LY, 2010, J NON-CRYST SOLIDS, V356, P2965, DOI 10.1016/j.jnoncrysol.2010.03.044
NR 42
TC 6
Z9 6
U1 0
U2 49
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2014
VL 102
IS 8
BP 2842
EP 2848
DI 10.1002/jbm.a.34955
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM6HH
UT WOS:000339964300037
PM 24115563
DA 2018-10-20
ER

PT J
AU Pan, HT
   Zheng, QX
   Yang, SH
   Guo, XD
   Wu, B
   Zou, ZW
   Duan, ZX
AF Pan, Haitao
   Zheng, Qixin
   Yang, Shuhua
   Guo, Xiaodong
   Wu, Bin
   Zou, Zhenwei
   Duan, Zhixia
TI A novel peptide-modified and gene-activated biomimetic bone matrix
   accelerating bone regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE gene-acivated matrix; bone regeneration; peptide modification;
   osteogenic differentiation; transforming growth factor beta 1
ID MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; STROMAL CELLS;
   TGF-BETA-1; SCAFFOLDS; DELIVERY; SYSTEM; DNA; ENHANCEMENT; EXPRESSION
AB The osteogenic differentiation of bone marrow stromal cells (BMSCs) can be regulated by systemic or local growth factor, especially by transforming growth factor beta 1 (TGF-beta 1). However, how to maintain the bioactivity of exogenous TGF-beta 1 is a great challenge due to its short half-life time. The most promising solution is to transfer TGF-beta 1 gene into seed cells through transgenic technology and then transgenic cells to continuously secret endogenous TGF-beta 1 protein via gene expression. In this study, a novel non-viral vector (K) 16GRGDSPC was chemically linked to bioactive bone matrices PLGA-[ASP-PEG]n using crosslinker to construct a novel non-viral gene transfer system. TGF-beta 1 gene was incubated with this system and subsequently rabbit-derived BMSCs were co-cultured with this gene-activated PLGA-[ASP-PEG] n, while co-cultured with PLGA-[ASP-PEG] n modified with (K) 16GRGDSPC only and original PLGA-[ASP-PEG] n as control. Thus we fabricated three kinds of composites: Group A (BMSCs-TGF-beta 1DNA-(K) 16GRGDSPC-PLGA-[ASP-PEG] n composite); Group B (BMSCs-(K) 16GRGDSPC-PLGA-[ASP-PEG] n composite); and Group C (BMSCs-PLGA-[ASP-PEG] n composite). TGF-beta 1 and other osteogenic phenotype markers of alkaline phosphatase, osteocalcin, osteopontin and type I collagen in Group A were all significantly higher than the other two groups ex vivo. In vivo, 15-mm long segmental rabbit bone defects were created and randomly implanted the aforementioned composites separately, and then fixed with plate-screws. The results demonstrated that the implants in Group A significantly accelerated bone regeneration compared with the other implants based on X-rays, histological and biomechanical examinations. Therefore, we conclude this novel peptide-modified and gene-activated biomimetic bone matrix of TGF-beta 1DNA-(K) 16GRGDSPC-PLGA-[ASP-PEG] n is a very promising scaffold biomaterial for accelerating bone regeneration. (C) 2013 Wiley Periodicals, Inc.
C1 [Pan, Haitao; Zheng, Qixin; Yang, Shuhua; Guo, Xiaodong; Wu, Bin; Zou, Zhenwei; Duan, Zhixia] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, Wuhan 430022, Peoples R China.
RP Zheng, QX (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, Wuhan 430022, Peoples R China.
EM zhengqixinwhxh@163.com
FU National Natural Science Foundation of China [30900292]
FX This work was financially supported by the National Natural Science
   Foundation of China (Project No. 30900292).
CR Bae SE, 2012, BIOMACROMOLECULES, V13, P2811, DOI 10.1021/bm300791h
   Chim H, 2012, CELL TISSUE RES, V350, P89, DOI 10.1007/s00441-012-1449-x
   Diao HJ, 2009, TISSUE ENG PT A, V15, P2687, DOI [10.1089/ten.tea.2008.0621, 10.1089/ten.TEA.2008.0621]
   Gonzalez AM, 2009, J GENE MED, V11, P679, DOI 10.1002/jgm.1354
   Guo T, 2006, INT J ARTIF ORGANS, V29, P612
   Huang CY, 2012, TISSUE ENG PT A, V18, P2106, DOI [10.1089/ten.tea.2012.0064, 10.1089/ten.TEA.2012.0064]
   Kim JL, 2012, EXP BIOL MED, V237, P417, DOI 10.1258/ebm.2011.011376
   Kolk A, 2011, BIOMATERIALS, V32, P6850, DOI 10.1016/j.biomaterials.2011.05.071
   Li RD, 2012, BMB REP, V45, P509, DOI 10.5483/BMBRep.2012.45.9.053
   Liberska A, 2011, CHEM COMMUN, V47, P12774, DOI 10.1039/c1cc15805h
   Liu G, 2004, CHIN J EXP SURG, P461
   Liu Y, 2005, CHIN J CLIN REHAB, V9, P232
   Luo BH, 2005, ACTA POLYM SIN, P327
   Mathews S, 2012, DIFFERENTIATION, V84, P185, DOI 10.1016/j.diff.2012.05.001
   Orsi S, 2012, ACTA BIOMATER, V8, P3228, DOI 10.1016/j.actbio.2012.05.010
   Orsi S, 2010, J MATER SCI-MATER M, V21, P1013, DOI 10.1007/s10856-009-3972-1
   Pan H, 2006, MED J CHINA, V86, P2766
   Pan H, 2006, J MED POSTGRADUATES, V19, P508
   [潘海涛 PAN Haitao], 2006, [中华医学杂志, National Medical Journal of China], V86, P2766
   Pan HT, 2007, J PEPT SCI, V13, P154, DOI 10.1002/psc.826
   Pan Haitao, 2007, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V21, P65
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Peng L, 2009, J BIOMED MATER RES A, V90A, P564, DOI 10.1002/jbm.a.32117
   Storrie H, ADV DRUG DELIV REV, V58, P500
   Tierney EG, 2013, J CONTROL RELEASE, V165, P173, DOI 10.1016/j.jconrel.2012.11.013
   Tierney EG, 2012, J CONTROL RELEASE, V158, P304, DOI 10.1016/j.jconrel.2011.11.026
   Visser R, 2009, BIOMATERIALS, V30, P2032, DOI 10.1016/j.biomaterials.2008.12.046
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Zhang JY, 2013, BIOTECHNOL BIOENG, V110, P1466, DOI 10.1002/bit.24796
   Zhao LM, 2011, VITAM HORM, V87, P127, DOI 10.1016/B978-0-12-386015-6.00042-1
   Zheng Q, 2001, CHIN J EXP SURG, V18, P352
NR 31
TC 8
Z9 9
U1 4
U2 40
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2014
VL 102
IS 8
BP 2864
EP 2874
DI 10.1002/jbm.a.34961
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM6HH
UT WOS:000339964300040
PM 24115366
DA 2018-10-20
ER

PT J
AU Huang, GP
   Yang, DF
   Sun, CF
   Huang, JP
   Chen, KP
   Zhang, CX
   Chen, HQ
   Yao, Q
AF Huang, Guoping
   Yang, Danfeng
   Sun, Chunfeng
   Huang, Jianping
   Chen, Keping
   Zhang, Chunxia
   Chen, Huiqing
   Yao, Qin
TI A quicker degradation rate is yielded by a novel kind of transgenic silk
   fibroin consisting of shortened silk fibroin heavy chains fused with
   matrix metalloproteinase cleavage sites
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VIVO DEGRADATION; LIGAMENT AUGMENTATION; DRUG-DELIVERY;
   RECONSTRUCTION; BIOMATERIALS; INHIBITORS; FIBERS; VITRO; BIODEGRADATION;
   POLYMER
AB Degradation performance of silk fibroin is an important property for its medical applications. Herein we constructed a shortened silk fibroin heavy chain protein fused with a matrix metalloproteinase cleavage site (SSFH-MMP) along with a glutathione S-transferase tag ahead. The digestion assay shows it can be cut by matrix metalloproteinase-2 (MMP-2) at its MMP cleavage site. Furthermore, we introduced the SSFH-MMP into silk fibroin by genetic modification of silkworms in order to increase the degradation rate of the silk fibroin. After acquisition of a race of transgenic silkworms with the coding sequence of the MMP cleavage site in their genomic DNA, we tested some properties of their silk fibroin designated TSF-MMP. The results show that the TSF-MMP has MMP cleavage sites and yields a quicker degradation rate during dilution in MMP-2 enzyme buffer or implantation into tumor tissues compared with that of normal silk fibroin. Moreover, the TSF-MMP is in vitro non-toxic to human bone marrow mesenchymal stem cells (hBM-MSCs) indicating that the TSF-MMP may become a biomaterial with a quicker degradation rate for its medical applications.
C1 [Huang, Guoping; Yang, Danfeng; Sun, Chunfeng; Chen, Keping; Zhang, Chunxia; Chen, Huiqing; Yao, Qin] Jiangsu Univ, Inst Life Sci, Zhenjiang 212013, Jiangsu, Peoples R China.
   [Huang, Jianping] Jiangxi Agr Univ, Coll Sci, Nanchang 330045, Jiangxi, Peoples R China.
RP Huang, GP (reprint author), Jiangsu Univ, Inst Life Sci, Zhenjiang 212013, Jiangsu, Peoples R China.
EM huanggp@ujs.edu.cn; kpchen@ujs.edu.cn
FU National Natural Science Foundation of China [31100118, 31272507];
   Science and Technology Support Program (social development) of the
   Jiangsu Province, China [BE2010705]; China Postdoctoral Science
   Foundation [201003560]; Jiangsu Government Scholarship for Overseas
   Studies; Startup Scientific Research Fund from Jiangsu University for
   Advanced Professionals [08JDG035]; Natural Science Foundation of Jiangsu
   Province [BK2011495]; National Basic Research Program of China
   [2012CB114604]; Jiangsu University [11A452]
FX This study was supported by grants from National Natural Science
   Foundation of China (31100118, 31272507); the Science and Technology
   Support Program (social development) of the Jiangsu Province, China. No.
   BE2010705; Special Fund of China Postdoctoral Science Foundation, No.
   201003560; the Jiangsu Government Scholarship for Overseas Studies; the
   Startup Scientific Research Fund from Jiangsu University for Advanced
   Professionals, No. 08JDG035; Natural Science Foundation of Jiangsu
   Province (BK2011495); The National Basic Research Program of China (No.
   2012CB114604); The student scientific research project of Jiangsu
   University, No. 11A452.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Budsberg SC, 2013, AM J VET RES, V74, P1198, DOI 10.2460/ajvr.74.9.1198
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   de Moraes MA, 2014, J BIOMED MATER RES B, V102, P869, DOI 10.1002/jbm.b.33069
   Diez-Torre A, 2013, ANDROLOGY-US, V1, P779, DOI 10.1111/j.2047-2927.2013.00109.x
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   Durselen L, 2001, J BIOMED MATER RES, V58, P666, DOI 10.1002/jbm.1067
   Grams F, 2001, BIOL CHEM, V382, P1277, DOI 10.1515/BC.2001.159
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Huang G, 2010, CELL PROLIFERAT, V43, P515, DOI 10.1111/j.1365-2184.2010.00701.x
   Janssens E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052915
   Kojima K, 2007, BIOSCI BIOTECH BIOCH, V71, P2943, DOI 10.1271/bbb.70353
   Kumar K, 1999, ARTHROSCOPY, V15, P422, DOI 10.1016/S0749-8063(99)70061-7
   Kumari SS, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.11601
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lawrence BD, 2010, MACROMOL BIOSCI, V10, P393, DOI 10.1002/mabi.200900294
   Long DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040150
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j
   McConkey P., 1994, CLIN J SPORT MED, V4, P204
   Moss LAS, 2012, AM J PATHOL, V181, P1895, DOI 10.1016/j.ajpath.2012.08.044
   Murphy G, 2002, ARTHRITIS RES THER, V4, DOI 10.1186/ar572
   Newman SDS, 2013, INT ORTHOP, V37, P321, DOI 10.1007/s00264-012-1654-y
   Pinlaor S, 2009, ACTA TROP, V111, P181, DOI 10.1016/j.actatropica.2009.04.011
   RICHMOND JC, 1992, AM J SPORT MED, V20, P24, DOI 10.1177/036354659202000107
   Shimokawa K, 2002, MOL HUM REPROD, V8, P32, DOI 10.1093/molehr/8.1.32
   Shin YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030393
   Sundrani D, 2013, REPRODUCTION, V145, P401, DOI 10.1530/REP-12-0520
   Suzuki Y, 2014, BIOMACROMOLECULES, V15, P104, DOI 10.1021/bm401346h
   TAKIYA S, 1990, EMBO J, V9, P489, DOI 10.1002/j.1460-2075.1990.tb08135.x
   Vessillier S, 2004, PROTEIN ENG DES SEL, V17, P829, DOI 10.1093/protein/gzh097
   WAGA S, 1993, J BIOL CHEM, V268, P6429
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Yang R, 2013, ONCOTARGETS THER, V6, P1139, DOI 10.2147/OTT.S50389
   Zhang F, 2012, BIOMACROMOLECULES, V13, P798, DOI 10.1021/bm201719s
   Zhang YN, 1997, J BIOL CHEM, V272, P1444, DOI 10.1074/jbc.272.3.1444
   Zitka O, 2010, CURR MED CHEM, V17, P3751, DOI 10.2174/092986710793213724
NR 43
TC 3
Z9 3
U1 2
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2014
VL 25
IS 8
BP 1833
EP 1842
DI 10.1007/s10856-014-5220-6
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM5DI
UT WOS:000339875800001
PM 24801061
DA 2018-10-20
ER

PT J
AU Atayde, LM
   Cortez, PP
   Pereira, T
   Armada-da-Silva, PAS
   Afonso, A
   Lopes, MA
   Santos, JD
   Mauricio, AC
AF Atayde, L. M.
   Cortez, P. P.
   Pereira, T.
   Armada-da-Silva, P. A. S.
   Afonso, A.
   Lopes, M. A.
   Santos, J. D.
   Mauricio, A. C.
TI A new sheep model with automatized analysis of biomaterial-induced bone
   tissue regeneration
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID GLASS-REINFORCED HYDROXYAPATITE; IN-VIVO EVALUATION; OVINE MODEL;
   CORTICAL BONE; ANIMAL-MODELS; REPAIR; AUGMENTATION; PHOSPHATE; FRACTURE;
   OSSEOINTEGRATION
AB Presently, several bone graft substitutes are being developed or already available for clinical use. However, the limited number of clinical and in vivo trials for direct comparison between these products may complicate this choice. One of the main reasons for this scarcity it is the use of models that do not readily allow the direct comparison of multiple bone graft substitutes, due especially to the small number of implantation sites. Although sheep cancellous bone models are now well established for these purposes, the limited availability of cancellous bone makes it difficult to find multiple comparable sites within a same animal. These limitations can be overcome by the monocortical model here proposed as it consists in 5-6 holes (5 mm ), in the femoral diaphysis, with similar bone structure, overlying soft tissue and loading pattern for all defects. Associated to this model, it is also described a fast histomorphometric analysis method using a computer image segmentation test (Threshold method) to assess bone regeneration parameters. The information compiled through the experimental use of 45 sheep in several studies allowed determining that this ovine model has the potential to demonstrate differences in bone-forming performance between various scaffolds. Additionally, the described histomorphometric method is fast, accurate and reproducible.
C1 [Atayde, L. M.; Cortez, P. P.; Pereira, T.; Mauricio, A. C.] Univ Porto, Dept Clin Vet, ICBAS, P-4050313 Oporto, Portugal.
   [Atayde, L. M.; Cortez, P. P.; Pereira, T.; Mauricio, A. C.] Inst Ciencias & Tecnol Agr & Agroalimentares ICET, CECA, P-4051401 Oporto, Portugal.
   [Armada-da-Silva, P. A. S.] Univ Tecn Lisboa, FMH, P-1499002 Cruz Quebrada Dafundo, Portugal.
   [Armada-da-Silva, P. A. S.] Univ Tecn Lisboa, FMH, CIPER FMH Ctr Interdisciplinar Estudo Performance, P-1499002 Cruz Quebrada Dafundo, Portugal.
   [Afonso, A.] Univ Porto FMDUP, Fac Med Dent, P-4200393 Oporto, Portugal.
   [Lopes, M. A.; Santos, J. D.] Univ Porto, Dept Engn Met & Mat, CEMUC, Fac Engn, P-4200465 Oporto, Portugal.
RP Atayde, LM (reprint author), Univ Porto, Dept Clin Vet, ICBAS, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal.
EM ataydelm@gmail.com
RI Lopes, Maria A./P-4442-2014; Armada-da-Silva, Paulo/L-5675-2013
OI Lopes, Maria A./0000-0003-4105-8148; Armada-da-Silva,
   Paulo/0000-0002-3814-6879; Cortez, Paulo/0000-0001-7132-6786; Mauricio,
   Ana Colette/0000-0002-0018-9363; Santos, Jose
   Domingos/0000-0002-6871-9850
FU QREN I&DT Cluster in Development of Products for Regenerative Medicine
   and Cell Therapies - Projects Biomat Cell QREN [2008/1372]; Project
   TRIBONE - European Community FEDER fund through ON2 - O Novo Norte -
   North Portugal Regional Operational Program [11458]; Fundacao para a
   Ciencia e Tecnologia (FCT) [FCT - EN-MED/0002/2010]; Ministerio da
   Educacao e da Ciencia and EuroNanoMed JTC Program; program COMPETE -
   Programa Operacional Factores de Competitividade
   [Pest-OE/AGR/UI0211/2011]
FX This research was supported by QREN I&DT Cluster in Development of
   Products for Regenerative Medicine and Cell Therapies - Projects Biomat
   & Cell QREN 2008/1372 and Project TRIBONE, No 11458, co-financed by the
   European Community FEDER fund through ON2 - O Novo Norte - North
   Portugal Regional Operational Program 2007-2013, by project FCT -
   EN-MED/0002/2010 from Fundacao para a Ciencia e Tecnologia (FCT),
   Ministerio da Educacao e da Ciencia and EuroNanoMed JTC 2010 Program,
   and by the program COMPETE - Programa Operacional Factores de
   Competitividade, Project Pest-OE/AGR/UI0211/2011. The authors are
   grateful to Mrs. Ana Mota (FMD-UP), for her technical assistance with
   the histological studies.
CR Bacchelli B, 2009, ACTA BIOMATER, V5, P2246, DOI 10.1016/j.actbio.2009.01.024
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Borsari V, 2009, J BIOMED MATER RES A, V89A, P550, DOI 10.1002/jbm.a.31995
   Boure LP, 2008, ECM 9 MUSCULOSKELETA
   Boyd D, 2009, J MATER SCI-MATER M, V20, P413, DOI 10.1007/s10856-008-3569-0
   Burger W, 2009, PRINCIPLES DIGITAL I, P259
   Reis ECC, 2010, BRAZ ARCH BIOL TECHN, V53, P817, DOI 10.1590/S1516-89132010000400010
   Chen D, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-56
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206
   Cortez PP, 2011, J BIOMED MATER RES B, V99B, P170, DOI 10.1002/jbm.b.31884
   Cortez PP, 2012, J BIOMATER APPL, V27, P201, DOI 10.1177/0885328211399479
   DAVIDSON MK, 1987, ISRAEL J MED SCI, V23, P551
   Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003
   Dwek JR, 2010, SKELETAL RADIOL, V39, P319, DOI 10.1007/s00256-009-0849-9
   Efford N., 2000, DIGITAL IMAGE PROCES, P352
   Gisep A, 2003, J BIOMED MATER RES A, V66A, P532, DOI 10.1002/jbm.a.10593
   GLIMCHER MJ, 1980, J BONE JOINT SURG AM, V62, P964, DOI 10.2106/00004623-198062060-00013
   Griffon DJ, 2005, AO PRINCIPLES FRACTU, P72
   GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   Hansen B, 2002, C STAT ART RES 3 RS
   Harms C, 2012, INT J NANOMED, V7, P2883, DOI 10.2147/IJN.S29314
   Huffer WE, 2007, J BIOMED MATER RES B, V82B, P460, DOI 10.1002/jbm.b.30751
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Lopes MA, 2001, J BIOMED MATER RES, V54, P463, DOI 10.1002/1097-4636(20010315)54:4<463::AID-JBM10>3.0.CO;2-Y
   Lopes MA, 1998, J BIOMED MATER RES, V39, P244, DOI 10.1002/(SICI)1097-4636(199802)39:2<244::AID-JBM11>3.0.CO;2-D
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006
   Martini L, 2001, COMPARATIVE MED, V51, P292
   Martini L, 2012, PLAST RECONSTR SURG, V129, p625E, DOI 10.1097/PRS.0b013e318244220d
   McMahon S, 2011, HIP INT, V21, P616, DOI 10.5301/HIP.2011.8704
   Nahid Mohebbian, 2003, Rev Belge Med Dent (1984), V58, P189
   NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/8756-3282(95)00026-A
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Pektas ZO, 2012, INT J ORAL MAX SURG, V41, P339, DOI 10.1016/j.ijom.2011.11.008
   Plecko M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-32
   Potes JC, 2008, EXP PATHOL HLTH SCI, V2, P29
   Rasband WS, 1997, IMAGEJ
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   Seeman E, 2003, NEW ENGL J MED, V349, P320, DOI 10.1056/NEJMp038101
   SHAPIRO F, 1988, J BONE JOINT SURG AM, V70A, P1067, DOI 10.2106/00004623-198870070-00016
   Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05
   Solchaga LA, 2012, SPINE, V37, pE461, DOI 10.1097/BRS.0b013e31823b01dc
   Somanathan Rakesh V, 2006, Acta Medica (Hradec Kralove), V49, P87
   Srivastav A, 2011, BIOMEDICAL ENGINEERING, TRENDS IN MATERIALS SCIENCE, P153
   van der Pol U, 2010, ACTA BIOMATER, V6, P3755, DOI 10.1016/j.actbio.2010.03.028
NR 48
TC 3
Z9 3
U1 0
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2014
VL 25
IS 8
BP 1885
EP 1901
DI 10.1007/s10856-014-5216-2
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM5DI
UT WOS:000339875800006
PM 24771285
DA 2018-10-20
ER

PT J
AU Hong, MH
   Kim, YH
   Ganbat, D
   Kim, DG
   Bae, CS
   Oh, DS
AF Hong, Min-Ho
   Kim, Yoon Hyuk
   Ganbat, Danaa
   Kim, Do-Gyoon
   Bae, Chun-Sik
   Oh, Daniel S.
TI Capillary action: enrichment of retention and habitation of cells via
   micro-channeled scaffolds for massive bone defect regeneration
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; MESENCHYMAL STEM-CELLS;
   MECHANICAL-PROPERTIES; COMPOSITE SCAFFOLDS; POROUS HYDROXYAPATITE;
   TISSUE; POROSITY; MACROPOROSITY; BIOMATERIALS; OSTEOGENESIS
AB The development of a biomaterial substitute that can promote bone regeneration in massive defects has remained as a significant clinical challenge even using bone marrow cells or growth factors. Without an active, thriving cell population present throughout and stable anchored to the construct, exceptional bone regeneration does not occur. An engineered micro-channel structures scaffold within each trabecular has been designed to overcome some current limitations involving the cultivation and habitation of cells in large, volumetric scaffolds to repair massive skeletal defect. We created a scaffold with a superior fluid retention capacity that also may absorb bone marrow cells and provide growth factor-containing body fluids such as blood clots and/or serum under physiological conditions. The scaffold is composed of 3 basic structures (1) porous trabecular network (300-400 mu m) similar to that of human trabecular bones, (2) micro-size channels (25-70 mu m) within each trabecular septum which mimic intra-osseous channels such as Haversian canals and Volkmann's canals with body fluid access, diffusion, nutritional supply and gas exchange, and (3) nano-size pores (100-400 nm) on the surface of each septum that allow immobilized cells to anchor. Combinatorial effects of these internal structures result in a host-adapting construct that enhances cell retention and habitation throughout the 3 cm-height and 4 cm-length bridge-shaped scaffold.
C1 [Hong, Min-Ho; Oh, Daniel S.] Columbia Univ, Dept Orthopaed Surg, Ctr Orthopaed Res, New York, NY 10027 USA.
   [Hong, Min-Ho; Kim, Yoon Hyuk; Ganbat, Danaa] Kyung Hee Univ, Yongin, South Korea.
   [Kim, Do-Gyoon] Ohio State Univ, Coll Dent, Div Orthodont, Columbus, OH 43210 USA.
   [Bae, Chun-Sik] Chonnam Natl Univ, Coll Vet Med, Kwangju, South Korea.
RP Oh, DS (reprint author), Columbia Univ, Dept Orthopaed Surg, Ctr Orthopaed Res, New York, NY 10027 USA.
EM dso2113@columbia.edu
OI Hong, Min-Ho/0000-0001-9268-9906
FU National Agenda Project (NAP) - Korea Research Council of Fundamental
   Science Technology [P-09-JC-LU63-C01]
FX This work was partially supported by National Agenda Project (NAP)
   funded by Korea Research Council of Fundamental Science & Technology
   (P-09-JC-LU63-C01).
CR [Anonymous], 2010, COSMOL CFD MOD US GU
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   Cohen IM, 2007, FLUID MECH, P765
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Manjubala I, 2005, J MATER SCI-MATER M, V16, P1111, DOI 10.1007/s10856-005-4715-6
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Mitton D, 1998, BONE, V22, P651, DOI 10.1016/S8756-3282(98)00036-2
   Oh DS, 2013, CERAM INT, V39, P8401, DOI 10.1016/j.ceramint.2013.04.021
   Ono I, 2004, BIOMATERIALS, V25, P4709, DOI 10.1016/j.biomaterials.2003.11.038
   Rosenson RS, 1996, CLIN CHEM, V42, P1189
   Rosina J, 2007, PHYSIOL RES, V56, pS93
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Tsutsumi H, 2003, POLYMER, V44, P6297, DOI 10.1016/S0032-3861(03)00675-X
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang YW, 2005, BIOMATERIALS, V26, P899, DOI 10.1016/j.biomaterials.2004.03.035
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
   Zou XH, 2009, CELL TRANSPLANT, V18, P433, DOI 10.3727/096368909788809839
NR 30
TC 6
Z9 6
U1 2
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2014
VL 25
IS 8
BP 1991
EP 2001
DI 10.1007/s10856-014-5225-1
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM5DI
UT WOS:000339875800014
PM 24796626
DA 2018-10-20
ER

PT J
AU Wang, L
   Cao, L
   Shansky, J
   Wang, Z
   Mooney, D
   Vandenburgh, H
AF Wang, Lin
   Cao, Lan
   Shansky, Janet
   Wang, Zheng
   Mooney, David
   Vandenburgh, Herman
TI Minimally Invasive Approach to the Repair of Injured Skeletal Muscle
   With a Shape-memory Scaffold
SO MOLECULAR THERAPY
LA English
DT Article
ID MYOBLAST TRANSFER THERAPY; GROWTH-FACTOR DELIVERY; RAT STRIATED-MUSCLE;
   CELL TRANSPLANTATION; ALGINATE HYDROGELS; EARLY MOBILIZATION; SATELLITE
   CELLS; CRUSH INJURY; REGENERATION; TISSUE
AB Repair of injured skeletal muscle by cell therapies has been limited by poor survival of injected cells. Use of a carrier scaffold delivering cells locally, may enhance in vivo cell survival, and promote skeletal muscle regeneration. Biomaterial scaffolds are often implanted into muscle tissue through invasive surgeries, which can result in trauma that delays healing. Minimally invasive approaches to scaffold implantation are thought to minimize these adverse effects. This hypothesis was addressed in the context of a severe mouse skeletal muscle injury model. A degradable, shape-memory alginate scaffold that was highly porous and compressible was delivered by minimally invasive surgical techniques to injured tibialis anterior muscle. The scaffold controlled was quickly rehydrated in situ with autologous myoblasts and growth factors (either insulin-like growth factor-1 (IGF-1) alone or IGF-1 with vascular endothelial growth factor (VEGF)). The implanted scaffolds delivering myoblasts and IGF-1 significantly reduced scar formation, enhanced cell engraftment, and improved muscle contractile function. The addition of VEGF to the scaffold further improved functional recovery likely through increased angiogenesis. Thus, the delivery of myoblasts and dual local release of VEGF and IGF-1 from degradable scaffolds implanted through a minimally invasive procedure effectively promoted the functional regeneration of injured skeletal muscle.
C1 [Wang, Lin; Cao, Lan; Mooney, David; Vandenburgh, Herman] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA USA.
   [Wang, Lin; Cao, Lan; Mooney, David; Vandenburgh, Herman] Harvard Univ, Wyss Inst, Cambridge, MA USA.
   [Wang, Lin] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.
   [Wang, Lin; Wang, Zheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Tissue Engn & Regenerat Med, Wuhan 430074, Peoples R China.
   [Wang, Lin; Wang, Zheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Med Res Ctr, Wuhan 430074, Peoples R China.
   [Shansky, Janet; Vandenburgh, Herman] Myomics, Providence, RI USA.
   [Vandenburgh, Herman] Miriam Hosp, Brown Med Sch, Dept Pathol, Providence, RI 02912 USA.
RP Vandenburgh, H (reprint author), Miriam Hosp, Brown Med Sch, Dept Pathol, Providence, RI 02912 USA.
EM Vandenburghlab@gmail.com
FU National Institutes of Health [RO1 DE013349, R43 AG029705]
FX We thank Frank Benesch-Lee (Myomics) for assisting in the design and
   manufacture of the molds for making the scaffolds, Cristina Borselli
   (Harvard University) for assisting with animal surgeries and
   experimental techniques, and Geoff Williams (Leduc Bio-imaging facility,
   Brown University) for imaging assistance. This work was supported by the
   National Institutes of Health Grants, RO1 DE013349 and R43 AG029705.
CR Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057
   Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Boldrin L, 2007, TISSUE ENG, V13, P253, DOI 10.1089/ten.2006.0093
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010
   Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479
   Dixon RW, 1996, J NEUROPATH EXP NEUR, V55, P1230, DOI 10.1097/00005072-199612000-00006
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483
   Gates C, 2005, OPER TECHN SPORT MED, V13, P247, DOI 10.1053/j.otsm.2006.01.012
   Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058
   Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022
   JARVINEN M, 1975, ACTA PATH MICRO IM A, VA 83, P269
   JARVINEN M, 1976, ACTA CHIR SCAND, V142, P47
   Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714
   Jarvinen TAH, 2007, BEST PRACT RES CL RH, V21, P317, DOI 10.1016/j.berh.2006.12.004
   Kong HJ, 2002, POLYMER, V43, P6239, DOI 10.1016/S0032-3861(02)00559-1
   Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lanza R, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P1
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Liao H, 2009, TISSUE ENG PART B-RE, V15, P319, DOI 10.1089/ten.teb.2009.0092
   Lubeck DP, 2003, BEST PRACT RES CL RH, V17, P529, DOI 10.1016/S1521-6942(03)00023-8
   McClatchey KD, 2004, ARCH PATHOL LAB MED, V128, P480
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Morath C, 2004, J AM SOC NEPHROL, V15, P1582, DOI 10.1097/01.ASN.0000126194.77004.9B
   Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002
   Philippou A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P208
   Philippou A, 2007, IN VIVO, V21, P45
   Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Saxena AK, 1999, TISSUE ENG, V5, P525, DOI 10.1089/ten.1999.5.525
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052
   Skuk D, 2003, J MUSCLE RES CELL M, V24, P285
   Skuk D, 2002, CELL TRANSPLANT, V11, P671, DOI 10.3727/000000002783985378
   Smythe GM, 2001, J CELL MOL MED, V5, P33, DOI 10.1111/j.1582-4934.2001.tb00136.x
   Soulillou JP, 2001, TRANSPLANTATION, V72, pSS89
   Thorrez L, 2006, MOL THER, V14, P442, DOI 10.1016/j.ymthe.2006.03.019
   Vandenburgh H, 1999, Methods Mol Med, V18, P217, DOI 10.1385/0-89603-516-6:217
   WAKELAM MJO, 1985, BIOCHEM J, V228, P1
   Wang L, 2012, TISSUE ENG PT A, V18, P2000, DOI [10.1089/ten.tea.2011.0663, 10.1089/ten.TEA.2011.0663]
NR 49
TC 32
Z9 32
U1 3
U2 40
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD AUG
PY 2014
VL 22
IS 8
BP 1441
EP 1449
DI 10.1038/mt.2014.78
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA AM3VD
UT WOS:000339780000009
PM 24769909
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Mellgren, A
   Matzel, KE
   Pollack, J
   Hull, T
   Bernstein, M
   Graf, W
AF Mellgren, A.
   Matzel, K. E.
   Pollack, J.
   Hull, T.
   Bernstein, M.
   Graf, W.
CA NASHA Dx Study Grp
TI Long-term efficacy of NASHA Dx injection therapy for treatment of fecal
   incontinence
SO NEUROGASTROENTEROLOGY AND MOTILITY
LA English
DT Article
DE fecal incontinence; injectable bulking agents; NASHA Dx; non-animal
   stabilized hyaluronic acid/dextranomer
ID INJECTABLE SILICONE BIOMATERIAL; QUALITY-OF-LIFE;
   DEXTRANOMER-HYALURONIC-ACID; ARTIFICIAL BOWEL SPHINCTER; SACRAL
   NERVE-STIMULATION; SUBMUCOSAL INJECTION; IMPLANTS; PTQ(TM); SAFETY;
   TRIAL
AB Background Injectable bulking treatment for fecal incontinence (FI) is intended to expand tissue in the anal canal and prevent fecal leakage. Use of injectable bulking agents is increasing because it can be performed in an outpatient setting and with low risk for morbidity. This study evaluated the long-term (36-month) clinical effectiveness and safety of injection of non-animal stabilized hyaluronic acid/dextranomer (NASHA Dx) on FI symptoms. Methods In a prospective multicenter trial, 136 patients with FI received the NASHA Dx bulking agent. Treatment success defined as a reduction in number of FI episodes by 50% or more compared with baseline (Responder(50)). Change from baseline in Cleveland Clinic Florida Fecal Incontinence Score (CCFIS) and Fecal Incontinence Quality of Life Scale (FIQL), and adverse events were also evaluated. Key Results Successful decrease in symptoms was achieved in 52% of patients at 6 months and this was sustained at 12 months (57%) and 36 months (52%). Mean CCFIS decreased from 14 at baseline to 11 at 36 months (p < 0.001). Quality-of-life scores for all four domains improved significantly between baseline and 36 months of follow-up. Severe adverse events were rare and most adverse events were transient and pertained to minor bleeding and pain or discomfort. Conclusions & Inferences Submucosal injection of NASHA Dx provided a significant improvement of FI symptoms in a majority of patients and this effect was stable during the course of the follow-up and maintained for 3 years.
C1 [Mellgren, A.] Univ Illinois, Div Colon & Rectal Surg, Chicago, IL USA.
   [Matzel, K. E.] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany.
   [Pollack, J.] Danderyd Hosp, Dept Surg, Stockholm, Sweden.
   [Hull, T.] Cleveland Clin Fdn, Cleveland, OH 44195 USA.
   [Bernstein, M.] NYU Langone Med Ctr, New York, NY USA.
   [Graf, W.] Uppsala Univ, Inst Surg Sci, Uppsala, Sweden.
RP Mellgren, A (reprint author), UIC Coll Med, Div Colon & Rectal Surg MC 958, 840 South Wood St 518 E CSB, Chicago, IL 60612 USA.
EM anders.mellgren@icloud.com
FU Q-Med AB
FX This research was funded by Q-Med AB. Oceana Therapeutics acquired a
   license for worldwide commercialization rights for NASHA/Dx in 2009.
   Oceana Therapeutics was acquired by Salix Pharmaceuticals, Inc., in
   2011. The authors affirm that they had complete access to the data that
   support the publication.
CR Aigner F, 2009, DIS COLON RECTUM, V52, P293, DOI 10.1007/DCR.0b013e318197d755
   Al-Ghnaniem R, 2001, ANN ROY COLL SURG, V83, P325
   Bordeianou L, 2008, COLORECTAL DIS, V10, P273, DOI 10.1111/j.1463-1318.2007.01288.x
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Danielson J, 2009, DIS COLON RECTUM, V52, P1101, DOI 10.1007/DCR.0b013e31819f5cbf
   Ganio E, 2008, TECH COLOPROCTOL, V12, P99, DOI 10.1007/s10151-008-0406-x
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   HALLGREN T, 1994, DIGEST DIS SCI, V39, P2612, DOI 10.1007/BF02087698
   Hussain ZI, 2011, BRIT J SURG, V98, P1526, DOI 10.1002/bjs.7645
   Lehur PA, 2010, DIS COLON RECTUM, V53, P1604, DOI 10.1007/DCR.0b013e3181f5d5f7
   Luo C, 2010, COLORECTAL DIS, V12, P296, DOI 10.1111/j.1463-1318.2009.01828.x
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   Maeda Y, 2013, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD007959.PUB3
   Melenhorst J, 2008, INT J COLORECTAL DIS, V23, P107, DOI 10.1007/s00384-007-0357-0
   Mellgren A, 2011, DIS COLON RECTUM, V54, P1065, DOI 10.1097/DCR.0b013e31822155e9
   Norton C, 2010, NEUROUROL URODYNAM, V29, P199, DOI 10.1002/nau.20803
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Schwandner O, 2011, SURG INNOV, V18, P130, DOI 10.1177/1553350610392243
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Smith S, 2007, BRIT J SURG, V94, P643, DOI 10.1002/bjs.5869
   Smith S, 2006, BRIT J SURG, V93, P1514
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Stenberg A, 2003, J UROLOGY, V169, P1109, DOI 10.1097/01.ju.0000053013.49676.89
   Stenberg AM, 1997, J UROLOGY, V158, P1937, DOI 10.1016/S0022-5347(01)64185-5
   Tan JJY, 2007, DIS COLON RECTUM, V50, P1950, DOI 10.1007/s10350-007-9009-2
   Thornton M J, 2004, Colorectal Dis, V6, P470, DOI 10.1111/j.1463-1318.2004.00714.x
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Wexner SD, 2010, ANN SURG, V251, P441, DOI 10.1097/SLA.0b013e3181cf8ed0
   Wong MTC, 2011, ANN SURG, V254, P951, DOI 10.1097/SLA.0b013e31823ac2bc
NR 30
TC 20
Z9 20
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1350-1925
EI 1365-2982
J9 NEUROGASTROENT MOTIL
JI Neurogastroenterol. Motil.
PD AUG
PY 2014
VL 26
IS 8
BP 1087
EP 1094
DI 10.1111/nmo.12360
PG 8
WC Gastroenterology & Hepatology; Clinical Neurology; Neurosciences
SC Gastroenterology & Hepatology; Neurosciences & Neurology
GA AM2GY
UT WOS:000339669500004
PM 24837493
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Feng, XM
   Lu, XH
   Huang, D
   Xing, J
   Feng, GJ
   Jin, GH
   Yi, X
   Li, LR
   Lu, YZ
   Nie, DK
   Chen, X
   Zhang, L
   Gu, ZF
   Zhang, XH
AF Feng, Xingmei
   Lu, Xiaohui
   Huang, Dan
   Xing, Jing
   Feng, Guijuan
   Jin, Guohua
   Yi, Xin
   Li, Liren
   Lu, Yuanzhou
   Nie, Dekang
   Chen, Xiang
   Zhang, Lei
   Gu, Zhifeng
   Zhang, Xinhua
TI 3D Porous Chitosan Scaffolds Suit Survival and Neural Differentiation of
   Dental Pulp Stem Cells
SO CELLULAR AND MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Chitosan porous scaffold; Neural differentiation; Dental pulp stem cells
   (DPSCs); Brain injury; Biocompatibility
ID TISSUE ENGINEERING APPLICATIONS; IN-VITRO; NERVOUS-SYSTEM; BRAIN-INJURY;
   BONE-MARROW; SPINAL-CORD; REGENERATION; HYDROGEL; NEURONS; REPAIR
AB A key aspect of cell replacement therapy in brain injury treatment is construction of a suitable biomaterial scaffold that can effectively carry and transport the therapeutic cells to the target area. In the present study, we created small 3D porous chitosan scaffolds through freeze-drying, and showed that these can support and enhance the differentiation of dental pulp stem cells (DPSCs) to nerve cells in vitro. The DPSCs were collected from the dental pulp of adult human third molars. At a swelling rate of similar to 4.33 +/- A 10.92 %, the scaffold displayed high porosity and interconnectivity of pores, as revealed by SEM. Cell counting kit-8 assay established the biocompatibility of the chitosan scaffold, supporting the growth and survival of DPSCs. The successful neural differentiation of DPSCs was assayed by RT-PCR, western blotting, and immunofluorescence. We found that the scaffold-attached DPSCs showed high expression of Nestin that decreased sharply following induction of differentiation. Exposure to the differentiation media also increased the expression of neural molecular markers Microtubule-associated protein 2, glial fibrillary acidic protein, and 2',3'-cyclic nucleotide phosphodiesterase. This study demonstrates that the granular 3D chitosan scaffolds are non-cytotoxic, biocompatible, and provide a conducive and favorable micro-environment for attachment, survival, and neural differentiation of DPSCs. These scaffolds have enormous potential to facilitate future advances in treatment of brain injury.
C1 [Feng, Xingmei; Lu, Xiaohui; Huang, Dan; Xing, Jing; Feng, Guijuan] Nantong Univ, Affiliated Hosp, Dept Stomatol, Nantong 226001, Jiangsu, Peoples R China.
   [Jin, Guohua; Yi, Xin; Chen, Xiang; Zhang, Lei; Zhang, Xinhua] Nantong Univ, Coll Med, Dept Human Anat, Nantong 226001, Jiangsu, Peoples R China.
   [Li, Liren] Nantong Univ, Affiliated Hosp, Dept Gastroenterol & Hepatol, Nantong 226001, Jiangsu, Peoples R China.
   [Lu, Yuanzhou] Tongzhou First Peoples Hosp, Dept Med Cardiol, Nantong 226300, Jiangsu, Peoples R China.
   [Nie, Dekang] Yancheng First Peoples Hosp, Dept Neurosurg, Yancheng 224005, Jiangsu, Peoples R China.
   [Gu, Zhifeng] Nantong Univ, Affiliated Hosp, Dept Rheumatol, Nantong 226001, Jiangsu, Peoples R China.
RP Zhang, XH (reprint author), Nantong Univ, Coll Med, Dept Human Anat, Nantong 226001, Jiangsu, Peoples R China.
EM guzhifeng@126.com; zhangxinhua@ntu.edu.cn
OI Zhang, Xin-hua/0000-0002-5702-6733
FU Graduate Student Innovation of Science and Technology Project in Jiangsu
   Province [YKC13084]; Graduate Student Innovation of Science and
   Technology Project in Nantong University [YKC13084]; "Top Six Types of
   Talents" Financial Assistance of Jiangsu Province Grant; National
   Natural Science Foundation of China [31171038]; Jiangsu Natural Science
   Foundation [BK2011385]; Nantong University for Innovation Talent;
   Priority Academic Program Development (PAPD) of Jiangsu Higher Education
   Institutions
FX This work was supported by Graduate Student Innovation of Science and
   Technology Projects in Jiangsu Province and in Nantong University
   (Grants No. YKC13084); the "Top Six Types of Talents" Financial
   Assistance of Jiangsu Province Grant (No. 7 and No. 10); National
   Natural Science Foundation of China (Grant No. 31171038), Jiangsu
   Natural Science Foundation (BK2011385); the Grant of Nantong University
   for Innovation Talent and a project funded by the Priority Academic
   Program Development (PAPD) of Jiangsu Higher Education Institutions. We
   thank Department of Human Anatomy of Medical College in Nantong
   University for technical assistance and equipment support.
CR Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979
   Arthur A, 2009, STEM CELLS, V27, P2229, DOI 10.1002/stem.138
   Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705
   Chai Y, 2000, DEVELOPMENT, V127, P1671
   d'Aquino R, 2009, J EXP ZOOL PART B, V312B, P408, DOI 10.1002/jez.b.21263
   Dokmeci MR, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3594781
   Feng XM, 2013, CELL MOL NEUROBIOL, V33, P1023, DOI 10.1007/s10571-013-9965-0
   Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044
   Gaspar VM, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/1/015101
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Itoh S, 2003, ARTIF ORGANS, V27, P1079, DOI 10.1111/j.1525-1594.2003.07208.x
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Ji CD, 2011, BIOMATERIALS, V32, P9719, DOI 10.1016/j.biomaterials.2011.09.003
   Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim NR, 2009, ORAL SURG ORAL MED O, V108, pE94, DOI 10.1016/j.tripleo.2009.07.031
   Lee M, 2008, J BIOMED MATER RES A, V87A, P1010, DOI 10.1002/jbm.a.31816
   Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Muzzarelli RAA, 2010, MAR DRUGS, V8, P292, DOI 10.3390/md8020292
   Nakashima M, 2005, J ENDODONT, V31, P711, DOI 10.1097/01.don.0000164138.49923.e5
   Nosrat IV, 2004, EUR J NEUROSCI, V19, P2388, DOI 10.1111/j.1460-9568.2004.03314.x
   Ribeiro MP, 2009, WOUND REPAIR REGEN, V17, P817, DOI 10.1111/j.1524-475X.2009.00538.x
   Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251
   Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009
   Tamaki Y, 2013, ODONTOLOGY, V101, P121, DOI 10.1007/s10266-012-0075-0
   Xu Y, 2013, J MOL NEUROSCI, V49, P250, DOI 10.1007/s12031-012-9917-z
   Yamagata M, 2013, STROKE, V44, P551, DOI 10.1161/STROKEAHA.112.676759
NR 30
TC 13
Z9 14
U1 4
U2 43
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0272-4340
EI 1573-6830
J9 CELL MOL NEUROBIOL
JI Cell. Mol. Neurobiol.
PD AUG
PY 2014
VL 34
IS 6
BP 859
EP 870
DI 10.1007/s10571-014-0063-8
PG 12
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA AL8IT
UT WOS:000339382500009
PM 24789753
DA 2018-10-20
ER

PT J
AU Shrestha, B
   Coykendall, K
   Li, YC
   Moon, A
   Priyadarshani, P
   Yao, L
AF Shrestha, Bikesh
   Coykendall, Katherine
   Li, Yongchao
   Moon, Alex
   Priyadarshani, Priyanka
   Yao, Li
TI Repair of injured spinal cord using biomaterial scaffolds and stem cells
SO STEM CELL RESEARCH & THERAPY
LA English
DT Review
ID TEMPLATED AGAROSE SCAFFOLDS; NEURAL STEM; FUNCTIONAL RECOVERY; AXONAL
   REGENERATION; SCHWANN-CELLS; NEUROTROPHIC FACTOR; BONE-MARROW; WALLERIAN
   DEGENERATION; PROMOTE REGENERATION; NERVE REGENERATION
AB The loss of neurons and degeneration of axons after spinal cord injury result in the loss of sensory and motor functions. A bridging biomaterial construct that allows the axons to grow through has been investigated for the repair of injured spinal cord. Due to the hostility of the microenvironment in the lesion, multiple conditions need to be fulfilled to achieve improved functional recovery. A scaffold has been applied to bridge the gap of the lesion as contact guidance for axonal growth and to act as a vehicle to deliver stem cells in order to modify the microenvironment. Stem cells may improve functional recovery of the injured spinal cord by providing trophic support or directly replacing neurons and their support cells. Neural stem cells and mesenchymal stem cells have been seeded into biomaterial scaffolds and investigated for spinal cord regeneration. Both natural and synthetic biomaterials have increased stem cell survival in vivo by providing the cells with a controlled microenvironment in which cell growth and differentiation are facilitated. This optimal multi-disciplinary approach of combining biomaterials, stem cells, and biomolecules offers a promising treatment for the injured spinal cord.
C1 [Shrestha, Bikesh; Coykendall, Katherine; Li, Yongchao; Moon, Alex; Priyadarshani, Priyanka; Yao, Li] Wichita State Univ, Dept Biol Sci, Wichita, KS 67260 USA.
RP Yao, L (reprint author), Wichita State Univ, Dept Biol Sci, Wichita, KS 67260 USA.
EM li.yao@wichita.edu
RI Yao, Li/J-1372-2016
FU Wichita State University; National Center for Research Resources [P20
   RR016475]; National Institute of General Medical Sciences, National
   Institutes of Health [P20 GM103418]
FX This work was supported by Li Yao's startup funding at Wichita State
   University, the National Center for Research Resources (P20 RR016475),
   and the National Institute of General Medical Sciences (P20 GM103418)
   from the National Institutes of Health.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Azari MF, 2010, CURR NEUROPHARMACOL, V8, P316, DOI 10.2174/157015910793358204
   Barry Frank P., 2003, Birth Defects Research, V69, P250, DOI 10.1002/bdrc.10021
   Bellenchi GC, 2013, J NEUROCHEM, V124, P159, DOI 10.1111/jnc.12084
   Bosse F, 2012, CELL TISSUE RES, V349, P5, DOI 10.1007/s00441-012-1389-5
   BOVOLENTA P, 1992, PROG BRAIN RES, V94, P367
   Bozkurt G, 2010, NEUROSURGERY, V67, P1733, DOI 10.1227/NEU.0b013e3181f9af35
   BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0
   Breslin K, 2012, PEDIATR EMERG CARE, V28, P1238, DOI 10.1097/PEC.0b013e3182724434
   Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001
   Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536
   Cardenas DD, 2013, NEUROLOGY, V80, P533, DOI 10.1212/WNL.0b013e318281546b
   Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]
   Cho SR, 2009, CELL TRANSPLANT, V18, P1359, DOI 10.3727/096368909X475329
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660
   Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339
   Deng LX, 2013, J NEUROSCI, V33, P5655, DOI 10.1523/JNEUROSCI.2973-12.2013
   Du BL, 2011, BRAIN RES, V1400, P87, DOI 10.1016/j.brainres.2011.05.019
   DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x
   Ellis-Behnke RG, 2009, CELL TRANSPLANT, V18, P1047, DOI 10.3727/096368909X471242
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   FERGUSON TA, 2011, J TISSUE ENG, V2, P1
   Gao MY, 2013, BIOMATERIALS, V34, P1529, DOI 10.1016/j.biomaterials.2012.10.070
   Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693
   Han QQ, 2010, BIOMATERIALS, V31, P9212, DOI 10.1016/j.biomaterials.2010.08.040
   He LM, 2009, TISSUE ENG PART C-ME, V15, P243, DOI 10.1089/ten.tec.2008.0255
   Hejcl A, 2006, CELL MOL NEUROBIOL, V26, P1111
   Hejcl A, 2010, STEM CELLS DEV, V19, P1535, DOI 10.1089/scd.2009.0378
   Hermanns S, 2001, J NEUROSCI METH, V110, P141, DOI 10.1016/S0165-0270(01)00427-7
   Hodgetts SI, 2013, EXP NEUROL, V248, P343, DOI 10.1016/j.expneurol.2013.06.018
   Hodgetts SI, 2013, CELL TRANSPLANT, V22, P393, DOI 10.3727/096368912X656081
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001
   Hwang DH, 2011, CELL TRANSPLANT, V20, P1361, DOI 10.3727/096368910X557155
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   Kang KN, 2011, TISSUE ENG PT A, V17, P2143, DOI [10.1089/ten.tea.2011.0122, 10.1089/ten.TEA.2011.0122]
   Kim BG, 2010, CYTOTHERAPY, V12, P841, DOI 10.3109/14653249.2010.501784
   Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987
   King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018
   King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033
   Li J, 2013, BIOMED RES INT, DOI 10.1155/2013/786475
   Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063
   Liang WB, 2010, BIOMATERIALS, V31, P8634, DOI 10.1016/j.biomaterials.2010.07.084
   Liu J, 2013, CYTOTHERAPY, V15, P185, DOI 10.1016/j.jcyt.2012.09.005
   Liu Y, 1999, J NEUROSCI, V19, P4370
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Madaghiele M, 2008, J BIOMED MATER RES A, V85A, P757, DOI 10.1002/jbm.a.31517
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Montgomery CT, 1996, EXP NEUROL, V137, P277, DOI 10.1006/exnr.1996.0026
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Nomura H, 2006, NEUROSURGERY, V59, P183, DOI 10.1227/NEU.0000219859.35349.EF
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   Okano H, 2010, EXP NEUROL, V0014-4886, P00378
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Ozdemir M, 2012, STEM CELL REV REP, V8, P953, DOI 10.1007/s12015-012-9376-5
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Pritchard CD, 2010, J NEUROSCI METH, V188, P258, DOI 10.1016/j.jneumeth.2010.02.019
   Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500
   Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803
   Rauch MF, 2009, EUR J NEUROSCI, V29, P132, DOI 10.1111/j.1460-9568.2008.06567.x
   Reeves A, 2012, ADV EXP MED BIOL, V760, P16
   Rooney GE, 2011, TISSUE ENG PT A, V17, P1287, DOI [10.1089/ten.tea.2010.0396, 10.1089/ten.TEA.2010.0396]
   Rooney GE, 2009, TISSUE ENG PT A, V15, P3049, DOI [10.1089/ten.tea.2009.0045, 10.1089/ten.TEA.2009.0045]
   Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009
   Sazo REG, 2012, BIOMATERIALS, V33, P8529, DOI 10.1016/j.biomaterials.2012.07.028
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Smith LA, 2008, SOFT MATTER, V4, P2144, DOI 10.1039/b807088c
   Spilker MH, 2001, RESTOR NEUROL NEUROS, V18, P23
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3025
   Tian DS, 2007, BRAIN RES, V1154, P206, DOI 10.1016/j.brainres.2007.04.005
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Vanscoy JE, 2011, J NEURAL ENG, V8, P1
   Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x
   Wang JM, 2011, BIOMATERIALS, V32, P7454, DOI 10.1016/j.biomaterials.2011.06.036
   Weaver LC, 2005, J NEUROTRAUM, V22, P1375, DOI 10.1089/neu.2005.22.1375
   Webber DJ, 2007, REGEN MED, V2, P929, DOI 10.2217/17460751.2.6.929
   Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689
   Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309
   Yoo J, 2013, J CELL BIOCHEM, V114, P743, DOI 10.1002/jcb.24427
   Yoshil S, 2009, J TISSUE ENG REGEN M, V3, P19, DOI 10.1002/term.130
   Yu D, 2009, STEM CELLS, V27, P1212, DOI 10.1002/stem.26
   Zeng X, 2011, CELL TRANSPLANT, V20, P1881, DOI 10.3727/096368911X566181
   Zhang W, 2010, BRAIN RES, V1359, P256, DOI 10.1016/j.brainres.2010.08.072
NR 96
TC 38
Z9 43
U1 5
U2 55
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD AUG 1
PY 2014
VL 5
AR 91
DI 10.1186/scrt480
PG 11
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA AM1UI
UT WOS:000339633500001
PM 25157690
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Kothapalli, CR
   Honarrnandi, P
AF Kothapalli, Chandrasekhar R.
   Honarrnandi, Peyman
TI Theoretical and experimental quantification of the role of diffusive
   chemogradients on neuritogenesis within three-dimensional collagen
   scaffolds
SO ACTA BIOMATERIALIA
LA English
DT Article
DE IGF-1; Microfluidics; Chemogradient; Steepness; Neurite outgrowth
ID NERVE GROWTH CONES; MICROFLUIDIC PLATFORM; GUIDANCE MOLECULES;
   CELL-MIGRATION; MOTOR-NEURONS; AXON GUIDANCE; IN-VIVO; GRADIENTS;
   CHEMOTAXIS; ASSAY
AB A critical challenge to regenerating close mimics of native axonal pathways under chronic neurodegenerative disease or injury conditions is the inability to stimulate, sustain and steer neurite outgrowth over a long distance, until they reach their intended targets. Understanding neurite outgrowth necessitates quantitative determination of the role of molecular gradients on growth cone navigation under dynamic physiological conditions. High-fidelity biomimetic platforms are needed to computationally and experimentally acquire and analyze spatiotemporal molecular gradient evolution and the growth cone response across multiple conditions along this gradient pathway. In this study, we utilized a simple microfluidic platform in which diffusive gradients were generated within a 3-D porous scaffold in a defined and reproducible manner. The platform's characteristics (spatiotemporal gradient, steepness, diffusion time, etc.) were precisely quantified at every specified location within the scaffold. Using this platform, we show that the cortical neurite response within 3-D collagen scaffolds, at both the cellular and molecular level, is extremely sensitive to subtle changes in localized concentration and gradient steepness of IGF-1 within that region. This platform could also be used to study other biological processes such as morphogenesis and cancer metastasis, where chemogradients are expected to significantly regulate the outcomes. Results from this study might be of tremendous use in designing biomaterial scaffolds for neural tissue engineering, axonal pathway regeneration under injury or disease, and in formulating targeted drug-delivery strategies. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kothapalli, Chandrasekhar R.] Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44141 USA.
   [Honarrnandi, Peyman] CUNY City Coll, Dept Mech Engn, New York, NY 10031 USA.
RP Kothapalli, CR (reprint author), Cleveland State Univ, Dept Chem & Biomed Engn, Cleveland, OH 44141 USA.
EM c.kothapalli@csuohio.edu
FU Cleveland State University
FX We thank Michael Sawonik and Kurt Farrell for help with simulations and
   experimental procedures and Stanford Microfluidics Foundry for help with
   device molds. C.K. would also like to express his gratitude for the
   startup funds, Faculty Research Development Award (2012-2013), and
   Provost Undergraduate Research and Creative Achievement Award (2012)
   from the Cleveland State University.
CR Albrecht DR, 2011, NAT METHODS, V8, P599, DOI [10.1038/NMETH.1630, 10.1038/nmeth.1630]
   Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036
   Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005
   Bagnard D, 2000, J NEUROSCI, V20, P1030, DOI 10.1523/JNEUROSCI.20-03-01030.2000
   Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010
   Buxboim A, 2010, NAT METHODS, V7, P695, DOI 10.1038/nmeth0910-695
   Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   Caserta S, 2013, AICHE J, V59, P4025, DOI 10.1002/aic.14164
   Cheng SY, 2007, LAB CHIP, V7, P763, DOI 10.1039/b618463d
   Chung Bong Geun, 2007, J Vis Exp, P271, DOI 10.3791/271
   Clemmons D. R., 1995, Progress in Growth Factor Research, V6, P357, DOI 10.1016/0955-2235(95)00013-5
   COMPSTON A, 1995, J INTERN MED, V237, P127, DOI 10.1111/j.1365-2796.1995.tb01152.x
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165
   Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021
   Du Y, 2009, LAB CHIP, V9, P761, DOI 10.1039/b815990d
   Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#
   Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349
   Funamoto K, 2012, LAB CHIP, V12, P4855, DOI 10.1039/c2lc40306d
   Goldberg JL, 1998, CURR BIOL, V8, pR310, DOI 10.1016/S0960-9822(98)70195-2
   Guarnieri D, 2007, J MATER SCI-MATER M, V18, P245, DOI 10.1007/s10856-006-0686-5
   Isbister CM, 2003, J NEUROSCI, V23, P193
   Jeong GS, 2011, ANAL CHEM, V83, P8454, DOI 10.1021/ac202170e
   Jones DM, 2003, J NEUROCHEM, V86, P1116, DOI 10.1046/j.1471-4159.2003.01925.x
   Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h
   Knoll B, 2007, NAT PROTOC, V2, P1216, DOI 10.1038/nprot.2007.157
   Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI [10.1039/c0lc00240b, 10.1039/c01c00240b]
   Kunze A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026187
   Kunze A, 2011, BIOTECHNOL BIOENG, V108, P2241, DOI 10.1002/bit.23128
   Kunze A, 2011, BIOMATERIALS, V32, P2088, DOI 10.1016/j.biomaterials.2010.11.047
   Kunze A, 2009, PROCEDIA CHEM, V1, P369, DOI 10.1016/j.proche.2009.07.092
   Lang S, 2008, ANAL BIOANAL CHEM, V390, P809, DOI 10.1007/s00216-007-1363-3
   LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4
   Logan Ann, 1994, Progress in Growth Factor Research, V5, P379, DOI 10.1016/0955-2235(94)00008-9
   Mazumder MMG, 2013, ACTA BIOENG BIOMECH, V15, P3, DOI 10.5277/abb130201
   Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745
   MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M
   Muinonen-Martin AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015309
   NEFF NT, 1993, J NEUROBIOL, V24, P1578, DOI 10.1002/neu.480241203
   Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000
   OLSON L, 1990, STEREOT FUNCT NEUROS, V54-5, P250, DOI 10.1159/000100220
   Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789
   Paguirigan AL, 2008, BIOESSAYS, V30, P811, DOI 10.1002/bies.20804
   Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765
   Pereira EAC, 2006, J ROY SOC MED, V99, P238, DOI 10.1258/jrsm.99.5.238
   Pujic Z, 2008, J NEUROSCI METH, V170, P220, DOI 10.1016/j.jneumeth.2008.01.014
   Robles Alfredo, 2009, Open Neurol J, V3, P27, DOI 10.2174/1874205X00903010027
   Rosentreter SM, 1998, J NEUROBIOL, V37, P541, DOI 10.1002/(SICI)1097-4695(199812)37:4<541::AID-NEU4>3.3.CO;2-C
   Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259
   Schapira AHV, 2007, ARCH NEUROL-CHICAGO, V64, P1083, DOI 10.1001/archneur.64.8.1083
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Shayegan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070590
   Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164
   TESSIERLAVIGNE M, 1991, TRENDS NEUROSCI, V14, P303, DOI 10.1016/0166-2236(91)90142-H
   Tharin S, 2012, INTEGR BIOL-UK, V4, P1398, DOI 10.1039/c2ib20019h
   Toh AGG, 2014, MICROFLUID NANOFLUID, V16, P1, DOI 10.1007/s10404-013-1236-3
   Vasaturo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052251
   Wang XXX, 2006, J CELL SCI, V119, P172, DOI 10.1242/jcs.02710
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Wilson D L, 1990, Restor Neurol Neurosci, V1, P197, DOI 10.3233/RNN-1990-13404
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   Zervantonakis IK, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3553237
   Zhang QC, 2012, BIONANOSCIENCE, V2, P277, DOI 10.1007/s12668-012-0051-8
   ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0
NR 67
TC 5
Z9 6
U1 3
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2014
VL 10
IS 8
BP 3664
EP 3674
DI 10.1016/j.actbio.2014.05.009
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AL9KH
UT WOS:000339459500029
PM 24830550
DA 2018-10-20
ER

PT J
AU Wang, W
   Liu, Q
   Zhang, YM
   Zhao, LZ
AF Wang, Wei
   Liu, Qian
   Zhang, Yumei
   Zhao, Lingzhou
TI Involvement of ILK/ERK1/2 and ILK/p38 pathways in mediating the enhanced
   osteoblast differentiation by micro/nanotopography
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Mitogen-activated protein kinases; Integrin-linked kinase; Osteoblast;
   Micro/nanotextured topography; Titanium
ID INTEGRIN-LINKED KINASE; ACTIVATED PROTEIN-KINASE; OSTEOGENIC
   DIFFERENTIATION; ACTIN CYTOSKELETON; SIGNALING PATHWAY; MG63
   DIFFERENTIATION; CELL-PROLIFERATION; CATENIN PATHWAY; MAP KINASE;
   ADHESION
AB The hierarchical micro/nanotextured topography (MNT) on titanium (Ti) implant surface significantly enhances osteoblast differentiation. We have demonstrated that integrin-linked kinase (ILK) is a key underlying signal molecule and beta-catenin is one of its downstream mediators in MNT-regulated osteoblast behavior. Here we propose that mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase 1/2 (ERK1/2), p38 and c-Jun NH2-terminal kinase (JNK), are other mediators downstream of ILK, and this study aims to confirm this. Firstly, the levels of ILK and MAPK activity in MG63 cells on MNT are examined by Western blot analysis. The ILK, ERK1/2 and p38 signals are significantly up-regulated by MNT, whereas the JNK activity is undetectable by Western blot. The MG63 cell morphology, proliferation and differentiation are studied in the absence and presence of the MAPK subgroup inhibitors to confirm their roles in cell functions on the Ti surface. The MAPK subgroup inhibitors obviously change the cell shape and depress cell proliferation. Blocking the ERK1/2 or p38 signaling, but not the JNK signaling, significantly down-regulates the cell osteogenesis-related gene expression, ALP production, collagen secretion and matrix mineralization. Afterwards, the ILK expression is down-regulated using ILK-specific siRNA (ILKsi) and then the MAPK activity is determined. ILKsi significantly attenuates the phosphorylated ERK1/2 and p38 levels on MNT, explicitly demonstrating that the ERK1/2 and p38 signalings are downstream effectors of ILK. In conclusion, these data demonstrate that both ILK/ERK1/2 and ILK/p38 pathways are involved in the mechanisms mediating the enhanced osteoblast differentiation by biomaterial surface topography, hopefully directing the biomaterial modification and biofunctionalization. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wang, Wei; Liu, Qian; Zhang, Yumei] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthet Dent, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
   [Wang, Wei] 463 Hosp PTA, Dept Stomatol, Shenyang 110042, Liaoning, Peoples R China.
   [Zhao, Lingzhou] Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
RP Zhang, YM (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Prosthet Dent, State Key Lab Mil Stomatol, 145 West Changle Rd, Xian 710032, Peoples R China.
EM wqtzym@fmmu.edu.cn; zhaolingzhou1983@hotmail.com
RI Zhao, Lingzhou/B-4408-2014
FU National Natural Science Foundation of China [31200716, 81070862,
   31170915]; School of Stomatology, The Fourth Military Medical University
FX The authors appreciate grants from the National Natural Science
   Foundation of China (31200716, 81070862 and 31170915) and financial
   support from the School of Stomatology, The Fourth Military Medical
   University to L.Z.Z.
CR Adachi S, 2009, PROSTAG OTH LIPID M, V90, P1, DOI 10.1016/j.prostaglandins.2009.06.002
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Appleford MR, 2007, BIOMATERIALS, V28, P2747, DOI 10.1016/j.biomaterials.2007.02.018
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   Chalkiadaki G, 2011, CANCER LETT, V312, P235, DOI 10.1016/j.canlet.2011.08.016
   Cuschieri J, 2005, CRIT CARE MED, V33, pS417, DOI 10.1097/01.CCM.0000191714.39495.A6
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dedhar S, 2000, CURR OPIN CELL BIOL, V12, P250, DOI 10.1016/S0955-0674(99)00083-6
   Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C
   Fan XF, 2009, TISSUE CELL, V41, P266, DOI 10.1016/j.tice.2008.12.007
   Filipenko NR, 2005, ONCOGENE, V24, P5837, DOI 10.1038/sj.onc.1208737
   Fragoso G, 2003, EXP NEUROL, V183, P34, DOI 10.1016/S0014-4886(03)00101-8
   Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501
   Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0
   Huang C, 2004, CELL CYCLE, V3, P4, DOI 10.4161/cc.3.1.601
   Huang Y, 2000, J CELL BIOL, V150, P861, DOI 10.1083/jcb.150.4.861
   Huang Z, 2013, BIOMATERIALS, V34, P3303, DOI 10.1016/j.biomaterials.2013.01.054
   Ishii T, 2001, J BIOL CHEM, V276, P42994, DOI 10.1074/jbc.M105198200
   Ishii T, 2009, LIFE SCI, V84, P530, DOI 10.1016/j.lfs.2009.01.025
   Kantawong F, 2009, BIOMATERIALS, V30, P4723, DOI 10.1016/j.biomaterials.2009.05.040
   Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200
   Katz S, 2006, INT J BIOCHEM CELL B, V38, P2082, DOI 10.1016/j.biocel.2006.05.018
   Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481
   Lal H, 2007, J MOL CELL CARDIOL, V43, P137, DOI 10.1016/j.yjmcc.2007.05.012
   Lu ZF, 2010, BIOCHEM BIOPH RES CO, V394, P323, DOI 10.1016/j.bbrc.2010.02.178
   McNamara L. E., 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/120623
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5
   Naska S, 2006, J NEUROSCI, V26, P13344, DOI 10.1523/JNEUROSCI.4462-06.2006
   Perera PM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3039
   Rescan C, 2001, MOL BIOL CELL, V12, P725, DOI 10.1091/mbc.12.3.725
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066
   Shie MY, 2013, BIOMATERIALS, V34, P6589, DOI 10.1016/j.biomaterials.2013.05.075
   Su JL, 2010, J BIOL CHEM, V285, P31325, DOI 10.1074/jbc.M109.087122
   Tabe Y, 2007, CANCER RES, V67, P684, DOI 10.1158/0008-5472.CAN-06-3166
   Wang W, 2013, BIOMATERIALS, V34, P631, DOI 10.1016/j.biomaterials.2012.10.021
   Wang W, 2012, BIOMATERIALS, V33, P7993, DOI 10.1016/j.biomaterials.2012.07.064
   Wang YS, 2011, BIOMATERIALS, V32, P6737, DOI 10.1016/j.biomaterials.2011.05.075
   Wu YK, 2013, ARCH ORAL BIOL, V58, P1357, DOI 10.1016/j.archoralbio.2013.03.011
   Yu CF, 2008, CELL SIGNAL, V20, P2208, DOI 10.1016/j.cellsig.2008.07.020
   Zhang YN, 2006, HEPATOLOGY, V44, P612, DOI 10.1002/hep.21315
   Zhao LZ, 2012, BIOMATERIALS, V33, P2629, DOI 10.1016/j.biomaterials.2011.12.024
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
   ZHU XY, 1995, MOL BIOL CELL, V6, P273
   Zhuang LF, 2012, J BIOMED MATER RES A, V100A, P125, DOI 10.1002/jbm.a.33247
NR 51
TC 27
Z9 27
U1 1
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2014
VL 10
IS 8
BP 3705
EP 3715
DI 10.1016/j.actbio.2014.04.019
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AL9KH
UT WOS:000339459500033
PM 24769109
DA 2018-10-20
ER

PT J
AU Ma, XY
   Feng, YF
   Ma, ZS
   Li, X
   Wang, J
   Wang, L
   Lei, W
AF Ma, Xiang-Yu
   Feng, Ya-Fei
   Ma, Zhen-Sheng
   Li, Xiang
   Wang, Jian
   Wang, Lin
   Lei, Wei
TI The promotion of osteointegration under diabetic conditions using
   chitosan/hydroxyapatite composite coating on porous titanium surfaces
SO BIOMATERIALS
LA English
DT Article
DE Porous titanium; Diabetes; Wnt/beta-catenin; Chitosan; Hydroxyapatite
ID WNT/BETA-CATENIN PATHWAY; MESENCHYMAL STEM-CELLS; WNT SIGNALING PATHWAY;
   GLYCEMIC CONTROL; BONE-FORMATION; CHITOSAN; MELLITUS; DIFFERENTIATION;
   OSSEOINTEGRATION; ACTIVATION
AB Composited Chitosan/Hydroxyapatite (CS/HA) material coated on titanium surface (cTi) is a promising approach to produce biomaterials with better osseointegration capacity, but its bio-performance under diabetic conditions and the mechanisms involved remain elusive. We propose that the alterations in the Wnt/beta-catenin pathway may play a role in mediating the improvement effect of cTi on diabetes-induced impaired implant osteointegration. To confirm the hypothesis, primary rat osteoblasts incubated on Ti and cTi were subjected to normal serum (NS), diabetic serum (DS), DS + Wnt3a (a specific Wnt agonist) and DS + Dkk1 (a specific Wnt antagonist) treatment. In vivo study was performed on diabetic sheep implanted with Ti or cTi into the bone defect on crista iliaca. Results showed that diabetes depressed osteoblast function evidenced by impaired cell adhesion and morphology, decreased cell proliferation and ALP activity, and higher apoptotic rate on Ti. Importantly, both cTi and Wnt3a treatment ameliorated osteoblastic dysfunction and apoptosis under diabetic condition. Implantation with cTi significantly improved osteointegration evidenced by Micro-CT and histological examinations compared with Ti. Moreover, the aforementioned promotive effects afforded by cTi were abolished by blocking Wnt pathway with Dkk1. Our study explicitly demonstrates that CS/HA composite material improves diabetes-induced impaired osteointegration of Ti via the reactivation of Wnt/beta-catenin pathway and provides a target point for biomaterial modification to attain better clinical performance in diabetic patients. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Ma, Xiang-Yu; Feng, Ya-Fei; Ma, Zhen-Sheng; Wang, Jian; Wang, Lin; Lei, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Shaanxi, Peoples R China.
   [Li, Xiang] Shanghai Jiao Tong Univ, Sch Mech Engn, State Key Lab Mech Syst & Vibrat, Shanghai 200240, Peoples R China.
RP Lei, W (reprint author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Shaanxi, Peoples R China.
EM wanglinxj@fmmu.edu.cn; leiwei@fmmu.edu.cn
RI Wang, Lin/J-8805-2018
OI Wang, Lin/0000-0001-5937-6318
FU Research Fund for the National Natural Science Foundation of China
   [81371933, 31170913/C10 02]; Ming Zhutui Project [XJZT13M08]; National
   Key Technology RD Program [2012BAI18B07]
FX This work was supported by the Research Fund for the National Natural
   Science Foundation of China (No. 81371933) to Lin Wang, Ming Zhutui
   Project (XJZT13M08) to Ya-Fei Feng, Project supported by National Key
   Technology R&D Program (2012BAI18B07) to Xiang Li, and the Research Fund
   for the National Natural Science Foundation of China (No. 31170913/C10
   02) to Wei Lei.
CR [Anonymous], GEN DENT
   Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037
   Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13
   Declercq H, 2004, BIOMATERIALS, V25, P757, DOI 10.1016/S0142-9612(03)00580-5
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Fujibayashi S, 2011, EUR SPINE J, V20, P1486, DOI 10.1007/s00586-011-1728-3
   Galli C, 2012, ACTA BIOMATER, V8, P2963, DOI 10.1016/j.actbio.2012.04.043
   Galli C, 2011, J DENT RES, V90, P360, DOI 10.1177/0022034510386488
   Galli C, 2014, CLIN ORAL IMPLAN RES, V25, pE133, DOI 10.1111/clr.12075
   Galli C, 2010, J BIOMED MATER RES A, V95A, P682, DOI 10.1002/jbm.a.32887
   Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200
   GOODMAN WG, 1984, DIABETES, V33, P825, DOI 10.2337/diabetes.33.9.825
   Hie M, 2011, INT J MOL MED, V28, P455, DOI 10.3892/ijmm.2011.697
   Hsu SH, 2013, BIOMATERIALS, V34, P4725, DOI 10.1016/j.biomaterials.2013.03.031
   Ip W, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-28
   ITO M, 1991, BIOMATERIALS, V12, P41, DOI 10.1016/0142-9612(91)90130-3
   Javed F, 2009, J PERIODONTOL, V80, P1719, DOI 10.1902/jop.2009.090283
   Jin T, 2008, MOL ENDOCRINOL, V22, P2383, DOI 10.1210/me.2008-0135
   Kashiwazaki H, 2009, BIO-MED MATER ENG, V19, P133, DOI 10.3233/BME-2009-0572
   KAWAKAMI T, 1992, BIOMATERIALS, V13, P759, DOI 10.1016/0142-9612(92)90014-F
   Kotsovilis S, 2006, CLIN ORAL IMPLAN RES, V17, P587, DOI 10.1111/j.1600-0501.2005.01245.X
   Li BQ, 2011, J BIOMAT SCI-POLYM E, V22, P505, DOI 10.1163/092050610X487800
   Li JX, 2010, MOL BIOL REP, V37, P1569, DOI 10.1007/s11033-009-9561-z
   Li X, 2013, MAT SCI ENG C-MATER, V33, P2987, DOI 10.1016/j.msec.2013.03.027
   Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011
   Liu HH, 2013, BIOMATERIALS, V34, P4404, DOI 10.1016/j.biomaterials.2013.02.048
   Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259
   McCabe LR, 2007, J CELL BIOCHEM, V102, P1343, DOI 10.1002/jcb.21573
   McCracken M, 2000, INT J ORAL MAX IMPL, V15, P345
   Mombelli A, 2006, CLIN ORAL IMPLAN RES, V17, P97, DOI 10.1111/j.1600-0501.2006.01354.x
   Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7
   Morris H F, 2000, Ann Periodontol, V5, P157, DOI 10.1902/annals.2000.5.1.157
   Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311
   Motyl KJ, 2011, AM J PHYSIOL-REG I, V300, pR1250, DOI 10.1152/ajpregu.00764.2010
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3
   Oates TW, 2009, J DENT RES, V88, P367, DOI 10.1177/0022034509334203
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2015, DOI 10.1016/j.biomaterials.2009.11.071
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606
   Portal-Nunez S, 2010, FEBS LETT, V584, P3095, DOI 10.1016/j.febslet.2010.05.047
   Prisby RD, 2008, J ENDOCRINOL, V199, P379, DOI 10.1677/JOE-08-0046
   Ramanathan T, 2004, ANN THORAC SURG, V77, P1408, DOI 10.1016/j.athoracsur.2003.10.016
   Redepenning J, 2003, J BIOMED MATER RES A, V66A, P411, DOI 10.1002/jbm.a.10571
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P673, DOI 10.1111/j.1600-0501.2010.01923.x
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   SASAKI T, 1991, ANAT REC, V231, P25, DOI 10.1002/ar.1092310105
   Sawada R, 2013, J BIOMED MATER RES A, V101, P2573, DOI 10.1002/jbm.a.34566
   Schlegel KA, 2013, CLIN ORAL IMPLAN RES, V24, P128, DOI 10.1111/j.1600-0501.2011.02380.x
   Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648
   Tao HY, 2013, EUR J PHARMACOL, V702, P85, DOI 10.1016/j.ejphar.2013.01.046
   VERHAEGHE J, 1990, DIABETES, V39, P477, DOI 10.2337/diabetes.39.4.477
   Wang W, 2012, BIOMATERIALS, V33, P7993, DOI 10.1016/j.biomaterials.2012.07.064
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   Yang JL, 2014, J BIOMED MATER RES A, V102, P1202, DOI 10.1002/jbm.a.34756
   Yu M, 2011, BONE, V49, P387, DOI 10.1016/j.bone.2011.05.025
   Yu WQ, 2012, COLLOID SURFACE B, V93, P135, DOI 10.1016/j.colsurfb.2011.12.025
   Zhang JZ, 2014, J BIOMAT SCI-POLYM E, V25, P61, DOI 10.1080/09205063.2013.836950
NR 58
TC 39
Z9 41
U1 7
U2 123
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2014
VL 35
IS 26
BP 7259
EP 7270
DI 10.1016/j.biomaterials.2014.05.028
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AL3NI
UT WOS:000339035000002
PM 24912815
DA 2018-10-20
ER

PT J
AU Hsu, SH
   Ho, TT
   Huang, NC
   Yao, CL
   Peng, LH
   Dai, NT
AF Hsu, Shan-hui
   Ho, Tung-Tso
   Huang, Nien-Chi
   Yao, Chao-Ling
   Peng, Luen-Hau
   Dai, Niann-Tzyy
TI Substrate-dependent modulation of 3D spheroid morphology self-assembled
   in mesenchymal stem cell-endothelial progenitor cell coculture
SO BIOMATERIALS
LA English
DT Article
DE Mesenchymal stem cells (MSCs); Coculture; Endothelial progenitor cells
   (EPCs); Cell-cell interaction; Integrin; Notch signaling
ID CIS-INHIBITION; NOTCH; DIFFERENTIATION; LIGAND
AB The structural evolution of three-dimensional spheroids self-assembled from two different types of cells on selective biomaterials is demonstrated in this study. The two types of cells involved in the self-assembly are human mesenchymal stem cells (MSCs) and endothelial progenitor cells (EPCs). When seeded in different population ratios, they can create a variety of cellular patterns on different biomaterial substrates. When the two populations are matched in initial numbers, they are self-assembled in co-spheroids with different morphologies (i.e. randomly mixed, bumped, or concentric spheroids). The morphologies are influenced by the specific cell-substrate interaction possibly through integrin signaling, as well as a substrate-dependent regulation of heterophilic cell-cell interaction possibly through Notch signaling. In particular, the self-assembled core-shell concentric spheroids from adipose-derived MSCs and EPCs show a greater angiogenic effect in vitro. This study reveals the possibility to modulate the self-assembled morphology as well as the effect of cocultured cells by changing the cell culture substratum. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Hsu, Shan-hui; Ho, Tung-Tso; Huang, Nien-Chi] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10617, Taiwan.
   [Hsu, Shan-hui] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10617, Taiwan.
   [Yao, Chao-Ling; Peng, Luen-Hau] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Chungli, Taiwan.
   [Dai, Niann-Tzyy] Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Plast & Reconstruct Surg, Taipei, Taiwan.
RP Hsu, SH (reprint author), Natl Taiwan Univ, Inst Polymer Sci & Engn, 1,Sec 4 Roosevelt Rd, Taipei 10617, Taiwan.
EM shhsu@ntu.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X
FU Program for Stem Cell and Regenerative Medicine Frontier Research -
   National Science Council Taiwan (NSC) [NSC102-2321-B-002-033]
FX This research was supported by the Program for Stem Cell and
   Regenerative Medicine Frontier Research (NSC102-2321-B-002-033)
   sponsored by the National Science Council Taiwan (NSC). We are grateful
   to the BIONET for supplying UCMSCs as well as staffs of TC5 Bio-Image
   Tools, Technology Commons in the College of Life Science and Precious
   Instrument Center of National Taiwan University sponsored by NSC, for
   assistance with the confocal laser scanning microscopy.
CR Abedin M, 2004, CIRC RES, V95, P671, DOI 10.1161/01.RES.0000143421.27684.12
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Bhang SH, 2012, TISSUE ENG PT A, V18, P310, DOI [10.1089/ten.tea.2011.0193, 10.1089/ten.TEA.2011.0193]
   Bhang SH, 2011, BIOMATERIALS, V32, P2734, DOI 10.1016/j.biomaterials.2010.12.035
   Chiang CL, 2013, STEM CELLS, V29, P1763
   Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457
   del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034
   Dufourcq P, 2008, STEM CELLS, V26, P2991, DOI 10.1634/stemcells.2008-0372
   Goerke SM, 2012, TISSUE ENG PT A, V18, P2395, DOI [10.1089/ten.tea.2012.0147, 10.1089/ten.TEA.2012.0147]
   Hsu SH, 2013, BIOMATERIALS, V34, P4725, DOI 10.1016/j.biomaterials.2013.03.031
   Huang GS, 2011, BIOMATERIALS, V32, P6929, DOI 10.1016/j.biomaterials.2011.05.092
   Jiang T, 2011, LANGMUIR, V27, P6440, DOI 10.1021/la201080z
   KAWANO Y, 1994, STEM CELLS, V12, P514, DOI 10.1002/stem.5530120507
   Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009
   Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705
   Kwon SM, 2009, TRENDS CARDIOVAS MED, V19, P170, DOI 10.1016/j.tcm.2009.10.002
   Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113
   Lee WY, 2011, BIOMATERIALS, V32, P8446, DOI 10.1016/j.biomaterials.2011.07.061
   Mansour A, 2011, CELL RES, V21, P1102, DOI 10.1038/cr.2011.21
   Nishi Nobusuke, 1997, Leukemia (Basingstoke), V11, P468
   Page H, 2013, CELL TISSUE RES, V352, P123, DOI 10.1007/s00441-012-1441-5
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Sacharidou A, 2010, BLOOD, V115, P5259, DOI 10.1182/blood-2009-11-252692
   Saleh F A, 2011, Eur Cell Mater, V22, P242
   Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959
   Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   Youssef J, 2011, P NATL ACAD SCI USA, V108, P6993, DOI 10.1073/pnas.1102559108
NR 28
TC 19
Z9 19
U1 1
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2014
VL 35
IS 26
BP 7295
EP 7307
DI 10.1016/j.biomaterials.2014.05.033
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AL3NI
UT WOS:000339035000005
PM 24909102
DA 2018-10-20
ER

PT J
AU Reithofer, MR
   Lakshmanan, A
   Ping, ATK
   Chin, JM
   Hauser, CAE
AF Reithofer, Michael R.
   Lakshmanan, Anupama
   Ping, Andy T. K.
   Chin, Jia M.
   Hauser, Charlotte A. E.
TI In situ synthesis of size-controlled, stable silver nanoparticles within
   ultrashort peptide hydrogels and their anti-bacterial properties
SO BIOMATERIALS
LA English
DT Article
DE Silver; Nanoparticle; Peptide; Hydrogel; Self-assembly; Anti-bacterial
ID SELF-ASSEMBLE; CYTOTOXICITY; BURNS
AB We have developed a silver-releasing biomaterial with promising potential for wound healing applications. The material is made of ultrashort peptides which can self-assemble in water to form hydrogels. Silver nanoparticles (Ag NPs) were synthesized in situ within the biomaterial, using only UV irradiation and no additional chemical reducing agents. The synthetic strategy allows precise control of the nanoparticle size, with the network of peptide fibers preventing aggregation of Ag NPs. The biomaterial shows increased mechanical strength compared to the hydrogel control. We observed a sustained release of Ag NPs over a period of 14 days. This is a crucial prerequisite for effective anti-bacterial therapy. The ability to inhibit bacterial growth was tested using different bacterial strains, namely gram-negative Escherichia coli and Pseudomonas aeruginosa and gram-positive Staphylococcus aureus. Inhibition of bacterial growth was observed for all strains. The best results were obtained for Pseudomonas aeruginosa which is known for exhibiting multidrug resistance. Biocompatibility studies on HDFa cells, using Ag NP-containing hydrogels, did not show any significant influence on cell viability. We propose this silverreleasing hydrogel as an excellent biomaterial with great potential for applications in wound healing due to its low silver content, sustained silver nanoparticle release and biocompatibility. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Reithofer, Michael R.; Lakshmanan, Anupama; Ping, Andy T. K.; Hauser, Charlotte A. E.] Inst Bioengn & Nanotechnol, Singapore 138669, Singapore.
   [Chin, Jia M.] Inst Mat Res & Engn, Singapore 117602, Singapore.
RP Hauser, CAE (reprint author), Inst Bioengn & Nanotechnol, 31 Biopolis Way,04-01, Singapore 138669, Singapore.
EM chinjm@imre.a-star.edu.sg; chauser@ibn.a-star.edu.sg
RI Hauser, Charlotte/C-1321-2014; Chin, Jia Min/O-9566-2016; Hauser,
   Charlotte/B-6850-2015
OI Hauser, Charlotte/0000-0001-8251-7246; Chin, Jia
   Min/0000-0002-0540-1597; Lakshmanan, Anupama/0000-0002-6702-837X;
   Reithofer, Michael/0000-0002-6328-1896
FU Institute of Bioengineering and Nanotechnology (Biomedical Research
   Council, Agency for Science, Technology and Research, Singapore);
   Institute of Materials Research and Engineering (Science and Engineering
   Research Council, Agency for Science, Technology and Research,
   Singapore); A*SC Young Researcher Collaborative Grant [12/3/06/ASC/02]
FX The authors would like to acknowledge Wei Yang Seow's support when using
   his recently developed ring-cast method for the preparation of
   hydrogels, see Materials and methods part. This work is supported by the
   Institute of Bioengineering and Nanotechnology (Biomedical Research
   Council, Agency for Science, Technology and Research, Singapore), the
   Institute of Materials Research and Engineering (Science and Engineering
   Research Council, Agency for Science, Technology and Research,
   Singapore) and by an A*SC 2012 Young Researcher Collaborative Grant
   (12/3/06/ASC/02).
CR Adhikari B, 2010, CHEM-EUR J, V16, P13698, DOI 10.1002/chem.201001240
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Brandt O, 2012, NANOMED-NANOTECHNOL, V8, P478, DOI 10.1016/j.nano.2011.07.005
   Fullenkamp DE, 2012, BIOMATERIALS, V33, P3783, DOI 10.1016/j.biomaterials.2012.02.027
   Hauser CAE, 2011, P NATL ACAD SCI USA, V108, P1361, DOI 10.1073/pnas.1014796108
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Klasen HJ, 2000, BURNS, V26, P131, DOI 10.1016/S0305-4179(99)00116-3
   Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4
   Lakshmanan A, 2013, P NATL ACAD SCI USA, V110, P519, DOI 10.1073/pnas.1217742110
   Leaper David J, 2006, Int Wound J, V3, P282, DOI 10.1111/j.1742-481X.2006.00265.x
   Martinez-Gutierrez F, 2012, NANOMED-NANOTECHNOL, V8, P328, DOI 10.1016/j.nano.2011.06.014
   Martinez-Gutierrez F, 2010, NANOMED-NANOTECHNOL, V6, P681, DOI 10.1016/j.nano.2010.02.001
   Mishra A, 2011, NANO TODAY, V6, P232, DOI 10.1016/j.nantod.2011.05.001
   Mohan YM, 2010, J COLLOID INTERF SCI, V342, P73, DOI 10.1016/j.jcis.2009.10.008
   Roy S, 2011, SOFT MATTER, V7, P5300, DOI 10.1039/c1sm05034f
   Rujitanaroj PO, 2008, POLYMER, V49, P4723, DOI 10.1016/j.polymer.2008.08.021
   Varaprasad K, 2010, J APPL POLYM SCI, V115, P1199, DOI 10.1002/app.31249
   Vimala K, 2010, COLLOID SURFACE B, V76, P248, DOI 10.1016/j.colsurfb.2009.10.044
   Wright JB, 2002, WOUND REPAIR REGEN, V10, P141, DOI 10.1046/j.1524-475X.2002.10308.x
NR 19
TC 64
Z9 64
U1 14
U2 159
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2014
VL 35
IS 26
BP 7535
EP 7542
DI 10.1016/j.biomaterials.2014.04.102
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AL3NI
UT WOS:000339035000027
PM 24933510
DA 2018-10-20
ER

PT J
AU Walker, J
   Shadanbaz, S
   Woodfield, TBF
   Staiger, MP
   Dias, GJ
AF Walker, Jemimah
   Shadanbaz, Shaylin
   Woodfield, Timothy B. F.
   Staiger, Mark P.
   Dias, George J.
TI Magnesium biomaterials for orthopedic application: A review from a
   biological perspective
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE biodegradation; biocompatibility/hard tissue; biocompatibility/soft
   tissue; orthopaedic; corrosion
ID SIMULATED BODY-FLUID; IN-VITRO DEGRADATION; BONE IMPLANT APPLICATION;
   DONOR-SITE MORBIDITY; MG-ZN ALLOY; CORROSION BEHAVIOR; PURE MAGNESIUM;
   RARE-EARTH; MECHANICAL-PROPERTIES; VIVO CORROSION
AB Magnesium (Mg) has a long history of investigation as a degradable biomaterial. Physicians first began using Mg for biomedical applications in the late 19th century. Experimentation continued with varying levels of success until the mid-20th century when interest in the metal waned. In recent years the field of Mg-based biomaterials has once again become popular, likely due to advancements in technology allowing improved control of corrosion. Although this has led to success in vascular applications, continued difficulties in predicting and controlling the corrosion rate of Mg in an intraosseous environment has impeded the development of Mg-based biomaterials for orthopedic applications. In this review, an initial summary of the basic properties and the physiological role of Mg are followed by a discussion of the physical characteristics of the metal which lend it to use as a degradable biomaterial. A description of the historical and modern applications for Mg in the medical field is followed by a discussion of the methods used to control and assess Mg corrosion, with an emphasis on alloying. The second part of this review concentrates on the methods used to assess the corrosion and biocompatibility of Mg-based orthopedic biomaterials. This review provides a summary of Mg as a biomaterial from a biological perspective. (C) 2014 Wiley Periodicals, Inc.
C1 [Walker, Jemimah; Shadanbaz, Shaylin; Dias, George J.] Univ Otago, Dept Anat & Struct Biol, Dunedin, New Zealand.
   [Woodfield, Timothy B. F.] Univ Otago, Dept Orthopaed Surg, Christchurch, New Zealand.
   [Staiger, Mark P.] Univ Canterbury, Dept Mech Engn, Christchurch 1, New Zealand.
RP Walker, J (reprint author), Univ Otago, Dept Anat & Struct Biol, Dunedin, New Zealand.
EM walkerjemimah@gmail.com
RI Woodfield, Tim/A-2705-2009; Staiger, Mark/H-2102-2011
OI Woodfield, Tim/0000-0002-5428-7575; Staiger, Mark/0000-0002-1517-4404
CR Abidin NIZ, 2011, CORROS SCI, V53, P862, DOI 10.1016/j.corsci.2010.10.008
   Aghion E, 2012, J MATER SCI-MATER M, V23, P805, DOI 10.1007/s10856-011-4536-8
   Allan R, 2012, Acute Med, V11, P3
   Altman F P, 1976, Prog Histochem Cytochem, V9, P1
   Alvarez-Lopez M, 2010, ACTA BIOMATER, V6, P1763, DOI 10.1016/j.actbio.2009.04.041
   Ambat R, 2000, J APPL ELECTROCHEM, V30, P865, DOI 10.1023/A:1004011916609
   An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   [Anonymous], 2004, F76304 ASTM
   [Anonymous], 2007, 1099312 ISO
   Atrens A, 2011, MATER SCI ENG B-ADV, V176, P1609, DOI 10.1016/j.mseb.2010.12.017
   Baker H, 1999, ASM SPECIALTY HDB, p[ix, 314]
   Barfield WR, 2012, CURR ORTHOP PRACT, V23, P146, DOI 10.1097/BCO.0b013e31824a553b
   Barlis P, 2007, EUR HEART J, V28, P2319, DOI 10.1093/eurheartj/ehm119
   Bennett DR, 1997, AM J FOREN MED PATH, V18, P148, DOI 10.1097/00000433-199706000-00008
   Bettman R, 1935, AM J DIG DIS, V2, P318
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   BOROVANSKY J, 1989, CHEM-BIOL INTERACT, V69, P279, DOI 10.1016/0009-2797(89)90085-9
   Brar HS, 2012, J MECH BEHAV BIOMED, V7, P87, DOI 10.1016/j.jmbbm.2011.07.018
   Brar HS, 2009, JOM-US, V61, P31, DOI 10.1007/s11837-009-0129-0
   BRUCE DW, 1963, TOXICOL APPL PHARM, V5, P750, DOI 10.1016/0041-008X(63)90067-X
   Buchanan J, 2012, J BONE JOINT SURG BR, V94, P113
   Carboneras M, 2011, CORROS SCI, V53, P1433, DOI 10.1016/j.corsci.2011.01.014
   Carter JD, 2009, SPINE J, V9, P434, DOI 10.1016/j.spinee.2008.11.004
   Cho SY, 2012, J BIOMED MATER RES B, V100B, P1535, DOI 10.1002/jbm.b.32722
   Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931
   Del Gaudio C, 2012, J MATER SCI-MATER M, V23, P2553, DOI 10.1007/s10856-012-4714-3
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Drynda A, 2010, J BIOMED MATER RES A, V93A, P763, DOI 10.1002/jbm.a.32582
   Drynda A, 2009, J BIOMED MATER RES A, V91A, P360, DOI 10.1002/jbm.a.32235
   Duygulu O, 2007, MATER SCI FORUM, V546-549, P421, DOI 10.4028/www.scientific.net/MSF.546-549.421
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Erdmann N, 2011, ACTA BIOMATER, V7, P1421, DOI 10.1016/j.actbio.2010.10.031
   Erdmann N, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-63
   Fekry AM, 2009, ELECTROCHIM ACTA, V54, P7280, DOI 10.1016/j.electacta.2009.07.047
   Fell JME, 1996, LANCET, V347, P1218, DOI 10.1016/S0140-6736(96)90735-7
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Fini M, 2003, J Appl Biomater Biomech, V1, P155
   Fischer J, 2011, MATER SCI ENG B-ADV, V176, P1773, DOI 10.1016/j.mseb.2011.06.002
   Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020
   FLATEN TP, 1990, ENVIRON GEOCHEM HLTH, V12, P152, DOI 10.1007/BF01734064
   Flaten TP, 2001, BRAIN RES BULL, V55, P187, DOI 10.1016/S0361-9230(01)00459-2
   Frankel Gerald S, 2008, Journal of ASTM International, V5, DOI 10.1520/JAI101241
   Friedrich H. E., 2006, MAGNESIUM TECHNOLOGY
   Gallo J, 2013, INNATE IMMUN-LONDON, V19, P213, DOI 10.1177/1753425912451779
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Ghali E, 2004, J MATER ENG PERFORM, V13, P7, DOI 10.1361/10599490417533
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Groves E., 1913, BRIT J SURG, V1, P438
   Groves EWH, 1912, BRIT MED J, V1912, P1102, DOI 10.1136/bmj.2.2704.1102-a
   Gu XN, 2011, MATER SCI ENG B-ADV, V176, P1778, DOI 10.1016/j.mseb.2011.05.032
   Gu XN, 2010, MATER LETT, V64, P1871, DOI 10.1016/j.matlet.2010.06.015
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Gums JG, 2004, AM J HEALTH-SYST PH, V61, P1569
   Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008
   HALEY TJ, 1965, J PHARM SCI-US, V54, P663, DOI 10.1002/jps.2600540502
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Hornberger H, 2011, MATER SCI ENG B-ADV, V176, P1746, DOI 10.1016/j.mseb.2011.07.018
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Hua JH, 2011, APPL SURF SCI, V257, P8772, DOI 10.1016/j.apsusc.2011.03.148
   Huan ZG, 2010, J MATER SCI-MATER M, V21, P2623, DOI 10.1007/s10856-010-4111-8
   Huan ZG, 2012, J BIOMED MATER RES B, V100B, P437, DOI 10.1002/jbm.b.31968
   Huehnerschulte TA, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-14
   Huehnerschulte TA, 2011, MATERIALS, V4, P1144, DOI 10.3390/ma4061144
   International Organization for Standardization(ISO), 2007, 109936 ISO
   ISO 10993-5, 1999, 109935 ISO
   Jia-Cheng Gao, 2010, Frontiers of Materials Science in China, V4, P120, DOI 10.1007/s11706-010-0029-9
   Jo JH, 2011, J MATER SCI-MATER M, V22, P2437, DOI 10.1007/s10856-011-4431-3
   Johnson I, 2012, J BIOMED MATER RES A, V100A, P477, DOI 10.1002/jbm.a.33290
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kannan MB, 2010, MATER LETT, V64, P739, DOI 10.1016/j.matlet.2010.01.022
   Kaya RA, 2007, J NEUROSURG-SPINE, V6, P141, DOI 10.3171/spi.2007.6.2.141
   Kim WC, 2008, MATER LETT, V62, P4146, DOI 10.1016/j.matlet.2008.06.028
   Kirkland NT, 2012, CORROS ENG SCI TECHN, V47, P322, DOI 10.1179/1743278212Y.0000000034
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Kirkland NT, 2012, J MATER SCI-MATER M, V23, P283, DOI 10.1007/s10856-011-4517-y
   Kirkland NT, 2010, J BIOMED MATER RES B, V95B, P91, DOI 10.1002/jbm.b.31687
   KOH JY, 1994, NEUROSCIENCE, V60, P1049, DOI 10.1016/0306-4522(94)90282-8
   Krause A, 2010, J MATER SCI, V45, P624, DOI 10.1007/s10853-009-3936-3
   Kuang F, 2010, RECENT PAT CORROSION, V2, P34
   Kutniy KV, 2009, MATERIALWISS WERKST, V40, P242, DOI 10.1002/mawe.200900434
   Laires MJ, 2004, FRONT BIOSCI-LANDMRK, V9, P262, DOI 10.2741/1223
   Lambotte A., 1932, B MEM SOC NAT CHIR, V28, P1325
   Lee DBN, 2010, ASAIO J, V56, P550, DOI 10.1097/MAT.0b013e3181e73f20
   Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012
   Li JN, 2010, BIOMATERIALS, V31, P5782, DOI 10.1016/j.biomaterials.2010.04.023
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Li YC, 2012, ACTA BIOMATER, V8, P3177, DOI 10.1016/j.actbio.2012.04.028
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2010, CORROS SCI, V52, P3341, DOI 10.1016/j.corsci.2010.06.003
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   Liu CL, 2007, MAT SCI ENG A-STRUCT, V456, P350, DOI 10.1016/j.msea.2006.12.020
   Loos A, 2007, MACROMOL SYMP, V253, P103, DOI 10.1002/masy.200750715
   Lorenz C, 2009, ACTA BIOMATER, V5, P2783, DOI 10.1016/j.actbio.2009.04.018
   Lu P, 2011, J BIOMED MATER RES B, V96B, P101, DOI 10.1002/jbm.b.31744
   Magnesium Vormann J., 2003, MOL ASPECTS MED, V24, P27
   Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972
   MAKAR GL, 1993, INT MATER REV, V38, P138, DOI 10.1179/imr.1993.38.3.138
   McBride E. D., 1938, SOUTH MED J, V31, P508
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   Mordike BL, 2001, MAT SCI ENG A-STRUCT, V302, P37, DOI 10.1016/S0921-5093(00)01351-4
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   Müller Wolf Dieter, 2007, Mat. Res., V10, P5, DOI 10.1590/S1516-14392007000100003
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Ng WF, 2010, MAT SCI ENG C-MATER, V30, P898, DOI 10.1016/j.msec.2010.04.003
   Nguyen TL, 2011, ADV ENG MATER, V13, P872, DOI 10.1002/adem.201100029
   Pardo A, 2008, CORROS SCI, V50, P823, DOI 10.1016/j.corsci.2007.11.005
   Park RS, 2012, J BIOMED MATER RES B, V100B, P911, DOI 10.1002/jbm.b.32652
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Persaud-Sharma Dharam, 2012, J Biomim Biomater Tissue Eng, V12, P25, DOI 10.4028/www.scientific.net/JBBTE.12.25
   Pietak A, 2008, J MATER SCI-MATER M, V19, P407, DOI 10.1007/s10856-007-3172-9
   Pinto R, 2011, ELECTROCHIM ACTA, V56, P1535, DOI 10.1016/j.electacta.2010.09.081
   Quamme GA, 2000, FRONT BIOSCI-LANDMRK, V5, pD694, DOI 10.2741/Quamme
   Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443
   Reifenrath J, 2010, MATERIALWISS WERKST, V41, P1054, DOI 10.1002/mawe.201000709
   Remennik S, 2011, MATER SCI ENG B-ADV, V176, P1653, DOI 10.1016/j.mseb.2011.07.011
   Ren YB, 2007, KEY ENG MATER, V342-343, P601, DOI 10.4028/www.scientific.net/KEM.342-343.601
   Ren Yibin, 2007, Frontiers of Materials Science in China, V1, P401, DOI 10.1007/s11706-007-0073-2
   Rosalbino F, 2013, J BIOMED MATER RES A, V101, P704, DOI 10.1002/jbm.a.34368
   Rosalbino F, 2010, J MATER SCI-MATER M, V21, P1091, DOI 10.1007/s10856-009-3956-1
   Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768
   Rudd AL, 2000, CORROS SCI, V42, P275, DOI 10.1016/S0010-938X(99)00076-1
   RUDE RK, 1981, ANNU REV MED, V32, P245, DOI 10.1146/annurev.me.32.020181.001333
   Rude RK, 2006, MODERN NUTR HLTH DIS, P224
   Salahshoor M, 2012, MATERIALS, V5, P135, DOI 10.3390/ma5010135
   Saldana L, 2007, BIOMATERIALS, V28, P4343, DOI 10.1016/j.biomaterials.2007.06.015
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Sawin PD, 1998, J NEUROSURG, V88, P255, DOI 10.3171/jns.1998.88.2.0255
   Schille C, 2011, MATER SCI ENG B-ADV, V176, P1797, DOI 10.1016/j.mseb.2011.04.007
   Schranz D, 2006, CATHETER CARDIO INTE, V67, P671, DOI 10.1002/ccd.20756
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Seuss F, 2011, J BIOMED MATER RES B, V99B, P276, DOI 10.1002/jbm.b.31896
   Shadanbaz S, 2012, ACTA BIOMATER, V8, P20, DOI 10.1016/j.actbio.2011.10.016
   Sherman W, 1935, AM J SURG, V29, P54
   Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008
   Song G, 1997, CORROS SCI, V39, P855, DOI 10.1016/S0010-938X(96)00172-2
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song GL, 1998, CORROS SCI, V40, P1769, DOI 10.1016/S0010-938X(98)00078-X
   Song GL, 2004, MAT SCI ENG A-STRUCT, V366, P74, DOI 10.1016/j.msea.2003.08.060
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Song GL, 2001, MAGNESIUM TECHNOLOGY 2001, P255
   Song YW, 2009, MAT SCI ENG C-BIO S, V29, P1039, DOI 10.1016/j.msec.2008.08.026
   Spiegel DM, 2011, BLOOD PURIFICAT, V31, P172, DOI 10.1159/000321837
   St Pierre C, 2010, J ORTHOP RES, V28, P1418, DOI DOI 10.1002/JOR.21149
   Staiger MP, 2010, MATER LETT, V64, P2572, DOI 10.1016/j.matlet.2010.08.049
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Thomann M, 2009, MATERIALWISS WERKST, V40, P82, DOI 10.1002/mawe.200800412
   Thomann M, 2010, J BIOMED MATER RES A, V93A, P1609, DOI 10.1002/jbm.a.32639
   Thomaz TR, 2010, CORROS SCI, V52, P2235, DOI 10.1016/j.corsci.2010.03.010
   Topf JM, 2003, REV ENDOCR METAB DIS, V4, P195, DOI 10.1023/A:1022950321817
   Touyz RM, 2004, FRONT BIOSCI-LANDMRK, V9, P1278, DOI 10.2741/1316
   Vojtech D, 2011, ACTA BIOMATER, V7, P3515, DOI 10.1016/j.actbio.2011.05.008
   von der Hoh N, 2009, MATERIALWISS WERKST, V40, P88, DOI 10.1002/mawe.200800378
   Waizy H, 2013, J MATER SCI, V48, P39, DOI 10.1007/s10853-012-6572-2
   Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015
   Walter R, 2011, MATER LETT, V65, P748, DOI 10.1016/j.matlet.2010.11.051
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Wang DW, 2011, J BIOMED MATER RES A, V99A, P166, DOI 10.1002/jbm.a.33134
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Wang H, 2011, J BIOMED MATER RES B, V98B, P203, DOI 10.1002/jbm.b.31769
   Wang HX, 2011, COLLOID SURFACE B, V88, P254, DOI 10.1016/j.colsurfb.2011.06.040
   Wang JC, 1999, SPINE, V24, P899, DOI 10.1097/00007632-199905010-00011
   Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707
   Wang Q, 2011, MATER SCI ENG B-ADV, V176, P1718, DOI 10.1016/j.mseb.2011.06.005
   Wang Y, 2009, MAT SCI ENG C-BIO S, V29, P1311, DOI 10.1016/j.msec.2008.09.051
   Wang Y, 2008, MATER LETT, V62, P2181, DOI 10.1016/j.matlet.2007.11.045
   Wang YP, 2012, CHINESE SCI BULL, V57, P2163, DOI 10.1007/s11434-012-5066-6
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   WESTER PO, 1987, AM J CLIN NUTR, V45, P1305, DOI 10.1093/ajcn/45.5.1305
   WILLS MR, 1983, LANCET, V2, P29
   Winzer N, 2005, ADV ENG MATER, V7, P659, DOI 10.1002/adem.200500071
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2006, MATERIALWISS WERKST, V37, P504, DOI 10.1002/mawe.200600027
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P3, DOI 10.1016/S0098-2997(02)00087-0
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Xin YC, 2011, CORROS SCI, V53, P1522, DOI 10.1016/j.corsci.2011.01.015
   Xin YC, 2009, J MATER RES, V24, P2711, DOI 10.1557/JMR.2009.0323
   Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Xue DC, 2012, J MATER SCI TECHNOL, V28, P261, DOI 10.1016/S1005-0302(12)60051-6
   Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015
   Yang CX, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045005
   Yang JX, 2012, J BIOMATER APPL, V27, P153, DOI 10.1177/0885328211398161
   Yang JX, 2011, ANN BIOMED ENG, V39, P1857, DOI 10.1007/s10439-011-0300-y
   Yang L, 2012, CELL BIOCHEM BIOPHYS, P1
   Yang L, 2009, MAT SCI ENG C-BIO S, V29, P1691, DOI 10.1016/j.msec.2009.01.014
   Yoshikawa H, 2009, J R SOC INTERFACE, V6, pS341, DOI 10.1098/rsif.2008.0425.focus
   Yu K, 2012, ACTA BIOMATER, V8, P2845, DOI 10.1016/j.actbio.2012.04.009
   Yun Y, 2009, MAT SCI ENG C-MATER, V29, P1814, DOI 10.1016/j.msec.2009.02.008
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang EL, 2010, ACTA BIOMATER, V6, P1756, DOI 10.1016/j.actbio.2009.11.024
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang EL, 2009, J BIOMED MATER RES A, V90A, P882, DOI 10.1002/jbm.a.32132
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhang SX, 2009, MAT SCI ENG C-MATER, V29, P1907, DOI 10.1016/j.msec.2009.03.001
   Zhang WJ, 2012, MATER DESIGN, V39, P379, DOI 10.1016/j.matdes.2012.03.006
   Zhang XP, 2007, J MATER SCI, V42, P8523, DOI 10.1007/s10853-007-1738-z
   Zhao MC, 2008, CORROS SCI, V50, P3168, DOI 10.1016/j.corsci.2008.08.023
   Zhao Y, 2012, CORROS SCI, V59, P360, DOI 10.1016/j.corsci.2012.03.020
   Zheng YF, 2010, ACTA BIOMATER, V6, P1783, DOI 10.1016/j.actbio.2009.10.009
   Zhou W, 2010, CORROS SCI, V52, P1035, DOI 10.1016/j.corsci.2009.11.030
   Zhuang HY, 2008, MAT SCI ENG C-BIO S, V28, P1462, DOI 10.1016/j.msec.2008.04.001
NR 217
TC 64
Z9 66
U1 5
U2 132
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2014
VL 102
IS 6
BP 1316
EP 1331
DI 10.1002/jbm.b.33113
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AL4ME
UT WOS:000339106300022
PM 24458999
DA 2018-10-20
ER

PT J
AU Seki, T
   Wakamatsu, Y
   Nakagawa, S
   Aoki, T
   Ishihara, A
   Matsuo, J
AF Seki, Toshio
   Wakamatsu, Yoshinobu
   Nakagawa, Shunichiro
   Aoki, Takaaki
   Ishihara, Akihiko
   Matsuo, Jiro
TI Biomaterial imaging with MeV-energy heavy ion beams
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 21st International Conference on Ion Beam Analysis (IBA)
CY JUN 23-28, 2013
CL Amer Vacuum Soc, Pacific NW Chapter, Seattle, WA
HO Amer Vacuum Soc, Pacific NW Chapter
DE SIMS; Biomaterial imaging; MeV-energy heavy ion; Rat cerebellum
ID MASS-SPECTROMETRY; TISSUE-SECTIONS; BOMBARDMENT; PEPTIDES; EMISSION;
   PROTEINS; LIPIDS; CELLS
AB The spatial distribution of several chemical compounds in biological tissues and cells can be obtained with mass spectrometry imaging (MSI). In conventional secondary ion mass spectrometry (SIMS) with key-energy ion beams, elastic collisions occur between projectiles and atoms of constituent molecules. The collisions produce fragments, making the acquisition of molecular information difficult. In contrast, ion beams with MeV-energy excite near-surface electrons and enhance the ionization of high-mass molecules; hence, SIMS spectra of fragment-suppressed ionized molecules can be obtained with MeV-SIMS. To compare between MeV and conventional SIMS, we used the two methods based on MeV and Bi-3-keV ions, respectively, to obtain molecular images of rat cerebellum. Conventional SIMS images of m/z 184 were clearly observed, but with the Bi-3 ion, the distribution of the molecule with m/z 772.5 could be observed with much difficulty. This effect was attributed to the low secondary ion yields and we could not get many signal counts with key-energy beam. On the other hand, intact molecular ion distributions of lipids were clearly observed with MeV-SIMS, although the mass of all lipid molecules was higher than 500 Da. The peaks of intact molecular ions in MeV-SIMS spectra allowed us to assign the mass. The high secondary ion sensitivity with MeV-energy heavy ions is very useful in biomaterial analysis. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Seki, Toshio; Wakamatsu, Yoshinobu; Nakagawa, Shunichiro] Kyoto Univ, Dept Nucl Engn, Uji, Kyoto 6110011, Japan.
   [Matsuo, Jiro] Kyoto Univ, Quantum Sci & Engn Ctr, Uji, Kyoto 6110011, Japan.
   [Aoki, Takaaki] Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158510, Japan.
   [Ishihara, Akihiko] Kyoto Univ, Grad Sch Human & Environm Studies, Lab Cell Biol & Life Sci, Sakyo Ku, Kyoto 6068501, Japan.
   [Seki, Toshio; Aoki, Takaaki; Matsuo, Jiro] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan.
RP Seki, T (reprint author), Kyoto Univ, Dept Nucl Engn, Uji, Kyoto 6110011, Japan.
EM seki@sakura.nucleng.kyoto-u.ac.jp
OI Seki, Toshio/0000-0002-0834-1657; Matsuo, Jiro/0000-0003-0684-3677;
   Aoki, Takaaki/0000-0002-5926-4903
CR Biesinger MC, 2002, ANAL CHEM, V74, P5711, DOI 10.1021/ac020311n
   Borner K, 2007, INT J MASS SPECTROM, V260, P128, DOI 10.1016/j.ijms.2006.09.014
   Brunelle A, 2005, J MASS SPECTROM, V40, P985, DOI 10.1002/jms.902
   Carado A, 2008, ANAL CHEM, V80, P7921, DOI 10.1021/ac801712s
   Chaurand P, 2004, ANAL CHEM, V76, p86A, DOI 10.1021/ac0415197
   Chaurand P, 2002, ELECTROPHORESIS, V23, P3125, DOI 10.1002/1522-2683(200209)23:18<3125::AID-ELPS3125>3.0.CO;2-#
   Dubey M, 2011, SURF INTERFACE ANAL, V43, P261, DOI 10.1002/sia.3537
   Guilhaus M, 2000, MASS SPECTROM REV, V19, P65, DOI 10.1002/(SICI)1098-2787(2000)19:2<65::AID-MAS1>3.0.CO;2-E
   Jones BN, 2011, SURF INTERFACE ANAL, V43, P249, DOI 10.1002/sia.3520
   Khatib-Shahidi S, 2006, ANAL CHEM, V78, P6448, DOI 10.1021/ac060788p
   Kollmer F, 2004, APPL SURF SCI, V231, P153, DOI 10.1016/j.apsusc.2004.03.101
   LEGGETT GJ, 1991, INT J MASS SPECTROM, V108, P29, DOI 10.1016/0168-1176(91)87004-K
   Marsching C, 2011, ANAL BIOANAL CHEM, V401, P53, DOI 10.1007/s00216-011-4802-0
   Nakata Y, 2009, NUCL INSTRUM METH B, V267, P2144, DOI 10.1016/j.nimb.2009.03.094
   Nakata Y, 2009, J MASS SPECTROM, V44, P128, DOI 10.1002/jms.1482
   Stoeckli M, 2002, ANAL BIOCHEM, V311, P33, DOI 10.1016/S0003-2697(02)00386-X
   Touboul D, 2004, ANAL CHEM, V76, P1550, DOI 10.1021/ac035243z
   Touboul D, 2011, CURR OPIN CHEM BIOL, V15, P725, DOI 10.1016/j.cbpa.2011.04.017
   Wakamatsu Y, 2010, AIP CONF PROC, V1321, P233
   Wakamatsu Y, 2011, NUCL INSTRUM METH B, V269, P2251, DOI 10.1016/j.nimb.2011.02.069
   Yamada H, 2010, NUCL INSTRUM METH B, V268, P1736, DOI 10.1016/j.nimb.2010.02.038
NR 21
TC 3
Z9 3
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
EI 1872-9584
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD AUG 1
PY 2014
VL 332
BP 326
EP 329
DI 10.1016/j.nimb.2014.02.088
PG 4
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA AL4UV
UT WOS:000339131200072
DA 2018-10-20
ER

PT J
AU Gu, XS
   Ding, F
   Williams, DF
AF Gu, Xiaosong
   Ding, Fei
   Williams, David F.
TI Neural tissue engineering options for peripheral nerve regeneration
SO BIOMATERIALS
LA English
DT Article
DE Neural tissue engineering; Peripheral nerve regeneration; Tissue
   engineered nerve graft (TENG); Neural templates; Physicochemical and
   biological cues
ID MESENCHYMAL STEM-CELLS; RAT SCIATIC-NERVE; ELECTRICAL-STIMULATION
   PROMOTES; OLFACTORY ENSHEATHING CELLS; ENDOTHELIAL GROWTH-FACTOR;
   DORSAL-ROOT GANGLIA; FUNCTIONAL MOTOR RECOVERY; SKIN-DERIVED PRECURSORS;
   FIBROIN-BASED SCAFFOLD; LONG NONCODING RNAS
AB Tissue engineered nerve grafts (TENGs) have emerged as a potential alternative to autologous nerve grafts, the gold standard for peripheral nerve repair. Typically, TENGs are composed of a biomaterial-based template that incorporates biochemical cues. A number of TENGs have been used experimentally to bridge long peripheral nerve gaps in various animal models, where the desired outcome is nerve tissue regeneration and functional recovery. So far, the translation of TENGs to the clinic for use in humans has met with a certain degree of success. In order to optimize the TENG design and further approach the matching of TENGs with autologous nerve grafts, many new cues, beyond the traditional ones, will have to be integrated into TENGs. Furthermore, there is a strong requirement for monitoring the real-time dynamic information related to the construction of TENGs. The aim of this opinion paper is to specifically and critically describe the latest advances in the field of neural tissue engineering for peripheral nerve regeneration. Here we delineate new attempts in the design of template (or scaffold) materials, especially in the context of biocompatibility, the choice and handling of support cells, and growth factor release systems. We further discuss the significance of RNAi for peripheral nerve regeneration, anticipate the potential application of RNAi reagents for TENGs, and speculate on the possible contributions of additional elements, including angiogenesis, electrical stimulation, molecular inflammatory mediators, bioactive peptides, antioxidant reagents, and cultured biological constructs, to TENGs. Finally, we consider that a diverse array of physicochemical and biological cues must be orchestrated within a TENG to create a self-consistent coordinated system with a close proximity to the regenerative microenvironment of the peripheral nervous system. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Gu, Xiaosong; Ding, Fei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuro regenerat, Nantong 226001, JS, Peoples R China.
   [Williams, David F.] Wake Forest Inst Regenerat Med, Winston Salem, NC USA.
RP Gu, XS (reprint author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuro regenerat, Nantong 226001, JS, Peoples R China.
EM nervegu@ntu.edu.cn; dfwillia@wakehealth.edu
FU National Key Basic Research Program of China (973 program)
   [2014CB542202]; Hi-Tech Research and Development Program of China (863
   Program) [2012AA020502]; National Natural Science Foundation of China
   [81130080, 81171180]; Priority Academic Program Development of Jiangsu
   Higher Education Institutions (PAPD)
FX XG and FD appreciate the financial support from the National Key Basic
   Research Program of China (973 program, Grant No. 2014CB542202), the
   Hi-Tech Research and Development Program of China (863 Program, Grant
   No. 2012AA020502), National Natural Science Foundation of China (Grant
   Nos. 81130080 and 81171180), and a Project Funded by the Priority
   Academic Program Development of Jiangsu Higher Education Institutions
   (PAPD). And they also thank Professor Jie Liu for help in the writing of
   this manuscript.
CR Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067
   Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Al-Majed AA, 2000, J NEUROSCI, V20, P2602
   Andrews MR, 2004, EXP NEUROL, V190, P311, DOI 10.1016/j.expneurol.2004.08.011
   Artico M, 1996, NEUROSURGERY, V39, P380, DOI 10.1097/00006123-199608000-00030
   Ashley WW, 2006, J NEUROSURG, V105, P452, DOI 10.3171/ped.2006.105.6.452
   Asplund M, 2009, NEUROEPIDEMIOLOGY, V32, P217, DOI 10.1159/000197900
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Battiston B, 2009, INT REV NEUROBIOL, V87, P1, DOI 10.1016/S0074-7742(09)87001-3
   Benowitz LI, 2011, CURR OPIN NEUROL, V24, P577, DOI 10.1097/WCO.0b013e32834c208d
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bini TB, 2004, J BIOMED MATER RES A, V68A, P286, DOI 10.1002/jbm.a.20050
   Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102
   Bremer J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012450
   Brushart TM, 2005, EXP NEUROL, V194, P221, DOI 10.1016/j.expneuro.2005.02.007
   Brushart TM, 2002, J NEUROSCI, V22, P6631
   Bushnell BD, 2008, J HAND SURG-AM, V33A, P1081, DOI 10.1016/j.jhsa.2008.03.015
   Cai J, 2005, J BIOMED MATER RES A, V75A, P374, DOI 10.1002/jbm.a.30432
   Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009
   Carriel V, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026022
   Chalfoun CT, 2006, J CELL MOL MED, V10, P309, DOI 10.1111/j.1582-4934.2006.tb00401.x
   Chang CJ, 2009, TISSUE ENG PT A, V15, P547, DOI 10.1089/ten.tea.2007.0342
   Chen ZG, 2012, STEM CELLS, V30, P2261, DOI 10.1002/stem.1186
   Cheng FC, 2010, J NEUROSURG, V112, P868, DOI 10.3171/2009.8.JNS09850
   Cheng Q, 2014, NEUROSCI LETT, V562, P7, DOI 10.1016/j.neulet.2013.12.015
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   Chung TW, 2011, BIOMATERIALS, V32, P734, DOI 10.1016/j.biomaterials.2010.09.023
   Costa FF, 2010, BIOESSAYS, V32, P599, DOI 10.1002/bies.200900112
   CRAWLEY WA, 1992, PLAST RECONSTR SURG, V90, P300, DOI 10.1097/00006534-199290020-00022
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   de Boer R, 2012, J BIOMED MATER RES A, V100A, P2139, DOI 10.1002/jbm.a.34088
   de Ruiter GC, 2008, NEUROSURGERY, V63, P144, DOI [10.1227/01.NEU.0000335081.47352.78, 10.1227/01.NEU.0000319521.28683.75]
   de Ruiter GC, 2008, J BIOMED MATER RES A, V84A, P643, DOI 10.1002/jbm.a.31298
   Dellon AL, 2006, J HAND SURG-AM, V31A, P1495, DOI 10.1016/j.jhsa.2006.07.003
   DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020
   Den Dunnen WFA, 1998, J MATER SCI-MATER M, V9, P811, DOI 10.1023/A:1008987910224
   den Dunnen WFA, 2001, BIOMATERIALS, V22, P1171, DOI 10.1016/S0142-9612(00)00339-2
   denDunnen WFA, 1996, J BIOMED MATER RES, V31, P105, DOI 10.1002/(SICI)1097-4636(199605)31:1<105::AID-JBM13>3.0.CO;2-M
   DERYUGINA EI, 1993, CRIT REV IMMUNOL, V13, P115
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   di Summa PG, 2011, NEUROSCIENCE, V181, P278, DOI 10.1016/j.neuroscience.2011.02.052
   Ding F, 2010, TISSUE ENG PT A, V16, P3779, DOI [10.1089/ten.tea.2010.0299, 10.1089/ten.TEA.2010.0299]
   Dombrowski MA, 2006, BRAIN RES, V1125, P1, DOI 10.1016/j.brainres.2006.09.089
   Donoghoe N, 2007, MICROSURG, V27, P595, DOI 10.1002/micr.20408
   Dubey N, 1999, EXP NEUROL, V158, P338, DOI 10.1006/exnr.1999.7095
   Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027
   Dunnen WFA, 1993, J MATER SCI-MATER M, V4, P521
   Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726
   Erba P, 2010, J PLAST RECONSTR AES, V63, pE811, DOI 10.1016/j.bjps.2010.08.013
   Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120
   Fairless R, 2005, INT J BIOCHEM CELL B, V37, P693, DOI 10.1016/j.biocel.2004.10.010
   Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181
   Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x
   Fickert S, 2003, OSTEOARTHR CARTILAGE, V11, P790, DOI 10.1016/S1063-4584(03)00467-5
   FINE EG, 1991, BIOMATERIALS, V12, P775, DOI 10.1016/0142-9612(91)90029-A
   Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Franchi S, 2012, PAIN, V153, P850, DOI 10.1016/j.pain.2012.01.008
   Fricker FR, 2013, BRAIN, V136, P2279, DOI 10.1093/brain/awt148
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Fu KY, 2011, ARTIF ORGANS, V35, P363, DOI 10.1111/j.1525-1594.2010.01105.x
   Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026
   Geremia NM, 2007, EXP NEUROL, V205, P347, DOI 10.1016/j.expneurol.2007.01.040
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   Goligorsky MS, 1999, CLIN EXP PHARMACOL P, V26, P269, DOI 10.1046/j.1440-1681.1999.03029.x
   Gonzalez-Hernandez T, 1999, J NEUROSCI RES, V55, P198, DOI 10.1002/(SICI)1097-4547(19990115)55:2<198::AID-JNR7>3.0.CO;2-M
   Gordon T, 2010, EXP NEUROL, V223, P192, DOI 10.1016/j.expneurol.2009.09.020
   Gu JH, 2012, CURR STEM CELL RES T, V7, P347
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Guan RG, 2013, MAT SCI ENG C-MATER, V33, P3661, DOI 10.1016/j.msec.2013.04.054
   Guerout N, 2011, MUSCLE NERVE, V43, P543, DOI 10.1002/mus.21907
   Guzman-Villanueva D, 2012, J PHARM SCI-US, V101, P4046, DOI 10.1002/jps.23300
   Haastert K, 2006, NEUROBIOL DIS, V21, P138, DOI 10.1016/j.nbd.2005.06.020
   Haastert K, 2008, NEUROSCI LETT, V443, P179, DOI 10.1016/j.neulet.2008.07.087
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Harrison DG, 1997, J CLIN INVEST, V100, P2153, DOI 10.1172/JCI119751
   Hausott B, 2009, MOL CELL NEUROSCI, V42, P328, DOI 10.1016/j.mcn.2009.08.005
   Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006
   Hill PS, 2011, TISSUE ENG PT A, V17, P1499, DOI 10.1089/ten.tea.2010.0184
   Hobson MI, 1997, BRIT J PLAST SURG, V50, P125, DOI 10.1016/S0007-1226(97)91325-4
   Hobson MI, 2000, J ANAT, V197, P591, DOI 10.1046/j.1469-7580.2000.19740591.x
   Hobson MI, 2002, ANN ROY COLL SURG, V84, P47
   Hoffmann N, 2011, NEUROSCI LETT, V494, P14, DOI 10.1016/j.neulet.2011.02.043
   HOPPEN HJ, 1990, BIOMATERIALS, V11, P286, DOI 10.1016/0142-9612(90)90012-F
   Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399
   Hsieh SC, 2011, J BIOMED MATER RES A, V99A, P576, DOI 10.1002/jbm.a.33157
   Hu N, 2013, BIOMATERIALS, V34, P100, DOI 10.1016/j.biomaterials.2012.09.020
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Hu XY, 2009, TISSUE ENG PT A, V15, P3297, DOI 10.1089/ten.TEA.2009.0017
   Hudson TW, 2000, ORTHOP CLIN N AM, V31, P485, DOI 10.1016/S0030-5898(05)70166-8
   Hvistendahl M, 2012, SCIENCE, V338, P900, DOI 10.1126/science.338.6109.900
   Ichihara S, 2009, TISSUE ENG PART C-ME, V15, P387, DOI 10.1089/ten.tec.2008.0508
   Ikeda M, 2014, J BIOMED MATER RES A, V102, P1370, DOI 10.1002/jbm.a.34816
   Iskandar ME, 2013, J BIOMED MATER RES A, V101, P2340, DOI 10.1002/jbm.a.34530
   Jansen K, 2004, J BIOMED MATER RES A, V69A, P334, DOI 10.1002/jbm.a.30004
   Jeans LA, 2007, J PLAST RECONSTR AES, V60, P1302, DOI 10.1016/j.bjps.2006.06.014
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Jin GZ, 2011, NEUROSCI LETT, V501, P10, DOI 10.1016/j.neulet.2011.06.023
   JOHNSON A, 1986, BLOOD, V68, P1348
   Johnson EO, 2008, INJURY, V39, pS37, DOI 10.1016/j.injury.2008.06.015
   Johnson EO, 2008, INJURY, V39, pS30, DOI 10.1016/j.injury.2008.05.018
   Kakinoki R, 1995, Neurosci Res, V23, P35
   Kakinoki R, 1997, INT ORTHOP, V21, P332, DOI 10.1007/s002640050179
   Karabekmez Furkan E, 2009, Hand (N Y), V4, P245, DOI 10.1007/s11552-009-9195-6
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Keilhoff G, 2002, NEUROREPORT, V13, P1463, DOI 10.1097/00001756-200208070-00023
   Kesharwani P, 2012, BIOMATERIALS, V33, P7138, DOI 10.1016/j.biomaterials.2012.06.068
   Khaing ZZ, 2012, NEUROSCI LETT, V519, P103, DOI 10.1016/j.neulet.2012.02.027
   Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5
   Kim J, 2001, J Foot Ankle Surg, V40, P318
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029
   Kokai LE, 2011, TISSUE ENG PT A, V17, P1263, DOI [10.1089/ten.tea.2010.0507, 10.1089/ten.TEA.2010.0507]
   Kokai LE, 2010, BIOMATERIALS, V31, P2313, DOI 10.1016/j.biomaterials.2009.11.075
   Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103
   Lee SK, 2009, ADV DRUG DELIVER REV, V61, P650, DOI 10.1016/j.addr.2009.03.016
   Lee YB, 2010, EXP NEUROL, V223, P645, DOI 10.1016/j.expneurol.2010.02.014
   Li JM, 2009, LANGMUIR, V25, P1813, DOI 10.1021/la803522f
   Li SY, 2012, J NEUROSCI RES, V90, P791, DOI 10.1002/jnr.22814
   Lin MY, 2013, HAND CLIN, V29, P331, DOI 10.1016/j.hcl.2013.04.003
   Liu GB, 2011, ARCH MED SCI, V7, P592, DOI 10.5114/aoms.2011.24127
   Liu JJ, 2011, J BIOMED MATER RES A, V96A, P13, DOI 10.1002/jbm.a.32946
   Lohmeyer JA, 2009, J RECONSTR MICROSURG, V25, P55, DOI 10.1055/s-0028-1103505
   Low WC, 2013, BIOMATERIALS, V34, P3581, DOI 10.1016/j.biomaterials.2013.01.093
   Lu MC, 2008, NEUROREHAB NEURAL RE, V22, P367, DOI 10.1177/1545968307313507
   Lundborg G, 1988, NERVE INJURY REPAIR
   MACKINNON SE, 1992, PLAST RECONSTR SURG, V90, P695, DOI 10.1097/00006534-199210000-00024
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   Madduri S, 2011, BIOMATERIALS, V31, P2323
   Madduri S, 2011, J CONTROL RELEASE, V161, P274
   Malik AF, 2011, P NATL ACAD SCI USA, V108, P20095, DOI 10.1073/pnas.1105152108
   Marchesi C, 2007, GLIA, V55, P425, DOI 10.1002/glia.20470
   Marquardt LM, 2013, CURR OPIN BIOTECHNOL
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132
   May F, 2008, EUR UROL, V54, P1179, DOI 10.1016/j.eururo.2008.02.003
   May F, 2013, INT J UROL, V20, P344, DOI 10.1111/iju.12078
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006
   Meek MF, 2008, ANN PLAS SURG, V60, P466, DOI 10.1097/SAP.0b013e31804d441c
   Meek MF, 2007, BIO-MED MATER ENG, V17, P329
   Meek MF, 1996, MICROSURG, V17, P555, DOI 10.1002/(SICI)1098-2752(1996)17:10<555::AID-MICR5>3.0.CO;2-P
   Meek MF, 1999, MICROSURG, V19, P247, DOI 10.1002/(SICI)1098-2752(1999)19:5<247::AID-MICR7>3.0.CO;2-E
   Meek MF, 2001, MUSCLE NERVE, V24, P753, DOI 10.1002/mus.1066
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872
   Mendonca AC, 2003, J NEUROSCI METH, V129, P183, DOI 10.1016/S0165-0270(03)00207-3
   Minguell JJ, 2006, EXP BIOL MED, V231, P39
   Mittnacht U, 2010, NANO LETT, V10, P3933, DOI 10.1021/nl1016909
   Mohammadi R, 2013, J SURG RES, V180, pE91, DOI 10.1016/j.jss.2012.04.011
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   Moore AM, 2010, PLAST RECONSTR SURG, V125, P138
   Murashov AK, 2007, FASEB J, V21, P656, DOI 10.1096/fj.06-6155com
   Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031
   Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005
   Navissano M, 2005, MICROSURG, V25, P268, DOI 10.1002/micr.20128
   Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]
   Nguyen HT, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046011
   Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Oh SH, 2008, BIOMATERIALS, V29, P1601, DOI 10.1016/j.biomaterials.2007.11.036
   Orbay H, 2012, J PLAST RECONSTR AES, V65, P657, DOI 10.1016/j.bjps.2011.11.035
   ORTIGUELA ME, 1987, J HAND SURG-AM, V12A, P1119, DOI 10.1016/S0363-5023(87)80129-6
   Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100
   Pancrazio JJ, 2007, BIOSENS BIOELECTRON, V22, P2803, DOI 10.1016/j.bios.2006.12.023
   Panseri S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-39
   Park BW, 2012, J TISSUE ENG REGEN M, V6, P113, DOI 10.1002/term.404
   Park SC, 2010, J BIOMED MATER RES B, V94B, P359, DOI 10.1002/jbm.b.31659
   Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Piquilloud G, 2007, EUR J NEUROSCI, V26, P1109, DOI 10.1111/j.1460-9568.2007.05748.x
   Pola R, 2004, NEUROBIOL AGING, V25, P1361, DOI 10.1016/j.neurobiolaging.2004.02.028
   Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617
   Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057
   Radtke C, 2009, BRAIN RES, V1254, P10, DOI 10.1016/j.brainres.2008.11.036
   Raimondo S, 2011, ANN ANAT, V193, P334, DOI 10.1016/j.aanat.2011.03.001
   Rajaram A, 2012, TISSUE ENG PART B-RE, V18, P454, DOI [10.1089/ten.teb.2012.0006, 10.1089/ten.TEB.2012.0006]
   Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206
   Ravichandran R, 2007, J R SOC INTERFACE S5, V7, pS559
   Ribeiro-Resende VT, 2009, BIOMATERIALS, V30, P5251, DOI 10.1016/j.biomaterials.2009.07.007
   Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480
   Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14
   Rinkel WD, 2013, J PLAST RECONSTR AES, V66, P151, DOI 10.1016/j.bjps.2012.08.035
   Robinson LR, 2000, MUSCLE NERVE, V23, P863, DOI 10.1002/(SICI)1097-4598(200006)23:6<863::AID-MUS4>3.0.CO;2-0
   Camara-Lemarroy CR, 2010, NEUROIMMUNOMODULAT, V17, P314, DOI 10.1159/000292020
   Rooney GE, 2008, TISSUE ENG PT A, V14, P681, DOI 10.1089/tea.2007.0260
   Rosson GD, 2009, MICROSURG, V29, P107, DOI 10.1002/micr.20580
   Runge MB, 2010, BIOMATERIALS, V31, P5916, DOI 10.1016/j.biomaterials.2010.04.012
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schlosshauer B, 2003, BRAIN RES, V963, P321, DOI 10.1016/S0006-8993(02)03930-6
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Scholz T, 2011, ARCH SURG-CHICAGO, V146, P666, DOI 10.1001/archsurg.2011.148
   SECKEL BR, 1990, MUSCLE NERVE, V13, P785, DOI 10.1002/mus.880130904
   Seidlits SK, 2008, NANOMEDICINE-UK, V3, P183, DOI 10.2217/17435889.3.2.183
   Seil JT, 2010, WIRES NANOMED NANOBI, V2, P635, DOI 10.1002/wnan.109
   Shen CC, 2012, J BIOMED MATER RES A, V100A, P48, DOI 10.1002/jbm.a.33227
   Shen Y, 2007, NEUROSCI LETT, V414, P145, DOI 10.1016/j.neulet.2006.12.005
   Smith RM, 2004, J INVEST SURG, V17, P339, DOI 10.1080/08941930490524417
   Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999
   Spivey EC, 2012, BIOMATERIALS, V33, P4264, DOI 10.1016/j.biomaterials.2012.02.043
   Starritt NE, 2011, LARYNGOSCOPE, V121, P1614, DOI 10.1002/lary.21868
   Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041
   Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423
   Suganuma S, 2013, J ORTHOP SCI, V18, P145, DOI 10.1007/s00776-012-0306-9
   Sun F, 2011, BIOMATERIALS, V32, P8118, DOI 10.1016/j.biomaterials.2011.07.031
   Sun WJ, 2007, J BIOMED MATER RES A, V83A, P1054, DOI 10.1002/jbm.a.31417
   Sundback C, 2003, BIOMATERIALS, V24, P819, DOI 10.1016/S0142-9612(02)00409-X
   Tang S, 2013, BIOMATERIALS, V34, P7086, DOI 10.1016/j.biomaterials.2013.05.080
   Tang X, 2013, MOL CELL BIOCHEM, V378, P237, DOI 10.1007/s11010-013-1614-x
   Tang X, 2012, BIOMATERIALS, V33, P3860, DOI 10.1016/j.biomaterials.2012.02.008
   Taras John S, 2005, J Hand Ther, V18, P191, DOI 10.1197/j.jht.2005.02.012
   Tavangarian F, 2012, CERAM INT, V38, P6075, DOI 10.1016/j.ceramint.2012.05.038
   Taylor CA, 2008, AM J PHYS MED REHAB, V87, P381, DOI 10.1097/PHM.0b013e31815e6370
   Timmer M, 2003, CELL TRANSPLANT, V12, P265, DOI 10.3727/000000003108746821
   Tohill M, 2004, BIOTECHNOL APPL BIOC, V40, P17, DOI 10.1042/BA20030173
   Tomita K, 2013, NEUROSCIENCE, V236, P55, DOI 10.1016/j.neuroscience.2012.12.066
   Tomita K, 2012, J NEUROSCI RES, V90, P1392, DOI 10.1002/jnr.23002
   Toth C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002014
   Tyner Tim R, 2007, Am J Surg, V193, pe1, DOI 10.1016/j.amjsurg.2006.08.026
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Uemura T, 2012, BIOCHEM BIOPH RES CO, V419, P130, DOI 10.1016/j.bbrc.2012.01.154
   Veith M, 2010, CERAM TRANS, V214, P117
   Verdu E, 1999, NEUROREPORT, V10, P1097, DOI 10.1097/00001756-199904060-00035
   Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011
   Walsh S, 2009, NEUROSCIENCE, V164, P1097, DOI 10.1016/j.neuroscience.2009.08.072
   Wang CY, 2012, J BIOMAT SCI-POLYM E, V23, P167, DOI 10.1163/092050610X545805
   Wang HK, 2012, BIOTECHNOL APPL BIOC, V59, P388, DOI 10.1002/bab.1031
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Wang Y, 2002, PLOS ONE, V7
   Wang YJ, 2013, NEUROSCI LETT, V548, P201, DOI 10.1016/j.neulet.2013.05.022
   Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   Wei YJ, 2011, J MATER SCI-MATER M, V22, P1947, DOI 10.1007/s10856-011-4370-z
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
   Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220
   Widmer MS, 1998, BIOMATERIALS, V19, P1945, DOI 10.1016/S0142-9612(98)00099-4
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2014, TISSUE ENG PT A, V20, P1129, DOI 10.1089/ten.tea.2013.0769
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Williams DF, 2014, ESSENTIAL B IN PRESS
   Wilson ADH, 2007, J PLAST RECONSTR AES, V60, P114, DOI 10.1016/j.bjps.2006.04.017
   Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909
   Wongtrakul S, 2002, J HAND SURG-AM, V27A, P277, DOI 10.1053/jhsu.2002.31158
   Wood MD, 2013, BIOTECHNOL BIOENG, V110, P1272, DOI 10.1002/bit.24800
   Wu D, 2011, NEUROSCIENCE, V190, P386, DOI 10.1016/j.neuroscience.2011.06.017
   Wu D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00055
   Xu YF, 2008, BRAIN RES, V1239, P49, DOI 10.1016/j.brainres.2008.08.088
   Xue CB, 2012, NEUROREHAB NEURAL RE, V26, P96, DOI 10.1177/1545968311420444
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang YM, 2011, TISSUE ENG PT A, V17, P2231, DOI [10.1089/ten.tea.2010.0633, 10.1089/ten.TEA.2010.0633]
   Yang YM, 2011, EUR J PHARM BIOPHARM, V79, P519, DOI 10.1016/j.ejpb.2011.06.008
   Yao L, 2010, TISSUE ENG PART C-ME, V16, P1585, DOI 10.1089/ten.TEC.2010.0152
   Yao L, 2011, TISSUE ENG PART B-RE, V17, P143, DOI [10.1089/ten.teb.2010.0561, 10.1089/ten.TEB.2010.0561]
   Yao L, 2010, BIOMATERIALS, V31, P5789, DOI 10.1016/j.biomaterials.2010.03.081
   Yao L, 2009, HIPPOCAMPUS, V19, P855, DOI 10.1002/hipo.20569
   Yeh CC, 2010, NEUROREHAB NEURAL RE, V24, P730, DOI 10.1177/1545968310376758
   Yu B, 2013, NEUROSCI LETT, V534, P117, DOI 10.1016/j.neulet.2012.12.014
   Yu B, 2012, NUCLEIC ACIDS RES, V40, P10356, DOI 10.1093/nar/gks750
   Yu B, 2012, J CELL SCI, V125, P2675, DOI 10.1242/jcs.098996
   Yun B, 2010, J NEUROSCI, V30, P7722, DOI 10.1523/JNEUROSCI.0876-10.2010
   Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067
   Zhang N, 2008, J MANUF SCI E-T ASME, V130
   Zhang PX, 2013, INT J MED SCI, V10, P171, DOI 10.7150/ijms.5312
   Zhang YJ, 2010, BIOMATERIALS, V31, P5312, DOI 10.1016/j.biomaterials.2010.03.029
   Zhou SL, 2014, J CELL SCI, V127, P967, DOI 10.1242/jcs.131672
   Zhou SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044768
   Zhou SL, 2011, NEUROSCI LETT, V494, P89, DOI 10.1016/j.neulet.2011.02.064
   Zochodne DW, 2012, J PERIPHER NERV SYST, V17, P1, DOI 10.1111/j.1529-8027.2012.00378.x
NR 279
TC 139
Z9 149
U1 21
U2 198
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2014
VL 35
IS 24
BP 6143
EP 6156
DI 10.1016/j.biomaterials.2014.04.064
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AL0GD
UT WOS:000338804500001
PM 24818883
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Christie, JK
   Ainsworth, RI
   de Leeuw, NH
AF Christie, Jamieson K.
   Ainsworth, Richard I.
   de Leeuw, Nora H.
TI Ab initio molecular dynamics simulations of structural changes
   associated with the incorporation of fluorine in bioactive phosphate
   glasses
SO BIOMATERIALS
LA English
DT Article
DE Fluorine; Glass; Bioactive glass; Modelling; Bioactivity
ID SHORT-RANGE STRUCTURE; IN-SITU RADIOTHERAPY; BIOMEDICAL APPLICATIONS;
   SILICATE-GLASSES; ELECTRONIC-PROPERTIES; AMORPHOUS SILICA; VECTORS;
   YTTRIUM; SODIUM
AB Phosphate-based bioactive glasses containing fluoride ions offer the potential of a biomaterial which combines the bioactive properties of the phosphate glass and the protection from dental caries by fluoride. We conduct accurate first-principles molecular dynamics simulations of two compositions of fluorinated phosphate-based glass to assess its suitability as a biomaterial. There is a substantial amount of F P bonding and as a result the glass network will be structurally homogeneous on medium-range length scales, without the inhomogeneities which reduce the bioactivity of other fluorinated bioactive glasses. We observe a decrease in the network connectivity with increasing F content, caused by the replacement of bridging oxygen atoms by non-bridging fluorine atoms, but this decrease is small and can be opposed by an increase in the phosphate content. We conclude that the structural changes caused by the incorporation of fluoride into phosphate-based glasses will not adversely affect their bioactivity, suggesting that fluorinated phosphate glasses offer a superior alternative to their silicate-based counterparts. (C) 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
C1 [Christie, Jamieson K.; Ainsworth, Richard I.; de Leeuw, Nora H.] UCL, Dept Chem, London WC1H 0AJ, England.
RP Christie, JK (reprint author), UCL, Dept Chem, 20 Gordon St, London WC1H 0AJ, England.
EM jamieson.christie@ucl.ac.uk
RI Ainsworth, Richard/E-4194-2013
OI Ainsworth, Richard/0000-0002-3350-5692; Christie,
   Jamieson/0000-0001-6105-561X
FU EPSRC [EP/J008095/1, EP/F067496, EP/L000202]; Engineering and Physical
   Sciences Research Council [EP/J008095/1]
FX We acknowledge the EPSRC (grant no. EP/J008095/1) for funding. Via our
   membership of the UK's HPC Materials Chemistry Consortium, which is
   funded by EPSRC (grant nos. EP/F067496 and EP/L000202), this work made
   use of the facilities of HECToR, the UK's national high-performance
   computing service.
CR Abou Neel EA, 2009, J MATER CHEM, V19, P690, DOI 10.1039/b810675d
   Ahmed I, 2004, BIOMATERIALS, V25, P491, DOI 10.1016/S0142-9612(03)00546-5
   Ainsworth RI, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4770295
   Brauer DS, 2011, MATER CHEM PHYS, V130, P121, DOI 10.1016/j.matchemphys.2011.06.015
   Brauer DS, 2010, ACTA BIOMATER, V6, P3275, DOI 10.1016/j.actbio.2010.01.043
   Brauer DS, 2009, J MATER CHEM, V19, P5629, DOI 10.1039/b900956f
   BROW RK, 1990, J NON-CRYST SOLIDS, V116, P39, DOI 10.1016/0022-3093(90)91043-Q
   Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1
   Christie JK, 2013, J PHYS CHEM B, V117, P10652, DOI 10.1021/jp4058115
   Christie JK, 2012, J PHYS CHEM B, V116, P12614, DOI 10.1021/jp304200f
   Christie JK, 2012, J MATER CHEM, V22, P12023, DOI 10.1039/c2jm31561k
   Christie JK, 2011, PHYS CHEM CHEM PHYS, V13, P17749, DOI 10.1039/c1cp21764j
   Christie JK, 2011, J PHYS CHEM B, V115, P2038, DOI 10.1021/jp110788h
   Christie JK, 2010, ADV ENG MATER, V12, pB326, DOI 10.1002/adem.200980081
   Christie JK, 2010, CHEM MATER, V22, P3725, DOI 10.1021/cm100847p
   Du JC, 2011, J AM CERAM SOC, V94, P2393, DOI 10.1111/j.1551-2916.2011.04514.x
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   Featherstone JDB, 2000, J AM DENT ASSOC, V131, P887, DOI 10.14219/jada.archive.2000.0307
   Gilchrist T, 1998, BRIT J PLAST SURG, V51, P231, DOI 10.1054/bjps.1997.0243
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Hoppe U, 2000, J NON-CRYST SOLIDS, V263, P29, DOI 10.1016/S0022-3093(99)00621-3
   Hoppe U, 1996, J NON-CRYST SOLIDS, V195, P138, DOI 10.1016/0022-3093(95)00524-2
   Jund P, 1999, PHYS REV LETT, V83, P2210, DOI 10.1103/PhysRevLett.83.2210
   Knowles JC, 2003, J MATER CHEM, V13, P2395, DOI 10.1039/b307119g
   Lakhkar NJ, 2013, ADV DRUG DELIVER REV, V65, P405, DOI 10.1016/j.addr.2012.05.015
   Lee TH, 2000, PHYS REV B, V81
   Liang Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.215504
   Lusvardi G, 2009, ACTA BIOMATER, V5, P3548, DOI 10.1016/j.actbio.2009.06.009
   Lusvardi G, 2009, J PHYS CHEM B, V113, P10331, DOI 10.1021/jp809805z
   Pedone A, 2012, J MATER CHEM, V22, P12599, DOI 10.1039/c2jm30890h
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Pickup DM, 2007, J MATER CHEM, V17, P4777, DOI 10.1039/b709955j
   Pickup DM, 2012, J BIOMATER APPL, V26, P613, DOI 10.1177/0885328210380761
   SARNTHEIN J, 1995, PHYS REV LETT, V74, P4682, DOI 10.1103/PhysRevLett.74.4682
   Sculean A, 2002, J PERIODONTOL, V73, P401, DOI 10.1902/jop.2002.73.4.401
   Tang E, 2010, ADV ENG MATER, V12, pB331, DOI 10.1002/adem.201080011
   Taraskin SN, 1997, PHYS REV B, V56, P8605, DOI 10.1103/PhysRevB.56.8605
   Tilocca A, 2006, J PHYS CHEM B, V110, P25810, DOI 10.1021/jp065146k
   Tilocca A, 2007, FARADAY DISCUSS, V136, P45, DOI 10.1039/b617540f
   Tilocca A, 2007, CHEM MATER, V19, P95, DOI 10.1021/cm061631g
   Tilocca A, 2006, J MATER CHEM, V16, P1950, DOI [10.1039/b517362k, 10.1039/B517362K]
   Tilocca A, 2010, J MATER CHEM, V20, P6848, DOI 10.1039/c0jm01081b
   Tilocca A, 2009, P ROY SOC A-MATH PHY, V465, P1003, DOI 10.1098/rspa.2008.0462
   Uo M, 1998, BIOMATERIALS, V19, P2277, DOI 10.1016/S0142-9612(98)00136-7
   Valappil SP, 2007, ANTIMICROB AGENTS CH, V51, P4453, DOI 10.1128/AAC.00605-07
   VandeVondele J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770708
   Vollmayr K, 1996, PHYS REV B, V54, P15808, DOI 10.1103/PhysRevB.54.15808
   Walter G, 2001, J NON-CRYST SOLIDS, V296, P212, DOI 10.1016/S0022-3093(01)00912-7
   ZAFFE D, 1993, J MATER SCI-MATER M, V4, P169, DOI 10.1007/BF00120387
NR 49
TC 18
Z9 18
U1 0
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2014
VL 35
IS 24
BP 6164
EP 6171
DI 10.1016/j.biomaterials.2014.04.032
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AL0GD
UT WOS:000338804500003
PM 24802671
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yavari, SA
   van der Stok, J
   Chai, YC
   Wauthle, R
   Birgani, ZT
   Habibovic, P
   Mulier, M
   Schrooten, J
   Weinans, H
   Zadpoor, AA
AF Yavari, Saber Amin
   van der Stok, Johan
   Chai, Yoke Chin
   Wauthle, Ruben
   Birgani, Zeinab Tahmasebi
   Habibovic, Pamela
   Mulier, Michiel
   Schrooten, Jan
   Weinans, Harrie
   Zadpoor, Amir Abbas
TI Bone regeneration performance of surface-treated porous titanium
SO BIOMATERIALS
LA English
DT Article
DE Bone grafting; Selective laser melting; Nanotopography; Surface
   chemistry; Bone regeneration; Surface-cell interaction
ID OSTEOBLAST FUNCTIONS; GROWTH-FACTORS; CELL-FUNCTION; ILIAC CREST;
   STEM-CELLS; NANOTOPOGRAPHY; CHEMISTRY; PHOSPHATE; CERAMICS; IMPLANTS
AB The large surface area of highly porous titanium structures produced by additive manufacturing can be modified using biofunctionalizing surface treatments to improve the bone regeneration performance of these otherwise bioinert biomaterials. In this longitudinal study, we applied and compared three types of biofunctionalizing surface treatments, namely acid-alkali (AcAl), alkali-acid-heat treatment (AlAcH), and anodizing-heat treatment (AnH). The effects of treatments on apatite forming ability, cell attachment, cell proliferation, osteogenic gene expression, bone regeneration, biomechanical stability, and bone-biomaterial contact were evaluated using apatite forming ability test, cell culture assays, and animal experiments. It was found that AcAl and AnH work through completely different routes. While AcAl improved the apatite forming ability of as-manufactured (AsM) specimens, it did not have any positive effect on cell attachment, cell proliferation, and osteogenic gene expression. In contrast, AnH did not improve the apatite forming ability of AsM specimens but showed significantly better cell attachment, cell proliferation, and expression of osteogenic markers. The performance of AlAcH in terms of apatite forming ability and cell response was in between both extremes of AnH and AsM. AcAl resulted in significantly larger volumes of newly formed bone within the pores of the scaffold as compared to AnH. Interestingly, larger volumes of regenerated bone did not translate into improved biomechanical stability as AnH exhibited significantly better biomechanical stability as compared to AcAl suggesting that the beneficial effects of cell-nanotopography modulations somehow surpassed the benefits of improved apatite forming ability. In conclusion, the applied surface treatments have considerable effects on apatite forming ability, cell attachment, cell proliferation, and bone ingrowth of the studied biomaterials. The relationship between these properties and the bone-implant biomechanics is, however, not trivial. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Yavari, Saber Amin; Weinans, Harrie; Zadpoor, Amir Abbas] Delft Univ Technol TU Delft, Fac Mech Maritime & Mat Engn, NL-2628 CD Delft, Netherlands.
   [Yavari, Saber Amin] FT Innovat BV, NL-5831 PW Boxmeer, Netherlands.
   [van der Stok, Johan; Weinans, Harrie] Erasmus Univ, Med Ctr, Dept Orthopaed, Orthopaed Res Lab, Rotterdam, Netherlands.
   [Chai, Yoke Chin] Katholieke Univ Leuven, Prometheus, Div Skeletal Tissue Engn, B-3000 Leuven, Belgium.
   [Chai, Yoke Chin] Katholieke Univ Leuven, Skeletal Biol & Engn Res Ctr, Tissue Engn Lab, B-3000 Leuven, Belgium.
   [Chai, Yoke Chin] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
   [Wauthle, Ruben] Katholieke Univ Leuven, Dept Mech Engn, Sect Prod Engn Machine Design & Automat PMA, B-3001 Leuven, Belgium.
   [Wauthle, Ruben] LayerWise NV, B-3001 Leuven, Belgium.
   [Birgani, Zeinab Tahmasebi; Habibovic, Pamela] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
   [Mulier, Michiel] Univ Hosp KU Leuven, UZ Pellenberg, Dept Orthopaed, B-3212 Lubbeek, Belgium.
   [Schrooten, Jan] Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Heverlee, Belgium.
   [Weinans, Harrie] UMC Utrecht, Dept Orthoped, NL-3584CX Utrecht, Netherlands.
   [Weinans, Harrie] UMC Utrecht, Dept Rheumatol, NL-3584CX Utrecht, Netherlands.
RP Yavari, SA (reprint author), Delft Univ Technol TU Delft, Fac Mech Maritime & Mat Engn, Mekelweg 2, NL-2628 CD Delft, Netherlands.
EM s.aminyavari@tudelft.nl
RI Amin Yavari, Saber/E-5360-2017; Zadpoor, Amir A/A-8510-2008; Amin
   Yavari, Saber/G-9486-2013
OI Amin Yavari, Saber/0000-0003-1677-5751; Amin Yavari,
   Saber/0000-0003-1677-5751; Zadpoor, Amir Abbas/0000-0003-3234-2112
FU BioMedical Materials institute [P2.04 BONE-IP]; Dutch Ministry of
   Economic Affairs
FX This research forms part of the Project P2.04 BONE-IP of the research
   program of the BioMedical Materials institute, co-funded by the Dutch
   Ministry of Economic Affairs. The technical supports of Harry Jansen and
   Patrick van Hoist for biomechanical testing is also acknowledged.
CR Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Beskardes IG, 2009, J BIOACT COMPAT POL, V24, P507, DOI 10.1177/0883911509349311
   Campoli G, 2013, MATER DESIGN, V49, P957, DOI 10.1016/j.matdes.2013.01.071
   Campoli G, 2012, J MECH BEHAV BIOMED, V10, P108, DOI 10.1016/j.jmbbm.2012.02.011
   Chai YC, 2011, TISSUE ENG PART C-ME, V18, P90
   Chen YJ, 2011, J MATER SCI-MATER M, V22, P839, DOI 10.1007/s10856-011-4280-0
   Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003
   Dimitriou R, 2011, INJURY, V42, pS3, DOI 10.1016/j.injury.2011.06.015
   Duan B, 2010, ACTA BIOMATER, V6, P4495, DOI 10.1016/j.actbio.2010.06.024
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Fukuda A, 2011, ACTA BIOMATER, V7, P2327, DOI 10.1016/j.actbio.2011.01.037
   George E., 2008, INT J NANOMED, V3, P257
   Goodridge RD, 2006, P I MECH ENG H, V220, P57, DOI 10.1243/095441105X69051
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Kim HN, 2013, ADV DRUG DELIVER REV, V65, P536, DOI 10.1016/j.addr.2012.07.014
   Kim MJ, 2013, BIOMATERIALS, V34, P7236, DOI 10.1016/j.biomaterials.2013.06.019
   Kokubo S, 2004, BIOMATERIALS, V25, P1795, DOI 10.1016/j.biomaterials.2003.08.030
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kulangara K, 2012, BIOMATERIALS, V33, P4998, DOI 10.1016/j.biomaterials.2012.03.053
   Li XA, 2010, RARE METAL MAT ENG, V39, P1697, DOI 10.1016/S1875-5372(10)60126-9
   Lin CY, 2007, J BIOMED MATER RES A, V83A, P272, DOI 10.1002/jbm.a.31231
   McNamara L. E., 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/120623
   Minagar S, 2013, J BIOMED MATER RES A, V101, P2726, DOI 10.1002/jbm.a.34575
   Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nebe JB, 2008, ACTA BIOMATER, V4, P1985, DOI 10.1016/j.actbio.2008.05.028
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Nishiguchi S, 2001, J BIOMED MATER RES, V54, P198, DOI 10.1002/1097-4636(200102)54:2<198::AID-JBM6>3.0.CO;2-7
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Pattanayak DK, 2011, J MATER SCI-MATER M, V22, P1803, DOI 10.1007/s10856-011-4372-x
   Pattanayak DK, 2011, ACTA BIOMATER, V7, P1398, DOI 10.1016/j.actbio.2010.09.034
   Pelissier P, 2004, J ORTHOPAED RES, V22, P73, DOI 10.1016/S0736-0266(03)00165-7
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Simpson RL, 2008, J BIOMED MATER RES B, V84B, P17, DOI 10.1002/jbm.b.30839
   Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306
   Takemoto M, 2006, BIOMATERIALS, V27, P2682, DOI 10.1016/j.biomaterials.2005.12.014
   van der Stok J, 2013, TISSUE ENG PT A, V19, P2605, DOI [10.1089/ten.tea.2013.0181, 10.1089/ten.TEA.2013.0181]
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   Vandenbroucke B, 2007, RAPID PROTOTYPING J, V13, P196, DOI 10.1108/13552540710776142
   Warnke PH, 2008, TISSUE ENG PART C-ME, V15, P115
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551
   Yavari SA, 2014, APPL SURF SCI, V290, P287, DOI 10.1016/j.apsusc.2013.11.069
   Yavari SA, 2013, MAT SCI ENG C-MATER, V33, P4849, DOI 10.1016/j.msec.2013.08.006
   Zadpoor AA, 2013, APPL MATH MODEL, V37, P5260, DOI 10.1016/j.apm.2012.10.049
   Zhang QY, 2005, BIOMATERIALS, V26, P2857, DOI 10.1016/j.biomaterials.2004.08.016
   Zhang WJ, 2013, BIOMATERIALS, V34, P3184, DOI 10.1016/j.biomaterials.2013.01.008
   Zhao CY, 2010, J BIOMED MATER RES B, V95B, P387, DOI 10.1002/jbm.b.31728
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
NR 50
TC 93
Z9 94
U1 8
U2 157
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2014
VL 35
IS 24
BP 6172
EP 6181
DI 10.1016/j.biomaterials.2014.04.054
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AL0GD
UT WOS:000338804500004
DA 2018-10-20
ER

PT J
AU Liu, Q
   Wang, W
   Zhang, L
   Zhao, LZ
   Song, W
   Duan, XH
   Zhang, YM
AF Liu, Qian
   Wang, Wei
   Zhang, Li
   Zhao, Lingzhou
   Song, Wen
   Duan, Xiaohong
   Zhang, Yumei
TI Involvement of N-cadherin/beta-catenin interaction in the
   micro/nanotopography induced indirect mechanotransduction
SO BIOMATERIALS
LA English
DT Article
DE Micro/nanotopography; MC3T3-E1; Mechanotransduction; N-cadherin;
   beta-catenin
ID MESENCHYMAL STEM-CELLS; BETA-CATENIN; OSTEOBLAST DIFFERENTIATION;
   OSTEOGENIC DIFFERENTIATION; MG63 DIFFERENTIATION; TITANIA NANOTUBES;
   BONE-FORMATION; PROLIFERATION; ADHESION; WNT
AB Topographical modification at micro- and nanoscale is widely applied to enhance the tissue integration properties of biomaterials, but the underlying molecular mechanism is poorly understood. The biomaterial topography modulates cell functions via mechanotransduction of direct and indirect. We propose that N-cadherin may play a role in the topographically induced indirect mechanotransduction by regulating the beta-catenin signaling. For confirmation, the cell functions, N-cadherin expression and beta-catenin signaling activation of osteoblasts on titanium (Ti) surfaces with micro- or/and nanotopography are systemically compared with naive and N-cadherin down-regulating MC3T3-E1 cells. We find that the N-cadherin expression is reversely related to the intracellular beta-catenin signaling and the N-cadherin/beta-catenin signaling is modulated differentially by the micro- and nanotopography. The nanotopography significantly up-regulates the N-cadherin expression leading to lower beta-catenin signaling activity and consequently depressed differentiation, whereas the microtopography down-regulates the N-cadherin expression resulting in enhanced beta-catenin signaling and thus osteoblast differentiation. Artificial down-regulation of the N-cadherin expression can significantly up-regulate the beta-catenin signaling and consequently enhance the osteoblast differentiation on all the Ti surfaces. The study for the first time clarifies the involvement of the N-cadherin/beta-catenin interaction in the micro/nanotopography induced indirect mechanotransduction and provides a potentially new approach for biomaterial modification and biofunctionalization by down-regulating the cell N-cadherin expression to achieve improved clinical performance. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Liu, Qian; Zhang, Li; Song, Wen; Zhang, Yumei] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthet Dent, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
   [Wang, Wei] Peoples Liberat Army, Hosp 463, Dept Stomatol, Shenyang 110042, Peoples R China.
   [Zhao, Lingzhou] Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
   [Duan, Xiaohong] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Biol, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
RP Zhao, LZ (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol, State Key Lab Mil Stomatol, 145 West Changle Rd, Xian 710032, Peoples R China.
EM zhaolingzhou1983@hotmail.com; wqtzym@fmmu.edu.cn
RI Zhao, Lingzhou/B-4408-2014
FU National Natural Science Foundation of China [31200716, 81070862,
   31170915]; School of Stomatology, The Fourth Military Medical University
FX This work was supported by National Natural Science Foundation of China
   Nos. 31200716, 81070862 and 31170915. L. Z. Zaho also appreciates the
   grant from School of Stomatology, The Fourth Military Medical
   University.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Arnsdorf EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005388
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Bravou V, 2006, J PATHOL, V208, P91, DOI 10.1002/path.1860
   Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633
   Cheng SL, 2000, J BONE MINER RES, V15, P2362, DOI 10.1359/jbmr.2000.15.12.2362
   Ferrari SL, 2000, J BONE MINER RES, V15, P198, DOI 10.1359/jbmr.2000.15.2.198
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Guntur AR, 2012, BONE, V50, P54, DOI 10.1016/j.bone.2011.09.036
   Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002
   Hay E, 2012, J BONE MINER RES, V27, P1852, DOI 10.1002/jbmr.1656
   Hay E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008284
   Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08
   Lai CF, 2006, J BONE MINER RES, V21, P1897, DOI 10.1359/JBMR.060906
   Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011
   Liu WF, 2006, J CELL BIOL, V173, P431, DOI 10.1083/jcb.200510087
   Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073
   Marie PJ., 2009, IBMS BONEKEY, V6, P150
   McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923
   McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623
   Miller JR., 2002, GENOME BIOL, V3
   Nelson CM, 2002, FEBS LETT, V514, P238, DOI 10.1016/S0014-5793(02)02370-0
   Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291
   Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y
   Oloumi A, 2004, BBA-MOL CELL RES, V1691, P1, DOI 10.1016/j.bbamcr.2003.12.002
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548
   Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0
   Santos A, 2010, BIOCHEM BIOPH RES CO, V391, P364, DOI 10.1016/j.bbrc.2009.11.064
   Schernthaner M, 2012, ACTA BIOMATER, V8, P2953, DOI 10.1016/j.actbio.2012.04.018
   STEIN GS, 1990, FASEB J, V4, P3111
   TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2
   Tamura Masato, 2010, Front Biosci (Elite Ed), V2, P1405
   Wang W, 2013, BIOMATERIALS, V34, P631, DOI 10.1016/j.biomaterials.2012.10.021
   Wang W, 2012, BIOMATERIALS, V33, P7993, DOI 10.1016/j.biomaterials.2012.07.064
   Wang Y, 2007, J TISSUE ENG REGEN M, V1, P39, DOI 10.1002/term.6
   Xu LL, 2013, MOL BIOL REP, V40, P2533, DOI 10.1007/s11033-012-2334-0
   Yu WQ, 2012, COLLOID SURFACE B, V93, P135, DOI 10.1016/j.colsurfb.2011.12.025
   Zhao LZ, 2012, BIOMATERIALS, V33, P2629, DOI 10.1016/j.biomaterials.2011.12.024
   Zhao LZ, 2011, J BIOMED MATER RES A, V96A, P100, DOI 10.1002/jbm.a.32918
   Zhao LZ, 2010, BIOMATERIALS, V31, P8341, DOI 10.1016/j.biomaterials.2010.07.036
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
   Zhao LZ, 2010, BIOMATERIALS, V31, P2055, DOI 10.1016/j.biomaterials.2009.11.103
NR 46
TC 24
Z9 25
U1 2
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2014
VL 35
IS 24
BP 6206
EP 6218
DI 10.1016/j.biomaterials.2014.04.068
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AL0GD
UT WOS:000338804500007
PM 24818888
DA 2018-10-20
ER

PT J
AU Pertici, V
   Trimaille, T
   Laurin, J
   Felix, MS
   Marqueste, T
   Pettmann, B
   Chauvin, JP
   Gigmes, D
   Decherchi, P
AF Pertici, Vincent
   Trimaille, Thomas
   Laurin, Jerome
   Felix, Marie-Solenne
   Marqueste, Tanguy
   Pettmann, Brigitte
   Chauvin, Jean-Paul
   Gigmes, Didier
   Decherchi, Patrick
TI Repair of the injured spinal cord by implantation of a synthetic
   degradable block copolymer in rat
SO BIOMATERIALS
LA English
DT Article
DE PLA-b-PHEMA; Behavioral recovery; Spinal cord hemisection; Axonal
   regrowth; Weight-bearing distribution
ID CENTRAL-NERVOUS-SYSTEM; AXONAL REGENERATION; IN-VITRO; SCHWANN-CELLS;
   STEM-CELLS; SCAFFOLDS; HYDROGELS; BIOMATERIALS; HEMISECTION; STRATEGIES
AB The present study is designed to assess the properties of a new degradable PLA-b-PHEMA block copolymer hydrogel and its therapeutic effectiveness after implantation following a thoracic spinal cord hemisection on rats. Degradable characteristics and porous aspect of the scaffold are respectively analyzed by the evaluation of its mass loss and by electron microscopy. The biomaterial toxicity is measured through in vitro tests based on motoneuron survival and neurite growth on copolymer substrate. Functional measurements are assessed by the Basso, Beattie and Bresnahan (BBB) and the Dynamic Weight Bearing (DWB) tests during 8 weeks post-surgery. Histological analyses are achieved to evaluate the presence of blood vessels and axons, the density of the glial scar, the inflammatory reaction and the myelination at the lesion site and around it. The results indicate that the synthetic PLA-b-PHEMA block copolymer is a non-toxic and degradable biomaterial that provides support for regenerating axons and seems to limit scar tissue formation. Additionally, the implantation of the porous PLA-b-PHEMA scaffold enhances locomotor improvement. The observed functional recovery highlights the potential benefits of plain tissue engineering material, which can further be optimized by bioactive molecule functionalization or transplanted cell encapsulation. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Pertici, Vincent; Laurin, Jerome; Felix, Marie-Solenne; Marqueste, Tanguy; Decherchi, Patrick] Aix Marseille Univ, Fac Sci Sport Marseille, CNRS, Inst Sci Mouvement Etienne Jules MAREY,Equipe PSN, F-13288 Marseille 09, France.
   [Trimaille, Thomas; Gigmes, Didier] Aix Marseille Univ, CNRS, ICR, Equipe CROPS,UMR 7273, F-13397 Marseille 20, France.
   [Pettmann, Brigitte] Aix Marseille Univ, INSERM, INMED, Equipe Plast Dev Synapses GABAerg,UMR S 901, F-13273 Marseille 09, France.
   [Chauvin, Jean-Paul] Aix Marseille Univ, CNRS, IBDM, UMR 7288, F-13288 Marseille 09, France.
RP Decherchi, P (reprint author), Aix Marseille Univ, Fac Sci Sport Marseille, CNRS, Inst Sci Mouvement Etienne Jules MAREY,Equipe PSN, Parc Scientifique & Technol Luminy, F-13288 Marseille 09, France.
EM didier.gigmes@univ-amu.fr; patrick.decherchi@univ-amu.fr
OI DECHERCHI, Patrick/0000-0001-5639-852X
FU Aix-Marseille Universite (AMU); Centre National de la Recherche
   Scientifique (CNRS); Agence Nationale de la Recherche (ANR) [TRAUMATISM
   09-BLAN-0295-02)]; Association Libre d'Aide a Recherche sur la Moelle
   Epiniere (ALARME); Demain Debout Association; Combattre la Paralysie
   Association; Association Mediterraneenne pour le Developpement des
   Transplantations (AMDT)
FX This work was supported by public [Aix-Marseille Universite (AMU),
   Centre National de la Recherche Scientifique (CNRS) and Agence Nationale
   de la Recherche (ANR - TRAUMATISM 09-BLAN-0295-02)] and private grants
   [Association Libre d'Aide a Recherche sur la Moelle Epiniere (ALARME),
   Demain Debout and Combattre la Paralysie Associations]. This work was
   also supported by Association Mediterraneenne pour le Developpement des
   Transplantations (AMDT). We are grateful to Jean-Louis CLEMENT for his
   help in the preparation of the porous scaffold and to Thelma COYLE for
   her help in Matlab data analysis. We are grateful to Alain DONNEAUD for
   technical support.
CR Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.3.CO;2-Y
   Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]
   Clement B, 2011, MACROMOL BIOSCI, V11, P1175, DOI 10.1002/mabi.201100067
   Clement B, 2009, BIOMACROMOLECULES, V10, P1436, DOI 10.1021/bm900003f
   Cloud BA, 2012, J NEUROSCI METH, V211, P179, DOI 10.1016/j.jneumeth.2012.08.024
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   Hejcl A, 2008, PHYSIOL RES, V57, pS121
   Hejcl A, 2010, STEM CELLS DEV, V19, P1535, DOI 10.1089/scd.2009.0378
   Henderson C., 1995, NEURAL CELL CULTURE
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Karp JM, 2003, J BIOMED MATER RES A, V64A, P388, DOI 10.1002/jbm.a.10420
   Li HY, 2013, J MATER SCI-MATER M, V24, P2001, DOI 10.1007/s10856-013-4956-8
   Maquet V, 2001, BIOMATERIALS, V22, P1137, DOI 10.1016/S0142-9612(00)00357-4
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Pertici V, 2014, BEHAV BRAIN RES, V259, P78, DOI 10.1016/j.bbr.2013.10.043
   Pertici V, 2013, ASN NEURO, V5, P149, DOI 10.1042/AN20120082
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Shibuya S, 2009, CELL ADHES MIGR, V3, P99, DOI 10.4161/cam.3.1.7372
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Vijayasekaran S, 2000, J BIOMAT SCI-POLYM E, V11, P599, DOI 10.1163/156856200743896
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Woerly S, 2000, NEUROSURG REV, V23, P59
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
NR 34
TC 11
Z9 12
U1 1
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2014
VL 35
IS 24
BP 6248
EP 6258
DI 10.1016/j.biomaterials.2014.04.020
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AL0GD
UT WOS:000338804500010
PM 24814425
DA 2018-10-20
ER

PT J
AU Yavari, SA
   Ahmadi, SM
   van der Stok, J
   Wauthle, R
   Riemslag, AC
   Janssen, M
   Schrooten, J
   Weinans, H
   Zadpoor, AA
AF Yavari, S. Amin
   Ahmadi, S. M.
   van der Stok, J.
   Wauthle, R.
   Riemslag, A. C.
   Janssen, M.
   Schrooten, J.
   Weinans, H.
   Zadpoor, A. A.
TI Effects of bio-functionalizing surface treatments on the mechanical
   behavior of open porous titanium biomaterials
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Titanium alloy; Open cellular materials; Chemical surface modifications;
   Fatigue; Mechanical testing; Additive manufacturing
ID BONE-GRAFT SUBSTITUTE; OPEN-CELL FOAMS; BIOMEDICAL APPLICATIONS;
   BIOACTIVE TITANIUM; IMPLANT SURFACES; CAP DEPOSITION; HEAT-TREATMENT;
   SBF SOLUTION; TI6AL4V; POROSITY
AB Bio-functionalizing surface treatments are often applied for improving the bioactivity of biomaterials that are based on otherwise bioinert titanium alloys. When applied on highly porous titanium alloy structures intended for orthopedic bone regeneration purposes, such surface treatments could significantly change the static and fatigue properties of these structures and, thus, affect the application of the biomaterial as bone substitute. Therefore, the interplay between biofunctionalizing surface treatments and mechanical behavior needs to be controlled. In this paper, we studied the effects of two bio-functionalizing surface treatments, namely alkali-acid heat treatment (AlAcH) and acid-alkali (AcAl), on the static and fatigue properties of three different highly porous titanium alloy implants manufactured using selective laser melting. It was found that AlAcH treatment results in minimal mass loss. The static and fatigue properties of AlAcH specimens were therefore not much different from as-manufactured (AsM) specimens. In contrast, AcAl resulted in substantial mass loss and also in significantly less static and fatigue properties particularly for porous structures with the highest porosity. The ratio of the static mechanical properties of AcAl specimens to that of AsM specimen was in the range of 1.5-6. The fatigue lives of AcAl specimens were much more severely affected by the applied surface treatments with fatigue lives up to 23 times smaller than that of AsM specimens particularly for the porous structures with the highest porosity. In conclusion, the fatigue properties of surface treated porous titanium are dependent not only on the type of applied surface treatment but also on the porosity of the biomaterial. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Yavari, S. Amin; Ahmadi, S. M.; Riemslag, A. C.; Janssen, M.; Weinans, H.; Zadpoor, A. A.] Delft Univ Technol, Fac Mech Maritime & Mat Engn, NL-2628 CD Delft, Netherlands.
   [Yavari, S. Amin] FT Innovat BV, NL-5831 PW Boxmeer, Netherlands.
   [van der Stok, J.] Erasmus Univ Rotterdam Med Ctr, Dept Orthoped, Orthopaed Res Lab, Rotterdam, Netherlands.
   [Wauthle, R.] Katholieke Univ Leuven, Dept Mech Engn, Sect Prod Engn Machine Design & Automat PMA, B-3001 Leuven, Belgium.
   [Wauthle, R.] LayerWise NV, Leuven, Belgium.
   [Schrooten, J.] Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Heverlee, Belgium.
   [Weinans, H.] UMC Utrecht, Dept Orthoped, NL-3584 CX Utrecht, Netherlands.
   [Weinans, H.] UMC Utrecht, Dept Rheumatol, NL-3584 CX Utrecht, Netherlands.
RP Yavari, SA (reprint author), Delft Univ Technol, Fac Mech Maritime & Mat Engn, Mekelweg 2, NL-2628 CD Delft, Netherlands.
EM s.aminyavari@tudelft.nl
RI Amin Yavari, Saber/E-5360-2017; Amin Yavari, Saber/G-9486-2013; Zadpoor,
   Amir A/A-8510-2008
OI Amin Yavari, Saber/0000-0003-1677-5751; Amin Yavari,
   Saber/0000-0003-1677-5751; Zadpoor, Amir Abbas/0000-0003-3234-2112
CR Balasundaram G, 2006, J MATER CHEM, V16, P3737, DOI 10.1039/b604966b
   Bertheville B, 2006, BIOMATERIALS, V27, P1246, DOI 10.1016/j.biomaterials.2005.09.014
   Campoli G, 2013, MATER DESIGN, V49, P957, DOI 10.1016/j.matdes.2013.01.071
   Campoli G, 2012, J MECH BEHAV BIOMED, V10, P108, DOI 10.1016/j.jmbbm.2012.02.011
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Ehrenfest DMD, 2010, TRENDS BIOTECHNOL, V28, P198, DOI 10.1016/j.tibtech.2009.12.003
   Giannatsis J, 2009, INT J ADV MANUF TECH, V40, P116, DOI 10.1007/s00170-007-1308-1
   Gilbert R., 1991, ASM HDB, V4
   Habijan T, 2013, MAT SCI ENG C-MATER, V33, P419, DOI 10.1016/j.msec.2012.09.008
   Heinl P, 2008, ADV ENG MATER, V10, P882, DOI 10.1002/adem.200800137
   Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013
   Imwinkelried T, 2007, J BIOMED MATER RES A, V81A, P964, DOI 10.1002/jbm.a.31118
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   Kruzic JJ, 2009, J MECH BEHAV BIOMED, V2, P384, DOI 10.1016/j.jmbbm.2008.10.008
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Laptev A, 2004, POWDER METALL, V47, P85, DOI 10.1179/003258904225015536
   Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   MORONI A, 1994, BIOMATERIALS, V15, P926, DOI 10.1016/0142-9612(94)90119-8
   Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219
   Murr LE, 2011, J MECH BEHAV BIOMED, V4, P1396, DOI 10.1016/j.jmbbm.2011.05.010
   Murr LE, 2010, PHILOS T R SOC A, V368, P1999, DOI 10.1098/rsta.2010.0010
   Narayanan R, 2008, J BIOMED MATER RES B, V85B, P279, DOI 10.1002/jbm.b.30932
   Parthasarathy J., 2011, J MANUF PROCESS, V13, P160, DOI DOI 10.1016/J.JMAPR0.2011.01.004
   Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006
   Pyka G, 2013, MATERIALS, V6, P4737, DOI 10.3390/ma6104737
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Takemoto M, 2006, BIOMATERIALS, V27, P2682, DOI 10.1016/j.biomaterials.2005.12.014
   Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   Tavangar A, 2011, ACTA BIOMATER, V7, P2726, DOI 10.1016/j.actbio.2011.02.020
   Turkan U, 2010, SURF COAT TECH, V205, P1904, DOI 10.1016/j.surfcoat.2010.08.071
   Turkan U, 2010, CERAM INT, V36, P1805, DOI 10.1016/j.ceramint.2010.03.030
   van der Stok J, 2013, TISSUE ENG PT A, V19, P2605, DOI [10.1089/ten.tea.2013.0181, 10.1089/ten.TEA.2013.0181]
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   Vandenbroucke B, 2007, RAPID PROTOTYPING J, V13, P196, DOI 10.1108/13552540710776142
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   Variola F, 2008, BIOMATERIALS, V29, P1285, DOI 10.1016/j.biomaterials.2007.11.040
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Variola F, 2009, SMALL, V5, P996, DOI 10.1002/smll.200801186
   Wang H., 2011, TISSUE ENG PART B-RE, V18, P24
   Xiong JY, 2008, ACTA BIOMATER, V4, P1963, DOI 10.1016/j.actbio.2008.04.022
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yavari SA, 2014, APPL SURF SCI, V290, P287, DOI 10.1016/j.apsusc.2013.11.069
   Yavari SA, 2013, MAT SCI ENG C-MATER, V33, P4849, DOI 10.1016/j.msec.2013.08.006
   Zadpoor AA, 2013, APPL MATH MODEL, V37, P5260, DOI 10.1016/j.apm.2012.10.049
   Zhao CY, 2010, MAT SCI ENG C-MATER, V30, P98, DOI 10.1016/j.msec.2009.09.004
   Zhao CY, 2010, J BIOMED MATER RES B, V95B, P387, DOI 10.1002/jbm.b.31728
   Zhao G, 2006, CLIN ORAL IMPLAN RES, V17, P258, DOI 10.1111/j.1600-0501.2005.01195.x
   Zhao XB, 2005, J BIOMED MATER RES A, V75A, P888, DOI 10.1002/jbm.a.30485
NR 53
TC 49
Z9 50
U1 2
U2 82
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD AUG
PY 2014
VL 36
BP 109
EP 119
DI 10.1016/j.jmbbm.2014.04.010
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AK7JY
UT WOS:000338605800011
PM 24831611
DA 2018-10-20
ER

PT J
AU Felice, B
   Prabhakaran, MP
   Rodriguez, AP
   Ramakrishna, S
AF Felice, Betiana
   Prabhakaran, Molamma P.
   Rodriguez, Andrea P.
   Ramakrishna, Seeram
TI Drug delivery vehicles on a nano-engineering perspective
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Review
DE Liposomes; biodegradable polymers; cancer; nanotechnology; targeted drug
   delivery; controlled release
ID BIODEGRADABLE POLYMERIC MICELLES; SERUM-ALBUMIN NANOPARTICLES; SMALL
   UNILAMELLAR LIPOSOMES; LIPID-BASED NANOPARTICLES; PROSTATE-CANCER CELLS;
   ACID) BLOCK-COPOLYMER; NON-HODGKINS-LYMPHOMA; IN-VIVO DELIVERY;
   POLY(ETHYLENE GLYCOL); MONOCLONAL-ANTIBODY
AB Nanoengineered drug delivery systems (nDDS) have been successfully used as clinical tools for not only modulation of pharmacological drug release profile but also specific targeting of diseased tissues. Until now, encapsulation of anti-cancer molecules such as paclitaxel, vincristin and doxorubicin has been the main target of nDDS, whereby liposomes and polymer-drug conjugates remained as the most popular group of nDDS used for this purpose. The success reached by these nanocarriers can be imitated by careful selection and optimization of the different factors that affect drug release profile (i.e. type of biomaterial, size, system architecture, and biodegradability mechanisms) along with the selection of an appropriate manufacture technique that does not compromise the desired release profile, while it also offers possibilities to scale up for future industrialization. This review focuses from an engineering perspective on the different parameters that should be considered before and during the design of new nDDS, and the different manufacturing techniques available, in such a way to ensure success in clinical application. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Felice, Betiana; Rodriguez, Andrea P.] Univ Nacl Tucuman, Labo Medios & Interfases, Dept Bioingn, RA-4000 San Miguel De Tucuman, Tucuman, Argentina.
   [Felice, Betiana; Rodriguez, Andrea P.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.
   [Felice, Betiana; Prabhakaran, Molamma P.; Ramakrishna, Seeram] Natl Univ Singapore, START Thrust 3, Singapore 138602, Singapore.
   [Ramakrishna, Seeram] Natl Univ Singapore, Dept Mech Engn, Singapore 138602, Singapore.
RP Prabhakaran, MP (reprint author), Natl Univ Singapore, START Thrust 3, Create Res Wing 03-08,1 Create Way, Singapore 138602, Singapore.
EM nnimpp@nus.edu.sg
FU Singapore National Research Foundation under CREATE programme: The
   Regenerative Medicine Initiative in Cardiac Restoration Therapy
   [R-398-001-065-592]; Nanoscience and Nanotechnology Initiative, Faculty
   of Engineering, National University of Singapore, Singapore
FX This study is supported by the Singapore National Research Foundation
   under CREATE programme: The Regenerative Medicine Initiative in Cardiac
   Restoration Therapy (Grant number: R-398-001-065-592) and the
   Nanoscience and Nanotechnology Initiative, Faculty of Engineering,
   National University of Singapore, Singapore
CR Acharya S, 2011, ADV DRUG DELIVER REV, V63, P170, DOI 10.1016/j.addr.2010.10.008
   Adler-Moore J, 2002, J ANTIMICROB CHEMOTH, V49, P21, DOI 10.1093/jac/49.suppl_1.21
   Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009
   Alam Masroor, 2005, Pain Pract, V5, P349, DOI 10.1111/j.1533-2500.2005.00048.x
   Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m
   Alhareth K, 2012, J CHROMATOGR B, V887, P128, DOI 10.1016/j.jchromb.2012.01.025
   Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037
   Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903
   Alley SC, 2010, CURR OPIN CHEM BIOL, V14, P529, DOI 10.1016/j.cbpa.2010.06.170
   Alvarez-Lorenzo C, 2009, PHOTOCHEM PHOTOBIOL, V85, P848, DOI 10.1111/j.1751-1097.2008.00530.x
   Andreas K, 2011, ACTA BIOMATER, V7, P1485, DOI 10.1016/j.actbio.2010.12.014
   Arias J.L., 2013, EXPERT OPIN THER PAT, V23, P1
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Aubert-Pouessel A, 2004, J CONTROL RELEASE, V95, P463, DOI 10.1016/j.jconrel.2003.12.012
   Babin J, 2009, ANGEW CHEM INT EDIT, V48, P3329, DOI 10.1002/anie.200900255
   BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6
   Bawa P, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/022001
   Bax BE, 2000, BRIT J HAEMATOL, V109, P549, DOI 10.1046/j.1365-2141.2000.02059.x
   Belliveau NM, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.28
   Benesch M, 2008, EXPERT OPIN PHARMACO, V9, P301, DOI [10.1517/14656566.9.2.301, 10.1517/14656566.9.2.301 ]
   Bhatta RS, 2012, INT J PHARMACEUT, V432, P105, DOI 10.1016/j.ijpharm.2012.04.060
   Bock N, 2012, PROG POLYM SCI, V37, P1510, DOI 10.1016/j.progpolymsci.2012.03.002
   Boehlke L, 2006, EXPERT OPIN BIOL TH, V6, P409, DOI 10.1517/14712598.6.4.409
   Boisseau P, 2011, CR PHYS, V12, P620, DOI 10.1016/j.crhy.2011.06.001
   Bolotin Elijah M., 1994, Journal of Liposome Research, V4, P455, DOI 10.3109/08982109409037057
   Bressler NM, 2000, INVEST OPHTH VIS SCI, V41, P624
   Brown SD, 2010, J AM CHEM SOC, V132, P4678, DOI 10.1021/ja908117a
   Buse J, 2010, NANOMEDICINE-UK, V5, P1237, DOI 10.2217/NNM.10.107
   Canal F, 2011, CURR OPIN BIOTECH, V22, P894, DOI 10.1016/j.copbio.2011.06.003
   Ceht B., 1995, LANGMUIR, V11, P3356
   Chalasani KB, 2007, J CONTROL RELEASE, V122, P141, DOI 10.1016/j.jconrel.2007.05.019
   Chen HB, 2011, DRUG DISCOV TODAY, V16, P354, DOI 10.1016/j.drudis.2010.02.009
   Cheng R, 2013, BIOMATERIALS, V34, P3647, DOI 10.1016/j.biomaterials.2013.01.084
   Cho EJ, 2002, APPL SPECTROSC, V56, P1385, DOI 10.1366/00037020260377661
   Cho EC, 2009, MAT SCI ENG C-BIO S, V29, P774, DOI 10.1016/j.msec.2008.07.014
   Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI [10.1038/nbt1340, 10.1038/nbtl340]
   Chowdhery R, 2011, IMMUNOTHERAPY-UK, V3, P17, DOI 10.2217/IMT.10.89
   Cirstoiu-Hapca A, 2007, INT J PHARM, V331, P190, DOI 10.1016/j.ijpharm.2006.12.002
   CULLIS P R, 1989, Advanced Drug Delivery Reviews, V3, P267, DOI 10.1016/0169-409X(89)90024-0
   D'Souza AJM, 2004, J PHARM SCI-US, V93, P1962, DOI 10.1002/jps.20096
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Dass CR, 2004, J MOL MED, V82, P579, DOI 10.1007/s00109-004-0558-8
   de la Rica R, 2012, ADV DRUG DELIVER REV, V64, P967, DOI 10.1016/j.addr.2012.01.002
   Deckert J., 2013, BLOOD, V322, P3500
   DEMEL RA, 1968, BIOCHIM BIOPHYS ACTA, V150, P655, DOI 10.1016/0005-2736(68)90055-2
   Desai I.N., 2007, DRUG DELIVERY REPORT
   Desgouilles S, 2003, LANGMUIR, V19, P9504, DOI 10.1021/la034999q
   DeSimone J.M., 2004, METHODS FABRICATING
   Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105
   DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1
   Dinndorf PA, 2007, ONCOLOGIST, V12, P991, DOI 10.1634/theoncologist.12-8-991
   Dos Santos N, 2004, BBA-BIOMEMBRANES, V1661, P47, DOI 10.1016/j.bbamem.2003.11.016
   Dosio F, 2001, J CONTROL RELEASE, V76, P107, DOI 10.1016/S0168-3659(01)00420-5
   Duncan B, 2010, J CONTROL RELEASE, V148, P122, DOI 10.1016/j.jconrel.2010.06.004
   Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958
   Eifler AC, 2011, METHODS MOL BIOL, V726, P325, DOI 10.1007/978-1-61779-052-2_21
   Ensign LM, 2012, ADV DRUG DELIVER REV, V64, P557, DOI 10.1016/j.addr.2011.12.009
   Etheridge ML, 2013, NANOMED-NANOTECHNOL, V9, P1, DOI 10.1016/j.nano.2012.05.013
   Faisant N, 2002, EUR J PHARM SCI, V15, P355, DOI 10.1016/S0928-0987(02)00023-4
   Fan YC, 2013, ASIAN J PHARM SCI, V8, P81, DOI 10.1016/j.ajps.2013.07.010
   Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550
   FOLKMAN J, 1990, BIOMATERIALS, V11, P615, DOI 10.1016/0142-9612(90)90017-K
   Fomina N, 2012, ADV DRUG DELIVER REV, V64, P1005, DOI 10.1016/j.addr.2012.02.006
   Forsgren J, 2010, J PHARM SCI-US, V99, P219, DOI 10.1002/jps.21814
   Frampton JE, 2008, DRUGS, V68, P839, DOI 10.2165/00003495-200868060-00007
   Fritze A, 2006, BBA-BIOMEMBRANES, V1758, P1633, DOI 10.1016/j.bbamem.2006.05.028
   Froudarakis ME, 2008, CANCER, V113, P2752, DOI 10.1002/cncr.23921
   Fu CH, 2007, EXPERT OPIN PHARMACO, V8, P1977, DOI 10.1517/14656566.8.12.1977
   Fu Q, 2009, RECENT PAT ANTI-CANC, V4, P262, DOI 10.2174/157489209789206869
   GABIZON A, 1994, CANCER RES, V54, P987
   GABIZON A, 1983, CANCER RES, V43, P4730
   Gelmon KA, 1999, J CLIN ONCOL, V17, P697, DOI 10.1200/JCO.1999.17.2.697
   Gillies ER, 2005, DRUG DISCOV TODAY, V10, P35, DOI 10.1016/S1359-6446(04)03276-3
   Goldsmith SJ, 2010, SEMIN NUCL MED, V40, P122, DOI 10.1053/j.semnuclmed.2009.11.002
   Gomez A, 1998, J AEROSOL SCI, V29, P561, DOI 10.1016/S0021-8502(97)10031-3
   Gopferich A, 1997, MACROMOLECULES, V30, P2598, DOI 10.1021/ma961627y
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Grabnar PA, 2011, J MICROENCAPSUL, V28, P323, DOI 10.3109/02652048.2011.569763
   Green MR, 2006, ANN ONCOL, V17, P1263, DOI 10.1093/annonc/mdl104
   Grull H, 2012, J CONTROL RELEASE, V161, P317, DOI 10.1016/j.jconrel.2012.04.041
   Grund S., 2011, ADV ENG, V13, P61
   Ha CS, 2005, CHEM REV, V105, P4205, DOI 10.1021/cr040419y
   Hamann PR, 2002, BIOCONJUGATE CHEM, V13, P47, DOI 10.1021/bc010021y
   Hao SL, 2013, MAT SCI ENG C-MATER, V33, P4562, DOI 10.1016/j.msec.2013.07.009
   Harashima H, 1995, J DRUG TARGET, V3, P253, DOI 10.3109/10611869509015954
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Harrison TS, 2004, CNS DRUGS, V18, P113
   Hasan AS, 2007, INT J PHARMACEUT, V344, P53, DOI 10.1016/j.ijpharm.2007.05.066
   Hayashi K, 2010, ACS APPL MATER INTER, V2, P1903, DOI 10.1021/am100237p
   He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065
   Heukers R, 2014, BIOMATERIALS, V35, P601, DOI 10.1016/j.biomaterials.2013.10.001
   Hiratsuka T, 2008, MACROMOL BIOSCI, V8, P231, DOI 10.1002/mabi.200700157
   Hoffman AS, 2013, ADV DRUG DELIVER REV, V65, P10, DOI 10.1016/j.addr.2012.11.004
   Hoffman AS, 2008, J CONTROL RELEASE, V132, P153, DOI 10.1016/j.jconrel.2008.08.012
   Hofheinz RD, 2005, ANTI-CANCER DRUG, V16, P691, DOI 10.1097/01.cad.0000167902.53039.5a
   Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6
   Huang YY, 1999, INT J PHARM, V182, P93, DOI 10.1016/S0378-5173(99)00060-5
   Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009
   Husseini GA, 2008, ADV DRUG DELIVER REV, V60, P1137, DOI 10.1016/j.addr.2008.03.008
   Igarashi E, 2008, TOXICOL APPL PHARM, V229, P121, DOI 10.1016/j.taap.2008.02.007
   Jackson TL, 2003, J THEOR BIOL, V220, P201, DOI 10.1006/jtbi.2003.3156
   Jager E, 2012, SOFT MATTER, V8, P9563, DOI 10.1039/c2sm26150b
   Jain D. S., 2013, BIOMED AGING PATHOL, V3, P201
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   Jesorka A, 2008, ANNU REV ANAL CHEM, V1, P801, DOI 10.1146/annurev.anchem.1.031207.112747
   Julien DC, 2011, MABS-AUSTIN, V3, P467, DOI 10.4161/mabs.3.5.16089
   Kaitin KI, 2010, CLIN PHARMACOL THER, V87, P356, DOI 10.1038/clpt.2009.293
   Kan P., 2011, J DRUG DELIV, V2011
   Karnik R, 2008, NANO LETT, V8, P2906, DOI 10.1021/nl801736q
   KAYE SB, 1979, CANCER CHEMOTH PHARM, V3, P81
   Keating M J, 1993, Leuk Lymphoma, V10 Suppl, P153, DOI 10.3109/10428199309149129
   Kim DH, 2006, BIOMATERIALS, V27, P3031, DOI 10.1016/j.biomaterials.2005.12.021
   Kim S, 2009, EUR J PHARM BIOPHARM, V71, P420, DOI 10.1016/j.ejpb.2008.09.021
   Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655
   KIRBY C, 1980, BIOCHEM J, V186, P591, DOI 10.1042/bj1860591
   Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199
   Kiss E, 2002, J COLLOID INTERF SCI, V245, P91, DOI 10.1006/jcis.2001.7954
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Kocbek P, 2007, J CONTROL RELEASE, V120, P18, DOI 10.1016/j.jconrel.2007.03.012
   Kolishetti N, 2010, P NATL ACAD SCI USA, V107, P17939, DOI 10.1073/pnas.1011368107
   Korth-Bradley JM, 2001, PHARMACOTHERAPY, V21, P1175, DOI 10.1592/phco.21.15.1175.33890
   Kost J, 2012, ADV DRUG DELIVER REV, V64, P327, DOI 10.1016/j.addr.2012.09.014
   Kouchakzadeh H, 2013, INT J PHARMACEUT, V447, P62, DOI 10.1016/j.ijpharm.2013.02.043
   Kumar A, 1998, BIOTECHNOL BIOENG, V59, P695, DOI 10.1002/(SICI)1097-0290(19980920)59:6<695::AID-BIT6>3.0.CO;2-A
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Kwon HY, 2001, COLLOID SURFACE A, V182, P123, DOI 10.1016/S0927-7757(00)00825-6
   Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002
   Lammers T, 2012, J CONTROL RELEASE, V161, P175, DOI 10.1016/j.jconrel.2011.09.063
   Lee H, 2007, MOL PHARM, V4, P769, DOI 10.1021/mp0700559
   Lemoine D, 1998, J CONTROL RELEASE, V54, P15, DOI 10.1016/S0168-3659(97)00241-1
   Li SD, 2010, J CONTROL RELEASE, V145, P178, DOI 10.1016/j.jconrel.2010.03.016
   Li WJ, 2007, PHARM RES, V24, P438, DOI 10.1007/s11095-006-9180-5
   Liu G, 2013, POLYM CHEM-UK, V4, P3431, DOI 10.1039/c3py21121e
   Liu Z, 2008, CANCER RES, V68, P6652, DOI 10.1158/0008-5472.CAN-08-1468
   Locatelli F, 2013, EXPERT OPIN PHARMACO, V14, P1277, DOI 10.1517/14656566.2013.799139
   Lu YM, 2014, BIOMATERIALS, V35, P530, DOI 10.1016/j.biomaterials.2013.09.093
   Lyass O, 2000, CANCER, V89, P1037, DOI 10.1002/1097-0142(20000901)89:5<1037::AID-CNCR13>3.0.CO;2-Z
   MacEwan SR, 2010, NANOMEDICINE-UK, V5, P793, DOI 10.2217/NNM.10.50
   Madani SY, 2011, INT J NANOMED, V6, P2963, DOI 10.2147/IJN.S16923
   Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   Maeng JH, 2010, BIOMATERIALS, V31, P4995, DOI 10.1016/j.biomaterials.2010.02.068
   Mahajan S, 2010, CURR NANOSCI, V6, P413, DOI 10.2174/157341310791658928
   Mahapatro A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-55
   Miele E, 2009, INT J NANOMED, V4, P99
   Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6
   Mohammed AR, 2004, INT J PHARM, V285, P23, DOI 10.1016/j.ijpharm.2004.07.010
   Morille M, 2010, BIOMATERIALS, V31, P321, DOI 10.1016/j.biomaterials.2009.09.044
   Muller HJ, 2000, BRIT J HAEMATOL, V110, P379, DOI 10.1046/j.1365-2141.2000.02187.x
   Munier S, 2005, COLLOID SURFACE B, V43, P163, DOI 10.1016/j.colsurfb.2005.05.001
   Mylonakis N, 2010, LUNG CANCER, V68, P240, DOI 10.1016/j.lungcan.2009.06.017
   Nagavarma B.V.N., 2012, ASIAN J PHARM CLIN R, V5, P16
   Nagpal K, 2010, CHEM PHARM BULL, V58, P1423, DOI 10.1248/cpb.58.1423
   Nakayama M, 2006, J CONTROL RELEASE, V115, P46, DOI 10.1016/j.jconrel.2006.07.007
   Ninomiya K, 2014, ULTRASON SONOCHEM, V21, P310, DOI 10.1016/j.ultsonch.2013.07.014
   Nyman D.W., 2005, J CLIN ONCOL, V23, P7775
   Oerlemans C, 2010, PHARM RES-DORDR, V27, P2569, DOI 10.1007/s11095-010-0233-4
   OKADA H, 1994, PHARMACEUT RES, V11, P1143, DOI 10.1023/A:1018936815654
   OKADA H, 1991, PHARMACEUT RES, V8, P787, DOI 10.1023/A:1015818504906
   Osada K, 2009, J R SOC INTERFACE, V6, pS325, DOI 10.1098/rsif.2008.0547.focus
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   Pancholi K, 2009, J MATER SCI-MATER M, V20, P917, DOI 10.1007/s10856-008-3638-4
   Pareta R, 2006, J R SOC INTERFACE, V3, P573, DOI 10.1098/rsif.2006.0120
   Park J, 2009, NANOMED-NANOTECHNOL, V5, P410, DOI 10.1016/j.nano.2009.02.002
   Peracchia MT, 1999, J CONTROL RELEASE, V60, P121, DOI 10.1016/S0168-3659(99)00063-2
   Pitt William G, 2004, Expert Opin Drug Deliv, V1, P37, DOI 10.1517/17425247.1.1.37
   Pollaro L, 2010, MEDCHEMCOMM, V1, P319, DOI 10.1039/c0md00111b
   Poon RTP, 2009, EXPERT OPIN PHARMACO, V10, P333, DOI [10.1517/14656560802677874, 10.1517/14656560802677874 ]
   POUTON CW, 1985, INT J PHARM, V27, P335, DOI 10.1016/0378-5173(85)90081-X
   Pratt G, 1998, HEMATOL ONCOL, V16, P47, DOI 10.1002/(SICI)1099-1069(199806)16:2<47::AID-HON622>3.3.CO;2-V
   Puri A, 2009, CRIT REV THER DRUG, V26, P523, DOI 10.1615/CritRevTherDrugCarrierSyst.v26.i6.10
   Rihova B, 1996, ADV DRUG DELIVER REV, V21, P157
   Roberts MJ, 2012, ADV DRUG DELIVER REV, V64, P116, DOI 10.1016/j.addr.2012.09.025
   Rosenholm JM, 2010, NANOSCALE, V2, P1870, DOI 10.1039/c0nr00156b
   Roser M, 1998, EUR J PHARM BIOPHARM, V46, P255, DOI 10.1016/S0939-6411(98)00038-1
   Sajeesh S, 2006, INT J PHARM, V325, P147, DOI 10.1016/j.ijpharm.2006.06.019
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Schreiber S, 2007, NEW ENGL J MED, V357, P239, DOI 10.1056/NEJMoa062897
   Schroeder A, 2007, LANGMUIR, V23, P4019, DOI 10.1021/la0631668
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   SENIOR J, 1982, LIFE SCI, V30, P2123, DOI 10.1016/0024-3205(82)90455-6
   Sharma A, 1997, INT J PHARM, V154, P123, DOI 10.1016/S0378-5173(97)00135-X
   Shen YQ, 2008, AICHE J, V54, P2979, DOI 10.1002/aic.11600
   Sherman MR, 2008, ADV DRUG DELIVER REV, V60, P59, DOI 10.1016/j.addr.2007.06.011
   Shimomura M, 2001, CURR OPIN COLLOID IN, V6, P11, DOI 10.1016/S1359-0294(00)00081-9
   Shum HC, 2008, J AM CHEM SOC, V130, P9543, DOI 10.1021/ja802157y
   Silverman JA, 2013, CANCER CHEMOTH PHARM, V71, P555, DOI 10.1007/s00280-012-2042-4
   Singer JW, 2005, J CONTROL RELEASE, V109, P120, DOI 10.1016/j.jconrel.2005.09.033
   Singla AK, 2002, INT J PHARM, V235, P179, DOI 10.1016/S0378-5173(01)00986-3
   Stopeck AT, 2001, CLIN CANCER RES, V7, P2285
   Sukhorukov GB, 2005, SMALL, V1, P194, DOI 10.1002/smll.200400075
   Sun L., 2013, POLYM CHEM
   Swenson CE, 2001, BREAST, V10, P1, DOI 10.1016/S0960-9776(01)80001-1
   Ta T, 2013, J CONTROL RELEASE, V169, P112, DOI 10.1016/j.jconrel.2013.03.036
   Tagami T, 2011, J CONTROL RELEASE, V154, P290, DOI 10.1016/j.jconrel.2011.05.020
   Tan I., 2009, ACS APPL MATER INTER, V1, P1869
   Tarahovsky YS, 2010, BIOCHEMISTRY-MOSCOW+, V75, P811, DOI 10.1134/S0006297910070023
   Tayebi L, 2012, CHEMPHYSCHEM, V13, P314, DOI 10.1002/cphc.201100573
   Tazina EV, 2011, PHARM CHEM J+, V45, P481, DOI 10.1007/s11094-011-0661-4
   Torchilin V, 2009, EUR J PHARM BIOPHARM, V71, P431, DOI 10.1016/j.ejpb.2008.09.026
   Valencia PM, 2012, NAT NANOTECHNOL, V7, P623, DOI 10.1038/nnano.2012.168
   Valo H, 2009, SMALL, V5, P1791, DOI 10.1002/smll.200801907
   van Swaay D, 2013, LAB CHIP, V13, P752, DOI 10.1039/c2lc41121k
   Veiseh O, 2010, ADV DRUG DELIVER REV, V62, P284, DOI 10.1016/j.addr.2009.11.002
   Vemuri S, 1995, Pharm Acta Helv, V70, P95, DOI 10.1016/0031-6865(95)00010-7
   Venugopal J, 2008, CURR PHARM DESIGN, V14, P2184, DOI 10.2174/138161208785740180
   Venugopal J, 2009, CURR PHARM DESIGN, V15, P1799, DOI 10.2174/138161209788186344
   Verma R. K., 2001, PHARM TECH, V25, P1
   Vermehren C, 1999, INT J PHARM, V183, P13, DOI 10.1016/S0378-5173(99)00051-4
   Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0
   von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9
   Vose JM, 2004, ONCOLOGIST, V9, P160, DOI 10.1634/theoncologist.9-2-160
   Wacker M, 2013, INT J PHARMACEUT, V457, P50, DOI 10.1016/j.ijpharm.2013.08.079
   Wang JJ, 2011, INT J NANOMED, V6, P765, DOI 10.2147/IJN.S17296
   Wang LN, 2012, BIOMATERIALS, V33, P5107, DOI 10.1016/j.biomaterials.2012.03.067
   Wang YS, 2002, ADV DRUG DELIVER REV, V54, P547, DOI 10.1016/S0169-409X(02)00027-3
   Wang Z, 2010, BIOMATERIALS, V31, P7115, DOI 10.1016/j.biomaterials.2010.05.075
   Wartlick H, 2004, J CONTROL RELEASE, V96, P483, DOI 10.1016/j.jconrel.2004.01.029
   Waterhouse Dawn N., 2001, Drug Safety, V24, P903, DOI 10.2165/00002018-200124120-00004
   Weiner A L, 1994, Immunomethods, V4, P201, DOI 10.1006/immu.1994.1021
   Wen H, 2013, EUR J PHARM BIOPHARM, V84, P91, DOI 10.1016/j.ejpb.2012.11.019
   Wiseman G.A., 1999, CLIN CANCER RES, V5, P3281
   Wiseman GA, 2001, CRIT REV ONCOL HEMAT, V39, P181, DOI 10.1016/S1040-8428(01)00107-X
   Xie JW, 2008, J COLLOID INTERF SCI, V317, P469, DOI 10.1016/j.jcis.2007.09.082
   Xie JW, 2006, BIOMATERIALS, V27, P3321, DOI 10.1016/j.biomaterials.2006.01.034
   Xin HL, 2010, INT J PHARMACEUT, V402, P238, DOI 10.1016/j.ijpharm.2010.10.005
   Xu XY, 2009, POLYM ADVAN TECHNOL, V20, P843, DOI 10.1002/pat.1341
   YAMAOKA T, 1994, J PHARM SCI, V83, P601, DOI 10.1002/jps.2600830432
   Yeo Y, 2004, ARCH PHARM RES, V27, P1, DOI 10.1007/BF02980037
   YOKOYAMA M, 1990, J CONTROL RELEASE, V11, P269
   Yoo HS, 2001, J CONTROL RELEASE, V70, P63, DOI 10.1016/S0168-3659(00)00340-0
   Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499
   Zamani M, 2013, INT J NANOMED, V8, P2997, DOI 10.2147/IJN.S43575
   Zhang Y, 2013, ADV DRUG DELIVER REV, V65, P104, DOI 10.1016/j.addr.2012.10.003
   Zhigaltsev I.V., 2005, J CONTROL RELEASE, V104, P103
NR 235
TC 69
Z9 69
U1 9
U2 170
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2014
VL 41
BP 178
EP 195
DI 10.1016/j.msec.2014.04.049
PG 18
WC Materials Science, Biomaterials
SC Materials Science
GA AK7KH
UT WOS:000338606700022
PM 24907751
DA 2018-10-20
ER

PT J
AU Calasans-Maia, M
   Calasans-Maia, J
   Santos, S
   Mavropoulos, E
   Farina, M
   Lima, I
   Lopes, RT
   Rossi, A
   Granjeiro, JM
AF Calasans-Maia, Monica
   Calasans-Maia, Jose
   Santos, Silvia
   Mavropoulos, Elena
   Farina, Marcos
   Lima, Inaya
   Lopes, Ricardo Tadeu
   Rossi, Alexandre
   Granjeiro, Jose Mauro
TI Short-term in vivo evaluation of zinc-containing calcium phosphate using
   a normalized procedure
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydroxyapatite; Zinc; Synthesis; Biocompatibility; Physico-chemical
   characterization
ID SUBSTITUTED HYDROXYAPATITE; BONE-FORMATION; OSSEOUS REPAIR; RABBIT
   FEMORA; HYDROXYLAPATITE; BIOCOMPATIBILITY; BIOMATERIAL; INTENSITIES;
   CERAMICS; DIVALENT
AB The effect of zinc-substituted calcium phosphate (CaP) on bone osteogenesis was evaluated using an in vivo normalized ISO 10993-6 protocol. Zinc-containing hydroxyapatite (ZnHA) powder with 0.3% by wt zinc (experimental group) and stoichiometric hydroxyapatite (control group) were shaped into cylindrical implants (2 x 6 mm) and were sintered at 1000 degrees C Thermal treatment transformed the ZnHA cylinder into a biphasic implant that was composed of Zn-substituted HA and Zn-substituted beta-tricalcium phosphate (ZnHA/beta ZnTCP); the hydroxyapatite cylinder was a highly crystalline and poorly soluble HA implant. In vivo tests were performed in New Zealand White rabbits by implanting two cylinders of ZnHA/beta ZnTCP in the left tibia and two cylinders of HA in the right tibia for 7, 14 and 28 days. Incorporation of 0.3% by wt zinc into CaP increased the rate of Zn release to the biological medium. Microfluorescence analyses (mu XRF-SR) using synchrotron radiation suggested that some of the Zn released from the biomaterial was incorporated into new bone near the implanted region. In contrast with previous studies, histomorphometric analysis did not show significant differences between the newly formed bone around ZnHA/beta ZnTCP and HA due to the dissolution profile of Zn-doped CaP. Despite the great potential of Zn-containing CaP matrices for future use in bone regeneration, additional in vivo studies must be conducted to explain the mobility of zinc at the CaP surface and its interactions with a biological medium. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Calasans-Maia, Monica; Calasans-Maia, Jose; Granjeiro, Jose Mauro] Univ Fed Fluminense, Dent Clin Res Ctr, Sch Dent, Rio De Janeiro, Brazil.
   [Santos, Silvia; Mavropoulos, Elena; Rossi, Alexandre] CBPF, LABIOMAT, Brazilian Ctr Phys Res, Rio De Janeiro, Brazil.
   [Farina, Marcos] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Lima, Inaya; Lopes, Ricardo Tadeu] Univ Fed Rio de Janeiro, COPPE, Nucl Instrumentat Lab, Nucl Engn Program, BR-21945 Rio De Janeiro, Brazil.
   [Granjeiro, Jose Mauro] Natl Inst Metrol Qual & Technol, Bioengn Div, Rio De Janeiro, Brazil.
RP Calasans-Maia, M (reprint author), Av Rui Barbosa 582-501, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM monicacalasansmaia@gmail.com; josecalasans@gmail.com;
   silviaquimica@gmail.com; elena@cbpf.br; mfarina@anato.ufrj.br;
   inayacorrea@gmail.com; rossi@cbpf.br; jmgranjeiro@gmail.com
RI Farina, Marcos/I-3744-2014; Calasans-Maia, Monica/G-6203-2013;
   Calasans-Maia, Jose/G-5270-2013
OI Granjeiro, Jose/0000-0002-8027-8293
FU LNLS; COPPE; Faperj [E-26/102.729/2008]; CNPq [303770/2007-4]; Finep
   [01.11.0090.00]
FX The authors acknowledge the support from LNLS and COPPE and financial
   support from Faperj (E-26/102.729/2008), CNPq (303770/2007-4) and Finep
   (01.11.0090.00).
CR BALMAIN N, 1982, CALCIFIED TISSUE INT, V34, pS93
   BIGI A, 1995, J INORG BIOCHEM, V58, P49, DOI 10.1016/0162-0134(94)00036-A
   BRANDAONETO J, 1995, NUTR RES, V15, P335, DOI 10.1016/0271-5317(95)00003-8
   Calasans-Maia M, 2008, KEY ENG MATER, V361-363, P1273, DOI 10.4028/www.scientific.net/KEM.361-363.1273
   Calasans-Maia M, 2008, KEY ENG MATER, V361-363, P1269, DOI 10.4028/www.scientific.net/KEM.361-363.1269
   Calasans-Maia MD, 2009, ACTA CIR BRAS, V24, P325, DOI 10.1590/S0102-86502009000400014
   Chappell H, 2009, KEY ENG MATER, V396-398, P729, DOI 10.4028/www.scientific.net/KEM.396-398.729
   Costa AM, 2004, KEY ENG MAT, V254-2, P119, DOI 10.4028/www.scientific.net/KEM.254-256.119
   de Lima IR, 2011, J BIOMED MATER RES A, V98A, P351, DOI 10.1002/jbm.a.33126
   DEBOER DKG, 1990, X-RAY SPECTROM, V19, P145, DOI 10.1002/xrs.1300190312
   Eid K, 2001, J ORTHOPAED RES, V19, P962, DOI 10.1016/S0736-0266(00)00080-2
   Grandjean-Laquerrier A, 2006, BIOMATERIALS, V27, P3195, DOI 10.1016/j.biomaterial.2006.01.024
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   International Organization for Standardization, 1992, 109936 ISO
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   Kawamura H, 2003, J BIOMED MATER RES A, V65A, P468, DOI 10.1002/jbm.a.10524
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y
   Li X, 2009, MAT SCI ENG C-BIO S, V29, P969, DOI 10.1016/j.msec.2008.08.021
   Luo X., 2013, ACTA BIOMATER
   Nascimento L., 2012, Key Engineering Materials, V493-494, P252, DOI 10.4028/www.scientific.net/KEM.493-494.252
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Resende RFB, 2013, J MATER SCI-MATER M, V24, P1455, DOI 10.1007/s10856-013-4865-x
   Shepherd D, 2008, KEY ENG MATER, V361-363, P159, DOI 10.4028/www.scientific.net/KEM.361-363.159
   Shi XC, 2008, KEY ENG MAT, V361-363, P139, DOI 10.4028/www.scientific.net/KEM.361-363.139
   SHIRAIWA T, 1966, JPN J APPL PHYS, V5, P886, DOI 10.1143/JJAP.5.886
   Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043
   Thian ES, 2013, J MATER SCI-MATER M, V24, P437, DOI 10.1007/s10856-012-4817-x
   Upman P.J., 2006, 109936 ISO, P50
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
NR 32
TC 11
Z9 11
U1 3
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 1
PY 2014
VL 41
BP 309
EP 319
DI 10.1016/j.msec.2014.04.054
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AK7KH
UT WOS:000338606700036
PM 24907765
DA 2018-10-20
ER

PT J
AU Kaiser, AM
   Orangio, GR
   Zutshi, M
   Alva, S
   Hull, TL
   Marcello, PW
   Margolin, DA
   Rafferty, JF
   Buie, WD
   Wexner, SD
AF Kaiser, Andreas M.
   Orangio, Guy R.
   Zutshi, Massarat
   Alva, Suraj
   Hull, Tracy L.
   Marcello, Peter W.
   Margolin, David A.
   Rafferty, Janice F.
   Buie, W. Donald
   Wexner, Steven D.
TI Current status: new technologies for the treatment of patients with
   fecal incontinence
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Review
ID SACRAL NERVE-STIMULATION; ARTIFICIAL BOWEL SPHINCTER; QUALITY-OF-LIFE;
   RADIOFREQUENCY ENERGY DELIVERY; INJECTABLE SILICONE BIOMATERIAL;
   EXTERNAL ANAL-SPHINCTER; LONG-TERM OUTCOMES; RECTAL PROLAPSE;
   SINGLE-INSTITUTION; HYALURONIC-ACID
AB Fecal incontinence is a frequent and debilitating condition that may result from a multitude of different causes. Treatment is often challenging and needs to be individualized. During the last several years, new technologies have been developed, and others are emerging from clinical trials to commercialization. Although their specific roles in the management of fecal incontinence have not yet been completely defined, surgeons have access to them and patients may request them. The purpose of this project is to put into perspective, for both the patient and the practitioner, the relative positions of new and emerging technologies in order to propose a treatment algorithm.
C1 [Kaiser, Andreas M.] Univ So Calif, Keck Sch Med, Dept Colorectal Surg, Los Angeles, CA 90033 USA.
   [Orangio, Guy R.] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA.
   [Zutshi, Massarat; Hull, Tracy L.] Cleveland Clin Fdn, Cleveland, OH 44195 USA.
   [Alva, Suraj] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA.
   [Marcello, Peter W.] Lahey Clin Fdn, Burlington, MA USA.
   [Margolin, David A.] Ochsner Clin & Alton Ochsner Med Fdn, New Orleans, LA USA.
   [Rafferty, Janice F.] Univ Cincinnati, Cincinnati, OH USA.
   [Buie, W. Donald] Univ Calgary, Calgary, AB, Canada.
   [Wexner, Steven D.] Cleveland Clin Florida, Weston, FL USA.
RP Kaiser, AM (reprint author), Univ So Calif, Keck Sch Med, Dept Colorectal Surg, 1441 Eastlake Ave,Suite 7418, Los Angeles, CA 90033 USA.
EM akaiser@usc.edu
RI Margolin, David/A-6017-2011
FU Oceana, Inc.
FX Dr. Andreas M. Kaiser is a consultant for Ethicon Endosurgery, American
   Medical Systems, and Salix Inc., and he has received speaker honoraria
   or royalties from GI Health Foundation, McGraw-Hill Publishers, and
   Uptodate. Dr. Janice F. Rafferty is a consultant for Aptalis and has
   received speaker honoraria from Lifecell, IFlow, and Aptalis. Dr. Tracy
   L. Hull has received research funding from Oceana, Inc. Dr. Massarat
   Zutshi is a speaker for Solesta. Dr. Steven D. Wexner is a consultant
   for Medtronic, Mederi Therapeutics, Renew Medical, Salix Therapeutics,
   and Incontinence Devices Inc. Drs. Guy R. Orangio, Peter W. Marcello,
   Suraj Alva, W. Donald Buie, and David A. Margolin have no conflicts of
   interest or financial ties to disclose.
CR Abbas MA, 2012, DIS COLON RECTUM, V55, P605, DOI 10.1097/DCR.0b013e3182415406
   Aigner F, 2009, DIS COLON RECTUM, V52, P293, DOI 10.1007/DCR.0b013e318197d755
   Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   Altomare DF, 2004, BRIT J SURG, V91, P1352, DOI 10.1002/bjs.4600
   Altomare DF, 2001, BRIT J SURG, V88, P1481, DOI 10.1046/j.0007-1323.2001.01895.x
   Altomare DF, 2009, DIS COLON RECTUM, V52, P11, DOI 10.1007/DCR.0b013e3181974444
   Barbe MF, 2011, J NEUROSURG-SPINE, V15, P526, DOI 10.3171/2011.6.SPINE11163
   Bartlett L, 2009, BRIT J SURG, V96, P1468, DOI 10.1002/bjs.6745
   Becmeur F, 2008, J PEDIATR SURG, V43, P1853, DOI 10.1016/j.jpedsurg.2008.03.043
   Beco J, 2004, BMC SURG, V4, P15
   Beggs AD, 2010, COLORECTAL DIS, V12, P935, DOI 10.1111/j.1463-1318.2009.01927.x
   Bock S, 2010, TECH COLOPROCTOL, V14, P41, DOI 10.1007/s10151-009-0554-7
   Boyle DJ, 2011, DIS COLON RECTUM, V54, P1271, DOI 10.1097/DCR.0b013e3182270af1
   Boyle DJ, 2010, DIS COLON RECTUM, V53, P432, DOI 10.1007/DCR.0b013e3181c75274
   Boyle DJ, 2009, DIS COLON RECTUM, V52, P1234, DOI 10.1007/DCR.0b013e31819f7400
   Brouwer R, 2010, DIS COLON RECTUM, V53, P273, DOI 10.1007/DCR.0b013e3181ceeb22
   Casal E, 2004, Colorectal Dis, V6, P180, DOI 10.1111/j.1463-1318.2004.00609.x
   Chan MKY, 2008, DIS COLON RECTUM, V51, P1015, DOI 10.1007/s10350-008-9326-0
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Chereau N, 2011, COLORECTAL DIS, V13, pE238, DOI 10.1111/j.1463-1318.2011.02651.x
   Christiansen J, 1999, ANN SURG, V230, P45, DOI 10.1097/00000658-199907000-00007
   Conaghan P, 2005, DIS COLON RECTUM, V48, P1610, DOI 10.1007/s10350-005-0062-4
   da Silva GM, 2004, DIS COLON RECTUM, V47, P204, DOI 10.1007/s10350-003-0039-0
   Danielson J, 2009, DIS COLON RECTUM, V52, P1101, DOI 10.1007/DCR.0b013e31819f5cbf
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   de la Portilla F, 2009, DIS COLON RECTUM, V52, P1427, DOI 10.1007/DCR.0b013e3181a7476a
   de Miguel M, 2011, COLORECTAL DIS, V13, P72, DOI 10.1111/j.1463-1318.2009.02066.x
   Devesa JM, 2002, DIS COLON RECTUM, V45, P1154, DOI 10.1007/s10350-004-6382-y
   Devroede G, 2012, FEMALE PELVIC MED RE, V18, P103, DOI 10.1097/SPV.0b013e3182486e60
   Dodi, 2000, Colorectal Dis, V2, P207, DOI 10.1046/j.1463-1318.2000.00157.x
   Dodi G, 2010, GASTROENT RES PRACT, DOI 10.1155/2010/467136
   Dudding TC, 2008, BRIT J SURG, V95, P1155, DOI 10.1002/bjs.6237
   Dudding TC, 2010, INT J COLORECTAL DIS, V25, P625, DOI 10.1007/s00384-010-0880-2
   Efron JE, 2003, DIS COLON RECTUM, V46, P1606, DOI 10.1097/01.DCR.0000098927.47914.D0
   Eleouet M, 2010, INT J COLORECTAL DIS, V25, P1127, DOI 10.1007/s00384-010-0960-3
   Felt-Bersma RJ, 2007, EUR J GASTROEN HEPAT, V19, P575, DOI 10.1097/MEG.0b013e32811ec010
   Finazzi-Agro E, 2009, NEUROUROL URODYNAM, V28, P320, DOI 10.1002/nau.20651
   Findlay John, 2010, Br J Nurs, V19, P750
   Ganio E, 2008, TECH COLOPROCTOL, V12, P99, DOI 10.1007/s10151-008-0406-x
   George AT, 2012, COLORECTAL DIS, V14, P98, DOI 10.1111/j.1463-1318.2010.02485.x
   George AT, 2012, DIS COLON RECTUM, V55, P302, DOI 10.1097/DCR.0b013e3182401ecd
   Gourcerol G, 2007, DIS COLON RECTUM, V50, P3, DOI 10.1007/s10350-006-0746-4
   Govaert B, 2010, COLORECTAL DIS, V12, P1236, DOI 10.1111/j.1463-1318.2009.02020.x
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   GREENE FL, 1983, ARCH SURG-CHICAGO, V118, P398
   Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174
   Hetzer FH, 2007, ARCH SURG-CHICAGO, V142, P8, DOI 10.1001/archsurg.142.1.8
   Holbrook C, 2012, SURG LAPARO ENDO PER, V22, pE58, DOI 10.1097/SLE.0b013e318244eb42
   Hotouras A, 2012, INT J COLORECTAL DIS, V27, P927, DOI 10.1007/s00384-011-1405-3
   Hull T, 2013, DIS COLON RECTUM, V56, P234, DOI 10.1097/DCR.0b013e318276b24c
   Jarrett MED, 2005, DIS COLON RECTUM, V48, P1243, DOI 10.1007/s10350-004-0919-y
   Jarrett MED, 2004, BRIT J SURG, V91, P1559, DOI 10.1002/bjs.4796
   Kim DW, 2009, AM J SURG, V197, P14, DOI 10.1016/j.amjsurg.2007.11.023
   Kumar D, 1998, BRIT J SURG, V85, P978
   Lefebure B, 2008, INT J COLORECTAL DIS, V23, P993, DOI 10.1007/s00384-008-0514-0
   Lehur PA, 2002, DIS COLON RECTUM, V45, P508, DOI 10.1007/s10350-004-6230-0
   Lehur PA, 1998, INT J COLORECTAL DIS, V13, P88, DOI 10.1007/s003840050141
   Lehur PA, 2000, DIS COLON RECTUM, V43, P1100, DOI 10.1007/BF02236557
   Lehur PA, 2010, DIS COLON RECTUM, V53, P1604, DOI 10.1007/DCR.0b013e3181f5d5f7
   Lim JT, 2011, DIS COLON RECTUM, V54, P969, DOI 10.1097/DCR.0b013e31821e57c2
   Lipham JC, 2012, SURG ENDOSC, V26, P2944, DOI 10.1007/s00464-012-2289-1
   Lundby L, 2011, DIS COLON RECTUM, V54, P318, DOI 10.1007/DCR.0b013e31820348ac
   Madoff RD, 2004, GASTROENTEROLOGY, V126, pS48, DOI 10.1053/j.gastro.2003.10.015
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Maslekar S, 2013, DIS COLON RECTUM, V56, P354, DOI 10.1097/DCR.0b013e3182805276
   MATZEL KE, 1995, LANCET, V346, P1124, DOI 10.1016/S0140-6736(95)91799-3
   Melenhorst J, 2007, COLORECTAL DIS, V9, P725, DOI 10.1111/j.1463-1318.2007.01241.x
   Melenhorst J, 2008, INT J COLORECTAL DIS, V23, P107, DOI 10.1007/s00384-007-0357-0
   Mellgren A, 2011, DIS COLON RECTUM, V54, P1065, DOI 10.1097/DCR.0b013e31822155e9
   Mentes B B, 2007, Tech Coloproctol, V11, P115, DOI 10.1007/s10151-007-0340-3
   Meurette G, 2011, COLORECTAL DIS, V13, pe182, DOI 10.1111/j.1463-1318.2010.02352.x
   Michelsen HB, 2010, DIS COLON RECTUM, V53, P414, DOI 10.1007/DCR.0b013e3181ca7dc2
   Michot F, 2003, ANN SURG, V237, P52, DOI 10.1097/00000658-200301000-00008
   Michot F, 2010, DIS COLON RECTUM, V53, P1155, DOI 10.1007/DCR.0b013e3181e19d68
   Mundy L, 2004, BRIT J SURG, V91, P665, DOI 10.1002/bjs.4587
   Munoz-Duyos A, 2008, BRIT J SURG, V95, P1037, DOI 10.1002/bjs.6140
   O'Brien PE, 2004, DIS COLON RECTUM, V47, P1852, DOI 10.1007/s10350-004-0717-6
   O'Brien PE, 2000, DIS COLON RECTUM, V43, P1213, DOI 10.1007/BF02237423
   OROURKE DA, 1985, AUST NZ J SURG, V55, P493, DOI 10.1111/j.1445-2197.1985.tb00929.x
   Ortiz H, 2003, INT J COLORECTAL DIS, V18, P349, DOI 10.1007/s00384-002-0472-x
   Ortiz H, 2002, BRIT J SURG, V89, P877, DOI 10.1046/j.1365-2168.2002.02137.x
   Parker SC, 2003, DIS COLON RECTUM, V46, P722, DOI 10.1097/01.DCR.0000070530.79998.86
   PARKS AG, 1966, P ROY SOC MED, V59, P477
   Peters KM, 2005, NEUROUROL URODYNAM, V24, P643, DOI 10.1002/nau.20174
   Queralto M, 2006, INT J COLORECTAL DIS, V21, P670, DOI 10.1007/s00384-005-0068-3
   Rao SSC, 2004, AM J GASTROENTEROL, V99, P1585, DOI 10.1111/j.1572-0241.2004.40105.x
   Rasmussen OO, 2004, DIS COLON RECTUM, V47, P1158, DOI 10.1007/s10350-004-0553-8
   Ratto C, 2005, DIS COLON RECTUM, V48, P1027, DOI 10.1007/s10350-004-0884-5
   Ratto C, 2012, COLORECTAL DIS, V14, pE297, DOI 10.1111/j.1463-1318.2012.03003.x
   Ripetti V, 2002, Tech Coloproctol, V6, P147, DOI 10.1007/s101510200034
   Robert-Yap J, 2010, DIS COLON RECTUM, V53, P428, DOI 10.1007/DCR.0b013e3181ca74b4
   Roman S, 2008, NEUROGASTROENT MOTIL, V20, P1127, DOI 10.1111/j.1365-2982.2008.01154.x
   Romano G, 2003, DIS COLON RECTUM, V46, P730, DOI 10.1097/01.DCR.0000070523.82577.A0
   Ruggieri MR, 2011, NEUROUROL URODYNAM, V30, P1695, DOI 10.1002/nau.21171
   Carmona MDR, 2009, COLORECTAL DIS, V11, P831, DOI 10.1111/j.1463-1318.2008.01652.x
   Ruiz D, 2010, DIS COLON RECTUM, V53, P1041, DOI 10.1007/DCR.0b013e3181defff8
   Schwandner O, 2011, SURG INNOV, V18, P130, DOI 10.1177/1553350610392243
   Shafik A, 2003, EUR SURG RES, V35, P103, DOI 10.1159/000069399
   Shobeiri SA, 2009, OBSTET GYNECOL, V114, P480, DOI 10.1097/AOG.0b013e3181ae6ad6
   Siddiqui AA, 2011, J PEDIATR GASTR NUTR, V52, P574, DOI 10.1097/MPG.0b013e3181ff6042
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Spinelli M, 2005, NEUROUROL URODYNAM, V24, P305, DOI 10.1002/nau.20118
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   Takahashi T, 2003, DIS COLON RECTUM, V46, P711, DOI 10.1097/01.DCR.0000070342.56449.4A
   Takahashi T, 2002, DIS COLON RECTUM, V45, P915, DOI 10.1007/s10350-004-6328-4
   Takahashi-Monroy T, 2008, DIS COLON RECTUM, V51, P355, DOI 10.1007/s10350-007-9169-0
   Thomas GP, 2013, DIS COLON RECTUM, V56, P1075, DOI 10.1097/DCR.0b013e31829bf940
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2007, DIS COLON RECTUM, V50, P1497, DOI 10.1007/s10350-007-9001-x
   Vaizey CJ, 1998, LANCET, V352, P105, DOI 10.1016/S0140-6736(97)11427-1
   Vallet C, 2010, COLORECTAL DIS, V12, P247, DOI 10.1111/j.1463-1318.2009.01899.x
   Veronique V, 2010, INT J COLORECTAL DIS, V25, P1017, DOI 10.1007/s00384-010-0962-1
   Vitton V, 2008, DIS COLON RECTUM, V51, P924, DOI 10.1007/s10350-008-9209-4
   Vitton V, 2009, INFLAMM BOWEL DIS, V15, P402, DOI 10.1002/ibd.20774
   Wald A, 2007, NEW ENGL J MED, V356, P1648, DOI 10.1056/NEJMcp067041
   Wexner SD, 2010, ANN SURG, V251, P441, DOI 10.1097/SLA.0b013e3181cf8ed0
   Wexner SD, 2009, DIS COLON RECTUM, V52, P1550, DOI 10.1007/DCR.0b013e3181af62f8
   Wong MTC, 2012, COLORECTAL DIS, V14, pE323, DOI 10.1111/j.1463-1318.2012.02995.x
   Wong MTC, 2011, ANN SURG, V254, P951, DOI 10.1097/SLA.0b013e31823ac2bc
   Wong MTC, 2011, DIS COLON RECTUM, V54, P773, DOI 10.1007/DCR.0b013e3182182689
   Wong WD, 1996, DIS COLON RECTUM, V39, P1345
   Wong WD, 2002, DIS COLON RECTUM, V45, P1139, DOI 10.1097/01.DCR.0000027038.03012.E3
   Yamana T, 2004, DIS COLON RECTUM, V47, P1982, DOI 10.1007/s10350-004-0675-z
   Yamout SZ, 2009, PEDIATR SURG INT, V25, P1081, DOI 10.1007/s00383-009-2496-6
NR 127
TC 15
Z9 15
U1 2
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0930-2794
EI 1432-2218
J9 SURG ENDOSC
JI Surg. Endosc.
PD AUG
PY 2014
VL 28
IS 8
BP 2277
EP 2301
DI 10.1007/s00464-014-3464-3
PG 25
WC Surgery
SC Surgery
GA AK9RK
UT WOS:000338764200004
PM 24609699
DA 2018-10-20
ER

PT J
AU Gao, Y
   Krpata, DM
   Criss, CN
   Liu, LJ
   Posielski, N
   Rosen, MJ
   Novitsky, YW
AF Gao, Yue
   Krpata, David M.
   Criss, Cory N.
   Liu, Lijia
   Posielski, Natasza
   Rosen, Michael J.
   Novitsky, Yuri W.
TI Effects of mesenchymal stem cell and fibroblast coating on immunogenic
   potential of prosthetic meshes in vitro
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE Mesh; Mesenchymal stem cell; Fibroblast; IL-1 beta; IL-6; VEGF
ID FOREIGN-BODY RESPONSE; GROWTH-FACTOR; LINE U937; TISSUE; MODEL;
   MACROPHAGES; EXPRESSION; INFLAMMATION; BIOMATERIAL; CYTOKINES
AB The aim of this study was to reveal the effect of fibroblast or mesenchymal stem cell (MSC) coating on the mesh-induced production of IL-1 beta, IL-6, and VEGF by macrophages.
   Four commonly used surgical meshes were tested in this study, including Parietex, SoftMesh, TIGR, and Strattice. One-square-centimeter pieces of each mesh were placed on top of a monolayer of human fibroblasts or rat MSCs. The coating status was monitored with a light microscope. The human promonocytic cell line U937 was induced to differentiate into macrophages (MI broken vertical bar). Three weeks later, meshes were transferred to new 24-well plates and cocultured with the MI broken vertical bar s for 72 h. Culture medium was collected and analyzed for IL-1 beta, IL-6, and VEGF production using standard ELISA essays. Parallel mesh samples were fixed with paraformaldehyde or glutaraldehyde for histology or transmission electronic microscopy (TEM) analyses, respectively.
   Uncoated meshes induced increased production of all three cytokines compared with macrophages cultured alone. HF coating further increased the production of both IL-6 and VEGF but reduced IL-1 beta production. Except for the SoftMesh group, MSC coating significantly blunted release of all cytokines to levels even lower than with MI broken vertical bar s cultured alone. MI broken vertical bar s tended to deteriorate in the presence of MSCs. Both histology and TEM revealed intimate interactions between cell-coated meshes and MI broken vertical bar s.
   Cytokine response to fibroblast coating varied, while MSC coating blunted the immunogenic effect of both synthetic and biologic meshes in vitro. Cell coating appears to affect mesh biocompatibility and may become a key process in mesh evolution.
C1 [Gao, Yue; Krpata, David M.; Criss, Cory N.; Liu, Lijia; Posielski, Natasza; Rosen, Michael J.; Novitsky, Yuri W.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.
RP Novitsky, YW (reprint author), Case Western Reserve Univ, Univ Hosp Case Med Ctr, 11100 Euclid Ave, Cleveland, OH 44106 USA.
EM yuri.novitsky@uhhospitals.org
FU Department of Surgery, University Hospitals Case Medical Center
FX This study was supported by an internal grant from Department of
   Surgery, University Hospitals Case Medical Center.
CR Asarias JR, 2011, J INVEST SURG, V24, P87, DOI 10.3109/08941939.2010.548904
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012
   BOXMAN I, 1993, J INVEST DERMATOL, V101, P316, DOI 10.1111/1523-1747.ep12365474
   Brandt CJ, 2011, J BIOMED MATER RES A, V99A, P335, DOI 10.1002/jbm.a.33136
   Calle Y, 2004, J PATHOL, V204, P460, DOI 10.1002/path.1651
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465
   Di Vita G, 2010, SURG INNOV, V17, P229, DOI 10.1177/1553350610371334
   Ding F, 2010, TISSUE ENG PT A, V16, P3779, DOI [10.1089/ten.tea.2010.0299, 10.1089/ten.TEA.2010.0299]
   Dolce CJ, 2010, SURG ENDOSC, V24, P2687, DOI 10.1007/s00464-010-1026-x
   Eggenhofer E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-12
   Ghosh CC, 2010, J IMMUNOL, V185, P3685, DOI 10.4049/jimmunol.0902230
   Glim JE, 2013, IMMUNOBIOLOGY, V218, P924, DOI 10.1016/j.imbio.2012.10.004
   Grotenhuis N, 2013, BIOCHEM BIOPH RES CO, V433, P115, DOI 10.1016/j.bbrc.2013.02.054
   Hjort H, 2012, HERNIA, V16, P191, DOI 10.1007/s10029-011-0885-y
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Hu BA, 2013, CURR OPIN RHEUMATOL, V25, P71, DOI 10.1097/BOR.0b013e32835b1352
   Iqbal SA, 2012, ARCH DERMATOL RES, V304, P665, DOI 10.1007/s00403-012-1225-5
   Joseph J, 2013, J BIOMED MATER RES A, V101, P2967, DOI 10.1002/jbm.a.34596
   Junge K, 2012, LANGENBECK ARCH SURG, V397, P255, DOI 10.1007/s00423-011-0780-0
   Kapischke M, 2005, SURG ENDOSC, V19, P791, DOI 10.1007/s00464-004-9222-1
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   KOVACS EJ, 1994, FASEB J, V8, P854
   Kyzer S, 1997, EUR SURG RES, V29, P84, DOI 10.1159/000129511
   Langer C, 2005, CHIRURG, V76, P876, DOI 10.1007/s00104-005-1036-8
   Li J, 2012, XENOTRANSPLANTATION, V19, P273, DOI 10.1111/xen.12000
   Lind M, 1998, J BONE JOINT SURG BR, V80B, P924, DOI 10.1302/0301-620X.80B5.8710
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252
   Malik AF, 2011, P NATL ACAD SCI USA, V108, P20095, DOI 10.1073/pnas.1105152108
   Matsusaki T, 2007, J ARTHROPLASTY, V22, P960, DOI 10.1016/j.arth.2007.03.013
   McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005
   Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109
   Nguyen PT, 2012, J INVEST SURG, V25, P330, DOI 10.3109/08941939.2011.639848
   Noort WA, 2012, J CELL MOL MED, V16, P1827, DOI 10.1111/j.1582-4934.2011.01455.x
   Norton LW, 2007, J BIOMED MATER RES A, V81A, P858, DOI 10.1002/jbm.a.31088
   Orenstein SB, 2010, HERNIA, V14, P401, DOI 10.1007/s10029-010-0634-7
   Orenstein SB, 2012, J SURG RES, V176, P423, DOI 10.1016/j.jss.2011.09.031
   Orenstein SB, 2011, SURG ENDOSC, V25, P1452, DOI 10.1007/s00464-010-1413-3
   Orenstein SB, 2010, SURG ENDOSC, V24, P805, DOI 10.1007/s00464-009-0664-3
   Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104
   Otto WR, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-20
   Pan H, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/6/065002
   Passmore JS, 2001, IMMUNOLOGY, V102, P146, DOI 10.1046/j.1365-2567.2001.01164.x
   Patel M, 2010, TISSUE ENG PT A, V16, P55, DOI [10.1089/ten.tea.2009.0027, 10.1089/ten.TEA.2009.0027]
   Peeters E, 2013, J SURG RES, V180, P274, DOI 10.1016/j.jss.2013.01.025
   Pereira-Lucena CG, 2010, HERNIA, V14, P299, DOI 10.1007/s10029-009-0621-z
   Pietila M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031671
   Rosen M J, 2007, Hernia, V11, P435, DOI 10.1007/s10029-007-0255-y
   Schneider RKM, 2008, DIFFERENTIATION, V76, P156, DOI 10.1111/j.1432-0436.2007.00204.x
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Shin L, 2013, STEM CELL TRANSL MED, V2, P33, DOI 10.5966/sctm.2012-0041
   TAIMI M, 1990, DIFFERENTIATION, V45, P55, DOI 10.1111/j.1432-0436.1990.tb00457.x
   Takahashi H, 2005, IMMUNOL LETT, V98, P189, DOI 10.1016/j.imlet.2004.11.012
   Templin C, 2012, CIRCULATION, V126, P430, DOI 10.1161/CIRCULATIONAHA.111.087684
   Tian WM, 2009, MATRIX BIOL, V28, P148, DOI 10.1016/j.matbio.2009.02.002
   Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007
   van Amerongen Machteld J., 2002, Angiogenesis, V5, P173, DOI 10.1023/A:1023822504224
   Weil BR, 2011, J SURG RES, V167, P78, DOI 10.1016/j.jss.2010.07.019
   Weyhe D, 2008, ANZ J SURG, V78, P55, DOI 10.1111/j.1445-2197.2007.04362.x
   Zagoura DS, 2012, GUT, V61, P894, DOI 10.1136/gutjnl-2011-300908
   Zhukareva V, 2010, CYTOKINE, V50, P317, DOI 10.1016/j.cyto.2010.01.004
NR 66
TC 1
Z9 1
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0930-2794
EI 1432-2218
J9 SURG ENDOSC
JI Surg. Endosc.
PD AUG
PY 2014
VL 28
IS 8
BP 2357
EP 2367
DI 10.1007/s00464-014-3470-5
PG 11
WC Surgery
SC Surgery
GA AK9RK
UT WOS:000338764200012
PM 24972922
DA 2018-10-20
ER

PT J
AU Roche, ET
   Hastings, CL
   Lewin, SA
   Shvartsman, DE
   Brudno, Y
   Vasilyev, NV
   O'Brien, FJ
   Walsh, CJ
   Duffy, GP
   Mooney, DJ
AF Roche, Ellen T.
   Hastings, Conn L.
   Lewin, Sarah A.
   Shvartsman, Dmitry E.
   Brudno, Yevgeny
   Vasilyev, Nikolay V.
   O'Brien, Fergal J.
   Walsh, Conor J.
   Duffy, Garry P.
   Mooney, David J.
TI Comparison of biomaterial delivery vehicles for improving acute
   retention of stem cells in the infarcted heart
SO BIOMATERIALS
LA English
DT Article
DE Alginate; Collagen; Cell viability; Heart; Hydrogel
ID CHRONIC ISCHEMIC CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; FUNCTIONAL
   IMPROVEMENT; ALGINATE HYDROGELS; CHITOSAN HYDROGEL; STRATEGIES;
   SCAFFOLDS; SURVIVAL; REPAIR; REGENERATION
AB Cell delivery to the infarcted heart has emerged as a promising therapy, but is limited by very low acute retention and engraftment of cells. The objective of this study was to compare a panel of biomaterials to evaluate if acute retention can be improved with a biomaterial carrier. Cells were quantified post-implantation in a rat myocardial infarct model in five groups (n = 7-8); saline injection (current clinical standard), two injectable hydrogels (alginate, chitosan/beta-glycerophosphate (chitosan/B-GP)) and two epicardial patches (alginate, collagen). Human mesenchymal stem cells (hMSCs) were delivered to the infarct border zone with each biomaterial. At 24 h, retained cells were quantified by fluorescence. All biomaterials produced superior fluorescence to saline control, with approximately 8- and 14-fold increases with alginate and chitosan/beta-GP injectables, and 47 and 59-fold increases achieved with collagen and alginate patches, respectively. Immunohistochemical analysis qualitatively confirmed these findings. All four biomaterials retained 50-60% of cells that were present immediately following transplantation, compared to 10% for the saline control. In conclusion, all four biomaterials were demonstrated to more efficiently deliver and retain cells when compared to a saline control. Biomaterial-based delivery approaches show promise for future development of efficient in vivo delivery techniques. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Roche, Ellen T.; Shvartsman, Dmitry E.; Brudno, Yevgeny; Walsh, Conor J.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Roche, Ellen T.; Lewin, Sarah A.; Shvartsman, Dmitry E.; Brudno, Yevgeny; Walsh, Conor J.; Mooney, David J.] Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.
   [Hastings, Conn L.; O'Brien, Fergal J.; Duffy, Garry P.] Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, Dublin 2, Ireland.
   [Hastings, Conn L.; O'Brien, Fergal J.; Duffy, Garry P.] Univ Dublin Trinity Coll, Coll Green, Trinity Ctr Bioengn, Dublin 2, Ireland.
   [Hastings, Conn L.; O'Brien, Fergal J.; Duffy, Garry P.] RCSI & TCD, Adv Mat & Bioengn Res AMBER Ctr, Dublin 2, Ireland.
   [Vasilyev, Nikolay V.] Boston Childrens Hosp, Boston, MA 02115 USA.
RP Mooney, DJ (reprint author), Pierce Hall Room 319,29 Oxford St, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
RI O'Brien, Fergal/F-9485-2011
OI O'Brien, Fergal/0000-0003-2030-8005; Duffy, Garry/0000-0002-4994-9511;
   Roche, Ellen/0000-0002-8952-2993; Brudno, Yevgeny/0000-0003-2963-3293
FU Fulbright ST fellowship; NIH [R01 HL069957]; SEAS/Harvard University;
   Wyss Institute; Albert Renold Travel Fellowship awarded by the European
   Foundation for the Study of Diabetes
FX We sincerely thank Dr. Marcello Rota for invaluable help with the
   surgical procedure. Funding was from the Fulbright S&T fellowship, the
   NIH (R01 HL069957), SEAS/Harvard University, the Wyss Institute. Funding
   also derived from an Albert Renold Travel Fellowship awarded by the
   European Foundation for the Study of Diabetes.
CR Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Ashraf M, 2008, J MOL CELL CARDIOL, V45, P567
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Blocklet D, 2006, STEM CELLS, V24, P333, DOI 10.1634/stemcells.2005-0201
   Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589
   Collins MC, 2012, OPEN TISSUE ENG REGE, V5, P17
   Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Hamdi H, 2009, ANN THORAC SURG, V87, P1196, DOI 10.1016/j.athoracsur.2008.12.074
   Hastings CL, 2012, J CONTROL RELEASE, V161, P73, DOI 10.1016/j.jconrel.2012.04.033
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   HOU D, 2005, CIRCULATION S1, V112, P150
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Malliaras K, 2011, BRIT MED BULL, V98, P161, DOI 10.1093/bmb/ldr018
   Mylotte LA, 2008, STEM CELLS, V26, P1325, DOI 10.1634/stemcells.2007-1072
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Qian L, 2012, TISSUE ENG PT A, V18, P1652, DOI [10.1089/ten.tea.2011.0591, 10.1089/ten.TEA.2011.0591]
   Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Smith Rachel Ruckdeschel, 2013, Biomatter, V3, DOI 10.4161/biom.24490
   Sutton EJ, 2009, OPT EXPRESS, V17, P24403, DOI 10.1364/OE.17.024403
   Templin C, 2011, INT J DEV BIOL, V55, P407, DOI 10.1387/ijdb.103219ct
   Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097
   Thornton AJ, 2004, J UROLOGY, V172, P763, DOI 10.1097/01.ju.0000130466.84214.f7
   Thornton AJ, 2004, TRANSPLANTATION, V77, P1798, DOI 10.1097/01.tp.0000131152.71117.0e
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Wang HB, 2010, J CELL MOL MED, V14, P1044, DOI 10.1111/j.1582-4934.2010.01046.x
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
NR 38
TC 48
Z9 48
U1 2
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2014
VL 35
IS 25
BP 6850
EP 6858
DI 10.1016/j.biomaterials.2014.04.114
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AK4IB
UT WOS:000338386800018
PM 24862441
OA Green Accepted
DA 2018-10-20
ER

PT J
AU McNamara, SL
   Rnjak-Kovacina, J
   Schmidt, DF
   Lo, TJ
   Kaplan, DL
AF McNamara, Stephanie L.
   Rnjak-Kovacina, Jelena
   Schmidt, Daniel F.
   Lo, Tim J.
   Kaplan, David L.
TI Silk as a biocohesive sacrificial binder in the fabrication of
   hydroxyapatite load bearing scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Silk; Hydroxyapatite; Bone tissue engineering; Ceramic structure;
   Porosity
ID CALCIUM-PHOSPHATE CERAMICS; POROUS HYDROXYAPATITE; BIOMATERIAL
   SCAFFOLDS; MECHANICAL-PROPERTIES; STARCH CONSOLIDATION; TCP SCAFFOLDS;
   BONE; TEMPERATURE; FIBROIN; COMPOSITES
AB Limitations of current clinical methods for bone repair continue to fuel the demand for a high strength, bioactive bone replacement material. Recent attempts to produce porous scaffolds for bone regeneration have been limited by the intrinsic weakness associated with high porosity materials. In this study, ceramic scaffold fabrication techniques for potential use in load-bearing bone repairs have been developed using naturally derived silk from Bombyx mori. Silk was first employed for ceramic grain consolidation during green body formation, and later as a sacrificial polymer to impart porosity during sintering. These techniques allowed preparation of hydroxyapatite (HA) scaffolds that exhibited a wide range of mechanical and porosity profiles, with some displaying unusually high compressive strength up to 152.4 +/- 9.1 MPa. Results showed that the scaffolds exhibited a wide range of compressive strengths and moduli (8.7 +/- 2.7 MPa to 152.4 +/- 9.1 MPa and 03 +/- 0.1 GPa to 8.6 +/- 03 GPa) with total porosities of up to 62.9 +/- 2.7% depending on the parameters used for fabrication. Moreover, HA-silk scaffolds could be molded into large, complex shapes, and further machined post-sinter to generate specific three-dimensional geometries. Scaffolds supported bone marrow-derived mesenchymal stem cell attachment and proliferation, with no signs of cytotoxicity. Therefore, silk-fabricated HA scaffolds show promise for load bearing bone repair and regeneration needs. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [McNamara, Stephanie L.; Rnjak-Kovacina, Jelena; Lo, Tim J.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Rnjak-Kovacina, Jelena] UNSW Australia, Grad Sch Biomed Engn, Sydney, NSW, Australia.
   [Schmidt, Daniel F.] Univ Massachusetts, Dept Plast Engn, Lowell, MA USA.
RP Kaplan, DL (reprint author), 4 Colby St, Medford, MA 02155 USA.
EM David.Kaplan@Tufts.edu
OI Schmidt, Daniel/0000-0003-2511-1906
FU National Institutes of Health [DE017207, EB002520, 2R01DE016525-06A1]
FX The authors thank the National Institutes of Health (DE017207, EB002520
   and 2R01DE016525-06A1) for support.
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF02402799
   Almirall A, 2004, BIOMATERIALS, V25, P3671, DOI 10.1016/j.biomaterials.2003.10.066
   [Anonymous], 2011, DATAMONITOR REPORTS, P1
   Astete CE, 2006, J BIOMAT SCI-POLYM E, V17, P247, DOI 10.1163/156856206775997322
   Bellucci D, 2013, MAT SCI ENG C-MATER, V33, P1091, DOI 10.1016/j.msec.2012.11.038
   Champion E, 2013, ACTA BIOMATER, V9, P5855, DOI 10.1016/j.actbio.2012.11.029
   Chevalier E, 2007, J PHARM SCI, V97, P1135
   Choong C, 2004, FOOD BIOPROD PROCESS, V82, P117, DOI 10.1205/0960308041614864
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   De Oliveira JF, 2003, ARTIF ORGANS, V27, P406
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x
   Fu Q, 2008, J BIOMED MATER RES B, V86B, P125, DOI 10.1002/jbm.b.30997
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P43, DOI 10.1098/rspa.1982.0088
   Gregorova E, 2006, J EUR CERAM SOC, V26, P1301, DOI 10.1016/j.jeurceramsoc.2005.02.015
   Gregorova E, 2011, J EUR CERAM SOC, V31, P2073, DOI 10.1016/j.jeurceramsoc.2011.05.018
   Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008
   Gugala Z, 2007, MACROMOL SYMP, V253, P147, DOI 10.1002/masy.200750722
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawata M, 2004, J MATER SCI-MATER M, V15, P817, DOI 10.1023/B:JMSM.0000032823.66093.aa
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kucharska M, 2012, MATER LETT, V85, P124, DOI 10.1016/j.matlet.2012.07.002
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lichte P, 2011, INJURY, V42, P569, DOI 10.1016/j.injury.2011.03.033
   Lin LL, 2013, P I MECH ENG H, V227, P50, DOI 10.1177/0954411912458739
   Liu DM, 1997, CERAM INT, V23, P135, DOI 10.1016/S0272-8842(96)00009-0
   Lyckfeldt O, 1998, J EUR CERAM SOC, V18, P131, DOI 10.1016/S0955-2219(97)00101-5
   Martin RB, 1998, SKELETAL TISSUE MECH
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Potoczek M, 2008, MATER LETT, V62, P1055, DOI 10.1016/j.matlet.2007.07.043
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Rezaei A, 2013, MAT SCI ENG C-MATER, V33, P390, DOI 10.1016/j.msec.2012.09.004
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rodriguez-Lorenzo LM, 2002, J BIOMED MATER RES, V60, P159, DOI 10.1002/jbm.1286
   Sahni V, 2011, J ADHESION, V87, P595, DOI 10.1080/00218464.2011.583588
   Sariibrahimoglu K, 2013, KEY ENG MATER, V529-530, P157, DOI 10.4028/www.scientific.net/KEM.529-530.157
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tian JT, 2001, J MATER SCI, V36, P3061, DOI 10.1023/A:1017935411108
   Valente JFA, 2012, MAT SCI ENG C-MATER, V32, P2596, DOI 10.1016/j.msec.2012.08.001
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Yunos DM, 2008, J MATER SCI, V43, P4433, DOI 10.1007/s10853-008-2552-y
NR 53
TC 22
Z9 24
U1 7
U2 100
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2014
VL 35
IS 25
BP 6941
EP 6953
DI 10.1016/j.biomaterials.2014.05.013
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AK4IB
UT WOS:000338386800026
PM 24881027
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hettiaratchi, MH
   Miller, T
   Temenoff, JS
   Guldberg, RE
   McDevitt, TC
AF Hettiaratchi, Marian H.
   Miller, Tobias
   Temenoff, Johnna S.
   Guldberg, Robert E.
   McDevitt, Todd C.
TI Heparin microparticle effects on presentation and bioactivity of bone
   morphogenetic protein-2
SO BIOMATERIALS
LA English
DT Article
DE Heparin; Glycosaminoglycan; Bone morphogenetic protein; Microparticle;
   Alkaline phosphatase; Bone tissue engineering
ID FIBROBLAST-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; ACID-BASED HYDROGELS;
   SMOOTH-MUSCLE-CELLS; RAT ECTOPIC MODEL; OSTEOGENIC ACTIVITY;
   CONTROLLED-RELEASE; IN-VITRO; OSTEOBLAST DIFFERENTIATION; POLY(ETHYLENE
   GLYCOL)
AB Biomaterials capable of providing localized and sustained presentation of bioactive proteins are critical for effective therapeutic growth factor delivery. However, current biomaterial delivery vehicles commonly suffer from limitations that can result in low retention of growth factors at the site of interest or adversely affect growth factor bioactivity. Heparin, a highly sulfated glycosaminoglycan, is an attractive growth factor delivery vehicle due to its ability to reversibly bind positively charged proteins, provide sustained delivery, and maintain protein bioactivity. This study describes the fabrication and characterization of heparin methacrylamide (HMAm) micropartides for recombinant growth factor delivery. HMAm microparticles were shown to efficiently bind several heparin-binding growth factors (e.g. bone morphogenetic protein-2 (BMP-2), vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (FGF-2)), including a wide range of BMP-2 concentrations that exceeds the maximum binding capacity of other common growth factor delivery vehicles, such as gelatin. BMP-2 bioactivity was assessed on the basis of alkaline phosphatase (ALP) activity induced in skeletal myoblasts (C2C12). Microparticles loaded with BMP-2 stimulated comparable C2C12 ALP activity to soluble BMP-2 treatment, indicating that BMP-2-loaded microparticles retain bioactivity and potently elicit a functional cell response. In summary, our results suggest that heparin microparticles stably retain large amounts of bioactive BMP-2 for prolonged periods of time, and that presentation of BMP-2 via heparin microparticles can elicit cell responses comparable to soluble BMP-2 treatment. Consequently, heparin microparticles present an effective method of delivering and spatially retaining growth factors that could be used in a variety of systems to enable directed induction of cell fates and tissue regeneration. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Hettiaratchi, Marian H.; Miller, Tobias; Temenoff, Johnna S.; McDevitt, Todd C.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Hettiaratchi, Marian H.; Miller, Tobias; Temenoff, Johnna S.; McDevitt, Todd C.] Emory Univ, Atlanta, GA 30332 USA.
   [Temenoff, Johnna S.; Guldberg, Robert E.; McDevitt, Todd C.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Guldberg, Robert E.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP McDevitt, TC (reprint author), 315 Ferst Dr,Suite 2311, Atlanta, GA 30332 USA.
EM todd.mcdevitt@bme.gatech.edu
OI Hettiaratchi, Marian/0000-0001-8187-4575
FU National Institutes of Health [TR01 AR062006]; National Science
   Foundation [NSF DMR 1207045]; Natural Science and Engineering Research
   Council (NSERC) of Canada
FX This work was supported by a Transformative Research Award from the
   National Institutes of Health (TR01 AR062006) and a grant from the
   National Science Foundation (NSF DMR 1207045). MHH is supported by
   funding from the Natural Science and Engineering Research Council
   (NSERC) of Canada. The authors would like to thank Ms. Shalini Saxena
   for her assistance with scanning electron microscopy, and Ms. Marissa
   Cooke for her assistance with manuscript preparation.
CR Abbah SA, 2012, TISSUE ENG PART A, V19, P350
   AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
   Al-Azzam W, 2005, J PHARM SCI-US, V94, P1808, DOI 10.1002/jps.20407
   Bhakta G, 2012, BIOMATERIALS, V33, P6113, DOI 10.1016/j.biomaterials.2012.05.030
   Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018
   Bramono DS, 2012, BONE, V50, P954, DOI 10.1016/j.bone.2011.12.013
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Capila I., 2002, ANGEW CHEM INT EDIT, V1, 3, p[41, 390], DOI DOI 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.C0;2-B
   Cui C, 2007, PHARM RES, V24, P2381, DOI 10.1007/s11095-007-9378-1
   DAMON DH, 1989, J CELL PHYSIOL, V138, P221, DOI 10.1002/jcp.1041380202
   Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200
   Denizli A, 1999, J APPL POLYM SCI, V74, P655, DOI 10.1002/(SICI)1097-4628(19991017)74:3<655::AID-APP19>3.0.CO;2-N
   Dombrowski C, 2009, STEM CELLS DEV, V18, P661, DOI 10.1089/scd.2008.0157
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   FERRARA N, 1991, J CELL BIOCHEM, V47, P211, DOI 10.1002/jcb.240470305
   Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105
   Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X
   Gandhi NS, 2012, BBA-PROTEINS PROTEOM, V1824, P1374, DOI 10.1016/j.bbapap.2012.07.002
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95
   Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3
   Hannink G, 2013, J MATER SCI-MATER M, V24, P325, DOI 10.1007/s10856-012-4802-4
   Hausser HJ, 2004, J CELL BIOCHEM, V91, P1062, DOI 10.1002/jcb.20007
   Hudalla GA, 2011, INTEGR BIOL-UK, V3, P832, DOI 10.1039/c1ib00021g
   ITO Y, 1991, BIOMATERIALS, V12, P449, DOI 10.1016/0142-9612(91)90141-V
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Jha AK, 2009, BIOMATERIALS, V30, P6964, DOI 10.1016/j.biomaterials.2009.09.009
   Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200
   Johnson MR, 2011, CLIN ORTHOP RELAT R, V469, P3111, DOI 10.1007/s11999-011-2012-x
   Kang SW, 2008, BIOTECHNOL LETT, V30, P1163, DOI 10.1007/s10529-008-9675-8
   Kanzaki S, 2008, J CELL PHYSIOL, V216, P844, DOI 10.1002/jcp.21468
   Kanzaki S, 2011, PHARMACOL REP, V63, P1222, DOI 10.1016/S1734-1140(11)70642-9
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348
   La WG, 2012, ARTIF ORGANS, V36, P642
   Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257
   Lim JJ, 2011, ACTA BIOMATER, V7, P986, DOI 10.1016/j.actbio.2010.10.009
   LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125
   Liu LS, 2002, J BIOMED MATER RES, V62, P128, DOI 10.1002/jbm.10238
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mathews S, 2014, J TISSUE ENG REGEN M, V8, P143, DOI 10.1002/term.1507
   Miller T, 2014, ACTA BIOMATER, V10, P1705, DOI 10.1016/j.actbio.2013.09.039
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Ratanavaraporn J, 2012, ACTA BIOMATER, V8, P173, DOI 10.1016/j.actbio.2011.09.035
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   Schonherr E, 2000, Dev Immunol, V7, P89, DOI 10.1155/2000/31748
   Schroeder-Tefft JA, 1997, J CONTROL RELEASE, V49, P291, DOI 10.1016/S0168-3659(97)10055-4
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Seto SP, 2012, CELL TISSUE RES, V347, P589, DOI 10.1007/s00441-011-1265-8
   SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0
   Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200
   Tao L, 2009, ORG BIOMOL CHEM, V7, P3481, DOI 10.1039/b907061c
   Teixeira S, 2010, J MATER SCI-MATER M, V21, P2385, DOI 10.1007/s10856-010-4097-2
   Terada Kumiko, 2013, Int J Cell Biol, V2013, P616294, DOI 10.1155/2013/616294
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Vaibhav B, 2007, INJURY, V38, P1227, DOI 10.1016/j.injury.2006.12.012
   van de Wetering P, 2005, J CONTROL RELEASE, V102, P619, DOI 10.1016/j.jconrel.2004.10.029
   Xu X, 2011, ACTA BIOMATER, V7, P3050, DOI 10.1016/j.actbio.2011.04.018
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Yang HS, 2010, TISSUE ENG PT A, V16, P1225, DOI [10.1089/ten.tea.2009.0390, 10.1089/ten.TEA.2009.0390]
   Yang LF, 2005, ATHEROSCLEROSIS, V179, P79, DOI 10.1016/j.atherosclerosis.2004.10.035
   Ye L, 2011, J BIOMAT SCI-POLYM E, V22, P389, DOI 10.1163/092050610X487710
   Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200
   Zhao JH, 2011, CARBOHYD POLYM, V86, P806, DOI 10.1016/j.carbpol.2011.05.026
   Zhao YL, 2011, J BIOMAT SCI-POLYM E, V22, P665, DOI 10.1163/092050610X489880
NR 69
TC 42
Z9 42
U1 3
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2014
VL 35
IS 25
BP 7228
EP 7238
DI 10.1016/j.biomaterials.2014.05.011
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AK4IB
UT WOS:000338386800053
PM 24881028
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Russo, L
   Sgambato, A
   Giannoni, P
   Quarto, R
   Vesentini, S
   Gautieri, A
   Cipolla, L
AF Russo, Laura
   Sgambato, Antonella
   Giannoni, Paolo
   Quarto, Rodolfo
   Vesentini, Simone
   Gautieri, Alfonso
   Cipolla, Laura
TI Response of osteoblast-like MG63 on neoglycosylated collagen matrices
SO MEDCHEMCOMM
LA English
DT Article
ID MOLECULAR-DYNAMICS; CELL-SURFACE; GLYCOSYLATION; INTERFACE; CHEMISTRY;
   CARTILAGE; IMPLANTS; ADHESION; EPITOPE; AMINO
AB Biomaterial surface properties, via introduction of specific signal biomolecules can influence cell adhesion and differentiation processes. Inspired by the monosaccharide motifs found in collagen glycosylation patterns, galactose being one of the most commonly found saccharidic residues, collagen matrices were modified in order to expose galactose residues to cells. The interaction of chemically neoglycosylated matrices was evaluated with osteosarcoma-derived cell line MG63.
C1 [Russo, Laura; Sgambato, Antonella; Cipolla, Laura] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy.
   [Giannoni, Paolo; Quarto, Rodolfo] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy.
   [Vesentini, Simone; Gautieri, Alfonso] Politecn Milan, Dept Elettron Informaz & Bioingn, I-20133 Milan, Italy.
RP Cipolla, L (reprint author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.
EM paolo.giannoni@unige.it; rodolfo.quarto@unige.it;
   laura.cipolla@unimib.it
RI Gautieri, Alfonso/L-7500-2015; Russo, Laura/I-3237-2014
OI Gautieri, Alfonso/0000-0003-0492-0130; Russo, Laura/0000-0002-5914-766X;
   Giannoni, Paolo/0000-0002-7206-376X; Quarto, Rodolfo/0000-0002-1146-894X
FU Fondazione Cariplo [2010-0378, 2011-0270]; MIUR [2010L9SH3K]
FX This work has been supported by Fondazione Cariplo, Grant no. 2010-0378,
   and Grant no. 2011-0270, MIUR under project PRIN 2010L9SH3K.
CR Abou Neel EA, 2013, ADV DRUG DELIVER REV, V65, P429, DOI 10.1016/j.addr.2012.08.010
   Bailey AJ, 2000, WOUND REPAIR REGEN, V8, P5, DOI 10.1046/j.1524-475x.2000.00005.x
   Boccafoschi F, 2005, BIOMATERIALS, V26, P7410, DOI 10.1016/j.biomaterials.2005.05.052
   Cipolla L., 2013, MAT BIOFUNCTIONALIZA
   Cipolla L, 2012, SPR CARB CH, V38, P416, DOI 10.1039/9781849734769-00416
   CURTIS ASG, 1984, J CELL SCI, V71, P17
   Dzhambazov B, 2005, EUR J IMMUNOL, V35, P357, DOI 10.1002/eji.200425637
   Franco A, 2000, NAT IMMUNOL, V1, P145, DOI 10.1038/77827
   Gautieri A, 2013, INT J NONLIN MECH, V56, P25, DOI 10.1016/j.ijnonlinmec.2013.03.012
   Gautieri A, 2012, J BIOMECH, V45, P2079, DOI 10.1016/j.jbiomech.2012.05.047
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jones J.R., 2005, BIOMATERIALS ARTIFIC
   Jurgensen HJ, 2011, J BIOL CHEM, V286, P32736, DOI 10.1074/jbc.M111.266692
   Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059761
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383
   Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019
   OIKARINEN A, 1976, BIOCHEM J, V156, P545, DOI 10.1042/bj1560545
   OKADA T, 1992, BIOMATERIALS, V13, P448, DOI 10.1016/0142-9612(92)90165-K
   Palmieri D, 2010, EXP CELL RES, V316, P789, DOI 10.1016/j.yexcr.2009.12.006
   Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d
   PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039
   Qin Z, 2012, LANGMUIR, V28, P1982, DOI 10.1021/la204052a
   Rainey JK, 2004, BIOINFORMATICS, V20, P2458, DOI 10.1093/bioinformatics/bth247
   Russo L, 2014, CARBOHYD RES, V389, P12, DOI 10.1016/j.carres.2013.11.008
   Russo L, 2014, ACS CHEM NEUROSCI, V5, P261, DOI 10.1021/cn400222s
   Russo L, 2014, LANGMUIR, V30, P1336, DOI 10.1021/la404310p
   Smart NJ, 2012, SURG INNOV, V19, P221, DOI 10.1177/1553350611429027
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Taga Y, 2013, J PROTEOME RES, V12, P2225, DOI 10.1021/pr400079d
   Taraballi F, 2013, J COLLOID INTERF SCI, V394, P590, DOI 10.1016/j.jcis.2012.11.041
   Tsai SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031200
   van Duin ACT, 2001, J PHYS CHEM A, V105, P9396, DOI 10.1021/jp004368u
   Vandrovcova M, 2011, PHYSIOL RES, V60, P797
   Veld PJ, 2008, BIOPHYS J, V95, P33, DOI 10.1529/biophysj.107.120659
   Wang QQ, 2011, J BIOMED MATER RES A, V99A, P125, DOI 10.1002/jbm.a.33142
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 39
TC 1
Z9 1
U1 1
U2 2
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-2503
EI 2040-2511
J9 MEDCHEMCOMM
JI MedChemComm
PD AUG
PY 2014
VL 5
IS 8
BP 1208
EP 1212
DI 10.1039/c4md00056k
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA AN1OP
UT WOS:000340353500023
OA Green Published
DA 2018-10-20
ER

PT J
AU Usharani, N
   Jayakumar, GC
   Kanth, SV
   Rao, JR
AF Usharani, Nagarajan
   Jayakumar, Gladstone Christopher
   Kanth, Swarna Vinodh
   Rao, Jonnalagadda Raghava
TI Stabilization of Collagen Through Bioconversion: An Insight in
   Protein-Protein Interaction
SO BIOPOLYMERS
LA English
DT Article
DE collagen; aldehyde forming enzyme; bioconversion; denaturation
   temperature; stabilization
ID SCHIZOPHYLLUM-COMMUNE; ENZYME; ACID
AB Collagen is a natural protein, which is used as a vital biomaterial in tissue engineering. The major concern about native collagen is lack of its thermal stability and weak resistance to proteolytic degradation. In this scenario, the crosslinking compounds used for stabilization of collagen are mostly of chemical nature and exhibit toxicity. The enzyme mediated crosslinking of collagen provides a novel alternative, nontoxic method for stabilization. In this study, aldehyde forming enzyme (AFE) is used in the bioconversion of hydroxylmethyl groups of collagen to formyl groups that results in the formation of peptidyl aldehyde. The resulted peptidyl aldehyde interacts with bipolar ions of basic amino acid residues of collagen. Further interaction leads to the formation of conjugated double bonds (aldol condensation involving the aldehyde group of peptidyl aldehyde) within the collagen. The enzyme modified collagen matrices have shown an increase in the denaturation temperature, when compared with native collagen. Enzyme modified collagen membranes exhibit resistance toward collagenolytic activity. Moreover, they exhibited a nontoxic nature. The catalytic activity of AFE on collagen as a substrate establishes an efficient modification, which enhances the structural stability of collagen. This finds new avenues in the context of protein-protein stabilization and discovers paramount application in tissue engineering. (C) 2014 Wiley Periodicals, Inc.
C1 [Usharani, Nagarajan; Kanth, Swarna Vinodh] CSIR, CHORD, CSIR Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
   [Jayakumar, Gladstone Christopher; Rao, Jonnalagadda Raghava] CSIR, Chem Lab, CSIR Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
RP Kanth, SV (reprint author), CSIR, CHORD, CSIR Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
EM bioclri@lycos.com
FU All India Council for Technical Education, New Delhi
FX One of the authors (Usharani) thanks the All India Council for Technical
   Education, New Delhi for the National Doctoral fellowship.
CR AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   DOYLE BB, 1975, BIOPOLYMERS, V14, P937, DOI 10.1002/bip.1975.360140505
   Jayakumar GC, 2012, CARBOHYD POLYM, V87, P1482, DOI 10.1016/j.carbpol.2011.09.042
   KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206
   Kanth SV, 2009, PROCESS BIOCHEM, V44, P869, DOI 10.1016/j.procbio.2009.04.008
   Kuznetsova NP, 2002, RUSS J APPL CHEM+, V75, P974, DOI 10.1023/A:1020353200456
   Nimni M. E., 1988, MOL STRUCTURES FUNCT, VI, P128
   Okuyama K, 2006, BIOPOLYMERS, V84, P421, DOI 10.1002/bip.20499
   Orban J. M., 2003, J BIOMED MATER RES A, V1, P756
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   RAMACHANDRAN GN, 1968, BIOPOLYMERS, V6, P1649, DOI 10.1002/bip.1968.360061109
   RAMACHANDRAN GN, 1968, BIOPOLYMERS, V6, P1771, DOI 10.1002/bip.1968.360061213
   RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0
   RYAN JN, 1971, BIOCHEM BIOPH RES CO, V44, P144, DOI 10.1016/S0006-291X(71)80170-5
   TACHIBANA S, 1981, J BIOL CHEM, V256, P6682
   TACHIBANA S, 1980, J NUTR SCI VITAMINOL, V26, P419
   Usharani N., 2013, INT J BIOL MACROMOL, V61, P404
   Usharani N, 2013, INT J PEPT RES THER, V19, P357, DOI 10.1007/s10989-013-9359-7
   Usharani N, 2012, J MACROMOL SCI A, V49, P666, DOI 10.1080/10601325.2012.697038
   Veelaert S, 1997, CARBOHYD POLYM, V32, P131, DOI 10.1016/S0144-8617(96)00160-9
   Wilhelm P., 1996, ANAL CHEM, V68, P3354
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 24
TC 5
Z9 6
U1 0
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD AUG
PY 2014
VL 101
IS 8
BP 903
EP 911
DI 10.1002/bip.22473
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AJ9IS
UT WOS:000338023100008
PM 25098180
DA 2018-10-20
ER

PT J
AU Huang, Y
   Wang, TH
   Ji, MZ
   Yang, JZ
   Zhu, CL
   Sun, DP
AF Huang, Yang
   Wang, Tianhe
   Ji, Mingzhong
   Yang, Jiazhi
   Zhu, Chunlin
   Sun, Dongping
TI Simple preparation of carbonized bacterial cellulose-Pt composite as a
   high performance electrocatalyst for direct methanol fuel cells (DMFC)
SO MATERIALS LETTERS
LA English
DT Article
DE CBC; Biomaterial; XPS; Electrocatalytic activity
ID PLATINUM CATALYSTS; OXIDATION; SUPPORT
AB Immobilization of ultrafine-sized Pt nanoparticles on carbonized bacterial cellulose (CBC) prepared from renewable biomaterial is described. The material was investigated as an anode catalytic substrate for direct methanol fuel cells (DMFC). Specific surface analysis and X-ray photoelectron spectroscopy (XPS) results demonstrated that CBC has both suitable structural and chemical properties when it acted as a substrate material. Transmission electron microscopy (TEM) and X-ray diffraction (XRD) measurements revealed that ultrafine-sized Pt nanopartides with narrow size distribution were successfully fabricated onto CBC. Compared with Pt/Vulcan, the Pt/CBC catalyst exhibited superior electrocatalytic activity with an improved tolerance to poisoning species in methanol electro-oxidation process. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Huang, Yang; Wang, Tianhe; Ji, Mingzhong; Yang, Jiazhi; Zhu, Chunlin; Sun, Dongping] Nanjing Univ Sci & Technol, Chemicobiol & Funct Mat Inst, Nanjing 210094, Jiangsu, Peoples R China.
RP Sun, DP (reprint author), Nanjing Univ Sci & Technol, Chemicobiol & Funct Mat Inst, Nanjing 210094, Jiangsu, Peoples R China.
EM sundpe301@163.com
FU Fundamental Research Funds for the Central Universities
   [30920130121001]; Priority Academic Program Development of Jiangsu
   Higher Education Institutions (PAPD, China)
FX This work was supported by the Fundamental Research Funds for the
   Central Universities (No. 30920130121001), and a project funded by the
   Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD, China).
CR Basri S, 2010, INT J HYDROGEN ENERG, V35, P7957, DOI 10.1016/j.ijhydene.2010.05.111
   Chen JH, 2006, J PHYS CHEM B, V110, P11775, DOI 10.1021/jp061045a
   Guha A, 2007, CARBON, V45, P1506, DOI 10.1016/j.carbon.2007.03.023
   Guo JS, 2006, CARBON, V44, P152, DOI 10.1016/j.carbon.2005.06.047
   Huang HJ, 2012, J POWER SOURCES, V204, P46, DOI 10.1016/j.jpowsour.2012.01.023
   Huang HX, 2008, J POWER SOURCES, V175, P166, DOI 10.1016/j.jpowsour.2007.08.107
   Lee J, 2002, ELECTROCHIM ACTA, V47, P2297, DOI 10.1016/S0013-4686(02)00075-0
   Mamat MS, 2010, INT J HYDROGEN ENERG, V35, P7580, DOI 10.1016/j.ijhydene.2010.04.147
   Pozio A, 2002, J POWER SOURCES, V105, P13, DOI 10.1016/S0378-7753(01)00921-1
   Qiao Y, 2011, J MATER CHEM, V21, P4027, DOI 10.1039/c0jm02871a
   Rhim YR, 2010, CARBON, V48, P1012, DOI 10.1016/j.carbon.2009.11.020
   Schlange A, 2012, J POWER SOURCES, V199, P22, DOI 10.1016/j.jpowsour.2011.09.107
   Selvarani G, 2007, ELECTROCHIM ACTA, V52, P4871, DOI 10.1016/j.electacta.2006.12.080
   Xie XF, 2008, HOLZFORSCHUNG, V62, P591, DOI 10.1515/HF.2008.090
   Yang JZ, 2009, ELECTROCHIM ACTA, V54, P6300, DOI 10.1016/j.electacta.2009.05.073
NR 15
TC 14
Z9 15
U1 2
U2 52
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD AUG 1
PY 2014
VL 128
BP 93
EP 96
DI 10.1016/j.matlet.2014.04.128
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AJ7KQ
UT WOS:000337876000024
DA 2018-10-20
ER

PT J
AU Zang, SS
   Sun, Z
   Liu, K
   Wang, G
   Zhang, R
   Liu, BF
   Yang, G
AF Zang, Shanshan
   Sun, Zhen
   Liu, Kun
   Wang, Gang
   Zhang, Ran
   Liu, Bifeng
   Yang, Guang
TI Ordered manufactured bacterial cellulose as biomaterial of tissue
   engineering
SO MATERIALS LETTERS
LA English
DT Article
DE Acetobacter xylinum; Bacterial cellulose; Micro/nano assembling;
   Microstructure; Biomaterials
ID CAPILLARY-ELECTROPHORESIS; CHIPS; SUBSTRATE
AB Bacterial cellulose (BC) is one of the best nanosized fibrous materials produced by Acetobacter xylinum in nature. Every bacteria secretes one cellulose fibril, which pushes bacteria forward and leads to cellulose aggradation and bacterial movement in a straight line. Usually, A. xylinum moves randomly in all directions and BC in irregular network is formed when it is cultured in static liquid medium. In this paper, a new engineering process based on advanced biomanufacturing technique to prepare ordered BC was put forward. Microgroove molds of agarose were prepared. The movement of A. xylinum in microgroove was restricted by oxygen and the groove. BC of grid and strip structure could be obtained after precise control of culture. This work can set the foundation for BC to be used as tissue engineering scaffold in repair of nerve, skeleton and hamstring. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zang, Shanshan; Sun, Zhen; Liu, Kun; Wang, Gang; Zhang, Ran; Liu, Bifeng; Yang, Guang] Huazhong Univ Sci & Technol, Dept Biomed Engn, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.
RP Yang, G (reprint author), Huazhong Univ Sci & Technol, Dept Biomed Engn, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.
EM yang_sunny@yahoo.com
FU National Natural Science Foundation of P.R. China [21074041]
FX This project was supported by the National Natural Science Foundation of
   P.R. China (21074041).
CR Ayres CE, 2008, J BIOMAT SCI-POLYM E, V19, P603, DOI 10.1163/156856208784089643
   Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484
   FAN ZH, 1994, ANAL CHEM, V66, P177, DOI 10.1021/ac00073a029
   Kondo T, 2001, BIOMACROMOLECULES, V2, P1324, DOI 10.1021/bm0101318
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P10774, DOI 10.1021/ja00076a038
   MANZ A, 1992, J CHROMATOGR, V593, P253, DOI 10.1016/0021-9673(92)80293-4
   Masuda K, 2003, SOLID STATE NUCL MAG, V23, P198, DOI 10.1016/S0926-2040(03)00013-4
   Putra A, 2008, POLYM J, V40, P137, DOI 10.1295/polymj.PJ2007180
   Uraki X, 2007, CARBOHYD POLYM, V69, P1
   Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616
   WITTMANN JC, 1991, NATURE, V352, P414, DOI 10.1038/352414a0
   Woolley AT, 1997, ANAL CHEM, V69, P2181, DOI 10.1021/ac961237+
   WOOLLEY AT, 1995, ANAL CHEM, V67, P3676, DOI 10.1021/ac00116a010
   YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032
   Yan L, 1998, J AM CHEM SOC, V120, P6179, DOI 10.1021/ja980770z
   Yang G., 2006, SCIENCE, V58, P14
   Yuan B, 2012, ADV MATER, V24, P890, DOI 10.1002/adma.201104589
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
NR 18
TC 14
Z9 16
U1 5
U2 57
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD AUG 1
PY 2014
VL 128
BP 314
EP 318
DI 10.1016/j.matlet.2014.04.183
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AJ7KQ
UT WOS:000337876000081
DA 2018-10-20
ER

PT J
AU Weissmueller, NT
   Schiffter, HA
   Pollard, AJ
   Tas, AC
AF Weissmueller, Nikolas T.
   Schiffter, Heiko A.
   Pollard, Andrew J.
   Tas, A. Cuneyt
TI Molten salt synthesis of potassium-containing hydroxyapatite
   microparticles used as protein substrate
SO MATERIALS LETTERS
LA English
DT Article
DE Hydroxyapatite; Biomaterial; Molten salt synthesis; Bovine serum
   albumin; Adsorption
ID SYNTHESIS ROUTE; ADSORPTION; BIOCERAMICS; WHISKERS
AB The bioactivity of a material may be favorably altered by exerting control over its protein sorption propensity. Spheroidal potassium-containing calcium phosphate bioceramic microparticles were manufactured by molten salt synthesis. The effects on particle characteristics and adsorption of bovine serum albumin (BSA) of different hydroxyapatite (HA, Ca-10(PO4)(6)(OH)(2) to salt flux (K2SO4) ratios were investigated. X-ray diffraction (XRD) patterns showed the emergence of minor phases in addition to the HA major phase with increased salt flux. Synthesized particles were found to increase in potassium content with increasing HA:K2SO4 ratio. Conversely, the amount of BSA adsorption onto microparticles, normalized for surface area, decreased with excess K2SO4. The results indicate that K2SO4 content can impact the morphology, composition, and BSA adsorption propensity of the resultant bioceramic microparticles. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Weissmueller, Nikolas T.; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 7LE, England.
   [Weissmueller, Nikolas T.; Pollard, Andrew J.] NIHR Oxford Biomed Res Inst, Oxford OX3 7LE, England.
   [Weissmueller, Nikolas T.; Schiffter, Heiko A.] Univ Oxford, Biotherapy &Biopharmaceut Lab, Oxford OX3 7DQ, England.
   [Weissmueller, Nikolas T.; Pollard, Andrew J.] Univ Oxford, Old Indian Inst, Oxford Martin Sch, Oxford OX1 3BD, England.
   [Tas, A. Cuneyt] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.
RP Weissmueller, NT (reprint author), Inst Biomed Engn, Old Rd Campus Res Bldg, Oxford OX3 7DQ, England.
EM nikolas.weissmueller@gmail.com
FU Oxford Martin School; Department of Paediatrics; Biomedical Ultrasonics,
   Biotherapy & Biopharmaceuticals Laboratory at the University of Oxford
FX The authors gratefully acknowledge the Oxford Martin School, the
   Department of Paediatrics and the Biomedical Ultrasonics, Biotherapy &
   Biopharmaceuticals Laboratory at the University of Oxford for the
   generous funding. The authors would also like to thank Dr P. Holdway
   (Oxford Materials Characterisation Service) for his assistance with
   X-ray diffraction.
CR Augustine R, 2009, MICROW OPT TECHN LET, V51, P2923, DOI 10.1002/mop.24752
   Cormack AN, 2012, PHILOS T R SOC A, V370, P1271, DOI 10.1098/rsta.2011.0371
   El Kady AA, 2009, CERAM INT, V35, P2933, DOI 10.1016/j.ceramint.2009.03.042
   Fujii E, 2006, ACTA BIOMATER, V2, P69, DOI 10.1016/j.actbio.2005.09.002
   HENCH LL, 1993, AM CERAM SOC BULL, V72, P93
   Kandori K, 2010, J PHYS CHEM B, V114, P2399, DOI 10.1021/jp911783r
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kimura T., 2011, ADV CERAMICS SYNTHES
   Tas AC, 2001, POWDER DIFFR, V16, P102, DOI 10.1154/1.1330273
   Tas AC, 2001, J AM CERAM SOC, V84, P295
   TOMAZIC BB, 1991, J CRYST GROWTH, V108, P670, DOI 10.1016/0022-0248(91)90247-3
   Vasile E, 2012, MATER LETT, V79, P85, DOI 10.1016/j.matlet.2012.03.099
   Zhang HG, 2006, J MATER SCI-MATER M, V17, P691, DOI 10.1007/s10856-006-9679-7
   Zhuang Z, 2013, J MATER SCI-MATER M, V24, P1211, DOI 10.1007/s10856-013-4879-4
NR 14
TC 2
Z9 2
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD AUG 1
PY 2014
VL 128
BP 421
EP 424
DI 10.1016/j.matlet.2014.04.154
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AJ7KQ
UT WOS:000337876000108
DA 2018-10-20
ER

PT J
AU Liu, C
   Thormann, E
   Claesson, PM
   Tyrode, E
AF Liu, Chao
   Thormann, Esben
   Claesson, Per M.
   Tyrode, Eric
TI Surface Grafted Chitosan Gels. Part II. Gel Formation and
   Characterization
SO LANGMUIR
LA English
DT Article
ID CROSS-LINKING; POLYELECTROLYTE MULTILAYERS; AQUEOUS-SOLUTION;
   THIN-FILMS; GLUTARALDEHYDE; SPECTROSCOPY; ACID; BIODEGRADATION;
   DERIVATIVES; MECHANISM
AB Responsive biomaterial hydrogels attract significant attention due to their biocompatibility and degradability. In order to make chitosan based gels, we first graft one layer of chitosan to silica, and then build a chitosan/poly(acrylic acid) multilayer using the layer-by-layer approach. After cross-linking the chitosan present in the polyelectrolyte multilayer, poly(acrylic acid) is partly removed by exposing the multilayer structure to a concentrated carbonate buffer solution at a high pH, leaving a surface-grafted cross-linked gel. Chemical cross-linking enhances the gel stability against detachment and decomposition. The chemical reaction between gluteraldehyde, the cross-linking agent, and chitosan was followed in situ using total internal reflection Raman (TIRR) spectroscopy, which provided a molecular insight into the complex reaction mechanism, as well as the means to quantify the cross-linking density. The amount of poly(acrylic acid) trapped inside the surface grafted films was found to decrease with decreasing cross-linking density, as confirmed in situ using TIRR, and ex situ by Fourier transform infrared (FTIR) measurements on dried films. The responsiveness of the chitosan-based gels with respect to pH changes was probed by quartz crystal microbalance with dissipation (QCM-D) and TIRR. Highly cross-linked gels show a small and fully reversible behavior when the solution pH is switched between pH 2.7 and 5.7. In contrast, low cross-linked gels are more responsive to pH changes, but the response is fully reversible only after the first exposure to the acidic solution, once an internal restructuring of the gel has taken place. Two distinct plc's for both chitosan and poly(acrylic acid), were determined for the cross-linked structure using TIRR. They are associated with populations of chargeable groups displaying either a bulk like dissociation behavior or forming ionic complexes inside the hydrogel film.
C1 [Liu, Chao; Claesson, Per M.; Tyrode, Eric] KTH Royal Inst Technol, Dept Chem Surface & Corros Sci, Sch Chem Sci & Engn, SE-10044 Stockholm, Sweden.
   [Thormann, Esben] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark.
   [Claesson, Per M.] SP Tech Res Inst Sweden, SE-11486 Stockholm, Sweden.
RP Tyrode, E (reprint author), KTH Royal Inst Technol, Dept Chem Surface & Corros Sci, Sch Chem Sci & Engn, Drottning Kristinas Vag 51, SE-10044 Stockholm, Sweden.
EM tyrode@kth.se
RI Thormann, Esben/C-9834-2014
OI Thormann, Esben/0000-0002-2364-3493
FU Swedish Research Council, VR; Swedish Foundation for Strategic Research
   (SSF)
FX All authors acknowledge individual financial support from the Swedish
   Research Council, VR. E.Th. and E.Ty. also acknowledge support from the
   Swedish Foundation for Strategic Research (SSF) through the programs
   "Microstructure, Corrosion and Friction Control" and "Future Research
   Leaders-5", respectively.
CR Argiielles-Monal W., 1988, MAKROMOL CHEM-RAPID, V9, P693
   Badawy MEI, 2004, BIOMACROMOLECULES, V5, P589, DOI 10.1021/bm0344295
   BARDET L, 1975, J MOL STRUCT, V24, P153, DOI 10.1016/0022-2860(75)85072-1
   Bechler SL, 2012, BIOMACROMOLECULES, V13, P1523, DOI 10.1021/bm300234q
   Bellamy L. J., 1980, INFRARED SPECTRA COM
   Bongaerts JHH, 2009, BIOMACROMOLECULES, V10, P1287, DOI 10.1021/bm801079a
   Boudou T, 2009, LANGMUIR, V25, P13809, DOI 10.1021/la9018663
   Choi J, 2005, MACROMOLECULES, V38, P116, DOI 10.1021/ma048596o
   Colthup NB, 1990, INTRO INFRARED RAMAN, P547
   Dedinaite A., 2007, ENCY SURFACE COLLOID, P1
   Dubas ST, 2001, J AM CHEM SOC, V123, P5368, DOI 10.1021/ja015774+
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Israelachvili J. N., 2011, INTERMOLECULAR SURFA, P674
   JOHANNSMANN D, 1992, PHYS REV B, V46, P7808, DOI 10.1103/PhysRevB.46.7808
   KAJIWARA K, 1992, NATURE, V355, P208, DOI 10.1038/355208a0
   Kildeeva NR, 2009, RUSS J BIOORG CHEM+, V35, P360, DOI 10.1134/S106816200903011X
   Kovacevic D, 2002, LANGMUIR, V18, P5607, DOI 10.1021/la025639q
   Lee K, 2013, CHEM COMMUN, V49, P3028, DOI 10.1039/c3cc40799c
   LEYTE JC, 1967, SPECTROCHIM ACTA A-M, VA 23, P1397, DOI 10.1016/0584-8539(67)80361-1
   Liu C., 2014, LANGMUIR, DOI [10.1021/1a5013186, DOI 10.1021/1A5013186]
   Liu C, 2012, SOFT MATTER, V8, P10241, DOI 10.1039/c2sm26615f
   Malinowski E.R, 2002, FACTOR ANAL CHEM
   Mansour JM, 2003, KINESIOLOGY MECH PAT, P1992
   MARGEL S, 1980, MACROMOLECULES, V13, P19, DOI 10.1021/ma60073a004
   Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01
   MONSAN P, 1975, BIOCHIMIE, V57, P1281
   MOW VC, 1984, J BIOMECH, V17, P377, DOI 10.1016/0021-9290(84)90031-9
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Rinaudo M, 1999, POLYMER, V40, P7029, DOI 10.1016/S0032-3861(99)00056-7
   Sashiwa H, 2003, BIOMACROMOLECULES, V4, P1244, DOI 10.1021/bm030021w
   SAURBREY G, 1959, Z PHYS, V155, P206
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Suto S, 1996, J APPL POLYM SCI, V61, P2273, DOI 10.1002/(SICI)1097-4628(19960926)61:13<2273::AID-APP5>3.0.CO;2-9
   Tokarev I, 2009, SOFT MATTER, V5, P511, DOI 10.1039/b813827c
   Tyrode E, 2013, J PHYS CHEM C, V117, P1780, DOI 10.1021/jp310732f
   Tyrode E, 2008, J AM CHEM SOC, V130, P17434, DOI 10.1021/ja805169z
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Wang BL, 2013, ACS APPL MATER INTER, V5, P4136, DOI 10.1021/am4000547
   Woods DA, 2012, ANALYST, V137, P35, DOI 10.1039/c1an15722a
   Yamamoto H, 1997, MACROMOLECULES, V30, P3936, DOI 10.1021/ma961766f
   Zhang YJ, 2005, BIOMACROMOLECULES, V6, P2365, DOI 10.1021/bm050058b
   Zhao ZM, 2009, BIOMACROMOLECULES, V10, P565, DOI 10.1021/bm801225m
NR 43
TC 16
Z9 17
U1 4
U2 63
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 29
PY 2014
VL 30
IS 29
BP 8878
EP 8888
DI 10.1021/la501319r
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AM2MY
UT WOS:000339686700029
PM 25006685
OA Bronze
DA 2018-10-20
ER

PT J
AU Rodrigo-Navarro, A
   Rico, P
   Saadeddin, A
   Garcia, AJ
   Salmeron-Sanchez, M
AF Rodrigo-Navarro, Aleixandre
   Rico, Patricia
   Saadeddin, Anas
   Garcia, Andres J.
   Salmeron-Sanchez, Manuel
TI Living biointerfaces based on non-pathogenic bacteria to direct cell
   differentiation
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LACTOCOCCUS-LACTIS; FIBRONECTIN CONFORMATION; BIOFILM FORMATION;
   POSITIVE ROLE; ADHESION; HYDROGELS; INTEGRIN; MORPHOGENESIS; SURFACES;
   BINDING
AB Genetically modified Lactococcus lactis, non-pathogenic bacteria expressing the FNIII7-10 fibronectin fragment as a protein membrane have been used to create a living biointerface between synthetic materials and mammalian cells. This FNIII7-10 fragment comprises the RGD and PHSRN sequences of fibronectin to bind alpha 5 beta 1 integrins and triggers signalling for cell adhesion, spreading and differentiation. We used L. lactis strain to colonize material surfaces and produce stable biofilms presenting the FNIII7-10 fragment readily available to cells. Biofilm density is easily tunable and remains stable for several days. Murine C2C12 myoblasts seeded over mature biofilms undergo bipolar alignment and form differentiated myotubes, a process triggered by the FNIII7-10 fragment. This biointerface based on living bacteria can be further modified to express any desired biochemical signal, establishing a new paradigm in biomaterial surface functionalisation for biomedical applications.
C1 [Rodrigo-Navarro, Aleixandre; Rico, Patricia] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia, Spain.
   [Saadeddin, Anas] Abengoa Res, Seville, Spain.
   [Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Rodrigo-Navarro, Aleixandre; Salmeron-Sanchez, Manuel] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow G12 8LT, Lanark, Scotland.
RP Salmeron-Sanchez, M (reprint author), Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow G12 8LT, Lanark, Scotland.
EM Manuel.Salmeron-Sanchez@glasgow.ac.uk
RI Rico, Patricia/N-2540-2014; Salmeron-Sanchez, Manuel/E-4680-2010
OI Rico, Patricia/0000-0002-4918-9313; Salmeron-Sanchez,
   Manuel/0000-0002-8112-2100; Rodrigo-Navarro,
   Aleixandre/0000-0002-3786-0464
FU ERC through HealInSynergy [306990]
FX The support from ERC through HealInSynergy 306990 is acknowledged.
CR AOTA S, 1994, J BIOL CHEM, V269, P24756
   Araujo JC, 2003, J ELECTRON MICROSC, V52, P429, DOI 10.1093/jmicro/52.4.429
   BACON JA, 1990, TOXICOL IN VITRO, V4, P384, DOI 10.1016/0887-2333(90)90085-8
   Bhaduri S, 2012, FOODBORNE PATHOG DIS, V9, P172, DOI 10.1089/fpd.2011.0979
   Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05
   Chatzizacharias NA, 2008, TOXICOLOGY, V245, P1, DOI 10.1016/j.tox.2007.12.003
   Clemente CFMZ, 2005, AM J PHYSIOL-REG I, V289, pR862, DOI 10.1152/ajpregu.00348.2004
   Connell SR, 2003, ANTIMICROB AGENTS CH, V47, P3675, DOI 10.1128/AAC.47.12.3675-3681.2003
   Cortes-Perez NG, 2008, VACCINE, V26, P5778, DOI 10.1016/j.vaccine.2008.08.044
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Dawson R. M. C., 1989, DATA BIOCH RES
   Dufrene YF, 2008, NAT PROTOC, V3, P1132, DOI 10.1038/nprot.2008.101
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Giaouris E, 2009, INT J FOOD MICROBIOL, V131, P2, DOI 10.1016/j.ijfoodmicro.2008.09.006
   GODON JJ, 1994, MOL MICROBIOL, V12, P655, DOI 10.1111/j.1365-2958.1994.tb01053.x
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697
   Guiot E, 2002, PHOTOCHEM PHOTOBIOL, V75, P570, DOI 10.1562/0031-8655(2002)075<0570:HODIMB>2.0.CO;2
   Habimana O, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-36
   Habimana O, 2009, APPL ENVIRON MICROB, V75, P7814, DOI 10.1128/AEM.01333-09
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kirschner CM, 2014, ADV HEALTHC MATER, V3, P649, DOI 10.1002/adhm.201300288
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304
   Mancini A, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-36
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Mercier C, 2002, MOL MICROBIOL, V46, P235, DOI 10.1046/j.1365-2958.2002.03160.x
   Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196
   Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39
   Oxaran V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050989
   Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Petrie TA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001002
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040
   Rico P, 2010, COLLOID SURFACE B, V78, P310, DOI 10.1016/j.colsurfb.2010.03.019
   Rieu A, 2008, APPL ENVIRON MICROB, V74, P4491, DOI 10.1128/AEM.00255-08
   Rivadeneira J, 2014, J APPL MICROBIOL, V116, P1438, DOI 10.1111/jam.12476
   Saadeddin A, 2013, ADV HEALTHC MATER, V2, P1213, DOI 10.1002/adhm.201200473
   Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x
   Salmeron-Sanchez M, 2011, BIOMATERIALS, V32, P2099, DOI 10.1016/j.biomaterials.2010.11.057
   Sastry SK, 1999, J CELL BIOL, V144, P1295, DOI 10.1083/jcb.144.6.1295
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99
   Schotte L, 2000, ENZYME MICROB TECH, V27, P761, DOI 10.1016/S0141-0229(00)00297-0
   Silva AKA, 2009, BIOMACROMOLECULES, V10, P9, DOI 10.1021/bm801103c
   Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x
   Todd SJ, 2009, LANGMUIR, V25, P7533, DOI 10.1021/la900376h
   UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039
   Ulijn RV, 2006, J MATER CHEM, V16, P2217, DOI 10.1039/b601776m
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   Weis S, 2013, ACTA BIOMATER, V9, P8059, DOI 10.1016/j.actbio.2013.06.019
   Zaidi AH, 2011, APPL ENVIRON MICROB, V77, P2602, DOI 10.1128/AEM.01709-10
NR 59
TC 5
Z9 5
U1 1
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 28
PY 2014
VL 4
AR 5849
DI 10.1038/srep05849
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM0CT
UT WOS:000339511300002
PM 25068919
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Xu, HL
   Cai, SB
   Xu, L
   Yang, YQ
AF Xu, Helan
   Cai, Shaobo
   Xu, Lan
   Yang, Yiqi
TI Water-Stable Three-Dimensional Ultrafine Fibrous Scaffolds from Keratin
   for Cartilage Tissue Engineering
SO LANGMUIR
LA English
DT Article
ID SODIUM DODECYL-SULFATE; ELECTROSPUN ZEIN FIBERS; MESENCHYMAL STEM-CELLS;
   IN-VITRO; EXTRACELLULAR MATRICES; NANOFIBROUS SCAFFOLDS; CROSS-LINKING;
   FABRICATION; CHITOSAN; BLEND
AB Intrinsically water-stable scaffolds composed of ultrafine keratin fibers oriented randomly and evenly in three dimensions were electrospun for cartilage tissue engineering. Keratin has been recognized as a biomaterial that could substantially support the growth and development of multiple cell lines. Besides, three-dimensional (3D) ultrafine fibrous structures were preferred in tissue engineering due to their structural similarity to native extracellular matrices in soft tissues. Recently, we have developed a nontraditional approach to developing 3D fibrous scaffolds from alcohol-soluble corn protein, zein, and verified their structural advantages in tissue engineering. However, keratin with highly cross-linked molecular structures could not be readily dissolved in common solvents for fiber spinning, which required the remarkable drawability of solution. So far, 3D fibrous scaffolds from pure keratin for biomedical applications have not been reported. In this research, the highly cross-linked keratin from chicken feathers was de-cross-linked and disentangled into linear and aligned molecules with preserved molecular weights, forming highly stretchable spinning dope. The solution was readily electrospun into scaffolds with ultrafine keratin fibers oriented randomly in three dimensions. Due to the highly cross-linked molecular structures, keratin scaffolds showed intrinsic water stability. Adipose-derived mesenchymal stem cells could penetrate much deeper, proliferate, and chondrogenically differentiate remarkably better on the 3D keratin scaffolds than on 2D PLA fibrous scaffolds, 3D soy protein fibrous scaffolds, or 3D commercial nonfibrous scaffolds. In summary, the electrospun 3D ultrafine fibrous scaffolds from keratin could be promising candidates for cartilage tissue engineering.
C1 [Xu, Helan; Cai, Shaobo; Yang, Yiqi] Univ Nebraska, Dept Text Merchandising & Fash Design, Lincoln, NE 68583 USA.
   [Cai, Shaobo; Yang, Yiqi] Donghua Univ, Key Lab Sci & Technol Ecotext, Minist Educ, Shanghai 201620, Peoples R China.
   [Xu, Lan] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68583 USA.
   [Yang, Yiqi] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68583 USA.
   [Yang, Yiqi] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68583 USA.
RP Yang, YQ (reprint author), Univ Nebraska, Dept Text Merchandising & Fash Design, 234 HECO Bldg, Lincoln, NE 68583 USA.
EM yyang2@unl.edu
RI Yang, Yiqi/A-6900-2009
OI Yang, Yiqi/0000-0001-8153-4159
FU Agricultural Research Division at the University of Nebraska-Lincoln;
   USDA Hatch Act, Multistate Research Project S-1054 [NEB 37-037]; Science
   and Technology Commission of Shanghai Municipality [12JC1400300]; John
   and Louise Skala Fellowship; AATCC student research grant
FX This research was financially supported by the Agricultural Research
   Division at the University of Nebraska-Lincoln, the USDA Hatch Act,
   Multistate Research Project S-1054 (NEB 37-037), and the key scientific
   and technological projects of the Science and Technology Commission of
   Shanghai Municipality no. 12JC1400300. We are grateful for the awarding
   of the John and Louise Skala Fellowship and an AATCC student research
   grant for H.X. and S.C. We also thank Dr. Han Chen for his help with
   SEM, Terri Fangman and Christian Elowsky for their help with CLSM, and
   Dr. Shadi Othman and Dr. Karin Wartella for their help with cell
   culturing.
CR Aluigi A, 2008, EUR POLYM J, V44, P2465, DOI 10.1016/j.eurpolymj.2008.06.004
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Burnett LR, 2013, BIOMATERIALS, V34, P2632, DOI 10.1016/j.biomaterials.2012.12.022
   Cai SB, 2013, LANGMUIR, V29, P2311, DOI [10.1021/la304414j, 10.1021/la304414]
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Gallezot P, 2007, GREEN CHEM, V9, P295, DOI 10.1039/b615413a
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   Ghosh S, 2002, BIOMACROMOLECULES, V3, P9, DOI 10.1021/bm005644d
   Holzwarth JM, 2011, J MATER CHEM, V21, P10243, DOI 10.1039/c1jm10522a
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Huang ZM, 2006, J BIOMED MATER RES A, V77A, P169, DOI 10.1002/jbm.a.30564
   Jiang QR, 2013, J BIOMED MATER RES A, V101, P1237, DOI 10.1002/jbm.a.34422
   Jiang QR, 2011, J BIOMAT SCI-POLYM E, V22, P1393, DOI 10.1163/092050610X508437
   Jiang QR, 2010, ACTA BIOMATER, V6, P4042, DOI 10.1016/j.actbio.2010.04.024
   JONES MN, 1967, J COLLOID INTERF SCI, V23, P36, DOI 10.1016/0021-9797(67)90082-3
   Ki CS, 2007, J MEMBRANE SCI, V302, P20, DOI 10.1016/j.memsci.2007.06.003
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li JS, 2009, POLYM DEGRAD STABIL, V94, P1800, DOI 10.1016/j.polymdegradstab.2009.06.004
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Liu XH, 2009, BIOMATERIALS, V30, P4094, DOI 10.1016/j.biomaterials.2009.04.024
   Meng LH, 2012, J MATER CHEM, V22, P19412, DOI 10.1039/c2jm31618h
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MOREN AK, 1995, LANGMUIR, V11, P3636, DOI 10.1021/la00010a009
   Moroni L, 2008, ADV FUNCT MATER, V18, P53, DOI 10.1002/adfm.200601158
   Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073
   Poole A. J., 2008, BIOMACROMOLECULES, V10, P1, DOI DOI 10.1021/BM8010648
   Reichl S, 2011, BIOMATERIALS, V32, P3375, DOI 10.1016/j.biomaterials.2011.01.052
   Simonet M, 2007, POLYM ENG SCI, V47, P2020, DOI 10.1002/pen.20914
   Solorio LD, 2012, J CONTROL RELEASE, V158, P224, DOI 10.1016/j.jconrel.2011.11.003
   Son WK, 2004, POLYMER, V45, P2959, DOI 10.1016/j.polymer.2004.02.006
   SUZUKI H, 1988, ANAL BIOCHEM, V172, P259, DOI 10.1016/0003-2697(88)90440-X
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Wada M, 2006, APPL MICROBIOL BIOT, V73, P48, DOI 10.1007/s00253-006-0587-z
   Xu HL, 2014, J BIOTECHNOL, V184, P179, DOI 10.1016/j.jbiotec.2014.05.011
   Xu HL, 2014, ACS SUSTAIN CHEM ENG, V2, P1404, DOI 10.1021/sc400461d
   Xu HL, 2014, RSC ADV, V4, P15451, DOI 10.1039/c3ra47547f
   Xu HL, 2013, J ENVIRON MANAGE, V125, P33, DOI 10.1016/j.jenvman.2013.03.050
   Xu HL, 2011, J MATER CHEM, V21, P18227, DOI 10.1039/c1jm11163a
   Yokoyama Y, 2009, MATER LETT, V63, P754, DOI 10.1016/j.matlet.2008.12.042
   Yuan J, 2008, POLYM INT, V57, P1188, DOI 10.1002/pi.2463
   Zhou SB, 2008, J PHYS CHEM B, V112, P11209, DOI 10.1021/jp800913k
NR 45
TC 50
Z9 50
U1 13
U2 93
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 22
PY 2014
VL 30
IS 28
BP 8461
EP 8470
DI 10.1021/la500768b
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AL9LQ
UT WOS:000339463000027
PM 25010870
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Montanari, E
   Meier, R
   Mahou, R
   Bosco, D
   Borcard, F
   Bollinger, A
   Seebach, J
   Wandrey, C
   Morel, P
   Gonelle-Gispert, C
   Buhler, L
AF Montanari, E.
   Meier, R.
   Mahou, R.
   Bosco, D.
   Borcard, F.
   Bollinger, A.
   Seebach, J.
   Wandrey, C.
   Morel, P.
   Gonelle-Gispert, C.
   Buhler, L.
TI Alginate-PEG Biomaterial for Cell Microencapsulation and
   Xenotransplantation.
SO TRANSPLANTATION
LA English
DT Meeting Abstract
CT World Transplant Congress
CY JUL 26-31, 2014
CL San Francisco, CA
SP Amer Soc Transplant Surg, Transplantat Soc, Amer Soc Transplantat
C1 [Montanari, E.; Meier, R.; Bosco, D.; Bollinger, A.; Morel, P.; Gonelle-Gispert, C.; Buhler, L.] Univ Hosp Geneva, Dept Surg, Geneva, Switzerland.
   [Montanari, E.; Meier, R.; Bosco, D.; Bollinger, A.; Seebach, J.; Morel, P.; Gonelle-Gispert, C.; Buhler, L.] Fac Med, Geneva, Switzerland.
   [Mahou, R.; Borcard, F.; Wandrey, C.] Ecole Polytech Fed Lausanne, Lausanne, Switzerland.
   [Seebach, J.] Univ Hosp Geneva, Div Immunol & Allergy, Geneva, Switzerland.
NR 0
TC 0
Z9 0
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD JUL 15
PY 2014
VL 98
SU 1
MA C1704
BP 357
EP 357
PG 1
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA AL4LN
UT WOS:000339104602113
DA 2018-10-20
ER

PT J
AU Radovanovic, Z
   Jokic, B
   Veljovic, D
   Dimitrijevic, S
   Kojic, V
   Petrovic, R
   Janackovic, D
AF Radovanovic, Zeljko
   Jokic, Bojan
   Veljovic, Djordje
   Dimitrijevic, Suzana
   Kojic, Vesna
   Petrovic, Rada
   Janackovic, Djordje
TI Antimicrobial activity and biocompatibility of Ag--(+) and Cu2+ -doped
   biphasic hydroxyapatite/alpha-tricalcium phosphate obtained from
   hydrothermally synthesized Ag+- and Cu2+ -doped hydroxyapatite
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE HAp/alpha-TCP; Ag+-doped; Cu2+-doped; Antimicrobial; Biocompatibility
ID SUBSTITUTED HYDROXYAPATITE; ESCHERICHIA-COLI; SILVER IONS; TOTAL HIP;
   ANTIBACTERIAL; COPPER; BIOCERAMICS; CEMENT; BONE; REPLACEMENT
AB Hydroxyapatite (HAp) powders doped with Ag+ or Cu2+ were synthesized by a hydrothermal method in order to obtain biomaterial with an antimicrobial effect. The synthesis was performed with two contents of dopant (Ag+ or Cu2+) by considering both the antimicrobial activities and biocompatibility of the powders. The doped HAp was annealed at 1200 C for 2 h with the intention of investigating the influence of doping with Ag+ and Cu2+ on the creation of the biphasic HAp/alpha-tricalcium phosphate (HAp/a-TCP) and determining the antimicrobial activity and biocompatibility of the obtained biphasic powders. Analyses of all powders, undoped and doped HAp and HAp/a-TCP, were performed by Field emission scanning electron microscopy (FESEM), X-ray diffraction (XRD), atomic absorption spectroscopy (AAS) and energydispersive X-ray spectroscopy (EDS). The in vitro antibacterial activities of the powders were evaluated against: Staphylococcus aureus, Escherichia co li, Pseudomonas aeruginosa and Candida albi cans. All powders showed good antimicrobial activity but generally the powders of doped HAp/a-TCP had more uniform results against all pathogenic microorganisms than the powders of doped HAp. In vitro biocompatibility tests, MU and DET, were used to evaluate the biocompatibility of Ag+- and Cu2+-doped HAp/a-TCP with MRC-5 human fibroblast cells. These tests confirmed that powders do not have a cytotoxic effect. The HAp/a-TCP powders doped with the lower content of Ag+ and Cu2+ showed especially good biocompatibility. Antimicrobial and biocompatibility tests recommend the Ag+- and Cu2+-doped HAp/a-TCP as promising material for use in reconstructive surgery of bone. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Radovanovic, Zeljko; Jokic, Bojan; Veljovic, Djordje; Dimitrijevic, Suzana; Petrovic, Rada; Janackovic, Djordje] Univ Belgrade, Fac Technol & Met, Belgrade 11000, Serbia.
   [Kojic, Vesna] Oncol Inst Vojvodina, Sremska Kamenica 21204, Serbia.
RP Radovanovic, Z (reprint author), Univ Belgrade, Fac Technol & Met, Karnegijeva 4, Belgrade 11000, Serbia.
EM zradovanovic@tmf.bg.ac.rs
FU Ministry of Education, Science and Technological Development of the
   Republic of Serbia [FP7-REGPOT-2009-1 NANOTECH FTM]
FX The authors wish to acknowledge the financial support for this research
   from the Ministry of Education, Science and Technological Development of
   the Republic of Serbia through projects III 45019 and FP7-REGPOT-2009-1
   NANOTECH FTM.
CR Badraoui B., 2002, EUR J INORG CHEM, V2002, P1864
   Bigi A, 2007, INORG CHIM ACTA, V360, P1009, DOI 10.1016/j.ica.2006.07.074
   Bogdanovic G., 1994, ONKOLOSKI ARHIV, V2, P181
   Borkow G, 2005, CURR MED CHEM, V12, P2163, DOI 10.2174/0929867054637617
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Carrodeguas RG, 2011, ACTA BIOMATER, V7, P3536, DOI 10.1016/j.actbio.2011.06.019
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Ciobanu CS, 2013, MAT SCI ENG C-MATER, V33, P1395, DOI 10.1016/j.msec.2012.12.042
   Ciobanu CS, 2011, DIG J NANOMATER BIOS, V6, P609
   Ciobanu CS, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-324
   Ciobanu CS, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-613
   CIOBANU CS, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/916218
   Costescu A., 2013, J NANOMATER, V2013
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Darouiche RO, 1999, CLIN INFECT DIS, V29, P1371, DOI 10.1086/313561
   Dion A, 2005, BIOMATERIALS, V26, P7276, DOI 10.1016/j.biomaterials.2005.05.072
   Dorozhkin Sergey V, 2011, Biomatter, V1, P3, DOI 10.4161/biom.1.1.16782
   Dorozhkin SV, 2012, ACTA BIOMATER, V8, P963, DOI 10.1016/j.actbio.2011.09.003
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Ellis DE, 2006, PHYS CHEM CHEM PHYS, V8, P967, DOI 10.1039/b509254j
   Ewald A, 2011, ACTA BIOMATER, V7, P4064, DOI 10.1016/j.actbio.2011.06.049
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Grandi G, 2011, MATER RES-IBERO-AM J, V14, P11, DOI 10.1590/S1516-14392011005000020
   HARRIS WH, 1990, NEW ENGL J MED, V323, P801, DOI 10.1056/NEJM199009203231206
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hunt M., 1998, CURR OPIN ORTHOP, V9, P28
   Janackovic D, 2003, KEY ENG MAT, V240-2, P437, DOI 10.4028/www.scientific.net/KEM.240-242.437
   Janackovic D, 2001, KEY ENG MATER, V192-195, P203
   Jokic B, 2006, KEY ENG MAT, V309-311, P821, DOI 10.4028/www.scientific.net/KEM.309-311.821
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   Knowles J. C., 1999, BIOCERAMICS, V1999, P341
   Kojic Z, 2009, GEN PHYSIOL BIOPHYS, V28, P168
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Li Y, 2010, MAT SCI ENG C-MATER, V30, P1137, DOI 10.1016/j.msec.2010.06.011
   Lowe NM, 2002, P NUTR SOC, V61, P181, DOI 10.1079/PNS2002154
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   NASSER S, 1992, ORTHOP CLIN N AM, V23, P265
   Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457
   NIGHTINGALE ER, 1959, J PHYS CHEM-US, V63, P1381, DOI 10.1021/j150579a011
   OPSAHL W, 1982, J NUTR, V112, P708
   PETERING HG, 1976, PHARMACOL THER PT A, V1, P127, DOI 10.1016/0362-5478(76)90002-4
   Radovanovic Z, 2012, J SERB CHEM SOC, V77, P1787, DOI 10.2298/JSC121019131R
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   SCHREURS WJA, 1982, J BACTERIOL, V152, P7
   Stanic V, 2011, APPL SURF SCI, V257, P4510, DOI 10.1016/j.apsusc.2010.12.113
   Stanic V, 2010, APPL SURF SCI, V256, P6083, DOI 10.1016/j.apsusc.2010.03.124
   Stern BR, 2010, J TOXICOL ENV HEAL A, V73, P114, DOI 10.1080/15287390903337100
   Stoodley P, 2011, CURR ORTHOP PRACT, V22, P558, DOI 10.1097/BCO.0b013e318230efcf
   Tamai M, 2006, KEY ENG MAT, V309-311, P263, DOI 10.4028/www.scientific.net/KEM.309-311.263
   Tamm T, 2006, J SOLID STATE CHEM, V179, P1581, DOI 10.1016/j.jssc.2006.02.012
   Thornes B, 2002, J BONE JOINT SURG BR, V84B, P758, DOI 10.1302/0301-620X.84B5.11907
   THORNES B, 2002, DEVELOPMENT, V84, P758
   VIK H, 1985, LANCET, V1, P872
   von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003
NR 55
TC 31
Z9 32
U1 4
U2 75
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JUL 15
PY 2014
VL 307
BP 513
EP 519
DI 10.1016/j.apsusc.2014.04.066
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA AI1FW
UT WOS:000336596700071
DA 2018-10-20
ER

PT J
AU Susano, MA
   Leonor, IB
   Reis, RL
   Azevedo, HS
AF Susano, Maria A.
   Leonor, Isabel B.
   Reis, Rui L.
   Azevedo, Helena S.
TI Elastic Biodegradable Starch/Ethylene-co-Vinyl Alcohol Fibre-Mesh
   Scaffolds for Tissue Engineering Applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biodegradable; biomaterials; porous materials; mechanical properties;
   elastomers
ID ARTICULAR-CARTILAGE; POLYMER SCAFFOLDS; IN-VITRO; MECHANICAL-PROPERTIES;
   BONE-FORMATION; PORE-SIZE; MICRO-CT; DESIGN; DEGRADATION; VIVO
AB The fabrication of a biomaterial scaffold, with adequate physical and structural properties for tissue engineering applications, is reported. A blend of starch with ethylene-vinyl alcohol (50/50 w/w, SEVA-C) is used to produce 3D fibre-mesh scaffolds by wet-spinning. The scaffolds are characterized in terms of morphology, porosity, interconnectivity, and pore size, using scanning electron microscopy (SEM) and microcomputed tomography (mu CT). The degradation behavior, as well as the mechanical properties of the scaffolds, is investigated in presence of alpha-amylase enzyme at physiological concentration. Scaffolds with porosities ranging from 43 to 52%, interconnectivity of similar to 70.5% and pore size between 118 and 159 mu m, can be fabricated using the proposed methodology. The scaffolds exhibit an elastic behavior in the wet state with a compressive modulus of 7.96 +/- 0.32 MPa. Degradation studies show that SEVA-C scaffolds are susceptible to enzymatic degradation by alpha-amylase, confirmed by the increase of weight loss (40% of weight loss after 12 weeks) and presence of degradation products (reducing sugars) in solution. The diameter of SEVA-C scaffolds decreases with degradation time, increasing the overall porosity, interconnectivity and pore size. In vitro cell studies with human osteosarcoma cell line (SaOs-2) showed a nontoxic and cytocompatible behavior of the developed fibre mesh scaffolds. The positive cellular response, together with structural and degradable properties, suggests that 3D SEVA-C fibre-meshes may be good candidates as tissue engineering scaffolds. (C) 2014 Wiley Periodicals, Inc.
C1 [Susano, Maria A.; Leonor, Isabel B.; Reis, Rui L.; Azevedo, Helena S.] Univ Minho, European Inst Excellence Tissue Engn & Regenerat, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4806909 Taipas, Guimaraes, Portugal.
   [Susano, Maria A.; Leonor, Isabel B.; Reis, Rui L.; Azevedo, Helena S.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
RP Azevedo, HS (reprint author), Univ Minho, European Inst Excellence Tissue Engn & Regenerat, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
EM hazevedo@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012; Leonor,
   Isabel/B-5260-2011; Azevedo, Helena/A-8298-2011
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456;
   Leonor, Isabel/0000-0002-4319-4883; Azevedo, Helena/0000-0002-5470-1844
FU Portuguese Foundation for Science and Technology [PTDC/CTM/67560/2006];
   European Regional Development Fund (ERDF) through the Operational
   Competitiveness Programme "COMPETE" [FCOMP-01-0124-FEDER007148]
FX This work was supported by national funds through the Portuguese
   Foundation for Science and Technology under the scope of the project
   PTDC/CTM/67560/2006 and by the European Regional Development Fund (ERDF)
   through the Operational Competitiveness Programme "COMPETE"
   (FCOMP-01-0124-FEDER007148). The authors thank Dr Emanuel Fernandes of
   the 3B's Research Group at the University of Minho for his assistance
   analyzing the data from mechanical tests.
CR Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Azevedo HS, 2009, ACTA BIOMATER, V5, P3021, DOI 10.1016/j.actbio.2009.04.039
   Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Chung S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045001
   Cordell JM, 2009, J MECH BEHAV BIOMED, V2, P560, DOI 10.1016/j.jmbbm.2009.01.009
   Correlo VM, 2010, MACROMOL BIOSCI, V10, P1495, DOI 10.1002/mabi.201000011
   Dellinger JG, 2006, J BIOMED MATER RES A, V79A, P223, DOI 10.1002/ibm.a.30523
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   EGGLI PS, 1988, ANAT REC, V222, P217, DOI 10.1002/ar.1092220302
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gomes ME, 2008, J TISSUE ENG REGEN M, V2, P243, DOI 10.1002/term.89
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Isenman L, 1999, AM J PHYSIOL-ENDOC M, V276, pE223, DOI 10.1152/ajpendo.1999.276.2.E223
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Malafaya PB, 2008, BIOMATERIALS, V29, P3914, DOI 10.1016/j.biomaterials.2008.06.023
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Martina M, 2007, POLYM INT, V56, P145, DOI 10.1002/pi.2108
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013
   Pashkuleva I, 2010, MAT SCI ENG C-MATER, V30, P981, DOI 10.1016/j.msec.2010.04.019
   Pavlov MP, 2004, MACROMOL BIOSCI, V4, P776, DOI 10.1002/mabi.200400002
   Reis RL, 1997, POLYM INT, V43, P347
   Suh SW, 2002, ASAIO J, V48, P460, DOI 10.1097/01.MAT.0000026344.66193.10
   SWANN AC, 1993, BRIT J RHEUMATOL, V32, P16
   Thomas WE, 2010, MRS BULL, V35, P578, DOI 10.1557/mrs2010.525
   Vanwanseele B, 2002, OSTEOARTHR CARTILAGE, V10, P408, DOI 10.1053/joca.2002.0529
   Weigel T, 2006, EXPERT REV MED DEVIC, V3, P835, DOI 10.1586/17434440.3.6.835
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
NR 40
TC 2
Z9 2
U1 0
U2 62
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUL 15
PY 2014
VL 131
IS 14
SI SI
AR 40504
DI 10.1002/APP.40504
PG 9
WC Polymer Science
SC Polymer Science
GA AF1CO
UT WOS:000334452200015
DA 2018-10-20
ER

PT J
AU Horiuchi, N
   Nakaguki, S
   Wada, N
   Nozaki, K
   Nakamura, M
   Nagai, A
   Katayama, K
   Yamashita, K
AF Horiuchi, N.
   Nakaguki, S.
   Wada, N.
   Nozaki, K.
   Nakamura, M.
   Nagai, A.
   Katayama, K.
   Yamashita, K.
TI Polarization-induced surface charges in hydroxyapatite ceramics
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID MONOCLINIC HYDROXYAPATITE; THIN-FILMS; BONE
AB Calcium hydroxyapatite (HAp; Ca-10(PO4)(6)(OH)(2)) is a well-known biomaterial that is the main inorganic component of bones and teeth. Control over the surface charge on HAp would be a key advance in the development of the material for tissue engineering. We demonstrate here that surface charge can be induced by an electrical poling process using the Kelvin method. Positive and negative charges were induced on the HAp surface in response to the applied electric field in the poling process. The surface charging is attributed to dipole polarization that is homogeneously distributed in HAp. Additionally, the surface charging is considered to originate from the organization of OH- ions into a polar phase in the structure. (C) 2014 AIP Publishing LLC.
C1 [Horiuchi, N.; Wada, N.; Nozaki, K.; Nakamura, M.; Nagai, A.; Yamashita, K.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Inorgan Mat, Chiyoda Ku, Tokyo 1010062, Japan.
   [Nakaguki, S.; Katayama, K.] Tokai Univ, Dept Appl Chem, Hiratsuka, Kanagawa 2591292, Japan.
RP Horiuchi, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Inorgan Mat, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM nhori.bcr@tmd.ac.jp
RI Nakamura, Miho/T-3166-2017
FU JSPS KAKENHI Research Project [23300178]
FX This work was supported by JSPS KAKENHI Research Project No. 23300178.
   We would like to thank Dr. N. Hiyama for assistance involving the
   measurements using the Kelvin probe method.
CR Bodhak S, 2011, MAT SCI ENG C-MATER, V31, P755, DOI 10.1016/j.msec.2011.01.003
   Bodhak S, 2010, ACTA BIOMATER, V6, P641, DOI 10.1016/j.actbio.2009.08.008
   Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023
   Chiatti F, 2012, J PHYS CHEM C, V116, P6108, DOI 10.1021/jp212595d
   Damjanovic D, 1998, REP PROG PHYS, V61, P1267, DOI 10.1088/0034-4885/61/9/002
   ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   Habraken W. J. E. M., 2013, NAT COMMUN, V4, P1507
   Haverty D, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.094103
   HITMI N, 1980, SOLID STATE COMMUN, V33, P1003, DOI 10.1016/0038-1098(80)90301-4
   HITMI N, 1986, CALCIFIED TISSUE INT, V38, P252, DOI 10.1007/BF02556603
   HITMI N, 1986, J PHYS CHEM SOLIDS, V47, P533, DOI 10.1016/0022-3697(86)90155-1
   Horiuchi N, 2013, J APPL PHYS, V113, DOI 10.1063/1.4799130
   Horiuchi N, 2012, J APPL PHYS, V112, DOI 10.1063/1.4754298
   Ikoma T, 1999, J MATER SCI LETT, V18, P1225, DOI 10.1023/A:1006610521173
   Johann F, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3269606
   Kumar D, 2010, ACTA BIOMATER, V6, P1549, DOI 10.1016/j.actbio.2009.11.008
   Lang SB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02215
   Lang SB, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3571294
   LANG SB, 1966, NATURE, V212, P705
   Nakamura M, 2009, ACS APPL MATER INTER, V1, P2181, DOI 10.1021/am900341v
   Nakamura S, 2002, J BIOMED MATER RES, V61, P593, DOI 10.1002/jbm.10224
   Nakamura S, 2001, J APPL PHYS, V89, P5386, DOI 10.1063/1.1357783
   Okino M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4819853
   REEDYK CW, 1968, J ELECTROCHEM SOC, V115, P49, DOI 10.1149/1.2411001
   Robin S, 2011, LANGMUIR, V27, P14968, DOI 10.1021/la203491q
   Tofail SAM, 2009, J APPL PHYS, V106, DOI 10.1063/1.3262628
   Tofail SAM, 2009, J APPL PHYS, V105, DOI 10.1063/1.3093863
   Tofail SAM, 2005, FERROELECTRICS, V319, P117, DOI 10.1080/00150190590965523
   Wada N, 2013, MATER RES BULL, V48, P3854, DOI 10.1016/j.materresbull.2013.05.105
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
   Yao YB, 2013, ADV MATER, V25, P711, DOI 10.1002/adma.201202079
   Yashima M, 2011, J PHYS CHEM C, V115, P25077, DOI 10.1021/jp208746y
   Zhang ZZ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3525373
NR 34
TC 9
Z9 9
U1 0
U2 30
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-8979
EI 1089-7550
J9 J APPL PHYS
JI J. Appl. Phys.
PD JUL 7
PY 2014
VL 116
IS 1
AR 014902
DI 10.1063/1.4886235
PG 7
WC Physics, Applied
SC Physics
GA AM1QB
UT WOS:000339621400064
DA 2018-10-20
ER

PT J
AU Zambuzzi, WF
   Bonfante, EA
   Jimbo, R
   Hayashi, M
   Andersson, M
   Alves, G
   Takamori, ER
   Beltrao, PJ
   Coelho, PG
   Granjeiro, JM
AF Zambuzzi, Willian F.
   Bonfante, Estevam A.
   Jimbo, Ryo
   Hayashi, Mariko
   Andersson, Martin
   Alves, Gutemberg
   Takamori, Esther R.
   Beltrao, Paulo J.
   Coelho, Paulo G.
   Granjeiro, Jose M.
TI Nanometer Scale Titanium Surface Texturing Are Detected by Signaling
   Pathways Involving Transient FAK and Src Activations
SO PLOS ONE
LA English
DT Article
ID PHOSPHATE-COATED IMPLANTS; OSTEOBLAST ADHESION; IN-VIVO; ENHANCED
   OSSEOINTEGRATION; BONE INTEGRATION; BEHAVIOR; CELLS; DIFFERENTIATION;
   ORGANIZATION; FIBRONECTIN
AB Background: It is known that physico/chemical alterations on biomaterial surfaces have the capability to modulate cellular behavior, affecting early tissue repair. Such surface modifications are aimed to improve early healing response and, clinically, offer the possibility to shorten the time from implant placement to functional loading. Since FAK and Src are intracellular proteins able to predict the quality of osteoblast adhesion, this study evaluated the osteoblast behavior in response to nanometer scale titanium surface texturing by monitoring FAK and Src phosphorylations.
   Methodology: Four engineered titanium surfaces were used for the study: machined (M), dual acid-etched (DAA), resorbable media microblasted and acid-etched (MBAA), and acid-etch microblasted (AAMB). Surfaces were characterized by scanning electron microscopy, interferometry, atomic force microscopy, x-ray photoelectron spectroscopy and energy dispersive X-ray spectroscopy. Thereafter, those 4 samples were used to evaluate their cytotoxicity and interference on FAK and Src phosphorylations. Both Src and FAK were investigated by using specific antibody against specific phosphorylation sites.
   Principal Findings: The results showed that both FAK and Src activations were differently modulated as a function of titanium surfaces physico/chemical configuration and protein adsorption.
   Conclusions: It can be suggested that signaling pathways involving both FAK and Src could provide biomarkers to predict osteoblast adhesion onto different surfaces.
C1 [Zambuzzi, Willian F.] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Quim & Bioquim, Sao Paulo, Brazil.
   [Bonfante, Estevam A.] Univ Sao Paulo, Fac Odontol Bauru, Sao Paulo, Brazil.
   [Jimbo, Ryo; Hayashi, Mariko] Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden.
   [Andersson, Martin] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.
   [Alves, Gutemberg] Univ Fed Fluminense, Dept Cell & Mol Biol, Inst Biol, Niteroi, RJ, Brazil.
   [Takamori, Esther R.] Excell Biomed Serv, Rio De Janeiro, Brazil.
   [Beltrao, Paulo J.; Granjeiro, Jose M.] Natl Inst Metrol Qual & Technol INMETRO, Rio De Janeiro, Brazil.
   [Coelho, Paulo G.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA.
RP Zambuzzi, WF (reprint author), Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Quim & Bioquim, Sao Paulo, Brazil.
EM wzambuzzi@ibb.unesp.br; jmgranjeiro@inmetro.gov.br
RI Alves, Gutemberg/E-2742-2013; Zambuzzi, Willian/F-9519-2012; Bonfante,
   Estevam/F-7238-2012
OI Alves, Gutemberg/0000-0003-0016-4809; Zambuzzi,
   Willian/0000-0002-4149-5965; Bonfante, Estevam/0000-0001-6867-8350;
   Granjeiro, Jose/0000-0002-8027-8293
FU Fapesp; CNPq; Faperj
FX This study was funded by Fapesp, CNPq and Faperj. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Bertazzo S, 2009, CLIN ORAL IMPLAN RES, V20, P288, DOI 10.1111/j.1600-0501.2008.01642.x
   Bertazzo S, 2010, CLIN ORAL IMPLAN RES, V21, P1411, DOI 10.1111/j.1600-0501.2010.01968.x
   Chuang SK, 2006, J DENT RES, V85, P1147, DOI 10.1177/154405910608501216
   Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264
   Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009
   Malaspina TSD, 2009, ARCH ORAL BIOL, V54, P642, DOI 10.1016/j.archoralbio.2009.03.011
   Esposito M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003815.pub3
   Frojd V, 2008, INT J ORAL MAX SURG, V37, P561, DOI 10.1016/j.ijom.2008.01.020
   Gemini-Piperni S, 2014, BIOTECHNOL BIOENG, V111, P1900, DOI 10.1002/bit.25246
   Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004
   Jimbo R, 2012, J DENT RES, V91, P1172, DOI 10.1177/0022034512463240
   Jimbo R, 2011, J DENT RES, V90, P1422, DOI 10.1177/0022034511422911
   Jimbo R, 2008, CLIN IMPLANT DENT R, V10, P55, DOI 10.1111/j.1708-8208.2007.00061.x
   Jimbo R, 2007, BIOMATERIALS, V28, P3469, DOI 10.1016/j.biomaterials.2007.04.029
   Jimbo R, 2011, ACTA BIOMATER, V7, P4229, DOI 10.1016/j.actbio.2011.07.017
   Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Marin C, 2012, CLIN ORAL IMPLAN RES, V23, P119, DOI 10.1111/j.1600-0501.2010.02155.x
   Meirelles L, 2008, INT J ORAL MAX IMPL, V23, P641
   Milani R, 2010, J CELL BIOCHEM, V109, P957, DOI 10.1002/jcb.22479
   Monjo M, 2008, BIOMATERIALS, V29, P3771, DOI 10.1016/j.biomaterials.2008.06.001
   Monjo M, 2012, INT J BIOMATER, DOI 10.1155/2012/181024
   Raes F, 2012, CLIN ORAL IMPLAN RES, V23, P602, DOI 10.1111/j.1600-0501.2011.02178.x
   Saruwatari L, 2005, J BONE MINER RES, V20, P2002, DOI 10.1359/JBMR-050703
   Sawase T, 2008, CLIN ORAL IMPLAN RES, V19, P491, DOI 10.1111/j.1600-0501.2007.01509.x
   Shapira L, 2009, CLIN ORAL IMPLAN RES, V20, P50, DOI 10.1111/j.1600-0501.2008.01594.x
   Sommerfeldt DW, 2001, BIOCHEM BIOPH RES CO, V285, P355, DOI 10.1006/bbrc.2001.5198
   Sul YT, 2010, INT J NANOMED, V5, P87
   Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057
   Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63
   Wennerberg A, 2009, ACTA ODONTOL SCAND, V67, P333, DOI 10.1080/00016350903188325
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WLODARSKI KH, 1986, CALCIFIED TISSUE INT, V39, P382, DOI 10.1007/BF02555175
   Yang Q, 2011, J BONE MINER RES, V26, P1188, DOI 10.1002/jbmr.337
   Zambuzzi WF, 2011, J BIOMED MATER RES A, V97A, P193, DOI 10.1002/jbm.a.32933
   Zambuzzi WF, 2010, BIOCHIMIE, V92, P327, DOI 10.1016/j.biochi.2010.01.002
   Zambuzzi WF, 2009, J CELL BIOCHEM, V108, P134, DOI 10.1002/jcb.22236
   Zhang WJ, 2013, BIOMATERIALS, V34, P3184, DOI 10.1016/j.biomaterials.2013.01.008
NR 39
TC 5
Z9 5
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 7
PY 2014
VL 9
IS 7
AR e95662
DI 10.1371/journal.pone.0095662
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK7WB
UT WOS:000338637300002
PM 24999733
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bharti, A
   Singh, S
   Meena, VK
   Goyal, N
AF Bharti, Amardeep
   Singh, Suman
   Meena, Vijay Kumar
   Goyal, Navdeep
TI Synthesis of Novel Multiple Shaped Silver Nanoparticles Incorporated
   Hydroxyapatite Nanocomposite for Orthopaedic Body Implants
SO ADVANCED SCIENCE LETTERS
LA English
DT Proceedings Paper
CT National Conference on Nanotechnology and Renewable Energy (NCNRE)
CY APR 28-29, 2014
CL New Delhi, INDIA
DE Hydroxyapatite; Silver; Bone; Nanocomposite; Orthopaedic Body Implant
ID CALCIUM-PHOSPHATE; BIOCERAMICS
AB Orthopaedic implants are now commonly used in many surgical procedures to support or replace a damaged bone. Hydroxyapatite (Ca-10(PO4)(6)(OH)(2)) fulfils the required structural and biological compatibility issue even-though contact site provides room to grow microbes. Hydroxyapatite is a cardinal biomaterial and is predominant inorganic integrant of bones and teeth and is widely used in orthopaedic body implants to help patients achieve a better quality of life. In this paper, synthesis of silver incorporated hydroxyapatite nanocomposite is reported to recover such problems in orthopaedic body implants.
C1 [Bharti, Amardeep; Goyal, Navdeep] Panjab Univ, Dept Phys, Chandigarh 160014, India.
   [Singh, Suman; Meena, Vijay Kumar] CSIR, Cent Sci Instruments Org, Chandigarh 160030, India.
RP Bharti, A (reprint author), Panjab Univ, Dept Phys, Chandigarh 160014, India.
OI Goyal, Navdeep/0000-0002-5226-031X; Goyal, Navdeep/0000-0002-6993-4085;
   Bharti, Amardeep/0000-0001-8462-6139
CR Bastys V, 2006, ADV FUNCT MATER, V16, P766, DOI 10.1002/adfm.200500667
   Chen W., 2006, J BIOMEDICAL MAT R A
   Ciobanu CS, 2013, J SPECTROSC, DOI 10.1155/2013/471061
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   Layrolle P, 1998, J AM CERAM SOC, V81, P1421
   MORTIER A, 1989, THERMOCHIM ACTA, V143, P265, DOI 10.1016/0040-6031(89)85065-8
   Pal S., 2007, APPL ENV MICROBIOLOG, V1712
   Penel G, 1997, J MATER SCI-MATER M, V8, P271, DOI 10.1023/A:1018504126866
   Dong PV, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-9
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Sambhy V, 2006, J AM CHEM SOC, V128, P9798, DOI 10.1021/ja061442z
   Shaltout AA, 2011, SPECTROCHIM ACTA A, V83, P56, DOI 10.1016/j.saa.2011.07.036
   Zhang Q, 2010, NANO LETT, V10, P5037, DOI 10.1021/nl1032233
NR 13
TC 4
Z9 4
U1 0
U2 3
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1936-6612
EI 1936-7317
J9 ADV SCI LETT
JI Adv. Sci. Lett.
PD JUL-SEP
PY 2014
VL 20
IS 7-9
SI SI
BP 1297
EP 1302
DI 10.1166/asl.2014.5508
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CB2ZE
UT WOS:000349496200009
DA 2018-10-20
ER

PT J
AU Hussain, MA
   Maqbool, A
   Khalid, FA
   Bakhsh, N
   Hussain, A
   Rahman, JU
   Park, JK
   Park, TG
   Hyun, LJ
   Kim, MH
AF Hussain, M. Asif
   Maqbool, Adnan
   Khalid, F. Ahmad
   Bakhsh, Nabi
   Hussain, Ali
   Rahman, Jamil Ur
   Park, Jong Kyu
   Park, Tae Gone
   Hyun, Lee Jae
   Kim, Myong Ho
TI Mechanical properties of CNT reinforced hybrid functionally graded
   materials for bioimplants
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE functionally graded materials; hydroxyapatite; nanocomposites;
   biomaterial; implant
ID 316L STAINLESS-STEEL; IN-VITRO; HYDROXYAPATITE COATINGS; CORROSION;
   LASER; BIOMATERIALS; TEMPERATURE; FABRICATION; COMPOSITES; PHOSPHATE
AB The hybrid functionally graded materials (FGM) of hydroxyapatite (HA), stainless steel 316L (SS316L) and carbon nanotubes (CNT) were synthesized for biomedical implants. Three different types of FGM were produced by the combination of SS316L and CNT to reinforce HA in discrete layers of FGM. In the first type of FGM, concentration of SS316L was varied from 10% to 40% (mass fraction) with an increment of 10% to reinforce micro HA. In the second type of FGM, 0.5% (mass fraction) functionalized CNT was added by maintaining the rest of composition as that of the first type of FGM. In the third type of FGM, mixture of micro and nano HA (mass ratio1:1) was used, keeping rest of composition similar to the second type of FGM. All types of FGM were subjected to uniaxial compaction and sintered by pressureless sintering technique at similar compaction and sintering parameters. The results show that the densification is enhanced with the addition of CNT and nanocrystalline HA in the FGM. Hardness and fracture toughness increase in both FGM reinforced with CNT, but the increase of the hardness and fracture toughness are more pronounced in FGM with micro and nanocrystalline HA.
C1 [Hussain, M. Asif; Maqbool, Adnan; Khalid, F. Ahmad; Bakhsh, Nabi] GIK Inst Engn Sci & Technol, Fac Mat Sci & Engn, Topi, Kpk, Pakistan.
   [Maqbool, Adnan; Hussain, Ali; Rahman, Jamil Ur; Park, Jong Kyu; Park, Tae Gone; Hyun, Lee Jae; Kim, Myong Ho] Changwon Natl Univ, Engn Res Ctr Integrated Mechatron Mat & Component, Gyeongnam 641773, South Korea.
RP Kim, MH (reprint author), Changwon Natl Univ, Engn Res Ctr Integrated Mechatron Mat & Component, Gyeongnam 641773, South Korea.
EM mhkim@changwon.ac.kr
RI Maqbool, Adnan/C-8170-2016; Khalid, Fazal Ahmad/G-3069-2015
OI Maqbool, Adnan/0000-0003-4678-9951; Hussain, Ali/0000-0001-6020-1654
FU GIK Institute; National Research Foundation of Korea (NRF) - Ministry,
   Science and Technology (MEST) [2011-0030058]
FX The authors are thankful to GIK Institute for financial assistance and
   providing research facilities. This work is also supported by the Basic
   Research program through the National Research Foundation of Korea (NRF)
   funded by Ministry, Science and Technology (MEST) (2011-0030058)
CR Ahmad I, 2010, J EUR CERAM SOC, V30, P865, DOI 10.1016/j.jeurceramsoc.2009.09.032
   Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013
   Cheng GJ, 2005, MAT SCI ENG C-BIO S, V25, P541, DOI 10.1016/j.msec.2005.05.002
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   GERMAN RM, 1996, SINTERING THEORY PRA, P181
   Haynes DR, 2000, J BIOMED MATER RES, V49, P167, DOI 10.1002/(SICI)1097-4636(200002)49:2<167::AID-JBM3>3.0.CO;2-9
   KOBAYASHI WK, 2006, J MATER SCI-MATER M, V17, P1089
   Lau A. K.-T., 2002, COMPOSITES B, V33, P263, DOI DOI 10.1016/S1359-8368(02)00012-4
   Li HP, 2008, COMPOS PART A-APPL S, V39, P1128, DOI 10.1016/j.compositesa.2008.04.007
   Metikos-Hukovic M, 2003, SURF COAT TECH, V165, P40, DOI 10.1016/S0257-8972(02)00732-6
   Miao X, 2001, J MATER SCI, V36, P3323, DOI 10.1023/A:1017915226015
   Mishina H, 2008, MAT SCI ENG A-STRUCT, V475, P141, DOI 10.1016/j.msea.2007.05.004
   Muralithran G, 2000, CERAM INT, V26, P221, DOI 10.1016/S0272-8842(99)00046-2
   Oh KT, 2002, J ELECTROCHEM SOC, V149, pB146, DOI 10.1149/1.1457984
   Pei XB, 2011, SURF COAT TECH, V205, P4380, DOI 10.1016/j.surfcoat.2011.03.036
   Reclaru L, 2001, BIOMATERIALS, V22, P269, DOI 10.1016/S0142-9612(00)00185-X
   SIVAKUMAR M, 1994, J MATER ENG PERFORM, V3, P744, DOI 10.1007/BF02818375
   Son JS, 2011, J CONTROL RELEASE, V153, P133, DOI 10.1016/j.jconrel.2011.03.010
   Sridhar TM, 2003, CORROS SCI, V45, P2337, DOI 10.1016/S0010-938X(03)00063-5
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sumita M, 2004, MAT SCI ENG C-BIO S, V24, P753, DOI 10.1016/j.msec.2004.08.030
   WANG PE, 1993, J MATER SCI-MATER M, V4, P150, DOI 10.1007/BF00120384
   Xu JL, 2009, MAT SCI ENG C-BIO S, V29, P44, DOI 10.1016/j.msec.2008.05.009
   YANG CY, 1995, J MATER SCI-MATER M, V6, P258, DOI 10.1007/BF00120268
   Zeng HT, 2000, BIOMATERIALS, V21, P23, DOI 10.1016/S0142-9612(99)00128-3
NR 25
TC 8
Z9 9
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1003-6326
EI 2210-3384
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD JUL
PY 2014
VL 24
SU 1
BP S90
EP S98
DI 10.1016/S1003-6326(14)63293-3
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA CF5QY
UT WOS:000352613200013
DA 2018-10-20
ER

PT J
AU Ruan, QC
   Moradian-Oldak, J
AF Ruan, Qichao
   Moradian-Oldak, Janet
TI Development of Amelogenin-chitosan Hydrogel for In Vitro Enamel Regrowth
   with a Dense Interface
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 89; Enamel; Amelogenin; Chitosan hydrogel;
   Apatite; Biomimetic; Erosion; Superficial enamel reconstruction; Dense
   interface
ID REPAIR; MINERALIZATION; NANOPARTICLES; FLUORIDE; APATITE
AB Biomimetic enamel reconstruction is a significant topic in material science and dentistry as a novel approach for the treatment of dental caries or erosion. Amelogenin has been proven to be a critical protein for controlling the organized growth of apatite crystals. In this paper, we present a detailed protocol for superficial enamel reconstruction by using a novel amelogenin-chitosan hydrogel. Compared to other conventional treatments, such as topical fluoride and mouthwash, this method not only has the potential to prevent the development of dental caries but also promotes significant and durable enamel restoration. The organized enamel-like microstructure regulated by amelogenin assemblies can significantly improve the mechanical properties of etched enamel, while the dense enamel-restoration interface formed by an in situ regrowth of apatite crystals can improve the effectiveness and durability of restorations. Furthermore, chitosan hydrogel is easy to use and can suppress bacterial infection, which is the major risk factor for the occurrence of dental caries. Therefore, this biocompatible and biodegradable amelogenin-chitosan hydrogel shows promise as a biomaterial for the prevention, restoration, and treatment of defective enamel.
C1 [Ruan, Qichao; Moradian-Oldak, Janet] Univ So Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90089 USA.
RP Moradian-Oldak, J (reprint author), Univ So Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90089 USA.
EM joldak@usc.edu
FU NIH-NIDCR [DE-13414, DE-020099]
FX The authors would like to thank Prof. Steven Nutt and Mr. Yuzheng Zhang
   for assistant with the Focus Ion Beam, and the Center for Electron
   Microscopy and Microanalysis (CEMMA) at USC for electron microscopy.
   Research was supported by NIH-NIDCR grants; DE-13414 and DE-020099 to
   J.M.O.
CR Bleek K, 2013, ACTA BIOMATER, V9, P6283, DOI 10.1016/j.actbio.2012.12.027
   Bromley KM, 2012, CRYST GROWTH DES, V12, P4897, DOI 10.1021/cg300754a
   Chen HF, 2006, ADV MATER, V18, P1846, DOI 10.1002/adma.200502401
   Eimar H, 2012, ACTA BIOMATER, V8, P3400, DOI 10.1016/j.actbio.2012.06.002
   Fan YW, 2007, BIOMATERIALS, V28, P3034, DOI 10.1016/j.biomaterials.2007.02.016
   Fan Y, 2009, BIOMATERIALS, V30, P478, DOI 10.1016/j.biomaterials.2008.10.019
   Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108
   Fletcher J, 2011, CRYSTENGCOMM, V13, P3692, DOI 10.1039/c0ce00806k
   Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271
   Hu CC, 1996, J DENT RES, V75, P1735, DOI 10.1177/00220345960750100501
   Li HY, 2011, CRYSTENGCOMM, V13, P1060, DOI 10.1039/c0ce00118j
   Li L, 2008, J MATER CHEM, V18, P4079, DOI 10.1039/b806090h
   Li L, 2011, ADV MATER, V23, P4695, DOI 10.1002/adma.201102773
   Moradian-Oldak J, 2012, FRONT BIOSCI-LANDMRK, V17, P1996, DOI 10.2741/4034
   Onuma K, 2005, J CRYST GROWTH, V282, P199, DOI 10.1016/j.jcrysgro.2005.04.085
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434
   Ruan Q., 2014, CONNECT TIS IN PRESS
   Ruan QC, 2013, ACTA BIOMATER, V9, P7289, DOI 10.1016/j.actbio.2013.04.004
   Wright J., AM J MED GENT A, V140, P2547
   Xie RQ, 2011, CRYST GROWTH DES, V11, P5206, DOI 10.1021/cg101708y
   Yamagishi K, 2005, NATURE, V433, P819, DOI 10.1038/433819a
   Yang XD, 2010, J PHYS CHEM B, V114, P2293, DOI 10.1021/jp910219s
   Yin YJ, 2009, CHEM COMMUN, P5892, DOI 10.1039/b911407f
NR 24
TC 3
Z9 3
U1 2
U2 24
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD JUL
PY 2014
IS 89
AR e51606
DI 10.3791/51606
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CB0DR
UT WOS:000349296100048
PM 25046057
OA Green Published, Green Accepted
DA 2018-10-20
ER

PT J
AU Nam, IH
   Chon, CM
   Kim, JG
AF Nam, In-Hyun
   Chon, Chul-Min
   Kim, Jae-Gon
TI Bioremediation of heavy metal contaminated soil using plant extract as
   biomaterial
SO NEW BIOTECHNOLOGY
LA English
DT Meeting Abstract
C1 [Nam, In-Hyun; Chon, Chul-Min; Kim, Jae-Gon] Korea Inst Geosci & Mineral Resources KIGAM, Gyeongju, South Korea.
NR 0
TC 0
Z9 0
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1871-6784
EI 1876-4347
J9 NEW BIOTECHNOL
JI New Biotech.
PD JUL
PY 2014
VL 31
SU S
MA PH-08
BP S135
EP S135
DI 10.1016/j.nbt.2014.05.1947
PG 1
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA AY0PJ
UT WOS:000347298600334
DA 2018-10-20
ER

PT J
AU Schwartz, JA
   Wang, W
   Goldstein, T
   Grande, DA
AF Schwartz, John A.
   Wang, William
   Goldstein, Todd
   Grande, Daniel A.
TI Tissue Engineered Meniscus Repair: Influence of Cell Passage Number,
   Tissue Origin, and Biomaterial Carrier
SO CARTILAGE
LA English
DT Article
DE cells; meniscus; tissue; meniscus; repair; tissue; knee; joint involved
ID KNEE-JOINT
AB Objective. Studies have shown that meniscal repairs have better outcomes over both partial and total meniscectomies. Tissue engineering strategies to repair meniscus tears have been explored using cell sources that involve a donor as well as a period of in vitro cell expansion before use. This study explored cell sources that could be easily harvested and rapidly isolated by enzymatic digestion and cannulated delivery. Methods. Bovine menisci were used to create a bucket handle tear. Cell lines were established from meniscus, synovium, and adipose tissue and fluorescently labeled. At passages P2, P4, and P8, cells were added to the defect from the following experimental groups: cells alone, collagen gel, collagen scaffold, or hyaluronic acid. Menisci constructs were xenografted subcutaneously onto the dorsum of athymic rats and incubated for 3, 6, and 9 weeks, at which time they were retrieved and processed for histology. Results. Meniscal cells were able to repair defects faster and significantly better than adipose or synovium derived cells. Adipose cells were the least effective in comparison. Repair was significantly better at 9 weeks compared with 6 and 3 weeks. Macroscopic examination of menisci that received cell implants showed the thickest tissue in menisci that had collagen implants, and the thinnest fill occurred in menisci treated with cells alone. Histology confirmed no cells or integrative repair in the control specimens. Conclusions. Delivery of cells alone outperformed the additional use of biomaterials. Our results suggest a strategy that would use both meniscus and synovial cells for arthroscopic meniscal repair.
C1 [Schwartz, John A.; Wang, William; Goldstein, Todd; Grande, Daniel A.] Feinstein Inst Med Res, Manhasset, NY 11030 USA.
RP Grande, DA (reprint author), Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY 11030 USA.
EM dgrande@nshs.edu
CR Adams Samuel B Jr, 2005, J Knee Surg, V18, P25
   Angele P, 2007, J BIOMED MATER RES A, V85, P445
   ARNOCZKY SP, 1982, AM J SPORT MED, V10, P90, DOI 10.1177/036354658201000205
   COX JS, 1977, CLIN ORTHOP RELAT R, P236
   Danzig L, 1981, T ORTHOP RES SOC, V6, P338
   DAVIES DV, 1948, ANN ROY COLL SURG, V2, P142
   FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664
   GHADIALLY FN, 1986, J BONE JOINT SURG BR, V68, P106
   Grande D, 2004, TISSUE ENG MUSCULOSK
   King D, 1936, J BONE JOINT SURG, V18, P333
   KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283
   Laible C, 2013, J AM ACAD ORTHOP SUR, V21, P204, DOI 10.5435/JAAOS-21-04-204
   LYNCH MA, 1983, CLIN ORTHOP RELAT R, P148
   MCDEVITT CA, 1990, CLIN ORTHOP RELAT R, P8
   Nepple JJ, 2012, J BONE JOINT SURG AM, V94A, P2222, DOI 10.2106/JBJS.K.01584
   Peretti GM, 2004, AM J SPORT MED, V32, P146, DOI 10.1177/0095399703258790
   RENSTROM P, 1990, CLIN SPORT MED, V9, P523
   SCAPINEL.R, 1968, ACTA ANAT, V70, P305
   SONNEHOLM S, 1980, ACTA ORTHOP SCAND, V51, P303, DOI 10.3109/17453678008990803
   Weinand C, 2006, AM J SPORT MED, V34, P1779, DOI 10.1177/0363546506290666
   Xu C, KNEE SURG SPORTS TRA
   Zellner J, 2010, J BIOMED MATER RES A, V94A, P1150, DOI 10.1002/jbm.a.32796
NR 22
TC 6
Z9 6
U1 1
U2 12
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1947-6035
EI 1947-6043
J9 CARTILAGE
JI Cartilage
PD JUL
PY 2014
VL 5
IS 3
BP 165
EP 171
DI 10.1177/1947603514526038
PG 7
WC Orthopedics
SC Orthopedics
GA AZ7ZN
UT WOS:000348434500004
PM 26069696
OA Green Published
DA 2018-10-20
ER

PT J
AU Mahmoudabadi, AZ
   Zarrin, M
   Kiasat, N
AF Mahmoudabadi, Ali Zarei
   Zarrin, Majid
   Kiasat, Neda
TI Biofilm Formation and Susceptibility to Amphotericin B and Fluconazole
   in Candida albicans
SO JUNDISHAPUR JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Candida albicans; Amphotericin B; Fluconazole
ID ANTIFUNGAL SUSCEPTIBILITY; IN-VITRO; VULVO-VAGINITIS; VIRULENCE;
   PHOSPHOLIPASE; URINE; BLOOD; CELLS
AB Background: The ability of Candida albicans to form biofilms and adhere to host tissues and biomaterial surfaces is an important factor in its pathogenesis. One of the main characteristics of biofilms is their resistance to broad-spectrum anti-microbial drugs.
   Objectives: In the present study the formation of biofilm by C. albicans from different sources was evaluated. In addition, the minimum biofilm inhibitory concentration (MBIC) for two antifungals was evaluated.
   Materials and Methods: In total, 120 isolates of C. albicans from different sources (patients with vaginitis, patients with candiduria, bucal cavity and environmental surfaces) were collected. Biofilm formation was determined by the 96-well micro-titeration plate method. MBIC testing was also performed, using the calorimetric indicator resazurin for amphotericin B and fluconazole.
   Results: The results indicated that 100% of C. albicans isolates from different sources had the ability to form biofilms in vitro. Amongst these isolates, 83.3% of isolates had the maximum potential (4+) to form biofilms, while only one (0.9%) of isolates had the minimum ability (1+) to form biofilms. Our results showed that 65.0% of the tested isolates are sensitive to amphotericin B at amounts lower than 10 mu g/mL, while only 26.7% are sensitive to fluconazole (had MBIC < 10 mu g/mL).
   Conclusions: Although biofilm formation was detected in all tested isolates, there were differences in the ability to form biofilms between isolates from different sources. In addition, there were differences in the MBIC against the two examined antifungals, amphotericin B and fluconazole.
C1 [Mahmoudabadi, Ali Zarei] Ahvaz Jundishapur Univ Med Sci, Hlth Res Inst, Infect & Trop Dis Res Ctr, Ahwaz, Iran.
   [Mahmoudabadi, Ali Zarei; Zarrin, Majid; Kiasat, Neda] Ahvaz Jundishapur Univ Med Sci, Dept Med Mycol, Ahwaz, Iran.
RP Mahmoudabadi, AZ (reprint author), Ahvaz Jundishapur Univ Med Sci, Hlth Res Inst, Infect & Trop Dis Res Ctr, Ahwaz, Iran.
EM zarei40@hotmail.com
RI Zarei Mahmoudabadi, Ali/G-6136-2016
OI Zarei Mahmoudabadi, Ali/0000-0002-5347-2082; Zarrin,
   Majid/0000-0001-7476-5485
FU Health Research Institute, Infectious and Tropical Diseases Research
   Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
   [OG-90135]
FX This study was supported by research grant No. OG-90135, provided by the
   Health Research Institute, Infectious and Tropical Diseases Research
   Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
CR Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7
   DiDone L, 2011, YEAST, V28, P561, DOI 10.1002/yea.1860
   Frade JP, 2011, MYCOSES, V54, pE154, DOI 10.1111/j.1439-0507.2010.01862.x
   Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000
   Gokce G, 2007, MYCOPATHOLOGIA, V164, P265, DOI 10.1007/s11046-007-9053-4
   Hahnel S, 2012, GERODONTOLOGY, V29, pE383, DOI 10.1111/j.1741-2358.2011.00485.x
   Jafari-Nodoushan AA, 2008, IRAN J PHARM RES, V7, P69
   Jain N, 2007, APPL ENVIRON MICROB, V73, P1697, DOI 10.1128/AEM.02439-06
   Jin Y, 2005, MYCOPATHOLOGIA, V160, P191, DOI 10.1007/s11046-005-6331-x
   Khan MSA, 2012, J ANTIMICROB CHEMOTH, V67, P618, DOI 10.1093/jac/dkr512
   Konopka K, 2010, ANTON LEEUW INT J G, V97, P413, DOI 10.1007/s10482-010-9417-5
   LaFleur MD, 2011, J ANTIMICROB CHEMOTH, V66, P820, DOI 10.1093/jac/dkq530
   Lal P, 2008, INDIAN J MICROBIOL, V48, P438, DOI 10.1007/s12088-008-0054-x
   Mohammadi P, 2012, JUNDISHAPUR J MICROB, V5, P533, DOI 10.5812/jjm.2640
   Mohanty S, 2007, INDIAN J MED RES, V126, P216
   Negri M. F., 2010, Revista de Ciencias Farmaceuticas Basica e Aplicada, V31, P89
   Oz Y., 2012, British Microbiology Research Journal, V2, P40
   Paiva LCF, 2012, MICRON, V43, P497, DOI 10.1016/j.micron.2011.09.013
   Paul N, 2007, J INFECTION, V55, P450, DOI 10.1016/j.jinf.2007.06.010
   Punithavathy PM, 2012, INDIAN J PATHOL MICR, V55, P72, DOI 10.4103/0377-4929.94861
   Richter SS, 2005, J CLIN MICROBIOL, V43, P2155, DOI 10.1128/JCM.43.5.2155-2162.2005
   Salehei Z, 2012, JUNDISHAPUR J MICROB, V5, P574, DOI 10.5812/jjm.4556
   Samaranayake YH, 2005, J MED MICROBIOL, V54, P583, DOI 10.1099/jmm.0.45762-0
   Silva MP, 2012, BRAZ ORAL RES, V26, P24, DOI 10.1590/S1806-83242012000100005
   Silva S, 2011, TRENDS MICROBIOL, V19, P241, DOI 10.1016/j.tim.2011.02.003
   Sudjana AN, 2012, MED MYCOL, V50, P863, DOI 10.3109/13693786.2012.683540
   Thein ZM, 2007, ARCH ORAL BIOL, V52, P761, DOI 10.1016/j.archoralbio.2007.01.009
   Tobudic S, 2012, MYCOSES, V55, P199, DOI 10.1111/j.1439-0507.2011.02076.x
   Tsang CSP, 2007, CLIN ORAL INVEST, V11, P361, DOI 10.1007/s00784-007-0122-3
   Villar-Vidal M, 2011, ENFERM INFEC MICR CL, V29, P660, DOI 10.1016/j.eimc.2011.06.009
   Yang Yun-Liang, 2003, Journal of Microbiology Immunology and Infection, V36, P187
   Yigit N, 2011, EURASIAN J MED, V43, P27, DOI 10.5152/eajm.2011.06
   Zarei Mahmoudabadi A, 2011, JUNDISHAPUR J MICROB, V4
NR 33
TC 8
Z9 9
U1 0
U2 9
PU AHVAZ JUNDISHAPUR UNIV MED SCI
PI AHVAZ
PA PO BOX 6357-33118, AHVAZ, 00000, IRAN
SN 2008-3645
EI 2008-4161
J9 JUNDISHAPUR J MICROB
JI Jundishapur J. Microbiol.
PD JUL
PY 2014
VL 7
IS 7
AR e17105
DI 10.5812/jjm.17105
PG 5
WC Microbiology
SC Microbiology
GA AY6MD
UT WOS:000347679400016
PM 25368806
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Likhitpanichkul, M
   Dreischarf, M
   Illien-Junger, S
   Walter, BA
   Nukaga, T
   Long, RG
   Sakai, D
   Hecht, AC
   Iatridis, JC
AF Likhitpanichkul, M.
   Dreischarf, M.
   Illien-Junger, S.
   Walter, B. A.
   Nukaga, T.
   Long, R. G.
   Sakai, D.
   Hecht, A. C.
   Iatridis, J. C.
TI FIBRIN-GENIPIN ADHESIVE HYDROGEL FOR ANNULUS FIBROSUS REPAIR:
   PERFORMANCE EVALUATION WITH LARGE ANIMAL ORGAN CULTURE, IN SITU
   BIOMECHANICS, AND IN VIVO DEGRADATION TESTS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Intervertebral disc; annulus fibrosus repair; injectable hydrogel;
   fibrin-genipin; adhesive biomaterial; organ culture; motion segment
   testing; in vivo degradation; herniation; discectomy
ID INTERVERTEBRAL DISC MECHANICS; LOW-BACK-PAIN; NEEDLE PUNCTURE INJURY;
   ISSLS PRIZE WINNER; LUMBAR SPINE; SOLUTE TRANSPORT; END-PLATE;
   DEGENERATION; VITRO; MODEL
AB Annulus fibrosus (AF) defects from annular tears, herniation, and discectomy procedures are associated with painful conditions and accelerated intervertebral disc (IVD) degeneration. Currently, no effective treatments exist to repair AF damage, restore IVD biomechanics and promote tissue regeneration. An injectable fibrin-genipin adhesive hydrogel (Fib-Gen) was evaluated for its performance repairing large AF defects in a bovine caudal IVD model using ex vivo organ culture and biomechanical testing of motion segments, and for its in vivo longevity and biocompatibility in a rat model by subcutaneous implantation. Fib-Gen sealed AF defects, prevented IVD height loss, and remained well-integrated with native AF tissue following approximately 14,000 cycles of compression in 6-day organ culture experiments. Fib-Gen repair also retained high viability of native AF cells near the repair site, reduced nitric oxide released to the media, and showed evidence of AF cell migration into the gel. Biomechanically, Fib-Gen fully restored compressive stiffness to intact levels validating organ culture findings. However, only partial restoration of tensile and torsional stiffness was obtained, suggesting opportunities to enhance this formulation. Subcutaneous implantation results, when compared with the literature, suggested Fib-Gen exhibited similar biocompatibility behaviour to fibrin alone but degraded much more slowly. We conclude that injectable Fib-Gen successfully sealed large AF defects, promoted functional restoration with improved motion segment biomechanics, and served as a biocompatible adhesive biomaterial that had greatly enhanced in vivo longevity compared to fibrin. Fib-Gen offers promise for AF repairs that may prevent painful conditions and accelerated degeneration of the IVD, and warrants further material development and evaluation.
C1 [Likhitpanichkul, M.; Illien-Junger, S.; Walter, B. A.; Long, R. G.; Hecht, A. C.; Iatridis, J. C.] Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA.
   [Likhitpanichkul, M.; Illien-Junger, S.; Nukaga, T.; Long, R. G.; Sakai, D.; Iatridis, J. C.] Collaborat Res Partner Annulus Fibrosus Rupture P, Davos, Switzerland.
   [Dreischarf, M.] Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
   [Nukaga, T.; Sakai, D.] Tokai Univ, Sch Med, Dept Orthopaed Surg, Kanagawa 2591100, Japan.
RP Iatridis, JC (reprint author), Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, One Gustave L Levy Pl,Box 1188, New York, NY 10029 USA.
EM James.iatridis@mssm.edu
RI Long, Rose/E-8969-2017
OI Long, Rose/0000-0001-9999-9288; Iatridis, James/0000-0002-2186-0590
FU NIAMS/NIH grant [R01 AR057397]; AO Exploratory Research Board;
   Studienstiftung des deutschen Volkes award
FX Funded by NIAMS/NIH grant R01 AR057397, a consortium grant from AO
   Exploratory Research Board, and Studienstiftung des deutschen Volkes
   award. We also gratefully acknowledge the support of Dr. Devina
   Purmessur, Mr. Damien Laudier, and Mr. Philip Nasser for their helpful
   assistance on several technical aspects of this project. We wish to
   confirm that there are no known conflicts of interest associated with
   this publication and there has been no significant financial support for
   this work that could have influenced its outcome.
CR Adams MA, 2012, J ANAT, V221, P497, DOI 10.1111/j.1469-7580.2012.01551.x
   Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004
   Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z
   Buser Z, 2011, SPINE, V36, pE1201, DOI 10.1097/BRS.0b013e31820566b2
   Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432
   Chan SCW, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13598
   Chan SCW, 2011, SPINE, V36, P2021, DOI 10.1097/BRS.0b013e318203aea5
   Chan SC, 2012, JOVE-J VIS EXP, V60, P3490
   Dare EV, 2009, CELLS TISSUES ORGANS, V190, P313, DOI 10.1159/000209230
   Demers CN, 2004, SPINE, V29, P2793, DOI 10.1097/01.brs.0000147744.74215.b0
   DePalma MJ, 2012, PAIN PHYSICIAN, V15, pE53
   Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508
   Dickneite G, 2003, THROMB RES, V112, P73, DOI 10.1016/j.thromres.2003.10.010
   DICKNEITE G, 1994, CIRC SHOCK, V42, P183
   Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2
   Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1
   Gantenbein B, 2006, SPINE, V31, P2665, DOI 10.1097/01.brs.0000244620.15386.df
   Guterl CC, 2014, TISSUE ENG A
   Guterl CC, 2013, EUR CELLS MATER, V25, P1
   Haglund L, 2011, TISSUE ENG PART C-ME, V17, P1011, DOI [10.1089/ten.tec.2011.0025, 10.1089/ten.TEC.2011.0025]
   HOLM S, 1981, CONNECT TISSUE RES, V8, P101, DOI 10.3109/03008208109152130
   Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002
   Iatridis JC, 2012, SPINE J, V12, P336, DOI 10.1016/j.spinee.2012.03.006
   Illien-Junger S, 2012, SPINE, V37, P1865, DOI 10.1097/BRS.0b013e3182544a8a
   Intaglietta M, 1996, CARDIOVASC RES, V32, P632
   Johannessen W, 2006, ANN BIOMED ENG, V34, P687, DOI 10.1007/s10439-005-9070-8
   Johannessen W, 2004, ANN BIOMED ENG, V32, P70, DOI 10.1023/B:ABME.0000007792.19071.8c
   Junger S, 2009, SPINE, V34, P1264, DOI 10.1097/BRS.0b013e3181a0193d
   Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273
   Korecki CL, 2008, SPINE, V33, P1403, DOI 10.1097/BRS.0b013e318175cae7
   Korecki CL, 2008, SPINE, V33, P235, DOI 10.1097/BRS.0b013e3181624504
   Korecki CL, 2007, EUR SPINE J, V16, P1029, DOI 10.1007/s00586-007-0327-9
   Lee CR, 2006, SPINE, V31, P515, DOI 10.1097/01.brs.0000201302.59050.72
   Leung VYL, 2009, J HISTOCHEM CYTOCHEM, V57, P249, DOI 10.1369/jhc.2008.952184
   Li ZM, 2014, J ORTHOP RES, V32, P262, DOI 10.1002/jor.22494
   Lorentz KM, 2011, BIOMATERIALS, V32, P430, DOI 10.1016/j.biomaterials.2010.08.109
   Malhotra NR, 2012, SPINE, V37, pE1099, DOI 10.1097/BRS.0b013e31825cdfb7
   Malonzo C, 2013, J TISSUE ENG REGEN M
   Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20
   Michalek AJ, 2012, SPINE J, V12, P425, DOI 10.1016/j.spinee.2012.04.001
   Michalek AJ, 2010, EUR SPINE J, V19, P2110, DOI 10.1007/s00586-010-1473-z
   OHSHIMA H, 1995, J ORTHOPAED RES, V13, P22, DOI 10.1002/jor.1100130106
   OSHIMA H, 1993, J ORTHOPAED RES, V11, P332, DOI 10.1002/jor.1100110304
   OSTI OL, 1992, J BONE JOINT SURG BR, V74, P678
   Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147
   PEARCY MJ, 1984, SPINE, V9, P582, DOI 10.1097/00007632-198409000-00008
   Purmessur D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2487
   Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Showalter BL, 2012, SPINE, V37, pE900, DOI 10.1097/BRS.0b013e31824d911c
   Sobajima S, 2005, SPINE, V30, P15, DOI 10.1097/01.brs.0000148048.15348.9b
   Steffen T, 1997, SPINE, V22, P156, DOI 10.1097/00007632-199701150-00006
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   URBAN JPG, 1977, CLIN ORTHOP RELAT R, P101
   USBJD/ USBJI, 2011, US BONE JOINT INITIA, V1, P21
   VernonRoberts B, 1997, SPINE, V22, P2641, DOI 10.1097/00007632-199711150-00012
   Walter BA, 2014, J BIOMECH, V47, P2095, DOI 10.1016/j.jbiomech.2014.03.015
   Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005
   Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005
   Wilke HJ, 2003, SPINE, V28, P2585, DOI 10.1097/01.BRS.0000096673.16363.C7
   Wiseman MA, 2005, SPINE, V30, P505, DOI 10.1097/01.brs.0000154615.22311.66
NR 62
TC 31
Z9 31
U1 0
U2 6
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2014
VL 28
BP 25
EP 38
DI 10.22203/eCM.v028a03
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA AU4EQ
UT WOS:000345562600003
PM 25036053
OA DOAJ Gold, Green Accepted
DA 2018-10-20
ER

PT J
AU Clauss, M
   Tafin, UF
   Betrisey, B
   van Garderen, N
   Trampuz, A
   Ilchmann, T
   Bohner, M
AF Clauss, M.
   Tafin, U. Furustrand
   Betrisey, B.
   van Garderen, N.
   Trampuz, A.
   Ilchmann, T.
   Bohner, M.
TI INFLUENCE OF PHYSICO-CHEMICAL MATERIAL CHARACTERISTICS ON STAPHYLOCOCCAL
   BIOFILM FORMATION - A QUALITATIVE AND QUANTITATIVE IN VITRO ANALYSIS OF
   FIVE DIFFERENT CALCIUM PHOSPHATE BONE GRAFTS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Biofilm; calcium phosphate; beta-TCP; S. aureus ATCC 29213; S.
   epidermidis RP62A ATCC 35984; microcalorimetry; sonication; bone graft
ID BETA-TRICALCIUM PHOSPHATE; INFECTED IMPLANTATION SITE; BIOMATERIAL
   SURFACE-CHEMISTRY; BIOLOGICAL PERFORMANCE; LOCAL INFECTION;
   BACTERIAL-COLONIZATION; ANTIMICROBIAL AGENTS; CRYSTAL-STRUCTURE;
   STAINLESS-STEEL; ADHESION
AB Various compositions of synthetic calcium phosphates (CaP) have been proposed and their use has considerably increased over the past decades. Besides differences in physicochemical properties, resorption and osseointegration, artificial CaP bone graft might differ in their resistance against biofilm formation. We investigated standardised cylinders of 5 different CaP bone grafts (cyclOS, chronOS (both beta-TCP (tricalcium phosphate)), dicalcium phosphate (DCP), calcium-deficient hydroxyapatite (CDHA) and alpha-TCP). Various physico-chemical characterisations e.g., geometrical density, porosity, and specific surface area were investigated. Biofilm formation was carried out in tryptic soy broth (TSB) and human serum (SE) using Staphylococcus aureus (ATCC 29213) and S. epidermidis RP62A (ATCC 35984). The amount of biofilm was analysed by an established protocol using sonication and microcalorimetry. Physico-chemical characterisation showed marked differences concerning macro-and micropore size, specific surface area and porosity accessible to bacteria between the 5 scaffolds. Biofilm formation was found on all scaffolds and was comparable for alpha-TCP, chronOS, CDHA and DCP at corresponding time points when the scaffolds were incubated with the same germ and/or growth media, but much lower for cyclOS. This is peculiar because cyclOS had an intermediate porosity, mean pore size, specific surface area, and porosity accessible to bacteria. Our results suggest that biofilm formation is not influenced by a single physico-chemical parameter alone but is a multi-step process influenced by several factors in parallel. Transfer from in vitro data to clinical situations is difficult; thus, advocating the use of cyclOS scaffolds over the four other CaP bone grafts in clinical situations with a high risk of infection cannot be clearly supported based on our data.
C1 [Clauss, M.; Ilchmann, T.] Kantonsspital Baselland Liestal, Clin Orthopaed & Trauma Surg, CH-4410 Liestal, Switzerland.
   [Clauss, M.; van Garderen, N.; Bohner, M.] RMS Fdn, Bettlach, Switzerland.
   [Clauss, M.; Betrisey, B.; Trampuz, A.] Univ Lausanne Hosp CHUV, Dept Internal Med, Infect Dis Serv, Lausanne, Switzerland.
   [Tafin, U. Furustrand] Univ Hosp Lausanne CHUV, Sept Surg Unit, Lausanne, Switzerland.
   [Trampuz, A.] Dept Traumatol & Reconstruct Surg, Charite, Berlin, Germany.
RP Clauss, M (reprint author), Kantonsspital Baselland Liestal, Clin Orthopaed & Trauma Surg, Rheinstr 26, CH-4410 Liestal, Switzerland.
EM martin.clauss@ksbl.ch
OI Bohner, Marc/0000-0002-5079-3286
FU RMS Foundation; Bettlach, Switzerland [E09_0001]; Swiss Society of
   Orthopaedics and Traumatology (SGOT/SSOT); 3R Foundation [S124-10]
FX This study was supported by research grants from the RMS Foundation;
   Bettlach, Switzerland (E09_0001), the Swiss Society of Orthopaedics and
   Traumatology (SGOT/SSOT) and 3R Foundation (S124-10). S. epidermidis
   RP62A (ATCC 35984) was kindly provided by Prof. P. Vaudaux from the
   Department of Infectious Disease, University Hospital, Geneva,
   Switzerland. At the RMS Foundation we want to thank S. Grunefelder and
   P. Brotschi for their help producing the scaffolds, W. Hirsinger for his
   help with the SEM studies and L. Galea for the BET and XRD analysis.
   Furthermore we have to thank S. Gersbach (Kantonsspital Baselland
   Liestal) for her help with data management and analysis.
CR Arens S, 1996, J BONE JOINT SURG BR, V78B, P647
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Bayston R, 1997, J NEUROSURG, V87, P247, DOI 10.3171/jns.1997.87.2.0247
   Bohner M, 2005, BIOMATERIALS, V26, P6099, DOI 10.1016/j.biomaterials.2005.03.026
   Bohner M, 2011, ACTA BIOMATER, V7, P478, DOI 10.1016/j.actbio.2010.08.008
   Bohner M, 2000, INJURY, V31, pS37
   Bohner M, 2001, KEY ENG MATER, V192, P765
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Ceri H, 2001, METHOD ENZYMOL, V337, P377, DOI 10.1016/S0076-6879(01)37026-X
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771
   Chaw KC, 2005, ANTIMICROB AGENTS CH, V49, P4853, DOI 10.1128/AAC.49.12.4853-4859.2005
   CHOW LC, 1991, NIPPON SERAM KYO GAK, V99, P954
   Clauss M, 2013, CLIN ORTHOP RELAT R, V471, P2312, DOI 10.1007/s11999-013-2919-5
   Clauss M, 2013, EUR CELLS MATER, V25, P159, DOI 10.22203/eCM.v025a11
   Clauss M, 2010, ACTA BIOMATER, V6, P3791, DOI 10.1016/j.actbio.2010.03.011
   CORDERO J, 1994, J BONE JOINT SURG BR, V76B, P717
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Crockarell JR, 1998, J BONE JOINT SURG AM, V80A, P1306, DOI 10.2106/00004623-199809000-00009
   CURRY NA, 1971, J CHEM SOC A, P3725, DOI 10.1039/j19710003725
   de Pol GJV, 2007, J BONE JOINT SURG BR, V89B, P1225
   Delloye C, 2007, J BONE JOINT SURG BR, V89B, P574, DOI 10.1302/0301-620X.89B5.19039
   DICKENS B, 1974, J SOLID STATE CHEM, V10, P232, DOI 10.1016/0022-4596(74)90030-9
   DICKENS B, 1972, ACTA CRYSTALL B-STRU, VB 28, P797, DOI 10.1107/S056774087200322X
   Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P59, DOI 10.1097/01.blo.0000175125.60214.a4
   Galea LG, 2008, BIOMATERIALS, V29, P3400, DOI 10.1016/j.biomaterials.2008.04.041
   Geurts J, 2011, INJURY, V42, pS82, DOI 10.1016/j.injury.2011.06.189
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Harris LG, 2007, J MATER SCI-MATER M, V18, P1151, DOI 10.1007/s10856-007-0143-0
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   Jakubowski W, 2008, ADV APPL CERAM, V107, P217, DOI 10.1179/174367608X263395
   Johansson A, 1999, INJURY, V30, P587, DOI 10.1016/S0020-1383(99)00153-9
   Kappe T, 2010, CELL TISSUE BANK, V11, P253, DOI 10.1007/s10561-009-9140-5
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Ketonis C, 2010, CLIN ORTHOP RELAT R, V468, P2113, DOI 10.1007/s11999-010-1322-8
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   MATHEW M, 1977, ACTA CRYSTALLOGR B, V33, P1325, DOI 10.1107/S0567740877006037
   Melcher GA, 1996, INJURY, V27, P23
   Meredith DO, 2005, J BIOMED MATER RES A, V75A, P541, DOI 10.1002/jbm.a.30457
   Merritt K, 1998, J BIOMED MATER RES, V39, P415, DOI 10.1002/(SICI)1097-4636(19980305)39:3<415::AID-JBM10>3.0.CO;2-9
   Moriarty TF, 2009, INT J ARTIF ORGANS, V32, P663
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   OSTERMANN PAW, 1994, ORTHOPEDICS, V17, P397
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Patel JD, 2003, J BIOMAT SCI-POLYM E, V14, P279, DOI 10.1163/156856203763572725
   Pattavilakom A, 2006, NEUROSURGERY, V58, P930, DOI 10.1227/01.NEU.0000210155.65102.E7
   Polonio RE, 2001, ANTIMICROB AGENTS CH, V45, P3262, DOI 10.1128/AAC.45.11.3262-3266.2001
   Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0
   Reizner W, 2014, EUR CELLS MATER, V27, P196, DOI 10.22203/eCM.v027a15
   Rodriguez-Carvajal J., 2001, COMMISSION POWDER DI, V26, P12
   Schlegel U, 2006, INJURY, V37, P67, DOI 10.1016/j.injury.2006.04.011
   Sheehan E, 2004, J ORTHOPAED RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9
   Stahli C, 2010, ACTA BIOMATER, V6, P2760, DOI 10.1016/j.actbio.2010.01.018
   Steffen T, 2001, EUR SPINE J, V10, pS132, DOI 10.1007/s005860100325
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Trampuz A, 2006, DRUGS, V66, P1089, DOI 10.2165/00003495-200666080-00005
   Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010
   VANBLITTERSWIJK CA, 1986, J BIOMED MATER RES, V20, P1197, DOI 10.1002/jbm.820200810
   VANBLITTERSWIJK CA, 1986, J BIOMED MATER RES, V20, P989, DOI 10.1002/jbm.820200713
   VANBLITTERSWIJK CA, 1986, J BIOMED MATER RES, V20, P1003, DOI 10.1002/jbm.820200714
   Vogely HC, 2000, J ORTHOPAED RES, V18, P485, DOI 10.1002/jor.1100180323
   Westas E, 2014, J BIOMED MATER RES A, V102, P1063, DOI 10.1002/jbm.a.34757
NR 66
TC 4
Z9 4
U1 0
U2 5
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2014
VL 28
BP 39
EP 50
DI 10.22203/eCM.v028a04
PG 12
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA AU4EQ
UT WOS:000345562600004
PM 25036054
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Mathieu, M
   Vigier, S
   Labour, MN
   Jorgensen, C
   Belamie, E
   Noel, D
AF Mathieu, M.
   Vigier, S.
   Labour, M-N.
   Jorgensen, C.
   Belamie, E.
   Noel, D.
TI INDUCTION OF MESENCHYMAL STEM CELL DIFFERENTIATION AND CARTILAGE
   FORMATION BY CROSS-LINKER-FREE COLLAGEN MICROSPHERES
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Biomaterial; cartilage engineering; chondrogenesis; collagen;
   injectable; mesenchymal stem cell; microspheres; safety; self-assembly;
   transforming growth factor-beta
ID MURINE KNEE-JOINT; CHONDROGENIC DIFFERENTIATION; TRANSFORMING
   GROWTH-FACTOR-BETA-1; BONE-MARROW; IN-VITRO; ARTICULAR-CARTILAGE;
   TGF-BETA; REGENERATIVE MEDICINE; OSTEOPHYTE FORMATION; MATRIX COMPONENTS
AB Because of poor self-healing ability, joint cartilage can undergo irreversible degradation in the course of various diseases or after injury. A promising approach for cartilage engineering consists of using of mesenchymal stem cells (MSC) and a differentiation factor combined with an injectable carrier biomaterial. We describe here a novel synthesis route for native collagen microspheres that does not involve the use of potentially toxic crosslinking agents. An emulsion was formed between a type I collagen solution and perfluorinated oil, stabilised by a biocompatible triblock perfluorinated copolymer surfactant. Spherical microparticles of fibrillar collagen were formed through a sol-gel transition induced by ammonia vapours. Electron microscopy observations showed that these self-cross-linked microspheres were constituted by a gel of striated collagen fibrils. Microspheres that were loaded with transforming growth factor beta (TGF-beta)3 progressively released this differentiation factor over a four weeks period. Human MSC rapidly adhered to TGF-beta 3-loaded microspheres and, after 21 d of culture, exhibited typical chondrocyte morphology and produced an uncalcified matrix made of the predominant cartilage components, aggrecan and type II collagen, but devoid of the hypertrophic marker type X collagen. Subcutaneous co-injection of MSC and TGF-beta 3-loaded microspheres in mice consistently led to the formation of a cartilage-like tissue, which was however hypertrophic, calcified and vascularised. In conclusion, we developed cross-linker free collagen microspheres that allowed chondrogenic differentiation of MSC in vitro and in vivo.
C1 [Mathieu, M.; Vigier, S.; Jorgensen, C.; Noel, D.] Hop St Eloi, INSERM, U844, F-34091 Montpellier 5, France.
   [Mathieu, M.; Jorgensen, C.; Noel, D.] Univ Montpellier I, UFR Med, Montpellier, France.
   [Jorgensen, C.] Hop Lapeyronie, Serv Immunorhumatol Therapeut, Montpellier, France.
   [Vigier, S.; Labour, M-N.; Belamie, E.] Ecole Prat Hautes Etud, Paris, France.
   [Vigier, S.; Labour, M-N.; Belamie, E.] Ecole Natl Super Chim Montpellier, Inst Charles Gerhardt, Equipe MACS, UMR 5253, F-34053 Montpellier, France.
RP Mathieu, M (reprint author), Hop St Eloi, INM, INSERM, U 844, 80 Ave Augustin Fliche, F-34091 Montpellier 5, France.
EM marc.mathieu@inserm.fr
RI Noel, Daniele/E-5719-2016
FU Inserm Institute; University of Montpellier I; CNRS (Programme
   Interdisciplinaire " Longevite & Vieillissement "); program "Bonus de
   l'Universite de Montpellier I de Soutien a la Recherche"; Agence de la
   Biomedecine; Agence Nationale pour la Recherche [ANR-11-INSB-005]
FX We thank Silvine Benth, Marisa Teigell and Heiani Touaitahuata for
   technical assistance. This study was supported by the Inserm Institute,
   the University of Montpellier I and funding from the CNRS (Programme
   Interdisciplinaire " Longevite & Vieillissement "), the program "Bonus
   de l'Universite de Montpellier I de Soutien a la Recherche" and the
   Agence de la Biomedecine. We thank the "Reseau des Animaleries de
   Montpellier" animal facility, the "Reseau d'Histologie Experimentale de
   Montpellier" histology facility for processing our animal tissues, and
   the "Montpellier RIO Imaging" platform. We also thank the Agence
   Nationale pour la Recherche for support of the national infrastructure
   "ECELLFRANCE: Development of a national adult mesenchymal stem cell
   based therapy platform" (ANR-11-INSB-005). We wish to confirm that there
   are no known conflicts of interest associated with this publication and
   there has been no significant financial support for this work that could
   have influenced its outcome.
CR Bakker AC, 2001, OSTEOARTHR CARTILAGE, V9, P128, DOI 10.1053/joca.2000.0368
   Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Clausell-Tormos J, 2008, CHEM BIOL, V15, P427, DOI 10.1016/j.chembiol.2008.04.004
   Crawford DC, 2012, J BONE JOINT SURG AM, V94A, P979, DOI 10.2106/JBJS.K.00533
   Djouad F, 2005, ARTHRITIS RES THER, V7, pR1304, DOI 10.1186/ar1827
   DURR J, 1993, EXP CELL RES, V207, P235, DOI 10.1006/excr.1993.1189
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   ENOMOTO M, 1993, EXP CELL RES, V205, P276, DOI 10.1006/excr.1993.1087
   Gerber HP, 1999, NAT MED, V5, P623
   Gobeaux F, 2008, J MOL BIOL, V376, P1509, DOI 10.1016/j.jmb.2007.12.047
   Grover CN, 2012, ACTA BIOMATER, V8, P3080, DOI 10.1016/j.actbio.2012.05.006
   Hamdoune F, 2000, NEW J CHEM, V24, P1037, DOI 10.1039/b006739n
   Han YS, 2010, JOINT BONE SPINE, V77, P27, DOI 10.1016/j.jbspin.2009.05.013
   Hedlund H, 1999, J BIOL CHEM, V274, P5777, DOI 10.1074/jbc.274.9.5777
   Holtze C, 2008, LAB CHIP, V8, P1632, DOI 10.1039/b806706f
   Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   LEVINE JH, 1993, AM J PATHOL, V143, P368
   Li CH, 2011, TISSUE ENG PT A, V17, P777, DOI [10.1089/ten.tea.2010.0078, 10.1089/ten.TEA.2010.0078]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Maumus M, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt55
   Mwale F, 2006, J ORTHOP RES, V24, P1791, DOI 10.1002/jor.20200
   Nakamura N, 2009, ARTHROSCOPY, V25, P531, DOI 10.1016/j.arthro.2009.02.007
   Ode A, 2010, J BIOMED MATER RES A, V95A, P1114, DOI 10.1002/jbm.a.32909
   Pacak CA, 2011, TISSUE ENG PART C-ME, V17, P879, DOI [10.1089/ten.tec.2010.0720, 10.1089/ten.TEC.2010.0720]
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2
   Ramage L, 2009, SCAND J MED SCI SPOR, V19, P457, DOI 10.1111/j.1600-0838.2009.00912.x
   ROSSLER B, 1995, J MICROENCAPSUL, V12, P49, DOI 10.3109/02652049509051126
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Sankar S, 1996, J CLIN INVEST, V97, P1436, DOI 10.1172/JCI118565
   Segat D, 2002, J BIOL CHEM, V277, P31612, DOI 10.1074/jbc.M203471200
   Shibuya H, 2006, J DERMATOL SCI, V41, P187, DOI 10.1016/j.jdermsci.2005.10.005
   Shoseyov O, 2013, TISSUE ENG PT A, V19, P1527, DOI [10.1089/ten.tea.2012.0347, 10.1089/ten.TEA.2012.0347]
   Solorio LD, 2012, STEM CELL TRANSL MED, V1, P632, DOI 10.5966/sctm.2012-0039
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Steck E, 2009, STEM CELLS DEV, V18, P969, DOI 10.1089/scd.2008.0213
   Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195
   Studer D, 2012, EUR CELLS MATER, V24, P118, DOI 10.22203/eCM.v024a09
   Tesseur I, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-15
   VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279
   Vinatier C, 2009, CURR STEM CELL RES T, V4, P318, DOI 10.2174/157488809789649205
   Weiss S, 2010, J CELL PHYSIOL, V223, P84, DOI 10.1002/jcp.22013
   WIEBE D, 1988, SURGERY, V104, P26
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143
   Zhu SX, 2005, J POLYM SCI POL PHYS, V43, P3685, DOI 10.1002/polb.20621
NR 55
TC 13
Z9 13
U1 0
U2 16
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2014
VL 28
BP 82
EP 97
DI 10.22203/eCM.v028a07
PG 16
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA AU4EQ
UT WOS:000345562600007
PM 25179212
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Moriarty, TF
   Grainger, DW
   Richards, RG
AF Moriarty, T. F.
   Grainger, D. W.
   Richards, R. G.
TI CHALLENGES IN LINKING PRECLINICAL ANTI-MICROBIAL RESEARCH STRATEGIES
   WITH CLINICAL OUTCOMES FOR DEVICE-ASSOCIATED INFECTIONS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Medical implants; infection strategy; antibiotic resistance; in vitro-in
   vivo correlations; clinical translational research
ID RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN;
   QUANTITATIVE TRANSCRIPT ANALYSIS; BIOMATERIAL-ASSOCIATED INFECTION;
   SURGICAL SITE INFECTIONS; MICROBIAL BIOFILM GROWTH; SURFACE
   DETERMINANT-B; OPERATING-ROOM; PSEUDOMONAS-AERUGINOSA; IN-VITRO
AB Infections related to implanted medical devices have become a significant health care issue in recent decades. Increasing numbers of medical devices are in use, often in an aging population, and these devices are implanted against a background of increasing antibiotic-resistant bacterial populations. Progressively more antibiotic resistant infections, requiring ever more refined treatment options, are therefore predicted to emerge with greater frequency in the coming decades. Improvements in the prevention, diagnosis and treatment of these device-associated infections will remain priority targets both for clinicians and the translational research community charged with addressing these challenges.
   Preclinical strategies, predictive of ultimate clinical efficacy, should serve as a control point for effective translation of new technologies to clinical applications. The development of new anti-infective medical devices requires a validated preclinical testing protocol; however, reliable validation of experimental and preclinical antimicrobial methodologies currently suffers from a variety of technical limitations. These include the lack of agreement or standardisation of experimental protocols, a general lack of correlation between in vitro and in vivo preclinical results and lack of validation between in vivo preclinical implant infection models and clinical (human) results. Device-associated infections pose additional challenges to practicing clinicians concerning diagnosis and treatment, both of which are complicated by the biofilms formed on the medical device.
   The critical challenges facing both preclinical research and clinical laboratories in improving both diagnosis and treatment of medical device-associated infections are the focus of this review.
C1 [Moriarty, T. F.; Richards, R. G.] AO Fdn, AO Res Inst Davos, CH-7270 Davos, Switzerland.
   [Grainger, D. W.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   [Grainger, D. W.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Moriarty, TF (reprint author), AO Fdn, AO Res Inst Davos, Clavadelerstr 8,Davos Pl, CH-7270 Davos, Switzerland.
EM fintan.moriarty@aofoundation.org
CR Aaron SD, 2005, LANCET, V366, P463, DOI 10.1016/S0140-6736(05)67060-2
   Alexander JW, 2013, SURG INFECT, V14, P345, DOI 10.1089/sur.2012.134
   Allo MD, 2005, SURG CLIN N AM, V85, P1291, DOI 10.1016/j.suc.2005.09.001
   An YHH, 1998, J INVEST SURG, V11, P139, DOI 10.3109/08941939809032193
   Berkes M, 2010, J BONE JOINT SURG AM, V92A, P823, DOI 10.2106/JBJS.I.00470
   Botelho-Nevers E, 2013, EXPERT REV VACCINES, V12, P1249, DOI 10.1586/14760584.2013.840091
   Brooks B, 2013, BIOMATERIALS ASS INF, P307
   Brown M, 2009, CLIN VACCINE IMMUNOL, V16, P1095, DOI 10.1128/CVI.00085-09
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   Calabro L, 2013, BIOMATERIALS ASS INF, P273
   Campoccia D, 2008, INT J ARTIF ORGANS, V31, P841
   Chaffin DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041329
   Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303
   Chan PF, 1998, MICROBIOL-SGM, V144, P2469, DOI 10.1099/00221287-144-9-2469
   Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5
   Collins J, 2010, ISME J, V4, P577, DOI 10.1038/ismej.2009.151
   Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204
   Daghighi S, 2014, EUR CELLS MATER, V27, P26, DOI 10.22203/eCM.v027a03
   Dalstrom DJ, 2008, J BONE JOINT SURG AM, V90A, P1022, DOI 10.2106/JBJS.G.00689
   Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317
   Darouiche R, 2013, BIOMATERIALS ASS INF, P485
   DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1
   Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198
   Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x
   Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918
   Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09
   Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603
   FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772
   Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005
   Fowler VG, 2013, JAMA-J AM MED ASSOC, V309, P1368, DOI 10.1001/jama.2013.3010
   Fuchs T, 2011, ARCH ORTHOP TRAUM SU, V131, P1419, DOI 10.1007/s00402-011-1321-6
   Garzoni C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-171
   Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7
   Goerke C, 2005, INFECT IMMUN, V73, P3415, DOI 10.1128/IAI.73.6.3415-3421.2005
   Goerke C, 2004, INT J MED MICROBIOL, V294, P195, DOI 10.1016/j.ijmm.2004.06.013
   Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000
   Goerke C, 2001, MOL MICROBIOL, V40, P1439, DOI 10.1046/j.1365-2958.2001.02494.x
   Gottenbos B, 1999, METHODS ENZYMOL, V310, P523
   Grainger DW, 2013, BIOMATERIALS, V34, P9237, DOI 10.1016/j.biomaterials.2013.08.043
   GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205
   GRISTINA AG, 1991, ORTHOP CLIN N AM, V22, P363
   GUILLOU PJ, 1993, LANCET, V342, P217, DOI 10.1016/0140-6736(93)92303-B
   GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004
   Haja MH, 2012, J TRANSPLANT, V2012
   Hanssen A D, 1997, Instr Course Lect, V46, P555
   Hardes J, 2007, BIOMATERIALS, V28, P2869, DOI 10.1016/j.biomaterials.2007.02.033
   Hendricks KJ, 2001, J BONE JOINT SURG AM, V83A, P855, DOI 10.2106/00004623-200106000-00006
   HOCH RC, 1993, CRIT CARE MED, V21, P839, DOI 10.1097/00003246-199306000-00010
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Holtfreter S, 2010, INT J MED MICROBIOL, V300, P176, DOI 10.1016/j.ijmm.2009.10.002
   Howard JL, 2007, J ARTHROPLASTY, V22, P6, DOI 10.1016/j.artli.2007.05.013
   Howe TS, 2013, OSTEOPOROSIS INT, V24, P1765, DOI 10.1007/s00198-012-2222-4
   Hudson MC, 1999, FEMS MICROBIOL LETT, V173, P279, DOI 10.1111/j.1574-6968.1999.tb13514.x
   James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x
   JAMES RC, 1961, BRIT J EXP PATHOL, V42, P266
   Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003
   Kalicke T, 2003, J ORTHOPAED RES, V21, P373, DOI 10.1016/S0736-0266(02)00149-3
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Keays T, 2009, J CYST FIBROS, V8, P122, DOI 10.1016/j.jcf.2008.10.005
   Kim A, 2009, CLIN THER, V31, P2765, DOI 10.1016/j.clinthera.2009.11.026
   KIM KS, 1981, ANTIMICROB AGENTS CH, V19, P1075, DOI 10.1128/AAC.19.6.1075
   Kollef M, 2013, BIOMATERIALS ASS INF, P531
   Korgaonkar A, 2013, P NATL ACAD SCI USA, V110, P1059, DOI 10.1073/pnas.1214550110
   Krettek C, 1998, CHIRURG, V69, P684, DOI 10.1007/s001040050477
   Kuijer R, 2007, BIOMATERIALS, V28, P5148, DOI 10.1016/j.biomaterials.2007.06.003
   Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006
   Lammers A, 2000, MICROBIOL-SGM, V146, P981, DOI 10.1099/00221287-146-4-981
   Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461
   Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7
   Lipinska U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022864
   Livermore DM, 2011, J ANTIMICROB CHEMOTH, V66, P1941, DOI 10.1093/jac/dkr262
   Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715
   Lynch RJ, 2009, AM J MED QUAL, V24, P45, DOI 10.1177/1062860608326419
   Massey RC, 2002, INFECT IMMUN, V70, P5339, DOI 10.1128/IAI.70.10.5339-5345.2002
   Mastropaolo MD, 2005, INFECT IMMUN, V73, P6055, DOI 10.1128/IAI.73.9.6055-6063.2005
   Matsukawa M, 2005, UROLOGY, V65, P440, DOI 10.1016/j.urology.2004.10.065
   McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200
   MOHLER KM, 1993, J IMMUNOL, V151, P1548
   Molina-Manso D, 2013, INT J ANTIMICROB AG, V41, P521, DOI 10.1016/j.ijantimicag.2013.02.018
   Montanaro L, 2008, INT J ARTIF ORGANS, V31, P771
   Moriarty TF, 2007, BRIT J BIOMED SCI, V64, P101, DOI 10.1080/09674845.2007.11732766
   Moriarty T. F., 2011, COMPREHENSIVE BIOMAT, V4, P75
   Moskowitz SM, 2011, PEDIATR PULM, V46, P184, DOI 10.1002/ppul.21350
   Neut D, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-258
   NORDEN CW, 1970, J INFECT DIS, V122, P410, DOI 10.1093/infdis/122.5.410
   Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x
   Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309
   Palmer M, 2011, CLIN ORTHOP RELAT R, V469, P3037, DOI 10.1007/s11999-011-1843-9
   Panahi P, 2012, CLIN ORTHOP RELAT R, V470, P2690, DOI 10.1007/s11999-012-2252-4
   Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069
   Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11
   Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008
   Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069
   Poelstra KA, 2000, TISSUE ENG, V6, P401, DOI 10.1089/107632700418100
   Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519
   Proctor RA, 2012, VACCINE, V30, P2921, DOI 10.1016/j.vaccine.2011.11.006
   Que YA, 2005, J EXP MED, V201, P1627, DOI 10.1084/jem.20050125
   Ramos ER, 2011, CRIT CARE MED, V39, P245, DOI 10.1097/CCM.0b013e3181feb83e
   Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06
   Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002
   Rudkin JK, 2012, J INFECT DIS, V205, P798, DOI 10.1093/infdis/jir845
   Schafer P, 2008, CLIN INFECT DIS, V47, P1403, DOI 10.1086/592973
   Scheman L, 1941, J AMER MED ASSOC, V117, P1525, DOI 10.1001/jama.1941.02820440033008
   Scully IL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00109
   Sellman BR, 2008, INFECT IMMUN, V76, P2950, DOI 10.1128/IAI.00055-08
   Sepandj F, 2004, PERITON DIALYSIS INT, V24, P65
   Sjollema J, 2010, BIOMATERIALS, V31, P1984, DOI 10.1016/j.biomaterials.2009.11.068
   Smith AL, 2003, CHEST, V123, P1495, DOI 10.1378/chest.123.5.1495
   Stone PW, 2010, MED CARE, V48, P433, DOI 10.1097/MLR.0b013e3181d5fb3f
   Stone PW, 2002, AM J INFECT CONTROL, V30, P145, DOI 10.1067/mic.2002.121099
   Subbiahdoss G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024827
   Subbiahdoss G, 2010, J BIOMED MATER RES A, V94A, P533, DOI 10.1002/jbm.a.32731
   Subbiahdoss G, 2010, EUR CELLS MATER, V19, P205, DOI 10.22203/eCM.v019a20
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Sun Y, 2008, WOUND REPAIR REGEN, V16, P805, DOI 10.1111/j.1524-475X.2008.00434.x
   Trampuz A, 2004, MAYO CLIN PROC, V79, P109, DOI 10.4065/79.1.109
   Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588
   Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281
   Uckay I, 2013, J HOSP INFECT, V84, P5, DOI 10.1016/j.jhin.2012.12.014
   Uckay I, 2010, EXPERT REV ANTI-INFE, V8, P657, DOI [10.1586/eri.10.41, 10.1586/ERI.10.41]
   van Oosten M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3584
   von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102
   Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506
   Vriesema AJM, 2000, INFECT IMMUN, V68, P1765, DOI 10.1128/IAI.68.4.1765-1772.2000
   Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405
   Wichmann MW, 1996, ARCH SURG-CHICAGO, V131, P995
   WIDMER AF, 1990, J INFECT DIS, V162, P96, DOI 10.1093/infdis/162.1.96
   Wiltshire MD, 2001, INFECT IMMUN, V69, P5198, DOI 10.1128/IAI.69.8.5198-5202.2001
   Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210
   Yarwood JM, 2002, J BACTERIOL, V184, P1095, DOI 10.1128/jb.184.4.1095-1101.2002
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 135
TC 15
Z9 15
U1 0
U2 27
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2014
VL 28
BP 112
EP 128
DI 10.22203/eCM.v028a09
PG 17
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA AU4EQ
UT WOS:000345562600009
PM 25214018
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Wang, C
   Li, Y
AF Wang, C.
   Li, Y.
TI Preparation and characterisation of S doped TiO2/natural zeolite with
   photocatalytic and adsorption activities
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Natural zeolite; S doping; TiO2; Photocatalysts
ID FERRITE COMPOSITE NANOPARTICLES; VISIBLE-LIGHT; BIOMATERIAL SYSTEM;
   NATURAL ZEOLITE; ANTIMICROBIAL ACTIVITY; TIO2 PHOTOCATALYSTS; MAGNETIC
   CORE; SHELL
AB Titanium dioxide has been attached much attention due to its unique antimicrobial, photocatalytic, self-cleaning activities. Practical applications of TiO2 are limited because of the problems of low recycling efficiency and photocatalytic activity of TiO2 fine particles. In this paper, natural zeolite supported S doped TiO2 photocatalysts were synthesised by TiCl4 hydrolysis method for the sake of improving the recovery and photocatalytic efficiency of fine TiO2. The as prepared materials were characterised by X-ray diffraction (XRD), scanning electron microscopy (SEM) and energy dispersive X-ray analysis (EDX), X-ray photoelectron spectroscopy (XPS), ultraviolet-visible diffuse reflection spectroscopy (UV-vis DRS) and photoluminescence (PL). Methyl orange was used to estimate the photocatalytic activity of the samples. The results showed that S ions (S6+) incorporated into the TiO2 crystal lattice or existed as SO42- on the surface of TiO2. The doped S ions stabilised the structure of anatase, restrained the transformation of anatase to rutile and the growth of TiO2 crystallite, and also improved the adsorption ability of the photocatalysts. The photocatalytic and adsorption activities of the S doped samples were obviously higher than that of the undoped sample.
C1 [Wang, C.] Shaanxi Univ Sci & Technol, Sch Mat Sci & Engn, Xian 710021, Peoples R China.
   [Wang, C.] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2V4, Canada.
   [Li, Y.] Shijiazhuang Univ Econ, Inst Mat Sci & Engn, Shijiazhuang 050031, Peoples R China.
RP Wang, C (reprint author), Shaanxi Univ Sci & Technol, Sch Mat Sci & Engn, Xian 710021, Peoples R China.
EM wangchengtj@163.com
FU State Key Laboratory of Advanced Technology for Materials Synthesis and
   Processing (Wuhan University of Technology) [2013-KF-13]; Foundation of
   Shaanxi University of Science and Technology [BJ12-18]; Shaanxi Natural
   Science Foundation, China [2013JQ6007]
FX The project supported by State Key Laboratory of Advanced Technology for
   Materials Synthesis and Processing (Wuhan University of Technology) (no.
   2013-KF-13), Foundation of Shaanxi University of Science and Technology
   (no. BJ12-18) and Shaanxi Natural Science Foundation, China (grant no.
   2013JQ6007).
CR Akurati KK, 2008, APPL CATAL B-ENVIRON, V79, P53, DOI 10.1016/j.apcatb.2007.09.036
   Cai HS, 2008, J RARE EARTH, V26, P71, DOI 10.1016/S1002-0721(08)60040-X
   Guan KH, 2005, SURF COAT TECH, V191, P155, DOI 10.1016/j.surfcoat.2004.02.022
   Huang ML, 2008, DYES PIGMENTS, V77, P327, DOI 10.1016/j.dyepig.2007.01.026
   Jin ZL, 2006, J MOL CATAL A-CHEM, V259, P275, DOI 10.1016/j.molcata.2006.06.035
   Liu SX, 2008, J HAZARD MATER, V152, P48, DOI 10.1016/j.jhazmat.2007.06.062
   Maira AJ, 2001, APPL CATAL B-ENVIRON, V29, P327, DOI 10.1016/S0926-3373(00)00211-3
   Ohno T, 2004, APPL CATAL A-GEN, V265, P115, DOI 10.1016/j.apcata.2004.01.007
   Panpa W, 2008, APPL CATAL B-ENVIRON, V80, P271, DOI 10.1016/j.apcatb.2007.11.029
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S., 2005, MAT SCI ENG C, VC119, P114
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wang BQ, 2006, APPL SURF SCI, V252, P2817, DOI 10.1016/j.apsusc.2005.04.025
   Wang C, 2012, APPL SURF SCI, V258, P4328, DOI 10.1016/j.apsusc.2011.12.108
   Wang C, 2011, APPL CLAY SCI, V53, P646, DOI 10.1016/j.clay.2011.05.017
   Wang C, 2011, APPL SURF SCI, V257, P6873, DOI 10.1016/j.apsusc.2011.03.021
   Wang YP, 2008, APPL SURF SCI, V254, P5276, DOI 10.1016/j.apsusc.2008.02.050
   Wu XW, 2009, APPL PHYS A-MATER, V97, P243, DOI 10.1007/s00339-009-5212-4
   Yu JC, 2002, CHEM MATER, V14, P3808, DOI 10.1021/cm020027c
   Zhang G. K., 2008, LANGMUIR, V23, P1026
   Znad H, 2009, J MOL CATAL A-CHEM, V314, P55, DOI 10.1016/j.molcata.2009.08.017
NR 26
TC 5
Z9 5
U1 5
U2 33
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD JUL
PY 2014
VL 29
IS 4
BP 204
EP 209
DI 10.1179/1753555714Y.0000000127
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA AT1SN
UT WOS:000344714300003
DA 2018-10-20
ER

PT J
AU Chen, ZG
   Zhu, L
   Xia, JX
   Xu, L
   Li, HM
   Zhang, J
   He, MQ
   Liu, J
AF Chen, Z. G.
   Zhu, L.
   Xia, J. X.
   Xu, L.
   Li, H. M.
   Zhang, J.
   He, M. Q.
   Liu, J.
TI Synthesis of flower-like Pd/BiOCl composites via reactable ionic liquid
   and their enhanced photocatalytic properties
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Photocatalytic; Pd/BiOCl; Ionic liquids; Visible light irradiation
ID VISIBLE-LIGHT IRRADIATION; SIMULATED SOLAR LIGHT; BIOMATERIAL SYSTEM;
   MAGNETIC CORE; ANTIMICROBIAL ACTIVITY; PD NANOPARTICLES; BIOCL;
   NANOCOMPOSITES; DEGRADATION; SHELL
AB A series of Pd/BiOCl catalysts have been prepared via a facile ethylene glycol (EG)-assisted solvothermal process in the presence of reactable ionic liquid 1-hexadecyl-3-methylimidazolium chloride ([C(16)mim] Cl). The as prepared products were characterised by powder X-ray diffraction, scanning electron microscopy, Fourier transform infrared spectroscopy, transient photocurrent response analysis, UV-vis diffuse reflectance spectra and photoluminescence spectroscopy. During the reaction process, [C(16)mim] Cl acted not only as Cl source but also as solvent, template and dispersing agent for the fabrication of Pd/BiOCl flower-like microspheres structures. The existence of ionic liquid was beneficial to generate small scale and steady Pd nanoparticles. Moreover, the photocatalytic activities of the Pd/BiOCl composite samples were evaluated by the photocatalytic degradation of rhodamine B. The effects of structure and morphology made by the introduction of Pd have been studied. A possible mechanism of Pd on the enhancement of visible light performance was also proposed.
C1 [Chen, Z. G.; Zhu, L.] Jiangsu Univ, Sch Environm & Safety Engn, Zhenjiang 212013, Peoples R China.
   [Chen, Z. G.] Jiangsu Univ, Minist Educ, Key Lab Modern Agr Equipment & Technol, Zhenjiang 212013, Peoples R China.
   [Xia, J. X.; Xu, L.; Li, H. M.; Zhang, J.; He, M. Q.; Liu, J.] Jiangsu Univ, Sch Chem & Chem Engn, Zhenjiang 212013, Peoples R China.
RP Xia, JX (reprint author), Jiangsu Univ, Sch Chem & Chem Engn, Zhenjiang 212013, Peoples R China.
EM xjx@ujs.edu.cn
FU Natural Science Foundation of Jiangsu Province [BK2012717]; Society
   Development Fund of Zhenjiang [SH2012020]; National Nature Science
   Foundation of China [21177050, 21206060]; priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD)
FX This work was financially supported by the Natural Science Foundation of
   Jiangsu Province (Grant No. BK2012717), Society Development Fund of
   Zhenjiang (Grant No. SH2012020), National Nature Science Foundation of
   China (Grant Nos. 21177050, 21206060) and A Project Funded by the
   priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD).
CR Ai ZH, 2011, J HAZARD MATER, V192, P361, DOI 10.1016/j.jhazmat.2011.05.033
   Bai XT, 2010, LANGMUIR, V26, P12209, DOI 10.1021/la101602a
   Cao J, 2012, CATAL COMMUN, V26, P204, DOI 10.1016/j.catcom.2012.05.025
   Cao SW, 2012, ACS APPL MATER INTER, V4, P418, DOI 10.1021/am201481b
   Chang C, 2013, APPL CATAL B-ENVIRON, V142, P553, DOI 10.1016/j.apcatb.2013.05.044
   Chen XB, 2010, CHEM REV, V110, P6503, DOI 10.1021/cr1001645
   Cheng HF, 2012, CHEM COMMUN, V48, P97, DOI 10.1039/c1cc15487g
   Di J, 2014, J MATER CHEM A, V2, P5340, DOI 10.1039/c3ta14617k
   Di J, 2013, RSC ADV, V3, P19624, DOI 10.1039/c3ra42269k
   Dong F, 2012, J HAZARD MATER, V219, P26, DOI 10.1016/j.jhazmat.2012.03.015
   Dupont J, 2010, CHEM SOC REV, V39, P1780, DOI 10.1039/b822551f
   Fardindoost S, 2010, INT J HYDROGEN ENERG, V35, P854, DOI 10.1016/j.ijhydene.2009.11.033
   Gao FD, 2012, PHYS CHEM CHEM PHYS, V14, P10572, DOI 10.1039/c2cp41045a
   Huang HY, 2009, CATAL COMMUN, V11, P58, DOI 10.1016/j.catcom.2009.08.012
   Jiang J, 2011, J PHYS CHEM C, V115, P20555, DOI 10.1021/jp205925z
   Lei YQ, 2009, CRYSTENGCOMM, V11, P1857, DOI 10.1039/b909013b
   Li HX, 2007, J AM CHEM SOC, V129, P4538, DOI 10.1021/ja069113u
   Li YY, 2011, CATAL COMMUN, V12, P660, DOI 10.1016/j.catcom.2010.12.011
   Liu YG, 2010, J HAZARD MATER, V184, P386, DOI 10.1016/j.jhazmat.2010.08.047
   Ma Z, 2010, ADV MATER, V22, P261, DOI 10.1002/adma.200900603
   Mohapatra SK, 2008, LANGMUIR, V24, P11276, DOI 10.1021/la801253f
   Nakamoto K., 1986, INFRARED SPECTRA INO
   Neouze MA, 2010, J MATER CHEM, V20, P9593, DOI 10.1039/c0jm00616e
   Novokreshchenova MN, 2005, CHEM SUSTAIN DEV, V13, P563
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Redel E, 2010, CHEM COMMUN, V46, P1159, DOI 10.1039/b921744d
   Shiraishi Y, 2013, ACS CATAL, V3, P312, DOI 10.1021/cs300756f
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Tong H, 2012, ADV MATER, V24, P229, DOI 10.1002/adma.201102752
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wang WC, 2012, PHYS CHEM CHEM PHYS, V14, P2450, DOI 10.1039/c2cp23186g
   Weng SX, 2013, J MATER CHEM A, V1, P3068, DOI 10.1039/c2ta01004f
   Wood A, 2001, J PHYS CHEM B, V105, P8810, DOI 10.1021/jp011576t
   Xia JX, 2013, CRYSTENGCOMM, V15, P10132, DOI 10.1039/c3ce41555d
   Xia JX, 2011, DALTON T, V40, P5249, DOI 10.1039/c0dt01511c
   Xiang QJ, 2012, CHEM SOC REV, V41, P782, DOI 10.1039/c1cs15172j
   Xiong JY, 2013, CHEM ENG J, V220, P228, DOI 10.1016/j.cej.2013.01.033
   Xu H, 2013, APPL CATAL B-ENVIRON, V129, P182, DOI 10.1016/j.apcatb.2012.08.015
   Xu L., 2011, EUR J INORG CHEM, V9, P1361
   Ye LQ, 2011, CHEM COMMUN, V47, P6951, DOI 10.1039/c1cc11015b
   Zhang KL, 2006, APPL CATAL B-ENVIRON, V68, P125, DOI 10.1016/j.apcatb.2006.08.002
   Zhang LL, 2010, ACS NANO, V4, P7030, DOI 10.1021/nn102308r
   Zhang L, 2009, APPL CATAL B-ENVIRON, V90, P458, DOI 10.1016/j.apcatb.2009.04.005
   Zhang X, 2008, J PHYS CHEM C, V112, P747, DOI 10.1021/jp077471t
   Zhang YY, 2012, APPL SURF SCI, V258, P10104, DOI 10.1016/j.apsusc.2012.06.083
NR 49
TC 4
Z9 4
U1 5
U2 60
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD JUL
PY 2014
VL 29
IS 4
BP 245
EP 251
DI 10.1179/1753555714Y.0000000146
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA AT1SN
UT WOS:000344714300011
DA 2018-10-20
ER

PT J
AU Meme, L
   Santarelli, A
   Marzo, G
   Emanuelli, M
   Nocini, PF
   Bertossi, D
   Putignano, A
   Dioguardi, M
   Lo Muzio, L
   Bambini, F
AF Meme, L.
   Santarelli, A.
   Marzo, G.
   Emanuelli, M.
   Nocini, P. F.
   Bertossi, D.
   Putignano, A.
   Dioguardi, M.
   Lo Muzio, L.
   Bambini, F.
TI NOVEL HYDROXYAPATITE BIOMATERIAL COVALENTLY LINKED TO RALOXIFENE
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Letter
DE raloxifene; nanohydroxiapatite; (3-Aminopropyl)-Triethoxysilane;
   covalent bond; osteo blast
ID BONE MORPHOGENETIC PROTEIN-2; IMPLANT SOFT-TISSUES; COMPOSITE SCAFFOLDS;
   OSTEOBLAST ADHESION; OVARIECTOMIZED RATS; NANOPHASE CERAMICS; ESTROGEN;
   CELLS; ALENDRONATE; EXPRESSION
AB Since raloxifene, a drug used in osteoporosis therapy, inhibits osteoclast, but not osteoblast functions, it has been suggested to improve recovery during implant surgery. The present paper describes an effective method to link raloxifene, through a covalent bond, to a nano-Hydroxyapatite-based biomaterial by interfacing with (3-aminopropyl)-Triethoxysilane as assessed by Infra Red-Fourier Transformed (IR-FT) spectroscopy and Scanning Electron Microscope (SEM). To evaluate the safety of this modified new material, the vitality of osteoblast-like cells cultured with the new biomaterial was then investigated. Raloxifene-conjugated HA-biomaterial has been shown to be a safe material easy to obtain which could be an interesting starting point for the use of a new functional biomaterial suitable in bone regeneration procedures.
C1 [Meme, L.; Santarelli, A.; Emanuelli, M.; Putignano, A.; Bambini, F.] Marche Polytech Univ, Dept Clin Specialist & Stomatol Sci, Ancona, Italy.
   [Santarelli, A.; Bambini, F.] Natl Inst Care & Res Ageing, Odontostomatol Clin, Ancona, Italy.
   [Marzo, G.] Univ Aquila, Dept Surg Sci, I-67100 Laquila, Italy.
   [Nocini, P. F.; Bertossi, D.] Univ Verona, Dept Maxillofacial Surg, I-37100 Verona, Italy.
   [Dioguardi, M.; Lo Muzio, L.] Foggia Univ, Dept Clin & Expt Med, Foggia, Italy.
RP Lo Muzio, L (reprint author), Via Rovelli 48, I-71122 Foggia, Italy.
EM lorenzo.lomuzio@unifg.it
RI Santarelli, Andrea/P-6310-2014
OI Santarelli, Andrea/0000-0003-4218-3354; MARZO,
   Giuseppe/0000-0001-9088-7749
CR Ahola M., 1999, International Journal of Pharmaceutics (Amsterdam), V181, P181, DOI 10.1016/S0378-5173(99)00022-8
   Bambini F, 2007, EUR J INFLAMM, V5, P121, DOI 10.1177/1721727X0700500302
   Bambini F, 2006, INT J IMMUNOPATH PH, V19, P905, DOI 10.1177/039463200601900420
   Bambini F, 2003, Minerva Stomatol, V52, P331
   Bambini F, 2013, EUR J INFLAMM, V11, P305, DOI 10.1177/1721727X1301100133
   Barboza EP, 2004, J PERIODONTOL, V75, P702, DOI 10.1902/jop.2004.75.5.702
   BLACK LJ, 1983, LIFE SCI, V32, P1031, DOI 10.1016/0024-3205(83)90935-9
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   Busilacchi A, 2013, CARBOHYD POLYM, V98, P665, DOI 10.1016/j.carbpol.2013.06.044
   Dupraz AMP, 1996, J BIOMED MATER RES, V30, P231, DOI 10.1002/(SICI)1097-4636(199602)30:2<231::AID-JBM13>3.0.CO;2-P
   EVANS G, 1994, ENDOCRINOLOGY, V134, P2283, DOI 10.1210/en.134.5.2283
   Garbuz DS, 2008, J BONE JOINT SURG AM, V90A, P1090, DOI 10.2106/JBJS.G.00415
   Gille J, 2002, INT ORTHOP, V26, P203, DOI 10.1007/s00264-002-0353-5
   Greiner SH, 2008, ACTA ORTHOP, V79, P717, DOI 10.1080/17453670810016768
   Helen W, 2007, BIOMATERIALS, V28, P2010, DOI 10.1016/j.biomaterials.2007.01.011
   Houshmand B, 2007, J PERIODONTAL RES, V42, P119, DOI 10.1111/j.1600-0765.2006.00923.x
   KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2
   Lepore S, 2013, J BIOL REG HOMEOS AG, V27, P531
   LINDSAY R, 1976, LANCET, V1, P1038
   Liu HC, 2011, TISSUE ENG PT A, V17, P2417, DOI [10.1089/ten.tea.2010.0620, 10.1089/ten.TEA.2010.0620]
   Liu XM, 2007, J CONTROL RELEASE, V122, P54, DOI 10.1016/j.jconrel.2007.06.021
   Lo Muzio L, 2013, EUR J INFLAMM, V11, P797
   Lo Muzio L, 2014, MOL CARCINOGEN, V53, P264, DOI 10.1002/mc.21960
   Ravarian R, 2011, IEEE ENG MED BIO, P3593, DOI 10.1109/IEMBS.2011.6090601
   RICHELSON LS, 1984, NEW ENGL J MED, V311, P1273, DOI 10.1056/NEJM198411153112002
   Santarelli A, 2009, Minerva Stomatol, V58, P445
   SATO M, 1994, J BONE MINER RES, V9, P715
   Shi XT, 2009, PHARM RES-DORD, V26, P422, DOI 10.1007/s11095-008-9759-0
   Sigurdsson T J, 1996, Int J Periodontics Restorative Dent, V16, P524
   Srisubut S, 2007, ORAL SURG ORAL MED O, V104, pE11, DOI 10.1016/j.tripleo.2007.04.022
   Tan RW, 2012, J TISSUE ENG REGEN M, V6, P614, DOI 10.1002/term.463
   Terheyden H, 1997, Mund Kiefer Gesichtschir, V1, P272
   Wang XJ, 2010, MED ENG PHYS, V32, P391, DOI 10.1016/j.medengphy.2010.02.002
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Woo KM, 2007, BIOMATERIALS, V28, P2622, DOI 10.1016/j.biomaterials.2007.02.004
   Xu CX, 2009, J BIOMED MATER RES A, V88A, P264, DOI 10.1002/jbm.a.31931
   Zhu WM, 2014, IN VITRO CELL DEV-AN, V50, P214, DOI 10.1007/s11626-013-9699-9
NR 39
TC 2
Z9 2
U1 0
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0394-6320
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD JUL-SEP
PY 2014
VL 27
IS 3
BP 437
EP 444
DI 10.1177/039463201402700315
PG 8
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA AP9JW
UT WOS:000342397100015
PM 25280036
OA Bronze
DA 2018-10-20
ER

PT J
AU Vesa, D
   Niculescu, B
   Tutunaru, D
   Ardeleanu, V
AF Vesa, Doinita
   Niculescu, Bianca
   Tutunaru, Dana
   Ardeleanu, Valeriu
TI Raw avian membrane as biomaterial for myringopexy
SO ROMANIAN BIOTECHNOLOGICAL LETTERS
LA English
DT Article
DE raw avian membrane; myringopexy
ID HEARING; CHILDREN; AUDIT
AB Myringopexy with raw avian membrane came out due to the necessity of establishing the influence of the perforation of the tympanic membrane characteristics on hearing after its closure. The aim of this study was to present a new technique for repairing the defects of the tympanic membrane and to obtain cheap, easy to get and effective biomaterial for myringopexy. The novelty lies in its innovative character and a better resistance in time of the neo-membrane as compared to the avian membrane thermally treated or to other types of mentors. The clinic-experimental study was carried out on a group of 230 patients, from patients within the ENT Clinic of, Saint Apostle Andrew" Emergency Hospital Galati which have been examined by otoscopy and microotoscopy. A number of 238 perforated tympanum membranes had been found (some patients presented with perforations on both ears); six of the examined tympanum had two perforations each, so a total of 244 perforations had been examined. A number of 182 patients with 188 perforations had suffered surgery for closing the perforations. The investigations are part of a succession of studies that have the purpose of establishing the relationship between tympanic perforation and transmission hypoacusia. The results are promising and lead to closure of the rupture/perforation with thin tympanic membrane and a significant improvement of the auditive function, without side-effects by using cheap biomaterials.
C1 [Vesa, Doinita; Tutunaru, Dana; Ardeleanu, Valeriu] Dunarea de Jos Univ Galati, Fac Med & Pharm, Galati 800008, Romania.
   Emergency Cty Hosp Sf Apostol Andrei, Galati, Romania.
RP Vesa, D (reprint author), Dunarea de Jos Univ Galati, Fac Med & Pharm, 35 Alexandru Ioan Cuza St, Galati 800008, Romania.
EM doina.vesa@ugal.ro; dana.tutunaru@ugal.ro
CR Albu S, 1998, AM J OTOL, V19, P136
   ATAMAN T., 2007, TRAUMATISMELE URECHI
   AUSTIN D.F., 1996, OTORHYNOLARYNGOLOGY
   Berger G, 1997, J LARYNGOL OTOL, V111, P1137
   BERGHOFER G, 1994, J SOLID STATE CHEM, V108, P395, DOI 10.1006/jssc.1994.1057
   Bhat NA, 2000, J OTOLARYNGOL, V29, P229
   BLACK JH, 1995, S AFR MED J, V85, P41
   BLACK JH, 1995, INT J PEDIATR OTORHI, V31, P95, DOI 10.1016/0165-5876(94)01067-8
   CIUCHI V., 2004, PATOLOGIA INFLAMATOR, p[198, 45, 252, 20, 11]
   De VISSCHER P., 2008, DINAMICA GRUPULUI
   Deguine Christian, 2003, Ear Nose Throat J, V82, P544
   GERSDORFF M, 1995, AM J OTOL, V16, P532
   HAVARNEANU C., 2006, METODOLOGIA CERCETAR
   Kotecha B, 1999, CLIN OTOLARYNGOL, V24, P126
   KRISTENSEN S, 1989, Ear Nose and Throat Journal, V68, P503
   KRISTENSEN S, 1992, J LARYNGOL OTOL, V106, P1037, DOI 10.1017/S0022215100121723
   Lee P, 2002, CLIN OTOLARYNGOL, V27, P331, DOI 10.1046/j.1365-2273.2002.00590.x
   Pignataro L, 2001, J LARYNGOL OTOL, V115, P369
   RYAN RM, 1993, CLIN OTOLARYNGOL, V18, P541, DOI 10.1111/j.1365-2273.1993.tb00632.x
   SCHAMBAUGH G., 2010, SURG EAR
   TONER J.G., 1997, S BROWNS OTOLARYNGOL, V3
   YUNG MW, 1983, J LARYNGOL OTOL, V97, P11, DOI 10.1017/S0022215100093749
NR 22
TC 0
Z9 0
U1 1
U2 1
PU ARS DOCENDI
PI BUCHAREST
PA SOS PANDURI 90, SECT 5, BUCHAREST, RO-050663, ROMANIA
SN 1224-5984
J9 ROM BIOTECH LETT
JI Rom. Biotech. Lett.
PD JUL-AUG
PY 2014
VL 19
IS 4
BP 9465
EP 9474
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AP3IY
UT WOS:000341970300002
DA 2018-10-20
ER

PT J
AU Alberti, C
AF Alberti, Contardo
TI About recent developments of synthetic polymers for a suitable cell
   adhesion/growth support in tissue engineering-based either augmentation
   cystoplasty or neobladder
SO ANNALI ITALIANI DI CHIRURGIA
LA English
DT Article
DE Coated biomaterials; Neurogenic bladder; Silk fibroin; Nanotechnology;
   Stem cells
ID REGENERATIVE MEDICINE; IN-VIVO; STEM-CELLS; SCAFFOLDS; CHALLENGES;
   DIFFERENTIATION; PROLIFERATION; CONSTRUCTION; BIOMATERIALS; PERSPECTIVES
AB Among the regenerative medicine technologies, the tissue engineering has emerged, in recent years, as a prominent tool, particularly given the tremendous developments in the field of synthetic polymer-based scaffolds. Scaffold surface coatings with either extracellular matrix (ECM) proteins or integrin-binding bioactive peptide sequences, such as RDG, proved to be extremely useful to enhance cell adhesion and growth. Nevertheless, about it, excellent effects may be reached by electrospinning-obtained nanofiber-structured synthetic polymer scaffold - such as polyurethane or polyethylene-terephthalate electrospun nanofibers - without resorting to surface-coated adhesion proteins. As for bladder tissue engineering, properly cell-seeded synthetic biomaterial-based scaffolds allow today timely chances to obtain constructs provided with specific bladder native tissue-like both histological-immunohistochemical and functional-dynamic features. Recent bright advances in the tissue engineering research, particularly in the area of materials science - together with increasing availability of suitable bioreactors - and stem cell biology, make foreseeable, in the near future, further technological improvements that might widen the clinical applications of bladder tissue engineering up to whole bladder replacement in radical tumor surgery.
EM eneide94@gmail.com
CR Adeloew C, 2008, BIOMATERIALS, V29, P314, DOI 10.1016/j.biomaterials.2007.09.036
   Alberti C, 2007, EUR REV MED PHARMACO, V11, P257
   Alberti C, 2000, Arch Ital Urol Androl, V72, P75
   ALBERTI C, 1980, BRIT J RADIOL, V53, P261, DOI 10.1259/0007-1285-53-627-261-b
   Alberti C, EUR REV MED PHARM SC, V17, P624
   Annabi N, 2014, ADV MATER, V26, P85, DOI 10.1002/adma.201303233
   Atala A, 2006, CURR OPIN UROL, V16, P305, DOI 10.1097/01.mou.0000232055.20084.f6
   Atala A, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.05.038
   Chun YW, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085104
   Courinho DF, 2012, ACTA BIOMATER, V8, P1490
   Davis NF, 2011, UROLOGY, V78, P954, DOI 10.1016/j.urology.2011.06.036
   Del Gaudio C, 2013, J BIOMED MAT RES A
   Del Gaudio C, 2013, BIOMED MATER, V8, P045
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Faulk DM, 2014, ACTA BIOMATER, V10, P183, DOI 10.1016/j.actbio.2013.09.006
   Ferguson DR, 1999, BJU INT, V84, P235
   Franck D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056237
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Gustafsson Y, 2012, BIOMATERIALS, V33, P8094, DOI 10.1016/j.biomaterials.2012.07.060
   Harrington DA, 2008, WORLD J UROL, V26, P315, DOI 10.1007/s00345-008-0273-0
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Horst M, 2013, J TISSUE ENG REGEN M, V7, P515, DOI 10.1002/term.547
   Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001
   Kafi MA, 2012, BIOMATERIALS, V33, P731, DOI 10.1016/j.biomaterials.2011.10.003
   Kellomaki M, 2000, J MATER SCI-MATER M, V11, P345, DOI 10.1023/A:1008977806693
   Kress S, 2012, ADV BIOCHEM ENG BIOT, V126, P263, DOI 10.1007/10_2011_108
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Lee SJ, 2008, BIOMATERIALS, V29, P1422, DOI 10.1016/j.biomaterials.2007.11.024
   Liu XL, 2014, CHEM SOC REV, V43, P2385, DOI 10.1039/c3cs60419e
   Lu LX, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015002
   Lu TL, 2013, INT J NANOMED, V8, P337, DOI 10.2147/IJN.S38635
   Murphy SV, 2013, BIOESSAYS, V35, P163, DOI 10.1002/bies.201200062
   Ovsianikov A, 2011, BIOMACROMOLECULES, V12, P851, DOI 10.1021/bm1015305
   Pattison M, 2007, MACROMOL BIOSCI, V7, P690, DOI 10.1002/mabi.200600297
   Pennisi CP, 2013, METHODS MOL BIOL, V1058, P77, DOI 10.1007/7651_2013_10
   Pokrywczynska M, 2013, POSTEP HIG MED DOSW, V67, P790
   Ravichandran R, 2012, MACROMOL BIOSCI, V12, P286, DOI 10.1002/mabi.201100325
   Seliktar D, 2013, ISR J CHEM, V53, P795, DOI 10.1002/ijch.201300084
   Shakhssalim N, 2013, INT J ARTIF ORGANS, V36, P113, DOI 10.5301/ijao.5000175
   Sharifi S, 2012, J APPL BIOMATER FUNC, V10, P280, DOI 10.5301/JABFM.2012.10367
   Shastri VP, 2009, ADV MATER, V21, P3246, DOI [10.1002/adma.200900608, 10.1002/adma.200990155]
   Su QX, 2010, J NANOSCI NANOTECHNO, V10, P6369, DOI 10.1166/jnn.2010.2535
   Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P29, DOI 10.1042/BA20030108
   Tu DD, 2013, BIOMATERIALS, V34, P8681, DOI 10.1016/j.biomaterials.2013.08.001
   Wang BY, 2011, J BIOMED MAT RES
   Wei X, 2011, CHINESE MED J-PEKING, V124, P568, DOI 10.3760/cma.j.issn.0366-6999.2011.04.016
   Xu C, BIOTECHNOL BIOENG, V109, P3152
   Yang Y, 2010, WIRES NANOMED NANOBI, V2, P478, DOI 10.1002/wnan.74
   Yao C, 2013, INT J NANOMED, V8, P3285, DOI 10.2147/IJN.S44901
   Yoo James J, 2011, Int Neurourol J, V15, P109, DOI 10.5213/inj.2011.15.3.109
   Zhang Yuanyuan, 2013, Methods Mol Biol, V945, P383, DOI 10.1007/978-1-62703-125-7_23
   Zhao X, 2004, TRENDS BIOTECHNOL, V22, P740
   Zhu Yu-Chun, 2013, Sichuan Da Xue Xue Bao Yi Xue Ban, V44, P196
NR 54
TC 6
Z9 6
U1 0
U2 10
PU EDIZIONI LUIGI POZZI
PI ROME
PA VIA PANAMA 68, 00198 ROME, ITALY
SN 0003-469X
EI 2239-253X
J9 ANN ITAL CHIR
JI Ann. Ital. Chir.
PD JUL-AUG
PY 2014
VL 85
IS 4
BP 309
EP 316
AR PII S0003469X14022842
PG 8
WC Surgery
SC Surgery
GA AO9KL
UT WOS:000341674500001
PM 25392868
DA 2018-10-20
ER

PT J
AU de Olyveira, GM
   dos Santos, ML
   Costa, LMM
   Daltro, PB
   Basmaji, P
   Daltro, GD
   Guastaldi, AC
AF de Olyveira, Gabriel Molina
   dos Santos, Marcio Luiz
   Manzine Costa, Ligia Maria
   Daltro, Paula Braga
   Basmaji, Pierre
   Daltro, Gildasio de Cerqueira
   Guastaldi, Antonio Carlos
TI Bacterial Cellulose Nanobiocomposites for Dental Materials Scaffolds
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Bacterial Cellulose; Nanoskin (R); Nanocomposites; Scaffolds; Dental
   Materials
ID BIOMEDICAL APPLICATIONS; NANOCOMPOSITES
AB Bacterial cellulose (BC) has become established as a remarkably versatile biomaterial and can be used in a wide variety of scientific applications, especially for medical devices. In this work, the bacterial cellulose fermentation process is modified by the addition of chondroitin sulfate and hyaluronic acid (1% w/w) to the culture medium before the bacteria is inoculated. Besides, biomimetic precipitation of calcium phosphate of biological interest from simulated body fluid on bacterial cellulose was studied. Chondroitin sulfate and hyaluronic acid effects in bacterial cellulose were analyzed using transmission infrared spectroscopy (FTIR), XRD (X-ray diffraction) and scanning electron microscopy (SEM). FTIR analysis showed interaction between bacterial cellulose nanobiocomposites and calcium phosphate. XRD demonstrated amorphous calcium phosphate, carbonated apatite and calcium chloride on bacterial cellulose nanobiocomposites. Monocalcium phosphate monohydrate phase formation [Ca(H2PO4)(2)center dot H2O] are here attested by FTIR, XRD and Ca/P relation.
C1 [de Olyveira, Gabriel Molina; dos Santos, Marcio Luiz; Daltro, Paula Braga; Guastaldi, Antonio Carlos] Univ Estadual Paulista, Dept Phys Chem, BR-14800900 Sao Paulo, Brazil.
   [Manzine Costa, Ligia Maria] Dept Nanosci & Adv Mat UFABC, BR-09210170 Santo Andre, SP, Brazil.
   [Basmaji, Pierre] Innovatecs Biotechnol Res & Dev, BR-13560042 Sao Carlos, SP, Brazil.
   [Daltro, Gildasio de Cerqueira] Univ Fed Bahia, Coll Hosp Complex Prof Edgard Santos COM HUPES, BR-40110910 Salvador, BA, Brazil.
RP de Olyveira, GM (reprint author), Univ Estadual Paulista, Dept Phys Chem, BR-14800900 Sao Paulo, Brazil.
RI Guastaldi, Antonio/O-7379-2014; Manzine Costa, Ligia Maria/N-1780-2015;
   dos Santos, Marcio/D-9905-2014
OI Guastaldi, Antonio/0000-0002-6433-3555; Manzine Costa, Ligia
   Maria/0000-0001-6483-7633; dos Santos, Marcio/0000-0002-3385-7516
CR Aoki H., 1999, SCI MED APPL HYDROXY, P214
   Aparecida AH, 2009, J MATER SCI-MATER M, V20, P1215, DOI 10.1007/s10856-008-3682-0
   Basmaji P, 2014, J BIOMATER TISS ENG, V4, P59, DOI 10.1166/jbt.2014.1133
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Costa L. M. M., 2011, J BIONANOSCIENCE, V5, P167
   DENLINGER JL, 1980, EXP EYE RES, V31, P81, DOI 10.1016/0014-4835(80)90092-5
   Filho L. X., 2013, J NANOSCI NANOTECHNO, V13, P1
   Gois P. B. P., 2013, INT REV BIOPHYSICAL, V3, P48
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P185, DOI 10.1166/jbt.2012.1044
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P48, DOI 10.1166/jbt.2012.1031
   Olyveira G. M., 2011, J NANOTECH ENG MED, V2, P34001
   Olyveira G. M., 2014, J BIOMATER TISS ENG, V4, P1
   Olyveira G. M., 2013, J BIOMATER TISS ENG, V2, P1
   Olyveira G. M., 2013, J BIOMEDICAL NANOTEC, V9, P1
   Olyveira GM, 2013, J BIOMATER TISS ENG, V3, P665, DOI 10.1166/jbt.2013.1127
   SINACORE MS, 1989, BIO-TECHNOL, V7, P1275
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Willians D. F., 1991, CONCISE ENCY MED DEN
   Willians D. F., 1981, BIOCOMPATIBILITY CLI
   Acasigua GAX, 2014, CURR STEM CELL RES T, V9, P117, DOI 10.2174/1574888X08666131124135654
   Zhbanko R. G., 1966, INFRARED SPECTRA CEL, P325
NR 29
TC 2
Z9 2
U1 2
U2 42
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD JUL
PY 2014
VL 4
IS 7
BP 536
EP 542
DI 10.1166/jbt.2014.1202
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA AP1ZP
UT WOS:000341871600002
DA 2018-10-20
ER

PT J
AU Tsuruwaka, Y
   Shimada, E
   Ogawa, T
   Hatada, Y
AF Tsuruwaka, Yusuke
   Shimada, Eriko
   Ogawa, Tomohisa
   Hatada, Yuji
TI A Novel Biomaterial: Fibroblast-Derived Cell Sheet Secreting Marine
   Collagen
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Fibroblast; Cell Sheet; Marine Collagen
ID TISSUE; SCAFFOLDS; MATRIX; SKIN
AB Marine collagen has been widely used in regenerative medicine. However, to date only cell sheets generated by mammalian fibroblasts have been used for transplants. We successfully constructed a cell sheet by culturing a novel fibroblast cell line established from thread-sail file fish (Stephanolepis cirrhifer) at high density with rat tail collagen I. The fish cell sheet was strong enough to be used as a biomaterial.
C1 [Tsuruwaka, Yusuke; Shimada, Eriko; Ogawa, Tomohisa; Hatada, Yuji] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Marine Bioresource Explorat Res Team MBE, Yokosuka, Kanagawa 2370061, Japan.
RP Tsuruwaka, Y (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Marine Bioresource Explorat Res Team MBE, Yokosuka, Kanagawa 2370061, Japan.
OI Tsuruwaka, Yusuke/0000-0003-3488-0731
FU JSPS KAKENHI Grant [24657057]
FX This work was supported by JSPS KAKENHI Grant Number 24657057.
CR Barry R. G., 2009, ATMOSPHERE WEATHER C, P30
   Chai HJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/757301
   Chen S, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/3/035001
   Cortizo AM, 2012, J BIOMATER TISS ENG, V2, P125, DOI 10.1166/jbt.2012.1039
   Flammer J, 2013, EUR HEART J, V34, P1270, DOI 10.1093/eurheartj/eht023
   Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X
   Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P156, DOI 10.1177/000348940611500213
   HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0
   Herchenhan A, 2013, DEV DYNAM, V242, P2, DOI 10.1002/dvdy.23896
   Hibino N, 2012, J THORAC CARDIOV SUR, V143, P696, DOI 10.1016/j.jtcvs.2011.06.046
   Inoue H, 2014, EMBO J, V33, P409, DOI 10.1002/embj.201387098
   Kawamura M., 2013, CIRCULATION, V128, P87
   KIMURA S, 1987, COMP BIOCHEM PHYS B, V88, P27, DOI 10.1016/0305-0491(87)90074-5
   Kobayashi J., 2013, J BIOMED MAT RES A
   Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095
   Fernandez JM, 2014, J BIOMATER TISS ENG, V4, P227, DOI 10.1166/jbt.2014.1158
   Ramanathan G, 2014, J BIOMATER TISS ENG, V4, P203, DOI 10.1166/jbt.2014.1157
   Sawa Y, 2013, BIOMED RES INT, DOI 10.1155/2013/583912
   Sugiura H, 2009, J BIOMAT SCI-POLYM E, V20, P1353, DOI 10.1163/092050609X12457418396658
   Takagi Y, 2007, J NANOSCI NANOTECHNO, V7, P757, DOI 10.1166/jnn.2007.503
   Tsuruwaka Y., 2014, WO Patent, Patent No. [2,014,021,329, 2014021329]
   Tsuruwaka Y, 2014, IN VITRO CELL DEV-AN, V50, P439, DOI 10.1007/s11626-013-9723-0
   Xu Z., 2012, MATER RES SOC S P, V1418, P189
NR 24
TC 1
Z9 1
U1 1
U2 5
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD JUL
PY 2014
VL 4
IS 7
BP 586
EP 589
DI 10.1166/jbt.2014.1201
PG 4
WC Cell & Tissue Engineering
SC Cell Biology
GA AP1ZP
UT WOS:000341871600010
DA 2018-10-20
ER

PT J
AU Yuan, L
   Giovanni, M
   Xie, JP
   Fan, CH
   Leong, DT
AF Yuan, Liang
   Giovanni, Marcella
   Xie, Jianping
   Fan, Chunhai
   Leong, David Tai
TI Ultrasensitive IgG quantification using DNA nano-pyramids
SO NPG ASIA MATERIALS
LA English
DT Article
ID RADICAL POLYMERIZATION; IMMUNOGLOBULIN-G; SINGLE-STEP; NANOSTRUCTURE;
   BINDING; IMMUNOASSAY; PLATFORM; LABEL; AMPLIFICATION; TETRAHEDRON
AB In addition to being a repository of genetic information, DNA is a bio-polymer that can be formed into various nanostructures. This profound ability to engineer various moieties has expanded its role from data storage to a structural biomaterial for sensing applications. In this study, we anchored DNA nano-pyramids (DPs) to gold electrodes for the electrochemical sensing of immunoglobulin G (IgG), an important antibody produced in response to infection. The pyramidal DNA structure not only avoids entanglement with neighboring probes through the use of spatially separating pendant probes but also reduces the local overcrowding effect with the overall enhanced packing of targets. The results from electrochemical impedance spectroscopy measurements also show that DP layer has better conductivity, with the hollow structure further facilitating electron transfer and increasing the sensitivity of electrochemical detection. We are able to selectively detect IgG in the presence of other proteins in an analyte solution. The limit of detection was 2.8 pg ml(-1). Our ferrocene-labeled sandwich immunoassay works at 37 degrees C under a neutral pH environment. It also produces stable and reproducible signals even after storage for 1 week at 4 degrees C, further demonstrating the potential of this sensing system for clinical applications.
C1 [Yuan, Liang; Giovanni, Marcella; Xie, Jianping; Leong, David Tai] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117585, Singapore.
   [Fan, Chunhai] Chinese Acad Sci, Shanghai Inst Appl Phys, Div Phys Biol, Shanghai, Peoples R China.
   [Fan, Chunhai] Chinese Acad Sci, Shanghai Inst Appl Phys, Bioimaging Ctr, Shanghai Synchrotron Radiat Facil, Shanghai, Peoples R China.
RP Leong, DT (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, 4 Engn Dr 4, Singapore 117585, Singapore.
EM cheltwd@nus.edu.sg
RI Leong, David/G-1056-2012; Yuan, Liang/E-9304-2017; XIE,
   Jianping/C-6211-2008; Fan, Chunhai/A-7569-2011
OI Leong, David/0000-0001-8539-9062; Yuan, Liang/0000-0002-2511-8561; XIE,
   Jianping/0000-0002-3254-5799; Fan, Chunhai/0000-0002-7171-7338
FU Singapore Ministry of Education [R-279-000-350-112, R-279-000-418-112];
   NUS Cross Faculty grant [R-279-000-414-112]
FX We thank Professor En-Tang Kang and Professor Koon Gee Neoh for their
   technical help and useful discussions. We also acknowledge funding from
   Singapore Ministry of Education Tier 1 and 2 (R-279-000-350-112 and
   R-279-000-418-112) and NUS Cross Faculty grant (R-279-000-414-112).
CR Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971
   Dou YH, 2012, ELECTROANAL, V24, P264, DOI 10.1002/elan.201100676
   Fu YM, 2013, J AM CHEM SOC, V135, P696, DOI 10.1021/ja3076692
   Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367
   Hjelholt A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056210
   Iijima M, 2011, BIOMATERIALS, V32, P9011, DOI 10.1016/j.biomaterials.2011.08.012
   Kang D, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.1
   Keum JW, 2009, CHEM COMMUN, P7036, DOI 10.1039/b917661f
   Kim K. B., 2012, CHEM COMMUN, V49, P2010
   Kim KR, 2013, BIOMATERIALS, V34, P5226, DOI 10.1016/j.biomaterials.2013.03.074
   Lim TK, 2001, BIOSENS BIOELECTRON, V16, P1063, DOI 10.1016/S0956-5663(01)00228-7
   Liu DS, 2011, NPG ASIA MATER, V3, P109, DOI 10.1038/asiamat.2011.147
   Liu XW, 2012, NANO LETT, V12, P4254, DOI 10.1021/nl301877k
   Lu N, 2012, J AM CHEM SOC, V134, P13148, DOI 10.1021/ja302447r
   Luque FA, 2007, INT REV NEUROBIOL, V79, P341, DOI 10.1016/S0074-7742(07)79015-3
   Mitchell N, 2009, ANGEW CHEM INT EDIT, V48, P525, DOI 10.1002/anie.200804264
   Modi S, 2009, NAT NANOTECHNOL, V4, P325, DOI [10.1038/NNANO.2009.83, 10.1038/nnano.2009.83]
   Pei H, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2013.22
   Pei H, 2011, CHEM COMMUN, V47, P6254, DOI 10.1039/c1cc11660f
   Pei H, 2010, ADV MATER, V22, P4754, DOI 10.1002/adma.201002767
   Qian J, 2011, BIOSENS BIOELECTRON, V28, P314, DOI 10.1016/j.bios.2011.07.045
   Rinker S, 2008, NAT NANOTECHNOL, V3, P418, DOI 10.1038/nnano.2008.164
   Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Simmel FC, 2005, SMALL, V1, P284, DOI 10.1002/smll.200400111
   Wang J, 2012, ANAL CHEM, V84, P4893, DOI 10.1021/ac300498v
   Wang ZG, 2012, CHEM COMMUN, V48, P9661, DOI 10.1039/c2cc35208g
   Wen YL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00867
   Wen YL, 2011, ANAL CHEM, V83, P7418, DOI 10.1021/ac201491p
   Wu ZS, 2008, BIOMATERIALS, V29, P2689, DOI 10.1016/j.biomaterials.2008.02.024
   Yuan L, 2012, ANAL CHEM, V84, P10737, DOI 10.1021/ac302439v
   Yuan L, 2012, BIOSENS BIOELECTRON, V38, P79, DOI 10.1016/j.bios.2012.05.007
   Yuan LA, 2011, CHEM-EUR J, V17, P976, DOI 10.1002/chem.201001271
   Yuan X, 2013, ANAL CHEM, V85, P1913, DOI 10.1021/ac3033678
   Zhang C, 2012, ANGEW CHEM INT EDIT, V51, P3382, DOI 10.1002/anie.201108710
   Zhang J, 2007, NAT PROTOC, V2, P2888, DOI 10.1038/nprot.2007.419
   Zhang M, 2013, ACS APPL MATER INTER, V5, P473, DOI 10.1021/am302321m
   Zhang SB, 2008, BIOSENS BIOELECTRON, V24, P129, DOI 10.1016/j.bios.2008.03.017
   Zhang YX, 2013, ACS APPL MATER INTER, V5, P8030, DOI 10.1021/am4021186
   Zhuo Y, 2009, BIOMATERIALS, V30, P2284, DOI 10.1016/j.biomaterials.2009.01.002
NR 40
TC 28
Z9 28
U1 6
U2 86
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1884-4049
EI 1884-4057
J9 NPG ASIA MATER
JI NPG Asia Mater.
PD JUL
PY 2014
VL 6
AR e112
DI 10.1038/am.2014.46
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA AO8SB
UT WOS:000341623400004
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Berruto, M
   Delcogliano, M
   de Caro, F
   Carimati, G
   Uboldi, F
   Ferrua, P
   Ziveri, G
   De Biase, CF
AF Berruto, Massimo
   Delcogliano, Marco
   de Caro, Francesca
   Carimati, Giulia
   Uboldi, Francesco
   Ferrua, Paolo
   Ziveri, Giovanni
   De Biase, Carlo Felice
TI Treatment of Large Knee Osteochondral Lesions With a Biomimetic Scaffold
   Results of a Multicenter Study of 49 Patients at 2-Year Follow-up
SO AMERICAN JOURNAL OF SPORTS MEDICINE
LA English
DT Article
DE osteochondral lesions; biomimetic scaffold; osteochondritis dissecans;
   osteonecrosis
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; COMPOSITE MULTILAYERED BIOMATERIAL;
   CARTILAGE-REPAIR; ARTICULAR-CARTILAGE; SURGICAL-TREATMENT; DISSECANS;
   BONE; REGENERATION; DEFECTS; PLUG
AB Background: Osteochondral knee lesions represent a challenging condition encountered by orthopaedic surgeons. A variety of methods have been developed to repair articular cartilage defects. However, these techniques are limited by donor site morbidity or by the requirement for a staged procedure.
   Purpose: To assess the effectiveness of a biomimetic osteochondral scaffold for the treatment of large osteochondral knee lesions.
   Study Design: Case series; Level of evidence, 4.
   Methods: From 2009 to 2011, a total of 49 patients affected by isolated large osteochondral knee lesions (mean [+/- SD] size, 4.35 +/- 1.26 cm(2)) were treated with the biomimetic scaffold. Patients were evaluated using the International Knee Documentation Committee (IKDC), Tegner, and visual analog scale (VAS) pain scores, as well as magnetic resonance imaging (MRI) up to 3-year follow-up. The MOCART (magnetic resonance observation of cartilage repair tissue) score was performed to analyze different variables. Biopsies were carried out in 5 patients. Four of the 5 second-look arthroscopies and biopsies were performed on patients with failed results because of ethical issues.
   Results: The mean IKDC subjective score increased significantly from 45.45 +/- 19.29 preoperatively to 70.86 +/- 18.08 at 1-year follow-up and to 75.42 +/- 19.31 at 2-year follow-up (P < .001). The IKDC objective score changed from 50% normal and nearly normal knees before treatment to 89.79% at the 2-year follow-up. There was a statistically significant improvement (P < .005) in VAS score from the preoperative level (6.69 +/- 1.88) to the 2-year follow-up (1.96 +/- 2.47). Tegner scores increased (P < .001) from the preoperative value (2.20 +/- 0.67) to the 2-year follow-up (4.9 +/- 1.73) without achieving preinjury level. A correlation was found between the IKDC subjective score and age (P < .001, r = 20.497, r = 20.502). Patients affected by osteochondritis dissecans (OCD) achieved a statistically significantly better outcome (P < .05). A subgroup of 19 competitive athletes showed a statistically significantly improvement (P < .001) in the subjective IKDC (86.5 +/- 13.2) compared with the nonathletic subpopulation (69.03 +/- 19.41) at the 2-year follow-up. The MRI findings of 30 patients were available at 2-year follow-up: 70% showed complete filling of the lesion, 63.3% had an intact articular surface, and 86% had mild or no effusion. In all cases, in dual T2-weighted fast spin echo sequence, the repair tissue showed a hyperintensive signal with respect to the surrounding subchondral bone; however, no edema was observed.
   Conclusion: The study findings indicate that the biomimetic scaffold that was investigated is an off-the-shelf, cell-free, and cost-effective implant that can regenerate either cartilage or subchondral bone. The scaffold allows a 1-step surgical procedure that can be used for osteochondral lesions, OCD, and in some cases osteonecrosis.
C1 Univ Hosp Parma, Gaetano Pini Orthoped Inst, Milan, Italy.
   Hosp San Carlo IDI, Rome, Italy.
RP Delcogliano, M (reprint author), Univ Hosp Parma, Orthoped Div, Via Gramsci 14, I-43126 Parma, Italy.
EM marcodelco@me.com
RI Uboldi, Francesco Mattia/N-1216-2016
OI Uboldi, Francesco Mattia/0000-0002-3199-3899; Ferrua,
   Paolo/0000-0002-4408-4248
CR Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P330, DOI 10.1302/0301-620X.87B3.15552
   Buda R, 2010, J BONE JOINT SURG AM, V92A, P2, DOI 10.2106/JBJS.J.00813
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   Chiang H, 2013, OSTEOARTHR CARTILAGE, V21, P589, DOI 10.1016/j.joca.2013.01.004
   Dhollander AAM, 2012, KNEE SURG SPORT TR A, V20, P1118, DOI 10.1007/s00167-011-1759-7
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Dhollander AM, 2011, AM J SPORTS MED, V40, P75
   Emmerson BC, 2007, AM J SPORT MED, V35, P907, DOI 10.1177/0363546507299932
   Filardo G, 2013, KNEE, V20, P570, DOI 10.1016/j.knee.2013.05.007
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891
   Filardo G, 2012, KNEE, V19, P658, DOI 10.1016/j.knee.2011.08.007
   Frisbie DD, 2009, AM J SPORT MED, V37, p71S, DOI 10.1177/0363546509348478
   Gillogly SD, 2005, ORTHOP CLIN N AM, V36, P433, DOI 10.1016/j.ocl.2005.06.005
   Gortz S, 2010, CLIN ORTHOP RELAT R, V468, P1269, DOI 10.1007/s11999-010-1250-7
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P468, DOI 10.1007/s00167-011-1714-7
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P450, DOI 10.1007/s00167-011-1780-x
   Kon E, 2014, KNEE SURG SPORT TR A, V22, P1452, DOI 10.1007/s00167-013-2467-2
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2012, J BONE JOINT SURG AM, V94, pe1
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Konst YE, 2012, KNEE SURG SPORT TR A, V20, P2263, DOI 10.1007/s00167-012-1891-z
   Krishnan SP, 2006, J BONE JOINT SURG BR, V88B, P203, DOI 10.1302/0301-620X.88B2.17009
   Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007
   Marlovits S, 2006, EUR J RADIOL, V57, P16, DOI 10.1016/j.ejrad.2005.08.007
   Marmotti A, 2012, KNEE SURG SPORT TR A, V20, P2590, DOI 10.1007/s00167-012-1920-y
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Ochs BG, 2011, AM J SPORT MED, V39, P764, DOI 10.1177/0363546510388896
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Wang XH, 2004, BIOMATERIALS, V25, P3681, DOI 10.1016/j.biomaterials.2003.10.102
NR 36
TC 17
Z9 17
U1 0
U2 10
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0363-5465
EI 1552-3365
J9 AM J SPORT MED
JI Am. J. Sports Med.
PD JUL
PY 2014
VL 42
IS 7
BP 1607
EP 1617
DI 10.1177/0363546514530292
PG 11
WC Orthopedics; Sport Sciences
SC Orthopedics; Sport Sciences
GA AN6QT
UT WOS:000340721900017
PM 24778267
DA 2018-10-20
ER

PT J
AU Chen, F
   Sun, TW
   Qi, C
   Wu, J
   Cui, DX
   Zhu, YJ
AF Chen Feng
   Sun Tuan-Wei
   Qi Chao
   Wu Jin
   Cui Da-Xiang
   Zhu Ying-Jie
TI Microwave-assisted Solvothermal Synthesis of Calcium Phosphate
   Microspheres and Polyhedra
SO JOURNAL OF INORGANIC MATERIALS
LA English
DT Article
DE biomaterials; calcium phosphate; microwave; self-assembling; protein
   adsorption
ID BOVINE SERUM-ALBUMIN; DRUG-DELIVERY; PHOSPHORUS SOURCE; HYDROXYAPATITE
   NANORODS; PROTEIN ADSORPTION; ORGANIC-SYNTHESIS; RAPID SYNTHESIS; BONE;
   COMPOSITE; SPHERES
AB Synthetic calcium phosphate (CaP) has been investigated as promising biomaterial due to its excellent biocompatibility. CaP nanosheet-assembled microspheres were prepared using Ca(CH3COO)(2), NaH2PO4 center dot 2H(2)O and PLA-mPEG in aqueous solution by microwave-assisted hydrothermal method at 120 degrees C for 30 min. Meanwhile, CaP polyhedral were prepared using Ca(CH3COO)(2), NaH2PO4 center dot 2H(2)O and PLA-mPEG in mixed solvent of water and ethylene glycol (EG) by microwave-assisted solvothermal method at 120 degrees C for 30 mm The products were characterized with X-ray powder diffraction (XRD), transmission electron microscope (TEM), scanning electron microscope (SEM) and thermogravimetric analysis (TG). EG showed a significant effect on the chemical composition and morphology of the product. The hemoglobin protein adsorption properties of the as-prepared products were investigated. The Hb adsorption amount increased with increasing Hb initial concentration, and were decreased with increasing volume of EG.
C1 [Chen Feng; Cui Da-Xiang] Shanghai Jiao Tong Univ, Res Inst Micro Nano Sci & Technol, Shanghai 200240, Peoples R China.
   [Chen Feng; Sun Tuan-Wei; Qi Chao; Wu Jin; Zhu Ying-Jie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Zhu, YJ (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM fchen@mail.sic.ac.cn; dxcui@sjtu.edu.cn; y.j.zhu@mail.sic.ac.cn
RI Qi, Chao/N-5957-2015; Chen, Feng/D-6406-2012; CHEN, Feng/E-4310-2016
OI Chen, Feng/0000-0002-1162-1684; CHEN, Feng/0000-0002-1162-1684
FU National Natural Science Foundation of China [51172260, 51102258,
   81171727]; Science and Technology Commission of Shanghai [11nm0506600,
   13JC1407300]
FX National Natural Science Foundation of China (51172260, 51102258,
   81171727); Science and Technology Commission of Shanghai (11nm0506600,
   13JC1407300)
CR Baghbanzadeh M, 2011, ANGEW CHEM INT EDIT, V50, P11312, DOI 10.1002/anie.201101274
   CHEN F, 2012, NANO BIOMED ENG, V4, P41, DOI DOI 10.5101/NBE.V4I1.P41-49
   Chen F, 2011, BIOMATERIALS, V32, P9031, DOI 10.1016/j.biomaterials.2011.08.032
   Chen F, 2011, CRYSTENGCOMM, V13, P1858, DOI 10.1039/c0ce00574f
   Chen F, 2010, ACTA BIOMATER, V6, P3013, DOI 10.1016/j.actbio.2010.02.015
   Chen X, 2012, MATER LETT, V89, P233, DOI 10.1016/j.matlet.2012.08.115
   Chen XQ, 2013, J INORG MATER, V28, P901, DOI 10.3724/SP.J.1077.2013.13058
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   GEDYE R, 1986, TETRAHEDRON LETT, V27, P279, DOI 10.1016/S0040-4039(00)83996-9
   GIGUERE RJ, 1986, TETRAHEDRON LETT, V27, P4945, DOI 10.1016/S0040-4039(00)85103-5
   Lai C, 2005, MATER LETT, V59, P210, DOI 10.1016/j.matlet.2004.08.037
   Lin KL, 2009, CRYST GROWTH DES, V9, P177, DOI 10.1021/cg800129u
   Luo HT, 2013, J INORG MATER, V28, P40, DOI 10.3724/SP.J.1077.2013.12038
   Ong JL, 2000, CRIT REV BIOMED ENG, V28, p667A
   Qi C, 2013, CHEM-EUR J, V19, P5332, DOI 10.1002/chem.201203886
   Qi C, 2013, CHEM-EUR J, V19, P981, DOI 10.1002/chem.201202829
   Tzaphlidou M, 2008, J BIOL PHYS, V34, P39, DOI 10.1007/s10867-008-9115-y
   Wang KW, 2010, CHEM-ASIAN J, V5, P2477, DOI 10.1002/asia.201000463
   Wang KF, 2012, INTERFACE FOCUS, V2, P259, DOI 10.1098/rsfs.2012.0012
   WASSELL DTH, 1995, BIOMATERIALS, V16, P697, DOI 10.1016/0142-9612(95)99697-K
   Yang SB, 2013, J INORG MATER, V28, P85, DOI 10.3724/SP.J.1077.2013.12318
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zhao J, 2013, MICROPOR MESOPOR MAT, V180, P79, DOI 10.1016/j.micromeso.2013.06.020
   Zhao XY, 2013, CHEM-ASIAN J, V8, P1313, DOI 10.1002/asia.201300142
   Zhu YJ, 2004, ANGEW CHEM INT EDIT, V43, P1410, DOI 10.1002/anie.200353101
NR 25
TC 4
Z9 4
U1 3
U2 50
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1000-324X
J9 J INORG MATER
JI J. Inorg. Mater.
PD JUL
PY 2014
VL 29
IS 7
BP 776
EP 780
DI 10.3724/SP.J.1077.2014.14148
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA AN6KQ
UT WOS:000340703800018
DA 2018-10-20
ER

PT J
AU Rotaru, I
   Olaru, D
AF Rotaru, I.
   Olaru, D.
TI Mechanical behaviour of p(HEMA) hydrogel for disc prosthesis on lumbar
   spine
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Biomaterial; Compression; Damping; Hydrogel; p(HEMA)
AB p(HEMA) - poly(hydroxyethyl methacrylate) - is a biocompatible material which in water forms a hydrogel and have multiple biomedical applications. The objective of this paper was to propose a biomaterial based on p(HEMA) for its use as damping element within disc prosthesis on lumbar spine and to analyse its mechanical behaviour. Intervertebral discs from healthy lumbar spine are mainly subjected to compressive stress and they have the capacity to ensure an adequate absorption of mechanical vibrations. In this study the mechanical behaviour of p(HEMA) has been evaluated by compression-decompression experimental tests on dry and wet biomaterial. The compression-decompression tests were performed with four different speeds: v(1) = 0.05 mm/s, v(2) = 0.1 mm/s, v(3) = 0.15 mm/s and v(4) = 0.2 mm/s. The results of this study highlighted the viscoelastic behaviour and damping capacity of swollen p(HEMA) hydrogel.
C1 [Rotaru, I.; Olaru, D.] Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, Dept Mech Engn Mechatron & Robot, Iasi 700050, Romania.
RP Rotaru, I (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, Dept Mech Engn Mechatron & Robot, B Dul Dimitrie Mangeron 61-63, Iasi 700050, Romania.
EM rotaruiuliana@tuiasi.ro
RI Rotaru, Ileana Cristina/C-7469-2009; Olaru, Dumitru/C-8878-2015
OI Rotaru, Ileana Cristina/0000-0002-8853-7050; Olaru,
   Dumitru/0000-0001-5989-0798
FU POSDRU CUANTUMDOC "DOCTORAL STUDIES FOR EUROPEAN PERFORMANCES IN
   RESEARCH AND INNOVATION" project - European Social Fund [ID79407];
   Romanian Government
FX This paper was realised with the support of POSDRU CUANTUMDOC "DOCTORAL
   STUDIES FOR EUROPEAN PERFORMANCES IN RESEARCH AND INNOVATION" ID79407
   project funded by the European Social Fund and Romanian Government.
CR Ambrosio L, 1998, P I MECH ENG H, V212, P93, DOI 10.1243/0954411981533863
   Bostan L. E., 2011, THESIS FACULTY CHEM
   Corneci M. C., 2012, THESIS INSA LYON FRA
   Gloria A, 2007, J MATER SCI-MATER M, V18, P2159, DOI 10.1007/s10856-007-3003-z
   Gloria A, 2011, J BIOMATER APPL, V25, P795, DOI 10.1177/0885328209360933
   Ilie M. B., 2011, THESIS FAC MECH ENG
   LeHuec JC, 2003, J SPINAL DISORD TECH, V16, P346, DOI 10.1097/00024720-200308000-00006
   McCutchen C, 1962, WEAR, V5, P1, DOI DOI 10.1016/0043-1648(62)90176-X
   Neha Tomar, 2012, International Journal of Health and Allied Sciences, V1, P224
   Pascovici MD, 2003, TRIBOL INT, V36, P791, DOI 10.1016/S0301-679X(03)00095-1
   Rotaru I., 2013, TEHNOMUS J, V20, P112
   Shaheen A, 2007, P I MECH ENG H, V221, P621, DOI 10.1243/09544119JEIM204
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Trunfio Sfarghiu A.-M., 2006, THESIS INSA LYON FRA
NR 14
TC 0
Z9 0
U1 1
U2 6
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
EI 1841-7132
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD JUL-AUG
PY 2014
VL 16
IS 7-8
BP 881
EP 886
PG 6
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA AN4SE
UT WOS:000340578000019
DA 2018-10-20
ER

PT J
AU Hardy, JG
   Pfaff, A
   Leal-Egana, A
   Muller, AHE
   Scheibel, TR
AF Hardy, John G.
   Pfaff, Andre
   Leal-Egana, Aldo
   Mueller, Axel H. E.
   Scheibel, Thomas R.
TI Glycopolymer Functionalization of Engineered Spider Silk Protein-based
   Materials for Improved Cell Adhesion
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
ID POLYMERS; RGD; BIOMATERIAL; SURFACES; COATINGS
AB Silk protein-based materials are promising biomaterials for application as tissue scaffolds, due to their processability, biocompatibility, and biodegradability. The preparation of films composed of an engineered spider silk protein (eADF4(C16)) and their functionalization with glycopolymers are described. The glycopolymers bind proteins found in the extracellular matrix, providing a biomimetic coating on the films that improves cell adhesion to the surfaces of engineered spider silk films. Such silk-based materials have potential as coatings for degradable implantable devices.
C1 [Hardy, John G.; Leal-Egana, Aldo; Scheibel, Thomas R.] Univ Bayreuth, Fak Ingenieurwissensch, Lehrstuhl Biomat, D-95440 Bayreuth, Germany.
   [Pfaff, Andre; Mueller, Axel H. E.] Univ Bayreuth, D-95440 Bayreuth, Germany.
   [Mueller, Axel H. E.] Johannes Gutenberg Univ Mainz, Inst Organ Chem, D-55099 Mainz, Germany.
RP Muller, AHE (reprint author), Univ Bayreuth, Univ Str 30, D-95440 Bayreuth, Germany.
EM axel.mueller@uni-mainz.de; thomas.scheibel@bm.uni-bayreuth.de
RI Scheibel, Thomas/I-1170-2014; Pfaff, Andre/G-4945-2011; Hardy,
   John/D-1501-2009
OI Scheibel, Thomas/0000-0002-0457-2423; Hardy, John/0000-0003-0655-2167;
   Mueller, Axel/0000-0001-9423-9829
FU Alexander von Humboldt Foundation; German Research Foundation (Deutsche
   Forschungsgemeinschaft) [SFB 840 TP A8]; European Science Foundation
FX The authors thank the Alexander von Humboldt Foundation for a
   postdoctoral fellowship for J.G.H., and the German Research Foundation
   (Deutsche Forschungsgemeinschaft, SFB 840 TP A8) for financial support
   for T.R.S. The authors thank the European Science Foundation for
   financial support of A. P. and A. H. E. M. via the SONS 2 program
   (BioSONS project). At the University of Bayreuth we thank Marietta Bohm
   for GPC measurements, Susanne Edinger for MALDI-ToF MS measurements, and
   Markus Hecht and Elke Fuchs for assistance with contact angle
   measurements.
CR Addison JB, 2013, BIOMACROMOLECULES, V14, P1140, DOI 10.1021/bm400019d
   Ahmed M, 2013, EUR POLYM J, V49, P3010, DOI 10.1016/j.eurpolymj.2013.06.025
   Babiuch K, 2011, MACROMOL BIOSCI, V11, P535, DOI 10.1002/mabi.201000374
   Bauer F, 2013, BIOMATER SCI-UK, V1, P1244, DOI 10.1039/c3bm60114e
   Bauer F, 2012, ANGEW CHEM INT EDIT, V51, P6521, DOI 10.1002/anie.201200591
   BIRD TP, 1966, J CHEM SOC C, P1913, DOI 10.1039/j39660001913
   Chen B, 2009, J CONTROL RELEASE, V140, P203, DOI 10.1016/j.jconrel.2009.05.021
   Cunliffe D, 2004, EUR POLYM J, V40, P5, DOI 10.1016/j.eurpolymj.2003.10.020
   Das S, 2012, BIOMACROMOLECULES, V13, P3695, DOI 10.1021/bm301170u
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Flitsch SL, 2000, CURR OPIN CHEM BIOL, V4, P619, DOI 10.1016/S1367-5931(00)00152-6
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Gadjanski I, 2012, STEM CELL REV REP, V8, P863, DOI 10.1007/s12015-011-9328-5
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hardy JG, 2013, MACROMOL BIOSCI, V13, P1431, DOI 10.1002/mabi.201300233
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   Hardy JG, 2009, J POLYM SCI POL CHEM, V47, P3957, DOI 10.1002/pola.23484
   Hardy JG, 2009, BIOCHEM SOC T, V37, P677, DOI 10.1042/BST0370677
   Hatzakis N. S., 2012, CHEM COMMUN, V2006
   Heidebrecht A, 2013, ADV APPL MICROBIOL, V82, P115, DOI 10.1016/B978-0-12-407679-2.00004-1
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Blanco JLJ, 2013, CHEM SOC REV, V42, P4518, DOI 10.1039/c2cs35219b
   Klappenberger F, 2007, CHEMPHYSCHEM, V8, P1782, DOI 10.1002/cphc.200700370
   KNAUF MJ, 1988, J BIOL CHEM, V263, P15064
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Ladmiral V, 2004, EUR POLYM J, V40, P431, DOI 10.1016/j.eurpolymj.2003.10.019
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Pfaff A, 2011, EUR POLYM J, V47, P805, DOI 10.1016/j.eurpolymj.2010.09.020
   Pfaff A, 2011, MACROMOLECULES, V44, P1266, DOI 10.1021/ma102794z
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Schatz C, 2010, MACROMOL RAPID COMM, V31, P1664, DOI 10.1002/marc.201000267
   Slavin S, 2011, EUR POLYM J, V47, P435, DOI 10.1016/j.eurpolymj.2010.09.019
   Spiess K, 2011, J MATER CHEM, V21, P13594, DOI 10.1039/c1jm11700a
   Sutherland TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016489
   Vazquez-Dorbatt V, 2012, CHEMBIOCHEM, V13, P2478, DOI 10.1002/cbic.201200480
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Voit B, 2010, MACROMOL CHEM PHYS, V211, P727, DOI 10.1002/macp.201000007
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   Widhe M, 2012, BIOPOLYMERS, V97, P468, DOI 10.1002/bip.21715
   Wohlrab S, 2012, J MATER CHEM, V22, P22050, DOI 10.1039/c2jm35075k
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
   Yang Q, 2010, ACS APPL MATER INTER, V2, P3555, DOI 10.1021/am1007276
   Yilmaz G, 2013, EUR POLYM J, V49, P3046, DOI 10.1016/j.eurpolymj.2013.06.001
   You LC, 2006, J AM CHEM SOC, V128, P13336, DOI 10.1021/ja064569x
   Zeiger AS, 2013, ACTA BIOMATER, V9, P7354, DOI 10.1016/j.actbio.2013.02.035
   Zeplin PH, 2014, ADV FUNCT MATER, V24, P2658, DOI 10.1002/adfm.201302813
NR 48
TC 15
Z9 15
U1 1
U2 44
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUL
PY 2014
VL 14
IS 7
BP 936
EP 942
DI 10.1002/mabi.201400020
PG 7
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA AN5XC
UT WOS:000340664400004
PM 24700586
DA 2018-10-20
ER

PT J
AU Boonyagul, S
   Banlunara, W
   Sangvanich, P
   Thunyakitpisal, P
AF Boonyagul, Sani
   Banlunara, Wijit
   Sangvanich, Polkit
   Thunyakitpisal, Pasutha
TI Effect of acemannan, an extracted polysaccharide from Aloe vera, on
   BMSCs proliferation, differentiation, extracellular matrix synthesis,
   mineralization, and bone formation in a tooth extraction model
SO ODONTOLOGY
LA English
DT Article
DE Acemannan; Aloe vera; BMSC; Differentiation; Mineralization; Tooth
   socket healing
ID MARROW STROMAL CELLS; IN-VITRO; OSTEOGENIC DIFFERENTIATION;
   CRYSTAL-FORMATION; RAT; HYDROXYAPATITE; EXPRESSION; PHOSPHOPROTEINS;
   MODULATION; COLLAGEN
AB Aloe vera is a traditional wound healing medicine. We hypothesized acemannan, a polysaccharide extracted from Aloe vera gel, could affect bone formation. Primary rat bone marrow stromal cells (BMSCs) were treated with various concentrations of acemannan. New DNA synthesis, VEGF, BMP-2, alkaline phosphatase activity, bone sialoprotein, osteopontin expression, and mineralization were determined by [H-3] thymidine incorporation assay, ELISA, biochemical assay, western blotting, and Alizarin Red staining, respectively. In an animal study, mandibular right incisors of male Sprague-Dawley rats were extracted and an acemannan treated sponge was placed in the socket. After 1, 2, and 4 weeks, the mandibles were dissected. Bone formation was evaluated by dual-energy X-ray absorptiometry and histopathological examination. The in vitro results revealed acemannan significantly increased BMSC proliferation, VEGF, BMP-2, alkaline phosphatase activity, bone sialoprotein and osteopontin expression, and mineralization. In-vivo results showed acemannan-treated groups had higher bone mineral density and faster bone healing compared with untreated controls. A substantial ingrowth of bone trabeculae was observed in acemannan-treated groups. These data suggest acemannan could function as a bioactive molecule inducing bone formation by stimulating BMSCs proliferation, differentiation into osteoblasts, and extracellular matrix synthesis. Acemannan could be a candidate natural biomaterial for bone regeneration.
C1 [Boonyagul, Sani] Chulalongkorn Univ, Dent Biomat Sci Program, Grad Sch, Fac Dent, Bangkok 10330, Thailand.
   [Boonyagul, Sani] Chulalongkorn Univ, Dept Mat Sci, Fac Sci, Bangkok 10330, Thailand.
   [Banlunara, Wijit] Chulalongkorn Univ, Dept Pathol, Fac Vet Sci, Bangkok 10330, Thailand.
   [Sangvanich, Polkit] Chulalongkorn Univ, Dept Chem, Fac Sci, Bangkok 10330, Thailand.
   [Thunyakitpisal, Pasutha] Chulalongkorn Univ, Dept Anat, Res Unit Herbal Med & Nat Prod Dent Applicat, Fac Dent, Bangkok 10330, Thailand.
RP Thunyakitpisal, P (reprint author), Chulalongkorn Univ, Dept Anat, Res Unit Herbal Med & Nat Prod Dent Applicat, Fac Dent, Bangkok 10330, Thailand.
EM pthunyak@yahoo.com
OI Sangvanich, Polkit/0000-0002-2766-7505
FU Higher Education Research Promotion; National Research University
   Project of Thailand [AS549A]; Asahi Glass Foundation; Thailand
   Government Research Fund; 90th Anniversary of Chulalongkorn University
   Fund
FX We thank Professor Dr. Visaka Limwong, Associate Professor Dr. Dolly
   Methatharathip, and Dr. Kevin A. Tompkins for their valuable
   suggestions. This work was supported by the Higher Education Research
   Promotion and National Research University Project of Thailand (AS549A),
   Oversea Research Grant of the Asahi Glass Foundation, Thailand
   Government Research Fund, and The 90th Anniversary of Chulalongkorn
   University Fund (Ratcha daphiseksomphot Endowment Fund).
CR AMLER MH, 1969, ORAL SURG ORAL MED O, V27, P309, DOI 10.1016/0030-4220(69)90357-0
   BODNER L, 1993, ORAL SURG ORAL MED O, V75, P367, DOI 10.1016/0030-4220(93)90153-U
   Chow JTN, 2005, CARBOHYD RES, V340, P1131, DOI 10.1016/j.carres.2005.02.016
   Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   GUGLIELMI G, 1995, EUR RADIOL, V5, P129, DOI 10.1007/BF00957107
   HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723
   HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175
   Jettanacheawchankit S, 2009, J PHARMACOL SCI, V109, P525, DOI 10.1254/jphs.08204FP
   Jittapiromsak N, 2007, J ORAL TISSUE ENG, V4, P149
   Jittapiromsak N, 2010, TISSUE ENG PT A, V16, P1997, DOI [10.1089/ten.tea.2009.0593, 10.1089/ten.TEA.2009.0593]
   KASUGAI S, 1991, J CELL PHYSIOL, V147, P111, DOI 10.1002/jcp.1041470115
   Keogh MB, 2010, CELL TISSUE RES, V340, P169, DOI 10.1007/s00441-010-0939-y
   Lecoeur L, 1997, BIOMATERIALS, V18, P989, DOI 10.1016/S0142-9612(97)00025-2
   Lennon DP, 2006, CULTURE SPECIALIZED, P30
   Lerouxel E, 2004, OSTEOPOROSIS INT, V15, P814, DOI 10.1007/s00198-004-1611-8
   LIN WL, 1994, ANAT REC, V240, P492, DOI 10.1002/ar.1092400407
   Mendes RM, 2008, ARCH ORAL BIOL, V53, P1155, DOI 10.1016/j.archoralbio.2008.07.001
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Reynolds T, 1999, J ETHNOPHARMACOL, V68, P3, DOI 10.1016/S0378-8741(99)00085-9
   Sato D, 2005, J ORAL TISSUE ENG, V2, P81
   Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213
   Wu Z, 2008, INT J ORAL MAX SURG, V37, P170, DOI 10.1016/j.ijom.2007.06.018
NR 24
TC 13
Z9 14
U1 0
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1618-1247
EI 1618-1255
J9 ODONTOLOGY
JI Odontology
PD JUL
PY 2014
VL 102
IS 2
BP 310
EP 317
DI 10.1007/s10266-012-0101-2
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AN6BZ
UT WOS:000340680000026
PM 23315202
DA 2018-10-20
ER

PT J
AU Xie, HQ
   Huang, FG
   Zhao, YF
   Qin, TW
   Li, XQ
   Liu, C
   Li-Ling, J
   Yang, ZM
AF Xie, Hui-Qi
   Huang, Fu-Guo
   Zhao, Yong-Fan
   Qin, Ting-Wu
   Li, Xiu-Qun
   Liu, Chang
   Li-Ling, Jesse
   Yang, Zhi-Ming
TI Tissue-engineered ribs for chest wall reconstruction: a case with
   12-year follow-up
SO REGENERATIVE MEDICINE
LA English
DT Article
DE allogenic bone-derived scaffold; bone marrow mesenchymal stem cells;
   chest wall; reconstruction; rib; tissue engineering
ID MESENCHYMAL STEM-CELLS; OF-THE-ART; BONE-MARROW; DESMOPLASTIC FIBROMA;
   REPAIR; EXPANSION; DEFECTS; SUBSTITUTE; GRAFT
AB We hereby report on a case in which a huge chest wall defect generated by resection of a massive aggressive tumor (desmoplastic fibroma) was repaired with osteogenic-induced mesenchymal stem cells embedded in a bone-derived biomaterial. In this case, there were three challenges to overcome: reconstruction of the soft tissue, repair of the skeletal defect of the thoracic wall and repair of the defect in the pleural cavity. The defects of soft tissue and pleural cavity were reconstructed, respectively, with an ipsilateral abdominal flap and a diaphragm muscular flap. The huge defect in the chest wall was successfully repaired with the tissue-engineered ribs, which was confirmed by long-term follow-up with computerized tomography and histological and immunohistochemical evaluations. In view of its effectiveness and safety, tissue-engineered bones may have a broad application for the repair of large skeletal defects and bone regeneration.
C1 [Xie, Hui-Qi; Qin, Ting-Wu; Li, Xiu-Qun; Yang, Zhi-Ming] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Lab Stem Cell & Tissue Engn, Chengdu 610041, Peoples R China.
   [Xie, Hui-Qi; Qin, Ting-Wu; Li, Xiu-Qun; Yang, Zhi-Ming] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu 610041, Peoples R China.
   [Huang, Fu-Guo] Sichuan Univ, West China Med Sch, West China Hosp, Dept Orthoped, Chengdu 610041, Peoples R China.
   [Zhao, Yong-Fan] Sichuan Univ, West China Med Sch, West China Hosp, Dept Cardiothorac Surg, Chengdu 610041, Peoples R China.
   [Liu, Chang] Sichuan Univ, West China Med Sch, West China Hosp, Dept Radiol, Chengdu 610041, Peoples R China.
   [Li-Ling, Jesse] Sichuan Univ, State Key Lab Biotherapy, Lab Dis Genom & Bioinformat, Chengdu 610041, Peoples R China.
RP Yang, ZM (reprint author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Lab Stem Cell & Tissue Engn, 1 Keyuan Silu, Chengdu 610041, Peoples R China.
EM yangzhiming@scu.edu.cn
FU National High Technology Research and Development Program of China
   [2012AA020503, 2002AA205011]
FX This work was supported by grants from the National High Technology
   Research and Development Program of China (2012AA020503 and
   2002AA205011). The authors have no other relevant affiliations or
   financial involvement with any organization or entity with a financial
   interest in or financial conflict with the subject matter or materials
   discussed in the manuscript apart from those disclosed.
CR Agrawal K, 1998, PLAST RECONSTR SURG, V102, P839, DOI 10.1097/00006534-199809030-00035
   Barbashina V, 2002, ARCH PATHOL LAB MED, V126, P721
   Bohm P, 1996, CANCER, V78, P1011, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1011::AID-CNCR11>3.0.CO;2-5
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097
   Delecrin J, 2000, SPINE, V25, P563, DOI 10.1097/00007632-200003010-00006
   Huang YZ, 2012, INT J ARTIF ORGANS, V35, P1061, DOI 10.5301/ijao.5000122
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   KAJIWARA H, 1995, ARTIF ORGANS, V19, P64, DOI 10.1111/j.1525-1594.1995.tb02246.x
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Losken A, 2004, BRIT J PLAST SURG, V57, P295, DOI 10.1016/j.bjps.2004.02.004
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pradel W, 2006, ORAL SURG ORAL MED O, V101, P285, DOI 10.1016/j.tripleo.2005.06.001
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schmelzeisen R, 2003, J CRANIO MAXILL SURG, V31, P34, DOI 10.1016/S1010-5182
   Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530
   Shen Bing, 2002, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V16, P429
   Skoracki RJ, 2006, J SURG ONCOL, V94, P455, DOI 10.1002/jso.20482
   Vacanti CA, 2001, NEW ENGL J MED, V344, P1511, DOI 10.1056/NEJM200105173442004
   Xie HQ, 2007, BIOMATERIALS, V28, P3314, DOI 10.1016/j.biomaterials.2007.04.001
   Yang Z, 2000, Hand Surg, V5, P49, DOI 10.1142/S0218810400000132
   Yang Zhi-ming, 2002, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V16, P311
NR 26
TC 4
Z9 4
U1 2
U2 4
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PD JUL
PY 2014
VL 9
IS 4
BP 431
EP 436
DI 10.2217/RME.14.24
PG 6
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA AO2XC
UT WOS:000341189500009
PM 25159061
DA 2018-10-20
ER

PT J
AU Lee, EJ
   Kwon, JS
   Om, JY
   Moon, SK
   Uhm, SH
   Choi, EH
   Kim, KN
AF Lee, Eun-Jung
   Kwon, Jae-Sung
   Om, Ji-Yeon
   Moon, Seung-Kyun
   Uhm, Soo-Hyuk
   Choi, Eun Ha
   Kim, Kyoung-Nam
TI The enhanced integrin-mediated cell attachment and osteogenic gene
   expression on atmospheric pressure plasma jet treated micro-structured
   titanium surfaces
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Plasma Biosciences (ISPB)
CY JUN 27-29, 2013
CL Jeju Island, SOUTH KOREA
DE Fibronectin; Integrin; Osteogenesis; Plasma; Surface chemistry
ID OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; ADHESION; FIBRONECTIN
AB The previous study has shown that the treatment of nitrogen-based non-thermal atmospheric pressure plasma jet (NTAPPJ) on titanium (Ti) surface resulted in promoted cell attachment. Nonetheless, essential understanding on enhanced cell-material interaction with NTAPPJ-treated surface and consequent differentiation of cell on the biomaterial is insufficient. Therefore in this study, effects of NTAPPJ on integrins, that play a fundamental role in regulating the activation of signaling pathways as well as adhesion of cell-material interactions, have been investigated. The Ti samples were exposed to NTAPPJ, where control samples were unexposed to NTAPPJ. The formations of chemical function groups on surface of Ti samples were investigated with X-ray photoelectron spectroscopy. Human plasma fibronectin (FN) adsorption was analyzed by protein assay kit and spectrophotometer. Also, for the investigation of specific gene expression of integrin subunits and osteoblast phenotype genes expression of MC3T3-E1 cells, quantitative PCR was carried out. The results showed that FN adsorption and gene expression levels of integrin subunits alpha(5), beta(1) and beta(3), and osteocalcin were significantly higher with cells cultured on NTAPPJ-treated samples. Therefore it was concluded that the cell differentiation along with the adhesion between cells and Ti biomaterials were promoted with NTAPPJ due to the improved integrin activation following the improved protein adsorption. Such results are expected to provide better understanding in application of NTAPPJ on biomaterials. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Lee, Eun-Jung; Kwon, Jae-Sung; Om, Ji-Yeon; Moon, Seung-Kyun; Uhm, Soo-Hyuk; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, Seoul 120749, South Korea.
   [Lee, Eun-Jung; Kwon, Jae-Sung; Uhm, Soo-Hyuk; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Brain Korea PLUS Project 21, Seoul 120749, South Korea.
   [Moon, Seung-Kyun] Osstem Implant R&D Ctr, Pusan, South Korea.
   [Choi, Eun Ha] Kwangwoon Univ, Plasma Biosci Res Ctr, Seoul, South Korea.
RP Kim, KN (reprint author), Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, Seoul 120749, South Korea.
EM kimkn@yuhs.ac
RI Kwon, Jae-Sung/M-5430-2018
OI Kwon, Jae-Sung/0000-0001-9803-7730
FU National Research Foundation of Korea (NRF) - Korea Government (MSIP)
   [NRF-2010-0027963, 2012R1A1A2008659]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea Government (MSIP) (NRF-2010-0027963 and
   2012R1A1A2008659).
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Briand E, 2010, TALANTA, V81, P1153, DOI 10.1016/j.talanta.2010.01.027
   Chen X, 2013, COLLOID SURFACE B, V107, P189, DOI 10.1016/j.colsurfb.2013.02.005
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   Glantotti F.G., 1999, SCIENCE, V283, P1028
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Hong YC, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3272089
   Kang BS, 2009, ACTA BIOMATER, V5, P2222, DOI 10.1016/j.actbio.2009.01.049
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005
   Kwon JS, 2013, CURR APPL PHYS, V13, pS42, DOI 10.1016/j.cap.2012.12.022
   Lee EJ, 2013, CURR APPL PHYS, V13, pS36, DOI 10.1016/j.cap.2012.12.023
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marie PJ, 2013, NAT REV ENDOCRINOL, V9, P288, DOI 10.1038/nrendo.2013.4
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Ungvari K, 2010, J BIOMED MATER RES B, V94B, P222, DOI 10.1002/jbm.b.31644
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
NR 21
TC 2
Z9 2
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
EI 1878-1675
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JUL
PY 2014
VL 14
SU 2
SI SI
BP S167
EP S171
DI 10.1016/j.cap.2013.12.033
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AN4TI
UT WOS:000340581000006
DA 2018-10-20
ER

PT J
AU Qian, ZY
   Fan, XQ
AF Qian, Zhuyun
   Fan, Xianqun
TI The Application and Progress of High-Density Porous Polyethylene in the
   Repair of Orbital Wall Defect
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE High-density porous polyethylene; orbital wall defect; orbital volume;
   biocompatibility; composite material; tissue engineering
ID COMPUTED-TOMOGRAPHY; RECONSTRUCTION; IMPLANTS; FLOOR; FRACTURES; MEDPOR;
   FIBROVASCULARIZATION; VASCULARIZATION; CELLS
AB High-density porous polyethylene is a type of polymeric biomaterial. When used to efficiently fill the extensive orbital volume and correct enophthalmos caused by orbital wall defect, it has a significant advantage of biocompatibility, which results in a low rate of postoperative exposure and infection. The major disadvantage of this material is its radiolucency. However, with the development of imaging techniques, it is now possible to use multidetector computed tomography to directly contour the implant and describe its position. The use of tissue engineering involving high-density porous polyethylene will further improve its biocompatibility. At the same time, composite materials will play an important role in the repair of orbital wall defect.
C1 [Qian, Zhuyun; Fan, Xianqun] Shanghai JiaoTong Univ Sch Med, Shanghai Peoples Hosp 9, Dept Ophthalmol, Shanghai 200011, Peoples R China.
RP Fan, XQ (reprint author), Shanghai JiaoTong Univ Sch Med, Shanghai Peoples Hosp 9, Dept Ophthalmol, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.
EM fanxq@sh163.net
FU Scientific Research Program of National Health and Family Planning
   Commission of China [201402014]; National Natural Science Foundation of
   China [81170876, 31271029]; Science and Technology Commission of
   Shanghai [13ZR1423600]
FX This work was supported by the Scientific Research Program of National
   Health and Family Planning Commission of China (201402014), the National
   Natural Science Foundation of China (81170876, 31271029), and the
   Science and Technology Commission of Shanghai (13ZR1423600).
CR Carinci F, 2006, J CRANIOFAC SURG, V17, P1243, DOI 10.1097/01.scs.0000248644.02718.28
   Coskun U, 2008, J CRANIOFAC SURG, V19, P156, DOI 10.1097/scs.0b013e31815c8a3a
   Ehrmantraut S, 2012, TISSUE ENG PT A, V18, P1562, DOI [10.1089/ten.TEA.2011.0340, 10.1089/ten.tea.2011.0340]
   Fan Xian-qun, 2003, Zhonghua Yan Ke Za Zhi, V39, P516
   Fan XQ, 2002, ZHONGHUA YAN KE ZA Z, V38, P38
   Garibaldi DC, 2007, OPHTHAL PLAST RECONS, V23, P439, DOI 10.1097/IOP.0b013e31815a1235
   Hillier RJ, 2009, OPHTHAL PLAST RECONS, V25, P238, DOI 10.1097/IOP.0b013e3181a394e7
   Hwang K, 2010, J CRANIOFAC SURG, V21, P847, DOI 10.1097/SCS.0b013e3181d7f2ff
   Kent SS, 2012, CAN J OPHTHALMOL, V47, P38
   Lane KA, 2009, OPHTHALMOLOGY, V116, P135, DOI 10.1016/j.ophtha.2008.08.042
   Lee JM, 2012, J CRANIOFAC SURG, V23, P1878, DOI 10.1097/SCS.0b013e318260efd4
   Lee SG, 2010, CLIN EXP OPHTHALMOL, V38, P885, DOI 10.1111/j.1442-9071.2010.02355.x
   Liu XJ, 2012, J CRANIOFAC SURG, V23, P758, DOI 10.1097/SCS.0b013e31824dbd2f
   Ma'luf RN, 2010, ORBIT, V29, P343, DOI 10.3109/01676830.2010.524267
   Mihora LD, 2011, OPHTHAL PLAST RECONS, V27, P117
   Nam SB, 2006, ANN PLAS SURG, V56, P263, DOI 10.1097/01.sap.0000199173.73610.bc
   Oliveira RV, 2009, J CRANIOFAC SURG, V20, P1120, DOI 10.1097/SCS.0b013e3181abb4ab
   Patel PJ, 2003, ARCH OPHTHALMOL-CHIC, V121, P400
   SHANBHAG A, 1990, ANN PLAS SURG, V24, P32, DOI 10.1097/00000637-199001000-00006
   Villarreal PM, 2002, PLAST RECONSTR SURG, V109, P877, DOI 10.1097/00006534-200203000-00007
   Ye J, 2006, INVEST OPHTH VIS SCI, V47, P509, DOI 10.1167/iovs.05-0816
NR 21
TC 4
Z9 4
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JUL
PY 2014
VL 25
IS 4
BP 1451
EP 1453
DI 10.1097/SCS.0000000000000798
PG 3
WC Surgery
SC Surgery
GA AN0EZ
UT WOS:000340257800122
PM 24911609
DA 2018-10-20
ER

PT J
AU Mueller, WD
   Hornberger, H
AF Mueller, Wolf-Dieter
   Hornberger, Helga
TI The Influence of MgH2 on the Assessment of Electrochemical Data to
   Predict the Degradation Rate of Mg and Mg Alloys
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE magnesium; magnesium alloys; magnesium hydride; corrosion; degradation
ID MAGNESIUM ALLOYS; CORROSION BEHAVIOR; ANODIC-DISSOLUTION; PURE
   MAGNESIUM; SURFACE-FILM; IMMERSION; COATINGS; CHLORIDE; METALS; AZ91
AB Mg and Mg alloys are becoming more and more of interest for several applications. In the case of biomaterial applications, a special interest exists due to the fact that a predictable degradation should be given. Various investigations were made to characterize and predict the corrosion behavior in vitro and in vivo. Mostly, the simple oxidation of Mg to Mg2+ ions connected with adequate hydrogen development is assumed, and the negative difference effect (NDE) is attributed to various mechanisms and electrochemical results. The aim of this paper is to compare the different views on the corrosion pathway of Mg or Mg alloys and to present a neglected pathway based on thermodynamic data as a guideline for possible reactions combined with experimental observations of a delay of visible hydrogen evolution during cyclic voltammetry. Various reaction pathways are considered and discussed to explain these results, like the stability of the Mg+ intermediate state, the stability of MgH2 and the role of hydrogen overpotential. Finally, the impact of MgH2 formation is shown as an appropriate base for the prediction of the degradation behavior and calculation of the corrosion rate of Mg and Mg alloys.
C1 [Mueller, Wolf-Dieter] Charite, Sch Dent, Biomat Res CC3, D-14197 Berlin, Germany.
   [Hornberger, Helga] Tech Univ Berlin, Dept Mat Sci & Technol EB13, D-10623 Berlin, Germany.
RP Mueller, WD (reprint author), Charite, Sch Dent, Biomat Res CC3, Assmannshauserstr 4-6, D-14197 Berlin, Germany.
EM wolf-dieter.mueller@charite.de; helga.hornberger@tu-berlin.de
CR Abidin NIZ, 2011, CORROS SCI, V53, P3542, DOI 10.1016/j.corsci.2011.06.030
   Atrens A, 2007, ADV ENG MATER, V9, P292, DOI 10.1002/adem.200600275
   Bender S, 2012, MATER CORROS, V63, P707, DOI 10.1002/maco.201106225
   Chong KZ, 2003, MATER CHEM PHYS, V80, P191, DOI 10.1016/S0254-0584(02)00481-9
   Dietzel W, 2010, ENG FRACT MECH, V77, P257, DOI 10.1016/j.engfracmech.2009.07.009
   Drazic DM, 1999, J APPL ELECTROCHEM, V29, P43, DOI 10.1023/A:1003447018115
   EZAKI H, 1993, ELECTROCHIM ACTA, V38, P557, DOI 10.1016/0013-4686(93)85012-N
   Gao JH, 2011, J MATER SCI-MATER M, V22, P1681, DOI 10.1007/s10856-011-4349-9
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Kaese V, 1999, MATER CORROS, V50, P191, DOI 10.1002/(SICI)1521-4176(199904)50:4<191::AID-MACO191>3.0.CO;2-C
   Kannan M.B., 2010, J BIOMED MATER RES B, V96, P303
   Lee CD, 2001, MET MATER INT, V7, P385, DOI 10.1007/BF03186084
   Liu LJ, 2009, CORROS SCI, V51, P1733, DOI 10.1016/j.corsci.2009.04.025
   Mensah-Darkwa K, 2013, J MATER SCI TECHNOL, V29, P788, DOI 10.1016/j.jmst.2013.04.019
   Mueller W.D., 2007, MAT RES, V10, P5
   Mueller W.D., 2008, J BIOMED MATER RES A, V90, P487
   Nam ND, 2012, J ALLOY COMPD, V542, P199, DOI 10.1016/j.jallcom.2012.07.083
   Pereda MD, 2011, MAT SCI ENG C-MATER, V31, P858, DOI 10.1016/j.msec.2011.01.010
   Perrault G.G., 1978, ENCY ELECTROCHEMISTR, P266
   Pourbaix M., 1963, ATLAS EQUILIBRES ELE
   San-Martin A., 1987, B ALLOY PHASE DIAGRA, V8, P431, DOI DOI 10.1007/BF02893152
   Santamaria M, 2007, ELECTROCHIM ACTA, V53, P1314, DOI 10.1016/j.electacta.2007.03.019
   Seyeux A, 2009, CORROS SCI, V51, P1883, DOI 10.1016/j.corsci.2009.06.002
   Shin KS, 2012, JOM-US, V64, P664, DOI 10.1007/s11837-012-0334-0
   Song G, 1997, CORROS SCI, V39, P855, DOI 10.1016/S0010-938X(96)00172-2
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Song YW, 2009, CORROS SCI, V51, P1087, DOI 10.1016/j.corsci.2009.03.011
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Swiatowska J, 2010, CORROS SCI, V52, P2372, DOI 10.1016/j.corsci.2010.02.038
   Thomaz TR, 2010, CORROS SCI, V52, P2235, DOI 10.1016/j.corsci.2010.03.010
   Tie D, 2013, EUR CELLS MATER, V25, P284, DOI 10.22203/eCM.v025a20
   Virtanen S, 2011, MATER SCI ENG B-ADV, V176, P1600, DOI 10.1016/j.mseb.2011.05.028
   Volovitch P, 2012, CORROSION, V68, P557, DOI 10.5006/i0010-9312-68-6-557
   Walker J, 2012, J BIOMED MATER RES B, V100B, P1134, DOI 10.1002/jbm.b.32680
   Weber CR, 2003, J BRAZIL CHEM SOC, V14, P584, DOI 10.1590/S0103-50532003000400015
   Xue DC, 2011, MAT SCI ENG C-MATER, V31, P215, DOI 10.1016/j.msec.2010.08.019
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhao X, 2013, J MATER SCI TECHNOL, V29, P781, DOI 10.1016/j.jmst.2013.05.017
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
NR 39
TC 0
Z9 0
U1 4
U2 28
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL
PY 2014
VL 15
IS 7
BP 11456
EP 11472
DI 10.3390/ijms150711456
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA AM7ID
UT WOS:000340038500017
PM 24972140
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Baek, SH
   Ahn, JW
   Nam, SH
   Yoon, CS
   Shin, JC
   Lee, SH
AF Baek, Seung-Hwa
   Ahn, Jun-Won
   Nam, Sung-Hee
   Yoon, Cheol-Sik
   Shin, Jae-Cheon
   Lee, Sang-Han
TI S-(-)-10,11-Dihydroxyfarnesoic Acid Methyl Ester Inhibits Melanin
   Synthesis in Murine Melanocyte Cells
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE dihydroxyfarnesoic acid; melanin; tyrosinase; inhibitor; insect juvenile
   hormone; whitening
ID SKIN; PIGMENTATION; MELANOGENESIS; PROTECTION; AGENTS
AB The development of antimelanogenic agents is important for the prevention of serious aesthetic problems such as melasmas, freckles, age spots, and chloasmas. In the course of screening for melanin synthesis inhibitors, we found that the culture broth from an insect morphopathogenic fungus, Beauveria bassiana CS1029, exhibits potent antimelanogenic activity. We isolated and purified an active metabolite and identified it as S-(-)-10,11-dihydroxyfarnesoic acid methyl ester (dhFAME), an insect juvenile hormone. To address whether dhFAME inhibits melanin synthesis, we first measured the size of the melanin biosynthesis inhibition zone caused by dhFAME. dhFAME also showed inhibitory activity against mushroom tyrosinase in Melan-a cells. Intracellular, dose-dependent tyrosinase inhibition activity was also confirmed by zymography. In addition, we showed that dhFAME strongly inhibits melanin synthesis in Melan-a cells. Furthermore, we compared levels of TYR, TRP-1, TRP-2, MITF, and MC1R mRNA expression by reverse-transcription polymerase chain reaction and showed that treatment of Melan-a cells with 35 mu M dhFAME led to an 11-fold decrease in TYR expression, a 6-fold decrease in TRP-2 expression, and a 5-fold decrease in MITF expression. Together, these results indicate that dhFAME is a potent inhibitor of melanin synthesis that can potentially be used for cosmetic biomaterial(s).
C1 [Baek, Seung-Hwa; Lee, Sang-Han] Kyungpook Natl Univ, Grad Sch, Dept Food Sci & Biotechnol, Taegu 702701, South Korea.
   [Ahn, Jun-Won; Lee, Sang-Han] Kyungpook Natl Univ, Grad Sch, Dept Nanosci & Technol, Taegu 702701, South Korea.
   [Ahn, Jun-Won] Nano Convergence Pract Applicat Ctr, Taegu 704801, South Korea.
   [Nam, Sung-Hee] Rural Adm Agcy, Natl Acad Agr Sci, Dept Agr Biol, Suwon 441707, South Korea.
   [Yoon, Cheol-Sik] Mycoplus Co Ltd, Anyang 431080, South Korea.
   [Shin, Jae-Cheon] Pohang Ctr Evaluat Biomat, Pohang 790834, South Korea.
   [Lee, Sang-Han] Kyungpook Natl Univ, Food & Bioind Res Inst, Taegu 702701, South Korea.
RP Shin, JC (reprint author), Pohang Ctr Evaluat Biomat, Pohang Technopk, Pohang 790834, South Korea.
EM micro340@hanmail.net; nmrtube@naver.com; creative716@korea.kr;
   mycoplus@naver.com; ilovehg@paran.com; sang@knu.ac.kr
FU BioGreen Agenda Project, Republic of Korea [2009101-060-005-001-02-00]
FX This work was supported by a grant of the BioGreen Agenda Project,
   Republic of Korea, under contract No. 2009101-060-005-001-02-00
   (S.-H.N). The authors thank Hyeong-U Son, Min-A Kim for their technical
   assistance.
CR Ahn SJ, 2006, CHEM PHARM BULL, V54, P281, DOI 10.1248/cpb.54.281
   Ando H, 2010, INT J MOL SCI, V11, P2566, DOI 10.3390/ijms11062566
   [Anonymous], 2013, Image J Software 1.48 version., Patent No. 101239631
   Callender VD, 2011, AM J CLIN DERMATOL, V12, P87, DOI 10.2165/11536930-000000000-00000
   Videira IFD, 2013, AN BRAS DERMATOL, V88, P76, DOI 10.1590/S0365-05962013000100009
   Elias PM, 2009, PIGM CELL MELANOMA R, V22, P420, DOI 10.1111/j.1755-148X.2009.00588.x
   Goh MJ, 2013, INT J MOL SCI, V14, P1655, DOI 10.3390/ijms14011655
   Gunn TM, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12059
   Guo HY, 2012, INT J MOL MED, V30, P636, DOI 10.3892/ijmm.2012.1028
   Hearing Vincent J, 2011, J Invest Dermatol, V131, pE8, DOI 10.1038/skinbio.2011.4
   ISHIHARA Y, 1991, J ANTIBIOT, V44, P25, DOI 10.7164/antibiotics.44.25
   Khalil SMS, 2006, J INSECT PHYSIOL, V52, P669, DOI 10.1016/j.jinsphys.2006.03.004
   Lamel SA, 2013, CUTAN OCUL TOXICOL, V32, P67, DOI 10.3109/15569527.2012.684419
   Lee AY, 2013, ARCH PHARM RES, V36, P792, DOI 10.1007/s12272-013-0130-6
   Lee CS, 2013, EXP DERMATOL, V22, P762, DOI 10.1111/exd.12248
   Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660
   MARS U, 1995, PIGM CELL RES, V8, P194, DOI 10.1111/j.1600-0749.1995.tb00663.x
   Melnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015
   Mishima Yutaka, 1994, Skin Research, V36, P134
   Nam S.H., 2013, Korea Patent, Patent No. [10-1239631, 101258699]
   Oh MJ, 2011, ARCH DERMATOL RES, V303, P161, DOI 10.1007/s00403-010-1089-5
   Park HY, 2004, J INVEST DERMATOL, V122, P159, DOI 10.1046/j.0022-202X.2003.22134.x
   Robinson S, 2010, J INVEST DERMATOL, V130, P1904, DOI 10.1038/jid.2010.48
   Sato K, 2008, BIOL PHARM BULL, V31, P33, DOI 10.1248/bpb.31.33
   Slama K, 2011, ANNU REV BIOCHEM, V40, P1079
   Smit N, 2009, INT J MOL SCI, V10, P5326, DOI 10.3390/ijms10125326
   Son HU, 2013, EXP THER MED, V6, P909, DOI 10.3892/etm.2013.1249
   Takizawa T, 2003, TOXICOL SCI, V73, P287, DOI 10.1093/toxsci/kfg094
   Wu Y, 2011, CLIN EXP DERMATOL, V36, P178, DOI 10.1111/j.1365-2230.2010.03916.x
NR 29
TC 6
Z9 6
U1 0
U2 8
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL
PY 2014
VL 15
IS 7
BP 12750
EP 12763
DI 10.3390/ijms150712750
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA AM7ID
UT WOS:000340038500096
PM 25046747
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Uykun, N
   Ergal, I
   Kurt, H
   Gokceoren, AT
   Gocek, I
   Kayaoglu, BK
   Akarsubasi, AT
   Sarac, AS
AF Uykun, Nurullah
   Ergal, Ipek
   Kurt, Halil
   Gokceoren, Argun T.
   Gocek, Ikilem
   Kayaoglu, Burcak K.
   Akarsubasi, Alper T.
   Sarac, A. Sezai
TI Electrospun antibacterial nanofibrous
   polyvinylpyrrolidone/cetyltrimethylammonium bromide membranes for
   biomedical applications
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Antibacterial nanofibers; electrospun antibacterial membranes;
   cetyltrimethylammonium bromide; electrospun polyvinylpyrrolidone fibers
   and membranes
ID BIPHASIC DRUG-RELEASE; SILVER NANOPARTICLES; QUATERNARY AMMONIUM;
   POLYURETHANE NANOFIBERS; TITANIUM-DIOXIDE; CROSS-LINKING; PVP; MATS;
   SCAFFOLDS; RADIATION
AB Nanoscale structures with large surface area-to-volume ratios are used as biomaterial scaffolds for vascular grafts, wound dressings, and air purifying filters. Using electrospinning, nanofibers containing an antibacterial agent, cetyltrimethylammonium bromide, were prepared for wound healing application. Polyvinylpyrrolidone, known as a biocompatible additive in food and drug industries, has been used as fiber processing agent with the organic active ingredient, cetyltrimethylammonium bromide. A series of samples with different polyvinylpyrrolidone/ cetyltrimethylammonium bromide ratios were successfully prepared by this method. The morphology and electroactive characteristics of nanofibers were investigated using scanning electron microscopy, atomic force microscopy, and electrochemical impedance spectroscopy. Fiber diameters and charge transfer resistances were found to decrease with salt content, while the double-layer capacitance increased with no apparent effect on the specific capacitance providing favorable conditions for the fabrication of biomaterials. In addition, the quaternary ammonium compound (cetyltrimethylammonium bromide) with a minimum ratio of 2.5 wt% showed reduction in bacterial activity of Klebsiella pneumonia, Staphylococcus aureus, and Escherichia coli.
C1 [Uykun, Nurullah; Gokceoren, Argun T.; Sarac, A. Sezai] Istanbul Tech Univ, Fac Sci & Letters, Dept Chem, TR-34469 Istanbul, Turkey.
   [Ergal, Ipek; Kurt, Halil; Akarsubasi, Alper T.] Istanbul Tech Univ, Fac Sci & Letters, Dept Mol Biol & Genet, TR-34469 Istanbul, Turkey.
   [Gocek, Ikilem; Kayaoglu, Burcak K.] Istanbul Tech Univ, Fac Text Technol & Design, TR-34469 Istanbul, Turkey.
RP Sarac, AS (reprint author), Istanbul Tech Univ, Fac Sci & Letters, Dept Chem, TR-34469 Istanbul, Turkey.
EM sarac@itu.edu.tr
RI Karaguzel Kayaoglu, Burcak/N-1993-2014; gocek, ikilem/A-6396-2016;
   Sarac, A.Sezai/N-1628-2014
OI gocek, ikilem/0000-0003-0682-5786; Sarac, A.Sezai/0000-0001-7513-1740
CR [Anonymous], 2007, 207432007 ISO
   Archana D, 2013, CARBOHYD POLYM, V95, P530, DOI 10.1016/j.carbpol.2013.03.034
   Barnabas J, 2014, J IND TEXT, V44, P232, DOI 10.1177/1528083713483782
   Bianco A, 2011, J BIOACT COMPAT POL, V26, P225, DOI 10.1177/0883911511406250
   Caillier L, 2009, EUR J MED CHEM, V44, P3201, DOI 10.1016/j.ejmech.2009.03.031
   Chang HI, 2010, REACT FUNCT POLYM, V70, P944, DOI 10.1016/j.reactfunctpolym.2010.09.005
   Charernsriwilaiwat N, 2013, INT J PHARMACEUT, V452, P333, DOI 10.1016/j.ijpharm.2013.05.012
   Cloete TE, 1998, BIODEGRADATION, V9, P23, DOI 10.1023/A:1008216209206
   D'Erricot G, 2008, BIOMACROMOLECULES, V9, P231, DOI 10.1021/bm7008137
   Dong GP, 2009, APPL SURF SCI, V255, P7623, DOI 10.1016/j.apsusc.2009.04.039
   Dorati R, 2007, POLYM DEGRAD STABIL, V92, P1660, DOI 10.1016/j.polymdegradstab.2007.06.020
   EI-Arini SK, 1995, INT J PHARMACEUT, V121, P141
   Fechine GJM, 2004, POLYMER, V45, P4705, DOI 10.1016/j.polymer.2004.05.006
   Fernandes IP, 2013, CARBOHYD POLYM, V98, P1229, DOI 10.1016/j.carbpol.2013.07.030
   Gazzarri M, 2013, J BIOACT COMPAT POL, V28, P492, DOI 10.1177/0883911513494625
   Goel NK, 2009, RADIAT PHYS CHEM, V78, P399, DOI 10.1016/j.radphyschem.2009.03.011
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hirata H, 2006, ENCY SURFACE COLLOID, V8, P6108
   Hong KH, 2007, POLYM ENG SCI, V47, P43, DOI 10.1002/pen.20660
   Huang LY, 2012, INT J PHARMACEUT, V436, P88, DOI 10.1016/j.ijpharm.2012.06.058
   Jeon HJ, 2008, APPL SURF SCI, V254, P5886, DOI 10.1016/j.apsusc.2008.03.141
   Jeong EH, 2007, MATER LETT, V61, P3991, DOI 10.1016/j.matlet.2007.01.003
   Jiang S, 2005, REACT FUNCT POLYM, V62, P209, DOI 10.1016/j.reactfunctpolym.2004.11.002
   Jiang YN, 2012, INT J PHARMACEUT, V438, P232, DOI 10.1016/j.ijpharm.2012.08.053
   Kaneda Y, 2004, BIOMATERIALS, V25, P3259, DOI 10.1016/j.biomaterials.2003.10.003
   Khodir WKWA, 2013, J BIOACT COMPAT POL, V28, P258, DOI 10.1177/0883911513481133
   Kumar V, 1999, INT J PHARM, V188, P221, DOI 10.1016/S0378-5173(99)00223-9
   Lee DY, 2010, J SOL-GEL SCI TECHN, V54, P63, DOI 10.1007/s10971-010-2158-0
   Lee K, 2012, J APPL POLYM SCI, V124, P4038, DOI 10.1002/app.34929
   Lopergolo LC, 2003, POLYMER, V44, P6217, DOI 10.1016/S0032-3861(03)00686-4
   Martins NCT, 2013, COLLOID SURFACE A, V417, P111, DOI 10.1016/j.colsurfa.2012.10.042
   McCool JM, 2014, J BIOACT COMPAT POL, V29, P32, DOI 10.1177/0883911513513661
   McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147
   Mereghetti L, 2000, APPL ENVIRON MICROB, V66, P5083, DOI 10.1128/AEM.66.11.5083-5086.2000
   Mirdamadi-Esfahani M, 2009, RADIAT PHYS CHEM, V78, P106, DOI 10.1016/j.radphyschem.2008.08.009
   Oliveira MJA, 2014, RADIAT PHYS CHEM, V94, P194, DOI 10.1016/j.radphyschem.2013.05.050
   Pant HR, 2011, J HAZARD MATER, V185, P124, DOI 10.1016/j.jhazmat.2010.09.006
   Paradies H. H., 2000, RIGAKU J, V17, P20
   Park IK, 2003, J CONTROL RELEASE, V86, P349, DOI 10.1016/S0168-3659(02)00365-6
   Puppi D, 2011, J BIOACT COMPAT POLY, V26, P2
   Risbud MV, 2001, J MATER SCI-MATER M, V12, P75, DOI 10.1023/A:1026769422026
   Sheikh FA, 2009, MACROMOL RES, V17, P688, DOI 10.1007/BF03218929
   Singh B, 2011, INT J BIOL MACROMOL, V48, P501, DOI 10.1016/j.ijbiomac.2011.01.013
   Son WK, 2006, CARBOHYD POLYM, V65, P430, DOI 10.1016/j.carbpol.2006.01.037
   Stoilova O, 2010, J BIOACT COMPAT POL, V25, P40, DOI 10.1177/0883911509353680
   Toncheva A, 2011, J BIOACT COMPAT POL, V26, P161, DOI 10.1177/0883911511398992
   Vashisth P, 2013, J BIOACT COMPAT POL, V28, P652, DOI 10.1177/0883911513502279
   Wu YG, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/24/245101
   Yao C, 2008, J MEMBRANE SCI, V320, P259, DOI 10.1016/j.memsci.2008.04.012
   Zhuang XP, 2010, CARBOHYD POLYM, V82, P524, DOI 10.1016/j.carbpol.2010.04.085
NR 50
TC 9
Z9 9
U1 3
U2 82
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2014
VL 29
IS 4
BP 382
EP 397
DI 10.1177/0883911514535153
PG 16
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA AM8NO
UT WOS:000340132800006
DA 2018-10-20
ER

PT J
AU You, YB
   Xue, T
   Cao, LY
   Zhao, LP
   Sun, HP
   Sim, BL
AF You, Yibo
   Xue, Ting
   Cao, Linyan
   Zhao, Liping
   Sun, Haipeng
   Sim, Baolin
TI Staphylococcus aureus glucose-induced biofilm accessory proteins, GbaAB,
   influence biofilm formation in a PIA-dependent manner
SO INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
DE S. aureus; gbaAB; ica; Biofilm; Glucose
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; FUNCTIONAL RSBU; TETR FAMILY; ICA
   LOCUS; EPIDERMIDIS; EXPRESSION; TRANSCRIPTION; MECHANISMS; STRESS;
   ACTIVATION
AB The Gram-positive bacteria Staphylococcus aureus and Staphylococcus epidermidis are capable of attaching to a biomaterial surface and forming resistant biofilms. The identification of biomolecular and regulatory factors involved in staphylococcal adhesion and biofilm formation is needed to understand biofilm-associated infection in humans. Here, we have identified a new operon, gbaAB (glucose induced biofilm accessory gene), that affects biofilm formation in S. aureus NCTC8325. Real-time reverse transcription PCR (RT-PCR) and electrophoretic mobility shift assay showed that GbaA and GbaB are transcribed from the same transcript, and GbaA directly inhibits the transcription of the gbaAB operon through self-repression. Our results indicated that the gbaA mutant displayed enhanced biofilm formation compared with the wild type. However, the gbaB and the gbaAB double mutant displayed reduced biofilm formation, suggesting that the gbaAB operon is involved in biofilm formation and that gbaB might be the key gene in biofilm regulation. Phenotypic analysis suggested that the gbaAB operon mediated biofilm formation of S. aureus at the multicellular aggregation stage rather than during initial attachment. In addition, real-time RT-PCR analysis showed that icaA was upregulated in the gbaA mutant and downregulated in the gbaB and gbaAB mutants compared with the wild type. In addition, the gbaA and the gbaB mutants affected the induction of biofilm formation by glucose. Our results suggest that the gbaAB operon is involved in the regulation of the multicellular aggregation step of S. aureus biofilm formation in response to glucose and that this regulation may be mediated through the ica operon. (C) 2014 Elsevier GmbH. All rights reserved.
C1 [You, Yibo; Xue, Ting; Cao, Linyan; Zhao, Liping; Sun, Haipeng; Sim, Baolin] Univ Sci & Technol China, Sch Life Sci, Dept Microbiol & Immunol, Hefei 230027, Anhui, Peoples R China.
RP Sim, BL (reprint author), Univ Sci & Technol China, Sch Life Sci, Dept Microbiol & Immunol, Hefei 230027, Anhui, Peoples R China.
EM sunb@ustc.edu.cn
RI Sun, Baolin/C-8354-2014; 薛, 挺/D-4799-2011
OI Sun, Baolin/0000-0002-2896-3015; 薛, 挺/0000-0002-5644-6613
FU National Natural Science Foundation of China [30970118, 31021061]
FX The authors thank the Network on Antimicrobial Resistance in
   Staphylococcus aureus (NARSA) for providing the bacterial strains. This
   study was supported by the National Natural Science Foundation of China
   (30970118, 31021061).
CR Anderson KL, 2010, FEMS IMMUNOL MED MIC, V60, P208, DOI 10.1111/j.1574-695X.2010.00736.x
   Aramaki H, 1995, PROTEIN ENG, V8, P1259, DOI 10.1093/protein/8.12.1259
   Bateman BT, 2001, INFECT IMMUN, V69, P7851, DOI 10.1128/IAI.69.12.7851-7857.2001
   Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003
   Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052
   Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1
   Conion K.M., 2002, J BACTERIOL, V184, P4400
   Conlon KM, 2002, FEMS MICROBIOL LETT, V216, P171, DOI 10.1016/S0378-1097(02)01031-5
   Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Cuaron JA, 2013, PHYTOTHER RES, V27, P390, DOI 10.1002/ptr.4738
   Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001
   Cue D, 2013, J BACTERIOL, V195, P1515, DOI 10.1128/JB.00012-13
   Cue D, 2009, J BACTERIOL, V191, P6363, DOI 10.1128/JB.00913-09
   Dobinsky S, 2003, J BACTERIOL, V185, P2879, DOI 10.1128/JB.185.9.2879-2886.2003
   Fey PD, 2010, CURR OPIN MICROBIOL, V13, P610, DOI 10.1016/j.mib.2010.09.007
   Fleibeit S., 2010, INFECT IMMUN, V78, P2877
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   George EA, 2007, CHEMBIOCHEM, V8, P847, DOI 10.1002/cbic.200700023
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Grkovic S, 1998, J BIOL CHEM, V273, P18665, DOI 10.1074/jbc.273.29.18665
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002
   Jefferson KK, 2004, J BACTERIOL, V186, P2449, DOI 10.1128/JB.186.8.2449-2456.2004
   Jeng WY, 2008, NUCLEIC ACIDS RES, V36, P1567, DOI 10.1093/nar/gkm1176
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Laverty G, 2013, FUTURE MICROBIOL, V8, P509, DOI [10.2217/FMB.13.7, 10.2217/fmb.13.7]
   Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002
   Lim Y, 2004, J BACTERIOL, V186, P722, DOI 10.1128/JB.186.3.722-729.2004
   Lin MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034388
   MACK D, 1992, INFECT IMMUN, V60, P2048
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08
   Otto M, 2008, CURR TOP MICROBIOL, V322, P207
   Rachid S, 2000, J BACTERIOL, V182, P6824, DOI 10.1128/JB.182.23.6824-6826.2000
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005
   Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104
   Riordan JT, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-30
   Seidl K, 2008, INFECT IMMUN, V76, P2044, DOI 10.1128/IAI.00035-08
   Ujimoto D.F., 2009, MOL MICROBIOL, V74, P1445
   Ulrich M, 2007, MOL MICROBIOL, V65, P1276, DOI 10.1111/j.1365-2958.2007.05863.x
   Valihrach L, 2012, J MICROBIOL METH, V90, P214, DOI 10.1016/j.mimet.2012.05.008
   Vuong C, 2005, J BACTERIOL, V187, P2967, DOI 10.1128/JB.187.9.2967-2973.2005
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Yu D, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-288
   Zhang B, 2011, J PROTEOME RES, V10, P3743, DOI 10.1021/pr200360w
NR 49
TC 17
Z9 17
U1 3
U2 38
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 1438-4221
EI 1618-0607
J9 INT J MED MICROBIOL
JI Int. J. Med. Microbiol.
PD JUL
PY 2014
VL 304
IS 5-6
BP 603
EP 612
DI 10.1016/j.fimm.2014.04.003
PG 10
WC Microbiology; Virology
SC Microbiology; Virology
GA AM3TL
UT WOS:000339775600011
PM 24836943
DA 2018-10-20
ER

PT J
AU Saengthong, S
   Piroonpan, T
   Tangthong, T
   Pasanphan, W
AF Saengthong, Salita
   Piroonpan, Thananchai
   Tangthong, Theeranan
   Pasanphan, Wanvimol
TI Fabrication of microporous chitosan/silk fibroin as a scaffold material
   using electron beam
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE chitosan; silk fibroin; PEGDMA; microporous; scaffold; crosslinking;
   electron beam
ID SILK FIBROIN; COLLAGEN; ACID; NANOPARTICLES; FILMS; BIOMATERIAL;
   HYDROGELS; CARTILAGE; SPONGES; CULTURE
AB The aim of this study is to develop microporous material from silk fibroin (SF) and chitosan (CS) using electron beam-induced crosslinking technique. Poly(ethylene glycol) dimethacrylate (PEGDMA) was used as radiation crosslinking agent. Comparative studies were done using two different polymeric components, i.e., CS and CS/SF. An effect of irradiation dose on crosslinking density and swelling degree were investigated. The chemical structure and packing conformation of the obtained microporous materials were characterized by Fourier transform infrared spectroscopy (FTIR) and X-ray diffraction (XRD) techniques. The morphology and microstructure were assessed using scanning electron microscope (SEM). The PEGDMA crosslinked in a CS/SF system (CS-PEGDMA-SF) possessed greater inter-connected porous network than that in a single CS component (CS-PEGDMA). The gel fraction was ranging from 90% to 100% when the irradiation doses of 10-80 kGy were carried out. The swelling degree increased by means of gel fraction and irradiation dose. The pore size CS-PEGDMA-SF and CS-PEGDMA varied in the range of 0.80-1.35 mu m and 8.07-16.32 mu m, respectively depending on the irradiation doses. The fabricated scaffolds showed the porosity ranging from 21% to 94%. Taken together, CS-PEGDMA-SF microporous material from electron-beam irradiation would serve as a good promising scaffold for tissue engineering.
C1 [Saengthong, Salita; Pasanphan, Wanvimol] Kasetsart Univ, Fac Sci, Dept Appl Radiat & Isotopes, Bangkok 10900, Thailand.
   [Piroonpan, Thananchai; Pasanphan, Wanvimol] Kasetsart Univ, Fac Sci, Dept Mat Sci, Bangkok 10900, Thailand.
   [Tangthong, Theeranan] Minist Sci & Technol, Thailand Inst Nucl Technol TINT, Nakhon Nayok 26120, Thailand.
RP Pasanphan, W (reprint author), Kasetsart Univ, Fac Sci, Dept Appl Radiat & Isotopes, Bangkok 10900, Thailand.
EM wanvimol.p@ku.ac.th
FU Kasetsart University Research and Development Institute (KURDI),
   Kasetsart University (KU); Graduates School for Budget Overseas Academic
   Conference (BOAC), Faculty of Science, KU
FX The authors acknowledge the Kasetsart University Research and
   Development Institute (KURDI), Kasetsart University (KU) and Graduates
   School for Budget Overseas Academic Conference (BOAC), Faculty of
   Science, KU, for the financial supports. We thank the Thailand Institute
   of Nuclear Technology (TINT), Ministry of Science and Technology,
   Thailand, for the electron-beam irradiation service. An appreciation is
   also extended to Department of Physics, Faculty of Science, KU, for
   FT-IR measurement.
CR Azevedo EP, 2012, CARBOHYD POLYM, V90, P894, DOI 10.1016/j.carbpol.2012.06.017
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Bodnar M, 2005, BIOMACROMOLECULES, V6, P2521, DOI 10.1021/bm0502258
   Burkhanova ND, 2000, CHEM NAT COMPD, V36, P352, DOI 10.1023/A:1002880411320
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Correia C., 2012, ACTA BIOMATER, V8, P2484
   Davidenko N, 2010, ACTA BIOMATER, V6, P3957, DOI 10.1016/j.actbio.2010.05.005
   Fan JC, 2009, B MATER SCI, V32, P521, DOI 10.1007/s12034-009-0077-x
   Fernandes LL, 2011, POLIMEROS, V21, P1, DOI 10.1590/S0104-14282011005000008
   Garcia-Fuentes M, 2009, BIOMATERIALS, V30, P5068, DOI 10.1016/j.biomaterials.2009.06.008
   Goy C., 2009, POLIMEROS, V19, P241
   Habraken W. J. E. M., 2007, ADV DRUG DELIV REV, V59, P239
   Hardy J. G., 2010, PROG POLYM SCI, V35, P1104
   Jayakumar R, 2011, INT J BIOL MACROMOL, V48, P336, DOI 10.1016/j.ijbiomac.2010.12.010
   Kundu B., 2012, ADV DRUG DELIV REV, V65, P463
   Kundu J, 2011, J BIOMAT SCI-POLYM E, V22, P519, DOI 10.1163/092050610X487864
   Liu HT, 2010, J APPL POLYM SCI, V117, P235, DOI 10.1002/app.31988
   Lorenzo CA, 2013, ADV DRUG DELIV REV, V65, P1148, DOI [10.1016/j.addr.2013.04.016, DOI 10.1016/J.ADDR.2013.04.016]
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Morimoto M, 2011, CARBOHYD POLYM, V84, P727, DOI 10.1016/j.carbpol.2010.03.035
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   MUZZARELLI RAA, 1980, ENZYME MICROB TECH, V2, P177, DOI 10.1016/0141-0229(80)90044-7
   Nunthanid J, 2001, DRUG DEV IND PHARM, V27, P143, DOI 10.1081/DDC-100000481
   Okhawilai M, 2010, INT J BIOL MACROMOL, V46, P544, DOI 10.1016/j.ijbiomac.2010.02.008
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Pasanphan W, 2008, J APPL POLYM SCI, V109, P38, DOI 10.1002/app.27953
   Pasanphan W, 2012, J APPL POLYM SCI, V123, P3309, DOI 10.1002/app.34919
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   Rao KSVK, 2012, CARBOHYD POLYM, V87, P920, DOI 10.1016/j.carbpol.2011.07.028
   Reiad NA, 2012, J ENVIRON SCI-CHINA, V24, P1425, DOI 10.1016/S1001-0742(11)60954-6
   She Z., 2008, POLYM DEGRAD STABIL, V93, P1318
   She ZD, 2008, J MATER SCI-MATER M, V19, P3545, DOI 10.1007/s10856-008-3526-y
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Tokatlian T, 2012, ACTA BIOMATER, V8, P3921, DOI 10.1016/j.actbio.2012.07.014
   Vasconcelos A., 2012, ACTA BIOMATER, V8, P3054
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vlierberghe S. V., 2011, BIOMACROMOLECULES, V12, P1395
   Wang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056330
   Xiao S., 2013, ADV POWDER IN PRESS
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yang C, 2010, CARBOHYD POLYM, V82, P1297, DOI 10.1016/j.carbpol.2010.07.013
   Yao RS, 2011, CARBOHYD POLYM, V85, P809, DOI 10.1016/j.carbpol.2011.03.055
   Zhang H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-117
   Zhang K., 2010, J BIOMED MATER RES, V95, P871
   Zhou JA, 2010, INT J BIOL MACROMOL, V47, P514, DOI 10.1016/j.ijbiomac.2010.07.010
   Zhou YS, 2013, INT J BIOL MACROMOL, V53, P88, DOI 10.1016/j.ijbiomac.2012.11.013
NR 47
TC 3
Z9 3
U1 1
U2 41
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
EI 2092-7673
J9 MACROMOL RES
JI Macromol. Res.
PD JUL
PY 2014
VL 22
IS 7
SI SI
BP 717
EP 724
DI 10.1007/s13233-014-2103-0
PG 8
WC Polymer Science
SC Polymer Science
GA AM3EO
UT WOS:000339735600006
DA 2018-10-20
ER

PT J
AU Doulabi, AH
   Mequanint, K
   Mohammadi, H
AF Doulabi, Azadehsadat Hashemi
   Mequanint, Kibret
   Mohammadi, Hadi
TI Blends and Nanocomposite Biomaterials for Articular Cartilage Tissue
   Engineering
SO MATERIALS
LA English
DT Review
DE blend; nanocomposite; biomaterial; articular cartilage; tissue
   engineering
ID MESENCHYMAL STEM-CELLS; POLYVINYL-ALCOHOL-HYDROGEL; CHONDROGENIC
   DIFFERENTIATION; MECHANICAL-PROPERTIES; IN-VITRO; CHONDROITIN SULFATE;
   BILAYERED SCAFFOLD; UNCONFINED COMPRESSION; BIODEGRADABLE POLYMERS;
   VISCOELASTIC BEHAVIOR
AB This review provides a comprehensive assessment on polymer blends and nanocomposite systems for articular cartilage tissue engineering applications. Classification of various types of blends including natural/natural, synthetic/synthetic systems, their combination and nanocomposite biomaterials are studied. Additionally, an inclusive study on their characteristics, cell responses ability to mimic tissue and regenerate damaged articular cartilage with respect to have functionality and composition needed for native tissue, are also provided.
C1 [Doulabi, Azadehsadat Hashemi; Mohammadi, Hadi] Univ British Columbia, Sch Engn, Fac Sci Appl, Kelowna, BC V1V 1V7, Canada.
   [Mequanint, Kibret] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
   [Mequanint, Kibret] Univ Western Ontario, Biomed Engn Grad Program, London, ON N6A 5B9, Canada.
   [Mohammadi, Hadi] Univ British Columbia, Biomed Engn Grad Program, Vancouver, BC V6T 1Z4, Canada.
RP Mohammadi, H (reprint author), Univ British Columbia, Sch Engn, Fac Sci Appl, Kelowna, BC V1V 1V7, Canada.
EM hashemi.azadeh@gmail.com; kmequani@uwo.ca; hadi.mohammadi@ubc.ca
OI Mequanint, Kibret/0000-0002-7888-418X
FU University of British Columbia; NSERC
FX The authors would like to thank the University of British Columbia
   (Startup Grant) and NSERC (Discovery Grant) for financially supporting
   this work.
CR Abedi G, 2011, J BIOMAT SCI-POLYM E, V22, P2445, DOI 10.1163/092050610X540503
   Ahn ES, 2001, NANO LETT, V1, P149, DOI 10.1021/nl0055299
   Aizawa Y, 2012, PROG POLYM SCI, V37, P645, DOI 10.1016/j.progpolymsci.2011.11.004
   AKIZUKI S, 1986, J ORTHOPAED RES, V4, P379, DOI 10.1002/jor.1100040401
   da Silva MLA, 2010, ACTA BIOMATER, V6, P1149, DOI 10.1016/j.actbio.2009.09.006
   Amanpour S, 2010, IRAN POLYM J, V19, P403
   Ateshian GA, 2004, J BIOMECH, V37, P391, DOI 10.1016/S0021-9290(03)00252-5
   Athanasiou K.A., 2009, SYNTHESIS LECT TISSU
   ATHANASOU NA, 1995, NEPHROL DIAL TRANSPL, V10, P1672
   Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694
   Bartlett Ii R.L., 2013, NANOMEDICINE, V9, P419
   Basalo IM, 2007, J BIOMECH, V40, P1847, DOI 10.1016/j.jbiomech.2006.07.007
   Bera B, 2009, SADHANA-ACAD P ENG S, V34, P823, DOI 10.1007/s12046-009-0048-3
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Bichara DA, 2010, J SURG RES, V163, P331, DOI 10.1016/j.jss.2010.03.070
   Bodugoz-Senturk H, 2009, BIOMATERIALS, V30, P589, DOI 10.1016/j.biomaterials.2008.10.010
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017
   Buchtova N, 2013, J MATER SCI-MATER M, V24, P1875, DOI 10.1007/s10856-013-4951-0
   Buckley MR, 2008, J BIOMECH, V41, P2430, DOI 10.1016/j.jbiomech.2008.05.021
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477
   BUCKWALTER JA, 1990, BRIS MYER Z, P19
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   Cai CB, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035001
   Campos DFD, 2012, CARTILAGE, V3, P205, DOI 10.1177/1947603512444722
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Casper ME, 2010, OSTEOARTHR CARTILAGE, V18, P981, DOI 10.1016/j.joca.2010.04.009
   Chen GP, 2004, BIOCHEM BIOPH RES CO, V322, P50, DOI 10.1016/j.bbrc.2004.07.071
   Chen GP, 2003, J BIOMED MATER RES A, V67A, P1170, DOI 10.1002/jbm.a.10164
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Cheung HY, 2007, COMPOS PART B-ENG, V38, P291, DOI 10.1016/j.compositesb.2006.06.014
   Chiang HS, 2009, J FORMOS MED ASSOC, V108, P87, DOI 10.1016/S0929-6646(09)60039-5
   Cho SH, 2009, J BIOMAT SCI-POLYM E, V20, P863, DOI 10.1163/156856209X444312
   Chou CH, 2007, J BIOMED MATER RES A, V82A, P757, DOI 10.1002/bjm.a.31186
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   Cohen B, 1998, J BIOMECH ENG-T ASME, V120, P491, DOI 10.1115/1.2798019
   Cohen NP, 1998, J ORTHOP SPORT PHYS, V28, P203, DOI 10.2519/jospt.1998.28.4.203
   Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Doulabi AH, 2013, MATER CHEM PHYS, V139, P515, DOI 10.1016/j.matchemphys.2013.01.051
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Engel E, 2008, TRENDS BIOTECHNOL, V26, P39, DOI 10.1016/j.tibtech.2007.10.005
   Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380
   Federico S, 2008, BIOMECH MODEL MECHAN, V7, P367, DOI 10.1007/s10237-007-0091-0
   Flik KR, 2007, CARTILAGE REPAIR STR, P1, DOI 10.1007/9781-59745343-1_1
   Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3
   Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0
   Getgood A, 2009, J BONE JOINT SURG BR, V91B, P565, DOI 10.1302/0301-620X.91B5.21832
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Gu Zheng-Qiu, 1998, Bio-Medical Materials and Engineering, V8, P75
   Gunatillake PA, 2003, EUR CELLS MATER, V20, P1
   Hashemi D., 2013, CARBOHYD POLYM, V92, P48, DOI DOI 10.1016/J.CARBP0L.2012.09.002.PUBMED
   HAUSELMANN HJ, 1992, MATRIX, V12, P116
   HEINEGARD D, 1989, FASEB J, V3, P2042
   Herzog W, 1998, J BIOMECH, V31, P1137, DOI 10.1016/S0021-9290(98)00136-5
   Hukins D.W.L., 1989, MAT PROPERTIES STRES, P44
   Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hunziker EB, 1997, MICROSC RES TECHNIQ, V37, P271
   Huyghe JM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049531
   Ibrahim NS, 2013, MATER LETT, V113, P25, DOI 10.1016/j.matlet.2013.09.026
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Johnstone B., 1999, CLIN ORTHOP RELAT R, V367, P156
   Jung Y, 2008, J BIOMAT SCI-POLYM E, V19, P61, DOI 10.1163/156856208783227712
   Kawamura S, 1998, ACTA ORTHOP SCAND, V69, P56, DOI 10.3109/17453679809002358
   KEMPSON GE, 1968, NATURE, V220, P1127, DOI 10.1038/2201127b0
   Kerin AJ, 1998, P I MECH ENG H, V212, P273, DOI 10.1243/0954411981534051
   Khademhosseini A, 2009, SCI AM, V300, P64, DOI 10.1038/scientificamerican0509-64
   Kim DD, 2011, STUD MECHANOBIOL TIS, V8, P329, DOI 10.1007/8415_2010_51
   Klein TJ, 2009, TISSUE ENG PART B-RE, V15, P143, DOI [10.1089/ten.teb.2008.0563, 10.1089/ten.TEB.2008.0563]
   Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Konst YE, 2012, KNEE SURG SPORT TR A, V20, P2263, DOI 10.1007/s00167-012-1891-z
   Kovach IS, 1996, BIOPHYS CHEM, V59, P61, DOI 10.1016/0301-4622(95)00115-8
   Kuo YC, 2010, ENG LIFE SCI, V10, P65, DOI 10.1002/elsc.200900048
   LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee CR, 2005, TISSUE ENG, V11, P1562, DOI 10.1089/ten.2005.11.1562
   Lee SY, 2009, ACTA BIOMATER, V5, P1919, DOI 10.1016/j.actbio.2009.02.014
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Lien SM, 2009, MAT SCI ENG C-BIO S, V29, P315, DOI 10.1016/j.msec.2008.07.017
   Lin LW, 2009, J BIOMED MATER RES A, V89A, P326, DOI 10.1002/jbm.a.31994
   Lin YC, 2009, ACTA BIOMATER, V5, P2591, DOI 10.1016/j.actbio.2009.03.038
   LINN FC, 1965, ARTHRITIS RHEUM-US, V8, P481, DOI 10.1002/art.1780080402
   Lopes JL, 2011, WEAR, V271, P2328, DOI 10.1016/j.wear.2010.12.042
   Lu Z., 2009, TISSUE ENG PART A, V16, P81
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Ma RY, 2010, J BIOMED MATER RES A, V93A, P1016, DOI 10.1002/jbm.a.32552
   Ma RY, 2009, MAT SCI ENG C-MATER, V29, P1979, DOI 10.1016/j.msec.2009.03.010
   MAK AF, 1986, J BIOMECH ENG-T ASME, V108, P123, DOI 10.1115/1.3138591
   Mankin H, 2000, ORTHOPAEDIC BASIC SC, V2, P443
   MAROUDAS A, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P166
   Martel-Pelletier J., 2010, OSTEOARTHR CARTILAGE, V18, P7
   Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   McMahon LA, 2008, ANN BIOMED ENG, V36, P185, DOI 10.1007/s10439-007-9416-5
   Meretoja VV, 2013, BIOMATERIALS, V34, P4266, DOI 10.1016/j.biomaterials.2013.02.064
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mimura T, 2008, OSTEOARTHR CARTILAGE, V16, P1083, DOI 10.1016/j.joca.2008.02.003
   Mohammadi H, 2013, P I MECH ENG H, V227, P402, DOI 10.1177/0954411912470239
   Mohan N, 2008, J BIOMED MATER RES B, V84B, P584, DOI 10.1002/jbm.b.30906
   Mohan N, 2010, J BIOMED MATER RES A, V94A, P146, DOI 10.1002/jbm.a.32680
   Moutos FT, 2008, BIORHEOLOGY, V45, P501, DOI 10.3233/BIR-2008-0491
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309
   MOW VC, 1984, J BIOMECH, V17, P377, DOI 10.1016/0021-9290(84)90031-9
   MOW VC, 1979, ANNU REV FLUID MECH, V11, P247, DOI 10.1146/annurev.fl.11.010179.001335
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Muzzarelli R. A. A., 2012, POLYM SCI COMPREHENS, V10, P153, DOI DOI 10.1016/B978-
   Muzzarelli RAA, 2012, CARBOHYD POLYM, V89, P723, DOI 10.1016/j.carbpol.2012.04.057
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nanda S, 2013, INDIAN J MAT SCI, V2013, DOI [10.1155/2013/516021, DOI 10.1155/2013/516021]
   Nesic D, 2006, ADV DRUG DELIVER REV, V58, P300, DOI 10.1016/j.addr.2006.01.012
   Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205
   O'Shea TM, 2008, TISSUE ENG PART B-RE, V14, P447, DOI 10.1089/ten.teb.2008.0327
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Oprenyeszk F, 2013, OSTEOARTHR CARTILAGE, V21, P1099, DOI 10.1016/j.joca.2013.04.017
   Pan YS, 2008, J MATER SCI-MATER M, V19, P1963, DOI 10.1007/s10856-007-3280-6
   Pan YS, 2007, J MATER SCI, V42, P5129, DOI 10.1007/s10853-006-1264-4
   Pan YS, 2010, J MATER SCI, V45, P5495, DOI 10.1007/s10853-010-4607-0
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   Patterson J., 2012, MATER TODAY, V13, P14
   Poole CA, 1997, J ANAT, V191, P1, DOI 10.1046/j.1469-7580.1997.19110001.x
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Qu D, 2011, J BIOMED MATER RES B, V96B, P9, DOI 10.1002/jbm.b.31697
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Responte Donald J., 2007, Critical Reviews in Biomedical Engineering, V35, P363
   Rhee SH, 2001, J AM CERAM SOC, V84, P459
   Sardinha VM, 2013, WEAR, V301, P218, DOI 10.1016/j.wear.2012.11.054
   Scholten PM, 2011, J BIOMED MATER RES A, V97A, P8, DOI 10.1002/jbm.a.33005
   Maiolo AS, 2012, MAT SCI ENG C-MATER, V32, P1490, DOI 10.1016/j.msec.2012.04.030
   Seo S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/806891
   Shi HC, 2012, MICRO NANO LETT, V7, P76, DOI 10.1049/mnl.2011.0628
   Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126
   Shirosaki Y, 2008, CHEM ENG J, V137, P122, DOI 10.1016/j.cej.2007.10.012
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Spadaccio C, 2009, ANN BIOMED ENG, V37, P1376, DOI 10.1007/s10439-009-9704-3
   STOCKWELL RA, 1971, J ANAT, V109, P411
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tamai N, 2005, OSTEOARTHR CARTILAGE, V13, P405, DOI 10.1016/j.joca.2004.12.014
   TARAVEL MN, 1993, BIOMATERIALS, V14, P930, DOI 10.1016/0142-9612(93)90135-O
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Thomson RC, 1995, ADV POLYM SCI, V122, P245
   Toh WS, 2011, STEM CELL REV REP, V7, P544, DOI 10.1007/s12015-010-9222-6
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   Trippel S.B., 1994, TRAUMATIC DISORDERS, P19
   UTRACKI LA, 1995, POLYM ENG SCI, V35, P2, DOI 10.1002/pen.760350103
   van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wang CC, 2011, BIOMATERIALS, V32, P7118, DOI 10.1016/j.biomaterials.2011.06.018
   Wang XH, 2004, BIOMATERIALS, V25, P3681, DOI 10.1016/j.biomaterials.2003.10.102
   WEISS C, 1968, J BONE JOINT SURG AM, VA 50, P663, DOI 10.2106/00004623-196850040-00002
   Wise JK, 2009, TISSUE ENG PT A, V15, P913, DOI 10.1089/ten.tea.2008.0109
   WOO SLY, 1976, J BIOMECH, V9, P785, DOI 10.1016/0021-9290(76)90186-X
   Yan JH, 2006, ARTIF CELL BLOOD SUB, V34, P27, DOI [10.1080/10731190500430024, 10.1080/107311090500430024]
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yang XQ, 2013, INT J BIOL MACROMOL, V61, P487, DOI 10.1016/j.ijbiomac.2013.07.021
   Yang YL, 2011, BIOMATERIALS, V32, P7932, DOI 10.1016/j.biomaterials.2011.07.018
   Yang Z, 2012, TISSUE ENG PT A, V18, P242, DOI [10.1089/ten.tea.2011.0315, 10.1089/ten.TEA.2011.0315]
   Zhang Lijie, 2009, Critical Reviews in Biomedical Engineering, V37, P1
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang YY, 2012, BIOMATERIALS, V33, P2926, DOI 10.1016/j.biomaterials.2012.01.006
   Zhu M, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/4/045005
NR 178
TC 22
Z9 22
U1 2
U2 71
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUL
PY 2014
VL 7
IS 7
BP 5327
EP 5355
DI 10.3390/ma7075327
PG 29
WC Materials Science, Multidisciplinary
SC Materials Science
GA AM6QM
UT WOS:000339989700021
PM 28788131
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Preslar, AT
   Parigi, G
   McClendon, MT
   Sefick, SS
   Moyer, TJ
   Haney, CR
   Waters, EA
   MacRenaris, KW
   Luchinat, C
   Stupp, SI
   Meade, TJ
AF Preslar, Adam T.
   Parigi, Giacomo
   McClendon, Mark T.
   Sefick, Samantha S.
   Moyer, Tyson J.
   Haney, Chad R.
   Waters, Emily A.
   MacRenaris, Keith W.
   Luchinat, Claudio
   Stupp, Samuel I.
   Meade, Thomas J.
TI Gd(III)-Labeled Peptide Nanofibers for Reporting on Biomaterial
   Localization in Vivo
SO ACS NANO
LA English
DT Article
DE self-assembly; peptide amphiphile; magnetic resonance imaging; contrast
   agent; biomaterials; nuclear magnetic relaxation dispersion
ID MRI CONTRAST AGENTS; NUCLEAR-SPIN RELAXATION; ELECTRON-SPIN;
   TRANSLATIONAL DIFFUSION; PARAMAGNETIC-COMPLEXES; AMPHIPHILE NANOFIBERS;
   SYSTEMS; RELAXIVITY; POLYMERS; SEQUENCE
AB Bioactive supramolecular nanostructures are of great importance in regenerative medicine and the development of novel targeted therapies. In order to use supramolecular chemistry to design such nanostructures, it is extremely important to track their fate in vivo through the use of molecular imaging strategies. Peptide amphiphiles (PAs) are known to generate a wide array of supramolecular nanostructures, and there is extensive literature on their use in areas such as tissue regeneration and therapies for disease. We report here on a series of PA molecules based on the well-established beta-sheet amino acid sequence V(3)A(3) conjugated to macrocyclic Gd(III) labels for magnetic resonance imaging (MRI). These conjugates were shown to form cylindrical supramolecular assemblies using cryogenic transmission electron microscopy and small-angle X-ray scattering. Using nuclear magnetic relaxation dispersion analysis, we observed that thermal annealing of the nanostructures led to a decrease in water exchange lifetime (tau(m)) of hundreds of nanoseconds only for molecules that self-assemble into nanofibers of high aspect ratio. We interpret this decrease to indicate more solvent exposure to the paramagnetic moiety on annealing, resulting in faster water exchange within angstroms of the macrocycle. We hypothesize that faster water exchange in the nanofiber-forming PAs arises from the dehydration and increase in packing density on annealing. Two of the self-assembling conjugates were selected for imaging PAs after intramuscular injections of the PA C(16)V(3)A(3)E(3)-NH2 in the tibialis anterior muscle of a murine model. Needle tracts were dearly discernible with MRI at 4 days postinjection. This work establishes Gd(III) macrocycle-conjugated peptide amphiphiles as effective tracking agents for peptide amphiphile materials in vivo over the timescale of days.
C1 [Preslar, Adam T.; McClendon, Mark T.; Sefick, Samantha S.; Moyer, Tyson J.; Stupp, Samuel I.] Northwestern Univ, Dept Chem Mat Sci & Engn, Evanston, IL 60208 USA.
   [Preslar, Adam T.; McClendon, Mark T.; Sefick, Samantha S.; Moyer, Tyson J.; Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Evanston, IL 60208 USA.
   [McClendon, Mark T.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Preslar, Adam T.; MacRenaris, Keith W.; Meade, Thomas J.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
   [Preslar, Adam T.; MacRenaris, Keith W.; Meade, Thomas J.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.
   [Preslar, Adam T.; MacRenaris, Keith W.; Meade, Thomas J.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.
   [Preslar, Adam T.; MacRenaris, Keith W.; Meade, Thomas J.] Northwestern Univ, Dept Radiol, Evanston, IL 60208 USA.
   [Parigi, Giacomo; Luchinat, Claudio] Univ Florence, Magnet Resonance Ctr CERM, I-50019 Sesto Fiorentino, Italy.
   [Parigi, Giacomo; Luchinat, Claudio] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy.
RP Stupp, SI (reprint author), Northwestern Univ, Dept Chem Mat Sci & Engn, 2145 Sheridan Rd, Evanston, IL 60208 USA.
EM s-stupp@northwestern.edu; tmeade@northwestern.edu
RI Stupp, Samuel/B-6737-2009; Parigi, Giacomo/A-4329-2018; Haney,
   Chad/A-3909-2008; Waters, Emily/B-1023-2009
OI Parigi, Giacomo/0000-0002-1989-4644; Haney, Chad/0000-0001-5981-2925;
   Waters, Emily/0000-0003-3479-6054; Luchinat, Claudio/0000-0003-2271-8921
FU National Institutes of Health's (NIH) National Heart, Lung and Blood
   Institute [P01HL108795]; Nation Institute of Biomedical Imaging and
   Engineering [EB005866]; National Cancer Institute Center for Cancer
   Nanotechnology Excellence initiative at Northwestern University
   [U54CA151880]; Ente Cassa di Risparmio di Firenze; European Commission
   [261863]; U.S. DOE [DE-AC02-06CH11357]
FX The authors gratefully acknowledge funding from National Institutes of
   Health's (NIH) National Heart, Lung and Blood Institute, under award
   P01HL108795, the Nation Institute of Biomedical Imaging and Engineering,
   under award EB005866, and the National Cancer Institute Center for
   Cancer Nanotechnology Excellence initiative at Northwestern University
   Award No. U54CA151880. NMRD work was supported by the Ente Cassa di
   Risparmio di Firenze, and the European Commission contract Bio-NMR No.
   261863. The Center for Advanced Molecular Imaging (CAMI) and the
   Quantitative Bioelemental Imaging Center (QBIC) at Northwestern provided
   instrumentation for in vivo studies. Compound purification and
   characterization was performed at the Institute for BioNanotechnology in
   Medicine (IBNAM) and the Integrated Molecular Structure Education and
   Research Center (IMSERC). The Biological Imaging Facility (BIF) and Keck
   Biophysics facilities at Northwestern, Magnetic Resonance Center (CERM)
   at the University of Florence, provided further instrumentation used in
   this work. Argonne National Lab's Advanced Photon Source (APS)
   Synchrotron was used to acquire small-angle X-ray scatter data. APS
   operates under the Department of Energy's Office of Science as a user
   facility. SAXS experiments were carried out at the
   DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT). DND-CAT is
   located at sector 5 of the APS and is a joint venture between The Dow
   Chemical Company, Northwestern University, and E.I. DuPont de Nemours &
   Company. Use of the Advanced Photon Source, an Office of Science User
   Facility operated for the U.S. Department of Energy (DOE) Office of
   Science by Argonne National Laboratory, was supported by the U.S. DOE
   under Contract No. DE-AC02-06CH11357. M. Allegrozzi (University of
   Florence) is acknowledged for NMRD sample preparation, S. Weigand
   (Argonne National Laboratory) for SAXS assistance, L. Palmer for helpful
   discussions, and M. Seniw for the preparation of graphics.
CR Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962
   Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   BERTINI I, 1995, J PHYS CHEM-US, V99, P14217, DOI 10.1021/j100039a006
   BERTINI I, 1995, J MAGN RESON SER A, V113, P151, DOI 10.1006/jmra.1995.1074
   Bertini I, 1999, J CHEM PHYS, V111, P5795, DOI 10.1063/1.479876
   Bull SR, 2005, NANO LETT, V5, P1, DOI 10.1021/nl0484898
   Bull SR, 2005, BIOCONJUGATE CHEM, V16, P1343, DOI 10.1021/bc050153h
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   Caravan P, 2007, INORG CHEM, V46, P6632, DOI 10.1021/ic700686k
   Frullano L, 2007, J BIOL INORG CHEM, V12, P939, DOI 10.1007/s00775-007-0265-3
   Ghosh A, 2012, J AM CHEM SOC, V134, P3647, DOI 10.1021/ja211113n
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hung AH, 2013, J PHYS CHEM C, V117, P16263, DOI 10.1021/jp406909b
   HWANG LP, 1975, J CHEM PHYS, V63, P4017, DOI 10.1063/1.431841
   Karfeld-Sulzer LS, 2011, MAGN RESON MED, V65, P220, DOI 10.1002/mrm.22587
   Karfeld-Sulzer LS, 2010, BIOMACROMOLECULES, V11, P1429, DOI 10.1021/bm901378a
   Kirchin Miles A, 2003, Top Magn Reson Imaging, V14, P426, DOI 10.1097/00002142-200310000-00007
   Kowalewski J, 2005, ADV INORG CHEM, V57, P41, DOI 10.1016/S0898-8838(04)57002-8
   Kowalewski J, 2002, J PHYS CHEM A, V106, P7376, DOI 10.1021/jp020608p
   Kruk D, 2001, PHYS CHEM CHEM PHYS, V3, P4907, DOI 10.1039/b106659p
   Lee S. S., 2012, BIOMATERIALS, P452
   Li WH, 2002, INORG CHEM, V41, P4018, DOI 10.1021/ic0200390
   Major JL, 2007, P NATL ACAD SCI USA, V104, P13881, DOI 10.1073/pnas.0706247104
   Manus LM, 2010, NANO LETT, V10, P484, DOI 10.1021/nl903264h
   Mastarone DJ, 2011, J AM CHEM SOC, V133, P5329, DOI 10.1021/ja1099616
   Matosziuk LM, 2013, INORG CHEM, V52, P12250, DOI 10.1021/ic400681j
   MERBACH AE, 2001, CHEM CONTRAST AGENTS
   MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0
   Nam KT, 2010, NAT MATER, V9, P454, DOI [10.1038/nmat2742, 10.1038/NMAT2742]
   Newcomb CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4321
   Ortony JH, 2014, NAT MATER, V13, P812, DOI [10.1038/NMAT3979, 10.1038/nmat3979]
   Palmer LC, 2008, ACCOUNTS CHEM RES, V41, P1674, DOI 10.1021/ar8000926
   Pashuck ET, 2010, J AM CHEM SOC, V132, P8819, DOI 10.1021/ja100613w
   Pashuck ET, 2010, J AM CHEM SOC, V132, P6041, DOI 10.1021/ja908560n
   POLNASZEK CF, 1984, J CHEM PHYS, V81, P4038, DOI 10.1063/1.448147
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Song Y, 2009, ANGEW CHEM INT EDIT, V48, P9143, DOI 10.1002/anie.200904666
   Storrie H, 2007, BIOMATERIALS, V28, P4608, DOI 10.1016/j.biomaterials.2007.06.026
   Stupp S. I., 2013, CHEM MATER, V26, P507
   TWEEDLE MF, 1991, MAGN RESON IMAGING, V9, P409, DOI 10.1016/0730-725X(91)90429-P
   Tweedle MF, 1997, EUR RADIOL, V7, pS225, DOI 10.1007/PL00006897
   Webber MJ, 2010, J INTERN MED, V267, P71, DOI 10.1111/j.1365-2796.2009.02184.x
   Webber MJ, 2013, ISR J CHEM, V53, P530, DOI 10.1002/ijch.201300046
   Webber MJ, 2011, P NATL ACAD SCI USA, V108, P13438, DOI 10.1073/pnas.1016546108
   Webber MJ, 2010, J TISSUE ENG REGEN M, V4, P600, DOI 10.1002/term.273
   Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031
   Zech SG, 2005, CHEMPHYSCHEM, V6, P2570, DOI 10.1002/cphc.200500250
   Zech SG, 2007, INORG CHEM, V46, P3576, DOI 10.1021/ic070011u
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
NR 51
TC 30
Z9 30
U1 0
U2 76
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD JUL
PY 2014
VL 8
IS 7
BP 7325
EP 7332
DI 10.1021/nn502393u
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AL9LR
UT WOS:000339463100090
PM 24937195
OA Green Accepted, Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Caliari, SR
   Harley, BAC
AF Caliari, Steven R.
   Harley, Brendan A. C.
TI Structural and Biochemical Modification of a Collagen Scaffold to
   Selectively Enhance MSC Tenogenic, Chondrogenic, and Osteogenic
   Differentiation
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTOR SUPPLEMENTATION; SYNOVIAL JOINT
   FORMATION; GAG SCAFFOLDS; IN-VITRO; EXTRACELLULAR-MATRIX; CROSS-LINKING;
   GLYCOSAMINOGLYCAN SCAFFOLD; BONE INSERTION; ROTATOR CUFF
AB Biomaterial approaches for engineering orthopedic interfaces such as the tendon-bone junction (TBJ) are limited by a lack of understanding of how insoluble (microstructure, composition) and soluble regulators of stem cell fate work in concert to promote bioactivity and differentiation. One strategy for regenerating the interface is to design biomaterials containing spatially graded structural properties sufficient to induce divergent mesenchymal stem cell (MSC) differentiation into multiple interface-specific phenotypes. This work explores the hypothesis that selective structural modification to a 3D collagen-glycosaminoglycan (CG) scaffold combined with biochemical supplementation can drive human bone-marrow-derived MSC differentiation down tenogenic, osteogenic, and chondrogenic lineages. Tenogenic differentiation is enhanced in geometrically anisotropic scaffolds versus a standard isotropic control. Notably, blebbistatin treatment abrogates this microstructurally driven effect. Further, enhanced osteogenic differentiation and new mineral synthesis are achieved by incorporation of a calcium phosphate mineral phase within the CG scaffold along with the use of osteogenic induction media. Finally, chondrogenic differentiation is optimally driven by combining chondrogenic induction media with a reduced density scaffold that promotes increased cellular condensation, significantly higher expression of chondrogenic genes, and increased GAG deposition. Together these data provide critical insight regarding design rules for elements of an integrated biomaterial platform for orthopedic interface regeneration.
C1 [Caliari, Steven R.; Harley, Brendan A. C.] Univ Illinois, Roger Adams Lab 104, Urbana, IL 61801 USA.
RP Harley, BAC (reprint author), Univ Illinois, Roger Adams Lab 104, 600 S Mathews St, Urbana, IL 61801 USA.
EM bharley@illinois.edu
OI Harley, Brendan/0000-0001-5458-154X; Caliari, Steven/0000-0002-7506-3079
FU National Science Foundation [1105300]; National Institute of Arthritis
   and Musculoskeletal and Skin Diseases of the National Institutes of
   Health [R21 AR063331, R03 AR062811]; Chemistry-Biology Interface
   Training Program NIH NIGMS [T32GM070421]; Chemical and Biomolecular
   Engineering Dept.; Institute for Genomic Biology (BAH) at the University
   of Illinois at Urbana-Champaign
FX The authors would like to acknowledge Daniel Weisgerber (MSE, UIUC) for
   fabrication of mineralized CG scaffolds, Donna Epps (IGB, UIUC) for
   assistance with histology, William Grier and Ji Sun Choi (CHBE, UIUC)
   for assistance with Western blots, Dr. Mayandi Sivaguru (IGB, UIUC) for
   assistance with confocal microscopy, and the IGB Core Facilities for
   assistance with real-time PCR. This material is based upon work
   supported by the National Science Foundation under Grant No. 1105300.
   Research reported in this publication was supported by the National
   Institute of Arthritis and Musculoskeletal and Skin Diseases of the
   National Institutes of Health under Award Numbers R21 AR063331 and R03
   AR062811. The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the National
   Institutes of Health. The authors are also grateful for the funding for
   this study provided by the Chemistry-Biology Interface Training Program
   NIH NIGMS T32GM070421 (SRC) as well as the Chemical and Biomolecular
   Engineering Dept. (BAH), and the Institute for Genomic Biology (BAH) at
   the University of Illinois at Urbana-Champaign.
CR Andalib MN, 2013, ACTA BIOMATER, V9, P7737, DOI 10.1016/j.actbio.2013.04.013
   Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997
   Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108
   Boileau P, 2005, J BONE JOINT SURG AM, V87A, P1229, DOI 10.2106/JBJS.D.02035
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Cheng XG, 2008, BIOMATERIALS, V29, P3278, DOI 10.1016/j.biomaterials.2008.04.028
   Choi JS, 2012, BIOMATERIALS, V33, P4460, DOI 10.1016/j.biomaterials.2012.03.010
   Costa MA, 2006, TISSUE ENG, V12, P1937, DOI 10.1089/ten.2006.12.1937
   Curtin CM, 2012, ADV MATER, V24, P749, DOI 10.1002/adma.201103828
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Date H, 2010, J ORTHOP RES, V28, P225, DOI 10.1002/jor.20981
   Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016
   Duffy GP, 2011, EUR CELLS MATER, V21, P15, DOI 10.22203/eCM.v021a02
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Galatz L, 2007, J ORTHOP RES, V25, P1621, DOI 10.1002/jor.20441
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Genin GM, 2009, BIOPHYS J, V97, P976, DOI 10.1016/j.bpj.2009.05.043
   Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704
   Hagerty P, 2012, BIOMATERIALS, V33, P6355, DOI 10.1016/j.biomaterials.2012.05.045
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Harley BAC, 2008, CHEM ENG J, V137, P102, DOI 10.1016/j.cej.2007.09.009
   Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Juncosa-Melvin N, 2006, TISSUE ENG, V12, P2291, DOI 10.1089/ten.2006.12.2291
   Kang YQ, 2011, BIOMATERIALS, V32, P6119, DOI 10.1016/j.biomaterials.2011.05.015
   Kapoor A, 2010, ACTA BIOMATER, V6, P2580, DOI 10.1016/j.actbio.2009.12.047
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415
   Lovati AB, 2012, INT J ARTIF ORGANS, V35, P996, DOI 10.5301/ijao.5000129
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Millar NL, 2009, CLIN ORTHOP RELAT R, V467, P966, DOI 10.1007/s11999-009-0706-0
   Moffat KL, 2008, P NATL ACAD SCI USA, V105, P7947, DOI 10.1073/pnas.0712150105
   Moffat KL, 2009, CLIN SPORT MED, V28, P157, DOI 10.1016/j.csm.2008.08.006
   Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004
   Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Park A, 2010, TISSUE ENG PT A, V16, P2941, DOI 10.1089/ten.tea.2009.0710
   Pauly S, 2010, EUR CELLS MATER, V20, P84, DOI 10.22203/eCM.v020a08
   Paxton JZ, 2012, TISSUE ENG PT A, V18, P277, DOI [10.1089/ten.tea.2011.0336, 10.1089/ten.TEA.2011.0336]
   Rowland CR, 2013, BIOMATERIALS, V34, P5802, DOI 10.1016/j.biomaterials.2013.04.027
   Sheehy EJ, 2013, ACTA BIOMATER, V9, P5484, DOI 10.1016/j.actbio.2012.11.008
   Shen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077613
   Subramony SD, 2013, BIOMATERIALS, V34, P1942, DOI 10.1016/j.biomaterials.2012.11.012
   Thomopoulos S, 2005, J HAND SURG-AM, V30A, P441, DOI 10.1016/j.jhsa.2004.12.006
   Thomopoulos S, 2003, J ORTHOPAED RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3
   Thomopoulos S, 2006, J BIOMECH, V39, P1842, DOI 10.1016/j.jbiomech.2005.05.021
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Vickers SM, 2010, J ORTHOP RES, V28, P1184, DOI 10.1002/jor.21113
   Weisgerber DW, 2013, J MECH BEHAV BIOMED, V28, P26, DOI 10.1016/j.jmbbm.2013.07.016
   Wopenka B, 2008, APPL SPECTROSC, V62, P1285, DOI 10.1366/000370208786822179
   Xu BY, 2012, J CELL PHYSIOL, V227, P2722, DOI 10.1002/jcp.23016
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
   Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083
   Zhou JA, 2011, ACTA BIOMATER, V7, P3999, DOI 10.1016/j.actbio.2011.06.040
NR 67
TC 34
Z9 35
U1 3
U2 49
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUL
PY 2014
VL 3
IS 7
BP 1086
EP 1096
DI 10.1002/adhm.201300646
PG 11
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA AM0QE
UT WOS:000339549900017
PM 24574180
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lindhe, J
   Cecchinato, D
   Donati, M
   Tomasi, C
   Liljenberg, B
AF Lindhe, Jan
   Cecchinato, Denis
   Donati, Mauro
   Tomasi, Cristiano
   Liljenberg, Birgitta
TI Ridge preservation with the use of deproteinized bovine bone mineral
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; bone formation; extraction socket; grafting; humans
ID HUMAN EXTRACTION SOCKETS; TOOTH EXTRACTION; BIO-OSS(R) COLLAGEN;
   AUTOLOGOUS BONE; TISSUE; DOG; SITES; AUGMENTATION; RESORPTION; DYNAMICS
AB Objective: The aim was to examine the tissue composition of extraction sockets that had been grafted with deproteinized bovine bone mineral and allowed to heal for 6 months.
   Material and methods: Twenty-five subjects with one tooth each scheduled for extraction and replacement with dental implants were recruited. The assigned teeth were carefully removed. The site/patient was thereafter allocated to a test or a control group. In the test group patients, Bio-Oss (R) Collagen was placed to fill the fresh extraction socket while in the controls no grafting was performed. After about 6 months of healing, a biopsy was sampled from the center of the extraction site. The specimens were decalcified, embedded in paraffin, sectioned, and stained in HTX. The proportions occupied by mineralized bone, osteoid, bone marrow, fibrous tissue, and Bio-Oss (R) particles were determined by morphometric point counting.
   Results: Mineralized bone made up 57.4 +/- 12.4% of the control sites (C) and 48.9 +/- 8.5% of the T1 sites (graft material not included). The amount of bone marrow (C: 7.1 +/- 6.1%, T1: 2.1 +/- 3.1%) and osteoid (C: 7.3 +/- 4.9%, T1: 1.9 +/- 2.1%) was about five times greater in the control than in the test sites. Fibrous tissue comprised 23.1 +/- 16.3% (C) and 40.0 +/- 11.9% (T1). I n the T2 sites (graft material included), the percentage mineralized bone was 39.9 +/- 8.6 while the proportions of bone marrow and osteoid were 1.8 +/- 2.5% and 1.6 +/- 1.8%. Fibrous tissue occupied 32.4 +/- 9.2% and Bio-Oss (R) particles 19.0 +/- 6.5% of the T2 sites.
   Conclusion: Placement of the biomaterial in the fresh extraction socket retarded healing. The Bio-Oss (R) particles were not resorbed but became surrounded by new bone. This may explain why grafted extraction sites may fail to undergo dimensional change.
C1 [Lindhe, Jan; Donati, Mauro; Tomasi, Cristiano; Liljenberg, Birgitta] Univ Gothenburg, Inst Odontol, Sahlgrenska Acad, Gothenburg, Sweden.
   [Cecchinato, Denis] Inst Franci, I-35125 Padua, Italy.
RP Cecchinato, D (reprint author), Inst Franci, Via Guizza 256, I-35125 Padua, Italy.
EM denis@deniscecchinato.it
RI Tomasi, Cristiano/B-4096-2008
OI Tomasi, Cristiano/0000-0002-3610-6574; DONATI, Mauro/0000-0002-6856-0237
CR Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   ATWOOD DA, 1963, J PROSTHET DENT, V13, P810, DOI 10.1016/0022-3913(63)90225-7
   ATWOOD DA, 1962, J PROSTHET DENT, V12, P441, DOI 10.1016/0022-3913(62)90125-7
   BECKER W, 1994, J PERIODONTOL, V65, P1128, DOI 10.1902/jop.1994.65.12.1128
   Becker W, 1996, J PERIODONTOL, V67, P1025, DOI 10.1902/jop.1996.67.10.1025
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   CARLSSON GE, 1967, ACTA ODONTOL SCAND, V25, P1
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   Gross Jeffrey, 1995, General Dentistry, V43, P364
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   JOHNSON K, 1969, Australian Dental Journal, V14, P241
   Johnson K, 1963, AUST DENT J, V8, P428
   Lindgren C, 2012, INT J ORAL MAX IMPL, V27, P1151
   Lindhe J, 2013, CLIN ORAL IMPLAN RES, V24, P372, DOI 10.1111/clr.12064
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   TALLGREN A, 1966, Acta Odontologica Scandinavica, V24, P195, DOI 10.3109/00016356609026127
   TALLGREN ANTJE, 1957, ACTA ODONTOL SCAND, V15, P1
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
NR 27
TC 34
Z9 36
U1 2
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUL
PY 2014
VL 25
IS 7
BP 786
EP 790
DI 10.1111/clr.12170
PG 5
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA AL8KR
UT WOS:000339388000005
PM 23556467
DA 2018-10-20
ER

PT J
AU Abdulmajeed, AA
   Walboomers, XF
   Massera, J
   Kokkari, AK
   Vallittu, PK
   Narhi, TO
AF Abdulmajeed, Aous A.
   Walboomers, X. F.
   Massera, Jonathan
   Kokkari, Anne K.
   Vallittu, Pekka K.
   Narhi, Timo O.
TI Blood and fibroblast responses to thermoset BisGMA-TEGDMA/glass
   fiber-reinforced composite implants in vitro
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE blood clotting; fiber-reinforced composite; human gingival fibroblasts;
   implant abutment; platelets adhesion; soft tissue attachment;
   trypsinization
ID SURFACE-ROUGHNESS; CELL-ADHESION; TITANIUM; PROLIFERATION;
   COMPATIBILITY; WETTABILITY; BIOMATERIAL; ORIENTATION; EXPANSION; DEFECTS
AB Objectives: This in vitro study was designed to evaluate both blood and human gingival fibroblast responses on fiber-reinforced composite (FRC) aimed to be used as oral implant abutment material.
   Material and methods: Two different types of substrates were investigated: (a) Plain polymer (BisGMA 50%-TEGDMA 50%) and (b) FRC. The average surface roughness (Ra) was measured using spinning-disk confocal microscope. The phase composition was identified using X-ray diffraction analyzer. The degree of monomer conversion (DC%) was determined using FTIR spectrometry. The blood response, including the blood-clotting ability and platelet adhesion morphology, was evaluated. Fibroblast cell responses were studied in cell culture environment using routine test conditions.
   Results: The Ra of the substrates investigated was less than 0.1 mu m with no signs of surface crystallization. The DC% was 89.1 +/- 0.5%. The FRC substrates had a shorter clotting time and higher platelets activation state than plain polymer substrates. The FRC substrates showed higher (P < 0.01-0.001) amount of adhered cells than plain polymer substrates at all time points investigated. The strength of attachment was evaluated using serial trypsinization, the number of cells detached from FRC substrates was 59 +/- 5%, whereas those detached from the plane polymer substrates was 70 +/- 5%, indicating a stronger (P < 0.01) cell attachment on the FRC surfaces. Fibroblasts grew more efficiently on FRC than on plain polymer substrates, showing significantly higher (P < 0.01) cell metabolic activities throughout the experiment.
   Conclusions: The presence of E-glass fibers enhances blood and fibroblast responses on composite surfaces in vitro.
C1 [Abdulmajeed, Aous A.; Kokkari, Anne K.; Narhi, Timo O.] Univ Turku, Inst Dent, Dept Prosthet Dent, FI-20520 Turku, Finland.
   [Abdulmajeed, Aous A.; Kokkari, Anne K.; Vallittu, Pekka K.; Narhi, Timo O.] Univ Turku, TCBC, Turku, Finland.
   [Abdulmajeed, Aous A.] Univ Turku, Inst Dent, Finnish Doctoral Program Oral Sci FINDOS, Turku, Finland.
   [Walboomers, X. F.] Radboud Univ Nijmegen Med Ctr, Dept Biomat, Coll Dent Sci, Nijmegen, Netherlands.
   [Massera, Jonathan] Abo Akad Univ, Proc Chem Ctr, Turku, Finland.
   [Vallittu, Pekka K.] Univ Turku, Inst Dent, Dept Biomat Sci, Turku, Finland.
   [Vallittu, Pekka K.] Univ Turku, BioCity Turku Biomat Res Program, Turku, Finland.
   [Narhi, Timo O.] Turku Univ Cent Hosp, Clin Oral Dis, Turku, Finland.
RP Abdulmajeed, AA (reprint author), Univ Turku, Inst Dent, Dept Prosthet Dent, Lemminkaisenkatu 2, FI-20520 Turku, Finland.
EM aoabdu@utu.fi
RI Walboomers, X.Frank/B-3692-2013
OI Massera, Jonathan/0000-0002-1099-8420
CR Abdulmajeed A.A., 2011, INT J BIOMATER, V2011
   Abdulmajeed AA, 2011, DENT MATER, V27, P313, DOI 10.1016/j.dental.2010.11.007
   Andrade J D, 1973, Med Instrum, V7, P110
   Anttila EJ, 2008, DENT MATER, V24, P1720, DOI 10.1016/j.dental.2008.07.006
   Ballo AM, 2009, CLIN ORAL IMPLAN RES, V20, P608, DOI 10.1111/j.1600-0501.2008.01700.x
   Ballo A.M., 2008, THESIS U TURKU TURKU
   Ballo Ahmed, 2008, J Contemp Dent Pract, V9, P41
   Ballo AM, 2007, J MATER SCI-MATER M, V18, P2025, DOI 10.1007/s10856-007-3159-6
   Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x
   BUSSCHER HJ, 1984, COLLOID SURFACE, V9, P319, DOI 10.1016/0166-6622(84)80175-4
   Cho CS, 1996, J BIOMED MATER RES, V32, P425, DOI 10.1002/(SICI)1097-4636(199611)32:3<425::AID-JBM16>3.0.CO;2-F
   Davies John E, 2003, J Dent Educ, V67, P932
   Dyer SR, 2004, DENT MATER, V20, P947, DOI 10.1016/j.dental.2003.12.003
   Eggers G, 2005, MAGN RESON MATER PHY, V18, P103, DOI 10.1007/s10334-005-0101-0
   FERRACANE JL, 1995, CRIT REV ORAL BIOL M, V6, P302, DOI 10.1177/10454411950060040301
   Fuentes GG, 2011, NUCL INSTRUM METH B, V269, P111, DOI 10.1016/j.nimb.2010.11.026
   GOODMAN SL, 1984, SEM 1984, V1, P279
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hautaamaki MP, 2008, ACTA ORTHOP, V79, P555, DOI 10.1080/17453670710015571
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   Kamel EM, 2003, EUR RADIOL, V13, P724, DOI 10.1007/s00330-002-1564-2
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   MACDOUGALL M, 1998, AM J DENT, V11, P11
   Mattila RH, 2009, ACTA BIOMATER, V5, P1639, DOI 10.1016/j.actbio.2009.01.020
   Meretoja VV, 2010, J BIOMED MATER RES A, V95A, P269, DOI 10.1002/jbm.a.32829
   Oshida Y., 1994, Bio-Medical Materials and Engineering, V4, P397
   Park JY, 2000, CLIN ORAL IMPLAN RES, V11, P530, DOI 10.1034/j.1600-0501.2000.011006530.x
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   SCHAKENRAAD JM, 1988, CELL BIOPHYS, V13, P75, DOI 10.1007/BF02797367
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SHARMA CP, 1984, J COLLOID INTERF SCI, V97, P585, DOI 10.1016/0021-9797(84)90332-1
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1045, DOI 10.1002/jbm.820250902
   Tezvergil A, 2003, DENT MATER, V19, P471, DOI 10.1016/S0109-5641(02)00092-1
   Travan A, 2012, BIOMACROMOLECULES, V13, P1564, DOI 10.1021/bm3002683
   Travan A, 2010, BIOMACROMOLECULES, V11, P583, DOI 10.1021/bm9011419
   Tuusa SMR, 2008, J BIOMED MATER RES B, V84B, P510, DOI 10.1002/jbm.b.30898
   WENNERBERG A, 1996, THESIS U GOTEBORG GO
   Zhao DS, 2009, MED ENG PHYS, V31, P461, DOI 10.1016/j.medengphy.2008.11.006
NR 41
TC 8
Z9 8
U1 1
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUL
PY 2014
VL 25
IS 7
BP 843
EP 851
DI 10.1111/clr.12151
PG 9
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA AL8KR
UT WOS:000339388000014
PM 23590531
DA 2018-10-20
ER

PT J
AU Kabir, MA
   Murata, M
   Kusano, K
   Zakaria, SM
   Noor, AM
   Khuda, F
   Hossain, I
   Sultana, S
   Saito, T
AF Kabir, Md. Arafat
   Murata, Masaru
   Kusano, Koaru
   Zakaria, Sayed Mohammad
   Noor, Abu Hena Mohammad
   Khuda, Fazle
   Hossain, Iqbal
   Sultana, Shamima
   Saito, Takashi
TI Radiological Evaluation of Human Dentin Autografts in Bangladesh
SO JOURNAL OF HARD TISSUE BIOLOGY
LA English
DT Article
DE Human; Demineralized dentin matrix; Bone regeneration; Autograft
ID BONE MORPHOGENETIC PROTEIN; IN-VITRO; INDUCTION; TOOTH; TISSUES; MATRIX;
   DIFFERENTIATION
AB In Dhaka 2013, autografts of demineralized dentin matrix (DDM) were first used as bone regenerative therapy with two patients in Bangladesh. In Case 1, a 29 year-old male presented with an infected periapical lesion involving #11 and #12. Root canal treatment followed by periapical surgery were done to remove the lesion. Tooth-derived granules were prepared from a vital non-functional tooth (#38) by hand-operated crush method, demineralized in 2 % HNO3 for 30 min and washed vigorously. DDM was grafted in the bone defect after the extirpation of the lesion. At 1 year after DDM graft, post-operative radiography indicated excellent bone healing by remodeling with dentin matrix. The pathological diagnosis was radicular granuloma. In Case 2, a 20 year-old female presented with a mesially inclined impacted 3rd molar (#48). Extraction of the impacted tooth and the autograft of the DDM were done simultaneously. Post-operative radiographs showed the extracted socket healed fully with new bone. The patient-own DDM granules from non-functional teeth could be recycled as osteoinductive materials for local bone regeneration. This works suggest that dentin might become a realistic alternative biomaterial to bone.
C1 [Kabir, Md. Arafat; Murata, Masaru; Kusano, Koaru] Hlth Sci Univ Hokkaido, Sch Dent, Div Oral & Maxillofacial Surg, Sapporo, Hokkaido, Japan.
   [Zakaria, Sayed Mohammad; Hossain, Iqbal] Pioneer Dent Coll & Hosp, Dept Oral & Maxillofacial Surg, Dhaka, Bangladesh.
   [Noor, Abu Hena Mohammad; Khuda, Fazle] Japan Bangla Dent Care, Dhaka, Bangladesh.
   [Sultana, Shamima; Saito, Takashi] Hlth Sci Univ Hokkaido, Sch Dent, Div Clin Cariol & Endodontol, Sapporo, Hokkaido, Japan.
RP Murata, M (reprint author), Hlth Sci Univ Hokkaido, Div Oral & Maxillofacial Surg, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan.
EM murata@hoku-iryo-u.ac.jp
CR Albrektsson T., 2001, EUR SPINE J, V10, P96
   BANG G, 1967, ARCH SURG-CHICAGO, V94, P781
   BASSETT CA, 1961, NATURE, V190, P460, DOI 10.1038/190460a0
   BESSHO K, 1990, J ORAL MAXIL SURG, V48, P162, DOI 10.1016/S0278-2391(10)80204-6
   BRIGHTON CT, 1971, J BONE JOINT SURG AM, VA 53, P719, DOI 10.2106/00004623-197153040-00011
   BUTLER WT, 1977, J DENT RES, V56, P228, DOI 10.1177/00220345770560030601
   FINKELMAN RD, 1990, J BONE MINER RES, V5, P717
   Fujita M, 2014, ADVANCES IN ORAL TISSUE ENGINEERING, P31
   HUGGINS C, 1970, J EXP MED, V132, P1250, DOI 10.1084/jem.132.6.1250
   KAWAI T, 1989, J DENT RES, V68, P1069, DOI 10.1177/00220345890680060301
   Murata M, 1998, INT J ORAL MAX SURG, V27, P391, DOI 10.1016/S0901-5027(98)80071-4
   Murata M, 2003, J DENT RES, V82, pB243
   Murata M, 2009, BIOCERAMICS, V22, P745
   Murata M., 2013, ADV BIOMATERIALS SCI, P391
   Murata M, 2010, J CERAM SOC JPN, V118, P438, DOI 10.2109/jcersj2.118.438
   Murata M, 2010, J CERAM SOC JPN, V118, P434, DOI 10.2109/jcersj2.118.434
   Reddi A H, 1974, Adv Biol Med Phys, V15, P1
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   YEOMANS JD, 1967, ARCH ORAL BIOL, V12, P999, DOI 10.1016/0003-9969(67)90095-7
NR 19
TC 0
Z9 0
U1 0
U2 2
PU JOURNAL HARD TISSUE BIOLOGY
PI MINATO KU
PA NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO
   106-0031, JAPAN
SN 1341-7649
J9 J HARD TISSUE BIOL
JI J. Hard Tissue Biol.
PD JUL
PY 2014
VL 23
IS 3
BP 363
EP 369
PG 7
WC Engineering, Biomedical
SC Engineering
GA AL9KR
UT WOS:000339460500013
DA 2018-10-20
ER

PT J
AU Pascaretti-Grizon, F
   Libouban, H
   Camprasse, G
   Camprasse, S
   Mallet, R
   Chappard, D
AF Pascaretti-Grizon, Florence
   Libouban, Helene
   Camprasse, Georges
   Camprasse, Serge
   Mallet, Romain
   Chappard, Daniel
TI The interface between nacre and bone after implantation in the sheep: a
   nanotomographic and Raman study
SO JOURNAL OF RAMAN SPECTROSCOPY
LA English
DT Article
DE nacre; bone; orthopedic device; nanotomography; Raman analysis
ID OSTEOBLASTS MAINTAINED INVITRO; IN-VITRO; CORTICAL BONE; MARROW; TISSUE;
   BIOMINERALIZATION; MINERALIZATION; COMPLICATIONS; OSTEOPOROSIS; BIOPSIES
AB Orthopedic bone devices can be prepared from the shells of giant pearl oysters. Nacre is biocompatible and composed of calcium carbonate (aragonite). Direct welding of bone onto the biomaterial surface has been reported but poorly investigated. Nacre from Pinctada maxima was used to prepare plates, screws and rods. Five sheep were implanted in the first metatarsus under general anesthesia and killed 2 months later. Bones were harvested and fixed in formalin. Analysis was performed by nanotomography and histology after embedding in poly(methyl methacrylate). Polished sections were imaged by scanning electron microscopy then analyzed on a Raman microscope. Nanotomography and histology evidenced the newly apposed bone composed of thin trabeculae with a lower mineralization than mature bone. Erosion of the nacre was also easily observed. The bone/nacre interface presented a characteristic toothed-comb appearance. Raman spectroscopy identified the typical bands of aragonite (1091 and 711 cm(-1)) in the devices. At a distance from the interface, the bone matrix presented the typical bands of hydroxyapatite at 960, 1044 and 594-610 cm(-1) with the amide bands of collagen at 1250 cm(-1). At the bone/nacre interface, a phosphate-rich layer was observed without proteins. The newly formed bone units exhibited a band at 1075 cm(-1) corresponding to a high amount of B-carbonate substitution. The carbonate/phosphate ratio decreased between new and mature bone, and crystallinity was improved. Raman spectroscopy confirmed the modifications of the bone matrix around the nacre implant and the direct apposition of bone without an interposing organic layer between the calcium carbonate (nacre) and the calcium phosphate (hydroxyapatite). Copyright (C) 2014 John Wiley & Sons, Ltd.
C1 [Pascaretti-Grizon, Florence; Libouban, Helene; Mallet, Romain; Chappard, Daniel] LUNAM Univ, GEROM Grp Etud Remodelage Osseux & BioMat LHEA, IRIS IBS Inst Biol Sante, CHU Angers, F-49933 Angers, France.
   [Mallet, Romain; Chappard, Daniel] LUNAM Univ, SCIAM, IRIS IBS Inst Biol Sante, CHU Angers, F-49933 Angers, France.
   [Camprasse, Georges; Camprasse, Serge] MEGA BIO PHARMA, F-91560 Crosne, France.
RP Chappard, D (reprint author), LUNAM Univ Nantes Angers Le Mans, GEROM LHEA, IRIS IBS Inst Biol Sante, CHU Angers, F-49933 Angers, France.
EM daniel.chappard@univ-angers.fr
FU Contrat Region Pays de la Loire: Bioregos2 program
FX This work was made possible by grants from Contrat Region Pays de la
   Loire: Bioregos2 program. Many thanks are given to Mrs Lechat for
   secretarial assistance.
CR Akkus O, 2004, BONE, V34, P443, DOI 10.1016/j.bone.2003.11.003
   Akkus O, 2003, J BONE MINER RES, V18, P1012, DOI 10.1359/jbmr.2003.18.6.1012
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019
   Bohic S, 2000, BONE, V26, P341, DOI 10.1016/S8756-3282(99)00276-8
   Boivin G, 2003, OSTEOPOROSIS INT, V14, pS19, DOI 10.1007/s00198-002-1347-2
   CAMPRASSE S, 1990, Clinical Materials, V5, P235, DOI 10.1016/0267-6605(90)90022-N
   Chappard D, 2011, OSTEOPOROSIS INT, V22, P2225, DOI 10.1007/s00198-011-1573-6
   Chappard D., 2008, Morphologie, V92, P162, DOI 10.1016/j.morpho.2008.10.003
   Cognet JM, 2003, REV CHIR ORTHOP, V89, P346
   Delattre O., 1997, EUR J ORTHOP SURG TR, V7, P143
   Duplat D, 2007, BIOMATERIALS, V28, P2155, DOI 10.1016/j.biomaterials.2007.01.015
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Freeman JJ, 2001, CALCIFIED TISSUE INT, V68, P156, DOI 10.1007/s002230001206
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Hamza S., 2012, APPL SURF SCI, V246, P485
   HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175
   Lamghari M, 2001, BIOMATERIALS, V22, P555, DOI 10.1016/S0142-9612(00)00213-1
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Lopez E., 1991, IMPLANTODONTIE, V3, P13
   Milet C, 2004, CR PALEVOL, V3, P493, DOI 10.1016/j.crpv.2004.07.010
   Misof BM, 2003, J CLIN ENDOCR METAB, V88, P1150, DOI 10.1210/jc.2002-021988
   Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217
   MullerMai C, 1996, J MATER SCI-MATER M, V7, P479, DOI 10.1007/BF00705429
   Park S, 2013, J CRANIOFAC SURG, V24, P1021, DOI 10.1097/SCS.0b013e31827fee09
   Paschalis EP, 1997, CALCIFIED TISSUE INT, V61, P480, DOI 10.1007/s002239900371
   Roschger P, 1998, BONE, V23, P319, DOI 10.1016/S8756-3282(98)00112-4
   Rousseau M, 2005, BIOMATERIALS, V26, P6254, DOI 10.1016/j.biomaterials.2005.03.028
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814
   Xiang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066564
   Yoon SJ, 2008, TISSUE ENG PT A, V14, P539, DOI 10.1089/tea.2007.0129
NR 34
TC 7
Z9 7
U1 4
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0377-0486
EI 1097-4555
J9 J RAMAN SPECTROSC
JI J. Raman Spectrosc.
PD JUL
PY 2014
VL 45
IS 7
SI SI
BP 558
EP 564
DI 10.1002/jrs.4506
PG 7
WC Spectroscopy
SC Spectroscopy
GA AL8WH
UT WOS:000339420000012
DA 2018-10-20
ER

PT J
AU Marean-Reardon, C
   Reardon, P
   Squier, T
   McAteer, K
AF Marean-Reardon, Carrie
   Reardon, Patrick
   Squier, Thomas
   McAteer, Kathleen
TI Characterization Of A Novel Synthetic Biomaterial For Protein
   Immobilization
SO PROTEIN SCIENCE
LA English
DT Meeting Abstract
CT 28th Annual Symposium of the Protein-Society
CY JUL 27-30, 2014
CL San Diego, CA
SP Prot Soc, Bristol Myers Squibb, Lilly, Biochemistry
C1 [Marean-Reardon, Carrie; McAteer, Kathleen] Washington State Univ, Richland, WA USA.
   [Reardon, Patrick] Pacific NW Natl Lab, Washington, DC USA.
   [Squier, Thomas] Western Univ Hlth Sci, Lebanon, OR USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0961-8368
EI 1469-896X
J9 PROTEIN SCI
JI Protein Sci.
PD JUL
PY 2014
VL 23
SU 1
MA 12-158
BP 128
EP 128
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AM0OU
UT WOS:000339545700148
DA 2018-10-20
ER

PT J
AU Twal, WO
   Klatt, SC
   Harikrishnan, K
   Gerges, E
   Cooley, MA
   Trusk, TC
   Zhou, BR
   Gabr, MG
   Shazly, T
   Lessner, SM
   Markwald, RR
   Argraves, WS
AF Twal, Waleed O.
   Klatt, Sandra C.
   Harikrishnan, Keerthi
   Gerges, Ebtesam
   Cooley, Marion A.
   Trusk, Thomas C.
   Zhou, Boran
   Gabr, Mohamed G.
   Shazly, Tarek
   Lessner, Susan M.
   Markwald, Roger R.
   Argraves, W. Scott
TI Cellularized Microcarriers as Adhesive Building Blocks for Fabrication
   of Tubular Tissue Constructs
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Macroporous microcarriers; Cultispher; Tissue engineering; Isotropic;
   Elastic; Biomaterial; Elastin; Collagen; Endothelial cells; Vascular
   smooth muscle cells; Replacement blood vessels
ID HUMAN ADIPOSE-TISSUE; ENGINEERED VASCULAR GRAFTS; MESENCHYMAL
   STEM-CELLS; FULL-THICKNESS-WOUNDS; MACROPOROUS MICROCARRIERS;
   ENDOTHELIAL-CELLS; ELASTIC FIBERS; ATHYMIC RATS; IN-VIVO; KERATINOCYTES
AB To meet demands of vascular reconstruction, there is a need for prosthetic alternatives to natural blood vessels. Here we explored a new conduit fabrication approach. Macroporous, gelatin microcarriers laden with human umbilical vein endothelial cells and aortic smooth muscle cells were dispensed into tubular agarose molds and found to adhere to form living tubular tissues. The ability of cellularized microcarriers to adhere to one another involved cellular and extracellular matrix bridging that included the formation of epithelium-like cell layers lining the lumenal and ablumenal surfaces of the constructs and the deposition of collagen and elastin fibers. The tubular tissues behaved as elastic solids, with a uniaxial mechanical response that is qualitatively similar to that of native vascular tissues and consistent with their elastin and collagen composition. Linearized measures of the mechanical response of the fabricated tubular tissues at both low and high strains were observed to increase with duration of static culture, with no significant loss of stiffness following decellularization. The findings highlight the utility of cellularized macroporous gelatin microcarriers as self-adhering building blocks for the fabrication of living tubular structures.
C1 [Twal, Waleed O.; Klatt, Sandra C.; Harikrishnan, Keerthi; Gerges, Ebtesam; Cooley, Marion A.; Trusk, Thomas C.; Markwald, Roger R.; Argraves, W. Scott] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.
   [Zhou, Boran; Gabr, Mohamed G.; Shazly, Tarek; Lessner, Susan M.] Univ S Carolina, Coll Engn & Comp, Biomed Engn Program, Columbia, SC 29208 USA.
   [Shazly, Tarek] Univ S Carolina, Dept Mech Engn, Coll Engn & Comp, Columbia, SC 29208 USA.
   [Lessner, Susan M.] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA.
RP Argraves, WS (reprint author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave,BSB 653, Charleston, SC 29425 USA.
EM argraves@musc.edu
OI Lessner, Susan/0000-0002-8409-5216
FU National Science Foundation/EPSCoR Grant [EPS-0903795]; NSF
   [CMMI-1200358]
FX This work was supported by the National Science Foundation/EPSCoR Grant
   (EPS-0903795) and by NSF CMMI-1200358. We thank Dr. Amy Bradshaw for
   providing expert advice on Picrosirius red staining and polarized light
   microscopy. We thank Michael Gore (University of South Carolina School
   of Medicine) for his fabrication of templates.
CR Auxenfans C, 2012, J TISSUE ENG REGEN M, V6, P512, DOI 10.1002/term.454
   Bashur CA, 2012, TISSUE ENG PART B-RE, V18, P203, DOI [10.1089/ten.teb.2011.0521, 10.1089/ten.TEB.2011.0521]
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Borschel GH, 2005, TISSUE ENG, V11, P778, DOI 10.1089/ten.2005.11.778
   Bradshaw AD, 2009, AM J PHYSIOL-HEART C, V298, pH614
   Buttafoco L, 2006, BIOMATERIALS, V27, P2380, DOI 10.1016/j.biomaterials.2005.10.017
   Chen MQ, 2011, BIOMATERIALS, V32, P7532, DOI 10.1016/j.biomaterials.2011.06.054
   Clark J M, 1981, Ann N Y Acad Sci, V369, P33, DOI 10.1111/j.1749-6632.1981.tb14175.x
   Clavijo-Alvarez JA, 2007, PLAST RECONSTR SURG, V119, P1839, DOI 10.1097/01.prs.0000260232.43019.a0
   Desai M, 2011, EUR J CARDIO-THORAC, V40, P394, DOI 10.1016/j.ejcts.2010.11.050
   Dutt K, 2003, TISSUE ENG, V9, P893, DOI 10.1089/107632703322495547
   Eldardiri M, 2012, TISSUE ENG PT A, V18, P587, DOI [10.1089/ten.tea.2011.0258, 10.1089/ten.TEA.2011.0258]
   Epstein AJ, 2011, JAMA-J AM MED ASSOC, V305, P1769, DOI 10.1001/jama.2011.551
   Faury G, 2001, PATHOL BIOL, V49, P310, DOI 10.1016/S0369-8114(01)00147-X
   Gustafson CJ, 2007, BURNS, V33, P726, DOI 10.1016/j.burns.2006.10.382
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Hirtenstein M, 1980, Dev Biol Stand, V46, P109
   HOEVE CAJ, 1974, BIOPOLYMERS, V13, P677, DOI 10.1002/bip.1974.360130404
   KERN PA, 1983, J CLIN INVEST, V71, P1822, DOI 10.1172/JCI110937
   Kielty CM, 2007, PHILOS T R SOC B, V362, P1293, DOI 10.1098/rstb.2007.2134
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Kim SS, 2005, J BIOMED MATER RES B, V75B, P369, DOI 10.1002/jbm.b.30302
   L'Heureux N, 1998, FASEB J, V12, P47
   Lee KW, 2011, P NATL ACAD SCI USA, V108, P2705, DOI 10.1073/pnas.1017834108
   LILLIE MA, 1994, CONNECT TISSUE RES, V31, P23, DOI 10.3109/03008209409005632
   Lillie MA, 1998, CONNECT TISSUE RES, V37, P121, DOI 10.3109/03008209809028905
   Lin K, 2008, CYTOTHERAPY, V10, P417, DOI 10.1080/14653240801982979
   Lippens E, 2010, TISSUE ENG PT A, V16, P617, DOI [10.1089/ten.tea.2009.0418, 10.1089/ten.TEA.2009.0418]
   Liu JY, 2004, WOUND REPAIR REGEN, V12, P148, DOI 10.1111/j.1067-1927.2004.012205.x
   Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3
   Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009
   Martin Y, 2011, TISSUE ENG PART B-RE, V17, P71, DOI 10.1089/ten.TEB.2010.0559
   Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281
   Mei Y, 2010, J BIOTECHNOL, V150, P438, DOI 10.1016/j.jbiotec.2010.09.953
   MIGNOT G, 1990, CYTOTECHNOLOGY, V4, P163, DOI 10.1007/BF00365097
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Naito Y, 2011, ADV DRUG DELIVER REV, V63, P312, DOI 10.1016/j.addr.2011.03.001
   NIKOLAI TJ, 1992, ENZYME MICROB TECH, V14, P203, DOI 10.1016/0141-0229(92)90067-X
   Palmiero C, 2010, ACTA BIOMATER, V6, P2548, DOI 10.1016/j.actbio.2010.01.026
   ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681
   Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103
   Seif-Naraghi SB, 2011, J CARDIOVASC TRANSL, V4, P545, DOI 10.1007/s12265-011-9293-z
   Seland H, 2011, BURNS, V37, P99, DOI 10.1016/j.burns.2010.03.014
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   VANWEZEL AL, 1967, NATURE, V216, P64, DOI 10.1038/216064a0
   Voigt M, 1999, TISSUE ENG, V5, P563, DOI 10.1089/ten.1999.5.563
   Wang XW, 2007, WORLD J SURG, V31, P682, DOI 10.1007/s00268-006-0731-z
   Yang Y, 2011, J BIOMED MATER RES A, V99A, P74, DOI 10.1002/jbm.a.33155
   Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047
   Zou Y, 2009, ANN BIOMED ENG, V37, P1572, DOI 10.1007/s10439-009-9724-z
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 51
TC 8
Z9 8
U1 0
U2 28
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2014
VL 42
IS 7
SI SI
BP 1470
EP 1481
DI 10.1007/s10439-013-0883-6
PG 12
WC Engineering, Biomedical
SC Engineering
GA AL2ZY
UT WOS:000338995900011
PM 23943070
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Sengupta, D
   Waldman, SD
   Li, S
AF Sengupta, Debanti
   Waldman, Stephen D.
   Li, Song
TI From In Vitro to In Situ Tissue Engineering
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Biomaterials; In situ; In vitro; Tissue engineering; Translational
   medicine
ID ELECTROSPUN NANOFIBROUS SCAFFOLDS; STEM-CELL DIFFERENTIATION;
   ENDOTHELIAL GROWTH-FACTOR; THERAPEUTIC ANGIOGENESIS; 3-DIMENSIONAL
   HYDROGELS; MACROPHAGE PHENOTYPE; BIOACTIVE HYDROGELS;
   CONTROLLED-RELEASE; SUSTAINED-RELEASE; ISCHEMIC DISEASE
AB In vitro tissue engineering enables the fabrication of functional tissues for tissue replacement. In addition, it allows us to build useful physiological and pathological models for mechanistic studies. However, the translation of in vitro tissue engineering into clinical therapies presents a number of technical and regulatory challenges. It is possible to circumvent the complexity of developing functional tissues in vitro by taking an in situ tissue engineering approach that uses the body as a native bioreactor to regenerate tissues. This approach harnesses the innate regenerative potential of the body and directs the appropriate cells to the site of injury. This review surveys the biomaterial-, cell-, and chemical factor-based strategies to engineer tissue in vitro and in situ.
C1 [Sengupta, Debanti; Li, Song] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Waldman, Stephen D.] Queens Univ, Dept Chem Engn, Dept Mech & Mat Engn, Kingston, ON K7L 3N6, Canada.
RP Li, S (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
EM debanti@berkeley.edu; song_li@berkeley.edu
OI Waldman, Stephen/0000-0001-6987-6973
FU Siebel Post-doctoral Fellowship; National Institute of Health
   [EB012240]; California Institute of Regenerative Medicine [RB3-05232]
FX This work is supported in part by a Siebel Post-doctoral Fellowship (to
   D. S.), a grant from the National Institute of Health (EB012240 to S.
   L.), and a grant from the California Institute of Regenerative Medicine
   (RB3-05232to S.L.).
CR Allaire E, 1997, SURGERY, V122, P73, DOI 10.1016/S0039-6060(97)90267-1
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Balachandran K, 2006, ANN BIOMED ENG, V34, P1655, DOI 10.1007/s10439-006-9167-8
   Beckstead BL, 2006, J BIOMED MATER RES A, V79A, P94, DOI 10.1002/jbm.a.30760
   BILLINGHAM RE, 1952, BRIT J PLAST SURG, V5, P25, DOI 10.1016/S0007-1226(52)80004-9
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Burczak K, 1996, BIOMATERIALS, V17, P2351, DOI 10.1016/S0142-9612(96)00076-2
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Chen L, 2010, J MATER SCI-MATER M, V21, P309, DOI 10.1007/s10856-009-3827-9
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Christensen LH, 2003, PLAST RECONSTR SURG, V111, P1883, DOI 10.1097/01.PRS.0000056873.87165.5A
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   DeForest CA, 2012, ANNU REV CHEM BIOMOL, V3, P421, DOI 10.1146/annurev-chembioeng-062011-080945
   Elcin YM, 2001, ARTIF ORGANS, V25, P558, DOI 10.1046/j.1525-1594.2001.025007558.x
   Ellis AJ, 1996, HEPATOLOGY, V24, P1446, DOI 10.1053/jhep.1996.v24.pm0008938179
   Engler A. J., 2005, BIOM ENG SOC ANN FAL
   Fischbach C, 2007, BIOMATERIALS, V28, P2069, DOI 10.1016/j.biomaterials.2006.12.029
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Henry TD, 2001, AM HEART J, V142, P872, DOI 10.1067/mhj.2001.118471
   Hoerstrup SP, 2000, TISSUE ENG, V6, P75, DOI 10.1089/107632700320919
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   JACKMAN RJ, 1995, SCIENCE, V269, P664, DOI 10.1126/science.7624795
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393
   Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319
   Kurpinski KT, 2010, BIOMATERIALS, V31, P3536, DOI 10.1016/j.biomaterials.2010.01.062
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Law B, 2006, BIOMACROMOLECULES, V7, P1261, DOI 10.1021/bm050920f
   Lee BLP, 2012, ACTA BIOMATER, V8, P2648, DOI 10.1016/j.actbio.2012.04.023
   Li S, 2014, WIRES SYST BIOL MED, V6, P61, DOI 10.1002/wsbm.1246
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Liau B, 2011, BIOMATERIALS, V32, P9180, DOI 10.1016/j.biomaterials.2011.08.050
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05
   Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Morishita M, 2007, J CONTROL RELEASE, V118, P177, DOI 10.1016/j.jconrel.2006.12.022
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Nerem R M, 1995, Tissue Eng, V1, P3, DOI 10.1089/ten.1995.1.3
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Pashuck E. T., 2012, SCI TRANSL MED, V4
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ruan MZ, 2013, SCI TRANSL MED, V5
   Schumacher B, 1998, CIRCULATION, V97, P645, DOI 10.1161/01.CIR.97.7.645
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Sengupta D, 2012, ADV HEALTHC MATER, V1, P785, DOI 10.1002/adhm.201200195
   Stock UA, 2006, BIOMATERIALS, V27, P1, DOI 10.1016/j.biomaterials.2005.05.100
   Straley KS, 2009, ADV MATER, V21, P4148, DOI 10.1002/adma.200901865
   Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0
   Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0
   Telemeco TA, 2005, ACTA BIOMATER, V1, P377, DOI 10.1016/j.actbio.2005.04.006
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
NR 83
TC 14
Z9 14
U1 1
U2 37
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2014
VL 42
IS 7
SI SI
BP 1537
EP 1545
DI 10.1007/s10439-014-1022-8
PG 9
WC Engineering, Biomedical
SC Engineering
GA AL2ZY
UT WOS:000338995900017
PM 24809723
DA 2018-10-20
ER

PT J
AU Bishop, CJ
   Kim, J
   Green, JJ
AF Bishop, Corey J.
   Kim, Jayoung
   Green, Jordan J.
TI Biomolecule Delivery to Engineer the Cellular Microenvironment for
   Regenerative Medicine
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Tissue engineering; Controlled drug delivery; Biomaterial; Cell therapy;
   Gene delivery
ID GROWTH-FACTOR DELIVERY; MARROW STROMAL CELLS; SPINAL-CORD-INJURY;
   STEM-CELLS; GENE-THERAPY; IN-VIVO; BONE REGENERATION; POLYMERIC
   NANOPARTICLES; PROGENITOR CELLS; SCAFFOLD DESIGN
AB To realize the potential of regenerative medicine, controlling the delivery of biomolecules in the cellular microenvironment is important as these factors control cell fate. Controlled delivery for tissue engineering and regenerative medicine often requires bioengineered materials and cells capable of spatiotemporal modulation of biomolecule release and presentation. This review discusses biomolecule delivery from the outside of the cell inwards through the delivery of soluble and insoluble biomolecules as well as from the inside of the cell outwards through gene transfer. Ex vivo and in vivo therapeutic strategies are discussed, as well as combination delivery of biomolecules, scaffolds, and cells. Various applications in regenerative medicine are highlighted including bone tissue engineering and wound healing.
C1 [Bishop, Corey J.; Kim, Jayoung; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Inst Nanobiotechnol, Dept Biomed Engn, Baltimore, MD 21231 USA.
   [Bishop, Corey J.; Kim, Jayoung; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol & Neurosurg, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21231 USA.
RP Green, JJ (reprint author), Johns Hopkins Univ, Sch Med, Dept Ophthalmol & Neurosurg, 400 North Broadway, Baltimore, MD 21231 USA.
EM green@jhu.edu
FU National Institutes of Health [R01EB016721-01, R21CA152473]
FX NSF GRF: DGE-0707427 to CJB and Samsung Scholarship to JK. This work was
   also supported in part by the National Institutes of Health
   (R01EB016721-01 and R21CA152473).
CR Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268
   Baraniak PR, 2011, BIOMATERIALS, V32, P3062, DOI 10.1016/j.biomaterials.2010.12.037
   Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537
   Behravesh E, 2003, J BIOMED MATER RES A, V66A, P698, DOI 10.1002/jbm.a.10003
   Bhatia SN, 1998, BIOTECHNOL PROGR, V14, P378, DOI 10.1021/bp980036j
   Blum JS, 2003, HUM GENE THER, V14, P1689, DOI 10.1089/104303403322611719
   Cha C, 2012, ACS NANO, V6, P9353, DOI 10.1021/nn304773b
   Chiu DT, 2000, P NATL ACAD SCI USA, V97, P2408, DOI 10.1073/pnas.040562297
   Cowan DB, 1998, CIRC RES, V82, P786, DOI 10.1161/01.RES.82.7.786
   Das H, 2009, CELL TRANSPLANT, V18, P305, DOI 10.3727/096368909788534870
   Davis HE, 2011, BIOTECHNOL BIOENG, V108, P2727, DOI 10.1002/bit.23227
   De Laporte L, 2010, ACTA BIOMATER, V6, P2889, DOI 10.1016/j.actbio.2010.02.018
   Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Filareto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2550
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001
   Fujisato T, 1996, BIOMATERIALS, V17, P155, DOI 10.1016/0142-9612(96)85760-7
   Gelse K, 2003, ARTHRITIS RHEUM, V48, P430, DOI 10.1002/art.10759
   GERTLER A, 1970, CAN J BIOCHEM CELL B, V48, P384, DOI 10.1139/o70-061
   Haider HK, 2004, J MOL MED-JMM, V82, P539, DOI 10.1007/s00109-004-0546-z
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105
   Jiang T, 2010, ACTA BIOMATER, V6, P3457, DOI 10.1016/j.actbio.2010.03.023
   Johnson MR, 2011, CLIN ORTHOP RELAT R, V469, P3111, DOI 10.1007/s11999-011-2012-x
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kim HK, 2009, TISSUE ENG PT A, V15, P923, DOI 10.1089/ten.tea.2007.0407
   Kimelman-Bleich N, 2011, MOL THER, V19, P53, DOI 10.1038/mt.2010.190
   Kircheis R, 2001, GENE THER, V8, P28, DOI 10.1038/sj.gt.3301351
   Kofron MD, 2004, CURR OPIN BIOTECH, V15, P399, DOI 10.1016/j.copbio.2004.07.004
   Lemarchand C, 2004, EUR J PHARM BIOPHARM, V58, P327, DOI 10.1016/j.ejpb.2004.02.016
   Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177
   Liu DC, 1996, P NATL ACAD SCI USA, V93, P7832, DOI 10.1073/pnas.93.15.7832
   Lorentz KM, 2012, BIOMATERIALS, V33, P494, DOI 10.1016/j.biomaterials.2011.09.088
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0
   Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755
   Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301
   Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013
   Musah S, 2012, ACS NANO, V6, P10168, DOI 10.1021/nn3039148
   Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Park HJ, 2012, BIOMATERIALS, V33, P9148, DOI 10.1016/j.biomaterials.2012.09.005
   Park J, 2007, BIOMATERIALS, V28, P2772, DOI 10.1016/j.biomaterials.2007.012.009
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ramirez F, 2003, MATRIX BIOL, V22, P101, DOI 10.1016/S0945-053X(03)00002-7
   Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ridewood W. G., 1898, P ZOOL SOC LOND, V66, P101
   Rives CB, 2009, BIOMATERIALS, V30, P394, DOI 10.1016/j.biomaterials.2008.09.013
   Rothstein SN, 2009, BIOMATERIALS, V30, P1657, DOI 10.1016/j.biomaterials.2008.12.002
   Rufaihah AJ, 2010, REGEN MED, V5, P231, DOI 10.2217/RME.09.83
   Rusk N, 2007, NAT METHODS, V4, P684, DOI 10.1038/nmeth0907-684a
   Santos T, 2012, ACS NANO, V6, P10463, DOI 10.1021/nn304541h
   Seol YJ, 2012, SOFT MATTER, V8, P1730, DOI 10.1039/c1sm06863f
   Serda RE, 2011, BBA-GEN SUBJECTS, V1810, P317, DOI 10.1016/j.bbagen.2010.05.004
   Seshadri G, 2010, BIOMATERIALS, V31, P1372, DOI 10.1016/j.biomaterials.2009.10.045
   Sheyn D, 2008, STEM CELLS, V26, P1056, DOI 10.1634/stemcells.2007-0858
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Simoes S, 2000, BBA-BIOMEMBRANES, V1463, P459, DOI 10.1016/S0005-2736(99)00238-2
   Spallanzani L, 1769, PHYSIKALISCHE MATH A
   Sun QH, 2010, PHARM RES-DORD, V27, P264, DOI 10.1007/s11095-009-0014-0
   Sunshine JC, 2011, THER DELIV, V2, P493, DOI 10.4155/TDE.11.14
   Tang MD, 2003, J AM CHEM SOC, V125, P12988, DOI 10.1021/ja037677h
   TORCHILIN VP, 1995, ADV DRUG DELIVER REV, V16, P141, DOI 10.1016/0169-409X(95)00022-Y
   TREMBLEY A, 1744, MEMOIRES SERVIR HIST
   Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9
   Wang X, 2013, BIOMATERIALS, V34, P2865, DOI 10.1016/j.biomaterials.2013.01.021
   Wojtowicz AM, 2010, TISSUE ENG PT A, V16, P2795, DOI [10.1089/ten.tea.2010.0025, 10.1089/ten.TEA.2010.0025]
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yang F, 2010, P NATL ACAD SCI USA, V107, P3317, DOI 10.1073/pnas.0905432106
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yazici C, 2011, MOL THER, V19, P1416, DOI 10.1038/mt.2010.294
   Ye L, 2011, BIOMATERIALS, V32, P2424, DOI 10.1016/j.biomaterials.2010.12.008
   Yilgor P, 2010, J MATER SCI-MATER M, V21, P2999, DOI 10.1007/s10856-010-4150-1
   Zhao MZ, 2006, J CEREBR BLOOD F MET, V26, P1176, DOI 10.1038/sj.jcbfm.9600273
NR 92
TC 5
Z9 5
U1 0
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2014
VL 42
IS 7
SI SI
BP 1557
EP 1572
DI 10.1007/s10439-013-0932-1
PG 16
WC Engineering, Biomedical
SC Engineering
GA AL2ZY
UT WOS:000338995900019
PM 24170072
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Chang, HM
   Wang, ZH
   Luo, HN
   Xu, M
   Ren, XY
   Zheng, GX
   Wu, BJ
   Zhang, XH
   Lu, XY
   Chen, F
   Jing, XH
   Wang, L
AF Chang, H. M.
   Wang, Z. H.
   Luo, H. N.
   Xu, M.
   Ren, X. Y.
   Zheng, G. X.
   Wu, B. J.
   Zhang, X. H.
   Lu, X. Y.
   Chen, F.
   Jing, X. H.
   Wang, L.
TI Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)-based scaffolds for tissue
   engineering
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE PHBHHx; Tissue engineering; Biomaterial
ID MESENCHYMAL STEM-CELLS; SILK FIBROIN; MICROBIAL POLYHYDROXYALKANOATES;
   PHYSICOCHEMICAL PROPERTIES; MECHANICAL-PROPERTIES; PHBHHX NANOPARTICLES;
   CARTILAGE; BIOCOMPATIBILITY; GROWTH; CHONDROCYTES
AB Development and selection of an ideal scaffold is of importance for tissue engineering. Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) is a biocompatible bioresorbable copolymer that belongs to the polyhydroxyalkanoate family. Because of its good biocompatibility, PHBHHx has been widely used as a cell scaffold for tissue engineering. This review focuses on the utilization of PHBHHx-based scaffolds in tissue engineering. Advances in the preparation, modification, and application of PHBHHx scaffolds are discussed.
C1 [Chang, H. M.] Xian Med Univ, Affiliated Hosp, Dept Otolaryngol Head & Neck Surg, Xian, Peoples R China.
   [Wang, Z. H.; Luo, H. N.; Xu, M.; Ren, X. Y.; Zheng, G. X.; Wu, B. J.; Zhang, X. H.; Chen, F.; Jing, X. H.; Wang, L.] Xi An Jiao Tong Univ, Hosp 2, Dept Otolaryngol Head & Neck Surg, Xian 710004, Peoples R China.
   [Lu, X. Y.] Xi An Jiao Tong Univ, Sch Life Sci, Xian 710004, Peoples R China.
RP Wang, ZH (reprint author), Xi An Jiao Tong Univ, Hosp 2, Dept Otolaryngol Head & Neck Surg, Xian 710004, Peoples R China.
EM wangzhenghui77@mail.xjtu.edu.cn; ehui4298@163.com
FU Natural Science Foundation of China [81000416]; Fundamental Research
   Funds for the Central Universities; Funds for the Second Hospital of
   Xi'an Jiaotong University
FX Research supported by the Natural Science Foundation of China
   (#81000416), the Fundamental Research Funds for the Central Universities
   (2011) and the Funds for the Second Hospital of Xi'an Jiaotong
   University (2011, 2012, 2013).
CR Bian YZ, 2009, BIOMATERIALS, V30, P217, DOI 10.1016/j.biomaterials.2008.09.036
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Chen GQ, 2005, KEY ENG MAT, V288-289, P437, DOI 10.4028/www.scientific.net/KEM.288-289.437
   Chen WH, 2012, ACTA BIOMATER, V8, P540, DOI 10.1016/j.actbio.2011.09.026
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9
   Dong Y, 2010, BIOMATERIALS, V31, P8921, DOI 10.1016/j.biomaterials.2010.08.001
   Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jeong CG, 2010, BIOMATERIALS, V31, P4304, DOI 10.1016/j.biomaterials.2010.01.145
   Jin R, 2009, BIOMATERIALS, V30, P2544, DOI 10.1016/j.biomaterials.2009.01.020
   Khang G, 2001, BIO-MED MATER ENG, V11, P89
   Kose GT, 2003, J MATER SCI-MATER M, V14, P121
   Lee DE, 2010, APPL RADIAT ISOTOPES, V68, P1896, DOI 10.1016/j.apradiso.2010.04.029
   Li J, 2005, J BIOMED MATER RES A, V75A, P985, DOI 10.1002/jbm.a.30504
   Li XT, 2008, J BIOMED MATER RES A, V87A, P832, DOI 10.1002/jbm.a.31890
   Li XT, 2008, BIOMATERIALS, V29, P3720, DOI 10.1016/j.biomaterials.2008.06.004
   Lomas AJ, 2013, TISSUE ENG PART C-ME, V19, P577, DOI [10.1089/ten.tec.2012.0457, 10.1089/ten.TEC.2012.0457]
   Lu X., 2013, ADV BIOSCI BIOTECHNO, V4, P731, DOI [10.4236/abb.2013.46097, DOI 10.4236/ABB.2013.46097]
   Lu XY, 2010, J APPL POLYM SCI, V116, P2944, DOI 10.1002/app.31806
   Martin D. P., 1999, US Patent Appl, Patent No. 359086
   Mei N, 2006, J MATER SCI-MATER M, V17, P749, DOI 10.1007/s10856-006-9686-8
   Peng Q, 2013, ACTA BIOMATER, V9, P5063, DOI 10.1016/j.actbio.2012.09.034
   Peng Q, 2012, BIOMATERIALS, V33, P1583, DOI 10.1016/j.biomaterials.2011.10.072
   Pereira TF, 2012, VIRTUAL PHYS PROTOTY, V7, P275, DOI 10.1080/17452759.2012.738551
   Potter M, 2005, BIOMACROMOLECULES, V6, P552, DOI 10.1021/bm049401n
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Qu XH, 2006, BIOMATERIALS, V27, P2944, DOI 10.1016/j.biomaterials.2006.01.013
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Shangguan YY, 2006, BIOMATERIALS, V27, P2349, DOI 10.1016/j.biomaterials.2005.11.024
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P915, DOI 10.1023/B:JMSM.0000036280.98763.c1
   Sun M, 2009, J MATER SCI-MATER M, V20, P1743, DOI 10.1007/s10856-009-3739-8
   Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027
   Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8
   Unverdorben M, 2002, CARDIOVASC INTER RAD, V25, P127, DOI 10.1007/s00270-001-0118-3
   Wang CC, 2011, BIOMATERIALS, V32, P7118, DOI 10.1016/j.biomaterials.2011.06.018
   Wang L, 2010, BIOMATERIALS, V31, P1691, DOI 10.1016/j.biomaterials.2009.11.053
   Wang Y, 2008, BIOMATERIALS, V29, P2858, DOI 10.1016/j.biomaterials.2008.03.021
   Wang Y, 2013, BIOMATERIALS, V34, P3737, DOI 10.1016/j.biomaterials.2013.01.088
   Wang Y, 2012, BIOMATERIALS, V33, P485, DOI 10.1016/j.biomaterials.2011.09.089
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   Webb WR, 2013, BIOMATERIALS, V34, P6683, DOI 10.1016/j.biomaterials.2013.05.041
   Weng YX, 2011, POLYM TEST, V30, P372, DOI 10.1016/j.polymertesting.2011.02.001
   Xu XY, 2010, BIOMATERIALS, V31, P3967, DOI 10.1016/j.biomaterials.2010.01.132
   Yang HX, 2011, MAT SCI, DOI [10.5402/2011/389872, DOI 10.5402/2011/389872]
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Ye C, 2009, BIOMATERIALS, V30, P4401, DOI 10.1016/j.biomaterials.2009.05.001
   You ML, 2011, BIOMATERIALS, V32, P2305, DOI 10.1016/j.biomaterials.2010.12.009
   Yu BY, 2012, J BIOMAT SCI-POLYM E, V23, P1, DOI 10.1163/092050610X541386
   Yu BY, 2008, DESALINATION, V234, P204, DOI 10.1016/j.desal.2007.09.087
   Zhao K, 2003, BIOCHEM ENG J, V16, P115, DOI 10.1016/S1369-703X(03)00029-9
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
   Zhong TY, 2012, J BIOMED MATER RES A, V100A, P1983, DOI 10.1002/jbm.a.33307
   Zhou J, 2010, BIOMATERIALS, V31, P7512, DOI 10.1016/j.biomaterials.2010.06.044
NR 58
TC 11
Z9 11
U1 0
U2 30
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD JUL
PY 2014
VL 47
IS 7
BP 533
EP 539
DI 10.1590/1414-431X20143930
PG 7
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA AL3RK
UT WOS:000339046100001
PM 25003631
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Avila-Ortiz, G
   Rodriguez, JC
   Rudek, I
   Benavides, E
   Rios, H
   Wang, HL
AF Avila-Ortiz, Gustavo
   Rodriguez, Juan Carlos
   Rudek, Ivan
   Benavides, Erika
   Rios, Hector
   Wang, Hom-Lay
TI Effectiveness of Three Different Alveolar Ridge Preservation Techniques:
   A Pilot Randomized Controlled Trial
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID QUALITY-OF-LIFE; SINUS AUGMENTATION OUTCOMES; BEAM COMPUTED-TOMOGRAPHY;
   FACIAL BONE WALL; SOCKET PRESERVATION; DIMENSIONAL CHANGES; EXTRACTION
   SOCKETS; TOOTH EXTRACTION; BIOACTIVE GLASS; CHEWING ABILITY
AB The aim of this pilot study was to obtain preliminary data regarding the effectiveness of three different alveolar ridge preservation modalities as compared with a control. Subjects in need of single-rooted tooth extraction were recruited and randomly allocated to one of four treatment groups: group 1 (control)-collagen plug; group 2-socket grafting and polytetrafluoroethylene (PTFE) barrier; group 3-socket grafting, buccal overbuilding, and PTFE barrier; group 4-socket grafting, collagen barrier, and PTFE barrier. The grafting material used in all groups was an allograft. At 16 weeks, surgical reentry was performed, and a bone core biopsy was harvested for histomorphometric analysis. A cone beam computed tomography scan was obtained at baseline and before surgical reentry. Clinical (keratinized mucosa [KM] and buccolingual ridge width [RW] changes) and volumetric outcomes were statistically analyzed. A total of 20 patients were recruited (5 patients per group). KM and buccolingual RW changes were minimal during the 16-week healing period for all groups, with no statistically significant differences. Volumetric analyses revealed comparable alveolar ridge resorption values for groups 1, 2, and 4 (3%, 7%, and 5%, respectively), while group 3 exhibited more reduction (16%). Histomorphometric analysis revealed the presence of adequate average values of mineralized tissue (group 1, 46.4%; group 2, 28.88%; group 3, 48.81%; group 4, 41.13%). Based on the clinical and volumetric outcomes, none of the ridge preservation modalities was superior to the control. The combination allograft (freeze-dried bone allograft and demineralized freeze-dried bone allograft) employed in this study appears to be a safe and adequate biomaterial for intraoral grafting.
C1 [Avila-Ortiz, Gustavo] Univ Iowa, Dept Periodont, Iowa City, IA 52242 USA.
   [Avila-Ortiz, Gustavo; Rodriguez, Juan Carlos; Rudek, Ivan; Benavides, Erika; Rios, Hector; Wang, Hom-Lay] Univ Michigan, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.
RP Avila-Ortiz, G (reprint author), Univ Iowa, Dept Periodont, 801 Newton Rd, Iowa City, IA 52242 USA.
EM gustavo-avila@uiowa.edu
RI Avila-Ortiz, Gustavo/R-7784-2018
OI Avila-Ortiz, Gustavo/0000-0002-5763-0201
FU Osteogenics Biomedical; University of Michigan Graduate Periodontics
   Research Fund
FX This study was conducted thanks to the support provided by Osteogenics
   Biomedical and the University of Michigan Graduate Periodontics Research
   Fund. Dr Hom-Lay Wang has received lecture fees from Osteogenics
   Biomedical. All the other authors reported no conflicts of interest
   related to this study.
CR Aimetti M, 2009, INT J ORAL MAX IMPL, V24, P901
   Al-Hezaimi K, 2013, CLIN ORAL IMPLAN RES, V24, P1152, DOI 10.1111/j.1600-0501.2012.02526.x
   Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P9, DOI 10.1111/j.1600-0501.2010.01937.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Avila G, 2010, J PERIODONTOL, V81, P1041, DOI 10.1902/jop.2010.090686
   Avila-Ortiz G, 2012, INT J ORAL MAX IMPL, V27, P1230
   Avila-Ortiz G, 2012, CLIN ORAL IMPLAN RES, V23, P1082, DOI 10.1111/j.1600-0501.2011.02270.x
   Barber HD, 2007, J ORAL MAXIL SURG, V65, P748, DOI 10.1016/j.joms.2006.10.042
   Barone A, 2008, J PERIODONTOL, V79, P1370, DOI 10.1902/jop.2008.070628 
   Barone A, 2013, CLIN ORAL IMPLAN RES, V24, P1231, DOI 10.1111/j.1600-0501.2012.02535.x
   Braut V, 2011, INT J PERIODONT REST, V31, P125
   Brennan DS, 2008, QUAL LIFE RES, V17, P227, DOI 10.1007/s11136-007-9293-2
   Brownfield LA, 2012, J PERIODONTOL, V83, P581, DOI 10.1902/jop.2011.110365
   Brugnami F, 2011, INT J PERIODONT REST, V31, P67
   Caiazzo A, 2010, J ORAL MAXIL SURG, V68, P2503, DOI 10.1016/j.joms.2010.05.044
   Camargo PM, 2000, ORAL SURG ORAL MED O, V90, P581, DOI 10.1067/moe.2000.110035
   Cardaropoli D, 2012, INT J PERIODONT REST, V32, P421
   Clozza E, 2012, INT J ORAL MAX IMPL, V27, P770
   Festa VM, 2013, CLIN IMPLANT DENT R, V15, P707, DOI 10.1111/j.1708-8208.2011.00398.x
   Fickl S, 2009, J CLIN PERIODONTOL, V36, P898, DOI 10.1111/j.1600-051X.2009.01463.x
   Fickl S, 2009, J CLIN PERIODONTOL, V36, P442, DOI 10.1111/j.1600-051X.2009.01381.x
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Galindo-Moreno P, 2010, CLIN ORAL IMPLAN RES, V21, P122, DOI 10.1111/j.1600-0501.2009.01814.x
   Hoffmann O, 2008, J PERIODONTOL, V79, P1355, DOI 10.1902/jop.2008.070502 
   Horvath A, 2013, CLIN ORAL INVEST, V17, P341, DOI 10.1007/s00784-012-0758-5
   Huynh-Ba G, 2010, CLIN ORAL IMPLAN RES, V21, P37, DOI 10.1111/j.1600-0501.2009.01870.x
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   Inukai M, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-118
   Januario AL, 2011, CLIN ORAL IMPLAN RES, V22, P1168, DOI 10.1111/j.1600-0501.2010.02086.x
   Kentros G A, 1985, Implantologist, V3, P53
   Lambert F, 2012, J CLIN PERIODONTOL, V39, P887, DOI 10.1111/j.1600-051X.2012.01900.x
   Morjaria KR, 2014, CLIN IMPLANT DENT R, V16, P1, DOI 10.1111/j.1708-8208.2012.00450.x
   Poulias E, 2013, J PERIODONTOL, V84, P1567, DOI 10.1902/jop.2013.120585
   Price AM, 2011, J PERIODONTOL, V82, P1245, DOI 10.1902/jop.2011.100601
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P71, DOI 10.1111/j.1600-0501.2009.01805.x
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Steele JG, 2004, COMMUNITY DENT ORAL, V32, P107, DOI 10.1111/j.0301-5661.2004.00131.x
   Tan WL, 2012, CLIN ORAL IMPLAN RES, V23, P1, DOI 10.1111/j.1600-0501.2011.02375.x
   Ten Heggeler JMAG, 2011, CLIN ORAL IMPLAN RES, V22, P779, DOI 10.1111/j.1600-0501.2010.02064.x
   Van der Weijden F, 2009, J CLIN PERIODONTOL, V36, P1048, DOI 10.1111/j.1600-051X.2009.01482.x
   Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x
   Yun JH, 2011, J PERIODONTAL IMPLAN, V41, P253, DOI 10.5051/jpis.2011.41.5.253
NR 42
TC 6
Z9 6
U1 0
U2 20
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
EI 1945-3388
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD JUL-AUG
PY 2014
VL 34
IS 4
BP 509
EP 521
DI 10.11607/prd.1838
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AL2TD
UT WOS:000338977400008
PM 25006768
OA Bronze
DA 2018-10-20
ER

PT J
AU Fournier, E
   Devaney, R
   Palmer, M
   Kramer, J
   El Khaja, R
   Fonte, M
AF Fournier, Eric
   Devaney, Robert
   Palmer, Matthew
   Kramer, Joshua
   El Khaja, Ragheb
   Fonte, Matthew
TI Superelastic Orthopedic Implant Coatings
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE arthroplasty; biomaterial; coatings and paints; hip replacement;
   nitinol; orthopedics; porous materials
ID TOTAL HIP-ARTHROPLASTY; BONE INGROWTH; SURFACE
AB The demand for hip and knee replacement surgery is substantial and growing. Unfortunately, most joint replacement surgeries will fail within 10-25 years, thereby requiring an arduous, painful, and expensive revision surgery. To address this issue, a novel orthopedic implant coating material ("eXalt") has been developed. eXalt is comprised of super elastic nitinol wire that is knit into a three-dimensional spacer fabric structure. eXalt expands in vivo to conform to the implantation site and is porous to allow for bone ingrowth. The safety and efficacy of eXalt were evaluated through structural analysis, mechanical testing, and a rabbit implantation model. The results demonstrate that eXalt meets or exceeds the performance of current coating technologies with reduced micromotion, improved osseointegration, and stronger implant fixation in vivo.
C1 [Fournier, Eric; Devaney, Robert; Palmer, Matthew; El Khaja, Ragheb; Fonte, Matthew] MX Orthoped Corp, Billerica, MA 01821 USA.
   [Kramer, Joshua] Charter Preclin Serv, West Roxbury, MA USA.
RP Fournier, E (reprint author), MX Orthoped Corp, Billerica, MA 01821 USA.
EM efournier@mxortho.com; rdevaney@mxortho.com; mpalmer@mxortho.com;
   jkramercps@gmail.com; relkhaja@mxortho.com; mfonte@mxortho.com
CR Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P570, DOI 10.2106/JBJS.D.02121
   DALTON JE, 1995, J BONE JOINT SURG AM, V77A, P97, DOI 10.2106/00004623-199501000-00012
   Fabi D. W., 2012, ASM HDB, V23, P307
   Fender D, 2000, J BONE JOINT SURG BR, V82B, P944, DOI 10.1302/0301-620X.82B7.10762
   Friedman RJ, 1996, J ORTHOPAED RES, V14, P455, DOI 10.1002/jor.1100140316
   Mendenhall S., 2013, ORTHOP NETW NEWS, P1
   PILLIAR RM, 1983, CLIN ORTHOP RELAT R, P42
   PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108
   Sandborn P M, 1988, J Arthroplasty, V3, P337, DOI 10.1016/S0883-5403(88)80034-2
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   Surdam JW, 2007, J ARTHROPLASTY, V22, P204, DOI 10.1016/j.arth.2006.06.002
   Wolff J, 1892, GESETZ TRANSFORMATIO
NR 12
TC 2
Z9 2
U1 1
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD JUL
PY 2014
VL 23
IS 7
SI SI
BP 2464
EP 2470
DI 10.1007/s11665-014-1008-6
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA AL3FC
UT WOS:000339010700027
DA 2018-10-20
ER

PT J
AU Fernandes, FMB
   Oliveira, JP
   Machado, A
   Schell, N
AF Braz Fernandes, Francisco Manuel
   Oliveira, J. P.
   Machado, A.
   Schell, Norbert
TI XRD Study of NiTi Endodontic Files Using Synchrotron Radiation
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE advanced characterization; biomaterial; intermetallic
ID CYCLIC FATIGUE RESISTANCE; TITANIUM ROTARY FILES;
   FINITE-ELEMENT-ANALYSIS; MECHANICAL-BEHAVIOR; BENDING BEHAVIOR;
   INSTRUMENTS; MODELS; MOVEMENT; STRESSES; PROTAPER
AB Two types of endodontic files (ProFile and Mtwo) were studied in order to analyze the effect of geometry on the stress-induced martensitic (SIM) transformation during bending. The use of a fine beam spot of synchrotron radiation allowed a detailed structural characterization with a fine spatial resolution. Experimental evidence of the effect of the cross-section geometry on the stress localization giving rise to different degrees of SIM transformation is presented for the first time in the published literature.
C1 [Braz Fernandes, Francisco Manuel; Oliveira, J. P.; Machado, A.] FCT UNL, Dept Mat Sci, CENIMAT I3N, Monte De Caparica, Portugal.
   [Schell, Norbert] HZG, Inst Mat Res, D-21502 Geesthacht, Germany.
RP Fernandes, FMB (reprint author), FCT UNL, Dept Mat Sci, CENIMAT I3N, Monte De Caparica, Portugal.
EM fbf@fct.unl.pt; jp.oliveira@campus.fct.unl.pt;
   amp.machado@campus.fct.unl.pt; norbert.schell@hzg.de
RI Machado, Angela/K-1410-2016; Braz Fernandes, Francisco
   Manuel/E-6176-2011; Oliveira, Joao Pedro/G-4372-2012
OI Machado, Angela/0000-0001-6135-0483; Braz Fernandes, Francisco
   Manuel/0000-0003-3185-0019; Oliveira, Joao Pedro/0000-0001-6906-1870
FU CENIMAT by FCT/MCTES [PEst-C/CTM/LA0025/2013-14, LA 25]; Project
   NiTi-Fail [PTDC/EME-PME/122795/2011]; EC [I-20120244 EC, 312284]
FX FMBF, JPO and AM acknowledge the funding of CENIMAT by FCT/MCTES through
   the PEst-C/CTM/LA0025/2013-14 (Strategic Project - LA 25 - 2013-2014)
   and the Project NiTi-Fail (PTDC/EME-PME/122795/2011). The beam time
   project I-20120244 EC, at P-07 (PETRA-III, DESY), has been funded by the
   EC 7th. Framework Programme (FP7/2007-2013) under grant agreement no.
   312284.
CR Arbab-Chirani R, 2011, ORAL SURG ORAL MED O, V111, P115, DOI 10.1016/j.tripleo.2010.07.017
   Avoaka MC, 2010, BOSNIAN J BASIC MED, V10, P107
   Berutti E, 2003, J ENDODONT, V29, P15, DOI 10.1097/00004770-200301000-00005
   Bhagabati N, 2012, J ENDODONT, V38, P515, DOI 10.1016/j.joen.2011.12.034
   Chevalier V, 2010, ORAL SURG ORAL MED O, V109, pE111, DOI 10.1016/j.tripleo.2009.10.039
   Condorelli GG, 2010, INT ENDOD J, V43, P866, DOI 10.1111/j.1365-2591.2010.01759.x
   De-Deus G, 2010, INT ENDOD J, V43, P1063, DOI 10.1111/j.1365-2591.2010.01756.x
   Gavini G, 2010, J ENDODONT, V36, P1183, DOI 10.1016/j.joen.2010.03.032
   Grande NM, 2006, INT ENDOD J, V39, P755, DOI 10.1111/j.1365-2591.2006.01143.x
   Kim HC, 2008, J ENDODONT, V34, P743, DOI 10.1016/j.joen.2008.03.015
   Kim HC, 2010, J ENDODONT, V36, P147, DOI 10.1016/j.joen.2009.09.037
   Lee MH, 2011, J ENDODONT, V37, P1152, DOI 10.1016/j.joen.2011.03.025
   Lopes HP, 2010, J ENDODONT, V36, P1653, DOI 10.1016/j.joen.2010.06.026
   Lopes HP, 2011, ORAL SURG ORAL MED O, V111, P792, DOI 10.1016/j.tripleo.2010.12.006
   Montalvao D, 2011, J ENDODONT, V37, P1158, DOI 10.1016/j.joen.2011.05.018
   Pedulla E, 2011, J ENDODONT, V37, P1139, DOI 10.1016/j.joen.2011.04.008
   Plotino G, 2012, INT ENDOD J, V45, P614, DOI 10.1111/j.1365-2591.2012.02015.x
   Tripi TR, 2006, ORAL SURG ORAL MED O, V102, pE106, DOI 10.1016/j.tripleo.2005.12.012
   Tsao CC, 2013, INT ENDOD J, V46, P379, DOI 10.1111/iej.12025
   Vilaverde Correia S., 2009, THESIS U LISBON LISB
   Vilaverde Correia S., 2009, P ESOMAT 09 EUR S MA, DOI [10.1051/esomat/200907004, DOI 10.1051/ESOMAT/200907004]
   Xu XJ, 2006, J ENDODONT, V32, P372, DOI 10.1016/j.joen.2005.08.012
   Zhang EW, 2010, J ENDODONT, V36, P1394, DOI 10.1016/j.joen.2010.04.017
NR 23
TC 4
Z9 4
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD JUL
PY 2014
VL 23
IS 7
SI SI
BP 2477
EP 2481
DI 10.1007/s11665-014-1056-y
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA AL3FC
UT WOS:000339010700029
DA 2018-10-20
ER

PT J
AU Pandini, S
   Ricco, T
   Borboni, A
   Bodini, I
   Vetturi, D
   Cambiaghi, D
   Toselli, M
   Paderni, K
   Messori, M
   Pilati, F
   Chiellini, F
   Bartoli, C
AF Pandini, Stefano
   Ricco, Theonis
   Borboni, Alberto
   Bodini, Ileana
   Vetturi, David
   Cambiaghi, Danilo
   Toselli, Maurizio
   Paderni, Katia
   Messori, Massimo
   Pilati, Francesco
   Chiellini, Federica
   Bartoli, Cristina
TI Tailored One-Way and Two-Way Shape Memory Capabilities of
   Poly(epsilon-Caprolactone)-Based Systems for Biomedical Applications
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE advanced characterization testing; biomaterial; creep and stress
   rupture; mechanical
ID POLYMER NETWORKS; STENTS
AB This paper investigates the shape memory capabilities of semicrystalline networks, focusing the attention on poly(epsilon-caprolactone) (PCL) systems, a class of materials that allows to satisfy important requirements for their applications as biomedical devices, such as the good biocompatibility, the fast recovery of large "temporary" shape configurations, and the easy tailoring of the transformation temperatures. The materials were prepared with various crosslink densities and crosslinking methodologies; in particular, beside a thermal crosslinking based on reactive methacrylic end groups, a novel type of covalently crosslinked semicrystalline systems was prepared by a sol-gel approach from alkoxysilane-terminated PCL precursors, so as to avoid potentially toxic additives typically used for free-radical thermal curing. The materials were subjected to biological tests, to study their ability in sustaining cell adhesion and proliferation, and to thermal characterizations, to evaluate the possibility to tailor their melting and crystallization temperatures. The one-way shape memory (i.e., the possibility to set the material in a given configuration and to recover its pristine shape) and the two-way shape memory response (i.e., the triggered change between two distinguished shapes on the application of an on-off stimulus) were studied by applying optimized thermo-mechanical cyclic histories. The ability to fix the applied shape and to recover the original one on the application of heating (i.e., the one-way effect) was evaluated on tensile bars; further, to investigate a potential application as self-expandable stents, isothermal shape memory experiments were carried out also on tubular specimens, previously folded in a temporary compact configuration. The two-way response was studied through the application of a constant load and of a heating/cooling cycle from above melting to below the crystallization temperature, leading to a reversible elongation/contraction effect, involving maximum strain changes up to about 80%, whose extent may be controlled through the crosslink density.
C1 [Pandini, Stefano; Ricco, Theonis; Borboni, Alberto; Bodini, Ileana; Vetturi, David; Cambiaghi, Danilo; Toselli, Maurizio; Paderni, Katia; Messori, Massimo; Pilati, Francesco; Chiellini, Federica; Bartoli, Cristina] Univ Brescia, Dept Mech & Ind Engn Brescia, Brescia, Italy.
RP Pandini, S (reprint author), Univ Brescia, Dept Mech & Ind Engn Brescia, Brescia, Italy.
EM stefano.pandini@unibs.it
RI Messori, Massimo/C-9745-2011; Chiellini, Federica/F-3233-2010
OI Messori, Massimo/0000-0003-3598-4241; Chiellini,
   Federica/0000-0003-4680-9975; TOSELLI, MAURIZIO/0000-0003-3615-5728;
   VETTURI, David/0000-0002-1798-7935; Borboni,
   Alberto/0000-0001-7069-1095; Bodini, Ileana/0000-0003-4904-2044
FU INSTM (Firenze, Italy); Regione Lombardia
FX The authors gratefully acknowledge INSTM (Firenze, Italy), Regione
   Lombardia, and the Department of Mechanical and Industrial Engineering
   of the University of Brescia for providing financial support to this
   research, Mrs. Gloria Spagnoli for the support for the materials
   characterization, and Mr. Luca Dassa for the design of the folding
   equipment.
CR Baer GM, 2009, J BIOMED MATER RES B, V90B, P421, DOI 10.1002/jbm.b.31301
   Baer GM, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-43
   Barot G, 2006, Z ANGEW MATH PHYS, V57, P652, DOI 10.1007/s00033-005-0009-6
   Chung T, 2008, MACROMOLECULES, V41, P184, DOI 10.1021/ma071517z
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, J POLYM SCI POL CHEM, V43, P1369, DOI 10.1002/pola.20598
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Leng JS, 2011, PROG MATER SCI, V56, P1077, DOI 10.1016/j.pmatsci.2011.03.001
   Messori M, 2013, J MATER SCI, V48, P424, DOI 10.1007/s10853-012-6757-8
   Paderni K, 2012, J MATER SCI, V47, P4354, DOI 10.1007/s10853-012-6289-2
   Pandini S, 2013, POLYMER, V54, P4253, DOI 10.1016/j.polymer.2013.06.016
   Sanda F, 2002, MACROMOLECULES, V35, P680, DOI 10.1021/ma011341f
   Tamai H, 2000, CIRCULATION, V102, P399
   Westbrook K.K., 2010, J ENG MATER-T ASME, V132
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xue LA, 2010, BIOMATERIALS, V31, P8132, DOI 10.1016/j.biomaterials.2010.07.043
   Yakacki CM, 2008, ADV FUNCT MATER, V18, P2428, DOI 10.1002/adfm.200701049
   Yakacki CM, 2007, BIOMATERIALS, V28, P2255, DOI 10.1016/j.biomaterials.2007.01.030
   Zotzmann J, 2010, ADV MATER, V22, P3424, DOI 10.1002/adma.200904202
NR 20
TC 6
Z9 6
U1 3
U2 59
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD JUL
PY 2014
VL 23
IS 7
SI SI
BP 2545
EP 2552
DI 10.1007/s11665-014-1033-5
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA AL3FC
UT WOS:000339010700039
DA 2018-10-20
ER

PT J
AU Wohlschlogel, M
   Steegmuller, R
   Schussler, A
AF Wohlschloegel, Markus
   Steegmueller, Rainer
   Schuessler, Andreas
TI Effect of Inclusion Size and Distribution on the Corrosion Behavior of
   Medical-Device Grade Nitinol Tubing
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE biomaterial; corrosion and wear; microscopy
AB Nonmetallic inclusions in Nitinol, such as carbides (TiC) and intermetallic oxides (Ti4Ni2O (x) ), are known to be triggers for fatigue failure of Nitinol medical devices. These mechanically brittle inclusions are introduced during the melting process. As a result of hot and cold working in the production of Nitinol tubing inclusions are fractionalized due to the mechanical deformation imposed. While the role of inclusions regarding Nitinol fatigue performance has been studied extensively in the past, their effect on Nitinol corrosion behavior was investigated in only a limited number of studies. The focus of the present work was to understand the effect of inclusion size and distribution on the corrosion behavior of medical-device grade Nitinol tubing made from three different ingot sources during different manufacturing stages: (i) for the initial stage (hollow: round bar with centric hole), (ii) after hot drawing, and (iii) after the final drawing step (final tubing dimensions: outer diameter 0.3 mm, wall thickness 0.1 mm). For one ingot source, two different material qualities were investigated. Potentiodynamic polarization tests were performed for electropolished samples of the above-mentioned stages. Results indicate that inclusion size rather than inclusion quantity affects the susceptibility of electropolished Nitinol to pitting corrosion.
C1 [Wohlschloegel, Markus; Steegmueller, Rainer; Schuessler, Andreas] ADMEDES Schuessler GmbH, Pforzheim, Germany.
RP Wohlschlogel, M (reprint author), ADMEDES Schuessler GmbH, Pforzheim, Germany.
EM mwohlschloegel@admedes.com
CR [Anonymous], 2012, F206312 ASTM
   [Anonymous], 2008, F212908 ASTM
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Hwang WS, 1996, 13 INT CORR C MELB A, P381
   Pelton AR, 2003, JOM-J MIN MET MAT S, V55, P33, DOI 10.1007/s11837-003-0243-3
   Rahim M, 2013, ACTA MATER, V61, P3667, DOI 10.1016/j.actamat.2013.02.054
   Reinoehl M., 2000, P INT C SHAP MEM SUP, P397
   SHABALOVSKAYA S, 2003, P INT C SHAP MEM SUP, P399
   Toro A, 2009, J MATER ENG PERFORM, V18, P448, DOI 10.1007/s11665-009-9410-1
   Trepanier C, 1998, J BIOMED MATER RES, V43, P433, DOI 10.1002/(SICI)1097-4636(199824)43:4<433::AID-JBM11>3.0.CO;2-#
   Wohlschlogel M, 2012, J BIOMED MATER RES B, V100B, P2231, DOI 10.1002/jbm.b.32814
NR 11
TC 7
Z9 7
U1 1
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD JUL
PY 2014
VL 23
IS 7
SI SI
BP 2635
EP 2640
DI 10.1007/s11665-014-0996-6
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA AL3FC
UT WOS:000339010700051
DA 2018-10-20
ER

PT J
AU Zhukova, YS
   Pustov, YA
   Konopatsky, AS
   Filonov, MR
   Prokoshkin, SD
AF Zhukova, Yu. S.
   Pustov, Yu. A.
   Konopatsky, A. S.
   Filonov, M. R.
   Prokoshkin, S. D.
TI Electrochemical Behavior of Novel Superelastic Biomedical Alloys in
   Simulated Physiological Media Under Cyclic Load
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE biomaterial; corrosion and wear; titanium
ID TOTAL JOINT REPLACEMENT; SHAPE-MEMORY ALLOYS; TITANIUM-ALLOYS; TI;
   TRANSFORMATION; NB; MECHANISM; TA; FILMS; ZR
AB The aim of the present work was to study corrosion and electrochemical behavior of Ti-22Nb-6Ta and Ti-22Nb-6Zr (at.%) superelastic alloys under conditions which imitate the performance mode of target devices (bone implants), i.e., under cyclic load in simulated physiological solutions. Open circuit potential (OCP) measurements were carried out on wire specimens in Hank's solution and artificial saliva at 37 A degrees C with various strain values up to 1.5%. It is shown that at clinically relevant strain values (about 0.2%) the alloys exhibit OCP growth indicating their high stability and resistance to corrosion fatigue under these cycling conditions. At much higher strains (about 1%), fatigue crack initiation and propagation take place, however, the corresponding OCP variation indicates that the fracture process is significantly restrained by reversible martensitic transformation during cycling.
C1 [Zhukova, Yu. S.; Pustov, Yu. A.; Konopatsky, A. S.; Filonov, M. R.; Prokoshkin, S. D.] Natl Univ Sci & Technol MISIS, Moscow 119049, Russia.
RP Zhukova, YS (reprint author), Natl Univ Sci & Technol MISIS, 4 Leninskiy Prosp, Moscow 119049, Russia.
EM zhukova@misis.ru
FU Russian Science Foundation
FX This work was supported by the Russian Science Foundation.
CR Baker C., 1971, Metal Science Journal, V5, P92
   Brailovski V, 2011, MAT SCI ENG C-MATER, V31, P643, DOI 10.1016/j.msec.2010.12.008
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Dubinskiy S, 2014, MATER CHARACT, V88, P127, DOI 10.1016/j.matchar.2013.12.008
   Gutman E.M., 1981, MECHANOCHEMISTRY MET
   Helsen JA, 2010, BIOL MED PHYS BIOMED, P1
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054
   Park J. B., 2003, BIOMATERIALS PRINCIP
   Pustov Yu.A., 2011, CORROS MAT PROT, V10, P12
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Robertson SW, 2007, ACTA MATER, V55, P6198, DOI 10.1016/j.actamat.2007.07.028
   Sheremet'ev VA, 2013, MET SCI HEAT TREAT+, V55, P100, DOI 10.1007/s11041-013-9588-6
   Shorshorov M.Kh., 1985, PHYS MET METALLOGR, V60, P109
   Talling RJ, 2009, ACTA MATER, V57, P1188, DOI 10.1016/j.actamat.2008.11.013
   Yaszemski M. J., 2004, BIOMATERIALS ORTHOPE
   Yi S, 2000, INT J SOLIDS STRUCT, V37, P5315, DOI 10.1016/S0020-7683(99)00213-9
   Zhukova YS, 2014, J ALLOY COMPD, V586, pS535, DOI 10.1016/j.jallcom.2013.01.151
   Zhukova YS, 2012, PROT MET PHYS CHEM+, V48, P315, DOI 10.1134/S2070205112030203
NR 22
TC 6
Z9 6
U1 0
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD JUL
PY 2014
VL 23
IS 7
SI SI
BP 2677
EP 2681
DI 10.1007/s11665-014-1061-1
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA AL3FC
UT WOS:000339010700056
DA 2018-10-20
ER

PT J
AU Zhao, JH
   Tsai, CH
   Chang, YC
AF Zhao, Jiing-Huei
   Tsai, Chung-Hung
   Chang, Yu-Chao
TI Management of radicular cysts using platelet-rich fibrin and bioactive
   glass: A report of two cases
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Article
DE bioactive glass; platelet-rich fibrin; radicular cyst; tissue
   regeneration
ID SOLE GRAFTING MATERIAL; TISSUE REGENERATION; INTRABONY DEFECTS; BONE
   REGENERATION; IN-VITRO; MEMBRANE; FIBROBLASTS; OSTEOBLASTS; PRF
AB Platelet-rich fibrin (PRF) created by Choukroun's protocol concentrates most platelets and leukocytes from a blood harvest into a single autologous fibrin biomaterial. However, no current data is available concerning the use of PRF for the treatment of periapical lesions. Two cases of radicular cysts were reported using an interdisciplinary approach, including regular endodontic therapy followed by surgical management with PRF and bioactive glass. Two cases of radicular cysts presented as an incidental radiographic finding, appearing as an apical radiolucency with well-circumscribed sclerotic borders. After regular endodontic retreatment, cystic lining/granulation tissues were enucleated and the periradicular bony defect was grafted using PRF and bioactive glass. Then, PRF was applied to serve as a membrane over the grafted defects. Recall periapical radiographs of Case 1 and cone beam computer tomography of Case 2 showed satisfactory healing of the periapical pathosis. In Case 2, the bony defect appeared completely healed at 4 months surgical reentry and the new bone was clinically very dense and mature. The results of these case reports show that the combination of PRF and bioactive glass is an effective modality of regenerative treatment for radicular cysts. Copyright (C) 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
C1 [Zhao, Jiing-Huei; Chang, Yu-Chao] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan.
   [Tsai, Chung-Hung] Chung Shan Med Univ Hosp, Dept Oral Pathol, Taichung, Taiwan.
   [Chang, Yu-Chao] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan.
RP Chang, YC (reprint author), Chung Shan Med Univ, Sch Dent, 110,Sect 1,Chien Kuo North Rd, Taichung, Taiwan.
EM cyc@csmu.edu.tw
CR Allan I, 2001, BIOMATERIALS, V22, P1683, DOI 10.1016/S0142-9612(00)00330-6
   Bashutski JD, 2009, J ENDODONT, V35, P321, DOI 10.1016/j.joen.2008.11.023
   Chang IC, 2010, J BIOMED MATER RES A, V95A, P327, DOI 10.1002/jbm.a.32839
   Chang YC, 2011, AUST DENT J, V56, P365, DOI 10.1111/j.1834-7819.2011.01362.x
   Chang YC, 2011, J DENT SCI, V6, P181, DOI 10.1016/j.jds.2011.05.010
   Choukroun J, 2000, IMPLANTODONTIE, V42, P55
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Dohan DM, 2006, ORAL SURG ORAL MED O, V101, P45, DOI DOI 10.1016/J.TRIPLE0.2005.07.009
   Ehrenfest DMD, 2010, J PERIODONTOL, V81, P546, DOI 10.1902/jop.2009.090531
   Ehrenfest DMD, 2009, ORAL SURG ORAL MED O, V108, P341, DOI 10.1016/j.tripleo.2009.04.020
   Ehrenfest DMD, 2009, GROWTH FACTORS, V27, P63, DOI 10.1080/08977190802636713
   Gouldin AG, 1996, J CLIN PERIODONTOL, V23, P485, DOI 10.1111/j.1600-051X.1996.tb00579.x
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Huang FM, 2010, J ENDODONT, V36, P1628, DOI 10.1016/j.joen.2010.07.004
   Mellonig JT, 1998, INT J PERIODONT REST, V18, P129
   Mengel R, 2006, J PERIODONTOL, V77, P1781, DOI 10.1902/jop.2006.060029
   Schepers E, 1996, BIOCERAMICS, V9, P99
   Simon BJ, 2011, INT J PERIODONT REST, V31, P284
   Simonpieri A, 2011, IMPLANT DENT, V20, P2, DOI 10.1097/ID.0b013e3181faa8af
   Tobon S, 2002, INT ENDOD J, V35, P635, DOI 10.1046/j.1365-2591.2002.00523.x
   Toffler M, 2010, IMPLANT DENT, V19, P447, DOI 10.1097/ID.0b013e3181f57288
   Tsai CH, 2009, J DENT SCI, V4, P130, DOI 10.1016/S1991-7902(09)60018-0
   Zhao JH, 2011, J DENT SCI, V6, P116, DOI 10.1016/j.jds.2011.03.004
NR 23
TC 9
Z9 9
U1 0
U2 10
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD JUL
PY 2014
VL 113
IS 7
BP 470
EP 476
DI 10.1016/j.jfma.2011.09.027
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA AL4FJ
UT WOS:000339088000012
PM 24961190
OA Bronze
DA 2018-10-20
ER

PT J
AU Bahrami, F
   Aitchison, JS
   Mojahedi, M
AF Bahrami, Farshid
   Aitchison, J. Stewart
   Mojahedi, Mo
TI Multimode spectroscopy using dielectric grating coupled to a surface
   plasmon resonance sensor
SO OPTICS LETTERS
LA English
DT Article
ID BIOSENSORS; THICKNESS; IMPLEMENTATION; CONSTANT
AB A new platform is proposed to solve one of the main shortcomings of surface plasmon resonance biosensors, namely, the cross sensitivity to surface and bulk effects. This approach is based on multimode spectroscopy in which three different modes are excited simultaneously. The proposed design consists of an SPR sensor loaded with a dielectric grating. The design parameters (dimensions and wavelength) are optimized with a genetic algorithm. The optimized design has two resonance modes excited with TM polarized light, each sensitive to surface effects, and one TE mode mostly sensitive to variations in the bulk fluid refractive index. Numerical and analytical methods are used to justify the simulation results, which are in good agreement. Finally, it is shown that, by applying three-mode spectroscopy, decoupling the properties of the attached biomaterial from the background index variations is possible with the proposed design. (C) 2014 Optical Society of America
C1 [Bahrami, Farshid; Aitchison, J. Stewart; Mojahedi, Mo] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.
RP Bahrami, F (reprint author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.
EM farshid.bahrami@mail.utoronto.ca
FU Natural Science and Engineering Research Council of Canada-Biopsys
   Network [486537]
FX This work was supported by the Natural Science and Engineering Research
   Council of Canada-Biopsys Network under grant no. 486537.
CR Adam P, 2006, SENSOR ACTUAT B-CHEM, V113, P774, DOI 10.1016/j.snb.2005.07.029
   Bahrami F, 2013, PLASMONICS, V8, P465, DOI 10.1007/s11468-012-9411-z
   Bahrami F., 2012, IEEE PHOT C, P208
   Bernard P. M., 2009, APPL DIGITAL OPTICS
   Chinowsky TM, 1998, SENSOR ACTUAT B-CHEM, V51, P321, DOI 10.1016/S0925-4005(98)00207-X
   Chulia-Jordan R, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3682081
   DEBRUIJN HE, 1991, OPT COMMUN, V82, P425, DOI 10.1016/0030-4018(91)90353-F
   Granet G, 1996, J OPT SOC AM A, V13, P1019, DOI 10.1364/JOSAA.13.001019
   Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9
   Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P16, DOI 10.1016/S0925-4005(98)00322-0
   Homola J, 2003, ANAL BIOANAL CHEM, V377, P528, DOI 10.1007/s00216-003-2101-0
   JOHNSTON KS, 1995, MATER CHEM PHYS, V42, P242, DOI 10.1016/0254-0584(95)01659-I
   MOHARAM MG, 1995, J OPT SOC AM A, V12, P1077, DOI 10.1364/JOSAA.12.001077
   Nehru N, 2014, IEEE T NANOTECHNOL, V13, P55, DOI 10.1109/TNANO.2013.2287700
   Nizamov S, 2011, BIOSENS BIOELECTRON, V28, P263, DOI 10.1016/j.bios.2011.07.030
   Peterlinz KA, 1996, OPT COMMUN, V130, P260, DOI 10.1016/0030-4018(96)00238-6
   Phelps JM, 1996, J PHYS D APPL PHYS, V29, P1080, DOI 10.1088/0022-3727/29/4/023
   Skivesen N, 2007, BIOSENS BIOELECTRON, V22, P1282, DOI 10.1016/j.bios.2006.05.025
NR 18
TC 3
Z9 3
U1 1
U2 14
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 0146-9592
EI 1539-4794
J9 OPT LETT
JI Opt. Lett.
PD JUL 1
PY 2014
VL 39
IS 13
BP 3946
EP 3949
DI 10.1364/OL.39.003946
PG 4
WC Optics
SC Optics
GA AL2CJ
UT WOS:000338933200065
PM 24978778
DA 2018-10-20
ER

PT J
AU Bharatham, H
   Zakaria, MZAB
   Perimal, EK
   Yusof, LM
   Hamid, M
AF Bharatham, Hemabarathy
   Zakaria, Md Zuki Abu Bakar
   Perimal, Enoch Kumar
   Yusof, Loqman Mohamad
   Hamid, Muhajir
TI Mineral and Physiochemical Evaluation of Cockle Shell (Anadara granosa)
   and Other Selected Molluscan Shell as Potential Biomaterials
SO SAINS MALAYSIANA
LA English
DT Article
DE Anadara granosa; aragonite; bone tissue engineering; calcium carbonate;
   Oliva sayana; Strombus canarium; Terebra dislocata
ID HYDROXYAPATITE
AB Molluscan shells are attracting research interest due to the diverse application properties possessed. As shells are very similar to bones, this study was conducted to analyze the mineral and physiochemical composition of Cockle (Anadara granosa) shell and three other types of molluscan shell, namely Strombus canarium, Oliva sayana and Terebra dislocata as potential biomaterial for bone tissue engineering applications. Approximately 200 g of shells from each species were processed and powdered for the purpose of this study. Carbon was analyzed using the carbon analyzer while minerals and heavy metals through ICP-MS. The phase purity and crystallographic structures of the powders were identified using X-Ray Diffractometer (XRD) while the chemical functionality was determined using the Fourier transform infrared (FTIR) spectrophotometer. The analysis showed that Cockle shells contained higher content of calcium and carbon including varying amount of other minor elements comparatively. However, all four types of shell powders were found to contain below detectable levels of toxic elements. Physiochemical analysis on phase purity and crystallographic structures showed similar characteristics of carbonate group present in all four shell types. A predominantly aragonite form of calcium carbonate was detected in both XRD diffractogram and FTIR spectra for all samples. Our findings demonstrated that different types of molluscan shells have almost similar mineral and physiochemical characteristics and a predominantly aragonite form of calcium carbonate that provides a strong basis for their use as a potential bone tissues engineering material.
C1 [Bharatham, Hemabarathy] Univ Kebangsaan Malaysia, Fac Hlth Sci, Sch Diagnost & Appl Sci, Kuala Lumpur 50300, Malaysia.
   [Bharatham, Hemabarathy; Zakaria, Md Zuki Abu Bakar; Yusof, Loqman Mohamad] Univ Putra Malaysia, Fac Vet Med, Dept Vet Preclin Sci, Serdang 43400, Selangor Darul, Malaysia.
   [Zakaria, Md Zuki Abu Bakar] Univ Putra Malaysia, Inst Biosci, Serdang 43400, Selangor Darul, Malaysia.
   [Perimal, Enoch Kumar] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Serdang 43400, Selangor Darul, Malaysia.
   [Hamid, Muhajir] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Microbiol, Serdang 43400, Selangor Darul, Malaysia.
RP Zakaria, MZAB (reprint author), Univ Putra Malaysia, Fac Vet Med, Dept Vet Preclin Sci, Serdang 43400, Selangor Darul, Malaysia.
EM zuki@ibs.upm.edu.my
OI Hamid, Muhajir/0000-0002-2475-7628
FU Faculty of Veterinary Medicine, Universiti Putra Malaysia; Faculty of
   Medicine and Health Sciences, Universiti Putra Malaysia; Institute of
   Bioscience, Universiti Putra Malaysia; Research University Grant (RUGS)
FX The authors would like to thank the Faculty of Veterinary Medicine,
   Faculty of Medicine and Health Sciences and the Institute of Bioscience,
   Universiti Putra Malaysia for the support given. This research was
   funded by the Research University Grant (RUGS 2010-2012).
CR Awang-Hazmi AJ, 2007, J ANIM VET ADV, V6, P591
   Chang F, 2007, FOOD CHEM, V104, P1171, DOI 10.1016/j.foodchem.2007.01.032
   Chen B, 2008, COMP MATER SCI, V44, P201, DOI 10.1016/j.commatsci.2008.01.013
   Fadhlia Z.Z., 2007, J NUCL RELATED TECHN, V4, P181
   Islam KN, 2012, J NANOMATER, DOI 10.1155/2012/534010
   Kim S, 2010, BIOMATERIALS, V31, P6628, DOI 10.1016/j.biomaterials.2010.05.004
   Lemos AF, 2006, J EUR CERAM SOC, V26, P3639, DOI 10.1016/j.jeurceramsoc.2005.12.011
   Sokolova IM, 2000, J EXP MAR BIOL ECOL, V245, P1, DOI 10.1016/S0022-0981(99)00132-X
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391
   Vecchio KS, 2007, ACTA BIOMATER, V3, P910, DOI 10.1016/j.actbio.2007.06.003
   Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j
   Zakaria Z.A.B., 2004, J ANIMAL VET ADV, V3, P445
NR 13
TC 2
Z9 2
U1 0
U2 6
PU UNIV KEBANGSAAN MALAYSIA
PI SELANGOR
PA FACULTY SCIENCE & TECHNOLOGY, BANGI, SELANGOR, 43600, MALAYSIA
SN 0126-6039
J9 SAINS MALAYS
JI Sains Malays.
PD JUL
PY 2014
VL 43
IS 7
BP 1023
EP 1029
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AL5DA
UT WOS:000339152500008
DA 2018-10-20
ER

PT J
AU Fernandez, T
   Olave, G
   Valencia, CH
   Arce, S
   Quinn, JMW
   Thouas, GA
   Chen, QZ
AF Fernandez, Tulio
   Olave, Gilberto
   Valencia, Carlos H.
   Arce, Sandra
   Quinn, Julian M. W.
   Thouas, George A.
   Chen, Qi-Zhi
TI Effects of Calcium Phosphate/Chitosan Composite on Bone Healing in Rats:
   Calcium Phosphate Induces Osteon Formation
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID CRITICAL-SIZE; IN-VIVO; CALVARIAL DEFECT; REGENERATION; ANGIOGENESIS;
   BIOMATERIALS; GROWTH; MICROCIRCULATION; OSTEOGENESIS; SUBSTITUTES
AB Vascularization of an artificial graft represents one of the most significant challenges facing the field of bone tissue engineering. Over the past decade, strategies to vascularize artificial scaffolds have been intensively evaluated using osteoinductive calcium phosphate (CaP) biomaterials in animal models. In this work, we observed that CaP-based biomaterials implanted into rat calvarial defects showed remarkably accelerated formation and mineralization of new woven bone in defects in the initial stages, at a rate of similar to 60 mu m/day (0.8mg/day), which was considerably higher than normal bone growth rates (several mm/day, 0.1mg/day) in implant-free controls of the same age. Surprisingly, we also observed histological evidence of primary osteon formation, indicated by blood vessels in early-region fibrous tissue, which was encapsulated by lamellar osteocyte structures. These were later fully replaced by compact bone, indicating complete regeneration of calvarial bone. Thus, the CaP biomaterial used here is not only osteoinductive, but vasculogenic, and it may have contributed to the bone regeneration, despite an absence of osteons in normal rat calvaria. Further investigation will involve how this strategy can regulate formation of vascularized cortical bone such as by control of degradation rate, and use of models of long, dense bones, to more closely approximate repair of human cortical bone.
C1 [Fernandez, Tulio; Quinn, Julian M. W.; Thouas, George A.; Chen, Qi-Zhi] Monash Univ, Dept Mat Engn, Monash Med Sch, Clayton, Vic 3800, Australia.
   [Fernandez, Tulio; Olave, Gilberto; Valencia, Carlos H.] Univ Valle, Sch Dent, Cali, Colombia.
   [Arce, Sandra] Autonomous Univ Occident, Fac Engn, Cali, Colombia.
   [Quinn, Julian M. W.] Prince Henrys Inst Med Res, Clayton, Vic, Australia.
RP Chen, QZ (reprint author), Monash Univ, Dept Mat Engn, Monash Med Sch, Clayton, Vic 3800, Australia.
EM qizhi.chen@monash.edu
OI Valencia, Carlos H./0000-0003-4892-9786
CR Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Aronin CEP, 2009, J BIOMED MATER RES A, V89A, P632, DOI 10.1002/jbm.a.32015
   Balaguer T, 2010, TISSUE ENG PT A, V16, P3495, DOI [10.1089/ten.tea.2010.0227, 10.1089/ten.TEA.2010.0227]
   Bohner M, 2012, J EUR CERAM SOC, V32, P2663, DOI 10.1016/j.jeurceramsoc.2012.02.028
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002
   Chen ML, 2011, INT J MOL MED, V27, P545, DOI 10.3892/ijmm.2011.619
   Chen Qizhi, 2012, PROG BIOMATER, V1, P1, DOI DOI 10.1186/2194-0517-1-2
   Currey J.D., 2002, BONES STRUCTURE MECH
   Develioglu H, 2009, DENT MATER J, V28, P396, DOI 10.4012/dmj.28.396
   Egan KP, 2012, HISTOPATHOLOGY, V61, P1168, DOI 10.1111/j.1365-2559.2012.04333.x
   Emmett Holt L., 1925, J BIOL CHEM, V64, P23
   Fielding G, 2013, ACTA BIOMATER, V9, P9137, DOI 10.1016/j.actbio.2013.07.009
   Geffre CP, 2010, J INVEST SURG, V23, P134, DOI 10.3109/08941930903564100
   Gosain AK, 2000, PLAST RECONSTR SURG, V106, P360, DOI 10.1097/00006534-200008000-00018
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   HANSSON LI, 1972, CALC TISS RES, V10, P238, DOI 10.1007/BF02012553
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Ignjatovic NL, 2010, J BIOMED MATER RES B, V94B, P108, DOI 10.1002/jbm.b.31630
   Jones L, 2007, J CRANIO MAXILL SURG, V35, P350, DOI 10.1016/j.jcms.2007.06.004
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kochi G, 2009, ORAL SURG ORAL MED O, V107, pE42, DOI 10.1016/j.tripleo.2009.02.010
   Lange T, 2011, BIOMATERIALS, V32, P4067, DOI 10.1016/j.biomaterials.2011.02.039
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Martiniakova M., 2005, SCR MED, V1, P45
   Mills LA, 2012, J BONE JOINT SURG BR, V94B, P865, DOI 10.1302/0301-620X.94B7.27370
   Naito Y, 2010, J BIOMED MATER RES A, V92A, P542, DOI 10.1002/jbm.a.32367
   Okuda T, 2010, ANN PLAS SURG, V64, P98, DOI 10.1097/SAP.0b013e3181999ec1
   Ophoff J., 2005, BONEKEY OSTEOVISION, V2, P26
   Pannarale L, 1997, ANAT RECORD, V247, P462, DOI 10.1002/(SICI)1097-0185(199704)247:4<462::AID-AR4>3.0.CO;2-T
   Pincus J.B., 1925, J BIOL CHEM, V66, P23
   RAMAN A, 1969, ACTA ORTHOP SCAND, V40, P193, DOI 10.3109/17453676908989498
   Roldan JC, 2010, J CRANIO MAXILL SURG, V38, P423, DOI 10.1016/j.jcms.2010.01.003
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   SCHMITZ JP, 1990, ACTA ANAT, V138, P185
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   Tavassol F, 2011, TISSUE ENG PART C-ME, V17, P1151, DOI [10.1089/ten.tec.2011.0065, 10.1089/ten.TEC.2011.0065]
   Thompson J.C., 2009, BASIC SCI
   Thompson P.C., 2004, PHARMACEUTICS, V31
   Thormann U, 2013, BIOMATERIALS, V34, P8589, DOI 10.1016/j.biomaterials.2013.07.036
   Vajgel A., 2013, CLIN ORAL IMPLAN RES, DOI [10.1111/clr.12194, DOI 10.1111/CLR.12194]
   Wernike E, 2010, EUR CELLS MATER, V19, P30
   Yuan H, 2006, J BIOMED MATER RES A, V78A, P139, DOI 10.1002/jbm.a.30707
   Zanetti AS, 2013, J BIOMED MATER RES B, V101B, P187, DOI 10.1002/jbm.b.32817
NR 46
TC 9
Z9 10
U1 0
U2 27
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUL
PY 2014
VL 20
IS 13-14
BP 1948
EP 1960
DI 10.1089/ten.tea.2013.0696
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AL5KG
UT WOS:000339171900017
PM 24460696
DA 2018-10-20
ER

PT J
AU Cimpean, AM
   Crainiceanu, Z
   Mihailovici, D
   Bratu, T
   Raica, M
AF Cimpean, Anca Maria
   Crainiceanu, Zorin
   Mihailovici, Dorina
   Bratu, Tiberiu
   Raica, Marius
TI Human Conchal Cartilage and Temporal Fascia: An Evidence-based Roadmap
   from Rhinoplasty to an In Vivo Study and Beyond
SO IN VIVO
LA English
DT Article
DE Conchal cartilage; temporal fascia; chick embryo choriallantoic membrane
ID EMBRYO CHORIOALLANTOIC MEMBRANE; ENDOTHELIAL GROWTH-FACTOR;
   ARTICULAR-CARTILAGE; AUGMENTATION RHINOPLASTY; GRAFTS; ANGIOGENESIS;
   TUMSTATIN; SURVIVAL; SURGERY; JOINTS
AB Conchal cartilage or cartilage/temporal fascia composite grafting (DC-F) used for rhinoplasty is applied by plastic surgeons for reconstructive purposes. Previous studies on experimental models such as mice or rabbits have elucidated on the late events following grafting, with tissue specimens being harvested two months after implantation. Early microscopic and molecular events following DC-F grafting are completely unknown. We designed a chick embryo chorioallantoic membrane model for human grafts study, regarding the dynamic observation of graft survival and its mutual interrelation with the chick embryo chorioallantoic membrane microenvironment. The DC-F graft preserved its cartilage component in a normal state compared to cartilage graft-only because of protective factors provided by temporal fascia. Its strong adherence to the cartilage, lack of angiogenic factors and high content of collagen IV-derived fragments with anti-angiogenic effects make the temporal fascia a good protective tissue to prevent implanted cartilage degeneration. The cartilage graft produced high inflammation, stromal fibrosis and activated angiogenic cascade through VEGF-mediated pathways followed by cartilage degeneration. Also, high content of podoplanin from conchal cartilage chondrocytes exerted a major role in inflammation accompanying cartilage graft. The presently employed experimental model allowed us to characterize the early histological and molecular events triggered by temporal fascia, cartilage or composite graft DC-F implanted on chick embryo chorioallantoic membrane. Our microscopic and molecular observations may help explain some post-surgical complications generated after using cartilage alone as biomaterial for nasal augmentation, supporting the use of DC-F composite graft, with the aim to reduce unwanted post-surgical events.
C1 [Cimpean, Anca Maria; Raica, Marius] Victor Babes Univ Med & Pharm, Angiogenesis Res Ctr, Dept Microscop Morphol Histol, Timisoara 300041, Romania.
   [Crainiceanu, Zorin; Mihailovici, Dorina; Bratu, Tiberiu] Victor Babes Univ Med & Pharm, Dept Plast & Reconstruct Surg, Timisoara 300041, Romania.
RP Cimpean, AM (reprint author), Victor Babes Univ Med & Pharm, Angiogenesis Res Ctr, Dept Microscop Morphol Histol, Piata Eftimie Murgu 2, Timisoara 300041, Romania.
EM ancacimpean1972@yahoo.com
CR Albirmawy O A, 2010, J Laryngol Otol, V124, P967, DOI 10.1017/S0022215110000885
   Antohi N, 2012, AESTHET SURG J, V32, P833, DOI 10.1177/1090820X12456196
   BAKER TM, 1994, PLAST RECONSTR SURG, V93, P802, DOI 10.1097/00006534-199404000-00023
   Brenner KA, 2006, PLAST RECONSTR SURG, V117, P105, DOI 10.1097/01.prs.0000195082.38311.f4
   Burgess JK, 2010, AM J RESP CRIT CARE, V181, P106, DOI 10.1164/rccm.200904-0631OC
   Calvert JW, 2006, PLAST RECONSTR SURG, V118, P230, DOI 10.1097/01.prs.0000220463.73865.78
   Coskun BU, 2005, LARYNGOSCOPE, V115, P668, DOI 10.1097/01.mlg.0000161356.35697.f6
   Daniel RK, 2004, PLAST RECONSTR SURG, V113, P2156, DOI 10.1097/01.PRS.0000122544.87086.B9
   Esipov R, 2012, BIOCHIMIE, V94, P1368, DOI 10.1016/j.biochi.2012.03.007
   Fatemi MJ, 2012, ANN PLAS SURG, V69, P326, DOI 10.1097/SAP.0b013e3182275d6a
   Firtina Z, 2009, J BIOL CHEM, V284, P35872, DOI 10.1074/jbc.M109.060384
   GUERREROSANTOS J, 1984, PLAST RECONSTR SURG, V74, P465, DOI 10.1097/00006534-198410000-00001
   Harbison JM, 2012, CURR OPIN OTOLARYNGO, V20, P267, DOI 10.1097/MOO.0b013e328355b1f2
   HOLT GR, 1987, OTOLARYNG CLIN N AM, V20, P853
   Issing W, 2011, EUR ARCH OTO-RHINO-L, V268, P83, DOI 10.1007/s00405-010-1286-z
   Jang YJ, 2012, CURR OPIN OTOLARYNGO, V20, P280, DOI 10.1097/MOO.0b013e328354b390
   Jang YJ, 2009, LARYNGOSCOPE, V119, P1088, DOI 10.1002/lary.20242
   Kim HK, 2011, J PLAST RECONSTR AES, V64, pE193, DOI 10.1016/j.bjps.2011.02.003
   KIROLLES S, 1992, SURG RADIOL ANAT, V14, P331, DOI 10.1007/BF01794760
   Lingaraj K, 2010, ANN ACAD MED SINGAP, V39, P399
   Meisel H H, 1976, Dtsch Zahnarztl Z, V31, P262
   MILLER TA, 1988, PLAST RECONSTR SURG, V81, P524, DOI 10.1097/00006534-198804000-00007
   Miyamoto Y, 2013, MOL IMMUNOL, V54, P199, DOI 10.1016/j.molimm.2012.11.013
   MUENKER R, 1984, AESTHET PLAST SURG, V8, P37, DOI 10.1007/BF01572783
   NAUMANN A, 1995, LARYNGO RHINO OTOL, V74, P69, DOI 10.1055/s-2007-997692
   Pfander D, 2001, ANN RHEUM DIS, V60, P1070, DOI 10.1136/ard.60.11.1070
   Ribatti D, 2008, ROM J MORPHOL EMBRYO, V49, P131
   Ribatti D, 1996, INT J DEV BIOL, V40, P1189
   Sajjadian Ali, 2010, Plast Reconstr Surg, V125, p40e, DOI 10.1097/PRS.0b013e3181c82f12
   Savoldelli C, 2012, REV STOMATOL CHIR, V113, P100, DOI [10.1016/j.stomax.2012.12.010, 10.1016/j.stomax.2011.12.010]
   Scholz B, 2010, EUR CELLS MATER, V20, P24
   SIEMIAN WR, 1988, PLAST RECONSTR SURG, V82, P395, DOI 10.1097/00006534-198809000-00003
   Trimble J R, 1976, Cutis, V17, P777
   Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002
   Wietecha MS, 2013, CURR TOP MICROBIOL, V367, P3, DOI 10.1007/82_2012_287
NR 35
TC 2
Z9 2
U1 0
U2 3
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0258-851X
EI 1791-7549
J9 IN VIVO
JI In Vivo
PD JUL-AUG
PY 2014
VL 28
IS 4
BP 505
EP 514
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AK9VU
UT WOS:000338777500012
PM 24982216
DA 2018-10-20
ER

PT J
AU Lucariello, A
   Cinelli, M
   De Novellis, A
   Nikolopoulos, C
   Esposito, V
   Guerra, G
AF Lucariello, Angela
   Cinelli, Mariapia
   De Novellis, Antonello
   Nikolopoulos, Charalampos
   Esposito, Vicenzo
   Guerra, Germano
TI Effects of the Combined Use of a Dermal Substitute with a Cleansing
   Process in the Simulation of Autologous Skin: A Pilot Study
SO IN VIVO
LA English
DT Article
DE Dermal substitute; Langerhans cells; keratinocytes; TEM
ID CELLS; ANGIOGENESIS; FIBROBLASTS
AB Historically, in severe trauma, such as extensive burns and large loss of substance of the soft tissues, increased emphasis is given to the survival of the traumatized person and less attention is placed on the recovery of the actual traumatized organ. Today, recovery of complete functionality of the injured part and the possibility of minimizing scars in order to make them as acceptable and invisible as possible are also important. The present study analyzed morphologically the events occurring in the wounds of patients in which a dermal substitute was used in combination with a cleansing process. Pre-treatment of the lesion by cleansing followed by the application of a biomaterial showed that in the tissue that forms, a reduced number of cells are present, the collagen is more undulating with interstitial spaces, and Langerhans cells are evident. In addition, these cells participate in the growth and turnover of keratinocytes. The mediating role of these elements would also be strongly dependent on the components of the extracellular matrix of the dermis.
C1 [Lucariello, Angela; De Novellis, Antonello; Nikolopoulos, Charalampos; Esposito, Vicenzo] Univ Naples 2, Sect Human Anat, Dept Mental & Phys Hlth & Prevent Med, I-80138 Naples, Italy.
   [Cinelli, Mariapia] Univ Naples Federico II, Dept Biomorphol & Funct Sci, Naples, Italy.
   [Guerra, Germano] Univ Molise, Dept Med & Hlth Sci, Campobasso, Italy.
RP Lucariello, A (reprint author), Univ Naples 2, Sect Human Anat, Dept Mental & Phys Hlth & Prevent Med, Via L Armanni 5, I-80138 Naples, Italy.
EM angela.lucariello@gmail.com
FU Second University of Naples
FX This study was partially supported by Second University of Naples. The
   Authors would like to thank Dr Pia Furno for editorial assistance.
CR Bache SE, 2011, J PLAST RECONSTR AES, V64, P559, DOI 10.1016/j.bjps.2010.07.032
   Bloch W, 2000, FASEB J, V14, P2373
   Bloemen MCT, 2010, PLAST RECONSTR SURG, V125, P1450, DOI 10.1097/PRS.0b013e3181d62b08
   Campitiello E, 2005, Acta Biomed, V76 Suppl 1, P69
   Cavani Andrea, 2008, V94, P93, DOI 10.1159/000154934
   Esposito V, 2012, ENVIRON POLLUT, V171, P162, DOI 10.1016/j.envpol.2012.07.006
   Igyarto BZ, 2013, CURR OPIN IMMUNOL, V25, P115, DOI 10.1016/j.coi.2012.11.007
   Jeschke MG, 2004, PLAST RECONSTR SURG, V113, P525, DOI 10.1097/01.PRS.0000100813.39746.5A
   Leffler M, 2010, J PLAST RECONSTR AES, V63, P32
   Nguyen D Q A, 2006, J Wound Care, V15, P373
   Nguyen DQA, 2010, BURNS, V36, P23, DOI 10.1016/j.burns.2009.07.011
   Nolte SV, 2008, CELLS TISSUES ORGANS, V187, P165, DOI 10.1159/000111805
   O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6
   Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676
   Wilgus TA, 2008, LAB INVEST, V88, P579, DOI 10.1038/labinvest.2008.36
   Wolter TP, 2005, BRIT J PLAST SURG, V58, P416, DOI 10.1016/j.bjps.2004.04.008
   Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x
NR 17
TC 1
Z9 1
U1 0
U2 0
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0258-851X
EI 1791-7549
J9 IN VIVO
JI In Vivo
PD JUL-AUG
PY 2014
VL 28
IS 4
BP 639
EP 643
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AK9VU
UT WOS:000338777500031
PM 24982235
DA 2018-10-20
ER

PT J
AU Wu, JY
   Li, CW
   Tsai, CH
   Chou, CW
   Chen, DR
   Wang, GJ
AF Wu, Jau-Yi
   Li, Ching-Wen
   Tsai, Ching-Hsiu
   Chou, Chih-Wei
   Chen, Dar-Ren
   Wang, Gou-Jen
TI Synthesis of antibacterial TiO2/PLGA composite biofilms
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
DE Titanium dioxide; TiO2/PLGA composite biofilm; Antibacterial material;
   Artificial dressing
ID WOUND DRESSING APPLICATIONS; MESENCHYMAL STEM-CELLS; IN-VITRO;
   TITANIUM-DIOXIDE; STAPHYLOCOCCUS-AUREUS; TIO2 NANOPARTICLES; AG2O
   NANOPARTICLES; BACTERIA; INFLAMMATION; SCAFFOLDS
AB This study developed a TiO2/PLGA [poly(lactic-co-glycolic acid)] composite biomaterial, which possesses antibacterial properties but is biocompatible, for artificial dressing applications. A sol-gel method was used for the preparation of the nano TiO2 powder with anatase phase. Several concentration ratios of TiO2 versus PLGA were analyzed to optimize the disinfection efficiency of the composite biomaterial. The antibacterial activity of the fabricated TiO2/PLGA composite was measured against Staphylococcus aureus and Escherichia coli. To evaluate the feasibility of the biomaterial on wound healing in vitro, human keratinocytes (HaCaTs), fibroblasts (L929s), and bovine carotid artery endothelial cells (BECs) were seeded on the TiO2/PLGA composite biofilms. To investigate the histological effect of the biocompatible biofilm in vivo, a rat subcutaneous implantation was performed. Our results show that TiO2/PLGA composite biofilms containing 10% TiO2 nanoparticles have an effective antibacterial property, a good survival rate on HaCaTs and L929s, and relative safe stability in tissue implantation.
   From the Clinical Editor: This study reports the development of titanium dioxide-polylactic-co-glycolic acid composite biofilms, which possess antibacterial properties and are biocompatible for dressing applications, as demonstrated in a model system. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wu, Jau-Yi; Wang, Gou-Jen] Natl Chung Hsing Univ, Grad Inst Biomed Engn, Taichung 40227, Taiwan.
   [Li, Ching-Wen; Wang, Gou-Jen] Natl Chung Hsing Univ, PhD Program Tissue Engn & Regenerat Med, Taichung 40227, Taiwan.
   [Tsai, Ching-Hsiu] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan.
   [Wang, Gou-Jen] Natl Chung Hsing Univ, Dept Mech Engn, Taichung 40227, Taiwan.
   [Chou, Chih-Wei] China Med Univ, Dept Cosmeceut, Taichung, Taiwan.
   [Chen, Dar-Ren] Changhua Christian Hosp, Comprehens Breast Canc Ctr, Changhua, Taiwan.
RP Wang, GJ (reprint author), Natl Chung Hsing Univ, Grad Inst Biomed Engn, Taichung 40227, Taiwan.
EM sally82876756@hotmail.com; fayeshin2@hotmail.com;
   chtsai1@dragon.nchu.edu.tw; cwchou@mail.cmu.edu.tw; 1886@cch.org.tw;
   gjwang@dragon.nchu.edu.tw
RI Wang, Gou-Jen/K-1265-2017
OI Wang, Gou-Jen/0000-0002-2405-5474
FU National Science Council of Taiwan [NSC-100-2815-C-005-018-E]
FX This publication was supported by the National Science Council of Taiwan
   under grant number NSC-100-2815-C-005-018-E.
CR Allahverdiyev AM, 2011, FUTURE MICROBIOL, V6, P933, DOI [10.2217/FMB.11.78, 10.2217/fmb.11.78]
   Altankov G, 2003, MATERIALWISS WERKST, V34, P1120, DOI 10.1002/mawe.200300699
   Ambalavanan N, 2013, AM J PHYSIOL-LUNG C, V304, pL152, DOI 10.1152/ajplung.00013.2012
   [Anonymous], 2007, 221962007 ISO
   Arora S, 2009, TOXICOL APPL PHARM, V236, P310, DOI 10.1016/j.taap.2009.02.020
   Arora S, 2012, TOXICOL APPL PHARM, V258, P151, DOI 10.1016/j.taap.2011.11.010
   Asahara T, 2009, JPN J INFECT DIS, V62, P378
   Benabbou AK, 2007, APPL CATAL B-ENVIRON, V76, P257, DOI 10.1016/j.apcatb.2007.05.026
   Buyukhatipoglu K, 2011, J BIOMED MATER RES A, V96A, P186, DOI 10.1002/jbm.a.32972
   Cai KY, 2006, COLLOID SURFACE B, V50, P1, DOI 10.1016/j.colsurfb.2006.03.016
   Cao Y, 2008, J BIOMED MATER RES A, V87A, P719, DOI 10.1002/jbm.a.31781
   Chang H, 2013, EXP TOXICOL PATHOL, V65, P887, DOI 10.1016/j.etp.2013.01.001
   Chien KB, 2012, ACTA BIOMATER, V8, P694, DOI 10.1016/j.actbio.2011.09.036
   Chwalibog A, 2010, INT J NANOMED, V5, P1085, DOI 10.2147/IJN.S13532
   Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1
   Duncan MR, 1991, J INVEST DERMATOL, V97, P689
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Hitkova H, 2012, J OPTOELECTRON BIOME, V4, P9
   Ho CC, 2013, NANOTOXICOLOGY, V7, P105, DOI 10.3109/17435390.2011.635814
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Huang ZB, 2008, LANGMUIR, V24, P4140, DOI 10.1021/la7035949
   Iavicoli I, 2011, EUR REV MED PHARMACO, V15, P481
   Ibanez JA, 2003, J PHOTOCH PHOTOBIO A, V157, P81, DOI 10.1016/S1010-6030(03)00074-1
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kaitainen S, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025009
   Kang BC, 2005, EXP ANIM TOKYO, V54, P37, DOI 10.1538/expanim.54.37
   Kao WJ, 1999, J MATER SCI-MATER M, V10, P601, DOI 10.1023/A:1008971222932
   Kumar PTS, 2010, CARBOHYD POLYM, V80, P761, DOI 10.1016/j.carbpol.2009.12.024
   Li D, 2006, J AM CHEM SOC, V128, P968, DOI 10.1021/ja056609n
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Marano F, 2011, ARCH TOXICOL, V85, P733, DOI 10.1007/s00204-010-0546-4
   McGrath JA, 2004, ROOKS TXB DERMATOLOG, P4190
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Mitoraj D, 2007, PHOTOCH PHOTOBIO SCI, V6, P642, DOI 10.1039/b617043a
   Negi H, 2013, J GEN APPL MICROBIOL, V59, P83, DOI 10.2323/jgam.59.83
   Nissen NN, 1998, AM J PATHOL, V152, P1445
   Paszek E, 2012, J BIOMED NANOTECHNOL, V8, P957, DOI 10.1166/jbn.2012.1463
   PIVARCSI A, 2005, CURR IMMUNOL REV, V1, P29
   Rincon AG, 2003, APPL CATAL B-ENVIRON, V44, P263, DOI 10.1016/S0926-3373(03)00076-6
   Seil JT, 2011, ACTA BIOMATER, V7, P2579, DOI 10.1016/j.actbio.2011.03.018
   Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4
   Tang L, 2010, BRIT J DERMATOL, V163, P38, DOI 10.1111/j.1365-2133.2010.09748.x
   Tucci P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.76
   Varghese S, 2013, J NANOSCI
   Wang GJ, 2010, BIOMED MICRODEVICES, V12, P841, DOI 10.1007/s10544-010-9438-x
   Wang JX, 2008, TOXICOLOGY, V254, P82, DOI 10.1016/j.tox.2008.09.014
   Waser-Althaus J, 2014, J MATER SCI-MATER M, V25, P515, DOI 10.1007/s10856-013-5072-5
   Xue CB, 2010, J NANOSCI NANOTECHNO, V10, P8500, DOI 10.1166/jnn.2010.2682
   Yu BY, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/11/115603
NR 50
TC 26
Z9 28
U1 7
U2 67
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
EI 1549-9642
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD JUL
PY 2014
VL 10
IS 5
BP 1097
EP 1107
DI 10.1016/j.nano.2014.01.002
PG 11
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA AK9GS
UT WOS:000338736200022
PM 24486464
DA 2018-10-20
ER

PT J
AU Murphy, KC
   Fang, SY
   Leach, JK
AF Murphy, Kaitlin C.
   Fang, Sophia Y.
   Leach, J. Kent
TI Human mesenchymal stem cell spheroids in fibrin hydrogels exhibit
   improved cell survival and potential for bone healing
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE Spheroid; Fibrin; Mesenchymal stem cell; Cell survival; Osteogenic
   potential
ID TROPHIC FACTOR SECRETION; MULTICELLULAR SPHEROIDS; ENDOTHELIAL-CELLS;
   STROMAL CELLS; CORD BLOOD; DIFFERENTIATION; SCAFFOLDS; ANGIOGENESIS;
   CULTURE; GELS
AB Mesenchymal stem cells (MSCs) have great therapeutic potential for the repair of nonhealing bone defects, because of their proliferative capacity, multilineage potential, trophic factor secretion and lack of immunogenicity. However, a major challenge to the translation of cell-based therapies into clinical practice is ensuring their survival and function upon implantation into the defect site. We hypothesize that forming MSCs into more physiologic three-dimensional spheroids, rather than employing dissociated cells from two-dimensional monolayer culture, will enhance their survival when exposed to a harsh microenvironment but maintain their osteogenic potential. MSC spheroids were formed by using the hanging drop method with increasing cell numbers. Compared with larger spheroids, the smallest spheroids, which contained 15,000 cells, exhibited increased metabolic activity, reduced apoptosis and the most uniform distribution of proliferating cells. Spheroids were then entrapped in fibrin gels and cultured in serum-free medium and 1 % oxygen. Compared with identical numbers of dissociated MSCs in fibrin gels, spheroids exhibited significantly reduced apoptosis and secreted up to 100-fold more vascular endothelial growth factor. Moreover, fibrin gels containing spheroids and those containing an equivalent number of dissociated cells exhibited similar expression levels of early and late markers of osteogenic differentiation. Thus, MSC spheroids exhibit greater resistance to apoptosis and enhanced proangiogenic potential while maintaining similar osteogenic potential to dissociated MSCs entrapped in a clinically relevant biomaterial, supporting the use of MSC spheroids in cell-based approaches to bone repair.
C1 [Murphy, Kaitlin C.; Fang, Sophia Y.; Leach, J. Kent] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
   [Fang, Sophia Y.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA.
   [Leach, J. Kent] Univ Calif Davis, Sch Med, Dept Orthopaed Surg, Sacramento, CA 95817 USA.
RP Leach, JK (reprint author), Univ Calif Davis, Dept Biomed Engn, 451 Hlth Sci Dr, Davis, CA 95616 USA.
EM jkleach@ucdavis.edu
OI Fogg, Kaitlin/0000-0003-3572-778X
FU NIH [1R03DE021704-01]; Clinical and Translational Science Center (CTSC)
FX This project was supported by NIH Grant 1R03DE021704-01 to J.K.L.; S.F.
   was supported by the Clinical and Translational Science Center (CTSC)
   T32 Pre-Doctoral Clinical Research Training Program.
CR Baraniak PR, 2012, CELL TISSUE RES, V347, P701, DOI 10.1007/s00441-011-1215-5
   Barsotti MC, 2011, CELL PROLIFERAT, V44, P33, DOI 10.1111/j.1365-2184.2010.00715.x
   Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107
   Bhang SH, 2012, TISSUE ENG PT A, V18, P310, DOI [10.1089/ten.tea.2011.0193, 10.1089/ten.TEA.2011.0193]
   Bhang SH, 2012, TISSUE ENG PT A, V18, P2138, DOI [10.1089/ten.tea.2011.0640, 10.1089/ten.TEA.2011.0640]
   Bhang SH, 2011, BIOMATERIALS, V32, P2734, DOI 10.1016/j.biomaterials.2010.12.035
   Binder BY, 2014, TISSUE EN A IN PRESS
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Curcio E, 2007, BIOMATERIALS, V28, P5487, DOI 10.1016/j.biomaterials.2007.08.033
   Davis HE, 2013, TISSUE ENG PT A, V19, P1773, DOI [10.1089/ten.tea.2012.0288, 10.1089/ten.TEA.2012.0288]
   de Sampaio PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030753
   Decaris ML, 2012, TISSUE ENG PT A, V18, P2148, DOI [10.1089/ten.TEA.2011.0677, 10.1089/ten.tea.2011.0677]
   Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fey SJ, 2012, TOXICOL SCI, V127, P403, DOI 10.1093/toxsci/kfs122
   Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226
   Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI [10.1089/ten.tec.2009.0432, 10.1089/ten.TEC.2009.0432]
   He JW, 2010, TISSUE ENG PT A, V16, P127, DOI 10.1089/ten.TEA.2009.0255
   He JW, 2012, TISSUE ENG PT A, V18, P1520, DOI [10.1089/ten.TEA.2011.0127, 10.1089/ten.tea.2011.0127]
   Herrmann JL, 2010, SHOCK, V33, P24, DOI 10.1097/SHK.0b013e3181b7d137
   Hoch AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035579
   Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341
   Kunz-Schughart LA, 1998, INT J EXP PATHOL, V79, P1, DOI 10.1046/j.1365-2613.1998.00051.x
   Lai YZ, 2012, JALA-J LAB AUTOM, V17, P284, DOI 10.1177/2211068212442503
   Laschke MW, 2013, ACTA BIOMATER, V9, P6876, DOI 10.1016/j.actbio.2013.02.013
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Lee EJ, 2012, MOL THER, V20, P1424, DOI 10.1038/mt.2012.58
   Leu A, 2009, TISSUE ENG PT A, V15, P877, DOI 10.1089/ten.tea.2008.0018
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109
   Murphy Kaitlin C, 2012, BMC Res Notes, V5, P423, DOI 10.1186/1756-0500-5-423
   O'Keefe RJ, 2011, TISSUE ENG PART B-RE, V17, P389, DOI [10.1089/ten.teb.2011.0475, 10.1089/ten.TEB.2011.0475]
   Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025
   Potier E, 2007, TISSUE ENG, V13, P1325, DOI 10.1089/ten.2006.0325
   Shaikh FM, 2008, CELLS TISSUES ORGANS, V188, P333, DOI 10.1159/000139772
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   SHWEIKI D, 1995, P NATL ACAD SCI USA, V92, P768, DOI 10.1073/pnas.92.3.768
   Siddappa R, 2007, J ORTHOP RES, V25, P1029, DOI 10.1002/jor.20402
   Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797
   Wang CC, 2009, STEM CELLS, V27, P724, DOI 10.1634/stemcells.2008-0944
   Wenger A, 2004, TISSUE ENG, V10, P1536, DOI 10.1089/1076327042500283
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
NR 48
TC 35
Z9 38
U1 2
U2 26
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD JUL
PY 2014
VL 357
IS 1
BP 91
EP 99
DI 10.1007/s00441-014-1830-z
PG 9
WC Cell Biology
SC Cell Biology
GA AK9PV
UT WOS:000338759900009
PM 24781147
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Nguyen, MK
   Alsberg, E
AF Minh Khanh Nguyen
   Alsberg, Eben
TI Bioactive factor delivery strategies from engineered polymer hydrogels
   for therapeutic medicine
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Polymerization; Polymeric biomaterial; Bioactive molecules; Controlled
   release; Release mechanism
ID POLY(ETHYLENE GLYCOL) HYDROGELS; BLOCK-COPOLYMER HYDROGELS;
   BIODEGRADABLE TRIBLOCK COPOLYMER; CONTROLLED DRUG-DELIVERY; SITU FORMING
   HYDROGELS; HUMAN GROWTH-HORMONE; PEO-PPO-PEO;
   CYCLODEXTRIN/PEG-CHOLESTEROL HYDROGELS; PHOTOCROSSLINKED ALGINATE
   HYDROGELS; INJECTABLE THERMOSENSITIVE HYDROGEL
AB Polymer hydrogels have been widely explored as therapeutic delivery matrices because of their ability to present sustained, localized and controlled release of bioactive factors. Bioactive factor delivery from injectable biopolymer hydrogels provides a versatile approach to treat a wide variety of diseases, to direct cell function and to enhance tissue regeneration. The innovative development and modification of both natural- (e.g., alginate (ALG), chitosan, hyaluronic acid (HA), gelatin, heparin (HEP), etc.) and synthetic- (e.g., polyesters, polyethyleneimine (PEI), etc.) based polymers has resulted in a variety of approaches to design drug delivery hydrogel systems from which loaded therapeutics are released. This review presents the state-of-the-art in a wide range of hydrogels that are formed though self-assembly of polymers and peptides, chemical crosslinking, ionic crosslinking and biomolecule recognition. Hydrogel design for bioactive factor delivery is the focus of the first section. The second section then thoroughly discusses release strategies of payloads from hydrogels for therapeutic medicine, such as physical incorporation, covalent tethering, affinity interactions, on demand release and/or use of hybrid polymer scaffolds, with an emphasis on the last 5 years. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Minh Khanh Nguyen; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, Cleveland, OH 44106 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, 204 Wickenden,10900 Euclid Ave, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
OI Alsberg, Eben/0000-0002-3487-4625
FU National Institutes of Health [R01AR063194, R56DE022376, R21AR061265];
   Department of Defense Congressionally Directed Medical Research Programs
   [OR110196]; AO Foundation; New Scholar in Aging grant from the Ellison
   Medical Foundation
FX We apologize that space limitations prevent us from including all of the
   excellent work that has been done in this rapidly growing area. The
   authors gratefully acknowledge funding from the National Institutes of
   Health (R01AR063194, R56DE022376, R21AR061265), the Department of
   Defense Congressionally Directed Medical Research Programs (OR110196),
   the AO Foundation, and a New Scholar in Aging grant from the Ellison
   Medical Foundation. We thank Daniel Alt, Julia Samorezov and Alex
   Gilewski for providing critical comments on the manuscript.
CR ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   Anumolu SS, 2011, BIOMATERIALS, V32, P1204, DOI 10.1016/j.biomaterials.2010.08.117
   Arciello M, 2005, BIOCHEM BIOPH RES CO, V327, P454, DOI 10.1016/j.bbrc.2004.12.022
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P82, DOI 10.1021/bm1010195
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P153, DOI 10.1021/bm010137x
   Bhat A, 2013, FASEB J, V27, P4844, DOI 10.1096/fj.12-213611
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033
   Branco MC, 2009, BIOMATERIALS, V30, P1339, DOI 10.1016/j.biomaterials.2008.11.019
   BROWNLEE M, 1979, SCIENCE, V206, P1190, DOI 10.1126/science.505005
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Butler MF, 2003, J POLYM SCI POL CHEM, V41, P3941, DOI 10.1002/pola.10960
   Censi R, 2009, J CONTROL RELEASE, V140, P230, DOI 10.1016/j.jconrel.2009.06.003
   Censi R, 2010, BIOMACROMOLECULES, V11, P2143, DOI 10.1021/bm100514p
   Censi R, 2010, MACROMOLECULES, V43, P5771, DOI 10.1021/ma100606a
   Chen PC, 2004, J BIOMED MATER RES A, V70A, P459, DOI 10.1002/jbm.a.30101
   Chen SB, 2005, INT J PHARM, V288, P207, DOI 10.1016/j.ijpharm.2004.09.026
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Cheng YL, 2012, BIOMACROMOLECULES, V13, P2053, DOI 10.1021/bm3004308
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chiu YL, 2009, BIOMATERIALS, V30, P4877, DOI 10.1016/j.biomaterials.2009.05.052
   Choh SY, 2011, BIOMACROMOLECULES, V12, P1126, DOI 10.1021/bm101451k
   Choi S, 2004, PHARM RES, V21, P827, DOI 10.1023/B:PHAM.0000026435.27086.94
   Choi S, 2003, PHARM RES, V20, P2008, DOI 10.1023/B:PHAM.0000008050.99985.5c
   Chun C, 2009, BIOMATERIALS, V30, P4752, DOI 10.1016/j.biomaterials.2009.05.031
   Chun C, 2009, BIOMATERIALS, V30, P2349, DOI 10.1016/j.biomaterials.2008.12.083
   Chung C, 2006, J BIOMED MATER RES A, V77A, P518, DOI 10.1002/jbm.a.30660
   Chung HJ, 2005, CURR APPL PHYS, V5, P485, DOI 10.1016/j.cap.2005.01.015
   Clark M, 2009, POLYM INT, V58, P1190, DOI 10.1002/pi.2650
   Cohn D, 2006, BIOMATERIALS, V27, P1718, DOI 10.1016/j.biomaterials.2005.10.035
   Cohn D, 2003, BIOMATERIALS, V24, P3707, DOI 10.1016/S0142-9612(03)00245-X
   Huynh CT, 2012, POLYMER, V53, P4069, DOI 10.1016/j.polymer.2012.07.031
   Huynh CT, 2011, SOFT MATTER, V7, P8984, DOI 10.1039/c1sm05919j
   Huynh CT, 2011, MACROMOLECULES, V44, P6629, DOI 10.1021/ma201261m
   Huynh CT, 2011, ACTA BIOMATER, V7, P3123, DOI 10.1016/j.actbio.2011.05.004
   Huynh CT, 2011, SOFT MATTER, V7, P4974, DOI 10.1039/c1sm05080j
   Crescenzi V, 2007, BIOMACROMOLECULES, V8, P1844, DOI 10.1021/bm0700800
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Davis NE, 2010, BIOMATERIALS, V31, P7288, DOI 10.1016/j.biomaterials.2010.06.003
   de Jong SJ, 2000, MACROMOLECULES, V33, P3680, DOI 10.1021/ma992067g
   de Jong SJ, 1998, MACROMOLECULES, V31, P6397, DOI 10.1021/ma980553i
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   DeFail AJ, 2006, J BIOMED MATER RES A, V79A, P954, DOI 10.1002/jbm.a.30865
   des Rieux A, 2011, J CONTROL RELEASE, V150, P272, DOI 10.1016/j.jconrel.2010.11.028
   Ding CX, 2010, BIOMACROMOLECULES, V11, P1043, DOI 10.1021/bm1000179
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   DuValla GA, 2009, ANTI-CANCER DRUG, V20, P89, DOI 10.1097/CAD.0b013e3283222c12
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   Elstad NL, 2009, ADV DRUG DELIVER REV, V61, P785, DOI 10.1016/j.addr.2009.04.010
   Epstein-Barash H, 2010, BIOMATERIALS, V31, P5208, DOI 10.1016/j.biomaterials.2010.03.008
   Esposito E, 1996, INT J PHARM, V142, P9, DOI 10.1016/0378-5173(96)04649-2
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Ferretti M, 2006, TISSUE ENG, V12, P2657, DOI 10.1089/ten.2006.12.2657
   Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   GANDER B, 1989, PHARMACEUT RES, V6, P578, DOI 10.1023/A:1015949330425
   Garbern JC, 2010, BIOMACROMOLECULES, V11, P1833, DOI 10.1021/bm100318z
   Garripelli VK, 2010, ACTA BIOMATER, V6, P477, DOI 10.1016/j.actbio.2009.07.005
   Garripelli VK, 2012, J BIOMAT SCI-POLYM E, V23, P1505, DOI 10.1163/092050611X584414
   Gary DJ, 2007, J CONTROL RELEASE, V121, P64, DOI 10.1016/j.jconrel.2007.05.021
   Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026
   Glassman MJ, 2013, ADV FUNCT MATER, V23, P1182, DOI 10.1002/adfm.201202034
   GLATTER O, 1994, MACROMOLECULES, V27, P6046, DOI 10.1021/ma00099a017
   Gong CY, 2009, J PHARM SCI-US, V98, P3707, DOI 10.1002/jps.21694
   Gordon S, 2010, EUR J PHARM SCI, V41, P360, DOI 10.1016/j.ejps.2010.07.004
   GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317
   GREENBERG CS, 1991, FASEB J, V5, P3071
   Greenwald RB, 1996, J MED CHEM, V39, P424, DOI 10.1021/jm950475e
   Grove TZ, 2010, J AM CHEM SOC, V132, P14024, DOI 10.1021/ja106619w
   Haines-Butterick LA, 2008, BIOMATERIALS, V29, P4164, DOI 10.1016/j.biomaterials.2008.07.009
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hiemstra C, 2005, MACROMOL SYMP, V224, P119, DOI 10.1002/masy.200550611
   Hiemstra C, 2007, BIOMACROMOLECULES, V8, P1548, DOI 10.1021/bm061191m
   Hiemstra C, 2006, BIOMACROMOLECULES, V7, P2790, DOI 10.1021/bm060630e
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hornof MD, 2003, EUR J PHARM BIOPHARM, V55, P185, DOI 10.1016/S0939-6411(02)00162-5
   Hu BH, 2003, J AM CHEM SOC, V125, P14298, DOI 10.1021/ja038593b
   Huang YC, 2005, GENE THER, V12, P418, DOI 10.1038/sj.gt.3302439
   Hudson SP, 2010, BIOMATERIALS, V31, P1444, DOI 10.1016/j.biomaterials.2009.11.016
   Huynh DP, 2008, BIOMATERIALS, V29, P2527, DOI 10.1016/j.biomaterials.2008.02.016
   Huynh DP, 2009, POLYMER, V50, P2565, DOI 10.1016/j.polymer.2009.03.060
   Hyun H, 2007, BIOMACROMOLECULES, V8, P1093, DOI 10.1021/bm060771u
   ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625
   Ito T, 2007, BIOMATERIALS, V28, P3418, DOI 10.1016/j.biomaterials.2007.04.017
   Jeon O, 2013, ADV FUNCT MATER, V23, P4765, DOI 10.1002/adfm.201300529
   Jeon O, 2013, ADV MATER, V25, P6366, DOI 10.1002/adma.201302364
   Jeon O, 2014, ACTA BIOMATER, V10, P47, DOI 10.1016/j.actbio.2013.09.004
   Jeon O, 2013, TISSUE ENG PT A, V19, P1424, DOI [10.1089/ten.tea.2012.0581, 10.1089/ten.TEA.2012.0581]
   Jeon O, 2012, BIOMATERIALS, V33, P3503, DOI 10.1016/j.biomaterials.2012.01.041
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Jeon O, 2010, TISSUE ENG PT A, V16, P2915, DOI [10.1089/ten.tea.2010.0096, 10.1089/ten.TEA.2010.0096]
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Jeong B, 1999, COLLOID SURFACE B, V16, P185, DOI 10.1016/S0927-7765(99)00069-7
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jeong SI, 2012, EUR CELLS MATER, V24, P331, DOI 10.22203/eCM.v024a24
   Jin J, 2004, BIOMACROMOLECULES, V5, P162, DOI 10.1021/bm034286m
   Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032
   Jonker AM, 2012, CHEM MATER, V24, P759, DOI 10.1021/cm202640w
   Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b
   Kang GD, 2006, INT J PHARM, V319, P29, DOI 10.1016/j.ijpharm.2006.03.032
   Kast CE, 2001, BIOMATERIALS, V22, P2345, DOI 10.1016/S0142-9612(00)00421-X
   Katakam M, 1997, INT J PHARM, V152, P53, DOI 10.1016/S0378-5173(97)04920-X
   Nguyen K, 2013, ACTA BIOMATER, V9, P4487, DOI 10.1016/j.actbio.2012.08.012
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   Kim KS, 2011, ACTA BIOMATER, V7, P666, DOI 10.1016/j.actbio.2010.09.030
   Kim MS, 2006, J APPL POLYM SCI, V102, P1561, DOI 10.1002/app.23528
   Kim YJ, 2001, PHARMACEUT RES, V18, P548, DOI 10.1023/A:1011074915438
   Kim YM, 2012, ACS NANO, V6, P5757, DOI 10.1021/nn300842a
   King WJ, 2009, SOFT MATTER, V5, P2399, DOI 10.1039/b819060g
   Kirchmajer DM, 2013, RSC ADV, V3, P1073, DOI 10.1039/c2ra22859a
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   KITANO S, 1992, J CONTROL RELEASE, V19, P162
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Ko DY, 2013, PROG POLYM SCI, V38, P672, DOI 10.1016/j.progpolymsci.2012.08.002
   Kopecek J, 2012, ANGEW CHEM INT EDIT, V51, P7396, DOI 10.1002/anie.201201040
   Kopecek J, 2009, ACTA BIOMATER, V5, P805, DOI 10.1016/j.actbio.2008.10.001
   Krebs MD, 2010, J BIOMED MATER RES A, V92A, P1131, DOI 10.1002/jbm.a.32441
   Krebs MD, 2009, J AM CHEM SOC, V131, P9204, DOI 10.1021/ja9037615
   Kulkarni RV, 2009, J BIOACT COMPAT POL, V24, P368, DOI 10.1177/0883911509104475
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Kurisawa M, 2005, CHEM COMMUN, P4312, DOI 10.1039/b506989k
   Kwon KW, 2002, POLYMER, V43, P3353, DOI 10.1016/S0032-3861(02)00155-6
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee DS, 2001, MACROMOL RAPID COMM, V22, P587, DOI 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8
   Lee F, 2009, J CONTROL RELEASE, V134, P186, DOI 10.1016/j.jconrel.2008.11.028
   Lee J, 2010, PHARM RES-DORDR, V27, P767, DOI 10.1007/s11095-010-0067-0
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee KY, 2003, ADV MATER, V15, P1828, DOI 10.1002/adma.200305406
   Lee KY, 2001, ADV MATER, V13, P837, DOI 10.1002/1521-4095(200106)13:11<837::AID-ADMA837>3.0.CO;2-D
   Lee PY, 2003, PHARM RES, V20, P1995, DOI 10.1023/B:PHAM.0000008048.58777.da
   Lee SC, 2013, ADV DRUG DELIVER REV, V65, P17, DOI 10.1016/j.addr.2012.07.015
   Lee SB, 1999, MACROMOLECULES, V32, P7820, DOI 10.1021/ma990645n
   Lei YG, 2009, BIOMATERIALS, V30, P254, DOI 10.1016/j.biomaterials.2008.09.027
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Li CM, 2005, BIOMACROMOLECULES, V6, P994, DOI 10.1021/bm049331k
   Li J, 2006, BIOMATERIALS, V27, P4132, DOI 10.1016/j.biomaterials.2006.03.025
   LI J, 1994, POLYM J, V26, P1019, DOI 10.1295/polymj.26.1019
   Li J, 2003, J BIOMED MATER RES A, V65A, P196, DOI 10.1002/jbm.a.10444
   Li J, 2001, MACROMOLECULES, V34, P7236, DOI 10.1021/ma010742s
   Li J, 2010, NPG ASIA MATER, V2, P112, DOI 10.1038/asiamat.2010.84
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Li ZH, 2003, PHARMACEUT RES, V20, P884, DOI 10.1023/A:1023887203111
   Lin CC, 2009, ADV FUNCT MATER, V19, P2325, DOI 10.1002/adfm.200900107
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Loh XJ, 2007, BIOMATERIALS, V28, P4113, DOI 10.1016/j.biomaterials.2007.05-016
   Lu HD, 2012, BIOMATERIALS, V33, P2145, DOI 10.1016/j.biomaterials.2011.11.076
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Ma D, 2011, J COLLOID INTERF SCI, V364, P566, DOI 10.1016/j.jcis.2011.08.051
   Maia J, 2005, POLYMER, V46, P9604, DOI 10.1016/j.polymer.2005.07.089
   Malkoch M, 2006, CHEM COMMUN, P2774, DOI 10.1039/b603438a
   Manaka T, 2011, BIOMATERIALS, V32, P9642, DOI 10.1016/j.biomaterials.2011.08.026
   Masters KS, 2004, J BIOMED MATER RES A, V71A, P172, DOI 10.1002/jbm.a.30149
   Matsumoto A, 2012, ANGEW CHEM INT EDIT, V51, P2124, DOI 10.1002/anie.201106252
   McCall JD, 2012, BIOMACROMOLECULES, V13, P2410, DOI 10.1021/bm300671s
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   Miyata T, 2006, P NATL ACAD SCI USA, V103, P1190, DOI 10.1073/pnas.0506786103
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Miyata T, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P65, DOI 10.1007/978-1-4419-5919-5_4
   Moffat KL, 2004, J BIOMED MATER RES B, V71B, P181, DOI 10.1002/jbm.b.30070
   Morch YA, 2006, BIOMACROMOLECULES, V7, P1471, DOI 10.1021/bm060010d
   MORTENSEN K, 1993, MACROMOLECULES, V26, P4128, DOI 10.1021/ma00068a010
   Mosiewicz KA, 2010, J AM CHEM SOC, V132, P5972, DOI 10.1021/ja9098164
   Moura MJ, 2007, BIOMACROMOLECULES, V8, P3823, DOI 10.1021/bm700762w
   Mukose T, 2004, MACROMOL BIOSCI, V4, P361, DOI 10.1002/mabi.200300112
   Murdan S, 2003, J CONTROL RELEASE, V92, P1, DOI 10.1016/S0168-3659(03)00303-1
   Nagai Y, 2006, J CONTROL RELEASE, V115, P18, DOI 10.1016/j.jconrel.2006.06.031
   Namgung R, 2009, BIOMATERIALS, V30, P5225, DOI 10.1016/j.biomaterials.2009.05.073
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nguyen MK, 2009, POLYMER, V50, P5205, DOI 10.1016/j.polymer.2009.09.040
   Nguyen MK, 2009, BIOMACROMOLECULES, V10, P728, DOI 10.1021/bm900183j
   Ni XP, 2009, J BIOMED MATER RES A, V88A, P1031, DOI 10.1002/jbm.a.31906
   Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019
   Nimmo CM, 2011, BIOMACROMOLECULES, V12, P824, DOI 10.1021/bm101446k
   O'Lenick TG, 2010, LANGMUIR, V26, P8787, DOI 10.1021/la9045308
   Ogushi Y, 2007, J BIOSCI BIOENG, V104, P30, DOI 10.1263/jbb.104.30
   Oh HJ, 2008, MACROMOLECULES, V41, P8204, DOI 10.1021/ma8014504
   Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002
   Ossipov DA, 2006, MACROMOLECULES, V39, P1709, DOI 10.1021/ma052545p
   Park KM, 2010, BIOMACROMOLECULES, V11, P706, DOI 10.1021/bm9012875
   Park MR, 2010, BIOMATERIALS, V31, P1349, DOI 10.1016/j.biomaterials.2009.10.022
   Park MH, 2012, ACCOUNTS CHEM RES, V45, P424, DOI 10.1021/ar200162j
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Proske D, 2005, APPL MICROBIOL BIOT, V69, P367, DOI 10.1007/s00253-005-0193-5
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Radu-Wu LC, 2009, BIOMACROMOLECULES, V10, P2319, DOI 10.1021/bm9005084
   Reeves R, 2010, POLYMERS-BASEL, V2, P252, DOI 10.3390/polym2030252
   Robb SA, 2007, BIOMACROMOLECULES, V8, P2294, DOI 10.1021/bm070267r
   Saik JE, 2011, ACTA BIOMATER, V7, P133, DOI 10.1016/j.actbio.2010.08.018
   Saito H, 2007, J BIOACT COMPAT POL, V22, P589, DOI 10.1177/0883911507084653
   Sakai S, 2010, ACTA BIOMATER, V6, P1446, DOI 10.1016/j.actbio.2009.10.004
   Sakai S, 2009, J MATER CHEM, V19, P230, DOI 10.1039/b812086b
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakloetsakun D, 2009, BIOMATERIALS, V30, P6151, DOI 10.1016/j.biomaterials.2009.07.060
   Saraf A, 2006, ADV DRUG DELIVER REV, V58, P592, DOI 10.1016/j.addr.2006.03.005
   Satarkar NS, 2008, J CONTROL RELEASE, V130, P246, DOI 10.1016/j.jconrel.2008.06.008
   Satarkar NS, 2008, ACTA BIOMATER, V4, P11, DOI 10.1016/j.actbio.2007.07.009
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Schacht E, 1997, REACT FUNCT POLYM, V33, P109, DOI 10.1016/S1381-5148(97)00047-3
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Schillemans JP, 2011, J CONTROL RELEASE, V150, P266, DOI 10.1016/j.jconrel.2010.11.027
   Shih H, 2012, BIOMACROMOLECULES, V13, P2003, DOI 10.1021/bm300752j
   Shim MS, 2002, J BIOMED MATER RES, V61, P188, DOI 10.1002/jbm.10164
   Shim WS, 2007, INT J PHARM, V331, P11, DOI 10.1016/j.ijpharm.2006.09.027
   Shim WS, 2006, BIOMACROMOLECULES, V7, P1935, DOI 10.1021/bm0600567
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Shung AK, 2003, TISSUE ENG, V9, P243, DOI 10.1089/107632703764664710
   Siemoneit U, 2006, INT J PHARM, V312, P66, DOI 10.1016/j.ijpharm.2005.12.046
   Singh A, 2009, BIOMATERIALS, V30, P5187, DOI 10.1016/j.biomaterials.2009.06.001
   Singla AK, 2002, INT J PHARM, V235, P179, DOI 10.1016/S0378-5173(01)00986-3
   Sivakumaran D, 2011, BIOMACROMOLECULES, V12, P4112, DOI 10.1021/bm201170h
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Solorio LD, 2012, STEM CELL TRANSL MED, V1, P632, DOI 10.5966/sctm.2012-0039
   Solorio LD, 2012, J CONTROL RELEASE, V158, P224, DOI 10.1016/j.jconrel.2011.11.003
   Soontornworajit B, 2011, BIOMATERIALS, V32, P6839, DOI 10.1016/j.biomaterials.2011.05.074
   Soontornworajit B, 2010, BIOMACROMOLECULES, V11, P2724, DOI [10.1021/bm1007741, 10.1021/bm100774t]
   Soontornworajit B, 2010, CHEM COMMUN, V46, P1857, DOI 10.1039/b924909e
   Storrie H, 2006, ADV DRUG DELIVER REV, V58, P500, DOI 10.1016/j.addr.2006.03.004
   Sun QH, 2010, PHARM RES-DORD, V27, P264, DOI 10.1007/s11095-009-0014-0
   Sundaram M, 2003, P NATL ACAD SCI USA, V100, P651, DOI 10.1073/pnas.252643299
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Tae G, 2005, BIOMATERIALS, V26, P5259, DOI 10.1016/j.biomaterials.2005.01.042
   Takahashi H, 2010, J CONTROL RELEASE, V147, P400, DOI 10.1016/j.jconrel.2010.08.019
   Tan HP, 2010, MATERIALS, V3, P1746, DOI 10.3390/ma3031746
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Tang T, 2006, MACROMOL CHEM PHYSIC, V207, P1718, DOI 10.1002/macp.200600309
   Teixeira LSM, 2012, BIOMATERIALS, V33, P1281, DOI 10.1016/j.biomaterials.2011.10.067
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Thomopoulos S, 2007, J ORTHOP RES, V25, P1358, DOI 10.1002/jor.20444
   Timko BP, 2010, ADV MATER, V22, P4925, DOI 10.1002/adma.201002072
   Tizzotti M, 2010, J POLYM SCI POL CHEM, V48, P2733, DOI 10.1002/pola.24015
   Toledano S, 2006, J AM CHEM SOC, V128, P1070, DOI 10.1021/ja056549l
   Tran NQ, 2010, BIOMACROMOLECULES, V11, P617, DOI 10.1021/bm100047y
   Tsumoto K., 2001, ENCY LIFE SCI
   van de Manakker F, 2008, LANGMUIR, V24, P12559, DOI 10.1021/la8023748
   van de Manakker F, 2008, MACROMOLECULES, V41, P1766, DOI 10.1021/ma702607r
   van de Manakker F, 2009, ADV FUNCT MATER, V19, P2992, DOI 10.1002/adfm.200900603
   van de Weert Marco, 2005, Expert Opin Drug Deliv, V2, P1029, DOI 10.1517/17425247.2.6.1029
   van Dijk M, 2010, BIOMACROMOLECULES, V11, P1608, DOI 10.1021/bm1002637
   Van Thienen TG, 2007, INT J PHARM, V337, P31, DOI 10.1016/j.ijpharm.2006.12.022
   Van Tomme SR, 2008, INT J PHARM, V355, P1, DOI 10.1016/j.ijpharm.2008.01.057
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Verheyen E, 2010, MACROMOL BIOSCI, V10, P1517, DOI 10.1002/mabi.201000168
   Vernon B, 2003, J BIOMED MATER RES A, V64A, P447, DOI 10.1002/jbm.a.10369
   Wang QG, 2008, SOFT MATTER, V4, P550, DOI 10.1039/b715439a
   Wang YY, 2010, RES J BIOTECHNOL, V5, P5
   Watanabe M, 1998, J AM CHEM SOC, V120, P5577, DOI 10.1021/ja973070n
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Wong DY, 2010, MACROMOLECULES, V43, P2824, DOI 10.1021/ma9023679
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Wood MD, 2009, J BIOMED MATER RES A, V89A, P909, DOI 10.1002/jbm.a.32043
   Wu C, 1998, PHYS REV LETT, V80, P4092, DOI 10.1103/PhysRevLett.80.4092
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Xiong XY, 2005, POLYMER, V46, P1841, DOI 10.1016/j.polymer.2005.01.01
   Xun W, 2009, MACROMOL BIOSCI, V9, P1219, DOI 10.1002/mabi.200900298
   Yan B, 2012, J AM CHEM SOC, V134, P16558, DOI 10.1021/ja308876j
   Yang JY, 2006, BIOMACROMOLECULES, V7, P1187, DOI 10.1021/bm051002k
   Yi H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-211
   Yoon JJ, 2007, J BIOMED MATER RES A, V83A, P597, DOI 10.1002/jbm.a.31271
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yung CW, 2007, J BIOMED MATER RES A, V83A, P1039, DOI 10.1002/jbm.a.31431
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang J, 2009, CARBOHYD POLYM, V77, P583, DOI 10.1016/j.carbpol.2009.01.023
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang Y, 2005, J CONTROL RELEASE, V105, P260, DOI 10.1016/j.jconrel.2005.04.001
   Zhao F, 2011, LANGMUIR, V27, P1510, DOI 10.1021/la103982e
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
   Zhu W, 2006, J APPL POLYM SCI, V99, P2375, DOI 10.1002/app.22674
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
   Zustiak SP, 2011, BIOTECHNOL BIOENG, V108, P197, DOI 10.1002/bit.22911
NR 292
TC 89
Z9 89
U1 21
U2 316
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
EI 1873-1619
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD JUL
PY 2014
VL 39
IS 7
BP 1235
EP 1265
DI 10.1016/j.progpolymsci.2013.12.001
PG 31
WC Polymer Science
SC Polymer Science
GA AK7LI
UT WOS:000338609400001
PM 25242831
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Higuchi, A
   Ling, QD
   Kumar, S
   Munusamy, M
   Alarfajj, AA
   Umezawa, A
   Wu, GJ
AF Higuchi, Akon
   Ling, Qing-Dong
   Kumar, Suresh
   Munusamy, Murugan
   Alarfajj, Abdullah A.
   Umezawa, Akihiro
   Wu, Gwo-Jang
TI Design of polymeric materials for culturing human pluripotent stem
   cells: Progress toward feeder-free and xeno-free culturing
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Biomaterial; Embryonic stem cells; Extracellular matrix; Cell culture;
   Hydrogel; Microcarrier; Microcapsule
ID TERM SELF-RENEWAL; MICROCARRIER SUSPENSION-CULTURES; EXTRACELLULAR
   MATRICES; RECOMBINANT VITRONECTIN; BIOMEDICAL APPLICATIONS;
   MYOCARDIAL-INFARCTION; STABLE PROPAGATION; SCALABLE EXPANSION; DEFINED
   CONDITIONS; DIFFERENTIATION
AB This review describes recent developments regarding the use of natural and synthetic polymers to support the propagation of human pluripotent stem cells (hPSCs), human embryonic stem cells (hESCs), and induced pluripotent stem cells (hiPSCs) while maintaining pluripotency in feeder-free and xeno-free cultures. The development of methods for culturing these cells without using mouse embryonic fibroblasts (MEFs) as a feeder layer will enable more reproducible culture conditions and reduce the risk of xenogenic contaminants, thus increasing the potential clinical applications of differentiated hPSCs. Human or recombinant fibronectin, laminin-511, and vitronectin, which are components of the extracellular matrix (ECM), have been used instead of Matrigel for the feeder-free growth of undifferentiated hPSCs. Successful hPSC cultures have been described for the following conditions: on oligopeptide-immobilized surfaces derived from vitronectin, on microcarriers prepared from synthetic polymers, and encapsulated within three-dimensional (3D) hydrogels composed of alginate and other hydrophilic natural polymers. Recently, synthetic biomaterials that allow hPSCs to maintain pluripotency by secreting endogenous ECM components have been designed. The combination of human ECM proteins or cell adhesion molecules (e.g., oligopeptides and poly-D-lysine) and synthetic biomaterials with well-designed surfaces and/or structures (e.g., scaffolds, hydrogels, microcarriers, microcapsules, or microfibers) in the presence of a chemically defined medium containing recombinant growth factors would offer a xeno-free alternative to feeder cells for culturing hPSCs and maintaining their pluripotency. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Higuchi, Akon; Kumar, Suresh] Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan 32001, Taiwan.
   [Higuchi, Akon; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod, Tokyo 1578535, Japan.
   [Higuchi, Akon; Ling, Qing-Dong] Cathay Gen Hosp, Cathay Med Res Inst, Taipei 221, Taiwan.
   [Ling, Qing-Dong] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Taoyuan 32001, Taiwan.
   [Kumar, Suresh] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Slangor, Malaysia.
   [Munusamy, Murugan; Alarfajj, Abdullah A.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
   [Wu, Gwo-Jang] Tri Serv Gen Hosp, Natl Def Med Ctr, Grad Inst Med Sci, Taipei 114, Taiwan.
   [Wu, Gwo-Jang] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Obstet & Gynecol, Taipei 114, Taiwan.
RP Higuchi, A (reprint author), Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan 32001, Taiwan.
EM higuchi@ncu.edu.tw
OI Kumar S, Suresh/0000-0002-0505-7554; Higuchi, Akon/0000-0003-2970-8531
FU National Science Council of Taiwan [NSC100-2120-M-008-004,
   NSC101-2120-M-008-003]; LandSeed Hospital project [NCU-LSH-101-A-001,
   NCU-LSH-102-A-003]; Cathay General Hospital Project [101CGH-NCU-A2,
   102NCU-CGH-02]; Cathay General Hospital Medical Research Project
   [CGH-MR-10025, CGH-MR-10103, CGH-MR-A10204]; National Defense Medical
   Center Project [102NCU-NDMC-01]; Ministry of Education, Culture, Sports,
   Science, and Technology of Japan [24560968]
FX This research was partially supported by the National Science Council of
   Taiwan under Grant Nos. NSC100-2120-M-008-004 and NSC101-2120-M-008-003.
   This work was also supported by the LandSeed Hospital project
   (NCU-LSH-101-A-001 and NCU-LSH-102-A-003), the Cathay General Hospital
   Project (101CGH-NCU-A2 and 102NCU-CGH-02), the Cathay General Hospital
   Medical Research Project (CGH-MR-10025, CGH-MR-10103 and CGH-MR-A10204),
   and the National Defense Medical Center Project (102NCU-NDMC-01). A
   Grant-in-Aid for Scientific Research (No. 24560968) from the Ministry of
   Education, Culture, Sports, Science, and Technology of Japan is also
   acknowledged. Deanship of Scientific Research, College of Science
   Research Centre, King Saud University, Saudi Arabia is also
   acknowledged. Some sentences in Sections 3.1 and 4.3 were taken from
   Refs. 42 and 24, respectively with permission from American Chemical
   Society (copyright 2011, 2013).
CR Abraham S, 2010, BIOTECHNOL PROGR, V26, P1126, DOI 10.1002/btpr.412
   Abraham S, 2009, REGEN MED, V4, P561, DOI [10.2217/rme.09.23, 10.2217/RME.09.23]
   Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z
   Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147
   Amit M, 2011, NAT PROTOC, V6, P572, DOI 10.1038/nprot.2011.325
   Amit M, 2010, STEM CELL REV REP, V6, P248, DOI 10.1007/s12015-010-9149-y
   Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112
   Bardy J, 2013, TISSUE ENG PART C-ME, V19, P166, DOI [10.1089/ten.tec.2012.0146, 10.1089/ten.TEC.2012.0146]
   Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235
   Bergstrom R, 2011, METHODS MOL BIOL, V767, P125, DOI 10.1007/978-1-61779-201-4_9
   Bigdeli N, 2008, J BIOTECHNOL, V133, P146, DOI 10.1016/j.jbiotec.2007.08.045
   Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291
   Brafman DA, 2010, BIOMATERIALS, V31, P9135, DOI 10.1016/j.biomaterials.2010.08.007
   Carlson AL, 2012, FASEB J, V26, P3240, DOI 10.1096/fj.11-192732
   Carpenter MK, 2004, DEV DYNAM, V229, P243, DOI 10.1002/dvdy.10431
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chen AKL, 2011, STEM CELL RES, V7, P97, DOI 10.1016/j.scr.2011.04.007
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Chowdhury F, 2010, PLOS ONE, V5
   Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]
   Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004
   D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259
   Dedhar S, 2000, CURR OPIN CELL BIOL, V12, P250, DOI 10.1016/S0955-0674(99)00083-6
   Elefanty AG, 2010, NAT METHODS, V7, P967, DOI 10.1038/nmeth1210-967
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evseenko D, 2009, STEM CELLS DEV, V18, P919, DOI 10.1089/scd.2008.0293
   Fernandes AM, 2009, BRAZ J MED BIOL RES, V42, P515, DOI 10.1590/S0100-879X2009000600007
   Fu X, 2011, REGEN MED, V6, P327, DOI [10.2217/rme.11.18, 10.2217/RME.11.18]
   Fu X, 2011, TISSUE ENG PART C-ME, V17, P927, DOI [10.1089/ten.tec.2010.0735, 10.1089/ten.TEC.2010.0735]
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699
   Hakala H, 2009, TISSUE ENG PT A, V15, P1775, DOI 10.1089/ten.tea.2008.0316
   Harb N, 2008, PLOS ONE, V3
   Hayashi Y, 2010, PLOS ONE, V5
   Heng BC, 2012, STEM CELLS DEV, V21, P1701, DOI 10.1089/scd.2011.0509
   Hernandez D, 2011, STEM CELLS DEV, V20, P1089, DOI 10.1089/scd.2009.0507
   Higuchi A, 2005, BIOMACROMOLECULES, V6, P691, DOI 10.1021/bm0494850
   Higuchi A, 2004, BIOMACROMOLECULES, V5, P1770, DOI 10.1021/bm049737x
   Higuchi A, 2000, J BIOMAT SCI-POLYM E, V11, P149, DOI 10.1163/156856200743625
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Higuchi A, 2012, CHEM REV, V112, P4507, DOI 10.1021/cr3000169
   Higuchi A, 2011, CHEM REV, V111, P3021, DOI 10.1021/cr1003612
   Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102
   Hongisto H, 2012, STEM CELL RES, V8, P97, DOI 10.1016/j.scr.2011.08.005
   Huang XB, 2012, J BIOSCI BIOENG, V114, P1, DOI 10.1016/j.jbiosc.2012.02.024
   Hughes CS, 2011, PROTEOMICS, V11, P3983, DOI 10.1002/pmic.201100030
   Hwang ST, 2010, BIOMATERIALS, V31, P8012, DOI 10.1016/j.biomaterials.2010.07.031
   Hwang YS, 2011, REGEN MED, V6, P505, DOI [10.2217/RME.11.38, 10.2217/rme.11.38]
   Ilic D, 2012, CYTOTHERAPY, V14, P122, DOI 10.3109/14653249.2011.623692
   Irwin EE, 2011, BIOMATERIALS, V32, P6912, DOI 10.1016/j.biomaterials.2011.05.058
   Jang M, 2013, BIOMATERIALS, V34, P3571, DOI 10.1016/j.biomaterials.2013.01.073
   Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0
   Kaupisch A, 2012, J CARDIOVASC TRANSL, V5, P605, DOI 10.1007/s12265-012-9379-2
   Kim BS, 2011, PROG POLYM SCI, V36, P238, DOI 10.1016/j.progpolymsci.2010.10.001
   Kim S, 2007, STEM CELLS, V25, P2601, DOI 10.1634/stemcells.2006-0814
   Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532
   Ko DY, 2013, PROG POLYM SCI, V38, P672, DOI 10.1016/j.progpolymsci.2012.08.002
   Kolhar P, 2010, J BIOTECHNOL, V146, P143, DOI 10.1016/j.jbiotec.2010.01.016
   Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671
   Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393
   Larijani MR, 2011, STEM CELLS DEV, V20, P1911, DOI 10.1089/scd.2010.0517
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lei T, 2007, CELL RES, V17, P682, DOI 10.1038/cr.2007.61
   Li JA, 2010, BIOINTERPHASES, V5, pFA132, DOI 10.1116/1.3525804
   Li ZS, 2010, BIOMATERIALS, V31, P404, DOI 10.1016/j.biomaterials.2009.09.070
   Liu YX, 2012, MACROMOL BIOSCI, V12, P1034, DOI 10.1002/mabi.201200043
   Lock LT, 2009, TISSUE ENG PT A, V15, P2051, DOI 10.1089/ten.tea.2008.0455
   Lu HF, 2012, BIOMATERIALS, V33, P2419, DOI 10.1016/j.biomaterials.2011.11.077
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Mahlstedt MM, 2010, BIOTECHNOL BIOENG, V105, P130, DOI 10.1002/bit.22520
   Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014
   Manton KJ, 2010, STEM CELLS DEV, V19, P1297, DOI 10.1089/scd.2009.0504
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629
   Meng GL, 2012, STEM CELLS DEV, V21, P2036, DOI 10.1089/scd.2011.0489
   Meng GL, 2010, STEM CELLS DEV, V19, P547, DOI 10.1089/scd.2009.0303
   Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111
   Nagaoka M, 2010, BMC DEV BIOL, V10
   Nandivada H, 2011, NAT PROTOC, V6, P1037, DOI 10.1038/nprot.2011.342
   Nie Y, 2009, BIOTECHNOL PROGR, V25, P20, DOI [10.1021/bp.110, 10.1002/btpr.110]
   Nishishita N, 2012, PLOS ONE, V7
   Marinho PAN, 2013, TISSUE ENG PART C-ME, V19, P146, DOI [10.1089/ten.TEC.2012.0141, 10.1089/ten.tec.2012.0141]
   Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005
   Olmer R, 2010, STEM CELL RES, V5, P51, DOI 10.1016/j.scr.2010.03.005
   Pashuck ET, 2012, SCI TRANSL MED, V4, P160
   Phillips BW, 2008, J BIOTECHNOL, V138, P24, DOI 10.1016/j.jbiotec.2008.07.1997
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prewitz M, 2012, MACROMOL RAPID COMM, V33, P1420, DOI 10.1002/marc.201200382
   Prowse ABJ, 2010, BIOMATERIALS, V31, P8281, DOI 10.1016/j.biomaterials.2010.07.037
   Rajala K, 2010, PLOS ONE, V5
   Rajala K, 2007, HUM REPROD, V22, P1231, DOI 10.1093/humrep/del523
   Ranga A, 2012, CURR OPIN CELL BIOL, V24, P236, DOI 10.1016/j.ceb.2012.01.006
   Rao BM, 2005, CURR OPIN BIOTECH, V16, P568, DOI 10.1016/j.copbio.2005.08.001
   Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620
   Ross AM, 2012, POLYMER, V53, P2533, DOI 10.1016/j.polymer.2012.03.064
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Saito T, 2011, TRANSPLANTATION, V92, P1231, DOI 10.1097/TP.0b013e3182375835
   Sampsell-Barron Tori, 2013, Methods Mol Biol, V1001, P81, DOI 10.1007/978-1-62703-363-3_8
   Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979
   Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9
   Serra M, 2011, PLOS ONE, V6
   Serra M, 2012, TRENDS BIOTECHNOL, V30, P350, DOI 10.1016/j.tibtech.2012.03.003
   Serra M, 2010, J BIOTECHNOL, V148, P208, DOI 10.1016/j.jbiotec.2010.06.015
   Siti-Ismail N, 2008, BIOMATERIALS, V29, P3946, DOI 10.1016/j.biomaterials.2008.04.027
   Steiner D, 2010, NAT BIOTECHNOL, V28, P361, DOI 10.1038/nbt.1616
   Stelling MP, 2013, GLYCOBIOLOGY, V23, P337, DOI 10.1093/glycob/cws133
   Stephenson E, 2012, NAT PROTOC, V7, P1366, DOI 10.1038/nprot.2012.080
   Storm MP, 2010, BIOTECHNOL BIOENG, V107, P683, DOI 10.1002/bit.22850
   Sugii S, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.199
   Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106
   Sun Y, 2012, PLOS ONE, V7
   Swistowski A, 2009, PLOS ONE, V4
   Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tamura A, 2012, BIOMATERIALS, V33, P3803, DOI 10.1016/j.biomaterials.2012.01.060
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tsutsui H, 2011, NAT COMMUN, V2
   Ullmann U, 2007, MOL HUM REPROD, V13, P21, DOI 10.1093/molehr/gal091
   Valamehr B, 2011, REGEN MED, V6, P623, DOI [10.2217/RME.11.54, 10.2217/rme.11.54]
   Vazin T, 2010, RESTOR NEUROL NEUROS, V28, P589, DOI 10.3233/RNN-2010-0543
   Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631
   Want AJ, 2012, REGEN MED, V7, P71, DOI [10.2217/RME.11.101, 10.2217/rme.11.101]
   Wei H, 2009, PROG POLYM SCI, V34, P893, DOI 10.1016/j.progpolymsci.2009.05.002
   Wilson JL, 2013, BIOTECHNOL BIOENG, V110, P667, DOI 10.1002/bit.24802
   Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
   Yap LYW, 2011, TISSUE ENG PART C-ME, V17, P193, DOI 10.1089/ten.TEC.2010.0328
   Yoon TM, 2010, STEM CELL REV REP, V6, P425, DOI 10.1007/s12015-010-9158-x
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zhang R, 2013, NAT COMMUN, V4
   Zonca MR, 2013, MACROMOL BIOSCI, V13, P177, DOI 10.1002/mabi.201200315
   Zweigerdt R, 2011, NAT PROTOC, V6, P689, DOI 10.1038/nprot.2011.318
NR 136
TC 35
Z9 35
U1 12
U2 127
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD JUL
PY 2014
VL 39
IS 7
BP 1348
EP 1374
DI 10.1016/j.progpolymsci.2014.01.002
PG 27
WC Polymer Science
SC Polymer Science
GA AK7LI
UT WOS:000338609400005
DA 2018-10-20
ER

PT J
AU Bertagnolli, C
   Uhart, A
   Dupin, JC
   da Silva, MGC
   Guibal, E
   Desbrieres, J
AF Bertagnolli, Caroline
   Uhart, Arnaud
   Dupin, Jean-Charles
   Carlos da Silva, Meuris Gurgel
   Guibal, Eric
   Desbrieres, Jacques
TI Biosorption of chromium by alginate extraction products from Sargassum
   filipendula: Investigation of adsorption mechanisms using X-ray
   photoelectron spectroscopy analysis
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Biosorption; Seaweed; Alginate-extraction; Chromium; XPS
ID HEAVY-METAL BIOSORPTION; HEXAVALENT CHROMIUM; TRIVALENT CHROMIUM;
   ACTIVATED CARBONS; WHEAT BRAN; BIOMATERIAL; REMEDIATION; ADSORBENTS;
   SORPTION; REMOVAL
AB The alginate extraction products from Brazilian brown seaweed Sargassum filipendula were studied for chromium biosorption. Batch experiments were conducted at pH 2 and 3 and 20 degrees C to determine the sorption capacity of this biosorbents for chromium (VI) and (III). The biomass was characterized before and after metal binding by X-ray photoelectron spectroscopy (XPS) in order to determine the mechanisms of chromium biosorption. The residue has a high adsorption capacity, close the value obtained with seaweed and higher than that of alginate for both Cr(III) and Cr(VI). XPS analysis of the biosorbents revealed that carboxyl, amino and sulfonate groups are responsible for the binding of the metal ions. The analysis also indicated that the Cr(VI) bound to the biomass was reduced to Cr(III). (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Bertagnolli, Caroline; Carlos da Silva, Meuris Gurgel] Univ Estadual Campinas, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
   [Bertagnolli, Caroline; Guibal, Eric] Ecole Mines Ales, Ctr Mat Mines Ales MPA BCI C2MA, F-30319 Ales, France.
   [Uhart, Arnaud; Dupin, Jean-Charles; Desbrieres, Jacques] Univ Pau & Pays Adour, Inst Sci Analyt & Physicochim Environm & Mat IPRE, F-64053 Pau, France.
RP Bertagnolli, C (reprint author), Univ Estadual Campinas, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
EM carolinebertagnolli@gmail.com
RI Guibal, Eric/H-4915-2012; Silva, Meuris/D-5272-2016
OI Guibal, Eric/0000-0002-2767-6305; Bertagnolli,
   Caroline/0000-0002-6857-1737; DUPIN, jean-charles/0000-0002-5336-7629
FU CNPq - Brazil
FX Caroline Bertagnolli acknowledges her Doctoral fellowship supported by
   CNPq - Brazil.
CR [Anonymous], 2007, D168702 ASTM INT
   Araujo MM, 1997, INT BIODETER BIODEGR, V40, P63, DOI 10.1016/S0964-8305(97)00064-4
   Bertagnolli C, 2014, CHEM ENG J, V237, P362, DOI 10.1016/j.cej.2013.10.024
   Bouanda J, 2002, ANAL BIOANAL CHEM, V373, P174, DOI 10.1007/s00216-002-1305-z
   Brundle C.R., 1980, ELECT SPECTROSCOPY T
   Calero M, 2009, J HAZARD MATER, V171, P886, DOI 10.1016/j.jhazmat.2009.06.082
   Cazon J.P., 2012, BIORESOURCE TECHNOL, V116, P195
   Chen JP, 2005, IND ENG CHEM RES, V44, P9931, DOI 10.1021/ie050678t
   Chen JP, 2002, LANGMUIR, V18, P9413, DOI 10.1021/la026060v
   Cieslak-Golonka M, 1995, POLYHEDRON, V15, P3667
   Cui HJ, 2011, J HAZARD MATER, V186, P1625, DOI 10.1016/j.jhazmat.2010.12.050
   Dambies L, 2001, COLLOID SURFACE A, V177, P203, DOI 10.1016/S0927-7757(00)00678-6
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   Dupont L, 2003, ENVIRON SCI TECHNOL, V37, P4235, DOI 10.1021/es0342345
   EDGELL MJ, 1986, APPL SURF SCI, V26, P129, DOI 10.1016/0169-4332(86)90001-2
   Escudero C., ARAB J CHEM IN PRESS
   Figueira MM, 1999, ENVIRON SCI TECHNOL, V33, P1840, DOI 10.1021/es981111p
   Fourest E, 1996, ENVIRON SCI TECHNOL, V30, P277, DOI 10.1021/es950315s
   GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7
   Kushwaha S, 2012, BIORESOURCE TECHNOL, V116, P15, DOI 10.1016/j.biortech.2012.04.009
   LEYVARAMOS R, 1995, J CHEM TECHNOL BIOT, V62, P64, DOI 10.1002/jctb.280620110
   McHugh DJ, 1987, PRODUCTION PROPERTIE
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Murphy V, 2009, CHEM ENG J, V148, P425, DOI 10.1016/j.cej.2008.09.029
   Papageorgiou SK, 2006, J HAZARD MATER, V137, P1765, DOI 10.1016/j.jhazmat.2006.05.017
   Park D, 2006, IND ENG CHEM RES, V45, P2405, DOI 10.1021/ie0509387
   Park D, 2008, J COLLOID INTERF SCI, V317, P54, DOI 10.1016/j.jcis.2007.09.049
   RICHARD FC, 1991, WATER RES, V25, P807, DOI 10.1016/0043-1354(91)90160-R
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   Suwalsky M, 2008, J INORG BIOCHEM, V102, P842, DOI 10.1016/j.jinorgbio.2007.11.020
   Wagner CD, 1979, HDB XRAY PHOTOELECTR
   Yang L, 2008, BIORESOURCE TECHNOL, V99, P297, DOI 10.1016/j.biortech.2006.12.021
   Yuan SJ, 2013, CORROS SCI, V74, P353, DOI 10.1016/j.corsci.2013.04.058
NR 35
TC 25
Z9 27
U1 1
U2 74
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
EI 1873-2976
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD JUL
PY 2014
VL 164
BP 264
EP 269
DI 10.1016/j.biortech.2014.04.103
PG 6
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA AK8WX
UT WOS:000338710500037
PM 24862002
DA 2018-10-20
ER

PT J
AU Perdisa, F
   Filardo, G
   Di Matteo, B
   Marcacci, M
   Kon, E
AF Perdisa, Francesco
   Filardo, Giuseppe
   Di Matteo, Berardo
   Marcacci, Maurilio
   Kon, Elizaveta
TI Platelet rich plasma: a valid augmentation for cartilage scaffolds? a
   systematic review
SO HISTOLOGY AND HISTOPATHOLOGY
LA English
DT Review
DE Platelet-rich plasma; Cartilage; Regenerative medicine; Scaffold
ID COMPOSITE MULTILAYERED BIOMATERIAL; MARROW-DERIVED CELLS; OSTEOCHONDRAL
   REGENERATION; BONE-MARROW; AUTOLOGOUS CHONDROCYTE; HYALURONIC-ACID;
   GROWTH-FACTORS; UP-REGULATION; STEM-CELLS; FOLLOW-UP
AB It has been shown that modern regenerative scaffold-based procedures for the treatment of articular cartilage defects offer good clinical results, although the properties of native healthy cartilage have not yet been matched by any substitute. Several implants have been tested and clinically used over the years to promote articular surface restoration, some of them producing a hyaline-like reparative tissue. There has been an increase in the number of new biological strategies, alone and in combination with scaffolds, to enhance the clinical outcome in patients with chondral disease. Among these innovative methods, one of the most widely used is Platelet-rich Plasma (PRP), based on the rationale of using the growth factors contained in platelet alpha granules to promote tissue regeneration. The aim of the present manuscript is to review systematically the current evidence in pre-clinical and clinical studies for the use of PRP augmented scaffolds to treat chondral or osteochondral disorders.
C1 [Filardo, Giuseppe; Kon, Elizaveta] Rizzoli Orthopaed Inst, Nanobiotechnol Lab, Clin 2, I-40136 Bologna, Italy.
   [Perdisa, Francesco; Di Matteo, Berardo; Marcacci, Maurilio] Rizzoli Orthopaed Inst, Biomech Lab, Clin 2, I-40136 Bologna, Italy.
RP Kon, E (reprint author), Rizzoli Orthopaed Inst, Nanobiotechnol Lab, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM e.kon@biomec.ior.it
OI Filardo, Giuseppe/0000-0002-8136-0977
FU Finceramica, Italy; Fidia, Italy
FX M. Marcacci receives royalties and research institutional support from
   Fin-Ceramica Faenza SpA, Italy. E. Kon is a consultant for CartiHeal
   (2009) Ltd, Israel and has stocks of CartiHeal (2009) Ltd, Israel, and
   she received fees for paid presentation from Finceramica, Italy, and
   Fidia, Italy. F. Perdisa, G. Filardo and B. Di Matteo have nothing to
   disclose.
CR Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   Betsch M., 2013, PLOS ONE, V12
   Boswell SG, 2012, ARTHROSCOPY, V28, P429, DOI 10.1016/j.arthro.2011.10.018
   Buda Roberto, 2013, Musculoskelet Surg, V97, P145, DOI 10.1007/s12306-013-0242-7
   Buda R, 2010, J BONE JOINT SURG AM, V92A, P2, DOI 10.2106/JBJS.J.00813
   Dhollander AAM, 2011, KNEE SURG SPORT TR A, V19, P536, DOI 10.1007/s00167-010-1337-4
   Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009
   Filardo G, 2013, KNEE SURG S IN PRESS
   Filardo G, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-229
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891
   Filardo G, 2011, AM J SPORT MED, V39, P2153, DOI 10.1177/0363546511415658
   Filardo Giuseppe, 2010, Orthopedics, V33, P120, DOI 10.3928/01477447-20100104-31
   Foster TE, 2009, AM J SPORT MED, V37, P2259, DOI 10.1177/0363546509349921
   Giannini S, 2010, INJURY, V41, P1196, DOI 10.1016/j.injury.2010.09.028
   Giannini S, 2009, CLIN ORTHOP RELAT R, V467, P3307, DOI 10.1007/s11999-009-0885-8
   Gille J, 2010, KNEE SURG SPORT TR A, V18, P1456, DOI 10.1007/s00167-010-1042-3
   Koh YG, 2013, ARTHROSCOPY, V29, P748, DOI 10.1016/j.arthro.2012.11.017
   Kon E, 2013, BONE JOINT RES, V2, P18, DOI 10.1302/2046-3758.22.2000092
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2012, J KNEE SURG, V25, P17, DOI 10.1055/s-0031-1299651
   Kon E, 2011, ARTHROSCOPY, V27, P1490, DOI 10.1016/j.arthro.2011.05.011
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2011, KNEE SURG SPORT TR A, V19, P516, DOI 10.1007/s00167-010-1306-y
   Kon E, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-220
   Kon E, 2009, AM J SPORT MED, V37, p156S, DOI 10.1177/0363546509351649
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Kreuz PC, 2013, OSTEOARTHR CARTILAGE, V21, P1997, DOI 10.1016/j.joca.2013.09.007
   Labusca L, 2013, STEM CELL RES THER, V4, DOI 10.1186/1757-6512-4-118
   Lee HR, 2012, J BIOMED MATER RES A, V100A, P3099, DOI 10.1002/jbm.a.34254
   Lee HR, 2012, J CONTROL RELEASE, V159, P332, DOI 10.1016/j.jconrel.2012.02.008
   Marcacci M, 2013, INJURY, V44, pS11, DOI 10.1016/S0020-1383(13)70004-4
   Marmotti A, 2012, KNEE SURG SPORT TR A, V20, P2590, DOI 10.1007/s00167-012-1920-y
   Marmotti A, 2013, EUR CELLS MATER, V26, P15, DOI 10.22203/eCM.v026a02
   Marx R E, 2001, Implant Dent, V10, P225
   Melton JTK, 2010, EXPERT REV MED DEVIC, V7, P333, DOI 10.1586/ERD.10.15
   Mifune Y, 2013, OSTEOARTHR CARTILAGE, V21, P175, DOI 10.1016/j.joca.2012.09.018
   Mishra A, 2009, CLIN SPORT MED, V28, P113, DOI 10.1016/j.csm.2008.08.007
   Qi YY, 2009, CELL TRANSPLANT, V18, P1161, DOI 10.3727/096368909X12483162197169
   Sanchez AR, 2003, INT J ORAL MAX IMPL, V18, P93
   Sanchez M, 2003, MED SCI SPORT EXER, V35, P1648, DOI 10.1249/01.MSS.0000089344.44434.50
   Sell SA, 2011, TISSUE ENG PT A, V17, P2723, DOI [10.1089/ten.tea.2010.0663, 10.1089/ten.TEA.2010.0663]
   Siclari A., 2013, KNEE SURG S IN PRESS
   Siclari A, 2012, CLIN ORTHOP RELAT R, V470, P910, DOI 10.1007/s11999-011-2107-4
   Sun Y, 2010, INT ORTHOP, V34, P589, DOI 10.1007/s00264-009-0793-2
   Torricelli P, 2011, INT ORTHOP, V35, P1569, DOI 10.1007/s00264-011-1237-3
   Tschon Matilde, 2011, Front Biosci (Elite Ed), V3, P96
   Wu W, 2009, MED HYPOTHESES, V72, P455, DOI 10.1016/j.mehy.2008.11.032
   Xie XT, 2012, BIOMATERIALS, V33, P7008, DOI 10.1016/j.biomaterials.2012.06.058
NR 50
TC 11
Z9 12
U1 2
U2 10
PU F HERNANDEZ
PI MURCIA
PA PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN
SN 0213-3911
EI 1699-5848
J9 HISTOL HISTOPATHOL
JI Histol. Histopath.
PD JUL
PY 2014
VL 29
IS 7
BP 805
EP 814
PG 10
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA AK7RH
UT WOS:000338624900001
PM 24458849
DA 2018-10-20
ER

PT J
AU Rupp, F
   Gittens, RA
   Scheideler, L
   Marmur, A
   Boyan, BD
   Schwartz, Z
   Geis-Gerstorfer, J
AF Rupp, Frank
   Gittens, Rolando A.
   Scheideler, Lutz
   Marmur, Abraham
   Boyan, Barbara D.
   Schwartz, Zvi
   Geis-Gerstorfer, Juergen
TI A review on the wettability of dental implant surfaces I: Theoretical
   and experimental aspects
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Wettability; Hydrophilicity; Surface energy; Contact angle hysteresis;
   Roughness induced wetting
ID CONTACT-ANGLE HYSTERESIS; PARTIALLY EDENTULOUS PATIENTS; OSTEOBLAST
   LINEAGE CELLS; PROSPECTIVE CASE SERIES; PLASMA-SPRAYED SURFACE;
   ACID-ETCHED SURFACE; TITANIUM IMPLANTS; PROTEIN ADSORPTION; ROUGH
   SURFACES; SOLID-SURFACES
AB The surface wettability of biomaterials determines the biological cascade of events at the biomaterial/host interface. Wettability is modulated by surface characteristics, such as surface chemistry and surface topography. However, the design of current implant surfaces focuses mainly on specific micro- and nano-topographical features, and is still far from predicting the concomitant wetting behavior. There is an increasing interest in understanding the wetting mechanisms of implant surfaces and the role of wettability in the biological response at the implant/bone or implant/soft tissue interface. Fundamental knowledge related to the influence of surface roughness (i.e. a quantification of surface topography) on titanium and titanium alloy surface wettability, and the different associated wetting regimes, can improve our understanding of the role of wettability of rough implant surfaces on the biological outcome. Such an approach has been applied to biomaterial surfaces only in a limited way. Focusing on titanium dental and orthopaedic implants, the present study reviews the current knowledge on the wettability of biomaterial surfaces, encompassing basic and applied aspects that include measurement techniques, thermodynamic aspects of wetting and models predicting topographical and roughness effects on the wetting behavior. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Rupp, Frank; Scheideler, Lutz; Geis-Gerstorfer, Juergen] Univ Tubingen Hosp, Dept Prosthet Dent, Sect Med Mat & Technol, D-72076 Tubingen, Germany.
   [Gittens, Rolando A.] Inst Sci Res & High Technol Serv INDICASAT AIP, Ctr Biodivers & Drug Discovery, Panama City, Panama.
   [Marmur, Abraham] Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel.
   [Boyan, Barbara D.; Schwartz, Zvi] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA.
   [Schwartz, Zvi] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA.
RP Rupp, F (reprint author), Univ Tubingen Hosp, Dept Prosthet Dent, Sect Med Mat & Technol, Osianderstr 2-8, D-72076 Tubingen, Germany.
EM frank.rupp@med.uni-tuebingen.de
OI Gittens, Rolando A./0000-0002-0286-3956
FU ITI Foundation (Basel, Switzerland) ITI Foundation (Basel, Switzerland),
   of the German Research Foundation (DFG, Deutsche Forschungsgemeinschaft,
   Bonn, Germany); Baden-Wuerttemberg Stiftung (Stuttgart, Germany);
   Government of Panama (IFARHU-SENACYT); IMI Program of the National
   Science Foundation (ICMR Program) [DMR04-09848]; National Institutes of
   Health, United States (US PHS) [AR052102]
FX Support of the ITI Foundation (Basel, Switzerland), of the German
   Research Foundation (DFG, Deutsche Forschungsgemeinschaft, Bonn,
   Germany) and the Baden-Wuerttemberg Stiftung (Stuttgart, Germany) is
   gratefully acknowledged.; R.A.G. is thankful for the support of the
   Government of Panama (IFARHU-SENACYT) and the IMI Program of the
   National Science Foundation (ICMR Program, Award No. DMR04-09848).
   B.D.B., Z.S. and R.A.G. are supported by the National Institutes of
   Health, United States (US PHS Grant AR052102).
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   ANDRIEU C, 1994, LANGMUIR, V10, P2077, DOI 10.1021/la00019a010
   Baier R E, 1988, J Dent Educ, V52, P788
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   BELLONFONTAINE MN, 1990, CELL BIOPHYS, V17, P93, DOI 10.1007/BF02989805
   Blunt L, DEV METHODS CHARACTE, P230
   Brandon S, 2003, J COLLOID INTERF SCI, V263, P237, DOI 10.1016/S0021-9797(03)00285-6
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Buser D, 2012, CLIN IMPLANT DENT R, V14, P839, DOI 10.1111/j.1708-8208.2012.00456.x
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Chappuis V, 2013, CLIN IMPLANT DENT R, V15, P780, DOI 10.1111/cid.12056
   Checco A, 2003, PHYS REV LETT, V91
   Cochran DL, 2011, J PERIODONTOL, V82, P990, DOI 10.1902/jop.2011.100464
   Combe EC, 2004, DENT MATER, V20, P262, DOI 10.1016/S0109-5641(03)00102-7
   CRAIG RG, 1960, J PHYS CHEM-US, V64, P541, DOI 10.1021/j100834a007
   Cwikel D, 2010, LANGMUIR, V26, P15289, DOI 10.1021/la1020252
   Davies J, 1996, COLLOID SURFACE B, V6, P181, DOI 10.1016/0927-7765(96)01253-2
   Decker EL, 1996, LANGMUIR, V12, P2100, DOI 10.1021/la951021n
   Della Volpe C, 2001, OIL GAS SCI TECHNOL, V56, P9, DOI 10.2516/ogst:2001002
   do Serro APVA, 1997, COLLOID SURFACE B, V10, P95, DOI 10.1016/S0927-7765(97)00060-X
   do Serro APVA, 1999, J BIOMED MATER RES, V46, P376, DOI 10.1002/(SICI)1097-4636(19990905)46:3<376::AID-JBM10>3.0.CO;2-T
   Donald AM, 2003, NAT MATER, V2, P511, DOI 10.1038/nmat898
   Duske K, 2012, J CLIN PERIODONTOL, V39, P400, DOI 10.1111/j.1600-051X.2012.01853.x
   Eichler M, 2011, BIOMATERIALS, V32, P9168, DOI 10.1016/j.biomaterials.2011.08.063
   Feng L, 2008, LANGMUIR, V24, P4114, DOI 10.1021/la703821h
   Gittens RA, 2013, ACTA BIOMATER, V9, P6268, DOI 10.1016/j.actbio.2012.12.002
   Gittens RA, 2012, BIOMATERIALS, V33, P8986, DOI 10.1016/j.biomaterials.2012.08.059
   GOODE R, 1993, COMMERCIAL AND CONSUMER LAW, P3
   Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021
   Hayashi M, 2012, ACTA BIOMATER, V8, P2411, DOI 10.1016/j.actbio.2012.03.010
   Herminghaus S, 2000, EUROPHYS LETT, V52, P165, DOI 10.1209/epl/i2000-00418-8
   Hilditch CJ, 2008, SLEEP, V31, P367, DOI 10.1093/sleep/31.3.367
   Ishino C, 2004, EUROPHYS LETT, V68, P419, DOI 10.1209/epl/i2004-10206-6
   JOHNSON RE, 1964, J PHYS CHEM-US, V68, P1744, DOI 10.1021/j100789a012
   KAELBLE DH, 1970, J ADHESION, V2, P66, DOI 10.1080/0021846708544582
   Kajiyama T, 1991, J Biomater Appl, V6, P42, DOI 10.1177/088532829100600103
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Khandelwal N, 2013, CLIN ORAL IMPLAN RES, V24, P13, DOI 10.1111/j.1600-0501.2011.02369.x
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   KILPADI DV, 1994, J BIOMED MATER RES, V28, P1419, DOI 10.1002/jbm.820281206
   Kohavi D, 2013, CLIN ORAL IMPLAN RES, V24, P1002, DOI 10.1111/j.1600-0501.2012.02508.x
   Krishnan A, 2005, COLLOID SURFACE B, V43, P95, DOI 10.1016/j.colsurfb.2005.04.003
   Lafuma A, 2003, NAT MATER, V2, P457, DOI 10.1038/nmat924
   LANDER LM, 1993, LANGMUIR, V9, P2237, DOI 10.1021/la00032a055
   Levine RA, 2012, INT J PERIODONT REST, V32, P39
   Liu J.L., 2007, J PHYS CONDENS MATTE, V19
   Marmur A, 2002, LANGMUIR, V18, P8919, DOI 10.1021/la026167i
   Marmur A, 1997, J COLLOID INTERF SCI, V186, P462, DOI 10.1006/jcis.1996.4666
   Marmur A, 2008, LANGMUIR, V24, P7573, DOI 10.1021/la800304r
   Marmur A, 2012, SOFT MATTER, V8, P6867, DOI 10.1039/c2sm25443c
   Marmur A, 2009, CONTACT ANGLE, WETTABILITY AND ADHESION, VOL 6, P3
   Marmur A, 2010, LANGMUIR, V26, P5568, DOI 10.1021/la9038478
   Marmur A, 2009, ANNU REV MATER RES, V39, P473, DOI 10.1146/annurev.matsci.38.060407.132425
   Marshall SJ, 2010, DENT MATER, V26, pE11, DOI 10.1016/j.dental.2009.11.157
   Martinelli E, 2012, MACROMOL CHEM PHYS, V213, P1448, DOI 10.1002/macp.201200163
   Meiron TS, 2004, J COLLOID INTERF SCI, V274, P637, DOI 10.1016/j.jcis.2004.02.036
   Mendez-Vilas A, 2009, SMALL, V5, P1366, DOI 10.1002/smll.200800819
   Menzies KL, 2010, OPTOMETRY VISION SCI, V87, P387, DOI 10.1097/OPX.0b013e3181da863e
   Muller C, 2011, ANAL BIOANAL CHEM, V400, P679, DOI 10.1007/s00216-010-4613-8
   Narhe RD, 2006, EUROPHYS LETT, V75, P98, DOI 10.1209/epl/i2006-10069-9
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Park JH, 2012, BIOMATERIALS, V33, P7386, DOI 10.1016/j.biomaterials.2012.06.066
   Park JH, 2012, BIOMATERIALS, V33, P5267, DOI 10.1016/j.biomaterials.2012.03.074
   Qu AL, 2008, J MATER SCI TECHNOL, V24, P693
   Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434
   Rosina J, 2007, PHYSIOL RES, V56, pS93
   Ruiz-Cabello FJM, 2011, LANGMUIR, V27, P9638, DOI 10.1021/la201248z
   Rupp F, 2002, J BIOMED MATER RES, V62, P567, DOI 10.1002/jbm.10198
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Rupp F, 2010, ACTA BIOMATER, V6, P4566, DOI 10.1016/j.actbio.2010.06.021
   Rupp F, 2002, CHEM ENG TECHNOL, V25, P877, DOI 10.1002/1521-4125(20020910)25:9<877::AID-CEAT877>3.0.CO;2-D
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Rupp F, 2011, INT J ORAL MAX IMPL, V26, P1256
   Rykaczewski K, 2011, APPL PHYS LETT, V98
   Sardin S, 2004, J ORAL REHABIL, V31, P140, DOI 10.1046/j.0305-182X.2003.01136.x
   Scheideler L, 2007, DENT MATER, V23, P469, DOI 10.1016/j.dental.2006.03.005
   Schindelholz E, 2012, CORROS REV, V30, P135, DOI 10.1515/corrrev-2012-0015
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   Shalel-Levanon S, 2003, J COLLOID INTERF SCI, V262, P489, DOI 10.1016/S0021-9797(02)00231-X
   Sharma PK, 2002, ADV COLLOID INTERFAC, V98, P341, DOI 10.1016/S0001-8686(02)00004-0
   SMITH T, 1978, J COLLOID INTERF SCI, V66, P363, DOI 10.1016/0021-9797(78)90318-1
   Stadler H, 2003, ANAL BIOANAL CHEM, V375, P53, DOI 10.1007/s00216-002-1664-5
   STEINBERG D, 1995, BIOMATERIALS, V16, P1339, DOI 10.1016/0142-9612(95)91050-9
   Stockelhuber KW, 1999, COLLOID SURFACE A, V156, P323, DOI 10.1016/S0927-7757(99)00084-9
   UEDA T, 1995, J BIOMED MATER RES, V29, P381, DOI 10.1002/jbm.820290313
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   VOGLER EA, 1992, LANGMUIR, V8, P2013, DOI 10.1021/la00044a023
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Volpe CD, 2002, COLLOID SURFACE A, V206, P47
   WANG JH, 1994, LANGMUIR, V10, P3887, DOI 10.1021/la00022a080
   Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331
   Wennerberg A, 2013, CLIN ORAL IMPLAN RES, V24, P203, DOI 10.1111/j.1600-0501.2012.02429.x
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Wolansky G, 1999, COLLOID SURFACE A, V156, P381, DOI 10.1016/S0927-7757(99)00098-9
   Yan YY, 2011, ADV COLLOID INTERFAC, V169, P80, DOI 10.1016/j.cis.2011.08.005
   Young T, 1804, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
NR 106
TC 91
Z9 94
U1 6
U2 128
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2014
VL 10
IS 7
BP 2894
EP 2906
DI 10.1016/j.actbio.2014.02.040
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AK4NU
UT WOS:000338402200002
PM 24590162
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Dinjaski, N
   Suri, S
   Valle, J
   Lehman, SM
   Lasa, I
   Prieto, MA
   Garcia, AJ
AF Dinjaski, Nina
   Suri, Shalu
   Valle, Jaione
   Lehman, Susan M.
   Lasa, Inigo
   Auxiliadora Prieto, Maria
   Garcia, Andres J.
TI Near-infrared fluorescence imaging as an alternative to bioluminescent
   bacteria to monitor biomaterial-associated infections
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomaterial-associated infection; Bioluminescence; Near infrared
   fluorescence; Noninvasive monitoring; Staphylococcus aureus
ID STAPHYLOCOCCUS-AUREUS; IN-VIVO; MICE; PROTEINS; IDENTIFICATION;
   INFLAMMATION; BIOFILMS; PLASMA; LIGHT; PROBE
AB Biomaterial-associated infection is one of the most common complications related to the implantation of any biomedical device. Several in vivo imaging platforms have emerged as powerful diagnostic tools to longitudinally monitor biomaterial-associated infections in small animal models. In this study, we directly compared two imaging approaches: bacteria engineered to produce luciferase to generate bioluminescence and reactive oxygen species (ROS) imaging of the inflammatory response associated with the infected implant. We performed longitudinal imaging of bioluminescence associated with bacteria strains expressing plasmid-integrated luciferase driven by different promoters or a strain with the luciferase gene integrated into the chromosome. These luminescent strains provided an adequate signal for acute (0-4 days) monitoring of the infection, but the bioluminescence signal decreased over time and leveled off at 7 days post-implantation. This loss in the bioluminescence signal was attributed to changes in the metabolic activity of the bacteria. In contrast, near-infrared fluorescence imaging of ROS associated with inflammation to the implant provided sensitive and dose-dependent signals of biomaterial-associated bacteria. ROS imaging exhibited higher sensitivity than the bioluminescence imaging and was independent of the bacteria strain. Near-infrared fluorescence imaging of inflammatory responses represents a powerful alternative to bioluminescence imaging for monitoring biomaterial-associated bacterial infections. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Dinjaski, Nina; Auxiliadora Prieto, Maria] CSIC, Ctr Invest Biol, Madrid 28040, Spain.
   [Lehman, Susan M.; Garcia, Andres J.] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Valle, Jaione; Lasa, Inigo] UPNA CSIC Gobiemo De Navarra, Inst Agrobiotecnol, Pamplona 31006, Spain.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Prieto, Maria Auxiliadora/I-8092-2015; Lasa, Inigo/F-2947-2011; jaione,
   valle/G-6213-2011
OI Lasa, Inigo/0000-0002-6625-9221; jaione, valle/0000-0003-3115-0207;
   Prieto Jimenez, M. Auxiliadora/0000-0002-8038-1223
FU Ministerio of Economia y Competitividad [BIO2010-21049, 201120E092]; US
   National Institutes of Health [R21 AI094624]; Georgia Tech/Emory Center
   for the Engineering of Living Tissues; Atlanta Clinical and
   Translational Science Institute under PHS Grant from the Clinical and
   Translational Science Award Program [UL RR025008]
FX We thank Biopolis S.L. for the supplied polymer. This work was supported
   by the Ministerio of Economia y Competitividad (BIO2010-21049,
   201120E092), the US National Institutes of Health grant R21 AI094624
   (A.J.G.), the Georgia Tech/Emory Center for the Engineering of Living
   Tissues, the Atlanta Clinical and Translational Science Institute under
   PHS Grant UL RR025008 from the Clinical and Translational Science Award
   Program.
CR Anderson J. M., 2013, BIOMATERIALS ASS INF, P119
   Auer JA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-72
   Bettegowda C, 2005, P NATL ACAD SCI USA, V102, P1145, DOI 10.1073/pnas.0408861102
   Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001
   Dai TH, 2009, ANTIMICROB AGENTS CH, V53, P3929, DOI 10.1128/AAC.00027-09
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dinjaski N, 2014, BIOMATERIALS, V35, P14, DOI 10.1016/j.biomaterials.2013.09.059
   Doyle TC, 2004, CELL MICROBIOL, V6, P303, DOI 10.1111/j.1462-5822.2004.00378.x
   Escapa IF, 2011, APPL MICROBIOL BIOT, V89, P1583, DOI 10.1007/s00253-011-3099-4
   FDA, 1987, GUID VAL LIM AM LYS
   Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0
   Francois P, 2000, J LAB CLIN MED, V135, P32, DOI 10.1016/S0022-2143(00)70018-7
   Francois P, 1998, ANN VASC SURG, V12, P34, DOI 10.1007/s100169900112
   Furrer P, 2007, J MICROBIOL METH, V69, P206, DOI 10.1016/j.mimet.2007.01.002
   Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042
   Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029
   Kadurugamuwa JL, 2003, ANTIMICROB AGENTS CH, V47, P3130, DOI 10.1128/AAC.47.10.3130-3137.2003
   Keyaerts M, 2012, TRENDS MOL MED, V18, P164, DOI 10.1016/j.molmed.2012.01.005
   Kiedrowski MR, 2011, ANN NY ACAD SCI, V1241, P104, DOI 10.1111/j.1749-6632.2011.06281.x
   Kong Y, 2010, P NATL ACAD SCI USA, V107, P12239, DOI 10.1073/pnas.1000643107
   Lasa I, 2006, INT MICROBIOL, V9, P21
   Leevy WM, 2008, BIOCONJUGATE CHEM, V19, P686, DOI 10.1021/bc700376v
   Leevy WM, 2006, J AM CHEM SOC, V128, P16476, DOI 10.1021/ja0665592
   Mack D, 2013, BIOMATERIALS ASS INF, P25, DOI 10.1007/9781-46141031-7
   Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08
   Mesak LR, 2009, PLASMID, V61, P182, DOI 10.1016/j.plasmid.2009.01.003
   *NAT RES COUNC, 1985, NIH PUBLICATION
   Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320
   Ning XH, 2011, NAT MATER, V10, P602, DOI [10.1038/NMAT3074, 10.1038/nmat3074]
   Piatkevich KD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3153
   Selvam S, 2011, BIOMATERIALS, V32, P7785, DOI 10.1016/j.biomaterials.2011.07.020
   Waidmann Mark S, 2011, Bioeng Bugs, V2, P8, DOI 10.4161/bbug.2.1.13566
   White AG, 2012, BIOORG MED CHEM LETT, V22, P2833, DOI 10.1016/j.bmcl.2012.02.078
   Zaat S. A. J., 2013, BIOMATERIALS ASS INF, P175
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 38
TC 10
Z9 10
U1 4
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2014
VL 10
IS 7
BP 2935
EP 2944
DI 10.1016/j.actbio.2014.03.005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AK4NU
UT WOS:000338402200005
PM 24632360
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Baker, DW
   Zhou, J
   Tsai, YT
   Patty, KM
   Weng, H
   Tang, EN
   Nair, A
   Hu, WJ
   Tang, LP
AF Baker, David W.
   Zhou, Jun
   Tsai, Yi-Ting
   Patty, Kaitlen M.
   Weng, Hong
   Tang, Ewin N.
   Nair, Ashwin
   Hu, Wen-Jing
   Tang, Liping
TI Development of optical probes for in vivo imaging of polarized
   macrophages during foreign body reactions
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Macrophage polarization; In vivo imaging; Optical probe; Inflammation;
   Biomaterials
ID ACTIVATED MACROPHAGES; INFLAMMATORY RESPONSES; MURINE MACROPHAGES;
   ALTERNATIVE ACTIVATION; MANNOSYLATED LIPOSOMES; IFN-GAMMA; CELLS;
   ARTHRITIS; VITRO; NANOPARTICLES
AB Plasticity of macrophage (MO) phenotypes exist in a spectrum from classically activated (M1) cells, to alternatively activated (M2) cells, contributing to both the normal healing of tissues and the pathogenesis of implant failure. Here, folate- and mannose-based optical probes were fabricated to simultaneously determine the degree of MO polarization. In vitro tests show the ability of these probes to specifically target M1 and M2 cells. In an in vivo murine model, they were able to distinguish between the M1-dominated inflammatory response to infection and the M2-dominated regenerative response to particle implants. Finally, the probes were used to assess the inflammatory/regenerative properties of biomaterial implants. Our results show that these probes can be used to monitor and quantify the dynamic processes of MO polarization and their role in cellular responses in real time. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Baker, David W.; Zhou, Jun; Tsai, Yi-Ting; Patty, Kaitlen M.; Weng, Hong; Tang, Ewin N.; Nair, Ashwin; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Hu, Wen-Jing] Progenitec Inc, Arlington, TX 76001 USA.
   [Tang, Liping] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, Box 19138, Arlington, TX 76019 USA.
EM itang@uta.edu
FU National Institutes of Health (NIH) [EB014404, GM101776]
FX We thank the National Institutes of Health (NIH) for the financial
   support (NIH Grants EB014404 and GM101776). In addition, we would like
   to thank Dr. Baohong Yuan and Ms. Yuan Liu for their help with preparing
   the NIR images (Fig. S2).
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Antohe F, 2005, CELL TISSUE RES, V320, P277, DOI 10.1007/s00441-004-1071-7
   Arora S, 2005, J IMMUNOL, V174, P6346, DOI 10.4049/jimmunol.174.10.6346
   Arora S, 2011, INFECT IMMUN, V79, P1915, DOI 10.1128/IAI.01270-10
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   BARRATT GM, 1987, ANN INST PASTEUR IMM, V138, P437, DOI 10.1016/S0769-2625(87)80054-5
   Basu MK, 2004, CURR MOL MED, V4, P681, DOI 10.2174/1566524043360186
   Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Buhtoiarov IN, 2005, J IMMUNOL, V174, P6013, DOI 10.4049/jimmunol.174.10.6013
   Chen WT, 2005, ARTHRITIS RES THER, V7, pR310, DOI 10.1186/ar1483
   DOYLE AG, 1994, EUR J IMMUNOL, V24, P1441, DOI 10.1002/eji.1830240630
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dube D, 2002, BIOCONJUGATE CHEM, V13, P685, DOI 10.1021/bc010084g
   Godek ML, 2006, J BIOMAT SCI-POLYM E, V17, P1141, DOI 10.1163/156856206778530731
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Gratchev A, 2006, IMMUNOBIOLOGY, V211, P473, DOI 10.1016/j.imbio.2006.05.017
   Hattori Y, 2006, BIOL PHARM BULL, V29, P1516, DOI 10.1248/bpb.29.1516
   Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533
   Jiang WW, 2007, J BIOMED MATER RES A, V82A, P492, DOI 10.1002/jbm.a.31175
   Kassab R, 2002, BIOORGAN MED CHEM, V10, P1767, DOI 10.1016/S0968-0896(02)00028-7
   Kodelja V, 1997, IMMUNOBIOLOGY, V197, P478, DOI 10.1016/S0171-2985(97)80080-0
   Koning GA, 2006, ARTHRITIS RHEUM, V54, P1198, DOI 10.1002/art.21719
   LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216
   Liu F, 2010, MOL IMAGING BIOL, V12, P595, DOI 10.1007/s11307-010-0305-1
   Locke LW, 2012, BIOMATERIALS, V33, P7785, DOI 10.1016/j.biomaterials.2012.07.022
   Lu YJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3304
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Martinez-Pomares L, 2003, J LEUKOCYTE BIOL, V73, P604, DOI 10.1189/jlb.0902450
   Michaelis M, 2000, ANTI-CANCER DRUG, V11, P369, DOI 10.1097/00001813-200006000-00007
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Mukherjee S, 2009, J BIOL CHEM, V284, P29391, DOI 10.1074/jbc.M109.005272
   MULLER CD, 1989, BIOCHIM BIOPHYS ACTA, V986, P97, DOI 10.1016/0005-2736(89)90277-0
   Nahar M, 2009, PHARM RES-DORD, V26, P2588, DOI 10.1007/s11095-009-9973-4
   Nair A, 2011, ACTA BIOMATER, V7, P3887, DOI 10.1016/j.actbio.2011.06.050
   Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799
   Nayak S, 2004, J AM CHEM SOC, V126, P10258, DOI 10.1021/ja0474143
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Paulos CM, 2004, ADV DRUG DELIVER REV, V56, P1205, DOI 10.1016/j.addr.2004.01.012
   Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050
   Ruan G, 2003, BIOMATERIALS, V24, P5037, DOI 10.1016/S0142-9612(03)00419-8
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272
   Sun C, 2006, J BIOMED MATER RES A, V78A, P550, DOI 10.1002/jbm.a.30781
   Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010
   Suzuki K, 2007, INT J HEMATOL, V85, P384, DOI 10.1532/IJH97.06213
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Turk MJ, 2002, ARTHRITIS RHEUM, V46, P1947, DOI 10.1002/art.10405
   Turk MJ, 2004, CANCER LETT, V213, P165, DOI 10.1016/j.canlet.2003.12.028
   Wang HJ, 2010, BIOMATERIALS, V31, P4129, DOI 10.1016/j.biomaterials.2010.01.089
   Weng H, 2004, J BIOMAT SCI-POLYM E, V15, P1167, DOI 10.1163/1568562041753106
   Xia W, 2009, BLOOD, V113, P438, DOI 10.1182/blood-2008-04-150789
   Yu DG, 2012, INT J NANOMED, V7, P5725, DOI [10.2147/IJN.S37455, 10.2147/IJN.S29961]
   Zhou J, 2012, FREE RADICAL BIO MED, V52, P218, DOI 10.1016/j.freeradbiomed.2011.10.452
   Zhou J, 2011, BIOMATERIALS, V32, P9383, DOI 10.1016/j.biomaterials.2011.08.064
NR 61
TC 12
Z9 12
U1 0
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2014
VL 10
IS 7
BP 2945
EP 2955
DI 10.1016/j.actbio.2014.04.001
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AK4NU
UT WOS:000338402200006
PM 24726956
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hiraguchi, Y
   Nagahashi, K
   Shibayama, T
   Hayashi, T
   Yano, TA
   Kushiro, K
   Takai, M
AF Hiraguchi, Yukari
   Nagahashi, Koji
   Shibayama, Takashi
   Hayashi, Tomohiro
   Yano, Taka-aki
   Kushiro, Keiichiro
   Takai, Madoka
TI Effect of the distribution of adsorbed proteins on cellular adhesion
   behaviors using surfaces of nanoscale phase-reversed amphiphilic block
   copolymers
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Self-assembly; Phosphorylcholine; Cell adhesion; Protein adsorption; AFM
   (atomic force microscopy)
ID ADSORPTION; EFFICIENCY; MIGRATION; MOTILITY; FILMS
AB In order to create suitable biocompatible materials for various tissue engineering applications, it is important to be able to understand protein adsorption and cell adhesion behaviors on the material's surfaces. It is known that the nanoscale distribution of adsorbed proteins affects cell adhesion behaviors. However, how nanoscale structures affect cell adhesion behaviors is still unclear. Therefore, in this study, we investigate the effect of the distribution of adsorbed proteins by the phase reversal of amphiphilic block copolymers composed of protein-non-adsorptive poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) and protein-adsorptive poly(3-methacryloyloxy propyltris(trimethylsilyloxy) silane) (PMPTSSi) on cell adhesion behaviors. The nanodomain structures of phase-separated block copolymers were successfully confirmed using transmission electron microscopy and atomic force microscopy. Surfaces that had PMPC dot-like domains (23 +/- 4 nm) and ones that had PMPTSSi dot-like domains (25 +/- 6 nm) were made. From protein adsorption and L929 cell adhesion measurements, it was found that even on surfaces with equal quantities of protein adsorption, the number of cells on surfaces with PMPC dot-like domains was larger than those with PMPTSSi dot-like domains. This suggests that the simple phase-reversal of the distribution of adsorbed proteins can be used to affect cell adhesion behaviors for designing biomaterial surfaces for tissue engineering applications. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Hiraguchi, Yukari; Nagahashi, Koji; Kushiro, Keiichiro; Takai, Madoka] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Shibayama, Takashi; Takai, Madoka] Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Hayashi, Tomohiro; Yano, Taka-aki] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268502, Japan.
RP Takai, M (reprint author), Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM takai@mpc.t.u-tokyo.ac.jp
RI Hayashi, Tomohiro/E-6135-2011
OI Hayashi, Tomohiro/0000-0002-4065-1807
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
FX This work was partly supported by a Grant-in-Aid for Scientific Research
   on Innovative Areas "Molecular Soft-Interface Science", and Grant-in-Aid
   for Scientific Research (A) from the Ministry of Education, Culture,
   Sports, Science and Technology of Japan.
CR Arai Y, 2011, LANGMUIR, V27, P2478, DOI 10.1021/la104178h
   Arima Y, 2007, J MATER CHEM, V17, P4079, DOI 10.1039/b708099a
   Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Beer AGF, 2010, PHYS REV, V81, P51914
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   Bonnie OL, 2012, J ELECT SPECTROSC RE, V185, P406
   Choi S, 2013, BIOMACROMOLECULES, V14, P92, DOI 10.1021/bm301390q
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   George PA, 2009, BIOMATERIALS, V30, P4732, DOI 10.1016/j.biomaterials.2009.05.039
   Horbett TA, 1995, ACS SYM SER, V602, P1
   Horbett TA, 1995, ACS SYM SER, V602, P2
   Ishihara K, 1990, POLYM J, V22, P335
   Jeyachandran YL, 2010, J COLLOID INTERF SCI, V341, P136, DOI 10.1016/j.jcis.2009.09.007
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Matsuura K, 2011, BIOMATERIALS, V32, P73355
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   Palacio MLB, 2011, J R SOC INTERFACE, V8, P630, DOI 10.1098/rsif.2010.0557
   Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095
   Sauerbrey G, 1959, Z PHYS, V155, P222
   Seo JH, 2011, SOFT MATTER, V7, P2968, DOI 10.1039/c0sm01292k
   Seo JH, 2009, BIOMATERIALS, V30, P5330, DOI 10.1016/j.biomaterials.2009.06.031
   Shibayama T, 2011, T MAT RES SOC JPN, V36, P577
   Spatz JP, 2000, LANGMUIR, V16, P407, DOI 10.1021/1a990070n
   Tateishi T, 2013, J BIOMED MAT RES A
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Ukawa M, 2010, BIOMATERIALS, V31, P6355, DOI 10.1016/j.biomaterials.2010.04.031
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zhang Z, 2010, BIOMATERIALS, V31, P7873, DOI 10.1016/j.biomaterials.2010.07.014
NR 29
TC 6
Z9 6
U1 2
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2014
VL 10
IS 7
BP 2988
EP 2995
DI 10.1016/j.actbio.2014.03.019
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AK4NU
UT WOS:000338402200010
PM 24690479
DA 2018-10-20
ER

PT J
AU Baker, DW
   Tsai, YT
   Weng, H
   Tang, LP
AF Baker, David W.
   Tsai, Yi-Ting
   Weng, Hong
   Tang, Liping
TI Alternative strategies to manipulate fibrocyte involvement in the
   fibrotic tissue response: Pharmacokinetic inhibition and the feasibility
   of directed-adipogenic differentiation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Fibrocyte; Fibrosis; Differentiation; Adipocyte; Foreign body response
ID PERIPHERAL-BLOOD FIBROCYTES; GROWTH-FACTOR-BETA; PROTEIN-KINASE
   INHIBITOR; FOREIGN-BODY REACTION; CIRCULATING FIBROCYTES;
   PULMONARY-FIBROSIS; INFLAMMATORY RESPONSES; LUNG FIBROSIS; BONE-MARROW;
   GIANT-CELLS
AB Fibrocytes have previously been identified as important mediators in several inflammatory and fibrotic diseases. However, there is no effective treatment thus far to reduce fibrotic tissue responses without affecting wound healing reactions. Here we investigate two strategies to alleviate fibrocyte interactions at the biomaterial interface, reducing collagen production and scar tissue formation. First, in an indirect approach, TGF-beta inhibitor-SB431542 and IL-1 beta/TNF-alpha inhibitor SB203580 were locally released from scaffold implants to block their respective signaling pathways. We show that the inhibition of IL-1 beta/TNF-alpha has no influence on overall fibrotic tissue reactions to the implants. However, the reduction of localized TGF-beta significantly decreases the fibrocyte accumulation and myofibroblast activation while reducing the fibrotic tissue formation. Since fibrocytes can be differentiated into non-fibrotic cell types, such as adipocytes, we further sought a more direct approach to reduce fibrocyte responses by directing fibrocyte differentiation into adipocytes. Interestingly, by initiating fibrocyte-to-adipocyte differentiation through sustained differentiation cocktail release, we find that adipogenic differentiation forces incoming fibrocytes away from the traditional myofibroblast lineage, leading to a substantial reduction in the collagen formation and fibrotic response. Our results support a novel and effective strategy to improve implant safety by reducing implant-associated fibrotic tissue reactions via directing non-fibrotic differentiation of fibrocytes. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Baker, David W.; Tsai, Yi-Ting; Weng, Hong; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Tang, Liping] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
EM Itang@uta.edu
FU NIH [RO1 EB007271, EB014404]
FX This work was supported by NIH grant RO1 EB007271 and EB014404.
CR Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453
   Bakhshayesh M, 2012, INFLAMMATION, V35, P138, DOI 10.1007/s10753-011-9298-4
   Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654
   Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004
   Chan A, 2008, ARTHRITIS RHEUM, V58, P707, DOI 10.1002/art.23264
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Chesney J, 1998, J IMMUNOL, V160, P419
   Choi YH, 2010, INT J BIOCHEM CELL B, V42, P662, DOI 10.1016/j.biocel.2009.12.011
   Crawford JR, 2010, J IMMUNOL METHODS, V363, P9, DOI 10.1016/j.jim.2010.09.025
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   Gu ZX, 2009, J ALLOY COMPD, V474, P450, DOI 10.1016/j.jallcom.2008.06.150
   Hong KM, 2005, FASEB J, V19, P2029, DOI 10.1096/fj.05-4295fje
   Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200
   Ishida Y, 2007, AM J PATHOL, V170, P843, DOI 10.2353/ajpath.2007.051213
   Jin N, 2011, INT IMMUNOPHARMACOL, V11, P1319, DOI 10.1016/j.intimp.2011.04.015
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kagari T, 2002, J IMMUNOL, V169, P1459, DOI 10.4049/jimmunol.169.3.1459
   Keeley EC, 2010, INT J BIOCHEM CELL B, V42, P535, DOI 10.1016/j.biocel.2009.10.014
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Kou PM, 2010, J BIOMED MATER RES A, V96, P239
   Koumas L, 2003, AM J PATHOL, V163, P1291, DOI 10.1016/S0002-9440(10)63488-8
   Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58
   Lavoie P, 2005, J HYPERTENS, V23, P1895, DOI 10.1097/01.hjh.0000182521.44440.c5
   Luttikhuizen DT, 2007, J BIOMED MATER RES A, V83A, P879, DOI 10.1002/jbm.a.31420
   Mehrad B, 2009, INT J BIOCHEM CELL B, V41, P1708, DOI 10.1016/j.biocel.2009.02.020
   Metz CN, 2003, CELL MOL LIFE SCI, V60, P1342, DOI 10.1007/s00018-003-2328-0
   Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4
   Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC
   Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011
   Mulsow JJ, 2005, ANN SURG, V242, P7
   Mulsow JJW, 2005, ANN SURG, V242, P880, DOI 10.1097/01.sla.0000189606.58343.cd
   Nair A, 2011, ACTA BIOMATER, V7, P3887, DOI 10.1016/j.actbio.2011.06.050
   Nair A, 2010, TISSUE ENG PART C-ME, V16, P23, DOI 10.1089/ten.TEC.2009.0094
   Niedermeier M, 2009, P NATL ACAD SCI USA, V106, P17892, DOI 10.1073/pnas.0906070106
   Phan Sem H, 2008, Proc Am Thorac Soc, V5, P334, DOI 10.1513/pats.200708-146DR
   Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997
   PIGUET PF, 1989, J EXP MED, V170, P655, DOI 10.1084/jem.170.3.655
   PIGUET PF, 1993, CYTOKINE, V5, P57, DOI 10.1016/1043-4666(93)90024-Y
   Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005
   RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069
   Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990
   Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103
   Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380
   SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584
   Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Tuan RS, 2008, J AM ACAD ORTHOP SUR, V16, pS42, DOI 10.5435/00124635-200800001-00010
   Tullberg-Reinert H, 1999, HISTOCHEM CELL BIOL, V112, P271, DOI 10.1007/s004180050447
   Wada T, 2007, KIDNEY INT, V72, P269, DOI 10.1038/sj.ki.5002325
   Waghabi MC, 2009, ANTIMICROB AGENTS CH, V53, P4694, DOI 10.1128/AAC.00580-09
   Xiao YQ, 2009, INVEST OPHTH VIS SCI, V50, P1698, DOI 10.1167/iovs.08-1675
   Yang LJ, 2002, LAB INVEST, V82, P1183, DOI 10.1097/01.LAB.0000027841.50269.61
   Zhou J, 2011, FREE RADIC BIOL MED, V52, P218
   Zhou J, 2011, BIOMATERIALS, V32, P9383, DOI 10.1016/j.biomaterials.2011.08.064
   Zhou WD, 2010, HUM REPROD, V25, P3110, DOI 10.1093/humrep/deq287
NR 61
TC 4
Z9 4
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2014
VL 10
IS 7
BP 3108
EP 3116
DI 10.1016/j.actbio.2014.03.011
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AK4NU
UT WOS:000338402200022
PM 24657674
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Fearing, BV
   Van Dyke, ME
AF Fearing, Bailey V.
   Van Dyke, Mark E.
TI In vitro response of macrophage polarization to a keratin biomaterial
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Keratin; Macrophage; Inflammation; Polarization; Immune response
ID HUMAN HAIR; MUSCULAR-DYSTROPHY; RECONSTITUTED KERATIN; NERVE
   REGENERATION; SKELETAL-MUSCLE; COMPOSITE FILM; OVINE MODEL; MOUSE MODEL;
   TNF-ALPHA; PHENOTYPE
AB Macrophage response to biomaterials is emerging as a major focus in tissue repair and wound healing. Macrophages are able to differentiate into two distinct states, eliciting divergent effects. The M1 phenotype is considered pro-inflammatory and up-regulates activity related to tissue destruction, whereas the M2 phenotype is considered anti-inflammatory and supports tissue remodeling. Both are necessary but a fine balance must be maintained as dysregulation of naive macrophages to M1 or M2 polarization has been implicated in several disease and injury models, and has been suggested as a potential cause for poor outcomes. Keratin biomaterials have been shown using different animal models to promote regeneration in several tissues. A potential common mechanism may be the general capability for keratin biomaterials to elicit beneficial inflammatory responses during the early stages of regeneration. In the present study, a keratin biomaterial was utilized in vitro to examine its effects on polarization toward one of these two macrophage phenotypes, and thus its role in inflammation. Exposure of a monocytic cell line to keratin biomaterial substrates was shown to bias macrophages toward an M2 phenotype, while a collagen control surface produced both M1 and M2 macrophages. Furthermore, keratin treatment was similar to the M2 positive control and was similarly effective at down-regulating the M1 response. Keratin biomaterial influenced greater production of anti-inflammatory cytokines and decreased amounts of pro-inflammatory cytokines. The use of a keratin biomaterial in regenerative medicine may therefore provide additional benefit by regulating a positive remodeling response. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Fearing, Bailey V.] Wake Forest Univ, Sch Med, Dept Orthopaed Surg, Winston Salem, NC 27157 USA.
   [Van Dyke, Mark E.] Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
RP Van Dyke, ME (reprint author), Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
EM mvandyk5@vt.edu
FU Errett Fisher Foundation; KeraNetics
FX The authors would like to thank Drs. Roche de Guzman and Maria Rahmany
   for their technical assistance and advice, Kenneth Grant for confocal
   imaging assistance, and KeraNetics and the Errett Fisher Foundation for
   funding support.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Barrette B, 2008, J NEUROSCI, V28, P9363, DOI 10.1523/JNEUROSCI.1447-08.2008
   Belcarz A, 2009, J BIOMED MATER RES B, V89B, P102, DOI 10.1002/jbm.b.31192
   Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Burnett LR, 2014, J BIOMATER APPL, V28, P869, DOI 10.1177/0885328213484975
   Burnett LR, 2013, BIOMATERIALS, V34, P2632, DOI 10.1016/j.biomaterials.2012.12.022
   de Guzman RC, 2013, BIOMATERIALS, V34, P1644, DOI 10.1016/j.biomaterials.2012.11.002
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   Dias GJ, 2010, J BIOMED MATER RES A, V95A, P1084, DOI 10.1002/jbm.a.32908
   Dias GJ, 2010, J BIOMED MATER RES A, V92A, P513, DOI 10.1002/jbm.a.32394
   Fearing BV, ISRN BIOMAT IN PRESS
   Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Grotenhuis N, 2013, BIOCHEM BIOPH RES CO, V433, P115, DOI 10.1016/j.bbrc.2013.02.054
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Hill PS, 2011, TISSUE ENG PT A, V17, P1499, DOI 10.1089/ten.tea.2010.0184
   ITO H, 1982, KOBUNSHI RONBUNSHU, V39, P249, DOI 10.1295/koron.39.249
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Lee KY, 1998, J BIOMAT SCI-POLYM E, V9, P905, DOI 10.1163/156856298X00235
   Li JS, 2012, J BIOMED MATER RES B, V100B, P896, DOI 10.1002/jbm.b.32645
   Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC370, DOI 10.1152/ajpcell.00453.2002
   Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029
   Pace LA, 2014, TISSUE ENG PT A, V20, P507, DOI 10.1089/ten.TEA.2013.0084
   Pace LA, 2013, BIOMATERIALS, V34, P5907, DOI 10.1016/j.biomaterials.2013.04.024
   Pechter PM, 2012, WOUND REPAIR REGEN, V20, P236, DOI 10.1111/j.1524-475X.2012.00768.x
   Peplow PV, 2009, J BIOMED MATER RES A, V89A, P255, DOI 10.1002/jbm.a.32038
   Poranki D, J BIOMATER IN PRESS
   Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003
   Quinn MT, 2009, J INNATE IMMUN, V1, P509, DOI 10.1159/000228158
   Rahmany MB, 2013, BIOMATERIALS, V34, P2492, DOI 10.1016/j.biomaterials.2012.12.008
   Reichl S, 2011, BIOMATERIALS, V32, P3375, DOI 10.1016/j.biomaterials.2011.01.052
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Richter JR, 2011, BIOMATERIALS, V32, P7555, DOI 10.1016/j.biomaterials.2011.06.061
   Sando L, 2010, J BIOMED MATER RES A, V95A, P901, DOI 10.1002/jbm.a.32913
   Saul JM, 2011, J BIOMED MATER RES A, V98A, P544, DOI 10.1002/jbm.a.33147
   Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011
   Shen DL, 2011, BIOMATERIALS, V32, P9290, DOI 10.1016/j.biomaterials.2011.08.057
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Srinivasan B, 2010, J BIOMED MATER RES B, V92B, P5, DOI 10.1002/jbm.b.31483
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073
   Szalay K, 1997, EUR J CELL BIOL, V74, P391
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Thilagar S, 2009, J BIOMED MATER RES B, V88B, P12, DOI 10.1002/jbm.b.31024
   Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265
   Torrente Y, 2003, CELL TRANSPLANT, V12, P91, DOI 10.3727/000000003783985115
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Villalta SA, 2011, J IMMUNOL, V187, P5419, DOI 10.4049/jimmunol.1101267
   Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523
   Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376
   Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Zhang LP, 2012, J BIOL CHEM, V287, P6177, DOI 10.1074/jbc.M111.292649
NR 67
TC 25
Z9 25
U1 1
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2014
VL 10
IS 7
BP 3136
EP 3144
DI 10.1016/j.actbio.2014.04.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AK4NU
UT WOS:000338402200025
PM 24726958
DA 2018-10-20
ER

PT J
AU Lozano, D
   Sanchez-Salcedo, S
   Portal-Nunez, S
   Vila, M
   Lopez-Herradon, A
   Ardura, JA
   Mulero, F
   Gomez-Barrena, E
   Vallet-Regi, M
   Esbrit, P
AF Lozano, Daniel
   Sanchez-Salcedo, Sandra
   Portal-Nunez, Sergio
   Vila, Mercedes
   Lopez-Herradon, Ana
   Antonio Ardura, Juan
   Mulero, Francisca
   Gomez-Barrena, Enrique
   Vallet-Regi, Maria
   Esbrit, Pedro
TI Parathyroid hormone-related protein (107-111) improves the bone
   regeneration potential of gelatin-glutaraldehyde biopolymer-coated
   hydroxyapatite
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Macroporous scaffolds; Hydroxyapatite; PTHrP (107-111); In vivo bone
   regeneration; Rat
ID C-TERMINAL FRAGMENTS; OSTEOBLASTIC CELLS; IN-VIVO; PTHRP; BIOCERAMICS;
   RESORPTION; FOAMS; MODEL; MICE; ANGIOGENESIS
AB Biopolymer-coated nanocrystalline hydroxyapatite (HA) made as macroporous foams which are degradable and flexible are promising candidates as orthopaedic implants. The C-terminal (107-111) epitope of parathyroid hormone-related protein (PTHrP) exhibits osteogenic properties. The main aim of this study was to evaluate whether PTHrP (107-111) loading into gelatin-glutaraldehyde biopolymer-coated HA (HA(GIu)) scaffolds would produce an optimal biomaterial for tissue engineering applications. HA(GIu) scaffolds with and without PTHrP (107-111) were implanted into a cavitary defect performed in both distal tibial metaphysis of adult rats. Animals were sacrificed after 4 weeks for histological, microcomputerized tomography and gene expression analysis of the callus. At this time, bone healing occurred only in the presence of PTHrP (107-111)-containing HA(Giu) implant, related to an increase in bone volume/tissue volume and trabecular thickness, cortical thickness and gene expression of osteocalcin and vascular cell adhesion molecule I, but a decreased gene expression of Wnt inhibitors, SOST and dickkopf homolog 1. The autonomous osteogenic effect of the PTHrP (107-111)-loaded HA(Giu) scaffolds was confirmed in mouse and human osteoblastic cell cultures. Our findings demonstrate the advantage of loading PTHrP (107-111) into degradable HA(GIu) scaffolds for achieving an optimal biomaterial that is promising for low load bearing clinical applications. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Lozano, Daniel; Portal-Nunez, Sergio; Lopez-Herradon, Ana; Antonio Ardura, Juan; Esbrit, Pedro] Fdn Jimenez Diaz, IIS, Lab Metab Mineral & Oseo, E-28040 Madrid, Spain.
   [Lozano, Daniel; Portal-Nunez, Sergio; Lopez-Herradon, Ana; Antonio Ardura, Juan; Esbrit, Pedro] Inst Salud Carlos III RETICEF, Madrid 28040, Spain.
   [Lozano, Daniel; Gomez-Barrena, Enrique] Univ La Paz IdiPAZ, Inst Invest Hosp, Grp Invest Cirugia Osteo Articular, Madrid 28046, Spain.
   [Sanchez-Salcedo, Sandra; Vila, Mercedes; Vallet-Regi, Maria] UCM, Inst Invest Sanitaria Hosp 12 Octubre I 12, Fac Farm, Dept Quim Inorgan & Bioinorgan, Madrid 28040, Spain.
   [Mulero, Francisca] CNIO, Unidad Imagen Mol, Madrid 28029, Spain.
   [Sanchez-Salcedo, Sandra; Vila, Mercedes; Vallet-Regi, Maria] Ctr Invest Perteneciente Red Bioingn Biomat & Nan, Zaragoza, Spain.
RP Vallet-Regi, M (reprint author), Fac Farm UCM, Dto Quim Inorgan & Bioinorgan, Pza Ramon y Cajal S-N, Madrid 28040, Spain.
EM vallet@ucm.es
RI Portal-Nunez, Sergio/L-7391-2014; SANCHEZ-SALCEDO, SANDRA/N-4501-2014;
   GOMEZ-BARRENA, ENRIQUE/A-2799-2008; Lozano, Daniel/B-5081-2017; Mulero,
   Francisca/M-3289-2014; Vallet-Regi, Maria/M-3378-2014
OI Portal-Nunez, Sergio/0000-0003-0659-1545; SANCHEZ-SALCEDO,
   SANDRA/0000-0002-1889-2057; GOMEZ-BARRENA, ENRIQUE/0000-0003-1065-6137;
   Lozano, Daniel/0000-0001-5902-9201; Mulero,
   Francisca/0000-0001-9584-4211; Vallet-Regi, Maria/0000-0002-6104-4889;
   Ardura Rodriguez, Juan Antonio/0000-0002-2827-3364; Vila,
   Mercedes/0000-0002-8473-0881
FU Ministerio de Economia y Competitividad [CSO2010-11384-E]; Ministerio de
   Ciencia e Innovacion [MAT2012-35556]; Ministerio de Economia y
   Competitividad (RE-TICEF) [RD12/0043/0008]; Comunidad Autonoma de Madrid
   [S-2009/MAT-1472]; postdoctoral research contracts from Comunidad
   Autonoma de Madrid [S-2009/MAT-1472]; RETICEF [RD12/0043/0008,
   RD06/0013/1002]; Ministerio de Ciencia e Innovacion-Juan de la Cierva
   program [JCI-2011-09548]; Fundacion Conchita Rabago and Ministerio de
   Educacion-FPU program [AP2009-1871]
FX The Spanish and European Network of Excellence for the Prevention and
   Treatment of Osteoporotic Fractures "Ageing" is financially supported by
   the Ministerio de Economia y Competitividad through the project
   CSO2010-11384-E. This research was supported by Grants from the
   Ministerio de Ciencia e Innovacion (MAT2012-35556), Ministerio de
   Economia y Competitividad (RE-TICEF RD12/0043/0008) and Comunidad
   Autonoma de Madrid (S2009 MAT-1472). D.L., S.P.-N. and J.A.A. are
   recipients of postdoctoral research contracts from Comunidad Autonoma de
   Madrid (S-2009/Mat-1472), RETICEF (RD06/0013/1002 and RD12/0043/0008)
   and Ministerio de Ciencia e Innovacion-Juan de la Cierva program
   (JCI-2011-09548), respectively. A.L.-H. was supported by Fundacion
   Conchita Rabago and Ministerio de Educacion-FPU program (AP2009-1871).
   We are indebted to Dr. C. Castilla (Animal Facility, IIS-Fundacion
   Jimenez Diaz) for expert advice on the surgical procedures.
CR Agholme F, 2011, BONE, V48, P988, DOI 10.1016/j.bone.2011.02.008
   Albrektsson T., 2001, EUR SPINE J, V10, P96
   [Anonymous], 2005, BONE JOINT DECADE
   Arvidson K, 2011, J CELL MOL MED, V15, P718, DOI 10.1111/j.1582-4934.2010.01224.x
   Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.3.CO;2-I
   Caetano-Lopes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016947
   Chou J, 2013, MAR DRUGS, V11, P5148, DOI 10.3390/md11125148
   Cicuendez M, 2012, ACTA BIOMATER, V8, P802, DOI 10.1016/j.actbio.2011.09.019
   Cornish J, 1999, J BONE MINER RES, V14, P915, DOI 10.1359/jbmr.1999.14.6.915
   Cornish J, 1997, ENDOCRINOLOGY, V138, P1299, DOI 10.1210/en.138.3.1299
   Datta NS, 2009, CELL SIGNAL, V21, P245
   de Gortazar AR, 2006, CALCIFIED TISSUE INT, V79, P360, DOI 10.1007/s00223-006-0099-y
   Driscoll P., 2009, ORTHOPEDIC BIOMATERI
   Esbrit P, 2013, BIOCHEM PHARMACOL, V85, P1417, DOI 10.1016/j.bcp.2013.03.002
   FENTON AJ, 1991, ENDOCRINOLOGY, V129, P1762, DOI 10.1210/endo-129-4-1762
   de Castro LF, 2010, TISSUE ENG PT A, V16, P1157, DOI [10.1089/ten.tea.2009.0355, 10.1089/ten.TEA.2009.0355]
   de Castro LF, 2012, J CELL PHYSIOL, V227, P1752, DOI 10.1002/jcp.22902
   Garcia-Martin A, 2013, J CELL BIOCHEM, V114, P1404, DOI 10.1002/jcb.24482
   Gil-Albarova J, 2012, ACTA BIOMATER, V8, P3777, DOI 10.1016/j.actbio.2012.06.019
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802
   Liekens S, 2001, BIOCHEM PHARMACOL, V61, P253, DOI 10.1016/S0006-2952(00)00529-3
   Lopez-Herradon A, 2013, J CELL BIOCHEM, V114, P1908, DOI 10.1002/jcb.24535
   Lozano D, 2011, BRIT J PHARMACOL, V162, P1424, DOI 10.1111/j.1476-5381.2010.01155.x
   Lozano D, 2012, ACTA BIOMATER, V8, P2770, DOI 10.1016/j.actbio.2012.04.002
   Lozano D, 2012, ACTA BIOMATER, V8, P2317, DOI 10.1016/j.actbio.2012.03.014
   Lozano D, 2010, ACTA BIOMATER, V6, P797, DOI 10.1016/j.actbio.2009.08.033
   Nejati E, 2009, MAT SCI ENG C-BIO S, V29, P942, DOI 10.1016/j.msec.2008.07.038
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Portal-Nunez S, 2012, HISTOL HISTOPATHOL, V27, P559, DOI 10.14670/HH-27.559
   RihaniBasharat S, 1997, CALCIFIED TISSUE INT, V61, P426, DOI 10.1007/s002239900359
   Rodriguez-de la Rosa L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087536
   RODRIGUEZCARVAJAL J, 1993, PHYSICA B, V192, P55, DOI 10.1016/0921-4526(93)90108-I
   Salinas AJ, 2013, BIOMATER SCI-UK, V1, P40, DOI 10.1039/c2bm00071g
   Sanchez-Salcedo S, 2010, J MATER CHEM, V20, P6956, DOI 10.1039/c0jm01260b
   Schieker M, 2006, EUR J TRAUMA, V32, P114, DOI DOI 10.1007/S00068-006-6047-8
   Shors EC, 1999, ORTHOP CLIN N AM, V30, P599, DOI 10.1016/S0030-5898(05)70113-9
   Thompson Z, 2002, J ORTHOPAED RES, V20, P1091, DOI 10.1016/S0736-0266(02)00017-7
   Trejo CG, 2010, BIOMATERIALS, V31, P8564, DOI 10.1016/j.biomaterials.2010.07.103
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Valin A, 2001, ENDOCRINOLOGY, V142, P2752, DOI 10.1210/en.142.7.2752
   Vallet-Regi M, 2009, WOODHEAD PUBL MATER, P194, DOI 10.1533/9781845696610.2.194
   Vallet-Regi M, 2011, ADV MATER, V23, P5177, DOI 10.1002/adma.201101586
   Vallet-Regi M, 2010, CR CHIM, V13, P174, DOI 10.1016/j.crci.2009.03.004
   Vila M, 2011, J HAZARD MATER, V192, P71, DOI 10.1016/j.jhazmat.2011.04.100
NR 45
TC 9
Z9 9
U1 8
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2014
VL 10
IS 7
BP 3307
EP 3316
DI 10.1016/j.actbio.2014.03.025
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AK4NU
UT WOS:000338402200042
PM 24704694
OA Green Published
DA 2018-10-20
ER

PT J
AU Bronk, JK
   Russell, BH
   Rivera, JJ
   Pasqualini, R
   Arap, W
   Hook, M
   Barbu, EM
AF Bronk, Julianna K.
   Russell, Brooke H.
   Rivera, Jose J.
   Pasqualini, Renata
   Arap, Wadih
   Hoeoek, Magnus
   Barbu, E. Magda
TI A multifunctional streptococcal collagen-mimetic protein coating
   prevents bacterial adhesion and promotes osteoid formation on titanium
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biofilm; Titanium implants; Streptococcal collagen mimetic proteins;
   Osseointegration
ID STAPHYLOCOCCUS-AUREUS; INFECTIOUS-DISEASES; BIOACTIVE HYDROGELS;
   BINDING; BIOFILMS; REVISION; CELLS; DIFFERENTIATION; GLYCOPROTEIN;
   BIOMATERIAL
AB The major barriers to the clinical success of orthopedic and dental implants are poor integration of fixtures with bone tissue and biomaterial-associated infections. Although multifunctional device coatings have long been considered a promising strategy, their development is hindered by difficulties in integrating biocompatibility, anti-infective activity and antithrombotic properties within a single grafting agent. In this study, we used cell adhesion assays and confocal microscopy of primary murine osteoblasts and human osteoblast cell lines MG-63 and Saos-2 to demonstrate that a streptococcal collagen-like protein engineered to display the alpha 1 and alpha 2 integrin recognition sequences enhances osteoblast adhesion and spreading on titanium fixtures. By measuring calcium deposition and alkaline phosphatase activity, we also showed that selective activation of alpha 2 beta 1 integrin induces osteoblast differentiation, osteoid formation and mineralization. Moreover, cell adhesion assays and scanning electron microscopy of clinical isolates Staphylococcus aureus Philips and Staphylococcus epidermidis 9491 indicated that streptococcal collagen-mimetic proteins inhibit bacterial colonization and biofilm formation irrespective of their interaction with integrins. Given that streptococcal collagenous substrates neither interact with platelets nor trigger a strong immune response, this novel bioactive coating appears to have desirable multifaceted properties with promising translational applications. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bronk, Julianna K.; Pasqualini, Renata; Arap, Wadih; Barbu, E. Magda] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr Appl Res, Houston, TX 77030 USA.
   [Russell, Brooke H.; Rivera, Jose J.; Hoeoek, Magnus] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA.
   [Bronk, Julianna K.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.
   [Pasqualini, Renata; Arap, Wadih] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA.
   [Barbu, E. Magda] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA.
RP Hook, M (reprint author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, 2121 Holcombe Blvd, Houston, TX 77030 USA.
EM mhook@ibt.tamhsc.edu; mbarbu@SyntheticGenomics.com
FU Department of Defense [W81XWH-10-1-0866]; Rosalie B. Hite Foundation
FX We thank J. Gu and R. Serda for help with SEM. This work was supported
   by award number W81XWH-10-1-0866 from the Department of Defense to E.M.
   Barbu. J.K. Bronk is a fellow of the Rosalie B. Hite Foundation.
CR Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651
   Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2
   Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011
   Boyan BD, 2001, ANN REV MATER RES, V31, P357, DOI 10.1146/annurev.matsci.31.1.357
   Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015
   Browning MB, 2013, BIOMACROMOLECULES, V14, P2225, DOI 10.1021/bm400634j
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Corrigan RM, 2009, MICROBIOLOGY, V9, P22
   Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0
   Godin B, 2010, J BIOMED MATER RES A, V94A, P1236, DOI 10.1002/jbm.a.32807
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Labek G, 2011, J BONE JOINT SURG BR, V93B, P293, DOI 10.1302/0301-620X.93B3.25467
   Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   McCrea KW, 2000, MICROBIOL-UK, V146, P1535, DOI 10.1099/00221287-146-7-1535
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Munnix ICA, 2008, J THROMB HAEMOST, V6, P2132, DOI 10.1111/j.1538-7836.2008.03167.x
   Muramatsu K, 2003, J BIOMED MATER RES A, V65A, P409, DOI 10.1002/jbm.a.10494
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PATTI JM, 1993, BIOCHEMISTRY-US, V32, P11428, DOI 10.1021/bi00093a021
   Peng YY, 2010, BIOMATERIALS, V31, P2755, DOI 10.1016/j.biomaterials.2009.12.040
   PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature0189
   Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357
   Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415
   Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Ulrich SD, 2008, INT ORTHOP, V32, P597, DOI 10.1007/s00264-007-0364-3
   Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 48
TC 16
Z9 16
U1 2
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2014
VL 10
IS 7
BP 3354
EP 3362
DI 10.1016/j.actbio.2014.04.005
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AK4NU
UT WOS:000338402200047
PM 24732634
DA 2018-10-20
ER

PT J
AU Motoyama, K
   Tanida, Y
   Hata, K
   Hayashi, T
   Higashi, T
   Ishitsuka, Y
   Kondo, Y
   Irie, T
   Kaneko, S
   Arima, H
AF Motoyama, Keiichi
   Tanida, Yuki
   Hata, Kyona
   Hayashi, Tomoya
   Higashi, Taishi
   Ishitsuka, Yoichi
   Kondo, Yuki
   Irie, Tetsumi
   Kaneko, Shinichiro
   Arima, Hidetoshi
TI Potential Use of a Megamolecular Polysaccharide Sacran as a
   Hydrogel-Based Sustained Release System
SO CHEMICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE sacran; biomaterial; hydrogel; polysaccharide; sustained release system
ID DRUG-DELIVERY; APHANOTHECE-SACRUM; GLYCOSAMINOGLYCANS; CHEMOKINES;
   INTERACT; MATRICES
AB A megamolecular polysaccharide sacran was newly extracted from cyanobacterium Aphanothece sacrum. Sacran has many preferable properties for transdermal application, e.g. a safe biomaterial, a high moisturizing effect, a formation of film and hydrogel. Additionally, it was recently discovered that sacran has an anti-inflammatory effect for atopic dermatitis model mice. In this study, in order to evaluate the feasibility of sacran-hydrogel as a novel sustained release system, we prepared a sacran-hydrogel containing 4-biphenyl acetic acid (BPAA, an acidic drug), prednisolone (PD, a neutral drug) or chlorpheniramine maleate (CPM, a basic drug), and performed the in vitro release studies. The sacran-hydrogel containing BPAA, PD or CPM provided a sustained release profile in accordance with a quasi-Fickian diffusion model. Furthermore, the release rate of drugs from sacran-hydrogels can be controlled by adjusting the concentration of aluminum chloride as a cross linker. These results suggest the potential use of sacran-hydrogel as a sustained release system for drugs.
C1 [Motoyama, Keiichi; Tanida, Yuki; Hata, Kyona; Hayashi, Tomoya; Higashi, Taishi; Ishitsuka, Yoichi; Kondo, Yuki; Irie, Tetsumi; Arima, Hidetoshi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Kumamoto 8620973, Japan.
   [Irie, Tetsumi; Arima, Hidetoshi] Kumamoto Univ, Program Leading Grad Sch, HIGO Hlth Life Sci Interdisciplinary & Glocal Ori, Chuo Ku, Kumamoto 8620973, Japan.
   [Kaneko, Shinichiro] Green Sci Mat Inc, Higashi Ku, Kumamoto 8618038, Japan.
RP Arima, H (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 5-1 Oehonmachi, Kumamoto 8620973, Japan.
EM arimah@gpo.kumamoto-u.ac.jp
FU Adaptable and Seamless Technology Transfer Program (A-STEP) from the
   Japan Science and Technology Agency
FX We acknowledge Dr. Maiko K. Okajima and Dr. Tatsuo Kaneko from
   Department of Material Science and Technology (JAIST) for their helps.
   We wish to thank for technical assistance of Mr. Kei Watanabe in
   Kumamoto University. This work was supported by Adaptable and Seamless
   Technology Transfer Program (A-STEP) from the Japan Science and
   Technology Agency.
CR Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Fujishiro T, 2004, APPL ENVIRON MICROB, V70, P3338, DOI 10.1128/AEM.70.6.3338-3345.2004
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Higashi T, 2008, BIOMATERIALS, V29, P3866, DOI 10.1016/j.biomaterials.2008.06.019
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Jogani Viral, 2008, Recent Pat Drug Deliv Formul, V2, P25
   Kajima MK, 2009, LANGMUIR, V25, P8526, DOI 10.1021/la8036956
   Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200
   Kidane A, 2005, CURR OPIN CHEM BIOL, V9, P347, DOI 10.1016/j.cbpa.2005.06.006
   KORSMEYER RW, 1986, J POLYM SCI POL PHYS, V24, P409, DOI 10.1002/polb.1986.090240215
   Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d
   Ngatu NR, 2012, ANN ALLERG ASTHMA IM, V108, P117, DOI 10.1016/j.anai.2011.10.013
   Okajima MK, 2008, MACROMOLECULES, V41, P4061, DOI 10.1021/ma800307w
   Okajima MK, 2010, BIOMACROMOLECULES, V11, P3172, DOI 10.1021/bm101012u
   Okajima MK, 2010, BIOMACROMOLECULES, V11, P1773, DOI 10.1021/bm100231q
   Okajima MK, 2009, MACROMOLECULES, V42, P3057, DOI 10.1021/ma802829x
   Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918
   Park HY, 2011, FOOD CHEM TOXICOL, V49, P1745, DOI 10.1016/j.fct.2011.04.020
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Van Tomme SR, 2007, EXPERT REV MED DEVIC, V4, P147, DOI 10.1586/17434440.4.2.147
   Volpi N, 2006, CURR MED CHEM, V13, P1799, DOI 10.2174/092986706777452470
   Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289
NR 27
TC 10
Z9 10
U1 1
U2 16
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0009-2363
J9 CHEM PHARM BULL
JI Chem. Pharm. Bull.
PD JUL
PY 2014
VL 62
IS 7
BP 636
EP 641
PG 6
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA AK2SN
UT WOS:000338269900003
PM 24739952
DA 2018-10-20
ER

PT J
AU Suganya, S
   Venugopal, J
   Ramakrishna, S
   Lakshmi, BS
   Dev, VRG
AF Suganya, S.
   Venugopal, J.
   Ramakrishna, S.
   Lakshmi, B. S.
   Dev, V. R. Giri
TI Naturally derived biofunctional nanofibrous scaffold for skin tissue
   regeneration
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Aloe vera; Silk fibroin; Skin tissue regeneration
ID VERA LEAF GEL; SILK FIBROIN; ALOE-VERA; IN-VITRO; BIOMATERIALS;
   CYTOCOMPATIBILITY; CHALLENGES; GROWTH; CELLS; MATS
AB Significant wound healing activity of Aloe vera (AV) and higher elastic strength of Silk fibroin (SF) along with mammalian cell compatibility makes AV and SF an attractive material for tissue engineering. The purpose of the present work was to combine their unique properties, with the advantage of electro-spinning to prepare a hybrid transdermal biomaterial for dermal substitutes. The physico-chemical characterization of the developed scaffold showed finer morphology expressing amino and esteric groups with improved hydrophilic properties and favorable tensile strain of 116% desirable for skin tissue engineering. Their biological response showed favorable fibroblast proliferation compared to control which almost increased linearly by (p < 0.01)34.68% on day 3, (p < 0.01) 19.13% on day 6, and (p < 0.001) 97.86% on day 9 with higher expression of CMFDA, collagen and F-actin proteins. The obtained results prove that the nanofibrous scaffold with synergistic property of AV and SF would be a potential biomaterial for skin tissue regeneration. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Suganya, S.; Dev, V. R. Giri] Anna Univ, Dept Text Technol, Madras 600025, Tamil Nadu, India.
   [Suganya, S.; Lakshmi, B. S.] Anna Univ, Ctr Biotechnol, Madras 600025, Tamil Nadu, India.
   [Venugopal, J.; Ramakrishna, S.] Natl Univ Singapore, Fac Engn, Nanosci & Nanotechnol Initiat, Singapore 117548, Singapore.
RP Dev, VRG (reprint author), Anna Univ, Dept Text Technol, AC Tech, Madras 600025, Tamil Nadu, India.
EM vrgiridev@yahoo.com
OI Jayarama Reddy, Venugopal/0000-0001-5867-8007
FU Department of Textile Technology, Anna University, Chennai, India;
   National University of Singapore, Singapore
FX This study was supported by the Department of Textile Technology, Anna
   University, Chennai, India and National University of Singapore,
   Singapore.
CR Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bishara S.A., 2005, BURNS, V31, P944
   Chan B., 2008, EUR SPINE J, V17, P467, DOI DOI 10.1007/S00586-008-0745-3
   Chen G, 2004, J MATER SCI-MATER M, V15, P671, DOI 10.1023/B:JMSM.0000030208.89523.2a
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chithra P, 1998, MOL CELL BIOCHEM, V181, P71, DOI 10.1023/A:1006813510959
   DAVIS RH, 1994, J AM PODIAT MED ASSN, V84, P77, DOI 10.7547/87507315-84-2-77
   DAVIS RH, 1989, J AM PODIAT MED ASSN, V79, P559, DOI 10.7547/87507315-79-11-559
   Fan SN, 2013, INT J BIOL MACROMOL, V56, P83, DOI 10.1016/j.ijbiomac.2013.01.033
   Gunn J, 2010, TRENDS BIOTECHNOL, V28, P189, DOI 10.1016/j.tibtech.2009.12.006
   Hamman JH, 2008, MOLECULES, V13, P1599, DOI 10.3390/molecules13081599
   Hetel P., 2011, TRENDS BIOMATER ARTI, V25, P20
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Joseph B, 2010, INT J PHARM SCI REV, V4, P106
   Krishnan P., 2006, CURR ANAESTH CRIT CA, V17, P21
   Li XY, 2012, MATER LETT, V73, P103, DOI 10.1016/j.matlet.2011.12.108
   Liu TL, 2010, J ZHEJIANG UNIV-SC B, V11, P10, DOI 10.1631/jzus.B0900163
   Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031
   Lu TL, 2013, INT J NANOMED, V8, P337, DOI 10.2147/IJN.S38635
   Miki H, 2000, AM J RESP CRIT CARE, V162, P2259, DOI 10.1164/ajrccm.162.6.9812029
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Min SJ, 2012, J BIOMAT SCI-POLYM E, V23, P97, DOI 10.1163/092050610X543609
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Noh HK, 2006, BIOMATERIALS, V27, P3934, DOI 10.1016/j.biomaterials.2006.03.016
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Park JS, 2012, J APPL POLYM SCI, V125, pE595, DOI 10.1002/app.36833
   Pauwels E.K., 2005, DRUG NEWS PERSPECT, V20, P579
   Radha Devi, 2005, Natural Product Radiance, V4, P322
   Reynolds T, 1999, J ETHNOPHARMACOL, V68, P3, DOI 10.1016/S0378-8741(99)00085-9
   Shakespeare P, 2001, BURNS, V27, P517, DOI 10.1016/S0305-4179(01)00017-1
   Sheng XY, 2013, INT J BIOL MACROMOL, V56, P49, DOI 10.1016/j.ijbiomac.2013.01.029
   Stashak T.S., 2008, EQUINE WOUND MANAGEM, P81119
   Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052
   Tian F, 2008, J BIOMED MATER RES A, V84A, P291, DOI 10.1002/jbm.a.31304
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wei GB, 2008, ADV FUNCT MATER, V18, P3568, DOI 10.1002/adfm.200800662
   Wynn S.G., 2007, TEXTBOOK VET HERBAL, P450
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
NR 40
TC 28
Z9 29
U1 3
U2 51
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUL
PY 2014
VL 68
BP 135
EP 143
DI 10.1016/j.ijbiomac.2014.04.031
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AK4SO
UT WOS:000338414600023
PM 24768969
DA 2018-10-20
ER

PT J
AU Rodriguez, IZ
   Pablos, DL
   Uceda, MIF
   Lobato, RD
   Aniceto, GS
AF Zubillaga Rodriguez, I.
   Lora Pablos, D.
   Falguera Uceda, M. I.
   Diez Lobato, R.
   Sanchez Aniceto, G.
TI Frontal sinus obliteration after trauma: analysis of bone regeneration
   for two selected methods
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE subcranial approach; Hounsfield units (HU); frontal sinus; demineralized
   bone matrix (DBM); calvarial bone dust
ID MANAGEMENT; FRACTURES; MATRIX
AB We present a prospective randomized experimental study comparing bone regeneration obtained in 60 post-traumatic frontal sinuses obliterated with either calvarial bone dust (n = 30, group I) or calvarial bone and demineralized bone matrix (DBM; n = 30, group II). Radiological follow-up included high-resolution computed tomography with quantitative micro-density analysis in Hounsfield units (HU), together with a volumetric evaluation of the ossification at 6 and 24 months after surgical treatment. Epidemiological information and potential drawbacks were analysed. Bone volume and density data (HU) for the regenerated areas were subjected to statistical analysis at 6 and 24 months for both groups. Results were compared with reference values obtained from frontal and temporal bone in every patient. Complications developed for 10% of operated sinuses. The resulting bone formation (HU) in group I patients was significantly better than that obtained in group II. Ossification progressed in a statistically significant manner in both groups when compared at 6 and 24 months postoperatively. The use of DBM as a biomaterial associated with calvarial bone dust for sinus obliteration shows long-term safe results, similar to autogenous bone, but with a lower final bone density.
C1 [Zubillaga Rodriguez, I.; Falguera Uceda, M. I.; Sanchez Aniceto, G.] 12 Octubre Univ Hosp, Oral & Maxillofacial Surg Dept, Madrid 28041, Spain.
   [Lora Pablos, D.] 12 Octubre Univ Hosp, Clin Res Dept, CIBERESP, IMAS12, Madrid 28041, Spain.
   [Diez Lobato, R.] 12 Octubre Univ Hosp, Dept Neurosurg, Madrid 28041, Spain.
RP Rodriguez, IZ (reprint author), 12 Octubre Univ Hosp, Avda Cordoba S-N, Madrid 28041, Spain.
EM ignaciozubillaga@yahoo.es
CR Altman JI, 2007, OTOLARYNG HEAD NECK, V137, P264, DOI 10.1016/j.otohns.2007.01.020
   Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3
   Fattahi T, 2005, J ORAL MAXIL SURG, V63, P487, DOI 10.1016/j.joms.2004.10.007
   Gerzmann AA, 2001, CELL TISSUE BANK, V2, P87
   Gosain AK, 2000, PLAST RECONSTR SURG, V106, P360, DOI 10.1097/00006534-200008000-00018
   GRAHNE B, 1971, ACTA OTO-LARYNGOL, V72, P215, DOI 10.3109/00016487109122475
   HILDING A. C., 1963, LARYNGOSCOPE, V73, P1201, DOI 10.1288/00005537-196309000-00004
   IOANNIDES C, 1984, J MAXILLOFAC SURG, V12, P255, DOI 10.1016/S0301-0503(84)80255-6
   Kalavrezos ND, 1999, J CRANIO MAXILL SURG, V27, P20, DOI 10.1016/S1010-5182(99)80005-5
   Kellman RM, 2012, ANTERIOR SUBCRANIAL
   KNAUFF HA, 1963, ARCHIV OTOLARYNGOL, V78, P707
   MCNEILL RA, 1967, LARYNGOSCOPE, V77, P202, DOI 10.1288/00005537-196702000-00005
   Rodriguez IZ, 2013, INT J ORAL MAX SURG, V42, P71, DOI 10.1016/j.ijom.2012.10.001
   ROHRICH RJ, 1992, CLIN PLAST SURG, V19, P219
   ROHRICH RJ, 1995, PLAST RECONSTR SURG, V95, P580, DOI 10.1097/00006534-199503000-00026
   Schumrick KA, 1994, ARCH OTOLARYNGOL, V120, P1003
   Strong EB, 2009, CRANIOMAX TRAUM REC, V2, P161, DOI [10.1055/s-0029-1234020.ISSN1943-3875, 10.1055/s-0029-1234020]
   WOLFE SA, 1988, PLAST RECONSTR SURG, V82, P781, DOI 10.1097/00006534-198811000-00009
NR 18
TC 1
Z9 2
U1 0
U2 2
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
EI 1399-0020
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD JUL
PY 2014
VL 43
IS 7
BP 827
EP 833
DI 10.1016/j.ijom.2014.02.012
PG 7
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA AK4RJ
UT WOS:000338411500008
PM 24656495
DA 2018-10-20
ER

PT J
AU Dai, WD
   Kay, GL
   Kloner, RA
AF Dai, Wangde
   Kay, Gregory L.
   Kloner, Robert A.
TI The Therapeutic Effect of Cell Transplantation Versus Noncellular
   Biomaterial Implantation on Cardiac Structure and Function Following
   Myocardial Infarction
SO JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
LA English
DT Article
DE myocardial infarction; cell therapy; cardiac tissue engineering
ID STEM-CELLS; ISCHEMIC CARDIOMYOPATHY; HEART; RAT; CARDIOMYOCYTES;
   INJECTION; REPAIR; DELIVERY; MODEL; TRIAL
AB Although numerous studies demonstrated that localized delivery of either cells or biomaterials improved postinfarction cardiac function, the underlying mechanisms for this effect remain unclear. We performed a comparison of the effects of fetal, neonatal, and human embryonic stem cell-derived cardiac cell as well as mesenchymal stem cell transplantation versus biomaterial (collagen/extracellular matrix) implantation therapy in rat myocardial infarction model in our laboratory, specifically comparing their effects on infarct wall thickness, neovascularization, infarct wall motion, and left ventricular ejection fraction (LVEF). Both cell and biomaterial treatment had similar beneficial effects on cardiac structure (increasing infarct wall thickness and preventing infarct expansion) and function (preventing paradoxical LV systolic bulging and improving LVEF). In this review, we also discussed the underlying mechanisms of cell and biomaterial therapies, their advantages and disadvantages, and future research directions in the field of regenerative cardiology.
C1 [Dai, Wangde; Kay, Gregory L.; Kloner, Robert A.] Univ So Calif, Good Samaritan Hosp, Inst Heart, Los Angeles, CA 90017 USA.
   [Dai, Wangde; Kay, Gregory L.; Kloner, Robert A.] Univ So Calif, Div Cardiovasc Med, Keck Sch Med, Los Angeles, CA 90017 USA.
RP Dai, WD (reprint author), Univ So Calif, Good Samaritan Hosp, Inst Heart, 1225 Wilshire Blvd, Los Angeles, CA 90017 USA.
EM wangdedai@yahoo.com
FU Los Angeles Thoracic and Cardiovascular Foundation
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship and/or publication of this article: This study
   was supported in part by the Los Angeles Thoracic and Cardiovascular
   Foundation.
CR Anand IS, 2004, HEART FAILURE COMPAN, P229
   BELTRAMI CA, 1994, CIRCULATION, V89, P151, DOI 10.1161/01.CIR.89.1.151
   Binsalamah ZM, 2011, INT J NANOMED, V6, P2667, DOI 10.2147/IJN.S25175
   Chachques JC, 2007, CELL TRANSPLANT, V16, P927, DOI 10.3727/096368907783338217
   Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627
   Clifford DM, 2012, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD006536.pub3, DOI 10.1002/14651858.CD006536.PUB3]
   Dai W, 2007, J MOL CELL CARDIOL, V43, P504, DOI 10.1016/j.yjmcc.2007.07.001
   Dai WD, 2013, J CARDIOVASC PHARM T, V18, P270, DOI 10.1177/1074248412472257
   Dai WD, 2013, CELL TRANSPLANT, V22, P563, DOI 10.3727/096368911X627570
   Dai WD, 2009, REGEN MED, V4, P387, DOI 10.2217/RME.09.2
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937
   Eschenhagen T, 2012, AM J PHYSIOL-HEART C, V303, pH133, DOI 10.1152/ajpheart.00007.2012
   Gajarsa JJ, 2011, HEART FAIL REV, V16, P13, DOI 10.1007/s10741-010-9181-7
   Gepstein L, 2002, CIRC RES, V91, P866, DOI 10.1161/01.RES.0000041435.95082.84
   Gorman RC, 2011, J CARDIOVASC TRANSL, V4, P73, DOI 10.1007/s12265-010-9244-0
   Ii M, 2011, LAB INVEST, V91, P539, DOI 10.1038/labinvest.2010.191
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kearns-Jonker M, 2012, J STEM CELL RES TH S, V1
   Kreke M, 2012, EXPERT REV CARDIOVAS, V10, P1185, DOI [10.1586/erc.12.102, 10.1586/ERC.12.102]
   Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559
   Leor J, 2000, CIRCULATION, V102, P56
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Menasche P, 2011, J MOL CELL CARDIOL, V50, P258, DOI 10.1016/j.yjmcc.2010.06.010
   Morita M, 2011, ANN THORAC SURG, V92, P617, DOI 10.1016/j.athoracsur.2011.04.051
   Muller-Ehmsen J, 2002, CIRCULATION, V105, P1720, DOI 10.1161/01.CIR.0000013782.76324.92
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Potapova IA, 2007, J ELECTROCARDIOL, V40, pS199, DOI 10.1016/j.jelectrocard.2007.05.025
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Ravichandran R, 2012, INT J NANOMED, V7, P5969, DOI 10.2147/IJN.S37575
   Reffelmann T, 2003, J MOL CELL CARDIOL, V35, P607, DOI 10.1016/S0022-2828(03)00081-6
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wenk JF, 2011, ANN THORAC SURG, V92, P935, DOI 10.1016/j.athoracsur.2011.04.089
   Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610
   Yao M, 2003, J MOL CELL CARDIOL, V35, P661, DOI 10.1016/S0022-2828(03)00098-1
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
NR 43
TC 5
Z9 6
U1 0
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1074-2484
EI 1940-4034
J9 J CARDIOVASC PHARM T
JI J. Cardiovasc. Pharmacol. Ther.
PD JUL
PY 2014
VL 19
IS 4
BP 350
EP 357
DI 10.1177/1074248413517746
PG 8
WC Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy
SC Cardiovascular System & Cardiology; Pharmacology & Pharmacy
GA AK4KS
UT WOS:000338394200004
PM 24414282
DA 2018-10-20
ER

PT J
AU Hayashi, R
   Ueno, T
   Migita, S
   Tsutsumi, Y
   Doi, H
   Ogawa, T
   Hanawa, T
   Wakabayashi, N
AF Hayashi, R.
   Ueno, T.
   Migita, S.
   Tsutsumi, Y.
   Doi, H.
   Ogawa, T.
   Hanawa, T.
   Wakabayashi, N.
TI Hydrocarbon Deposition Attenuates Osteoblast Activity on Titanium
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE implant dentistry; biomaterial(s); biocompatibility; surface chemistry;
   wettability; osseointegration
ID PROTEIN ADSORPTION; IMPLANT SURFACES; BONE; ADHESION; CARBON; CELLS;
   WETTABILITY; BIOACTIVITY; VINCULIN; ACTIN
AB Although the reported percentage of bone-implant contact is far lower than 100%, the cause of such low levels of bone formation has rarely been investigated. This study tested the negative biological effect of hydrocarbon deposition onto titanium surfaces, which has been reported to be inevitable. Osteogenic MC3T3-E1 cells were cultured on titanium disks on which the carbon concentration was experimentally regulated to achieve carbon/titanium (C/Ti) ratios of 0.3, 0.7, and 1.0. Initial cellular activities such as cell attachment and cell spreading were concentration-dependently suppressed by the amount of carbon on the titanium surface. The osteoblastic functions of alkaline phosphatase activity and calcium mineralization were also reduced by more than 40% on the C/Ti (1.0) surface. These results indicate that osteoblast activity is influenced by the degree of hydrocarbon contamination on titanium implants and suggest that hydrocarbon decomposition before implant placement may increase the biocompatibility of titanium.
C1 [Hayashi, R.; Ueno, T.; Wakabayashi, N.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138549, Japan.
   [Migita, S.; Tsutsumi, Y.; Doi, H.; Hanawa, T.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   [Ogawa, T.] Univ Calif Los Angeles, Sch Dent, LBIS, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Los Angeles, CA 90095 USA.
RP Ueno, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.
EM takepro1@tmd.ac.jp
RI Migita, Satoshi/G-2815-2017
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [24592903]
FX This study was supported by a Grant-in-Aid for Scientific Research from
   the Ministry of Education, Culture, Sports, Science and Technology of
   Japan (24592903). The authors declare no potential conflicts of interest
   with respect to the authorship and/or publication of this article.
CR Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Att W, 2009, BIOMATERIALS, V30, P4268, DOI 10.1016/j.biomaterials.2009.04.048
   Berglundh T, 2007, CLIN ORAL IMPLAN RES, V18, P147, DOI 10.1111/j.1600-0501.2006.01309.x
   BOEHM HP, 1971, DISCUSS FARADAY SOC, P264
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Chuang SK, 2002, J DENT RES, V81, P572, DOI 10.1177/154405910208100814
   COUVRAT P, 1995, DIAM RELAT MATER, V4, P1251, DOI 10.1016/0925-9635(95)00307-X
   Endlich N, 2006, EUR J CELL BIOL, V85, P229, DOI 10.1016/j.ejcb.2005.09.006
   Gongadze E, 2011, INT J NANOMED, V6, P1801, DOI [10.2147/IJN.S21755, 10.2147/IJN.S16982]
   Hori N, 2010, ACTA BIOMATER, V6, P4175, DOI 10.1016/j.actbio.2010.05.006
   Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036
   Ianno NJ, 1995, THIN SOLID FILMS, V270, P275, DOI 10.1016/0040-6090(95)06710-8
   Kilpadi DV, 2000, INT J ORAL MAX IMPL, V15, P219
   Kim WJ, 2009, LANGMUIR, V25, P11692, DOI 10.1021/la901615e
   Li S, 2008, J CELL PHYSIOL, V215, P204, DOI 10.1002/jcp.21302
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Martins PA, 2013, J DENT RES, V92, P575, DOI 10.1177/0022034513490957
   Massaro C, 2002, J MATER SCI-MATER M, V13, P535, DOI 10.1023/A:1015170625506
   Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6
   Mitura E, 1996, DIAM RELAT MATER, V5, P998, DOI 10.1016/0925-9635(95)00469-6
   Morra M, 2003, INT J ORAL MAX IMPL, V18, P40
   Ogawa T, 2003, INT J ORAL MAX IMPL, V18, P200
   Serro AP, 2003, BIOMATERIALS, V24, P4749, DOI 10.1016/S0142-9612(03)00372-7
   Takeda S, 1999, J NON-CRYST SOLIDS, V249, P41, DOI 10.1016/S0022-3093(99)00297-5
   Takeuchi M, 2005, J PHYS CHEM B, V109, P15422, DOI 10.1021/jp058075i
   Tu Q, 2007, TISSUE ENG, V13, P2431, DOI 10.1089/ten.2006.0406
   Ueno T, 2012, J BIOMED MATER RES B, V100B, P2279, DOI 10.1002/jbm.b.32799
   Weinlaender M, 1992, Int J Oral Maxillofac Implants, V7, P491
   Wen KK, 2009, J BIOL CHEM, V284, P30463, DOI 10.1074/jbc.M109.021295
   WESTALL J, 1980, ADV COLLOID INTERFAC, V12, P265, DOI 10.1016/0001-8686(80)80012-1
   Zareidoost A, 2012, J MATER SCI-MATER M, V23, P1479, DOI 10.1007/s10856-012-4611-9
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 32
TC 17
Z9 17
U1 0
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD JUL
PY 2014
VL 93
IS 7
BP 698
EP 703
DI 10.1177/0022034514536578
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AK5XC
UT WOS:000338499200015
PM 24868012
OA Green Published
DA 2018-10-20
ER

PT J
AU Chen, L
   Gu, Y
   Feng, Y
   Zhu, XS
   Wang, CZ
   Liu, HL
   Niu, HY
   Zhang, C
   Yang, HL
AF Chen, Liang
   Gu, Yong
   Feng, Yu
   Zhu, Xue-Song
   Wang, Chun-Zeng
   Liu, Hai-Long
   Niu, Hai-Yun
   Zhang, Chi
   Yang, Hui-Lin
TI Bioactivity of porous biphasic calcium phosphate enhanced by recombinant
   human bone morphogenetic protein 2/silk fibroin microsphere
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VIVO; CONTROLLED-RELEASE; HA/BETA-TCP; DELIVERY; RHBMP-2; SCAFFOLDS;
   DEFECTS; FUSION; VITRO; MICROPARTICLES
AB To prepare a bioactive bone substitute, which integrates biphasic calcium phosphate (BCP) and rhBMP-2/silk fibroin (SF) microsphere, and to evaluate its characteristics. Hydroxyapatite and beta-tricalcium phosphate were integrated with a ratio of 60-40 %. RhBMP-2/SF (0.5 mu g/1 mg) microsphere was prepared, and its rhBMP-2-release kinetics was assed. After joining pore-forming agent (Sodium chloride, NaCl), porous BCP/rhBMP-2/SF were manufactured, and its characteristics and bioactivity in vitro were evaluated. Mean diameter of rhBMP-2/SF microsphere was 398.7 +/- A 99.86 nm, with a loading rate of 4.53 +/- A 0.08 %. RhBMP-2 was released in a dual-phase pattern, of which fast-release (nearly half of protein released) focused on the initial 3 days, and slow-release sustained more than 28 days. With the increase in concentration of NaCl, greater was porosity and pore size, but smaller mechanical strength of BCP/rhBMP-2/SF. Material with 150 % (w/v) NaCl had an optimal performance, with a porosity of 78.83 %, pore size of 293.25 +/- A 42.77 mu m and mechanical strength of 31.03 MPa. Proliferation of human placenta-derived mesenchymal stem cells (hPMSCs) on leaching extract medium was similar to the normal medium (P = 0.89), which was better than that on control group (P = 0.03). Activity of alkaline phosphatase on BCP/rhBMP-2/SF surface was higher than on pure BCP at each time point except at 1 day (P < 0.05). RhBMP-2 has a burst release on early times and a sustaining release on later times. BCP/rhBMP-2/SF with 150 % (w/v) pore-forming agent has excellent porosity, pore size and mechanical strength. The biomaterial induces proliferation and differentiation hPMSCs effectively.
C1 [Chen, Liang; Gu, Yong; Feng, Yu; Zhu, Xue-Song; Wang, Chun-Zeng; Liu, Hai-Long; Niu, Hai-Yun; Zhang, Chi; Yang, Hui-Lin] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Suzhou 215006, Peoples R China.
RP Gu, Y (reprint author), Soochow Univ, Affiliated Hosp 1, Dept Orthopaed Surg, 188 Shizi St, Suzhou 215006, Peoples R China.
EM guyongsuzhou@163.com
FU National Natural Science Foundation of China [81071450, 81371930,
   81171689, 81301559]; Natural Science Foundation of Jiang Su Province
   [BK2011264]; Key Talented Man Project of Jiang Su Province [RC2011102];
   Young Instructor Science Project of Soochow University [SDY2011A35]
FX The study was financially supported by the National Natural Science
   Foundation of China (81071450, 81371930, 81171689 and 81301559), Natural
   Science Foundation of Jiang Su Province (BK2011264), Key Talented Man
   Project of Jiang Su Province (RC2011102), and Young Instructor Science
   Project of Soochow University (SDY2011A35).
CR Alam I, 2001, J Biomed Mater Res, V54, P129
   Alt V, 2009, EUR SPINE J, V18, P800, DOI 10.1007/s00586-009-0935-7
   Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8
   Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451
   Bessa PC, 2010, J TISSUE ENG REGEN M, V4, P349, DOI 10.1002/term.245
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Bodde EWH, 2007, J BIOMED MATER RES A, V82A, P711, DOI 10.1002/bjm.a.30990
   Burkus JK, 2009, J BONE JOINT SURG AM, V91A, P1181, DOI 10.2106/JBJS.G.01485
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Diab T, 2012, J MECH BEHAV BIOMED, V11, P123, DOI 10.1016/j.jmbbm.2011.11.007
   Ebrahimi M, 2013, J BIOMED MATER RES B, V102, P52, DOI DOI 10.1002/JBM.B.32979
   Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006
   Houmard M, 2013, J BIOMED MATER RES B, V101, P1233, DOI 10.1002/jbm.b.32935
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kim JW, 2012, J BIOMED MATER RES A, V100A, P3304, DOI 10.1002/jbm.a.34278
   Kim S, 2011, INT J ORAL MAX IMPL, V26, P265
   Krijnen MR, 2009, J BIOMED MATER RES B, V89B, P9, DOI 10.1002/jbm.b.31181
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Levengood SKL, 2010, ACTA BIOMATER, V6, P3283, DOI 10.1016/j.actbio.2010.02.026
   Lim HP, 2013, J MATER SCI-MATER M, V24, P1895, DOI 10.1007/s10856-013-4939-9
   Lomelino RD, 2012, J MATER SCI-MATER M, V23, P781, DOI 10.1007/s10856-011-4530-1
   Matsumoto T, 2004, BIOMATERIALS, V25, P3807, DOI 10.1016/j.biomaterials.2003.10.081
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Oda Shigeru, 1997, Journal of Medical and Dental Sciences, V44, P53
   Rong F, 2008, J CHENGDU MED COLL, V3, P259
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Schumacher M, 2010, J MATER SCI-MATER M, V21, P3119, DOI 10.1007/s10856-010-4166-6
   Shi PJ, 2013, BIOMACROMOLECULES, V14, P4465, DOI 10.1021/bm401381s
   Yang C, 2013, J BIOMED MATER RES B, V102, P80
   Zhang DM, 2012, CYTOTECHNOLOGY, V64, P701, DOI 10.1007/s10616-012-9450-5
NR 32
TC 11
Z9 12
U1 3
U2 32
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2014
VL 25
IS 7
BP 1709
EP 1719
DI 10.1007/s10856-014-5194-4
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AK3NM
UT WOS:000338331200010
PM 24659100
DA 2018-10-20
ER

PT J
AU Kim, YJ
   Lee, JY
   Kim, JE
   Park, JC
   Shin, SW
   Cho, KS
AF Kim, Yu-Jin
   Lee, Jeong-Yol
   Kim, Jong-Eun
   Park, Jung-Chul
   Shin, Sang-Wan
   Cho, Kyoo-Sung
TI Ridge Preservation Using Demineralized Bone Matrix Gel With Recombinant
   Human Bone Morphogenetic Protein-2 After Tooth Extraction: A Randomized
   Controlled Clinical Trial
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID FREEZE-DRIED BONE; INDUCE; ALLOGRAFT; DEFECTS; REPAIR; AUGMENTATION;
   ABILITY; AGE
AB Purpose: The aim of the present randomized controlled trial was to determine the safety and efficacy of injectable demineralized bone matrix (DBM) gel combined with recombinant human bone morphogenetic protein-2 (rhBMP-2) on alveolar ridge preservation after tooth extraction.
   Materials and Methods: A total of 69 patients were randomly assigned to either a test group (n = 35) or a control group (n = 34). In the test group, DBM, together with rhBMP-2 (0.05 mg/mL; rhBMP-2/DBM) was transplanted into the extraction sockets. The control group received DBM alone. The safety of rhBMP-2/DBM was evaluated by oral examination, serum chemistry, and hematologic examination. The radiographic changes in alveolar bone height and width were measured using computed tomography scans performed immediately after transplant and again 3 months thereafter.
   Results: Healing was uneventful in all subjects, with no anticipated adverse events and no clinically significant changes in the serum chemistry and hematologic findings. No meaningful immune response was found among the study groups. No significant difference was found in the radiographic changes of alveolar bone height and width (P >.05).
   Conclusions: This new injectable biomaterial can be used easily and safely in clinical applications. (C) 2014 American Association of Oral and Maxillofacial Surgeons
C1 [Kim, Yu-Jin; Park, Jung-Chul; Cho, Kyoo-Sung] Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, Seoul 120752, South Korea.
   [Lee, Jeong-Yol; Kim, Jong-Eun; Shin, Sang-Wan] Korea Univ, Guro Hosp, Inst Clin Dent Res, Dept Prosthodont, Seoul, South Korea.
RP Cho, KS (reprint author), Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM kscho@yuhs.ac
FU Yonsei University College of Dentistry [6-2011-0051]
FX The present study was supported by a faculty research grant from Yonsei
   University College of Dentistry for 2011 (grant 6-2011-0051).
CR BECKER W, 1994, J PERIODONTOL, V65, P1128, DOI 10.1902/jop.1994.65.12.1128
   Burkus JK, 2011, SPINE, V36, P2158, DOI 10.1097/BRS.0b013e3182059a8c
   Fiorellini JP, 2005, J PERIODONTOL, V76, P605, DOI 10.1902/jop.2005.76.4.605
   Garrett MP, 2010, NEUROSURGERY, V66, P1044, DOI 10.1227/01.NEU.0000369517.21018.F2
   Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008
   Han B, 2005, J ORTHOP RES, V23, P855, DOI 10.1016/j.orthres.2004.11.007
   Jang JW, 2012, OR SURG OR MED OR PA, V113, P480, DOI 10.1016/j.tripleo.2011.04.013
   JERGESEN HE, 1991, CLIN ORTHOP RELAT R, P253
   Kim JW, 2012, J BIOMED MATER RES A, V100A, P3304, DOI 10.1002/jbm.a.34278
   Kubler N, 1995, J CRANIO MAXILL SURG, V23, P337, DOI 10.1016/S1010-5182(05)80128-3
   LANDSBERG CJ, 1994, INT J ORAL MAXILLOF, V9, P586
   Laurell L, 1998, J PERIODONTOL, V69, P303, DOI 10.1902/jop.1998.69.3.303
   Lee JH, 2010, BIOMATERIALS, V31, P3512, DOI 10.1016/j.biomaterials.2010.01.075
   Maddox E, 2000, TISSUE ENG, V6, P441, DOI 10.1089/107632700418146
   Misch CM, 2010, INT J ORAL MAX IMPL, V25, P1246
   Niederwanger M, 1996, J Oral Implantol, V22, P210
   Orgeas GV, 2013, INT J ORAL MAX IMPL, V28, P1049, DOI 10.11607/jomi.2670
   Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227
   Rosenthal RK, 1999, CLIN ORTHOP RELAT R, P61
   Schwartz Z, 1996, J PERIODONTOL, V67, P918, DOI 10.1902/jop.1996.67.9.918
   Schwartz Z, 1998, J PERIODONTOL, V69, P470, DOI 10.1902/jop.1998.69.4.470
   Schwartz Z, 1998, J PERIODONTOL, V69, P1337, DOI 10.1902/jop.1998.69.12.1337
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VAIL TB, 1994, VET SURG, V23, P386, DOI 10.1111/j.1532-950X.1994.tb00499.x
   van den Bergh JPA, 2000, J CLIN PERIODONTOL, V27, P627, DOI 10.1034/j.1600-051x.2000.027009627.x
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
   Zhou Shuanhu, 2005, Cell and Tissue Banking, V6, P33, DOI 10.1007/s10561-005-4253-y
NR 28
TC 18
Z9 18
U1 0
U2 7
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0278-2391
EI 1531-5053
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD JUL
PY 2014
VL 72
IS 7
BP 1281
EP 1290
DI 10.1016/j.joms.2014.01.022
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AK4WI
UT WOS:000338424500012
PM 24709512
DA 2018-10-20
ER

PT J
AU Ramadan, MH
   Prata, JE
   Karacsony, O
   Duner, G
   Washburn, NR
AF Ramadan, Mohamed H.
   Prata, Joseph E.
   Karacsony, Orsolya
   Duner, Gunnar
   Washburn, Newell R.
TI Reducing Protein Adsorption with Polymer-Grafted Hyaluronic Acid
   Coatings
SO LANGMUIR
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; POLY(L-LYSINE)-G-POLY(ETHYLENE GLYCOL)
   LAYERS; METAL-OXIDE SURFACES; CHEMICAL-MODIFICATION; BROAD RANGE;
   DERIVATIVES; DEXTRAN; SERUM; RESISTANCE; FIBRINOGEN
AB We report a thermoresponsive chemical modification strategy of hyaluronic acid (HA) for coating onto a broad range of biomaterials without relying on chemical functionalization of the surface. Poly(di(ethylene glycol) methyl ether methacrylate) (PMEO(2)MA), a polymer with a lower critical solution temperature of 26 degrees C in water, was grafted onto HA to allow facile formation of biopolymer coatings. While the mechanism for film formation appears to involve a complex combination of homogeneous nucleation followed by heterogeneous film growth, we demonstrate that it resulted in hydrophilic coatings that significantly reduce protein adsorption despite the high fraction of hydrophobic (PMEO(2)MA). Structural characterization was performed using atomic force microscopy (AFM), which showed the formation of a dense, continuous coating based on 200 nm domains that were stable in protein solutions for at least 15 days. The coatings had a water contact angle of 16, suggesting the formation of hydrophilic but not fully wetting films. Quartz crystal microbalance with dissipation monitoring (QCM-D) as well as biolayer interferometry (BLI) techniques were used to measure adsorption of bovine serum albumin (BSA), fibrinogen (Fbg), and human immunoglobulin (IgG), with results indicating that HA-PMEO(2)MA-coated surfaces effectively inhibited adsorption of all three serum proteins. These results are consistent with previous studies demonstrating that this degree of hydrophilicity is sufficient to generate an effectively nonfouling surface and suggest that segregation during the solubility transition resulted in a surface that presented the hydrophilic HA component of the hybrid biopolymer. We conclude that PMEO(2)MA-grafted HA is a versatile platform for the passivation of hydrophobic biomaterial surfaces without need for substrate functionalization.
C1 [Ramadan, Mohamed H.; Prata, Joseph E.; Karacsony, Orsolya; Washburn, Newell R.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA.
   [Duner, Gunnar] Carnegie Mellon Univ, Dept Chem Engn, Pittsburgh, PA 15213 USA.
   [Washburn, Newell R.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
RP Washburn, NR (reprint author), Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.
EM washburn@andrew.cmu.edu
CR Akizawa T., 1989, T AM SOC ART INT ORG, V35, P333
   Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   Bridges Amanda W, 2008, J Diabetes Sci Technol, V2, P984
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Bumgardner J. D., CONTACT ANGLE PROTEI
   Cao B, 2014, CHEM COMMUN, V50, P3234, DOI 10.1039/c3cc48878k
   CHURAEV NV, 1995, J COLLOID INTERF SCI, V169, P300, DOI 10.1006/jcis.1995.1037
   Coessens V, 1999, MACROMOL RAPID COMM, V20, P127, DOI 10.1002/(SICI)1521-3927(19990301)20:3<127::AID-MARC127>3.0.CO;2-2
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Dubois J, 2009, COLLOID SURFACE B, V71, P293, DOI 10.1016/j.colsurfb.2009.03.002
   Garland A, 2012, PROG SURF SCI, V87, P1, DOI 10.1016/j.progsurf.2012.02.001
   Geelhood SJ, 2007, J BIOMED MATER RES B, V81B, P251, DOI 10.1002/jbm.b.30660
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Grymonpre KR, 2001, BIOMACROMOLECULES, V2, P422, DOI 10.1021/bm005656z
   HAREWOOD K, 1973, ANAL BIOCHEM, V55, P573, DOI 10.1016/0003-2697(73)90146-2
   Heinze T, 2009, ACS SYM SER, V1019, P195
   Hook F, 2007, SPRINGER SER CHEM SE, V5, P425, DOI 10.1007/5346_034
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Krozer A, 1997, J VAC SCI TECHNOL A, V15, P1704, DOI 10.1116/1.580924
   KUO JW, 1991, BIOCONJUGATE CHEM, V2, P232, DOI 10.1021/bc00010a007
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   Larsson C, 2003, ANAL CHEM, V75, P5080, DOI 10.1021/ac034269n
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019
   LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526
   Lutz JF, 2008, J POLYM SCI POL CHEM, V46, P3459, DOI 10.1002/pola.22706
   MAUZAC M, 1984, BIOMATERIALS, V5, P301, DOI 10.1016/0142-9612(84)90078-4
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   MIURA M, 1994, J BIOMAT SCI-POLYM E, V5, P555, DOI 10.1163/156856294X00202
   Neumann A, 1999, FEBS LETT, V453, P283, DOI 10.1016/S0014-5793(99)00731-0
   Penfold J, 2002, LANGMUIR, V18, P5755, DOI 10.1021/la011546h
   Popova MV, 2004, COLLOID J+, V66, P567, DOI 10.1023/B:COLL.0000043839.76486.c8
   Reimhult E, 2004, ANAL CHEM, V76, P7211, DOI 10.1021/ac0492970
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Schante CE, 2011, CARBOHYD POLYM, V85, P469, DOI 10.1016/j.carbpol.2011.03.019
   Schasfoort R. B. M., 2008, HDB SURFACE PLASMON, P426
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Shi JB, 2012, MEMBRANES, V2, DOI 10.3390/membranes2010070
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Tizzotti M, 2010, MACROMOL RAPID COMM, V31, P1751, DOI 10.1002/marc.201000072
   VIG JR, 1985, J VAC SCI TECHNOL A, V3, P1027, DOI 10.1116/1.573115
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   VROMAN L, 1980, BLOOD, V55, P156
   Yamamoto SI, 2008, J POLYM SCI POL CHEM, V46, P194, DOI 10.1002/pola.22371
   Zengin A, 2013, J POLYM SCI POL CHEM, V51, P954, DOI 10.1002/pola.26460
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 52
TC 15
Z9 15
U1 4
U2 85
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 1
PY 2014
VL 30
IS 25
BP 7485
EP 7495
DI 10.1021/la500918p
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AK5TF
UT WOS:000338488600027
PM 24892924
DA 2018-10-20
ER

PT J
AU Wang, HF
   Li, J
   Yang, HL
   Liu, C
   Ruan, JM
AF Wang, Huifeng
   Li, Jing
   Yang, Hailin
   Liu, Chao
   Ruan, Jianming
TI Fabrication, characterization and in vitro biocompatibility evaluation
   of porous Ta-Nb alloy for bone tissue engineering
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterials; Porous Ta-Nb alloy; Powder metallurgy; Mechanical
   properties; Biocompatibility
ID MECHANICAL-PROPERTIES; INTERBODY FUSION; PART 1; TANTALUM; TITANIUM;
   IMPLANTS; SCAFFOLDS; OSTEOGENESIS; SUBSTITUTES; BIOMATERIAL
AB Porous Ta-Nb alloys were fabricated using the sponge impregnation technique and the powder metallurgy-technique (P/M) in combination. All porous Ta-Nb alloys displayed interconnected open cell structures with porosities around 64% and pore sizes in the range of 300-500 mu m. No carbide, oxide, or intermetallic-related phases were detected by the X-ray diffraction (XRD). Porous Ta-Nb alloys displayed sintering neck growth, smoother surface of the particles and more shrinkage of the micropores, with Nb contents increasing from 5% to 15%. The compressive strength and Young's modulus of the Ta-Nb alloys agreed well with the requirements of trabecular bone. The normalized compressive plateau stress and Young's modulus increased from 52.27 MPa to 85.43 MPa and from 1.850 GPa to 2.540 GPa, respectively, with Nb contents increasing from 5% to 15%. Porous Ta-Nb alloys had no cytotoxicity and possessed the excellent biocompatibility similar to porous Ta scaffolds. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Wang, Huifeng; Li, Jing; Yang, Hailin; Liu, Chao; Ruan, Jianming] Cent S Univ, Powder Met Res Inst, Changsha 410083, Peoples R China.
RP Ruan, JM (reprint author), Cent S Univ, Powder Met Res Inst, Changsha 410083, Peoples R China.
EM jianming@csu.edu.cn
FU National Natural Science Foundation of China [51274247]; National High
   Technology Research and Development Program of China [2012BAE06B00]
FX This research was supported under the National Natural Science
   Foundation of China (No. 51274247) and the National High Technology
   Research and Development Program of China (No. 2012BAE06B00).
CR Assad M, 2003, J BIOMED MATER RES B, V64B, P107, DOI 10.1002/jbm.b.10530
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Bermudez MD, 2005, WEAR, V258, P693, DOI 10.1016/j.wear.2004.09.023
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   Esen Z, 2007, SCRIPTA MATER, V56, P341, DOI 10.1016/j.scriptamat.2006.11.010
   Fantigrossi A, 2007, MED ENG PHYS, V29, P101, DOI 10.1016/j.medengphy.2006.02.007
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   GROOT KD, 1998, P I MECH ENG H, V212, P137
   Itin V.I., 1994, J MATER SCI-MATER M, V32, P179
   Johansson CB, 1991, CLIN ORAL IMPLAN RES, V2, P24, DOI 10.1034/j.1600-0501.1991.020103.x
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kukubo T., 2003, BIOMATERIALS, V24, P2161
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Levine Brett, 2007, J Knee Surg, V20, P185
   Likibi F, 2005, ANN CHIR, V130, P235, DOI 10.1016/j.anchir.2004.12.006
   LIMBERGER F, 1991, Deutsche Stomatologie, V41, P407
   Lin CY, 2007, J BIOMED MATER RES A, V83A, P272, DOI 10.1002/jbm.a.31231
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Odgarg A., 1991, BIOMECHANICS, V24, P691
   REY C, 1990, Biomaterials, V11, P13
   Ruhaimi K.A. A., 2001, INT J ORAL MAXILLOF, V16, P105
   Scheneider S., 2005, MAT RES, V8, P435
   Seah KHW, 1998, CORROS SCI, V40, P547, DOI 10.1016/S0010-938X(97)00152-2
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Takemoto M., 1999, J NEUROSURG, V91, P435
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   ZHANG N, 1992, MAT SCI ENG A-STRUCT, V150, P263, DOI 10.1016/0921-5093(92)90120-P
   Zhou YS, 2013, MATER LETT, V99, P8, DOI 10.1016/j.matlet.2013.02.068
NR 35
TC 5
Z9 5
U1 2
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2014
VL 40
BP 71
EP 75
DI 10.1016/j.msec.2014.03.031
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA AK4IO
UT WOS:000338388400010
PM 24857467
DA 2018-10-20
ER

PT J
AU Lukaszczyk, J
   Janicki, B
   Lopez, A
   Skolucka, K
   Wojdyla, H
   Persson, C
   Piaskowski, S
   Smiga-Matuszowicz, M
AF Lukaszczyk, Jan
   Janicki, Bartosz
   Lopez, Alejandro
   Skolucka, Karolina
   Wojdyla, Henryk
   Persson, Cecilia
   Piaskowski, Sylwester
   Smiga-Matuszowicz, Monika
TI Novel injectable biomaterials for bone augmentation based on isosorbide
   dimethacrylic monomers
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterials; Isosorbide; Dimethacrylic monomers
ID PERCUTANEOUS VERTEBROPLASTY; MECHANICAL-PROPERTIES; HIGH-VISCOSITY;
   BISPHENOL-A; CEMENT; MODULUS; HYDROXYAPATITE; RESIN; PMMA; EXPRESSION
AB Drawbacks with the commonly used PMMA-based bone cements, such as an excessive elastic modulus and potentially toxic residual monomer content, motivate the development of alternative cements. In this work an attempt to prepare an injectable biomaterial based on isosorbide-alicyclic diol derived from renewable resources was presented. Two novel dimethacrylic monomers ISDGMA - 2,5-bis(2-hydroxy-3-methacryloyloxypropoxy)-1,4:3,6-dianhydro-sorbitol and ISETDMA - dimethacrylate of ethoxylated isosorbide were synthesized and used to prepare a series of low-viscosity compositions comprising bioactive nano-sized hydroxyapatite in the form of a two-paste system. Formulations exhibited a non-Newtonian shear-thinning behavior, setting times between 2.6 min and 53 min at 37 degrees C and maximum curing temperatures of 65 degrees C. Due to the hydrophilic nature of ISDGMA, cured compositions could absorb up to 13.6% water and as a result the Young's modulus decreased from 1429 MPa down to 470 MPa. Both, poly(ISDGMA) and poly(ISETDMA) were subjected to a MU study on mice fibroblasts (BALB/3T3) and gave relative cell viabilities above 70% of control. A selected model bone cement was additionally investigated using human osteosarcoma cells (SaOS-2) in an MTS test, which exhibited concentration-dependent cell viability. The preliminary results, presented in this work reveal the potential of two novel dimethacrylic monomers in the preparation of an injectable biomaterial for bone augmentation, which could overcome some of the drawbacks typical for conventional acrylic bone cement. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Lukaszczyk, Jan; Janicki, Bartosz; Smiga-Matuszowicz, Monika] Silesian Tech Univ, Fac Chem, Dept Phys Chem & Technol Polymers, PL-44100 Gliwice, Poland.
   [Wojdyla, Henryk] PCC Rokita SA, PL-56120 Brzeg Dolny, Poland.
   [Skolucka, Karolina; Piaskowski, Sylwester] Celther Poland Sp, PL-05170 Zakroczym, Poland.
   [Lopez, Alejandro; Persson, Cecilia] Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Angstrom Lab, S-75120 Uppsala, Sweden.
RP Lukaszczyk, J (reprint author), Ul M Strzody 9, PL-44100 Gliwice, Poland.
EM Jan.Lukaszczyk@polsl.pl
RI Smiga-Matuszowicz, Monika/R-9838-2018
OI Smiga-Matuszowicz, Monika/0000-0003-4651-5619
FU PCC Rokita SA polyol division; DoktoRIS - Scholarship Program for
   Innovative Silesia and VINNOVA [VINNMER 2010-02073]
FX We would like to acknowledge the support of the PCC Rokita SA polyol
   division in the ethoxylation process. Financial support from DoktoRIS -
   Scholarship Program for Innovative Silesia and VINNOVA (VINNMER
   2010-02073) is also gratefully acknowledged. This work was partly
   facilitated by the BioMat platform/Science for Life Laboratory at
   Uppsala University.
CR Almeida T, 2011, MAT SCI ENG C-MATER, V31, P658, DOI 10.1016/j.msec.2010.12.020
   Anancharungsuk W, 2010, COLLOID SURFACE B, V78, P328, DOI 10.1016/j.colsurfb.2010.03.025
   [Anonymous], 58332001 ISOFDIS
   [Anonymous], 1099352009 PN EN ISO
   Boesel LF, 2008, PROG POLYM SCI, V33, P180, DOI 10.1016/j.progpolymsci.2007.09.001
   Boger A, 2009, EUR SPINE J, V18, P1272, DOI 10.1007/s00586-009-1037-2
   Boger A, 2008, J BIOMED MATER RES B, V86B, P474, DOI 10.1002/jbm.b.31044
   Boger A, 2008, ACTA BIOMATER, V4, P1688, DOI 10.1016/j.actbio.2008.06.019
   Carrodeguas RG, 2004, J BIOMED MATER RES B, V68B, P94, DOI 10.1002/jbm.b.20007
   Chang MC, 2009, BIOMATERIALS, V30, P4070, DOI 10.1016/j.biomaterials.2009.04.034
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   Chrysanthos M, 2011, POLYMER, V52, P3611, DOI 10.1016/j.polymer.2011.06.001
   Deb S, 2005, BIOMATERIALS, V26, P3713, DOI 10.1016/j.biomaterials.2004.09.065
   Deb S, 2001, BIOMATERIALS, V22, P2177, DOI 10.1016/S0142-9612(00)00409-9
   Deramond H, 1999, BONE S, V25, P17
   Engstrand J, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035013
   Erbe EM, 2001, EUR SPINE J, V10, P147
   Gheduzzi S, 2006, J MATER SCI-MATER M, V17, P421, DOI 10.1007/s10856-006-8469-6
   Gohil RM, 2009, POLYM ENG SCI, V49, P544, DOI 10.1002/pen.20840
   Golub MS, 2010, BIRTH DEFECTS RES B, V89, P441, DOI 10.1002/bdrb.20275
   Gough JE, 2001, J BIOMED MATER RES, V57, P497, DOI 10.1002/1097-4636(20011215)57:4<497::AID-JBM1195>3.0.CO;2-U
   Hasenwinkel JM, 2002, J BIOMED MATER RES, V59, P411, DOI 10.1002/jbm.1257
   Heini P.F., 2001, EUR SPINE J, V10, P205
   Helgason B, 2008, CLIN BIOMECH, V23, P135, DOI 10.1016/j.clinbiomech.2007.08.024
   Hernandez L, 2009, J MATER SCI-MATER M, V20, P89, DOI 10.1007/s10856-008-3542-y
   Ito S, 2005, BIOMATERIALS, V26, P6449, DOI 10.1016/j.biomaterials.2005.04.052
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kuzbari O, 2013, REPROD TOXICOL, V37, P24, DOI 10.1016/j.reprotox.2013.01.005
   Lam WM, 2011, J BIOMED MATER RES B, V96B, P76, DOI 10.1002/jbm.b.31741
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Lewis G, 2006, J BIOMED MATER RES B, V76B, P456, DOI 10.1002/jbm.b.30398
   Lewis G, 2011, J BIOMED MATER RES B, V98B, P171, DOI 10.1002/jbm.b.31835
   Li S, 1999, J ORTHOPAED RES, V17, P891, DOI 10.1002/jor.1100170614
   Lopez A, 2011, BIO-MED MATER ENG, V21, P323, DOI 10.3233/BME-2012-0679
   Lukaszczyk J., 2012, EUR CELL MAT S3, V23, P47
   Lukaszczyk J., 2012, J MATER SCI-MATER M, V25, P1149
   Lukaszczyk J, 2013, J APPL POLYM SCI, V130, P2514, DOI 10.1002/app.39435
   Lukaszczyk J, 2011, EUR POLYM J, V47, P1601, DOI 10.1016/j.eurpolymj.2011.05.009
   Madigan S, 2006, J MATER SCI-MATER M, V17, P307, DOI 10.1007/s10856-006-8227-9
   Malhotra SV, 2007, BRIDGE, V37, P17
   Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X
   Nazarian A, 2008, CALCIFIED TISSUE INT, V83, P368, DOI 10.1007/s00223-008-9174-x
   Otsuka M, 1997, BIOMATERIALS, V18, P1559, DOI 10.1016/S0142-9612(97)00097-5
   Park HS, 2012, J BIOMATER APPL, V27, P99, DOI 10.1177/0885328212447245
   Pomrink GJ, 2003, BIOMATERIALS, V24, P1023, DOI 10.1016/S0142-9612(02)00443-X
   Pstoriza-Gallego M.J., 2011, NANOSCALE RES LETT, V6, P560
   Roether JA, 2004, J MATER SCI-MATER M, V15, P413, DOI 10.1023/B:JMSM.0000021112.51065.40
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   Sideridou I, 2002, BIOMATERIALS, V23, P1819, DOI 10.1016/S0142-9612(01)00308-8
   STROSS P, 1991, ADV CARBOHYD CHEM BI, V49, P93
   Theilig C, 2000, J BIOMED MATER RES, V53, P632, DOI 10.1002/1097-4636(2000)53:6<632::AID-JBM3>3.0.CO;2-J
   Trout AT, 2006, AM J NEURORADIOL, V27, P217
   Uppin AA, 2003, RADIOLOGY, V226, P119, DOI 10.1148/radiol.2261011911
   Vallo CI, 1999, J BIOMED MATER RES, V48, P150
   Vazifehasl Z., 2012, MACROMOL RES
   Vazquez B, 2005, BIOMATERIALS, V26, P4309, DOI 10.1016/j.biomaterials.2004.10.042
   Yamamuro T, 1998, BIOMATERIALS, V19, P1479, DOI 10.1016/S0142-9612(98)00062-3
NR 57
TC 6
Z9 6
U1 3
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2014
VL 40
BP 76
EP 84
DI 10.1016/j.msec.2014.03.046
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA AK4IO
UT WOS:000338388400011
PM 24857468
DA 2018-10-20
ER

PT J
AU Perestrelo, AR
   Grenha, A
   da Costa, AMR
   Belo, JA
AF Perestrelo, Ana Rubina
   Grenha, Ana
   Rosa da Costa, Ana M.
   Belo, Jose Antonio
TI Locust bean gum as an alternative polymeric coating for embryonic stem
   cell culture
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Embryonic stem cell culture; Locust bean gum; Natural polymers; Gelatin
   substitute growth support; Pluripotency
ID SELF-RENEWAL; IN-VITRO; DIFFERENTIATION; DENSITY; CHARGE; CUES; GELS
AB Pluripotent embryonic stem cells (ESCs) have self-renewal capacity and the potential to differentiate into any cellular type depending on specific cues (pluripotency) and, therefore, have become a vibrant research area in the biomedical field. ESCs are usually cultured in gelatin or on top of a monolayer of feeder cells such as mitotically inactivated mouse embryonic fibroblasts (MEFsi). The latter is the gold standard support to maintain the ESCs in the pluripotent state. Examples of versatile, non-animal derived and inexpensive materials that are able to support pluripotent ESCs are limited. Therefore, our aim was to find a biomaterial able to support ESC growth in a pluripotent state avoiding laborious and time consuming parallel culture of MEFsi and as simple to handle as gelatin. Many of the new biomaterials used to develop stem cell microenvironments are using natural polymers adsorbed or covalently attached to the surface to improve the biocompatibility of synthetic polymers. Locust beam gum (LBG) is a natural, edible polymer, which has a wide range of potential applications in different fields, such as food and pharmaceutical industry, due to its biocompatibility, adhesiveness and thickening properties. The present work brings a natural system based on the use of LBG as a coating for ESC culture. Undifferentiated mouse ESCs were cultured on commercially available LBG to evaluate its potential in maintaining pluripotent ESCs. In terms of morphology, ESC colonies in LBG presented the regular dome shape with bright borders, similar to the colonies obtained in co-cultures with MEFsi and characteristic of pluripotent ESC colonies. In short-term cultures, ESC proliferation in LBG coating was similar to ESC cultured in gelatin and the cells maintained their viability. The activity of alkaline phosphatase and Nanog, Sox2 and Oct4 expression of mouse ESCs cultured in LBG were comparable or in some cases higher than in ESCs cultured in gelatin. An in vitro differentiation assay revealed that mouse ESCs cultured in LBG preserve their tri-lineage differentiation capacity. In conclusion, our data indicate that LBG coating promotes mouse ESC growth in an undifferentiated state demonstrating to be a viable, non-animal derived alternative to gelatin to support pluripotent mouse ESCs in culture. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Perestrelo, Ana Rubina; Belo, Jose Antonio] Univ Algarve, Dept Ciencias Biomed & Med, Regenerat Med Program, Faro, Portugal.
   [Perestrelo, Ana Rubina; Grenha, Ana; Belo, Jose Antonio] Univ Algarve, Ctr Mol & Struct Biomed CBME, IBB, Faro, Portugal.
   [Perestrelo, Ana Rubina] Univ Algarve, PhD Program Biomed Sci, Faro, Portugal.
   [Rosa da Costa, Ana M.] Univ Algarve, CIQA, Fac Ciencias & Tecnol, Faro, Portugal.
   [Rosa da Costa, Ana M.] Univ Algarve, Dept Quim & Farm, Fac Ciencias & Tecnol, Faro, Portugal.
   [Belo, Jose Antonio] Univ Nova Lisboa, Fac Ciencias Med, P-1169056 Lisbon, Portugal.
RP Belo, JA (reprint author), Univ Nova Lisboa, Fac Ciencias Med, Edificio CEDOC 2,Rua Camara Pestana 6,6-A & 6-B, P-1150082 Lisbon, Portugal.
EM jose.belo@fcm.unl.pt
RI CIQA, CIQA/N-6549-2013; Belo, Jose A./F-4444-2012; Grenha,
   Ana/H-1392-2017; Rosa da Costa, Ana/E-2165-2012
OI Belo, Jose A./0000-0001-7384-0949; Grenha, Ana/0000-0002-2136-1396; Rosa
   da Costa, Ana/0000-0003-0225-9537
FU FCT grants; IBB/CBME, LA [PEst-OE/EQB/LA0023/2013]
FX E14GPF8 mouse ESCs were kindly provided by Dr. Tristan Rodriguez
   (Imperial College London). We thank all the members of the Embryology
   and Genetic Manipulation Laboratory and the staff of Gene Expression
   facility for technical support. We acknowledge Dr. Paulo N.G. Pereira
   for providing writing assistance and proof reading the article. A.R.P.
   is an FCT Doctoral Fellow (SFRH/BD/65624/2009). This work was supported
   by FCT grants and IBB/CBME, LA to J.A.B. in the framework of Project No.
   PEst-OE/EQB/LA0023/2013.
CR Ardehali R, 2011, P NATL ACAD SCI USA, V108, P3282, DOI 10.1073/pnas.1019047108
   Blin G, 2010, BIOMATERIALS, V31, P1742, DOI 10.1016/j.biomaterials.2009.11.055
   BORYSENKO JZ, 1979, EXP CELL RES, V118, P215, DOI 10.1016/0014-4827(79)90146-0
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Dakia PA, 2008, FOOD HYDROCOLLOID, V22, P807, DOI 10.1016/j.foodhyd.2007.03.007
   de Jong S, 2007, FOOD HYDROCOLLOID, V21, P1172, DOI 10.1016/j.foodhyd.2006.09.004
   Dionisio M, 2012, J PHARM BIOALLIED SC, V4, P175, DOI 10.4103/0975-7406.99013
   Ellison A.J., 2008, Gum coatings for cell culture, methods of manufacture and methods of use, Patent No. [US 2008/0220526 A1, 20080220526]
   European Commitee for Standardization, 2009, 1099352009 IS EN ISO
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Freshney R, 2005, CULTURE ANIMAL CELLS
   Gorgieva S., 2011, BIOMATER APPL NANOME, P18
   Hauser J, 2010, J BIOMED MATER RES A, V94A, P19, DOI 10.1002/jbm.a.32672
   Jana S, 2011, J PHARMASCITECH, V1, P16
   Ji LJ, 2012, EUR CELLS MATER, V23, P135, DOI 10.22203/eCM.v023a10
   Jia L, 2013, MAT SCI ENG C-MATER, V33, P4640, DOI 10.1016/j.msec.2013.07.021
   Kaivosoja E, 2012, ANN MED, V44, P635, DOI 10.3109/07853890.2011.573805
   KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532
   Lanza R, 2009, ESSENTIALS OF STEM CELL BIOLOGY, 2ND EDITION, pXV, DOI 10.1016/B978-0-12-374729-7.00073-1
   LUNDIN L, 1995, CARBOHYD POLYM, V26, P129, DOI 10.1016/0144-8617(94)00070-A
   Manjanna K.M., 2013, AM J MED SCI MED, V1, P5, DOI DOI 10.12691/AJMSM-1-1-2
   Marti M, 2013, NAT PROTOC, V8, P223, DOI 10.1038/nprot.2012.154
   MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441
   McNamara L. E., 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/120623
   Meade KA, 2013, J BIOL CHEM, V288, P5530, DOI 10.1074/jbc.M112.423012
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Perestrelo A.R., 2013, J TISSUE ENG REGEN M
   Petzold O.N., 2009, Irradiation induced grafting of polysaccharides to cell culture vessels, Patent No. [US 2011/0053271 A1, 20110053271]
   Qi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059022
   Ramirez MA, 2011, CELL PROLIFERAT, V44, P75, DOI 10.1111/j.1365-2184.2010.00732.x
   Razavi S. M. A., 2011, Electronic Journal of Environmental, Agricultural and Food Chemistry, V10, P2826
   Ryan JA., 2008, BIOFILES, V3, P8
   Shi GL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt39
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Wang J, 2007, J COLLOID INTERF SCI, V309, P373, DOI 10.1016/j.jcis.2006.10.086
   YAMAMOTO K, 1988, MECH AGEING DEV, V42, P183, DOI 10.1016/0047-6374(88)90073-5
   Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968
   Yue XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032707
NR 41
TC 10
Z9 10
U1 0
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2014
VL 40
BP 336
EP 344
DI 10.1016/j.msec.2014.04.022
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA AK4IO
UT WOS:000338388400044
PM 24857501
DA 2018-10-20
ER

PT J
AU Karimi, S
   Alfantazi, AM
AF Karimi, Shima
   Alfantazi, Akram M.
TI Ion release and surface oxide composition of AISI 316L, Co-28Cr-6Mo, and
   Ti-6Al-4V alloys immersed in human serum albumin solutions
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Oxide film; Immersion test; Protein; Ion release; Surface
   concentration
ID X-RAY PHOTOELECTRON; QUASI-BIOLOGICAL ENVIRONMENTS; BUFFERED SALINE
   SOLUTIONS; TOTAL HIP REPLACEMENTS; CORROSION BEHAVIOR; STAINLESS-STEEL;
   ELECTROCHEMICAL CHARACTERIZATION; XPS CHARACTERIZATION; IMPLANT ALLOYS;
   LIGAND-BINDING
AB The long-term weight loss, ion release, and surface composition of 316L, Co-28Cr-6Mo and Ti-6Al-4V alloys were investigated in a simulated body environment. The samples were immersed in phosphate-buffered saline (PBS) solutions with various human serum albumin (HSA) concentrations for 8,14, and 22 weeks. The specimens initially lost weight up to 14 weeks and then slightly gained weight The analysis of the released ions was performed by induced coupled plasma-optical emission spectrometer (ICP-OES). The results revealed that the precipitation of the dissolved Fe and Co could cause the weight gain of the 316L and Co-28Cr-6Mo alloys. The surface chemistry of the specimens was determined by X-ray photoelectron spectroscopy (XPS). The XPS analysis of Co-28Cr-6Mo alloy showed that the interaction of Mo with HSA is different from Mo with bovine serum albumin (BSA). This was also observed for Na adsorption into the oxide layer of Ti-6Al-4V alloy in the presence of HSA and BSA. Crown Copyright (C) 2014 Published by Elsevier B.V. All rights reserved.
C1 [Karimi, Shima; Alfantazi, Akram M.] Univ British Columbia, Dept Mat Engn, Vancouver, BC V6T 1Z4, Canada.
RP Karimi, S (reprint author), Univ British Columbia, Dept Mat Engn, 309-6350 Stores Rd, Vancouver, BC V6T 1Z4, Canada.
EM shimak80@gmail.com
OI alfantazi, akram/0000-0002-4039-5110
FU Natural Science and Engineering Research Council of Canada (NSERC)
FX We would like to acknowledge financial support of the Natural Science
   and Engineering Research Council of Canada (NSERC).
CR ADAMS PA, 1980, BIOCHEM J, V191, P95, DOI 10.1042/bj1910095
   Bastidas JM, 2002, CORROS SCI, V44, P625, DOI 10.1016/S0010-938X(01)00072-5
   BIANCHI CL, 1993, APPL SURF SCI, V70-1, P211, DOI 10.1016/0169-4332(93)90429-F
   Bianco PD, 1997, J MATER SCI-MATER M, V8, P525, DOI 10.1023/A:1018590513178
   BONNELLE JP, 1975, J ELECTRON SPECTROSC, V7, P151, DOI 10.1016/0368-2048(75)80047-8
   Brodner W, 2003, J BONE JOINT SURG AM, V85A, P2168, DOI 10.2106/00004623-200311000-00017
   Cahoon J., 2004, J BIOMED MATER RES, V2, P1
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   CARTER DC, 1994, EUR J BIOCHEM, V226, P1049, DOI 10.1111/j.1432-1033.1994.01049.x
   CIMINO A, 1975, J CATAL, V36, P11, DOI 10.1016/0021-9517(75)90004-4
   Cobb AG, 2006, P I MECH ENG H, V220, P385, DOI 10.1243/09544119JEIM78
   D ASTM Standard, 2005, STAND PRACT CLEAN LA
   Ducheyne P., 1992, BONE BONDING BIOMATE, P62
   F ASTM Standard, 2008, STAND TEST METH COND
   Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093
   Feng B, 2002, MATER CHARACT, V49, P129, DOI 10.1016/S1044-5803(02)00341-8
   G ASTM Standard, 2004, STAND PRACT LAB IMM
   Granchi D, 2000, BIOMATERIALS, V21, P1789, DOI 10.1016/S0142-9612(00)00070-3
   Hallab NJ, 2003, J BIOMED MATER RES A, V65A, P311, DOI 10.1002/jbm.a.10429
   HAMMOND JS, 1981, CORROS SCI, V21, P239, DOI 10.1016/0010-938X(81)90033-0
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   Hanawa T, 2002, MATER TRANS, V43, P3088, DOI 10.2320/matertrans.43.3088
   Hanawa T, 2001, APPL SURF SCI, V183, P68, DOI 10.1016/S0169-4332(01)00551-7
   He X.M., 1992, ATOMIC STRUCTURE CHE
   Hiromoto S, 2005, BIOMATERIALS, V26, P4912, DOI 10.1016/j.biomaterials.2005.01.028
   Hodgson AWE, 2004, ELECTROCHIM ACTA, V49, P2167, DOI 10.1016/j.electacta.2003.12.043
   Huang HH, 2003, BIOMATERIALS, V24, P275, DOI 10.1016/S0142-9612(02)00315-0
   JOYNER DJ, 1980, J AM CHEM SOC, V102, P1910, DOI 10.1021/ja00526a025
   Karimi S, 2013, J ELECTROCHEM SOC, V160, pC206, DOI 10.1149/2.052306jes
   Karimi S, 2012, APPL SURF SCI, V258, P6087, DOI 10.1016/j.apsusc.2012.03.008
   Karimi S, 2011, CORROS SCI, V53, P3262, DOI 10.1016/j.corsci.2011.06.009
   KAWAFUNE I, 1991, INORG CHIM ACTA, V188, P33, DOI 10.1016/S0020-1693(00)80913-5
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Koike M, 2001, BIOMATERIALS, V22, P2931, DOI 10.1016/S0142-9612(01)00040-0
   Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695
   Kuhn A.T., 1986, USE SYNTHETIC ENV CO, P79
   LAUSSAC JP, 1984, BIOCHEMISTRY-US, V23, P2832, DOI 10.1021/bi00307a046
   Lewis AC, 2006, J ORTHOP RES, V24, P1587, DOI 10.1002/jor.20198
   Lewis AC, 2005, J BIOMED MATER RES A, V73A, P456, DOI 10.1002/jbm.a.30368
   Lhotka C, 2003, J ORTHOP RES, V21, P189, DOI 10.1016/S0736-0266(02)00152-3
   Lin HY, 2004, BIOMATERIALS, V25, P1233, DOI 10.1016/j.biomaterials.2003.08.016
   Lori JA, 2001, CORROS SCI, V43, P2111, DOI 10.1016/S0010-938X(01)00003-8
   LOWENBERG BF, 1994, J MATER SCI-MATER M, V5, P467, DOI 10.1007/BF00058985
   Marcus P., 2006, XPS CHARACTERISATION, P365
   Martin EJ, 2013, LANGMUIR, V29, P4813, DOI 10.1021/la304046q
   MCINTYRE NS, 1975, ANAL CHEM, V47, P2208, DOI 10.1021/ac60363a034
   Milosev I, 2005, J ORTHOP RES, V23, P526, DOI 10.1016/j.orthres.2004.12.007
   Moriyama Y, 1996, J PROTEIN CHEM, V15, P265, DOI 10.1007/BF01887115
   Mothes E, 2007, BIOCHEMISTRY-US, V46, P2267, DOI 10.1021/bi061783p
   NECHAY BR, 1986, ARCH BIOCHEM BIOPHYS, V251, P128, DOI 10.1016/0003-9861(86)90059-7
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   OKU M, 1976, J ELECTRON SPECTROSC, V8, P475, DOI 10.1016/0368-2048(76)80034-5
   Oliva FY, 2003, J COLLOID INTERF SCI, V261, P299, DOI 10.1016/S0021-9797(03)00029-8
   Olsson COA, 2003, ELECTROCHIM ACTA, V48, P1093, DOI 10.1016/S0013-4686(02)00841-1
   Omanovic S, 1999, LANGMUIR, V15, P8315, DOI 10.1021/la990474f
   Ouerd A, 2008, ELECTROCHIM ACTA, V53, P4461, DOI 10.1016/j.electacta.2008.01.025
   Patel B, 2012, MAT SCI ENG C-MATER, V32, P1222, DOI 10.1016/j.msec.2012.03.012
   Pradier CM, 2003, J PHYS CHEM B, V107, P6766, DOI 10.1021/jp026365i
   Purcell M, 2001, CAN J CHEM, V79, P1415, DOI 10.1139/cjc-79-10-1415
   RAE T, 1981, J BONE JOINT SURG BR, V63, P435
   Savarino L, 2003, J BIOMED MATER RES A, V66A, P450, DOI 10.1002/jbm.a.10595
   Schaffer AW, 1999, J TOXICOL-CLIN TOXIC, V37, P839, DOI 10.1081/CLT-100102463
   Shih CC, 2004, CORROS SCI, V46, P427, DOI 10.1016/S0010-938X(03)00148-3
   Sokolowska M, 2009, J INORG BIOCHEM, V103, P1005, DOI 10.1016/j.jinorgbio.2009.04.011
   Speight J. G., 2005, LANGES HDB CHEM
   TAN BJ, 1990, CHEM MATER, V2, P186, DOI 10.1021/cm00008a021
   Tateishi T., 1997, MAT T, V38, P78
   Valero Vidal C., 2010, COLLOID SURFACE B, V80, P1
   Vidal CV, 2008, CORROS SCI, V50, P1954, DOI 10.1016/j.corsci.2008.04.002
   Wagner C., 1992, HDB XRAY PHOTOELECTR
   Wang W, 2013, J ELECTROCHEM SOC, V160, pC1, DOI 10.1149/2.003302jes
   Wang W, 2012, CORROS SCI, V57, P11, DOI 10.1016/j.corsci.2011.12.039
   WINTER GD, 1974, J BIOMED MATER RES, V8, P11, DOI 10.1002/jbm.820080304
   WOODMAN JL, 1984, J BIOMED MATER RES, V18, P99, DOI 10.1002/jbm.820180110
   Yan Y, 2007, TRIBOL INT, V40, P1492, DOI 10.1016/j.triboint.2007.02.019
NR 75
TC 8
Z9 9
U1 1
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2014
VL 40
BP 435
EP 444
DI 10.1016/j.msec.2014.04.007
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AK4IO
UT WOS:000338388400055
PM 24857512
DA 2018-10-20
ER

PT J
AU Fortunati, D
   Chau, DYS
   Wang, Z
   Collighan, RJ
   Griffin, M
AF Fortunati, Dario
   Chau, David Yi San
   Wang, Zhuo
   Collighan, Russell John
   Griffin, Martin
TI Cross-linking of collagen I by tissue transglutaminase provides a
   promising biomaterial for promoting bone healing
SO AMINO ACIDS
LA English
DT Article
DE Tissue transglutaminase; Cross-linking; Collagen I; HOB; Integrins
ID CELL-ADHESION; FIBRONECTIN; INHIBITION; DEPOSITION; SYNDECAN-4; COMPLEX;
   KINASE
AB Transglutaminases (TGs) stabilize proteins by the formation of epsilon(gamma-glutamyl)lysine cross-links. Here, we demonstrate that the cross-linking of collagen I (COL I) by tissue transglutaminase (TG2) causes an alteration in the morphology and rheological properties of the collagen fibers. Human osteoblasts (HOB) attach, spread, proliferate, differentiate and mineralize more rapidly on this cross-linked matrix compared to native collagen. When seeded on cross-linked COL I, HOB are more resistant to the loss of cell spreading by incubation with RGD containing peptides and with alpha 1, alpha 2 and beta 1 integrin blocking antibodies. Following adhesion on cross-linked collagen, HOB show increased phosphorylation of the focal adhesion kinase, and increased expression of beta 1 and beta 3 integrins. Addition of human bone morphogenetic protein to HOB seeded on TG2 cross-linked COL I enhanced the expression of the differentiation marker bone alkaline phosphatase when compared to cross-linked collagen alone. In summary, the use of TG2-modified COL I provides a promising new scaffold for promoting bone healing.
C1 [Fortunati, Dario; Chau, David Yi San; Wang, Zhuo; Collighan, Russell John; Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.
RP Griffin, M (reprint author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.
EM m.griffin@aston.ac.uk
OI Griffin, Martin/0000-0003-3824-306X; Chau, David/0000-0001-9200-6749;
   WANG, ZHUO/0000-0002-2212-8318
FU European Community [MRTN-CT-2006-036032]; EPSRC [GR/S21755/02];
   Engineering and Physical Sciences Research Council [GR/S21755/02]
FX This work was financially supported by the European Community programme
   TRACKS where D. F. was a recipient of a Marie Curie postdoctoral
   Fellowship with contract MRTN-CT-2006-036032 and by the Grant EPSRC
   (GR/S21755/02). We would like to thank Professor John Mitchell and Dr
   Matthew Boyd (University of Nottingham) for their kind help with the COL
   I gel rheology. We would like to thank Mr. A. Parchure for the technical
   assistance with the beta 1 integrin detection.
CR Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567
   Aravamudhan A, 2013, CURR PHARM DESIGN, V19, P3420, DOI 10.2174/1381612811319190008
   Bergamini Carlo M, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P1
   Cameron K, 2013, J BIOMED MATER RES A, V101, P13, DOI 10.1002/jbm.a.34261
   Chan KLS, 2014, J BIOMED MATER RES A, V102, P3186, DOI 10.1002/jbm.a.34990
   Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   FOLK JE, 1973, ADV ENZYMOL RAMB, V38, P109
   FREUND KF, 1994, BIOCHEMISTRY-US, V33, P10109, DOI 10.1021/bi00199a039
   Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234
   Heath DJ, 2001, J BONE MINER RES, V16, P1477, DOI 10.1359/jbmr.2001.16.8.1477
   Huang LH, 2009, KIDNEY INT, V76, P383, DOI 10.1038/ki.2009.230
   Kotsakis P, 2011, AMINO ACIDS, V41, P909, DOI 10.1007/s00726-010-0790-1
   Kruger TE, 2013, SCI WORLD J, DOI 10.1155/2013/812718
   McKleroy W, 2013, AM J PHYSIOL-LUNG C, V304, pL709, DOI 10.1152/ajplung.00418.2012
   Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029
   Olsen KC, 2011, AM J RESP CRIT CARE, V184, P699, DOI 10.1164/rccm.201101-0013OC
   Orlandi A, 2009, AMINO ACIDS, V36, P755, DOI 10.1007/s00726-008-0129-3
   Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373
   Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x
   Piercy-Kotb SA, 2012, J CELL PHYSIOL, V227, P2936, DOI 10.1002/jcp.23040
   Plant AL, 2009, BBA-MOL CELL RES, V1793, P893, DOI 10.1016/j.bbamcr.2008.10.012
   Rodgers SD, 2013, J NEUROSURG-SPINE, V18, P582, DOI [10.3171/2013.2.SPINE12377, 10.3171/2013.3.SPINE12377]
   Tarantino U, 2013, AMINO ACIDS, V44, P199, DOI 10.1007/s00726-011-1181-y
   Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200
   Wang Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.318
   Wang Z, 2011, EXP CELL RES, V317, P367, DOI 10.1016/j.yexcr.2010.10.015
   Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057017
   Wang Z, 2012, J BIOL CHEM, V287, P13063, DOI 10.1074/jbc.M111.294819
   Wang Z, 2012, AMINO ACIDS, V42, P939, DOI 10.1007/s00726-011-1008-x
   Wang Z, 2010, J BIOL CHEM, V285, P40212, DOI 10.1074/jbc.M110.123703
NR 31
TC 11
Z9 13
U1 3
U2 43
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0939-4451
EI 1438-2199
J9 AMINO ACIDS
JI Amino Acids
PD JUL
PY 2014
VL 46
IS 7
BP 1751
EP 1761
DI 10.1007/s00726-014-1732-0
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AJ9JT
UT WOS:000338026700013
PM 24710705
DA 2018-10-20
ER

PT J
AU Niu, CH
   Baylak, T
   Wilson, DI
   Zhang, M
AF Niu, C. H.
   Baylak, T.
   Wilson, D. I.
   Zhang, M.
TI Pelletisation of canola meal by extrusion-spheronisation for ethanol
   dehydration
SO BIOMASS & BIOENERGY
LA English
DT Article
DE Bioethanol; Canola meal; Dehdyration; Extrusion; Pelletization;
   Spheronisation
ID LIQUID-PHASE MIGRATION; MICROCRYSTALLINE CELLULOSE PASTES; WATER;
   ADSORPTION; PELLETS; ADSORBENT; CORNMEAL
AB Canola meal has been previously demonstrated to be an attractive biomaterial for dehydrating wet ethanol vapours in bioethanol manufacture. Extrusion spheronisation was employed to prepare reasonably spherical pellets of canola meal for use in dehydration units. Canola meal pastes were prepared at water volume fractions of 57-70% and extruded through single and multi-holed dies with diameters 2, 3.5 and 4.5 mm. The pressure required to extrude the pastes, size and shape distribution of pellets and strength of dried pellets were measured. Formulations with a water volume fraction of 70% gave low extrusion pressures and highest pellet strength. Die land diameters of 2 mm gave the best combination of specific surface area, size and shape distribution, packing density and ethanol adsorption. Dehydration testing confirmed that the canola meal pellets could dehydrate water/ethanol vapour from an ethanol mass fraction of 92.5% (below the azeotrope at 1 bara) to 99%. The equilibrium water loading of 47.3 mg water per g adsorbent is larger than other biomass-based adsorbents reported for this application. (c) 2014 Elsevier Ltd. All rights reserved.
C1 [Niu, C. H.; Wilson, D. I.; Zhang, M.] Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England.
   [Niu, C. H.; Baylak, T.] Univ Saskatchewan, Dept Chem & Biol Engn, Saskatoon, SK S7N 5N9, Canada.
   [Zhang, M.] Xi An Jiao Tong Univ, Sch Pharm, Hlth Sci Ctr, Xian 710061, Shannxi, Peoples R China.
RP Wilson, DI (reprint author), Dept Chem Engn & Biotechnol, New Museums Site,Pembroke St, Cambridge CB2 3RA, England.
EM diw11@cam.ac.uk
FU University of Saskatchewan Research Sababtical travel fund; Agriculture
   Bioproduct Innovative Program of Canada; Saskatchewan Agriculture
   Development Fund; Saskatchewan Canola Development Commission
FX Authors Niu and Baylak were supported by the University of Saskatchewan
   Research Sababtical travel fund, Agriculture Bioproduct Innovative
   Program of Canada, Saskatchewan Agriculture Development Fund and
   Saskatchewan Canola Development Commission. Zlako Saragevic (Cambridge)
   performed pycnometry and particle analyses; Dr. Ramin Azargohar and Mr.
   Chuck Oraedu (Saskatoon) determined the surface area of raw canola meal
   and pellets; and Ms. Marcela Mann measured the bed voidage and packing
   density of the packed bed.
CR Al-Asheh S, 2004, CHEM ENG RES DES, V82, P855, DOI 10.1205/0263876041596779
   [Anonymous], 3A MOL SIEV
   Anozie AN, 2010, SEP SCI TECHNOL, V45, P1482, DOI 10.1080/01496391003775998
   Baylak T, 2012, ENERG FUEL, V26, P5226, DOI 10.1021/ef300118s
   Beery KE, 1998, ADSORPTION, V4, P321, DOI 10.1023/A:1008846003116
   Benbow J., 1993, PASTE FLOW EXTRUSION
   Benson TJ, 2005, ADSORPTION, V11, P697, DOI 10.1007/s10450-005-6009-1
   Canola Council of Canada, 2009, CAN MEAL FEED IND GU
   Chang H, 2006, IND ENG CHEM RES, V45, P3916, DOI 10.1021/ie051043x
   Chang H, 2006, CHEM ENG TECHNOL, V29, P454, DOI 10.1002/ceat.200500384
   Chopra R, 2002, EUR J PHARM BIOPHARM, V53, P327, DOI 10.1016/S0939-6411(02)00015-2
   DEXTER AR, 1985, J AGR ENG RES, V31, P139, DOI 10.1016/0021-8634(85)90066-6
   GELDART D, 1984, POWDER TECHNOL, V37, P25, DOI 10.1016/0032-5910(84)80003-0
   Kim Y, 2011, IND ENG CHEM RES, V50, P8678, DOI 10.1021/ie2003297
   LUKASIEWICZ SJ, 1978, AM CERAM SOC BULL, V57, P798
   Mascia S, 2006, EUR J PHARM SCI, V29, P22, DOI 10.1016/j.ejps.2006.04.011
   Newton JM, 2008, PHARM DOSAGE FORMS T, V1
   Rough SL, 2000, INT J PHARM, V204, P117, DOI 10.1016/S0378-5173(00)00478-6
   Rough SL, 2003, POWDER TECHNOL, V132, P249, DOI 10.1016/S0032-5910(03)00075-5
   Rough SL, 2002, CHEM ENG RES DES, V80, P701, DOI 10.1205/026387602320776786
   Simo M, 2009, IND ENG CHEM RES, V48, P9247, DOI 10.1021/ie900446v
   Sousa JJ, 2002, INT J PHARM, V232, P91, DOI 10.1016/S0378-5173(01)00908-5
   Vervaet C, 1996, INT J PHARM, V133, P29, DOI 10.1016/0378-5173(95)04408-6
   VERVAET C, 1995, INT J PHARM, V116, P131, DOI 10.1016/0378-5173(94)00311-R
   Wilson DI, 2007, HDB POWDER TECHNOLOG, VII
   Zhang M, 2011, INT J PHARMACEUT, V416, P210, DOI 10.1016/j.ijpharm.2011.06.043
NR 26
TC 4
Z9 4
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0961-9534
EI 1873-2909
J9 BIOMASS BIOENERG
JI Biomass Bioenerg.
PD JUL
PY 2014
VL 66
BP 116
EP 125
DI 10.1016/j.biombioe.2014.03.035
PG 10
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA AJ7LB
UT WOS:000337877100012
DA 2018-10-20
ER

PT J
AU Palecek, E
   Rimankova, L
AF Palecek, Emil
   Rimankova, Ludmila
TI Chitosan catalyzes hydrogen evolution at mercury electrodes
SO ELECTROCHEMISTRY COMMUNICATIONS
LA English
DT Article
DE Chitosan; Glucosamine-containing polymers; Catalytic hydrogen evolution;
   Voltammetry and chronopotentiometry; Mercury and solid amalgam
   electrodes; Chitosan multilayers
ID AMALGAM ELECTRODES; NUCLEIC-ACIDS; POLYSACCHARIDES; PEPTIDES; PROTEINS;
   ELECTROCATALYSIS; ELECTROCHEMISTRY; POLYLYSINE
AB In recent decades chitosan has attracted great attention as biodegradable biomaterial with interesting properties, making chitosan useful in biomedicine and various fields of practical life. Chitosan was generally considered as an electrochemically inactive polysaccharide. Here we show that chitosan (containing glucosamine residues) produced voltammetric and chronopotentiometric reduction peaks at mercury and solid amalgam electrodes in a wide pH range. These peaks strongly increased with the buffer concentration and with decreasing pH and were assigned to the catalytic hydrogen evolution reaction. Under the same conditions chitin oligomers (containing N-acetylated glucosamines) displayed no significant electroactivity. Polyanionic polymers, such as DNA and hyaluronic acid, formed multilayers with the adsorbed chitosan. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Palecek, Emil; Rimankova, Ludmila] Acad Sci Czech Republic, Inst Biophys, Vvi, CS-61265 Brno, Czech Republic.
RP Palecek, E (reprint author), Acad Sci Czech Republic, Inst Biophys, Ivv, Kralovopolska 135, CS-61265 Brno, Czech Republic.
EM palecek@ibp.cz
FU Czech Science Foundation [P301/11/2055]
FX We are indebted to Dr. V. Ostatna for critical reading of the manuscript
   and stimulating discussion and to Mgr. M. Markova for technical
   assistance. This work was supported by Czech Science Foundation
   P301/11/2055.
CR Armstrong F. A., 2002, BIOELECTROCHEMISTRY, V9, P11
   Cai XH, 1996, ANAL CHIM ACTA, V332, P49, DOI 10.1016/0003-2670(96)00189-4
   Dorcak V, 2013, ELECTROCHEM COMMUN, V31, P80, DOI 10.1016/j.elecom.2013.03.016
   Hammerich O, 2008, BIOINORGANIC ELECTRO
   Heyrovsky M, 2004, ELECTROANAL, V16, P1067, DOI 10.1002/elan.200403008
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kurzatkowska K, 2013, ELECTROCHIM ACTA, V106, P43, DOI 10.1016/j.electacta.2013.05.057
   Ostatna V, 2010, J AM CHEM SOC, V132, P9408, DOI 10.1021/ja102427y
   PALECEK E, 1968, BIOPOLYMERS, V6, P917, DOI 10.1002/bip.1968.360060703
   Palecek E, 2007, ELECTROANAL, V19, P2383, DOI 10.1002/elan.200704033
   Palecek E, 2014, ANAL CHIM ACTA, V828, P1, DOI 10.1016/j.aca.2014.03.029
   Palecek E, 2012, CHEM REV, V112, P3427, DOI 10.1021/cr200303p
   Palecek E, 2012, CHEM REC, V12, P27, DOI 10.1002/tcr.201100029
   Palecek E, 2011, J AM CHEM SOC, V133, P7190, DOI 10.1021/ja201006s
   Palecek E, 2009, ELECTROANAL, V21, P239, DOI 10.1002/elan.200804416
   Saburo M.M., 2006, MAT SCI CHITIN CHITO, P191
   Strmecki S, 2012, ELECTROCHEM COMMUN, V18, P100, DOI 10.1016/j.elecom.2012.02.029
   Strmecki S, 2009, ELECTROCHEM COMMUN, V11, P2032, DOI 10.1016/j.elecom.2009.08.056
   Suginta W, 2013, CHEM REV, V113, P5458, DOI 10.1021/cr300325r
   Trefulka M, 2010, ELECTROANAL, V22, P1837, DOI 10.1002/elan.201000218
   Vargova V, 2013, ELECTROANAL, V25, P2130, DOI 10.1002/elan.201300170
   Yosypchuk B, 2002, ELECTROANAL, V14, P1488, DOI 10.1002/1521-4109(200211)14:21<1488::AID-ELAN1488>3.0.CO;2-X
   Yosypchuk B, 2009, CRIT REV ANAL CHEM, V39, P189, DOI 10.1080/10408340903011838
   Zivanovic M, 2010, ELECTROANAL, V22, P2064, DOI 10.1002/elan.201000088
NR 24
TC 21
Z9 21
U1 0
U2 27
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1388-2481
EI 1873-1902
J9 ELECTROCHEM COMMUN
JI Electrochem. Commun.
PD JUL
PY 2014
VL 44
BP 59
EP 62
DI 10.1016/j.elecom.2014.04.015
PG 4
WC Electrochemistry
SC Electrochemistry
GA AJ8ZU
UT WOS:000337997400016
DA 2018-10-20
ER

PT J
AU Dang, N
   Sivakumaran, H
   Harrich, D
   Shaw, PN
   Coombes, AGA
AF Dang, Nhung
   Sivakumaran, Haran
   Harrich, David
   Shaw, P. Nicholas
   Coombes, Allan G. A.
TI Evaluation of Polycaprolactone Matrices for Sustained Vaginal Delivery
   of Nevirapine in the Prevention of Heterosexual HIV Transmission
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE nevirapine; solid dispersion; microbicides; polycaprolactone matrix;
   vaginal delivery; biomaterial; drug delivery systems; controlled release
ID MICROBICIDES; RELEASE; DISSOLUTION; INFECTION; TENOFOVIR
AB Nevirapine (NVP) was loaded in polycaprolactone (PCL) matrices to produce vaginal inserts with the aim of preventing HIV transmission. NVP dispersions in PCL were prepared, at 10% (w/w) theoretical loading, measured with respect to the PCL content of the matrices, in the form of (1) NVP only, (2) a physical mixture of NVP with polyethylene glycol (PEG) 6000 or (c) a solid dispersion (SD) with PEG produced by co-dissolution in ethanol. Characterisation of SD by differential scanning calorimetry and attenuated total reflectance-Fourier transform infrared spectroscopy suggested transformation of the crystalline structure of NVP to an amorphous form which consequently increased the dissolution rate of drug. A low-loading efficiency of 13% was obtained for NVP-loaded matrices and less than 20% for matrices prepared using physical mixtures of drug and PEG. The loading efficiency was improved significantly to around 40% when a 1:4 NVP-PEG SD was used for matrix production. After 30 days, 40% of the drug content was released from NVP-loaded matrices, 55% from matrices containing 1:4 NVP-PEG physical mixtures and 60% from matrices loaded with 1:4 NVP-PEG SDs. The in vitro anti-viral activity of released NVP was assessed using a luciferase reporter gene assay following the infection of HeLa cells with pseudo-typed HIV-1. NVP released from PCL matrices in simulated vaginal fluid retained over 75% anti-HIV activity compared with the non-formulated NVP control. In conclusion, 1:4 NVP-PEG SDs when loaded in PCL matrices increase drug loading efficiency and improve release behaviour. (c) 2014 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:2107-2115, 2014
C1 [Dang, Nhung; Shaw, P. Nicholas; Coombes, Allan G. A.] Univ Queensland, Sch Pharm, St Lucia, Qld 4072, Australia.
   [Sivakumaran, Haran; Harrich, David] Queensland Inst Med Res, Mol Virol Lab, Brisbane, Qld 4811, Australia.
RP Coombes, AGA (reprint author), Univ Queensland, Sch Pharm, St Lucia, Qld 4072, Australia.
EM AllanCoombes@imu.edu.my
RI Shaw, Paul/G-4418-2010; Dang, Nhung/F-6689-2015
OI Shaw, Paul/0000-0001-7154-592X; Dang, Nhung/0000-0002-9604-5523;
   Sivakumaran, Haran/0000-0002-4691-4989
CR ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   CRAIG DQM, 1995, THERMOCHIM ACTA, V248, P189, DOI 10.1016/0040-6031(94)01886-L
   Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8
   Dang NTT, 2013, J PHARM SCI-US, V102, P3725, DOI 10.1002/jps.23684
   Dang NTT, 2013, J BIOMATER APPL, V28, P74, DOI 10.1177/0885328212437393
   Delaney WE, 2005, ANTIVIR RES, V65, pA31
   Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505
   Friend DR, 2013, ANTIVIR RES, V99, P391, DOI 10.1016/j.antiviral.2013.06.021
   Grayson ML, 2010, KUCERS USE ANTIBIOTI, P3157
   Kiser PF, 2012, AIDS REV, V14, P62
   Lin PF, 2008, ANTIMICROB AGENTS CH, V52, P1759, DOI 10.1128/AAC.01313-07
   Malcolm RK, 2005, J ANTIMICROB CHEMOTH, V56, P954, DOI 10.1093/jac/dki326
   Marrazzo J, 2013, C RETR OPP INF ATL G
   Microbicide Trial Network, 2010, UND RES CAPRISA 004
   Microbicide Trial Network, 2011, MTN STAT DEC DISC US
   Miyajima M, 1999, J CONTROL RELEASE, V60, P199, DOI 10.1016/S0168-3659(99)00083-8
   Obiero J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-289
   Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4
   Pereira BG, 2007, CRYST GROWTH DES, V7, P2016, DOI 10.1021/cg0704495
   Romano JW, 2012, CURR HIV RES, V10, P9, DOI 10.2174/157016212799304625
   Stieger N, 2009, PHARMAZIE, V64, P690, DOI 10.1016/ph.2009.9163
   The Japanese Pharmacopoeia, 2001, JAPANESE PHARMACOPOE, VII, P967
   United Nations Joint Programme on HIV and AIDS (UNAIDS), 2013, GLOB REP UNAIDS REP
   Woolfson AD, 2006, INT J PHARM, V325, P82, DOI 10.1016/j.ijpharm.2006.06.026
NR 25
TC 1
Z9 1
U1 0
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3549
EI 1520-6017
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD JUL
PY 2014
VL 103
IS 7
BP 2107
EP 2115
DI 10.1002/jps.24030
PG 9
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA AJ9IX
UT WOS:000338023700020
PM 24867411
DA 2018-10-20
ER

PT J
AU Sun, Q
   Lou, JT
   Kang, F
   Chen, JF
   Wang, JX
AF Sun, Qian
   Lou, Jin-Ting
   Kang, Fang
   Chen, Jian-Feng
   Wang, Jie-Xin
TI Facile preparation of hydroxyapatite nanotubes assisted by needle-like
   calcium carbonate
SO POWDER TECHNOLOGY
LA English
DT Article
DE Needle-like CaCO3; Templates; Hydroxyapatite nanotubes; Ion-exchange
   reaction
ID HOLLOW SILICA NANOTUBES; DRUG-DELIVERY; FABRICATION; NANOPARTICLES;
   CACO3; TRANSFORMATION
AB Hydroxyapatite (HA) is a famous biomaterial and its performance depends greatly on its morphology and 3D architecture. So the synthesis for HA with specific structures has been widely paid attention. In this research, a cost-effective way to prepare HA nanotubes with no post-processing template removal step was presented through Kirkendall effect-assisted ion-exchange process by using inexpensive needle-like CaCO3 nanoparticles as templates and calcium sources. The effects of reaction time, temperature and pH value on the formation of HA nanotubes were investigated. The as-prepared HA nanotube products were characterized by transmission electron microscopy (TEM), scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR) and Brunauer-Emmett-Teller (BET). It was found that HA nanotubes had uniform tubular hollow structures with big openings, a length of 2-4 mu m, the average inner diameters at the two ends of 300-400 nm and 150-250 nm, respectively, as well as a wall thickness of approximately 35 nm and a specific surface area of 60 m(2)/g. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Sun, Qian; Kang, Fang; Chen, Jian-Feng; Wang, Jie-Xin] Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Beijing 100029, Peoples R China.
   [Lou, Jin-Ting; Chen, Jian-Feng; Wang, Jie-Xin] Beijing Univ Chem Technol, Res Ctr, Minist Educ High Grav Engn & Technol, Beijing 100029, Peoples R China.
RP Wang, JX (reprint author), Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Beijing 100029, Peoples R China.
EM wangjx@mail.buct.edu.cn
FU National Natural Science Foundation of China [21121064]; Program for New
   Century Excellent Talents in University of China [NCET-12-0760];
   National "863" Program of China [2012AA030307, 2012AA030305]; Beijing
   Higher Education Young Elite Teacher Project [YETP0485]
FX This work was financially supported by National Natural Science
   Foundation of China (No. 21121064), Program for New Century Excellent
   Talents in University of China (NCET-12-0760), National "863" Program of
   China (Nos. 2012AA030307 and 2012AA030305) and Beijing Higher Education
   Young Elite Teacher Project (YETP0485).
CR Bakan F, 2013, POWDER TECHNOL, V233, P295, DOI 10.1016/j.powtec.2012.08.030
   Elliot J. C., 1998, CALCIUM PHOSPHATE MA
   Fan HJ, 2006, NAT MATER, V5, P627, DOI 10.1038/nmat1673
   Gao LD, 2006, MATER LETT, V60, P3882, DOI 10.1016/j.matlet.2006.03.133
   Hui JF, 2009, INORG CHEM, V48, P5614, DOI 10.1021/ic900697b
   Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396
   Lee YI, 2013, SCRIPTA MATER, V68, P463, DOI 10.1016/j.scriptamat.2012.11.020
   Li DD, 2013, MATER RES BULL, V48, P2201, DOI 10.1016/j.materresbull.2013.02.049
   Li YG, 2006, J AM CHEM SOC, V128, P14258, DOI 10.1021/ja065308q
   Liu ZQ, 2005, J AM CHEM SOC, V127, P6, DOI 10.1021/ja0445239
   Markov I.N., 2003, GRYSTAL GROWTH BEGIN
   MORENO EC, 1974, NATURE, V247, P64, DOI 10.1038/247064a0
   Park JH, 2004, MATER CHEM PHYS, V87, P301, DOI 10.1016/j.matchemphys.2004.05.013
   Puvvada N, 2010, NANOSCALE, V2, P2631, DOI 10.1039/c0nr00611d
   Richter G, 2010, SCRIPTA MATER, V63, P933, DOI 10.1016/j.scriptamat.2010.07.007
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Schmidt OG, 2001, NATURE, V410, P168, DOI 10.1038/35065525
   Singh RK, 2012, MATER LETT, V75, P130, DOI 10.1016/j.matlet.2012.01.129
   Sommerdijk NAJM, 2008, CHEM REV, V108, P4499, DOI 10.1021/cr078259o
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Wang JX, 2004, SCRIPTA MATER, V51, P1035, DOI 10.1016/j.scriptamat.2004.08.016
   Wang M, 2004, POWDER TECHNOL, V142, P166, DOI 10.1016/j.powtec.2004.05.003
   Wang SF, 2005, J CRYST GROWTH, V282, P79, DOI 10.1016/j.jcrysgro.2005.04.082
   Wang YC, 2011, J CRYST GROWTH, V327, P245, DOI 10.1016/j.jcrysgro.2011.05.024
   Wang YS, 2010, J COLLOID INTERF SCI, V352, P393, DOI 10.1016/j.jcis.2010.08.060
   Wang ZL, 2000, ADV MATER, V12, P1295, DOI 10.1002/1521-4095(200009)12:17<1295::AID-ADMA1295>3.0.CO;2-B
   Xia W, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/30/305610
   Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087
   Ye F, 2010, ACTA BIOMATER, V6, P2212, DOI 10.1016/j.actbio.2009.12.014
   Yuan Y, 2008, MATER CHEM PHYS, V112, P275, DOI 10.1016/j.matchemphys.2008.05.068
   Zhuang Z, 2012, POWDER TECHNOL, V222, P193, DOI 10.1016/j.powtec.2012.02.046
NR 31
TC 8
Z9 9
U1 1
U2 62
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0032-5910
EI 1873-328X
J9 POWDER TECHNOL
JI Powder Technol.
PD JUL
PY 2014
VL 261
BP 49
EP 54
DI 10.1016/j.powtec.2014.04.014
PG 6
WC Engineering, Chemical
SC Engineering
GA AJ7KL
UT WOS:000337875500006
DA 2018-10-20
ER

PT J
AU Tieng, V
   Stoppini, L
   Villy, S
   Fathi, M
   Dubois-Dauphin, M
   Krause, KH
AF Tieng, Vannary
   Stoppini, Luc
   Villy, Sabrina
   Fathi, Marc
   Dubois-Dauphin, Michel
   Krause, Karl-Heinz
TI Engineering of Midbrain Organoids Containing Long-Lived Dopaminergic
   Neurons
SO STEM CELLS AND DEVELOPMENT
LA English
DT Article
ID EMBRYONIC STEM-CELLS; IN-VITRO; NEURAL DIFFERENTIATION;
   PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; NERVOUS-SYSTEM; HUMAN ES;
   SURVIVAL; TISSUE; CULTURE
AB The possibility to generate dopaminergic (DA) neurons from pluripotent stem cells represents an unlimited source of material for tissue engineering and cell therapy for neurodegenerative disease. We set up a protocol based on the generation of size-calibrated neurospheres for a rapid production (3 weeks) of a high amount of DA neurons (>60%) oriented toward a midbrain-like phenotype, characterized by the expression of FOXA2, LMX1A, tyrosine hydroxylase (TH), NURR1, and EN1. By using -secretase inhibitors and varying culture time of neurospheres, we controlled maturation and cellular composition of a three-dimensional (3D) engineered nervous tissue (ENT). ENT contained neurons and glial cells expressing various markers of maturity, such as synaptophysin, neuronal nuclei-specific protein (NeuN), and glial fibrillary acidic protein (GFAP), and were electrophysiologically active. We found that 3-week-old neurospheres were optimal to generate 3D tissue containing DA neurons with typical A9 morphology. ENT generated from 4-week-old neurospheres launched glial cell type since astrocytes and myelin could be detected massively at the expense of TH-immunoreactive neurons. All -secretase inhibitors were not equivalent; compound E was more efficient than DAPT in generating DA neurons. This DA tissue provides a tool for drug screening, and toxicology. It should also become a useful biomaterial for studies on Parkinson's disease.
C1 [Tieng, Vannary; Dubois-Dauphin, Michel; Krause, Karl-Heinz] Univ Geneva, Univ Med Ctr, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland.
   [Stoppini, Luc] Univ Appl Sci Western Switzerland, Hepia, Geneva, Switzerland.
   [Stoppini, Luc] Swiss Ctr Appl Toxicol SCAHT, Geneva, Switzerland.
   [Villy, Sabrina; Fathi, Marc; Krause, Karl-Heinz] Geneva Hosp, Dept Genet & Lab Med, Geneva, Switzerland.
RP Tieng, V (reprint author), Univ Geneva, Univ Med Ctr, Dept Pathol & Immunol, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.
EM vannary.tiengcaulet@unige.ch
RI Krause, Karl-Heinz/E-8030-2011
FU Fonds National de la Recherche Suisse (FNRS; Prometheus consortium,
   Sinergia project); Clayton Foundation; Carigest SA
FX The authors thank Fonds National de la Recherche Suisse (FNRS;
   Prometheus consortium, Sinergia project), Clayton Foundation, Carigest
   SA, for financial support. The authors also thank Olivier Brun and
   Francois Prodon (Faculty of Medicine, Geneva) for their help in confocal
   microscopy and image J analysis, respectively; Outi Hovatta from
   Karolinska Institute, Stockholm, Sweden, for providing human ES cell
   line HS415; and Tomo Saric from University of Cologne, Germany, for
   providing iPSC line NP0026.
CR Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533
   Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183
   Bedard C, 2011, PARKINSONISM RELAT D, V17, P593, DOI 10.1016/j.parkreldis.2011.05.012
   Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874
   Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408
   Borkenhagen M, 1998, J BIOMED MATER RES, V40, P392, DOI 10.1002/(SICI)1097-4636(19980603)40:3<392::AID-JBM8>3.0.CO;2-C
   Bratt-Leal AM, 2009, BIOTECHNOL PROGR, V25, P43, DOI [10.1021/bp.139, 10.1002/btpr.139]
   Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915
   Brito C, 2012, METHODS, V56, P452, DOI 10.1016/j.ymeth.2012.03.005
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   CHOI HK, 1993, J NEUROSCI METH, V46, P233, DOI 10.1016/0165-0270(93)90072-Y
   Chung S, 2011, P NATL ACAD SCI USA, V108, P9703, DOI 10.1073/pnas.1016443108
   Debernard KAB, 2012, NEUROCHEM INT, V61, P79, DOI 10.1016/j.neuint.2012.04.002
   Dewitt DD, 2009, TISSUE ENG PT A, V15, P2785, DOI [10.1089/ten.tea.2008.0406, 10.1089/ten.TEA.2008.0406]
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   Dottori Mirella, 2008, V438, P19, DOI 10.1007/978-1-59745-133-8_3
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dubois-Dauphin ML, 2010, BIOMATERIALS, V31, P7032, DOI 10.1016/j.biomaterials.2010.06.017
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   FAWCETT JW, 1995, EXP BRAIN RES, V106, P275
   Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev000141
   Finkelstein DI, 2000, NEUROSCIENCE, V97, P99, DOI 10.1016/S0306-4522(00)00009-9
   Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065
   Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106
   Garcia-Yague AJ, 2013, J BIOL CHEM, V288, P5506, DOI 10.1074/jbc.M112.439190
   Kirkeby Agnete, 2012, Front Cell Neurosci, V6, P64, DOI 10.3389/fncel.2012.00064
   Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648
   Kung L, 1998, J COMP NEUROL, V390, P52, DOI 10.1002/(SICI)1096-9861(19980105)390:1<52::AID-CNE5>3.0.CO;2-P
   MADISON R, 1985, EXP NEUROL, V88, P767, DOI 10.1016/0014-4886(85)90087-1
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Nakatani T, 2010, DEV BIOL, V339, P101, DOI 10.1016/j.ydbio.2009.12.017
   O'Connor SM, 2000, J NEUROSCI METH, V102, P187, DOI 10.1016/S0165-0270(00)00303-4
   Ogura A, 2013, STEM CELLS DEV, V22, P374, DOI 10.1089/scd.2012.0198
   Oishi K, 2004, DEV BIOL, V276, P172, DOI 10.1016/j.ydbio.2004.08.039
   Ojeda V, 2003, J NEUROSCI RES, V73, P686, DOI 10.1002/jnr.10705
   Orlacchio A, 2010, CURR MED CHEM, V17, P595, DOI 10.2174/092986710790416272
   Oya S, 2009, NEUROSCIENCE, V158, P683, DOI 10.1016/j.neuroscience.2008.10.043
   Pardo B, 2000, J NEUROSCI RES, V59, P504, DOI 10.1002/(SICI)1097-4547(20000215)59:4<504::AID-JNR5>3.0.CO;2-N
   Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101
   Preynat-Seauve O, 2009, STEM CELLS, V27, P509, DOI 10.1634/stemcells.2008-0600
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565
   Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310
   Wells MR, 1997, EXP NEUROL, V146, P395, DOI 10.1006/exnr.1997.6543
   Yang MS, 2011, BIOCHEM BIOPH RES CO, V404, P133, DOI 10.1016/j.bbrc.2010.11.080
   Zhang XQ, 2010, METHODS MOL BIOL, V584, P355, DOI 10.1007/978-1-60761-369-5_19
   Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504
NR 48
TC 21
Z9 21
U1 0
U2 25
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1547-3287
EI 1557-8534
J9 STEM CELLS DEV
JI Stem Cells Dev.
PD JUL 1
PY 2014
VL 23
IS 13
BP 1535
EP 1547
DI 10.1089/scd.2013.0442
PG 13
WC Cell & Tissue Engineering; Hematology; Medicine, Research &
   Experimental; Transplantation
SC Cell Biology; Hematology; Research & Experimental Medicine;
   Transplantation
GA AJ8LK
UT WOS:000337955400010
PM 24576173
DA 2018-10-20
ER

PT J
AU Tagler, D
   Makanji, Y
   Tu, T
   Bernabe, BP
   Lee, R
   Zhu, J
   Kniazeva, E
   Hornick, JE
   Woodruff, TK
   Shea, LD
AF Tagler, David
   Makanji, Yogeshwar
   Tu, Tao
   Bernabe, Beatriz Penalver
   Lee, Raymond
   Zhu, Jie
   Kniazeva, Ekaterina
   Hornick, Jessica E.
   Woodruff, Teresa K.
   Shea, Lonnie D.
TI Promoting extracellular matrix remodeling via ascorbic acid enhances the
   survival of primary ovarian follicles encapsulated in alginate hydrogels
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE tissue engineering; regenerative medicine; ovarian follicle development;
   primary follicle; ascorbic acid; extracellular matrix; biomaterial;
   alginate hydrogel
ID DEVELOPMENT IN-VITRO; MARMOSET CALLITHRIX-JACCHUS; BOVINE PREANTRAL
   FOLLICLES; FREE CULTURE-SYSTEM; PRIMORDIAL FOLLICLES;
   STIMULATING-HORMONE; 3-DIMENSIONAL CULTURE; OXIDATIVE STRESS; MOUSE
   OOCYTES; DEVELOPMENTAL COMPETENCE
AB The in vitro growth of ovarian follicles is an emerging technology for fertility preservation. Various strategies support the culture of secondary and multilayer follicles from various species including mice, non-human primate, and human; however, the culture of early stage (primary and primordial) follicles, which are more abundant in the ovary and survive cryopreservation, has been limited. Hydrogel-encapsulating follicle culture systems that employed feeder cells, such as mouse embryonic fibroblasts (MEFs), stimulated the growth of primary follicles (70-80 mu m); yet, survival was low and smaller follicles (<70 mu m) rapidly lost structure and degenerated. These morphologic changes were associated with a breakdown of the follicular basement membrane; hence, this study investigated ascorbic acid based on its role in extracellular matrix (ECM) deposition/remodeling for other applications. The selection of ascorbic acid was further supported by a microarray analysis that suggested a decrease in mRNA levels of enzymes within the ascorbate pathway between primordial, primary, and secondary follicles. The supplementation of ascorbic acid (50 mu g/mL) significantly enhanced the survival of primary follicles (<80 mu m) cultured in alginate hydrogels, which coincided with improved structural integrity. Follicles developed antral cavities and increased to diameters exceeding 250 mu m. Consistent with improved structural integrity, the gene/protein expression of ECM and cell adhesion molecules was significantly changed. This research supports the notion that modifying the culture environment (medium components) can substantially enhance the survival and growth of early stage follicles. Biotechnol. Bioeng. 2014;111: 1417-1429. (c) 2013 Wiley Periodicals, Inc.
C1 [Tagler, David; Tu, Tao; Bernabe, Beatriz Penalver; Kniazeva, Ekaterina; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, McCormick Sch Engn, Technol Inst E136, Evanston, IL 60208 USA.
   [Tagler, David; Tu, Tao; Bernabe, Beatriz Penalver; Kniazeva, Ekaterina; Shea, Lonnie D.] Northwestern Univ, Inst BioNanotechnol Med IBNAM, Chicago, IL 60611 USA.
   [Makanji, Yogeshwar; Lee, Raymond; Zhu, Jie; Hornick, Jessica E.; Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Makanji, Yogeshwar; Lee, Raymond; Zhu, Jie; Hornick, Jessica E.; Woodruff, Teresa K.; Shea, Lonnie D.] Northwestern Univ, CRS, Evanston, IL 60208 USA.
   [Makanji, Yogeshwar; Lee, Raymond; Zhu, Jie; Hornick, Jessica E.; Woodruff, Teresa K.; Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
   [Woodruff, Teresa K.; Shea, Lonnie D.] Northwestern Univ, Chem Life Proc Inst CLP, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, McCormick Sch Engn, Technol Inst E136, 2145 Sheridan Rd, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
OI Woodruff, Teresa/0000-0002-1197-3399
FU National Institutes of Health (NIH) [PL1EB008542]; Eunice Kennedy
   Shriver National Institute of Child Health and Human Development (NICHD)
   [U54HD41857, U54HD076188]; National Health and Medical Research Council
   (NHMRC; Australia) [GNT1016460]; Northwestern University
FX Contract grant sponsor: National Institutes of Health (NIH); Contract
   grant number: PL1EB008542; Contract grant sponsor: Eunice Kennedy
   Shriver National Institute of Child Health and Human Development
   (NICHD); Grant numbers: U54HD41857; U54HD076188; Contract grant sponsor:
   National Health and Medical Research Council (NHMRC; Australia);
   Contract grant number: GNT1016460; Contract grant sponsor: Northwestern
   University
CR Abir R, 1999, HUM REPROD, V14, P1299, DOI 10.1093/humrep/14.5.1299
   Abir R, 2006, HISTOL HISTOPATHOL, V21, P887, DOI 10.14670/HH-21.887
   Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Berkholtz CB, 2006, HISTOCHEM CELL BIOL, V126, P583, DOI 10.1007/s00418-006-0194-1
   Berkholtz CB, 2006, SEMIN REPROD MED, V24, P262, DOI 10.1055/s-2006-948575
   BLASCHUK OW, 1989, DEV BIOL, V136, P564, DOI 10.1016/0012-1606(89)90283-2
   Carabatsos MJ, 2000, DEV BIOL, V226, P167, DOI 10.1006/dbio.2000.9863
   Dalvit G, 2005, REPROD DOMEST ANIM, V40, P93, DOI 10.1111/j.1439-0531.2004.00522.x
   Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224
   Duleba AJ, 2004, HUM REPROD, V19, P1519, DOI 10.1093/humrep/deh299
   Durlinger ALL, 2001, ENDOCRINOLOGY, V142, P4891, DOI 10.1210/en.142.11.4891
   Eppig JJ, 1998, BIOL REPROD, V59, P1445, DOI 10.1095/biolreprod59.6.1445
   Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197
   EPPIG JJ, 1977, DEV BIOL, V60, P371, DOI 10.1016/0012-1606(77)90135-X
   Eppig JJ, 2000, MOL CELL ENDOCRINOL, V163, P109, DOI 10.1016/S0303-7207(99)00247-6
   Giebel J, 1996, TISSUE CELL, V28, P379, DOI 10.1016/S0040-8166(96)80024-3
   Giebel J, 1997, TISSUE CELL, V29, P525, DOI 10.1016/S0040-8166(97)80053-5
   Hornick JE, 2013, REPRODUCTION, V145, P19, DOI 10.1530/REP-12-0233
   Hornick JE, 2012, HUM REPROD, V27, P1801, DOI 10.1093/humrep/der468
   Hulmes DJS, 1992, ESSAYS BIOCHEM, V27, P49
   Irving-Rodgers HF, 2006, SEMIN REPROD MED, V24, P195, DOI 10.1055/s-2006-948549
   Itoh Takehiro, 2000, In Vitro Cellular and Developmental Biology Animal, V36, P235, DOI 10.1290/1071-2690(2000)036<0235:EIALTV>2.3.CO;2
   Jin SY, 2010, FERTIL STERIL, V93, P2633, DOI 10.1016/j.fertnstert.2009.10.027
   Kim SS, 2004, FERTIL STERIL, V82, P679, DOI 10.1016/j.fertnstert.2004.05.022
   Kreeger PK, 2006, BIOMATERIALS, V27, P714, DOI 10.1016/j.biomaterials.2005.06.016
   Kreeger PK, 2005, BIOL REPROD, V73, P942, DOI 10.1095/biolreprod.105.042390
   Lenie S, 2004, BIOL REPROD, V71, P1730, DOI 10.1095/biolreprod.104.028415
   Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LUCK MR, 1995, BIOL REPROD, V52, P262, DOI 10.1095/biolreprod52.2.262
   Machell NH, 2000, BIOL REPROD, V63, P797, DOI 10.1095/biolreprod63.3.797
   Mackay S, 1999, ANAT EMBRYOL, V200, P91, DOI 10.1007/s004290050263
   Mao JD, 2002, BIOL REPROD, V67, P1197, DOI 10.1095/biolreprod.102.003152
   McLaughlin M, 2010, REPRODUCTION, V139, P971, DOI 10.1530/REP-10-0025
   Meirow D, 2008, HUM REPROD, V23, P1007, DOI 10.1093/humrep/den055
   MEISTER A, 1994, J BIOL CHEM, V269, P9397
   Murray AA, 2001, REPRODUCTION, V121, P89, DOI 10.1530/rep.0.1210089
   Muruvi W, 2005, THERIOGENOLOGY, V64, P1357, DOI 10.1016/j.theriogenology.2005.02.010
   Muruvi W, 2009, ANIM REPROD SCI, V112, P36, DOI 10.1016/j.anireprosci.2008.04.001
   Nation A, 2009, REPRODUCTION, V138, P247, DOI 10.1530/REP-09-0028
   Nayudu PL, 2003, REPROD DOMEST ANIM, V38, P90, DOI 10.1046/j.1439-0531.2003.00398.x
   NAYUDU PL, 1992, J REPROD FERTIL, V95, P349
   Nilsson EE, 2002, MOL CELL ENDOCRINOL, V188, P65, DOI 10.1016/S0303-7207(01)00746-8
   Nugent D, 1998, J REPROD FERTIL, V114, P341
   O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029
   Olson SE, 2000, BIOL REPROD, V62, P248, DOI 10.1095/biolreprod62.2.248
   ONO M, 1990, EXP CELL RES, V187, P309, DOI 10.1016/0014-4827(90)90096-S
   Pangas SA, 2003, TISSUE ENG, V9, P1013, DOI 10.1089/107632703322495655
   Parrish EM, 2011, REPRODUCTION, V142, P309, DOI 10.1530/REP-10-0481
   Picton HM, 2008, REPRODUCTION, V136, P703, DOI 10.1530/REP-08-0290
   PINNELL SR, 1985, YALE J BIOL MED, V58, P553
   Rodgers HF, 1998, BIOL REPROD, V59, P1334, DOI 10.1095/biolreprod59.6.1334
   Rodgers RJ, 2003, REPRODUCTION, V126, P415, DOI 10.1530/rep.0.1260415
   Rose UM, 1999, BIOL REPROD, V61, P503, DOI 10.1095/biolreprod61.2.503
   Rossetto R, 2009, DOMEST ANIM ENDOCRIN, V37, P112, DOI 10.1016/j.domaniend.2009.04.003
   Saha S, 2000, ANIM REPROD SCI, V63, P27, DOI 10.1016/S0378-4320(00)00162-7
   Shaw J, 1997, HUM REPROD, V12, P403
   Shikanov A, 2009, BIOMATERIALS, V30, P5476, DOI 10.1016/j.biomaterials.2009.06.054
   Skory RM, 2013, MOL REPROD DEV, V80, P132, DOI 10.1002/mrd.22144
   Smith MF, 2002, MOL CELL ENDOCRINOL, V191, P45, DOI 10.1016/S0303-7207(02)00054-0
   Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027
   Tagler D, 2013, BIOTECHNOL BIOENG, V110, P3258, DOI 10.1002/bit.24986
   Tagler D, 2012, TISSUE ENG PT A, V18, P1229, DOI [10.1089/ten.TEA.2011.0418, 10.1089/ten.tea.2011.0418]
   Tao Y, 2010, REPROD DOMEST ANIM, V45, P19, DOI 10.1111/j.1439-0531.2008.01129.x
   Telfer EE, 2008, HUM REPROD, V23, P1151, DOI 10.1093/humrep/den070
   Thomas FH, 2001, REPRODUCTION, V122, P487, DOI 10.1530/rep.0.1220487
   TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242
   Tingen CM, 2011, REPRODUCTION, V141, P809, DOI 10.1530/REP-10-0483
   TORRANCE C, 1989, J REPROD FERTIL, V87, P367
   Vitt UA, 1998, BIOL REPROD, V59, P854, DOI 10.1095/biolreprod59.4.854
   Wang C, 2010, ENDOCRINOLOGY, V151, P2319, DOI 10.1210/en.2009-1489
   Wang X, 2002, FERTIL STERIL, V78, P1272, DOI 10.1016/S0015-0282(02)04236-X
   Wehrenberg U, 2000, MOL HUM REPROD, V6, P504, DOI 10.1093/molehr/6.6.504
   West ER, 2007, BIOMATERIALS, V28, P4439, DOI 10.1016/j.biomaterials.2007.07.001
   Woodruff Teresa K., 2007, V138, P3
   Woodruff Teresa K, 2007, Reprod Sci, V14, P6, DOI 10.1177/1933719107309818
   Woodruff TK, 2010, NAT REV CLIN ONCOL, V7, P466, DOI 10.1038/nrclinonc.2010.81
   Woodruff TK, 2007, ONCOFERTILITY FERTIL
   Wu J, 2001, BIOL REPROD, V64, P375, DOI 10.1095/biolreprod64.1.375
   Xu J, 2013, HUM REPROD, V28, P2187, DOI 10.1093/humrep/det093
   Xu J, 2011, HUM REPROD, V26, P1061, DOI 10.1093/humrep/der049
   Xu M, 2006, TISSUE ENG, V12, P2739, DOI 10.1089/ten.2006.12.2739
   Xu M, 2006, BIOL REPROD, V75, P916, DOI 10.1095/biolreprod.106.054833
   Xu M, 2009, BIOL REPROD, V81, P587, DOI 10.1095/biolreprod.108.074732
   Xu M, 2009, HUM REPROD, V24, P2531, DOI 10.1093/humrep/dep228
   Yamada S, 1999, MOL HUM REPROD, V5, P607, DOI 10.1093/molehr/5.7.607
NR 87
TC 14
Z9 14
U1 2
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUL
PY 2014
VL 111
IS 7
BP 1417
EP 1429
DI 10.1002/bit.25181
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AJ3PU
UT WOS:000337580000015
PM 24375265
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Grotenhuis, N
   Toom, HFEV
   Kops, N
   Bayon, Y
   Deerenberg, EB
   Mulder, IM
   van Osch, GJVM
   Lange, JF
   Bastiaansen-Jenniskens, YM
AF Grotenhuis, N.
   Toom, H. F. E. Vd
   Kops, N.
   Bayon, Y.
   Deerenberg, E. B.
   Mulder, I. M.
   van Osch, G. J. V. M.
   Lange, J. F.
   Bastiaansen-Jenniskens, Y. M.
TI In vitro model to study the biomaterial-dependent reaction of
   macrophages in an inflammatory environment
SO BRITISH JOURNAL OF SURGERY
LA English
DT Article
ID VENTRAL HERNIA REPAIR; ABDOMINAL-WALL; BIOLOGICAL MESHES; SURGICAL
   MESHES; TISSUE REACTION; POLARIZATION; ACTIVATION
AB Background: Macrophages play an important role in the reaction to biomaterials, which sometimes have to be used in a surgical field at risk of contamination. The macrophage phenotype in reaction to biomaterials in an inflammatory environment was evaluated in both an in vivo and in vitro setting.
   Methods: In the in vivo setting, polypropylene (PP) biomaterial was implanted for 28 days in the contaminated abdominal wall of rats, and upon removal analysed by routine histology as well as immunohistochemistry for CD68 (marker for macrophages), inducible nitric oxide synthase (iNOS - a marker for proinflammatory M1 macrophages) and CD206 (marker for anti-inflammatory M2 macrophages). For the in vitro model, human peripheral blood monocytes were cultured for 3 days on biomaterials made from PP, collagen (COL), polyethylene terephthalate (PET) and PET coated with collagen (PET+COL). These experiments were performed both with and without lipopolysaccharide and interferon gamma stimulation. Secretion of both M1- and M2-related proteins was measured, and a relative M1/M2 index was calculated.
   Results: In vivo, iNOS-and CD206-positive cells were found around the fibres of the implanted PP biomaterial. In vitro, macrophages on both PP and COL biomaterial had a relatively low M1/M2 index. Macrophages on the PET biomaterial had a high M1/M2 index, with the highest increase of M1 cytokines in an inflammatory environment. Macrophages on the PET+COL biomaterial also had a high M1/M2 index.
   Conclusion: Macrophages in an inflammatory environment in vitro still react in a biomaterial-dependent manner. This model can help to select biomaterials that are tolerated best in a surgical environment at risk of contamination.
C1 [Grotenhuis, N.; Toom, H. F. E. Vd; van Osch, G. J. V. M.] Erasmus MC Univ Med Ctr Rotterdam, Dept Otorhinolaryngol, NL-3015 GE Rotterdam, Netherlands.
   [Grotenhuis, N.; Deerenberg, E. B.; Mulder, I. M.; Lange, J. F.] Erasmus MC Univ Med Ctr Rotterdam, Dept Gen Surg, NL-3015 GE Rotterdam, Netherlands.
   [Kops, N.; van Osch, G. J. V. M.; Bastiaansen-Jenniskens, Y. M.] Erasmus MC Univ Med Ctr Rotterdam, Dept Orthopaed, NL-3015 GE Rotterdam, Netherlands.
   [Bayon, Y.] Covidien Sofradim Prod, Trevoux, France.
RP Bastiaansen-Jenniskens, YM (reprint author), Erasmus MC Univ Med Ctr Rotterdam, Dept Orthopaed Ee1618c, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.
EM y.bastiaansen@erasmusmc.nl
OI Bastiaansen-Jenniskens, Yvonne/0000-0002-2921-1237
FU Dutch Technology Foundation STW; Covidien; Dutch Arthritis Association
   [LLP11]
FX Y.M.B.-J. is supported by a Veni fellowship from the Dutch Technology
   Foundation STW. This study was supported financially by Covidien and the
   Dutch Arthritis Association (no. LLP11). None of these supporters was
   involved in the design, conduct or analysis of the study. Y.B. is an
   employee of Covidien, but was not restricted in any way.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Burger JWA, 2006, SURG ENDOSC, V20, P1320, DOI 10.1007/s00464-005-0706-4
   Cavallaro A, 2010, WORLD J GASTROENTERO, V16, P1928, DOI 10.3748/wjg.v16.i15.1928
   DABROWIECKI S, 1991, EUR SURG RES, V23, P240, DOI 10.1159/000129159
   Deeken CR, 2012, SURG ENDOSC, V26, P566, DOI 10.1007/s00464-011-1899-3
   Deerenberg EB, 2012, BRIT J SURG, V99, P1734, DOI 10.1002/bjs.8954
   Engelsman AF, 2008, BRIT J SURG, V95, P1051, DOI 10.1002/bjs.6154
   Engelsman AF, 2010, ANN SURG, V251, P133, DOI 10.1097/SLA.0b013e3181b61d9a
   Grotenhuis N, 2013, BIOCHEM BIOPH RES CO, V433, P115, DOI 10.1016/j.bbrc.2013.02.054
   Hiles M, 2009, SURG INNOV, V16, P26, DOI 10.1177/1553350609331397
   Kaleya Ronald N, 2005, Hernia, V9, P269, DOI 10.1007/s10029-005-0003-0
   Kubota K, 2010, SCAND J IMMUNOL, V71, P199, DOI 10.1111/j.1365-3083.2009.02366.x
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   Mayer A, 2011, CLIN HEMORHEOL MICRO, V48, P57, DOI 10.3233/CH-2011-1395
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Orenstein SB, 2012, J SURG RES, V176, P423, DOI 10.1016/j.jss.2011.09.031
   Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC
   Primus FE, 2013, HERNIA, V17, P21, DOI 10.1007/s10029-012-1037-8
   Schreinemacher MHF, 2009, BRIT J SURG, V96, P305, DOI 10.1002/bjs.6446
   Smart NJ, 2012, SURG-J R COLL SURG E, V10, P159, DOI 10.1016/j.surge.2012.02.006
   Tomida M, 2011, EUR J MED RES, V16, P249, DOI 10.1186/2047-783X-16-6-249
NR 27
TC 15
Z9 16
U1 3
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1323
EI 1365-2168
J9 BRIT J SURG
JI Br. J. Surg.
PD JUL
PY 2014
VL 101
IS 8
BP 983
EP 992
DI 10.1002/bjs.9523
PG 10
WC Surgery
SC Surgery
GA AJ4ZY
UT WOS:000337690800012
PM 24838620
DA 2018-10-20
ER

PT J
AU Buizer, AT
   Veldhuizen, AG
   Bulstra, SK
   Kuijer, R
AF Buizer, Arina T.
   Veldhuizen, Albert G.
   Bulstra, Sjoerd K.
   Kuijer, Roel
TI Static versus vacuum cell seeding on high and low porosity ceramic
   scaffolds
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Cell seeding; porous; porosity; beta-tricalcium phosphate; mesenchymal
   stem cells; bone regeneration; cell culture techniques
ID BETA-TRICALCIUM PHOSPHATE; BONE-GRAFT SUBSTITUTES; MARROW STROMAL CELLS;
   IN-VITRO; BIODEGRADABLE SCAFFOLDS; POROUS SCAFFOLDS; STEM-CELLS; VIVO;
   OSTEOGENESIS; BIOCERAMICS
AB An adequate cell seeding technique is essential for effective bone regeneration on cell seeded constructs of porous tricalcium phosphates. In previous studies, dynamic cell seeding, in which an external force is applied to seed cells on a biomaterial, resulted in more homogeneous cell seeding in low porosity scaffolds than static seeding. The optimal cell seeding technique for high porosity scaffolds has not been defined yet. Human mesenchymal stem cells were isolated from bone marrow and characterized. The cells were seeded on low porosity (45%) and high porosity (90%) tricalcium phosphate scaffolds using a static and a vacuum seeding technique. LIVE/DEAD (R) staining of the cell-scaffold complexes followed by confocal laser scanning microscopy was used to measure cell proliferation, cell distribution and cell viability one, three and seven days after seeding. Cell proliferation was also quantified using a DNA quantification assay. Neither static nor vacuum seeding resulted in homogeneous cell seeding on both low and high porosity scaffolds. Cell density was lower on the inside than on the outside of the scaffolds. On low porosity scaffolds, the vacuum method yielded the highest numbers of cells compared to the static method. Low porosity scaffolds were seeded most homogeneously using the static seeding method. Seven days after seeding, numbers of adherent cells were comparable for both scaffold types and independent of the cell seeding technique used. In conclusion, on high porosity scaffolds, static seeding results in more homogeneous cell seeding and it is easier to use than a vacuum seeding technique.
C1 [Buizer, Arina T.; Veldhuizen, Albert G.; Bulstra, Sjoerd K.] Univ Groningen, Univ Med Ctr Groningen, Dept Orthopaed Surg, NL-9700 AD Groningen, Netherlands.
   [Buizer, Arina T.; Kuijer, Roel] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
RP Kuijer, R (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, FB 40,POB 196, NL-9700 AD Groningen, Netherlands.
EM r.kuijer@umcg.nl
RI Kuijer, Roel/A-6690-2015
OI Kuijer, Roel/0000-0002-7637-4944
FU Stichting voor Technische Wetenschappen (STW, Utrecht, the Netherlands)
   [10595]
FX This research project was founded by Stichting voor Technische
   Wetenschappen (STW, Utrecht, the Netherlands), grant number 10595.
CR BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barrere F, 2006, INT J NANOMED, V1, P317
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Epstein NE, 2009, SPINE J, V9, P630, DOI [10.1016/j.spinee.2008.03.009, 10.1016/j.spinee.2009.04.007]
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Galois L, 2002, INT ORTHOP, V26, P109, DOI 10.1007/s00264-001-0329-x
   Galois L, 2001, FOOT ANKLE SURG, V7, P217
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Hasegawa T, 2010, J DENT RES, V89, P854, DOI 10.1177/0022034510370022
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Kwon Brian, 2005, Spine J, V5, p224S, DOI 10.1016/j.spinee.2005.02.007
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mandoli C, 2010, MACROMOL BIOSCI, V10, P127, DOI 10.1002/mabi.200900323
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Melchels FPW, 2011, BIOMATERIALS, V32, P2878, DOI 10.1016/j.biomaterials.2011.01.023
   Muschler GF, 2003, J BIOMED BIOTECHNOL, P170
   Piccinini E, 2010, EUR CELLS MATER, V20, P38
   Roh JD, 2007, TISSUE ENG, V13, P2743, DOI 10.1089/ten.2007.0171
   Saragaglia D, 2011, INT ORTHOP, V35, P1151, DOI 10.1007/s00264-010-1102-9
   Solchaga LA, 2006, TISSUE ENG, V12, P1851, DOI 10.1089/ten.2006.12.1851
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tan LJ, 2012, J BIOMATER APPL, V26, P877, DOI 10.1177/0885328210389504
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Wang YC, 2003, TISSUE ENG, V9, P1205, DOI 10.1089/10763270360728116
   Wang Z, 2013, J SPINAL DISORD TECH, V26, pE40, DOI 10.1097/BSD.0b013e31823db5e6
   Wendt D, 2003, BIOTECHNOL BIOENG, V84, P205, DOI 10.1002/bit.10759
   Yoshii T, 2009, J ORTHOP RES, V27, P1, DOI 10.1002/jor.20630
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Zhou YF, 2006, J BIOMED MATER RES A, V78A, P183, DOI 10.1002/jbm.a.30685
NR 33
TC 8
Z9 8
U1 1
U2 19
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2014
VL 29
IS 1
BP 3
EP 13
DI 10.1177/0885328213512171
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ3JQ
UT WOS:000337562800001
PM 24327348
DA 2018-10-20
ER

PT J
AU Poranki, D
   Whitener, W
   Howse, S
   Mesen, T
   Howse, E
   Burnell, J
   Greengauz-Roberts, O
   Molnar, J
   Van Dyke, M
AF Poranki, D.
   Whitener, W.
   Howse, S.
   Mesen, T.
   Howse, E.
   Burnell, J.
   Greengauz-Roberts, O.
   Molnar, J.
   Van Dyke, M.
TI Evaluation of skin regeneration after burns in vivo and rescue of cells
   after thermal stress in vitro following treatment with a keratin
   biomaterial
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Keratin; burn; wound; heat shock; hydrogel; skin
ID PARTIAL-THICKNESS BURNS; EPIDERMAL-GROWTH-FACTOR; HUMAN HAIR;
   EXTRACELLULAR-MATRIX; OUTPATIENT MANAGEMENT; CHITOSAN HYDROGEL; GEL
   FORMULATION; OVINE MODEL; ALGINATE; COLLAGEN
AB Thermal burns typically display an injury pattern dictated by the transfer of the thermal energy into the skin and underlying tissues and creation of three zones of injury represented by a necrotic zone of disrupted cells and tissue, an intermediate zone of injured and dying cells, and a distant zone of stressed cells that will recover with proper treatment. The wound healing capabilities of a keratin biomaterial hydrogel were studied in two pilot studies, one using a chemical burn model in mice and the other a thermal burn model in swine. In both studies, keratin was shown to prevent enlargement of the initial wound area and promote faster wound closure. Interestingly, treating thermally stressed dermal fibroblast in culture demonstrated that soluble keratin was able to maintain cell viability and promote proliferation. Separation of so-called alpha and gamma fractions of the keratin biomaterial had differential effects, with the gamma fraction producing more pronounced cell survival and recovery. These results suggest that the gamma fraction, composed essentially of degraded alpha keratin proteins, may facilitate cell rescue after thermal injury. Treatment of burns with gamma keratin may therefore represent a potential therapy for wounds with an intermediate zone of damaged tissue that has the potential to contribute to spontaneous healing.
C1 [Poranki, D.; Whitener, W.; Howse, S.; Mesen, T.; Howse, E.; Burnell, J.; Greengauz-Roberts, O.] Wake Forest Inst Regenerat Med, Wake Forest Sch Med, Winston Salem, NC USA.
   [Molnar, J.] Wake Forest Sch Med, Dept Plast & Reconstruct Surg, Winston Salem, NC USA.
   [Van Dyke, M.] Wake Forest Sch Med, Dept Orthopaed Surg, Winston Salem, NC USA.
   [Van Dyke, M.] Virginia Tech, Wake Forest Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
RP Van Dyke, M (reprint author), Virginia Tech, Wake Forest Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
EM mvandyk5@vt.edu
FU Armed Forces Institute for Regenerative Medicine (DoD)
   [W81XWH-08-2-0032]; KeraNetics LLC.
FX This work is supported by the Armed Forces Institute for Regenerative
   Medicine (DoD Contract # W81XWH-08-2-0032) and KeraNetics LLC.
CR Adhirajan N, 2009, J PHARM PHARMACOL, V61, P1617, DOI 10.1211/jpp/61.12.0005
   Agren MS, 1996, BRIT J PLAST SURG, V49, P129, DOI 10.1016/S0007-1226(96)90088-0
   Alemdaroglu C, 2006, BURNS, V32, P319, DOI 10.1016/j.burns.2005.10.015
   Alsarra IA, 2009, INT J BIOL MACROMOL, V45, P16, DOI 10.1016/j.ijbiomac.2009.03.010
   Alvarez O, 1988, Ostomy Wound Manage, V21, P64
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   BARNETT SE, 1987, ANN ROY COLL SURG, V69, P153
   Barthelemy NR, 2012, ANAL BIOCHEM, V421, P43, DOI 10.1016/j.ab.2011.10.011
   Belcarz A, 2009, J BIOMED MATER RES B, V89B, P102, DOI 10.1002/jbm.b.31192
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   Bryan J, 2004, J Wound Care, V13, P227
   BUCHANAN JH, 1977, BIOCHEM J, V167, P489, DOI 10.1042/bj1670489
   Chang H, 1996, Dermatol Nurs, V8, P174
   Choi JS, 2010, J BIOMED MATER RES A, V95A, P564, DOI 10.1002/jbm.a.32848
   CREWTHER W. G. R. D. B. FRASER, 1965, ADVANCE PROTEIN CHEM, V20, P191, DOI 10.1016/S0065-3233(08)60390-3
   Dai TH, 2009, ANTIMICROB AGENTS CH, V53, P393, DOI 10.1128/AAC.00760-08
   Dantas MDM, 2011, J PHOTOCH PHOTOBIO B, V105, P51, DOI 10.1016/j.jphotobiol.2011.06.009
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   Degim Z, 2011, INT WOUND J, V8, P343, DOI 10.1111/j.1742-481X.2011.00795.x
   Dias GJ, 2010, J BIOMED MATER RES A, V95A, P1084, DOI 10.1002/jbm.a.32908
   Dias GJ, 2010, J BIOMED MATER RES A, V92A, P513, DOI 10.1002/jbm.a.32394
   do Nascimento EG, 2009, ACTA CIR BRAS, V24, P460, DOI 10.1590/S0102-86502009000600007
   Edwards J, 2010, BR J NURS, V19, pS4
   Edwards Jacky, 2010, Br J Nurs, V19, pS14
   Herndon David N., 2007, TOTAL BURN CARE
   Hill PS, 2011, TISSUE ENG PT A, V17, P1499, DOI 10.1089/ten.tea.2010.0184
   Honma I, 2009, CANCER IMMUNOL IMMUN, V58, P1803, DOI 10.1007/s00262-009-0691-x
   Horch RE, 1998, SCAND J PLAST RECONS, V32, P407, DOI 10.1080/02844319850158499
   Huang LY, 2011, ANTIMICROB AGENTS CH, V55, P3432, DOI 10.1128/AAC.01803-10
   Ishihara Masayuki, 2006, J Artif Organs, V9, P8, DOI 10.1007/s10047-005-0313-0
   JACKSON DM, 1953, BRIT J SURG, V40, P588, DOI 10.1002/bjs.18004016413
   Jin Y, 2007, BURNS, V33, P1027, DOI 10.1016/j.burns.2006.12.002
   Kammerlander Gerhard, 2003, Nurs Times, V99, P54
   Kondo S, 2012, J BIOMAT SCI-POLYM E, V23, P1729, DOI 10.1163/092050611X597799
   Landsman Adam, 2009, Clin Podiatr Med Surg, V26, P525, DOI 10.1016/j.cpm.2009.08.012
   Lee KY, 1998, J BIOMAT SCI-POLYM E, V9, P905, DOI 10.1163/156856298X00235
   Li DH, 2011, J NANOSCI NANOTECHNO, V11, P4733, DOI 10.1166/jnn.2011.4179
   Li F, 2004, ENDOTHELIUM-J ENDOTH, V11, P199, DOI 10.1080/10623320490512390
   Lu SY, 2008, BURNS, V34, P623, DOI 10.1016/j.burns.2007.08.020
   Muangman Pornprom, 2009, Journal of the Medical Association of Thailand, V92, P1300
   Neely Alice N., 1997, Wound Repair and Regeneration, V5, P302
   Nunes PS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/761593
   Nunez F, 2011, MICROCIRCULATION, V18, P663, DOI 10.1111/j.1549-8719.2011.00135.x
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Opasanon S, 2010, INT WOUND J, V7, P467, DOI 10.1111/j.1742-481X.2010.00718.x
   Papp A, 2004, BURNS, V30, P684, DOI 10.1016/j.burns.2004.03.021
   Park CH, 2004, J INVEST DERMATOL, V123, P1012, DOI 10.1111/j.0022-202X.2004.23487.x
   Pechter PM, 2012, WOUND REPAIR REGEN, V20, P236, DOI 10.1111/j.1524-475X.2012.00768.x
   PIACQUADIO D, 1992, J DERMATOL SURG ONC, V18, P992, DOI 10.1111/j.1524-4725.1992.tb02773.x
   Qin Yimin, 2005, Int Wound J, V2, P172, DOI 10.1111/j.1742-4801.2005.00101.x
   Reichl S, 2011, BIOMATERIALS, V32, P3375, DOI 10.1016/j.biomaterials.2011.01.052
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Ribeiro MP, 2009, WOUND REPAIR REGEN, V17, P817, DOI 10.1111/j.1524-475X.2009.00538.x
   Richter JR, 2011, BIOMATERIALS, V32, P7555, DOI 10.1016/j.biomaterials.2011.06.061
   Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X
   Saul JM, 2011, J BIOMED MATER RES A, V98A, P544, DOI 10.1002/jbm.a.33147
   Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161
   Sezer AD, 2008, BIOL PHARM BULL, V31, P2326, DOI 10.1248/bpb.31.2326
   Shen DL, 2011, BIOMATERIALS, V32, P9290, DOI 10.1016/j.biomaterials.2011.08.057
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Simsek S, 2011, ANN PLAS SURG, V67, P583, DOI 10.1097/SAP.0b013e31822af865
   Singer AJ, 2011, J BURN CARE RES, V32, P135, DOI 10.1097/BCR.0b013e318203337b
   Singh Onkar, 2011, J Cutan Aesthet Surg, V4, P12, DOI 10.4103/0974-2077.79180
   Suzuki Y, 1999, J BIOMED MATER RES, V48, P522, DOI 10.1002/(SICI)1097-4636(1999)48:4<522::AID-JBM18>3.0.CO;2-O
   Suzuki Y, 1998, J BIOMED MATER RES, V39, P317, DOI 10.1002/(SICI)1097-4636(199802)39:2<317::AID-JBM20>3.0.CO;2-8
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425
   Thilagar S, 2009, J BIOMED MATER RES B, V88B, P12, DOI 10.1002/jbm.b.31024
   Thomas S, 2008, INT WOUND J, V5, P602, DOI 10.1111/j.1742-481X.2008.00541.x
   Uygur F, 2008, BURNS, V34, P1011, DOI 10.1016/j.burns.2007.12.007
   Vloemans AFPM, 2003, BURNS, V29, P702, DOI 10.1016/S0305-4179(03)00161-X
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   Widra A, 1986, Patent, Patent No. [US 4570629, USA, 4570629]
   Williams C, 1998, Br J Nurs, V7, P975
   Williams C, 1998, Br J Nurs, V7, P550
   Williams C, 1999, Br J Nurs, V8, P313
   Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
NR 78
TC 22
Z9 23
U1 1
U2 25
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2014
VL 29
IS 1
BP 26
EP 35
DI 10.1177/0885328213513310
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ3JQ
UT WOS:000337562800003
PM 24272161
DA 2018-10-20
ER

PT J
AU Kido, HW
   Ribeiro, DA
   de Oliveira, P
   Parizotto, NA
   Camilo, CC
   Fortulan, CA
   Marcantonio, E
   da Silva, VHP
   Renno, ACM
AF Kido, Hueliton Wilian
   Ribeiro, Daniel Araki
   de Oliveira, Poliani
   Parizotto, Nivaldo Antonio
   Camilo, Claudia Cristiane
   Fortulan, Carlos Alberto
   Marcantonio, Elcio, Jr.
   Pereira da Silva, Victor Hugo
   Muniz Renno, Ana Claudia
TI Biocompatibility of a porous alumina ceramic scaffold coated with
   hydroxyapatite and bioglass
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE alumina; biocompatibility; DNA damage; bone repair
ID ALKALINE COMET ASSAY; IN-VITRO; MULTIPLE ORGANS; GLASS-CERAMICS; WISTAR
   RATS; BONE; CELLS; GENOTOXICITY
AB This study aimed to evaluate the osteointegration and genotoxic potential of a bioactive scaffold, composed of alumina and coated with hydroxyapatite and bioglass, after their implantation in tibias of rats. For this purpose, Wistar rats underwent surgery to induce a tibial bone defect, which was filled with the bioactive scaffolds. Histology analysis (descriptive and morphometry) of the bone tissue and the single-cell gel assay (comet) in multiple organs (blood, liver, and kidney) were used to reach this aim after a period of 30, 60, 90, and 180 days of material implantation. The main findings showed that the incorporation of hydroxyapatite and bioglass in the alumina scaffolds produced a suitable environment for bone ingrowth in the tibial defects and did not demonstrate any genotoxicity in the organs evaluated in all experimental periods. These results clearly indicate that the bioactive scaffolds used in this study present osteogenic potential and still exhibit local and systemic biocompatibility. These findings are promising once they convey important information about the behavior of this novel biomaterial in biological system and highlight its possible clinical application. (C) 2013 Wiley Periodicals, Inc.
C1 [Kido, Hueliton Wilian; de Oliveira, Poliani; Parizotto, Nivaldo Antonio] Fed Univ Sao Carlos UFSCar, Dept Physiotherapy, Postgrad Program Biotechnol, Sao Carlos, SP, Brazil.
   [Ribeiro, Daniel Araki; Pereira da Silva, Victor Hugo; Muniz Renno, Ana Claudia] Fed Univ Sao Paulo UNIFESP, Dept Biosci, Santos, SP, Brazil.
   [Camilo, Claudia Cristiane; Fortulan, Carlos Alberto] Univ Sao Paulo, Dept Mech Engn, Sao Carlos, SP, Brazil.
   [Marcantonio, Elcio, Jr.] Sao Paulo State Univ UNESP, Dept Dept Periodontol, Araraquara, SP, Brazil.
RP Renno, ACM (reprint author), Fed Univ Sao Paulo UNIFESP, Dept Biosci, Santos, SP, Brazil.
EM a.renno@unifesp.br
RI Parizotto, Nivaldo/D-5347-2014; Fortulan, Carlos/B-7138-2013; Kido,
   Hueliton/O-9970-2015; Renno, Ana Claudia/C-1266-2015
OI Parizotto, Nivaldo/0000-0003-1774-9053; Fortulan,
   Carlos/0000-0002-2259-9910; Kido, Hueliton/0000-0001-8554-432X;
   Marcantonio Junior, Elcio/0000-0003-1294-2305; Marcantonio Junior,
   Elcio/0000-0002-9660-4524
CR AULETTA A, 1988, ENVIRON MOL MUTAGEN, V11, P135, DOI 10.1002/em.2850110112
   Balasubramanyam A, 2009, MUTAGENESIS, V24, P245, DOI 10.1093/mutage/gep003
   Bose S, 2002, J MATER SCI-MATER M, V13, P23, DOI 10.1023/A:1013622216071
   Bossini PS, 2011, J TISSUE ENG REGEN M, V5, P229, DOI 10.1002/term.309
   Buzalaf MAR, 2006, B ENVIRON CONTAM TOX, V77, P700, DOI 10.1007/s00128-006-1119-3
   Camilo CC, 2009, KEY ENG MATER, V396-398, P679, DOI 10.4028/www.scientific.net/KEM.396-398.679
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Day RM, 2005, J BIOMED MATER RES A, V75A, P778, DOI 10.1002/jbm.a.30433
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   Dias AG, 2006, J BIOMATER APPL, V20, P253, DOI 10.1177/0885328206052466
   Granito RN, 2011, J BIOMED MATER RES B, V97B, P139, DOI 10.1002/jbm.b.31795
   Hartmann A, 2003, MUTAGENESIS, V18, P45, DOI 10.1093/mutage/18.1.45
   HEIMKE G, 1987, ADV CERAM MATER, V2, P764
   Hench L. L., 1993, INTRO BIOCERAMICS, P386
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   Le Nihouannen D, 2007, J MATER SCI-MATER M, V18, P225, DOI 10.1007/s10856-006-0684-7
   Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9
   Loty C, 2002, CONNECT TISSUE RES, V43, P524, DOI 10.1080/03008200290000619
   Meintieres S, 2003, ENVIRON MOL MUTAGEN, V41, P260, DOI 10.1002/em.10156
   Neira IS, 2010, ACS APPL MATER INTER, V2, P3276, DOI 10.1021/am100710b
   Piozzi R, 2009, J BIOMED MATER RES A, V88A, P342, DOI 10.1002/jbm.a.31876
   Reilly GC, 2007, BIOMATERIALS, V28, P4091, DOI 10.1016/j.biomaterials.2007.05.038
   RICCI JL, 1992, J ORAL MAXIL SURG, V50, P969, DOI 10.1016/0278-2391(92)90058-8
   Sarasin A, 2003, MUTAT RES-REV MUTAT, V544, P99, DOI 10.1016/j.mrrev.2003.06.024
   Sasaki YF, 2002, MUTAT RES-GEN TOX EN, V519, P103, DOI 10.1016/S1383-5718(02)00128-6
   Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
   van de Watering FCJ, 2012, CLIN ORAL IMPLAN RES, V23, P151, DOI 10.1111/j.1600-0501.2011.02218.x
   Yoo JJ, 2013, J ARTHROPLASTY, V28, P132, DOI 10.1016/j.arth.2012.04.030
   Zhang MB, 2011, MUTAT RES-GEN TOX EN, V720, P62, DOI 10.1016/j.mrgentox.2010.12.009
   Zhang Y, 2003, TISSUE ENG, V9, P337, DOI 10.1089/107632703764664800
NR 31
TC 7
Z9 7
U1 0
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2014
VL 102
IS 7
BP 2072
EP 2078
DI 10.1002/jbm.a.34877
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ3MJ
UT WOS:000337570400002
PM 23894045
DA 2018-10-20
ER

PT J
AU Cheng, J
   Huang, T
   Zheng, YF
AF Cheng, J.
   Huang, T.
   Zheng, Y. F.
TI Microstructure, mechanical property, biodegradation behavior, and
   biocompatibility of biodegradable Fe-Fe2O3 composites
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Fe-Fe2O3 composites; biodegradable metals; corrosion; cytotoxicity
ID FE-BASED ALLOYS; PURE IRON; IN-VITRO; CELL VIABILITY; STENTS; CORROSION;
   BIOMATERIAL; DEGRADATION; COMPATIBILITY; IMPLANTATION
AB In this study, the effects of Fe2O3 (addition, 2, 5, 10, and 50 wt %) on the microstructure, mechanical properties, corrosion behaviors, and in vitro biocompatibility of Fe-Fe2O3 composites fabricated by spark plasma sintering were systematically investigated as a novel-structure biodegradable metallic material. The results of X-ray diffraction analysis and optical microscopy indicated that Fe-Fe2O3 composite is composed of alpha-Fe and FeO instead of Fe2O3. Both eletrochemical measurements and immersion test showed a faster degradation rate of Fe-2Fe(2)O(3) and Fe-5Fe(2)O(3) composites than pure iron and Fe-5Fe(2)O(3) exhibited the fastest corrosion rate among these composites. Besides, the effect of Fe2O3 on the corrosion behavior of Fe-Fe2O3 composites was discussed. The extracts of Fe-Fe2O3 composite exhibited no cytotoxicity to both ECV304 and L929 cells, whereas greatly reduced cell viabilities of vascular smooth muscle cells. In addition, good hemocompatibility of all Fe-Fe2O3 composites and pure iron was obtained. To sum up, Fe-5Fe(2)O(3) composite is a promising alternative for biodegradable stent material with elevated corrosion rate, enhanced mechanical properties, as well as excellent biocompatibility. (C) 2013 Wiley Periodicals, Inc.
C1 [Cheng, J.; Zheng, Y. F.] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Biomed Mat & Tissue Engn, Beijing 100871, Peoples R China.
   [Huang, T.; Zheng, Y. F.] Peking Univ, State Key Lab Turbulence & Complex Syst, Dept Mat Sci & Engn, Coll Engn, Beijing 100871, Peoples R China.
RP Zheng, YF (reprint author), Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Biomed Mat & Tissue Engn, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010
OI Zheng, Yufeng/0000-0002-7402-9979
FU National Basic Research Program of China [2012CB619102, 2012CB619100];
   National Science Fund for Distinguished Young Scholars [51225101];
   Research Fund for the Doctoral Program of Higher Education
   [20100001110011]; National Natural Science Foundation of China
   [31170909]
FX Contract grant sponsor: The National Basic Research Program of China
   (973 Program); contract grant numbers: 2012CB619102 and 2012CB619100;
   Contract grant sponsor: National Science Fund for Distinguished Young
   Scholars; contract grant number: 51225101; Contract grant sponsor:
   Research Fund for the Doctoral Program of Higher Education; contract
   grant number: 20100001110011; Contract grant sponsor: National Natural
   Science Foundation of China; contract grant number: 31170909
CR [Anonymous], 2004, G3172 ASTM G USA
   [Anonymous], 2000, E989A ASTM E USA, V3
   [Anonymous], 2002, 109934 ISO E ANSIAAM
   ASTM, 2008, F75608 ASTM USA
   Chang E, 2002, BIOMATERIALS, V23, P2917, DOI 10.1016/S0142-9612(01)00420-3
   Cheng J, 2013, J BIOMED MATER RES B, V101B, P485, DOI 10.1002/jbm.b.32783
   Crichton R. R., 2001, INORGANIC BIOCH IRON
   CROCOMBETTE JP, 1995, PHYS REV B, V52, P3143, DOI 10.1103/PhysRevB.52.3143
   Garg S, 2010, J AM COLL CARDIOL, V56, pS43, DOI 10.1016/j.jacc.2010.06.008
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hermawan H, 2008, POWDER METALL, V51, P38, DOI 10.1179/174329008X284868
   Hermawan H, 2007, ADV MATER RES-SWITZ, V15-17, P107, DOI 10.4028/www.scientific.net/AMR.15-17.107
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Kim JS, 2006, TOXICOL SCI, V89, P338, DOI 10.1093/toxsci/kfj027
   Li W, 2000, J EUR CERAM SOC, V20, P2441, DOI 10.1016/S0955-2219(00)00152-7
   Libardi S, 2008, MAT SCI ENG A-STRUCT, V478, P243, DOI 10.1016/j.msea.2007.05.11
   Liu B, 2011, ACTA BIOMATER, V7, P1407, DOI 10.1016/j.actbio.2010.11.001
   Liu B, 2011, MATER LETT, V65, P540, DOI 10.1016/j.matlet.2010.10.068
   Liu XY, 2006, APPL SURF SCI, V253, P814, DOI 10.1016/j.apsusc.2006.01.038
   Meng GZ, 2008, CORROS SCI, V50, P3116, DOI 10.1016/j.corsci.2008.08.026
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Mueller PP, 2006, BIOMATERIALS, V27, P2193, DOI 10.1016/j.biomaterials.2005.10.042
   Nie FL, 2012, J BIOMED MATER RES B, V100B, P1404, DOI 10.1002/jbm.b.32713
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Pierson D, 2012, J BIOMED MATER RES B, V100B, P58, DOI 10.1002/jbm.b.31922
   Pisanic TR, 2007, BIOMATERIALS, V28, P2572, DOI 10.1016/j.biomaterials.2007.01.043
   Schaffer JE, 2012, METALL MATER TRANS B, V43, P984, DOI 10.1007/s11663-012-9661-3
   Schinhammer M, 2013, MAT SCI ENG C-MATER, V33, P782, DOI 10.1016/j.msec.2012.11.002
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Waksman Ron, 2006, J Interv Cardiol, V19, P414, DOI 10.1111/j.1540-8183.2006.00187.x
   Zhang EL, 2010, J MATER SCI-MATER M, V21, P2151, DOI 10.1007/s10856-010-4070-0
   Zhu SF, 2009, APPL SURF SCI, V256, P99, DOI 10.1016/j.apsusc.2009.07.082
   Zhu SF, 2009, SURF COAT TECH, V203, P1523, DOI 10.1016/j.surfcoat.2008.11.033
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 37
TC 22
Z9 23
U1 4
U2 70
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2014
VL 102
IS 7
BP 2277
EP 2287
DI 10.1002/jbm.a.34882
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ3MJ
UT WOS:000337570400024
PM 23894098
DA 2018-10-20
ER

PT J
AU McMahon, BJ
   Pfluger, CA
   Sun, B
   Ziemer, KS
   Burkey, DD
   Carrier, RL
AF McMahon, Brian J.
   Pfluger, Courtney A.
   Sun, Bing
   Ziemer, Katherine S.
   Burkey, Daniel D.
   Carrier, Rebecca L.
TI Photoinitiated chemical vapor deposition of cytocompatible
   poly(2-hydroxyethyl methacrylate) films
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE photoinitiated chemical vapor deposition; pHEMA; cell culture coating;
   degradation; swelling
ID 2-HYDROXYETHYL METHACRYLATE; PROTEIN ADSORPTION; IMPLANT MATERIALS;
   THIN-FILMS; HYDROGELS; BIOCOMPATIBILITY; MEMBRANE; SILICONE; SURFACES;
   CULTURES
AB Poly(2-hydroxyethyl methacrylate) (pHEMA) is a widely utilized biomaterial due to lack of toxicity and suitable mechanical properties; conformal thin pHEMA films produced via chemical vapor deposition (CVD) would thus have broad biomedical applications. Thin films of pHEMA were deposited using photoinitiated CVD (piCVD). Incorporation of ethylene glycol diacrylate (EGDA) into the pHEMA polymer film as a crosslinker, confirmed via Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy, resulted in varied swelling and degradation behavior. 2-Hydroxyethyl methacrylate-only films showed significant thickness loss (up to 40%), possibly due to extraction of low-molecular-weight species or erosion, after 24 h in aqueous solution, whereas films crosslinked with EGDA (9.25-12.4%) were stable for up to 21 days. These results differ significantly from those obtained with plasma-polymerized pHEMA, which degraded steadily over a 21-day period, even with crosslinking. This suggests that the piCVD films differ structurally from those fabricated via plasma polymerization (plasma-enhanced CVD). piCVD pHEMA coatings proved to be good cell culture materials, with Caco-2 cell attachment and viability comparable to results obtained on tissue-culture polystyrene. Thus, thin film CVD pHEMA offers the advantage of enabling conformal coating of a cell culture substrate with tunable properties depending on method of preparation and incorporation of crosslinking agents. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 2375-2382, 2014.
C1 [McMahon, Brian J.; Pfluger, Courtney A.; Sun, Bing; Ziemer, Katherine S.; Carrier, Rebecca L.] Northeastern Univ, Snell Engn Ctr 342, Dept Chem Engn, Boston, MA 02115 USA.
   [Burkey, Daniel D.] Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT 06269 USA.
RP Carrier, RL (reprint author), Northeastern Univ, Snell Engn Ctr 342, Dept Chem Engn, Boston, MA 02115 USA.
EM r.carrier@neu.edu
FU National Science Foundation [0727984]
FX Contract grant sponsor: National Science Foundation; contract grant
   number: 0727984
CR ABRAHAMSON EW, 1966, J CHEM PHYS, V44, P4082, DOI 10.1063/1.1726586
   Arica MY, 2000, J APPL POLYM SCI, V75, P1685, DOI 10.1002/(SICI)1097-4628(20000401)75:14<1685::AID-APP1>3.0.CO;2-6
   Baxamusa S, 2009, PHOTOINITIATED CHEM
   Baxamusa SH, 2008, BIOMACROMOLECULES, V9, P2857, DOI 10.1021/bm800632d
   Beamson G., 1992, HIGH RESOLUTION XPS
   Bose RK, 2011, THIN SOLID FILMS, V519, P4415, DOI 10.1016/j.tsf.2011.01.288
   Bose RK, 2009, CHEM VAPOR DEPOS, V15, P150, DOI 10.1002/cvde.200806748
   Burkey DD, 2004, J VAC SCI TECHNOL A, V22, P61, DOI 10.1116/1.1627766
   Chan K, 2005, LANGMUIR, V21, P11773, DOI 10.1021/la051469g
   Chan K, 2005, LANGMUIR, V21, P8930, DOI 10.1021/la051004q
   CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A
   CORKHILL PH, 1989, BIOMATERIALS, V10, P3, DOI 10.1016/0142-9612(89)90002-1
   Defrere S, 2011, MACROMOL BIOSCI, V11, P1336, DOI 10.1002/mabi.201100077
   Feng M, 1996, J COLLOID INTERF SCI, V177, P364, DOI 10.1006/jcis.1996.0045
   Fischer M, 2012, BIOMATERIALS, V33, P7677, DOI 10.1016/j.biomaterials.2012.07.007
   Fleckman P, 2012, J BIOMED MATER RES A, V100A, P1256, DOI 10.1002/jbm.a.34012
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Gloria A, 2007, J MATER SCI-MATER M, V18, P2159, DOI 10.1007/s10856-007-3003-z
   Holt B, 2011, J BIOMECH, V44, P1491, DOI 10.1016/j.jbiomech.2011.03.007
   HSIUE GH, 1994, BIOMATERIALS, V15, P163
   Kim J, 2008, INT J PHARMACEUT, V353, P205, DOI 10.1016/j.ijpharm.2007.11.049
   Li YF, 2011, SMALL, V7, P2769, DOI 10.1002/smll.201100313
   LOPEZ GP, 1993, MACROMOLECULES, V26, P3247, DOI 10.1021/ma00065a001
   Lu C, 2012, J PHARM SCI
   Maldonado-Codina Carole, 2005, Clin Exp Optom, V88, P396
   Maldonado-Codina C, 2006, OPHTHAL PHYSL OPT, V26, P408, DOI 10.1111/j.1475-1313.2006.00394.x
   McInnes SJ, 2012, ACS APPL MAT INTERFA
   Montero L, 2009, CHEM MATER, V21, P399, DOI 10.1021/cm802737m
   Peppas N. A., 1981, EYE CONT LENS, V7, P300
   Pfluger CA, 2010, BIOMACROMOLECULES, V11, P1579, DOI 10.1021/bm100209b
   Pfluger CA, 2009, MACROMOL RAPID COMM, V30, P126, DOI 10.1002/marc.200800647
   Poinern GEJ, 2011, INT J NANOMED, V6, P2167, DOI 10.2147/IJN.S24272
   Shepherd JNH, 2011, ADV FUNCT MATER, V21, P47, DOI 10.1002/adfm.201001746
   Shin J, 2012, ANAL CHIM ACTA, V752, P87, DOI 10.1016/j.aca.2012.09.026
   Sohn EH, 2012, MACROMOL BIOSCI, V12, P211, DOI 10.1002/mabi.201100235
   Sun LL, 2012, TISSUE ENG PT A, V18, P1741, DOI [10.1089/ten.tea.2011.0456, 10.1089/ten.TEA.2011.0456]
   Sung AY, 2012, J NANOSCI NANOTECHNO, V12, P5210, DOI 10.1166/jnn.2012.6276
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   Tarducci C, 2002, CHEM MATER, V14, P2541, DOI 10.1021/cm010939z
   Tomic SL, 2006, POLYM BULL, V57, P691, DOI 10.1007/s00289-006-0606-3
   TRIGO RM, 1994, BIOMATERIALS, V15, P1181, DOI 10.1016/0142-9612(94)90240-2
   Trinh P., 2008, J UNDERGRADUATE RES, V2010, P98
   Xu M, 2008, J AM CHEM SOC, V130, P3113, DOI [10.1021/ja077979, 10.1021/ja077979+]
   Yang R, 2012, LANGMUIR, V28, P12266, DOI 10.1021/la302059s
   Yang R, 2012, SOFT MATTER, V8, P31, DOI 10.1039/c1sm06334k
   Yang WJ, 2011, LANGMUIR, V27, P7065, DOI 10.1021/la200620s
   Zhang B, 2011, J BIOMED MATER RES A, V99A, P455, DOI 10.1002/jbm.a.33205
   Zubaidi, 1996, J APPL POLYM SCI, V61, P1579
NR 48
TC 3
Z9 4
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2014
VL 102
IS 7
BP 2375
EP 2382
DI 10.1002/jbm.a.34870
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ3MJ
UT WOS:000337570400034
PM 23852714
DA 2018-10-20
ER

PT J
AU Bhushan, B
   Schricker, SR
AF Bhushan, Bharat
   Schricker, Scott R.
TI A review of block copolymer-based biomaterials that control protein and
   cell interactions
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE block copolymer; biomaterial; protein adsorption; cell adhesion;
   surfaces
ID FREE-RADICAL POLYMERIZATION; DRUG-DELIVERY DEVICES; X-RAY MICROSCOPY;
   CLICK CHEMISTRY; FIBRONECTIN CONFORMATION; DIBLOCK COPOLYMERS;
   SURFACE-PROPERTIES; PLASMA-PROTEINS; POLY(GAMMA-BENZYL L-GLUTAMATE);
   POLY(LACTIC-GLYCOLIC ACID)
AB Block copolymers posses the ability to phase separate into micro and nanoscale patterns resulting in nonhomogeneous surfaces and solids. This nonhomogeneity has been harnessed to improve mechanical properties, control degradation, and add functionality to biomaterials. The ability of block copolymers to generate a wide variety of surface chemistries and morphologies can also be harnessed to control protein adsorption, protein conformation, and cell adhesion. Proteins and cells will respond to periodically structured surfaces, so block copolymers have a great deal of potential as biomaterials. This review will explore the ability of block copolymers to control specific biological responses such as cell adhesion, protein adsorption and conformation, parameters that govern the overall host response to a material. In addition, some of the specific applications of block copolymer, antithrombogenic materials and their ability to pattern proteins, will be discussed. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 2467-2480, 2014.
C1 [Bhushan, Bharat] Ohio State Univ, Nanoprobe Lab Bio & Nanotechnol & Biomimet, Columbus, OH 43210 USA.
   [Schricker, Scott R.] Ohio State Univ, Coll Dent, Div Restorat Prosthet Dent & Primary Care, Columbus, OH 43210 USA.
RP Schricker, SR (reprint author), Ohio State Univ, Coll Dent, Div Restorat Prosthet Dent & Primary Care, 3001Q Postle Hall,305 W 12th Ave, Columbus, OH 43210 USA.
EM schricker.1@osu.edu
RI Bhushan, Bharat/A-9684-2013; Schricker, Scott/A-3957-2008
OI Bhushan, Bharat/0000-0001-7161-6601; Schricker,
   Scott/0000-0003-1982-1282
CR Adams ML, 2003, J PHARM SCI, V92, P1343, DOI 10.1002/jps.10397
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Chiefari J, 1998, MACROMOLECULES, V31, P5559, DOI 10.1021/ma9804951
   Choi SH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.047802
   Dorati R, 2007, POLYM DEGRAD STABIL, V92, P1660, DOI 10.1016/j.polymdegradstab.2007.06.020
   Fang F, 2001, BIOPHYS J, V80, P2568, DOI 10.1016/S0006-3495(01)76228-5
   FERRUTI P, 1995, BIOMATERIALS, V16, P1423, DOI 10.1016/0142-9612(95)96879-5
   FETTERS LJ, 1969, J POLYM SCI POL SYM, P1
   FUNATSU E, 1988, POLYMER, V29, P177, DOI 10.1016/0032-3861(88)90219-4
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garric X, 2008, J MATER SCI-MATER M, V19, P1645, DOI 10.1007/s10856-007-3232-1
   George PA, 2010, BIOMATERIALS, V31, P641, DOI 10.1016/j.biomaterials.2009.09.094
   George PA, 2009, BIOMATERIALS, V30, P4732, DOI 10.1016/j.biomaterials.2009.05.039
   George PA, 2009, BIOMATERIALS, V30, P2449, DOI 10.1016/j.biomaterials.2009.01.012
   Giamblanco N, 2011, LANGMUIR, V27, P312, DOI 10.1021/la104127q
   Gondi SR, 2007, MACROMOLECULES, V40, P474, DOI 10.1021/ma061959v
   GOODMAN SL, 1990, J COLLOID INTERF SCI, V139, P561, DOI 10.1016/0021-9797(90)90129-C
   Grafahrend D, 2008, BIOTECHNOL BIOENG, V101, P609, DOI 10.1002/bit.21928
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P497, DOI 10.1163/156856294X00464
   Grubbs RB, 2001, MACROMOLECULES, V34, P8593, DOI 10.1021/ma011270k
   Hillmyer M, 1999, CURR OPIN SOLID ST M, V4, P559, DOI 10.1016/S1359-0286(00)00006-1
   Hillmyer MA, 1997, J AM CHEM SOC, V119, P2749, DOI 10.1021/ja963622m
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Huang LH, 2007, BIOMATERIALS, V28, P1741, DOI 10.1016/j.biomaterials.2006.12.007
   Huang SL, 2000, EUR POLYM J, V36, P285, DOI 10.1016/S0014-3057(99)00063-4
   Inoue Y, 2012, COLLOID SURFACE B, V89, P223, DOI 10.1016/j.colsurfb.2011.09.020
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   KENNEDY JP, 1979, MAKROMOL CHEM, P1
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Khor HL, 2007, BIOMACROMOLECULES, V8, P1530, DOI 10.1021/bm0611533
   Kim JK, 2010, PROG POLYM SCI, V35, P1325, DOI 10.1016/j.progpolymsci.2010.06.002
   Kim SY, 2001, BIOMATERIALS, V22, P1697, DOI 10.1016/S0142-9612(00)00292-1
   Krishnan A, 2004, LANGMUIR, V20, P5071, DOI 10.1021/la036218r
   KUMAKI T, 1985, J BIOMED MATER RES, V19, P785, DOI 10.1002/jbm.820190706
   Kumar N, 2005, LANGMUIR, V21, P6652, DOI 10.1021/la050331v
   Kumar N, 2001, ADV DRUG DELIVER REV, V53, P23, DOI 10.1016/S0169-409X(01)00219-8
   Kumar N, 2007, LANGMUIR, V23, P7416, DOI 10.1021/1a063563i
   Kumar N, 2007, J PHYS CHEM B, V111, P4581, DOI 10.1021/jp068509p
   KWON GS, 1995, ADV DRUG DELIVER REV, V16, P295, DOI 10.1016/0169-409X(95)00031-2
   Lai JT, 2002, MACROMOLECULES, V35, P6754, DOI 10.1021/ma020362m
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   Li L, 2008, J PHYS CHEM B, V112, P2150, DOI 10.1021/jp076583h
   Li L, 2006, J PHYS CHEM B, V110, P16763, DOI 10.1021/jp062442o
   Liu D, 2010, SOFT MATTER, V6, P5408, DOI 10.1039/c0sm00201a
   Liu D, 2009, LANGMUIR, V25, P4526, DOI 10.1021/la8038957
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   Lynn DM, 1996, J AM CHEM SOC, V118, P784, DOI 10.1021/ja950327d
   Marsden HR, 2009, MACROMOL BIOSCI, V9, P939, DOI 10.1002/mabi.200900057
   Matyjaszewski K, 2009, NAT CHEM, V1, P276, DOI [10.1038/NCHEM.257, 10.1038/nchem.257]
   MORI A, 1986, BIOMATERIALS, V7, P386, DOI 10.1016/0142-9612(86)90010-4
   Morin C, 2004, J ELECTRON SPECTROSC, V137, P785, DOI 10.1016/j.elspec.2004.02.158
   Nikonenko NA, 2009, APPL SPECTROSC, V63, P889, DOI 10.1366/000370209788964449
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   O'Reilly RK, 2005, POLYM PREPR AM CHEM, V46, P183
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   OKANO T, 1986, J BIOMED MATER RES, V20, P1035, DOI 10.1002/jbm.820200716
   Palacio M, 2010, J MICROSC-OXFORD, V240, P239, DOI 10.1111/j.1365-2818.2010.03420.x
   Palacio MLB, 2012, J BIOMED MATER RES A, V100A, P978, DOI 10.1002/jbm.a.34033
   Palacio MLB, 2012, J BIOMED MATER RES A, V100A, P18, DOI 10.1002/jbm.a.33219
   Palacio MLB, 2011, J R SOC INTERFACE, V8, P630, DOI 10.1098/rsif.2010.0557
   Penco M, 1996, BIOMATERIALS, V17, P1583, DOI 10.1016/0142-9612(95)00323-1
   PITT WG, 1993, J BIOMAT SCI-POLYM E, V4, P337, DOI 10.1163/156856293X00023
   Prabaharan M, 2009, BIOMATERIALS, V30, P3009, DOI 10.1016/j.biomaterials.2009.02.011
   Pressly ED, 2011, J POLYM SCI POL CHEM, V49, P814, DOI 10.1002/pola.24504
   Quemener D, 2006, CHEM COMMUN, P5051, DOI 10.1039/b611224b
   Rabotyagova OS, 2011, BIOMACROMOLECULES, V12, P269, DOI 10.1021/bm100928x
   Ranade SV, 2005, ACTA BIOMATER, V1, P137, DOI 10.1016/j.actbio.2004.09.004
   Ranjan R, 2007, MACROMOL RAPID COMM, V28, P2084, DOI 10.1002/marc.200700428
   Ranjan R, 2007, MACROMOLECULES, V40, P6217, DOI 10.1021/ma0705873
   Riegler S, 2004, MACROMOL SYMP, V217, P231, DOI 10.1002/masy.200451319
   Rosler A, 2012, ADV DRUG DELIVER REV, V64, P270, DOI 10.1016/j.addr.2012.09.026
   Rosler A, 2001, ADV DRUG DELIVER REV, V53, P95, DOI 10.1016/S0169-409X(01)00222-8
   Rozenberg BA, 2008, PROG POLYM SCI, V33, P40, DOI 10.1016/j.progpolymsci.2007.07.004
   Rubens FD, 1999, ANN THORAC SURG, V67, P689, DOI 10.1016/S0003-4975(99)00068-5
   Ruiz-Perez L, 2008, POLYMER, V49, P4475, DOI 10.1016/j.polymer.2008.07.048
   Schricker S, 2010, ULTRAMICROSCOPY, V110, P639, DOI 10.1016/j.ultramic.2010.02.025
   Schricker SR, 2011, MATER TODAY, V14, P616, DOI 10.1016/S1369-7021(11)70303-0
   Schricker SR, 2011, COLLOID POLYM SCI, V289, P219, DOI 10.1007/s00396-010-2352-1
   SCHROEN CGPH, 1995, LANGMUIR, V11, P3068, DOI 10.1021/la00008a036
   Seo JH, 2012, SOFT MATTER, V8, P5477, DOI 10.1039/c2sm25318f
   Serrano E, 2005, MACROMOL RAPID COMM, V26, P982, DOI 10.1002/marc.200500131
   Shim WS, 2006, BIOMATERIALS, V27, P5178, DOI 10.1016/j.biomaterials.2006.05.038
   SHIMADA M, 1983, POLYM J, V15, P649, DOI 10.1295/polymj.15.649
   Slater JH, 2008, J BIOMED MATER RES A, V87A, P176, DOI 10.1002/jbm.a.31725
   STUPP SI, 1977, J BIOMED MATER RES, V11, P237, DOI 10.1002/jbm.820110209
   TAKAHARA A, 1985, J BIOMED MATER RES, V19, P13, DOI 10.1002/jbm.820190104
   Tian HY, 2005, BIOMATERIALS, V26, P4209, DOI 10.1016/j.biomaterials.2004.11.002
   Torring T, 2011, CHEM SOC REV, V40, P5636, DOI 10.1039/c1cs15057j
   Tsai IY, 2004, J BIOMED MATER RES A, V71A, P462, DOI 10.1002/jbm.a.30183
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   VROMAN L, 1987, ANN NY ACAD SCI, V516, P300, DOI 10.1111/j.1749-6632.1987.tb33050.x
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   YOKOYAMA M, 1986, J BIOMED MATER RES, V20, P867, DOI 10.1002/jbm.820200702
   Yu Q, 2010, LANGMUIR, V26, P8582, DOI 10.1021/la904663m
   Zhu J, 2007, POLYMER, V48, P6992, DOI 10.1016/j.polymer.2007.10.004
NR 99
TC 10
Z9 10
U1 4
U2 57
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2014
VL 102
IS 7
BP 2467
EP 2480
DI 10.1002/jbm.a.34887
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ3MJ
UT WOS:000337570400041
PM 23893878
DA 2018-10-20
ER

PT J
AU Kim, BS
   Yang, SS
   Lee, J
AF Kim, Beom-Su
   Yang, Sun-Sik
   Lee, Jun
TI A polycaprolactone/cuttlefish bone-derived hydroxyapatite composite
   porous scaffold for bone tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cuttlefish bone; hydroxyapatite; polycaprolactone; porous scaffold; bone
   tissue engineering
ID ARAGONITIC CUTTLEFISH BONES; IN-VITRO CHARACTERIZATION; OSTEOBLAST
   RESPONSE; SURFACE-ROUGHNESS; CELLS; EXPRESSION; BIOCOMPATIBILITY;
   DIFFERENTIATION; PROLIFERATION; REGENERATION
AB Cuttlefish bone (CB) is an attractive natural biomaterial source to obtain hydroxyapatite (HAp). In this study, a porous polycaprolactone (PCL) scaffold incorporating CB-derived HAp (CB-HAp) powder was fabricated using the solvent casting and particulate leaching method. The presence of CB-HAp in PCL/CB-HAp scaffold was confirmed by X-ray diffraction (XRD). Scanning electron microscopy (SEM) and porosity analysis showed that the average pore dimension of the fabricated scaffold was approximately 200-300 mu m, with similar to 85% porosity, and that the compressive modulus increased after addition of CB-HAp powders. In vitro tests such as cell proliferation assay, cytotoxicity analysis, cell attachment observations, and alkaline phosphatase activity assays showed that the PCL/CB-HAp scaffold could improve the proliferation, viability, adherence, and osteoblast differentiation rate of MG-63 cells. When surgically implanted into rabbit calvarial bone defects, consistent with the in vitro results, PCL/CB-HAp scaffold implantation resulted in significantly higher new bone formation than did implantation of PCL alone. These findings suggest that addition of CB-HAp powder to the PCL scaffold can improve cellular response and that the PCL/CB-HAp composite scaffold has great potential for use in bone tissue engineering. (C) 2013 Wiley Periodicals, Inc.
C1 [Kim, Beom-Su; Yang, Sun-Sik; Lee, Jun] Wonkwang Univ, Wonkwang Bone Regenerat Res Inst, Iksan 570749, South Korea.
   [Kim, Beom-Su] Bonecell Biotech Inc, Taejon 302830, South Korea.
RP Lee, J (reprint author), Wonkwang Univ, Wonkwang Bone Regenerat Res Inst, Iksan 570749, South Korea.
EM omslee@wku.ac.kr
FU Fishery Commercialization Technology Development Program, Ministry for
   Food, Agriculture, Forestry and Fisheries, Republic of Korea
   [112092-03-1-CG000]
FX Contract grant sponsor: Fishery Commercialization Technology Development
   Program, Ministry for Food, Agriculture, Forestry and Fisheries,
   Republic of Korea; contract grant number: 112092-03-1-CG000
CR BIRCHALL JD, 1983, J MATER SCI, V18, P2081, DOI 10.1007/BF00555001
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   Boschett F, 2008, INT J ARTIF ORGANS, V31, P697
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Cho ML, 2001, J KOREAN FISH SOC, V34, P478
   Chuenjitkuntaworn B, 2010, J BIOMED MATER RES A, V94A, P241, DOI 10.1002/jbm.a.32657
   Tran CT, 2011, CELL TISSUE BANK, V12, P247, DOI 10.1007/s10561-010-9208-2
   Correlo VM, 2009, J BIOMED MATER RES A, V91A, P489, DOI 10.1002/jbm.a.32221
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Douglas T, 2009, J MATER SCI-MATER M, V20, P1909, DOI 10.1007/s10856-009-3756-7
   GERSTENFELD LC, 1987, DEV BIOL, V122, P49, DOI 10.1016/0012-1606(87)90331-9
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   Ivankovic H, 2010, J MATER SCI-MATER M, V21, P2711, DOI 10.1007/s10856-010-4115-4
   Ivankovic H, 2009, J MATER SCI-MATER M, V20, P1039, DOI 10.1007/s10856-008-3674-0
   Jung Y, 2005, BIOMATERIALS, V26, P6314, DOI 10.1016/j.biomaterials.2005.04.007
   Kannan S, 2007, ACTA BIOMATER, V3, P243, DOI 10.1016/j.actbio.2006.09.006
   Kim BS, 2013, J BIOMED MATER RES A, V101, P1550, DOI 10.1002/jbm.a.34456
   Kim BS, 2012, J BIOMED MATER RES A, V100A, P1673, DOI 10.1002/jbm.a.34113
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Lee SJ, 2007, J CERAM PROCESS RES, V8, P427
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Miramand P, 2006, SCI TOTAL ENVIRON, V361, P132, DOI 10.1016/j.scitotenv.2005.10.018
   Montjovent MO, 2005, TISSUE ENG, V11, P1640, DOI 10.1089/ten.2005.11.1640
   Mourino V, 2012, J R SOC INTERFACE, V9, P401, DOI 10.1098/rsif.2011.0611
   Nagashima T, 1995, Nihon Seikeigeka Gakkai Zasshi, V69, P222
   Park JW, 2008, J BIOMED MATER RES A, V87A, P203, DOI 10.1002/jbm.a.31768
   Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P1278, DOI 10.1111/j.1600-0501.2010.01944.x
   Park JS, 2012, KOREAN J CHEM ENG, V29, P931, DOI 10.1007/s11814-011-0271-6
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   PITT CG, 1981, BIOMATERIALS, V2, P215
   Ren J, 2008, J MATER SCI-MATER M, V19, P1075, DOI 10.1007/s10856-007-3181-8
   Rocha JHG, 2006, J BIOMED MATER RES A, V77A, P160, DOI 10.1002/jbm.a.30566
   Tuan HS, 2005, COMPUT AIDED DESIGN, V37, P1151, DOI 10.1016/j.cad.2005.02.006
   Wang YW, 2005, BIOMATERIALS, V26, P899, DOI 10.1016/j.biomaterials.2004.03.035
   Will J, 2008, J MATER SCI-MATER M, V19, P2781, DOI 10.1007/s10856-007-3346-5
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 39
TC 16
Z9 19
U1 2
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2014
VL 102
IS 5
BP 943
EP 951
DI 10.1002/jbm.b.33075
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ4TB
UT WOS:000337667900006
PM 24259295
DA 2018-10-20
ER

PT J
AU Rodriguez, LL
   Sundaram, PA
   Rosim-Fachini, E
   Padovani, AM
   Diffoot-Carlo, N
AF Rodriguez, L. Lara
   Sundaram, P. A.
   Rosim-Fachini, E.
   Padovani, A. M.
   Diffoot-Carlo, N.
TI Plasma electrolytic oxidation coatings on gamma TiAl alloy for potential
   biomedical applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE Ti-Al intermetallics; surface modification; plasma electrolytic
   oxidation; biomedical applications
ID MICRO-ARC OXIDATION; TITANIUM-ALLOYS; TI-48AL-2CR-2NB AT.PERCENT;
   SURFACE CHARACTERISTICS; CORROSION BEHAVIOR; CHEMICAL TREATMENT; CERAMIC
   COATINGS; TI-6AL-4V ALLOY; BONE; IMPLANTS
AB In an attempt to enhance the potential of gamma titanium aluminide intermetallic alloy as a biomaterial, its surface characteristics were successfully modified using a calcium and phosphorous rich electrolyte through the application of plasma electrolytic oxidation. Scanning electron microscopy and atomic force microscopy were used to characterize the morphology and topographical features of the resulting coating while X-ray diffraction and energy dispersive spectroscopy were used to determine the surface oxide composition. The mechanical properties of the surface coating were characterized by nanoindentation studies. The results observed show the formation of a submicron scale porous structure and a concomitant increase in the surface roughness. The surface oxide was composed of rutile and anatase phases. Composition gradients of Ca and P were also present which can possibly enhance the biomaterial application potential of this treated surface. Nanoindentation measurements indicate the formation of a fairly compact oxide during the process. (C) 2013 Wiley Periodicals, Inc.
C1 [Rodriguez, L. Lara; Sundaram, P. A.] Univ Puerto Rico, Dept Mech Engn, Mayaguez, PR 00681 USA.
   [Rosim-Fachini, E.] Univ Puerto Rico, Gen Studies Fac, Dept Phys Sci, San Juan, PR 00931 USA.
   [Padovani, A. M.] Univ Puerto Rico, Dept Gen Engn, Mayaguez, PR 00681 USA.
   [Diffoot-Carlo, N.] Univ Puerto Rico, Dept Biol, Mayaguez, PR 00681 USA.
RP Sundaram, PA (reprint author), Univ Puerto Rico, Dept Mech Engn, Mayaguez, PR 00681 USA.
EM paul.sundaram@upr.edu
FU National Institutes of Health (NIH) [SO6GM-08103]; National Institute of
   General Medical Sciences (NIGMS)/ MBRS-SCORE; University of Puerto Rico,
   Mayaguez Campus; National Science Foundation [DMR 0922994]
FX Contract grant sponsor: National Institutes of Health (NIH); contract
   grant number: SO6GM-08103; Contract grant sponsors: National Institute
   of General Medical Sciences (NIGMS)/ MBRS-SCORE and University of Puerto
   Rico, Mayaguez Campus; Contract grant sponsor: National Science
   Foundation; contract grant number: DMR 0922994 (MRI Program)
CR Beck U, 2007, BIOMOL ENG, V24, P47, DOI 10.1016/j.bioeng.2006.05.009
   Bello SA, 2010, J MATER SCI-MATER M, V21, P1739, DOI 10.1007/s10856-010-4016-6
   Bigi A, 2008, BIOMATERIALS, V29, P1730, DOI 10.1016/j.biomaterials.2007.12.011
   Castaneda-Munoz DF, 2007, J MATER SCI-MATER M, V18, P1433, DOI 10.1007/s10856-006-0095-9
   Ceschini L, 2008, WEAR, V264, P86, DOI 10.1016/j.wear.2007.01.045
   Chen JZ, 2006, MATER LETT, V60, P2538, DOI 10.1016/j.matlet.2006.01.035
   Crapper DR, 1986, NEUROBIOL AGING, V7, P525
   Cui X, 2009, DENT MATER, V25, P80, DOI 10.1016/j.dental.2008.04.012
   Delgado-Alvarado C, 2007, CORROS SCI, V49, P3732, DOI 10.1016/j.corsci.2007.04.001
   Delgado-Alvarado C, 2006, ACTA BIOMATER, V2, P701, DOI 10.1016/j.actbio.2006.05.012
   Elias CN, 2008, J MECH BEHAV BIOMED, V1, P234, DOI 10.1016/j.jmbbm.2007.12.002
   Ellingsen JE, 2003, BIOIMPLANT INTERFACE
   Esudero ML, 2004, INTERMETALLICS, V12, P253, DOI 10.1016/j.intermet.2003.10.004
   Frauchiger VM, 2004, BIOMATERIALS, V25, P593, DOI 10.1016/S0142-9612(03)00560-X
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Grizon F, 2002, J DENT, V30, P195, DOI 10.1016/S0300-5712(02)00018-0
   Habazaki H, 2007, SURF COAT TECH, V201, P8730, DOI 10.1016/j.surfcoat.2006.05.041
   Hu HJ, 2010, J ALLOY COMPD, V498, P172, DOI 10.1016/j.jallcom.2010.03.147
   IKONOPISOV S, 1977, ELECTROCHIM ACTA, V22, P1077, DOI 10.1016/0013-4686(77)80042-X
   Jager M, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/69036
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Kim DY, 2009, ACTA BIOMATER, V5, P2196, DOI 10.1016/j.actbio.2009.02.021
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lopez MF, 2002, ELECTROCHIM ACTA, V47, P1359, DOI 10.1016/S0013-4686(01)00860-X
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Matykina E, 2007, ELECTROCHIM ACTA, V53, P1987, DOI 10.1016/j.electacta.2007.08.074
   Mecuson FJ, 2007, SURF COAT TECH, V201, P8677
   Mudali UK, 2003, SADHANA-ACAD P ENG S, V28, P601
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Nakajima M, 2009, CORROS SCI, V51, P1534, DOI 10.1016/j.corsci.2008.10.021
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Oliveira V., 1998, BRAZ J CHEM ENG, V15, P326
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Park IS, 2007, ELECTROCHIM ACTA, V53, P863, DOI 10.1016/j.electacta.2007.07.067
   PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858
   Plenk H, 1998, J BIOMED MATER RES, V43, P350
   Rivera-Denizard O, 2008, J MATER SCI-MATER M, V19, P153, DOI 10.1007/s10856-006-0039-4
   Rodriguez-Mercado JJ, 2003, TOXICOL LETT, V144, P359, DOI 10.1016/S0378-4274(03)00255-8
   Song HJ, 2007, SURF COAT TECH, V201, P8738, DOI 10.1016/j.surfcoat.2006.11.022
   Song HJ, 2009, J MATER PROCESS TECH, V209, P864, DOI 10.1016/j.jmatprotec.2008.02.055
   Ward BC, 2004, MATER RES SOC SYMP P, V823, P249
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Wei DQ, 2008, APPL SURF SCI, V254, P1775, DOI 10.1016/j.apsusc.2007.07.144
   Yao ZP, 2008, APPL SURF SCI, V254, P4084, DOI 10.1016/j.apsusc.2007.12.062
   Yao ZP, 2007, J MATER PROCESS TECH, V190, P117, DOI 10.1016/j.jmatprotec.2007.03.070
   Yao ZP, 2005, SURF COAT TECH, V200, P2445, DOI 10.1016/j.surfcoat.2004.08.188
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 53
TC 15
Z9 15
U1 1
U2 36
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2014
VL 102
IS 5
BP 988
EP 1001
DI 10.1002/jbm.b.33079
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ4TB
UT WOS:000337667900010
DA 2018-10-20
ER

PT J
AU Zuidema, JM
   Rivet, CJ
   Gilbert, RJ
   Morrison, FA
AF Zuidema, Jonathan M.
   Rivet, Christopher J.
   Gilbert, Ryan J.
   Morrison, Faith A.
TI A protocol for rheological characterization of hydrogels for tissue
   engineering strategies
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biomaterial; hydrogel; rheology; agarose; collagen; fibrin; Matrigel
   (TM); methylcellulose
ID GEL POINT; LINEAR VISCOELASTICITY; CELLS FEEL; STIFFNESS; DELIVERY;
   CULTURES; SYSTEM
AB Hydrogels are studied extensively for many tissue engineering applications, and their mechanical properties influence both cellular and tissue compatibility. However, it is difficult to compare the mechanical properties of hydrogels between studies due to a lack of continuity between rheological protocols. This study outlines a straightforward protocol to accurately determine hydrogel equilibrium modulus and gelation time using a series of rheological tests. These protocols are applied to several hydrogel systems used within tissue engineering applications: agarose, collagen, fibrin, Matrigel (TM), and methylcellulose. The protocol is outlined in four steps: (1) Time sweep to determine the gelation time of the hydrogel. (2) Strain sweep to determine the linear-viscoelastic region of the hydrogel with respect to strain. (3) Frequency sweep to determine the linear equilibrium modulus plateau of the hydrogel. (4) Time sweep with values obtained from strain and frequency sweeps to accurately report the equilibrium moduli and gelation time. Finally, the rheological characterization protocol was evaluated using a composite Matrigel (TM)-methylcellulose hydrogel blend whose mechanical properties were previously unknown. The protocol described herein provides a standardized approach for proper analysis of hydrogel rheological properties. (C) 2013 Wiley Periodicals, Inc.
C1 [Zuidema, Jonathan M.; Rivet, Christopher J.; Gilbert, Ryan J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biomed Engn, Troy, NY 12180 USA.
   [Morrison, Faith A.] Michigan Technol Univ, Dept Chem Engn, Houghton, MI 49931 USA.
RP Morrison, FA (reprint author), Michigan Technol Univ, Dept Chem Engn, Houghton, MI 49931 USA.
EM fmorriso@mtu.edu
OI Zuidema, Jonathan/0000-0003-2258-0045
FU NIH [HD061096, NS062392]; NSF [NSF CAREER: 1150125]
FX Contract grant sponsor: NIH; contract grant numbers: HD061096, NS062392;
   Contract grant sponsor: NSF; contract grant number: NSF CAREER: 1150125
CR Ananthanarayanan B, 2011, BIOMATERIALS, V32, P7913, DOI 10.1016/j.biomaterials.2011.07.005
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P1263, DOI 10.1021/bm020067
   Bird R. B., 1987, DYNAMICS POLYM LIQUI, V1
   Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186
   CHAMBON F, 1987, J RHEOL, V31, P683, DOI 10.1122/1.549955
   CHAMBON F, 1986, MACROMOLECULES, V19, P2146, DOI 10.1021/ma00162a007
   DesKosky BJ, 2010, TISSUE ENG PART C-ME, V16, P1533
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Liao SW, 2009, J AM CHEM SOC, V131, P17638, DOI 10.1021/ja907097t
   Morrison F, 2001, UNDERSTANDING RHEOLO
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   Picout David R, 2003, ScientificWorldJournal, V3, P105
   ROSSMURPHY SB, 1993, BIORHEOLOGY, V30, P217
   Sharma RI, 2010, BIOMATERIALS, V31, P7695, DOI 10.1016/j.biomaterials.2010.06.046
   Spiller KL, 2008, ACTA BIOMATER, V4, P17, DOI 10.1016/j.actbio.2007.09.001
   Ta HT, 2009, BIOMATERIALS, V30, P4815, DOI 10.1016/j.biomaterials.2009.05.035
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p
   Zhao GH, 2011, INT J PHARMACEUT, V415, P95, DOI 10.1016/j.ijpharm.2011.05.054
   Zuidema JM, 2011, ACTA BIOMATER, V7, P1634, DOI 10.1016/j.actbio.2010.11.039
NR 28
TC 47
Z9 47
U1 2
U2 76
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2014
VL 102
IS 5
BP 1063
EP 1073
DI 10.1002/jbm.b.33088
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ4TB
UT WOS:000337667900017
PM 24357498
DA 2018-10-20
ER

PT J
AU Brooks, BD
   Sinclair, KD
   Davidoff, SN
   Lawson, S
   Williams, AG
   Coats, B
   Grainger, DW
   Brooks, AE
AF Brooks, Benjamin D.
   Sinclair, Kristofer D.
   Davidoff, Sherry N.
   Lawson, Scott
   Williams, Alex G.
   Coats, Brittany
   Grainger, David W.
   Brooks, Amanda E.
TI Molded polymer-coated composite bone void filler improves tobramycin
   controlled release kinetics
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bone void filler; osteomyelitis; tobramycin; controlled release;
   polycaprolactone; implant infection; joint replacement; revision surgery
ID PERIPROSTHETIC JOINT INFECTION; IN-VITRO; GRAFT SUBSTITUTES; CANCELLOUS
   BONE; ANTIBIOTICS; IMPLANTS; REPLACEMENT; REVISION; CARRIER; CEMENT
AB Infection remains a significant problem associated with biomedical implants and orthopedic surgeries, especially in revision total joint replacements. Recent advances in antibiotic-releasing bone void fillers (BVF) provide new opportunities to address these types of device-related orthopedic infections that often lead to substantial economic burdens and reduced quality of life. We report improvements made in fabrication and scalability of an antibiotic-releasing polycaprolactone-calcium carbonate/phosphate ceramic composite BVF using a new solvent-free, molten-cast fabrication process. This strategy provides the ability to tailor drug release kinetics from the BVF composite based on modifications of the inorganic substrate and/or the polymeric component, allowing extended tobramycin release at bactericidal concentrations. The mechanical properties of the new BVF composite are comparable to many reported BVFs and validate the relative homogeneity of fabrication. Most importantly, fabrication quality controls are correlated with favorable drug release kinetics, providing bactericidal activity to 10 weeks in vitro when the polycaprolactone component exceeds 98% w/w of the total polymer fraction. Furthermore, in a time kill study, tobramycin-releasing composite fragments inhibited S. aureus growth over 48 h at inoculums as high as 10(9) CFU/mL. This customizable antibiotic-releasing BVF polymer-inorganic biomaterial should provide osseointegrative and osteoconductive properties while contributing antimicrobial protection to orthopedic sites requiring the use of bone void fillers. (C) 2013 Wiley Periodicals, Inc.
C1 [Brooks, Benjamin D.; Grainger, David W.; Brooks, Amanda E.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   [Sinclair, Kristofer D.; Brooks, Amanda E.] Elute Inc, Salt Lake City, UT 84108 USA.
   [Davidoff, Sherry N.; Lawson, Scott; Williams, Alex G.; Grainger, David W.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   [Coats, Brittany] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA.
RP Brooks, AE (reprint author), Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
EM amanda.brooks@pharm.utah.edu
FU Elute Inc. (USA); State of Utah Technology Commercialization and
   Innovation Program; University of Utah Undergraduate Research Program
FX Contract grant sponsors: Elute Inc. (USA), the State of Utah Technology
   Commercialization and Innovation Program, and the University of Utah
   Undergraduate Research Program
CR Association for Professionals in Infection Control and Epidemiology, 2010, GUID EL ORTH SURG SI
   BEGG EJ, 1995, BRIT J CLIN PHARMACO, V39, P597
   BIEWENER AA, 1986, J EXP BIOL, V123, P383
   Bostrom Mathias P G, 2005, HSS J, V1, P9, DOI 10.1007/s11420-005-0111-5
   Bourne RB, 2004, J ARTHROPLASTY, V19, P69, DOI 10.1016/j.arth.2004.03.005
   BRANDL M, 1992, DRUG DEV IND PHARM, V18, P1423, DOI 10.3109/03639049209040849
   Brooks AE, 2013, DRUG DELIV TRANSL RE, V3, P518, DOI 10.1007/s13346-013-0155-x
   Brooks B, 2013, BIOMATERIALS ASS INF, P307
   Brooks BD, 2014, INT J BIOME IN PRESS
   Chuang WT, 2006, MACROMOL RES, V14, P45, DOI 10.1007/BF03219067
   Conterno L.O., 2009, COCHRANE DATABASE SY, V3
   Costerton JW, 1984, CLIN INFECT DIS, V6, pS608
   Davidoff Sherry N, 2010, Biomed Sci Instrum, V46, P184
   Garvin KL, 1999, CLIN ORTHOP RELAT R, P110
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Gunnam R, 2010, FUTURE ORTHOPEDIC IM
   Jiranek WA, 2006, J BONE JOINT SURG AM, V88A, P2487, DOI 10.2106/JBJS.E.01126
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   Koort JK, 2006, J BIOMED MATER RES A, V78A, P532, DOI 10.1002/jbm.a.30766
   Kurtz SM, 2008, J ARTHROPLASTY, V23, P2008, DOI DOI 10.1016/J.ARTH.2007.10.017
   Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022
   Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6
   Landersdorfer CB, 2009, CLIN PHARMACOKINET, V48, P2009, DOI DOI 10.2165/0003088-200948020-00002
   Liu KL, 2011, MOL PHARMACEUT, V8, P2173, DOI 10.1021/mp200513b
   McKee MD, 2002, J ORTHOP TRAUMA, V16, P622, DOI 10.1097/01.BOT.0000031145.58425.82
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   MOUSSET B, 1995, INT ORTHOP, V19, P157
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4
   Richards RG, 2012, J ORTHOP TRAUMA, V26, P703, DOI 10.1097/BOT.0b013e31826e37a2
   Roberts JA, 2008, CRIT CARE MED, V36, P2433, DOI 10.1097/CCM.0b013e318180fe62
   Schmidmaier G, 2013, BIOMATERIALS ASS INF, P435
   Sevy Justin O, 2010, Biomed Sci Instrum, V46, P136
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Terry AC, ANTIBIOTIC LADEN CEM
   Van der Stok J, 2011, ACTA BIOMATER, V7, P739, DOI 10.1016/j.actbio.2010.07.035
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Wei-Tsung Chuang KSS, 2005, J POLYM RES, V12, P197, DOI [10.1007/s10965-004-1868-9, DOI 10.1007/S10965-004-1868-9]
   Wenke JC, 2006, J BONE JOINT SURG BR, V88B, P1102, DOI 10.1302/0301-620X.88B8.17368
   Winkler H, 2008, J BONE JOINT SURG BR, V90B, P1580, DOI 10.1302/0301-620X.90B12.20742
   Winkler Heinz, 2006, Cell and Tissue Banking, V7, P319, DOI 10.1007/s10561-006-9010-3
   Witso E, 1999, ACTA ORTHOP SCAND, V70, P298, DOI 10.3109/17453679908997812
   Witso E, 2000, ACTA ORTHOP SCAND, V71, P80, DOI 10.1080/00016470052943955
NR 43
TC 9
Z9 9
U1 1
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2014
VL 102
IS 5
BP 1074
EP 1083
DI 10.1002/jbm.b.33089
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ4TB
UT WOS:000337667900018
PM 24376164
DA 2018-10-20
ER

PT J
AU Zheng, YY
   Xiong, CD
   Zhang, LF
AF Zheng, Yanyan
   Xiong, Chengdong
   Zhang, Lifang
TI Formation of bone-like apatite on plasma-carboxylated
   poly(etheretherketone) surface
SO MATERIALS LETTERS
LA English
DT Article
DE Poly(etheretherketone); Plasma polymerization; Acrylic acid (AAc);
   Bone-like apatite; Stimulated body fluid (SBF); Biomimetic
ID SELF-ASSEMBLED MONOLAYERS; CALCIUM-PHOSPHATE; POLYETHYLENE; NUCLEATION;
   COATINGS; SILANE; PEEK; XPS
AB Poly(etheretherketone) (PEEK) has attracted considerable research interest as a biomaterial for orthopedic or dental implants due to its bone-like stiffness and reasonable biocompatibility. However, PEEK is naturally bioinert, leading to limited biomedical applications, especially when direct boneimplant integration is desired. In this investigation, carboxyl groups were introduced on PEEK sheet surface using plasma polymerization of acrylic acid (AAc) for the first time. XPS confirmed the presence of carboxyl groups. When placed in stimulated body fluid for 4 weeks, apatite formed uniformly on plasma-carboxylated PEEK sample surface. SEM, EDS and FUR results confirmed the formation of bone-like apatite. This study provides a simple method to enhance the bioactivity of PEEK without sacrificing its excellent mechanical properties. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zheng, Yanyan; Xiong, Chengdong; Zhang, Lifang] Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
   [Zheng, Yanyan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Zhang, LF (reprint author), Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
EM zhanglfcioc@163.com
OI zheng, yanyan/0000-0003-0441-3008
FU key project of "Western Light" Foundation of Chinese Academy of Sciences
FX The authors thank Prof. Chua Xin (Analysis and Testing Center Chengdu
   Branch, Chinese Academy of Sciences) for XPS measurement and assisting
   analysis of the testing results. This work was supported financially by
   the key project of "Western Light" Foundation of Chinese Academy of
   Sciences. We also thank Dr. Hongwei Wang (Suzhou OPS Plasma Technology
   Co., Ltd.) for his help in plasma-modified experiment.
CR Abu Bakar MS, 2003, COMPOS SCI TECHNOL, V63, P421, DOI 10.1016/S0266-3538(02)00230-0
   Ambrosio AMA, 2001, J BIOMED MATER RES, V58, P295, DOI 10.1002/1097-4636(2001)58:3<295::AID-JBM1020>3.3.CO;2-#
   Balas F, 2006, BIOMATERIALS, V27, P1704, DOI 10.1016/j.biomaterials.2005.10.004
   Briggs D, 2002, SURF INTERFACE ANAL, V33, P283, DOI 10.1002/sia.1212
   Briggs D, 2003, SURF INTERFACE ANAL, V35, P156, DOI 10.1002/sia.1515
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   Ha SW, 1997, J MATER SCI-MATER M, V8, P683, DOI 10.1023/A:1018535923173
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Liu Q, 2002, BIOMATERIALS, V23, P3103, DOI 10.1016/S0142-9612(02)00050-9
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Toworfe GK, 2006, BIOMATERIALS, V27, P631, DOI 10.1016/j.biomaterials.2005.06.017
   Wang HY, 2009, ACTA BIOMATER, V5, P279, DOI 10.1016/j.actbio.2008.07.017
   Wu GM, 2009, SURF COAT TECH, V203, P2755, DOI 10.1016/j.surfcoat.2009.02.115
   Wu J, 2013, J BIOMED MATER RES A, V101, P2267, DOI 10.1002/jbm.a.34545
   Wu XM, 2012, INT J NANOMED, V7, P1215, DOI 10.2147/IJN.S28101
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
NR 19
TC 16
Z9 17
U1 1
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD JUL 1
PY 2014
VL 126
BP 147
EP 150
DI 10.1016/j.matlet.2014.04.021
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AJ4NG
UT WOS:000337652500039
DA 2018-10-20
ER

PT J
AU Liu, ZN
   Yang, Z
   Zhou, ZY
   Song, ZC
   Wang, HC
   Yang, JJ
   Tang, R
   Tan, Q
   Gu, Y
AF Liu, Zhengni
   Yang, Zhi
   Zhou, Zhiyuan
   Song, Zhicheng
   Wang, Huichun
   Yang, JianJun
   Tang, Rui
   Tan, Qiang
   Gu, Yan
TI Host tissue integration process in abdominal wall defect repair: a
   comparison of two porcine-derived grafts in a long-term study
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Article
DE abdominal wall defect; biomaterial; host tissue integration;
   porcine-derived
ID SMALL-INTESTINAL SUBMUCOSA; COLLAGEN IMPLANTS; HERNIA REPAIR; RAT MODEL;
   REGENERATION; RECONSTRUCTION
AB Background: The aim of this study was to compare the host tissue integration process and biomechanical behaviour after implantation of porcine small intestine submucosa (PSIS) and porcine acellular dermal matrix (PADM) grafts in a rat abdominal wall defect model during a long-term follow-up of 360 days.
   Objectives: Full-thickness abdominal wall defects were created in 40 Sprague-Dawley rats and repaired with either PSIS or PADM grafts. Rats were sacrificed at 14, 30, 90 and 360 days to evaluate the presence of herniation, infection, adhesions and changes in thickness and strength properties of the regenerated tissue at the defect site. Histopathology and immunohistochemistry were performed to evaluate the host tissue integration process assessed by the level of collagen deposition, vascularization and inflammatory host sub-chronic and chronic responses.
   Results: PADM grafts had greater strength in vitro (p < 0.01). Moreover, the strength of the PADM grafts integrated with the surrounding host tissues was greater than that of the PSIS grafts at 360 days postimplantation (p < 0.05). A stronger integration into the host tissue was observed for the PADM grafts, which showed oriented bands of collagen deposition intermixed with similar newly formed blood vessels compared to that of PSIS grafts after 360 days. The PADM grafts showed slower infiltration of macrophages but developed into a more heavily infiltrated tissue compared to the PSIS grafts (p < 0.05). The level of leukocyte infiltration after implantation was similar in both grafts (p > 0.05).
   Conclusion: PADM grafts exhibit more delayed but also more effective host integration than PSIS grafts during the 360 days following implantation, supporting the development of more robust abdominal wall strength.
C1 [Liu, Zhengni; Yang, Zhi; Zhou, Zhiyuan; Song, Zhicheng; Wang, Huichun; Yang, JianJun; Tang, Rui; Gu, Yan] Shanghai Jiao Tong Univ, Hernia & Abdominal Wall Surg Ctr, Shanghai Peoples Hosp 9, Sch Med,Dept Gen Surg, Shanghai 200011, Peoples R China.
   [Tan, Qiang] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Dept Pathol, Shanghai 200030, Peoples R China.
RP Gu, Y (reprint author), Shanghai Jiao Tong Univ, Hernia & Abdominal Wall Surg Ctr, Shanghai Peoples Hosp 9, Sch Med,Dept Gen Surg, Shanghai 200011, Peoples R China.
EM yangu@sjtu.edu.cn
FU National Natural Science Foundation of China [81270444]
FX This research was supported by National Natural Science Foundation of
   China (81270444). The authors also appreciate technical support from
   YinGen Pan. The authors have no other relevant affiliations or financial
   involvement with any organization or entity with a financial interest in
   or financial conflict with the subject matter or materials discussed in
   the manuscript apart from those disclosed.
CR Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Cavallaro A, 2010, WORLD J GASTROENTERO, V16, P1928, DOI 10.3748/wjg.v16.i15.1928
   Connor J, 2009, REGEN MED, V4, P185, DOI 10.2217/17460751.4.2.185
   Gobin AS, 2006, TISSUE ENG, V12, P3383, DOI 10.1089/ten.2006.12.3383
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   JENKINS SD, 1983, SURGERY, V94, P392
   Kissane NA, 2012, PLAST RECONSTR SURG, V130, P194, DOI DOI 10.1097/PRS.0B013E318265A5EC
   Konstantinovic ML, 2005, BJOG-INT J OBSTET GY, V112, P1554, DOI 10.1111/j.1471-0528.2005.00688.x
   Liu ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020520
   Meintjes J, 2011, EXPERT REV MED DEVIC, V8, P275, DOI [10.1586/erd.10.64, 10.1586/ERD.10.64]
   Meyer T, 2006, PEDIATR SURG INT, V22, P369, DOI 10.1007/s00383-006-1658-z
   Pascual G, 2012, WOUND REPAIR REGEN, V20, P402, DOI 10.1111/j.1524-475X.2012.00781.x
   Petter-Puchner AH, 2008, J SURG RES, V145, P105, DOI 10.1016/j.jss.2007.03.090
   Song ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064358
   Steurer JA, 2011, J INVEST SURG, V24, P227, DOI 10.3109/08941939.2011.584654
NR 15
TC 0
Z9 0
U1 1
U2 10
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1471-2598
EI 1744-7682
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PD JUL
PY 2014
VL 14
IS 7
BP 883
EP 892
DI 10.1517/14712598.2014.907783
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AI6YD
UT WOS:000337023000002
PM 24707915
DA 2018-10-20
ER

PT J
AU Pieretti, EF
   Costa, I
   Marques, RA
   Leivas, TP
   das Neves, MDM
AF Pieretti, Eurico F.
   Costa, Isolda
   Marques, Rogerio A.
   Leivas, Tomaz P.
   das Neves, Mauricio D. M.
TI Electrochemical Study of a Laser Marked Biomaterial in Albumin Solution
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE Albumin; ASTM F139; biomaterials; corrosion; EIS; laser marks
ID STAINLESS-STEEL; MESSENGER-RNA; FILMS; CATABOLISM; CORROSION; BEHAVIOR;
   CULTURE; RABBITS; BINDING; PROTEIN
AB Proteins are widely used in solutions in order to simulate the physiological fluids and study corrosion mechanisms. The present work appraised the ASTM F 139 austenitic stainless steel (SS), employed in prostheses manufacture, and engraved by a nanosecond laser beam, using a phosphate buffered solution with 10 g/L of bovine serum albumin (PBS + BSA). Due to the complexity of the interaction between protein and the biomaterial, it was necessary to use higher BSA concentrations, however, similar to those found in human serum. The electrochemical tests consisted in monitoring the open circuit potential (OCP), electrochemical impedance spectroscopy (EIS) and cyclic polarisation measurements. The results showed that the laser marked areas are more susceptible to corrosion; suggesting that the laser marking technique has a more preponderant effect on the passive film protective character than the albumin addition to the electrolyte.
C1 [Pieretti, Eurico F.; Costa, Isolda; Marques, Rogerio A.; das Neves, Mauricio D. M.] Inst Pesquisas Energet & Nucl IPEN CNEN SP, BR-05508000 Sao Paulo, Brazil.
   [Leivas, Tomaz P.] Univ Sao Paulo, Fac Med, Hosp Clin, Inst Ortopedia & Traumatol, BR-05403010 Sao Paulo, Brazil.
RP Pieretti, EF (reprint author), Inst Pesquisas Energet & Nucl IPEN CNEN SP, Av Prof Lineu Prestes,2242 Cidade Univ, BR-05508000 Sao Paulo, Brazil.
EM efpieretti@usp.br
RI Neves, Mauricio/D-7588-2012
OI Neves, Mauricio/0000-0002-1304-2117
CR AZUMI K, 1986, T JPN I MET, V27, P382, DOI 10.2320/matertrans1960.27.382
   BENTHANSEN L, 1991, MICROVASC RES, V41, P345, DOI 10.1016/0026-2862(91)90033-8
   Da Cunha Belo M, 1999, ELECTROCHIM ACTA, V44, P2473
   DEFEO P, 1992, AM J PHYSIOL, V263, pE794
   Diaci J, 2011, OPT LASER ENG, V49, P195, DOI 10.1016/j.optlaseng.2010.09.003
   Ge HH, 2003, APPL SURF SCI, V211, P321, DOI 10.1016/S0169-4332(03)00355-6
   GERISCHER H, 1989, CORROS SCI, V29, P257, DOI 10.1016/0010-938X(89)90034-6
   Hakiki NE, 2000, CORROS SCI, V42, P687, DOI 10.1016/S0010-938X(99)00082-7
   HAKIKI NE, 1995, CORROS SCI, V37, P1809, DOI 10.1016/0010-938X(95)00084-W
   Hong T, 1997, CORROS SCI, V39, P1665, DOI 10.1016/S0010-938X(97)00072-3
   Ji JA, 2004, COLLOID SURFACE B, V34, P185, DOI 10.1016/j.colsurfb.2003.12.015
   KERNOFF LM, 1971, BIOCHEM J, V124, P529, DOI 10.1042/bj1240529
   Kirsch R., 1968, NATURE, V9, P217
   KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17
   Leone C, 2010, J MATER PROCESS TECH, V210, P1297, DOI 10.1016/j.jmatprotec.2010.03.018
   Mansfeld F., 1988, J ELECTROCHEM SOC, V138, P1171
   MOSHAGE HJ, 1985, BIOCHIM BIOPHYS ACTA, V824, P27, DOI 10.1016/0167-4781(85)90025-9
   PEAVY DE, 1985, AM J PHYSIOL, V248, pE656
   Pieretti E. F., 2013, CORROSION 2013 NACE, P126
   Pieretti E. F., 2013, ELECTROCHIM ACTA
   Pieretti EF, 2013, ELECTROCHIM ACTA, V114, P838, DOI 10.1016/j.electacta.2013.05.101
   Prinsen BHCMT, 2004, CLIN CHIM ACTA, V347, P1, DOI 10.1016/j.cccn.2004.04.005
   SIDDIQUI UA, 1981, J BIOL CHEM, V256, P4544
   Taveira LV, 2010, CORROS SCI, V52, P2813, DOI 10.1016/j.corsci.2010.04.021
   TRAISNEL M, 1990, Clinical Materials, V5, P309, DOI 10.1016/0267-6605(90)90030-Y
   VALLNER JJ, 1977, J PHARM SCI-US, V66, P447, DOI 10.1002/jps.2600660402
   Virtanen S, 2008, ACTA BIOMATER, V4, P468, DOI 10.1016/j.actbio.2007.12.003
   Wan P, 2012, MAT SCI ENG C-MATER, V32, P510, DOI 10.1016/j.msec.2011.12.002
   YEDGAR S, 1983, AM J PHYSIOL, V244, pE101
NR 29
TC 5
Z9 5
U1 0
U2 9
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD JUL
PY 2014
VL 9
IS 7
BP 3828
EP 3836
PG 9
WC Electrochemistry
SC Electrochemistry
GA AI5IK
UT WOS:000336899000041
DA 2018-10-20
ER

PT J
AU Sin, JR
   Suner, S
   Neville, A
   Emami, N
AF Sin, J. Rituerto
   Suner, S.
   Neville, A.
   Emami, N.
TI Fretting corrosion of hafnium in simulated body fluids
SO TRIBOLOGY INTERNATIONAL
LA English
DT Article
DE Hafnium; Biomaterial; Corrosion; Fretting corrosion
ID BIOMEDICAL ALLOYS; BEHAVIOR; TITANIUM; IMPLANTS
AB Hafnium has been suggested as an interesting material for biomedical applications due to its good biocompatibility and osteogenesis. However, its behaviour under fretting corrosion conditions, found in applications such as dental and joint implants, has not been studied in depth. A three-electrode electrochemical cell integrated with a ball-on-flat reciprocating tribometer was used to investigate the corrosion of hafnium and commercially pure (CP) titanium in simulated body fluids. An increased susceptibility to pitting corrosion was observed when hafnium was subjected to fretting. Open circuit potential measurements showed a more severe mechanical depassivation due to fretting in the case of CP titanium in comparison to hafnium. In addition, the anodic currents measured during potentiostatic tests were also higher for CP titanium. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Sin, J. Rituerto; Suner, S.; Emami, N.] Lulea Univ Technol, Dept Engn Sci & Math, Div Machine Elements, S-97187 Lulea, Sweden.
   [Neville, A.] Univ Leeds, Sch Mech Engn, Inst Engn Thermofluids Surfaces & Interfaces, Leeds LS2 9JT, W Yorkshire, England.
RP Sin, JR (reprint author), Lulea Univ Technol, Dept Engn Sci & Math, Div Machine Elements, S-97187 Lulea, Sweden.
EM jorge.rituerto.sin@ltu.se
OI emami, nazanin/0000-0001-8676-8819; Neville, Anne/0000-0002-6479-1871
FU Centrum for Medicinsk Teknik och Physic (CMTF); Kempe Stiftelserna
FX This work was funded by the Centrum for Medicinsk Teknik och Physic
   (CMTF) and Kempe Stiftelserna.
CR Badawy WA, 1999, J MATER SCI, V34, P2483, DOI 10.1023/A:1004539421982
   Cerreta E, 2007, MAT SCI ENG A-STRUCT, V456, P243, DOI 10.1016/j.msea.2006.11.111
   Dimah MK, 2012, WEAR, V294, P409, DOI 10.1016/j.wear.2012.04.014
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Hallab NJ, 2009, BULL HOSP JT DIS, V67, P182
   Hiromoto S, 2006, WEAR, V261, P1002, DOI 10.1016/j.wear.2006.03.032
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Kumar S, 2010, TRIBOL INT, V43, P1245, DOI 10.1016/j.triboint.2009.12.007
   MACDONALD DD, 1992, J ELECTROCHEM SOC, V139, P3434, DOI 10.1149/1.2069096
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Mohammadi S, 2001, J MATER SCI-MATER M, V12, P603, DOI 10.1023/A:1011237610299
   Rituerto Sin J, 2013, J BIOMED MAT RES B
   Sivakumar B, 2011, TRIBOL-MATER SURF IN, V5, P158, DOI 10.1179/1751584X11Y.0000000020
   Suner S, 2012, TRIBOL-MATER SURF IN, V6, P39, DOI 10.1179/1751584X12Y.0000000005
   Taki N, 2005, J ORTHOP RES, V23, P376, DOI 10.1016/j.orhtes.2004.08.023
   Upadhyay D, 2006, MAT SCI ENG A-STRUCT, V432, P1, DOI 10.1016/j.msea.2006.05.003
   Urban RM, 2004, J ARTHROPLASTY, V19, P94, DOI 10.1016/j.arth.2004.09.013
   Vidal CV, 2008, CORROS SCI, V50, P1954, DOI 10.1016/j.corsci.2008.04.002
   Yan Y, 2007, WEAR, V263, P1105, DOI 10.1016/j.wear.2007.01.114
NR 20
TC 1
Z9 1
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-679X
EI 1879-2464
J9 TRIBOL INT
JI Tribol. Int.
PD JUL
PY 2014
VL 75
BP 10
EP 15
DI 10.1016/j.triboint.2014.03.003
PG 6
WC Engineering, Mechanical
SC Engineering
GA AI8XJ
UT WOS:000337210000002
OA Green Published
DA 2018-10-20
ER

PT J
AU Zhou, FF
   Cheng, Y
   Gan, L
   Chen, ZL
   Megharaj, M
   Naidu, R
AF Zhou, Fengfei
   Cheng, Ying
   Gan, Li
   Chen, Zuliang
   Megharaj, Mallavarapu
   Naidu, Ravendra
TI Burkholderia vietnamiensis C09V as the functional biomaterial used to
   remove crystal violet and Cu(II)
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article
DE Burkholderia vietnamiensis C09V; Crystal violet; Cu(II); Biodegradation;
   Biosorption
ID REMAZOL-BLACK-B; DE-OILED SOYA; HEAVY-METALS; SOIL-MICROORGANISMS;
   HAZARDOUS DYE; PHORMIDIUM SP; REACTIVE DYE; BOTTOM ASH; BIODEGRADATION;
   DEGRADATION
AB Burkholderia vietnamiensis C09V (B.V. C09V) was used to remove both crystal violet (CV) and Cu(II) because dye effluents often contain dyes and metal ions. Inhibiting the strain's growth through the biosorption of Cu(II) on B.V. C09V and promoting its growth by using CV as a carbon source led to the degradation of CV (30 mg/L). It fell to 36.9 percent and the amount of Cu(II) (50 mg/L) removed rose to 34.9 percent in the presence of both CV and Cu(II). This outcome is comparable to the single presence of CV and Cu(II). EDS analysis showed that Cu(II) was adsorbed onto the strain (the atomic percentage of Cu(II) was 1.9 percent), while kinetic studies indicated that firstly, the decolorization of CV fitted well to the pseudo first-order degradation kinetic model and secondly, the biosorption of Cu(II) fitted well to the pseudo second-order kinetic model. The degradation rate constants of CV were stable in the 0.1010.0068/h range and R-2 was both higher than 0.981 when Cu(II) concentrations were present. Furthermore, the biosorption capacity of Cu(II) ranged from 38.8 to 20.3 mg/g at the CV concentration of 30 mg/L (both R-2 > 0.96). This suggests that the strain has the potential to degrade CV and facilitate the biosorption of Cu(II) in dye effluent. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Zhou, Fengfei; Cheng, Ying; Gan, Li; Chen, Zuliang] Fujian Normal Univ, Sch Environm Sci & Engn, Fuzhou 350007, Fujian Province, Peoples R China.
   [Megharaj, Mallavarapu; Naidu, Ravendra] Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes, SA 5095, Australia.
RP Chen, ZL (reprint author), Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes, SA 5095, Australia.
EM Zuliang.chen@unisa.edu.au
RI Mallavarapu, Megharaj/D-3408-2011
OI Mallavarapu, Megharaj/0000-0002-6230-518X
FU Fujian Normal University
FX The financial support of the Fujian "Minjiang Fellowship" from Fujian
   Normal University is gratefully acknowledged.
CR Aksu Z, 2009, J HAZARD MATER, V168, P310, DOI 10.1016/j.jhazmat.2009.02.027
   Aksu Z, 2007, ENZYME MICROB TECH, V40, P1167, DOI 10.1016/j.enzmictec.2006.08.024
   Cabrera G, 2006, J HAZARD MATER, V135, P40, DOI 10.1016/j.jhazmat.2005.11.058
   Cheng Y, 2012, ECOTOX ENVIRON SAFE, V83, P108, DOI 10.1016/j.ecoenv.2012.06.017
   Cheriaa J, 2009, ANN MICROBIOL, V59, P57, DOI 10.1007/BF03175599
   Gopinath KP, 2011, BIORESOURCE TECHNOL, V102, P3687, DOI 10.1016/j.biortech.2010.11.072
   Gupta VK, 2007, J COLLOID INTERF SCI, V309, P464, DOI 10.1016/j.jcis.2006.12.010
   Gupta VK, 2011, WATER RES, V45, P2207, DOI 10.1016/j.watres.2011.01.012
   Gupta Vinod K, 2010, J Colloid Interface Sci, V342, P533, DOI 10.1016/j.jcis.2009.10.074
   Gupta VK, 2009, J COLLOID INTERF SCI, V335, P24, DOI 10.1016/j.jcis.2009.03.056
   Gupta VK, 2007, J HAZARD MATER, V142, P443, DOI 10.1016/j.jhazmat.2006.08.048
   Gupta VK, 2012, RSC ADV, V2, P6380, DOI 10.1039/c2ra20340e
   Gupta VK, 2006, J COLLOID INTERF SCI, V293, P16, DOI 10.1016/j.cis.2005.06.021
   Hong HB, 2007, J HAZARD MATER, V140, P145, DOI 10.1016/j.jhazmat.2006.06.049
   Jam AK, 2003, SEP SCI TECHNOL, V38, P463
   Jilani S., 2006, International Journal of Environmental Science and Technology, V3, P371
   Karthikeyan S, 2012, J MOL LIQ, V173, P153, DOI 10.1016/j.molliq.2012.06.022
   Kaushik P, 2009, ENVIRON INT, V35, P127, DOI 10.1016/j.envint.2008.05.010
   Kumar A, 2009, J MICROBIOL BIOTECHN, V19, P1028, DOI 10.4014/jmb.0811.634
   Lin C, 2010, J HAZARD MATER, V182, P771, DOI 10.1016/j.jhazmat.2010.06.101
   Lin YH, 2011, J ENVIRON SCI-CHINA, V23, P2055, DOI 10.1016/S1001-0742(10)60643-2
   Mittal A, 2008, J HAZARD MATER, V151, P821, DOI 10.1016/j.jhazmat.2007.06.059
   Mittal A, 2010, J COLLOID INTERF SCI, V343, P463, DOI 10.1016/j.jcis.2009.11.060
   Park KH, 2010, APPL MICROBIOL BIOT, V86, P947, DOI 10.1007/s00253-009-2388-7
   Parshetti GK, 2011, J ENVIRON SCI-CHINA, V23, P1384, DOI 10.1016/S1001-0742(10)60547-5
   Ren SZ, 2006, APPL MICROBIOL BIOT, V72, P1316, DOI 10.1007/s00253-006-0418-2
   Sadettin S, 2007, ENZYME MICROB TECH, V41, P175, DOI 10.1016/j.enzmictec.2006.12.015
   Sokhn J, 2001, LETT APPL MICROBIOL, V33, P164, DOI 10.1046/j.1472-765x.2001.00972.x
   Srinivasan A, 2010, J ENVIRON MANAGE, V91, P1915, DOI 10.1016/j.jenvman.2010.05.003
   Tastan BE, 2010, BIORESOURCE TECHNOL, V101, P870, DOI 10.1016/j.biortech.2009.08.099
   Wan W.S., 2011, CARBOHYD POLYM, V83, P1446
   Wang YP, 2007, J ENVIRON SCI-CHINA, V19, P848, DOI 10.1016/S1001-0742(07)60141-7
NR 32
TC 7
Z9 8
U1 2
U2 21
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD JUL
PY 2014
VL 105
BP 1
EP 6
DI 10.1016/j.ecoenv.2014.03.028
PG 6
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA AI5YW
UT WOS:000336947900001
PM 24780226
DA 2018-10-20
ER

PT J
AU Choi, BH
   Choi, KH
   Lee, HS
   Song, BR
   Park, SR
   Yang, JW
   Min, BH
AF Choi, Byung Hyune
   Choi, Kyoung-Hwan
   Lee, Hye Sook
   Song, Bo Ram
   Park, So Ra
   Yang, Jae Wook
   Min, Byoung-Hyun
TI Inhibition of blood vessel formation by a chondrocyte-derived
   extracellular matrix
SO BIOMATERIALS
LA English
DT Article
DE Chondrocyte-derived extracellular matrix; Biomaterial; Vessel invasion;
   Anti-angiogenesis; Corneal neovascularization
ID IN-VITRO; ENDOTHELIAL-CELLS; ARTICULAR-CARTILAGE; CHONDROMODULIN-I;
   TUMOR-GROWTH; STEM-CELLS; ANGIOGENESIS; MIGRATION; NEOVASCULARIZATION;
   THROMBOSPONDIN-1
AB In this study, the chondrocyte-derived extracellular matrix (CECM) was evaluated for its activity to inhibit vessel invasion in vitro and in vivo. Human umbilical vein endothelial cells (HUVECs) and rabbit chondrocytes were plated on a bio-membrane made of CECM or human amniotic membrane (HAM). The adhesion, proliferation, and tube formation activity of HUVECs and chondrocytes were examined. The CECM and HAM powders were then mixed individually in Matrigel and injected subcutaneously into nude mice to examine vessel invasion in vivo after 1 week. Finally, a rabbit model of corneal neovascularization (NV) was induced by 3-point sutures in the upper cornea, and CECM and HAM membranes were implanted onto the corneal surface at day 5 after suture injury. The rabbits were sacrificed at 7 days after transplantation and the histopathological analysis was performed. The adhesion and proliferation of HUVECs were more efficient on the HAM than on the CECM membrane. However, chondrocytes on each membrane showed an opposite result being more efficient on the CECM membrane. The vessel invasion in vivo also occurred more deeply and intensively in Matrigel containing HAM than in the one containing CECM. In the rabbit NV model, CECM efficiently inhibited the neovessels formation and histological remodeling in the injured cornea. In summary, our findings suggest that CECM, an integral cartilage ECM composite, shows an inhibitory effect on vessel invasion both in vitro and in vivo, and could be a useful tool in a variety of biological and therapeutic applications including the prevention of neovascularization after cornea injury. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Choi, Byung Hyune] Inha Univ, Coll Med, Dept Adv Biomed Sci, Inchon, South Korea.
   [Choi, Kyoung-Hwan; Song, Bo Ram; Min, Byoung-Hyun] Ajou Univ, Dept Mol Sci & Technol, Suwon 443380, South Korea.
   [Choi, Kyoung-Hwan; Song, Bo Ram; Min, Byoung-Hyun] Ajou Med Ctr, Cell Therapy Ctr, Suwon 443380, South Korea.
   [Lee, Hye Sook; Yang, Jae Wook] Inje Univ, Busan Paik Hosp, Ocular Neovasc Dis Res Ctr, Pusan 614735, South Korea.
   [Park, So Ra] Inha Univ, Coll Med, Dept Physiol, Inchon, South Korea.
   [Yang, Jae Wook] Inje Univ, Busan Paik Hosp, Coll Med, Dept Ophthalmol, Pusan 614735, South Korea.
   [Min, Byoung-Hyun] Ajou Univ, Sch Med, Dept Orthoped Surg, Suwon 443380, South Korea.
RP Min, BH (reprint author), Ajou Univ, Dept Mol Sci & Technol, Suwon 443380, South Korea.
EM oculoplasty@gmail.com; bhmin@ajou.ac.kr
FU Korea Healthcare Technology R&D Project, Ministry of Health and Welfare
   Affairs, Republic of Korea [HI12C0005, A091120]; Ministry of Science,
   ICT & Future Planning [2011-0019730]
FX This study was supported by grants from the Korea Healthcare Technology
   R&D Project, Ministry of Health and Welfare Affairs, Republic of Korea
   (HI12C0005 & A091120) and from the Ministry of Science, ICT & Future
   Planning (2011-0019730).
CR Ashraf S, 2008, CURR OPIN RHEUMATOL, V20, P573, DOI 10.1097/BOR.0b013e3283103d12
   AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8
   Bara JJ, 2012, CONNECT TISSUE RES, V53, P220, DOI 10.3109/03008207.2011.629310
   Calamia V, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4040
   Choi KH, 2012, TISSUE ENG REGEN MED, V9, P43, DOI 10.1007/s13770-012-0043-3
   Choi KH, 2010, BIOMATERIALS, V31, P5355, DOI 10.1016/j.biomaterials.2010.03.053
   Cursiefen C, 1998, CORNEA, V17, P611, DOI 10.1097/00003226-199811000-00008
   Davies CD, 2001, MICROVASC RES, V62, P26, DOI 10.1006/mvre.2001.2311
   de Rotth A, 1940, ARCH OPHTHALMOL-CHIC, V23, P522
   Delaney CE, 2006, EXP CELL RES, V312, P2476, DOI 10.1016/j.yexcr.2006.04.003
   Deroanne CF, 2001, CARDIOVASC RES, V49, P647, DOI 10.1016/S0008-6363(00)00233-9
   DICESARE PE, 1994, EUR J BIOCHEM, V223, P927, DOI 10.1111/j.1432-1033.1994.tb19070.x
   Dimmeler S, 2000, CIRC RES, V87, P434
   Erguen Sueleyman, 2001, Angiogenesis, V4, P193, DOI 10.1023/A:1014027218980
   EY RC, 1968, AM J OPHTHALMOL, V66, P1118, DOI 10.1016/0002-9394(68)90821-0
   Feng Y, 2014, CURR EYE RES
   Hiraki Y, 1997, J BIOL CHEM, V272, P32419, DOI 10.1074/jbc.272.51.32419
   Hooiveld M, 2003, AM J PATHOL, V162, P943, DOI 10.1016/S0002-9440(10)63889-8
   Ijiri S, 2007, AM J OPHTHALMOL, V144, P938, DOI 10.1016/j.ajo.2007.08.003
   Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517
   Jin CZ, 2007, ARTIF ORGANS, V31, P183, DOI 10.1111/j.1525-1594.2007.00363.x
   Jin CZ, 2011, TISSUE ENG PT A, V17, P3057, DOI [10.1089/ten.tea.2010.0605, 10.1089/ten.TEA.2010.0605]
   Jin CZ, 2010, J BIOMED MATER RES A, V92A, P1567, DOI 10.1002/jbm.a.32419
   Johnson WEB, 2005, SPINE, V30, P1139, DOI 10.1097/01.brs.0000162624.95262.73
   Kim EK, 2014, CORNEA, V33, P60, DOI 10.1097/ICO.0000000000000007
   Klinger P, 2011, ARTHRITIS RHEUM-US, V63, P2721, DOI 10.1002/art.30335
   Li TZ, 2012, ADV FUNCT MATER, V22, P4292, DOI 10.1002/adfm.201102695
   Montezuma SR, 2009, SEMIN OPHTHALMOL, V24, P52, DOI 10.1080/08820530902800017
   Oganesian A, 1997, J HISTOCHEM CYTOCHEM, V45, P1469, DOI 10.1177/002215549704501104
   OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6
   Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390
   Patra D, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.3
   Peyman GA, 2007, GRAEF ARCH CLIN EXP, V245, P1461, DOI 10.1007/s00417-007-0542-4
   Pufe T, 2004, MATRIX BIOL, V23, P267, DOI 10.1016/j.matbio.2004.06.003
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Shortt AJ, 2008, OPHTHALMOLOGY, V115, P1989, DOI 10.1016/j.ophtha.2008.04.039
   Shukunami C, 2001, OSTEOARTHR CARTILAGE, V9, pS91, DOI 10.1053/joca.2001.0450
   Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035
   Sipola A, 2009, CALCIFIED TISSUE INT, V85, P412, DOI 10.1007/s00223-009-9287-x
   Wang ZP, 2010, J BIOL CHEM, V285, P20806, DOI 10.1074/jbc.M110.118521
   Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414
NR 41
TC 9
Z9 9
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2014
VL 35
IS 22
BP 5711
EP 5720
DI 10.1016/j.biomaterials.2014.03.083
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AI2NI
UT WOS:000336694700008
PM 24768193
DA 2018-10-20
ER

PT J
AU Villasante, A
   Marturano-Kruik, A
   Vunjak-Novakovic, G
AF Villasante, Aranzazu
   Marturano-Kruik, Alessandro
   Vunjak-Novakovic, Gordana
TI Bioengineered human tumor within a bone niche
SO BIOMATERIALS
LA English
DT Article
DE Cancer; Tumor niche; Tissue engineering; Ewing's sarcoma; Therapeutic
   targets; Microenvironment
ID EMBRYONIC STEM-CELLS; EWINGS-SARCOMA; IN-VITRO; NEUROECTODERMAL TUMOR;
   3D SCAFFOLDS; CANCER; HYPOXIA; TISSUE; MICROENVIRONMENT; TARGET
AB Monolayer cultures of tumor cells and animal studies have tremendously advanced our understanding of cancer biology. However, we often lack animal models for human tumors, and cultured lines of human cells quickly lose their cancer signatures. In recent years, simple 3D models for cancer research have emerged, including cell culture in spheroids and on biomaterial scaffolds. Here we describe a bioengineered model of human Ewing's sarcoma that mimics the native bone tumor niche with high biological fidelity. In this model, cancer cells that have lost their transcriptional profiles after monolayer culture re-express genes related to focal adhesion and cancer pathways. The bioengineered model recovers the original hypoxic and glycolytic tumor phenotype, and enables re-expression of angiogenic and vasculogenic mimicry features that favor tumor adaptation. We propose that differentially expressed genes between the monolayer cell culture and native tumor environment are potential therapeutic targets that can be explored using the bioengineered tumor model. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Villasante, Aranzazu; Marturano-Kruik, Alessandro; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA.
RP Vunjak-Novakovic, G (reprint author), Columbia Univ, Lab Stem Cells & Tissue Engn, 622 West 168th St,VC12-234, New York, NY 10032 USA.
EM av2499@columbia.edu; am3934@columbia.edu; gv2131@columbia.edu
RI Villasante, Aranzazu/A-9100-2017
OI Villasante, Aranzazu/0000-0001-7919-9670; Vunjak-Novakovic,
   Gordana/0000-0002-9382-1574
FU Alfonso Martin Escudero Foundation; NIH [EB002520]
FX The authors thank Dr Marcos-Campos and Dr Bhumiratana for their
   contributions to the development of the tumor model, Dr. FY Lee for his
   help with Ewing's sarcoma tumor identification, Dr. Manuel Serrano
   (CNIO, Madrid, Spain) for kindly providing the U2OS osteosarcoma cell
   line, HEK293T cell line and the pBabe-Puro-GFP plasmid, and Dr. ER.
   Lawlor, University of Michigan, for kindly providing the lentiviral
   plasmid containing the EWS/FLI mutation. We gratefully acknowledge
   funding support of this work by Alfonso Martin Escudero Foundation
   (fellowship to AV) and NIH (grant EB002520 to GVN).
CR Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328
   Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867
   Carvajal R, 2005, HEMATOL ONCOL CLIN N, V19, P501, DOI 10.1016/j.hoc.2005.03.004
   Chitcholtan K, 2013, EXP CELL RES, V319, P75, DOI 10.1016/j.yexcr.2012.09.012
   de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6
   Fong ELS, 2013, P NATL ACAD SCI USA, V110, P6500, DOI 10.1073/pnas.1221403110
   Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7
   Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640
   Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019
   Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844
   Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290
   Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241
   Lu Q, 2009, CURR MED CHEM, V16, P1355, DOI 10.2174/092986709787846569
   Mackintosh C, 2010, CANCER BIOL THER, V9, P655, DOI 10.4161/cbt.9.9.11511
   Marcos-Campos I, 2012, BIOMATERIALS, V33, P8329, DOI 10.1016/j.biomaterials.2012.08.013
   Marolt D, 2012, P NATL ACAD SCI USA, V109, P8705, DOI 10.1073/pnas.1201830109
   Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483
   Mueller-Klieser W, 2000, CRIT REV ONCOL HEMAT, V36, P123, DOI 10.1016/S1040-8428(00)00082-2
   Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4
   O'Neill Alison, 2013, Sarcoma, P450478, DOI 10.1155/2013/450478
   Olechnowicz SWZ, 2014, CANCER RES, V74, P1625, DOI 10.1158/0008-5472.CAN-13-2645
   Pasque V, 2011, EMBO J, V30, P2373, DOI 10.1038/emboj.2011.144
   Riggi N, 2007, CANC LETT, V254, P110
   Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761
   Savola S., 2007, CANC LETT, V254, P1
   Scotlandi K, 1996, CANCER RES, V56, P4570
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sieh S, 2010, ORGANOGENESIS, V6, P181, DOI 10.4161/org.6.3.12041
   Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242
   Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052
   Tan PHS, 2011, BIOMATERIALS, V32, P6131, DOI 10.1016/j.biomaterials.2011.04.084
   Tsokos M, 2012, PEDIATR DEVEL PATHOL, V15, P108, DOI 10.2350/11-08-1078-PB.1
   van der Schaft DWJ, 2005, CANCER RES, V65, P11520, DOI 10.1158/008-5472.CAN-05-2468
   van der Warp HB, 2010, PLOS MED, V7
   von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305
   Wachsberger P, 2003, CLIN CANCER RES, V9, P1957
   Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055
   Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Zschenker O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034279
NR 45
TC 25
Z9 26
U1 1
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2014
VL 35
IS 22
BP 5785
EP 5794
DI 10.1016/j.biomaterials.2014.03.081
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AI2NI
UT WOS:000336694700015
PM 24746967
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Glass, KA
   Link, JM
   Brunger, JM
   Moutos, FT
   Gersbach, CA
   Guilak, F
AF Glass, Katherine A.
   Link, Jarrett M.
   Brunger, Jonathan M.
   Moutos, Franklin T.
   Gersbach, Charles A.
   Guilak, Farshid
TI Tissue-engineered cartilage with inducible and tunable immunomodulatory
   properties
SO BIOMATERIALS
LA English
DT Article
DE Bioactive biomaterial; Mesenchymal stem cell; Lentivirus; Cartilage
   repair; Osteoarthritis; Immunoengineering
ID MESENCHYMAL STEM-CELLS; NECROSIS-FACTOR-ALPHA; MARROW STROMAL CELLS;
   IN-VITRO; ARTICULAR-CARTILAGE; BONE-MARROW; GENE DELIVERY; ENDOCHONDRAL
   OSSIFICATION; SYNOVIAL-FLUID; POLY(EPSILON-CAPROLACTONE) SCAFFOLDS
AB The pathogenesis of osteoarthritis is mediated in part by inflammatory cytokines including interleukin-1 (IL-1), which promote degradation of articular cartilage and prevent human mesenchymal stem cell (MSC) chondrogenesis. In this study, we combined gene therapy and functional tissue engineering to develop engineered cartilage with immunomodulatory properties that allow chondrogenesis in the presence of pathologic levels of IL-1 by inducing overexpression of IL-1 receptor antagonist (IL-1Ra) in MSCs via scaffold-mediated lentiviral gene delivery. A doxycycline-inducible vector was used to transduce MSCs in monolayer or within 3D woven PCL scaffolds to enable tunable IL-1Ra production. In the presence of IL-1, IL-1Ra-expressing engineered cartilage produced cartilage-specific extracellular matrix, while resisting IL-1-induced upregulation of matrix metalloproteinases and maintaining mechanical properties similar to native articular cartilage. The ability of functional engineered cartilage to deliver tunable anti-inflammatory cytokines to the joint may enhance the long-term success of therapies for cartilage injuries or osteoarthritis. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Glass, Katherine A.; Link, Jarrett M.; Brunger, Jonathan M.; Moutos, Franklin T.; Gersbach, Charles A.; Guilak, Farshid] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27710 USA.
   [Glass, Katherine A.; Link, Jarrett M.; Brunger, Jonathan M.; Gersbach, Charles A.; Guilak, Farshid] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   [Guilak, Farshid] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.
RP Guilak, F (reprint author), Duke Univ, Med Ctr, 375 MSRB,Box 3093, Durham, NC 27710 USA.
EM charles.gersbach@duke.edu; guilak@duke.edu
OI Guilak, Farshid/0000-0001-7380-0330
FU NIH [AR061042, AR50245, AR48852, AG15768, AR48182, AG46927, OD008586,
   P01 CA47741]; NSF CAREER Award [CBET-1151035]; Collaborative Research
   Center, AO Foundation, Davos, Switzerland; Arthritis Foundation; Nancy
   Taylor Foundation; NSF GRFP
FX Supported by NIH grants AR061042, AR50245, AR48852, AG15768, AR48182,
   AG46927, OD008586, NSF CAREER Award CBET-1151035, the Collaborative
   Research Center, AO Foundation, Davos, Switzerland, the Arthritis
   Foundation, the Nancy Taylor Foundation, and the NSF GRFP. We thank
   Tyler Gibson for modifications to the TMPrtTA vector and Christopher
   Rowland for assistance with SEM imaging. We also thank Dr. Nelson Chao
   for providing bone marrow (NIH grant P01 CA47741).
CR Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2655
   Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359
   ATHANASIOU KA, 1994, J ORTHOPAED RES, V12, P340, DOI 10.1002/jor.1100120306
   Barde I, 2006, MOL THER, V13, P382, DOI 10.1016/j.ymthe.2005.09.012
   Basile P, 2008, MOL THER, V16, P466, DOI 10.1038/sj.mt.6300395
   Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006
   Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247
   Brandt KD, 2005, ARTHRITIS RHEUM-US, V52, P2015, DOI 10.1002/art.21122
   Brunger JM, 2014, P NATL ACAD SCI USA, V111, pE798, DOI 10.1073/pnas.1321744111
   Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065
   Chevalier X, 2009, ARTHRIT RHEUM-ARTHR, V61, P344, DOI 10.1002/art.24096
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Clark CA, 2005, BIOCHEM BIOPH RES CO, V328, P764, DOI 10.1016/j.bbrc.2004.11.074
   Cucchiarini M, 2005, MOL THER, V12, P229, DOI 10.1016/j.ymthe.2005.03.012
   Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI [10.1089/ten.tea.2009.0398, 10.1089/ten.TEA.2009.0398]
   Diekman BO, 2013, CURR OPIN RHEUMATOL, V25, P119, DOI 10.1097/BOR.0b013e32835aa28d
   EGG D, 1984, Z RHEUMATOL, V43, P89
   Evans CH, 2013, TRANSL RES, V161, P205, DOI 10.1016/j.trsl.2013.01.002
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Farrell E, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-31
   Fermor B, 2002, OSTEOARTHR CARTILAGE, V10, P792, DOI 10.1053/joca.2002.0832
   Ferreira E, 2013, J BIOL CHEM, V288, P29494, DOI 10.1074/jbc.M113.471268
   Gersbach CA, 2007, BIOMATERIALS, V28, P5121, DOI 10.1016/j.biomaterials.2007.07.047
   Gersbach CA, 2007, ANNU REV BIOMED ENG, V9, P87, DOI 10.1146/annurev.bioeng.9.060906.151949
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Goldring MB, 1996, AM J THER, V3, P9
   Goodrich LR, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.61
   Gorth DJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3932
   GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603
   Heldens GTH, 2012, TISSUE ENG PT A, V18, P45, DOI [10.1089/ten.tea.2011.0083, 10.1089/ten.TEA.2011.0083]
   Holladay C, 2011, MOL THER, V19, P969, DOI 10.1038/mt.2010.311
   Hu WW, 2007, GENE THER, V14, P891, DOI 10.1038/sj.gt.3302940
   Jacques C, 2006, VITAM HORM, V74, P371, DOI 10.1016/S0083-6729(06)74016-X
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196
   Kay JD, 2009, J GENE MED, V11, P605, DOI 10.1002/jgm.1334
   Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176
   Leddy HA, 2004, J BIOMED MATER RES B, V70B, P397, DOI 10.1002/jbm.b.30053
   Lee HH, 2013, OSTEOARTHR CARTILAGE, V21, P385, DOI 10.1016/j.joca.2012.11.010
   Liao IC, 2009, J CONTROL RELEASE, V139, P48, DOI 10.1016/j.jconrel.2009.06.007
   Lima EG, 2008, TISSUE ENG PT A, V14, P1721, DOI 10.1089/ten.tea.2007.0347
   Madry H, 2003, HUM GENE THER, V14, P393, DOI 10.1089/104303403321208998
   Mais A, 2006, J CELL BIOCHEM, V98, P798, DOI 10.1002/jcb.20786
   Mangiapani D, 2012, INHIBITION INTERLEUK
   McNulty AL, 2007, ARTHRITIS RHEUM, V56, P3033, DOI 10.1002/art.22839
   McNulty AL, 2013, J ORTHOP RES, V31, P1039, DOI 10.1002/jor.22334
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Moutos FT, 2010, TISSUE ENG PT A, V16, P1291, DOI [10.1089/ten.tea.2009.0480, 10.1089/ten.TEA.2009.0480]
   Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Mumme M, 2012, EUR CELLS MATER, V24, P224, DOI 10.22203/eCM.v024a16
   Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905
   Neumann AJ, 2013, MOL BIOTECHNOL, V53, P207, DOI 10.1007/s12033-012-9522-y
   Ousema PH, 2012, BIOMATERIALS, V33, P8967, DOI 10.1016/j.biomaterials.2012.08.045
   Phillips JE, 2008, P NATL ACAD SCI USA, V105, P12170, DOI [10.1073/pnas.0801988105, 10.1073/pnas.0B019BB105]
   Pountos I, 2011, J CELL MOL MED, V15, P525, DOI 10.1111/j.1582-4934.2010.01006.x
   Rainbow RS, 2013, OSTEOARTHR CARTILAGE, V21, P990, DOI 10.1016/j.joca.2013.04.011
   Ramachandran M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3459
   Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6
   Riera KM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3515
   Salmon P, 2007, CURR PROTOC HUM GENE, DOI DOI 10.1002/0471142905.HG0808S52
   Schlaak JF, 1996, CLIN EXP RHEUMATOL, V14, P155
   Scotti C, 2013, P NATL ACAD SCI USA, V110, P3997, DOI 10.1073/pnas.1220108110
   SECKINGER P, 1987, J IMMUNOL, V139, P1546
   Shamji MF, 2007, ARTHRITIS RHEUM, V56, P3650, DOI 10.1002/art.22952
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197
   Vacanti JP, 1999, LANCET, V354, pSI32
   Valonen PK, 2010, BIOMATERIALS, V31, P2193, DOI 10.1016/j.biomaterials.2009.11.092
   Watson RS, 2013, GENE THER, V20, P670, DOI 10.1038/gt.2012.81
   Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352
   Whitmire RE, 2012, BIOMATERIALS, V33, P7665, DOI 10.1016/j.biomaterials.2012.06.101
   Willard VP, 2013, OSTEOARTHR CARTILAGE, V21, pS281, DOI 10.1016/j.joca.2013.02.590
   Wilusz RE, 2008, J ORTHOP RES, V26, P504, DOI 10.1002/jor.20538
   Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914
NR 76
TC 25
Z9 24
U1 1
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2014
VL 35
IS 22
BP 5921
EP 5931
DI 10.1016/j.biomaterials.2014.03.073
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AI2NI
UT WOS:000336694700028
PM 24767790
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wang, Y
   Domingues, JED
   Subbiandoss, G
   van der Mei, HC
   Busscher, HJ
   Libera, M
AF Wang, Yi
   Domingues, Joana E. da Silva
   Subbiandoss, Guruprakash
   van der Mei, Henny C.
   Busscher, Henk J.
   Libera, Matthew
TI Conditions of lateral surface confinement that promote tissue-cell
   integration and inhibit biofilm growth
SO BIOMATERIALS
LA English
DT Article
DE Biofilm; Cell adhesion; Infection; Micropatterning; Osteoblast;
   Polyethylene oxide
ID BACTERIAL ADHESION; POLY(ETHYLENE GLYCOL); REVEALS
AB Surfaces with cell adhesiveness modulated at micro length scales can exploit differences between tissue/bacterial cell size, membrane/wall plasticity, and adhesion mechanisms to differentially control tissue-cell/material and bacteria/material interactions. This study explores the short-term interactions of Staphylococcus aureus and osteoblast-like cells with surfaces consisting of cell-adhesive circular patches (1-5 mu m diameter) separated by non-adhesive electron-beam patterned poly(ethylene glycol) hydrogel thin films at inter-patch distances of 0.5-10 mu m. Osteoblast-like U2OS cells both bind to and spread on the modulated surfaces, in some cases when the cell-adhesive area comprises only 9% of the total surface and in several cases at least as well as on the continuously adhesive control surfaces. In contrast, S. aureus adhesion rates are 7-20 times less on the modulated surfaces than on the control surfaces. Furthermore, the proliferation of those bacteria that do adhere is inhibited by the lateral confinement imposed by the non-adhesive boundaries surrounding each patch. These findings suggest a new approach to create biomaterial surfaces that may promote healing while simultaneously reducing the probability of infection. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Wang, Yi; Libera, Matthew] Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA.
   [Wang, Yi; Domingues, Joana E. da Silva; Subbiandoss, Guruprakash; van der Mei, Henny C.; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP Libera, M (reprint author), Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA.
EM mlibera@stevens.edu
RI Wang, Yi/L-8468-2014
OI Wang, Yi/0000-0001-5495-5839
FU U.S. Army Research Office [W911NF-12-1-0331]
FX This project was partially supported by the U.S. Army Research Office
   via grant #W911NF-12-1-0331. H.J. Busscher is also director of a
   consulting company, SASA BV (GN Schutterlaan 4, 9797 PC Thesinge, The
   Netherlands). The authors declare no potential conflicts of interest
   with respect to authorship and/or publication of this article. Opinions
   and assertions contained herein are those of the authors and are not
   construed as necessarily representing views of the funding organization
   or their respective employers.
CR Arnold M, 2009, SOFT MATTER, V5, P72, DOI 10.1039/b815634d
   Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Carnes EC, 2010, NAT CHEM BIOL, V6, P41, DOI [10.1038/nchembio.264, 10.1038/NCHEMBIO.264]
   Cavalcanti-Adam EA, 2008, HFSP J, V2, P276, DOI 10.2976/1.2976662
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   Cole MA, 2009, BIOMATERIALS, V30, P1827, DOI 10.1016/j.biomaterials.2008.12.026
   De Ruijter JE, 2001, TISSUE ENG, V7, P279, DOI 10.1089/10763270152044143
   Flickinger ST, 2011, J AM CHEM SOC, V133, P5966, DOI 10.1021/ja111131f
   Glass R, 2004, NEW J PHYS, V6, P1
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k
   Hyun JK, 2008, P NATL ACAD SCI USA, V105, P18188
   Ivanova E. P., 2013, NAT COMMUN, P4
   Kappell GM, 2009, ELECTRON J BIOTECHN, V12, P1215
   Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   Krsko P, 2003, LANGMUIR, V19, P5618, DOI 10.1021/la034157r
   Lewis Kim, 2012, Handb Exp Pharmacol, P121, DOI 10.1007/978-3-642-28951-4_8
   Magin CM, 2010, MATER TODAY, V13, P36, DOI 10.1016/S1369-7021(10)70058-4
   Malmstrom J, 2010, NANO LETT, V10, P686, DOI 10.1021/nl903875r
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957
   Vincent ME, 2010, CHEM SOC REV, V39, P974, DOI 10.1039/b917851a
   Wang QC, 2012, ACS APPL MATER INTER, V4, P2498, DOI 10.1021/am300197m
   Wang Y, 2013, J POLYM SCI POL PHYS, V51, P1543, DOI 10.1002/polb.23367
   Wang Y, 2011, ADV FUNCT MATER, V21, P3916, DOI 10.1002/adfm.201100659
   Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 33
TC 22
Z9 22
U1 4
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2014
VL 35
IS 21
BP 5446
EP 5452
DI 10.1016/j.biomaterials.2014.03.057
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AH7WL
UT WOS:000336346000003
PM 24726539
DA 2018-10-20
ER

PT J
AU Borah, BM
   Halter, TJ
   Xie, BQ
   Henneman, ZJ
   Siudzinski, TR
   Harris, S
   Elliott, M
   Nancollas, GH
AF Borah, Ballav M.
   Halter, Timothy J.
   Xie, Baoquan
   Henneman, Zachary J.
   Siudzinski, Thomas R.
   Harris, Stephen
   Elliott, Matthew
   Nancollas, George H.
TI Kinetics of canine dental calculus crystallization: An in vitro study on
   the influence of inorganic components of canine saliva
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Carbonated hydroxyapatite; Calcium phosphate; Calcium carbonate; Dental
   calculus; Saliva; Biomaterial; Nucleation; Supersaturated solution
ID CALCIUM; PRECIPITATION; SUPRAGINGIVAL; PHOSPHATE; DOG; PH
AB This work identifies carbonated hydroxyapatite (CAP) as the primary component of canine dental calculus, and corrects the long held belief that canine dental calculus is primarily CaCO3 (calcite). CAP is known to be the principal crystalline component of human dental calculus, suggesting that there are previously unknown similarities in the calcification that occurs in these two unique oral environments. In vitro kinetic experiments mimicking the inorganic components of canine saliva have examined the mechanisms of dental calculus formation. The solutions were prepared so as to mimic the inorganic components of canine saliva; phosphate, carbonate, and magnesium ion concentrations were varied individually to investigate the roll of these ions in controlling the nature of the phases that is nucleated. To date, the inorganic components of the canine oral systems have not been investigated at concentrations that mimic those in vivo. The mineral composition of the synthetic calculi grown under these conditions closely resembled samples excised from canines. This finding adds new information about calculus formation in humans and canines, and their sensitivity to chemicals used to treat these conditions. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Borah, Ballav M.; Halter, Timothy J.; Xie, Baoquan; Henneman, Zachary J.; Siudzinski, Thomas R.; Nancollas, George H.] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.
   [Harris, Stephen] Waltham Ctr Pet Nutr, Leicester LE14 4RT, Leics, England.
   [Elliott, Matthew] Mars Care & Treats Europe, Oakwell Way WF17 9LU, Birstall, England.
RP Nancollas, GH (reprint author), SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.
EM ghn@buffalo.edu
RI Borah, Ballav/B-3502-2014
OI Borah, Ballav/0000-0002-4436-029X; Harris, Stephen/0000-0002-4422-612X;
   Harris, Stephen/0000-0002-3843-159X
FU Waltham Centre for Pet Nutrition, Waltham on the Wolds, Melton Mowbray,
   Leicestershire, UK [LE14 4RT]; Mars Care & Treats Europe, Oakwell Way,
   Birstall, UK [WF17 9LU]; National Institute of Dental and Craniofacial
   Research (NIDCR) [DE003223]
FX We thank Waltham Centre for Pet Nutrition, Waltham on the Wolds, Melton
   Mowbray, Leicestershire, LE14 4RT, UK and Mars Care & Treats Europe,
   Oakwell Way, Birstall, WF17 9LU, UK and National Institute of Dental and
   Craniofacial Research (NIDCR) Grant DE003223 to G.H.N. for support of
   this work. We are also grateful to Dr. Sarbajit Banerjee for the
   micro-Raman studies.
CR Bertinetti L, 2009, LANGMUIR, V25, P5647, DOI 10.1021/la804230j
   Chowdhury EH, 2006, GENE, V376, P87, DOI 10.1016/j.gene.2006.02.028
   Chowdhury E.H., 2013, ADV BIOMATER SCI BIO, P265
   CHRISTOFFERSEN J, 1978, J CRYST GROWTH, V43, P501, DOI 10.1016/0022-0248(78)90350-0
   FRISKOPP J, 1984, SCAND J DENT RES, V92, P25
   Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271
   HAY DI, 1979, INORG PERSPECT BIOL, V2, P271
   JENSEN AT, 1954, J DENT RES, V33, P741, DOI 10.1177/00220345540330060201
   Jin Y, 2002, CRIT REV ORAL BIOL M, V13, P426, DOI 10.1177/154411130201300506
   LARMAS M, 1971, ACTA ODONTOL SCAND, V29, P205, DOI 10.3109/00016357109026516
   Larsen MJ, 2003, ARCH ORAL BIOL, V48, P317, DOI 10.1016/S0003-9969(03)00007-4
   LEGEROS RZ, 1974, J DENT RES, V53, P45
   LEGEROS RZ, 1979, J DENT RES, V58, P2371, DOI 10.1177/00220345790580120801
   Luoma H, 1988, Magnes Res, V1, P223
   Meldrum Fiona C., 2008, SCIENCE, V322, P1802
   Raz S, 2000, ADV MATER, V12, P38, DOI 10.1002/(SICI)1521-4095(200001)12:1<38::AID-ADMA38>3.3.CO;2-9
   ROBINSON C, 1995, DENTAL ENAMEL FORMAT
   SAITOH E, 1985, ARCH ORAL BIOL, V30, P641, DOI 10.1016/0003-9969(85)90086-X
   SCHROEDER JH, 1969, GEOL SOC AM BULL, V80, P1613, DOI 10.1130/0016-7606(1969)80[1613:PPIES]2.0.CO;2
   SHYU LJ, 1983, J DENT RES, V62, P398, DOI 10.1177/00220345830620031901
   Tribello Gareth A., 2009, J PHYS CHEM B, V113, P11680
   UYEN HM, 1989, J CLIN PERIODONTOL, V16, P393, DOI 10.1111/j.1600-051X.1989.tb01666.x
   Yang XD, 2011, CRYSTENGCOMM, V13, P1153, DOI 10.1039/c0ce00470g
NR 23
TC 3
Z9 3
U1 2
U2 33
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD JUL 1
PY 2014
VL 425
BP 20
EP 26
DI 10.1016/j.jcis.2014.03.029
PG 7
WC Chemistry, Physical
SC Chemistry
GA AG7TB
UT WOS:000335620500004
PM 24776659
DA 2018-10-20
ER

PT J
AU Serena, S
   Sainz, MA
   Caballero, A
AF Serena, S.
   Sainz, M. A.
   Caballero, A.
TI Single-phase silicocarnotite synthesis in the subsystem
   Ca-3(PO4)(2)-Ca2SiO4
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Silicocarnotite; Synthesis; Biomaterials
ID SILICON-SUBSTITUTED HYDROXYAPATITES; ALPHA-TRICALCIUM PHOSPHATE;
   DICALCIUM SILICATE; PART I; SYSTEM; GLASS; BIOCERAMICS; SPECTROSCOPY;
   BIOACTIVITY; POLYMORPHS
AB In the last years, the addition of silicon to hydroxyapatite and tricalcium-phosphate materials is being widely studied, due to the well-known influence of silicon on bone formation. Silicocarnotite (Ca-5(PO4)(2)SiO4) presents a structure type carnotite, very close to hydroxyapatite, with a wide range of Ca2+, SiO44- and PO43- solid solutions. These characteristics make silicocarnotite attractive as potential biomaterial.
   In this work, the synthesis of silicocarnotite has been studied by a simple and economical method. The formulation and thermal treatment have been designed based on the information supplied by the Ca-3(PO4)(2)-Ca2SiO4 phase diagram. Single-phase silicocarnotite material has been obtained from stoichiometric mixtures of tricalcium phosphate and dicalcium silicate. In order to optimize the synthesis conditions, a two-stage heating was used: heating at 1550 degrees C/2 h and subsequent annealing at 1400 degrees C/4 h. Mineralogical and microstructural characterizations of the obtained material have been determined by X-Ray Diffraction, Fourier Transform Infrared Spectrometry Attenuated Total Reflection and Micro-Raman and Scanning electron microscopy. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Serena, S.; Sainz, M. A.; Caballero, A.] CSIC, Inst Ceram & Vidrio, Dept Ceram, E-28049 Madrid, Spain.
RP Serena, S (reprint author), CSIC, Inst Ceram & Vidrio, Dept Ceram, Plaza Murillo 2, E-28049 Madrid, Spain.
EM serena@icv.csic.es
RI Caballero, Angel/U-3673-2017
OI Caballero, Angel/0000-0001-8659-7175
CR Balas F, 2003, J BIOMED MATER RES A, V66A, P364, DOI 10.1002/jbm.a.10579
   Bianco A, 2009, MATER RES BULL, V44, P345, DOI 10.1016/j.materresbull.2008.05.013
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Carrodeguas RG, 2008, J AM CERAM SOC, V91, P1281, DOI 10.1111/j.1551-2916.2008.02294.x
   DICKENS B, 1971, TSCHERMAKS MINERALOG, V0016
   FIX W, 1969, J AM CERAM SOC, V52, P346, DOI 10.1111/j.1151-2916.1969.tb11948.x
   GHOSH SN, 1979, J MATER SCI, V14, P1554, DOI 10.1007/BF00569274
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Gomes S, 2011, CRYST GROWTH DES, V11, P4017, DOI 10.1021/cg200587s
   Handke M, 2003, J MOL STRUCT, V651, P39, DOI 10.1016/S0022-2860(03)00099-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hristov V, 2009, CENT EUR J CHEM, V7, P702, DOI 10.2478/s11532-009-0067-2
   Hullbert S.F., 1982, CERAM INT, V8, P131
   Ibanez J, 2007, J RAMAN SPECTROSC, V38, P61, DOI 10.1002/jrs.1599
   Jillavenkatesa A, 1998, SPECTROSC LETT, V31, P1619, DOI 10.1080/00387019808007439
   Mami M, 2008, APPL SURF SCI, V254, P7386, DOI 10.1016/j.apsusc.2008.05.340
   NURSE RW, 1959, J CHEM SOC, P1077, DOI 10.1039/jr9590001077
   Oonishi H, 2000, J BIOMED MATER RES, V51, P37, DOI 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
   Palard M, 2008, J SOLID STATE CHEM, V181, P1950, DOI 10.1016/j.jssc.2008.04.027
   Pappas GS, 2008, J NON-CRYST SOLIDS, V354, P755, DOI 10.1016/j.jnoncrysol.2007.09.007
   PLIEGOCUERVO Y, 1978, CEMENT CONCRETE RES, V8, P519, DOI 10.1016/0008-8846(78)90033-9
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   PUERTAS F, 1985, CEMENT CONCRETE RES, V15, P127, DOI 10.1016/0008-8846(85)90017-1
   Radev L., 2011, PROCESS APPL CERAM, V5, P161
   Radev L, 2009, CENT EUR J CHEM, V7, P317, DOI 10.2478/s11532-009-0022-2
   Reid JW, 2006, BIOMATERIALS, V27, P2916, DOI 10.1016/j.biomaterials.2006.01.007
   Reis J.W., 2006, BIOMATERIALS, V27, P2916
   Remy C, 1997, J AM CERAM SOC, V80, P413
   Rubio V, 2011, J AM CERAM SOC, V94, P4459, DOI 10.1111/j.1551-2916.2011.04716.x
   Serena S, 2011, J AM CERAM SOC, V94, P3094, DOI 10.1111/j.1551-2916.2011.04445.x
   Szumera M, 2007, J THERM ANAL CALORIM, V88, P151, DOI 10.1007/s10973-006-8118-9
   Vallet-Regi M, 2005, J MATER CHEM, V15, P1509, DOI 10.1039/b414143a
NR 33
TC 14
Z9 14
U1 1
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD JUL
PY 2014
VL 40
IS 6
BP 8245
EP 8252
DI 10.1016/j.ceramint.2014.01.022
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA AG1UN
UT WOS:000335201800074
DA 2018-10-20
ER

PT J
AU Deniz, F
AF Deniz, Fatih
TI Effective Removal of Maxilon Red GRL from Aqueous Solutions by Walnut
   Shell: Nonlinear Kinetic and Equilibrium Models
SO ENVIRONMENTAL PROGRESS & SUSTAINABLE ENERGY
LA English
DT Article
DE biomaterials; dye biosorption; Maxilon Red GRL; nonlinear models; walnut
   shell
ID METHYLENE-BLUE; DYE ADSORPTION; BIOSORPTION; ISOTHERM; POWDER
AB The feasibility of walnut shell as a waste biomaterial for removing Maxilon Red GRL (MR GRL) dye from aqueous solutions was investigated in this work. The biosorption was studied as a function of pH, ionic strength, biosorbent dosage, particle size, temperature, initial dye concentration, and contact time. Nonlinear kinetic equations including the pseudo-first order, pseudo-second order, and Logistic were applied to the experimental data for describing the biosorption kinetics. The Logistic model showed the best correlation with the experimental data. Besides, intraparticle diffusion was not the sole rate-controlling factor. The Langmuir, Freundlich, Hill, and Dubinin-Radushkevich nonlinear isotherms were fitted to the equilibrium data, and the Hill model presented the best fit. Thus, this research highlights the potential of walnut shell as an effective biosorbent for the removal of MR GRL from aqueous media. (c) 2013 American Institute of Chemical Engineers Environ Prog, 33: 396-401, 2014
C1 Nigar Erturk Trade Vocat High Sch, TR-27590 Gaziantep, Turkey.
RP Deniz, F (reprint author), Nigar Erturk Trade Vocat High Sch, TR-27590 Gaziantep, Turkey.
EM f_deniz@windowslive.com
RI Deniz, Fatih/E-5471-2015
OI Deniz, Fatih/0000-0002-2771-2652
CR Aksu Z, 2010, J ENVIRON MANAGE, V91, P1546, DOI 10.1016/j.jenvman.2010.02.026
   Altun T, 2012, FOOD CHEM, V132, P693, DOI 10.1016/j.foodchem.2011.10.099
   Cazetta AL, 2011, CHEM ENG J, V174, P117, DOI 10.1016/j.cej.2011.08.058
   Chowdhury S, 2012, ENVIRON PROG SUSTAIN, V31, P415, DOI 10.1002/ep.10564
   Chowdhury S, 2010, CHEM ENG J, V164, P168, DOI 10.1016/j.cej.2010.08.050
   Das Saha P, 2012, COLLOID SURFACE B, V92, P262, DOI 10.1016/j.colsurfb.2011.11.057
   Dogan M, 2009, J HAZARD MATER, V164, P172, DOI 10.1016/j.jhazmat.2008.07.155
   Don MM, 2010, BIOCHEM ENG J, V49, P95, DOI 10.1016/j.bej.2009.12.001
   Eroglu E, 2010, INT J HYDROGEN ENERG, V35, P5293, DOI 10.1016/j.ijhydene.2010.03.063
   Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013
   Gadd GM, 2009, J CHEM TECHNOL BIOT, V84, P13, DOI 10.1002/jctb.1999
   Han XL, 2011, CHEM ENG J, V171, P1, DOI 10.1016/j.cej.2011.02.067
   Hu LC, 2012, PHYSICA A, V391, P731, DOI 10.1016/j.physa.2011.08.048
   Khambhaty Y, 2012, ECOL ENG, V41, P74, DOI 10.1016/j.ecoleng.2012.01.002
   Kousha M, 2012, CHEM ENG J, V179, P158, DOI 10.1016/j.cej.2011.10.073
   Kumar PS, 2010, DESALINATION, V261, P52, DOI 10.1016/j.desal.2010.05.032
   Li P, 2010, J HAZARD MATER, V179, P43, DOI 10.1016/j.jhazmat.2010.02.054
   Mahmoodi NM, 2012, IND CROP PROD, V35, P295, DOI 10.1016/j.indcrop.2011.07.015
   Mahmoodi NM, 2011, J APPL POLYM SCI, V122, P1489, DOI 10.1002/app.34235
   Mahmoodi NM, 2010, DESALINATION, V264, P134, DOI 10.1016/j.desal.2010.07.017
   Reddy MCS, 2012, J HAZARD MATER, V203, P118, DOI 10.1016/j.jhazmat.2011.11.083
   Ringot D, 2007, BIORESOURCE TECHNOL, V98, P1812, DOI 10.1016/j.biortech.2006.06.015
   Saadat S, 2011, CHEM ENG J, V173, P743, DOI 10.1016/j.cej.2011.08.042
   Safa Y, 2011, CAN J CHEM ENG, V89, P1554, DOI 10.1002/cjce.20473
   Sahmoune MN, 2012, ENVIRON PROG SUSTAIN, V31, P597, DOI 10.1002/ep.10594
   Salleh MAM, 2011, DESALINATION, V280, P1, DOI 10.1016/j.desal.2011.07.019
   Shah BA, 2011, ENVIRON PROG SUSTAIN, V30, P549, DOI 10.1002/ep.10505
   Sharma P, 2011, ENVIRON MONIT ASSESS, V183, P151, DOI 10.1007/s10661-011-1914-0
   Srinivasan A, 2008, BIORESOURCE TECHNOL, V99, P8217, DOI 10.1016/j.biortech.2008.03.072
   Zabihi M, 2010, J HAZARD MATER, V174, P251, DOI 10.1016/j.jhazmat.2009.09.044
NR 30
TC 2
Z9 2
U1 1
U2 30
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1944-7442
EI 1944-7450
J9 ENVIRON PROG SUSTAIN
JI Environ. Prog. Sustain. Energy
PD JUL
PY 2014
VL 33
IS 2
BP 396
EP 401
DI 10.1002/ep.11797
PG 6
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Engineering, Chemical; Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA AE9BL
UT WOS:000334298800009
DA 2018-10-20
ER

PT J
AU Resende, RR
   Fonseca, EA
   Tonelli, FMP
   Sousa, BR
   Santos, AK
   Gomes, KN
   Guatimosim, S
   Kihara, AH
   Ladeira, LO
AF Resende, Rodrigo R.
   Fonseca, Emerson A.
   Tonelli, Fernanda M. P.
   Sousa, Bruna R.
   Santos, Anderson K.
   Gomes, Katia N.
   Guatimosim, Silvia
   Kihara, Alexandre H.
   Ladeira, Luiz Orlando
TI Scale/Topography of Substrates Surface Resembling Extracellular Matrix
   for Tissue Engineering
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Review
DE Nanobiotechnology; Stem Cells; Tissue Engineering; Top-Down Approach;
   Extracellular Matrix
ID EMBRYONIC STEM-CELLS; 3-DIMENSIONAL COLLAGEN MATRICES; ULTRATHIN
   FIBRONECTIN FIBERS; INTEGRATIVE CARTILAGE REPAIR; NANO-STRUCTURED
   SURFACES; POLYMER-PEN LITHOGRAPHY; DRUG CONTROLLED-RELEASE; FOCAL
   ADHESION KINASE; FIBRO-POROUS MESHES; GLYCOL BLEND FIBERS
AB Biomaterial matrices are being developed that mimic the key characteristics of the extracellular matrix, including presenting adhesion sites and displaying growth factors in the context of a viscoelastic hydrogel. This review focuses on two classes of materials: those that are derived from naturally occurring molecules and those that recapitulate key motifs of biomolecules within biologically active synthetic materials. We also discussed some of the most significant biological features of the ECM, and several engineering methods currently being implemented to design and tune synthetic scaffolds to mimic these features. Understanding the cell-protein-material interaction is fundamental for developing more powerful tools in tissue engineering and regenerative medicine strategies. The design of model substrates including the presence of well-defined properties (chemistry, topography, stiffness) and even the gradient of these properties in three dimensional environments must lead in the near future to learn more about the specific roles of protein adsorption and the very dynamic process related to the cell fate of synthetic substrates: cell adhesion, matrix reorganisation, deposition and degradation at the cell-material interface. These materials will open new doors to biosurgical therapeutics in tissue engineering and regenerative medicine.
C1 [Resende, Rodrigo R.; Fonseca, Emerson A.; Tonelli, Fernanda M. P.; Sousa, Bruna R.; Santos, Anderson K.; Gomes, Katia N.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Cell Signaling & Nanobiotechnol Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Guatimosim, Silvia] Univ Fed Minas Gerais, Dept Physiol & Biophys, BR-31270901 Belo Horizonte, MG, Brazil.
   [Kihara, Alexandre H.] Univ Fed ABC, Ctr Matemat Comp & Cognicao, BR-09210580 Santo Andre, SP, Brazil.
   [Ladeira, Luiz Orlando] Univ Fed Minas Gerais, Dept Phys, Nanomat Lab, BR-31270901 Belo Horizonte, MG, Brazil.
   [Ladeira, Luiz Orlando] Univ Fed Minas Gerais, Ctr Microscopy, BR-31270901 Belo Horizonte, MG, Brazil.
RP Resende, RR (reprint author), Univ Fed Minas Gerais, Dept Biochem & Immunol, Cell Signaling & Nanobiotechnol Lab, BR-31270901 Belo Horizonte, MG, Brazil.
EM resende@icb.ufmg.br
RI Tonelli, Fernanda/B-2594-2012; Kihara, Alexandre/C-2458-2012; Kenedy
   Santos, Anderson/A-1796-2011
OI Tonelli, Fernanda/0000-0002-2285-6710; Kihara,
   Alexandre/0000-0002-4027-7261; Kenedy Santos,
   Anderson/0000-0002-6185-3491
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico);
   FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais);
   FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)
FX The authors are grateful for CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico), FAPEMIG (Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais) and FAPESP (Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo) financial supports.
CR Adler AF, 2011, BIOMATERIALS, V32, P3611, DOI 10.1016/j.biomaterials.2011.01.040
   Ahmed Z, 1999, CELL MOTIL CYTOSKEL, V42, P331
   Ahmed Z, 2000, CELL MOTIL CYTOSKEL, V46, P6
   Amaya M. J., 2013, TRENDS STEM CELL PRO, P93
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Annis D, 1978, Trans Am Soc Artif Intern Organs, V24, P209
   Arnold M, 2009, SOFT MATTER, V5, P72, DOI 10.1039/b815634d
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak Stephen F., 2005, Anatomical Record Part B:The New Anatomist, V287, P36, DOI 10.1002/ar.b.20081
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bae WC, 2004, ANN BIOMED ENG, V32, P360, DOI 10.1023/B:ABME.0000017553.01798.12
   Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Behonick DJ, 2003, MECH DEVELOP, V120, P1327, DOI 10.1016/j.mod.2003.05.002
   Behring J, 2008, ODONTOLOGY, V96, P1, DOI 10.1007/s10266-008-0087-y
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102
   Beningo Karen A, 2007, Methods Mol Biol, V370, P203
   Bernstein Lori R., 1994, Current Opinion in Oncology, V6, P106, DOI 10.1097/00001622-199401000-00015
   Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Biazar E, 2013, J BIOMED NANOTECHNOL, V9, P1471, DOI 10.1166/jbn.2013.1639
   Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744
   Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   BRANDLEY BK, 1989, DEV BIOL, V135, P74, DOI 10.1016/0012-1606(89)90159-0
   Bravenboer JV, 2004, ARTHRITIS RES THER, V6, pR469, DOI 10.1186/ar1216
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   Buyuktimkin B, 2012, MOL PHARMACEUT, V9, P979, DOI 10.1021/mp200614q
   Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8
   Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0
   Buxton PG, 2008, BONE, V43, P377, DOI 10.1016/j.bone.2008.03.028
   Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199
   CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Cheema U, 2007, BIOTECHNOL BIOPROC E, V12, P9, DOI 10.1007/BF02931797
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Chin CD, 2008, BIOMED MICRODEVICES, V10, P459, DOI 10.1007/s10544-007-9155-2
   Chou AM, 2006, INT J ORAL MAX IMPL, V21, P526
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   CLARK RAF, 1993, DERMATOL CLIN, V11, P647, DOI 10.1016/S0733-8635(18)30218-3
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Curtis A, 1999, BIOCHEM SOC SYMP, V65, P15
   Curtis A S G, 2004, Eur Cell Mater, V8, P27
   da Silva EE, 2009, NANO RES, V2, P462, DOI 10.1007/s12274-009-9042-7
   Dado D, 2009, SEMIN CELL DEV BIOL, V20, P656, DOI 10.1016/j.semcdb.2009.02.001
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Dang JM, 2007, ADV MATER, V19, P2775, DOI 10.1002/adma.200602159
   Datta P, 2013, J BIOMED NANOTECHNOL, V9, P870, DOI 10.1166/jbn.2013.1592
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   DESMOULIERE A, 1995, AM J PATHOL, V146, P56
   DESMOULIERE A, 1994, FASEB J, V8, pA903
   DiMicco MA, 2001, J ORTHOPAED RES, V19, P1105, DOI 10.1016/S0736-0266(01)00037-7
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Dubey N, 1999, EXP NEUROL, V158, P338, DOI 10.1006/exnr.1999.7095
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Elloumi-Hannachi I, 2010, J INTERN MED, V267, P54, DOI 10.1111/j.1365-2796.2009.02185.x
   Engelhardt EM, 2010, J TISSUE ENG REGEN M, V4, P123, DOI 10.1002/term.222
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eriksen THB, 2013, J BIOMED NANOTECHNOL, V9, P492, DOI 10.1166/jbn.2013.1553
   Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8
   Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540
   EZZELL RM, 1993, EXP CELL RES, V208, P442, DOI 10.1006/excr.1993.1266
   FINI ME, 1992, ACTA OPHTHALMOL, V70, P26
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fluck J, 1998, J INVEST DERMATOL, V110, P153, DOI 10.1046/j.1523-1747.1998.00095.x
   Fluck J, 1996, J INVEST DERMATOL, V107, P284
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6
   Fringer J, 2001, J BIOL CHEM, V276, P31047, DOI 10.1074/jbc.M101898200
   Fringer JM, 2000, MOL BIOL CELL, V11, p395A
   Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Georgeu GA, 2005, CELL TISSUE RES, V320, P229, DOI 10.1007/s00441-004-1031-2
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Giam LR, 2012, P NATL ACAD SCI USA, V109, P4377, DOI 10.1073/pnas.1201086109
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gillies AR, 2011, TISSUE ENG PART C-ME, V17, P383, DOI [10.1089/ten.tec.2010.0438, 10.1089/ten.TEC.2010.0438]
   Glaser T, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-12
   Gobin AS, 2006, TISSUE ENG, V12, P3383, DOI 10.1089/ten.2006.12.3383
   Goh SK, 2013, BIOMATERIALS, V34, P6760, DOI 10.1016/j.biomaterials.2013.05.066
   Gorschewsky O, 2005, AM J SPORT MED, V33, P1202, DOI 10.1177/0363546504271510
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585
   GREEN AM, 1994, J BIOMED MATER RES, V28, P647, DOI 10.1002/jbm.820280515
   Grinnell F, 2006, EXP CELL RES, V312, P86, DOI 10.1016/j.yexcr.2005.010.001
   Grinnell F, 2003, MOL BIOL CELL, V14, P384, DOI 10.1091/mbc.E02-08-0493
   Grinnell F, 1999, EXP CELL RES, V248, P608, DOI 10.1006/excr.1999.4440
   GRINNELL F, 1986, J INVEST DERMATOL, V87, P382, DOI 10.1111/1523-1747.ep12524859
   GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401
   GROSS J, 1958, J BIOL CHEM, V233, P355
   Grynpas MD, 2002, BIOMATERIALS, V23, P2063, DOI 10.1016/S0142-9612(01)00336-2
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Gullberg D, 1995, INT J DEV BIOL, V39, P845
   Hadjipanayi E, 2009, J TISSUE ENG REGEN M, V3, P77, DOI 10.1002/term.136
   Hadjipanayi E, 2009, CELL MOTIL CYTOSKEL, V66, P121, DOI 10.1002/cm.20331
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001
   HATTORI S, 1985, J COLLOID INTERF SCI, V104, P72, DOI 10.1016/0021-9797(85)90010-4
   Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   He W, 2006, TISSUE ENG, V12, P2457, DOI 10.1089/ten.2006.12.2457
   Henry JA, 2009, ACTA BIOMATER, V5, P29, DOI 10.1016/j.actbio.2008.08.020
   Hori Y, 2001, INT J ARTIF ORGANS, V24, P50
   Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Huo FW, 2008, SCIENCE, V321, P1658, DOI 10.1126/science.1162193
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Jeong KI, 2013, J BIOMED NANOTECHNOL, V9, P535, DOI 10.1166/jbn.2013.1503
   Ji LJ, 2012, EUR CELLS MATER, V23, P135, DOI 10.22203/eCM.v023a10
   Jin L, 2012, J BIOMED NANOTECHNOL, V8, P779, DOI 10.1166/jbn.2012.1443
   Jin L, 2012, J BIOMED NANOTECHNOL, V8, P1, DOI 10.1166/jbn.2012.1360
   Jin SC, 2013, J BIOMED NANOTECHNOL, V9, P475, DOI 10.1166/jbn.2013.1505
   Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI [10.1016/j.biomaterials.2005.07.047, 10.1016/j.niomaterials.2005.07.047]
   Kai D, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/9/095705
   Kalakouti E., 2013, TRENDS STEM CELL PRO, P277
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karamichos D, 2007, J BIOMED MATER RES A, V83A, P887, DOI 10.1002/jbm.a.31423
   Karamichos D, 2006, J BIOMED MATER RES A, V78A, P407, DOI 10.1002/jbm.a.30814
   Kavya KC, 2012, J BIOMED NANOTECHNOL, V8, P149, DOI 10.1166/jbn.2012.1363
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim CS, 2005, BIOMATERIALS, V26, P2501, DOI 10.1016/j.biomaterials.2004.07.015
   Kim DH, 2012, INTEGR BIOL-UK, V4, P1019, DOI 10.1039/c2ib20067h
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kim EJ, 2010, ACTA BIOMATER, V6, P160, DOI 10.1016/j.actbio.2009.06.016
   Kingham E, 2013, SMALL, V9, P2140, DOI 10.1002/smll.201202340
   Kinneberg KRC, 2010, J ORTHOP RES, V28, P1092, DOI 10.1002/jor.21095
   Kroehne V, 2008, J CELL MOL MED, V12, P1640, DOI 10.1111/j.1582-4934.2008.00238.x
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   Kushida A, 2000, J BIOMED MATER RES, V51, P216, DOI 10.1002/(SICI)1097-4636(200008)51:2<216::AID-JBM10>3.0.CO;2-K
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CSD, 2007, BIOMATERIALS, V28, P2987, DOI 10.1016/j.biomaterials.2007.02.035
   Lee JB, 2013, J BIOMED NANOTECHNOL, V9, P424, DOI 10.1166/jbn.2013.1514
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X
   Li WS, 2008, J MATER SCI-MATER M, V19, P847, DOI 10.1007/s10856-007-3087-5
   Liao X, 2010, SMALL, V6, P1082, DOI 10.1002/smll.200901538
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Lin YC, 1998, EXP CELL RES, V240, P377, DOI 10.1006/excr.1998.4013
   Lin YC, 2009, ACTA BIOMATER, V5, P2591, DOI 10.1016/j.actbio.2009.03.038
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lo CM, 1999, MOL BIOL CELL, V10, p259A
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Lumpkins SB, 2008, ACTA BIOMATER, V4, P808, DOI 10.1016/j.actbio.2008.01.016
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Mai JY, 2007, BIOMED MICRODEVICES, V9, P523, DOI 10.1007/s10544-007-9060-8
   Malmstrom J, 2011, NANO LETT, V11, P2264, DOI 10.1021/nl200447q
   Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166
   Mandeville JTH, 1997, J LEUKOCYTE BIOL, V61, P188
   Marenzana M, 2007, CELL TISSUE RES, V327, P293, DOI 10.1007/s00441-006-0316-z
   Martines E, 2004, IEEE T NANOBIOSCI, V3, P90, DOI [10.1109/TNB.2004.828268, 10.1109/10.1109/TNB.2004.828268]
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Martins PA, 2013, J DENT RES, V92, P575, DOI 10.1177/0022034513490957
   Mata A, 2002, BIOMED MICRODEVICES, V4, P267, DOI 10.1023/A:1020950022074
   Mata A, 2007, INT J NANOMED, V2, P389
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Mentlein R., 2013, TRENDS STEM CELL PRO, P339
   Metallo CM, 2008, BIOTECHNOL BIOENG, V100, P830, DOI 10.1002/bit.21809
   Meyer SR, 2006, J BIOMED MATER RES A, V79A, P254, DOI 10.1002/jbm.a.30777
   Meyle J, 1993, J Biomater Appl, V7, P362, DOI 10.1177/088532829300700404
   Migliorini E, 2011, BIOTECHNOL BIOENG, V108, P2736, DOI 10.1002/bit.23232
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018
   Moretti M, 2005, J BIOMECH, V38, P1846, DOI 10.1016/j.jbiomech.2004.08.021
   Moses MA, 1996, J CELL BIOCHEM, V60, P379, DOI 10.1002/(SICI)1097-4644(19960301)60:3<379::AID-JCB9>3.3.CO;2-0
   Mudera V, 2007, J TISSUE ENG REGEN M, V1, P192, DOI 10.1002/term.25
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Myers KA, 2011, J CELL BIOL, V192, P321, DOI 10.1083/jcb.201006009
   Naderi S, 2013, CELL J, V15, P166
   Nakamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054036
   Narins RS, 2005, CLIN PLAST SURG, V32, P151, DOI 10.1016/j.cps.2004.12.002
   Navarro M, 2004, BIOMATERIALS, V25, P4233, DOI 10.1016/j.biomaterials.2003.11.012
   Nichols JE, 2013, TISSUE ENG PT A, V19, P2045, DOI [10.1089/ten.tea.2012.0250, 10.1089/ten.TEA.2012.0250]
   Nikkhah M, 2010, BIOMATERIALS, V31, P4552, DOI 10.1016/j.biomaterials.2010.02.034
   Nirmala R, 2012, J BIOMED NANOTECHNOL, V8, P125, DOI 10.1166/jbn.2012.1359
   Nisbet DR, 2009, J BIOMATER APPL, V24, P7, DOI 10.1177/0885328208099086
   Nur-E-Kamal A, 2006, STEM CELLS, V24, P426, DOI 10.1634/stemcells.2005-0170
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152
   Parsons M, 1999, EXP CELL RES, V252, P319, DOI 10.1006/excr.1999.4618
   Peach MS, 2012, J BIOMED NANOTECHNOL, V8, P107, DOI 10.1166/jbn.2012.1368
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Petersen JP, 2008, J MATER SCI-MATER M, V19, P2029, DOI 10.1007/s10856-007-3291-3
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729
   Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002.0109
   Phillips JB, 2004, J PHYSIOL-LONDON, V557, P879, DOI 10.1113/jphysiol.2004.061804
   Pillat M., 2013, TRENDS STEM CELL PRO
   Pins GD, 2000, FASEB J, V14, P593
   Popat KC, 2007, J BIOMED MATER RES A, V80A, P955, DOI 10.1002/jbm.a.31028
   Pozzi A, 2011, CURR OPIN CELL BIOL, V23, P547, DOI 10.1016/j.ceb.2011.04.003
   Prasertsung I, 2008, J BIOMED MATER RES B, V85B, P210, DOI 10.1002/jbm.b.30938
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Raghavan S, 2010, LANGMUIR, V26, P17733, DOI 10.1021/la102955m
   Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7
   Reed CC, 2003, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444
   Rehfeldt F, 2012, INTEGR BIOL-UK, V4, P422, DOI 10.1039/c2ib00150k
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Remya KR, 2013, J BIOMED NANOTECHNOL, V9, P1483, DOI 10.1166/jbn.2013.1640
   Resende RR, 2010, BBA-MOL CELL RES, V1803, P246, DOI 10.1016/j.bbamcr.2009.11.008
   Resende RR, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-14
   Resende RR, 2010, STEM CELLS DEV, V19, P379, DOI 10.1089/scd.2008.0289
   Resende RR, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-20
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Rose FR, 2004, BIOMATERIALS, V25, P5507, DOI 10.1016/j.biomaterials.2004.01.012
   ROSENBER.N, 1970, SURGERY, V67, P951
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sahana H, 2013, J BIOMED NANOTECHNOL, V9, P193, DOI 10.1166/jbn.2013.1482
   Sanders JE, 2005, J BIOMED MATER RES A, V72A, P335, DOI 10.1002/jbm.a.30259
   Sanders JE, 2005, BIOMATERIALS, V26, P813, DOI 10.1016/j.biomaterials.2004.03.030
   Sanders JE, 2002, J BIOMED MATER RES, V62, P222, DOI 10.1002/jbm.10285
   Santos A. K., 2013, TRENDS STEM CELL PRO, V13
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Schor SL, 2006, CELL MOTIL CYTOSKEL, V63, P287, DOI 10.1002/cm.20123
   Scotti C, 2007, KNEE SURG SPORT TR A, V15, P1363, DOI 10.1007/s00167-007-0359-z
   Shalumon KT, 2013, J BIOMED NANOTECHNOL, V9, P1299, DOI 10.1166/jbn.2013.1630
   Shalumon KT, 2013, J BIOMED NANOTECHNOL, V9, P430, DOI 10.1166/jbn.2013.1559
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Silver FH, 2003, SKIN RES TECHNOL, V9, P3, DOI 10.1034/j.1600-0846.2003.00358.x
   Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007
   Smith LA, 2008, SOFT MATTER, V4, P2144, DOI 10.1039/b807088c
   Smith LA, 2009, BIOMATERIALS, V30, P2516, DOI 10.1016/j.biomaterials.2009.01.009
   Sochol RD, 2011, SOFT MATTER, V7, P4606, DOI 10.1039/c1sm05163f
   Sreerekha PR, 2013, J BIOMED NANOTECHNOL, V9, P790, DOI 10.1166/jbn.2013.1585
   Steedman MR, 2010, BIOMED MICRODEVICES, V12, P363, DOI 10.1007/s10544-009-9392-7
   Steinhoff G, 2000, CIRCULATION, V102, P50
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Taipale J, 1997, FASEB J, V11, P51
   Takano Y, 1999, J ORTHOP RES, V17, P59, DOI 10.1002/jor.1100170110
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   Toh Y., 2013, TRENDS STEM CELL PRO, P251
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Tonelli FMP, 2012, INT J NANOMED, V7, P4511, DOI 10.2147/IJN.S33612
   Torrejon KY, 2013, BIOTECHNOL BIOENG, V110, P3205, DOI 10.1002/bit.24977
   TRANQUILLO RT, 1992, CYTOTECHNOLOGY, V10, P225, DOI 10.1007/BF00146673
   Tsimbouri PM, 2012, ACS NANO, V6, P10239, DOI 10.1021/nn304046m
   VANDERREST M, 1991, FASEB J, V5, P2814
   Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039
   Venkatesan J, 2012, J BIOMED NANOTECHNOL, V8, P676, DOI 10.1166/jbn.2012.1410
   Venugopal J, 2008, J MATER SCI-MATER M, V19, P2039, DOI 10.1007/s10856-007-3289-x
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Walbeehm ET, 2004, CELL TISSUE RES, V316, P115, DOI 10.1007/s00441-004-0867-9
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Walboomers XF, 2000, J BIOMED MATER RES, V51, P529, DOI 10.1002/1097-4636(20000905)51:3<529::AID-JBM30>3.0.CO;2-R
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wang NP, 2006, BIOCHEM BIOPH RES CO, V341, P1244, DOI 10.1016/j.bbrc.2006.01.089
   Wang Q, 2008, J BIOMED MATER RES A, V85A, P881, DOI 10.1002/jbm.a.31544
   Wang Q, 2007, J BIOMED MATER RES A, V82A, P122, DOI 10.1002/jbm.a.31075
   Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000
   Wang Q, 2010, BIOMATERIALS, V31, P4980, DOI 10.1016/j.biomaterials.2010.02.052
   Weng SN, 2011, BIOMATERIALS, V32, P9584, DOI 10.1016/j.biomaterials.2011.09.006
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Wilkinson A, 2011, ACTA BIOMATER, V7, P2919, DOI 10.1016/j.actbio.2011.03.026
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   WOJCIAKSTOTHARD B, 1995, CELL MOTIL CYTOSKEL, V31, P147, DOI 10.1002/cm.970310207
   WojciakStothard B, 1997, IN VITRO CELL DEV-AN, V33, P110
   WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588
   Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026
   Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xu CC, 2007, TISSUE ENG, V13, P551, DOI 10.1089/ten.2006.0169
   Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052
   Yang Y, 2010, WIRES NANOMED NANOBI, V2, P478, DOI 10.1002/wnan.74
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   Yasui T, 2004, APPL OPTICS, V43, P2861, DOI 10.1364/AO.43.002861
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yoon J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P22
   YUAN L, 1973, BIOPOLYMERS, V12, P1437, DOI 10.1002/bip.1973.360120618
   Yukawa H, 2011, BIOMATERIALS, V32, P3729, DOI 10.1016/j.biomaterials.2011.01.013
   Zagris N, 2001, MICRON, V32, P427, DOI 10.1016/S0968-4328(00)00011-1
   Zanatta G, 2012, J BIOMED NANOTECHNOL, V8, P211, DOI 10.1166/jbn.2012.1382
   Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776
   Zhang ZJ, 2005, J ORTHOP RES, V23, P433, DOI 10.1016/j.orthres.2004.08.028
   Zhou CJ, 2011, COLLOID SURFACE B, V84, P155, DOI 10.1016/j.colsurfb.2010.12.030
   Zhou J, 2009, DEVELOPMENT, V136, P677, DOI 10.1242/dev.026211
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
   Zimmerman L. M., 1993, GREAT IDEAS HIST SUR
   ZIMMERMAN LM, 1961, GREAT IDEAS HIST SUR
NR 332
TC 17
Z9 18
U1 2
U2 162
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD JUL
PY 2014
VL 10
IS 7
BP 1157
EP 1193
DI 10.1166/jbn.2014.1850
PG 37
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA AD0NQ
UT WOS:000332931500001
PM 24804539
DA 2018-10-20
ER

PT J
AU Lee, CH
   Amini, R
   Gorman, RC
   Gorman, JH
   Sacks, MS
AF Lee, Chung-Hao
   Amini, Rouzbeh
   Gorman, Robert C.
   Gorman, Joseph H., III
   Sacks, Michael S.
TI An inverse modeling approach for stress estimation in mitral valve
   anterior leaflet valvuloplasty for in-vivo valvular biomaterial
   assessment
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE In-vivo stress estimation; Finite element (FE) inverse modeling; Genetic
   algorithm; Mapped collagen fiber architecture
ID FINITE-ELEMENT; DYNAMIC DEFORMATION; STRAIN BEHAVIOR; HEART-VALVES;
   REPAIR; DISEASE; CALCIFICATION; BIOMECHANICS; CHALLENGES; TISSUES
AB Estimation of regional tissue stresses in the functioning heart valve remains an important goal in our understanding of normal valve function and in developing novel engineered tissue strategies for valvular repair and replacement. Methods to accurately estimate regional tissue stresses are thus needed for this purpose, and in particular to develop accurate, statistically informed means to validate computational models of valve function. Moreover, there exists no currently accepted method to evaluate engineered heart valve tissues and replacement heart valve biomaterials undergoing valvular stresses in blood contact. While we have utilized mitral valve anterior leaflet valvuloplasty as an experimental approach to address this limitation, robust computational techniques to estimate implant stresses are required. In the present study, we developed a novel numerical analysis approach for estimation of the in-vivo stresses of the central region of the mitral valve anterior leaflet (MVAL) delimited by a sonocrystal transducer array. The in-vivo material properties of the MVAL were simulated using an inverse FE modeling approach based on three pseudo-hyperelastic constitutive models: the neo-Hookean, exponential-type isotropic, and full collagen fiber mapped transversely isotropic models. A series of numerical replications with varying structural configurations were developed by incorporating measured statistical variations in MVAL local preferred fiber directions and fiber splay. These model replications were then used to investigate how known variations in the valve tissue microstructure influence the estimated ROI stresses and its variation at each time point during a cardiac cycle. Simulations were also able to include estimates of the variation in tissue stresses for an individual specimen dataset over the cardiac cycle. Of the three material models, the transversely anisotropic model produced the most accurate results, with ROI averaged stresses at the fully-loaded state of 432.6 +/- 46.5 kPa and 241.4 +/- 40.5 kPa in the radial and circumferential directions, respectively. We conclude that the present approach can provide robust instantaneous mean and variation estimates of tissue stresses of the central regions of the MVAL. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Lee, Chung-Hao; Sacks, Michael S.] Univ Texas Austin, ICES, Ctr Cardiovasc Simulat, Dept Biomed Engn, Austin, TX 78712 USA.
   [Amini, Rouzbeh] Univ Akron, Dept Biomed Engn, Auburn Sci & Engn Ctr 275, Akron, OH 44325 USA.
   [Gorman, Robert C.; Gorman, Joseph H., III] Univ Penn, Gorman Cardiovasc Res Grp, Philadelphia, PA 19104 USA.
RP Sacks, MS (reprint author), Univ Texas Austin, ICES, Ctr Cardiovasc Simulat, Dept Biomed Engn, 201 East 24th St,ACES 5-236,1 Univ Stn CO200, Austin, TX 78712 USA.
EM msacks35@gmail.com
OI Amini, Rouzbeh/0000-0003-3632-6195
FU NIH [R01 HL119297, HL108330, HL63954, HL103723, HL73021, F32 HL110651];
   ICES Postdoctoral Fellowship
FX This work was funded by the funding from the NIH grants R01 HL119297,
   HL108330, HL63954, HL103723, HL73021, and F32 HL110651. Dr. C.H. Lee was
   supported in part by ICES Postdoctoral Fellowship.
CR Accola KD, 2005, ANN THORAC SURG, V79, P1276, DOI 10.1016/j.athoracsur.2004.09.035
   Amini R, 2012, ANN BIOMED ENG, V40, P1455, DOI 10.1007/s10439-012-0524-5
   Billiar KL, 1997, J BIOMECH, V30, P753, DOI 10.1016/S0021-9290(97)00019-5
   Braunberger E., 2001, CIRCULATION S1, V104, P18
   Buchanan R.M., 2013, BIOMECH MOD IN PRESS
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   CARPENTIER A, 1980, J THORAC CARDIOV SUR, V79, P338
   Eckert CE, 2013, ACTA BIOMATER, V9, P4653, DOI 10.1016/j.actbio.2012.09.031
   Eckert CE, 2009, ANN BIOMED ENG, V37, P1757, DOI 10.1007/s10439-009-9749-3
   Einstein DR, 2004, MED BIOL ENG COMPUT, V42, P832, DOI 10.1007/BF02345218
   Fasol R, 2004, ANN THORAC SURG, V77, P1985, DOI 10.1016/j.athoracsur.2003.11.023
   FDA/NHLBI/NSF, WORKSH COMP METH CAR
   Flameng W, 2003, CIRCULATION, V107, P1609, DOI 10.1161/01.CIR.0000058703.26715.9D
   Flameng W, 2008, J THORAC CARDIOV SUR, V135, P274, DOI 10.1016/j.jtcvs.2007.06.040
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   Gorman JH, 1996, J THORAC CARDIOV SUR, V112, P712, DOI 10.1016/S0022-5223(96)70056-9
   Grashow JS, 2006, ANN BIOMED ENG, V34, P1509, DOI 10.1007/s10439-006-9183-8
   Grashow JS, 2006, ANN BIOMED ENG, V34, P315, DOI [10.1007/s10439-005-9027-y, 10.1007/s10439-005-9027-v]
   He ZM, 2005, J BIOMECH ENG-T ASME, V127, P504, DOI 10.1115/1.1894385
   Krishnamurthy G, 2008, AM J PHYSIOL-HEART C, V295, pH1141, DOI 10.1152/ajpheart.00284.2008
   Krishnamurthy G, 2009, J BIOMECH, V42, P1909, DOI 10.1016/j.jbiomech.2009.05.018
   Kunzelman K S, 1993, J Heart Valve Dis, V2, P236
   Kunzelman K S, 1993, J Heart Valve Dis, V2, P326
   Lee C-H., 2013, FUNCTIONAL IMAGING M, P416
   Mol A, 2009, EXPERT REV MED DEVIC, V6, P259, DOI [10.1586/erd.09.12, 10.1586/ERD.09.12]
   Prot V, 2007, INT J NUMER METH ENG, V71, P987, DOI 10.1002/nme.1983
   Prot V, 2010, J MECH BEHAV BIOMED, V3, P167, DOI 10.1016/j.jmbbm.2009.05.004
   Rausch M.K., 2012, BIOMECHANICS MODELIN, P1
   Rausch MK, 2011, J BIOMECH, V44, P1149, DOI 10.1016/j.jbiomech.2011.01.020
   Sacks MS, 2007, BIOMATERIALS, V28, P5390, DOI 10.1016/j.biomaterials.2007.08.021
   Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122
   Sacks MS, 2006, EXPERT REV MED DEVIC, V3, P817, DOI 10.1586/17434440.3.6.817
   Sacks MS, 2006, ANN THORAC SURG, V82, P1369, DOI 10.1016/j.athoracsur.2006.03.117
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   Sacks MS, 1997, ANN BIOMED ENG, V25, P678, DOI 10.1007/BF02684845
   Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schoen FJ, 2005, CARDIOVASC PATHOL, V14, P189, DOI 10.1016/j.carpath.2005.03.005
   Stella JA, 2007, J BIOMECH ENG-T ASME, V129, P757, DOI 10.1115/1.2768111
   Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328
   Sun W, 2005, J BIOMECH ENG-T ASME, V127, P905, DOI 10.1115/1.2049337
   Votta E, 2008, PHILOS T R SOC A, V366, P3411, DOI 10.1098/rsta.2008.0095
   Woo S.L.Y., 1989, TISSUE ENG 1989
NR 45
TC 31
Z9 31
U1 2
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD JUN 27
PY 2014
VL 47
IS 9
SI SI
BP 2055
EP 2063
DI 10.1016/j.jbiomech.2013.10.058
PG 9
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA AK7QD
UT WOS:000338621900016
PM 24275434
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Griebel, AJ
   Khoshgoftar, M
   Novak, T
   van Donkelaar, CC
   Neu, CP
AF Griebel, A. J.
   Khoshgoftar, M.
   Novak, T.
   van Donkelaar, C. C.
   Neu, C. P.
TI Direct noninvasive measurement and numerical modeling of depth-dependent
   strains in layered agarose constructs
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Functional tissue engineering; Heterogeneous strains; Imaging
   elastography; Agarose scaffold; Finite element method
ID TISSUE-ENGINEERED CARTILAGE; ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES;
   CHONDROCYTE SUBPOPULATIONS; EXTRACELLULAR-MATRIX; CONFINED COMPRESSION;
   INHOMOGENEITY; DEFORMATION; INDENTATION; HYDROGEL
AB Biomechanical factors play an important role in the growth, regulation, and maintenance of engineered biomaterials and tissues. While physical factors (e.g. applied mechanical strain) can accelerate regeneration, and knowledge of tissue properties often guide the design of custom materials with tailored functionality, the distribution of mechanical quantities (e.g. strain) throughout native and repair tissues is largely unknown. Here, we directly quantify distributions of strain using noninvasive magnetic resonance imaging (MRI) throughout layered agarose constructs, a model system for articular cartilage regeneration Bulk mechanical testing, giving both instantaneous and equilibrium moduli, was incapable of differentiating between the layered constructs with defined amounts of 2% and 4% agarose. In contrast, MRI revealed complex distributions of strain, with strain transfer to softer (2%) agarose regions, resulting in amplified magnitudes. Comparative studies using finite element simulations and mixture (biphasic) theory confirmed strain distributions in the layered agarose. The results indicate that strain transfer to soft regions is possible in vivo as the biomaterial and tissue changes during regeneration and maturity. It is also possible to modulate locally the strain field that is applied to construct-embedded cells (e.g. chondrocytes) using stratified agarose constructs. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Griebel, A. J.; Novak, T.; Neu, C. P.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
   [Khoshgoftar, M.] Radboud Univ Nijmegen, Med Ctr, Orthopaed Res Lab, NL-6525 ED Nijmegen, Netherlands.
   [Khoshgoftar, M.; van Donkelaar, C. C.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands.
RP Neu, CP (reprint author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
EM cpneu@purdue.edu
RI van Donkelaar, Corrinus/E-7280-2011
OI van Donkelaar, Corrinus/0000-0002-2121-5604; Novak,
   Tyler/0000-0002-3679-352X
FU NSF [CMMI 1100554]; Charles C. Chappelle Fellowship; NIH [R01 AR063712,
   S10 RR13880]; NSF GRFP [DGE-0833366]
FX We acknowledge the contribution of Logan Worke. This work was funded by
   NSF CMMI 1100554 and NIH R01 AR063712 (CPN), the Charles C. Chappelle
   Fellowship (AJG), NSF GRFP DGE-0833366 (TN), and NIH S10 RR13880 (Alice
   Wyrwicz, Ph.D., CBMRR, Evanston, IL).
CR Aymard P, 2001, BIOPOLYMERS, V59, P131, DOI 10.1002/1097-0282(200109)59:3<131::AID-BIP1013>3.0.CO;2-8
   Bevill SL, 2010, OSTEOARTHR CARTILAGE, V18, P1310, DOI 10.1016/j.joca.2010.06.008
   BROOM ND, 1984, J ANAT, V139, P275
   Buckley CT, 2009, J MECH BEHAV BIOMED, V2, P512, DOI 10.1016/j.jmbbm.2008.12.007
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Chan DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033463
   Chan DD, 2011, SPINE, V36, P1438, DOI 10.1097/BRS.0b013e3181f8be52
   Chawla K, 2007, TISSUE ENG, V13, P1525, DOI 10.1089/ten.2007.0044
   Dimicco M.A., 2003, TRANSPORT POROUS MED, P50
   Griebel AJ, 2013, OSTEOARTHR CARTILAGE, V21, P394, DOI [10.1016/j.joca.201221.009, 10.1016/j.joca.2012.11.009]
   Griebel A.J., 2013, MAGNETIC RESONANCE M
   Gu WY, 2003, J BIOMECH, V36, P593, DOI 10.1016/S0021-9290(02)00437-2
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Hosseini S.M., 2013, BIOMECHANIC IN PRESS
   Khoshgoftar M, 2011, COMPUT METHOD BIOMEC, V14, P135, DOI 10.1080/10255842.2010.519335
   Klein TJ, 2003, OSTEOARTHR CARTILAGE, V11, P595, DOI 10.1016/S1063-4584(03)00090-6
   Kock LM, 2010, OSTEOARTHR CARTILAGE, V18, P1528, DOI 10.1016/j.joca.2010.09.001
   Kock L, 2012, CELL TISSUE RES, V347, P613, DOI 10.1007/s00441-011-1243-1
   Kock LM, 2013, TISSUE ENG PT A, V19, P1949, DOI [10.1089/ten.tea.2012.0688, 10.1089/ten.TEA.2012.0688]
   Kock LM, 2013, TISSUE ENG PT A, V19, P1621, DOI [10.1089/ten.tea.2012.0541, 10.1089/ten.TEA.2012.0541]
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   Mow V.C., 1991, BASIC ORTHOPAEDIC BI, P143
   Neu CP, 2009, J TISSUE ENG REGEN M, V3, P477, DOI 10.1002/term.188
   Neu CP, 2008, TISSUE ENG PART B-RE, V14, P235, DOI 10.1089/ten.teb.2008.0047
   Neu CP, 2008, MAGN RESON MED, V59, P149, DOI 10.1002/mrm.21464
   Neu CP, 2007, ARTHRITIS RHEUM-US, V56, P3706, DOI 10.1002/art.23024
   Neu CP, 2005, MAGNET RESON MED, V53, P321, DOI 10.1002/mrm.20343
   Ng KW, 2009, TISSUE ENG PT A, V15, P2315, DOI 10.1089/ten.tea.2008.0391
   Ng KW, 2005, J ORTHOP RES, V23, P134, DOI 10.1016/j.orthres.2004.05.015
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j
   Rennerfeldt DA, 2013, BIOMATERIALS, V34, P8241, DOI 10.1016/j.biomaterials.2013.07.052
   Sengers BG, 2004, ANN BIOMED ENG, V32, P1718, DOI 10.1007/s10439-004-7824-3
   Sniekers YH, 2005, BIOPHYS J, V89, P1302, DOI 10.1529/biophysj.104.053652
   van Donkelaar CC, 2011, COMPUT METHOD BIOMEC, V14, P425, DOI 10.1080/10255842.2011.554409
NR 36
TC 5
Z9 5
U1 2
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD JUN 27
PY 2014
VL 47
IS 9
SI SI
BP 2149
EP 2156
DI 10.1016/j.jbiomech.2013.09.025
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA AK7QD
UT WOS:000338621900028
PM 24182772
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Merk, V
   Chanana, M
   Gierlinger, N
   Hirt, AM
   Burgert, I
AF Merk, Vivian
   Chanana, Munish
   Gierlinger, Notburga
   Hirt, Ann M.
   Burgert, Ingo
TI Hybrid Wood Materials with Magnetic Anisotropy Dictated by the
   Hierarchical Cell Structure
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE wood modification; structural hierarchy; iron oxide nanoparticles;
   coprecipitation; magnetic anisotropy; hybrid material actuation
ID CELLULOSE FIBERS; BIOLOGICAL APPLICATIONS; FILMS; ROCKS; NANOPARTICLES;
   LOCOMOTION; TEMPLATES; PARTICLES; MAGHEMITE; AEROGELS
AB Anisotropic and hierarchical structures are bound in nature and highly desired in engineered materials, due to their outstanding functions and performance. Mimicking such natural features with synthetic materials and methods has been a highly active area of research in the last decades. Unlike these methods, we use the native biomaterial wood, with its intrinsic anisotropy and hierarchy as a directional scaffold for the incorporation of magnetic nanoparticles inside the wood material. Nanocrystalline iron oxide particles were synthesized in situ via coprecipitation of ferric and ferrous ions within the interconnected pore network of bulk wood. Imaging with low-vacuum and cryogenic electron microscopy as well as spectral Raman mapping revealed layered nanosize particles firmly attached to the inner surface of the wood cell walls. The mineralogy of iron oxide was identified by XRD powder diffraction and Raman spectroscopy as a mixture of the spinel phases magnetite and maghemite. The intrinsic structural architecture of native wood entails a three-dimensional assembly of the colloidal iron oxide which results in direction-dependent magnetic features of the wood-mineral hybrid material. This superinduced magnetic anisotropy, as quantified by direction-dependent magnetic hysteresis loops and low-field susceptibility tensors, allows for directional lift, drag, alignment, (re)orientation, and actuation, and opens up novel applications of the natural resource wood.
C1 [Merk, Vivian; Chanana, Munish; Gierlinger, Notburga; Burgert, Ingo] ETH, Inst Bldg Mat IfB, CH-8093 Zurich, Switzerland.
   [Merk, Vivian; Gierlinger, Notburga; Burgert, Ingo] Empa Swiss Fed Labs Mat Testing & Res, Appl Wood Mat Lab, CH-8600 Dubendorf, Switzerland.
   [Chanana, Munish] Univ Bayreuth, D-95447 Bayreuth, Germany.
   [Hirt, Ann M.] ETH, Inst Geophys Earth & Planetary Magnetism, CH-8092 Zurich, Switzerland.
RP Chanana, M (reprint author), ETH, Inst Bldg Mat IfB, Stefano Franscini Pl 3, CH-8093 Zurich, Switzerland.
EM munish.chanana@uni-bayreuth.de; iburgert@ethz.ch
RI Chanana, Munish/L-2266-2014; gierlinger, notburga/G-4787-2011
OI gierlinger, notburga/0000-0002-3699-9931; Hirt, Ann/0000-0002-2193-0472
FU Bundesamt fur Umwelt (BAFU); Lignum, Switzerland
FX We thank the Bundesamt fur Umwelt (BAFU) and Lignum, Switzerland for the
   financial support of the Wood Materials Science group. We thank
   Hans-Peter Hachler for the technical support during the magnetic
   measurements and Dr. Roger Wepf for the collection of cryo-SEM images
   (EMEZ, ETH Zurich).
CR Adachi N, 2009, MATERIALS, V2, P1923, DOI 10.3390/ma2041923
   Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255
   Ariga K, 2006, J NANOSCI NANOTECHNO, V6, P2278, DOI 10.1166/jnn.2006.503
   Bayer IS, 2011, ACS APPL MATER INTER, V3, P4024, DOI 10.1021/am200891f
   CarrazanaGarcia JA, 1997, COLLOID SURFACE A, V121, P61, DOI 10.1016/S0927-7757(96)03951-9
   Cornell R. M., 2003, IRON OXIDES STRUCTUR
   deFaria DLA, 1997, J RAMAN SPECTROSC, V28, P873, DOI 10.1002/(SICI)1097-4555(199711)28:11<873::AID-JRS177>3.0.CO;2-B
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   GIERER J, 1985, WOOD SCI TECHNOL, V19, P289
   Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949
   HARGRAVES RB, 1991, GEOPHYS RES LETT, V18, P2193, DOI 10.1029/91GL01777
   HARRIS EE, 1949, J PHYS COLLOID CHEM, V53, P344, DOI 10.1021/j150468a003
   JELINEK V, 1973, STUD GEOPHYS GEOD, V17, P36, DOI 10.1007/BF01614027
   JELINEK V, 1981, TECTONOPHYSICS, V79, pT63, DOI 10.1016/0040-1951(81)90110-4
   Jubb AM, 2010, ACS APPL MATER INTER, V2, P2804, DOI 10.1021/am1004943
   Katepetch C, 2011, CARBOHYD POLYM, V86, P162, DOI 10.1016/j.carbpol.2011.04.024
   Keckes J, 2003, NAT MATER, V2, P810, DOI 10.1038/nmat1019
   Kim J, 2011, NAT MATER, V10, P747, DOI [10.1038/NMAT3090, 10.1038/nmat3090]
   Kim W, 2012, TALANTA, V94, P348, DOI 10.1016/j.talanta.2012.03.001
   Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e
   Liu YD, 2013, CHEM SOC REV, V42, P2610, DOI 10.1039/c2cs35369e
   Long JW, 2004, J AM CHEM SOC, V126, P16879, DOI 10.1021/ja046044f
   Malvadkar NA, 2010, NAT MATER, V9, P1023, DOI 10.1038/NMAT2864
   MARCHESSAULT RH, 1992, POLYMER, V33, P4024, DOI 10.1016/0032-3861(92)90600-2
   MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188
   Mattheck C., 1996, WOOD INTERNAL OPTIMI
   Mosauer W, 1932, SCIENCE, V76, P583, DOI 10.1126/science.76.1982.583
   Nagata T, 1961, ROCK MAGNETISM
   Oka H, 2004, J MAGN MAGN MATER, V272, pE1693, DOI 10.1016/j.jmmm.2003.12.977
   Oka H, 2002, J APPL PHYS, V91, P7008, DOI 10.1063/1.1448796
   Oka H, 2002, J MAGN MAGN MATER, V239, P617, DOI 10.1016/S0304-8853(01)00684-9
   Oka H., 2005, INTERMAG Asia 2005: Digest of the IEEE International Magnetics Conference (IEEE Cat. No.05CH37655), P1099, DOI 10.1109/INTMAG.2005.1463979
   Oka H, 1999, IEEE T MAGN, V35, P3520, DOI 10.1109/20.800576
   Oka H., 2009, J APPL PHYS, P105
   Oka H, 2007, J MAGN MAGN MATER, V310, pE1028, DOI 10.1016/j.jmmm.2006.11.073
   Oka H, 2012, IEEE T MAGN, V48, P3498, DOI 10.1109/TMAG.2012.2196026
   OKADA H, 1990, CHEM MATER, V2, P89, DOI 10.1021/cm00008a001
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/nnano.2010.155, 10.1038/NNANO.2010.155]
   Paris O, 2013, ADV FUNCT MATER, V23, P4408, DOI 10.1002/adfm.201300217
   Persson PV, 2004, BIOMACROMOLECULES, V5, P1097, DOI 10.1021/bm034532u
   Pu Y, 2011, MATER LETT, V65, P2213, DOI 10.1016/j.matlet.2011.04.086
   Salmen L., 2009, HOLZFORSCHUNG, V63, P121
   Schnepp Z, 2010, ANGEW CHEM INT EDIT, V49, P6564, DOI 10.1002/anie.201001626
   Sedlar M, 2000, CERAM INT, V26, P507, DOI 10.1016/S0272-8842(99)00086-3
   Shebanova ON, 2003, J RAMAN SPECTROSC, V34, P845, DOI [10.1002/jrs.1056, 10.1002/jrs 1056]
   Shebanova ON, 2003, J SOLID STATE CHEM, V174, P424, DOI 10.1016/S0022-4596(03)00294-9
   Shimomura M, 2001, CURR OPIN COLLOID IN, V6, P11, DOI 10.1016/S1359-0294(00)00081-9
   Sia CK, 2009, J CERAM SOC JPN, V117, P958, DOI 10.2109/jcersj2.117.958
   Small AC, 2009, J COLLOID INTERF SCI, V331, P122, DOI 10.1016/j.jcis.2008.11.038
   Speck T, 2011, ANNU REV MATER RES, V41, P169, DOI 10.1146/annurev-matsci-062910-100425
   Trey SM, 2010, ACS APPL MATER INTER, V2, P3352, DOI 10.1021/am100778q
   Truskett VN, 2006, TRENDS BIOTECHNOL, V24, P312, DOI 10.1016/j.tibtech.2006.05.005
   Vukusic P, 2000, NATURE, V404, P457, DOI 10.1038/35006561
   WAINWRIGHT SA, 1978, SCIENCE, V202, P747, DOI 10.1126/science.202.4369.747
   Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j
   Zakaria S, 2005, MATER CHEM PHYS, V89, P216, DOI 10.1016/j.matchemphys.2003.12.026
   Zheng YM, 2010, NATURE, V463, P640, DOI 10.1038/nature08729
NR 57
TC 43
Z9 44
U1 16
U2 113
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 25
PY 2014
VL 6
IS 12
BP 9760
EP 9767
DI 10.1021/am5021793
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AK1ON
UT WOS:000338184500103
PM 24873330
DA 2018-10-20
ER

PT J
AU Nathanael, AJ
   Yuvakkumar, R
   Hong, SI
   Oh, TH
AF Nathanael, A. Joseph
   Yuvakkumar, R.
   Hong, Sun Ig
   Oh, Tae Hwan
TI Novel Zirconium Nitride and Hydroxyapatite Nanocomposite Coating:
   Detailed Analysis and Functional Properties
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE hydroxyapatite; nanocomposite; biomaterial; friction coefficient;
   biomineralization; bioactivity
ID IMPROVED CORROSION-RESISTANCE; SUBSTRATE-TEMPERATURE;
   MECHANICAL-PROPERTIES; THIN-FILMS; GROWTH; ALLOY; ZRN; MICROSTRUCTURE;
   COMPOSITES; DEPOSITION
AB A new type of high-quality zirconium nitride (ZrN) and hydroxyapatite (HA) bionanocomposite was prepared by radio-frequency (RF) magnetron sputtering for biomedical applications. Detailed analysis of this composite coating revealed that a higher substrate temperature (ST) (>300 degrees C) increased its crystallinity, uniformity, and functional properties. This nanocomposite showed some encouraging functional properties. Mechanical analyses of the nanocomposite showed improved hardness, modulus, and wear resistance, which were found to be due to the increasing volume fraction of ZrN at higher ST. Biomineralization and in vitro cell analysis revealed increased weight gain and enhanced cell activity with increased substrate temperature. Overall, the results of the present study indicate that this nanocomposite coating could become a promising alternative for biomedical applications.
C1 [Nathanael, A. Joseph; Oh, Tae Hwan] Yeungnam Univ, Dept Nano Med & Polymer Mat, Gyongsan 712749, South Korea.
   [Nathanael, A. Joseph; Yuvakkumar, R.; Hong, Sun Ig] Chungnam Natl Univ, Dept Nanomat Engn, Taejon 305764, South Korea.
RP Hong, SI (reprint author), Chungnam Natl Univ, Dept Nanomat Engn, Taejon 305764, South Korea.
EM sihong@cnu.ac.kr; taehwanoh@ynu.ac.kr
RI Nathanael, Joseph/C-5196-2018
OI Nathanael, Joseph/0000-0001-9043-5259
FU Fundamental R&D Programs for Core Technology of Materials; Yeungnam
   University
FX This research was supported by the Fundamental R&D Programs for Core
   Technology of Materials (2013) and by the Yeungnam University research
   grants in 2014.
CR Budke E, 1999, SURF COAT TECH, V112, P108, DOI 10.1016/S0257-8972(98)00791-9
   Cheng H, 2009, J MATER SCI TECHNOL, V25, P489
   Chou WJ, 2003, SURF COAT TECH, V167, P59, DOI 10.1016/S0257-8972(02)00882-4
   Hong SI, 2008, J MATER RES, V23, P478, DOI 10.1557/JMR.2008.0051
   Hong SI, 1999, MAT SCI ENG A-STRUCT, V265, P29, DOI 10.1016/S0921-5093(99)00006-4
   Hoppe A, 2014, J BIOMED MATER RES A, V102, P193, DOI 10.1002/jbm.a.34685
   Huang J. H., EFFECT NITROGEN FLOW, P31
   Larijani MM, 2011, CRYST RES TECHNOL, V46, P351, DOI 10.1002/crat.201100001
   Liang SC, 2011, APPL SURF SCI, V257, P7709, DOI 10.1016/j.apsusc.2011.04.014
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Lopez EO, 2013, ACS APPL MATER INTER, V5, P9435, DOI 10.1021/am4020007
   Moon BH, 2012, APPL SURF SCI, V258, P2088, DOI 10.1016/j.apsusc.2011.04.050
   Nathanael A. J., 2012, ADV SCI LETT, V15, P285
   Nathanael AJ, 2012, POWDER TECHNOL, V228, P410, DOI 10.1016/j.powtec.2012.06.001
   Nathanael AJ, 2012, CRYST GROWTH DES, V12, P3565, DOI 10.1021/cg3003959
   Nathanael AJ, 2011, CHEM ENG J, V173, P846, DOI 10.1016/j.cej.2011.07.053
   Nathanael AJ, 2010, THIN SOLID FILMS, V518, P7333, DOI 10.1016/j.tsf.2010.04.105
   Nathanael AJ, 2010, COMPOS SCI TECHNOL, V70, P1645, DOI 10.1016/j.compscitech.2010.06.010
   Nathanael AJ, 2010, COMPOS SCI TECHNOL, V70, P419, DOI 10.1016/j.compscitech.2009.11.009
   Park YG, 2007, J MATER SCI-MATER M, V18, P925, DOI 10.1007/s10856-006-0014-0
   Qi ZB, 2013, SURF COAT TECH, V231, P102, DOI 10.1016/j.surfcoat.2012.01.056
   Rizzo A, 2012, THIN SOLID FILMS, V520, P3532, DOI 10.1016/j.tsf.2012.01.005
   Shen ZJ, 2001, ADV MATER, V13, P214, DOI 10.1002/1521-4095(200102)13:3<214::AID-ADMA214>3.0.CO;2-5
   Subramanian B, 2011, MATER SCI ENG B-ADV, V176, P1, DOI 10.1016/j.mseb.2010.08.004
   Thian E. S., 2013, HYDROXYAPATITE COATI, P6
   Wang GC, 2010, MATERIALS, V3, P3994, DOI 10.3390/ma3073994
   WIIALA UK, 1990, SURF COAT TECH, V41, P191, DOI 10.1016/0257-8972(90)90167-B
   Wu CT, 2014, ACS APPL MATER INTER, V6, P4264, DOI 10.1021/am4060035
NR 28
TC 15
Z9 15
U1 0
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 25
PY 2014
VL 6
IS 12
BP 9850
EP 9857
DI 10.1021/am5023557
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AK1ON
UT WOS:000338184500114
PM 24895944
DA 2018-10-20
ER

PT J
AU Jhong, JF
   Venault, A
   Liu, LY
   Zheng, J
   Chen, SH
   Higuchi, A
   Huang, J
   Chang, Y
AF Jhong, Jheng-Fong
   Venault, Antoine
   Liu, Lingyun
   Zheng, Jie
   Chen, Sheng-Han
   Higuchi, Akon
   Huang, James
   Chang, Yung
TI Introducing Mixed-Charge Copolymers As Wound Dressing Biomaterials
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE mixed-charge copolymer; ePTFE-g-poly(SA-co-TMA) membrane; charge bias;
   antibiofouling biomaterial; wound healing
ID ULTRAFILTRATION MEMBRANES; BIOFOULING-RESISTANCE; PROTEIN ADSORPTION;
   ADHESION; HYDROGELS; CHITOSAN; SURFACES; POLYMERIZATION; METHACRYLATE);
   LEUKOCYTES
AB Herein, a pseudozwitterionic structure bearing moieties with mixed positive and negative charges is introduced to develop a potential biomaterial for wound dressing applications. New mixed-charge matrices were prepared by copolymerization of the negatively charged 3-sulfopropyl methacrylate (SA) and positively charged [2-(methacryloyloxy)ethyl] trimethylammonium (TMA) onto expanded polytetrafluoroethylene (ePTFE) membranes. The charge balance was effectively regulated through the control of the initial SA/TMA ratio. The focus was then laid on the assessment of a variety of essential properties of efficient wound dressings including, hydration property, resistance to fibrinogen adsorption, hemocompatibility, as well as resistance to fibroblast attachment and bacteria colonization. It was found that the pseudozwitterionic membranes, compared to those with charge bias in the poly(SA-co-TMA) structure, exhibited the best combination of major properties. Therefore, they were further tested for wound healing. Histological examination of mouse wound treated with the pseudozwitterionic membranes exhibited complete re-epithelialization and total formation of new connective tissues after 14 days, even leading to faster healing than using commercial dressing. Results presented in this work suggest that the mixed-charge copolymers with a perfect balance of positive and negative moieties represent the newest generation of biomaterials for wound dressings.
C1 [Jhong, Jheng-Fong; Venault, Antoine; Chen, Sheng-Han; Chang, Yung] Chung Yuan Christian Univ, Dept Chem Engn, Chung Li City 32023, Taiwan.
   [Jhong, Jheng-Fong; Chen, Sheng-Han; Chang, Yung] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Chung Li City 32023, Taiwan.
   [Liu, Lingyun; Zheng, Jie] Univ Akron, Akron, OH 44325 USA.
   [Higuchi, Akon] Natl Cent Univ, Dept Chem & Mat Engn, Chung Li City 32001, Taiwan.
   [Huang, James] Yeu Ming Tai Chem Ind Co Ltd, Taichung 407, Taiwan.
   [Higuchi, Akon; Chang, Yung] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
RP Chang, Y (reprint author), Chung Yuan Christian Univ, Dept Chem Engn, 200 Chung Pei Rd, Chung Li City 32023, Taiwan.
EM ychang@cycu.edu.tw
RI Zheng, Jie/B-5057-2013
OI Zheng, Jie/0000-0003-1547-3612; Higuchi, Akon/0000-0003-2970-8531;
   Venault, Antoine/0000-0002-0383-695X
FU Center-of-Excellence (COE) Program on Membrane Technology from the
   Ministry of Education (MOE), R.O.C.; Outstanding Professor Research
   Program in the Chung Yuan Christian University, Taiwan
   [CYCU-00RD-RA002-11757]; National Science Council
   [NSC97-2622-E-033-003-CC3, NSC98-2622-E-033-017-CC3,
   NSC100-2622-E-033-004-CC3]
FX The authors express their sincere gratitude to the Center-of-Excellence
   (COE) Program on Membrane Technology from the Ministry of Education
   (MOE), R.O.C., the Outstanding Professor Research Program in the Chung
   Yuan Christian University, Taiwan (CYCU-00RD-RA002-11757), and the
   National Science Council (NSC97-2622-E-033-003-CC3,
   NSC98-2622-E-033-017-CC3, and NSC100-2622-E-033-004-CC3) for their
   financial support. We acknowledge the International High Cited Research
   Group (IHCRG # 14-104), Deanship of Scientific Research, College of
   Science Research Center, King Saud University, Kingdom of Saudi Arabia.
   Y.C. and A.H. thank King Saud University, Riyadh, Kingdom of Saudi
   Arabia, for the Visiting Professorship.
CR Archana D, 2013, INT J BIOL MACROMOL, V57, P193, DOI 10.1016/j.ijbiomac.2013.03.002
   Barbucci R, 2003, BIOMACROMOLECULES, V4, P1506, DOI 10.1021/bm0340366
   Bernards MT, 2008, MACROMOLECULES, V41, P4216, DOI 10.1021/ma800185y
   Chang Y, 2011, ACS APPL MATER INTER, V3, P1228, DOI 10.1021/am200055k
   Chang Y, 2010, BIOMACROMOLECULES, V11, P1101, DOI 10.1021/bm100093g
   Chang Y, 2010, LANGMUIR, V26, P3522, DOI 10.1021/la903172j
   Chapman RG, 2000, J AM CHEM SOC, V122, P8303, DOI 10.1021/ja000774f
   Chen KY, 2009, BIOMACROMOLECULES, V10, P1642, DOI 10.1021/bm900238b
   Chen S. H., 2013, MAT SCI ENG C, V4, P2584
   Chen XR, 2011, J MEMBRANE SCI, V384, P44, DOI 10.1016/j.memsci.2011.09.002
   Chiag YC, 2012, LANGMUIR, V28, P1399, DOI 10.1021/la204012n
   Chiang YC, 2012, J MEMBRANE SCI, V389, P76, DOI 10.1016/j.memsci.2011.10.017
   CORKHILL PH, 1989, BIOMATERIALS, V10, P3, DOI 10.1016/0142-9612(89)90002-1
   Gong CY, 2013, BIOMATERIALS, V34, P6377, DOI 10.1016/j.biomaterials.2013.05.005
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hamdan M, 2006, CLIN IMPLANT DENT R, V8, P32, DOI 10.2310/6480.2005.00028
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Hsu LC, 1997, J CARDIOTHOR VASC AN, V11, P376, DOI 10.1016/S1053-0770(97)90108-7
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kaladhar K, 2004, LANGMUIR, V20, P11115, DOI 10.1021/la048644y
   Kalasin S, 2009, COLLOID SURFACE B, V73, P229, DOI 10.1016/j.colsurfb.2009.05.028
   Kane RS, 2003, LANGMUIR, V19, P2388, DOI 10.1021/la020737x
   Kim JO, 2008, INT J PHARMACEUT, V359, P79, DOI 10.1016/j.ijpharm.2008.03.021
   Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030
   Lalani R, 2012, BIOMACROMOLECULES, V13, P1853, DOI 10.1021/bm300345e
   Liu JZ, 2012, IND ENG CHEM RES, V51, P8308, DOI 10.1021/ie300878f
   Liu QS, 2013, BIOMACROMOLECULES, V14, P226, DOI 10.1021/bm301646y
   Moura LIF, 2013, ACTA BIOMATER, V9, P7093, DOI 10.1016/j.actbio.2013.03.033
   Tran NQ, 2011, BIOMACROMOLECULES, V12, P2872, DOI 10.1021/bm200326g
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Schroeder ME, 2013, BIOMACROMOLECULES, V14, P3112, DOI 10.1021/bm4007369
   SEYFERT S, 1995, BIOMATERIALS, V16, P201, DOI 10.1016/0142-9612(95)92118-P
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Stadler V, 2008, LANGMUIR, V24, P8151, DOI 10.1021/la800772m
   Suzuki Y, 1998, BIORHEOLOGY, V35, P155, DOI 10.1016/S0006-355X(99)80005-5
   Tachev KD, 2000, COLLOID SURFACE B, V19, P61, DOI 10.1016/S0927-7765(99)00164-2
   Tu CY, 2005, POLYMER, V46, P6976, DOI 10.1016/j.polymer.2005.05.116
   Venault A, 2013, J MEMBRANE SCI, V439, P48, DOI 10.1016/j.memsci.2013.03.041
   Wang T, 2006, J MEMBRANE SCI, V280, P343, DOI 10.1016/j.memsci.2006.01.038
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
   Xu CQ, 2012, RADIAT PHYS CHEM, V81, P1763, DOI 10.1016/j.radphyschem.2012.07.001
   Yang LJ, 2011, J PHYS CHEM B, V115, P12456, DOI 10.1021/jp207652h
   Yu HJ, 2009, J MEMBRANE SCI, V342, P6, DOI 10.1016/j.memsci.2009.05.041
   Zhao C, 2013, LANGMUIR, V29, P1517, DOI 10.1021/la304511s
   Zhao J, 2011, J MEMBRANE SCI, V369, P5, DOI 10.1016/j.memsci.2010.10.046
NR 47
TC 30
Z9 30
U1 8
U2 72
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 25
PY 2014
VL 6
IS 12
BP 9858
EP 9870
DI 10.1021/am502382n
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AK1ON
UT WOS:000338184500115
PM 24881869
DA 2018-10-20
ER

PT J
AU Liu, L
   Li, NF
   Lei, T
   Li, KM
   Zhang, YD
AF Liu, Ling
   Li, Nianfeng
   Lei, Ting
   Li, Kaimo
   Zhang, Yangde
TI The in vitro biological properties of Mg-Zn-Sr alloy and superiority for
   preparation of biodegradable intestinal anastomosis rings
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE Anastomosis; Surgical; Anti-Infective Agents; Drug-Eluting Stents;
   Magnesium; Materials Testing
ID MAGNESIUM ALLOYS; CYTOTOXICITY
AB Background: Magnesium (Mg) alloy is a metal-based biodegradable material that has received increasing attention in the field of clinical surgery, but it is currently seldom used in intestinal anastomosis. This study was conducted to comprehensively assess a ternary magnesium (Mg)-zinc (Zn)-strontium (Sr) alloy's biological superiorities as a preparation material for intestinal anastomosis ring.
   Material/Methods: Mouse L-929 fibroblasts were cultured with Mg-Zn-Sr alloy extract and compared with both positive (0.64% phenol) and negative (original broth culture) controls. The cell morphology of different groups was examined using microscopy, and a cytotoxicity assessment was performed. Fresh anticoagulated human blood was mixed with Mg-Zn-Sr alloy extract and compared with both positive (distilled water) and negative (normal saline) controls. The absorbance of each sample at 570 nm was used to calculate the Mg-Zn-Sr alloy hemolysis ratio in order to test the Mg alloy's blood compatibility. Bacterial cultures of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus were added to Mg-Zn-Sr alloy block samples and compared with positive (Ceftazidime), negative (316LSS stainless steel), and blank controls. The broth cultures were sampled to compare their bacterial colony counts so as to evaluate the antibacterial properties of the Mg-Zn-Sr alloy. The Mg-Zn-Sr alloy was surface-coated with a layer of poly(lactic-co-glycolic acid) carrying everolimus. The surface morphology and degradability of the coating were examined so as to demonstrate feasibility of coating, which can release the drug evenly.
   Results: The experiments proved that Mg-Zn-Sr alloy has good biocompatible, antibacterial, and drug-loaded coating performances, which are lacking in existing intestinal anastomosis devices/materials.
   Conclusions: The Mg-Zn-Sr alloy increases biocompatibility, and yields a safer and better therapeutic effect; therefore, it is a novel biomaterial that is feasible for use when preparing biodegradable intestinal anastomosis rings.
C1 [Liu, Ling; Li, Nianfeng; Zhang, Yangde] Cent S Univ, Natl Hepatobiliary & Enter Surg Res Ctr, Xiangya Hosp, Changsha, Hunan, Peoples R China.
   [Lei, Ting] Cent S Univ, State Key Lab Powder Met, Changsha, Hunan, Peoples R China.
   [Li, Kaimo] Hunan Ind Polytech, Dept Mech Engn, Changsha, Hunan, Peoples R China.
RP Li, NF (reprint author), Cent S Univ, Natl Hepatobiliary & Enter Surg Res Ctr, Xiangya Hosp, Changsha, Hunan, Peoples R China.
EM dlnf66@163.com
CR [Anonymous], 2002, ISO109934
   Bornapour M, 2013, ACTA BIOMATER, V9, P5319, DOI 10.1016/j.actbio.2012.07.045
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Fouda E, 2011, J GASTROINTEST SURG, V15, P137, DOI 10.1007/s11605-010-1364-y
   [耿丽彦 Geng Liyan], 2012, [材料保护, Journal of Materials Protection], V45, P28
   Ghitulescu GA, 2003, CAN J SURG, V46, P92
   Guo XX, 2013, J APPL POLYM SCI, V128, P21, DOI 10.1002/app.37701
   HARDY TG, 1985, DIS COLON RECTUM, V28, P484, DOI 10.1007/BF02554090
   Huang Yan, 2012, Zhonghua Wei Chang Wai Ke Za Zhi, V15, P377
   ISO 10993-5, 1999, 109935 ISO
   Kovacs T, 2003, WORLD J SURG, V27, P465, DOI 10.1007/s00268-002-6723-8
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Li ZJ, 2007, CHINESE J BONE JOINT, V22, P740
   Lu DY, 1996, MED MICROBIOLOGY
   Oberstein PE, 2012, J PANCREAS, V13, P169
   Pan Fu-sheng, 2011, Chinese Journal of Nonferrous Metals, V21, P2382
   Rosalbino F, 2013, J BIOMED MATER RES A, V101, P704, DOI 10.1002/jbm.a.34368
   Ryan S, 2006, VET SURG, V35, P740, DOI 10.1111/j.1532-950X.2006.00218.x
   Saidak Z, 2012, PHARMACOL THERAPEUT, V136, P216, DOI 10.1016/j.pharmthera.2012.07.009
   Snega S, 2013, J MATER SCI-MATER EL, V24, P135, DOI 10.1007/s10854-012-0956-6
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707
   Wang Pan, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P1279, DOI 10.3969/j.issn.1672-7347.2012.12.018
   Yamaguchi M, 2012, MOL CELL BIOCHEM, V359, P399, DOI 10.1007/s11010-011-1034-8
   Yang X, 2001, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V18, P123
   You SH, 2006, CHINA MED DEVICEINFO, V12, P49
   [Zhang Yan 张岩], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P8162
NR 27
TC 6
Z9 6
U1 1
U2 16
PU INT SCIENTIFIC LITERATURE, INC
PI SMITHTOWN
PA 361 FOREST LANE, SMITHTOWN, NY 11787 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD JUN 24
PY 2014
VL 20
BP 1056
EP 1066
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AK6VV
UT WOS:000338566300001
PM 24957079
OA Green Published
DA 2018-10-20
ER

PT J
AU Shinonaga, T
   Tsukamoto, M
   Miyaji, G
AF Shinonaga, Togo
   Tsukamoto, Masahiro
   Miyaji, Godai
TI Periodic nanostructures on titanium dioxide film produced using
   femtosecond laser with wavelengths of 388 nm and 775 nm
SO OPTICS EXPRESS
LA English
DT Article
ID MICRO-ARC OXIDATION; SURFACE MODIFICATION; IRRADIATION; MICROSTRUCTURES;
   PLATE; ALIGNMENT; ABLATION; ELECTRON; SILICON; BEAM
AB Titanium dioxide (TiO2) film is an important biomaterial used to improve the biocompatibility of titanium (Ti). We have used a film coating method with an aerosol beam and femtosecond laser irradiation to form periodic structures on biomaterials for control of the cell spreading. The control of cell spreading on biomaterials is important for the development of advanced biomaterials. In this study, nanostructures with periods of 130 and 230 nm were formed on a film using a femtosecond laser with wavelengths of 388 and 775 nm, respectively. The nanostructure period on the film was 30% of the laser wavelengths. Periods produced with wavelengths of 388 and 775 nm were calculated using a surface plasmon polariton (SPP) model and the experimental results for both wavelengths were in the range of the calculated periods, which suggests that the mechanism for the formation of the periodic nanostructures on the film with a femtosecond laser was due to the excitation of SPPs. (C)2014 Optical Society of America
C1 [Shinonaga, Togo; Tsukamoto, Masahiro] Osaka Univ, Joining & Welding Res Inst, Ibaraki, Osaka 5670047, Japan.
   [Miyaji, Godai] Tokyo Univ Agr & Technol, Grad Sch Engn, Tokyo 1848588, Japan.
RP Shinonaga, T (reprint author), Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.
EM togo@jwri.osaka-u.ac.jp
RI Miyaji, Godai/I-6031-2014
CR Akedo J, 1998, SENSOR ACTUAT A-PHYS, V69, P106, DOI 10.1016/S0924-4247(98)00059-4
   Buividas R, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/5/055304
   Das SK, 2009, J APPL PHYS, V105, DOI 10.1063/1.3117509
   Dufft D, 2009, J APPL PHYS, V105, DOI 10.1063/1.3074106
   Enright B, 1996, J PHYS CHEM-US, V100, P1027, DOI 10.1021/jp951142w
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Hanawa T, 2010, JPN DENT SCI REV, V46, P93, DOI 10.1016/j.jdsr.2009.11.001
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Matsugaki A, 2012, BIOMATERIALS, V33, P7327, DOI 10.1016/j.biomaterials.2012.06.022
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Miyaji G, 2008, OPT EXPRESS, V16, P16265, DOI 10.1364/OE.16.016265
   Miyaji G, 2012, OPT EXPRESS, V20, P14848, DOI 10.1364/OE.20.014848
   Miyazaki K, 2013, J APPL PHYS, V114, DOI 10.1063/1.4826078
   Okamuro K, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165417
   Palik E. D., 1997, HDB OPTICAL CONSTANT
   Raether H., 1988, SURFACE PLASMONS SMO
   Reif J, 2002, APPL SURF SCI, V197, P891, DOI 10.1016/S0169-4332(02)00450-6
   Sakabe S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.033409
   Shimotsume Y., 2003, PHYS REV LETT, V91, DOI DOI 10.1103/PhysRevLett.91.247405
   Shinonaga T, 2014, APPL SURF SCI, V288, P649, DOI 10.1016/j.apsusc.2013.10.090
   Sokolowski-Tinten K, 2000, PHYS REV B, V61, P2643, DOI 10.1103/PhysRevB.61.2643
   Tsukamoto M, 2008, APPL PHYS A-MATER, V93, P193, DOI 10.1007/s00339-008-4713-x
   Tsukamoto M, 2007, J PHYS CONF SER, V59, P666, DOI 10.1088/1742-6596/59/1/140
   Tsukamoto M, 2013, APPL PHYS A-MATER, V110, P679, DOI 10.1007/s00339-012-7185-y
   Tsukamoto M, 2003, JPN J APPL PHYS 2, V42, pL120, DOI 10.1143/JJAP.42.L120
   Tsukamoto M, 2006, VACUUM, V80, P1346, DOI 10.1016/j.vacuum.2006.01.016
   Tsutsumi Y, 2012, APPL SURF SCI, V262, P34, DOI 10.1016/j.apsusc.2012.01.024
   Umran FA, 2013, OPT EXPRESS, V21, P15259, DOI 10.1364/OE.21.015259
   Wang C, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/7/075304
   Yasumaru N, 2003, APPL PHYS A-MATER, V76, P983, DOI 10.1007/s00339-002-1979-2
NR 32
TC 10
Z9 10
U1 3
U2 45
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-4087
J9 OPT EXPRESS
JI Opt. Express
PD JUN 16
PY 2014
VL 22
IS 12
BP 14696
EP 14704
DI 10.1364/OE.22.014696
PG 9
WC Optics
SC Optics
GA AJ9PH
UT WOS:000338044300063
PM 24977565
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Harris, JP
   Struzyna, LA
   Murphy, PL
   Cullen, DK
AF Harris, J. P.
   Struzyna, L. A.
   Murphy, P. L.
   Cullen, D. K.
TI ADVANCED BIOMATERIAL STRATEGIES FOR MICRO-TISSUE ENGINEERED NEURAL
   NETWORKS TO RESTORE BRAIN CIRCUITS
SO JOURNAL OF NEUROTRAUMA
LA English
DT Meeting Abstract
CT 32nd Annual National Neurotrauma Symposium
CY JUN 29-JUL 02, 2014
CL San Francisco, CA
DE axonal tracts; biomaterials; cell replacement; tissue engineering
C1 [Harris, J. P.; Struzyna, L. A.; Murphy, P. L.; Cullen, D. K.] Univ Penn, Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA.
   [Harris, J. P.; Cullen, D. K.] Philadelphia Vet Adm Hosp, Philadelphia, PA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0897-7151
EI 1557-9042
J9 J NEUROTRAUM
JI J. Neurotrauma
PD JUN 15
PY 2014
VL 31
IS 12
MA T1-06
BP A4
EP A4
PG 1
WC Critical Care Medicine; Clinical Neurology; Neurosciences
SC General & Internal Medicine; Neurosciences & Neurology
GA AK5DC
UT WOS:000338443600007
DA 2018-10-20
ER

PT J
AU Wang, XJ
   Wang, GW
   Shan, SQ
   Hui, GY
   Guo, TK
   Liu, GY
   Zhao, YM
AF Wang, Xiaojing
   Wang, Guowei
   Shan, ShouQin
   Hui, Guangyan
   Guo, Tingkai
   Liu, Guangyan
   Zhao, Yimin
TI In vitro and in vivo study of a sodium chloride impregnated microarc
   oxidation-treated titanium implant surface
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID STAPHYLOCOCCUS-AUREUS ADHESION; PERI-IMPLANTITIS; INFECTION;
   BIOMATERIAL; INTEGRATION
AB Microarc oxidation (MAO) has been well-documented as an advantageous surface coating technique to improve implant osseointegration. Nevertheless, its strong susceptibility to bacteria critically impedes the development of MAO in clinical trials. Aimed at the efficient inhibition of bacterial invasion of MAO treated titanium (MAO-Ti) implants, a composite coating created by applying sodium chloride (NaCl) on a MAO-Ti implant surface layer was designed herein with the capacity to resist a broad spectrum of bacteria. In the present study, 10% NaCl was impregnated onto an optimized MAO-Ti implant to achieve a composite NaCl-MAO-Ti coating. First, Staphylococcus aureus (S. aureus), a frequently detected pathogen associated with peri-implantitis, was employed as an in vitro model. The visualization and quantification of S. aureus adhering to MAO-Ti and NaCl-MAO-Ti surfaces after incubation for 2, 4 and 24 h was described. Secondly, in an animal experiment, MAO-Ti and NaCl-MAO-Ti implants were placed into the tibia of male goats and these implants remained in situ for 9 weeks. The pen-implant soft tissue reactions, epithelial down growth and microorganisms separated from the inflammatory exudates were assessed during the whole process. The results of the in vitro study revealed that the NaCl-MAO-Ti implant surface significantly decreased the adhesion and multiplication of S. aureus compared to the untreated MAO-Ti. Moreover, the animal experiment established that the NaCl-MAO-Ti implants caused less pen-implant soft tissue infection and ultimately reduced the occurrence of peri-implantitis. Taken together, these data suggest that NaCl impregnated MAO-Ti implant products can effectively lower the risk of peri-implantitis and simultaneously preserve the osseointegration capacity of the MAO coating, which may help facilitate the application of NaCl-MAO-Ti implants in clinic trials.
C1 [Wang, Xiaojing; Shan, ShouQin; Hui, Guangyan] Qingdao First Sanat Jinan Mil Reg, Dept Stomatol, Qingdao 266071, Shandong, Peoples R China.
   [Wang, Xiaojing; Zhao, Yimin] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian 710032, Shaanxi, Peoples R China.
   [Wang, Guowei; Guo, Tingkai; Liu, Guangyan] Chinese PLA, Hosp 409, Dept Stomatol, Qingdao 266100, Shandong, Peoples R China.
RP Zhao, YM (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian 710032, Shaanxi, Peoples R China.
EM zhaoym_fmmu@163.com
FU National Natural Science Foundation of China [81271104]
FX The authors would like to thank Dr Pengliang Zhang in the clinical
   microbiology detection laboratory (Xijing Hospital, Fourth Military
   Medical University, China) for his great technical support. The authors
   would also like to thank Dr Minyong Li (Department of Chemistry, School
   of Pharmacy, Shandong University, China) for his kind review and
   constructive advice, which made this manuscript more readable. This work
   was supported by the National Natural Science Foundation of China (Grant
   No. 81271104 from Prof. Yimin Zhao).
CR Abu-Serriah MM, 2000, INT J ORAL MAX SURG, V29, P344, DOI 10.1016/S0901-5027(00)80049-1
   Armas J., 2013, DENT UPDATE, V40, P480
   Armas J., 2013, DENT UPDATE, V40, P476
   Armas Joshe, 2013, Dent Update, V40, P472
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Bazaka K, 2012, APPL MICROBIOL BIOT, V95, P299, DOI 10.1007/s00253-012-4144-7
   Becker W, 2000, Clin Implant Dent Relat Res, V2, P159, DOI 10.1111/j.1708-8208.2000.tb00007.x
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   ELEK SD, 1956, ANN NY ACAD SCI, V65, P85, DOI 10.1111/j.1749-6632.1956.tb36626.x
   Ewald A, 2009, ORAL SURG ORAL MED O, V107, P790, DOI 10.1016/j.tripleo.2008.12.028
   Francois P, 1996, INFECT CONT HOSP EP, V17, P514
   Gitto C A, 1994, Int J Oral Maxillofac Implants, V9, P197
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   Harris LG, 2004, J MATER SCI-MATER M, V15, P311, DOI 10.1023/B:JMSM.0000021093.84680.bb
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   JANSEN JA, 1991, BIOMATERIALS, V12, P25, DOI 10.1016/0142-9612(91)90127-V
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Leonhardt A, 2003, J PERIODONTOL, V74, P1415, DOI 10.1902/jop.2003.74.10.1415
   Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Li LH, 2005, J BIOMED MATER RES A, V73A, P48, DOI 10.1002/jbm.a.30244
   Lim YW, 2009, CLIN ORTHOP RELAT R, V467, P2251, DOI 10.1007/s11999-009-0879-6
   Meffert RM, 1988, DENT ED, V52, P810
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   PATTI JM, 1994, CURR OPIN CELL BIOL, V6, P752, DOI 10.1016/0955-0674(94)90104-X
   Persson GR, 2011, J PERIODONTOL, V82, P1267, DOI 10.1902/jop.2011.100660
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   PIATTELLI A, 1995, BIOMATERIALS, V16, P917, DOI 10.1016/0142-9612(95)93116-U
   Projan SJ, 2007, CURR OPIN MICROBIOL, V10, P441, DOI 10.1016/j.mib.2007.08.007
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   Rice LB, 2006, BIOCHEM PHARMACOL, V71, P991, DOI 10.1016/j.bcp.2005.09.018
   Schwartz AB, 2007, J DENT, V35, P881, DOI 10.1016/j.jdent.2007.08.003
   Wang XJ, 2008, J BIOMED MATER RES B, V87B, P508, DOI 10.1002/jbm.b.31137
   Wang XJ, 2009, SURF COAT TECH, V203, P3454, DOI 10.1016/j.surfcoat.2009.05.009
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
NR 42
TC 0
Z9 0
U1 2
U2 15
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD JUN 14
PY 2014
VL 2
IS 22
BP 3549
EP 3556
DI 10.1039/c4tb00072b
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA AI4IR
UT WOS:000336829400016
DA 2018-10-20
ER

PT J
AU Ngamviriyavong, P
   Patntirapong, S
   Janvikul, W
   Arphavasin, S
   Meesap, P
   Singhatanadgit, W
AF Ngamviriyavong, Patcharee
   Patntirapong, Somying
   Janvikul, Wanida
   Arphavasin, Suphakit
   Meesap, Preeyapan
   Singhatanadgit, Weerachai
TI Development of poly(butylene succinate)/calcium phosphate composites for
   bone engineering
SO COMPOSITE INTERFACES
LA English
DT Article
DE biocompatibility; bone engineering; calcium phosphate; poly (butylene
   succinate); bioactivity
ID IN-VITRO; CELLS; BIOCOMPATIBILITY; OSTEOBLASTS; SCAFFOLDS;
   MICROSTRUCTURE; WETTABILITY; CHITOSAN; MICE
AB Bone tissue engineering offers the prospect of alternative therapies for clinically relevant skeletal defects. Poly(butylene succinate) (PBSu) is a biodegradable and biocompatible polyester which possesses some unfavorable biomaterial properties. In order to improve this limitation, we developed PBSu/hydroxyapatite (HA) and PBSu/beta-tricalcium phosphate (TCP) composites to support the growth and osteogenic differentiation of human mesenchymal stem cells (hMSCs). The results showed that phase separation morphology of the composites were detected in both PBSu/HA and PBSu/TCP films where calcium phosphate (HA and TCP) dispersed thoroughly into PBSu. The addition of either HA or TCP increased the hydrophilicity of the resulting composites. All the materials appeared to be biocompatible and supported in vitro growth and osteoblast differentiation of hMSCs. In conclusion, the currently developed composite materials possess good biocompatibility and allow the growth and osteogenic differentiation of hMSCs in vitro, suggesting their potential application in stem cell-based bone engineering.
C1 [Ngamviriyavong, Patcharee; Janvikul, Wanida; Meesap, Preeyapan] Natl Met & Mat Technol Ctr, Pathum Thani, Thailand.
   [Patntirapong, Somying; Arphavasin, Suphakit; Singhatanadgit, Weerachai] Thammasat Univ, Fac Dent, Klongluang 12121, Pathumthani, Thailand.
RP Singhatanadgit, W (reprint author), Thammasat Univ, Fac Dent, Rangsit Campus 99 Moo 18 Pahonyothin Rd, Klongluang 12121, Pathumthani, Thailand.
EM s-wrch@tu.ac.th
OI Singhatanadgit, Weerachai/0000-0001-7594-1305
FU National Metal and Materials Technology Center [MT-B-53-BMD-13-187-G];
   Thammasat University, Thailand
FX The present study was financially supported by the National Metal and
   Materials Technology Center (MT-B-53-BMD-13-187-G) and Thammasat
   University, Thailand.
CR Abbondanzo SL, 1999, MODERN PATHOL, V12, P706
   Cheng LJ, 2010, ACTA BIOMATER, V6, P1569, DOI 10.1016/j.actbio.2009.10.050
   Correlo VM, 2009, J BIOMED MATER RES A, V91A, P489, DOI 10.1002/jbm.a.32221
   Costa-Pinto AR, 2012, J TISSUE ENG REGEN M, V6, P21, DOI 10.1002/term.391
   Costa-Pinto AR, 2009, BIOMACROMOLECULES, V10, P2067, DOI 10.1021/bm9000102
   Coutinho DF, 2008, BIOMACROMOLECULES, V9, P1139, DOI 10.1021/bm701268s
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Idris SB, 2010, J BIOACT COMPAT POL, V25, P567, DOI 10.1177/0883911510381368
   Jing Y, 2004, BIOMACROMOLECULES, V5, P2258, DOI 10.1021/bm049705+
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Li HY, 2005, MACROMOL BIOSCI, V5, P433, DOI 10.1002/mabi.200400183
   MUNDY GR, 1995, CLIN ORTHOP RELAT R, P19
   Salerno A, 2012, J BIOACT COMPAT POL, V27, P210, DOI 10.1177/0883911512442564
   Schander K, 2010, J BIOACT COMPAT POL, V25, P584, DOI 10.1177/0883911510383684
   Singhatanadgit W, 2006, J CELL PHYSIOL, V209, P912, DOI 10.1002/jcp.20799
   Vaccaro AR, 2002, ORTHOPEDICS, V25, pS571
   Wang HY, 2009, ACTA BIOMATER, V5, P279, DOI 10.1016/j.actbio.2008.07.017
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Wennberg C, 2000, J BONE MINER RES, V15, P1879, DOI 10.1359/jbmr.2000.15.10.1879
   Xu J, 2010, BIOTECHNOL J, V5, P1149, DOI 10.1002/biot.201000136
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
NR 25
TC 9
Z9 9
U1 1
U2 31
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0927-6440
EI 1568-5543
J9 COMPOS INTERFACE
JI Compos. Interfaces
PD JUN 13
PY 2014
VL 21
IS 5
BP 431
EP 441
DI 10.1080/15685543.2014.872959
PG 11
WC Materials Science, Composites
SC Materials Science
GA AE4ZF
UT WOS:000333996900005
DA 2018-10-20
ER

PT J
AU Liu, T
   Zeng, Z
   Liu, Y
   Wang, J
   Maitz, MF
   Wang, Y
   Liu, SH
   Chen, JY
   Huang, N
AF Liu, Tao
   Zeng, Zheng
   Liu, Yang
   Wang, Jian
   Maitz, Manfred F.
   Wang, Yuan
   Liu, Shihui
   Chen, Junying
   Huang, Nan
TI Surface Modification with Dopamine and Heparin/Poly-L-Lysine
   Nanoparticles Provides a Favorable Release Behavior for the Healing of
   Vascular Stent Lesions
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE heparin; nanoparticle; endothelial cell; thrombosis; restenosis
ID MUSCLE CELL-PROLIFERATION; CORONARY-ARTERY-DISEASE; DRUG-ELUTING STENTS;
   TIME-COURSE; INTIMAL HYPERPLASIA; RANDOMIZED-TRIAL; UNFRACTIONATED
   HEPARIN; INFLAMMATORY RESPONSE; BALLOON ANGIOPLASTY; ENDOTHELIAL-CELLS
AB Surface biofunctional modification of coronary artery stents to prevent thrombosis and restenosis formation, as well as accelerate endothelialization, has become a new hot spot. However, bioactive coatings on implants are not yet sufficiently developed for long-term activity, as they quickly lose efficiency in vivo and finally fail. On the basis of a novel time-ordered concept of biofunctionality for vascular stents, heparin/poly L-lysine nanoparticle (NP) was developed and immobilized on a polydopamine-coated titanium surface, with the aim of regulating and maintaining the intravascular biological response within the normal range after biomaterial implantation. An in vitro dynamic release model was established to mimic the blood flow condition in vivo with three phases: (1) An early phase (1-7 days) with release of predominantly anticoagulant and anti-inflammatory substances and to a minor degree antiproliferative effects against smooth muscle cells (SMCs); (2) this is followed by a phase (7-14 days) of supported endothelial cell (ECs) proliferation and suppressed SMC proliferation with persisting high antithrombogenicity and anti-inflammatory properties of the surface. (3) Finally, a stable stage (14-28 days) with adequate biomolecules on the surface that maintain hemocompatibility and anti inflammation as well as inhibit SMCs proliferation and promote ECs growth. In vivo animal tests further confirmed that the NP-modified surface provides a favorable release behavior to apply a stage-adjusted remedy. We suggested that these observations provide important guidance and potential means for reasonable and suitable platform construction on a stent surface.
C1 [Liu, Tao; Zeng, Zheng; Liu, Yang; Wang, Jian; Maitz, Manfred F.; Wang, Yuan; Liu, Shihui; Chen, Junying; Huang, Nan] Southwest Jiaotong Univ, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
   [Zeng, Zheng] Southwest Jiaotong Univ, Sch Life Sci & Technol, Chengdu 610031, Peoples R China.
   [Maitz, Manfred F.] Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Liu, Shihui] Naton Med Grp, Naton Inst Med Technol, Beijing 100082, Peoples R China.
RP Chen, JY (reprint author), Southwest Jiaotong Univ, Minist Educ, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
EM chenjy@263.net
RI Umlauf, Ursula/D-3356-2014; Maitz, Manfred/E-6749-2010
OI Maitz, Manfred/0000-0002-0671-048X
FU Key Basic Research Program [2011CB606204]; National Natural Science
   Foundation of China [31170916#, 3127002.0#]; Fundamental Research Funds
   for the Central Universities [SWJTU11ZT11]
FX The authors gratefully acknowledge the assistance from Prof. Yuancong
   Zhao, and the financial support of Key Basic Research Program
   (2011CB606204), National Natural Science Foundation of China (31170916#,
   No. 3127002.0#), and the Fundamental Research Funds for the Central
   Universities (SWJTU11ZT11).
CR Adriaenssens T, 2007, J AM COLL CARDIOL, V49, P1265, DOI 10.1016/j.jacc.2007.02.021
   Ahn YK, 1999, CATHETER CARDIO INTE, V48, P324, DOI 10.1002/(SICI)1522-726X(199911)48:3<324::AID-CCD20>3.0.CO;2-K
   Atalar E, 2001, CLIN CARDIOL, V24, P159, DOI 10.1002/clc.4960240211
   BAGELOVA J, 1994, BIOCHEM J, V297, P99, DOI 10.1042/bj2970099
   Beck GC, 2004, CRIT CARE, V8, P485, DOI 10.1186/cc2879
   Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038
   Byrne RA, 2010, J AM COLL CARDIOL, V55, P2536, DOI 10.1016/j.jacc.2010.03.020
   Byrne RA, 2009, EUR HEART J, V30, P923, DOI 10.1093/eurheartj/ehp044
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Cervinka P., 2009, AM COLL CARD ANN SCI
   Chen CY, 1997, J SURG RES, V67, P106, DOI 10.1006/jsre.1996.4922
   Cindhuchao N, 2003, BIOCHEM BIOPH RES CO, V302, P84, DOI 10.1016/S0006-291X(03)00068-8
   Ettelaie C, 2011, BBA-MOL BASIS DIS, V1812, P1591, DOI 10.1016/j.bbadis.2011.09.007
   Geary RL, 1996, ARTERIOSCL THROM VAS, V16, P34, DOI 10.1161/01.ATV.16.1.34
   GEARY RL, 1994, CIRC RES, V74, P14, DOI 10.1161/01.RES.74.1.14
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   GUYTON JR, 1980, CIRC RES, V46, P625, DOI 10.1161/01.RES.46.5.625
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   HANKE H, 1990, CIRC RES, V67, P651, DOI 10.1161/01.RES.67.3.651
   HAUDE M, 1993, AM HEART J, V126, P15, DOI 10.1016/S0002-8703(07)80005-6
   Hoshi RA, 2013, BIOMATERIALS, V34, P30, DOI 10.1016/j.biomaterials.2012.09.046
   Jaster M, 2003, THROMB RES, V112, P285, DOI 10.1016/j.thromres.2003.09.022
   KASTRATI A, 1993, CIRCULATION, V87, P1498, DOI 10.1161/01.CIR.87.5.1498
   Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6
   Lakshmi TSR, 2010, J BIOMED MATER RES A, V95A, P118, DOI 10.1002/jbm.a.32791
   Lansky AJ, 2004, CIRCULATION, V109, P1948, DOI 10.1161/01.CIR.0000127129.94129.6F
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   LETOURNEUR D, 1995, J CELL PHYSIOL, V165, P687, DOI 10.1002/jcp.1041650328
   Li GC, 2011, CYTOKINE, V56, P208, DOI 10.1016/j.cyto.2011.06.020
   Li GC, 2011, BIOMATERIALS, V32, P4691, DOI 10.1016/j.biomaterials.2011.03.025
   Li JJ, 2007, MED HYPOTHESES, V68, P945, DOI 10.1016/j.mehy.2006.05.069
   Li JJ, 2004, CLIN CHIM ACTA, V350, P115, DOI 10.1016/j.cccn.2004.07.013
   Li L, 2012, CARDIOVASC DRUG THER, V26, P479, DOI 10.1007/s10557-012-6419-8
   Li X, 2012, CYTOKINE, V60, P114, DOI 10.1016/j.cyto.2012.06.008
   Libby P, 2001, CIRCULATION, V103, P1718, DOI 10.1161/01.CIR.103.13.1718
   Lin PH, 2003, J VASC INTERV RADIOL, V14, P603, DOI 10.1097/01.RVI.0000071088.76348.23
   Liu T, 2014, J BIOMED MATER RES A, V102, P3754, DOI 10.1002/jbm.a.35025
   Liu T, 2014, ACTA BIOMATER, V10, P1940, DOI 10.1016/j.actbio.2013.12.013
   Mak KH, 1996, J AM COLL CARDIOL, V27, P494, DOI 10.1016/0735-1097(95)00466-1
   Mitsi M, 2008, J BIOL CHEM, V283, P34796, DOI 10.1074/jbc.M806692200
   Miyazaki K, 2000, J CARDIOVASC SURG, V41, P885
   Monchaux Emmanuelle, 2010, Front Biosci (Schol Ed), V2, P239
   Park DW, 2010, J AM COLL CARDIOL, V56, P1366, DOI 10.1016/j.jacc.2010.03.097
   Puleo D. A., 2009, BIOL INTERACTIONS MA, P1
   Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X
   SMITH PK, 1980, ANAL BIOCHEM, V109, P466, DOI 10.1016/0003-2697(80)90679-X
   Tamai Hideo, 2004, Am Heart J, V147, pE9
   Verheye S, 2009, JACC-CARDIOVASC INTE, V2, P205, DOI 10.1016/j.jcin.2008.12.011
   Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC
   Welt FGP, 2002, ARTERIOSCL THROM VAS, V22, P1769, DOI 10.1161/01.ATV.0000037100.44766.5B
   Weng YJ, 2011, BIOMATERIALS, V32, P1253, DOI 10.1016/j.biomaterials.2010.10.039
   Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1
   Windecker S, 2007, CIRCULATION, V116, P1952, DOI 10.1161/CIRCULATIONAHA.106.683995
   Young E, 1999, THROMB RES, V96, P373, DOI 10.1016/S0049-3848(99)00125-5
   Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026
NR 55
TC 28
Z9 29
U1 7
U2 108
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 11
PY 2014
VL 6
IS 11
BP 8729
EP 8743
DI 10.1021/am5015309
PG 15
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AJ0JN
UT WOS:000337336900094
PM 24731022
DA 2018-10-20
ER

PT J
AU Zeng, Y
   Yao, XH
   Liu, XH
AF Zeng, Ye
   Yao, Xing-Hong
   Liu, Xiao-Heng
TI Numerical simulation of the effect of permeability on the hydrodynamics
   in a parallel-plate coculture flow chamber
SO COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING
LA English
DT Article
DE flow chamber; computational fluid dynamics; hydrodynamics; shear rate;
   mechanobiology; coculture; biomaterial; permeability
ID VASCULAR ENDOTHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; SHEAR-STRESS; IN-VITRO;
   LEUKOCYTE MIGRATION; BLOOD-VESSELS; MONOLAYERS; ADHESION;
   ATHEROSCLEROSIS; SCAFFOLDS
AB To study the effect of the porous membrane permeability on the hydrodynamics in a parallel-plate coculture flow chamber (PPcFC), we demonstrated the permeability of the porous membrane as a function of some parameters, such as porosity, membrane thickness, pore size and shape of the membrane. The effect of permeability on the flow in the PPcFC was analysed using the commercial software - Fluent. Results showed that the permeability was directly proportional to the thickness, the porosity and the pore size of the membrane, and inversely proportional to the surface shape factor. To ensure the best flow pattern, the inlet velocity range was limited by the membrane permeability and fluid viscosity, and then restricted the available magnitudes of shear rate on the permeable membrane. Our findings are helpful in designing and preparing the biomaterials that have adequate mechanical properties for the functional vascular grafts production, and in using of the flow chamber in various investigations.
C1 [Zeng, Ye; Liu, Xiao-Heng] Sichuan Univ, West China Hosp, Lab Cardiovasc Dis, Chengdu 610064, Peoples R China.
   [Zeng, Ye; Liu, Xiao-Heng] Sichuan Univ, Inst Biomed Engn, West China Sch Preclin & Forens Med, Chengdu 610064, Peoples R China.
   [Yao, Xing-Hong] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China.
RP Liu, XH (reprint author), Sichuan Univ, West China Hosp, Lab Cardiovasc Dis, Chengdu 610064, Peoples R China.
EM liuxiaohg@scu.edu.cn
OI Zeng, Ye/0000-0001-5440-6194
FU National Natural Science Foundation of China [10772127, 10972148,
   11172189]; Sichuan Youth Science & Technology Foundation [06ZQ026-009];
   Programme for New Century Excellent Talents in University of China
   [NCET-06-0791]; China Medical Board [82-412]
FX This study was supported in part by grant from National Natural Science
   Foundation of China (Grant Nos 10772127, 10972148, 11172189), Sichuan
   Youth Science & Technology Foundation (Grant No. 06ZQ026-009), Programme
   for New Century Excellent Talents in University of China (Grant No.
   NCET-06-0791) and China Medical Board (No. 82-412).
CR Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   ALBELDA SM, 1988, J APPL PHYSIOL, V64, P308
   Baguneid M, 2004, BIOTECHNOL APPL BIOC, V39, P151, DOI 10.1042/BA20030148
   Barakat AI, 2003, CELL BIOCHEM BIOPHYS, V38, P323, DOI 10.1385/CBB:38:3:323
   BOWEN BD, 1985, J COLLOID INTERF SCI, V106, P367, DOI 10.1016/S0021-9797(85)80011-4
   Chen HQ, 1989, BLOOD RHEOLOGY ITS C
   Chien S, 2006, CIRC RES, V98, P863, DOI 10.1161/01.RES.0000219686.29872.e2
   Chiu JJ, 2003, BLOOD, V101, P2667, DOI 10.1182/blood-2002-08-2560
   Chotard-Ghodsnia R, 2002, J BIOMECH ENG-T ASME, V124, P258, DOI 10.1115/1.1448520
   Chua LP, 2007, ARTIF ORGANS, V31, P560, DOI 10.1111/j.1525-1594.2007.00422.x
   Chung BJ, 2003, COMPUT STRUCT, V81, P535, DOI 10.1016/S0045-7949(02)00416-9
   COOPER JA, 1987, J APPL PHYSIOL, V62, P1076
   DAHURON L, 1988, AICHE J, V34, P130, DOI 10.1002/aic.690340115
   ELIMELECH M, 1994, SEPAR TECHNOL, V4, P186, DOI 10.1016/0956-9618(94)80024-3
   Feugier P, 2005, BIOMATERIALS, V26, P1457, DOI 10.1016/j.biomaterials.2004.04.050
   Fox RW, 2003, INTRO FLUID MECH
   Garg K, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/031001
   HALL C. WILLIAM, 1967, J BIOMED MAT RES, V1, P179, DOI 10.1002/jbm.820010202
   Hoenig MR, 2005, ARTERIOSCL THROM VAS, V25, P1128, DOI 10.1161/01.ATV.0000158996.03867.72
   Hofbauer R, 1998, LIFE SCI, V63, P1725, DOI 10.1016/S0024-3205(98)00444-5
   Hofbauer R, 1999, J INVEST MED, V47, P57
   Huang J, 2009, J BIOMECH, V42, P743, DOI 10.1016/j.jbiomech.2009.01.038
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Krenning G, 2008, TRENDS CARDIOVAS MED, V18, P312, DOI 10.1016/j.tcm.2009.01.004
   Li SH, 2003, TISSUE ENG, V9, P535, DOI 10.1089/107632703322066714
   Liang S, 2005, EXP CELL RES, V310, P282, DOI 10.1016/j.yexcr.2005.07.028
   Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035
   McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847
   Michel CC, 1999, PHYSIOL REV, V79, P703
   Nackman GB, 1998, SURGERY, V124, P353, DOI 10.1016/S0039-6060(98)70141-2
   Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z
   ORSZAG SA, 1983, J FLUID MECH, V128, P347, DOI 10.1017/S0022112083000518
   Perry Robert, 1997, PERRYS CHEM ENG HDB
   Rainger GE, 2001, J IMMUNOL METHODS, V255, P73, DOI 10.1016/S0022-1759(01)00427-6
   ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043
   Scheidegger AE, 1974, PHYS FLOW POROUS MED
   SILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535
   VANWAGENEN RA, 1980, J COLLOID INTERF SCI, V76, P305, DOI 10.1016/0021-9797(80)90374-4
   WESOLOWSKI SA, 1972, B NEW YORK ACAD MED, V48, P331
   Westerhof N, 2004, SNAPSHOTS HEMODYNAMI
   YEDGAR S, 1982, J BIOL CHEM, V257, P2188
   [曾烨 ZENG Ye], 2007, [航天医学与医学工程, Space Medicine & Medical Engineering], V20, P227
NR 42
TC 0
Z9 0
U1 0
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1025-5842
EI 1476-8259
J9 COMPUT METHOD BIOMEC
JI Comput. Methods Biomech. Biomed. Eng.
PD JUN 11
PY 2014
VL 17
IS 8
BP 875
EP 887
DI 10.1080/10255842.2012.723699
PG 13
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical
SC Computer Science; Engineering
GA AE6CF
UT WOS:000334075400007
PM 22994242
DA 2018-10-20
ER

PT J
AU Gasparotto, VPO
   Landim-Alvarenga, FC
   Oliveira, ALR
   Simoes, GF
   Lima-Neto, JF
   Barraviera, B
   Ferreira, RS
AF Gasparotto, Vinicius P. O.
   Landim-Alvarenga, Fernanda C.
   Oliveira, Alexandre L. R.
   Simoes, Gustavo Ferreira
   Lima-Neto, Joao F.
   Barraviera, Benedito
   Ferreira, Rui S., Jr.
TI A new fibrin sealant as a three-dimensional scaffold candidate for
   mesenchymal stem cells
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
ID DURISSUS-TERRIFICUS VENOM; IN-VITRO; OSTEOGENIC DIFFERENTIATION;
   ADIPOSE-TISSUE; BONE-MARROW; PROLIFERATION; INJECTION; MEDICINE; BLOOD
AB Introduction: The optimization of an organic scaffold for specific types of applications and cells is vital to successful tissue engineering. In this study, we investigated the effects of a new fibrin sealant derived from snake venom as a scaffold for mesenchymal stem cells, to demonstrate the ability of cells to affect and detect the biological microenvironment.
   Methods: The characterization of CD34, CD44 and CD90 expression on mesenchymal stem cells was performed by flow cytometry. In vitro growth and cell viability were evaluated by light and electron microscopy. Differentiation into osteogenic, adipogenic and chondrogenic lineages was induced.
   Results: The fibrin sealant did not affect cell adhesion, proliferation or differentiation and allowed the adherence and growth of mesenchymal stem cells on its surface. Hoechst 33342 and propidium iodide staining demonstrated the viability of mesenchymal stem cells in contact with the fibrin sealant and the ability of the biomaterial to maintain cell survival.
   Conclusions: The new fibrin sealant is a three-dimensional scaffolding candidate that is capable of maintaining cell survival without interfering with differentiation, and might also be useful in drug delivery. Fibrin sealant has a low production cost, does not transmit infectious diseases from human blood and has properties of a suitable scaffold for stem cells because it permits the preparation of differentiated scaffolds that are suitable for every need.
C1 [Gasparotto, Vinicius P. O.; Barraviera, Benedito; Ferreira, Rui S., Jr.] Univ Estadual Paulista, UNESP, Sao Paulo State Univ, Dept Trop Dis & Image Diag,Botucatu Med Sch, BR-18618970 Sao Paulo, Brazil.
   [Landim-Alvarenga, Fernanda C.; Oliveira, Alexandre L. R.; Lima-Neto, Joao F.; Barraviera, Benedito; Ferreira, Rui S., Jr.] Univ Estadual Paulista, UNESP, Sao Paulo State Univ, Ctr Study Venoms & Venomous Anim UNESP,CEVAP, BR-18610307 Sao Paulo, Brazil.
   [Landim-Alvarenga, Fernanda C.] Univ Estadual Paulista, UNESP, Sao Paulo State Univ, Dept Anim Reprod & Vet Radiol,Sch Vet Med & Anim, BR-18618970 Sao Paulo, Brazil.
   [Oliveira, Alexandre L. R.; Simoes, Gustavo Ferreira] Univ Estadual Campinas, UNICAMP, Dept Struct & Funct Biol, Lab Nerve Regenerat, BR-13083865 Sao Paulo, Brazil.
RP Ferreira, RS (reprint author), Univ Estadual Paulista, UNESP, Sao Paulo State Univ, Dept Trop Dis & Image Diag,Botucatu Med Sch, Av Prof Montenegro,Dist Rubiao Jr S-N, BR-18618970 Sao Paulo, Brazil.
EM rseabra@cevap.org.br
RI Gasparotto, Vinicius/J-8753-2016; Seabra Ferreira Jr, Rui/D-1285-2012;
   Oliveira, Alexandre/C-4436-2012
OI Seabra Ferreira Jr, Rui/0000-0001-6952-0512; Oliveira,
   Alexandre/0000-0003-4224-4575; Barraviera, Benedito/0000-0002-9855-5594;
   Ferreira, Rui/0000-0003-1856-2792; , Gustavo/0000-0001-5362-4085;
   Gasparotto, Vinicius/0000-0001-7847-2364
FU FAPESP [2009/53846-9, 2009/06280-0, 2012/08101-8]; CNPq [563582/2010-3];
   CAPES AUX-PE Toxinology [1219/2011, 23038.000823/2011-21]
FX The authors are grateful for funding received through FAPESP Proc. No.
   2009/53846-9 (BB and RSFJr), FAPESP Proc. No. 2009/06280-0 (RSFJr),
   FAPESP Proc. No. 2012/08101-8 (RSFJr), CNPq Proc. No. 563582/2010-3
   (BB), CAPES AUX-PE Toxinology 1219/2011 and Proc. No.
   23038.000823/2011-21 (BB). Special thanks are also extended to the
   Centre for the Study of Venoms and Venomous Animals, CEVAP, and the
   Tropical Diseases Department at Sao Paulo State University, UNESP,
   Brazil. RSFJr is a CNPq DTI fellow researcher (310207/2011-8).
   Additionally, the authors thank the Nerve Regeneration Laboratory
   (Laboratorio de Regeneracao Nervosa) in the Department of Anatomy
   (Departamento de Anatomia) and the Electron Microscopy Laboratory,
   Institute of Biology, State University of Campinas (Laboratorio de
   Microscopia Eletronica do Instituto de Biologia da Universidade Estadual
   de Campinas) - UNICAMP.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Ahmed TAE, 2007, TISSUE ENG, V13, P1469, DOI 10.1089/ten.2006.0354
   Ahmed TAE, 2011, TISSUE ENG PT A, V17, P323, DOI [10.1089/ten.tea.2009.0773, 10.1089/ten.TEA.2009.0773]
   Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
   Barbizan R, 2013, PLOS ONE, V8, P63260
   Barros LC, 2011, J VENOM ANIM TOXINS, V17, P23, DOI 10.1590/S1678-91992011000100004
   Barros LC, 2009, J TOXICOL ENV HEAL B, V12, P553, DOI 10.1080/10937400903442514
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Buchta C, 2004, VOX SANG, V86, P257, DOI 10.1111/j.0042-9007.2004.00516.x
   Bydlowski Sergio P., 2009, Rev. Bras. Hematol. Hemoter., V31, P25
   Caplan AI, 2011, PRINCIPLES OF REGENERATIVE MEDICINE, 2ND EDITION, P253, DOI 10.1016/B978-0-12-381422-7.10014-8
   Carless PA, 2002, BRIT J SURG, V89, P695, DOI 10.1046/j.1365-2168.2002.02098.x
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   Dare EV, 2009, CELLS TISSUES ORGANS, V190, P313, DOI 10.1159/000209230
   De Gemmis P, 2006, STEM CELLS DEV, V15, P719
   Ferreira ASSBS, 2013, TOXICON, V69, P50, DOI 10.1016/j.toxicon.2013.01.003
   Fu LJ, 2008, STEM CELLS DEV, V17, P1109, DOI 10.1089/scd.2008.0068
   Gardin C, 2011, INT J MOL SCI, V12, P6749, DOI 10.3390/ijms12106749
   Hashimoto J, 2006, STEM CELLS, V24, P2346, DOI 10.1634/stemcells.2005-0605
   Hassan W, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt182
   Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70
   Lima SAF, 2012, PESQUISA VET BRASIL, V32, P463, DOI 10.1590/S0100-736X2012000500016
   Lima-Neto JF, 2010, CELL TISSUE BANK, V11, P261, DOI 10.1007/s10561-009-9131-6
   Maumus M, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt55
   Mehlhorn AT, 2006, TISSUE ENG, V12, P2853, DOI 10.1089/ten.2006.12.2853
   Park KS, 2006, J VET SCI, V7, P343, DOI 10.4142/jvs.2006.7.4.343
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Stolf HO, 1999, J VENOM ANIM TOXINS, V5, P227, DOI DOI 10.1590/S0104-79301999000200011
   Thomazini-Santos IA, 2001, J VENOM ANIM TOXINS, V7, P159
   Trubiani O, 2008, J BIOMED MATER RES A, V87A, P986, DOI 10.1002/jbm.a.31837
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
NR 31
TC 30
Z9 30
U1 0
U2 17
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD JUN 10
PY 2014
VL 5
AR 78
DI 10.1186/scrt467
PG 10
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA AK5LD
UT WOS:000338465200001
PM 24916098
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Jones, MC
   Jones, SA
   Riffo-Vasquez, Y
   Spina, D
   Hoffman, E
   Morgan, A
   Patel, A
   Page, C
   Forbes, B
   Dailey, LA
AF Jones, Marie-Christine
   Jones, Stuart A.
   Riffo-Vasquez, Yanira
   Spina, Domenico
   Hoffman, Ewelina
   Morgan, Anna
   Patel, Aateka
   Page, Clive
   Forbes, Ben
   Dailey, Lea Ann
TI Quantitative assessment of nanoparticle surface hydrophobicity and its
   influence on pulmonary biocompatibility
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Nanomedicine; Pulmonary drug delivery; Hydrophobicity; Nanotoxicology;
   Polystyrene; Lipid nanocapsules
ID NANOSTRUCTURED LIPID CARRIERS; DRUG-DELIVERY; IN-VITRO; POLYMERIC
   NANOCARRIERS; ALVEOLAR MACROPHAGES; POLYETHYLENE-GLYCOL;
   BIOLOGICAL-SYSTEMS; ANTICANCER DRUGS; OXIDATIVE STRESS; EPITHELIAL-CELLS
AB To date, the role of nanoparticle surface hydrophobicity has not been investigated quantitatively in relation to pulmonary biocompatibility. A panel of nanoparticles spanning three different biomaterial types, pegylated lipid nanocapsules, polyvinyl acetate (PVAc) and polystyrene nanoparticles, were characterized for size, surface charge, and stability in biofluids. Surface hydrophobicity of five nanoparticles (50-150 nm) was quantified using hydrophobic interaction chromatography (HIC) and classified using a purpose-developed hydrophobicity scale: the HIC index, range from 0.00 (hydrophilic) to 1.00 (hydrophobic). This enabled the relationship between the nanomaterial HIC index value and acute lung inflammation after pulmonary administration to mice to be investigated. The nanomaterials with low HIC index values (between 0.50 and 0.64) elicited little or no inflammation at low (22 cm(2)) or high (220 cm(2)) nanoparticle surface area doses per animal, whereas equivalent surface area doses of the two nanoparticles with high HIC index values (0.88- 0.96) induced neutrophil infiltration, elevation of pro-inflammatory cytokines and adverse histopathology findings. In summary, a HIC index is reported that provides a versatile, discriminatory, and widely available measure of nanoparticle surface hydrophobicity. The avoidance of high (HIC index > -0.8) surface hydrophobicity appears to be important for the design of safe nanomedicines for inhalation therapy. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Jones, Marie-Christine; Jones, Stuart A.; Riffo-Vasquez, Yanira; Spina, Domenico; Hoffman, Ewelina; Morgan, Anna; Patel, Aateka; Page, Clive; Forbes, Ben; Dailey, Lea Ann] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England.
RP Forbes, B (reprint author), Kings Coll London, Inst Pharmaceut Sci, 150 Stamford St, London SE1 9NH, England.
EM ben.forbes@kcl.ac.uk; lea_ann.dailey@kcl.ac.uk
RI Geracitano, Laura/E-6926-2013
OI Spina, Domenico/0000-0002-6815-1564; Hoffman,
   Ewelina/0000-0002-7998-924X; Page, Clive Peter/0000-0002-9358-3799
FU UK Medical Research Council [G0900953]; Medical Research Council
   [G0900953]; National Centre for the Replacement, Refinement and
   Reduction of Animals in Research (NC3Rs) [NC/C013109/1, NC/C013203/1]
FX The authors would like to thank the UK Medical Research Council for
   funding this study (G0900953).
CR [Anonymous], 1992, J AM COLL TOXICOL, V11, P465
   Bailey MM, 2009, MED RES REV, V29, P196, DOI 10.1002/med.20140
   Bakand S, 2012, INHAL TOXICOL, V24, P125, DOI 10.3109/08958378.2010.642021
   Banquy X, 2009, SOFT MATTER, V5, P3984, DOI 10.1039/b821583a
   Beck-Broichsitter M, 2012, J CONTROL RELEASE, V161, P214, DOI 10.1016/j.jconrel.2011.12.004
   Bermudez E, 2004, TOXICOL SCI, V77, P347, DOI 10.1093/toxsci/kfh019
   Beyerle A, 2011, BIOMATERIALS, V32, P8694, DOI 10.1016/j.biomaterials.2011.07.082
   Beyerle A, 2011, J CONTROL RELEASE, V151, P51, DOI 10.1016/j.jconrel.2010.12.017
   Bharatwaj B, 2010, BIOMATERIALS, V31, P7376, DOI 10.1016/j.biomaterials.2010.06.005
   Bivas-Benita M, 2005, EUR J PHARM BIOPHARM, V61, P214, DOI 10.1016/j.ejpb.2005.04.009
   Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240
   Cahouet A, 2002, INT J PHARM, V242, P367, DOI 10.1016/S0378-5173(02)00218-1
   CARSTENSEN H, 1991, INT J PHARM, V67, P29, DOI 10.1016/0378-5173(91)90262-M
   Chana J, 2008, J NANOSCI NANOTECHNO, V8, P5739, DOI 10.1166/jnn.2008.475
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Cho WS, 2012, TOXICOL SCI, V126, P469, DOI 10.1093/toxsci/kfs006
   Dailey LA, 2006, TOXICOL APPL PHARM, V215, P100, DOI 10.1016/j.tapp2.006.01.016
   Dailey LA, 2003, J CONTROL RELEASE, V86, P131, DOI 10.1016/S0168-3659(02)00370-X
   Dhanikula AB, 2007, BIOMATERIALS, V28, P1248, DOI 10.1016/j.biomaterials.2006.10.036
   Doktorovova S, 2012, EUR J PHARM SCI, V45, P606, DOI 10.1016/j.ejps.2011.12.016
   Donaldson Ken, 2005, Part Fibre Toxicol, V2, P10
   Duffin R, 2007, INHAL TOXICOL, V19, P849, DOI 10.1080/08958370701479323
   Garcion E, 2006, MOL CANCER THER, V5, P1710, DOI 10.1158/1535-7163.MCT-06-0289
   Grenha A, 2007, EUR J PHARM SCI, V31, P73, DOI 10.1016/j.ejps.2007.02.008
   Gul MO, 2009, INHAL TOXICOL, V21, P631, DOI 10.1080/08958370802353435
   Heurtault B, 2003, COLLOID SURFACE B, V30, P225, DOI 10.1016/S0927-7765(03)00096-1
   Hureaux J, 2009, EUR J PHARM BIOPHARM, V73, P239, DOI 10.1016/j.ejpb.2009.06.013
   Jin CY, 2013, J APPL TOXICOL, V33, P1442, DOI 10.1002/jat.2808
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kemp SJ, 2008, AM J RESP CELL MOL, V39, P591, DOI 10.1165/rcmb.2007-0334OC
   Lacoeuille F, 2007, J NANOSCI NANOTECHNO, V7, P4612, DOI 10.1166/jnn.2007.006
   Luyts K, 2013, ENVIRON SCI-PROC IMP, V15, P23, DOI 10.1039/c2em30237c
   Maynard AD, 2011, TOXICOL SCI, V120, pS109, DOI 10.1093/toxsci/kfq372
   Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905
   Nag A, 1996, ANAL BIOCHEM, V237, P224, DOI 10.1006/abio.1996.0233
   Nassimi M, 2010, EUR J PHARM BIOPHARM, V75, P107, DOI 10.1016/j.ejpb.2010.02.014
   Nassimi Matthias, 2009, Inhal Toxicol, V21 Suppl 1, P104, DOI 10.1080/08958370903005769
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Nicolete R, 2011, INT IMMUNOPHARMACOL, V11, P1557, DOI 10.1016/j.intimp.2011.05.014
   Nikula KJ, 2014, TOXICOL PATHOL, V42, P472, DOI 10.1177/0192623313507003
   OECD, 2010, SER TEST ASS
   Pandey R, 2003, J ANTIMICROB CHEMOTH, V52, P981, DOI 10.1093/jac/dkg477
   Poland C, 2009, NANOTOXICITY IN VIVO, P61
   Rudmann DG, 2013, TOXICOL PATHOL, V41, P970, DOI 10.1177/0192623312474726
   Ruge CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040775
   Ruge CA, 2011, NANOMED-NANOTECHNOL, V7, P690, DOI 10.1016/j.nano.2011.07.009
   Rytting E, 2008, EXPERT OPIN DRUG DEL, V5, P629, DOI [10.1517/17425247.5.6.629 , 10.1517/17425240802141568]
   Sager TM, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-15
   Sahoo SK, 2002, J CONTROL RELEASE, V82, P105, DOI 10.1016/S0168-3659(02)00127-X
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004
   Stern ST, 2008, TOXICOL SCI, V106, P140, DOI 10.1093/toxsci/kfn137
   Stern ST, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-20
   Stern ST, 2008, AUTOPHAGY, V4, P1097, DOI 10.4161/auto.7142
   Tang Y, 2013, BIOMATERIALS, V34, P8741, DOI 10.1016/j.biomaterials.2013.07.087
   Taratula O, 2013, J CONTROL RELEASE, V171, P349, DOI 10.1016/j.jconrel.2013.04.018
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Vaine CA, 2013, J IMMUNOL, V190, P3525, DOI 10.4049/jimmunol.1200492
   Vonarbourg A, 2006, J BIOMED MATER RES A, V78A, P620, DOI 10.1002/jbm.a.30711
   Weber S, 2014, EUR J PHARM BIOPHARM, V86, P7, DOI 10.1016/j.ejpb.2013.08.013
   Xia XR, 2011, ACS NANO, V5, P9074, DOI 10.1021/nn203303c
   Xia XR, 2010, NAT NANOTECHNOL, V5, P671, DOI [10.1038/NNANO.2010.164, 10.1038/nnano.2010.164]
   Xiao Y, 2012, J HAZARD MATER, V215, P146, DOI 10.1016/j.jhazmat.2012.02.043
   Zhang HY, 2012, ACS NANO, V6, P4349, DOI 10.1021/nn3010087
NR 65
TC 37
Z9 37
U1 1
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUN 10
PY 2014
VL 183
BP 94
EP 104
DI 10.1016/j.jconrel.2014.03.022
PG 11
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA AG6UQ
UT WOS:000335554400011
PM 24657808
DA 2018-10-20
ER

PT J
AU Ventura, M
   Boerman, OC
   Franssen, GM
   Bronkhorst, E
   Jansen, JA
   Walboomers, XF
AF Ventura, Manuela
   Boerman, Otto C.
   Franssen, Gerben M.
   Bronkhorst, Ewald
   Jansen, John A.
   Walboomers, X. Frank
TI Monitoring the biological effect of BMP-2 release on bone healing by
   PET/CT
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE BMP (bone morphogenetic protein); Drug delivery; Calcium phosphate
   cement; Bone tissue engineering; Small animal imaging; Positron Emission
   Tomography
ID CALCIUM-PHOSPHATE CEMENTS; RAY COMPUTED MICROTOMOGRAPHY; F-18
   FLUORIDE-ION; IN-VIVO; INDUCTIVE PROPERTIES; DRUG-DELIVERY; MODEL;
   F-18-FLUORIDE; SCAFFOLDS; DEFECTS
AB Bone morphogenetic protein-2 (BMP-2) releasing scaffolds are routinely used in bone tissue engineering to accelerate regeneration. Thus, assessing growth factor activity, and tissue regeneration around a biomaterial delivery system is extremely important to optimize the stages of bone healing. Such assessment commonly relies on histology. A non-invasive method would allow longitudinal monitoring of the regeneration process. The present study sought to explore the feasibility of Positron Emission Tomography (PET) as a non-invasive method to monitor the osteogenic potential of a BMP-2 releasing calcium phosphate cement (CPC) bone substitute. In a calvarial defect model in rats, F-18-Fluoride PET was used to quantify F-18-Fluoride uptake around the BMP-2/CPC material. As controls, non-loaded porous CPC, dense CPC and autograft samples were used. PET was performed every two weeks, during a period of 8 weeks post-implantation. In parallel, computed tomography (CT) imaging was performed for anatomical reference. Four specimens were evaluated per group per time point. The highest F-18-Fluoride signal intensity was measured in the BMP-2 group (approximately 5 times higher than the baseline value), followed by the controls in the order, from high to low, porous, dense and autograft. The same trend was maintained during the entire experimental period. Histology and measurements of the bone volume percentage confirmed the significantly higher new bone formation in the BMP-2 releasing group (about 25%), compared to the controls. Moreover, F-18-Fluoride PET uptake showed a statistically significant positive correlation (r = 0.6038, P = 0.0171) with the newly formed bone volume. In conclusion, our results support the use of a PET/CT method for the longitudinal monitoring of BMP-2 releasing scaffolds, in vivo. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Ventura, Manuela; Bronkhorst, Ewald; Jansen, John A.; Walboomers, X. Frank] Radboudumc, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   [Boerman, Otto C.; Franssen, Gerben M.] Radboudumc, Dept Nucl Med, NL-6500 HB Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Radboudumc, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM John.Jansen@radboudumc.nl
RI Walboomers, X.Frank/B-3692-2013; Bronkhorst, Ewald/L-4230-2015; Boerman,
   Otto/A-8112-2014; Jansen, John/H-8055-2014
OI Boerman, Otto/0000-0001-6832-101X; Bronkhorst, Ewald/0000-0003-0953-8053
FU European Community's Seventh Framework Programme [238551]
FX The authors would like to thank Vincent Cuijpers, Martijn Martens,
   Bianca Lemmers-van de Weem, and Kitty Lemmens-Hermans for their
   technical assistance and Dr. Danny Gerrits for the assistance with PET
   quantifications. The research leading to these results has received
   funding from the European Community's Seventh Framework Programme
   (MultiTERM, grant agreement no. 238551).
CR Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Blom EJ, 2001, MATERIALWISS WERKST, V32, P962, DOI 10.1002/1521-4052(200112)32:12<962::AID-MAWE962>3.3.CO;2-T
   Bodde EWH, 2008, J BIOMED MATER RES A, V87A, P780, DOI 10.1002/jbm.a.31830
   Chenard KE, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/601549
   Dell Ralph B, 2002, ILAR J, V43, P207
   Felix Lanao R.P., 2012, J TISSUE ENG REGEN M, V18, P1171
   Galois Laurent, 2004, Acta Orthop Belg, V70, P598
   Ginebra MP, 2012, ADV DRUG DELIVER REV, V64, P1090, DOI 10.1016/j.addr.2012.01.008
   Grant FD, 2008, J NUCL MED, V49, P68, DOI 10.2967/jnumed.106.037200
   Griffith JF, 2011, CURR RHEUMATOL REP, V13, P241, DOI 10.1007/s11926-011-0174-x
   Guskuma MH, 2010, J APPL ORAL SCI, V18, P346, DOI 10.1590/S1678-77572010000400005
   Habraken WJEM, 2009, J BIOMED MATER RES A, V91A, P614, DOI 10.1002/jbm.a.32263
   Habraken WJEM, 2008, J BIOMAT SCI-POLYM E, V19, P1171, DOI 10.1163/156856208785540136
   Hoekstra JWM, 2013, CLIN ORAL IMPLAN RES, V24, P210, DOI 10.1111/j.1600-0501.2012.02421.x
   Hsu WK, 2008, J NUCL MED, V49, P414, DOI 10.2967/jnumed.107.045666
   Huse RO, 2004, CLIN ORAL IMPLAN RES, V15, P741, DOI 10.1111/j.1600-0501.2004.01068.x
   Iatecola Amilton, 2013, Braz. Dent. J., V24, P456, DOI 10.1590/0103-6440201302265
   Klijn RJ, 2012, TISSUE ENG PT A, V18, P1171, DOI [10.1089/ten.TEA.2011.0444, 10.1089/ten.tea.2011.0444]
   Komlev VS, 2010, EUR CELLS MATER, V19, P136, DOI 10.22203/eCM.v019a14
   Kroese-Deutman HC, 2005, BIOMATERIALS, V26, P1131, DOI 10.1016/j.biomaterials.2004.04.021
   Lanao RPF, 2011, BIOMATERIALS, V32, P8839, DOI 10.1016/j.biomaterials.2011.08.005
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee SW, 2009, J ORTHOP RES, V27, P295, DOI 10.1002/jor.20736
   Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9
   Li R.H., 2011, 28 INT S CONTR REL B
   Li ZC, 2011, J NUCL MED, V52, P769, DOI 10.2967/jnumed.110.085456
   Lin CY, 2012, BIOMATERIALS, V33, P3682, DOI 10.1016/j.biomaterials.2012.02.007
   MESSA C, 1993, J CLIN ENDOCR METAB, V77, P949, DOI 10.1210/jc.77.4.949
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Nancy E, 2013, SURG NEUROL INT, V4, pS343
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Papadimitropoulos A, 2007, BIOTECHNOL BIOENG, V98, P271, DOI 10.1002/bit.21418
   Piert M, 2001, J NUCL MED, V42, P1091
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   Toegel S, 2006, EUR J NUCL MED MOL I, V33, P491, DOI 10.1007/s00259-005-0026-x
   van de Watering FCJ, 2012, J CONTROL RELEASE, V159, P69, DOI 10.1016/j.jconrel.2011.12.041
   van de Watering FCJ, 2012, J CONTROL RELEASE, V164, P283, DOI 10.1016/j.jconrel.2012.07.007
   Ventura M., 2014, J TISSUE ENG REGEN M
   Ventura M, 2013, TISSUE ENG PART C-ME, V19, P405, DOI 10.1089/ten.tec.2012.0007
   Wang HN, 2013, J CONTROL RELEASE, V166, P172, DOI 10.1016/j.jconrel.2012.12.015
NR 41
TC 7
Z9 7
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUN 10
PY 2014
VL 183
BP 138
EP 144
DI 10.1016/j.jconrel.2014.03.044
PG 7
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA AG6UQ
UT WOS:000335554400015
PM 24704712
DA 2018-10-20
ER

PT J
AU Faruqui, N
   Bella, A
   Ravi, J
   Ray, S
   Lamarre, B
   Ryadnov, MG
AF Faruqui, Nilofar
   Bella, Angelo
   Ravi, Jascindra
   Ray, Santanu
   Lamarre, Baptiste
   Ryadnov, Maxim G.
TI Differentially Instructive Extracellular Protein Micro-nets
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; QUARTZ-CRYSTAL MICROBALANCE; MAMMALIAN-CELLS;
   COILED-COIL; PEPTIDE; ADSORPTION; ADHESION; MATRICES; BIOMATERIALS;
   BACTERIAL
AB An ability to construct biological matter from the molecule up holds promise for applications ranging from smart materials to integrated biophysical models for synthetic biology. Biomolecular self-assembly is an efficient strategy for biomaterial construction which can be programmed to support desired function. A challenge remains in replicating the strategy synthetically, that is at will, and differentially, that is a specific function at a given length scale. Here we introduce a self-assembly topology enabling a net-like architectural mimetic of native extracellular matrices capable of differential responses to cell adhesion-enhanced mammalian cell attachment and proliferation, and enhanced resistance to bacterial colonization-at the native sub-millimeter length scales. The biological performance of such protein micro-nets directly correlates with their morphological and chemical properties, offering thus an application model for differential extracellular matrices.
C1 [Faruqui, Nilofar; Bella, Angelo; Ravi, Jascindra; Ray, Santanu; Lamarre, Baptiste; Ryadnov, Maxim G.] Natl Phys Lab, Teddington TW11 0LW, Middx, England.
   [Ryadnov, Maxim G.] Univ Edinburgh, Sch Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland.
RP Ryadnov, MG (reprint author), Natl Phys Lab, Hampton Rd, Teddington TW11 0LW, Middx, England.
EM max.ryadnov@npl.co.uk
RI Ray, Santanu/H-1200-2011
OI Ray, Santanu/0000-0002-2414-2930
FU UK's Department of Business, Innovation and Skills; Strategic Research
   Programme of the National Physical Laboratory
FX We acknowledge funding from the UK's Department of Business, Innovation
   and Skills and the Strategic Research Programme of the National Physical
   Laboratory. We thank Tony Fry and Maud Seraffon for their help with the
   XRD measurements.
CR Aldaye FA, 2010, J AM CHEM SOC, V132, P14727, DOI 10.1021/ja105431h
   Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/108705710527635
   Balasubramanian L, 2008, AM J PHYSIOL-CELL PH, V295, pC954, DOI 10.1152/ajpcell.00009.2008
   Bella A, 2012, ANGEW CHEM INT EDIT, V51, P428, DOI 10.1002/anie.201104647
   Brown AEX, 2009, SCIENCE, V325, P741, DOI 10.1126/science.1172484
   Buell AK, 2012, METHODS MOL BIOL, V849, P101, DOI 10.1007/978-1-61779-551-0_8
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058
   Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831
   Corrigan AM, 2006, J AM CHEM SOC, V128, P14740, DOI 10.1021/ja064455l
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Enkhbayar P, 2006, PROTEINS, V64, P691, DOI 10.1002/prot.21026
   Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309
   GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0
   GRINNELL F, 1979, CELL, V17, P117, DOI 10.1016/0092-8674(79)90300-3
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Han TH, 2008, J NANOSCI NANOTECHNO, V8, P5547, DOI 10.1166/jnn.2008.1311
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Hasan J, 2013, TRENDS BIOTECHNOL, V31, P31, DOI 10.1016/j.tibtech.2013.01.017
   Hicks MR, 2010, CHEM SOC REV, V39, P3380, DOI 10.1039/b912917k
   Hirst AR, 2010, NAT CHEM, V2, P1089, DOI 10.1038/NCHEM.861
   Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Jiang HM, 2005, MOL BIOL CELL, V16, P5070, DOI 10.1091/mbc.E05-01-0007
   Kopecek J, 2012, ANGEW CHEM INT EDIT, V51, P7396, DOI 10.1002/anie.201201040
   Li Y, 2013, ANGEW CHEM INT EDIT, V52, P674, DOI 10.1002/anie.201206053
   Liang MN, 2000, P NATL ACAD SCI USA, V97, P13092, DOI 10.1073/pnas.230451697
   Luk YY, 2000, LANGMUIR, V16, P9604, DOI 10.1021/la0004653
   Luo ZL, 2012, CHEM SOC REV, V41, P4736, DOI 10.1039/c2cs15360b
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Marsden HR, 2010, ANGEW CHEM INT EDIT, V49, P2988, DOI 10.1002/anie.200904943
   MORRISETT JD, 1977, BIOCHIM BIOPHYS ACTA, V472, P93, DOI 10.1016/0304-4157(77)90015-6
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]
   OFFER G, 1995, J MOL BIOL, V249, P967, DOI 10.1006/jmbi.1995.0352
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Papapostolou D, 2007, P NATL ACAD SCI USA, V104, P10853, DOI 10.1073/pnas.0700801104
   Paul S, 2008, J PHYS CHEM C, V112, P11822, DOI 10.1021/jp800975t
   Pichot V, 2013, SCI REP-UK, V3, DOI 10.1038/srep02159
   Pomerantz WC, 2011, J AM CHEM SOC, V133, P13604, DOI 10.1021/ja204874h
   Rakowska PD, 2013, P NATL ACAD SCI USA, V110, P8918, DOI 10.1073/pnas.1222824110
   Ryadnov MG, 2009, J AM CHEM SOC, V131, P13240, DOI 10.1021/ja905539h
   Ryadnov MG, 2005, J AM CHEM SOC, V127, P12407, DOI 10.1021/ja052972i
   Ryadnov MG, 2003, ANGEW CHEM INT EDIT, V42, P3021, DOI 10.1002/anie.200351418
   Ryadnov MG, 2003, J AM CHEM SOC, V125, P9388, DOI 10.1021/ja0352045
   Salick DA, 2007, J AM CHEM SOC, V129, P14793, DOI 10.1021/ja076300z
   Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695
   Schafer C, 2009, EXP CELL RES, V315, P1212, DOI 10.1016/j.yexcr.2008.11.008
   Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244
   Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260
   Stallaert W., 2007, PLOS ONE, V7
   Statz AR, 2008, BIOFOULING, V24, P439, DOI 10.1080/08927010802331829
   Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046
   Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312
NR 55
TC 22
Z9 22
U1 1
U2 38
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JUN 4
PY 2014
VL 136
IS 22
BP 7889
EP 7898
DI 10.1021/ja411325c
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA AI6VF
UT WOS:000337014400025
PM 24825365
DA 2018-10-20
ER

PT J
AU Kreipke, TC
   Rivera, NC
   Garrison, JG
   Easley, JT
   Turner, AS
   Niebur, GL
AF Kreipke, Tyler C.
   Rivera, Nicole C.
   Garrison, Jacqueline G.
   Easley, Jeremiah T.
   Turner, A. Simon
   Niebur, Glen L.
TI Alterations in trabecular bone microarchitecture in the ovine spine and
   distal femur following ovariectomy
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Microarchitecture; Ovariectomy; Osteoporosis; Sheep; Vertebrae; Femur
ID LARGE ANIMAL-MODEL; CANCELLOUS BONE; MINERAL DENSITY;
   MECHANICAL-PROPERTIES; BIOMATERIAL RESEARCH; SHEEP; QUALITY;
   ARCHITECTURE; BIOMECHANICS; MICRODAMAGE
AB Osteoporosis is a bone disease resulting in increased fracture risk as a result of alterations in both quantity and quality of bone. Bone quality is a combination of metabolic and microarchitectural properties of bone that can help to explain the increased susceptibility to fracture. Translational animal models are essential to understanding the pathology and for evaluating potential treatments of this disease. Large animals, such as the ovariectomized sheep, have been used as models for postmenopausal osteoporosis. However, long-term studies have not been carried out to observe the effects of ovariectomy after more than one year. This study employed micro-computed tomography to quantify changes in microarchitectural and mechanical parameters in femoral condyles and vertebral bodies of sheep that were sacrificed one or two years following ovariectomy. In the vertebral body, microarchitectural characteristics were significantly degraded following one year of ovariectomy in comparison to controls. The mechanical anisotropy, determined from micro-scale finite element models, was also greater in the ovariectomized groups, although the fabric tensor anisotropy was similar. There was no greater architectural degradation following two years of ovariectomy compared to one. Ovariectomy had minimal effects on the trabecular architecture of the distal femur even after two years. These results indicate that the vertebral body is the preferred anatomic site for studying bone from the ovariectomized sheep model, and that architectural changes stabilize after the first year. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Kreipke, Tyler C.; Rivera, Nicole C.; Garrison, Jacqueline G.; Niebur, Glen L.] Univ Notre Dame, Bioengn Grad Program, Tissue Mech Lab, Notre Dame, IN 46556 USA.
   [Kreipke, Tyler C.; Rivera, Nicole C.; Garrison, Jacqueline G.; Niebur, Glen L.] Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA.
   [Easley, Jeremiah T.; Turner, A. Simon] Colorado State Univ, Dept Clin Sci, Surg Res Lab, Ft Collins, CO 80523 USA.
RP Niebur, GL (reprint author), Univ Notre Dame, Bioengn Grad Program, Tissue Mech Lab, 147 Multidisciplinary Res Bldg, Notre Dame, IN 46556 USA.
EM gniebur@nd.edu
RI Niebur, Glen/A-2352-2008
OI Niebur, Glen/0000-0002-7134-2716
FU U.S. National Institutes of Health [AR052008]
FX This study was supported by the U.S. National Institutes of Health
   AR052008.
CR Bagi CM, 1997, CALCIFIED TISSUE INT, V61, P336, DOI 10.1007/s002239900344
   Bouxsein ML, 2003, OSTEOPOROSIS INT, V14, pS118, DOI 10.1007/s00198-003-1489-x
   COWIN SC, 1985, MECH MATER, V4, P137, DOI 10.1016/0167-6636(85)90012-2
   Ding M, 2010, SPINE, V35, P363, DOI 10.1097/BRS.0b013e3181b8e0ff
   Fazzalari NL, 1998, BONE, V22, P381, DOI 10.1016/S8756-3282(97)00298-6
   Garrison JG, 2009, BONE, V44, P924, DOI 10.1016/j.bone.2008.12.030
   Giavaresi G, 2001, INT J ARTIF ORGANS, V24, P814
   Hernandez CJ, 2006, BONE, V39, P1173, DOI 10.1016/j.bone.2006.06.001
   Holland JC, 2011, J ANAT, V218, P619, DOI 10.1111/j.1469-7580.2011.01376.x
   Krug R, 2005, OSTEOPOROSIS INT, V16, P1307, DOI 10.1007/s00198-005-1907-3
   Lill CA, 2002, OSTEOPOROSIS INT, V13, P480, DOI 10.1007/s001980200058
   MacLeay JM, 2004, J BONE MINER METAB, V22, P561, DOI 10.1007/s00774-004-0524-0
   Mittra E, 2005, J BIOMECH, V38, P1229, DOI 10.1016/j.jbiomech.2004.06.007
   MOSEKILDE L, 1993, BONE, V14, P1, DOI 10.1016/8756-3282(93)90248-9
   Newton BI, 2004, J COMP PATHOL, V130, P323, DOI 10.1016/j.jcpa.2003.12.007
   *NIH CONS DEV PAN, 2001, SOUTH MED J, V94, P569, DOI DOI 10.1097/00007611-200106000-00005
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Perilli E, 2008, J BIOMECH, V41, P438, DOI 10.1016/j.jbiomech.2007.08.003
   Schorlemmer S, 2003, J BONE MINER RES, V18, P2010, DOI 10.1359/jbmr.2003.18.11.2010
   Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001
   SEEMAN E, 2003, OSTEOPOROS INT S5, V14, P3
   Sigrist IM, 2007, J BONE MINER METAB, V25, P28, DOI 10.1007/s00774-006-0724-x
   Teo JCM, 2006, CLIN BIOMECH, V21, P235, DOI 10.1016/j.clinbiomech.2005.11.001
   Turner A.S., 1995, BONE, V17, P395
   Turner A. Simon, 2001, European Cells & Materials, V1, P66
   Turner CH, 2002, OSTEOPOROSIS INT, V13, P97, DOI 10.1007/s001980200000
   Van Staa TP, 2001, BONE, V29, P517, DOI 10.1016/S8756-3282(01)00614-7
   VanRietbergen B, 1996, J BIOMECH, V29, P1653, DOI 10.1016/0021-9290(96)00093-0
   Wegrzyn J, 2010, J BONE MINER RES, V25, P2324, DOI 10.1002/jbmr.164
   WHO, 1993, AM J MED, V941, P646
   WRONSKI TJ, 1989, CALCIFIED TISSUE INT, V45, P360, DOI 10.1007/BF02556007
   Wu ZX, 2008, MED ENG PHYS, V30, P1112, DOI 10.1016/j.medengphy.2008.01.007
   Wu ZH, 2013, BONE, V55, P208, DOI 10.1016/j.bone.2013.02.019
   Zarrinkalam MR, 2009, EUR SPINE J, V18, P244, DOI 10.1007/s00586-008-0813-8
   Zysset PK, 1998, J BIOMECH ENG-T ASME, V120, P640, DOI 10.1115/1.2834756
   Zysset PK, 1996, J BIOMECH, V29, P1549, DOI 10.1016/S0021-9290(96)80006-6
NR 36
TC 6
Z9 6
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD JUN 3
PY 2014
VL 47
IS 8
BP 1918
EP 1921
DI 10.1016/j.jbiomech.2014.03.025
PG 4
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA AI4ZZ
UT WOS:000336876500025
PM 24720887
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kuboki, T
   Chen, W
   Kidoaki, S
AF Kuboki, Thasaneeya
   Chen, Wei
   Kidoaki, Satoru
TI Time-Dependent Migratory Behaviors in the Long-Term Studies of
   Fibroblast Durotaxis on a Hydrogel Substrate Fabricated with a Soft Band
SO LANGMUIR
LA English
DT Article
ID CELL-MIGRATION; GRADIENT; COLLAGEN; STIFFNESS; MOVEMENT; RIGIDITY;
   MOTILITY; GELATIN; MATRIX
AB Durotaxis, biased cell movement up a stiffness gradient on culture substrates, is one of the useful taxis behaviors for manipulating cell migration on engineered biomaterial surfaces. In this study, long-term durotaxis was investigated on gelatinous substrates containing a soft band of 20, SO, and 150 mu m in width fabricated using photolithographic elasticity patterning; sharp elasticity boundaries with a gradient strength of 300 kPa/50 mu m were achieved. Time-dependent migratory behaviors of 3T3 fibroblast cells were observed during a time period of 3 days. During the first day, most of the cells were strongly repelled by the soft band independent of bandwidth, exhibiting the typical durotaxis behavior. However, the repellency by the soft band diminished, and more cells crossed the soft band or exhibited other mixed migratory behaviors during the course of the observation. It was found that durotaxis strength is weakened on the substrate with the narrowest soft band and that adherent affinity-induced entrapment becomes apparent on the widest soft band with time. Factors, such as changes in surface topography, elasticity, and/or chemistry, likely contributing to the apparent diminishing durotaxis during the extended culture were examined. Immunofluorescence analysis indicated preferential collagen deposition onto the soft band, which is derived from secretion by fibroblast cells, resulting in the increasing contribution of haptotaxis toward the soft band over time. The deposited collagen did not affect surface topography or surface elasticity but did change surface chemistry, especially on the soft band. The observed time-dependent durotaxis behaviors are the result of the mixed mechanical and chemical cues. In the studies and applications of cell migratory behavior under a controlled stimulus, it is important to thoroughly examine other (hidden) compounding stimuli in order to be able to accurately interpret data and to design suitable biomaterials to manipulate cell migration.
C1 [Kuboki, Thasaneeya; Kidoaki, Satoru] Kyushu Univ, Inst Mat Chem & Engn, Lab Biomed & Biophys Chem, Fukuoka 8190395, Japan.
   [Chen, Wei] Mt Holyoke Coll, Dept Chem, S Hadley, MA 01075 USA.
RP Chen, W (reprint author), Mt Holyoke Coll, Dept Chem, S Hadley, MA 01075 USA.
EM weichen@mtholyoke.edu; kidoaki@ms.ifoc.kyushu-u.ac.jp
RI U-ID, Kyushu/C-5291-2016
FU National Institutes of Health [2R15EB139-2]; Ministry of Education,
   Culture, Sports, Science and Technology (MEXT) of Japan [24300173]
FX Financial support was provided by the National Institutes of Health
   (2R15EB139-2), a Grant-in-Aid for Scientific Research (24300173), and
   the Management Expenses Grants for National Universities Corporations
   "Nano-Macro Materials, Devices and System Research Alliance" from the
   Ministry of Education, Culture, Sports, Science and Technology (MEXT) of
   Japan.
CR Bernstein Lori R., 1994, Current Opinion in Oncology, V6, P106, DOI 10.1097/00001622-199401000-00015
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   CARTER SB, 1967, EXP CELL RES, V48, P189, DOI 10.1016/0014-4827(67)90298-4
   ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296
   Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585
   Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144
   Hadjipanayi E, 2009, CELL MOTIL CYTOSKEL, V66, P121, DOI 10.1002/cm.20331
   Hale NA, 2010, ACS APPL MATER INTER, V2, P2317, DOI 10.1021/am100346k
   Herzt H., 1881, J REINE ANGEW MATH, V92, P156
   Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021
   Itoga K, 2004, BIOMATERIALS, V25, P2047, DOI 10.1016/j.biomaterials.2003.08.052
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   Kawano T, 2011, BIOMATERIALS, V32, P2725, DOI 10.1016/j.biomaterials.2011.01.009
   Kidoaki A, 2008, J BIOTECHNOL, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015
   Kidoaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078067
   Kuboki T, 2012, CELL STRUCT FUNCT, V37, P127, DOI 10.1247/csf.12012
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lowe B, 1997, J EXP BIOL, V200, P1593
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Miyoshi H, 2010, BIOMATERIALS, V31, P8539, DOI 10.1016/j.biomaterials.2010.07.076
   NARAYANAN AS, 1989, BIOCHEM J, V260, P463, DOI 10.1042/bj2600463
   Narayanan AS, 1997, AM J RESP CELL MOL, V17, P84, DOI 10.1165/ajrcmb.17.1.2732
   Okino H, 2002, J BIOMED MATER RES, V59, P233, DOI 10.1002/jbm.1237
   RADMACHER M, 1995, BIOPHYS J, V69, P264, DOI 10.1016/S0006-3495(95)79897-6
   Saranak J, 1997, NATURE, V387, P465, DOI 10.1038/387465a0
   Tjia JS, 1999, BIOMATERIALS, V20, P2223, DOI 10.1016/S0142-9612(99)00153-2
   WEISS P, 1958, INT REV CYTOL, V7, P391, DOI 10.1016/S0074-7696(08)62692-3
   WEISS P, 1947, YALE J BIOL MED, V19, P235
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Wu HW, 1998, SCANNING, V20, P389
   Wu JD, 2012, INTERFACE FOCUS, V2, P337, DOI 10.1098/rsfs.2011.0124
NR 32
TC 7
Z9 7
U1 2
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 3
PY 2014
VL 30
IS 21
BP 6187
EP 6196
DI 10.1021/la501058j
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AI6AS
UT WOS:000336952800024
PM 24851722
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Thiruppathi, E
   Mani, G
AF Thiruppathi, Eagappanath
   Mani, Gopinath
TI Vitamin-C Delivery from CoCr Alloy Surfaces Using Polymer-Free and
   Polymer-Based Platforms For Cardiovascular Stent Applications
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; CORONARY-ARTERY DISEASE; IN-VITRO
   DEGRADATION; SMOOTH-MUSCLE-CELLS; DRUG-ELUTING STENTS;
   PLATELET-AGGREGATION; ANTIOXIDANT VITAMINS; PACLITAXEL DELIVERY; BALLOON
   ANGIOPLASTY; WARFARIN THERAPY
AB Antiproliferative drugs such as paclitaxel and sirolimus are delivered from stents to inhibit the growth of smooth muscle cells (SMCs) for preventing neointimal hyperplasia. However, these drugs delay the growth of endothelial cells (ECs) as well and cause late stent thrombosis. We recently demonstrated the use of Vitamin-C (L-ascorbic acid, L-AA) over paclitaxel and sirolimus for inhibiting SMCs growth and promoting EC growth simultaneously. In this study, we have investigated the delivery of L-AA from CoCr alloy surfaces for potential use in stents. A polymer-free phosphoric acid (PA) platform and a polymer-based poly-(lactic-co-glycolic acid) (PLGA) platform were used for coating L-AA onto CoCr surfaces. For the PA platform, FTIR confirmed that the PA was coated on CoCr, while the AFM showed that the PA coating on the CoCr surface was homogeneous. The successful deposition of L-AA on PA-coated CoCr was also confirmed by FTIR. The uniform distribution of L-AA crystals on PA-coated CoCr was shown by SEM, optical profilometer, and AFM. The drug release studies showed that L-AA (276 mu g/cm(2)) was burst released from the PA platform by 1 h. For the PLGA platform, SEM showed that the L-AA incorporated polymer films were smoothly and uniformly coated on CoCr. FTIR showed that L-AA was incorporated into the bulk of the PLGA film. DSC showed that the L-AA was present in an amorphous form and formed an intermolecular bonding interaction with PLGA. The drug release studies showed that L-AA was sustained released from the PLGA coated CoCr for up to 24 h. The SEM, FTIR, and DSC characterizations of samples collected post drug release shed light on the mechanism of L-AA release from PLGA coated CoCr. Thus, this study demonstrated the delivery of L-AA from biomaterial surfaces for potential applications in stents and other implantable medical devices.
C1 [Thiruppathi, Eagappanath; Mani, Gopinath] Univ S Dakota, Biomed Engn Program, Sioux Falls, SD 57107 USA.
RP Mani, G (reprint author), Univ S Dakota, Biomed Engn Program, 4800 North Career Ave, Sioux Falls, SD 57107 USA.
EM Gopinath.Mani@usd.edu
CR Aguirre R, 2008, PHARMACOL THERAPEUT, V119, P96, DOI 10.1016/j.pharmthera.2008.05.002
   Bairn D. S., 2006, CIRCULATION, V113, P891
   BORDIA A, 1985, CLIN CARDIOL, V8, P552, DOI 10.1002/clc.4960081012
   Brodie B, 2012, JACC-CARDIOVASC INTE, V5, P1043, DOI 10.1016/j.jcin.2012.06.013
   Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366
   DeEugenio D, 2007, PHARMACOTHERAPY, V27, P691, DOI 10.1592/phco.27.5.691
   Farbstein D, 2010, MOLECULES, V15, P8098, DOI 10.3390/molecules15118098
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Florence AT, 2011, PHYSICOCHEMICAL PRIN
   Gallo A, 2013, APPL SURF SCI, V279, P216, DOI 10.1016/j.apsusc.2013.04.072
   Garg S, 2010, J AM COLL CARDIOL, V56, pS1, DOI 10.1016/j.jacc.2010.06.007
   Gatica N, 2006, J CHIL CHEM SOC, V51, P945, DOI 10.4067/S0717-97072006000300003
   Gawalt ES, 2001, LANGMUIR, V17, P6743, DOI 10.1021/la010595r
   Gocke N., 1999, CIRCULATION, V99, P3234
   Heller R, 2001, J BIOL CHEM, V276, P40, DOI 10.1074/jbc.M004392200
   Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030
   Kakade S, 2013, DRUG DES DEV THER, V7, P529, DOI 10.2147/DDDT.S45162
   Karjalainen PP, 2007, EUR HEART J, V28, P726, DOI 10.1093/eurheartj/ehl488
   Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048
   Lancaster S, 2012, LANGMUIR, V28, P11511, DOI 10.1021/la301636z
   Libby P, 2002, CIRCULATION, V105, P1396, DOI 10.1161/01.CIR.0000012513.58079.EA
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Mani G, 2008, BIOMATERIALS, V29, P4561, DOI 10.1016/j.biomaterials.2008.08.014
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Mani G, 2013, THER DELIV, V4, P1079, DOI [10.4155/tde.13.63, 10.4155/TDE.13.63]
   Mani G, 2011, BIOINTERPHASES, V6, P33, DOI 10.1116/1.3575530
   Mani G, 2010, BIOMATERIALS, V31, P5372, DOI 10.1016/j.biomaterials.2010.03.043
   Mello VA, 2011, QUIM NOVA, V34, P933
   Morice Marie-Claude, 2006, EuroIntervention, V2, P45
   Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I
   Park DW, 2008, JACC-CARDIOVASC INTE, V1, P494, DOI 10.1016/j.jcin.2008.06.011
   Quinones R, 2007, LANGMUIR, V23, P10123, DOI 10.1021/la701110p
   Raman A, 2006, LANGMUIR, V22, P6469, DOI 10.1021/la060636p
   Rossig L, 2001, CIRCULATION, V104, P2182, DOI 10.1161/hc4301.098284
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   Siegel SJ, 2006, EUR J PHARM BIOPHARM, V64, P287, DOI 10.1016/j.wjpb.2006.06.009
   Silverstein R. M., 1998, SPECTROMETRIC IDENTI, P71
   Siow RCM, 1998, ARTERIOSCL THROM VAS, V18, P1662, DOI 10.1161/01.ATV.18.10.1662
   Stevanovic M, 2007, COLLOID SURFACE B, V59, P215, DOI 10.1016/j.colsurfb.2007.05.011
   Tsujino I, 2007, EXPERT OPIN DRUG DEL, V4, P287, DOI 10.1517/17425247.4.3.287
   Ulrich-Merzenich G, 2002, EUR J NUTR, V41, P27, DOI 10.1007/s003940200003
   Ulrich-Merzenich G, 2007, EUR J NUTR, V46, P87, DOI 10.1007/s00394-006-0636-5
   Weng YJ, 2008, APPL SURF SCI, V254, P2712, DOI 10.1016/j.apsusc.2007.10.107
   Wessely R, 2005, ARTERIOSCL THROM VAS, V25, P748, DOI 10.1161/01.ATV.0000157579.52566.ee
   Wilkinson IB, 1999, J CARDIOVASC PHARM, V34, P690, DOI 10.1097/00005344-199911000-00010
   Wu KK, 1996, ANNU REV MED, V47, P315
NR 47
TC 10
Z9 10
U1 1
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 3
PY 2014
VL 30
IS 21
BP 6237
EP 6249
DI 10.1021/la501448h
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AI6AS
UT WOS:000336952800029
PM 24832897
DA 2018-10-20
ER

PT J
AU Selim, SA
   Adam, ME
   Hassan, SM
   Albalawi, AR
AF Selim, Samy A.
   Adam, Mohammed E.
   Hassan, Sherif M.
   Albalawi, Abdulrhman R.
TI Chemical composition, antimicrobial and antibiofilm activity of the
   essential oil and methanol extract of the Mediterranean cypress
   (Cupressus sempervirens L.)
SO BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
DE Mediterranean Cupressus sempervirens L; Methanol extract; Essential oil;
   GC-MS; Antimicrobial activity; Antibiofilm activity
ID ANTIBACTERIAL ACTIVITY; BIOFILM FORMATION; ANTIOXIDANT; BACTERIA
AB Background: Cupressus sempervirens is a medicinal plant traditional, its dried leaves are used in treatment of stomach pain, diabetes, inflammation, toothache, laryngitis and as contraceptive.
   Methods: The present study was conducted to evaluate the in vitro antimicrobial, antibiofilm and determination chemical contents of the essential oil (Eo) and methanol extract from Mediterranean C. sempervirens L. The chemical composition of a hydrodistilled Eo of C. sempervirens was analyzed by a GC and GC/MS system.
   Results: A total of 20 constituents representing 98.1% of the oil were identified: alpha-pinene (48.6%), delta-3-carene (22.1%), limonene (4.6%) and alpha-terpinolene (4.5%) were the main components comprising 79.8% of the oil. The antimicrobial test results showed that the methanol extract of C. sempervirens strongly inhibited the growth of the test bacteria studied, except for yeast species while the Eo had moderate antibacterial, but no anti-candida activity. Klebsiella pneumoniae was proven to be the most susceptible against methanol extract. The exposure time of Eo and methanol extract for complete inhibition of cell viability of K. pneumoniae was found to be 250 mu g at 30 min and 500 mu g at 120 min, respectively. The antibiofilm potential of the samples was evaluated using methods of PVC microtiter and eradication on biomaterial. Visual results showed visible biofilm eradication from the surface of intravenous infusion tube at 500 mu g of Eo and methanol extract.
   Conclusions: The results presented here may suggest that the Eo and extracts of C. sempervirens possess antimicrobial and antibiofilm properties, and therefore, can be used as natural preservative ingredients in food and/or pharmaceuticals.
C1 [Selim, Samy A.; Adam, Mohammed E.; Hassan, Sherif M.; Albalawi, Abdulrhman R.] Aljouf Univ, Coll Appl Med Sci, Det Clin Lab Sci, Sakaka, Saudi Arabia.
   [Selim, Samy A.] Suez Canal Univ, Fac Sci, Dept Bot, Ismailia, Egypt.
   [Adam, Mohammed E.] WKU, Nuhud, Sudan.
   [Hassan, Sherif M.] Beni Suef Univ, Fac Sci, Dept Bot, Bani Suwayf, Egypt.
RP Selim, SA (reprint author), Aljouf Univ, Coll Appl Med Sci, Det Clin Lab Sci, PO 2014, Sakaka, Saudi Arabia.
EM sadomm2003@yahoo.com
RI Selim, Samy/C-4258-2015
OI Selim, Samy/0000-0003-4025-8586
FU Deanship of Scientific Research (DSR), Aljouf University, Aljouf, KSA;
   DSR
FX This work was funded by the Deanship of Scientific Research (DSR),
   Aljouf University, Aljouf, KSA, under grant for student project. The
   authors, therefore, acknowledge with thanks DSR technical and financial
   support.
CR Adams R. P., 2001, QUADRUPOLE MASS SPEC, P456
   Boukhris M, 2013, J ARID LAND STUD, V22-1, P329
   Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022
   Cerca N, 2005, RES MICROBIOL, V156, P650, DOI 10.1016/j.resmic.2005.02.004
   Chanegriha N., 1997, Journal of Essential Oil Research, V9, P555
   Chanegriha N, 1993, J ESSENT OIL RES, V5, P671
   Demirci B, 2007, FOOD CHEM, V105, P1512, DOI 10.1016/j.foodchem.2007.05.036
   Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002
   Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x
   Emami S.A., 2006, IRAN J PHARM SCI, V2, P103
   Hashimoto H, 2001, J JAPANESE ASS INFEC, V75, P678
   Klueh I, 2000, J BIOMEDICAL MAT RES, V53, P621
   Kumar CG, 1998, INT J FOOD MICROBIOL, V42, P9, DOI 10.1016/S0168-1605(98)00060-9
   Delamare APL, 2007, FOOD CHEM, V100, P603, DOI 10.1016/j.foodchem.2005.09.078
   MASCOLO N, 1987, PHYTOTHER RES, V1, P28
   Mazari K, 2010, J MED PLANTS RES, V4, P959
   MEADOWS PS, 1971, ARCH MIKROBIOL, V75, P374, DOI 10.1007/BF00407699
   Nehdi IA, 2013, IND CROP PROD, V41, P381, DOI 10.1016/j.indcrop.2012.04.046
   Ofek I, 2003, FEMS IMMUNOL MED MIC, V38, P181, DOI 10.1016/S0928-8244(03)00228-1
   Pierre-Leandri C, 2003, J ESSENT OIL RES, V15, P242, DOI 10.1080/10412905.2003.9712130
   Rawat P, 2010, FITOTERAPIA, V81, P162, DOI 10.1016/j.fitote.2009.08.014
   Selim S., 2012, African Journal of Biotechnology, V11, P416
   SELIM S, 2013, LIFE SCI J, V10, P1450
   Selim S. A., 2013, African Journal of Pharmacy and Pharmacology, V7, P725
   Selim SA, 2012, WORLD ACAD SCI ENG T, V61, P1154
   Selim SA, 2011, GRASAS ACEITES, V62, P55, DOI 10.3989/gya.033810
   Tapondjou AL, 2005, J STORED PROD RES, V41, P91, DOI 10.1016/j.jspr.2004.01.004
   Usher G, 1974, DICT PLANTS USED MAN
   Xiao J, 2007, ARCH ORAL BIOL, V52, P869, DOI 10.1016/j.archoralbio.2007.02.009
   Yang JK, 2007, FITOTERAPIA, V78, P149, DOI 10.1016/j.fitote.2006.09.026
NR 30
TC 15
Z9 17
U1 0
U2 35
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6882
J9 BMC COMPLEM ALTERN M
JI BMC Complement. Altern. Med.
PD JUN 2
PY 2014
VL 14
AR 179
DI 10.1186/1472-6882-14-179
PG 8
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA AJ0EM
UT WOS:000337322400001
PM 24890383
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Molino, PJ
   Yue, ZL
   Zhang, BB
   Tibbens, A
   Liu, X
   Kapsa, RMI
   Higgins, MJ
   Wallace, GG
AF Molino, Paul J.
   Yue, Zhilian
   Zhang, Binbin
   Tibbens, Anthony
   Liu, Xiao
   Kapsa, Robert. M. I.
   Higgins, Michael J.
   Wallace, Gordon G.
TI Influence of Biodopants on PEDOT Biomaterial Polymers: Using QCM-D to
   Characterize Polymer Interactions with Proteins and Living Cells
SO ADVANCED MATERIALS INTERFACES
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; BOVINE SERUM-ALBUMIN; FIBRONECTIN
   ADSORPTION; CONDUCTING POLYMERS; CHONDROITIN SULFATE; NEURITE OUTGROWTH;
   SURFACE-ENERGY; IN-VITRO; ADHESION; COLLAGEN
AB Organic conducting polymers (OCPs) are currently the subject of intense research in the area of biomaterials and bioelectronics. Of the OCPs, poly(3,4-ethylenedioxythiophene) (PEDOT) has attracted significant interest, however there has been little work on investigating the incorporation of biological compounds as the dopant species in the polymer which are aimed at enhancing the biocompatibility and biofunctionality of the material. Here, we incorporate the biological dopants dextran sulphate, chondroitin sulphate, and alginate, into PEDOT polymers and investigate their influence on a suite of physicochemical and electrochemical properties. We employ QCM-D to study the mass of adsorption and the viscoelastic properties of the important extracellular matrix proteins fibronectin and collagen. Furthermore, we use QCM-D to study the adhesion of PC12 neural cells to the PEDOT-biodopant polymers with and without an adsorbed protein conditioning layer. QCM-D was found to be an excellent tool with which to study conducting polymer-biological interactions, with this report the first time that QCM-D has been used to study cell interactions with conducting polymer biomaterials.
C1 [Molino, Paul J.; Yue, Zhilian; Zhang, Binbin; Tibbens, Anthony; Liu, Xiao; Kapsa, Robert. M. I.; Higgins, Michael J.; Wallace, Gordon G.] Univ Wollongong, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, AIIM Facil, Wollongong, NSW 2522, Australia.
RP Molino, PJ (reprint author), Univ Wollongong, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, AIIM Facil, Innovat Campus, Wollongong, NSW 2522, Australia.
EM pmolino@uow.edu.au; gordon_wallace@uow.edu.au
RI Zhang, Binbin/A-3483-2015
OI Zhang, Binbin/0000-0002-2488-4221; Molino, Paul/0000-0002-8868-2733;
   Wallace, Gordon/0000-0002-0381-7273
FU Australian Research Council; National Health and Medical Research
   Council [573430]; Vice Chancellors Fellowship award (UOW)
FX The authors gratefully acknowledge the Australian Research Council and
   the National Health and Medical Research Council (Grant No. 573430). PJM
   acknowledges funding support through the Vice Chancellors Fellowship
   award (UOW). We also acknowledge the Australian National Nanofabrication
   Facility (ANFF) for access to equipment, and the use of the facilities
   and the assistance of Mr Tony Romeo at the UOW Electron Microscopy
   Centre.
CR BABA M, 1988, P NATL ACAD SCI USA, V85, P6132, DOI 10.1073/pnas.85.16.6132
   BARKALOW FJ, 1994, J BIOL CHEM, V269, P3957
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   Dolatshahi-Pirouz A, 2009, LANGMUIR, V25, P2971, DOI 10.1021/la803142u
   Dufrene Y. F., 1999, LANGMUIR, V15, P2971
   Elliott JT, 2007, BIOMATERIALS, V28, P576, DOI 10.1016/j.biomaterials.2006.09.023
   Gelmi A, 2010, BIOMATERIALS, V31, P1974, DOI 10.1016/j.biomaterials.2009.11.040
   Gilmore K. J., 2010, BIOMATERIALS, V30, P5292
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   GRYTE DM, 1993, BIOTECHNOL PROGR, V9, P105, DOI 10.1021/bp00019a016
   HALL M, 1952, J CLIN PATHOL, V5, P366, DOI 10.1136/jcp.5.4.366
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hovgaard MB, 2008, J PHYS CHEM B, V112, P8241, DOI 10.1021/jp801103n
   Khang D, 2007, BIOMATERIALS, V28, P4756, DOI 10.1016/j.biomaterials.2007.07.018
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Kowalczynska HM, 2003, CELL BIOL INT, V27, P101, DOI 10.1016/S1065-6995(02)00290-1
   Kowalczynska HM, 2002, J BIOMED MATER RES, V61, P260, DOI 10.1002/jbm.10151
   Lord MS, 2006, BIOMATERIALS, V27, P4856, DOI 10.1016/j.biomaterials.2006.05.037
   Luo SC, 2008, LANGMUIR, V24, P8071, DOI 10.1021/la800333g
   MACHADO JM, 1989, POLYMER, V30, P1992, DOI 10.1016/0032-3861(89)90284-X
   Malmstrom J, 2007, LANGMUIR, V23, P9760, DOI 10.1021/la701233y
   Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i
   Marx KA, 2001, BIOSENS BIOELECTRON, V16, P773, DOI 10.1016/S0956-5663(01)00219-6
   Michiardi A, 2007, BIOMATERIALS, V28, P586, DOI 10.1016/j.biomaterials.2006.09.040
   Coelho NM, 2011, TISSUE ENG PT A, V17, P2245, DOI [10.1089/ten.tea.2010.0713, 10.1089/ten.TEA.2010.0713]
   Modin C, 2006, BIOMATERIALS, V27, P1346, DOI 10.1016/j.biomaterials.2005.09.022
   Molino PJ, 2012, LANGMUIR, V28, P8433, DOI 10.1021/la300692y
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   O'Sullivan CK, 1999, BIOSENS BIOELECTRON, V14, P663, DOI 10.1016/S0956-5663(99)00040-8
   OSADA Y, 1993, PROG POLYM SCI, V18, P187, DOI 10.1016/0079-6700(93)90025-8
   OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0
   Pamula E, 2004, J COLLOID INTERF SCI, V271, P80, DOI 10.1016/j.jcis.2003.11.012
   Pernodet N, 2003, J BIOMED MATER RES A, V64A, P684, DOI 10.1002/jbm.a.10394
   Pompe T, 2005, BIOPHYS J, V88, P527, DOI [10.1529/biophysj.104.048074, 10.1529/biophysj.104.049074]
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Redpenning J., 1993, ANAL CHEM, V65, P3378
   Renner L, 2005, LANGMUIR, V21, P4571, DOI 10.1021/la046801n
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Ronca F, 1998, OSTEOARTHR CARTILAGE, V6, P14, DOI 10.1016/S1063-4584(98)80006-X
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sela MN, 2007, CLIN ORAL IMPLAN RES, V18, P630, DOI 10.1111/j.1600-0501.2007.01373.x
   Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005
   Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285
   Sung KE, 2009, BIOMATERIALS, V30, P4833, DOI 10.1016/j.biomaterials.2009.05.043
   Syritski V, 2004, SYNTHETIC MET, V144, P235, DOI 10.1016/j.synthmet.2004.03.008
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Wallace G. G, 2009, CONDUCTIVE ELECTROAC
   Wallace G, 2007, SOFT MATTER, V3, P665, DOI 10.1039/b618204f
   Wegener J, 2000, BIOPHYS J, V78, P2821, DOI 10.1016/S0006-3495(00)76825-1
   Wegener J, 1998, EUR BIOPHYS J BIOPHY, V28, P26, DOI 10.1007/s002490050180
   Yang JY, 2006, J MATER RES, V21, P1124, DOI 10.1557/JMR.2006.0145
   Ying PQ, 2004, COLLOID SURFACE B, V33, P259, DOI 10.1016/j.colsurfb.2003.10.015
   Zhou T, 2000, BIOTECHNOL PROGR, V16, P268, DOI 10.1021/bp000003f
NR 57
TC 21
Z9 21
U1 1
U2 52
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2196-7350
J9 ADV MATER INTERFACES
JI Adv. Mater. Interfaces
PD JUN
PY 2014
VL 1
IS 3
AR 1300122
DI 10.1002/admi.201300122
PG 12
WC Chemistry, Multidisciplinary; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA AZ5TO
UT WOS:000348282900021
DA 2018-10-20
ER

PT J
AU Khnouf, R
   Oweis, R
   Albiss, B
   Haddad, S
AF Khnouf, Ruba
   Oweis, Rami
   Albiss, Borhan
   Haddad, Shereen
TI Preparation of Polystyrene/Single-Walled Carbon Nanotube Composite and
   Its Characterization for Biochemical Applications
SO JOURNAL OF NANOELECTRONICS AND OPTOELECTRONICS
LA English
DT Article
DE Polymer Nanocomposite; Polystyrene; SWNT; Membrane Porosity;
   Biocompatibility
ID MECHANICAL-PROPERTIES; MEMBRANES; NANOCOMPOSITES; CYTOTOXICITY;
   FABRICATION
AB This study focuses on manipulating the properties of pure polystyrene by the fabrication of a novel composite incorporating nanotubes with the polymer. Polystyrene-single walled carbon nanotube (PS-SWNT) composite was prepared with different SWNT/polymer compositions, the resulting nanocomposite materials were studied and the effect of the different nanotube compositions on a variety of properties was studied. A change in the microstructure was observed using scanning electron microscopy where the nanocomposite had a more dense morphology and decreased porosity. In addition, the contact angle test showed that the incorporation of SWNTs enhanced the polymer's interaction with water and increased its hydrophilicity, while the conductivity test showed that this incorporation led to an increase in the polymer's conductivity depending on the percentage of SWNT in the composite. Finally, to investigate the possibility of using this PS-SWNT composite in biomedical and biochemical applications, the biocompatibility of the nanocomposite, pure polystyrene, and pure SWNT was investigated using polymerase chain reaction (PCR) and showed no effect on the biochemical reaction, ascertaining that the novel composite can be used as a biomaterial at least in in vitro biochemical applications.
C1 [Khnouf, Ruba; Oweis, Rami; Haddad, Shereen] Jordan Univ Sci & Technol, Dept Biomed Engn, Irbid 22110, Jordan.
   [Albiss, Borhan] Jordan Univ Sci & Technol, Dept Appl Phys Sci, Irbid 22110, Jordan.
RP Khnouf, R (reprint author), Jordan Univ Sci & Technol, Dept Biomed Engn, Irbid 22110, Jordan.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Baker LA, 2005, CRIT REV SOLID STATE, V30, P183, DOI 10.1080/10408430500198169
   Celik E, 2011, WATER RES, V45, P274, DOI 10.1016/j.watres.2010.07.060
   Chang TE, 2006, POLYMER, V47, P7740, DOI 10.1016/j.polymer.2006.09.013
   Choi JH, 2006, J MEMBRANE SCI, V284, P406, DOI [10.1016/j.memsci.2006.08.013, 10.1016/j.memsei.2006.08.013]
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Haggenmueller R, 2000, CHEM PHYS LETT, V330, P219, DOI 10.1016/S0009-2614(00)01013-7
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Lamour G, 2010, J CHEM EDUC, V87, P1403, DOI 10.1021/ed100468u
   Liu Z, 2009, NANO RES, V2, P85, DOI 10.1007/s12274-009-9009-8
   Lopez-Manchado MA, 2005, CARBON, V43, P1499, DOI 10.1016/j.carbon.2005.01.031
   Mei Q, 2007, BIOTECHNOL PROGR, V23, P1305, DOI 10.1021/bp070133p
   Olive-Monllau R, 2010, SENSOR ACTUAT B-CHEM, V146, P353, DOI 10.1016/j.snb.2010.02.017
   Putz K, 2007, POLYMER, V48, P3540, DOI 10.1016/j.polymer.2007.03.072
   Ramanathan T, 2005, J POLYM SCI POL PHYS, V43, P2269, DOI 10.1002/polb.20510
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Shobha D.R.J., 2007, CARBON, V45, P1340
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Sinha N, 2005, IEEE T NANOBIOSCI, V4, P180, DOI 10.1109/TNB.2005.850478
   Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011
   Solanki PR, 2009, SENSOR ACTUAT B-CHEM, V137, P727, DOI 10.1016/j.snb.2008.12.044
   Wang J, 2003, ANAL CHEM, V75, P2075, DOI 10.1021/ac030007+
   Wang Z, 2006, MATER CHEM PHYS, V100, P77, DOI 10.1016/j.matchemphys.2005.12.008
   Wu HQ, 2010, J MEMBRANE SCI, V362, P374, DOI 10.1016/j.memsci.2010.06.064
   Xiaoming L., 2009, BIOMEDICAL MAT, V5
   Yang WR, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/41/412001
   Zhang ZZ, 2008, BIOTECHNIQUES, V44, P537, DOI 10.2144/000112692
NR 28
TC 2
Z9 2
U1 0
U2 7
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1555-130X
EI 1555-1318
J9 J NANOELECTRON OPTOE
JI J. Nanoelectron. Optoelectron.
PD JUN
PY 2014
VL 9
IS 3
BP 427
EP 431
DI 10.1166/jno.2014.1592
PG 5
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Physics, Applied
SC Engineering; Science & Technology - Other Topics; Physics
GA AU4XS
UT WOS:000345612400018
DA 2018-10-20
ER

PT J
AU Nascimento, RM
   Faita, FL
   Agostini, DLS
   Job, AE
   Guimaraes, FEG
   Bechtold, IH
AF Nascimento, R. M.
   Faita, F. L.
   Agostini, D. L. S.
   Job, A. E.
   Guimaraes, F. E. G.
   Bechtold, I. H.
TI Production and characterization of natural rubber-Ca/P blends for
   biomedical purposes
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Natural rubber; Calcium phosphate; Biomaterial; Tissue regeneration
ID GUIDED BONE REGENERATION; TISSUE REGENERATION; LATEX; MEMBRANE;
   PHOSPHATE; CALCIUM; BIOMATERIALS; COMPOSITES; PARTICLES; PROTEINS
AB This study presents the development of natural rubber-Ca/P blends, as promising candidates for biomedical purposes. The specific objective was the incorporation of Ca/P into a natural rubber polymeric matrix. Ca/P crystalline phases were synthesized by the sol-gel method and the polymeric matrices were produced using natural rubber extracted from latex of the Hevea brasiliensis. The shape and size of natural rubber particles present in the NR membrane, as well as, the way the Ca/P powder grains aggregate in the polymeric matrix were investigated, giving information about the interactions between the Ca/P and the natural rubber particles. Confocal fluorescence scanning microscopy measurements allowed us to propose a structure where the Ca/P grains are surrounded by natural rubber particles. This structure may mediate Ca2+ release for tissue regeneration. The system investigated may open new horizons for development of a bandage which provides the controlled-release of biomaterials. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Nascimento, R. M.; Faita, F. L.; Bechtold, I. H.] Univ Fed Santa Catarina, Dept Fis, BR-88040900 Florianopolis, SC, Brazil.
   [Nascimento, R. M.] Univ Estadual Paulista, Dept Fis, BR-13506900 Rio Claro, SP, Brazil.
   [Agostini, D. L. S.; Job, A. E.] UNESP, Fac Ciencias & Tecnol, Dept Fis Quim & Biol, BR-19060080 Presidente Prudente, SP, Brazil.
   [Guimaraes, F. E. G.] Univ Sao Paulo, Dept Fis & Ciencia Mat, Inst Fis Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil.
RP Nascimento, RM (reprint author), Univ Fed Santa Catarina, Dept Fis, BR-88040900 Florianopolis, SC, Brazil.
RI Sao Carlos Institute of Physics, IFSC/USP/M-2664-2016; do Nascimento,
   Rubens/H-1448-2012; Faita, Fabricio/A-2484-2014; Bechtold,
   Ivan/P-6968-2015
OI do Nascimento, Rubens/0000-0001-9094-0044; Bechtold,
   Ivan/0000-0001-6393-7245; Job, Aldo/0000-0002-1979-8257
FU CNPq [555100/2010-3]; CAPES [PNPD/2583/2011]; INCT/INEO; NanoBiomed
FX The authors are grateful to the Brazilian governmental agencies CNPq
   (project #555100/2010-3), CAPES (project PNPD/2583/2011), INCT/INEO and
   NanoBiomed for financial support and the Central Laboratory of Electron
   Microscopy (LCME-UFSC) by SEM and EDS facilities. The XRD experiment was
   carried out in the Laboratorio de Difracao de Raios-X (LDRX-CFM/UFSC).
CR Abdel-Fattah WI, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034121
   Abraham E, 2012, POLYM DEGRAD STABIL, V97, P2378, DOI 10.1016/j.polymdegradstab.2012.07.028
   Agostini DLS, 2008, J THERM ANAL CALORIM, V91, P703, DOI 10.1007/s10973-007-8351-x
   Aparecida Anahí Herrera, 2007, Quím. Nova, V30, P892, DOI 10.1590/S0100-40422007000400024
   Balabanian Claudia A C A, 2006, J Oral Sci, V48, P201, DOI 10.2334/josnusd.48.201
   Bateman L, 1963, CHEM PHYS RUBBER LIK
   Berthelot K., 2013, BIOCH BIOPHYS ACTA
   Broz P., 2010, RSC NANOSCIENCE NANO, V9, P1
   Ereno C, 2010, J BIOMED MATER RES A, V95A, P932, DOI 10.1002/jbm.a.32919
   Faita FL, 2014, EUR POLYM J, V50, P249, DOI 10.1016/j.eurpolymj.2013.11.006
   Ferreira M, 2009, BRAZ J PHYS, V39, P564, DOI 10.1590/S0103-97332009000500010
   FRADE MAC, 2004, MED CUTAN IBER LAT A, V32, P157
   Ha BY, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.031507
   HADENFELDT C, 1994, Z ANORG ALLG CHEM, V620, P1247, DOI 10.1002/zaac.19946200719
   Herculano RD, 2011, MAT SCI ENG C-MATER, V31, P272, DOI 10.1016/j.msec.2010.09.007
   Herculano RD, 2009, MATER RES-IBERO-AM J, V12, P253, DOI 10.1590/S1516-14392009000200023
   Inorganic Crystal Structure Database (ICSD), 2007, IN CRYST STRUCT DAT
   Kikuchi M, 2004, BIOMATERIALS, V25, P5979, DOI 10.1016/j.biomaterials.2004.02.001
   LeGeros R Z, 1991, Monogr Oral Sci, V15, P1
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Mrue Fatima, 2004, Mat. Res., V7, P277, DOI 10.1590/S1516-14392004000200010
   Nawamawat K, 2011, COLLOID SURFACE A, V390, P157, DOI 10.1016/j.colsurfa.2011.09.021
   Neves-Junior WFP, 2006, BRAZ J PHYS, V36, P586, DOI 10.1590/S0103-97332006000400021
   Owen GR, 2005, BIOMATERIALS, V26, P7447, DOI 10.1016/j.biomaterials.2005.05.055
   Pichayakorn W, 2013, CHEM ENG RES DES, V91, P520, DOI 10.1016/j.cherd.2012.09.011
   Reviakine I, 2000, LANGMUIR, V16, P1473, DOI 10.1021/la990806g
   Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c
   RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558
   Rippel MM, 2005, J COLLOID INTERF SCI, V288, P449, DOI 10.1016/j.jcis.2005.03.014
   Rippel MM, 2005, COLLOID POLYM SCI, V283, P570, DOI 10.1007/s00396-004-1187-z
   Rolland JM, 2008, CLIN EXP ALLERGY, V38, P898, DOI 10.1111/j.1365-2222.2008.02984.x
   Sansatsadeekul J, 2011, J BIOSCI BIOENG, V111, P628, DOI 10.1016/j.jbiosc.2011.01.013
   Satarkar NS, 2008, ACTA BIOMATER, V4, P11, DOI 10.1016/j.actbio.2007.07.009
   Satarkar NS, 2010, SOFT MATTER, V6, P2364, DOI 10.1039/b925218p
   Sculean A, 2005, J CLIN PERIODONTOL, V32, P720, DOI 10.1111/j.1600-051X.2005.00758.x
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Smith AM, 2007, CLIN EXP ALLERGY, V37, P1349, DOI 10.1111/j.1365-2222.2007.02787.x
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Thein-Han W, 2012, DENT MATER, V28, P1059, DOI 10.1016/j.dental.2012.06.009
   Wititsuwannakul R, 2008, PHYTOCHEMISTRY, V69, P1111, DOI 10.1016/j.phytochem.2007.12.007
   Xu HHK, 2011, DENT MATER, V27, P762, DOI 10.1016/j.dental.2011.03.016
   Xu HHK, 2009, DENT MATER, V25, P535, DOI 10.1016/j.dental.2008.10.009
NR 42
TC 10
Z9 11
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2014
VL 39
BP 29
EP 34
DI 10.1016/j.msec.2014.02.019
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA AS0DS
UT WOS:000343949200005
PM 24863193
OA Green Published
DA 2018-10-20
ER

PT J
AU Sun, GF
   Ma, J
   Zhang, SM
AF Sun, Guangfei
   Ma, Jun
   Zhang, Shengmin
TI Electrophoretic deposition of zinc-substituted hydroxyapatite coatings
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Zinc substitution; Hydroxyapatite; Electrophoretic deposition;
   n-Butanol; Triethanolamine; Coatings
ID CALCIUM-PHOSPHATE; COMPOSITE COATINGS; TITANIUM SUBSTRATE;
   STAINLESS-STEEL; ELECTRODEPOSITION; ORTHOPHOSPHATES; NANOPARTICLES;
   BIOMATERIAL; SURFACES; ALLOYS
AB Zinc-substituted hydroxyapatite nanoparticles synthesized by the co-precipitation method were used to coat stainless steel plates by electrophoretic deposition in n-butanol with triethanolamine as a dispersant. The effect of zinc concentration in the synthesis on the morphology and microstructure of coatings was investigated. It is found that the deposition current densities significantly increase with the increasing zinc concentration. The zinc-substituted hydroxyapatite coatings were analyzed by X-ray diffraction, scanning electron microscopy and Fourier transform infrared spectroscopy. It is inferred that hydroxyapatite and triethanolamine predominate in the chemical composition of coatings. With the increasing Zn/Ca ratios, the contents of triethanolamine decrease in the final products. The triethanolamine can be burnt out by heat treatment. The tests of adhesive strength have confirmed good adhesion between the coatings and substrates. The formation of new apatite layer on the coatings has been observed after 7 days of immersion in a simulated body fluid. In summary, the results show that dense, uniform zinc-substituted hydroxyapatite coatings are obtained by electrophoretic deposition when the Zn/Ca ratio reaches 5%. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Sun, Guangfei; Ma, Jun; Zhang, Shengmin] Huazhong Univ Sci & Technol, Adv Biomat & Tissue Engn Ctr, Wuhan 430074, Peoples R China.
   [Ma, Jun; Zhang, Shengmin] Huazhong Univ Sci & Technol, Dept Biomed Engn, Wuhan 430074, Peoples R China.
RP Ma, J (reprint author), Huazhong Univ Sci & Technol, Life Sci Bldg,1037 Luoyu Rd, Wuhan 430074, Peoples R China.
EM caltary@gmail.com
RI Ma, Jun/K-2084-2012
OI Ma, Jun/0000-0001-5167-1750
FU National Basic Research Program of China [2012CB933601]; National
   Natural Science Foundation of China [51202075]; National High-Technology
   Research and Development Program of China [2012AA020503]; National Key
   Technology Research and Development Program of China [2012BAI17B02]
FX This work was supported by the National Basic Research Program of China
   (Grant No: 2012CB933601), the National Natural Science Foundation of
   China (Grant No: 51202075), the National High-Technology Research and
   Development Program of China (Grant No: 2012AA020503) and the National
   Key Technology Research and Development Program of China (Grant No:
   2012BAI17B02). We are also grateful to the Analytical and Testing Center
   (HUST).
CR Besra L, 2007, PROG MATER SCI, V52, P1, DOI 10.1016/j.pmatsci.2006.07.001
   Boccaccini AR, 2010, J R SOC INTERFACE, V7, pS581, DOI 10.1098/rsif.2010.0156.focus
   Chai YC, 2011, ACTA BIOMATER, V7, P2310, DOI 10.1016/j.actbio.2010.12.032
   Chung CJ, 2011, ACTA BIOMATER, V7, P4081, DOI 10.1016/j.actbio.2011.07.004
   de Jonge LT, 2008, PHARM RES-DORDR, V25, P2357, DOI 10.1007/s11095-008-9617-0
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Farrokhi-Rad M, 2013, CERAM INT, V39, P7007, DOI 10.1016/j.ceramint.2013.02.038
   Gopi D, 2012, SURF COAT TECH, V206, P2859, DOI 10.1016/j.surfcoat.2011.12.011
   Guan RG, 2012, J BIOMED MATER RES A, V100A, P999, DOI 10.1002/jbm.a.34042
   He CL, 2012, J MATER CHEM, V22, P2111, DOI 10.1039/c1jm14631a
   Hu W, 2012, MAT SCI ENG C-MATER, V32, P2404, DOI 10.1016/j.msec.2012.07.014
   Huang SP, 2008, J MATER SCI-MATER M, V19, P437, DOI 10.1007/s10856-006-0104-z
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   Javidi M, 2008, MAT SCI ENG C-BIO S, V28, P1509, DOI 10.1016/j.msec.2008.04.003
   Lin CJ, 2008, J MATER SCI-MATER M, V19, P2569, DOI 10.1007/s10856-007-3196-1
   Lin DY, 2011, CERAM INT, V37, P403, DOI 10.1016/j.ceramint.2010.08.018
   Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021
   Ma R, 2011, MATER LETT, V65, P681, DOI 10.1016/j.matlet.2010.11.069
   Matsunaga K, 2010, ACTA BIOMATER, V6, P2289, DOI 10.1016/j.actbio.2009.11.029
   Meng XW, 2006, J BIOMED MATER RES B, V78B, P373, DOI 10.1002/jbm.b.30497
   Meng XW, 2008, DENT MATER J, V27, P666, DOI 10.4012/dmj.27.666
   Miyaji F, 2005, MATER RES BULL, V40, P209, DOI 10.1016/j.materresbull.2004.10.020
   Ou KL, 2010, J BIOMED MATER RES A, V92A, P906, DOI 10.1002/jbm.a.32454
   Parente P, 2013, J PHYS CHEM B, V117, P1600, DOI 10.1021/jp305176h
   Rad AT, 2013, COLLOID SURFACE B, V103, P200, DOI 10.1016/j.colsurfb.2012.10.027
   Raja KS, 2005, MATER LETT, V59, P2137, DOI 10.1016/j.matlet.2005.01.084
   Roland T, 2013, J APPL ELECTROCHEM, V43, P53, DOI 10.1007/s10800-012-0504-3
   Shadanbaz S, 2012, ACTA BIOMATER, V8, P20, DOI 10.1016/j.actbio.2011.10.016
   Swetha M, 2012, J NANOSCI NANOTECHNO, V12, P167, DOI 10.1166/jnn.2012.5142
   Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043
   Thian ES, 2013, J MATER SCI-MATER M, V24, P437, DOI 10.1007/s10856-012-4817-x
   Ustundag CB, 2013, J PHYS CHEM B, V117, P1571, DOI 10.1021/jp305057p
   Wang C, 2002, MATER LETT, V57, P99, DOI 10.1016/S0167-577X(02)00706-1
   Wang R, 2003, J BIOMED MATER RES A, V67A, P270, DOI 10.1002/jbm.a.10114
   Wei M, 2005, J MATER SCI-MATER M, V16, P101, DOI 10.1007/s10856-005-5995-6
   Xiao XF, 2008, J MATER SCI-MATER M, V19, P175, DOI 10.1007/s10856-007-0161-y
   Xiao XF, 2006, MATER LETT, V60, P2627, DOI 10.1016/j.matlet.2006.01.048
   Xiao XF, 2009, J MATER SCI-MATER M, V20, P691, DOI 10.1007/s10856-008-3619-7
NR 40
TC 22
Z9 22
U1 2
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2014
VL 39
BP 67
EP 72
DI 10.1016/j.msec.2014.02.023
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA AS0DS
UT WOS:000343949200011
PM 24863199
DA 2018-10-20
ER

PT J
AU Huang, L
   Fozo, EM
   Zhang, T
   Liaw, PK
   He, W
AF Huang, Lu
   Fozo, Elizabeth M.
   Zhang, Tao
   Liaw, Peter K.
   He, Wei
TI Antimicrobial behavior of Cu-bearing Zr-based bulk metallic glasses
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Bulk metallic glass; Antimicrobial behavior; Copper
ID TRANSPORT-SYSTEM; INFECTION; COPPER; BIOMATERIAL; PROSTHESIS; RESISTANT;
   ADHESION; IMPLANTS; SURFACES
AB The antimicrobial behavior of Cu-bearing Zr-based bulk metallic glasses (BMGs) was investigated for the first time against the Gram positive bacterium Staphylococcus aureus to evaluate their potential applications in healthcare settings. Despite their lack of bacteria-killing effect under a relatively severe experimental setting of dynamic immersion, the biocidal potency of the two Zr-based BMGs was demonstrated via a moist contact assay. There was a significant reduction in viable bacterial populations after 4 h of contact on the Zr-based BMGs, which was evidenced by the pronounced reduction in viable bacterial populations. To understand the mechanism of cell death, a direct relationship was established between the killing efficiency and the ability of the substrate to release Cu ions. Findings in this study will direct the future design of antimicrobial BMGs with enhanced killing efficacy. Published by Elsevier B.V.
C1 [Huang, Lu; Liaw, Peter K.; He, Wei] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   [Fozo, Elizabeth M.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.
   [Zhang, Tao] Beihang Univ, Key Lab Aerosp Mat & Performance, Sch Mat Sci & Engn, Minist Educ, Beijing 100191, Peoples R China.
   [He, Wei] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.
RP He, W (reprint author), Univ Tennessee, Dept Mat Sci & Engn, 303 Ferris Hall, Knoxville, TN 37996 USA.
EM whe5@utk.edu
RI Huang, Lu/H-5325-2012; Zhang, Tao/O-4911-2014; He, Wei/K-7218-2013
OI Huang, Lu/0000-0001-8318-2687; He, Wei/0000-0002-6638-9691
FU US National Science Foundation (NSF) [CMMI-1100080]; National Natural
   Science Foundation of China [51161130526]; Office of Research and
   Engagement at the University of Tennessee; NSF [DMR-0909037,
   CMMI-0900271]; Department of Energy (DOE), Office of Energy's Nuclear
   Energy University Program (NEUP) [00119262]; DOE, Office of Fossil
   Energy; National Energy Technology Laboratory [DE-FE-0008855,
   DE-FE-0011194]
FX This work was financially supported by US National Science Foundation
   (NSF, CMMI-1100080) and National Natural Science Foundation of China
   (No. 51161130526). LH appreciates the financial support under Summer
   Graduate Research Assistantship Fund from the Office of Research and
   Engagement at the University of Tennessee. PKL acknowledges the
   financial support from the NSF (DMR-0909037 and CMMI-0900271), the
   Department of Energy (DOE), Office of Energy's Nuclear Energy University
   Program (NEUP) 00119262, and the DOE, Office of Fossil Energy, and
   National Energy Technology Laboratory (DE-FE-0008855 and DE-FE-0011194).
CR Ashby MF, 2006, SCRIPTA MATER, V54, P321, DOI 10.1016/j.scriptamat.2005.09.051
   Borkow G, 2005, CURR MED CHEM, V12, P2163, DOI 10.2174/0929867054637617
   Borkow G., 2009, CURR CHEM BIOL, V3, P272, DOI DOI 10.2174/187231309789054887
   Chiang PT, 2012, MATER TECHNOL, V27, P107, DOI 10.1179/175355511X13240279339923
   Dancer SJ, 2009, J HOSP INFECT, V73, P378, DOI 10.1016/j.jhin.2009.03.030
   Davis J. R., 2001, COPPER COPPER ALLOYS
   Demetriou MD, 2010, JOM-US, V62, P83, DOI 10.1007/s11837-010-0038-2
   Grass G, 2011, APPL ENVIRON MICROB, V77, P1541, DOI 10.1128/AEM.02766-10
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hendriks JGE, 2004, BIOMATERIALS, V25, P545, DOI 10.1016/S0142-9612(03)00554-4
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861
   Horton JA, 2003, MATER RES SOC SYMP P, V754, P179
   Hua NB, 2011, J MATER RES, V26, P539, DOI 10.1557/jmr.2010.65
   Huang L, 2011, ACTA BIOMATER, V7, P395, DOI 10.1016/j.actbio.2010.08.002
   Huang L, 2009, INTERMETALLICS, V17, P195, DOI 10.1016/j.intermet.2008.07.020
   Jin K, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1948513
   Kowalski W, 2009, ULTRAVIOLET GERMICIDAL IRRADIATION HANDBOOK, P1, DOI 10.1007/978-3-642-01999-9
   Lin B, 2012, CHINESE SCI BULL, V57, P1069, DOI 10.1007/s11434-012-4997-2
   Luo J, 2006, MATER TRANS, V47, P450, DOI 10.2320/matertrans.47.450
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Otter JA, 2009, LETT APPL MICROBIOL, V49, P803, DOI 10.1111/j.1472-765X.2009.02728.x
   Santo CE, 2010, APPL ENVIRON MICROB, V76, P1341, DOI 10.1128/AEM.01952-09
   Senthi S, 2011, INT ORTHOP, V35, P253, DOI 10.1007/s00264-010-1144-z
   Sitthisak S, 2007, MICROBIOL-SGM, V153, P4274, DOI 10.1099/mic.0.2007/009860-0
   Smyth ETM, 2008, J HOSP INFECT, V69, P230, DOI 10.1016/j.jhin.2008.04.020
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zheng YF, 2011, ACTA BIOMATER, V7, P2758, DOI 10.1016/j.actbio.2011.02.010
NR 28
TC 9
Z9 9
U1 1
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2014
VL 39
BP 325
EP 329
DI 10.1016/j.msec.2014.03.017
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA AS0DS
UT WOS:000343949200042
PM 24863231
DA 2018-10-20
ER

PT J
AU Zhou, K
   Thouas, G
   Bernard, C
   Forsythe, JS
AF Zhou, Kun
   Thouas, George
   Bernard, Claude
   Forsythe, John S.
TI 3D presentation of a neurotrophic factor for the regulation of neural
   progenitor cells
SO NANOMEDICINE
LA English
DT Article
DE brain-derived neurotrophic factor; immobilization; layer-by-layer;
   neural tissue engineering; polyelectolyte; self-assembly nanofiber
ID BY-LAYER DEPOSITION; STEM-CELLS; PROTEIN ADSORPTION; POLYELECTROLYTE
   MULTILAYERS; ELECTROSPUN NANOFIBERS; AXONAL GROWTH; DIFFERENTIATION;
   SCAFFOLDS; CHITOSAN; BDNF
AB Background: Adequate cell-scaffold interactions and neurotrophin support are essential factors for neural regeneration. Aim: To provide insight into the biofunctionalization of complex 3D scaffolds with nanoscale precision, as well as the effect of spatial distribution of brain-derived neurotrophic factor (BDNF) and its prolonged stimulation in combination with enhanced cell affinity of nanofibrous scaffolds on the survival/proliferation and neurite outgrowth. Methods & materials: We developed a versatile approach using layer-by-layer self-assembly to incorporate cell adhesion and spatial representation of neurotrophic factors into complex nanofibrous scaffolds. Results: Heparin/poly-L-lysine (PLL) polyelectrolyte multilayers (PEMs) were deposited on electrospun poly-epsilon-caprolatone nanofibers. Well-controlled amounts of BDNF were immobilized on the PEM-modified nanofibers. In addition, longer neurite outgrowth was observed in neural progenitor cells cultured on PLL-terminating PEM scaffolds. The immobilized BDNF on PLL-terminated PEM scaffolds resulted in significantly longer neurites and higher cell numbers (p < 0.01) compared with BDNF-free and BDNF-adsorbed PLL-terminating scaffolds. Interestingly, there was no upregulation of TrkB-FL, TrkB-T1 or GAP-43 mRNAs with immobilized BDNF in day 5 cultures. Discussion & conclusion: This work reinforces the importance of the combinatorial effects of biomaterial scaffold nanostructure and spatial presentation of neurotrophins in directing neural progenitor cell fates.
C1 [Zhou, Kun; Forsythe, John S.] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
   [Zhou, Kun; Bernard, Claude] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia.
   [Thouas, George] Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia.
RP Forsythe, JS (reprint author), Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
EM john.forsythe@monash.edu
OI Bernard, Claude Charles Andre/0000-0003-2816-5328; Forsythe,
   John/0000-0003-2849-229X
FU Australian Research Council [DP0985433]; Eva and Les ErdiAUSiMED
   Fellowship in Neurological Diseases; National Health and Medical
   Research Council of Australia; Australian Research Council
FX This work was supported by the Australian Research Council (DP0985433),
   the Eva and Les ErdiAUSiMED Fellowship in Neurological Diseases and the
   National Health and Medical Research Council of Australia. This research
   used equipment funded by the Australian Research Council grant. The
   authors have no other relevant affiliations or financial involvement
   with any organization or entity with a financial interest in or
   financial conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X
   Aspler JS, 1987, J PULP PAP SCI, V13, P55
   Baranes K, 2012, BIOTECHNOL BIOENG, V109, P1791, DOI 10.1002/bit.24444
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Cheng K, 2010, BIOTECHNOL PROGR, V26, P838, DOI 10.1002/btpr.391
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   Croll TI, 2006, BIOMACROMOLECULES, V7, P1610, DOI 10.1021/bm060044l
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Fang F, 2005, BIOPHYS J, V89, P1516, DOI 10.1529/biophysj.104.055079
   Fang F, 2001, BIOPHYS J, V80, P2568, DOI 10.1016/S0006-3495(01)76228-5
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Il Cho Y, 2010, ACTA BIOMATER, V6, P4725, DOI 10.1016/j.actbio.2010.06.019
   Islam O, 2009, CURR NEUROVASC RES, V6, P42, DOI 10.2174/156720209787466028
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0
   Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Liu GM, 2008, J PHYS CHEM B, V112, P3333, DOI 10.1021/jp710600f
   Liu H, 2006, BIOMATERIALS, V27, P5978, DOI 10.1016/j.biomaterials.2006.05.053
   Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216
   Mahairaki V, 2011, TISSUE ENG PT A, V17, P855, DOI [10.1089/ten.tea.2010.0377, 10.1089/ten.TEA.2010.0377]
   Nagappan G, 2005, TRENDS NEUROSCI, V28, P464, DOI 10.1016/j.tins.2005.07.003
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Stanwick JC, 2012, J CONTROL RELEASE, V160, P666, DOI 10.1016/j.jconrel.2012.03.024
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stroh M, 2004, NAT MATER, V3, P489, DOI 10.1038/nmat1159
   VAZQUEZ G, 1995, J CHEM ENG DATA, V40, P611, DOI 10.1021/je00019a016
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026
   Yu LMY, 2008, J NEUROSCI METH, V171, P253, DOI 10.1016/j.jneumeth.2008.03.023
   Yu LMY, 2010, BIOMATERIALS, V31, P6987, DOI 10.1016/j.biomaterials.2010.05.070
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhou K, 2012, ACS APPL MATER INTER, V4, P4524, DOI 10.1021/am3007565
   Zhou K, 2011, BIOINTERPHASES, V6, P189, DOI 10.1116/1.3656249
NR 39
TC 7
Z9 7
U1 0
U2 17
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
EI 1748-6963
J9 NANOMEDICINE-UK
JI Nanomedicine
PD JUN
PY 2014
VL 9
IS 8
BP 1239
EP 1251
DI 10.2217/NNM.13.112
PG 13
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA AO1TO
UT WOS:000341097900016
PM 24102327
DA 2018-10-20
ER

PT J
AU Henry, PYT
AF Henry, Pierre-Yves T.
TI BENDING PROPERTIES OF A MACROALGA: ADAPTATION OF PEIRCE'S CANTILEVER
   TEST FOR IN SITU MEASUREMENTS OF LAMINARIA DIGITATA (LAMINARIACEAE)
SO AMERICAN JOURNAL OF BOTANY
LA English
DT Article
DE bending test; bending modulus; biomaterial; biomechanics; flexural
   rigidity; Laminaria digitata; Laminariaceae; macroalga
ID PTERYGOPHORA-CALIFORNICA; MECHANICAL-PROPERTIES; AQUATIC VEGETATION;
   TURBINARIA-ORNATA; FLOW; BIOMECHANICS; STIFFNESS; RECONFIGURATION;
   BUOYANCY; STRESS
AB Premise of the study: The mechanical properties of a plant are key variables governing the interaction between the plant and its environment. Thus, measuring variables such as the flexural rigidity (bending) of a plant element is necessary to understand and predict the plant-flow interaction. However, plant elements such as macrophyte blades can be relatively thin and flexible, thus difficult to characterize. Different adaptations of the classical 3-point bending tests can also affect the interpretation of the flexural rigidity of an element. A simple, robust, method is newly applied to a biomaterial and validated here as an alternative to measure flexural rigidity of thin, flexible plant elements.
   Methods: Based on a bending test procedure developed for the textile industry, an apparatus for in-situ measurements was developed and compared with other normalized methods, then used in a field test on the blade of a marine macroalga (Laminaria digitata) to assess its suitability to measure the bending modulus of a biomaterial.
   Key results: Results of the presented method on selected surrogate materials agree with a normalized cantilever method (ISO 9073-7:1998) and 3-point bending test (ISO 178: 2010). Values determined for the bending moduli for blades of L. digitaria were in the typical range for algal material. The range of validity of the method is discussed.
   Conclusion: By validating this method with existing norms, this study suggests a better approach to measure bending properties of different biomaterials in the field compared with more traditional bending tests and opens new possibilities.
C1 Norwegian Univ Sci & Technol, Dept Marine Technol, NO-7491 Trondheim, Norway.
RP Henry, PYT (reprint author), Norwegian Univ Sci & Technol, Dept Marine Technol, NO-7491 Trondheim, Norway.
EM pierre-yves.henry@ntnu.no
OI Henry, Pierre-Yves/0000-0003-3714-254X
CR BIEDKA RF, 1987, MAR ECOL PROG SER, V36, P163, DOI 10.3354/meps036163
   Boller ML, 2007, J EXP BIOL, V210, P1874, DOI 10.1242/jeb.02775
   Booth J. E., 1969, PRINCIPLES TEXTILE T
   Bouma TJ, 2005, ECOLOGY, V86, P2187, DOI 10.1890/04-1588
   de Langre E, 2012, CR MECANIQUE, V340, P35, DOI 10.1016/j.crme.2011.11.005
   Demes KW, 2011, J PHYCOL, V47, P1360, DOI 10.1111/j.1529-8817.2011.01066.x
   Denny M, 2002, J EXP BIOL, V205, P1355
   Gaylord B, 1997, J EXP BIOL, V200, P3141
   HALE B, 2001, THESIS STANFORD U ST
   Harder DL, 2006, AM J BOT, V93, P1426, DOI 10.3732/ajb.93.10.1426
   ISO, 2010, ISO1782010
   ISO [International Organization for Standardization], 1998, 907371998 ISO
   JOHNSON AS, 1994, J EXP BIOL, V195, P381
   Koehl MAR, 1999, J EXP BIOL, V202, P3469
   Lamouroux J. V. F., 1813, ANN MUS HIST NAT PAR, V20, P267
   Lamouroux JV, 1813, ANN MUS HIST NAT PAR, V20, P21
   Lamouroux JV, 1813, ANN MUS HIST NAT PAR, V20, P115
   Luhar M, 2011, LIMNOL OCEANOGR, V56, P2003, DOI 10.4319/lo.2011.56.6.2003
   Luning K., 1990, SEAWEEDS THEIR ENV B
   Martone PT, 2008, J EXP BIOL, V211, P3433, DOI 10.1242/jeb.020495
   Miler O, 2012, AQUAT SCI, V74, P31, DOI 10.1007/s00027-011-0188-5
   Nepf HM, 2012, ANNU REV FLUID MECH, V44, P123, DOI 10.1146/annurev-fluid-120710-101048
   Niklas KJ, 2006, AM J BOT, V93, P1369, DOI 10.3732/ajb.93.10.1369
   NIKLAS KJ, 1992, PLANT BIOMECHANICS E
   Nikora V, 2010, RIVER RES APPL, V26, P367, DOI 10.1002/rra.1291
   Nikora V., 2012, ENV FLUID MECH MEMOR, P217, DOI [10.1201/b12283-1210.1201/b12283-12, DOI 10.1201/B12283-1210.1201/B12283-12]
   Paul M, 2014, COAST ENG, V84, P73, DOI 10.1016/j.coastaleng.2013.11.007
   Paul M., 2014, J HYDRODYNA IN PRESS
   Peirce F, 1930, J TEXT I, V21, P377
   Stewart HL, 2006, J PHYCOL, V42, P43, DOI 10.1111/j.1529-8817.2006.00184.x
   Stewart HL, 2004, J MARINE SYST, V49, P157, DOI 10.1016/j.jmarsys.2003.05.007
   Szablewski P, 2003, FIBRES TEXT EAST EUR, V11, P54
   Young WC, 2011, ROARKS FORMULAS STRE
NR 33
TC 3
Z9 4
U1 0
U2 19
PU BOTANICAL SOC AMER INC
PI ST LOUIS
PA PO BOX 299, ST LOUIS, MO 63166-0299 USA
SN 0002-9122
EI 1537-2197
J9 AM J BOT
JI Am. J. Bot.
PD JUN
PY 2014
VL 101
IS 6
BP 1050
EP 1055
DI 10.3732/ajb.1400163
PG 6
WC Plant Sciences
SC Plant Sciences
GA AN2ZA
UT WOS:000340453400014
PM 24907250
OA Bronze
DA 2018-10-20
ER

PT J
AU Hindie, M
   Camand, E
   Agniel, R
   Carreiras, F
   Pauthe, E
   Van Tassel, P
AF Hindie, Mathilde
   Camand, Emeline
   Agniel, Remy
   Carreiras, Franck
   Pauthe, Emmanuel
   Van Tassel, Paul
TI Effects of human fibronectin and human serum albumin sequential
   adsorption on preosteoblastic cell adhesion
SO BIOINTERPHASES
LA English
DT Article
ID PLASMA FIBRONECTIN; POLYMER SURFACES; IN-VITRO; HYDROXYAPATITE;
   CONFORMATION; DIFFERENTIATION; PROTEINS; BIOMATERIALS; MODULATION;
   ACTIVATION
AB Fibronectin (Fn) is widely reported to promote cell adhesion and spreading, and recent reports attest to the synergistic effect of coadsorbed albumin (unexpected due to the passivating character of the latter protein). In this study, the sequential adsorption of fibronectin and albumin, and the morphology of cultured MC3T3-E1 preosteoblastic cells are investigated on three important biomaterial surfaces: silicon oxide, poly(styrene) (PS), and hydroxyapatite (HA). Using quartz crystal microgravimetry with dissipation analysis, the adsorbed protein composition and mechanics are determined. Interestingly, cell morphological changes correlate neither with the amount of Fn nor the rigidity of the protein layer. On the PS surface, Alb is seen to significantly diminish cell spreading, possibly due to Alb aggregation with a partially denatured initially placed Fn layer. HA appears to be a particularly favorable substrate for osteoblast adhesion, despite having low Fn adsorption and protein layer rigidity. (C) 2014 American Vacuum Society.
C1 [Hindie, Mathilde; Camand, Emeline; Agniel, Remy; Carreiras, Franck; Pauthe, Emmanuel] Univ Cergy Pontoise, ERRMECe, I MAT, F-95302 Cergy Pontoise, France.
   [Van Tassel, Paul] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.
RP Van Tassel, P (reprint author), Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.
EM emmanuel.pauthe@u-cergy.fr
RI Van Tassel, Paul/D-1087-2017
OI AGNIEL, Remy/0000-0002-2956-7532
CR Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Bonsignore LA, 2013, BONE, V52, P93, DOI 10.1016/j.bone.2012.09.011
   Chatzinikolaidou M, 2010, ACTA BIOMATER, V6, P4405, DOI 10.1016/j.actbio.2010.06.009
   Collier T O, 1997, Biomed Sci Instrum, V33, P178
   Dolatshahi-Pirouz A, 2009, LANGMUIR, V25, P2971, DOI 10.1021/la803142u
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Hindie M, 2011, ACTA BIOMATER, V7, P387, DOI 10.1016/j.actbio.2010.08.001
   Hovgaard MB, 2008, J PHYS CHEM B, V112, P8241, DOI 10.1021/jp801103n
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974
   Kim DH, 2011, MOL BIOL CELL, V22
   Kingshott P, 2011, CURR OPIN CHEM BIOL, V15, P667, DOI 10.1016/j.cbpa.2011.07.012
   Koenig AL, 2003, J BIOMED MATER RES A, V64A, P20, DOI 10.1002/jbm.a.10316
   Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009
   Lord MS, 2008, BIOMATERIALS, V29, P2581, DOI 10.1016/j.biomaterials.2008.03.002
   Molino PJ, 2012, LANGMUIR, V28, P8433, DOI 10.1021/la300692y
   Monkawa A, 2006, BIOMATERIALS, V27, P5748, DOI 10.1016/j.biomaterials.2006.07.029
   Moreau JL, 2009, J BIOMED MATER RES A, V91A, P605, DOI 10.1002/jbm.a.32248
   Patel S, 2004, BIOCHEMISTRY-US, V43, P1724, DOI 10.1021/bi0347104
   Patel S, 2006, INT J BIOCHEM CELL B, V38, P1547, DOI 10.1016/j.biocel.2006.03.005
   Pauthe E, 2002, BBA-PROTEIN STRUCT M, V1597, P12, DOI 10.1016/S0167-4838(02)00271-6
   Pelta J, 2000, BIOCHEMISTRY-US, V39, P5146, DOI 10.1021/bi992770x
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   Poulouin L, 1999, PROTEIN EXPRES PURIF, V17, P146, DOI 10.1006/prep.1999.1103
   Raffaini G, 2007, MACROMOL BIOSCI, V7, P552, DOI 10.1002/mabi.200600278
   Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252
   Renner L, 2005, LANGMUIR, V21, P4571, DOI 10.1021/la046801n
   Rondeau P, 2011, BIOCHIMIE, V93, P645, DOI 10.1016/j.biochi.2010.12.003
   Sechler JL, 1998, ANN NY ACAD SCI, V857, P143, DOI 10.1111/j.1749-6632.1998.tb10114.x
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   Tagaya M, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/3/034411
   Tagaya M, 2011, LANGMUIR, V27, P7645, DOI 10.1021/la200621p
   Ventre M, 2012, J R SOC INTERFACE, V9, P2017, DOI 10.1098/rsif.2012.0308
   Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893
   Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Weir MD, 2010, J BIOMED MATER RES A, V94A, P223, DOI 10.1002/jbm.a.32665
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zelzer M, 2012, PLASMA PROCESS POLYM, V9, P149, DOI 10.1002/ppap.201100054
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 45
TC 7
Z9 7
U1 0
U2 40
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2014
VL 9
IS 2
AR 029008
DI 10.1116/1.4867598
PG 9
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA AM4IM
UT WOS:000339817200008
PM 24985212
DA 2018-10-20
ER

PT J
AU Cunningham, A
   Faircloth, H
   Jones, M
   Johnson, C
   Coleman, T
   Wicks, G
   Postma, G
   Weinberger, P
AF Cunningham, Aaron
   Faircloth, Hunter
   Jones, Matthew
   Johnson, Christopher
   Coleman, Tiffany
   Wicks, George
   Postma, Gregory
   Weinberger, Paul
TI A Reporter Assay for the Next Generation of Biomaterials: Porous-Wall
   Hollow Glass Microspheres
SO LARYNGOSCOPE
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the American-Laryngological-Association
CY APR 10-11, 2013
CL Orlando, FL
SP Amer Laryngol Assoc
DE Porous-wall hollow glass microspheres; nanocrystals; assay; Nuance FX
   multispectral imaging system; biomaterial; regenerative medicine;
   laryngology; tracheal transplant; head and neck surgery
ID DRUG-DELIVERY; GROWTH-FACTOR; QUANTUM DOTS; STEM-CELLS; REGENERATION;
   REPAIR; AIRWAY; TRANSPLANTATION; MICROSCOPY; CHEMOKINES
AB Objectives/Hypothesis: The primary objective was to design a reporter assay to measure molecular release kinetics from a new porous-wall hollow glass microsphere biomaterial with great potential in regenerative medicine and drug delivery. Second, future avenues for research will be discussed specifically in regard to potential clinical uses in laryngology.
   Study Design: Basic science data report.
   Methods: We developed an assay using fluorescent nanocrystals or quantum dots (Qdot 605) as a reporter. A Nuance FX multispectral imaging system was used to detect fluorescence in aqueous phase. Spectral output of known concentrations of aqueous Qdot 605 was measured by the Nuance system to create a standard curve.
   Results: These data were plotted and fit to a curve. Qdot 605 emission demonstrates excellent correlation with concentration in a log-log relationship [R-2 = 0.99649, median error=9.9%], indicating that the Qdot 605 assay is reliable and should be explored regarding its ability to evaluate the drug-eluting properties of this material.
   Conclusions: We have derived a method to measure Qdot concentration using fluorescent microscopy, which will facilitate future research on this exciting new biomaterial. This material has great potential for use in head and neck surgery. Specific avenues within laryngology to be investigated include laryngeal and tracheal reconstruction, vocal fold healing, and nerve regeneration. Furthermore, we believe this is the first documented use of the Nuance system to determine aqueous molecular concentrations.
C1 [Cunningham, Aaron; Faircloth, Hunter; Jones, Matthew] Georgia Regents Univ, Med Coll Georgia, Augusta, GA 30912 USA.
   [Johnson, Christopher; Coleman, Tiffany; Postma, Gregory; Weinberger, Paul] Georgia Regents Univ, Dept Otolaryngol, Ctr Voice Airway & Swallowing, Augusta, GA 30912 USA.
   [Weinberger, Paul] Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.
   [Wicks, George] Savannah River Nucl Solut, Savannah River Natl Lab, Aiken, SC USA.
RP Weinberger, P (reprint author), Georgia Regents Univ, Dept Otolaryngol, Ctr Voice Airway & Swallowing, 1120 15th St BP4109, Augusta, GA 30912 USA.
EM pweinberger@gru.edu
RI Weinberger, Paul/B-7007-2008
OI Weinberger, Paul/0000-0002-5885-2631; Cunningham,
   Aaron/0000-0003-0395-1461
CR Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933
   Chhetri DK, 2011, LARYNGOSCOPE, V121, P785, DOI 10.1002/lary.21417
   Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009
   Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x
   Gomperts BN, 2006, J IMMUNOL, V176, P1916, DOI 10.4049/jimmunol.176.3.1916
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Jana T, 2013, EUR ARCH OTO-RHINO-L, V270, P181, DOI 10.1007/s00405-012-2105-5
   Jin ZW, 2012, TRENDS BIOTECHNOL, V30, P394, DOI 10.1016/j.tibtech.2012.04.005
   Jungebluth P, 2012, CLIN PHARMACOL THER, V91, P81, DOI 10.1038/clpt.2011.270
   Jungebluth P, 2012, BIOMATERIALS, V33, P4319, DOI 10.1016/j.biomaterials.2012.03.016
   Kishimoto Y, 2010, LARYNGOSCOPE, V120, P108, DOI 10.1002/lary.20642
   Krause Diane S, 2008, Proc Am Thorac Soc, V5, P323, DOI 10.1513/pats.200712-169DR
   Lee H, 2002, TRANSPLANTATION, V73, P1589, DOI 10.1097/00007890-200205270-00011
   Levenson RM, 2008, ILAR J, V49, P78, DOI 10.1093/ilar.49.1.78
   Levenson RM, 2006, CYTOM PART A, V69A, P748, DOI 10.1002/cyto.a.20319
   Li SY, 2010, NANOMED-NANOTECHNOL, V6, P127, DOI 10.1016/j.nano.2009.06.004
   Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054256
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298
   Ohno T, 2007, ANN OTO RHINOL LARYN, V116, P762, DOI 10.1177/000348940711601008
   PIRENNE J, 1994, NUCL MED BIOL, V21, P545, DOI 10.1016/0969-8051(94)90076-0
   REED MA, 1988, PHYS REV LETT, V60, P535, DOI 10.1103/PhysRevLett.60.535
   Robinson R, 2011, ACS NANO, V5, P4392, DOI 10.1021/nn103146p
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224
   Wicks GG, 2008, AM CERAM SOC BULL, V87, P23
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   Wood MD, 2013, REGEN MED, V8, P27, DOI [10.2217/RME.12.105, 10.2217/rme.12.105]
   Xu W, 2011, ANN OTO RHINOL LARYN, V120, P123, DOI 10.1177/000348941112000209
NR 29
TC 2
Z9 2
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0023-852X
EI 1531-4995
J9 LARYNGOSCOPE
JI Laryngoscope
PD JUN
PY 2014
VL 124
IS 6
BP 1392
EP 1397
DI 10.1002/lary.24414
PG 6
WC Medicine, Research & Experimental; Otorhinolaryngology
SC Research & Experimental Medicine; Otorhinolaryngology
GA AL9SF
UT WOS:000339480400031
PM 24122790
DA 2018-10-20
ER

PT J
AU Al-Nawas, B
   Schiegnitz, E
AF Al-Nawas, Bilal
   Schiegnitz, Elk
TI Augmentation procedures using bone substitute materials or autogenous
   bone - a systematic review and meta-analysis
SO EUROPEAN JOURNAL OF ORAL IMPLANTOLOGY
LA English
DT Review
DE bone augmentation procedures; bone substitute materials; dental
   implants; meta-analysis; oral implants; survival rate
ID SINUS FLOOR ELEVATION; RANDOMIZED CONTROLLED-TRIAL; VERTICAL RIDGE
   AUGMENTATION; ANORGANIC BOVINE BONE; CONTROLLED CLINICAL-TRIAL; DELAYED
   DENTAL IMPLANT; MAXILLARY SINUS; FOLLOW-UP; LONGER IMPLANTS;
   RETROSPECTIVE ANALYSIS
AB Aims: Bone substitute materials (BSM) are described as a reasonable alternative to autologous bone (AB) to simplify the grafting procedure. In a systematic review and meta-analysis, the influence of BSM compared to AB on treatment success in augmentation procedures of the edentulous jaw was analysed.
   Material and methods: Literature analysis resulted in only two studies addressing reconstruction of the totally edentulous jaw using BSM. Therefore the literature analysis was extended to partially and totally edentulous jaws. The following augmentation procedures were analysed: maxillary sinus floor augmentation (MSFA) and vertical and/or lateral alveolar ridge augmentation; guided bone regeneration (minor and contained defects) were excluded. Meta-analysis was implemented using the literature from the years 2000 to early 2014 and only studies with a mean follow-up of at least 10 months were included.
   Results: After screening 843 abstracts from the electronic database, 52 studies in qualitative and 14 in quantitative synthesis were included. In studies examining MSFA, the mean implant survival rate was 98.6% +/- 2.6 for BSM, 88.6 +/- 4.1% for BSM mixed with AB and 97.4 +/- 2.2% for AB alone. For MSFA, meta-analysis showed a trend towards a higher implant survival when using BSM compared to AB, however the difference was not statistically significant ([OR], 0.59; [CI], 0.33-1.03). No statistically significant difference in implant survival for MSFA between BSM mixed with AB and AB was seen ([OR], 0.84; [CI], 0.5-1.42). Concerning ridge augmentation, the mean implant survival rate was 97.4 +/- 2.5% for BSM, 100 +/- 0% for BSM mixed with AB and 98.6 +/- 2.9% for AB alone. Meta-analysis revealed no statistically significant difference in implant survival for ridge augmentation using BSM or AB ([OR], 1.85; [CI], 0.38 to 8.94). For BSM mixed with AB versus AB alone, a meta-analysis was not possible due to missing data.
   Conclusions: Within the limitation of the meta-analytical approach taken, implant survival seems to be independent of the biomaterial used in MSFA and alveolar ridge augmentation. Therefore, based on the current literature, there is no evidence that AB is superior to BSM. The conclusions are limited by the fact that influence of defect size, augmented volume and regenerative capacity of the defects is not well described in the respective literature.
C1 [Al-Nawas, Bilal; Schiegnitz, Elk] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Oral & Maxillofacial Surg Plast Surg, D-55131 Mainz, Germany.
RP Schiegnitz, E (reprint author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Oral & Maxillofacial Surg Plast Surg, Augustuspl 2, D-55131 Mainz, Germany.
EM eik.schiegnitz@unimedizin-mainz.de
RI Al-Nawas, Bilal/C-8885-2013
OI Al-Nawas, Bilal/0000-0002-8665-5803
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Aguirre Zorzano Luis Antonio, 2007, Med Oral Patol Oral Cir Bucal, V12, pE532
   Al-Nawas B, 2012, CLIN IMPLANT DENT R, V14, P896, DOI 10.1111/j.1708-8208.2010.00324.x
   Al-Nawas B, 2012, CLIN IMPLANT DENT R, V14, P127, DOI 10.1111/j.1708-8208.2009.00237.x
   Al-Nawas B, 2011, INT J ORAL MAX IMPL, V26, P1309
   Altman DG, 2001, BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224
   Bae JH, 2010, ORAL SURG ORAL MED O, V109, pE14, DOI 10.1016/j.tripleo.2009.10.047
   Barone A, 2011, J ORAL MAXIL SURG, V69, P2298, DOI 10.1016/j.joms.2011.01.014
   Becktor JP, 2004, INT J ORAL MAX IMPL, V19, P107
   Beitlitum I, 2010, CLIN ORAL IMPLAN RES, V21, P1242, DOI 10.1111/j.1600-0501.2010.01936.x
   Bornstein MM, 2008, CLIN ORAL IMPLAN RES, V19, P1034, DOI 10.1111/j.1600-0501.2008.01573.x
   Boronat A, 2010, INT J ORAL MAX IMPL, V25, P189
   Browaeys H, 2007, CLIN IMPLANT DENT R, V9, P166, DOI 10.1111/j.1708-8208.2007.00050
   Calori GM, 2011, INJURY, V42, pS56, DOI 10.1016/j.injury.2011.06.011
   Calvo-Guirado JL, 2010, MED ORAL PATOL ORAL, V15, pE366, DOI 10.4317/medoral.15.e366
   Cannizzaro G, 2013, EUR J ORAL IMPLANTOL, V6, P13
   Canullo L, 2012, CLIN IMPLANT DENT R, V14, P412, DOI 10.1111/j.1708-8208.2009.00261.x
   Canullo L, 2010, EUR J ORAL IMPLANTOL, V3, P59
   Caubet J, 2011, J ORAL MAXIL SURG, V69, P482, DOI 10.1016/j.joms.2010.10.037
   Cha HS, 2014, CLIN IMPLANT DENT R, V16, P337, DOI 10.1111/cid.12012
   Chen ST, 2009, INT J ORAL MAX IMPL, V24, P272
   Chiapasco M, 2012, CLIN ORAL IMPLAN RES, V23, P1012, DOI 10.1111/j.1600-0501.2011.02262.x
   Chiapasco M, 2009, INT J ORAL MAX IMPL, V24, P237
   Cho-Lee GY, 2010, INT J ORAL MAX IMPL, V25, P1019
   Cordaro L, 2010, INT J ORAL MAX SURG, V39, P350, DOI 10.1016/j.ijom.2010.02.016
   Cordaro L, 2011, CLIN ORAL IMPLAN RES, V22, P1145, DOI 10.1111/j.1600-0501.2010.02093.x
   Covani U, 2011, CLIN ORAL IMPLAN RES, V22, P481, DOI 10.1111/j.1600-0501.2010.02042.x
   Diserens V, 2005, CLIN IMPLANT DENT R, V7, P70, DOI 10.1111/j.1708-8208.2005.tb00049.x
   Dottore AM, 2012, CLIN IMPLANT DENT RE
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Esposito M, 2012, EUR J ORAL IMPLANTOL, V5, P19
   Esposito M, 2011, EUR J ORAL IMPLANTOL, V4, P301
   Esposito M, 2010, EUR J ORAL IMPLANTOL, V3, P297
   Esposito M, 2009, EUR J ORAL IMPLANTOL, V2, P167
   Felice P, 2013, EUR J ORAL IMPLANTOL, V6, P153
   Felice P, 2012, EUR J ORAL IMPLANTOL, V5, P149
   Felice P, 2009, CLIN ORAL IMPLAN RES, V20, P1386, DOI 10.1111/j.1600-0501.2009.01765.x
   Ferreira CEA, 2009, J PERIODONTOL, V80, P1920, DOI 10.1902/jop.2009.090263
   Fontana F, 2008, INT J ORAL MAX IMPL, V23, P1003
   Garlini G, 2010, J ORAL MAXIL SURG, V68, P1152, DOI 10.1016/j.joms.2009.05.440
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hallman M, 2008, PERIODONTOL 2000, V47, P172, DOI 10.1111/j.1600-0757.2008.00251.x
   Handschel Jorg, 2009, Head Face Med, V5, P12, DOI 10.1186/1746-160X-5-12
   Hansen EJ, 2011, EUR J ORAL IMPLANTOL, V4, P257
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   Iturriaga MTM, 2004, J ORAL MAXIL SURG, V62, P344, DOI 10.1016/j.joms.2003.08.013
   Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218
   Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P263, DOI 10.1111/j.1600-0501.2011.02168.x
   Kammerer PW, 2013, CLIN ORAL IMPLANTS R
   Kaptein MLA, 1998, J ORAL MAXIL SURG, V56, P1376, DOI 10.1016/S0278-2391(98)90396-2
   Karabuda C, 2006, J PERIODONTOL, V77, P1991, DOI 10.1092/jop.2006.060102
   Kim YK, 2011, ORAL SURG ORAL MED O, V111, P164, DOI 10.1016/j.tripleo.2010.04.011
   Klein MO, 2011, EUR J ORAL IMPLANTOL, V4, P11
   Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002
   Lambert F, 2010, INT J ORAL MAX IMPL, V25, P598
   Le B, 2010, J ORAL MAXIL SURG, V68, P428, DOI 10.1016/j.joms.2009.04.059
   Lee DZ, 2012, CLIN ORAL IMPLAN RES, V23, P918, DOI 10.1111/j.1600-0501.2011.02239.x
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Lindgren C, 2012, INT J ORAL MAX IMPL, V27, P1151
   Lopez-Cedrun JL, 2011, INT J ORAL MAXILLOFA, V26, P195
   Lopez-Cedrun JL, 2011, INT J ORAL MAX IMPL, V26, P195
   Meijndert L, 2008, CLIN ORAL IMPLAN RES, V19, P1295, DOI 10.1111/j.1600-0501.2008.01523.x
   Meijndert L, 2007, CLIN ORAL IMPLAN RES, V18, P715, DOI 10.1111/j.1600-0501.2007.01415.x
   Merli M, 2013, EUR J ORAL IMPLANTOL, V6, P27
   Merli M, 2010, INT J ORAL MAX IMPL, V25, P801
   Miller SA, 2001, J EVID-BASED DENT PR, V1, P136, DOI DOI 10.1016/S1532-3382(01)70024-3
   Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
   Molly L, 2006, CLIN ORAL IMPLAN RES, V17, P481, DOI 10.1111/j.1600-0501.2006.01286.x
   Nissan J, 2011, CLIN IMPLANT DENT R, V13, P104, DOI 10.1111/j.1708-8208.2009.00193.x
   Nissan J, 2011, CLIN IMPLANT DENT R, V13, P279, DOI 10.1111/j.1708-8208.2009.00219.x
   Nkenke E, 2004, INT J ORAL MAX SURG, V33, P157, DOI 10.1054/ijom.2003.0465
   Nkenke E, 2009, CLIN ORAL IMPLAN RES, V20, P124, DOI 10.1111/j.1600-0501.2009.01776.x
   Peleg M, 2004, J ORAL MAXIL SURG, V62, P1535, DOI 10.1016/j.joms.2004.06.048
   Pelo S, 2010, INT J ORAL MAX SURG, V39, P227, DOI 10.1016/j.ijom.2009.11.004
   Pieri F, 2012, CLIN IMPLANT DENT R, V14, pe67, DOI 10.1111/j.1708-8208.2011.00360.x
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   Proskin HM, 2007, INT J ORAL MAX IMPL, V22, P11
   Rickert D, 2012, INT J ORAL MAX SURG, V41, P160, DOI 10.1016/j.ijom.2011.10.001
   Sakka S, 2011, J CRANIO MAXILL SURG, V39, P187, DOI 10.1016/j.jcms.2010.04.007
   Sbordone C, 2014, CLIN ORAL IMPLAN RES, V25, P1056, DOI 10.1111/clr.12222
   Sbordone L, 2011, CLIN ORAL IMPLAN RES, V22, P485, DOI 10.1111/j.1600-0501.2010.02030.x
   Scarano A, 2010, J ORAL MAXIL SURG, V68, P1869, DOI 10.1016/j.joms.2009.09.015
   Schiegnitz E, 2014, CLIN ORAL INVEST, V18, P687, DOI 10.1007/s00784-013-1134-9
   Schmitt C, 2014, CLIN ORAL IMPLAN RES, V25, pE38, DOI 10.1111/clr.12045
   Si MS, 2013, J CLIN PERIODONTOL, V40, P396, DOI 10.1111/jcpe.12066
   Simion M, 2001, CLIN ORAL IMPLAN RES, V12, P35, DOI 10.1034/j.1600-0501.2001.012001035.x
   Sivolella S, 2011, QUINTESSENCE INT, V42, P851
   Tetsch J, 2010, CLIN ORAL IMPLAN RES, V21, P497, DOI 10.1111/j.1600-0501.2008.01661.x
   Uckan S, 2010, J ORAL MAXIL SURG, V68, P1642, DOI 10.1016/j.joms.2009.08.028
   Urban I, 2010, INT J ORAL MAXILLOF, V25, P1023
   Urban IA, 2011, INT J ORAL MAX IMPL, V26, P404
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   van Steenberghe D, 1997, CLIN ORAL INVEST, V1, P102
   Velich N, 2004, J CRANIOFAC SURG, V15, P38, DOI 10.1097/00001665-200401000-00013
   Viscioni A, 2011, CELL TISSUE BANK, V12, P263, DOI 10.1007/s10561-010-9192-6
   Wagner W, 2012, CLIN ORAL IMPLAN RES, V23, P1112, DOI 10.1111/j.1600-0501.2011.02275.x
NR 98
TC 60
Z9 61
U1 1
U2 23
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 1756-2406
EI 1756-2414
J9 EUR J ORAL IMPLANTOL
JI Eur. J. Oral Implant.
PD SUM
PY 2014
VL 7
SU 2
BP S219
EP S234
PG 16
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AM1XK
UT WOS:000339642400010
PM 24977257
DA 2018-10-20
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Raaen, S
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Raaen, Steinar
TI Cr/Fe RATIO BY XPS SPECTRA OF MAGNETOELECTROPOLISHED AISI 316L SS FITTED
   BY GAUSSIAN-LORENTZIAN SHAPE LINES
SO TEHNICKI VJESNIK-TECHNICAL GAZETTE
LA English
DT Article
DE Cr/Fe ratio; magnetoelectropolishing MEP; 316L stainless steel; XPS
   spectra fitting
ID STAINLESS-STEEL; MAGNETIC-FIELD; SURFACE; IRON; FE
AB In the paper, the analyses of Fe2p(3/2) and chromium Cr2p(3/2) XPS spectra with fitting by symmetrical and asymmetrical line shapes, are presented. The calculations are performed on AISI 316L SS biomaterial after magnetoelectropolishing MEP operation. The best results were obtained for fitting by GL(30) and by LA(1,3; 4; 5) plus GL(40) line shapes. It was found, the chromium-to-iron ratio after magnetoelectropolishing MEP was increasing in the range from 16,4 to 22,4 times versus that one of bulk material.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz] Koszalin Univ Technol, Fac Mech Engn, PL-75620 Koszalin, Poland.
   [Raaen, Steinar] NTNU, Dept Phys, NO-7491 Trondheim, Norway.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Fac Mech Engn, Raclawicka 15-17, PL-75620 Koszalin, Poland.
EM rokosz@tu.koszalin.pl; Tadeusz.Hryniewicz@tu.koszalin.pl; sraaen@ntnu.no
CR [Anonymous], 2010, CASXPS MAN 2315 REV, P19
   Biesinger MC, 2011, APPL SURF SCI, V257, P2717, DOI 10.1016/j.apsusc.2010.10.051
   Crist B.V., 2000, HDB MONOCHROMATIC XP
   Descostes M, 2000, APPL SURF SCI, V165, P288, DOI 10.1016/S0169-4332(00)00443-8
   Fantauzzi M, 2010, ANAL BIOANAL CHEM, V396, P2889, DOI 10.1007/s00216-010-3576-0
   Grosvenor AP, 2004, SURF INTERFACE ANAL, V36, P1564, DOI 10.1002/sia.1984
   Hryniewicz T, 2008, CORROS SCI, V50, P2676, DOI 10.1016/j.corsci.2008.06.048
   Hryniewicz T, 2008, CORROSION, V64, P660, DOI 10.5006/1.3279927
   Hryniewicz T, 2008, SURF COAT TECH, V202, P1668, DOI 10.1016/j.surfcoat.2007.07.067
   Hryniewicz T, 2007, T I MET FINISH, V85, P325, DOI 10.1179/174591907X246537
   Hryniewicz T, 2010, MATER CHEM PHYS, V123, P47, DOI 10.1016/j.matchemphys.2010.03.060
   Hryniewicz T, 2010, SURF COAT TECH, V204, P2583, DOI 10.1016/j.surfcoat.2010.02.005
   Hryniewicz T, 2010, MATER CHEM PHYS, V122, P169, DOI 10.1016/j.matchemphys.2010.02.055
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Rokicki R., US Patent, Patent No. 7632390
   Rokosz K., 2012, POLEROWANIE ELEKTROC, V219
   Rokosz K, 2012, STEEL RES INT, V83, P910, DOI 10.1002/srin.201200046
   Tauson V. L., 2010, GEOCHEM INT, V48, P565
   Walton J., 2009, CASA COOKBOOK CASA 1
NR 19
TC 18
Z9 18
U1 3
U2 14
PU UNIV OSIJEK, TECH FAC
PI SLAVONSKI BROD
PA TRG IVANE BRLIC-MAZURANIC 2, SLAVONSKI BROD, HR-35000, CROATIA
SN 1330-3651
EI 1848-6339
J9 TEH VJESN
JI Teh. Vjesn.
PD JUN
PY 2014
VL 21
IS 3
BP 533
EP 538
PG 6
WC Engineering, Multidisciplinary
SC Engineering
GA AK9UU
UT WOS:000338774200011
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Keane, TJ
   Badylak, SF
AF Keane, Timothy J.
   Badylak, Stephen F.
TI Biomaterials for tissue engineering applications
SO SEMINARS IN PEDIATRIC SURGERY
LA English
DT Article
DE Tissue engineering; Biomaterials; Bioactive molecules
ID SMALL-INTESTINAL SUBMUCOSA; POLY(ETHYLENE GLYCOL) HYDROGELS;
   EXTRACELLULAR-MATRIX SCAFFOLDS; MUSCLE-CELL-ADHESION; GROWTH-FACTOR;
   REGENERATIVE MEDICINE; STEM-CELLS; OSTEOGENIC DIFFERENTIATION;
   FLUOROGENIC SUBSTRATE; NERVE REGENERATION
AB With advancements in biological and engineering sciences, the definition of an ideal biomaterial has evolved over the past 50 years from a substance that is inert to one that has select bioinductive properties and integrates well with adjacent host tissue. Biomaterials are a fundamental component of tissue engineering, which aims to replace diseased, damaged, or missing tissue with reconstructed functional tissue. Most biomaterials are less than satisfactory for pediatric patients because the scaffold must adapt to the growth and development of the surrounding tissues and organs over time. The pediatric community, therefore, provides a distinct challenge for the tissue engineering community. (C) 2014 Published by Elsevier Inc.
C1 [Keane, Timothy J.; Badylak, Stephen F.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Keane, Timothy J.; Badylak, Stephen F.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, Bridgeside Point 2,450 Technol Dr, Pittsburgh, PA 15219 USA.
EM badylaksf@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689; Keane, Timothy/0000-0002-7975-0538
CR Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106
   Aimetti AA, 2009, BIOMACROMOLECULES, V10, P1484, DOI 10.1021/bm9000926
   Ambrosio F, 2010, PHYS THER, V90, P1807, DOI 10.2522/ptj.20100030
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arul GS, 2008, ANN ROY COLL SURG, V90, P7, DOI 10.1308/003588408X242222
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 2011, TISSUE ENG PT A, V17, P1643, DOI 10.1089/ten.tea.2010.0739
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Barradas AMC, 2012, ACTA BIOMATER, V8, P2969, DOI 10.1016/j.actbio.2012.04.021
   Beningo KA, 2002, J CELL SCI, V115, P849
   Boruch AV, 2010, J SURG RES, V161, P217, DOI 10.1016/j.jss.2009.02.014
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Cass DL, 1997, PEDIATR SURG INT, V12, P484, DOI 10.1007/BF01258707
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Champion JA, 2007, P NATL ACAD SCI USA, V104, P11901, DOI 10.1073/pnas.0705326104
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cohen M, 2004, CHEMBIOCHEM, V5, P1393, DOI 10.1002/cbic.200400162
   Collie AMB, 2011, J BIOMED MATER RES A, V96A, P162, DOI 10.1002/jbm.a.32963
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136
   Dalby MJ, 2007, J CELL BIOCHEM, V100, P326, DOI 10.1002/jcb.21058
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Euliss LE, 2006, CHEM SOC REV, V35, P1095, DOI 10.1039/b600913c
   Fats JE, 2004, BREAST CANCER RES, V6, P1
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Franz S, 2012, ACTA BIOMATER
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   French KM, 2012, ACTA BIOMATER
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Gallo G, 2012, EUR J PEDIATR SURG, V22, P420, DOI 10.1055/s-0032-1331459
   Gaubert HE, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/13/135101
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   Gilbert TW, 2008, ANN THORAC SURG, V86, P967, DOI 10.1016/j.athoracsur.2008.04.071
   Giovanelli M, 2009, TRANSPLANTATION, V87, P1695, DOI 10.1097/TP.0b013e3181a5e9f8
   Gobin AS, 2003, BIOTECHNOL PROGR, V19, P1781, DOI 10.1021/bp0341390
   Gobin AS, 2003, J BIOMED MATER RES A, V67A, P255, DOI 10.1002/jbm.a.10110
   Gravante G, 2007, J BURN CARE RES, V28, P269, DOI 10.1097/BCR.0B013E318031A236
   Harada KM, 2009, TRANSPL P, V41, P3667, DOI 10.1016/j.transproceed.2009.04.013
   He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Herten M, 2009, CLIN ORAL IMPLAN RES, V20, P116, DOI 10.1111/j.1600-0501.2008.01622.x
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hohlfeld J, 2005, LANCET, V366, P840, DOI 10.1016/S0140-6736(05)67107-3
   Hoppo T, 2012, WORLD J SURG
   Humphries MJ, 1998, TRENDS CELL BIOL, V8, P78, DOI 10.1016/S0962-8924(98)80016-0
   HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X
   Hynd MR, 2007, J NEUROSCI METH, V162, P255, DOI 10.1016/j.jneumeth.2007.01.024
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   Lee SH, 2005, BIOTECHNOL PROGR, V21, P1736, DOI 10.1021/bp0502429
   Lee SH, 2007, BIOMATERIALS, V28, P3163, DOI 10.1016/j.biomaterials.2007.03.004
   Lin P, 2004, TISSUE ENG, V10, P1046, DOI 10.1089/ten.2004.10.1046
   Liu SQ, 2009, BIOMATERIALS, V30, P1453, DOI 10.1016/j.biomaterials.2008.11.023
   Liu T.V., 2007, FASEB J, V21, P790
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Magee JC, 2008, AM J TRANSPLANT, V8, P935, DOI 10.1111/j.1600-6143.2008.02172.x
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Midha R, 2003, J NEUROSURG, V99, P555, DOI 10.3171/jns.2003.99.3.0555
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Moreau JL, 2007, J ORAL MAXIL SURG, V65, P2503, DOI 10.1016/j.joms.2007.06.648
   Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315
   Nieponice A, 2012, J SURG RES
   Nieponice A, 2009, GASTROINTEST ENDOSC, V69, P289, DOI 10.1016/j.gie.2008.04.022
   Nieponice A, 2006, ANN THORAC SURG, V82, P2050, DOI 10.1016/j.athoracsur.2006.06.036
   Oosterlee A Rahmel A, 2008, EUROTRANSPLANT INT F
   Paganelli C, 2006, J ORAL REHABIL, V33, P625, DOI 10.1111/j.1365-2842.2005.01594.x
   Patel M, 2008, PEDIATR RES, V63, P497, DOI 10.1203/01.PDR.0b013e318165eb3e
   Patel PN, 2005, TISSUE ENG, V11, P1498, DOI 10.1089/ten.2005.11.1498
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Raeber GP, 2007, ACTA BIOMATER, V3, P615, DOI 10.1016/j.actbio.2007.03.013
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Reding R, 2005, ACTA GASTRO-ENT BELG, V68, P453
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Remlinger NT, 2010, BIOMATERIALS, V31, P3520, DOI 10.1016/j.biomaterials.2010.01.067
   ROBINSON KA, 2005, CIRCULATION, V112, P1135
   Roessingh ASDB, 2006, CELL TRANSPLANT, V15, P823
   Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c
   Romano NH, 2011, BBA-GEN SUBJECTS, V1810, P339, DOI 10.1016/j.bbagen.2010.07.005
   Ruoslahti E, 2003, MATRIX BIOL, V22, P459, DOI 10.1016/S0945-053X(03)00083-0
   Saha K, 2007, J BIOMED MATER RES A, V81A, P240, DOI 10.1002/jbm.a.30986
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Saxena AK, 2010, PEDIATR SURG INT, V26, P557, DOI 10.1007/s00383-010-2591-8
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   SCOTT JE, 1995, J ANAT, V187, P259
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073
   Tiao Gregory M, 2006, Semin Pediatr Surg, V15, P218, DOI 10.1053/j.sempedsurg.2006.03.008
   Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009
   Tottey S, 2011, TISSUE ENG PT A, V17, P37, DOI [10.1089/ten.tea.2010.0188, 10.1089/ten.TEA.2010.0188]
   U.S. Department of Health and Human Services HRaSA Healthcare Systems Bureau Division of Transplantation, 2008, 2008 ANN REP US ORG
   Underwood RA, 2011, J BIOMED MATER RES A, V98A, P499, DOI 10.1002/jbm.a.33125
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Valentin JE, 2010, BIOMATERIALS, V31, P7475, DOI 10.1016/j.biomaterials.2010.06.039
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   van den Dries K, 2012, CELL MOL LIFE SCI, V69, P1889, DOI 10.1007/s00018-011-0908-y
   Velardi F, 2006, CHILD NERV SYST, V22, P1158, DOI 10.1007/s00381-006-0100-0
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wainwright JM, 2012, CELLS TISSUES ORGANS, V195, P159, DOI 10.1159/000331400
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   Weber LM, 2008, MATRIX BIOL, V27, P667, DOI 10.1016/j.matbio.2008.08.001
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zhu JM, 2009, BIOCONJUGATE CHEM, V20, P333, DOI 10.1021/bc800441v
NR 133
TC 29
Z9 31
U1 5
U2 67
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1055-8586
EI 1532-9453
J9 SEMIN PEDIATR SURG
JI Semin. Pediatr. Surg.
PD JUN
PY 2014
VL 23
IS 3
BP 112
EP 118
DI 10.1053/j.sempedsurg.2014.06.010
PG 7
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA AL1SL
UT WOS:000338906300003
PM 24994524
DA 2018-10-20
ER

PT J
AU Wong, FSY
   Chan, BP
   Lo, ACY
AF Wong, Francisca S. Y.
   Chan, Barbara P.
   Lo, Amy C. Y.
TI Carriers in Cell-Based Therapies for Neurological Disorders
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE age-related neurodegeneration; drug delivery and drug-likeness;
   blood-brain barrier; biomaterials; cell encapsulation; microcarriers;
   central nervous system injury; peripheral nervous system
ID PERIPHERAL-NERVE REGENERATION; NEURAL STEM-CELLS; CILIARY NEUROTROPHIC
   FACTOR; PIGMENT EPITHELIAL-CELLS; MARROW STROMAL CELLS; NEUROPROTECTIVE
   GENE-THERAPY; ADRENAL CHROMAFFIN CELLS; BASAL FOREBRAIN NEURONS;
   TRAUMATIC BRAIN-INJURY; SCHWANN-CELLS
AB There is a pressing need for long-term neuroprotective and neuroregenerative therapies to promote full function recovery of injuries in the human nervous system resulting from trauma, stroke or degenerative diseases. Although cell-based therapies are promising in supporting repair and regeneration, direct introduction to the injury site is plagued by problems such as low transplanted cell survival rate, limited graft integration, immunorejection, and tumor formation. Neural tissue engineering offers an integrative and multifaceted approach to tackle these complex neurological disorders. Synergistic therapeutic effects can be obtained from combining customized biomaterial scaffolds with cell-based therapies. Current scaffold-facilitated cell transplantation strategies aim to achieve structural and functional rescue via offering a three-dimensional permissive and instructive environment for sustainable neuroactive factor production for prolonged periods and/or cell replacement at the target site. In this review, we intend to highlight important considerations in biomaterial selection and to review major biodegradable or non-biodegradable scaffolds used for cell transplantation to the central and peripheral nervous system in preclinical and clinical trials. Expanded knowledge in biomaterial properties and their prolonged interaction with transplanted and host cells have greatly expanded the possibilities for designing suitable carrier systems and the potential of cell therapies in the nervous system.
C1 [Wong, Francisca S. Y.; Lo, Amy C. Y.] Univ Hong Kong, Dept Ophthalmol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Barbara P.] Univ Hong Kong, Fac Engn, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China.
   [Lo, Amy C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China.
RP Lo, ACY (reprint author), Univ Hong Kong, Dept Ophthalmol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.
EM frannwong@gmail.com; bpchan@hku.hk; amylo@hku.hk
CR Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696
   AEBISCHER P, 1991, BRAIN RES, V560, P43, DOI 10.1016/0006-8993(91)91212-J
   Ao QA, 2011, BIOMATERIALS, V32, P787, DOI 10.1016/j.biomaterials.2010.09.046
   Bachoud-Levi AC, 2000, HUM GENE THER, V11, P1723, DOI 10.1089/10430340050111377
   Ballios BG, 2011, PRINCIPLES OF REGENERATIVE MEDICINE, 2ND EDITION, P1023, DOI 10.1016/B978-0-12-381422-7.10055-0
   Beigi MH, 2014, J BIOMED MATER RES A, V102, P4554, DOI 10.1002/jbm.a.35119
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Bible E, 2012, BIOMATERIALS, V33, P7435, DOI 10.1016/j.biomaterials.2012.06.085
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Binder C, 2013, J BIOMED MATER RES B, V101, P1200, DOI 10.1002/jbm.b.32931
   Bloch J, 2004, HUM GENE THER, V15, P968, DOI 10.1089/hum.2004.15.968
   Borlongan CV, 2007, CELL TRANSPLANT, V16, P987, DOI 10.3727/000000007783472426
   Borlongan CV, 1998, EXP NEUROL, V151, P203, DOI 10.1006/exnr.1998.6790
   Borlongan CV, 2004, STROKE, V35, P2206, DOI 10.1161/01.STR.0000138954.25825.0b
   Borlongan CV, 2004, NEUROREPORT, V15, P1543, DOI 10.1097/01.wnr.0000133298.84901.cf
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   Bryan DJ, 2000, TISSUE ENG, V6, P129, DOI 10.1089/107632700320757
   Buchser E, 1996, ANESTHESIOLOGY, V85, P1005, DOI 10.1097/00000542-199611000-00007
   Cai L, 2012, LANGMUIR, V28, P12557, DOI 10.1021/la302868q
   Cai L, 2012, BIOMACROMOLECULES, V13, P342, DOI 10.1021/bm201763n
   Chen CJ, 2007, EXP NEUROL, V204, P443, DOI 10.1016/j.expneurol.2006.12.004
   Cheng B, 2002, MICROSURG, V22, P133, DOI 10.1002/micr.21740
   Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043
   Cherksey BD, 1996, NEUROSCIENCE, V75, P657, DOI 10.1016/0306-4522(96)00262-X
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Chuang TH, 2013, TISSUE ENG PART C-ME, V19, P427, DOI [10.1089/ten.tec.2012.0021, 10.1089/ten.TEC.2012.0021]
   Chung TW, 2011, BIOMATERIALS, V32, P734, DOI 10.1016/j.biomaterials.2010.09.023
   Clarke JC, 2011, HEARING RES, V278, P96, DOI 10.1016/j.heares.2011.05.004
   Clements I.P., 2013, BIOMATERIALS SCI, P1291
   de Vos P, 2014, ADV DRUG DELIVER REV, V67-68, P15, DOI 10.1016/j.addr.2013.11.005
   Deglon N, 1996, HUM GENE THER, V7, P2135, DOI 10.1089/hum.1996.7.17-2135
   Del Priore LV, 2004, INVEST OPHTH VIS SCI, V45, P985, DOI 10.1167/iovs.03-0662
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   Doudet DJ, 2004, EXP NEUROL, V189, P361, DOI 10.1016/j.expneurol.2004.06.009
   Dunnett SB, 2014, NEUROBIOL DIS, V61, P79, DOI 10.1016/j.nbd.2013.05.004
   EMERICH DF, 1994, EXP NEUROL, V130, P141, DOI 10.1006/exnr.1994.1193
   EMERICH DF, 1994, J COMP NEUROL, V349, P148, DOI 10.1002/cne.903490110
   Emerich DF, 1997, NATURE, V386, P395, DOI 10.1038/386395a0
   Emerich DF, 1996, J NEUROSCI, V16, P5168
   Emerich DF, 1996, CELL TRANSPLANT, V5, P589, DOI 10.1016/0963-6897(96)00086-3
   Emerich DF, 2006, NEUROBIOL DIS, V23, P471, DOI 10.1016/j.nbd.2006.01.014
   Emerich DF, 2014, ADV DRUG DELIVER REV, V67-68, P131, DOI 10.1016/j.addr.2013.07.008
   Emerich DF, 2009, NEUROTOX RES, V15, P205, DOI 10.1007/s12640-009-9021-5
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Farag ES, 2009, NEUROLOGY, V73, P1095, DOI 10.1212/WNL.0b013e3181bbff1c
   Flores J, 2007, J NEUROPATH EXP NEUR, V66, P585, DOI 10.1097/nen.0b013e318093e53a
   Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005
   Garbayo E, 2011, J NEUROCHEM, V119, P972, DOI 10.1111/j.1471-4159.2011.07272.x
   Garcia P, 2010, J NEUROSCI, V30, P7516, DOI 10.1523/JNEUROSCI.4182-09.2010
   Georgiou M, 2013, BIOMATERIALS, V34, P7335, DOI 10.1016/j.biomaterials.2013.06.025
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Griffin J, 2011, J BIOMED MATER RES A, V97A, P230, DOI 10.1002/jbm.a.33049
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Guo BF, 2009, OTOLARYNG HEAD NECK, V140, P159, DOI 10.1016/j.otohns.2008.10.039
   Guo BL, 2012, ACTA BIOMATER, V8, P144, DOI 10.1016/j.actbio.2011.09.027
   Haastert K, 2006, NEUROBIOL DIS, V21, P138, DOI 10.1016/j.nbd.2005.06.020
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   HOFFMAN D, 1993, EXP NEUROL, V122, P100, DOI 10.1006/exnr.1993.1111
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Hsu SH, 2009, ARTIF ORGANS, V33, P26, DOI 10.1111/j.1525-1594.2008.00671.x
   Hsu SH, 2013, ACTA BIOMATER, V9, P6606, DOI 10.1016/j.actbio.2013.01.025
   Hu N, 2013, BIOMATERIALS, V34, P100, DOI 10.1016/j.biomaterials.2012.09.020
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Huang YC, 2011, J BIOMED MATER RES A, V99A, P86, DOI 10.1002/jbm.a.33164
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Hynes SR, 2010, GRAEF ARCH CLIN EXP, V248, P763, DOI 10.1007/s00417-009-1263-7
   Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Jurga M, 2011, BIOMATERIALS, V32, P3423, DOI 10.1016/j.biomaterials.2011.01.049
   Kalbermatten DF, 2008, J PLAST RECONSTR AES, V61, P669, DOI 10.1016/j.bjps.2007.12.015
   Kanter-Schlifle I, 2009, EXP NEUROL, V216, P413, DOI 10.1016/j.expneurol.2008.12.021
   Karumbaiah L, 2012, BIOMATERIALS, V33, P5983, DOI 10.1016/j.biomaterials.2012.05.021
   Katsuragi S, 2005, AM J OBSTET GYNECOL, V192, P1137, DOI 10.1016/j.ajog.2004.10.619
   Kauper K, 2012, INVEST OPHTH VIS SCI, V53, P7484, DOI 10.1167/iovs.12-9970
   Keilhoff G, 2003, BIOMATERIALS, V24, P2779, DOI 10.1016/S0142-9612(03)00084-X
   Kijenska E, 2012, J BIOMED MATER RES B, V100B, P1093, DOI 10.1002/jbm.b.32676
   Kishima H, 2004, NEUROBIOL DIS, V16, P428, DOI 10.1016/j.nbd.2004.03.012
   Komiyama T, 2004, J NEUROSCI METH, V134, P133, DOI 10.1016/j.jneumeth.2003.11.020
   KORDOWER JH, 1994, P NATL ACAD SCI USA, V91, P10898, DOI 10.1073/pnas.91.23.10898
   Krick K, 2011, CURR OPIN BIOTECH, V22, P741, DOI 10.1016/j.copbio.2011.04.002
   Kuo YC, 2011, COLLOID SURFACE B, V82, P624, DOI 10.1016/j.colsurfb.2010.10.032
   Kuramoto S, 2011, BRAIN RES, V1368, P281, DOI 10.1016/j.brainres.2010.10.054
   Lai BQ, 2013, BIOMATERIALS, V34, P2888, DOI 10.1016/j.biomaterials.2012.12.046
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   Levenberg S, 2005, TISSUE ENG, V11, P506, DOI 10.1089/ten.2005.11.506
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Levesque SG, 2006, BIOMATERIALS, V27, P5277, DOI 10.1016/j.biomaterials.2006.06.004
   Lewitus DY, 2011, ADV FUNCT MATER, V21, P2624, DOI 10.1002/adfm.201002429
   Li QF, 2006, MICROSURG, V26, P116, DOI 10.1002/micr.20192
   Lietz M, 2006, BIOTECHNOL BIOENG, V93, P99, DOI 10.1002/bit.20688
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Low WC, 2013, BIOMATERIALS, V34, P3581, DOI 10.1016/j.biomaterials.2013.01.093
   Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.000028004/.85651.4F
   Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016
   MACKINNON SE, 1984, ANN PLAS SURG, V13, P112, DOI 10.1097/00000637-198408000-00004
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934
   Masaeli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057157
   McCreedy DA, 2012, NEUROSCI LETT, V519, P115, DOI 10.1016/j.neulet.2012.02.025
   McGrath AM, 2012, NEUROSCI LETT, V516, P171, DOI 10.1016/j.neulet.2012.03.041
   Mikos A.G., 2013, BIOMATERIALS SCI, P1138
   Modi G, 2009, PROG NEUROBIOL, V88, P272, DOI 10.1016/j.pneurobio.2009.05.002
   Mooney R, 2011, TISSUE ENG PT A, V17, P2805, DOI 10.1089/ten.tea.2010.0654
   Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684
   Mosahebi A, 2001, GLIA, V34, P8, DOI 10.1002/glia.1035
   Murakami T, 2003, BRAIN RES, V974, P17, DOI 10.1016/S0006-8993(03)02539-3
   Nafea EH, 2011, J CONTROL RELEASE, V154, P110, DOI 10.1016/j.jconrel.2011.04.022
   Namba RM, 2009, ACTA BIOMATER, V5, P1884, DOI 10.1016/j.actbio.2009.01.036
   Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]
   Nilsson A, 2005, SCAND J PLAST RECONS, V39, P1, DOI 10.1080/02844310410017979
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Park JW, 2014, BIOCHEM BIOPH RES CO, V447, P400, DOI 10.1016/j.bbrc.2014.03.145
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Pettingill LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018733
   Phillips JB, 2005, TISSUE ENG, V11, P1611, DOI 10.1089/ten.2005.11.1611
   Popovic N, 2006, INT J PHARM, V314, P120, DOI 10.1016/j.ijpharm.2005.09.040
   Read TA, 2001, NAT BIOTECHNOL, V19, P29, DOI 10.1038/83471
   Rejali D, 2007, HEARING RES, V228, P180, DOI 10.1016/j.heares.2007.02.010
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   Rutkowski GE, 2004, J NEURAL ENG, V1, P151, DOI 10.1088/1741-2560/1/3/004
   SAGEN J, 1993, J NEUROSCI, V13, P2415
   SAGOT Y, 1995, EUR J NEUROSCI, V7, P1313, DOI 10.1111/j.1460-9568.1995.tb01122.x
   Sagot Y, 1996, J NEUROSCI, V16, P2335
   Sajadi A, 2006, NEUROBIOL DIS, V22, P119, DOI 10.1016/j.nbd.2005.10.006
   Saporta S, 1997, CELL TRANSPLANT, V6, P579, DOI 10.1016/S0963-6897(97)00115-2
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shi Y, 2009, ACTA OTO-LARYNGOL, V129, P906, DOI 10.1080/00016480802468153
   Shingo T, 2002, J NEUROSCI RES, V69, P946, DOI 10.1002/jnr.10375
   Shoffstall AJ, 2012, NEUROSCI LETT, V519, P147, DOI 10.1016/j.neulet.2012.01.058
   Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103
   Sirivisoot S, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0050
   Stang F, 2005, BIOMATERIALS, V26, P3083, DOI 10.1016/j.biomaterials.2004.07.060
   Stover NP, 2008, NEUROTHERAPEUTICS, V5, P252, DOI 10.1016/j.nurt.2008.02.006
   Stover NP, 2005, ARCH NEUROL-CHICAGO, V62, P1833, DOI 10.1001/archneur.62.12.1833
   Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479
   Tan SA, 1996, CELL TRANSPLANT, V5, P577, DOI 10.1016/0963-6897(96)00081-4
   Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292
   Tatard VM, 2004, CELL TRANSPLANT, V13, P573, DOI 10.3727/000000004783983675
   Tatard VM, 2007, BIOMATERIALS, V28, P1978, DOI 10.1016/j.biomaterials.2006.12.021
   Tatard VM, 2005, CURR DRUG TARGETS, V6, P81, DOI 10.2174/1389450053344885
   Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154
   Tate MC, 2002, CELL TRANSPLANT, V11, P283
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thanos CG, 2004, TISSUE ENG, V10, P1617, DOI 10.1089/ten.2004.10.1617
   Thomas AM, 2013, BIOMATERIALS, V34, P2213, DOI 10.1016/j.biomaterials.2012.12.002
   Tomita M, 2005, STEM CELLS, V23, P1579, DOI 10.1634/stemcells.2005-0111
   Udina E, 2004, GLIA, V47, P120, DOI 10.1002/glia.20025
   Wang GL, 2011, IN VITRO CELL DEV-AN, V47, P234, DOI 10.1007/s11626-010-9381-4
   Wang TY, 2014, J BIOL CHEM, V289, P15044, DOI 10.1074/jbc.M113.537381
   Wang TY, 2012, BIOMATERIALS, V33, P9188, DOI 10.1016/j.biomaterials.2012.09.013
   Watts RL, 2003, J NEURAL TRANSM-SUPP, P215
   Wei YJ, 2011, J MATER SCI-MATER M, V22, P1947, DOI 10.1007/s10856-011-4370-z
   Weigel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050714
   Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Wise AK, 2011, NEUROTHERAPEUTICS, V8, P774, DOI 10.1007/s13311-011-0070-0
   Wosnick J.H., 2008, PRINCIPLES REGENERAT, P1248
   Wu SL, 2011, ARTIF ORGANS, V35, P294, DOI 10.1111/j.1525-1594.2010.01059.x
   Xie H, 2013, ACTA BIOMATER, V9, P7845, DOI 10.1016/j.actbio.2013.04.038
   Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032
   Xu B, 2013, BIOMATERIALS, V34, P6306, DOI 10.1016/j.biomaterials.2013.05.009
   Xu HX, 2014, BIOMATERIALS, V35, P225, DOI 10.1016/j.biomaterials.2013.10.002
   Xue CB, 2012, NEUROREHAB NEURAL RE, V26, P96, DOI 10.1177/1545968311420444
   Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067
   Yasuhara T, 2005, J NEUROSURG, V102, P80, DOI 10.3171/jns.2005.102.1.0080
   Zanin MP, 2012, J CONTROL RELEASE, V160, P3, DOI 10.1016/j.jconrel.2012.01.021
   Zhang K, 2011, P NATL ACAD SCI USA, V108, P6241, DOI 10.1073/pnas.1018987108
   Zhang YQ, 2012, CELLS TISSUES ORGANS, V195, P313, DOI 10.1159/000327724
   Zheng L, 2012, J MATER SCI-MATER M, V23, P2291, DOI 10.1007/s10856-012-4694-3
NR 176
TC 10
Z9 10
U1 2
U2 39
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN
PY 2014
VL 15
IS 6
BP 10669
EP 10723
DI 10.3390/ijms150610669
PG 55
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA AK7WS
UT WOS:000338639000088
PM 24933636
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lu, Y
   Tekinalp, HL
   Eberle, CC
   Peter, W
   Naskar, AK
   Ozcan, S
AF Lu, Yuan
   Tekinalp, Halil Levent
   Eberle, Claude Clifford
   Peter, William
   Naskar, Amit Kumar
   Ozcan, Soydan
TI Nanocellulose in polymer composites and biomedical applications
SO TAPPI JOURNAL
LA English
DT Article
ID BACTERIAL CELLULOSE; NANOCOMPOSITE MATERIALS; MICROFIBRILLATED
   CELLULOSE; MECHANICAL-PROPERTIES; MICROBIAL CELLULOSE; OXIDIZED
   CELLULOSE; WHISKERS; NANOCRYSTALS; SURFACE; REGENERATION
AB Nanocellulose materials are nano-sized cellulose fibrils or crystals produced by bacteria or derived from plants. These materials exhibit exceptional strength characteristics, light weight, transparency, and excellent biocompatibility. Compared with some other nanomaterials, nanocellulose is renewable and less expensive to produce, and a wide range of applications for nanocellulose has been envisioned. The areas most extensively studied include polymer composites and biomedical applications. Cellulose nanofibrils and nanocrystals have been used to reinforce both thermoplastic and thermoset polymers. Given the hydrophilic nature of these materials, the interfacial properties with most polymers are often poor; thus, various surface modification procedures have been adopted to improve the interaction between polymer matrix and cellulose nanofibrils or nanocrystals. The applications of nanocellulose as a biomaterial also have been explored, including wound dressing, tissue repair, and medical implants. Nanocellulose materials for wound healing and periodontal tissue recovery have become commercially available, demonstrating the great potential of nanocellulose as a new generation of biomaterials.
C1 [Lu, Yuan; Tekinalp, Halil Levent; Eberle, Claude Clifford; Peter, William; Naskar, Amit Kumar; Ozcan, Soydan] Oak Ridge Natl Lab, Div Mat Sci & Technol, Carbon & Composites Grp, Oak Ridge, TN 37830 USA.
RP Lu, Y (reprint author), Oak Ridge Natl Lab, Div Mat Sci & Technol, Carbon & Composites Grp, Oak Ridge, TN 37830 USA.
EM ozcan@ornl.gov
OI Ozcan, Soydan/0000-0002-3825-4589
FU Laboratory Directed Research and Development Program of Oak Ridge
   National Laboratory; U.S. Department of Agriculture Forest Products
   Laboratory
FX This research was sponsored in part by the Laboratory Directed Research
   and Development Program of Oak Ridge National Laboratory, managed by
   UT-Battelle, LLC, for the U.S. Department of Energy. The authors
   acknowledge the support of the U.S. Department of Agriculture Forest
   Products Laboratory for providing nanocellulose, as well as many
   invaluable discussions that allowed this work to be carried out.
CR Ahrem H, 2014, ACTA BIOMATER, V10, P1341, DOI 10.1016/j.actbio.2013.12.004
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Bahar E, 2012, J APPL POLYM SCI, V125, P2882, DOI 10.1002/app.36445
   Barud HS, 2011, J NANOMATER, DOI 10.1155/2011/721631
   Batista EL, 1999, J PERIODONTOL, V70, P1000, DOI 10.1902/jop.1999.70.9.1000
   Berlioz S, 2009, BIOMACROMOLECULES, V10, P2144, DOI 10.1021/bm900319k
   Berndt S, 2013, CELLULOSE, V20, P771, DOI 10.1007/s10570-013-9870-1
   Blaker JJ, 2009, GREEN CHEM, V11, P1321, DOI 10.1039/b913740h
   Bragd PL, 2004, TOP CATAL, V27, P49, DOI 10.1023/B:TOCA.0000013540.69309.46
   Bulota M, 2011, J MATER SCI, V46, P3387, DOI 10.1007/s10853-010-5227-4
   Bulota M, 2012, J MATER SCI, V47, P5517, DOI 10.1007/s10853-012-6443-x
   Cao XD, 2009, J MATER CHEM, V19, P7137, DOI 10.1039/b910517d
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   de Menezes AJ, 2009, POLYMER, V50, P4552, DOI 10.1016/j.polymer.2009.07.038
   Diez I, 2011, MACROMOL BIOSCI, V11, P1185, DOI 10.1002/mabi.201100099
   Dong H, 2012, CARBOHYD POLYM, V87, P2488, DOI 10.1016/j.carbpol.2011.11.015
   dos Anjos B, 1998, J PERIODONTOL, V69, P454, DOI 10.1902/jop.1998.69.4.454
   Dubief D, 1999, MACROMOLECULES, V32, P5765, DOI 10.1021/ma990274a
   Fang B, 2009, TISSUE ENG PT A, V15, P1091, DOI 10.1089/ten.tea.2008.0110
   Fu LN, 2013, MAT SCI ENG C-MATER, V33, P2995, DOI 10.1016/j.msec.2013.03.026
   Fujisawa S, 2013, BIOMACROMOLECULES, V14, P1541, DOI 10.1021/bm400178m
   Gatenholm P, 2010, MRS BULL, V35, P208, DOI 10.1557/mrs2010.653
   Goffin AL, 2011, POLYMER, V52, P1532, DOI 10.1016/j.polymer.2011.02.004
   Goffin AL, 2011, BIOMACROMOLECULES, V12, P2456, DOI 10.1021/bm200581h
   Gousse C, 2002, POLYMER, V43, P2645, DOI 10.1016/S0032-3861(02)00051-4
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Habibi Y, 2006, CELLULOSE, V13, P679, DOI 10.1007/s10570-006-9075-y
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hu X, 2013, COMPOS SCI TECHNOL, V78, P63, DOI 10.1016/j.compscitech.2013.02.002
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   Hubbe MA, 2008, BIORESOURCES, V3, P929
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D, 2009, MACROMOL SYMP, V280, P60, DOI 10.1002/masy.200950608
   Kolakovic R, 2012, EUR J PHARM BIOPHARM, V82, P308, DOI 10.1016/j.ejpb.2012.06.011
   Kowalska-Ludwicka K, 2011, ARCH MED SCI, V9, P527, DOI [10.5114/aoms.2013.33433.20, DOI 10.5114/AOMS.2013.33433.20]
   Kramer F, 2006, MACROMOL SYMP, V244, P136, DOI 10.1002/masy.200651213
   KROONBATENBURG LMJ, 1986, POLYM COMMUN, V27, P290
   Lacerda PSS, 2013, BIOMACROMOLECULES, V14, P2063, DOI 10.1021/bm400432b
   Lee SJ, 2011, BIOMACROMOLECULES, V12, P306, DOI 10.1021/bm100856g
   Li J, 2009, MAT SCI ENG C-BIO S, V29, P1635, DOI 10.1016/j.msec.2009.01.006
   Li Y, 2011, ADVANCES IN DIVERSE INDUSTRIAL APPLICATIONS OF NANOCOMPOSITES, P17
   Lin N, 2013, MACROMOLECULES, V46, P5570, DOI 10.1021/ma4010154
   Lin N, 2012, ACS APPL MATER INTER, V4, P4948, DOI 10.1021/am301325r
   Liu DG, 2013, CELLULOSE, V20, P2981, DOI 10.1007/s10570-013-0073-6
   Ljungberg N, 2005, BIOMACROMOLECULES, V6, P2732, DOI 10.1021/bm050222v
   Lonnberg H, 2011, COMPOS SCI TECHNOL, V71, P9, DOI 10.1016/j.compscitech.2010.09.007
   Lu J, 2008, COMPOS PART A-APPL S, V39, P738, DOI 10.1016/j.compositesa.2008.02.003
   Marcovich NE, 2006, J MATER RES, V21, P870, DOI 10.1557/JMR.2006.0105
   Nakagaito AN, 2009, COMPOS SCI TECHNOL, V69, P1293, DOI 10.1016/j.compscitech.2009.03.004
   Nimeskern L, 2013, J MECH BEHAV BIOMED, V22, P12, DOI 10.1016/j.jmbbm.2013.03.005
   Noorani S, 2007, CELLULOSE, V14, P577, DOI 10.1007/s10570-007-9119-y
   Novaes A B Jr, 1992, Int J Oral Maxillofac Implants, V7, P536
   Paakko M, 2007, BIOMACROMOLECULES, V8, P1934, DOI 10.1021/bm061215p
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Pretzel D, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4231
   Rosen CL, 2011, NEUROSURGERY, V69, P1093, DOI 10.1227/NEU.0b013e3182284aca
   Ruszymah BHI, 2011, INT J PEDIATR OTORHI, V75, P805, DOI 10.1016/j.ijporl.2011.03.012
   Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s
   Salata LA, 1998, INT J ORAL MAX IMPL, V13, P44
   Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685
   Saska S, 2011, INT J BIOMATER, DOI 10.1155/2011/175362
   SASSI JF, 1995, CELLULOSE, V2, P111, DOI 10.1007/BF00816384
   Sayers RD, 1998, BRIT J SURG, V85, P934
   Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y
   Sebe G, 2013, BIOMACROMOLECULES, V14, P2937, DOI 10.1021/bm400854n
   SINGH M, 1982, BIOMATERIALS, V3, P16, DOI 10.1016/0142-9612(82)90055-2
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   SZILAGYI DE, 1986, J VASC SURG, V3, P421
   Tanem BS, 2006, ACS SYM SER, V938, P48
   Tang CY, 2008, COMPOS PART A-APPL S, V39, P1638, DOI 10.1016/j.compositesa.2008.07.005
   Wagberg L, 2008, LANGMUIR, V24, P784, DOI 10.1021/la702481v
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Xhanari K, 2011, J COLLOID INTERF SCI, V356, P58, DOI 10.1016/j.jcis.2010.12.083
   Xu S., 2013, PRODUCTION APPL CELL, P97
   Xu XZ, 2013, ACS APPL MATER INTER, V5, P2999, DOI 10.1021/am302624t
   Yuan HH, 2006, BIOMACROMOLECULES, V7, P696, DOI 10.1021/bm050828j
   Zhou LB, 2011, TISSUE ENG PT A, V17, P1573, DOI 10.1089/ten.tea.2010.0627
NR 80
TC 14
Z9 14
U1 2
U2 68
PU TECH ASSOC PULP PAPER IND INC
PI NORCROSS
PA 15 TECHNOLOGY PARK SOUTH, NORCROSS, GA 30092 USA
SN 0734-1415
J9 TAPPI J
JI TAPPI J.
PD JUN
PY 2014
VL 13
IS 6
BP 47
EP 54
PG 8
WC Materials Science, Paper & Wood
SC Materials Science
GA AK6AM
UT WOS:000338509500006
DA 2018-10-20
ER

PT J
AU Montanari, E
   Meier, R
   Mahou, R
   Bosco, D
   Borcard, F
   Bollinger, A
   Seebach, J
   Wandrey, C
   Morel, P
   Gonelle-Gispert, C
   Buhler, L
AF Montanari, E.
   Meier, R.
   Mahou, R.
   Bosco, D.
   Borcard, F.
   Bollinger, A.
   Seebach, J.
   Wandrey, C.
   Morel, P.
   Gonelle-Gispert, C.
   Buhler, L.
TI Alginate-PEG Biomaterial for Cell Microencapsulation and
   Xenotransplantation.
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Meeting Abstract
CT World Transplant Congress
CY JUL 26-31, 2014
CL San Francisco, CA
C1 [Montanari, E.; Meier, R.; Bosco, D.; Bollinger, A.; Morel, P.; Gonelle-Gispert, C.; Buhler, L.] Univ Hosp Geneva, Dept Surg, Geneva, Switzerland.
   [Montanari, E.; Meier, R.; Bosco, D.; Bollinger, A.; Seebach, J.; Morel, P.; Gonelle-Gispert, C.; Buhler, L.] Fac Med, Geneva, Switzerland.
   [Mahou, R.; Borcard, F.; Wandrey, C.] Ecole Polytech Fed Lausanne, Lausanne, Switzerland.
   [Seebach, J.] Univ Hosp Geneva, Div Immunol & Allergy, Geneva, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD JUN
PY 2014
VL 14
SU 3
MA C1704
BP 357
EP 357
PG 1
WC Surgery; Transplantation
SC Surgery; Transplantation
GA AJ9LU
UT WOS:000338033301506
DA 2018-10-20
ER

PT J
AU Kelly, VR
   Jones, SP
   Sammartino, HL
   Arocena, DIS
   Madore, SJ
AF Kelly, Victoria R.
   Jones, Susan P.
   Sammartino, Holly L.
   Arocena, Dennis Ian S.
   Madore, Steven J.
TI Donor Verification Using Short Tandem Repeat (STR) Analysis Directly
   from Blood Collected in PAXgene RNA Tubes
SO BIOPRESERVATION AND BIOBANKING
LA English
DT Article
ID DNA
AB Biorepository processing includes nucleic acid extractions in batch mode from a large number of blood samples from many different donors. Handling such a large number of biospecimens presents the challenge of ensuring that samples are not switched or mislabeled during processing. One approach for confirming donor identity from DNA samples is the use of multiplexed fluorescent PCR for detecting Short Tandem Repeat (STR) allelic-size polymorphisms for a set of common autosomal loci. While donor identity of DNA extracted directly from blood collected in standard tubes containing anticoagulants can be easily verified by generating STR profiles, RNA from blood collected in PAXgene Blood RNA tubes (PAXgene RNA tubes) is depleted of DNA and is not amenable to STR fingerprinting for donor identity verification. We investigated the feasibility of isolating DNA directly from blood collected in PAXgene RNA tubes for use as template for STR DNA fingerprinting for blood donor identity verification. We determined that DNA extraction can be performed manually with the QIAamp DNA Blood Minikit or on the QIAxtractor instrument with minimal pre-processing protocol additions, and that DNA isolated from blood collected in PAXgene RNA tubes is of sufficient quantity and quality for successful STR fingerprint analysis. Adaptation of quality assurance methods such as the PAXgene RNA tube DNA extraction/STR fingerprinting assay described here is a good practice that ensures that biobanking collections provide scientists with high quality, donor-verified biomaterial.
C1 [Kelly, Victoria R.; Jones, Susan P.; Sammartino, Holly L.; Arocena, Dennis Ian S.; Madore, Steven J.] Coriell Inst Med Res, Mol Biol Grp, Camden, NJ 08103 USA.
RP Kelly, VR (reprint author), Coriell Inst Med Res, Mol Biol Grp, 403 Haddon Ave, Camden, NJ 08103 USA.
EM vkelly@coriell.org
CR Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x
   Butler JM, 2004, ELECTROPHORESIS, V25, P1397, DOI 10.1002/elps.200305822
   Butler John M, 2007, Biotechniques, V43, pii
   EDWARDS A, 1991, AM J HUM GENET, V49, P746
   FREGEAU CJ, 1993, BIOTECHNIQUES, V15, P100
   JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0
   Oostdik K, 2012, BRIDGING DATABASES T
NR 7
TC 2
Z9 2
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1947-5535
EI 1947-5543
J9 BIOPRESERV BIOBANK
JI Biopreserv. Biobank.
PD JUN
PY 2014
VL 12
IS 3
BP 217
EP 219
DI 10.1089/bio.2013.0080
PG 3
WC Cell Biology; Chemistry, Applied; Medical Laboratory Technology
SC Cell Biology; Chemistry; Medical Laboratory Technology
GA AK0WI
UT WOS:000338136400009
PM 24955736
DA 2018-10-20
ER

PT J
AU Chaussain, C
   Poliard, A
AF Chaussain, C.
   Poliard, A.
TI Minimal intervention dentistry: part 8. Biotherapies for the dental pulp
SO BRITISH DENTAL JOURNAL
LA English
DT Article
ID EXFOLIATED DECIDUOUS TEETH; MINERAL TRIOXIDE AGGREGATE; STEM-CELLS;
   STEM/PROGENITOR CELLS; IN-VIVO; REPAIR; REGENERATION; POPULATION
AB The development of new therapies, the biotherapies, can now be envisioned in dentistry thanks to the important development of research in the stem cell and biomaterial fields. Indeed, the recent discovery of stem cells in different tissues of the body, and in particular in the dental pulp, should allow the development of new therapeutic approaches for pulpo-dentinal lesions. In case of moderate pulp injury, the stimulation by biomolecules of pulp stem cells located in the remaining pulp is the approach to be considered. In case of more severe lesions requiring a total removal of pulp tissues, a cell therapy could be considered. The objective of this article is to present these innovative therapeutic approaches for the future of dentistry.
C1 [Chaussain, C.; Poliard, A.] PRES Sorbonne Paris Cite, UFR Odontol Paris Descartes, EA Pathol & Biotherapies Dent 2496, F-92120 Montrouge, France.
   [Chaussain, C.] AP HP, Serv Odontol Bretonneau, F-75018 Paris, France.
RP Chaussain, C (reprint author), PRES Sorbonne Paris Cite, UFR Odontol Paris Descartes, EA Pathol & Biotherapies Dent 2496, F-92120 Montrouge, France.
EM Catherine.chaussain@parisdescartes.fr
OI chaussain, Catherine/0000-0002-3463-3936
CR Boukpessi T, 2010, AM J PATHOL
   Chaussain C, 2009, EUR CELLS MATER, V18, P84, DOI 10.22203/eCM.v018a08
   Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009
   d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07
   Dammaschke T, 2010, J ENDODONT, V36, P814, DOI 10.1016/j.joen.2010.02.001
   Galler KM, 2012, TISSUE ENG PT A, V18, P176, DOI [10.1089/ten.tea.2011.0222, 10.1089/ten.TEA.2011.0222]
   Goldberg M, 2008, CLIN ORAL INVEST, V12, P109, DOI 10.1007/s00784-007-0172-6
   Goldberg M, 2004, CRIT REV ORAL BIOL M, V15, P13, DOI 10.1177/154411130401500103
   Goldberg Michel, 2006, Dent Clin North Am, V50, P277, DOI 10.1016/j.cden.2005.11.008
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617
   Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Nakashima Misako, 2014, J Endod, V40, pS26, DOI 10.1016/j.joen.2014.01.020
   Okiji T, 2009, INT J DENT, V464, P280
   Six N, 2007, J DENT RES, V86, P780, DOI 10.1177/154405910708600818
   Suzuki T, 2011, J DENT RES, V90, P1013, DOI 10.1177/0022034511408426
   Torabinejad M, 2010, J ENDODONT, V36, P190, DOI 10.1016/j.joen.2009.09.010
NR 21
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0007-0610
EI 1476-5373
J9 BRIT DENT J
JI Br. Dent. J.
PD JUN
PY 2014
VL 216
IS 11
BP 619
EP +
DI 10.1038/sj.bdj.2014.450
PG 3
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AK5FK
UT WOS:000338449900010
PM 24923934
DA 2018-10-20
ER

PT J
AU Mertens, C
   Wiens, D
   Steveling, HG
   Sander, A
   Freier, K
AF Mertens, Christian
   Wiens, Daniel
   Steveling, Helmut G.
   Sander, Anja
   Freier, Kolja
TI Maxillary Sinus-Floor Elevation with Nanoporous Biphasic Bone Graft
   Material for Early Implant Placement
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE atrophic maxilla; bone augmentation; bone resorption; maxillary
   sinus-floor elevation; sinus-floor elevation
ID RADIOGRAPHIC EVALUATION; MEMBRANE ELEVATION; AUTOGENOUS BONE;
   VENOUS-BLOOD; AUGMENTATION; SILICA; HYDROXYAPATITE; REHABILITATION;
   PHOSPHATE; MIXTURE
AB Background Insufficient bone height in the posterior maxilla is caused by bone atrophy after tooth extraction and continued pneumatization of the maxillary sinus. To allow for implant placement in this area, external sinus-floor elevations are performed. For this indication, the application of various bone graft materials can be a reliable alternative to autologous bone. Purpose The aim of this study was to analyze a nanoporous bone graft material under the condition of early implant treatment in sinus floor elevations. Materials and Methods Sixty-six patients received 94 individual external sinus-floor elevations as a precondition for implant surgery. As grafting material, a synthetic, nanoporous bone graft material consisting of a mixture of nano-hydroxyapatite and nano--tricalciumphosphate crystals, combined with blood from the defect side, was used. Depending on the remaining vertical bone height, implant placement was performed either simultaneously with bone augmentation or consecutively in a delayed approach. After a 4-month healing period, the patients received 218 implants and were followed up clinically, radiographically, and histologically. To quantify the bone situation at implant placement, immunohistochemical analysis using tenascin-C was performed. Results We achieved an average vertical bone increase of 8.28mm (SD, 2.59) for the one-stage approach and 10.99mm (SD, 1.73) for the two-stage approach after sinus-floor elevation. The augmented areas showed mean resorption rates of 10.32% (one stage) and 10.82% (two stages) of vertical graft during the observation period. Immunohistochemical analysis after 4 months of healing showed high tenascin activity, indicating bone growth. Good primary stability was achieved during implant placement. Mean peri-implant marginal bone loss was 0.45mm (SD, 0.31). Conclusion After a mean observation time of 21.45 months, the biomaterial showed good osseointegration and bone stability radiographically. Adding to this the positive histological and immunohistochemical findings, we conclude that, after a relatively short 4-month healing period, the biomaterial showed predictable results.
C1 [Mertens, Christian; Wiens, Daniel; Freier, Kolja] Univ Heidelberg Hosp, Dept Oral & Maxillofacial Surg, D-69120 Heidelberg, Germany.
   [Sander, Anja] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany.
RP Mertens, C (reprint author), Univ Heidelberg Hosp, Dept Oral & Maxillofacial Surg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.
EM christian.mertens@med.uni-heidelberg.de
OI Mertens, Christian/0000-0002-6305-364X
CR AABOE M, 1995, BRIT J ORAL MAX SURG, V33, P312, DOI 10.1016/0266-4356(95)90045-4
   Albrektsson T, 1986, INT J ORAL MAXILLOF, V1, P11
   Areva S, 2007, J MATER SCI-MATER M, V18, P1633, DOI 10.1007/s10856-007-3064-z
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P136, DOI 10.1111/j.1600-0501.2006.01357.x
   Crespi R, 2007, INT J ORAL MAX IMPL, V22, P527
   Emmerich D, 2005, J PERIODONTOL, V76, P1237, DOI 10.1902/jop.2005.76.8.1237
   Esposito M, 2009, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD003607.PUB4
   Galindo-Moreno P, 2007, CLIN ORAL IMPLAN RES, V18, P376, DOI 10.1111/j.1600-0501.2007.01337.x
   Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Hallman M, 2002, J ORAL MAXIL SURG, V60, P277, DOI 10.1053/joms.2002.30576
   Hallman M, 2002, J ORAL MAXILLOFAC SU, V60, P285
   Hatano N, 2004, CLIN ORAL IMPLAN RES, V15, P339, DOI 10.1111/j.1600-0501.2004.00996.x
   Hatano N, 2007, CLIN IMPLANT DENT R, V9, P150, DOI 10.1111/j.1708-8208.2007.00043.x
   Herford AS, 2003, J ORAL MAXIL SURG, V61, P358, DOI 10.1053/joms.2003.50071
   HIDAKA S, 1993, ARCH ORAL BIOL, V38, P405, DOI 10.1016/0003-9969(93)90212-5
   Iturriaga MTM, 2004, J ORAL MAXIL SURG, V62, P344, DOI 10.1016/j.joms.2003.08.013
   Kang YM, 2009, ACTA BIOMATER, V5, P462, DOI 10.1016/j.actbio.2008.07.004
   Kilian O, 2008, CALCIFIED TISSUE INT, V83, P101, DOI 10.1007/s00223-008-9156-z
   Kirmeier R, 2007, J ORAL MAXIL SURG, V65, P2235, DOI 10.1016/j.jams.2006.11.038
   Lundgren Stefan, 2004, Clin Implant Dent Relat Res, V6, P165, DOI 10.1111/j.1708-8208.2004.tb00217.x
   Palma VC, 2006, CLIN IMPLANT DENT R, V8, P11, DOI 10.2310/6480.2005.00026
   Rosen PS, 1999, INT J ORAL MAX IMPL, V14, P853
   Simunek A, 2008, INT J ORAL MAX IMPL, V23, P935
   Stricker A, 2003, CLIN ORAL IMPLAN RES, V14, P207, DOI 10.1034/j.1600-0501.2003.140211.x
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Thor A, 2007, J ORAL MAXIL SURG, V65, P64, DOI 10.1016/j.joms.2006.10.047
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Zijderveld SA, 2009, CLIN ORAL IMPLAN RES, V20, P691, DOI [10.1111/j.1600-0501.2008.01697.x, 10.1111/j.1600-0501.2009.01697.x]
NR 30
TC 4
Z9 4
U1 1
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD JUN
PY 2014
VL 16
IS 3
BP 365
EP 373
DI 10.1111/j.1708-8208.2012.00484.x
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AJ9MQ
UT WOS:000338035800007
PM 22897709
DA 2018-10-20
ER

PT J
AU Wimardhani, YS
   Suniarti, DF
   Freisleben, HJ
   Wanandi, SI
   Siregar, NC
   Ikeda, MA
AF Wimardhani, Yuniardini S.
   Suniarti, Dewi F.
   Freisleben, Hans J.
   Wanandi, Septelia I.
   Siregar, Nurjati C.
   Ikeda, Masa-Aki
TI Chitosan exerts anticancer activity through induction of apoptosis and
   cell cycle arrest in oral cancer cells
SO JOURNAL OF ORAL SCIENCE
LA English
DT Article
DE cell cycle; proliferation; apoptosis; electron microscopy; chitosan;
   oral cancer
ID MOLECULAR-WEIGHT; DNA-SYNTHESIS; IN-VITRO; TGF-BETA; PROLIFERATION;
   CARCINOMA; LINE; NANOPARTICLES; CHITIN
AB Chitosan, a multipurpose biomaterial, has been shown to exert effects against several types of cancer including oral cancer. However, the mechanisms underlying the anticancer activities of chitosan on oral squamous cell carcinoma (SCC) cells remain largely unknown. The present study aimed to compare the effects of low-molecular-weight chitosan (LMWC) and cisplatin on oral SCC Ca9-22 and non-cancer keratinocyte HaCaT cell lines. Cell viability and cell cycle profiles were measured by MTT assay and laser scanning cytometry, respectively. Apoptosis was examined by TUNEL assay and electron microscopy, followed by analysis of caspase activity. LMWC exhibited cytotoxic effects on Ca9-22, but not HaCaT cells, whereas cisplatin induced apoptosis in both types of cells. Exposure of Ca9-22 cells to LMWC led to G1/S cell cycle arrest and an increase of TUNEL-positive cells accompanied by an early apoptotic cell morphology and subtle increases of caspase activity. Short-term LMWC exposure was less cytotoxic to HaCaT cells than to Ca9-22 cells, and anticancer activity was exerted through induction of apoptosis and cell cycle arrest, suggesting that LMWC could be a promising natural anticancer agent with fewer side effects on normal cells.
C1 [Wimardhani, Yuniardini S.] Univ Indonesia, Fac Med, Grad Study Program Biomed Sci, Jakarta 10430, Indonesia.
   [Wimardhani, Yuniardini S.] Univ Indonesia, Fac Dent, Dept Oral Med, Jakarta 10430, Indonesia.
   [Suniarti, Dewi F.] Univ Indonesia, Fac Dent, Dept Oral Biol, Jakarta 10430, Indonesia.
   [Freisleben, Hans J.] Univ Indonesia, Fac Med, Med Res Unit, Jakarta 10430, Indonesia.
   [Wanandi, Septelia I.] Univ Indonesia, Fac Med, Dept Biochem & Mol Biol, Jakarta 10430, Indonesia.
   [Siregar, Nurjati C.] Univ Indonesia, Fac Med, Dept Anat Pathol, Jakarta 10430, Indonesia.
   [Ikeda, Masa-Aki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Mol Embryol, Tokyo, Japan.
RP Wimardhani, YS (reprint author), Univ Indonesia, Fac Dent, Dept Oral Med, Jalan Salemba Raya 4, Jakarta 10430, Indonesia.
EM yuniardini@ui.ac.id
OI Wimardhani, Yuniardini/0000-0002-0217-291X
FU Ministry of Health Republic of Indonesia; Riset Madya 2012 Universitas
   Indonesia; Bilateral JSPS-DGHE Joint Research Project of the Japan
   Society for the Promotion of Science (JSPS).
FX This work was supported in part by a Risbin Iptekdok Grant 2011 from The
   Ministry of Health Republic of Indonesia and Riset Madya 2012
   Universitas Indonesia, and in part by the Bilateral JSPS-DGHE Joint
   Research Project of the Japan Society for the Promotion of Science
   (JSPS). The authors are grateful to all the staff at the Oral Biology
   Laboratory Universitas Indonesia and Fellowship students at Tokyo
   Medical and Dental University, Japan, for their kind help and support
   throughout this study.
CR Andreadis C, 2003, ORAL ONCOL, V39, P380, DOI 10.1016/S1368-8375(02)00141-0
   Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009
   Darzynkiewicz Z, 2010, ADV EXP MED BIOL, V676, P137
   Dou CM, 2004, WORLD J GASTROENTERO, V10, P2091, DOI 10.3748/wjg.v10.i14.2091
   Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124
   HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Huang M, 2004, PHARM RES, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Hwang JY, 2008, CANCER RES, V68, P5849, DOI 10.1158/0008-5472.CAN-07-6130
   Lin SY, 2007, J CELL BIOCHEM, V100, P1573, DOI 10.1002/jcb.21152
   Liu J, 2009, BIOCHEM BIOPH RES CO, V390, P989, DOI 10.1016/j.bbrc.2009.10.090
   Liu XP, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-76
   Qi LF, 2005, WORLD J GASTROENTERO, V11, P5136
   REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831
   SAKAI E, 1992, ONCOGENE, V7, P927
   Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769
   SUGANO M, 1980, AM J CLIN NUTR, V33, P787
   Takimoto Hiroyuki, 2004, Drug Metab Pharmacokinet, V19, P76, DOI 10.2133/dmpk.19.76
   Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x
   Wiegand C, 2010, SKIN PHARMACOL PHYS, V23, P164, DOI 10.1159/000276996
   Wimardani Y.S., 2012, INT J ORAL RES, V3, pe1
   Zhang JL, 2010, MAR DRUGS, V8, P1962, DOI 10.3390/md8071962
NR 25
TC 19
Z9 20
U1 2
U2 12
PU NIHON UNIV, SCHOOL DENTISTRY
PI TOYKO
PA 1--13 KANDA-SURUGADAI, CHIYODA-KU, TOYKO, 101-8310, JAPAN
SN 1343-4934
EI 1880-4926
J9 J ORAL SCI
JI J. Oral Sci.
PD JUN
PY 2014
VL 56
IS 2
BP 119
EP 126
DI 10.2334/josnusd.56.119
PG 8
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA AK4UX
UT WOS:000338420700004
PM 24930748
OA Bronze
DA 2018-10-20
ER

PT J
AU Pezzotti, G
AF Pezzotti, Giuseppe
TI Bioceramics for Hip Joints: The Physical Chemistry Viewpoint
SO MATERIALS
LA English
DT Review
DE hip joint; ceramics; oxygen vacancy; alumina-zirconia composites;
   silicon nitride; cathodoluminescence spectroscopy
ID ZIRCONIA-TOUGHENED ALUMINA; SILICON-NITRIDE CERAMICS;
   PARTIALLY-STABILIZED ZIRCONIA; FRACTURE-TOUGHNESS; RESIDUAL-STRESSES;
   ALPHA-ALUMINA; GAMMA-ALUMINA; MONOCLINIC TRANSFORMATION; OXYGEN
   VACANCIES; PHASE-STABILITY
AB Which intrinsic biomaterial parameter governs and, if quantitatively monitored, could reveal to us the actual lifetime potential of advanced hip joint bearing materials? An answer to this crucial question is searched for in this paper, which identifies ceramic bearings as the most innovative biomaterials in hip arthroplasty. It is shown that, if in vivo exposures comparable to human lifetimes are actually searched for, then fundamental issues should lie in the physical chemistry aspects of biomaterial surfaces. Besides searching for improvements in the phenomenological response of biomaterials to engineering protocols, hip joint components should also be designed to satisfy precise stability requirements in the stoichiometric behavior of their surfaces when exposed to extreme chemical and micromechanical conditions. New spectroscopic protocols have enabled us to visualize surface stoichiometry at the molecular scale, which is shown to be the key for assessing bioceramics with elongated lifetimes with respect to the primitive alumina biomaterials used in the past.
C1 [Pezzotti, Giuseppe] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068126, Japan.
   [Pezzotti, Giuseppe] Loma Linda Univ, Dept Orthoped Res, Loma Linda, CA 92354 USA.
   [Pezzotti, Giuseppe] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan.
   [Pezzotti, Giuseppe] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Cell Physiol, Kamigyo Ku, Kyoto 6020841, Japan.
RP Pezzotti, G (reprint author), Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068126, Japan.
EM pezzotti@kit.ac.jp
CR Adiga SP, 2007, J PHYS CHEM C, V111, P7422, DOI 10.1021/jp0701035
   Ahn J, 1997, SURF SCI, V388, P121, DOI 10.1016/S0039-6028(97)00383-X
   Bal BS, 2012, ACTA BIOMATER, V8, P2889, DOI 10.1016/j.actbio.2012.04.031
   Bal BS, 2008, J BIOMED MATER RES B, V87B, P447, DOI 10.1002/jbm.b.31123
   Barceinas-Sanchez JDO, 1998, ACTA MATER, V46, P6475, DOI 10.1016/S1359-6454(98)00292-4
   Basu B., 2011, TRIBOLOGY CERAMICS C
   Becher PF, 2006, MAT SCI ENG A-STRUCT, V422, P85, DOI 10.1016/j.msea.2006.01.006
   Becher PF, 1998, J AM CERAM SOC, V81, P2821
   BRANDT G, 1987, WEAR, V115, P243, DOI 10.1016/0043-1648(87)90215-8
   Buban JP, 2006, SCIENCE, V311, P212, DOI 10.1126/science.1119839
   Burger W., 2001, KEY ENG MATER, p[192, 545], DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.545
   Castaing J, 2000, ACTA MATER, V48, P1495, DOI 10.1016/S1359-6454(99)00449-8
   CHEN JG, 1986, J CHEM PHYS, V84, P5906, DOI 10.1063/1.449902
   Chevalier J, 2009, BIOMATERIALS, V30, P5279, DOI 10.1016/j.biomaterials.2009.06.022
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Munisso MC, 2007, J PHYS CHEM A, V111, P3526, DOI 10.1021/jp068557+
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   Clarke I.C., 2006, BIOCERAMICS MAT APPL, V147
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   Courpied JP, 2011, INT ORTHOP, V35, P149, DOI 10.1007/s00264-011-1207-9
   DAHL LB, 1985, ANN RHEUM DIS, V44, P817, DOI 10.1136/ard.44.12.817
   Dante RC, 2012, WEAR, V288, P27, DOI 10.1016/j.wear.2012.03.001
   DECKMAN DE, 1991, WEAR, V149, P155, DOI 10.1016/0043-1648(91)90370-A
   Della Gatta G., 1997, J CHEM SOC FARADAY T, V73, P1040
   Dillon S., 2010, INT J MATER RES, V101, P1
   DONG X, 1993, WEAR, V165, P169, DOI 10.1016/0043-1648(93)90332-G
   DRAEGER BG, 1979, PHYS REV B, V19, P1172, DOI 10.1103/PhysRevB.19.1172
   Elam JW, 1998, J PHYS CHEM B, V102, P7008, DOI 10.1021/jp981070j
   EVANS AG, 1978, ACTA METALL MATER, V26, P1845, DOI 10.1016/0001-6160(78)90097-4
   Fabris S, 2002, ACTA MATER, V50, P5171, DOI 10.1016/S1359-6454(02)00385-3
   Fernandez EM, 2007, COMP MATER SCI, V39, P587, DOI 10.1016/j.commatsci.2006.08.010
   FREDERICK BG, 1991, SURF SCI, V244, P67, DOI 10.1016/0039-6028(91)90170-W
   Freund HJ, 1996, REP PROG PHYS, V59, P283, DOI 10.1088/0034-4885/59/3/001
   Fukatsu K, 2012, ACTA BIOMATER, V8, P1639, DOI 10.1016/j.actbio.2011.12.019
   Garrett Q, 1999, BIOMATERIALS, V20, P1345, DOI 10.1016/S0142-9612(99)00037-X
   Gates R.S., 1995, NATL I STANDARDS NIS, V876
   Ghamnia M, 2003, J ELECTRON SPECTROSC, V133, P55, DOI 10.1016/j.elspec.2003.08.003
   Gholinia A, 1997, J MATER SCI, V32, P6625, DOI 10.1023/A:1018644218284
   Gorth DJ, 2012, INT J NANOMED, V7, P4829, DOI 10.2147/IJN.S35190
   Gregori G, 1999, MAT SCI ENG A-STRUCT, V271, P401, DOI 10.1016/S0921-5093(99)00383-4
   Guo X, 2003, J AM CERAM SOC, V86, P1867, DOI 10.1111/j.1151-2916.2003.tb03574.x
   Guo X, 1998, SOLID STATE IONICS, V112, P113, DOI 10.1016/S0167-2738(98)00212-4
   Guo X, 1999, J PHYS CHEM SOLIDS, V60, P539, DOI 10.1016/S0022-3697(98)00301-1
   Hampshire S, 2007, J ACHIEV MAT MANUF E, V24, P43
   Hannink RHJ, 2000, J AM CERAM SOC, V83, P461
   Hass KC, 1998, SCIENCE, V282, P265, DOI 10.1126/science.282.5387.265
   HENDRIKS.BA, 1972, J CATAL, V24, P82, DOI 10.1016/0021-9517(72)90010-3
   Ikeda J, 2006, KEY ENG MAT, V309-311, P1243, DOI 10.4028/www.scientific.net/KEM.309-311.1243
   Insley GM, 2004, KEY ENG MAT, V254-2, P675, DOI 10.4028/www.scientific.net/KEM.254-256.675
   JENG MC, 1993, WEAR, V161, P111
   Jia ZS, 2001, CARBOHYD RES, V333, P1, DOI 10.1016/S0008-6215(01)00112-4
   Kalin M, 2003, WEAR, V254, P1141, DOI 10.1016/S0043-1648(03)00326-0
   Kawanabe K, 2007, CER ORTHO, P83, DOI 10.1007/978-3-7985-1783-7_11
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Kim TI, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804139
   Kleebe HJ, 1999, J AM CERAM SOC, V82, P1857, DOI 10.1111/j.1151-2916.1999.tb02009.x
   KLEEBE HJ, 1993, J AM CERAM SOC, V76, P1969, DOI 10.1111/j.1151-2916.1993.tb08319.x
   KNOZINGER H, 1978, CATAL REV, V17, P31, DOI 10.1080/03602457808080878
   Kreher W., 1988, INTERNAL STRESSES HE
   KROGER FA, 1958, J PHYS CHEM SOLIDS, V5, P208, DOI 10.1016/0022-3697(58)90069-6
   Kuntz M, 2006, SEMIN ARTHROPLASTY, V17, P141
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   LARCHE FC, 1985, ACTA METALL MATER, V33, P331, DOI 10.1016/0001-6160(85)90077-X
   Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7
   LEE KH, 1979, PHYS REV B, V19, P3217, DOI 10.1103/PhysRevB.19.3217
   Leto A, 2014, J MECH BEHAV BIOMED, V31, P135, DOI 10.1016/j.jmbbm.2013.10.026
   Li JF, 1997, J MATER SCI, V32, P1149, DOI 10.1023/A:1018567414745
   LI P, 1993, PHYS REV B, V48, P10063, DOI 10.1103/PhysRevB.48.10063
   Lippens B.C., 1970, PHYS CHEM ASPECTS AD
   Liu XS, 1997, J AM CHEM SOC, V119, P9856, DOI 10.1021/ja971214s
   Lushchik A, 2006, NUCL INSTRUM METH B, V250, P330, DOI 10.1016/j.nimb.2006.04.133
   MA Q, 1994, ACTA METALL MATER, V42, P1673, DOI 10.1016/0956-7151(94)90377-8
   MA Q, 1994, J AM CERAM SOC, V77, P298, DOI 10.1111/j.1151-2916.1994.tb06996.x
   Manaka M, 2004, J BIOMED MATER RES B, V69B, P149, DOI 10.1002/jbm.b.20033
   Matsui K, 2005, J AM CERAM SOC, V88, P3346, DOI 10.1111/j.1551-2916.2005.00620.x
   Matsui K, 2008, J AM CERAM SOC, V91, P1888, DOI 10.1111/j.1551-2916.2008.02350.x
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2889, DOI 10.1007/s10856-008-3437-y
   McHale JM, 1997, SCIENCE, V277, P788, DOI 10.1126/science.277.5327.788
   McHale JM, 1997, J PHYS CHEM B, V101, P603, DOI 10.1021/jp9627584
   Medical Devices Agency-Adverse Incident Centre, 1996, 9617 MDA SN
   Mishina H, 2008, WEAR, V265, P655, DOI 10.1016/j.wear.2007.12.006
   Mizuhara K., 1992, TRIBOL SER, V21, P323
   MOHAPATRA SK, 1977, J AM CERAM SOC, V60, P381, DOI 10.1111/j.1151-2916.1977.tb15517.x
   MORI S, 1991, J JPN SOC TRIBOLOGIS, V36, P130
   MORIKAWA H, 1988, NIPPON SERAM KYO GAK, V96, P253
   MORTERRA C, 1993, J CHEM SOC FARADAY T, V89, P135, DOI 10.1039/ft9938900135
   Morterra C, 1996, CATAL TODAY, V27, P497, DOI 10.1016/0920-5861(95)00163-8
   MORTERRA C, 1976, J CHEM SOC FARAD T 1, V72, P2722, DOI 10.1039/f19767202722
   Mullens S, 2005, AM CERAM SOC BULL, V84, P9101
   Muratov VA, 1998, TRIBOL INT, V31, P601, DOI 10.1016/S0301-679X(98)00081-4
   Nakanishi T, 2007, KEY ENG MATER, V330-332, P1267, DOI 10.4028/www.scientific.net/KEM.330-332.1267
   Nasu H, 2008, J CERAM SOC JPN, V116, P835, DOI 10.2109/jcersj2.116.835
   Nevelos J, 2000, J ARTHROPLASTY, V15, P793, DOI 10.1054/arth.2000.8100
   Nevelos JE, 2001, J BONE JOINT SURG BR, V83B, P598
   Nygren MA, 1997, SURF SCI, V380, P113, DOI 10.1016/S0039-6028(97)01596-3
   Okita S, 2014, J MECH BEHAV BIOMED, V31, P55, DOI 10.1016/j.jmbbm.2013.01.022
   Oonishi H, 2004, J BIOMED MATER RES A, V70A, P523, DOI 10.1002/jbm.a.30021
   PERI JB, 1960, J PHYS CHEM-US, V64, P1526, DOI 10.1021/j100839a044
   PERI JB, 1965, J PHYS CHEM-US, V69, P211, DOI 10.1021/j100885a032
   Petrik NG, 1999, J APPL PHYS, V85, P6770, DOI 10.1063/1.370192
   Pezzotti G., 2013, ADV MAT JOINT IMPLAN
   Pezzotti G., 2006, BIOCERAMICS MAT APPL, V147, P141
   Pezzotti G, 2008, J AM CERAM SOC, V91, P1199, DOI 10.1111/j.1551-2916.2007.01507.x
   Pezzotti G, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2234307
   Pezzotti G, 2007, EXPERT REV MED DEVIC, V4, P165, DOI 10.1586/17434440.4.2.165
   Pezzotti G, 2014, J MECH BEHAV BIOMED, V31, P3, DOI 10.1016/j.jmbbm.2013.06.001
   Pezzotti G, 2012, WEAR, V284, P91, DOI 10.1016/j.wear.2012.02.007
   Pezzotti G, 2011, J BIOMAT SCI-POLYM E, V22, P2165, DOI 10.1163/092050610X537129
   Pezzotti G, 2010, J BIOMED MATER RES B, V95B, P250, DOI 10.1002/jbm.b.31706
   Pezzotti G, 2010, BIOMATERIALS, V31, P6901, DOI 10.1016/j.biomaterials.2010.05.035
   Pezzotti G, 2009, J AM CERAM SOC, V92, P1817, DOI 10.1111/j.1551-2916.2009.03114.x
   Pezzotti G, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2710247
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   Puppulin L, 2014, J MECH BEHAV BIOMED, V31, P45, DOI 10.1016/j.jmbbm.2013.01.004
   Rainforth WM, 2004, J MATER SCI, V39, P6705, DOI 10.1023/B:JMSC.0000045601.49480.79
   Rasanen P, 2007, ACTA ORTHOP, V78, P108, DOI 10.1080/17453670610013501
   Richter HG, 1999, BRIT CERAM T, V98, P29, DOI 10.1179/096797899680219
   RIETH PH, 1976, AM CERAM SOC BULL, V55, P717
   ROSSI PF, 1994, J CHEM SOC FARADAY T, V90, P363, DOI 10.1039/ft9949000363
   Samaras Dimitrios, 2011, Am J Orthop (Belle Mead NJ), V40, pE14
   Scardi P, 1996, THIN SOLID FILMS, V278, P96, DOI 10.1016/0040-6090(95)08163-1
   Schlenker B.R., 1974, INTRO MAT SCI SI EDI
   Schubert H, 2005, J EUR CERAM SOC, V25, P1597, DOI 10.1016/j.jeurceramsoc.2004.03.025
   Shapovalov V, 2000, J PHYS CHEM B, V104, P9859, DOI 10.1021/jp001399g
   Shishido T, 2003, J BIOMED MATER RES B, V67B, P638, DOI 10.1002/jbm.b.10048
   Smits K, 2007, PHYS STATUS SOLIDI C, V4, P770, DOI 10.1002/pssc.200673850
   Smits K., 2010, THESIS U LATVIA RIGA
   Stea S, 2002, ACTA ORTHOP SCAND, V73, P40, DOI 10.1080/000164702760379549
   Sun EY, 1998, J AM CERAM SOC, V81, P2831
   Sun EY, 1999, ACTA MATER, V47, P2777, DOI 10.1016/S1359-6454(99)00122-6
   Takahashi Y, 2012, J MATER SCI-MATER M, V23, P591, DOI 10.1007/s10856-011-4502-5
   Takahashi Y, 2011, J MECH BEHAV BIOMED, V4, P993, DOI 10.1016/j.jmbbm.2011.02.014
   Takahashi Y, 2010, ACTA BIOMATER, V6, P3583, DOI 10.1016/j.actbio.2010.02.051
   Tateishi T., 1993, Clinical Materials, V12, P219, DOI 10.1016/0267-6605(93)90076-J
   THIEL PA, 1987, SURF SCI REP, V7, P211, DOI 10.1016/0167-5729(87)90001-X
   Tomizawa T.E., 1986, ASLE T, V30, P41
   Tsyganenko AA, 1996, J CHEM SOC FARADAY T, V92, P4843, DOI 10.1039/ft9969204843
   TSYGANENKO AA, 1990, MATER CHEM PHYS, V26, P35, DOI 10.1016/0254-0584(90)90044-B
   VENABLE RL, 1965, J PHYS CHEM-US, V69, P317, DOI 10.1021/j100885a050
   VOLANTE M, 1989, J MATER SCI LETT, V8, P1076, DOI 10.1007/BF01730492
   WADE WH, 1960, J PHYS CHEM-US, V64, P1196, DOI 10.1021/j100838a020
   Wang XG, 2000, PHYS REV LETT, V84, P3650, DOI 10.1103/PhysRevLett.84.3650
   Webster TJ, 2012, ACTA BIOMATER, V8, P4447, DOI 10.1016/j.actbio.2012.07.038
   West GD, 2007, J EUR CERAM SOC, V27, P1913, DOI 10.1016/j.jeurceramsoc.2006.07.001
   Williams D.F., 1999, TISSUE ENG PROSTHETI
   Willmann G, 2000, CLIN ORTHOP RELAT R, P22
   YAO YFY, 1965, J PHYS CHEM-US, V69, P3930, DOI 10.1021/j100895a049
   Zeghad A, 2007, PHILOS MAG, V87, P1401, DOI 10.1080/14786430601009509
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zhang W, 2010, J MATER SCI-MATER M, V21, P3049, DOI 10.1007/s10856-010-4144-z
   Zhu WL, 2014, J MECH BEHAV BIOMED, V31, P68, DOI 10.1016/j.jmbbm.2013.01.018
   Zhu WL, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.127002
   Zhu WL, 2009, APPL SPECTROSC, V63, P185, DOI 10.1366/000370209787392085
   Ziegler G., 2007, J MATER SCI, V22, P3041
NR 154
TC 11
Z9 11
U1 2
U2 46
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUN
PY 2014
VL 7
IS 6
BP 4367
EP 4410
DI 10.3390/ma7064367
PG 44
WC Materials Science, Multidisciplinary
SC Materials Science
GA AK6DC
UT WOS:000338517300017
PM 28788682
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chung, SI
   Kim, TH
   Rico, CW
   Kang, MY
AF Chung, Soo Im
   Kim, Tae Hyeong
   Rico, Catherine W.
   Kang, Mi Young
TI Effect of Instant Cooked Giant Embryonic Rice on Body Fat Weight and
   Plasma Lipid Profile in High Fat-Fed Mice
SO NUTRIENTS
LA English
DT Article
DE body fat; giant embryo mutant; instant cooked rice; plasma lipid
ID ORYZA-SATIVA L.; GAMMA-ORYZANOL; ADIPOSE-TISSUE; CARNITINE
   PALMITOYLTRANSFERASE; SPECTROPHOTOMETRIC ASSAY; GENE-EXPRESSION; BROWN
   RICE; BRAN OIL; OBESITY; METABOLISM
AB The comparative effects of instant cooked rice made from giant embryo mutant or ordinary normal rice on body weight and lipid profile in high fat-fed mice were investigated. The animals were given experimental diets for seven weeks: normal control (NC), high fat (HF), and HF supplemented with instant normal white (HF-NW), normal brown (HF-NB), giant embryonic white (HF-GW), or giant embryonic brown (HF-GB) rice. The HF group showed markedly higher body weight, body fat, plasma and hepatic triglyceride and cholesterol concentrations, and atherogenic index relative to NC group. However, instant rice supplementation counteracted this high fat-induced hyperlipidemia through regulation of lipogenesis and adipokine production. The GB rice exhibited greater hypolipidemic and body fat-lowering effects than the GW or NB rice. These findings illustrate that the giant embryo mutant may be useful as functional biomaterial for the development of instant rice with strong preventive action against high fat diet-induced hyperlipidemia and obesity.
C1 [Chung, Soo Im; Rico, Catherine W.; Kang, Mi Young] Kyungpook Natl Univ, Dept Food Sci & Nutr, Brain Korea Plus 21, Taegu 702701, South Korea.
   [Kim, Tae Hyeong] CJ Cheil Jedang Foods Res & Dev, Seoul 152050, South Korea.
RP Kang, MY (reprint author), Kyungpook Natl Univ, Dept Food Sci & Nutr, Brain Korea Plus 21, Taegu 702701, South Korea.
EM zizibe0312@nate.com; rice@cj.net; ckwrico@gmail.com; mykang@knu.ac.kr
FU Cooperative Research Program for Agriculture Science and Technology
   Development, Rural Development Administration, Republic of Korea
   [PJ00817601]
FX This work was carried out with the support of Cooperative Research
   Program for Agriculture Science and Technology Development (Project No.
   PJ00817601), Rural Development Administration, Republic of Korea.
CR [Anonymous], 1977, J Nutr, V107, P1340
   AOAC, 2003, AOAC OFF METH AN
   Berndt J, 2007, DIABETOLOGIA, V50, P1472, DOI 10.1007/s00125-007-0689-x
   BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Chakuton K., 2012, Asian Journal of Plant Sciences, V11, P285, DOI 10.3923/ajps.2012.285.293
   Choi WH, 2013, NUTR RES, V33, P572, DOI 10.1016/j.nutres.2013.04.006
   Cicero AFG, 2001, PHYTOTHER RES, V15, P277, DOI 10.1002/ptr.907
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GIBSON DM, 1960, BIOCHEM BIOPH RES CO, V3, P531, DOI 10.1016/0006-291X(60)90169-8
   HALMINSKI MA, 1991, J NUTR, V121, P1554
   HULCHER FH, 1973, J LIPID RES, V14, P625
   Kozuka C, 2013, OBES RES CLIN PRACT, V7, pE165, DOI 10.1016/j.orcp.2013.02.003
   Kwak E.J., 2010, J KOREAN SOC FOOD SC, V39, P1201
   Lazarow P B, 1981, Methods Enzymol, V72, P315
   Lee Y.R., 2005, J KOREAN SOC APPL BI, V48, P358
   Lee YR, 2007, ANN NUTR METAB, V51, P519, DOI 10.1159/000112733
   Marques-Vidal P, 2010, NUTR METAB CARDIOVAS, V20, P669, DOI 10.1016/j.numecd.2009.06.001
   Min B, 2012, FOOD CHEM, V133, P715, DOI 10.1016/j.foodchem.2012.01.079
   OCHOA S, 1955, METHOD ENZYMOL, V1, P735, DOI 10.1016/0076-6879(55)01128-2
   Oh CH, 2004, J MED FOOD, V7, P19, DOI 10.1089/109662004322984653
   Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003
   Patel M, 2004, J SCI IND RES INDIA, V63, P569
   Pitkanen E, 1997, EUR J CLIN CHEM CLIN, V35, P761
   Reitman S., 1975, METHODS ENZYMATIC AN
   Rewthong O, 2011, J FOOD ENG, V103, P258, DOI 10.1016/j.jfoodeng.2010.10.022
   Sang YJ, 2006, CARBOHYD POLYM, V63, P167, DOI 10.1016/j.carbpol.2005.07.022
   Seo WD, 2011, J KOREAN SOC APPL BI, V54, P700, DOI 10.3839/jksabc.2011.106
   Silha JV, 2006, OBESITY, V14, P1320, DOI 10.1038/oby.2006.150
   Son MJ, 2010, J CLIN BIOCHEM NUTR, V46, P150, DOI 10.3164/jcbn.09-98
   Stefanovic-Racic M, 2008, AM J PHYSIOL-ENDOC M, V294, pE969, DOI 10.1152/ajpendo.00497.2007
   Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI 10.1042/BST0331078
   Wang Y, 2006, DRUG DEVELOP RES, V67, P677, DOI 10.1002/ddr.20141
   Zhang LL, 2005, J FOOD BIOCHEM, V29, P653, DOI 10.1111/j.1745-4514.2005.00039.x
   Zhao SM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-6
   Zhu LJ, 2012, PLANT BIOTECHNOL J, V10, P353, DOI 10.1111/j.1467-7652.2011.00667.x
NR 36
TC 5
Z9 6
U1 3
U2 9
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUN
PY 2014
VL 6
IS 6
BP 2266
EP 2278
DI 10.3390/nu6062266
PG 13
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA AK1RA
UT WOS:000338192000011
PM 24932656
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Mewalal, R
   Mizrachi, E
   Mansfield, SD
   Myburg, AA
AF Mewalal, Ritesh
   Mizrachi, Eshchar
   Mansfield, Shawn D.
   Myburg, Alexander A.
TI Cell Wall-Related Proteins of Unknown Function: Missing Links in Plant
   Cell Wall Development
SO PLANT AND CELL PHYSIOLOGY
LA English
DT Review
DE Domain of unknown function; Plant cell wall; Proteins of obscure
   features; Proteins of unknown function
ID SECONDARY XYLEM DEVELOPMENT; ARABIDOPSIS-THALIANA; WOOD FORMATION;
   GENE-FUNCTION; CELLULOSE BIOSYNTHESIS; COEXPRESSION NETWORKS; LIGNIN
   BIOSYNTHESIS; REVERSE GENETICS; SUBCELLULAR-LOCALIZATION; BIOENERGY
   PRODUCTION
AB Lignocellulosic biomass is an important feedstock for the pulp and paper industry as well as emerging biofuel and biomaterial industries. However, the recalcitrance of the secondary cell wall to chemical or enzymatic degradation remains a major hurdle for efficient extraction of economically important biopolymers such as cellulose. It has been estimated that approximately 10-15% of about 27,000 protein-coding genes in the Arabidopsis genome are dedicated to cell wall development; however, only about 130 Arabidopsis genes thus far have experimental evidence validating cell wall function. While many genes have been implicated through co-expression analysis with known genes, a large number are broadly classified as proteins of unknown function (PUFs). Recently the functionality of some of these unknown proteins in cell wall development has been revealed using reverse genetic approaches. Given the large number of cell wall-related PUFs, how do we approach and subsequently prioritize the investigation of such unknown genes that may be essential to or influence plant cell wall development and structure? Here, we address the aforementioned question in two parts; we first identify the different kinds of PUFs based on known and predicted features such as protein domains. Knowledge of inherent features of PUFs may allow for functional inference and a concomitant link to biological context. Secondly, we discuss omics-based technologies and approaches that are helping identify and prioritize cell wall-related PUFs by functional association. In this way, hypothesis-driven experiments can be designed for functional elucidation of many proteins that remain missing links in our understanding of plant cell wall biosynthesis.
C1 [Mewalal, Ritesh; Mizrachi, Eshchar; Myburg, Alexander A.] Univ Pretoria, Dept Genet, FABI, ZA-0028 Pretoria, South Africa.
   [Mansfield, Shawn D.] Univ British Columbia, Dept Wood Sci, Vancouver, BC V6T 1Z4, Canada.
RP Myburg, AA (reprint author), Univ Pretoria, Dept Genet, FABI, Private Bag X20, ZA-0028 Pretoria, South Africa.
EM zander.myburg@up.ac.za
RI Mizrachi, Eshchar/N-3179-2014
OI Mansfield, Shawn/0000-0002-0175-554X; Myburg,
   Alexander/0000-0003-0644-5003
FU National Research Foundation of South Africa
FX The National Research Foundation of South Africa [a Prestigious and
   Equity PhD Scholarship to R.M.].
CR Albenne C, 2009, MOL PLANT, V2, P977, DOI 10.1093/mp/ssp059
   Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391
   Amoutzias GD, 2004, EMBO REP, V5, P274, DOI 10.1038/sj.embor.7400096
   Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013
   Asif M, 2007, RENEW SUST ENERG REV, V11, P1388, DOI 10.1016/j.rser.2005.12.004
   Atmodjo MA, 2013, ANNU REV PLANT BIOL, V64, P747, DOI 10.1146/annurev-arplant-042811-105534
   Bayer EM, 2006, PROTEOMICS, V6, P301, DOI 10.1002/pmic.200500046
   Bergmann S., 2003, PLOS BIOL, V2, P0085
   Bischoff V, 2010, PLANT SIGNAL BEHAV, V5, P1057, DOI 10.4161/psb.5.8.12414
   Bischoff V, 2010, PLANT PHYSIOL, V153, P590, DOI 10.1104/pp.110.153320
   Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095
   Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938
   BOLWELL GP, 1983, BIOCHEM J, V210, P497, DOI 10.1042/bj2100497
   Borderies G, 2003, ELECTROPHORESIS, V24, P3421, DOI 10.1002/elps.200305608
   Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003
   Bornberg-Bauer E, 2005, CELL MOL LIFE SCI, V62, P435, DOI 10.1007/s00018-004-4416-1
   Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008
   Bradford JR, 2010, PLANT J, V61, P713, DOI 10.1111/j.1365-313X.2009.04097.x
   Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232
   Brown D, 2011, PLANT J, V66, P401, DOI 10.1111/j.1365-313X.2011.04501.x
   Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542
   Capron A, 2013, J EXP BOT, V64, P185, DOI 10.1093/jxb/ers319
   Carpita N, 2001, PLANT MOL BIOL, V47, P1, DOI 10.1023/A:1010603527077
   Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125
   Cassman C.K., 2007, BIOFUEL BIOPROD BIOR, V1, P18
   Chaffey N, 2002, PHYSIOL PLANTARUM, V114, P594, DOI 10.1034/j.1399-3054.2002.1140413.x
   Chang VS, 2000, APPL BIOCHEM BIOTECH, V84-6, P5, DOI 10.1385/ABAB:84-86:1-9:5
   Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311
   Chavigneau H., 2012, OPEN J GENET, V2, P7
   Chen XY, 2009, J PLANT PHYSIOL, V166, P675, DOI 10.1016/j.jplph.2008.09.010
   Chivasa S, 2002, ELECTROPHORESIS, V23, P1754, DOI 10.1002/1522-2683(200206)23:11<1754::AID-ELPS1754>3.0.CO;2-E
   Chou KC, 2003, J CELL BIOCHEM, V90, P1250, DOI 10.1002/jcb.10719
   Clare A, 2006, BIOINFORMATICS, V22, P1130, DOI 10.1093/bioinformatics/btl051
   Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746
   Cosgrove DJ, 1997, ANNU REV CELL DEV BI, V13, P171, DOI 10.1146/annurev.cellbio.13.1.171
   Courtial A., 2013, THEOR APPL GENET, V126, P1
   Courtial A, 2012, MAYDICA, V57, P56
   Creux N.M., 2013, TREE GENET GENOMES, V9, P1
   Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335
   Demura T, 2002, P NATL ACAD SCI USA, V99, P15794, DOI 10.1073/pnas.232590499
   Ding J, 2012, PLANT PHYSIOL, V158, P145, DOI 10.1104/pp.111.186080
   Doering A, 2012, MOL PLANT, V5, P769, DOI 10.1093/mp/sss049
   Drevensek S, 2012, PLANT CELL, V24, P178, DOI 10.1105/tpc.111.089748
   Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755
   Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x
   Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131
   Feiz L, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-10
   Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047
   Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759
   Freeling M, 2009, CURR OPIN PLANT BIOL, V12, P126, DOI 10.1016/j.pbi.2009.01.005
   Galperin MY, 2010, TRENDS BIOTECHNOL, V28, P398, DOI 10.1016/j.tibtech.2010.05.006
   Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885
   Gao YS, 2012, PLANT CELL PHYSIOL, V53, P592, DOI 10.1093/pcp/pcs014
   Gao Y, 2011, J EXP BOT, V62, P3647, DOI 10.1093/jxb/err068
   Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646
   Gille S, 2011, PLANT CELL, V23, P4041, DOI 10.1105/tpc.111.091728
   Gollery M, 2007, TRENDS PLANT SCI, V12, P492, DOI 10.1016/j.tplants.2007.08.018
   Gollery M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r57
   Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944
   Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001
   Gu Y, 2010, P NATL ACAD SCI USA, V107, P12866, DOI 10.1073/pnas.1007092107
   GUNNERAS SA, 2006, PLANT J, V45, P144
   Hansen BG, 2008, TRENDS PLANT SCI, V13, P72, DOI 10.1016/j.tplants.2007.11.008
   Hansen S.F., 2012, FRONT PLANT SCI, V3, P1
   Hansen SF, 2009, J PROTEOME RES, V8, P743, DOI 10.1021/pr800808m
   Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863
   Hertzberg M, 2001, P NATL ACAD SCI USA, V98, P14732, DOI 10.1073/pnas.261293398
   Heyndrickx KS, 2012, PLANT PHYSIOL, V159, P884, DOI 10.1104/pp.112.196725
   Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016
   Horan K, 2008, PLANT PHYSIOL, V147, P41, DOI 10.1104/pp.108.117366
   Hossain Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030425
   HU HI, 1994, PLANT PHYSIOL, V105, P681, DOI 10.1104/pp.105.2.681
   Hu HN, 1996, J EXP BOT, V47, P227, DOI 10.1093/jxb/47.2.227
   Irshad M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-94
   Jamet E, 2006, TRENDS PLANT SCI, V11, P33, DOI [10.1016/j.tplants.2005.11.006, 10.1016/j.tplants.2005.11.008]
   Jamet E, 2008, PROTEOMICS, V8, P893, DOI 10.1002/pmic.200700938
   Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1
   Jensen JK, 2011, PLANT J, V66, P387, DOI 10.1111/j.1365-313X.2010.04475.x
   Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x
   Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240
   Kersting AR, 2012, GENOME BIOL EVOL, V4, P316, DOI 10.1093/gbe/evs004
   Ko JH, 2006, MOL GENET GENOMICS, V276, P517, DOI 10.1007/s00438-006-0157-1
   Ko JH, 2012, PLANT BIOTECHNOL J, V10, P587, DOI 10.1111/j.1467-7652.2012.00690.x
   Kourmpetis YAI, 2011, PLANT PHYSIOL, V155, P271, DOI 10.1104/pp.110.162164
   Kullan ARK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-60
   Kuromori T, 2004, PLANT J, V37, P897, DOI [10.1111/j.1365.313X.2004.02009.x, 10.1111/j.1365-313X.2003.02009.x]
   Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090
   Lan H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-358
   Lee C, 2012, PLANT CELL PHYSIOL, V53, P1934, DOI 10.1093/pcp/pcs138
   Lee CH, 2011, PLANT CELL PHYSIOL, V52, P1289, DOI 10.1093/pcp/pcr075
   Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603
   Lefebvre V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016645
   Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378
   Li SD, 2012, P NATL ACAD SCI USA, V109, P185, DOI 10.1073/pnas.1118560109
   Ligat L, 2011, PROTEOMICS, V11, P1798, DOI 10.1002/pmic.201000781
   Lloyd J, 2012, PLANT PHYSIOL, V158, P1115, DOI 10.1104/pp.111.192393
   Lockton S, 2005, TRENDS GENET, V21, P60, DOI 10.1016/j.tig.2004.11.013
   LOOMIS WD, 1992, BIOFACTORS, V3, P229
   Luhua S, 2008, PLANT PHYSIOL, V148, P280, DOI 10.1104/pp.108.124875
   Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612
   Mansfield SD, 2012, NEW PHYTOL, V194, P91, DOI 10.1111/j.1469-8137.2011.04031.x
   Mansfield SD, 2009, CURR OPIN BIOTECH, V20, P286, DOI 10.1016/j.copbio.2009.05.001
   McCann MC, 2008, CURR OPIN PLANT BIOL, V11, P314, DOI 10.1016/j.pbi.2008.04.001
   Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-99
   Millar DJ, 2009, PROTEOMICS, V9, P2355, DOI 10.1002/pmic.200800721
   Minic Z, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-6
   Mizrachi E, 2012, NEW PHYTOL, V194, P54, DOI 10.1111/j.1469-8137.2011.03971.x
   Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681
   Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153
   Mutwil M, 2011, PLANT CELL, V23, P895, DOI 10.1105/tpc.111.083667
   Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318
   Mutwil M, 2009, MOL PLANT, V2, P1015, DOI 10.1093/mp/ssp055
   Nookaraju A, 2013, MOL PLANT, V6, P8, DOI 10.1093/mp/sss111
   Obayashi T, 2011, PLANT CELL PHYSIOL, V52, P213, DOI 10.1093/pcp/pcq203
   Ohashi-Ito K, 2010, PLANT CELL, V22, P3461, DOI 10.1105/tpc.110.075036
   Ohtani M, 2011, PLANT J, V67, P499, DOI 10.1111/j.1365-313X.2011.04614.x
   Oikawa A., 2010, PLOS ONE, V5, P263
   Parsons HT, 2012, PLANT PHYSIOL, V159, P12, DOI 10.1104/pp.111.193151
   Patel RV, 2012, PLANT J, V71, P1038, DOI 10.1111/j.1365-313X.2012.05055.x
   Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102
   Pilate G, 2002, NAT BIOTECHNOL, V20, P607, DOI 10.1038/nbt0602-607
   Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.127.4.1513
   Pont-Lezica R, 2010, ADV GENET RES SER, V1, P265
   Price AH, 2006, TRENDS PLANT SCI, V11, P213, DOI 10.1016/j.tplants.2006.03.006
   Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065
   Quadrelli R, 2007, ENERG POLICY, V35, P5938, DOI 10.1016/j.enpol.2007.07.001
   Ranjan P, 2010, BIOENERG RES, V3, P172, DOI 10.1007/s12155-009-9060-z
   Reiter WD, 2002, CURR OPIN PLANT BIOL, V5, P536, DOI 10.1016/S1369-5266(02)00306-0
   Ro DK, 2001, PLANT PHYSIOL, V126, P317, DOI 10.1104/pp.126.1.317
   Rose JKC, 2010, PLANT PHYSIOL, V153, P433, DOI 10.1104/pp.110.154872
   Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a
   Rost B, 2003, CELL MOL LIFE SCI, V60, P2637, DOI 10.1007/s00018-003-3114-8
   Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190
   Ruprecht C., 2011, FRONT PLANT SCI, V2, P1
   Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006
   Schauer K., 2010, MICROBIAL PATHOGENOM, P48
   Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190
   Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630
   SHOWALTER AM, 1993, PLANT CELL, V5, P9
   Siew N, 2004, NUCLEIC ACIDS RES, V32, pD281, DOI 10.1093/nar/gkh116
   Siew N, 2003, PROTEINS, V53, P241, DOI 10.1002/prot.10423
   Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106
   Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765
   Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858
   Taylor NG, 2008, NEW PHYTOL, V178, P239, DOI 10.1111/j.1469-8137.2008.02385.x
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Urbanowicz BR, 2012, P NATL ACAD SCI USA, V109, P14253, DOI 10.1073/pnas.1208097109
   Vandepoele K, 2009, PLANT PHYSIOL, V150, P535, DOI 10.1104/pp.109.136028
   Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005
   Vanholme R, 2012, NEW PHYTOL, V196, P978, DOI 10.1111/j.1469-8137.2012.04337.x
   Vanholme R, 2012, PLANT CELL, V24, P3506, DOI 10.1105/tpc.112.102574
   Vazquez-Lobo A, 2012, MOL PHYLOGENET EVOL, V63, P510, DOI 10.1016/j.ympev.2012.02.001
   Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016
   Vogel JP, 2004, PLANT J, V40, P968, DOI 10.1111/j.1365-313X.2004.02264.x
   Walker MG, 1999, GENOME RES, V9, P1198, DOI 10.1101/gr.9.12.1198
   Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537
   Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009
   Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x
   Yamaguchi M, 2011, PLANT J, V66, P579, DOI 10.1111/j.1365-313x.2011.04514.x
   Yang XD, 2011, BUILD SIMUL-CHINA, V4, P181, DOI 10.1007/s12273-011-0047-2
   Ye CY, 2011, PLANT SCI, V181, P688, DOI 10.1016/j.plantsci.2011.01.021
   Yong WD, 2005, PLANTA, V221, P747, DOI 10.1007/s00425-005-1563-z
   Yuan YX, 2013, PLANT CELL PHYSIOL, V54, P1186, DOI 10.1093/pcp/pct070
   Zhong RQ, 2010, MOL PLANT, V3, P1087, DOI 10.1093/mp/ssq062
   Zhou YH, 2009, PLANT J, V57, P446, DOI 10.1111/j.1365-313X.2008.03703.x
   Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367
   Zuniga-Sanchez E., 2012, PROTEIN INTERACTIONS, P119
NR 167
TC 12
Z9 12
U1 1
U2 48
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0032-0781
EI 1471-9053
J9 PLANT CELL PHYSIOL
JI Plant Cell Physiol.
PD JUN
PY 2014
VL 55
IS 6
BP 1031
EP 1043
DI 10.1093/pcp/pcu050
PG 13
WC Plant Sciences; Cell Biology
SC Plant Sciences; Cell Biology
GA AK0TG
UT WOS:000338127800001
PM 24683037
OA Bronze
DA 2018-10-20
ER

PT J
AU LeBlanc, G
   Winter, KM
   Crosby, WB
   Jennings, GK
   Cliffel, DE
AF LeBlanc, Gabriel
   Winter, Kevin M.
   Crosby, William B.
   Jennings, G. Kane
   Cliffel, David E.
TI Integration of Photosystem I with Graphene Oxide for Photocurrent
   Enhancement
SO ADVANCED ENERGY MATERIALS
LA English
DT Article
ID ELECTRON-TRANSFER; GOLD ELECTRODE; MONOLAYERS; REDUCTION; COMPLEXES;
   PROTEIN
AB Photosystem I is a photoactive membrane protein used in nature to photo-excite electrons with nearly unit internal quantum efficiency, sparking interest in using this biomaterial for solar energy conversion. Films of PSI deposited on p-doped silicon have previously demonstrated significant photocurrents with an electrochemical mediator; however, improvement in electron transfer is needed. Here, it is investigated how PSI can be combined with graphene oxide (GO) or reduced graphene oxide (RGO) to generate composite films capable of improved photoelectrochemical performance. It is found that both composite films outperformed the PSI film alone, and the PSI-GO composite film is found to perform the best. The enhancement is attributed to the decreased impedance and shift in the onset potential of the composite films.
C1 [LeBlanc, Gabriel; Winter, Kevin M.; Crosby, William B.; Cliffel, David E.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA.
   [Jennings, G. Kane] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA.
RP Cliffel, DE (reprint author), Vanderbilt Univ, Dept Chem, Box 1583, Nashville, TN 37235 USA.
EM d.cliffel@vanderbilt.edu
FU National Science Foundation [DMR 0907619]; NSF EPSCoR [EPS 1004083];
   USDA [2013-67021-21029]; Scialog Program from the Research Corporation
   for Science Advancement; ACS Division of Analytical Chemistry Summer
   Fellowship
FX We gratefully acknowledge the financial support from the National
   Science Foundation (DMR 0907619), the NSF EPSCoR (EPS 1004083), the USDA
   (2013-67021-21029), and the Scialog Program from the Research
   Corporation for Science Advancement. G. L. was supported in part by an
   ACS Division of Analytical Chemistry Summer Fellowship.
CR Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687
   Baba K, 1996, PHOTOSYNTH RES, V47, P121, DOI 10.1007/BF00016175
   Badura A, 2011, ENERG ENVIRON SCI, V4, P3263, DOI 10.1039/c1ee01285a
   Bai H, 2010, CHEM COMMUN, V46, P2376, DOI 10.1039/c000051e
   Brettel K, 2001, BBA-BIOENERGETICS, V1507, P100, DOI 10.1016/S0005-2728(01)00202-X
   Carmeli I, 2007, J AM CHEM SOC, V129, P12352, DOI 10.1021/ja073040c
   Ciesielski PN, 2010, ADV FUNCT MATER, V20, P4048, DOI 10.1002/adfm.201001193
   Ciesielski PN, 2010, BIORESOURCE TECHNOL, V101, P3047, DOI 10.1016/j.biortech.2009.12.045
   Ciobanu M, 2005, LANGMUIR, V21, P692, DOI 10.1021/la048075
   Ciobanu M, 2007, J ELECTROANAL CHEM, V599, P72, DOI 10.1016/j.jelechem.2006.09.019
   Das R, 2004, NANO LETT, V4, P1079, DOI 10.1021/nl049579f
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Faulkner CJ, 2008, LANGMUIR, V24, P8409, DOI 10.1021/la800670b
   Fernandez-Merino MJ, 2010, J PHYS CHEM C, V114, P6426, DOI 10.1021/jp100603h
   Frolov L, 2005, ADV MATER, V17, P2434, DOI 10.1002/adma.200500295
   Gunther D., 2013, LANGMUIR
   Kondo M, 2012, BIOMACROMOLECULES, V13, P432, DOI 10.1021/bm201457s
   LeBlanc G, 2012, ADV MATER, V24, P5959, DOI 10.1002/adma.201202794
   Li CX, 2012, NAT NANOTECHNOL, V7, P421, DOI [10.1038/NNANO.2012.62, 10.1038/nnano.2012.62]
   Mao S, 2012, RSC ADV, V2, P2643, DOI 10.1039/c2ra00663d
   Mershin A., 2012, SCI REP, P234
   Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740
   Reeves SG, 1980, METHOD ENZYMOL, V69, P85
   Singh V, 2011, PROG MATER SCI, V56, P1178, DOI 10.1016/j.pmatsci.2011.03.003
   Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969
   Terasaki N, 2009, ANGEW CHEM INT EDIT, V48, P1585, DOI 10.1002/anie.200805748
   Yan X, 2012, LANGMUIR, V28, P15080, DOI 10.1021/la302611a
NR 27
TC 12
Z9 12
U1 4
U2 54
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1614-6832
EI 1614-6840
J9 ADV ENERGY MATER
JI Adv. Energy Mater.
PD JUN
PY 2014
VL 4
IS 9
AR 1301953
DI 10.1002/aenm.201301953
PG 5
WC Chemistry, Physical; Energy & Fuels; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Energy & Fuels; Materials Science; Physics
GA AJ9IL
UT WOS:000338022300022
DA 2018-10-20
ER

PT J
AU Amini, AA
   Nair, LS
AF Amini, Ashley A.
   Nair, Lakshmi S.
TI Recombinant Human Lactoferrin as a Biomaterial for Bone Tissue
   Engineering: Mechanism of Antiapoptotic and Osteogenic Activity
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID TRANSCRIPTION FACTOR; BETA-CATENIN; OSTEOBLASTIC CELLS; SIGNALING
   PATHWAYS; HYDROGELS; ACID; DELIVERY; GROWTH; WNT; DIFFERENTIATION
AB Lactoferrin is a bioactive globular protein with unique properties towards musculo-skeletal cells and anabolic to bone in vivo. Even though the potent anti-apoptotic and osteogenic activity of lactoferrin has been reported, the mechanism of action has not been fully elucidated. The study demonstrates that the anti-apoptotic effect of rhLF towards MC3T3 pre-osteoblast cells is mediated by Wnt5a/PKA pathway and the stabilization of beta-catenin by rhLF is dependent on PKA/LRP6 signaling pathway. The study also investigates the feasibility of developing rhLF as a biomaterial for cell delivery. The injectable rhLF cell delivery vehicles are prepared by enzymatic crosslinking of tyramine-modified rhLF in the presence of hydrogen peroxide and horseradish peroxidase. The modified rhLF shows bioactivity similar to unmodified rhLF. The rhLF gels support encapsulated MC3T3 cell viability, proliferation, and differentiation, as well as phosphorylation of signaling proteins. In conclusion, the study demonstrates the involvement of Wnt5a, LRP6, and PKA signaling in rhLF-mediated bioactivity towards MC3T3 cells and the feasibility of developing an injectable cell delivery vehicle from rhLF.
C1 [Amini, Ashley A.] Univ Connecticut, Ctr Hlth, Sch Dent Med, Farmington, CT 06030 USA.
   [Nair, Lakshmi S.] Univ Connecticut, Ctr Hlth, Dept Orthoped Surg, Inst Regenerat Engn Raymond, Farmington, CT 06030 USA.
   [Nair, Lakshmi S.] Univ Connecticut, Ctr Hlth, Beverly Sackler Ctr Biomed Biol Phys & Engn Sci, Farmington, CT 06030 USA.
   [Nair, Lakshmi S.] Univ Connecticut, Inst Mat Sci, Dept Chem Mat & Biomol Engn Biomed Engn, Storrs, CT 06269 USA.
RP Nair, LS (reprint author), Univ Connecticut, Ctr Hlth, Dept Orthoped Surg, Inst Regenerat Engn Raymond, Farmington, CT 06030 USA.
EM nair@uchc.edu
FU Department of Defense [W81XWH-10-1-0947]; NIH [AR-061575]; NIH (F30)
   [DE022497]; UConn CSTC; Raymond and Beverly Sackler Center for
   Biomedical, Biological, Physical and Engineering Sciences
FX The authors greatly acknowledge the support from the Department of
   Defense (W81XWH-10-1-0947), NIH AR-061575, NIH (F30) DE022497, UConn
   CSTC and from Raymond and Beverly Sackler Center for Biomedical,
   Biological, Physical and Engineering Sciences, and Dr. Zhanwu Cui for
   helping with the in vivo studies.
CR Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502165200
   Amini AA, 2011, CURR MED CHEM, V18, P1220
   Amini A. A., 2011, BIOMED MATER, V7
   Amini AA, 2013, TISSUE ENG PT A, V19, P1047, DOI [10.1089/ten.tea.2012.0227, 10.1089/ten.TEA.2012.0227]
   Amini AA, 2012, J BIOACT COMPAT POL, V27, P342, DOI 10.1177/0883911512444713
   Blais A, 2009, AM J PHYSIOL-ENDOC M, V296, pE1281, DOI 10.1152/ajpendo.90938.2008
   BROCK JH, 1976, BIOCHIM BIOPHYS ACTA, V446, P214, DOI 10.1016/0005-2795(76)90112-4
   Chaudhary LR, 2000, J CELL BIOCHEM, V76, P354, DOI 10.1002/(SICI)1097-4644(20000301)76:3<354::AID-JCB2>3.0.CO;2-U
   Chen SX, 1999, EUR J BIOCHEM, V260, P726, DOI 10.1046/j.1432-1327.1999.00199.x
   Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249
   Cornish J, 2004, BIOMETALS, V17, P331, DOI 10.1023/B:BIOM.0000027713.18694.91
   Cornish J, 2004, ENDOCRINOLOGY, V145, P4366, DOI 10.1210/en.2003-1307
   Davis J. R., 2000, AM INDIAN LAW REV, P1
   Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Fernandez-Tresguerres-Hernandez-Gil Isabel, 2006, Med Oral Patol Oral Cir Bucal, V11, pE47
   Fernandez-Tresguerres-Hernandez-Gil Isabel, 2006, Med Oral Patol Oral Cir Bucal, V11, pE151
   Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188
   Ganesh N, 2013, INT J BIOL MACROMOL, V55, P289, DOI 10.1016/j.ijbiomac.2012.12.045
   Gonzalez-Chavez SA, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.020
   Grey A, 2006, MOL CELL ENDOCRINOL, V251, P96, DOI 10.1016/j.mce.2006.03.002
   Huang N, 2008, IN VITRO CELL DEV-AN, V44, P464, DOI 10.1007/s11626-008-9136-7
   Jin R, 2010, BIOMATERIALS, V31, P3103, DOI 10.1016/j.biomaterials.2010.01.013
   Jin R, 2010, TISSUE ENG PT A, V16, P2429, DOI [10.1089/ten.tea.2009.0764, 10.1089/ten.TEA.2009.0764]
   Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014
   Komori T, 2002, J CELL BIOCHEM, V87, P1, DOI 10.1002/jcb.10276
   Lai CF, 2002, J BIOL CHEM, V277, P15514, DOI 10.1074/jbc.M200794200
   Lee F, 2009, J CONTROL RELEASE, V134, P186, DOI 10.1016/j.jconrel.2008.11.028
   Lih E, 2012, ACTA BIOMATER, V8, P3261, DOI 10.1016/j.actbio.2012.05.001
   Lorget F, 2002, BIOCHEM BIOPH RES CO, V296, P261, DOI 10.1016/S0006-291X(02)00849-5
   Lumelsky NL, 2007, TISSUE ENG, V13, P1393, DOI 10.1089/ten.2007.0100
   Marolt D, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt10
   Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   Nair LS, 2007, BIOMACROMOLECULES, V8, P3779, DOI 10.1021/bm7006967
   Sakai S., 2010, J BIOMATER SCI POLYM
   Sakai S, 2008, J BIOMED MATER RES A, V85A, P345, DOI 10.1002/jbm.a.31299
   Silkstone D, 2008, NAT CLIN PRACT RHEUM, V4, P413, DOI 10.1038/ncprheum0838
   Tang L, 2010, WOUND REPAIR REGEN, V18, P123, DOI 10.1111/j.1524-475X.2009.00563.x
   Torii K, 2008, CELL SIGNAL, V20, P1256, DOI 10.1016/j.cellsig.2008.02.013
   Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453
NR 41
TC 6
Z9 6
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUN
PY 2014
VL 3
IS 6
BP 897
EP 905
DI 10.1002/adhm.201300496
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA AJ5AO
UT WOS:000337692900015
PM 24352833
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lemon, G
   Lim, ML
   Ajalloueian, F
   Macchiarini, P
AF Lemon, Greg
   Lim, Mei Ling
   Ajalloueian, Fatemeh
   Macchiarini, Paolo
TI The development of the bioartificial lung
SO BRITISH MEDICAL BULLETIN
LA English
DT Article
DE lung failure; artificial lung; stem cells
ID EMBRYONIC STEM-CELLS; ARTIFICIAL PUMP-LUNG; EXTRACELLULAR-MATRIX;
   RESPIRATORY SUPPORT; ENDOTHELIAL-CELLS; IN-VITRO; TISSUE; BIOMATERIALS;
   SCAFFOLDS; MODEL
AB The incidence of chronic lung disease is increasing worldwide due to the spread of risk factors and ageing population. An important advance in treatment would be the development of a bioartificial lung where the blood-gas exchange surface is manufactured from a synthetic or natural scaffold material that is seeded with the appropriate stem or progenitor cells to mimic the functional tissue of the natural lung.
   Articles relating to bioartificial lungs were sourced through PubMed and ISI Web of Knowledge.
   There is a consensus that advances in bioartificial lung engineering will be beneficial to patients with chronic lung failure. Ultimate success will require the concerted efforts of researchers drawn from a broad range of disciplines, including clinicians, cell biologists, materials scientists and engineers.
   As a source of cells for use in bioartificial lungs it is proposed to use human embryonic stem cells; however, there are ethical and safety concerns regarding the use of these cells.
   There is a need to identify the optimum strategies for differentiating progenitor cells into functional lung cells; a need to better understand cell-biomaterial/ECM interactions and a need to understand how to harness the body's natural capacity to regenerate the lung.
   Biomaterial technologies for recreating the natural lung ECM and architecture need further development. Mathematical modelling techniques should be developed for determining optimal scaffold seeding strategies and predicting gas exchange performance.
C1 [Lemon, Greg; Lim, Mei Ling; Ajalloueian, Fatemeh; Macchiarini, Paolo] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Adv Ctr Translat Regenerat Med ACTREM, SE-14186 Stockholm, Sweden.
   [Lim, Mei Ling; Macchiarini, Paolo] Karolinska Univ Hosp, Div Ear Nose & Throat, Stockholm, Sweden.
RP Macchiarini, P (reprint author), Karolinska Inst, Adv Ctr Translat & Regenerat Med, KFC Novum, Halsovagen 7,Hiss A,Plan 6,Exp 615, SE-14186 Stockholm, Sweden.
EM paolo.macchiarini@ki.se
RI Lim, Mei Ling/N-8596-2014; Ajalloueian, Fatemeh/N-2827-2017;
   Ajalloueian, Fatemeh/O-3121-2017; Macchiarini, Paolo/E-6878-2013;
   Ajalloueian, Fatemeh/S-5033-2018
OI Ajalloueian, Fatemeh/0000-0001-5061-827X; Ajalloueian,
   Fatemeh/0000-0001-5061-827X; Ajalloueian, Fatemeh/0000-0001-5061-827X
FU Harvard Apparatus Regenerative Technology Inc.
FX G.L. and F.A. are supported by fellowships from Harvard Apparatus
   Regenerative Technology Inc.
CR Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Banerjee ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033165
   Bartlett RH, 2005, ASAIO J, V51, P487, DOI 10.1097/01.mat.0000179141.08834.cb
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Burgess KA, 2009, BIOMED MICRODEVICES, V11, P117, DOI 10.1007/s10544-008-9215-2
   Chang R, 2008, TISSUE ENG PT C-METH, V14, P157, DOI 10.1089/ten.tec.2007.0392
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Chung S, 2011, BIOTECHNOL APPL BIOC, V58, P423, DOI 10.1002/bab.60
   Consigny PM, 1998, J VASC INTERV RADIOL, V9, P479, DOI 10.1016/S1051-0443(98)70303-3
   Daly AB, 2012, TISSUE ENG PT A, V18, P1, DOI [10.1089/ten.tea.2011.0301, 10.1089/ten.TEA.2011.0301]
   Fan W, 2011, DIFFERENTIATION, V81, P181, DOI 10.1016/j.diff.2010.12.003
   Fritsche CS, 2009, INT J ARTIF ORGANS, V32, P701
   Galletti PM, 2000, BIOMEDICAL ENG HDB, P1
   Garcia JP, 2010, J THORAC CARDIOVASC, V139, P137
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hoganson DM, 2011, LAB CHIP, V11, P700, DOI 10.1039/c0lc00158a
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Jungebluth P, 2009, J THORAC CARDIOV SUR, V138, P586, DOI 10.1016/j.jtcvs.2008.09.085
   Kaestle SM, 2007, AM J PHYSIOL-LUNG C, V293, P859
   Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324
   Kassmer SH, 2010, EXP HEMATOL, V38, P564, DOI 10.1016/j.exphem.2010.04.011
   Liu MY, 2000, J APPL PHYSIOL, V89, P2078
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Miller C, 2010, J TISSUE ENG REGEN M, V4, P619, DOI 10.1002/term.277
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Polk AA, 2010, BIOTECHNOL BIOENG, V106, P490, DOI 10.1002/bit.22675
   Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]
   Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040
   Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Song JJ, 2012, AM J TRANSPLANT, V12, P283, DOI 10.1111/j.1600-6143.2011.03808.x
   Sueblinvong V, 2008, AM J RESP CRIT CARE, V177, P701, DOI 10.1164/rccm.200706-859OC
   Taskin ME, 2012, J MED DEVICES, V6, P12
   Tawhai M. H., 2011, Critical Reviews in Biomedical Engineering, V39, P319, DOI 10.1615/CritRevBiomedEng.v39.i4.50
   Vats A, 2005, J ROY SOC MED, V98, P346, DOI 10.1258/jrsm.98.8.346
   Vittet D, 1996, BLOOD, V88, P3424
   Wagner WR, 2010, SCIENCE, V329, P520, DOI 10.1126/science.1194087
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wu ZJJ, 2012, ARTIF ORGANS, V36, P387, DOI 10.1111/j.1525-1594.2011.01369.x
   Wu ZJJ, 2012, ANN THORAC SURG, V93, P274, DOI 10.1016/j.athoracsur.2011.08.076
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Yoshikawa HY, 2012, J PHYS CHEM B, V116, P8024, DOI 10.1021/jp212385p
NR 51
TC 6
Z9 6
U1 0
U2 20
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-1420
EI 1471-8391
J9 BRIT MED BULL
JI Br. Med. Bull.
PD JUN
PY 2014
VL 110
IS 1
BP 35
EP 45
DI 10.1093/bmb/ldt037
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA AJ8RL
UT WOS:000337974600004
PM 24352896
OA Bronze
DA 2018-10-20
ER

PT J
AU Pereira, R
   Benelli, R
   Scaranari, M
   Canciani, B
   Daculsi, G
   Cancedda, R
   Gentili, C
AF Pereira, R.
   Benelli, R.
   Scaranari, M.
   Canciani, B.
   Daculsi, G.
   Cancedda, R.
   Gentili, C.
TI Calcium biomaterial-released ions effect on human mesenchymal stromal
   cells results in robust in vivo bone formation sustained by a consistent
   angiogenesis
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Pereira, R.; Scaranari, M.; Canciani, B.; Cancedda, R.; Gentili, C.] Univ Genoa, Dept Expt Med, Genoa, Italy.
   [Pereira, R.; Scaranari, M.; Canciani, B.; Cancedda, R.; Gentili, C.] Regenerat Med Units AOU San Martino IST, Genoa, Italy.
   [Benelli, R.] Immunol Units AOU San Martino, Genoa, Italy.
   [Daculsi, G.] Univ Nantes, INSERM, Nantes, France.
RI Daculsi, Guy/P-1320-2014
OI Daculsi, Guy/0000-0003-1030-3446
CR Cancedda R, 2001, N ENGL J MED
   Daculsi G, 2008, BIOMATERIALS, P4
   Ripamonti C, 2011, INJURY
NR 3
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2014
VL 8
SU 1
SI SI
MA OP236
BP 168
EP 169
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AJ4AW
UT WOS:000337612600304
DA 2018-10-20
ER

PT J
AU Thery, A
   Blery, P
   Malard, O
   Guicheux, J
   Pilet, P
   Sourice, S
   Weiss, P
   Espitalier, F
AF Thery, A.
   Blery, P.
   Malard, O.
   Guicheux, J.
   Pilet, P.
   Sourice, S.
   Weiss, P.
   Espitalier, F.
TI Role of the stromal vascular fraction from adipose tissue associated to
   a biomaterial to regenerate bone in irradiated area
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
ID MESENCHYMAL STEM-CELLS
C1 [Thery, A.; Malard, O.; Espitalier, F.] Univ Hosp, Serv Chirurg Cerv Faciale, INSERM, U791,LIOAD, Nantes, France.
   [Blery, P.; Guicheux, J.; Pilet, P.; Sourice, S.; Weiss, P.] Univ Nantes, INSERM, U791, LIOAD, Nantes, France.
RI guicheux, Jerome/F-7767-2013; Espitalier, Florent/P-6582-2014; Weiss,
   Pierre/P-1372-2014; Paul, Pilet/A-3755-2015; Blery, Pauline/P-6279-2014;
   Malard, Olivier/A-4742-2012
OI guicheux, Jerome/0000-0003-2754-3024; Weiss, Pierre/0000-0002-6159-8590;
   
CR Astori G, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-55
   Espitalier F, 2009, BIOMATERIALS, V30, P763, DOI 10.1016/j.biomaterials.2008.10.051
   Kim A, 2012, CYTOTHERAPY, V14, P296, DOI 10.3109/14653249.2011.627915
NR 3
TC 0
Z9 0
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2014
VL 8
SU 1
SI SI
MA OP270
BP 187
EP 187
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AJ4AW
UT WOS:000337612600337
DA 2018-10-20
ER

PT J
AU Mamonov, V
   Drize, N
   Chemis, A
   Berkovskiy, A
   Sats, N
   Proskurina, N
   Kargaltsev, A
   Komlev, V
AF Mamonov, V.
   Drize, N.
   Chemis, A.
   Berkovskiy, A.
   Sats, N.
   Proskurina, N.
   Kargaltsev, A.
   Komlev, Vladimir
TI Composite biomaterial based on fibrin hydrogel and beta-threecalcium
   phosphate granules as the carrier of autologous multipotent mesenchymal
   stromal cells: in vivo study on the rabbit model
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Mamonov, V.; Drize, N.; Chemis, A.; Berkovskiy, A.; Sats, N.; Proskurina, N.; Kargaltsev, A.] Russian Natl Hematol Res Ctr, Moscow, Russia.
   [Komlev, Vladimir] Baikov Inst Met & Mat Sci RAS, Moscow, Russia.
RI komlev, vladimir/F-8678-2010
OI komlev, vladimir/0000-0003-2068-7746
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2014
VL 8
SU 1
SI SI
MA PP54
BP 237
EP 237
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AJ4AW
UT WOS:000337612600424
DA 2018-10-20
ER

PT J
AU Pilmane, M
   Salma, I
   Salms, G
   Skagers, A
   Loca, D
AF Pilmane, M.
   Salma, I.
   Salms, G.
   Skagers, A.
   Loca, D.
TI Combination of biomaterial and stem cell implants for treatment of
   osteoporotic bone in experimental animals
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Pilmane, M.] Riga Stradins Univ, Inst Anat & Anthropol, Riga, Latvia.
   [Salma, I.; Salms, G.; Skagers, A.] Riga Stradins Univ, Inst Stomatol, Riga, Latvia.
   [Loca, D.] R Cimdins Riga Biomat Innovat & Dev Ctr, Riga, Latvia.
CR Cao L, 2012, BIOMATERIALS, V33, P5076, DOI 10.1016/j.biomaterials.2012.03.069
   Moore A, 2013, J AM ACAD NURSE PRAC, V25, P126, DOI 10.1111/j.1745-7599.2012.00804.x
   von Schewelov T, 2012, ACTA ORTHOP, V83, P153, DOI 10.3109/17453674.2011.641107
   Yu ZR, 2012, INT ORTHOP, V36, P2163, DOI 10.1007/s00264-012-1543-4
NR 4
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2014
VL 8
SU 1
SI SI
MA PP168
BP 305
EP 305
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AJ4AW
UT WOS:000337612600531
DA 2018-10-20
ER

PT J
AU Terada, D
   Hattori, S
   Kobayashi, H
   Tamada, Y
AF Terada, D.
   Hattori, S.
   Kobayashi, H.
   Tamada, Y.
TI The outermost surface properties of silk fibroin films reflect
   ethanol-insolubilization conditions in biomaterial use
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Terada, D.] Toyama Ind Technol Ctr, Takaoka, Toyama 9330981, Japan.
   [Hattori, S.; Kobayashi, H.] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan.
   [Tamada, Y.] Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 386, Japan.
RI kobayashi, hisatoshi/H-2720-2011
OI kobayashi, hisatoshi/0000-0001-9487-0725
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2014
VL 8
SU 1
SI SI
MA PP232
BP 343
EP 343
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AJ4AW
UT WOS:000337612600593
DA 2018-10-20
ER

PT J
AU Herrero-Mendez, A
   Castro, B
   Alonso-Varona, A
   Granado, MH
   Herrero, J
   Palomares, T
AF Herrero-Mendez, A.
   Castro, B.
   Alonso-Varona, A.
   Granado, M. H.
   Herrero, J.
   Palomares, T.
TI Scaling up manufacturing of HR007: a new biomaterial from porcine origin
   that mimic extracellular matrix
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Herrero-Mendez, A.; Castro, B.; Granado, M. H.; Herrero, J.] Histocell, Histocell SL, Derio, Spain.
   [Alonso-Varona, A.; Palomares, T.] Univ Basque Country UPV EHU, Fac Med, Leioa, Spain.
CR Herrero-Mendez A, 2014, J TISSUE EN IN PRESS
NR 1
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2014
VL 8
SU 1
SI SI
MA PP411
BP 445
EP 446
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AJ4AW
UT WOS:000337612601102
DA 2018-10-20
ER

PT J
AU Malayeri, A
   Hatton, PV
   Ortega, I
   Claeyssens, F
AF Malayeri, A.
   Hatton, P. V.
   Ortega, I.
   Claeyssens, F.
TI In vitro biocompatibility of a poly(high internal phase emulsion)
   biomaterial
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Malayeri, A.; Hatton, P. V.; Ortega, I.; Claeyssens, F.] Univ Sheffield, Ctr Biomat & Tissue Engn, Sheffield, S Yorkshire, England.
RI Ortega, Ilida/G-1036-2015
CR Johnson DW, 2013, ADV MATER, V25, P3178, DOI 10.1002/adma.201300552
NR 1
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2014
VL 8
SU 1
SI SI
MA PP426
BP 452
EP 453
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AJ4AW
UT WOS:000337612601115
DA 2018-10-20
ER

PT J
AU Street, M
   Musson, D
   Calon, K
   Tuari, D
   Cornish, J
   Coleman, B
AF Street, M.
   Musson, D.
   Calon, K.
   Tuari, D.
   Cornish, J.
   Coleman, B.
TI Rotator cuff repair; an in vivo study utilizing novel
   biomaterial/lactoferrin scaffolds
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Street, M.; Musson, D.; Calon, K.; Tuari, D.; Cornish, J.; Coleman, B.] Univ Auckland, Auckland 1, New Zealand.
CR Cornish J, 2004, BIOMETALS, V17, P331, DOI 10.1023/B:BIOM.0000027713.18694.91
   Duquin TR, 2010, AM J SPORT MED, V38, P835, DOI 10.1177/0363546509359679
   Gallatz LM, 2004, J BONE JOINT SURG AM, V86-A, P219
   Mall NA, 2013, ARTHROSCOPY, V29, P366, DOI 10.1016/j.arthro.2012.06.024
NR 4
TC 0
Z9 0
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2014
VL 8
SU 1
SI SI
MA PP504
BP 497
EP 497
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AJ4AW
UT WOS:000337612601187
DA 2018-10-20
ER

PT J
AU Armentano, I
   Montanucci, P
   Morena, F
   Bicchi, I
   Basta, G
   Fortunati, E
   Mattioli, S
   Calafiore, R
   Martino, S
   Kenny, JM
AF Armentano, I.
   Montanucci, P.
   Morena, F.
   Bicchi, I.
   Basta, G.
   Fortunati, E.
   Mattioli, S.
   Calafiore, R.
   Martino, S.
   Kenny, J. M.
TI Nano-engineered PLLA based biomaterial drives stem cell responses
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Meeting Abstract
C1 [Armentano, I.; Fortunati, E.; Mattioli, S.; Kenny, J. M.] Univ Perugia, UdR INSTM, Mat Engn Ctr, Terni, Italy.
   [Montanucci, P.; Basta, G.; Calafiore, R.] Univ Perugia, Dept Internal Med, I-06100 Perugia, Italy.
   [Morena, F.; Bicchi, I.; Martino, S.] Univ Perugia, Dept Chem Biol & Biotechnol, I-06100 Perugia, Italy.
RI Mattioli, Samantha/K-2101-2013; Martino, Sabata/F-2309-2014
OI Martino, Sabata/0000-0002-3942-237X
CR Armentano I, 2014, PROGR POLYM SCI, V38, P1720
   D'Angelo F, 2012, BIOMACROMOLECULES, V13, P1350, DOI 10.1021/bm3000716
NR 2
TC 0
Z9 0
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2014
VL 8
SU 1
SI SI
MA PP512
BP 501
EP 502
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AJ4AW
UT WOS:000337612601193
DA 2018-10-20
ER

PT J
AU Kim, SE
   Wang, J
   Jordan, AM
   Korley, LTJ
   Baer, E
   Pokorski, JK
AF Kim, Si-Eun
   Wang, Jia
   Jordan, Alex M.
   Korley, LaShanda T. J.
   Baer, Eric
   Pokorski, Jonathan K.
TI Surface Modification of Melt Extruded Poly(epsilon-caprolactone)
   Nanofibers: Toward a New Scalable Biomaterial Scaffold
SO ACS MACRO LETTERS
LA English
DT Article
ID AZIDE-ALKYNE CYCLOADDITION; ELECTROSPUN NANOFIBERS; RADICAL
   POLYMERIZATION; CELL-MIGRATION; PCL; GELATIN; POLYCAPROLACTONE;
   DIFFERENTIATION; OPTIMIZATION; COMPOSITES
AB A photochemical modification of melt-extruded polymeric nanofibers is described. A bioorthogonal functional group is used to decorate fibers made exclusively from commodity polymers, covalently attach fluorophores and peptides, and direct cell growth. Our process begins by using a layered coextrusion method, where poly(e-caprolactone) (PCL) nanofibers are incorporated within a macroscopic poly(ethylene oxide) (PEO) tape through a series of die multipliers within the extrusion line. The PEO layer is then removed with a water wash to yield rectangular PCL nanofibers with controlled cross-sectional dimensions. The fibers can be subsequently modified using photochemistry to yield a "clickable" handle for performing the copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction on their surface. We have attached fluorophores, which exhibit dense surface coverage when using ligand-accelerated CuAAC reaction conditions. In addition, an RGD peptide motif was coupled to the surface of the fibers. Subsequent cell-based studies have shown that the RGD peptide is biologically accessible at the surface, leading to increased cellular adhesion and spreading versus PCL control surfaces. This functionalized coextruded fiber has the advantages of modularity and scalability, opening a potentially new avenue for biomaterials fabrication.
C1 [Kim, Si-Eun; Wang, Jia; Jordan, Alex M.; Korley, LaShanda T. J.; Baer, Eric; Pokorski, Jonathan K.] Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA.
RP Pokorski, JK (reprint author), Case Western Reserve Univ, Dept Macromol Sci & Engn, Cleveland, OH 44106 USA.
EM jon.pokorski@case.edu
OI Pokorski, Jonathan/0000-0001-5869-6942; Korley,
   LaShanda/0000-0002-8266-5000
FU National Science Foundation (NSF) Center for Layered Polymeric Systems
   [DMR 0423914]; NIH [R00EB011530]; NSF [DMR 0423914, CMMI 1335276];
   Defense University Research Instrumentation Program [W911NF1110343]
FX J.K.P. acknowledges the National Science Foundation (NSF) Center for
   Layered Polymeric Systems for start-up funds (DMR 0423914) and generous
   use of the center's confocal microscope, as well as a NIH Pathway to
   Independence Award for funding (R00EB011530). E.B. and L.T.J.K.
   acknowledge funding from the NSF (DMR 0423914 (E.B., L.T.J.K.) and CMMI
   1335276 (L.T.J.K)). Prof. Horst von Recum is thanked for the donation of
   the NIH3T3 cells, and Jack Edelbrock is thanked for his assistance in
   figure making. L.T.J.K. also acknowledges funding from the Defense
   University Research Instrumentation Program (Grant W911NF1110343).
CR Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Callahan LAS, 2013, BIOMATERIALS, V34, P9089, DOI 10.1016/j.biomaterials.2013.08.028
   Canesi EV, 2012, ACS MACRO LETT, V1, P366, DOI 10.1021/mz200208b
   Causa F, 2010, LANGMUIR, V26, P9875, DOI 10.1021/la100207q
   Chen M, 2011, ACS NANO, V5, P1549, DOI 10.1021/nn103577g
   Choi JS, 2011, J MATER CHEM, V21, P5258, DOI 10.1039/c0jm03706k
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   Dias J, 2013, ADV MATER RES-SWITZ, V683, P137, DOI 10.4028/www.scientific.net/AMR.683.137
   Dongargaonkar AA, 2013, BIOMACROMOLECULES, V14, P4038, DOI 10.1021/bm401143p
   Ghasemi-Mobarakeh L, 2010, MAT SCI ENG C-MATER, V30, P1129, DOI 10.1016/j.msec.2010.06.004
   Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050
   Hartman O, 2010, BIOMATERIALS, V31, P5700, DOI 10.1016/j.biomaterials.2010.03.017
   Hartman O, 2009, BIOMACROMOLECULES, V10, P2019, DOI 10.1021/bm8012764
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087
   Lagunas A, 2012, NANOMED-NANOTECHNOL, V8, P432, DOI 10.1016/j.nano.2011.08.001
   Lancuski A, 2012, ACS APPL MATER INTER, V4, P6499, DOI 10.1021/am301458y
   Li K, 2014, J THERM ANAL CALORIM, V116, P1351, DOI 10.1007/s10973-013-3583-4
   Liu WW, 2013, ACS MACRO LETT, V2, P466, DOI 10.1021/mz4000688
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   Ma HY, 2012, ACS MACRO LETT, V1, P723, DOI 10.1021/mz300163h
   McClure MJ, 2012, J MECH BEHAV BIOMED, V10, P48, DOI 10.1016/j.jmbbm.2012.02.026
   Persano L, 2013, MACROMOL MATER ENG, V298, P504, DOI 10.1002/mame.201200290
   Pokorski JK, 2011, CHEMBIOCHEM, V12, P2441, DOI 10.1002/cbic.201100469
   Pokorski JK, 2011, J AM CHEM SOC, V133, P9242, DOI 10.1021/ja203286n
   Prucker O, 1999, J AM CHEM SOC, V121, P8766, DOI 10.1021/ja990962+
   Rieger KA, 2013, J MATER CHEM B, V1, P4531, DOI 10.1039/c3tb20795a
   Sisson K, 2010, J BIOMED MATER RES A, V94A, P1312, DOI 10.1002/jbm.a.32756
   Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s
   Stone DA, 2012, ACS MACRO LETT, V1, P80, DOI 10.1021/mz200049v
   Temel G, 2009, MACROMOLECULES, V42, P6098, DOI 10.1021/ma901162y
   TSCHOPP JF, 1994, THROMB HAEMOSTASIS, V72, P119
   Wanasekara ND, 2012, MACROMOLECULES, V45, P9092, DOI 10.1021/ma301896u
   Wang J, 2014, POLYMER, V55, P673, DOI 10.1016/j.polymer.2013.12.025
   Yu L, 2009, POLYMER, V50, P2133, DOI 10.1016/j.polymer.2009.03.003
   Zheng JK, 2013, POLYM CHEM-UK, V4, P2215, DOI 10.1039/c3py00153a
   Zheng JK, 2012, J AM CHEM SOC, V134, P17274, DOI 10.1021/ja307647x
   Zhu Y, 2013, RSC ADV, V3, P2509, DOI 10.1039/c2ra22358a
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
NR 41
TC 34
Z9 35
U1 2
U2 66
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2161-1653
J9 ACS MACRO LETT
JI ACS Macro Lett.
PD JUN
PY 2014
VL 3
IS 6
BP 585
EP 589
DI 10.1021/mz500112d
PG 5
WC Polymer Science
SC Polymer Science
GA AJ4KG
UT WOS:000337644500019
PM 24977107
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Cornock, R
   Beirne, S
   Thompson, B
   Wallace, GG
AF Cornock, R.
   Beirne, S.
   Thompson, B.
   Wallace, G. G.
TI Coaxial additive manufacture of biomaterial composite scaffolds for
   tissue engineering
SO BIOFABRICATION
LA English
DT Article
DE additive fabrication; additive biofabrication; co-axial extrusion;
   tissue engineering; cell encapsulation; alginate; polycaprolactone
ID IN-VITRO; ALGINATE HYDROGELS; POLYCAPROLACTONE; BLENDS
AB An inherent difficulty associated with the application of suitable bioscaffolds for tissue engineering is the incorporation of adequate mechanical characteristics into the materials which recapitulate that of the native tissue, whilst maintaining cell proliferation and nutrient transfer qualities. Biomaterial composites fabricated using rapid prototyping techniques can potentially improve the functionality and patient-specific processing of tissue engineering scaffolds. In this work, a technique for the coaxial melt extrusion printing of core-shell scaffold structures was designed, implemented and assessed with respect to the repeatability, cell efficacy and scaffold porosity obtainable. Encapsulated alginate hydrogel/thermoplastic polycaprolactone (Alg-PCL) cofibre scaffolds were fabricated. Selective laser melting was used to produce a high resolution stainless steel 316 L coaxial extrusion nozzle, exhibiting diameters of 300 mu m/900 mu m for the inner and outer nozzles respectively. We present coaxial melt extrusion printed scaffolds of Alg-PCL cofibres with similar to 0.4 volume fraction alginate, with total fibre diameter as low as 600 mu m and core material offset as low as 10% of the total diameter. Furthermore the tuneability of scaffold porosity, pore size and interconnectivity, as well as the preliminary inclusion, compatibility and survival of an L-929 mouse fibroblast cell-line within the scaffolds were explored. This preliminary cell work highlighted the need for optimal material selection and further design reiteration in future research.
C1 [Cornock, R.; Beirne, S.; Thompson, B.; Wallace, G. G.] Univ Wollongong, ARC Ctr Excellence Electromat Sci, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia.
RP Cornock, R (reprint author), Univ Wollongong, ARC Ctr Excellence Electromat Sci, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia.
EM gwallace@uow.edu.au
RI Wallace, Gordon/H-1123-2011
OI Wallace, Gordon/0000-0002-0381-7273
FU Australian Research Council Centre of Excellence for Electromaterials
   Science (ACES)
FX The authors acknowledge the Australian Research Council Centre of
   Excellence for Electromaterials Science (ACES) for funding this
   research, the Australian National Fabrication Facility (ANFF) for
   provision of materials and equipment access, the use of facilities and
   assistance of Mr Tony Romeo at the UOW Electron Microscopy Centre, as
   well as the contributions of Mr Fletcher Thompson to this research.
CR Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Averous L, 2000, POLYMER, V41, P4157, DOI 10.1016/S0032-3861(99)00636-9
   Ben-Shabat S, 2003, J POLYM SCI POL CHEM, V41, P3781, DOI 10.1002/pola.10958
   Berthiaume F, 2010, ARTECH HSE METH BIOE, P1
   Cornock R, 2013, IEEE ASME INT C ADV, P973, DOI 10.1109/AIM.2013.6584220
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Gun'ko VM, 2010, SOFT MATTER, V6, P5351, DOI 10.1039/c0sm00617c
   Harley BA, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P219, DOI 10.1016/B978-012370615-7/50020-2
   Hollister S J, 2005, Orthod Craniofac Res, V8, P162, DOI 10.1111/j.1601-6343.2005.00329.x
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O
   Labet M, 2009, CHEM SOC REV, V38, P3484, DOI 10.1039/b820162p
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lannutti J, 2007, MAT SCI ENG C-BIO S, V27, P504, DOI 10.1016/j.msec.2006.05.019
   Lanza R, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P1
   Li ZQ, 2011, POLYMERS-BASEL, V3, P740, DOI 10.3390/polym3020740
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Mouthuy P, 2011, BIOMATERIALS, P23
   Ms Estells J, 2007, J MATER SCI-MATER M, V19, P189
   Murphy MB, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P309, DOI 10.1016/B978-012370615-7/50026-3
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Rattanakit P, 2012, INT J PHARMACEUT, V422, P254, DOI 10.1016/j.ijpharm.2011.11.007
   Schuurman W, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/021001
   Sepideh H, 2010, TISSUE ENG
   Sharaf B, 2012, J ORAL MAXIL SURG, V70, P647, DOI 10.1016/j.joms.2011.07.029
   Shim JH, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034102
   Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044
   Van de Velde K, 2002, POLYM TEST, V21, P433, DOI 10.1016/S0142-9418(01)00107-6
   Wang Y, 2008, J MATER SCI-MATER M, V20, P719
   Xie WY, 2009, POLYM DEGRAD STABIL, V94, P1040, DOI 10.1016/j.polymdegradstab.2009.04.005
   Xu FL, 2005, MATER SCI FORUM, V486-487, P189, DOI 10.4028/www.scientific.net/MSF.486-487.189
   Xu FL, 2005, MATER SCI FORUM, P189
   Xu FL, 2005, MATER SCI FORUM, P486
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zamora D O, 2012, JOVE-J VIS EXP, V64, P3624
   Zhou YF, 2007, POLYM INT, V56, P333, DOI 10.1002/pi.2138
NR 37
TC 14
Z9 14
U1 4
U2 74
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD JUN
PY 2014
VL 6
IS 2
AR 025002
DI 10.1088/1758-5082/6/2/025002
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ5EL
UT WOS:000337705000017
PM 24658021
DA 2018-10-20
ER

PT J
AU Park, JH
   Jung, JW
   Kang, HW
   Cho, DW
AF Park, Jeong Hun
   Jung, Jin Woo
   Kang, Hyun-Wook
   Cho, Dong-Woo
TI Indirect three-dimensional printing of synthetic polymer scaffold based
   on thermal molding process
SO BIOFABRICATION
LA English
DT Article
DE scaffold fabrication; three-dimensional printing (3DP); projection-based
   micro-stereolithography (pMSTL); injection molding system (IMS); thermal
   molding process
ID FREE-FORM FABRICATION; TISSUE; STEREOLITHOGRAPHY; SYSTEMS; DESIGN; MODEL
AB One of the major issues in tissue engineering has been the development of three-dimensional (3D) scaffolds, which serve as a structural template for cell growth and extracellular matrix formation. In scaffold-based tissue engineering, 3D printing (3DP) technology has been successfully applied for the fabrication of complex 3D scaffolds by using both direct and indirect techniques. In principle, direct 3DP techniques rely on the straightforward utilization of the final scaffold materials during the actual scaffold fabrication process. In contrast, indirect 3DP techniques use a negative mold based on a scaffold design, to which the desired biomaterial is cast and then sacrificed to obtain the final scaffold. Such indirect 3DP techniques generally impose a solvent-based process for scaffold fabrication, resulting in a considerable increase in the fabrication time and poor mechanical properties. In addition, the internal architecture of the resulting scaffold is affected by the properties of the biomaterial solution. In this study, we propose an advanced indirect 3DP technique using projection-based micro-stereolithography and an injection molding system (IMS) in order to address these challenges. The scaffold was fabricated by a thermal molding process using IMS to overcome the limitation of the solvent-based molding process in indirect 3DP techniques. The results indicate that the thermal molding process using an IMS has achieved a substantial reduction in scaffold fabrication time and has also provided the scaffold with higher mechanical modulus and strength. In addition, cell adhesion and proliferation studies have indicated no significant difference in cell activity between the scaffolds prepared by solvent-based and thermal molding processes.
C1 [Park, Jeong Hun; Jung, Jin Woo; Cho, Dong-Woo] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, South Korea.
   [Kang, Hyun-Wook] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA.
RP Park, JH (reprint author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, South Korea.
EM dwcho@postech.ac.kr
FU National Research Foundation of Korea (NRF) - Korea government (MSIP)
   [2010-0018294, 2011-0030075]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (No. 2010-0018294 and
   2011-0030075).
CR Arya R K, 2012, INT J SCI TECH RES, V1, P48
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Joo YH, 2013, TISSUE ENG REGEN MED, V10, P65, DOI 10.1007/s13770-013-0358-8
   Jung JW, 2012, INT J PRECIS ENG MAN, V13, P445, DOI 10.1007/s12541-012-0057-8
   Kalogiannis CG, 2006, J CHEM ENG DATA, V51, P107, DOI 10.1021/je0502602
   Kang HW, 2012, TISSUE ENG C
   Kang HW, 2012, SENSOR ACTUAT A-PHYS, V178, P223, DOI 10.1016/j.sna.2012.01.016
   Kim S Y, 2004, J APPL POLYM SCI
   Kolan KCR, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/025004
   Lee JS, 2012, J BIOMED MATER RES A, V100A, P1846, DOI 10.1002/jbm.a.34149
   Lee M, 2005, BIOMATERIALS, V26, P4281, DOI 10.1016/j.biomaterials.2004.10.040
   Liu C Z, 2007, J BIOMED MATER RES B, V85B, P519
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Moroni L, 2006, BIOMATERIALS, V27, P4911, DOI 10.1016/j.biomaterials.2006.05.027
   Papenburg BJ, 2007, BIOMATERIALS, V28, P1998, DOI 10.1016/j.biomaterials.2006.12.023
   Park JH, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035004
   Schumacher M, 2010, J MATER SCI-MATER M, V21, P3119, DOI 10.1007/s10856-010-4166-6
   Seol YJ, 2012, SOFT MATTER, V8, P1730, DOI 10.1039/c1sm06863f
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Shor L, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/1/015003
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Vogrin N, 2002, J MEMBRANE SCI, V207, P139, DOI 10.1016/S0376-7388(02)00119-9
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
NR 24
TC 18
Z9 18
U1 1
U2 56
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD JUN
PY 2014
VL 6
IS 2
AR 025003
DI 10.1088/1758-5082/6/2/025003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ5EL
UT WOS:000337705000018
PM 24658060
DA 2018-10-20
ER

PT J
AU Zieber, L
   Or, S
   Ruvinov, E
   Cohen, S
AF Zieber, Liran
   Or, Shira
   Ruvinov, Emil
   Cohen, Smadar
TI Microfabrication of channel arrays promotes vessel-like network
   formation in cardiac cell construct and vascularization in vivo
SO BIOFABRICATION
LA English
DT Article
DE alginate scaffold; cardiac tissue engineering; micro-channels;
   sequential cell seeding; vascularization
ID POROUS ALGINATE SCAFFOLDS; ENGINEERED HEART-TISSUE; ENDOTHELIAL-CELLS;
   SEQUENTIAL DELIVERY; CONTROLLED-RELEASE; MUSCLE; BIOMATERIAL; BINDING;
   ANGIOGENESIS; REGENERATION
AB Pre-vascularization is important for the reconstruction of dense and metabolically active myocardial tissue and its integration with the host myocardium after implantation. Herein, we demonstrate that the fabrication of micro-channels in alginate scaffold combined with the presentation of adhesion peptides and an angiogenic growth factor promote vessel-like networks in the construct, both in vitro and in vivo. Using a CO2 laser engraving system, 200 mu m diameter channels were formed from top to bottom of the 2 mm thick alginate scaffold, with a channel-to-channel distance of 400 mu m. Cells were seeded in a sequential manner onto the scaffolds: first, human umbilical vascular endothelial cells (HUVECs) were seeded and cultured for three days, then neonatal rat cardiomyocytes (CMs) and cardiofibroblasts were added at a final cell ratio of 50: 35: 15, respectively, and the constructs were cultivated for an additional seven days. A vessel-like network was formed within the cell constructs, wherein HUVECs were organized around the channels in a multilayer manner, while the CMs were located in-between the channels and exhibited the characteristic morphological features of a mature cardiac fiber. Acellular scaffolds with the affinity-bound basic fibroblast growth factor were implanted subcutaneously in mice. Increased cell penetration into the channeled scaffold and greater vessel density were found in comparison with the nonchanneled scaffolds. Our results thus point to the importance of micro-channels as a major structural promoter of vascularization in scaffolds, in conjunction with the sequential preculture of ECs and angiogenic factor presentation.
C1 [Zieber, Liran; Or, Shira; Ruvinov, Emil; Cohen, Smadar] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
   [Cohen, Smadar] Ben Gurion Univ Negev, Regenerat Med & Stem Cell RMSC Res Ctr, IL-84105 Beer Sheva, Israel.
   [Cohen, Smadar] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel.
RP Cohen, S (reprint author), Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
EM scohen@bgu.ac.il
FU Zvika Grinberg (Universal Laser Systems, Caliber Engineering and
   Computer Ltd, Herzelia, Israel)
FX We acknowledge the generous help and guidance of Zvika Grinberg
   (Universal Laser Systems, Caliber Engineering and Computer Ltd,
   Herzelia, Israel) with the laser fabrication work. Professor Cohen holds
   the Claire and Harold Oshry Professor Chair in Biotechnology.
CR Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Dvir T., 2008, ADV TISSUE ENG, P517
   Dvir T, 2007, TISSUE ENG, V13, P2185, DOI 10.1089/ten.2006.0364
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Iyer RK, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035002
   Iyer RK, 2009, J BIOMED MATER RES A, V89A, P616, DOI 10.1002/jbm.a.32014
   Iyer RK, 2009, J TISSUE ENG REGEN M, V3, P196, DOI 10.1002/term.153
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Kim JY, 2010, TISSUE ENG PT A, V16, P2229, DOI [10.1089/ten.tea.2009.0644, 10.1089/ten.TEA.2009.0644]
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047
   Naito H, 2006, CIRCULATION, V114, pI72, DOI 10.1161/CIRCULATIONAHA.105.001560
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Parker KK, 2007, PHILOS T R SOC B, V362, P1267, DOI 10.1098/rstb.2007.2114
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ruvinov E, 2012, CARDIAC TISSUE ENG P, P1
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Sapir Y, 2012, BIOMATERIALS, V33, P4100, DOI 10.1016/j.biomaterials.2012.02.037
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 33
TC 21
Z9 22
U1 0
U2 31
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD JUN
PY 2014
VL 6
IS 2
AR 024102
DI 10.1088/1758-5082/6/2/024102
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AJ5EL
UT WOS:000337705000004
PM 24464741
DA 2018-10-20
ER

PT J
AU Muszanska, AK
   Rochford, ETJ
   Gruszka, A
   Bastian, AA
   Busscher, HJ
   Norde, W
   van der Mei, HC
   Herrmann, A
AF Muszanska, Agnieszka K.
   Rochford, Edward T. J.
   Gruszka, Agnieszka
   Bastian, Andreas A.
   Busscher, Henk J.
   Norde, Willem
   van der Mei, Henny C.
   Herrmann, Andreas
TI Antiadhesive Polymer Brush Coating Functionalized with Antimicrobial and
   RGD Peptides to Reduce Biofilm Formation and Enhance Tissue Integration
SO BIOMACROMOLECULES
LA English
DT Article
ID BACTERIAL ADHESION; MICROBIAL ADHESION; CATIONIC PEPTIDES;
   ANTIBACTERIAL; SURFACES; INFECTIONS; RESISTANCE; BINDING; PROTEIN; CELLS
AB This paper describes the synthesis and characterization of polymer peptide conjugates to be used as infection-resistant coating for biomaterial implants and devices. Antiadhesive polymer brushes composed of block copolymer Pluronic F-127 (PF127) were functionalized with antimicrobial peptides (AMP), able to kill bacteria on contact, and arginine glycine aspartate (RGD) peptides to promote the adhesion and spreading of host tissue cells. The antiadhesive and antibacterial properties of the coating were investigated with three bacterial strains: Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa. The ability of the coating to support mammalian cell growth was determined using human fibroblast cells. Coatings composed of the appropriate ratio of the functional components: PF127, PF127 modified with AMP, and PF127 modified with RGD showed good antiadhesive and bactericidal properties without hampering tissue compatibility.
C1 [Muszanska, Agnieszka K.; Rochford, Edward T. J.; Busscher, Henk J.; Norde, Willem; van der Mei, Henny C.] Univ Groningen, NL-9700 AD Groningen, Netherlands.
   [Muszanska, Agnieszka K.; Rochford, Edward T. J.; Busscher, Henk J.; Norde, Willem; van der Mei, Henny C.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
   [Gruszka, Agnieszka; Bastian, Andreas A.; Herrmann, Andreas] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands.
RP Herrmann, A (reprint author), Univ Groningen, Zernike Inst Adv Mat, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.
EM a.herrmann@rug.nl
RI Herrmann, Andreas/F-3189-2016
OI Herrmann, Andreas/0000-0002-8886-0894
FU University of Groningen-University Medical Center Groningen, Groningen,
   The Netherlands
FX This research was funded by the University of Groningen-University
   Medical Center Groningen, Groningen, The Netherlands. H.J.B. is also
   director of a consulting company, SASA BV (GN Schutterlaan 4, 9797 PC
   Thesinge, The Netherlands).
CR Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Bieser A. M., 2012, MACROMOL BIOSCI, V11, P111
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006
   Chitnis AS, 2012, INFECT CONT HOSP EP, V33, P993, DOI 10.1086/667745
   Christopher D., 2012, NAT REV DRUG DISCOV, V11, P37
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Follmann HDM, 2012, BIOMACROMOLECULES, V13, P3711, DOI 10.1021/bm3011962
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x
   Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Glinel K, 2009, BIOCONJUGATE CHEM, V20, P71, DOI 10.1021/bc800280u
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Kobayashi M, 2012, LANGMUIR, V28, P7212, DOI 10.1021/la301033h
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mai J, 2011, ANTIMICROB AGENTS CH, V55, P5205, DOI 10.1128/AAC.05175-11
   Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005
   Muszanska AK, 2012, ANTIMICROB AGENTS CH, V56, P4961, DOI 10.1128/AAC.00431-12
   Muszanska AK, 2011, BIOMATERIALS, V32, P6333, DOI 10.1016/j.biomaterials.2011.05.016
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923
   Pag U, 2008, J ANTIMICROB CHEMOTH, V61, P341, DOI 10.1093/jac/dkm479
   Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2
   Rehor A, 2008, BIOMATERIALS, V29, P1958, DOI 10.1016/j.biomaterials.2007.12.035
   Rokitskaya T. I., 2011, BIOCHIM BIOPHYS ACTA, V1, P91
   Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micnif.2006.03.011
   Shimoda A, 2011, MACROMOL BIOSCI, V11, P882, DOI 10.1002/mabi.201000491
   Singhai M, 2012, J GLOB INFECT DIS, V4, P193, DOI 10.4103/0974-777X.103896
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Tugulu S, 2007, BIOMATERIALS, V28, P2536, DOI 10.1016/j.biomaterials.2007.02.006
   Wagner VE, 2004, BIOMATERIALS, V25, P2247, DOI 10.1016/j.biomaterials.2003.09.020
   Wang Y, 2011, ADV FUNCT MATER, V21, P3916, DOI 10.1002/adfm.201100659
   Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
NR 38
TC 39
Z9 40
U1 3
U2 122
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUN
PY 2014
VL 15
IS 6
BP 2019
EP 2026
DI 10.1021/bm500168s
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AJ2OL
UT WOS:000337497100009
PM 24833130
DA 2018-10-20
ER

PT J
AU Belair, DG
   Khalil, AS
   Miller, MJ
   Murphy, WL
AF Belair, David G.
   Khalil, Andrew S.
   Miller, Michael J.
   Murphy, William L.
TI Serum-Dependence of Affinity-Mediated VEGF Release from Biomimetic
   Microspheres
SO BIOMACROMOLECULES
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; POLY(ETHYLENE GLYCOL) HYDROGELS; FETAL BOVINE
   SERUM; EXTRACELLULAR-MATRIX; FACTOR-RECEPTOR; ANGIOGENIC RESPONSE;
   SUSTAINED-RELEASE; HEPARAN-SULFATE; TYROSINE KINASE; CARCINOMA-CELLS
AB Vascular endothelial growth factor (VEGF) activity is demanded proteolysis to release the sequestered VEGF. Numerous 7 studies have demonstrated that VEGF activity mediates cellular events leading to angiogenesis and capillary formation in vivo. This has motivated the study of biomaterials to sustain VEGF release, and in many cases, the materials are inspired by the structure and function of the native ECM. However, there remains a need for materials that can bind to VEGF with high specificity, as the in vivo environment is rich in a variety of growth factors (GFs) and GF-binding moieties. Here we describe a strategy to control VEGF release using hydrogel microspheres with tethered peptides derived from VEGF receptor 2 (VEGFR2). Using biomaterials covalently modified with varying concentrations of two distinct VEGFR2-derived peptides with varying serum stability, we analyzed both biomaterial and environmental variables that influence VEGF release and activity. The presence of tethered VEGF-binding peptides (VBPs) resulted in significantly extended VEGF release relative to control conditions, and the resulting released VEGF significantly increased the expansion of human umbilical vein endothelial cells in culture. VEGF release rates were also strongly influenced by the concentration of serum. The presence of Feline McDonough Sarcoma-like tyrosine kinase 1 (sFlt-1), a serumborne receptor fragment derived from VEGF receptor 1, increased VEGF release rates, although sFlt-1 was not sufficient to recapitulate the release profile of VEGF in serum. Further, the influence of serum on VEGF release was not due to protease activity or nonspecific VEGF interactions in the presence of serum-borne heparin. VEGF release kinetics correlated well with a generalizable mathematical model describing affinity-mediated release of VEGF from hydrogel microspheres in defined conditions. Modeling results suggest a potential mechanism whereby competition between VEGF and multiple VEGF-binding serum proteins including sFlt-1, soluble kinase insert domain receptor (sKDR), and alpha 2-macroglobulin (alpha 2-M) likely influenced VEGF release from microspheres. The materials and mathematical model described in this approach may be useful in a range of applications in which sustained, biologically active GF release of a specific GF is desirable.
C1 [Belair, David G.; Khalil, Andrew S.; Murphy, William L.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Miller, Michael J.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.
   [Murphy, William L.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53706 USA.
RP Murphy, WL (reprint author), Wisconsin Inst Med Res II, 1111 Highland Ave Room 5405, Madison, WI 53705 USA.
EM wlmurphy@wisc.edu
OI Belair, David/0000-0003-2145-3829
FU National Institutes of Health [T32 HL007936-12, RO1HL093282, R21
   EB016381, 5T32GM08349]
FX The authors acknowledge support from the National Institutes of Health
   (T32 HL007936-12, RO1HL093282, R21 EB016381, and 5T32GM08349).
CR Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049
   Bala K, 2011, TISSUE CELL, V43, P216, DOI 10.1016/j.tice.2011.03.004
   Banks RE, 1998, BRIT J CANCER, V77, P956, DOI 10.1038/bjc.1998.158
   Barleon B, 1997, J BIOL CHEM, V272, P10382
   Belair DG, 2013, ACTA BIOMATER, V9, P8823, DOI 10.1016/j.actbio.2013.06.033
   Belgore FM, 2001, CLIN SCI, V100, P567, DOI 10.1042/CS20000234
   Belotti D, 2003, CANCER RES, V63, P5224
   Bhattacharjee G, 2000, J BIOL CHEM, V275, P26806
   Borselli C, 2010, J BIOMED MATER RES A, V92A, P94, DOI 10.1002/jbm.a.32332
   Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Chung YI, 2010, J CONTROL RELEASE, V143, P282, DOI 10.1016/j.jconrel.2010.01.010
   Cooper S, 2003, FASEB J, V17, P333, DOI 10.1096/fj.02-0352rev
   Cunningham SA, 1999, J BIOL CHEM, V274, P18421, DOI 10.1074/jbc.274.26.18421
   De la Riva B, 2010, J CONTROL RELEASE, V143, P45, DOI 10.1016/j.jconrel.2009.11.026
   Dill B., 1937, J BIOL CHEM, P569
   Ebos JML, 2004, MOL CANCER RES, V2, P315
   Eppler SM, 2002, CLIN PHARMACOL THER, V72, P20, DOI 10.1067/mcp.2002.126179
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8
   Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590
   Finley SD, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00196
   Franssen O, 1998, INT J PHARM, V168, P1, DOI 10.1016/S0378-5173(98)00071-4
   Germeroth L., 2003, THROMB HAEMOSTASIS, P501, DOI DOI 10.1160/TH03-02-0106
   Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036
   Hofmann-Kiefer KF, 2009, EUR J MED RES, V14, P526
   HONN KV, 1975, P SOC EXP BIOL MED, V149, P344
   Hornig C, 2000, LAB INVEST, V80, P443, DOI 10.1038/labinvest.3780050
   Howdieshell TR, 1998, ANN SURG, V228, P707, DOI 10.1097/00000658-199811000-00011
   Hudalla GA, 2011, ADV FUNCT MATER, V21, P1754, DOI 10.1002/adfm.201002468
   Impellitteri NA, 2012, BIOMATERIALS, V33, P3475, DOI 10.1016/j.biomaterials.2012.01.032
   Issaq HJ, 2007, CHEM REV, V107, P3601, DOI 10.1021/cr068287r
   Kaitu'u-Lino TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032509
   Kulapaditharom B, 2012, J ONCOL, DOI 10.1155/2012/687934
   Lagerholm BC, 1998, BIOPHYS J, V74, P1215, DOI 10.1016/S0006-3495(98)77836-1
   Lee KW, 2004, TRANSPLANT P, V36, P2464, DOI 10.1016/j.transproceed.2004.08.078
   Lee RJ, 2000, CIRCULATION, V102, P898
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lip PL, 2000, INVEST OPHTH VIS SCI, V41, P2115
   Maharaj ASR, 2007, MICROVASC RES, V74, P100, DOI 10.1016/j.mvr.2007.03.004
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Nagai N, 2010, J MATER SCI-MATER M, V21, P1891, DOI 10.1007/s10856-010-4054-0
   Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1
   Nguyen CB, 2000, DRUG METAB DISPOS, V28, P598
   OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090
   Oh D, 2012, P NATL ACAD SCI USA, V109, P14024, DOI 10.1073/pnas.1203397109
   Oliviero O, 2012, ACTA BIOMATER, V8, P3294, DOI 10.1016/j.actbio.2012.05.019
   Pavlakovic H, 2010, ANN NY ACAD SCI, V1207, pE7, DOI 10.1111/j.1749-6632.2010.05714.x
   Phelps EA, 2009, REGEN MED, V4, P65, DOI 10.2217/17460751.4.1.65
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Piossek C, 1999, J BIOL CHEM, V274, P5612, DOI 10.1074/jbc.274.9.5612
   Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   SKEEL RD, 1990, SIAM J SCI STAT COMP, V11, P1, DOI 10.1137/0911001
   Soker S, 1997, J BIOL CHEM, V272, P31582, DOI 10.1074/jbc.272.50.31582
   Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77
   Tae G, 2006, J BIOMAT SCI-POLYM E, V17, P187, DOI 10.1163/156856206774879090
   Takano S, 1996, CANCER RES, V56, P2185
   Tanaka K, 1997, JPN J CANCER RES, V88, P867, DOI 10.1111/j.1349-7006.1997.tb00463.x
   Toepke MW, 2012, ADV HEALTHC MATER, V1, P457, DOI 10.1002/adhm.201200077
   Tunstall A. M., 1975, J CLIN PATHOL, P133
   Vempati P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-59
   von Tiedemann B, 2002, BIOSENS BIOELECTRON, V17, P983, DOI 10.1016/S0956-5663(02)00090-8
   WALKER C, 1987, J CELL SCI, V87, P739
   Wang AY, 2008, BIOMACROMOLECULES, V9, P2929, DOI 10.1021/bm800727z
   Weber L. M., 2010, J BIOMED MATER RES A, V90, P720
   Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Wu N, 2005, J CONTROL RELEASE, V102, P569, DOI 10.1016/j.jconrel.2004.11.002
   Yen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027514
   Yokoyama H, 1999, KIDNEY INT, V56, P650, DOI 10.1046/j.1523-1755.1999.00591.x
   Zhang J, 2009, BIOTECHNOL PROGR, V25, P1703, DOI 10.1002/btpr.252
   Zhang Q, 2004, ACTA PHARMACOL SIN, V25, P991
   Zheng XY, 2006, BIOTECHNOL PROGR, V22, P1294, DOI 10.1021/bp060121o
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zustiak SP, 2011, BIOTECHNOL BIOENG, V108, P197, DOI 10.1002/bit.22911
   Zustiak SP, 2010, ACTA BIOMATER, V6, P3404, DOI 10.1016/j.actbio.2010.03.040
   Zustiak SP, 2010, SOFT MATTER, V6, P3609, DOI [10.1039/c0sm00111b, 10.1039/C0SM00111B]
NR 80
TC 13
Z9 14
U1 1
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUN
PY 2014
VL 15
IS 6
BP 2038
EP 2048
DI 10.1021/bm500177c
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AJ2OL
UT WOS:000337497100011
PM 24773176
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Loth, T
   Hotzel, R
   Kascholke, C
   Anderegg, U
   Schulz-Siegmund, M
   Hacker, MC
AF Loth, Tina
   Hoetzel, Rudi
   Kascholke, Christian
   Anderegg, Ulf
   Schulz-Siegmund, Michaela
   Hacker, Michael C.
TI Gelatin-Based Biomaterial Engineering with Anhydride-Containing
   Oligomeric Cross-Linkers
SO BIOMACROMOLECULES
LA English
DT Article
ID IN-VITRO; ELECTROSPUN GELATIN; BIODEGRADABLE HYDROGELS;
   CONTROLLED-RELEASE; BUILDING-BLOCKS; LINKING METHODS; STEM-CELLS;
   COLLAGEN; DELIVERY; GENIPIN
AB Chemically cross-linked gelatin hydrogels are versatile cell-adhesive hydrogel materials that have been established for a variety of biomedical applications. The most prominent cross-linker is glutaraldehyde, which, however, has been described to cause compatibility problems and loss of microscopic but relevant structural features. A recently developed oligomeric cross-linker that contains anhydride functionalities was evaluated as cross-linker for the fabrication of gelatin-based hydrogels and microparticles. In a fast curing reaction, hydrogels composed of gelatin and oligomeric crosslinker were fabricated with good conversion over a wide concentration range of constituents and with cross-linkers of different anhydride contents. Hydrogel properties, such as dry weight and mechanics, could be controlled by hydrogel composition and rheological properties correlated to elastic moduli from I to 10 kPa. The gels were shown to be cytocompatible and promoted cell adhesion. In soft formulations, cells migrated into the hydrogel bulk. Gelatin microparticles prepared by a standard water-in-oil emulsion technique were also treated with the novel oligomers, and cross-linking degrees matching those obtained with glutaraldehyde were obtained. At the same time, fewer interparticular cross-links were observed. Fluorescein-derivatized cross-linkers yielded labeled microparticles in a concentration-dependent manner. The oligomeric cross-linkers are presented as an efficient and possibly more functional and compatible alternative to glutaraldehyde. The engineered hydrogel materials hold potential for various biomedical applications.
C1 [Loth, Tina; Hoetzel, Rudi; Kascholke, Christian; Schulz-Siegmund, Michaela; Hacker, Michael C.] Univ Leipzig, Inst Pharm, D-04317 Leipzig, Germany.
   [Anderegg, Ulf] Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04103 Leipzig, Germany.
   [Loth, Tina; Hoetzel, Rudi; Kascholke, Christian; Anderegg, Ulf; Schulz-Siegmund, Michaela; Hacker, Michael C.] Collaborat Res Ctr SFB Transregio 67, Leipzig, Germany.
   [Loth, Tina; Hoetzel, Rudi; Kascholke, Christian; Anderegg, Ulf; Schulz-Siegmund, Michaela; Hacker, Michael C.] Collaborat Res Ctr SFB Transregio 67, Dresden, Germany.
RP Hacker, MC (reprint author), Univ Leipzig, Inst Pharm, Eilenburger Str 15a, D-04317 Leipzig, Germany.
EM mhacker@uni-leipzig.de
RI Hacker, Michael/D-3935-2011
OI Hacker, Michael/0000-0002-4776-2294; Schulz-Siegmund,
   Michaela/0000-0003-1340-1850
FU German Research Council (DFG) [SFB/Transregio 67]; German Federal
   Ministry of Education and Research (BMBF) [0313909]
FX Financial support by the German Research Council (DFG SFB/Transregio 67,
   projects A1 and B4) is gratefully acknowledged. T.L. also acknowledges
   support by the German Federal Ministry of Education and Research (BMBF,
   0313909). Gelita AG generously provided all gelatin materials for this
   study. Confocal laser scanning microscopy of cell-laden hydrogels was
   performed at a Leica TCS SP5 STED with the kind assistance of Barbara
   Goettgens (Faculty of Biosciences, Pharmacy and Psychology, Universitat
   Leipzig). We are grateful to Thomas Magin (Translational Centre for
   Regenerative Medicine and Institute of Biology, Universitat Leipzig) for
   access to the Zeiss laser scanning microscope for hydrogel pore imaging.
   We thank Annett Majok (Department of Dermatology, Universitat Leipzig)
   for excellent technical assistance during histological analysis of
   cell-laden hydrogels. Thanks are also due to Katharina Schwabe, Sylva
   Gehring and Anja Lubs (Institute of Pharmacy, Universitat Leipzig). K.S.
   assisted during direct contact cytocompatibility studies. S.G.
   contributed to the microparticle cross-linking protocol and adaptation
   of the TNBS assay. A.L. perfomed osmometric measurements and helped with
   HPLC analytics.
CR Ambrosch K, 2012, ACTA BIOMATER, V8, P1303, DOI 10.1016/j.actbio.2011.11.020
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Bertoldo M, 2007, MACROMOL BIOSCI, V7, P328, DOI 10.1002/mabi.200600215
   Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Billiet T, 2013, MACROMOL BIOSCI, V13, P1531, DOI 10.1002/mabi.201300143
   Bratt-Leal AM, 2013, BIOMATERIALS, V34, P7227, DOI 10.1016/j.biomaterials.2013.05.079
   Chen KY, 2008, MACROMOL BIOSCI, V8, P942, DOI 10.1002/mabi.200800007
   Dawlee S, 2005, BIOMACROMOLECULES, V6, P2040, DOI 10.1021/bm050013a
   DeForest CA, 2012, ANNU REV CHEM BIOMOL, V3, P421, DOI 10.1146/annurev-chembioeng-062011-080945
   Del Gaudio C, 2013, BIOMATERIALS, V34, P7754, DOI 10.1016/j.biomaterials.2013.06.040
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Dreesmann L, 2007, BIOMATERIALS, V28, P5536, DOI 10.1016/j.biomaterials.2007.08.040
   Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002
   Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158
   Gauthier M. A., 2009, ANGEW CHEM, V121, P50, DOI DOI 10.1002/ANGE.200801951
   Heino J, 2009, INT J BIOCHEM CELL B, V41, P341, DOI 10.1016/j.biocel.2008.08.021
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Kirchmajer DM, 2013, RSC ADV, V3, P1073, DOI 10.1039/c2ra22859a
   Kniazeva E, 2011, TISSUE ENG PT A, V17, P905, DOI [10.1089/ten.tea.2010.0275, 10.1089/ten.TEA.2010.0275]
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Lien SM, 2008, MAT SCI ENG C-BIO S, V28, P36, DOI 10.1016/j.msec.2006.12.015
   Lin RZ, 2013, BIOMATERIALS, V34, P6785, DOI 10.1016/j.biomaterials.2013.05.060
   Liu YX, 2010, BIOMATERIALS, V31, P1158, DOI 10.1016/j.biomaterials.2009.10.040
   Loth T, 2013, REACT FUNCT POLYM, V73, P1480, DOI 10.1016/j.reactfunctpolym.2013.08.002
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   MAROIS Y, 1995, BIOMATERIALS, V16, P1131, DOI 10.1016/0142-9612(95)93576-Y
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Ozeki M, 2005, J BIOMAT SCI-POLYM E, V16, P549, DOI 10.1163/1568562053783731
   Panzavolta S, 2011, ACTA BIOMATER, V7, P1702, DOI 10.1016/j.actbio.2010.11.021
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Patterson J, 2010, MATER TODAY, V13, P14, DOI 10.1016/S1369-7021(10)70013-4
   Plant AL, 2009, BBA-MOL CELL RES, V1793, P893, DOI 10.1016/j.bbamcr.2008.10.012
   Rattanaruengsrikul V, 2009, MACROMOL BIOSCI, V9, P1004, DOI 10.1002/mabi.200900131
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L
   Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2
   Salchert K, 2003, J CHROMATOGR A, V1005, P113, DOI 10.1016/S0021-9673(03)00932-4
   Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471
   Scott RA, 2013, WIRES NANOMED NANOBI, V5, P388, DOI 10.1002/wnan.1223
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   Shi XF, 2008, J BIOMED MATER RES A, V86A, P813, DOI 10.1002/jbm.a.31671
   Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s
   Son TI, 2010, ACTA BIOMATER, V6, P4005, DOI 10.1016/j.actbio.2010.05.018
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus
   Terao K, 2003, J BIOMAT SCI-POLYM E, V14, P1197, DOI 10.1163/156856203322553437
   van der Smissen A, 2013, ACTA BIOMATER, V9, P7775, DOI 10.1016/j.actbio.2013.04.023
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   Wang LS, 2010, BIOMATERIALS, V31, P8608, DOI 10.1016/j.biomaterials.2010.07.075
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Yung CW, 2007, J BIOMED MATER RES A, V83A, P1039, DOI 10.1002/jbm.a.31431
   Zhang YZ, 2006, POLYMER, V47, P2911, DOI 10.1016/j.polymer.2006.02.046
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 61
TC 15
Z9 16
U1 2
U2 59
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUN
PY 2014
VL 15
IS 6
BP 2104
EP 2118
DI 10.1021/bm500241y
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AJ2OL
UT WOS:000337497100017
PM 24806218
DA 2018-10-20
ER

PT J
AU Larsson, PA
   Berglund, LA
   Wagberg, L
AF Larsson, Per A.
   Berglund, Lars A.
   Wagberg, Lars
TI Ductile All-Cellulose Nanocomposite Films Fabricated from Core-Shell
   Structured Cellulose Nanofibrils
SO BIOMACROMOLECULES
LA English
DT Article
ID BARRIER PROPERTIES; PERIODATE-OXIDATION; HIGH TOUGHNESS; TRANSPARENT;
   PAPERBOARD; HYDROLYSATE; CONSTANTS; FIBERS; MATRIX; OXYGEN
AB Cellulosic materials have many desirable properties such as high mechanical strength and low oxygen permeability and will be an important component in a sustainable biomaterial-based society, but unfortunately they often lack the ductility and formability offered by petroleum-based materials. This paper describes the fabrication and characterization of nanocomposite films made of core-shell modified cellulose nanofibrils (CNEs) surrounded by a shell of ductile dialcohol cellulose, created by heterogeneous periodate oxidation followed by borohydride reduction of the native cellulose in the external parts of the individual fibrils. The oxidation with periodate selectively produces dialdehyde cellulose, and the process does not increase the charge density of the material. Yet the modified cellulose fibers could easily be homogenized to CNFs. Prior to film fabrication, the CNF was shown by atomic force microscopy to be 0.5-2 mu m long and 4-10 nm wide. The films were fabricated by filtration, and besides uniaxial tensile testing at different relative humidities, they were characterized by scanning electron microscopy and oxygen permeability. The strength-at-break at 23 degrees C and 50% RH was 175 MPa, and the films could, before rupture, be strained, mainly by plastic deformation, to about 15% and 37% at 50% RH and 90% RH, respectively. This moisture plasticization was further utilized to form a demonstrator consisting of a double-curved structure with a nominal strain of 24% over the curvature. At a relative humidity of 80%, the films still acted as a good oxygen barrier, having an oxygen permeability of 5.5 mL-mu L/(m(2).24 h.kPa). These properties indicate that this new material has a potential for use as a barrier in complex-shaped structures and hence ultimately reduce the need for petroleum-based plastics.
C1 [Larsson, Per A.; Berglund, Lars A.; Wagberg, Lars] KTH Royal Inst Technol, KTH Fibre & Polymer Technol, SE-10044 Stockholm, Sweden.
   [Larsson, Per A.; Berglund, Lars A.; Wagberg, Lars] KTH Royal Inst Technol, BiMaC Innovat, SE-10044 Stockholm, Sweden.
   [Berglund, Lars A.; Wagberg, Lars] KTH Royal Inst Technol, Wallenberg Wood Sci Ctr, SE-10044 Stockholm, Sweden.
RP Larsson, PA (reprint author), KTH Royal Inst Technol, Dept Fibre & Polymer Technol, Teknikringen 56, SE-10044 Stockholm, Sweden.
EM per.larsson@polymer.kth.se
RI Berglund, Lars/A-6971-2010; Larsson, Per/E-8901-2011
OI Berglund, Lars/0000-0001-5818-2378; Larsson, Per/0000-0002-7410-0333
FU VINNOVA, the Swedish Governmental Agency for Innovation Systems, through
   the BiMaC Innovation Excellence Centre
FX Dr. Gustav Nystrom, KTH Wallenberg Wood Science Center, is acknowledged
   for skillful assistance in preparing CNFs. Mr. Jonas Sundstrom,
   Innventia AB, is acknowledged for assistance in setting up the tensile
   testing in Innventia's climate chamber. The financial support from
   VINNOVA, the Swedish Governmental Agency for Innovation Systems, through
   the BiMaC Innovation Excellence Centre, is also respectfully recognized.
CR Aulin C, 2012, NANOSCALE, V4, P6622, DOI 10.1039/c2nr31726e
   Aulin C, 2010, CELLULOSE, V17, P559, DOI 10.1007/s10570-009-9393-y
   BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805
   Callister W. D., 2001, FUNDAMENTALS MAT SCI
   Calvini P, 2004, CELLULOSE, V11, P99, DOI 10.1023/B:CELL.0000014766.31671.8d
   Edlund U, 2012, ANAL CHEM, V84, P3676, DOI 10.1021/ac300152g
   Fukuzumi H, 2011, BIOMACROMOLECULES, V12, P4057, DOI 10.1021/bm201079n
   Fukuzumi H, 2009, BIOMACROMOLECULES, V10, P162, DOI 10.1021/bm801065u
   Grondahl M, 2004, BIOMACROMOLECULES, V5, P1528, DOI 10.1021/bm049925n
   Henriksson M, 2008, BIOMACROMOLECULES, V9, P1579, DOI 10.1021/bm800038n
   Huang H, 2012, NORD PULP PAP RES J, V27, P211, DOI 10.3183/NPPRJ-2012-27-02-p211-225
   Johansson C, 2012, BIORESOURCES, V7, P2506
   Kasai W, 2014, CELLULOSE, V21, P769, DOI 10.1007/s10570-013-0153-7
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Kochumalayil JJ, 2013, BIOMACROMOLECULES, V14, P84, DOI 10.1021/bm301382d
   Larsson PA, 2013, 15 FUND RES S ADV PU, P851
   Larsson PA, 2014, CELLULOSE, V21, P323, DOI 10.1007/s10570-013-0099-9
   Lavoine N, 2012, CARBOHYD POLYM, V90, P735, DOI 10.1016/j.carbpol.2012.05.026
   Liu AD, 2012, CARBOHYD POLYM, V87, P53, DOI 10.1016/j.carbpol.2011.07.019
   Liu AD, 2011, BIOMACROMOLECULES, V12, P633, DOI 10.1021/bm101296z
   Matsumura H, 2000, J APPL POLYM SCI, V78, P2242, DOI 10.1002/1097-4628(20001220)78:13<2242::AID-APP20>3.0.CO;2-5
   Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b
   MOROOKA T, 1989, J APPL POLYM SCI, V38, P849, DOI 10.1002/app.1989.070380508
   Morooka T., 1991, SEN-I GAKKAISHI, V47, P328
   Nishino T, 2004, MACROMOLECULES, V37, P7683, DOI 10.1021/ma049300h
   Nogi M, 2009, ADV MATER, V21, P1595, DOI 10.1002/adma.200803174
   Ostlund M, 2011, PACKAG TECHNOL SCI, V24, P331, DOI 10.1002/pts.942
   PAINTER TJ, 1988, CARBOHYD RES, V179, P259, DOI 10.1016/0008-6215(88)84123-5
   Ryberg YZZ, 2011, BIOMACROMOLECULES, V12, P1355, DOI 10.1021/bm200128s
   SAKURADA I, 1962, J POLYM SCI, V57, P651, DOI 10.1002/pol.1962.1205716551
   Sehaqui H, 2011, SOFT MATTER, V7, P7342, DOI 10.1039/c1sm05325f
   SIHTOLA H, 1960, MAKROMOLEKUL CHEM, V35, P250
   SUGIYAMA J, 1991, MACROMOLECULES, V24, P4168, DOI 10.1021/ma00014a033
   SYMONS MCR, 1955, J CHEM SOC, P2794, DOI 10.1039/jr9550002794
   Syverud K, 2009, CELLULOSE, V16, P75, DOI 10.1007/s10570-008-9244-2
   TASHIRO K, 1991, POLYMER, V32, P1516, DOI 10.1016/0032-3861(91)90435-L
   Vishtal A, 2012, BIORESOURCES, V7, P4424
   Yang QL, 2011, BIOMACROMOLECULES, V12, P2766, DOI 10.1021/bm200766v
   Zheng GY, 2013, MRS BULL, V38, P320, DOI 10.1557/mrs.2013.59
NR 39
TC 28
Z9 28
U1 4
U2 73
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUN
PY 2014
VL 15
IS 6
BP 2218
EP 2223
DI 10.1021/bm500360c
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AJ2OL
UT WOS:000337497100029
PM 24773125
OA Bronze
DA 2018-10-20
ER

PT J
AU Shin, SJ
   Her, Y
   Yu, DS
   Kim, CW
   Kim, SS
AF Shin, Soo Jung
   Her, Young
   Yu, Dong Soo
   Kim, Chul Woo
   Kim, Sang Seok
TI Twenty-Four-Week Multicenter, Evaluator-Blinded Clinical Study of the
   Efficacy and Safety of a Dextran Filler in the Treatment of Nasolabial
   Folds
SO DERMATOLOGIC SURGERY
LA English
DT Article
ID SOFT-TISSUE FILLERS; SUBCUTANEOUS AUGMENTATION; MICROPARTICLES;
   BIOMATERIAL
AB BACKGROUND Cross-linked dextran shows complete degradation in the vital tissue and has characteristics of neocollagenesis. However, its efficacy as a dermal filler in treating facial soft tissue defects has not been investigated.
   OBJECTIVE To evaluate the efficacy and safety of subcutaneous injection of a dextran filler in treating nasolabial folds for 24 weeks.
   METHODS AND MATERIALS Twenty patients were enrolled in this 24-week multicenter, evaluator-blinded clinical study. Each patient received a single session of a dextran filler treatment in both nasolabial folds, and no touch-up injections were given. Treatment efficacy was evaluated by blinded investigators at 4, 12, and 24 weeks after baseline. Safety data were collected from patient diaries and interviews at each follow-up visit.
   RESULTS There were significant improvements (p<.0001) in the Wrinkle Severity Rating Scale scores compared with those at baseline with a mean decrease of 1.50 +/- 0.51 at 24 weeks. Only 1 mild treatment-related adverse event was noted throughout the 24-week follow-up period.
   CONCLUSION Cross-linked dextran-derived injectable filler is considered to be a favorable measure in tissue augmentation of the nasolabial folds. Further investigation is needed to demonstrate the long-term efficacy and safety of dextran fillers.
C1 [Shin, Soo Jung; Kim, Chul Woo; Kim, Sang Seok] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Dermatol, Seoul, South Korea.
   [Her, Young] Kangwon Univ, Coll Med, Kangwon Natl Univ Hosp, Dept Dermatol, Chunchon, South Korea.
   [Yu, Dong Soo] Catholic Univ Korea, Uijeongbu St Marys Hosp, Dept Dermatol, Uijongbu, South Korea.
RP Kim, SS (reprint author), Kangdong Sacred Heart Hosp, Dept Dermatol, Seongnae Gil 150, Seoul 134701, South Korea.
EM drkimss@naver.com
OI Kim, Chul Woo/0000-0002-0970-0439
CR EPPLEY BL, 1994, ANN PLAS SURG, V32, P463, DOI 10.1097/00000637-199405000-00004
   EPPLEY BL, 1994, AESTHET PLAST SURG, V18, P413, DOI 10.1007/BF00451350
   Hug SY, 2010, ANN DERMATOL, V22, P81
   Laeschke K, 2004, SEMIN CUTAN MED SURG, V23, P214, DOI 10.1016/j.sder.2004.09.005
   Lemperle G, 2003, AESTHET PLAST SURG, V27, P354, DOI 10.1007/s00266-003-3022-1
   Massone C, 2009, AM J DERMATOPATH, V31, P197, DOI 10.1097/DAD.0b013e318194816d
   Narins RS, 2003, DERMATOL SURG, V29, P588, DOI 10.1046/j.1524-4725.2003.29150.x
   Requena L, 2011, J AM ACAD DERMATOL, V64, P1, DOI 10.1016/j.jaad.2010.02.064
   STENBERG A, 1995, J UROLOGY, V154, P800, DOI 10.1016/S0022-5347(01)67168-4
   Stenberg A, 1999, SCAND J UROL NEPHROL, V33, P355
   Wischke C, 2006, J CONTROL RELEASE, V114, P359, DOI 10.1016/j.jconrel.2006.06.020
NR 11
TC 3
Z9 3
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1076-0512
EI 1524-4725
J9 DERMATOL SURG
JI Dermatol. Surg.
PD JUN
PY 2014
VL 40
IS 6
BP 652
EP 657
DI 10.1111/dsu.0000000000000006
PG 6
WC Dermatology; Surgery
SC Dermatology; Surgery
GA AJ5FP
UT WOS:000337708400007
PM 24852469
DA 2018-10-20
ER

PT J
AU Ricci, KB
   Higgins, R
   Daniels, VC
   Kilic, A
AF Ricci, Kevin B.
   Higgins, Robert
   Daniels, Vincent C.
   Kilic, Ahmet
TI Bovine Pericardial Reconstruction of the Diaphragm After a Heart
   Transplant
SO EXPERIMENTAL AND CLINICAL TRANSPLANTATION
LA English
DT Article
DE Diaphragm; Devices; Surgical complications
ID REPAIR
AB Diaphragmatic hernias are a known complication of explanting a left ventricular assist device. The increasing use of left ventricular assist devices has resulted in an increased risk of this complication. We present the case of a patient who presented with diaphragmatic hernias on routine follow-up after a heart transplant. A left thoracotomy was performed to expose and reduce the hernia using a bovine pericardial patch to repair the defect. This biomaterial represents a viable alternative to traditional GORE-TEX patches with the probability of decreased infectious complications.
C1 [Ricci, Kevin B.; Higgins, Robert; Kilic, Ahmet] Ohio State Univ, Div Cardiac Surg, Wexner Med Ctr, Columbus, OH 43201 USA.
   [Daniels, Vincent C.] Ohio State Univ, Div Thorac Surg, Wexner Med Ctr, Columbus, OH 43201 USA.
RP Ricci, KB (reprint author), Ohio State Univ, Div Cardiac Surg, Wexner Med Ctr, N831 Doan Hall,410 W 10th Ave, Columbus, OH 43201 USA.
EM kevin.ricci@osumc.edu
CR Chatterjee S, 2004, ANN THORAC SURG, V77, P2111, DOI 10.1016/j.athoracsur.2003.10.108
   Kilic A, 2012, EXPERT REV CARDIOVAS, V10, P649, DOI [10.1586/ERC.12.17, 10.1586/erc.12.17]
   Mori T, 2012, ANN THORAC CARDIOVAS, V18, P297, DOI 10.5761/atcs.ra.12.01882
   PHILLIPS WS, 1992, ANN THORAC SURG, V53, P482, DOI 10.1016/0003-4975(92)90273-7
   Phillips WS, 1992, ANN THORAC SURG, V53, P485
   Zardo P, 2011, THORAC CARDIOV SURG, V59, P40, DOI 10.1055/s-0030-1250499
NR 6
TC 4
Z9 4
U1 0
U2 3
PU BASKENT UNIV
PI ANKARA
PA TASKENT CADDESI NO 77, KAT 4, BAHCELIEVLER, ANKARA, 06490, TURKEY
SN 1304-0855
J9 EXP CLIN TRANSPLANT
JI Exp. Clin. Transplant.
PD JUN
PY 2014
VL 12
IS 3
BP 277
EP 278
DI 10.6002/ect.2013.0068
PG 2
WC Transplantation
SC Transplantation
GA AJ4ON
UT WOS:000337655800019
PM 24568137
OA Bronze
DA 2018-10-20
ER

PT J
AU Ghanem, MA
   Dehoux, T
   Zouani, OF
   Gadalla, A
   Durrieu, MC
   Audoin, B
AF Ghanem, Maroun Abi
   Dehoux, Thomas
   Zouani, Omar F.
   Gadalla, Atef
   Durrieu, Marie-Christine
   Audoin, Bertrand
TI Remote opto-acoustic probing of single-cell adhesion on metallic
   surfaces
SO JOURNAL OF BIOPHOTONICS
LA English
DT Article
DE photoacoustic; ultrasound; cell adhesion; cell mechanics
ID PICOSECOND LIGHT-PULSES; ATOMIC-FORCE MICROSCOPY; LIVING CELLS;
   INTERFERENCE; ARCHITECTURE; ULTRASONICS; ELASTICITY; GENERATION; FATE
AB The reflection of picosecond ultrasonic pulses from a cell-substrate interface is used to probe cell-biomaterial adhesion with a subcell resolution. We culture monocytes on top of a thin biocompatible Ti metal film, supported by a transparent sapphire substrate. Low-energy femtosecond pump laser pulses are focused at the bottom of the Ti film to a micron spot. The subsequent ultrafast thermal expansion launches a longitudinal acoustic pulse in Ti, with a broad spectrum extending up to 100 GHz. We measure the acoustic echoes reflected from the Ti-cell interface through the transient optical reflectance changes. The time-frequency analysis of the reflected acoustic pulses gives access to a map of the cell acoustic impedance Z(c) and to a map of the film-cell interfacial stiffness K simultaneously. Variations in Z(c) across the cell are attributed to rigidity and density fluctuations within the cell, whereas variations in K are related to interfacial intermolecular forces and to the nano-architecture of the transmembrane bonds.
   [GRAPHICS]
   Measuring the acoustic reflection coefficient r(ac) across cells.
C1 [Ghanem, Maroun Abi; Dehoux, Thomas; Gadalla, Atef; Audoin, Bertrand] Univ Bordeaux, I2M, UMR 5295, F-33400 Talence, France.
   [Ghanem, Maroun Abi; Dehoux, Thomas; Gadalla, Atef; Audoin, Bertrand] CNRS, I2M, UMR 5295, F-33400 Talence, France.
   [Zouani, Omar F.; Durrieu, Marie-Christine] Univ Bordeaux 1, UMR CNRS 5248, CBMN, F-33607 Pessac, France.
RP Audoin, B (reprint author), Univ Bordeaux, I2M, UMR 5295, F-33400 Talence, France.
EM bertrand.audoin@u-bordeaux1.fr
RI DURRIEU, Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289; dehoux,
   thomas/0000-0003-0808-4037
FU Agence Nationale de la Recherche; competitiveness cluster Route des
   Lasers
FX We acknowledge the Agence Nationale de la Recherche and the
   competitiveness cluster Route des Lasers for their financial support.
CR Anderson O. L., 1965, PHYSICAL ACOUSTIC  B, V3, P43
   Antonelli GA, 2006, MRS BULL, V31, P607, DOI 10.1557/mrs2006.157
   Audoin B, 2010, ULTRASONICS, V50, P202, DOI 10.1016/j.ultras.2009.09.019
   Audoin B., 2011, SPIE BIOS
   Ayouch A, 2012, ACS NANO, V6, P10614, DOI 10.1021/nn303631d
   Bazett-Jones DP, 2008, CHROMOSOME RES, V16, P397, DOI 10.1007/s10577-008-1237-3
   Burmeister JS, 1998, BIOMATERIALS, V19, P307, DOI 10.1016/S0142-9612(97)00109-9
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Das RK, 2013, ACS NANO, V7, P3351, DOI 10.1021/nn4001325
   Dehoux T, 2012, J APPL PHYS, V112, DOI 10.1063/1.4769294
   Dehoux T., 2009, ULTRASONICS, V50, P197
   Dehoux T, 2012, SOFT MATTER, V8, P2586, DOI 10.1039/c2sm07146k
   Dehoux T, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235409
   Guillet Y, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035456
   Hettich M, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3604790
   Holt MR, 2008, J MICROSC-OXFORD, V232, P73, DOI 10.1111/j.1365-2818.2008.02069.x
   Iwanaga Y, 2001, EUR BIOPHYS J BIOPHY, V30, P17, DOI 10.1007/s002490000119
   Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621
   KENDALL K, 1971, PROC R SOC LON SER-A, V323, P321, DOI 10.1098/rspa.1971.0108
   Ladoux B, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/11/116601
   Li Z, 2009, NANO LETT, V9, P3575, DOI 10.1021/nl901774m
   Losego MD, 2012, NAT MATER, V11, P502, DOI [10.1038/NMAT3303, 10.1038/nmat3303]
   Mante PA, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4750140
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   Raman A, 2011, NAT NANOTECHNOL, V6, P809, DOI [10.1038/NNANO.2011.186, 10.1038/nnano.2011.186]
   ROKHLIN SI, 1991, J ACOUST SOC AM, V89, P503, DOI 10.1121/1.400374
   Rossignol C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988470
   Rouai L, 1999, J APPL PHYS, V85, P8155, DOI 10.1063/1.370654
   Rullo J, 2012, J CELL BIOL, V197, P115, DOI 10.1083/jcb.201107140
   Sagvolden G, 1999, P NATL ACAD SCI USA, V96, P471, DOI 10.1073/pnas.96.2.471
   Schoen I, 2010, NANO LETT, V10, P1823, DOI 10.1021/nl100533c
   Simon A, 2006, MICRON, V37, P1, DOI 10.1016/j.micron.2005.06.006
   Tas G, 1998, APPL PHYS LETT, V72, P2235, DOI 10.1063/1.121276
   TATTERSALL HG, 1973, J PHYS D APPL PHYS, V6, P819, DOI 10.1088/0022-3727/6/7/305
   THOMSEN C, 1986, PHYS REV B, V34, P4129, DOI 10.1103/PhysRevB.34.4129
   THOMSEN C, 1984, PHYS REV LETT, V53, P989, DOI 10.1103/PhysRevLett.53.989
   Valier-Brasier T, 2012, J APPL PHYS, V112, DOI 10.1063/1.4733949
   Wang W, 2012, LANGMUIR, V28, P13373, DOI 10.1021/la301712h
   Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228
   Zhao Y, 2006, SENSOR ACTUAT B-CHEM, V114, P1108, DOI 10.1016/j.snb.2005.07.071
   Zouani OF, 2013, BIOMATERIALS, V34, P2157, DOI 10.1016/j.biomaterials.2012.12.007
   Zouani OF, 2012, J CELL SCI, V125, P1217, DOI 10.1242/jcs.093229
NR 42
TC 4
Z9 4
U1 1
U2 27
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1864-063X
EI 1864-0648
J9 J BIOPHOTONICS
JI J. Biophotonics
PD JUN
PY 2014
VL 7
IS 6
BP 453
EP 459
DI 10.1002/jbio.201300098
PG 7
WC Biochemical Research Methods; Biophysics; Optics
SC Biochemistry & Molecular Biology; Biophysics; Optics
GA AJ5CQ
UT WOS:000337699300011
DA 2018-10-20
ER

PT J
AU Vega-Valencia, Y
   Victoria, MTCY
   Mendoza, MGV
   Sosa, IA
AF Vega-Valencia, Y.
   Cruz y Victoria, M. T.
   Vizcarra Mendoza, M. G.
   Anaya Sosa, I.
TI Intermittent Drying of Nopal (Opuntia Ficus Indica) in a Fluidized Bed
   Pilot Dryer Adapted with Revolving Chambers
SO JOURNAL OF FOOD PROCESS ENGINEERING
LA English
DT Article
ID KINETICS; INVERTASE
AB Intermittent drying is a novel method for improving the food drying kinetics, enhancing product quality and reducing energy consumption per unit of moisture removed at the lab scale. However, the drying protocol itself makes it difficult to implement it at the pilot plant scale without important energy loses. Taking this into account, an accessory for a fluidized bed pilot dryer was developed using an arrangement of revolving chambers that could increase the efficiency of the drying process; nopal (Opuntia ficus indica) was employed as a food material. Several drying experiments were conducted at the laboratory scale in order to establish the most appropriate drying condition to be further tested at the pilot plant scale. No statistical difference was observed between the drying curves obtained in the laboratory and pilot plant dryers under conventional and intermittent drying conditions, which means that the arrangement of chambers guarantees equal and consistent treatment of the solid. Interestingly, the results indicate that a drying protocol of nopal size E using the adapted fluidized bed dryer with tempering cycles at pilot plant scale can be regarded as an excellent and cost-effective methodology for processing vegetables without chemical quality losses. Practical Applications In this work, the performance of a novel fluidized bed dryer, adapted with an arrangement of revolving chambers specially designed to increase the efficiency of intermittent drying at the pilot plant scale, was evaluated. Cubes of nopal (Opuntia ficus indica) was chosen to take advantage of a biomaterial with high nutrimental characteristics. It was concluded that the arrangement of the equipment was able to maintain an equal and consistent treatment of the solid that in consequence, lead to a high chemical quality of the final dried product, comparable to that obtained at the laboratory scale. Additionally, the results indicate that the scaling of the process in the dryer prototype was highly efficient as it allowed to increase 300% the amount of biomaterial to be processed in one single drying operation. It was proposed that the use of the dryer adaptor has a great potential to increase the efficiency of drying processes of other biomaterials.
C1 [Vega-Valencia, Y.; Cruz y Victoria, M. T.; Anaya Sosa, I.] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Unidad Profes Lazaro Cardenas, Del Miguel Hidalgo 11340, DF, Mexico.
   [Vizcarra Mendoza, M. G.] Univ Autonoma Metropolitana Iztapalapa, Del Iztapalapa, DF, Mexico.
RP Sosa, IA (reprint author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Unidad Profes Lazaro Cardenas, Prolongac Carpio & Plan de Ayala S-N, Del Miguel Hidalgo 11340, DF, Mexico.
EM i_anaya_sosa@yahoo.com.mx
FU Instituto de Ciencia y Tecnologia del Distrito Federal [PICSO 10-49];
   Instituto Politecnico Nacional [20131778]; Consejo Nacional de Ciencia y
   Tecnologia, Mexico
FX The authors acknowledge the financial support from Instituto de Ciencia
   y Tecnologia del Distrito Federal (Grant PICSO 10-49), Instituto
   Politecnico Nacional (Grant 20131778) and Consejo Nacional de Ciencia y
   Tecnologia, Mexico.
CR Anaya I, 2003, INT J FOOD PROP, V6, P449, DOI 10.1081/JFP-120021336
   [Anonymous], 2005, 1851993 CODEX STAN, P1
   AOAC, 2005, OFFICIAL METHODS ANA
   Carrillo M Juan Pablo, 2010, INT J FOOD SCI TECH, V45, P1270
   Chou SK, 2001, PROCEEDINGS OF THE SECOND INTER-AMERICAN DRYING CONFERENCE, P69
   Chua KJ, 2003, BIORESOURCE TECHNOL, V90, P285, DOI 10.1016/S0960-8524(03)00133-0
   Clark J. R., 1964, EXPT BIOCH, P224
   Fano C. P., 2008, INT J FOOD PROP, V11, P13
   Gawrzynski Z, 1996, DRY TECHNOL, V14, P1121, DOI 10.1080/07373939608917142
   Geankoplis G. C., 2003, TRANSPORT PROCESSES, P575
   Hernandez U. M. I., 2010, OPEN NUTR J, V4, P11
   Jumah R.Y., 1996, ESAIM-MATH MODEL NUM, P339
   Krokida MK, 2003, J FOOD ENG, V57, P1, DOI 10.1016/S0260-8774(02)00214-5
   Kunii D., 1977, FLUIDIZATION ENG, P70
   Lafraya A, 2011, APPL ENVIRON MICROB, V77, P6148, DOI 10.1128/AEM.05032-11
   Medina T. L., 2008, LWT-FOOD SCI TECHNOL, V41, P1183
   Mirzarakhmetova DT, 1999, CHEM NAT COMPD, V35, P665, DOI 10.1007/BF02236299
   Nitz M, 2007, J FOOD ENG, V80, P249, DOI 10.1016/j.jfoodeng.2006.05.025
   Ranganna S., 1986, HDB ANAL QUALITY CON, P415
   San Martin A., 2004, THESIS I POLITECNICO
   WHITAKER JR, 1994, PRINCIPLES ENZYMOLOG, P416
NR 21
TC 0
Z9 0
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0145-8876
EI 1745-4530
J9 J FOOD PROCESS ENG
JI J. Food Process Eng.
PD JUN
PY 2014
VL 37
IS 3
BP 211
EP 219
DI 10.1111/jfpe.12072
PG 9
WC Engineering, Chemical; Food Science & Technology
SC Engineering; Food Science & Technology
GA AJ5WR
UT WOS:000337761500001
DA 2018-10-20
ER

PT J
AU Phe, V
   Benadiba, S
   Roupret, M
   Granger, B
   Richard, F
   Chartier-Kastler, E
AF Phe, Veronique
   Benadiba, Steeve
   Roupret, Morgan
   Granger, Benjamin
   Richard, Francois
   Chartier-Kastler, Emmanuel
TI Long-term functional outcomes after artificial urinary sphincter
   implantation in women with stress urinary incontinence
SO BJU INTERNATIONAL
LA English
DT Article
DE urinary incontinence; artificial device; urinary sphincter; biomaterial
ID III INCONTINENCE; EAU GUIDELINES; COMPLICATIONS; MEN; EXPERIENCE;
   MANAGEMENT
AB Objective To assess the long-term outcomes obtained after artificial urinary sphincter (AUS) implantation in women with stress urinary incontinence (SUI). Materials and Methods Women with SUI caused by intrinsic sphincter deficiency who underwent an AUS placement between 1984 and 1992 were included. Explantation, revision and deactivation rates of the AUS were reported. Continence, defined as no pad use, was assessed at the end of the follow-up. Kaplan-Meier survival curves were generated to evaluate the survival rate of the device without explantation or revision. Results A total of 34 patients were included. The median (interquartile range [IQR]) age of the patients at surgery was 56.5 (50-64.7) years and the median (IQR) follow-up was 17 (12-19) years. Overall, 26 women (74%) still had their AUS in place at the end of the follow-up, while eight patients underwent an explantation of the device. The 10-, 15- and 20-year device survival rates without explantation were 80, 80 and 74%, respectively. The 10-, 15- and 20-year survival rates of the device without revision were 79, 65 and 40%, respectively. After 20 years of follow-up, 11 women still had successful outcomes (61%). Conclusion The AUS provided satisfactory very long-term functional results among women with SUI caused by intrinsic sphincter deficiency.
C1 [Phe, Veronique; Benadiba, Steeve; Roupret, Morgan; Granger, Benjamin; Richard, Francois; Chartier-Kastler, Emmanuel] Univ Paris 06, AP HP, Dept Urol & Stat, Pitie Salpetriere Acad Hosp,Pierre & Marie Curie, Paris, France.
RP Phe, V (reprint author), Pitie Salpetriere Acad Hosp, Dept Urol, 47-83 Blvd Hop, F-75013 Paris, France.
EM veronique.phe@psl.aphp.fr
FU American Medical System; Coloplast; Allergan; Pfizer; Lilly; Zambon
FX Dr Chartier-Kastler reports personal fees and other support from
   American Medical System, personal fees and other support from Coloplast,
   personal fees and other support from Allergan, personal fees and other
   support from Astellas, personal fees from Pfizer, non-financial support
   from AB Science, personal fees from Lilly, and personal fees from
   Zambon, outside the submitted work.
CR Chartier-Kastler E, 2011, BJU INT, V107, P1618, DOI 10.1111/j.1464-410X.2010.09610.x
   Chung E, 2011, INT UROGYNECOL J, V22, P363, DOI 10.1007/s00192-010-1268-0
   Chung E, 2010, BJU INT, V106, P1664, DOI 10.1111/j.1464-410X.2010.09419.x
   Costa P, 2001, J UROLOGY, V165, P1172, DOI 10.1016/S0022-5347(05)66459-2
   Costa P, 2013, EUR UROL, V63, P753, DOI 10.1016/j.eururo.2012.03.008
   DIOKNO AC, 1987, J UROLOGY, V138, P778, DOI 10.1016/S0022-5347(17)43370-2
   Lee R, 2009, J UROLOGY, V181, P2622, DOI 10.1016/j.juro.2009.01.113
   Leibovich BC, 1997, WORLD J UROL, V15, P316, DOI 10.1007/BF02202018
   LIGHT JK, 1985, J UROLOGY, V134, P476, DOI 10.1016/S0022-5347(17)47245-4
   Lucas MG, 2012, EUR UROL, V62, P1118, DOI 10.1016/j.eururo.2012.09.023
   Mandron E, 2010, BJU INT, V106, P1194, DOI 10.1111/j.1464-410X.2010.09206.x
   Matsushita K, 2012, UROLOGY, V80, P667, DOI 10.1016/j.urology.2012.04.065
   Mitropoulos D, 2012, EUR UROL, V61, P341, DOI 10.1016/j.eururo.2011.10.033
   Ngninkeu BN, 2005, EUR UROL, V47, P793, DOI 10.1016/j.eururo.2005.01.010
   Petero VG, 2006, J UROLOGY, V175, P605, DOI 10.1016/S0022-5347(05)00243-0
   Petrou SP, 2000, UROLOGY, V56, P353, DOI 10.1016/S0090-4295(00)00683-X
   Phe V, 2013, EUR UROL, V63, P407, DOI 10.1016/j.eururo.2012.10.040
   Revaux A, 2011, INT UROGYNECOL J, V22, P1319, DOI 10.1007/s00192-011-1425-0
   Roupret M, 2005, PROG UROL, V15, P489
   Roupret M, 2010, EUR UROL, V57, P499, DOI 10.1016/j.eururo.2009.03.045
   Thomas K, 2002, J UROLOGY, V167, P1720, DOI 10.1016/S0022-5347(05)65185-3
   Vayleux B, 2011, EUR UROL, V59, P1048, DOI 10.1016/j.eururo.2011.03.006
   Venn SN, 2000, J UROLOGY, V164, P702, DOI 10.1016/S0022-5347(05)67285-0
   WEBSTER GD, 1992, UROLOGY, V39, P499, DOI 10.1016/0090-4295(92)90001-D
NR 24
TC 12
Z9 12
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-4096
EI 1464-410X
J9 BJU INT
JI BJU Int.
PD JUN
PY 2014
VL 113
IS 6
BP 961
EP 967
DI 10.1111/bju.12360
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA AJ3PZ
UT WOS:000337580500023
PM 24053369
OA Bronze
DA 2018-10-20
ER

PT J
AU Romano, CL
   Logoluso, N
   Meani, E
   Romano, D
   De Vecchi, E
   Vassena, C
   Drago, L
AF Romano, C. L.
   Logoluso, N.
   Meani, E.
   Romano, D.
   De Vecchi, E.
   Vassena, C.
   Drago, L.
TI A comparative study of the use of bioactive glass S53P4 and
   antibiotic-loaded calcium-based bone substitutes in the treatment of
   chronic osteomyelitis A RETROSPECTIVE COMPARATIVE STUDY
SO BONE & JOINT JOURNAL
LA English
DT Article
ID CHRONIC OTITIS-MEDIA; IN-VITRO; STAGING SYSTEM; CEMENT; OBLITERATION;
   INFECTIONS; SURGERY; ANGIOGENESIS; DIAGNOSIS; BACTERIA
AB The treatment of chronic osteomyelitis often includes surgical debridement and filling the resultant void with antibiotic-loaded polymethylmethacrylate cement, bone grafts or bone substitutes. Recently, the use of bioactive glass to treat bone defects in infections has been reported in a limited series of patients. However, no direct comparison between this biomaterial and antibiotic-loaded bone substitute has been performed.
   In this retrospective study, we compared the safety and efficacy of surgical debridement and local application of the bioactive glass S53P4 in a series of 27 patients affected by chronic osteomyelitis of the long bones (Group A) with two other series, treated respectively with an antibiotic-loaded hydroxyapatite and calcium sulphate compound (Group B; n = 27) or a mixture of tricalcium phosphate and an antibiotic-loaded demineralised bone matrix (Group C; n = 22). Systemic antibiotics were also used in all groups.
   After comparable periods of follow-up, the control of infection was similar in the three groups. In particular, 25 out of 27 (92.6%) patients of Group A, 24 out of 27 (88.9%) in Group B and 19 out of 22 (86.3%) in Group C showed no infection recurrence at means of 21.8 (12 to 36), 22.1 (12 to 36) and 21.5 (12 to 36) months follow-up, respectively, while Group A showed a reduced wound complication rate.
   Our results show that patients treated with a bioactive glass without local antibiotics achieved similar eradication of infection and less drainage than those treated with two different antibiotic-loaded calcium-based bone substitutes.
C1 [Romano, C. L.; Logoluso, N.; Meani, E.; Romano, D.; De Vecchi, E.; Vassena, C.; Drago, L.] IRCCS Galeazzi Orthopaed Inst, Milan, Italy.
RP Romano, CL (reprint author), IRCCS Galeazzi Orthopaed Inst, Dept Reconstruct Surg Osteoarticular Infect, Milan, Italy.
EM carlo.romano@grupposandonato.it
RI De Vecchi, Elena/B-8209-2017
OI De Vecchi, Elena/0000-0001-9781-8607; Lorenzo, Drago/0000-0002-5206-540X
FU Italian Ministry of Health [4060/2010]
FX This study was partially funded by the Italian Ministry of Health
   (project number 4060/2010). We thank Prof A. Zerbi and Dr N. Tramontana
   for their contribution to this paper.
CR Anagnostakos K, 2008, ACTA ORTHOP, V79, P302, DOI 10.1080/17453670710015120
   Anagnostakos K, 2009, J BIOMED MATER RES B, V90B, P467, DOI 10.1002/jbm.b.31281
   Arkudas A, 2013, TISSUE ENG PART C-ME, V19, P479, DOI [10.1089/ten.tec.2012.0572, 10.1089/ten.TEC.2012.0572]
   Bridgens J, 2008, J BONE JOINT SURG BR, V90B, P643, DOI 10.1302/0301-620X.90B5.19803
   Cierny G, 2003, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000088564.81746.62
   Coraca-Huber DC, 2014, J ORTHOP RES, V32, P175, DOI 10.1002/jor.22463
   Cormack AN, 2012, PHILOS T R SOC A, V370, P1271, DOI 10.1098/rsta.2011.0371
   Cui X, 2013, J MATER SCI-MATER M, V24, P2391, DOI 10.1007/s10856-013-4996-0
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Drago L, 2013, J ORTHOP RES, V31, P1694, DOI 10.1002/jor.22423
   Drakou A, 2011, J BONE JOINT SURG BR, V93, P323
   Geurts J, 2011, INJURY, V42, pS82, DOI 10.1016/j.injury.2011.06.189
   Haas DW, 1996, AM J MED, V101, P550, DOI 10.1016/S0002-9343(96)00260-4
   Hanssen AD, 2005, CLIN ORTHOP RELAT R, P91, DOI 10.1097/01.blo.0000175713.30506.77
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   Hu S, 2009, J MATER SCI-MATER M, V20, P281, DOI 10.1007/s10856-008-3564-5
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5
   Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5
   Lindfors NC, 2010, BONE, V47, P212, DOI 10.1016/j.bone.2010.05.030
   Luca R. C, 2011, EUR ORTHOP TRAUMATOL, V1, P207, DOI DOI 10.1007/S12570-011-0056-8
   McAndrew J, 2013, IRISH J MED SCI, V182, P509, DOI 10.1007/s11845-012-0895-5
   McLaren AC, 2004, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000143554.56897.26
   McPherson EJ, 2002, CLIN ORTHOP RELAT R, P8, DOI 10.1097/01.blo.0000030172.56585.c6
   Munukka E, 2008, J MATER SCI-MATER M, V19, P27, DOI 10.1007/s10856-007-3143-1
   Parsons B, 2004, AM J SURG, V188, p57S, DOI 10.1016/S0002-9610(03)00292-7
   Peltola M, 2006, HEAD NECK-J SCI SPEC, V28, P834, DOI 10.1002/hed.20436
   Sarin J, 2012, ANN OTO RHINOL LARYN, V121, P563, DOI 10.1177/000348941212100901
   Silvola JT, 2012, OTOLARYNG HEAD NECK, V147, P119, DOI 10.1177/0194599812438168
   Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901
   Stoor P, 2010, ANN OTO RHINOL LARYN, V119, P377, DOI 10.1177/000348941011900603
   Valimaki VV, 2006, SCAND J SURG, V95, P95
   Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148
   Wilson APR, 2004, BRIT MED J, V329, P720, DOI 10.1136/bmj.38232.646227.DE
   WILSON APR, 1986, LANCET, V1, P311
   Xie ZP, 2013, ANTIMICROB AGENTS CH, V57, P3293, DOI 10.1128/AAC.00284-13
   Zalavras CG, 2004, CLIN ORTHOP RELAT R, P86, DOI 10.1097/01.blo.0000143571.18892.8d
NR 37
TC 45
Z9 46
U1 0
U2 19
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 2049-4394
J9 BONE JOINT J
JI Bone Joint J.
PD JUN
PY 2014
VL 96B
IS 6
BP 845
EP 850
DI 10.1302/0301-620X.96B6.33014
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA AI4KU
UT WOS:000336834900023
PM 24891588
DA 2018-10-20
ER

PT J
AU Lindenmair, A
   Nurnberger, S
   Stadler, G
   Meinl, A
   Hackl, C
   Eibl, J
   Gabriel, C
   Hennerbichler, S
   Redl, H
   Wolbank, S
AF Lindenmair, Andrea
   Nuernberger, Sylvia
   Stadler, Guido
   Meinl, Alexandra
   Hackl, Christa
   Eibl, Johann
   Gabriel, Christian
   Hennerbichler, Simone
   Redl, Heinz
   Wolbank, Susanne
TI Intact human amniotic membrane differentiated towards the chondrogenic
   lineage
SO CELL AND TISSUE BANKING
LA English
DT Article
DE Amniotic membrane; Chondrogenic; Differentiation; Tissue engineering;
   Cartilage; Human
ID MESENCHYMAL STEM-CELLS; LYSOSOMAL STORAGE DISEASES;
   FIBROBLAST-GROWTH-FACTOR; EPITHELIAL-CELLS; IN-VITRO; POSTOPERATIVE
   ADHESIONS; TISSUE-TRANSPLANTATION; SKELETAL MYOBLAST; SHEET TECHNIQUE;
   ADIPOSE-TISSUE
AB Human amniotic membrane (hAM) represents a tissue that is well established as biomaterial in the clinics with potential for new applications in regenerative medicine. For tissue engineering (TE) strategies, cells are usually combined with inductive factors and a carrier substrate. We have previously recognized that hAM represents a natural, preformed sheet including highly potent stem cells. In the present approach for cartilage regeneration we have induced chondrogenesis in hAM in vitro. For this, hAM biopsies were cultured for up to 56 days under chondrogenic conditions. The induced hAM was characterized for remaining viability, glycosaminoglycan (GAG) accumulation using histochemical analysis, and a quantitative assay. Collagen I, II and X was immunohistochemically determined and cartilage-specific mRNA expression of (sex determining region Y-) box 9, cartilage oligomeric matrix protein (COMP), aggrecan (AGC1), versican (CSPG2), COL1A1, COL9A2, melanoma inhibitory activity (MIA), and cartilage-linking protein 1 (CRTL1) analyzed by quantitative real-time polymerase chain reaction. Human AM was successfully induced to accumulate GAG, as demonstrated by Alcianblue staining and a significant (p < 0.001) increase of GAG/viability under chondrogenic conditions peaking in a 29.9 +/- A 0.9-fold induction on day 56. Further, upon chondrogenic induction collagen II positive areas were identified within histological sections and cartilage-specific markers including COMP, AGC1, CSPG2, COL1A1, COL9A2, MIA, and CRTL1 were found upregulated at mRNA level. This is the first study, demonstrating that upon in vitro induction viable human amnion expresses cartilage-specific markers and accumulates GAGs within the biomatrix. This is a promising first step towards a potential use of living hAM for cartilage TE.
C1 [Lindenmair, Andrea; Nuernberger, Sylvia; Stadler, Guido; Meinl, Alexandra; Redl, Heinz; Wolbank, Susanne] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria.
   [Lindenmair, Andrea; Hackl, Christa; Gabriel, Christian; Hennerbichler, Simone] Red Cross Blood Transfus Serv Upper Austria, A-4017 Linz, Austria.
   [Lindenmair, Andrea; Nuernberger, Sylvia; Stadler, Guido; Meinl, Alexandra; Hackl, Christa; Gabriel, Christian; Hennerbichler, Simone; Redl, Heinz; Wolbank, Susanne] Austrian Cluster Tissue Regenerat, Vienna, Austria.
   [Nuernberger, Sylvia; Meinl, Alexandra] Bernhard Gottlieb Univ, Sch Dent, A-1090 Vienna, Austria.
   [Nuernberger, Sylvia] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria.
   [Eibl, Johann] Bioprod & Bioengn AG, A-1010 Vienna, Austria.
RP Nurnberger, S (reprint author), AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Donaueschingenstr 13, A-1200 Vienna, Austria.
EM sylvia.nuernberger@meduniwien.ac.at
RI Gabriel, Christian/A-1689-2014
OI Gabriel, Christian/0000-0003-2043-9320; Nurnberger,
   Sylvia/0000-0002-5175-5118
FU European scientific grant NovusSanguis of the Fondation Jerome LeJeune;
   FIT-IT grant (NanoDetect) of the Austrian Research Promotion Agency
   (FFG)
FX This work has been supported by the European scientific grant
   NovusSanguis of the Fondation Jerome LeJeune and the FIT-IT 2011 grant
   (NanoDetect) of the Austrian Research Promotion Agency (FFG). We thank
   Florian Hildner for technical assistance and input during manuscript
   preparation.
CR Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x
   AKLE CA, 1981, LANCET, V2, P1003
   Alviano F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-11
   ARORA M, 1994, EUR J OBSTET GYN R B, V55, P179, DOI 10.1016/0028-2243(94)90035-3
   Arya SK, 2010, NEPAL J OPHTHALMOL, V2, P145, DOI 10.3126/nepjoph.v2i2.3722
   Banerjee A, 2014, CELL TISSUE BANK, V15, P227, DOI 10.1007/s10561-013-9401-1
   Bosserhoff AK, 1997, CANCER RES, V57, P3149
   Buckley CT, 2012, J MECH BEHAV BIOMED, V11, P102, DOI 10.1016/j.jmbbm.2011.09.004
   Cheng T, 2012, BIOCHEM BIOPH RES CO, V426, P544, DOI 10.1016/j.bbrc.2012.08.124
   DHALL K, 1984, BRIT J OBSTET GYNAEC, V91, P279, DOI 10.1111/j.1471-0528.1984.tb04768.x
   Diaz-Prado S, 2010, TISSUE ENG PART C-ME, V17, P49
   Diaz-Prado S, 2010, CELL TISSUE BANK, V11, P183, DOI 10.1007/s10561-009-9144-1
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   FAULK WP, 1980, LANCET, V1, P1156
   Gajiwala Kalpesh, 2004, Cell and Tissue Banking, V5, P73, DOI 10.1023/B:CATB.0000034076.16744.4b
   Ganatra M A, 2003, J Pak Med Assoc, V53, P29
   Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a
   GRUSS JS, 1978, CAN MED ASSOC J, V118, P1237
   Hamdi H, 2013, CARDIOVASC RES
   Handorf AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022887
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   He Qingyi, 2002, Chin J Traumatol, V5, P200
   Hennerbichler Simone, 2007, Cell and Tissue Banking, V8, P1, DOI 10.1007/s10561-006-9002-3
   Hildner F, 2010, J BIOMED MATER RES A, V94A, P978, DOI 10.1002/jbm.a.32761
   Hopkinson A, 2008, TISSUE ENG PART C-ME, V14, P371, DOI 10.1089/ten.tec.2008.0315
   Kabiri A, 2012, BIOCHEM BIOPH RES CO, V424, P234, DOI 10.1016/j.bbrc.2012.06.082
   Kang JW, 2012, J VET SCI, V13, P23, DOI 10.4142/jvs.2012.13.1.23
   Kim J C, 1995, Korean J Ophthalmol, V9, P32
   Kim JH, 2011, TISSUE ENG PT A, V17, P991, DOI [10.1089/ten.tea.2010.0277, 10.1089/ten.TEA.2010.0277]
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Kock L, 2012, CELL TISSUE RES, V347, P613, DOI 10.1007/s00441-011-1243-1
   Kronsteiner B, 2011, STEM CELLS DEV, V20, P2115, DOI 10.1089/scd.2011.0031
   Kronsteiner B, 2011, CELL IMMUNOL, V267, P30, DOI 10.1016/j.cellimm.2010.11.001
   Lambeth LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068362
   Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048
   Li Q, 2011, BIOMATERIALS, V32, P4773, DOI 10.1016/j.biomaterials.2011.03.020
   Lindenmair Andrea, 2012, Cells, V1, P1061, DOI 10.3390/cells1041061
   Lindenmair A, 2010, BIOMATERIALS, V31, P8659, DOI 10.1016/j.biomaterials.2010.07.090
   Maeda S, 2011, J BIOSCI BIOENG, V111, P489, DOI 10.1016/j.jbiosc.2010.11.022
   Magatti M, 2008, STEM CELLS, V26, P182, DOI 10.1634/stemcells.2007-0491
   Magatti M, 2009, CELL TRANSPLANT, V18, P899, DOI 10.3727/096368909X471314
   Mendes LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041051
   Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Mligiliche N, 2002, J BIOMED MATER RES, V63, P591, DOI 10.1002/jbm.10349
   Narita T, 2013, INT J CARDIOL, V168, P261, DOI 10.1016/j.ijcard.2012.09.081
   Narita T, 2013, MOL THER, V21, P860, DOI 10.1038/mt.2013.9
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   NISOLLE M, 1992, J GYNECOL SURG, V8, P25, DOI 10.1089/gyn.1992.8.25
   Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594
   Peacock JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026769
   Perrier E, 2011, BIOTECHNOL LETT, V33, P2091, DOI 10.1007/s10529-011-0653-1
   Petter-Puchner AH, 2011, SURG ENDOSC, V25, P2125, DOI 10.1007/s00464-010-1507-y
   Philip Justin, 2013, Eplasty, V13, pe31
   Poghosyan T, 2013, TISSUE ENG PT A, V19, P2242, DOI [10.1089/ten.tea.2012.0565, 10.1089/ten.TEA.2012.0565]
   Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101
   Pratama G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026136
   Rennekampff H O, 1994, J Invest Surg, V7, P187, DOI 10.3109/08941939409018285
   Riau AK, 2010, BIOMATERIALS, V31, P216, DOI 10.1016/j.biomaterials.2009.09.034
   Ricci E, 2013, CELL TISSUE BANK, V14, P475, DOI 10.1007/s10561-012-9337-x
   Rommel N, 2013, BRIT J ORAL MAX SURG, V51, pE224, DOI 10.1016/j.bjoms.2013.01.016
   SAKURAGAWA N, 1992, BRAIN DEV-JPN, V14, P7, DOI 10.1016/S0387-7604(12)80272-5
   Solchaga LA, 2010, TISSUE ENG PT A, V16, P1009, DOI [10.1089/ten.tea.2009.0100, 10.1089/ten.TEA.2009.0100]
   Spoerl E, 2004, OPHTHAL RES, V36, P71, DOI 10.1159/000076884
   Stadler G, 2008, CYTOTHERAPY, V10, P743, DOI 10.1080/14653240802345804
   SUBRAHMANYAM M, 1995, BRIT J PLAST SURG, V48, P477, DOI 10.1016/0007-1226(95)90123-X
   Sudo K, 2007, STEM CELLS, V25, P1610, DOI 10.1634/stemcells.2006-0504
   Takagi R, 2012, WORLD J GASTROENTERO, V18, P5145, DOI 10.3748/wjg.v18.i37.5145
   Tallheden T, 2004, OSTEOARTHR CARTILAGE, V12, P525, DOI 10.1016/j.joca.2004.03.004
   Tosi GM, 2005, J CELL PHYSIOL, V202, P849, DOI 10.1002/jcp.20181
   Tuei VC, 2011, LIFE SCI, V88, P810, DOI 10.1016/j.lfs.2011.02.022
   TYLKISZYMANSKA A, 1985, J INHERIT METAB DIS, V8, P101, DOI 10.1007/BF01819289
   Wainwright EN, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110155
   WARD DJ, 1989, BRIT J PLAST SURG, V42, P463, DOI 10.1016/0007-1226(89)90015-5
   Wei JP, 2009, CLONING STEM CELLS, V11, P19, DOI 10.1089/clo.2008.0027
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
   Wolbank S, 2009, J TISSUE ENG REGEN M, V3, P651, DOI 10.1002/term.207
   Yang J, 2006, J CONTROL RELEASE, V116, P193, DOI 10.1016/j.jconrel.2006.06.022
   YEAGER AM, 1985, AM J MED GENET, V22, P347, DOI 10.1002/ajmg.1320220219
   Yokoi H, 2009, DEV BIOL, V329, P1, DOI 10.1016/j.ydbio.2009.01.002
   Yokoyama A, 2007, CELL TISSUE RES, V329, P469, DOI 10.1007/s00441-007-0438-y
   YOUNG RL, 1991, FERTIL STERIL, V55, P624
   Zhou JJ, 2011, INT ORTHOP, V35, P941, DOI 10.1007/s00264-010-1116-3
   Zimmermann D., 2000, PROTEOGLYCANS STRUCT, P327, DOI DOI 10.1201/9780203909720.CH13
NR 84
TC 6
Z9 7
U1 1
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-9333
EI 1573-6814
J9 CELL TISSUE BANK
JI Cell Tissue Banking
PD JUN
PY 2014
VL 15
IS 2
SI SI
BP 213
EP 225
DI 10.1007/s10561-014-9454-9
PG 13
WC Cell Biology; Engineering, Biomedical
SC Cell Biology; Engineering
GA AI7FW
UT WOS:000337051300005
PM 24828570
DA 2018-10-20
ER

PT J
AU Banerjee, A
   Nurnberger, S
   Hennerbichler, S
   Riedl, S
   Schuh, CMAP
   Hacobian, A
   Teuschl, A
   Eibl, J
   Redl, H
   Wolbank, S
AF Banerjee, Asmita
   Nuernberger, Sylvia
   Hennerbichler, Simone
   Riedl, Sabrina
   Schuh, Christina M. A. P.
   Hacobian, Ara
   Teuschl, Andreas
   Eibl, Johann
   Redl, Heinz
   Wolbank, Susanne
TI In toto differentiation of human amniotic membrane towards the Schwann
   cell lineage
SO CELL AND TISSUE BANKING
LA English
DT Article
DE Schwann cells; Human amniotic membrane; In toto differentiation;
   Amniotic epithelial cells; Peripheral nerve regeneration;
   Adipose-derived stem cells
ID MESENCHYMAL STEM-CELLS; PERIPHERAL-NERVE REGENERATION;
   SPINAL-CORD-INJURY; EPITHELIAL-CELLS; EXTRACELLULAR-MATRIX;
   ADIPOSE-TISSUE; VITRO; PLACENTA; THERAPY; TRANSPLANTATION
AB Human amniotic membrane (hAM) is a tissue containing cells with proven stem cell properties. In its decellularized form it has been successfully applied as nerve conduit biomaterial to improve peripheral nerve regeneration in injury models. We hypothesize that viable hAM without prior cell isolation can be differentiated towards the Schwann cell lineage to generate a possible alternative to commonly applied tissue engineering materials for nerve regeneration. For in vitro Schwann cell differentiation, biopsies of hAM of 8 mm diameter were incubated with a sequential order of neuronal induction and growth factors for 21 days and characterized for cellular viability and the typical glial markers glial fibrillary acidic protein (GFAP), S100 beta, p75 and neurotrophic tyrosine kinase receptor (NTRK) using immunohistology. The secretion of the neurotrophic factors brain-derived neurotrophic factor (BDNF) and glial cell-derived neurotrophic factor (GDNF) was quantified by ELISA. The hAM maintained high viability, especially under differentiation conditions (90.2 % +/- A 41.6 day 14; 80.0 % +/- A 44.5 day 21 compared to day 0). Both, BDNF and GDNF secretion was up-regulated upon differentiation. The fresh membrane stained positive for GFAP and p75 and NTRK, which was strongly increased after culture in differentiation conditions. Especially the epithelial layer within the membrane exhibited a change in morphology upon differentiation forming a multi-layered epithelium with intense accumulations of the marker proteins. However, S100 beta was expressed at equal levels and equal distribution in fresh and cultured hAM conditions. Viable hAM may be a promising alternative to present formulations used for peripheral nerve regeneration.
C1 [Banerjee, Asmita; Nuernberger, Sylvia; Riedl, Sabrina] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria.
   [Banerjee, Asmita; Hennerbichler, Simone; Riedl, Sabrina; Schuh, Christina M. A. P.; Hacobian, Ara; Teuschl, Andreas; Redl, Heinz; Wolbank, Susanne] Austrian Cluster Tissue Regenerat, Vienna, Austria.
   [Nuernberger, Sylvia] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria.
   [Nuernberger, Sylvia] Bernhard Gottlieb Univ, Clin Dent, A-1090 Vienna, Austria.
   [Hennerbichler, Simone] Red Cross Blood Transfus Serv Upper Austria, A-4017 Linz, Austria.
   [Teuschl, Andreas] Univ Appl Sci Technikum Wien, City Vienna Competence Team Tissue Engn Bioreacto, A-1200 Vienna, Austria.
   [Teuschl, Andreas] Univ Appl Sci Technikum Wien, Dept Biochem Engn, A-1200 Vienna, Austria.
   [Eibl, Johann] Bioprod & Bioengn AG, A-1010 Vienna, Austria.
RP Hennerbichler, S (reprint author), Red Cross Blood Transfus Serv Upper Austria, Krankenhausstr, A-4017 Linz, Austria.
EM simone.hennerbichler@o.roteskreuz.at
RI Gabriel, Christian/A-1689-2014
OI Gabriel, Christian/0000-0003-2043-9320; Schuh, Christina
   M.A.P./0000-0001-9475-4513; Nurnberger, Sylvia/0000-0002-5175-5118;
   Teuschl, Andreas/0000-0002-3817-1572; Hacobian, Ara/0000-0003-1684-9458
CR ADINOLFI M, 1982, NATURE, V295, P325, DOI 10.1038/295325a0
   Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49
   Caddick J, 2006, GLIA, V54, P840, DOI 10.1002/glia.20421
   Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857
   Chernousov MA, 2008, GLIA, V56, P1498, DOI 10.1002/glia.20740
   DAVIS GE, 1987, SCIENCE, V236, P1106, DOI 10.1126/science.3576223
   di Summa PG, 2013, TISSUE ENG PT A, V19, P368, DOI [10.1089/ten.tea.2012.0124, 10.1089/ten.TEA.2012.0124]
   Hennerbichler Simone, 2007, Cell and Tissue Banking, V8, P1, DOI 10.1007/s10561-006-9002-3
   Hubert T, 2009, CELL MOL LIFE SCI, V66, P1223, DOI 10.1007/s00018-008-8561-9
   Insausti CL, 2010, HISTOL HISTOPATHOL, V25, P91, DOI 10.14670/HH-25.91
   Jiang L, 2008, NEUROREPORT, V19, P1015, DOI 10.1097/WNR.0b013e3283040efc
   Kakishita K, 2003, BRAIN RES, V980, P48, DOI 10.1016/S0006-8993(03)02875-0
   Keilhoff G, 2006, TISSUE ENG, V12, P1451, DOI 10.1089/ten.2006.12.1451
   Keilhoff G, 2006, CELL MOL NEUROBIOL, V26, P1235, DOI 10.1007/s10571-006-9029-9
   Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029
   Kronsteiner B, 2011, STEM CELLS DEV, V20, P2115, DOI 10.1089/scd.2011.0031
   Kronsteiner B, 2011, CELL IMMUNOL, V267, P30, DOI 10.1016/j.cellimm.2010.11.001
   Liang HS, 2009, ACTA NEUROCHIR, V151, P1113, DOI 10.1007/s00701-009-0322-5
   Liang HS, 2012, J BIOMED MATER RES B, V100B, P2131, DOI 10.1002/jbm.b.32778
   Lindenmair A, 2010, BIOMATERIALS, V31, P8659, DOI 10.1016/j.biomaterials.2010.07.090
   Mahay D, 2008, EXP CELL RES, V314, P2692, DOI 10.1016/j.yexcr.2008.05.013
   Mahmoudi-Rad M, 2013, CLIN EXP DERMATOL, V38, P646, DOI 10.1111/ced.12087
   Manuelpillai U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038631
   Miki T, 2006, STEM CELL REV, V2, P133, DOI 10.1007/s12015-006-0020-0
   Mligiliche N, 2002, J BIOMED MATER RES, V63, P591, DOI 10.1002/jbm.10349
   Ndubaku U, 2008, ACTA HISTOCHEM, V110, P182, DOI 10.1016/j.acthis.2007.10.003
   Park HW, 2010, GLIA, V58, P1118, DOI 10.1002/glia.20992
   Parolini O, 2010, STEM CELLS DEV, V19, P143, DOI 10.1089/scd.2009.0404
   Peterbauer-Scherb A, 2012, J TISSUE ENG REGEN M, V6, P434, DOI 10.1002/term.446
   Pratama G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026136
   Riau AK, 2010, BIOMATERIALS, V31, P216, DOI 10.1016/j.biomaterials.2009.09.034
   Ricci E, 2012, CELL TISSUE BANK
   Sakuragawa N, 2004, J NEUROSCI RES, V78, P208, DOI 10.1002/jnr.20257
   Stadler G, 2008, CYTOTHERAPY, V10, P743, DOI 10.1080/14653240802345804
   Takashima S, 2008, TISSUE CELL, V40, P75, DOI 10.1016/j.tice.2007.09.001
   Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x
   Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077
   Tomita K, 2013, NEUROSCIENCE, V236, P55, DOI 10.1016/j.neuroscience.2012.12.066
   Uchida S, 2000, J NEUROSCI RES, V62, P585, DOI 10.1002/1097-4547(20001115)62:4<585::AID-JNR13>3.0.CO;2-U
   Uziyel Y, 2000, GLIA, V32, P109, DOI 10.1002/1098-1136(200011)32:2<109::AID-GLIA10>3.0.CO;2-1
   Wallquist W, 2005, J NEUROSCI, V25, P3692, DOI 10.1523/JNEUROSCI.5225-04.2005
   Wang J, 2009, BRAIN RES, V1262, P7, DOI 10.1016/j.brainres.2009.01.056
   Whittle WL, 2000, PLACENTA, V21, P394, DOI 10.1053/plac.1999.0482
   Wilshaw SP, 2008, TISSUE ENG PT A, V14, P463, DOI 10.1089/tea.2007.0145
   Wolbank S, 2009, J TISSUE ENG REGEN M, V3, P651, DOI 10.1002/term.207
   Xu YF, 2008, BRAIN RES, V1239, P49, DOI 10.1016/j.brainres.2008.08.088
   Xue H, 2013, J BIOMED MATER RES A, V101, P145, DOI 10.1002/jbm.a.34311
   Yan ZJ, 2013, NEUROCHEM RES, V38, P1022, DOI 10.1007/s11064-013-1012-5
   Yang S, 2013, NEUROSCI LETT, V539, P86, DOI 10.1016/j.neulet.2013.01.046
NR 49
TC 12
Z9 15
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-9333
EI 1573-6814
J9 CELL TISSUE BANK
JI Cell Tissue Banking
PD JUN
PY 2014
VL 15
IS 2
SI SI
BP 227
EP 239
DI 10.1007/s10561-013-9401-1
PG 13
WC Cell Biology; Engineering, Biomedical
SC Cell Biology; Engineering
GA AI7FW
UT WOS:000337051300006
PM 24166477
DA 2018-10-20
ER

PT J
AU Barboza, EP
   Stutz, B
   Mandarino, D
   Rodrigues, DM
   Ferreira, VF
AF Barboza, Eliane Porto
   Stutz, Bianca
   Mandarino, Denize
   Rodrigues, Diogo Moreira
   Ferreira, Vinicius Farias
TI Evaluation of a Dense Polytetrafluoroethylene Membrane to Increase
   Keratinized Tissue: A Randomized Controlled Clinical Trial
SO IMPLANT DENTISTRY
LA English
DT Article
DE biomaterial; keratinized tissue; guided bone regeneration
ID DENTAL IMPLANT; BONE DEFECTS; REGENERATION; MUCOSA; EXTRACTION; DOGS;
   PRESERVATION; MONKEYS; DISEASE; BARRIER
AB Background: The presence of an adequate zone of keratinized tissue has been associated with implant health. This study evaluated the increasing of the zone of keratinized tissue using dense polytetrafluoroethylene (d-PTFE) membranes over extraction sites, without primary closure.
   Materials and Methods: Fifteen sites received d-PTFE membranes. The control sites received no membranes. All cases were sutured with no attempt to achieve primary closure. Before surgery, initial measurements of buccal and lingual keratinized tissue were taken from the mucogingival line (MGL) to the most coronal gingival margins. Final measurements were taken from the buccal MGL to the lingual MGL, 60 and 90 days after extractions.
   Results: In the test group, a mean increase in the zone of keratinized tissue of 7.06 +/- 2.63 mm and 6.6 +/- 2.84 mm was observed in 60 and 90 days, respectively. In the control group, a mean increase of 2.46 +/- 1.59 mm and 1.40 +/- 1.40 mm was observed in 60 and 90 days, respectively.
   Conclusion: Nonexpanded d-PTFE membranes can predictably be used to increase the zone of keratinized tissue in preparation to implant placement.
C1 [Barboza, Eliane Porto; Mandarino, Denize; Rodrigues, Diogo Moreira] Univ Fed Fluminense, Dept Periodontol, BR-24040110 Rio De Janeiro, Brazil.
   [Ferreira, Vinicius Farias] Univ Estado Rio De Janeiro, Dept Periodontol, Rio De Janeiro, Brazil.
RP Barboza, EP (reprint author), Univ Fed Fluminense, Dept Periodontol, Rua Mario Braga 29, BR-24040110 Rio De Janeiro, Brazil.
EM barbozae@uol.com.br
CR ATWOOD DA, 1971, J PROSTHET DENT, V26, P266, DOI 10.1016/0022-3913(71)90069-2
   Barber HD, 2007, J ORAL MAXIL SURG, V65, P748, DOI 10.1016/j.joms.2006.10.042
   Barboza E P, 1999, Implant Dent, V8, P167, DOI 10.1097/00008505-199908020-00010
   Barboza EP, 2010, IMPLANT DENT, V19, P2, DOI 10.1097/ID.0b013e3181cda72c
   Barboza EP, 1999, INT J PERIODONT REST, V19, P601
   Barboza EP, 1993, THESIS BOSTON U BOST, P155
   Bartee B K, 1995, J Oral Implantol, V21, P88
   Bartee B K, 1998, Compend Contin Educ Dent, V19, P1256
   Bartee B K, 1995, Tex Dent J, V112, P11
   Bartee B K, 1995, Implant Dent, V4, P21, DOI 10.1097/00008505-199504000-00004
   Bartee BK, 2001, J ORAL IMPLANTOL, V27, P194
   BARTEE BK, 1998, COMPEND CONTIN ED DE, V19, P1260
   BARTEE BK, 1998, COMPEND CONTIN ED DE, V19, P1262
   Becker W, 1994, Int J Oral Maxillofac Implants, V9, P31
   BECKER W, 1990, INT J PERIODONT REST, V10, P377
   Bengazi F, 1996, CLIN ORAL IMPLAN RES, V7, P303, DOI 10.1034/j.1600-0501.1996.070401.x
   Berglundh T, 1996, J CLIN PERIODONTOL, V23, P971, DOI 10.1111/j.1600-051X.1996.tb00520.x
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P22, DOI 10.1034/j.1600-0501.1990.010104.x
   Casado PL, 2013, IMPLANT DENT, V22, P143, DOI 10.1097/ID.0b013e3182818792
   DAHLIN C, 1990, SCAND J PLAST RECONS, V24, P13, DOI 10.3109/02844319009004514
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Fiorellini JP, 1998, J PERIODONTOL, V69, P528, DOI 10.1902/jop.1998.69.5.528
   Hoffmann O, 2008, J PERIODONTOL, V79, P1355, DOI 10.1902/jop.2008.070502 
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   Jeong SM, 2008, J PERIODONTOL, V79, P2151, DOI [10.1902/jop.2008.070647, 10.1902/jop.2008.070647 ]
   JOVANOVIC S A, 1992, International Journal of Oral and Maxillofacial Implants, V7, P233
   LANG NP, 1994, CLIN ORAL IMPLAN RES, V5, P92, DOI 10.1034/j.1600-0501.1994.050205.x
   Lin GH, 2013, J PERIODONTOL, V84, P1755, DOI 10.1902/jop.2013.120688
   MacDonald ES, 1998, J PERIODONTOL, V69, P445, DOI 10.1902/jop.1998.69.4.445
   Moon IS, 1999, J CLIN PERIODONTOL, V26, P658, DOI 10.1034/j.1600-051X.1999.261005.x
   NEVINS M, 1992, INT J PERIODONT REST, V12, P97
   NYMAN S, 1991, J CLIN PERIODONTOL, V18, P494, DOI 10.1111/j.1600-051X.1991.tb02322.x
   PIETROKO.J, 1971, J PROSTHET DENT, V26, P119, DOI 10.1016/0022-3913(71)90041-2
   Schulz KF, 2010, OBSTET GYNECOL, V115, P1063, DOI 10.1097/AOG.0b013e3181d9d421
   Simion M, 1996, Int J Oral Maxillofac Implants, V11, P735
   SIMION M, 1994, INT J PERIODONT REST, V14, P167
   Vergara JA, 1997, J PERIODONTOL, V68, P217, DOI 10.1902/jop.1997.68.3.217
NR 37
TC 1
Z9 2
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD JUN
PY 2014
VL 23
IS 3
BP 289
EP 294
DI 10.1097/ID.0000000000000060
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AI5ID
UT WOS:000336898200012
PM 24844389
DA 2018-10-20
ER

PT J
AU Lee, JS
   Baek, SD
   Venkatesan, J
   Bhatnagar, I
   Chang, HK
   Kim, HT
   Kim, SK
AF Lee, Jong Seo
   Baek, Sang Dae
   Venkatesan, Jayachandran
   Bhatnagar, Ira
   Chang, Hee Kyung
   Kim, Hui Taek
   Kim, Se-Kwon
TI In vivo study of chitosan-natural nano hydroxyapatite scaffolds for bone
   tissue regeneration
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chitosan; Natural hydroxyapatite; Marine biomaterials
ID COMPOSITE SCAFFOLDS; PERIODONTAL TISSUE; MINERALIZATION; BIOCERAMICS;
   PARTICLES; CERAMICS; ENAMEL
AB Significant development has been achieved with bioceramics and biopolymer scaffolds in the construction of artificial bone. In the present study, we have developed and compared chitosan-micro hydroxyapatite (chitosan-mHA) and chitosan-nano hydroxyapatite (chitosan-nHA) scaffolds as bone graft substitutes. The biocompatibility and cell proliferation of the prepared scaffolds were checked with preosteoblast (MC3T3-E1) cells. Total Volume (TV), bone volume (BV), bone surface (BS), trabecular thickness (Tb.Th), trabecular number (Tb.N) and trabecular separation (Tb.Sp) were found to be higher in chitosan-nHA than chitosan-mHA scaffold. Hence, we suggest that chitosan-nHA scaffold could be a promising biomaterial for bone tissue engineering. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Lee, Jong Seo; Kim, Hui Taek] Pusan Natl Univ Hosp, Dept Orthopaed Surg, Pusan 602739, South Korea.
   [Baek, Sang Dae] Pusan Natl Univ, Grad Sch, Dept Med, Pusan 602739, South Korea.
   [Venkatesan, Jayachandran; Kim, Se-Kwon] Pukyong Natl Univ, Dept Marine Bio Convergence Sci, Pusan 608737, South Korea.
   [Venkatesan, Jayachandran; Kim, Se-Kwon] Pukyong Natl Univ, Marine Bioproc Res Ctr, Pusan 608737, South Korea.
   [Bhatnagar, Ira] Ctr Cellular & Mol Biol, Nanotheranost Lab, Hyderabad 500007, Andhra Pradesh, India.
   [Chang, Hee Kyung] Kosin Univ, Coll Med, Dept Pathol, Pusan 602739, South Korea.
RP Kim, SK (reprint author), Pukyong Natl Univ, Dept Marine Bio Convergence Sci, Pusan 608737, South Korea.
EM venkatichem@pknu.ac.kr; kimht@pusan.ac.kr; sknkim@pknu.ac.kr
OI Kim, Se-Kwon/0000-0001-6507-9539
FU Marine Bioprocess Research Center of the Marine Biotechnology Program;
   Ministry of Oceans and Fisheries, Republic of Korea
FX This research was supported by a grant from Marine Bioprocess Research
   Center of the Marine Biotechnology Program funded by the Ministry of
   Oceans and Fisheries, Republic of Korea.
CR Barakat NAM, 2009, J MATER PROCESS TECH, V209, P3408, DOI 10.1016/j.jmatprotec.2008.07.040
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   Cai X, 2009, ACTA BIOMATER, V5, P2693, DOI 10.1016/j.actbio.2009.03.005
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Chen JD, 2009, J BIOMAT SCI-POLYM E, V20, P1555, DOI 10.1163/092050609X12464345036768
   Chen Y., 2012, NANOMATER J, V2012, P5
   Cheng XM, 2009, MAT SCI ENG C-BIO S, V29, P29, DOI 10.1016/j.msec.2008.05.008
   Dhandayuthapani B., 2011, INT J POLYM SCI, V2011, P19, DOI DOI 10.1155/2011/290602
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Huang Z, 2011, CARBOHYD POLYM, V85, P261, DOI 10.1016/j.carbpol.2011.02.029
   Huang Z, 2011, MAT SCI ENG C-MATER, V31, P683, DOI 10.1016/j.msec.2010.12.014
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Je JY, 2005, BIOORGAN MED CHEM, V13, P6551, DOI 10.1016/j.bmc.2005.07.004
   Jeon YJ, 2000, FOOD REV INT, V16, P159, DOI 10.1081/FRI-100100286
   Jiang LY, 2008, CARBOHYD POLYM, V74, P680, DOI 10.1016/j.carbpol.2008.04.035
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Katti KS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034122
   Kim SE, 2008, J MATER CHEM, V18, P4994, DOI 10.1039/b810328c
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30
   Li XY, 2012, INT J BIOL MACROMOL, V50, P43, DOI 10.1016/j.ijbiomac.2011.09.021
   Liu HH, 2013, BIOMATERIALS, V34, P4404, DOI 10.1016/j.biomaterials.2013.02.048
   Liuyun Jiang, 2009, J Biomed Sci, V16, P65, DOI 10.1186/1423-0127-16-65
   Manjubala I, 2006, ACTA BIOMATER, V2, P75, DOI 10.1016/j.actbio.2005.09.007
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Orr TE, 2001, BIOMATERIALS, V22, P1953, DOI 10.1016/S0142-9612(00)00370-7
   Pallela R, 2012, J BIOMED MATER RES A, V100A, P486, DOI 10.1002/jbm.a.33292
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   Saravanan S, 2011, INT J BIOL MACROMOL, V49, P188, DOI 10.1016/j.ijbiomac.2011.04.010
   Sowmya S, 2013, PROG POLYM SCI, V38, P1748, DOI 10.1016/j.progpolymsci.2013.05.005
   Tang XJ, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044115
   Tavakol S, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-012-1373-8
   Teng SH, 2009, J BIOMED MATER RES A, V88A, P569, DOI 10.1002/jbm.a.31897
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Venkatesan J, 2012, ADV MATER RES-SWITZ, V584, P212, DOI 10.4028/www.scientific.net/AMR.584.212
   Venkatesan J, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/035003
   Venkatesan J, 2010, MATERIALS, V3, P4761, DOI 10.3390/ma3104761
   Venkatesan J, 2011, CARBOHYD POLYM, V83, P569, DOI 10.1016/j.carbpol.2010.08.019
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wang F, 2014, J BIOMED MATER RES A, V102, P760, DOI 10.1002/jbm.a.34747
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Yuan H, 2008, J NANJING MED U, V22, P372
   Zhang L, 2005, J MATER SCI-MATER M, V16, P213, DOI 10.1007/s10856-005-6682-3
   Zhang L., 2005, FUNCT MAT J, V3
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhang YF, 2007, J BIOMATER APPL, V21, P333, DOI 10.1177/0885328206063853
NR 51
TC 29
Z9 31
U1 5
U2 64
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUN
PY 2014
VL 67
BP 360
EP 366
DI 10.1016/j.ijbiomac.2014.03.053
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AI5BU
UT WOS:000336881200049
PM 24705167
DA 2018-10-20
ER

PT J
AU Zhao, HS
   Heusler, E
   Jones, G
   Li, LH
   Werner, V
   Germershaus, O
   Ritzer, J
   Luehmann, T
   Meinel, L
AF Zhao, Hongshi
   Heusler, Eva
   Jones, Gabriel
   Li, Linhao
   Werner, Vera
   Germershaus, Oliver
   Ritzer, Jennifer
   Luehmann, Tessa
   Meinel, Lorenz
TI Decoration of silk fibroin by click chemistry for biomedical application
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Silk fibroin; Decoration; Fibroblast growth factor 2; Click chemistry
ID FIBROBLAST-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; IN-VITRO; SURFACE
   MODIFICATION; ESCHERICHIA-COLI; CROSS-LINKING; AMINO-ACID; SCAFFOLDS;
   BIOMATERIALS; FILMS
AB Silkfibroin (SF) has an excellent biocompatibility and its remarkable structure translates into exciting mechanical properties rendering this biomaterial particularly fascinating for biomedical application. To further boost the material's biological/preclinical impact, SF is decorated with biologics, typically by carbodiimide/N-hydroxysuccinimide coupling (EDC/NHS). For biomedical application, this chemistry challenges the product risk profile due to the formation of covalent aggregates, particularly when decoration is with biologics occurring naturally in humans as these aggregates may prime for autoimmunity. Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC; click chemistry) provides the necessary specificity to avoid such intermolecular, covalent aggregates. We present a blueprint outlining the necessary chemistry rendering SF compatible with CuAAC and with a particular focus on structural consequences. For that, the number of SF carboxyl groups (carboxyl-SF; required for EDC/NHS chemistry) or azido groups (azido-SF; required for click chemistry) was tailored by means of diazonium coupling of the SF tyrosine residues. Structural impact on SF and decorated SF was characterized by Fourier transform infrared spectroscopy (FTIR). The click chemistry yielded a better controlled product as compared to the EDC/NHS chemistry with no formation of inter- and intramolecular crosslinks as demonstrated for SF decorated with fluorescent model compounds or a biologic, fibroblast growth factor 2 (FGF2), respectively. In conclusion, SF can readily be translated into a scaffold compatible with click chemistry yielding decorated products with a better risk profile for biomedical application. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Zhao, Hongshi; Heusler, Eva; Jones, Gabriel; Li, Linhao; Werner, Vera; Germershaus, Oliver; Ritzer, Jennifer; Luehmann, Tessa; Meinel, Lorenz] Univ Wurzburg, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany.
   [Li, Linhao] Chongqing Univ, Coll Bioengn, Key Lab Biorheol Sci & Technol, Chongqing 400030, Peoples R China.
RP Meinel, L (reprint author), Univ Wurzburg, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany.
EM l.meinel@pharmazie.uni-wuerzburg.de
RI Meinel, Lorenz/D-9997-2015; Luhmann, Tessa/E-1209-2015
OI Meinel, Lorenz/0000-0002-7549-7627; Germershaus,
   Oliver/0000-0002-8440-2781; Li, Linhao/0000-0001-5518-8790
FU Cornelia Heindl with the genetic engineering of the FGF2; German
   Alexander von Humboldt Foundation; IZKF [D-218]; CCMX Grant program
   MatLife (Lausanne, Switzerland)
FX We acknowledge superb technical support by Cornelia Heindl with the
   genetic engineering of the FGF2. Financial support was by the German
   Alexander von Humboldt Foundation to HZ, by IZKF (Wuerzburg, Germany)
   with Grant number D-218 and by the CCMX Grant program MatLife (Lausanne,
   Switzerland). The generous gift of cocoons by Trudel (Zuerich,
   Switzerland) is acknowledged.
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26
   BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043
   CUNNIFF PM, 1994, ACS SYM SER, V544, P234
   Dabbagh HA, 2007, DYES PIGMENTS, V73, P239, DOI 10.1016/j.dyepig.2005.12.002
   Das S, 2012, BIOMACROMOLECULES, V13, P3695, DOI 10.1021/bm301170u
   Doherty DH, 2005, BIOCONJUGATE CHEM, V16, P1291, DOI 10.1021/bc050172r
   Enami I, 1998, J BIOL CHEM, V273, P4629, DOI 10.1074/jbc.273.8.4629
   Gasparian ME, 2009, BIOCHEMISTRY-MOSCOW+, V74, P221, DOI 10.1134/S000629790902014X
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu XA, 2010, BIOMACROMOLECULES, V11, P3178, DOI 10.1021/bm1010504
   Hu YP, 2012, ADV MATER SCI ENG, DOI 10.1155/2012/185905
   Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kolb HC, 2003, DRUG DISCOV TODAY, V8, P1128, DOI 10.1016/S1359-6446(03)02933-7
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   Koren E, 2008, J IMMUNOL METHODS, V333, P1, DOI 10.1016/j.jim.2008.01.001
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu R, 2012, FIBER POLYM, V13, P613, DOI 10.1007/s12221-012-0613-y
   Lopez-Alonso JP, 2009, BIOCONJUGATE CHEM, V20, P1459, DOI 10.1021/bc9001486
   LUCAS F, 1958, ADV PROTEIN CHEM, V13, P107, DOI 10.1016/S0065-3233(08)60599-9
   Luhmann T, 2009, BIOMATERIALS, V30, P4503, DOI 10.1016/j.biomaterials.2009.05.041
   Lv Q, 2008, J BIOMED MATER RES A, V84A, P198, DOI 10.1002/jbm.a.31366
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Nakayama K, 2005, BIOCONJUGATE CHEM, V16, P1360, DOI 10.1021/bc04972g
   PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003
   Patten P A, 2003, Dev Biol (Basel), V112, P81
   Rosenberg AS, 2006, AAPS J, V8, pE501
   Sampaio S, 2011, POLYM INT, V60, P1737, DOI 10.1002/pi.3143
   Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P3, DOI 10.1093/ndt/gfh1092
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SQUIRES CH, 1988, J BIOL CHEM, V263, P16297
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   van de Weert M, 2001, ANAL BIOCHEM, V297, P160, DOI 10.1006/abio.2001.5337
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vepari C, 2010, J BIOMED MATER RES A, V93A, P595, DOI 10.1002/jbm.a.32565
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Yagi T, 2011, J ARTIF ORGANS, V14, P89, DOI 10.1007/s10047-011-0554-z
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 54
TC 24
Z9 24
U1 9
U2 109
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JUN
PY 2014
VL 186
IS 3
BP 420
EP 430
DI 10.1016/j.jsb.2014.02.009
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA AI5BQ
UT WOS:000336880800013
PM 24576682
DA 2018-10-20
ER

PT J
AU Salcedo, L
   Penn, M
   Damaser, M
   Balog, B
   Zutshi, M
AF Salcedo, Levilester
   Penn, Marc
   Damaser, Margot
   Balog, Brian
   Zutshi, Massarat
TI Functional Outcome After Anal Sphincter Injury and Treatment With
   Mesenchymal Stem Cells
SO STEM CELLS TRANSLATIONAL MEDICINE
LA English
DT Article
DE Mesenchymal stem cells; Anal sphincter; Anal pressures; i.v. infusion;
   Fecal incontinence
ID STRESS URINARY-INCONTINENCE; SACRAL NERVE-STIMULATION; INJECTABLE
   SILICONE BIOMATERIAL; RETRACTED ARTICLE. SEE; FECAL INCONTINENCE;
   BULKING AGENT; RAT MODEL; REPAIR; INJECTION; THERAPY
AB This research demonstrates the regenerative effects of mesenchymal stem cells (MSCs) on the injured anal sphincter by comparing anal sphincter pressures following intramuscular and serial intravascular MSC infusion in a rat model of anal sphincter injury. Fifty rats were divided into injury (n = 35) and no injury (NI; n = 15) groups. Each group was further divided into i.m., serial i.v., or no-treatment (n = 5) groups and followed for 5 weeks. The injury consisted of an excision of 25% of the anal sphincter complex. Twenty-four hours after injury, 5 x 105 green fluorescent protein-labeled MSCs in 0.2 ml of phosphate-buffered saline (PBS) or PBS alone (sham) were injected into the anal sphincter for i.m. treatment; i.v. and sham i.v. treatments were delivered daily for 6 consecutive days via the tail vein. Anal pressures were recorded before injury and 10 days and 5 weeks after treatment. Ten days after i.m. MSC treatment, resting and peak pressures were significantly increased compared with those in sham i.m. treatment (p < .001). When compared with the NI group, the injury groups had anal pressures that were not significantly different 5 weeks after i.m./i.v. treatment. Both resting and peak pressures were also significantly increased after i.m./i.v. MSC treatment compared with treatment with PBS (p < .001), suggesting recovery. Statistical analysis was done using paired t test with Bonferroni correction. Marked decrease in fibrosis and scar tissue was seen in both MSC-treated groups. Both i.m. and i.v. MSC treatment after injury caused an increase in anal pressures sustained at 5 weeks, although fewer cells were injected i.m. The MSC-treated groups showed less scarring than the PBS-treated groups, with the i.v. infusion group showing the least scarring.
C1 [Salcedo, Levilester; Zutshi, Massarat] Cleveland Clin, Dept Colorectal Surg, Cleveland, OH 44106 USA.
   [Damaser, Margot; Balog, Brian] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Penn, Marc] Summa Cardiovasc Inst, Akron, OH USA.
   [Penn, Marc] Northeast Ohio Med Univ, Akron, OH USA.
   [Damaser, Margot; Balog, Brian] Vet Affairs Med Ctr, Adv Platform Technol Ctr, Louis Stokes Cleveland Dept, Cleveland, OH USA.
RP Zutshi, M (reprint author), Cleveland Clin Fdn, 9500 Euclid Ave,A-30, Cleveland, OH 44195 USA.
EM zutshim@cct.org
FU Department of Colorectal Surgery, Cleveland Clinic, Cleveland, Ohio, USA
FX The project was funded by the Department of Colorectal Surgery,
   Cleveland Clinic, Cleveland, Ohio, USA. We acknowledge the technical
   help received from Matthew Kiedrowski, Lauren Sun, and Mei Kuang.
CR Aghaee-afshar M, 2009, DIS COLON RECTUM, V52, P1753, DOI 10.1007/DCR.0b013e3181b55112
   Altomare DF, 2009, DIS COLON RECTUM, V52, P11, DOI 10.1007/DCR.0b013e3181974444
   Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Fu Q, 2010, UROLOGY, V75, P718, DOI 10.1016/j.urology.2009.10.003
   Furuta A, 2007, NEUROUROL URODYNAM, V26, P966, DOI 10.1002/nau.20448
   Furuta A, 2007, EXPERT OPIN BIOL TH, V7, P1483, DOI 10.1517/14712598.7.10.1483
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P731, DOI DOI 10.1007/S10350-003-0114-6
   Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6
   Ho JH, 2012, CELL TRANSPLANT, V21, P997, DOI 10.3727/096368911X603611
   Jarrett MED, 2004, BRIT J SURG, V91, P1559, DOI 10.1002/bjs.4796
   Kajbafzadeh AM, 2010, DIS COLON RECTUM, V53, P1415, DOI 10.1007/DCR.0b013e3181e53088
   Kang SB, 2008, DIS COLON RECTUM, V51, P1367, DOI 10.1007/s10350-008-9360-y
   Kenefick NJ, 2006, GUT, V55, P1824
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kenefick NJ, 2002, BRIT J SURG, V89, P882, DOI 10.1046/j.1365-2168.2002.02132.x
   Lin GT, 2010, CYTOTHERAPY, V12, P88, DOI 10.3109/14653240903350265
   Lorenzi B, 2008, DIS COLON RECTUM, V51, P411, DOI 10.1007/s10350-007-9153-8
   Macmillan AK, 2004, DIS COLON RECTUM, V47, P1341, DOI 10.1007/s10350-004-0593-0
   Malouf AJ, 2000, LANCET, V355, P260, DOI 10.1016/S0140-6736(99)05218-6
   Maslekar S, 2007, J AM COLL SURGEONS, V204, P40
   Mitterberger M, 2008, BJU INT, V102, P1731, DOI 10.1111/j.1464-410X.2008.07892.x
   Nikiteas N, 1996, DIS COLON RECTUM, V39, P1164, DOI 10.1007/BF02081420
   Pathi SD, 2012, OBSTET GYNECOL, V119, P134, DOI 10.1097/AOG.0b013e3182397009
   Penn MS, 2008, EXPERT OPIN BIOL TH, V8, P17, DOI 10.1517/14712598.8.1.17
   Penn Marc S., 2006, V129, P329
   Penn MS, 2004, INT J CARDIOL, V95, pS23, DOI 10.1016/j.ijcard.2004.04.000
   Salcedo L, 2013, STEM CELL RES, V10, P95, DOI 10.1016/j.scr.2012.10.002
   Salcedo L, 2011, INT J COLORECTAL DIS, V26, P1577, DOI 10.1007/s00384-011-1269-6
   Salcedo L, 2010, DIS COLON RECTUM, V53, P1209, DOI 10.1007/DCR.0b013e3181de7fe0
   Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293
   Smaldone MC, 2008, WORLD J UROL, V26, P327, DOI 10.1007/s00345-008-0269-9
   Stangel-Wojcikiewicz K, 2010, GINEKOL POL, V81, P378
   Sundararaman S, 2011, GENE THER, V18, P867
   Tjandra JJ, 2003, DIS COLON RECTUM, V46, P937, DOI 10.1097/01.DCR.0000074687.97942.92
   Tjandra JJ, 2003, DIS COLON RECTUM, V46, P942
   Tjandra JJ, 2008, DIS COLON RECTUM, V51, P494, DOI 10.1007/s10350-007-9103-5
   Vaizey CJ, 2004, DIS COLON RECTUM, V47, P858, DOI 10.1007/s10350-003-0112-8
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
   Wang A, 2006, INT UROGYNECOL J, V17, P253, DOI 10.1007/s00192-005-1338-x
   White AB, 2010, OBSTET GYNECOL, V115, P815, DOI 10.1097/AOG.0b013e3181d56cc5
   Yamamoto T, 2010, INT J UROL, V17, P896, DOI 10.1111/j.1442-2042.2010.02634.x
   Yamamoto T, 2010, INT J UROL, V17, P75, DOI 10.1111/j.1442-2042.2009.02429.x
   Young CJ, 1998, DIS COLON RECTUM, V41, P344, DOI 10.1007/BF02237489
   Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com
   Zhao WM, 2011, EUR UROL, V59, P155, DOI 10.1016/j.eururo.2010.10.038
   Zutshi M, 2009, DIS COLON RECTUM, V52, P1321, DOI 10.1007/DCR.0b013e31819f746d
   Zutshi M, 2009, DIS COLON RECTUM, V52, P1089, DOI 10.1007/DCR.0b013e3181a0a79c
NR 50
TC 18
Z9 18
U1 0
U2 4
PU ALPHAMED PRESS
PI DURHAM
PA 318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA
SN 2157-6564
EI 2157-6580
J9 STEM CELL TRANSL MED
JI Stem Cells Transl. Med.
PD JUN
PY 2014
VL 3
IS 6
BP 760
EP 767
DI 10.5966/sctm.2013-0157
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA AI5WL
UT WOS:000336940000021
PM 24797828
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zhang, H
   Brown, KD
   Lowe, SP
   Liu, GS
   Steele, D
   Abberton, K
   Daniell, M
AF Zhang, Hong
   Brown, Karl David
   Lowe, Sue Peng
   Liu, Guei-Sheung
   Steele, David
   Abberton, Keren
   Daniell, Mark
TI Acrylic Acid Surface-Modified Contact Lens for the Culture of Limbal
   Stem Cells
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID OCULAR SURFACE; CORNEAL REGENERATION; AMNIOTIC MEMBRANE; EPITHELIAL
   SHEETS; IN-VITRO; P63; DIFFERENTIATION; PROLIFERATION; COLLAGEN; THERAPY
AB Surface treatment to a biomaterial surface has been shown to modify and help cell growth. Our aim was to determine the best surface-modified system for the treatment of limbal stem cell deficiency (LSCD), which would facilitate expansion of autologous limbal epithelial cells, while maintaining cultivated epithelial cells in a less differentiated state. Commercially available contact lenses (CLs) were variously surface modified by plasma polymerization with ratios of acrylic acid to octadiene tested at 100% acrylic acid, 50:50% acrylic acid: octadiene, and 100% octadiene to produce high-, mid-, and no-acid. X-ray photoelectron spectroscopy was used to analyze the chemical composition of the plasma polymer deposited layer. Limbal explants cultured on high acid-modified CLs outgrew more cells. Immunofluorescence and RT2-PCR array results indicated that a higher acrylic acid content can also help maintain progenitor cells during ex vivo expansion of epithelial cells. This study provides the first evidence for the ability of high acid-modified CLs to preserve the stemness and to be used as substrates for the culture of limbal cells in the treatment of LSCD.
C1 [Zhang, Hong] Harbin Med Univ, Hosp Eye, Harbin, Heilongjiang Pr, Peoples R China.
   [Zhang, Hong; Brown, Karl David; Liu, Guei-Sheung; Daniell, Mark] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Vic 3002, Australia.
   [Brown, Karl David; Liu, Guei-Sheung; Abberton, Keren] OBrien Inst, Fitzroy, Vic, Australia.
   [Lowe, Sue Peng; Steele, David] Mawson Inst SA, Adelaide, SA, Australia.
RP Zhang, H (reprint author), Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, 32 Gisborne St, East Melbourne, Vic 3002, Australia.
EM hong.zhang@unimelb.edu.au; daniellm@unimelb.edu.au
RI Liu, Guei-Sheung/Q-6472-2018
OI Liu, Guei-Sheung/0000-0003-3379-724X; Brown, Karl/0000-0003-1847-2789
FU Australia-India Strategic Research Fund [BF020074]; National Natural
   Science Foundation of China [81201184]
FX The Australia-India Strategic Research Fund BF020074 and the National
   Natural Science Foundation of China 81201184. ("An Advanced Surface for
   the Cell Therapy of Limbal Epithelium for Ocular Surface Disease: Proof
   of Concept and Clinical Trials").
CR Ambrose WM, 2009, J BIOMED MATER RES B, V90B, P818, DOI 10.1002/jbm.b.31351
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI 10.1089/tea.2007.0224
   Deshpande P, 2009, TISSUE ENG PT A, V15, P2889, DOI [10.1089/ten.tea.2008.0528, 10.1089/ten.TEA.2008.0528]
   Di Girolamo N, 2007, BRIT J OPHTHALMOL, V91, P459, DOI 10.1136/bjo.2006.103895
   Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102
   Erikstein BS, 2010, J CELL BIOCHEM, V111, P574, DOI 10.1002/jcb.22741
   Han B, 2002, CORNEA, V21, P505, DOI 10.1097/01.ICO.0000016343.19018.1D
   He YG, 1999, CORNEA, V18, P570, DOI 10.1097/00003226-199909000-00010
   Higa K, 2007, INVEST OPHTH VIS SCI, V48, P597, DOI 10.1167/iovs.06-0664
   Kawakita T, 2009, INVEST OPHTH VIS SCI, V50, P4611, DOI 10.1167/iovs.08-2586
   Kolli S, 2010, STEM CELLS, V28, P597, DOI 10.1002/stem.276
   Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Levrero M, 2000, J CELL SCI, V113, P1661
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Morita Y, 2006, BLOOD, V108, P2850, DOI 10.1182/blood-2006-03-010207
   Nakatsu MN, 2011, INVEST OPHTH VIS SCI, V52, P4734, DOI 10.1167/iovs.10-6486
   Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47
   O'Callaghan AR, 2011, STEM CELLS, V29, P1923, DOI 10.1002/stem.756
   Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x
   Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0
   Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098
   Perrot S, 2003, TOXICOL SCI, V72, P122, DOI 10.1093/toxsci/kfg014
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016
   Selvam S, 2006, OCUL SURF, V4, P120, DOI 10.1016/S1542-0124(12)70039-3
   Shortt AJ, 2007, STEM CELLS, V25, P1402, DOI 10.1634/stemcells.2006-0580
   Tsai RJF, 2010, EYE CONTACT LENS, V36, P305, DOI 10.1097/ICL.0b013e3181efff40
   Vercauteren SM, 2004, BLOOD, V104, P2315, DOI 10.1182/blood-2004-01-0204
   Watanabe K, 2004, FEBS LETT, V565, P6, DOI 10.1016/j.febslet.2004.03.064
   Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214
   Yang A, 1999, NATURE, V398, P714
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yang YZ, 2002, BIOMATERIALS, V23, P1383, DOI 10.1016/S0142-9612(01)00259-9
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028
NR 39
TC 7
Z9 8
U1 0
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUN
PY 2014
VL 20
IS 11-12
BP 1593
EP 1602
DI 10.1089/ten.tea.2013.0320
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AI5JI
UT WOS:000336901700004
PM 24377804
DA 2018-10-20
ER

PT J
AU Araujo, J
   Padrao, J
   Silva, JP
   Dourado, F
   Correia, DM
   Botelho, G
   Ribelles, JLG
   Lanceros-Mendez, S
   Sencadas, V
AF Araujo, J.
   Padrao, J.
   Silva, J. P.
   Dourado, F.
   Correia, D. M.
   Botelho, G.
   Gomez Ribelles, J. L.
   Lanceros-Mendez, S.
   Sencadas, V.
TI Processing and characterization of alpha-elastin electrospun membranes
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID CONNECTIVE TISSUES; POLYMER; FIBERS; TROPOELASTIN; BIOCHEMISTRY;
   BIOMATERIAL; ASSEMBLIES; MORPHOLOGY; CHEMISTRY; NANOFIBER
AB Elastin isolated from fresh bovine ligaments was dissolved in a mixture of 1,1,1,3,3,3-Hexafluoro-2-propanol and water were electrospun into fiber membranes under different processing conditions. Fiber mats of randomly and aligned fibers were obtained with fixed and rotating ground collectors and fibrils were composed by thin ribbons whose width depends on electrospinning conditions; fibrils with 721 nm up to 2.12 mu m width were achieved. After cross-linking with glutaraldehyde, alpha-elastin can uptake as much as 1700 % of PBS solution and a slight increase on fiber thickness was observed. The glass transition temperature of electrospun fiber mats was found to occur at similar to 80 A degrees C. Moreover, alpha-Elastin showed to be a perfect elastomeric material, and no mechanical hysteresis was found in cycle mechanical measurements. The elastic modulus obtained for random and aligned fibers mats in a PBS solution was 330 +/- 10 kPa and 732 +/- 165 kPa, respectively. Finally, the electrospinning and cross-linking process does not inhibit MC-3T3-E1 cell adhesion. Cell culture results showed good cell adhesion and proliferation in the cross-linked elastin fiber mats.
C1 [Araujo, J.; Padrao, J.; Silva, J. P.; Dourado, F.] Univ Minho, Inst Biotechnol & Bioengn, Ctr Biol Engn, P-4710057 Braga, Portugal.
   [Correia, D. M.; Lanceros-Mendez, S.; Sencadas, V.] Univ Minho, Ctr Dept Fis, P-4710057 Braga, Portugal.
   [Correia, D. M.; Botelho, G.] Univ Minho, Dept Quim, Ctr Quim, P-4710057 Braga, Portugal.
   [Gomez Ribelles, J. L.] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, Valencia 46022, Spain.
   [Gomez Ribelles, J. L.] Ciber Bioingn Biomat & Nanomed CIBER BBN, Valencia, Spain.
   [Sencadas, V.] Inst Politecn Cavado & Ave, Escola Super Tecnol, P-4750810 Barcelos, Portugal.
RP Sencadas, V (reprint author), Univ Minho, Ctr Dept Fis, Campus Gualtar, P-4710057 Braga, Portugal.
EM vsencadas@fisica.uminho.pt
RI lanceros-mendez, senentxu/A-1730-2011; Botelho, Gabriela/M-4538-2013;
   Dourado, Fernando/O-5619-2015; Sencadas, Vitor/A-3932-2008; Silva,
   Joao/E-8444-2012; Gomez Ribelles, Jose Luis/L-5629-2014
OI lanceros-mendez, senentxu/0000-0001-6791-7620; Botelho,
   Gabriela/0000-0002-4680-0834; Dourado, Fernando/0000-0001-9239-7209;
   Sencadas, Vitor/0000-0003-1986-1348; Silva, Joao/0000-0002-5656-0897;
   Gomez Ribelles, Jose Luis/0000-0001-9099-0885; Padrao,
   Jorge/0000-0001-5630-6621; Correia, Daniela Maria/0000-0002-3118-4717
FU FEDER funds through the "Programa Operacional Factores de
   Competitividade-COMPETE"; FCT-Fundacao para a Ciencia e a Tecnologia
   [NANO/NMed-SD/0156/2007, PTDC/CTM-NAN/112574/2009,
   PEST-C/FIS/UI607/2011]; "Matepro-Optimizing Materials and Processes"
   [NORTE-07-0124-FEDER-000037]; COST Action [MP1003]; FCT
   [SFRH/BD/48708/2008, SFRH/BD/64901/2009, SFRH/BPD/64958/2009,
   SFRH/BPD/63148/2009, SFRH/BD/82411/2011]; Spanish Ministry of Science
   and Innovation [MAT2010-21611-C03-01]; VI National RDi Plan; Iniciativa
   Ingenio; Consolider Program; CIBER Actions; Instituto de Salud Carlos
   III with assistance from the European Regional Development Fund;
   "Programa Operacional Regional do Norte", under the "Quadro de
   Referencia Estrategico Nacional" (QREN), through the "Fundo Europeu de
   Desenvolvimento Regional" (FEDER) [ON.2-O Novo Norte]
FX This work is funded by FEDER funds through the "Programa Operacional
   Factores de Competitividade-COMPETE" and by national funds arranged by
   FCT-Fundacao para a Ciencia e a Tecnologia, project references
   NANO/NMed-SD/0156/2007, PTDC/CTM-NAN/112574/2009, and
   PEST-C/FIS/UI607/2011. The authors also thank funding from
   "Matepro-Optimizing Materials and Processes", ref.
   "NORTE-07-0124-FEDER-000037", cofunded by the "Programa Operacional
   Regional do Norte" (ON.2-O Novo Norte), under the "Quadro de Referencia
   Estrategico Nacional" (QREN), through the "Fundo Europeu de
   Desenvolvimento Regional" (FEDER). The authors also thank support from
   the COST Action MP1003, 2010 'European Scientific Network for Artificial
   Muscles'. VS, JP, JS, and DMC thank the FCT for the SFRH/BD/48708/2008,
   SFRH/BD/64901/2009, SFRH/BPD/64958/2009 and SFRH/BPD/63148/2009, and
   SFRH/BD/82411/2011 grants, respectively. JLGR acknowledges the support
   of the Spanish Ministry of Science and Innovation through project No.
   MAT2010-21611-C03-01 (including the FEDER financial support). CIBER-BBN
   is an initiative funded by the VI National R&D&i Plan 2008-2011,
   Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed
   by the Instituto de Salud Carlos III with assistance from the European
   Regional Development Fund.
CR AARON BB, 1981, BIOPOLYMERS, V20, P1247, DOI 10.1002/bip.1981.360200611
   Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Arinstein A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056303
   BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   CECCORULLI G, 1977, BIOPOLYMERS, V16, P1505, DOI 10.1002/bip.1977.360160710
   Chalmers GWG, 1999, J EXP BIOL, V202, P301
   Clarisse R., 2011, SCI TECHNOL ADV MAT, V12
   COX BA, 1974, J BIOL CHEM, V249, P997
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   DEBELLE L, 1995, J BIOL CHEM, V270, P26099, DOI 10.1074/jbc.270.44.26099
   Demir MM, 2002, POLYMER, V43, P3303, DOI 10.1016/S0032-3861(02)00136-2
   El-Kurdi MS, 2008, BIOMATERIALS, V29, P3213, DOI 10.1016/j.biomaterials.2008.04.009
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   Gao K, 2006, MAT SCI ENG B-SOLID, V131, P100, DOI 10.1016/j.mseb.2006.03.035
   GOTTE L, 1963, BIOCHEM J, V87, P344, DOI 10.1042/bj0870344
   INDIK Z, 1987, P NATL ACAD SCI USA, V84, P5680, DOI 10.1073/pnas.84.16.5680
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Koombhongse S, 2001, J POLYM SCI POL PHYS, V39, P2598, DOI 10.1002/polb.10015
   Li B, 2002, J MUSCLE RES CELL M, V23, P561, DOI 10.1023/A:1023474909980
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Machado R, 2009, J NANO RES, V6, P133, DOI 10.4028/www.scientific.net/JNanoR.6.133
   Megelski S, 2002, MACROMOLECULES, V35, P8456, DOI 10.1021/ma020444a
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   Ofner CM, 1996, PHARM RES-DORDR, V13, P1821
   PARTRIDGE SM, 1955, BIOCHEM J, V61, P21, DOI 10.1042/bj0610021
   Popescu MC, 2010, BIOPOLYMERS, V93, P1072, DOI 10.1002/bip.21524
   Qin XH, 2004, POLYMER, V45, P6409, DOI 10.1016/j.polymer.2004.06.031
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Ribeiro C, 2010, SOFT MATER, V8, P274, DOI 10.1080/1539445X.2010.495630
   Rodriguez-Cabello JC, 1999, MACROMOL CHEM PHYSIC, V200, P1831, DOI 10.1002/(SICI)1521-3935(19990801)200:8<1831::AID-MACP1831>3.0.CO;2-V
   Samouillan V, 2011, J FUNCT BIOMATER, V2, P230, DOI 10.3390/jfb2030230
   Sencadas V, 2012, POLYM TEST, V31, P1062, DOI 10.1016/j.polymertesting.2012.07.010
   Sencadas V, 2012, APPL PHYS A-MATER, V109, P685, DOI 10.1007/s00339-012-7101-5
   Sencadas V, 2012, CARBOHYD POLYM, V87, P1295, DOI 10.1016/j.carbpol.2011.09.017
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Tarnawski Rafal, 1993, Upsala Journal of Medical Sciences, V98, P53
   Tatham AS, 2000, TRENDS BIOCHEM SCI, V25, P567, DOI 10.1016/S0968-0004(00)01670-4
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   UITTO J, 1979, J INVEST DERMATOL, V72, P1, DOI 10.1111/1523-1747.ep12530093
   Urry D.W., 2006, WHAT SUSTAINS LIFE C
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111
   Zhao SL, 2004, J APPL POLYM SCI, V91, P242, DOI 10.1002/app.13196
NR 47
TC 6
Z9 6
U1 2
U2 38
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
EI 1432-0630
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD JUN
PY 2014
VL 115
IS 4
BP 1291
EP 1298
DI 10.1007/s00339-013-7984-9
PG 8
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AH8CY
UT WOS:000336362900026
DA 2018-10-20
ER

PT J
AU Huang, HJ
   Zhang, X
   Hu, XQ
   Dai, LH
   Zhu, JX
   Man, ZT
   Chen, HF
   Zhou, CY
   Ao, YF
AF Huang, Hongjie
   Zhang, Xin
   Hu, Xiaoqing
   Dai, Linghui
   Zhu, Jingxian
   Man, Zhentao
   Chen, Haifeng
   Zhou, Chunyan
   Ao, Yingfang
TI Directing chondrogenic differentiation of mesenchymal stem cells with a
   solid-supported chitosan thermogel for cartilage tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE mesenchymal stem cell; thermogel; demineralized bone matrix;
   chondrogenesis; cartilage tissue engineering
ID MARROW STROMAL CELLS; CORTICAL BONE-MATRIX; IN-VIVO;
   ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; DEFECT REPAIR; HYDROGELS;
   VITRO; THERAPY; MICROFRACTURE
AB Hydrogels are attractive for cartilage tissue engineering because of their high plasticity and similarity with the native cartilage matrix. However, one critical drawback of hydrogels for osteochondral repair is their inadequate mechanical strength. To address this limitation, we constructed a solid-supported thermogel comprising a chitosan hydrogel system and demineralized bone matrix. Scanning electron microscopy, the equilibrium scanning ratio, the biodegradation rate, biomechanical tests, biochemical assays, metabolic activity tests, immunostaining and cartilage-specific gene expression analysis were used to evaluate the solid-supported thermogel. Compared with pure hydrogel or demineralized matrix, the hybrid biomaterial showed superior porosity, equilibrium swelling and degradation rate. The hybrid scaffolds exhibited an increased mechanical strength: 75% and 30% higher compared with pure hydrogels and demineralized matrix, respectively. After three days culture, bone-derived mesenchymal stem cells (BMSCs) maintained viability above 90% in all three materials; however, the cell retention of the hybrid scaffolds was more efficient and uniform than the other materials. Matrix production and chondrogenic differentiation of BMSCs in the hybrid scaffolds were superior to its precursors, based on glycosaminoglycan quantification and hyaline cartilage marker expression after three weeks in culture. Its easy preparation, favourable biophysical properties and chondrogenic capacity indicated that this solid-supported thermogel could be an attractive biomaterial framework for cartilage tissue engineering.
C1 [Huang, Hongjie; Zhang, Xin; Hu, Xiaoqing; Dai, Linghui; Zhu, Jingxian; Man, Zhentao; Ao, Yingfang] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100191, Peoples R China.
   [Dai, Linghui; Zhu, Jingxian; Zhou, Chunyan] Peking Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China.
   [Chen, Haifeng] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China.
RP Zhou, CY (reprint author), Peking Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.
EM chunyanzhou@bjmu.edu.cn; yingfang.ao@gmail.com
FU National Natural Science Foundation of China [90919022, 81101390];
   Specialized Research Fund for the Doctoral Program of Higher Education
   [20110001130001]; 111 Project of China [B07001]; National Basic Research
   Program of China [2012CB933903]
FX This work was supported by grants from the National Natural Science
   Foundation of China (grant nos 90919022, 81101390), the Specialized
   Research Fund for the Doctoral Program of Higher Education
   (20110001130001), the 111 Project of China (B07001), and the National
   Basic Research Program of China (2012CB933903).
CR Amini AA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024105
   Becerra J, 1996, J BONE MINER RES, V11, P1703
   Bian LM, 2013, BIOMATERIALS, V34, P413, DOI 10.1016/j.biomaterials.2012.09.052
   Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Dessi M, 2013, J BIOMED MATER RES A, V101, P2984, DOI 10.1002/jbm.a.34592
   Dexheimer V, 2012, STEM CELLS DEV, V21, P2160, DOI 10.1089/scd.2011.0670
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Eckstein F, 2001, ANAT EMBRYOL, V203, P147, DOI 10.1007/s004290000154
   Epure V, 2011, CARBOHYD POLYM, V83, P947, DOI 10.1016/j.carbpol.2010.09.003
   Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033
   Foley PL, 2013, BIOMATERIALS, V34, P2539, DOI 10.1016/j.biomaterials.2012.12.035
   Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919
   Gao JZ, 2004, CLIN ORTHOP RELAT R, pS62, DOI 10.1097/01.blo.0000143819.82510.0d
   Gardner OFW, 2013, HISTOL HISTOPATHOL, V28, P23, DOI 10.14670/HH-28.23
   Gloria A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0833
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Hoemann CD, 2007, J BIOMED MATER RES A, V83A, P521, DOI 10.1002/jbm.a.31365
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Hu X, 2012, STEM CELLS DEV, V22, P248, DOI [10.1089/scd.2012.010522873791, DOI 10.1089/SCD.2012.010522873791]
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5
   Lee DA, 2011, J CELL BIOCHEM, V112, P1, DOI 10.1002/jcb.22758
   Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040
   Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045
   Liu Y, 2009, J BIOMED MATER RES B, V90B, P492, DOI 10.1002/jbm.b.31310
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Makino H, 2004, J BIOSCI BIOENG, V98, P374, DOI 10.1263/jbb.98.374
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370
   Naveena N, 2012, J MATER CHEM, V22, P5239, DOI 10.1039/c1jm14401d
   Oh DX, 2013, BIOTECHNOL PROGR, V29, P505, DOI 10.1002/btpr.1691
   Oldershaw RA, 2012, INT J EXP PATHOL, V93, P389, DOI 10.1111/j.1365-2613.2012.00837.x
   Panoskaltsis N, 2005, J BIOSCI BIOENG, V100, P28, DOI 10.1263/jbb.100.28
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Rennerfeldt DA, 2013, BIOMATERIALS, V34, P8241, DOI 10.1016/j.biomaterials.2013.07.052
   Reys LL, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/045002
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shao ZX, 2012, BIOMATERIALS, V33, P3375, DOI 10.1016/j.biomaterials.2012.01.033
   Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838
   Sukarto A, 2012, BIOMACROMOLECULES, V13, P2490, DOI 10.1021/bm300733n
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Toh WS, 2012, BIOMATERIALS, V33, P3835, DOI 10.1016/j.biomaterials.2012.01.065
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Wang LM, 2010, BIOMATERIALS, V31, P3976, DOI 10.1016/j.biomaterials.2010.01.131
   Wang MD, 2007, EXPERT REV ANTICANC, V7, P833, DOI 10.1586/14737140.7.6.833
   Zhang X, 2008, BIOMATERIALS, V29, P4616, DOI 10.1016/j.biomaterials.2008.07.051
NR 57
TC 20
Z9 20
U1 3
U2 50
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2014
VL 9
IS 3
AR 035008
DI 10.1088/1748-6041/9/3/035008
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AI3DA
UT WOS:000336738000009
PM 24770944
DA 2018-10-20
ER

PT J
AU Huang, YX
   Lu, JY
   Huang, JX
AF Huang, Yao-Xiong
   Lu, Jian-Yi
   Huang, Jin-Xia
TI KrF excimer laser precision machining of hard and brittle ceramic
   biomaterials
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE KrF excimer laser machining; hard-brittle ceramic biomaterial; calcium
   phosphate glass-ceramics; hydroxyapatite
ID SURFACES
AB KrF excimer laser precision machining of porous hard-brittle ceramic biomaterials was studied to find a suitable way of machining the materials into various desired shapes and sizes without distorting their intrinsic structure and porosity. Calcium phosphate glass ceramics (CPGs) and hydroxyapatite (HA) were chosen for the study. It was found that KrF excimer laser can cut both CPGs and HA with high efficiency and precision. The ablation rates of CPGs and HA are respectively 0.081 mu m/(pulse.J cm(-2)) and 0.048 mu m/(pulse.J cm(-2)), while their threshold fluences are individually 0.72 and 1.5 J cm(-2). The cutting quality (smoothness of the cut surface) is a function of laser repetition rate and cutting speed. The higher the repetition rate and lower the cutting speed, the better the cutting quality. A comparison between the cross sections of CPGs and HA cut using the excimer laser and using a conventional diamond cutting blade indicates that those cut by the excimer laser could retain their intrinsic porosity and geometry without distortion. In contrast, those cut by conventional machining had distorted geometry and most of their surface porosities were lost. Therefore, when cutting hard-brittle ceramic biomaterials to prepare scaffold and implant or when sectioning them for porosity evaluation, it is better to choose KrF excimer laser machining.
C1 [Huang, Yao-Xiong; Lu, Jian-Yi; Huang, Jin-Xia] Ji Nan Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China.
RP Huang, YX (reprint author), Ji Nan Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China.
EM tyxhuang@jnu.edu.cn
CR Bruckschen B, 2011, BIOMED TECH S, V50, P1609
   Callewaert K, 2003, APPL SURF SCI, V208, P218, DOI 10.1016/S0169-4332(02)01376-4
   Chryssolouris G, 1997, J MANUF SCI E-T ASME, V119, P766, DOI 10.1115/1.2836822
   Cormack AN, 2012, PHILOS T R SOC A, V370, P1271, DOI 10.1098/rsta.2011.0371
   DELLERBA M, 1992, COMPOS MANUF, V3, P14
   DOREMUS RH, 1992, J MATER SCI, V27, P285, DOI 10.1007/BF00543915
   Dubey AK, 2008, INT J MACH TOOL MANU, V48, P609, DOI 10.1016/j.ijmachtools.2007.10.017
   Eugenio S, 2005, BIOMATERIALS, V26, P6780, DOI 10.1016/j.biomaterials.2005.03.047
   GALANTUCCI LM, 1998, CIRP ANN-MANUF TECHN, V47, P141
   Huang J-X, 2007, CURR APPL PHYS, V7S1, pe45
   Huang YX, 2005, CURR APPL PHYS, V5, P549, DOI 10.1016/j.cap.2005.01.029
   ISLAM MU, 1993, MATER MANUF PROCESS, V8, P611, DOI DOI 10.1080/10426919308934870
   Lootz D, 2001, BIOMATERIALS, V22, P2447, DOI 10.1016/S0142-9612(00)00245-3
   Majumdar JD, 2003, SADHANA-ACAD P ENG S, V28, P495
   Nakata K, 2007, SURF COAT TECH, V201, P4943, DOI 10.1016/j.surfcoat.2006.07.146
   Narayan RJ, 2005, ADV MATER PROCESS, V163, P39
   Oh S., 2006, AM J BIOCH BIOTECHNO, V2, P49, DOI DOI 10.3844/AJBBSP.2006.49.56
   Slutsker A. I., 2002, Science of Sintering, V34, P143, DOI 10.2298/SOS0202143S
   Vales F, 1999, J MATER SCI, V34, P4081, DOI 10.1023/A:1004632503249
NR 19
TC 1
Z9 1
U1 1
U2 10
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2014
VL 9
IS 3
AR 035009
DI 10.1088/1748-6041/9/3/035009
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AI3DA
UT WOS:000336738000010
PM 24784833
DA 2018-10-20
ER

PT J
AU Xu, LC
   Siedlecki, CA
AF Xu, Li-Chong
   Siedlecki, Christopher A.
TI Staphylococcus epidermidis adhesion on hydrophobic and hydrophilic
   textured biomaterial surfaces
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE bacterial adhesion; textured surface; S. epidermidis; hydrophobicity;
   AFM
ID CARE-ASSOCIATED INFECTIONS; BIOFILM FORMATION; BACTERIAL ADHESION;
   GLOW-DISCHARGE; POLYURETHANE BIOMATERIALS; ANTIBIOTIC-RESISTANCE;
   PLATELET-ADHESION; PROTEIN; AUREUS; ATTACHMENT
AB It is of great interest to use nano-or micro-structured surfaces to inhibit microbial adhesion and biofilm formation and thereby to prevent biomaterial-associated infection, without modification of the surface chemistry or bulk properties of the materials and without use of the drugs. Our previous study showed that a submicron textured polyurethane surface can inhibit staphylococcal bacterial adhesion and biofilm formation. To further understand the effect of the geometry of textures on bacterial adhesion as well as the underlying mechanism, in this study, submicron and micron textured polyurethane surfaces featuring ordered arrays of pillars were fabricated and modified to have different wettabilities. All the textured surfaces were originally hydrophobic and showed significant reductions in Staphylococcus epidermidis RP62A adhesion in phosphate buffered saline or 25% platelet poor plasma solutions under shear, as compared to smooth surfaces. After being subjected to an air glow discharge plasma treatment, all polyurethane surfaces were modified to hydrophilic, and reductions in bacterial adhesion on surfaces were subsequently found to be dependent on the size of the patterns. The submicron patterned surfaces reduced bacterial adhesion, while the micron patterned surfaces led to increased bacterial adhesion. The extracellular polymeric substances (EPS) from the S. epidermidis cell surfaces were extracted and purified, and were coated on a glass colloidal surface so that the adhesion force and separation energy in interactions of the EPS and the surface could be measured by colloidal probe atomic force microscopy. These results were consistent with the bacterial adhesion observations. Overall, the data suggest that the increased surface hydrophobicity and the decreased availability of the contact area contributes to a reduction in bacterial adhesion to the hydrophobic textured surfaces, while the availability of the contact area is the primary determinant factor for bacterial adhesion on hydrophilic textured surfaces.
C1 [Xu, Li-Chong; Siedlecki, Christopher A.] Penn State Univ, Inst Biomed Engn, Coll Med, Dept Surg, Hershey, PA 17033 USA.
   [Siedlecki, Christopher A.] Penn State Univ, Inst Biomed Engn, Coll Med, Dept Bioengn, Hershey, PA 17033 USA.
RP Xu, LC (reprint author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, H151,500 Univ Dr, Hershey, PA 17033 USA.
EM lxx5@psu.edu
FU National Science Foundation [DMR-0804873]; Surgery Feasibility Grant of
   Penn State College of Medicine
FX This study is financially supported from the National Science Foundation
   (DMR-0804873), Surgery Feasibility Grant of Penn State College of
   Medicine. The authors also would like to acknowledge Dr Paul Ehrlich in
   Penn State College of Medicine for help in lyophilization of EPS.
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Balazs DJ, 2003, SURF INTERFACE ANAL, V35, P301, DOI 10.1002/sia.1533
   Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   Bazaka K, 2011, ACTA BIOMATER, V7, P2015, DOI 10.1016/j.actbio.2010.12.024
   Bhushan B, 2011, PROG MATER SCI, V56, P1, DOI 10.1016/j.pmatsci.2010.04.003
   Bhushan B, 2009, PHILOS T R SOC A, V367, P1631, DOI 10.1098/rsta.2009.0014
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Christner M, 2010, MOL MICROBIOL, V75, P187, DOI 10.1111/j.1365-2958.2009.06981.x
   Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405
   Delgado S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-82
   Diaz C, 2007, LANGMUIR, V23, P11206, DOI 10.1021/la700650q
   Donlan RM, 2000, ASAIO J, V46, pS47, DOI 10.1097/00002480-200011000-00037
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Dumitrescu O, 2010, M S-MED SCI, V26, P943, DOI 10.1051/medsci/20102611943
   Edwards KJ, 2001, CHEM GEOL, V180, P19, DOI 10.1016/S0009-2541(01)00303-5
   Epstein AK, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494007
   Estrela AB, 2009, CURR MED CHEM, V16, P1512, DOI 10.2174/092986709787909640
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   FLETCHER M, 1982, APPL ENVIRON MICROB, V44, P184
   Francolini I, 2010, ACTA BIOMATER, V6, P3482, DOI 10.1016/j.actbio.2010.03.042
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x
   Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001
   Guerrero G, 2009, PATHOL BIOL, V57, P36, DOI 10.1016/j.patbio.2008.07.032
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Hussain M, 1997, INFECT IMMUN, V65, P519
   Jabbouri S, 2010, FEMS IMMUNOL MED MIC, V59, P280, DOI 10.1111/j.1574-695X.2010.00695.x
   Katsikogianni M, 2008, COLLOID SURFACE B, V65, P257, DOI 10.1016/j.colsurfb.2008.04.017
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   LELAH MD, 1985, J BIOMED MATER RES, V19, P1011, DOI 10.1002/jbm.820190913
   Lelievre C, 2002, CHEM ENG SCI, V57, P1287, DOI 10.1016/S0009-2509(02)00019-2
   Ma HY, 2013, APPL MICROBIOL BIOT, V97, P317, DOI 10.1007/s00253-012-4179-9
   Magin CM, 2010, MATER TODAY, V13, P36, DOI 10.1016/S1369-7021(10)70058-4
   Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001
   Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08
   Pavithra D, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034003
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Quere D, 2002, NAT MATER, V1, P14, DOI 10.1038/nmat715
   Rabbi M, 2008, SINGLE MOL TECHNIQUE, P371
   Rothstein JP, 2010, ANNU REV FLUID MECH, V42, P89, DOI 10.1146/annurev-fluid-121108-145558
   Ruiz-Cabello FJM, 2011, LANGMUIR, V27, P9638, DOI 10.1021/la201248z
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   Sanchis MR, 2007, J APPL POLYM SCI, V105, P1077, DOI 10.1002/app.26250
   Sartori S, 2008, REACT FUNCT POLYM, V68, P809, DOI 10.1016/j.reactfunctpolym.2007.12.002
   Scardino AJ, 2009, BIOFOULING, V25, P757, DOI 10.1080/08927010903165936
   Scardino AJ, 2009, BIOFOULING, V25, P83, DOI 10.1080/08927010802538480
   Scardino AJ, 2011, BIOFOULING, V27, P73, DOI 10.1080/08927014.2010.536837
   Schumacher JF, 2008, LANGMUIR, V24, P4931, DOI 10.1021/la703421v
   Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957
   Sousa C, 2009, J ADHES SCI TECHNOL, V23, P1657, DOI 10.1163/156856109X452710
   Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196
   Tang HY, 2009, J BIOMED MATER RES A, V88A, P454, DOI 10.1002/jbm.a.31788
   Tang PF, 2011, J NANOMATER, DOI 10.1155/2011/178921
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   Vadillo-Rodriguez V, 2006, ENVIRON SCI TECHNOL, V40, P2983, DOI 10.1021/es052365v
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   Wenzel RP, 2007, CLIN INFECT DIS, V45, P85, DOI 10.1086/518136
   Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487
   Whitehead KA, 2006, FOOD BIOPROD PROCESS, V84, P253, DOI 10.1205/fbp06035
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Xu LC, 2005, ENVIRON SCI TECHNOL, V39, P3592, DOI 10.1021/es048377i
   Xu LC, 2007, J BIOMAT SCI-POLYM E, V18, P353, DOI 10.1163/156856207780425013
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
   Xu LC, 2010, ACTA BIOMATER, V6, P1938, DOI 10.1016/j.actbio.2009.11.031
   Xu LC, 2010, J BIOMED MATER RES A, V92A, P126, DOI 10.1002/jbm.a.32340
   Xu LC, 2009, LANGMUIR, V25, P3675, DOI 10.1021/la803258h
   Yoshimitsu Z, 2002, LANGMUIR, V18, P5818, DOI 10.1021/la020088p
   Zhang L, 2011, INT J ANTIMICROB AG, V38, P9, DOI 10.1016/j.ijantimicag.2011.01.020
NR 75
TC 17
Z9 17
U1 2
U2 72
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2014
VL 9
IS 3
AR 035003
DI 10.1088/1748-6041/9/3/035003
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AI3DA
UT WOS:000336738000004
PM 24687453
DA 2018-10-20
ER

PT J
AU Cheng, CC
   Mi, FL
   Hsu, SH
   Don, TM
AF Cheng, Chia-Chu
   Mi, Fwu-Long
   Hsu, Shan-hui
   Don, Trong-Ming
TI Structure characterizations and protein resistance of chitosan membranes
   selectively crosslinked by poly(ethylene glycol) dimethacrylate
SO CELLULOSE
LA English
DT Article
DE Chitosan; Poly(ethylene glycol) dimethacrylate; Copolymer membrane;
   Protein resistance
ID BETA-GLUCOSIDASE; COMPATIBILITY; HEMODIALYSIS; HYDROLYSIS; HYDROGELS;
   RELEASE
AB Chitosan (CS) is a fragile material with a high modulus of elasticity. Improving its flexibility as well as membrane permeability are the key aspects that need to be addressed for using CS as a biomaterial. Poly(ethylene glycol) (PEG) has several unique properties such as protein resistance, low toxicity, immunogenicity, and good solubility in both water and organic solvents. In this study, a vinyl compound was grafted to the C-6 position of CS by protection-grafting-deprotection. The vinyl CS was then crosslinked with PEG dimethacrylate (PEGDMA) selectively at its C-6 position to form CS-g-PEG copolymer membranes. Analyses from spectra of Fourier-transform infrared and nuclear magnetic resonance confirmed the chemical structure of the crosslinking CS-g-PEG copolymer membranes. Thermal and mechanical properties of the prepared CS-g-PEG membranes were measured and well-correlated to their structures. The incorporation of PEGDMA into the CS increased the material's flexibility and thermal resistance. Finally, the CS-g-PEG membranes were found to have good protein resistance and blood compatibility; therefore, it has potential application as the biomedical material especially for hemodialysis.
C1 [Cheng, Chia-Chu; Don, Trong-Ming] Tamkang Univ, Dept Chem & Mat Engn, New Taipei City 25137, Taiwan.
   [Mi, Fwu-Long] Taipei Med Univ, Sch Med, Dept Biochem, Taipei 110, Taiwan.
   [Mi, Fwu-Long] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan.
   [Hsu, Shan-hui] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan.
RP Don, TM (reprint author), Tamkang Univ, Dept Chem & Mat Engn, New Taipei City 25137, Taiwan.
EM tmdon@mail.tku.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X; Don, Trong-Ming/0000-0002-2577-2782
FU National Science Council in Taiwan
FX The authors wish to express their appreciation for the financial support
   from the National Science Council in Taiwan. The authors also want to
   thank Ms. Ching-Wei Lu in National Taiwan University for the help on the
   elemental analysis.
CR AMIJI MM, 1995, BIOMATERIALS, V16, P593, DOI 10.1016/0142-9612(95)93856-9
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Chang J, 2013, INT J BIOL MACROMOL, V61, P465, DOI 10.1016/j.ijbiomac.2013.08.014
   Chang MY, 2008, INT J BIOL MACROMOL, V43, P48, DOI 10.1016/j.ijbiomac.2007.10.004
   Colonna C, 2008, INT J PHARM, V358, P230, DOI 10.1016/j.ijpharm.2008.03.012
   Don TM, 2005, CARBOHYD POLYM, V61, P334, DOI 10.1016/j.carbpol.2005.05.025
   Don TM, 2011, J APPL POLYM SCI, V120, P1, DOI 10.1002/app.32806
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   Li QZ, 2009, INT J BIOL MACROMOL, V44, P121, DOI 10.1016/j.ijbiomac.2008.11.001
   Lin WJ, 2007, CARBOHYD POLYM, V67, P474, DOI 10.1016/j.carbpol.2006.06.017
   Mao S, 2005, PHARM RES, V22, P2058, DOI 10.1007/s11095-005-8175-y
   Peng HL, 2010, J FOOD ENG, V101, P113, DOI 10.1016/j.jfoodeng.2010.06.019
   Prashanth KVH, 2007, TRENDS FOOD SCI TECH, V18, P117, DOI 10.1016/j.tifs.2006.10.022
   Radhakumary C, 2009, J APPL POLYM SCI, V114, P2873, DOI 10.1002/app.30862
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Zheng P, 2013, PROCESS BIOCHEM, V48, P683, DOI 10.1016/j.procbio.2013.02.027
NR 16
TC 0
Z9 0
U1 1
U2 29
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
EI 1572-882X
J9 CELLULOSE
JI Cellulose
PD JUN
PY 2014
VL 21
IS 3
BP 1431
EP 1444
DI 10.1007/s10570-014-0231-5
PG 14
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA AH7OL
UT WOS:000336322800032
DA 2018-10-20
ER

PT J
AU Ledala, N
   Zhang, B
   Seravalli, J
   Powers, R
   Somerville, GA
AF Ledala, Nagender
   Zhang, Bo
   Seravalli, Javier
   Powers, Robert
   Somerville, Greg A.
TI Influence of Iron and Aeration on Staphylococcus aureus Growth,
   Metabolism, and Transcription
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID INTERCELLULAR ADHESIN EXPRESSION; VIRULENCE GENE-EXPRESSION; BIOFILM
   FORMATION; BACTERIAL METABOLISM; EPIDERMIDIS; POLYSACCHARIDE; ACID;
   ACETATE; STRESS; CODY
AB Staphylococcus aureus is a prominent nosocomial pathogen and a major cause of biomaterial-associated infections. The success of S. aureus as a pathogen is due in part to its ability to adapt to stressful environments. As an example, the transition from residing in the nares to residing in the blood or deeper tissues is accompanied by changes in the availability of nutrients and elements such as oxygen and iron. As such, nutrients, oxygen, and iron are important determinants of virulence factor synthesis in S. aureus. In addition to influencing virulence factor synthesis, oxygen and iron are critical cofactors in enzymatic and electron transfer reactions; thus, a change in iron or oxygen availability alters the bacterial metabolome. Changes in metabolism create intracellular signals that alter the activity of metabolite-responsive regulators such as CodY, RpiRc, and CcpA. To assess the extent of metabolomic changes associated with oxygen and iron limitation, S. aureus cells were cultivated in iron-limited medium and/or with decreasing aeration, and the metabolomes were examined by nuclear magnetic resonance (NMR) spectroscopy. As expected, oxygen and iron limitation dramatically decreased tricarboxylic acid (TCA) cycle activity, creating a metabolic block and significantly altering the metabolome. These changes were most prominent during post-exponential-phase growth, when TCA cycle activity was maximal. Importantly, many of the effects of iron limitation were obscured by aeration limitation. Aeration limitation not only obscured the metabolic effects of iron limitation but also overrode the transcription of iron-regulated genes. Finally, in contrast to previous speculation, we confirmed that acidification of the culture medium occurs independent of the availability of iron.
C1 [Ledala, Nagender; Somerville, Greg A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.
   [Zhang, Bo; Powers, Robert] Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA.
   [Seravalli, Javier] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA.
RP Somerville, GA (reprint author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.
EM gsomerville3@unl.edu
RI Somerville, Greg/B-1326-2013
OI Somerville, Greg/0000-0002-0991-8737; Zhang, Bo/0000-0001-8858-1425
FU Hatch Act to the University of Nebraska Institute of Agriculture and
   Natural Resources; National Institutes of Health [AI087668]; NIH [P20
   RR-17675, P30 GM103335, RR015468-01]; American Heart Association
   [0860033Z]
FX G.A.S. was supported by funds provided through the Hatch Act to the
   University of Nebraska Institute of Agriculture and Natural Resources
   and by funds provided through the National Institutes of Health (grant
   AI087668) to G.A.S. and R.P. R.P. was supported by funds provided
   through the NIH (grants P20 RR-17675 and P30 GM103335) and from the
   American Heart Association (grant 0860033Z). Portions of this research
   were performed in facilities renovated with support from the NIH (grant
   RR015468-01).
CR Akiyama Kenji, 2008, In Silico Biology, V8, P339
   Beasley FC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-199
   BLUMENTHAL HJ, 1972, STAPHYLOCOCCI, P111
   Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006
   COHEN S, 1967, J BACTERIOL, V93, P1227
   Dassy B, 1996, INFECT IMMUN, V64, P2408
   DEIGHTON M, 1993, INFECT IMMUN, V61, P4473
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x
   DOWNLINGING A, 2004, PROTEIN NMR TECHNIQU, V278, P40
   ELEK SD, 1959, STAPHYLOCOCCUS PYOGE, P54
   Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187
   ERNST JF, 1978, J BACTERIOL, V135, P928
   Ferreira MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058277
   FOX JB, 1968, J BACTERIOL, V95, P1548
   Friedman DB, 2006, PLOS PATHOG, V2, P777, DOI 10.1371/journal.ppat.0020087
   Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07
   FULLER JR, 2011, FRONT CELL INFECT MI, V1, DOI DOI 10.3389/FCIMB.2011
   GARDNER JF, 1962, J GEN MICROBIOL, V29, P157, DOI 10.1099/00221287-29-1-157
   Golbraikh A, 2002, J MOL GRAPH MODEL, V20, P269, DOI 10.1016/S1093-3263(01)00123-1
   GOLDSCHMIDT MC, 1953, ARCH BIOCHEM BIOPHYS, V46, P154, DOI 10.1016/0003-9861(53)90178-7
   Hu KF, 2011, J AM CHEM SOC, V133, P1662, DOI 10.1021/ja1095304
   JACOBS NJ, 1967, J BACTERIOL, V93, P278
   Jaeger T, 2008, J BACTERIOL, V190, P6598, DOI 10.1128/JB.00642-08
   Johnson M, 2008, INFECT IMMUN, V76, P1756, DOI 10.1128/IAI.01635-07
   Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008
   Kendall AI, 1930, J INFECT DIS, V47, P223, DOI 10.1093/infdis/47.3.223
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Krebs HA, 1937, BIOCHEM J, V31, P661, DOI 10.1042/bj0310661
   Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Majerczyk CD, 2008, J BACTERIOL, V190, P2257, DOI 10.1128/JB.01545-07
   Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10
   Markley JL, 2008, J BIOMOL NMR, V40, P153, DOI 10.1007/s10858-008-9221-y
   Morrissey JA, 2000, INFECT IMMUN, V68, P6281, DOI 10.1128/IAI.68.11.6281-6288.2000
   Neidhardt FC, 2006, NAT REV MICROBIOL, V4, P876, DOI 10.1038/nrmicro1554
   NYCHAS GJ, 1991, J APPL BACTERIOL, V70, P344, DOI 10.1111/j.1365-2672.1991.tb02947.x
   PASTEUR L, 1861, CR HEBD ACAD SCI, V52, P344
   Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207
   Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12
   Sadykov MR, 2008, J BACTERIOL, V190, P7621, DOI 10.1128/JB.00806-08
   Sadykov MR, 2011, MICROBIOL-SGM, V157, P3458, DOI 10.1099/mic.0.051243-0
   Sadykov MR, 2010, J BIOL CHEM, V285, P36616, DOI 10.1074/jbc.M110.152843
   Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006
   Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95
   SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328
   SHEPPARD LN, 1993, ARZNEIMITTEL-FORSCH, V43-1, P659
   Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x
   Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003
   Somerville GA, 2003, INFECT IMMUN, V71, P4724, DOI 10.1128/IAI.71.8.4724-4732.2003
   Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002
   Somerville GA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-9
   Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09
   Team RDC, 2011, R LANG ENV STAT COMP
   THEODORE TS, 1965, J GEN MICROBIOL, V39, P75, DOI 10.1099/00221287-39-1-75
   THEODORE TS, 1965, J GEN MICROBIOL, V40, P385, DOI 10.1099/00221287-40-3-385
   Trivier D, 1996, FEMS MICROBIOL LETT, V141, P117, DOI 10.1111/j.1574-6968.1996.tb08373.x
   Ulrich M, 2007, MOL MICROBIOL, V65, P1276, DOI 10.1111/j.1365-2958.2007.05863.x
   VANDENESCH F, 1991, J BACTERIOL, V173, P6313, DOI 10.1128/jb.173.20.6313-6320.1991
   Vuong C, 2005, J BACTERIOL, V187, P2967, DOI 10.1128/JB.187.9.2967-2973.2005
   Werth MT, 2010, ANAL BIOCHEM, V399, P58, DOI 10.1016/j.ab.2009.12.022
   Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810
   Worley B, 2013, ANAL BIOCHEM, V433, P102, DOI 10.1016/j.ab.2012.10.011
   ZHANG B, 2013, J INTEGR OMICS, V3, P120
   Zhang B, 2011, J PROTEOME RES, V10, P3743, DOI 10.1021/pr200360w
   Zhu YF, 2011, J BACTERIOL, V193, P6187, DOI 10.1128/JB.05930-11
NR 68
TC 27
Z9 28
U1 0
U2 18
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD JUN
PY 2014
VL 196
IS 12
BP 2178
EP 2189
DI 10.1128/JB.01475-14
PG 12
WC Microbiology
SC Microbiology
GA AI1EU
UT WOS:000336593900006
PM 24706736
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Song, SH
   Kim, JE
   Lee, YJ
   Kwak, MH
   Sung, GY
   Kwon, SH
   Son, HJ
   Lee, HS
   Jung, YJ
   Hwang, DY
AF Song, Sung Hwa
   Kim, Ji Eun
   Lee, Young Ju
   Kwak, Moon Hwa
   Sung, Geum Yong
   Kwon, Soon Hong
   Son, Hong Joo
   Lee, Hee Seob
   Jung, Young Jin
   Hwang, Dae Youn
TI Cellulose film regenerated from Styela clava tunics have
   biodegradability, toxicity and biocompatibility in the skin of SD rats
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID THERMAL-DEGRADATION; BIOMATERIALS; DERIVATIVES; PLA
AB Cellulose is one of the most widespread biomolecules in nature and has been exploited in various applications including scaffolding, tissue engineering, and tissue formation. To evaluate the biocompatibility of cellulose film manufactured from Styela clava tunics (SCT-CF), these films were implanted in Sprague-Dawley (SD) rats for various lengths of time, after which they were subjected to mechanical and biological analyses. The cellulose powders (12-268 m) obtained from SCT was converted into films via casting methods without adding any additives. SCT-CF contained about 98 % alpha-cellulose and very low concentrations of beta beta-cellulose. Additionally, the crystallinity index (CrI) of SCT-CF was lower (10.71 %) than that of wood pulp-cellulose films (WP-CF) (33.78 %). After implantation for 90 days, the weight loss and formation of surface corrugations were greater in SCT-CF than that of WP-CF, while the surface roughness was significantly higher in WP-CF than SCT-CF. However, there were no differences in the number of white blood cells between SCT-CF implanted rats and vehicle implanted rats. The level of metabolic enzymes representing liver and kidney toxicity in the serum of SCT-CF implanted rats was maintained at levels consistent with vehicle implanted rats. Moreover, no significant alteration of the epidermal hyperplasia, inflammatory cell infiltration, redness, and edema were observed in SD rats implanted with SCT-CF. Taken together, these results indicate that SCT-CF showed good degradability and non-toxicity without inducing an immune response in SD rats. Further, the data presented here constitute strong evidence that SCT-CF has the potential for use as a powerful biomaterial for medical applications including stitching fiber, wound dressing, scaffolding, absorbable hemostats and hemodialysis membrane.
C1 [Song, Sung Hwa; Kim, Ji Eun; Lee, Young Ju; Kwak, Moon Hwa; Sung, Geum Yong; Kwon, Soon Hong; Son, Hong Joo; Jung, Young Jin; Hwang, Dae Youn] Pusan Natl Univ, Life & Ind Convergence Res Inst, Coll Nat Resources & Life Sci, Dept Biomat Sci, Miryang 627706, South Korea.
   [Lee, Hee Seob] Pusan Natl Univ, Coll Human Ecol, Pusan 609735, South Korea.
RP Hwang, DY (reprint author), Pusan Natl Univ, Life & Ind Convergence Res Inst, Coll Nat Resources & Life Sci, Dept Biomat Sci, 50 Cheonghak Ri, Miryang 627706, South Korea.
EM dyhwang@pusan.ac.kr
FU Korea Institute of Planning Evaluation for Technology of Food,
   Agriculture, Forestry and Fisheries [112088-3]
FX This study was supported by a grant to Professor, Dae Youn Hwang from
   the Korea Institute of Planning Evaluation for Technology of Food,
   Agriculture, Forestry and Fisheries (112088-3).
CR BERGMEYER HU, 1974, METHODS ENZYMATIC AN, V1
   Crepy L, 2012, J BIOMED MATER RES B, V100B, P1000, DOI 10.1002/jbm.b.32665
   FRANZ G, 1986, ADV POLYM SCI, V76, P1
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   Gissinger D, 1980, PHARM IND, V42, P189
   Hayes A. W., 1982, PRINCIPLES METHODS T
   Hirano S, 1996, Biotechnol Annu Rev, V2, P237, DOI 10.1016/S1387-2656(08)70012-7
   Huang FY, 2012, POLYMERS-BASEL, V4, P1012, DOI 10.3390/polym4021012
   Huang MR, 1998, J APPL POLYM SCI, V68, P293, DOI 10.1002/(SICI)1097-4628(19980411)68:2<293::AID-APP11>3.0.CO;2-Z
   Hwang SK, 1999, J KOREAN IND ENG CHE, V10, P939
   ITO H, 1986, J APPL POLYM SCI, V31, P2491, DOI 10.1002/app.1986.070310810
   Jagur-Grodzinski J, 1999, REACT FUNCT POLYM, V39, P99, DOI 10.1016/S1381-5148(98)00054-6
   JAIN RK, 1985, J APPL POLYM SCI, V30, P897, DOI 10.1002/app.1985.070300302
   Jung YJ, 2008, J KOR FISH SOC, V41, P237
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Kim DH, 2006, KOREAN J ELECT MICRO, V36, P173
   Kim Hyeong-Jin, 2010, Laboratory Animal Research, V26, P7
   Kim MC, 2009, REACT FUNCT POLYM, V69, P287, DOI 10.1016/j.reactfunctpolym.2009.01.013
   Kim SM, 2005, J KOR ORAL MAXILLOFA, V31, P440
   Kingkaew J, 2010, J BIOMAT SCI-POLYM E, V21, P1009, DOI 10.1163/156856209X462763
   Lavoine N, 2012, CARBOHYD POLYM, V90, P735, DOI 10.1016/j.carbpol.2012.05.026
   Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002
   Lojewska J, 2005, POLYM DEGRAD STABIL, V88, P512, DOI 10.1016/j.polymdegradstab.2004.12.012
   Ma WJ, 2008, CARBOHYD POLYM, V72, P75, DOI 10.1016/j.carbpol.2007.07.033
   Martinez AT, 2005, INT MICROBIOL, V8, P195
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   Matasuzaki K, 1985, MACROMOL CHEM PHYS, V186, P449
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Olyveira G. M., 2011, J BIOMATER NANOBIOTE, V02, P239
   Prussin Calman, 2003, Journal of Allergy and Clinical Immunology, V111, pS486
   Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Spencer P C, 1985, Trans Am Soc Artif Intern Organs, V31, P495
   Watanabe H, 1998, NATURE, V394, P330, DOI 10.1038/28527
   Xiang Q, 2003, APPL BIOCHEM BIOTECH, V105, P505
   You A. S., 2007, KOREAN J PESTIC SCI, V11, P222
   Zhang H, 2005, MACROMOLECULES, V38, P8273
NR 38
TC 8
Z9 8
U1 3
U2 33
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2014
VL 25
IS 6
BP 1519
EP 1530
DI 10.1007/s10856-014-5182-8
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AI5KE
UT WOS:000336904200012
PM 24577945
DA 2018-10-20
ER

PT J
AU Scherner, M
   Reutter, S
   Klemm, D
   Sterner-Kock, A
   Guschlbauer, M
   Richter, T
   Langebartels, G
   Madershahian, N
   Wahlers, T
   Wippermann, J
AF Scherner, Maximilian
   Reutter, Stefanie
   Klemm, Dieter
   Sterner-Kock, Anja
   Guschlbauer, Maria
   Richter, Thomas
   Langebartels, Georg
   Madershahian, Navid
   Wahlers, Thorsten
   Wippermann, Jens
TI In vivo application of tissue-engineered blood vessels of bacterial
   cellulose as small arterial substitutes: proof of concept?
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE Bacterial cellulose; Vascular surgery; Vascular tissue engineering;
   Artificial small-diameter vascular grafts
ID VASCULAR PROSTHESIS; BIOCOMPATIBILITY; GRAFTS; VITRO; CELLS
AB Background: Tissue-engineered blood vessels (TEBVs) represent an innovative approach for overcoming reconstructive problems associated with vascular diseases by providing small-caliber vascular grafts. This study aimed to evaluate a novel biomaterial of bacterially synthesized cellulose (BC) as a potential scaffold for small-diameter TEBV.
   Methods: Small-diameter blood vessels with a supramolecular fiber network structure consisting of tubular hydrogels from biodesigned cellulose were created using Gluconacetobacter strains and Matrix reservoir technology. BC tubes (length: 100 mm, inner diameter: 4.0-5.0 mm) were applied to replace the carotid arteries of 10 sheep for a period of 3 mo to gain further insights into (a) functional (in vivo) performance, (b) ability of providing a scaffold for the neoformation of a vascular wall and (c) their proinflammatory potential, and the (d) technical feasibility of the procedure.
   Results: Preoperative analysis revealed a bursting strength of the grafts of approximately 800 mm Hg and suture retention strength of 4-5 N. Postexplantation analysis showed a patency rate of 50% (n = 5) and physiological performance of the patent grafts at 4, 8, and 12 wk postoperatively, compared with native arteries. Histologic analysis revealed a neoformation of a vascular wall-like structure along the BC scaffold consisting of immigrated vascular smooth muscle cells and a homogeneous endothelialization of the inner graft surface without signs of prothrombogenic or inflammatory potential. Scanning electron microscopy revealed a confluent luminal endothelial cell layer and the immigration of vascular smooth muscle cells into the BC matrix.
   Conclusions: BC grafts provide a scaffold for the neoformation of a three-layered vascular wall exhibit attractive properties for their use in future TEBV programs for cardiovascular surgery. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Scherner, Maximilian; Reutter, Stefanie; Langebartels, Georg; Madershahian, Navid; Wahlers, Thorsten; Wippermann, Jens] Univ Hosp Cologne, Dept Cardiothorac Surg, D-50937 Cologne, Germany.
   [Klemm, Dieter; Richter, Thomas] Univ Jena, Dept Organ Chem, Jena, Germany.
   [Sterner-Kock, Anja; Guschlbauer, Maria] Univ Hosp Cologne, Dept Expt Med, D-50937 Cologne, Germany.
RP Scherner, M (reprint author), Univ Hosp Cologne, Dept Cardiothorac Surg, Kerpener Str 62, D-50937 Cologne, Germany.
EM maximilian.scherner@uk-koeln.de
OI Guschlbauer, Maria/0000-0002-5401-4542
FU Koln fortune program; Marga and Walter Boll Foundation; Cologne Fortune
   Program
FX This project was supported by the Koln fortune program and the Marga and
   Walter Boll Foundation.; This study was supported by the Cologne Fortune
   Program.
CR Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Banz Y, 2006, XENOTRANSPLANTATION, V13, P19, DOI 10.1111/j.1399-3089.2005.00266.x
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   Caglayan E, J AM COLL CARDIOL, V57, P2527
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, ANGEW CHEM, V50, P5438
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Malm CJ, SCAND CARDIOVASC J, V46, P57
   MATSUMOTO H, 1973, SURGERY, V74, P519
   MAZZUCOTELLI JP, 1993, ARTIF ORGANS, V17, P787
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Petersen N, APPL MICROBIOL BIOTE, V91, P1277
   Quint C, J VASC SURG, V55, P790
   Sarkar S, 2007, MED BIOL ENG COMPUT, V45, P327, DOI 10.1007/s11517-007-0176-z
   SCHRAMM M, 1954, BIOCHEM J, V56, P163, DOI 10.1042/bj0560163
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
NR 23
TC 32
Z9 33
U1 4
U2 90
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
EI 1095-8673
J9 J SURG RES
JI J. Surg. Res.
PD JUN
PY 2014
VL 189
IS 2
BP 340
EP 347
DI 10.1016/j.jss.2014.02.011
PG 8
WC Surgery
SC Surgery
GA AH8ZB
UT WOS:000336425900020
PM 24726059
DA 2018-10-20
ER

PT J
AU Balint, R
   Cassidy, NJ
   Cartmell, SH
AF Balint, Richard
   Cassidy, Nigel J.
   Cartmell, Sarah H.
TI Conductive polymers: Towards a smart biomaterial for tissue engineering
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Conductive polymer; Drug release; Biocompatibility; Polypyrrole;
   Polyaniline
ID NERVE GROWTH-FACTOR; POTENTIAL BIOMEDICAL APPLICATIONS; POLYSTYRENE
   LATEX-PARTICLES; IN-VITRO BIOCOMPATIBILITY; CARBON NANOTUBE COMPOSITE;
   COATED POLYESTER FABRICS; ATOMIC-FORCE MICROSCOPY; POLYPYRROLE FILMS;
   ELECTRICAL-STIMULATION; CELL-ADHESION
AB Developing stimulus-responsive biomaterials with easy-to-tailor properties is a highly desired goal of the tissue engineering community. A novel type of electroactive biomaterial, the conductive polymer, promises to become one such material. Conductive polymers are already used in fuel cells, computer displays and microsurgical tools, and are now finding applications in the field of biomaterials. These versatile polymers can be synthesised alone, as hydrogels, combined into composites or electrospun into microfibres. They can be created to be biocompatible and biodegradable. Their physical properties can easily be optimized for a specific application through binding biologically important molecules into the polymer using one of the many available methods for their functionalization. Their conductive nature allows cells or tissue cultured upon them to be stimulated, the polymers' own physical properties to be influenced post-synthesis and the drugs bound in them released, through the application of an electrical signal. It is thus little wonder that these polymers are becoming very important materials for biosensors, neural implants, drug delivery devices and tissue engineering scaffolds. Focusing mainly on polypyrrole, polyaniline and poly(3,4-ethylenedioxythiophene), we review conductive polymers from the perspective of tissue engineering. The basic properties of conductive polymers, their chemical and electrochemical synthesis, the phenomena underlying their conductivity and the ways to tailor their properties (functionalization, composites, etc.) are discussed. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
C1 [Balint, Richard; Cartmell, Sarah H.] Univ Manchester, Fac Engn & Phys Sci, Sch Mat, Manchester M1 7HS, Lancs, England.
   [Cassidy, Nigel J.] Keele Univ, Sch Phys & Geog Sci, Stoke On Trent ST5 5BG, Staffs, England.
RP Cartmell, SH (reprint author), Univ Manchester, Fac Engn & Phys Sci, Sch Mat, Manchester M1 7HS, Lancs, England.
EM sarah.cartmell@manchester.ac.uk
RI Balint, Richard/J-4253-2014
FU Orthopaedic Research UK; EPSRC DTA award; Engineering and Physical
   Sciences Research Council [EP/F033125/1]
FX The authors thank Orthopaedic Research UK and the EPSRC DTA award for
   funding this work. We also thank Dr. limbo Dugan and Judit Balintne
   Farkas for their help in preparing the manuscript.
CR Aasmundtveit KE, 1999, SYNTHETIC MET, V101, P561, DOI 10.1016/S0379-6779(98)00315-4
   Abidian MR, 2009, ADV MATER, V21, P3764, DOI 10.1002/adma.200900887
   Ahuja T, 2007, BIOMATERIALS, V28, P791, DOI 10.1016/j.biomaterials.2006.09.046
   Akkouch A, 2010, J BIOMED MATER RES A, V92A, P221, DOI 10.1002/jbm.a.32357
   Alikacem N, 1999, ARTIF ORGANS, V23, P910, DOI 10.1046/j.1525-1594.1999.06231.x
   Aoki T, 1996, BIOMATERIALS, V17, P1971, DOI 10.1016/0142-9612(96)00015-4
   ARMES SP, 1987, SYNTHETIC MET, V20, P365, DOI 10.1016/0379-6779(87)90833-2
   Arora K, 2006, BIOSENS BIOELECTRON, V21, P1777, DOI 10.1016/j.bios.2005.09.002
   Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141
   Ateh DD, 2006, TISSUE ENG, V12, P645, DOI 10.1089/ten.2006.12.645
   Aznar-Cervantes S, 2012, BIOELECTROCHEMISTRY, V85, P36, DOI 10.1016/j.bioelechem.2011.11.008
   BATZ P, 1991, PHYS REV B, V43, P9178, DOI 10.1103/PhysRevB.43.9178
   Bax DV, 2012, ACTA BIOMATER, V8, P2538, DOI 10.1016/j.actbio.2012.03.023
   Bay L, 2001, J PHYS CHEM B, V105, P8492, DOI 10.1021/jp003872w
   Bettinger CJ, 2009, BIOMATERIALS, V30, P3050, DOI 10.1016/j.biomaterials.2009.02.018
   Bidez PR, 2006, J BIOMAT SCI-POLYM E, V17, P199, DOI 10.1163/156856206774879180
   Blinova NV, 2008, POLYM INT, V57, P66, DOI 10.1002/pi.2312
   Bolin MH, 2009, SENSOR ACTUAT B-CHEM, V142, P451, DOI 10.1016/j.snb.2009.04.062
   Borriello A, 2011, J MATER SCI-MATER M, V22, P1053, DOI 10.1007/s10856-011-4259-x
   Bousalem S, 2004, COLLOID POLYM SCI, V282, P1301, DOI 10.1007/s00396-004-1065-8
   Bousalem S, 2003, POLYM ADVAN TECHNOL, V14, P820, DOI 10.1002/pat.401
   Brahim S, 2005, ELECTROANAL, V17, P556, DOI 10.1002/elan.200403109
   BREDAS JL, 1985, ACCOUNTS CHEM RES, V18, P309, DOI 10.1021/ar00118a005
   Calvo PA, 2002, SYNTHETIC MET, V126, P111, DOI 10.1016/S0379-6779(01)00560-4
   CAO Y, 1989, POLYMER, V30, P2305, DOI 10.1016/0032-3861(89)90266-8
   Castano H, 2004, MACROMOL BIOSCI, V4, P785, DOI 10.1002/mabi.200300123
   Cen Lian, 2004, Biomacromolecules, V5, P2238, DOI 10.1021/bm040048v
   Cetiner S, 2010, TEXT RES J, V80, P1784, DOI 10.1177/0040517510365953
   Chen MC, 2013, ACTA BIOMATER, V9, P5562, DOI 10.1016/j.actbio.2012.10.024
   Chen SY, 2013, SENSOR ACTUAT A-PHYS, V193, P141, DOI 10.1016/j.sna.2013.01.033
   Chiu LLY, 2013, CURR OPIN CHEM ENG, V2, P41, DOI 10.1016/j.coche.2013.01.002
   Choi SJ, 2002, J ELECTROCHEM SOC, V149, pE26, DOI 10.1149/1.1432675
   Chronakis IS, 2006, POLYMER, V47, P1597, DOI 10.1016/j.polymer.2006.01.032
   Collazos-Castro JE, 2010, BIOMATERIALS, V31, P9244, DOI 10.1016/j.biomaterials.2010.08.057
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cortes MT, 2003, E-POLYMERS, V4, P1
   Cosnier S, 1999, BIOSENS BIOELECTRON, V14, P443, DOI 10.1016/S0956-5663(99)00024-X
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   Cullen DK, 2008, J NEURAL ENG, V5, P374, DOI 10.1088/1741-2560/5/4/002
   Dai L, 2004, INTELLIGENT MACROMOL, P41
   De Giglio E, 1999, J BIOMAT SCI-POLYM E, V10, P845, DOI 10.1163/156856299X00919
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   DEMER LL, 1993, AM J PHYSIOL, V264, pH2094
   Epstein A.J., 1999, CONDUCTIVE POLYM PLA, P1
   Ferraz N, 2012, J BIOMED MATER RES A, V100A, P2128, DOI 10.1002/jbm.a.34070
   Fonner JM, 2010, POLYMER, V51, P4985, DOI 10.1016/j.polymer.2010.08.024
   GANDHI MR, 1995, SYNTHETIC MET, V73, P247, DOI 10.1016/0379-6779(95)80022-0
   Garner B, 1999, J MATER SCI-MATER M, V10, P19, DOI 10.1023/A:1008835925998
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   Gelmi A, 2010, BIOMATERIALS, V31, P1974, DOI 10.1016/j.biomaterials.2009.11.040
   GENIES EM, 1993, SYNTHETIC MET, V57, P3677, DOI 10.1016/0379-6779(93)90496-J
   George PM, 2006, ADV MATER, V18, P577, DOI 10.1002/adma.200501242
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Ghasemi-Mobarakeh L, 2009, TISSUE ENG PT A, V15, P3605, DOI 10.1089/ten.TEA.2008.0689
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059
   Girija TC, 2006, SYNTHETIC MET, V156, P244, DOI 10.1016/j.synthmet.2005.12.006
   Gizdavic-Nikolaidis M, 2011, J POLYM SCI POL CHEM, V49, P4902, DOI 10.1002/pola.24946
   Gizdavic-Nikolaidis M, 2010, MACROMOL BIOSCI, V10, P1424, DOI 10.1002/mabi.201000237
   Gomez N, 2007, ADV FUNCT MATER, V17, P1645, DOI 10.1002/adfm.200600669
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Guimard NKE, 2009, MACROMOLECULES, V42, P502, DOI 10.1021/ma8019859
   Guiseppi-Elie A, 2010, BIOMATERIALS, V31, P2701, DOI 10.1016/j.biomaterials.2009.12.052
   Guo BL, 2013, PROG POLYM SCI, V38, P1263, DOI 10.1016/j.progpolymsci.2013.06.003
   Guo Y, 2007, BIOMACROMOLECULES, V8, P3025, DOI 10.1021/bm070266z
   Han DH, 2005, ELECTROCHIM ACTA, V50, P3085, DOI 10.1016/j.electacta.2004.10.085
   Herrasti P, 2004, ELECTROCHIM ACTA, V49, P3693, DOI 10.1016/j.electacta.2004.01.074
   HODGSON AJ, 1994, SUPRAMOL SCI, V1, P77
   Hsiao CW, 2013, BIOMATERIALS, V34, P1063, DOI 10.1016/j.biomaterials.2012.10.065
   Hu J, 2008, BIOMACROMOLECULES, V9, P2637, DOI 10.1021/bm800705t
   Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001
   Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511
   Huang LH, 2008, BIOMACROMOLECULES, V9, P850, DOI 10.1021/bm7011828
   Huang LH, 2007, BIOMATERIALS, V28, P1741, DOI 10.1016/j.biomaterials.2006.12.007
   Humpolicek P, 2012, SYNTHETIC MET, V162, P722, DOI 10.1016/j.synthmet.2012.02.024
   Jager E. W., 2009, INT SOL STAT SENS AC, P1778
   Jager EWH, 2013, IEEE ASME INT C ADV, P1661, DOI 10.1109/AIM.2013.6584335
   Jakubiec B, 1998, J BIOMED MATER RES, V41, P519, DOI 10.1002/(SICI)1097-4636(19980915)41:4<519::AID-JBM2>3.0.CO;2-F
   Jeong SI, 2008, MACROMOL BIOSCI, V8, P627, DOI 10.1002/mabi.200800005
   Jha SK, 2009, BIOSENS BIOELECTRON, V24, P2637, DOI 10.1016/j.bios.2009.01.024
   Jiang XP, 2002, TISSUE ENG, V8, P635, DOI 10.1089/107632702760240553
   Justin G, 2010, J BIOACT COMPAT POL, V25, P121, DOI 10.1177/0883911509350660
   Kamalesh S, 2000, J BIOMED MATER RES, V52, P467, DOI 10.1002/1097-4636(20001205)52:3<467::AID-JBM4>3.3.CO;2-Y
   KANETO K, 1995, SYNTHETIC MET, V71, P2211, DOI 10.1016/0379-6779(94)03226-V
   KAPLIN DA, 1995, POLYMER, V36, P1275, DOI 10.1016/0032-3861(95)93931-B
   Karagkiozaki V, 2013, BBA-GEN SUBJECTS, V1830, P4294, DOI 10.1016/j.bbagen.2012.12.019
   Kaynak A, 2000, MATER RES BULL, V35, P813, DOI 10.1016/S0025-5408(00)00280-4
   Kaynak A, 1997, MATER RES BULL, V32, P271, DOI 10.1016/S0025-5408(96)00200-0
   KHOR E, 1995, BIOMATERIALS, V16, P657, DOI 10.1016/0142-9612(95)93864-A
   Khor E, 1996, BIOMATERIALS, V17, P1877, DOI 10.1016/0142-9612(95)00347-9
   Kim DH, 2004, J BIOMED MATER RES A, V71A, P577, DOI 10.1002/jbm.a.30124
   Kim DH, 2007, ADV FUNCT MATER, V17, P79, DOI 10.1002/adfm.200500594
   Kim S, 2011, BIOMATERIALS, V32, P2342, DOI 10.1016/j.biomaterials.2010.11.080
   Kirchmeyer S, 2005, J MATER CHEM, V15, P2077, DOI 10.1039/b417803n
   Kontturi K, 1998, J ELECTROANAL CHEM, V453, P231, DOI 10.1016/S0022-0728(98)00246-0
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Ku SH, 2012, BIOMATERIALS, V33, P6098, DOI 10.1016/j.biomaterials.2012.05.018
   Kudoh Y, 1998, SYNTHETIC MET, V98, P65, DOI 10.1016/S0379-6779(98)00148-9
   Kumar D, 1998, EUR POLYM J, V34, P1053, DOI 10.1016/S0014-3057(97)00204-8
   Lakard B, 2009, BIOELECTROCHEMISTRY, V75, P148, DOI 10.1016/j.bioelechem.2009.03.010
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee JY, 2009, J R SOC INTERFACE, V6, P801, DOI 10.1098/rsif.2008.0403
   Lee JW, 2006, BIOMACROMOLECULES, V7, P1692, DOI 10.1021/bm060220q
   Li CM, 2005, SURF COAT TECH, V198, P474, DOI 10.1016/j.surfcoat.2004.10.065
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Li YL, 2005, J BIOMED MATER RES A, V73A, P171, DOI 10.1002/jbm.a.30286
   Li YL, 2004, J COLLOID INTERF SCI, V275, P488, DOI 10.1016/j.jcis.2004.02.060
   Liu X., 2009, J NEURAL ENG, V6, P1
   Liu X, 2011, BIOMATERIALS, V32, P7309, DOI 10.1016/j.biomaterials.2011.06.047
   Luo SC, 2008, LANGMUIR, V24, P8071, DOI 10.1021/la800333g
   Luo XL, 2011, BIOMATERIALS, V32, P5551, DOI 10.1016/j.biomaterials.2011.04.051
   MACDIARMID AG, 1987, SYNTHETIC MET, V18, P285, DOI 10.1016/0379-6779(87)90893-9
   MACDIARMID AG, 1995, SYNTHETIC MET, V69, P85, DOI 10.1016/0379-6779(94)02374-8
   Madden JD, 2000, SYNTHETIC MET, V113, P185, DOI 10.1016/S0379-6779(00)00195-8
   Martins NCT, 2008, ELECTROCHIM ACTA, V53, P4754, DOI 10.1016/j.electacta.2008.01.059
   Massoumi B, 2002, POLYM INT, V51, P555, DOI 10.1002/pi.885
   Meng SY, 2008, J BIOMED MATER RES A, V87A, P332, DOI 10.1002/jbm.a.31735
   MILLER LL, 1987, MACROMOLECULES, V20, P1594, DOI 10.1021/ma00173a027
   Mondal SK, 2005, SYNTHETIC MET, V148, P275, DOI 10.1016/j.synthmet.2004.10.010
   Nien PC, 2006, ELECTROANAL, V18, P1408, DOI 10.1002/elan.200603552
   Okuzaki H, 2009, SYNTHETIC MET, V159, P2233, DOI 10.1016/j.synthmet.2009.07.054
   Patra S, 2008, SYNTHETIC MET, V158, P430, DOI 10.1016/j.synthmet.2008.03.002
   Pelto J, 2010, J BIOMED MATER RES A, V93A, P1056, DOI 10.1002/jbm.a.32603
   Peramo A, 2008, TISSUE ENG PT A, V14, P423, DOI 10.1089/tea.2007.0123
   POUGET JP, 1991, MACROMOLECULES, V24, P779, DOI 10.1021/ma00003a022
   Prabhakar N, 2007, ANAL BIOCHEM, V366, P71, DOI 10.1016/j.ab.2007.03.009
   Prabhakaran MP, 2011, J BIOSCI BIOENG, V112, P501, DOI 10.1016/j.jbiosc.2011.07.010
   PRON A, 1988, SYNTHETIC MET, V24, P193, DOI 10.1016/0379-6779(88)90257-3
   Ramanaviciene A, 2007, J PHARM PHARMACOL, V59, P311, DOI 10.1211/jpp.59.2.0017
   Ranella A, 2010, ACTA BIOMATER, V6, P2711, DOI 10.1016/j.actbio.2010.01.016
   Ravichandran R, 2010, J R SOC INTERFACE, V7, pS559, DOI 10.1098/rsif.2010.0120.focus
   Ribo JM, 1992, B SOC CAT CIEN, V13, P335
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   Richardson-Burns SM, 2007, J NEURAL ENG, V4, pL6, DOI 10.1088/1741-2560/4/2/L02
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Serra Moreno J., 2008, BIOELECTROCHEMISTRY, V72, P3, DOI DOI 10.1016/J.BIOELECHEM.2007.11.002
   Shi GX, 2008, BIOMATERIALS, V29, P3792, DOI 10.1016/j.biomaterials.2008.06.010
   Shi GX, 2008, J BIOMED MATER RES A, V84A, P1026, DOI 10.1002/jbm.a.31337
   Shi GX, 2004, BIOMATERIALS, V25, P2477, DOI 10.1016/j.biomaterials.2003.09.032
   SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578
   Silk T, 1998, SYNTHETIC MET, V93, P59, DOI 10.1016/S0379-6779(98)80131-8
   Small CJ, 1997, POLYM GELS NETW, V5, P251, DOI 10.1016/S0966-7822(96)00044-5
   Smela E, 1999, ADV MATER, V11, P953
   Song HK, 2006, BIOMATERIALS, V27, P473, DOI 10.1016/j.biomaterials.2005.06.030
   Stauffer WR, 2006, BIOMATERIALS, V27, P2405, DOI 10.1016/j.biomaterials.2005.10.024
   STREET GB, 1985, MOL CRYST LIQ CRYST, V118, P137, DOI 10.1080/00268948508076201
   Subramanian A, 2012, J MATER SCI-MATER M, V23, P1797, DOI 10.1007/s10856-012-4654-y
   Subramony SD, 2013, BIOMATERIALS, V34, P1942, DOI 10.1016/j.biomaterials.2012.11.012
   SUTTON SJ, 1995, POLYMER, V36, P1849, DOI 10.1016/0032-3861(95)90931-Q
   Svennersten K, 2011, LAB CHIP, V11, P3287, DOI 10.1039/c1lc20436j
   Tan Y, 2013, SYNTHETIC MET, V175, P183, DOI 10.1016/j.synthmet.2013.05.014
   Tessier D, 2000, J BIOMAT SCI-POLYM E, V11, P87, DOI 10.1163/156856200743517
   Thomas CA, 2000, ADV MATER, V12, P222, DOI 10.1002/(SICI)1521-4095(200002)12:3<222::AID-ADMA222>3.0.CO;2-D
   Thompson BC, 2010, J CONTROL RELEASE, V141, P161, DOI 10.1016/j.jconrel.2009.09.016
   TOURILLON G, 1985, MOL CRYST LIQ CRYST, V118, P221, DOI 10.1080/00268948508076214
   von Hoist H, 2009, BIOMED MATER, V4, P1
   Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027
   Wallace GG, 1999, TRAC-TREND ANAL CHEM, V18, P245, DOI 10.1016/S0165-9936(98)00113-7
   Wallace G, 2007, SOFT MATTER, V3, P665, DOI 10.1039/b618204f
   Wan M., 2008, CONDUCTING POLYM MIC, P1
   Wang JJ, 2005, J ELECTROANAL CHEM, V575, P139, DOI 10.1016/j.jelechem.2004.08.023
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Wang ZX, 2003, J BIOMED MATER RES A, V66A, P738, DOI 10.1002/jbm.a.10037
   Wang ZX, 2004, J BIOMED MATER RES A, V70A, P28, DOI 10.1002/jbm.a.30047
   Weng B, 2012, SYNTHETIC MET, V162, P1375, DOI 10.1016/j.synthmet.2012.05.022
   WILLIAMS RL, 1994, J MATER SCI-MATER M, V5, P429, DOI 10.1007/BF00058978
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Xu HX, 2014, BIOMATERIALS, V35, P225, DOI 10.1016/j.biomaterials.2013.10.002
   Yu QZ, 2008, MATER SCI ENG B-ADV, V150, P70, DOI 10.1016/j.mseb.2008.02.008
   Zare EN, 2014, SYNTHETIC MET, V187, P9, DOI 10.1016/j.synthmet.2013.09.045
   Zelikin AN, 2002, ANGEW CHEM INT EDIT, V41, P141, DOI 10.1002/1521-3773(20020104)41:1<141::AID-ANIE141>3.0.CO;2-V
   Zhang L, 2010, MACROMOL BIOSCI, V10, P1456, DOI 10.1002/mabi.201000176
   Zhang QS, 2010, MAT SCI ENG C-MATER, V30, P160, DOI 10.1016/j.msec.2009.09.013
   Zhang QS, 2009, BIOMED MATER, V4, P1
   Zhang XY, 2004, J AM CHEM SOC, V126, P12714, DOI 10.1021/ja046359v
   Zhang Z, 2001, J BIOMED MATER RES, V57, P63, DOI 10.1002/1097-4636(200110)57:1<63::AID-JBM1142>3.0.CO;2-L
   Zhang Z, 2007, ARTIF ORGANS, V31, P13, DOI 10.1111/j.1525-1594.2007.00335.x
   Zhou DD, 2010, BIOL MED PHYS BIOMED, P217, DOI 10.1007/978-0-387-98120-8_8
   Zhou HH, 2013, ACTA BIOMATER, V9, P6439, DOI 10.1016/j.actbio.2013.01.042
NR 183
TC 357
Z9 360
U1 79
U2 846
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2014
VL 10
IS 6
BP 2341
EP 2353
DI 10.1016/j.actbio.2014.02.015
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AH7WK
UT WOS:000336345900001
PM 24556448
OA Other Gold
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Costa, P
   Gautrot, JE
   Connelly, JT
AF Costa, Patricia
   Gautrot, Julien E.
   Connelly, John T.
TI Directing cell migration using micropatterned and dynamically adhesive
   polymer brushes
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Polymer brush; Micropattern; Click chemistry; Cell migration; Integrin
ID CLICK CHEMISTRY; SHAPE; MICROENVIRONMENTS; ORIENTATION; SURFACES; SERUM
AB Micropatterning techniques, such as photolithography and microcontact printing, provide robust tools for controlling the adhesive interactions between cells and their extracellular environment. However, the ability to modify these interactions in real time and examine dynamic cellular responses remains a significant challenge. Here we describe a novel strategy to create dynamically adhesive, micropatterned substrates, which afford precise control of cell adhesion and migration over both space and time. Specific functionalization of micropatterned poly(ethylene glycol methacrylate) (POEGMA) brushes with synthetic peptides, containing the integrin-binding arginine-glycine-aspartic acid (RGD) motif, was achieved using thiol-yne coupling reactions. RGD activation of POEGMA brushes promoted fibroblast adhesion, spreading and migration into previously non-adhesive areas, and migration speed could be tuned by adjusting the surface ligand density. We propose that this technique is a robust strategy for creating dynamically adhesive biomaterial surfaces and a useful assay for studying cell migration. (C) 2014 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Costa, Patricia; Connelly, John T.] Univ London, Barts & London Sch Med & Dent, London E1 2AT, England.
   [Gautrot, Julien E.] Univ London, Sch Engn & Mat Sci, London E1 4NS, England.
   [Connelly, John T.] Univ London, Inst Bioengn, London E1 2AT, England.
RP Connelly, JT (reprint author), Univ London, Barts & London Sch Med & Dent, 4 Newark St, London E1 2AT, England.
EM j.connelly@qmul.ac.uk
RI Gautrot, Julien/S-7920-2016
OI Gautrot, Julien/0000-0002-1614-2578; Connelly, John/0000-0002-5955-8848
FU BBSRC, New Investigator Award [BB/J000914/1]; Biotechnology and
   Biological Sciences Research Council [BB/J000914/1]
FX This work was funded by the BBSRC, New Investigator Award
   (BB/J000914/1). We thank Filipe Almeida (Queen Mary, University of
   London) for his assistance preparing gold-coated coverslips and Nigel
   Jones (Essen Bioscience) for his assistance with live cell imaging and
   analysis.
CR Azioune A, 2009, LAB CHIP, V9, P1640, DOI 10.1039/b821581m
   Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104
   Boekhoven J, 2013, ANGEW CHEM INT ED EN
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI [10.1038/ncb, 10.1038/ncb2074]
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Fairbanks BD, 2009, MACROMOLECULES, V42, P211, DOI 10.1021/ma801903w
   Gautrot JE, 2010, BIOMATERIALS, V31, P5030, DOI 10.1016/j.biomaterials.2010.02.066
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoyle CE, 2010, CHEM SOC REV, V39, P1355, DOI 10.1039/b901979k
   Hucknall A, 2009, ADV MATER, V21, P1968, DOI 10.1002/adma.200803125
   Jonkheijm P, 2008, ANGEW CHEM INT EDIT, V47, P4421, DOI 10.1002/anie.200800101
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   Lee KB, 2003, J AM CHEM SOC, V125, P5588, DOI 10.1021/ja034236p
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Massi A, 2012, ORG BIOMOL CHEM, V10, P3791, DOI 10.1039/c2ob25217a
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Park S, 2008, LANGMUIR, V24, P6201, DOI 10.1021/la8005663
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Raghavan S, 2010, LANGMUIR, V26, P17733, DOI 10.1021/la102955m
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762
   Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307
   Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103
   Trmcic-Cvitas J, 2009, BIOMACROMOLECULES, V10, P2885, DOI 10.1021/bm900706r
   van Dongen SFM, 2013, ADV MATER, V25, P1687, DOI 10.1002/adma.201204474
   Vignaud T, 2012, J CELL SCI, V125, P2134, DOI 10.1242/jcs.104901
   Weis S, 2013, ACTA BIOMATER, V9, P8059, DOI 10.1016/j.actbio.2013.06.019
   Welch M, 2011, SOFT MATTER, V7, P297, DOI 10.1039/c0sm00035c
NR 30
TC 25
Z9 25
U1 2
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2014
VL 10
IS 6
BP 2415
EP 2422
DI 10.1016/j.actbio.2014.01.029
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AH7WK
UT WOS:000336345900006
PM 24508539
DA 2018-10-20
ER

PT J
AU Teuschl, AH
   Neutsch, L
   Monforte, X
   Ruenzler, D
   van Griensven, M
   Gabor, F
   Redl, H
AF Teuschl, Andreas H.
   Neutsch, Lukas
   Monforte, Xavier
   Ruenzler, Dominik
   van Griensven, Martijn
   Gabor, Franz
   Redl, Heinz
TI Enhanced cell adhesion on silk fibroin via lectin surface modification
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cell adhesion; Lectin; Silk fibroin; Tissue engineering; Biomaterial
ID MESENCHYMAL STEM-CELLS; IN-VITRO BIOCOMPATIBILITY; MARROW STROMAL CELL;
   BONE-MARROW; ANTERIOR CRUCIATE; ADIPOSE-TISSUE; DRUG-DELIVERY;
   SCAFFOLDS; CARTILAGE; CHITOSAN
AB Various tissue engineering (TE) approaches are based on silk fibroin (SF) as scaffold material because of its superior mechanical and biological properties compared to other materials. The translation of one-step TE approaches to clinical application has generally failed so far due to the requirement of a prolonged cell seeding step before implantation. Here, we propose that the plant lectin WGA (wheat germ agglutinin), covalently bound to SF, will mediate cell adhesion in a time frame acceptable to be part of a one-step surgical intervention. After the establishment of a modification protocol utilizing carbodiimide chemistry, we examined the attachment of cells, with a special focus on adipose-derived stromal cells (ASC), on WGA-SF compared to pure native SF. After a limited time frame of 20 min the attachment of ASCs to WGA-SF showed an increase of about 17-fold, as compared to pure native SF. The lectin-mediated cell adhesion further showed an enhanced resistance to trypsin (as a protease model) and to applied fluid shear stress (mechanical stability). Moreover, we could demonstrate that the adhesion of ASCs on the WGA-SF does not negatively influence proliferation or differentiation potential into the osteogenic lineage. To test for in vitro immune response, the proliferation of peripheral blood mononuclear cells in contact with the WGA-SF was determined, showing no alterations compared to plain SF. All these findings suggest that the WGA modification of SF offers important benefits for translation of SF scaffolds into clinical applications. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Teuschl, Andreas H.; Monforte, Xavier; Ruenzler, Dominik] Univ Appl Sci Tech Wien, Dept Biochem Engn, A-1200 Vienna, Austria.
   [Teuschl, Andreas H.; Monforte, Xavier; Ruenzler, Dominik; van Griensven, Martijn; Redl, Heinz] Austrian Cluster Tissue Regenerat, Vienna, Austria.
   [Neutsch, Lukas; Gabor, Franz] Univ Vienna, Dept Pharmaceut Technol & Biopharmaceut, A-1090 Vienna, Austria.
   [van Griensven, Martijn; Redl, Heinz] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria.
RP Teuschl, AH (reprint author), Univ Appl Sci Tech Wien, Dept Biochem Engn, Hochstadtpl 5, A-1200 Vienna, Austria.
EM andreas.teuschl@technikum-wien.at
RI van Griensven, Martijn/F-5808-2012
OI van Griensven, Martijn/0000-0001-5104-9881; Runzler,
   Dominik/0000-0002-6020-3411; Teuschl, Andreas/0000-0002-3817-1572
FU City of Vienna (MA 27) [12-06, 14-06]; Austrian Research Agency FFG
   [815471]
FX The authors would like to thank James Ferguson for native language
   review. The financial support by the City of Vienna (MA 27, Project
   12-06 and MA 23, Project 14-06) and by the Austrian Research Agency FFG
   (Bridge 815471) is gratefully acknowledged.
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   BARONDES SH, 1988, TRENDS BIOCHEM SCI, V13, P480, DOI 10.1016/0968-0004(88)90235-6
   Batty L, 2011, ANZ J SURG, V81, P18, DOI 10.1111/j.1445-2197.2010.05495.x
   Bayrak A, 2010, BIOMATERIALS, V31, P3793, DOI 10.1016/j.biomaterials.2010.01.120
   Bessa PC, 2010, J TISSUE ENG REGEN M, V4, P349, DOI 10.1002/term.245
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048
   Gabor F, 2004, ADV DRUG DELIVER REV, V56, P459, DOI 10.1016/j.addr.2003.10.015
   Ghanaati S, 2010, J TISSUE ENG REGEN M, V4, P464, DOI 10.1002/term.257
   Helder MN, 2007, TISSUE ENG, V13, P1799, DOI 10.1089/ten.2006.0165
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Jurgens WJ, 2011, J ORTHOP RES, V29, P853, DOI 10.1002/jor.21314
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kardestuncer T, 2006, CLIN ORTHOP RELAT R, P234, DOI 10.1097/01.blo.0000205879.50834.fe
   Kinahan ME, 2011, BIOMACROMOLECULES, V12, P1504, DOI 10.1021/bm1014624
   Kundu SC, 2012, BIOPOLYMERS
   Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Liu XH, 2005, J BIOMED MATER RES A, V74A, P84, DOI 10.1002/jbm.a.30367
   Marlovits S, 2006, EUR J RADIOL, V57, P24, DOI 10.1016/j.ejrad.2005.08.009
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   NAGINENI CN, 1992, J ORTHOP RES, V10, P465, DOI 10.1002/jor.1100100402
   Neutsch L, 2011, J UROLOGY, V186, P1481, DOI 10.1016/j.juro.2011.05.040
   Nishimura H, 2004, EXP CELL RES, V295, P119, DOI 10.1016/j.yexcr.2003.12.018
   Pisal DS, 2010, J PHARM SCI-US, V99, P2557, DOI 10.1002/jps.22054
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prymak O, 2005, BIOMATERIALS, V26, P5801, DOI 10.1016/j.biomaterials.2005.02.029
   Ratzinger G, 2010, LANGMUIR, V26, P1855, DOI 10.1021/la902602z
   Rauvala H, 1981, CELL, P88
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Seo YK, 2009, CELL BIOL TOXICOL, V25, P513, DOI 10.1007/s10565-008-9105-7
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Talaei-Khozani T, 2011, GLYCOCONJUGATE J, V28, P89, DOI 10.1007/s10719-011-9326-5
   Toegel S, 2007, J CONTROL RELEASE, V117, P121, DOI 10.1016/j.jconrel.2006.10.004
   Treves C, 2010, J BIOMED MATER RES A, V92A, P1623, DOI 10.1002/jbm.a.32507
   VANVLASSELAER P, 1994, BLOOD, V84, P753
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   Wanschitz F, 2005, CLIN ORAL IMPLAN RES, V16, P570, DOI 10.1111/j.1600-0501.2005.01150.x
   Weber B, 2011, EUR HEART J, V32, P2830, DOI 10.1093/eurheartj/ehr059
   Weissenbock A, 2004, J CONTROL RELEASE, V99, P383, DOI 10.1016/j.jconrel.2004.07.025
   Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Yin YS, 2007, J CONTROL RELEASE, V123, P27, DOI 10.1016/j.jconrel.2007.06.024
NR 45
TC 14
Z9 16
U1 2
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2014
VL 10
IS 6
BP 2506
EP 2517
DI 10.1016/j.actbio.2014.02.012
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AH7WK
UT WOS:000336345900015
PM 24530561
DA 2018-10-20
ER

PT J
AU Kaemmerer, E
   Melchels, FPW
   Holzapfel, BM
   Meckel, T
   Hutmacher, DW
   Loessner, D
AF Kaemmerer, Elke
   Melchels, Ferry P. W.
   Holzapfel, Boris M.
   Meckel, Tobias
   Hutmacher, Dietmar W.
   Loessner, Daniela
TI Gelatine methacrylamide-based hydrogels: An alternative
   three-dimensional cancer cell culture system
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Animal model; Cell encapsulation; ECM; Hydrogel; Mechanical properties
ID EPITHELIAL OVARIAN-CANCER; EXTRACELLULAR-MATRIX; HYALURONIC-ACID;
   IN-VITRO; MALIGNANT PHENOTYPE; EARLY RESPONSE; GROWTH-FACTORS;
   BREAST-CANCER; 3D; DIFFUSION
AB Modern cancer research requires physiological, three-dimensional (3-D) cell culture platforms, wherein the physical and chemical characteristics of the extracellular matrix (ECM) can be modified. In this study, gelatine methacrylamide (GelMA)-based hydrogels were characterized and established as in vitro and in vivo spheroid-based models for ovarian cancer, reflecting the advanced disease stage of patients, with accumulation of multicellular spheroids in the tumour fluid (ascites). Polymer concentration (2.5-7% w/v) strongly influenced hydrogel stiffness (0.5 +/- 0.2 kPa to 9.0 +/- 1.8 kPa) but had little effect on solute diffusion. The diffusion coefficient of 70 kDa fluorescein isothiocyanate (FITC)-labelled dextran in 7% GelMA-based hydrogels was only 2.3 times slower compared to water. Hydrogels of medium concentration (5% w/v GelMA) and stiffness (3.4 kPa) allowed spheroid formation and high proliferation and metabolic rates. The inhibition of matrix metalloproteinases and consequently ECM degradability reduced spheroid formation and proliferation rates. The incorporation of the ECM components laminin-411 and hyaluronic acid further stimulated spheroid growth within GelMA-based hydrogels. The feasibility of pre-cultured GelMA-based hydrogels as spheroid carriers within an ovarian cancer animal model was proven and led to tumour development and metastasis. These tumours were sensitive to treatment with the anti-cancer drug paclitaxel, but not the integrin antagonist ATN-161. While paclitaxel and its combination with ATN-161 resulted in a treatment response of 33-37.8%, ATN-161 alone had no effect on tumour growth and peritoneal spread. The semi-synthetic biomaterial GelMA combines relevant natural cues with tunable properties, providing an alternative, bioengineered 3-D cancer cell culture in in vitro and in vivo model systems. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kaemmerer, Elke; Melchels, Ferry P. W.; Holzapfel, Boris M.; Hutmacher, Dietmar W.] Inst Hlth & Biomed Innovat, Regenerat Med Program, Brisbane, Qld 4059, Australia.
   [Loessner, Daniela] Inst Hlth & Biomed Innovat, Canc Program, Brisbane, Qld 4059, Australia.
   [Kaemmerer, Elke; Melchels, Ferry P. W.; Holzapfel, Boris M.; Hutmacher, Dietmar W.] Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia.
   [Loessner, Daniela] Queensland Univ Technol, Fac Hlth, Brisbane, Qld 4001, Australia.
   [Kaemmerer, Elke; Meckel, Tobias] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany.
   [Melchels, Ferry P. W.] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.
   [Holzapfel, Boris M.] Univ Wurzburg, Dept Orthopaed Surg, Orthopaed Ctr Musculoskeletal Res, D-97070 Wurzburg, Germany.
RP Loessner, D (reprint author), Inst Hlth & Biomed Innovat, Canc Program, 60 Musk Ave, Brisbane, Qld 4059, Australia.
EM daniela.lossner@qut.edu.au
RI Meckel, Tobias/F-4372-2010; Loessner, Daniela/L-2265-2017
OI Meckel, Tobias/0000-0003-0759-2072; Loessner,
   Daniela/0000-0001-5891-3441; Hutmacher, Dietmar
   Werner/0000-0001-5678-2134
FU Australian Research Council; Cancer Council Queensland; Institute of
   Health and Biomedical Innovation, Queensland University of Technology,
   Australia; European Union [PIOF-GA-2010-272286]; German Research
   Foundation [HO 5068/1-1]
FX The authors are grateful to Hendrik Deschout and Kevin Braeckmans for
   sharing their Mat lab code for rFRAP and fruitful discussions about the
   FRAP analysis, and Christina Theodoropoulos for her assistance with the
   microscopy techniques. This study was supported by the Australian
   Research Council, the Cancer Council Queensland and a Cells and Tissue
   Domain Collaborative Research Development Grant awarded to Daniela
   Loessner from the Institute of Health and Biomedical Innovation,
   Queensland University of Technology, Australia. Ferry PW Melchels is
   funded by the European Union through a Marie Curie Fellowship
   (PIOF-GA-2010-272286). Boris M Holzapfel is funded by the German
   Research Foundation (HO 5068/1-1).
CR Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123
   Ahmed N, 2005, CLIN EXP METASTAS, V22, P391, DOI 10.1007/s10585-005-1262-y
   Amsden B, 1998, POLYM GELS NETW, V6, P13, DOI 10.1016/S0966-7822(97)00012-9
   Anttila MA, 2000, CANCER RES, V60, P150
   Barkan D, 2011, CLIN CANCER RES, V17, P7219, DOI 10.1158/1078-0432.CCR-11-0642
   BENNETT NT, 1993, AM J SURG, V165, P728, DOI 10.1016/S0002-9610(05)80797-4
   Braeckmans K, 2003, BIOPHYS J, V85, P2240, DOI 10.1016/S0006-3495(03)74649-9
   Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186
   BYERS LJ, 1995, CANCER LETT, V88, P67, DOI 10.1016/0304-3835(94)03625-S
   Cianfrocca ME, 2006, BRIT J CANCER, V94, P1621, DOI 10.1038/sj.bjc.6603171
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046
   David L, 2004, MATRIX BIOL, V23, P183, DOI 10.1016/j.matbio.2004.05.005
   de Belder A. N., 1973, CARBOHYD RES, V30, P375
   Deschout H, 2010, OPT EXPRESS, V18, P22886, DOI 10.1364/OE.18.022886
   DeVolder R, 2012, WIRES SYST BIOL MED, V4, P351, DOI 10.1002/wsbm.1174
   Do TV, 2008, MOL CANCER RES, V6, P695, DOI 10.1158/1541-7786.MCR-07-0294
   Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015
   Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106
   Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/hh0302.105345
   Gardner MJ, 1996, CLIN EXP METASTAS, V14, P325, DOI 10.1007/BF00123391
   Geberhiwot T, 2001, J CELL SCI, V114, P423
   Gieni RS, 2008, J CELL BIOCHEM, V104, P1964, DOI 10.1002/jcb.21364
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001
   Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012
   Hubbell JA, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P297, DOI 10.1016/B978-012370615-7/50025-1
   Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001
   Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619
   Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001
   Karam A, 2012, ANTI-CANCER AGENT ME, V12, P764, DOI 10.2174/187152012802650174
   Kenny HA, 2009, CELL CYCLE, V8, P683, DOI 10.4161/cc.8.5.7703
   Khalili P, 2006, MOL CANCER THER, V5, P2271, DOI 10.1158/1535-7163.MCT-06-0100
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kutty JK, 2007, BIOMATERIALS, V28, P4928, DOI 10.1016/j.biomaterials.2007.08.007
   L'Esperance S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-99
   Langdon SP, 1998, ENDOCR-RELAT CANCER, V5, P283, DOI 10.1677/erc.0.0050283
   Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015
   Lee JM, 2013, LAB INVEST, V93, P528, DOI 10.1038/labinvest.2013.41
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Levett PA, 2014, ACTA BIOMATER, V10, P214, DOI 10.1016/j.actbio.2013.10.005
   Lieleg O, 2011, TRENDS CELL BIOL, V21, P543, DOI 10.1016/j.tcb.2011.06.002
   Lieleg O, 2009, BIOPHYS J, V97, P1569, DOI 10.1016/j.bpj.2009.07.009
   Liu J, 2012, NAT MATER, V11, P734, DOI [10.1038/nmat3361, 10.1038/NMAT3361]
   Ljubimova JY, 2001, CANCER RES, V61, P5601
   Loessner D, 2013, INTEGR BIOL-UK, V5, P597, DOI 10.1039/c3ib20252f
   Loessner D, 2013, BIOMATERIALS, V34, P7389, DOI 10.1016/j.biomaterials.2013.06.009
   Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064
   Magzoub M, 2008, FASEB J, V22, P276, DOI 10.1096/fj.07-9150com
   Masaro L, 1999, PROG POLYM SCI, V24, P731, DOI 10.1016/S0079-6700(99)00016-7
   Negi LM, 2012, J DRUG TARGET, V20, P561, DOI 10.3109/1061186X.2012.702767
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396
   Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471
   Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032
   Stroh M, 2005, NAT MED, V11, P678, DOI 10.1038/nm1247
   Szot CS, 2011, BIOMATERIALS, V32, P7905, DOI 10.1016/j.biomaterials.2011.07.001
   TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234
   Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546
   Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yang ZH, 2011, INT J NANOMED, V6, P303, DOI 10.2147/IJN.S15279
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 71
TC 52
Z9 52
U1 13
U2 106
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2014
VL 10
IS 6
BP 2551
EP 2562
DI 10.1016/j.actbio.2014.02.035
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AH7WK
UT WOS:000336345900019
PM 24590158
DA 2018-10-20
ER

PT J
AU Bell, JS
   Christmas, J
   Mansfield, JC
   Everson, RM
   Winlove, CP
AF Bell, J. S.
   Christmas, J.
   Mansfield, J. C.
   Everson, R. M.
   Winlove, C. P.
TI Micromechanical response of articular cartilage to tensile load measured
   using nonlinear microscopy
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cartilage; Biomechanics; Microstructure; Nonlinear microscopy; Bayesian
   modeling
ID INTERSTITIAL FLUID PRESSURIZATION; MECHANICAL-PROPERTIES; CONFINED
   COMPRESSION; FEMORAL CONDYLES; COLLAGEN NETWORK; DEFORMATION;
   ORGANIZATION; BEHAVIOR; SURFACE; MATRIX
AB Articular cartilage (AC) is a highly anisotropic biomaterial, and its complex mechanical properties have been a topic of intense investigation for over 60 years. Recent advances in the field of nonlinear optics allow the individual constituents of AC to be imaged in living tissue without the need for exogenous contrast agents. Combining mechanical testing with nonlinear microscopy provides a wealth of information about microscopic responses to load. This work investigates the inhomogeneous distribution of strain in loaded AC by tracking the movement and morphological changes of individual chondrocytes using point pattern matching and Bayesian modeling. This information can be used to inform models of mechanotransduction and pathogenesis, and is readily extendable to various other connective tissues. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bell, J. S.; Mansfield, J. C.; Winlove, C. P.] Univ Exeter, Dept Phys, Exeter EX4 4QL, Devon, England.
   [Christmas, J.; Everson, R. M.] Univ Exeter, Dept Comp Sci, Exeter EX4 4QF, Devon, England.
RP Bell, JS (reprint author), Univ Exeter, Dept Phys, Stocker Rd, Exeter EX4 4QL, Devon, England.
EM j.s.bell@exeter.ac.uk
OI Bell, James/0000-0001-8371-9851
FU EPSRC DTA scholarship; Anthony Coote Equine Research Fund; Exeter
   Imaging Networks "Bridging the Gaps" fund; Arthritis Research UK [19432]
FX This project was sponsored by an EPSRC DTA scholarship and the Anthony
   Coote Equine Research Fund. An Exeter Imaging Networks "Bridging the
   Gaps" fund sponsored the development of cell tracking and point pattern
   matching algorithms. The authors thank workshop engineer Kevyn White for
   expert manufacture of the tensile testing rig.
CR ASPDEN RM, 1981, PROC R SOC SER B-BIO, V212, P299, DOI 10.1098/rspb.1981.0040
   Bae WC, 2006, J BIOMECH, V39, P1039, DOI 10.1016/j.jbiomech.2005.02.018
   Bell JS, 2009, BIOMATERIALS, V30, P6394, DOI 10.1016/j.biomaterials.2009.08.026
   Benninghof A, 1925, Z ZELLFORSCH, V2, P783, DOI DOI 10.1007/BF00583443
   Bevill SL, 2010, OSTEOARTHR CARTILAGE, V18, P1310, DOI 10.1016/j.joca.2010.06.008
   Brama PAJ, 2001, EQUINE VET J, V33, P26, DOI 10.2746/042516401776767377
   BULLOUGH P, 1968, Journal of Bone and Joint Surgery British Volume, V50-B, P852
   Charlebois M, 2004, J BIOMECH ENG-T ASME, V126, P129, DOI 10.1115/1.1688771
   Christmas J, 2013, INEXACT BAYESIAN POI
   CLARK JM, 1990, J ANAT, V171, P117
   EGGLI PS, 1988, ANAT REC, V222, P217, DOI 10.1002/ar.1092220302
   Elliott DM, 2002, J BIOMECH ENG-T ASME, V124, P223, DOI 10.1115/1.1449905
   FUNG YCB, 1967, AM J PHYSIOL, V213, P1532
   Gibson GJ, 2001, J ORTHOPAED RES, V19, P33, DOI 10.1016/S0736-0266(00)00008-5
   Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691
   Guilak F, 1999, OSTEOARTHR CARTILAGE, V7, P59, DOI 10.1053/joca.1998.0162
   Kaab MJ, 1998, J ORTHOP RES, V16, P743, DOI 10.1002/jor.1100160617
   KAMALANATHAN S, 1993, J ANAT, V183, P567
   KEMPSON GE, 1976, BIOCHIM BIOPHYS ACTA, V428, P741, DOI 10.1016/0304-4165(76)90205-1
   KEMPSON GE, 1973, BIOCHIM BIOPHYS ACTA, V297, P456, DOI 10.1016/0304-4165(73)90093-7
   KEMPSON GE, 1968, NATURE, V220, P1127, DOI 10.1038/2201127b0
   LEWIS PR, 1959, NATURE, V184, P1285, DOI 10.1038/1841285a0
   Lilledahl MB, 2011, IEEE T MED IMAGING, V30, P1635, DOI 10.1109/TMI.2011.2139222
   Lutz V, 2012, SKIN RES TECHNOL, V18, P168, DOI 10.1111/j.1600-0846.2011.00549.x
   Mansfield J, 2009, J ANAT, V215, P682, DOI 10.1111/j.1469-7580.2009.01149.x
   Mansfield JC, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2950318
   Mansour JM, 2004, KINESIOLOGY MECH PAT, P66
   MCCUTCHEN CW, 1959, NATURE, V184, P1284, DOI 10.1038/1841284a0
   MCCUTCHEN CW, 1969, LUBRICATION WEAR JOI, P117
   MEACHIM G, 1974, J ANAT, V118, P101
   Moger CJ, 2007, OSTEOARTHR CARTILAGE, V15, P682, DOI 10.1016/j.joca.2006.12.006
   Moger CJ, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049478
   MOW VC, 1979, ANNU REV FLUID MECH, V11, P247, DOI 10.1146/annurev.fl.11.010179.001335
   Nickien M, 2013, WIRES SYST BIOL MED, V5, P495, DOI 10.1002/wsbm.1220
   Oliver NM, 2000, IEEE T PATTERN ANAL, V22, P831, DOI 10.1109/34.868684
   OLOYEDE A, 1991, CLIN BIOMECH, V6, P206, DOI 10.1016/0268-0033(91)90048-U
   OLOYEDE A, 1994, CLIN BIOMECH, V9, P149, DOI 10.1016/0268-0033(94)90014-0
   Palero JA, 2007, BIOPHYS J, V93, P992, DOI 10.1529/biophysj.106.099457
   Park SH, 2003, J BIOMECH, V36, P1785, DOI 10.1016/S0021-9290(03)00231-8
   Pierce DM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3148471
   Pierce DM, 2012, INT J NUMER METH BIO, V2012, P807
   Rieppo J, 2008, MICROSC RES TECHNIQ, V71, P279, DOI 10.1002/jemt.20551
   ROTH V, 1980, J BONE JOINT SURG AM, V62, P1102, DOI 10.2106/00004623-198062070-00007
   Sasazaki Y, 2006, J ANAT, V208, P681, DOI 10.1111/j.1469-7580.2006.00569.x
   Soltz MA, 1998, J BIOMECH, V31, P927, DOI 10.1016/S0021-9290(98)00105-5
   Soltz MA, 2000, ANN BIOMED ENG, V28, P150, DOI 10.1114/1.239
   Thambyah A, 2007, OSTEOARTHR CARTILAGE, V15, P1410, DOI 10.1016/j.joca.2007.05.006
   Thambyah A, 2006, J ANAT, V209, P611, DOI 10.1111/j.1469-7580.2006.00646.x
   Thambyah A, 2013, COMPUT MATH METHOD M, DOI 10.1155/2013/358192
   Wilson W, 2004, J BIOMECH, V37, P357, DOI 10.1016/S0021-9290(03)00267-7
   WOO SLY, 1979, J BIOMECH, V12, P437, DOI 10.1016/0021-9290(79)90028-9
   WOO SLY, 1976, J BIOMECH, V9, P785, DOI 10.1016/0021-9290(76)90186-X
   Yeh AT, 2005, OSTEOARTHR CARTILAGE, V13, P345, DOI 10.1016/j.joca.2004.12.007
NR 53
TC 7
Z9 7
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2014
VL 10
IS 6
BP 2574
EP 2581
DI 10.1016/j.actbio.2014.02.008
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AH7WK
UT WOS:000336345900021
PM 24525036
DA 2018-10-20
ER

PT J
AU Kim, TH
   Eltohamy, M
   Kim, M
   Perez, RA
   Kim, JH
   Yun, YR
   Jang, JH
   Lee, EJ
   Knowles, JC
   Kim, HW
AF Kim, Tae-Hyun
   Eltohamy, Mohamed
   Kim, Meeju
   Perez, Roman A.
   Kim, Joong-Hyun
   Yun, Ye-Rang
   Jang, Jun-Hyeog
   Lee, Eun-Jung
   Knowles, Jonathan C.
   Kim, Hae-Won
TI Therapeutic foam scaffolds incorporating biopolymer-shelled mesoporous
   nanospheres with growth factors
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Protein delivery; Growth factors; Therapeutic system; Mesoporous
   nanospheres; Tissue regeneration
ID SILICA NANOPARTICLES; BONE REGENERATION; PROTEIN ADSORPTION;
   DRUG-DELIVERY; COLLAGEN; BIOMATERIAL; DOXORUBICIN; RELEASE; DESIGN;
   MATRIX
AB A novel therapeutic scaffolding system of engineered nanocarriers within a foam matrix for the long-term and sequential delivery of growth factors is reported. Mesoporous silica nanospheres were first functionalized to have an enlarged mesopore size (12.2 nm) and aminated surface, which was then shelled by a biopolymer, poly(lactic acid) (PLA) or poly(ethylene glycol) (PEG), via electrospraying. The hybrid nanocarrier was subsequently combined with collagen to produce foam scaffolds. Bovine serum albumin (BSA), used as a model protein, was effectively loaded within the enlarged nanospheres. The biopolymer shell substantially prolonged the release period of BSA (2-3 weeks from shelled nanospheres vs. within 1 week from bare nanospheres), and the release rate was highly dependent on the shell composition (PEG > PLA). Collagen foam scaffolding of the shelled nanocarrier further slowed down the protein release, while enabling the incorporation of a rapidly releasing protein, which is effective for sequential protein delivery. Acidic fibroblast growth factor (aFGF), loaded onto the shelled-nanocarrier scaffolds, was released over a month at a highly sustainable rate, profiling a release pattern similar to that of BSA. The biological activity of the aFGF was evidenced by the significant proliferation of osteoblastic precursor cells in the aFGF-releasing scaffolds. Furthermore, the aFGF-delivering scaffolds implanted in rat subcutaneous tissue for 2 weeks showed a substantially enhanced invasion of fibroblasts with a homogeneous population. Taken together, it is concluded that the biopolymer encapsulation of mesoporous nanospheres effectively prolongs the release of growth factors over weeks to a month, providing a nanocarrier platform for a long-term growth factor delivery. Moreover, the foam scaffolding of the nanocarrier system is a potential therapeutic three-dimensional matrix for cell culture and tissue engineering. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
C1 [Kim, Tae-Hyun; Eltohamy, Mohamed; Kim, Meeju; Perez, Roman A.; Kim, Joong-Hyun; Yun, Ye-Rang; Lee, Eun-Jung; Knowles, Jonathan C.; Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan 330714, South Korea.
   [Kim, Tae-Hyun; Eltohamy, Mohamed; Kim, Meeju; Perez, Roman A.; Kim, Joong-Hyun; Yun, Ye-Rang; Lee, Eun-Jung; Knowles, Jonathan C.; Kim, Hae-Won] Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan 330714, South Korea.
   [Kim, Tae-Hyun; Eltohamy, Mohamed; Kim, Meeju; Perez, Roman A.; Kim, Joong-Hyun; Yun, Ye-Rang; Lee, Eun-Jung; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan 330714, South Korea.
   [Jang, Jun-Hyeog] Inha Univ, Coll Med, Dept Biochem, Inchon, South Korea.
   [Knowles, Jonathan C.] UCL, Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1X 8LD, England.
   [Kim, Hae-Won] Dankook Univ, Coll Dent, Dept Biomat Sci, Cheonan 330714, South Korea.
RP Kim, HW (reprint author), Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan 330714, South Korea.
EM kimhw@dku.edu
RI Eltohamy, Mohamed/J-8507-2015
OI Eltohamy, Mohamed/0000-0003-2344-3501; Perez, Roman/0000-0002-0823-2303;
   Knowles, Jonathan Campbell/0000-0003-3917-3446
FU Priority Research Centers Program through the National Research
   Foundation (NRF), Republic of Korea [2009-0093829]
FX This work was supported by a Priority Research Centers Program (grant
   2009-0093829) through the National Research Foundation (NRF), Republic
   of Korea.
CR Atala A, 1999, Curr Opin Urol, V9, P517, DOI 10.1097/00042307-199911000-00005
   Chen AM, 2009, SMALL, V5, P2673, DOI 10.1002/smll.200900621
   Eltohamy M, 2011, MATER LETT, V65, P3570, DOI 10.1016/j.matlet.2011.07.112
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Jang JH, 2005, IN VITRO CELL DEV-AN, V41, P126
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Jin L, 2012, J TISSUE ENG, V3, DOI DOI 10.1177/2041731412454420
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Kim H. J., 2012, J TISSUE ENG, V3
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P698, DOI 10.1002/jbm.a.30848
   Klagsbrun M, 1989, Prog Growth Factor Res, V1, P207, DOI 10.1016/0955-2235(89)90012-4
   Kwon S, 2013, J TISSUE ENG, V4, P1, DOI DOI 10.1177/2041731413503357
   Lai W., 2013, J TISSUE ENG, V4
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047
   Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012
   Meng HA, 2010, ACS NANO, V4, P4539, DOI 10.1021/nn100690m
   Mollerup JM, 2008, CHEM ENG TECHNOL, V31, P864, DOI 10.1002/ceat.200800082
   Muniruzzaman M, 2000, J BIOACT COMPAT POL, V15, P365, DOI 10.1106/GTTN-BDXH-CLJ8-JGCD
   Oh SA, 2012, TISSUE ENG PT A, V18, P1087, DOI [10.1089/ten.tea.2011.0360, 10.1089/ten.TEA.2011.0360]
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Perez RA, 2013, ADV DRUG DELIVER REV, V65, P471, DOI 10.1016/j.addr.2012.03.009
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pullisaar H., 2013, J TISSUE ENG, V4
   Roman AP, 2014, ACTA BIOMATER, V10, P520
   Seo SJ, 2013, NANOMEDICINE-UK, V8, P1875, DOI 10.2217/nnm.13.165
   Shin S. H., 2012, J TISSUE ENG, V3, DOI DOI 10.1177/2041731412443530
   SHIRAHAMA H, 1990, J COLLOID INTERF SCI, V139, P177, DOI 10.1016/0021-9797(90)90455-W
   Singh RK, 2013, TISSUE ENG REGEN MED, V10, P296, DOI 10.1007/s13770-013-1092-y
   Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012
   SPRUGEL KH, 1987, AM J PATHOL, V129, P601
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Vansant E.E., 1995, CHARACTERIZATION CHE
   Wang LS, 2001, ACS NANO, V4, P4371
   WRIGHT AK, 1975, BIOPHYS J, V15, P137, DOI 10.1016/S0006-3495(75)85797-3
   Xia TA, 2009, ACS NANO, V3, P3273, DOI 10.1021/nn900918w
   Yun YR, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/218142
NR 40
TC 15
Z9 15
U1 1
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2014
VL 10
IS 6
BP 2612
EP 2621
DI 10.1016/j.actbio.2014.02.005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AH7WK
UT WOS:000336345900025
PM 24530558
OA Other Gold
DA 2018-10-20
ER

PT J
AU Montanari, E
   Meier, RP
   Mahou, R
   Bosco, D
   Borcard, F
   Bollinger, A
   Seebach, JD
   Wandrey, C
   Morel, P
   Gonelle-Gispert, C
   Buhler, LH
AF Montanari, E.
   Meier, R. P.
   Mahou, R.
   Bosco, D.
   Borcard, F.
   Bollinger, A.
   Seebach, J. D.
   Wandrey, C.
   Morel, P.
   Gonelle-Gispert, C.
   Buhler, L. H.
TI Alginate-PEG biomaterial for cell microencapsulation and
   xenotransplantation
SO BRITISH JOURNAL OF SURGERY
LA English
DT Meeting Abstract
CT 101st Annual Congress of the Swiss-Society-of-Surgery
CY MAY 21-23, 2014
CL Berne, SWITZERLAND
SP Swiss Soc Surg
C1 [Montanari, E.; Meier, R. P.; Bosco, D.; Bollinger, A.; Morel, P.; Gonelle-Gispert, C.; Buhler, L. H.] Univ Hosp Geneva, Dept Surg, Geneva, Switzerland.
   [Montanari, E.; Meier, R. P.; Bosco, D.; Bollinger, A.; Seebach, J. D.; Morel, P.; Gonelle-Gispert, C.; Buhler, L. H.] Med Fac Geneva, Geneva, Switzerland.
   [Mahou, R.; Borcard, F.; Wandrey, C.] Ecole Polytech Fed Lausanne, Lausanne, Switzerland.
   [Seebach, J. D.] Univ Hosp Geneva, Div Immunol & Allergy, Geneva, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1323
EI 1365-2168
J9 BRIT J SURG
JI Br. J. Surg.
PD JUN
PY 2014
VL 101
SU 5
BP 18
EP 18
PG 1
WC Surgery
SC Surgery
GA AH2PM
UT WOS:000335963400057
DA 2018-10-20
ER

PT J
AU Zhou, CC
   Ye, XJ
   Fan, YJ
   Qing, FZ
   Chen, HJ
   Zhang, XD
AF Zhou, C. C.
   Ye, X. J.
   Fan, Y. J.
   Qing, F. Z.
   Chen, H. J.
   Zhang, X. D.
TI Synthesis and characterization of CaP/Col composite scaffolds for
   load-bearing bone tissue engineering
SO COMPOSITES PART B-ENGINEERING
LA English
DT Article
DE Ceramic-matrix composites (CMCs); Porosity; Mechanical properties;
   Sintering
ID CROSS-LINKING; IN-VITRO; HYDROXYAPATITE; COLLAGEN; NANOCOMPOSITES;
   POLYETHYLENE; BIOCERAMICS; BIOMATERIAL; FABRICATION; BEHAVIOR
AB Porous calcium phosphate (Cap) ceramics are widely used in bone tissue engineering due to their excellent biological properties. However, the inherent brittleness of CaP ceramics has restricted their applications in the repair of load-bearing bones. This study aimed to improve the mechanical strength of CaP-based scaffolds by compositing CaP with collagen (Col). In this study, the influences of CaP porous structure, collagen content and cross-linking method on scaffolds mechanical strength were investigated. The morphologies of the composites were characterized by scanning electron microscope, and the mechanical properties of the scaffolds were assessed by dynamic mechanical analysis. The biocompatibility of the scaffolds was evaluated by culturing human bone marrow mesenchymal stem cells (MSCs) in vitro. The results show that the mechanical properties of scaffolds can be significantly improved by optimizing composite processes. Furthermore, remarkable viability and proliferation of MSCs on scaffolds was observed, which demonstrated good biocompatibility of the scaffolds. These results suggest that Cap/Col composite can be a promising scaffold for repair of load-bearing bones. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zhou, C. C.; Ye, X. J.; Fan, Y. J.; Qing, F. Z.; Chen, H. J.; Zhang, X. D.] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Zhou, CC (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM changchunzhou@scu.edu.cn
FU National Natural Science Foundation of China [81190131]; National Basic
   Research Program ("973" Program) [2011CB606201]; National Sci & Tech
   Support Plan [2012BAI17B01]
FX The authors appreciate Miss Wanlu Zhao for her helpful suggestions and
   criticism. This work was supported by the National Natural Science
   Foundation of China (No. 81190131), the National Basic Research Program
   ("973" Program, No. 2011CB606201) and the National Sci & Tech Support
   Plan (2012BAI17B01).
CR Chen L, 2014, COMPOS PART B-ENG, V56, P504, DOI 10.1016/j.compositesb.2013.08.005
   De Oliveira JF, 2003, ARTIF ORGANS, V27, P406
   Du YC, 2014, COMPOS PART B-ENG, V56, P717, DOI 10.1016/j.compositesb.2013.09.012
   Englert C, 2007, ARTHRITIS RES THER, V9, P47
   Fang LM, 2007, COMPOS PART B-ENG, V38, P345, DOI 10.1016/j.compositesb.2006.05.004
   Frohbergh ME, 2012, BIOMATERIALS, V33, P9167, DOI 10.1016/j.biomaterials.2012.09.009
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hong SG, 2013, BIOPROC BIOSYST ENG, V36, P205, DOI 10.1007/s00449-012-0776-3
   Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604
   Johari N, 2012, COMPOS PART B-ENG, V43, P1671, DOI 10.1016/j.compositesb.2012.01.013
   John A, 2001, J BIOMAT SCI-POLYM E, V12, P689, DOI 10.1163/156856201316883485
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   Kim SW, 2013, COMPOS PART B-ENG, V45, P1689, DOI 10.1016/j.compositesb.2012.09.077
   Kumar V, 2014, COMPOS PART B-ENG, V56, P184, DOI 10.1016/j.compositesb.2013.08.021
   Kyomoto M, 2008, J BIOMED MATER RES B, V84B, P320, DOI 10.1002/jbm.b.30874
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Liu CZ, 2009, ACTA BIOMATER, V5, P661, DOI 10.1016/j.actbio.2008.09.022
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Nikpour MR, 2012, COMPOS PART B-ENG, V43, P1881, DOI 10.1016/j.compositesb.2012.01.056
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Sung HW, 2000, J BIOMED MATER RES, V52, P77, DOI 10.1002/1097-4636(200010)52:1<77::AID-JBM10>3.0.CO;2-6
   Tang CY, 2013, COMPOS PART B-ENG, V55, P22, DOI 10.1016/j.compositesb.2013.05.052
   Veis A, 2005, SCIENCE, V307, P1419, DOI 10.1126/science.1109440
   Wang KF, 2012, INTERFACE FOCUS, V2, P259, DOI 10.1098/rsfs.2012.0012
   Wilson CE, 2006, BIOMATERIALS, V27, P302, DOI 10.1016/j.biomaterials.2005.06.041
   Wilson CE, 2004, J BIOMED MATER RES A, V68A, P123, DOI 10.1002/jbm.a.20015
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yu XZ, 2009, J MATER SCI-MATER M, V20, P2025, DOI 10.1007/s10856-009-3764-7
NR 36
TC 10
Z9 10
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-8368
EI 1879-1069
J9 COMPOS PART B-ENG
JI Compos. Pt. B-Eng.
PD JUN
PY 2014
VL 62
BP 242
EP 248
DI 10.1016/j.compositesb.2014.03.008
PG 7
WC Engineering, Multidisciplinary; Materials Science, Composites
SC Engineering; Materials Science
GA AH5QY
UT WOS:000336187200028
DA 2018-10-20
ER

PT J
AU Kaya, M
   Baran, T
   Mentes, A
   Asaroglu, M
   Sezen, G
   Tozak, KO
AF Kaya, Murat
   Baran, Talat
   Mentes, Ayfer
   Asaroglu, Muammer
   Sezen, Goksal
   Tozak, Kabil Ozcan
TI Extraction and Characterization of alpha-Chitin and Chitosan from Six
   Different Aquatic Invertebrates
SO FOOD BIOPHYSICS
LA English
DT Article
DE Nanofibre; Chitin; Chitosan; Biomaterial; Aquatic insect
ID PHYSICOCHEMICAL CHARACTERIZATION; SHIITAKE STIPES; DERIVATIVES;
   MUSHROOMS; SHELLS
AB Chitin and chitosan were extracted from six different aquatic invertebrate species. Species dry weights varied between 5 % and 20 % chitin, and the chitosan productivity of these chitins varied between 66 % and 74 %. Chitin and chitosan structures were characterized by FTIR, TGA, XRD, and SEM. FTIR results showed that the chitins obtained from the organisms were observed in alpha form. Chitin thermal stabilities were in the order Ranatra linearis > Anax imperator > Hydrophilus piceus > Notonecta glauca > Agabus bipustulatus > Asellus aquaticus, and chitosan thermal stabilities in the order N. glauca > A. bipustulatus > A. imperator > R. linearis > H. piceus > A. aquaticus. The crystalline index values of chitins varied between 76.4 % and 90.6 %. Their surface morphology was examined by SEM, revealing nanofibre structures. These six aquatic invertebrate species with characterized chitin and chitosan structures may be used as alternative chitin and chitosan sources for various technological purposes.
C1 [Kaya, Murat] Aksaray Univ, Fac Sci & Letters, Dept Biotechnol & Mol Biol, TR-68100 Aksaray, Turkey.
   [Kaya, Murat; Baran, Talat; Mentes, Ayfer; Tozak, Kabil Ozcan] Aksaray Univ, Sci & Technol Applicat & Res Ctr, TR-68100 Aksaray, Turkey.
   [Baran, Talat; Mentes, Ayfer; Tozak, Kabil Ozcan] Aksaray Univ, Fac Sci & Letters, Dept Chem, Aksaray, Turkey.
   [Asaroglu, Muammer] Minist Hlth, TR-06100 Ankara, Turkey.
   [Sezen, Goksal] Harran Univ, Fac Sci Literature, Dept Biol, Sanliurfa, Turkey.
RP Kaya, M (reprint author), Aksaray Univ, Fac Sci & Letters, Dept Biotechnol & Mol Biol, TR-68100 Aksaray, Turkey.
EM muratkaya3806@gmail.com
RI Mentes, Ayfer/F-8710-2011; University, Aksaray/A-1857-2018; Science and
   Arts Faculty, Aksaray University/Q-7606-2016
OI Kaya, Murat/0000-0001-6954-2703; MENTES, AYFER/0000-0003-3946-4075;
   BARAN, TALAT/0000-0003-0206-3841
CR Abdou ES, 2008, BIORESOURCE TECHNOL, V99, P1359, DOI 10.1016/j.biortech.2007.01.051
   Ai H, 2008, CARBOHYD POLYM, V72, P419, DOI 10.1016/j.carbpol.2007.09.010
   Al Sagheer FA, 2009, CARBOHYD POLYM, V77, P410, DOI 10.1016/j.carbpol.2009.01.032
   Aranaz I, 2009, CURR CHEM BIOL, V3, P203, DOI DOI 10.2174/187231309788166415
   Bo M, 2012, INT J BIOL MACROMOL, V51, P129, DOI 10.1016/j.ijbiomac.2012.04.016
   Cahn H.Y., 2001, FUNG SCI, V16, P39
   Cardenas G, 2004, J APPL POLYM SCI, V93, P1876, DOI 10.1002/app.20647
   Chatterjee S, 2005, PROCESS BIOCHEM, V40, P395, DOI 10.1016/j.procbio.2004.01.025
   Cortizo MS, 2008, CARBOHYD POLYM, V74, P10, DOI 10.1016/j.carbpol.2008.01.004
   Di Mario F, 2008, INT J BIOL MACROMOL, V43, P8, DOI 10.1016/j.ijbiomac.2007.10.005
   Einbu A, 2004, BIOMACROMOLECULES, V5, P2048, DOI 10.1021/bm049710d
   Felse PA, 1999, BIOPROCESS ENG, V20, P505, DOI 10.1007/s004490050622
   Ifuku S, 2011, MATERIALS, V4, P1417, DOI 10.3390/ma4081417
   Isa M.T., 2012, J PRACT TECHNOL, V21, P73
   Jang MK, 2004, J POLYM SCI POL CHEM, V42, P3423, DOI 10.1002/pola.20179
   Juarez-de La Rosa BA, 2012, J MATER SCI, V47, P990, DOI 10.1007/s10853-011-5878-9
   Kaya M, 2013, EXCLI J, V12, P503
   Kucukgulmez A, 2011, FOOD CHEM, V126, P1144, DOI 10.1016/j.foodchem.2010.11.148
   Liu SF, 2012, MOLECULES, V17, P4604, DOI 10.3390/molecules17044604
   Majtan J, 2007, INT J BIOL MACROMOL, V40, P237, DOI 10.1016/j.ijbiomac.2006.07.010
   Park BK, 2010, INT J MOL SCI, V11, P5153, DOI 10.3390/ijms11125152
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   PENG T, 1994, J POLYM SCI POL CHEM, V32, P591, DOI 10.1002/pola.1994.080320322
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sajomsang W, 2010, MAT SCI ENG C-MATER, V30, P357, DOI 10.1016/j.msec.2009.11.014
   Synowiecki J, 2003, CRIT REV FOOD SCI, V43, P145, DOI 10.1080/10408690390826473
   Tajik H, 2008, MOLECULES, V13, P1263, DOI 10.3390/molecules13061263
   Tolaimate A, 2003, POLYMER, V44, P7939, DOI 10.1016/j.polymer.2003.10.025
   Vetter J, 2007, FOOD CHEM, V102, P6, DOI 10.1016/j.foodchem.2006.01.037
   Wang YC, 2013, CARBOHYD POLYM, V92, P90, DOI 10.1016/j.carbpol.2012.09.084
   Yen MT, 2009, CARBOHYD POLYM, V75, P15, DOI 10.1016/j.carbpol.2008.06.006
   Yen MT, 2007, LWT-FOOD SCI TECHNOL, V40, P558, DOI 10.1016/j.lwt.2005.10.008
   Yen MT, 2007, LWT-FOOD SCI TECHNOL, V40, P472, DOI 10.1016/j.lwt.2006.01.002
   YEN MT, 2004, ANN TAINAN WOMANS CO, V23, P229
   Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3
NR 35
TC 37
Z9 37
U1 2
U2 53
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1858
EI 1557-1866
J9 FOOD BIOPHYS
JI Food Biophys.
PD JUN
PY 2014
VL 9
IS 2
BP 145
EP 157
DI 10.1007/s11483-013-9327-y
PG 13
WC Food Science & Technology
SC Food Science & Technology
GA AH8FA
UT WOS:000336369500006
DA 2018-10-20
ER

PT J
AU Grazziotin-Soares, R
   Nekoofar, MH
   Davies, TE
   Bafail, A
   Alhaddar, E
   Hubler, R
   Busato, ALS
   Dummer, PMH
AF Grazziotin-Soares, R.
   Nekoofar, M. H.
   Davies, T. E.
   Bafail, A.
   Alhaddar, E.
   Huebler, R.
   Busato, A. L. S.
   Dummer, P. M. H.
TI Effect of bismuth oxide on white mineral trioxide aggregate: chemical
   characterization and physical properties
SO INTERNATIONAL ENDODONTIC JOURNAL
LA English
DT Article
DE chemical properties; energy-dispersive X-ray; mineral trioxide
   aggregate; physical properties; radiopacifiers; X-ray diffraction
   analysis
ID END FILLING MATERIAL; ACCELERATED PORTLAND-CEMENT; TRICALCIUM SILICATE
   CEMENT; SURFACE MICROHARDNESS; DENTAL BIOMATERIAL; ENDODONTIC SURGERY;
   CALCIUM-CHLORIDE; SEALING ABILITY; IN-VITRO; MTA
AB AimTo assess the effect of bismuth oxide (Bi2O3) on the chemical characterization and physical properties of White mineral trioxide aggregate (MTA) Angelus.
   MethodologyCommercially available White MTA Angelus and White MTA Angelus without Bi2O3 provided by the manufacturer especially for this study were subjected to the following tests: Rietveld X-ray diffraction analysis (XRD), energy-dispersive X-ray analysis (EDX), scanning electron microscopy (SEM), compressive strength, Vickers microhardness test and setting time. Chemical analysis data were reported descriptively, and physical properties were expressed as means and standard deviations. Data were analysed using Student's t-test and Mann-Whitney U test (P=0.05).
   ResultsCalcium silicate peaks were reduced in the diffractograms of both hydrated materials. Bismuth particles were found on the surface of White MTA Angelus, and a greater amount of particles characterized as calcium hydroxide was observed by visual examination on White MTA without Bi2O3. The material without Bi2O3 had the shortest final setting time (38.33min, P=0.002), the highest Vickers microhardness mean value (72.35MPa, P=0.000) and similar compressive strength results (P=0.329) when compared with the commercially available White MTA Angelus containing Bi2O3.
   ConclusionThe lack of Bi2O3 was associated with an increase in Vickers microhardness, a reduction in final setting time, absence of Bi2O3 peaks in diffractograms, as well as a large amount of calcium and a morphology characteristic of calcium hydroxide in EDX/SEM analysis.
C1 [Grazziotin-Soares, R.; Busato, A. L. S.] Univ Luterana Brasil, Sch Dent, Canoas, RS, Brazil.
   [Nekoofar, M. H.] Univ Tehran Med Sci, Sch Dent, Dept Endodont, Tehran, Iran.
   [Nekoofar, M. H.; Bafail, A.; Alhaddar, E.; Dummer, P. M. H.] Cardiff Univ, Sch Dent, Endodontol Res Grp, Cardiff CF10 3AX, S Glam, Wales.
   [Davies, T. E.] Cardiff Univ, Sch Chem, Cardiff CF10 3AX, S Glam, Wales.
   [Huebler, R.] Pontificia Univ Catolica Rio Grande do Sul, Sch Phys, Mat & Nanosci Lab, Porto Alegre, RS, Brazil.
RP Grazziotin-Soares, R (reprint author), Univ Luterana Brasil ULBRA, Av Farroupilha 8001,Predio 59,3 Andar, BR-92425900 Canoas, RS, Brazil.
EM regrazziotin@gmail.com
RI Dummer, Paul/F-3063-2012; Nekoofar, Mohammad/C-1816-2014;
   Grazziotin-Soares, Renata/D-9597-2012; davies, thomas/F-7066-2010;
   Hubler, Roberto/H-8337-2012
OI Dummer, Paul/0000-0002-0726-7467; Grazziotin-Soares,
   Renata/0000-0002-7843-4103; Hubler, Roberto/0000-0002-8625-5607
FU CAPES [6904-10-6]
FX The authors acknowledge the financial assistance from CAPES (Process
   number 6904-10-6), which enabled Renata Grazziotin-Soares to hold a
   Visiting Research Fellow at the Cardiff University School of Dentistry.
CR Asgary S, 2009, J ENDODONT, V35, P243, DOI 10.1016/j.joen.2008.10.026
   Belio-Reyes IA, 2009, J ENDODONT, V35, P875, DOI 10.1016/j.joen.2009.03.004
   Bortoluzzi EA, 2009, J ENDODONT, V35, P550, DOI 10.1016/j.joen.2008.12.018
   Camilleri J, 2008, INT ENDOD J, V41, P408, DOI 10.1111/j.1365-2591.2007.01370.x
   Camilleri J, 2008, INT ENDOD J, V41, P151
   Camilleri J, 2007, INT ENDOD J, V40, P462, DOI 10.1111/j.1365-2591.2007.01248.x
   Camilleri J, 2005, DENT MATER, V21, P297, DOI 10.1016/j.dental.2004.05.010
   Camilleri J, 2012, INT ENDOD J, V45, P737, DOI 10.1111/j.1365-2591.2012.02027.x
   Camilleri J, 2011, DENT MATER, V27, P836, DOI 10.1016/j.dental.2011.04.010
   Camilleri J, 2011, DENT MATER, V27, P845, DOI 10.1016/j.dental.2011.04.011
   Camilleri J, 2010, INT ENDOD J, V43, P231, DOI 10.1111/j.1365-2591.2009.01670.x
   Camilleri J, 2010, INT ENDOD J, V43, P21, DOI 10.1111/j.1365-2591.2009.01621.x
   Camilleri J, 2005, INT ENDOD J, V38, P834, DOI 10.1111/j.1365-2591.2005.01028.x
   Camilleri J, 2010, J ENDODONT, V36, P502, DOI 10.1016/j.joen.2009.10.018
   Cavenago BC, 2014, INT ENDOD J, V47, P120, DOI 10.1111/iej.12120
   Chen CC, 2009, J ENDODONT, V35, P1288, DOI 10.1016/j.joen.2009.05.036
   Chiang TY, 2010, J ENDODONT, V36, P1683, DOI 10.1016/j.joen.2010.07.003
   Chng HK, 2005, J ENDODONT, V31, P665, DOI 10.1097/01.don.0000157993.89164.be
   Chong BS, 2003, INT ENDOD J, V36, P520, DOI 10.1046/j.1365-2591.2003.00682.x
   Coomaraswamy KS, 2007, J ENDODONT, V33, P295, DOI 10.1016/j.joen.2006.11.018
   Coutinho T, 2008, ORAL SURG ORAL MED O, V106, pE69, DOI 10.1016/j.tripleo.2008.07.028
   Cutajar A, 2011, DENT MATER, V27, P879, DOI 10.1016/j.dental.2011.04.012
   da Silva GF, 2011, INT ENDOD J, V44, P100, DOI 10.1111/j.1365-2591.2010.01803.x
   De-Deus G, 2009, J ENDODONT, V35, P1387, DOI 10.1016/j.joen.2009.06.022
   Erdem AP, 2011, PEDIATR DENT, V33, P165
   Bernabe PFE, 2010, ORAL SURG ORAL MED O, V109, P309, DOI 10.1016/j.tripleo.2009.07.019
   Formosa LM, 2012, INT ENDOD J, V45, P326, DOI 10.1111/j.1365-2591.2011.01980.x
   Fridland M, 2003, J ENDODONT, V29, P814, DOI 10.1097/00004770-200312000-00007
   Gandolfi MG, 2010, J ENDODONT, V36, P851, DOI 10.1016/j.joen.2009.12.007
   Giuliani V, 2010, J ENDODONT, V36, P1883, DOI 10.1016/j.joen.2010.08.015
   Hewlett PC, 2004, LEAS CHEM CEMENT CON
   Duarte MAH, 2012, J ENDODONT, V38, P394, DOI 10.1016/j.joen.2011.11.005
   Hwang YC, 2009, ORAL SURG ORAL MED O, V107, pE96, DOI 10.1016/j.tripleo.2008.11.015
   Islam I, 2006, J ENDODONT, V32, P193, DOI 10.1016/j.joen.2005.10.043
   Islam I, 2006, INT ENDOD J, V39, P220, DOI 10.1111/j.1365-2591.2006.01077.x
   Kang JS, 2012, SCANNING, V34, P207, DOI 10.1002/sca.20295
   Kayahan MB, 2009, INT ENDOD J, V42, P1004, DOI 10.1111/j.1365-2591.2009.01610.x
   Kim EC, 2008, ORAL SURG ORAL MED O, V105, pE54, DOI 10.1016/j.tripleo.2007.08.001
   LEE SJ, 1993, J ENDODONT, V19, P541, DOI 10.1016/S0099-2399(06)81282-3
   Lee YL, 2004, BIOMATERIALS, V25, P787, DOI 10.1016/S0142-9612(03)00591-X
   Lindeboom JAH, 2005, ORAL SURG ORAL MED O, V100, P495, DOI 10.1016/j.tripleo.2005.03.027
   Mente J, 2010, J ENDODONT, V36, P208, DOI 10.1016/j.joen.2009.10.012
   Min KS, 2009, ORAL SURG ORAL MED O, V108, pE82, DOI 10.1016/j.tripleo.2009.05.022
   Nair PNR, 2008, INT ENDOD J, V41, P128
   Nekoofar MH, 2007, INT ENDOD J, V40, P453, DOI 10.1111/j.1365-2591.2007.01236.x
   Nekoofar MH, 2011, INT ENDOD J, V44, P1011, DOI 10.1111/j.1365-2591.2011.01909.x
   Nekoofar MH, 2010, INT ENDOD J, V43, P849, DOI 10.1111/j.1365-2591.2010.01750.x
   Nekoofar MH, 2010, INT ENDOD J, V43, P782, DOI 10.1111/j.1365-2591.2010.01745.x
   Nekoofar MH, 2010, INT ENDOD J, V43, P312, DOI 10.1111/j.1365-2591.2010.01683.x
   Neville AM, 2000, PROPERTIES CONCRETE
   Parirokh M, 2011, J ENDODONT, V37, P786, DOI 10.1016/j.joen.2011.03.010
   Saghiri MA, 2012, INT ENDOD J, V45, P979, DOI 10.1111/j.1365-2591.2012.02056.x
   Saliba E, 2009, INT ENDOD J, V42, P322, DOI 10.1111/j.1365-2591.2008.01512.x
   SESTAK J, 2010, AMORPHOUS NANO CRYST
   Shokouhinejad N, 2012, INT ENDOD J, V45, P1127, DOI 10.1111/j.1365-2591.2012.02083.x
   TORABINEJAD M, 1993, J ENDODONT, V19, P591, DOI 10.1016/S0099-2399(06)80271-2
   TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2
   Torabinejad M., 1995, U. S. Patent, Patent No. [5415547, 5,415,547]
   Vivan RR, 2010, ORAL SURG ORAL MED O, V110, P250, DOI 10.1016/j.tripleo.2010.04.021
   von Arx T, 2012, J ENDODONT, V38, P570, DOI 10.1016/j.joen.2012.02.002
   Zarrabi MH, 2010, J ENDODONT, V36, P1778, DOI 10.1016/j.joen.2010.08.024
   Zeferino EG, 2010, INT ENDOD J, V43, P843, DOI 10.1111/j.1365-2591.2010.01747.x
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
NR 63
TC 17
Z9 19
U1 2
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0143-2885
EI 1365-2591
J9 INT ENDOD J
JI Int. Endod. J.
PD JUN
PY 2014
VL 47
IS 6
BP 520
EP 533
DI 10.1111/iej.12181
PG 14
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AG6SU
UT WOS:000335549500005
PM 24025109
DA 2018-10-20
ER

PT J
AU Rivadeneira, J
   Di Virgilio, AL
   Audisio, MC
   Boccaccini, AR
   Gorustovich, AA
AF Rivadeneira, J.
   Di Virgilio, A. L.
   Audisio, M. C.
   Boccaccini, A. R.
   Gorustovich, A. A.
TI Evaluation of antibacterial and cytotoxic effects of nano-sized
   bioactive glass/collagen composites releasing tetracycline hydrochloride
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
DE antibacterial activity; antibiotic; bioactive glass; collagen
ID SURGICAL-WOUND INFECTION; DRUG-DELIVERY; DIFFERENT ANTIBIOTICS;
   HYDROXYAPATITE; GLASS; 45S5; SCAFFOLDS; TITANIUM; EFFICACY; COLLAGEN
AB Aims: To evaluate the antibacterial efficacy of silicate bioactive glass nanoparticles/collagen composites functionalized with tetracycline hydrochloride (TCH).
   Methods and Results: Different concentrations of tetracycline hydrochloride (TCH) were incorporated on silicate bioactive glass nanoparticles/collagen composites by dipping these biomaterials for 48h at 37 degrees C in a solution of simulated body fluid (SBF) plus 0 center dot 05, 0 center dot 20 or 0 center dot 35mgml(-1) of the antibiotic. TCH release was assessed in double-distilled water at 37 degrees C up to 72h. The antibacterial activity of the samples has been evaluated in two ways: inhibition zone test and plate count method. The experiments were performed in vitro up to 48h on four staphylococci strains (Staphylococcus aureus ATCC29213, ATCC25923, ATCC6538P and Staphylococcus epidermidis ATCC12228). The new composites were also tested for cytotoxicity on MG-63 human osteosarcoma cells. The results showed that the incorporation and release of TCH was dependent on the initial concentration of TCH in SBF. The biomaterials also inhibited the Staph.aureus cell growth even though the efficacy was similar for all concentration. On the other hand, no cytotoxic effects were found on osteoblast-like cells, even at the highest concentration.
   Conclusions: Considering all results, it can be concluded that the new composite acts as a suitable bioactive carrier of TCH and could have potential in the prevention of biomaterial related infections.
   Significance and Impact of the Study: The results suggest a potential application as wound dressing.
C1 [Rivadeneira, J.; Gorustovich, A. A.] Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn INTECIN UBA CONI, Inst Tecnol & Ciencias Ingn, Grp Interdisciplinario Mat,Univ Catolica Salta IE, Salta, Argentina.
   [Di Virgilio, A. L.] Univ Nacl La Plata, Fac Ciencias Exactas, Catedra Bioquim Patol, La Plata, Buenos Aires, Argentina.
   [Audisio, M. C.] Univ Nacl Salta UNSa, Consejo Nacl Invest Cient & Tecn INIQUI CONICET, Inst Invest Ind Quim, Salta, Argentina.
   [Boccaccini, A. R.] Univ Erlangen Nurnberg, Inst Biomat, D-91054 Erlangen, Germany.
RP Rivadeneira, J (reprint author), Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn INTECIN UBA CONI, Inst Tecnol & Ciencias Ingn, Grp Interdisciplinario Mat,Univ Catolica Salta IE, Campo Castanares S-N, Salta, Argentina.
EM jrivadeneira@conicet.gov.ar
RI Boccaccini, Aldo/C-7905-2013
FU Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET
   [PIP0184]
FX This work was supported by the Consejo Nacional de Investigaciones
   Cientificas y Tecnicas, CONICET (PIP0184 to A.A.G). The authors declare
   no conflict of interest related to this work. We thank Prof. W. Stark
   and Dr. D. Mohn (Functional Materials XLaboratory, ETH Zurich) for
   providing the bioactive glass nanoparticles.
CR Allan I, 2001, BIOMATERIALS, V22, P1683, DOI 10.1016/S0142-9612(00)00330-6
   Andrade AL, 2009, J NON-CRYST SOLIDS, V355, P811, DOI 10.1016/j.jnoncrysol.2009.01.015
   Andrade AL, 2006, J NON-CRYST SOLIDS, V352, P3502, DOI 10.1016/j.jnoncrysol.2006.03.083
   Arcos D, 2013, ACTA MATER, V61, P890, DOI 10.1016/j.actamat.2012.10.039
   Bettany J T, 1998, Adv Dent Res, V12, P136
   Brunner TJ, 2006, CHEM COMMUN, P1384, DOI 10.1039/b517501a
   Burd A, 2007, WOUND REPAIR REGEN, V15, P94, DOI 10.1111/j.1524-475X.2006.00190.x
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Cavalu S, 2013, J MOL STRUCT, V1040, P47, DOI 10.1016/j.molstruc.2013.02.016
   COLTON MB, 1953, J AM DENT ASSOC, V47, P524, DOI 10.14219/jada.archive.1953.0206
   Cover Natasha F, 2012, Int J Nanomedicine, V7, P2411, DOI 10.2147/IJN.S27328
   Dashti A, 2010, J BIOMED MATER RES B, V93B, P394, DOI 10.1002/jbm.b.31594
   Domingues ZR, 2004, BIOMATERIALS, V25, P327, DOI 10.1016/S0142-9612(03)00524-6
   Duewelhenke N, 2007, ANTIMICROB AGENTS CH, V51, P54, DOI 10.1128/AAC.00729-05
   Giavaresi G, 2012, J MATER SCI-MATER M, V23, P1247, DOI 10.1007/s10856-012-4585-7
   Hu S, 2009, J MATER SCI-MATER M, V20, P281, DOI 10.1007/s10856-008-3564-5
   Hum J, 2012, J MATER SCI-MATER M, V23, P2317, DOI 10.1007/s10856-012-4580-z
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Marelli B, 2010, BIOMACROMOLECULES, V11, P1470, DOI 10.1021/bm1001087
   MIOLA M, 2012, J BIOMATER APPL, V28, P308
   MISRA DN, 1991, CALCIFIED TISSUE INT, V48, P362, DOI 10.1007/BF02556156
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   Novy P, 2011, J ANTIMICROB CHEMOTH, V66, P1298, DOI 10.1093/jac/dkr108
   Onche I, 2004, NIGER J SURG RES, V6, P37
   Oyane A, 2006, BIOMATERIALS, V27, P3295, DOI 10.1016/j.biomaterials.2006.01.029
   Paocharoen Veeraya, 2009, Journal of the Medical Association of Thailand, V92, P898
   Poon VKM, 2004, BURNS, V30, P140, DOI 10.1016/j.burns.2003.09.030
   Reilly J, 2001, J HOSP INFECT, V49, P245, DOI 10.1053/jhin.2001.1086
   Rivadeneira J, 2013, J APPL MICROBIOL, V115, P604, DOI 10.1111/jam.12254
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007
   Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004
   Stigter M, 2002, BIOMATERIALS, V23, P4143, DOI 10.1016/S0142-9612(02)00157-6
   Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011
   Waltimo T, 2007, J DENT RES, V86, P754, DOI 10.1177/154405910708600813
   Wu YQ, 2005, INT J PHARM, V290, P1, DOI 10.1016/j.ijpharm.2004.10.015
   Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x
   Zhao LZ, 2008, MICROPOR MESOPOR MAT, V109, P210, DOI 10.1016/j.micromeso.2007.04.041
NR 39
TC 20
Z9 22
U1 2
U2 43
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1364-5072
EI 1365-2672
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD JUN
PY 2014
VL 116
IS 6
BP 1438
EP 1446
DI 10.1111/jam.12476
PG 9
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA AH2WW
UT WOS:000335983700006
PM 24528382
OA Bronze
DA 2018-10-20
ER

PT J
AU He, ZL
   Wang, Q
   Sun, Y
   Shen, M
   Zhu, MJ
   Gu, ML
   Wang, Y
   Duan, YR
AF He, Zelai
   Wang, Qi
   Sun, Ying
   Shen, Ming
   Zhu, Mingjie
   Gu, Malin
   Wang, Yi
   Duan, Yourong
TI The biocompatibility evaluation of mPEG-PLGA-PLL copolymer and different
   LA/GA ratio effects for biocompatibility
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE copolymer; nanoparticles; cytotoxicity; biocompatibility; zebrafish
   embryos
ID IMPROVING SIRNA DELIVERY; ZEBRAFISH DANIO-RERIO; PLASMA-PROTEINS;
   BREAST-CANCER; NANOPARTICLES; TOXICITY; HEMOCOMPATIBILITY; EFFICACY;
   EMBRYO; CELLS
AB Biomaterial poly(lactic-co-glycolic acid) (PLGA), a FDA-approved material for clinical application, showed broad prospects in the past, but gradually can no longer meet present clinical developments and requirements, which we synthesized monomethoxy(polyethylene glycol)-poly(d,l-lactic-co-glycolic acid)-poly(l-lysine) (mPEG-PLGA-PLL) (PEAL) and have had some relevant reports. But studies on biocompatibility and the impacts of LA and GA ratio (LA/GA=60/40, 70/30, and 80/20) in main material have not yet been reported. Hemolysis experiment indicates that the hemolysis rate of PEAL extraction medium is less than 5%. Whole blood clotting time (CT), plasma recalcification time, activated partial thromboplastin time, prothrombin time evaluations, and dynamic CT assay show that the anticoagulant time of PEAL copolymer for blood is longer than that under negative and positive control. Protein adsorption assay indicates that PEAL films adsorb less protein than PLGA films (p<0.01); but comparing with expanded polytetrafluoroethylene, the aforementioned difference is not significant (p>0.05). Complement activation test shows that PEAL surface does not induce complement activation. CCK8 measurement shows that the relative growth rates of Huh7, L02, and L929 cells co-incubated with PEAL nanoparticles (NPs) are more than 90%. PEAL NPs co-incubated with 5% foetal bovine serum or 2% bovine serum albumin, through dynamic light scattering assay, remain stable. Different concentrations of PEAL NPs co-incubated with zebrafish embryos at 6-72h post fertilization show that comparing with negative control, 10, 100, or 500M of NPs for embryos development has no significant effects (p>0.05), only 1000 or 2000M of NPs has some effects (p<0.05). It is concluded that the PEAL copolymer, with excellent biocompatibility, proves to be a high-safety dose as drug carrier and implant candidate in vivo.
C1 [He, Zelai; Wang, Qi; Sun, Ying; Shen, Ming; Zhu, Mingjie; Gu, Malin; Duan, Yourong] Shanghai Jiao Tong Univ, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Renji Hosp,Sch Med, Shanghai 200032, Peoples R China.
   [Wang, Yi] Fudan Univ, JingAn Branch, Huashan Hosp, Dept Ultrasound, Shanghai 200040, Peoples R China.
RP Wang, Y (reprint author), Fudan Univ, JingAn Branch, Huashan Hosp, Dept Ultrasound, Shanghai 200040, Peoples R China.
EM y_wang1111@hotmail.com; yrduan@shsci.org
FU National Natural Science Foundation of China [81301973, 81272568];
   Shanghai Municipality Natural Science Foundation of China [13ZR1440200];
   Foundation of Shanghai Municipal Health Bureau [20124070]; Master and
   Doctor Foundation of Shanghai Cancer Institute, Renji Hospital, School
   of Medicine, Shanghai Jiao Tong University [SB 11-04]
FX We gratefully acknowledge the financial support from the National
   Natural Science Foundation of China [grant number 81301973], [grant
   number 81272568]; the Shanghai Municipality Natural Science Foundation
   of China [grant number 13ZR1440200]; the Foundation of Shanghai
   Municipal Health Bureau [grant number 20124070]; Master and Doctor
   Foundation of Shanghai Cancer Institute, Renji Hospital, School of
   Medicine, Shanghai Jiao Tong University [grant number SB 11-04].
CR Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009
   Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148
   Bender EA, 2012, INT J PHARMACEUT, V426, P271, DOI 10.1016/j.ijpharm.2012.01.051
   Clements LN, 2012, ARCH ENVIRON CON TOX, V63, P391, DOI 10.1007/s00244-012-9774-3
   Costantini DL, 2008, J NUCL MED, V49, P1498, DOI 10.2967/jnumed.108.051771
   Du J, 2012, INT J MOL SCI, V13, P516, DOI 10.3390/ijms13010516
   Du J, 2011, J GENE MED, V13, P312, DOI 10.1002/jgm.1574
   Durgadas CV, 2012, BIOMATERIALS, V33, P6420, DOI 10.1016/j.biomaterials.2012.05.051
   Essa S, 2011, INT J PHARMACEUT, V411, P178, DOI 10.1016/j.ijpharm.2011.02.039
   Henn K, 2011, COMP BIOCHEM PHYS C, V153, P91, DOI 10.1016/j.cbpc.2010.09.003
   Ispas C, 2009, ENVIRON SCI TECHNOL, V43, P6349, DOI 10.1021/es9010543
   Karakus G, 2013, J BIOMAT SCI-POLYM E, V24, P1260, DOI 10.1080/09205063.2012.750209
   Leitao AF, 2013, COLLOID SURFACE B, V111, P493, DOI 10.1016/j.colsurfb.2013.06.031
   Li DX, 2013, INT J PHARMACEUT, V441, P365, DOI 10.1016/j.ijpharm.2012.11.019
   Li YT, 2011, INT J NANOMED, V6, P2805, DOI 10.2147/IJN.S24596
   Liu PF, 2012, BIOMATERIALS, V33, P6739, DOI 10.1016/j.biomaterials.2012.06.008
   Liu PF, 2012, BIOMATERIALS, V33, P4403, DOI 10.1016/j.biomaterials.2012.02.041
   Liu XY, 2011, WATER RES, V45, P105, DOI 10.1016/j.watres.2010.08.022
   Manju S, 2012, J COLLOID INTERF SCI, V368, P144, DOI 10.1016/j.jcis.2011.11.024
   Ogawara K, 2004, J CONTROL RELEASE, V100, P451, DOI 10.1016/j.jconrel.2004.07.028
   Pei J, 2011, BIOMATERIALS, V32, P8968, DOI 10.1016/j.biomaterials.2011.08.034
   Prabhu BM, 2010, NANOTOXICOLOGY, V4, P150, DOI 10.3109/17435390903337693
   Pruvot B, 2011, HAEMATOL-HEMATOL J, V96, P612, DOI 10.3324/haematol.2010.031401
   Qin LB, 2013, J BIOMAT SCI-POLYM E, V24, P1757, DOI 10.1080/09205063.2013.801702
   Ramanlal Chaudhari K, 2011, J CONTROL RELEASE, V158, P470
   Safi M, 2011, BIOMATERIALS, V32, P9353, DOI 10.1016/j.biomaterials.2011.08.048
   Sami H, 2013, J BIOMAT SCI-POLYM E, V24, P1165, DOI 10.1080/09205063.2012.743062
   Senthilkumar S, 2013, MAT SCI ENG C-MATER, V33, P3615, DOI 10.1016/j.msec.2013.04.043
   Szott LM, 2011, J BIOMED MATER RES A, V96A, P150, DOI 10.1002/jbm.a.32954
   Tian LL, 2013, J BIOMAT SCI-POLYM E, V24, P1952, DOI 10.1080/09205063.2013.814096
   Truong L, 2012, NANOTOXICOLOGY, V6, P691, DOI 10.3109/17435390.2011.604440
   Truong L, 2011, ARCH TOXICOL, V85, P787, DOI 10.1007/s00204-010-0627-4
   Wang XB, 2014, J COLLOID INTERF SCI, V420, P88, DOI 10.1016/j.jcis.2014.01.016
   Zhang C, 2008, BIOMATERIALS, V29, P1233, DOI 10.1016/j.biomaterials.2007.11.029
   Zhang EL, 2010, J MATER SCI-MATER M, V21, P2151, DOI 10.1007/s10856-010-4070-0
   Zhao XS, 2013, AQUAT TOXICOL, V136, P49, DOI 10.1016/j.aquatox.2013.03.019
   Zhou HJ, 2012, BIOMATERIALS, V33, P6933, DOI 10.1016/j.biomaterials.2012.06.064
   Zhou Y, 2012, J BIOMED SCI, V19, P2
NR 38
TC 14
Z9 14
U1 6
U2 55
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JUN
PY 2014
VL 25
IS 9
BP 943
EP 964
DI 10.1080/09205063.2014.914705
PG 22
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AH9AP
UT WOS:000336431000007
PM 24811211
DA 2018-10-20
ER

PT J
AU Catauro, M
   Bollino, F
   Papale, F
AF Catauro, Michelina
   Bollino, Flavia
   Papale, Ferdinando
TI Synthesis of SiO2 system via sol-gel process: Biocompatibility tests
   with a fibroblast strain and release kinetics
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE sol-gel; bioglasses; biocompatibility; drug release
ID HYBRID MATERIALS; BIOACTIVE GLASS; DRUG-DELIVERY; AMPICILLIN
AB SiO2 glass has been synthesized via sol-gel process and enriched with 5 wt % sodium ampicillin. To verify the biocompatibility of the obtained biomaterial, fibroblasts have been grown on a glass surface and were tested for viability after 24 h. The results of the Water-Soluble Tetrazolium (WST)-8 analysis suggest that SiO2 glass has an adequate biocompatibility. The amorphous nature of the gels has been ascertained by X-ray diffraction analysis. Release kinetics have been subsequently investigated in a simulated body fluid. The amount of sodium ampicillin released has been detected by ultraviolet-visible spectroscopy. The release kinetics seems to occur in more than one stage. High-performance liquid chromatography analysis has also been carried out to ensure the integrity of ampicillin after the synthesis treatment. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1677-1680, 2014.
C1 [Catauro, Michelina; Bollino, Flavia; Papale, Ferdinando] Univ Naples 2, Dept Ind & Informat Engn, I-81031 Aversa, Italy.
RP Catauro, M (reprint author), Univ Naples 2, Dept Ind & Informat Engn, I-81031 Aversa, Italy.
EM michelina.catauro@unina2.it
OI Bollino, Flavia/0000-0001-9444-6609
CR Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Catauro M, 2007, LETT DRUG DES DISCOV, V4, P453
   Catauro M, 2006, J MATER SCI-MATER M, V17, P413, DOI 10.1007/s10856-006-8468-7
   Catauro M, 2006, J BIOMED MATER RES A, V77A, P340, DOI 10.1002/jbm.a.30617
   Catauro M, 2008, J MATER SCI-MATER M, V19, P531, DOI 10.1007/s10856-007-3065-y
   Catauro M, 2014, J BIOMED MATER RES A, V102, P392, DOI 10.1002/jbm.a.34721
   Catauro M, 2013, J APPL BIOMATER FUNC, V11, P172, DOI 10.5301/JABFM.2012.9256
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Huiras P, 2012, PHARMACOTHERAPY, V32, P1006, DOI 10.1002/phar.1135
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Muscariello L, 2005, J CELL PHYSIOL, V205, P328, DOI 10.1002/jcp.20444
   Papale F, 2013, J CELL PHYSIOL, V228, P968, DOI 10.1002/jcp.24242
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
NR 14
TC 15
Z9 15
U1 2
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2014
VL 102
IS 6
BP 1677
EP 1680
DI 10.1002/jbm.a.34836
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF1QQ
UT WOS:000334488800004
PM 23776153
DA 2018-10-20
ER

PT J
AU Du, BL
   Zeng, CG
   Zhang, W
   Quan, DP
   Ling, EA
   Zeng, YS
AF Du, Bao-ling
   Zeng, Chen-guang
   Zhang, Wei
   Quan, Da-ping
   Ling, Eng-ang
   Zeng, Yuan-shan
TI A comparative study of gelatin sponge scaffolds and PLGA scaffolds
   transplanted to completely transected spinal cord of rat
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE gelatin sponge scaffold; PLGA scaffold; acid sensing ion channel 1a;
   neuron survival; spinal cord injury
ID SENSING ION CHANNELS; NEURAL STEM-CELLS; FUNCTIONAL RECOVERY; AXON
   REGENERATION; NEURONS; GRAFTS; GROWTH; TISSUE; INFLAMMATION; DEGRADATION
AB This study sought to investigate whether gelatin sponge (GS) scaffold would produce less acidic medium in injured spinal cord, as compared with poly(lactic-co-glycolic acid) (PLGA) scaffold, to determine which of the two scaffolds as the biomaterial is more suitable for transplantation into spinal cord. GS scaffold or PLGA scaffold was transplanted into a transected spinal cord in this study. Two months after transplantation of scaffolds, acid sensing ion channel 1a (ASIC1a) positive cells expressing microtubule associated protein 2 (Map2) were observed as well as expressing adenomatous polyposis coli (APC) in spinal cord. GFAP positive cells were distributed at the rostral and caudal of the injury/graft area in the GS and PLGA groups. Western blot showed ASIC1a and GFAP expression of injured spinal cord was downregulated in the GS group. The number of CD68 positive cells was fewer and NF nerve fibers were more in the GS group. Nissl staining and cell counting showed that the number of survival neurons was comparable between the GS and PLGA groups in the pyramidal layer of sensorimotor cortex and the red nucleus of midbrain. However, in the Clarke's nucleus at L1 spinal segment, the surviving neurons in the GS group were more numerous than that in the PLGA group. H&E staining showed that the tissue cavities in the GS group were smaller in size than that in the PLGA group. The results suggest that GS scaffold is more suitable for transplantation to promote the recovery of spinal cord injury compared with PLGA scaffold. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1715-1725, 2014.
C1 [Du, Bao-ling; Zhang, Wei; Zeng, Yuan-shan] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, Div Neurosci, Guangzhou 510080, Guangdong, Peoples R China.
   [Zeng, Chen-guang; Quan, Da-ping] Sun Yat Sen Univ, Sch Chem & Chem Engn, Guangzhou 510127, Guangdong, Peoples R China.
   [Ling, Eng-ang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117597, Singapore.
   [Zeng, Yuan-shan] Sun Yat Sen Univ, Key Lab Stem Cells & Tissue Engn, Minist Educ, Guangzhou 510080, Guangdong, Peoples R China.
   [Zeng, Yuan-shan] Sun Yat Sen Univ, Inst Spinal Cord Injury, Guangzhou 510120, Guangdong, Peoples R China.
RP Zeng, YS (reprint author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, Div Neurosci, Guangzhou 510080, Guangdong, Peoples R China.
EM zengysh@mail.sysu.edu.cn
FU Chinese National Natural Science Foundation [30973721]; National 863
   Project [2011AA020112]; Emphasis Foundation of Social Developmental
   Field of Guangdong Province [2011A030300004]; Scientific Foundation of
   Guangzhou City [2012J4100077]
FX Contract grant sponsor: the Chinese National Natural Science Foundation;
   contract grant number: 30973721; Contract grant sponsor: National 863
   Project; contract grant number: 2011AA020112; Contract grant sponsor:
   Emphasis Foundation of Social Developmental Field of Guangdong Province;
   contract grant number: 2011A030300004; Contract grant sponsor:
   Scientific Foundation of Guangzhou City; contract grant number:
   2012J4100077) to Y.S. Zeng
CR Arias RL, 2008, NEUROBIOL DIS, V31, P334, DOI 10.1016/j.nbd.2008.05.008
   Du BL, 2011, BRAIN RES, V1400, P87, DOI 10.1016/j.brainres.2011.05.019
   Friedman JA, 2002, NEUROSURGERY, V51, P742, DOI 10.1097/00006123-200209000-00024
   Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668
   Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   He LM, 2009, TISSUE ENG PART C-ME, V15, P243, DOI 10.1089/ten.tec.2008.0255
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Lee SY, 2003, BIOMATERIALS, V24, P5049, DOI 10.1016/S0142-9612(03)00411-3
   Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200
   Midha R, 2003, J NEUROSURG, V99, P555, DOI 10.3171/jns.2003.99.3.0555
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   PAINO CL, 1991, EXP NEUROL, V114, P254, DOI 10.1016/0014-4886(91)90043-C
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Pearlman A L, 1996, Prog Brain Res, V108, P117
   Pignataro Giuseppe, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P1
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Sugiura T, 2005, J NEUROSCI, V25, P2617, DOI 10.1523/JNEUROSCI.2894-04.2005
   Sun X, 2011, BRAIN RES, V1396, P77, DOI 10.1016/j.brainres.2011.04.011
   Sutherland S P, 2000, Prog Brain Res, V129, P21
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Uchida K, 2002, SPINE, V27, P480, DOI 10.1097/00007632-200203010-00008
   Voilley N, 2001, J NEUROSCI, V21, P8026
   Vukicevic M, 2004, AM J PHYSIOL-CELL PH, V287, pC682, DOI 10.1152/ajpcell.00127.2004
   Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0
   Wang YZ, 2011, MOL NEUROBIOL, V44, P350, DOI 10.1007/s12035-011-8204-2
   WEIS J, 1989, J NEUROSURG, V71, P588, DOI 10.3171/jns.1989.71.4.0588
   Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014
   Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218
   Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200
   Weng XC, 2007, ACTA PHARMACOL SIN, V28, P1621, DOI 10.1111/j.1745-7254.2007.00627.x
   Xiong Y, 2009, BIOMATERIALS, V30, P3711, DOI 10.1016/j.biomaterials.2009.03.046
   Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   Yabe JT, 2001, CELL MOTIL CYTOSKEL, V50, P1, DOI 10.1002/cm.1037
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   Yoshii S, 2003, SPINE, V28, P2346, DOI 10.1097/01.BRS.0000085302.95413.16
   Zeng X, 2011, CELL TRANSPLANT, V20, P1881, DOI 10.3727/096368911X566181
   Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132
NR 41
TC 14
Z9 15
U1 5
U2 31
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2014
VL 102
IS 6
BP 1715
EP 1725
DI 10.1002/jbm.a.34835
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF1QQ
UT WOS:000334488800008
PM 23776140
DA 2018-10-20
ER

PT J
AU Sanzana, ES
   Navarro, M
   Ginebra, MP
   Planell, JA
   Ojeda, AC
   Montecinos, HA
AF Sanzana, Edgardo S.
   Navarro, Melba
   Ginebra, Maria-Pau
   Planell, Josep A.
   Ojeda, Alvaro C.
   Montecinos, Hernan A.
TI Role of porosity and pore architecture in the in vivo bone regeneration
   capacity of biodegradable glass scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE scaffolds; calcium phosphate glasses; tissue engineering; bone
   substitutes; in vivo
ID CALCIUM-PHOSPHATE GLASSES; SOL-GEL GLASS; CONTROLLED SOLUBILITY;
   BEHAVIOR; HYDROXYAPATITE; DEGRADATION; CERAMICS; DEFECTS
AB The aim of this work is to shed light on the role of porosity and pore architecture in the in vivo bone regeneration capacity of biodegradable glass scaffolds. A calcium phosphate glass in the system P2O5-CaO-Na2O-TiO2 was foamed using two different porogens, namely albumen and hydrogen peroxide (H2O2); the resulting three-dimensional porous structures were characterized and implanted in New Zealand rabbits to study their in vivo behavior. Scaffolds foamed with albumen displayed a monomodal pore size distribution centered around 150 m and a porosity of 82%, whereas scaffolds foamed with H2O2 showed lower porosity (37%), with larger elongated pores, and multimodal size distribution. After 12 weeks of implantation, histology results revealed a good osteointegration for both types of scaffolds. The quantitative morphometric analysis showed the substitution of the biomaterial by new bone in the case of glasses foamed with albumen. In contrast, bone neoformation and material resorption were significantly lower in the defects filled with the scaffolds foamed with H2O2. The results obtained in this study showed that both calcium phosphate glass scaffolds were osteoconductive, biocompatible, and biodegradable materials. However, differences in porosity, pore architecture, and microstructure led to substantially different in vivo response. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1767-1773, 2014.
C1 [Sanzana, Edgardo S.; Ojeda, Alvaro C.] Univ Concepcion, Surg Res Ctr, Fac Med, Dept Surg, Concepcion 4070386, Chile.
   [Navarro, Melba; Planell, Josep A.] Inst Bioengn Catalonia IBEC, Barcelona 08028, Spain.
   [Navarro, Melba; Ginebra, Maria-Pau; Planell, Josep A.] CIBER BBN, Zaragoza, Spain.
   [Ginebra, Maria-Pau; Planell, Josep A.] Tech Univ Catalonia, Biomat Biomech & Tissue Engn Grp, Dept Met Engn & Mat Sci, Barcelona 08028, Spain.
   [Montecinos, Hernan A.] Univ Concepcion, Fac Biol Sci, Dept Cellular Biol, Concepcion 4070386, Chile.
RP Sanzana, ES (reprint author), Univ Concepcion, Surg Res Ctr, Fac Med, Dept Surg, Concepcion 4070386, Chile.
EM esanzana@udec.cl
RI Ginebra, Maria-Pau/J-8149-2017
OI Ginebra, Maria-Pau/0000-0002-4700-5621
FU Spanish government [MAT2009-13547]; University of Concepcion, Chile
   [DIUC 208.081.027-1.0]; Generalitat de Catalunya through the prize
   "ICREA Academia" for excellence in research; Spanish MINECO (Ramon y
   Cajal Programme)
FX Contract grant sponsor: Spanish government; contract grant number:
   MAT2009-13547; Contract grant sponsor: University of Concepcion, Chile;
   contract grant number: DIUC 208.081.027-1.0; Contract grant sponsor:
   Generalitat de Catalunya through the prize "ICREA Academia" for
   excellence in research (to MPG); Contract grant sponsor: Spanish MINECO
   (Ramon y Cajal Programme; to MN)
CR Aguirre A, 2012, EUR CELLS MATER, V24, P90, DOI 10.22203/eCM.v024a07
   Avila G, 2005, P INT C POR CER MAT
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Bohner M, 2005, BIOMATERIALS, V26, P6099, DOI 10.1016/j.biomaterials.2005.03.026
   Descamps M, 2008, J EUR CERAM SOC, V28, P149, DOI 10.1016/j.jeurceramsoc.2007.05.025
   Flautre B, 2001, J MATER SCI-MATER M, V12, P679, DOI 10.1023/A:1011256107282
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gil-Albarova J, 2005, BIOMATERIALS, V26, P4374, DOI 10.1016/j.biomaterials.2004.11.006
   Gil-Albarova J, 2004, BIOMATERIALS, V25, P4639, DOI 10.1016/j.biomaterials.2003.12.009
   Ginebra MP, 2007, J BIOMED MATER RES A, V80A, P351, DOI 10.1002/jbm.a.30886
   Jinawath S, 2002, MAT SCI ENG C-BIO S, V22, P41, DOI 10.1016/S0928-4931(02)00111-X
   Juhasz JA, 2012, J MATER SCI, V47, P610, DOI 10.1007/s10853-011-6063-x
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   KATTHAGEN BD, 1984, ARCH ORTHOP TRAUM SU, V103, P291, DOI 10.1007/BF00432417
   Li SH, 2002, J BIOMED MATER RES, V61, P109, DOI 10.1002/jbm.10163
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Navarro M, 2006, ADV POLYM SCI, V200, P209, DOI 10.1007/12_068
   Navarro M, 2005, KEY ENG MATER, V284-286, P893, DOI 10.4028/www.scientific.net/KEM.284-286.893
   Navarro M, 2004, BIOMATERIALS, V25, P4233, DOI 10.1016/j.biomaterials.2003.11.012
   Navarro M, 2003, J BIOMED MATER RES A, V67A, P1009, DOI 10.1002/jbm.a.20014
   Navarro M, 2003, J AM CERAM SOC, V86, P1345, DOI 10.1111/j.1151-2916.2003.tb03474.x
   Sanzana ES, 2008, ACTA BIOMATER, V4, P1924, DOI 10.1016/j.actbio.2008.04.023
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   Texeira S, 2010, J BIOMED MATER RES A, V95, P1
NR 24
TC 17
Z9 18
U1 1
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2014
VL 102
IS 6
BP 1767
EP 1773
DI 10.1002/jbm.a.34845
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF1QQ
UT WOS:000334488800013
PM 23813739
DA 2018-10-20
ER

PT J
AU Hang, RQ
   Gao, A
   Huang, XB
   Wang, XG
   Zhang, XY
   Qin, L
   Tang, B
AF Hang, Ruiqiang
   Gao, Ang
   Huang, Xiaobo
   Wang, Xiaoguang
   Zhang, Xiangyu
   Qin, Lin
   Tang, Bin
TI Antibacterial activity and cytocompatibility of Cu-Ti-O nanotubes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE antibacterial activity; cytocompatibility; Cu-Ti-O nanotubes
ID SILVER NANOPARTICLES; CELL-GROWTH; THIN-FILMS; IN-VITRO; TITANIUM;
   SURFACES; PROLIFERATION; FABRICATION
AB TiO2 nanotubes (NTs) have favorable biological properties, but the poor antibacterial activity limits their application especially in orthopedics fields. In this article, Cu-Ti-O nanotubes with different Cu contents are fabricated on sputtered TiCu films. Scanning electron microscopy reveals the NTs can be formed on sputtered TiCu films when the Cu content is less than 14.6 at %. X-ray photoelectron spectroscopy results indicate the NTs are consist of CuO mixed with TiO2 and the Cu content in NTs decreases dramatically compared with that in TiCu films. Biological experiments show that although these NTs have poor release antibacterial activity, their contact antibacterial activity has proven to be excellent, indicating the NT surface can effectively inhibit biomaterial-associated infections. The cytocompatibility of the NTs is closely related to the Cu content and when its content is relatively low (1.01 at %), there is no appreciable cytotoxicity. So Cu-Ti-O NTs with 1 at % Cu may be suitable to achieve proper antibacterial activity and desired cytocompatibility. The Cu-Ti-O NTs integrate the favorable antibacterial activity of Cu and excellent biological properties of TiO2 NTs therefore have potential applications in orthopedics, dentistry, and other biomedical fields. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1850-1858, 2014.
C1 [Hang, Ruiqiang; Gao, Ang; Huang, Xiaobo; Wang, Xiaoguang; Zhang, Xiangyu; Qin, Lin; Tang, Bin] Taiyuan Univ Technol, Res Inst Surface Engn, Taiyuan 030024, Peoples R China.
RP Tang, B (reprint author), Taiyuan Univ Technol, Res Inst Surface Engn, Taiyuan 030024, Peoples R China.
EM tangbin@tyut.edu.cn
RI Wang, Xiaoguang/J-2567-2015
OI Wang, Xiaoguang/0000-0002-0141-0701
FU National Natural Science Foundation of China [51171125, 51201113];
   Shanxi Province Programs for Science and Technology Development
   [20110321051]; Natural Science Foundation of Shanxi Province
   [2012021021-7]
FX Contract grant sponsor: National Natural Science Foundation of China;
   contract grant numbers: 51171125; 51201113; Contract grant sponsor:
   Shanxi Province Programs for Science and Technology Development;
   contract grant number: 20110321051; Contract grant sponsor: Natural
   Science Foundation of Shanxi Province; contract grant number:
   2012021021-7
CR Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Cao HL, 2013, ACTA BIOMATER, V9, P5100, DOI 10.1016/j.actbio.2012.10.017
   Cao HL, 2011, BIOMATERIALS, V32, P693, DOI 10.1016/j.biomaterials.2010.09.066
   Hu H, 2012, ACTA BIOMATER, V8, P904, DOI 10.1016/j.actbio.2011.09.031
   Kunze J, 2008, ELECTROCHIM ACTA, V53, P6995, DOI 10.1016/j.electacta.2008.01.027
   Liu XY, 2010, MAT SCI ENG R, V70, P275, DOI 10.1016/j.mser.2010.06.013
   Mohan CC, 2012, J MATER CHEM, V22, P1326, DOI 10.1039/c1jm13726c
   Mor GK, 2006, THIN SOLID FILMS, V496, P42, DOI 10.1016/j.tsf.2005.08.190
   Necula BS, 2009, ACTA BIOMATER, V5, P3573, DOI 10.1016/j.actbio.2009.05.010
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Pittrof A, 2011, ACTA BIOMATER, V7, P424, DOI 10.1016/j.actbio.2010.09.028
   Prasad R., 2012, ADV SCI ENG MED, V4, P279
   Premchand YD, 2006, ELECTROCHEM COMMUN, V8, P1840, DOI 10.1016/j.elecom.2006.08.028
   Ren L, 2012, J MATER SCI-MATER M, V23, P1235, DOI 10.1007/s10856-012-4584-8
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Shirai T, 2009, J BIOMED MATER RES B, V91B, P373, DOI 10.1002/jbm.b.31412
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Sul YT, 2010, INT J NANOMED, V5, P87
   Sunada K, 2012, J HAZARD MATER, V235, P265, DOI 10.1016/j.jhazmat.2012.07.052
   von Wilmowsky C, 2009, J BIOMED MATER RES B, V89B, P165, DOI 10.1002/jbm.b.31201
   Wood JA, 2012, EXP CELL RES, V318, P2438, DOI 10.1016/j.yexcr.2012.06.022
   Wu C, 2012, BIOMATERIALS, V34, P422
   Yasuda K, 2007, J ELECTROCHEM SOC, V154, pC472, DOI 10.1149/1.2749091
   Zhang L, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/5/055602
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
NR 31
TC 38
Z9 38
U1 4
U2 49
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2014
VL 102
IS 6
BP 1850
EP 1858
DI 10.1002/jbm.a.34847
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF1QQ
UT WOS:000334488800023
PM 23907848
DA 2018-10-20
ER

PT J
AU Salbach-Hirsch, J
   Ziegler, N
   Thiele, S
   Moeller, S
   Schnabelrauch, M
   Hintze, V
   Scharnweber, D
   Rauner, M
   Hofbauer, LC
AF Salbach-Hirsch, Juliane
   Ziegler, Nicole
   Thiele, Sylvia
   Moeller, Stephanie
   Schnabelrauch, Matthias
   Hintze, Vera
   Scharnweber, Dieter
   Rauner, Martina
   Hofbauer, Lorenz C.
TI Sulfated Glycosaminoglycans Support Osteoblast Functions and
   Concurrently Suppress Osteoclasts
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE OSTEOBLASTS (OB); OSTEOCLASTS (OC); HYALURONIC ACID; HYALURONAN (HA)
   SULFATE; CHONDROITIN SULFATE (CS); GLYCOSAMINOGLYCANS (GAG)
ID MESENCHYMAL STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; CHONDROITIN
   SULFATE; SIGNALING PATHWAYS; MATRICES ENHANCE; STEM-CELLS; BONE;
   HYALURONAN; OSTEOPROTEGERIN; DERIVATIVES
AB In order to improve bone regeneration, development and evaluation of new adaptive biomaterials is warranted. Glycosaminoglycans (GAGs) such as hyaluronan (HA) and chondroitin sulfate (CS) are major extracellular matrix (ECM) components of bone, and display osteogenic properties that are potentially useful for biomaterial applications. Using native and synthetic sulfate-modified GAGs, we manufactured artificial collagen/GAG ECM (aECMs) coatings, and evaluated how the presence of GAGs and their degree of sulfation affects the differentiation of murine mesenchymal stem cells to osteoblasts (OB) cultivated on these aECMs. GAG sulfation regulated osteogenesis at all key steps of OB development. Adhesion, but not migration, was diminished by 50% (P<0.001). Proliferation and metabolic activity were slightly (P<0.05) and cell death events strongly (P<0.001) down-regulated due to a switch from proliferative to matrix synthesis state. When exposed to sulfated GAGs, OB marker genes, such as alkaline phosphatase, osteoprotegerin (OPG), and osteocalcin increased by up to 28-fold (P<0.05) and calcium deposition up to 4-fold (P<0.05). Furthermore, GAG treatment of OBs suppressed their ability to support osteoclast (OC) differentiation and resorption. In conclusion, GAG sulfation controls bone cell homeostasis by concurrently promoting osteogenesis and suppressing their paracrine support of OC functions, thus displaying a favorable profile on bone remodeling. Whether these cellular properties translate into improved bone regeneration needs to be validated in vivo. J. Cell. Biochem. 115: 1101-1111, 2014. (c) 2014 Wiley Periodicals, Inc.
C1 [Salbach-Hirsch, Juliane; Ziegler, Nicole; Thiele, Sylvia; Rauner, Martina; Hofbauer, Lorenz C.] Dresden Tech Univ Med Ctr, Dresden, Germany.
   [Moeller, Stephanie; Schnabelrauch, Matthias] INNOVENT eV, Biomat Dept, Jena, Germany.
   [Hintze, Vera; Scharnweber, Dieter] Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, D-01062 Dresden, Germany.
   [Scharnweber, Dieter; Hofbauer, Lorenz C.] Ctr Regenerat Therapies Dresden, Dresden, Germany.
RP Hofbauer, LC (reprint author), Univ Klinikum Carl Gustav Carus, Fetscherstr 74, D-01307 Dresden, Germany.
EM lorenz.hofbauer@uniklinikum-dresden.de
RI Rauner, Martina/A-1665-2015; Hofbauer, Lorenz/G-2490-2010;
   Salbach-Hirsch, Juliane/H-9409-2013
OI Hofbauer, Lorenz/0000-0002-8691-8423; Salbach-Hirsch,
   Juliane/0000-0001-7097-9953
FU Deutsche Forschungsgemeinschaft [TRR67-B2, TRR67-A2, TRR67-A3]
FX Grant sponsor: Deutsche Forschungsgemeinschaft; Grant numbers: TRR67-B2,
   TRR67-A2, TRR67-A3.
CR Atkins GJ, 2003, J BONE MINER RES, V18, P1088, DOI 10.1359/jbmr.2003.18.6.1088
   Bierbaum S, 2006, J BIOMED MATER RES A, V77A, P551, DOI 10.1002/jbm.a.30572
   Bierbaum Susanne, 2012, Biomatter, V2, P132, DOI 10.4161/biom.20921
   Brown SH, 2008, CURR PHARM BIOTECHNO, V9, P239, DOI 10.2174/138920108785161488
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   Buttner M, 2013, J CELL PHYSIOL, V228, P330, DOI 10.1002/jcp.24135
   CHEN CC, 1985, CALCIFIED TISSUE INT, V37, P395, DOI 10.1007/BF02553709
   Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h
   Haupt LM, 2009, J CELL PHYSIOL, V220, P780, DOI 10.1002/jcp.21825
   Hempel U, 2012, ACTA BIOMATER, V8, P4064, DOI 10.1016/j.actbio.2012.06.039
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hess R, 2012, BIOMATERIALS, V33, P8975, DOI 10.1016/j.biomaterials.2012.08.056
   Hintze V, 2012, ACTA BIOMATER, V8, P2144, DOI 10.1016/j.actbio.2012.03.021
   Hintze V, 2012, J TISSUE ENG REGEN M, DOI 10.1002/term.1528
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4382, DOI 10.1210/en.140.10.4382
   Hoshiba T, 2009, J BIOL CHEM, V284, P31164, DOI 10.1074/jbc.M109.054676
   Kliemt S, 2013, J PROTEOME RES, V12, P378, DOI 10.1021/pr300640h
   Kunze R, 2010, GLYCOCONJUGATE J, V27, P151, DOI 10.1007/s10719-009-9270-9
   Lamoureux F, 2009, CANCER RES, V69, P526, DOI 10.1158/0008-5472.CAN-08-2648
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lutter AH, 2010, J CELL BIOCHEM, V109, P1025, DOI 10.1002/jcb.22485
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065
   MARK M P, 1990, International Journal of Developmental Biology, V34, P191
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Mucci A, 2000, CARBOHYD POLYM, V41, P37, DOI 10.1016/S0144-8617(99)00075-2
   Nagahata M, 2004, BIOCHEM BIOPH RES CO, V315, P603, DOI 10.1016/j.bbrc.2004.01.098
   Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120
   Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2
   Plotkin LI, 2013, BONE, V52, P157, DOI 10.1016/j.bone.2012.09.030
   PRINCE CW, 1983, J NUTR, V113, P1576
   Rauner M, 2009, J BONE MINER RES, V24, P78, DOI 10.1359/JBMR.080902
   Robey PG, 2009, PRIMER METABOLIC BON, P32
   Salbach J, 2012, BIOMATERIALS, V33, P8418, DOI 10.1016/j.biomaterials.2012.08.028
   Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2
   Salbach-Hirsch J, 2013, BIOMATERIALS, V34, P7653, DOI 10.1016/j.biomaterials.2013.06.053
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Spector M, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/040401
   Thomas GP, 2001, J ENDOCRINOL, V170, P451, DOI 10.1677/joe.0.1700451
   Wojak-Cwik IM, 2013, J BIOMED MATER RES A, V101, P3109, DOI 10.1002/jbm.a.34620
NR 41
TC 16
Z9 17
U1 0
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD JUN
PY 2014
VL 115
IS 6
BP 1101
EP 1111
DI 10.1002/jcb.24750
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA AF2DR
UT WOS:000334523300011
PM 24356935
DA 2018-10-20
ER

PT J
AU Ma, R
   Fang, L
   Luo, ZK
   Weng, LQ
   Song, SH
   Zheng, RS
   Sun, HY
   Fu, HD
AF Ma, Rui
   Fang, Lin
   Luo, Zhongkuan
   Weng, Luqian
   Song, Shenhua
   Zheng, Ruisheng
   Sun, Hongyuan
   Fu, Huide
TI Mechanical performance and in vivo bioactivity of functionally graded
   PEEK-HA biocomposite materials
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Functionally graded material; Biomaterials; Composites materials;
   Bioactivity; Hydroxyapatite
ID COMPOSITES; MICROSTRUCTURE; IMPLANTS
AB A functionally graded material (FGM) of polyetheretherketone (PEEK)-hydroxyapatite (HA) with a symmetrical three-layer structure containing 8.7, 2.6 and 8.7 vol% HA, respectively, is successfully fabricated by hot pressing and evaluated by scanning electron microscopy and tensile testing. A good bonding between the HA particles and the PEEK matrix is achieved by virtue of an in situ method in fabricating each PEEK-HA composite layer. There are no apparent microcracks and microscopic interfaces within each layer of the FGM. The symmetrical PEEK-HA FGM does not fall apart or delaminate during loading with a tensile strength of 86.2 MPa, and its fracture energy is 56.5 kJ/m(2). Furthermore, in vivo bioactivity of the FGM sample is also evaluated, showing that it has sound biocompability and bioactivity. Accordingly, the FGM in the future may be a promising biomaterial to be used as replacement implant of human bone through a proper design to balance mechanical properties and bioactivity.
C1 [Ma, Rui; Zheng, Ruisheng] Shenzhen Univ, Minist Educ, Key Lab Optoelect Devices & Syst, Shenzhen 518060, Peoples R China.
   [Ma, Rui; Zheng, Ruisheng] Shenzhen Univ, Coll Optoelect Engn, Shenzhen 518060, Peoples R China.
   [Ma, Rui; Fang, Lin; Luo, Zhongkuan; Sun, Hongyuan; Fu, Huide] Shenzhen Univ, Coll Chem & Chem Engn, Shenzhen 518060, Peoples R China.
   [Weng, Luqian; Song, Shenhua] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China.
RP Fang, L (reprint author), Shenzhen Univ, Coll Chem & Chem Engn, Shenzhen 518060, Peoples R China.
EM fanglinhit@163.com
FU National Natural Science Foundation of China [61136001]; Specialized
   Research Fund for the Doctoral Program of Higher Education of China
   [20114408110002]; Key Laboratory of New Lithium-ion Battery Cathode
   Materials in Shenzhen City
FX This work was supported by the Key Program of the National Natural
   Science Foundation of China (Grant No. 61136001), the Specialized
   Research Fund for the Doctoral Program of Higher Education of China
   (Grant No. 20114408110002), and the Key Laboratory of New Lithium-ion
   Battery Cathode Materials in Shenzhen City.
CR Abdal-hay A, 2012, J SOL-GEL SCI TECHN, V64, P756, DOI 10.1007/s10971-012-2912-6
   Afzal MAF, 2012, MAT SCI ENG C-MATER, V32, P1164, DOI 10.1016/j.msec.2012.03.003
   Bakar MSA, 2003, COMPOS SCI TECHNOL, V3-4, P421
   Bakar MSA, 2003, BIOMATERIALS, V13, P2245
   Dhanalakshmi CP, 2012, J BIOMATER TISS ENG, V2, P314, DOI 10.1166/jbt.2012.1052
   Draenert FG, 2013, CLIN ORAL IMPLAN RES, V24, P750, DOI 10.1111/j.1600-0501.2012.02481.x
   Fan JP, 2004, BIOMATERIALS, V25, P5363, DOI 10.1016/j.biomaterials.2003.12.050
   Feng B, 2012, J HARD TISSUE BIOL, V21, P481, DOI 10.2485/jhtb.21.481
   Ghomi H, 2011, J SOL-GEL SCI TECHN, V58, P642, DOI 10.1007/s10971-011-2439-2
   Kutvonen A, 2012, PHYS REV E, V4
   Lim YM, 2001, J SOL-GEL SCI TECHN, V21, P123, DOI 10.1023/A:1011230221011
   Ma R, 2012, J SOL-GEL SCI TECHN, V62, P52, DOI 10.1007/s10971-012-2682-1
   Ma R, 2012, MATER LETT, V71, P117, DOI 10.1016/j.matlet.2011.12.007
   Mishina H, 2008, MAT SCI ENG A-STRUCT, V475, P141, DOI 10.1016/j.msea.2007.05.004
   Odegard GM, 2005, POLYMER, V46, P553, DOI 10.1016/j.polymer.2004.11.022
   Pei XB, 2011, SURF COAT TECH, V205, P4380, DOI 10.1016/j.surfcoat.2011.03.036
   Rabiei A, 2007, MAT SCI ENG C-BIO S, V27, P529, DOI 10.1016/j.msec.2006.05.036
   Wang L, 2011, MAT SCI ENG A-STRUCT, V528, P3689, DOI 10.1016/j.msea.2011.01.064
   Wang L, 2010, MATER LETT, V64, P2201, DOI 10.1016/j.matlet.2010.06.067
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   Wong KL, 2009, BIOMATERIALS, V30, P3810, DOI 10.1016/j.biomaterials.2009.04.016
   Zhang QW, 2012, BIOMATERIALS, V33, P5067, DOI 10.1016/j.biomaterials.2012.03.063
NR 22
TC 6
Z9 6
U1 4
U2 42
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
EI 1573-4846
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PD JUN
PY 2014
VL 70
IS 3
BP 339
EP 345
DI 10.1007/s10971-014-3287-7
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA AH7HQ
UT WOS:000336304200002
OA Other Gold
DA 2018-10-20
ER

PT J
AU Schumacher, TC
   Volkmann, E
   Yilmaz, R
   Wolf, A
   Treccani, L
   Rezwan, K
AF Schumacher, Thomas C.
   Volkmann, Eike
   Yilmaz, Rumeysa
   Wolf, Artur
   Treccani, Laura
   Rezwan, Kurosch
TI Mechanical evaluation of calcium-zirconium-silicate (baghdadite)
   obtained by a direct solid-state synthesis route
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Baghdadite; Fracture toughness; Bending strength; Hardness; Solid-state
   synthesis
ID IN-VITRO BIOACTIVITY; NOTCH-ROOT RADIUS; FRACTURE-TOUGHNESS; CERAMICS;
   BONE; SCAFFOLDS; RESPONSES; IMPLANTS; CELLS; ZINC
AB Ca3ZrSi2O9 (baghdadite) has become a major research focus within the biomaterial community due to its remarkable in-vitro and in-vivo bioactivity. Although baghdadite seems to exhibit interesting biological properties, as yet there has been no data published concerning its mechanical properties. This lack of knowledge hinders targeting this novel bioactive material towards potential applications. In this study we prepare dense Ca3ZrSi2O9 bulk ceramics for the first time, allowing the evaluation of its mechanical properties including hardness, bending strength, Young's modulus, and fracture toughness. The preparation of baghdadite has been accomplished by a direct solid-state synthesis in combination with conventional sintering at 1350-1450 degrees C for 3 h. Our results show that samples sintered at 1400 degrees C exhibit the best mechanical properties, resulting in a bending strength, fracture toughness, and hardness of 98 +/- 16 MPa, 1.3 +/- 0.1 MPa m(0.5), and 7.9 +/- 0.2 GPa. With a comparable mechanical strength to hydroxyapatite, but with an increased fracture toughness by 30% and hardness by 13% baghdadite is highly suitable for potential applications in non-load bearing areas (e.g. coatings or filler materials). (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Schumacher, Thomas C.; Volkmann, Eike; Yilmaz, Rumeysa; Wolf, Artur; Treccani, Laura; Rezwan, Kurosch] Univ Bremen, D-28359 Bremen, Germany.
RP Rezwan, K (reprint author), Univ Bremen, Biol Garten 2, D-28359 Bremen, Germany.
EM krezwan@uni-bremen.de
RI Rezwan, Kurosch/K-9451-2013; Treccani, Laura/R-1725-2016
OI Rezwan, Kurosch/0000-0002-7318-1119; Treccani, Laura/0000-0001-5365-9827
FU European Research Council within the Biocer Eng [205509]
FX Paul Pringle is gratefully acknowledged for proofreading of the
   manuscript. We thank the crystallography group of Prof. Reinhard X.
   Fischer from the University of Bremen for supplying the XRD facilities
   and the European Research Council for financial support within the
   Biocer Eng, Project No. 205509.
CR American Society for Testing and Materials, 2008, C1161A ASTM
   Borger A, 2002, J EUR CERAM SOC, V22, P1425, DOI 10.1016/S0955-2219(01)00458-7
   Damani R, 1996, J EUR CERAM SOC, V16, P695, DOI 10.1016/0955-2219(95)00197-2
   de Aza PN, 2000, J MICROSC-OXFORD, V197, P60
   Deutsches Institut fur Normung, 2003, 6233 DIN EN
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Fu Q, 2011, MAT SCI ENG C-MATER, V31, P1245, DOI 10.1016/j.msec.2011.04.022
   Gou ZG, 2004, J EUR CERAM SOC, V24, P93, DOI 10.1016/S0955-2219(03)00320-0
   Gou ZR, 2004, J EUR CERAM SOC, V24, P3491, DOI 10.1016/j.jeurceramsoc.2003.11.023
   HALOUANI R, 1994, J MATER SCI-MATER M, V5, P563, DOI 10.1007/BF00124890
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Holand W., 2012, GLASS CERAMIC TECHNO
   ISO, 2012, 23317 ISO
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Landuyt P.V., 1995, J MATER SCI-MATER M, V6, P8
   Liang Y, 2010, APPL SURF SCI, V256, P4677, DOI 10.1016/j.apsusc.2010.02.071
   Luo J, 1999, CERAM INT, V25, P281, DOI 10.1016/S0272-8842(98)00037-6
   Luo T, 2012, J BIOMED MATER RES A, V100A, P2269, DOI 10.1002/jbm.a.34161
   Munz D, 1999, MAT SCI
   Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582
   NISHIDA T, 1994, J AM CERAM SOC, V77, P606, DOI 10.1111/j.1151-2916.1994.tb07038.x
   Oyane A, 2003, J BIOMED MATER RES A, V64A, P339, DOI 10.1002/jbm.a.10426
   Ramaswamy Y, 2008, BIOMATERIALS, V29, P4392, DOI 10.1016/j.biomaterials.2008.08.006
   Ramaswamy Y, 2008, ACTA BIOMATER, V4, P1487, DOI 10.1016/j.actbio.2008.04.014
   Rodriguez-Lorenzo LM, 2002, J BIOMED MATER RES, V60, P159, DOI 10.1002/jbm.1286
   Roohani-Esfahani SI, 2012, ACTA BIOMATER, V8, P4162, DOI 10.1016/j.actbio.2012.07.036
   RYSHKEWITCH E, 1953, J AM CERAM SOC, V36, P65, DOI 10.1111/j.1151-2916.1953.tb12837.x
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Veljovic D, 2009, CERAM INT, V35, P1407, DOI 10.1016/j.ceramint.2008.07.007
   VOGEL W, 1987, ANGEW CHEM INT EDIT, V26, P527, DOI 10.1002/anie.198705271
   Wu CT, 2010, ACTA BIOMATER, V6, P2237, DOI 10.1016/j.actbio.2009.12.022
   Zhong HB, 2011, CERAM INT, V37, P2459, DOI 10.1016/j.ceramint.2011.03.037
   Zreiqat H, 2010, BIOMATERIALS, V31, P3175, DOI 10.1016/j.biomaterials.2010.01.024
NR 34
TC 17
Z9 17
U1 1
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUN
PY 2014
VL 34
BP 294
EP 301
DI 10.1016/j.jmbbm.2014.02.021
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AH9MU
UT WOS:000336467300031
PM 24657744
DA 2018-10-20
ER

PT J
AU Delcogliano, M
   de Caro, F
   Scaravella, E
   Ziveri, G
   De Biase, CF
   Marotta, D
   Marenghi, P
   Delcogliano, A
AF Delcogliano, Marco
   de Caro, Francesca
   Scaravella, Edoardo
   Ziveri, Giovanni
   De Biase, Carlo Felice
   Marotta, Domenico
   Marenghi, Pietro
   Delcogliano, Antonio
TI Use of innovative biomimetic scaffold in the treatment for large
   osteochondral lesions of the knee
SO KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
LA English
DT Article
DE Large osteochondral lesions; Biomimetic scaffold; Knee cartilage;
   Osteochondritis dissecans
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; COMPOSITE MULTILAYERED BIOMATERIAL;
   ARTICULAR-CARTILAGE; SURGICAL-TREATMENT; REPAIR; BONE; REGENERATION;
   DISSECANS; TISSUE; DEFECTS
AB Large osteochondral defects involve two different tissues characterized by different intrinsic healing capacity. Different techniques have been proposed to treat these lesions with results still under discussion. The aim of the study is to evaluate the clinical outcome of 19 patients treated with a type I collagen-hydroxyapatite nanostructural biomimetic osteochondral scaffold at minimum follow-up of 2 years.
   Twenty lesions, 19 patients were treated with this scaffold implantation. The lesions size went from 4 to 8 cm(2) (mean size 5.2 +/- A 1.6 cm(2)). All patients were clinically evaluated using the International Repair Cartilage Society score, the Tegner Score and EQ-VAS. MRI was performed at 12 and 24 months after surgery and then every 12 months and evaluated with magnetic resonance observation of cartilage repair tissue scoring scale.
   The IKDC subjective score improved from a mean score of 35.7 +/- A 6.3 at the baseline evaluation to 67.7 +/- A 13.4 at 12-month follow-up (p < 0.0005). A further improvement was documented from 12 to 24 months (mean score of 72.9 +/- A 12.4 at 24 months) (p < 0.0005). The IKDC objective score confirmed the results. The Tegner activity score improvement was statistically significant (p < 0.0005). The EQ-VAS showed a significant improvement from 3.15 +/- A 1.09 to 7.35 +/- A 1.14 (p < 0.0005) at 2-year follow-up. The lesion' site seems to influence the results showing a better outcome in the patients affected in the medial femoral condyle.
   The use of the MaioRegen scaffold is a good procedure for the treatment for large osteochondral defects where other classic techniques are difficult to apply. It is an open one-step surgery with promising stable results at medium follow-up.
   IV.
C1 [Delcogliano, Marco; de Caro, Francesca; Scaravella, Edoardo; Ziveri, Giovanni; De Biase, Carlo Felice; Marenghi, Pietro] Univ Hosp Parma, I-43126 Parma, Italy.
   [Marotta, Domenico; Delcogliano, Antonio] San Carlo IDI Hosp, I-00165 Rome, Italy.
RP de Caro, F (reprint author), Univ Hosp Parma, Via Gramsci 14, I-43126 Parma, Italy.
EM francesca.decaro@hotmail.com
CR Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P330, DOI 10.1302/0301-620X.87B3.15552
   Benthien JP, 2011, KNEE SURG SPORT TR A, V19, P1316, DOI 10.1007/s00167-010-1356-1
   Buda R, 2010, J BONE JOINT SURG AM, V92A, P2, DOI 10.2106/JBJS.J.00813
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   Deponti D, 2012, TISSUE ENG PT A, V18, P1109, DOI [10.1089/ten.tea.2011.0272, 10.1089/ten.TEA.2011.0272]
   Dhollander AAM, 2012, KNEE SURG SPORT TR A, V20, P1118, DOI 10.1007/s00167-011-1759-7
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Dhollander AAM, 2012, AM J SPORT MED, V40, P75, DOI 10.1177/0363546511423013
   Emmerson BC, 2007, AM J SPORT MED, V35, P907, DOI 10.1177/0363546507299932
   Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891
   Filardo G, 2012, KNEE, V19, P658, DOI 10.1016/j.knee.2011.08.007
   Gillogly SD, 2005, ORTHOP CLIN N AM, V36, P433, DOI 10.1016/j.ocl.2005.06.005
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P468, DOI 10.1007/s00167-011-1714-7
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P450, DOI 10.1007/s00167-011-1780-x
   Hangody L, 2010, AM J SPORT MED, V38, P1125, DOI 10.1177/0363546509360405
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2012, J BONE JOINT SURG AM, V4, P94
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Konst YE, 2012, KNEE SURG SPORT TR A, V20, P2263, DOI 10.1007/s00167-012-1891-z
   Krishnan SP, 2006, J BONE JOINT SURG BR, V88B, P203, DOI 10.1302/0301-620X.88B2.17009
   Marcacci M, 2013, KNEE SURG SPORT TR A, V21, P2509, DOI 10.1007/s00167-013-2388-0
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   Marmotti A, 2012, KNEE SURG SPORT TR A, V20, P2590, DOI 10.1007/s00167-012-1920-y
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Minas T, 1999, CLIN SPORT MED, V18, P13, DOI 10.1016/S0278-5919(05)70128-9
   Nesic D, 2006, ADV DRUG DELIVER REV, V58, P300, DOI 10.1016/j.addr.2006.01.012
   Ochs BG, 2011, AM J SPORT MED, V39, P764, DOI 10.1177/0363546510388896
   Pallante AL, 2009, AM J SPORT MED, V37, p24S, DOI 10.1177/0363546509351496
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   Peterson L, 2003, MASTER TECHNIQUES OR, P353
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Ventura A, 2012, KNEE SURG SPORT TR A, V20, P121, DOI 10.1007/s00167-011-1575-0
NR 36
TC 27
Z9 27
U1 0
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0942-2056
EI 1433-7347
J9 KNEE SURG SPORT TR A
JI Knee Surg. Sports Traumatol. Arthrosc.
PD JUN
PY 2014
VL 22
IS 6
BP 1260
EP 1269
DI 10.1007/s00167-013-2717-3
PG 10
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA AH7AL
UT WOS:000336284300009
PM 24146051
DA 2018-10-20
ER

PT J
AU Volpi, P
   Bait, C
   Quaglia, A
   Redaelli, A
   Prospero, E
   Cervellin, M
   Stanco, D
   de Girolamo, L
AF Volpi, P.
   Bait, C.
   Quaglia, A.
   Redaelli, A.
   Prospero, E.
   Cervellin, M.
   Stanco, D.
   de Girolamo, L.
TI Autologous collagen-induced chondrogenesis technique (ACIC) for the
   treatment of chondral lesions of the talus
SO KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
LA English
DT Article
DE Chondral lesions; Talus; Cartilage repair; Autologous collagen-induced
   chondrogenesis (ACIC); Bone marrow mesenchymal stem cells
ID MESENCHYMAL STEM-CELLS; MATRIX-INDUCED CHONDROGENESIS; OSTEOCHONDRAL
   LESIONS; MARROW STIMULATION; ANKLE; KNEE; TRANSPLANTATION; DEFECTS;
   SCALE; RECONSTRUCTION
AB Autologous collagen-induced chondrogenesis technique (ACIC) combines microfractures with the use of an injectable atelocollagen matrix that allows performing the whole cartilage repair treatment arthroscopically. The aim of this study was to evaluate the in vitro cytocompatibility of this biomaterial using human bone marrow mesenchymal stem cells and human chondrocytes. Moreover, the preliminary data of five patients affected by chondral lesion of the talus treated with the ACIC technique are shown.
   Human bone marrow mesenchymal stem cells and human chondrocytes were seeded on solid and pre-solid atelocollagen scaffolds. Cell-scaffold constructs were cultured for 7 days and then prepared for histological analyses. Arthroscopic ACIC was performed in five patients affected by chondral lesions of the talus; they were clinically evaluated with AOFAS, VAS and Tegner score before and then after 6 months from surgery.
   In vitro results showed that both bone marrow mesenchymal stem cells and chondrocytes were able to efficiently colonize the whole construct, from the surface to the core, only when seeded on the pre-solid atelocollagen scaffold, but not on its solid form. No adverse events were observed in the patients treated with the ACIC technique; a significant improvement in VAS pain scale and in AOFAS score was found at 6 months follow up.
   Injectable atelocollagen can be considered a feasible scaffold for cartilage repair treatment, in particular if used in its pre-solid form. ACIC leads to good clinical results in the treatment for chondral lesions of the talus even if longer follow-up and a higher number of patients are necessary to confirm these data.
   IV.
C1 [Volpi, P.; Bait, C.; Quaglia, A.; Redaelli, A.; Prospero, E.; Cervellin, M.] Ist Clin Humanitas, Rozzano, Italy.
   [Stanco, D.; de Girolamo, L.] IRCCS Ist Ortoped Galeazzi, Orthopaed Biotechnol Lab, Milan, Italy.
RP Volpi, P (reprint author), Ist Clin Humanitas, Via Manzoni 56, Rozzano, Italy.
EM volpi.piero@libero.it
RI Redaelli, Andrea/B-8111-2017
OI Redaelli, Andrea/0000-0003-2907-6263; DE GIROLAMO,
   LAURA/0000-0002-9979-3092
CR Barnes Christopher J, 2003, Foot Ankle Clin, V8, P243, DOI 10.1016/S1083-7515(03)00016-0
   Becher C, 2010, KNEE SURG SPORT TR A, V18, P656, DOI 10.1007/s00167-009-1036-1
   CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X
   Chen CY, 2004, INJURY, V35, P809, DOI 10.1016/j.injury.2003.09.035
   de Girolamo L, 2010, INJURY, V41, P1172, DOI 10.1016/j.injury.2010.09.027
   Dhollander AAM, 2011, KNEE SURG SPORT TR A, V19, P536, DOI 10.1007/s00167-010-1337-4
   Frisbie DD, 2003, CLIN ORTHOP RELAT R, P215, DOI 10.1097/01.blo.0000030514.43495.f3
   Giannini S, 2001, FOOT ANKLE INT, V22, P513, DOI 10.1177/107110070102200612
   Gille J, 2010, KNEE SURG SPORT TR A, V18, P1456, DOI 10.1007/s00167-010-1042-3
   Gobbi A, 2006, ARTHROSCOPY, V22, P1085, DOI 10.1016/j.arthro.2006.05.016
   Guyton GP, 2001, FOOT ANKLE INT, V22, P779, DOI 10.1177/107110070102201003
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   Hui JHP, 2012, ORTHOP CLIN N AM, V43, P255, DOI 10.1016/j.ocl.2012.01.002
   Imhoff AB, 2011, AM J SPORT MED, V39, P1487, DOI 10.1177/0363546510397726
   Kitaoka HB, 1997, FOOT ANKLE INT, V18, P443, DOI 10.1177/107110079701800713
   Lopa S, 2013, J BIOMED MATER RES A, V101, P3396, DOI 10.1002/jbm.a.34649
   LYSHOLM J, 1982, AM J SPORT MED, V10, P150, DOI 10.1177/036354658201000306
   Madeley NJ, 2012, FOOT ANKLE INT, V33, P57, DOI 10.3113/FAI.2012.0057
   Mei-Dan O, 2012, AM J SPORT MED, V40, P534, DOI 10.1177/0363546511431238
   Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038
   Porada CD, 2010, ADV DRUG DELIVER REV, V62, P1156, DOI 10.1016/j.addr.2010.08.010
   Ronga M, 2005, FOOT ANKLE SURG, V11, P29
   Schmitt A, 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/394962
   Seo S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/806891
   Seo Seung-Suk, 2011, Knee Surg Relat Res, V23, P185, DOI 10.5792/ksrr.2011.23.4.185
   Shetty AA, 2013, ORTHOPEDICS, V36, pE648, DOI 10.3928/01477447-20130426-30
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Steinwachs MR, 2008, INJURY, V39, pS26, DOI 10.1016/j.injury.2008.01.042
   TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43
   Valderrabano V, 2013, AM J SPORT MED, V41, P519, DOI 10.1177/0363546513476671
   van Eekeren ICM, 2012, SPORTS MED, V42, P857, DOI 10.2165/11635420-000000000-00000
   Verhagen Ronald A W, 2003, Foot Ankle Clin, V8, P233, DOI 10.1016/S1083-7515(02)00064-5
   Wiewiorski M, 2013, FOOT ANKLE CLIN, V18, P151, DOI 10.1016/j.fcl.2012.12.009
   Wiewiorski M, 2011, ARCH ORTHOP TRAUM SU, V131, P293, DOI 10.1007/s00402-010-1048-9
   Zengerink M, 2010, KNEE SURG SPORT TR A, V18, P238, DOI 10.1007/s00167-009-0942-6
NR 35
TC 8
Z9 8
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0942-2056
EI 1433-7347
J9 KNEE SURG SPORT TR A
JI Knee Surg. Sports Traumatol. Arthrosc.
PD JUN
PY 2014
VL 22
IS 6
BP 1320
EP 1326
DI 10.1007/s00167-013-2830-3
PG 7
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA AH7AL
UT WOS:000336284300017
PM 24414378
DA 2018-10-20
ER

PT J
AU Wang, XF
   You, Z
   Sha, HL
   Gong, SX
   Niu, QJ
   Sun, W
AF Wang, Xiaofeng
   You, Zheng
   Sha, Hailiang
   Gong, Shixing
   Niu, Qingjuan
   Sun, Wei
TI Direct electrochemistry and electrocatalysis of myoglobin using an ionic
   liquid-modified carbon paste electrode coated with Co3O4 nanorods and
   gold nanoparticles
SO MICROCHIMICA ACTA
LA English
DT Article
DE Myoglobin; Ionic liquid; Carbon paste electrode; Co3O4 nanorods; Gold
   nanoparticles; Direct electrochemistry
ID BY-LAYER FILMS; HEMOGLOBIN; NAFION; PERFORMANCE; BIOSENSORS; CATALYSIS;
   PROTEIN; ACID; DNA
AB A nanohybrid biomaterial was fabricated by mixing Co3O4 nanorods, gold nanoparticles (Au-NPs) and myoglobin (Mb), and depositing it on the surface of a carbon paste electrode containing the ionic liquid N-hexylpyridinium hexafluorophosphate as the binder. UV-vis and FT-IR revealed the Mb in the composite film to have remained in its native structure. A pair of well-defined redox peaks appears in cyclic voltammograms and indicates direct electron transfer from the Mb to the underlying electrode. The results are attributed to the favorable orientation of Mb in the composite film, to the synergistic effects of Co3O4 nanorods and Au-NPs. The modified electrode shows excellent electrocatalytic ability towards the reduction of substrates such as trichloroacetic acid and nitrite, and displays good stability and reproducibility.
C1 [Wang, Xiaofeng; You, Zheng] Tsinghua Univ, Dept Precis Instrument, Beijing 100084, Peoples R China.
   [Sha, Hailiang] Beijing Stomatol Hosp, Dept Orthodont, Beijing 100050, Peoples R China.
   [Gong, Shixing; Niu, Qingjuan; Sun, Wei] Qingdao Univ Sci & Technol, Coll Chem & Mol Engn, Qingdao 266042, Peoples R China.
RP Sun, W (reprint author), Qingdao Univ Sci & Technol, Coll Chem & Mol Engn, Qingdao 266042, Peoples R China.
EM sunwei@qust.edu.cn
FU National Natural Science Foundation of China [30901700, 50905096]
FX We are grateful to the financial support of the National Natural Science
   Foundation of China (Nos. 30901700, 50905096).
CR Ding Y, 2010, BIOSENS BIOELECTRON, V26, P542, DOI 10.1016/j.bios.2010.07.050
   Freire RS, 2003, J BRAZIL CHEM SOC, V14, P230, DOI 10.1590/S0103-50532003000200008
   FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0
   Gao HW, 2012, J ELECTROANAL CHEM, V664, P88, DOI 10.1016/j.jelechem.2011.10.018
   Gao RF, 2009, ELECTROCHEM COMMUN, V11, P1527, DOI 10.1016/j.elecom.2009.05.046
   Gong JM, 2003, MICROCHEM J, V75, P51, DOI 10.1016/S0026-265X(03)00053-5
   Hamasaki A, 2008, CHEM LETT, V37, P1292, DOI 10.1246/cl.2008.1292
   He PL, 2002, BIOMACROMOLECULES, V3, P139, DOI 10.1021/bm015599p
   Jia WZ, 2009, J ELECTROANAL CHEM, V625, P27, DOI 10.1016/j.jelechem.2008.09.020
   Jiang J, 2010, CRYST GROWTH DES, V10, P70, DOI 10.1021/cg9001835
   Li XQ, 2010, ELECTROCHIM ACTA, V55, P2173, DOI 10.1016/j.electacta.2009.11.052
   Lojou E, 2004, ELECTROANAL, V16, P1113, DOI 10.1002/elan.200403001
   Lu XB, 2006, BIOMACROMOLECULES, V7, P975, DOI 10.1021/bm050933t
   Lu XB, 2007, J MATER CHEM, V17, P1427, DOI 10.1039/b615467k
   Maduraiveeran G, 2011, INT J NANOTECHNOL, V8, P925, DOI 10.1504/IJNT.2011.044437
   Maleki N, 2006, ANAL CHEM, V78, P3820, DOI 10.1021/ac060070+
   Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716
   Opallo M, 2011, J ELECTROANAL CHEM, V656, P2, DOI 10.1016/j.jelechem.2011.01.008
   Pang H, 2012, DALTON T, V41, P5862, DOI 10.1039/c2dt12494g
   Pingarron JM, 2008, ELECTROCHIM ACTA, V53, P5848, DOI 10.1016/j.electacta.2008.03.005
   Ruan CX, 2012, MICROCHIM ACTA, V177, P457, DOI 10.1007/s00604-012-0796-3
   Scheller FW, 2005, ADV COLLOID INTERFAC, V116, P111, DOI 10.1016/j.cis.2005.05.006
   SONG YP, 1992, LANGMUIR, V8, P257, DOI 10.1021/la00037a048
   Sun H, 2005, ANALYST, V130, P76, DOI 10.1039/b411430b
   Sun W, 2008, TALANTA, V80, P2177
   Sun W, 2008, ELECTROCHEM COMMUN, V10, P298, DOI 10.1016/j.elecom.2007.12.012
   Sun W, 2010, BIOSENS BIOELECTRON, V25, P1264, DOI 10.1016/j.bios.2009.10.011
   Sun W, 2009, J PHYS CHEM C, V113, P11294, DOI 10.1021/jp8114594
   Sun W, 2009, ELECTROANAL, V21, P959, DOI 10.1002/elan.200804498
   Sun W, 2009, BIOELECTROCHEMISTRY, V75, P170, DOI 10.1016/j.bioelechem.2009.03.012
   Wang H, 2000, POWDER TECHNOL, V111, P175, DOI 10.1016/S0032-5910(00)00253-9
   Wang SF, 2005, LANGMUIR, V21, P9260, DOI 10.1021/la050947k
   Yan L, 2002, CHEM COMMUN, P860, DOI 10.1039/b201237e
   Zhan TR, 2010, J COLLOID INTERF SCI, V346, P188, DOI 10.1016/j.jcis.2010.02.007
   Zhang YH, 2008, SENSOR ACTUAT B-CHEM, V130, P682, DOI 10.1016/j.snb.2007.10.034
NR 35
TC 14
Z9 14
U1 2
U2 48
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0026-3672
EI 1436-5073
J9 MICROCHIM ACTA
JI Microchim. Acta
PD JUN
PY 2014
VL 181
IS 7-8
BP 767
EP 774
DI 10.1007/s00604-013-1110-8
PG 8
WC Chemistry, Analytical
SC Chemistry
GA AH8HS
UT WOS:000336378600010
DA 2018-10-20
ER

PT J
AU Elbersen, BS
   Annevelink, E
   Klein-Lankhorst, JR
   Lesschen, JP
   Staritsky, I
   Langeveld, JWA
   Elbersen, HW
   Sanders, JPM
AF Elbersen, B. S.
   Annevelink, E.
   Klein-Lankhorst, J. Roos
   Lesschen, J. P.
   Staritsky, I.
   Langeveld, J. W. A.
   Elbersen, H. W.
   Sanders, J. P. M.
TI A framework with an integrated computer support tool to assess regional
   biomass delivery chains
SO REGIONAL ENVIRONMENTAL CHANGE
LA English
DT Article
DE Biomass delivery chains; Sustainability; Resource efficiency
ID NETHERLANDS; SCENARIOS
AB In this paper, we first provide a brief overview of other decision support tools for bioenergy and assess to which extent the integrated tool central in this paper is different and novel. Next, a description is given of the tool, the different models used and the functionalities. The working of the tool is then illustrated with three case studies based in the northern part of The Netherlands. The computerised tool is meant to support the communication process between stakeholders to come to the implementation of regional biomass delivery chains. It helps to create a quick and common understanding of optimal biomass use in a region. Although the tool has been applied only to bioenergy chains, other biochemical and biomaterial chains are also suitable to be incorporated. The three case studies presented include a conventional sugar beet bioethanol production chain, an advanced Miscanthus bioethanol conversion chain and a straw-based electricity chain. The main conclusions are that optimal biomass use for non-food purposes from a sustainability and resource-efficient perspective depend on many different factors specific to the conversion chains. For example, the green house gas (GHG) emission and mitigation potential of a sugar beet-based bioethanol chain requires careful organisation particularly on the primary biomass production and transport, while in a straw-based electricity chain, the largest efficiency gains can be reached in the conversion part. Land use change (LUC) to sugar beet generally causes more negative environmental impacts than LUC to Miscanthus. This applies to both GHG efficiency, soil organic carbon content and emissions of nitrogen to surface waters. At the same time, it becomes clear that the different scenario assumptions can be very influential, particularly on the final economic performance of a chain. Overall, it is clear from the cases that the users understand much better under which circumstances and through which mechanisms the designed chains can become profitable and can become more environmentally sustainable.
C1 [Elbersen, B. S.; Klein-Lankhorst, J. Roos; Lesschen, J. P.; Staritsky, I.] Alterra Wageningen UR, NL-6700 AA Wageningen, Netherlands.
   [Annevelink, E.; Elbersen, H. W.] Wageningen UR Food & Biobased Res, NL-6700 AA Wageningen, Netherlands.
   [Langeveld, J. W. A.] Biomass Res, NL-6700 AA Wageningen, Netherlands.
   [Sanders, J. P. M.] Wageningen UR, NL-6700 AA Wageningen, Netherlands.
RP Elbersen, BS (reprint author), Alterra Wageningen UR, POB 47, NL-6700 AA Wageningen, Netherlands.
EM berien.elbersen@wur.nl; bert.annevelink@wur.nl;
   janpeter.lesschen@wur.nl; igor.Staritsky@wur.nl;
   hans@biomassresearch.eu; wolter.elbersen@wur.nl; johan.sanders@wur.nl
FU research programme BSIK, the Ministry of Economic Affairs
   [KB-13-005-009]; Shell
FX This paper is based on the results of the ME4 project. We thank all
   partners for their contribution to the project results, of which the
   integrated framework including a computerised tool are presented in this
   paper. We also thank the research programme BSIK, the Ministry of
   Economic Affairs (KB-13-005-009) and Shell for funding the research. The
   presented framework in this paper will be further elaborated in an
   EU-project S2BIOM (http://www.s2biom.eu/) that started in September 2013
   and will run for 3 years. In this project, the framework functionalities
   will be improved, new technologies included and it will be tested for
   several EU regions. A further integration with the BeWhere model (IIASA,
   see Table 1) is to be made.
CR [Anonymous], 2012, BIOMASS FUTURES PROJ
   Brentrup F, 2009, IFA P, V639
   Brouwer F, 2002, OPBRENGSTDERVINGSPER, P38
   CBS/LEI, 2007, OOGSTRAMINGSDATA
   Cuppen E, 2010, THESIS, P89
   de Jong E, 2012, BIO BAS CHEM VAL ADD
   De Wolf M, 2006, 354 PPO
   EC, 2011, COM2011571
   EEA, 2013, 62013 EEA
   Eggleston HS, 2006, IGES HAY JAP
   Eickhout B, 2007, LAND USE POLICY, V24, P562, DOI 10.1016/j.landusepol.2006.01.004
   Eurobserv'er, 2011, SOL BIOM BAR
   Fraters B., 2007, 6807160022007 RIVM
   Houtsma J, 2008, COMMUNICATION
   Intergovernmental Panel on Climate Change - IPCC, 2000, IPCC SPEC REP EM SCE
   Kalf R, 2011, MANUAL DEALING NON T
   Koomen E, 2002, E0214 IVM
   Langeveld JWA, 2010, BIOFUEL BIOPROD BIOR, V4, P484, DOI 10.1002/bbb.240
   Langeveld JWA, 2010, 18 EUR BIOM C EXH LY, P2358
   Lensink S, 2009, BIOMASS BIOENERG, V34, P218
   Lesschen JP, 2009, 1891 ALT
   Pedroli B, 2012, IMPACTS RENEWABLE EN
   Van Bakel P., 2007, 200713 STOWA
   van der Hilst F, 2012, RENEW SUST ENERG REV, V16, P2053, DOI 10.1016/j.rser.2012.01.027
   van der Hilst F, 2010, AGR SYST, V103, P403, DOI 10.1016/j.agsy.2010.03.010
   Verboom J, 2007, ECOL ECON, V62, P267, DOI 10.1016/j.ecolecon.2006.04.009
NR 26
TC 2
Z9 2
U1 0
U2 8
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-3798
EI 1436-378X
J9 REG ENVIRON CHANGE
JI Reg. Envir. Chang.
PD JUN
PY 2014
VL 14
IS 3
SI SI
BP 967
EP 980
DI 10.1007/s10113-014-0584-1
PG 14
WC Environmental Sciences; Environmental Studies
SC Environmental Sciences & Ecology
GA AH3OX
UT WOS:000336035100010
DA 2018-10-20
ER

PT J
AU Shaheen, T
   Edirisinghe, T
   Gabriel, M
   Bourdoumis, A
   Buchholz, N
   Knight, M
AF Shaheen, Tabassum
   Edirisinghe, Thiaga
   Gabriel, Melissa
   Bourdoumis, Andreas
   Buchholz, Noor
   Knight, Martin
TI In vitro encrustation of a semi-permanent polymer-covered nitinol ureter
   stent: an artificial urine model
SO UROLITHIASIS
LA English
DT Article
DE Ureter; Stent; Nitinol; Polymer; Encrustation; Artificial urine; Allium
   stent
ID BIOMATERIAL ENCRUSTATION
AB To measure and compare the percentage of surface and luminal thickness of encrustation in Allium and conventional double J ureteric stents after exposure for 6 weeks to an accelerated encrustation model.
   An artificial urine solution was prepared and three stents were immersed into each of six containers allocated to each stent type, representing each week of encrustation. Slight agitation was accomplished by placing a magnetic stirrer at the bottom of each container. Images were obtained by examination under a stereomicroscope and analyzed with the aid of specialized image analysis software (Image J).
   By week 2, nearly 100 % of the stent surface was covered by a thin layer of encrustation, gradually increasing in thickness through weeks 3-6. On completion of 6 weeks of encrustation, the 10 mm length double J stent specimens did not show visible encrustation, while the 60 mm long Allium stents showed 100 % surface coverage. This was most evident in the mid-section of the stents compared to the ends, suggesting a correlation between stent length and encrustation formation. There was also no blockage of the lumen of either stents between weeks 1-6.
   The designed accelerated encrustation model was successful and showed 80 % surface coverage after 6 weeks. In our study, there appears to be a slightly reduced level of surface encrustation to that of earlier reports. A correlation between stent length and geometry was suggested. This model may be used to compare encrustation for a variety of polymeric stent materials.
C1 [Shaheen, Tabassum; Bourdoumis, Andreas; Buchholz, Noor] Bartshlth NHS Trust, Royal London Hosp, Endourol Serv, London, England.
   [Shaheen, Tabassum; Bourdoumis, Andreas; Buchholz, Noor] Bartshlth NHS Trust, Royal London Hosp, Stone Serv, London, England.
   [Edirisinghe, Thiaga; Gabriel, Melissa; Knight, Martin] Queen Mary Univ London, Sch Engn & Mat Sci, London, England.
RP Buchholz, N (reprint author), Bartshlth NHS Trust, Royal London Hosp, Endourol Serv, London, England.
EM nb@londonurologyconsultant.com
OI Knight, Martin/0000-0003-3755-1597
CR Cox A J, 1987, Eng Med, V16, P37
   COX AJ, 1987, BRIT J UROL, V59, P159, DOI 10.1111/j.1464-410X.1987.tb04810.x
   Gilmore FB, 2010, J BIOMED MATER RES, V93, P128
   Jones DS, 2006, J BIOMED MATER RES B, V76B, P1, DOI 10.1002/jbm.b.30230
   Nediko T, 2011, EUR UROL SUPPL, V10, P479
   Patel D, 2011, CURR UROL, V5, P72, DOI [10.1159/000327454, DOI 10.1159/000327454]
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 1996, BIOMATERIALS, V17, P1025, DOI 10.1016/0142-9612(96)84679-5
NR 8
TC 3
Z9 4
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 2194-7228
EI 2194-7236
J9 UROLITHIASIS
JI Urolithiasis
PD JUN
PY 2014
VL 42
IS 3
BP 203
EP 207
DI 10.1007/s00240-014-0652-5
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA AH8JG
UT WOS:000336383500003
PM 24639093
DA 2018-10-20
ER

PT J
AU Boehler, RM
   Kuo, R
   Shin, S
   Goodman, AG
   Pilecki, MA
   Leonard, JN
   Shea, LD
AF Boehler, R. M.
   Kuo, R.
   Shin, S.
   Goodman, A. G.
   Pilecki, M. A.
   Leonard, J. N.
   Shea, L. D.
TI Lentivirus Delivery of IL-10 to Promote and Sustain Macrophage
   Polarization Towards an Anti-Inflammatory Phenotype
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE macrophage; macrophage phenotype; gene delivery; lentivirus; IL-10;
   transduction efficiency
ID SPINAL-CORD-INJURY; KAPPA-B; IMMUNE-RESPONSES; GENE-EXPRESSION;
   INFLAMMATION; REGENERATION; ACTIVATION; REPAIR; MODULATION; RESOLUTION
AB Gene delivery from biomaterials can create an environment that promotes and guides tissue formation. However, the immune response induced upon biomaterial implantation can be detrimental to tissue regeneration. Macrophages play a central role in mediating early phases of this response, and functional polarization of macrophages towards M1 (inflammatory) or M2 (anti-inflammatory) phenotypes may bias the local immune state at the implant site. Since gene delivery from biomaterial scaffolds can confer transgene expression in macrophages in vivo, we investigated whether transduction of macrophages with an IL-10 encoding lentivirus can (1) induce macrophage polarization toward an M2 phenotype even in an pro-inflammatory environment, and (2) prevent a shift in polarization from M2 to M1 following exposure to pro-inflammatory stimuli. IL-10 lentivirus delivery to pre-polarized M1 macrophages reduced TNF- production 1.5-fold when compared to cells treated with either a control virus or a bolus delivery of recombinant IL-10 protein. IL-10 lentivirus delivery to naive macrophages reduced the amount of TNF- produced following an inflammatory challenge by 2.5-fold compared to cells treated with both the control virus and recombinant IL-10. At a mechanistic level, IL-10 lentivirus delivery mediated sustained reduction in NF-B activation and, accordingly, reduced transcription of TNF-. In sum, lentiviral delivery of IL-10 to macrophages represents a promising strategy for directing and sustaining macrophage polarization towards an M2 phenotype in order to promote local immune responses that facilitate tissue engineering. Biotechnol. Bioeng. 2014;111: 1210-1221. (c) 2014 Wiley Periodicals, Inc.
C1 [Boehler, R. M.; Kuo, R.; Shin, S.; Goodman, A. G.; Pilecki, M. A.; Leonard, J. N.; Shea, L. D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Leonard, J. N.; Shea, L. D.] Northwestern Univ, Chem Life Proc Inst CLP, Evanston, IL USA.
   [Shea, L. D.] Northwestern Univ, Inst BioNanotechnol Med IBNAM, Evanston, IL USA.
   [Shea, L. D.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Leonard, J. N.; Shea, L. D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009; Leonard, Joshua/B-7649-2009
OI Leonard, Joshua/0000-0003-4359-6126
FU National Institutes of Biomedical Imaging and Bioengineering (NIBIB) at
   the National Institutes of Health (NIH) [R01EB005678, R01EB009910,
   R01CA173745, R01GM097220]
FX Contract grant sponsor: National Institutes of Biomedical Imaging and
   Bioengineering (NIBIB) at the National Institutes of Health (NIH); Grant
   numbers: R01EB005678; R01EB009910; R01CA173745; R01GM097220
CR Ahn KS, 2005, ANN NY ACAD SCI, V1056, P218, DOI 10.1196/annals.1352.026
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322
   Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005
   Bode JG, 2012, CELL SIGNAL, V24, P1185, DOI 10.1016/j.cellsig.2012.01.018
   Boehler RM, 2013, BIOMATERIALS, V34, P5431, DOI 10.1016/j.biomaterials.2013.04.009
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Breckpot K, 2010, J VIROL, V84, P5627, DOI 10.1128/JVI.00014-10
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Chuang Y, RESOLUTION INC UNPUB
   Croyle MA, 2001, J VIROL, V75, P4792, DOI 10.1128/JVI.75.10.4792-4801.2001
   Dokka S, 2001, AM J PHYSIOL-LUNG C, V280, pL1196
   Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009
   Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240
   Erwig LP, 1998, J IMMUNOL, V161, P1983
   FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
   Gower RM, 2014, BIOMATERIALS, V35, P2024, DOI 10.1016/j.biomaterials.2013.11.036
   Herbert DR, 2010, J IMMUNOL, V184, P6438, DOI 10.4049/jimmunol.0902009
   Herrero C, 2003, J IMMUNOL, V171, P5034, DOI 10.4049/jimmunol.171.10.5034
   Higashikawa F, 2001, VIROLOGY, V280, P124, DOI 10.1006/viro.2000.0743
   Hyde SC, 2008, NAT BIOTECHNOL, V26, P549, DOI 10.1038/nbt1399
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Jones TB, 2002, J NEUROSCI, V22, P2690, DOI 10.1523/JNEUROSCI.22-07-02690.2002
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kim S, 2013, MOL MED, V19, P88, DOI 10.2119/molmed.2012.00306
   Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6
   Laliberte AM, 2013, EXP NEUROL, V247, P282, DOI 10.1016/j.expneurol.2013.01.008
   Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088
   Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371
   Popovich PG, 2003, TRENDS PHARMACOL SCI, V24, P13, DOI 10.1016/S0165-6147(02)00006-8
   Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x
   Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106
   Pruss H, 2011, BRAIN PATHOL, V21, P652, DOI 10.1111/j.1750-3639.2011.00488.x
   Shames BD, 1998, SHOCK, V10, P389, DOI 10.1097/00024382-199812000-00002
   Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113
   Shin S, 2010, MOL THER, V18, P700, DOI 10.1038/mt.2009.300
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   Weiss MS, 2012, BIOMATERIALS, V33, P3548, DOI 10.1016/j.biomaterials.2012.01.055
   Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144
   Zhang Xia, 2009, V531, P123, DOI 10.1007/978-1-59745-396-7_9
NR 49
TC 39
Z9 41
U1 5
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUN
PY 2014
VL 111
IS 6
BP 1210
EP 1221
DI 10.1002/bit.25175
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AG1DC
UT WOS:000335154300017
PM 24375008
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Feng, YQ
   Borrelli, M
   Reichl, S
   Schrader, S
   Geerling, G
AF Feng, Yaqing
   Borrelli, Maria
   Reichl, Stephan
   Schrader, Stefan
   Geerling, Gerd
TI Review of Alternative Carrier Materials for Ocular Surface
   Reconstruction
SO CURRENT EYE RESEARCH
LA English
DT Review
DE Amniotic membrane; biomaterial; ocular surface; reconstruction; tissue
   engineering
ID RECOMBINANT HUMAN COLLAGEN; ANTERIOR LENS CAPSULE; STEM-CELL DEFICIENCY;
   CORNEAL EPITHELIAL-CELLS; HUMAN AMNIOTIC MEMBRANE; CARBOXYMETHYLATED
   FEATHER KERATINS; INTERPENETRATING POLYMER NETWORKS; SILK FIBROIN
   MEMBRANES; EX-VIVO EXPANSION; THERMAL EYE BURNS
AB Severe ocular surface disorders can result in deficiency of limbal stem cells that is potentially associated with chronic inflammation, impaired vision and even blindness. Advanced stem cells deficiency requires reconstruction of the OS with autologous or allogeneic limbal stem cells. To address such deficiency, a limbal tissue biopsy is taken and limbal cells are expanded on a carrier, which then can be used for OS reconstruction. Human amniotic membrane - currently the most common carrier for transplantation of limbal epithelial stem cells - has the downsides of carrying the risk of disease transmission, limited transparency, variable and unstable quality and low mechanical strength. This article reviews the advantages and disadvantages of the established carrier materials for limbal stem cell transplantation, as well as discussing emerging alternatives, including carriers based on collagen, fibrin, siloxane hydrogel contact lenses, poly(epsilon-caprolactone), gelatin-chitosan, silk fibroin, human anterior lens capsule, keratin, poly(lactide-co-glycolide), polymethacrylate, hydroxyethylmethacrylate and poly(ethylene glycol) for their potential use in the treatment of limbal stem cell deficiency.
C1 [Feng, Yaqing; Borrelli, Maria; Schrader, Stefan; Geerling, Gerd] Univ Dusseldorf, Dept Ophthalmol, D-40225 Dusseldorf, Germany.
   [Reichl, Stephan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Technol, D-38106 Braunschweig, Germany.
RP Geerling, G (reprint author), Univ Dusseldorf, Dept Ophthalmol, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM geerling@med.uni-duesseldorf.de
CR Ang LPK, 2006, INVEST OPHTH VIS SCI, V47, P105, DOI 10.1167/iovs.05-0512
   Baharvand H, 2007, MOL VIS, V13, P1711
   Balasubramanian S, 2008, INDIAN J MED RES, V128, P616
   Basu S, 2012, AM J OPHTHALMOL, V153, P643, DOI 10.1016/j.ajo.2011.09.016
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Borrelli M, 2013, J MATER SCI-MATER M, V24, P221, DOI 10.1007/s10856-012-4774-4
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   CHEN JJY, 1991, INVEST OPHTH VIS SCI, V32, P2219
   Cheng YH, 2010, TISSUE ENG PT A, V16, P695, DOI 10.1089/ten.TEA.2009.0229
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI 10.1089/tea.2007.0224
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022
   Danysh BP, 2008, ANAT REC, V291, P1619, DOI 10.1002/ar.20753
   Daya SM, 2000, CORNEA, V19, P443, DOI 10.1097/00003226-200007000-00007
   Deshpande P, 2010, REGEN MED, V5, P395, DOI [10.2217/rme.10.16, 10.2217/RME.10.16]
   Di Girolamo N, 2007, BRIT J OPHTHALMOL, V91, P459, DOI 10.1136/bjo.2006.103895
   Di Girolamo N, 2009, TRANSPLANTATION, V87, P1571, DOI 10.1097/TP.0b013e3181a4bbf2
   Dravida S, 2008, J TISSUE ENG REGEN M, V2, P263, DOI 10.1002/term.91
   DUA HS, 1990, AM J OPHTHALMOL, V110, P646, DOI 10.1016/S0002-9394(14)77062-X
   Dua HS, 2000, BRIT J OPHTHALMOL, V84, P273, DOI 10.1136/bjo.84.3.273
   Duchesne B, 2001, CORNEA, V20, P230, DOI 10.1097/00003226-200103000-00027
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Rendal-Vazquez ME, 2012, CELL TISSUE BANK, V13, P513, DOI 10.1007/s10561-012-9300-x
   Fagerholm P., 2010, SCI TRANSL MED, V2, P46
   Fagerholm P, 2009, CTS-CLIN TRANSL SCI, V2, P162, DOI 10.1111/j.1752-8062.2008.00083.x
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   FRIEND J, 1982, INVEST OPHTH VIS SCI, V23, P41
   Fujii T, 2008, J MATER SCI-MATER M, V19, P2335, DOI 10.1007/s10856-007-3341-x
   Galal A, 2007, CORNEA, V26, P473, DOI 10.1097/ICO.0b013e318033bd0f
   GEGGEL HS, 1985, INVEST OPHTH VIS SCI, V26, P901
   Han B, 2002, CORNEA, V21, P505, DOI 10.1097/01.ICO.0000016343.19018.1D
   Hartmann L, 2011, J BIOMED MATER RES B, V98B, P8, DOI 10.1002/jbm.b.31806
   HE YG, 1991, CURR EYE RES, V10, P851, DOI 10.3109/02713689109013881
   Higa K, 2008, CORNEA, V27, P41
   Higa K., 2010, J BIOMATER SCI POLYM
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Holland E J, 1996, Trans Am Ophthalmol Soc, V94, P677
   Hutmacher DW, 2005, GENE, V347, P1, DOI 10.1016/j.gene.2004.12.040
   Ijiri S, 2007, AM J OPHTHALMOL, V144, P938, DOI 10.1016/j.ajo.2007.08.003
   KENYON KR, 1989, OPHTHALMOLOGY, V96, P709
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kim TI, 2003, INVEST OPHTH VIS SCI, V44, P1912, DOI 10.1167/iovs.02-0977
   Kinoshita S, 2004, EXP EYE RES, V78, P483, DOI 10.1016/j.exer.2003.09.004
   Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506
   Koizumi N, 2000, CORNEA, V19, P65, DOI 10.1097/00003226-200001000-00013
   Kozak I, 2003, CORNEA, V22, P359, DOI 10.1097/00003226-200305000-00015
   Krag S, 1997, INVEST OPHTH VIS SCI, V38, P357
   Kratz G, 1997, SCAND J PLAST RECONS, V31, P119, DOI 10.3109/02844319709085478
   Kruse F E, 2008, Dev Ophthalmol, V41, P159, DOI 10.1159/000131087
   Kuckelkorn R, 2001, KLIN MONATSBL AUGENH, V218, P542, DOI 10.1055/s-2001-17136
   Kuckelkorn R, 1996, ACTA OPHTHALMOL SCAN, V74, P442
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Lagali N, 2008, INVEST OPHTH VIS SCI, V49, P3895, DOI 10.1167/iovs.07-1354
   LAGOUTTE FM, 1989, BRIT J OPHTHALMOL, V73, P757, DOI 10.1136/bjo.73.9.757
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lee KH, 2007, INT J BIOL MACROMOL, V41, P168, DOI 10.1016/j.ijbiomac.2007.01.011
   Levis HJ, 2010, BIOMATERIALS, V31, P7726, DOI 10.1016/j.biomaterials.2010.07.012
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Liu Y, 2006, BIOMACROMOLECULES, V7, P1819, DOI 10.1021/bm060160o
   Ma AH, 2011, J MATER SCI-MATER M, V22, P663, DOI 10.1007/s10856-011-4244-4
   McIntosh Ambrose W, 2009, J BIOMED MATER RES B, V90, P818
   Meller D, 1999, INVEST OPHTH VIS SCI, V40, P878
   Merrett K, 2012, COLLAGEN TYPE 1 PROM, P1
   Merrett K, 2008, INVEST OPHTH VIS SCI, V49, P3887, DOI 10.1167/iovs.07-1348
   Mi SL, 2010, J BIOMED MATER RES A, V95A, P447, DOI 10.1002/jbm.a.32861
   Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195
   Nakamura T, 2003, CORNEA, V22, P70, DOI 10.1097/00003226-200301000-00017
   Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497
   Nakamura T, 2004, ACTA OPHTHALMOL SCAN, V82, P468, DOI 10.1111/j.1600-0420.2004.00285.x
   Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Oelker AM, 2012, IEEE T NANOBIOSCI, V11, P37, DOI 10.1109/TNB.2011.2166978
   Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   Reichl S, 2011, BIOMATERIALS, V32, P3375, DOI 10.1016/j.biomaterials.2011.01.052
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Rimmer S, 2007, BIOMATERIALS, V28, P5319, DOI 10.1016/j.biomaterials.2007.08.028
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Schrooyen PMM, 2000, J AGR FOOD CHEM, V48, P4326, DOI 10.1021/jf9913155
   Schrooyen PMM, 2001, J AGR FOOD CHEM, V49, P221, DOI 10.1021/jf0004154
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Shangkai C, 2007, TISSUE ENG, V13, P483, DOI 10.0189/ten.2006.0181
   SHAPIRO MS, 1981, INVEST OPHTH VIS SCI, V21, P135
   Sharma S, 2011, MOL VIS, V17, P2898
   Shimmura S, 2003, CORNEA, V22, P81
   SHORE JW, 1992, OPHTHALMOLOGY, V99, P383
   Shortt AJ, 2008, OPHTHALMOLOGY, V115, P1989, DOI 10.1016/j.ophtha.2008.04.039
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Solomon A, 2003, OPHTHALMOLOGY, V110, P93, DOI 10.1016/S0161-6420(02)01441-0
   Song E, 2005, CHINESE MED J-PEKING, V118, P927
   Srinivasan B, 2010, J BIOMED MATER RES B, V92B, P5, DOI 10.1002/jbm.b.31483
   Sugahara T, 2006, BIOSCI BIOTECH BIOCH, V70, P2131, DOI 10.1271/bbb.60076
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   TAKEZAWA T, 1992, J CELL SCI, V101, P495
   TAKEZAWA T, 1990, BIO-TECHNOL, V8, P854, DOI 10.1038/nbt0990-854
   Talbot M, 2006, MOL VIS, V12, P65
   Tan XW, 2013, J MATER SCI-MATER M, V24, P967, DOI 10.1007/s10856-012-4848-3
   Tanioka H, 2006, INVEST OPHTH VIS SCI, V47, P3820, DOI 10.1167/iovs.06-0293
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   TSAI RJF, 1994, CORNEA, V13, P389, DOI 10.1097/00003226-199409000-00003
   Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431
   VASTINE DW, 1982, OPHTHALMOLOGY, V89, P1072
   Verma V., 2008, BIOMED MATER, V3, P1
   Wan PX, 2011, INVEST OPHTH VIS SCI, V52, P724, DOI 10.1167/iovs.10-5291
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Zhu X, 2005, J BIOMED MATER RES A, V73A, P264, DOI 10.1002/jbm.a.30211
   Zhu X, 2006, ANN ACAD MED SINGAP, V35, P210
NR 113
TC 29
Z9 30
U1 3
U2 43
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0271-3683
EI 1460-2202
J9 CURR EYE RES
JI Curr. Eye Res.
PD JUN
PY 2014
VL 39
IS 6
BP 541
EP 552
DI 10.3109/02713683.2013.853803
PG 12
WC Ophthalmology
SC Ophthalmology
GA AH2AQ
UT WOS:000335923500001
PM 24405104
DA 2018-10-20
ER

PT J
AU Ruttermann, S
   Beikler, T
   Janda, R
AF Ruettermann, Stefan
   Beikler, Thomas
   Janda, Ralf
TI Contact angle and surface free energy of experimental resin-based dental
   restorative materials after chewing simulation
SO DENTAL MATERIALS
LA English
DT Article
DE Dental resin composite; Chewing simulation; Contact angle; Surface free
   energy
ID STREPTOCOCCUS-MUTANS ADHESION; BACTERIAL ADHESION; BIOFILM FORMATION;
   BIOMATERIAL SURFACES; ORAL STREPTOCOCCI; PLAQUE-FORMATION; IN-SITU;
   COMPOSITES; ROUGHNESS; ENAMEL
AB Objective. To investigate contact angle and surface free energy of experimental dental resin composites containing novel delivery systems of polymeric hollow beads and low-surface tension agents after chewing simulation test.
   Methods. A delivery system of novel polymeric hollow beads differently loaded with two low-surface tension agents was used in different amounts to modify commonly formulated experimental dental resin composites. The non-modified resin was used as standard. Surface roughness R-a, contact angle Theta, total surface free energy gamma S, its apolar gamma(LW)(S), polar gamma(AB)(S), Lewis acid gamma(+)(S) Sand base gamma(-)(S) terms were determined and the results prior to and after chewing simulation test were compared. Significance was p < 0.05.
   Results. After chewing simulation R-a increased, Theta decreased, R-a increased for two test materials and gamma(S) decreased or remained constant for the standard or the test materials after chewing simulation. R-a of one test material was higher than of the standard, Theta and gamma(S) of the test materials remained lower than of the standard and, indicating their highly hydrophobic character (Theta approximate to 60-75 degrees, gamma(S) approximate to 30 mJ m(-2)). gamma(LW)(S), and gamma(-)(S) of the test materials were lower than of the standard. Some of the test materials had lower gamma(SAB) and gamma(vertical bar)(S) than of the standard.
   Significance. Delivery systems based on novel polymeric hollow beads highly loaded with low-surface tension agents were found to significantly increase contact angle and thus to reduce surface free energy of experimental dental resin composites prior to and after chewing simulation test. (C) 2014 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Ruettermann, Stefan; Beikler, Thomas; Janda, Ralf] Univ Dusseldorf, Fac Med, Ctr Dent, Dept Operat & Prevent Dent & Endodont, D-40225 Dusseldorf, Germany.
RP Janda, R (reprint author), Univ Dusseldorf, Fac Med, Ctr Dent, Dept Operat & Prevent Dent & Endodont, Moorenstr 5,Geb 18-13, D-40225 Dusseldorf, Germany.
EM Ralf.Janda@uni-duesseldorf.de
FU DFG Deutsche Forschungsgemeinschaft, Bonn, Germany [RU 825/3-1]
FX This study was supported by the DFG Deutsche Forschungsgemeinschaft,
   Bonn, Germany (Project No. RU 825/3-1).
CR Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203
   Buergers R, 2007, J PROSTHET DENT, V98, P461, DOI 10.1016/S0022-3913(07)60146-2
   Buergers R, 2009, DENT MATER, V25, P269, DOI 10.1016/j.dental.2008.07.011
   Carlen A, 2001, BIOMATERIALS, V22, P481, DOI 10.1016/S0142-9612(00)00204-0
   Della Volpe C, 2000, J ADHES SCI TECHNOL, V14, P235, DOI 10.1163/156856100742546
   Eick JD, 2007, DENT MATER, V23, P1011, DOI 10.1016/j.dental.2006.09.002
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Gyo M, 2008, APPL ENVIRON MICROB, V74, P1428, DOI 10.1128/AEM.02039-07
   Hahnel S, 2008, J MATER SCI-MATER M, V19, P2619, DOI 10.1007/s10856-007-3352-7
   Hahnel S, 2009, DENT MATER, V25, P969, DOI 10.1016/j.dental.2009.02.003
   Hahnel S, 2008, J DENT, V36, P977, DOI 10.1016/j.jdent.2008.08.004
   HAMADA S, 1980, MICROBIOL REV, V44, P331
   Hannig M, 2007, J NANOSCI NANOTECHNO, V7, P4642, DOI 10.1166/jnn.2007.005
   Heintze SD, 2006, DENT MATER, V22, P712, DOI 10.1016/j.dental.2006.02.002
   Knorr SD, 2005, DENT MATER, V21, P272, DOI 10.1016/j.dental.2004.06.002
   Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381
   Krejci I, 1990, Schweiz Monatsschr Zahnmed, V100, P1285
   Lee SP, 2009, ANGLE ORTHOD, V79, P353, DOI 10.2319/021308-88.1
   MCBRIDE BC, 1984, INFECT IMMUN, V44, P68
   Mei L, 2009, EUR J ORAL SCI, V117, P419, DOI 10.1111/j.1600-0722.2009.00648.x
   Milleding P, 1999, EUR J ORAL SCI, V107, P384, DOI 10.1046/j.0909-8836.1999.eos107510.x
   Morgan TD, 2001, J APPL MICROBIOL, V91, P47, DOI 10.1046/j.1365-2672.2001.01338.x
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   QUIRYNEN M, 1989, J DENT RES, V68, P796, DOI 10.1177/00220345890680050801
   QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x
   ROSENBERG M, 1983, INFECT IMMUN, V42, P831
   Ruettermann S, 2012, ARCH ORAL BIOL, V57, P1512
   Ruettermann S, 2011, ACTA BIOMATER, V7, P1160
   Rupp F, 2002, J BIOMED MATER RES, V62, P567, DOI 10.1002/jbm.10198
   RUSSELL MW, 1989, ORAL MICROBIOL IMMUN, V4, P106, DOI 10.1111/j.1399-302X.1989.tb00107.x
   SAKAGUCHI RL, 1986, DENT MATER, V2, P235, DOI 10.1016/S0109-5641(86)80034-3
   Sipahi C, 2001, J DENT, V29, P197, DOI 10.1016/S0300-5712(01)00011-2
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   WEERKAMP AH, 1988, J DENT RES, V67, P1483, DOI 10.1177/00220345880670120801
   Weinmann W, 2005, DENT MATER, V21, P68, DOI 10.1016/j.dental.2004.10.007
   WESTERGREN G, 1983, INFECT IMMUN, V40, P432
   Yamanaka-Okada Ayumi, 2008, Bull Tokyo Dent Coll, V49, P107
NR 38
TC 7
Z9 7
U1 1
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD JUN
PY 2014
VL 30
IS 6
BP 702
EP 707
DI 10.1016/j.dental.2014.03.009
PG 6
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA AH2AY
UT WOS:000335924300014
PM 24768134
DA 2018-10-20
ER

PT J
AU Xu, Z
   Liang, GB
   Jin, L
   Wang, ZL
   Xing, C
   Jiang, Q
   Zhang, ZG
AF Xu, Zhewu
   Liang, Guobin
   Jin, Lin
   Wang, Zhenling
   Xing, Chao
   Jiang, Qing
   Zhang, Zhiguang
TI Synthesis of sodium caseinate-calcium carbonate microspheres and their
   mineralization to bone-like apatite
SO JOURNAL OF CRYSTAL GROWTH
LA English
DT Article
DE Biomaterials; Crystal morphology; Surfaces; Growth from solutions;
   Biological macromolecules; Calcium compounds
ID DRUG-DELIVERY; MITOCHONDRIAL RESPIRATION; TITANIUM; CACO3;
   HYDROXYAPATITE; NEUROTOXICITY; INHIBITION; COATINGS; SYSTEM
AB Phosphoproteins can induce and stabilize calcium carbonate (CaCO3) vaterite, which has desirable features for high reactivity. The purpose of this study was to synthesize bioactive CaCO3 microspheres for bone regeneration. Sodium caseinate (NaCas)-containing CaCO3 microspheres, with the crystal phase of vaterite, were synthesized by fast precipitation in an aqueous solution of CaCl2, Na2CO3, and 2 mg/mL of NaCas. The uniform microspheres exhibited rougher surfaces and lower negative charges than CaCO3 particles without NaCas addition. Fourier-transform infrared spectroscopy (FT-IR) of the microspheres showed characteristic peaks or bands corresponding to phosphate and hydroxyl groups. Thermogravimetric analysis (TGA) curves exhibited approximately 5% weight loss below 600 degrees C due to the decomposition of NaCas. Scanning electron microscope (SEM) images showed lath-like hydroxyapatite (HAp) on the surface after soaking in simulated body fluid (SEE) at 37 degrees C for 5 and 10 days. Energy dispersive X-ray spectrometry (EDS) revealed that the agglomerates were composed of Ca, C, O, P, Na, and Mg elements, and the Ca/P ratios ranged from 1.53 to 1.56. X-ray diffraction (XRD) patterns exhibited peaks characteristic of hydroxyapatite. The results of this study demonstrated that the addition of NaCas induced the formation of vaterite microspheres which possesses an enhanced apatite formation after soaking in SBF at 37 degrees C for 5 and 10 clays. These NaCas-CaCO3 microspheres may be a potential biomaterial for bone regeneration. (C) 2014 Elsevier B.V. All rights reserved
C1 [Xu, Zhewu; Xing, Chao; Zhang, Zhiguang] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Dept Oral & Maxillofacial Surg, Guangzhou 510055, Guangdong, Peoples R China.
   [Liang, Guobin] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Dept Prosthodont, Guangzhou 510055, Guangdong, Peoples R China.
   [Xu, Zhewu; Liang, Guobin; Xing, Chao; Zhang, Zhiguang] Guangdong Prov Key Lab Stomatol, Guangzhou 515073, Guangdong, Peoples R China.
   [Jin, Lin; Wang, Zhenling] Zhou Normal Univ, Key Lab Rare Earth Funct Mat & Applicat, Zhoukou 466001, Peoples R China.
   [Jiang, Qing] Sun Yat Sen Univ, Guangdong Prov Key Lab Sensor Technol & Biomed In, Sch Engn, Dept Biomed Engn, Guangzhou 510006, Guangdong, Peoples R China.
RP Zhang, ZG (reprint author), Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Dept Oral & Maxillofacial Surg, Guangzhou 510055, Guangdong, Peoples R China.
EM drzhangzg@163.com
FU National Natural Science Foundation of China [81271115]; Key Clinical
   Program of Ministiy of Health China [(2010)439]
FX The authors thank the National Natural Science Foundation of China for
   their support (No. 81271115) and the Key Clinical Program of Ministiy of
   Health China [(2010)439].
CR BENSHACHAR D, 1995, J NEUROCHEM, V64, P718
   BERROCAL R, 1989, J DAIRY RES, V56, P335, DOI 10.1017/S0022029900028776
   Beuvier B.C. T, 2011, J MATER CHEM, V6, P9757
   Bigi A, 2005, BIOMATERIALS, V26, P4085, DOI 10.1016/j.biomaterials.2004.10.034
   Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023
   Cedric Verwilghena M.C., 2009, MAT SCI ENG C, V29, P771
   Dalgleish D.G., 1997, STRUCTURE FUNCTION R, P199
   Donida BM, 2009, PEPTIDES, V30, P2233, DOI 10.1016/j.peptides.2009.08.003
   Elzoghby AO, 2011, J CONTROL RELEASE, V153, P206, DOI 10.1016/j.jconrel.2011.02.010
   Etzion Y, 2004, J DAIRY SCI, V87, P2779, DOI 10.3168/jds.S0022-0302(04)73405-0
   Green D, 2004, J MATER CHEM, V14, P2206, DOI 10.1039/b400486h
   HALLORAN BA, 1995, COMP BIOCHEM PHYS B, V111, P221, DOI 10.1016/0305-0491(94)00245-P
   He CL, 2014, ACTA BIOMATER, V10, P419, DOI 10.1016/j.actbio.2013.08.041
   Holt C, 1998, J DAIRY SCI, V81, P2994, DOI 10.3168/jds.S0022-0302(98)75863-1
   Horne D. S., 2006, Current Opinion in Colloid and Interface Science, V11, P148, DOI 10.1016/j.cocis.2005.11.004
   Hsiang SW, 2011, J R SOC INTERFACE, V8, P1622, DOI 10.1098/rsif.2011.0009
   Kim S, 2010, BIOMATERIALS, V31, P6628, DOI 10.1016/j.biomaterials.2010.05.004
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Liu Y, 2012, LANGMUIR, V28, P6097, DOI 10.1021/la300320r
   Livney YD, 2010, CURR OPIN COLLOID IN, V15, P73, DOI 10.1016/j.cocis.2009.11.002
   Loste R.M.W. E, 2003, J CRYST GROWTH, V254, P206
   Ma J, 2003, NANOTECHNOLOGY, V14, P619, DOI 10.1088/0957-4484/14/6/310
   Manoli E.D. F, 2001, J CRYST GROWTH, V222, P293
   McMahon D. J., 2013, PROTEINS BASIC ASP A, P185
   Niel L., 1982, GEOCHIM COSMOCHIM AC, V46, P1011
   Nikos Spanos P.G.K., 1998, J CRYST GROWTH, V191, P783
   Rodriguez-Blanco JD, 2011, NANOSCALE, V3, P265, DOI 10.1039/c0nr00589d
   SAPORITO MS, 1992, J PHARMACOL EXP THER, V260, P1400
   Sato M, 2008, J BIOMED MATER RES A, V84A, P265, DOI 10.1002/jbm.a.31469
   Silva GA, 2003, J MATER SCI-MATER M, V14, P1055, DOI 10.1023/B:JMSM.0000004002.11278.30
   Sommerdijk NAJM, 2008, CHEM REV, V108, P4499, DOI 10.1021/cr078259o
   Svenskaya Y, 2013, BIOPHYS CHEM, V182, P11, DOI 10.1016/j.bpc.2013.07.006
   Tong H, 2004, BIOMATERIALS, V25, P3923, DOI 10.1016/j.biomaterials.2003.10.038
   Wang CY, 2006, INT J PHARM, V308, P160, DOI 10.1016/j.ijpharm.2005.11.004
   Zhang Y.X. Z, 2012, J CRYST GROWTH, V343, P62
NR 35
TC 8
Z9 8
U1 2
U2 78
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0248
EI 1873-5002
J9 J CRYST GROWTH
JI J. Cryst. Growth
PD JUN 1
PY 2014
VL 395
BP 116
EP 122
DI 10.1016/j.jcrysgro.2014.03.023
PG 7
WC Crystallography; Materials Science, Multidisciplinary; Physics, Applied
SC Crystallography; Materials Science; Physics
GA AH1UF
UT WOS:000335906000020
DA 2018-10-20
ER

PT J
AU Liu, HJ
   Wise, SG
   Rnjak-Kovacina, J
   Kaplan, DL
   Bilek, MMM
   Weiss, AS
   Fei, J
   Bao, SS
AF Liu, Hongjuan
   Wise, Steven G.
   Rnjak-Kovacina, Jelena
   Kaplan, David L.
   Bilek, Marcela M. M.
   Weiss, Anthony S.
   Fei, Jian
   Bao, Shisan
TI Biocompatibility of silk-tropoelastin protein polymers
SO BIOMATERIALS
LA English
DT Article
DE Silk; Tropoelastin; Subcutaneous implant; IL-1 beta; Inflammation
ID FOREIGN-BODY REACTION; SURFACE-CHEMISTRY; INTERLEUKIN-1 GENERATION;
   MACROPHAGE ACTIVATION; ADHERENT MACROPHAGES; INTEGRIN BINDING; IN-VIVO;
   BIOMATERIALS; RESPONSES; ELASTIN
AB Blended polymers are used extensively in many critical medical conditions as components of permanently implanted devices. Hybrid protein polymers containing recombinant human tropoelastin and silk fibroin have favorable characteristics as implantable scaffolds in terms of mechanical and biological properties. A firefly luciferase transgenic mouse model was used to monitor real-time IL-1 beta production localized to the site of biomaterial implantation, to observe the acute immune response (up to 5 days) to these materials. Significantly reduced levels of IL-1 beta were observed in silk/tropoelastin implants compared to control silk only implants at 1, 2 and 3 days post-surgery. Subsequently, mice (n = 9) were euthanized at 10 days (10D) and 3 weeks (3W) post-surgery to assess inflammatory cell infiltration and collagen deposition, using histopathology and immunohistochemistry. Compared to control silk only implants, fewer total inflammatory cells were found in silk/tropoelastin (similar to 29% at 10D and similar to 47% at 3W). Also fewer ingrowth cells (similar to 42% at 10D and similar to 63% at 3W) were observed within the silk/tropoelastin implants compared to silk only. Lower IL-6 ( similar to 52%) and MMP-2 ( similar to 84%) (pro-inflammatory) were also detected for silk/tropoelastin at 10 days. After 3 weeks implantation, reduced neovascularization (vWF similar to 43%), fewer proliferating cells (1(167 similar to 58% and PCNA similar to 41%), macrophages (F4/80 similar to 64%), lower IL-10 (similar to 47%) and MMP-9 (similar to 55%) were also observed in silk/tropoelastin materials compared to silk only. Together, these results suggest that incorporation of tropoelastin improves on the established biocompatibility of silk fibroin, uniquely measured here as a reduced foreign body inflammatory response. Crown Copyright (C) 2014 Published by Elsevier Ltd. All rights reserved.
C1 [Liu, Hongjuan; Bao, Shisan] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia.
   [Liu, Hongjuan; Bao, Shisan] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia.
   [Wise, Steven G.] Heart Res Inst, Sydney, NSW 2042, Australia.
   [Wise, Steven G.; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
   [Rnjak-Kovacina, Jelena; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Rnjak-Kovacina, Jelena] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2051, Australia.
   [Bilek, Marcela M. M.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.
   [Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
   [Liu, Hongjuan; Weiss, Anthony S.; Bao, Shisan] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.
   [Fei, Jian] Shanghai Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.
   [Fei, Jian] Res Ctr Model Organisms, Shanghai, Peoples R China.
RP Bao, SS (reprint author), Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia.
EM jfei@tongji.edu.cn; bob.bao@sydney.edu.auor
RI Wise, Steven/G-2630-2018
OI Wise, Steven/0000-0001-7964-819X; Bilek, Marcela/0000-0003-3363-2664;
   WEISS, ANTHONY/0000-0002-8106-4836
FU Lishui Municipality; National Key Project [2010CB945501, 2010CB912604];
   E-Institutes of Shanghai Municipal Education Commission [E03003];
   Australian Research Council; Australian Defense Health Foundation;
   National Health and Medical Research Council [APP1033079, APP1039072];
   National Institutes of Health [EB014283, HL107503]; University of Sydney
   Travel Fellowship
FX We acknowledge funding from Lishui Municipality (J.F. and S.B.) and
   National Key Project (2010CB945501, J.F. 2010CB912604, J.F.) and the
   E-Institutes of Shanghai Municipal Education Commission (E03003 J.F.)
   and the Australian Research Council (M.M.M.B and A.S.W.), Australian
   Defense Health Foundation (A.S.W.), National Health and Medical Research
   Council (APP1033079 and APP1039072; A.S.W. and M.M.M.B and National
   Institutes of Health (EB014283 and HL107503; A.S.W. and D.L.K). A.S.W.
   is the Scientific Founder of Elastagen Pty Ltd. The authors declare no
   conflict of interest in this work. The authors also acknowledge the
   facilities as well as scientific and technical assistance at the
   Australian Centre for Microscopy and Microanalysis. Sydney Medical
   School, The University of Sydney Travel Fellowship is also acknowledged
   (H. L).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   An FM, 2012, APOPTOSIS, V17, P702, DOI 10.1007/s10495-012-0704-7
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Bax DV, 2011, BIOMATERIALS, V32, P5100, DOI 10.1016/j.biomaterials.2011.03.079
   Bird S, 2002, CYTOKINE GROWTH F R, V13, P483, DOI 10.1016/S1359-6101(02)00028-X
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   COGSWELL JP, 1994, J IMMUNOL, V153, P712
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Fang BA, 2013, INT J CARDIOL, V168, P4839, DOI 10.1016/j.ijcard.2013.07.157
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Hu X, 2012, MATER TODAY, V15, P208, DOI 10.1016/S1369-7021(12)70091-3
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Hwang JJ, 2005, J BIOMAT SCI-POLYM E, V16, P237, DOI 10.1163/1568562053115480
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   John M, 2002, EXP LUNG RES, V28, P55, DOI 10.1080/019021402753355535
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   KRAUSE TJ, 1990, ARCH SURG-CHICAGO, V125, P1158
   Li LM, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-49
   Li LM, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-16
   Li MC, 2004, WORLD J GASTROENTERO, V10, P620, DOI 10.3748/wjg.v10.i5.620
   Liu Y, 2009, DIABETES CARE, V32, P117, DOI [10.2337/dc08-0763, 10.2337/dc09-1394]
   Luttikhuizen DT, 2006, BIOMATERIALS, V27, P5763, DOI 10.1016/j.biomaterials.2006.07.004
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mithieux SM, 2009, BIOMATERIALS, V30, P431, DOI 10.1016/j.biomaterials.2008.10.018
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002
   Schmidt DR, 2007, BIOMATERIALS, V28, P371, DOI 10.1016/j.biomaterials.2006.08.041
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tang LP, 1998, J BIOMAT SCI-POLYM E, V9, P1257
   Tavakoli NN, 2012, INT J MOL MED, V30, P545, DOI 10.3892/ijmm.2012.1034
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Weber B, 2011, SEMIN IMMUNOPATHOL, V33, P307, DOI 10.1007/s00281-011-0258-8
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Wise SG, 2009, ADV PROTEIN CHEM STR, V78, P1, DOI [10.1016/S1876-1623(08)78001-5, 10.1016/S1876-1623(09)78001-5]
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719
   Zambuzzi WF, 2009, J MOL HISTOL, V40, P301, DOI 10.1007/s10735-009-9241-2
NR 55
TC 26
Z9 27
U1 3
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2014
VL 35
IS 19
BP 5138
EP 5147
DI 10.1016/j.biomaterials.2014.03.024
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AG8YU
UT WOS:000335705600011
PM 24702962
DA 2018-10-20
ER

PT J
AU Treter, J
   Bonatto, F
   Krug, C
   Soares, GV
   Baumvol, IJR
   Macedo, AJ
AF Treter, Janine
   Bonatto, Fernando
   Krug, Cristiano
   Soares, Gabriel Vieira
   Rabin Baumvol, Israel Jacob
   Macedo, Alexandre Jose
TI Washing-resistant surfactant coated surface is able to inhibit
   pathogenic bacteria adhesion
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Biomedical surface; Biofilm; Pluronic F127; Staphylococcus epidermidis
ID OXIDE) TRIBLOCK COPOLYMERS; SELF-ASSEMBLED MONOLAYERS;
   STAPHYLOCOCCUS-EPIDERMIDIS; POLYMER BRUSHES; POLYSTYRENE SURFACES;
   BIOFILM FORMATION; FREE-ENERGY; INFECTIONS; HYDROPHOBICITY;
   BIOTECHNOLOGY
AB Surface-active substances, which are able to organize themselves spontaneously on surfaces, triggering changes in the nature of the solid-liquid interface, are likely to influence microorganism adhesion and biofilm formation. Therefore, this study aimed to evaluate chemical non-ionic surfactants activity against pathogenic microbial biofilms and to cover biomaterial surfaces in order to obtain an anti-infective surface. After testing 11 different surfactants, Pluronic F127 was selected for further studies due to its non-biocidal properties and capability to inhibit up to 90% of biofilm formation of Gram-positive pathogen and its clinical isolates. The coating technique using direct impregnation on the surface showed important antibiofilm formation characteristics, even after extensive washes. Surface roughness and bacterial surface polarity does not influence the adhesion of Staphylococcus epidermidis, however, the material coated surface became extremely hydrophilic. The phenotype of S. epidermidis does not seem to have been affected by the contact with surfactant, reinforcing the evidence that a physical phenomenon is responsible for the activity. This paper presents a simple method of surface coating employing a synthetic surfactant to prevent S. epidermidis biofilm formation. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Treter, Janine; Macedo, Alexandre Jose] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Biofilmes & Diversidade Microbiana, BR-91501970 Porto Alegre, RS, Brazil.
   [Treter, Janine; Macedo, Alexandre Jose] Univ Fed Rio Grande do Sul, Fac Farm, Lab Tecnol Bioquim, BR-90610000 Porto Alegre, RS, Brazil.
   [Bonatto, Fernando; Krug, Cristiano; Rabin Baumvol, Israel Jacob] Univ Fed Rio Grande do Sul, Inst Fis, BR-91509900 Porto Alegre, RS, Brazil.
   [Soares, Gabriel Vieira; Rabin Baumvol, Israel Jacob] Univ Caxias do Sul, BR-95070560 Caxias Do Sul, RS, Brazil.
RP Macedo, AJ (reprint author), Univ Fed Rio Grande do Sul, Fac Farm, Brazil Av Ipiranga 2752, BR-90610000 Porto Alegre, RS, Brazil.
EM alexandre.macedo@ufrgs.br
RI Vieira Soares, Gabriel/E-5065-2010
OI Vieira Soares, Gabriel/0000-0002-6875-0145; Bonatto,
   Fernando/0000-0003-3530-690X
FU Brazilian National Council for Research and Development (CNPq/Brazil);
   FAPERGS (Brazil); CAPES NANOBIOTEC (Brazil)
FX The authors are grateful to the Brazilian National Council for Research
   and Development (CNPq/Brazil), FAPERGS (Brazil) and CAPES NANOBIOTEC
   (Brazil) for scholarships and financial support.
CR ALEXANDRIDIS P, 1994, MACROMOLECULES, V27, P2414, DOI 10.1021/ma00087a009
   Aly NYA, 2008, MED PRIN PRACT, V17, P373, DOI 10.1159/000141500
   Antunes A.L.S., 2001, MEM I O CRUZ, V106, p51 
   Ayres N, 2010, POLYM CHEM-UK, V1, P769, DOI 10.1039/b9py00246d
   Blondel-Hill E., 2007, MANUAL CLIN MICROBIO
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Brown DG, 2006, ENVIRON SCI TECHNOL, V40, P195, DOI 10.1021/es051183y
   Bruce RL, 2010, J APPL PHYS, V107, DOI 10.1063/1.3373587
   Castro-Garza J, 2007, J MED MICROBIOL, V56, P733, DOI 10.1099/jmm.0.46915-0
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   da D., 2011, BRAZ J MICROBIOL, V42, P1329
   da D., 2011, J ETHNOPHARMACOL, V137, P327
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Everaert EPJM, 1998, COLLOID SURFACE B, V10, P179, DOI 10.1016/S0927-7765(98)00003-4
   Florence A.T., 2003, PRINCIPIOS FISICOQUI, P279
   Foka A, 2012, EUR CELLS MATER, V24, P386, DOI 10.22203/eCM.v024a28
   France RM, 1998, LANGMUIR, V14, P4827, DOI 10.1021/la9713053
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316
   Jacobs T, 2012, PLASMA CHEM PLASMA P, V32, P1039, DOI 10.1007/s11090-012-9394-8
   Karunakaran E, 2011, APPL MICROBIOL BIOT, V90, P1869, DOI 10.1007/s00253-011-3293-4
   Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306
   Li JT, 1996, BIOCONJUGATE CHEM, V7, P592, DOI 10.1021/bc960048v
   Limsuwan S, 2008, FEMS IMMUNOL MED MIC, V53, P429, DOI 10.1111/j.1574-695X.2008.00445.x
   Liou YB, 2011, J TAIWAN INST CHEM E, V42, P533, DOI 10.1016/j.jtice.2010.09.011
   Marsh LH, 2002, J BIOMED MATER RES, V61, P641, DOI 10.1002/jbm.10174
   Matl FD, 2008, ANTIMICROB AGENTS CH, V52, P1957, DOI 10.1128/AAC.01438-07
   National Institute of Health, 2002, RES MICR BIOF PA 03
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   Nejadnik MR, 2009, LANGMUIR, V25, P6245, DOI 10.1021/la9001169
   Neu TR, 1996, MICROBIOL REV, V60, P151
   Nostro A, 2004, LETT APPL MICROBIOL, V38, P423, DOI 10.1111/j.1472-765X.2004.01509.x
   Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x
   Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252
   Rendueles O, 2011, MBIO, V2, DOI 10.1128/mBio.00043-11
   Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   Roosjen A, 2006, PROG COLL POL SCI S, V132, P138, DOI 10.1007/2882_026
   Roosjen A, 2006, MICROBIOL-SGM, V152, P2673, DOI 10.1099/mic.0.29005-0
   SCHROEN CGPH, 1995, LANGMUIR, V11, P3068, DOI 10.1021/la00008a036
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   SHEU MS, 1992, J ADHES SCI TECHNOL, V6, P995, DOI 10.1163/156856192X00890
   Singh A, 2007, BIOTECHNOL ADV, V25, P99, DOI 10.1016/j.biotechadv.2006.10.004
   Souli M, 2008, EUROSURVEILLANCE, V13, P1
   Su YL, 2008, APPL SURF SCI, V254, P4606, DOI 10.1016/j.apsusc.2008.01.073
   Tang HY, 2009, J BIOMED MATER RES A, V88A, P454, DOI 10.1002/jbm.a.31788
   Tote K, 2009, INT J ANTIMICROB AG, V33, P525, DOI 10.1016/j.ijantimicag.2008.11.004
   Toutain-Kidd CM, 2009, ANTIMICROB AGENTS CH, V53, P136, DOI 10.1128/AAC.00500-08
   Treter J., 2011, SCI MICROBIAL PATHOG, P835
   Tu Q, 2013, COLLOID SURFACE B, V102, P361, DOI 10.1016/j.colsurfb.2012.08.033
   Van Hamme JD, 2006, BIOTECHNOL ADV, V24, P604, DOI 10.1016/j.biotechadv.2006.08.001
   Verza SG, 2012, PHARMAZIE, V67, P288, DOI 10.1691/ph.2012.1102
   Wenzel RP, 2007, CLIN INFECT DIS, V45, P85, DOI 10.1086/518136
NR 57
TC 7
Z9 8
U1 0
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JUN 1
PY 2014
VL 303
BP 147
EP 154
DI 10.1016/j.apsusc.2014.02.123
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA AE8ZR
UT WOS:000334293200021
OA Bronze
DA 2018-10-20
ER

PT J
AU Oryan, A
   Bigham-Sadegh, A
   Abbasi-Teshnizi, F
AF Oryan, Ahmad
   Bigham-Sadegh, Amin
   Abbasi-Teshnizi, Fatemeh
TI Effects of osteogenic medium on healing of the experimental critical
   bone defect in a rabbit model
SO BONE
LA English
DT Article
DE Osteogenic medium; Maintenance medium; Bone healing; Rabbit model
ID MESENCHYMAL STROMAL CELLS; ASCORBIC-ACID 2-PHOSPHATE;
   SMOOTH-MUSCLE-CELLS; STEM-CELLS; BIOMECHANICAL EVALUATION; MORPHOGENETIC
   PROTEIN-2; CORTICAL AUTOGRAFT; FRACTURE REPAIR; ADIPOSE-TISSUE;
   DIFFERENTIATION
AB Today, finding an ideal biomaterial to treat the large bone defects, delayed unions and non-unions remains a challenge for orthopedic surgeons and researchers. Several studies have been carried out on the subject of bone regeneration, each having its own advantages. At the same time, a variety of disadvantages still remain. The present study has been designed in vivo to evaluate the effects of osteogenic medium on healing of experimental critical bone defect in a rabbit model. Twenty New Zealand albino rabbits, 12 months old, of both sexes, weighing 2.0 +/- 0.5 kg were used in this study. An approximately 10 mm segmental defect was created in the mid portion of each radius as a critical size bone defect. In the osteogenic medium group (n = 5) 1 ml osteogenic medium, in the maintenance medium group (n = 5) 1 ml maintenance medium, and in the normal saline group (n = 5) 1 ml normal saline were injected in the defected area while the defects of the rabbits of the control group (n = 5) were left empty. Radiological evaluation was done on the 1st day and then at the 2nd, 4th, 6th and 8th weeks post injury. Biomechanical and histopathological evaluations were done 8 weeks post injury. The radiological, histological and biomechanical findings of the present study indicated a superior bone healing capability in the osteogenic and maintenance medium groups, by the end of 8 weeks post-surgery, in comparison to the normal saline and control groups. In conclusion, this study demonstrated that the osteogenic medium and maintenance medium could promote bone regeneration in long bone defects better than the control group in rabbit model. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Oryan, Ahmad; Abbasi-Teshnizi, Fatemeh] Shiraz Univ, Sch Vet Med, Dept Vet Pathol, Shiraz, Iran.
   [Bigham-Sadegh, Amin] Fac Vet Med, Shahrekord, Iran.
RP Bigham-Sadegh, A (reprint author), Shahrekord Univ, Sch Vet Med, Dept Vet Surg & Radiol, Shahrekord, Iran.
EM dr.bigham@gmail.com
RI Oryan, Ahmad/J-6539-2014
OI Oryan, Ahmad/0000-0003-1697-2376; Oryan, Ahmad/0000-0001-8804-1832
FU Veterinary School, Shiraz University
FX The authors would like to thank the authorities of the Veterinary
   School, Shiraz University for their financial support and cooperation.
CR Baltzer AWA, 2000, GENE THER, V7, P734, DOI 10.1038/sj.gt.3301166
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Bao CLM, 2013, REGENERATIVE MEDICINE AND TISSUE ENGINEERING, P599, DOI 10.5772/55916
   Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Bigham AS, 2008, J ORTHOP TRAUMATOL, V9, P73, DOI 10.1007/s10195-008-0006-6
   Bigham AS, 2009, CELL TISSUE BANK, V10, P33, DOI 10.1007/s10561-008-9107-y
   Bigham AS, 2009, COMP CLIN PATHOL, V18, P163, DOI DOI 10.1007/S00580-008-0777-4
   Bigham-Sadegh A, 2013, J VET SCI, V14, P337, DOI 10.4142/jvs.2013.14.3.337
   Bigham-Sadegh A, 2012, CONNECT TISSUE RES, V53, P334, DOI 10.3109/03008207.2012.660585
   BOLANDER ME, 1986, J BONE JOINT SURG AM, V68A, P1264, DOI 10.2106/00004623-198668080-00018
   BOSTROM MPG, 1995, J ORTHOPAED RES, V13, P357, DOI 10.1002/jor.1100130309
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   Di Bella C, 2008, TISSUE ENG PT A, V14, P483, DOI 10.1089/tea.2007.0137
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Dudas JR, 2006, ANN PLAS SURG, V56, P543, DOI 10.1097/01.sap.0000210629.17727.bd
   El-Ghannam A., 2005, BONE RECONSTRUCTION
   Furlan JC, 2007, USE OSTEOGENIC PROTE
   Garrison KR., 2007, CLIN EFFECTIVENESS C
   Garrison KR, 2010, COCHRANE DATABASE SY, V6
   Giusta MS, 2010, CYTOTHERAPY, V12, P478, DOI 10.3109/14653240903580270
   [郝葆青 Hao Baoqing], 2002, [生物医学工程学杂志, Journal of Biomedical Engineering], V19, P140
   HATA RI, 1989, J CELL PHYSIOL, V138, P8, DOI 10.1002/jcp.1041380103
   HEIPLE KG, 1987, ORTHOP CLIN N AM, V18, P179
   KANATANI M, 1995, J BONE MINER RES, V10, P1681, DOI 10.1002/jbmr.5650101110
   KIRKERHEAD CA, 1995, VET SURG, V24, P408, DOI 10.1111/j.1532-950X.1995.tb01352.x
   Kumbar SG, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/6/065005
   LANE JM, 1987, ORTHOP CLIN N AM, V18, P213
   Lee JY, 2002, HUM GENE THER, V13, P1201, DOI 10.1089/104303402320138989
   Li JF, 2011, J ORTHOP RES, V29, P1745, DOI 10.1002/jor.21439
   Li JF, 2010, MAT SCI ENG C-MATER, V30, P1272, DOI 10.1016/j.msec.2010.07.011
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   Matos Marcos A, 2008, J Orthop Surg Res, V3, P4, DOI 10.1186/1749-799X-3-4
   McAuliffe John A, 2003, J Hand Ther, V16, P180
   Mori K, 1999, ARTERIOSCL THROM VAS, V19, P2112, DOI 10.1161/01.ATV.19.9.2112
   MOW VC, 1997, BASIC ORTHOPAEDIC BI
   Ogawa R, 2004, BIOCHEM BIOPH RES CO, V313, P871, DOI 10.1016/j.bbrc.2003.12.017
   Oryan A, 2012, CELL TISSUE BANK, V13, P639, DOI 10.1007/s10561-011-9285-x
   Oryan A, 2013, HARD TISSUE, V2, P1
   Parizi AM, 2013, J ORTHOP TRAUMATOL, V14, P259, DOI 10.1007/s10195-013-0261-z
   Parizi AM, 2012, J MATER SCI-MATER M, V23, P473, DOI 10.1007/s10856-011-4478-1
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708
   Pollat O, 2007, ADV THER, V24, P154
   REDDI AH, 1995, CLIN ORTHOP RELAT R, P115
   Shafiei Z, 2009, CELL TISSUE BANK, V10, P19, DOI 10.1007/s10561-008-9105-0
   Shafiei-Sarvestani Z, 2012, INT J SURG, V10, P96, DOI 10.1016/j.ijsu.2011.12.010
   SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Stevenson S, 1998, CLIN ORTHOP RELAT R, pS239
   Sundin M, 2007, HAEMATOL-HEMATOL J, V92, P1208, DOI 10.3324/haematol.11446
   Takamizawa S, 2004, CELL BIOL INT, V28, P255, DOI 10.1016/j.cellbi.2004.01.010
   Tirkkonen L, 2012, J TISSUE ENG REGEN M, V6, P264
   TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K
   Vacanti JP, 1999, LANCET, V354, pSI32
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Wheeler DL, 1997, J BIOMED MATER RES, V35, P249, DOI 10.1002/(SICI)1097-4636(199705)35:2<249::AID-JBM12>3.0.CO;2-C
   Wozney JM, 2004, CURR OPIN BIOTECH, V15, P392, DOI 10.1016/j.copbio.2004.08.001
   Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102
   Zuk P, 2011, CONNECT TISSUE RES, V52, P119, DOI 10.3109/03008207.2010.484515
NR 60
TC 14
Z9 14
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
EI 1873-2763
J9 BONE
JI Bone
PD JUN
PY 2014
VL 63
BP 53
EP 60
DI 10.1016/j.bone.2014.02.010
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AG0GP
UT WOS:000335094200008
PM 24582803
DA 2018-10-20
ER

PT J
AU Popa, M
   Moreno, JMC
   Vasilescu, C
   Drob, SI
   Neacsu, EI
   Coer, A
   Hmeljak, J
   Zerjav, G
   Milosev, I
AF Popa, Monica
   Moreno, Jose Maria Calderon
   Vasilescu, Cora
   Drob, Silviu Iulian
   Neacsu, Elena Ionela
   Coer, Andrej
   Hmeljak, Julija
   Zerjav, Gregor
   Milosev, Ingrid
TI Structural Analysis, Electrochemical Behavior, and Biocompatibility of
   Novel Quaternary Titanium Alloy with near beta Structure
SO METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND
   MATERIALS SCIENCE
LA English
DT Article
ID CORROSION-FATIGUE STRENGTH; TI-29NB-13TA-4.6ZR ALLOY; PHYSIOLOGICAL
   SOLUTION; MECHANICAL-PROPERTIES; TI-13NB-13ZR ALLOY; CALCIUM-PHOSPHATE;
   PASSIVE FILM; RESISTANCE; SURFACE; TI
AB This article analyses the microstructure, electrochemical behavior, and biocompatibility of a novel Ti-20Nb-10Zr-5Ta alloy with low Young's modulus (59 GPa) much closer to that of bone, between 10 and 30 GPa, than Ti and other Ti alloys used as implant biomaterial. XRD and SEM measurements revealed a near beta crystalline microstructure containing beta phase matrix and secondary alpha phase, with a typical grain size of around 200 mu m. The corrosion behavior in neutral Ringer solution evidenced: self-passivation behavior characterizing a very resistant passive film; an easy passivation as a result of favorable influence of the alloying elements Nb, Zr, and Ta that participate with their passive oxides to the formation of the alloy passive film; low corrosion and ion release rates corresponding with very low toxicity. In MEM solution, the novel alloy demonstrated very high corrosion resistance and no susceptibility to localized corrosion. Biocompatibility was evaluated on in vitro human osteoblast-like and human immortalized pulmonary fibroblast cell (Wi-38) lines and the new Ti-20Nb-10Zr-5Ta alloy exhibited no cytotoxicity. The new Ti-20Nb-10Zr5Ta alloy is a promising material for implants due to combined properties of low elastic modulus, very low corrosion rate, and good biocompatibility.
C1 [Popa, Monica; Moreno, Jose Maria Calderon; Vasilescu, Cora; Drob, Silviu Iulian; Neacsu, Elena Ionela] Ilie Murgulescu Romanian Acad, Inst Phys Chem, Bucharest 060021, Romania.
   [Coer, Andrej; Hmeljak, Julija] Univ Primorska, Coll Hlth Care, Izola 6310, Slovenia.
   [Zerjav, Gregor; Milosev, Ingrid] Jozef Stefan Inst, Ljubljana 1000, Slovenia.
RP Popa, M (reprint author), Ilie Murgulescu Romanian Acad, Inst Phys Chem, Spl Independentei 202,POB 12-194, Bucharest 060021, Romania.
EM josecalderonmoreno@yahoo.com
RI Zerjav, Gregor/A-3186-2017; Calderon Moreno, Jose/B-2867-2008
OI Calderon Moreno, Jose/0000-0001-8376-9082; Vasilescu,
   Cora/0000-0002-8991-9544
FU European transnational MNT-ERA Net project-SURFUNCTI; EU (ERDF);
   Romanian Government infrastructure POS-CCE O 2.2.1 project
   INFRA-NANOCHEM [19/2009]; Ministry of Higher Education, Science and
   Technology, Republic of Slovenia
FX This work was supported by European transnational MNT-ERA Net
   project-SURFUNCTI. Also, support of the EU (ERDF) and Romanian
   Government infrastructure POS-CCE O 2.2.1 project INFRA-NANOCHEM-No.
   19/2009 is gratefully acknowledged. The financial support by the
   Ministry of Higher Education, Science and Technology, Republic of
   Slovenia is acknowledged.
CR Alves VA, 2009, CORROS SCI, V51, P2473, DOI 10.1016/j.corsci.2009.06.035
   Assis SL, 2008, MATER CORROS, V59, P739, DOI 10.1002/maco.200804148
   Atapour M, 2010, METALL MATER TRANS A, V41A, P2318, DOI 10.1007/s11661-010-0304-5
   Baker MA, 2008, SURF INTERFACE ANAL, V40, P220, DOI 10.1002/sia.2616
   Banerjee R, 2004, BIOMATERIALS, V25, P3413, DOI 10.1016/j.biomaterials.2003.10.041
   Baufeld B, 2010, METALL MATER TRANS A, V41A, P1917, DOI 10.1007/s11661-010-0255-x
   Cvijovic-Alagic I, 2011, CORROS SCI, V53, P796, DOI 10.1016/j.corsci.2010.11.014
   Ebramzadeh E, 2003, BIOMATERIALS, V24, P3351, DOI 10.1016/S0142-9612(03)00187-X
   Fukuda A, 2011, ACTA BIOMATER, V7, P1379, DOI 10.1016/j.actbio.2010.09.026
   Guo S, 2012, METALL MATER TRANS A, V43A, P3447, DOI 10.1007/s11661-012-1324-0
   Karthega M, 2007, ACTA BIOMATER, V3, P1019, DOI 10.1016/j.actbio.2007.02.009
   Kasuga T, 2003, BIOMATERIALS, V24, P283, DOI 10.1016/S0142-9612(02)00316-2
   Kirkpatrick C. J., 2005, ITBM RBM, V26, P192
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   Lee JW, 2009, J BIOMED MATER RES B, V91B, P643, DOI 10.1002/jbm.b.31440
   Li SJ, 2004, BIOMATERIALS, V25, P2525, DOI 10.1016/j.biomaterials.2003.09.039
   Liu B, 2011, ACTA BIOMATER, V7, P1407, DOI 10.1016/j.actbio.2010.11.001
   Markelc B., GENE THER, DOI [10.1038/gt2011.97, DOI 10.1038/GT2011.97]
   Milosev I, 2008, ELECTROCHIM ACTA, V53, P3547, DOI 10.1016/j.electacta.2007.12.041
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Moulder J.F., 1995, HDB XRAY PHOTOELECTR
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Palmquist A, 2009, J BIOMED MATER RES B, V91B, P309, DOI 10.1002/jbm.b.31404
   PARK JB, 1992, BIOMATERIALS INTRO
   Popa M, 2012, MET MATER INT, V18, P639, DOI 10.1007/s12540-012-4026-7
   Pound BG, 2010, J BIOMED MATER RES B, V94B, P287, DOI 10.1002/jbm.b.31647
   Robin A, 2008, MATER CORROS, V59, P929, DOI 10.1002/maco.200805014
   Saji VS, 2009, CORROS SCI, V51, P1658, DOI 10.1016/j.corsci.2009.04.013
   Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013
   Sun S, 2010, METALL MATER TRANS A, V41A, P1573, DOI 10.1007/s11661-010-0187-5
   Taddei E. B., 2010, MAT RES, V10, P289
   Taddei EB, 2005, MATER SCI FORUM, V498-499, P34, DOI 10.4028/www.scientific.net/MSF.498-499.34
   Tanaka Y, 2008, CORROS SCI, V50, P2111, DOI 10.1016/j.corsci.2008.06.002
   Valker P. R., 1990, BIOCHEMISTRY-US, V28, P3911
   Vasilescu E, 2010, MATER CORROS, V61, P947, DOI 10.1002/maco.201005740
   Vasilescu E, 2009, CORROS SCI, V51, P2885, DOI 10.1016/j.corsci.2009.08.014
   WANG K, 1993, BETA TITANIUM 1990S, P2697
   Wu J, 2010, J BIOMED MATER RES B, V92B, P298, DOI 10.1002/jbm.b.31515
   Yamaguchi S, 2010, J MATER SCI-MATER M, V21, P439, DOI 10.1007/s10856-009-3904-0
   Yu SY, 1997, CORROSION, V53, P965, DOI 10.5006/1.3290281
   Zhao LZ, 2010, J BIOMED MATER RES A, V92A, P432, DOI 10.1002/jbm.a.32348
   ZITTER H, 1987, J BIOMED MATER RES, V21, P881, DOI 10.1002/jbm.820210705
   Zysset P K, 1998, Technol Health Care, V6, P429
NR 44
TC 4
Z9 4
U1 2
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1073-5623
EI 1543-1940
J9 METALL MATER TRANS A
JI Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.
PD JUN
PY 2014
VL 45A
IS 7
BP 3130
EP 3143
DI 10.1007/s11661-014-2254-9
PG 14
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA AG1JM
UT WOS:000335171300020
DA 2018-10-20
ER

PT J
AU Choi, JW
   Park, JK
   Chang, JW
   Kim, DY
   Kim, MS
   Shin, YS
   Kim, CH
AF Choi, Jae Won
   Park, Ju Kyeong
   Chang, Jae Won
   Kim, Da Yeon
   Kim, Moon Suk
   Shin, Yoo Seob
   Kim, Chul-Ho
TI Small intestine submucosa and mesenchymal stem cells composite gel for
   scarless vocal fold regeneration
SO BIOMATERIALS
LA English
DT Article
DE Extracellular matrix; Mesenchymal stem cells; Vocal fold; Wound healing;
   Small intestine submucosa; In vivo fluorescence live imaging system
ID HYALURONIC-ACID; ATELOCOLLAGEN SPONGE; EXTRACELLULAR-MATRIX; CANINE
   MODEL; HYDROGEL; SCAFFOLD; BONE; IMPLANTATION; FIBROBLASTS; EXPRESSION
AB The purpose of this study is to demonstrate scarless vocal fold (VF) regeneration by using a composite gel composed of small intestine submucosa (SIS) and mesenchymal stem cells (MSCs). A scar was made with an electrocoagulator on both VFs in 24 rabbits, followed by injection of either MSCs, SIS, or MSCs-SIS composite gel in the right side VF, while the left side VF was left untreated. VF scars were evaluated with in vivo fluorescence live imaging system (IFLIS), endoscopy, histology, and videokymography (VKG) after eight weeks. IFLIS demonstrated that SIS enabled the MSCs to survive and be engrafted in the VF. The histological analysis showed increased hyaluronic acid accumulation and controlled collagen deposition by MSCs-SIS composite gel. VKG analysis showed more favorable vibrations of MSCs-SIS injected VF, compared to other treatment group. In conclusion, the injectable SIS supplied a niche for the MSCs to stably settle down in scarred VFs and helped to regulate ECM synthesis. The ECM remodeling underwent by the surviving MSCs eventually led to the functional improvement of the VF. The results of the present investigation suggest that SIS-MSCs composite gel is a plausible biomaterial for prolonged survival of MSCs in VPs and promotes scarless VF healing. (c) 2014 Elsevier Ltd. All rights reserved.
C1 [Choi, Jae Won; Park, Ju Kyeong; Chang, Jae Won; Shin, Yoo Seob; Kim, Chul-Ho] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 441749, South Korea.
   [Choi, Jae Won; Park, Ju Kyeong; Kim, Da Yeon; Kim, Moon Suk; Kim, Chul-Ho] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.
RP Shin, YS (reprint author), 164 Worldcup St, Suwon 442749, South Korea.
EM drbasket@hanmail.net; ostium@ajou.ac.kr
OI Chang, Jae Won/0000-0002-6596-931X
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education, Science and Technology
   [2012R1A1A1038861]
FX This work was supported by Basic Science Research Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Education, Science and Technology (2012R1A1A1038861).
CR Allen J, 2010, CURR OPIN OTOLARYNGO, V18, P475, DOI 10.1097/MOO.0b013e32833fecd1
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bless DM, 2010, CURR OPIN OTOLARYNGO, V18, P481, DOI 10.1097/MOO.0b013e3283407d87
   Chhetri DK, 2010, CURR OPIN OTOLARYNGO, V18, P498, DOI 10.1097/MOO.0b013e32833f85d1
   Choi JW, 2013, ARTIF ORGANS, V37, P648, DOI 10.1111/aor.12041
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   Gilbert TW, 2007, TISSUE ENG, V13, P1313, DOI 10.1089/ten.2006.0318
   Gray SD, 2000, ANN OTO RHINOL LARYN, V109, P77, DOI 10.1177/000348940010900115
   Gray SD, 1999, LARYNGOSCOPE, V109, P845, DOI 10.1097/00005537-199906000-00001
   Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.0.CO;2-4
   Hansen JK, 2006, J VOICE, V20, P110, DOI 10.1016/j.jvoice.2004.12.005
   Hertegard S, 2006, LARYNGOSCOPE, V116, P1248, DOI 10.1097/01.mlg.0000224548.68499.35
   Hou N, 2011, ACTA OTO-LARYNGOL, V131, P645, DOI 10.3109/00016489.2010.547517
   Johnson BQ, 2010, LARYNGOSCOPE, V120, P537, DOI 10.1002/lary.20782
   Kang KN, 2012, BIOMATERIALS, V33, P4828, DOI 10.1016/j.biomaterials.2012.03.043
   Kang KN, 2011, INT J PHARMACEUT, V420, P266, DOI 10.1016/j.ijpharm.2011.08.047
   Kim KS, 2010, BIOMATERIALS, V31, P1104, DOI 10.1016/j.biomaterials.2009.10.020
   Kutty JK, 2009, TISSUE ENG PART B-RE, V15, P249, DOI 10.1089/ten.TEB.2008.0588
   Kutty JK, 2010, J TISSUE ENG REGEN M, V4, P62, DOI 10.1002/term.219
   Kwon SK, 2013, LARYNGOSCOPE, V123, P1694, DOI 10.1002/lary.23879
   Lee SJ, 2004, J BIOMAT SCI-POLYM E, V15, P1003, DOI 10.1163/1568562041526487
   Li HH, 2012, CELL TISSUE RES, V348, P371, DOI 10.1007/s00441-012-1393-9
   Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054256
   Long JL, 2010, CURR OPIN OTOLARYNGO, V18, P521, DOI 10.1097/MOO.0b013e32833febf2
   MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1
   Ohno S, 2011, ANN OTO RHINOL LARYN, V120, P401, DOI 10.1177/000348941112000610
   Ohno S, 2009, ANN OTO RHINOL LARYN, V118, P805, DOI 10.1177/000348940911801110
   Park SH, 2011, TISSUE ENG PT A, V17, P1277, DOI [10.1089/ten.tea.2010.0337, 10.1089/ten.TEA.2010.0337]
   Peng H, 2013, BIOMATERIALS, V34, P9026, DOI 10.1016/j.biomaterials.2013.08.004
   Piazza C, 2012, EUR ARCH OTO-RHINO-L, V269, P207, DOI 10.1007/s00405-011-1780-y
   Rousseau B, 2004, J VOICE, V18, P116, DOI 10.1016/j.jvoice.2003.06.001
   Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007
   Schweinfurth JM, 2008, LARYNGOSCOPE, V118, P1692, DOI 10.1097/MLG.0b013e3181782754
   Shin YS, 2012, TISSUE ENG REGEN MED, V9, P203, DOI 10.1007/s13770-012-0347-3
   Sung MW, 1999, LARYNGOSCOPE, V109, P1859, DOI 10.1097/00005537-199911000-00027
   Svensson B, 2010, LARYNGOSCOPE, V120, P1370, DOI 10.1002/lary.20926
   Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4
   Wu MH, 2009, AM J PATHOL, V175, P1041, DOI 10.2353/ajpath.2009.090241
   Xie MW, 2013, J INVEST DERMATOL, V133, P553, DOI 10.1038/jid.2012.326
   Yan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017201
NR 40
TC 24
Z9 27
U1 3
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2014
VL 35
IS 18
BP 4911
EP 4918
DI 10.1016/j.biomaterials.2014.03.008
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AG0HG
UT WOS:000335095900005
PM 24679493
DA 2018-10-20
ER

PT J
AU Teimouri, A
   Ghorbanian, L
   Chermahini, AN
   Emadi, R
AF Teimouri, Abbas
   Ghorbanian, Leila
   Chermahini, Alireza Najafi
   Emadi, Rahmatollah
TI Fabrication and characterization of silk/forsterite composites for
   tissue engineering applications
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Ceramics; Forsterite; Microporous materials; Silk fibroin; Tissue
   engineering
ID MORI SILK FIBROIN; BIOMATERIAL SCAFFOLDS; IN-VITRO; NANOCOMPOSITE
   SCAFFOLDS; FORSTERITE; BIOCERAMICS; DEGRADATION; BONE
AB In this research, novel composite scaffolds consisting of silk fibroin and forsterite powder were prepared by a freeze-drying method. In addition, the effects of forsterite powder contents on the structure of the scaffolds were investigated to provide an appropriate composite for bone tissue engineering applications. The morphology studies using scanning electron microscopy (SEM) and transmission electron microscopy (TEM) techniques showed that the forsterite ceramic was well distributed throughout the structures of SF/forsterite scaffolds. Furthermore, the forsterite powder (up to 40 wt%) was homogenously distributed within the silk fibroin as a matrix. Crown Copyright (C) 2013 Published by Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Teimouri, Abbas] Payame Noor Univ, Dept Chem, Tehran, Iran.
   [Ghorbanian, Leila] Isfahan Univ Med Sci, Sch Dent, Torabinejad Dent Res Ctr, Esfahan, Iran.
   [Ghorbanian, Leila] Isfahan Univ Med Sci, Sch Dent, Dept Oral & Maxillofacial Pathol, Esfahan, Iran.
   [Chermahini, Alireza Najafi] Isfahan Univ Technol, Dept Chem, Esfahan 841543111, Iran.
   [Ghorbanian, Leila; Emadi, Rahmatollah] Isfahan Univ Technol, Dept Mat Engn, Esfahan 8415683111, Iran.
RP Teimouri, A (reprint author), Payame Noor Univ, Dept Chem, POB 19395-4697, Tehran, Iran.
EM a_teimouri@pnu.ac.ir
RI Najafi Chermahini, Alireza/F-8271-2017
OI Najafi Chermahini, Alireza/0000-0001-9803-7837
FU Payame Noor University in Isfahan Research Council
FX Supports from the Payame Noor University in Isfahan Research Council and
   contribution from Isfahan University of Technology are gratefully
   acknowledged. Authors would like to thank Dr. M.S. Yalfani and Dr. H.
   Jalali for critical reading of the manuscript. The author also would
   like to thank Dr. M. Bagherzadeh for transmission electron microscopy
   (TEM) analysis.
CR Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   DEMURA M, 1989, BIOSENSORS, V4, P361, DOI 10.1016/0265-928X(89)80002-1
   Ghorbanian L, 2013, INT J BIOL MACROMOL, V58, P275, DOI 10.1016/j.ijbiomac.2013.04.004
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6
   Gregg S. J, 1982, ADSORPTION SURFACE A
   Hamlehkhan Azhang, 2012, Key Engineering Materials, V493-494, P909, DOI 10.4028/www.scientific.net/KEM.493-494.909
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu K, 2006, J BIOACT COMPAT POL, V21, P23, DOI 10.1177/0883911506060455
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HW, 2007, APPL PHYS A-MATER, V86, P361, DOI 10.1007/s00339-006-3774-y
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kutz M., 2002, STANDARD HDB BIOMEDI
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ni SY, 2008, J MATER SCI-MATER M, V19, P359, DOI 10.1007/s10856-007-3186-3
   Ni SY, 2007, CERAM INT, V33, P83, DOI 10.1016/j.ceramint.2005.07.021
   Poursamar SA, 2011, COLLOID SURFACE B, V84, P310, DOI 10.1016/j.colsurfb.2011.01.015
   PRUITT LA, 2011, MECH BIOMATERIALS FU
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Sasikala TS, 2008, J ALLOY COMPD, V461, P555, DOI 10.1016/j.jallcom.2007.07.084
   Tavangarian F, 2011, CERAM INT, V37, P2275, DOI 10.1016/j.ceramint.2011.03.022
   Tavangarian F, 2011, MATER LETT, V65, P740, DOI 10.1016/j.matlet.2010.11.014
   Weak E, 2011, J CONTROL RELEASE, V150, P128
   Zhang Q, 2009, MATERIALS, V2, P2276, DOI 10.3390/ma2042276
NR 28
TC 18
Z9 18
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD JUN
PY 2014
VL 40
IS 5
BP 6405
EP 6411
DI 10.1016/j.ceramint.2013.12.051
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA AD8AE
UT WOS:000333488100004
DA 2018-10-20
ER

PT J
AU Abd Rashid, R
   Shamsudin, R
   Hamid, MAA
   Jalar, A
AF Abd Rashid, Rashita
   Shamsudin, Roslinda
   Hamid, Muhammad Azmi Abdul
   Jalar, Azman
TI In-vitro bioactivity of wollastonite materials derived from limestone
   and silica sand
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Wollastonite; In-vitro bioactivity; Limestone; Silica sand
ID GLASS-CERAMIC MATERIALS; SIMULATED BODY-FLUID; HYDROXYAPATITE;
   BIOCERAMICS; COATINGS; FTIR; SBF
AB This paper describes the behaviour of bioactive wollastonite materials containing Malaysian limestone and silica sand. Wollastonite, which is also known as calcium silicate (CaSiO3), is an industrial mineral composed of calcium, silicon and oxygen. Pseudowollastonite, which is a primary crystal of wollastonite, was synthesised via a solid-state reaction at a temperature of 1450 degrees C. The in-vitro bioactivity of wollastonite was examined by soaking it in simulated body fluid (SBF) solution for 1-7 days at 36.5 degrees C. The soaked wollastonite samples were characterised using XRD, SEM-EDX, FTIR and ICP analyses. Apatite particles precipitated on the surface of the wollastonite sample after the sample was soaked in the SBF. The XRD analysis indicated the presence of an increasing amount of the hydroxyapatite phase as the soaking time increased. The SEM and EDX analyses indicated the formation of granules of agglomerated apatite particles on the surface of the soaked wollastonite sample. During the formation of apatite, phosphate ions from the SBF solution were consumed. This process was confirmed by ICP, which revealed a decrease in ion concentration after the soaking process. The FTIR analysis indicated that the peaks of the phosphate ions increase when the apatite layer forms on the surface of the wollastonite sample. After the soaking process, a calcium deficient hydroxyapatite layer was observed on the wollastonite sample. The study concludes that wollastonite produced from Malaysian limestone and silica sand is bioactive and may be used as an implantable biomaterial. (c) 2013 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Abd Rashid, Rashita; Shamsudin, Roslinda; Hamid, Muhammad Azmi Abdul; Jalar, Azman] Univ Kebangsaan Malaysia, Sch Appl Phys, Fac Sci & Technol, Bangi 43600, Selangor, Malaysia.
RP Shamsudin, R (reprint author), Univ Kebangsaan Malaysia, Sch Appl Phys, Fac Sci & Technol, Bangi 43600, Selangor, Malaysia.
EM linda@ukm.my
FU Ministry of Natural Resources and Environmental Malaysia for Research
   and Development [P23 10900]; School of Applied Physics, Universiti
   Kebangsaan Malaysia [ERGS/1/2013/STG05/UKM/02/2]
FX This work was supported by the Ministry of Natural Resources and
   Environmental Malaysia for Research and Development Grant (P23 10900)
   and the School of Applied Physics, Universiti Kebangsaan Malaysia
   (ERGS/1/2013/STG05/UKM/02/2).
CR Al-Noaman A, 2013, MATER LETT, V94, P69, DOI 10.1016/j.matlet.2012.12.017
   Alemany MI, 2005, J NON-CRYST SOLIDS, V351, P1716, DOI 10.1016/j.jnoncrysol.2005.04.062
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Branda F, 1996, BIOMATERIALS, V17, P2247, DOI 10.1016/0142-9612(95)00328-2
   Chaipanich A, 2011, APPL SURF SCI, V257, P8385, DOI 10.1016/j.apsusc.2011.04.046
   de la Casa-Lillo MA, 2011, J MATER SCI-MATER M, V22, P907, DOI 10.1007/s10856-011-4254-2
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Greenspan DC, 1999, CURR OPIN SOLID ST M, V4, P389, DOI 10.1016/S1359-0286(99)00021-2
   Grigoryan G. O., 2012, THEOR FOUND CHEM ENG, V44, P476
   Kheradmandfard M, 2012, CERAM INT, V38, P169, DOI 10.1016/j.ceramint.2011.05.157
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Liu XY, 2008, BIOMED PHARMACOTHER, V62, P526, DOI 10.1016/j.biopha.2008.07.051
   Lutisanova G, 2011, CERAM-SILIKATY, V55, P199
   Magallanes-Perdomo M, 2011, J EUR CERAM SOC, V31, P1549, DOI 10.1016/j.jeurceramsoc.2011.03.007
   Nour WMN, 2008, CERAM INT, V34, P101, DOI 10.1016/j.ceramint.2006.08.019
   Paluszkiewicz C, 2008, VIB SPECTROSC, V48, P263, DOI 10.1016/j.vibspec.2008.02.020
   Podporska J., 2008, PROCESS APPL CERAM, V2, P19
   Rajkumar M, 2011, DIG J NANOMATER BIOS, V6, P169
   Ryu H. S., 2002, J MATER RES, V20, P1154
   Sainz MA, 2010, ACTA BIOMATER, V6, P2797, DOI 10.1016/j.actbio.2010.01.003
   Saravanapavan P, 2003, J NON-CRYST SOLIDS, V318, P1, DOI 10.1016/S0022-3093(02)01864-1
   Siddharthan A., 2005, TRENDS BIOMATER ARTI, V18, P110
   Siriphannon P, 2002, J EUR CERAM SOC, V22, P511, DOI 10.1016/S0955-2219(01)00301-6
   Vichaphund S, 2011, J EUR CERAM SOC, V31, P2435, DOI 10.1016/j.jeurceramsoc.2011.02.026
   Wang HP, 2008, CERAM INT, V34, P1405, DOI 10.1016/j.ceramint.2007.05.001
   Will B. A., 1985, MINERAL PROCESSING T
   Xia L., 2007, J BIOMED MATER RES B, V83, P431
   Xin R., 2012, J NONCRYST SOLIDS, V356, P1180
   Yazdani A, 2010, J CERAM PROCESS RES, V11, P348
   Zuleta F, 2011, MAT SCI ENG C-MATER, V31, P377, DOI 10.1016/j.msec.2010.10.013
NR 30
TC 12
Z9 12
U1 0
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD JUN
PY 2014
VL 40
IS 5
BP 6847
EP 6853
DI 10.1016/j.ceramint.2013.12.004
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA AD8AE
UT WOS:000333488100058
DA 2018-10-20
ER

PT J
AU Maya-Johnson, S
   Lopez, D
AF Maya-Johnson, S.
   Lopez, D.
TI Effect of the cooling rate in the corrosion behavior of a hot worked
   Ti-6Al-4V extra-low interstitial alloy
SO MATERIALS & DESIGN
LA English
DT Article
DE Titanium alloy; Forging; Corrosion resistance; Thermomechanical
   processing
ID PHASE-TRANSFORMATION; TITANIUM-ALLOYS; MECHANICAL-PROPERTIES;
   MICROSTRUCTURE; TEMPERATURES; EVOLUTION; TI6AL4V
AB This work discusses the effect of the cooling rate during a forging process on the microstructure and corrosion behavior of a Ti-6Al-4V extra-low interstitial (ELI) alloy, which is commonly used as biomaterial. The samples were hot forged at two different temperatures, both of them within the dual phase field (alpha + beta) and a constant strain rate of 4 x 10(-3) s(-1) was employed during the tests. The samples were cooled in three different cooling media (water, air and clay) and the microstructure was analyzed using scanning electron microscopy (SEM). The corrosion resistance was determined by cyclic polarization tests in Ringer's solution at 37 degrees C. Comparison between the results obtained for forged and commercial samples allowed to establish some correlations between cooling rate, microstructure and corrosion resistance. It was found that the clay as a cooling medium is a good candidate to obtain a proper microstructure and properties for biomedical applications, eliminating the requirement of subsequent heat treatment and reducing costs. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Maya-Johnson, S.; Lopez, D.] Univ Nacl Colombia, Tribol & Surfaces Grp, Medellin 050041, Colombia.
RP Lopez, D (reprint author), Univ Nacl Colombia, Tribol & Surfaces Grp, Cra 80 N 65-223, Medellin 050041, Colombia.
EM dmlopez3@unal.edu.co
CR [Anonymous], 1988, ASM HDB, V14
   [Anonymous], 1991, ASM HDB, V4
   Arun J. V., 2006, TITANIUM ALLOYS ATLA
   Bruschi S, 2004, MATER LETT, V58, P3622, DOI 10.1016/j.matlet.2004.06.058
   Cordoba Roman LC, 2009, THESIS NATL U COLOMB
   Gill P, 2011, J MATER ENG PERFORM, V20, P819, DOI 10.1007/s11665-011-9874-7
   He LJ, 2012, MAT SCI ENG A-STRUCT, V549, P163, DOI 10.1016/j.msea.2012.04.025
   Hsu RWW, 2004, MATER CHEM PHYS, V86, P269, DOI 10.1016/j.matchemphys.2004.02.025
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   Jovanovic MT, 2006, MATER DESIGN, V27, P192, DOI 10.1016/j.matdes.2004.10.017
   Kay L. E., 2010, CYCLIC POTENTIODYNAM
   Khaled M, 2001, SURF COAT TECH, V148, P46, DOI 10.1016/S0257-8972(01)01326-3
   Kubiak K, 1998, J MATER PROCESS TECH, V78, P117, DOI 10.1016/S0924-0136(97)00472-X
   Lee MH, 2000, MET MATER-KOREA, V6, P373, DOI 10.1007/BF03028085
   Lee YM, 2008, J MATER SCI-MATER M, V19, P1851, DOI 10.1007/s10856-007-3265-5
   Lutjering G, 1998, MAT SCI ENG A-STRUCT, V243, P32, DOI 10.1016/S0921-5093(97)00778-8
   Malinov S, 2001, METALL MATER TRANS A, V32, P879, DOI 10.1007/s11661-001-0345-x
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Paul S, 2011, J MATER ENG PERFORM, V20, P422, DOI 10.1007/s11665-010-9691-4
   Russell A. M., 2005, STRUCTURE PROPERTY R
   Tait W. S, 1994, INTRO ELECTROCHEMICA
   Vasilescu E, 2009, CORROS SCI, V51, P2885, DOI 10.1016/j.corsci.2009.08.014
   Wang Y, 2005, JOM-US, V57, P32, DOI 10.1007/s11837-005-0112-3
   Williams J. C., 2007, TITANIUM ENG MAT PRO
   Yoshiki Oshida, 2007, BIOSCIENCE BIOENGINE
   Yu CY, 2007, SCRIPTA MATER, V56, P1019, DOI 10.1016/j.scriptamat.2007.03.004
NR 26
TC 4
Z9 4
U1 1
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0261-3069
EI 1873-4197
J9 MATER DESIGN
JI Mater. Des.
PD JUN
PY 2014
VL 58
BP 175
EP 181
DI 10.1016/j.matdes.2014.01.024
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA AD7ED
UT WOS:000333423900021
DA 2018-10-20
ER

PT J
AU Premnath, P
   Tan, B
   Venkatakrishnan, K
AF Premnath, Priyatha
   Tan, Bo
   Venkatakrishnan, Krishnan
TI Nanostructured Hybrid of Immiscible Gold and Silicon and Its Effect on
   Proliferation and Adhesion of Fibroblasts and Osteoblasts
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Gold-Silicon; Femtosecond Laser; Hybrid Biomaterials; Nanostructured;
   Cell Proliferation
ID BONE-FORMATION; SCAFFOLDS; NANOPARTICLES; CULTURE; GROWTH; CELLS
AB Hybrid biomaterials are a combination of two or more different materials that work synergistically to produce superior properties. Nano structuring of such hybrid materials has also posed complications. In this study, we present, for the first time a nanofibrous hybrid of gold and silicon fabricated by femtosecond laser synthesis for tissue engineering applications. The formation of a completely new phase, Au3Si (212) is reported. The formation mechanism is explained by vapor condensation. Particle sizes of 2-10 nm and 37-49 nm for gold and gold concentrations of 35-78% are achieved. The effect of this hybrid on cell growth was assessed using fibroblasts and osteoblasts. There was a significant decrease in both osteoblast and fibroblast proliferation with the increase of gold in the hybrid nanostructure. This novel hybrid nanofibrous matrix provides a method to effectively control the proliferation and adhesion of cells. Femtosecond laser synthesis presents a new standard by which not only a single element biomaterial but also multiple immiscible element hybrid biomaterials can be fabricated. This technique provides a paradigm shift in the fabrication of novel nanostructured immiscible hybrid biomaterials.
C1 [Premnath, Priyatha; Venkatakrishnan, Krishnan] Ryerson Univ, Dept Mech & Ind Engn, Toronto, ON M5B 2K3, Canada.
   [Tan, Bo] Ryerson Univ, Dept Aerosp Engn, Toronto, ON M5B 2K3, Canada.
RP Tan, B (reprint author), Ryerson Univ, Dept Aerosp Engn, Toronto, ON M5B 2K3, Canada.
EM tanbo@ryerson.ca
OI Venkatakrishnan, Krishnan/0000-0002-6491-3971; Tan,
   Bo/0000-0001-8141-4819
FU Natural Sciences and Engineering Research Council of Canada (NSERC)
FX This research was funded by Natural Sciences and Engineering Research
   Council of Canada (NSERC).
CR Chang JF, 2004, MATER CHEM PHYS, V83, P199, DOI 10.1016/S0254-0584(03)00240-2
   Chen KL, 2012, TISSUE ENG PT A, V18, P1399, DOI [10.1089/ten.tea.2011.0376, 10.1089/ten.TEA.2011.0376]
   Chevallay B, 2000, J BIOMED MATER RES, V49, P448, DOI 10.1002/(SICI)1097-4636(20000315)49:4<448::AID-JBM3>3.0.CO;2-L
   Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Kim G. M., 2007, SMALL, V3, P1941
   Kim GM, 2005, CHEM MATER, V17, P4949, DOI 10.1021/cm0508120
   KOZIN F, 1982, J COLLOID INTERF SCI, V88, P326, DOI 10.1016/0021-9797(82)90262-4
   Lee J, 2009, BIOMATERIALS, V30, P4488, DOI 10.1016/j.biomaterials.2009.05.028
   Lei B, 2012, J MATER CHEM, V22, P14133, DOI 10.1039/c2jm31290e
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liu XH, 2012, MACROMOL BIOSCI, V12, P911, DOI 10.1002/mabi.201100466
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Premnath P, 2012, BIORESEARCH OPEN ACC, V1, P231, DOI 10.1089/biores.2012.0254
   Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712
   Sivayoganathan M, 2012, OPT MATER EXPRESS, V2, P987, DOI 10.1364/OME.2.000987
   St-Pierre JP, 2005, BIOMATERIALS, V26, P7319, DOI 10.1016/j.biomaterials.2005.05.046
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tan B, 2009, OPT EXPRESS, V17, P1064, DOI 10.1364/OE.17.001064
   Tavangar A, 2011, ACTA BIOMATER, V7, P2726, DOI 10.1016/j.actbio.2011.02.020
   Vitale-Brovarone C, 2007, ACTA BIOMATER, V3, P199, DOI 10.1016/j.actbio.2006.07.012
NR 24
TC 2
Z9 2
U1 0
U2 65
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD JUN
PY 2014
VL 10
IS 6
BP 1061
EP 1067
DI 10.1166/jbn.2014.1805
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 276DX
UT WOS:000328729400015
PM 24749400
DA 2018-10-20
ER

PT J
AU Kaur, J
   Kumari, A
AF Kaur, Jasleen
   Kumari, Anita
TI Exigency for fusion of graphene and carbon nanotube with biomaterials
SO TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY
LA English
DT Article
DE graphene; graphene oxide; CNT; biomaterials; reduced graphene oxide
ID GLIOBLASTOMA-MULTIFORME CELLS; TOTAL HIP-ARTHROPLASTY; BIOMEDICAL
   APPLICATIONS; ORTHOPEDIC IMPLANTS; QUANTUM DOTS; IN-VITRO;
   MECHANICAL-PROPERTIES; PHOTOTHERMAL THERAPY; GLUCOSE BIOSENSORS;
   MONOLAYER GRAPHENE
AB Biomaterial industry is a widely growing field that is closely related to advanced materials. With development in fabrication techniques new materials are being created by researchers daily. The currently used biomaterials for biomedical applications have some limitations. This review examines those limitations such as corrosion, short fatigue life, less wear resistance, and inadequate mechanical properties. These limitations may lead to adverse effects. To overcome these limitations carbon-based nanomaterials may be incorporated such that these biomaterials reach the level of ideal biomaterials. Upgrade of biomaterials with graphene and carbon nanotubes (CNTs) needs to be done only after checking the safety profile of these materials. Biocompatibility of functionalized graphene and CNT is found to be adequate for the use in many applications such as drug delivery, biosensing and imaging, cancer therapeutics, and tissue regeneration whereas pristine graphene and CNT may produce adverse effects. The potential of carbon-based nanomaterials and graphene (and its derivatives) in overcoming those limitations and enhancing biological activities of ongoing biomaterials by acting as composites and coating material is examined. In addition, nanomaterials employ new techniques in biomedical application such as cancer therapy for more efficient results.
C1 [Kaur, Jasleen; Kumari, Anita] Lovely Profess Univ, Sch Elect Engn, Jalandhar, India.
RP Kumari, A (reprint author), Lovely Profess Univ, Sch Elect Engn, Jalandhar, India.
EM Anita.k07@gmail.com
CR Artiles MS, 2011, ADV DRUG DELIVER REV, V63, P1352, DOI 10.1016/j.addr.2011.07.005
   Avdoshenko SM, 2012, NANOSCALE, V4, P3168, DOI 10.1039/c2nr30097d
   Bai Y, 2011, J WUHAN UNIV TECHNOL, V26, P867, DOI 10.1007/s11595-011-0327-9
   Baktur R, 2013, J NANOMATER, DOI 10.1155/2013/904083
   Basketter DA, 2003, CONTACT DERMATITIS, V49, P1, DOI 10.1111/j.0105-1873.2003.00149.x
   Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7
   Bhatia I.S., 2013, INT J ADV RES COMPUT, V2, P4464
   Bobrinetsky I., 2014, AM J TISSUE ENG STEM, V1, P27
   Bokara Kiran Kumar, 2013, Anat Cell Biol, V46, P85, DOI 10.5115/acb.2013.46.2.85
   Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024
   Borm Paul J A, 2006, Part Fibre Toxicol, V3, P11, DOI 10.1186/1743-8977-3-11
   Bosi S, 2013, NANOTECHNOL REV, V2, P47, DOI 10.1515/ntrev-2012-0067
   Carpio IEM, 2012, NANOSCALE, V4, P4746, DOI 10.1039/c2nr30774j
   Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Chen H, 2008, ADV MATER, V20, P3557, DOI 10.1002/adma.200800757
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   Choi HJ, 2012, NANO ENERGY, V1, P534, DOI 10.1016/j.nanoen.2012.05.001
   Chowdhury SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02584
   Cohen-Karni T, 2010, NANO LETT, V10, P1098, DOI 10.1021/nl1002608
   Cooper HJ, 2012, J BONE JOINT SURG AM, V94A, P1655, DOI 10.2106/JBJS.K.01352
   Corr SJ, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-208
   Coyuco JC, 2011, INT J NANOMED, V6, P2253, DOI 10.2147/IJN.S23962
   Davis H, 2008, MULTIFUNCTIONAL BIOM, P1
   Davis J. R., 2003, HDB MAT MED DEVICES, P1, DOI DOI 10.1361/HMMD2003P001
   Dong L., 2012, J NANOTECHNOLOGY
   Dresselhaus MS, 2010, NANO LETT, V10, P751, DOI 10.1021/nl904286r
   Evans SL, 1998, BIOMATERIALS, V19, P1329, DOI 10.1016/S0142-9612(97)00217-2
   Faghihi S, 2014, J APPL PHYS, V115, DOI 10.1063/1.4864153
   Falconi M, 2007, CELL BIOL TOXICOL, V23, P313, DOI 10.1007/s10565-006-0148-3
   Fan L., 2013, US Patent, Patent No. [US 20130 110 215A1, 20130110215]
   Farvadi F, 2014, RES PHARM SCI, V9, P1
   Fisher C, 2012, J NANOMATER, DOI 10.1155/2012/315185
   Fubo Rao, 2010, Proceedings 2010 IEEE 4th International Conference on Nano/Molecular Medicine and Engineering (NANOMED 2010), P172, DOI 10.1109/NANOMED.2010.5749828
   Galeotti A, 2013, PROG ORTHOD, V14, DOI 10.1186/2196-1042-14-15
   Garber C., 2006, NANOWERK LLC
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877
   Glatkowski P.J., 2007, US Patent, Patent No. [7,195,754 B1, 7195754]
   Graphene Flagship, 2013, GRAPH FLAGSH Q A
   Guazza M, 2004, BIOMATERIALS, V25, P5045, DOI 10.1016/j.biomaterials.2004.02.036
   Guazzato M, 2004, INT J PROSTHODONT, V17, P142
   Gurunathan S, 2013, INT J NANOMED, V8, P1015, DOI 10.2147/IJN.S42047
   Hadidi N, 2012, IRAN J PHARM RES, V11, P27
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hansen DC, 2008, ELECTROCHEM SOC INTE, V17, P31
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hedge C., 2010, INT J ORAL IMPLANTOL, V1, P43
   Helmus M.N., 2002, BIOMATERIALS DESIGN, P1
   Hess LH, 2013, P IEEE, V101, P1780, DOI 10.1109/JPROC.2013.2261031
   Hess LH, 2011, ADV MATER, V23, P5045, DOI 10.1002/adma.201102990
   Hilder TA, 2008, 2008 INTERNATIONAL CONFERENCE ON NANOSCIENCE AND NANOTECHNOLOGY, P109, DOI 10.1109/ICONN.2008.4639258
   Hinzmann M, 2014, INT J NANOMED, V9, P2409, DOI 10.2147/IJN.S62497
   Horvath L, 2013, CARBON, V64, P45, DOI 10.1016/j.carbon.2013.07.005
   Hritcu L, 2011, CENT EUR J BIOL, V6, P497, DOI 10.2478/s11535-011-0022-z
   Hunt JA, 1995, J MATER SCI-MATER M, V6, P839, DOI 10.1007/BF00134328
   Iancu C, 2011, INT J NANOMED, V6, P1675, DOI 10.2147/IJN.S23588
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P1447, DOI 10.2106/00004623-199810000-00006
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Jastrzebska A.M., 2012, J NANOPART RES, V14, P1302
   Jaworski S, 2013, INT J NANOMED, V8, P413, DOI 10.2147/IJN.S39456
   Johnson BB, 2009, MECH MATER, V41, P1108, DOI 10.1016/j.mechmat.2009.04.003
   Johnson D., 2008, IEEE SPECTRUM
   Joviano-Santos JV, 2014, BRAZ J MED BIOL RES, V47, P560, DOI 10.1590/1414-431X20143894
   Kalbacova M, 2012, J BIOMED MATER RES A, V100A, P3001, DOI 10.1002/jbm.a.34231
   Kaner Richard B., 2013, KURZWEIL ACCELERATIN
   Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818
   Karimi H, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-71
   Kaya C, 2008, ADV ENG MATER, V10, P131, DOI 10.1002/adem.200700241
   Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174
   KENNADY MC, 1989, INT J ORAL MAX SURG, V18, P307, DOI 10.1016/S0901-5027(89)80101-8
   Khot M.B., 2011, INT J PHARM PHYTOPHA, V3, P337
   Kiani M.J., 2013, BIOSENS BIOELECTRON, V4, P131
   Ku SH, 2013, ADV HEALTHC MATER, V2, P244, DOI 10.1002/adhm.201200307
   Kumar S., 2012, INT J PHARM SCI NANO, V5, P1685
   Kuzmany H, 2004, SYNTHETIC MET, V141, P113, DOI 10.1016/j.synthmet.2003.08.018
   Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015
   Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233
   Lammel T, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-27
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Lee SK, 2013, CARBON LETT, V14, P63, DOI 10.5714/CL.2013.14.2.063
   Li JH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04359
   Li JJ, 2010, POLYM INT, V59, P169, DOI 10.1002/pi.2703
   Li N, 2014, CHINESE SCI BULL, V59, P1341, DOI 10.1007/s11434-014-0158-0
   Li RB, 2011, CARBON, V49, P1797, DOI 10.1016/j.carbon.2011.01.003
   Li RB, 2010, ACS NANO, V4, P1399, DOI 10.1021/nn9011225
   Li Y, 2012, J AM CHEM SOC, V134, P15, DOI 10.1021/ja206030c
   Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v
   Lin WS, 2009, J NANOPART RES, V11, P25, DOI 10.1007/s11051-008-9419-7
   Liu LZ, 2012, NANOSCALE, V4, P5910, DOI 10.1039/c2nr31164j
   Liu SB, 2011, ACS NANO, V5, P6971, DOI 10.1021/nn202451x
   Liu Y, 2014, CARBON, V67, P250, DOI 10.1016/j.carbon.2013.09.088
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Magrez A, 2006, NANO LETT, V6, P1121, DOI 10.1021/nl060162e
   Makharza S, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-2099-y
   Mandal HS, 2014, ACTA BIOMATER, V10, P2446, DOI 10.1016/j.actbio.2014.02.029
   Mandal HS, 2012, THERANOSTICS, V2, P251, DOI 10.7150/thno.3726
   Mannoor M.S., 2013, NATURE COMMUNICATION, p[3, 763]
   Marrs B, 2006, J BIOMED MATER RES A, V77A, P269, DOI 10.1002/jbm.a.30651
   Marrs B., 2008, ENERGEIA, V19, P1
   Martinesi M, 2013, J MATER SCI-MATER M, V24, P1501, DOI 10.1007/s10856-013-4902-9
   McLucas E, 2008, J MATER SCI-MATER M, V19, P975, DOI 10.1007/s10856-006-0087-9
   Mihailovic M, 2011, CHEM IND CHEM ENG Q, V17, P45, DOI 10.2298/CICEQ100326052M
   Mihov D, 2010, TRAKIA J SCI, V8, P119, DOI DOI 10.13040/1JPSR.0975-8232.7(7).2748-55
   Mikhailov S, 2011, PHYSICS AND APPLICATIONS OF GRAPHENE - THEORY, P1, DOI 10.5772/1938
   Mogharabi M., 2014, DARU, V22, P23
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Movia D, 2011, ACS NANO, V5, P9278, DOI 10.1021/nn203659m
   Mudali UK, 2003, SADHANA-ACAD P ENG S, V28, P601
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Nepal D, 2008, NANO LETT, V8, P1896, DOI 10.1021/nl080522t
   Niinomi M, 2007, INT J FATIGUE, V29, P992, DOI 10.1016/j.ijfatigue.2006.09.021
   Oldani C., 2012, RECENT ADV ARTHROPLA, P149
   Orecchioni M, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-138
   Ovid'ko IA, 2013, REV ADV MATER SCI, V34, P1
   Pacurari M, 2008, ENVIRON HEALTH PERSP, V116, P1211, DOI 10.1289/ehp.10924
   Parchi P., 2013, NANOMEDICINE BIOTHER, V3, P114
   Parida P., 2012, INT J ADV APPL SCI, V1, p125 
   Patel N. R., 2012, INT J EMERGING TECHN, V2, P91
   Paul W., 2011, TRENDS BIOMATERIALS, V25, P91
   Pavlidis IV, 2014, TRENDS BIOTECHNOL, V32, P312, DOI 10.1016/j.tibtech.2014.04.004
   Pinto AM, 2013, COLLOID SURFACE B, V104, P229, DOI 10.1016/j.colsurfb.2012.12.006
   Podila R, 2013, RSC ADV, V3, P1660, DOI 10.1039/c2ra23073a
   Pop E, 2012, MRS BULL, V37, P1273, DOI 10.1557/mrs.2012.203
   Prodana M, 2011, DIG J NANOMATER BIOS, V6, P549
   Pumera M, 2011, MATER TODAY, V14, P308, DOI 10.1016/S1369-7021(11)70160-2
   Raicopol M, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-316
   Rajesh R., 2012, INT J PHARM PHARM SC, V4, P23
   Robinson JT, 2011, J AM CHEM SOC, V133, P6825, DOI 10.1021/ja2010175
   Robinson JT, 2010, NANO RES, V3, P779, DOI 10.1007/s12274-010-0045-1
   Rong PF, 2014, THERANOSTICS, V4, P229, DOI 10.7150/thno.8070
   Ruiz ON, 2011, ACS NANO, V5, P8100, DOI 10.1021/nn202699t
   Ryoo SR, 2010, ACS NANO, V4, P6587, DOI 10.1021/nn1018279
   Sanchez VC, 2012, CHEM RES TOXICOL, V25, P15, DOI 10.1021/tx200339h
   Santos C.M., 2012, NANOTECHNOLOGY, V25, P55101
   Sayes CM, 2006, TOXICOL LETT, V161, P135, DOI 10.1016/j.toxlet.2005.08.011
   Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/NNANO.2010.89, 10.1038/nnano.2010.89]
   Sefcovicova J., 2014, CHEM PAPERS, V68, p1 
   Sezer AD, 2011, BIOMATERIALS APPLICATIONS FOR NANOMEDICINE, P383
   Shan CS, 2009, ANAL CHEM, V81, P2378, DOI 10.1021/ac802193c
   Shao YY, 2010, ELECTROANAL, V22, P1027, DOI 10.1002/elan.200900571
   Sheet I., 2013, International Journal of Current Microbiology and Applied Sciences, V2, P1
   Shen H, 2012, THERANOSTICS, V2, P283, DOI 10.7150/thno.3642
   Shen JH, 2012, CHEM COMMUN, V48, P3686, DOI 10.1039/c2cc00110a
   Singh SK, 2011, ACS NANO, V5, P4987, DOI 10.1021/nn201092p
   Sinha N, 2005, IEEE T NANOBIOSCI, V4, P180, DOI 10.1109/TNB.2005.850478
   Srinivasaraghavan V, 2014, BIOMED MICRODEVICES, V16, P689, DOI 10.1007/s10544-014-9873-1
   Sulur V.S., 2011, US Patent, Patent No. [20120101056 A1, 20120101056]
   Sundar L.S., 2007, BIOMEDICAL ENG TECHN, p115 
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Thamaraiselvi T. V., 2004, TRENDS BIOMATER ARTI, V18, P9
   Thyssen JP, 2009, J AM ACAD DERMATOL, V61, P799, DOI 10.1016/j.jaad.2009.03.030
   Tyagi M.G., 2013, WORLD J PHARM PHARM, V3, P339
   Vandrovcova M, 2011, PHYSIOL RES, V60, P403
   Vashist S.K., 2013, AUSTIN J NANOMEDICIN, V1, P1
   Vozzi G, 2013, J APPL POLYM SCI, V129, P528, DOI 10.1002/app.38235
   Vyalikh A, 2008, NANOMEDICINE-UK, V3, P321, DOI 10.2217/17435889.3.3.321
   Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Williams DF, 2003, SADHANA-ACAD P ENG S, V28, P563, DOI 10.1007/BF02706447
   Winslow L, 2008, EZINEARTICLE    0814
   Wojtoniszak M, 2012, COLLOID SURFACE B, V89, P79, DOI 10.1016/j.colsurfb.2011.08.026
   Wong J.Y., 2007, BIOMATERIALS
   Wu P, 2008, ANGEW CHEM INT EDIT, V47, P5022, DOI 10.1002/anie.200705363
   Xie YT, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/2/025009
   Yan L, 2013, CHINESE SCI BULL, V58, P2347, DOI 10.1007/s11434-013-5800-8
   Yoo YR, 2008, MET MATER INT, V14, P729, DOI 10.3365/met.mat.2008.12.729
   Yuan XC, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-108
   Zhang H, 2013, ACS APPL MATER INTER, V5, P1761, DOI 10.1021/am303005j
   Zhang W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04097
   Zhang W, 2011, BIOMATERIALS, V32, P8555, DOI 10.1016/j.biomaterials.2011.07.071
   Zhang Y, 2012, NANOSCALE, V4, P3833, DOI 10.1039/c2nr31040f
   Zhang YB, 2010, ACS NANO, V4, P3181, DOI 10.1021/nn1007176
   Zheng D, 2013, MATERIALS, V6, P1011, DOI 10.3390/ma6031011
   Zhu L, 2014, CARBON, V75, P161, DOI 10.1016/j.carbon.2014.03.049
   Zhu Yanwu, 2010, ADV MATER, VXX, P1
   Zhu ZG, 2012, SENSORS-BASEL, V12, P5996, DOI 10.3390/s120505996
   Zhuang Liu, 2010, Proceedings 8th International Vacuum Electron Sources Conference and Nanocarbon (2010 IVESC), DOI 10.1109/IVESC.2010.5644372
   Zuo PP, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-39
NR 179
TC 2
Z9 2
U1 2
U2 39
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0277-2248
EI 1029-0486
J9 TOXICOL ENVIRON CHEM
JI Toxicol Environ. Chem.
PD MAY 28
PY 2014
VL 96
IS 5
BP 699
EP 721
DI 10.1080/02772248.2014.978127
PG 23
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA AW5UZ
UT WOS:000346340400002
DA 2018-10-20
ER

PT J
AU Nazir, R
   Danilevicius, P
   Ciuciu, AI
   Chatzinikolaidou, M
   Gray, D
   Flamigni, L
   Farsari, M
   Gryko, DT
AF Nazir, Rashid
   Danilevicius, Paulius
   Ciuciu, Adina I.
   Chatzinikolaidou, Maria
   Gray, David
   Flamigni, Lucia
   Farsari, Maria
   Gryko, Daniel T.
TI pi-Expanded Ketocoumarins as Efficient, Biocompatible Initiators for
   Two-Photon-Induced Polymerization
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID ABSORPTION CROSS-SECTIONS; PHOTOPOLYMERIZATION REACTIONS; PHOTOINDUCED
   POLYMERIZATION; PHOTOINITIATING SYSTEMS; CYCLOPENTANONE DYES;
   VISIBLE-LIGHT; MICROFABRICATION; DERIVATIVES; SKELETON; CRYSTALS
AB A series of pi-expanded coumarins comprising of 4-5 conjugated rings were designed and synthesized. The strategic placement of two dialkylamino groups containing long alkyl chains attached to the peripheral ends of bis-coumarins resulted in dyes with superb solubility. As alpha,beta-unsaturated ketones, these compounds display properties of donor-acceptor-donor (D-A-D)-type chromophores. Photophysical studies of the new functional dyes revealed a combination of favorable properties: strong absorption of blue and green light, weak fluorescence, reasonable two-photon absorption (2PA) cross-section, and complete solubility in nonpolar solvents. The fluorescence lifetimes of coumarin-derived alpha,beta-unsaturated ketones were measured for the first time. The placement of two amine groups at peripheral positions of the dyes produced two-photon absorption cross-section values at the level of 150-400 GM around 800 nm, which generated two-photon photoinitiation. The highest 2PA cross-section was approximately 400 GM for the derivative of 4-methylcyclohexanone. Directly using these compounds as sensitizer or initiator, two (2D)- and three-dimensional (3D) nanopatterns were successfully fabricated by two-photon initiated polymerization. 3,3'-Carbonyl-biscoumarin, which contains two dihexylamino substituents at positions 7 and 7' possesses the largest fabrication window. MC3T3-E1 preosteoblastic cells exhibited strong adherence to all pi-expanded coumarins and the same spindle-shaped morphology as the tissue culture treated polystyrene control surface. Additionally, our results showed an increase in cell proliferation after 3 and 7 days in culture, as well as a high cell viability of approximately 100% on all materials compared to the control surface. These findings confirm that D-A-D-type ketocoumarin derivatives used as potential photoinitiators are noncytotcodc and can be used in the fabrication of biomaterial scaffolds for tissue engineering applications.
C1 [Nazir, Rashid; Gryko, Daniel T.] Warsaw Univ Technol, Fac Chem, PL-00664 Warsaw, Poland.
   [Danilevicius, Paulius; Gray, David; Farsari, Maria] Fdn Res & Technol Hellas FORTH, IESL, Iraklion 71110, Crete, Greece.
   [Ciuciu, Adina I.; Flamigni, Lucia] CNR, ISOF, I-40129 Bologna, Italy.
   [Chatzinikolaidou, Maria] Univ Crete, Dept Mat Sci & Technol, Rethimnon 74100, Greece.
   [Gryko, Daniel T.] Polish Acad Sci, Inst Organ Chem, Warsaw, Poland.
RP Flamigni, L (reprint author), CNR, ISOF, Via Gobetti 101, I-40129 Bologna, Italy.
EM lucia.flamigni@isof.cnr.it; mfarsari@iesl.forth.gr; dtgryko@icho.edu.Pl
RI Gray, David/A-2396-2014; Ciuciu, Adina Iuliana/F-9702-2013; Gryko,
   Daniel/A-7998-2008; Farsari, Maria/B-3767-2011; Flamigni,
   Lucia/B-4058-2009; Chatzinikolaidou, Maria/H-1061-2014
OI Gray, David/0000-0003-3466-7367; Gryko, Daniel/0000-0002-2146-1282;
   Farsari, Maria/0000-0003-2435-4156; Flamigni, Lucia/0000-0001-9273-1334;
   Chatzinikolaidou, Maria/0000-0002-2749-2506
FU European Community [PITN-GA-2010-264362]
FX The research leading to these results has received funding from the
   European Community's Seventh Framework Marie Curie ITN program TopBio
   (PITN-GA-2010-264362). We thank Jillian Larsen for amending the
   manuscript.
CR Albota M, 1998, SCIENCE, V281, P1653, DOI 10.1126/science.281.5383.1653
   An LT, 2008, CATAL COMMUN, V9, P349, DOI 10.1016/j.catcom.2007.06.004
   Belfield KD, 2004, CHEM MATER, V16, P2267, DOI 10.1021/cm035253g
   Belfield KD, 2000, J AM CHEM SOC, V122, P1217, DOI 10.1021/ja991990v
   Belfield KD, 2000, J PHYS ORG CHEM, V13, P837, DOI 10.1002/1099-1395(200012)13:12<837::AID-POC315>3.0.CO;2-5
   Chen YS, 2007, CHEM MATER, V19, P3858, DOI 10.1021/cm0710812
   Chung SJ, 1999, J PHYS CHEM B, V103, P10741, DOI 10.1021/jp992846z
   Davis R, 2008, ARCH PHARM, V341, P440, DOI 10.1002/ardp.200800028
   Feng J. G., 2008, J MED CHEM, V51, P3654
   Flamigni L, 2003, CHEM-EUR J, V9, P2649, DOI 10.1002/chem.200204502
   FOUASSIER JP, 1992, J APPL POLYM SCI, V44, P1779, DOI 10.1002/app.1992.070441010
   Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031
   Hao FY, 2014, SPECTROCHIM ACTA A, V118, P538, DOI 10.1016/j.saa.2013.09.051
   Ibrahim A, 2013, PHOTOCHEM PHOTOBIOL, V89, P1283, DOI 10.1111/php.12132
   James W., 1999, CAN J CHEM, V77, P903
   JONES G, 1982, TETRAHEDRON LETT, V23, P5505, DOI 10.1016/S0040-4039(00)85879-7
   LaFratta CN, 2007, ANGEW CHEM INT EDIT, V46, P6238, DOI 10.1002/anie.200603995
   Li ZQ, 2013, MACROMOLECULES, V46, P352, DOI 10.1021/ma301770a
   Ligon SC, 2014, CHEM REV, V114, P557, DOI 10.1021/cr3005197
   Lu WE, 2011, J MATER CHEM, V21, P5650, DOI 10.1039/c0jm04025h
   Maruo S, 1997, OPT LETT, V22, P132, DOI 10.1364/OL.22.000132
   MONROE BM, 1991, J IMAGING SCI, V35, P19
   Nazir R, 2013, MACROMOLECULES, V46, P7239, DOI 10.1021/ma4010988
   Ovsianikov A, 2008, ACS NANO, V2, P2257, DOI 10.1021/nn800451w
   Pucher N, 2009, MACROMOLECULES, V42, P6519, DOI 10.1021/ma9007785
   Radke A, 2011, ADV MATER, V23, P3018, DOI 10.1002/adma.201100543
   Raimondi MT, 2013, ACTA BIOMATER, V9, P4579, DOI 10.1016/j.actbio.2012.08.022
   Rurack K, 2011, ANAL CHEM, V83, P1232, DOI 10.1021/ac101329h
   Sakellari I, 2012, ACS NANO, V6, P2302, DOI 10.1021/nn204454c
   Schafer KJ, 2004, J PHOTOCH PHOTOBIO A, V162, P497, DOI 10.1016/S1010-6030(03)00394-0
   SPECHT DP, 1982, TETRAHEDRON, V38, P1203, DOI 10.1016/0040-4020(82)85104-1
   Tasior M, 2010, CHEM-ASIAN J, V5, P130, DOI 10.1002/asia.200900345
   Tehfe MA, 2013, MACROMOLECULES, V46, P3761, DOI 10.1021/ma400766z
   Tehfe MA, 2013, MACROMOLECULES, V46, P3332, DOI 10.1021/ma4005082
   Tehfe MA, 2013, MACROMOLECULES, V46, P736, DOI 10.1021/ma3024359
   Tehfe MA, 2012, MACROMOLECULES, V45, P8639, DOI 10.1021/ma301931p
   Telitel S, 2013, MACROMOLECULES, V46, P43, DOI 10.1021/ma302009p
   Telitel S, 2012, MACROMOLECULES, V45, P6864, DOI 10.1021/ma301293m
   Terzaki K, 2013, J BIOMED MATER RES A, V101, P2283, DOI 10.1002/jbm.a.34516
   Vasilantonakis N, 2012, ADV MATER, V24, P1101, DOI 10.1002/adma.201104778
   Versace DL, 2013, ACS MACRO LETT, V2, P341, DOI 10.1021/mz400081p
   von Freymann G, 2010, ADV FUNCT MATER, V20, P1038, DOI 10.1002/adfm.200901838
   Wang T, 2007, DYES PIGMENTS, V75, P104, DOI 10.1016/j.dyepig.2006.04.019
   WATANABE K, 1982, B CHEM SOC JPN, V55, P3208, DOI 10.1246/bcsj.55.3208
   Xiao P, 2014, MACROMOLECULES, V47, P601, DOI 10.1021/ma402376x
   Xiao P, 2014, MACROMOLECULES, V47, P26, DOI 10.1021/ma402149g
   Xiao P, 2013, MACROMOLECULES, V46, P6786, DOI 10.1021/ma401389t
   Xiao P, 2013, MACROMOLECULES, V46, P7661, DOI 10.1021/ma401766v
   Xiao P, 2013, ACS MACRO LETT, V2, P736, DOI 10.1021/mz400316y
   Xue JQ, 2008, J PHOTOCH PHOTOBIO A, V195, P261, DOI 10.1016/j.jphotochem.2007.10.012
   Xue JQ, 2010, J PHYS CHEM A, V114, P5171, DOI 10.1021/jp909745q
NR 51
TC 21
Z9 21
U1 5
U2 88
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
EI 1520-5002
J9 CHEM MATER
JI Chem. Mat.
PD MAY 27
PY 2014
VL 26
IS 10
BP 3175
EP 3184
DI 10.1021/cm500612w
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA AI1TF
UT WOS:000336637000021
DA 2018-10-20
ER

PT J
AU Sengstock, C
   Lopian, M
   Motemani, Y
   Borgmann, A
   Khare, C
   Buenconsejo, PJS
   Schildhauer, TA
   Ludwig, A
   Koller, M
AF Sengstock, Christina
   Lopian, Michael
   Motemani, Yahya
   Borgmann, Anna
   Khare, Chinmay
   Buenconsejo, Pio John S.
   Schildhauer, Thomas A.
   Ludwig, Alfred
   Koeller, Manfred
TI Structure-related antibacterial activity of a titanium nanostructured
   surface fabricated by glancing angle sputter deposition
SO NANOTECHNOLOGY
LA English
DT Article
DE antibacterial; nanotopography; titanium; biomimetic material
ID SCULPTURED THIN-FILMS; ORTHOPEDIC IMPLANT; CELLS; INFECTIONS; COATINGS;
   DEVICES; SILVER
AB The aim of this study was to reproduce the physico-mechanical antibacterial effect of the nanocolumnar cicada wing surface for metallic biomaterials by fabrication of titanium (Ti) nanocolumnar surfaces using glancing angle sputter deposition (GLAD). Nanocolumnar Ti thin films were fabricated by GLAD on silicon substrates. S. aureus as well as E. coli were incubated with nanostructured or reference dense Ti thin film test samples for one or three hours at 37 degrees C. Bacterial adherence, morphology, and viability were analyzed by fluorescence staining and scanning electron microscopy and compared to human mesenchymal stem cells (hMSCs). Bacterial adherence was not significantly different after short (1 h) incubation on the dense or the nanostructured Ti surface. In contrast to S. aureus the viability of E. coli was significantly decreased after 3 h on the nanostructured film compared to the dense film and was accompanied by an irregular morphology and a cell wall deformation. Cell adherence, spreading and viability of hMSCs were not altered on the nanostructured surface. The results show that the selective antibacterial effect of the cicada wing could be transferred to a nanostructured metallic biomaterial by mimicking the natural nanocolumnar topography.
C1 [Sengstock, Christina; Borgmann, Anna; Schildhauer, Thomas A.; Koeller, Manfred] Ruhr Univ Bochum, Dept Surg, BG Univ Hosp Bergmannsheil, Bochum, Germany.
   [Lopian, Michael; Motemani, Yahya; Khare, Chinmay; Buenconsejo, Pio John S.; Ludwig, Alfred] Ruhr Univ Bochum, Fac Mech Engn, Inst Mat, Bochum, Germany.
RP Sengstock, C (reprint author), Ruhr Univ Bochum, Dept Surg, BG Univ Hosp Bergmannsheil, Bochum, Germany.
EM Christina.greulich@rub.de
RI Ludwig, Alfred/G-1111-2011
OI Ludwig, Alfred/0000-0003-2802-6774; Schildhauer,
   Thomas/0000-0002-3232-9869; Buenconsejo, Pio John/0000-0001-7775-1150
CR Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Brammer KS, 2011, ACTA BIOMATER, V7, P683, DOI 10.1016/j.actbio.2010.09.022
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Diaz C, 2010, ACS APPL MATER INTER, V2, P2530, DOI 10.1021/am100313z
   Dmitriev BA, 2004, J BACTERIOL, V186, P7141, DOI 10.1128/JB.186.21.7141-7148.2004
   Dolatshahi-Pirouz A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/9/095101
   ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4
   Ferraris M, 2010, ADV ENG MATER, V12, pB276, DOI 10.1002/adem.200980076
   Hasan J, 2013, APPL MICROBIOL BIOT, V97, P9257, DOI 10.1007/s00253-012-4628-5
   Hayes JS, 2012, ADV BIOCHEM ENG BIOT, V126, P1, DOI 10.1007/10_2011_110
   Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015
   Ivanova EP, 2012, SMALL, V8, P2489, DOI 10.1002/smll.201200528
   Khare C, 2011, J VAC SCI TECHNOL A, V29, DOI 10.1116/1.3607409
   Kim KH, 2009, DENT MATER J, V28, P20, DOI 10.4012/dmj.28.20
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Malac M, 1999, J VAC SCI TECHNOL B, V17, P2671, DOI 10.1116/1.591046
   Motemani Y, 2014, APPL SURF SCI, V292, P626, DOI 10.1016/j.apsusc.2013.12.022
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   NIEUWENHUIZEN JM, 1966, PHILIPS TECH REV, V27, P87
   Patzig C, 2007, J VAC SCI TECHNOL B, V25, P833, DOI 10.1116/1.2737436
   Patzig C, 2010, PHYS STATUS SOLIDI B, V247, P1322, DOI 10.1002/pssb.200945526
   Pennisi CP, 2011, COLLOID SURFACE B, V85, P189, DOI 10.1016/j.colsurfb.2011.02.028
   Pickard R, 2012, LANCET, V380, P1927, DOI 10.1016/S0140-6736(12)61380-4
   Pogodin S, 2013, BIOPHYS J, V104, P835, DOI 10.1016/j.bpj.2012.12.046
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Reshes G, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/046001
   Robbie K, 1998, J VAC SCI TECHNOL B, V16, P1115, DOI 10.1116/1.590019
   Robbie K, 1996, NATURE, V384, P616, DOI 10.1038/384616a0
   Robbie K, 1997, J VAC SCI TECHNOL A, V15, P1460, DOI 10.1116/1.580562
   Romano CL, 2013, J CHEMOTHERAPY, V25, P67, DOI 10.1179/1973947812Y.0000000045
   Roy SC, 2007, BIOMATERIALS, V28, P4667, DOI 10.1016/j.biomaterials.2007.07.045
   Shapiro IM, 2012, EUR CELLS MATER, V23, P362, DOI 10.22203/eCM.v023a28
   Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007
   Toms AD, 2006, J BONE JOINT SURG BR, V88B, P149, DOI 10.1302/0301-620X.88B2.17058
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Venkataraman S, 2010, BIOMATERIALS, V31, P1751, DOI 10.1016/j.biomaterials.2009.11.030
   Vetrone F, 2009, NANO LETT, V9, P659, DOI 10.1021/nl803051f
   Visai L, 2011, INT J ARTIF ORGANS, V34, P929, DOI 10.5301/ijao.5000050
   Wisdom KM, 2013, P NATL ACAD SCI USA, V110, P7992, DOI 10.1073/pnas.1210770110
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zimmerli W, 2012, FEMS IMMUNOL MED MIC, V65, P158, DOI 10.1111/j.1574-695X.2012.00938.x
NR 42
TC 31
Z9 31
U1 0
U2 78
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD MAY 16
PY 2014
VL 25
IS 19
AR 195101
DI 10.1088/0957-4484/25/19/195101
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA AG4HC
UT WOS:000335379200001
PM 24763247
DA 2018-10-20
ER

PT J
AU Brodano, GB
   Giavaresi, G
   Lolli, F
   Salamanna, F
   Parrilli, A
   Martini, L
   Griffoni, C
   Greggi, T
   Arcangeli, E
   Pressato, D
   Boriani, S
   Fini, M
AF Brodano, Giovanni Barbanti
   Giavaresi, Gianluca
   Lolli, Francesco
   Salamanna, Francesca
   Parrilli, Annapaola
   Martini, Lucia
   Griffoni, Cristiana
   Greggi, Tiziana
   Arcangeli, Elena
   Pressato, Daniele
   Boriani, Stefano
   Fini, Milena
TI Hydroxyapatite-Based Biomaterials Versus Autologous Bone Graft in Spinal
   Fusion An In Vivo Animal Study
SO SPINE
LA English
DT Article
DE spinal fusion; autologous bone; autograft; substitute; biomaterial;
   magnesium-hydroxyapatite; demineralized bone matrix; osteointegration;
   osteoconduction; osteoinduction
ID MAGNESIUM-ENRICHED HYDROXYAPATITE; MESENCHYMAL STEM-CELLS; ILIAC CREST
   BONE; LUMBAR SPINE; MORPHOGENETIC PROTEIN-2; SUBSTITUTED HYDROXYAPATITE;
   DEGENERATIVE DISEASE; CALCIUM-SULFATE; MARROW ASPIRATE; MATRIX
AB Study Design. An in vivo study was designed to compare the efficacy of biomimetic magnesium-hydroxyapatite (MgHA) and of human demineralized bone matrix (HDBM), both dispersed in a mixture of biomimetic MgHA nanoparticles, with that of an autologous bone graft.
   Objective. The objective of this study was to evaluate 2 new bone substitutes as alternatives to a bone autograft for spinal fusion, determining their osteoinductive and osteoconductive properties, and their capacity of remodeling, using a large animal model.
   Summary of Background Data. Spinal fusion is a common surgical procedure and it is performed for different conditions. A successful fusion requires potentially osteogenic, osteoinductive, and osteoconductive biomaterials.
   Methods. A posterolateral spinal fusion model involved 18 sheep, bilaterally implanting test materials between the vertebral transverse processes. The animals were divided into 2 groups: 1 fusion level was treated with MgHA (group 1) or with HDBM-MgHA (group 2). The other fusion level received bone autografts in both groups.
   Results. Radiographical, histological, and microtomographic results indicated good osteointegration between the spinous process and the vertebral foramen for both materials. Histomorphometry revealed no significant differences between MgHA and autologous bone for all the parameters examined, whereas significantly lower values of bone volume were observed between HDBMMgHA and autologous bone. Moreover, the normalization of the histomorphometric data with autologous bone revealed that MgHA showed a significantly higher value of bone volume and a lower value of trabecular number, more similar to autologous bone than HDBM-MgHA.
   Conclusion. The study showed that the use of MgHA in an ovine model of spinal fusion led to the deposition of new bone tissue without qualitative and quantitative differences with respect to new bone formed with autologous bone, whereas the HDBM-MgHA led to a reduced deposition of newly formed bone tissue.
C1 [Brodano, Giovanni Barbanti; Griffoni, Cristiana; Boriani, Stefano] Rizzoli Orthopaed Inst, Dept Oncol & Degenerat Spine Surg, I-40136 Bologna, Italy.
   [Giavaresi, Gianluca; Salamanna, Francesca; Parrilli, Annapaola; Martini, Lucia; Fini, Milena] Rizzoli Orthopaed Inst, Lab Biocompatibil Innovat Technol & Adv Therapies, I-40136 Bologna, Italy.
   [Giavaresi, Gianluca; Martini, Lucia; Fini, Milena] Rizzoli Orthopaed Inst, Lab Preclin & Surg Studies, I-40136 Bologna, Italy.
   [Greggi, Tiziana] Rizzoli Orthopaed Inst, Dept Deform Spine Surg, I-40136 Bologna, Italy.
   [Arcangeli, Elena; Pressato, Daniele] Fin Ceram Faenza SpA, Faenza, RA, Italy.
RP Brodano, GB (reprint author), Rizzoli Orthopaed Inst, Dept Oncol & Degenerat Spine Surg, I-40136 Bologna, Italy.
EM giovanni@barbantibrodano.com
RI Salamanna, Francesca/J-6032-2016; Fini, Milena/J-4808-2016
OI Salamanna, Francesca/0000-0001-7402-4054; Fini,
   Milena/0000-0002-3732-3570; Giavaresi, Gianluca/0000-0001-7843-5969;
   Boriani, Stefano/0000-0002-8426-9108
FU Fin-Ceramica Faenza SpA; Rizzoli Orthopaedic Institute
FX Fin-Ceramica Faenza SpA and Rizzoli Orthopaedic Institute funds were
   received to support this work.
CR Abdullah KG, 2011, SPINE, V36, pE1328, DOI 10.1097/BRS.0b013e318209952b
   Agarwal R, 2009, J NEUROSURG-SPINE, V11, P729, DOI 10.3171/2009.6.SPINE08669
   BIGI A, 1993, J INORG BIOCHEM, V49, P69, DOI 10.1016/0162-0134(93)80049-F
   Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005
   Boden SD, 2002, SPINE, V27, pS26, DOI 10.1097/01.BRS.0000020731.64266.B2
   Brodano GB, 2012, EUR SPINE J, V21, pS3, DOI 10.1007/s00586-012-2233-z
   Cammisa FP, 2004, SPINE, V29, P660, DOI 10.1097/01.BRS.0000116588.17129.B9
   Caneva M, 2011, CLIN ORAL IMPLAN RES, V22, P512, DOI 10.1111/j.1600-0501.2010.02040.x
   Carragee EJ, 2013, J BONE JOINT SURG AM, V95A, P1537, DOI 10.2106/JBJS.L.01483
   Carragee EJ, 2009, SPINE J, V9, P873, DOI 10.1016/j.spinee.2009.09.001
   Carreon LY, 2005, SPINE, V30, pE243, DOI 10.1097/01.brs.0000160846.85397.44
   Carter JD, 2009, SPINE J, V9, P434, DOI 10.1016/j.spinee.2008.11.004
   Cazalbou S, 2005, J MATER SCI-MATER M, V16, P405, DOI 10.1007/s10856-005-6979-2
   Checchi V, 2011, INT J ORAL MAX SURG, V40, P526, DOI 10.1016/j.ijom.2010.12.005
   Crespi R, 2012, INT J ORAL MAX IMPL, V27, P95
   Crespi R, 2009, J PERIODONTOL, V80, P210, DOI [10.1902/jop.2009.080400, 10.1902/jop.2009.080400 ]
   Dai LY, 2008, SPINE, V33, P1299, DOI 10.1097/BRS.0b013e3181732a8e
   Dallari D, 2012, BIOMATERIALS, V33, P72, DOI 10.1016/j.biomaterials.2011.09.029
   Devine John G, 2012, Evid Based Spine Care J, V3, P35, DOI 10.1055/s-0031-1298616
   Dimar JR, 2009, SPINE J, V9, P880, DOI 10.1016/j.spinee.2009.03.013
   Epstein NE, 2009, SPINE J, V9, P630, DOI [10.1016/j.spinee.2008.03.009, 10.1016/j.spinee.2009.04.007]
   Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006
   Grabowski G, 2013, J AM ACAD ORTHOP SUR, V21, P51, DOI 10.5435/JAAOS-21-01-51
   Kamoda H, 2012, SPINE, V37, P1727, DOI 10.1097/BRS.0b013e31825567b7
   Kang J, 2012, SPINE, V37, P1083, DOI 10.1097/BRS.0b013e31823ed817
   Kim DH, 2009, SPINE J, V9, P886, DOI 10.1016/j.spinee.2009.05.006
   Kurien T, 2013, BONE JOINT J, V95B, P583, DOI 10.1302/0301-620X.95B5.30286
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y
   Lerner T, 2009, EUR SPINE J, V18, P170, DOI 10.1007/s00586-008-0844-1
   Manfrini M, 2013, J CELL PHYSIOL, V228, P1229, DOI 10.1002/jcp.24276
   Martin GJ, 1999, SPINE, V24, P637, DOI 10.1097/00007632-199904010-00005
   Martinetti R, 2005, ANAL BIOANAL CHEM, V381, P634, DOI 10.1007/s00216-004-2957-7
   Mesfin A, 2013, J BONE JOINT SURG AM, V95A, P1546, DOI 10.2106/JBJS.L.01730
   Mobbs RJ, 2013, ORTHOP SURG, V5, P153, DOI [10.1111/os.12048, 10.1111/j.1757-7861.2012.00185.x]
   Nagineni VV, 2012, SPINE, V37, pE1264, DOI 10.1097/BRS.0b013e318265e22e
   Neen D, 2006, SPINE, V31, pE636, DOI 10.1097/01.brs.0000232028.97590.12
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016
   Rebaudi A, 2010, INT J PERIODONT REST, V30, P53
   Ren F, 2010, ACTA BIOMATER, V6, P2787, DOI 10.1016/j.actbio.2009.12.044
   Resnick DK, 2005, J NEUROSURG-SPINE, V2, P733, DOI 10.3171/spi.2005.2.6.0733
   Resnick DK, 2005, J NEUROSURG-SPINE, V2, P737, DOI 10.3171/spi.2005.2.6.0737
   Rihn JA, 2010, SPINE, V35, P1629, DOI 10.1097/BRS.0b013e3181d25803
   Schizas C, 2008, ARCH ORTHOP TRAUM SU, V128, P621, DOI 10.1007/s00402-007-0495-4
   Simmonds MC, 2013, ANN INTERN MED, V158, P877, DOI 10.7326/0003-4819-158-12-201306180-00005
   Smoljanovic T, 2010, J NEUROSURG-SPINE, V13, P407, DOI 10.3171/2010.1.SPINE091008
   Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0
   Tay BKB, 1998, SPINE, V23, P2276, DOI 10.1097/00007632-199811010-00005
   Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010
   Vaccaro AR, 2007, ORTHOPEDICS, V30, P567
   Walsh WR, 2004, EUR SPINE J, V13, P359, DOI 10.1007/s00586-003-0597-9
   Wang JC, 2007, EUR SPINE J, V16, P1233, DOI 10.1007/s00586-006-0282-x
   Whang Peter G, 2003, Spine J, V3, P155, DOI 10.1016/S1529-9430(02)00539-9
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
NR 55
TC 5
Z9 5
U1 2
U2 16
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0362-2436
EI 1528-1159
J9 SPINE
JI SPINE
PD MAY 15
PY 2014
VL 39
IS 11
BP E661
EP E668
DI 10.1097/BRS.0000000000000311
PG 8
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA AJ2CM
UT WOS:000337462700001
PM 24718060
DA 2018-10-20
ER

PT J
AU Alabbasi, A
   Mehjabeen, A
   Kannan, MB
   Ye, QS
   Blawert, C
AF Alabbasi, Alyaa
   Mehjabeen, Afrin
   Kannan, M. Bobby
   Ye, Qingsong
   Blawert, Carsten
TI Biodegradable polymer for sealing porous PEO layer on pure magnesium: An
   in vitro degradation study
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Magnesium; Biomaterial; Plasma electrolytic oxidation; Poly-L-lactide;
   Degradation
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; CORROSION BEHAVIOR; ALLOY;
   OXIDATION; COATINGS; DEPOSITION; PHOSPHATE; SILICATE
AB An attempt was made to seal the porous silicate-based plasma electrolytic oxidation (PEO) layer on pure magnesium (Mg) with a biodegradable polymer, poly(L-lactide) (PLLA), to delay the localized degradation of magnesium-based implants in body fluid for better in-service mechanical integrity. Firstly, a silicate-based PEO coating on pure magnesium was performed using a pulsed constant current method. In order to seal the pores in the PEO layer, PLLA was coated using a two-step spin coating method. The performance of the PEO-PLLA Mg was evaluated using electrochemical impedance spectroscopy (EIS) and potentiodynamic polarization. The EIS results showed that the polarization resistance (R-p) of the PEO-PLLA Mg was close to two orders of magnitude higher than that of the PEO Mg. While the corrosion current density (i(corr)) of the pure Mg was reduced by 65% with the PEO coating, the PEO-PLLA coating reduced the i(corr) by almost 100%. As expected, the R-p of the PEO-PLLA Mg decreased with increase in exposure time. However, it was noted that the R-p of the PEO-PLLA Mg even after 100 h was six times higher than that of the PEO Mg after 48 h exposure, and did not show any visible localized attack. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Alabbasi, Alyaa; Mehjabeen, Afrin; Kannan, M. Bobby] James Cook Univ, Biomat & Engn Mat BEM Lab, Townsville, Qld 4811, Australia.
   [Ye, Qingsong] James Cook Univ, Discipline Dent, Townsville, Qld 4811, Australia.
   [Blawert, Carsten] Helmholtz Zentrum Geesthacht, Inst Mat Res, Magnesium Innovat Ctr, D-21502 Geesthacht, Germany.
RP Kannan, MB (reprint author), James Cook Univ, Biomat & Engn Mat BEM Lab, Townsville, Qld 4811, Australia.
EM bobby.mathan@jcu.edu.au
RI Blawert, Carsten/I-3833-2013
OI Ye, Qingsong/0000-0002-2868-9247; Mathan, Bobby
   Kannan/0000-0003-0480-8587
CR Alabbasi A, 2013, MATER LETT, V106, P18, DOI 10.1016/j.matlet.2013.04.047
   Alabbasi A, 2012, THIN SOLID FILMS, V520, P6841, DOI 10.1016/j.tsf.2012.07.090
   Cai JS, 2011, APPL SURF SCI, V257, P3804, DOI 10.1016/j.apsusc.2010.11.153
   DESCHEERDER IK, 1995, ATHEROSCLEROSIS, V114, P105, DOI 10.1016/0021-9150(94)05472-U
   Durdu S, 2012, APPL SURF SCI, V261, P774, DOI 10.1016/j.apsusc.2012.08.099
   Ghasemi A, 2008, SURF COAT TECH, V202, P3513, DOI 10.1016/j.surfcoat.2007.12.033
   Guo HF, 2006, MATER LETT, V60, P1538, DOI 10.1016/j.martlet.2005.11.066
   Harada Y, 2013, SURF COAT TECH, V228, P59, DOI 10.1016/j.surfcoat.2013.04.004
   Hong J, 2011, COLLOID SURFACE A, V381, P7, DOI 10.1016/j.colsurfa.2011.02.014
   Hua L. G., 2010, CHINESE PHYS B, V19
   Ignatius A. A., 1996, BIOMATERIALS, V17, P631
   Kannan M. B., 2013, MATER CHEM PHYS, V142, P1
   Kannan MB, 2013, MAT SCI ENG C-MATER, V33, P675, DOI 10.1016/j.msec.2012.10.017
   Kannan MB, 2012, MATER LETT, V76, P109, DOI 10.1016/j.matlet.2012.02.050
   Kannan MB, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045003
   Kannan MB, 2010, MATER LETT, V64, P739, DOI 10.1016/j.matlet.2010.01.022
   Liang J, 2010, ELECTROCHIM ACTA, V55, P6802, DOI 10.1016/j.electacta.2010.05.087
   Liang J, 2009, ELECTROCHIM ACTA, V54, P3842, DOI 10.1016/j.electacta.2009.02.004
   Lu P, 2011, J BIOMED MATER RES B, V96B, P101, DOI 10.1002/jbm.b.31744
   Rapheal G, 2011, WEAR, V271, P1987, DOI 10.1016/j.wear.2010.12.013
   Song G., 2003, ADV ENG MATER, V12, P837
   Veya E., 2008, POLYM DEGRADATION ST, V93, P1869
   Walter R, 2011, MATER LETT, V65, P748, DOI 10.1016/j.matlet.2010.11.051
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   Zeng LY, 2010, ELECTROCHIM ACTA, V55, P3376, DOI 10.1016/j.electacta.2010.01.041
   ZHANG XC, 1994, J BIOACT COMPAT POL, V9, P80
NR 26
TC 8
Z9 10
U1 0
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAY 15
PY 2014
VL 301
SI SI
BP 463
EP 467
DI 10.1016/j.apsusc.2014.02.100
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA AG0HD
UT WOS:000335095600068
DA 2018-10-20
ER

PT J
AU Shah, R
   Saha, N
   Kitano, T
   Saha, P
AF Shah, Rushita
   Saha, Nabanita
   Kitano, Takeshi
   Saha, Petr
TI Preparation of CaCO3- Based Biomineralized Polyvinylpyrrolidone-
   Carboxymethylcellulose Hydrogels and Their Viscoelastic Behavior
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomimetic; swelling; functionalization of polymers; CaCO3;
   biomineralized hydrogel
ID PVP-CMC HYDROGEL; CALCIUM-CARBONATE; BIOMIMETIC MINERALIZATION;
   CRYSTALLIZATION
AB In the blend of natural and synthetic polymer-based biomaterial of polyvinylpyrrolidone (PVP) and carboxymethylcellulose (CMC), fabrication of CaCO3 was successfully accomplished using simple liquid diffusion technique. The present study emphasizes the biomimetic mineralization in PVP-CMC hydrogel, and furthermore, several properties of this regenerated and functionalized hydrogel membranes were investigated. The physical properties were studied and confirmed the presence of CaCO3 mineral in hydrogel by Fourier transform infrared spectroscopy and Scanning electron microscopy. Moreover, the absorptivity of water and mineral by PVP-CMC hydrogel was studied to determine its absorption capacity. Further, the viscoelastic properties (storage modulus, loss modulus, and complex viscosity) of mineralized and swelled samples (time: 5-150 min) were measured against angular frequency. It is interesting to know the increase of elastic nature of mineralized hydrogel filled with CaCO3 maintaining the correlation between elastic property and viscous one of pure hydrogel. All these properties of biomineralized hydrogel suggest its application in biomedical field, like bone treatment, bone tissue regeneration, dental plaque and tissue replacement, etc. (c) 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014, 131, 40237.
C1 [Shah, Rushita; Saha, Nabanita; Kitano, Takeshi; Saha, Petr] Tomas Bata Univ Zlin, Fac Technol, Polymer Ctr, Zlin 76272, Czech Republic.
   [Saha, Nabanita; Kitano, Takeshi; Saha, Petr] Tomas Bata Univ Zlin, Univ Inst, Ctr Polymer Syst, Zlin 76001, Czech Republic.
RP Saha, N (reprint author), Tomas Bata Univ Zlin, Fac Technol, Polymer Ctr, Nam TG Masaryka 275, Zlin 76272, Czech Republic.
EM nabanitas@yahoo.com
RI Saha, Petr/F-3952-2016
OI Saha, Petr/0000-0002-1873-4163; SAHA, NABANITA/0000-0002-7549-2260
FU Research and Development for Innovation Operational Program; European
   Regional Development Fund (ERDF); national budget of the Czech Republic
   [CZ.1.05/2.1.00/03.0111, CZ.1.07/2.3.00/20.0104]; "Education for
   Competitiveness" Operational Program; European Social Fund (ESF)
FX The authors are thankful for the support of Research and Development for
   Innovation Operational Program co-funded by the European Regional
   Development Fund (ERDF) and national budget of the Czech Republic within
   the framework of the Centre of Polymer Systems project (reg. number:
   CZ.1.05/2.1.00/03.0111) and the support of the "Education for
   Competitiveness" Operational Program co-funded by the European Social
   Fund (ESF) and the national budget of the Czech Republic, within the
   "Advanced Theoretical and Experimental Studies of Polymer Systems"
   project (reg. number: CZ.1.07/2.3.00/20.0104).
CR Aizenberg J, 2004, ADV MATER, V16, P1295, DOI 10.1002/adma.200400759
   Carrillo N. A., 2010, J EUR POLYM J, V46, P1184
   Fathi M, 2013, J POLYM RES, V20, DOI 10.1007/s10965-013-0125-5
   Guzun S. A., 2012, ULTRASON SONOCHEM, V19, P909
   Huang JJ, 2012, CHEM MATER, V24, P1331, DOI 10.1021/cm203764f
   Junji W., 2006, BIOMACROMOLECULES, V7, P3008
   Kim Y. S., 2009, J APPL POLYM SCI, V113, P3460
   Kuang M, 2005, CHEM MATER, V17, P656, DOI 10.1021/cm0484596
   Li HY, 2007, CRYSTENGCOMM, V9, P1153, DOI 10.1039/b709068d
   Ma YF, 2011, J SOLID STATE CHEM, V184, P1008, DOI 10.1016/j.jssc.2011.03.008
   Mahdavinia R. G., 2009, EXPRESS POLYM LETT, V5, P279
   Ni M, 2008, SURF INTERFACE ANAL, V40, P1356, DOI 10.1002/sia.2904
   Nonoyama T, 2012, SOFT MATTER, V8, P11531, DOI 10.1039/c2sm26538a
   Older O y M., 2012, J MATER SCI-MATER M, V23, P1619
   Pasqui D., 2013, J BIOMED MATER RES A, V00A, P1
   Rauch MW, 2012, EUR J INORG CHEM, P5192, DOI 10.1002/ejic.201200575
   Roy N, 2012, CARBOHYD POLYM, V89, P346, DOI 10.1016/j.carbpol.2012.03.008
   Roy N, 2010, J APPL POLYM SCI, V117, P1703, DOI 10.1002/app.32056
   Saha N., 2011, J BIOMATER NANOBIOTE, V2, P85, DOI DOI 10.4236/JBNB.2011.21011
   Saha N, 2013, AIP CONF PROC, V1526, P292, DOI 10.1063/1.4802623
   Saha P, Patent, Patent No. 302405
   Sinha A, 2002, J MATER SYNTH PROCES, V10, P149, DOI 10.1023/A:1021990714066
   Smith E. A., 2012, ADV FUNCT MATER, V22, P2891
   Xia YQ, 2012, BIOMACROMOLECULES, V13, P2299, DOI 10.1021/bm300539f
   Yang X, 2012, CHEM MATER, V24, P1690, DOI 10.1021/cm300298n
   Zhang FJ, 2012, J CENT SOUTH UNIV, V19, P1802, DOI 10.1007/s11771-012-1211-2
   Zhang JT, 2009, ACTA BIOMATER, V5, P488, DOI 10.1016/j.actbio.2008.06.012
   Zhuwei D, 2009, CHINE J CHEM, V27, p2237 
NR 28
TC 8
Z9 8
U1 2
U2 55
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAY 15
PY 2014
VL 131
IS 10
AR 40237
DI 10.1002/app.40237
PG 9
WC Polymer Science
SC Polymer Science
GA AF4EU
UT WOS:000334665000013
DA 2018-10-20
ER

PT J
AU Maho, A
   Detriche, S
   Fonder, G
   Delhalle, J
   Mekhalif, Z
AF Maho, Anthony
   Detriche, Simon
   Fonder, Gregory
   Delhalle, Joseph
   Mekhalif, Zineb
TI Electrochemical Co-Deposition of Phosphonate-Modified Carbon Nanotubes
   and Tantalum on Nitinol
SO CHEMELECTROCHEM
LA English
DT Article
DE electrochemistry; nanotubes; nitinol; phosphonate; tantalum
ID ELECTROPHORETIC DEPOSITION; COMPOSITE COATINGS; MATRIX COMPOSITES;
   ELECTRODEPOSITION; NANOPARTICLES; TITANIUM; SURFACE; FUNCTIONALIZATION;
   HYDROXYAPATITE; FILMS
AB Nitinol substrates are coated with thin surface films made of carbon nanotubes (CNTs) and tantalum (Ta), with the aim of fostering their osseointegration aptitudes. Exceptional mechanical and chemical characteristics of CNTs combined with the resistance to corrosion and strong bioactive properties of tantalum allow for the generation of adherent, protective and functional layers on metallic biomaterial platforms. The composite coatings are elaborated on Nitinol through a two-step electrochemical protocol; firstly, through the electrophoretic deposition of phosphonate-modified CNTs and, secondly, with electrodeposition of Ta. As a preliminary step, phosphonate groups, acting, in addition, as specific Ta-capture entities, are introduced on the CNT sidewalls by means of diazonium derivatives, which imply no hard oxidative treatment. X-ray photoelectron spectroscopy as well as scanning and transmission electronic microscopies are used to analyse the chemical composition, structure and morphology of the different layers.
C1 [Maho, Anthony; Detriche, Simon; Fonder, Gregory; Delhalle, Joseph; Mekhalif, Zineb] Univ Namur, Lab Chem & Electrochem Surfaces, B-5000 Namur, Belgium.
   [Maho, Anthony] Fonds Format Rech Ind & Agr, B-1000 Brussels, Belgium.
RP Maho, A (reprint author), Univ Namur, Lab Chem & Electrochem Surfaces, Rue Bruxelles 61, B-5000 Namur, Belgium.
EM zineb.mekhalif@unamur.be
OI Maho, Anthony/0000-0002-3813-6240
FU Fonds de la Recherche Scientifique (FNRS)
FX A.M. is grateful to Fonds de la Recherche Scientifique (FNRS) for FRIA
   doctoral fellowship.
CR Arnould C, 2008, ELECTROCHIM ACTA, V53, P5632, DOI 10.1016/j.electacta.2008.03.003
   Bahr JL, 2001, CHEM MATER, V13, P3823, DOI 10.1021/cm0109903
   Bai Y, 2010, MAT SCI ENG C-MATER, V30, P1043, DOI 10.1016/j.msec.2010.05.007
   Bakshi SR, 2010, INT MATER REV, V55, P41, DOI 10.1179/095066009X12572530170543
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Besra L, 2007, PROG MATER SCI, V52, P1, DOI 10.1016/j.pmatsci.2006.07.001
   Bicelli LP, 2008, INT J ELECTROCHEM SC, V3, P356
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   Boccaccini A.R., 2012, ELECTROPHORETIC DEPO, P157
   Boccaccini AR, 2006, CARBON, V44, P3149, DOI 10.1016/j.carbon.2006.06.021
   Brovelli D, 1999, LANGMUIR, V15, P4324, DOI 10.1021/la981758n
   Cai JY, 2012, CARBON, V50, P4655, DOI 10.1016/j.carbon.2012.05.055
   Cheng Y, 2006, J MATER SCI, V41, P4961, DOI 10.1007/s10853-006-0096-6
   Cho J, 2009, J MATER SCI, V44, P1934, DOI 10.1007/s10853-009-3262-9
   Datsyuk V, 2008, CARBON, V46, P833, DOI 10.1016/j.carbon.2008.02.012
   De Nardo L, 2012, COATINGS FOR BIOMEDICAL APPLICATIONS, P106
   De Riccardis MF, 2009, KEY ENG MATER, V412, P87, DOI 10.4028/www.scientific.net/KEM.412.87
   Detriche S, 2009, J NANOSCI NANOTECHNO, V9, P6015, DOI 10.1166/jnn.2009.1568
   Elahinia MH, 2012, PROG MATER SCI, V57, P911, DOI 10.1016/j.pmatsci.2011.11.001
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Guerrero G, 2013, DALTON T, V42, P12569, DOI 10.1039/c3dt51193f
   Guirado-Lopez RA, 2007, J PHYS CHEM C, V111, P57, DOI 10.1021/kp064651e
   Harris PJF, 2004, INT MATER REV, V49, P31, DOI 10.1179/095066004225010505
   Jaehne E, 2008, PROG ORG COAT, V61, P211, DOI 10.1016/j.porgcoat.2007.09.044
   Jiang Kyle, 2010, Cutting Edge Nanotechnology, P391
   Kashiwagi T, 2005, NAT MATER, V4, P928, DOI 10.1038/nmat1502
   Kim JC, 2013, MATER LETT, V104, P13, DOI 10.1016/j.matlet.2013.04.013
   Low CTJ, 2006, SURF COAT TECH, V201, P371, DOI 10.1016/j.surfcoat.2005.11.123
   Maho A, 2013, ELECTROCHIM ACTA, V89, P346, DOI 10.1016/j.electacta.2012.11.026
   Maho A, 2013, MAT SCI ENG C-MATER, V33, P2686, DOI 10.1016/j.msec.2013.02.025
   Mantovani D, 2000, JOM-J MIN MET MAT S, V52, P36, DOI 10.1007/s11837-000-0082-4
   Milosev I, 2012, MAT SCI ENG C-MATER, V32, P2604, DOI 10.1016/j.msec.2012.08.010
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR, P33
   Musiani M, 2000, ELECTROCHIM ACTA, V45, P3397, DOI 10.1016/S0013-4686(00)00438-2
   Oki A, 2008, MATER LETT, V62, P918, DOI 10.1016/j.matlet.2007.07.030
   Okpalugo TIT, 2005, CARBON, V43, P153, DOI 10.1016/j.carbon.2004.08.033
   Raicopol M, 2012, SURF INTERFACE ANAL, V44, P1081, DOI 10.1002/sia.4830
   Reclaru L, 1998, BIOMATERIALS, V19, P85, DOI 10.1016/S0142-9612(97)00179-8
   Sainsbury T, 2004, CHEM MATER, V16, P3780, DOI 10.1021/cm049151h
   Schubert T., 2008, ELECTRODEPOSITION IO, P83
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Sirivisoot S, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295101
   Sun YP, 2002, ACCOUNTS CHEM RES, V35, P1096, DOI 10.1021/ar010160v
   Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o
   Tsai MC, 2008, MATER CHEM PHYS, V109, P422, DOI 10.1016/j.matchemphys.2007.12.010
   Yang GC, 2012, J SOLID STATE ELECTR, V16, P2967, DOI 10.1007/s10008-012-1713-8
   Zhao B, 2005, CHEM MATER, V17, P3235, DOI 10.1021/cm0500399
NR 47
TC 2
Z9 2
U1 1
U2 28
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 2196-0216
J9 CHEMELECTROCHEM
JI ChemElectroChem
PD MAY 13
PY 2014
VL 1
IS 5
BP 896
EP 902
DI 10.1002/celc.201300197
PG 7
WC Electrochemistry
SC Electrochemistry
GA AK3BD
UT WOS:000338296500009
DA 2018-10-20
ER

PT J
AU Momeni, A
   Filiaggi, MJ
AF Momeni, Arash
   Filiaggi, Mark Joseph
TI Comprehensive Study of the Chelation and Coacervation of Alkaline Earth
   Metals in the Presence of Sodium Polyphosphate Solution
SO LANGMUIR
LA English
DT Article
ID LONG-CHAIN POLYPHOSPHATES; PHOSPHATE-BASED GLASSES; POLYELECTROLYTE
   SOLUTIONS; COUNTERION CONDENSATION; LIMITING LAWS; HYDROLYTIC
   DEGRADATION; CALCIUM POLYPHOSPHATE; VISCOSITY BEHAVIOR; MAGNESIUM;
   CATIONS
AB The effect of chelation of three alkaline earth metals (Ca, Sr, and Ba) by polyphosphates on the pH and viscosity of the solution is examined and correlated to the phosphate glass properties. Also, the impact of the polyphosphate average degree of polymerization ((D-p) over bar) as well as the type and amount of chelated divalent cation on the degradation rate of the chains is studied. Subsequently, the number of divalent cations required for polyphosphate chain agglomeration to form a coacervate, and the resulting composition of these coacervates, was investigated. A decrease in polyphosphate solution pH during chelation was routinely obtained, with a sudden shift in the rate of pH drop occurring around a divalent cation/phosphorus molar ratio of 0.18. Longer chains or cations with a smaller ionic radius accelerated the rate of (D-p) over bar reduction. The number of divalent cations required for coacervation depends on different variables such as the polyphosphate concentration, the (D-p) over bar, and the type of divalent cation. The formed coacenrate retains the (D-p) over bar of polyphosphate originally used for coacervation, and the resulting Ca/P molar ratio depends largely on the amount of calcium being used during coacervation. Overall, this article helps one to understand the coacervation of polyphosphates in order to exploit their potential as a biomaterial.
C1 [Momeni, Arash; Filiaggi, Mark Joseph] Dalhousie Univ, Sch Biomed Engn, Halifax, NS B3H 3J5, Canada.
   [Filiaggi, Mark Joseph] Dalhousie Univ, Dept Appl Oral Sci, Fac Dent, Halifax, NS B3H 3J5, Canada.
RP Filiaggi, MJ (reprint author), Dalhousie Univ, Sch Biomed Engn, Halifax, NS B3H 3J5, Canada.
EM filiaggi@dal.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   NSERC CREATE BioMedic program
FX We gratefully acknowledge funding from the Natural Sciences and
   Engineering Research Council of Canada (NSERC) and the NSERC CREATE
   BioMedic program (AM).
CR Ahmed I, 2005, J BIOMATER APPL, V20, P65, DOI 10.1177/088532805049396
   Bigerelle M, 2001, J MATER SCI LETT, V20, P1037, DOI 10.1023/A:1010964525476
   Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1
   CALLIS CF, 1954, CHEM REV, V54, P777, DOI 10.1021/cr60171a002
   Conway B. E., 1981, IONIC HYDRATION CHEM
   da Silva RV, 2007, J CRANIOFAC SURG, V18, P281, DOI 10.1097/scs.0b013e31802d8ac4
   Das SS, 2001, PHYS CHEM GLASSES, V42, P74
   de Oliveira CIR, 2005, SPECTROCHIM ACTA A, V61, P2023, DOI 10.1016/j.saa.2004.01.036
   de Oliveira LFC, 2009, J SOL-GEL SCI TECHN, V50, P158, DOI 10.1007/s10971-009-1965-7
   deSouza EF, 1997, POLYMER, V38, P6285
   Dias Filho F. A., 2005, LANGMUIR, V21, P1776
   Frankenthal L, 1944, J AM CHEM SOC, V66, P2124, DOI 10.1021/ja01240a504
   Gander B., 2007, ENCY PHARM TECHNOLOG, P600
   GILL JB, 1969, J CHEM SOC A, P183, DOI 10.1039/j19690000183
   Gomez F, 1997, J NON-CRYST SOLIDS, V222, P415, DOI 10.1016/S0022-3093(97)90144-7
   Griffith E. J., 1975, 2 S IN PHOSPH COMP P
   HANDLOSER CS, 1973, J CHEM EDUC, V50, P510, DOI 10.1021/ed050p510
   Hoppe U, 1996, J NON-CRYST SOLIDS, V195, P138, DOI 10.1016/0022-3093(95)00524-2
   HUFFMAN EO, 1960, J PHYS CHEM-US, V64, P240, DOI 10.1021/j100831a014
   Iost A, 1999, J MATER SCI, V34, P3991, DOI 10.1023/A:1004699528748
   Jia P., 2009, J CHEM PHYS, V131
   KANAZAWA T, 1974, B CHEM SOC JPN, V47, P1419, DOI 10.1246/bcsj.47.1419
   Lee IH, 2013, J NON-CRYST SOLIDS, V363, P57, DOI 10.1016/j.jnoncrysol.2012.11.036
   Lima ECD, 1995, J COLLOID INTERF SCI, V176, P388
   MANNING GS, 1969, J CHEM PHYS, V51, P934, DOI 10.1063/1.1672158
   MANNING GS, 1969, J CHEM PHYS, V51, P3249, DOI 10.1063/1.1672502
   MANNING GS, 1969, J CHEM PHYS, V51, P924, DOI 10.1063/1.1672157
   Martell AE, 1974, CRITICAL STABILITY C, V1
   Masson NC, 1997, COLLOID SURFACE A, V121, P247, DOI 10.1016/S0927-7757(96)03985-4
   MCCULLOUGH JF, 1956, J AM CHEM SOC, V78, P4528, DOI 10.1021/ja01599a006
   MEHROTRA RC, 1975, PURE APPL CHEM, V44, P201, DOI 10.1351/pac197544020201
   MEHROTRA RC, 1961, J POLYM SCI, V55, P81, DOI 10.1002/pol.1961.1205516109
   MILLER DL, 1969, J AM CHEM SOC, V91, P6882, DOI 10.1021/ja01052a076
   Momeni A, 2013, J NON-CRYST SOLIDS, V382, P11, DOI 10.1016/j.jnoncrysol.2013.10.003
   PALAVIT G, 1995, J NON-CRYST SOLIDS, V189, P277, DOI 10.1016/0022-3093(95)00236-7
   PFANSTIEL R, 1952, J AM CHEM SOC, V74, P6059, DOI 10.1021/ja01143a069
   Pickup DM, 2014, J BIOMATER APPL, V28, P1226, DOI 10.1177/0885328213502586
   Radeva T., 2001, PHYS CHEM POLYELECTR
   Sabbagh I, 1999, EUR PHYS J B, V12, P253, DOI 10.1007/s100510051002
   Sabbagh I, 2000, EUR PHYS J E, V1, P75, DOI 10.1007/s101890050009
   Salih V, 2007, BIOMED MATER, V2, P11, DOI 10.1088/1748-6041/2/1/003
   Sillen L. G., 1964, STABILITY CONSTANTS
   Silva MAP, 2008, J PHYS CHEM A, V112, P5385, DOI 10.1021/jp801585v
   Silva MAP, 2010, MATER CHEM PHYS, V124, P547, DOI 10.1016/j.matchemphys.2010.07.008
   Sinyaev VA, 2001, INORG MATER+, V37, P619, DOI 10.1023/A:1017572502092
   Strauss U.P., 1967, J POLYM SCI C, V16, P2171, DOI [10.1002/polc.5070160431, DOI 10.1002/POLC.5070160431]
   STRAUSS UP, 1959, J AM CHEM SOC, V81, P5299, DOI 10.1021/ja01529a013
   THILO E, 1962, ADV INORG CHEM, V4, P1, DOI 10.1016/S0065-2792(08)60265-4
   Tischendorf B, 2001, J NON-CRYST SOLIDS, V282, P147, DOI 10.1016/S0022-3093(01)00350-7
   Toyoda S, 2003, J NON-CRYST SOLIDS, V321, P169, DOI 10.1016/S0022-3093(03)00174-1
   UMEGAKI T, 1979, B CHEM SOC JPN, V52, P2124, DOI 10.1246/bcsj.52.2124
   UMEGAKI T, 1975, B CHEM SOC JPN, V48, P1452, DOI 10.1246/bcsj.48.1452
   VANSTEVENINCK J, 1966, BIOCHEMISTRY-US, V5, P1998, DOI 10.1021/bi00870a030
   VANWAZER JR, 1958, CHEM REV, V58, P1011, DOI 10.1021/cr50024a001
   VANWAZER JR, 1956, J AM CHEM SOC, V78, P5715, DOI 10.1021/ja01603a002
   VANWAZER JR, 1958, PHOSPHORUS ITS COMPO, V1
   Wazer J. R. V., 1950, J AM CERAM SOC, V72, P655
   Willot G, 2002, CR CHIM, V5, P899, DOI 10.1016/S1631-0748(02)01454-6
   WOLHOFF JA, 1959, RECL TRAV CHIM PAY B, V78, P759, DOI 10.1002/recl.19590781005
   YOZA N, 1994, FRESEN J ANAL CHEM, V348, P633, DOI 10.1007/BF00325563
NR 60
TC 11
Z9 11
U1 7
U2 62
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 13
PY 2014
VL 30
IS 18
BP 5256
EP 5266
DI 10.1021/la500474j
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AH3JZ
UT WOS:000336020800027
PM 24746316
DA 2018-10-20
ER

PT J
AU Kundu, B
   Schlimp, CJ
   Nurnberger, S
   Redl, H
   Kundu, SC
AF Kundu, Banani
   Schlimp, Christoph J.
   Nuernberger, Sylvia
   Redl, Heinz
   Kundu, S. C.
TI Thromboelastometric and platelet responses to silk biomaterials
SO SCIENTIFIC REPORTS
LA English
DT Article
ID WHOLE-BLOOD; BIOMEDICAL APPLICATIONS; FIBROIN; COAGULATION;
   ANTICOAGULANT; SCAFFOLDS; MICROPARTICLES; ACTIVATION; MEMBRANE;
   BIOCOMPATIBILITY
AB Silkworm's silk is natural biopolymer with unique properties including mechanical robustness, all aqueous base processing and ease in fabrication into different multifunctional templates. Additionally, the nonmulberry silks have cell adhesion promoting tri-peptide (RGD) sequences, which make it an immensely potential platform for regenerative medicine. The compatibility of nonmulberry silk with human blood is still elusive; thereby, restricts its further application as implants. The present study, therefore, evaluate the haematocompatibility of silk biomaterials in terms of platelet interaction after exposure to nonmulberry silk of Antheraea mylitta using thromboelastometry (ROTEM (R)). The mulberry silk of Bombyx mori and clinically used Uni-Graft((R)) W biomaterial serve as references. Shortened clotting time, clot formation times as well as enhanced clot strength indicate the platelet mediated activation of blood coagulation cascade by tested biomaterials; which is comparable to controls.
C1 [Kundu, Banani; Kundu, S. C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Schlimp, Christoph J.; Nuernberger, Sylvia; Redl, Heinz] Austrian Cluster Tissue Regenerat, Ludwig Boltzmann Inst Expt & Clin Traumatol, AUVA Res Ctr, Vienna, Austria.
RP Redl, H (reprint author), Austrian Cluster Tissue Regenerat, Ludwig Boltzmann Inst Expt & Clin Traumatol, AUVA Res Ctr, Vienna, Austria.
EM office@trauma.lbg.ac.at; kundu@hijli.iitkgp.ernet.in
RI Kundu, Subhas/P-1989-2016; Kundu, Banani/O-9320-2016
OI Kundu, Subhas/0000-0002-7170-2291; Kundu, Banani/0000-0003-1251-700X;
   Nurnberger, Sylvia/0000-0002-5175-5118
FU OEAD Indo-Austria collaborative fund; Department of Science and
   Technology; Department of Biotechnology (SCK); Council of Scientific and
   Industrial Research, Govt of India, New Delhi
FX The work was financially supported by OEAD Indo-Austria collaborative
   fund, Department of Science and Technology, Department of Biotechnology
   (SCK), and Council of Scientific and Industrial Research (for individual
   fellowship to Banani), Govt of India, New Delhi. We thank Anna Khadem
   and Anton Klotz from the Ludwig Boltzmann Institute for Experimental and
   Clinical Traumatology for their technical assistance. One of the ROTEM
   devices used in this study was provided by TEM International.
CR Anderson J. M., 1996, INTRO MAT MED, P165
   Basmadjian D, 1997, BIOMATERIALS, V18, P1511, DOI 10.1016/S0142-9612(97)00101-4
   Campbell E. J., 1994, ASAIO J, V40, pM241
   Capila I., 2002, ANGEW CHEM INT EDIT, V1, 3, p[41, 390], DOI DOI 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.C0;2-B
   Chandy T, 2000, BIOMATERIALS, V21, P699, DOI 10.1016/S0142-9612(99)00231-8
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   Hanke AA, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-12
   Heijnen HFG, 1999, BLOOD, V94, P3791
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   Iwata H, 2004, BIOCHEM BIOPH RES CO, V316, P65, DOI 10.1016/j.bbrc.2004.02.020
   Ji XB, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-44
   JY W, 1992, J LAB CLIN MED, V119, P334
   Kasahara K., 2009, BLOOD, V115, P1277
   Klement P, 2002, BIOMATERIALS, V23, P527, DOI 10.1016/S0142-9612(01)00135-1
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Lauer P, 2002, THROMB HAEMOSTASIS, V88, P967
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Li QL, 2009, J BIOMED MATER RES A, V89A, P575, DOI 10.1002/jbm.a.31999
   Lippi G, 2008, SEMIN THROMB HEMOST, V34, P604, DOI 10.1055/s-0028-1104539
   Liu HF, 2011, BIOMATERIALS, V32, P3784, DOI 10.1016/j.biomaterials.2011.02.002
   Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031
   Mandal BB, 2009, ACTA BIOMATER, V5, P2579, DOI 10.1016/j.actbio.2009.02.033
   Motta A, 2002, J BIOACT COMPAT POL, V17, P23, DOI 10.1106/088391102023195
   Murugesan S, 2006, LANGMUIR, V22, P3461, DOI 10.1021/la0534468
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nishlbe T, 2007, VASCULAR, V15, P356, DOI 10.2310/6670.2007.00053
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   Perrone GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4385
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Schlimp CJ, 2013, THROMB HAEMOSTASIS, V109, P356, DOI 10.1160/TH12-09-0646
   Schlimp CJ, 2012, BLOOD TRANSFUS, V13, P1, DOI DOI 10.2450/2012.0171-12
   Schmidtke C, 2013, EUR J CARDIO-THORAC, V43, P585, DOI 10.1093/ejcts/ezs318
   Schochl H, 2010, NETH J CRIT CARE, V14, P23
   Schochl H, 2013, J TRAUMA ACUTE CARE, V74, P1587, DOI 10.1097/TA.0b013e31828c3171
   Schochl H, 2012, THROMB RES, V130, pE107, DOI 10.1016/j.thromres.2012.03.006
   Schochl H, 2011, MOL MED, V17, P266, DOI 10.2119/molmed.2010.00159
   Seib FP, 2012, BIOMATERIALS, V33, P1017, DOI 10.1016/j.biomaterials.2011.10.063
   Shankarraman V, 2012, J BIOMED MATER RES B, V100B, P230, DOI 10.1002/jbm.b.31942
   Snyder TA, 2007, J BIOMED MATER RES A, V81A, P85, DOI 10.1002/jbm.a.31006
   Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041
   Tamada Y, 2004, BIOMATERIALS, V25, P377, DOI 10.1016/S0142-9612(03)00533-7
   TANS G, 1991, BLOOD, V77, P2641
   Wei HL, 2013, ACS APPL MATER INTER, V5, P12571, DOI 10.1021/am403882x
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Zipperle J, 2013, THROMB HAEMOSTASIS, V109, P869, DOI 10.1160/TH12-10-0767
   ZWAAL RFA, 1989, MOL CELL BIOCHEM, V91, P23, DOI 10.1007/BF00228075
NR 49
TC 4
Z9 4
U1 0
U2 33
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 13
PY 2014
VL 4
AR 4945
DI 10.1038/srep04945
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AG9FR
UT WOS:000335725300002
PM 24824624
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zhang, TY
   Klapper, I
AF Zhang, Tianyu
   Klapper, Isaac
TI Critical occlusion via biofilm induced calcite precipitation in porous
   media
SO NEW JOURNAL OF PHYSICS
LA English
DT Article
DE biofilms; mineralization; porous media
ID CARBONATE PRECIPITATION; KINETICS; LEAKAGE; WATER; FLOW
AB A model for biofilm induced calcite precipitation with pressure driven flow is presented at the scale of a single pore within a porous medium. The system, an extension of previous work (Zhang and Klapper 2010 Water Sci. Technol. 61 2957-64, Zhang and Klapper 2011 Int. J. Non-Linear Mech. 46 657-66), is based on a mixture model including biomaterial, mineral, and water with dissolved components. Computational results suggest the possibility of critical occlusion in the sense that there is a distinguished trans-pore pressure head such that for pressure drops below this level, pore clogging occurs relatively quickly while for pressure drops above, clogging occurs after much longer times if at all. Beyond its relevance to engineered biofilm applications, this phenomenon is suggestive of the subtleties of embedding simple biofilm models in larger media.
C1 [Zhang, Tianyu] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA.
   [Klapper, Isaac] Temple Univ, Dept Math, Philadelphia, PA 19122 USA.
RP Zhang, TY (reprint author), Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA.
EM klapper@temple.edu
FU NSF [DMS-0934696]
FX The authors would like to thank James Connolly and Robin Gerlach for
   their assistance and would like to acknowledge support by the NSF
   through grant DMS-0934696.
CR Al-Thawadi S M, 2011, J ADV SCI ENG RES, V1, P98
   Allison D, 1991, MINITEQ2 PRODEFA2 GE
   Cunningham AB, 2011, ENRGY PROCED, V4, P5178, DOI 10.1016/j.egypro.2011.02.495
   Davies C W, 1962, ION ASS, P37
   De Muynck W, 2010, ECOL ENG, V36, P118, DOI 10.1016/j.ecoleng.2009.02.006
   Doi M., 1995, INTRO POLYM PHYS
   Ebigbo A, 2010, ADV WATER RESOUR, V33, P762, DOI 10.1016/j.advwatres.2010.04.004
   Guermond JL, 2006, COMPUT METHOD APPL M, V195, P6011, DOI 10.1016/j.cma.2005.10.010
   Guy R, 2004, THESIS U UTAH
   Harned HS, 1958, PHYS CHEM ELECTROLYT
   HELGESON HC, 1969, AM J SCI, V267, P729, DOI 10.2475/ajs.267.7.729
   Klapper I, 2010, SIAM REV, V52, P221, DOI 10.1137/080739720
   Lewandowski Z, 2007, FUNDAMENTALS BIOFILM
   Marini L., 2007, GEOLOGICAL SEQUESTRA
   Mitchell AC, 2005, GEOCHIM COSMOCHIM AC, V69, P4199, DOI 10.1016/j.gca.2005.03.014
   Phillips AJ, 2013, ENVIRON SCI TECHNOL, V47, P142, DOI 10.1021/es301294q
   Pintelon TRR, 2012, BIOTECHNOL BIOENG, V109, P1031, DOI 10.1002/bit.24381
   Shaw T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098102
   Zhang T, 2010, WATER SCI TECHNOL, V61, P2957, DOI 10.2166/wst.2010.064
   Zhang T, 2008, COMMUN COMPUT PHYS, V4, P72
   Zhang TY, 2011, INT J NONLIN MECH, V46, P657, DOI 10.1016/j.ijnonlinmec.2010.12.008
   Zhang YP, 1998, APPL GEOCHEM, V13, P177, DOI 10.1016/S0883-2927(97)00061-9
   Zuddas P, 1998, GEOCHIM COSMOCHIM AC, V62, P757, DOI 10.1016/S0016-7037(98)00026-X
NR 23
TC 5
Z9 5
U1 0
U2 12
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1367-2630
J9 NEW J PHYS
JI New J. Phys.
PD MAY 9
PY 2014
VL 16
AR 055009
DI 10.1088/1367-2630/16/5/055009
PG 22
WC Physics, Multidisciplinary
SC Physics
GA AL0VD
UT WOS:000338844100003
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Russo, L
   Gautieri, A
   Raspanti, M
   Taraballi, F
   Nicotra, F
   Vesentini, S
   Cipolla, L
AF Russo, Laura
   Gautieri, Alfonso
   Raspanti, Mario
   Taraballi, Francesca
   Nicotra, Francesco
   Vesentini, Simone
   Cipolla, Laura
TI Carbohydrate-functionalized collagen matrices: design and
   characterization of a novel neoglycosylated biomaterial
SO CARBOHYDRATE RESEARCH
LA English
DT Article
DE Neoglycosylation; Reductive amination; Lactose; Collagen; AFM; Lectins
ID MOLECULAR-DYNAMICS; TRIPLE-HELIX; CLICK CHEMISTRY; MODEL PEPTIDES;
   IN-VITRO; GLYCOSYLATION; STABILITY; DIFFERENTIATION; BIOCONJUGATION;
   REGENERATION
AB Collagen matrices have been neoglycosylated with lactose by reductive amination at lysine side chains. AFM analysis highlights that the chemical does not affect molecular assembly into fibrils. Moreover, ELLA biochemical assays show that the glycan moiety is efficiently exposed on the matrix surface for receptor recognition. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Russo, Laura; Nicotra, Francesco; Cipolla, Laura] Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy.
   [Gautieri, Alfonso; Vesentini, Simone] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy.
   [Raspanti, Mario] Univ Insubria, Dipartimento Sci Chirurg & Morfol, I-21100 Varese, Italy.
   [Taraballi, Francesca] Methodist Hosp, Res Inst, Dept Nanomed, Houston, TX 77030 USA.
   [Taraballi, Francesca] Fdn IRCCS Policlin San Matteo, Pain Therapy Serv, I-27100 Pavia, Italy.
RP Cipolla, L (reprint author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Piazza Sci 2, Milan, Italy.
EM laura.cipolla@unimib.it
RI Russo, Laura/I-3237-2014; Gautieri, Alfonso/L-7500-2015
OI Russo, Laura/0000-0002-5914-766X; Gautieri, Alfonso/0000-0003-0492-0130;
   Taraballi, Francesca/0000-0002-4959-1169; Cipolla,
   Laura/0000-0003-2678-8329
FU Fondazione Cariplo [2011-0270]
FX This work has been supported by Fondazione Cariplo, grant no 2011-0270.
CR Abou Neel EA, 2013, ADV DRUG DELIVER REV, V65, P429, DOI 10.1016/j.addr.2012.08.010
   Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241
   Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Chawla K, 2012, BIOMATERIALS, V33, P6052, DOI 10.1016/j.biomaterials.2012.04.058
   Cipolla L., 2012, SPECIALIST PERIODICA, V38
   Duin ACTv, 2001, J PHYS CHEM A, V105, P9396
   Ehrlich H, 2009, INT J BIOL MACROMOL, V44, P51, DOI 10.1016/j.ijbiomac.2008.10.001
   Erdmann RS, 2012, ORG BIOMOL CHEM, V10, P1982, DOI 10.1039/c2ob06720j
   Esser-Kahn AP, 2008, ANGEW CHEM INT EDIT, V47, P3751, DOI 10.1002/anie.200705564
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Fields GB, 2010, ORG BIOMOL CHEM, V8, P1237, DOI 10.1039/b920670a
   Gautieri A, 2008, J BIOMECH, V41, P3073, DOI 10.1016/j.jbiomech.2008.06.028
   Gautieri A, 2010, J CHEM THEORY COMPUT, V6, P1210, DOI 10.1021/ct100015v
   Gautieri A, 2009, INT J MATER RES, V100, P921, DOI 10.3139/146.110132
   GRAY GR, 1974, ARCH BIOCHEM BIOPHYS, V163, P426, DOI 10.1016/0003-9861(74)90495-0
   Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053
   Hudak JE, 2012, ANGEW CHEM INT EDIT, V51, P4161, DOI 10.1002/anie.201108130
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jurgensen HJ, 2011, J BIOL CHEM, V286, P32736, DOI 10.1074/jbc.M111.266692
   Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349
   Koepsel JT, 2012, CHEMBIOCHEM, V13, P1717, DOI 10.1002/cbic.201200226
   Masand SN, 2012, BIOMATERIALS, V33, P790, DOI 10.1016/j.biomaterials.2011.10.013
   Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]
   Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019
   OIKARINEN A, 1976, BIOCHEM J, V156, P545, DOI 10.1042/bj1560545
   Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d
   Persikov AV, 2000, BIOPOLYMERS, V55, P436, DOI 10.1002/1097-0282(2000)55:6<436::AID-BIP1019>3.0.CO;2-D
   PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039
   Rainey J., 2004, PROTEIN SCI, V13, P2748
   Rainey JK, 2004, BIOINFORMATICS, V20, P2458, DOI 10.1093/bioinformatics/bth247
   Santoyo-Gonzalez F, 2009, CHEM SOC REV, V38, P3449, DOI 10.1039/b909363j
   Sapsford KE, 2013, CHEM REV, V113, P1904, DOI 10.1021/cr300143v
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Slaney AM, 2011, ACS APPL MATER INTER, V3, P1601, DOI 10.1021/am200158y
   Sricholpech M, 2012, J BIOL CHEM, V287, P22998, DOI 10.1074/jbc.M112.343954
   Srinivasan M, 2010, MATH MECH SOLIDS, V15, P755, DOI 10.1177/1081286510374550
   Srinivasan M, 2009, J STRUCT BIOL, V168, P503, DOI 10.1016/j.jsb.2009.08.015
   Stephanopoulos N, 2011, NAT CHEM BIOL, V7, P876, DOI [10.1038/nchembio.720, 10.1038/NCHEMBIO.720]
   Taga Y, 2013, J PROTEOME RES, V12, P2225, DOI 10.1021/pr400079d
   Taraballi F, 2013, J COLLOID INTERF SCI, V394, P590, DOI 10.1016/j.jcis.2012.11.041
   Tilley SD, 2008, WILEY ENCY CHEM BIOL
   Tirrell DA, 2004, NATURE, V430, P837, DOI 10.1038/430837a
   van Dongen S. F. M., 2009, BIOCONJUCATE CHEM, V1, P20
   van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203
   Veld PJ, 2008, BIOPHYS J, V95, P33, DOI 10.1529/biophysj.107.120659
NR 48
TC 10
Z9 10
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0008-6215
EI 1873-426X
J9 CARBOHYD RES
JI Carbohydr. Res.
PD MAY 7
PY 2014
VL 389
BP 12
EP 17
DI 10.1016/j.carres.2013.11.008
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA AF5MC
UT WOS:000334756600003
PM 24332940
DA 2018-10-20
ER

PT J
AU Prabhawathi, V
   Boobalan, T
   Sivakumar, PM
   Doble, M
AF Prabhawathi, Veluchamy
   Boobalan, Thulasinathan
   Sivakumar, Ponnurengam Malliappan
   Doble, Mukesh
TI Antibiofilm Properties of Interfacially Active Lipase Immobilized Porous
   Polycaprolactam Prepared by LB Technique
SO PLOS ONE
LA English
DT Article
ID LANGMUIR-BLODGETT-FILMS; BACTERIAL ADHESION; HYDROPHOBICITY; ATTACHMENT;
   SURFACES; ACTIVATION; ADSORPTION; STRATEGIES; MONOLAYERS; STABILITY
AB Porous biomaterial is the preferred implant due to the interconnectivity of the pores. Chances of infection due to biofilm are also high in these biomaterials because of the presence of pores. Although biofilm in implants contributes to 80% of human infections [1], there are no commercially available natural therapeutics against it. In the current study, glutaraldehyde cross linked lipase was transferred onto a activated porous polycaprolactam surface using Langmuir-Blodgett deposition technique, and its thermostability, slimicidal, antibacterial, biocompatibility and surface properties were studied. There was a 20% increase in the activity of the covalently crosslinked lipase when compared to its free form. This immobilized surface was thermostable and retained activity and stability until 100 degrees C. There was a 2 and 7 times reduction in carbohydrate and 9 and 5 times reduction in biofilm protein of Staphylococcus aureus and Escherichia coli respectively on lipase immobilized polycaprolactam (LIP) when compared to uncoated polycaprolactam (UP). The number of live bacterial colonies on LIP was four times less than on UP. Lipase acted on the cell wall of the bacteria leading to its death, which was confirmed from AFM, fluorescence microscopic images and amount of lactate dehydrogenase released. LIP allowed proliferation of more than 90% of 3T3 cells indicating that it was biocompatible. The fact that LIP exhibits antimicrobial property at the air-water interface to hydrophobic as well as hydrophilic bacteria along with lack of cytotoxicity makes it an ideal biomaterial for biofilm prevention in implants.
C1 [Prabhawathi, Veluchamy; Boobalan, Thulasinathan; Sivakumar, Ponnurengam Malliappan; Doble, Mukesh] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
RP Doble, M (reprint author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
EM mukeshd@iitm.ac.in
OI Sivakumar, Ponnurengam Malliappan/0000-0002-5880-9596; Doble,
   Mukeshd/0000-0002-4335-0698
CR Amro NA, 2000, LANGMUIR, V16, P2789, DOI 10.1021/la991013x
   Aumsuwan N, 2008, BIOMACROMOLECULES, V9, P1712, DOI 10.1021/bm800176t
   Britt DW, 2001, LANGMUIR, V17, P3757, DOI 10.1021/la001240v
   BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0
   Candan F, 2003, J ETHNOPHARMACOL, V87, P215, DOI 10.1016/S0378-8741(03)00149-1
   Carvajal JC, 2009, US patent, Patent No. [0238811 A1, 0238811]
   Chiou SH, 2004, BIOMATERIALS, V25, P197, DOI 10.1016/S0142-9612(03)00482-4
   Chui WK, 1997, J MICROENCAPSUL, V14, P51, DOI 10.3109/02652049709056467
   Ciston S, 2008, J MEMBRANE SCI, V320, P101, DOI 10.1016/j.memsci.2008.03.065
   Clifford JS, 2005, BIOTECHNOL BIOENG, V92, P231, DOI 10.1002/bit.20595
   Corpe W., 1980, ADSORPTION MICROORGA, P105
   Costa SA, 2005, ENZYME IMMOBILIZATIO, P301
   Dave RN, 2011, ANTIMICROB AGENTS CH, V55, P845, DOI 10.1128/AAC.00477-10
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x
   Doi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049051
   EGINTON PJ, 1995, COLLOID SURFACE B, V5, P153, DOI 10.1016/0927-7765(95)01219-9
   EMBS F, 1991, ADV MATER, V3, P25, DOI 10.1002/adma.19910030106
   FERNANDEZLAFUENTE R, 1993, ENZYME MICROB TECH, V15, P546, DOI 10.1016/0141-0229(93)90016-U
   Gaines G. L., 1966, INSOLUBLE MONOLAYER
   Girard-Egrot AP, 2010, INT J NANOTECHNOL, V7, P753, DOI 10.1504/IJNT.2010.031743
   Gupta R, 2004, APPL MICROBIOL BIOT, V64, P763, DOI 10.1007/s00253-004-1568-8
   Habash MB, 2000, COLLOID SURFACE B, V19, P13, DOI 10.1016/S0927-7765(00)00131-4
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kristensen JB, 2008, BIOTECHNOL ADV, V26, P471, DOI 10.1016/j.biotechadv.2008.05.005
   Kumar D, 2012, J MICROBIOL BIOTECHN, V2, P521
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Lin DQ, 2003, BIOTECHNOL BIOENG, V83, P149, DOI 10.1002/bit.10654
   MACRITCHIE F, 1977, J COLLOID INTERF SCI, V61, P223, DOI 10.1016/0021-9797(77)90384-8
   Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018
   Meincken A, 2005, ANTIMICROB AGENTS CH, V49, P4085, DOI 10.1128/AAC.49.10.4085-4092.2005
   Miller BF, 1992, ENCY DICT MED NURSIN
   NICOLINI C, 1993, BIOCHIM BIOPHYS ACTA, V1158, P273, DOI 10.1016/0304-4165(93)90025-4
   Nicolini C, 2008, BIOSYSTEMS, V94, P228, DOI 10.1016/j.biosystems.2008.06.010
   Nuhiji E, 2012, ACS APPL MATER INTER, V4, P2912, DOI 10.1021/am300087k
   Pavithra D, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034003
   Petersen MTN, 2001, J BIOTECHNOL, V85, P115
   Potera C, 2010, ENVIRON HEALTH PERSP, V118, pA288, DOI 10.1289/ehp.118-a288
   Prabhawathi V, 2012, IND ENG CHEM RES, V51, P5230, DOI 10.1021/ie2029392
   Prasanna SS, 2008, J INDIAN I SCI, V88, P27
   Rather PN, 2005, ENVIRON MICROBIOL, V7, P1065, DOI 10.1111/j.1462-2920.2005.00806.x
   REIFSTECK F, 1987, J MED MICROBIOL, V24, P65, DOI 10.1099/00222615-24-1-65
   Rodrigues RC, 2013, CHEM SOC REV, V42, P6290, DOI 10.1039/c2cs35231a
   Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1016/0378-1097(80)90106-8
   Sanchez-Gonzalez J, 2003, J COLLOID INTERF SCI, V267, P286, DOI 10.1016/S0021-9797(03)00754-9
   Sawant SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063311
   Schwartz MK, 1966, METHOD ENZYMOL, V9, P294, DOI 10.1016/0076-6879(66)09062-1
   Sivakumar PM, 2010, COLLOID SURFACE B, V81, P439, DOI 10.1016/j.colsurfb.2010.07.037
   Sivakumar PM, 2010, APPL SURF SCI, V256, P6018, DOI 10.1016/j.apsusc.2010.03.112
   Sivakumar PM, 2010, CARBOHYD POLYM, V79, P717, DOI 10.1016/j.carbpol.2009.09.027
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Veluchamy P, 2011, J AGR FOOD CHEM, V59, P10869, DOI 10.1021/jf201124v
   Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15
   Zanon NCM, 2012, J COLLOID INTERF SCI, V373, P69, DOI 10.1016/j.jcis.2011.07.095
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zhao Q, 2007, APPL SURF SCI, V253, P8674, DOI 10.1016/j.apsusc.2007.04.044
NR 57
TC 3
Z9 4
U1 2
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 5
PY 2014
VL 9
IS 5
AR e96152
DI 10.1371/journal.pone.0096152
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI1ZV
UT WOS:000336656000041
PM 24798482
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Rodrigues, C
   de Assis, AM
   Moura, DJ
   Halmenschlager, G
   Saffi, J
   Xavier, LL
   Fernandes, MD
   Wink, MR
AF Rodrigues, Cristiano
   de Assis, Adriano M.
   Moura, Dinara J.
   Halmenschlager, Graziele
   Saffi, Jenifer
   Xavier, Leder Leal
   Fernandes, Marilda da Cruz
   Wink, Marcia Rosangela
TI New Therapy of Skin Repair Combining Adipose-Derived Mesenchymal Stem
   Cells with Sodium Carboxymethylcellulose Scaffold in a Pre-Clinical Rat
   Model
SO PLOS ONE
LA English
DT Article
ID COMET ASSAY; DNA-DAMAGE; STROMAL CELLS; GROWTH-FACTOR; WOUND REPAIR;
   BONE-MARROW; GEL TEST; TISSUE; DIFFERENTIATION
AB Lesions with great loss of skin and extensive burns are usually treated with heterologous skin grafts, which may lead rejection. Cell therapy with mesenchymal stem cells is arising as a new proposal to accelerate the healing process. We tested a new therapy consisting of sodium carboxymethylcellulose (CMC) as a biomaterial, in combination with adipose-derived stem cells (ADSCs), to treat skin lesions in an in vivo rat model. This biomaterial did not affect membrane viability and induced a small and transient genotoxicity, only at the highest concentration tested (40 mg/mL). In a rat wound model, CMC at 10 mg/mL associated with ADSCs increased the rate of cell proliferation of the granulation tissue and epithelium thickness when compared to untreated lesions (Sham), but did not increase collagen fibers nor alter the overall speed of wound closure. Taken together, the results show that the CMC is capable to allow the growth of ADSCs and is safe for this biological application up to the concentration of 20 mg/mL. These findings suggest that CMC is a promising biomaterial to be used in cell therapy.
C1 [Rodrigues, Cristiano; de Assis, Adriano M.; Wink, Marcia Rosangela] Univ Fed Ciencias Saude Porto Alegre, Dept Ciencias Basicas Saude, Lab Pesquisa Biol Celular, Porto Alegre, RS, Brazil.
   [Moura, Dinara J.; Halmenschlager, Graziele; Saffi, Jenifer] Univ Fed Ciencias Saude Porto Alegre, Dept Ciencias Basicas Saude, Porto Alegre, RS, Brazil.
   [de Assis, Adriano M.] Univ Fed Rio Grande do Sul, Dept Bioquim, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil.
   [Xavier, Leder Leal] Pontificia Univ Catolica Rio Grande do Sul, Dept Ciencias Morfofisiol, Lab Biol Celular & Tecidual, Porto Alegre, RS, Brazil.
   [Fernandes, Marilda da Cruz] Univ Fed Ciencias Saude Porto Alegre, Dept Ciencias Basicas Saude, Lab Pesquisa Patol, Porto Alegre, RS, Brazil.
RP Wink, MR (reprint author), Univ Fed Ciencias Saude Porto Alegre, Dept Ciencias Basicas Saude, Lab Pesquisa Biol Celular, Porto Alegre, RS, Brazil.
EM mwink@ufcspa.edu.br
RI Xavier, Leder/G-4540-2014; Fernandes, Marilda/L-2819-2016; de Assis,
   Adriano/H-2606-2013
OI Xavier, Leder/0000-0002-7213-4935; Fernandes,
   Marilda/0000-0003-4234-797X; de Assis, Adriano/0000-0002-1953-7831;
   Moura, Dinara/0000-0002-7232-5002
FU CAPES-REUNI program (Coordenacao de aperfeicoamento de Pessoal de Nivel
   Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico); PRONEX; PRONEM - FAPERGS (Fundacao de Amparo a Pesquisa do
   Estado do Rio Grande do Sul); PROBITEC-CAPES
FX C. Rodrigues was the recipient of a Master fellowship from CAPES-REUNI
   program (Coordenacao de aperfeicoamento de Pessoal de Nivel Superior);
   M. R. Wink, L. L. Xavier, and J. Saffi are recipients of research
   fellowships from CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico). This study was supported by PRONEX and PRONEM - FAPERGS
   (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul) and
   PROBITEC-CAPES. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Albuquerque-Júnior Ricardo Luiz Cavalcanti de, 2009, Int. J. Morphol., V27, P1105, DOI 10.4067/S0717-95022009000400025
   Balaji S, 2012, ADV WOUND CARE, V1, P159, DOI 10.1089/wound.2012.0361
   Balbino Carlos Aberto, 2005, Rev. Bras. Cienc. Farm., V41, P27, DOI 10.1590/S1516-93322005000100004
   Chen Ming, 2009, Critical Reviews in Biomedical Engineering, V37, P399
   de Souza DB, 2012, J ANDROL, V33, P735, DOI 10.2164/jandrol.111.014225
   Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8
   Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908
   Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159
   Harding Keith G, 2005, Int Wound J, V2, P364, DOI 10.1111/j.1742-4801.2005.00149.x
   Hartmann A, 1997, TOXICOL LETT, V90, P183, DOI 10.1016/S0378-4274(96)03847-7
   Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009
   Johnson A, 2013, FASEB J, V27, P3893, DOI 10.1096/fj.12-214189
   Khosrotehrani K, 2013, EXP DERMATOL, V22, P307, DOI 10.1111/exd.12141
   Kim CH, 2011, J KOREAN MED SCI, V26, P726, DOI 10.3346/jkms.2011.26.6.726
   Kirschner N, 2010, EUR J CELL BIOL, V89, P839, DOI 10.1016/j.ejcb.2010.07.010
   Lipp C, 2010, J WOUND CARE, V19, P220, DOI 10.12968/jowc.2010.19.6.48468
   Liuyun Jiang, 2009, J Biomed Sci, V16, P65, DOI 10.1186/1423-0127-16-65
   LOGAN A, 1992, J NEUROSCI, V12, P3828
   Meirelles LD, 2009, FRONT BIOSCI, V14, P4281, DOI 10.2741/3528
   Motawi TM, 2013, CELL BIOCH BIOPHYS, V13, P9698
   Nadin SB, 2001, J HISTOCHEM CYTOCHEM, V49, P1183, DOI 10.1177/002215540104900912
   Neuman MG, 2011, J PHARM PHARM SCI, V14, P425, DOI 10.18433/J3QS3J
   Peroni D, 2008, EXP CELL RES, V314, P603, DOI 10.1016/j.yexcr.2007.10.007
   Phinney DG, 1999, J CELL BIOCHEM, V72, P570
   Ramli NA, 2011, INT J PHARMACEUT, V403, P73, DOI 10.1016/j.ijpharm.2010.10.023
   Shimamura MK, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041804
   Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Speit G, 1999, METH MOL B, V113, P203
   Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028
   Sudhakar Y, 2006, J CONTROL RELEASE, V114, P15, DOI 10.1016/j.jconrel.2006.04.012
   Thomas P, 2009, NAT PROTOC, V4, P825, DOI 10.1038/nprot.2009.53
   TICE RR, 1995, STEM CELLS, V13, P207
   van Zuijlen PPM, 2001, PLAST RECONSTR SURG, V108, P1938, DOI 10.1097/00006534-200112000-00014
   Wendt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021833
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032
   Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002
   Zhou SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058324
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 41
TC 16
Z9 18
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 2
PY 2014
VL 9
IS 5
AR e96241
DI 10.1371/journal.pone.0096241
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI1ZS
UT WOS:000336655700067
PM 24788779
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Dinh, ND
   Chiang, YY
   Hardelauf, H
   Waide, S
   Janasek, D
   West, J
AF Dinh, Ngoc-Duy
   Chiang, Ya-Yu
   Hardelauf, Heike
   Waide, Sarah
   Janasek, Dirk
   West, Jonathan
TI Preparation of Neuronal Co-cultures with Single Cell Precision
SO Jove-Journal of Visualized Experiments
LA English
DT Article
DE Neuroscience; Issue 87; microfluidic arraying; single cell; biomaterial
   patterning; co-culture; compartmentalization; Alzheimer and Parkinson
   Diseases; neurite outgrowth; high throughput screening
ID NERVE GROWTH-FACTOR; LOCAL-CONTROL; TRANSPORT; REGENERATION; INFECTION;
   CULTURE; SYSTEM; INJURY
AB Microfluidic embodiments of the Campenot chamber have attracted great interest from the neuroscience community. These interconnected co-culture platforms can be used to investigate a variety of questions, spanning developmental and functional neurobiology to infection and disease propagation. However, conventional systems require significant cellular inputs (many thousands per compartment), inadequate for studying low abundance cells, such as primary dopaminergic substantia nigra, spiral ganglia, and Drosophilia melanogaster neurons, and impractical for high throughput experimentation. The dense cultures are also highly locally entangled, with few outgrowths (<10%) interconnecting the two cultures. In this paper straightforward microfluidic and patterning protocols are described which address these challenges: (i) a microfluidic single neuron arraying method, and (ii) a water masking method for plasma patterning biomaterial coatings to register neurons and promote outgrowth between compartments. Minimalistic neuronal co-cultures were prepared with high-level (>85%) intercompartment connectivity and can be used for high throughput neurobiology experiments with single cell precision.
C1 [Dinh, Ngoc-Duy; Chiang, Ya-Yu; Hardelauf, Heike; Waide, Sarah; Janasek, Dirk; West, Jonathan] ISAS, Leibniz Inst Analyt Wissensch, Dortmund, Germany.
   [Chiang, Ya-Yu] UCL, Dept Biochem Engn, London WC1E 6BT, England.
   [West, Jonathan] Univ Southampton, Inst Life Sci, Southampton SO9 5NH, Hants, England.
RP West, J (reprint author), ISAS, Leibniz Inst Analyt Wissensch, Dortmund, Germany.
EM J.J.West@soton.ac.uk
RI Janasek, Dirk/G-4902-2010; West, Jonathan/F-3512-2012
OI Janasek, Dirk/0000-0002-4231-1224; West, Jonathan/0000-0002-5709-6790
FU Deutsche Forschungsgemeinschaft (DFG) [WE3737/3-1]; Bundesministerium
   fur Bildung und Forschung grant (BMBF) [0101-31P6541]; Ministerium fur
   Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen;
   International Leibniz Graduate School "Systems Biology Lab-on-a-Chip"
FX The authors are grateful to Ulrich Marggraf (ISAS) for SU-8 fabrication
   and Maria Becker (ISAS) for SEM imaging. The research was financially
   supported by the Deutsche Forschungsgemeinschaft (DFG WE3737/3-1), a
   Bundesministerium fur Bildung und Forschung grant (BMBF 0101-31P6541)
   and by the Ministerium fur Innovation, Wissenschaft und Forschung des
   Landes Nordrhein-Westfalen. Heike Hardelauf thanks the International
   Leibniz Graduate School "Systems Biology Lab-on-a-Chip" for financial
   support.
CR Brenneman KA, 2000, TOXICOL APPL PHARM, V169, P238, DOI 10.1006/taap.2000.9073
   CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516
   CAMPENOT RB, 1982, DEV BIOL, V93, P1, DOI 10.1016/0012-1606(82)90232-9
   Di Carlo D, 2006, ANAL CHEM, V78, P4925, DOI 10.1021/ac060541s
   Diogenes MJ, 2012, J NEUROSCI, V32, P11750, DOI 10.1523/JNEUROSCI.0234-12.2012
   Egger B, 2013, NAT PROTOC, V8, P958, DOI 10.1038/nprot.2013.052
   Frimat JP, 2011, LAB CHIP, V11, P231, DOI [10.1039/c0lc00172d, 10.1039/c01c00172d]
   Frimat JP, 2010, LAB CHIP, V10, P701, DOI 10.1039/b922193j
   Frimat JP, 2009, ANAL BIOANAL CHEM, V395, P601, DOI 10.1007/s00216-009-2824-7
   Hardelauf H, 2011, LAB CHIP, V11, P2763, DOI 10.1039/c1lc20257j
   Haubert K, 2006, LAB CHIP, V6, P1548, DOI 10.1039/b610567j
   Hellman AN, 2010, LAB CHIP, V10, P2083, DOI 10.1039/b927153h
   Huang LR, 2004, SCIENCE, V304, P987, DOI 10.1126/science.1094567
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Kilinc D, 2011, NEUROTOX RES, V19, P149, DOI 10.1007/s12640-010-9152-8
   Kim YT, 2009, LAB CHIP, V9, P2576, DOI 10.1039/b903720a
   Kunze A, 2011, BIOTECHNOL BIOENG, V108, P2241, DOI 10.1002/bit.23128
   Li L, 2012, ANAL CHEM, V84, P6444, DOI 10.1021/ac3013708
   Li NZ, 2005, EXP CELL RES, V311, P307, DOI 10.1016/j.yexcr.2005.10.007
   Liu WW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002382
   Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005
   Markus A, 2011, J VIROL, V85, P6220, DOI 10.1128/JVI.02396-10
   Dinh ND, 2013, LAB CHIP, V13, P1402, DOI 10.1039/c3lc41224e
   Tan WH, 2007, P NATL ACAD SCI USA, V104, P1146, DOI 10.1073/pnas.0606625104
   Taylor A.M., 2005, NAT METH, V2, P559
   Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Yang Z, 2010, J R SOC INTERFACE, V7, pS411, DOI 10.1098/rsif.2010.0158.focus
NR 28
TC 2
Z9 2
U1 1
U2 16
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD MAY
PY 2014
IS 87
AR e51389
DI 10.3791/51389
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CA4VV
UT WOS:000348905400042
PM 24894871
OA Green Published
DA 2018-10-20
ER

PT J
AU Saez-Martinez, V
   Olalde, B
   Martinez-Redondo, D
   Braceras, I
   Morin, F
   Valero, J
   Castro, B
AF Saez-Martinez, Virginia
   Olalde, Beatriz
   Martinez-Redondo, Diana
   Braceras, Inigo
   Morin, Fabrice
   Valero, Jesus
   Castro, Begona
TI Degradable poly(ethylene glycol)-based hydrogels: Synthesis,
   physico-chemical properties and in vitro characterization
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Degradable; degradation; photopolymerized; hydrogel; poly(ethylene
   glycol); swelling; in vitro; human adipose stem cell; cell
   proliferation; human adipose; stem cells
ID TISSUE ENGINEERING APPLICATIONS; DRUG-DELIVERY; PORE-SIZE; CARTILAGE;
   CHONDROCYTES; SCAFFOLD; PEPTIDE; BIOMATERIALS; FABRICATION; MACROMERS
AB Designing degradable hydrogels is complicated by the structural and temporal complexities of the gel and evolving tissue. A major challenge is to create scaffolds with sufficient mechanical properties to restore initial function while simultaneously controlling temporal changes in the gel structure to facilitate tissue formation. Poly(ethylene glycol) was used in this work, to form biodegradable poly(ethylene glycol)-based hydrogels with hydrolyzable poly-L-lactide segments in the backbone. Non-degradable poly(ethylene glycol) was also introduced in the formulation to obtain control of the degradation profile that encompasses cell growth and new tissue formation. The dependence on polymer composition was observed by higher degradation profiles and decreased mechanical properties as the content of degradable segments was increased in the formulation. Based on in vitro tests, no toxicity of extracts or biomaterial in direct contact with human adipose tissue stem cells was observed, and the ultraviolet light treatment did not affect the proliferation capacity of the cells.
C1 [Saez-Martinez, Virginia; Olalde, Beatriz; Braceras, Inigo; Morin, Fabrice; Valero, Jesus] CIBER Bioengn Biomat & Nanomed, Hlth Div, TECNALIA, San Sebastian, Guipuzcoa, Spain.
   [Martinez-Redondo, Diana; Castro, Begona] HISTOCELL, Derio, Bizkaia, Spain.
RP Saez-Martinez, V (reprint author), CIBER Bioengn Biomat & Nanomed, Hlth Div, TECNALIA, San Sebastian, Guipuzcoa, Spain.
EM virgisaezm@hotmail.com
RI Braceras, Inigo/I-1871-2015
OI Braceras, Inigo/0000-0001-9095-7663
FU Centro de Investigacion Biomedica en Red en Bioingenieria, Biomateriales
   y Nanomedicina (CIBER-BBN)
FX This study was supported by the Centro de Investigacion Biomedica en Red
   en Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN).
CR Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI 10.1089/ten.TEB.2009.0639
   Bai Y, 2013, J BIOACT COMPAT POLY, V28, P126
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bryant SJ, 2001, BIOMATERIALS, V22, P619, DOI 10.1016/S0142-9612(00)00225-8
   Burdick JA, 2001, BIOMATERIALS, V22, P1779, DOI 10.1016/S0142-9612(00)00347-1
   Dhote V, 2013, J MECH BEHAV BIOMED, V19, P61, DOI 10.1016/j.jmbbm.2012.10.016
   Era J., 2009, J MEMBRANE BIOL, V20, P877
   Garagorri N, 2008, ACTA BIOMATER, V4, P1139, DOI 10.1016/j.actbio.2008.05.007
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   Han J, 2009, INT J BIOL MACROMOL, V44, P229, DOI 10.1016/j.ijbiomac.2008.12.009
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Jiang ZQ, 2008, J BIOMED MATER RES A, V87A, P45, DOI 10.1002/jbm.a.31699
   Jo S, 2000, POLYMER, V41, P7595, DOI 10.1016/S0032-3861(00)00117-8
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Martens P, 2000, POLYMER, V41, P7715, DOI 10.1016/S0032-3861(00)00123-3
   Mason MN, 2001, MACROMOLECULES, V34, P4630, DOI 10.1021/ma010025y
   Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Rinki K, 2011, INT J POLYM MATER, V60, P988, DOI 10.1080/00914037.2011.553849
   Saez-Martinez V, 2013, INT J POLYM MATER PO, V62, P502, DOI 10.1080/00914037.2012.734353
   Santo VE, 2011, J BIOACT COMPAT POLY, V26, P493
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Solaro R, 2013, J BIOACT COMPAT POL, V28, P3, DOI 10.1177/0883911512467222
   Studer K, 2005, EUR POLYM J, V41, P157, DOI 10.1016/j.eurpolymj.2004.09.004
   Wang XH, 2013, J BIOACT COMPAT POL, V28, P303, DOI 10.1177/0883911513491359
   Wnek G.E., 2008, ENCY BIOMATERIALS BI
   Xiao WQ, 2012, J BIOACT COMPAT POL, V27, P327, DOI 10.1177/0883911512448692
   Yoon JJ, 2004, BIOMATERIALS, V25, P5613, DOI 10.1016/j.biomaterials.2004.01.014
   Zhang JX, 2008, BIOMATERIALS, V29, P4521, DOI 10.1016/j.biomaterials.2008.08.008
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 35
TC 1
Z9 1
U1 0
U2 19
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAY
PY 2014
VL 29
IS 3
BP 270
EP 283
DI 10.1177/0883911514528597
PG 14
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA AM8NG
UT WOS:000340132000006
DA 2018-10-20
ER

PT J
AU Kodavaty, J
   Deshpande, AP
AF Kodavaty, Jagadeeshwar
   Deshpande, Abhijit P.
TI Mechanical and Swelling Properties of Poly (vinyl alcohol) and
   Hyaluronic Acid Gels used in Biomaterial Systems - a Comparative Study
SO DEFENCE SCIENCE JOURNAL
LA English
DT Article
DE Poly (vinyl alcohol); hyaluronic acid; biomaterial; rheology; gel
ID POLY(VINYL ALCOHOL); DRUG-DELIVERY; VISCOELASTIC PROPERTIES;
   POLYVINYL-ALCOHOL; HYDROGELS; COMPOSITES; BEHAVIOR; FILMS; PH;
   DIHYDRAZIDE
AB There is an increasing demand for designing controlled drug delivery systems with materials which are more biocompatible, economical and materials which can be processed easily. Poly (vinyl alcohol) (PVA) and hyaluronic acid (HA) are promising polymers for applications in drug delivery. PVA forms gel based on the acetal bridges when crosslinked with glutaraldehyde (GA). On the other hand, HA a natural polymer, forms gel with divinyl sulfone (DVS) as a crosslinker. PVA and HA blends upon crosslinking PVA with GA or HA with DVS, in the presence of the other polymer, form gels that are more adaptable to the drug delivery systems. In this work, the mechanical properties and swelling behaviour of PVAHA gels were characterized. The effect of composition on viscoelastic moduli and degree of swelling was determined. The storage modulus (G '') of various gels made of PVA, HA and PVAHA blends were measured using rheology and compared with the values available in the literature. Swelling properties were measured and compared among various PVA and HA gels. Collagen is added to PVA solution and the rheological properties were measured in the gel state. Based on the values of storage modulus, gels of various compositions of PVA, HA and collagen might be selected as potential biomaterials for drug delivery system depending on careful understanding the type of application.
C1 [Kodavaty, Jagadeeshwar; Deshpande, Abhijit P.] Indian Inst Technol, Dept Chem Engn, Madras 600036, Tamil Nadu, India.
RP Kodavaty, J (reprint author), Indian Inst Technol, Dept Chem Engn, Madras 600036, Tamil Nadu, India.
EM abhijit@iitm.ac.in
OI Deshpande, Abhijit/0000-0002-8971-0345
CR Agostino A.D., 2012, J BIOTECHNOL BIOMATE, V2, P1
   Baino F, 2011, ACTA BIOMATER, V7, P921, DOI 10.1016/j.actbio.2010.10.030
   Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   Banerjee M, 2012, J APPL PHYS, V111, DOI 10.1063/1.4708058
   Banerjee M, 2009, J SCI CONF PROC, V1, P86, DOI 10.1166/jcp.2009.016
   Brigham MD, 2009, TISSUE ENG PT A, V15, P1645, DOI 10.1089/ten.tea.2008.0441
   Chen JH, 2008, J WUHAN UNIV TECHNOL, V23, P617, DOI 10.1007/s11595-007-5617-x
   Collins MN, 2008, J MATER SCI-MATER M, V19, P3335, DOI 10.1007/s10856-008-3476-4
   Collins MN, 2008, J APPL POLYM SCI, V109, P923, DOI 10.1002/app.27631
   Coronado R, 2011, POLYM BULL, V67, P101, DOI 10.1007/s00289-010-0407-6
   Feng S., 2013, SCI REPORTS, V3, P1038
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010
   Huin-Amargier C, 2006, J BIOMED MATER RES A, V76A, P416, DOI 10.1002/jbm.a.30536
   Hyland LL, 2012, BIOPOLYMERS, V97, P177, DOI 10.1002/bip.21722
   Kim J.-T., 2010, NATURAL SCI, V2, P764
   Kim J, 2008, J MATER SCI-MATER M, V19, P3311, DOI 10.1007/s10856-008-3469-3
   Kim SH, 2005, POLYMER, V46, P7156, DOI 10.1016/j.polymer.2005.05.089
   Kim SJ, 2004, J APPL POLYM SCI, V92, P1467, DOI 10.1002/app.13717
   Kim SJ, 2004, BIOSENS BIOELECTRON, V19, P531, DOI 10.1016/S0956-5663(03)00277-X
   Kim SJ, 2003, REACT FUNCT POLYM, V55, P291, DOI 10.1016/S1381-5148(03)00019-1
   Lee F, 2008, SOFT MATTER, V4, P880, DOI 10.1039/b719557e
   Lee YM, 1996, J APPL POLYM SCI, V62, P301, DOI 10.1002/(SICI)1097-4628(19961010)62:2<301::AID-APP5>3.0.CO;2-0
   Leone G, 2010, J MATER SCI-MATER M, V21, P2491, DOI 10.1007/s10856-010-4092-7
   LI RH, 1994, J MEMBRANE SCI, V88, P115, DOI 10.1016/0376-7388(93)E0182-J
   LINDSEY SE, 1984, SYNTHETIC MET, V10, P67, DOI 10.1016/0379-6779(84)90080-8
   Liu L, 2007, EUR POLYM J, V43, P2672, DOI 10.1016/j.eurpolymj.2007.02.045
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Malay O, 2009, INT J PHARMACEUT, V380, P120, DOI 10.1016/j.ijpharm.2009.07.011
   Matsuyama H, 1997, J MEMBRANE SCI, V126, P151, DOI 10.1016/S0376-7388(96)00287-6
   Mensitieri M, 1996, J MATER SCI-MATER M, V7, P695, DOI 10.1007/BF00123409
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   Moghadam M.N., 2013, 19 C EUR SOC BIOM PA
   Moura MJ, 2007, BIOMACROMOLECULES, V8, P3823, DOI 10.1021/bm700762w
   Mukherjee GS, 2009, J THERM ANAL CALORIM, V96, P21, DOI 10.1007/s10973-008-9833-1
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Peng ZY, 2012, J MACROMOL SCI B, V51, P1934, DOI 10.1080/00222348.2012.660060
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P339, DOI 10.1021/bc00028a010
   Stasko J, 2009, P EST ACAD SCI, V58, P63, DOI 10.3176/proc.2009.1.11
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   Su WY, 2010, ACTA BIOMATER, V6, P3044, DOI 10.1016/j.actbio.2010.02.037
   Tomihata K, 1997, BIOMATERIALS, V18, P189, DOI 10.1016/S0142-9612(96)00116-0
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   Wang T, 2004, POLYM INT, V53, P911, DOI 10.1002/pi.1461
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zhao X, 2010, MACROMOLECULES, V43, P2357, DOI 10.1021/ma902862u
NR 48
TC 6
Z9 6
U1 3
U2 26
PU DEFENCE SCIENTIFIC INFORMATION DOCUMENTATION CENTRE
PI DELHI
PA METCALFE HOUSE, DELHI 110054, INDIA
SN 0011-748X
EI 0976-464X
J9 DEFENCE SCI J
JI Def. Sci. J.
PD MAY
PY 2014
VL 64
IS 3
SI SI
BP 222
EP 229
DI 10.14429/dsj.64.7320
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AM5VT
UT WOS:000339929800005
OA Other Gold
DA 2018-10-20
ER

PT J
AU Katis, IN
   Holloway, JA
   Madsen, J
   Faust, SN
   Garbis, SD
   Smith, PJS
   Voegeli, D
   Bader, DL
   Eason, RW
   Sones, CL
AF Katis, Ioannis N.
   Holloway, Judith A.
   Madsen, Jens
   Faust, Saul N.
   Garbis, Spiros D.
   Smith, Peter J. S.
   Voegeli, David
   Bader, Dan L.
   Eason, Robert W.
   Sones, Collin L.
TI Paper-based colorimetric enzyme linked immunosorbent assay fabricated by
   laser induced forward transfer
SO BIOMICROFLUIDICS
LA English
DT Article
ID EXCIMER-LASER; MICROARRAYS; DEVICES; CELLS; BIOMATERIALS; BIOMOLECULES;
   DEPOSITION; BIOSENSOR; LAYER
AB We report the Laser Induced Forward Transfer (LIFT) of antibodies from a liquid donor film onto paper receivers for application as point-of-care diagnostic sensors. To minimise the loss of functionality of the active biomolecules during transfer, a dynamic release layer was employed to shield the biomaterial from direct exposure to the pulsed laser source. Cellulose paper was chosen as the ideal receiver because of its inherent bio-compatibility, liquid transport properties, wide availability and low cost, all of which make it an efficient and suitable platform for point-of-care diagnostic sensors. Both enzyme-tagged and untagged IgG antibodies were LIFT-printed and their functionality was confirmed via a colorimetric enzyme-linked immunosorbent assay. Localisation of the printed antibodies was exhibited, which can allow the creation of complex 2-d patterns such as QR codes or letters for use in a final working device. Finally, a calibration curve was determined that related the intensity of the colour obtained to the concentration of active antibodies to enable quantitative assessment of the device performance. The motivation for this work was to implement a laser-based procedure for manufacturing low-cost, point-of-care diagnostic devices on paper. (C) 2014 AIP Publishing LLC.
C1 [Katis, Ioannis N.; Eason, Robert W.; Sones, Collin L.] Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England.
   [Holloway, Judith A.; Madsen, Jens; Faust, Saul N.] Univ Southampton, Fac Med, Southampton SO17 1BJ, Hants, England.
   [Holloway, Judith A.; Madsen, Jens; Faust, Saul N.; Smith, Peter J. S.] Univ Southampton, Inst Life Sci, Southampton SO17 1BJ, Hants, England.
   [Holloway, Judith A.; Madsen, Jens; Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, NIHR Wellcome Trust Clin Res Facil, Southampton, Hants, England.
   [Holloway, Judith A.; Madsen, Jens; Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, Resp Biomed Res Unit, Southampton, Hants, England.
   [Garbis, Spiros D.] Univ Southampton, Ctr Prote Res Canc Sci & Clin & Expt Med, Inst Life Sci, Southampton SO17 1BJ, Hants, England.
   [Smith, Peter J. S.] Univ Southampton, Ctr Biol Sci, Southampton SO17 1BJ, Hants, England.
   [Voegeli, David; Bader, Dan L.] Univ Southampton, Fac Hlth Sci, Southampton SO17 1BJ, Hants, England.
RP Katis, IN (reprint author), Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England.
EM ik6g11@orc.soton.ac.uk
RI Madsen, Jens/N-8082-2013; Garbis, Spiros/L-3099-2013; Katis,
   Ioannis/R-1934-2017; Holloway, Judith/A-1757-2010; Faust,
   Saul/J-9779-2014
OI Madsen, Jens/0000-0003-1664-7645; Garbis, Spiros/0000-0002-1050-0805;
   Katis, Ioannis/0000-0002-2016-557X; Holloway,
   Judith/0000-0002-2268-3071; Faust, Saul/0000-0003-3410-7642; Smith,
   Peter/0000-0003-4400-6853; Voegeli, David/0000-0003-3457-7177; Sones,
   Collin/0000-0002-3738-7662
FU EPSRC [EP/J008052/1, EP/K023454/1]; Institute for Life Sciences of the
   University of Southampton; Faculty of Health Sciences of the University
   of Southampton; Southampton UK National Institute of Health Research
   (NIHR) Wellcome Trust Clinical Research Facility; NIHR Respiratory
   Biomedical Research Unit; Wessex Medical Trust; Engineering and Physical
   Sciences Research Council [1304065, EP/K023454/1, EP/J008052/1]
FX The authors acknowledge the funding received via the EPSRC Grant Nos.
   EP/J008052/1 and EP/K023454/1. The authors also acknowledge the funding
   received via the Knowledge Mobilisation Fellowship for Dr. Collin Sones
   from the Institute for Life Sciences and the Faculty of Health Sciences
   of the University of Southampton. Saul N. Faust receives funding from
   the Southampton UK National Institute of Health Research (NIHR) Wellcome
   Trust Clinical Research Facility and NIHR Respiratory Biomedical
   Research Unit. Spiros Garbis acknowledges support from the Wessex
   Medical Trust.
CR Arnold CB, 2007, MRS BULL, V32, P9, DOI 10.1557/mrs2007.9
   Arnold CB, 2007, MRS BULL, V32, P23, DOI 10.1557/mrs2007.11
   Banks DP, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/38003
   Barbulovic-Nad I, 2006, CRIT REV BIOTECHNOL, V26, P237, DOI 10.1080/07388550600978358
   Barron JA, 2005, PROTEOMICS, V5, P4138, DOI 10.1002/pmic.200401294
   Barron JA, 2005, ANN BIOMED ENG, V33, P121, DOI 10.1007/s10439-005-8971-x
   Barron JA, 2004, BIOSENS BIOELECTRON, V20, P246, DOI [10.1016/j.bios.2004.01.011, 10.1016/j.bios..2004.01.011]
   Barron JA, 2004, BIOMED MICRODEVICES, V6, P139, DOI 10.1023/B:BMMD.0000031751.67267.9f
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   BOHANDY J, 1986, J APPL PHYS, V60, P1538, DOI 10.1063/1.337287
   Boutopoulos C, 2008, PHYS STATUS SOLIDI A, V205, P2505, DOI 10.1002/pssa.200780206
   Chatzipetrou M, 2011, PROCEDIA ENGINEER, V25, DOI 10.1016/j.proeng.2011.12.209
   Cheng CM, 2010, ANGEW CHEM INT EDIT, V49, P4771, DOI 10.1002/anie.201001005
   Colina M, 2005, BIOSENS BIOELECTRON, V20, P1638, DOI 10.1016/j.bios.2004.08.047
   Dinca V, 2008, BIOMED MICRODEVICES, V10, P719, DOI 10.1007/s10544-008-9183-6
   Doraiswamy A, 2006, APPL SURF SCI, V252, P4743, DOI 10.1016/j.apsusc.2005.07.166
   Fernandez-Pradas JM, 2004, THIN SOLID FILMS, V453, P27, DOI 10.1016/j.tsf.2003.11.154
   Hopp B, 2004, J APPL PHYS, V96, P3478, DOI 10.1063/1.1782275
   Hopp B, 2012, OPT ENG, V51, DOI 10.1117/1.OE.51.1.014302
   Karaiskou A, 2003, APPL SURF SCI, V208, P245, DOI 10.1016/S0169-4332(02)01396-X
   Kattamis NT, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2799877
   Kaur KS, 2009, J APPL PHYS, V105, DOI 10.1063/1.3132822
   Koch L, 2012, BIOTECHNOL BIOENG, V109, P1855, DOI 10.1002/bit.24455
   Li MS, 2012, ANGEW CHEM INT EDIT, V51, P5497, DOI 10.1002/anie.201201822
   Li X, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3687398
   Lin YF, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003132
   Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989
   Nery EW, 2013, ANAL BIOANAL CHEM, V405, P7573, DOI 10.1007/s00216-013-6911-4
   NGO TT, 1982, MOL CELL BIOCHEM, V44, P3, DOI 10.1007/BF00573840
   Palla-Papavlu A, 2010, J OPT-UK, V12, DOI 10.1088/2040-8978/12/12/124014
   Ringeisen BR, 2004, TISSUE ENG, V10, P483, DOI 10.1089/107632704323061843
   Schiele NR, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/032001
   Sones CL, 2010, APPL PHYS A-MATER, V101, P333, DOI 10.1007/s00339-010-5827-5
   Stratakis E, 2009, PROG QUANT ELECTRON, V33, P127, DOI 10.1016/j.pquantelec.2009.06.001
   Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h
   Zergioti I, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1906325
NR 36
TC 13
Z9 13
U1 8
U2 67
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1932-1058
J9 BIOMICROFLUIDICS
JI Biomicrofluidics
PD MAY
PY 2014
VL 8
IS 3
AR 036502
DI 10.1063/1.4878696
PG 9
WC Biochemical Research Methods; Biophysics; Nanoscience & Nanotechnology;
   Physics, Fluids & Plasmas
SC Biochemistry & Molecular Biology; Biophysics; Science & Technology -
   Other Topics; Physics
GA AL3DB
UT WOS:000339004500021
PM 24926392
OA Green Published
DA 2018-10-20
ER

PT J
AU Umezu, S
AF Umezu, Shinjiro
TI Precision printing of gelatin utilizing electrostatic inkjet
SO JAPANESE JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; CROSS-LINKING; IN-VITRO; ALGINATE; COLLAGEN;
   FILMS; FABRICATION; SCAFFOLDS; PROLIFERATION; REGENERATION
AB The precision printing of biomaterials is essential for fabricating bio devices, and two-dimensional (2D) and three-dimensional (3D) cell structures. To fabricate 3D cell structure artificially, biomaterials should be installed between cells to support the gravity force of cells. In general, the viscosity of ink from biomaterials is relatively high. An electrostatic inkjet is used for the bioprinting of cells and biomaterials because it has good merits, i.e., high printing resolution and good capability to eject highly viscous ink. In this paper, gelatin, an important biomaterial is printed using an electrostatic inkjet. The width of the finest printed line is 6 m. The precisely printed line can be used as a scaffold of living cells. (C) 2014 The Japan Society of Applied Physics
C1 [Umezu, Shinjiro] Waseda Univ, Sch Creat Sci & Engn, Dept Modern Mech Engn, Shinjuku Ku, Tokyo 1698555, Japan.
   [Umezu, Shinjiro] Tokai Univ, Sch Engn, Dept Mech Engn, Hiratsuka, Kanagawa 2591292, Japan.
RP Umezu, S (reprint author), Waseda Univ, Sch Creat Sci & Engn, Dept Modern Mech Engn, Shinjuku Ku, Tokyo 1698555, Japan.
EM umeshin@waseda.jp
OI Umezu, Shinjiro/0000-0003-2146-5344
FU JST A-step; MEXT/JSPS KAKENHI [25420224]
FX We would like to express our thanks to Mr. Ryosuke Araki, Mr. Masaki
   Hara, and Mr. Taishi Shinkawa. This work was supported by a grant of JST
   A-step and a MEXT/JSPS KAKENHI Grant Number 25420224.
CR Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Chan E.-S., 2011, PARTICUOLOGY, V9, P228
   Chan LW, 2006, CARBOHYD POLYM, V63, P176, DOI 10.1016/j.carbpol.2005.07.033
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Cuadros TR, 2012, CARBOHYD POLYM, V89, P1198, DOI 10.1016/j.carbpol.2012.03.094
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Engelhardt EM, 2011, BIOMATERIALS, V32, P3969, DOI 10.1016/j.biomaterials.2011.02.012
   Goto E, 2010, J BIOSCI BIOENG, V109, P512, DOI 10.1016/j.jbiosc.2009.11.002
   Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027
   Hayashi K, 2011, ACTA BIOMATER, V7, P2797, DOI 10.1016/j.actbio.2011.04.013
   Henmi C., 2007, ALTERNATIVES ANIMAL, V14, P689
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Kanungo B., 2008, BIOMATERIALS, V4, P490
   Li SS, 2013, MICROELECTRON ENG, V110, P70, DOI 10.1016/j.mee.2013.01.053
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Liu ZY, 2012, FOOD HYDROCOLLOID, V26, P311, DOI 10.1016/j.foodhyd.2011.06.008
   Machida-Sano I., 2012, INT J BIOMATER, V2012, P8
   Machida-Sano I, 2010, BIOTECHNOL APPL BIOC, V55, P1, DOI 10.1042/BA20090215
   Matsiko A, 2012, J MECH BEHAV BIOMED, V11, P41, DOI 10.1016/j.jmbbm.2011.11.012
   Nagahama H, 2009, CARBOHYD POLYM, V76, P255, DOI 10.1016/j.carbpol.2008.10.015
   Nakamura M, 2008, J IMAGING SCI TECHN, V52, DOI 10.2352/J.ImagingSci.Technol.(2008)52:6(060201)
   Nwe N, 2010, PROCESS BIOCHEM, V45, P457, DOI 10.1016/j.procbio.2009.11.002
   Onoe H, 2013, NAT MATER, V12, P584, DOI [10.1038/NMAT3606, 10.1038/nmat3606]
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007
   Sakaguchi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01316
   Sazo REG, 2012, BIOMATERIALS, V33, P8529, DOI 10.1016/j.biomaterials.2012.07.028
   Seo J, 2012, RES VET SCI, V93, P1481, DOI 10.1016/j.rvsc.2012.02.013
   Shi CY, 2011, BIOMATERIALS, V32, P2508, DOI 10.1016/j.biomaterials.2010.12.026
   Tan HY, 2010, SENSOR ACTUAT B-CHEM, V151, P133, DOI 10.1016/j.snb.2010.09.035
   Umezu S, 2011, SENSOR ACTUAT A-PHYS, V166, P251, DOI 10.1016/j.sna.2009.12.004
   Umezu S., 2012, LIFE ROBOTICS, V17, P59
   Umezu S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.05DB20
   Umezu S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.05DC23
   Wang CC, 2012, BIOMATERIALS, V33, P120, DOI 10.1016/j.biomaterials.2011.09.042
   Yow SZ, 2009, BIOMATERIALS, V30, P1133, DOI [10.1016/j.biomaterials.2008.11.003, 10.1016/j.biomaterials.2008:11.003]
NR 37
TC 4
Z9 4
U1 2
U2 73
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0021-4922
EI 1347-4065
J9 JPN J APPL PHYS
JI Jpn. J. Appl. Phys.
PD MAY
PY 2014
VL 53
IS 5
SI 3
AR 05HC01
DI 10.7567/JJAP.53.05HC01
PG 3
WC Physics, Applied
SC Physics
GA AK3II
UT WOS:000338316400030
DA 2018-10-20
ER

PT J
AU Li, YH
   Sun, ZQ
   Li, XL
   Ding, PP
   Gong, LK
AF Li, Yong-Hua
   Sun, Zhen-Qian
   Li, Xiao-Long
   Ding, Pan-Pan
   Gong, Ling-Kai
TI Recent progress of biomedical porous titanium for bone implants
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Porous titanium; Biomaterial; Biocompatibility; Implant
ID MECHANICAL-PROPERTIES; SPACE-HOLDER; APATITE FORMATION; ALLOYS; FOAMS;
   SIZE; NACL
AB Biocompatible porous titanium could be used for surgical implants like bones, joint prostheses or dental roots due to its excellent biocompatibility and osteoconductivity. Porous structure permits ingrowth of bone tissue, transportation of body fluid and nutrients. Mechanical property like elastic modulus and compressive strength depends on the pore characteristics like porosity, pore size, pore morphology of the porous titanium fabricated by different methods. The tailored elastic modulus of porous titanium matches that of cancellous bones. Deposition of hydroxyapatite coating on the surface of porous titanium can improve its bioactivity and biocompatibility. The fabrication method, surface modification, in vitro and in vivo studies and future research directions of porous titanium are reviewed in this literature.
C1 [Li, Yong-Hua; Sun, Zhen-Qian; Li, Xiao-Long; Ding, Pan-Pan; Gong, Ling-Kai] Shenyang Ligong Univ, Sch Mat Sci & Engn, Shenyang 110159, Peoples R China.
RP Li, YH (reprint author), Shenyang Ligong Univ, Sch Mat Sci & Engn, Shenyang 110159, Peoples R China.
EM yhlicn@163.com
OI Li, Yong-Hua/0000-0003-0005-3789
FU Science Public Welfare Research Funds of Liaoning Province in China
   [2012002008]; Innovation Training Project for Graduate in Liaoning
   Province in China [201310144020]
FX The authors are grateful for the financial support of Science Public
   Welfare Research Funds of Liaoning Province in China under Grant
   No.2012002008 and Innovation Training Project for Graduate in Liaoning
   Province in China under Grant No. 201310144020.
CR Barbas A, 2012, J MECH BEHAV BIOMED, V9, P34, DOI 10.1016/j.jmbbm.2012.01.008
   Chen LJ, 2009, T NONFERR METAL SOC, V19, P1174, DOI 10.1016/S1003-6326(08)60424-0
   Eichenseer C, 2010, J MATER SCI-MATER M, V21, P131, DOI 10.1007/s10856-009-3857-3
   Fukuda A, 2011, ACTA BIOMATER, V7, P2327, DOI 10.1016/j.actbio.2011.01.037
   Gao ZF, 2012, MATER DESIGN, V42, P13, DOI 10.1016/j.matdes.2012.05.041
   He G, 2012, J MECH BEHAV BIOMED, V5, P16, DOI 10.1016/j.jmbbm.2011.09.016
   Kim SW, 2013, MAT SCI ENG C-MATER, V33, P2808, DOI 10.1016/j.msec.2013.03.011
   Lee B, 2014, MATER DESIGN, V57, P712, DOI 10.1016/j.matdes.2013.12.078
   Lee JH, 2009, MATER LETT, V63, P1995, DOI 10.1016/j.matlet.2009.06.023
   Li Y.H., 2013, RARE METAL MAT ENG, V40, P84
   Li YH, 2013, OPTOELECTRON ADV MAT, V7, P541
   Li YH, 2009, J ALLOY COMPD, V485, P215, DOI 10.1016/j.jallcom.2009.06.003
   Liang FH, 2003, SURF COAT TECH, V165, P133, DOI 10.1016/S0257-8972(02)00735-1
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Qu J, 2011, J BIOMED MATER RES B, V97B, P40, DOI 10.1002/jbm.b.31784
   Rubshtein AP, 2014, MAT SCI ENG C-MATER, V35, P363, DOI 10.1016/j.msec.2013.11.020
   Singh R, 2009, ACTA BIOMATER, V5, P477, DOI 10.1016/j.actbio.2008.06.014
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Takemoto M, 2006, BIOMATERIALS, V27, P2682, DOI 10.1016/j.biomaterials.2005.12.014
   Torres Y, 2012, J MATER PROCESS TECH, V212, P1061, DOI 10.1016/j.jmatprotec.2011.12.015
   Torres Y, 2014, MAT SCI ENG C-MATER, V37, P148, DOI 10.1016/j.msec.2013.11.036
   Tuncer N, 2014, J MATER PROCESS TECH, V214, P1352, DOI 10.1016/j.jmatprotec.2014.02.016
   Tuncer N, 2011, MAT SCI ENG A-STRUCT, V530, P633, DOI 10.1016/j.msea.2011.10.036
   Wang XH, 2013, T NONFERR METAL SOC, V23, P2317, DOI 10.1016/S1003-6326(13)62735-1
   Xiang CS, 2012, PROCEDIA ENGINEER, V27, P768, DOI 10.1016/j.proeng.2011.12.518
   Xie FX, 2013, ELECTROCHIM ACTA, V105, P121, DOI 10.1016/j.electacta.2013.04.105
   Xie JH, 2008, SURF COAT TECH, V202, P2960, DOI 10.1016/j.surfcoat.2007.10.040
   Ye B, 2010, MAT SCI ENG A-STRUCT, V528, P691, DOI 10.1016/j.msea.2010.09.054
   Yook SW, 2009, MATER LETT, V63, P1502, DOI 10.1016/j.matlet.2009.03.056
   Zhang EL, 2009, ACTA BIOMATER, V5, P1732, DOI 10.1016/j.actbio.2009.01.014
   Zhao CY, 2010, MAT SCI ENG C-MATER, V30, P98, DOI 10.1016/j.msec.2009.09.004
   Zhou R, 2014, CERAM INT, V40, P501, DOI 10.1016/j.ceramint.2013.06.030
NR 32
TC 4
Z9 4
U1 0
U2 31
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
EI 1841-7132
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD MAY-JUN
PY 2014
VL 16
IS 5-6
BP 513
EP 518
PG 6
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA AK5SQ
UT WOS:000338487100003
DA 2018-10-20
ER

PT J
AU Laurenti, KC
   Haach, LCD
   dos Santos, AR
   Rollo, JMDD
   Reiff, RBD
   Gaspar, AMM
   Purquerio, BD
   Fortulan, CA
AF Laurenti, Karen Cristina
   de Albuquerque Haach, Lourdes Cristina
   dos Santos, Arnaldo Rodrigues, Jr.
   Domingos de Almeida Rollo, Joao Manuel
   de Menezes Reiff, Rodrigo Bezerra
   Minarelli Gaspar, Ana Maria
   Purquerio, Benedito de Moraes
   Fortulan, Carlos Alberto
TI Cartilage Reconstruction Using Self-anchoring Implant with Functional
   Gradient
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE osteochondral defect; polyurethane; microfiber 45S5 bioglass; cartilage
   repair; functional gradient
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; LARGE OSTEOCHONDRAL DEFECTS;
   ARTICULAR-CARTILAGE; ENGINEERED CARTILAGE; REPAIR; SCAFFOLDS;
   REGENERATION; RABBITS; GRAFTS; KNEE
AB This study presents an innovative and original biomaterial designed to substitute for articular cartilage and mimic its mechanical behavior, including elastic cushioning and the characteristics of fiber-reinforced gel. The material was composed of polyurethane and bioglass microfiber 45S5. It was designed to present a tribological surface to the cartilage of the tibial plateau, and to convert over a functional gradient to an osteointegrable region for self-anchorage to the subchondral bone. The biomaterial samples showed no toxicity and promoted cell spreading. Subsequent in vivo studies in rabbits demonstrated the formation of a rigid structure similar to bone trabeculae in the distal region of the tribological surface of the implant. The tribological surface of the proximal region showed a fibrocartilaginous tissue with highly vascularized chondrocytes, thus validating the proposed concept for the design of the implant incorporating a functional gradient and auto-stability.
C1 [Laurenti, Karen Cristina; de Albuquerque Haach, Lourdes Cristina; Purquerio, Benedito de Moraes; Fortulan, Carlos Alberto] Univ Sao Paulo, Dept Mech Engn, BR-13566590 Sao Carlos, SP, Brazil.
   [dos Santos, Arnaldo Rodrigues, Jr.] Univ ABC, Ctr Nat Sci & Humanities, BR-09210971 Santo Andre, SP, Brazil.
   [Domingos de Almeida Rollo, Joao Manuel] Univ Sao Paulo, Bioengn Interunits, BR-13566590 Sao Carlos, SP, Brazil.
   [de Menezes Reiff, Rodrigo Bezerra] Fed Univ Sao Carlos UFSCar, BR-13565905 Sao Carlos, SP, Brazil.
   [Minarelli Gaspar, Ana Maria] Univ Estadual Paulista Julio de Mesquita, UNESP, Lab Morfol, BR-14801903 Sao Paulo, Brazil.
RP Fortulan, CA (reprint author), Univ Sao Paulo, Dept Mech Engn, Av Trabalhador Sao Carlense 400, BR-13566590 Sao Carlos, SP, Brazil.
EM cfortula@sc.usp.br
RI Rollo, Joao/M-7967-2017; de Moraes Purquerio, Benedito/O-5524-2015;
   Fortulan, Carlos/B-7138-2013
OI Rollo, Joao/0000-0003-0768-644X; de Moraes Purquerio,
   Benedito/0000-0001-8538-3378; Fortulan, Carlos/0000-0002-2259-9910;
   Minarelli Gaspar, Ana Maria/0000-0002-7168-9971
FU CAPES [PE 0652008481500/2007-3]
FX The authors would like to thank Luciana Portal for providing the medical
   polyurethane and Ted Day from Mo-Sci Corporation for supplying samples
   of bioglass microfiber. The authors acknowledge the financial support
   provided by CAPES (Project number PE 0652008481500/2007-3).
CR AMIEL D, 1985, J BONE JOINT SURG AM, V67A, P911, DOI 10.2106/00004623-198567060-00013
   [Anonymous], 2007, F81307 ASTM
   Associacao Brasileira de Normas Tecnicas-ABNT, 1999, 10993 ABNT NBR ISO 1
   Bastiaansen-Jenniskens YM, 2008, OSTEOARTHR CARTILAGE, V16, P359, DOI 10.1016/j.joca.2007.07.003
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   Beris AE, 2005, INJURY, V36, pS14, DOI 10.1016/j.injury.2005.10.007
   BUCKWALTER JA, 2000, ORTHOPAEDIC BASIC SC
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Day RM, 2004, BIOMATERIALS, V25, P5857, DOI 10.1016/j.biomaterials.2004.01.043
   Frenkel SR, 2005, OSTEOARTHR CARTILAGE, V13, P798, DOI 10.1016/j.joca.2005.04.018
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Hasegawa M, 1999, BIOMATERIALS, V20, P1969, DOI 10.1016/S0142-9612(99)00106-4
   Hattori K, 2005, J ORTHOP RES, V23, P1179, DOI 10.1016/j.orthres.2005.03.014
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Henderson I, 2005, KNEE, V12, P209, DOI 10.1016/j.knee.2004.07.002
   Huntley JS, 2005, OSTEOARTHR CARTILAGE, V13, P665, DOI 10.1016/j.joca.2005.04.007
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Lemos C, 2000, BOGLIOLO PATOLOGIA, P873
   MANKIN HJ, 1962, J BONE JOINT SURG AM, V44, P688, DOI 10.2106/00004623-196244040-00009
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151
   Reiff RBM, 2010, THESIS U SAO PAULO S
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Ribeiro José Leão, 2004, Acta ortop. bras., V12, P16, DOI 10.1590/S1413-78522004000100003
   Rosowski M, 2006, ARTIF ORGANS, V30, P775, DOI 10.1111/j.1525-1594.2006.00300.x
NR 26
TC 4
Z9 4
U1 0
U2 17
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD MAY-JUN
PY 2014
VL 17
IS 3
BP 638
EP 649
DI 10.1590/S1516-14392014005000030
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA AJ9HA
UT WOS:000338017600015
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Maluckov, BS
AF Maluckov, B. S.
TI Ti-based biomaterials-properties and production
SO OPTOELECTRONICS AND ADVANCED MATERIALS-RAPID COMMUNICATIONS
LA English
DT Article
DE Titanium; Biomaterials
ID BIOMEDICAL TITANIUM-ALLOYS; POROUS TITANIUM; MECHANICAL-PROPERTIES;
   CORROSION-RESISTANCE; SURFACE MODIFICATION; BIOACTIVE TITANIUM;
   ANODIC-OXIDATION; IN-VITRO; IMPLANTS; ROUGHNESS
AB The development of new biomaterials is one of the most challenging tasks in the material science. They can improve the quality and length of human life. Biomaterials should have such properties that ensure implants and devices durability and thus completely avoid reoperation or increased service period. Titanium (Ti) is a suitable biomaterial because it cannot magnetise and has suitable mechanical and surface properties. The characteristics of Ti and of its alloys can be improved selectively by using proper technique of the surface processing which preserves the most useful material characteristics.
C1 Univ Belgrade, Tech Fac Bor, Bor 19210, Serbia.
RP Maluckov, BS (reprint author), Univ Belgrade, Tech Fac Bor, Vojske Jugoslavije 12, Bor 19210, Serbia.
EM bmaluckov@tf.bor.ac.rs
CR An YB, 2006, SURF COAT TECH, V200, P4300, DOI 10.1016/j.surfcoat.2005.02.127
   An YB, 2005, MATER CHEM PHYS, V95, P242, DOI 10.1016/j.matchemphys.2005.06.011
   An YB, 2005, SCRIPTA MATER, V53, P905, DOI 10.1016/j.scriptamat.2005.06.033
   An YB, 2005, MATER LETT, V59, P2178, DOI 10.1016/j.matlet.2005.02.059
   BLACK J, 1988, J BONE JOINT SURG BR, V70, P517
   Blackwood DJ, 2000, CORROS SCI, V42, P481, DOI 10.1016/S0010-938X(99)00103-1
   Chen XB, 2009, ACTA BIOMATER, V5, P2290, DOI 10.1016/j.actbio.2009.02.027
   Cheng S, 2011, APPL SURF SCI, V257, P2657, DOI 10.1016/j.apsusc.2010.10.038
   Chiang CY, 2009, DENT MATER, V25, P1022, DOI 10.1016/j.dental.2009.03.001
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cui CX, 2011, MATER DESIGN, V32, P1684, DOI 10.1016/j.matdes.2010.09.011
   Cui CX, 2005, MATER LETT, V59, P3144, DOI 10.1016/j.matlet.2005.05.037
   Cui X, 2009, DENT MATER, V25, P80, DOI 10.1016/j.dental.2008.04.012
   Czarnowska E, 1999, J MATER PROCESS TECH, V93, P190
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Fawzy AS, 2009, DENT MATER, V25, P48, DOI 10.1016/j.dental.2008.05.007
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   HERNANDEZ JRV, 2006, INT J PHARMACEUT, V322, P161
   Inagaki M, 2003, SURF COAT TECH, V173, P1, DOI 10.1016/S0257-8972(03)00513-9
   Jonasova L, 2002, BIOMATERIALS, V23, P3095, DOI 10.1016/S0142-9612(02)00043-1
   Karimi S, 2011, CORROS SCI, V53, P3262, DOI 10.1016/j.corsci.2011.06.009
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Koike M, 2001, BIOMATERIALS, V22, P2931, DOI 10.1016/S0142-9612(01)00040-0
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Li QN, 2009, BIOMATERIALS, V30, P4708, DOI 10.1016/j.biomaterials.2009.05.015
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   MILES AW, 2008, ORTHOPAEDICS 1 GEN P, P90
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Nakagawa Y, 1997, MUTAT RES-GEN TOX EN, V394, P125, DOI 10.1016/S1383-5718(97)00126-5
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Olmedo DG, 2008, INT J ORAL MAX SURG, V37, P1032, DOI 10.1016/j.ijom.2008.05.013
   Orru R, 2009, MAT SCI ENG R, V63, P127, DOI 10.1016/j.mser.2008.09.003
   PAITAL R, 2009, MAT SCI ENG R, V66, P1
   PETERSSON UI, 2009, BIOMATERIALS, V30, P4471
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   Schiff N, 2002, BIOMATERIALS, V23, P1995, DOI 10.1016/S0142-9612(01)00328-3
   Shibata Y., 2005, INT C, V1284, P284
   SONG P, 2007, ELECTROCHIM ACTA, V53, P863
   Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011
   Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Thompson SA, 2000, INT ENDOD J, V33, P297, DOI 10.1046/j.1365-2591.2000.00339.x
   TREPANIER C, 2000, SHAPE MEMORY IMPLANT, P35, DOI DOI 10.1007/978-3-642-59768-8_3
   Warheit DB, 2008, PHARMACOL THERAPEUT, V120, P35, DOI 10.1016/j.pharmthera.2008.07.001
   Warheit DB, 2007, TOXICOLOGY, V230, P90, DOI 10.1016/j.tox.2006.11.002
   Wennerberg A, 1998, INT J MACH TOOL MANU, V38, P657, DOI 10.1016/S0890-6955(97)00114-4
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   YOSHIMITSU O, 2011, MAT SCI ENG C, V31, P325
   Zaffe D, 2003, BIOMATERIALS, V24, P1093, DOI 10.1016/S0142-9612(02)00424-6
   Zhang QY, 2005, BIOMATERIALS, V26, P2857, DOI 10.1016/j.biomaterials.2004.08.016
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
NR 54
TC 1
Z9 1
U1 0
U2 7
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1842-6573
EI 2065-3824
J9 OPTOELECTRON ADV MAT
JI Optoelectron. Adv. Mater.-Rapid Commun.
PD MAY-JUN
PY 2014
VL 8
IS 5-6
BP 545
EP 550
PG 6
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA AK5SP
UT WOS:000338487000039
DA 2018-10-20
ER

PT J
AU Bunzen, DL
   Lins, N
   Leal, MD
   Lira, MMD
   Neto, SDC
AF Bunzen, Debora Lopes
   Lins, Nathalia
   Leal, Mariana de Carvalho
   de Melo Lira, Mariana Montenegro
   Caldas Neto, Silvio da Silva
TI Middle ear packing materials: comparison between absorbable hemostatic
   gelatine sponge and sugarcane biopolymer sponge in rats
SO BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY
LA English
DT Article
DE Biocompatible materials; Otologic surgical procedures; Gelatine sponge,
   absorbable; Biopolymers
ID HYALURONIC-ACID; GELFOAM; AGENTS
AB Introduction: Several biomaterials can be used in ear surgery to pack the middle ear or support the graft. The absorbable gelatin sponge is the most widely used, but it may produce fibrosis and impair ventilation of the middle ear.
   Objective: This experimental study aimed to investigate the inflammatory effects of the sugarcane biopolymer sponge (BP) in the rat middle ear compared with absorbable gelatin sponge (AGS).
   Materials and methods: Prospective experimental study design. Thirty adult female Wistar rats were allocated to receive the BP sponge into the right ear and AGS into the left ear. Animals were randomly killed at 4 and 12 weeks post-procedure. Qualitative histological assessments were performed to evaluate the inflammatory reaction in the tympanic bullae.
   Results: The BP sponge caused inflammation more intense and persistent than AGS. The BP was not absorbed during the experiment. Fibrosis was observed only in the ears with AGS. There were thickening of the mucosa and neoangiogenesis in the group of AGS.
   Conclusion: Despite inflammation, the BP sponge produced less fibrosis and neoangiogenesis compared to AGS. The sponge BP appeared to be a non-absorbable biomaterial in the middle ear. (C) 2014 Associacao Brasileira de Otorrinolaringologia e Cirurgia Cervico-Facial. Published by Elsevier Editora Ltda. All rights reserved.
C1 [Bunzen, Debora Lopes; Leal, Mariana de Carvalho; Caldas Neto, Silvio da Silva] Univ Fed Pernambuco UFPE, Serv Otorhinolaryngol, Recife, PE, Brazil.
   [Lins, Nathalia] Univ Fed Pernambuco UFPE, Ctr Expt Res, Recife, PE, Brazil.
   [de Melo Lira, Mariana Montenegro] Univ Fed Pernambuco UFPE, Hosp Clin, Dept Pathol, Recife, PE, Brazil.
RP Bunzen, DL (reprint author), Univ Fed Pernambuco UFPE, Serv Otorhinolaryngol, Recife, PE, Brazil.
EM dbunzen@gmail.com
CR Aguiar José Lamartine de Andrade, 2007, Acta Cir. Bras., V22, P77, DOI 10.1590/S0102-86502007000700015
   Assis FD, 2004, AN FM U FED PERNAMB, V49, P73
   Bahadir O, 2003, EUR ARCH OTO-RHINO-L, V260, P19, DOI 10.1007/s00405-002-0494-6
   Blaine G., 1951, LANCET, V2, P427
   Mayer DLB, 2011, BRAZ J OTORHINOLAR, V77, P44, DOI 10.1590/S1808-86942011000100008
   Dogru S, 2009, OTOLARYNG HEAD NECK, V140, P177, DOI 10.1016/j.otohns.2008.10.023
   HELLSTROM S, 1983, ACTA OTO-LARYNGOL, V96, P269, DOI 10.3109/00016488309132899
   Huang GL, 2011, OTOLARYNG HEAD NECK, V145, P131, DOI 10.1177/0194599811400834
   Jang CH, 2008, INT J PEDIATR OTORHI, V72, P1517, DOI 10.1016/j.ijporl.2008.07.005
   Krupala JL, 1998, AM J OTOL, V19, P546
   LAURENT C, 1986, AM J OTOLARYNG, V7, P181, DOI 10.1016/S0196-0709(86)80004-7
   Li G, 2001, ARCH OTOLARYNGOL, V127, P534, DOI 10.1001/archotol.127.5.534
   Liening DA, 1997, OTOLARYNG HEAD NECK, V116, P454, DOI 10.1016/S0194-5998(97)70294-8
   Loffroy R, 2009, CURR VASC PHARMACOL, V7, P250, DOI 10.2174/157016109787455617
   Lucena R, 2007, THESIS U FEDERAL PER
   McGhee MA, 1999, AM J OTOL, V20, P712
   Park AH, 2006, OTOL NEUROTOL, V27, P1170, DOI 10.1097/01.mao.0000227893.50162.9e
   Paterson-Beedle M, 2000, CARBOHYD POLYM, V42, P375, DOI 10.1016/S0144-8617(99)00179-4
   SCHUKNECHT H F, 1962, Acta Otolaryngol, V54, P336, DOI 10.3109/00016486209126953
   SCHUKNECHT HF, 1971, ANN OTO RHINOL LARYN, V80, P415, DOI 10.1177/000348947108000320
   Shen Y, 2011, LARYNGOSCOPE, V121, P1040, DOI 10.1002/lary.21470
   Silva DB, 2006, AN FM U FED PERNAMB, V51, P45
   Tonnaer ELGM, 2003, LARYNGOSCOPE, V113, P322, DOI 10.1097/00005537-200302000-00023
   WULLSTEIN H, 1956, Ann Otol Rhinol Laryngol, V65, P1021
   ZOLLNER F, 1957, Ann Otol Rhinol Laryngol, V66, P907
NR 25
TC 3
Z9 4
U1 1
U2 20
PU ASSOC BRASILEIRA OTORRINOLARINGOLOGIA & CIRURGIA CERVICOFACIAL
PI SAO PAULO
PA AV INDIANOPOLOS 740, MOEMA, SAO PAULO, SP 04062-001, BRAZIL
SN 1808-8694
EI 1808-8686
J9 BRAZ J OTORHINOLAR
JI Braz. J. Otorhinolaryngol.
PD MAY-JUN
PY 2014
VL 80
IS 3
BP 237
EP 244
DI 10.1016/j.bjorl.2013.08.001
PG 8
WC Otorhinolaryngology
SC Otorhinolaryngology
GA AJ8ZL
UT WOS:000337996500011
PM 25153109
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bat, E
   Zhang, Z
   Feijen, J
   Grijpma, DW
   Poot, AA
AF Bat, Erhan
   Zhang, Zheng
   Feijen, Jan
   Grijpma, Dirk W.
   Poot, Andre A.
TI Biodegradable elastomers for biomedical applications and regenerative
   medicine
SO REGENERATIVE MEDICINE
LA English
DT Review
DE biodegradable elastomer; elastic; flexible; polymeric biomaterial;
   regenerative medicine
ID EPSILON-CAPROLACTONE POLYMER; IN-VIVO BEHAVIOR; POLY(TRIMETHYLENE
   CARBONATE); MECHANICAL-PROPERTIES; 1,3-TRIMETHYLENE CARBONATE;
   TRIMETHYLENE CARBONATE; CROSS-LINKING; POLY(GLYCEROL SEBACATE);
   DEGRADATION BEHAVIOR; TISSUE-RESPONSE
AB Synthetic biodegradable polymers are of great value for the preparation of implants that are required to reside only temporarily in the body. The use of biodegradable polymers obviates the need for a second surgery to remove the implant, which is the case when a nondegradable implant is used. After implantation in the body, biomedical devices may be subjected to degradation and erosion. Understanding the mechanisms of these processes is essential for the development of biomedical devices or implants with a specific function, for example, scaffolds for tissue-engineering applications. For the engineering and regeneration of soft tissues (e.g., blood vessels, cardiac muscle and peripheral nerves), biodegradable polymers are needed that are flexible and elastic. The scaffolds prepared from these polymers should have tuneable degradation properties and should perform well under long-term cyclic deformation conditions. The required polymers, which are either physically or chemically crosslinked biodegradable elastomers, are reviewed in this article.
C1 [Bat, Erhan; Zhang, Zheng; Feijen, Jan; Grijpma, Dirk W.; Poot, Andre A.] Univ Twente, Dept Biomat Sci & Technol, MIRA Inst Biomed Technol, NL-7500 AE Enschede, Netherlands.
   [Grijpma, Dirk W.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands.
   [Grijpma, Dirk W.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP Poot, AA (reprint author), Univ Twente, Dept Biomat Sci & Technol, MIRA Inst Biomed Technol, POB 217, NL-7500 AE Enschede, Netherlands.
EM a.a.poot@utwente.nl
RI Bat, Erhan/J-5430-2015; Zhang, Zheng/J-4929-2013
OI Zhang, Zheng/0000-0001-8345-5913
FU Dutch Program for Tissue Engineering (DPTE); The Netherlands foundation
   for Scientific Research (NWO)
FX E Bat and Z Zhang were financially supported by respectively the Dutch
   Program for Tissue Engineering (DPTE) and The Netherlands foundation for
   Scientific Research (NWO). DW Grijpma and J Feijen are co-founders and
   shareholders of Medisse, a spin-off company of the University of Twente
   that develops medical implants based on poly(trimethylene carbonate).
   The authors have no other relevant affiliations or financial involvement
   with any organization or entity with a financial interest in or
   financial conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR ALBERTSSON AC, 1992, J MACROMOL SCI PURE, V29, P43, DOI 10.1080/10101329208054106
   Allcock HR, 2012, POLYM CHEM-UK, V3, P578, DOI 10.1039/c1py00468a
   Almeida LR, 2013, ACTA BIOMATER, V9, P8167, DOI 10.1016/j.actbio.2013.05.019
   Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   BAKKUM EA, 1995, J MATER SCI-MATER M, V6, P41, DOI 10.1007/BF00121246
   Balguid A, 2007, TISSUE ENG, V13, P1501, DOI 10.1089/ten.2006.0279
   Bat E, 2008, BIOMACROMOLECULES, V9, P3208, DOI 10.1021/bm8007988
   Bat E, 2011, ACTA BIOMATER, V7, P1939, DOI 10.1016/j.actbio.2011.01.010
   Bat E, 2010, BIOMACROMOLECULES, V11, P2692, DOI 10.1021/bm1007234
   Bat E, 2010, J BIOMED MATER RES A, V95A, P940, DOI 10.1002/jbm.a.32921
   Behl M, 2010, J MATER CHEM, V20, P3335, DOI 10.1039/b922992b
   Benoit DSW, 2006, TISSUE ENG, V12, P1663, DOI 10.1089/ten.2006.12.1663
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bettinger CJ, 2009, J BIOMED MATER RES A, V91A, P1077, DOI 10.1002/jbm.a.32306
   Bezemer JM, 2000, J CONTROL RELEASE, V67, P249, DOI 10.1016/S0168-3659(00)00212-1
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Chandran KB, 1992, CARDIOVASCULAR BIOME
   Chapanian R, 2009, BIOMATERIALS, V30, P295, DOI 10.1016/j.biomaterials.2008.09.038
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Claase MB, 2003, J BIOMED MATER RES A, V64A, P291, DOI 10.1002/jbm.a.10418
   Cortizo MS, 2008, J TISSUE ENG REGEN M, V2, P33, DOI 10.1002/term.62
   Cowin S., 1987, HDB BIOENGINEERING
   Deng M, 2010, SOFT MATTER, V6, P3119, DOI 10.1039/b926402g
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ella V, 2007, J MATER SCI-MATER M, V18, P1253, DOI 10.1007/s10856-007-0144-z
   Ella Ville, 2011, Biomatter, V1, P102, DOI 10.4161/biom.1.1.17447
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fabre T, 2001, BIOMATERIALS, V22, P2951, DOI 10.1016/S0142-9612(01)00012-6
   Filipczak K, 2006, MACROMOL BIOSCI, V6, P261, DOI 10.1002/mabi.200500215
   Foks MA, 2005, J CONTROL RELEASE, V101, P325
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   GOPFERICH A, 1993, MACROMOLECULES, V26, P4105, DOI 10.1021/ma00068a006
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Gupta BS, 1997, J BIOMED MATER RES, V34, P341
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   Hou QP, 2009, ACTA BIOMATER, V5, P1543, DOI 10.1016/j.actbio.2008.12.012
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hubbell JA, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P297, DOI 10.1016/B978-012370615-7/50025-1
   Ifkovits JL, 2009, ACS APPL MATER INTER, V1, P1878, DOI 10.1021/am900403k
   Jayasinghe SN, 2013, ANALYST, V138, P2215, DOI 10.1039/c3an36599a
   Jeong SI, 2005, BIOMATERIALS, V26, P1405, DOI 10.1016/j.biomaterials.2004.04.036
   Jie C, 1996, POLYM INT, V41, P369, DOI 10.1002/(SICI)1097-0126(199612)41:4<369::AID-PI615>3.0.CO;2-V
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   LANG RM, 1994, CIRCULATION, V90, P1875, DOI 10.1161/01.CIR.90.4.1875
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEE JM, 1985, CIRC RES, V57, P475, DOI 10.1161/01.RES.57.3.475
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105
   Mark JE, 2007, RUBBERLIKE ELASTICITY: A MOLECULAR PRIMER, 2ND EDITION, P1, DOI 10.1017/CBO9780511541322
   Mazuchowski EL, 2003, SUMM BIOENG C, P1205
   MILLESI HMD, 1995, CLIN ORTHOP RELAT R, V314, P76
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Moutos FT, 2010, TISSUE ENG PT A, V16, P1291, DOI [10.1089/ten.tea.2009.0480, 10.1089/ten.TEA.2009.0480]
   Murphy MB, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P309, DOI 10.1016/B978-012370615-7/50026-3
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Nochel U, 2013, EUR POLYM J, V49, P2457, DOI 10.1016/j.eurpolymj.2013.01.022
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Pego AP, 2003, TISSUE ENG, V9, P981, DOI 10.1089/107632703322495628
   Pego AP, 2003, POLYMER, V44, P6495, DOI 10.1016/S0032-3861(03)00668-2
   Pego AP, 2003, J MATER SCI-MATER M, V14, P767, DOI 10.1023/A:1025084304766
   Pomerantseva I, 2009, J BIOMED MATER RES A, V91A, P1038, DOI 10.1002/jbm.a.32327
   Puskas JE, 2004, BIOMACROMOLECULES, V5, P1141, DOI 10.1021/bm034513k
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   Schappacher M, 2001, BIOMATERIALS, V22, P2849, DOI 10.1016/S0142-9612(01)00029-1
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Schuller-Ravoo S, 2011, MACROMOL BIOSCI, V11, P1662, DOI 10.1002/mabi.201100203
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Serrano MC, 2010, ADV FUNCT MATER, V20, P192, DOI 10.1002/adfm.200901040
   Shah PN, 2009, POLYMER, V50, P2281, DOI 10.1016/j.polymer.2009.02.048
   Sharifi S, 2013, BIOMATERIALS, V34, P8105, DOI 10.1016/j.biomaterials.2013.07.061
   Sharifi S, 2012, MACROMOL BIOSCI, V12, P1423, DOI 10.1002/mabi.201200155
   Shi R, 2009, INT J MOL SCI, V10, P4223, DOI 10.3390/ijms10104223
   Song Y, 2011, TISSUE ENG PT A, V17, P381, DOI 10.1089/ten.TEA.2009.0805
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Storey RF, 1997, POLYMER, V38, P6295, DOI 10.1016/S0032-3861(97)00208-5
   Sun ZJ, 2009, BIOMATERIALS, V30, P5209, DOI 10.1016/j.biomaterials.2009.06.007
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Thambyah A, 2006, OSTEOARTHR CARTILAGE, V14, P580, DOI 10.1016/j.joca.2006.01.015
   Townsend-Nicholson A, 2006, BIOMACROMOLECULES, V7, P3364, DOI 10.1021/bm060649h
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Vacanti J, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P3, DOI 10.1016/B978-012370615-7/50005-6
   van Dijkhuizen-Radersma R, 2008, ACAD PR SER BIOM ENG, P193, DOI 10.1016/B978-0-12-370869-4.00007-0
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Xie J, 2006, TISSUE ENG, V12, P449, DOI 10.1089/ten.2006.12.449
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang HH, 2008, J POLYM SCI POL CHEM, V46, P8131, DOI 10.1002/pola.23110
   Zhang Z, 2006, BIOMATERIALS, V27, P1741, DOI 10.1016/j.biomaterials.2005.09.017
   Zhang Z, 2004, MACROMOL CHEM PHYSIC, V205, P867, DOI 10.1002/macp.200300184
NR 97
TC 24
Z9 24
U1 9
U2 104
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PD MAY
PY 2014
VL 9
IS 3
BP 385
EP 398
DI 10.2217/RME.14.4
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA AJ7ZU
UT WOS:000337922200014
PM 24935047
DA 2018-10-20
ER

PT J
AU Rolandi, M
   Rolandi, R
AF Rolandi, Marco
   Rolandi, Ranieri
TI Self-assembled chitin nanofibers and applications
SO ADVANCES IN COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Chitin; Chitosan; Nanofiber; Self-assembly; Chitin nanofiber ink
ID NAOH/UREA AQUEOUS-SOLUTION; IONIC LIQUID; BETA-CHITIN;
   BIOLOGICAL-MATERIALS; ALPHA-CHITIN; DIFFRACTION; COMPOSITE; CHITOSAN;
   BEHAVIOR; SCIENCE
AB Self-assembled natural biomaterials offer a variety of ready-made nanostructures available for basic science research and technological applications. Most natural structural materials are made of self-assembled nanofibers with diameters in the nanometer range. Among these materials, chitin is the second most abundant polysaccharide after cellulose and is part of the exoskeleton or arthropods and mollusk shells. Chitin has several desirable properties as a biomaterial including mechanical strength, chemical and thermal stability, and biocompatibility. However, chitin insolubility in most organic solvents has somewhat limited its use. In this research highlight, we describe recent developments in producing biogenic chitin nanofibers using self-assembly from a solution of squid pen beta-chitin in hexafluoroisopropanol. With this solution based assembly, we have demonstrated chitin-silk composite self-assembly, chitin nanofiber fabrication across length-scales, and manufacturing of chitin nanofiber substrates for tissue engineering. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Rolandi, Marco] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.
   [Rolandi, Ranieri] Univ Genoa, Dept Phys, I-16146 Genoa, Italy.
RP Rolandi, M (reprint author), Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.
EM rolandi@uw.edu; rolandi@unige.it
RI Rolandi, Ranieri/C-4765-2012
OI Rolandi, Ranieri/0000-0002-0580-1611
FU Washington Research Foundation; Coulter Foundation; University of
   Washington Center for Commercialization; Infectious Disease Research
   Institute; 3M Nontenured Faculty Award; University of Genoa (PRA)
FX We thank Chao Zhong, Jungho Jin, Pegah Hassanzadeh, Adnan Kapetanovic,
   Ashley Cooper, Giovanni Perotto, Fiorenzo Omenetto, Mashid Kharaziah,
   Mehdi Nikkhah, Miqin Zhang, and All Khademhosseni for contributing to
   the work reviewed here. We also thank Ornella Cavalleri for her
   preliminary work on chitin nanofibers at the University of Genoa. M.R.
   acknowledges funding from the Washington Research Foundation, the
   Coulter Foundation, the University of Washington Center for
   Commercialization, the Infectious Disease Research Institute, and a 3M
   Nontenured Faculty Award. R.R. acknowledges funding from the University
   of Genoa (PRA).
CR Barber PS, 2013, GREEN CHEM, V15, P601, DOI 10.1039/c2gc36582k
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Biswas SK, 2013, J CHITIN CHITOSAN SC, V1, P138, DOI 10.1166/jcc.2013.1021
   Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003
   Cooper A, 2012, J MATER CHEM, V22, P3105, DOI 10.1039/c2jm15487k
   Deng YX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02481
   Fan YM, 2008, BIOMACROMOLECULES, V9, P1919, DOI 10.1021/bm800178b
   Hassanzadeh P, 2014, J MAT CHEM B
   Hassanzadeh P, 2013, J MATER CHEM B, V1, P4217, DOI [10.1039/c3tb20782j, 10.1039/C3TB20782J]
   Hu XW, 2007, CARBOHYD POLYM, V70, P451, DOI 10.1016/j.carbpol.2007.05.002
   Hu XW, 2011, CARBOHYD POLYM, V83, P1128, DOI 10.1016/j.carbpol.2010.09.014
   Ifuku S, 2012, NANOSCALE, V4, P3308, DOI 10.1039/c2nr30383c
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Jin J, 2013, ADV HEALTHC MAT
   Jin JH, 2013, ADV MATER, V25, P4482, DOI 10.1002/adma.201301429
   Kadokawa J-I., 2013, GREEN SUSTAIN CHEM, V3, P19, DOI DOI 10.4236/GSC.2013.32A003
   Kobayashi K, 2010, CARBOHYD POLYM, V79, P882, DOI 10.1016/j.carbpol.2009.10.020
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Li GX, 2010, CARBOHYD POLYM, V80, P970, DOI 10.1016/j.carbpol.2010.01.014
   Louvier-Hernandez JF, 2005, J BIOMED NANOTECHNOL, V1, P109, DOI 10.1166/jbn.2005.002
   Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854
   Min BM, 2004, POLYMER, V45, P7137, DOI 10.1016/j.polymer.2004.08.048
   MUZZARELLI RAA, 1977, CHITIN
   Muzzarelli RAAMaC, 2005, CHITIN CHITOSAN OPPO
   Muzzarelli RAA, 2012, CARBOHYD POLYM, V87, P995, DOI 10.1016/j.carbpol.2011.09.063
   Noh HK, 2006, BIOMATERIALS, V27, P3934, DOI 10.1016/j.biomaterials.2006.03.016
   Ortiz C, 2008, SCIENCE, V319, P1053, DOI 10.1126/science.1154295
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   RUIZHERRERA J, 1975, P NATL ACAD SCI USA, V72, P2706, DOI 10.1073/pnas.72.7.2706
   Saito Y, 1997, MACROMOLECULES, V30, P3867, DOI 10.1021/ma961787+
   Setoguchi T, 2012, INT J BIOL MACROMOL, V50, P861, DOI 10.1016/j.ijbiomac.2011.11.007
   Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7
   Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941
   Wan ACA, 2013, BIOTECHNOL ADV, V31, P1776, DOI 10.1016/j.biotechadv.2013.09.007
   Wu Y, 2008, POLYMER, V49, P2321, DOI 10.1016/j.polymer.2008.03.027
   Zhang K, 2012, J PHYS CHEM B, V116, P4584, DOI 10.1021/jp210469x
   Zheng H, 2002, J APPL POLYM SCI, V86, P1679, DOI 10.1002/app.11043
   Zhong C, 2011, ADV MATER, V23, P4776, DOI 10.1002/adma.201102639
   Zhong C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1489
   Zhong C, 2010, SOFT MATTER, V6, P5298, DOI 10.1039/c0sm00450b
NR 43
TC 32
Z9 33
U1 8
U2 139
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-8686
EI 1873-3727
J9 ADV COLLOID INTERFAC
JI Adv. Colloid Interface Sci.
PD MAY
PY 2014
VL 207
SI SI
BP 216
EP 222
DI 10.1016/j.cis.2014.01.019
PG 7
WC Chemistry, Physical
SC Chemistry
GA AJ4NF
UT WOS:000337652400018
PM 24556234
DA 2018-10-20
ER

PT J
AU Brunger, JM
   Huynh, NPT
   Moutos, FT
   Guilak, F
   Gersbach, CA
AF Brunger, Jonathan M.
   Huynh, Nguyen P. T.
   Moutos, Franklin T.
   Guilak, Farshid
   Gersbach, Charles A.
TI Biomaterial-Mediated Lentiviral Gene Delivery for Osteochondral Tissue
   Engineering
SO MOLECULAR THERAPY
LA English
DT Meeting Abstract
CT 17th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy
   (ASGCT)
CY MAY 21-24, 2014
CL Washington, DC
SP Amer Soc Gene & Cell Therapy, Genzyme
C1 [Brunger, Jonathan M.; Huynh, Nguyen P. T.; Moutos, Franklin T.; Guilak, Farshid; Gersbach, Charles A.] Duke Univ, Durham, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD MAY
PY 2014
VL 22
SU 1
MA 407
BP S155
EP S155
PG 1
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA AI9ED
UT WOS:000337231300404
OA Other Gold
DA 2018-10-20
ER

PT J
AU Rosa, CB
   de Castro, ICV
   Reis, JA
   Aragao, JS
   Barbosa, AFS
   Silveira, L
   Pinheiro, ALB
AF Rosa, Cristiane Becher
   Vieira de Castro, Isabele Cardoso
   Reis Junior, Joao Alves
   Aragao, Juliana Silveira
   Santos Barbosa, Artur Felipe
   Silveira, Landulfo, Jr.
   Pinheiro, Antonio L. B.
TI The efficacy of the use of IR laser phototherapy (LPT) on bone defect
   grafted with biphasic ceramic on rats with iron deficiency anemia: Raman
   spectroscopy analysis
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Biomaterial; Bone repair; LLLT; Laser therapy; Raman spectroscopy
ID MINERAL TRIOXIDE AGGREGATE; MORPHOGENETIC PROTEINS; RODENT MODEL;
   REGENERATION; IRRADIATION; REPAIR; THERAPY; IMPACT
AB The aim of this study was to evaluate bone repair in anemic and non-anemic rats submitted or not to laser phototherapy and hydroxyapatite graft. Animals were divided in eight groups of five animals: Clot; Laser; Graft; Graft + Laser; iron deficiency anemia (IDA) + Clot; IDA + Laser; IDA + graft; IDA + graft + Laser. When appropriate irradiation with infrared laser was done during 15 days at a 48-h interval. Animals were killed at day 30; samples were analyzed by Raman spectroscopy. Three shifts were studied and statistically analyzed: similar to 960, similar to 1,070, and similar to 1,454 cm(-1). Graft + laser showed highest similar to 960 peak was statistically different from all other healthy groups. No statistical difference was found between Clot and IDA + Clot in any shift. The IDA + Graft and IDA + Graft + Laser groups had low mean peak values for shifts similar to 960, similar to 1,070, and similar to 1,454 cm(-1). The results in this study indicate that using hydroxyapatite (HA) and laser irradiation in healthy subjects is favorable to mineral deposition and bone maturation, this being of importance for some groups at risk, such as astronauts. In iron deficiency anemia cases, the use of graft, associated or not to laser irradiation, resulted in low collagen and low carbonate and phosphate HA.
C1 [Rosa, Cristiane Becher; Vieira de Castro, Isabele Cardoso; Reis Junior, Joao Alves; Aragao, Juliana Silveira; Santos Barbosa, Artur Felipe; Pinheiro, Antonio L. B.] Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
   [Silveira, Landulfo, Jr.; Pinheiro, Antonio L. B.] Univ Camilo Castelo Branco, Nucleo Parque Tecnol Sao Jose dos Campos Rod, BR-12247004 Sao Jose Dos Campos, SP, Brazil.
   [Pinheiro, Antonio L. B.] Univ Sao Paulo, Natl Inst Opt & Photon, Phys Inst Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, Av Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
EM becherrosa@gmail.com; isabeledecastro@gmail.com; jotareis19@hotmail.com;
   aragao.juliana@yahoo.com.br; arturfelipes@gmail.com;
   landulfo.silveira@gmail.com; albp@ufba.br
RI Pinheiro, Antonio Luiz/A-1962-2008; Silveira, Landulfo/I-2474-2012;
   Barbosa, Artur/G-3839-2012; Sao Carlos Institute of Physics,
   IFSC/USP/M-2664-2016
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321; Silveira,
   Landulfo/0000-0002-6616-3334; DE CASTRO, ISABELE CARDOSO
   VIEIRA/0000-0002-6425-649X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
FX We would like to thank the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) for providing financial support for this
   project.
CR Pinheiro ALB, 2013, LASER MED SCI, V28, P815, DOI 10.1007/s10103-012-1166-4
   Benoist B, 2012, WORLDWIDE PREVALENCE
   Carvalho FB, 2001, P SOC PHOTO-OPT INS, V7887
   Chhabra D, 2008, CLIN J AM SOC NEPHRO, V3, P1168, DOI 10.2215/CJN.04641007
   Coutinho Geraldo Gaspar Paes Leme, 2005, Sao Paulo Med. J., V123, P88, DOI 10.1590/S1516-31802005000200011
   Demir H, 2004, LASER SURG MED, V35, P84, DOI 10.1002/lsm.20046
   Denadai AS, 2009, LASER MED SCI, V24, P689, DOI 10.1007/s10103-008-0595-6
   Ekiz C, 2005, HEMATOL J, V5, P579, DOI 10.1038/sj.thj.6200574
   Gorustovich AA, 2006, ARCH ORAL BIOL, V51, P246, DOI 10.1016/j.archoralbio.2005.08.002
   HEPPENSTALL RB, 1977, CLIN ORTHOP RELAT R, P253
   Killip S, 2007, AM FAM PHYSICIAN, V75, P671
   Lobo AR, 2011, BIOL TRACE ELEM RES, V143, P403, DOI 10.1007/s12011-010-8871-2
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Luger EJ, 1998, LASER SURG MED, V22, P97, DOI 10.1002/(SICI)1096-9101(1998)22:2<97::AID-LSM5>3.0.CO;2-R
   Medrado ARAP, 2003, LASER SURG MED, V32, P239, DOI 10.1002/lsm.10126
   Mester AR, 2002, P 2 INT C NEAR FIELD
   Morris MD, 2011, CLIN ORTHOP RELAT R, V469, P2160, DOI 10.1007/s11999-010-1692-y
   Mullick S, 2006, INDIAN J MED RES, V124, P647
   Nicolau RA, 2003, LASER MED SCI, V18, P89, DOI 10.1007/s10103-003-0260-z
   Sampaio SCPO, 2013, LASER MED SCI, V28, P799, DOI 10.1007/s10103-012-1161-9
   Pinheiro AL, 2010, PHOTOMED LASER SURG, V28, P89
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2013, LASER MED SCI, V28, P513, DOI 10.1007/s10103-012-1096-1
   Pinheiro ALB, 2012, LASER MED SCI, V27, P903, DOI 10.1007/s10103-011-1010-2
   Pinheiro ALB, 2011, J BIOMED MATER RES A, V98A, P212, DOI 10.1002/jbm.a.33107
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pretel H, 2007, LASER SURG MED, V39, P788, DOI 10.1002/lsm.20585
   Rosa AP, 2012, LASER MED SCI, V27, P971, DOI 10.1007/s10103-011-1022-y
   Rosa CB, 2011, P SOC PHOTO-OPT INS, V7887
   Shegarfi Hamid, 2009, J Orthop Surg (Hong Kong), V17, P206
   Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161
   Tajali SB, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-1
   Timlin JA, 1999, APPL SPECTROSC, V53, P1429, DOI 10.1366/0003702991945786
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Zhao GY, 2012, BIOL TRACE ELEM RES, V150, P487, DOI 10.1007/s12011-012-9511-9
NR 35
TC 0
Z9 0
U1 0
U2 8
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
EI 1435-604X
J9 LASER MED SCI
JI Lasers Med. Sci.
PD MAY
PY 2014
VL 29
IS 3
BP 1251
EP 1259
DI 10.1007/s10103-013-1496-x
PG 9
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA AI9JG
UT WOS:000337248300051
PM 24414036
DA 2018-10-20
ER

PT J
AU Green, DW
   Lai, WF
   Jung, HS
AF Green, David W.
   Lai, Wing-Fu
   Jung, Han-Sung
TI Evolving Marine Biomimetics for Regenerative Dentistry
SO MARINE DRUGS
LA English
DT Review
DE regenerative dentistry; biomimetics; marine invertebrates; bone; dentine
ID REPLAMINEFORM POROUS BIOMATERIALS; MESOPOROUS SILICA NANOPARTICLES;
   MESENCHYMAL STEM-CELLS; WATER-SOLUBLE MATRIX; OF-THE-ART; IN-VITRO;
   ALGINATE HYDROGELS; BONE REGENERATION; HUMAN OSTEOBLASTS;
   NATURAL-PRODUCTS
AB New products that help make human tissue and organ regeneration more effective are in high demand and include materials, structures and substrates that drive cell-to-tissue transformations, orchestrate anatomical assembly and tissue integration with biology. Marine organisms are exemplary bioresources that have extensive possibilities in supporting and facilitating development of human tissue substitutes. Such organisms represent a deep and diverse reserve of materials, substrates and structures that can facilitate tissue reconstruction within lab-based cultures. The reason is that they possess sophisticated structures, architectures and biomaterial designs that are still difficult to replicate using synthetic processes, so far. These products offer tantalizing pre-made options that are versatile, adaptable and have many functions for current tissue engineers seeking fresh solutions to the deficiencies in existing dental biomaterials, which lack the intrinsic elements of biofunctioning, structural and mechanical design to regenerate anatomically correct dental tissues both in the culture dish and in vivo.
C1 [Green, David W.; Jung, Han-Sung] Univ Hong Kong, Fac Dent, Hong Kong, Peoples R China.
   [Lai, Wing-Fu; Jung, Han-Sung] Yonsei Univ Coll Dent, Div Anat & Dev Biol, Dept Oral Biol, Oral Sci Res Ctr,PLUS Project BK21, Seoul 120752, South Korea.
RP Jung, HS (reprint author), Univ Hong Kong, Fac Dent, Hong Kong, Peoples R China.
EM dwgreen@hku.hk; rori0610@graduate.hku.hk; hsjung@hku.hk
RI Lai, W. F./J-3170-2015
FU Korea Health Technology R & D Project, Ministry of Health and Welfare,
   Korea [HI12C02970100]
FX We would like to thank Associate K. Heimann (James Cook University) for
   providing us with high quality samples of diatomaceous earth consisting
   mainly of intact skeletons. Our thanks go to Professor Besim Ben-Nissan
   for generating microCT images of Foraminifera macrospheres. This study
   was supported by a grant of the Korea Health Technology R & D Project,
   Ministry of Health and Welfare, Korea (HI12C02970100).
CR Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482
   Abramovitch-Gottlib L, 2006, TISSUE ENG, V12, P729, DOI 10.1089/ten.2006.12.729
   Addad S, 2011, MAR DRUGS, V9, P967, DOI 10.3390/md9060967
   Allison DP, 2008, METHOD CELL BIOL, V90, P61, DOI 10.1016/S0091-679X(08)00804-2
   Almeida MJ, 2001, J BIOMED MATER RES, V57, P306, DOI 10.1002/1097-4636(200111)57:2<306::AID-JBM1172>3.0.CO;2-H
   Almqvist N, 2001, J MICROSC-OXFORD, V202, P518, DOI 10.1046/j.1365-2818.2001.00887.x
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Aw MS, 2013, J BIOMATER APPL, V28, P163, DOI 10.1177/0885328212441846
   Aw MS, 2011, NANOMEDICINE-UK, V6, P1159, DOI [10.2217/NNM.11.29, 10.2217/nnm.11.29]
   Bariana M, 2013, INT J PHARMACEUT, V443, P230, DOI 10.1016/j.ijpharm.2012.12.012
   Bedouet L, 2006, COMP BIOCHEM PHYS B, V144, P532, DOI 10.1016/j.cbpb.2006.05.012
   Ben-Nissan B, 2004, BIOMATERIALS, V25, P4971, DOI 10.1016/j.biomaterials.2004.02.006
   Bermueller C, 2013, TISSUE ENG PT A, V19, P2201, DOI [10.1089/ten.tea.2012.0650, 10.1089/ten.TEA.2012.0650]
   Bluteau G, 2008, EUR CELLS MATER, V16, P1
   Bobbio A, 1972, Bull Hist Dent, V20, P1
   Bozarth A, 2009, APPL MICROBIOL BIOT, V82, P195, DOI 10.1007/s00253-008-1804-8
   Bradbury J, 2004, PLOS BIOL, V2, P1512, DOI 10.1371/journal.pbio.0020306
   Carlson NE, 2002, J AM DENT ASSOC, V133, P1383, DOI 10.14219/jada.archive.2002.0054
   CHIROFF RT, 1975, J BIOMED MATER RES, V9, P29, DOI 10.1002/jbm.820090407
   CHIROFF RT, 1977, J BIOMED MATER RES, V11, P165, DOI 10.1002/jbm.820110203
   Choi AH, 2013, J DENT RES, V92, P853, DOI 10.1177/0022034513497754
   Chou J, 2014, J TISSUE ENG REGEN M, V8, P771, DOI 10.1002/term.1576
   Chou J, 2014, NANOMEDICINE-UK, V9, P1131, DOI [10.2217/nnm.13.116, 10.2217/NNM.13.116]
   Chou J, 2016, J TISSUE ENG REGEN M, V10, pE195, DOI 10.1002/term.1784
   Chou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071821
   Chou J, 2013, BIORESEARCH OPEN ACC, V2, P67, DOI 10.1089/biores.2012.0269
   Chou JH, 2011, ADV ENG MATER, V13, P93, DOI 10.1002/adem.201000208
   Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405
   Cimetta E, 2013, LAB CHIP, V13, P355, DOI 10.1039/c2lc40836h
   Clarke SA, 2011, BIOTECHNOL ADV, V29, P610, DOI 10.1016/j.biotechadv.2011.04.003
   Dawkins D, 1996, CLIMBING MOUNT IMPRO
   De Stefano L, 2008, ACTA BIOMATER, V4, P126, DOI 10.1016/j.actbio.2007.09.003
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Dobretsov S, 2013, BIOFOULING, V29, P423, DOI 10.1080/08927014.2013.776042
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   Drum RW, 2003, TRENDS BIOTECHNOL, V21, P325, DOI 10.1016/S0167-7799(03)00169-0
   Drummond JL, 2008, J DENT RES, V87, P710, DOI 10.1177/154405910808700802
   Duckworth A, 2009, MAR BIOTECHNOL, V11, P669, DOI 10.1007/s10126-009-9213-2
   Dunlap WC, 2007, METHODS, V42, P358, DOI 10.1016/j.ymeth.2007.03.001
   Dunlap WC, 2006, CURR MED CHEM, V13, P697, DOI 10.2174/092986706776055643
   Dunlop JWC, 2011, MATER TODAY, V14, P70, DOI 10.1016/S1369-7021(11)70056-6
   Ebada SS, 2008, NAT PROTOC, V3, P1820, DOI 10.1038/nprot.2008.182
   Ehrlich H, 2010, INT J BIOL MACROMOL, V47, P132, DOI 10.1016/j.ijbiomac.2010.05.007
   Ehrlich H., 2010, BIOL MAT MARINE ORIG
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Fadeeva E, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0048
   Fattahi P, 2014, ADV MATER, V26, P1846, DOI 10.1002/adma.201304496
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Gordon R, 2005, J NANOSCI NANOTECHNO, V5, P35, DOI 10.1166/jnn.2005.002
   Green D, 2003, TISSUE ENG, V9, P1159, DOI 10.1089/10763270360728062
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Green DW, 2013, MAR DRUGS, V11, P1203, DOI 10.3390/md11041203
   Green DW, 2012, ADV HEALTHC MATER, V1, P140, DOI 10.1002/adhm.201100039
   Green DW, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034010
   Griffith CK, 2005, TISSUE ENG, V11, P257, DOI 10.1089/ten.2005.11.257
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Hannig C, 2010, MED HYPOTHESES, V74, P670, DOI 10.1016/j.mehy.2009.11.007
   Hannig M, 2012, Adv Dent Res, V24, P53, DOI 10.1177/0022034512450446
   Hannig M, 2010, NAT NANOTECHNOL, V5, P565, DOI [10.1038/NNANO.2010.83, 10.1038/nnano.2010.83]
   Harink B, 2013, LAB CHIP, V13, P3512, DOI 10.1039/c3lc50293g
   Hayward DC, 2002, P NATL ACAD SCI USA, V99, P8106, DOI 10.1073/pnas.112021499
   Heinemann S, 2007, BIOMACROMOLECULES, V8, P3452, DOI 10.1021/bm700574y
   Heinemann S, 2007, INT J MATER RES, V98, P603, DOI 10.3139/146.101519
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Jeong SI, 2007, BIOMATERIALS, V28, P1115, DOI 10.1016/j.biomaterials.2006.10.025
   Jiang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018514
   JODAIKIN A, 1984, J ULTRA MOL STRUCT R, V89, P324, DOI 10.1016/S0022-5320(84)80048-9
   JODAIKIN A, 1986, ARCH ORAL BIOL, V31, P685, DOI 10.1016/0003-9969(86)90098-1
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kim H, 2012, BIOMATERIALS, V33, P7489, DOI 10.1016/j.biomaterials.2012.06.098
   Kim SK, 2013, MARINE BIOMATERIALS: CHARACTERIZATION, ISOLATION AND APPLICATIONS, P1, DOI 10.1201/b14723
   Kim TW, 2008, NANO LETT, V8, P3724, DOI 10.1021/nl801976m
   Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657
   Kroger N, 2007, CURR OPIN CHEM BIOL, V11, P662, DOI 10.1016/j.cbpa.2007.10.009
   Lacefield W R, 1998, Implant Dent, V7, P315, DOI 10.1097/00008505-199807040-00010
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Langer R, 2000, MOL THER, V1, P12, DOI 10.1006/mthe.1999.0003
   Langer R, 1997, PHARMACEUT RES, V14, P840, DOI 10.1023/A:1012131329148
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Lautenschlager E P, 1993, Int Dent J, V43, P245
   Lee H, 2012, NAT NANOTECHNOL, V7, P389, DOI [10.1038/nnano.2012.73, 10.1038/NNANO.2012.73]
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Li L, 2011, ADV MATER, V23, P4695, DOI 10.1002/adma.201102773
   Li X, 2013, CRYSTENGCOMM, V15, P4351, DOI 10.1039/c3ce26947g
   Lieder R, 2012, INT J BIOL MACROMOL, V51, P675, DOI 10.1016/j.ijbiomac.2012.07.005
   Lin Z, 2011, INT J BIOL SCI, V7, P968, DOI 10.7150/ijbs.7.968
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Lu XL, 2012, INT J NANOMED, V7, P2153, DOI 10.2147/IJN.S29851
   LUMSDEN AGS, 1988, DEVELOPMENT, V103, P155
   Mann S, 1997, CIBA F SYMP, V205, P261
   MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   Mann S, 1997, CIB FDN S, V205, P269
   Mann S., 2001, BIOMINERALIZATION PR, V5
   Marris E, 2006, NATURE, V443, P904, DOI 10.1038/443904a
   Matsumura G, 2013, BIOMATERIALS, V34, P6422, DOI 10.1016/j.biomaterials.2013.05.037
   Matsumura G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035760
   Melo MAS, 2013, TRENDS BIOTECHNOL, V31, P459, DOI 10.1016/j.tibtech.2013.05.010
   MINA M, 1987, ARCH ORAL BIOL, V32, P123, DOI 10.1016/0003-9969(87)90055-0
   Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487
   Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217
   Muzzarelli RAA, 2011, MAR DRUGS, V9, P1510, DOI 10.3390/md9091510
   Nakashima Syozi, 2009, J Oral Sci, V51, P69
   Ni M, 2003, BIOMATERIALS, V24, P4323, DOI 10.1016/S0142-9612(03)00236-9
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Ohara T, 2010, J BIOMED MATER RES A, V94A, P800, DOI 10.1002/jbm.a.32749
   Ohazama A, 2005, J DENT RES, V84, P603, DOI 10.1177/154405910508400704
   Oliveira SM, 2013, ADV HEALTHC MATER, V2, P422, DOI 10.1002/adhm.201200204
   Pallela R, 2011, INT J BIOL MACROMOL, V49, P85, DOI 10.1016/j.ijbiomac.2011.03.019
   Parker AR, 2007, NAT NANOTECHNOL, V2, P347, DOI 10.1038/nnano.2007.152
   Parkinson J, 1999, TRENDS BIOTECHNOL, V17, P190, DOI 10.1016/S0167-7799(99)01321-9
   PARR GR, 1985, J PROSTHET DENT, V54, P410, DOI 10.1016/0022-3913(85)90562-1
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Putnam D, 2014, P NATL ACAD SCI USA, V111, P3903, DOI 10.1073/pnas.1401746111
   Radjasa OK, 2011, BIOORGAN MED CHEM, V19, P6658, DOI 10.1016/j.bmc.2011.07.017
   Reddy ST, 2011, J ENDOUROL, V25, P1547, DOI 10.1089/end.2010.0611
   Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Saunders SA, 2009, CLIN COSMET INVESTIG, V1, P47, DOI 10.2147/CCIDE.S7722
   Scheller EL, 2009, J ORAL REHABIL, V36, P368, DOI 10.1111/j.1365-2842.2009.01939.x
   Sen D, 2011, SCI REP-UK, V1, DOI 10.1038/srep00035
   Senni K, 2011, MAR DRUGS, V9, P1664, DOI 10.3390/md9091664
   Shakir A, 2012, OTOLARYNG HEAD NECK, V147, P509, DOI 10.1177/0194599812442867
   Shields RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055339
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   Sjostrom T, 2013, NANOMEDICINE-UK, V8, P89, DOI [10.2217/NNM.12.177, 10.2217/nnm.12.177]
   Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012
   Slowing II, 2007, J AM CHEM SOC, V129, P8845, DOI 10.1021/ja0719780
   Soffer E, 2003, ORAL SURG ORAL MED O, V95, P521, DOI 10.1067/moe.2003.152
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Song JS, 2012, TISSUE ENG PT A, V18, P2040, DOI [10.1089/ten.tea.2011.0318, 10.1089/ten.TEA.2011.0318]
   Soost F, 1996, CHIRURG, V67, P1193, DOI 10.1007/s001040050125
   SOUYRIS F, 1985, J MAXILLOFAC SURG, V13, P64, DOI 10.1016/S0301-0503(85)80018-7
   Stowe SD, 2011, MAR DRUGS, V9, P2010, DOI 10.3390/md9102010
   Subhash G, 2005, J NANOSCI NANOTECHNO, V5, P50, DOI 10.1166/jnn.2005.006
   Svetlicic V, 2011, MAR DRUGS, V9, P666, DOI 10.3390/md9040666
   Swider P, 2007, J BIOMECH, V40, P2112, DOI 10.1016/j.jbiomech.2006.10.002
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Thomas Mark V, 2005, J Long Term Eff Med Implants, V15, P585
   Tiffany MA, 2005, J NANOSCI NANOTECHNO, V5, P131, DOI 10.1166/jnn.2005.011
   Tomisa A.P., 2011, INT J ORAL MAXILLOF, V26, P45
   Tomsia AP, 2011, INT J ORAL MAX IMPL, V26, P25
   Tonzum TF, 2003, J CAN DENT ASSOC, V69, P664
   Townley HE, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/29/295101
   Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P117, DOI 10.1111/j.1600-051X.2008.01265.x
   Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136
   Uchida T, 1998, EUR J ORAL SCI, V106, P308, DOI 10.1111/j.1600-0722.1998.tb02191.x
   Ure David, 2003, Dent Update, V30, P10
   Vadgama P., 2005, SURFACES INTERFACES, P802
   Van Nieuwenhuysen JP, 2003, J DENT, V31, P395, DOI 10.1016/S0300-5712(03)00084-8
   Varoni EM, 2012, CURR MED CHEM, V19, P1706
   Vecchio KS, 2007, ACTA BIOMATER, V3, P785, DOI 10.1016/j.actbio.2007.03.009
   Vincent J.F.V., 2002, MATER TODAY, V5, P28, DOI DOI 10.1016/S1369-7021(02)01237-3
   Walsh PJ, 2008, CHEM ENG J, V137, P173, DOI 10.1016/j.cej.2007.10.016
   Walsh PJ, 2011, P I MECH ENG H, V225, P563, DOI 10.1177/0954411910396306
   Wang S, 2014, COLLOID SURFACE B, V113, P483, DOI 10.1016/j.colsurfb.2013.09.024
   Wei XL, 2013, INT J BIOL MACROMOL, V54, P71, DOI 10.1016/j.ijbiomac.2012.10.022
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   WHITE EW, 1975, J BIOMED MATER RES, V9, P23, DOI 10.1002/jbm.820090406
   WHITE RA, 1972, SCIENCE, V176, P922, DOI 10.1126/science.176.4037.922
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wu YC, 2009, J MATER SCI-MATER M, V20, P1273, DOI 10.1007/s10856-009-3695-3
   Wysokowski M, 2013, FRONT MATER SCI, V7, P248, DOI 10.1007/s11706-013-0212-x
   Yao S, 2007, J NANOSCI NANOTECHNO, V7, P4465, DOI 10.1166/jnn.2007.904
   Young JR, 1999, J STRUCT BIOL, V126, P195, DOI 10.1006/jsbi.1999.4132
   Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299
   Zheng MH, 2007, MACROMOL SYMP, V253, P179, DOI 10.1002/masy.200750725
   Zhou YZ, 2012, ACS APPL MATER INTER, V4, P6900, DOI 10.1021/am302041b
   Zoccola D, 2009, MAR BIOTECHNOL, V11, P260, DOI 10.1007/s10126-008-9141-6
   Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
NR 181
TC 12
Z9 12
U1 3
U2 36
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD MAY
PY 2014
VL 12
IS 5
BP 2877
EP 2912
DI 10.3390/md12052877
PG 36
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AI8JU
UT WOS:000337160500030
PM 24828293
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Venkatesan, J
   Jayakumar, R
   Mohandas, A
   Bhatnagar, I
   Kim, SK
AF Venkatesan, Jayachandran
   Jayakumar, Rangasamy
   Mohandas, Annapoorna
   Bhatnagar, Ira
   Kim, Se-Kwon
TI Antimicrobial Activity of Chitosan-Carbon Nanotube Hydrogels
SO MATERIALS
LA English
DT Article
DE marine biomaterials; tissue engineering; chitosan; carbon nanotube;
   antimicrobial activity
ID NANOCOMPOSITES; DISPERSION; COMPOSITE; SCAFFOLDS; MODE
AB In the present study, we have prepared chitosan-carbon nanotube (Chitosan-CNT) hydrogels by the freeze-lyophilization method and examined their antimicrobial activity. Different concentrations of CNT were used in the preparation of Chitosan-CNT hydrogels. These differently concentrated CNT hydrogels were chemically characterized using Fourier Transform-Infrared Spectroscopy, Scanning Electron Microscopy and Optical microscopy. The porosity of the hydrogels were found to be >94%. Dispersion of chitosan was observed in the CNT matrix by normal photography and optical microscopy. The addition of CNT in the composite scaffold significantly reduced the water uptake ability. In order to evaluate antimicrobial activity, the serial dilution method was used towards Staphylococcus aureus, Escherichia coli and Candida tropicalis. The composite Chitosan-CNT hydrogel showed greater antimicrobial activity with increasing CNT concentration, suggesting that Chitosan-CNT hydrogel scaffold will be a promising biomaterial in biomedical applications.
C1 [Venkatesan, Jayachandran; Kim, Se-Kwon] Pukyong Natl Univ, Marine Bioproc Res Ctr, Pusan 608737, South Korea.
   [Venkatesan, Jayachandran; Kim, Se-Kwon] Pukyong Natl Univ, Dept Marine Bio Convergence Sci, Pusan 608737, South Korea.
   [Jayakumar, Rangasamy; Mohandas, Annapoorna] Amrita Ctr Nanosci & Mol Med, Amrita Inst Med Sci & Res Ctr, Kochi 682041, Kerala, India.
   [Bhatnagar, Ira] Ctr Cellular & Mol Biol, Nanotheranost Lab, Hyderabad 500007, Andhra Pradesh, India.
RP Kim, SK (reprint author), Pukyong Natl Univ, Marine Bioproc Res Ctr, Pusan 608737, South Korea.
EM venkatjchem@pknu.ac.kr; rjayakumar@aims.amrita.edu;
   annapoornamohandas@aims.amrita.edu; ibhatnagar@gmail.com;
   sknkim@pknu.ac.kr
OI Kim, Se-Kwon/0000-0001-6507-9539
FU Marine Bioprocess Research Center of the Marine Biotechnology Program -
   Ministry of Oceans and Fisheries, Republic of Korea
FX This research was supported by a grant from the Marine Bioprocess
   Research Center of the Marine Biotechnology Program, funded by the
   Ministry of Oceans and Fisheries, Republic of Korea.
CR Akhavan O, 2011, J MATER CHEM, V21, P387, DOI 10.1039/c0jm02395g
   Amiri A, 2012, MATER LETT, V72, P153, DOI 10.1016/j.matlet.2011.12.114
   Aslan S, 2013, SOFT MATTER, V9, P2136, DOI 10.1039/c2sm27444b
   Aslan S, 2012, J COLLOID INTERF SCI, V388, P268, DOI 10.1016/j.jcis.2012.08.025
   Aziz MA, 2012, ANTIMICROB AGENTS CH, V56, P280, DOI 10.1128/AAC.05463-11
   Chen HQ, 2013, SMALL, V9, P2735, DOI 10.1002/smll.201202792
   Deokar AR, 2013, J MATER CHEM B, V1, P2639, DOI 10.1039/c3tb20188k
   Kang S, 2008, ENVIRON SCI TECHNOL, V42, P7528, DOI 10.1021/es8010173
   Kang S, 2007, LANGMUIR, V23, P8670, DOI 10.1021/la701067r
   Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Liu XF, 2001, J APPL POLYM SCI, V79, P1324
   Mei N., 2009, CARBOHYD POLYM, V78, P54
   Mohamed NA, 2012, INT J MOL SCI, V13, P11194, DOI 10.3390/ijms130911194
   Moridi Z, 2011, CELL CHEM TECHNOL, V45, P549
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Rhim JW, 2006, J AGR FOOD CHEM, V54, P5814, DOI 10.1021/jf060658h
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006
   Sanpui P, 2008, INT J FOOD MICROBIOL, V124, P142, DOI 10.1016/j.ijfoodmicro.2008.03.004
   Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001
   Shang SM, 2013, COMPOS SCI TECHNOL, V86, P129, DOI 10.1016/j.compscitech.2013.07.010
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Venkatesan J, 2012, INT J BIOL MACROMOL, V50, P393, DOI 10.1016/j.ijbiomac.2011.12.032
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wang XY, 2006, POLYMER, V47, P6738, DOI 10.1016/j.polymer.2006.07.026
   Zheng LY, 2003, CARBOHYD POLYM, V54, P527, DOI 10.1016/j.carbpol.2003.07.009
NR 26
TC 29
Z9 30
U1 3
U2 56
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2014
VL 7
IS 5
BP 3946
EP 3955
DI 10.3390/ma7053946
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA AI9KF
UT WOS:000337250800038
PM 28788658
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Tsou, CH
   Kao, BJ
   Suen, MC
   Yang, MC
   Wu, TY
   Tsou, CY
   Chen, JC
   Yao, WH
   Chu, CK
   Tuan, XM
   Hwang, JZ
   Hung, WS
   Lee, KR
   Lai, JY
AF Tsou, C. -H.
   Kao, B. -J.
   Suen, M. -C.
   Yang, M. -C.
   Wu, T. -Y.
   Tsou, C. -Y.
   Chen, J. -C.
   Yao, W. -H.
   Chu, C. -K.
   Tuan, X. -M.
   Hwang, J. -Z.
   Hung, W. -S.
   Lee, K. -R.
   Lai, J. -Y.
TI Crystallisation behaviour and biocompatibility of poly(butylene
   succinate)/poly(lactic acid) composites
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE Poly(butylene succinate); Poly(lactic acid); Crystallisation;
   Biocompatibility
ID MELTING BEHAVIOR; SUCCINATE); KINETICS; BIOMATERIAL; MORPHOLOGY
AB Biodegradable poly(butylene succinate) (PBS)/poly(lactic acid) (PLA) composites were prepared by melt compounding. Differential scanning calorimetry and wide angle X-ray diffraction were used to characterise PBS, PBS/PLA composites and PLA in terms of their non-isothermal crystallisation, melting behaviour, isothermal crystallisation kinetics, spherulitic morphology and crystal structure. The results show that the addition of PLA has a slight heterogeneous nucleation effect on the crystallisation of PBS, particularly in the case of PBS/PLA ratios of 90 : 10 and 80 : 20. Hence, the crystallisation rate is enhanced during both non-isothermal and isothermal crystallisation of the composites. However, the crystal form of PBS is free from the addition of PLA. L929 fibroblasts cells were chosen to assess the cytocompatibility, and it is found that the cell growth in the neat PBS is similar to that in the PBS/PLA composites.
C1 [Tsou, C. -H.; Kao, B. -J.; Yang, M. -C.; Wu, T. -Y.; Tsou, C. -Y.; Tuan, X. -M.] Natl Taiwan Univ Sci & Technol, Dept Mat Sci & Engn, Taipei, Taiwan.
   [Tsou, C. -H.; Hung, W. -S.; Lee, K. -R.; Lai, J. -Y.] Chung Yuan Christian Univ, Dept Chem Engn, R&D Ctr Membrane Technol, Chungli, Taiwan.
   [Tsou, C. -H.; Chen, J. -C.; Yao, W. -H.; Chu, C. -K.] Oriental Inst Technol, Dept Mat & Text, Pan Chiao 22064, Taiwan.
   [Suen, M. -C.] Taoyuan Innovat Inst Technol, Dept Creat Fash Design, Jhongli 32091, Taiwan.
   [Hwang, J. -Z.] Tamkang Univ, Dept Chem, Nanotech Res Ctr, Tamsui 25137, Taiwan.
RP Yang, MC (reprint author), Natl Taiwan Univ Sci & Technol, Dept Mat Sci & Engn, Taipei, Taiwan.
EM myang@mail.ntust.edu.tw
CR Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380
   Bhari K., 1998, POLYM DEGRAD STABIL, V62, P551
   CHAN TW, 1994, POLYM ENG SCI, V34, P461, DOI 10.1002/pen.760340602
   Gan ZH, 2001, BIOMACROMOLECULES, V2, P605, DOI 10.1021/bm015535e
   Han SI, 2005, ADV FUNCT MATER, V15, P367, DOI 10.1002/adfm.200400079
   Hoffman J. D., 1976, TREATISE SOLID STATE
   Kimura M., US patent, Patent No. [7,632,897B2, 7632897]
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   Li HY, 2005, MACROMOL BIOSCI, V5, P433, DOI 10.1002/mabi.200400183
   Ljungberg N, 2003, POLYMER, V44, P7679, DOI 10.1016/j.polymer.2003.09.055
   Newman B, 1998, Breast Dis, V10, P3
   Papageorgiou GZ, 2007, MACROMOL CHEM PHYS, V208, P1250, DOI 10.1002/macp.200700084
   Qiu ZB, 2004, POLYM J, V36, P642, DOI 10.1295/polymj.36.642
   Qiu ZB, 2006, POLYMER, V47, P6429, DOI 10.1016/j.polymer.2006.07.001
   Ratto JA, 1999, POLYMER, V40, P6777, DOI 10.1016/S0032-3861(99)00014-2
   Song L, 2009, POLYM DEGRAD STABIL, V94, P632, DOI 10.1016/j.polymdegradstab.2009.01.009
   Wang XH, 2007, EUR POLYM J, V43, P3163, DOI 10.1016/j.eurpolymj.2007.05.013
   Wunderlich B., 1976, MACROMOLECULAR PHYS, V2
   Yang SL, 2009, J POLYM SCI POL PHYS, V47, P1136, DOI 10.1002/polb.21716
   Yoo ES, 1999, J POLYM SCI POL PHYS, V37, P1357, DOI 10.1002/(SICI)1099-0488(19990701)37:13<1357::AID-POLB2>3.0.CO;2-Q
NR 20
TC 10
Z9 10
U1 2
U2 44
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1432-8917
EI 1433-075X
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD MAY
PY 2014
VL 18
SU 2
BP 372
EP 376
DI 10.1179/1432891714Z.000000000435
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA AI8FZ
UT WOS:000337146600072
DA 2018-10-20
ER

PT J
AU Sanggaard, KW
   Bechsgaard, JS
   Fang, XD
   Duan, JJ
   Dyrlund, TF
   Gupta, V
   Jiang, XT
   Cheng, L
   Fan, DD
   Feng, Y
   Han, LJ
   Huang, ZY
   Wu, ZZ
   Liao, L
   Settepani, V
   Thogersen, IB
   Vanthournout, B
   Wang, T
   Zhu, YB
   Funch, P
   Enghild, JJ
   Schauser, L
   Andersen, SU
   Villesen, P
   Schierup, MH
   Bilde, T
   Wang, J
AF Sanggaard, Kristian W.
   Bechsgaard, Jesper S.
   Fang, Xiaodong
   Duan, Jinjie
   Dyrlund, Thomas F.
   Gupta, Vikas
   Jiang, Xuanting
   Cheng, Ling
   Fan, Dingding
   Feng, Yue
   Han, Lijuan
   Huang, Zhiyong
   Wu, Zongze
   Liao, Li
   Settepani, Virginia
   Thogersen, Ida B.
   Vanthournout, Bram
   Wang, Tobias
   Zhu, Yabing
   Funch, Peter
   Enghild, Jan J.
   Schauser, Leif
   Andersen, Stig U.
   Villesen, Palle
   Schierup, Mikkel H.
   Bilde, Trine
   Wang, Jun
TI Spider genomes provide insight into composition and evolution of venom
   and silk
SO NATURE COMMUNICATIONS
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; GENE SEQUENCE; RNA-SEQ;
   PROTEINS; EXPRESSION; IDENTIFICATION; PHARMACOLOGY; ALIGNMENT; FAMILY
AB Spiders are ecologically important predators with complex venom and extraordinarily tough silk that enables capture of large prey. Here we present the assembled genome of the social velvet spider and a draft assembly of the tarantula genome that represent two major taxonomic groups of spiders. The spider genomes are large with short exons and long introns, reminiscent of mammalian genomes. Phylogenetic analyses place spiders and ticks as sister groups supporting polyphyly of the Acari. Complex sets of venom and silk genes/proteins are identified. We find that venom genes evolved by sequential duplication, and that the toxic effect of venom is most likely activated by proteases present in the venom. The set of silk genes reveals a highly dynamic gene evolution, new types of silk genes and proteins, and a novel use of aciniform silk. These insights create new opportunities for pharmacological applications of venom and biomaterial applications of silk.
C1 [Sanggaard, Kristian W.; Dyrlund, Thomas F.; Gupta, Vikas; Thogersen, Ida B.; Enghild, Jan J.; Andersen, Stig U.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark.
   [Sanggaard, Kristian W.; Thogersen, Ida B.; Enghild, Jan J.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark.
   [Bechsgaard, Jesper S.; Settepani, Virginia; Vanthournout, Bram; Wang, Tobias; Funch, Peter; Schierup, Mikkel H.; Bilde, Trine] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark.
   [Fang, Xiaodong; Jiang, Xuanting; Cheng, Ling; Fan, Dingding; Feng, Yue; Han, Lijuan; Huang, Zhiyong; Wu, Zongze; Liao, Li; Zhu, Yabing; Wang, Jun] BGI Shenzhen, BGI Tech, Shenzhen 518083, Peoples R China.
   [Fang, Xiaodong; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen, Denmark.
   [Duan, Jinjie; Gupta, Vikas; Villesen, Palle; Schierup, Mikkel H.] Aarhus Univ, Bioinformat Res Ctr BiRC, DK-8000 Aarhus C, Denmark.
   [Schauser, Leif] Aarhus Univ, CLC Bio, DK-8000 Aarhus C, Denmark.
   [Villesen, Palle] Aarhus Univ, Dept Clin Med, DK-8000 Aarhus C, Denmark.
   [Wang, Jun] King Abdulaziz Univ, Jeddah 21441, Saudi Arabia.
RP Schierup, MH (reprint author), Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark.
EM mheide@birc.au.dk; trine.bilde@biology.au.dk; wangj@genomics.org.cn
RI Bilde, Trine/J-2872-2013; Funch, Peter/B-7437-2009; FANG,
   xiaodong/K-6743-2018; Wang, Jun/C-8434-2016; Schierup,
   Mikkel/F-1675-2010; Wang, Tobias/I-7946-2013
OI Bilde, Trine/0000-0002-0341-161X; Funch, Peter/0000-0002-0184-1552;
   FANG, xiaodong/0000-0001-7061-3337; Wang, Jun/0000-0002-8540-8931;
   Schierup, Mikkel/0000-0002-5028-1790; Wang, Tobias/0000-0002-4350-3682;
   Wang, Jun/0000-0002-2113-5874; Enghild, Jan
   Johannes/0000-0001-9292-9172; Andersen, Stig U./0000-0002-1096-1468
FU grant (Novenia) from the Danish Research Council for Strategic Research;
   ERC Starting Grant
FX This work was supported by a grant (Novenia) from the Danish Research
   Council for Strategic Research to J.J.E., and an ERC Starting Grant to
   T.B. We thank Tanza Crouch for help with collection of S. mimosarum. We
   are indebted to Tom Tregenza, Gonzalo Giribet, Fritz Vollrath and Sara
   Goodacre for comments on the manuscript. We thank Tania A. Nielsen for
   assisting during DNA and RNA purification and LC-MS/MS sample
   preparation, and Sanne E. Lauridsen and Line R. Thomsen for collecting
   tarantula venom and tarantula tissue samples. We thank Lena Grinsted for
   the drawings of spider silk (Fig. 4d).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962
   Ayoub NA, 2013, MOL BIOL EVOL, V30, P589, DOI 10.1093/molbev/mss254
   Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573
   CANDELAS GC, 1986, J EXP ZOOL, V237, P281, DOI 10.1002/jez.1402370214
   Cao ZJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3602
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Clement H, 2012, TOXICON, V60, P1223, DOI 10.1016/j.toxicon.2012.08.018
   Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315
   Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231
   Da Silveira RB, 2007, BIOCHEM J, V406, P355, DOI 10.1042/BJ20070363
   De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Dimitrov D, 2012, P ROY SOC B-BIOL SCI, V279, P1341, DOI 10.1098/rspb.2011.2011
   Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109
   Elices M, 2011, J MECH BEHAV BIOMED, V4, P658, DOI 10.1016/j.jmbbm.2010.09.008
   Escoubas P, 2000, BIOCHIMIE, V82, P893, DOI 10.1016/S0300-9084(00)01166-4
   Foradori MJ, 2006, COMP BIOCHEM PHYS B, V143, P257, DOI 10.1016/j.cbpb.2005.08.012
   Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356
   Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936
   Hilbrant M, 2012, DEVELOPMENT, V139, P2655, DOI 10.1242/dev.078204
   Janssen R, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-15
   Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5
   Khadjeh S, 2012, P NATL ACAD SCI USA, V109, P4921, DOI 10.1073/pnas.1116421109
   King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650
   Kini RM, 2003, TOXICON, V42, P827
   Kuhn-Nentwig L, 2011, ADV INSECT PHYSIOL, V40, P1, DOI 10.1016/B978-0-12-387668-3.00001-5
   Lane K. L., 2013, BMC GENOMICS, V14, P846
   Langellotto GA, 2004, OECOLOGIA, V139, P1, DOI 10.1007/s00442-004-1497-3
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632
   Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118
   Liang S, 2008, EXPERT REV PROTEOMIC, V5, P731, DOI 10.1586/14789450.5.5.731
   Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102
   Mattila TM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-70
   Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200
   Nyffeler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058120
   PALMER JM, 1985, J MORPHOL, V186, P195, DOI 10.1002/jmor.1051860205
   Pechmann M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002342
   Pepato AR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-235
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Platnick N. I., 1991, AM MUS NOVIT, V3016, P1
   Platnick NI, 2012, AM MUSEUM NATURAL HI
   Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4
   Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742
   Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273
   Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851
   SAVELNIEMANN A, 1989, BIOL CHEM H-S, V370, P485, DOI 10.1515/bchm3.1989.370.1.485
   SCHANBAC.FL, 1973, TOXICON, V11, P21, DOI 10.1016/0041-0101(73)90147-5
   Schmitz OJ, 1997, ECOLOGY, V78, P1388
   Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468
   Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379
   Starrett J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038084
   Sunagar K, 2012, MOL BIOL EVOL, V29, P1807, DOI 10.1093/molbev/mss058
   Talavera G, 2007, SYSTEMATIC BIOL, V56, P564, DOI 10.1080/10635150701472164
   Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016
   Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Vasanthavada K, 2007, J BIOL CHEM, V282, P35088, DOI 10.1074/jbc.M705791200
   Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069
   Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
NR 70
TC 93
Z9 94
U1 8
U2 113
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY
PY 2014
VL 5
AR 3765
DI 10.1038/ncomms4765
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AJ0TR
UT WOS:000337369400001
PM 24801114
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Boulila, S
   El Feki, A
   Oudadesse, H
   El Feki, H
AF Boulila, S.
   El Feki, A.
   Oudadesse, H.
   El Feki, H.
TI Protection of rats against nickel chloride by using biomaterial-based
   carbonated orthophosphate
SO FUNDAMENTAL & CLINICAL PHARMACOLOGY
LA English
DT Meeting Abstract
DE apatite; detoxification; kidney; oxidative stress
C1 [Boulila, S.; Oudadesse, H.] Univ Rennes 1, Rennes, France.
   [Boulila, S.] Fac Sci Sfax, Sfax, Tunisia.
   [El Feki, A.; El Feki, H.] Fac Sci, Sfax, Tunisia.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0767-3981
EI 1472-8206
J9 FUND CLIN PHARMACOL
JI Fundam. Clin. Pharmacol.
PD MAY
PY 2014
VL 28
SU 1
SI SI
BP 82
EP 83
PG 2
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AI7DD
UT WOS:000337041300378
DA 2018-10-20
ER

PT J
AU Peter, A
   Mihaly-Cozmuta, L
   Mihaly-Cozmuta, A
   Nicula, C
   Tudoran, LB
   Baia, L
AF Peter, A.
   Mihaly-Cozmuta, L.
   Mihaly-Cozmuta, A.
   Nicula, C.
   Tudoran, L. B.
   Baia, L.
TI Efficiency of Cu/TiO2 to remove salicylic acid by photocatalytic
   decomposition: kinetic modelling
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Cu-TiO2; Photoactivity; XRD; TEM; FTIR; Kinetics; Diffusion model
ID FERRITE COMPOSITE NANOPARTICLES; NICKEL FERRITE; BIOMATERIAL SYSTEM;
   ANTIMICROBIAL ACTIVITY; MAGNETIC CORE; TIO2 AEROGELS; TITANIA;
   DEGRADATION; DEPOSITION; REDUCTION
AB Titanium dioxide has waste applications as photocatalyst, as antimicrobial material and in biomedical field. By modifying the surface of TiO2 with noble metals its photoactivity will be enhanced. This paper aims to explain the role of the copper particles deposited on titania surface during the photodecomposition of salicylic acid and to provide evidence about which kinetic model describes best the photocatalysis. The research explains why the photodecomposition rate of salicylic acid is higher in Cu/TiO2 composite as compared to in TiO2. It consists in kinetic approach of the photocatalytic behaviour of Cu-TiO2 and TiO2, thus being possible to discuss the photodecomposition mechanism. This research will allow improvement of the techniques to remove salicylic acid from synthetic solution. This could be extended to other organic pollutants.
C1 [Peter, A.; Mihaly-Cozmuta, L.; Mihaly-Cozmuta, A.; Nicula, C.] Tech Univ Cluj Napoca, North Univ Ctr Baia Mare, Dept Biol & Chem, Baia Mare 430083, Romania.
   [Tudoran, L. B.] Univ Babes Bolyai, Fac Biol & Geol, Cluj Napoca 400006, Romania.
   [Baia, L.] Univ Babes Bolyai, Fac Phys, Cluj Napoca 400084, Romania.
   [Baia, L.] Univ Babes Bolyai, Inst Interdisciplinar Res Bionanosci, Cluj Napoca 400084, Romania.
RP Peter, A (reprint author), Tech Univ Cluj Napoca, North Univ Ctr Baia Mare, Dept Biol & Chem, Victor Babes 76, Baia Mare 430083, Romania.
EM peteranca@yahoo.com
RI Baia, Lucian/B-9711-2011
OI Baia, Lucian/0000-0003-3196-4868
FU SMARTPACK project, program MNT-ERANET - UEFISCDI Romania
   [7-065/26.09.2012]
FX We have conducted the research work within the framework of the
   SMARTPACK project, program MNT-ERANET (contract no. 7-065/26.09.2012),
   financed by UEFISCDI Romania.
CR Anandan S, 2010, APPL CATAL B-ENVIRON, V100, P502, DOI 10.1016/j.apcatb.2010.08.029
   Arana J, 2005, CATAL TODAY, V101, P261, DOI 10.1016/j.cattod.2005.03.006
   Baia L, 2006, THIN SOLID FILMS, V511, P512, DOI 10.1016/j.tsf.2005.12.024
   Bouker M., 2003, J CATAL, V217, P427
   Choi SS, 2004, J SOL-GEL SCI TECHN, V30, P215, DOI 10.1023/B:JSST.0000039530.09380.bc
   Einaga H, 2004, ENVIRON SCI TECHNOL, V38, P285, DOI 10.1012/es034336v
   Gubbala S, 2006, MATER SCI TECH-LOND, V22, P845, DOI 10.1179/174328406X91096
   Gunay A, 2007, J HAZARD MATER, V146, P362, DOI 10.1016/j.jhazmat.2006.12.034
   HERRMANN JM, 1988, J CATAL, V113, P72, DOI 10.1016/0021-9517(88)90238-2
   Kim S, 2002, J PHYS CHEM B, V106, P13311, DOI 10.1021/jp0262261
   Kohno Y, 1999, J PHOTOCH PHOTOBIO A, V126, P117, DOI 10.1016/S1010-6030(99)00113-6
   Liu LF, 2012, CHEM ENG J, V181, P189, DOI 10.1016/j.cej.2011.11.060
   Mihaly Cozmuta L., 2010, WATER SA, V38, P269
   Nie X. L., 2002, PHYS REV B, V65B, P75
   Nogawa T., 2010, MATER LETT, V82, P174
   Ondok V, 2010, J PHOTOCH PHOTOBIO A, V209, P158, DOI 10.1016/j.jphotochem.2009.11.009
   Peter A, 2010, J OPTOELECTRON ADV M, V12, P1071
   Popa M, 2010, MICROPOR MESOPOR MAT, V132, P80, DOI 10.1016/j.micromeso.2009.12.024
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S., 2005, MAT SCI ENG C, VC119, P114
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Schaaff TG, 2002, NANO LETT, V2, P507, DOI 10.1021/nl010088u
   Shah J, 2009, MAT SCI ENG A-STRUCT, V523, P199, DOI 10.1016/j.msea.2009.05.059
   Shah JS, 2011, ADV ENG MATER, V13, pB41, DOI 10.1002/adem.201080051
   Stathatos E, 2000, LANGMUIR, V16, P2398, DOI 10.1021/la981783t
   Sun B, 2003, LANGMUIR, V19, P3151, DOI 10.1021/la0264670
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Trgo M, 2006, J ENVIRON MANAGE, V79, P298, DOI 10.1016/j.jenvman.2005.07.009
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Xin BF, 2008, APPL SURF SCI, V254, P2569, DOI 10.1016/j.apsusc.2007.09.002
NR 33
TC 9
Z9 9
U1 1
U2 31
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD MAY
PY 2014
VL 29
IS 3
BP 129
EP 133
DI 10.1179/1753555713Y.0000000121
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA AI7UK
UT WOS:000337105500001
DA 2018-10-20
ER

PT J
AU Zhang, LL
   Li, HJ
   Song, Q
   Lu, JH
   Zhang, YL
   Li, W
   Hampshire, J
   Cao, S
AF Zhang, L. L.
   Li, H. J.
   Song, Q.
   Lu, J. H.
   Zhang, Y. L.
   Li, W.
   Hampshire, J.
   Cao, S.
TI Surface characterisation and in vitro behaviour of carbon/carbon
   composites with various surface modifications
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Surface modification; In vitro; Diamond-like carbon coating; Cell
   response; Carbon/carbon composites
ID TRIBOLOGICAL BEHAVIOR; COATINGS; BONE; OSTEOBLASTS; SCAFFOLDS;
   OXIDATION; STRENGTH; GROWTH; HA
AB The success of implants is determined by the cell response to biomaterials and the integration into the tissue. The surface characteristic of the biomaterial is considered as a key factor to influence the cell response and integration. The aim of this work is to determine the effect of various surface modifications for carbon/carbon (C/C) composites on the MG63 cell responses. Surface modified C/C composites including rough shaped C/C composites (RCC), post-deposition treated C/C composites (PCC) and diamond-like carbon coated C/C composites (DCC) were prepared. The surface characterisation was performed on three kinds of surface modified C/C composites using scanning electron microscopy, Raman spectroscopy, laser confocal scanning microscope and video based contact angle measuring device. Evaluation of the human osteoblast-like MG63 cell responses to the three kinds of surface modified C/C composites was carried out. The RCC had a rough surface with some grooves. The PCC and DCC showed spherical morphologies with different grain sizes. The surface roughnesses for RCC, PCC and DCC were R-a=1.60 +/- 0.10, 0.69 +/- 0.10 and 0.76 +/- 0.10 mu m respectively. The RCC, PCC and DCC had similar water contact angles of 85.7 +/- 4.1, 83.6 +/- 0.4 and 92.7 +/- 2.3 degrees respectively. The cell responses showed that both PCC and DCC had better cell spreading than RCC. The cell proliferation behaviour of the three kinds of surface modified C/C composites was in the following order: DCC>PCC>RCC. The DCC shows favourable cell compatibility and further has the potential to be used in orthopaedic applications.
C1 [Zhang, L. L.; Li, H. J.; Song, Q.; Lu, J. H.; Zhang, Y. L.; Li, W.; Cao, S.] Northwestern Polytech Univ, State Key Lab Solidificat Proc, Xian 710072, Peoples R China.
   [Hampshire, J.] Teer Coatings Ltd, Miba Coating Grp, Droitwich WR9 9AS, Worcs, England.
RP Zhang, LL (reprint author), Northwestern Polytech Univ, State Key Lab Solidificat Proc, Xian 710072, Peoples R China.
EM zhangleilei1121@aliyun.com
FU National Natural Science Foundation of China [51202194]; China
   Postdoctoral Science Foundation [2011M501473]; Research Fund of the
   State Key Laboratory of Solidification Processing (NWPU), China
   [11-BZ-2012]; '111' project of china [B08040]
FX This work was supported by the National Natural Science Foundation of
   China (grant no. 51202194), the China Postdoctoral Science Foundation
   (grant no. 2011M501473), the Research Fund of the State Key Laboratory
   of Solidification Processing (NWPU), China (grant no. 11-BZ-2012) and
   the '111' project of china (grant no. B08040).
CR Baas J, 2008, BIOMATERIALS, V29, P2915, DOI 10.1016/j.biomaterials.2008.03.010
   Baralena G., 2012, SOFT MATTER, V8, P673
   Braceras I, 2009, INT J ORAL MAX SURG, V38, P274, DOI 10.1016/j.ijom.2008.12.016
   Cao N, 2010, J BIOMED MATER RES A, V92A, P1019, DOI 10.1002/jbm.a.32424
   Depan D, 2012, NANOSCALE, V4, P6325, DOI 10.1039/c2nr31345f
   Depan D, 2011, ACTA BIOMATER, V7, P3432, DOI 10.1016/j.actbio.2011.05.019
   Diefenbeck M, 2011, BIOMATERIALS, V32, P8041, DOI 10.1016/j.biomaterials.2011.07.046
   Ferguson SJ, 2006, J BIOMED MATER RES A, V78A, P291, DOI 10.1002/jbm.a.30678
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Jarratt M, 2003, DIAM RELAT MATER, V12, P1003, DOI 10.1016/S0925-9635(02)00296-0
   Lucie B., 2001, J BIOMED MATER RES, V54, P567
   Pesakova V, 2005, J MATER SCI-MATER M, V16, P143, DOI 10.1007/s10856-005-5933-7
   Puchi-Cabrera ES, 2010, MAT SCI ENG A-STRUCT, V527, P498, DOI 10.1016/j.msea.2009.09.030
   Stallard J, 2004, SURF COAT TECH, V188, P525, DOI 10.1016/j.surfcoat.2004.07.078
   Stallard J, 2004, SURF COAT TECH, V177, P545, DOI 10.1016/S0257-8972(03)00925-3
   Stary V, 2003, THIN SOLID FILMS, V433, P191, DOI 10.1016/S0040-6090(03)00309-2
   Sui JL, 2005, SURF COAT TECH, V190, P287, DOI 10.1016/j.surfcoat.2004.02.042
   Sui Y. T., 2002, BIOMATERIALS, V23, P1809
   von der Mark K, 2013, PROG MATER SCI, V58, P327, DOI 10.1016/j.pmatsci.2012.09.002
   Wang HY, 2010, BIOMATERIALS, V31, P8181, DOI 10.1016/j.biomaterials.2010.07.054
   Wen XQ, 2010, VACUUM, V85, P34, DOI 10.1016/j.vacuum.2010.03.007
   Xiong XB, 2009, ACTA BIOMATER, V5, P1785, DOI 10.1016/j.actbio.2008.12.007
   Zareidoost A, 2012, J MATER SCI-MATER M, V23, P1479, DOI 10.1007/s10856-012-4611-9
   Zhai YQ, 2007, MATER CHEM PHYS, V106, P22, DOI 10.1016/j.matchemphys.2007.05.013
   Zhang LL, 2008, J INORG MATER, V23, P341, DOI 10.3724/SP.J.1077.2008.00341
   Zhang LL, 2009, SURF REV LETT, V16, P683, DOI 10.1142/S0218625X09013165
   Zhao XN, 2012, APPL SURF SCI, V258, P5117, DOI 10.1016/j.apsusc.2012.01.144
   Zhao XN, 2011, APPL SURF SCI, V257, P3612, DOI 10.1016/j.apsusc.2010.11.088
NR 28
TC 2
Z9 2
U1 1
U2 32
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD MAY
PY 2014
VL 29
IS 3
BP 134
EP 138
DI 10.1179/1753555713Y.0000000094
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA AI7UK
UT WOS:000337105500002
DA 2018-10-20
ER

PT J
AU Yang, YJ
   Liu, XS
   Feng, FJ
AF Yang, Y. J.
   Liu, X. S.
   Feng, F. J.
TI Effects of barium content on microstructure and magnetic properties of
   Sr0.7-xBaxLa0.3Fe11.8Zn0.2O19 M type hexaferrites
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Hexaferrites; La-Zn substitution; Barium content; Magnetic properties;
   X-ray diffraction
ID LA-ZN SUBSTITUTION; REVERSE MICELLE TECHNIQUE; COMPOSITE NANOPARTICLES;
   NANOCRYSTALLINE NICKEL; TEMPERATURE-DEPENDENCE; BIOMATERIAL SYSTEM;
   DRUG-DELIVERY; SOL-GEL; FERRITES; CO
AB M type hexaferrite Sr0.7-xBaxLa0.3Fe11.8Zn0.2O19 (0 <= x <= 0.7) magnetic powders and magnets were prepared by the ceramic process. X-ray diffraction was used to investigate phase compositions of the magnetic powders. X-ray diffraction patterns show that the hexagonal single phase is obtained in all samples. A field emission scanning electron microscopy was employed to examine the micrographs of the magnets. All magnets have formed hexagonal structures, and the particles are distributed homogeneously. Magnetic properties of the magnets were measured by a magnetic properties test instrument. The remanence, intrinsic coercivity, magnetic induction coercivity and maximum energy product of the magnets continuously decrease with increasing barium content x.
C1 [Yang, Y. J.; Liu, X. S.; Feng, F. J.] Anhui Univ, Sch Phys & Mat Sci, Engn Technol Res Ctr Magnet Mat, Hefei 230039, Anhui, Peoples R China.
RP Liu, XS (reprint author), Anhui Univ, Sch Phys & Mat Sci, Engn Technol Res Ctr Magnet Mat, Hefei 230039, Anhui, Peoples R China.
EM xiansongliu@ahu.edu.cn
FU National Natural Science Foundation of China [51072002, 51272003]; Key
   Program of the Education Department of Anhui Province [KJ2010A008,
   KJ2013B057, KJ2012A027]; Anhui University '211 Project' Academic
   Innovation Team projects [02303402]; Research Fund for the Doctoral
   Program of Higher Education of China [20123401110008]
FX The authors acknowledge the financial support from the National Natural
   Science Foundation of China under grant nos. 51072002 and 51272003, the
   Key Program of the Education Department of Anhui Province (grant nos.
   KJ2010A008, KJ2013B057 and KJ2012A027), Anhui University '211 Project'
   Academic Innovation Team projects under grant no. 02303402 and from the
   Research Fund for the Doctoral Program of Higher Education of China
   under project no. 20123401110008.
CR An SY, 2002, J MAGN MAGN MATER, V242, P413, DOI 10.1016/S0304-8853(01)01220-3
   Bai JM, 2000, MAT SCI ENG B-SOLID, V68, P182, DOI 10.1016/S0921-5107(99)00593-0
   CAREY R, 1994, J APPL PHYS, V75, P6789, DOI 10.1063/1.356831
   Cernea M, 2013, J ALLOY COMPD, V561, P121, DOI 10.1016/j.jallcom.2013.01.081
   Corral-Huacuz JC, 2002, J MAGN MAGN MATER, V242, P430, DOI 10.1016/S0304-8853(01)01141-6
   Goldman A., 2006, MODERN FERRITE TECHN
   Hessien MM, 2009, J ALLOY COMPD, V476, P373, DOI 10.1016/j.jallcom.2008.08.076
   Hua ZH, 2007, MAT SCI ENG A-STRUCT, V448, P326, DOI 10.1016/j.msea.2006.11.153
   Jia Z, 2011, MATER TECHNOL, V26, P200, DOI 10.1179/175355511X13109965351112
   Jia Z, 2010, MATER TECHNOL, V25, P307, DOI 10.1179/175355510X12856832934269
   Kale A, 2004, J MAGN MAGN MATER, V277, P350, DOI 10.1016/j.jmmm.2003.11.015
   Koutzarova T, 2013, J ALLOY COMPD, V579, P174, DOI 10.1016/j.jallcom.2013.06.049
   Lee SW, 2005, J MAGN MAGN MATER, V290, P231, DOI 10.1016/j.jmmm.2004.11.190
   Liu XS, 2002, J MAGN MAGN MATER, V238, P207, DOI 10.1016/S0304-8853(01)00914-3
   Liu XX, 2000, J APPL PHYS, V87, P2503, DOI 10.1063/1.372210
   Misra RDK, 2004, MAT SCI ENG B-SOLID, V111, P164, DOI 10.1016/j.mseb.2004.04.014
   Nathani H, 2004, MAT SCI ENG B-SOLID, V111, P95, DOI 10.1016/j.mseb.2004.03.002
   Qiao LA, 2007, J MAGN MAGN MATER, V318, P74, DOI 10.1016/j.jmmm.2007.04.028
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rashad MM, 2005, MATER CHEM PHYS, V94, P365, DOI 10.1016/j.matchemphys.2005.05.028
   Reddy KM, 2004, MATER RES BULL, V39, P1491, DOI [10.1016/j.materresbull.2004.04.022, 10.1016/j.materresbult.2004.04.022]
   SHIRK BT, 1969, J APPL PHYS, V40, P1294, DOI 10.1063/1.1657636
   Tenaud P, 2004, J ALLOY COMPD, V370, P331, DOI 10.1016/j.jallcom.2003.09.106
   Wagner TR, 1998, J SOLID STATE CHEM, V136, P120, DOI 10.1006/jssc.1997.7681
   Yang Z, 2002, MAT SCI ENG B-SOLID, V90, P142, DOI 10.1016/S0921-5107(01)00925-4
   Zhang J, 2008, ACTA BIOMATER, V4, P40, DOI 10.1016/j.actbio.2007.06.006
   Zhang WJ, 2013, J ALLOY COMPD, V546, P234, DOI 10.1016/j.jallcom.2012.08.029
NR 29
TC 4
Z9 4
U1 1
U2 12
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD MAY
PY 2014
VL 29
IS 3
BP 188
EP 192
DI 10.1179/1753555714Y.0000000135
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA AI7UK
UT WOS:000337105500010
DA 2018-10-20
ER

PT J
AU Cleophas, RTC
   Riool, M
   van Ufford, HCQ
   Zaat, SAJ
   Kruijtzer, JAW
   Liskamp, RMJ
AF Cleophas, Rik T. C.
   Riool, Martijn
   van Ufford, H. (Linda) C. Quarles
   Zaat, Sebastian A. J.
   Kruijtzer, John A. W.
   Liskamp, Rob M. J.
TI Convenient Preparation of Bactericidal Hydrogels by Covalent Attachment
   of Stabilized Antimicrobial Peptides Using Thiol-ene Click Chemistry
SO ACS MACRO LETTERS
LA English
DT Article
ID CATIONIC PEPTIDES; BROAD-SPECTRUM; INFECTION; SURFACES; COATINGS;
   TITANIUM; RELEASE; AGENTS
AB This report describes the design and synthesis of a bactericidal poly(ethylene glycol)-based (PEG) hydrogel coating with covalently attached antimicrobial peptides (AMP) stabilized against proteolytic degradation. As such, mimics of the highly active AMP HHC10 (H-KRWWKWIRW-NH2) were designed for optimal stability in human serum while retaining strong antimicrobial activity against Staphylococcus aureus and Staphylococcus epidermidis, the major causative agents of biomaterial associated infection. In order to investigate the selectivity of the AMPs, their hemolytic activity was determined. A N-terminal cysteine facilitated thiol-ene chemistry for a fast, single-step immobilization/photopolymerization strategy. The antimicrobial activity of the resulting thin layer hydrogel coating on a PET surface was established using the Japanese Industrial Standard (JIS) Z2801 assay, showing complete killing (>99.9%) of inocula of S. aureus ATCC 49230, S. epidermidis ATCC 35984, and E. coli ATCC 8739.
C1 [Cleophas, Rik T. C.; van Ufford, H. (Linda) C. Quarles; Kruijtzer, John A. W.; Liskamp, Rob M. J.] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Dept Med Chem & Chem Biol, NL-3584 CA Utrecht, Netherlands.
   [Riool, Martijn; Zaat, Sebastian A. J.] Univ Amsterdam, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands.
RP Liskamp, RMJ (reprint author), Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Dept Med Chem & Chem Biol, Univ Weg 99, NL-3584 CA Utrecht, Netherlands.
EM r.m.j.liskamp@uu.nl
RI Liskamp, Rob/I-5889-2012; Riool, Martijn/A-8404-2018
OI Riool, Martijn/0000-0002-5444-3179
FU Dutch Ministry of Economic Affairs; Project P4.01 NANTICO of the
   research program of the BioMedical Material Institute
FX This research forms part of the Project P4.01 NANTICO of the research
   program of the BioMedical Material Institute, cofunded by the Dutch
   Ministry of Economic Affairs.
CR Aimetti AA, 2009, BIOMATERIALS, V30, P6048, DOI 10.1016/j.biomaterials.2009.07.043
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Chen YX, 2006, CHEM BIOL DRUG DES, V67, P162, DOI 10.1111/j.1747-0285.2006.00349.x
   Cherkasov A, 2009, ACS CHEM BIOL, V4, P65, DOI 10.1021/cb800240j
   De Giglio E, 2011, ACTA BIOMATER, V7, P882, DOI 10.1016/j.actbio.2010.07.030
   Fulmer PA, 2011, ACS APPL MATER INTER, V3, P2878, DOI 10.1021/am2005465
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Giacometti A, 2005, PEPTIDES, V26, P2111, DOI 10.1016/j.peptides.2005.03.009
   Gupta N, 2010, NAT CHEM, V2, P138, DOI [10.1038/NCHEM.478, 10.1038/nchem.478]
   Hamamoto K, 2002, MICROBIOL IMMUNOL, V46, P741, DOI 10.1111/j.1348-0421.2002.tb02759.x
   Hancock R. E. W., 2008, World Patent, Patent No. [WO 2008/022444, 2008022444]
   Hancock R. E. W., 2008, JAPANESE INDUSTRIAL
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Kazemzadeh-Narbat M, 2012, J BIOMED MATER RES B, V100B, P1344, DOI 10.1002/jbm.b.32701
   Klibanov AM, 2007, J MATER CHEM, V17, P2479, DOI 10.1039/b702079a
   Knappe D, 2010, ANTIMICROB AGENTS CH, V54, P4003, DOI 10.1128/AAC.00300-10
   Kwakman PHS, 2006, ANTIMICROB AGENTS CH, V50, P3977, DOI 10.1128/AAC.00575-06
   Li Y, 2012, LANGMUIR, V28, P12134, DOI 10.1021/la302732w
   Lynn M. A., 2011, PLOS NEGLECT TROP D, V5, P1141
   Necula BS, 2009, ACTA BIOMATER, V5, P3573, DOI 10.1016/j.actbio.2009.05.010
   Nguyen L. T., 2010, PLOS ONE, V5, P11, DOI [DOI 10.1371/JOURNAL.PONE.0012684, 10.1371/journal.pone.0012684]
   Onaizi S. A., 2010, J BIOTECHNOL ADV, V29, P67
   Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085
   Pickard R., 2012, LANCET, V6736, P1
   Raguse TL, 2002, J AM CHEM SOC, V124, P12774, DOI 10.1021/ja0270423
   Schaer T. P., 2011, BIOMATERIALS, V33, P1245
   Song AR, 2012, ACTA BIOMATER, V8, P41, DOI 10.1016/j.actbio.2011.10.004
   Wong SY, 2010, J AM CHEM SOC, V132, P17840, DOI 10.1021/ja106288c
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhou CC, 2011, BIOMATERIALS, V32, P2704, DOI 10.1016/j.biomaterials.2010.12.040
NR 35
TC 32
Z9 32
U1 3
U2 112
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2161-1653
J9 ACS MACRO LETT
JI ACS Macro Lett.
PD MAY
PY 2014
VL 3
IS 5
BP 477
EP 480
DI 10.1021/mz5001465
PG 4
WC Polymer Science
SC Polymer Science
GA AH8WD
UT WOS:000336418000017
DA 2018-10-20
ER

PT J
AU Ding, HJ
   Zhong, MJ
   Kim, YJ
   Pholpabu, P
   Balasubramanian, A
   Hui, CM
   He, HK
   Yang, H
   Matyjaszewski, K
   Bettinger, CJ
AF Ding, Hangjun
   Zhong, Mingjiang
   Kim, Young Jo
   Pholpabu, Pitirat
   Balasubramanian, Aditya
   Hui, Chin Ming
   He, Hongkun
   Yang, Huai
   Matyjaszewski, Krzysztof
   Bettinger, Christopher John
TI Biologically Derived Soft Conducting Hydrogels Using Heparin-Doped
   Polymer Networks
SO ACS NANO
LA English
DT Article
DE hydrogel; polymer; biomaterial; electronically active
ID NEURAL INTERFACES; BIOMEDICAL APPLICATIONS; ELECTRICAL-CONDUCTIVITY;
   POLYANILINE NANOTUBES; LARGE-AREA; ELECTRODES; FILMS; SUPERCAPACITORS;
   TRANSISTORS; PERFORMANCE
AB The emergence of flexible and stretchable electronic components expands the range of applications of electronic devices. Flexible devices are ideally suited for electronic biointerfaces because of mechanically permissive structures that conform to curvilinear structures found in native tissue. Most electronic materials used in these applications exhibit elastic moduli on the order of 0.1-1 MPa. However, many electronically excitable tissues exhibit elasticities in the range of 1-10 kPa, several orders of magnitude smaller than existing components used in flexible devices. This work describes the use of biologically derived heparins as scaffold materials for fabricating networks with hybrid electronic/ionic conductivity and ultracompliant mechanical properties. Photo-cross-linkable heparin methacrylate hydrogels serve as templates to control the microstructure and doping of in situ polymerized polyaniline structures. Macroscopic heparin-doped polyaniline hydrogel dual networks exhibit impedances as low as Z = 4.17 Omega at 1 kHz and storage moduli of G' = 900 +/- 100 Pa. The conductivity of heparin/polyaniline networks depends on the oxidation state and microstructure of secondary polyaniline networks. Furthermore, heparin/polyaniline networks support the attachment, proliferation, and differentiation of mu rifle myoblasts without any surface treatments. Taken together, these results suggest that heparin/polyaniline hydrogel networks exhibit suitable physical properties as an electronically active biointerface material that can match the mechanical properties of soft tissues composed of excitable cells.
C1 [Ding, Hangjun] Univ Sci & Technol Beijing, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
   [Ding, Hangjun; Zhong, Mingjiang; Hui, Chin Ming; He, Hongkun; Matyjaszewski, Krzysztof] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA.
   [Kim, Young Jo; Balasubramanian, Aditya; Bettinger, Christopher John] Carnegie Mellon Univ, Dept Mat Sci & Engn, Pittsburgh, PA 15213 USA.
   [Pholpabu, Pitirat; Bettinger, Christopher John] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
   [Yang, Huai] Peking Univ, Sch Engn, Beijing 100187, Peoples R China.
RP Matyjaszewski, K (reprint author), Carnegie Mellon Univ, Dept Chem, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.
EM km3b@andrew.cmu.edu; cbetting@andrew.cmu.edu
RI Zhong, Mingjiang/F-3470-2011; Bettinger, Christopher/A-3895-2009;
   Matyjaszewski, Krzysztof/A-2508-2008; He, Hongkun/B-4759-2011
OI Zhong, Mingjiang/0000-0001-7533-4708; Matyjaszewski,
   Krzysztof/0000-0003-1960-3402; He, Hongkun/0000-0002-7214-3313
FU Shurl and Kay Curci Foundation; Berkman Foundation; American Chemical
   Society Petroleum Research Fund (ACS PRF) [51980-DNI7]; National Science
   Foundation [DMR 09-69301]; National Institutes of Health (NIH)
   [R21EB015165]; U.S. Army Materiel Command [W81XWH1210626]; National
   Natural Science Foundation of China [NSFC51273022]; Molecular Biosensor
   & Imaging Center in Carnegie Mellon University
FX Funding provided by the following organizations: the Shurl and Kay Curci
   Foundation, the Berkman Foundation, the American Chemical Society
   Petroleum Research Fund (ACS PRF #51980-DNI7), the National Science
   Foundation DMR 09-69301 and the National Institutes of Health (NIH;
   R21EB015165), U.S. Army Materiel Command (W81XWH1210626), the National
   Natural Science Foundation of China (NSFC51273022). NMR instrumentation
   at CMU was partially supported by National Science Foundation
   (CHE-0130903 and CHE-1039870). The authors also acknowledge the support
   from Molecular Biosensor & Imaging Center in Carnegie Mellon University.
CR Abidian MR, 2008, BIOMATERIALS, V29, P1273, DOI 10.1016/j.biomaterials.2007.11.022
   ALBERY WJ, 1989, FARADAY DISCUSS, V88, P247, DOI 10.1039/dc9898800247
   Bellamkonda RV, 2012, MRS BULL, V37, P557, DOI 10.1557/mrs.2012.122
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Bhadra S, 2009, PROG POLYM SCI, V34, P783, DOI 10.1016/j.progpolymsci.2009.04.003
   Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Bisquert J, 1998, J ELECTROANAL CHEM, V452, P229, DOI 10.1016/S0022-0728(98)00115-6
   CANAL T, 1989, J BIOMED MATER RES, V23, P1183, DOI 10.1002/jbm.820231007
   CAO Y, 1989, POLYMER, V30, P2305, DOI 10.1016/0032-3861(89)90266-8
   CHEN SA, 1995, MACROMOLECULES, V28, P2858, DOI 10.1021/ma00112a035
   Ding HJ, 2008, MACROMOL CHEM PHYSIC, V209, P864, DOI 10.1002/macp.200700624
   Ding HJ, 2007, ADV MATER, V19, P465, DOI 10.1002/adma.200600831
   Famm K, 2013, NATURE, V496, P159, DOI 10.1038/496159a
   Friedrich BM, 2012, SOFT MATTER, V8, P3223, DOI 10.1039/c2sm06450b
   Ghosh S, 2000, J ELECTROCHEM SOC, V147, P1872, DOI 10.1149/1.1393450
   Ghosh S, 1999, ADV MATER, V11, P1214, DOI 10.1002/(SICI)1521-4095(199910)11:14<1214::AID-ADMA1214>3.0.CO;2-3
   Ghosh S, 1998, ADV MATER, V10, P1097, DOI 10.1002/(SICI)1521-4095(199810)10:14<1097::AID-ADMA1097>3.0.CO;2-M
   Graudejus O, 2012, ADV FUNCT MATER, V22, P640, DOI 10.1002/adfm.201102290
   Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254
   Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047
   Green RA, 2012, MACROMOL BIOSCI, V12, P494, DOI 10.1002/mabi.201100490
   Guiseppi-Elie A, 2010, BIOMATERIALS, V31, P2701, DOI 10.1016/j.biomaterials.2009.12.052
   Guo BL, 2013, PROG POLYM SCI, V38, P1263, DOI 10.1016/j.progpolymsci.2013.06.003
   Guo B, 2011, BIOMACROMOLECULES, V12, P2601, DOI 10.1021/bm200389t
   Kim DH, 2004, J BIOMED MATER RES A, V71A, P577, DOI 10.1002/jbm.a.30124
   Kim DH, 2010, ACTA BIOMATER, V6, P57, DOI 10.1016/j.actbio.2009.07.034
   Kim M, 2012, MACROMOL RES, V20, P271, DOI 10.1007/s13233-012-0058-6
   Kim YJ, 2013, P NATL ACAD SCI USA, V110, P20912, DOI 10.1073/pnas.1314345110
   Kim YJ, 2013, J MATER CHEM B, V1, P3781, DOI 10.1039/c3tb20183j
   Kishi R, 2012, J POLYM SCI POL PHYS, V50, P790, DOI 10.1002/polb.23066
   Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984
   Lacour SP, 2003, APPL PHYS LETT, V82, P2404, DOI 10.1063/1.1565683
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Li T, 2004, APPL PHYS LETT, V85, P3435, DOI 10.1063/1.1806275
   Long YZ, 2003, MACROMOL RAPID COMM, V24, P938, DOI 10.1002/marc.200300039
   Mano N, 2007, J AM CHEM SOC, V129, P7006, DOI 10.1021/ja071946c
   Marcasuzaa P, 2010, BIOMACROMOLECULES, V11, P1684, DOI 10.1021/bm100379z
   Mawad D, 2012, ADV FUNCT MATER, V22, P2692, DOI 10.1002/adfm.201102373
   McCullough LA, 2007, MACROMOLECULES, V40, P7745, DOI 10.1021/ma071172k
   McCullough LA, 2010, MOL CRYST LIQ CRYST, V521, P1, DOI 10.1080/15421401003719951
   McCullough LA, 2009, MACROMOLECULES, V42, P8129, DOI 10.1021/ma901560k
   Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706
   Naficy S, 2012, CHEM MATER, V24, P3425, DOI 10.1021/cm301666w
   PAASCH G, 1993, ELECTROCHIM ACTA, V38, P2653, DOI 10.1016/0013-4686(93)85083-B
   Pan LJ, 2006, ADV FUNCT MATER, V16, P1279, DOI 10.1002/adfm.200500543
   Pan LJ, 2012, P NATL ACAD SCI USA, V109, P9287, DOI 10.1073/pnas.1202636109
   Park MK, 2003, LANGMUIR, V19, P8550, DOI 10.1021/la034827t
   Petrova J, 2012, J PHYS CHEM B, V116, P6543, DOI 10.1021/jp301814u
   Poole-Warren L, 2010, EXPERT REV MED DEVIC, V7, P35, DOI 10.1586/ERD.09.58
   RAMMELT U, 1990, ELECTROCHIM ACTA, V35, P1045, DOI 10.1016/0013-4686(90)90040-7
   Rao L, 2012, ACTA BIOMATER, V8, P2233, DOI 10.1016/j.actbio.2012.03.001
   Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383
   Rubinson JF, 2009, CHEM SOC REV, V38, P3339, DOI 10.1039/b904083h
   Sekine S, 2010, J AM CHEM SOC, V132, P13174, DOI 10.1021/ja1062357
   Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309
   Sekitani T, 2010, ADV MATER, V22, P2228, DOI 10.1002/adma.200904054
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shi W, 2006, MACROMOL RAPID COMM, V27, P926, DOI 10.1002/marc.200600102
   Siddhanta SK, 2005, POLYMER, V46, P2993, DOI 10.1016/j.polymer.2005.01.084
   Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101
   Viventi J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000738
   Vosgueritchian M, 2012, ADV FUNCT MATER, V22, P421, DOI 10.1002/adfm.201101775
   Wang DW, 2009, ACS NANO, V3, P1745, DOI 10.1021/nn900297m
   Wang YG, 2006, ADV MATER, V18, P2619, DOI 10.1002/adma.200600445
   Wei ZX, 2003, ADV MATER, V15, P136, DOI 10.1002/adma.200390027
   Wu H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2941
   Xia YY, 2011, SOFT MATTER, V7, P9388, DOI 10.1039/c1sm05890h
   Xu YX, 2013, ACS NANO, V7, P4042, DOI 10.1021/nn4000836
   Yoo JE, 2007, J MATER CHEM, V17, P1268, DOI 10.1039/b618521e
NR 69
TC 42
Z9 43
U1 9
U2 156
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD MAY
PY 2014
VL 8
IS 5
BP 4348
EP 4357
DI 10.1021/nn406019m
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AI1UM
UT WOS:000336640600025
PM 24738911
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Guerrero-Cazares, H
   Tzeng, SY
   Young, NP
   Abutaleb, AO
   Quinones-Hinojosa, A
   Green, JJ
AF Guerrero-Cazares, Hugo
   Tzeng, Stephany Y.
   Young, Noah P.
   Abutaleb, Ameer O.
   Quinones-Hinojosa, Alfredo
   Green, Jordan J.
TI Biodegradable Polymeric Nanoparticles Show High Efficacy and Specificity
   at DNA Delivery to Human Glioblastoma in Vitro and in Vivo
SO ACS NANO
LA English
DT Article
DE glioblastoma; nonviral gene delivery; nanomedicine; targeted delivery
ID SUICIDE GENE-THERAPY; P53 GENE; PROLONGING SURVIVAL; THYMIDINE KINASE;
   BRAIN-TUMORS; SIRNA; CANCER; MULTIFORME; RESECTION; ADJUVANT
AB Current glioblastoma therapies are insufficient to prevent tumor recurrence and eventual death. Here, we describe a method to treat malignant glioma by nonviral DNA delivery using biodegradable poly(beta-amino ester)s (PBAEs), with a focus on the brain tumor initiating cells (BTICs), the tumor cell population believed to be responsible for the formation of new tumors and resistance to many conventional therapies. We show transfection efficacy of >60% and low biomaterial-mediated cytotoxicity in primary human BTICs in vitro even when the BT1Cs are grown as 3-D oncospheres. Intriguingly, we find that these polymeric nanoparticles show intrinsic specificity for nonviral transfection of primary human BTICs over primary healthy human neural progenitor cells and that this specificity is not due to differences in cellular growth rate or total cellular uptake of nanoparticles. Moreover, we demonstrate that biodegradable PBAE/DNA nanoparticles can be fabricated, lyophilized, and then stored for at least 2 years without losing efficacy, increasing the translational relevance of this technology. Using lyophilized nanoparticles, we show transgene expression by tumor cells after intratumoral injection into an orthotopic murine model of human glioblastoma. PBAE/DNA nanoparticles were more effective than naked DNA at exogenous gene expression in vivo, and tumor cells were transfected more effectively than noninvaded brain parenchyma in vivo. This work shows the potential of nonviral gene delivery tools to target human brain tumors.
C1 [Guerrero-Cazares, Hugo; Abutaleb, Ameer O.; Quinones-Hinojosa, Alfredo; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21231 USA.
   [Tzeng, Stephany Y.; Young, Noah P.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21231 USA.
   [Tzeng, Stephany Y.; Young, Noah P.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
   [Quinones-Hinojosa, Alfredo; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Inst Nanobiotechnol, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21231 USA.
RP Quinones-Hinojosa, A (reprint author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, 400 North Broadway, Baltimore, MD 21231 USA.
EM aquinon2@jhmi.edu; green@jhu.edu
FU National Institutes of Health [1R01EB016721, R21CA152473]; MSCRF-TEDCO;
   National Science Foundation
FX This work was supported in part by the National Institutes of Health
   (1R01EB016721 and R21CA152473) and MSCRF-TEDCO. We thank Xiaobu Ye for
   help with statistical analysis. S.Y.T. thanks the National Science
   Foundation for fellowship support.
CR Bhise NS, 2012, SMALL, V8, P367, DOI 10.1002/smll.201101718
   Bishop CJ, 2013, J AM CHEM SOC, V135, P6951, DOI 10.1021/ja4002376
   BOGLER O, 1995, GLIA, V15, P308, DOI 10.1002/glia.440150311
   Chaichana KL, 2013, J NEUROSURG, V118, P812, DOI 10.3171/2012.9.JNS1277
   Chaichana KL, 2011, NEUROL RES, V33, P759, DOI 10.1179/1743132811Y.0000000006
   Chiocca EA, 2003, CANCER J, V9, P167, DOI 10.1097/00130404-200305000-00005
   Chiocca EA, 2004, MOL THER, V10, P958, DOI 10.1016/j.ymthe.2004.07.021
   Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956
   Goodman JC, 1996, HUM GENE THER, V7, P1241, DOI 10.1089/hum.1996.7.10-1241
   Guerrero-Cazares H, 2009, METHODS MOL BIOL, V568, P73, DOI 10.1007/978-1-59745-280-9_6
   Huang YH, 2009, CANCER RES, V69, P6184, DOI 10.1158/0008-5472.CAN-09-0061
   Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012
   Jiang QY, 2011, BIOMATERIALS, V32, P7253, DOI 10.1016/j.biomaterials.2011.06.015
   Kamat CD, 2013, MOL CANCER THER, V12, P405, DOI 10.1158/1535-7163.MCT-12-0956
   Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]
   Kim J, 2014, BIOCONJUGATE CHEM, V25, P43, DOI 10.1021/bc4002322
   King GD, 2011, MOL THER, V19, P1793, DOI 10.1038/mt.2011.77
   Lang FF, 2003, J CLIN ONCOL, V21, P2508, DOI 10.1200/JCO.2003.11.138
   McGirt M.J., 2009, NEUROSURGERY, V65, p)469
   McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9
   McGirt MJ, 2009, J NEUROSURG, V110, P583, DOI 10.3171/2008.5.17557
   McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536
   Nance E. A., 2012, SCI TRANS MED, P4
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066
   Rainov NG, 2000, HUM GENE THER, V11, P2389, DOI 10.1089/104303400750038499
   Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421
   Scholz C, 2012, J CONTROL RELEASE, V161, P554, DOI 10.1016/j.jconrel.2011.11.014
   Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Sunshine J. C., 2012, PLOS ONE, V7, P123
   Sunshine JC, 2012, MOL PHARMACEUT, V9, P3375, DOI 10.1021/mp3004176
   Sunshine JC, 2011, BIOMACROMOLECULES, V12, P3592, DOI 10.1021/bm200807s
   Tai CK, 2005, MOL THER, V12, P842, DOI 10.1016/j.ymthe.2005.03.017
   Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103
   Tobias A, 2013, J NEUROL NEUROSUR PS, V84, P213, DOI 10.1136/jnnp-2012-302946
   Tolcher AW, 2006, J CLIN ONCOL, V24, P2052, DOI 10.1200/JCO.2005.03.6756
   Tzeng SY, 2013, J BIOMED MATER RES A, V101, P1837, DOI 10.1002/jbm.a.34616
   Tzeng SY, 2013, ADV HEALTHC MATER, V2, P468, DOI 10.1002/adhm.201200257
   Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016
   Zhang Y, 2012, MOL THER, V20, P1298, DOI 10.1038/mt.2012.79
   Zuckerman JE, 2012, P NATL ACAD SCI USA, V109, P3137, DOI 10.1073/pnas.1200718109
NR 42
TC 64
Z9 65
U1 9
U2 97
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD MAY
PY 2014
VL 8
IS 5
BP 5141
EP 5153
DI 10.1021/nn501197v
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AI1UM
UT WOS:000336640600106
PM 24766032
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Crespi, R
   Cappare, P
   Polizzi, EM
   Gherlone, EF
AF Crespi, Roberto
   Cappare, Paolo
   Polizzi, Elisabetta Maria
   Gherlone, Enrico F.
TI Tissue Remodeling After Bone Expansion in Grafted and Ungrafted Sockets
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE biomaterial; bone remodeling; fresh socket
ID HUMAN EXTRACTION SOCKETS; SINGLE-TOOTH EXTRACTION; SINUS FLOOR
   ELEVATION; PORCINE BONE; IMPLANTS; SITES; RIDGE; HYDROXYAPATITE;
   REGENERATION; PLACEMENT
AB Purpose: The aim of this clinical study was to assess horizontal width changes in grafted and ungrafted sites after bone expansion and implant placement. Materials and Methods: Twenty-three patients were included in this prospective study. Each patient required extraction of two teeth and replacement with implants. After dental extraction in 23 alveoli (group 1), a collagen sponge was used to cover fresh sockets, and the remaining 23 alveoli (group 2) were grafted with corticocancellous porcine bone. Three months after extraction, bone expansion was performed in each site, and 46 dental implants were placed. To evaluate tissue volume changes, the variations in width of the buccal ridge were recorded with a periodontal probe immediately after tooth extraction, 3 months later (before implant placement), and 3 months after implant placement. Results: In group 1, at 3 months after implant placement, mean volume changes of +1.6 +/- 0.8 mm for incisors and canines, +1.4 +/- 0.5 mm for premolars, and +0.8 +/- 0.5 mm for molars were seen. In group 2, mean changes of +1.5 +/- 0.8 mm for incisors and canines, +1.3 +/- 0.3 mm for premolars, and +2.8 +/- 0.6 mm for molars were observed. Statistically significant differences were found only for molars. Conclusions: In both groups, incisor, canine, and premolar sites showed no differences in volume changes, but statistically significant differences were found between molars in the two groups; the biomaterial graft prevented collapse of the large defects and significant volume loss.
C1 [Crespi, Roberto; Cappare, Paolo; Gherlone, Enrico F.] Univ Vita Salute San Raffaele, Hosp San Raffaele, Dept Dent, I-20123 Milan, Italy.
   [Polizzi, Elisabetta Maria] Univ Vita Salute San Raffaele, Div Dent Hyg & Prevent, Dept Dent, I-20123 Milan, Italy.
   [Polizzi, Elisabetta Maria] Hosp San Raffaele, I-20132 Milan, Italy.
RP Crespi, R (reprint author), Univ Vita Salute San Raffaele, Hosp San Raffaele, Dept Dent, Via Olgettina 48, I-20123 Milan, Italy.
EM robcresp@libero.it
RI Cappare, Paolo/A-2025-2016
OI Cappare, Paolo/0000-0002-7277-6583
CR AMLER MH, 1969, ORAL SURG ORAL MED O, V27, P309, DOI 10.1016/0030-4220(69)90357-0
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Becker W, 1994, Int J Oral Maxillofac Implants, V9, P31
   BENQUE EP, 1985, J BIOL BUCCALE, V13, P271
   Bragger U, 2004, CLIN ORAL IMPLAN RES, V15, P158, DOI 10.1111/j.1600-0501.2004.00988.x
   Cammack GV, 2005, INT J PERIODONT REST, V25, P231
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Chen ST, 2004, INT J ORAL MAX IMPL, V19, P12
   Crespi R, 2013, ORAL MAXILLOFAC SURG
   Crespi R, 2012, CLIN IMPLANT DENT RE
   Crespi R, 2013, INT J ORAL MAX IMPL, V28, P869, DOI 10.11607/jomi.2679
   Crespi R, 2011, INT J ORAL MAX IMPL, V26, P1057
   Crespi R, 2011, INT J ORAL MAX IMPL, V26, P866
   Crespi R, 2009, J PERIODONTOL, V80, P1616, DOI 10.1902/jop.2009.090156
   de Oliveira RR, 2007, INT J ORAL MAX IMPL, V22, P63
   EVIAN CI, 1982, J PERIODONTOL, V53, P81, DOI 10.1902/jop.1982.53.2.81
   Friberg B, 1999, INT J ORAL MAX SURG, V28, P297
   Hurzeler MB, 1998, INT J ORAL MAX SURG, V27, P315, DOI 10.1016/S0901-5027(05)80623-X
   Langer B, 1990, Int J Periodontics Restorative Dent, V10, P208
   Leonetti J A, 2000, Implant Dent, V9, P177, DOI 10.1097/00008505-200009020-00012
   Molly L, 2008, J PERIODONTOL, V79, P1108, DOI [10.1902/jop.2008.070476, 10.1902/jop.2008.070476 ]
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   NEVINS M, 1992, INT J PERIODONT REST, V12, P97
   Norton MR, 2002, INT J ORAL MAX IMPL, V17, P249
   Okamoto T, 1983, J Nihon Univ Sch Dent, V25, P202
   Pinho Marcia N, 2006, Implant Dent, V15, P53, DOI 10.1097/01.id.0000202596.18254.e1
   Rosen PS, 1999, INT J ORAL MAX IMPL, V14, P853
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Scipioni A, 1994, INT J PERIODONT REST, V14, P451
   Sclar AG, 2004, J ORAL MAXIL SURG, V62, P90, DOI 10.1016/j.joms.2004.06.041
   Simion M, 1992, Int J Periodontics Restorative Dent, V12, P462
   Summers R B, 1994, Compendium, V15, P436
   Summers R B, 1998, J Esthet Dent, V10, P164, DOI 10.1111/j.1708-8240.1998.tb00352.x
   Ten Heggeler JMAG, 2011, CLIN ORAL IMPLAN RES, V22, P779, DOI 10.1111/j.1600-0501.2010.02064.x
   Zubillaga G, 2003, J PERIODONTOL, V74, P965, DOI 10.1902/jop.2003.74.7.965
NR 36
TC 7
Z9 7
U1 0
U2 2
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAY-JUN
PY 2014
VL 29
IS 3
BP 699
EP 704
DI 10.11607/jomi.3535
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AH8WW
UT WOS:000336419900019
PM 24818210
OA Bronze
DA 2018-10-20
ER

PT J
AU Manivasagam, G
   Suwas, S
AF Manivasagam, G.
   Suwas, S.
TI Biodegradable Mg and Mg based alloys for biomedical implants
SO MATERIALS SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Magnesium alloy; bio-degradable material; orthopedic implant
ID IN-VITRO; BIOCORROSION BEHAVIOR; ORTHOPEDIC IMPLANTS; MAGNESIUM ALLOYS;
   CORROSION; DEGRADATION; CYTOTOXICITY; BIOMATERIAL; COMPOSITE; TITANIUM
AB Mg and its alloys become natural biomaterials as the elemental Mg is found in the human body in abundance and their mechanical properties being akin to the natural bone as well as due to their inherent bioabsorbable/bioresorbable property. This paper discusses the development of new Mg alloys and their corrosion characteristics in detail. The latest advancements in coating of Mg alloys to control their degradation rate are also reviewed along with the future challenges that need to be addressed.
C1 [Manivasagam, G.] Vellore Inst Technol Univ, Vellore 632014, Tamil Nadu, India.
   [Suwas, S.] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
RP Suwas, S (reprint author), Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
EM satyamsuwas@materials.iisc.ernet.in
OI Manivasagam, Geetha/0000-0003-3326-3176
CR Blasier R D, 1997, Instr Course Lect, V46, P531
   Brar HS, 2012, J MECH BEHAV BIOMED, V7, P87, DOI 10.1016/j.jmbbm.2011.07.018
   CLARKE I, BIOMATERIALS OVERVIE
   Gao JH, 2011, MATER LETT, V65, P691, DOI 10.1016/j.matlet.2010.11.015
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018
   Gu X.N., 2009, BIOMED MATER, V4, P1
   Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Konttinen YT, 2001, J BONE MINER RES, V16, P1780, DOI 10.1359/jbmr.2001.16.10.1780
   LI N, 2013, J MATER SCI TECHNOL, V26, P489
   Logothetidis S, 2007, DIAM RELAT MATER, V16, P1847, DOI 10.1016/j.diamond.2007.05.012
   Lorenz C, 2009, ACTA BIOMATER, V5, P2783, DOI 10.1016/j.actbio.2009.04.018
   *MERCK, 2011, MERCK MANUAL 2 CH12, pCH12
   Meyer-Lindenberg A., 2006, US Patent, Patent No. 200410241036
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106
   Park J.B., 2003, BIOMATERIALS PRINCIP, P1
   Quach NC, 2008, CR CHIM, V11, P1043, DOI 10.1016/j.crci.2008.06.007
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Revell PA, 2004, KEY ENG MAT, V254-2, P447, DOI 10.4028/www.scientific.net/KEM.254-256.447
   Rong-chang Z., 2007, T NONFERR METAL SOC, V17, P166
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Scheideler L, 2013, ACTA BIOMATER, V9, P8740, DOI 10.1016/j.actbio.2013.02.020
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sumner DR, 1998, J BIOMECH, V31, P909, DOI 10.1016/S0021-9290(98)00096-7
   Virtanen S, 2011, MATER SCI ENG B-ADV, V176, P1600, DOI 10.1016/j.mseb.2011.05.028
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Williams David, 2006, Med Device Technol, V17, P9
   Wise D.L., 2000, BIOMATERIALS ENG DEV, P205
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Xu L. P., 2009, BIOMATERIALS, V30, P512
   Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
   Yang L, 2013, ACTA BIOMATER, V9, P8475, DOI 10.1016/j.actbio.2012.10.001
   Yang L, 2009, MAT SCI ENG C-BIO S, V29, P1691, DOI 10.1016/j.msec.2009.01.014
   Zhang XB, 2012, MATER LETT, V86, P42, DOI 10.1016/j.matlet.2012.07.030
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 42
TC 24
Z9 24
U1 2
U2 53
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0836
EI 1743-2847
J9 MATER SCI TECH-LOND
JI Mater. Sci. Technol.
PD MAY
PY 2014
VL 30
IS 5
BP 515
EP 520
DI 10.1179/1743284713Y.0000000500
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA AI3CP
UT WOS:000336736900002
DA 2018-10-20
ER

PT J
AU Gangil, S
AF Gangil, Sandip
TI Polymeric Consolidation in Briquetted Biofuel as Compared to Raw
   Biomaterial: A TG-Vision for Pigeon Pea Stalks
SO ENERGY & FUELS
LA English
DT Article
ID MASS SPECTROMETRIC ANALYSIS; AGRICULTURAL RESIDUES;
   THERMAL-DECOMPOSITION; RENEWABLE ENERGY; AGRO-RESIDUES; BIOMASS;
   PYROLYSIS; KINETICS; INDIA; GASIFICATION
AB The consolidation of different polymeric bioconstituents was clearly observed in briquetted biofiiel produced from pigeon pea crop residues. Critical thermogravimetric diagnosis showed that the scattering of tail end segments of thermograms taken at different heating rates was remarkably low in briquetted biofiiel as compared to the scattering in raw material. The consolidation of polymeric cellulose and lignin was discussed and explained. Kinetics was evaluated using isoconversional integral Ozawa-Flynn-Wall method. The activation energy profile of briquetted biofuel dominated over the raw pigeon pea stalks showing higher thermal stability, which was evidence, positive toward the consolidation of intrinsic biopolymers due to briquetting process.
C1 Cent Inst Agr Engn, Agr Energy & Power Div, Bhopal 462038, Madhya Pradesh, India.
RP Gangil, S (reprint author), Cent Inst Agr Engn, Agr Energy & Power Div, Bhopal 462038, Madhya Pradesh, India.
EM gangilsandip@yahoo.co.in
OI GANGIL, SANDIP/0000-0003-2213-1901
CR ABASAEED AE, 1992, ENERGY, V17, P877, DOI 10.1016/0360-5442(92)90105-9
   Caballero JA, 1997, J ANAL APPL PYROL, V42, P159, DOI 10.1016/S0165-2370(97)00015-6
   Chen LJ, 2009, RENEW SUST ENERG REV, V13, P2689, DOI 10.1016/j.rser.2009.06.025
   Chou CS, 2009, FUEL PROCESS TECHNOL, V90, P1041, DOI 10.1016/j.fuproc.2009.04.007
   Coates W, 2000, BIOMASS BIOENERG, V18, P201, DOI 10.1016/S0961-9534(99)00087-2
   Damartzis T, 2011, BIORESOURCE TECHNOL, V102, P6230, DOI 10.1016/j.biortech.2011.02.060
   Dercan B, 2012, RENEW SUST ENERG REV, V16, P1516, DOI 10.1016/j.rser.2011.10.017
   Fengmin L, 2011, ENERGY PROCEDIA, V5, P2449
   Gadde B, 2009, ENVIRON POLLUT, V157, P1554, DOI 10.1016/j.envpol.2009.01.004
   Gangil S, 2014, ENVIRON ENG SCI, V31, P183, DOI 10.1089/ees.2013.0415
   Gangil S, 2014, BIORESOURCE TECHNOL, V155, P15, DOI 10.1016/j.biortech.2013.12.087
   Grover P. D., 1996, 46 FAO UN
   Hu JJ, 2014, ENERGY, V64, P557, DOI 10.1016/j.energy.2013.10.028
   Idris SS, 2010, BIORESOURCE TECHNOL, V101, P4584, DOI 10.1016/j.biortech.2010.01.059
   Kaliyan N, 2009, BIOMASS BIOENERG, V33, P337, DOI 10.1016/j.biombioe.2008.08.005
   Karunanithy C, 2012, Biotechnol Res Int, V2012, P165202, DOI 10.1155/2012/165202
   Ledakowicz S, 2002, CHEM PAP, V56, P378
   Lopez-Gonzalez D, 2013, BIORESOURCE TECHNOL, V143, P562, DOI 10.1016/j.biortech.2013.06.052
   Mythili R, 2013, J SCI IND RES INDIA, V72, P58
   Purohit P, 2006, ENERGY, V31, P1321, DOI 10.1016/j.energy.2005.06.004
   Rajkumar D, 2013, INT J POWER ENG ENER, V4, P414
   Ramirez-Gomez A, 2014, PARTICUOLOGY, V12, P100, DOI 10.1016/j.partic.2013.05.007
   Sanchez-Silva L, 2012, BIORESOURCE TECHNOL, V109, P163, DOI 10.1016/j.biortech.2012.01.001
   Sbirrazzuoli N, 2009, CHEMOMETR INTELL LAB, V96, P219, DOI 10.1016/j.chemolab.2009.02.002
   Sengar S. H., 2013, GLOBAL J RES ENG C, V13, P21
   Shen DK, 2010, CARBOHYD POLYM, V82, P39, DOI 10.1016/j.carbpol.2010.04.018
   Singh RN, 2008, RENEW ENERG, V33, P1868, DOI 10.1016/j.renene.2007.10.007
   Singh RN, 2007, RENEW ENERG, V32, P474, DOI 10.1016/j.renene.2006.02.001
   Stolarski MJ, 2013, RENEW ENERG, V57, P20, DOI 10.1016/j.renene.2013.01.005
   Tripathi AK, 1998, BIOMASS BIOENERG, V14, P479, DOI 10.1016/S0961-9534(97)10023-X
   Tripathi AK, 1998, ENERG CONVERS MANAGE, V39, P1611, DOI 10.1016/S0196-8904(98)00030-2
   Tsamba AJ, 2006, FUEL PROCESS TECHNOL, V87, P523, DOI 10.1016/j.fuproc.2005.12.002
   Tumuluru J., 2010, 1009401 ASABE
   Vasile C, 2011, CELL CHEM TECHNOL, V45, P29
   Vyazovkin S, 2006, MACROMOL RAPID COMM, V27, P1515, DOI 10.1002/marc.200600404
   WHITE J, 2011, ANAL APPL PYROLYSIS, P1
   Xu YL, 2013, BIORESOURCE TECHNOL, V146, P485, DOI 10.1016/j.biortech.2013.07.086
NR 37
TC 5
Z9 5
U1 1
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0887-0624
EI 1520-5029
J9 ENERG FUEL
JI Energy Fuels
PD MAY
PY 2014
VL 28
IS 5
BP 3248
EP 3254
DI 10.1021/ef5004304
PG 7
WC Energy & Fuels; Engineering, Chemical
SC Energy & Fuels; Engineering
GA AH5VN
UT WOS:000336199300043
DA 2018-10-20
ER

PT J
AU Chong, DST
   Lindsey, B
   Dalby, MJ
   Gadegaard, N
   Seifalian, AM
   Hamilton, G
AF Chong, D. S. T.
   Lindsey, B.
   Dalby, M. J.
   Gadegaard, N.
   Seifalian, A. M.
   Hamilton, G.
TI Luminal Surface Engineering, 'Micro and Nanopatterning': Potential for
   Self Endothelialising Vascular Grafts?
SO EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
LA English
DT Review
DE Endothelialisation; Surface topography; Vascular grafts
ID BONDED EPTFE GRAFT; CELL MIGRATION; SAPHENOUS-VEIN;
   CONFORMATIONAL-CHANGES; SIGNAL-TRANSDUCTION; PLATELET-ADHESION;
   SHEAR-STRESS; HUMAN BLOOD; NANOTOPOGRAPHY; SCAFFOLDS
AB Objective: New technologies are being explored to meet the clinical need for an 'off-the-shelf' small diameter vascular graft with superior or at least equivalent properties to autologous vessel. The field of nanotechnology and fabrication promises major advances in biomaterial design and wall structure to deliver biomimetic grafts. This review brings together recent work on this topic.
   Methods: A literature search was conducted of PubMed and ISI Web of Knowledge using relevant keywords: Articles published after January 2005 were given preference. Personal communications and PhD theses were also used as sources.
   Results: An evolving focus on surface patterning of biomaterials has been found to carry great potential. Influencing cellular behaviour on prosthetic grafts using graft luminal surface modulation at the micro- and nano-levels is the basis of this recent concept in vascular graft development.
   Conclusion: This technology may deliver small diameter grafts with the potential for spontaneous in situ endothelialisation without the need for prior 'seeding', with the potential to open a new chapter in vascular graft development. (C) 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
C1 [Chong, D. S. T.; Lindsey, B.; Hamilton, G.] Royal Free London NHS Fdn Trust, Dept Vasc Surg, London NW3 2QG, England.
   [Chong, D. S. T.; Seifalian, A. M.; Hamilton, G.] UCL, Ctr Nanotechnol & Regenerat Med, Div Surg & Intervent Sci, London, England.
   [Dalby, M. J.] Univ Glasgow, Ctr Cell Engn, Glasgow, Lanark, Scotland.
   [Gadegaard, N.] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow, Lanark, Scotland.
RP Hamilton, G (reprint author), Royal Free London NHS Fdn Trust, Dept Vasc Surg, Pond St, London NW3 2QG, England.
EM g.hamilton@ucl.ac.uk
RI Gadegaard, Nikolaj/E-9243-2010
OI Gadegaard, Nikolaj/0000-0002-3396-846X; Dalby,
   Matthew/0000-0002-0528-3359
FU Wellcome Trust; Royal Free Charity; European Society of Vascular Surgery
FX The authors would like to acknowledge research grants from The Wellcome
   Trust, Royal Free Charity and European Society of Vascular Surgery.
CR Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051
   Anderson DEJ, 2011, ANN BIOMED ENG, V39, P2329, DOI 10.1007/s10439-011-0352-z
   Ayres CE, 2010, WIRES NANOMED NANOBI, V2, P20, DOI 10.1002/wnan.55
   Battaglia G, 2006, J CARDIOVASC SURG, V47, P41
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003
   Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196
   Biswas A, 2012, ADV COLLOID INTERFAC, V170, P2, DOI 10.1016/j.cis.2011.11.001
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Byrom MJ, 2010, J VASC SURG, V52, P176, DOI 10.1016/j.jvs.2009.10.080
   Chen L, 2011, COLLOID SURFACE B, V85, P2, DOI 10.1016/j.colsurfb.2010.10.034
   Csaderova L, 2010, SMALL, V6, P2755, DOI 10.1002/smll.201000193
   Curtis ASG, 2006, NANOMEDICINE-UK, V1, P67, DOI 10.2217/17435889.1.1.67
   Curtis ASG, 2006, J R SOC INTERFACE, V3, P393, DOI 10.1098/rsif.2005.0104
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, IEEE T NANOBIOSCI, V1, P18, DOI 10.1109/TNB.2002.806933
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   de Valence S, 2012, BIOMATERIALS, V33, P38, DOI 10.1016/j.biomaterials.2011.09.024
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Deutsch M, 2009, J VASC SURG, V49, P352, DOI 10.1016/j.jvs.2008.08.101
   Dickinson LE, 2012, J BIOMED MATER RES A, V100A, P1457, DOI 10.1002/jbm.a.34059
   Dorigo W, 2012, J CARDIOVASC SURG, V53, P187
   Dorigo W, 2008, ANN VASC SURG, V22, P79, DOI 10.1016/j.avsg.2007.07.025
   Farsari M, 2009, NAT PHOTONICS, V3, P450, DOI 10.1038/nphoton.2009.131
   Feynman R. P., 1992, Journal of Microelectromechanical Systems, V1, P60, DOI 10.1109/84.128057
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Garg K, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/031001
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   Hasan A, 2014, ACTA BIOMATER, V10, P11, DOI 10.1016/j.actbio.2013.08.022
   Huo FW, 2008, SCIENCE, V321, P1658, DOI 10.1126/science.1162193
   Hwang SY, 2010, ANAL CHEM, V82, P3016, DOI 10.1021/ac100107z
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   Jay SM, 2013, CIRC RES, V113, P933, DOI 10.1161/CIRCRESAHA.113.300215
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Le Saux G, 2011, BIOPHYS J, V101, P764, DOI 10.1016/j.bpj.2011.06.064
   Le Saux G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021869
   Li S, 2001, BIORHEOLOGY, V38, P101
   Liao X., 2013, NAT COMMUN, V4
   Liliensiek SJ, 2010, BIOMATERIALS, V31, P5418, DOI 10.1016/j.biomaterials.2010.03.045
   Lin CC, 2005, BIOMATERIALS, V26, P3655, DOI 10.1016/j.biomaterials.2004.09.051
   McClure MJ, 2011, J VIS EXP
   McCracken KE, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-11
   McNamara LE, 2012, BIOMATERIALS, V33, P2835, DOI 10.1016/j.biomaterials.2011.11.047
   Mehta RI, 2011, CARDIOVASC PATHOL, V20, P213, DOI 10.1016/j.carpath.2010.06.005
   Morgan JT, 2012, BIOMATERIALS, V33, P4126, DOI 10.1016/j.biomaterials.2012.02.047
   Olausson M, 2012, LANCET, V380, P230, DOI 10.1016/S0140-6736(12)60633-3
   Pranov H, 2006, POLYM ENG SCI, V46, P160, DOI 10.1002/pen.20459
   Ranjan AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007718
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Schleicher M, 2012, INT J BIOMATER, V2012
   Seunarine K, 2008, MICROELECTRON ENG, V85, P1350, DOI 10.1016/j.mee.2008.02.002
   Shiu YT, 2004, BIOPHYS J, V86, P2558, DOI 10.1016/S0006-3495(04)74311-8
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sivaraman B, 2012, LANGMUIR, V28, P2745, DOI 10.1021/la204777x
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Stormonth-Darling JM, 2012, MACROMOL MATER ENG, V297, P1075, DOI 10.1002/mame.201100397
   Uttayarat P, 2008, AM J PHYSIOL-HEART C, V294, pH1027, DOI 10.1152/ajpheart.00816.2007
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   Vartanian KB, 2008, BIOCHEM BIOPH RES CO, V371, P787, DOI 10.1016/j.bbrc.2008.04.167
   Walpoth BH, 2005, EXPERT REV MED DEVIC, V2, P647, DOI 10.1586/17434440.2.6.647
   WEISS P, 1958, INT REV CYTOL, V7, P391, DOI 10.1016/S0074-7696(08)62692-3
   Wood MA, 2002, NANOTECHNOLOGY, V13, P605, DOI 10.1088/0957-4484/13/5/312
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
   Zorlutuna P, 2010, J TISSUE ENG REGEN M, V4, P628, DOI 10.1002/term.278
   Zorlutuna P, 2009, ACTA BIOMATER, V5, P2451, DOI 10.1016/j.actbio.2009.03.027
NR 68
TC 18
Z9 18
U1 1
U2 61
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1078-5884
EI 1532-2165
J9 EUR J VASC ENDOVASC
JI Eur. J. Vasc. Endovasc. Surg.
PD MAY
PY 2014
VL 47
IS 5
BP 566
EP 576
DI 10.1016/j.ejvs.2014.02.007
PG 11
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA AH4QT
UT WOS:000336113800018
PM 24642295
OA Bronze
DA 2018-10-20
ER

PT J
AU Eder, C
   Meissner, J
   Bretschneider, W
   Schildbock, S
   Ogon, M
AF Eder, C.
   Meissner, J.
   Bretschneider, W.
   Schildboeck, S.
   Ogon, M.
TI Analysis of a beta-TCP bone graft extender explanted during revision
   surgery after 28 months in vivo
SO EUROPEAN SPINE JOURNAL
LA English
DT Article
DE Bone graft; beta-TCP; Spinal fusion; Histological analysis
ID IDIOPATHIC SCOLIOSIS; SUBSTITUTE; FUSION
AB Analysis of a beta-tricalcium phosphate (beta-TCP) bone graft soaked with bone marrow aspirate explanted during revision surgery after 28 months.
   A 41-year-old female patient undergoing scoliosis correction Th4-L5 in 2007 was revised due to screw loosening in 2008. During revision surgery, a beta-TCP bone graft (chronOS(A (R)) chips) soaked with bone marrow aspirate was applied. Due to implant failure, the patient was revised again 2011. The bone graft was removed and taken to the laboratory for histological analysis. The biomaterial samples were stained with DAPI and analyzed under a fluorescence microscope. Five biomaterial chips were maintained in tissue culture to evaluate outgrowing cells. The remaining samples were embedded in paraffin, sectioned into 7 mu m sections and stained with Hemalaun/eosin.
   The morphology and rigidity of the beta-TCP bone graft were comparable to the original. The pores were not filled with tissue and could be clearly identified. Only single vital cells were detected on the graft. The outgrowth culture yielded only erythrocytes-no cells of the osteoblastic lineage cells could be harvested. Histological analysis demonstrated a failure of resorption and the absence of new bone formation.
   Histological analysis of bone grafts is rare after implantation in humans due to ethical and clinical limitations of sample harvest. In this study, implantation of a beta-TCP bone graft did not result in bone formation after 28 months in vivo.
C1 [Eder, C.; Meissner, J.; Bretschneider, W.; Schildboeck, S.; Ogon, M.] Orthopad Spital Speising, Orthopad Abt 3, A-1130 Vienna, Austria.
RP Eder, C (reprint author), Orthopad Spital Speising, Orthopad Abt 3, Speisinger Str 109, A-1130 Vienna, Austria.
EM claudia.eder@oss.at
CR Andersen Thomas, 2003, Spine J, V3, P285, DOI 10.1016/S1529-9430(03)00030-5
   BURNER WL, 1982, J PEDIATR ORTHOPED, V2, P383, DOI 10.1097/01241398-198210000-00006
   Cheng JC, 2001, SPINE, V26, P19
   COOK SD, 1987, J PEDIATR ORTHOPED, V7, P168, DOI 10.1097/01241398-198703000-00011
   Delecrin J, 2000, SPINE, V25, P563, DOI 10.1097/00007632-200003010-00006
   Le Huec J C, 1997, Acta Orthop Belg, V63, P202
   Muschik M, 2001, EUR SPINE J, V10, pS178, DOI 10.1007/s005860100271
   Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3
   Schulze-Spate Ulrike, 2012, Compend Contin Educ Dent, V33, P364
   Sengupta DK, 2006, SPINE, V31, P985, DOI 10.1097/01.brs.0000215048.51237.3c
   Uchiyama K, 2005, J ORTHOP SCI, V10, P77, DOI 10.1007/s00776-004-0857-5
   Whang Peter G, 2003, Spine J, V3, P155, DOI 10.1016/S1529-9430(02)00539-9
NR 12
TC 2
Z9 3
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0940-6719
EI 1432-0932
J9 EUR SPINE J
JI Eur. Spine J.
PD MAY
PY 2014
VL 23
SU 2
BP S157
EP S160
DI 10.1007/s00586-013-2802-9
PG 4
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA AH8TG
UT WOS:000336410500003
PM 23636843
DA 2018-10-20
ER

PT J
AU Orczykowska, M
   Dziubinski, M
AF Orczykowska, Magdalena
   Dziubinski, Marek
TI Viscoelastic Properties of Soft Materials on a Basis of Starch Mixtures
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE corn starch; fractional linear standard solid model; rice starch; sugar;
   viscoelastic behavior
ID RHEOLOGICAL PROPERTIES; GRANULE SIZE; RICE STARCH; BEHAVIOR;
   DISPERSIONS; RELAXATION; COMPOSITES; SUCROSE; PASTES; MODEL
AB The effect of concentration of carbohydrates on viscoelastic properties of corn and rice starch is discussed in this paper. The texture of starch pastes was estimated using a fractional rheological linear standard solid model. Rheological parameters of the model were identified and their changes for different values of sugar concentrations in the 2 tested starches were discussed.
   Practical ApplicationThe fractional rheological models can be very useful to control the biomaterial texture for the needs of final product, which is particularly significant from the point of view of materials engineering. The proposed method for interpretation of the results of rheological measurements of these pastes allows for a comprehensive estimation of the analyzed biomaterial texture.
C1 [Orczykowska, Magdalena; Dziubinski, Marek] Tech Univ Lodz, Fac Proc & Environm Engn, Dept Chem Engn, PL-90924 Lodz, Poland.
RP Orczykowska, M (reprint author), Tech Univ Lodz, Fac Proc & Environm Engn, Dept Chem Engn, Ul Wolczanska 213, PL-90924 Lodz, Poland.
EM orczykow@wipos.p.lodz.pl
CR Acquarone VM, 2003, CARBOHYD POLYM, V51, P451, DOI 10.1016/S0144-8617(02)00217-5
   Ahmad FB, 1999, BIOPOLYMERS, V50, P401, DOI 10.1002/(SICI)1097-0282(19991005)50:4<401::AID-BIP6>3.3.CO;2-M
   Alcoutlabi M, 1998, POLYMER, V39, P6269, DOI 10.1016/S0032-3861(98)00168-2
   Chang YH, 2004, J FOOD ENG, V64, P521, DOI 10.1016/j.jfoodeng.2003.08.017
   CHEN M, 2011, CHINESE PHYS LETT, V28
   Dinzart F, 2009, ARCH MECH, V61, P459
   Dobraszczyk BJ, 2003, J CEREAL SCI, V38, P229, DOI 10.1016/S0733-5210(03)00059-6
   Ikeda S, 2001, FOOD HYDROCOLLOID, V15, P401, DOI 10.1016/S0268-005X(01)00052-2
   KOKINI JL, 1994, CARBOHYD POLYM, V25, P319, DOI 10.1016/0144-8617(94)90058-2
   Lubiewski Z., 2011, ZYWN-NAUK TECHNOL JA, V76, P53
   MITA T, 1992, CARBOHYD POLYM, V17, P269, DOI 10.1016/0144-8617(92)90169-Q
   Molenda Marek, 2006, Polish Journal of Food and Nutrition Sciences, V15, P161
   Mours M, 1996, MACROMOLECULES, V29, P7221, DOI 10.1021/ma9517097
   Orczykowska M, 2012, CHEM PROCESS ENG-INZ, V33, P141, DOI 10.2478/v10176-012-0013-2
   PRUSKAKDZIOR A, 2006, AGR U POZNA SCI MONO, V373, P13
   Ptaszek P, 2014, FOOD BIOPHYS, V9, P76, DOI 10.1007/s11483-013-9320-5
   Rao MA, 1999, CARBOHYD POLYM, V38, P123, DOI 10.1016/S0144-8617(98)00112-X
   Rao MA, 1997, CARBOHYD POLYM, V33, P273, DOI 10.1016/S0144-8617(97)00025-8
   Rao VK, 2000, J CEREAL SCI, V31, P159, DOI 10.1006/jcrs.1999.0295
   Reyes-Melo ME, 2004, J OPTOELECTRON ADV M, V6, P1037
   Sikora M., 2008, ZYWN-NAUK TECHNOL JA, V1, P23
   Singh N, 2003, FOOD CHEM, V81, P219, DOI 10.1016/S0308-8146(02)00416-8
   Sodhi NS, 2003, FOOD CHEM, V80, P99, DOI 10.1016/S0308-8146(02)00246-7
   SWINKELS JJM, 1985, STARKE, V37, P1, DOI 10.1002/star.19850370102
   Tattiyakul J, 2000, CARBOHYD POLYM, V43, P215, DOI 10.1016/S0144-8617(00)00160-0
   WONG RBK, 1982, STARKE, V34, P231, DOI 10.1002/star.19820340705
   Wu Y, 2009, FOOD RES INT, V42, P221, DOI 10.1016/j.foodres.2008.11.001
   Yoo D, 2005, STARCH-STARKE, V57, P254, DOI 10.1002/star.200400356
NR 28
TC 2
Z9 2
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD MAY
PY 2014
VL 79
IS 5
BP E849
EP E858
DI 10.1111/1750-3841.12445
PG 10
WC Food Science & Technology
SC Food Science & Technology
GA AG5XI
UT WOS:000335491600012
PM 24712691
DA 2018-10-20
ER

PT J
AU Xiong, Y
   Fu, ZY
   Pouchly, V
   Maca, K
   Shen, ZJ
AF Xiong, Yan
   Fu, Zhengyi
   Pouchly, Vaclav
   Maca, Karel
   Shen, Zhijian
TI Preparation of Transparent 3Y-TZP Nanoceramics with No Low-Temperature
   Degradation
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID ZIRCONIA NANOPARTICLES; DENTAL APPLICATIONS; TRANSFORMATIONS;
   BIOMATERIAL; CERAMICS; ALUMINA; FUTURE
AB The progresses of the relative density, average grain size (GS), and maximum pore size entering into the final sintering stage are investigated in 3mol% yttria-stabilized tetragonal zirconia polycrystals (3Y-TZP) compacts in the range of 87%similar to 99% theoretical density. It is found that during conventional pressureless sintering, the pores in the compact enlarged dramatically, which appears to be the major obstacle for preparing fully dense nanoceramics. Transparent 3Y-TZP nanoceramics with an average GS of 87nm were prepared by exploiting microstructural refinement on nanoscale. The yields a maximal optical transmittance of 67% and shows no noticeable low-temperature degradation after 100h aging at 134 degrees C under a hydrothermal pressure of two bars.
C1 [Xiong, Yan] Hubei Univ Technol, Sch Mat Sci & Engn, Hubei Prov Key Lab Green Mat Light Ind, Wuhan 430068, Peoples R China.
   [Xiong, Yan; Shen, Zhijian] Stockholm Univ, Arrhenius Lab, Dept Mat & Environm Chem, S-10691 Stockholm, Sweden.
   [Fu, Zhengyi] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China.
   [Pouchly, Vaclav; Maca, Karel] Brno Univ Technol, CEITEC BUT, Brno 61600, Czech Republic.
RP Shen, ZJ (reprint author), Stockholm Univ, Arrhenius Lab, Dept Mat & Environm Chem, S-10691 Stockholm, Sweden.
EM shen@mmk.su.se
RI Maca, Karel/D-7520-2012; Pouchly, Vaclav/D-6853-2012
OI Maca, Karel/0000-0002-7535-6920; Pouchly, Vaclav/0000-0002-3301-026X
FU State Key Laboratory of Advanced Technology for Materials Synthesis and
   Processing (Wuhan University of Technology) [2014-KF-12]; Swedish
   Research Council [621-2008-5730]; project "CEITEC-Central European
   Institute of Technology" from European Regional Development Fund
   [CZ.1.05/1.1.00/02.0068]; SRF for ROCS, SEM
FX The work was supported by the SRF for ROCS, SEM, State Key Laboratory of
   Advanced Technology for Materials Synthesis and Processing (Wuhan
   University of Technology, no. 2014-KF-12), Swedish Research Council
   through grant 621-2008-5730 and by the project "CEITEC-Central European
   Institute of Technology" (CZ.1.05/1.1.00/02.0068) from European Regional
   Development Fund. The authors thank Ms. Xiao Liu and Ms. Jianghao Liu
   for conducting part of the experiments.
CR Anselmi-Tamburini U, 2006, SCRIPTA MATER, V54, P823, DOI 10.1016/j.scriptamat.2005.11.015
   Anselmi-Tamburini U, 2007, ADV FUNCT MATER, V17, P3267, DOI 10.1002/adfm.200600959
   Apetz R, 2003, J AM CERAM SOC, V86, P480, DOI 10.1111/j.1151-2916.2003.tb03325.x
   Binner J, 2008, J EUR CERAM SOC, V28, P1329, DOI 10.1016/j.jeurceramsoc.2007.12.024
   Cascolo S. R., 2008, SCRIPTA MATER, V58, P516
   Cattani-Lorente M, 2011, ACTA BIOMATER, V7, P858, DOI 10.1016/j.actbio.2010.09.020
   Chen I. W., 2000, NATURE, V404, P8
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Exner HE, 2009, J AM CERAM SOC, V92, P1384, DOI 10.1111/j.1551-2916.2009.02978.x
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Kang S.-J. L., 2005, SINTERING DENSIFICAT
   Keuper M, 2013, ACTA BIOMATER, V9, P4826, DOI 10.1016/j.actbio.2012.08.032
   Kingery W. D., 1976, INTRO CERAMICS
   Klimke J, 2011, J AM CERAM SOC, V94, P1850, DOI 10.1111/j.1551-2916.2010.04322.x
   Kohorst P, 2012, ACTA BIOMATER, V8, P1213, DOI 10.1016/j.actbio.2011.11.016
   LANGE FF, 1982, J MATER SCI, V17, P225, DOI 10.1007/BF00809057
   Li L. F., 1997, J MATER SCI, V32, P1149, DOI 10.1023/A:1018567414745
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Mazaheri M, 2008, J EUR CERAM SOC, V28, P2933, DOI 10.1016/j.jeurceramsoc.2008.04.030
   McHale JM, 1997, SCIENCE, V277, P788, DOI 10.1126/science.277.5327.788
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Santacruz I, 2008, J AM CERAM SOC, V91, P398, DOI 10.1111/j.1551-2916.2007.02164.x
   Schwarz S, 2013, J EUR CERAM SOC, V33, P637, DOI 10.1016/j.jeurceramsoc.2012.10.002
   Srdic VV, 2000, J AM CERAM SOC, V83, P1853
   Suresh A, 2003, J AM CERAM SOC, V86, P360, DOI 10.1111/j.1151-2916.2003.tb00025.x
   Trunec M, 2008, SCRIPTA MATER, V59, P23, DOI 10.1016/j.scriptamat.2008.02.015
   Trunec M, 2007, J AM CERAM SOC, V90, P2735, DOI 10.1111/j.1551-2916.2007.01781.x
   Vichi A, 2011, DENT MATER, V27, P97, DOI 10.1016/j.dental.2010.10.018
   Xiong Y, 2011, J AM CERAM SOC, V94, P4269, DOI 10.1111/j.1551-2916.2011.04829.x
NR 31
TC 9
Z9 9
U1 4
U2 44
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-7820
EI 1551-2916
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD MAY
PY 2014
VL 97
IS 5
BP 1402
EP 1406
DI 10.1111/jace.12919
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA AH0KS
UT WOS:000335809400014
DA 2018-10-20
ER

PT J
AU Ryu, MJ
   Gang, SN
   Lim, SH
AF Ryu, Min-Ju
   Gang, Sung-Nam
   Lim, Sung-Hoon
TI Effect of silica coating on bond strength between a gold alloy and metal
   bracket bonded with chemically cured resin
SO KOREAN JOURNAL OF ORTHODONTICS
LA English
DT Article
DE Bonding; Biomaterial science; Silicoating; Chemically cured resin
ID NOBLE-METAL; ENAMEL; PORCELAIN; SURFACE; PRIMER; ADHESIVE; CEMENT
AB Objective: The purpose of this study was to evaluate the effects of three different surface conditioning methods on the shear bond strength (SBS) of metal brackets bonded directly to gold alloy with chemically cured resin. Methods: Two hundred ten type 111 gold alloy specimens were randomly divided into six groups according to the combination of three different surface conditioning methods (aluminum oxide sandblasting only, application of a metal primer after aluminum oxide sandblasting, silica coating and silanation) and thermocycling (with thermocycling, without thermocyding). After performing surface conditioning of specimens in accordance with each experimental condition, metal brackets were bonded to all specimens using a chemically cured resin. The SBS was measured at the moment of bracket debonding, and the resin remnants on the specimen surface were evaluated using the adhesive remnant index. Results: Application of metal primer after aluminum oxide sandblasting yielded a higher bond strength than that with aluminum oxide sandblasting alone (p < 0.001), and silica coating and silanation yielded a higher bond strength than that with metal primer after aluminum oxide sandblasting (p < 0.001). There was no significant change in SBS after thermocycling in all groups. Conclusions: With silica coating and silanation, clinically satisfactory bond strength can be attained when metal brackets are directly bonded to gold alloys using a chemically cured resin.
C1 [Ryu, Min-Ju; Gang, Sung-Nam; Lim, Sung-Hoon] Chosun Univ, Sch Dent, Dept Orthodont, Kwangju 501825, South Korea.
RP Gang, SN (reprint author), Chosun Univ, Sch Dent, Dept Orthodont, 303 Pilmun Daero, Kwangju 501825, South Korea.
EM 022bracket@gmail.com
OI Lim, Sung-Hoon/0000-0003-4528-8514
FU Chosun University
FX This study was supported by a research fund from Chosun University,
   2011.
CR Antoniadou M, 2000, J PROSTHET DENT, V84, P554, DOI 10.1067/mpr.2000.109986
   ARTUN J, 1984, AM J ORTHOD DENTOFAC, V85, P333, DOI 10.1016/0002-9416(84)90190-8
   Atsu SS, 2006, ANGLE ORTHOD, V76, P857, DOI 10.2319/052505-189
   Bishara SE, 2003, AM J ORTHOD DENTOFAC, V123, P21, DOI 10.1067/mod.2003.1
   BOYD RL, 1992, ANGLE ORTHOD, V62, P117
   Bulbul M, 2010, J PROSTHET DENT, V103, P303, DOI 10.1016/S0022-3913(10)60063-7
   Buyukyilmaz T, 1998, ANGLE ORTHOD, V68, P337
   BUYUKYILMAZ T, 1995, AM J ORTHOD DENTOFAC, V108, P510, DOI 10.1016/S0889-5406(95)70051-X
   Cozza P, 2006, ANGLE ORTHOD, V76, P851, DOI 10.2319/061205-201
   Jung MH, 2013, KOREAN J ORTHOD, V43, P127, DOI 10.4041/kjod.2013.43.3.127
   Jung MH, 2010, KOREAN J ORTHOD, V40, P27, DOI 10.4041/kjod.2010.40.1.27
   Lee YK, 2009, KOREAN J ORTHOD, V39, P320, DOI 10.4041/kjod.2009.39.5.320
   Matinlinna JP, 2004, INT J PROSTHODONT, V17, P155
   Matsumura H, 1999, J PROSTHET DENT, V81, P710, DOI 10.1016/S0022-3913(99)70111-3
   Nergiz I, 2004, AM J ORTHOD DENTOFAC, V125, P42, DOI 10.1016/S0889-5406(03)00507-9
   Patusco VC, 2009, ANGLE ORTHOD, V79, P122, DOI 10.2319/072507-345.1
   SCHNEIDER W, 1992, DENT MATER, V8, P211, DOI 10.1016/0109-5641(92)90086-R
   Shon WJ, 2012, EUR J ORTHODONT, V34, P72, DOI 10.1093/ejo/cjq163
   Sun R, 2000, J DENT, V28, P441, DOI 10.1016/S0300-5712(00)00006-3
   Van Meerbeek B, 2003, OPER DENT, V28, P215
   Watanabe T, 2008, DENT MATER J, V27, P16, DOI 10.4012/dmj.27.16
   WOOD DP, 1986, AM J ORTHOD DENTOFAC, V89, P194, DOI 10.1016/0002-9416(86)90032-1
   Yoshida K, 1999, DENT MATER, V15, P332, DOI 10.1016/S0109-5641(99)00053-6
   Zachrisson B. U., 1993, J CLIN ORTHOD, V27, P661
NR 24
TC 3
Z9 3
U1 0
U2 0
PU KOREAN ASSOC ORTHODONTISTS
PI SEOUL
PA 603 TRAPALACE II, 1327 SEOCHO-DONG, SEOCHO-GU, SEOUL, 137-070, SOUTH
   KOREA
SN 2234-7518
EI 2005-372X
J9 KOREAN J ORTHOD
JI Korean J. Orthod.
PD MAY
PY 2014
VL 44
IS 3
BP 105
EP 112
DI 10.4041/kjod.2014.44.3.105
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AH6KE
UT WOS:000336239000002
PM 24892023
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Nyska, A
   Schiffenbauer, YS
   Brami, CT
   Maronpot, RR
   Ramot, Y
AF Nyska, Abraham
   Schiffenbauer, Yael S.
   Brami, Catherine T.
   Maronpot, Robert R.
   Ramot, Yuval
TI Histopathology of biodegradable polymers: challenges in interpretation
   and the use of a novel compact MRI for biocompatibility evaluation
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Review
DE safety assessment; histopathology; MRI; toxicologic pathology
ID SOFT-TISSUE AUGMENTATION; DRUG-INDUCED THROMBOSIS; IN-VITRO; SAFETY;
   PATHOLOGY; DEGRADATION; TOXICITY; DEVICES; SYSTEMS; FILLERS
AB Toxicologic pathology is the art of assessment of potential adverse effects at the tissue level in pre-clinical studies. In the case of biomaterials and medical devices, the toxicologic pathologists assess the safety (biocompatibility) and efficacy (conditions of the use) of the implantable materials. Proper assessment of biocompatibility of biomaterials is of utmost importance, since it helps to determine their safety after implantation in humans. Biomaterial-related toxicity can be attributed to several factors, including for example leachable compounds from the material leading to thrombosis or carcinogenesis, or biodegradation of the material causing changes in its physical and compatibility properties. Evaluation of biocompatibility and biofunctionality involves assessment of cytotoxicity, allergic responses, irritation, inflammation and systemic and chronic toxicity. In many of these assessments, the toxicologic pathologist has an important role in determining product safety and potential toxicity. In this article, we review the special needs for proper toxicologic pathology assessment of biomaterials and degradable polymers. We review common adverse effects expected with biomaterials and describe their pathological picture and their clinical relevance. We also introduce a novel compact MR imaging technology as a tool for assessing biocompatibility and efficacy of implanted biodegradable materials, since it allows for the longitudinal imaging and quantification of inflammation in vivo caused by the device implantation, and enabling general inspection of shape, location and integrity of the device in vivo. Since the MR imaging technique is non-invasive, the effects of the implantable device can be monitored longitudinally in the same animal without perturbation of the pathology. Copyright (c) 2014 John Wiley & Sons, Ltd.
C1 [Nyska, Abraham] Tel Aviv Univ, Sackler Sch Med, IL-36576 Timrat, Israel.
   [Schiffenbauer, Yael S.; Brami, Catherine T.] Aspect Imaging Ltd, IL-60850 Shoham, Israel.
   [Maronpot, Robert R.] Maronpot Consulting LLC, Raleigh, NC 27607 USA.
   [Ramot, Yuval] Hadassah Hebrew Univ Med Ctr, IL-91120 Jerusalem, Israel.
RP Nyska, A (reprint author), Tel Aviv Univ, Sackler Sch Med, IL-36576 Timrat, Israel.
EM anyska@bezeqint.net
CR Andre P, 2004, J EUR ACAD DERMATOL, V18, P422, DOI 10.1111/j.1468-3083.2004.00934.x
   [Anonymous], 2012, 10993 ISO
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6
   Buijs G. J., 2006, J DENT RES, P85
   Duranti F, 1998, DERMATOL SURG, V24, P1317, DOI 10.1111/j.1524-4725.1998.tb00007.x
   Edwards PC, 2007, CLIN INTERV AGING, V2, P509, DOI 10.2147/CIA.S382
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Gaspardone A, 2005, AM J CARDIOL, V96, p65L, DOI 10.1016/j.amjcard.2005.09.064
   Gopinath C, 1996, INFLAMM RES, V45, pS74
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Khan W, 2013, J CONTROL RELEASE, V168, P70, DOI 10.1016/j.jconrel.2013.02.012
   Koschwanez HE, 2007, BIOMATERIALS, V28, P3687, DOI 10.1016/j.biomaterials.2007.03.034
   Lemperle G, 2003, AESTHET PLAST SURG, V27, P354, DOI 10.1007/s00266-003-3022-1
   Mann PC, 2012, TOXICOL PATHOL, V40, P7, DOI 10.1177/0192623312438738
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Morton D, 2006, TOXICOL PATHOL, V34, P806, DOI 10.1080/01926230601034624
   Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003
   Ramot Y, 2007, TOXICOL PATHOL, V35, P208, DOI 10.1080/01926230601156237
   Ramot Y, 2013, DRUG SAFETY, V36, P585, DOI 10.1007/s40264-013-0054-6
   Ramot Y, 2008, TOXICOL PATHOL, V36, P385, DOI 10.1177/0192623308315831
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Requena L, 2011, J AM ACAD DERMATOL, V64, P1, DOI 10.1016/j.jaad.2010.02.064
   Rihova B, 2000, ADV DRUG DELIVER REV, V42, P65
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schuh JCL, 2008, TOXICOL PATHOL, V36, P63, DOI 10.1177/0192623307309926
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Vaisman B, 2010, J BIOMED MATER RES A, V92A, P419, DOI 10.1002/jbm.a.32342
   VERT M, 1992, Clinical Materials, V10, P3, DOI 10.1016/0267-6605(92)90077-7
   WILLIAMS SJ, 1986, BRIT J CLIN PHARMACO, V22, P610, DOI 10.1111/j.1365-2125.1986.tb02943.x
   Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E
NR 34
TC 13
Z9 13
U1 0
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-7147
EI 1099-1581
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD MAY
PY 2014
VL 25
IS 5
SI SI
BP 461
EP 467
DI 10.1002/pat.3238
PG 7
WC Polymer Science
SC Polymer Science
GA AF0AL
UT WOS:000334373700005
DA 2018-10-20
ER

PT J
AU Selmin, F
   Gennari, CGM
   Minghetti, P
   Marotta, LA
   Viviani, B
   Vagdama, P
   Montanari, L
   Cilurzo, F
AF Selmin, Francesca
   Gennari, Chiara G. M.
   Minghetti, Paola
   Marotta, Laura A.
   Viviani, Barbara
   Vagdama, Pankaj
   Montanari, Luisa
   Cilurzo, Francesco
TI Enhanced hydration stability of Bombyx mori silk fibroin/PEG 600
   composite scaffolds for tissue engineering
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE composite materials; scaffolds; mechanical properties; silk fibroin
ID BIOMATERIAL SCAFFOLDS; MEMBRANES; FILMS; CONFORMATION; DEGRADATION;
   WATER
AB Silk fibroin scaffolds obtained via regeneration by Ajisawa's reagent (CaCl2/H2O/EtOH, mole ratio 1:8:2) and freeze-drying followed by steam sterilization resulted unstable when incubated in physiological medium over 1-month period since the oxygen diffusivity and mechanical resistance to compression significantly decreased. Blending of regenerated silk fibroin with PEG 600 lead to a novel scaffold with an improved water stability. Multi-parameter characterization has revealed that scaffolds made by composite material were stable in physiological media over at least 1 month of incubation. Interestingly, the presence of PEG has a notable impact on wettability and protein adsorption. This increase in hydrophilicity could be beneficial for initial cell adhesion and survival as well as for the adsorptive loading of growth factors. Copyright (c) 2014 John Wiley & Sons, Ltd.
C1 [Selmin, Francesca; Gennari, Chiara G. M.; Minghetti, Paola; Marotta, Laura A.; Montanari, Luisa; Cilurzo, Francesco] Univ Milan, Dept Pharmaceut Sci, I-20133 Milan, Italy.
   [Viviani, Barbara] Univ Milan, Dept Pharmacol & Biomol Sci, I-20133 Milan, Italy.
   [Vagdama, Pankaj] Queen Mary Univ London, Sch Engn & Mat Sci, IRC Biomed Mat, London E1 4NS, England.
RP Cilurzo, F (reprint author), Univ Milan, Dept Pharmaceut Sci, Via G Colombo 71, I-20133 Milan, Italy.
EM francesco.cilurzo@unimi.it
RI Cilurzo, Francesco/F-6663-2012
OI Cilurzo, Francesco/0000-0003-3560-291X; MONTANARI,
   LUISA/0000-0003-2576-9871; Minghetti, Paola/0000-0001-7723-441X; Selmin,
   Francesca/0000-0002-3680-6124; Gennari, Chiara/0000-0001-8814-1673
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   [Anonymous], 2009, CPMPICH28395
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Charles-Harris M, 2005, J MATER SCI-MATER M, V16, P1125, DOI 10.1007/s10856-005-4717-4
   Cheema U, 2012, J TISSUE ENG REGEN M, V6, P77, DOI 10.1002/term.402
   Chen X, 2003, ACTA CHIM SINICA, V61, P625
   Cilurzo F, 2011, INT J PHARMACEUT, V414, P218, DOI 10.1016/j.ijpharm.2011.05.023
   Gil ES, 2014, MACROMOL BIOSCI, V14, P257, DOI 10.1002/mabi.201300321
   Han P, 1996, J PHYS CHEM-US, V100, P5597, DOI 10.1021/jp952903y
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Rong Z, 2009, ELECTROCHIM ACTA, V54, P4949, DOI 10.1016/j.electacta.2009.03.091
   TSUKADA M, 1986, J POLYM SCI POL PHYS, V24, P457, DOI 10.1002/polb.1986.090240219
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Vehoff T, 2007, BIOPHYS J, V93, P4425, DOI 10.1529/biophysj.106.099309
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
NR 23
TC 6
Z9 6
U1 2
U2 48
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-7147
EI 1099-1581
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD MAY
PY 2014
VL 25
IS 5
SI SI
BP 532
EP 538
DI 10.1002/pat.3282
PG 7
WC Polymer Science
SC Polymer Science
GA AF0AL
UT WOS:000334373700012
DA 2018-10-20
ER

PT J
AU Irani, S
   Zandi, M
   Salamian, N
   Saeed, SM
   Joupari, MD
   Atyabi, SM
AF Irani, Shiva
   Zandi, Mojgan
   Salamian, Najmeh
   Saeed, Seyed Mahdi
   Joupari, Morteza Daliri
   Atyabi, Seyed Mohammad
TI The study of P19 stem cell behavior on aligned oriented electrospun
   poly(lactic-co-glycolic acid) nano-fibers for neural tissue engineering
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE electrospinning; P19 stem cell; aligned nano-fiber
ID EXTRACELLULAR-MATRIX; NERVE REGENERATION; RETINOIC ACID; SCAFFOLDS;
   NEURONS
AB Recent medical cell therapy using polymeric biomaterial-loaded stem cells with the capability of differentiation to specific neural population has directed focuses toward the recovery of central nervous system. Definite culture conditions that regulate cell morphogenesis, proliferation, survival, and differentiation to lineage specific cells have a great influence on the cells' life. In this research, random and aligned poly(lactic-co-glycolic acid) fibrous scaffolds with nano-structure were prepared, and the effect of nano-fiber morphology on the pluripotent P19 embryonic carcinoma cell proliferation and neural differentiation in response to retinoic acid induction was studied. Fiber morphology was assessed by scanning electron microscope (SEM). For in vitro studies, SEM, (4,5-dimethylazol-2-yl)-2,5-diphenyl-2H tetrazolium bromide assay, and immunofluorescent staining were carried out for the assessment of biological properties of the seeded cells. Our results showed that, because of their similarity with natural extracellular matrix, the aligned fibrous substrates provide the suitable surface for cell function as well as the augmentation of cell differentiation. Copyright (c) 2014 John Wiley & Sons, Ltd.
C1 [Irani, Shiva; Salamian, Najmeh] Islamic Azad Univ, Sch Basic Sci, Dept Biol, Sci & Res Branch, Tehran, Iran.
   [Zandi, Mojgan; Saeed, Seyed Mahdi] Iranian Polymer & Petrochem Inst, Dept Biomat, Tehran, Iran.
   [Joupari, Morteza Daliri] Natl Inst Genet Engn & Biotechnol, Dept Anim & Marine Biotechnol, Tehran, Iran.
   [Atyabi, Seyed Mohammad] Pasteur Inst Iran, Dept Pilot Biotechnol, Tehran, Iran.
RP Zandi, M (reprint author), Iranian Polymer & Petrochem Inst, Dept Biomat, Tehran, Iran.
EM m.zandi@ippi.ac.ir; atyabi@pasteur.ac.ir
OI Irani, Shiva/0000-0002-4202-9931
CR Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167
   Fine EG, 2002, EUR J NEUROSCI, V15, P589, DOI 10.1046/j.1460-9568.2002.01892.x
   Forch R, 2009, SURFACE DESIGN APPL, P471
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253
   Lan CW, 2003, J BIOMED MATER RES A, V66A, P38, DOI 10.1002/jbm.a.10507
   Lee S., ACTA BIOMATER, V7, P3868
   Li H., SHENG WU GONG CHENG, V28, P15
   Moore Amy M, 2009, Hand (N Y), V4, P180, DOI 10.1007/s11552-008-9158-3
   Mukhatyar V. J., BIOMATERIALS, V32, P3958
   Nisbet DR, 2007, J NEURAL ENG, V4, P35, DOI 10.1088/1741-2560/4/2/004
   NISHIDA T, 1988, INVEST OPHTH VIS SCI, V29, P1887
   Rim N. G., BIOMED MAT, V8
   Salamian N., 2013, NANO B, V2
   TANAKA Y, 1992, BRAIN RES, V596, P269, DOI 10.1016/0006-8993(92)91557-U
   Wang B., J MECH BEHAV BIOMED, V4, P600
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
   Yang F, 2004, J BIOMAT SCI-POLYM E, V15, P1483, DOI 10.1163/1568562042459733
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yarwood SJ, 2001, P NATL ACAD SCI USA, V98, P4472, DOI 10.1073/pnas.081069098
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
NR 23
TC 9
Z9 9
U1 0
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-7147
EI 1099-1581
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD MAY
PY 2014
VL 25
IS 5
SI SI
BP 562
EP 567
DI 10.1002/pat.3280
PG 6
WC Polymer Science
SC Polymer Science
GA AF0AL
UT WOS:000334373700016
DA 2018-10-20
ER

PT J
AU Mhanna, R
   Kashyap, A
   Palazzolo, G
   Vallmajo-Martin, Q
   Becher, J
   Moller, S
   Schnabelrauch, M
   Zenobi-Wong, M
AF Mhanna, Rami
   Kashyap, Aditya
   Palazzolo, Gemma
   Vallmajo-Martin, Queralt
   Becher, Jana
   Moeller, Stephanie
   Schnabelrauch, Matthias
   Zenobi-Wong, Marcy
TI Chondrocyte Culture in Three Dimensional Alginate Sulfate Hydrogels
   Promotes Proliferation While Maintaining Expression of Chondrogenic
   Markers
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ARTICULAR-CARTILAGE; TRANSPLANTATION GRAFTS; GENE-EXPRESSION;
   NERVOUS-SYSTEM; COLLAGEN; KNEE; PROTEOGLYCANS; IMPLANTATION; DEFECTS;
   DIFFERENTIATION
AB The loss of expression of chondrogenic markers during monolayer expansion remains a stumbling block for cell-based treatment of cartilage lesions. Here, we introduce sulfated alginate hydrogels as a cartilage biomimetic biomaterial that induces cell proliferation while maintaining the chondrogenic phenotype of encapsulated chondrocytes. Hydroxyl groups of alginate were converted to sulfates by incubation with sulfur trioxide-pyridine complex (SO3/pyridine), yielding a sulfated material cross-linkable with calcium chloride. Passage 3 bovine chondrocytes were encapsulated in alginate and alginate sulfate hydrogels for up to 35 days. Cell proliferation was five-fold higher in alginate sulfate compared with alginate (p=0.038). Blocking beta1 integrins in chondrocytes within alginate sulfate hydrogels significantly inhibited proliferation (p=0.002). Sulfated alginate increased the RhoA activity of chondrocytes compared with unmodified alginate, an increase that was blocked by 1 blocking antibodies (p=0.017). Expression and synthesis of type II collagen, type I collagen, and proteoglycan was not significantly affected by the encapsulation material evidenced by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and immunohistochemistry. Alginate sulfate constructs showed an opaque appearance in culture, whereas the unmodified alginate samples remained translucent. In conclusion, alginate sulfate provides a three dimensional microenvironment that promotes both chondrocyte proliferation and maintenance of the chondrogenic phenotype and represents an important advance for chondrocyte-based cartilage repair therapies providing a material in which cell expansion can be done in situ.
C1 [Mhanna, Rami; Kashyap, Aditya; Palazzolo, Gemma; Vallmajo-Martin, Queralt; Zenobi-Wong, Marcy] ETH, CH-8093 Zurich, Switzerland.
   [Becher, Jana; Moeller, Stephanie; Schnabelrauch, Matthias] INNOVENT eV, Biomat Dept, Jena, Germany.
RP Zenobi-Wong, M (reprint author), ETH, Schafmattstr 22, CH-8093 Zurich, Switzerland.
EM marcy.zenobi@hest.ethz.ch
RI Zenobi-Wong, Marcy/J-5398-2013
OI Zenobi-Wong, Marcy/0000-0002-8522-9909; Palazzolo,
   Gemma/0000-0003-4070-1971
FU European Union [NMP4-SL-2009-229292]; NICHD
FX The work was funded by the European Union Seventh Framework Programme
   (FP7/2007-2013) under grant agreement no NMP4-SL-2009-229292
   (Find&Bind). The type II collagen antibody II-II6B3 developed by T. F.
   Linsenmayer, type I collagen antibody M-38 developed by J.A McDonald,
   proteoglycan hyaluronic acid-binding region antibody 12/21/1-C-6
   developed by B. Caterson, beta1 antibody AIIB2 and alpha5 antibody BIIG2
   developed by C. H. Damsky were obtained from the Developmental Studies
   Hybridoma Bank developed under the auspices of the NICHD and maintained
   by The University of Iowa, Department of Biology, Iowa City, IA 52242.
   We also thank Prof. Janos Voros (Laboratory of Biosensors and
   Bioelectronics, ETH Zurich, Switzerland) for his valuable scientific
   input/use of lab space and Nadiia Kondratiuk for help with
   immunostaining.
CR Abu Al-Soud W, 2005, FEMS IMMUNOL MED MIC, V44, P177, DOI 10.1016/j.femsim.2004.12.004
   Albrecht C, 2011, OSTEOARTHR CARTILAGE, V19, P1219, DOI 10.1016/j.joca.2011.07.004
   ANDERSSON LO, 1976, THROMB RES, V9, P575, DOI 10.1016/0049-3848(76)90105-5
   Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   Becerra J, 2010, TISSUE ENG PART B-RE, V16, P617, DOI [10.1089/ten.teb.2010.0191, 10.1089/ten.TEB.2010.0191]
   Becher J, 2012, ACS SYM SER, V1107, P315
   Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn025
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465
   Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4
   Campo GM, 2004, LIFE SCI, V74, P1289, DOI 10.1016/j.lfs.2003.08.010
   Chiang HS, 2009, J FORMOS MED ASSOC, V108, P87, DOI 10.1016/S0929-6646(09)60039-5
   Fan LH, 2011, CARBOHYD POLYM, V83, P1797, DOI 10.1016/j.carbpol.2010.10.038
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006
   Giannoni P, 2006, CELLS TISSUES ORGANS, V184, P1, DOI 10.1159/000096946
   Gigout A, 2005, OSTEOARTHR CARTILAGE, V13, P1012, DOI 10.1016/j.joca.2005.06.003
   Grande D A, 1995, Tissue Eng, V1, P345, DOI 10.1089/ten.1995.1.345
   Haddo O, 2004, KNEE, V11, P51, DOI 10.1016/S0968-0160(03)00041-3
   Hauselmann HJ, 1996, AM J PHYSIOL-CELL PH, V271, pC742
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   Huang RH, 2003, CARBOHYD POLYM, V52, P19
   Kasai Y, 2008, KOBUNSHI RONBUNSHU, V65, P295, DOI 10.1295/koron.65.295
   KIEFER MC, 1990, P NATL ACAD SCI USA, V87, P6985, DOI 10.1073/pnas.87.18.6985
   Kim KS, 2003, POLYM-KOREA, V27, P583
   Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243
   Kobo M, 2009, LIFE SCI, V85, P477, DOI [10.1016/j.lfs.2009.08.005, 10.1016/j.lfs.209.08.005]
   Koyano Y, 1996, CONNECT TISSUE RES, V34, P213, DOI 10.3109/03008209609000700
   Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002
   Lim HC, 2012, CLIN ORTHOP RELAT R, V470, P2261, DOI 10.1007/s11999-012-2304-9
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Mhanna RF, 2011, BIOMACROMOLECULES, V12, P609, DOI 10.1021/bm1012772
   Michel BA, 2005, ARTHRITIS RHEUM, V52, P779, DOI 10.1002/art.20867
   MURRAY G, 1947, AM J MED, V3, P468, DOI 10.1016/0002-9343(47)90177-0
   Nuernberger S, 2011, BIOMATERIALS, V32, P1032, DOI 10.1016/j.biomaterials.2010.08.100
   Phillips JA, 2005, EXP CELL RES, V310, P79, DOI 10.1016/j.yexcr.2005.03.039
   Re'em T, 2012, BIOMATERIALS, V33, P751, DOI 10.1016/j.biomaterials.2011.10.007
   Rodgers KD, 2008, DEV DYNAM, V237, P2622, DOI 10.1002/dvdy.21593
   Schiltz J. R., 1973, DIFFERENTIATION, V1, P97
   Strauss EJ, 2011, BULL HOSP JT DIS, V69, P63
   Tallheden T, 2005, ARTHRITIS RES THER, V7, pR560, DOI 10.1186/ar1709
   vanSusante JLC, 1995, ACTA ORTHOP SCAND, V66, P549, DOI 10.3109/17453679509002314
   Vasiliadis HS, 2010, KNEE SURG SPORT TR A, V18, P1645, DOI 10.1007/s00167-010-1050-3
   Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200
   Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655
NR 52
TC 24
Z9 24
U1 1
U2 30
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAY 1
PY 2014
VL 20
IS 9-10
BP 1454
EP 1464
DI 10.1089/ten.tea.2013.0544
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AG8IG
UT WOS:000335661400011
PM 24320935
OA Green Published
DA 2018-10-20
ER

PT J
AU Yang, W
   Lee, S
   Jo, YH
   Lee, KM
   Nemeno, JG
   Nam, BM
   Kim, BY
   Jang, IJ
   Kim, HN
   Takebe, T
   Lee, JI
AF Yang, W.
   Lee, S.
   Jo, Y. H.
   Lee, K. M.
   Nemeno, J. G.
   Nam, B. M.
   Kim, B. Y.
   Jang, I. J.
   Kim, H. N.
   Takebe, T.
   Lee, J. I.
TI Effects of Natural Cartilaginous Extracellular Matrix on Chondrogenic
   Potential for Cartilage Cell Transplantation
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article; Proceedings Paper
CT 13th Congress of the Asian-Society-of-Transplantation
CY SEP 02-06, 2013
CL Kyoto, JAPAN
SP Asian Soc Transplantat
ID SCAFFOLD; CULTURE; DIFFERENTIATION; REGENERATION
AB Autologous chondrocyte transplantation (ACT) has been established to contribute cartilage regeneration over the past years; however, many obstacles need to be overcome. Recently, newer ACT technique involves cotransplantation of chondrocytes and biomaterial. Although various proposed intelligent biomaterials exist, many of them remain insufficient and controversial. In this study, we aimed to examine the effects of natural extracellular matrix (ECM) to the proliferation rate and differentiation on the chondrocytes. We first derived a natural ECM sheet from 10-mu m-thick frozen sections of porcine knee cartilages. We then cultured the chondrocytes derived from a rabbit's knee on a dish precoated with the natural ECM. Then we assessed differentiation and chondrogenic potential of the cells compared with those grown in untreated culture dishes. We characterized the gene expression of chondrogenic markers, such as collagen type II, SOX-9, and aggrecan, as well as the level of ECM protein with the use of reverse-transcription polymerase chain reaction analysis. The cells cultured with the ECM sheet showed highest chondrogenic potential and differentiation. Therefore, we can induce good chondrogenesis by with the use of a natural ECM sheet on the culture dish. The readily available and easy-to-handle thin ECM sheets create an environment that promotes efficient cartilage regeneration. Our data suggest that this natural ECM scaffold improved the chondrogenic differentiation of the cells in vitro by providing a favorable microenvironment.
C1 [Yang, W.; Lee, S.; Jo, Y. H.; Lee, K. M.; Nemeno, J. G.; Nam, B. M.; Kim, B. Y.; Jang, I. J.; Kim, H. N.; Lee, J. I.] Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Regenerat Med Lab,Ctr Stem Cell Res, Seoul 143701, South Korea.
   [Takebe, T.] Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Yokohama, Kanagawa 232, Japan.
   [Takebe, T.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan.
RP Lee, JI (reprint author), Konkuk Univ, 120 Neungdong Ro Hwayang Dong, Seoul 143701, South Korea.
EM jeongik@konkuk.ac.kr
RI Lee, Jeong Ik/D-8312-2011
OI Lee, Jeong Ik/0000-0003-2740-2432
CR Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Balanescu A, 2002, J CELL MOL MED, V6, P415, DOI 10.1111/j.1582-4934.2002.tb00520.x
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   CHESTERMAN P J, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P184
   Eyre DR, 2002, BIOCHEM SOC T, V30, P894, DOI 10.1042/bst0300894
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Jin CZ, 2007, ARTIF ORGANS, V31, P183, DOI 10.1111/j.1525-1594.2007.00363.x
   Jin CZ, 2010, J BIOMED MATER RES A, V92A, P1567, DOI 10.1002/jbm.a.32419
   LANCE EM, 1970, J BONE JOINT SURG AM, VA 52, P145, DOI 10.2106/00004623-197052010-00014
   Lee HJ, ARTIF ORGANS, V30, P707
   Lubke C, 2005, OSTEOARTHR CARTILAGE, V13, P478, DOI 10.1016/j.joca.2004.01.009
   Melrose J, 2005, HISTOCHEM CELL BIOL, V123, P561, DOI 10.1007/s00418-005-0789-y
   O'Driscoll SW, 1999, CLIN ORTHOP RELAT R, pS186, DOI 10.1097/00003086-199910001-00020
   Robert H, 2007, REV CHIR ORTHOP, V93, P701, DOI 10.1016/S0035-1040(07)73255-5
   Rowland CR, 2013, BIOMATERIALS, V34, P5802, DOI 10.1016/j.biomaterials.2013.04.027
   Takezawa T, 2002, FASEB J, V16, P1847, DOI 10.1096/fj.00-0405fje
NR 16
TC 7
Z9 7
U1 1
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
EI 1873-2623
J9 TRANSPL P
JI Transplant. Proc.
PD MAY
PY 2014
VL 46
IS 4
BP 1247
EP 1250
DI 10.1016/j.transproceed.2013.11.082
PG 4
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA AH8VE
UT WOS:000336415500059
PM 24815172
DA 2018-10-20
ER

PT J
AU Salamanca, E
   Lin, HK
   Feng, SW
   Huang, HM
   Teng, NC
   Chang, WJ
AF Salamanca, Eisner
   Lin, Hsi-Kuei
   Feng, Sheng-Wei
   Huang, Haw-Ming
   Teng, Nai-Chia
   Chang, Wei-Jen
TI Histological evaluation of socket preservation with different bone
   grafting materials
SO JOURNAL OF POLYMER ENGINEERING
LA English
DT Article
DE bone substitute; HA/beta-TCP; socket preservation
ID TOOTH EXTRACTION; BIO-OSS(R); PHOSPHATE; DEFECTS; RIDGE; REGENERATION;
   DOGS
AB The aim of this study was to compare different bone grafting materials and their contribution to socket preservation. In six beagle dogs, bilateral mandibular second, third, and fourth premolars were hemisectioned and extracted. The following four treatment modalities were randomly allocated: (1) empty control site, (2) collagen plug, (3) Bio Oss-collagen, (4) HA/beta-TCP-collagen. After 2 and 4 weeks, the animals were sacrificed, and decalcified sections were obtained for histological analysis. New bone formation was homogeneous, progressive, and centripetal in all materials. Remodeling as well as the calcification of the newly formed bone was observed. In addition, well-connected trabeculae surrounding the degraded materials were observed. Nearly mature bone, which demonstrated less cellular, more mineralized, and structurally more organized into lamellar bone was noted in HA/beta-TCP-collagen composite. In this study, Bio Oss-collagen and HA/beta-TCP-collagen produced a newly biomimetic composite biomaterial and could prove to be a superior bone substitute material, both structurally and functionally, which could be used in the repair of bone defects collagen composite.
C1 [Salamanca, Eisner; Lin, Hsi-Kuei; Feng, Sheng-Wei; Teng, Nai-Chia; Chang, Wei-Jen] Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei, Taiwan.
   [Chang, Wei-Jen] Taipei Med Univ, Shuang Ho Hosp, Dept Dent, Taipei, Taiwan.
   [Lin, Hsi-Kuei] Taipei Med Univ, Shuang Ho Hosp, Dept Dent, Taipei, Taiwan.
   [Huang, Haw-Ming] Taipei Med Univ, Coll Oral Med, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan.
   [Teng, Nai-Chia] Taipei Med Univ Hosp, Dept Dent, Taipei, Taiwan.
RP Chang, WJ (reprint author), Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei, Taiwan.
EM cweijen1@tmu.edu.tw
CR Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2001, J CLIN PERIODONTOL, V28, P73, DOI 10.1034/j.1600-051x.2001.280111.x
   Cardaropoli G, 2005, J CLIN PERIODONTOL, V32, P435, DOI 10.1111/j.1600-051X.2005.00692.x
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Fickl S, 2009, J CLIN PERIODONTOL, V36, P898, DOI 10.1111/j.1600-051X.2009.01463.x
   John A, 2003, J BIOMATER APPL, V18, P63, DOI 10.1177/088532803032826
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Lai C-H, 2012, J PERIODONTOL, V84, P950
   Morjaria KR, 2012, CLIN IMPLANT DENT R, DOI [10.1111/j.1708-8208.2012.00450, DOI 10.1111/J.1708-8208.2012.00450]
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Oortgiesen DAW, 2012, J CLIN PERIODONTOL, V39, P546, DOI 10.1111/j.1600-051X.2012.01877.x
   Ramseier CA, 2012, PERIODONTOL 2000, V59, P185, DOI 10.1111/j.1600-0757.2011.00432.x
   Torres J, 2008, CLIN IMPLANT DENT R, V10, P106, DOI 10.1111/j.1708-8208.2007.00068.x
   Wang RE, 2012, CLIN ORAL IMPLAN RES, V23, P147, DOI 10.1111/j.1600-0501.2012.02560.x
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
NR 15
TC 1
Z9 1
U1 1
U2 15
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-6447
EI 2191-0340
J9 J POLYM ENG
JI J. Polym. Eng.
PD MAY
PY 2014
VL 34
IS 3
SI SI
BP 225
EP 230
DI 10.1515/polyeng-2013-0212
PG 6
WC Polymer Science
SC Polymer Science
GA AH1TP
UT WOS:000335904300005
DA 2018-10-20
ER

PT J
AU Zhang, X
   Yang, YH
   Yao, JR
   Shao, ZZ
   Chen, X
AF Zhang, Xia
   Yang, Yuhong
   Yao, Jinrong
   Shao, Zhengzhong
   Chen, Xin
TI Strong Collagen Hydrogels by Oxidized Dextran Modification
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Proteins; Polysaccharides; Hydrogels; Mechanical properties;
   Biocompatibility
ID CROSS-LINKED COLLAGEN; CHITOSAN HYDROGELS; MECHANICAL-PROPERTIES;
   ULTRAVIOLET-A; IN-VITRO; TISSUE; LINKING; SCAFFOLDS; BIOMATERIALS;
   RIBOFLAVIN
AB Collagen hydrogel has been regarded as an excellent biomaterial because it is an abundant and sustainable resource and has good biocompatibility and controllable cell-based biodegradability. However, the poor mechanical properties of. collagen hydrogel are the main disadvantage preventing it from having wide applications. In this communication, we use aldehyde-functionalized dextran, which is prepared from the oxidation of another natural polymer dextran, as a macromolecular cross-linker to enhance the strength of the collagen hydrogel. The resulting collagen/aldehyde-functionalized dextran (Col/DAD) hydrogels are much stronger and show better thermostability than the pristine collagen hydrogel, as expected. The maximum compressive strength of the Col/DAD hydrogel is 32.5 +/- 1.6 kPa, which is about 20 times more than that of the pristine collagen hydrogel. We also prove that our method maintains the good biocompatibility of the collagen hydrogel and does not bring the cytotoxicity often observed from conventional chemical cross-linking in the product. Therefore, the strong collagen hydrogel made by oxidized dextran modification may have a great potential in tissue engineering and other biomedical fields.
C1 [Zhang, Xia; Yao, Jinrong; Shao, Zhengzhong; Chen, Xin] Fudan Univ, Adv Mat Lab, Dept Macromol Sci, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
   [Yang, Yuhong] Fudan Univ, Res Ctr Anal & Measurement, Shanghai 200433, Peoples R China.
RP Chen, X (reprint author), Fudan Univ, Adv Mat Lab, Dept Macromol Sci, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
EM chenx@fudan.edu.cn
RI Chen, Xin/F-6802-2015
OI Chen, Xin/0000-0001-7706-4166
FU National Natural Science Foundation of China [21274028, 21034003];
   National High Technology Research and Development Program of China (863
   Program) [2012AA030309]; Specialized Research Fund for the Doctoral
   Program of Higher Education, MOE of China [20110071110008]
FX This work is supported by the National Natural Science Foundation of
   China (No. 21274028, 21034003), National High Technology Research and
   Development Program of China (863 Program) (No. 2012AA030309), and
   Specialized Research Fund for the Doctoral Program of Higher Education,
   MOE of China (No. 20110071110008). The authors thank Miss Han Cao, Miss
   Suhang Wang, and Mr. Shengjie Ling for their help during the revision of
   the manuscript.
CR Asran AS, 2010, POLYMER, V51, P868, DOI 10.1016/j.polymer.2009.12.046
   Boccafoschi F, 2005, BIOMATERIALS, V26, P7410, DOI 10.1016/j.biomaterials.2005.05.052
   Bouhadir KH, 1999, POLYMER, V40, P3575, DOI 10.1016/S0032-3861(98)00550-3
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   Dai WD, 2010, BIOMATERIALS, V31, P2141, DOI 10.1016/j.biomaterials.2009.11.070
   Drexler JW, 2011, TISSUE ENG PART C-ME, V17, P9, DOI [10.1089/ten.tec.2009.0754, 10.1089/ten.TEC.2009.0754]
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hafezi F, 2007, J CATARACT REFR SURG, V33, P2035, DOI 10.1016/j.jcrs.2007.07.028
   Hahn MS, 2006, BIOMATERIALS, V27, P1104, DOI 10.1016/j.biomaterials.2005.07.022
   He LR, 2011, INT J BIOL MACROMOL, V48, P354, DOI 10.1016/j.ijbiomac.2010.12.012
   Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010
   Hoyer B, 2012, BIOMACROMOLECULES, V13, P1059, DOI 10.1021/bm201776r
   Jayawarna V, 2009, ACTA BIOMATER, V5, P934, DOI 10.1016/j.actbio.2009.01.006
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lin YH, 2005, BIOMATERIALS, V26, P2105, DOI 10.1016/j.biomaterials.2004.06.011
   Lu JT, 2007, BIOMATERIALS, V28, P1486, DOI 10.1016/j.biomaterials.2006.11.023
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma L, 2013, POLYM CHEM-UK, V4, P5425, DOI 10.1039/c3py00557g
   Madhavan K, 2010, ACTA BIOMATER, V6, P1413, DOI 10.1016/j.actbio.2009.09.028
   Maeda H, 1999, LANGMUIR, V15, P8505, DOI 10.1021/la981738l
   Maia J, 2005, POLYMER, V46, P9604, DOI 10.1016/j.polymer.2005.07.089
   Maia J, 2011, POLYMER, V52, P258, DOI 10.1016/j.polymer.2010.11.058
   Mu CD, 2007, BIOPOLYMERS, V86, P282, DOI 10.1002/bip.20742
   Mu CD, 2010, MACROMOL MATER ENG, V295, P100, DOI 10.1002/mame.200900292
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039
   Rousseau CF, 2002, BIOMATERIALS, V23, P1503, DOI 10.1016/S0142-9612(01)00276-9
   Saito H, 2008, J MATER SCI-MATER M, V19, P1297, DOI 10.1007/s10856-007-3239-7
   Schoof H, 2001, J BIOMED MATER RES, V58, P352, DOI 10.1002/jbm.1028
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Wang LM, 2010, BIOMATERIALS, V31, P3976, DOI 10.1016/j.biomaterials.2010.01.131
   Weng L, 2008, BIOMATERIALS, V29, P3905, DOI 10.1016/j.biomaterials.2008.06.025
   Wu XM, 2007, J BIOMED MATER RES A, V81A, P59, DOI 10.1002/jbm.a.31003
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zhang SA, 2011, CARBON, V49, P4040, DOI 10.1016/j.carbon.2011.05.056
   Zheng L, 2013, IRAN POLYM J, V22, P833, DOI 10.1007/s13726-013-0182-y
NR 44
TC 27
Z9 28
U1 9
U2 89
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD MAY
PY 2014
VL 2
IS 5
BP 1318
EP 1324
DI 10.1021/sc500154t
PG 7
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA AG6SB
UT WOS:000335547600031
DA 2018-10-20
ER

PT J
AU Wittenburg, G
   Flade, V
   Garbe, AI
   Lauer, G
   Labudde, D
AF Wittenburg, Gretel
   Flade, Viktoria
   Garbe, Annette I.
   Lauer, Guenter
   Labudde, Dirk
TI Scaffold preferences of mesenchymal stromal cells and adipose-derived
   stem cells from green fluorescent protein transgenic mice influence the
   tissue engineering of bone
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Article
DE NanoBone (R); BONITmatrix (R); Mesenchymal stromal cells;
   Adipose-derived stem cells; Osteoblast-like cells; Bone tissue
   engineering; Green fluorescent protein; Hydroxyapatite
ID MARROW; MOUSE; DIFFERENTIATION; HYDROXYAPATITE; OSTEOGENESIS
AB We have analysed the growth and differentiation of mesenchymal stromal cells (MSC) from bone marrow, and of adipose derived stem cells (AS C) from murine abdominal fat tissue, of green fluorescent protein (GFP) transgenic animals grown directly on two types of hydroxyapatite ceramic bone substitutes. BONITmatrix (R) and NanoBone (R) have specific mechanical and physiochemical properties such as porosity and an inner surface that influence cellular growth. Both MSC and ASC were separately seeded on 200 mg of each biomaterial and cultured for 3 weeks under osteogenic differentiation conditions. The degree of mineralisation was assessed by alizarin red dye and the specific alkaline phosphatase activity of the differentiated cells. The morphology of the cells was examined by scanning electron microscopy and confocal microscopy. The osteoblastic phenotype of the cells was confirmed by analysing the expression of bone-specific genes (Runx2, osteocalcin, osteopontin, and osteonectin) by semiquantitative reverse transcriptase polymerase chain reaction (PCR).
   Comparison of BONITmatrix (R) and NanoBone (R) showed cell type-specific preferences in terms of osteogenic differentiation. MSC-derived osteoblast-like cells spread optimally on the surface of NanoBone (R) but not BONITmatrix (R) granules. In contrast BONITmatrix (R) granules conditioned the growth of osteoblast-like cells derived from ASC. The osteoblastic phenotype of the cultured cells on all matrices was confirmed by specific gene expression.
   Our results show that the in vitro growth and osteogenic differentiation of murine MSC or ASC of GFP transgenic mice are distinctly influenced by the ceramic substratum. While NanoBone (R) granules support the proliferation and differentiation of murine MSC isolated from bone marrow, the growth of murine ASC is supported by BONITmatrix (R) granules. NanoBone (R) is therefore recommended for use as scaffold in tissue engineering that requires MSC, whereas ASC can be combined with BONITmatrix (R) for in vitro bone engineering. (C) 2014 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Wittenburg, Gretel; Flade, Viktoria; Lauer, Guenter] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Clin Oral & Maxillofacial Surg, D-01307 Dresden, Germany.
   [Garbe, Annette I.] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Physiol Chem, D-01307 Dresden, Germany.
   [Wittenburg, Gretel; Labudde, Dirk] Univ Appl Sci Mittweida, Dept Bioinformat, D-09648 Mittweida, Germany.
   [Wittenburg, Gretel; Lauer, Guenter] Ctr Translat Bone Joint & Soft Tissue Res, D-01307 Dresden, Germany.
RP Wittenburg, G (reprint author), Univ Hosp Carl Gustav Carus, Clin Oral & Maxillofacial Surg, Tissue Engn Lab, Fetscherstr 74, D-01307 Dresden, Germany.
EM gretel.wittenburg@uniklinikum-dresden.de
RI Garbe, Annette/A-4824-2014
FU DFG excellence cluster Center of Regenerative Therapies Dresden (CRTD);
   Free State of Saxony, Germany
FX The authors thank Diana Ringer for technical assistance, Carola Petto
   for help with the statistical analysis, and Gert Richter for help with
   the scanning electron microscopy. A Seed Grant of the DFG excellence
   cluster Center of Regenerative Therapies Dresden (CRTD) and a re-entry
   scholarship of the Free State of Saxony, Germany financially supported
   this study.
CR Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006
   Dong J, 2001, J BIOMED MATER RES, V57, P208, DOI 10.1002/1097-4636(200111)57:2<208::AID-JBM1160>3.0.CO;2-N
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Gerber T, 2006, EUR J TRAUMA, P132
   Gerike W., 2006, Folia Morphologica, V65, P54
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Hao W, 2007, J US CHINA MED SCI, V4, P19
   Henkel KO, 2005, J CRANIO MAXILL SURG, V33, P45, DOI 10.1016/j.jcms.2004.08.005
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Kunert-Keil C, 2009, J PHYSIOL PHARMACOL, V60, P57
   Lakshmipathy U, 2009, EMERGING TECHNOLOGY, P439
   Phinney DG, 1999, J CELL BIOCHEM, V72, P570
   Ramos TV, 2009, J TISSUE ENG REGEN M, V3, P430, DOI 10.1002/term.177
   Reigstad O, 2007, J BIOMED MATER RES B, V83B, P9, DOI 10.1002/jbm.b.30762
   Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132
   Yamamoto N, 2007, J DERMATOL SCI, V48, P43, DOI 10.1016/j.jdermsci.2007.05.015
NR 17
TC 5
Z9 6
U1 0
U2 13
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
EI 1532-1940
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD MAY
PY 2014
VL 52
IS 5
BP 409
EP 414
DI 10.1016/j.bjoms.2014.02.023
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA AG6EX
UT WOS:000335512700006
PM 24685477
OA Other Gold
DA 2018-10-20
ER

PT J
AU Stellwagen, SD
   Opell, BD
   Short, KG
AF Stellwagen, Sarah D.
   Opell, Brent D.
   Short, Kelly G.
TI Temperature mediates the effect of humidity on the viscoelasticity of
   glycoprotein glue within the droplets of an orb-weaving spider's prey
   capture threads
SO JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE Argiope aurantia; Biomaterial; Glycoprotein; Hygroscopic; Viscoelastic
ID WEBS; EVOLUTION; ADHESION; SPUN; EXTENSIBILITY; PERFORMANCE; BEHAVIOR;
   SILK
AB Sticky viscous prey capture threads retain insects that strike araneoid orb-webs. The threads' two axial fibers support a series of glue droplets, each featuring a core of adhesive viscoelastic glycoprotein covered by an aqueous solution. After sticking, the glue extends, summing the adhesion of multiple droplets, and dissipates some of the energy of a struggling prey. As a day progresses, threads experience a drop in humidity and an increase in temperature, environmental variables that have the potential to alter thread and web function. We hypothesize that thread droplets respond to these opposing environmental changes in a manner that stabilizes their performance, and test this by examining threads spun by Argiope aurantia, a species that occupies exposed, weedy habitats. We confirmed that decreased humidity increases glycoprotein viscosity and found that increased temperature had the opposite effect. To evaluate the combined effect of temperature and humidity on a droplet's ability to transfer adhesive force and dissipate energy, we extended a droplet and measured both the deflection of the axial line supporting the droplet and the duration of its tensive load. The cumulative product of these two indices, which reflects the energy required to extend a droplet, was greatest under afternoon (hot and dry) conditions, less under morning (cool and humid) conditions, and least under hot and humid afternoon conditions. Although the opposing effects of temperature and humidity tend to stabilize glycoprotein performance, A. aurantia thread droplets appear to function optimally during the afternoon, equipping this species to capture large orthopterans, which are most active at this time.
C1 [Stellwagen, Sarah D.; Opell, Brent D.; Short, Kelly G.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.
RP Stellwagen, SD (reprint author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.
EM sstellw@vt.edu
FU State Council for Higher Education for Virginia
FX Funds from the State Council for Higher Education for Virginia provided
   the digital camera used in this study.
CR Agnarsson I, 2009, J ZOOL, V278, P134, DOI 10.1111/j.1469-7998.2009.00558.x
   Apstein C. H., 1889, ARCH NATURGESCH, V1889, P29
   Betz O, 2004, ARTHROPOD STRUCT DEV, V33, P3, DOI 10.1016/j.asd.2003.10.002
   Blackledge TA, 2007, BIOLOGY LETT, V3, P456, DOI 10.1098/rsb1.2007.0218
   Blackledge TA, 2006, ETHOLOGY, V112, P1194, DOI 10.1111/j.1439-0310.2006.01277.x
   Boys C. V., 1889, NATURE, V40, P247
   Cambillau C., 1995, GLYCOPROTEINS, P59
   Choresh O, 2009, BIOMACROMOLECULES, V10, P2852, DOI 10.1021/bm900681w
   EDMONDS DT, 1992, P ROY SOC B-BIOL SCI, V248, P145, DOI 10.1098/rspb.1992.0055
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Harmer AMT, 2011, J R SOC INTERFACE, V8, P457, DOI 10.1098/rsif.2010.0454
   HARWOOD RH, 1974, AM MIDL NAT, V91, P130, DOI 10.2307/2424516
   Kappner I, 2000, MAR ECOL PROG SER, V204, P309, DOI 10.3354/meps204309
   Kelly SP, 2011, ZOOLOGY, V114, P233, DOI 10.1016/j.zool.2011.02.001
   Opell BD, 2008, J EXP BIOL, V211, P2243, DOI 10.1242/jeb.016147
   Opell BD, 2007, J EXP BIOL, V210, P2352, DOI 10.1242/jeb.004952
   Opell BD, 2007, J EXP BIOL, V210, P553, DOI 10.1242/jeb.02682
   Opell BD, 2013, J EXP BIOL, V216, P3023, DOI 10.1242/jeb.084822
   Opell BD, 2011, J EXP BIOL, V214, P2988, DOI 10.1242/jeb.055996
   Opell BD, 2011, J EXP ZOOL PART A, V315A, P376, DOI 10.1002/jez.684
   Opell BD, 2009, J EXP BIOL, V212, P3026, DOI 10.1242/jeb.030064
   Plateau J. A. F., 1873, STATIQUE EXPT THEORI
   Rayleigh J. W. S., 1892, SCI PAPERS, V3, P585
   REED C F, 1969, Developmental Psychobiology, V2, P120, DOI 10.1002/dev.420020212
   Rhodes J. M., 1993, GLYCOPROTEIN ANAL BI, P247
   Sahni V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00041
   Sahni V, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1019
   SEKIGUCHI KOICHI, 1952, ANNOT ZOOL JAPONENSES, V25, P394
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   Sensenig AT, 2013, J EXP BIOL, V216, P3388, DOI 10.1242/jeb.085571
   Sensenig AT, 2012, J R SOC INTERFACE, V9, P1880, DOI 10.1098/rsif.2011.0851
   Tillinghast E. K., 1992, MRS P, V292, P9
   Warburton C., 1890, Q J MICROSC SCI, V31, P29
NR 33
TC 18
Z9 18
U1 0
U2 15
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0022-0949
EI 1477-9145
J9 J EXP BIOL
JI J. Exp. Biol.
PD MAY
PY 2014
VL 217
IS 9
BP 1563
EP 1569
DI 10.1242/jeb.097816
PG 7
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA AG7FK
UT WOS:000335583500026
PM 24501134
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Mewhort, HEM
   Turnbull, JD
   Meijndert, C
   Ngu, JMC
   Fedak, PWM
AF Mewhort, Holly E. M.
   Turnbull, Jeannine D.
   Meijndert, Christopher
   Ngu, Janet M. C.
   Fedak, Paul W. M.
TI Epicardial infarct repair with basic fibroblast growth factor-enhanced
   CorMatrix-ECM biomaterial attenuates postischemic cardiac remodeling
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; EXTRACELLULAR-MATRIX SCAFFOLD; MATRICELLULAR
   PROTEINS; PARACRINE MECHANISM; HEART-FAILURE; TRANSPLANTATION; CELLS;
   MODEL; DIFFERENTIATION; DISEASE
AB Objectives: Dysregulation of extracellular matrix (ECM) following myocardial infarction is a key contributor to myocardial fibrosis, chamber dilation, and progression to heart failure. Basic fibroblast growth factor is a potent inhibitor of fibrosis. We propose a novel surgical procedure leveraging a commercially available ECM biomaterial for the treatment of ischemic heart failure.
   Methods: Epicardial infarct repair using CorMatrix-ECM biomaterial patch (CorMatrix Cardiovascular Inc, Roswell, Ga) was compared with sham in a rat myocardial infarction model. Key indices of ischemic remodeling, including inflammation, fibrosis, and myocardial performance were evaluated 16 weeks post-treatment.
   Results: Histology and immunohistochemistry demonstrated comprehensive integration of CorMatrix-ECM biomaterial patch without evidence of immune reaction and an increase in basic fibroblast growth factor expression in treated animals. Functional analysis by serial echocardiography of normal (n = 13), sham (n = 15), nonenhanced CorMatrix-ECM patch (n = 18), and basic fibroblast growth factor-enhanced CorMatrix-ECM patch (n = 10) animals revealed an improvement in ejection fraction in basic fibroblast growth factor-enhanced CorMatrix-ECM patch animals compared with shams (55.3% +/- 8.0% vs 35.1% +/- 7.6%; P<.001).Prevention of left ventricle remodeling was also confirmed by pressure volume loop analysis, which demonstrated reduced left ventricular end diastolic volumes in basic fibroblast growth factor-enhanced CorMatrix-ECM patch animals (n = 5) compared with shams (n = 6) (208.0 +/- 59.3 mu L vs 363. 1 +/- 108.7 mu L; P<.01) and improved left ventricle contractility in nonenhanced CorMatrix-ECM patch (n = 7) and basic fibroblast growth factor-enhanced CorMatrix-ECM patch animals compared with shams (0.709 +/- 0.306 and 0.609 +/- 0.160 vs 0.437 +/- 0.218; P<.05).
   Conclusions: Epicardial infarct repair with basic growth factor-enhanced CorMatrix-ECM biomaterial patch attenuates myocardial remodeling and improves cardiac performance after subacute myocardial infarction in a rat coronary ligation model. These observations establish proof-of-concept for this novel surgical approach.
C1 [Mewhort, Holly E. M.; Turnbull, Jeannine D.; Meijndert, Christopher; Ngu, Janet M. C.; Fedak, Paul W. M.] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Cardiac Sci, Campbell Cardiovasc Translat Res Program,Div Card, Calgary, AB, Canada.
RP Fedak, PWM (reprint author), C880,1403 29th St NW, Calgary, AB T2N 2T9, Canada.
EM paul.fedak@gmail.com
OI Fedak, Paul/0000-0003-0658-9381
FU Heart and Stroke Foundation of Canada; Alberta Innovates [201201075]
FX Support for this work was provided by the Heart and Stroke Foundation of
   Canada.
CR Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Beattie AJ, 2009, TISSUE ENG PT A, V15, P1119, DOI 10.1089/ten.tea.2008.0162
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802
   Canadian Council on Animal Care, GUID CAR US EXP AN
   Costanzo MR, 2012, J CARD FAIL, V18, P446, DOI 10.1016/j.cardfail.2012.04.004
   Daly KA, 2009, TISSUE ENG PT A, V15, P3877, DOI 10.1089/ten.TEA.2009.0089
   Fazel S, 2005, J THORAC CARDIOV SUR, V130, P1310, DOI 10.1016/j.jtcvs.2005.07.012
   Fedak PWM, 2012, CIRC-HEART FAIL, V5, P349, DOI 10.1161/CIRCHEARTFAILURE.111.965889
   Fedak PWM, 2010, CARDIOVASC RES, V87, P8, DOI 10.1093/cvr/cvq124
   Fedak PWM, 2008, SEMIN THORAC CARDIOV, V20, P87, DOI 10.1053/j.semtcvs.2008.04.001
   Fedak PWM, 2005, J THORAC CARDIOV SUR, V130, P1430, DOI 10.1016/j.jtcvs.2005.05.055
   Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P49, DOI 10.1016/j.carpath.2005.01.005
   Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011
   Gilbert TW, 2008, J SURG RES, V147, P61, DOI 10.1016/j.jss.2007.04.035
   Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f
   Graham HK, 2008, ACTA PHYSIOL, V194, P3, DOI 10.1111/j.1748-1716.2008.01881.x
   Hodde J P, 2005, J Wound Care, V14, P23
   Kang K, 2012, J AM COLL CARDIOL, V60, P2237, DOI 10.1016/j.jacc.2012.08.985
   Kempf T, 2012, J MOL MED, V90, P361, DOI 10.1007/s00109-011-0847-y
   Khouw IMSL, 1999, BIOMATERIALS, V20, P1815, DOI 10.1016/S0142-9612(99)00077-0
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609
   National Academy of Sciences, 1996, GUIDE CARE USE LAB A
   Ohno N, 2003, J THORAC CARDIOV SUR, V126, P1537, DOI 10.1016/S0022-5223(03)01021-3
   Oliveira VC, 2010, HISTOL HISTOPATHOL, V25, P1017, DOI 10.14670/HH-25.1017
   Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138
   Quarti A, 2011, INTERACT CARDIOV TH, V13, P569, DOI 10.1510/icvts.2011.280016
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030
   Suma H, 2012, SEMIN THORAC CARDIOV, V24, P294, DOI 10.1053/j.semtcvs.2013.01.002
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
NR 37
TC 17
Z9 17
U1 0
U2 5
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
EI 1097-685X
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD MAY
PY 2014
VL 147
IS 5
BP 1650
EP 1659
DI 10.1016/j.jtcvs.2013.08.005
PG 10
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA AG5EX
UT WOS:000335443300037
PM 24075463
OA Bronze
DA 2018-10-20
ER

PT J
AU Ivanovic, A
   Nikou, G
   Miron, RJ
   Nikolidakis, D
   Sculean, A
   Dent, M
AF Ivanovic, Aleksandar
   Nikou, George
   Miron, Richard J.
   Nikolidakis, Dimitris
   Sculean, Anton
   Dent, Med
TI Which biomaterials may promote periodontal regeneration in intrabony
   periodontal defects? A systematic review of preclinical studies
SO QUINTESSENCE INTERNATIONAL
LA English
DT Review
DE animal studies; histology; intrabony periodontal defects; preclinical
   studies; systematic review
ID ENAMEL-MATRIX-PROTEINS; GUIDED TISSUE REGENERATION; HEALING/REGENERATION
   FOLLOWING IMPLANTATION; HUMAN GROWTH/DIFFERENTIATION FACTOR-5;
   BOVINE-DERIVED XENOGRAFTS; EXPERIMENTAL BONE DEFECTS;
   FIBROBLAST-GROWTH-FACTOR; ILIAC CANCELLOUS BONE; FREEZE-DRIED BONE;
   BEAGLE DOGS
AB Objective: To systematically analyze the regenerative effect of the available biomaterials either alone or in various combinations for the treatment of periodontal intrabony defects as evaluated in preclinical histologic studies.
   Data Sources: A protocol covered all aspects of the systematic review methodology. A literature search was performed in Medline, including hand searching. Combinations of searching terms and several criteria were applied for study identification, selection, and inclusion. The preliminary outcome variable was periodontal regeneration after reconstructive surgery obtained with the various regenerative materials, as demonstrated through histologic/histomorphometric analysis. New periodontal ligament, new cementum, and new bone formation as a linear measurement in mm or as a percentage of the instrumented root length were recorded. Data were extracted based on the general characteristics, study characteristics, methodologic characteristics, and conclusions. Study selection was limited to preclinical studies involving histologic analysis, evaluating the use of potential regenerative materials (ie, barrier membranes, grafting materials, or growth factors/proteins) for the treatment of periodontal intrabony defects. Any type of biomaterial alone or in various combinations was considered. All studies reporting histologic outcome measures with a healing period of at least 6 weeks were included. A meta-analysis was not possible due to the heterogeneity of the data.
   Conclusion: Flap surgery in conjunction with most of the evaluated biomaterials used either alone or in various combinations has been shown to promote periodontal regeneration to a greater extent than control therapy (flap surgery without biomaterials). Among the used biomaterials, autografts revealed the most favorable outcomes, whereas the use of most biologic factors showed inferior results compared to flap surgery.
C1 [Ivanovic, Aleksandar; Miron, Richard J.; Sculean, Anton; Dent, Med] Univ Bern, Sch Dent Med, Dept Periodontol, CH-3010 Bern, Switzerland.
   [Nikou, George] Private Periodontal Practice, Tripolis, Greece.
   [Miron, Richard J.] Univ Laval, Quebec City, PQ, Canada.
   [Nikolidakis, Dimitris] Private Periodontal Practice, Iraklion, Greece.
RP Sculean, A (reprint author), Univ Bern, Dept Periodontol, Freiburgstr 7, CH-3010 Bern, Switzerland.
EM anton.sculean@zmk.unibe.ch
CR Artzi Z, 2003, J PERIODONTOL, V74, P1143, DOI 10.1902/jop.2003.74.8.1143
   Artzi Z, 2003, J PERIODONTOL, V74, P1153, DOI 10.1902/jop.2003.74.8.1153
   Artzi Z, 2006, J PERIODONTOL, V77, P1658, DOI 10.1902/jop.2006.060041
   BARNEY VC, 1986, J PERIODONTOL, V57, P764, DOI 10.1902/jop.1986.57.12.764
   BLUMENTHAL N, 1986, J PERIODONTOL, V57, P84, DOI 10.1902/jop.1986.57.2.84
   Blumenthal NM, 2003, J PERIODONTOL, V74, P10, DOI 10.1902/jop.2003.74.1.10
   Blumenthal NM, 2002, J PERIODONTOL, V73, P1494, DOI 10.1902/jop.2002.73.12.1494
   Blumenthal NM, 2000, INT J PERIODONT REST, V20, P61
   Bosshardt DD, 2009, PERIODONTOL 2000, V51, P208, DOI 10.1111/j.1600-0757.2009.00317.x
   CATON J, 1994, J PERIODONTOL, V65, P1143, DOI 10.1902/jop.1994.65.12.1143
   Caton JG, 1993, PERIODONTOL 2000, V1, P9
   Choi SH, 2002, J PERIODONTOL, V73, P63, DOI 10.1902/jop.2002.73.1.63
   Cirelli CC, 2003, AM J ORTHOD DENTOFAC, V123, P666, DOI 10.1016/S0889-5406(03)00154-9
   CLAFFEY N, 1995, J CLIN PERIODONTOL, V22, P690, DOI 10.1111/j.1600-051X.1995.tb00828.x
   Clergeau LP, 1996, J PERIODONTOL, V67, P140, DOI 10.1902/jop.1996.67.2.140
   Cochran DL, 2003, J PERIODONTOL, V74, P1043, DOI 10.1902/jop.2003.74.7.1043
   Cochran DL, 2003, J PERIODONTOL, V74, P1269, DOI 10.1902/jop.2003.74.9.1269
   de Waal H, 1988, Int J Periodontics Restorative Dent, V8, P48
   ELLEGAARD B, 1976, J PERIODONTAL RES, V11, P299, DOI 10.1111/j.1600-0765.1976.tb00084.x
   ELLEGAARD B, 1974, J PERIODONTOL, V45, P368, DOI 10.1902/jop.1974.45.5.2.368
   Felipe MEMC, 2009, J PERIODONTOL, V80, P808, DOI 10.1902/jop.2009.080583
   Fetner A E, 1994, Compendium, V15, P935
   Fujinami K, 2007, BIOMED RES-TOKYO, V28, P107, DOI 10.2220/biomedres.28.107
   Hayashi C, 2006, J PERIODONTOL, V77, P940, DOI 10.1902/jop.2006.050283
   Hurzeler MB, 1997, J PERIODONTOL, V68, P489
   Ishikawa I, 1994, DENT JAPAN, V31, P141
   Kaldahl WB, 1996, J PERIODONTOL, V67, P93, DOI 10.1902/jop.1996.67.2.93
   Kim CK, 1998, J PERIODONTOL, V69, P982, DOI 10.1902/jop.1998.69.9.982
   Kim CK, 1998, INT DENT J, V48, P330, DOI 10.1111/j.1875-595X.1998.tb00725.x
   Kim CS, 2005, J CLIN PERIODONTOL, V32, P583, DOI 10.1111/j.1600-051X.2005.00729.x
   Kim CS, 2004, J PERIODONTOL, V75, P229, DOI 10.1902/jop.2004.75.2.229
   Kim HY, 2002, J PERIODONTOL, V73, P1457, DOI 10.1902/jop.2002.73.12.1457
   Kim IY, 2007, BIOMED MATER, V2, pS106, DOI 10.1088/1748-6041/2/3/S04
   Kim TG, 2009, J CLIN PERIODONTOL, V36, P589, DOI 10.1111/j.1600-051X.2009.01420.x
   Kwon HR, 2010, J CLIN PERIODONTOL, V37, P739, DOI 10.1111/j.1600-051X.2010.01576.x
   Laurell L, 2006, J CLIN PERIODONTOL, V33, P596, DOI 10.1111/j.1600-051X.2006.00951.x
   Lee JS, 2010, J CLIN PERIODONTOL, V37, P382, DOI 10.1111/j.1600-051X.2010.01544.x
   Levin M P, 1974, J Clin Periodontol, V1, P197
   LEVIN MP, 1974, ORAL SURG ORAL MED O, V38, P344, DOI 10.1016/0030-4220(74)90359-4
   Ling L J, 1994, Zhonghua Yi Xue Za Zhi (Taipei), V54, P209
   Matuliene G, 2008, J CLIN PERIODONTOL, V35, P685, DOI 10.1111/j.1600-051X.2008.01245.x
   Min DH, 2005, KEY ENG MAT, V284-286, P851, DOI 10.4028/www.scientific.net/KEM.284-286.851
   Minegishi D, 1988, Int J Periodontics Restorative Dent, V8, P50
   Miron RJ, 2011, J DENT RES, V90, P1428, DOI 10.1177/0022034511422718
   Miron RJ, 2013, CLIN IMPLANT DENT R, V15, P481, DOI 10.1111/j.1708-8208.2012.00440.x
   Moon IS, 1996, J CLIN PERIODONTOL, V23, P945, DOI 10.1111/j.1600-051X.1996.tb00516.x
   Morris MS, 2008, J PERIODONTOL, V79, P1465, DOI [10.1902/jop.2008.070659, 10.1902/jop.2008.070659 ]
   Murakami S, 1999, J PERIODONTAL RES, V34, P425, DOI 10.1111/j.1600-0765.1999.tb02277.x
   Nakanishi S, 2009, J BIOMATER APPL, V24, P89, DOI 10.1177/0885328208094427
   Neamat A, 2009, ARCH ORAL BIOL, V54, P1083, DOI 10.1016/j.archoralbio.2009.09.003
   Needleman IG, 2002, J CLIN PERIODONTOL, V29, P6, DOI 10.1034/j.1600-051X.29.s3.15.x
   Nemcovsky CE, 2006, J PERIODONTOL, V77, P996, DOI 10.1902/jop.2006.050317
   NERY EB, 1990, J PERIODONTOL, V61, P166, DOI 10.1902/jop.1990.61.3.166
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Nunez J, 2010, J PERIODONTOL, V81, P1064, DOI 10.1902/jop.2010.090678
   Ol Y, 2009, DENT MATER J, V28, P162
   Onodera H, 2005, BIOMED RES-TOKYO, V26, P69, DOI 10.2220/biomedres.26.69
   Ozmeric N, 2000, Periodontal Clin Investig, V22, P22
   Papapanou PN, 2000, PERIODONTOL 2000, V22, P8, DOI 10.1034/j.1600-0757.2000.2220102.x
   Park JS, 2003, J CLIN PERIODONTOL, V30, P443, DOI 10.1034/j.1600-051X.2003.10283.x
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   POLSON AM, 1978, J CLIN PERIODONTOL, V5, P13, DOI 10.1111/j.1600-051X.1978.tb01902.x
   Sakata J, 2006, INT J PERIODONT REST, V26, P161
   Schwarz F, 2006, CLIN ORAL INVEST, V10, P29, DOI 10.1007/s00784-005-0019-y
   Sculean A, 1997, J CLIN PERIODONTOL, V24, P932, DOI 10.1111/j.1600-051X.1997.tb01214.x
   Sculean A, 2001, J PERIODONTAL RES, V36, P260, DOI 10.1034/j.1600-0765.2001.036004260.x
   Sculean A, 1998, J PERIODONTAL RES, V33, P453
   Sculean A, 2000, J CLIN PERIODONTOL, V27, P466, DOI 10.1034/j.1600-051x.2000.027007466.x
   Sculean Anton, 2002, Clin Oral Investig, V6, P175
   Sculean A, 2011, CLIN ADV PERIODONTIC, V1, P101, DOI 10.1902/cap.2011.110047
   Shirakata Y, 2007, J PERIODONTOL, V78, P889, DOI 10.1902/jop.2007.060353
   Shirakata Y, 2010, J CLIN PERIODONTOL, V37, P374, DOI 10.1111/j.1600-051X.2010.01539.x
   Song WS, 2005, J PERIODONTOL, V76, P22, DOI 10.1902/jop.2005.76.1.22
   STABHOLZ A, 1977, J PERIODONTOL, V48, P413, DOI 10.1902/jop.1977.48.7.413
   Stavropoulos A, 2010, J CLIN PERIODONTOL, V37, P534, DOI 10.1111/j.1600-051X.2010.01566.x
   Stoecklin-Wasmer C, 2013, J DENT RES, V92, P773, DOI 10.1177/0022034513496428
   Tabata M, 2005, J BIOMED MATER RES B, V75B, P378, DOI 10.1002/jbm.b.30316
   Um YJ, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044113
   Villaça José Henrique, 2005, Braz. Dent. J., V16, P67, DOI 10.1590/S0103-64402005000100012
   Weinberg MA, 1999, J CLIN PERIODONTOL, V26, P335, DOI 10.1034/j.1600-051X.1999.260601.x
   WEST TL, 1985, J PERIODONTOL, V56, P348, DOI 10.1902/jop.1985.56.6.348
   WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208
   Yamada S, 2002, INT J PERIODONT REST, V22, P389
   Yamamoto S, 2007, INT J PERIODONT REST, V27, P471
   Yeo YJ, 2005, J BIOMED MATER RES B, V72B, P86, DOI 10.1002/jbm.b.30121
   Yun JH, 2005, J PERIODONTAL RES, V40, P453, DOI 10.1111/j.1600-0765.2005.00825.x
NR 86
TC 8
Z9 8
U1 2
U2 18
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0033-6572
EI 1936-7163
J9 QUINTESSENCE INT
JI Quintessence Int.
PD MAY
PY 2014
VL 45
IS 5
BP 385
EP 395
DI 10.3290/j.qi.a31538
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AG8AC
UT WOS:000335639000005
PM 24634903
DA 2018-10-20
ER

PT J
AU Wong, ML
   Griffiths, LG
AF Wong, Maelene L.
   Griffiths, Leigh G.
TI Immunogenicity in xenogeneic scaffold generation: Antigen removal vs.
   decellularization
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Antigen removal; Decellularization; Xenogeneic scaffold; Extracellular
   matrix; Tissue engineering
ID 2-DIMENSIONAL GEL-ELECTROPHORESIS; HEART-VALVE TISSUE; ALPHA-GAL
   EPITOPE; IMMUNE-RESPONSE; EXTRACELLULAR-MATRIX; BOVINE PERICARDIUM;
   EXTRACTION TECHNIQUES; BIOPROSTHETIC VALVE; ACELLULAR MATRIX; HOST
   RESPONSE
AB Decades of research have been undertaken towards the goal of tissue engineering using xenogeneic scaffolds. The primary advantages associated with use of xenogeneic tissue-derived scaffolds for in vitro development of replacement tissues and organs stem from the inherent extracellular matrix (ECM) composition and architecture. Native ECM possesses appropriate mechanical properties for physiological function of the biomaterial and signals for cell binding, growth and differentiation. Additionally, xenogeneic tissue is readily available. However, translation of xenogeneic scaffold-derived engineered tissues or organs into clinical therapies requires xenoantigenicity of the material to be adequately addressed prior to implantation. Failure to achieve this goal will result in a graft-specific host immune rejection response, jeopardizing in vivo survival of the resultant scaffold, tissue or organ. This review explores (i) the appropriateness of scaffold acellularity as an outcome measure for assessing reduction of the immunological barriers to the use of xenogeneic scaffolds for tissue engineering applications and (ii) the need for tissue engineers to strive for antigen removal during xenogeneic scaffold generation. Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
C1 [Wong, Maelene L.; Griffiths, Leigh G.] Univ Calif Davis, Dept Vet Med Med & Epidemiol, Davis, CA 95616 USA.
   [Wong, Maelene L.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
RP Griffiths, LG (reprint author), Univ Calif Davis, Dept Vet Med Med & Epidemiol, 1 Shields Ave, Davis, CA 95616 USA.
EM lggriffiths@ucdavis.edu
FU NIH [R01HL115205]; AHA [SDG4980023]; CIRM [TR3-05626]
FX The authors thank Dr. Christopher W. Simmons for illustrations of
   stepwise solubilization-based antigen removal (Fig. 2). We acknowledge
   support from NIH R01HL115205 (M.L.W. and L.G.G.), AHA SDG4980023
   (L.G.G.) and CIRM TR3-05626 (L.G.G.).
CR Affonso da Costa FD, 2005, EUR J CARDIO-THORAC, V27, P572
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bastian F, 2008, BIOMATERIALS, V29, P1824, DOI 10.1016/j.biomaterials.2008.01.005
   Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445
   Bayrak A, 2010, BIOMATERIALS, V31, P3793, DOI 10.1016/j.biomaterials.2010.01.120
   BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985
   Bloch O, 2011, TISSUE ENG PT A, V17, P2399, DOI [10.1089/ten.tea.2011.0046, 10.1089/ten.TEA.2011.0046]
   Boer U, 2011, BIOMATERIALS, V32, P9730, DOI 10.1016/j.biomaterials.2011.09.015
   Brouard S, 1999, HUM IMMUNOL, V60, P455, DOI 10.1016/S0198-8859(99)00020-8
   Cascalho M, 2001, IMMUNITY, V14, P437, DOI 10.1016/S1074-7613(01)00124-8
   Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804
   Chen G, 2005, NAT MED, V11, P1295, DOI 10.1038/nm1330
   Clark EDB, 1998, CURR OPIN BIOTECH, V9, P157
   COHN LH, 1985, J THORAC CARDIOV SUR, V90, P872
   Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   Cooper DKC, 1998, XENOTRANSPLANTATION, V5, P6, DOI 10.1111/j.1399-3089.1998.tb00003.x
   COOPER DKC, 1994, IMMUNOL REV, V141, P31, DOI 10.1111/j.1600-065X.1994.tb00871.x
   Cordwell Stuart J., 2008, V424, P139, DOI 10.1007/978-1-60327-064-9_12
   Cozzi E, 2005, BRIT MED BULL, V75-76, P99, DOI 10.1093/bmb/ldh061
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Daly KA, 2009, TISSUE ENG PT A, V15, P3877, DOI 10.1089/ten.TEA.2009.0089
   Dierselhuis M, 2009, CURR OPIN ORGAN TRAN, V14, P419, DOI 10.1097/MOT.0b013e32832d399c
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   ELLINGSWORTH LR, 1986, J IMMUNOL, V136, P877
   Ezzelarab M, 2005, IMMUNOL CELL BIOL, V83, P396, DOI 10.1111/j.1440-1711.2005.01344.x
   Funamoto S, 2010, BIOMATERIALS, V31, P3590, DOI 10.1016/j.biomaterials.2010.01.073
   Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9
   Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gillies AR, 2011, TISSUE ENG PART C-ME, V17, P383, DOI [10.1089/ten.tec.2010.0438, 10.1089/ten.TEC.2010.0438]
   Goldstein S, 2000, ANN THORAC SURG, V70, P1962, DOI 10.1016/S0003-4975(00)01812-9
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   Griffiths LG, 2008, BIOMATERIALS, V29, P3514, DOI 10.1016/j.biomaterials.2008.05.006
   Griffiths LG, 2008, ELECTROPHORESIS, V29, P4508, DOI 10.1002/elps.200800108
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Hancock WW, 1998, NAT MED, V4, P1392, DOI 10.1038/3982
   HAWKINS JA, 1992, J THORAC CARDIOV SUR, V104, P910
   Hawkins JA, 2003, J THORAC CARDIOV SUR, V126, P247, DOI 10.1016/S0022-5223(03)00116-8
   Human P, 2001, ANN THORAC SURG, V71, pS385, DOI 10.1016/S0003-4975(01)02492-4
   Iop L, 2009, BIOMATERIALS, V30, P4104, DOI 10.1016/j.biomaterials.2009.04.031
   Iwai S, 2007, J ARTIF ORGANS, V10, P29, DOI 10.1007/s10047-006-0360-1
   Juthier F, 2006, J THORAC CARDIOV SUR, V131, P843, DOI 10.1016/j.jtcvs.2005.11.037
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Kasimir MT, 2005, TISSUE ENG, V11, P1274, DOI 10.1089/ten.2005.11.1274
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kneib C, 2012, TISSUE ANTIGENS, V80, P165, DOI 10.1111/j.1399-0039.2012.01885.x
   Koolman J, 2005, ISOLATION ANAL PROTE, P78
   Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171
   MAGILLIGAN DJ, 1985, J THORAC CARDIOV SUR, V89, P499
   Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Mantovani F, 2003, EUR UROL, V44, P600, DOI 10.1016/S0302-2838(03)00212-4
   Masutani H, 2005, CELL DEATH DIFFER, V12, P991, DOI 10.1038/sj.cdd.4401625
   McMorrow IM, 1997, TRANSPLANTATION, V64, P501, DOI 10.1097/00007890-199708150-00021
   Meyer SR, 2006, J BIOMED MATER RES A, V79A, P254, DOI 10.1002/jbm.a.30777
   Molloy MP, 1998, ELECTROPHORESIS, V19, P837, DOI 10.1002/elps.1150190539
   Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI 10.1089/ten.TEA.2009.0602
   Nakayama KH, 2011, TISSUE ENG PT A, V17, P2891, DOI [10.1089/ten.tea.2010.0714, 10.1089/ten.TEA.2010.0714]
   Nam J, 2012, KOREAN J THORAC CARD, V45, P380
   Naso F, 2012, XENOTRANSPLANTATION, V19, P215, DOI 10.1111/j.1399-3089.2012.00714.x
   NOZAKI Y, 1971, J BIOL CHEM, V246, P2211
   NOZAKI Y, 1963, J BIOL CHEM, V238, P4074
   OBRIEN TK, 1984, T AM SOC ART INT ORG, V30, P440
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Park S, 2009, J KOREAN MED SCI, V24, P1126, DOI 10.3346/jkms.2009.24.6.1126
   PEUGH WN, 1986, IMMUNOGENETICS, V23, P30, DOI 10.1007/BF00376519
   Platt J, 2002, CIRCULATION, V106, P1043, DOI 10.1161/01.CIR.0000031064.67525.28
   Pompilio G, 2004, ANN THORAC SURG, V78, P557, DOI 10.1016/j.athoracsur.2004.02.037
   RABILLOUD T, 2002, PROTEIN PROTOCOLS HD, P131
   Ramaswamy S, 2010, BIOMATERIALS, V31, P1114, DOI 10.1016/j.biomaterials.2009.10.019
   Rieder E, 2005, CIRCULATION, V111, P2792, DOI 10.1161/CIRCULATIONAHA.104.473629
   Rieder E, 2006, BIOMATERIALS, V27, P5634, DOI 10.1016/j.biomaterials.2006.06.020
   ROCCHINI AP, 1981, CIRCULATION, V64, P162
   Ross EA, 2012, ORGANOGENESIS, V8, P49, DOI 10.4161/org.20209
   Ruffer A, 2010, EUR J CARDIO-THORAC, V38, P78, DOI 10.1016/j.ejcts.2010.01.044
   Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225
   Sandor M, 2008, TISSUE ENG PT A, V14, P2021, DOI 10.1089/ten.tea.2007.0317
   Sayk F, 2005, ANN THORAC SURG, V79, P1755, DOI 10.1016/j.athoracsur.2003.11.049
   Scalea J, 2012, XENOTRANSPLANTATION, V19, P23, DOI 10.1111/j.1399-3089.2011.00687.x
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Sellaro TL, 2010, TISSUE ENG PT A, V16, P1075, DOI [10.1089/ten.tea.2008.0587, 10.1089/ten.TEA.2008.0587]
   Shaw MM, 2003, PROTEOMICS, V3, P1408, DOI 10.1002/pmic.200300471
   Shinoka T, 1995, ANN THORAC SURG, V60, pS513, DOI 10.1016/0003-4975(95)00733-4
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Smith M, 2007, AM SURGEON, V73, P514
   Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154
   Syedain ZH, 2013, TISSUE ENG PT A, V19, P759, DOI [10.1089/ten.tea.2012.0365, 10.1089/ten.TEA.2012.0365]
   Tedder ME, 2011, TISSUE ENG PT A, V17, P25, DOI [10.1089/ten.tea.2010.0138, 10.1089/ten.TEA.2010.0138]
   Ueyama K, 2002, ARTIF ORGANS, V26, P1059, DOI 10.1046/j.1525-1594.2002.07005_4.x
   Umashankar PR, 2013, J BIOMED MATER RES A, V101, P2202, DOI 10.1002/jbm.a.34535
   Weiss W, 2008, PROTEOMICS SAMPLE PR, P135
   WILLIAMS DB, 1982, J THORAC CARDIOV SUR, V84, P446
   Wong ML, 2013, ACTA BIOMATER, V9, P6492, DOI 10.1016/j.actbio.2012.12.034
   Wong ML, 2011, BIOMATERIALS, V32, P8129, DOI 10.1016/j.biomaterials.2011.07.030
   Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
   Xu H, 2009, TISSUE ENG PT A, V15, P1807, DOI 10.1089/ten.tea.2008.0384
   Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099
   Yeh P, 2010, XENOTRANSPLANTATION, V17, P197, DOI 10.1111/j.1399-3089.2010.00579.x
   Zhou JY, 2010, BIOMATERIALS, V31, P2549, DOI 10.1016/j.biomaterials.2009.11.088
   Zhou P, 2011, LIVER TRANSPLANT, V17, P418, DOI 10.1002/lt.22270
NR 109
TC 60
Z9 61
U1 4
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2014
VL 10
IS 5
BP 1806
EP 1816
DI 10.1016/j.actbio.2014.01.028
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AG0HA
UT WOS:000335095300003
PM 24486910
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Avula, MN
   Rao, AN
   McGill, LD
   Grainger, DW
   Solzbacher, F
AF Avula, M. N.
   Rao, A. N.
   McGill, L. D.
   Grainger, D. W.
   Solzbacher, F.
TI Foreign body response to subcutaneous biomaterial implants in a mast
   cell-deficient Kit(w-sh) murine model
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Host response; Continuous glucose monitoring sensors; Combination
   device; Inflammation; Local drug delivery
ID TYROSINE KINASE INHIBITOR; C-KIT RECEPTOR; IN-VITRO; PLGA MICROSPHERES;
   MEDIATOR RELEASE; GROWTH-FACTOR; MICE; DEXAMETHASONE; DELIVERY; LIGAND
AB Mast cells (MCs)_are recognized for their functional role in wound-healing and allergic and inflammatory responses - host responses that are frequently detrimental to implanted biomaterials if extended beyond acute reactivity. These tissue reactions impact especially on the performance of sensing implants such as continuous glucose monitoring (CGM) devices. Our hypothesis that effective blockade of MC activity around implants could alter the host foreign body response (FBR) and enhance the in vivo lifetime of these implantable devices motivated this study. Stem cell factor and its ligand c-KIT receptor are critically important for MC survival, differentiation and degranulation. Therefore, an MC-deficient sash mouse model was used to assess MC relationships to the in vivo performance of CGM implants. Additionally, local delivery of a tyrosine kinase inhibitor (TKI) that inhibits c-KIT activity was also used to evaluate the role of MCs in modulating the FBR. Model sensor implants comprising polyester fibers coated with a rapidly dissolving polymer coating containing drug-releasing degradable microspheres were implanted subcutaneously in sash mice for various time points, and the FBR was evaluated for chronic inflammation and fibrous capsule formation around the implants. No significant differences were observed in the foreign body capsule formation between control and drug-releasing implant groups in MC-deficient mice. However, fibrous encapsulation was significantly greater around the drug-releasing implants in sash mice compared to drug-releasing implants in wild-type (e.g. MC-competent) mice. These results provide insights into the role of MCs in the FBR, suggesting that MC deficiency provides alternative pathways for host inflammatory responses to implanted biomaterials. (C) 2014 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Avula, M. N.; Grainger, D. W.; Solzbacher, F.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   [Rao, A. N.; Grainger, D. W.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   [McGill, L. D.] Univ Utah, Associated Reg & Univ Pathol Labs, Salt Lake City, UT 84112 USA.
   [Solzbacher, F.] Univ Utah, Dept Elect & Comp Engn, Salt Lake City, UT 84112 USA.
RP Grainger, DW (reprint author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
EM david.grainger@utah.edu
OI Avula, Mahender/0000-0001-5287-8972
FU University of Utah Research Foundation
FX The authors acknowledge support from the University of Utah Research
   Foundation in the form of both SEED and Technology Commercialization
   grants. P. Hogrebe (Utah) is thanked for his support and help in
   technical discussions.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Avula MN, 2013, BIOMATERIALS, V34, P9737, DOI 10.1016/j.biomaterials.2013.08.090
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   COLUMBO M, 1992, J IMMUNOL, V149, P599
   Crivellato E, 2004, HISTOL HISTOPATHOL, V19, P259, DOI 10.14670/HH-19.259
   Daneshian M, 2006, J IMMUNOL METHODS, V313, P169, DOI 10.1016/j.jim.2006.04.009
   Distler JHW, 2007, ARTHRITIS RHEUM, V56, P311, DOI 10.1002/art.22314
   Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258
   Dvorak AM, 1991, BASOPHIL MAST CELL D
   Egozi EI, 2003, WOUND REPAIR REGEN, V11, P46, DOI 10.1046/j.1524-475X.2003.11108.x
   Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782
   Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X
   Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036
   Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5
   Hirota K, 2007, J CONTROL RELEASE, V119, P69, DOI 10.1016/j.jconrel.2007.01.013
   HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V
   Iba Y, 2004, INT IMMUNOPHARMACOL, V4, P1873, DOI 10.1016/j.intimp.2004.08.009
   Jay SM, 2010, J BIOMED MATER RES A, V93A, P189, DOI 10.1002/jbm.a.32513
   Ju YM, 2010, J BIOMED MATER RES A, V93A, P200, DOI 10.1002/jbm.a.32512
   Klueh U, 2006, DIABETES TECHNOL THE, V8, P402, DOI 10.1089/dia.2006.8.402
   Klueh U, 2010, BIOMATERIALS, V31, P4540, DOI 10.1016/j.biomaterials.2010.02.023
   KRZYWICKI HJ, 1967, AM J CLIN NUTR, V20, P305
   Nauta AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059167
   Nichols SP, 2011, ANAL CHEM, V83, P1180, DOI 10.1021/ac103070t
   Norton LW, 2007, J BIOMED MATER RES A, V81A, P858, DOI 10.1002/jbm.a.31088
   OKAYAMA Y, 1994, J IMMUNOL METHODS, V169, P153, DOI 10.1016/0022-1759(94)90259-3
   Orenstein SB, 2010, HERNIA, V14, P511, DOI 10.1007/s10029-010-0680-1
   TAKAISHI T, 1994, ALLERGY, V49, P837, DOI 10.1111/j.1398-9995.1994.tb00784.x
   Taylor AM, 1996, IMMUNOPHARMACOLOGY, V34, P63, DOI 10.1016/0162-3109(96)00109-9
   Taylor WE, 1996, ENDOCRINOLOGY, V137, P5407, DOI 10.1210/en.137.12.5407
   Urtz N, 2004, MOL CELL BIOL, V24, P8765, DOI 10.1128/MCB.24.19.8765-8777.2004
   Wang YW, 2012, BIOMATERIALS, V33, P8540, DOI 10.1016/j.biomaterials.2012.07.039
   Weller K, 2006, FASEB J, V20, P2366, DOI 10.1096/fj.06-5837fje
   WILLIAMS DE, 1990, CELL, V63, P167, DOI 10.1016/0092-8674(90)90297-R
   Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4
NR 38
TC 20
Z9 21
U1 4
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2014
VL 10
IS 5
BP 1856
EP 1863
DI 10.1016/j.actbio.2013.12.056
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AG0HA
UT WOS:000335095300008
PM 24406200
DA 2018-10-20
ER

PT J
AU Guillaume, O
   Daly, A
   Lennon, K
   Gansau, J
   Buckley, SF
   Buckley, CT
AF Guillaume, Olivier
   Daly, Andrew
   Lennon, Kerri
   Gansau, Jennifer
   Buckley, Shane F.
   Buckley, Conor T.
TI Shape-memory porous alginate scaffolds for regeneration of the annulus
   fibrosus: Effect of TGF-beta 3 supplementation and oxygen culture
   conditions
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Shape-memory; Scaffold; Alginate; Annulus fibrosus; Intervertebral disc
ID LOW-BACK-PAIN; INTERVERTEBRAL DISC CELLS; GROWTH IN-VITRO;
   ANULUS-FIBROSUS; EXTRACELLULAR-MATRIX; HYDRAULIC PERMEABILITY; NUCLEUS
   REPLACEMENT; REPAIR; DEGENERATION; DISKECTOMY
AB Disc herniation as a result of degenerative or traumatic injury is believed to be the primary instigator of low back pain. At present there is a lack of viable treatment options to repair damaged annulus fibrosus (AF) tissue. Developing alternative strategies to fill and repair ruptured AF tissue is a key challenge. In this work we developed a porous alginate scaffold with shape-memory properties which can be delivered using minimally invasive approaches and recover its original geometry once hydrated. Covalently cross-linked alginate hydrogels were created using carbodiimide chemistry, followed by a freeze-drying step to impart porosity and create porous scaffolds. Results showed that porous alginate scaffolds exhibited shape-memory recovery and mechanical behaviour that could be modulated depending on the crosslinker concentrations. The scaffold can be repeatedly compressed and expanded, which provides the potential to deliver the biomaterial directly to the damaged area of the AF tissue. In vitro experiments demonstrated that scaffolds were cytocompatible and supported cell seeding, penetration and proliferation under intervertebral-disc-like microenvironmental conditions (low glucose media and low oxygen concentration). Extracellular matrix (ECM) was secreted by AF cells with TGF-beta 3 stimulation and after 21 days had filled the porous scaffold network. This biological matrix was rich in sulfated glycosaminoglycan and collagen type I, which are the main compounds of native AF tissue. Successful ECM deposition was also confirmed by the increase in the peak stress of the scaffold. However, the immaturity of the matrix network after only 21 days of in vitro culture was not sufficient to attain native AF tissue mechanical properties. The ability to deliver porous scaffolds using minimal invasive approaches that can potentially promote the regeneration of AF defects provides an exciting new avenue for disc repair. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Buckley, Conor T.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin 2, Ireland.
   Univ Dublin Trinity Coll, Sch Engn, Dept Mech Engn, Dublin 2, Ireland.
RP Buckley, CT (reprint author), Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Trinity Ctr Bioengn, Dublin 2, Ireland.
EM conor.buckley@tcd.ie
OI Buckley, Conor/0000-0001-7452-4534
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bailey A, 2013, SPINE, V38, P1161, DOI 10.1097/BRS.0b013e31828b2e2f
   Bartels EM, 1998, SPINE, V23, P1, DOI 10.1097/00007632-199801010-00001
   BERTOLO A, 2012, NATL GEOGR, V221, P6
   Bhattacharjee M, 2012, ACTA BIOMATER, V8, P3313, DOI 10.1016/j.actbio.2012.05.023
   Biyani A, 2004, J AM ACAD ORTHOP SUR, V12, P106, DOI 10.5435/00124635-200403000-00006
   Blanquer SBG, 2012, J APPL BIOMATER FUNC, V10, P177, DOI 10.5301/JABFM.2012.10354
   Bron JL, 2012, J MATER SCI-MATER M, V23, P813, DOI 10.1007/s10856-011-4545-7
   Bron JL, 2011, J MECH BEHAV BIOMED, V4, P1196, DOI 10.1016/j.jmbbm.2011.04.002
   Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x
   Buckley CT, 2009, J MECH BEHAV BIOMED, V2, P512, DOI 10.1016/j.jmbbm.2008.12.007
   CASSIDY JJ, 1989, CONNECT TISSUE RES, V23, P75, DOI 10.3109/03008208909103905
   Chang G, 2007, EUR SPINE J, V16, P1848, DOI 10.1007/s00586-007-0364-4
   Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011
   DePalma MJ, 2012, PAIN PHYSICIAN, V15, pE53
   Feng G, 2013, OSTEOARTHR CARTILAGE, V21, P582, DOI 10.1016/j.joca.2013.01.001
   Gantenbein-Ritter B, 2011, COMPREHENSIVE BIOMAT, P161
   Grunhagen T, 2006, J BONE JOINT SURG AM, V88A, P30, DOI 10.2106/JBJS.E.01290
   Guterl CC, 2010, J BIOMECH, V43, P1343, DOI 10.1016/j.jbiomech.2010.01.021
   Heuer F, 2008, J NEUROSURG-SPINE, V9, P307, DOI 10.3171/SPI/2008/9/9/307
   Iatridis JC, 1998, J BIOMECH, V31, P535, DOI 10.1016/S0021-9290(98)00046-3
   Ishihara H, 1999, J ORTHOPAED RES, V17, P829, DOI 10.1002/jor.1100170607
   Johnson WE, 2006, EUR SPINE J, V15, pS389, DOI 10.1007/s00586-006-0125-9
   Johnson WEB, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2405
   Kafienah Wa'el, 2004, Methods Mol Biol, V238, P217
   Le Maitre CL, 2005, J PATHOL, V207, P445, DOI 10.1002/path.1862
   Ledic D, 2007, SPINE J, V7, p123S
   Lee DC, 2007, J ANAT, V210, P294, DOI 10.1111/j.1469-7580.2007.00692.x
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Li CH, 2013, SURG NEUROL INT, V4, pS295
   MAROUDAS A, 1975, Journal of Anatomy, V120, P113
   Martin MD, 2002, NEUROSURG FOCUS, V13, P1
   Mizuno H, 2006, BIOMATERIALS, V27, P362, DOI 10.1016/j.biomaterials.2005.06.042
   MOORE RJ, 1994, SPINE, V19, P2787, DOI 10.1097/00007632-199412150-00010
   Mwale F, 2004, Eur Cell Mater, V8, P58
   Mwale F, 2011, SPINE, V36, pE131, DOI 10.1097/BRS.0b013e3181d52b9e
   Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Park C, 2005, SPINE, V30, pE259, DOI 10.1097/01.brs.0000162531.49297.43
   Perie D, 2005, J BIOMECH, V38, P2164, DOI 10.1016/j.jbiomech.2004.10.002
   Recuerda M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-195
   Recuerda M, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004411
   Richardson SM, 2007, HISTOL HISTOPATHOL, V22, P1033, DOI 10.14670/HH-22.1033
   Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1
   Saad L, 2004, J BIOMED MATER RES A, V71A, P233, DOI 10.1002/jbm.a.30150
   Sato M, 2003, MED BIOL ENG COMPUT, V41, P365, DOI 10.1007/BF02348444
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/bjm.a.31030
   Sherman J, 2010, SPINE J, V10, P108, DOI 10.1016/j.spinee.2009.08.453
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Spoor AB, 2013, J NEUROSURG SCI, V57, P203
   Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285
   Thornton AJ, 2004, TRANSPLANTATION, V77, P1798, DOI 10.1097/01.tp.0000131152.71117.0e
   Trummer M, 2013, CLIN NEUROL NEUROSUR, V115, P1440, DOI 10.1016/j.clineuro.2013.01.007
   Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52
   Vadala G, 2012, EUR SPINE J, V21, pS20, DOI 10.1007/s00586-012-2235-x
   Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031
   Wan YQ, 2007, MACROMOL BIOSCI, V7, P1217, DOI 10.1002/mabi.200700053
   Wang L, 2012, TISSUE ENG PT A, V18, P2000, DOI [10.1089/ten.tea.2011.0663, 10.1089/ten.TEA.2011.0663]
   Whatley BR, 2012, MAT SCI ENG C-MATER, V32, P61, DOI 10.1016/j.msec.2011.10.011
   Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x
   Yao H, 2002, ANN BIOMED ENG, V30, P1234, DOI 10.1114/1.1523920
   Yorimitsu E, 2001, SPINE, V26, P652, DOI 10.1097/00007632-200103150-00019
NR 63
TC 25
Z9 27
U1 8
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2014
VL 10
IS 5
BP 1985
EP 1995
DI 10.1016/j.actbio.2013.12.037
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AG0HA
UT WOS:000335095300020
PM 24380722
DA 2018-10-20
ER

PT J
AU Zhu, MF
   Wang, K
   Mei, JJ
   Li, C
   Zhang, JM
   Zheng, WT
   An, D
   Xiao, NN
   Zhao, Q
   Kong, DL
   Wang, LY
AF Zhu, Meifeng
   Wang, Kai
   Mei, Jingjing
   Li, Chen
   Zhang, Jiamin
   Zheng, Wenting
   An, Di
   Xiao, Nannan
   Zhao, Qiang
   Kong, Deling
   Wang, Lianyong
TI Fabrication of highly interconnected porous silk fibroin scaffolds for
   potential use as vascular grafts
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk fibroin scaffolds; Freeze-drying; Neovascularization; Heparin;
   Vascular graft
ID TISSUE ENGINEERING APPLICATIONS; SMOOTH-MUSCLE-CELLS; DRUG-DELIVERY;
   GROWTH-FACTOR; HEPARIN; ANGIOGENESIS; PROLIFERATION; BIOMATERIAL;
   INFILTRATION; REGENERATION
AB Silk fibroin (SF) scaffolds have been designed and fabricated for multiple organ engineering owing to SF's remarkable mechanical property, excellent biocompatibility and biodegradability, as well as its low immunogenicity. In this study, an easy-to-adopt and mild approach based on a modified freeze-drying method was developed to fabricate a highly interconnected porous SF scaffold. The physical properties of the SF scaffold, including pore morphology, pore size, porosity and compressive modulus, could be adjusted by the amount of ethanol added, the freezing temperature and the concentration of SF. Fourier transform infrared spectroscopy illustrated that treatment of the lyophilized scaffolds with 90% methanol led to a structure transition of SF from silk I (random coil) to silk II (beta-sheet), which stabilized the SF scaffolds in water. We also incorporated heparin during fabrication to obtain a heparin-loaded scaffold which possessed excellent anticoagulant property. The heparin that was incorporated into the SF scaffolds could be released in a sustain manner for approximately 7 days, inhibiting the proliferation of human smooth muscle cells within the scaffold in vitro while promoting neovascularization in vivo. We therefore propose that the SF porous scaffold fabricated here may be an attractive candidate for use as a potential vascular graft for implantation based on its high porosity, excellent blood compatibility and mild fabrication process. (C) 2014 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhu, Meifeng; Wang, Kai; Mei, Jingjing; Zhang, Jiamin; Zheng, Wenting; An, Di; Xiao, Nannan; Zhao, Qiang; Kong, Deling; Wang, Lianyong] Nankai Univ, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, State Key Lab Med Chem Biol, Key Lab Bioact Mat,Minist Educ,Coll Life Sci, Tianjin 300071, Peoples R China.
   [Li, Chen; Kong, Deling] Chinese Acad Med Sci, Tianjin Key Lab Biomat Res, Inst Biomed Engn, Tianjin 300192, Peoples R China.
RP Kong, DL (reprint author), Nankai Univ, Collaborat Innovat Ctr Chem Sci & Engn Tianjin, State Key Lab Med Chem Biol, Key Lab Bioact Mat,Minist Educ,Coll Life Sci, Tianjin 300071, Peoples R China.
EM kongdeling@nankai.edu.cn; wly@nankai.edu.cn
FU National Natural Science Foundation of China (NSFC) [51173084, 81171478,
   31100699]; National Program on Key Basic Research Project
   [2011CB606202]; Tianjin Research Program of Application Foundation and
   Advanced Technology [11 JCYBJC 10300]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC) (Project Nos. 51173084, 81171478, 31100699), National
   Program on Key Basic Research Project (973 Program, No. 2011CB606202)
   and Tianjin Research Program of Application Foundation and Advanced
   Technology (11 JCYBJC 10300).
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200
   Blaukovitch CI, 2010, J CELL BIOCHEM, V110, P382, DOI 10.1002/jcb.22543
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   Cao ZB, 2013, MAT SCI ENG C-MATER, V33, P3522, DOI 10.1016/j.msec.2013.04.045
   Chen P, 2008, MACROMOL RES, V16, P539, DOI 10.1007/BF03218556
   CLOWES AW, 1977, NATURE, V265, P625, DOI 10.1038/265625a0
   Darnell MC, 2013, BIOMATERIALS, V34, P8042, DOI 10.1016/j.biomaterials.2013.06.061
   EHRLICH HP, 1988, EXP MOL PATHOL, V48, P244, DOI 10.1016/0014-4800(88)90061-5
   Garg T, 2012, CRIT REV THER DRUG, V29, P1
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Hinrichs WLJ, 1997, J CONTROL RELEASE, V45, P163, DOI 10.1016/S0168-3659(96)01571-4
   Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105
   Janairo RRR, 2012, IEEE T NANOBIOSCI, V11, P22, DOI 10.1109/TNB.2012.2188926
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Khang G., 2006, ENCY MED DEVICES INS
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kurpinski KT, 2010, BIOMATERIALS, V31, P3536, DOI 10.1016/j.biomaterials.2010.01.062
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Leijon J, 2013, TISSUE ENG PT A, V19, P1336, DOI [10.1089/ten.tea.2011.0712, 10.1089/ten.TEA.2011.0712]
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Ma HY, 2010, ADV FUNCT MATER, V20, P2833, DOI 10.1002/adfm.201000922
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Mao ZW, 2009, ACTA BIOMATER, V5, P2983, DOI 10.1016/j.actbio.2009.04.004
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Nishiguchi KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013493
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Oliveira AL, 2012, ACTA BIOMATER, V8, P1530, DOI 10.1016/j.actbio.2011.12.015
   Patel ZS, 2004, J BIOMAT SCI-POLYM E, V15, P701, DOI 10.1163/156856204774196117
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Savage JM, 2001, J CELL PHYSIOL, V187, P283, DOI 10.1002/jcp.1076
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Stewart EM, 2012, ACTA BIOMATER, V8, P194, DOI 10.1016/j.actbio.2011.07.029
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang ZL, 2012, BIOMATERIALS, V33, P6615, DOI 10.1016/j.biomaterials.2012.06.055
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
NR 49
TC 48
Z9 51
U1 10
U2 123
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2014
VL 10
IS 5
BP 2014
EP 2023
DI 10.1016/j.actbio.2014.01.022
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AG0HA
UT WOS:000335095300023
PM 24486642
DA 2018-10-20
ER

PT J
AU Mishra, A
   Singh, SK
   Dash, D
   Aswal, VK
   Maiti, B
   Misra, M
   Maiti, P
AF Mishra, Abhinay
   Singh, Sunil K.
   Dash, Debabrata
   Aswal, Vinod K.
   Maiti, Biswajit
   Misra, Manjusri
   Maiti, Pralay
TI Self-assembled aliphatic chain extended polyurethane nanobiohybrids:
   Emerging hemocompatible biomaterials for sustained drug delivery
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Polyurethane; Self assembly; Biomaterial; Drug delivery;
   Hemocompatibility
ID SEGMENTED COPOLY(ETHER UREA)S; SHAPE-MEMORY POLYMERS; UNIFORM HARD
   SEGMENTS; ENZYMATIC DEGRADATION; GRAPHENE OXIDE; NANOCOMPOSITES;
   MORPHOLOGY; NANOCLAY; MICROSTRUCTURE; BIODEGRADATION
AB Novel polyurethanes (PUs) have been synthesized using an aliphatic diisocyanate and aliphatic chain extenders with varying chain length. Nanocomposites of PUs have been prepared by dispersing 2-D nanoclay in poly-ol followed by prepolymerization and subsequent chain extension using various chain extenders. Systematic improvement in toughness and adequate enhancement in stiffness in the presence of nanoclay has been observed for PUs with longer chain extenders, and these new classes of nanocomposites exhibit no toughness stiffness trade-off. Bottom-up self-assembly starting from the molecular level to micron-scale crystallite has been revealed through electronic structure calculation, X-ray diffraction, small-angle neutron scattering, atomic force microscopy and optical images. The role of hydrogen bonding has been revealed for this type of supramolecular assembly, and in the presence of organically modified nanoclay hydrogen bonding contributes to the formation of bigger clusters of nanocomposites. Controlled biodegradation of PU and its nanocomposites has been investigated in enzymatic media. Biocompatibility of these novel nanocomposites has been extensively verified through platelet adhesion, aggregation and hemolysis assay. Sustained drug delivery by biocompatible pristine PU and its nanocomposites has been demonstrated either by controlling the crystallite size of the polyurethane through alteration of the aliphatic chain length of the extender or by incorporating disc-like nanoclay, creating a tortuous path that results in delayed diffusion. Hence, the developed nanohybrids are potential biomaterials for tissue engineering and drug delivery. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mishra, Abhinay; Maiti, Pralay] Banaras Hindu Univ, Indian Inst Technol, Sch Mat Sci & Technol, Varanasi 221005, Uttar Pradesh, India.
   [Singh, Sunil K.; Dash, Debabrata] Banaras Hindu Univ, Inst Med Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India.
   [Aswal, Vinod K.] Bhabha Atom Res Ctr, SolidState Phys Div, Mumbai 400085, Maharashtra, India.
   [Maiti, Biswajit] Banaras Hindu Univ, Dept Chem, Varanasi 221005, Uttar Pradesh, India.
   [Misra, Manjusri] Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
   [Maiti, Pralay] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada.
RP Maiti, P (reprint author), Banaras Hindu Univ, Indian Inst Technol, Sch Mat Sci & Technol, Varanasi 221005, Uttar Pradesh, India.
EM pmaiti.mst@itbhu.ac.in
RI Mishra, Abhinay/D-8109-2011
FU Council of Scientific and Industrial Research (CSIR), New Delhi; CSIR
   [22(0399)/06/EMR-II]
FX A.M. gratefully acknowledges financial support from the Council of
   Scientific and Industrial Research (CSIR), New Delhi in the form of a
   fellowship (JRF, SRF and RA). The authors acknowledge a research grant
   from CSIR Project No. 22(0399)/06/EMR-II). The authors acknowledge the
   kind assistance of Prof. R.M. Banik and Mr. Govinda Kapusetti with the
   drug release study and statistical analyses, respectively. Authors are
   thankful to Dr. D.K. Avasthi and Mr. Pawan K. Kulriya of IUAC, New Delhi
   for their kind helped with the XRD measurements.
CR Bihari P, 2010, TOXICOLOGY, V269, P148, DOI 10.1016/j.tox.2009.08.011
   Chen ZP, 2011, BIOSENS BIOELECTRON, V29, P53, DOI 10.1016/j.bios.2011.07.065
   Christenson EM, 2006, BIOMATERIALS, V27, P3920, DOI 10.1016/j.biomaterials.2006.03.012
   Depan D, 2009, ACTA BIOMATER, V5, P93, DOI 10.1016/j.aetbio.2008.08.007
   Fernandez CE, 2010, MACROMOLECULES, V43, P4161, DOI 10.1021/ma100299p
   Frisch MJ, 2007, GAUSSIAN 03
   Gu XZ, 2011, BIOMACROMOLECULES, V12, P3066, DOI 10.1021/bm2006938
   Pinto FCH, 2011, J NANOMATER, DOI 10.1155/2011/528628
   Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515
   Katti K.S., 2008, BIOMED MATER, V3, P1, DOI DOI 10.1088/1748-6041/3/3/034122
   Klinedinst DB, 2005, POLYMER, V46, P10191, DOI 10.1016/j.polymer.2005.07.065
   Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059
   Koevoets RA, 2005, J AM CHEM SOC, V127, P2999, DOI 10.1021/ja0451160
   Korley LTJ, 2006, MACROMOLECULES, V39, P7030, DOI 10.1021/ma061383+
   Kwok CS, 1999, J CONTROL RELEASE, V62, P301, DOI 10.1016/S0168-3659(99)00105-4
   Lahiri D, 2009, ACS APPL MATER INTER, V1, P2470, DOI 10.1021/am900423q
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Liao KH, 2011, ACS APPL MATER INTER, V3, P2607, DOI 10.1021/am200428v
   Liff SM, 2007, NAT MATER, V6, P76, DOI 10.1038/nmat1798
   Maji PK, 2009, ACS APPL MATER INTER, V1, P289, DOI 10.1021/am800020k
   McLean RS, 1997, MACROMOLECULES, V30, P8314, DOI 10.1021/ma970350e
   Meckel W., 1987, THERMOPLASTIC ELASTO
   Mishra A, 2012, J PHYS CHEM C, V116, P2260, DOI 10.1021/jp210560s
   Mishra A, 2010, MACROMOLECULES, V43, P9928, DOI 10.1021/ma101909j
   Mishra A, 2010, J PHYS CHEM B, V114, P5292, DOI 10.1021/jp100599u
   Mishra JK, 2003, MACROMOL RAPID COMM, V24, P671, DOI 10.1002/marc.20035008
   Nayak MK, 2011, THROMB HAEMOSTASIS, V106, P624, DOI 10.1160/TH11-03-0178
   Oertel G, 1993, POLYURETHANE HDB CHE
   Pattanayak A, 2005, POLYMER, V46, P3275, DOI 10.1016/j.polymer.2005.02.081
   Pattanayak A, 2005, POLYMER, V46, P5183, DOI 10.1016/j.polymer.2005.04.035
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Radomski A, 2005, BRIT J PHARMACOL, V146, P882, DOI 10.1038/sj.bjp.0706386
   Rogulska M, 2007, EUR POLYM J, V43, P1402, DOI 10.1016/j.eurpolymj.2007.01.014
   Schierholz JM, 1997, BIOMATERIALS, V18, P839, DOI 10.1016/S0142-9612(96)00199-8
   Semberova J, 2009, NANO LETT, V9, P3312, DOI 10.1021/nl901603k
   Shah D, 2005, ADV MATER, V17, P525, DOI 10.1002/adma.200400984
   Shah D, 2004, ADV MATER, V16, P1173, DOI 10.1002/adma.200306355
   Sheth JP, 2005, MACROMOLECULES, V38, P10074, DOI 10.1021/ma051063a
   Shrivastava S, 2009, ACS NANO, V3, P1357, DOI 10.1021/nn900277t
   Singh NK, 2011, J MATER CHEM, V21, P15919, DOI 10.1039/c1jm12427g
   Singh NK, 2010, ACS APPL MATER INTER, V2, P69, DOI 10.1021/am900584r
   Singh SK, 2011, ACS NANO, V5, P4987, DOI 10.1021/nn201092p
   Tatai L, 2007, BIOMATERIALS, V28, P5407, DOI 10.1016/j.biomaterials.2007.08.035
   Velankar S, 1998, MACROMOLECULES, V31, P9181, DOI 10.1021/ma9811472
   Versteegen RM, 2006, MACROMOLECULES, V39, P772, DOI 10.1021/ma051874e
   Versteegen RM, 2005, MACROMOLECULES, V38, P3176, DOI 10.1021/ma0478207
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   Wang LF, 2007, POLYMER, V48, P7414, DOI 10.1016/j.polymer.2007.10.017
   Wang Z, 1998, CHEM MATER, V10, P3769, DOI 10.1021/cm980448n
   Xu RJ, 2001, MACROMOLECULES, V34, P337, DOI 10.1021/ma0013657
   Yilgor E, 2002, POLYMER, V43, P6551
   Zhang CL, 2010, J MOL MODEL, V16, P1391, DOI 10.1007/s00894-010-0645-4
   Zhang YM, 2010, J MATER CHEM, V20, P9976, DOI 10.1039/c0jm01944e
   Zilg C, 1999, ADV MATER, V11, P49, DOI 10.1002/(SICI)1521-4095(199901)11:1<49::AID-ADMA49>3.0.CO;2-N
NR 55
TC 29
Z9 29
U1 3
U2 87
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2014
VL 10
IS 5
BP 2133
EP 2146
DI 10.1016/j.actbio.2013.12.035
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AG0HA
UT WOS:000335095300035
PM 24374322
DA 2018-10-20
ER

PT J
AU Henderson, SE
   Verdelis, K
   Maiti, S
   Pal, S
   Chung, WL
   Chou, DT
   Kumta, PN
   Almarza, AJ
AF Henderson, Sarah E.
   Verdelis, Konstantinos
   Maiti, Spandan
   Pal, Siladitya
   Chung, William L.
   Chou, Da-Tren
   Kumta, Ptashant N.
   Almarza, Alejandro J.
TI Magnesium alloys as a biomaterial for degradable craniofacial screws
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biodegradable metal; Magnesium; Craniofacial implants; Finite-element
   modeling
ID SURFACE MACHINING TREATMENTS; IN-VIVO CORROSION; RABBIT MODEL;
   RESORBABLE IMPLANTS; BONE RESPONSE; CALCIUM-PHOSPHATE; BIOCOMPATIBILITY;
   FIXATION; BEHAVIOR; MGCA0.8
AB Recently, magnesium (Mg) alloys have received significant attention as potential biomaterials for degradable implants, and this study was directed at evaluating the suitability of Mg for craniofacial bone screws. The objective was to implant screws fabricated from commercially available pure Mg and alloy AZ31 in vivo in a rabbit mandible. First, Mg and AZ31 screws were compared to stainless steel screws in an in vitro pull-out test and determined to have a similar holding strength (similar to 40 N). A finite-element model of the screw was created using the pull-out test data, and this model can be used for future Mg alloy screw design. Then, Mg and AZ31 screws were implanted for 4, 8 and 12 weeks, with two controls of an osteotomy site (hole) with no implant and a stainless steel screw implanted for 12 weeks. Microcomputed tomography was used to assess bone remodeling and Mg/AZ31 degradation, both visually and qualitatively through volume fraction measurements for all time points. Histological analysis was also completed for the Mg and AZ31 at 12 weeks. The results showed that craniofacial bone remodeling occurred around both Mg and AZ31 screws. Pure Mg had a different degradation profile than AZ31; however, bone growth occurred around both screw types. The degradation rate of both Mg and AZ31 screws in the bone marrow space and the muscle were faster than in the cortical bone space at 12 weeks. Furthermore, it was shown that by alloying Mg, the degradation profile could be changed. These results indicate the promise of using Mg alloys for craniofacial applications. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Henderson, Sarah E.; Maiti, Spandan; Pal, Siladitya; Chou, Da-Tren; Kumta, Ptashant N.; Almarza, Alejandro J.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Verdelis, Konstantinos] Univ Pittsburgh, Dept Restorat Dent Comprehens Care, Pittsburgh, PA 15261 USA.
   [Chung, William L.] Univ Pittsburgh, Pittsburgh, PA 15261 USA.
   [Kumta, Ptashant N.; Almarza, Alejandro J.] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA 15261 USA.
   [Kumta, Ptashant N.; Almarza, Alejandro J.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15261 USA.
RP Almarza, AJ (reprint author), Univ Pittsburgh, Dept Bioengn, 566 Salk Hall,3501 Terrace St, Pittsburgh, PA 15261 USA.
EM aja19@pitt.edu
FU National Science Foundation [0812348]; National Institutes of Health
   [T32 EB003392-01]; University of Pittsburgh School of Dental Medicine;
   Complex Engineered Multifunctional Materials (CCEMM) at University of
   Pittsburgh
FX We would like to acknowledge J. Andrew Holmes at the University of
   Pittsburgh SCPI for screw fabrication. We would also like to acknowledge
   funding from the National Science Foundation under grant no.0812348, as
   well as from the National Institutes of Health under grant no.T32
   EB003392-01, and the University of Pittsburgh School of Dental Medicine.
   P.N.K. would also like to acknowledge support from the Edward R.
   Weildein Chair Professorship and the Center for Complex Engineered
   Multifunctional Materials (CCEMM) at the University of Pittsburgh.
CR Bell RB, 2006, J ORAL MAXIL SURG, V64, P31, DOI 10.1016/j.joms.2005.09.010
   Bondarenko A, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-32
   Denkena B, 2005, P 5 EUSP INT C MONTP
   Denkena B, 2005, BIOMATERIALIEN, V6, P171
   Duygulu O, 2007, MATER SCI FORUM, V546-549, P421, DOI 10.4028/www.scientific.net/MSF.546-549.421
   Erdmann N, 2011, ACTA BIOMATER, V7, P1421, DOI 10.1016/j.actbio.2010.10.031
   Erdmann N, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-63
   Hampp C, 2013, MAT SCI ENG C-MATER, V33, P317, DOI 10.1016/j.msec.2012.08.046
   Hampp C, 2012, ADV ENG MATER, V14, pB28, DOI 10.1002/adem.201180066
   Huehnerschulte TA, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-14
   Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037
   Kim SM, 2014, J BIOMED MATER RES A, V102, P429, DOI 10.1002/jbm.a.34718
   Krause A, 2010, J MATER SCI, V45, P624, DOI 10.1007/s10853-009-3936-3
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Meslemani D, 2012, CURR OPIN OTOLARYNGO, V20, P304, DOI 10.1097/MOO.0b013e3283543a9d
   Meyer-Lindenberg A, 2010, KLEINTIERPRAXIS, V55, P349
   Poon CCH, 2013, INT J ORAL MAX SURG, V42, P736, DOI 10.1016/j.ijom.2012.12.009
   SUURONEN R, 1992, J ORAL MAXIL SURG, V50, P255, DOI 10.1016/0278-2391(92)90322-Q
   Thomann M, 2009, MATERIALWISS WERKST, V40, P82, DOI 10.1002/mawe.200800412
   Thomann M, 2010, J BIOMED MATER RES A, V93A, P1609, DOI 10.1002/jbm.a.32639
   Turvey TA, 2011, INT J ORAL MAX SURG, V40, P244, DOI 10.1016/j.ijom.2010.11.024
   van den Bos T, 2008, BONE, V43, P459, DOI 10.1016/j.bone.2008.05.009
   Von der Hoeh N, 2006, DEUT TIERARZTL WOCH, V113, P439
   von der Hoh N, 2009, MATERIALWISS WERKST, V40, P88, DOI 10.1002/mawe.200800378
   von der Hoh N, 2010, MATER SCI FORUM, V638-642, P742, DOI 10.4028/www.scientific.net/MSF.638-642.742
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   Waizy H, 2012, J MATER SCI-MATER M, V23, P649, DOI 10.1007/s10856-011-4544-8
   Willbold E, 2011, MATER SCI ENG B-ADV, V176, P1835, DOI 10.1016/j.mseb.2011.02.010
   Willbold E, 2013, ACTA BIOMATER, V9, P8509, DOI 10.1016/j.actbio.2013.02.015
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012
   Witte F, 2004, WERKSTATTSTECHNIK ON, V94, P692
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Yang JX, 2012, J BIOMATER APPL, V27, P153, DOI 10.1177/0885328211398161
   Zhang EL, 2009, J BIOMED MATER RES A, V90A, P882, DOI 10.1002/jbm.a.32132
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
NR 40
TC 41
Z9 43
U1 4
U2 90
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2014
VL 10
IS 5
BP 2323
EP 2332
DI 10.1016/j.actbio.2013.12.040
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AG0HA
UT WOS:000335095300054
PM 24384125
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Bozza, A
   Coates, EE
   Incitti, T
   Ferlin, KM
   Messina, A
   Menna, E
   Bozzi, Y
   Fisher, JP
   Casarosa, S
AF Bozza, Angela
   Coates, Emily E.
   Incitti, Tania
   Ferlin, Kimberly M.
   Messina, Andrea
   Menna, Elisabetta
   Bozzi, Yuri
   Fisher, John P.
   Casarosa, Simona
TI Neural differentiation of pluripotent cells in 3D alginate-based
   cultures
SO BIOMATERIALS
LA English
DT Article
DE Neural differentiation; Pluripotent cells; Three dimensional cultures;
   Alginate; Hyaluronic acid
ID EMBRYONIC STEM-CELLS; IN-VITRO DIFFERENTIATION; NEURONAL
   DIFFERENTIATION; DIRECTED DIFFERENTIATION; EXTRACELLULAR-MATRIX;
   SUBSTRATE STIFFNESS; NERVOUS-SYSTEM; SPINAL-CORD; HYDROGEL; BIOMATERIALS
AB Biomaterial-supported culture methods, allowing for directed three-dimensional differentiation of stem cells are an alternative to canonical two-dimensional cell cultures. In this paper, we evaluate the suitability of alginate for three-dimensional cultures to enhance differentiation of mouse embryonic stem cells (mESCs) towards neural lineages. We tested whether encapsulation of mESCs within alginate beads could support and/or enhance neural differentiation with respect to two-dimensional cultures. We encapsulated cells in beads of alginate with or without modification by fibronectin (Fn) or hyaluronic acid (HA). Gene expression analysis showed that cells grown in alginate and alginate-HA present increased differentiation toward neural lineages with respect to the two-dimensional control and to Fn group. Immunocytochemistry analyses confirmed these results, further showing terminal differentiation of neurons as seen by the expression of synaptic markers and markers of different neuronal subtypes. Our data show that alginate, alone or modified, is a suitable biomaterial to promote in vitro differentiation of pluripotent cells toward neural fates. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Bozza, Angela; Incitti, Tania; Messina, Andrea; Bozzi, Yuri; Casarosa, Simona] Univ Trento, Ctr Integrat Biol CIBIO, I-38123 Trento, Italy.
   [Coates, Emily E.; Ferlin, Kimberly M.; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Menna, Elisabetta] CNR, Inst Neurosci, I-20133 Milan, Italy.
   [Menna, Elisabetta] Humanitas Clin & Res Ctr, I-20133 Milan, Italy.
   [Bozzi, Yuri; Casarosa, Simona] CNR, Inst Neurosci, I-56124 Pisa, Italy.
RP Casarosa, S (reprint author), Univ Trento, Ctr Integrat Biol, Via Regole 101, I-38123 Trento, Italy.
EM casarosa@science.unitn.it
OI Bozza, Angela/0000-0002-5514-6459; Incitti, Tania/0000-0002-5573-1914
FU University of Trento; Cassa di Risparmio di Trento e Rovereto
   [2011.0251]
FX The Authors acknowledge NHLBI-BayGenomics and NCRRMMRRC (UC Davis) for
   the E14Tg2A cell line. The Authors would like to thank Isabella Pesce
   for help with flow cytometry counts and Patrizia Paoli and Giorgia Moser
   for administrative support. E.M. would like to thank the Monzino
   Foundation (Milano, Italy) for its generous gift of the LSM 510 Meta and
   Perkin Elmer Ultraview confocal microscopes. This work was supported by
   University of Trento Startup Grant (S.C. and Y.B.) and by Cassa di
   Risparmio di Trento e Rovereto Grant n. 2011.0251 (S.C.).
CR Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286
   Addae C, 2012, DIFFERENTIATION, V83, P233, DOI 10.1016/j.diff.2012.03.001
   Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912
   Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005
   Bandtlow CE, 2000, PHYSIOL REV, V80, P1267
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358
   Candiello J, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-9
   Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832
   Chayosumrit M, 2010, BIOMATERIALS, V31, P505, DOI 10.1016/j.biomaterials.2009.09.071
   Coates E, 2012, J TISSUE ENG REGEN M, V6, P179, DOI 10.1002/term.411
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Estes BT, 2004, CURR TOP DEV BIOL, V60, P91
   Fico A, 2008, STEM CELLS DEV, V17, P573, DOI 10.1089/scd.2007.0130
   Frampton JP, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015002
   Franze K, 2013, DEVELOPMENT, V140, P3069, DOI 10.1242/dev.079145
   Freeman MR, 2006, CURR OPIN NEUROBIOL, V16, P119, DOI 10.1016/j.conb.2005.12.004
   Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Her GJ, 2013, ACTA BIOMATER, V9, P5170, DOI 10.1016/j.actbio.2012.10.012
   Huang XB, 2012, J BIOSCI BIOENG, V114, P1, DOI 10.1016/j.jbiosc.2012.02.024
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776
   KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9
   Kim J, 2013, STEM CELL RES, V11, P978, DOI 10.1016/j.scr.2013.06.005
   Kuo YC, 2013, COLLOID SURFACE B, V102, P405, DOI 10.1016/j.colsurfb.2012.08.061
   Kuo YC, 2012, BIOMATERIALS, V33, P8955, DOI 10.1016/j.biomaterials.2012.08.073
   Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536
   Li LL, 2011, BIOMATERIALS, V32, P4489, DOI 10.1016/j.biomaterials.2011.03.019
   Li XQ, 2006, BIOTECHNOL PROGR, V22, P1683, DOI 10.1021/bp060185z
   Lu HF, 2012, BIOMATERIALS, V33, P9179, DOI 10.1016/j.biomaterials.2012.09.006
   MARGOLIS RU, 1975, BIOCHEMISTRY-US, V14, P85, DOI 10.1021/bi00672a014
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   Matyash M, 2012, TISSUE ENG PT A, V18, P55, DOI [10.1089/ten.tea.2011.0097, 10.1089/ten.TEA.2011.0097]
   Novikova LN, 2006, J BIOMED MATER RES A, V77A, P242, DOI 10.1002/jbm.a.30603
   Pachernik J, 2002, REPROD NUTR DEV, V42, P317, DOI 10.1051/rnd:2002028
   Perris R, 2000, MECH DEVELOP, V95, P3, DOI 10.1016/S0925-4773(00)00365-8
   Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684
   Phillips MJ, 2011, INVEST OPHTH VIS SCI, V52, P1439, DOI 10.1167/iovs.10-6400
   Polak JM, 2006, ANN NY ACAD SCI, V1068, P352, DOI 10.1196/annals.1346.001
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Preston Marnie, 2011, Front Biosci (Schol Ed), V3, P1165
   Prewitz M, 2012, MACROMOL RAPID COMM, V33, P1420, DOI 10.1002/marc.201200382
   Purcell EK, 2009, TISSUE ENG PART C-ME, V15, P541, DOI 10.1089/ten.tec.2008.0302
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435
   Teixeira AI, 2009, BIOMATERIALS, V30, P4567, DOI 10.1016/j.biomaterials.2009.05.013
   Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278
   Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X
   Wang N, 2009, J BIOTECHNOL, V144, P304, DOI 10.1016/j.jbiotec.2009.08.008
   Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033
   Wang Y, 2011, PHARM RES-DORDR, V28, P1406, DOI 10.1007/s11095-011-0452-3
   Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
   Wu SF, 2001, NEUROSCI LETT, V312, P173, DOI 10.1016/S0304-3940(01)02219-4
   Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P337, DOI 10.1089/ten.TEC.2010.0172
   Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780
   Yoon DM, 2007, BIOMATERIALS, V28, P299, DOI 10.1016/j.biomaterials.2006.08.039
NR 64
TC 27
Z9 28
U1 2
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2014
VL 35
IS 16
BP 4636
EP 4645
DI 10.1016/j.biomaterials.2014.02.039
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AG1UJ
UT WOS:000335201400004
PM 24631250
DA 2018-10-20
ER

PT J
AU Poranki, DR
   Van Dyke, ME
AF Poranki, Deepika R.
   Van Dyke, Mark E.
TI The effect of gamma keratose on cell viability in vitro after thermal
   stress and the regulation of cell death pathway-specific gene expression
SO BIOMATERIALS
LA English
DT Article
DE Keratin; Thermal; Apoptosis; Autophagy; Burn; Skin
ID TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-B; HEAT-SHOCK; INDUCED APOPTOSIS;
   L929 CELLS; AUTOPHAGY; AKT; ACTIVATION; SURVIVAL; TRANSDUCTION
AB When skin is thermally burned, transfer of heat energy into the skin results in the destruction of cells. Some of these cells are damaged but may be capable of self-repair and survival, thereby contributing to spontaneous healing of the wound. Keratin protein-based biomaterials have been suggested as potential treatments for burn injury. Isolation of cortical proteins from hair fibers results in an acid soluble fraction of keratin proteins referred to as "gamma" keratose. In the present study, treatment with this fraction dissolved in media was able to maintain cell viability after thermal stress in an in vitro model using primary mouse dermal fibroblasts. PCR array analysis demonstrated that gamma keratose treatment may assist in the survival and salvage of thermally stressed cells by maintaining their viability through regulation of cell death pathway-related genes. Gamma keratose may be a promising biomaterial for burn treatment that aids in spontaneous wound healing from viable tissue surrounding the burn. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Poranki, Deepika R.] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
   [Van Dyke, Mark E.] Virginia Polytech Inst & State Univ, Virginia Tech, Wake Forest Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
RP Van Dyke, ME (reprint author), Virginia Polytech Inst & State Univ, Virginia Tech, Wake Forest Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
EM mvandyke2013@gmail.com
FU Armed Forces Institute for Regenerative Medicine [W81XWH-08-2-0032];
   KeraNetics LLC
FX This work was supported by the Armed Forces Institute for Regenerative
   Medicine (DoD Contract #W81XWH-08-2-0032) and KeraNetics LLC.
CR Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627
   Bang OS, 2000, BIOCHEM BIOPH RES CO, V278, P306, DOI 10.1006/bbrc.2000.3805
   Bortner CD, 2002, ANNU REV PHARMACOL, V42, P259, DOI 10.1146/annurev.pharmtox.42.083101.143836
   BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711
   delPeso L, 1997, SCIENCE, V278, P687
   Devin A, 2003, EMBO REP, V4, P623, DOI 10.1038/sj.embor.embor854
   Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185
   Giles N, 2008, WOUND REPAIR REGEN, V16, P58, DOI 10.1111/j.1524-475X.2007.00331.x
   Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447
   Goossens V, 1999, ANTIOXID REDOX SIGN, V1, P285, DOI 10.1089/ars.1999.1.3-285
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Harada T, 1996, BURNS, V22, P578, DOI 10.1016/0305-4179(96)88886-3
   HARMON BV, 1990, INT J RADIAT BIOL, V58, P845, DOI 10.1080/09553009014552221
   Herndon DN, 2004, LANCET, V363, P1895, DOI 10.1016/S0140-6736(04)16360-5
   Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044
   Hsu YL, 2011, EXP EYE RES, V93, P405, DOI 10.1016/j.exer.2011.06.005
   JACKSON DM, 1953, BRIT J SURG, V40, P588, DOI 10.1002/bjs.18004016413
   KABAKOV AE, 1995, EXP CELL RES, V217, P15, DOI 10.1006/excr.1995.1058
   Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353
   Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Kuranaga E, 2002, ARCH HISTOL CYTOL, V65, P291, DOI 10.1679/aohc.65.291
   Lanier ST, 2011, WOUND REPAIR REGEN, V19, P622, DOI 10.1111/j.1524-475X.2011.00725.x
   Li S, 1999, J ORTHOPAED RES, V17, P891, DOI 10.1002/jor.1100170614
   Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660
   Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046
   Machado NM, 2011, NUTR HOSP, V26, P692, DOI [10.3305/nh.2011.26.4.5217, 10.1590/S0212-16112011000400005]
   Madden DT, 2007, AUTOPHAGY, V3, P519
   MAILHOS C, 1994, J NEUROCHEM, V63, P1787
   Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163
   Pereira CT, 2005, J BURN CARE REHABIL, V26, P194, DOI 10.1097/01.BCR.0000162369.84374.18
   Poranki D, 2013, J BIOMATER IN PRESS
   Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303
   Ruiz-Vela A, 2005, EMBO REP, V6, P379, DOI 10.1038/sj.embor.7400375
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Shaw M, 1998, BIOCHEM J, V336, P241, DOI 10.1042/bj3360241
   Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192
   Takacs-Vellai K, 2005, CURR BIOL, V15, P1513, DOI 10.1016/j.cub.2005.07.035
   Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y
   Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919
   Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252
   Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477
   Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200
   Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103
   Yu YM, 1999, JPEN-PARENTER ENTER, V23, P160, DOI 10.1177/0148607199023003160
   Zhang Y, 2011, INT J HYPERTHER, V27, P409, DOI 10.3109/02656736.2011.552087
NR 48
TC 7
Z9 7
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2014
VL 35
IS 16
BP 4646
EP 4655
DI 10.1016/j.biomaterials.2014.02.044
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AG1UJ
UT WOS:000335201400005
PM 24631248
DA 2018-10-20
ER

PT J
AU Nagarajan, U
   Kawakami, K
   Zhang, SL
   Chandrasekaran, B
   Nair, BU
AF Nagarajan, Usharani
   Kawakami, Kohsaku
   Zhang, Shaoling
   Chandrasekaran, Bangaru
   Nair, Balachandran Unni
TI Fabrication of Solid Collagen Nanoparticles Using Electrospray
   Deposition
SO CHEMICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE nanoparticle; collagen; controlled release; cross-linking; electrospray
   deposition
ID ORAL-DRUG DELIVERY; BIOMEDICAL APPLICATIONS; NANOCARRIERS; DISPERSIONS;
   STABILITY; FORMS
AB Collagen is a promising biomaterial for drug delivery due to advantages including high biocompatibility and biodegradable property. However, transforming collagen into solid nanoparticles is difficult, although the solid dosage form is advantageous for some administration routes including pulmonary and oral drug delivery. In this study, collagen solid nanoparticles are prepared in one-step using electrospray deposition under ambient temperature and pressure conditions. Although collagen molecules formed micron-sized aggregates in acetic acid solutions spontaneously, electrospraying the collagen solutions resulted in formation of nanofibers. Solid nanoparticles were obtained by increasing conductivity of the solution and/or inducing structural perturbation of the collagen molecules using salts. The ability of solid collagen particles as a drug carrier was demonstrated by incorporating theophylline as a model drug using a coaxial spray technique. Release of theophylline was controlled by cross-linking collagen molecules. Electrospray deposition was proved to be a powerful method for producing solid collagen nanoparticles for drug delivery.
C1 [Nagarajan, Usharani; Kawakami, Kohsaku; Zhang, Shaoling] Natl Inst Mat Sci, Biomat Unit, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan.
   [Nagarajan, Usharani; Chandrasekaran, Bangaru; Nair, Balachandran Unni] Cent Leather Res Inst, Council Sci & Ind Res, Chennai 600020, Tamil Nadu, India.
RP Kawakami, K (reprint author), Natl Inst Mat Sci, Biomat Unit, Int Ctr Mat Nanoarchitecton MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
EM kawakami.kohsaku@nims.go.jp
FU World Premier International Research Center (WPI) Initiative on
   Materials Nanoarchitectonics, the Ministry of Education, Culture,
   Sports, Science and Technology (MEXT) of Japan
FX This work was supported in part by World Premier International Research
   Center (WPI) Initiative on Materials Nanoarchitectonics, the Ministry of
   Education, Culture, Sports, Science and Technology (MEXT) of Japan.
CR Ariga K, 2011, ADV DRUG DELIVER REV, V63, P762, DOI 10.1016/j.addr.2011.03.016
   Beachley V, 2010, PROG POLYM SCI, V35, P868, DOI 10.1016/j.progpolymsci.2010.03.003
   BIANCHI E, 1967, J BIOL CHEM, V242, P1361
   Bigi A, 2001, J STRUCT BIOL, V136, P137, DOI 10.1006/jsbi.2001.4426
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Chakraborty S, 2009, ADV DRUG DELIVER REV, V61, P1043, DOI 10.1016/j.addr.2009.07.013
   Ensign LM, 2012, ADV DRUG DELIVER REV, V64, P557, DOI 10.1016/j.addr.2011.12.009
   Francis MF, 2004, PURE APPL CHEM, V76, P1321, DOI 10.1351/pac200476071321
   Glover W, 2008, INT J PHARM, V349, P314, DOI 10.1016/j.ijpharm.2007.08.013
   Hickey A., 2006, INHALATION AEROSOLS
   Kawakami K, 2001, J PHYS CHEM B, V105, P2374, DOI 10.1021/jp000087a
   Kawakami K, 2012, INT J PHARMACEUT, V433, P71, DOI 10.1016/j.ijpharm.2012.04.082
   Kawakami K, 2012, ADV DRUG DELIVER REV, V64, P480, DOI 10.1016/j.addr.2011.10.009
   Kawakami K, 2010, INT J PHARMACEUT, V390, P250, DOI 10.1016/j.ijpharm.2010.02.018
   Kesisoglou F, 2007, ADV DRUG DELIVER REV, V59, P631, DOI 10.1016/j.addr.2007.05.003
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Matsumura Y, 2008, ADV DRUG DELIVER REV, V60, P899, DOI 10.1016/j.addr.2007.11.010
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Patton JS, 2007, NAT REV DRUG DISCOV, V6, P67, DOI 10.1038/nrd2153
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007
   Sasaki Y, 2010, CHEM REC, V10, P366, DOI 10.1002/tcr.201000008
   Smith H., 1994, ICRP PUBLICATION
   Sou T, 2011, TRENDS BIOTECHNOL, V29, P191, DOI 10.1016/j.tibtech.2010.12.009
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   Yang W, 2008, INT J PHARMACEUT, V356, P239, DOI 10.1016/j.ijpharm.2008.02.011
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhang J, 2011, ADV DRUG DELIVER REV, V63, P441, DOI 10.1016/j.addr.2010.11.002
   Zhang SL, 2011, MOL PHARMACEUT, V8, P807, DOI 10.1021/mp100401d
   Zhang SL, 2010, INT J PHARMACEUT, V397, P211, DOI 10.1016/j.ijpharm.2010.07.007
NR 31
TC 7
Z9 7
U1 2
U2 36
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0009-2363
J9 CHEM PHARM BULL
JI Chem. Pharm. Bull.
PD MAY
PY 2014
VL 62
IS 5
BP 422
EP 428
DI 10.1248/cpb.c13-01004
PG 7
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA AG2UY
UT WOS:000335273800004
PM 24789924
OA Bronze
DA 2018-10-20
ER

PT J
AU Choudhury, S
   Batabyal, S
   Mondol, T
   Sao, D
   Lemmens, P
   Pal, SK
AF Choudhury, Susobhan
   Batabyal, Subrata
   Mondol, Tanumoy
   Sao, Dilip
   Lemmens, Peter
   Pal, Samir Kumar
TI Ultrafast Dynamics of Solvation and Charge Transfer in a DNA- Based
   Biomaterial
SO CHEMISTRY-AN ASIAN JOURNAL
LA English
DT Article
DE charge transfer; DNA; quantum dots; solvation dynamics; thin films
ID REVERSE MICELLES; MINOR-GROOVE; QUANTUM DOTS; FTIR SPECTROSCOPY;
   WATER-MOLECULES; GENOMIC DNA; AEROSOL-OT; RECOGNITION; HYDRATION; SODIUM
AB Charge migration along DNA molecules is a key factor for DNA-based devices in optoelectronics and biotechnology. The association of a significant amount of water molecules in DNA-based materials for the intactness of the DNA structure and their dynamic role in the charge-transfer (CT) dynamics is less documented in contemporary literature. In the present study, we have used a genomic DNA-cetyltrimethyl ammonium chloride (CTMA) complex, a technological important biomaterial, and Hoechest 33258 (H258), a well-known DNA minor groove binder, as fluorogenic probe for the dynamic solvation studies. The CT dynamics of CdSe/ZnS quantum dots (QDs; 5.2nm) embedded in the as-prepared and swollen biomaterial have also been studied and correlated with that of the timescale of solvation. We have extended our studies on the temperature-dependent CT dynamics of QDs in a nanoenvironment of an anionic, sodium bis(2-ethylhexyl)sulfosuccinate reverse micelle (AOT RMs), whereby the number of water molecules and their dynamics can be tuned in a controlled manner. A direct correlation of the dynamics of solvation and that of the CT in the nanoenvironments clearly suggests that the hydration barrier within the Arrhenius framework essentially dictates the charge-transfer dynamics.
C1 [Choudhury, Susobhan; Batabyal, Subrata; Mondol, Tanumoy; Sao, Dilip; Pal, Samir Kumar] SN Bose Natl Ctr Basic Sci, Dept Chem Biol & Macromol Sci, Kolkata 700098, India.
   [Lemmens, Peter] Tech Univ Carolo Wilhelmina Braunschweig, Inst Condensed Matter Phys, D-38106 Braunschweig, Germany.
RP Pal, SK (reprint author), SN Bose Natl Ctr Basic Sci, Dept Chem Biol & Macromol Sci, Block JD,Sect 3, Kolkata 700098, India.
EM skpal@bose.res.in
RI Lemmens, Peter/C-8398-2009
OI Lemmens, Peter/0000-0002-0894-3412; Mondol, Tanumoy/0000-0002-4859-4640
FU CSIR, India; DST (India) [SB/S1/PC-011/2013, DST/TM/SERI/2k11/103]
FX S.C. and S. B. thank the CSIR, India for the research fellowships. We
   thank DST (India) for financial grants (SB/S1/PC-011/2013 and
   DST/TM/SERI/2k11/103).
CR Adhikary A, 2003, NUCLEIC ACIDS RES, V31, P2178, DOI 10.1093/nar/gkg308
   [Anonymous], 2004, ANGEW CHEM, V116, P62
   Arai S, 2005, NUCLEIC ACIDS RES, V33, P3017, DOI 10.1093/nar/gki616
   Banerjee D, 2008, J PHYS CHEM A, V112, P7314, DOI 10.1021/jp801778e
   Banerjee D, 2006, CHEM PHYS LETT, V432, P257, DOI 10.1016/j.cplett.2006.10.018
   Batabyal S, 2013, BIOCHIMIE, V95, P2168, DOI 10.1016/j.biochi.2013.08.015
   Behera GB, 1999, ADV COLLOID INTERFAC, V82, P1, DOI 10.1016/S0001-8686(98)00086-4
   CORREA NM, 1995, J COLLOID INTERF SCI, V172, P71, DOI 10.1006/jcis.1995.1226
   Cosa G, 2001, PHOTOCHEM PHOTOBIOL, V73, P585, DOI 10.1562/0031-8655(2001)073<0585:PPOFDD>2.0.CO;2
   DREW HR, 1981, J MOL BIOL, V151, P535, DOI 10.1016/0022-2836(81)90009-7
   Fink HW, 1999, NATURE, V398, P407, DOI 10.1038/18855
   Gorner H, 2001, PHOTOCHEM PHOTOBIOL, V73, P339, DOI 10.1562/0031-8655(2001)073<0339:DASPOB>2.0.CO;2
   GOTO A, 1993, LANGMUIR, V9, P86, DOI 10.1021/la00025a020
   Hagen JA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2197973
   HORNG ML, 1995, J PHYS CHEM-US, V99, P17311, DOI 10.1021/j100048a004
   JAIN TK, 1989, J PHYS CHEM-US, V93, P7409, DOI 10.1021/j100358a032
   JIMENEZ R, 1994, NATURE, V369, P471, DOI 10.1038/369471a0
   Kamat PV, 2008, J PHYS CHEM C, V112, P18737, DOI 10.1021/jp806791s
   Kasumov AY, 2001, SCIENCE, V291, P280, DOI 10.1126/science.291.5502.280
   Kawai K, 2009, NAT CHEM, V1, P156, DOI [10.1038/NCHEM.171, 10.1038/nchem.171]
   KAWAI T, 1985, J COLLOID INTERF SCI, V103, P56, DOI 10.1016/0021-9797(85)90076-1
   Kwon YW, 2009, J MATER CHEM, V19, P1353, DOI 10.1039/b808030e
   Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026
   Lee SL, 2004, J PHYS CHEM B, V108, P3098, DOI 10.1021/jp0311409
   LIEPINSH E, 1992, NUCLEIC ACIDS RES, V20, P6549, DOI 10.1093/nar/20.24.6549
   MACDONALD H, 1986, LANGMUIR, V2, P704, DOI 10.1021/la00072a005
   Makhal A, 2010, J PHYS CHEM C, V114, P627, DOI 10.1021/jp908376b
   MARONCELLI M, 1989, SCIENCE, V243, P1674, DOI 10.1126/science.243.4899.1674
   Mitra RK, 2008, J FLUORESC, V18, P423, DOI 10.1007/s10895-007-0282-1
   Mitra RK, 2008, LANGMUIR, V24, P49, DOI 10.1021/la7025895
   Nandi N, 2000, CHEM REV, V100, P2013, DOI 10.1021/cr980127v
   Narayanan SS, 2008, CHEM PHYS LETT, V452, P99, DOI 10.1016/j.cplett.2007.12.040
   Pal S, 2003, J PHYS CHEM B, V107, P5194, DOI 10.1021/jp022349+
   Pal SK, 2002, J PHYS CHEM B, V106, P12376, DOI 10.1021/jp0213506
   Pal SK, 2003, P NATL ACAD SCI USA, V100, P8113, DOI 10.1073/pnas.1433066100
   Pal SK, 2004, CHEM REV, V104, P2099, DOI 10.1021/cr020689l
   Pechstedt K, 2010, J PHYS CHEM C, V114, P12069, DOI 10.1021/jp100415k
   Range K, 2005, NUCLEIC ACIDS RES, V33, P1257, DOI 10.1093/nar/gki272
   Robel I, 2007, J AM CHEM SOC, V129, P4136, DOI 10.1021/ja070099a
   Sarkar R, 2006, BIOPOLYMERS, V83, P675, DOI 10.1002/bip.20606
   Schlag EW, 2000, P NATL ACAD SCI USA, V97, P9849, DOI 10.1073/pnas.140196597
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   ShankaraNarayanan S., 2008, CHEM PHYS LETT, V463, P160
   Shui XQ, 1998, BIOCHEMISTRY-US, V37, P8341, DOI 10.1021/bi973073c
   Singh T., 2010, ORGANIC ELECT ADV PO, V223, P73
   Steckl AJ, 2007, NAT PHOTONICS, V1, P3, DOI 10.1038/nphoton.2006.56
   Sun Q, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2841671
   Sun QJ, 2009, ACS NANO, V3, P737, DOI 10.1021/nn8009079
   Tereshko V, 1999, J AM CHEM SOC, V121, P3590, DOI 10.1021/ja984346+
   TSO TL, 1985, J PHYS CHEM-US, V89, P1612, DOI 10.1021/j100255a014
   Wan CZ, 2005, CHEM PHYS LETT, V412, P158, DOI 10.1016/j.cplett.2005.06.101
   Wan CZ, 2000, P NATL ACAD SCI USA, V97, P14052, DOI 10.1073/pnas.250483297
   Wang LL, 2001, CHEM MATER, V13, P1273, DOI 10.1021/cm000869g
   Warman JM, 1996, CHEM PHYS LETT, V249, P319, DOI 10.1016/0009-2614(95)01429-2
   Wolter M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4821594
   Yang M, 2011, J PHYS CHEM B, V115, P1262, DOI 10.1021/jp1090697
   Yang YG, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1931062
   Zhao L, 2004, ANGEW CHEM INT EDIT, V43, P60, DOI 10.1002/anie.200352961
NR 58
TC 13
Z9 13
U1 0
U2 18
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1861-4728
EI 1861-471X
J9 CHEM-ASIAN J
JI Chem.-Asian J.
PD MAY
PY 2014
VL 9
IS 5
BP 1395
EP 1402
DI 10.1002/asia.201400062
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA AF5UP
UT WOS:000334779000028
PM 24665050
DA 2018-10-20
ER

PT J
AU Shirvani, A
   Asgary, S
AF Shirvani, Armin
   Asgary, Saeed
TI Mineral trioxide aggregate versus formocresol pulpotomy: a systematic
   review and meta-analysis of randomized clinical trials
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Review
DE Biomaterial(s); Meta-analysis; MTA; Pediatric dentistry; Systematic
   reviews and evidence-based medicine
ID 2-YEAR FOLLOW-UP; PRIMARY TEETH; PRIMARY MOLARS
AB This study systematically reviewed randomized clinical trials (RCTs) investigating the effectiveness of primary molar pulpotomies with mineral trioxide aggregate (MTA) and formocresol. The study also aimed to assess the possible association of reported prognostic factors on the success rate and relative risk using meta-regression analysis.
   A comprehensive literature search using Medline, EMBASE, and Cochrane Central databases up to March 2013 was conducted. After scoring and data extraction of qualified trials (n = 19, representing 1,585 patients), meta-analyses were performed using Mantel-Haenszel model and inverse variance-weighted method.
   The results revealed that MTA is more effective than formocresol in primary molars pulpotomy, resulting in a lower failure rate with a relative risk of 0.26 (CI, 0.13-0.49), 0.37 (CI, 0.19-0.70), and 0.41 (CI, 0.25-0.68) for 6-, 12-, and 24-month follow-ups (test for statistical heterogeneity: p = 0.99, p = 0.98, and p = 0.23), respectively. Compared to amalgam restoration, success rate was significantly greater with SS crown (P < 0.05); however, no evidence for association between other reported prognostic factors such as selection of first/second molar, upper/lower jaw, gender, and various follow-up times with treatment success was observed.
   Based on the quality, homogeneity, and sufficient number of included RCTs, primary molar pulpotomy with MTA can produce a higher success rate in comparison with formocresol.
   When compared with formocresol, MTA pulpotomy is superior in treating primary molars.
C1 [Shirvani, Armin; Asgary, Saeed] Shahid Beheshti Univ Med Sci, Iranian Ctr Endodont Res, Res Inst Dent Sci, Shahid Beheshti Dent Sch, Tehran, Iran.
RP Asgary, S (reprint author), Shahid Beheshti Univ Med Sci, Iranian Ctr Endodont Res, Res Inst Dent Sci, Shahid Beheshti Dent Sch, Tehran, Iran.
EM saasgary@yahoo.com
CR Aeinehchi M, 2007, INT ENDOD J, V40, P261, DOI 10.1111/j.1365-2591.2007.01209.x
   Agamy HA, 2004, PEDIATR DENT, V26, P302
   Airen P, 2012, J CLIN PEDIATR DENT, V37, P143, DOI 10.17796/jcpd.37.2.h427vr8157444462
   Ansari G, 2010, INT ENDOD J, V43, P413, DOI 10.1111/j.1365-2591.2010.01695.x
   Asgary S, 2014, INT ENDOD J, V47, P611, DOI 10.1111/iej.12190
   Attari N, 2006, EUR ARCH PAEDIATR DE, V1, P58, DOI 10.1007/BF03320816
   Attari N, 2006, EUR ARCH PAEDIAT DEN, V7, P63
   Ding YJ, 2013, INT ENDOD J, V46, P999, DOI 10.1111/iej.12092
   Eidelman E, 2001, Pediatr Dent, V23, P15
   Erdem AP, 2011, PEDIATR DENT, V33, P165
   Farsi Najat, 2005, J Clin Pediatr Dent, V29, P307
   Godhi B, 2011, CONTEMP CLIN DENT, V2, P296, DOI 10.4103/0976-237X.91792
   Higgins JPT, 2008, COCHRANE HDB SYSTEMA
   Holan G, 2005, PEDIATR DENT, V27, P129
   Hugar SM, 2010, CONTEMP CLIN DENT, V1, P146, DOI 10.4103/0976-237X.72779
   Jabbarifar SE, 2004, J RES MED SCI, V6, P55
   Liu H, 2011, CHIN J DENT RES, V14, P121
   Mehrdad L, 2013, EUR ARCH PAEDIATR DE, V14, P191, DOI 10.1007/s40368-013-0038-3
   Mettlach Sarah E, 2013, Pediatr Dent, V35, pE87
   Moretti ABS, 2008, INT ENDOD J, V41, P547, DOI 10.1111/j.1365-2591.2008.01377.x
   Nadin G, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003220, DOI 10.1002/14651858.CD003220]
   Naik S, 2005, J Indian Soc Pedod Prev Dent, V23, P13
   Ng FK, 2008, EUR ARCH PAEDIATR DE, V9, P4, DOI 10.1007/BF03321589
   Noorollahian H, 2008, BRIT DENT J, V204, DOI 10.1038/sj.bdj.2008.319
   Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147
   Peng Li, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V102, pe40, DOI 10.1016/j.tripleo.2006.05.017
   Sackett DL, 1996, BRIT MED J, V312, P71
   Simancas-Pallares MA, 2010, MED ORAL PATOL ORAL, V15, pE942, DOI 10.4317/medoral.15.e942
   Sonmez D, 2008, J ENDODONT, V34, P950, DOI 10.1016/j.joen.2008.05.009
   Srinivasan Daya, 2011, Indian J Dent Res, V22, P385, DOI 10.4103/0970-9290.87058
   Subramaniam P, 2009, J CLIN PEDIATR DENT, V33, P311, DOI 10.17796/jcpd.33.4.r83r38423x58h38w
   Sushynski John M, 2012, Pediatr Dent, V34, P120
   van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/00007632-200306150-00014
   Zealand CM, 2010, PEDIATR DENT, V32, P393
NR 34
TC 8
Z9 8
U1 2
U2 21
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD MAY
PY 2014
VL 18
IS 4
BP 1023
EP 1030
DI 10.1007/s00784-014-1189-2
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AG3JH
UT WOS:000335311400001
PM 24452827
DA 2018-10-20
ER

PT J
AU Aminabhavi, TM
   Nadagouda, MN
   Joshi, SD
   More, UA
AF Aminabhavi, Tejraj M.
   Nadagouda, Mallikarjuna N.
   Joshi, Shrinivas D.
   More, Uttam A.
TI Guar gum as platform for the oral controlled release of therapeutics
SO EXPERT OPINION ON DRUG DELIVERY
LA English
DT Review
DE colon delivery; controlled release; guar gum; oral route; therapeutics
ID DRUG-DELIVERY-SYSTEMS; IN-VITRO EVALUATION; COLON-SPECIFIC DELIVERY;
   ALBENDAZOLE-BETA-CYCLODEXTRIN; SOLUBLE METOPROLOL TARTRATE;
   HEALTHY-HUMAN VOLUNTEERS; 3-LAYER MATRIX TABLETS; PHARMACOKINETIC
   EVALUATION; HYDROGEL MICROSPHERES; VIVO EVALUATION
AB Introduction: The past decade of research has witnessed a huge advancement in research efforts on guar gum (GG)-based polymers as controlled release (CR) formulations for the delivery of therapeutics.
   Areas covered: The unique structure and beneficial properties of GG makes it an attractive biomaterial in CR applications. Current status on GG-based polymers has been addressed as a CR formulation in the form of microspheres, nanoparticles, hydrogels and matrix tablets for the delivery of various types of therapeutics having a wide range of physicochemical properties. Majority of literature on GG as a platform technology has dealt with oral route of drug administration as it is the most convenient, patient-compliant and preferred approach. Recent reports on GG-based polymers are summarized and critically discussed to narrate their usefulness as oral delivery systems.
   Expert opinion: The research on GG-based formulations has been focused on optimization of the therapy by designing CR dosage forms with a minimum number of excipients. In this context, GG-based polymers are quite attractive. The present review summarizes published reports on these systems and offers expert opinion relevant to oral delivery of therapeutics.
C1 [Aminabhavi, Tejraj M.; Nadagouda, Mallikarjuna N.; Joshi, Shrinivas D.; More, Uttam A.] SETs Coll Pharm, Dept Pharmaceut Engn & Chem, Dharwad 580002, Karnataka, India.
RP Aminabhavi, TM (reprint author), SETs Coll Pharm, Dept Pharmaceut Engn & Chem, Dharwad 580002, Karnataka, India.
EM aminabhavi@yahoo.com
OI More, Uttam/0000-0003-0436-8630
FU Indian Council of Medical Research [64/ 4/ 2011-BMS]; IRIS, New Delhi,
   India [2010-08710]
FX The research was supported by Indian Council of Medical Research, File
   No. 64/ 4/ 2011-BMS, IRIS Cell No. 2010-08710, New Delhi, India.
CR Agnihotri SA, 2005, DRUG DEV IND PHARM, V31, P491, DOI 10.1080/03639040500215875
   Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Al-Saidan S. M., 2005, Current Drug Delivery, V2, P155, DOI 10.2174/1567201053586010
   Al-Saidan Saleh M, 2005, AAPS PharmSciTech, V6, pE14, DOI 10.1208/pt060105
   Al-Saidan SM, 2004, EUR J PHARM BIOPHARM, V58, P697, DOI 10.1016/j.ejpb.2004.04.013
   Altaf SA, 1998, PHARMACEUT RES, V15, P1196, DOI 10.1023/A:1011931622536
   Angadi SC, 2013, IND ENG CHEM RES, V52, P6399, DOI 10.1021/ie302581m
   Babu VR, 2008, EXPERT OPIN DRUG DEL, V5, P403, DOI 10.1517/17425247.5.4.403 
   Berner-Strzelczyk Aneta, 2006, Polim Med, V36, P3
   Bhat Subramanya K., 2013, PHARM CHEM, V5, P221
   Bhawna G, 2011, INT J PHARM BIO SCI, V2, P528
   Bhawna Gauri, 2011, INT J DRUG DELIVERY, V3, P503
   Bhosale A, 2009, INT J PHARM TECH RES, V1, P328
   Chandrasekhar Y, 2011, INT J RES PHARM BIOM, V2, P245
   Chaturvedi K, 2013, J CONTROL RELEASE, V165, P129, DOI 10.1016/j.jconrel.2012.11.005
   Chaturvedi K, 2011, EXPERT OPIN DRUG DEL, V8, P1455, DOI 10.1517/17425247.2011.610790
   Chaurasia M., 2006, AAPS PHARMSCITECH, V7, pE1
   Chavda HV, 2012, RES PHARM SCI, V7, P57
   Chickpetty S. M., 2010, INT J PHARM TECH RES, V2, P1714
   Choudhury PK, 2012, ASIAN J PHARM CLIN R, V5, P86
   Chourasia MK, 2004, J DRUG TARGET, V12, P435, DOI 10.1080/10611860400006604
   Das A, 2006, DRUG DELIV, V13, P139, DOI 10.1080/10717540500313455
   Draganoiu ES, 2003, THESIS U CINCINNATI
   Durig T, 2002, J CONTROL RELEASE, V80, P45, DOI 10.1016/S0168-3659(01)00546-6
   El-Mahdi IM, 2000, J MICROENCAPSUL, V17, P133
   Elias EJ, 2010, NAT PROD COMMUN, V5, P915
   Fiszman S, 2013, FOOD HYDROCOLLOID, V32, P147, DOI 10.1016/j.foodhyd.2012.12.010
   Friend D. R., 1997, P INT S CONTR REL BI, V24, P311
   Ghosh P, 2010, ASIAN J PHARM, V4, P173
   Ghosh S, 2010, TROP J PHARM RES, V9, P265
   Girish B., 2012, INT J PHARM PHARM SC, V4, P120
   Hartzell A, 2011, ULCERATIVE COLITIS T, DOI [10.5772/27138, DOI 10.5772/27138]
   Huang YH, 2007, CARBOHYD POLYM, V69, P774, DOI 10.1016/j.carbpol.2007.02.016
   Ji CM, 2009, J BIOMATER APPL, V23, P311, DOI 10.1177/0885328208089617
   Ji Chong-min, 2007, Yaoxue Xuebao, V42, P656
   Kajjari PB, 2012, AAPS PHARMSCITECH, V13, P1147, DOI 10.1208/s12249-012-9838-8
   Kajjari PB, 2011, IND ENG CHEM RES, V50, P13280, DOI 10.1021/ie2012856
   Kaushik D, 2009, INT J PHARM SCI DRUG, V1, P83
   Kaushik Dinesh, 2009, Yaoxue Xuebao, V44, P1278
   Khemchand G, 2011, RES J PHARM TECHNOL, V4, P1240
   Krishna K. V., 2012, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V3, P506
   Krishnaiah YSR, 2003, EUR J DRUG METAB PH, V28, P287, DOI 10.1007/BF03220181
   Krishnaiah YSR, 2003, J CONTROL RELEASE, V88, P95, DOI 10.1016/S0168-3659(02)00483-2
   Krishnaiah YSR, 2003, DRUG DELIV, V10, P263, DOI 10.1080/10717540390235634
   Krishnaiah YSR, 2003, EUR J PHARM SCI, V19, P355, DOI 10.1016/S0928-0987(03)00139-8
   Krishnaiah YSR, 2003, J DRUG TARGET, V11, P109, DOI 10.1080/1061186031000138614
   Krishnaiah YSR, 2003, DRUG DELIV, V10, P111, DOI 10.1080/10717540390169674
   Krishnaiah YSR, 2002, EUR J DRUG METAB PH, V27, P273, DOI 10.1007/BF03192338
   Krishnaiah YSR, 2002, J DRUG TARGET, V10, P579, DOI 10.1080/1061186021000072690
   Krishnaiah YSR, 2002, J CONTROL RELEASE, V81, P45, DOI 10.1016/S0168-3659(02)00031-7
   Krishnaiah YSR, 2002, J CONTROL RELEASE, V83, P231, DOI 10.1016/S0168-3659(02)00215-8
   Krishnaiah YSR, 2002, INT J PHARM, V241, P353, DOI 10.1016/S0378-5173(02)00273-9
   Krishnaiah YSR, 2002, J DRUG TARGET, V10, P247, DOI 10.1080/10611860290022697
   Krishnaiah YSR, 2002, INT J PHARM, V236, P43, DOI 10.1016/S0378-5173(02)00006-6
   Krishnaiah YSR, 2002, EUR J PHARM SCI, V16, P185, DOI 10.1016/S0928-0987(02)00081-7
   Krishnaiah YSR, 2001, J CONTROL RELEASE, V77, P87, DOI 10.1016/S0168-3659(01)00461-8
   Krishnaiah YSR, 2001, J PHARM PHARM SCI, V4, P235
   Kumar SR, 2011, CHEM PHARM BULL, V59, P185, DOI 10.1248/cpb.59.185
   Lakshmi K Rajya, 2012, INT J PHARM PHARM SC, V4, P284
   Martinez A, 2012, DELIVERY NANOPARTICL, DOI [10.5772/34156, DOI 10.5772/34156]
   Mishra B., 2004, ACTA PHARM TURC, V46
   Miyan SS, 2011, RES J PHARM TECHNOL, V4, P1060
   Mor J, 2011, PHARM RES, V5, P176
   Mothilal M, 2012, RES J PHARM BIOL CHE, V3, P1062
   Mughal MA, 2011, AAPS PHARMSCITECH, V12, P77, DOI 10.1208/s12249-010-9570-1
   Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013
   Mundargi RC, 2007, DRUG DEV IND PHARM, V33, P79, DOI 10.1080/03639040600975030
   Mundargi RC, 2007, DRUG DEV IND PHARM, V33, P255, DOI 10.1080/03639040600897127
   Mundargi RC, 2007, CARBOHYD POLYM, V69, P130, DOI 10.1016/j.carbpol.2006.09.007
   Murad F, 1990, PHARMACOL BASIS THER, P764
   Nep E. I., 2011, J EXCIPIENTS FOOD CH, V2, P3
   Niranjan K, 2013, ASIAN J PHARM CLIN R, V6, P310
   Patra CN, 2004, INDIAN J PHARM SCI, V66, P636
   Potu A, 2011, ASIAN J PHARM CLIN R, V4, P88
   Prabaharan M, 2011, INT J BIOL MACROMOL, V49, P117, DOI 10.1016/j.ijbiomac.2011.04.022
   Rangapriya M, 2011, INT J PHARM TECHNOL, V3, P3682
   Reddy KM, 2006, DES MONOMERS POLYM, V9, P491, DOI 10.1163/156855506778538047
   Rideout TC, 2008, VASC HEALTH RISK MAN, V4, P1023, DOI 10.2147/VHRM.S3512
   Rudzinski WE, 2010, INT J PHARMACEUT, V399, P1, DOI 10.1016/j.ijpharm.2010.08.022
   Sarmah JK, 2011, INT J BIOL MACROMOL, V49, P390, DOI 10.1016/j.ijbiomac.2011.05.020
   Sathyaraj A, 2012, INT J PHARM SCI RES, V3, P247, DOI 10.13040/IJPSR.0975-8232.3(1).247-56
   Sekhar E. C., 2011, J APPL PHARM SCI, V1, P199
   Seshasayana A., 2001, Indian Journal of Pharmaceutical Sciences, V63, P337
   Shah P, 2010, INT J PHARM RES, V2, P52
   Shaikh AA, 2012, INT J PHARM SCI RES, V3, P1411, DOI 10.13040/IJPSR.0975-8232.3(5).1411-14
   Sharma M, 2013, J BIOMED NANOTECHNOL, V9, P96, DOI 10.1166/jbn.2013.1474
   Sharma S, 2013, INT J BIOL MACROMOL, V62, P636, DOI 10.1016/j.ijbiomac.2013.09.045
   Shukla RK, 2012, CURR NANOSCI, V8, P571
   Shukla RK, 2012, J APPL POLYM SCI, V126, P304, DOI 10.1002/app.36900
   Shyale S, 2006, DRUG DEVELOP RES, V67, P154, DOI 10.1002/ddr.20072
   Shyale S, 2005, DRUG DEVELOP RES, V65, P76, DOI 10.1002/ddr.20010
   Sinha VR, 2005, INT J PHARM, V289, P79, DOI 10.1016/j.ijpharm.2004.10.019
   Sinha VR, 2004, DRUG DEV IND PHARM, V30, P143, DOI 10.1081/DDC-120028709
   Sinha VR, 2004, INT J PHARM, V269, P101, DOI 10.1016/j.ijpharm.2003.09.036
   Soppimath KS, 2001, J CONTROL RELEASE, V75, P331, DOI 10.1016/S0168-3659(01)00404-7
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Soppimath KS, 2000, J BIOMAT SCI-POLYM E, V11, P27, DOI 10.1163/156856200743472
   Soppirnath KS, 2002, EUR J PHARM BIOPHARM, V53, P87, DOI 10.1016/S0939-6411(01)00205-3
   Srivastava P., 2010, Pharmacognosy Journal, V2, P525
   Sullad AG, 2011, J APPL POLYM SCI, V122, P452, DOI 10.1002/app.34173
   Sullad AG, 2010, IND ENG CHEM RES, V49, P7323, DOI 10.1021/ie100389v
   Suresh S, 2011, PHARM LETT, V3, P237
   Syed IA, 2011, INT J DRUG DELIV, V1, P286
   Tiwari A, 2010, J BIOMAT SCI-POLYM E, V21, P937, DOI 10.1163/156856209X452278
   Toti US, 2004, J APPL POLYM SCI, V93, P2245, DOI 10.1002/app.20768
   Toti US, 2004, J CONTROL RELEASE, V95, P567, DOI 10.1016/j.jconrel.2003.12.019
   Varshosaz J, 2006, DRUG DELIV, V13, P113, DOI 10.1080/10717540500313356
   Yadav AS, 2010, J PHARM SCI TECHNOL, V2, P156
   Yi JZ, 2007, J APPL POLYM SCI, V103, P3553, DOI 10.1002/app.24566
NR 109
TC 15
Z9 15
U1 0
U2 21
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1742-5247
EI 1744-7593
J9 EXPERT OPIN DRUG DEL
JI Expert Opin. Drug Deliv.
PD MAY
PY 2014
VL 11
IS 5
BP 753
EP 766
DI 10.1517/17425247.2014.897326
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AF9AT
UT WOS:000335008000010
PM 24650099
DA 2018-10-20
ER

PT J
AU Garg, T
   Goyal, AK
AF Garg, Tarun
   Goyal, Amit K.
TI Biomaterial-based scaffolds - current status and future directions
SO EXPERT OPINION ON DRUG DELIVERY
LA English
DT Review
DE biomaterial-based scaffold; hydrogels; microspheres; nano-fibre; porous
   matrix
ID DRUG-DELIVERY SYSTEM; MESENCHYMAL STEM-CELLS; IN-VITRO CHARACTERIZATION;
   COLON-SPECIFIC DELIVERY; ORAL INSULIN DELIVERY; WATER-SOLUBLE DRUGS;
   CONTROLLED-RELEASE; PHASE-SEPARATION; HYALURONIC-ACID; NANO-FIBER
AB Introduction: Biomaterial-based scaffold formulations (three-dimensional Porous matrix, nano-fibre mesh, hydrogels and microspheres) are the major components that are used to deliver the bioactive molecules into the body organs through different routes for an effective treatment of various diseases.
   Areas covered: Various fabrication techniques such as freeze-drying, polymerisation, spray drying, gas foaming, supercritical fluid technology, etc., are successfully used for fabrication of scaffold formulations. Due to their unique characteristics, these formulations are widely used against various diseases such as tuberculosis, bone defects, cartilage repair, skin diseases, cardiovascular diseases, periodontal diseases, wound dressing, etc.
   Expert opinion: The study of biomaterial-based scaffold formulations is exhilarating with novel approaches to drug/cell/gene delivery being developed all the time. At present, there is a huge extent of research being performed worldwide on all aspects of tissue engineering/drug or gene delivery. In the future, the main focus will be on the development of more patient compliant, sustained and controlled delivery systems against various diseases by modification of polymers, manufacturing technologies as well as carrier systems.
C1 [Garg, Tarun; Goyal, Amit K.] ISF Coll Pharm, Dept Pharmaceut, Moga, Punjab, India.
RP Garg, T (reprint author), ISF Coll Pharm, Dept Pharmaceut, Moga, Punjab, India.
EM tarun.garg9@gmail.com
FU IYBA [BT/01/IYBA/ 2009]
FX Authors AK Goyal (under IYBA scheme; BT/01/IYBA/2009 dated 24/05/2010)
   and T Garg are thankful to Department of Biotechnology (DBT), New Delhi,
   India and Punjab Technical University, Jalandhar.
CR Ahearne M, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035004
   Ahmad MZ, 2012, EXPERT OPIN DRUG DEL, V9, P141, DOI 10.1517/17425247.2012.633507
   Almeida JS, 2012, DRUG DEV IND PHARM, V38, P792, DOI 10.3109/03639045.2011.628676
   Aoshima M, 2002, J COLLOID INTERF SCI, V253, P455, DOI 10.1006/jcis.2002.8451
   Asghar LFA, 2008, J DRUG TARGET, V16, P741, DOI [10.1080/10611860802473345, 10.1080/10611860802473345 ]
   Ashley GW, 2013, P NATL ACAD SCI USA, V110, P2318, DOI 10.1073/pnas.1215498110
   Attia J, 2007, LANGMUIR, V23, P9523, DOI 10.1021/1a701366f
   Batrakova EV, 2011, EXPERT OPIN DRUG DEL, V8, P415, DOI 10.1517/17425247.2011.559457
   Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033
   Blaker JJ, 2008, ACTA BIOMATER, V4, P264, DOI 10.1016/j.actbio.2007.09.011
   Brus C, 2004, J CONTROL RELEASE, V95, P119, DOI 10.1016/j.jconrel.2003.10.021
   Campistol JM, 1996, KIDNEY INT, V50, P1262, DOI 10.1038/ki.1996.436
   Centola M, 2013, TISSUE ENG PT A, V19, P1960, DOI [10.1089/ten.tea.2012.0455, 10.1089/ten.TEA.2012.0455]
   Chang JY, 2002, J CONTROL RELEASE, V82, P39, DOI 10.1016/S0168-3659(02)00086-X
   Chang NJ, 2013, OSTEOARTHR CARTILAGE, V21, P1613, DOI 10.1016/j.joca.2013.07.016
   Chaturvedi K, 2013, J CONTROL RELEASE, V165, P129, DOI 10.1016/j.jconrel.2012.11.005
   Chen ML, 2012, ACS NANO, V6, P4835, DOI 10.1021/nn300106t
   Cheng QY, 2013, J NANOSCI NANOTECHNO, V13, P755, DOI 10.1166/jnn.2013.6058
   Chung TW, 2006, INT J PHARM, V311, P122, DOI 10.1016/j.ijpharm.2005.12.038
   Codling DJ, 2013, J PHYS CHEM B, V117, P2734, DOI 10.1021/jp311044a
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Das A, 2006, DRUG DELIV, V13, P139, DOI 10.1080/10717540500313455
   Deriase Samiha F., 2001, Acta Microbiologica Polonica, V50, P45
   Dhanda DS, 2013, J CONTROL RELEASE, V168, P239, DOI 10.1016/j.jconrel.2013.03.027
   Ding K, 2013, CELL BIOL INT, V37, P977, DOI 10.1002/cbin.10123
   El-Leithy ES, 2010, AAPS PHARMSCITECH, V11, P1695, DOI 10.1208/s12249-010-9544-3
   Endres T, 2012, J CONTROL RELEASE, V160, P583, DOI 10.1016/j.jconrel.2012.04.013
   Falconi M, 2013, J MICROENCAPSUL, V31, P41
   Fatunmbi HO, 2013, LANGMUIR, V29, P4974, DOI 10.1021/la3040853
   Fernandez-Carballido A, 2008, INT J PHARM, V352, P50, DOI 10.1016/j.ijpharm.2007.10.007
   Foged C, 2008, EXPERT OPIN DRUG DEL, V5, P105, DOI 10.1517/17425247.5.1.105
   Fu J, 2010, J BIOMED NANOTECHNOL, V6, P725, DOI 10.1166/jbn.2010.1135
   Fukui T, 2012, J BONE MINER RES, V27, P1118, DOI 10.1002/jbmr.1558
   Garg T, 2013, CRIT REV THER DRUG, V30, P369, DOI 10.1615/CritRevTherDrugCarrierSyst.2013007259
   Garg T, 2012, CRIT REV THER DRUG, V29, P1
   Genc L, 1998, J MICROENCAPSUL, V15, P45, DOI 10.3109/02652049809006834
   Gerberich BG, 2013, BIOTECHNOL J, V8, P73, DOI 10.1002/biot.201200131
   Gokhale Kedar S, 2013, PDA J Pharm Sci Technol, V67, P255, DOI 10.5731/pdajpst.2013.00919
   Goyal G, 2013, DRUG DELIV
   Grenier S, 2007, J BIOMED MATER RES A, V82A, P802, DOI 10.1002/jbm.a.31194
   Guo BL, 2007, CARBOHYD RES, V342, P2416, DOI 10.1016/j.carres.2007.07.007
   Guo YJ, 2013, MAT SCI ENG C-MATER, V33, P3583, DOI 10.1016/j.msec.2013.04.021
   Hadizadeh F, 2013, J SCI FOOD AGR, V93, P304, DOI 10.1002/jsfa.5757
   Hagerstrom H, 2001, J PHARM PHARMACOL, V53, P1589, DOI 10.1211/0022357011778197
   Halberstadt Craig, 2013, Methods Mol Biol, V1001, P279, DOI 10.1007/978-1-62703-363-3_23
   Hassan W, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt182
   He P, 2013, INT J PHARMACEUT, V455, P259, DOI 10.1016/j.ijpharm.2013.07.022
   He XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060473
   Hidalgo-Bastida LA, 2007, ACTA BIOMATER, V3, P457, DOI 10.1016/j.actbio.2006.12.006
   Hu CZ, 2013, J BIOSCI BIOENG, V116, P126, DOI 10.1016/j.jbiosc.2013.01.011
   Hu WZ, 2011, J SCI FOOD AGR, V91, P1499, DOI 10.1002/jsfa.4340
   Hu YY, 2003, J BIOMED MATER RES A, V67A, P591, DOI 10.1002/jbm.a.10070
   Huang S, 2012, J DERMATOL SCI, V66, P29, DOI 10.1016/j.jdermsci.2012.02.002
   Hutmacher D, 2008, J BIOMAT SCI-POLYM E, V19, P541, DOI 10.1163/156856208784089634
   Huynh DP, 2009, J CONTROL RELEASE, V137, P20, DOI 10.1016/j.jconrel.2009.02.021
   Hwang HD, 2012, COLLOID SURFACE B, V91, P106, DOI 10.1016/j.colsurfb.2011.10.052
   Hwang K, 2012, J CRANIOFAC SURG, V23, P1174, DOI 10.1097/SCS.0b013e31824f6647
   Hwang S, 2011, J NANOSCI NANOTECHNO, V11, P610, DOI 10.1166/jnn.2011.3243
   Ige PP, 2012, ARCH PHARM RES, V35, P487, DOI 10.1007/s12272-012-0312-7
   Jain RA, 2000, J MICROENCAPSUL, V17, P343
   Jesmeen T, 2013, CURR DRUG DELIV, V10, P765
   Jia BQ, 2011, CARBOHYD RES, V346, P1337, DOI 10.1016/j.carres.2011.04.040
   Jiang TY, 2014, DRUG DEV IND PHARM, V40, P252, DOI 10.3109/03639045.2012.756511
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Junwei Z, 2013, SCI WORLD J, V2013
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kianfar F, 2014, DRUG DEV IND PHARM, V40, P361, DOI 10.3109/03639045.2012.762655
   Kim H, 2005, BIOCHEM BIOPH RES CO, V332, P1053, DOI 10.1016/j.bbrc.2005.05.051
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Kloxin AM, 2009, SCIENCE, V324, P59
   Koli JM, 2011, J FOOD SCI, V76, pE503, DOI 10.1111/j.1750-3841.2011.02266.x
   Konishi M, 2005, J CONTROL RELEASE, V103, P7, DOI 10.1016/j.conrel.2004.11.014
   Kovacs EW, 2007, BIOCONJUGATE CHEM, V18, P1140, DOI 10.1021/bc070006e
   Kumar PTS, 2012, ACS APPL MATER INTER, V4, P2618, DOI 10.1021/am300292v
   Kundu B, 2010, J MATER SCI-MATER M, V21, P2955, DOI 10.1007/s10856-010-4127-0
   Langdon SR, 2013, J CHEM INF MODEL, V53, P1100, DOI 10.1021/ci400100c
   Lee GS, 2011, ACTA BIOMATER, V7, P3178, DOI 10.1016/j.actbio.2011.04.008
   Lee J, 2010, J CONTROL RELEASE, V146, P61, DOI 10.1016/j.jconrel.2010.05.026
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Li L, 2009, J BIOMAT SCI-POLYM E, V20, P341, DOI 10.1163/156856209X412209
   Liang L, 1996, TALANTA, V43, P1883, DOI 10.1016/0039-9140(96)01964-9
   Lima AC, 2012, EXPERT OPIN DRUG DEL, V9, P231, DOI 10.1517/17425247.2012.652614
   Llano R, 2009, CATHETER CARDIO INTE, V73, P251, DOI 10.1002/ccd.21781
   Loh XJ, 2010, J CONTROL RELEASE, V143, P175, DOI 10.1016/j.jconrel.2009.12.030
   Madhaiyan K, 2013, INT J PHARMACEUT, V444, P70, DOI 10.1016/j.ijpharm.2013.01.040
   Manning CN, 2013, ACTA BIOMATER, V9, P6905, DOI 10.1016/j.actbio.2013.02.008
   Mao GH, 2009, BIOMATERIALS, V30, P1706, DOI 10.1016/j.biomaterials.2008.12.030
   Mathieu E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051991
   Melaiye A, 2005, J AM CHEM SOC, V127, P2285, DOI 10.1021/ja040226s
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Mohanraj K, 2013, J BIOMED MATER RES B, V101B, P840, DOI 10.1002/jbm.b.32888
   Monajjemzadeh F, 2013, DRUG RES
   Montero RB, 2012, ACTA BIOMATER, V8, P1778, DOI 10.1016/j.actbio.2011.12.008
   Moshaverinia A, 2013, ACTA BIOMATER, V9, P9343, DOI 10.1016/j.actbio.2013.07.023
   Moshaverinia A, 2013, BIOMATERIALS, V34, P6572, DOI 10.1016/j.biomaterials.2013.05.048
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   Musumeci T, 2013, INT J PHARMACEUT, V440, P135, DOI 10.1016/j.ijpharm.2012.10.014
   Mutsuga M, 2009, INTERACT CARDIOV TH, V8, P06
   Mutsuga Masato, 2009, Interact Cardiovasc Thorac Surg, V8, P402, DOI 10.1510/icvts.2008.192831
   Na SY, 2012, J MATER SCI-MATER M, V23, P2303, DOI 10.1007/s10856-012-4689-0
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Nanjwade BK, 2012, EUR J DRUG METAB PH, V37, P117, DOI 10.1007/s13318-011-0070-9
   Natesan S, 2010, TISSUE ENG PT A, V16, P1369, DOI [10.1089/ten.tea.2009.0404, 10.1089/ten.TEA.2009.0404]
   Nath SD, 2013, J BIOMATER APPL
   Nava-Arzaluz Maria G, 2012, Recent Pat Drug Deliv Formul, V6, P209
   Nguyen TH, 2011, J BIOMED MATER RES B, V96B, P225, DOI 10.1002/jbm.b.31756
   Niu XF, 2011, ARTIF ORGANS, V35, pE119, DOI 10.1111/j.1525-1594.2011.01274.x
   Niwa T, 2010, CHEM PHARM BULL, V58, P195, DOI 10.1248/cpb.58.195
   Oh SH, 2011, J BIOMED MATER RES A, V97A, P441, DOI 10.1002/jbm.a.33079
   Oh SH, 2010, J BIOMAT SCI-POLYM E
   OLIVE D, 1993, CRIT REV THER DRUG, V10, P29
   Pagar KP, 2014, PHARM DEV TECHNOL, V19, P385, DOI 10.3109/10837450.2013.784334
   Panda P, 2008, LAB CHIP, V8, P1056, DOI 10.1039/b804234a
   Paquay YC, 1996, ASAIO J, V42, P961, DOI 10.1097/00002480-199642060-00008
   Park JS, 2007, J CONTROL RELEASE, V124, P51, DOI 10.1016/j.jconrel.2007,08.030
   Parnami N, 2013, ARTIF CELLS NANOMED
   Pasquinelli G, 2008, J ANAT, V213, P520, DOI 10.1111/j.1469-7580.2008.00974.x
   Petersen S, 2013, J MATER SCI-MATER M, V24, P2589, DOI 10.1007/s10856-013-5001-7
   Phaechamud T, 2008, AAPS PHARMSCITECH, V9, P668, DOI 10.1208/s12249-008-9085-1
   Phaechamud T, 2007, DRUG DEV IND PHARM, V33, P595, DOI 10.1080/03639040601015521
   Phull MK, 2013, J MATER SCI-MATER M, V24, P461, DOI 10.1007/s10856-012-4806-0
   Pignatello R, 2009, DRUG DELIV, V16, P176, DOI 10.1080/10717540902861267
   Pinon-Segundo Elizabeth, 2012, Recent Pat Drug Deliv Formul, V6, P224
   Popa E. G., 2013, J TISSUE ENG REGEN M
   Prescott RS, 2008, J ENDODONT, V34, P421, DOI 10.1016/j.joen.2008.02.005
   Qi AS, 2011, ACS NANO, V5, P9583, DOI 10.1021/nn202833n
   Ramasamy T, 2013, DRUG DELIV, V20, P65, DOI 10.3109/10717544.2012.762434
   Rath SN, 2012, J BIOMATER APPL, V27, P277, DOI 10.1177/0885328211402243
   Goncalves APR, 2013, BRAZ ORAL RES, V27, P70, DOI 10.1590/S1806-83242013000100012
   Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c
   Sahni J, 2008, INDIAN J PHARM SCI, V70, P61, DOI 10.4103/0250-474X.40333
   Sarojini HII, 2007, BIOTECHNIQUES, V43, P213, DOI 10.2144/000112493
   Shahzad MK, 2013, ADV CLIN EXP MED, V22, P177
   Singh B, 2009, BIOMACROMOLECULES, V10, P2515, DOI 10.1021/bm9004645
   Singh D, 2011, J BIOMAT SCI-POLYM E, V22, P1733, DOI 10.1163/092050610X522486
   Skop NB, 2013, ACTA BIOMATER, V9, P6834, DOI 10.1016/j.actbio.2013.02.043
   Sohier J, 2006, J CONTROL RELEASE, V111, P95, DOI 10.1016/j.conrel.2005.11.016
   Son JS, 2011, J CONTROL RELEASE, V153, P133, DOI 10.1016/j.jconrel.2011.03.010
   Sukarto A, 2012, BIOMACROMOLECULES, V13, P2490, DOI 10.1021/bm300733n
   Sundar SS, 2012, J MATER SCI-MATER M, V23, P1421, DOI 10.1007/s10856-012-4610-x
   Sweet JL, 2007, DRUG DELIV, V14, P309, DOI 10.1080/10717540701203067
   Tang JH, 2012, PHARMAZIE, V67, P756, DOI 10.1691/ph.2012.1152
   Teles H, 2010, J CONTROL RELEASE, V147, P298, DOI 10.1016/j.jconrel.2010.07.098
   Tsuboi Y, 2008, J PHYS CHEM B, V112, P2562, DOI 10.1021/jp711128s
   Tuzlakoglu K, 2005, J MATER SCI-MATER M, V16, P1099, DOI 10.1007/s10856-005-4713-8
   Vaghani SS, 2012, CURR DRUG DELIV, V9, P628
   van Dijken JWV, 1998, AM J DENT, V11, P165
   Wang JL, 2012, J BIOMED MATER RES A, V100A, P1438, DOI 10.1002/jbm.a.34081
   Wang LM, 2013, CELLS TISSUES ORGANS, V197, P333, DOI 10.1159/000348359
   Wang MJ, 2010, MOL PHARMACEUT, V7, P2232, DOI 10.1021/mp100227m
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Whang K, 2000, BIOMATERIALS, V21, P2545, DOI 10.1016/S0142-9612(00)00122-8
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xu K, 2013, MOL MED REP, V8, P1300, DOI 10.3892/mmr.2013.1673
   Xu Y, 2013, DRUG DEV IND PHARM
   Yang Y, 2012, NMR BIOMED, V25, P227, DOI 10.1002/nbm.1735
   Yin AL, 2013, J BIOMED MATER RES A, V101, P1292, DOI 10.1002/jbm.a.34434
   Yoon H, 2011, J PHARM SCI-US, V100, P424, DOI 10.1002/jps.22310
   Zachariadis GA, 2013, BIOMED CHROMATOGR, V27, P299, DOI 10.1002/bmc.2791
   Zamora DO, 2012, JOVE-J VIS EXP, V64, pe3624
   Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109
   Zhang J, DEVELOPMENT
   Zhang JJ, 2012, OPT LETT, V37, P2925, DOI 10.1364/OL.37.002925
   Zhang JF, 2013, INT J PHARMACEUT, V448, P168, DOI 10.1016/j.ijpharm.2013.03.021
   Zhang W, 2009, J COLLOID INTERF SCI, V333, P346, DOI 10.1016/j.jcis.2009.01.058
   Zhou YL, 2011, TISSUE ENG PT A, V17, P2981, DOI 10.1089/ten.tea.2010.0707
   Zustiak SP, 2013, BIOTECHNOL PROGR, V29, P1255, DOI 10.1002/btpr.1761
NR 167
TC 86
Z9 90
U1 26
U2 277
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1742-5247
EI 1744-7593
J9 EXPERT OPIN DRUG DEL
JI Expert Opin. Drug Deliv.
PD MAY
PY 2014
VL 11
IS 5
BP 767
EP 789
DI 10.1517/17425247.2014.891014
PG 23
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AF9AT
UT WOS:000335008000011
PM 24669779
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Prabunathan, P
   Sethuraman, K
   Alagar, M
AF Prabunathan, P.
   Sethuraman, K.
   Alagar, Muthukaruppan
TI Development of bio-based F-SBA-15 reinforced epoxy nanocomposites for
   low-k dielectric applications
SO HIGH PERFORMANCE POLYMERS
LA English
DT Article
DE epoxy composites; low-k dielectric constant; mesoporous SBA-15; Rice
   husk ash
ID RICE HUSK ASH; SILICA; COMPOSITES; POLYIMIDE
AB The present work focuses on the utilization of renewable biomaterial as reinforcement for the development of nanocomposites for high-performance low-k microelectronic applications. In the present work, rice husk ash (RHA) was chemically treated and processed to obtain two-dimensional mesoporous silica (SBA-15), which was functionalized using 3-glycidoxypropyl trimethoxy silane through sonication process. The surface functionalized SBA-15 (F-SBA-15) with varying weight percentages (1, 3, and 5 wt%) was incorporated into the epoxy resin. The resulting F-SBA-15-reinforced epoxy composites were characterized by Fourier transform infrared spectroscopy, x-ray diffraction, differential scanning calorimetry, thermogravimetric analysis, and impedance analyzer. Among the composite samples with varying loadings, the dielectric behavior of 5 wt% F-SBA-15-loaded composite sample possesses the lowest value of dielectric constant, that is, 2.14 at 1 MHz frequency when compared with that of other samples. Further, the thermal stability was also enhanced to an appreciable extent, when compared with that of the samples with lower F-SBA-15 loadings.
C1 [Prabunathan, P.; Sethuraman, K.; Alagar, Muthukaruppan] Anna Univ, Dept Chem Engn, Polymer Composite Lab, Madras 600025, Tamil Nadu, India.
RP Alagar, M (reprint author), Anna Univ, Dept Chem Engn, Polymer Composite Lab, Madras 600025, Tamil Nadu, India.
EM mkalagar@yahoo.com
CR Arayapranee W, 2005, J APPL POLYM SCI, V98, P34, DOI 10.1002/app.21004
   Bhagiyalakshmi M, 2010, J HAZARD MATER, V175, P928, DOI 10.1016/j.jhazmat.2009.10.097
   Bondioli F, 2007, J EUR CERAM SOC, V27, P3483, DOI 10.1016/j.jeurceramsoc.2007.01.019
   Bondioli F, 2010, J AM CERAM SOC, V93, P121, DOI 10.1111/j.1551-2916.2009.03337.x
   Chang FW, 2004, J CHEM TECHNOL BIOT, V79, P691, DOI 10.1002/jctb.1029
   Devaraju S, 2013, MICROPOR MESOPOR MAT, V179, P157, DOI 10.1016/j.micromeso.2013.05.028
   Devaraju S, 2011, J SOL-GEL SCI TECHN, V60, P33, DOI 10.1007/s10971-011-2547-z
   Devaraju S, 2012, HIGH PERFORM POLYM, V23, P99
   Devaraju S, 2012, HIGH PERFORM POLYM, V24, P85, DOI 10.1177/0954008311433606
   Kanimozhi K, 2013, HIGH PERFORM POLYM, V25, P658, DOI 10.1177/0954008313478825
   Lee YJ, 2005, POLYMER, V46, P173, DOI 10.1016/j.polymer.2004.10.003
   Lin JJ, 2008, EUR POLYM J, V44, P1414, DOI 10.1016/j.eurpolymj.2008.02.022
   Naiya TK, 2009, ENVIRON PROG SUSTAIN, V28, P535, DOI 10.1002/ep.10346
   Naskar MK, 2004, J EUR CERAM SOC, V24, P3499, DOI 10.1016/j.jeurceramsoc.2003.11.029
   Sun YY, 2005, POLYMER, V46, P2297, DOI 10.1016/j.polymer.2005.01.041
   Vengatesan MR, 2012, J MATER CHEM, V22, P7559, DOI 10.1039/c2jm16566j
   Vengatesan MR, 2011, POLYM COMPOSITE, V32, P1702
   Wang Q, 2012, ADV MATER RES, V1, P93, DOI 10.12989/amr.1.1.093
NR 18
TC 16
Z9 16
U1 3
U2 28
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-0083
EI 1361-6412
J9 HIGH PERFORM POLYM
JI High Perform. Polym.
PD MAY
PY 2014
VL 26
IS 3
BP 283
EP 289
DI 10.1177/0954008313511347
PG 7
WC Polymer Science
SC Polymer Science
GA AG6GR
UT WOS:000335517600005
DA 2018-10-20
ER

PT J
AU de Oliveira, KP
   de Moraes, PH
   da Silva, JSP
   de Queiroz, WF
   Germano, AR
AF de Oliveira, K. P.
   de Moraes, P. H.
   da Silva, J. S. P.
   de Queiroz, W. F.
   Germano, A. R.
TI In vitro mechanical assessment of 2.0-mm system three-dimensional
   miniplates in anterior mandibular fractures
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE internal fracture fixation; mandibular fractures; biomaterial;
   biomechanics; trauma
ID ANGLE FRACTURES; RIGID FIXATION; OSTEOSYNTHESIS; PLATES
AB This study constituted a comparative assessment of the mechanical resistance of square and rectangular 2.0-mm system three-dimensional miniplates as compared to the standard configuration using two straight miniplates. 90 polyurethane replica mandibles were used for the mechanical trials. Groups 1, 2,, and 3 simulated complete symphyseal fractures characterized by linear separation of the central incisors; groups 4, 5, and 6 simulated parasymphyseal fractures with an oblique configuration. Groups 1 and 4 represented the standard method with two straight miniplates set parallel to one another. Square miniplates were used in groups 2 and 5, and rectangular miniplates in groups 3 and 6. A universal testing machine set to a velocity of 10 mm/min and delivering a vertical linear load to the first left molar was used to test each group. Maximum load values and load values with pre-established dislocation of 5 mm were obtained and submitted to statistical analysis using a calculated reliability interval of 95%. The mechanical performances of the devices were similar, except in the case of rectangular plates used in the parasymphyseal fractures. The innovative fixation methods used showed significantly better results in the case of symphyseal fractures.
C1 [de Oliveira, K. P.; de Moraes, P. H.; da Silva, J. S. P.; de Queiroz, W. F.; Germano, A. R.] Univ Fed Rio Grande do Norte, Hosp Univ Onofre Lopes, Dept Oral & Maxillofacial Surg, BR-59072970 Natal, RN, Brazil.
RP Germano, AR (reprint author), Fed Univ Rio Grande Norte UFRN, Hosp Univ Onofre Lopes, Dept Oral & Maxillofacial Surg, Av Nilo Pecanha 620, BR-59012300 Petropolis, Brazil.
EM adrianogermanoufrn@yahoo.com.br
CR Ardary WC, 1989, J ORAL MAXILLOFAC SU, V47, P720
   Asprino L, 2005, COMP RESISTENCIA CAR
   Boulorian R, 2002, J ORAL MAXILLOFAC SU, V60, P167
   Brasileiro BF, 2007, AVALIACAO BIOMECANIC
   Bredbenner TL, 2000, ORAL SURG ORAL MED O, V90, P574, DOI 10.1067/moe.2000.111025
   Champy M, 1976, Rev Stomatol Chir Maxillofac, V77, P569
   Champy M, 1976, Rev Stomatol Chir Maxillofac, V77, P577
   Chiodo Thomas A, 2009, Atlas Oral Maxillofac Surg Clin North Am, V17, P19, DOI 10.1016/j.cxom.2008.10.008
   Cordey J, 2000, INJURY, V31, P1
   Farmand M, 1996, Fortschr Kiefer Gesichtschir, V41, P85
   Fernandez JR, 2003, J BIOMECH, V36, P329, DOI 10.1016/S0021-9290(02)00416-5
   Brasileiro BF, 2006, ORAL SURG ORAL MED O, V102, P28, DOI 10.1016/j.tripleo.2005.07.023
   Gabrielli MAC, 2003, J ORAL MAXIL SURG, V61, P430, DOI 10.1053/joms.2003.50083
   Gear AJL, 2005, J ORAL MAXIL SURG, V63, P655, DOI 10.1016/j.joms.2004.02.016
   Guimaraes-Filho R, 2003, AVALIACAO IN VITRO R
   Haug RH, 1999, J ORAL MAXIL SURG, V57, P300, DOI 10.1016/S0278-2391(99)90677-8
   Jain MK, 2012, J CRANIO MAXILL SURG, V40, pE475, DOI 10.1016/j.jcms.2012.03.007
   Jain MK, 2010, J ORAL MAXIL SURG, V68, P1568, DOI 10.1016/j.joms.2009.07.083
   Ji BH, 2010, ORAL SURG ORAL MED O, V109, pE21, DOI 10.1016/j.tripleo.2009.11.003
   KIM HC, 1995, J CRANIO MAXILL SURG, V23, P54, DOI 10.1016/S1010-5182(05)80257-4
   KROON FHM, 1991, J CRANIO MAXILL SURG, V19, P199, DOI 10.1016/S1010-5182(05)80547-5
   Lovald S, 2010, J ORAL MAXIL SURG, V68, P1833, DOI 10.1016/j.joms.2009.09.108
   Lovald ST, 2009, J ORAL MAXIL SURG, V67, P973, DOI 10.1016/j.joms.2008.12.032
   Madsen MJ, 2008, J ORAL MAXIL SURG, V66, P2012, DOI 10.1016/j.joms.2008.06.013
   Meyer C, 2006, J CRANIO MAXILL SURG, V34, P173, DOI 10.1016/j.jcms.2005.09.005
   Peterson LJ, 2005, CONT ORAL MAXILLOFAC
   PREIN J, 1998, MANUAL INTERNAL FIXA
   Rudderman RH, 2008, PLAST RECONSTR SURG, V121, P596, DOI 10.1097/01.prs.0000297646.86919.b7
   Rudman RA, 1997, ORAL SURG ORAL MED O, V84, P129, DOI 10.1016/S1079-2104(97)90057-3
   Sato FR, 2009, THESIS UNICAMP PIRAC
   Sauerbier S, 2008, J CRANIO MAXILL SURG, V36, P251, DOI 10.1016/j.jcms.2007.08.011
   SPINA AM, 2000, ORAL MAXILLOFACIAL S, P85
   Tams J, 1997, INT J ORAL MAX SURG, V26, P383, DOI 10.1016/S0901-5027(97)80803-X
   TATE GS, 1994, J ORAL MAXIL SURG, V52, P734, DOI 10.1016/0278-2391(94)90489-8
   Trivellato AE, 2001, RESISTENCIA FLEXAO F
   Van Sickels JE, 2005, J ORAL MAXIL SURG, V63, P1620, DOI 10.1016/j.joms.2005.06.008
   Oliveira TRE, 2011, J ORAL MAXIL SURG, V69, pE141, DOI 10.1016/j.joms.2010.11.030
   Wong RCW, 2010, INT J ORAL MAX SURG, V39, P313, DOI 10.1016/j.ijom.2009.11.003
   Zix J, 2007, J ORAL MAXIL SURG, V65, P1758, DOI 10.1016/j.joms.200/.03.013
NR 39
TC 2
Z9 2
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
EI 1399-0020
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD MAY
PY 2014
VL 43
IS 5
BP 564
EP 571
DI 10.1016/j.ijom.2013.10.008
PG 8
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA AG3CM
UT WOS:000335293400007
PM 24239141
DA 2018-10-20
ER

PT J
AU Williams, DF
AF Williams, David F.
TI Carcinogenicity of implantable materials: experimental and
   epidemiological evidence
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Article
DE Polypropylene; Carcinogenicity; Mesh; Animal models; Biomaterials
ID BREAST IMPLANTS; HIP-REPLACEMENT; CANCER
AB Recent product-liability litigation concerning polypropylene meshes has been associated with a number of claims about the suitability of these meshes for conditions such as pelvic organ prolapse (POP) surgery. It has been stated, for example, that they pose a risk for tumor formation on the basis of some animal studies that have appeared in the literature and on a few suggestions of circumstantial evidence. However, it is clear that studies of biomaterial-related tumors in animals have no relevance to clinical performance in humans. If anything, these studies predict that smooth, flat, implant surfaces are more at risk, which places polypropylene meshes in the least-risk category. Attempts to demonstrate implant-induced carcinogenicity from population studies in humans with many types of devices have routinely failed to do so.
C1 Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Williams, DF (reprint author), Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
EM dfwillia@wakehealth.edu
CR Birolini C, 2014, HERNIA, V18, P897, DOI 10.1007/s10029-013-1083-x
   Deapen D, 2007, PLAST RECONSTR SURG, V120, p70S, DOI 10.1097/01.prs.0000286577.70026.5d
   GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539
   Gillespie WJ, 1996, CLIN ORTHOP RELAT R, pS290
   Handel Neal, 2006, Aesthet Surg J, V26, P265, DOI 10.1016/j.asj.2006.04.001
   Kirkpatrick CJ, 2000, AM J PATHOL, V156, P1455, DOI 10.1016/S0002-9440(10)65014-6
   Lindgren L, 2008, J BONE JOINT SURG, V90, P7
   McGregor DB, 2000, EUR J CANCER, V36, P307, DOI 10.1016/S0959-8049(99)00312-3
   PEDLEY RB, 1981, FUNDAMENTAL ASPECTS, V2, P175
   Smith AJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2383
   Turner FC, 1941, J NATL CANCER I, V2, P81
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams GM, 2009, REGUL TOXICOL PHARM, V53, P107, DOI 10.1016/j.yrtph.2008.10.009
NR 13
TC 7
Z9 7
U1 0
U2 7
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD MAY
PY 2014
VL 25
IS 5
BP 577
EP 580
DI 10.1007/s00192-014-2346-5
PG 4
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA AG0WH
UT WOS:000335135900004
PM 24614957
DA 2018-10-20
ER

PT J
AU Naganuma, T
   Traversa, E
AF Naganuma, Tamaki
   Traversa, Enrico
TI The effect of cerium valence states at cerium oxide nanoparticle
   surfaces on cell proliferation
SO BIOMATERIALS
LA English
DT Article
DE Cell proliferation; Adhesion; Scaffold; Surface modification;
   Nanoparticles
ID MESENCHYMAL STEM-CELLS; CEO2 NANOPARTICLES; PROTEIN ADSORPTION;
   FUNCTIONAL-GROUPS; REDOX STATE; DIFFERENTIATION; NANOCERIA; HYDROGEL;
   SIZE
AB Understanding and controlling cell proliferation on biomaterial surfaces is critical for scaffold/artificial-niche design in tissue engineering. The mechanism by which underlying integrin ligates with functionalized biomaterials to induce cell proliferation is still not completely understood. In this study, poly-L-lactide (PL) scaffold surfaces were functionalized using layers of cerium oxide nanoparticles (CNPs), which have recently attracted attention for use in therapeutic application due to their catalytic ability of Ce4+ and Ce3+ sites. To isolate the influence of Ce valance states of CNPs on cell proliferation, human mesenchymal stem cells (hMSCs) and osteoblast-like cells (MG63) were cultured on the PL/CNP surfaces with dominant Ce4+ and Ce3+ regions. Despite cell type (hMSCs and MG63 cells), different surface features of Ce4+ and Ce3+ regions clearly promoted and inhibited cell spreading, migration and adhesion behavior, resulting in rapid and slow cell proliferation, respectively. Cell proliferation results of various modified CNPs with different surface charge and hydrophobicity/hydrophilicity, indicate that Ce valence states closely correlated with the specific cell morphologies and cell-material interactions that trigger cell proliferation. This finding suggests that the cell-material interactions, which influence cell proliferation, may be controlled by introduction of metal elements with different valence states onto the biomaterial surface. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Naganuma, Tamaki] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Smart Biomat Grp, Nanolife Field,Biomat Unit, Tsukuba, Ibaraki 3050044, Japan.
   [Traversa, Enrico] King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Thuwal 239556900, Saudi Arabia.
RP Naganuma, T (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Smart Biomat Grp, Nanolife Field,Biomat Unit, Tsukuba, Ibaraki 3050044, Japan.
EM NAGANUMA.Tamaki@nims.go.jp
RI Traversa, Enrico/E-4547-2011
OI Traversa, Enrico/0000-0001-6336-941X
FU World Premier International (WPI) Research Center Initiative Program
FX This work was supported, in part, by the World Premier International
   (WPI) Research Center Initiative Program. Technical support by the
   Bio-Organic Materials Facility in the Nanotechnology Innovation Station,
   NIMS, Japan is acknowledged. The authors thank Ms. H. Morita and Dr. X.
   LI for technical support and suggestions about biological experiments,
   Ms. S. Kajiwara for technical support of confocal microscope
   observations (Nanotechnology Innovation Station, NIMS, Japan). We would
   like to thank Prof. T. Aoyagi (International Center for Materials
   Nanoarchitectonics, NIMS, Japan) and Dr. L Ghibelli (University of Rome
   Tor Vergata) for invaluable discussions.
CR Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Celardo I, 2011, ACS NANO, V5, P4537, DOI 10.1021/nn200126a
   Celardo I, 2011, NANOSCALE, V3, P1411, DOI 10.1039/c0nr00875c
   Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91
   Dadsetan M, 2012, ACTA BIOMATER, V8, P1430, DOI 10.1016/j.actbio.2011.12.031
   Das S, 2012, BIOMATERIALS, V22, P7746
   Friedrich J, 2010, NAT PROTOC, V5, P1355
   Heckert EG, 2008, BIOMATERIALS, V29, P2705, DOI 10.1016/j.biomaterials.2008.03.014
   Karakoti A, 2010, CHEM SOC REV, V39, P4422, DOI 10.1039/b919677n
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Korsvik C, 2007, CHEM COMMUN, P1056, DOI 10.1039/b615134e
   Limbach LK, 2005, ENVIRON SCI TECHNOL, V39, P9370, DOI 10.1021/es051043o
   Mandoli C, 2010, ADV FUNCT MATER, V20, P1617, DOI 10.1002/adfm.200902363
   Marrocchelli D, 2012, ADV FUNCT MATER, V22, P1958, DOI 10.1002/adfm.201102648
   Naganuma T, 2012, NANOSCALE, V4, P4950, DOI 10.1039/c2nr30406f
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Pagliari F, 2012, ACS NANO, V6, P3767, DOI 10.1021/nn2048069
   Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029
   Paun C, 2012, J PHYS CHEM C, V116, P7312, DOI 10.1021/jp300342b
   Pirmohamed T, 2010, CHEM COMMUN, V46, P2736, DOI 10.1039/b922024k
   Rodea-Palomares I, 2011, TOXICOL SCI, V119, P135, DOI 10.1093/toxsci/kfq311
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Seo JH, 2009, BIOMATERIALS, V30, P5330, DOI 10.1016/j.biomaterials.2009.06.031
   Singh S, 2011, BIOMATERIALS, V32, P6745, DOI 10.1016/j.biomaterials.2011.05.073
   Su GX, 2012, J PHYS CHEM C, V116, P4993, DOI 10.1021/jp211041m
   Vincent A, 2010, LANGMUIR, V26, P7188, DOI 10.1021/la904285g
   Vincent A, 2009, ACS NANO, V3, P1203, DOI 10.1021/nn9000148
   Wilhelm C, 2003, BIOMATERIALS, V24, P1001, DOI 10.1016/S0142-9612(02)00440-4
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
NR 31
TC 40
Z9 40
U1 7
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2014
VL 35
IS 15
BP 4441
EP 4453
DI 10.1016/j.biomaterials.2014.01.074
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF6JA
UT WOS:000334819800004
PM 24612920
DA 2018-10-20
ER

PT J
AU Battiston, KG
   Cheung, JWC
   Jain, D
   Santerre, JP
AF Battiston, Kyle G.
   Cheung, Jane W. C.
   Jain, Devika
   Santerre, J. Paul
TI Biomaterials in co-culture systems: Towards optimizing tissue
   integration and cell signaling within scaffolds
SO BIOMATERIALS
LA English
DT Review
DE Co-culture; Biomaterials; Tissue engineering; Cellular interactions;
   Stem cells; Monocytes
ID MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; SELF-ASSEMBLED MONOLAYERS;
   VASCULAR ENDOTHELIAL-CELLS; 3-DIMENSIONAL FIBRIN GELS; IN-VITRO MODEL;
   ARTICULAR CHONDROCYTES; HUMAN OSTEOPROGENITORS; HYDROGEL CONSTRUCTS;
   BRAIN ANGIOGENESIS
AB Most natural tissues consist of multi-cellular systems made up of two or more cell types. However, some of these tissues may not regenerate themselves following tissue injury or disease without some form of intervention, such as from the use of tissue engineered constructs. Recent studies have increasingly used co-cultures in tissue engineering applications as these systems better model the natural tissues, both physically and biologically. This review aims to identify the challenges of using co-culture systems and to highlight different approaches with respect to the use of biomaterials in the use of such systems. The application of co-culture systems to stimulate a desired biological response and examples of studies within particular tissue engineering disciplines are summarized. A description of different analytical co-culture systems is also discussed and the role of biomaterials in the future of co-culture research are elaborated on. Understanding the complex cell cell and cell biomaterial interactions involved in co-culture systems will ultimately lead the field towards biomaterial concepts and designs with specific biochemical, electrical, and mechanical characteristics that are tailored towards the needs of distinct co-culture systems. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Battiston, Kyle G.; Cheung, Jane W. C.; Jain, Devika; Santerre, J. Paul] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5G 1G6, Canada.
   [Santerre, J. Paul] Univ Toronto, Fac Dent, Dept Biomat, Toronto, ON M5G 1G6, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Ctr Biomat, 124 Edward St,Room 464D, Toronto, ON M5G 1G6, Canada.
EM paul.santerre@utoronto.ca
FU Natural Sciences and Engineering Research Council (NSERC) [360520];
   NSERC Alexander Graham Bell Canada Graduate Scholarship [CGS D3];
   Canadian Institutes of Health Research (CIHR) [230762]; Ontario Graduate
   Scholarship Program; CIHR-Cell Signals Training Fellowship program
   [TGF-53877]
FX This review was supported from funding by the Natural Sciences and
   Engineering Research Council (NSERC) Discovery (360520), NSERC Alexander
   Graham Bell Canada Graduate Scholarship (CGS D3), Canadian Institutes of
   Health Research (CIHR) Grant (230762), Ontario Graduate Scholarship
   Program, and CIHR-Cell Signals Training Fellowship program (TGF-53877).
CR Aizawa Y, 2012, BIOMATERIALS, V33, P5198, DOI 10.1016/j.biomaterials.2012.03.062
   Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Alge DL, 2013, BIOMACROMOLECULES, V14, P949, DOI 10.1021/bm4000508
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Battiston KG, 2012, ACTA BIOMATER, V8, P89, DOI 10.1016/j.actbio.2011.09.015
   Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183
   Bergmeister H, 2013, ACTA BIOMATER, V9, P6032, DOI 10.1016/j.actbio.2012.12.009
   Bhatia SN, 1998, BIOTECHNOL PROGR, V14, P378, DOI 10.1021/bp980036j
   Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Burguera EF, 2010, EUR CELLS MATER, V19, P166, DOI 10.22203/eCM.v019a17
   Caicedo-Carvajal C.E., 2011, J TISSUE ENG, V2011
   Cantu DA, 2012, STEM CELL TRANSL MED, V1, P740, DOI 10.5966/sctm.2012-0061
   Carrion B, 2010, BIOTECHNOL BIOENG, V107, P1020, DOI 10.1002/bit.22891
   Ceylan H, 2011, BIOMATERIALS, V32, P8797, DOI 10.1016/j.biomaterials.2011.08.018
   Chen K, 2010, J CELL BIOCHEM, V111, P29, DOI 10.1002/jcb.22680
   Chitteti BR, 2010, J CELL BIOCHEM, V111, P284, DOI 10.1002/jcb.22694
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Choi SW, 2010, LANGMUIR, V26, P19001, DOI 10.1021/la104206h
   Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a
   Clarkin CE, 2008, J CELL PHYSIOL, V214, P537, DOI 10.1002/jcp.21234
   Clinchy B, 2003, J IMMUNOL METHODS, V282, P53, DOI 10.1016/j.jim.2003.07.013
   Co CC, 2005, J AM CHEM SOC, V127, P1598, DOI 10.1021/ja044382a
   Cohen HC, 2013, AM J PATHOL, V182, P2180, DOI 10.1016/j.ajpath.2013.02.022
   CONTARD P, 1993, J INVEST DERMATOL, V100, P35, DOI 10.1111/1523-1747.ep12349952
   Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018
   Dai JW, 2012, BIOMATERIALS, V33, P7699, DOI 10.1016/j.biomaterials.2012.07.020
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Das A, 2011, TISSUE ENG PART B-RE, V17, P403, DOI [10.1089/ten.teb.2011.0190, 10.1089/ten.TEB.2011.0190]
   Dickinson LE, 2012, LAB CHIP, V12, P4244, DOI 10.1039/c2lc40819h
   Dinardo CL, 2012, BIORHEOLOGY, V49, P365, DOI 10.3233/BIR-120621
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dohle E, 2011, EUR CELLS MATER, V21, P144, DOI 10.22203/eCM.v021a12
   DONNELLY T, 1994, TOXICOL IN VITRO, V8, P631, DOI 10.1016/0887-2333(94)90032-9
   Eckermann CW, 2011, CELL BIOL INT, V35, P1097, DOI 10.1042/CBI20100718
   Efremov AN, 2013, BIOMATERIALS, V34, P1757, DOI 10.1016/j.biomaterials.2012.11.034
   Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565
   FLEISCHMAJER R, 1993, J HISTOCHEM CYTOCHEM, V41, P1359, DOI 10.1177/41.9.7689083
   Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357
   Fuse Y, 2007, DENT MATER J, V26, P814, DOI 10.4012/dmj.26.814
   GAY R, 1992, TOXICOL IN VITRO, V6, P303, DOI 10.1016/0887-2333(92)90020-R
   Ghanaati S, 2011, J TISSUE ENG REGEN M, V5, pE136, DOI 10.1002/term.373
   Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018
   Guillemette MD, 2010, TISSUE ENG PT A, V16, P2617, DOI 10.1089/ten.tea.2009.0612
   Guillotin B, 2008, BONE, V42, P1080, DOI 10.1016/j.bone.2008.01.025
   Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342
   Guyton A.C.H.J., 2006, TXB MED PHYSL
   Hammoudi TM, 2010, TISSUE ENG PART C-ME, V16, P1621, DOI [10.1089/ten.tec.2010.0146, 10.1089/ten.TEC.2010.0146]
   Hanson SE, 2011, TISSUE ENG PT A, V17, P2463, DOI [10.1089/ten.tea.2010.0716, 10.1089/ten.TEA.2010.0716]
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   Houchin-Ray T, 2007, BIOMATERIALS, V28, P2603, DOI 10.1016/j.biomaterials.2007.01.042
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104
   Hussain A, 2013, BIOTECHNOL BIOENG, V110, P637, DOI 10.1002/bit.24727
   Iyer RK, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035002
   Janvier R, 1997, ANTICANCER RES, V17, P1551
   Jeong JY, 2012, J MATER SCI-MATER M, V23, P2773, DOI 10.1007/s10856-012-4718-z
   Jiang J, 2005, BIOCHEM BIOPH RES CO, V338, P762, DOI 10.1016/j.bbrc.2005.10.025
   Jones GL, 2009, BIOMATERIALS, V30, P5376, DOI 10.1016/j.biomaterials.2009.07.028
   Kempf M, 2011, BIOMATERIALS, V32, P4782, DOI 10.1016/j.biomaterials.2011.03.023
   Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035
   Kim K, 2012, BIOMATERIALS, V33, P1406, DOI 10.1016/j.biomaterials.2011.10.084
   Kim S, 2008, BIOMATERIALS, V29, P1043, DOI 10.1016/j.biomaterials.2007.11.005
   Kinto N, 1997, FEBS LETT, V404, P319, DOI 10.1016/S0014-5793(97)00014-8
   Kirkpatrick CJ, 2011, ADV DRUG DELIVER REV, V63, P291, DOI 10.1016/j.addr.2011.01.009
   Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com
   Kostadinova R, 2013, TOXICOL APPL PHARM, V268, P1, DOI 10.1016/j.taap.2013.01.012
   Kunz-Schughart LA, 2006, AM J PHYSIOL-CELL PH, V290, pC1385, DOI 10.1152/ajpcell.00248.2005
   Lamponi S, 2010, J BIOMED MATER RES A, V92A, P733, DOI 10.1002/jbm.a.32364
   Lee HS, 2009, FEBS J, V276, P4622, DOI 10.1111/j.1742-4658.2009.07174.x
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee MJ, 2012, ARTERIOSCL THROM VAS, V32, P2733, DOI 10.1161/ATVBAHA.112.300230
   Lehmann AD, 2011, EUR J PHARM BIOPHARM, V77, P398, DOI 10.1016/j.ejpb.2010.10.014
   Li H, 2013, ACTA BIOMATER, V9, P6981, DOI 10.1016/j.actbio.2013.02.014
   Liu X, 2007, BIOTECHNOL LETT, V29, P1685, DOI 10.1007/s10529-007-9457-8
   Luo JZQ, 2011, BONE MARROW TRANSPL, V46, P1128, DOI 10.1038/bmt.2010.278
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lv XJ, 2012, CONNECT TISSUE RES, V53, P492, DOI 10.3109/03008207.2012.694926
   Ma JL, 2011, TISSUE ENG PART C-ME, V17, P349, DOI [10.1089/ten.tec.2010.0215, 10.1089/ten.TEC.2010.0215]
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252
   Maidhof R, 2012, J TISSUE ENG REGEN M, V6, pe12, DOI 10.1002/term.525
   March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085
   Mayer A, 2011, CLIN HEMORHEOL MICRO, V49, P423, DOI 10.3233/CH-2011-1492
   McBane JE, 2012, ACTA BIOMATER, V8, P488, DOI 10.1016/j.actbio.2011.09.018
   McBane JE, 2011, BIOMATERIALS, V32, P3584, DOI 10.1016/j.biomaterials.2011.01.069
   Meretoja VV, 2012, BIOMATERIALS, V33, P6362, DOI 10.1016/j.biomaterials.2012.05.042
   MESZAROS K, 1995, INFECT IMMUN, V63, P363
   Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030
   Mosser DM, 2010, NAT REV IMMUNOL, V10, P460, DOI 10.1038/nri2788
   Mussig E, 2009, J OROFAC ORTHOP, V70, P351, DOI 10.1007/s00056-009-0905-z
   Mussig E, 2008, ADV FUNCT MATER, V18, P2919, DOI 10.1002/adfm.200800381
   Nakahama K, 2010, CELL MOL LIFE SCI, V67, P4001, DOI 10.1007/s00018-010-0479-3
   Nam MH, 2011, BBA-GEN SUBJECTS, V1810, P907, DOI 10.1016/j.bbagen.2011.06.005
   Nehls V, 1998, CELL TISSUE RES, V293, P479, DOI 10.1007/s004410051140
   Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871
   Niklason LE, 2001, J VASC SURG, V33, P628, DOI 10.1067/mva.2001.111747
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   OHNO M, 1995, J CLIN INVEST, V95, P1363, DOI 10.1172/JCI117787
   Palama IE, 2012, INTEGR BIOL-UK, V4, P228, DOI 10.1039/c2ib00116k
   Pang Y, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/4/045004
   Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005
   RATNER B, 1996, BIOMATERIALS SCI
   Rauch MF, 2009, EUR J NEUROSCI, V29, P132, DOI 10.1111/j.1460-9568.2008.06567.x
   Rose SL, 2008, J BIOMED MATER RES A, V84A, P661, DOI 10.1002/jbm.a.31305
   Rumsey JW, 2010, BIOMATERIALS, V31, P8218, DOI 10.1016/j.biomaterials.2010.07.027
   Santos MI, 2009, BIOMATERIALS, V30, P4407, DOI 10.1016/j.biomaterials.2009.05.004
   Schmidt D, 2011, ACTA BIOMATER, V7, P515, DOI 10.1016/j.actbio.2010.08.022
   SCHROEDER H, 1986, PERIODONTIUM
   Schubert SY, 2008, ARTERIOSCL THROM VAS, V28, P97, DOI 10.1161/ATVBAHA.107.157537
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Sharma RI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031504
   Sheehy EJ, 2013, ACTA BIOMATER, V9, P5484, DOI 10.1016/j.actbio.2012.11.008
   Shephard P, 2004, AM J PATHOL, V164, P2055, DOI 10.1016/S0002-9440(10)63764-9
   Sicchieri LG, 2012, J TISSUE ENG REGEN M, V6, P155, DOI 10.1002/term.422
   Sinclair SSK, 2011, J BIOMAT SCI-POLYM E, V22, P789, DOI 10.1163/092050610X496260
   Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001
   Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463
   Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756
   Song Y, 2011, CLIN HEMORHEOL MICRO, V49, P357, DOI 10.3233/CH-2011-1486
   Sorrell JM, 2007, CELLS TISSUES ORGANS, V186, P157, DOI 10.1159/000106670
   Steiner D, 2012, J ORTHOP RES, V30, P1682, DOI 10.1002/jor.22130
   Sun T, 2006, BIOMATERIALS, V27, P3459, DOI 10.1016/j.biomaterials.2006.01.058
   Suri S, 2010, TISSUE ENG PT A, V16, P1703, DOI 10.1089/ten.tea.2009.0381
   Taba M Jr, 2005, Orthod Craniofac Res, V8, P292
   Talavera-Adame D, 2011, STEM CELL REV REP, V7, P532, DOI 10.1007/s12015-011-9232-z
   Tandara AA, 2007, WOUND REPAIR REGEN, V15, P497, DOI 10.1111/j.1524-475X.2007.00257.x
   Thomas RJ, 2005, CELLS TISSUES ORGANS, V181, P67, DOI 10.1159/000091096
   Tibbitt MW, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004804
   Traphagen SB, 2013, J TISSUE ENG REGEN M, V7, P621, DOI 10.1002/term.554
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Tremblay PL, 2005, AM J TRANSPLANT, V5, P1002, DOI 10.1111/j.1600-6143.2005.00790.x
   Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002
   Tufan H, 2012, J MOL CELL CARDIOL, V53, P695, DOI 10.1016/j.yjmcc.2012.08.008
   Umbach JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036049
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   van Luyn MJA, 2002, BIOMATERIALS, V23, P4793, DOI 10.1016/S0142-9612(02)00230-2
   Ventre M, 2012, J R SOC INTERFACE, V9, P2017, DOI 10.1098/rsif.2012.0308
   Wakelin SJ, 2006, IMMUNOL LETT, V106, P1, DOI 10.1016/j.imlet.2006.04.007
   Wei Y, 2010, CELL PROLIFERAT, V43, P606, DOI 10.1111/j.1365-2184.2010.00710.x
   Wein F, 2013, INTEGR BIOL-UK, V5, P703, DOI 10.1039/c3ib20250j
   Wen SJ, 2007, CHINESE MED J-PEKING, V120, P1331
   Wenger A, 2005, CELLS TISSUES ORGANS, V181, P80, DOI 10.1159/000091097
   Williams C, 2005, ANN BIOMED ENG, V33, P920, DOI 10.1007/s10439-005-3238-0
   Wong KHK, 2012, ANNU REV BIOMED ENG, V14, P205, DOI [10.1146/annurev-bioeng-071811-150052, 10.1146/annurev.bioeng-071811-150052]
   Wu Y, 2013, J PERIODONTAL RES, V48, P52, DOI 10.1111/j.1600-0765.2012.01503.x
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035
   Yang IH, 2005, J BIOMED MATER RES A, V75A, P976, DOI 10.1002/jbm.a.30509
   Yen BL, 2008, TISSUE ENG PT A, V14, P9, DOI 10.1089/ten.a.2006.0352
   Zeiger AS, 2013, ACTA BIOMATER, V9, P7354, DOI 10.1016/j.actbio.2013.02.035
   Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503
   Zhang XH, 2009, BIOMATERIALS, V30, P3213, DOI 10.1016/j.biomaterials.2009.02.002
   Zhang YQ, 2012, CELLS TISSUES ORGANS, V195, P313, DOI 10.1159/000327724
   Zoldan J, 2011, BIOMATERIALS, V32, P9612, DOI 10.1016/j.biomaterials.2011.09.012
NR 162
TC 52
Z9 53
U1 11
U2 146
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2014
VL 35
IS 15
BP 4465
EP 4476
DI 10.1016/j.biomaterials.2014.02.023
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF6JA
UT WOS:000334819800006
PM 24602569
DA 2018-10-20
ER

PT J
AU Dalonneau, F
   Liu, XQ
   Sadir, R
   Almodovar, J
   Mertani, HC
   Bruckert, F
   Albiges-Rizo, C
   Weidenhaupt, M
   Lortat-Jacob, H
   Picart, C
AF Dalonneau, Fabien
   Liu, Xi Qiu
   Sadir, Rabia
   Almodovar, Jorge
   Mertani, Hichem C.
   Bruckert, Franz
   Albiges-Rizo, Corinne
   Weidenhaupt, Marianne
   Lortat-Jacob, Hugues
   Picart, Catherine
TI The effect of delivering the chemokine SDF-1 alpha in a matrix-bound
   manner on myogenesis
SO BIOMATERIALS
LA English
DT Article
DE Polyelectrolyte multilayer film; Drug delivery; SDF-1 alpha/CXCL12;
   CXCR4; Myoblast; Migration
ID POLYELECTROLYTE MULTILAYER FILMS; SKELETAL-MUSCLE REGENERATION;
   BONE-MARROW; BIOMEDICAL APPLICATIONS; STEM/PROGENITOR CELLS;
   EXTRACELLULAR-MATRIX; RECEPTOR CXCR4; TISSUE-REPAIR; IN-VITRO; MIGRATION
AB Several chemokines are important in muscle myogenesis and in the recruitment of muscle precursors during muscle regeneration. Among these, the SDF-1 alpha chemokine (CXCL12) is a potent chemoattractant known to be involved in muscle repair. SDF-1 alpha was loaded in polyelectrolyte multilayer films made of poly(L-lysine) and hyaluronan to be delivered locally to myoblast cells in a matrix-bound manner. The adsorbed amounts of SDF-1 alpha were tuned over a large range from 100 ng/cm(2) to 5 mu g/cm(2), depending on the initial concentration of SDF-1 alpha in solution, its pH, and on the film crosslinking extent. Matrix-bound SDF-1 alpha induced a striking increase in myoblast spreading, which was revealed when it was delivered from weakly crosslinked films. It also significantly enhanced cell migration in a dose-dependent manner, which again depended on its presentation by the biopolymeric film. The low-crosslinked film was the most efficient in boosting cell migration. Furthermore, matrix-bound SDF-1 alpha also increased the expression of myogenic markers but the fusion index decreased in a dose-dependent manner with the adsorbed amount of SDF-1 alpha. At high adsorbed amounts of SDF-1 alpha, a large number of Troponin T-positive cells had only one nucleus. Overall, this work reveals the importance of the presentation mode of SDF-1 alpha to emphasize its effect on myogenic processes. These films may be further used to provide insight into the role of SDF-1 alpha presented by a biomaterial in physiological or pathological processes. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Dalonneau, Fabien; Liu, Xi Qiu; Almodovar, Jorge; Bruckert, Franz; Weidenhaupt, Marianne; Picart, Catherine] CNRS, LMGP, UMR 5628, F-38016 Grenoble, France.
   [Dalonneau, Fabien; Liu, Xi Qiu; Almodovar, Jorge; Bruckert, Franz; Weidenhaupt, Marianne; Picart, Catherine] Univ Grenoble Alpes, LMGP, F-38016 Grenoble, France.
   [Liu, Xi Qiu] FONDAT ARC, F-94803 Villejuif, France.
   [Sadir, Rabia; Lortat-Jacob, Hugues] Univ Grenoble Alpes, Inst Biol Struct, F-38027 Grenoble, France.
   [Sadir, Rabia; Lortat-Jacob, Hugues] CNRS, IBS, F-38027 Grenoble, France.
   [Sadir, Rabia; Lortat-Jacob, Hugues] CEA, DSV, IBS, F-38027 Grenoble, France.
   [Mertani, Hichem C.] CNRS 5286, UMR INSERM 1052, Ctr Rech Cancerol Lyon, F-69373 Lyon 08, France.
   [Albiges-Rizo, Corinne] Univ Grenoble 1, Inst Albert Bonniot, ERL CNRS5284, Inserm U823, F-38042 Grenoble 9, France.
RP Lortat-Jacob, H (reprint author), Univ Grenoble Alpes, Inst Biol Struct, F-38027 Grenoble, France.
EM hugues.lortat-jacob@ibs.fr; catherine.picart@grenoble-inp.fr
RI Albiges-Rizo, Corinne/M-2568-2013
OI PICART, Catherine/0000-0003-0130-1000; Almodovar,
   Jorge/0000-0002-1151-3878
FU ARC (Association Recherche contre le Cancer) foundation
   [PDF20121206052]; Canceropole Lyon Auvergne Rhone-Alpes (CLARA);
   Canceropole Lyon Auvergne Rhone-Alpes (MICAN); ANR [NT05-4_41976];
   European Commission via a European Research Council [GA 259370]
FX The authors are grateful to Thomas Boudou for technical assistance with
   the AFM experiments, Cedric Laguri for SDF-1 alpha production and to
   Jean-Paul Rieu for fruitful discussions. We also thank Justyna Lisowska
   and Alexander Kyumurkov for help with the Western Blot experiments. JA
   acknowledges the Whitaker International Fellows and Scholars Program and
   XQL the ARC (Association Recherche contre le Cancer) foundation for
   providing a postdoctoral fellowship (PDF20121206052). The present study
   was supported by a grant from the Canceropole Lyon Auvergne Rhone-Alpes
   (CLARA, MICAN project), by ANR in the frame of the Chemoglycan
   (NT05-4_41976) project to HLJ and by the European Commission (FP7
   program) via a European Research Council starting grant to CP (FP7, ERC
   BIOMIM, GA 259370).
CR Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23
   Almodovar J, 2013, LAB CHIP, V13, P1562, DOI 10.1039/c3lc41407h
   Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611
   BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6
   Baumann L, 2012, J CONTROL RELEASE, V162, P68, DOI 10.1016/j.jconrel.2012.04.049
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Brzoska E, 2012, BIOL CELL, V104, P722, DOI 10.1111/boc.201200022
   Calve S, 2012, FASEB J, V26, P2538, DOI 10.1096/fj.11-200162
   Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766
   Cosgrove BD, 2009, DIFFERENTIATION, V78, P185, DOI 10.1016/j.diff.2009.08.004
   Crouzier T, 2011, ADV MATER, V23, pH111, DOI 10.1002/adma.201004637
   Crouzier T, 2009, SMALL, V5, P598, DOI 10.1002/smll.200800804
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Du Y, 2009, LAB CHIP, V9, P761, DOI 10.1039/b815990d
   Ge YJ, 2013, PLOS ONE, V8
   Goncalves RM, 2012, EUR CELLS MATER, V23, P249, DOI 10.22203/eCM.v023a19
   Goncalves RM, 2012, EUR CELLS MATER, V23, P260
   Goodrich W, 2012, HTRF LIGAND BINDING
   Griffin CA, 2010, J CELL SCI, V123, P3052, DOI 10.1242/jcs.066241
   Hesselgesser J, 1998, J IMMUNOL, V160, P877
   Hidalgo-Esteven AM, 2008, MOL IMMUNOL, V46, P106, DOI 10.1016/j.molimm.2008.07.004
   Hubbell JA, 2006, SWISS MED WKLY, V136, P387
   Hunger C, 2012, EXP CELL RES, V318, P2178, DOI 10.1016/j.yexcr.2012.06.020
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Janowska-Wieczorek A, 2000, EXP HEMATOL, V28, P1274, DOI 10.1016/S0301-472X(00)00532-4
   Jansen KM, 2006, J CELL BIOL, V174, P403, DOI 10.1083/jcb.200601102
   Ko IK, 2012, FASEB J, V26, P158, DOI 10.1096/fj.11-182998
   Kucia M, 2006, ARCH IMMUNOL THER EX, V54, P121, DOI 10.1007/s00005-006-0015-1
   Kumar R, 2012, CELL IMMUNOL, V272, P230, DOI 10.1016/j.cellimm.2011.09.015
   Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lortat-Jacob H, 2009, CURR OPIN STRUC BIOL, V19, P543, DOI 10.1016/j.sbi.2009.09.003
   Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706
   Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505
   Melchonna R, 2010, MUSCLE NERVE, V41, P828, DOI 10.1002/mus.21611
   Mylona E, 2006, J CELL PHYSIOL, V209, P314, DOI 10.1002/jcp.20724
   Odemis V, 2005, MOL CELL NEUROSCI, V30, P494, DOI 10.1016/j.mcn.2005.07.019
   Odemis V, 2007, J CELL SCI, V120, P4050, DOI 10.1242/jcs.010009
   Ottoson NC, 2001, J IMMUNOL, V167, P1857, DOI 10.4049/jimmunol.167.4.1857
   Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845
   Peng SB, 2005, MOL CANCER RES, V3, P227
   Purcell BP, 2012, BIOMATERIALS, V33, P7849, DOI 10.1016/j.biomaterials.2012.07.005
   Rabbany SY, 2010, TISSUE ENG PT A, V16, P2157, DOI [10.1089/ten.tea.2010.0183, 10.1089/ten.TEA.2010.0183]
   Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363
   Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297
   Ren KF, 2010, ACTA BIOMATER, V6, P4238, DOI 10.1016/j.actbio.2010.06.014
   ROBERTSON TA, 1993, NEUROPATH APPL NEURO, V19, P350, DOI 10.1111/j.1365-2990.1993.tb00451.x
   Rueda P, 2012, CIRCULATION, V126, P1882, DOI 10.1161/CIRCULATIONAHA.112.113290
   Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Thorsteinsdottir S, 2011, DEV BIOL, V354, P191, DOI 10.1016/j.ydbio.2011.03.015
   Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205
   Wang YN, 2011, BIOMATERIALS, V32, P4903, DOI 10.1016/j.biomaterials.2011.03.027
   Yusuf F, 2006, DEV DYNAM, V235, P3007, DOI 10.1002/dvdy.20951
   Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200
   Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269
NR 59
TC 17
Z9 17
U1 3
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2014
VL 35
IS 15
BP 4525
EP 4535
DI 10.1016/j.biomaterials.2014.02.008
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF6JA
UT WOS:000334819800012
PM 24612919
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lebourg, M
   Martinez-Diaz, S
   Garcia-Giralt, N
   Torres-Claramunt, R
   Ribelles, JLG
   Vila-Canet, G
   Monllau, JC
AF Lebourg, M.
   Martinez-Diaz, S.
   Garcia-Giralt, N.
   Torres-Claramunt, R.
   Ribelles, J. L. Gomez
   Vila-Canet, G.
   Monllau, J. C.
TI Cell-free cartilage engineering approach using hyaluronic
   acid-polycaprolactone scaffolds: A study invivo
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE cell-free PCL scaffold; Cartilage regeneration; hyaluronic acid;
   osteoarthritis; tissue engineering
ID ARTICULAR-CARTILAGE; AUTOLOGOUS CHONDROCYTE; STEM-CELLS; REPAIR;
   DEFECTS; RABBITS; GROWTH; TRANSPLANTATION; MICROFRACTURE; KNEE
AB Polycaprolactone scaffolds modified with cross-linked hyaluronic acid were prepared in order to establish whether a more hydrophilic and biomimetic microenvironment benefits the progenitor cells arriving from bone marrow in a cell-free tissue-engineering approach. The polycaprolactone and polycaprolactone/hyaluronic acid scaffolds were characterized in terms of morphology and water absorption capacity. The polycaprolactone and polycaprolactone/hyaluronic acid samples were implanted in a chondral defect in rabbits; bleeding of the subchondral bone was provoked to generate a spontaneous healing response. Repair at 1, 4, 12, and 24 weeks was assessed macroscopically using the International Cartilage Repair Society score and the Oswestry Arthroscopy Score and microscopically using immunohistological staining for collagen type I and type II, and for Ki-67. The presence of hyaluronic acid improves scaffold performance, which supports a good repair response without biomaterial pre-seeding.
C1 [Lebourg, M.; Ribelles, J. L. Gomez] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Valencia, Spain.
   [Martinez-Diaz, S.; Garcia-Giralt, N.; Torres-Claramunt, R.] Univ Autonoma Barcelona, Hosp del Mar, Dept Orthopaed Surg & Traumatol, IMIM Hosp del Mar Med Res Inst,RETICEF, Barcelona 08003, Spain.
   [Ribelles, J. L. Gomez] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46071 Valencia, Spain.
   [Vila-Canet, G.; Monllau, J. C.] Univ Autonoma Barcelona, ICATME Inst Univ Dexeus, Barcelona 08003, Spain.
   [Monllau, J. C.] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Orthoped Surg & Traumatol, Barcelona 08003, Spain.
RP Garcia-Giralt, N (reprint author), Univ Autonoma Barcelona, Hosp del Mar, Dept Orthopaed Surg & Traumatol, IMIM Hosp del Mar Med Res Inst,RETICEF, Dr Aiguader 88, Barcelona 08003, Spain.
EM ngarcia@imim.es
RI Gomez Ribelles, Jose Luis/L-5629-2014
OI Gomez Ribelles, Jose Luis/0000-0001-9099-0885; Garcia-Giralt,
   Natalia/0000-0001-6507-0147
FU Spanish Ministry of Science [MAT2010-21611-C03-01,
   MAT2010-21611-C03-02]; Catalan Department of Universities, Research and
   the Information Society [2005SGR 00762, 2005SGR 00848]; Red Tematica de
   Investigacion Cooperativa en Envejecimiento y Fragilidad (RETICEF); UPV
   through the PAID-10 project funds; CIBER-BBN; VI National RDI Plan;
   Iniciativa Ingenio; Consolider Program; CIBER Actions; Instituto de
   Salud Carlos III; European Regional Development Fund
FX JLGR, JAGT and JCM acknowledge the support of the Spanish Ministry of
   Science through projects No. MAT2010-21611-C03-01 and -02. The support
   of Grant 2005SGR 00762 and 2005SGR 00848 (Catalan Department of
   Universities, Research and the Information Society) and the Red Tematica
   de Investigacion Cooperativa en Envejecimiento y Fragilidad (RETICEF) is
   also acknowledged. Myriam Lebourg acknowledges funding from UPV through
   the PAID-10 project funds and from CIBER-BBN. CIBER-BBN is an initiative
   funded by the VI National R&D&I Plan 2008-2011, Iniciativa Ingenio 2010,
   Consolider Program, CIBER Actions and financed by the Instituto de Salud
   Carlos III with assistance from the European Regional Development Fund.
CR Brittberg M, 1996, CLIN ORTHOP RELAT R, P270
   Brittberg M, 1998, ICRS NEWSLETTER, V1, P5
   Brittberg M, 2008, ACAD PR SER BIOM ENG, P533, DOI 10.1016/B978-0-12-370869-4.00018-5
   Brun P, 2003, OSTEOARTHR CARTILAGE, V11, P208, DOI 10.1016/S1063-4584(02)00352-7
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Cohen SB, 2003, BIOMATERIALS, V24, P2653, DOI 10.1016/S0142-9612(03)00058-9
   Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912
   Girotto D, 2003, BIOMATERIALS, V24, P3265, DOI 10.1016/S0142-9612(03)00160-1
   Grigolo B, 2005, BIOMATERIALS, V26, P5668, DOI 10.1016/j.biomaterials.2005.02.030
   Grogan SP, 2007, ARTHRITIS RHEUM, V56, P586, DOI 10.1002/art.22408
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hunziker EB, 2007, OSTEOARTHR CARTILAGE, V15, P403, DOI 10.1016/j.joca.2006.09.010
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Im GI, 2010, J BIOMED MATER RES B, V92B, P552, DOI 10.1002/jbm.b.31552
   Ito S, 2012, BIOMATERIALS, V33, P5278, DOI 10.1016/j.biomaterials.2012.03.073
   Kose GT, 2005, BIOMATERIALS, V26, P5187, DOI 10.1016/j.biomaterials.2005.01.037
   Lebourg M, 2013, J BIOMED MATER RES A, V101, P518, DOI 10.1002/jbm.a.34349
   Maher SA, 2007, J BIOMED MATER RES A, V83A, P145, DOI 10.1002/jbm.a.31255
   Martinez-Diaz S, 2010, AM J SPORT MED, V38, P509, DOI 10.1177/0363546509352448
   Patti AM, 2001, TISSUE CELL, V33, P294, DOI 10.1054/tice.2001.0178
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Smith GD, 2005, ARTHROSCOPY, V21, P1462, DOI 10.1016/j.arthro.2005.09.007
   Song Hong-xing, 2006, Chin J Traumatol, V9, P266
   Steadman JR, 1999, ORTHOPADE, V28, P26, DOI 10.1007/PL00003545
   Trzeciak T, 2006, TRANSPLANT P, V38, P305, DOI 10.1016/j.transproceed.2005.12.028
   Van den Borne MPJ, 2007, OSTEOARTHR CARTILAGE, V15, P1397, DOI 10.1016/j.joca.2007.05.005
   van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806
   Wang Y, 2008, BIOMATERIALS, V29, P2858, DOI 10.1016/j.biomaterials.2008.03.021
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
NR 30
TC 17
Z9 18
U1 0
U2 22
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2014
VL 28
IS 9
BP 1304
EP 1315
DI 10.1177/0885328213507298
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF3UB
UT WOS:000334636700002
PM 24108064
DA 2018-10-20
ER

PT J
AU Barros, J
   Grenho, L
   Manuel, CM
   Ferreira, C
   Melo, L
   Nunes, OC
   Monteiro, FJ
   Ferraz, MP
AF Barros, J.
   Grenho, L.
   Manuel, C. M.
   Ferreira, C.
   Melo, L.
   Nunes, O. C.
   Monteiro, F. J.
   Ferraz, M. P.
TI Influence of nanohydroxyapatite surface properties on Staphylococcus
   epidermidis biofilm formation
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE nanohydroxyapatite; biofilm formation; Inoculum concentration;
   biomaterial surface area; biomaterial roughness
ID HYDROXYAPATITE CERAMICS; MEDICAL APPLICATIONS; BACTERIAL ADHERENCE;
   CELL-ADHESION; GLASS; BONE; SIZE; HYDROPHOBICITY; PROLIFERATION;
   MICROSPHERES
AB Nanohydroxyapatite (nanoHA), due to its chemical properties, has appeared as an exceptionally promising bioceramic to be used as bone regeneration material. Staphylococcus epidermidis have emerged as major nosocomial pathogens associated with infections of implanted medical devices. In this work, the purpose was to study the influence of the nanoHA surface characteristics on S. epidermidis RP62A biofilm formation. Therefore, two different initial inoculum concentrations (C-i) were used in order to check if these would affect the biofilm formed on the nanoHA surfaces. Biofilm formation was followed by the enumeration of cultivable cells and by scanning electron microscopy. Surface topography, contact angle, total surface area and porosimetry of the biomaterials were studied and correlated with the biofilm data. The surface of nanoHA sintered at 830celcius (nanoHA830) showed to be more resistant to S. epidermidis attachment and accumulation than that of nanoHA sintered at 1000celcius (nanoHA1000). The biofilm formed on nanoHA830 presented differences in terms of structure, surface coverage and EPS production when compared to the one formed on nanoHA1000 surface. It was observed that topography and surface area of nanoHA surfaces had influence on the bacterial attachment and accumulation. C-i influenced bacteria attachment and accumulation on nanoHA surfaces over time. The choice of the initial inoculum concentration was relevant proving to have an effect on the extent of adherence thus being a critical point for human health if these materials are used in implantable devices. This study showed that the initial inoculum concentration and surface material properties determine the rate of microbial attachment to substrata and consequently are related to biofilm-associated infections in biomaterials.
C1 [Barros, J.; Grenho, L.; Monteiro, F. J.; Ferraz, M. P.] Univ Porto, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Barros, J.; Grenho, L.; Monteiro, F. J.] Univ Porto, FEUP Fac Med, Dept Met & Mat Engn, P-4150180 Oporto, Portugal.
   [Ferraz, M. P.] Univ Fernando Pessoa, CEBIMED Ctr Estudos Biomed, Oporto, Portugal.
   [Barros, J.; Manuel, C. M.; Ferreira, C.; Melo, L.; Nunes, O. C.] Univ Porto, Fac Engn, Dept Engn Quim, LEPAE, P-4150180 Oporto, Portugal.
   [Manuel, C. M.] ULP, Oporto, Portugal.
RP Barros, J (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM joanabarros@fe.up.pt
RI Grenho, Liliana/I-4540-2015; Ferraz, Maria/M-6316-2013
OI Grenho, Liliana/0000-0001-9476-2839; Ferraz, Maria/0000-0002-0274-106X;
   Melo, Luis/0000-0002-8469-4462; Monteiro, Fernando/0000-0002-1361-4605;
   Barros, Joana/0000-0002-8205-5675; Duarte Manuel, Candida
   Maria/0000-0002-7030-1525; Nunes, Olga/0000-0003-4742-2537
FU FEDER funds through COMPETE; FCT - Fundacao para a Ciencia e a
   Tecnologia [PTDC/SAU-BMA/111233/2009]
FX J.B. is supported by a research grant from FEDER funds through COMPETE
   and by FCT - Fundacao para a Ciencia e a Tecnologia in the framework of
   the project NanoBiofilm (PTDC/SAU-BMA/111233/2009).
CR Anselme K, 2010, J ADHES SCI TECHNOL, V24, P831, DOI 10.1163/016942409X12598231568186
   Bazaka K, 2012, APPL MICROBIOL BIOT, V95, P299, DOI 10.1007/s00253-012-4144-7
   Carlen A, 2001, BIOMATERIALS, V22, P481, DOI 10.1016/S0142-9612(00)00204-0
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   Cerca N, 2004, LETT APPL MICROBIOL, V39, P420, DOI 10.1111/j.1472-765X.2004.01601.x
   Chin MYH, 2007, BIOMATERIALS, V28, P2032, DOI 10.1016/j.biomaterials.2006.12.014
   Clauss M, 2010, ACTA BIOMATER, V6, P3791, DOI 10.1016/j.actbio.2010.03.011
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Fenoglio I, 2011, ADV DRUG DELIVER REV, V63, P1186, DOI 10.1016/j.addr.2011.08.001
   Ferraz MP, 2007, J BIOMED MATER RES A, V81A, P994, DOI 10.1002/jbm.a.31151
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Ferraz MP, 2001, BIOMATERIALS, V22, P3105, DOI 10.1016/S0142-9612(01)00059-X
   Fonseca AP, 2001, J MATER SCI-MATER M, V12, P543, DOI 10.1023/A:1011227915575
   Furuzono T, 2001, J MATER SCI LETT, V20, P111, DOI 10.1023/A:1006725931450
   Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2
   He ZM, 2005, BIOMATERIALS, V26, P1613, DOI 10.1016/j.biomaterials.2004.05.027
   Ho TA, 2011, P NATL ACAD SCI USA, V108, P16170, DOI 10.1073/pnas.1105189108
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Katsikogianni MG, 2010, ACTA BIOMATER, V6, P1107, DOI 10.1016/j.actbio.2009.08.006
   Kinnari TJ, 2009, J MED MICROBIOL, V58, P132, DOI 10.1099/jmm.0.002758-0
   Kolenbrander PE, 2000, S SOC GEN MICR
   Laranjeira MS, 2010, J BIOMED MATER RES A, V95A, P891, DOI 10.1002/jbm.a.32916
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   McCann MT, 2008, J PHARM PHARMACOL, V60, P1551, DOI 10.1211/jpp/60.12.0001
   Melo LF, 1997, EXP THERM FLUID SCI, V14, P375, DOI 10.1016/S0894-1777(96)00139-2
   Mizunaga S, 2005, J ANTIMICROB CHEMOTH, V56, P91, DOI 10.1093/jac/dki163
   Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001
   Montag D, 2012, BIOFOULING, V28, P315, DOI 10.1080/08927014.2012.673219
   Muralithran G, 2000, CERAM INT, V26, P221, DOI 10.1016/S0272-8842(99)00046-2
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Mateus AYP, 2008, J BIOMED MATER RES A, V86A, P483, DOI 10.1002/jbm.a.31.634
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Pereira MA, 2000, J IND MICROBIOL BIOT, V24, P181, DOI 10.1038/sj.jim.2900799
   Pereni CI, 2006, COLLOID SURFACE B, V48, P143, DOI 10.1016/j.colsurfb.2006.02.004
   Quirynen M, 2000, HDB BACTERIAL ADHESI, P91
   Rimondini L, 2005, J Appl Biomater Biomech, V3, P1
   Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005
   Sanders DL, 2013, SURG ENDOSC, V27, P978, DOI 10.1007/s00464-012-2545-4
   Schwarz F, 2007, ORAL MAXILLOFAC SURG, V11, P333, DOI 10.1007/s10006-007-0079-z
   Singh C, 2011, NANOSCALE, V3, P3244, DOI 10.1039/c1nr10215j
   Sousa C, 2009, INT J BIOMATER, DOI 10.1155/2009/718017
   Suzuki T, 1999, J BIOSCI BIOENG, V87, P320, DOI 10.1016/S1389-1723(99)80039-5
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   Tihan TG, 2009, MATER CHEM PHYS, V118, P265, DOI 10.1016/j.matchemphys.2009.03.019
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Vandiver J, 2005, BIOMATERIALS, V26, P271, DOI 10.1016/j.biomaterials.2004.02.053
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   Yao YF, 2005, INFECT IMMUN, V73, P1856, DOI 10.1128/IAI.73.3.1856-1860.2005
NR 50
TC 11
Z9 12
U1 1
U2 25
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2014
VL 28
IS 9
BP 1325
EP 1335
DI 10.1177/0885328213507300
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF3UB
UT WOS:000334636700004
PM 24122400
DA 2018-10-20
ER

PT J
AU Jabaiah, A
   Wang, X
   Raman, SK
   Ragan, R
   Da Silva, NA
   Wang, SW
AF Jabaiah, Abeer
   Wang, Xi
   Raman, Senthil Kumar
   Ragan, Regina
   Da Silva, Nancy A.
   Wang, Szu-Wen
TI Nanoscale architecture and cellular adhesion of biomimetic collagen
   substrates
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE stability; biomaterial; Collagen; cell adhesion; biomimetic; recombinant
   protein; atomic force microscopy
ID ATOMIC-FORCE MICROSCOPY; ADSORBED COLLAGEN; TRIPLE-HELIX; THIN-FILMS; I
   COLLAGEN; ADSORPTION; STABILITY; PEPTIDE; POLYSTYRENE; SURFACES
AB The ability to engineer bioactive sites within the biopolymer collagen has significant potential to dictate cellular microenvironments and processes. We have developed a novel recombinant DNA platform that enables such molecular-level control over this important material. In this investigation, we demonstrated the production of synthetic human collagen using yeast strains that were engineered with human prolyl hydroxylase alpha and beta genes integrated into the genome and a codon-optimized collagen gene carried on a plasmid. To understand the extent to which this synthetic collagen can mimic native human collagen, we examined the relationships between the structural topology and physical stability with the ability to support adhesion of HT-1080 cells. Characterization of these biopolymers included evaluation using circular dichroism spectroscopy, atomic force microscopy, and MTT metabolic activity assays. Although the apparent melting temperatures of the recombinant collagens were similar to 3-5celcius less than native sources, the recombinant and native collagens exhibited comparable triple helical structure, polymeric dimensions, adsorption on polystyrene, and cellular adhesion properties below their respective melting temperature values. These results support the feasibility of producing molecularly-engineered collagens that can mimic native substrates for therapeutic and tissue engineering applications.
C1 [Jabaiah, Abeer; Wang, Xi; Raman, Senthil Kumar; Ragan, Regina; Da Silva, Nancy A.; Wang, Szu-Wen] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Irvine, CA 92697 USA.
RP Wang, SW (reprint author), Univ Calif Irvine, Dept Chem Engn & Mat Sci, 916 Engn Tower, Irvine, CA 92697 USA.
EM ndasilva@uci.edu; wangsw@uci.edu
FU National Science Foundation [CBET-1034566, DMR-1006999, CHE-0748912]
FX We gratefully acknowledge Dr Matthew Shindel's assistance in initial AFM
   studies, Dr Polly Chan and Richard Que for assistance in expression and
   purification of proteins, and Dr Sarah Adams and Daniel Kha Le for
   assistance in polystyrene spin-coating. This work was funded by the
   National Science Foundation (CBET-1034566, DMR-1006999, and
   CHE-0748912).
CR Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   BIRK DE, 1991, CELL BIOL EXTRACELLU, P221
   Chan SWP, 2010, BIOMACROMOLECULES, V11, P1460, DOI 10.1021/bm100052y
   Chan SWP, 2012, THESIS U CALIFORNIA
   Chan SWP, 2012, BMC BIOTECHNOL, P12
   DAVIS JM, 1993, J BIOL CHEM, V268, P25965
   Dewez JL, 1997, J COLLOID INTERF SCI, V191, P1, DOI 10.1006/jcis.1997.4908
   Dupont-Gillain CC, 2001, LANGMUIR, V17, P7261, DOI 10.1021/la010042g
   Elliott JT, 2003, LANGMUIR, V19, P1506, DOI 10.1021/la026216r
   Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030
   Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818
   Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241
   Gaudet C, 2003, BIOPHYS J, V85, P3329, DOI 10.1016/S0006-3495(03)74752-3
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204
   Jacquemart I, 2004, J COLLOID INTERF SCI, V278, P63, DOI 10.1016/j.jcis.2004.05.040
   Keresztes Z, 2006, J BIOMED MATER RES A, V76A, P223, DOI 10.1002/jbm.a.30472
   Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200
   Knotts TA, 2008, BIOPHYS J, V94, P4473, DOI 10.1529/biophysj.107.123158
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Koutsopoulos S, 2004, LANGMUIR, V20, P6401, DOI 10.1021/la049821y
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Li Y, 2007, LANGMUIR, V23, P9785, DOI 10.1021/la0636311
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Maeda H, 1999, LANGMUIR, V15, P8505, DOI 10.1021/la981738l
   Majsterek I, 2003, PROTEIN SCI, V12, P2063, DOI 10.1110/ps.0385103
   Mansky P, 1997, SCIENCE, V275, P1458, DOI 10.1126/science.275.5305.1458
   MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337
   Pamula E, 2004, J COLLOID INTERF SCI, V271, P80, DOI 10.1016/j.jcis.2003.11.012
   Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Wang SW, 2004, J PHARM SCI-US, V93, P2755, DOI 10.1002/jps.20183
   Yamamoto S, 2000, J ELECTRON MICROSC, V49, P423, DOI 10.1093/oxfordjournals.jmicro.a023824
   Zoungrana T, 1997, J COLLOID INTERF SCI, V190, P437, DOI 10.1006/jcis.1997.4895
NR 36
TC 5
Z9 5
U1 0
U2 18
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2014
VL 28
IS 9
BP 1354
EP 1365
DI 10.1177/0885328213508328
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF3UB
UT WOS:000334636700007
PM 24146435
DA 2018-10-20
ER

PT J
AU Lisman, A
   Butruk, B
   Wasiak, I
   Ciach, T
AF Lisman, Anna
   Butruk, Beata
   Wasiak, Iga
   Ciach, Tomasz
TI Dextran/Albumin hydrogel sealant for Dacron (R) vascular prosthesis
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE dextran; Albumin; vascular prosthesis; sealant; dextran oxidation;
   hydrogel
ID DEXTRAN-BASED HYDROGELS; POLYALDEHYDE DEXTRAN; ARTERIAL PROSTHESES;
   BLOOD COMPATIBILITY; OXIDIZED DEXTRAN; PROTEIN-BINDING; CROSS-LINKING;
   HUMAN-SERUM; GELATIN; RELEASE
AB In this paper, the authors describe a novel type of hydrogel coating prepared from the copolymer of human serum albumin and oxidized dextran. The material was designed as a hydrogel sealant for polyester (Dacron (R))-based vascular grafts. Dextran was chosen as a coating material due to its anti-thrombogenic properties. Prepared hydrogels were compared with similar, already known biomaterial made from gelatine with the same cross-linking agent. Obtained hydrogels, prepared from various ratios of oxidized dextran/albumin or oxidized dextran/gelatine, showed different cross-linking densities, which caused differences in swelling, degradation rate and mechanical properties. Permeability tests confirmed the complete tightness of the hydrogel-modified prosthesis. Results showed that application of the hydrogel coating provided leakage-free prosthesis and eliminated the need of pre-clotting.
C1 [Lisman, Anna; Butruk, Beata; Wasiak, Iga; Ciach, Tomasz] Warsaw Univ Technol, Fac Chem & Proc Engn, Biomed Engn Lab, PL-00645 Warsaw, Poland.
RP Ciach, T (reprint author), Warsaw Univ Technol, Fac Chem & Proc Engn, Warynskiego St 1, PL-00645 Warsaw, Poland.
EM t.ciach@ichip.pw.edu.pl
OI Ciach, Tomasz/0000-0002-8726-8944; Butruk-Raszeja,
   Beata/0000-0002-2074-1944
CR Battersby J, 1996, J CONTROL RELEASE, V42, P143, DOI 10.1016/0168-3659(96)01370-3
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Bhatia SK, 2007, BIOTECHNOL LETT, V29, P1645, DOI 10.1007/s10529-007-9465-8
   Butruk B, 2012, MAT SCI ENG C-MATER, V32, P1601, DOI 10.1016/j.msec.2012.04.050
   Carballal S, 2007, AMINO ACIDS, V32, P543, DOI 10.1007/s00726-006-0430-y
   Chiba Y, 1999, SURG TODAY, V29, P1225
   DAY JF, 1979, J BIOL CHEM, V254, P595
   Dhaneshwar Suneela S., 2006, Indian Journal of Pharmaceutical Sciences, V68, P705
   Dhillon S, 2011, DRUGS, V71, P1893, DOI 10.2165/11207700-000000000-00000
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fuentes M, 2004, PROTEOMICS, V4, P2602, DOI 10.1002/pmic.200300766
   GUIDOIN R, 1989, BIOMATERIALS, V10, P156, DOI 10.1016/0142-9612(89)90018-5
   Heindel ND, 1990, BIOCONJUGATE CHEM, V1, P77, DOI 10.1021/bc00001a010
   Khaffaf AI- H, 1996, J VASC SURG, V23, P686
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Liu G, 2009, MACROMOL SYMP, V279, P151, DOI 10.1002/masy.200950523
   Maia J, 2005, POLYMER, V46, P9604, DOI 10.1016/j.polymer.2005.07.089
   Maia J, 2009, ACTA BIOMATER, V5, P1948, DOI 10.1016/j.actbio.2009.02.008
   Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3
   Miksa D, 2004, MAT RES SOC S P E, V826E
   Muangsiri W, 2006, INT J PHARM, V315, P30, DOI 10.1016/j.ijpharm.2006.02.016
   Neishlos AL, 2004, RUSS J APPL CHEM+, V77, P128, DOI 10.1023/B:RJAC.0000024592.71970.98
   Nonami Y., 1994, Japanese Journal of Artificial Organs, V23, P821
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Phaneuf MD, 2001, BIOMATERIALS, V22, P463, DOI 10.1016/S0142-9612(00)00202-7
   Rosiak JM, 1999, NUCL INSTRUM METH B, V151, P56, DOI 10.1016/S0168-583X(99)00118-4
   SAWYER PN, 1979, J BIOMED MATER RES, V13, P937, DOI 10.1002/jbm.820130611
   Schacht E, 1997, REACT FUNCT POLYM, V33, P109, DOI 10.1016/S1381-5148(97)00047-3
   SHEEHAN SJ, 1989, BIOMATERIALS, V10, P75, DOI 10.1016/0142-9612(89)90034-3
   Suvorova OB, 2001, RUSS J APPL CHEM+, V74, P1016, DOI 10.1023/A:1013011911022
   Weng L, 2008, BIOMATERIALS, V29, P3905, DOI 10.1016/j.biomaterials.2008.06.025
   Yasim A, 2006, EUR J VASC ENDOVASC, V32, P425, DOI 10.1016/j.ejvs.2006.03.014
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   ZHAO H, 1991, PHARMACEUT RES, V8, P400, DOI 10.1023/A:1015866104055
   Ziaja K, 2001, POL SURG, V3, P179
NR 36
TC 6
Z9 6
U1 0
U2 30
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2014
VL 28
IS 9
BP 1386
EP 1396
DI 10.1177/0885328213509676
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF3UB
UT WOS:000334636700010
PM 24221140
DA 2018-10-20
ER

PT J
AU Niu, LN
   Jiao, K
   Wang, TD
   Zhang, W
   Camilleri, J
   Bergeron, BE
   Feng, HL
   Mao, J
   Chen, JH
   Pashley, DH
   Tay, FR
AF Niu, Li-na
   Jiao, Kai
   Wang, Tian-da
   Zhang, Wei
   Camilleri, Josette
   Bergeron, Brian E.
   Feng, Hai-lan
   Mao, Jing
   Chen, Ji-hua
   Pashley, David H.
   Tay, Franklin R.
TI A review of the bioactivity of hydraulic calcium silicate cements
SO JOURNAL OF DENTISTRY
LA English
DT Review
DE Bioactivity; Calcium silicate; Hydraulic cement; In vitro; In vivo
ID MINERAL TRIOXIDE AGGREGATE; END FILLING MATERIALS; OSTEOBLAST-LIKE
   CELLS; SIMULATED BODY-FLUID; IN-VITRO BIOACTIVITY; C-S-H; TRANSMISSION
   ELECTRON-MICROSCOPY; PERIODONTAL-LIGAMENT FIBROBLASTS; BONELIKE APATITE
   FORMATION; PHOSPHATE-CONTAINING FLUID
AB Objectives: In tissue regeneration research, the term "bioactivity" was initially used to describe the resistance to removal of a biomaterial from host tissues after intraosseous implantation. Hydraulic calcium silicate cements (HCSCs) are putatively accepted as bioactive materials, as exemplified by the increasing number of publications reporting that these cements produce an apatite-rich surface layer after they contact simulated body fluids.
   Methods: In this review, the same definitions employed for establishing in vitro and in vivo bioactivity in glass-ceramics, and the proposed mechanisms involved in these phenomena are used as blueprints for investigating whether HCSCs are bioactive.
   Results: The literature abounds with evidence that HCSCs exhibit in vitro bioactivity; however, there is a general lack of stringent methodologies for characterizing the calcium phosphate phases precipitated on HCSCs. Although in vivo bioactivity has been demonstrated for some HCSCs, a fibrous connective tissue layer is frequently identified along the bone-cement interface that is reminiscent of the responses observed in bioinert materials, without accompanying clarifications to account for such observations.
   Conclusions: As bone-bonding is not predictably achieved, there is insufficient scientific evidence to substantiate that HCSCs are indeed bioactive. Objective appraisal criteria should be developed for more accurately defining the bioactivity profiles of HCSCs designed for clinical use. Published by Elsevier B.V.
C1 [Niu, Li-na; Chen, Ji-hua] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian 710032, Peoples R China.
   [Jiao, Kai] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Anat & Physiol & TMD, Xian 710032, Peoples R China.
   [Wang, Tian-da; Feng, Hai-lan] Peking Univ, Sch Stomatol, Dept Prosthodont, Beijing 100871, Peoples R China.
   [Zhang, Wei; Mao, Jing] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Stomatol, Wuhan 430074, Peoples R China.
   [Camilleri, Josette] Univ Malta, Fac Dent Surg, Dept Restorat Dent, Msida, Malta.
   [Bergeron, Brian E.; Tay, Franklin R.] Georgia Regents Univ, Coll Dent Med, Dept Endodont, Augusta, GA USA.
   [Pashley, David H.; Tay, Franklin R.] Georgia Regents Univ, Coll Grad Studies, Augusta, GA USA.
RP Chen, JH (reprint author), Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China.
EM jhchen@fmmu.edu.cn; ftay@gru.edu
RI Bergeron, Brian/O-3110-2016; Camilleri, Josette/N-9409-2015
OI Camilleri, Josette/0000-0003-3556-6365
FU NIDCR [R01 DE015306-06]; National Nature Science Foundation of China
   [81130078, 81300898]
FX This work was supported by grant R01 DE015306-06 from NIDCR (PI. David H
   Pashley), grant 81130078 (PI. Jihua Chen) and grant 81300898 (PI. Kai
   Jiao) from the National Nature Science Foundation of China.
CR Al-Rabeah E, 2006, J ENDODONT, V32, P872, DOI 10.1016/j.joen.2006.03.019
   Andersen MD, 2003, INORG CHEM, V42, P2280, DOI 10.1021/ic020607b
   Cintra LTA, 2010, J APPL ORAL SCI, V18, P75, DOI 10.1590/S1678-77572010000100013
   Asefa T, 2009, ANALYST, V134, P1980, DOI 10.1039/b911965p
   Asgary S, 2009, AUST ENDOD J, V35, P147, DOI 10.1111/j.1747-4477.2008.00137.x
   Balto HA, 2004, J ENDODONT, V30, P25, DOI 10.1097/00004770-200401000-00005
   Bird DC, 2012, J ENDODONT, V38, P1093, DOI 10.1016/j.joen.2012.04.017
   Bodier-Houlle P, 1998, ACTA CRYSTALLOGR D, V54, P1377, DOI 10.1107/S0907444998005769
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Bonson S, 2004, J DENT RES, V83, P408, DOI 10.1177/154405910408300511
   Bosetti M, 2003, J BIOMED MATER RES A, V64A, P189, DOI 10.1002/jbm.a.10415
   Bozeman TB, 2006, J ENDODONT, V32, P425, DOI 10.1016/j.joen.2005.08.009
   Branda F, 2002, BIOMATERIALS, V23, P711, DOI 10.1016/S0142-9612(01)00173-9
   Brouwers HJH, 2003, CEMENT CONCRETE RES, V33, P191, DOI 10.1016/S0008-8846(02)01022-0
   BROWN WE, 1962, NATURE, V196, P1050, DOI 10.1038/1961050a0
   BROWN WE, 1962, NATURE, V196, P1048, DOI 10.1038/1961048b0
   Budiraharjo R, 2010, INT ENDOD J, V43, P930, DOI 10.1111/j.1365-2591.2010.01771.x
   Cado G, 2013, ADV FUNCT MATER, V23, P4801, DOI 10.1002/adfm.201300416
   Camilleri J, 2007, INT ENDOD J, V40, P462, DOI 10.1111/j.1365-2591.2007.01248.x
   Camilleri J, 2005, DENT MATER, V21, P297, DOI 10.1016/j.dental.2004.05.010
   Camilleri J, 2013, DENT MATER, V29, P580, DOI 10.1016/j.dental.2013.03.007
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Chen CC, 2009, J ENDODONT, V35, P1554, DOI 10.1016/j.joen.2009.08.006
   Chen W, 2010, CEMENT CONCRETE RES, V40, P716, DOI 10.1016/j.cemconres.2009.12.007
   Chiang TY, 2013, J MED BIOL ENG
   CHICKERUR NS, 1980, CALCIFIED TISSUE INT, V32, P55, DOI 10.1007/BF02408521
   Cho SB, 1996, J BIOMED MATER RES, V33, P145, DOI 10.1002/(SICI)1097-4636(199623)33:3<145::AID-JBM4>3.0.CO;2-Q
   Cintra LTA, 2006, J ENDODONT, V32, P556, DOI 10.1016/j.joen.2005.07.007
   Coleman NJ, 2007, CEMENT CONCRETE RES, V37, P1518, DOI 10.1016/j.cemconres.2007.08.008
   Combes C, 2010, ACTA BIOMATER, V6, P3362, DOI 10.1016/j.actbio.2010.02.017
   DAMEN JJM, 1992, J DENT RES, V71, P453, DOI 10.1177/00220345920710030601
   Darvell BW, 2011, DENT MATER, V27, P407, DOI 10.1016/j.dental.2011.02.001
   Davies JE, 1993, BONE BIOMATERIAL INT
   Dey A, 2010, NAT MATER, V9, P1010, DOI 10.1038/NMAT2900
   Dorozhkin Sergey V, 2011, Biomatter, V1, P121, DOI 10.4161/biom.18790
   Dorvee JR, 2013, J STRUCT BIOL, V183, P278, DOI 10.1016/j.jsb.2013.06.007
   Eanes E D, 2001, Monogr Oral Sci, V18, P130
   EIDELMAN N, 1987, CALCIFIED TISSUE INT, V41, P18, DOI 10.1007/BF02555126
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Elliot JC, 1994, STUDIES INORGANIC CH
   Formosa LM, 2013, DENT MATER, V29, pE11, DOI 10.1016/j.dental.2012.11.006
   Formosa LM, 2012, DENT MATER, V28, P584, DOI 10.1016/j.dental.2012.02.006
   FOWLER BO, 1993, CHEM MATER, V5, P1417, DOI 10.1021/cm00034a009
   Gandolfi MG, 2011, INT ENDOD J, V44, P938, DOI 10.1111/j.1365-2591.2011.01907.x
   Gandolfi MG, 2010, INT ENDOD J, V43, P917, DOI 10.1111/j.1365-2591.2010.01768.x
   Gandolfi MG, 2013, J BIOMED MATER RES B, V101, P1107, DOI 10.1002/jbm.b.32920
   Gandolfi MG, 2011, MAT SCI ENG C-MATER, V31, P1412, DOI 10.1016/j.msec.2011.05.012
   Gandolfi MG, 2011, DENT MATER, V27, pE134, DOI 10.1016/j.dental.2011.03.011
   Gandolfi M, 2010, CLIN ORAL INVEST, V14, P659, DOI 10.1007/s00784-009-0356-3
   Gandolfi MG, 2010, DENT MATER, V26, P974, DOI 10.1016/j.dental.2010.06.002
   Gandolfi MG, 2010, J ENDODONT, V36, P851, DOI 10.1016/j.joen.2009.12.007
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Gerhardt LC, 2013, J BIOMED MATER RES A, V101, P827, DOI 10.1002/jbm.a.34373
   Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032
   Gomes JE, 2011, J ENDODONT, V37, P250, DOI 10.1016/j.joen.2010.11.005
   Gomes-Filho JE, 2010, ORAL SURG ORAL MED O, V110, pE93, DOI 10.1016/j.tripleo.2010.05.065
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Gou ZG, 2005, J BIOMED MATER RES B, V73B, P244, DOI 10.1002/jbm.b.30203
   GREENSPAN DC, 1976, J BIOMED MATER RES, V10, P503, DOI 10.1002/jbm.820100405
   Greenspan DC, 1999, TANDLAKARTIDNINGEN A, V91
   Hakki SS, 2012, INT ENDOD J, V45, P240, DOI 10.1111/j.1365-2591.2011.01968.x
   Han L, 2013, INT ENDOD J, V46, P808, DOI 10.1111/iej.12062
   Han L, 2011, INT ENDOD J, V44, P1081, DOI 10.1111/j.1365-2591.2011.01924.x
   Han LL, 2010, DENT MATER J, V29, P512, DOI 10.4012/dmj.2009-133
   Han S, 2013, CELL BIOL TOXICOL, V29, P75, DOI 10.1007/s10565-013-9239-0
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   Hench LL, 1988, ANN NY ACAD SCI, V523, P554
   HENCH LL, 1993, INTRO BIOCERAMICS, P41
   HENCH LL, 1982, BIOMATERIALS INTERFA
   Hench LL, 1991, J AM CERAM SOC, V74, P1487
   HENCH LL, 1971, J BIOMED MATER RES, V5, P117, DOI DOI 10.1002/JBM.820050611
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225
   Katsamakis S, 2013, J CLIN PERIODONTOL, V40, P334, DOI 10.1111/jcpe.12058
   KITSUGI T, 1987, J BIOMED MATER RES, V21, P1255, DOI 10.1002/jbm.820211008
   Koh ET, 1998, J ENDODONT, V24, P543, DOI 10.1016/S0099-2399(98)80074-5
   Koh ET, 1997, J BIOMED MATER RES, V37, P432, DOI 10.1002/(SICI)1097-4636(19971205)37:3<432::AID-JBM14>3.0.CO;2-D
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Labbez C, 2006, J PHYS CHEM B, V110, P9219, DOI 10.1021/jp057096+
   LEGEROS RZ, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P3
   LeGeros RZ, 1991, CALCIUM PHOSPHATE OR
   Leu A, 2009, TISSUE ENG PT A, V15, P877, DOI 10.1089/ten.tea.2008.0018
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105
   Mahamid J, 2011, CELLS TISSUES ORGANS, V194, P92, DOI 10.1159/000324229
   Mahamid J, 2010, P NATL ACAD SCI USA, V107, P6316, DOI 10.1073/pnas.0914218107
   Marie PJ, 2010, BONE, V46, P571, DOI 10.1016/j.bone.2009.07.082
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Mathew M, 2001, J RES NATL INST STAN, V106, P1035, DOI 10.6028/jres.106.054
   MERWIN GE, 1982, OTOLARYNG HEAD NECK, V90, P461, DOI 10.1177/019459988209000417
   Mitchell PJC, 1999, BIOMATERIALS, V20, P167, DOI 10.1016/S0142-9612(98)00157-4
   Miyazaki T, 2001, J CERAM SOC JPN, V109, P929, DOI 10.2109/jcersj.109.1275_929
   Miyazaki T, 2001, J SOL-GEL SCI TECHN, V21, P83, DOI 10.1023/A:1011265701447
   Moretton TR, 2000, J BIOMED MATER RES, V52, P528, DOI 10.1002/1097-4636(20001205)52:3<528::AID-JBM11>3.0.CO;2-9
   Nakayama A, 2005, INT ENDOD J, V38, P203, DOI 10.1111/j.1365-2591.2004.00917.x
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Niu LN, 2013, DENT MAT
   Pan HH, 2010, CHEM COMMUN, V46, P7415, DOI 10.1039/c0cc00971g
   Pardal X, 2009, CEMENT CONCRETE RES, V39, P637, DOI 10.1016/j.cemconres.2009.05.001
   Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009
   Parirokh M, 2010, J ENDODONT, V36, P16, DOI 10.1016/j.joen.2009.09.006
   Peltola T, 1998, J BIOMED MATER RES, V41, P504, DOI 10.1002/(SICI)1097-4636(19980905)41:3<504::AID-JBM22>3.3.CO;2-5
   Primus C, 2011, Patent, Patent No. [US 7,892,342 B2, 7892342]
   Qia YP, 2012, ACTA BIOMATER, V8, P836, DOI 10.1016/j.actbio.2011.10.033
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rahimi S, 2012, MED ORAL PATOL ORAL, V17, pE907, DOI 10.4317/medoral.18136
   Maia FR, 2013, ACTA BIOMATER, V9, P8773, DOI 10.1016/j.actbio.2013.08.004
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Reyes-Carmona JF, 2009, J ENDODONT, V35, P731, DOI 10.1016/j.joen.2009.02.011
   Richardson IG, 2008, CEMENT CONCRETE RES, V38, P137, DOI 10.1016/j.cemconres.2007.11.005
   RICHARDSON IG, 1993, J AM CERAM SOC, V76, P2285, DOI 10.1111/j.1151-2916.1993.tb07765.x
   Roberts HW, 2008, DENT MATER, V24, P149, DOI 10.1016/j.dental.2007.04.007
   Saidon J, 2003, ORAL SURG ORAL MED O, V95, P483, DOI 10.1067/moe.2003.20
   Samara A, 2011, J ENDODONT, V37, P865, DOI 10.1016/j.joen.2011.03.011
   Saravanapavan P, 2004, BIO-MED MATER ENG, V14, P467
   Saravanapavan P, 2003, J BIOMED MATER RES A, V66A, P110, DOI 10.1002/jbm.a.10532
   Sarkar NK, 2005, J ENDODONT, V31, P97, DOI 10.1097/01.DON.0000133155.04468.41
   Schroder HC, 2012, J CELL BIOCHEM, V113, P3197, DOI 10.1002/jcb.24196
   SEITZ TL, 1982, J BIOMED MATER RES, V16, P195, DOI 10.1002/jbm.820160303
   Shaw CA, 2013, IMMUNOL RES, V56, P304, DOI 10.1007/s12026-013-8403-1
   Shokouhinejad N, 2012, INT ENDOD J, V45, P1127, DOI 10.1111/j.1365-2591.2012.02083.x
   Shrikant Sharma, 2011, International Journal BIOAutomation, V15, P223
   Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3
   Sousa CJA, 2004, INT ENDOD J, V37, P738, DOI 10.1111/j.1365-2591.2004.00861.x
   Taddei P, 2009, J MOL STRUCT, V924, P548, DOI 10.1016/j.molstruc.2008.11.002
   Taddei P, 2009, J RAMAN SPECTROSC, V40, P1858, DOI 10.1002/jrs.2333
   TAVES DR, 1963, NATURE, V200, P1312, DOI 10.1038/2001312a0
   Tay FR, 2007, J ENDODONT, V33, P1347, DOI 10.1016/j.joen.2007.07.008
   Tingey MC, 2008, J ENDODONT, V34, P45, DOI 10.1016/j.joen.2007.09.013
   Tjaderhane L, 2013, DENT MATER, V29, P999, DOI 10.1016/j.dental.2013.07.016
   Torabinejad M, 1998, J ENDODONT, V24, P468, DOI 10.1016/S0099-2399(98)80048-4
   Torabinejad M, 2005, J ENDODONT, V31, P563, DOI 10.1097/01.don.0000164137.28104.2f
   TORABINEJAD M, 1995, J ENDODONT, V21, P569, DOI 10.1016/S0099-2399(06)80987-8
   Torabinejad M., 1993, US Patent, Patent No. 5415547
   Tseng YH, 2006, J AM CHEM SOC, V128, P6909, DOI 10.1021/ja060336u
   Uchida M, 2001, J AM CERAM SOC, V84, P2041
   Valerio P, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045011
   Wan XH, 2005, MAT SCI ENG C-BIO S, V25, P455, DOI 10.1016/j.msec.2004.12.003
   Willershausen I, 2013, ARCH ORAL BIOL, V58, P1232, DOI 10.1016/j.archoralbio.2013.04.002
   Williams D. F., 1987, DEFINITIONS BIOMATER
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WILSON J, 1990, HDB BIOACTIVE CERAMI, V1
   Xin RL, 2006, J CRYST GROWTH, V289, P339, DOI 10.1016/j.jcrysgro.2005.11.010
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Yang Q, 2011, J BONE MINER RES, V26, P1188, DOI 10.1002/jbmr.337
   Zhang LF, 2013, J TOXICOL SCI, V38, P255, DOI 10.2131/jts.38.255
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
   Zhong J, 1995, P 8 INT S CER MED BI, V8, P489
   Zhong J. P., 1994, BIOCERAMICS, P61
   Zhu Q, 2000, J ENDODONT, V26, P404, DOI 10.1097/00004770-200007000-00006
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 159
TC 34
Z9 36
U1 2
U2 73
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0300-5712
EI 1879-176X
J9 J DENT
JI J. Dent.
PD MAY
PY 2014
VL 42
IS 5
BP 517
EP 533
DI 10.1016/j.jdent.2013.12.015
PG 17
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AF5HQ
UT WOS:000334745000002
PM 24440449
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Qu, T
   Tomar, V
AF Qu, Tao
   Tomar, Vikas
TI An analysis of the effects of temperature and structural arrangements on
   the thermal conductivity and thermal diffusivity of
   tropocollagen-hydroxyapatite interfaces
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Tropocollagen; Hydroxyapatite; Thermal diffusivity; Thermal
   conductivity; Molecular dynamics
ID COLLAGEN-LIKE PEPTIDE; NANOSCALE MECHANICAL-BEHAVIOR;
   MOLECULAR-DYNAMICS; ELASTIC PROPERTIES; HARD BIOMATERIALS; YOUNGS
   MODULUS; BONE; FIBRILS; STRENGTH; FRACTURE
AB The ability of a biomaterial to transport energy by conduction is best characterized in the steady state by its thermal conductivity and in the non-steady state by its thermal diffusivity. The complex hierarchical structure of most biomaterials makes the direct determination of the thermal diffusivity and thermal conductivity difficult using experimental methods. This study presents a classical molecular simulation based approach for the thermal diffusivity and thermal conductivity prediction for a set of tropocollagen and hydroxyapatite based idealized biomaterial interfaces. The thermal diffusivity and thermal conductivity values are calculated using the presented approach at three different temperatures (300 K, 500 K and 700 K). The effects of temperature, structural arrangements, and size of simulated systems on the thermal properties are analyzed. Analyses point out important role played by the interface orientation, interface area, and structural hierarchy. Ensuing discussions establish that the interface structural arrangement and interface orientation combined with biomimetic structural hierarchy can lead to non-intuitive thermal property variations as a function of structural features. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Qu, Tao; Tomar, Vikas] Purdue Univ, Sch Aeronaut & Astronaut, W Lafayette, IN 47907 USA.
RP Tomar, V (reprint author), Purdue Univ, Sch Aeronaut & Astronaut, W Lafayette, IN 47907 USA.
EM tomar@purdue.edu
FU U.S. Department of Energy, Office of Science, Basic Energy Sciences
   [DE-SC0008619]
FX This work was supported by the U.S. Department of Energy, Office of
   Science, Basic Energy Sciences, under Award DE-SC0008619 (Program
   Manager: Dr. Michael Markowitz).
CR Algaer E. A., 2011, SOFT MATER, V10, P42
   Anderson D., 2005, COLLAGEN SELF ASSEMB
   Autumn K, 2000, NATURE, V405, P681
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   BIYIKLI S, 1986, J BIOMED MATER RES, V20, P1335, DOI 10.1002/jbm.820200908
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236
   Dubey D.K., 2010, APPL PHYS LETT, V96
   Dubey D. K., 2009, J PHYS CONDENS MATTE, V21
   Dubey DK, 2010, J COMPUT THEOR NANOS, V7, P1306, DOI 10.1166/jctn.2010.1485
   Dubey DK, 2010, ANN BIOMED ENG, V38, P2040, DOI 10.1007/s10439-010-9988-3
   Dubey DK, 2010, J MATER SCI-MATER M, V21, P161, DOI 10.1007/s10856-009-3837-7
   Dubey DK, 2009, J MECH PHYS SOLIDS, V57, P1702, DOI 10.1016/j.jmps.2009.07.002
   Dubey DK, 2009, ACTA BIOMATER, V5, P2704, DOI 10.1016/j.actbio.2009.02.035
   Dubey DK, 2009, MAT SCI ENG C-MATER, V29, P2133, DOI 10.1016/j.msec.2009.04.015
   ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   Eppell SJ, 2006, J ROY SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100
   FRATZL P, 1991, CALCIFIED TISSUE INT, V48, P407, DOI 10.1007/BF02556454
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Gao HJ, 2005, MECH MATER, V37, P275, DOI 10.1016/j.mechmat.2004.03.008
   Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4
   Gupta HS, 2006, INT J FRACTURE, V139, P425, DOI 10.1007/s10704-006-6635-y
   Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103
   Handgraaf JW, 2006, PROTEINS, V64, P711, DOI 10.1002/prot.21019
   Hauptmann S, 2003, PHYS CHEM CHEM PHYS, V5, P635, DOI 10.1039/b208209h
   Hopkins P. E., 2013, ISRN MECH ENG, V2013
   Huang C C, 1998, Pac Symp Biocomput, P349
   Huang XP, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/9/095416
   Huiskes R., 1980, ACTA ORTHOP SCAND, V51, P43
   Isgro J.P. Tim, 2012, ANAL SPECIFIC HEAT, P50
   Jager I, 2000, BIOPHYS J, V79, P1737
   Jeng M.-S., 2008, J HEAT TRANSF, V130
   Ji BH, 2008, J BIOMECH, V41, P259, DOI 10.1016/j.jbiomech.2007.09.022
   Klein TE, 1999, BIOPOLYMERS, V49, P167
   Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017
   Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066
   Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192
   Liang LH, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/36/365201
   Lorenzo AC, 2005, J BIOMECH, V38, P1527, DOI 10.1016/j.jbiomech.2004.07.011
   MOSES WM, 1995, EXP THERM FLUID SCI, V11, P34, DOI 10.1016/0894-1777(94)00109-L
   Nadareishvili M., 2012, PULSED DIFFERENTIAL
   NELSON JS, 1988, LASER SURG MED, V8, P494, DOI 10.1002/lsm.1900080508
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27
   Radmer RJ, 2004, BIOCHEMISTRY-US, V43, P5314, DOI 10.1021/bi035676w
   Samvedi V., 2010, J PHYS D, V43
   Samvedi V., 2009, J APPL PHYS, V105
   Samvedi V., 2009, NANOTECHNOLOGY, V20
   Samvedi V, 2009, J APPL PHYS, V105, DOI 10.1063/1.3056135
   Sarnvedi V., 2011, J ENG MATER-T ASME, V133
   SASAKI N, 1995, J BIOMECH, V28, P809, DOI 10.1016/0021-9290(94)00130-V
   Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Schelling PK, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144306
   Vesentini S, 2005, BIOMECH MODEL MECHAN, V3, P224, DOI 10.1007/s10237-004-0064-5
   WEINER S, 1983, INT J BIOL MACROMOL, V5, P325, DOI 10.1016/0141-8130(83)90055-7
   WIGGINS KL, 1976, J BIOMECH, V9, P553, DOI 10.1016/0021-9290(76)90095-6
   Yang R., 2005, PHYS REV B, P72
   Yang R., 2004, PHYS REV B, P69
   Zelenov E., 1986, MECH COMPOS MATER, V21, P759
   Zhang DJ, 2007, ANN BIOMED ENG, V35, P1216, DOI 10.1007/s10439-007-9296-8
   Zhou Y., 2007, J CHEM PHYS, V127
NR 64
TC 5
Z9 5
U1 3
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2014
VL 38
BP 28
EP 38
DI 10.1016/j.msec.2014.01.039
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AF8RX
UT WOS:000334984400004
PM 24656349
DA 2018-10-20
ER

PT J
AU Kandiah, K
   Muthusamy, P
   Mohan, S
   Venkatachalam, R
AF Kandiah, Kavitha
   Muthusamy, Prabhu
   Mohan, Selvam
   Venkatachalam, Rajendran
TI TiO2-graphene nanocomposites for enhanced osteocalcin induction
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Titania-graphene; Cytotoxicity; Biocompatibility; Osteocalcin; MG-63
   cell line; Surface area
ID GRAPHENE OXIDE; BIOMEDICAL APPLICATIONS; TIO2 NANOPARTICLES; COMPOSITE
   COATINGS; IN-VITRO; CHITOSAN; FABRICATION; NANOSHEETS; CELLS; BONE
AB Bone defects and damages are common these days, which increases the usage of biomaterial for humans. To prepare a potential biomaterial, we synthesised a series of titania-graphene nanocomposites (TGS) (2:x (0.25, 0.5, 1.0, 2.0, and 4.0 g)) using in situ sol-gel method. The obtained structural results show that the prepared TGS nanocomposites are an irregular sheet with spherical TiO2 intercalated morphology. The SSA of the nanocomposites ranging from 167.98 to 234.56 m(2) g(-1) with mesoporosity and swelling tendency ranging from 11.55 to 26.13% leads to an enhancement in human cell attachment as well as avoids the migration and agglomeration of the nanoparticles in the body. Further, the biological analysis in simulated body fluid and human cell lines (AGS and MG-63) collectively reveals that the TG2 (2:2) and TG4 (2:4) samples are found to be more favourable materials for biomimic bone action among the prepared TGS nanocomposites. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kandiah, Kavitha; Muthusamy, Prabhu; Mohan, Selvam; Venkatachalam, Rajendran] KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
RP Venkatachalam, R (reprint author), KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
EM veerajendran@gmail.com
RI VENKATACHALAM, RAJENDRAN/H-5099-2012
OI VENKATACHALAM, RAJENDRAN/0000-0001-9471-5311
FU UGC-DAE-Consortium for Scientific Research, Kalpakkam
   [CSR/Acctts/2010-11/1136]
FX This work was financially supported by UGC-DAE-Consortium for Scientific
   Research, Kalpakkam (CSR/Acctts/2010-11/1136 dt.06.01.2011). The authors
   thank Dr. G. Amarendra (Head, Metal Physics Section, Indira Gandhi
   Centre for Atomic Research, Kalpakkam node) for constructive
   suggestions. The authors also thank Dr. G. Kumaresan and Mr. P.
   Jayaprakash (Department of Genetics, School of Biological Sciences,
   Madurai Kamaraj University) for their technical support in the toxicity
   studies.
CR Akhavan O, 2010, ACS NANO, V4, P5731, DOI 10.1021/nn101390x
   Amin KAM, 2012, POLYMERS-BASEL, V4, P590, DOI 10.3390/polym4010590
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Bitounis D, 2013, ADV MATER, V25, P2258, DOI 10.1002/adma.201203700
   Chen HW, 2012, NANO RES, V5, P815, DOI 10.1007/s12274-012-0265-7
   Compton OC, 2012, ACS NANO, V6, P2008, DOI 10.1021/nn202928w
   Condon J. B., 2006, SURFACE AREA POROSIT
   Hua D, 2007, T NONFERR METAL SOC, V17, pS700
   DREW WL, 1972, APPL MICROBIOL, V24, P240
   Duraisamy N, 2012, THIN SOLID FILMS, V520, P5070, DOI 10.1016/j.tsf.2012.03.003
   Fan Y, 2011, COLLOID SURFACE B, V83, P78, DOI 10.1016/j.colsurfb.2010.10.048
   Gerhardt LC, 2007, J MATER SCI-MATER M, V18, P1287, DOI 10.1007/s10856-006-0062-5
   Guo JJ, 2011, ULTRASON SONOCHEM, V18, P1082, DOI 10.1016/j.ultsonch.2011.03.021
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   Huang YW, 2012, COLLOID SURFACE A, V401, P97, DOI 10.1016/j.colsurfa.2012.03.031
   Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406
   Kalbacova M, 2010, CARBON, V48, P4323, DOI 10.1016/j.carbon.2010.07.045
   Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763
   KASPERK C, 1995, J CLIN ENDOCR METAB, V80, P2511, DOI 10.1210/jc.80.8.2511
   Kavitha K, 2013, CURR NANOSCI, V9, P308, DOI 10.2174/1573413711309030003
   Kavitha K, 2013, CARBOHYD POLYM, V93, P731, DOI 10.1016/j.carbpol.2012.12.031
   Krishnamoorthy K, 2013, ULTRASON SONOCHEM, V20, P644, DOI 10.1016/j.ultsonch.2012.09.007
   Krishnamoorthy K, 2012, J PHYS CHEM C, V116, P17280, DOI 10.1021/jp3047054
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Lambert TN, 2011, NANOSCALE, V3, P188, DOI 10.1039/c0nr00638f
   Liang YY, 2010, NANO RES, V3, P701, DOI 10.1007/s12274-010-0033-5
   Lim HN, 2011, INT J NANOMED, V6, P1817, DOI 10.2147/IJN.S23392
   Luo YB, 2009, APPL SURF SCI, V255, P6795, DOI 10.1016/j.apsusc.2009.02.074
   Ma XM, 2013, EUR POLYM J, V49, P389, DOI 10.1016/j.eurpolymj.2012.10.034
   Nathanael AJ, 2010, THIN SOLID FILMS, V518, P7333, DOI 10.1016/j.tsf.2010.04.105
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Rajkumar M, 2013, MAT SCI ENG C-MATER, V33, P3237, DOI 10.1016/j.msec.2013.04.005
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Rani VVD, 2011, CARBOHYD POLYM, V83, P858, DOI 10.1016/j.carbpol.2010.08.065
   Remya NS, 2013, MAT SCI ENG C-MATER, V33, P575, DOI 10.1016/j.msec.2012.09.015
   Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011
   Selvam M., 2013, B MAT SCI, V36
   Siriphannon P, 2002, J EUR CERAM SOC, V22, P511, DOI 10.1016/S0955-2219(01)00301-6
   Song P, 2012, NANOSCALE, V4, P1800, DOI 10.1039/c2nr11938b
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Varma HK, 1999, BIOMATERIALS, V20, P879, DOI 10.1016/S0142-9612(98)00243-9
   Yan L, 2001, INT J INORG MATER, V3, P633, DOI 10.1016/S1466-6049(01)00164-7
   Yan XB, 2010, ACS APPL MATER INTER, V2, P2521, DOI 10.1021/am100293r
   Yang YQ, 2013, MATER TODAY, V16, P365, DOI 10.1016/j.mattod.2013.09.004
   Zhang XY, 2010, J MATER CHEM, V20, P2801, DOI 10.1039/b917240h
   Zhang XY, 2012, INT J HYDROGEN ENERG, V37, P811, DOI 10.1016/j.ijhydene.2011.04.053
   Zhang XY, 2012, TOXICOL RES-UK, V1, P62, DOI 10.1039/c2tx20006f
   Zhang Y, 2012, NANOSCALE, V4, P3833, DOI 10.1039/c2nr31040f
   Zhou H., 2011, ACTA BIOMATER, V7, P2269
NR 50
TC 18
Z9 19
U1 2
U2 48
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2014
VL 38
BP 252
EP 262
DI 10.1016/j.msec.2014.02.010
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AF8RX
UT WOS:000334984400031
PM 24656376
DA 2018-10-20
ER

PT J
AU Vasilev, K
AF Vasilev, Krasimir
TI Nanoengineered Plasma Polymer Films for Biomaterial Applications
SO PLASMA CHEMISTRY AND PLASMA PROCESSING
LA English
DT Article
DE Plasma polymerization; Thin films; Surface modification; Biomaterials;
   Nanostructures; Antibacterial surfaces; Drug release
ID ANTIBACTERIAL SURFACES; ZINC ACETYLACETONATE; CONTAINING MONOMERS;
   BIOMEDICAL DEVICES; GLOW-DISCHARGE; CELL-ADHESION; THIN-FILMS; COATINGS;
   GENERATION; DEPOSITION
AB Plasma polymerization has evolved in an important technology for generation of thin films that have found numerous advanced applications. The orthodox view to plasma polymers is as continuous, homogeneous and pinhole-free coatings. However, there is an emerging trend towards creating more advanced films though engineering them at the nanoscale. This paper presents a summary of our work and published studies, from other groups, which demonstrate the potential of plasma polymerization to generate advanced nanostructured interfaces. The focus is on applications in the area of biomaterials. Strategies for generation of antibacterial coatings through inclusion of metallic nanoparticles in plasma polymer films are described. Drug delivery platforms developed via templating and incorporation of drug particles are outlined. A record of recent progress in fabrication of cell guidance surfaces facilitated by nanoengineering of plasma polymer film is also included. The paper concludes with the author's view to the future outlook of the niche area of nanoengineered plasma polymer films.
C1 [Vasilev, Krasimir] Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
   [Vasilev, Krasimir] Univ S Australia, Sch Engn, Mawson Lakes, SA 5095, Australia.
RP Vasilev, K (reprint author), Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
EM krasimir.vasilev@unisa.edu.au
FU ARC [FT100100292]
FX The author thanks ARC for Fellowship No. FT100100292.
CR Alissawi N, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0928-z
   BIEDERMAN H, 1990, VACUUM, V40, P377, DOI 10.1016/0042-207X(90)90095-G
   Biederman H, 1996, VACUUM, V47, P1385, DOI 10.1016/S0042-207X(96)00185-6
   BIEDERMAN H, 1994, INT J ELECTRON, V76, P937, DOI 10.1080/00207219408926001
   Boldyryeva H, 2003, THIN SOLID FILMS, V442, P86, DOI 10.1016/S0040-6090(03)00950-7
   Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923
   Di Mundo R, 2010, PLASMA PROCESS POLYM, V7, P212, DOI 10.1002/ppap.200900112
   Favia P, 2002, VIDE, V57, P40
   Favia P, 2001, SURF COAT TECH, V142, P1, DOI 10.1016/S0257-8972(01)01191-4
   Foerch R, 2007, CHEM VAPOR DEPOS, V13, P280
   Fracassi F, 1996, THIN SOLID FILMS, V272, P60, DOI 10.1016/0040-6090(95)06971-2
   GOODMAN J, 1960, J POLYM SCI, V44, P551, DOI 10.1002/pol.1960.1204414428
   Goreham RV, 2013, RSC ADV, V3, P10309, DOI 10.1039/c3ra23193c
   Goreham RV, 2013, THIN SOLID FILMS, V528, P106, DOI 10.1016/j.tsf.2012.04.087
   Goreham RV, 2011, J PHYS CHEM C, V115, P3429, DOI 10.1021/jp111221g
   Hopp I, 2013, BIOMATERIALS, V34, P5070, DOI 10.1016/j.biomaterials.2013.03.075
   Intranuovo F, 2011, BIOMACROMOLECULES, V12, P380, DOI 10.1021/bm101136n
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kumar V, 2013, J BIOMED MATER RES A, V101, P1121, DOI 10.1002/jbm.a.34419
   Linder EG, 1931, J PHYS CHEM-US, V35, P3649, DOI 10.1021/j150330a017
   Lopez LC, 2006, ADV FUNCT MATER, V16, P1417, DOI 10.1002/adfm.200500502
   Losic D, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/24/245704
   Lotz A, 2012, J MATER CHEM, V22, P19455, DOI 10.1039/c2jm30344b
   Malzahn K, 2013, PLASMA PROCESS POLYM, V10, P243, DOI 10.1002/ppap.201200106
   McInnes SJP, 2012, ACS APPL MATER INTER, V4, P3566, DOI 10.1021/am300621k
   Michelmore A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/41/415601
   Michelmore A, 2011, PLASMA PROCESS POLYM, V8, P367, DOI 10.1002/ppap.201000140
   Mierczynska A, 2012, SOFT MATTER, V8, P8399, DOI 10.1039/c2sm25221j
   Ostrikov K, 2013, ADV PHYS, V62, P113, DOI 10.1080/00018732.2013.808047
   Ostrikov K, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/17/174001
   Ploux L, 2012, J NANOMATER, DOI 10.1155/2012/674145
   Robinson DE, 2008, ADV MATER, V20, P1166, DOI 10.1002/adma.200702586
   Rosso F, 2006, J CELL PHYSIOL, V207, P636, DOI 10.1002/jcp.20595
   Sardella E, 2008, PLASMA PROCESS POLYM, V5, P540, DOI 10.1002/ppap.200800005
   Sekine R, 2013, ENVIRON SCI TECHNOL, V47, P9308, DOI 10.1021/es400839h
   Simovic S, 2011, PHARM TECHNOL, V35, P68
   Simovic S, 2010, CHEM COMMUN, V46, P1317, DOI 10.1039/b919840g
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Susut C, 2005, INT J PHARM, V288, P253, DOI 10.1016/j.ijpharm.2004.10.004
   Vasilev K, 2008, J PHYS CHEM B, V112, P10915, DOI 10.1021/jp803678w
   Vasilev K, 2011, ACS APPL MATER INTER, V3, P4831, DOI 10.1021/am201320a
   Vasilev K, 2011, PLASMA PROCESS POLYM, V8, P1010, DOI 10.1002/ppap.201100097
   Vasilev K, 2010, PLASMA PROCESS POLYM, V7, P824, DOI 10.1002/ppap.201000030
   Vasilev K, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/21/215102
   Vasilev K, 2010, NANO LETT, V10, P202, DOI 10.1021/nl903274q
   Vasilev K, 2010, BIOMATERIALS, V31, P532, DOI 10.1016/j.biomaterials.2009.09.074
   Vasilev K, 2010, BIOMATERIALS, V31, P392, DOI 10.1016/j.biomaterials.2009.09.056
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Vasilev K, 2009, J PHYS CHEM B, V113, P7059, DOI 10.1021/jp807986k
   Vasilev K, 2009, CHEM COMMUN, P3600, DOI 10.1039/b904367e
   WESTWOOD AR, 1971, EUR POLYM J, V7, P363, DOI 10.1016/0014-3057(71)90007-3
   Whittle JD, 2003, CHEM COMMUN, P1766, DOI 10.1039/b305445b
   Zanini S, 2013, MATER CHEM PHYS, V138, P850, DOI 10.1016/j.matchemphys.2012.12.070
   Zhu T, 2003, LANGMUIR, V19, P9518, DOI 10.1021/la035157u
NR 54
TC 19
Z9 19
U1 2
U2 53
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0272-4324
EI 1572-8986
J9 PLASMA CHEM PLASMA P
JI Plasma Chem. Plasma Process.
PD MAY
PY 2014
VL 34
IS 3
SI SI
BP 545
EP 558
DI 10.1007/s11090-013-9506-0
PG 14
WC Engineering, Chemical; Physics, Applied; Physics, Fluids & Plasmas
SC Engineering; Physics
GA AF0WI
UT WOS:000334434800012
DA 2018-10-20
ER

PT J
AU Conway, A
   Schaffer, DV
AF Conway, Anthony
   Schaffer, David V.
TI Biomaterial Microenvironments to Support the Generation of New Neurons
   in the Adult Brain
SO STEM CELLS
LA English
DT Article
DE Stem cell-microenvironment interactions; Neural stem cells; Neural
   differentiation; Adult stem cells
ID NEURAL STEM-CELLS; DE-NOVO NEUROGENESIS; HIPPOCAMPAL NEUROGENESIS; SONIC
   HEDGEHOG; IN-VIVO; PROGENITOR PROLIFERATION; DENTATE GYRUS;
   REGENERATION; MICE; QUIESCENT
AB Neural stem cells (NSC) in two regions of the adult mammalian brain-the subventricular zone (SVZ) and hippocampus-continuously generate new neurons, enabled by a complex repertoire of factors that precisely regulate the activation, proliferation, differentiation, and integration of the newborn cells. A growing number of studies also report low-level neurogenesis in regions of the adult brain outside these established neurogenic niches-potentially via NSC recruitment or activation of local, quiescent NSCs-under perturbations such as ischemia, cell death, or viral gene delivery of proneural growth factors. We have explored whether implantation of engineered biomaterials can stimulate neurogenesis in normally quiescent regions of the brain. Specifically, recombinant versions of factors found within the NSC microenvironment, Sonic hedgehog, and ephrin-B2 were conjugated to long polymers, thereby creating highly bioactive, multivalent ligands that begin to emulate components of the neurogenic niche. In this engineered biomaterial microenvironment, new neuron formation was observed in normally non-neurogenic regions of the brain, the striatum, and the cortex, and combining these multivalent biomaterials with stromal cell-derived factor-1 alpha increased neuronal commitment of newly divided cells seven- to eightfold in these regions. Additionally, the decreased hippocampal neurogenesis of geriatric rodents was partially rescued toward levels of young animals. We thus demonstrate for the first time de novo neurogenesis in both the cortex and striatum of adult rodents stimulated solely by delivery of synthetic biomaterial forms of proteins naturally found within adult neurogenic niches, offering the potential to replace neurons lost in neurodegenerative disease or injury as an alternative to cell implantation. Stem Cells 2014;32:1220-1229
C1 [Conway, Anthony; Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.
   [Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.
   [Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.
RP Schaffer, DV (reprint author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley Stem Cell Ctr, Berkeley, CA 94720 USA.
EM schaffer@berkeley.edu
FU NIH [R21 EB007295]; California Institute for Regenerative Medicine
   (CIRM) grant [RT2-02022]; CIRM [T1-00007]
FX We thank T. Miyamoto (Keio University) for mouse ephrin-B2 cDNA. This
   work was supported by NIH R21 EB007295 and California Institute for
   Regenerative Medicine (CIRM) grant RT2-02022. A.C. was partially
   supported by training grant fellowships from CIRM (T1-00007).
CR Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747
   Ashton RS, 2012, NAT NEUROSCI, V15, P1399, DOI 10.1038/nn.3212
   Benraiss A, 2012, GENE THER, V19, P582, DOI 10.1038/gt.2011.182
   Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541
   Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008
   Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395
   Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107
   Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215
   Conway A, METHOD MOL BIOL, DOI [10.1007/7651_2013_32, DOI 10.1007/7651_2013_32]
   Conway A, 2013, NAT NANOTECHNOL, V8, P831, DOI [10.1038/NNANO.2013.205, 10.1038/nnano.2013.205]
   Conway A, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt141
   DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638
   Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010
   Erggelet C, 2007, BIOMATERIALS, V28, P5570, DOI 10.1016/j.biomaterials.2007.09.005
   Fong ELS, 2011, BIOMATERIALS, V32, P395, DOI 10.1016/j.biomaterials.2010.08.101
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018
   Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995
   Iwai M, 2001, Hum Cell, V14, P27
   Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201
   Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x
   Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0
   Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Leuner B, 2009, J COMP NEUROL, V517, P123, DOI 10.1002/cne.22107
   Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108
   LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174
   Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017
   Magavi SS, 2000, NATURE, V405, P951
   Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016
   Miranda CJ, 2012, AGING CELL, V11, P542, DOI 10.1111/j.1474-9726.2012.00816.x
   Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473
   Okamoto M, 2011, FASEB J, V25, P3570, DOI 10.1096/fj.11-184697
   Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393
   Petrie TA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001002
   Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010
   Politis M, 2010, SCI TRANSL MED, V2, DOI DOI 10.1126/SCITRANSLMED.3000976
   Pritchard CD, 2011, BIOMATERIALS, V32, P587, DOI 10.1016/j.biomaterials.2010.08.106
   Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001
   Shan XY, 2006, STEM CELLS, V24, P1280, DOI 10.1634/stemcells.2005-0487
   Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023
   Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x
   Vazin T, 2014, BIOMATERIALS, V35, P941, DOI 10.1016/j.biomaterials.2013.10.025
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Wall ST, 2008, BIOCONJUGATE CHEM, V19, P806, DOI 10.1021/bc700265k
NR 50
TC 14
Z9 14
U1 1
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1066-5099
EI 1549-4918
J9 STEM CELLS
JI Stem Cells
PD MAY
PY 2014
VL 32
IS 5
BP 1220
EP 1229
DI 10.1002/stem.1650
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA AF3FP
UT WOS:000334597200016
PM 24449485
OA Bronze
DA 2018-10-20
ER

PT J
AU Braghirolli, DI
   Steffens, D
   Quintiliano, K
   Acasigua, GAX
   Gamba, D
   Fleck, RA
   Petzhold, CL
   Pranke, P
AF Braghirolli, Daikelly Iglesias
   Steffens, Daniela
   Quintiliano, Kerlin
   Xavier Acasigua, Gerson Arisoly
   Gamba, Douglas
   Fleck, Roland A.
   Petzhold, Cesar L.
   Pranke, Patricia
TI The effect of sterilization methods on electronspun
   poly(lactide-co-glycolide) and subsequent adhesion efficiency of
   mesenchymal stem cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE PLGA; biomaterials; electrospinning; nanofibers; sterilization
ID SCAFFOLDS; IRRADIATION
AB The sterilization of scaffolds is an essential step for tissue engineering in vitro and, mainly, clinical biomaterial use. However, this process can cause changes in the structure and surface of the scaffolds. Therefore, the objective of this study was to investigate the effect of sterilization by ethanol, ultraviolet radiation (UVR) or antimicrobial solution (AMS) on poly(lactide-co-glycolide) (PLGA) scaffolds produced by the electrospinning technique. The properties of nanofibers and the cellular adhesion of mesenchymal stem cells to the scaffolds were analyzed after the treatments. All methods generated sterile scaffolds but showed some kind of damage to the scaffolds. Ethanol and AMS caused changes in the morphology and scaffold dimensions, which were not observed when using the UVR method. However, UVR caused a greater reduction in polymeric molecular weight, which increased proportionally with exposure time of treatment. Nanofibers sterilized with AMS for 1 h and 2 h showed greater cellular adhesion than the other methods, demonstrating their potential as a method for sterilizing PLGA nanofibers. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 700-708, 2014.
C1 [Braghirolli, Daikelly Iglesias; Steffens, Daniela; Quintiliano, Kerlin; Xavier Acasigua, Gerson Arisoly; Pranke, Patricia] Univ Fed Rio Grande do Sul, Fac Pharm, Hematol & Stem Cell Lab, BR-90610000 Porto Alegre, RS, Brazil.
   [Braghirolli, Daikelly Iglesias; Steffens, Daniela; Pranke, Patricia] Univ Fed Rio Grande do Sul, Post Grad Programme Mat Sci, BR-91501970 Porto Alegre, RS, Brazil.
   [Quintiliano, Kerlin] Univ Fed Rio Grande do Sul, Post Grad Programme Neurosci, BR-90050170 Porto Alegre, RS, Brazil.
   [Xavier Acasigua, Gerson Arisoly] Univ Fed Rio Grande do Sul, Post Grad Programme Dent, BR-90035003 Porto Alegre, RS, Brazil.
   [Gamba, Douglas; Petzhold, Cesar L.] Univ Fed Rio Grande do Sul, Inst Chem, BR-91501970 Porto Alegre, RS, Brazil.
   [Fleck, Roland A.] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England.
   [Pranke, Patricia] Stem Cell Res Inst, BR-90020010 Porto Alegre, RS, Brazil.
RP Pranke, P (reprint author), Univ Fed Rio Grande do Sul, Fac Pharm, Hematol & Stem Cell Lab, BR-90610000 Porto Alegre, RS, Brazil.
EM patriciapranke@ufrgs.br
RI Petzhold, Cesar/F-8001-2012; Gamba, Douglas/A-7872-2013
OI Petzhold, Cesar/0000-0002-5919-8133; Gamba, Douglas/0000-0003-1889-2601
FU National Counsel of Technological and Scientific Development (CNPq);
   Stem Cell Research Institute
FX Contract grant sponsor: National Counsel of Technological and Scientific
   Development (CNPq) and Stem Cell Research Institute
CR Andrews KD, 2007, BIOMATERIALS, V28, P1014, DOI 10.1016/j.biomaterials.2006.10.014
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bernardi L, 2011, J ENDODONT, V37, P973, DOI 10.1016/j.joen.2011.04.010
   Costa L. M. M., 2012, J BIOMATER NANOBIOTE, V3, P92, DOI [10.4236/jbnb.2012.31012, DOI 10.4236/JBNB.2012.31012]
   Cottam E, 2009, MED ENG PHYS, V31, P221, DOI 10.1016/j.medengphy.2008.07.005
   Dong YX, 2008, TISSUE ENG PT A, V14, P1321, DOI 10.1089/ten.tea.2007.0395
   Heunis TD, 2010, J BIOMED BIOTECHNOL, V2010
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   Hwang CM, 2009, BIOMED MICRODEVICES, V11, P739, DOI 10.1007/s10544-009-9287-7
   Inanc B, 2009, J BIOMED MATER RES A, V90A, P186, DOI 10.1002/jbm.a.32066
   Jeong SI, 2008, MACROMOL BIOSCI, V8, P627, DOI 10.1002/mabi.200800005
   Kim SJ, 2010, POLYMER, V51, P1320, DOI 10.1016/j.polymer.2010.01.025
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011
   Lucas E. F., 2001, CARACTERIZACAO POLIM
   Ma JQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/812135
   Odelius K, 2008, BIOMATERIALS, V29, P129, DOI 10.1016/j.biomaterials.2007.08.046
   Olivas-Armendariz I, 2012, J BIOMATER NANOBIOTE, V3, P440
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Seo S, 2011, BIOTECHNOL, V2011, P806
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Siritientong T, 2011, AAPS PHARMSCITECH, V12, P771, DOI 10.1208/s12249-011-9641-y
NR 22
TC 15
Z9 16
U1 0
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2014
VL 102
IS 4
BP 700
EP 708
DI 10.1002/jbm.b.33049
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE8IT
UT WOS:000334244300007
PM 24259451
DA 2018-10-20
ER

PT J
AU Gao, Y
   Liu, LJ
   Blatnik, JA
   Krpata, DM
   Anderson, JM
   Criss, CN
   Posielski, N
   Novitsky, YW
AF Gao, Yue
   Liu, Li-Jia
   Blatnik, Jeffrey A.
   Krpata, David M.
   Anderson, James M.
   Criss, Corry N.
   Posielski, Natasza
   Novitsky, Yuri W.
TI Methodology of fibroblast and mesenchymal stem cell coating of surgical
   meshes: A pilot analysis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cell culture; foreign body reactions (response); biocompatibility/soft
   tissue; fibroblasts; stem cells
ID RANDOMIZED CONTROLLED-TRIAL; VENTRAL HERNIA REPAIR; TERM-FOLLOW-UP;
   INCISIONAL HERNIA; RAT MODEL; IN-VITRO; ADHESION; SCAFFOLD; TITANIUM;
   BIOMATERIAL
AB Coating of various synthetic, absorbable, and biologic meshes with mesenchymal stem cells (MSCs) and fibroblasts was analyzed qualitatively and quantitatively. Five hernia meshes-light weight monofilament polypropylene (Soft Mesh), polyester (Parietex-TET), polylactide composite (TIGR), heavy weight monofilament polypropylene (Marlex), and porcine dermal collagen (Strattice)-were coated with three cell lines: human dermal fibroblasts (HFs), rat kidney fibroblasts (NRKs), and rat MSCs. Cell densities were determined at different time points. Samples also underwent histology and transmission electron microscopic (TEM) analyses. It required HFs 3 weeks to cover the entire mesh, while only 2 weeks for NRKs and MSCs to do so. MSCs had no preference for any of the meshes and produced the highest cell densities on Parietex and TIGR. Substrate-preference accounted for the significantly lower fibroblast densities on TIGR than Parietex. Fibroblasts failed to coat Marlex. Strattice, which had the least surface area, generated comparable cell densities to Parietex. Both histology and TEM confirmed cell coating of mesh surface. Various prosthetics can be coated by certain cell strains. Both mesh composition and cell preference dramatically influence the coating process. This methodology provides foundation for novel avenues of modulation of host response to various modern synthetic and biologic meshes. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 797-805, 2014.
C1 [Gao, Yue; Liu, Li-Jia; Blatnik, Jeffrey A.; Krpata, David M.; Anderson, James M.; Criss, Corry N.; Posielski, Natasza; Novitsky, Yuri W.] Case Western Reserve Univ, Dept Surg, Case Comprehens Hernia Ctr, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.
RP Novitsky, YW (reprint author), Case Western Reserve Univ, Dept Surg, Case Comprehens Hernia Ctr, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.
EM yuri.novitsky@uhhospitals.org
FU Department of Surgery University Hospitals Case Medical Center
FX Contract grant sponsor: Department of Surgery University Hospitals Case
   Medical Center
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI 10.1089/ten.TEB.2009.0639
   Bakhshandeh H, 2011, INT J NANOMED, V6, P1509, DOI 10.2147/IJN.S19011
   Binnebosel M, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-1
   Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012
   Bonfield TL, 2010, J INFLAMM-LOND, V25, P51
   Brandt CJ, 2011, J BIOMED MATER RES A, V99A, P335, DOI 10.1002/jbm.a.33136
   Bras LED, 2012, HERNIA, V16, P77, DOI 10.1007/s10029-011-0859-0
   Burger JWA, 2004, ANN SURG, V240, P578
   Burger JWA, 2004, ANN SURG, V240, P583
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Carman CV, 2009, J CELL SCI, V122, P3025, DOI 10.1242/jcs.047522
   Chen GP, 2005, BIOMATERIALS, V26, P2559, DOI 10.1016/j.biomaterials.2004.07.034
   Deeken CR, 2012, HERNIA, V16, P69, DOI 10.1007/s10029-011-0854-5
   Destaing O, 2010, MOL BIOL CELL, V21, P4108, DOI 10.1091/mbc.E10-07-0580
   Ding F, 2010, TISSUE ENG PT A, V16, P3779, DOI [10.1089/ten.tea.2010.0299, 10.1089/ten.TEA.2010.0299]
   Dolce CJ, 2010, SURG ENDOSC, V24, P2687, DOI 10.1007/s00464-010-1026-x
   Gentile F, 2010, BIOMATERIALS, V31, P7205, DOI 10.1016/j.biomaterials.2010.06.016
   Gongadze E, 2011, INT J NANOMED, V6, P1801, DOI [10.2147/IJN.S21755, 10.2147/IJN.S16982]
   Hamdan M, 2006, CLIN IMPLANT DENT R, V8, P32, DOI 10.2310/6480.2005.00028
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Junge K, 2011, LANGENBECKS ARCH SUR
   Kapischke M, 2005, SURG ENDOSC, V19, P791, DOI 10.1007/s00464-004-9222-1
   Kral JG, 1999, PLAST RECONSTR SURG, V104, P1732, DOI 10.1097/00006534-199911000-00018
   Kyzer S, 1997, EUR SURG RES, V29, P84, DOI 10.1159/000129511
   Lancaster J, 2010, TISSUE ENG PT A, V16, P3065, DOI [10.1089/ten.tea.2009.0589, 10.1089/ten.TEA.2009.0589]
   Langer C, 2005, CHIRURG, V76, P876, DOI 10.1007/s00104-005-1036-8
   Lavenus S, 2011, ACTA BIOMATER, V7, P1525, DOI 10.1016/j.actbio.2010.12.033
   Lu CL, 2010, BLOOD, V115, P221, DOI 10.1182/blood-2009-06-228494
   Ma T, 2010, J BIOL CHEM, V285, P29911, DOI 10.1074/jbc.M109.099697
   McPhee G, 2010, MED BIOL ENG COMPUT, V48, P1043, DOI 10.1007/s11517-010-0657-3
   Monroy A, 2007, INT J PEDIATR OTORHI, V71, P547, DOI 10.1016/j.ijporl.2006.11.025
   Orenstein SB, 2011, SURG ENDOSC, V25, P1452, DOI 10.1007/s00464-010-1413-3
   Otto WR, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-20
   Patel M, 2010, TISSUE ENG PT A, V16, P55, DOI [10.1089/ten.tea.2009.0027, 10.1089/ten.TEA.2009.0027]
   Pierce LM, 2009, AM J OBSTET GYNECOL, V200, pe1
   Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211
   Raimondo T, 2010, INT J NANOMED, V5, P647, DOI 10.2147/IJN.S13047
   Ribeiro C, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035004
   Rosen M J, 2007, Hernia, V11, P435, DOI 10.1007/s10029-007-0255-y
   Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008
   Skala CE, 2009, REGEN MED, V4, P197, DOI 10.2217/17460751.4.2.197
   Song Y, 2011, J BIOMED MAT RES A
   Svensson HG, 2008, EUR J IMMUNOL, V38, P818, DOI 10.1002/eji.200737331
   Tolde O, 2010, EUR J CELL BIOL, V89, P674, DOI 10.1016/j.ejcb.2010.04.003
   Urita Y, 2008, PEDIATR SURG INT, V24, P1041, DOI 10.1007/s00383-008-2212-y
   Weil BR, 2011, J SURG RES, V167, P78, DOI 10.1016/j.jss.2010.07.019
   Wilshaw SP, 2009, J BIOMED MATER RES B, V88B, P49, DOI 10.1002/jbm.b.31148
   Zhou HY, 2011, ANN SURG, V253, P1033, DOI 10.1097/SLA.0b013e31821260f3
NR 50
TC 6
Z9 7
U1 2
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2014
VL 102
IS 4
BP 797
EP 805
DI 10.1002/jbm.b.33061
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE8IT
UT WOS:000334244300018
PM 24142485
DA 2018-10-20
ER

PT J
AU Stoppel, WL
   White, JC
   Horava, SD
   Henry, AC
   Roberts, SC
   Bhatia, SR
AF Stoppel, Whitney L.
   White, Joseph C.
   Horava, Sarena D.
   Henry, Anna C.
   Roberts, Susan C.
   Bhatia, Surita R.
TI Terminal sterilization of alginate hydrogels: Efficacy and impact on
   mechanical properties
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE Pluronic (R) F68; alginate; rheology; composite hydrogel; terminal
   sterilization
ID HYDROPHOBICALLY-MODIFIED ALGINATE; MOLECULAR-WEIGHT DISTRIBUTION;
   DRUG-DELIVERY SYSTEMS; WOUND DRESSINGS; IN-VITRO; DEGRADATION;
   ENCAPSULATION; TRANSPORT; FIBER
AB Terminal, or postprocessing, sterilization of composite biomaterials is crucial for their use in wound healing and tissue-engineered devices. Recent research has focused on optimizing traditional biomaterial formulations to create better products for commercial and academic use which incorporate hydrophobic compounds or secondary gel networks. To use a hydrogel in a clinical setting, terminal sterilization is necessary to ensure patient safety. Lyophilization, gamma-irradiation, and ethylene oxide treatment all have negative consequences when applied to alginate scaffolds for clinical use. Here, we aim to find alternative terminal sterilization methods for alginate and alginate-based composite hydrogels which maintain the structure of composite alginate networks for use in biomedical applications. A thorough investigation of the effect of common sterilization methods on swollen alginate-based hydrogels has not been reported and therefore, this work examines autoclaving, ethanol washing, and ultraviolet light as sterilization techniques for alginate and alginate/Pluronic (R) F68 composite hydrogels. Preservation of structural integrity is evaluated using shear rheology and analysis of water retention, and efficacy of sterilization is determined via bacterial persistence within the hydrogel. Results indicate that ethanol sterilization is the best method of those investigated because ethanol washing results in minimal effects on mechanical properties and water retention and eliminates bacterial persistence. Furthermore, this study suggests that ethanol treatment is an efficacious method for terminally sterilizing interpenetrating networks or other composite hydrogel systems. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 877-884, 2014.
C1 [Stoppel, Whitney L.; White, Joseph C.; Horava, Sarena D.; Henry, Anna C.; Roberts, Susan C.; Bhatia, Surita R.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
   [Bhatia, Surita R.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.
   [Bhatia, Surita R.] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11793 USA.
RP Stoppel, WL (reprint author), Univ Texas Austin, Austin, TX 78712 USA.
EM surita.bhatia@stonybrook.edu
RI White, Joe/I-8148-2015; Bhatia, Surita/B-4536-2008
FU National Science Foundation (NSF) [CMMI-0531171]; University of
   Massachusetts Commercial Ventures and Intellectual Property Office; NSF
   [DMR-0213695, DGE-0654128]; National Research Service Award from the
   National Institutes of Health [T32 GM08515]; University of Massachusetts
   Commonwealth Honors College; University of Massachusetts Amherst
   Institute for Cellular Engineering NSF Research Experience for
   Undergraduates [EEC-1005083]
FX Contract grant sponsor: National Science Foundation (NSF)-sponsored
   Center for Hierarchical Manufacturing;; contract grant number:
   CMMI-0531171; Contract grant sponsor: University of Massachusetts
   Commercial Ventures and Intellectual Property Office; Contract grant
   sponsor: NSF-funded Materials Research Science and Engineering Center
   (MRSEC) on Polymers;; contract grant number: DMR-0213695; Contract grant
   sponsor: National Research Service Award from the National Institutes of
   Health (to W. L. S.);; contract grant number: T32 GM08515; Contract
   grant sponsor: NSF-sponsored Institute for Cellular Engineering IGERT
   program;; contract grant number: DGE-0654128 (to W. L. S.); Contract
   grant sponsor: NSF-sponsored Institute for Cellular Engineering IGERT
   program (to J.C.W.);; contract grant number: DGE-0654128; Contract grant
   sponsor: University of Massachusetts Commonwealth Honors College (to S.
   D. H); Contract grant sponsor: University of Massachusetts Amherst
   Institute for Cellular Engineering NSF Research Experience for
   Undergraduates (to A. C. H.);; contract grant number: EEC-1005083
CR Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   BRANNONPEPPAS L, 1991, CHEM ENG SCI, V46, P715, DOI 10.1016/0009-2509(91)80177-Z
   Choudhary S, 2009, 2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P18
   Choudhary S, 2009, MRS S P E
   Choudhary S, 2012, CARBOHYD POLYM, V87, P524, DOI 10.1016/j.carbpol.2011.08.025
   Choudhary S, 2011, RHEOL ACTA, V50, P39, DOI 10.1007/s00397-010-0499-9
   Doyle JW, 1996, J BIOMED MATER RES, V32, P561, DOI 10.1002/(SICI)1097-4636(199612)32:4<561::AID-JBM9>3.3.CO;2-#
   DRAGET KI, 1990, CARBOHYD POLYM, V14, P159
   Fraker CA, 2011, J PHYS CHEM B, V115, P10547, DOI 10.1021/jp204146n
   Galant C, 2006, J PHYS CHEM B, V110, P190, DOI 10.1021/jp0518759
   Gattas-Asfura KM, 2012, J BIOMED MATER RES A, V100A, P1963, DOI 10.1002/jbm.a.34052
   GILCHRIST T, 1983, BIOMATERIALS, V4, P317, DOI 10.1016/0142-9612(83)90036-4
   Hilton JR, 2004, CLIN INFECT DIS, V39, pS100, DOI 10.1086/383270
   Huebsch N, 2005, J BIOMED MATER RES B, V74B, P440, DOI 10.1002/jbm.b.30155
   Kanjickal D, 2008, J BIOMED MATER RES A, V87A, P608, DOI 10.1002/jbm.a.31811
   Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   Lee DW, 2003, J AGR FOOD CHEM, V51, P4819, DOI 10.1021/jf021053y
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Li QA, 2011, J AGR FOOD CHEM, V59, P1962, DOI 10.1021/jf1020347
   Lin HY, 2012, BIO-MED MATER ENG, V22, P321, DOI [10.3233/BME-2012-0722, 10.4161/biom.22817]
   Mei L, 2009, J PHARM SCI-US, V98, P2040, DOI 10.1002/jps.21581
   Oh KT, 2004, J CONTROL RELEASE, V94, P411, DOI 10.1016/j.jcornel.2003.10.018
   Pawar HV, 2013, COLLOID SURFACE B, V102, P102, DOI 10.1016/j.colsurfb.2012.08.014
   PEPPAS NA, 1985, J BIOMED MATER RES, V19, P397, DOI 10.1002/jbm.820190405
   Qin YM, 2006, J APPL POLYM SCI, V100, P2516, DOI 10.1002/app.23668
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Saarai A, 2013, J MECH BEHAV BIOMED, V18, P152, DOI 10.1016/j.jmbbm.2012.11.010
   Sahu A, 2011, J BIOMATER APPL, V25, P619, DOI 10.1177/0885328209357110
   Stoppel WL, 2011, ACTA BIOMATER, V7, P3988, DOI 10.1016/j.actbio.2011.07.009
   Suzuki Y, 1998, J BIOMED MATER RES, V39, P317, DOI 10.1002/(SICI)1097-4636(199802)39:2<317::AID-JBM20>3.0.CO;2-8
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   White JC, 2013, J BIOMED MATER RES A, V101, P438, DOI 10.1002/jbm.a.34344
   Yang JS, 2012, CARBOHYD POLYM, V87, P1503, DOI 10.1016/j.carbpol.2011.09.046
   Yao BL, 2010, BIOPROC BIOSYST ENG, V33, P457, DOI 10.1007/s00449-009-0349-2
NR 37
TC 15
Z9 15
U1 5
U2 56
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2014
VL 102
IS 4
BP 877
EP 884
DI 10.1002/jbm.b.33070
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE8IT
UT WOS:000334244300026
PM 24259507
DA 2018-10-20
ER

PT J
AU Fukushima, A
   Mayanagi, G
   Nakajo, K
   Sasaki, K
   Takahashi, N
AF Fukushima, A.
   Mayanagi, G.
   Nakajo, K.
   Sasaki, K.
   Takahashi, N.
TI Microbiologically Induced Corrosive Properties of the Titanium Surface
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE microbiologically induced corrosion; bacterial metabolism; Streptococcus
   mutans; electrochemical behavior; biofilm-metal interface; oxygen
   concentration cells
ID COMMERCIALLY PURE TITANIUM; HYDROGEN-PEROXIDE; IMPLANT FAILURE;
   RESISTANCE; BIOMATERIAL; SENSITIVITY; BACTERIA; BEHAVIOR; STEEL; ACID
AB Corrosion of titanium is the major concern when it is used for dental treatment. This study aimed to investigate the mechanism of the microbiologically induced corrosive properties of titanium. An experimental well was made of polymethyl methacrylate with pure titanium at the bottom. Viable or killed cells of Streptococcus mutans were packed into the well, and pH at the bacteria-titanium interface was monitored with and without glucose. Before and after 90-minute incubation, the electrochemical behavior on the titanium surface was measured by means of a potentiostat. The oxygen concentration under bacterial cells was monitored with oxygen-sensitive fluorescent film. The amount of titanium eluted was measured by inductively coupled plasma-mass spectrometry. The corrosion current and passive current under killed cells were low and stable during 90 min, while those under viable cells increased, regardless of the glucose-induced pH fall. The polarization resistance and oxygen concentration under killed cells were high and stable, while those under viable cells decreased. No elution of titanium was detected. Viable bacterial cells may form 'oxygen concentration cells' through metabolism-coupled oxygen consumption and subsequently induce corrosive properties of the titanium surface.
C1 [Fukushima, A.; Sasaki, K.] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Sendai, Miyagi 980, Japan.
   [Fukushima, A.; Nakajo, K.; Takahashi, N.] Tohoku Univ, Grad Sch Dent, Div Oral Ecol & Biochem, Sendai, Miyagi 980, Japan.
   [Mayanagi, G.] Tohoku Univ, Grad Sch Dent, Res Unit Interface Oral Hlth Sci, Sendai, Miyagi 980, Japan.
RP Takahashi, N (reprint author), Tohoku Univ, Grad Sch Dent, Div Oral Ecol & Biochem, Sendai, Miyagi 980, Japan.
EM nobu-t@dent.tohoku.ac.jp
FU MEXT, Japan [23792270, 23792201]
FX This study was supported in part by Research and Education Funding for
   Inter-University Research Project (Highly-Functional Interface Science)
   and a program to enhance the university's research function based on its
   specialty (Innovative Research for Biosis-Abiosis Intelligent
   Interface), and in part by Grants-in-Aid for Young Scientists B
   (23792270 and 23792201) from MEXT, Japan. The authors declare no
   potential conflicts of interest with respect to the authorship and/or
   publication of this article.
CR ABBE K, 1991, Proceedings of the Finnish Dental Society, V87, P477
   ABDALLAH HI, 1994, ANN THORAC SURG, V57, P1017, DOI 10.1016/0003-4975(94)90228-3
   [Anonymous], 2000, T0302 JIS
   Bai Y, 2013, J MAT SCI ENG C, V33, P2159
   Barbour ME, 2007, J MATER SCI-MATER M, V18, P1439, DOI 10.1007/s10856-007-0141-2
   Bearinger JP, 2003, J BIOMED MATER RES A, V67A, P702, DOI 10.1002/jbm.a.10116
   Guindy JS, 2004, INT J ORAL MAX IMPL, V19, P826
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Koike M, 2001, BIOMATERIALS, V22, P2931, DOI 10.1016/S0142-9612(01)00040-0
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   Mabilleau G, 2006, ACTA BIOMATER, V2, P121, DOI 10.1016/j.actbio.2005.09.004
   Massaro C, 2002, J MATER SCI-MATER M, V13, P535, DOI 10.1023/A:1015170625506
   Mayanagi G, 2011, J DENT RES, V90, P1446, DOI 10.1177/0022034511423392
   Merritt K, 1996, CLIN ORTHOP RELAT R, P71
   Page CL, 1988, 60CSC RILEM, P3
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   QUIRYNEN M, 1994, CLIN ORAL IMPLAN RES, V5, P239, DOI 10.1034/j.1600-0501.1994.050407.x
   Raupach M, 1996, CONSTR BUILD MATER, V10, P329, DOI 10.1016/0950-0618(95)00018-6
   Scarano Antonio, 2005, J Oral Implantol, V31, P269, DOI 10.1563/753.1
   Souza JCM, 2010, BIOFOULING, V26, P471, DOI 10.1080/08927011003767985
   Steinemann SG, 1998, PERIODONTOL 2000, V17, P7, DOI 10.1111/j.1600-0757.1998.tb00119.x
   TAKAHASHI N, 1991, ORAL MICROBIOL IMMUN, V6, P299, DOI 10.1111/j.1399-302X.1991.tb00497.x
   Traudt M, 1996, ARCH ORAL BIOL, V41, P965, DOI 10.1016/S0003-9969(96)00044-1
   Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002
   Videla HA, 2005, INT MICROBIOL, V8, P169
   Zhang SM, 2013, J MATER SCI-MATER M, V24, P1229, DOI 10.1007/s10856-013-4888-3
NR 27
TC 8
Z9 8
U1 3
U2 22
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD MAY
PY 2014
VL 93
IS 5
BP 525
EP 529
DI 10.1177/0022034514524782
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AE8PZ
UT WOS:000334265100015
PM 24554541
DA 2018-10-20
ER

PT J
AU Horisberger, M
   Paul, J
   Wiewiorski, M
   Henninger, HB
   Khalifa, MS
   Barg, A
   Valderrabano, V
AF Horisberger, Monika
   Paul, Jochen
   Wiewiorski, Martin
   Henninger, Heath B.
   Khalifa, Muhammad S.
   Barg, Alexej
   Valderrabano, Victor
TI Commercially Available Trabecular Metal Ankle Interpositional Spacer for
   Tibiotalocalcaneal Arthrodesis Secondary to Severe Bone Loss of the
   Ankle
SO JOURNAL OF FOOT & ANKLE SURGERY
LA English
DT Article
DE complication; intramedullary nail; nonunion; tantalum; total ankle
   replacement
ID COATED ACETABULAR COMPONENTS; POROUS TANTALUM BIOMATERIAL; TOTAL KNEE
   ARTHROPLASTY; DONOR SITE MORBIDITY; ILIAC CREST; TIBIAL COMPONENT;
   SALVAGE; REPLACEMENT; REVISION; GRAFT
AB Retrograde tibiotalocalcaneal nailing arthrodesis has proved to be a viable salvage procedure; however, extended bone loss around the ankle has been associated with high rates of nonunion and considerable shortening of the hindfoot. We present the surgical technique and the first 2 cases in which a trabecular metal((TM)) interpositional spacer, specifically designed for tibiotalocalcaneal nailing arthrodesis, was used. The spacer can be implanted using either an anterior or a lateral approach. An integrated hole in the spacer allows a retrograde nail to be inserted, which provides excellent primary stability of the construct. Trabecular metal((TM)) is a well-established and well-described material used to supplement deficient bone stock in surgery of the spine, hip, and knee. It has shown excellent incorporation and reduces the need for auto- and allografts. The trabecular metal((TM)) interpositional ankle spacer is the first trabecular metal spacer designed specifically for ankle surgery. Its shape and variable size will make it a valuable tool for reconstructing bone loss in tibiotalocalcaneal nailing arthrodesis. (C) 2014 by the American College of Foot and Ankle Surgeons. All rights reserved.
C1 [Horisberger, Monika; Paul, Jochen; Wiewiorski, Martin; Barg, Alexej; Valderrabano, Victor] Univ Basel Hosp, Dept Orthopaed, CH-4031 Basel, Switzerland.
   [Henninger, Heath B.] Univ Utah, Dept Orthopaed, Harold K Dunn Orthopaed Res Lab, Salt Lake City, UT USA.
   [Khalifa, Muhammad S.] Rashid Hosp, Dept Orthopaed, Dubai, U Arab Emirates.
RP Valderrabano, V (reprint author), Univ Basel Hosp, Dept Orthopaed, Spitalstr 21, CH-4031 Basel, Switzerland.
EM Monika.Horisberger@hotmail.com
CR Abolghasemian M, 2013, BONE JOINT J, V95B, P166, DOI 10.1302/0301-620X.95B2.30608
   Berkowitz MJ, 2012, FOOT ANKLE CLIN, V17, P725, DOI 10.1016/j.fcl.2012.08.009
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Borland WS, 2012, ACTA ORTHOP, V83, P347, DOI 10.3109/17453674.2012.718518
   Bouchard M, 2004, FOOT ANKLE INT, V25, P39, DOI 10.1177/107110070402500109
   Conti SF, 2002, FOOT ANKLE INT, V23, P521, DOI 10.1177/107110070202300609
   D'Angelo F, 2008, INDIAN J ORTHOP, V42, P275, DOI 10.4103/0019-5413.39553
   Delawi D, 2007, SPINE, V32, P1865, DOI 10.1097/BRS.0b013e318107674e
   Derome P, 2014, J ARTHROPLASTY, V29, P122, DOI 10.1016/j.arth.2013.04.033
   Donnenwerth MP, 2013, CLIN PODIATR MED SUR, V30, P199, DOI 10.1016/j.cpm.2012.10.007
   ENGH CA, 1993, J BONE JOINT SURG AM, V75A, P814, DOI 10.2106/00004623-199306000-00003
   Fernandez-Fairen M, 2008, SPINE, V33, P465, DOI 10.1097/BRS.0b013e3181657f49
   Ferrao P, 2012, FOOT ANKLE INT, V33, P173, DOI 10.3113/FAI.2012.0173
   Frigg A, 2010, CLIN ORTHOP RELAT R, V468, P209, DOI 10.1007/s11999-009-0948-x
   Ghalayini SRA, 2012, KNEE, V19, P872, DOI 10.1016/j.knee.2012.05.001
   GROTH HE, 1987, CLIN ORTHOP RELAT R, P244
   Heary RF, 2002, NEUROSURGERY, V50, P510, DOI 10.1097/00006123-200203000-00015
   Henricson A, 2010, ACTA ORTHOP, V81, P745, DOI 10.3109/17453674.2010.533936
   Hopgood P, 2006, J BONE JOINT SURG BR, V88B, P1032, DOI 10.1302/0301-620X.88B8
   Jager M, 2005, ORTHOPADE, V34, P976, DOI 10.1007/s00132-005-0839-0
   Jehan S, 2011, ACTA ORTHOP BELG, V77, P644
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kitaoka H B, 1992, J Arthroplasty, V7, P277, DOI 10.1016/0883-5403(92)90049-V
   KITAOKA HB, 1991, CLIN ORTHOP RELAT R, P37
   Klein GR, 2008, J ARTHROPLASTY, V23, P619, DOI 10.1016/j.arth.2007.05.004
   Klos K, 2013, ORTHOPADE, V42, P364, DOI 10.1007/s00132-013-2086-0
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Niedhart C, 2003, Z ORTHOP GRENZGEB, V141, P481, DOI 10.1055/s-2003-41565
   Ochman S, 2012, J FOOT ANKLE SURG, V51, P675, DOI 10.1053/j.jfas.2012.04.015
   Owens JB, 2012, J ARTHROPLASTY, V27, P1251, DOI 10.1016/j.arth.2012.01.025
   PIDHORZ LE, 1993, J ARTHROPLASTY, V8, P213
   Rammelt S, 2013, FOOT ANKLE INT, V34, P1245, DOI 10.1177/1071100713487526
   Sagherian BH, 2012, FOOT ANKLE INT, V33, P179, DOI 10.3113/FAI.2012.0179
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83
   SAVIO JA, 1994, CLIN MATER, V15, P101
   Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008
   Skytta ET, 2011, J ARTHROPLASTY, V26, P342, DOI 10.1016/j.arth.2010.01.106
   Sternheim A, 2012, J BONE JOINT SURG BR, V94B, P158, DOI 10.1302/0301-620X.94B2.27871
   Thomas RL, 2012, J AM ACAD ORTHOP SUR, V20, P1, DOI 10.5435/JAAOS-20-01-001
   Welldon KJ, 2008, J BIOMED MATER RES A, V84A, P691, DOI 10.1002/jbm.a.31336
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
NR 43
TC 10
Z9 11
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1067-2516
EI 1542-2224
J9 J FOOT ANKLE SURG
JI J. Foot Ankle Surg.
PD MAY-JUN
PY 2014
VL 53
IS 3
BP 383
EP 387
DI 10.1053/j.jfas.2013.11.004
PG 5
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA AF1YD
UT WOS:000334508900031
PM 24666978
DA 2018-10-20
ER

PT J
AU Bai, L
   Zhan, KH
   Hu, Q
   Xu, JM
AF Bai, Lun
   Zhan, Kuihua
   Hu, Qi
   Xu, Jianmei
TI Endothelial tubes form from intracellular vacuoles in implanted
   biomaterial in vivo of rat
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POROUS SILK FIBROIN; GROWTH-FACTOR; TUMOR ANGIOGENESIS; FIBROBLAST
   CELLS; HYPOXIA; ATTACHMENT; CULTURE
AB When the porous biomaterials are used to implant in vivo of animal for repairing wound, the angiogenesis in microenvironment of porous biomaterial is a key process in order to achieve the goal of treatment. While clarifying the process of vascularization and its mechanism is of great significance for design and development of medical biomaterials. In this area, it is noted that the endothelial tubes of new capillaries are formed by intracellular vacuoles, which has been proved in vitro model of angiogenesis. However, there is still no conclusive evidence in vivo model for mammals. By experimental tracking and observation of angiogenesis in the biomaterials implanted in rats, the angiogenesis process and the characteristics were explored. This study focused on the behavior of endothelial cell (EC)s and the capillary lumen formatting from EC cord in sprouting. Through marking and observing the ECs, the experimental evidences of angiogenesis after implanted materials into rats were obtained, which including various stages, such as rapidly proliferating of ECs, assembling of ECs to build up cell cord and vacuoles formation in ECs. An important mechanism of lumen formation for mammal in vivo was proved, which complemented the experimental results of the assembly of endothelial tubes in vivo through the formation and fusion of vacuoles for transgenic zebrafish. Our results provide support for the model of lumen formation of new capillary in mammal.
C1 [Bai, Lun; Zhan, Kuihua; Hu, Qi; Xu, Jianmei] Soochow Univ, Sch Text & Clothing Engn, Suzhou 215021, Peoples R China.
   [Bai, Lun] Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan.
   [Zhan, Kuihua] Soochow Univ, Sch Mech & Elect Engn, Suzhou 215006, Peoples R China.
RP Bai, L (reprint author), Soochow Univ, Sch Text & Clothing Engn, Suzhou 215021, Peoples R China.
EM bailun1948@gmail.com
OI Zhan, Kuihua/0000-0003-3638-9743
CR Acker T, 2003, CELL TISSUE RES, V314, P145, DOI 10.1007/s00441-003-0763-8
   Altankov G, 2010, NATO SCI PEACE SEC A, P19, DOI 10.1007/978-90-481-8790-4_2
   Bai L, 2007, J MATER SCI-MATER M, V18, P1917
   Bai L, 2011, J MATER SCI-MATER M, V22, P927, DOI 10.1007/s10856-011-4258-y
   Downs KM, 2003, MICROCIRCULATION, V10, P5, DOI 10.1038/sj.mn.7800171
   FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0
   FOLKMAN J, 1980, T OPHTHAL SOC UK, V100, P346
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923
   Kremer C, 1997, CANCER RES, V57, P3852
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Liu Y, 2005, MICROCIRCULATION MAP, P182
   Lun B, 2009, FIBER BIOENG INFORM, V2, P150
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0
   Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
NR 21
TC 2
Z9 2
U1 1
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2014
VL 25
IS 5
BP 1275
EP 1282
DI 10.1007/s10856-014-5148-x
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF1VZ
UT WOS:000334503300007
PM 24464724
DA 2018-10-20
ER

PT J
AU Durao, SF
   Gomes, PS
   Colaco, BJ
   Silva, JC
   Fonseca, HM
   Duarte, JR
   Felino, AC
   Fernandes, MH
AF Durao, S. F.
   Gomes, P. S.
   Colaco, B. J.
   Silva, J. C.
   Fonseca, H. M.
   Duarte, J. R.
   Felino, A. C.
   Fernandes, M. H.
TI The biomaterial-mediated healing of critical size bone defects in the
   ovariectomized rat
SO OSTEOPOROSIS INTERNATIONAL
LA English
DT Article
DE Animal model; Biomaterial; Bone regeneration; Osteoporosis
ID ESTROGEN-RECEPTOR-BETA; CALVARIAL DEFECTS; OSTEOPENIC RATS;
   OSTEOPOROSIS; HYDROXYAPATITE; MODEL; MICE; REGENERATION; PHOSPHATE;
   CAPACITY
AB This study demonstrated an impaired biomaterial-mediated bone regeneration in a critical sized calvarial defect established within an ovariectomized rat model. Histological and microtomographic evidences were supported by an impaired osteoblastic gene expression and altered expression of estrogen receptors and adipogenic markers.
   This work aims to address the bone regeneration process in the ovariectomized rat model, by assessing a calvarial critical size defect implanted with a biocompatible bovine bone mineral graft.
   Animals were randomly divided into two groups: Ovx (bilateral ovariectomy) and Sham (control surgery). Following 8 weeks, all animals were submitted to a surgical bicortical craniotomy (5-mm circular critical size defect), which was filled with a biocompatible mineral graft. Animals were euthanized at 1, 3, and 6 months following graft implantation (n = 10), and results on the orthotopic bone regeneration process were blindly evaluated by radiographic, microtomographic, histological, histomorphometric, and gene expression techniques.
   In the attained model, in both Sham and Ovx groups, the bone regenerative process was found to occur in a slow-paced manner. Likewise, a qualitative evaluation of the microtomographic and histological analysis, as well as quantitative data from histomorphometric indexes, revealed reduced bone regeneration in Ovx animals, at the assayed time points. Significant differences were attained at the 3 and 6 months. Gene expression analysis revealed a reduced expression of osteoblastic-related genes and an altered expression of estrogen receptors and adipogenic markers, within the regenerating bone of Ovx animals.
   Due to the similarities between the osteoporotic animal model and the human condition of postmenopausal osteoporosis, it might be relevant to consider the potential clinical implication of the osteoporotic condition in the biomaterial-mediated bone tissue healing/regeneration process.
C1 [Durao, S. F.; Felino, A. C.] Univ Porto, Fac Med Dent, Dept Surg, P-4200393 Oporto, Portugal.
   [Gomes, P. S.; Silva, J. C.; Fernandes, M. H.] Univ Porto, Fac Med Dent, Lab Bone Metab & Regenerat, P-4200393 Oporto, Portugal.
   [Colaco, B. J.] Univ Tras Os Montes & Alto Douro, ECAV, Ctr Study Anim Sci CECA, Dept Zootechny, P-5001801 Vila Real, Portugal.
   [Fonseca, H. M.; Duarte, J. R.] Univ Porto, Fac Sports, Dept Biochem, P-4200450 Oporto, Portugal.
   [Gomes, P. S.; Fernandes, M. H.] Univ Porto, Ctr Drug Discovery & Innovat Med, MedInUP, P-4200319 Oporto, Portugal.
RP Gomes, PS (reprint author), Univ Porto, Fac Med Dent, Lab Bone Metab & Regenerat, Rua Dr Manuel Pereira Silva, P-4200393 Oporto, Portugal.
EM pgomes@fmd.up.pt
RI Fernandes, Maria Helena/K-6917-2014; Gomes, Pedro/K-2433-2014; Colaco,
   Bruno/K-8682-2013
OI Gomes, Pedro/0000-0001-5365-2123; Colaco, Bruno/0000-0003-4879-8624;
   Fonseca, Helder/0000-0002-9002-8976; Duarte, Jose
   Alberto/0000-0003-4756-5917; Fernandes, Maria Helena/0000-0001-9391-9574
FU Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/DES/103047/2008]
FX Financial support from the Fundacao para a Ciencia e Tecnologia (FCT),
   project PTDC/DES/103047/2008, is greatly acknowledged.
CR Asarian L, 2002, HORM BEHAV, V42, P461, DOI 10.1006/hbeh.2002.1835
   Benisch P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045142
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Brown LM, 2010, J STEROID BIOCHEM, V122, P65, DOI 10.1016/j.jsbmb.2009.12.005
   Chagin AS, 2004, J BONE MINER RES, V19, P72, DOI 10.1359/JBMR.0301203
   Ribeiro DCD, 2012, MICROSC RES TECHNIQ, V75, P133, DOI 10.1002/jemt.21035
   Dominguez Ligia J, 2010, Acta Biomed, V81 Suppl 1, P55
   Durao SFO, 2012, INT J ORAL MAX IMPL, V27, P1400
   Egermann M, 2005, OSTEOPOROSIS INT, V16, pS129, DOI 10.1007/s00198-005-1859-7
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Fini M, 2000, J MATER SCI-MATER M, V11, P579, DOI 10.1023/A:1008932303913
   Fuegl A, 2011, CLIN ORAL IMPLAN RES, V22, P524, DOI 10.1111/j.1600-0501.2010.02048.x
   Gomes PS, 2011, LAB ANIM-UK, V45, P14, DOI 10.1258/la.2010.010085
   Hara T, 2001, ARCH ORAL BIOL, V46, P443, DOI 10.1016/S0003-9969(00)00135-7
   Hatano H, 2004, J BONE MINER METAB, V22, P224, DOI 10.1007/s00774-003-0482-y
   HAYASHI K, 1994, BIOMATERIALS, V15, P11, DOI 10.1016/0142-9612(94)90189-9
   Hayashi K, 1989, J Arthroplasty, V4, P257, DOI 10.1016/S0883-5403(89)80022-1
   He YX, 2011, BONE, V48, P1388, DOI 10.1016/j.bone.2011.03.720
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   IWASHITA Y, 1992, J APPL BIOMATER, V3, P259, DOI 10.1002/jab.770030404
   Ke HZ, 2005, J BONE MINER METAB, V23, P84, DOI 10.1007/BF03026330
   Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JC133612
   Komlev VS, 2010, EUR CELLS MATER, V19, P136, DOI 10.22203/eCM.v019a14
   Lelovas PP, 2008, COMPARATIVE MED, V58, P424
   Leppanen O, 2008, PLOS ONE, V2, pe2540
   Luvizuto ER, 2011, BIOMATERIALS, V32, P3855, DOI 10.1016/j.biomaterials.2011.01.076
   Mikosch P, 2012, PRINCIPLES OF OSTEOIMMUNOLOGY: MOLECULAR MECHANISMS AND CLINICAL APPLICATIONS, P137
   NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis and Therapy, 2001, J AM MED ASS, V285, P785
   Okazaki A, 2000, BIOMATERIALS, V21, P483, DOI 10.1016/S0142-9612(99)00198-2
   Rodriguez JP, 2008, CURR STEM CELL RES T, V3, P208, DOI 10.2174/157488808785740325
   Poole K.E., 2011, PLOS ONE, V6
   Rawlinson S, 2008, J DENT RES, V88, P615
   Rodriguez JP, 1999, J CELL BIOCHEM, V75, P414, DOI 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.3.CO;2-3
   Saxon LK, 2005, BONE, V36, P185, DOI 10.1016/j.bone.2004.08.003
   Surve VV, 2001, ACTA ORTHOP SCAND, V72, P525, DOI 10.1080/000164701753532880
   Tami AE, 2009, BONE, V45, P1117, DOI 10.1016/j.bone.2009.07.090
   Teofilo JM, 2004, ARCH ORAL BIOL, V49, P755, DOI 10.1016/j.archoralbio.2004.02.013
   Thomsen JS, 2005, J MICROSC-OXFORD, V218, P171, DOI 10.1111/j.1365-2818.2005.01469.x
   Turner R T, 2001, Rev Endocr Metab Disord, V2, P117, DOI 10.1023/A:1010067326811
   Yeung DKW, 2005, J MAGN RESON IMAGING, V22, P279, DOI 10.1002/jmri.20367
   Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504
NR 41
TC 16
Z9 18
U1 2
U2 11
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-941X
EI 1433-2965
J9 OSTEOPOROSIS INT
JI Osteoporosis Int.
PD MAY
PY 2014
VL 25
IS 5
BP 1535
EP 1545
DI 10.1007/s00198-014-2656-y
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AF0OU
UT WOS:000334414700013
PM 24573401
DA 2018-10-20
ER

PT J
AU Emoto, S
   Yamaguchi, H
   Kamei, T
   Ishigami, H
   Suhara, T
   Suzuki, Y
   Ito, T
   Kitayama, J
   Watanabe, T
AF Emoto, Shigenobu
   Yamaguchi, Hironori
   Kamei, Takao
   Ishigami, Hironori
   Suhara, Takashi
   Suzuki, Yukimitsu
   Ito, Taichi
   Kitayama, Joji
   Watanabe, Toshiaki
TI Intraperitoneal administration of cisplatin via an in situ
   cross-linkable hyaluronic acid-based hydrogel for peritoneal
   dissemination of gastric cancer
SO SURGERY TODAY
LA English
DT Article
DE Intraperitoneal chemotherapy; Hyaluronic acid; Hydrogel; Cisplatin;
   Peritoneal dissemination
ID DRUG-DELIVERY; OVARIAN-CANCER; ANTITUMOR BIOCONJUGATE; MESOTHELIAL
   CELLS; REGIONAL DELIVERY; PACLITAXEL; CHEMOTHERAPY; CARCINOMATOSIS;
   PREVENTION; ADHESION
AB To develop a drug-delivery system for the prolonged retention of intraperitoneally (i.p.) administered cisplatin (CDDP) to deliver intraperitoneal chemotherapy against peritoneal carcinomatosis effectively.
   CDDP was encapsulated inside an in situ cross-linkable hyaluronic acid (HA)-based hydrogel. The gelation and degradation kinetics of the hydrogel and the release kinetics of CDDP were investigated in vitro, and the antitumor effect was investigated in a mouse model of peritoneal dissemination of human gastric cancer.
   The gelation time varied according to the concentration of two polymers: HA-adipic dihydrazide and HA-aldehyde. CDDP was released from the hydrogel for more than 4 days. A cell proliferation assay showed that the polymers themselves were not cytotoxic toward MKN45P, a human gastric cancer cell line. By mixing the two polymers in the peritoneum, in situ gelation was achieved. The weight of peritoneal nodules decreased in the hydrogel-conjugated CDDP group, whereas no significant antitumor effect was observed in the free CDDP group.
   In situ cross-linkable HA hydrogels represent a promising biomaterial to prolong the retention and sustain the release of intraperitoneally administered CDDP in the peritoneal cavity and to enhance its antitumor effects against peritoneal dissemination.
C1 [Emoto, Shigenobu; Yamaguchi, Hironori; Kamei, Takao; Ishigami, Hironori; Kitayama, Joji; Watanabe, Toshiaki] Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, Tokyo 1138655, Japan.
   [Suhara, Takashi; Suzuki, Yukimitsu; Ito, Taichi] Univ Tokyo, Dept Chem Syst Engn, Tokyo 1138655, Japan.
   [Ito, Taichi] Univ Tokyo, Ctr Dis Biol & Integrat Med, Tokyo 1138655, Japan.
RP Emoto, S (reprint author), Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.
EM semoto-tky@umin.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
   Ministry of Health, Labor and Welfare of Japan
FX This study was funded by the Ministry of Education, Culture, Sports,
   Science and Technology of Japan and the Ministry of Health, Labor and
   Welfare of Japan. We thank Kikkoman for providing HA. We thank Nippon
   Kayaku for providing CDDP. We thank Baxter for providing the dual
   syringes.
CR Alberts DS, 1996, NEW ENGL J MED, V335, P1950, DOI 10.1056/NEJM199612263352603
   Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985
   Auzenne E, 2007, NEOPLASIA, V9, P479, DOI 10.1593/neo.07229
   Bajaj G, 2012, J CONTROL RELEASE, V158, P386, DOI 10.1016/j.jconrel.2011.12.001
   Bajaj G, 2010, PHARM RES-DORDR, V27, P735, DOI 10.1007/s11095-009-0031-z
   Brigand C, 2004, DIGEST DIS, V22, P366, DOI 10.1159/000083600
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Cai S, 2008, J SURG RES, V147, P247, DOI 10.1016/j.jss.2008.02.048
   Cai SA, 2010, J PHARM SCI-US, V99, P2664, DOI 10.1002/jps.22016
   De Stefano I, 2011, CANCER CHEMOTH PHARM, V68, P107, DOI 10.1007/s00280-010-1462-2
   Dedrick RL, 1997, J NATL CANCER I, V89, P480, DOI 10.1093/jnci/89.7.480
   Echarri Gonzalez MJ, 2011, ONCOLOGY WILLISTON P, V25, P170
   Echarri Gonzalez MJ, 2011, ONCOLOGY WILLISTON P, V25, P156
   FRANCIS P, 1995, J CLIN ONCOL, V13, P2961, DOI 10.1200/JCO.1995.13.12.2961
   Hahn SK, 2007, J BIOMED MATER RES A, V80A, P916, DOI 10.1002/jbm.a.30997
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Howell SB, 2008, INT J GYNECOL CANCER, V18, P20, DOI 10.1111/j.1525-1438.2007.01099.x
   Ikeguchi M, 2009, SURG TODAY, V39, P290, DOI 10.1007/s00595-008-3860-1
   Isayeva I, 2010, J BIOMED MATER RES B, V95B, P9, DOI 10.1002/jbm.b.31677
   Ishigami H, 2010, ANN ONCOL, V21, P67, DOI 10.1093/annonc/mdp260
   Isobe Y, 2011, GASTRIC CANCER, V14, P301, DOI 10.1007/s10120-011-0085-6
   Ito T, 2007, BIOMATERIALS, V28, P975, DOI 10.1016/j.biomaterials.2006.10.021
   Jeong YI, 2008, J PHARM SCI-US, V97, P1268, DOI 10.1002/jps.21103
   Jia XQ, 2004, BIOMATERIALS, V25, P4797, DOI 10.1016/j.biomaterials.2003.12.012
   Kamei T, 2010, CANCER SCI, V102, P200
   Kodera Y, 2007, HEPATO-GASTROENTEROL, V54, P960
   Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-204S(08)70035-4
   Kondo A, 1996, BRIT J CANCER, V73, P1166, DOI 10.1038/bjc.1996.225
   Kwak MK, 2010, INVEST NEW DRUG, V28, P284, DOI 10.1007/s10637-009-9253-5
   Lessan K, 1999, AM J PATHOL, V154, P1525, DOI 10.1016/S0002-9440(10)65406-5
   Liao YH, 2005, DRUG DELIV, V12, P327, DOI 10.1080/10717540590952555
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Luo Y, 1999, BIOCONJUGATE CHEM, V10, P755, DOI 10.1021/bc9900338
   Luo Y, 2000, BIOMACROMOLECULES, V1, P208, DOI 10.1021/bm000283n
   Markman M, 2006, J CLIN ONCOL, V24, P988, DOI 10.1200/JCO.2005.05.2456
   MARKMAN M, 1992, J CLIN ONCOL, V10, P1485, DOI 10.1200/JCO.1992.10.9.1485
   Markman M, 2003, LANCET ONCOL, V4, P277, DOI 10.1016/S1470-2045(03)01074-X
   Oertl A, 2005, WORLD J GASTROENTERO, V11, P6243, DOI 10.3748/wjg.v11.i40.6243
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Sako A, 2004, CANCER RES, V64, P3624, DOI 10.1158/0008-5472.CAN-04-0304
   Sugarbaker PH, 2005, ONCOLOGIST, V10, P112, DOI 10.1634/theoncologist.10-2-112
   TAKAHASHI K, 1985, JPN J CANCER RES, V76, P68
   Tsujitani S, 1999, ONCOLOGY-BASEL, V57, P77, DOI 10.1159/000012004
   Wang YY, 2010, RES J BIOTECHNOL, V5, P5
   Wu W, 2011, INT J PHARMACEUT, V416, P104, DOI 10.1016/j.ijpharm.2011.06.015
   Yamada J, 2008, CANCER LETT, V272, P307, DOI 10.1016/j.canlet.2008.07.024
   Yeo Y, 2007, BIOMATERIALS, V28, P3704, DOI 10.1016/j.biomaterials.2007.04.033
   Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043
   Yu J, 2012, INVEST NEW DRUG, V30, P1, DOI 10.1007/s10637-010-9499-y
   Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023
NR 50
TC 26
Z9 27
U1 1
U2 34
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0941-1291
EI 1436-2813
J9 SURG TODAY
JI Surg. Today
PD MAY
PY 2014
VL 44
IS 5
BP 919
EP 926
DI 10.1007/s00595-013-0674-6
PG 8
WC Surgery
SC Surgery
GA AF2DW
UT WOS:000334523800019
PM 23887848
DA 2018-10-20
ER

PT J
AU de Melo, WM
   de Oliveira, FS
   Marcantonio, E
   Beloti, MM
   de Oliveira, PT
   Rosa, AL
AF de Melo, Willian M.
   de Oliveira, Fabiola S.
   Marcantonio, Elcio, Jr.
   Beloti, Marcio M.
   de Oliveira, Paulo T.
   Rosa, Adalberto L.
TI Autogenous bone combined with anorganic bovine bone for maxillary sinus
   augmentation: analysis of the osteogenic potential of cells derived from
   the donor and the grafted sites
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE osteoblast; autogenous bone; maxillary sinus augmentation; gene
   expression; cell culture; bone grafts; anorganic bovine bone
ID FLOOR AUGMENTATION; IMPLANT PLACEMENT; IN-VITRO; GROWTH-FACTORS;
   FOLLOW-UP; SURVIVAL; ASSAY; DOG; BIO-OSS((R)); BIOMATERIAL
AB Objectives
   This study aimed to comparatively evaluate the in vitro osteogenic potential of cells obtained from the mandibular ramus (MR, autogenous bone donor site) and from the maxillary sinus (MS) bone grafted with a mixture of anorganic bovine bone (ABB) and MR prior to titanium implant placement (MS, grafted implant site).
   Material and methods
   Cells were obtained from three patients subjected to MS floor augmentation with a 1:1 mixture of ABB (GenOx Inorg((R))) and MR. At the time of the sinus lift procedure and after 8months, prior to implant placement, bone fragments were taken from MR and MS, respectively, and subjected to trypsin-collagenase digestion for primary cell culturing. Subcultured cells were grown under osteogenic condition for up to 21days and assayed for proliferation/viability, osteoblast marker mRNA levels, alkaline phosphatase (ALP) activity and calcium content/Alizarin red staining. ALP activity was also determined in primary explant cultures exposed to GenOx Inorg((R)) (1:1 with MR) for 7days. Data were compared using either the Mann-Whitney U-test or the Kruskal-Wallis test.
   Results
   MS cultures exhibited a significantly lower osteogenic potential compared with MR cultures, with a progressive increase in cell proliferation together with a decrease in osteoblast markers, reduced ALP activity and calcium content. Exposure of MR-derived primary cultures to GenOx Inorg((R)) inhibited ALP activity.
   Conclusion
   These results suggest that the use of GenOx Inorg((R)) in combination with MR fragments for MS floor augmentation inhibits the osteoblast cell differentiation at the implant site in the long term.
C1 [de Melo, Willian M.; de Oliveira, Fabiola S.; Beloti, Marcio M.; de Oliveira, Paulo T.; Rosa, Adalberto L.] Univ Sao Paulo, Sch Dent Ribeirao Preto, BR-14040904 Ribeirao Preto, SP, Brazil.
   [Marcantonio, Elcio, Jr.] Sao Paulo State Univ, Sch Dent Araraquara, Araraquara, SP, Brazil.
RP Rosa, AL (reprint author), Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Oral & Maxillofacial Surg & Periodontol, BR-14040904 Ribeirao Preto, SP, Brazil.
EM adalrosa@forp.usp.br
RI Tambasco de Oliveira, Paulo/F-9749-2010; Oliveira, Fabiola/J-6915-2014;
   Rosa, Adalberto/A-6314-2008; Beloti, Marcio/E-7473-2012
OI Tambasco de Oliveira, Paulo/0000-0002-6662-0486; Oliveira,
   Fabiola/0000-0003-0855-5118; Rosa, Adalberto/0000-0002-6495-2778;
   Beloti, Marcio/0000-0003-0149-7189; Marcantonio Junior,
   Elcio/0000-0002-9660-4524; Marcantonio Junior, Elcio/0000-0003-1294-2305
FU FAPESP; CAPES (Brazil)
FX The authors would like to thank FAPESP for financial support. Willian
   Morais de Melo was the recipient of a Masters fellowship from CAPES
   (Brazil). Roger Rodrigo Fernandes is acknowledged for technical
   assistance in cell culture experiments.
CR Accorsi-Mendonça Thais, 2008, Braz. oral res., V22, P5, DOI 10.1590/S1806-83242008000100002
   Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Beloti MM, 2008, CLIN ORAL IMPLAN RES, V19, P48, DOI 10.1111/j.1600-0501.2007.01420.x
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Bernhardt A, 2011, CLIN ORAL IMPLAN RES, V22, P651, DOI 10.1111/j.1600-0501.2010.02015.x
   Botticelli D, 2004, CLIN ORAL IMPLAN RES, V15, P285, DOI 10.1046/j.1600-0501.2003.01008.x
   Carmagnola D, 2000, J CLIN PERIODONTOL, V27, P799, DOI 10.1034/j.1600-051x.2000.027011799.x
   Chaushu G, 2009, J PERIODONTOL, V80, P422, DOI [10.1902/jop.2009.080451, 10.1902/jop.2009.080451 ]
   Cho-Lee GY, 2010, INT J ORAL MAX IMPL, V25, P1019
   de Oliva MA, 2009, J HISTOCHEM CYTOCHEM, V57, P265, DOI 10.1369/jhc.2008.952713
   de Oliveira PT, 2008, J HISTOCHEM CYTOCHEM, V56, P629, DOI 10.1369/jhc.2008.950758
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   Bernabe PFE, 2012, CLIN ORAL IMPLAN RES, V23, P384, DOI 10.1111/j.1600-0501.2011.02166.x
   Bernabe PFE, 2010, ORAL SURG ORAL MED O, V109, P309, DOI 10.1016/j.tripleo.2009.07.019
   Ferreira CEA, 2009, J PERIODONTOL, V80, P1920, DOI 10.1902/jop.2009.090263
   Galindo-Moreno P, 2010, CLIN ORAL IMPLAN RES, V21, P122, DOI 10.1111/j.1600-0501.2009.01814.x
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Hatano M., 2004, CLIN ORAL IMPLAN RES, V15, P339
   Hausamen J E, 1992, Eur Arch Otorhinolaryngol Suppl, V1, P163
   Herten M, 2009, CLIN ORAL INVEST, V13, P149, DOI 10.1007/s00784-008-0214-8
   Iezzi G, 2008, J PERIODONTOL, V79, P192, DOI 10.1902/jop.2008.070105 
   Jensen T, 2013, CLIN ORAL IMPLAN RES, V24, P635, DOI 10.1111/j.1600-0501.2012.02438.x
   Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P263, DOI 10.1111/j.1600-0501.2011.02168.x
   Kahnberg KE, 2011, CLIN IMPLANT DENT R, V13, P231, DOI 10.1111/j.1708-8208.2009.00201.x
   Kim YK, 2009, ORAL SURG ORAL MED O, V107, pE21, DOI 10.1016/j.tripleo.2008.09.033
   Klijn RJ, 2010, TISSUE ENG PART B-RE, V16, P295, DOI [10.1089/ten.teb.2009.0558, 10.1089/ten.TEB.2009.0558]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mladenovic Z, 2013, CLIN ORAL IMPLAN RES, V24, P329, DOI 10.1111/j.1600-0501.2011.02334.x
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nkenke E, 2009, CLIN ORAL IMPLAN RES, V20, P124, DOI 10.1111/j.1600-0501.2009.01776.x
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Patel K. S., 2012, CLOUD COMP EM MARK C, P1, DOI DOI 10.1111/J.1600-0501.2012.02500.X
   Sbordone L, 2009, INT J ORAL MAX IMPL, V24, P316
   Serra E, 2006, J ORAL MAXILLOFAC SU, V64, P931
   Sohn DS, 2010, IMPLANT DENT, V19, P259, DOI 10.1097/ID.0b013e3181df1406
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Trubiani O, 2010, EUR CELLS MATER, V20, P72
NR 38
TC 3
Z9 4
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2014
VL 25
IS 5
BP 603
EP 609
DI 10.1111/clr.12100
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA AE6BD
UT WOS:000334072400010
PM 23289911
DA 2018-10-20
ER

PT J
AU Amensag, S
   McFetridge, PS
AF Amensag, Salma
   McFetridge, Peter S.
TI Tuning scaffold mechanics by laminating native extracellular matrix
   membranes and effects on early cellular remodeling
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE rolling approach; tissue engineering; early remodeling
ID PERIPHERAL-NERVE REGENERATION; HUMAN AMNIOTIC MEMBRANE; HEART-VALVES;
   TISSUE; CELLS; DECELLULARIZATION; RECELLULARIZATION; TRANSPLANTATION;
   PERMEABILITY; CULTURE
AB At approximately 50 mu m thin, the human amniotic membrane (hAM) has been shown to be a versatile biomaterial with applications ranging from ocular transplants to skin and nerve regeneration. These investigations describe laminating layers of the hAM into a multilayered, conformation creating a thicker, more robust biomaterial for applications requiring more supportive structures. Amniotic membranes were decellularized using 4 M NaCl and prepared as either flat single-layered sheets or rolled into concentric five-layered configurations. Constructs were seeded with human vascular smooth muscle cells and cultured over 40 days to quantify biological and mechanical changes that occurred during early remodeling events. By day 40 single-layered constructs displayed a decreasing trend in cellular densities and glycosaminoglycan (GAG) concentration, comparative to multilayered constructs with increasing cell densities (from 9.1 to 32 x 10(6) cells/g) and GAG concentrations (from 6.07 to 17.4 mg/g). Oxygen diffusion was calculated and found to be sufficient to maintain cell populations through the constructs full thickness. Although an overall decrease in the modulus of elasticity was noted, the modulus in the failure range of rolled constructs stabilized at values 25 times higher than single-layered constructs. Rolled constructs typically displayed an upregulation of contractile and matrix remodeling markers (alpha-actin, SM22 and type 1 collagen, MMP-2 respectively) indicating biological adaptation. Considerable design flexibility can be achieved by varying the number of scaffold layers, allowing the possibility of tuning the constructs physical dimensions, shape and tensile properties to suit specific targeted vascular locations. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1325-1333, 2014.
C1 [Amensag, Salma; McFetridge, Peter S.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
RP McFetridge, PS (reprint author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
EM pmcfetridge@bme.ufl.edu
FU NHLBI NIH HHS [R01 HL088207]
CR Amensag S, 2012, TISSUE ENG PART C-ME, V18, P903, DOI [10.1089/ten.tec.2012.0119, 10.1089/ten.TEC.2012.0119]
   Cheema U, 2009, INT J ARTIF ORGANS, V32, P318
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Guarino RD, 2004, BIOTECHNOL BIOENG, V86, P775, DOI 10.1002/bit.20072
   Jin CZ, 2007, TISSUE ENG, V13, P693, DOI 10.1089/ten.2006.0184
   Kheirkhah A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1059, DOI 10.1001/archopht.126.8.1059
   Kim WG, 2002, INT J ARTIF ORGANS, V25, P791
   Koizumi N, 2007, GRAEF ARCH CLIN EXP, V245, P123, DOI 10.1007/s00417-005-0095-3
   Lim LS, 2009, MOL VIS, V15, P1962
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Maharajan VS, 2007, CLIN EXP OPHTHALMOL, V35, P140, DOI 10.1111/j.1442-9071.2006.01408.x
   McFetridge PS, 2007, ASAIO J, V53, P623, DOI 10.1097/MAT.0b013e31812f3b7e
   Mligiliche N, 2002, J BIOMED MATER RES, V63, P591, DOI 10.1002/jbm.10349
   Mohammad J, 2000, PLAST RECONSTR SURG, V105, P660, DOI 10.1097/00006534-200002000-00027
   Moore M, 2012, J BIOMED MATER RES A, V100A, P2194, DOI 10.1002/jbm.a.34092
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   PORTA M, 1989, BIOCHIM BIOPHYS ACTA, V980, P220, DOI 10.1016/0005-2736(89)90402-1
   Portmann-Lanz CB, 2007, PLACENTA, V28, P6, DOI 10.1016/j.placenta.2006.01.004
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Seliktar D, 2003, TISSUE ENG, V9, P657, DOI 10.1089/107632703768247359
   Tamhane A, 2005, OPHTHALMOLOGY, V112, P1963, DOI 10.1016/j.ophtha.2005.05.022
   Tosun Z, 2013, BIOTECHNOL BIOENG, V110, P2035, DOI 10.1002/bit.24934
   Uzarski JS, 2013, J BIOMED MATER RES A, V101, P123, DOI 10.1002/jbm.a.34308
   Vadapalli A, 2000, AM J PHYSIOL-HEART C, V279, pH657
   Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008
   Wilshaw SP, 2008, TISSUE ENG PT A, V14, P463, DOI 10.1089/tea.2007.0145
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
   Xu CC, 2007, TISSUE ENG, V13, P551, DOI 10.1089/ten.2006.0169
   Yoshita T, 2004, AM J OPHTHALMOL, V138, P486, DOI 10.1016/j.ajo.2004.03.021
NR 31
TC 10
Z9 10
U1 2
U2 23
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2014
VL 102
IS 5
BP 1325
EP 1333
DI 10.1002/jbm.a.34791
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD4JB
UT WOS:000333215600012
PM 23666819
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Dixon, AR
   Moraes, C
   Csete, ME
   Thouless, MD
   Philbert, MA
   Takayama, S
AF Dixon, Angela R.
   Moraes, Christopher
   Csete, Marie E.
   Thouless, M. D.
   Philbert, Martin A.
   Takayama, Shuichi
TI One-dimensional patterning of cells in silicone wells via
   compression-induced fracture
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE compression; polydimethyl siloxane; patterning; fracture; biomaterial
   design
ID MESENCHYMAL STEM-CELLS; MATRIX ADHESIONS; SOFT LITHOGRAPHY; NUCLEAR
   SHAPE; 3D; DIFFERENTIATION; 3RD-DIMENSION; CULTURE; LINEAGE; SURFACE
AB We have adapted our existing compression-induced fracture technology to cell culture studies by generating linear patterns on a complex cell culture well structure rather than on simple solid constructs. We present a simple method to create one-dimensional (1D), submicron, and linear patterns of extracellular matrix on a multilayer silicone material. We identified critical design parameters necessary to optimize compression-induced fracture patterning on the wells, and applied stresses using compression Hoffman clamps. Finite-element analyses show that the incorporation of the well improves stress homogeneity (stress variation = 25%), and, thus, crack uniformity over the patterned region. Notably, a shallow well with a thick base (vs. deeper wells with thinner bases) reduces out-of-plane deflections by greater than a sixth in the cell culture region, improving clarity for optical imaging. The comparison of cellular and nuclear shape indices of a neuroblast line cultured on patterned 1D lines and unpatterned 2D surfaces reveals significant differences in cellular morphology, which could impact many cellular functions. Because 1D cell cultures recapitulate many important phenotypical traits of 3D cell cultures, our culture system offers a simple means to further study the relationship between 1D and 3D cell culture environments, without demanding expensive engineering techniques and expertise. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1361-1369, 2014.
C1 [Dixon, Angela R.; Philbert, Martin A.] Univ Michigan, Sch Publ Hlth, Toxicol Program, Ann Arbor, MI 48109 USA.
   [Dixon, Angela R.; Moraes, Christopher; Takayama, Shuichi] Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Csete, Marie E.] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48109 USA.
   [Csete, Marie E.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.
   [Csete, Marie E.] AABB Ctr Cellular Therapies, Bethesda, MD USA.
   [Thouless, M. D.] Univ Michigan, Coll Engn, Dept Mech Engn, Ann Arbor, MI 48109 USA.
   [Thouless, M. D.] Univ Michigan, Coll Engn, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Takayama, Shuichi] Univ Michigan, Coll Engn, Macromol Sci & Engn Program, Ann Arbor, MI 48109 USA.
RP Takayama, S (reprint author), Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
EM takayama@umich.edu
OI Moraes, Christopher/0000-0002-8950-2212
FU University of Michigan National Center for Institutional Diversity
   postdoctoral fellowship program; Natural Sciences and Engineering
   Research Council of Canada/Banting postdoctoral fellowship programs; NIH
   [EB 003793, HG 004653]; NSF [CMMI 0700232]
FX Contract grant sponsors: University of Michigan National Center for
   Institutional Diversity postdoctoral fellowship program to ARD and the
   Natural Sciences and Engineering Research Council of Canada/Banting
   postdoctoral fellowship programs to CM; Contract grant sponsor: NIH;
   contract grant number: EB 003793 and HG 004653; Contract grant sponsor:
   NSF; contract grant number: CMMI 0700232
CR Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Green A, 2007, ADV DRUG DELIV REV, V59, P1293
   Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671
   Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009
   Kriparamanan R, 2006, J NANOSCI NANOTECHNO, V6, P1905, DOI 10.1166/jnn.2006.330
   Kulangara K, 2009, SOFT MATTER, V5, P4072, DOI 10.1039/b910132m
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Levina EM, 2001, J CELL SCI, V114, P4335
   Li F, 2008, CELL MOTIL CYTOSKEL, V65, P332, DOI 10.1002/cm.20263
   Martinez E, 2008, NANOMEDICINE, V4, P65
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mills KL, 2008, J MATER RES, V23, P37, DOI 10.1557/JMR.2008.0029
   Moraes C, 2012, ANN BIOMED ENG, V40, P1211, DOI 10.1007/s10439-011-0455-6
   Moraes C, 2011, INTEGR BIOL-UK, V3, P959, DOI 10.1039/c1ib00056j
   Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068
   Nathan AS, 2011, ACTA BIOMATER, V7, P57, DOI 10.1016/j.actbio.2010.08.007
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Picone R., 2010, PLOS BIOL, P8
   Raghavan S, 2010, J CELL SCI, V123, P2877, DOI 10.1242/jcs.055079
   Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242
   ten Elshof JE, 2010, J EUR CERAM SOC, V30, P1555, DOI 10.1016/j.jeurceramsoc.2010.01.016
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Thouless MD, 2011, J MECH PHYS SOLIDS, V59, P1927, DOI 10.1016/j.jmps.2011.04.009
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   Uchida T, 2009, LANGMUIR, V25, P3102, DOI 10.1021/la801986k
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   Vignaud T, 2012, TRENDS CELL BIOL, V22, P671, DOI 10.1016/j.tcb.2012.08.012
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhou W, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2149513
   Zhu XY, 2005, NAT MATER, V4, P403, DOI 10.1038/nmat1365
NR 46
TC 4
Z9 4
U1 3
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2014
VL 102
IS 5
BP 1361
EP 1369
DI 10.1002/jbm.a.34814
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD4JB
UT WOS:000333215600016
PM 23733484
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Halpern, JM
   Urbanski, R
   Weinstock, AK
   Iwig, DF
   Mathers, RT
   von Recum, HA
AF Halpern, Jeffrey M.
   Urbanski, Richard
   Weinstock, Allison K.
   Iwig, David F.
   Mathers, Robert T.
   von Recum, Horst A.
TI A biodegradable thermoset polymer made by esterification of citric acid
   and glycerol
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE glycerol; degradable polymers; citric acid; polyester; controlled drug
   release
ID ANTIMICROBIAL ACTIVITY; DRUG-DELIVERY; ELASTOMERS; SCAFFOLDS; IMPLANT;
   AGENTS
AB A new biomaterial, a degradable thermoset polymer, was made from simple, economical, biocompatable monomers without the need for a catalyst. Glycerol and citric acid, nontoxic and renewable reagents, were crosslinked by a melt polymerization reaction at temperatures from 90 to 150 degrees C. Consistent with a condensation reaction, water was determined to be the primary byproduct. The amount of crosslinking was controlled by the reaction conditions, including temperature, reaction time, and ratio between glycerol and citric acid. Also, the amount of crosslinking was inversely proportional to the rate of degradation. As a proof-of-principle for drug delivery applications, gentamicin, an antibiotic, was incorporated into the polymer with preliminary evaluations of antimicrobial activity. The polymers incorporating gentamicin had significantly better bacteria clearing of Staphylococcus aureus compared to non-gentamicin gels for up to 9 days. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1467-1477, 2014.
C1 [Halpern, Jeffrey M.; von Recum, Horst A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Urbanski, Richard; Weinstock, Allison K.; Mathers, Robert T.] Penn State Univ, Dept Chem, New Kensington, PA 15068 USA.
   [Iwig, David F.] Alcoa Tech Ctr, Alcoa Ctr, PA 15069 USA.
RP von Recum, HA (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM hav1@case.edu
OI Halpern, Jeffrey/0000-0003-0814-1986
FU Alcoa Foundation; National Institutes of Health Ruth L. Kirschstein
   National Research Service Award [T32 AR007505]
FX Contract grant sponsor: National Institutes of Health Ruth L.
   Kirschstein National Research Service Award; contract grant number: T32
   AR007505
CR Anand A, 2009, INDIAN J PHARM SCI, V71, P377, DOI 10.4103/0250-474X.57285
   [Anonymous], 2010, E214910 ASTM INT
   Bettinger CJ, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P341, DOI 10.1016/B978-012370615-7/50028-7
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Bhatta RS, 2012, INT J PHARMACEUT, V432, P105, DOI 10.1016/j.ijpharm.2012.04.060
   BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004
   Bretti C, 2006, J CHEM ENG DATA, V51, P1660, DOI 10.1021/je060132t
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Chung EJ, 2011, J MATER SCI-MATER M, V22, P2131, DOI 10.1007/s10856-011-4393-5
   Doi Y., 2002, BIOPOLYMERS POLYESTE
   Engineer C, 2011, TRENDS BIOMATER ARTI, V25, P79
   Guarda A, 2011, INT J FOOD MICROBIOL, V146, P144, DOI 10.1016/j.ijfoodmicro.2011.02.011
   Halpern JM, 2014, BIOMATERIALS AND REGENERATIVE MEDICINE, P419
   Haynes W.M., 2010, CRC HDB CHEM PHYS, P8
   Holland TA, 2006, ADV BIOCHEM ENG BIOT, V102, P161, DOI 10.1007/b137205
   Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306
   Lee DW, 2012, BONE, V50, P974, DOI 10.1016/j.bone.2012.01.007
   Manzer LE, 2006, FEEDSTOCKS FUTURE RE
   Mathers RT, 2011, GREEN POLYM METHODS
   Naeini AT, 2010, NANOMED-NANOTECHNOL, V6, P556, DOI 10.1016/j.nano.2009.11.008
   Nam HY, 2009, BIOMATERIALS, V30, P665, DOI 10.1016/j.biomaterials.2008.10.013
   Namazi H, 2007, COLLOID POLYM SCI, V285, P1527, DOI 10.1007/s00396-007-1717-6
   Namazi H, 2005, BIOMATERIALS, V26, P1175, DOI 10.1016/j.biomaterials.2004.04.014
   Namazi H, 2011, J POLYM RES, V18, P1431, DOI 10.1007/s10965-010-9548-4
   Otera J., 2010, ESTERIFICATION METHO
   Pachence JM, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P323, DOI 10.1016/B978-012370615-7/50027-5
   Parmanick D, 1988, POLYM B, V19, P365
   Porter W. L., 1980, AUTOXIDATION FOOD BI, P295
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Scholz MS, 2011, COMPOS SCI TECHNOL, V71, P1791, DOI 10.1016/j.compscitech.2011.08.017
   Sharma Monica, 2009, Reviews in Environmental Science and Bio/Technology, V8, P343, DOI 10.1007/s11157-009-9175-x
   Silici S, 2006, LETT APPL MICROBIOL, V43, P318, DOI 10.1111/j.1472-765X.2006.01949.x
   Sousa Simone Maria Galvão de, 2005, Braz. Dent. J., V16, P3, DOI 10.1590/S0103-64402005000100001
   Thatiparti TR, 2010, BIOMATERIALS, V31, P2335, DOI 10.1016/j.biomaterials.2009.11.087
   TRAUB WH, 1995, J ANTIMICROB CHEMOTH, V35, P149, DOI 10.1093/jac/35.1.149
   Wang NX, 2011, MACROMOL BIOSCI, V11, P321, DOI 10.1002/mabi.201000206
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wiskur SL, 2004, CHEM-EUR J, V10, P3792, DOI 10.1002/chem.200305737
   WITOWSKI J, 1994, INT J ARTIF ORGANS, V17, P252
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yin HQ, 1999, J BURN CARE REHABIL, V20, P195, DOI 10.1097/00004630-199905000-00006
   Zhang XQ, 2009, BIOMATERIALS, V30, P2632, DOI 10.1016/j.biomaterials.2009.01.021
NR 43
TC 37
Z9 38
U1 3
U2 93
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2014
VL 102
IS 5
BP 1467
EP 1477
DI 10.1002/jbm.a.34821
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD4JB
UT WOS:000333215600028
PM 23737239
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhu, CL
   Li, F
   Zhou, XY
   Lin, L
   Zhang, TY
AF Zhu, Changlai
   Li, Feng
   Zhou, Xinyang
   Lin, Lin
   Zhang, Tianyi
TI Kombucha-synthesized bacterial cellulose: Preparation, characterization,
   and biocompatibility evaluation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Schwann cells; characterization; Kampuchea; biocompatibility; cellulose
ID PERIPHERAL-NERVE REGENERATION; SILK FIBROIN; IN-VITRO; CELLS; ADDITIVES;
   SCAFFOLD; GROWTH
AB Bacterial cellulose (BC) is a natural biomaterial with unique properties suitable for tissue engineering applications, but it has not yet been used for preparing nerve conduits to repair peripheral nerve injuries. The objectives of this study were to prepare and characterize the Kampuchea-synthesized bacterial cellulose (KBC) and further evaluate the biocompatibility of KBC with peripheral nerve cells and tissues in vitro and in vivo. KBC membranes were composed of interwoven ribbons of about 20-100 nm in width, and had a high purity and the same crystallinity as that of cellulose I alpha. The results from light and scanning electron microscopy, MTT assay, flow cytometry, and RT-PCR indicated that no significant differences in the morphology and cell function were observed between Schwann cells (SCs) cultured on KBC membranes and glass slips. We also fabricated a nerve conduit using KBC, which was implanted into the spatium intermusculare of rats. At 1, 3, and 6 weeks post-implantation, clinical chemistry and histochemistry showed that there were no significant differences in blood counts, serum biochemical parameters, and tissue reactions between implanted rats and sham-operated rats. Collectively, our data indicated that KBC possessed good biocompatibility with primary cultured SCs and KBC did not exert hematological and histological toxic effects on nerve tissues in vivo. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1548-1557, 2014.
C1 [Zhu, Changlai; Zhou, Xinyang; Lin, Lin; Zhang, Tianyi] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.
   [Li, Feng] Nantong Univ, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China.
RP Zhang, TY (reprint author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.
EM pro_zty001@163.com
CR ATALLA RH, 1984, SCIENCE, V223, P283, DOI 10.1126/science.223.4633.283
   Castro C, 2011, CARBOHYD POLYM, V84, P96, DOI 10.1016/j.carbpol.2010.10.072
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Dufresne C, 2000, FOOD RES INT, V33, P409, DOI 10.1016/S0963-9969(00)00067-3
   Feng YY, 2012, CARBOHYD POLYM, V87, P644, DOI 10.1016/j.carbpol.2011.08.039
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Hall S, 2001, J HAND SURG-BRIT EUR, V26, P129, DOI 10.1054/jhsb.2000.0497
   Hirai A, 1998, CELLULOSE, V5, P201, DOI 10.1023/A:1009233323237
   Hood B, 2009, NEUROSURG FOCUS, V26, P1770
   Hsu SH, 2011, BIOMATERIALS, V32, P3764, DOI 10.1016/j.biomaterials.2011.01.065
   Hu Y, 2011, ACTA BIOMATER, V7, P2835, DOI 10.1016/j.actbio.2011.03.028
   Keilhoff G, 2006, TISSUE ENG, V12, P1451, DOI 10.1089/ten.2006.12.1451
   Kim G, 2010, BIOMATERIALS, V31, P2517, DOI 10.1016/j.biomaterials.2009.12.013
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   Maeda H, 2006, J MATER SCI, V41, P5646, DOI 10.1007/s10853-006-0297-z
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Nakamura T, 2004, BRAIN RES, V1027, P18, DOI 10.1016/j.brainres.2004.08.040
   Novaes A B Jr, 1993, Clin Oral Implants Res, V4, P106, DOI 10.1034/j.1600-0501.1993.040207.x
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Seves A, 2001, MACROMOL MATER ENG, V286, P524, DOI 10.1002/1439-2054(20010901)286:9<524::AID-MAME524>3.3.CO;2-2
   Shalumon KT, 2011, J BIOMED NANOTECHNOL, V7, P609, DOI 10.1166/jbn.2011.1337
   Stang F, 2005, BIOMATERIALS, V26, P3083, DOI 10.1016/j.biomaterials.2004.07.060
   VANDERHART DL, 1984, MACROMOLECULES, V17, P1465, DOI 10.1021/ma00138a009
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yang YM, 2011, EUR J PHARM BIOPHARM, V79, P519, DOI 10.1016/j.ejpb.2011.06.008
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
   Zhang Y, 2012, MATER LETT, V68, P218, DOI 10.1016/j.matlet.2011.10.061
   Zhijiang C., 2012, CARBOHYD POLYM, V87, P1073, DOI DOI 10.1016/J.CARBP0L.2011.08.037
NR 32
TC 11
Z9 11
U1 6
U2 93
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2014
VL 102
IS 5
BP 1548
EP 1557
DI 10.1002/jbm.a.34796
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD4JB
UT WOS:000333215600036
PM 23666905
DA 2018-10-20
ER

PT J
AU Dishowitz, MI
   Zhu, FC
   Sundararaghavan, HG
   Ifkovits, JL
   Burdick, JA
   Hankenson, KD
AF Dishowitz, Michael I.
   Zhu, Fengchang
   Sundararaghavan, Harini G.
   Ifkovits, Jamie L.
   Burdick, Jason A.
   Hankenson, Kurt D.
TI Jagged1 immobilization to an osteoconductive polymer activates the Notch
   signaling pathway and induces osteogenesis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Notch signaling; osteoblast differentiation; Jagged1; osteoinduction;
   translational medicine
ID ALAGILLE-SYNDROME; OSTEOBLAST DIFFERENTIATION; CELL-DIFFERENTIATION;
   FUTURE-DIRECTIONS; BONE REGENERATION; FRACTURES; PROLIFERATION;
   MUTATIONS; INTERFACE; CHILDREN
AB Treatment of nonunion fractures is a significant problem. Common therapeutics, including autologous bone grafts and bone morphogenetic proteins, show well-established limitations. Therefore, a need persists for the identification of novel clinical therapies to promote healing. The Notch signaling pathway regulates bone development. Clinically, loss-of-function mutations to the Notch ligand Jagged1 decrease bone mass and increase fracture risk. Jagged1 is also the most highly upregulated ligand during fracture repair, identifying it as a potential target to promote bone formation. Therefore, the objective of this study was to develop a clinically translatable construct comprised of Jagged1 and an osteoconductive scaffold, and characterize its activity in human mesenchymal stem cells (hMSC). We first evaluated the effects of Jagged1 directly immobilized to a novel poly(beta-amino ester) relative to indirect coupling via antibody. Direct was more effective at activating hMSC Notch target gene expression and osteogenic activity. We then found that directly immobilized Jagged1 constructs induced osteoblast differentiation. This is the first study to demonstrate that Jagged1 delivery transiently activates Notch signaling and increases osteogenesis. A positive correlation was found between Jagged1-induced Notch and osteogenic expression. Collectively, these results indicate that Jagged1 coupled to an osteogenic biomaterial could promote bone tissue formation during fracture healing. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1558-1567, 2014.
C1 [Dishowitz, Michael I.; Sundararaghavan, Harini G.; Ifkovits, Jamie L.; Burdick, Jason A.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Zhu, Fengchang; Hankenson, Kurt D.] Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Philadelphia, PA 19104 USA.
   [Hankenson, Kurt D.] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA.
RP Hankenson, KD (reprint author), 311 Hill Pavilion,380 S Univ Ave, Philadelphia, PA 19103 USA.
EM kdhank@vet.upenn.edu
OI Hankenson, Kurt/0000-0001-6361-143X
FU Congressionally Directed Medical Research Program [W81XWH-10-1-0825];
   Osteosynthesis and Trauma Care Foundation, the Penn Center for
   Musculoskeletal Disorders [NIH/NIAMS P30 AR050950]; Ruth L. Kirschstein
   National Research Service Award [NIH/NIDCR F31DE020231]
FX Contract grant sponsor: Congressionally Directed Medical Research
   Program; contract grant number: W81XWH-10-1-0825; Contract grant
   sponsor: Osteosynthesis and Trauma Care Foundation, the Penn Center for
   Musculoskeletal Disorders; contract grant number: NIH/NIAMS P30
   AR050950; Contract grant sponsor: Ruth L. Kirschstein National Research
   Service Award; contract grant number: NIH/NIDCR F31DE020231
CR Anderson DG, 2006, ADV MATER, V18, P2614, DOI 10.1002/adma.200600529
   Audige L, 2005, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000163836.66906.74
   Bales CB, 2010, J PEDIATR GASTR NUTR, V51, P66, DOI 10.1097/MPG.0b013e3181cb9629
   Beckstead BL, 2006, J BIOMED MATER RES A, V79A, P94, DOI 10.1002/jbm.a.30760
   Beckstead BL, 2009, J BIOMED MATER RES A, V91A, P436, DOI 10.1002/jbm.a.32214
   Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025
   Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x
   Brey DM, 2010, J BIOMED MATER RES A, V93A, P807, DOI 10.1002/jbm.a.32769
   Carragee EJ, 2011, SPINE J, V11, P695, DOI 10.1016/j.spinee.2011.08.418
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Dishowitz MI, 2012, J ORTHOP RES, V30, P296, DOI 10.1002/jor.21518
   Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911
   Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Goncalves RM, 2009, BIOMATERIALS, V30, P6879, DOI 10.1016/j.biomaterials.2009.09.010
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716
   Kohn A, 2012, DEVELOPMENT, V139, P1198, DOI 10.1242/dev.070649
   Kramer H, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.29.pe1
   Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978
   Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243
   Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106
   Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200
   Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235
   Oldershaw RA, 2008, STEM CELLS, V26, P666, DOI 10.1634/stemcells.2007-0806
   Olsen IE, 2005, J PEDIATR GASTR NUTR, V40, P76, DOI 10.1097/00005176-200501000-00014
   Osathanon T, 2013, J BIOMED MATER RES A, V101, P358, DOI 10.1002/jbm.a.34332
   Salie R, 2010, BONE, V46, P680, DOI 10.1016/j.bone.2009.10.022
   Sekine C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3758
   Tao JN, 2010, J BONE MINER RES, V25, P2175, DOI 10.1002/jbmr.115
   Tezuka K, 2002, J BONE MINER RES, V17, P231, DOI 10.1359/jbmr.2002.17.2.231
   Vas V, 2004, J LEUKOCYTE BIOL, V75, P714, DOI 10.1189/jlb.1003462
   Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140
   Zhu FC, 2013, STEM CELLS, V31, P1181, DOI 10.1002/stem.1353
NR 34
TC 14
Z9 17
U1 1
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2014
VL 102
IS 5
BP 1558
EP 1567
DI 10.1002/jbm.a.34825
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD4JB
UT WOS:000333215600037
PM 23775982
DA 2018-10-20
ER

PT J
AU Leong, NL
   Petrigliano, FA
   McAllister, DR
AF Leong, Natalie L.
   Petrigliano, Frank A.
   McAllister, David R.
TI Current tissue engineering strategies in anterior cruciate ligament
   reconstruction
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE anterior cruciate ligament; tissue engineering; scaffold; review; growth
   factor
ID MESENCHYMAL STEM-CELLS; MEDIAL COLLATERAL LIGAMENT; MARROW STROMAL
   CELLS; EPIDERMAL-GROWTH-FACTOR; POLYMER FIBER SCAFFOLD; BRAID-TWIST
   SCAFFOLD; IN-VITRO; ACL RECONSTRUCTION; GENE-EXPRESSION; SILK SCAFFOLD
AB Rupture of the anterior cruciate ligament (ACL) is one of the most common ligamentous injuries of the knee. Limitations of allografts and autografts in ACL reconstruction as well as recent advancements in biology and materials science have spurred interest in developing tissue-engineered ACL replacements that have the potential to mimic the native ACL in terms of both biological and mechanical properties. This article reviews the current literature regarding contemporary tissue engineering strategies. The four basic components of tissue engineering, biomaterial scaffolds, cell sources, growth factors, and mechanical stimuli, as applied to the development of tissue-engineered ACL replacement grafts, will be systematically addressed. In addition, animal models that have been used to test these tissue-engineered ACL replacements will also be reviewed. To date, there is no tissue-engineered ACL construct that has been successfully implanted in humans. We expect that continued progress in designing a viable tissue-engineered ACL replacement will accompany rapidly advancing techniques in materials science and biology. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1614-1624, 2014.
C1 [Leong, Natalie L.; Petrigliano, Frank A.; McAllister, David R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA.
RP Leong, NL (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA.
EM NLeong@mednet.ucla.edu
OI Leong, Natalie/0000-0001-6556-9781
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje
   AMIEL D, 1995, MED SCI SPORT EXER, V27, P844
   ANDERSSON C, 1991, CLIN ORTHOP RELAT R, P255
   ANGELLO JC, 1987, J CELL PHYSIOL, V132, P125, DOI 10.1002/jcp.1041320117
   Bedi A, 2010, J BONE JOINT SURG AM, V92A, P2387, DOI 10.2106/JBJS.I.01270
   Bedi Asheesh, 2009, HSS J, V5, P51, DOI 10.1007/s11420-008-9096-1
   Bellincampi LD, 1998, J ORTHOP RES, V16, P414, DOI 10.1002/jor.1100160404
   Berry CC, 2003, TISSUE ENG, V9, P613, DOI 10.1089/107632703768247313
   Berry CC, 2003, BIORHEOLOGY, V40, P337
   BOLTON CW, 1985, CLIN ORTHOP RELAT R, P202
   Bourke SL, 2004, TISSUE ENG, V10, P43, DOI 10.1089/107632704322791682
   Buma P, 2004, INT ORTHOP, V28, P91, DOI 10.1007/s00264-003-0515-0
   BUSS DD, 1993, J BONE JOINT SURG AM, V75A, P1346, DOI 10.2106/00004623-199309000-00009
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Cardwell RD, 2012, J TISSUE ENG REGEN M
   Caruso AB, 2005, J BIOMED MATER RES A, V73A, P388, DOI 10.1002/jbm.a.30233
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chung AS, 2012, J BIOMED MATER RES B, V100B, P274, DOI 10.1002/jbm.b.31950
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Cristino S, 2005, J BIOMED MATER RES A, V73A, P275, DOI 10.1002/jbm.a.30261
   Dagher E, 2009, CLIN ORTHOP RELAT R, V467, P281, DOI 10.1007/s11999-008-0512-0
   Darabos N, 2011, KNEE SURG SPORT TR A, V19, pS36, DOI 10.1007/s00167-011-1458-4
   Date H, 2010, J ORTHOP RES, V28, P225, DOI 10.1002/jor.20981
   Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700
   DESROSIERS EA, 1993, ANN CHIR, V47, P874
   DUNN MG, 1995, J BIOMED MATER RES, V29, P1363, DOI 10.1002/jbm.820291107
   Eagan MJ, 2012, J TISSUE ENG REGEN M, V6, P702, DOI 10.1002/term.474
   Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012
   Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048
   Fennema EM, 2009, ACTA ORTHOP, V80, P618, DOI 10.3109/17453670903278241
   FETTO JF, 1980, CLIN ORTHOP RELAT R, P29
   Fisher MB, 2012, KNEE SURG SPORT TR A, V20, P1357, DOI 10.1007/s00167-011-1800-x
   FLICKINGER KS, 1992, EXP CELL RES, V203, P466, DOI 10.1016/0014-4827(92)90022-Z
   FRANK C, 1983, AM J SPORT MED, V11, P379, DOI 10.1177/036354658301100602
   Freeman JW, 2007, J BIOMECH, V40, P2029, DOI 10.1016/j.jbiomech.2006.09.025
   Freeman JW, 2011, J BIOMECH, V44, P694, DOI 10.1016/j.jbiomech.2010.10.043
   Freeman JW, 2009, J BIOMAT SCI-POLYM E, V20, P1709, DOI 10.1163/156856208X386282
   Fu SC, 2012, KNEE SURG SPORT TR A, V26, P6857
   Fulzele S, 2010, J ORTHOP RES, V28, P1113, DOI 10.1002/jor.21112
   Garcia-Olmo D, 2009, INT J COLORECTAL DIS, V24, P27, DOI 10.1007/s00384-008-0559-0
   GIRGIS FG, 1975, CLIN ORTHOP RELAT R, P216
   Goulet F, 2011, PRINCIPLES TISSUE EN, P911
   Gudi SRP, 1998, AM J PHYSIOL-CELL PH, V274, pC1424, DOI 10.1152/ajpcell.1998.274.5.C1424
   Guidoin MF, 2000, BIOMATERIALS, V21, P2461, DOI 10.1016/S0142-9612(00)00114-9
   Haddad-Weber M, 2010, CYTOTHERAPY, V12, P505, DOI 10.3109/14653241003709652
   Hankemeier S, 2005, TISSUE ENG, V11, P41, DOI 10.1089/ten.2005.11.41
   Hansson A, 2012, CARBOHYD POLYM, V90, P1494, DOI 10.1016/j.carbpol.2012.07.020
   Harrison RD, 2005, J BIOMED MATER RES A, V75A, P841, DOI 10.1002/jbm.a.30486
   Hayami JWS, 2010, J BIOMED MATER RES A, V92A, P1407, DOI 10.1002/jbm.a.32472
   Hays PL, 2008, J BONE JOINT SURG AM, V90A, P565, DOI 10.2106/JBJS.F.00531
   HEFTI FL, 1991, J BONE JOINT SURG AM, V73A, P373, DOI 10.2106/00004623-199173030-00008
   Henshaw DR, 2006, J ORTHOP RES, V24, P481, DOI 10.1002/jor.20050
   Hildebrand KA, 1998, AM J SPORT MED, V26, P549, DOI 10.1177/03635465980260041401
   Hofstaetter JG, 2007, BBA-GEN SUBJECTS, V1770, P997, DOI 10.1016/j.bbagen.2007.02.006
   Horan Rebecca L, 2009, J Knee Surg, V22, P82
   JACKSON DW, 1993, AM J SPORT MED, V21, P176, DOI 10.1177/036354659302100203
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   James R, 2011, METHODS MOL BIOL, V726, P243, DOI 10.1007/978-1-61779-052-2_16
   Joshi SM, 2009, AM J SPORT MED, V37, P2401, DOI 10.1177/0363546509339915
   Juncosa-Melvin N, 2007, TISSUE ENG, V13, P1219, DOI 10.1089/ten.2006.0339
   Kaeding CC, 2011, SPORTS HEALTH, V3, P73, DOI 10.1177/1941738110386185
   Kawamura S, 2005, J ORTHOP RES, V23, P1425, DOI 10.1016/j.orthres.2005.01.014
   Kimura Y, 2008, TISSUE ENG PT C-METH, V14, P47, DOI 10.1089/tec.2007.0286
   Kobayashi D, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P189, DOI 10.1007/s001670050049
   Koob TJ, 2001, J BIOMED MATER RES, V56, P40, DOI 10.1002/1097-4636(200107)56:1<40::AID-JBM1066>3.3.CO;2-9
   Kreja L, 2012, J MATER SCI-MATER M, V23, P2575, DOI 10.1007/s10856-012-4710-7
   Langan P, 1987, Orthop Rev, V16, P317
   Larson RV, 1996, AAOS INSTR COURS LEC, V45, P235
   Laurencin CT, 2005, BIOMATERIALS, V26, P7530, DOI 10.1016/j.biomaterials.2005.05.073
   Laurent CP, 2012, J MECH BEHAV BIOMED, V12, P184, DOI 10.1016/j.jmbbm.2012.03.005
   Li F, 2007, KNEE SURG SPORT TR A, V15, P1219, DOI 10.1007/s00167-007-0385-x
   Li H, 2011, PLAST RECONSTR SURG, V128, P663, DOI 10.1097/PRS.0b013e318221db33
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lin VS, 1999, TISSUE ENG, V5, P443, DOI 10.1089/ten.1999.5.443
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   Ma JJ, 2012, TISSUE ENG PT A, V18, P103, DOI [10.1089/ten.tea.2011.0231, 10.1089/ten.TEA.2011.0231]
   Madry H, 2013, AM J SPORT MED, V41, P194, DOI 10.1177/0363546512465840
   Majima T, 2007, P I MECH ENG H, V221, P537, DOI 10.1243/09544119JEIM203
   Majima T, 2005, J ORTHOP SCI, V10, P302, DOI 10.1007/s00776-005-0891-y
   Marui T, 1997, J ORTHOPAED RES, V15, P18, DOI 10.1002/jor.1100150104
   Masuko T, 2005, BIOMATERIALS, V26, P5339, DOI 10.1016/j.biomaterials.2005.01.062
   Matava MJ, 2005, SPORTS MED, V5
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Millard SM, 2012, BIOESSAYS
   Mizutani N, 2013, J ARTIF ORGANS, V16, P49, DOI 10.1007/s10047-012-0665-1
   MODY BS, 1993, J BONE JOINT SURG BR, V75, P818
   Moreau JE, 2008, TISSUE ENG PT A, V14, P1161, DOI [10.1089/ten.tea.2007.0147, 10.1089/tea.2007.0147]
   Muller AM, 2010, EUR CELLS MATER, V19, P127
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Murray MM, 2007, J ORTHOP RES, V25, P1007, DOI 10.1002/jor.20367
   Murray MM, 2006, J ORTHOP RES, V24, P820, DOI 10.1002/jor.20073
   Murray MM, 2000, J ORTHOP RES, V18, P557, DOI 10.1002/jor.1100180407
   Murray MM, 2001, BIOMATERIALS, V22, P2393
   Murray MM, 2003, J ORTHOPAED RES, V21, P238, DOI 10.1016/S0736-0266(02)00142-0
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Palmer I, 2007, CLIN ORTHOP RELAT R, P17, DOI 10.1097/BLO.0b013e31802c7915
   Panas-Perez E, 2013, J MATER SCI-MATER M, V24, P257, DOI 10.1007/s10856-012-4781-5
   Park SA, 2006, J BIOSCI BIOENG, V102, P402, DOI 10.1263/jbb.102.402
   Pascher A, 2004, MOL THER, V10, P327, DOI 10.1016/j.ymthe.2004.03.012
   Peach MS, 2012, J BIOMED NANOTECHNOL, V8, P107, DOI 10.1166/jbn.2012.1368
   Pedicini A, 2003, POLYMER, V44, P6857, DOI 10.1016/j.polymer.2003.08.040
   Petrigliano FA, 2006, ARTHROSCOPY, V22, P441, DOI 10.1016/j.arthro.2006.01.017
   Petrigliano FA, 2007, TISSUE ENG, V13, P2721, DOI 10.1089/ten.2006.0434
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   RICHMOND JC, 1992, AM J SPORT MED, V20, P24, DOI 10.1177/036354659202000107
   Riggs JW, 2013, STEM CELLS DEV, V22, P37, DOI 10.1089/scd.2012.0375
   Ritchie JR, 1996, CLIN ORTHOP RELAT R, P65
   Robayo LM, 2011, WOUND REPAIR REGEN, V19, P38, DOI 10.1111/j.1524-475X.2010.00640.x
   Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2250, DOI 10.2106/JBJS.F.00409
   Sahoo S, 2010, DIFFERENTIATION, V79, P102, DOI 10.1016/j.diff.2009.11.001
   Savarese A, 1993, Ital J Orthop Traumatol, V19, P79
   Scherping SC, 1997, CONNECT TISSUE RES, V36, P1, DOI 10.3109/03008209709160209
   SCHMIDT CC, 1995, J ORTHOP RES, V13, P184, DOI 10.1002/jor.1100130206
   Seo YK, 2009, J ORTHOP RES, V27, P495, DOI 10.1002/jor.20752
   Shao HJ, 2010, BIOMATERIALS, V31, P4695, DOI 10.1016/j.biomaterials.2010.02.037
   Shao HJ, 2010, J BIOMED MATER RES A, V93A, P1297, DOI 10.1002/jbm.a.32629
   SIMONDS RJ, 1992, NEW ENGL J MED, V326, P726, DOI 10.1056/NEJM199203123261102
   Spalazzi JP, 2008, J BIOMED MATER RES A, V86A, P1, DOI 10.1002/jbm.a.32073
   Steinert AF, 2008, BIOMATERIALS, V29, P904, DOI 10.1016/j.biomaterials.2007.10.054
   Tempfer H, 2009, HISTOCHEM CELL BIOL, V131, P733, DOI 10.1007/s00418-009-0581-5
   Tischer T, 2007, ARCH ORTHOP TRAUM SU, V127, P735, DOI 10.1007/s00402-007-0320-0
   Tovar N, 2012, J BIOMED MATER RES A, V100A, P2913, DOI 10.1002/jbm.a.34229
   Tremblay P, 2011, CELL TRANSPLANT, V20, P535, DOI 10.3727/096368910X536482
   van Aalst JA, 2008, ANN PLAS SURG, V60, P577, DOI 10.1097/SAP.0b013e318168db3e
   Van Eijk F, 2004, TISSUE ENG, V10, P893, DOI 10.1089/1076327041348428
   Vavken P, 2010, J ORTHOP RES, V28, P1107, DOI 10.1002/jor.21111
   Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037
   Wada N, 2011, STEM CELLS DEV, V20, P647, DOI 10.1089/scd.2010.0246
   Walters VI, 2012, CONNECT TISSUE RES, V53, P255, DOI 10.3109/03008207.2011.634532
   WOO SLY, 1987, AM J SPORT MED, V15, P22, DOI 10.1177/036354658701500104
   WOO SLY, 1982, BIORHEOLOGY, V19, P397
   WOO SLY, 1991, AM J SPORT MED, V19, P217, DOI 10.1177/036354659101900303
   WOO SLY, 1987, J BONE JOINT SURG AM, V69A, P1200, DOI 10.2106/00004623-198769080-00014
   Woo SLY, 1999, AM J SPORT MED, V27, P533, DOI 10.1177/03635465990270042301
   Woo YK, 2007, J ORTHOP RES, V25, P73, DOI 10.1002/jor.20266
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Zantop T, 2006, KNEE SURG SPORT TR A, V14, P982, DOI 10.1007/s00167-006-0076-z
   Zhang GC, 2012, STEM CELLS DEV, V21, P955, DOI 10.1089/scd.2011.0649
   Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135
NR 141
TC 44
Z9 46
U1 9
U2 78
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2014
VL 102
IS 5
BP 1614
EP 1624
DI 10.1002/jbm.a.34820
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD4JB
UT WOS:000333215600042
PM 23737190
DA 2018-10-20
ER

PT J
AU Song, J
   Cheng, HX
   Shen, XY
   Hu, JX
   Tong, H
AF Song, Juan
   Cheng, Haixia
   Shen, Xinyu
   Hu, Jingxiao
   Tong, Hua
TI Characterization of calcium carbonate crystals in pigeon yolk sacs with
   different incubation times
SO MICRON
LA English
DT Article
DE Biomineralization; Pigeon; Yolk sac; Calcium carbonate; Vaterite
ID ARAGONITE; CHICK; BIOMINERALIZATION; VATERITE; MINERALIZATION;
   MORPHOLOGIES; PATHWAYS; PROTEINS; EGGSHELL; EMBRYOS
AB Calcium carbonate crystals are known to form in the yolk sacs of fertile pigeon eggs at late stages of incubation. The composition and structure of these crystals were investigated, the crystallization environment was inspected, and the physical chemistry constants of the yolk fluid were determined through the incubation period. Polarized light microscopy was used to observe the generation and distribution of calcium carbonate crystals in the yolk sac. In addition, X-ray diffraction was employed to analyze the composition and crystal phase of the yolk sac. A decalcification and deproteination method was established to analyze the ultrastructure and composition of the crystals, as well as the internal relationship between inorganic and organic phases of the crystals. Additionally, scanning electron microscopy, transmission electron microscopy, X-ray energy dispersive spectroscopy, and Fourier transform infrared spectroscopy were used to evaluate the characteristics of the crystals. Our results demonstrated that the calcium carbonate crystals were mainly composed of vaterite and calcite, with vaterite being the major component. Vaterite, a type of biomaterial generated by an organic template control, presented as a concentric hierarchical spherical structure. The organic nature of the biomaterial prevented vaterite from transforming into calcite, which is more thermodynamically stable than vaterite. Additionally, the configuration, size, and aggregation of vaterite were also mediated by the organic template. This bio-vaterite was found during the incubation period and is valuable in calcium transport during embryonic development. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Song, Juan; Cheng, Haixia; Shen, Xinyu; Hu, Jingxiao; Tong, Hua] Wuhan Univ, Coll Chem & Mol Sci, Key Lab Analyt Chem Biol & Med, Minist Educ, Wuhan 430072, Peoples R China.
   [Song, Juan] Hubei Univ Technol, Analyt & Testing Ctr, Wuhan 430068, Peoples R China.
RP Tong, H (reprint author), Wuhan Univ, Coll Chem & Mol Sci, Key Lab Analyt Chem Biol & Med, Minist Educ, Wuhan 430072, Peoples R China.
EM huatong09@126.com
FU National Natural Science Foundation of China [31071265]
FX Financial support of this research was received from the National
   Natural Science Foundation of China (31071265) (to H. Tong)
CR ADLER HH, 1962, AM MINERAL, V47, P700
   Arias J.L., 2007, BIOMINERALIZATION PA
   Arias JL, 2003, MATER CHARACT, V50, P189, DOI 10.1016/S1044-5803(03)00088-3
   BEHRENS P, 2007, HDB BIOMINERALIZATIO
   Bentov S, 2010, J STRUCT BIOL, V171, P207, DOI 10.1016/j.jsb.2010.04.007
   CHEVILLE N, 1984, AM J VET RES, V45, P2458
   CORRADINO RA, 1973, J CELL BIOL, V58, P64, DOI 10.1083/jcb.58.1.64
   Dauphin Y., 2006, ZOOLOGY, V109, P95
   Faatz M, 2005, MAT SCI ENG C-BIO S, V25, P153, DOI 10.1016/j.msec.2005.01.005
   Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67
   Gago-Duport L, 2008, J STRUCT BIOL, V162, P422, DOI 10.1016/j.jsb.2008.02.007
   Gautron J, 1997, CONNECT TISSUE RES, V36, P195, DOI 10.3109/03008209709160220
   Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548
   HART LE, 1992, J COMP PHYSIOL B, V162, P535
   He HP, 1978, J WUHAN U NATURE SCI, V4, P32
   HINCKE MT, 1992, BRIT POULTRY SCI, V33, P505, DOI NO_DOI
   JUURLINK BH, 1973, CAN J ZOOL, V51, P509, DOI 10.1139/z73-076
   Killian C.E., 2008, CHEM REV, V11, P4463
   Kuther J, 1998, J MATER CHEM, V8, P641, DOI 10.1039/a705859d
   Lowenstam HA, 1989, BIOMINERALIZATION
   Lu X.F., 1999, J CAP NORM U NAT SCI, V3, P66
   Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015
   Mann S, 2001, BIOMINERALIZATION PR, P198
   Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856
   MOBBS IG, 1981, AM J ANAT, V160, P285, DOI 10.1002/aja.1001600307
   Nudelman F, 2006, J STRUCT BIOL, V153, P176, DOI 10.1016/j.jsb.2005.09.009
   ONO T, 1991, DEV BIOL, V144, P167, DOI 10.1016/0012-1606(91)90488-O
   Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028
   Sethmann I, 2008, MICRON, V39, P209, DOI 10.1016/j.micron.2007.01.006
   Shepherd N., 2007, AM J PHYSIOL-CELL PH, V292C, P1942
   Soldati AL, 2008, MINERAL MAG, V72, P579, DOI 10.1180/minmag.2008.072.2.579
   Song SM, 2011, KOREAN J CHEM ENG, V28, P1749, DOI 10.1007/s11814-011-0022-8
   Spanos N, 1998, J CRYST GROWTH, V191, P783, DOI 10.1016/S0022-0248(98)00385-6
   Takahashi K, 2004, CHEM COMMUN, P996, DOI 10.1039/b315478e
   Tang RK, 2004, ANGEW CHEM INT EDIT, V43, P2697, DOI 10.1002/anie.200353652
   TOWE KM, 1967, J ULTRA MOL STRUCT R, V17, P1, DOI 10.1016/S0022-5320(67)80015-7
   Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001
   WILBUR KM, 1963, ANN NY ACAD SCI, V109, P82, DOI 10.1111/j.1749-6632.1963.tb13463.x
   Yadgary L, 2010, POULTRY SCI, V89, P2441, DOI 10.3382/ps.2010-00681
   Yu JG, 2004, J SOLID STATE CHEM, V177, P681, DOI 10.1016/j.jssc.2003.08.017
   Zhou GT, 2004, NEW J CHEM, V28, P1027, DOI 10.1039/b315198k
NR 41
TC 3
Z9 4
U1 1
U2 36
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD MAY
PY 2014
VL 60
BP 39
EP 48
DI 10.1016/j.micron.2014.01.003
PG 10
WC Microscopy
SC Microscopy
GA AE2DD
UT WOS:000333782600005
PM 24602270
DA 2018-10-20
ER

PT J
AU Ngai, TL
   Lu, L
   Chen, JB
   Zhang, JH
   Li, YY
AF Ngai, Tungwai Leo
   Lu, Lu
   Chen, Jingbao
   Zhang, Junhong
   Li, Yuanyuan
TI Preparation of SiC reinforced Ti3SiC2-base composite and its
   biocompatibility evaluation
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Ti3SiC2; Biomedical applications; Composite; Powders-solid state
   reaction; SiC
ID HIGH-PURITY TI3SIC2; ELEMENTAL POWDERS; RAPID SYNTHESIS; SINTERING
   TECHNIQUE; LIQUID REACTION; POROUS TI3SIC2; DENSE TI3SIC2; TEMPERATURE;
   CARBIDE; FABRICATION
AB Soft Ti3SiC2 ceramic is a new class of potential biomaterial for orthopaedic applications and dental implants. Introducing SiC into Ti3SiC2 can compensate for the relatively low hardness of the Ti3SiC2 implants. In this study, SiC reinforced Ti3SiC2-base composites were fabricated by reactive sintering of powder compacts. Mechanical properties and phase constitution of the prepared samples were studied. Biocompatibility of the composite was evaluated by implanting the material onto the shaft surface of the femur of a rabbit, while, biostability was studied by immersing the material into human blood plasma and also into a simulated body fluid (Hank's) for prolonged time. (C) 2013 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Ngai, Tungwai Leo; Lu, Lu; Zhang, Junhong; Li, Yuanyuan] S China Univ Technol, Natl Engn Res Ctr Near Net Shape Forming Metall M, Guangzhou, Guangdong, Peoples R China.
   [Chen, Jingbao] Guangdong Prov Hosp Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China.
RP Ngai, TL (reprint author), S China Univ Technol, Natl Engn Res Ctr Near Net Shape Forming Metall M, Guangzhou, Guangdong, Peoples R China.
EM dhni@scut.edu.cn
FU National Natural Science Foundation of China [51074077, 50774036];
   Guangdong Provincial Natural Science Foundation [8151064101000029]
FX The work was supported by National Natural Science Foundation of China
   (Grant no. 51074077 and Grant no. 50774036) and also by Guangdong
   Provincial Natural Science Foundation (Grant no. 8151064101000029).
CR Barsoum MW, 2000, PROG SOLID STATE CH, V28, P201, DOI 10.1016/S0079-6786(00)00006-6
   Barsoum MW, 2003, NAT MATER, V2, P107, DOI 10.1038/nmat814
   Barsoum MW, 1997, SCRIPTA MATER, V36, P535, DOI 10.1016/S1359-6462(96)00418-6
   Barsoum MW, 1999, METALL MATER TRANS A, V30, P363, DOI 10.1007/s11661-999-0325-0
   Barsoum MW, 1996, J AM CERAM SOC, V79, P1953, DOI 10.1111/j.1151-2916.1996.tb08018.x
   Daculsi G., 2004, MICROMACROPOROUS CAL, P117
   Fraczkiewicz M, 2006, ACTA MATER, V54, P5261, DOI 10.1016/j.actamat.2006.06.052
   Gao NF, 2002, J EUR CERAM SOC, V22, P2365, DOI 10.1016/S0955-2219(02)00021-3
   Gao NF, 1999, J MATER SCI, V34, P4385, DOI 10.1023/A:1004664500254
   Gao NF, 2002, J MATER SCI LETT, V21, P783, DOI 10.1023/A:1015753826417
   Hwang SS, 2005, J ALLOY COMPD, V392, P285, DOI 10.1016/j.jallcom.2004.08.089
   JEITSCHKO W, 1967, MONATSH CHEM, V98, P329, DOI 10.1007/BF00899949
   Kuang YH, 2009, MATER SCI FORUM, V610-613, P1263, DOI 10.4028/www.scientific.net/MSF.610-613.1263
   Li H, 2004, CERAM INT, V30, P2289, DOI 10.1016/j.ceramint.2004.01.009
   Li H, 2004, MATER LETT, V58, P1741, DOI 10.1016/j.matlet.2003.10.057
   Li SB, 2005, MAT SCI ENG A-STRUCT, V407, P315, DOI 10.1016/j.msea.2005.07.043
   Li XD, 2005, J BIOMED MATER RES B, V72B, P353, DOI 10.1002/jbm.b.30168
   Liang BY, 2008, J ALLOY COMPD, V460, P440, DOI 10.1016/j.jallcom.2007.05.074
   Lis J, 1997, SOLID STATE IONICS, V101, P59, DOI 10.1016/S0167-2738(97)84009-X
   LIS J, 1993, CERAM INT, V19, P219, DOI 10.1016/0272-8842(93)90052-S
   MOROZUMI S, 1985, J MATER SCI, V20, P3976, DOI 10.1007/BF00552387
   Ngai TL, 2012, CERAM INT, V38, P463, DOI 10.1016/j.ceramint.2011.07.028
   Orthner HR, 2002, MAT SCI ENG A-STRUCT, V336, P202, DOI 10.1016/S0921-5093(01)01963-3
   Poon B, 2011, J MECH PHYS SOLIDS, V59, P2238, DOI 10.1016/j.jmps.2011.03.012
   Radhakrishnan R, 1999, J ALLOY COMPD, V285, P85, DOI 10.1016/S0925-8388(99)00003-1
   Sun ZM, 1999, SCRIPTA MATER, V41, P61
   Sun ZM, 2005, ACTA MATER, V53, P4359, DOI 10.1016/j.actamat.2005.05.034
   Tang K, 2001, J EUR CERAM SOC, V21, P617, DOI 10.1016/S0955-2219(00)00246-6
   Villars P., 1997, HDB TERNARY ALLOY PH
   Zhang JF, 2007, J ALLOY COMPD, V437, P203, DOI 10.1016/j.jallcom.2006.07.059
   Zhang ZF, 2002, J EUR CERAM SOC, V22, P2957, DOI 10.1016/S0955-2219(02)00044-4
   Zhang ZF, 2001, SCRIPTA MATER, V45, P1461, DOI 10.1016/S1359-6462(01)01184-8
   Zhang ZF, 2002, METALL MATER TRANS A, V33, P3321, DOI 10.1007/s11661-002-0320-1
   Zhou WB, 2005, MATER LETT, V59, P1547, DOI 10.1016/j.matlet.2005.01.019
   Zou Y, 2008, CERAM INT, V34, P119, DOI 10.1016/j.ceramint.2006.08.010
   Zou Y, 2007, J ALLOY COMPD, V441, P192, DOI 10.1016/j.jallcom.2006.08.342
NR 36
TC 5
Z9 5
U1 1
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAY
PY 2014
VL 40
IS 4
BP 5343
EP 5348
DI 10.1016/j.ceramint.2013.10.113
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA AC1PJ
UT WOS:000332268200033
DA 2018-10-20
ER

PT J
AU Shen, Y
   Fu, Y
   Wang, J
   Li, G
   Zhang, X
   Xu, YZ
   Lin, YF
AF Shen, Yun
   Fu, Yao
   Wang, Jing
   Li, Guo
   Zhang, Xu
   Xu, Yuanzhi
   Lin, Yunfeng
TI Biomaterial and Mesenchymal Stem Cell for Articular Cartilage
   Reconstruction
SO CURRENT STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Articular cartilage; chondrogenic differentiation; hypertrophy;
   mesenchymal stem cells; regenerative medicine; tissue engineering
ID GROWTH-FACTOR-BETA; HUMAN BONE-MARROW; HUMAN ADIPOSE-TISSUE; AUTOLOGOUS
   OSTEOCHONDRAL MOSAICPLASTY; HUMAN OSTEOGENIC PROTEIN-1; IN-VITRO
   CHONDROGENESIS; SIGNALING CROSS-TALK; UMBILICAL-CORD BLOOD;
   AGE-RELATED-CHANGES; STROMAL CELLS
AB Cartilage has poor ability of spontaneous repair. Traditional treatments such as microfracture, bone drilling and autologous osteochondral graft were not fully satisfactory to fulfill the clinical needs. The idea of mesenchymal stem cell (MSCs-based cartilage regeneration has been put forward for decades. Large number of studies have been conducted on the biological properties of MSCs, the factors which might facilitate chondrogenic differentiation of MSCs, as well as the scaffold materials for tissue engineering. Promising results have been reported for cartilage repair in animal models. But before massive clinical application of MSCs, more efforts are needed on: differentiation improvement toward mature cartilage chondrocytes instead of hypertrophic chondrocyes and in vitro/in vivo phenotype maintenance; engineering an ideal biomaterial, which can meet the needs of the cartilage regeneration; and performing more studies on critical defects of large animals.
C1 [Shen, Yun; Wang, Jing; Zhang, Xu; Xu, Yuanzhi] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Stomatol, Shanghai 200072, Peoples R China.
   [Fu, Yao; Li, Guo; Lin, Yunfeng] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Sichuan Provinc, Peoples R China.
RP Xu, YZ (reprint author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Stomatol, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.
EM amyxyz01@hotmail.com; yunfenglin@scu.edu.cn
RI Fu, Yao/M-1937-2018; Lin, Yunfeng/H-3393-2011; Lin, Yunfeng/M-5438-2013
OI Fu, Yao/0000-0001-7571-8699; Lin, Yunfeng/0000-0003-1224-6561; Lin,
   Yunfeng/0000-0003-1224-6561
FU National Natural Science Foundation of China [31170929]; Doctoral Fund
   of Ministry of Education of China [20130181110012]
FX This work was funded by National Natural Science Foundation of China
   (31170929), Doctoral Fund of Ministry of Education of China
   (20130181110012).
CR Abulencia JP, 2003, J BIOL CHEM, V278, P28388, DOI 10.1074/jbc.M301378200
   Agung M, 2006, KNEE SURG SPORT TR A, V14, P1307, DOI 10.1007/s00167-006-0124-8
   Alfaro MP, 2010, J BIOL CHEM, V285, P35645, DOI 10.1074/jbc.M110.135335
   Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105
   da Silva MLA, 2010, BIOMACROMOLECULES, V11, P3228, DOI 10.1021/bm100476r
   An CH, 2010, ANN BIOMED ENG, V38, P1647, DOI 10.1007/s10439-009-9892-x
   Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181
   Archer Charles W., 2003, Birth Defects Research, V69, P144, DOI 10.1002/bdrc.10015
   Atoui R, 2008, ANN THORAC SURG, V86, P327, DOI 10.1016/j.athoracsur.2008.03.038
   Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Bai XD, 2011, MED BIOL ENG COMPUT, V49, P687, DOI 10.1007/s11517-010-0729-4
   Barcellos-Hoff MH, 2005, SEMIN CANCER BIOL, V15, P138, DOI 10.1016/j.semcancer.2004.08.010
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bartha L, 2006, J ORTHOP SPORT PHYS, V36, P739, DOI 10.2519/jospt.2006.2182
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bertram H, 2009, STEM CELLS DEV, V18, P881, DOI 10.1089/scd.2008.0306
   Brian EG, 2013, CELLS BONE RES, V2013, P12
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc
   Callahan LA, 2013, ACTA BIOMATER
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   Caterson EJ, 2001, J BIOMED MATER RES, V57, P394, DOI 10.1002/1097-4636(20011205)57:3<394::AID-JBM1182>3.0.CO;2-9
   Chang CH, 2011, J ORTHOP RES, V29, P1874, DOI 10.1002/jor.21461
   Chen GP, 2004, BIOCHEM BIOPH RES CO, V322, P50, DOI 10.1016/j.bbrc.2004.07.071
   Cheng NC, 2013, TISSUE ENG PT A, V19, P484, DOI [10.1089/ten.tea.2012.0384, 10.1089/ten.TEA.2012.0384]
   Choi S, 2013, INT J ORAL SCI, V5, P7, DOI 10.1038/ijos.2013.19
   Chubinskaya S, 2002, BBA-MOL BASIS DIS, V1588, P126, DOI 10.1016/S0925-4439(02)00158-8
   Chubinskaya Susan, 2008, J Knee Surg, V21, P192
   Coates EE, 2012, J BIOMED MAT RES A
   Coleman CM, 2013, STEM CELLS DEV
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Davatchi F, 2011, INT J RHEUM DIS, V14, P211, DOI 10.1111/j.1756-185X.2011.01599.x
   de la Cruz-Merino L, 2009, CLIN TRANSL ONCOL, V11, P715, DOI 10.1007/s12094-009-0433-8
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   Deutsch D, 2011, EUR J ORAL SCI, V119, P55, DOI 10.1111/j.1600-0722.2011.00861.x
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Estes BT, 2004, CURR TOP DEV BIOL, V60, P91
   Fan Z, 2004, CLIN EXP RHEUMATOL, V22, P103
   Farrell E, 2009, TISSUE ENG PART C-ME, V15, P285, DOI 10.1089/ten.tec.2008.0297
   Feng G, 2008, GROWTH FACTORS, V26, P132, DOI 10.1080/08977190802105917
   Festy F, 2005, HISTOCHEM CELL BIOL, V124, P113, DOI 10.1007/s00418-005-0014-z
   Fitzgerald JB, 2008, J BIOL CHEM, V283, P6735, DOI 10.1074/jbc.M708670200
   Flechtenmacher J, 1996, ARTHRITIS RHEUM-US, V39, P1896, DOI 10.1002/art.1780391117
   Fortier LA, 2002, J BONE JOINT SURG BR, V84B, P276, DOI 10.1302/0301-620X.84B2.11167
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8
   Gawlitta D, 2012, TISSUE ENG PT A, V18, P1957, DOI [10.1089/ten.TEA.2011.0657, 10.1089/ten.tea.2011.0657]
   Ge ZG, 2006, ARTHRIT RHEUM-ARTHR, V55, P493, DOI 10.1002/art.21994
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gemmiti CV, 2006, TISSUE ENG, V12, P469, DOI 10.1089/ten.2006.12.469
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Grad S, 2003, BIOMATERIALS, V24, P5163, DOI 10.1016/S0142-9612(03)00462-9
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Grottkau BE, 2013, BONE RES, V1, P282, DOI 10.4248/BR201303006
   Guimont P, 2007, AM J PHYSIOL-CELL PH, V293, pC172, DOI 10.1152/ajpcell.00349.2006
   Hagmann S, 2013, CELL PROLIFERAT, V46, P396, DOI 10.1111/cpr.12046
   Hangody L, 2008, INJURY, V39, pS32, DOI 10.1016/j.injury.2008.01.041
   Harris DT, 2008, STEM CELL REV, V4, P269, DOI 10.1007/s12015-008-9039-8
   Hatakeyama Y, 2004, J CELL BIOCHEM, V91, P1204, DOI 10.1002/jcb.20019
   Havlas V, 2011, ACTA CHIR ORTHOP TR, V78, P138
   Hayes AJ, 2001, ANAT EMBRYOL, V203, P469, DOI 10.1007/s004290100178
   Hayes AJ, 2008, J HISTOCHEM CYTOCHEM, V56, P125, DOI 10.1369/jhc.7A7320.20071
   Hellingman CA, 2011, TISSUE ENG PT A, V17, P1157, DOI [10.1089/ten.tea.2010.0043, 10.1089/ten.TEA.2010.0043]
   Hoffman AS, 2001, ANN NY ACAD SCI, V944, P62
   HOLDER N, 1977, J EMBRYOL EXP MORPH, V39, P115
   Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251
   Honda M, 2000, J ORAL MAXIL SURG, V58, P767, DOI 10.1053/joms.2000.7262
   Hu MY, 2013, BONE RES, V1, DOI 10.4248/BR201301007
   Hu XH, 2009, MACROMOL BIOSCI, V9, P1194, DOI 10.1002/mabi.200900275
   Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998
   Huch K, 1997, ARTHRITIS RHEUM, V40, P2157, DOI 10.1002/art.1780401209
   Hunziker EB, 2007, OSTEOARTHR CARTILAGE, V15, P403, DOI 10.1016/j.joca.2006.09.010
   Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ichinose S, 2005, CELL TISSUE RES, V322, P217, DOI 10.1007/s00441-005-1140-6
   Iwasaki N, 2007, AM J SPORT MED, V35, P2096, DOI 10.1177/0363546507306465
   Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272
   Izuta Y, 2005, KNEE, V12, P217, DOI 10.1016/j.knee.2001.06.001
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446
   Kannan RY, 2006, J BIOMATER APPL, V21, P5, DOI 10.1177/0885328206065728
   Karagiannides I, 2001, AM J PHYSIOL-REG I, V280, pR1772
   Kawakami Y, 2006, CURR OPIN CELL BIOL, V18, P723, DOI 10.1016/j.ceb.2006.10.007
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Khalil S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128729
   Kim M, 2012, BIOMACROMOLECULES, V13, P2287, DOI 10.1021/bm3005353
   Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   King JA, 1996, ANN NY ACAD SCI, V785, P70, DOI 10.1111/j.1749-6632.1996.tb56245.x
   Klein TJ, 2003, OSTEOARTHR CARTILAGE, V11, P595, DOI 10.1016/S1063-4584(03)00090-6
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Koepp HE, 1999, INFLAMM RES, V48, P199, DOI 10.1007/s000110050446
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Kou I, 2004, J BIOL CHEM, V279, P50942, DOI 10.1074/jbc.M406786200
   Kundu J, 2013, J TISSUE ENG REGEN M
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le Roith D, 2001, TRENDS ENDOCRIN MET, V12, P48
   Lee CCI, 2006, STEM CELLS DEV, V15, P209, DOI 10.1089/scd.2006.15.209
   Lee J, 2008, BIOMATERIALS, V29, P1872, DOI 10.1016/j.biomaterials.2007.12.029
   Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311
   Lee KBL, 2012, ANN ACAD MED SINGAP, V41, P511
   Lee YH, 2011, GENESIS, V49, P200, DOI 10.1002/dvg.20717
   Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137
   Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Liu CX, 2012, BIOMATERIALS, V33, P1052, DOI 10.1016/j.biomaterials.2011.10.041
   Liu X, 2012, INT J MOL MED
   Loeser RF, 2003, ARTHRITIS RHEUM, V48, P2188, DOI 10.1002/art.11209
   Longobardi L, 2006, J BONE MINER RES, V21, P626, DOI 10.1359/JBMR.051213
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Madonna R, 2011, EUR J CLIN INVEST, V41, P126, DOI 10.1111/j.1365-2362.2010.02384.x
   Madonna R, 2009, ARTERIOSCL THROM VAS, V29, P1723, DOI 10.1161/ATVBAHA.109.187179
   Maniwa S, 2001, ACTA ORTHOP SCAND, V72, P299, DOI 10.1080/00016470152846664
   Mankin H J, 1964, Clin Orthop Relat Res, V34, P170
   MANKIN HJ, 1964, LAB INVEST, V13, P465
   Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681
   Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McCoy RJ, 2010, TISSUE ENG PART B-RE, V16, P587, DOI [10.1089/ten.teb.2010.0370, 10.1089/ten.TEB.2010.0370]
   Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932
   Minas T, 1999, Instr Course Lect, V48, P629
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414
   MITROVIC D, 1978, AM J ANAT, V151, P475, DOI 10.1002/aja.1001510403
   Miyakoshi N, 2005, ARCH ORTHOP TRAUM SU, V125, P683, DOI 10.1007/s00402-005-0052-y
   Miyamoto C, 2007, J ORTHOP SCI, V12, P555, DOI 10.1007/s00776-007-1176-4
   Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009
   Mohan N, 2009, J MATER SCI-MATER M, V20, P49, DOI 10.1007/s10856-008-3481-7
   Mosna F, 2010, STEM CELLS DEV, V19, P1449, DOI 10.1089/scd.2010.0140
   Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370
   Mueller MB, 2013, INT ORTHOP, V37, P945, DOI 10.1007/s00264-013-1800-1
   Mukherjee N, 2001, J ORTHOPAED RES, V19, P524, DOI 10.1016/S0736-0266(00)00045-0
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   Nishida Y, 2004, OSTEOARTHR CARTILAGE, V12, P374, DOI 10.1016/j.joca.2004.01.008
   Nishida Y, 2000, ARTHRITIS RHEUM, V43, P206, DOI 10.1002/1529-0131(200001)43:1<206::AID-ANR25>3.0.CO;2-1
   Nixon AJ, 1999, J ORTHOPAED RES, V17, P475, DOI 10.1002/jor.1100170404
   Nochi H, 2004, J BONE MINER RES, V19, P111, DOI 10.1359/jbmr.2004.19.1.111
   Ogawa T, 2010, J BIOMAT SCI-POLYM E, V21, P609, DOI 10.1163/156856209X434638
   Okada-Ban M, 1999, ONCOGENE, V18, P6719, DOI 10.1038/sj.onc.1203092
   OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3
   Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7
   Pachon-Pena G, 2011, J CELL PHYSIOL, V226, P843, DOI 10.1002/jcp.22408
   Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010
   Panepucci RA, 2004, STEM CELLS, V22, P1263, DOI 10.1634/stemcells.2004-0024
   Park KH, 2008, J BIOSCI BIOENG, V106, P74, DOI 10.1263/jbb.106.74
   Pelaia G, 2007, J CELL PHYSIOL, V210, P489, DOI 10.1002/jcp.20884
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Pountos I, 2010, J ORTHOP TRAUMA, V24, P552, DOI 10.1097/BOT.0b013e3181efa8fe
   Pozzobon M, 2010, PEDIATR SURG INT, V26, P3, DOI 10.1007/s00383-009-2478-8
   Qi MC, 2009, INT J ORAL SCI, V1, P143, DOI 10.4248/IJOS.09021
   Qi YY, 2012, MOL BIOL REP, V39, P1231, DOI 10.1007/s11033-011-0853-8
   Ramasamy R, 2012, CELL PROLIFERAT, V45, P132, DOI 10.1111/j.1365-2184.2012.00808.x
   Rampichova M, 2013, CELL PROLIFERAT, V46, P23, DOI 10.1111/cpr.12001
   Reiss M, 1999, MICROBES INFECT, V1, P1327, DOI 10.1016/S1286-4579(99)00251-8
   Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Saad B, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00775
   Saad B, 1999, INT J BIOL MACROMOL, V25, P293, DOI 10.1016/S0141-8130(99)00044-6
   Sahar DE, 2005, DEV BIOL, V280, P344, DOI 10.1016/j.ydbio.2005.01.022
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Schulz RM, 2007, EUR BIOPHYS J BIOPHY, V36, P539, DOI 10.1007/s00249-007-0139-1
   Shafiee A, 2011, J BIOMED MATER RES A, V99A, P467, DOI 10.1002/jbm.a.33206
   Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118
   Sharma B, 2007, TISSUE ENG, V13, P405, DOI 10.1089/ten.2006.0068
   Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076
   Sheehy EJ, 2012, BIOCHEM BIOPH RES CO, V417, P305, DOI 10.1016/j.bbrc.2011.11.105
   Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412
   Shen G, 2005, Orthod Craniofac Res, V8, P11, DOI 10.1111/j.1601-6343.2004.00308.x
   Shibata S, 2003, J ANAT, V203, P425, DOI 10.1046/j.1469-7580.2003.00226.x
   Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5
   Shim JH, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034102
   Siebert CH, 2003, ARTHROSCOPY, V19, P182, DOI 10.1053/jars.2003.50000
   Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100
   Silva MMCG, 2006, BIOMATERIALS, V27, P5909, DOI 10.1016/j.biomaterials.2006.08.010
   Song SH, 2000, P NATL ACAD SCI USA, V97, P8658, DOI 10.1073/pnas.140210697
   Steadman J Richard, 2002, J Knee Surg, V15, P170
   Steadman JR, 2003, J KNEE SURG, V16, P83
   Steinert A, 2003, J ORTHOPAED RES, V21, P1090, DOI 10.1016/S0736-0266(03)00100-1
   Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064
   Stewart AA, 2007, AM J VET RES, V68, P941, DOI 10.2460/ajvr.68.9.941
   Strem BM, 2005, TRENDS BIOTECHNOL, V23, P64, DOI 10.1016/j.tibtech.2004.12.003
   Tagil M, 1999, J ORTHOPAED RES, V17, P200, DOI 10.1002/jor.1100170208
   Tatebe M, 2005, CYTOTHERAPY, V7, P520, DOI 10.1080/14653240500361350
   Thorpe SD, 2010, ANN BIOMED ENG, V38, P2896, DOI 10.1007/s10439-010-0059-6
   Tsai CL, 2002, ARTIF ORGANS, V26, P18, DOI 10.1046/j.1525-1594.2002.06732.x
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Tuxhorn JA, 2002, CANCER RES, V62, P6021
   Lopez MAV, 2011, STEM CELLS DEV, V20, P1011, DOI 10.1089/scd.2010.0355
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Wakitani S, 2003, RHEUMATOLOGY, V42, P162, DOI 10.1093/rheumatology/keg024
   Wang W, 2010, BIOMATERIALS, V31, P8964, DOI 10.1016/j.biomaterials.2010.08.018
   Weber M, 2002, BIOMATERIALS, V23, P2003, DOI 10.1016/S0142-9612(01)00329-5
   Ween MP, 2012, INT J MOL SCI, V13, P10461, DOI 10.3390/ijms130810461
   Weiss S, 2010, J CELL PHYSIOL, V223, P84, DOI 10.1002/jcp.22013
   Welt C, 2002, EXP BIOL MED, V227, P724
   Wescoe KE, 2008, CELL BIOCHEM BIOPHYS, V52, P85, DOI 10.1007/s12013-008-9029-0
   Wilke MM, 2007, J ORTHOP RES, V25, P913, DOI 10.1002/jor.20382
   WOODRUFF TK, 1995, ANNU REV PHYSIOL, V57, P219
   Yamasaki T, 2005, J BIOMED MATER RES A, V75A, P23, DOI 10.1002/jbm.a.30369
   Yang YQ, 2012, INT J ORAL SCI, V4, P64, DOI 10.1038/ijos.2012.33
   Yokoo N, 2005, ARTHRITIS RHEUM, V52, P164, DOI 10.1002/art.20739
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Yoon DM, 2008, TISSUE ENG PT A, V14, P1263, DOI 10.1089/ten.tea.2007.0172
   Yoon DM, 2006, ADV EXP MED BIOL, V585, P67
   Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z
   Yoshioka M, 1997, OSTEOARTHR CARTILAGE, V5, P251, DOI 10.1016/S1063-4584(97)80021-0
   Yue B, 2005, CALCIFIED TISSUE INT, V77, P395, DOI 10.1007/s00223-005-0180-y
   Zhang X, 2011, J CELL BIOCHEM, V112, P1206, DOI 10.1002/jcb.23042
   Zhuo YF, 2010, J THORAC CARDIOV SUR, V139, P1286, DOI 10.1016/j.jtcvs.2009.08.052
   Zscharnack M, 2009, CELLS TISSUES ORGANS, V190, P81, DOI 10.1159/000178024
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JC134174
NR 224
TC 7
Z9 8
U1 0
U2 45
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1574-888X
EI 2212-3946
J9 CURR STEM CELL RES T
JI Curr. Stem Cell Res. Ther.
PD MAY
PY 2014
VL 9
IS 3
BP 254
EP 267
DI 10.2174/1574888X09666140213202700
PG 14
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA AD0QQ
UT WOS:000332939600012
PM 24524788
DA 2018-10-20
ER

PT J
AU Zeglinski, J
   Nolan, M
   Thompson, D
   Tofail, SAM
AF Zeglinski, Jacek
   Nolan, Michael
   Thompson, Damien
   Tofail, Syed A. M.
TI Reassigning the most stable surface of hydroxyapatite to the water
   resistant hydroxyl terminated (010) surface
SO SURFACE SCIENCE
LA English
DT Article
DE Biomaterial nanostructure; Hydroxyapatite; Implant biocompatibility;
   Surface structure; Surface wetting; Density functional theory
ID MOLECULAR-DYNAMICS SIMULATION; GLYCINE ADSORPTION; B3LYP; INTERFACES;
   PROTEIN
AB Understanding the surface stability and crystal growth morphology of hydroxyapatite is important to comprehend bone growth and repair processes and to engineer protein adsorption, cellular adhesion and biomineralization on calcium phosphate based bone grafts and implant coatings. It has generally been assumed from electronic structure calculations that the most stable hydroxyapatite surface is the (001) surface, terminated just above hydroxyl ions perpendicular to the (001) crystal plane. However, this is inconsistent with the known preferential growth direction of hydroxyapatite crystals and previous experimental work which indicates that, contrary to currently accepted theoretical predictions, it is actually the (010) surface that is preferentially exposed. The surface structure of the (010) face is still debated and needs reconciliation. In this work, we use a large set of density functional theory calculations to model the interaction of water with hydroxyapatite surfaces and probe the surface stability and resistance to hydrolytic remodeling of a range of surface faces including the (001) surface and the phosphate-exposed, calcium-exposed, and hydroxyl-exposed terminations of the (010) surface. For the (001) surface and the phosphate-exposed (010) surface, dissociative water adsorption is favorable. In contrast, the hydroxyl-terminated (010) surface will not split water and only molecular adsorption of water is possible. Our calculations show, overall, that the hydroxyl-terminated (010) surface is the most stable and thus should be the predominant form of the hydroxyapatite surface exposed in experiments. This finding reconciles discrepancies between the currently proposed surface terminations of hydroxyapatite and the experimentally observed crystal growth direction and surface stability, which may aid efforts to accelerate biomineralization and better control bone-repair processes on hydroxyapatite surfaces. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zeglinski, Jacek; Tofail, Syed A. M.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland.
   [Zeglinski, Jacek; Tofail, Syed A. M.] Univ Limerick, Dept Phys & Energy, Limerick, Ireland.
   [Nolan, Michael; Thompson, Damien] Natl Univ Ireland Univ Coll Cork, Tyndall Natl Inst, Cork, Ireland.
RP Zeglinski, J (reprint author), Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland.
EM jacek.zeglinski@ul.ie; tofail.syed@ul.ie
RI Nolan, Michael/A-9319-2008; thompson, damien/G-6138-2015
OI Nolan, Michael/0000-0002-5224-8580; thompson,
   damien/0000-0003-2340-5441; Zeglinski, Jacek/0000-0002-0022-2653
FU Science Foundation Ireland (SFI); Higher Education Authority; SFI
   Starting Investigator Research Grant Program, project "EMOIN" [SFI
   09/SIRG/I1620]; SFI [SFI 11/SIRG/B2111]
FX We acknowledge the Science Foundation Ireland (SFI) and Higher Education
   Authority funded Irish Centre for High End Computing (ICHEC) for the
   access to the computational facilities. MN acknowledges support from the
   SFI Starting Investigator Research Grant Program, project "EMOIN" grant
   number SFI 09/SIRG/I1620. DT thanks SFI for the financial support under
   grant number SFI 11/SIRG/B2111.
CR Almora-Barrios N, 2012, CRYST GROWTH DES, V12, P756, DOI 10.1021/cg201092s
   Almora-Barrios N, 2010, CRYSTENGCOMM, V12, P960, DOI 10.1039/b917179g
   Almora-Barrios N, 2009, LANGMUIR, V25, P5018, DOI 10.1021/la803842g
   Astala R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075427
   Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   Canepa P, 2011, PHYS CHEM CHEM PHYS, V13, P1099, DOI 10.1039/c0cp01143f
   Chen X, 2007, J PHYS CHEM C, V111, P1284, DOI 10.1021/jp0646630
   Chiatti F, 2012, J PHYS CHEM C, V116, P6108, DOI 10.1021/jp212595d
   Corno M, 2007, EUR J MINERAL, V19, P757, DOI 10.1127/0935-1221/2007/0019-1764
   Corno M, 2010, PHYS CHEM CHEM PHYS, V12, P6309, DOI 10.1039/c002146f
   Corno M, 2009, LANGMUIR, V25, P2188, DOI 10.1021/la803253k
   de Leeuw NH, 2010, J MATER CHEM, V20, P5376, DOI 10.1039/b921400c
   Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k
   Jimenez-Izal E, 2012, J PHYS CHEM C, V116, P14561, DOI 10.1021/jp304473p
   Juang HY, 1996, BIOMATERIALS, V17, P2059, DOI 10.1016/0142-9612(96)88882-X
   Kobayashi T, 2012, CRYSTENGCOMM, V14, P1143, DOI 10.1039/c1ce06114c
   Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169
   KRESSE G, 1994, J PHYS-CONDENS MAT, V6, P8245, DOI 10.1088/0953-8984/6/40/015
   Lou ZY, 2012, APPL SURF SCI, V258, P4911, DOI 10.1016/j.apsusc.2012.01.116
   Ma XY, 2008, BIOMATERIALS, V29, P257, DOI 10.1016/j.biomaterials.2007.10.001
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Ospina CA, 2012, COLLOID SURFACE B, V89, P15, DOI 10.1016/j.colsurfb.2011.08.016
   Pan HH, 2007, LANGMUIR, V23, P8972, DOI 10.1021/la700567r
   PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671
   Pieske O., 2009, TRAUMA MANAGE OUTCOM, V3, P11
   Reuter K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.035406
   Rimola A, 2012, J AM CHEM SOC, V134, P10899, DOI 10.1021/ja302262y
   Rimola A, 2012, PHILOS T R SOC A, V370, P1478, DOI 10.1098/rsta.2011.0236
   Rimola A, 2011, J PHYS CHEM LETT, V2, P1390, DOI 10.1021/jz200457x
   Rimola A, 2009, PHYS CHEM CHEM PHYS, V11, P9005, DOI 10.1039/b913311a
   Rimola A, 2008, J AM CHEM SOC, V130, P16181, DOI 10.1021/ja806520d
   Sato K, 2002, J AM CERAM SOC, V85, P3054
   SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   Zahn D, 2003, PHYS CHEM CHEM PHYS, V5, P4004, DOI 10.1039/b306358e
NR 35
TC 7
Z9 7
U1 0
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
EI 1879-2758
J9 SURF SCI
JI Surf. Sci.
PD MAY
PY 2014
VL 623
BP 55
EP 63
DI 10.1016/j.susc.2014.01.008
PG 9
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA AD0FO
UT WOS:000332910100009
DA 2018-10-20
ER

PT J
AU Rao, PJ
   Pelletier, MH
   Walsh, WR
   Mobbs, RJ
AF Rao, Prashanth J.
   Pelletier, Matthew H.
   Walsh, William R.
   Mobbs, Ralph J.
TI Spine Interbody Implants: Material Selection and Modification,
   Functionalization and Bioactivation of Surfaces to Improve
   Osseointegration
SO ORTHOPAEDIC SURGERY
LA English
DT Review
DE Bioactive conversion; Interbody spinal implant; Osseointegration
ID BONE MORPHOGENETIC PROTEIN-2; FIBER-REINFORCED POLY(ETHERETHERKETONE);
   ANTERIOR CERVICAL DISKECTOMY; PLASMA-SPRAYED TITANIUM; SILICON-NITRIDE;
   FUSION CAGES; IN-VIVO; TANTALUM IMPLANTS; BONDING ABILITY;
   HEAT-TREATMENT
AB The clinical outcome of lumbar spinal fusion is correlated with achievement of bony fusion. Improving interbody implant bone on-growth and in-growth may enhance fusion, limiting pseudoarthrosis, stress shielding, subsidence and implant failure. Polyetheretherketone (PEEK) and titanium (Ti) are commonly selected for interbody spacer construction. Although these materials have desirable biocompatibility and mechanical properties, they require further modification to support osseointegration. Reports of extensive research on this topic are available in biomaterial-centric published reports; however, there are few clinical studies concerning surface modification of interbody spinal implants. The current article focuses on surface modifications aimed at fostering osseointegration from a clinician's point of view. Surface modification of Ti by creating rougher surfaces, modifying its surface topography (macro and nano), physical and chemical treatment and creating a porous material with high interconnectivity can improve its osseointegrative potential and bioactivity. Coating the surface with osteoconductive materials like hydroxyapatite (HA) can improve osseointegration. Because PEEK spacers are relatively inert, creating a composite by adding Ti or osteoconductive materials like HA can improve osseointegration. In addition, PEEK may be coated with Ti, effectively bio-activating the coating.
C1 [Rao, Prashanth J.; Mobbs, Ralph J.] Prince Wales Hosp, Neurospine Clin, Sydney, NSW, Australia.
   [Rao, Prashanth J.; Pelletier, Matthew H.; Walsh, William R.; Mobbs, Ralph J.] Univ New S Wales, Sydney, NSW, Australia.
   [Rao, Prashanth J.; Pelletier, Matthew H.; Walsh, William R.] Surg & Orthopaed Res Lab, Sydney, NSW, Australia.
RP Rao, PJ (reprint author), Prince Wales Private Hosp, Suite 7A,Level 7,Barker St, Sydney, NSW, Australia.
EM prashanthdr@gmail.com
OI Mobbs, Ralph/0000-0001-6542-6836
CR Adogwa O, 2011, J NEUROSURG-SPINE, V15, P393, DOI 10.3171/2011.4.SPINE10822
   Anderson MC, 2010, J BIOMED MATER RES A, V92A, P1598, DOI 10.1002/jbm.a.32498
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bal BS, 2012, ACTA BIOMATER, V8, P2889, DOI 10.1016/j.actbio.2012.04.031
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barkarmo S, 2013, J BIOMED MATER RES A, V101, P465, DOI 10.1002/jbm.a.34358
   Bertollo N, 2012, J ARTHROPLASTY, V27, P1429, DOI 10.1016/j.arth.2012.02.025
   Bonfield W, 1988, Ann N Y Acad Sci, V523, P173, DOI 10.1111/j.1749-6632.1988.tb38510.x
   BRANTIGAN JW, 1993, SPINE, V18, P2106, DOI 10.1097/00007632-199310001-00030
   Burkus JK, 2009, J BONE JOINT SURG AM, V91A, P1181, DOI 10.2106/JBJS.G.01485
   Burkus JK, 2003, SPINE, V28, P372, DOI 10.1097/00007632-200302150-00012
   Carragee EJ, 2013, J BONE JOINT SURG AM, V95A, P1537, DOI 10.2106/JBJS.L.01483
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Converse GL, 2010, ACTA BIOMATER, V6, P856, DOI 10.1016/j.actbio.2009.08.004
   Converse GL, 2009, J MECH BEHAV BIOMED, V2, P627, DOI 10.1016/j.jmbbm.2009.07.002
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   dos Santos MV, 2011, CLIN IMPLANT DENT R, V13, P215, DOI 10.1111/j.1708-8208.2009.00202.x
   Fernandez-Fairen M, 2008, SPINE, V33, P465, DOI 10.1097/BRS.0b013e3181657f49
   Fujibayashi S, 2001, J BIOMED MATER RES, V56, P562, DOI 10.1002/1097-4636(20010915)56:4<562::AID-JBM1128>3.3.CO;2-D
   Fujibayashi S, 2011, EUR SPINE J, V20, P1486, DOI 10.1007/s00586-011-1728-3
   GLOWACKI J, 1985, CLIN PLAST SURG, V12, P233
   GOODMAN S, 1992, BIOMATERIALS, V13, P944, DOI 10.1016/0142-9612(92)90118-8
   Gorth DJ, 2012, INT J NANOMED, V7, P4829, DOI 10.2147/IJN.S35190
   Guedes e Silva CC, 2008, J BIOMED MATER RES A, V84, P337
   Ha SW, 1997, J MATER SCI-MATER M, V8, P891, DOI 10.1023/A:1018562023599
   Ha SW, 1997, J MATER SCI-MATER M, V8, P881, DOI 10.1023/A:1018557922690
   Han CM, 2010, BIOMATERIALS, V31, P3465, DOI 10.1016/j.biomaterials.2009.12.030
   Hasegawa Toru, 2005, Spine J, V5, P239, DOI 10.1016/j.spinee.2004.11.010
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Ito Z, 2010, SPINE, V35, pE1101, DOI 10.1097/BRS.0b013e3181de4f2e
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jasty M, 1997, J BONE JOINT SURG AM, V79A, P707, DOI 10.2106/00004623-199705000-00010
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022
   Kim HM, 2000, BIOMATERIALS, V21, P353, DOI 10.1016/S0142-9612(99)00190-8
   Kim IY, 2009, J BIOMATER APPL, V24, P105, DOI 10.1177/0885328208094557
   Kim P, 1998, J NEUROSURG, V88, P21, DOI 10.3171/jns.1998.88.1.0021
   Kim YJ, 2005, SPINE, V30, P468, DOI 10.1097/01.brs.0000153392.74639.ea
   Krayenbuhl N, 2008, J CLIN NEUROSCI, V15, P11, DOI 10.1016/j.jocn.2006.12.011
   Kroppenstedt S, 2008, SPINE, V33, P2083, DOI 10.1097/BRS.0b013e31818448a9
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Kwon Brian, 2005, Spine J, V5, p224S, DOI 10.1016/j.spinee.2005.02.007
   Lee JH, 2011, SPINE J, V11, P647, DOI 10.1016/j.spinee.2011.04.029
   Leucht P, 2007, BONE, V40, P919, DOI 10.1016/j.bone.2006.10.027
   Lin A, 2009, INT J ORAL MAX IMPL, V24, P808
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   Mobbs RJ, 2013, ORTHOP SURG, V5, P77, DOI 10.1111/os.12030
   Mroz TE, 2010, SPINE, V35, pS86, DOI 10.1097/BRS.0b013e3181d81ef2
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Nishiguchi S, 1999, J BIOMED MATER RES, V48, P689, DOI 10.1002/(SICI)1097-4636(1999)48:5<689::AID-JBM13>3.0.CO;2-C
   Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4
   Niu CC, 2010, J SPINAL DISORD TECH, V23, P310, DOI 10.1097/BSD.0b013e3181af3a84
   Olivares-Navarrete R, 2012, SPINE J, V12, P265, DOI 10.1016/j.spinee.2012.02.002
   Park HW, 2009, SPINE, V34, pE591, DOI 10.1097/BRS.0b013e3181ab8b9a
   Pelletier M, 2012, J SPINAL DISORD TECH, DOI [10.1097/BSD.0b013e31826851a4, DOI 10.1097/BSD.0B013E31826851A4]
   Pflugmacher R, 2004, SPINE, V29, P1717, DOI 10.1097/01.BRS.0000134565.17078.4C
   PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Rosa Adalberto Luiz, 2003, Braz. Dent. J., V14, P16, DOI 10.1590/S0103-64402003000100003
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Sanden B, 2002, J BONE JOINT SURG BR, V84B, P387, DOI 10.1302/0301-620X.84B3.12388
   Sandhu HS, 2002, SPINE, V27, P567, DOI 10.1097/00007632-200203150-00003
   Schroder K, 2010, J ADHES SCI TECHNOL, V24, P905, DOI 10.1163/016942409X12598231567989
   SHIRAZIADL A, 1993, J BIOMED MATER RES, V27, P167, DOI 10.1002/jbm.820270205
   Sinclair SK, 2012, SPINE, V37, pE571, DOI 10.1097/BRS.0b013e318240f981
   Stadelmann VA, 2008, BONE, V42, P358, DOI 10.1016/j.bone.2007.09.055
   Steinberg EL, 2013, J MECH BEHAV BIOMED, V17, P221, DOI 10.1016/j.jmbbm.2012.09.013
   Takemoto M, 2007, J NEUROSURG-SPINE, V7, P435, DOI 10.3171/SPI-07/10/435
   Tarnita D, 2009, ROM J MORPHOL EMBRYO, V50, P15
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Vaidya R, 2007, EUR SPINE J, V16, P1257, DOI 10.1007/s00586-007-0351-9
   Vandrovcova M, 2011, PHYSIOL RES, V60, P403
   Webster TJ, 2012, ACTA BIOMATER, V8, P4447, DOI 10.1016/j.actbio.2012.07.038
   Wong KL, 2009, BIOMATERIALS, V30, P3810, DOI 10.1016/j.biomaterials.2009.04.016
   Wu XM, 2012, INT J NANOMED, V7, P1215, DOI 10.2147/IJN.S28101
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 80
TC 45
Z9 46
U1 10
U2 74
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-7853
EI 1757-7861
J9 ORTHOP SURG
JI Orthop. Surg.
PD MAY
PY 2014
VL 6
IS 2
BP 81
EP 89
DI 10.1111/os.12098
PG 9
WC Orthopedics
SC Orthopedics
GA CS5AG
UT WOS:000362087100001
PM 24890288
OA Bronze
DA 2018-10-20
ER

PT J
AU Renberg, B
   Andersson-Svahn, H
   Hedhammar, M
AF Renberg, Bjorn
   Andersson-Svahn, Helene
   Hedhammar, My
TI Mimicking silk spinning in a microchip
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Spider silk; Microfluidics; Spinning
ID SPIDER SILK; PROTEINS; FIBERS; MICROSPHERES; MICROFLUIDICS; BIOMATERIAL
AB Nature's high performance material, spider silk, is formed during the passage of a protein solution through a spinning duct. Herein we present a microfluidic device with dual laminar mobile phases where silk formation can be mimicked and investigated. Recombinant miniature spidroins, with or without the pH-switching N-terminal domain, were used to investigate spinning conditions into silk-like fibers using this setup. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Renberg, Bjorn; Andersson-Svahn, Helene] Royal Inst Technol, Sch Biotechnol, Div Nanobiotechnol, Stockholm, Sweden.
   [Hedhammar, My] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden.
RP Hedhammar, M (reprint author), Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden.
EM My.Hedhammar@slu.se
FU Swedish Foundation for strategic research; Swedish Research Council
FX This work was supported by The Swedish Foundation for strategic research
   and the Swedish Research Council. We thank Spider Technologies AB for
   providing proteins. Andreas Barth and Nadja Eremina are acknowledged for
   help with FTIR measurements.
CR Arcidiacono Steven, 2013, Methods Mol Biol, V996, P43, DOI 10.1007/978-1-62703-354-1_3
   Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Bogush VG, 2009, J NEUROIMMUNE PHARM, V4, P17, DOI 10.1007/s11481-008-9129-z
   Breslauer DN, 2010, BIOMACROMOLECULES, V11, P643, DOI 10.1021/bm901209u
   Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Hermanson KD, 2007, PHYS CHEM CHEM PHYS, V9, P6442, DOI 10.1039/b709808a
   Jaudzems K, 2012, J MOL BIOL, V422, P477, DOI 10.1016/j.jmb.2012.06.004
   Karjalainen EL, 2011, J PHYS CHEM B, V115, P749, DOI 10.1021/jp109918c
   Kinahan ME, 2011, BIOMACROMOLECULES, V12, P1504, DOI 10.1021/bm1014624
   Landreh M, 2010, J MOL BIOL, V404, P328, DOI 10.1016/j.jmb.2010.09.054
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Stephens JS, 2005, BIOMACROMOLECULES, V6, P1405, DOI 10.1021/bm049296h
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Vollrath F, 1998, P ROY SOC B-BIOL SCI, V265, P817, DOI 10.1098/rspb.1998.0365
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Zhou SB, 2008, J PHYS CHEM B, V112, P11209, DOI 10.1021/jp800913k
NR 34
TC 12
Z9 12
U1 3
U2 60
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD MAY
PY 2014
VL 195
BP 404
EP 408
DI 10.1016/j.snb.2014.01.023
PG 5
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA AC3KQ
UT WOS:000332417600054
DA 2018-10-20
ER

PT J
AU Zhang, ZH
   Liu, SL
   Shi, Y
   Dou, J
   Fang, SM
AF Zhang, Zhihong
   Liu, Shunli
   Shi, Yu
   Dou, Jun
   Fang, Shaoming
TI DNA Detection and Cell Adhesion on Plasma-Polymerized Pyrrole
SO BIOPOLYMERS
LA English
DT Article
DE plasma polymerization; DNA immobilization; hybridization; cell adhesion;
   electrochemical impedance spectroscopy
ID QUARTZ-CRYSTAL MICROBALANCE; INDUCED GRAFT-POLYMERIZATION;
   PROTEIN-ADSORPTION; PROBE IMMOBILIZATION; SURFACE; FILMS; HYBRIDIZATION;
   POLYPYRROLE; ALLYLAMINE; TITANIUM
AB This study investigates the application of Plasma-polymerized pyrrole (ppPY) as bioactive platform for DNA immobilization and cell adhesion based on the fundamental properties of ppPY, such as chemical structure, electrochemical property, and protein adsorption. Variations in electrochemical properties of the ppPY film deposited under different plasma conditions before and after DNA immobilization were measured using electrochemical impedance spectroscopy (EIS). The equilibrium concentration of the probe DNA immobilized on the ppPY surface was deduced by detecting the variations in the surface charge transfer resistance (R-ct) of the ppPY films after DNA immobilization with different concentrations. In addition, the detection limit of the target DNA hybridization with probe DNA, the association constant, K-a, and the dissociation constant were deduced from Langmuir isotherm equations simulated using the experimental data collected by EIS. Moreover, inverted microscope was used to observe the cell adhesions onto the surface of the ppPY films prepared under different plasma conditions. Different adhesive behaviors of cells were observed, demonstrating that ppPY films could be an alternative biomaterial used as the sensitive layer for DNA sensor or cell adhesion. (c) 2013 Wiley Periodicals, Inc. Biopolymers 101: 496-503, 2014.
C1 [Zhang, Zhihong; Liu, Shunli; Shi, Yu; Dou, Jun; Fang, Shaoming] Zhengzhou Univ Light Ind, Henan Prov Key Lab Surface & Interface Sci, Zhengzhou 450002, Peoples R China.
RP Zhang, ZH (reprint author), Zhengzhou Univ Light Ind, Henan Prov Key Lab Surface & Interface Sci, 5 Dong Feng Rd, Zhengzhou 450002, Peoples R China.
EM mainzhh@163.com
FU National Natural Science Foundation of China (NSFC) [51173172]
FX Contract grant sponsor: National Natural Science Foundation of China
   (NSFC); Contract grant number: 51173172
CR Barbier V, 2006, LANGMUIR, V22, P5230, DOI 10.1021/la053289c
   Chen KS, 2007, MAT SCI ENG C-BIO S, V27, P716, DOI 10.1016/j.msec.2006.07.004
   Chen Q, 2004, CHEM MATER, V16, P614, DOI 10.1021/cm034529h
   Chu LQ, 2008, BIOSENS BIOELECTRON, V24, P118, DOI 10.1016/j.bios.2008.03.026
   Chu LQ, 2006, PLASMA PROCESS POLYM, V3, P498, DOI 10.1002/ppap.200600010
   Dhillon A, 2010, PROG ORG COAT, V69, P396, DOI 10.1016/j.porgcoat.2010.08.002
   Ding Z, 2004, BIOMATERIALS, V25, P1059, DOI 10.1016/S0142-9612(03)00615-X
   Dultsev FN, 2012, LANGMUIR, V28, P13793, DOI 10.1021/la302907r
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Goktas H, 2009, SYNTHETIC MET, V159, P2001, DOI 10.1016/j.synthmet.2009.07.003
   Goodrich TT, 2004, J AM CHEM SOC, V126, P4086, DOI 10.1021/ja039823p
   Gu HR, 2005, J PHYS CHEM B, V109, P13611, DOI 10.1021/jp050625p
   Gu MH, 2012, BIOMATERIALS, V33, P1261, DOI 10.1016/j.biomaterials.2011.11.001
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Hayakawa T, 2004, BIOMATERIALS, V25, P119, DOI 10.1016/S0142-9612(03)00484-8
   Hosono K, 2004, MATER LETT, V58, P1371, DOI 10.1016/j.matlet.2003.09.029
   Hu YW, 2011, CHEM COMMUN, V47, P1743, DOI 10.1039/c0cc04514d
   Kannan B, 2011, ANAL CHEM, V83, P3415, DOI 10.1021/ac1033243
   KUMAR GS, 1995, CANCER LETT, V92, P27, DOI 10.1016/0304-3835(95)03753-J
   Li AX, 2007, BIOSENS BIOELECTRON, V22, P1716, DOI 10.1016/j.bios.2006.07.033
   Loukidou MX, 2004, COLLOID SURFACE A, V242, P93, DOI 10.1016/j.colsurfa.2004.03.030
   Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i
   Miyachi H, 2000, BIOTECHNOL BIOENG, V69, P323, DOI 10.1002/1097-0290(20000805)69:3<323::AID-BIT10>3.0.CO;2-T
   Miyachi H, 2004, BIOSENS BIOELECTRON, V20, P184, DOI 10.1016/j.bios.2004.02.022
   Nastase F, 2005, COMPOS PART A-APPL S, V36, P503, DOI 10.1016/j.compositesa.2004.10.010
   Olayo R, 2008, J MATER SCI-MATER M, V19, P817, DOI 10.1007/s10856-007-3080-z
   Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029
   SCHWEIGERER L, 1985, P NATL ACAD SCI USA, V82, P5751, DOI 10.1073/pnas.82.17.5751
   Su XD, 2002, BIOCHEM BIOPH RES CO, V290, P962, DOI 10.1006/bbrc.2001.6297
   Tong ZS, 1997, APPL SURF SCI, V119, P93, DOI 10.1016/S0169-4332(97)00166-9
   Twite RL, 1998, PROG ORG COAT, V33, P91, DOI 10.1016/S0300-9440(98)00015-0
   Wang JG, 2004, THIN SOLID FILMS, V446, P205, DOI 10.1016/j.tsf.2003.09.074
   Zanini S, 2010, J COLLOID INTERF SCI, V341, P53, DOI 10.1016/j.jcis.2009.09.012
   Zhang Z, 2005, MACROMOLECULES, V38, P1271, DOI 10.1021/ma049716v
   Zhang ZH, 2003, MACROMOLECULES, V36, P7689, DOI 10.1021/ma034673o
   Zhang ZH, 2007, APPL SURF SCI, V253, P8915, DOI 10.1016/j.apsusc.2007.05.027
   Zhang ZH, 2008, BIOMACROMOLECULES, V9, P1613, DOI 10.1021/bm800111a
   Zhang ZH, 2011, PLASMA PROCESS POLYM, V8, P923, DOI 10.1002/ppap.201000156
   Zou L, 2011, J MEMBRANE SCI, V369, P420, DOI 10.1016/j.memsci.2010.12.023
NR 39
TC 1
Z9 1
U1 0
U2 51
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD MAY
PY 2014
VL 101
IS 5
BP 496
EP 503
DI 10.1002/bip.22408
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AB2KE
UT WOS:000331620800006
PM 24122355
DA 2018-10-20
ER

PT J
AU Aina, V
   Magistris, C
   Cerrato, G
   Martra, G
   Viscardi, G
   Lusvardi, G
   Malavasi, G
   Menabue, L
AF Aina, Valentina
   Magistris, Claudio
   Cerrato, Giuseppina
   Martra, Gianmario
   Viscardi, Guido
   Lusvardi, Gigliola
   Malavasi, Gianluca
   Menabue, Ledi
TI New Formulation of Functionalized Bioactive Glasses to Be Used as
   Carriers for the Development of pH-Stimuli Responsive Biomaterials for
   Bone Diseases
SO LANGMUIR
LA English
DT Article
ID DRUG-DELIVERY; BIONANOTECHNOLOGY; HYPERTHERMIA; BIOCERAMICS;
   TEMPERATURE; LIPOSOME; SYSTEMS; MODEL
AB The aim of the present contribution is to prepare a functionalized bioactive glass potentially useful as prosthetic material, but also able to release organic molecules in response to a change of the pH environment. By this approach it is possible to develop devices which can be used for a triggered drug release in response to specific stimuli; this is an attractive research field, in order to avoid either systemic and/or local toxic effects of drugs. In particular, in the present paper we report data related to the development of a new formulation of bioactive glasses, their functionalization with organic molecules to obtain a pH-sensitive bond, their physicochemical characterization and in vitro bioactivity in simulated biological fluids (SBF), and organic molecule delivery tests at different pH. The glass functionalization, by means of a covalent reaction, allows us to produce a model of pH-responsive bioactive biomaterial: when it is exposed to specific pH changes, it can favor the release of the organic molecules directly at the target site. Cysteamine and 5-aminofluorescein are used as model molecules to simulate a drug. The materials, before and after the different functionalization steps and in vitro release tests at different pH, have been characterized by means of different experimental techniques such as X-ray powder diffraction (XRPD), Raman, FTIR and fluorescence spectroscopies, N-2 adsorption, thermogravimetric (TGA) and elemental analysis.
C1 [Aina, Valentina; Magistris, Claudio; Cerrato, Giuseppina; Martra, Gianmario; Viscardi, Guido] Univ Turin, Interdept Ctr Nanostruct Interfaces & Surface NIS, Dept Chem, INSTM Italian Natl Consortium Mat Sci & Technol, I-10125 Turin, Italy.
   [Lusvardi, Gigliola; Malavasi, Gianluca; Menabue, Ledi] Univ Modena & Reggio Emilia, Dept Chem & Geol Sci, I-41125 Modena, Italy.
RP Aina, V (reprint author), Univ Turin, Interdept Ctr Nanostruct Interfaces & Surface NIS, Dept Chem, INSTM Italian Natl Consortium Mat Sci & Technol, Via P Giuria 7, I-10125 Turin, Italy.
EM valentina.aina@unito.it
RI Menabue, Ledi/L-7324-2015; Viscardi, Guido/N-1111-2015; Lusvardi,
   Gigliola/L-6941-2015; Malavasi, Gianluca/H-4658-2013
OI Menabue, Ledi/0000-0002-7984-3208; Viscardi, Guido/0000-0002-9387-2849;
   Lusvardi, Gigliola/0000-0002-0772-6037; Malavasi,
   Gianluca/0000-0002-4557-8135; Martra, Gianmario/0000-0002-8012-5342
FU Compagnia di San Paolo [ORTO11RRTS]; Fondazione di Vignola
FX The authors acknowledge Dr. C. Giovannoli for acid-base titration
   measurements, Prof. E. Diana for Raman measurements, and Dr. R Buscaino
   for mass spectrometry. The authors thank Ms. F. Malafronte and Mr. W.
   Intelisano for their valuable commitment and help. V.A., G.C., and G.M.
   acknowledge Compagnia di San Paolo for the financial support (Project:
   ORTO11RRTS). G.L. acknowledges Fondazione di Vignola for the financial
   support (Progetto "Materiali per la teranostica: progettazione di
   sistemi contenenti nanoparticelle e molecole di interesse biologico").
CR Aina V, 2011, J PHYS CHEM C, V115, P22461, DOI 10.1021/jp207217a
   Arcos D, 2013, ACTA MATER, V61, P890, DOI 10.1016/j.actamat.2012.10.039
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Branda F, 2007, COLLOID SURFACE A, V299, P252, DOI 10.1016/j.colsurfa.2006.11.048
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Caldorera-Moore M, 2009, ADV DRUG DELIVER REV, V61, P1391, DOI 10.1016/j.addr.2009.09.002
   Franchini M, 2012, MAT SCI ENG C-MATER, V32, P1401, DOI 10.1016/j.msec.2012.04.016
   Gao WW, 2010, MOL PHARMACEUT, V7, P1913, DOI 10.1021/mp100253e
   Gregg S. J., 1995, ADSORPTION SURFACE A
   Gupta G, 2006, INDIAN J CHEM B, V45, P697
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   Kataoka K, 2000, J CONTROL RELEASE, V64, P143, DOI 10.1016/S0168-3659(99)00133-9
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Lin S, 2009, J MATER CHEM, V19, P1276, DOI 10.1039/b814292k
   LIPPENS BC, 1965, J CATAL, V4, P319, DOI 10.1016/0021-9517(65)90307-6
   Lusvardi G, 2010, LANGMUIR, V26, P10303, DOI 10.1021/la100472p
   Manzano M, 2012, PROG SOLID STATE CH, V40, P17, DOI 10.1016/j.progsolidstchem.2012.05.001
   Martina M, 2005, BIOMATERIALS, V26, P5609, DOI 10.1016/j.biomaterials.2005.02.011
   McCoy CP, 2010, EXPERT OPIN DRUG DEL, V7, P605, DOI 10.1517/17425241003677731
   Misra SK, 2008, BIOMATERIALS, V29, P1750, DOI 10.1016/j.biomaterials.2007.12.040
   Needham D, 2000, CANCER RES, V60, P1197
   Pardoe H, 2003, MAGN RESON IMAGING, V21, P483, DOI 10.1016/S0730-725X(03)00072-9
   Park JW, 2002, BREAST CANCER RES, V4, P93
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Rapoport N, 2004, INT J PHARMACEUT, V277, P155, DOI 10.1016/j.ijpharm.2003.09.048
   SHEN WC, 1981, BIOCHEM BIOPH RES CO, V102, P1048, DOI 10.1016/0006-291X(81)91644-2
   Shruti S., 2013, MAT SCI ENG C, V33, P3190
   Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012
   Ulbrich K, 2004, ADV DRUG DELIVER REV, V56, P1023, DOI 10.1016/j.addr.2003.10.040
   Verne E, 2009, J BIOMED MATER RES A, V90A, P981, DOI 10.1002/jbm.a.32153
   Vitale-Brovarone C, 2004, J MATER SCI-MATER M, V15, P209, DOI 10.1023/B:JMSM.0000015480.49061.e1
   Zhang HT, 2011, EUR J PHARM SCI, V42, P517, DOI 10.1016/j.ejps.2011.02.006
NR 33
TC 5
Z9 5
U1 0
U2 43
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD APR 29
PY 2014
VL 30
IS 16
BP 4703
EP 4715
DI 10.1021/la5003989
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AG3DZ
UT WOS:000335297300022
PM 24701982
DA 2018-10-20
ER

PT J
AU Li, QL
   Ning, TY
   Cao, Y
   Zhang, WB
   Mei, ML
   Chu, CH
AF Li, Quan-Li
   Ning, Tian-Yun
   Cao, Ying
   Zhang, Wei-bo
   Mei, May Lei
   Chu, Chun Hung
TI A novel self-assembled oligopeptide amphiphile for biomimetic
   mineralization of enamel
SO BMC BIOTECHNOLOGY
LA English
DT Article
DE Amelogenin; Peptide; Remineralization; Enamel; Biomimetic;
   Mineralization; Self-assemble
ID AMELOGENIN NANOSPHERES; CALCIUM-PHOSPHATE; TOOTH ENAMEL;
   REMINERALIZATION; DENTIN; PEPTIDE; CRYSTALLIZATION; HYDROXYAPATITE;
   REGENERATION; PERSPECTIVE
AB Background: Researchers are looking for biomimetic mineralization of ena/mel to manage dental erosion. This study evaluated biomimetic mineralization of demineralized enamel induced by a synthetic and self-assembled oligopeptide amphiphile (OPA).
   Results: The results showed that the OPA self-assembled into nano-fibres in the presence of calcium ions and in neutral acidity. The OPA was alternately immersed in calcium chloride and sodium hypophosphate solutions to evaluate its property of mineralization. Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) showed nucleation and growth of amorphous calcium phosphate along the self-assembled OPA nano-fibres when it was repetitively exposed to solutions with calcium and phosphate ions. Energy dispersive spectrometry (EDS) confirmed that these nano-particles contained calcium and phosphate. Furthermore, electron diffraction pattern suggested that the nano-particles precipitated on OPA nano-fibres were comparable to amorphous calcium phosphate. Acid-etched human enamel slices were incubated at 37 degrees C in metastable calcium phosphate solution with the OPA for biomimetic mineralization. SEM and X-ray diffraction indicated that the OPA induced the formation of hydroxyapatite crystals in organized bundles on etched enamel. TEM micrographs revealed there were 20-30 nm nano-amorphous calcium phosphate precipitates in the biomimetic mineralizing solution. The particles were found separately bound to the oligopeptide fibres. Biomimetic mineralization with or without the oligopeptide increased demineralized enamel microhardness.
   Conclusions: A novel OPA was successfully fabricated, which fostered the biomimetic mineralization of demineralized enamel. It is one of the primary steps towards the design and construction of novel biomaterial for future clinical therapy of dental erosion.
C1 [Li, Quan-Li; Cao, Ying; Zhang, Wei-bo] Anhui Med Univ, Coll & Hosp Stomatol, Hefei 230032, Peoples R China.
   [Ning, Tian-Yun; Cao, Ying; Mei, May Lei; Chu, Chun Hung] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.
RP Li, QL (reprint author), Anhui Med Univ, Coll & Hosp Stomatol, Hefei 230032, Peoples R China.
EM ql-li@126.com; chchu@hku.hk
RI Chu, Chun Hung/F-7838-2010
OI Chu, Chun Hung/0000-0002-3239-3051; Chu, Chun Hung/0000-0002-8167-0430
FU NSFC [30973352]; NSFC/RGC Joint Research Scheme [N_HKU 776/10,
   81061160511]; Youth Foundation of Anhui Provincial Natural Science
   Foundation [1208085QH144]
FX This study was supported by NSFC (No.30973352) and NSFC/RGC Joint
   Research Scheme (N_HKU 776/10 and No.81061160511), and Youth Foundation
   of Anhui Provincial Natural Science Foundation (No.1208085QH144).
CR Bertassoni LE, 2009, CARIES RES, V43, P70, DOI 10.1159/000201593
   Busch S, 2004, ANGEW CHEM INT EDIT, V43, P1428, DOI 10.1002/anie.200352183
   Cao Y, 2013, J DENT, V41, P818, DOI 10.1016/j.jdent.2013.06.008
   Chen HF, 2006, ADV MATER, V18, P1846, DOI 10.1002/adma.200502401
   Chu CH, 2008, J DENT, V36, P387, DOI 10.1016/j.jdent.2008.02.013
   Chu C. H., 2011, General Dentistry, V59, P115
   Chu CH, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-13
   Cochrane NJ, 2010, J DENT RES, V89, P1187, DOI 10.1177/0022034510376046
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675
   Fan Y, 2012, J BIOACT COMPAT POLY, V27, P14
   Fan YW, 2007, BIOMATERIALS, V28, P3034, DOI 10.1016/j.biomaterials.2007.02.016
   Fan Y, 2009, BIOMATERIALS, V30, P478, DOI 10.1016/j.biomaterials.2008.10.019
   Featherstone J D B, 2009, Adv Dent Res, V21, P4, DOI 10.1177/0895937409335590
   Fowler CE, 2005, J MATER CHEM, V15, P3317, DOI 10.1039/b503312h
   Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hosseinkhani H, 2006, J BIOACT COMPAT POL, V21, P277, DOI 10.1177/0883911506066934
   Jee SS, 2010, ACTA BIOMATER, V6, P3676, DOI 10.1016/j.actbio.2010.03.036
   Kirkham J, 2007, J DENT RES, V86, P426, DOI 10.1177/154405910708600507
   Luo JJ, 2012, KEY ENG MATER, V512-515, P1727, DOI 10.4028/www.scientific.net/KEM.512-515.1727
   Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h
   Ning TY, 2012, J BIOMED MATER RES B, V100B, P138, DOI 10.1002/jbm.b.31931
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Semino CE, 2008, J DENT RES, V87, P606, DOI 10.1177/154405910808700710
   Uskokovic V, 2011, J CRYST GROWTH, V316, P106, DOI 10.1016/j.jcrysgro.2010.12.005
   Yamagishi K, 2005, NATURE, V433, P819, DOI 10.1038/433819a
   Yamane S, 2009, J BIOACT COMPAT POL, V24, P151, DOI 10.1177/0883911508101554
   Yang S, 2011, CHEM COMMUN, V47, P10100, DOI 10.1039/c1cc13661e
   Ye W, 2007, MATER LETT, V61, P4062, DOI 10.1016/j.matlet.2007.01.040
   Zhou YZ, 2012, ACS APPL MATER INTER, V4, P6900, DOI 10.1021/am302041b
NR 32
TC 17
Z9 17
U1 1
U2 68
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6750
J9 BMC BIOTECHNOL
JI BMC Biotechnol.
PD APR 27
PY 2014
VL 14
AR 32
DI 10.1186/1472-6750-14-32
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AG3ZS
UT WOS:000335359100001
PM 24766767
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Steinhagen, M
   Hoffmeister, PG
   Nordsieck, K
   Hotzel, R
   Baumann, L
   Hacker, MC
   Schulz-Siegmund, M
   Beck-Sickinger, AG
AF Steinhagen, Max
   Hoffmeister, Peter-Georg
   Nordsieck, Karoline
   Hoetzel, Rudi
   Baumann, Lars
   Hacker, Michael C.
   Schulz-Siegmund, Michaela
   Beck-Sickinger, Annette G.
TI Matrix Metalloproteinase 9 (MMP-9) Mediated Release of MMP-9 Resistant
   Stromal Cell-Derived Factor 1 alpha (SDF-1 alpha) from Surface Modified
   Polymer Films
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE Stromal cell-derived factor 1 alpha; cross-linked macromer;
   immobilization; matrix metalloproteinase 9; release; tissue regeneration
ID EXPRESSED PROTEIN LIGATION; MESENCHYMAL STEM-CELLS; FACTOR-I;
   PEPTIDASE-IV; MOBILIZATION; CXCR4; SDF-1; FACTOR-1-ALPHA; SDF-1/CXCL12;
   RECRUITMENT
AB Preparation of smart materials by coatings of established surfaces with biomolecules will lead to the next generation of functionalized biomaterials. Rejection of implants is still a major problem in medical applications but masking the implant material with protein coatings is a promising approach. These layers not only disguise the material but also equip it with a certain biological function. The anti-inflammatory chemokine stromal cell-derived factor 1 alpha (SDF-1 alpha) is well suited to take over this function, because it efficiently attracts stem cells and promotes their differentiation and proliferation. At least the initial stem cell homing requires the formation of a concentration gradient. Thus, a reliable and robust release mechanism of SDF-1 alpha from the material is essential. Several proteases, most notably matrix metalloproteinases, are upregulated during inflammation, which, in principle, can be exploited for a tightly controlled release of SDF-1 alpha. Herein, we present the covalent immobilization of M-[S4V]-SDF-1 alpha on novel biodegradable polymer films, which consist of heterobifunctional poly(ethylene glycol) and oligolactide-based functionalized macromers. A peptidic linker with a trimeric matrix metalloproteinase 9 (MMP-9) cleavage site (MCS) was used as connection and the linkage between the three components was achieved by combination of expressed protein ligation and Cu(I) catalyzed azide/alkyne cycloaddition. The MCS was used for MMP-9 mediated release of M4S4V]-SDF-1 alpha from the biomaterial and the released SDF-1 alpha derivative was biologically active and induced strong cell migration, which demonstrates the great potential of this system.
C1 [Steinhagen, Max; Nordsieck, Karoline; Baumann, Lars; Beck-Sickinger, Annette G.] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, D-04103 Leipzig, Germany.
   [Hoffmeister, Peter-Georg; Hoetzel, Rudi; Hacker, Michael C.; Schulz-Siegmund, Michaela] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Pharm, D-04317 Leipzig, Germany.
RP Beck-Sickinger, AG (reprint author), Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, Bruderstr 34, D-04103 Leipzig, Germany.
EM beck-sickinger@uni-leipzig.de
RI Baumann, Lars/H-7991-2015; Hacker, Michael/D-3935-2011
OI Hacker, Michael/0000-0002-4776-2294
FU DFG [TRR67, A1, A4]; Graduate School "Leipzig School of Natural Sciences
   - Building with Molecules and Nanoobjects" (BuildMoNa); European Union;
   Free State of Saxony (ESF)
FX The authors gratefully thank Regina Reppich-Sacher for excellent
   technical assistance in mass spectrometry, Janet Schwesinger for her
   help in molecular biology and Kristin Lobner for the assistance in cell
   culture. We also thank Benno Muller for his help with contact angle
   measurements. The financial support of the DFG (TRR67, A1 and A4) and
   the Graduate School "Leipzig School of Natural Sciences - Building with
   Molecules and Nanoobjects" (BuildMoNa) is kindly acknowledged. The
   project was funded by the European Union and the Free State of Saxony
   (ESF).
CR Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Auras R, 2004, MACROMOL BIOSCI, V4, P835, DOI 10.1002/mabi.200400043
   Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200
   Baumann L, 2013, METHODS MOL BIOL, V1047, P103, DOI 10.1007/978-1-62703-544-6_7
   Baumann L, 2012, J CONTROL RELEASE, V162, P68, DOI 10.1016/j.jconrel.2012.04.049
   Baumann L, 2010, BIOPOLYMERS, V94, P771, DOI 10.1002/bip.21465
   Bridges JF, 2000, BIOMATERIALS, V21, P199, DOI 10.1016/S0142-9612(99)00172-6
   Cencioni C, 2012, CARDIOVASC RES, V94, P400, DOI 10.1093/cvr/cvs132
   Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996
   Davis DA, 2005, BLOOD, V105, P4561, DOI 10.1182/blood-2004-12-4618
   Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941
   Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO;2-6
   Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169
   Hassert R, 2012, BIOCONJUGATE CHEM, V23, P2129, DOI 10.1021/bc3003875
   Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354
   Hazama Y, 2010, INFLAMM REGEN, V30, P193
   Ho TK, 2010, J VASC SURG, V51, P689, DOI 10.1016/j.jvs.2009.10.044
   Holmes WD, 2001, PROTEIN EXPRES PURIF, V21, P367, DOI 10.1006/prep.2001.1402
   Huang YC, 2012, ACTA BIOMATER, V8, P1048, DOI 10.1016/j.actbio.2011.12.009
   Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1
   Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Lipfert J, 2013, NEUROPATH APPL NEURO, V39, P667, DOI 10.1111/nan.12015
   Maquet V, 2000, J BIOMED MATER RES, V52, P639, DOI 10.1002/1097-4636(20001215)52:4<639::AID-JBM8>3.0.CO;2-G
   Mariner PD, 2013, J ORTHOP RES, V31, P401, DOI 10.1002/jor.22243
   Marquez-Curtis L, 2008, STEM CELLS, V26, P1211, DOI 10.1634/stemcells.2007-0725
   Marshall D, 1996, BRIT J CANCER, V73, P565, DOI 10.1038/bjc.1996.99
   McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705
   Nordsieck K, 2012, CHEMBIOCHEM, V13, P2558, DOI 10.1002/cbic.201200467
   Ohtsuki T, 1998, FEBS LETT, V431, P236, DOI 10.1016/S0014-5793(98)00763-7
   Otto TE, 1996, J BIOMED MATER RES, V32, P513, DOI 10.1002/(SICI)1097-4636(199612)32:4<513::AID-JBM3>3.0.CO;2-U
   Ozawa T, 2002, CIRCULATION, V106, P1176
   Penk A, 2013, MAGN RESON MED, V70, P925, DOI 10.1002/mrm.24541
   Ray P, 2012, BIOCHEM J, V442, P433, DOI 10.1042/BJ20111341
   Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
   Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004
   Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4
   Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053
   Tomoe C. W., 2002, J ORG CHEM, V67, P3057, DOI DOI 10.1021/JO011148J
   Tuomisto TT, 2004, ATHEROSCLEROSIS, V174, P111, DOI 10.1016/j.atherosclerosis.2004.01.015
   Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273
   Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200
   Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev
   Werkmeister J. A., 1992, BIOMATERIALS CLIN MA, V9, P137
   Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22
   Yousef M, 2012, PHARMACOL RES, V66, P66, DOI 10.1016/j.phrs.2012.03.013
NR 54
TC 11
Z9 11
U1 1
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 23
PY 2014
VL 6
IS 8
BP 5891
EP 5899
DI 10.1021/am500794q
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AG0DR
UT WOS:000335086000068
PM 24646074
DA 2018-10-20
ER

PT J
AU Alves, D
   Pereira, MO
AF Alves, Diana
   Pereira, Maria Olivia
TI Mini-review: Antimicrobial peptides and enzymes as promising candidates
   to functionalize biomaterial surfaces
SO BIOFOULING
LA English
DT Review
DE antimicrobial peptides; antibacterial coatings; biofilm-dispersing
   enzymes; biomaterial-associated infections
ID MEDIATES BIOFILM FORMATION; HOST-DEFENSE PEPTIDES; COVALENT
   IMMOBILIZATION; ANTIBACTERIAL COATINGS; POLYMER BRUSHES; POLYELECTROLYTE
   MULTILAYERS; STAPHYLOCOCCUS-AUREUS; TISSUE INTEGRATION; BACTERIAL
   BIOFILMS; CATIONIC PEPTIDES
AB Biomaterial-associated infections remain a serious concern in modern healthcare. The development of materials that can resist or prevent bacterial attachment constitutes a promising approach to dealing with this problem. Antimicrobial peptides (AMPs) and enzymes have been recognized as promising candidates for the new generation of antimicrobial surfaces. AMPs have been the focus of great interest in recent years owing to a low propensity for developing bacterial resistance, broad-spectrum activity, high efficacy at very low concentrations, target specificity, and synergistic action with classical antibiotics. Biofilm-dispersing enzymes have been shown to inhibit biofilm formation, detach established biofilm, and increase biofilm susceptibility to other antimicrobials. This review critically examines the potential of these protein-like compounds for developing antibacterial coatings by reporting their immobilization into different substrata using different immobilization strategies.
C1 [Alves, Diana; Pereira, Maria Olivia] Univ Minho, IBB, Ctr Biol Engn, P-4710057 Braga, Portugal.
RP Pereira, MO (reprint author), Univ Minho, IBB, Ctr Biol Engn, Campus Gualtar, P-4710057 Braga, Portugal.
EM mopereira@deb.uminho.pt
RI Pereira, Maria/O-4859-2015
OI Pereira, Maria/0000-0002-4307-3985; Alves, Diana/0000-0001-8750-5439
FU IBB-CEB; Portuguese Foundation for Science and Technology
   [SFRH/BD/78063/2011, PTDC/SAUSAP/113196/2009 /
   FCOMP-01-0124-FEDER-016012]
FX The authors acknowledge financial support from IBB-CEB and the
   Portuguese Foundation for Science and Technology (PhD grant
   SFRH/BD/78063/2011 and project PTDC/SAUSAP/113196/2009 /
   FCOMP-01-0124-FEDER-016012).
CR Altman H, 2006, J ANTIMICROB CHEMOTH, V58, P198, DOI 10.1093/jac/dkl181
   Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D
   Appendini P, 2001, J APPL POLYM SCI, V81, P609, DOI 10.1002/app.1476
   Ariga K, 2007, PHYS CHEM CHEM PHYS, V9, P2319, DOI 10.1039/b700410a
   Asri LATW, 2014, ADV FUNCT MATER, V24, P346, DOI 10.1002/adfm.201301686
   Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Baveja JK, 2004, BIOMATERIALS, V25, P5003, DOI 10.1016/j.biomaterials.2004.02.051
   Bieser AM, 2011, MACROMOL BIOSCI, V11, P526, DOI 10.1002/mabi.201000398
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Busscher H. J., 2012, SCI TRANSL MED, V4
   Caro A, 2010, J COLLOID INTERF SCI, V349, P13, DOI 10.1016/j.jcis.2009.12.001
   Caro A, 2009, J PHYS CHEM B, V113, P2101, DOI 10.1021/jp805284s
   Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y
   Chen GL, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/46/465706
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454
   Cho WM, 2007, BIOORG MED CHEM LETT, V17, P5772, DOI 10.1016/j.bmcl.2007.08.056
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005
   Cordeiro AL, 2011, J ADHES SCI TECHNOL, V25, P2317, DOI 10.1163/016942411X574961
   Cordeiro AL, 2011, BIOTECHNOL LETT, V33, P1897, DOI 10.1007/s10529-011-0643-3
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Cotton L. A., 2009, J EXP MICROBIOL IMMU, V13, P58
   Darouiche RO, 2009, J ANTIMICROB CHEMOTH, V64, P88, DOI 10.1093/jac/dkp158
   David AE, 2011, METHODS MOL BIOL, V679, P49, DOI 10.1007/978-1-60761-895-9_6
   Davis N, 1999, J BONE JOINT SURG BR, V81B, P886, DOI 10.1302/0301-620X.81B5.9545
   de Carvalho Carla C C R, 2007, Recent Pat Biotechnol, V1, P49
   del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.2007.6100247
   Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   El-Asrar Ahmed M. Abu, 1997, International Ophthalmology, V21, P71
   Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4
   Etienne O, 2004, ANTIMICROB AGENTS CH, V48, P3662, DOI 10.1128/AAC.48.10.3662-3669.2004
   Everaert EPJM, 1999, ARCH OTOLARYNGOL, V125, P1329, DOI 10.1001/archotol.125.12.1329
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Gao GZ, 2011, BIOMACROMOLECULES, V12, P3715, DOI 10.1021/bm2009697
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Ghasemi M, 2011, J PHYS CHEM B, V115, P10228, DOI 10.1021/jp204097a
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Glinel K, 2009, BIOCONJUGATE CHEM, V20, P71, DOI 10.1021/bc800280u
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756
   Green J-BD, 2011, SCI MICROBIAL PATHOG, V1
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004
   Guyomard A, 2008, ADV FUNCT MATER, V18, P758, DOI 10.1002/adfm.200700793
   Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951
   Han H, 2011, LANGMUIR, V27, P4010, DOI 10.1021/la1046904
   Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hanefeld U, 2013, CHEM SOC REV, V42, P6211, DOI 10.1039/c3cs90042h
   Hangler M, 2009, BIOFOULING, V25, P667, DOI 10.1080/08927010903096008
   Hansen EH, 2003, APPL ENVIRON MICROB, V69, P4611, DOI 10.1128/AEM.69.8.4611-4617.2003
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Hequet A, 2011, COLLOID SURFACE B, V84, P301, DOI 10.1016/j.colsurfb.2011.01.012
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Humblot V, 2009, BIOMATERIALS, V30, P3503, DOI 10.1016/j.biomaterials.2009.03.025
   Iconomopoulou SM, 2005, J CONTROL RELEASE, V102, P223, DOI 10.1016/j.jconrel.2004.10.006
   Itoh Y, 2005, J BACTERIOL, V187, P382, DOI 10.1128/JB.187.1.382-387.2005
   Izano EA, 2008, MICROB PATHOGENESIS, V44, P52, DOI 10.1016/j.micpath.2007.08.004
   Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004
   Johansen C, 1997, APPL ENVIRON MICROB, V63, P3724
   Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403
   Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4692.2003
   Kaplan JB, 2009, INT J ARTIF ORGANS, V32, P545
   Kazmierska Katarzyna A., 2009, Recent Patents on Biomedical Engineering, V2, P1, DOI 10.2174/1874764710902010001
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Knappe D, 2010, ANTIMICROB AGENTS CH, V54, P4003, DOI 10.1128/AAC.00300-10
   Koszalka P, 2011, ACTA BIOCHIM POL, V58, P111
   Kristensen JB, 2008, BIOTECHNOL ADV, V26, P471, DOI 10.1016/j.biotechadv.2008.05.005
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0
   Kupferwasser LI, 1999, ANTIMICROB AGENTS CH, V43, P2395, DOI 10.1128/AAC.43.10.2395
   Lamppa JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017042
   Leroy C, 2008, BIOFOULING, V24, P11, DOI 10.1080/08927010701784912
   Lewis K, 2005, TRENDS BIOTECHNOL, V23, P343, DOI 10.1016/j.tibtech.2005.05.004
   Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x
   Lopez-Gallego F, 2005, J BIOTECHNOL, V119, P70, DOI 10.1016/j.jbiotec.2005.05.021
   Maathuis PGM, 2007, BIOMATERIALS MODERN
   Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2
   Mecikoglu M, 2006, J BONE JOINT SURG AM, V88A, P1208, DOI 10.2106/JBJS.E.00007
   Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095
   Minier M, 2005, LANGMUIR, V21, P5957, DOI 10.1021/la0501278
   Mitchell BA, 1998, ANTIMICROB AGENTS CH, V42, P475
   Mohorcic M, 2010, J MATER SCI-MATER M, V21, P2775, DOI 10.1007/s10856-010-4136-z
   Mowery BP, 2007, J AM CHEM SOC, V129, P15474, DOI 10.1021/ja077288d
   Muszanska AK, 2011, BIOMATERIALS, V32, P6333, DOI 10.1016/j.biomaterials.2011.05.016
   Nablo BJ, 2005, BIOMATERIALS, V26, P917, DOI 10.1016/j.biomaterials.2004.03.031
   Nobile CJ, 2007, CURR BIOL, V17, pR349, DOI 10.1016/j.cub.2007.02.035
   Onaizi SA, 2011, BIOTECHNOL ADV, V29, P67, DOI 10.1016/j.biotechadv.2010.08.012
   Otto M, 2009, CONTRIB MICROBIOL, V16, P136, DOI 10.1159/000219377
   Pavlukhina SV, 2012, ACS APPL MATER INTER, V4, P4708, DOI 10.1021/am3010847
   Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405
   Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023
   Prakash B, 2003, CURR SCI INDIA, V85, P1299
   Ramos R, 2013, BIOTECHNOL PROGR, V29, P17, DOI 10.1002/btpr.1650
   Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x
   Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005
   Roosjen A, 2006, PROG COLL POL SCI S, V132, P138, DOI 10.1007/2882_026
   Schneeberger PM, 2002, J HOSP INFECT, V51, P179, DOI 10.1053/jhin.2002.1256
   Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829
   SHAFER WM, 1984, INFECT IMMUN, V45, P29
   Shah A, 2004, ANTIMICROB AGENTS CH, V48, P2704, DOI 10.1128/AAC.48.7.2704-2707.2004
   Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X
   Shalev T, 2012, J MATER CHEM, V22, P2026, DOI 10.1039/c1jm13994k
   Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082
   Shukla A, 2010, BIOMATERIALS, V31, P2348, DOI 10.1016/j.biomaterials.2009.11.082
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   Sileika TS, 2011, ACS APPL MATER INTER, V3, P4602, DOI 10.1021/am200978h
   Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#
   Statz AR, 2008, BIOFOULING, V24, P439, DOI 10.1080/08927010802331829
   Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738
   Steven MD, 2008, J APPL POLYM SCI, V110, P2665, DOI 10.1002/app.27638
   Strauss J, 2010, COLLOID SURFACE B, V75, P156, DOI 10.1016/j.colsurfb.2009.08.026
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Swartjes JJTM, 2013, ADV FUNCT MATER, P1
   Tasso M, 2009, MACROMOL BIOSCI, V9, P922, DOI 10.1002/mabi.200900005
   Tew GN, 2002, P NATL ACAD SCI USA, V99, P5110, DOI 10.1073/pnas.082046199
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Von Eiff C, 2005, INT J ARTIF ORGANS, V28, P1146
   Vreuls C, 2010, J MATER CHEM, V20, P8092, DOI 10.1039/c0jm01419b
   Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487
   Willcox MDP, 2008, J APPL MICROBIOL, V105, P1817, DOI 10.1111/j.1365-2672.2008.03942.x
   Xavier JB, 2005, MICROBIOL-SGM, V151, P3817, DOI 10.1099/mic.0.28165-0
   Yala JF, 2011, APPL MICROBIOL BIOT, V89, P623, DOI 10.1007/s00253-010-2930-7
   Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4
   Yuan SJ, 2011, LANGMUIR, V27, P2761, DOI 10.1021/la104442f
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhang LJ, 2005, ANTIMICROB AGENTS CH, V49, P2921, DOI 10.1128/AAC.49.7.2921-2927.2005
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 135
TC 57
Z9 59
U1 11
U2 206
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0892-7014
EI 1029-2454
J9 BIOFOULING
JI Biofouling
PD APR 21
PY 2014
VL 30
IS 4
BP 483
EP 499
DI 10.1080/08927014.2014.889120
PG 17
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA AE5HS
UT WOS:000334019000009
PM 24666008
DA 2018-10-20
ER

PT J
AU Kubiak, K
   Kurzawa, M
   Jedrzejczak-Krzepkowska, M
   Ludwicka, K
   Krawczyk, M
   Migdalski, A
   Kacprzak, MM
   Loska, D
   Krystynowicz, A
   Bielecki, S
AF Kubiak, Katarzyna
   Kurzawa, Marta
   Jedrzejczak-Krzepkowska, Marzena
   Ludwicka, Karolina
   Krawczyk, Mariusz
   Migdalski, Andrzej
   Kacprzak, Magdalena M.
   Loska, Damian
   Krystynowicz, Alina
   Bielecki, Stanislaw
TI Complete genome sequence of Gluconacetobacter xylinus E25
   strain-Valuable and effective producer of bacterial nanocellulose
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Bacterial nanocellulose; Next generation sequencing (NGS); Cellulose
   synthase operon; Gluconacetobacter xylinus genome
ID ACETOBACTER-XYLINUM; CELLULOSE
AB This study reports the release of complete genome sequence of the producer of bacterial nanocellulose (BNC) - Gluconacetobacter xylinus E25, a vinegar-isolated strain. Preliminary sequence analysis revealed complexity of the genome structure and familiarized genetic basis of productive properties of E25 strain. The genome consists of one chromosome and five plasmids. Whole genome sequencing has opened up new perspectives for further bioinformatics and experimental studies allowing the elucidation of molecular mechanisms responsible for regulation of production of BNC - a valuable biomaterial. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kubiak, Katarzyna; Kurzawa, Marta; Jedrzejczak-Krzepkowska, Marzena; Ludwicka, Karolina; Krystynowicz, Alina; Bielecki, Stanislaw] Lodz Univ Technol, Inst Tech Biochem, PL-90924 Lodz, Poland.
   [Krawczyk, Mariusz; Migdalski, Andrzej; Kacprzak, Magdalena M.; Loska, Damian] Genomed SA, PL-02971 Warsaw, Poland.
   [Krawczyk, Mariusz; Loska, Damian] Polish Japanese Inst Informat Technol, PL-02008 Warsaw, Poland.
RP Kubiak, K (reprint author), Lodz Univ Technol, Inst Tech Biochem, Stefanowskiego 4-10, PL-90924 Lodz, Poland.
EM katarzyna.kubiak@p.lodz.pl
RI Kacprzak, Michal/S-9714-2016
OI Kubiak, Katarzyna/0000-0003-3815-1712
FU European Community from the European Social Fund within the INTERKADRA
   project
FX Part of this work was financially supported by the European Community
   from the European Social Fund within the INTERKADRA project.
CR Andres J, 2013, GENOME BIOL EVOL, V5, P934, DOI 10.1093/gbe/evt061
   Brown AJ, 1886, J CHEM SOC, V49, P432, DOI DOI 10.1039/CT8864900432
   Chevreux B., 1999, COMPUTER SCIENCE AND, V99, P45
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698
   Gama M, 2013, PERSPECT NANOTECHNOL, P1
   Hu SQ, 2010, P NATL ACAD SCI USA, V107, P17957, DOI 10.1073/pnas.1000601107
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Iyer PR, 2010, J BACTERIOL, V192, P4256, DOI 10.1128/JB.00588-10
   Koo HM, 1998, BIOSCI BIOTECH BIOCH, V62, P2257, DOI 10.1271/bbb.62.2257
   Kowalska-Ludwicka K, 2013, ARCH MED SCI, V9, P527, DOI 10.5114/aoms.2013.33433
   Krystynowicz A, 2002, J IND MICROBIOL BIOT, V29, P189, DOI 10.1038/sj.jim.7000303
   Mazur A, 2013, ARCH MICROBIOL, V195, P255, DOI 10.1007/s00203-013-0874-x
   Ogino H, 2011, J BACTERIOL, V193, P6997, DOI 10.1128/JB.06158-11
   SAXENA IM, 1994, J BACTERIOL, V176, P5735
   Shelud'ko AV, 2012, FOLIA MICROBIOL, V57, P5, DOI 10.1007/s12223-011-0074-5
   Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361
   Weidner S., 2013, GENOME ANNOUNC, V1, DOI [DOI 10.1128/GENOMEA.00013-12, 10.1128/genomeA.00013-12]
   Yasutake Y, 2006, PROTEINS, V64, P1069, DOI 10.1002/prot.21052
   Yu CG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-52
NR 20
TC 17
Z9 17
U1 1
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
EI 1873-4863
J9 J BIOTECHNOL
JI J. Biotechnol.
PD APR 20
PY 2014
VL 176
BP 18
EP 19
DI 10.1016/j.jbiotec.2014.02.006
PG 2
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AD8SA
UT WOS:000333534700003
PM 24556328
DA 2018-10-20
ER

PT J
AU Achak, M
   Hafidi, A
   Mandi, L
   Ouazzani, N
AF Achak, M.
   Hafidi, A.
   Mandi, L.
   Ouazzani, N.
TI Removal of phenolic compounds from olive mill wastewater by adsorption
   onto wheat bran
SO DESALINATION AND WATER TREATMENT
LA English
DT Article
DE Wheat bran; Adsorption; Phenolic compounds; Olive mill wastewaters;
   Desorption
ID AQUEOUS-SOLUTIONS; ACTIVATED CARBON; LIQUID-PHASE; SUBSTANCES;
   ISOTHERMS; SLURRY
AB The use of wheat bran for the removal of phenolic compounds from olive mill wastewater (OMW) at different adsorbent doses (10-60g/L), pH (3-11), and contact time (0.25-24h) was investigated. Our findings demonstrate that wheat bran, an inexpensive and easily available biomaterial, can be an alternative for the more costly adsorbents used for the removal of phenolic compounds from OMW. Increase in the wheat bran dosage from 10 to 50g/L significantly increased the phenolic compounds adsorption rate from 45 to 67%. Increase in pH to high alkalinity resulted in an increase in the phenolic compounds' adsorption capacity. The adsorption process was found to be relatively fast, and it reached equilibrium in 4h of contact time. The Freundlich and Langmuir adsorption models were used for the mathematical description of the adsorption equilibrium and it was found that the experimental data fitted very well in the Freundlich model. Batch adsorption models based on the assumption of the pseudo-first-order, pseudo-second-order, and intraparticle diffusion mechanism were applied to examine the kinetics of the adsorption. The results showed that kinetic data followed more closely the pseudo-second-order model, than the pseudo-first-order and intraparticle diffusion. Desorption studies showed that at low pH value, the desorption of phenolic compounds was efficient.
C1 [Achak, M.; Mandi, L.; Ouazzani, N.] Univ Cadi Ayyad, Fac Sci Semlalia, Lab Hydrobiol Ecotoxicol & Assainissment, Marrakech 2390, Morocco.
   [Mandi, L.; Ouazzani, N.] Univ Cadi Ayyad, Ctr Natl Etud & Rech Eau & Energie, Marrakech 40000, Morocco.
   [Hafidi, A.] Univ Cadi Ayyad, Fac Sci Semlalia, Lab Sci Aliments, Marrakech 2390, Morocco.
RP Ouazzani, N (reprint author), Univ Cadi Ayyad, Fac Sci Semlalia, Lab Hydrobiol Ecotoxicol & Assainissment, Blvd Prince Moulay Abdelah, Marrakech 2390, Morocco.
EM ouazzani@ucam.ac.ma
OI Hafidi, Abdellatif/0000-0002-6439-8340
FU pole of competences of Water and Environment (PC2E); PROTARS II [34 2005
   - 2010]; European project, FP7 SOWAEUMED (Network in Solid Waste and
   Water Treatment between Europe and Mediterranean Countries) [245843]
FX This work was supported by:; The pole of competences of Water and
   Environment (PC2E).; PROTARS II contract No 34 2005 - 2010.; European
   project, FP7 SOWAEUMED (Network in Solid Waste and Water Treatment
   between Europe and Mediterranean Countries, Contract No 245843).
CR Achak M, 2009, J HAZARD MATER, V166, P117, DOI 10.1016/j.jhazmat.2008.11.036
   Achak M., 2008, REV SCI EAU, V21, P53
   AFNOR, 1983, REC NORM FRANC EAU M, P621
   Ahmaruzzaman M, 2005, J COLLOID INTERF SCI, V287, P14, DOI 10.1016/j.jcis.2005.01.075
   Aksu Z, 2001, WASTE MANAGE, V21, P695, DOI 10.1016/S0956-053X(01)00006-X
   Allouche N, 2004, J AGR FOOD CHEM, V52, P267, DOI 10.1021/jf034944u
   APHA, 1992, STAND METH AN WAST W
   Balicen V., 1984, GRASAS ACEITES, V25, P178
   Banat F, 2004, CHEM ENG TECHNOL, V27, P80, DOI 10.1002/ceat.200401868
   Bhatnagar A, 2007, J HAZARD MATER, V139, P93, DOI 10.1016/j.jhazmat.2006.06.139
   BOX JD, 1983, WATER RES, V17, P511, DOI 10.1016/0043-1354(83)90111-2
   Brenes M, 1999, J AGR FOOD CHEM, V47, P3535, DOI 10.1021/jf990009o
   Calace N, 2002, ENVIRON POLLUT, V118, P315, DOI 10.1016/S0269-7491(01)00303-7
   Cichelli A, 1984, RIV MERCEOL, V22, P55
   Dabrowski A, 2005, CHEMOSPHERE, V58, P1049, DOI 10.1016/j.chemosphere.2004.09.067
   Din ATM, 2009, J HAZARD MATER, V161, P1522, DOI 10.1016/j.jhazmat.2008.05.009
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Dursun G, 2005, J HAZARD MATER, V125, P175, DOI 10.1016/j.jhazmat.2005.05.023
   Garcia-Araya JF, 2003, ADSORPTION, V9, P107, DOI 10.1023/A:1024228708675
   Goud V. V., 2005, CHEM ENG TECHNOL, V28, P814, DOI 10.1002/(ISSN)1521-4125
   Ho S., 2002, PROCESS BIOCHEM, V37, P1421
   HUNT GM, 1980, PHYTOCHEMISTRY, V19, P1415, DOI 10.1016/0031-9422(80)80185-3
   Iqbal Y., 2005, INT J ENVIRON STUD, V62, P47, DOI 10.1080/ 0020723042000253875
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Laszlo K, 2003, LANGMUIR, V19, P5287, DOI 10.1021/la026761s
   Li H, 2004, CHROMATOGRAPHIA, V60, P425, DOI 10.1365/s10337-004-0403-9
   Lin KL, 2009, J HAZARD MATER, V161, P231, DOI 10.1016/j.jhazmat.2008.03.076
   NAMASIVAYAM C, 1992, J CHEM TECHNOL BIOT, V53, P153
   NAMASIVAYAM C, 1992, WATER AIR SOIL POLL, V65, P101, DOI 10.1007/BF00482752
   Ozer A, 1997, PROCESS BIOCHEM, V32, P319, DOI 10.1016/S0032-9592(96)00091-X
   Ranalli A., 1991, OLIVAE, V37, P30
   Razmkhab S, 2002, J AGR FOOD CHEM, V50, P7432, DOI 10.1021/jf025733c
   Richard D, 2009, CHEM ENG J, V148, P1, DOI 10.1016/j.cej.2008.07.023
   RODIER J, 1984, ANAL EAU EAUX NATURE, P1365
   Sathishkumar M, 2007, BIORESOURCE TECHNOL, V98, P866, DOI 10.1016/j.biortech.2006.03-002
   Stasinakis AS, 2008, J HAZARD MATER, V160, P408, DOI 10.1016/j.jhazmat.2008.03.012
   Sthishkumar M., 2007, BIORESOURCE TECHNOL, V98, P866
   Thawornchaisit U, 2007, BIORESOURCE TECHNOL, V98, P140, DOI 10.1016/j.biortech.2005.11.004
   Vazequez-Roncero A., 1974, GRASAS ACEITES, V25, P341
   Vazquez I, 2007, J HAZARD MATER, V147, P395, DOI 10.1016/j.jhazmat.2007.01.019
   Vinciguerra V., 1993, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V58, P1811
   Wagner H., 1984, PLANT DRUG ANAL, P42
   Wang SB, 2005, CHEMOSPHERE, V60, P1401, DOI 10.1016/j.chemosphere.2005.01.091
   Xiaoli C., 2006, J HAZARD MAT B, VB137, P410
   Zenjari B., 1999, AGROCHEM, VXLIII1, P276
   Zhou ML, 1998, WATER RES, V32, P1109, DOI 10.1016/S0043-1354(96)00148-0
NR 46
TC 9
Z9 9
U1 0
U2 16
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 520 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1944-3994
EI 1944-3986
J9 DESALIN WATER TREAT
JI Desalin. Water Treat.
PD APR 16
PY 2014
VL 52
IS 13-15
BP 2875
EP 2885
DI 10.1080/19443994.2013.819166
PG 11
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA AE3NY
UT WOS:000333884400061
DA 2018-10-20
ER

PT J
AU Picaud, L
   Thibault, B
   Mery, E
   Ouali, M
   Martinez, A
   Delord, JP
   Couderc, B
   Ferron, G
AF Picaud, Laetitia
   Thibault, Benoit
   Mery, Eliane
   Ouali, Monia
   Martinez, Alejandra
   Delord, Jean-Pierre
   Couderc, Bettina
   Ferron, Gwenael
TI Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose
   barrier on ovarian tumor progression
SO JOURNAL OF OVARIAN RESEARCH
LA English
DT Article
DE Ovarian adenocarcinoma; Surgery; Anti-adhesion membranes; Hyaluronic
   acid
ID HA-CMC BARRIER; CANCER CELLS; IN-VITRO; GYNECOLOGIC MALIGNANCIES;
   MEMBRANE SEPRAFILM; ADHESION FORMATION; MEDIATED MOTILITY;
   MOLECULAR-WEIGHT; CD44; METASTASIS
AB Background: Hyaluronic acid is a prognostic factor in ovarian cancers. It is also a component of Hyaluronic Acid-Carboxymethyl Cellulose (HA-CMC) barrier, an anti-adhesion membrane widely used during abdominal surgeries in particular for ovarian carcinosis. 70% of patients who undergo ovarian surgery will relapse due to the persistence of cancer cells. This study's objective was to determine the oncological risk from use of this material, in the presence of residual disease, despite the benefit gained by it decreasing post-surgical adhesions in order to provide an unambiguous assessment of its appropriateness for use in ovarian surgical management.
   Methods: We assessed the effects of HA-CMC barrier on the in vitro proliferation of human ovarian tumor cell lines (OVCAR-3, IGROV-1 and SKOV-3). We next evaluated, in vivo in nude mice, the capacity of this biomaterial to regulate the tumor progression of subcutaneous and intraperitoneal models of ovarian tumor xenografts.
   Results: We showed that HA-CMC barrier does not increase in vitro proliferation of ovarian cancer cell lines compared to control. In vivo, HA-CMC barrier presence with subcutaneous xenografts induced neither an increase in tumor volume nor cell proliferation (Ki67 and mitotic index). With the exception of an increased murine carcinosis score in peritoneum, the presence of HA-CMC barrier with intraperitoneal xenografts modified neither macro nor microscopic tumor growth. Finally, protein analysis of survival (Akt), proliferation (ERK) and adhesion (FAK) pathways highlighted no activation on the xenografts imputable to HA-CMC barrier.
   Conclusions: For the most part, our results support the lack of tumor progression activation due to HA-CMC barrier. We conclude that the benefits gained from using HA-CMC barrier membrane during ovarian cancer surgeries seem to outweigh the potential oncological risks.
C1 [Picaud, Laetitia; Thibault, Benoit; Mery, Eliane; Delord, Jean-Pierre; Couderc, Bettina; Ferron, Gwenael] Inst Claudius Regaud, EA4553, F-31052 Toulouse, France.
   [Picaud, Laetitia; Martinez, Alejandra; Ferron, Gwenael] Inst Claudius Regaud, Dept Surg, F-31052 Toulouse, France.
   [Ouali, Monia] Inst Claudius Regaud, Biostat Unit, F-31052 Toulouse, France.
   [Delord, Jean-Pierre; Couderc, Bettina] Univ Toulouse 3, F-31062 Toulouse, France.
RP Couderc, B (reprint author), Inst Claudius Regaud, EA4553, 20-24 Rue Pont St Pierre, F-31052 Toulouse, France.
EM couderc.bettina@claudiusregaud.fr
RI Mery-Lamarche, Eliane/P-2795-2014; Martinez, Alejandra/A-4097-2015;
   Couderc, Bettina/P-1576-2014; Ferron, Gwenael/P-6193-2014; Thibault,
   Benoit/A-1682-2016; DELORD, Jean-Pierre/I-8866-2014
OI Mery-Lamarche, Eliane/0000-0002-0354-4519; Martinez,
   Alejandra/0000-0002-7633-3536; Couderc, Bettina/0000-0002-4530-5508;
   Ferron, Gwenael/0000-0002-8545-4700; Thibault,
   Benoit/0000-0003-3250-1988; DELORD, Jean-Pierre/0000-0001-7305-5561
FU Groupe de Recherche Institut Claudius Regaud
FX We are grateful to the Groupe de Recherche Institut Claudius Regaud for
   the grant support. We are grateful to Lourdes Gasquet and Jocelyne
   Meilhon at the animal facility. The manuscript was revised by
   Angloscribe (Clarensac) for English language editing.
CR Anttila MA, 2000, CANCER RES, V60, P150
   Bae DS, 2013, J KOREAN SURG SOC, V85, P199, DOI 10.4174/jkss.2013.85.5.199
   Baiocchi G, 2011, J SURG ONCOL, V104, P250, DOI 10.1002/jso.21940
   Bashir S, 2013, DIS COLON RECTUM, V56, P1174, DOI 10.1097/DCR.0b013e31829ec889
   Bourdel N, 2008, J MINIM INVAS GYN, V15, P321, DOI 10.1016/j.jmig.2008.02.004
   Bourguignon LYW, 2007, J BIOL CHEM, V282, P1265, DOI 10.1074/jbc.M604672200
   Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200
   Bristow RE, 2005, GYNECOL ONCOL, V99, P301, DOI 10.1016/j.ygyno.2005.06.057
   Bristow RE, 2007, GYNECOL ONCOL, V104, P739, DOI 10.1016/j.ygyno.2006.09.029
   CANNISTRA SA, 1993, CANCER RES, V53, P3830
   Carpenter PM, 2003, ANTICANCER RES, V23, P3985
   Chereau E, 2009, B CANCER, V96, P1189, DOI 10.1684/bdc.2009.0985
   Diamond MP, 2012, GYNECOL SURG, V9, P237, DOI 10.1007/s10397-012-0741-9
   Gardner MJ, 1996, CLIN EXP METASTAS, V14, P325, DOI 10.1007/BF00123391
   Gladieff L, 2009, B CANCER, V96, P1235, DOI 10.1684/bdc.2009.0982
   Hiltunen ELJ, 2002, CANCER RES, V62, P6410
   Hubbard SC, 2002, DIS COLON RECTUM, V45, P334
   Hubbard SC, 2002, DIS COLON RECTUM, V45, P341
   JONES LMH, 1995, CLIN EXP METASTAS, V13, P373
   Kayastha S, 1999, CLIN CANCER RES, V5, P1073
   Kouvidi K, 2011, J BIOL CHEM, V286, P38509, DOI 10.1074/jbc.M111.275875
   Krill LS, 2011, GYNECOL ONCOL, V120, P220, DOI 10.1016/j.ygyno.2010.10.037
   Kusunoki M, 2005, SURG TODAY, V35, P940, DOI 10.1007/s00595-005-3061-0
   Leitao MM, 2010, GYNECOL ONCOL, V119, P208, DOI 10.1016/j.ygyno.2010.07.027
   Li CZ, 2008, FOLIA BIOL-PRAGUE, V54, P180
   Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x
   Mizrahy S, 2011, J CONTROL RELEASE, V156, P231, DOI 10.1016/j.jconrel.2011.06.031
   Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102
   Oikonomakis L, 2002, DIS COLON RECTUM, V45, P1376, DOI 10.1097/01.DCR.0000029589.75029.17
   Pucciarelli S, 2003, BRIT J SURG, V90, P66, DOI 10.1002/bjs.4006
   Ricciardelli C, 2006, SEMIN REPROD MED, V24, P270, DOI 10.1055/s-2006-948556
   Tabata T, 2010, INT J GYNECOL CANCER, V20, P188, DOI 10.1111/IGC.0b013e3181c7fe84
   Tan A, 2009, ANN SURG ONCOL, V16, P499, DOI 10.1245/s10434-008-0235-1
   Tan B, 2001, BRIT J SURG, V88, P246, DOI 10.1046/j.1365-2168.2001.01664.x
   Thibault B, 2013, CANCER METAST REV, V33, P17, DOI DOI 10.1007/S10555-013-9456-2
   Ward BC, 2011, J SURG RES, V165, P91, DOI 10.1016/j.jss.2009.09.015
   Ween MP, 2011, CLIN EXP METASTAS, V28, P113, DOI 10.1007/s10585-010-9363-7
   Yabushita H, 2004, ONCOL REP, V12, P739
NR 38
TC 6
Z9 7
U1 0
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-2215
J9 J OVARIAN RES
JI J. Ovarian Res.
PD APR 16
PY 2014
VL 7
AR 40
DI 10.1186/1757-2215-7-40
PG 12
WC Reproductive Biology
SC Reproductive Biology
GA AF7DO
UT WOS:000334873900001
PM 24739440
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Sah, MK
   Pramanik, K
AF Sah, Mahesh Kumar
   Pramanik, Krishna
TI Soluble-Eggshell-Membrane-Protein-Modified Porous Silk Fibroin Scaffolds
   with Enhanced Cell Adhesion and Proliferation Properties
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biocompatibility; bioengineering; biomaterials; porous materials;
   properties and characterization
ID TISSUE ENGINEERING-SCAFFOLD; IN-VITRO; BIOMATERIAL SCAFFOLDS;
   MECHANICAL-PROPERTIES; SURFACE MODIFICATION; POLYMER SCAFFOLDS; MATRIX
   PROTEINS; CROSS-LINKING; EGG-SHELL; CARTILAGE
AB In this study, a porous silk fibroin (SF) scaffold was modified with soluble eggshell membrane protein (SEP) with the aim of improving the cell affinity properties of the scaffold for tissue regeneration. The pore size and porosity of the prepared scaffold were in the ranges 200-300 m and 85-90%, respectively. The existence of SEP on the scaffold surface and the structural and thermal stability were confirmed by energy-dispersive X-ray spectroscopy, X-ray diffraction, Fourier transform infrared spectroscopy, differential scanning calorimetry, and thermogravimetric analysis. The cell culture study indicated a significant improvement in the cell adhesion and proliferation of mesenchymal stem cells (MSCs) on the SF scaffold modified with SEP. The cytocompatibility of the SEP-conjugated SF scaffold was confirmed by a 3-(4,5-dimethyltriazol-2-y1)-2,5-diphenyl tetrazolium assay. Thus, this study demonstrated that the biomimic properties of the scaffold could be enhanced by surface modification with SEP. (c) 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014, 131, 40138.
C1 [Sah, Mahesh Kumar; Pramanik, Krishna] Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela 769008, India.
RP Pramanik, K (reprint author), Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela 769008, India.
EM kpr@nitrkl.ac.in
RI Pramanik, Krishna/M-3729-2018
OI Pramanik, Krishna/0000-0002-5676-7740
FU National Institute of Technology (Rourkela, India)
FX The authors are thankful to the Department of Biotechnology (New Delhi,
   India) and the Government of India for providing the research facility
   and the National Institute of Technology (Rourkela, India) for providing
   a fellowship to one of the authors.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Ahlborn G, 2005, POULTRY SCI, V84, P1935, DOI 10.1093/ps/84.12.1935
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Araki Y, 2001, ENDOSCOPY, V33, P85, DOI 10.1055/s-2001-11178
   BAKER J. R., 1962, BIOCHEM JOUR, V82, P352
   Burdick JA, 2011, BIOMATERIALS FOR TISSUE ENGINEERING APPLICATIONS: A REVIEW OF THE PAST AND FUTURE TRENDS, P1, DOI 10.1007/978-3-7091-0385-2_1
   Burley R. W., 1989, AVIAN EGG CHEM BIOL, P472
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   CORY AH, 1991, CANCER COMMUN, V3, P207
   CROMBIE G, 1981, BIOCHIM BIOPHYS ACTA, V640, P365, DOI 10.1016/0005-2736(81)90560-5
   deGroot JH, 1996, BIOMATERIALS, V17, P163, DOI 10.1016/0142-9612(96)85761-9
   Dinerman AA, 2002, J CONTROL RELEASE, V82, P277, DOI 10.1016/S0168-3659(02)00134-7
   Dobkowski J, 1999, J BIOMED MATER RES, V47, P234, DOI 10.1002/(SICI)1097-4636(199911)47:2<234::AID-JBM14>3.0.CO;2-X
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Gil ES, 2007, MAT SCI ENG C-BIO S, V27, P426, DOI 10.1016/j.msec.2006.05.017
   Gomathi K, 2003, BIOMATERIALS, V24, P2767, DOI 10.1016/S0142-9612(03)00059-0
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P785
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jung H, 2008, COLLOID SURFACE A, V313, P562, DOI 10.1016/j.colsurfa.2007.05.070
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HM, 1999, J BIOMED MATER RES, V46, P228, DOI 10.1002/(SICI)1097-4636(199908)46:2<228::AID-JBM12>3.0.CO;2-J
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kodali VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018187
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEACH RM, 1981, ARCH BIOCHEM BIOPHYS, V207, P353, DOI 10.1016/0003-9861(81)90042-4
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   MA PX, 2005, ENCY POLYM SCI TECHN, V12, P261
   MAEDA K, 1982, BURNS, V8, P313, DOI 10.1016/0305-4179(82)90029-8
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Mayer J, 2000, J CONTROL RELEASE, V64, P81, DOI 10.1016/S0168-3659(99)00136-4
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nakano T, 2003, POULTRY SCI, V82, P510, DOI 10.1093/ps/82.3.510
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nys Y, 2001, WORLD POULTRY SCI J, V57, P401, DOI 10.1079/WPS20010029
   Ohgo K, 2003, POLYMER, V44, P841, DOI 10.1016/S0032-3861(02)00819-4
   Oki A, 2006, MATER LETT, V60, P2751, DOI 10.1016/j.matlet.2006.01.084
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   Remy M, 1999, BIOMATERIALS, V20, P241, DOI 10.1016/S0142-9612(98)00167-7
   Rice MA, 2005, OTOLARYNG CLIN N AM, V38, P199, DOI 10.1016/j.otc.2004.10.010
   Rose MLH, 2009, CELL MOL LIFE SCI, V66, P2707, DOI 10.1007/s00018-009-0046-y
   Sah MK, 2011, AFR J BIOTECHNOL, V10, P7878
   Sun XJ, 2008, CLIN ORAL IMPLAN RES, V19, P804, DOI 10.1111/j.1600-0501.2008.01577.x
   SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0
   SUYAMA K, 1977, J AGR FOOD CHEM, V25, P799, DOI 10.1021/jf60212a045
   Takahashi K, 1996, BIOSCI BIOTECH BIOCH, V60, P1299, DOI 10.1271/bbb.60.1299
   TAVASSOLI M, 1983, EXPERIENTIA, V39, P411, DOI 10.1007/BF01963153
   Torres FG, 2007, COMPOS SCI TECHNOL, V67, P1139, DOI 10.1016/j.compscitech.2006.05.018
   Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Wang JL, 2011, COLLOID SURFACE B, V85, P241, DOI 10.1016/j.colsurfb.2011.02.035
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wilson A. P, 2000, ANIMAL CELL CULTURE, P175
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P1513, DOI 10.1016/S0142-9612(99)00062-9
   Yi F, 2004, BIOMATERIALS, V25, P4591, DOI 10.1016/j.biomaterials.2003.11.052
   Yi F, 2003, MACROMOL BIOSCI, V3, P234, DOI 10.1002/mabi.200390030
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 71
TC 8
Z9 8
U1 5
U2 42
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD APR 15
PY 2014
VL 131
IS 8
AR 40138
DI 10.1002/app.40138
PG 11
WC Polymer Science
SC Polymer Science
GA AE2MC
UT WOS:000333806100066
DA 2018-10-20
ER

PT J
AU Zang, SS
   Zhuo, Q
   Chang, X
   Qiu, GX
   Wu, ZH
   Yang, G
AF Zang, Shanshan
   Zhuo, Qi
   Chang, Xiao
   Qiu, Guixing
   Wu, Zhihong
   Yang, Guang
TI Study of osteogenic differentiation of human adipose-derived stem cells
   (HASCs) on bacterial cellulose
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Bacterial cellulose; Human adipose-derived stem cells; Bone tissue
   engineering; Biomaterials; Artificial scaffold
ID BIOMEDICAL APPLICATIONS; EXTRACELLULAR-MATRIX; MICROBIAL CELLULOSE;
   GENE-EXPRESSION; BONE-MARROW; TISSUE; HYDROXYAPATITE; NANOCOMPOSITES;
   CARTILAGE; BIOCOMPATIBILITY
AB Bacterial cellulose (BC) has been proposed as a biomaterial applied in biomedical scope due to its good biocompatibility. Recent reports showed that human adipose-derived stem cells (HASCs) have become a new choice to be used as seeding cells in tissue engineering. The objective of this study is to explore the potential of using BC and HASCs as scaffold and seeding cells in bone tissue engineering. The osteogenic differentiation was investigated by Von Kossa, Alizarin Red, ALP cellular staining and RT-PCR. The results showed that HASCs took a successful osteogenic differentiation on BC. Moreover, the in vivo animal test also provided the confirmation of the repair ability of BC on damaged bone. In conclusion, the author demonstrates the osteogenic differentiation of HASCs on BC and the feasibility of using BC and HASCs as scaffold and seeding cells in bone tissue engineering. Crown Copyright (C) 2014 Published by Elsevier Ltd. All rights reserved.
C1 [Zang, Shanshan; Yang, Guang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biomed Engn, Wuhan 430074, Peoples R China.
   [Zhuo, Qi] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed Surg, Beijing 100853, Peoples R China.
   [Chang, Xiao; Qiu, Guixing; Wu, Zhihong] Peking Union Med Coll, Dept Orthopaed, Beijing 100730, Peoples R China.
RP Wu, ZH (reprint author), Peking Union Med Coll, Dept Orthopaed, Beijing 100730, Peoples R China.
EM wuzh3000@126.com; yang_sunny@yahoo.com
OI Qiu, Guixing/0000-0002-4597-9350
FU National Natural Science Foundation of P.R. China [21074041, 81201404]
FX This work was supported by the National Natural Science Foundation of
   P.R. China (21074041, 81201404).
CR Aravamudhan A, 2013, J BIOMED NANOTECHNOL, V9, P719, DOI 10.1166/jbn.2013.1574
   Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Fu LN, 2012, J MATER CHEM, V22, P12349, DOI 10.1039/c2jm00134a
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Hu YY, 2011, CHEM MATER, V23, P2481, DOI 10.1021/cm200355n
   Huang JI, 2002, PLAST RECONSTR SURG, V109, P1033, DOI 10.1097/00006534-200203000-00037
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047
   Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234
   Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030
   Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371
   OWEN M, 1988, CIBA F SYMP, V136, P42
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   RODAN GA, 1992, BONE, V13, pS3, DOI 10.1016/S8756-3282(09)80003-3
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schlichting KE, 2011, ACTA BIOMATER, V7, P3094, DOI 10.1016/j.actbio.2011.04.010
   Shi ZJ, 2012, RSC ADV, V2, P1040, DOI 10.1039/c1ra00719j
   Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86, DOI 10.1007/s005860100283
   Stylios G, 2007, INJURY, V38, pS63, DOI 10.1016/j.injury.2007.02.011
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000
   Yamamoto H, 1996, CELLULOSE, V3, P229, DOI 10.1007/BF02228804
   Yasuda K, 2005, BIOMATERIALS, V26, P4468, DOI 10.1016/j.biomaterials.2004.11.021
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 45
TC 7
Z9 8
U1 0
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD APR 15
PY 2014
VL 104
BP 158
EP 165
DI 10.1016/j.carbpol.2014.01.019
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA AE2FC
UT WOS:000333787700022
PM 24607173
DA 2018-10-20
ER

PT J
AU Chetibi, L
   Hamana, D
   Achour, S
AF Chetibi, Loubna
   Hamana, Djamel
   Achour, Slimane
TI Growth and characterization of hydroxyapatite nanorice on TiO2
   nanofibers
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterial; XPS; SEM; TEM; Electron probe; Corrosion
ID SIMULATED BODY-FLUID; ELECTROPHORETIC DEPOSITION; TITANIUM SUBSTRATE;
   COATINGS; SURFACE; ELECTRODEPOSITION; NANOTUBES; OXIDATION; CORROSION;
   ALLOY
AB Hydroxyapatite (HA) coating with nanoparticles like nanorice is fabricated on chemically pretreated titanium (Ti) surface, through an electrochemical deposition approach, for biomaterial applications. The Ti surface was chemically patterned with anatase TiO2 nanofibers. These nanofibers were prepared by in situ oxidation of Ti foils in a concentrated solution of H2O2 and NaOH, followed by proton exchange and calcinations. Afterward, TiO2 nanofibers on Ti substrate were coated with HA nanoparticles like nanorice. The obtained samples were annealed at high temperature to produce inter diffusion between TiO2 and HA layers. The resultant layers were characterized by Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM), X-ray Photoelectron Spectroscopy (XPS), X-ray Diffraction (XRD), Infrared Spectroscopy (FTIR), corrosion tests in SBF solution, and Electron Probe Micro Analysis (EPMA). It was found that only Ti from the titanium substrate diffuses into the HA coating and a good corrosion resistance in simulated body fluid was obtained. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Chetibi, Loubna; Hamana, Djamel] Univ Constantine, Unit Mat Sci & Applicat, Constantine 25000, Algeria.
   [Achour, Slimane] Univ Constantine, Ceram Lab, Constantine 25000, Algeria.
RP Achour, S (reprint author), Univ Constantine, Ceram Lab, Constantine 25000, Algeria.
EM Ch_loubna@hotmail.com; d_hamana@yahoo.fr; achourslimane11@yahoo.fr
FU King Abdullah University of Science and Technology (KAUST)
FX The authors acknowledge C. Sahraoui from King Abdullah University of
   Science and Technology (KAUST) for his funding and assistance in
   analysis.
CR Abidov A., 2013, J MAT MECH MANUF, V1, P294
   Advincula MC, 2007, J BIOMED MATER RES B, V80B, P107, DOI 10.1002/jbm.b.30575
   Afshar A, 2006, MAT SCI ENG B-SOLID, V128, P243, DOI 10.1016/j.mseb.2005.11.022
   Anselme K., 2011, J OSTEOPOROS INT, V22, P2037
   Armstong A.R., 2004, J CHEM INT EDN, V43, P2286
   BAN S, 1993, JPN J APPL PHYS 2, V32, pL1577, DOI 10.1143/JJAP.32.L1577
   Belyakov AV, 1997, GLASS CERAM+, V54, P317, DOI 10.1007/BF02765866
   Cabrini M, 1997, BIOMATERIALS, V18, P783, DOI 10.1016/S0142-9612(96)00205-0
   Chern Lin J.H., 1995, J MAT CHEM PHYS, V41, P282
   Conforto E, 2008, ACTA BIOMATER, V4, P1934, DOI 10.1016/j.actbio.2008.05.001
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Fan HY, 2012, APPL CATAL B-ENVIRON, V119, P49, DOI 10.1016/j.apcatb.2012.02.016
   Gu YW, 2004, BIOMATERIALS, V25, P4127, DOI 10.1016/j.biomaterials.2003.11.030
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1111, DOI 10.1002/jbm.820240813
   Kar A, 2006, SURF COAT TECH, V201, P3723, DOI 10.1016/j.surfcoat.2006.09.008
   Kasuga T, 1999, ADV MATER, V11, P1307, DOI 10.1002/(SICI)1521-4095(199910)11:15<1307::AID-ADMA1307>3.0.CO;2-H
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Kunze J, 2008, ELECTROCHIM ACTA, V53, P6995, DOI 10.1016/j.electacta.2008.01.027
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Laik A, 2006, METALL MATER TRANS A, V37A, P2919, DOI 10.1007/s11661-006-0173-0
   Langer R., 2004, J NAT, P428
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Macwan DP, 2011, J MATER SCI, V46, P3669, DOI 10.1007/s10853-011-5378-y
   Mohan L, 2012, CERAM INT, V38, P3435, DOI 10.1016/j.ceramint.2011.12.056
   Okido M, 2002, SOLID STATE IONICS, V151, P47, DOI 10.1016/S0167-2738(02)00603-3
   Park JH, 2005, SURF COAT TECH, V195, P252, DOI 10.1016/j.surfcoat.2004.08.185
   Park JH, 2006, MATER LETT, V60, P2573, DOI 10.1016/j.matlet.2005.07.091
   Rath PC, 2012, CERAM INT, V38, P3209, DOI 10.1016/j.ceramint.2011.12.026
   SAUER GR, 1988, J BIOL CHEM, V263, P13718
   Scanlon DO, 2013, NAT MATER, V12, P798, DOI [10.1038/nmat3697, 10.1038/NMAT3697]
   Shashwat S.B., 2011, J ADV BIOMATER, V13, P11
   Shaylin S., 2012, J ACTA BIOMATER, V8, P20
   Sobon G, 2012, OPT EXPRESS, V20, P19463, DOI 10.1364/OE.20.019463
   Souto RM, 2003, BIOMATERIALS, V24, P4213, DOI 10.1016/S0142-9612(03)00362-4
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   Voigts F, 2009, SURF SCI, V603, P40, DOI 10.1016/j.susc.2008.10.016
   Wang LQ, 1995, SURF SCI, V344, P237, DOI 10.1016/0039-6028(95)00859-4
   Wang YQ, 2008, T NONFERR METAL SOC, V18, P631, DOI 10.1016/S1003-6326(08)60110-7
   Wang ZW, 2011, CURR APPL PHYS, V11, P1405, DOI 10.1016/j.cap.2011.04.011
   Wu Y, 2009, J NANOTECHNOL, V20
   Xiao XF, 2006, SURF COAT TECH, V200, P4406, DOI 10.1016/j.surfcoat.2005.02.205
   Xiaoli J., 2012, INT J MOL SCI, V13, P5242
   Yan XB, 2006, J PHYS CHEM B, V110, P25844, DOI 10.1021/jp065434g
   Yao ZQ, 2010, ACTA BIOMATER, V6, P2816, DOI 10.1016/j.actbio.2009.12.053
   Yingchao S., 2012, I J ELECTROCHEM SCI, V7, P11497
   Yoshida R, 2005, J SOLID STATE CHEM, V178, P2179, DOI 10.1016/j.jssc.2005.04.025
   You CK, 2001, J SOL-GEL SCI TECHN, V21, P49, DOI 10.1023/A:1011253431489
   Zhang BK, 2011, J MATER SCI-MATER M, V22, P2249, DOI 10.1007/s10856-011-4416-2
   Zhang ZT, 2002, MATER RES SOC SYMP P, V703, P291
   Zhao XH, 2009, CHINESE J CHEM ENG, V17, P667, DOI 10.1016/S1004-9541(08)60261-X
   Zhu L, 2006, J BIOMED MATER RES A, V78A, P515, DOI 10.1002/jbm.e.30745
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
NR 53
TC 6
Z9 6
U1 2
U2 49
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD APR 15
PY 2014
VL 144
IS 3
BP 301
EP 309
DI 10.1016/j.matchemphys.2013.12.037
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA AD8CF
UT WOS:000333493400013
DA 2018-10-20
ER

PT J
AU Franca, R
   Samani, TD
   Bayade, G
   Yahia, L
   Sacher, E
AF Franca, Rodrigo
   Samani, Taraneh Djavanbakht
   Bayade, Ghislaine
   Yahia, L'Hocine
   Sacher, Edward
TI Nanoscale surface characterization of biphasic calcium phosphate, with
   comparisons to calcium hydroxyapatite and p-tricalcium phosphate
   bioceramics
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Biphasic calcium phosphate; FTIR; Hydroxyapatite; beta-tricalcium
   phosphate; Porosity; SEM; TOF-SIMS; XPS; XRD
ID BONE-GRAFT SUBSTITUTES; CERAMICS IN-VITRO; PROTEIN ADSORPTION;
   SOFT-TISSUE; VIVO; POROSITY; XPS; TCP; NANOPARTICLES; BIOACTIVITY
AB Objectives: It is our aim to understand the mechanisms that make calcium phosphates, such as bioactive calcium hydroxyapatite (HA), and biphasic calcium (BCP) and p-tricalcium (I3-TCP) phosphates, desirable for a variety of biological applications, such as the filling of bone defects. Methods: Here, we have characterized these materials by X-ray photoelectron spectroscopy (XPS), X-ray diffraction (XRD), scanning electron microscopy (SEM), Fourier-transform infrared (FTIR), time-of-flight secondary ion mass spectroscopy (TOP-SIMS) and laser granulometry. Results: SEM shows clearly that BCP is a matrix made of macro-organized microstructure, giving insight to the specially chosen composition of the BCP that offers both an adequate scaffold and good porosity for further bone growth. As revealed by laser granulometry, the particles exhibit a homogeneous size distribution, centered at a value somewhat larger than the expected 500 p.m. XPS has revealed the presence of adventitious carbon at all sample surfaces, and has shown that Ca/P and 0/Ca ratios in the outer layers of all the samples differ significantly from those expected. A peak-by-peak XPS comparison for all samples has revealed that TCP and BCP are distinct from one another in the relative intensities of their oxygen peaks. The PO/PO i and CaOH+/Ca+ TOF-SIMS intensity ratios were used to distinguish among the samples, and to demonstrate that the OH- fragment, present in all the samples, is not formed during fragmentation but exists at the sample surface, probably as a contaminant. Conclusions: This study provides substantial insight into the nanoscale surface properties of BCP, HA and 13-TCP. Further research is required to help identify the effect of surfaces of these bioceramics with proteins and several biological fluids. Clinical relevance: The biological performance of implanted synthetic graft bone biomaterials is strongly influenced by their nanosurface characteristics, the structures and properties of the outer layer of the biomaterial. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Franca, Rodrigo; Samani, Taraneh Djavanbakht; Bayade, Ghislaine; Yahia, L'Hocine; Sacher, Edward] Ecole Polytech, Lab Innovat & Anal Bioperformance, Montreal, PQ H3C 3A7, Canada.
   [Franca, Rodrigo] Univ Manitoba, Dent Biomat Res Lab, Dept Restorat Dent, Fac Dent, Winnipeg, MB R3E 0W2, Canada.
   [Sacher, Edward] Ecole Polytech, Dept Genie Phys, Montreal, PQ H3C 3A7, Canada.
RP Franca, R (reprint author), Univ Manitoba, Dent Biomat Res Lab, Dept Restorat Dent, Fac Dent, 780 Bannatyne Ave, Winnipeg, MB R3E 0W2, Canada.
EM rodrigo_franca@umanitoba.ca
OI Franca, Rodrigo/0000-0003-2905-3803
FU ITI Foundation for the Promotion of Implantology
FX Financial support, by the ITI Foundation for the Promotion of
   Implantology, is gratefully acknowledged. We thank Straumann, Inc., for
   furnishing the Straumann BoneCeramic 500.
CR Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Bayazit V., 2010, DIG J NANOMATER BIOS, V7, P267
   Cazalbou S, 2005, J MATER SCI-MATER M, V16, P405, DOI 10.1007/s10856-005-6979-2
   Chusuei CC, 1999, ANAL CHEM, V71, P149, DOI 10.1021/ac9806963
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Daculsi G., 2008, BIOCERAMICS THEIR CL
   Dietze S., 2006, Folia Morphologica, V65, P63
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Franca R, 2013, J COLLOID INTERF SCI, V389, P292, DOI 10.1016/j.jcis.2012.08.065
   Franca R, 2013, J BIOMED MATER RES B, V101, P1444, DOI 10.1002/jbm.b.32964
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Hayakawa S., 2008, BIOCERAMICS THEIR CL
   Hench L.L., 1991, J AM CERAM SOC, V74, P487
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Jensen SS, 2007, CLIN ORAL IMPLAN RES, V18, P752, DOI 10.1111/j.1600-0501.2007.01417.x
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Kauschke E., 2006, Folia Morphologica, V65, P37
   KIM HM, 2003, SOLID STATE MAT SCI, V7, P289
   Knabe C., 2008, BIOCERAMICS THEIR CL
   LANGFORD JI, 1978, J APPL CRYSTALLOGR, V11, P102, DOI 10.1107/S0021889878012844
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   Lu HB, 2000, ANAL CHEM, V72, P2886, DOI 10.1021/ac990812h
   Marchi J, 2009, INT J APPL CERAM TEC, V6, P60, DOI 10.1111/j.1744-7402.2008.02254.x
   Mbeh DA, 2012, J BIOMED MATER RES A, V100A, P1637, DOI 10.1002/jbm.a.34096
   McLeod K, 2010, APPL SURF SCI, V256, P7178, DOI 10.1016/j.apsusc.2010.05.047
   McLeod K, 2006, APPL SURF SCI, V253, P2644, DOI 10.1016/j.apsusc.2006.05.031
   MORENO EC, 1991, CALCIFIED TISSUE INT, V49, P6, DOI 10.1007/BF02555895
   Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Rompen E, 2006, CLIN ORAL IMPLAN RES, V17, P55, DOI 10.1111/j.1600-0501.2006.01367.x
   Rumpel E., 2006, Folia Morphologica, V65, P43
   Scherrer P., 1918, NACHR GES WISS GOTT, V2, P98, DOI [DOI 10.1007/978-3-662-33915-2, 10.1007/978-3-662-33915-2_7]
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   Wiltfang J, 2002, J BIOMED MATER RES, V63, P115, DOI 10.1002/jbm.10084
   Xin RL, 2005, BIOMATERIALS, V26, P6477, DOI 10.1016/j.biomaterials.2005.04.028
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yoganand CP, 2010, CERAM INT, V36, P1757, DOI 10.1016/j.ceramint.2010.02.048
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Zhu XD, 2010, ACTA BIOMATER, V6, P1536, DOI 10.1016/j.actbio.2009.10.032
   Zhu XD, 2009, ACTA BIOMATER, V5, P1311, DOI 10.1016/j.actbio.2008.11.024
NR 43
TC 24
Z9 25
U1 1
U2 60
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD APR 15
PY 2014
VL 420
BP 182
EP 188
DI 10.1016/j.jcis.2013.12.055
PG 7
WC Chemistry, Physical
SC Chemistry
GA AC2RN
UT WOS:000332351800025
PM 24559717
DA 2018-10-20
ER

PT J
AU Dempsey, DK
   Robinson, JL
   Iyer, AV
   Parakka, JP
   Bezwada, RS
   Cosgriff-Hernandez, EM
AF Dempsey, David K.
   Robinson, Jennifer L.
   Iyer, Ananth V.
   Parakka, James P.
   Bezwada, Rao S.
   Cosgriff-Hernandez, Elizabeth M.
TI Characterization of a resorbable poly(ester urethane) with biodegradable
   hard segments
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE hydrolysis; mechanical properties; resorbable; aromatic isocyanate;
   cytocompatibility; polyurethanes
ID DEGRADABLE POLYURETHANE ELASTOMERS; STRUCTURE-PROPERTY RELATIONSHIPS;
   TYROSINE-BASED POLYURETHANES; WOUND DRESSING APPLICATIONS; IN-VITRO
   DEGRADATION; POLY(ETHYLENE GLYCOL); TRANSFECTION EFFICIENCY; BIOMATERIAL
   APPLICATIONS; MECHANICAL-PROPERTIES; EPSILON-CAPROLACTONE
AB The rapid growth of regenerative medicine and drug delivery fields has generated a strong need for improved polymeric materials that degrade at a controlled rate into safe, non-cytotoxic by-products. Polyurethane thermoplastic elastomers offer several advantages over other polymeric materials including tunable mechanical properties, excellent fatigue strength, and versatile processing. The variable segmental chemistry in developing resorbable polyurethanes also enables fine control over the degradation profile as well as the mechanical properties. Linear aliphatic isocyanates are most commonly used in biodegradable polyurethane formulations; however, these aliphatic polyurethanes do not match the mechanical properties of their aromatic counterparts. In this study, a novel poly(ester urethane) (PEsU) synthesized with biodegradable aromatic isocyanates based on glycolic acid was characterized for potential use as a new resorbable material in medical devices. Infrared spectral analysis confirmed the aromatic and phase-separated nature of the PEsU. Uniaxial tensile testing displayed stress-strain behavior typical of a semi-crystalline polymer above its T-g, in agreement with calorimetric findings. PEsU outperformed aliphatic PCL-based polyurethanes likely due to the enhanced cohesion of the aromatic hard domains. Accelerated degradation of the PEsU using 0.1 M sodium hydroxide resulted in hydrolysis of the polyester soft segment on the surface, reduced molecular weight, surface cracking, and a 30% mass loss after four weeks. Calorimetric studies indicated a disruption of the soft segment crystallinity after incubation which corresponded with a drop in initial modulus of the PEsU. Finally, cytocompatibility testing with 3T3 mouse fibroblasts exhibited cell viability on PEsU films comparable to a commercial poly(ether urethane urea) after 24 h followed by 85% cell viability at 72 h. Overall, this new resorbable polyurethane shows strong potential for use in wide range of biomedical applications.
C1 [Dempsey, David K.; Robinson, Jennifer L.; Cosgriff-Hernandez, Elizabeth M.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
   [Iyer, Ananth V.; Parakka, James P.] DSM Biomed, Berkeley, CA 94710 USA.
   [Bezwada, Rao S.] Bezwada Biomed LLC, Hillsborough, NJ 08844 USA.
RP Cosgriff-Hernandez, EM (reprint author), Texas A&M Univ, Dept Biomed Engn, 5033 Emerging Technol Bldg, College Stn, TX 77843 USA.
EM cosgriff.hernandez@tamu.edu
RI Cosgriff-Hernandez, Elizabeth/E-6391-2016
OI Cosgriff-Hernandez, Elizabeth/0000-0002-4701-5600
CR Adhikari R, 2010, J MATER SCI-MATER M, V21, P1081, DOI 10.1007/s10856-009-3955-2
   Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Ayres E, 2007, EUR POLYM J, V43, P3510, DOI 10.1016/j.eurpolymj.2007.05.014
   Bachelder EM, 2008, MOL PHARMACEUT, V5, P876, DOI 10.1021/mp800068x
   Bense CA, 1999, J BIOMED MATER RES, V46, P305, DOI 10.1002/(SICI)1097-4636(19990905)46:3<305::AID-JBM1>3.0.CO;2-A
   Bernacca GM, 2002, J BIOMED MATER RES, V61, P138, DOI 10.1002/jbm.10149
   Bezwada R, 2006, US patent, Patent No. [20060188547 A1, 20060188547A1]
   Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   Chan-Chan LH, 2010, ACTA BIOMATER, V6, P2035, DOI 10.1016/j.actbio.2009.12.010
   Chiono V, 2011, MACROMOL BIOSCI, V11, P245, DOI 10.1002/mabi.201000354
   Choi T, 2011, J BIOMAT SCI-POLYM E, V22, P973, DOI 10.1163/092050610X540684
   COURY A, 2004, BIOMATERIALS SCI INT, P411
   da Silva GR, 2010, POLYM DEGRAD STABIL, V95, P491, DOI 10.1016/j.polymdegradstab.2010.01.001
   David G, 2011, DIG J NANOMATER BIOS, V6, P1575
   Dawlee S, 2011, BIOMED MATER, V6, P1
   deGroot JH, 1996, BIOMATERIALS, V17, P163, DOI 10.1016/0142-9612(96)85761-9
   Dempsey D, 2012, SZYCHERS HDB POLYURE, P671
   Dillon J, 1989, INFARED SPECTROSCOPI
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   GOLDBERG D, 1995, J ENVIRON POLYM DEGR, V3, P61, DOI 10.1007/BF02067481
   Gong CY, 2009, J APPL POLYM SCI, V113, P1111, DOI 10.1002/app.29946
   Gorna K, 2002, POLYM DEGRAD STABIL, V75, P113, DOI 10.1016/S0141-3910(01)00210-5
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guelcher S, 2007, TISSUE ENG, V13, P2321, DOI 10.1089/ten.2006.0395
   Gultekin G, 2009, J MATER SCI-MATER M, V20, P421, DOI 10.1007/s10856-008-3572-5
   Han J, 2009, FRONT MAT SCI CHINA, V3, P25, DOI [10.1007/s11706-009-0013-4, DOI 10.1007/S11706-009-0013-4]
   Hashizume R, 2010, BIOMATERIALS, V31, P3253, DOI 10.1016/j.biomaterials.2010.01.051
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   Hirsch DJ, 1997, ARTIF ORGANS, V21, P349
   Hung WC, 2009, J CONTROL RELEASE, V133, P68, DOI 10.1016/j.jconrel.2008.09.082
   Jaffe M, 2003, POLYMER, V44, P6033, DOI 10.1016/S0032-3861(03)00559-7
   Jiang X, 2007, EUR POLYM J, V43, P1838, DOI 10.1016/j.eurpolymj.2007.02.029
   Khosroshahi ME, 2004, IRAN POLYM J, V13, P503
   Kim SE, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/044106
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Legendre D, 2003, ARTIF ORGANS, V27, P457, DOI 10.1046/j.1525-1594.2003.07238.x
   LELAH MD, 1986, J BIOMED MATER RES, V20, P433, DOI 10.1002/jbm.820200403
   LELAH MD, 1987, POLYURETHANES MED
   Li ZBA, 2009, J BIOMAT SCI-POLYM E, V20, P1179, DOI 10.1163/156856209X452944
   Liu XY, 2009, BIOMATERIALS, V30, P6665, DOI 10.1016/j.biomaterials.2009.08.052
   Madra H, 2009, POLYM TEST, V28, P773, DOI 10.1016/j.polymertesting.2009.05.013
   MCCOY TJ, 1990, J BIOMED MATER RES, V24, P107, DOI 10.1002/jbm.820240110
   Moravek S, 2007, POLYM PREPR, V48, P568
   NATHAN A, 1992, MACROMOLECULES, V25, P4476, DOI 10.1021/ma00044a004
   PAVLOVA M, 1993, BIOMATERIALS, V14, P1024, DOI 10.1016/0142-9612(93)90196-9
   Reddy TT, 2006, MACROMOL SYMP, V242, P241, DOI 10.1002/masy.200651033
   Salacinski HJ, 2002, J BIOMED MATER RES, V59, P207
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Schawe JEK, 1998, J THERM ANAL CALORIM, V54, P565, DOI 10.1023/A:1010142510263
   SHARMA CP, 1983, CURR SCI INDIA, V52, P1057
   Shau MD, 2006, J BIOMED MATER RES A, V77A, P736, DOI 10.1002/jbm.a.30605
   Skarja GA, 2000, J APPL POLYM SCI, V75, P1522, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1522::AID-APP11>3.3.CO;2-1
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Spaans C, 1999, POLYM PREPR, V40, P589
   Spaans CJ, 1998, POLYM BULL, V41, P131, DOI 10.1007/s002890050343
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   Szycher M, 1999, SZYCHERS HDB POLYURE
   Tang YW, 2002, J BIOMAT SCI-POLYM E, V13, P463, DOI 10.1163/156856202320253965
   Thomas V, 2008, J MATER SCI-MATER M, V19, P2721, DOI 10.1007/s10856-008-3367-8
   Thomas V, 2009, J BIOMED MATER RES A, V89A, P192, DOI 10.1002/jbm.a.31937
   Tseng SJ, 2005, BIOCONJUGATE CHEM, V16, P1375, DOI 10.1021/bc050005r
   ULUBAYRAM K, 1992, POLYMER, V33, P2084, DOI 10.1016/0032-3861(92)90874-V
   Visscher SH, 2009, J BIOMED MATER RES B, V91B, P957, DOI 10.1002/jbm.b.31481
   WALPOTH B, 1986, Life Support Systems, V4, P82
   Ward R, 1994, 8 CIMTEC FOR NEW MAT
   Yang TF, 2004, BIOMACROMOLECULES, V5, P1926, DOI 10.1021/bm049763v
   Yucedag F, 2010, J APPL POLYM SCI, V115, P1347, DOI 10.1002/app.30788
   Zhang DW, 2011, J POLYM SCI POL CHEM, V49, P754, DOI 10.1002/pola.24488
   Zhang SB, 2004, J CONTROL RELEASE, V100, P165, DOI 10.1016/j.jconrel.2004.08.019
   Zhou CR, 1999, BIOMATERIALS, V20, P2093, DOI 10.1016/S0142-9612(99)00080-0
NR 73
TC 8
Z9 8
U1 4
U2 68
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD APR 13
PY 2014
VL 25
IS 6
BP 535
EP 554
DI 10.1080/09205063.2014.880247
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AE5RN
UT WOS:000334046600001
PM 24483140
DA 2018-10-20
ER

PT J
AU Schellenberg, A
   Ross, R
   Abagnale, G
   Joussen, S
   Schuster, P
   Arshi, A
   Pallua, N
   Jockenhoevel, S
   Gries, T
   Wagner, W
AF Schellenberg, Anne
   Ross, Robin
   Abagnale, Giulio
   Joussen, Sylvia
   Schuster, Philipp
   Arshi, Annahit
   Pallua, Norbert
   Jockenhoevel, Stefan
   Gries, Thomas
   Wagner, Wolfgang
TI 3D Non-Woven Polyvinylidene Fluoride Scaffolds: Fibre Cross Section and
   Texturizing Patterns Have Impact on Growth of Mesenchymal Stromal Cells
SO PLOS ONE
LA English
DT Article
ID HUMAN PLATELET LYSATE; FIBROBLASTS IN-VITRO; STEM-CELLS; CULTURE
   EXPANSION; DIFFERENTIATION; PROLIFERATION; ADHESION; MATRIX; REPAIR;
   PVDF
AB Several applications in tissue engineering require transplantation of cells embedded in appropriate biomaterial scaffolds. Such structures may consist of 3D non-woven fibrous materials whereas little is known about the impact of mesh size, pore architecture and fibre morphology on cellular behavior. In this study, we have developed polyvinylidene fluoride (PVDF) non-woven scaffolds with round, trilobal, or snowflake fibre cross section and different fibre crimp patterns (10, 16, or 28 needles per inch). Human mesenchymal stromal cells (MSCs) from adipose tissue were seeded in parallel on these scaffolds and their growth was compared. Initial cell adhesion during the seeding procedure was higher on non-wovens with round fibres than on those with snowflake or trilobal cross sections. All PVDF non-woven fabrics facilitated cell growth over a time course of 15 days. Interestingly, proliferation was significantly higher on non-wovens with round or trilobal fibres as compared to those with snowflake profile. Furthermore, proliferation increased in a wider, less dense network. Scanning electron microscopy (SEM) revealed that the MSCs aligned along the fibres and formed cellular layers spanning over the pores. 3D PVDF non-woven scaffolds support growth of MSCs, however fibre morphology and mesh size are relevant: proliferation is enhanced by round fibre cross sections and in rather wide-meshed scaffolds.
C1 [Schellenberg, Anne; Abagnale, Giulio; Joussen, Sylvia; Wagner, Wolfgang] Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn, Aachen, Germany.
   [Ross, Robin; Schuster, Philipp; Arshi, Annahit; Jockenhoevel, Stefan; Gries, Thomas] Rhein Westfal TH Aachen, Inst Text Technol, Aachen, Germany.
   [Pallua, Norbert] Rhein Westfal TH Aachen, Burn Ctr, Dept Plast & Reconstruct Surg, Aachen, Germany.
   [Jockenhoevel, Stefan] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Dept Appl Med Engn, Aachen, Germany.
RP Wagner, W (reprint author), Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn, Aachen, Germany.
EM wwagner@ukaachen.de
RI Gries, Thomas/M-8206-2018
OI Gries, Thomas/0000-0002-2480-8333; Wagner, Wolfgang/0000-0002-1971-3217;
   Jockenhoevel, Stefan/0000-0003-0584-9444
FU Stem Cell Network North Rhine Westphalia; Else-Kroner-Fresenius
   Stiftung; German Research Foundation [WA 1706/3-2, SPP1327]
FX This work was supported by the Stem Cell Network North Rhine Westphalia,
   by the Else-Kroner-Fresenius Stiftung, and by the German Research
   Foundation (WA 1706/3-2 within SPP1327). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Baumchen F, 2009, ORAL SURG ORAL MED O, V108, P505, DOI 10.1016/j.tripleo.2009.05.004
   Berger D, 2009, HERNIA, V13, P167, DOI 10.1007/s10029-008-0435-4
   Cardwell RD, 2012, J TISSUE ENG REGEN M
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chandrasekaran AR, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015001
   Cholewa D, 2011, CELL TRANSPLANT, V20, P1409, DOI 10.3727/096368910X557218
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Edwards SL, 2011, TISSUE ENG PART C-ME, V17, P123, DOI [10.1089/ten.tec.2010.0182, 10.1089/ten.TEC.2010.0182]
   Emans PJ, 2013, J TISSUE ENG REGEN M, V7, P751, DOI 10.1002/term.1477
   Engelmayr GC, 2006, J BIOMECH, V39, P1819, DOI 10.1016/j.jbiomech.2005.05.020
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Garcia JL, 2010, MOLECULES, V15, P2845, DOI 10.3390/molecules15042845
   GL de, 2013, CURR PHARM DESIGN, V19, P2459
   Grayson WL, 2004, BIOTECHNOL PROGR, V20, P905, DOI 10.1021/bp034296z
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Hegewald AA, 2013, J TISSUE ENG REGEN M
   Horn P, 2011, METHODS MOL BIOL, V698, P23, DOI 10.1007/978-1-60761-999-4_3
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Klinge U, 2002, BIOMATERIALS, V23, P3487, DOI 10.1016/S0142-9612(02)00070-4
   Klink CD, 2011, J INVEST SURG, V24, P292, DOI 10.3109/08941939.2011.589883
   LAROCHE G, 1995, J BIOMED MATER RES, V29, P1525, DOI 10.1002/jbm.820291209
   Leisten I, 2012, BIOMATERIALS, V33, P1736, DOI 10.1016/j.biomaterials.2011.11.034
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lohmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037839
   Luna SM, 2011, J BIOMATER APPL, V26, P101, DOI 10.1177/0885328210362924
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Mary C, 1998, ASAIO J, V44, P199, DOI 10.1097/00002480-199805000-00015
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Morgan SM, 2009, BIOMATERIALS, V30, P1910, DOI 10.1016/j.biomaterials.2008.12.033
   Neuss S, 2008, CELL TRANSPLANT, V17, P977, DOI 10.3727/096368908786576462
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Pasquinelli G, 2008, J ANAT, V213, P520, DOI 10.1111/j.1469-7580.2008.00974.x
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Puppi D, 2012, BIOMED MICRODEVICES, V14, P1115, DOI 10.1007/s10544-012-9677-0
   Roessger A, 2009, BIOMATERIALS, V30, P3723, DOI 10.1016/j.biomaterials.2009.03.041
   Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269
   Sarkar S, 2005, ACTA BIOMATER, V1, P93, DOI 10.1016/j.actbio.2004.08.003
   Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x
   Schellenberg A, 2012, CYTOTHERAPY, V14, P401, DOI 10.3109/14653249.2011.640669
   Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391
   Sensebe L., 2009, VOX SANG, V98, P93
   Sun T, 2009, J MATER SCI-MATER M, V20, P1483, DOI 10.1007/s10856-009-3703-7
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Tschoeke B, 2008, ARTIF ORGANS, V32, P800, DOI 10.1111/j.1525-1594.2008.00601.x
   Tuzlakoglu K, 2009, TISSUE ENG PART B-RE, V15, P17, DOI 10.1089/ten.teb.2008.0016
   URBAN E, 1994, ASAIO J, V40, P145
   Walenda G, 2012, TISSUE ENG PART C-ME, V18, P924, DOI [10.1089/ten.tec.2011.0541, 10.1089/ten.TEC.2011.0541]
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 56
TC 6
Z9 6
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 11
PY 2014
VL 9
IS 4
AR e94353
DI 10.1371/journal.pone.0094353
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI3CI
UT WOS:000336736200066
PM 24728045
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Choi, BH
   Cheong, H
   Jo, YK
   Bahn, SY
   Seo, JH
   Cha, HJ
AF Choi, Bong-Hyuk
   Cheong, Hogyun
   Jo, Yun Kee
   Bahn, So Yeong
   Seo, Jeong Hyun
   Cha, Hyung Joon
TI Highly purified mussel adhesive protein to secure biosafety for in vivo
   applications
SO MICROBIAL CELL FACTORIES
LA English
DT Article
DE Mussel adhesive protein; Gram-negative Escherichia coli; High resolution
   purification; Biosafety; Lipopolysaccharide; Endotoxin; In vivo standard
ID ENDOTOXIN REMOVAL; ESCHERICHIA-COLI; MYTILUS-EDULIS; TRITON X-114;
   RECOMBINANT; EXPRESSION
AB Background: Unique adhesive and biocompatibility properties of mussel adhesive proteins (MAPs) are known for their great potential in many tissue engineering and biomedical applications. Previously, it was successfully demonstrated that redesigned hybrid type MAP, fp-151, mass-produced in Gram-negative bacterium Escherichia coli, could be utilized as a promising adhesive biomaterial. However, purification of recombinant fp-151 has been unsatisfactory due to its adhesive nature and polarity which make separation of contaminants (especially, lipopolysaccharide, a toxic Gram-negative cell membrane component) very difficult.
   Results: In the present work, we devised a high resolution purification approach to secure safety standards of recombinant fp-151 for the successful use in in vivo applications. Undesirable impurities were remarkably eliminated as going through sequential steps including treatment with multivalent ion and chelating agent for cell membrane washing, mechanical cell disruption, non-ionic surfactant treatment for isolated inclusion body washing, acid extraction of washed inclusion body, and ion exchange chromatography purification of acid extracted sample. Through various analyses, such as high performance liquid chromatographic purity assay, limulus amoebocyte lysate endotoxin assay, and in vitro mouse macrophage cell tests on inflammation, viability, cytotoxicity, and apoptosis, we confirmed the biological safety of bacterial-derived purified recombinant fp-151.
   Conclusions: Through this purification design, recombinant fp-151 achieved 99.90% protein purity and 99.91% endotoxin reduction that nearly no inflammation response was observed in in vitro experiments. Thus, the highly purified recombinant MAP would be successfully used as a safety-secured in vivo bioadhesive for tissue engineering and biomedical applications.
C1 [Choi, Bong-Hyuk; Cheong, Hogyun; Jo, Yun Kee; Seo, Jeong Hyun; Cha, Hyung Joon] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea.
   [Bahn, So Yeong; Cha, Hyung Joon] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea.
   [Seo, Jeong Hyun] Yeungnam Univ, Sch Chem Engn, Kyongsan 712749, South Korea.
RP Cha, HJ (reprint author), Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea.
EM hjcha@postech.ac.kr
FU Marine Biotechnology program; Ministry of Oceans and Fisheries, Korea
   and Rising Star program -; POSTECH
FX This work was supported by the Marine Biotechnology program funded by
   the Ministry of Oceans and Fisheries, Korea and Rising Star program
   funded by POSTECH.
CR AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U
   Cho Hyung Joon, 2008, Biotechnology Journal, V3, P631, DOI 10.1002/biot.200700258
   Choi BH, 2010, BIOMATERIALS, V31, P8980, DOI 10.1016/j.biomaterials.2010.08.027
   DOVE J, 1986, J AM DENT ASSOC, V112, P879
   EDELSTEIN C, 1984, J LIPID RES, V25, P630
   El-Moghazy ANA, 2011, J SCI IND RES INDIA, V70, P55
   FILPULA DR, 1990, BIOTECHNOL PROGR, V6, P171, DOI 10.1021/bp00003a001
   Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200
   Hedhammar M, 2010, BIOMACROMOLECULES, V11, P953, DOI 10.1021/bm9014039
   Hwang DS, 2007, BIOMATERIALS, V28, P3560, DOI 10.1016/j.biomaterials.2007.04.039
   Hwang DS, 2005, BIOTECHNOL PROGR, V21, P965, DOI 10.1021/bp050014e
   Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004
   Kamino K, 2000, J BIOL CHEM, V275, P27360
   Kim BJ, 2012, ANGEW CHEM INT EDIT, V51, P675, DOI 10.1002/anie.201105789
   Kumar A, 2012, PROTEIN EXPRES PURIF, V83, P226, DOI 10.1016/j.pep.2012.04.002
   LEIVE L, 1968, J BIOL CHEM, V243, P6384
   LEIVE L, 1974, ANN NY ACAD SCI, V235, P109, DOI 10.1111/j.1749-6632.1974.tb43261.x
   Lezin G, 2011, BIOTECHNOL BIOENG
   Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0
   Ma R, 2012, ANAL BIOCHEM, V424, P124, DOI 10.1016/j.ab.2012.02.015
   Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388
   Miernikiewicz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038902
   Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6
   Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027
   SALERNO AJ, 1993, APPL MICROBIOL BIOT, V39, P221
   Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x
   Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172
   WAITE JH, 1983, J BIOL CHEM, V258, P2911
   Wang XY, 2010, SUBCELL BIOCHEM, V53, P3, DOI 10.1007/978-90-481-9078-2_1
   Wilson MJ, 2001, J BIOTECHNOL, V88, P67, DOI 10.1016/S0168-1656(01)00256-5
NR 30
TC 12
Z9 12
U1 4
U2 24
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2859
J9 MICROB CELL FACT
JI Microb. Cell. Fact.
PD APR 11
PY 2014
VL 13
AR 52
DI 10.1186/1475-2859-13-52
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AF4YE
UT WOS:000334719700001
PM 24725543
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU McKinnon, DD
   Domaille, DW
   Cha, JN
   Anseth, KS
AF McKinnon, Daniel D.
   Domaille, Dylan W.
   Cha, Jennifer N.
   Anseth, Kristi S.
TI Bis-Aliphatic Hydrazone-Linked Hydrogels Form Most Rapidly at
   Physiological pH: Identifying the Origin of Hydrogel Properties with
   Small Molecule Kinetic Studies
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID 3-DIMENSIONAL POLYMERS; BULK DEGRADATION; RELEASE; NETWORKS; MODEL;
   NANOPARTICLES; TEMPERATURE; ELASTICITY; ASSEMBLIES; COPOLYMERS
AB Rheological and small molecule kinetic studies were performed to study the formation and hydrolysis of the bis-aliphatic hydrazone bond. The rate of gelation was found to correspond closely with the rate of bond formation and the rate of gel relaxation with the rate of hydrolysis, indicating that small molecule kinetic studies can play an important role in material design. Furthermore, unlike aryl or acyl hydrazone bonds, the bis-aliphatic hydrazone bond forms rapidly under physiological conditions without requiring aniline catalysis yet maintains a pH-dependent rate of hydrolysis. These results suggest the bis-aliphatic hydrazone bond should find use alongside existing bioorthogonal click chemistries for bioconjugation, biomaterial synthesis, and controlled release applications.
C1 [McKinnon, Daniel D.; Domaille, Dylan W.; Cha, Jennifer N.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80303 USA.
   [McKinnon, Daniel D.; Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80303 USA.
   [Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA.
RP Cha, JN (reprint author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80303 USA.
EM Jennifer.Cha@colorado.edu; Kristi.Anseth@colorado.edu
OI Domaille, Dylan Wythe/0000-0003-0127-7485; DOMAILLE,
   DYLAN/0000-0003-2694-2832
FU Office of Naval Research [N00014-13-1-0283]; National Science Foundation
   [CBET 1236662]; Howard Hughes Medical Institute
FX Office of Naval Research (N00014-13-1-0283), the National Science
   Foundation (CBET 1236662), and the Howard Hughes Medical Institute
   funded this work.
CR Adzima BJ, 2010, ADV MATER, V22, P2784, DOI 10.1002/adma.200904138
   Azagarsamy MA, 2013, ANGEW CHEM INT EDIT, V52, P13803, DOI 10.1002/anie.201308174
   Azagarsamy MA, 2012, BIOMACROMOLECULES, V13, P2219, DOI 10.1021/bm300646q
   BAXANDALL LG, 1989, MACROMOLECULES, V22, P1982, DOI 10.1021/ma00194a076
   Blanden AR, 2011, BIOCONJUGATE CHEM, V22, P1954, DOI 10.1021/bc2001566
   CARPINO LA, 1994, J CHEM SOC CHEM COMM, P201, DOI 10.1039/c39940000201
   Chang BS, 2013, CHEM MATER, V25, P574, DOI 10.1021/cm3037197
   Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879
   Crisalli P, 2013, J ORG CHEM, V78, P1184, DOI 10.1021/jo302746p
   Deng GH, 2010, MACROMOLECULES, V43, P1191, DOI 10.1021/ma9022197
   Dirksen A, 2006, J AM CHEM SOC, V128, P15602, DOI 10.1021/ja067189k
   Dirksen A, 2010, ANGEW CHEM INT EDIT, V49, P2023, DOI 10.1002/anie.200906756
   Dirksen A, 2008, BIOCONJUGATE CHEM, V19, P2543, DOI 10.1021/bc800310p
   Domaille DW, 2013, CHEM COMMUN, V49, P1759, DOI 10.1039/c3cc38871a
   Dong HC, 2009, CHEM MATER, V21, P3965, DOI 10.1021/cm901143e
   Flory PJ, 1942, J PHYS CHEM-US, V46, P132, DOI 10.1021/j150415a016
   FLORY PJ, 1979, POLYMER, V20, P1317, DOI 10.1016/0032-3861(79)90268-4
   Flory PJ, 1941, J AM CHEM SOC, V63, P3083, DOI 10.1021/ja01856a061
   Gillies ER, 2004, J AM CHEM SOC, V126, P11936, DOI 10.1021/ja0463738
   Gillies ER, 2005, BIOCONJUGATE CHEM, V16, P361, DOI 10.1021/bc049851c
   Griffin DR, 2012, ACS MACRO LETT, V1, P1330, DOI 10.1021/mz300366s
   Griffin DR, 2012, J AM CHEM SOC, V134, P13103, DOI 10.1021/ja305280w
   Gumbley P, 2014, CHEM MATER, V26, P1450, DOI 10.1021/cm403979p
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Jing J, 2013, CHEM MATER, V25, P3867, DOI 10.1021/cm4019925
   Kalia J, 2008, ANGEW CHEM INT EDIT, V47, P7523, DOI 10.1002/anie.200802651
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kim J, 2012, SCIENCE, V335, P1201, DOI 10.1126/science.1215309
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kool ET, 2013, J AM CHEM SOC, V135, P17663, DOI 10.1021/ja407407h
   McKinnon DD, 2014, ADV MATER, V26, P865, DOI 10.1002/adma.201303680
   Metters A, 2005, BIOMACROMOLECULES, V6, P290, DOI 10.1021/bm049607o
   Metters AT, 2000, J PHYS CHEM B, V104, P7043, DOI 10.1021/jp000523t
   Metters AT, 2001, J PHYS CHEM B, V105, P8069, DOI 10.1021/jp004083h
   Nguyen R, 2003, CHEM COMMUN, P942, DOI 10.1039/b211645f
   OMURA K, 1978, TETRAHEDRON, V34, P1651, DOI 10.1016/0040-4020(78)80197-5
   Rodriguez-Hernandez J, 2005, J AM CHEM SOC, V127, P2026, DOI 10.1021/ja043920g
   Rubinstein M., 2003, POLYM PHYS
   Scott TF, 2005, SCIENCE, V308, P1615, DOI 10.1126/science.1110505
   Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516
   Wang H, 2013, P NATL ACAD SCI USA, V110, P19336, DOI 10.1073/pnas.1306369110
   Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039969
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]
   Zhang J, 2000, MACROMOLECULES, V33, P102, DOI 10.1021/ma991398q
NR 44
TC 41
Z9 41
U1 1
U2 67
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
EI 1520-5002
J9 CHEM MATER
JI Chem. Mat.
PD APR 8
PY 2014
VL 26
IS 7
BP 2382
EP 2387
DI 10.1021/cm5007789
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA AF2WD
UT WOS:000334572300024
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Ng, SS
   Wang, YL
   Feng, HX
   Chen, WN
   Chan-Park, MB
   Li, C
   Chan, V
AF Zhang, Ying
   Ng, Soon Seng
   Wang, Yilei
   Feng, Huixing
   Chen, Wei Ning
   Chan-Park, Mary B.
   Li, Chuan
   Chan, Vincent
TI Collective cell traction force analysis on aligned smooth muscle cell
   sheet between three-dimensional microwalls
SO INTERFACE FOCUS
LA English
DT Article
DE micropatterned scaffold; cell traction force microscopy; aligned smooth
   muscle cell sheet; mechanical stress
ID CYTOSKELETAL TENSION; CONTACT INHIBITION; GEOMETRIC CONTROL; E-CADHERIN;
   LC-MS/MS; ADHESION; MECHANOTRANSDUCTION; SUBSTRATE; MECHANICS; HYDROGELS
AB During the past two decades, novel biomaterial scaffold for cell attachment and culture has been developed for applications in tissue engineering, biosensing and regeneration medicine. Tissue engineering of blood vessels remains a challenge owing to the complex three-layer histology involved. In order to engineer functional blood vessels, it is essential to recapitulate the characteristics of vascular smooth muscle cells (SMCs) inside the tunica media, which is known to be critical for vasoconstriction and vasodilation of the circulatory system. Until now, there has been a lack of understanding on the mechanotransduction of the SMC layer during the transformation from viable synthetic to quiescent contractile phenotypes. In this study, microfabricated arrays of discontinuous microwalls coated with fluorescence microbeads were developed to probe the mechanotransduction of the SMC layer. First, the system was exploited for stimulating the formation of a highly aligned orientation of SMCs in native tunica medium. Second, atomic force microscopy in combination with regression analysis was applied to measure the elastic modulus of a polyacrylamide gel layer coated on the discontinuous microwall arrays. Third, the conventional traction force assay for single cell measurement was extended for applications in three-dimensional cell aggregates. Then, the biophysical effects of discontinuous microwalls on the mechanotransduction of the SMC layer undergoing cell alignment were probed. Generally, the cooperative multiple cell-cell and cell-microwall interactions were accessed quantitatively by the newly developed assay with the aid of finite-element modelling. The results show that the traction forces of highly aligned cells lying in the middle region between two opposing microwalls were significantly lower than those lying adjacent to the microwalls. Moreover, the spatial distributions of Von Mises stress during the cell alignment process were dependent on the collective cell layer orientation. Immunostaining of the SMC sheet further demonstrated that the collective mechanotransduction induced by three-dimensional topographic cues was correlated with the reduction of actin and vinculin expression. In addition, the online twodimensional LC-MS/MS analysis verified the modulation of focal adhesion formation under the influence of microwalls through the regulation in the expression of three key cytoskeletal proteins.
C1 [Zhang, Ying; Ng, Soon Seng; Wang, Yilei; Feng, Huixing; Chen, Wei Ning; Chan-Park, Mary B.; Chan, Vincent] Nanyang Technol Univ, Ctr Biotechnol, Sch Chem & Biomed Engn, Singapore 639798, Singapore.
   [Li, Chuan] Natl Yang Ming Univ, Dept Biomed Engn, Taipei 11221, Taiwan.
   [Li, Chuan] Natl Cent Univ, Dept Mech Engn, Tao Yuan 32001, Taiwan.
RP Li, C (reprint author), Natl Yang Ming Univ, Dept Biomed Engn, Taipei 11221, Taiwan.
EM cli10@ncu.edu.tw; mvchan@ntu.edu.sg
RI Chan-Park, Mary/G-6196-2010; Chan, Vincent/G-6197-2010
OI Chan-Park, Mary/0000-0003-3761-7517; Chan, Vincent/0000-0003-2149-4479
CR ABERCROMBIE M, 1970, IN VITRO CELL DEV B, V6, P128
   Abercrombie M, 1967, Natl Cancer Inst Monogr, V26, P249
   Angelini TE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.168104
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109
   Borghi N, 2010, P NATL ACAD SCI USA, V107, P13324, DOI 10.1073/pnas.1002662107
   Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Cao Y, 2010, BIOMATERIALS, V31, P6228, DOI 10.1016/j.biomaterials.2010.04.059
   CASTOR LN, 1968, J CELL PHYSIOL, V72, P161, DOI 10.1002/jcp.1040720304
   Chan-Park MB, 2009, J BIOMED MATER RES A, V91A, P629, DOI 10.1002/jbm.a.32597
   Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X
   Danjo Y, 1998, J CELL SCI, V111, P3323
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006
   du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Feng HX, 2010, J PROTEOMICS, V73, P1421, DOI 10.1016/j.jprot.2009.12.004
   Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114
   Garcia-Castro MI, 2000, SCIENCE, V288, P1047, DOI 10.1126/science.288.5468.1047
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gomez EW, 2010, J CELL BIOCHEM, V110, P44, DOI 10.1002/jcb.22545
   Gui L, 2000, EXP FLUIDS, V28, P36, DOI 10.1007/s003480050005
   Gui LC, 1996, EXP FLUIDS, V21, P465, DOI 10.1007/BF00189049
   Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699
   Hall MS, 2013, EXP CELL RES, V319, P2396, DOI 10.1016/j.yexcr.2013.06.009
   HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736
   Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316
   Jensen A, 2001, EXP FLUIDS, V30, P500, DOI 10.1007/s003480000229
   Kandow CE, 2007, METHOD CELL BIOL, V83, P29, DOI 10.1016/S0091-679X(07)83002-0
   Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476
   Krauss P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036575
   Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148
   Lecuit T, 2005, TRENDS CELL BIOL, V15, P34, DOI 10.1016/j.tcb.2004.11.007
   Li L, 2012, CELL MOL LIFE SCI, V69, P2779, DOI 10.1007/s00018-012-0951-3
   MARTZ E, 1972, J CELL PHYSIOL, V79, P189, DOI 10.1002/jcp.1040790205
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McGregor E, 2004, MOL CELL PROTEOMICS, V3, P115, DOI 10.1074/mcp.M300046-MCP200
   Mertz AF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.198101
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   Ng SS, 2011, INTERFACE FOCUS, V1, P777, DOI 10.1098/rsfs.2011.0036
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062
   Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109
   Shen JY, 2006, TISSUE ENG, V12, P2229, DOI 10.1089/ten.2006.12.2229
   Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102
   Sui JJ, 2008, MOL CELL PROTEOMICS, V7, P1007, DOI 10.1074/mcp.M700485-MCP200
   Sveen J., 2004, QUANTITATIVE IMAGING
   Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/nmat3025, 10.1038/NMAT3025]
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   TAN KL, 1993, MACROMOLECULES, V26, P2832, DOI 10.1021/ma00063a030
   Thakar RG, 2003, BIOCHEM BIOPH RES CO, V307, P883, DOI 10.1016/S0006-291X(03)01285-3
   Thurner PJ, 2009, WIRES NANOMED NANOBI, V1, P624, DOI 10.1002/wnan.56
   Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269
   Vedula SRK, 2012, P NATL ACAD SCI USA, V109, P12974, DOI 10.1073/pnas.1119313109
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7
   Watanabe N, 1999, NAT CELL BIOL, V1, P136
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Yang ZC, 2006, J THEOR BIOL, V242, P607, DOI 10.1016/j.jtbi.2006.05.005
   Yu F, 2011, J PEDIATR SURG, V46, P1948, DOI 10.1016/j.jpedsurg.2011.06.024
   Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586
NR 71
TC 5
Z9 6
U1 2
U2 33
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2042-8898
EI 2042-8901
J9 INTERFACE FOCUS
JI Interface Focus
PD APR 6
PY 2014
VL 4
IS 2
SI SI
AR 20130056
DI 10.1098/rsfs.2013.0056
PG 15
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA AC3CR
UT WOS:000332393100003
PM 24748953
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Chen, JL
   Duan, L
   Zhu, WM
   Xiong, JY
   Wang, DP
AF Chen, Jie-Lin
   Duan, Li
   Zhu, Weimin
   Xiong, Jianyi
   Wang, Daping
TI Extracellular matrix production in vitro in cartilage tissue engineering
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Review
DE Cartilage; Tissue engineering; Extracellular matrix; Collagen type II
ID MESENCHYMAL STEM-CELLS; HUMAN ARTICULAR CHONDROCYTES; TRANSFORMING
   GROWTH-FACTOR-BETA-1 TGF-BETA-1; INTERMITTENT HYDROSTATIC-PRESSURE; BONE
   MORPHOGENETIC PROTEIN-2; II COLLAGEN-SYNTHESIS; CHONDROGENIC
   DIFFERENTIATION; GENE-EXPRESSION; GROWTH-FACTOR; DOWN-REGULATION
AB Cartilage tissue engineering is arising as a technique for the repair of cartilage lesions in clinical applications. However, fibrocartilage formation weakened the mechanical functions of the articular, which compromises the clinical outcomes. Due to the low proliferation ability, dedifferentiation property and low production of cartilage-specific extracellular matrix (ECM) of the chondrocytes, the cartilage synthesis in vitro has been one of the major limitations for obtaining high-quality engineered cartilage constructs. This review discusses cells, biomaterial scaffolds and stimulating factors that can facilitate the cartilage-specific ECM production and accumulation in the in vitro culture system. Special emphasis has been put on the factors that affect the production of ECM macromolecules such as collagen type II and proteoglycans in the review, aiming at providing new strategies to improve the quality of tissue-engineered cartilage.
C1 [Chen, Jie-Lin; Duan, Li; Zhu, Weimin; Xiong, Jianyi; Wang, Daping] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Key Lab Tissue Engn, Shenzhen 518035, Guangdong, Peoples R China.
   [Chen, Jie-Lin; Duan, Li] Sun Yat Sen Univ, Sch Med, Guangzhou 510182, Guangdong, Peoples R China.
   [Chen, Jie-Lin; Duan, Li; Zhu, Weimin; Xiong, Jianyi; Wang, Daping] Shenzhen Second Peoples Hosp, Dept Orthoped, Shenzhen 518035, Guangdong, Peoples R China.
RP Wang, DP (reprint author), Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Key Lab Tissue Engn, Shenzhen 518035, Guangdong, Peoples R China.
EM dapingwang1963@qq.com
FU Shenzhen Science and Technology Key Project [201001013]; Shenzhen
   Science and Technology International Cooperative Project
   [20130326210545]
FX Our work was funded by Shenzhen Science and Technology Key Project
   (Project NO. 201001013) and Shenzhen Science and Technology
   International Cooperative Project (Project NO. 20130326210545).
CR Abazari A, 2013, CRYOBIOLOGY, V66, P201, DOI 10.1016/j.cryobiol.2013.03.001
   Abukawa H, 2013, J CRANIOFAC SURG, V24, P1026, DOI 10.1097/SCS.0b013e31827ff323
   Albrecht C, 2013, INT ORTHOP, V37, P2297, DOI 10.1007/s00264-013-2009-z
   Ando W, 2012, EUR CELLS MATER, V24, P292, DOI 10.22203/eCM.v024a21
   Barbero A, 2006, J CELL BIOCHEM, V98, P1140, DOI 10.1002/jcb.20754
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9
   Bueno EM, 2005, TISSUE ENG, V11, P1699, DOI 10.1089/ten.2005.11.1699
   Chadjichristos C, 2002, J BIOL CHEM, V277, P43903, DOI 10.1074/jbc.M206111200
   Chen WC, 2011, CYTOTECHNOLOGY, V63, P13, DOI 10.1007/s10616-010-9314-9
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109
   DUNKELMAN NS, 1995, BIOTECHNOL BIOENG, V46, P299, DOI 10.1002/bit.260460402
   Endres M, 2012, J ORTHOP TRAUMA RES, V7, P1
   Enochson L, 2012, BIORESEARCH OPEN ACC, V1, P306, DOI 10.1089/biores.2012.0277
   Forsey RW, 2012, BIOTECHNOL APPL BIOC, V59, P142, DOI 10.1002/bab.1009
   FREED LE, 1994, BIOTECHNOL BIOENG, V43, P605, DOI 10.1002/bit.260430710
   Furumatsu T, 2013, J BIOMECH, V46, P1508, DOI 10.1016/j.jbiomech.2013.03.028
   GALERA P, 1992, EXP CELL RES, V200, P379, DOI 10.1016/0014-4827(92)90186-C
   GALERA P, 1992, J CELL PHYSIOL, V153, P596, DOI 10.1002/jcp.1041530322
   Garza-Veloz I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4260
   Giannoni P, 2005, OSTEOARTHR CARTILAGE, V13, P589, DOI 10.1016/j.joca.2005.02.015
   Gooch KJ, 2001, BIOTECHNOL BIOENG, V72, P402, DOI 10.1002/1097-0290(20000220)72:4<402::AID-BIT1002>3.0.CO;2-Q
   Grogan SP, 2007, ARTHRITIS RHEUM, V56, P586, DOI 10.1002/art.22408
   Grogan SP, 2013, TISSUE ENG PART A, V20, P264
   Hamada T, 2013, NAGOYA J MED SCI, V75, P101
   Hansen U, 2001, J BIOMECH, V34, P941, DOI 10.1016/S0021-9290(01)00050-1
   Henrotin YE, 2006, J RHEUMATOL, V33, P1668
   Hicks DL, 2007, OTOLARYNG HEAD NECK, V136, P373, DOI 10.1016/j.otohns.2006.10.040
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Hu JC, 2006, TISSUE ENG, V12, P1337, DOI 10.1089/ten.2006.12.1337
   Huang AH, 2010, J BIOMECH, V43, P128, DOI 10.1016/j.jbiomech.2009.09.018
   Itoh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071156
   Iwasa J, 2009, KNEE SURG SPORT TR A, V17, P561, DOI 10.1007/s00167-008-0663-2
   Jiang YZ, 2011, CELL TRANSPLANT, V20, P593, DOI 10.3727/096368910X532738
   Jin CZ, 2007, ARTIF ORGANS, V31, P183, DOI 10.1111/j.1525-1594.2007.00363.x
   Kaitainen S, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025009
   Kanazawa T, 2012, J ORTHOP RES, V30, P468, DOI 10.1002/jor.21528
   Kon E, 2012, J KNEE SURG, V25, P17, DOI 10.1055/s-0031-1299651
   Kubota S, 2011, J CELL COMMUN SIGNAL, V5, P209, DOI 10.1007/s12079-011-0123-5
   Lee CR, 2005, TISSUE ENG, V11, P1562, DOI 10.1089/ten.2005.11.1562
   Lee CR, 2003, J BIOMED MATER RES A, V64A, P560, DOI 10.1002/jbm.a.10443
   Lee HS, 2013, PHYTOTHER RES, V27, P1414, DOI 10.1002/ptr.4857
   Legendre F, 2003, J BIOL CHEM, V278, P2903, DOI 10.1074/jbc.M110773200
   Legendre F, 2013, TISSUE ENG PART C-ME, V19, P550, DOI [10.1089/ten.tec.2012.0508, 10.1089/ten.TEC.2012.0508]
   Li D, 2012, OSTEOARTHR CARTILAGE, V20, P1647, DOI 10.1016/j.joca.2012.08.009
   Lu HX, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045011
   Lyu SR, 2013, COLLOID SURFACE B, V103, P304, DOI 10.1016/j.colsurfb.2012.11.002
   Ma KG, 2013, J MATER SCI-MATER M, V24, P405, DOI 10.1007/s10856-012-4811-3
   Madry H, 2005, GENE THER, V12, P1171, DOI 10.1038/sj.gt.3302515
   Mafi P, 2012, CURR STEM CELL RES T, V7, P302, DOI 10.2174/157488812800793045
   Mahmoudifar N, 2012, TRENDS BIOTECHNOL, V30, P166, DOI 10.1016/j.tibtech.2011.09.002
   Mahmoudifar N, 2010, BIOMATERIALS, V31, P3858, DOI 10.1016/j.biomaterials.2010.01.090
   Meretoja VV, 2013, BIOMATERIALS, V34, P4266, DOI 10.1016/j.biomaterials.2013.02.064
   Mo XT, 2009, BONE, V45, P42, DOI 10.1016/j.bone.2008.07.240
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Park JS, 2012, BIOMATERIALS, V33, P7151, DOI 10.1016/j.biomaterials.2012.06.023
   Petrera M, 2013, ARTHROSCOPY, V29, P1685, DOI 10.1016/j.arthro.2013.07.259
   Qu CJ, 2013, INT J BIOCHEM CELL B, V45, P1802, DOI 10.1016/j.biocel.2013.05.029
   Rosenzweig DH, 2013, ACTA BIOMATER, V9, P9360, DOI 10.1016/j.actbio.2013.07.024
   Rutgers M, 2013, TISSUE ENG PT A, V19, P59, DOI [10.1089/ten.tea.2011.0416, 10.1089/ten.TEA.2011.0416]
   Ryu B, 2012, CARBOHYD RES, V350, P55, DOI 10.1016/j.carres.2011.12.028
   Saha S, 2013, CELL TISSUE RES, V352, P495, DOI 10.1007/s00441-013-1586-x
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126
   Scherer K, 2004, BIORHEOLOGY, V41, P323
   Schwarz S, 2015, J TISSUE ENG REGEN M, V9, pE239, DOI 10.1002/term.1650
   Shahin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023119
   Shao XX, 2013, CHINESE MED J-PEKING, V126, P2523, DOI 10.3760/cma.j.issn.0366-6999.20112153
   Shen H, 2008, BIOMATERIALS, V29, P2388, DOI 10.1016/j.biomaterials.2008.02.008
   Song J, 2013, BIOCHEM BIOPH RES CO, V431, P210, DOI 10.1016/j.bbrc.2012.12.133
   Tomita N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059226
   Tong JC, 2007, J BIOACT COMPAT POL, V22, P232, DOI 10.1177/0883911507076460
   Vats A, 2006, TISSUE ENG, V12, P1687, DOI 10.1089/ten.2006.12.1687
   Vinardell T, 2012, TISSUE ENG PT A, V18, P1161, DOI [10.1089/ten.tea.2011.0544, 10.1089/ten.TEA.2011.0544]
   Waldman SD, 2006, OSTEOARTHR CARTILAGE, V14, P323, DOI 10.1016/j.joca.2005.10.007
   Wang J, 2004, ANN RHEUM DIS, V63, P61, DOI 10.1136/ard.2002.005298
   Willers C, 2005, TISSUE ENG, V11, P1065, DOI 10.1089/ten.2005.11.1065
   Xia ZD, 2013, CELL TISSUE BANK, V14, P267, DOI 10.1007/s10561-012-9328-y
   Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Yang YH, 2012, STEM CELL TRANSL MED, V1, P843, DOI 10.5966/sctm.2012-0083
   Yasuda T, 2002, ARTHRITIS RHEUM, V46, P138, DOI 10.1002/1529-0131(200201)46:1<138::AID-ART10051>3.0.CO;2-K
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z
   Zhang F, 2015, J TISSUE ENG REGEN M, V9, P1036, DOI 10.1002/term.1656
   Zhang L, 2012, PHYTOTHER RES, V26, P1385, DOI 10.1002/ptr.3733
   Zhang XQ, 2009, BIOMATERIALS, V30, P2632, DOI 10.1016/j.biomaterials.2009.01.021
   Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246
NR 89
TC 20
Z9 22
U1 1
U2 40
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD APR 5
PY 2014
VL 12
AR 88
DI 10.1186/1479-5876-12-88
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AI5QW
UT WOS:000336925200003
PM 24708713
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Allouche, FN
   Guibal, E
   Mameri, N
AF Allouche, Fella-Naouel
   Guibal, Eric
   Mameri, Nabil
TI Preparation of a new chitosan-based material and its application for
   mercury sorption
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article
DE Chitosan; Foams; Hg(II); Biosorption; Modeling
ID MODIFIED MAGNETIC CHITOSAN; AQUEOUS-SOLUTIONS; METAL-IONS; HEAVY-METALS;
   HG(II) IONS; GEL BEADS; EQUILIBRIUM; ADSORPTION; REMOVAL; BIOSORPTION
AB A novel chitosan sponge-like structure has been prepared by freeze-drying technique and then tested to remove Hg(II). Chitosan as biosorbent has been used in the form of flakes and cylindrical foams. In this study, column experiment on recirculation mode was conducted in order to determine the sorption properties of the cylindrical foams in various operating conditions (pH, initial metal ion concentration, flow rate, depth of column). The sorption behavior of the materials was examined through equilibrium, kinetic experiments. Hg(II) equilibrium isotherm data is very well fitted by the Langmuir model. Based on the sorption capacity, it was shown that a chitosan flake was more effective than foam. At pH 4, the sorption capacities (qm) were found up to 850 mg of Hg g(-1) for chitosan flake and only 350 mg of Hg g(-1) for chitosan foam. Two-region model performed for predicting and determining the sorption capacity of foam were distinguished. The pseudo-second-order chemisorption kinetic has shown success for short sorption times, while the cylindrical diffusion model was able to predict the end of the sorption times. The nature and morphology of the biomaterial before and after mercury sorption was studied by SEM-EDAX analysis. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Allouche, Fella-Naouel] CDER, Lab Bioenergie & Environm, Algiers 16340, Algeria.
   [Guibal, Eric] Ecole Mines Ales, Ctr Mat Mines Ales, MPA BCI C2MA, F-30319 Ales, France.
   [Mameri, Nabil] Ecole Natl Polytech, Lab Biotechnol Environm & Genie Proc BIOGEP, El Harrach Algiers, Algeria.
RP Allouche, FN (reprint author), CDER, Lab Bioenergie & Environm, BP 62 Route Observ Bouzareah, Algiers 16340, Algeria.
EM allouchenaouel2000@yahoo.fr
RI Guibal, Eric/H-4915-2012
OI Guibal, Eric/0000-0002-2767-6305
FU Grant PNE (Programme National Exceptionnel, Ministere de l'Enseignement
   Superieur et de la Recherche Scientifique-Algerie)
FX This research was financially supported by Grant PNE (Programme National
   Exceptionnel, Ministere de l'Enseignement Superieur et de la Recherche
   Scientifique-Algerie). The authors acknowledge the personal J.-M.
   Taulemesse (from Centre des Materiaux de Grande Diffusion, Ecole des
   Mines d'Ales) for SEM/SEM-EDAX. Sincere thanks go to Pr E-Benyoussef
   (from Ecole Nationale Polytechnique-Alger).
CR Allouche FN, 2011, CHEM ENG J, V168, P1174, DOI 10.1016/j.cej.2011.02.005
   Arvanitoyannis IS, 1998, CARBOHYD POLYM, V37, P371, DOI 10.1016/S0144-8617(98)00083-6
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Bassi R, 2000, SEPAR SCI TECHNOL, V35, P547, DOI 10.1081/SS-100100175
   Bhatnagar A, 2010, CHEM ENG J, V157, P277, DOI 10.1016/j.cej.2010.01.007
   Carro L, 2011, J HAZARD MATER, V192, P284, DOI 10.1016/j.jhazmat.2011.05.017
   Crini G, 2008, PROG POLYM SCI, V33, P399, DOI 10.1016/j.progpolymsci.2007.11.001
   de Godoi FC, 2013, CHEM ENG J, V234, P423, DOI 10.1016/j.cej.2013.09.006
   Donia AM, 2008, J HAZARD MATER, V151, P372, DOI 10.1016/j.jhazmat.2007.05.083
   Erosa MSD, 2001, HYDROMETALLURGY, V61, P157
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Green-Ruiz C, 2006, BIORESOURCE TECHNOL, V97, P1907, DOI 10.1016/j.biortech.2005.08.014
   Guibal E, 1998, IND ENG CHEM RES, V37, P1454, DOI 10.1021/ie9703954
   Guibal E, 1999, INT J BIOL MACROMOL, V24, P49, DOI 10.1016/S0141-8130(98)00067-1
   Guibal E, 2004, SEP PURIF TECHNOL, V38, P43, DOI 10.1016/j.seppur.2003.10.004
   Guibal E., 2007, SEP SCI TECHNOL, V43, P2406
   Herrero R, 2005, WATER RES, V39, P3199, DOI 10.1016/j.watres.2005.05.041
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Jeon C, 2005, WATER RES, V39, P3938, DOI 10.1016/j.watres.2005.07.020
   Jeon C, 2003, WATER RES, V37, P4770, DOI 10.1016/S0043-1354(03)00431-7
   Jouannin C, 2011, APPL CATAL B-ENVIRON, V103, P444, DOI 10.1016/j.apcatb.2011.02.008
   Kapoor A, 1995, BIORESOURCE TECHNOL, V53, P195, DOI 10.1016/0960-8524(95)00072-1
   Kapoor K., 2008, BIOTECHNOL ADV, V26, P266
   KURITA K, 1979, J APPL POLYM SCI, V23, P511, DOI 10.1002/app.1979.070230221
   Kushwaha S, 2011, CARBOHYD POLYM, V86, P1055, DOI 10.1016/j.carbpol.2011.06.028
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Liu CX, 2006, J MEMBRANE SCI, V279, P336, DOI 10.1016/j.memsci.2005.12.019
   Ma F, 2009, J HAZARD MATER, V172, P792, DOI 10.1016/j.jhazmat.2009.07.066
   Merrifield JD, 2004, WATER RES, V38, P3132, DOI 10.1016/j.watres.2004.04.008
   Miretzky P, 2009, J HAZARD MATER, V167, P10, DOI 10.1016/j.jhazmat.2009.01.060
   Monier M, 2012, J HAZARD MATER, V209, P240, DOI 10.1016/j.jhazmat.2012.01.015
   Ng JCY, 2002, J COLLOID INTERF SCI, V255, P64, DOI 10.1006/jcis.2002.8664
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Qu RJ, 2009, J HAZARD MATER, V167, P717, DOI 10.1016/j.jhazmat.2009.01.043
   Rae IB, 2009, J HAZARD MATER, V164, P1601, DOI 10.1016/j.jhazmat.2008.09.052
   Rao MM, 2009, J ENVIRON MANAGE, V90, P634, DOI 10.1016/j.jenvman.2007.12.019
   Reategui M, 2010, APPL BIOCHEM BIOTECH, V162, P805, DOI 10.1007/s12010-010-8912-5
   Roberts G, 1992, CHITIN CHEM
   Romera E, 2007, BIORESOURCE TECHNOL, V98, P3344, DOI 10.1016/j.biotech.2006.09.026
   Shafaei A, 2007, CHEM ENG J, V133, P311, DOI 10.1016/j.cej.2007.02.016
   Shawky H-A., 2012, J APPL POLYM SCI, V125, P93
   Shinde RN, 2013, WATER RES, V47, P3497, DOI 10.1016/j.watres.2013.03.059
   Tuzun I, 2005, J ENVIRON MANAGE, V77, P85, DOI 10.1016/j.jenvman.2005.01.028
   Vieira RS, 2011, COLLOID SURFACE A, V374, P108, DOI 10.1016/j.colsurfa.2010.11.022
   Vieira RS, 2006, WATER RES, V40, P1726, DOI 10.1016/j.watres.2006.02.027
   Vieira RS, 2005, ADSORPTION, V11, P731, DOI 10.1007/s10450-005-6015-3
   Vincent T, 2004, ENVIRON SCI TECHNOL, V38, P4233, DOI 10.1021/es034862m
   Wang L, 2010, INT J BIOL MACROMOL, V46, P524, DOI 10.1016/j.ijbiomac.2010.03.003
   Wang Y, 2013, J HAZARD MATER, V260, P9, DOI 10.1016/j.jhazmat.2013.05.001
   WANNGAH WS, 2002, REACT FUNCT POLYM, V50, P181, DOI DOI 10.1016/S1381-5148(01)00113-4
   World Health Organization (W.H.O), 1993, MERC DRINK WAT GUID, V1
   Xiong CH, 2013, CARBOHYD POLYM, V98, P1222, DOI 10.1016/j.carbpol.2013.07.034
   Zeroual Y, 2003, BIORESOURCE TECHNOL, V90, P349, DOI 10.1016/S0960-8524(03)00122-6
   Zhou L, 2007, MOD CHEM IND, V27, P175
   Zhou LM, 2009, J HAZARD MATER, V161, P995, DOI 10.1016/j.jhazmat.2008.04.078
NR 55
TC 24
Z9 25
U1 3
U2 70
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
EI 1873-4359
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD APR 5
PY 2014
VL 446
BP 224
EP 232
DI 10.1016/j.colsurfa.2014.01.025
PG 9
WC Chemistry, Physical
SC Chemistry
GA AD8AF
UT WOS:000333488200028
DA 2018-10-20
ER

PT J
AU Depanche, K
   Bennett, JA
   Mikheenko, IP
   Omajali, J
   Wells, AS
   Meadows, RE
   Wood, J
   Macaskie, LE
AF Depanche, K.
   Bennett, J. A.
   Mikheenko, I. P.
   Omajali, J.
   Wells, A. S.
   Meadows, R. E.
   Wood, J.
   Macaskie, L. E.
TI Catalytic activity of biomass-supported Pd nanoparticles: Influence of
   the biological component in catalytic efficacy and potential application
   in 'green' synthesis of fine chemicals and pharmaceuticals
SO APPLIED CATALYSIS B-ENVIRONMENTAL
LA English
DT Article
DE Catalysis; Cr(VI) reduction; Heck coupling; Hydrogenase; Suzuki reaction
ID SULFATE-REDUCING BACTERIA; SHEWANELLA-ONEIDENSIS MR-1; S-LAYER PROTEINS;
   ESCHERICHIA-COLI; DESULFOVIBRIO-DESULFURICANS; BACILLUS-SPHAERICUS;
   PALLADIUM CATALYSTS; COUPLING REACTIONS; PRECIOUS METALS; HECK REACTION
AB Five gram negative and two gram positive bacterial strains known for their heavy metal tolerance or ability to reduce metal ions were coated with Pd(0) nanoparticles (NPs) via reduction of soluble Pd(II) ions under H-2 following an initial uptake of PdCl42- without added electron donor ('biosorption'), where the gram negative strains had a similar to 5-fold greater capacity for Pd(II). Cupriavidis metallidurans accumulated Pd(II) exceptionally; the possibility of reduction to Pd(0) via an endogenous electron donor was not discounted. The initial rate of subsequent H-2-mediated Pd(II) reduction correlated with the Pd(II) removed during biosorption (r(2) = 0.9). TEM showed strain-specific variations of Pd-NPs. At a 1:3 loading of Pd:biomass the cell surfaces of Escherichia coli and Desulfovibrio desulfuricans showed uniform coverage with small NPs with the other strains showing larger aggregates. NPs made by the gram positive cells appeared larger than their gram negative counterparts. At a loading of 1:19 all were active catalysts in Cr(VI) reduction and in two Heck coupling reactions. BioPd(E. coli) and bioPd(D. desulfuricans) and bioPd(A. oxydans) were consistently the best and worst catalysts respectively. BioPd(E. culi) was further tested as a process catalyst according to industrial protocols in Fleck and Suzuki coupling reactions. Laboratory and industrial tests (coupling of phenyl iodide and ethyl acrylate) gave 75% and 78% conversion to ethyl cinnamate, respectively. The biomaterial catalysed Heck and Suzuki reactions using bromoacetophenone and 4-bromoanisole (Heck) and 4-chloroanisole (Suzuki) but not 3-chlorotoluene. In accordance with known chemical catalysis the catalytic efficacy was related to electron-withdrawing substituents on the phenyl ring, with more than 90% conversion (Suzuki) using 4-bromobenzotrifluoride. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.
C1 [Depanche, K.; Mikheenko, I. P.; Omajali, J.; Macaskie, L. E.] Univ Birmingham, Sch Biosci, Unit Funct Bionanomat, Birmingham B15 2TT, W Midlands, England.
   [Bennett, J. A.; Wood, J.] Univ Birmingham, Dept Chem Engn, Birmingham B15 2TT, W Midlands, England.
   [Wells, A. S.; Meadows, R. E.] AstraZeneca R&D Charnwood, Loughborough LE11 5RH, Leics, England.
RP Macaskie, LE (reprint author), Univ Birmingham, Sch Biosci, Unit Funct Bionanomat, Birmingham B15 2TT, W Midlands, England.
EM l.e.macaskie@bham.ac.uk
OI Mikheenko, Iryna/0000-0001-6361-6740; Deplanche,
   Kevin/0000-0002-2068-8637; Omajali, PhD, Jacob B./0000-0002-5438-7613
FU BBSRC [BB/C516128/1]; EPSRC [EP/I007806/1, EP/D05768X/1]; British
   Council Entente Cordiale fellowship; BBSRC/Royal Society Industrial
   Fellowship; Biotechnology and Biological Sciences Research Council
   [BB/C516128/1, BB/E003788/1]; Engineering and Physical Sciences Research
   Council [EP/I007806/1, EP/H029567/1, EP/D05768X/1]
FX This work was supported by the BBSRC (Grant No. BB/C516128/1), EPSRC
   (grants no EP/I007806/1 and EP/D05768X/1) and by a British Council
   Entente Cordiale fellowship to K.D. L.E.M. was supported by a
   BBSRC/Royal Society Industrial Fellowship. We thank Mr. Graham Burns
   (School of Chemistry, University of Birmingham, U.K.) for his help with
   HPLC analysis and Prof G. Attard (University of Cardiff) for useful
   discussions.
CR Allan VJM, 2002, MICROBIOL-SGM, V148, P277, DOI 10.1099/00221287-148-1-277
   Angelov A, 2006, J BIOTECHNOL, V126, P3, DOI 10.1016/j.jbiotec.2006.02.017
   [Anonymous], 2008, Resource Efficiency KTN, Material Security - Ensuring Resource Avail-ability for the UK Economy, Patent No. [WO/2006/087334, 200605094]
   [Anonymous], 2008, RESOURCE EFFICIENCY
   Astana T.V., 2004, CURR MICROBIOL, V49, P321
   Attard G, 2012, LANGMUIR, V28, P5267, DOI 10.1021/la204495z
   Baxter-Plant V, 2003, BIODEGRADATION, V14, P83, DOI 10.1023/A:1024084611555
   Beauregard DA, 2010, BIOTECHNOL BIOENG, V107, P11, DOI 10.1002/bit.22791
   Beeby A, 2004, NEW J CHEM, V28, P600, DOI 10.1039/b401077a
   Beletskaya IP, 2000, CHEM REV, V100, P3009, DOI 10.1021/cr9903048
   Bennett JA, 2013, APPL CATAL B-ENVIRON, V140, P700, DOI 10.1016/j.apcatb.2013.04.022
   BEVERIDGE TJ, 1990, J BACTERIOL, V172, P1609, DOI 10.1128/jb.172.3.1609-1620.1990
   Beveridge TJ, 1999, J BACTERIOL, V181, P4725
   Bonthrone KM, 2000, ENVIRON TECHNOL, V21, P123, DOI 10.1080/09593330.2000.9618893
   Briggs BD, 2012, J PHYS CHEM LETT, V3, P405, DOI 10.1021/jz2016473
   CABRI W, 1995, ACCOUNTS CHEM RES, V28, P2, DOI 10.1021/ar00049a001
   Camargo FAO, 2003, J ENVIRON QUAL, V32, P1228, DOI 10.2134/jeq2003.1228
   Chariot G., 1978, DOSAGES ABSORPTIOMET, P380
   CHURCHILL SA, 1995, J ENVIRON ENG-ASCE, V121, P706, DOI 10.1061/(ASCE)0733-9372(1995)121:10(706)
   Coelho AV, 2007, TETRAHEDRON LETT, V48, P7671, DOI 10.1016/j.tetlet.2007.08.091
   Creamer NJ, 2007, CATAL TODAY, V128, P80, DOI 10.1016/j.cattod.2007.04.014
   Creamer NJ, 2006, BIOTECHNOL LETT, V28, P1475, DOI 10.1007/s10529-006-9120-9
   De Corte S, 2012, MICROB BIOTECHNOL, V5, P5, DOI 10.1111/j.1751-7915.2011.00265.x
   de Vargas I, 2004, J CHEM TECHNOL BIOT, V79, P49, DOI 10.1002/jctb.928
   De Vargas I., 2005, 16 INT BIOH S CAP TO, P605
   DEMOPOULOS GP, 1989, CIM BULL, V82, P165
   Deplanche K, 2009, ENVIRON TECHNOL, V30, P681, DOI 10.1080/09593330902860712
   Deplanche K., 2011, NANOMATERIALS
   DEPLANCHE K, 2008, THESIS U BIRMINGHAM
   Deplanche K, 2012, J R SOC INTERFACE, V9, P1705, DOI 10.1098/rsif.2012.0003
   Deplanche K, 2010, MICROBIOL-SGM, V156, P2630, DOI 10.1099/mic.0.036681-0
   Edwards R.I., 1986, GMELIN HDB INORG S A, V1, P1
   Fahmy K, 2006, BIOPHYS J, V91, P996, DOI 10.1529/biophysj.105.079137
   Foulkes JM, 2011, ACS CATAL, V1, P1589, DOI 10.1021/cs200400t
   Greenwood N. N., 1984, CHEM ELEMENTS, P1328
   Guibal E, 2004, SEP PURIF TECHNOL, V38, P43, DOI 10.1016/j.seppur.2003.10.004
   Haferburg G, 2007, J BASIC MICROB, V47, P474, DOI 10.1002/jobm.200700256
   Heidenreich RG, 2002, J MOL CATAL A-CHEM, V182, P499, DOI 10.1016/S1381-1169(01)00499-X
   Hewitt CJ, 2000, BIOTECHNOL BIOENG, V70, P381, DOI 10.1002/1097-0290(20001120)70:4<381::AID-BIT3>3.0.CO;2-0
   Humphries AC, 2004, BIOTECHNOL LETT, V26, P1529, DOI 10.1023/B:BILE.0000044457.80314.4d
   Jana S, 2009, TETRAHEDRON LETT, V50, P4820, DOI 10.1016/j.tetlet.2009.05.098
   Kamionka M, 2011, CURR PHARM BIOTECHNO, V12, P268, DOI 10.2174/138920111794295693
   Ledrich ML, 2005, BIOMETALS, V18, P643, DOI 10.1007/s10534-005-3858-8
   Leung WC, 2000, WATER SCI TECHNOL, V41, P233
   Lie TJ, 1996, ARCH MICROBIOL, V166, P204, DOI 10.1007/s002030050376
   Lin Z., 2012, CHINESE SCI BULL, V47, P1262
   Lin ZY, 2002, CHINESE SCI BULL, V47, P1262, DOI 10.1360/02tb9279
   Liu CX, 2002, BIOTECHNOL BIOENG, V80, P637, DOI 10.1002/bit.10430
   Lloyd JR, 1997, BIOTECHNOL BIOENG, V55, P505, DOI 10.1002/(SICI)1097-0290(19970805)55:3<505::AID-BIT6>3.0.CO;2-G
   Lloyd JR, 1998, APPL ENVIRON MICROB, V64, P4607
   Lloyd JR, 2001, HYDROMETALLURGY, V59, P327, DOI 10.1016/S0304-386X(00)00175-4
   Lloyd JR, 2003, FEMS MICROBIOL REV, V27, P411, DOI 10.1016/S0168-6445(03)00044-5
   Lloyd JR, 1997, J BACTERIOL, V179, P2014, DOI 10.1128/jb.179.6.2014-2021.1997
   Lo W, 2001, APPL BIOCHEM BIOTECH, V92, P1
   LOVLEY DR, 1995, J IND MICROBIOL, V14, P85, DOI 10.1007/BF01569889
   LOVLEY DR, 1992, APPL ENVIRON MICROB, V58, P850
   LOVLEY DR, 1991, MICROBIOL REV, V55, P259
   LOVLEY DR, 1994, APPL ENVIRON MICROB, V60, P726
   Lovley DR, 2004, ADV MICROB PHYSIOL, V49, P219, DOI 10.1016/S0065-2911(04)49005-5
   Mabbett A.N., 2001, BIOHYDROMETALLURGY F, P335
   Mabbett AN, 2006, ENVIRON SCI TECHNOL, V40, P1015, DOI 10.1021/es0509836
   Mabbett AN, 2004, BIOTECHNOL BIOENG, V87, P104, DOI 10.1002/bit.20105
   Mabbett AN, 2002, J CHEM TECHNOL BIOT, V77, P1169, DOI 10.1002/jctb.693
   Macaskie L. E., 2011, COMPREHENSIVE BIOTEC, P719
   Macaskie LE, 2005, BIOCHEM SOC T, V33, P76, DOI 10.1042/BST0330076
   Macaskie LE, 2012, J CHEM TECHNOL BIOT, V87, P1430, DOI 10.1002/jctb.3763
   Marshall MJ, 2008, ENVIRON MICROBIOL, V10, P125, DOI 10.1111/j.1462-2920.2007.01438.x
   Marshall ST, 2010, NAT MATER, V9, P853, DOI [10.1038/nmat2849, 10.1038/NMAT2849]
   Megharaj M, 2003, CURR MICROBIOL, V47, P51, DOI 10.1007/s00284-002-3889-0
   Merroun ML, 2005, APPL ENVIRON MICROB, V71, P5532, DOI 10.1128/AEM.71.9.5532-5543.2005
   Meshulam-Simon G, 2007, APPL ENVIRON MICROB, V73, P1153, DOI 10.1128/AEM.01588-06
   Messner P., 2010, MICROBIAL GLYCOBIOLO, P109
   Mikheenko IP, 2008, APPL ENVIRON MICROB, V74, P6144, DOI 10.1128/AEM.02538-07
   Mikheenko I.P., 2001, BIOHYDROMETALLURGY F, P525
   MIKHEENKO IP, 2004, THESIS U BIRMINGHAM
   Mondaca M.A., 2002, TheScientificWorldJOURNAL, V2, P972
   Nakajima A, 2004, J RADIOANAL NUCL CH, V260, P13, DOI 10.1023/B:JRNC.0000027055.16768.1e
   Orozco RL, 2010, BIOTECHNOL LETT, V32, P1837, DOI 10.1007/s10529-010-0383-9
   Parkin A, 2012, FEBS LETT, V586, P536, DOI 10.1016/j.febslet.2011.07.044
   Pollmann K, 2005, MICROBIOL-SGM, V151, P2961, DOI 10.1099/mic.0.28201-0
   Raszka A, 2006, ACTA HYDROCH HYDROB, V34, P411, DOI 10.1002/aheh.200500640
   Reith F, 2006, SCIENCE, V313, P233, DOI 10.1126/science.1125878
   Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106
   Rotaru AE, 2012, BIOTECHNOL BIOENG, V109, P1889, DOI 10.1002/bit.24500
   Rousset M., 2006, International Application, Patent No. [2006087334, PCT/EP2006/05094]
   Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000
   Selenska-Pobell S, 1999, FEMS MICROBIOL ECOL, V29, P59, DOI 10.1111/j.1574-6941.1999.tb00598.x
   SHEN H, 1994, J ENVIRON ENG-ASCE, V120, P560, DOI 10.1061/(ASCE)0733-9372(1994)120:3(560)
   Skibar W., 2005, NOVEL PRECIOUS METAL
   Tagata T, 2003, J ORG CHEM, V68, P9412, DOI 10.1021/jo034970r
   Taylor S., 2012, THESIS U BIRMINGHAM
   Van Nostrand JD, 2007, MICROB ECOL, V53, P670, DOI 10.1007/s00248-006-9160-7
   Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102
   Vincent T, 2004, ENVIRON SCI TECHNOL, V38, P4233, DOI 10.1021/es034862m
   Visconti CG, 2007, APPL CATAL A-GEN, V330, P49, DOI 10.1016/j.apcata.2007.07.009
   Volesky B., 1999, BIOHYDROMETALLURGY E
   von Rozycki T, 2005, COMP FUNCT GENOM, V6, P17, DOI 10.1002/cfg.454
   Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057
   Wiatrowski HA, 2006, ENVIRON SCI TECHNOL, V40, P6690, DOI 10.1021/es061046g
   Wolfe JP, 1999, J AM CHEM SOC, V121, P9550, DOI 10.1021/ja992130h
   Wolfe JP, 1999, ANGEW CHEM INT EDIT, V38, P2413, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2413::AID-ANIE2413>3.0.CO;2-H
   WOOLFOLK CA, 1962, J BACTERIOL, V84, P647
   YANKE LJ, 1995, ANAEROBE, V1, P61, DOI 10.1016/S1075-9964(95)80457-9
   Yin LX, 2007, CHEM REV, V107, P133, DOI 10.1021/cr0505674
   Yong P, 2007, BIOTECHNOL LETT, V29, P539, DOI 10.1007/s10529-006-9283-4
   Yong P, 2002, BIOTECHNOL BIOENG, V80, P369, DOI 10.1002/bit.10369
   Yong P, 2003, ENVIRON TECHNOL, V24, P289, DOI 10.1080/09593330309385561
   Yong P., 2002, J CHEM TECHNOL BIOT, V77, P1
   Yong P, 2010, BIOTECHNOL LETT, V32, P1821, DOI 10.1007/s10529-010-0378-6
   Zhao FY, 2000, CHEM-EUR J, V6, P843, DOI 10.1002/(SICI)1521-3765(20000303)6:5<843::AID-CHEM843>3.0.CO;2-G
   Zhu J., 2011, C P HYBR MAT 2 INT C
NR 111
TC 12
Z9 12
U1 5
U2 107
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0926-3373
EI 1873-3883
J9 APPL CATAL B-ENVIRON
JI Appl. Catal. B-Environ.
PD APR 5
PY 2014
VL 147
BP 651
EP 665
DI 10.1016/j.apcatb.2013.09.045
PG 15
WC Chemistry, Physical; Engineering, Environmental; Engineering, Chemical
SC Chemistry; Engineering
GA 300UL
UT WOS:000330489400071
OA Other Gold
DA 2018-10-20
ER

PT J
AU Coppoolse, JMS
   Van Kooten, TG
   Heris, HK
   Mongeau, L
   Li, NYK
   Thibeault, SL
   Pitaro, J
   Akinpelu, O
   Daniel, SJ
AF Coppoolse, Jiska M. S.
   Van Kooten, T. G.
   Heris, Hossein K.
   Mongeau, Luc
   Li, Nicole Y. K.
   Thibeault, Susan L.
   Pitaro, Jacob
   Akinpelu, Olubunmi
   Daniel, Sam J.
TI An In Vivo Study of Composite Microgels Based on Hyaluronic Acid and
   Gelatin for the Reconstruction of Surgically Injured Rat Vocal Folds
SO JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH
LA English
DT Article
DE injectable biomaterial; composite hydrogel; tissue engineering; wound
   healing; vocal fold lamina propria; scarring
ID EXTRACELLULAR-MATRIX; RABBIT MODEL; HISTOLOGIC CHARACTERIZATION;
   GRANULATION-TISSUE; LAMINA PROPRIA; CANINE MODEL; COLLAGEN; REPAIR;
   SCAR; CORD
AB Purpose: The objective of this study was to investigate local injection with a hierarchically microstructured hyaluronic acid-gelatin (HA-Ge) hydrogel for the treatment of acute vocal fold injury using a rat model.
   Method: Vocal fold stripping was performed unilaterally in 108 Sprague-Dawley rats. A volume of 25 mu l saline (placebo controls), HA-bulk, or HA-Ge hydrogel was injected into the lamina propria (LP) 5 days after surgery. The vocal folds were harvested at 3, 14, and 28 days after injection and analyzed using hematoxylin and eosin staining and immunohistochemistry staining for macrophages, myofibroblasts, elastin, collagen type I, and collagen type III.
   Results: The macrophage count was statistically significantly lower in the HA-Ge group than in the saline group (p < .05) at Day 28. Results suggested that the HA-Ge injection did not induce inflammatory or rejection response. Myofibroblast counts and elastin were statistically insignificant across treatment groups at all time points. Increased elastin deposition was qualitatively observed in both HA groups from Day 3 to Day 28, and not in the saline group. Significantly more elastin was observed in the HA-bulk group than in the uninjured group at Day 28. Significantly more collagen type I was observed in the HA-bulk and HA-Ge groups than in the saline group (p < .05) at Day 28. The collagen type I concentration in the HA-Ge and saline groups was found to be comparable to that in the uninjured controls at Day 28. The concentration of collagen type III in all treatment groups was similar to that in uninjured controls at Day 28.
   Conclusion: Local HA-Ge and HA-bulk injections for acute injured vocal folds were biocompatible and did not induce adverse response.
C1 [Coppoolse, Jiska M. S.; Van Kooten, T. G.] Univ Groningen, NL-9700 AB Groningen, Netherlands.
   [Heris, Hossein K.; Mongeau, Luc; Pitaro, Jacob; Akinpelu, Olubunmi; Daniel, Sam J.] McGill Univ, Montreal, PQ, Canada.
   [Li, Nicole Y. K.] Univ Maryland, College Pk, MD 20742 USA.
   [Thibeault, Susan L.] Univ Wisconsin, Madison, WI 53706 USA.
RP Mongeau, L (reprint author), McGill Univ, Montreal, PQ, Canada.
EM luc.mongeau@mcgill.ca
OI Mongeau, Luc/0000-0003-0344-227X
FU National Institute on Deafness and Other Communication Disorders (NIDCD)
   [DC 005788]; NIDCD [DC 004336]
FX This work has been supported by the National Institute on Deafness and
   Other Communication Disorders (NIDCD) Grant DC 005788 (L. Mongeau, PI).
   We acknowledge the support of NIDCD Grant DC 004336 (Thibeault, PI) for
   the collagen III staining and analysis, performed at the University of
   Wisconsin. We thank the staffs of the Bone Centre and Imaging Centre of
   McGill University for the use of their facilities and of the University
   of Wisconsin-Madison for their technical support. We acknowledge Drew
   Roenneburg and Sarah Wang for staining of histological slides against
   collagen III and associated image analysis. We also acknowledge Mario
   Mujica-Mota for helping with the surgeries.
CR ARNOLD GE, 1963, ARCHIV OTOLARYNGOL, V78, P179
   ARONSON AE, 1966, J SPEECH HEAR DISORD, V31, P115, DOI 10.1044/jshd.3102.115
   Benninger MS, 1996, OTOLARYNG HEAD NECK, V115, P474, DOI 10.1016/S0194-5998(96)70087-6
   BRANDENBURG JH, 1992, LARYNGOSCOPE, V102, P495, DOI 10.1288/00005537-199205000-00005
   Chan RW, 2007, ANN BIOMED ENG, V35, P1471, DOI 10.1007/s10439-007-9314-x
   Chan RW, 1999, LARYNGOSCOPE, V109, P1142, DOI 10.1097/00005537-199907000-00026
   Chan RW, 1999, J ACOUST SOC AM, V106, P2008, DOI 10.1121/1.427947
   Courey MS, 1996, ANN OTO RHINOL LARYN, V105, P525, DOI 10.1177/000348949610500706
   DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103
   DESMOULIERE A, 1995, AM J PATHOL, V146, P56
   Dorsett-Martin WA, 2004, WOUND REPAIR REGEN, V12, P591, DOI 10.1111/j.1067-1927.2004.12601.x
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   FORD CN, 1984, LARYNGOSCOPE, V94, P513, DOI 10.1288/00005537-198404000-00016
   Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   Gilbert TW, 2009, LARYNGOSCOPE, V119, P1856, DOI 10.1002/lary.20575
   Gonzales R.C., 2001, DIGITAL IMAGE PROCES
   Gray SD, 1999, ANN OTO RHINOL LARYN, V108, P1
   Gray SD, 2000, ANN OTO RHINOL LARYN, V109, P77, DOI 10.1177/000348940010900115
   Greenspan DS, 2005, TOP CURR CHEM, V247, P149, DOI 10.1007/b103822
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P225, DOI 10.1177/000348940611500311
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P156, DOI 10.1177/000348940611500213
   Hahn MS, 2005, ANN OTO RHINOL LARYN, V114, P451, DOI 10.1177/000348940511400607
   Hallen L, 1999, ACTA OTO-LARYNGOL, V119, P107
   Hammond TH, 1997, J VOICE, V11, P59, DOI 10.1016/S0892-1997(97)80024-0
   Hansen JK, 2006, J VOICE, V20, P110, DOI 10.1016/j.jvoice.2004.12.005
   Hansen JK, 2005, ANN OTO RHINOL LARYN, V114, P662, DOI 10.1177/000348940511400902
   Heris HK, 2013, J MECH BEHAV BIOMED, V28, P383, DOI 10.1016/j.jmbbm.2013.05.026
   Heris HK, 2012, MACROMOL BIOSCI, V12, P202, DOI 10.1002/mabi.201100335
   Hertegard S, 2002, LARYNGOSCOPE, V112, P2211, DOI 10.1097/00005537-200212000-00016
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771
   Hirano S, 2009, J VOICE, V23, P399, DOI 10.1016/j.jvoice.2007.12.002
   Hirano Shigeru, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P143, DOI 10.1097/01.moo.0000162261.49739.b7
   Jha AK, 2009, MACROMOLECULES, V42, P537, DOI 10.1021/ma8019442
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Kazemirad S, 2013, J ACOUST SOC AM, V133, P3186, DOI 10.1121/1.4798668
   Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961
   KOUFMAN JA, 1986, LARYNGOSCOPE, V96, P726
   Krischke S, 2005, J VOICE, V19, P132, DOI 10.1016/j.jvoice.2004.01.007
   Perazzo PSL, 2009, J VOICE, V23, P95, DOI 10.1016/j.jvoice.2007.05.006
   Miri AK, 2013, ACTA BIOMATER, V9, P7957, DOI 10.1016/j.actbio.2013.04.044
   Miri AK, 2012, LARYNGOSCOPE, V122, P356, DOI 10.1002/lary.22460
   Petersen A, 2012, TISSUE ENG PT A, V18, P1804, DOI [10.1089/ten.tea.2011.0514, 10.1089/ten.TEA.2011.0514]
   Rousseau B, 2004, J VOICE, V18, P116, DOI 10.1016/j.jvoice.2003.06.001
   Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007
   Sahiner N, 2008, J BIOMAT SCI-POLYM E, V19, P223, DOI 10.1163/156856208783432462
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Suehiro A, 2012, LARYNGOSCOPE, V122, P600, DOI 10.1002/lary.22470
   Tateya T, 2006, ANN OTO RHINOL LARYN, V115, P285, DOI 10.1177/000348940611500406
   Tateya T, 2005, ANN OTO RHINOL LARYN, V114, P183, DOI 10.1177/000348940511400303
   Tateya T, 2007, ANN OTO RHINOL LARYN, V116, P156, DOI 10.1177/000348940711600212
   Thibeault SL, 2004, LARYNGOSCOPE, V114, P760, DOI 10.1097/00005537-200404000-00031
   Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Ward PD, 2002, J VOICE, V16, P303, DOI 10.1016/S0892-1997(02)00101-7
   WEIGEL PH, 1986, J THEOR BIOL, V119, P219, DOI 10.1016/S0022-5193(86)80076-5
   Welham NV, 2009, J SPEECH LANG HEAR R, V52, P1008, DOI 10.1044/1092-4388(2009/08-0049)
NR 58
TC 10
Z9 10
U1 1
U2 15
PU AMER SPEECH-LANGUAGE-HEARING ASSOC
PI ROCKVILLE
PA 10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA
SN 1092-4388
EI 1558-9102
J9 J SPEECH LANG HEAR R
JI J. Speech Lang. Hear. Res.
PD APR
PY 2014
VL 57
IS 2
BP S658
EP S673
DI 10.1044/2014_JSLHR-S-12-0292
PG 16
WC Audiology & Speech-Language Pathology; Linguistics; Rehabilitation
SC Audiology & Speech-Language Pathology; Linguistics; Rehabilitation
GA AZ4MM
UT WOS:000348195600005
PM 24687141
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Eliseeff, J
AF Eliseeff, Jennifer
TI Biomaterial scaffolds in regenerative medicine
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 26-30, 2014
CL San Diego, CA
SP Cenveo, LI COR, Wiley, Mead Johnson Pediat Nutr Inst, IPRECIO, F1000 Res, Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut
C1 [Eliseeff, Jennifer] Johns Hopkins Univ, Translat Tissue Engn Ctr, Baltimore, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2014
VL 28
IS 1
SU S
MA 81.2
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA AX0MP
UT WOS:000346646704413
DA 2018-10-20
ER

PT J
AU Ahad, IU
   Budner, B
   Korczyc, B
   Fiedorowicz, H
   Bartnik, A
   Kostecki, J
   Burdynska, S
   Brabazon, D
AF Ahad, I. U.
   Budner, B.
   Korczyc, B.
   Fiedorowicz, H.
   Bartnik, A.
   Kostecki, J.
   Burdynska, S.
   Brabazon, D.
TI Polycarbonate Polymer Surface Modification by Extreme Ultraviolet (EUV)
   Radiation
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 48th Zakopane-School-of-Physics International Symposium on Breaking
   Frontiers - Submicron Structures in Physics and Biology
CY MAY 20-25, 2013
CL Zakopane, POLAND
ID LASER; BIOMATERIALS; IRRADIATION; ABLATION
AB The degree of the biocompatibility of polycarbonate (PC) polymer used as biomaterial can be controlled by surface modification for various biomedical engineering applications. In the past, PC samples were treated by excimer laser for surface reorganization however associated process alteration of bulk properties is reported. Extreme ultraviolet radiation can be employed in order to avoid bulk material alteration due to its limited penetration. In this study, a 10 Hz laser-plasma EUV source based on a double-stream gas-puff target irradiated with a 3 ns and 0.8 J Nd:YAG laser pulse was used to irradiate PC samples. The PC samples were irradiated with different number of EUV shots. Pristine and EUV treated samples were investigated by scanning electron microscopy and atomic force microscopy for detailed morphological characterization of micropatterns introduced by the EUV irradiation. Associated chemical modifications were investigated by X-ray photoelectron spectroscopy. Pronounced wall-type micro- and nanostructures appeared on the EUV modified surface resulting in a change of surface roughness and wettability.
C1 [Ahad, I. U.; Budner, B.; Korczyc, B.; Fiedorowicz, H.; Bartnik, A.; Kostecki, J.; Burdynska, S.] Mil Univ Technol, Inst Optoelect, PL-00908 Warsaw, Poland.
   [Ahad, I. U.; Brabazon, D.] Dublin City Univ, Fac Engn & Comp, Sch Mech & Mfg Engn, Adv Proc Technol Res Ctr, Dublin 9, Ireland.
RP Ahad, IU (reprint author), Mil Univ Technol, Inst Optoelect, S Kaliskiego 2, PL-00908 Warsaw, Poland.
EM iuahad@wat.edu.pl
RI Ahad, Inam Ul/M-6262-2017
OI Ahad, Inam Ul/0000-0002-3802-6156; Brabazon, Dermot/0000-0003-3214-6381;
   Kostecki, Jerzy/0000-0003-0105-0109; Budner,
   Boguslaw/0000-0002-9395-6073; Fiedorowicz, Henryk/0000-0002-7022-3408
FU EU [FPA-2012-0033]; 7th Framework Programme's Laser lab Europe project
   [284464]
FX Authors acknowledge financial support from the EU FP7 Erasmus Mundus
   Joint Doctorate Programme EXTATIC under framework partnership agreement
   FPA-2012-0033. With support from the 7th Framework Programme's Laser lab
   Europe project (No. 284464).
CR Ahad I.U., 2013, EUR CELLS MAT S6, V26, P145
   Ahad I.U., 2013, J BIOMED MAT RES A
   Antonio PD, 2012, BBA-BIOMEMBRANES, V1818, P3141, DOI 10.1016/j.bbamem.2012.08.001
   ARENHOLZ E, 1991, APPL PHYS A-MATER, V53, P330, DOI 10.1007/BF00357196
   Bartnik A, 2011, NUCL INSTRUM METH A, V647, P125, DOI 10.1016/j.nima.2011.05.033
   Bartnik A, 2012, APPL PHYS A-MATER, V109, P39, DOI 10.1007/s00339-012-7243-5
   FIEDOROWICZ H, 1993, APPL PHYS LETT, V62, P2778, DOI 10.1063/1.109232
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Hadjizadeh A, 2010, J MECH BEHAV BIOMED, V3, P574, DOI 10.1016/j.jmbbm.2010.07.002
   Heitz J, 1997, APPL PHYS A-MATER, V65, P259, DOI 10.1007/s003390050575
   Jagur-Grodzinski J, 1999, REACT FUNCT POLYM, V39, P99, DOI 10.1016/S1381-5148(98)00054-6
   Jorgensen J. F., 1993, Nanotechnology, V4, P152, DOI 10.1088/0957-4484/4/3/004
   Laurens P, 2000, APPL SURF SCI, V154, P211, DOI 10.1016/S0169-4332(99)00443-2
   Lippert T, 1996, MACROMOLECULES, V29, P6301, DOI 10.1021/ma9517198
   Liu YM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1862775
   Reisinger B, 2010, APPL PHYS A-MATER, V100, P511, DOI 10.1007/s00339-010-5845-3
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
NR 17
TC 10
Z9 10
U1 0
U2 9
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
EI 1898-794X
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD APR
PY 2014
VL 125
IS 4
BP 924
EP 928
DI 10.12693/APhysPolA.125.924
PG 5
WC Physics, Multidisciplinary
SC Physics
GA AM4NA
UT WOS:000339830200018
OA Bronze
DA 2018-10-20
ER

PT J
AU Carinci, F
   Santarelli, A
   Laino, L
   Pezzetti, E
   De Lillo, A
   Parisi, D
   Bambini, F
   Procaccini, M
   Testa, NF
   Cocchi, R
   Lo Muzio, L
AF Carinci, F.
   Santarelli, A.
   Laino, L.
   Pezzetti, E.
   De Lillo, A.
   Parisi, D.
   Bambini, F.
   Procaccini, M.
   Testa, N. F.
   Cocchi, R.
   Lo Muzio, L.
TI PRE-CLINICAL EVALUATION OF A NEW CORAL-BASED BONE SCAFFOLD
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE bone; coral; scaffold; polymer; cDNA microarray
ID MANDIBULAR DISTRACTION OSTEOGENESIS; IMPLANT SOFT-TISSUES;
   CALCIUM-CARBONATE; MORPHOGENETIC PROTEINS; MICROARRAY TECHNOLOGY;
   GENE-EXPRESSION; LOCALIZATION; TITANIUM; SULFATE; RALOXIFENE
AB Coral is used worldwide for bone reconstruction. The favorable characteristics that make this material desirable for implantation are (i) osteoinduction, (ii) and osteoconduction. These proprieties have been demonstrated by in vivo studies with animal models and clinical trials over a twenty-year period. Also poly(2-hydroxyethylmethacrylate) [poly(HEMA)] is a widely used biomaterial. By using coral and poly(HEMA), a scaffold for bone reconstruction application has been recently synthesized. Cytological, histological and genetic analyses were performed to characterize this new alloplastic material. Four samples were analyzed: (a) white coral (WC), (b) red coral (RC), (c) WC plus polymer (WCP) and (d) RC plus polymer (RCP). Quantification of mitochondrial dehydrogenase activity by MTT assay was performed as indirect detector of cytotoxicity. In vivo effects were revealed by implanting corals and coral-based polymers in rabbit tibia. Samples were collected after 4 weeks and subjected to histological analysis. To evaluate the genetic response of cells to corals and coral-derived polymers an osteoblast, like cell line (i.e. MG63) was cultured in wells containing (a) medium, (b) medium plus corals and (c) medium plus two types of scaffolds (RCP or WCP). RNAs extracted from cells were retro-transcribed and hybridized on DNA 19.2K microarrays. No cytotoxicity was detected in corals and coral-based biopolymers. No inflammation or adverse effect was revealed by histological examination. By microarray analysis 154 clones were differentially expressed between RC and WC (81 up and 73 down regulated) whereas only 15 clones were repressed by the polymer. Histological evaluation not only confirmed that coral is a biocompatible material, but also that the polymer has no adverse effect Microarray results were in agreement with cytological and histological analyses and provided further data regarding the genetic effects of RC, WC and the new polymer.
C1 [Carinci, F.] Univ Ferrara, Dept Expt Morphol Surg & Med, I-44100 Ferrara, Italy.
   [Santarelli, A.; Bambini, F.; Procaccini, M.] Marche Polytech Univ, Dept Clin Specialist & Stomatol Sci, Ancona, Italy.
   [Laino, L.; De Lillo, A.; Parisi, D.; Lo Muzio, L.] Foggia Univ, Dept Clin & Expt Med, Foggia, Italy.
   [Pezzetti, E.] Univ Bologna, Dept Specialist Diagnost & Expt Med, Bologna, Italy.
   [Testa, N. F.] Univ Bari, Interdisciplinary Dept Med, Bari, Italy.
   [Cocchi, R.] S Giovanni Rotondo, IRCCS Casa Sollievo Sofferenza, Foggia, Italy.
RP Lo Muzio, L (reprint author), Via Rovelli 48, I-71122 Foggia, Italy.
EM lorenzo.lomuzio@unifg.it
RI Cocchi, Roberto/C-4598-2017; Santarelli, Andrea/P-6310-2014
OI Cocchi, Roberto/0000-0001-6080-0016; Santarelli,
   Andrea/0000-0003-4218-3354; PARISI, DOMENICO/0000-0002-7755-9115; testa,
   nunzio francesco/0000-0001-5710-3877
FU National Scientific Research Programme PRIN [20087BNE3K_003]; University
   of Ferrara, Italy; Guya-bioscience, Ferrara, Italy; Fondazione CARISBO;
   National Research Council (C.N.R.), Rome, Italy (AP); Ministry of
   Education, University and Research (M.I.U.R.), Rome, Italy (AP); AROD
   (Research Association for Dentistry and Dermatology), Chieti, Italy (AP)
FX This work was supported in whole or in part by the National Scientific
   Research Programme PRIN 2008 number 20087BNE3K_003; by grants from
   University of Ferrara, Italy (F.C.), Guya-bioscience, Ferrara, Italy
   (F.C.), and Fondazione CARISBO (F.P.); by the National Research Council
   (C.N.R.), Rome, Italy (AP); by the Ministry of Education, University and
   Research (M.I.U.R.), Rome, Italy (AP) and by AROD (Research Association
   for Dentistry and Dermatology), Chieti, Italy (AP).
CR Alvarez J, 2002, DEVELOPMENT, V129, P1913
   Atzet S, 2008, BIOMACROMOLECULES, V9, P3370, DOI 10.1021/bm800686h
   Bambini F, 2007, EUR J INFLAMM, V5, P121, DOI 10.1177/1721727X0700500302
   Bambini F, 2006, INT J IMMUNOPATH PH, V19, P905, DOI 10.1177/039463200601900420
   Bambini F, 2013, EUR J INFLAMM, V11, P305, DOI 10.1177/1721727X1301100133
   Campisi P, 2003, PLAST RECONSTR SURG, V111, P201, DOI 10.1097/01.PRS.0000034932.99249.34
   Campisi P, 2003, PLAST RECONSTR SURG, P9
   Carinci F, 2004, J BIOMED MATER RES B, V71B, P260, DOI 10.1002/jbm.b.30133
   Cuif JP, 2003, GEOCHIM COSMOCHIM AC, V67, P75, DOI 10.1016/S0016-7037(02)01041-4
   DAMIEN CJ, 1994, CALCIFIED TISSUE INT, V55, P151, DOI 10.1007/BF00297191
   De Rosa M, 2004, J CELL PHYSIOL, V198, P133, DOI 10.1002/jcp.10397
   GRILLO MC, 1993, MAR BIOL, V117, P119, DOI 10.1007/BF00346433
   JAMMET P, 1994, J CRANIO MAXILL SURG, V22, P103, DOI 10.1016/S1010-5182(05)80019-8
   Lepore S, 2013, J BIOL REG HOMEOS AG, V27, P531
   Li G, 2000, CELL BIOL INT, V24, P25, DOI 10.1006/cbir.1999.0449
   Li XN, 2013, CLIN ORTHOP RELAT R, V471, P2540, DOI 10.1007/s11999-012-2644-5
   Lo Muzio L, 2013, EUR J INFLAMM, V11, P797
   Marchac D, 1994, J Craniofac Surg, V5, P213, DOI 10.1097/00001665-199409000-00003
   Piattelli A, 1997, BIOMATERIALS, V18, P623, DOI 10.1016/S0142-9612(96)00158-5
   POLLICK S, 1995, J ORAL MAXIL SURG, V53, P915, DOI 10.1016/0278-2391(95)90281-3
   Saini Rajesh, 2012, Methods Mol Biol, V906, P321, DOI 10.1007/978-1-61779-953-2_26
   Sandor GKB, 2003, DENT TRAUMATOL, V19, P221, DOI 10.1034/j.1600-9657.2003.00164.x
   Santarelli A, 2009, Minerva Stomatol, V58, P445
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   SOUYRIS F, 1985, J MAXILLOFAC SURG, V13, P64, DOI 10.1016/S0301-0503(85)80018-7
   Steinbrech DS, 2000, PLAST RECONSTR SURG, V105, P2028, DOI 10.1097/00006534-200005000-00018
   Su J, 2009, EXP EYE RES, V88, P445, DOI 10.1016/j.exer.2008.10.029
   Suhag GS, 2008, J BIOMAT SCI-POLYM E, V19, P1189, DOI 10.1163/156856208785540118
   TABAS JA, 1991, GENOMICS, V9, P283, DOI 10.1016/0888-7543(91)90254-C
   Yazawa M, 2003, J ORAL MAXIL SURG, V61, P587, DOI 10.1053/joms.2003.50116
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
NR 31
TC 1
Z9 1
U1 2
U2 11
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0394-6320
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD APR-JUN
PY 2014
VL 27
IS 2
BP 221
EP 234
DI 10.1177/039463201402700209
PG 14
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA AL1RT
UT WOS:000338904500009
PM 25004834
OA Bronze
DA 2018-10-20
ER

PT J
AU Idrus, RBH
   Rameli, MAB
   Low, KC
   Law, JX
   Chua, KH
   Latiff, MB
   Bin Saim, A
AF Idrus, Ruszymah Bt Hj
   Rameli, Mohd Adha Bin P.
   Low, Kiat Cheong
   Law, Jia Xian
   Chua, Kien Hui
   Latiff, Mazlyzam Bin Abdul
   Bin Saim, Aminuddin
TI Full-Thickness Skin Wound Healing Using Autologous Keratinocytes and
   Dermal Fibroblasts with Fibrin: Bilayered Versus Single-Layered
   Substitute
SO ADVANCES IN SKIN & WOUND CARE
LA English
DT Article
DE autologous skin substitute; keratinocytes; fibroblasts; fibrin; sheep
   model
ID ENDOTHELIAL GROWTH-FACTOR; BIOENGINEERED SKIN; RECONSTRUCTION;
   MANAGEMENT; BURNS; REGENERATION; SCAFFOLDS; CELLS
AB Split-skin grafting (SSG) is the gold standard treatment for full-thickness skin defects. For certain patients, however, an extensive skin lesion resulted in inadequacies of the donor site. Tissue engineering offers an alternative approach by using a very small portion of an individual's skin to harvest cells for propagation and biomaterials to support the cells for implantation. The objective of this study was to determine the effectiveness of autologous bilayered tissue-engineered skin (BTES) and single-layer tissue-engineered skin composed of only keratinocytes (SLTES-K) or fibroblasts (SLTES-F) as alternatives for full-thickness wound healing in a sheep model. Full-thickness skin biopsies were harvested from adult sheep. Isolated fibroblasts were cultured using medium Ham's F12: Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum, whereas the keratinocytes were cultured using Define Keratinocytes Serum Free Medium. The BTES, SLTES-K, and SLTES-F were constructed using autologous fibrin as a biomaterial. Eight full-thickness wounds were created on the dorsum of the body of the sheep. On 4 wounds, polyvinyl chloride rings were used as chambers to prevent cell migration at the edge. The wounds were observed at days 7, 14, and 21. After 3 weeks of implantation, the sheep were euthanized and the skins were harvested. The excised tissues were fixed in formalin for histological examination via hematoxylin-eosin, Masson trichrome, and elastin van Gieson staining. The results showed that BTES, SLTES-K, and SLTES-F promote wound healing in nonchambered and chambered wounds, and BTES demonstrated the best healing potential. In conclusion, BTES proved to be an effective tissue-engineered construct that can promote the healing of full-thickness skin lesions. With the support of further clinical trials, this procedure could be an alternative to SSG for patients with partial-and full-thickness burns.
C1 [Idrus, Ruszymah Bt Hj; Rameli, Mohd Adha Bin P.; Chua, Kien Hui] Ampang Puteri Specialist Hosp, Tissue Engn Ctr, Ampang, Selangor, Malaysia.
   [Idrus, Ruszymah Bt Hj; Law, Jia Xian; Chua, Kien Hui] Ampang Puteri Specialist Hosp, Fac Med, Dept Physiol, Ampang, Selangor, Malaysia.
   [Low, Kiat Cheong] Ampang Puteri Specialist Hosp, Fac Med, Lab Anim Resource Unit, Ampang, Selangor, Malaysia.
   [Latiff, Mazlyzam Bin Abdul] Ampang Puteri Specialist Hosp, Fac Hlth Sci, Sch Diagnost, Ampang, Selangor, Malaysia.
   [Latiff, Mazlyzam Bin Abdul] Ampang Puteri Specialist Hosp, Fac Hlth Sci, Sch Appl Hlth Sci, Ampang, Selangor, Malaysia.
   [Bin Saim, Aminuddin] Ampang Puteri Specialist Hosp, Ear Nose & Throat Consultant Clin, Ampang, Selangor, Malaysia.
RP Idrus, RBH (reprint author), Ampang Puteri Specialist Hosp, Tissue Engn Ctr, Ampang, Selangor, Malaysia.
RI Law, Jia Xian/M-9728-2017
OI Law, Jia Xian/0000-0001-9045-5145
FU Ministry of Science, Technology and Innovation (MOSTI), Malaysia
   [06-02-02-0003-BTK/ER/022]
FX The authors have disclosed that they have no financial relationships
   related to this article. This work was financially supported by a
   research grant from the Ministry of Science, Technology and Innovation
   (MOSTI), Malaysia 06-02-02-0003-BTK/ER/022. Submitted April 12, 2013;
   accepted in revised form October 18, 2013.
CR Atiyeh BS, 2007, BURNS, V33, P405, DOI 10.1016/j.burns.2006.11.002
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   Bottcher-Haberzeth S, 2010, BURNS, V36, P450, DOI 10.1016/j.burns.2009.08.016
   Braziulis E, 2012, TISSUE ENG PART C-ME, V18, P464, DOI [10.1089/ten.TEC.2011.0561, 10.1089/ten.tec.2011.0561]
   Currie LJ, 2001, PLAST RECONSTR SURG, V108, P1713, DOI 10.1097/00006534-200111000-00045
   Demling RH, 1999, BURNS, V25, P256, DOI 10.1016/S0305-4179(98)00165-X
   Epstein FH, 1999, NEW ENGL J MED, V341, P738, DOI DOI 10.1056/NEJM199909023411006.PMID:10471461
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   Guo R, 2011, BIOMATERIALS, V32, P1019, DOI 10.1016/j.biomaterials.2010.08.087
   Huzaira M, 2001, J INVEST DERMATOL, V116, P846, DOI 10.1046/j.0022-202x.2001.01337.x
   Khan MAA, 2010, J PLAST RECONSTR AES, V63, P2168, DOI 10.1016/j.bjps.2010.03.017
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Llames SG, 2004, TRANSPLANTATION, V77, P350, DOI 10.1097/01.TP.0000112381.80964.85
   Majewska I, 2011, ACTA BIOCHIM POL, V58, P449
   Mazlyzam AL, 2007, BURNS, V33, P355, DOI 10.1016/j.burns.2006.08.022
   Mazlyzam A L, 2008, Med J Malaysia, V63 Suppl A, P32
   Moiemen NS, 2010, BURNS, V36, P764, DOI 10.1016/j.burns.2010.04.011
   PERTOVAARA L, 1994, J BIOL CHEM, V269, P6271
   Pham C, 2007, BURNS, V33, P946, DOI 10.1016/j.burns.2007.03.020
   QUINN KJ, 1985, BIOMATERIALS, V6, P369, DOI 10.1016/0142-9612(85)90095-X
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Ring A, 2006, BURNS, V32, P35, DOI 10.1016/j.burns.2005.07.009
   Seet WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040978
   Tonello C, 2005, FASEB J, V19, P1546, DOI 10.1096/fj.05-3804fje
   Wong VW, 2012, EXP DERMATOL, V21, P729, DOI 10.1111/j.1600-0625.2012.01542.x
   Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100
NR 27
TC 14
Z9 17
U1 0
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1527-7941
EI 1538-8654
J9 ADV SKIN WOUND CARE
JI Adv. Skin Wound Care
PD APR
PY 2014
VL 27
IS 4
BP 171
EP 180
DI 10.1097/01.ASW.0000445199.26874.9d
PG 10
WC Dermatology; Nursing; Surgery
SC Dermatology; Nursing; Surgery
GA AI2ZK
UT WOS:000336727500005
PM 24637651
DA 2018-10-20
ER

PT J
AU Bychuk, MA
   Kil'deeva, NR
   Cherdyntseva, TA
AF Bychuk, M. A.
   Kil'deeva, N. R.
   Cherdyntseva, T. A.
TI Films of a Biodegradable Polyester Mixture with Antimicrobial and
   Proteolytic Activity
SO PHARMACEUTICAL CHEMISTRY JOURNAL
LA English
DT Article
DE polyhydroxybutyrate; polycaprolactone
AB The possibility of preparing a biomaterial based on a mixture of biocompatible and biodegradable polymers, polyhydroxybutyrate and polycaprolactone, was studied. Samples for laboratory tests were prepared by forming films from an emulsion of solutions of biologically active compounds in a solution of the polymers in an organic solvent. Trypsin was used as the proteolytic component. Films containing chlorhexidine digluconate, pefloxacin, and furazolidone were studied in order to find the optimum antimicrobial component. The optimum composition of the molding mixture for preparing films with the optimal properties, i.e., trypsin activity 52.5% of the initial value, vapor permeability 4.5 mg/cm2, furazolidone desorption rate 25% C (tau)/C (a), and properties 90% stable after storing in normal saline, was determined.
C1 [Bychuk, M. A.; Kil'deeva, N. R.] Moscow State Univ Design & Technol, Moscow 115535, Russia.
   [Cherdyntseva, T. A.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119991, Russia.
RP Bychuk, MA (reprint author), Moscow State Univ Design & Technol, Moscow 115535, Russia.
CR [Anonymous], TU 9393 001 0269944
   Blatun L. A., 2007, KHIRURGIVA, P9
   Budnevskii S. V., 2004, THESIS MOSCOW
   Dai ZW, 2009, BIOMATERIALS, V30, P3075, DOI 10.1016/j.biomaterials.2009.02.015
   Dong HQ, 2008, COLLOID SURFACE B, V66, P26, DOI 10.1016/j.colsurfb.2008.05.007
   Fedorov M B, 2007, Prikl Biokhim Mikrobiol, V43, P685
   Foster LJR, 2009, POLYM INT, V58, P1442, DOI 10.1002/pi.2682
   Kapritchkoff FM, 2006, J BIOTECHNOL, V122, P453, DOI 10.1016/j.jbiotec.2005.09.009
   Kil'deeva N R, 2006, Prikl Biokhim Mikrobiol, V42, P716
   Kil'deeva N. R., 2000, KHIM VOLOKNA*, P24
   Lutsevich O E, 2011, Khirurgiia (Mosk), P72
   Ol'khov A. A., 2012, ENTSIKL INZH KHIM, P17
   Romanovskaya I. I., 2009, DOP NATS AKAD NAUK U, P182
NR 13
TC 2
Z9 2
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0091-150X
EI 1573-9031
J9 PHARM CHEM J+
JI Pharm. Chem. J.
PD APR
PY 2014
VL 48
IS 1
BP 60
EP 64
DI 10.1007/s11094-014-1047-1
PG 5
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AI7NG
UT WOS:000337077900017
DA 2018-10-20
ER

PT J
AU Lau, NS
   Ch'ng, DHE
   Chia, KH
   Wong, YM
   Sudesh, K
AF Lau, Nyok-Sean
   Ch'ng, Diana Hooi-Ean
   Chia, Kim-Hou
   Wong, Yoke-Ming
   Sudesh, Kumar
TI Advances in Polyhydroxyalkanoate (PHA): Unraveling the Development and
   New Perspectives
SO JOURNAL OF BIOBASED MATERIALS AND BIOENERGY
LA English
DT Review
DE Bioplastics; Polyhydroxyalkanoate; PHA Producer; PHA Biosynthesis; PHA
   Synthase
ID RECOMBINANT ESCHERICHIA-COLI; FED-BATCH CULTURE; RALSTONIA-EUTROPHA;
   BIOTECHNOLOGICAL PRODUCTION; BIODEGRADABLE PLASTICS; ALCALIGENES-LATUS;
   POLY(3-HYDROXYBUTYRATE) PRODUCTION; BACTERIAL POLYHYDROXYALKANOATES;
   CHROMOBACTERIUM-VIOLACEUM; PSEUDOMONAS-AERUGINOSA
AB Polyhydroxyalkanoate (PHA), a naturally-occurring carbon and energy storage compound in microorganisms, is a potential biomaterial for various biotechnological applications. Despite numerous favorable properties, the development of this biodegradable plastic for commercialization is slowed down by its comparably higher production cost compared to synthetic plastics. Extensive efforts have been directed towards lowering the cost of production in order to make this bioplastic competitive with conventional plastics. The strategies taken include the development of "super bugs" capable of maximizing the production of PHA from the carbon feedstock fed, identification of inexpensive, renewable and non-food grade carbon sources and the implementation of various efficient fermentation and extraction procedures. Among the more than 300 PHA producers identified, only a few of them are suitable candidates for large scale PHA production. This review highlights the most extensively-studied PHA producers and summarizes the advantages of using them for PHA production. The use of genetically engineered microbes that confer benefits that are not found in wild type strain has become increasingly important. Examples on the expression of PHA biosynthetic enzymes in recombinant microorganism for the metabolic engineering of PHA are also discussed.
C1 [Lau, Nyok-Sean; Ch'ng, Diana Hooi-Ean; Chia, Kim-Hou; Wong, Yoke-Ming; Sudesh, Kumar] Univ Sains Malaysia, Sch Biol Sci, Ecobiomat Res Lab, George Town 11800, Malaysia.
RP Sudesh, K (reprint author), Univ Sains Malaysia, Sch Biol Sci, Ecobiomat Res Lab, George Town 11800, Malaysia.
EM ksudesh@usm.my
RI Sudesh, Kumar/C-2942-2011
OI Sudesh, Kumar/0000-0003-4756-9192; Lau, Nyok Sean/0000-0002-0708-5970
FU Ministry of Science, Technology and innovation, Malaysia (MOSTI);
   Universiti Sains Malaysia Graduate Assistant Scheme; APEX DE grant;
   Universiti Sains Malaysia Fellowship
FX N.-S. Lau, D.H.-E. Ch'ng and Y.-M. Wong are recipients of the Universiti
   Sains Malaysia Fellowship. K.-H. Chia thanks My Master program supported
   by The Ministry of Science, Technology and innovation, Malaysia (MOSTI)
   and Universiti Sains Malaysia Graduate Assistant Scheme. APEX DE grant
   supported this study.
CR ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Andreessen B, 2010, APPL ENVIRON MICROB, V76, P622, DOI 10.1128/AEM.02097-09
   Antonio RV, 2000, FEMS MICROBIOL LETT, V182, P111, DOI 10.1111/j.1574-6968.2000.tb08883.x
   Bhubalan K, 2010, MALAYS J MICROBIOL, V6, P81, DOI 10.21161/mjm.21809
   Bhubalan K, 2011, APPL ENVIRON MICROB, V77, P2926, DOI 10.1128/AEM.01997-10
   Bhubalan K, 2010, POLYM DEGRAD STABIL, V95, P1436, DOI 10.1016/j.polymdegradstab.2009.12.018
   Braunegg G, 1998, J BIOTECHNOL, V65, P127, DOI 10.1016/S0168-1656(98)00126-6
   CALLOWAY DH, 1969, APPL MICROBIOL, V17, P176
   Ch'ng DHE, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-22
   Chee JY, 2010, J POLYM ENVIRON, V18, P584, DOI 10.1007/s10924-010-0204-1
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   Chia KH, 2010, POLYM DEGRAD STABIL, V95, P2226, DOI 10.1016/j.polymdegradstab.2010.09.011
   Choi MH, 2010, BIORESOURCE TECHNOL, V101, P4540, DOI 10.1016/j.biortech.2010.01.082
   Chuah JA, 2013, APPL ENVIRON MICROB, V79, P3813, DOI 10.1128/AEM.00564-13
   Dennis D, 1998, J BIOTECHNOL, V64, P177, DOI 10.1016/S0168-1656(98)00110-2
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   DOI Y, 1988, APPL MICROBIOL BIOT, V28, P330, DOI 10.1007/BF00268190
   Don TM, 2006, J BIOMAT SCI-POLYM E, V17, P1425, DOI 10.1163/156856206778937208
   Fukui T, 1998, APPL MICROBIOL BIOT, V49, P333, DOI 10.1007/s002530051178
   Fukui T, 1997, J BACTERIOL, V179, P4821, DOI 10.1128/jb.179.15.4821-4830.1997
   Grothe E, 2000, BIOPROCESS ENG, V22, P441, DOI 10.1007/s004490050757
   Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8
   Hiraishi T, 2009, MINI-REV ORG CHEM, V6, P44, DOI 10.2174/157019309787316139
   Hofer P, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-70
   HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305
   Hori K, 2011, BIOCHEM ENG J, V53, P196, DOI 10.1016/j.bej.2010.10.011
   Houmiel KL, 1999, PLANTA, V209, P547, DOI 10.1007/s004250050760
   Hu PH, 1999, APPL BIOCHEM BIOTECH, V77-9, P445
   HUIJBERTS GNM, 1992, APPL ENVIRON MICROB, V58, P536
   Jacquel N, 2008, BIOCHEM ENG J, V39, P15, DOI 10.1016/j.bej.2007.11.029
   Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838
   Kahar P, 2004, POLYM DEGRAD STABIL, V83, P79, DOI 10.1016/S0141-3910(03)00227-1
   Kamilah H, 2013, MALAYS J MICROBIOL, V9, P51, DOI 10.21161/mjm.45012
   Keenan TM, 2006, J IND MICROBIOL BIOT, V33, P616, DOI 10.1007/s10295-006-0131-2
   Keenan TM, 2004, BIOTECHNOL PROGR, V20, P1697, DOI 10.1021/bp049873d
   Khanna S, 2005, PROCESS BIOCHEM, V40, P607, DOI 10.1016/j.procbio.2004.01.053
   Kim DY, 2000, INT J BIOL MACROMOL, V28, P23, DOI 10.1016/S0141-8130(00)00150-1
   Kim JS, 2005, BIOCHEM ENG J, V23, P169, DOI 10.1016/j.bej.2005.01.016
   Kolibachuk D, 1999, APPL ENVIRON MICROB, V65, P3561
   Koller M, 2008, BIORESOURCE TECHNOL, V99, P4854, DOI 10.1016/j.biortech.2007.09.049
   Koller M, 2007, MACROMOL SYMP, V253, P33, DOI 10.1002/masy.200750704
   Kunasundari B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078528
   Laroche M, 2001, J CONSUM MARK, V18, P503, DOI 10.1108/EUM0000000006155
   Lau NS, 2010, BIORESOURCE TECHNOL, V101, P7916, DOI 10.1016/j.biortech.2010.05.049
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Lee SY, 1998, POLYM DEGRAD STABIL, V59, P387, DOI 10.1016/S0141-3910(97)00176-6
   Lee SY, 1996, TRENDS BIOTECHNOL, V14, P431, DOI 10.1016/0167-7799(96)10061-5
   Lee WH, 2008, BIORESOURCE TECHNOL, V99, P6844, DOI 10.1016/j.biortech.2008.01.051
   LEMOIGNE M, 1926, B SOC CHIM BIOL, V8, P770
   Lenz RW, 2005, BIOMACROMOLECULES, V6, P1, DOI 10.1021/bm049700c
   Loo C.Y., 2007, MALAYS POLYM J, V3, P31
   Loo CY, 2005, BIOTECHNOL LETT, V27, P1405, DOI 10.1007/s10529-005-0690-8
   LUZIER WD, 1992, P NATL ACAD SCI USA, V89, P839, DOI 10.1073/pnas.89.3.839
   Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21
   Marsudi S, 2008, APPL MICROBIOL BIOT, V78, P955, DOI 10.1007/s00253-008-1388-3
   Matsumoto K, 2009, BIOMACROMOLECULES, V10, P686, DOI 10.1021/bm8013878
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Mooney BP, 2009, BIOCHEM J, V418, P219, DOI 10.1042/BJ20081769
   Nomura CT, 2007, APPL MICROBIOL BIOT, V73, P969, DOI 10.1007/s00253-006-0566-4
   Philip S, 2007, J CHEM TECHNOL BIOT, V82, P233, DOI 10.1002/jctb.1667
   Pohlmann A., 2006, NAT BIOTECHNOL, V10, P1227
   POIRIER Y, 1992, SCIENCE, V256, P520, DOI 10.1126/science.256.5056.520
   POIRIER Y, 1995, BIO-TECHNOL, V13, P142, DOI 10.1038/nbt0295-142
   Poirier Y, 2001, BIOPOLYESTERS, V3A, P401
   Quillaguaman J, 2008, APPL MICROBIOL BIOT, V78, P227, DOI 10.1007/s00253-007-1297-x
   Quillaguaman J, 2010, APPL MICROBIOL BIOT, V85, P1687, DOI 10.1007/s00253-009-2397-6
   RAMSAY BA, 1989, APPL ENVIRON MICROB, V55, P584
   RAMSAY BA, 1990, APPL ENVIRON MICROB, V56, P2093
   Rathbone S, 2010, J BIOMED MATER RES A, V93A, P1391, DOI 10.1002/jbm.a.32641
   Rathi DN, 2013, MALAYS J MICROBIOL, V9, P140, DOI 10.21161/mjm.47012
   Reddy CSK, 2003, BIORESOURCE TECHNOL, V87, P137, DOI 10.1016/S0960-8524(02)00212-2
   Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254
   Reinecke F, 2009, J MOL MICROB BIOTECH, V16, P91, DOI 10.1159/000142897
   RODRIGUES MFA, 1995, APPL MICROBIOL BIOT, V43, P880
   Shin HD, 2002, BIOTECHNOL LETT, V24, P539, DOI 10.1023/A:1014899607533
   Shozui F, 2010, APPL MICROBIOL BIOT, V85, P949, DOI 10.1007/s00253-009-2100-y
   Somleva MN, 2008, PLANT BIOTECHNOL J, V6, P663, DOI 10.1111/j.1467-7652.2008.00350.x
   STEINBUCHEL A, 1993, APPL MICROBIOL BIOT, V39, P443, DOI 10.1007/BF00205030
   Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   Sudesh K, 2007, MACROMOL BIOSCI, V7, P1199, DOI 10.1002/mabi.200700086
   Suriyamongkol P, 2007, BIOTECHNOL ADV, V25, P148, DOI 10.1016/j.biotechadv.2006.11.007
   Taguchi S, 2004, MACROMOL BIOSCI, V4, P145, DOI 10.1002/mabi.200300111
   Taguchi S, 2003, BIOCHEM ENG J, V16, P107, DOI 10.1016/S1369-703X(03)00027-5
   Tanadchangsaeng N, 2009, BIOMACROMOLECULES, V10, P2866, DOI 10.1021/bm900696c
   Tsuge T, 2004, MACROMOL BIOSCI, V4, P238, DOI 10.1002/mabi.200300077
   Tsuge T, 2010, POLYM DEGRAD STABIL, V95, P1345, DOI 10.1016/j.polymdegradstab.2010.01.028
   Valentin HE, 1999, MACROMOLECULES, V32, P7389, DOI 10.1021/ma9905167
   van Beilen JB, 2008, PLANT J, V54, P684, DOI 10.1111/j.1365-313X.2008.03431.x
   Wang FL, 1997, APPL ENVIRON MICROB, V63, P4765
   Xu Y, 2010, PROCESS BIOCHEM, V45, P153, DOI 10.1016/j.procbio.2009.09.001
   Yamada M, 2010, BIOMACROMOLECULES, V11, P815, DOI 10.1021/bm901437z
   Yamane T, 1996, BIOTECHNOL BIOENG, V50, P197
   Zhu CJ, 2010, BIOTECHNOL PROGR, V26, P424, DOI 10.1002/btpr.355
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 98
TC 6
Z9 6
U1 8
U2 107
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1556-6560
EI 1556-6579
J9 J BIOBASED MATER BIO
JI J. Biobased Mater. Bioenergy
PD APR
PY 2014
VL 8
IS 2
SI SI
BP 118
EP 129
DI 10.1166/jbmb.2014.1418
PG 12
WC Chemistry, Applied; Energy & Fuels; Materials Science, Biomaterials
SC Chemistry; Energy & Fuels; Materials Science
GA AH8XE
UT WOS:000336420700002
DA 2018-10-20
ER

PT J
AU Schafer-Nolte, F
   Hennecke, K
   Reimers, K
   Schnabel, R
   Allmeling, C
   Vogt, PM
   Kuhbier, JW
   Mirastschijski, U
AF Schaefer-Nolte, Franziska
   Hennecke, Kathleen
   Reimers, Kerstin
   Schnabel, Reinhild
   Allmeling, Christina
   Vogt, Peter M.
   Kuhbier, Joern W.
   Mirastschijski, Ursula
TI Biomechanics and Biocompatibility of Woven Spider Silk Meshes During
   Remodeling in a Rodent Fascia Replacement Model
SO ANNALS OF SURGERY
LA English
DT Article
DE biomaterial; degradation; hernia mesh; immune response; spider silk
ID CLAVIPES DRAGLINE SILK; CONGENITAL DIAPHRAGMATIC-HERNIA;
   SMALL-INTESTINAL SUBMUCOSA; NEPHILA-CLAVIPES; EXTRACELLULAR-MATRIX;
   MECHANICAL-PROPERTIES; PROSTHETIC MESHES; ESCHERICHIA-COLI;
   IMMUNE-RESPONSE; RABBIT MODEL
AB Objective: The aim of this study was to investigate biomechanical and immunogenic properties of spider silk meshes implanted as fascia replacement in a rat in vivo model.
   Background: Meshes for hernia repair require optimal characteristics with regard to strength, elasticity, and cytocompatibility. Spider silk as a biomaterial with outstanding mechanical properties is potentially suitable for this application.
   Methods: Commercially available meshes used for hernia repair (Surgisis and Ultrapro) were compared with handwoven meshes manufactured from native dragline silk of Nephila spp. All meshes were tied onto the paravertebral fascia, whereas sham-operated rats were sutured without mesh implantation. After 4 or 14 days, 4 weeks, and 4 or 8 months, tissue samples were analyzed concerning inflammation and biointegration both by histological and biochemical methods and by biomechanical stability tests.
   Results: Histological sections revealed rapid cell migration into the spider silk meshes with increased numbers of giant cells compared with controls with initial decomposition of silk fibers after 4 weeks. Four months postoperatively, spider silk was completely degraded with the formation of a stable scar verified by constant tensile strength values. Surgisis elicited excessive stability loss from day 4 to day 14 (P < 0.001), with distinct inflammatory reaction demonstrated by lymphocyte and neutrophil invasion. Ultrapro also showed decreasing strength and poor elongation behavior, whereas spider silk samples had the highest relative elongation (P < 0.05).
   Conclusions: Hand-manufactured spider silk meshes with good biocompatibility and beneficial mechanical properties seem superior to standard biological and synthetic meshes, implying an innovative alternative to currently used meshes for hernia repair.
C1 [Schaefer-Nolte, Franziska; Hennecke, Kathleen; Reimers, Kerstin; Schnabel, Reinhild; Allmeling, Christina; Vogt, Peter M.; Kuhbier, Joern W.; Mirastschijski, Ursula] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-30625 Hannover, Germany.
RP Kuhbier, JW (reprint author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM Kuhbier.Joern@mh-hannover.de
RI Mirastschijski, Ursula/F-2708-2015
OI Mirastschijski, Ursula/0000-0003-3964-8851
FU Else-Kroner-Fresenius-Stiftung; StrucMed program of Hannover Medical
   School
FX Supported by funding from the Else-Kroner-Fresenius-Stiftung and the
   StrucMed program of Hannover Medical School.
CR Agnarsson I, 2008, J EXP ZOOL PART A, V309A, P494, DOI 10.1002/jez.480
   Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   Bellon JM, 2007, J LAPAROENDOSC ADV S, V17, P160, DOI 10.1089/lap.2006.0028
   Bellon JM, 2012, SURG ENDOSC, V26, P27, DOI 10.1007/s00464-011-1823-x
   Bohm G, 2011, J BIOMATER APPL, V25, P771, DOI 10.1177/0885328209360423
   Bohm G, 2011, J BIOMATER APPL, V25, P721, DOI 10.1177/0885328210361543
   Bogush VG, 2009, J NEUROIMMUNE PHARM, V4, P17, DOI 10.1007/s11481-008-9129-z
   Brown CN, 2010, ANN ROY COLL SURG, V92, P272, DOI 10.1308/003588410X12664192076296
   Brown CP, 2012, ACS NANO, V6, P1961, DOI 10.1021/nn300130q
   Burger JWA, 2006, SURG ENDOSC, V20, P1320, DOI 10.1007/s00464-005-0706-4
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Clark RH, 1998, J PEDIATR SURG, V33, P1004, DOI 10.1016/S0022-3468(98)90522-X
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   DONG ZY, 1991, ARCH BIOCHEM BIOPHYS, V284, P53, DOI 10.1016/0003-9861(91)90262-H
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Foelix RF, 2011, BIOL SPIDERS
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0
   Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hakimi O, 2010, J BIOMED MATER RES A, V92A, P1366, DOI 10.1002/jbm.a.32462
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hodde J, 2006, ANZ J SURG, V76, P1096, DOI 10.1111/j.1445-2197.2006.03948.x
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Kuhbier JW, 2011, J BIOMED MATER RES B, V97B, P381, DOI 10.1002/jbm.b.31825
   Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032
   Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i
   LALLY KP, 1993, J PEDIATR SURG, V28, P45, DOI 10.1016/S0022-3468(05)80352-5
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Liang MK, 2013, WORLD J SURG, V37, P530, DOI 10.1007/s00268-012-1873-9
   Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Mirastschijski U, 2005, EUR SURG RES, V37, P68, DOI 10.1159/000083150
   Moss RL, 2001, J PEDIATR SURG, V36, P152
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Raeder RH, 2002, TRANSPL IMMUNOL, V10, P15, DOI 10.1016/S0966-3274(01)00044-2
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Shah BC, 2011, HERNIA, V15, P165, DOI 10.1007/s10029-010-0768-7
   SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060
   Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k
   Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Vollrath F, 2002, IN VIVO, V16, P229
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Wendt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021833
   WORK RW, 1982, J ARACHNOL, V10, P1
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
NR 55
TC 12
Z9 12
U1 1
U2 30
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0003-4932
EI 1528-1140
J9 ANN SURG
JI Ann. Surg.
PD APR
PY 2014
VL 259
IS 4
BP 781
EP 792
DI 10.1097/SLA.0b013e3182917677
PG 12
WC Surgery
SC Surgery
GA AH6NK
UT WOS:000336247400042
PM 23873006
DA 2018-10-20
ER

PT J
AU Gogoi, D
   Choudhury, AJ
   Chutia, J
   Pal, AR
   Khan, M
   Choudhury, M
   Pathak, P
   Das, G
   Patil, DS
AF Gogoi, Dolly
   Choudhury, Arup Jyoti
   Chutia, Joyanti
   Pal, Arup Ratan
   Khan, Mojibur
   Choudhury, Manash
   Pathak, Pallabi
   Das, Gouranga
   Patil, Dinkar S.
TI Development of Advanced Antimicrobial and Sterilized Plasma
   Polypropylene Grafted Muga (antheraea assama) Silk as Suture Biomaterial
SO BIOPOLYMERS
LA English
DT Article
DE Silk suture; plasma graft polymerization; sterilization; antibacterial;
   histopathology
ID TISSUE ENGINEERING APPLICATIONS; PHYSICAL-PROPERTIES; BOMBYX-MORI;
   RAMAN-SPECTROSCOPY; NONWOVEN SCAFFOLD; FIBROIN FILMS; FIBERS;
   METHACRYLATE; FABRICATION; ACID
AB Surface modification of silk fibroin (SF) materials using environmentally friendly and non-hazardous process to tailor them for specific application as biomaterials has drawn a great deal of interest in the field of biomedical research. To further explore this area of research, in this report, polypropylene (PP) grafted muga (Antheraea assama) SF (PP-AASF) suture is developed using plasma treatment and plasma graft polymerization process. For this purpose, AASF is first sterilized in argon (Ar) plasma treatment followed by grafting PP onto its surface. AASF is a non-mulberry variety having superior qualities to mulberry SF and is still unexplored in the context of suture biomaterial. AASF, Ar plasma treated AASF (AASF(Ar)) and PP-AASF are subjected to various characterization techniques for better comparison and the results are attempted to correlate with their observed properties. Excellent mechanical strength, hydrophobicity, antibacterial behavior, and remarkable wound healing activity of PP-AASF over AASF and AASF(Ar) make it a promising candidate for application as sterilized suture biomaterial. (C) 2013 Wiley Periodicals, Inc.
C1 [Gogoi, Dolly; Choudhury, Arup Jyoti; Chutia, Joyanti; Pal, Arup Ratan] Inst Adv Study Sci & Technol, Div Phys Sci, Gauhati 781035, India.
   [Khan, Mojibur] Inst Adv Study Sci & Technol, Div Life Sci, Gauhati 781035, India.
   [Choudhury, Manash] Assam Agr Univ, Dept Vet Surg & Radiol, Gauhati 781022, India.
   [Pathak, Pallabi; Das, Gouranga] Assam Agr Univ, Dept Parasitol, Gauhati 781022, India.
   [Patil, Dinkar S.] Bhabha Atom Res Ctr, Div Laser & Plasma Technol, Bombay 400085, Maharashtra, India.
RP Chutia, J (reprint author), Inst Adv Study Sci & Technol, Div Phys Sci, Gauhati 781035, India.
EM joyanti_c@sify.com
RI Khan, Mojibur/H-9741-2014; PAL, ARUP/C-6711-2012
OI PAL, ARUP/0000-0003-3893-1305
FU Board of Research in Nuclear Sciences, Department of Atomic Energy;
   Government of India [2007/34/16-BRNS/1370]
FX Contract grant sponsor: Board of Research in Nuclear Sciences,
   Department of Atomic Energy; Government of India; Contract grant number:
   2007/34/16-BRNS/1370
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Boothe H. W., 1993, SUTURE MAT TISSUE AD, P235
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Celeste C., 2008, SELECTION SUTURE MAT, P194
   Chu C. C., 2002, TEXTILE BASED BIOMAT, P501
   Cohen I.K., 1992, WOUND HEALING BIOCH
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Das A, 2001, J APPL POLYM SCI, V81, P2633, DOI 10.1002/app.1707
   Das A, 2000, BIORESOURCE TECHNOL, V74, P213, DOI 10.1016/S0960-8524(00)00020-1
   Devi D, 2011, J TEXT I, V102, P527, DOI 10.1080/00405000.2010.498172
   Domenech J., 2007, RES PROGR METALLOTHE, P21
   Edwards H. G. M., 2005, CASE STUDY ANCIENT T, P318
   EDWARDS HGM, 1995, J RAMAN SPECTROSC, V26, P901, DOI 10.1002/jrs.1250260842
   FREDDI G, 1994, J APPL POLYM SCI, V52, P775, DOI 10.1002/app.1994.070520608
   Fridman A., 2008, PLASMA CHEM, P642
   Frushour B. G., 1975, RAMAN SPECTROSCOPY P, P35
   Garcia-Fuentes M, 2009, BIOMATERIALS, V30, P5068, DOI 10.1016/j.biomaterials.2009.06.008
   Garg N., 2007, TXB ENDODONTICS, P308
   Ghosh G. K., 1995, INDIAN TEXTILES PRES, P71
   Ghosh P., 2003, FIBER SCI TECHNOLOGY, P98
   Glisovic A., 2010, MULBERRY SILK SPIDER, P239
   Gogoi D, 2012, PLASMA CHEM PLASMA P, V32, P1293, DOI 10.1007/s11090-012-9410-z
   Gogoi D, 2011, APPL SURF SCI, V258, P126, DOI 10.1016/j.apsusc.2011.08.018
   Han YH, 2007, COMPOS INTERFACE, V14, P559, DOI 10.1163/156855407781291272
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Karmakar S. R., 1999, TEXTILE SCI TECHNOLO, V12, P15
   Kasoju N, 2012, J BIOMED MATER RES B, V100B, P1854, DOI 10.1002/jbm.b.32753
   Kasoju N, 2010, ADV ENG MATER, V12, pB139, DOI 10.1002/adem.200980055
   Kasoju N, 2009, MATER LETT, V63, P2466, DOI 10.1016/j.matlet.2009.08.037
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   Khan M. M. R., 2007, Journal of Silk Science and Technology of Japan, V16, P107
   Khan MMR, 2010, BIORESOURCE TECHNOL, V101, P8439, DOI 10.1016/j.biortech.2010.05.100
   Krimm S., 1986, VIB SPECTROSC, P181
   Kudur MH, 2009, INDIAN J DERMATOL VE, V75, P425, DOI 10.4103/0378-6323.53155
   Liew A. W. C., 2005, DATA MINING BIOINFOR, P95
   LUCAS F, 1958, ADV PROTEIN CHEM, V13, P107, DOI 10.1016/S0065-3233(08)60599-9
   Mackenzie D, 1973, Med Hist, V17, P158
   Matsumoto A., 2006, HDB FIBER CHEM, P400
   Monti P, 1998, J RAMAN SPECTROSC, V29, P297, DOI 10.1002/(SICI)1097-4555(199804)29:4<297::AID-JRS240>3.0.CO;2-G
   MOORE WH, 1976, BIOPOLYMERS, V15, P2465, DOI 10.1002/bip.1976.360151211
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Nielsen AS, 2002, POLYMER, V43, P2671, DOI 10.1016/S0032-3861(02)00053-8
   Painter P. C., 1976, RAMAN SPECTROSCOPY P, P575
   Pudner R., 2005, WOUND HEALING SURG P, P53
   Quin G., 2011, SILK BASED BIOMATERI, P422
   Sergent F, 2010, AM J SURG, V200, P406, DOI 10.1016/j.amjsurg.2009.09.024
   Souza C. H. M., 2011, SUTURE MAT BASIC SUT, P155
   Tau A. T., 1982, RAMAN SPECTROSCOPY B, P65
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P1407, DOI 10.1002/polb.1994.090320812
   TSUKADA M, 1995, J POLYM SCI POL PHYS, V33, P1995, DOI 10.1002/polb.1995.090331402
   Tsukada M, 1998, J APPL POLYM SCI, V67, P1393, DOI 10.1002/(SICI)1097-4628(19980222)67:8<1393::AID-APP5>3.0.CO;2-9
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P1175, DOI 10.1002/polb.1994.090320705
   XUE G, 1994, PROG POLYM SCI, V19, P317, DOI 10.1016/0079-6700(94)90009-4
   Yool D. A., 2012, SMALL ANIMAL SOFT TI, P31
   Zhang JF, 2009, THIN SOLID FILMS, V517, P3850, DOI 10.1016/j.tsf.2009.01.161
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 57
TC 12
Z9 12
U1 1
U2 43
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD APR
PY 2014
VL 101
IS 4
BP 355
EP 365
DI 10.1002/bip.22369
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI0XZ
UT WOS:000336575300006
PM 23913788
DA 2018-10-20
ER

PT J
AU Herrmann, FEM
   Lehner, A
   Hollweck, T
   Haas, U
   Fano, C
   Fehrenbach, D
   Kozlik-Feldmann, R
   Wintermantel, E
   Eissner, G
   Hagl, C
   Akra, B
AF Herrmann, Florian E. M.
   Lehner, Anja
   Hollweck, Trixi
   Haas, Ulrike
   Fano, Cornelia
   Fehrenbach, David
   Kozlik-Feldmann, Rainer
   Wintermantel, Erich
   Eissner, Gunther
   Hagl, Christian
   Akra, Bassil
TI In vitro biological and mechanical evaluation of various scaffold
   materials for myocardial tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; cell transplantation; heart disease; stem cells; tissue
   engineering
ID POLYURETHANE VASCULAR GRAFTS; BONE-MARROW-CELLS; INTRACORONARY
   INJECTION; STEM-CELLS; CARDIOMYOCYTES; CHALLENGES; INFARCTION; ADHESION;
   MATRIX
AB A cardiac patch is a construct devised in regenerative medicine to replace necrotic heart tissue after myocardial infarctions. The cardiac patch consists of a scaffold seeded with stem cells. To identify the best scaffold for cardiac patch construction we compared polyurethane, Collagen Cell Carriers, ePTFE, and ePTFE SSP1-RGD regarding their receptiveness to seeding with mesenchymal stem cells isolated from umbilical cord tissue. Seeding was tested at an array of cell seeding densities. The bioartificial patches were cultured for up to 35 days and evaluated by scanning electron microscopy, microscopy of histological stains, fluorescence microscopy, and mitochondrial assays. Polyurethane was the only biomaterial which resulted in an organized multilayer (seeding density: 0.750 x 10(6) cells/cm(2)). Cultured over 35 days at this seeding density the mitochondrial activity of the cells on polyurethane patches continually increased. There was no decrease in the E Modulus of polyurethane once seeded with cells. Seeding of CCC could only be realized at a low seeding density and both ePTFE and ePTFE SSP1-RGD were found to be unreceptive to seeding. Of the tested scaffolds polyurethane thus crystallized as the most appropriate for seeding with mesenchymal stem cells in the framework of myocardial tissue engineering. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 958-966, 2014.
C1 [Herrmann, Florian E. M.; Lehner, Anja; Hollweck, Trixi; Haas, Ulrike; Eissner, Gunther; Hagl, Christian; Akra, Bassil] Univ Munich, Grosshadern Med Ctr, Dept Cardiac Surg, Lab Tissue Engn, D-81377 Munich, Germany.
   [Lehner, Anja; Kozlik-Feldmann, Rainer] Univ Munich, Grosshadern Med Ctr, Dept Pediat Cardiol & Pediat Intens Care, D-81377 Munich, Germany.
   [Fano, Cornelia] Inst Text Technol & Proc Engn, D-73770 Denkendorf, Germany.
   [Fehrenbach, David; Wintermantel, Erich] Tech Univ Munich, Chair Med Engn, D-85748 Garching, Germany.
RP Akra, B (reprint author), Univ Munich, Grosshadern Med Ctr, Dept Cardiac Surg, Lab Tissue Engn, Marchioninistr 15, D-81377 Munich, Germany.
EM bassil.akra@med.uni-muenchen.de
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Beitnes JO, 2011, EUR J ECHOCARDIOGR, V12, DOI 10.1093/ejechocard/jeq116
   Bergmeister H, 2012, ARTIF ORGANS, V36, P54, DOI 10.1111/j.1525-1594.2011.01297.x
   Callegari A, 2007, BIOMATERIALS, V28, P5449, DOI 10.1016/j.biomaterials.2007.07.022
   Ciardelli G, 2006, POLYM ADVAN TECHNOL, V17, P786, DOI 10.1002/pat.781
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gulbins H, 2006, THORAC CARDIOV SURG, V54, P102, DOI 10.1055/s-2005-865916
   Hollweck T, 2010, BIOMED MATER, P5
   Hudson JE, 2011, TISSUE ENG PT A, V17, P2279, DOI [10.1089/ten.TEA.2010.0743, 10.1089/ten.tea.2010.0743]
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Kawase T, 2010, J MATER SCI-MATER M, V21, P731, DOI 10.1007/s10856-009-3896-9
   Larsen CC, 2006, BIOMATERIALS, V27, P4846, DOI 10.1016/j.biomaterials.2006.05.009
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Nelson TJ, 2006, ANAT REC PART A, V288A, P1216, DOI 10.1002/ar.a.20388
   Seshareddy K, 2008, METHOD CELL BIOL, V86, P101, DOI 10.1016/S0091-679X(08)00006-X
   Tee R, 2010, ANZ J SURG, V80, P683, DOI 10.1111/j.1445-2197.2010.05435.x
   Tse JR, 2011, PLOS ONE, V6
   Tsuji H, 2010, CIRC RES, V106, P1613, DOI 10.1161/CIRCRESAHA.109.205260
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
NR 24
TC 6
Z9 6
U1 0
U2 37
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2014
VL 102
IS 4
BP 958
EP 966
DI 10.1002/jbm.a.34786
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB1LH
UT WOS:000331552700005
PM 23650018
DA 2018-10-20
ER

PT J
AU Tobaben, NE
   Domann, JP
   Arnold, PM
   Friis, EA
AF Tobaben, Nicholas E.
   Domann, John P.
   Arnold, Paul M.
   Friis, Elizabeth A.
TI Theoretical model of a piezoelectric composite spinal fusion interbody
   implant
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE piezoelectric; composite; electrical stimulation; spine; fusion
ID ELECTRIC-POWER GENERATION; STIMULATION; ALLOGRAFT; CERAMICS; WALKING;
   LOADS
AB Failure rates of spinal fusion are high in smokers and diabetics. The authors are investigating the development of a piezoelectric composite biomaterial and interbody device design that could generate clinically relevant levels of electrical stimulation to help improve the rate of fusion for these patients. A lumped parameter model of the piezoelectric composite implant was developed based on a model that has been utilized to successfully predict power generation for piezoceramics. Seven variables (fiber material, matrix material, fiber volume fraction, fiber aspect ratio, implant cross-sectional area, implant thickness, and electrical load resistance) were parametrically analyzed to determine their effects on power generation within reasonable implant constraints. Influences of implant geometry and fiber aspect ratio were independent of material parameters. For a cyclic force of constant magnitude, implant thickness was directly and cross-sectional area inversely proportional to power generation potential. Fiber aspect ratios above 30 yielded maximum power generation potential while volume fractions above 15% showed superior performance. This investigation demonstrates the feasibility of using composite piezoelectric biomaterials in medical implants to generate therapeutic levels of direct current electrical stimulation. The piezoelectric spinal fusion interbody implant shows promise for helping increase success rates of spinal fusion. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 975-981, 2014.
C1 [Tobaben, Nicholas E.; Domann, John P.; Friis, Elizabeth A.] Univ Kansas, Dept Mech Engn, Lawrence, KS 66045 USA.
   [Arnold, Paul M.] Univ Kansas, Med Ctr, Dept Neurosurg, Kansas City, KS 66160 USA.
RP Friis, EA (reprint author), Univ Kansas, Dept Mech Engn, Lawrence, KS 66045 USA.
EM lfriis@ku.edu
RI Domann, John/J-8981-2018
OI Domann, John/0000-0001-6970-571X
FU Institute for Advancing Medical Innovation
FX Contract grant sponsor: Institute for Advancing Medical Innovation
CR AN HS, 1995, J SPINAL DISORD, V8, P131
   Biomet, 2009, IMPL SPIN FUS STIM P
   CAPPOZZO A, 1984, Journal of Orthopaedic Research, V1, P292
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Cheng CK, 1998, BIO-MED MATER ENG, V8, P155
   Cook Stephen D, 2004, Spine J, V4, P300
   CROMWELL R, 1989, J ORTHOPAED RES, V7, P371, DOI 10.1002/jor.1100070309
   Dejardin L M, 2001, Spine J, V1, P341, DOI 10.1016/S1529-9430(01)00100-0
   Epstein Nancy E, 2011, Surg Neurol Int, V2, P115, DOI 10.4103/2152-7806.83929
   Epstein Nancy E, 2011, Surg Neurol Int, V2, P10, DOI 10.4103/2152-7806.76147
   Glazer PA, 2002, ORTHOP J HARVARD MED, V4, P63
   Green S., PEEK OPTIMA POLYM IM
   KANE WJ, 1988, SPINE, V13, P363, DOI 10.1097/00007632-198803000-00026
   KHOO BCC, 1995, MED ENG PHYS, V17, P27, DOI 10.1016/1350-4533(95)90374-K
   Kucharzyk DW, 1999, SPINE, V24, P465, DOI 10.1097/00007632-199903010-00012
   Lei A, 2011, PROC IEEE MICR ELECT, P125, DOI 10.1109/MEMSYS.2011.5734377
   Ltd I, 2004, TYP MAT PROP GRAN
   MERIL AJ, 1994, SPINE, V19, P2393, DOI 10.1097/00007632-199411000-00004
   MOONEY V, 1990, SPINE, V15, P708, DOI 10.1097/00007632-199007000-00016
   NINDS, 2011, LOW BACK PAIN FACT S
   Platt SR, 2005, IEEE-ASME T MECH, V10, P455, DOI 10.1109/TMECH.2005.852482
   Platt SR, 2005, IEEE-ASME T MECH, V10, P240, DOI 10.1109/TMECH.2005.844704
   Roundy S., 2003, ENERGY SCAVENGING WI
   Tobaben N., 2012, DEV NOVEL PIEZOELECT
   Toth JM, 2000, SPINE, V25, P2580, DOI 10.1097/00007632-200010150-00007
   Tsuang YH, 2009, MED ENG PHYS, V31, P565, DOI 10.1016/j.medengphy.2008.11.012
   Van den Ende D, 2010, J APPL PHYS, V107
   van den Ende DA, 2012, J APPL PHYS, V111, DOI 10.1063/1.4729814
   Walpole SC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-439
   Wang M, 2008, MAT SCI ENG R, V63, P1, DOI 10.1016/j.mser.2008.07.001
   Wilson SA, 1999, THESIS CRANFIELD U
   Yoshida T, 2009, J ORTHOP SCI, V14, P320, DOI 10.1007/s00776-009-1333-z
NR 32
TC 5
Z9 5
U1 0
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2014
VL 102
IS 4
BP 975
EP 981
DI 10.1002/jbm.a.34750
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB1LH
UT WOS:000331552700007
PM 23589373
DA 2018-10-20
ER

PT J
AU Wang, XJ
   Cui, J
   Zhang, BQ
   Zhang, HY
   Bi, Y
   Kang, Q
   Wang, N
   Bie, P
   Yang, ZY
   Wang, HZ
   Liu, XD
   Haydon, RC
   Luu, HH
   Tang, N
   Dong, JH
   He, TC
AF Wang, Xiaojun
   Cui, Jing
   Zhang, Bing-Qiang
   Zhang, Hongyu
   Bi, Yang
   Kang, Quan
   Wang, Ning
   Bie, Ping
   Yang, Zhanyu
   Wang, Huaizhi
   Liu, Xiangde
   Haydon, Rex C.
   Luu, Hue H.
   Tang, Ni
   Dong, Jiahong
   He, Tong-Chuan
TI Decellularized liver scaffolds effectively support the proliferation and
   differentiation of mouse fetal hepatic progenitors
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cell transplantation; liver progenitor cells; immortalized progenitors;
   decellularized scaffolds; tissue engineering; regenerative medicine
ID BMP-9-INDUCED OSTEOGENIC DIFFERENTIATION; SUPPRESSES TUMOR-GROWTH;
   MESENCHYMAL STEM-CELLS; HUMAN OSTEOSARCOMA; OSTEOBLAST DIFFERENTIATION;
   RECOMBINANT ADENOVIRUSES; MATRIX SCAFFOLDS; PROTEIN; SYSTEM; TISSUE
AB Decellularized whole organs represent ideal scaffolds for engineering new organs and/or cell transplantation. Here, we investigate whether decellularized liver scaffolds provide cell-friendly biocompatible three-dimensional (3-D) environment to support the proliferation and differentiation of hepatic progenitor cells. Mouse liver tissues are efficiently decellularized through portal vein perfusion. Using the reversibly immortalized mouse fetal hepatic progenitor cells (iHPCs), we are able to effectively recellularize the decellularized liver scaffolds. The perfused iHPCs survive and proliferate in the 3-D scaffolds in vitro for 2 weeks. When the recellularized scaffolds are implanted into the kidney capsule of athymic nude mice, cell survival and proliferation of the implanted scaffolds are readily detected by whole body imaging for 10 days. Furthermore, epidermal growth factor (EGF) is shown to significantly promote the proliferation and differentiation of the implanted iHPCs. Histologic and immunochemical analyzes indicate that iHPCs are able to proliferate and differentiate to mature hepatocytes upon EGF stimulation in the scaffolds. The recellularization of the biomaterial scaffolds is accompanied with vascularization. Taken together, these results indicate that decullarized liver scaffolds effectively support the proliferation and differentiation of iHPCs, suggesting that decellularized liver matrix may be used as ideal biocompatible scaffolds for hepatocyte transplantation. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1017-1025, 2014.
C1 [Wang, Xiaojun; Wang, Ning; Bie, Ping; Yang, Zhanyu; Wang, Huaizhi; Liu, Xiangde; Dong, Jiahong] Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing 400038, Peoples R China.
   [Wang, Xiaojun; Cui, Jing; Zhang, Bing-Qiang; Zhang, Hongyu; Bi, Yang; Kang, Quan; Wang, Ning; Haydon, Rex C.; Luu, Hue H.; Tang, Ni; He, Tong-Chuan] Univ Chicago, Med Ctr, Mol Oncol Lab, Dept Surg, Chicago, IL 60637 USA.
   [Cui, Jing; Zhang, Bing-Qiang; Zhang, Hongyu; Bi, Yang; Kang, Quan; Tang, Ni; He, Tong-Chuan] Chongqing Med Univ, Chinese Minist Educ, Key Lab Diagnost Med Designated, Chongqing 400016, Peoples R China.
   [Cui, Jing; Zhang, Bing-Qiang; Zhang, Hongyu; Bi, Yang; Kang, Quan; Tang, Ni; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chongqing 400016, Peoples R China.
   [Dong, Jiahong] Chinese Peoples Liberat Army Gen Hosp, Hosp & Inst Hepatobiliary Surg, Chinese PLA Postgrad Med Sch, Beijing 100853, Peoples R China.
RP He, TC (reprint author), Univ Chicago, Med Ctr, Mol Oncol Lab, Dept Surg, Chicago, IL 60637 USA.
EM dongjh301@163.com; tche@uchicago.edu
FU National Institutes of Health; Natural Science Foundation of China
   (NSFC) [81100309, 30972586, 31171307]; Key National S T Program
   [2013ZX10002002-005-003, 2012ZX10002005-003-002]
FX Contract grant sponsor: National Institutes of Health (to TCH, RCH, and
   HHL); Contract grant sponsor: Natural Science Foundation of China
   (NSFC); contract grant numbers: #81100309 (to YB) and #30972586 and
   #31171307 (to NT); Contract grant sponsor: Key National S & T Program;
   contract grant numbers: #2013ZX10002002-005-003 and
   #2012ZX10002005-003-002 (to NT)
CR Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133
   Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017
   Fukumitsu K, 2011, TRANSPL P, V43, P2137, DOI 10.1016/j.transproceed.2011.05.014
   Gilbert TW, 2012, J CELL BIOCHEM, V113, P2217, DOI 10.1002/jcb.24130
   Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719
   Haydon RC, 2002, CLIN CANCER RES, V8, P1288
   He BC, 2011, MOL PHARMACOL, V79, P211, DOI 10.1124/mol.110.068668
   He BC, 2011, INT J ONCOL, V38, P437, DOI 10.3892/ijo.2010.858
   He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231
   Huang E, 2012, PLOS ONE, V7
   Huang EY, 2012, J BONE MINER RES, V27, P1566, DOI 10.1002/jbmr.1622
   Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x
   Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298
   Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130
   Kang Yu-Zhan, 2009, Zhonghua Yi Xue Za Zhi, V89, P1135
   Liu J., 2011, PLOS ONE, V6
   Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135
   Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200
   Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98
   Orlando Giuseppe, 2011, Transpl Int, V24, P223, DOI 10.1111/j.1432-2277.2010.01182.x
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200
   Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182
   Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200
   Shupe T, 2010, ORGANOGENESIS, V6, P134, DOI 10.4161/org.6.2.11546
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Su Y, 2011, ONCOGENE, V30, P3907, DOI 10.1038/onc.2011.97
   Sullivan DC, 2012, BIOMATERIALS, V33, P7756, DOI 10.1016/j.biomaterials.2012.07.023
   Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x
   Traphagen S, 2009, REGEN MED, V4, P747, DOI 10.2217/RME.09.38
   Westerman KA, 1996, P NATL ACAD SCI USA, V93, P8971, DOI 10.1073/pnas.93.17.8971
   Yang K, 2012, J INVEST DERMATOL, V132, P2479, DOI 10.1038/jid.2012.145
   Zhang W, 2010, PLOS ONE, V5
   Zhou P, 2011, LIVER TRANSPLANT, V17, P418, DOI 10.1002/lt.22270
NR 40
TC 22
Z9 28
U1 1
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2014
VL 102
IS 4
BP 1017
EP 1025
DI 10.1002/jbm.a.34764
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB1LH
UT WOS:000331552700012
PM 23625886
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ni, YS
   Jiang, Y
   Wen, JC
   Shao, ZZ
   Chen, X
   Sun, S
   Yu, HQ
   Li, W
AF Ni, Yusu
   Jiang, Yi
   Wen, Jianchuan
   Shao, Zhenzhong
   Chen, Xin
   Sun, Shan
   Yu, Huiqian
   Li, Wen
TI Construction of a functional silk-based biomaterial complex with
   immortalized chondrocytes in vivo
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; cytocompatibility; cartilage; silk fibroin
ID MANDIBULAR CONDYLAR CARTILAGE; FIBROIN 3D SCAFFOLDS; HUMAN FIBROBLASTS;
   EPITHELIAL-CELLS; VITRO; PROLIFERATION; DEGRADATION; TELOMERASE;
   SENESCENCE; CULTURE
AB To explore the feasibility of constructing a functional biomaterial complex with regenerated silk fibroin membrane and immortalized chondrocytes in vivo. Rat auricular chondrocytes (RACs) were transfected with the lentivirus vector pGC-FU-hTERT-3FLAG or pGC-FU-GFP-3FLAG, encoding the human telomerase reverse transcriptase (hTERT) or GFP gene. The effects of regenerated silk fibroin film on the adhesion, growth of immortalized chondrocytes and expression of collagen II in vitro were analyzed with immunofluorescent histochemistry. Immortalized RACs were transformed. Induction by nutrient medium promoted higher expression levels of collagen II in transformed chondrocytes. The regenerated silk fibroin film was not cytotoxic to immortalized chondrocytes and had no adverse influence on their adhesion. Collagen II expression was good in the immortalized chondrocytes in vivo. The construction of a silk-based biomaterial complex with immortalized chondrocytes may provide a feasible kind of functional biomaterial for the repair of cartilage defects in clinical applications. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1071-1078, 2014.
C1 [Ni, Yusu; Sun, Shan; Yu, Huiqian; Li, Wen] Fudan Univ, Shanghai Med Sch, Eye & ENT Hosp, Dept Otolaryngol, Shanghai 200433, Peoples R China.
   [Jiang, Yi] Tongji Univ, Dongfang Hosp, Dept Ophthalmol, Shanghai 200092, Peoples R China.
   [Wen, Jianchuan; Shao, Zhenzhong; Chen, Xin] Fudan Univ, Key Lab Mol Engn Polymer, MOE, Shanghai 200433, Peoples R China.
   [Wen, Jianchuan; Shao, Zhenzhong; Chen, Xin] Fudan Univ, Dept Macromol Sci, Shanghai 200433, Peoples R China.
RP Ni, YS (reprint author), Fudan Univ, Shanghai Med Sch, Eye & ENT Hosp, Dept Otolaryngol, Shanghai 200433, Peoples R China.
EM niyusu@yahoo.com.cn
RI Chen, Xin/F-6802-2015
OI Chen, Xin/0000-0001-7706-4166; Wen, Jianchuan/0000-0002-0993-1042
FU Shanghai Science and Technology Committee [10411962100]; Shanghai Health
   Pudong New Area Bureau [PW2012A-41]
FX Contract grant sponsor: Shanghai Science and Technology Committee;
   contract grant number: 10411962100; Contract grant sponsor: Shanghai
   Health Pudong New Area Bureau; contract grant number: PW2012A-41
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   ENGEL FE, 1990, J DENT RES, V69, P1753, DOI 10.1177/00220345900690110801
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   GIRDLER NM, 1993, INT J ORAL MAX SURG, V22, P178, DOI 10.1016/S0901-5027(05)80248-6
   GOLDRING MB, 1986, J BIOL CHEM, V261, P9049
   Granger MP, 2002, CRIT REV ONCOL HEMAT, V41, P29, DOI 10.1016/S1040-8428(01)00188-3
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Illeperuma RP, 2012, J MATER SCI-MATER M, V23, P753, DOI 10.1007/s10856-011-4473-6
   Ke MW, 2012, REPROD DOMEST ANIM, V47, P553, DOI 10.1111/j.1439-0531.2011.01916.x
   KormannBortolotto MH, 1996, MECH AGEING DEV, V89, P45, DOI 10.1016/0047-6374(96)01742-3
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MORI H, 2000, REV MOL BIOTECHNOL, V74, P95, DOI DOI 10.1016/S1389-0352(00)00004-0
   Murata K, 2007, IN VITRO CELL DEV-AN, V43, P235, DOI 10.1007/s11626-007-9048-y
   Ni Y, 2008, OTOLARYNG HEAD NECK, V139, P256, DOI 10.1016/j.otohns.2008.03.028
   Shao ZZ, 2004, China Patent Z L, Patent No. [200410024711.9, 2004100247119]
   Steinert S, 2000, BIOCHEM BIOPH RES CO, V273, P1095, DOI 10.1006/bbrc.2000.3080
   Stewart SA, 2002, ONCOGENE, V21, P627, DOI 10.1038/sj.onc.1205062
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Xie Y, 2013, IN VITRO CELL DEV-AN, V49, P8, DOI 10.1007/s11626-012-9554-4
   Yang SY, 2000, ANN PLAS SURG, V44, P405, DOI 10.1097/00000637-200044040-00009
NR 24
TC 3
Z9 3
U1 1
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2014
VL 102
IS 4
BP 1071
EP 1078
DI 10.1002/jbm.a.34763
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB1LH
UT WOS:000331552700018
PM 23625883
DA 2018-10-20
ER

PT J
AU Lin, CY
   Li, LT
   Su, WT
AF Lin, Chuang-Yu
   Li, Li-Tzu
   Su, Wen-Ta
TI Study of subcellular dynamics on cell-substrate interactions by live
   cell imaging
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cell-substrate interaction; membrane expansion; live cell imaging;
   confocal microscopy
ID FIBROBLASTS; ATTACHMENT; SRC
AB Cellular adhesiveness to biomaterial is one of the important properties for the success of tissue engineering. The cell-biomaterial interactions involve close cooperation of adhesion proteins, plasma membrane, and cytoskeletons to form focal adhesions during the process of anchoring. Dynamic development of the plasma membrane in the process reflects the cellular biocompatibility and motility. The process of cell attachment beginning from seeding, contact, attachment, and spreading has not been investigated. In this study, we monitored the whole process of cells attaching to the substrate surface by time-lapse confocal microscopy. We observed that the surface configuration of the substratum effects plasma membrane expansion and genomic materials distribution. In contrast to the cells grown on the plate, the cells attached on pillars are with rounded nuclei and with prominent lamellipodia spreading out. Membrane expansion is involved in dynamic development of the plasma membrane and lamellipodia formation for attachment, migration, or proliferation and reflects the cellular physiology status of the cells. This study provides a platform for investigation of cell behavior and dynamic development of subcellular structures regarding cell-biomaterial interactions. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1149-1154, 2014.
C1 [Lin, Chuang-Yu; Su, Wen-Ta] Natl Taipei Univ Technol, Dept Chem Engn, Taipei 106, Taiwan.
   [Li, Li-Tzu] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.
RP Su, WT (reprint author), Natl Taipei Univ Technol, Dept Chem Engn, Taipei 106, Taiwan.
EM f10549@ntut.edu.tw
FU National Science Council, Taiwan [97-2221-E-027-099]
FX Contract grant sponsor: National Science Council, Taiwan; contract grant
   number: 97-2221-E-027-099
CR Altmann B, 2012, BIOMED MICRODEVICES, V14, P291, DOI 10.1007/s10544-011-9605-8
   AMIEVA MR, 1995, EXP CELL RES, V219, P180, DOI 10.1006/excr.1995.1218
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Clark AG, 2011, RESULTS PROBL CELL D, V53, P31, DOI 10.1007/978-3-642-19065-0_3
   Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000
   Kolind K, 2010, BIOMATERIALS, V31, P9182, DOI 10.1016/j.biomaterials.2010.08.048
   Kumari T. V., 2002, TRENDS BIOMATER ARTI, V15, P37
   Mas-Moruno C, 2013, J BIOMED MATER RES A, V101, P87, DOI 10.1002/jbm.a.34303
   Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127
   Sperry AO, 2012, BIOL CELL, V104, P297, DOI 10.1111/boc.201100102
   Su WT, 2006, MICRON, V37, P699, DOI 10.1016/j.micron.2006.03.007
   Su WT, 2011, BIOMED MICRODEVICES, V13, P11, DOI 10.1007/s10544-010-9466-6
   Su WT, 2010, J BIOMED MATER RES A, V93A, P1463, DOI 10.1002/jbm.a.32643
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Trichet L, 2007, BIOPHYS J, V92, P1081, DOI 10.1529/biophysj.106.091884
   Wang HG, 2013, J BIOMED MATER RES A, V101, P413, DOI 10.1002/jbm.a.34339
   Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469
   Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x
   Zawislak JD, 2009, PHYS STATUS SOLIDI A, V206, P1356, DOI 10.1002/pssa.200881037
NR 19
TC 5
Z9 5
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2014
VL 102
IS 4
BP 1149
EP 1154
DI 10.1002/jbm.a.34771
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB1LH
UT WOS:000331552700027
PM 23630045
DA 2018-10-20
ER

PT J
AU Rahmanian-Schwarz, A
   Held, M
   Knoeller, T
   Stachon, S
   Schmidt, T
   Schaller, HE
   Just, L
AF Rahmanian-Schwarz, Afshin
   Held, Manuel
   Knoeller, Tabea
   Stachon, Susanne
   Schmidt, Timo
   Schaller, Hans-Eberhard
   Just, Lothar
TI biocompatibility and biodegradation of a novel thin and mechanically
   stable collagen scaffold
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen; scaffold; tissue engineering; biomaterial; in vivo;
   biocompatibility
ID CROSS-LINKING; DEHYDROTHERMAL TREATMENT; GAG SCAFFOLDS; TISSUE;
   EXPRESSION; FIBERS; BOVINE; BIOMATERIALS; DELIVERY; DISEASE
AB The demand for scaffolds comprised of natural materials such as collagen has increased in recent years. However, many scaffolds rely on chemical or physical modifications in order to comply with the necessary requirements for biomedical engineering. We evaluated the in vivo biocompatibility and biodegradation of a novel, thin, mechanically stable, and chemically non-crosslinked collagen cell carrier (CCC). CCC was implanted subcutaneously into 25 adult Lewis rats and biopsies were taken on days 7, 14, 21, 42, and 84 after surgery. For histological analysis, paraffin sections of implanted skin were immunolabeled for CD68 and stained by hematoxylin-eosin and Masson-Goldner's trichrome method. Macroscopic analysis of skin surface during wound healing process showed a normal physiological reaction. Biodegradation of CCC was completed 42 days after subcutaneous implantation. Histological evaluation revealed no evidence of encapsulation, scar formation, or long-term vascularization and inflammation. The collagen type I based biomaterial demonstrated a high in vivo biocompatibility, low irritability, complete resorption, and replacement by autologous tissue. The in vivo biocompatibility and degradation behavior encourage for further evaluation of CCC in surgical applications and regenerative medicine. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1173-1179, 2014.
C1 [Rahmanian-Schwarz, Afshin; Held, Manuel; Knoeller, Tabea; Schaller, Hans-Eberhard] Univ Tubingen, BG Trauma Ctr, Dept Plast Reconstruct Hand & Burn Surg, Tubingen, Germany.
   [Stachon, Susanne; Schmidt, Timo; Just, Lothar] Univ Tubingen, Ctr Regenerat Biol & Med, Inst Anat, Tubingen, Germany.
RP Rahmanian-Schwarz, A (reprint author), Univ Tubingen, BG Trauma Ctr, Dept Plast Reconstruct Hand & Burn Surg, Tubingen, Germany.
EM arahmanian@bgu-tuebingen.de
CR Alexakis C, 2006, NEPHRON EXP NEPHROL, V102, pE71, DOI 10.1159/000089684
   Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Bou-Akl T, 2013, J BIOMED MAT RES A
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chajra H, 2008, BIO-MED MATER ENG, V18, pS33
   CHIGNIER E, 1985, J BIOMED MATER RES, V19, P115, DOI 10.1002/jbm.820190203
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   Ekaputra AK, 2011, BIOMATERIALS, V32, P8108, DOI 10.1016/j.biomaterials.2011.07.022
   Fernandes H, 2009, TISSUE ENG PT A, V15, P3857, DOI 10.1089/ten.tea.2009.0011
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955
   Hayami JWS, 2010, J BIOMED MATER RES A, V92A, P1407, DOI 10.1002/jbm.a.32472
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   Lai ES, 2011, ACTA BIOMATER, V7, P2448, DOI 10.1016/j.actbio.2011.03.012
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Leong J, 2011, J BIOMATER APPL
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Parenteau-Bareil R, 2011, ACTA BIOMATER, V7, P3757, DOI 10.1016/j.actbio.2011.06.020
   QUTEISH D, 1990, J BIOMED MATER RES, V24, P749, DOI 10.1002/jbm.820240609
   Rodrigues MT, 2012, J TISSUE ENG REGEN M
   Schmidt T, 2011, TISSUE ENG PART C-ME, V17, P1161, DOI [10.1089/ten.tec.2011.0201, 10.1089/ten.TEC.2011.0201]
   Schroder A, 1988, Eur J Vasc Surg, V2, P315, DOI 10.1016/S0950-821X(88)80007-0
   Sehgal PK, 2009, EXPERT OPIN DRUG DEL, V6, P687, DOI 10.1517/17425240903025736
   Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240
   Stover DA, 2011, MOL BIOL EVOL, V28, P533, DOI 10.1093/molbev/msq221
   Takasaki Yoshinari, 2009, Nihon Rinsho, V67, P458
   Thompson KJ, 2011, WORLD J GASTROENTERO, V17, P2473, DOI 10.3748/wjg.v17.i20.2473
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Zhao Xiang, 2011, Orthop Surg, V3, P127, DOI 10.1111/j.1757-7861.2011.00128.x
NR 35
TC 20
Z9 22
U1 0
U2 31
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2014
VL 102
IS 4
BP 1173
EP 1179
DI 10.1002/jbm.a.34793
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB1LH
UT WOS:000331552700030
PM 23666868
DA 2018-10-20
ER

PT J
AU Correia, CO
   Caridade, SG
   Mano, JF
AF Correia, Cristina O.
   Caridade, Sofia G.
   Mano, Joao F.
TI Chitosan Membranes Exhibiting Shape Memory Capability by the Action of
   Controlled Hydration
SO POLYMERS
LA English
DT Article
DE shape memory; glass transition dynamics; biopolymers; biomaterials;
   smart systems
ID VISCOELASTIC PROPERTIES; POLYMER; DERIVATIVES; MISCIBILITY; MOISTURE;
   BLENDS
AB Chitosan membranes can undergo a glass transition at room temperature triggered by hydration. The mechanical properties of the membranes were followed by a tension test and dynamic mechanical analysis (DMA), with the sample in wet conditions after being immersed in varying compositions of water/ethanol mixtures. Results show that with the increasing of water content, the Young's and storage modulus decrease systematically. For water contents of ca. 35 vol%, chitosan (CHT) exhibits a glass transition, showing an elastomeric plateau in the elastic modulus above this hydration level and the occurrence of a peak in the loss factor. Due to the semi-crystalline nature of CHT, membranes of this biomaterial present a shape memory capability induced by water uptake. By fixation of the permanent shape by further covalent cross-linking, the membranes can have different permanent shapes appropriate for different applications, including in the biomedical area.
C1 [Correia, Cristina O.; Caridade, Sofia G.; Mano, Joao F.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   [Correia, Cristina O.; Caridade, Sofia G.; Mano, Joao F.] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal.
RP Mano, JF (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM cristina.oliveira.correia@gmail.com; sofia.caridade@dep.uminho.pt;
   jmano@dep.uminho.pt
RI Caridade, Sofia/P-1925-2015; Group, 3Bs/E-4374-2012; Mano,
   Joao/A-4418-2009
OI Caridade, Sofia/0000-0002-0448-1871; Group, 3Bs/0000-0002-5195-3456;
   Mano, Joao/0000-0002-2342-3765
FU Portuguese Foundation for Science and Technology Foundation (FCT)
   [PTDC/FIS/115048/2009]
FX This work was supported by the Portuguese Foundation for Science and
   Technology Foundation (FCT) through project PTDC/FIS/115048/2009.
CR Alves NM, 2008, INT J BIOL MACROMOL, V43, P401, DOI 10.1016/j.ijbiomac.2008.09.007
   Caridade SG, 2009, CARBOHYD POLYM, V75, P651, DOI 10.1016/j.carbpol.2008.09.011
   Chen MC, 2007, BIOMACROMOLECULES, V8, P2774, DOI 10.1021/bm7004615
   Chen MC, 2009, BIOMATERIALS, V30, P5560, DOI 10.1016/j.biomaterials.2009.06.039
   Cheung MK, 2002, J APPL POLYM SCI, V86, P1253, DOI 10.1002/app.11091
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Du HY, 2010, SOFT MATTER, V6, P3370, DOI 10.1039/b922220k
   Fan K, 2011, EXPRESS POLYM LETT, V5, P409, DOI 10.3144/expresspolymlett.2011.40
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Lv HB, 2008, ADV ENG MATER, V10, P592, DOI 10.1002/adem.200800002
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mano JF, 2008, MACROMOL BIOSCI, V8, P69, DOI 10.1002/mabi.200700139
   Mota J, 2012, ACTA BIOMATER, V8, P4173, DOI 10.1016/j.actbio.2012.06.040
   Pierce BF, 2011, INT J ARTIF ORGANS, V34, P172, DOI 10.5301/IJAO.2011.6413
   Sakurai K, 2000, POLYMER, V41, P7051, DOI 10.1016/S0032-3861(00)00067-7
   Toffey A, 2001, CELLULOSE, V8, P35, DOI 10.1023/A:1016695522968
   Wang CC, 2012, COMPOS SCI TECHNOL, V72, P1178, DOI 10.1016/j.compscitech.2012.03.027
   Xie T, 2011, POLYMER, V52, P4985, DOI 10.1016/j.polymer.2011.08.003
   Yang B, 2006, POLYMER, V47, P1348, DOI 10.1016/j.polymer.2005.12.051
   Yang B, 2004, SMART MATER STRUCT, V13, P191, DOI 10.1088/0964-1726/13/1/022
NR 20
TC 9
Z9 10
U1 1
U2 42
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD APR
PY 2014
VL 6
IS 4
BP 1178
EP 1186
DI 10.3390/polym6041178
PG 9
WC Polymer Science
SC Polymer Science
GA AH1QR
UT WOS:000335896500013
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Veliz, DS
   Alam, C
   Toivola, DM
   Toivakka, M
   Alam, P
AF Veliz, Diosangeles Soto
   Alam, Catharina
   Toivola, Diana M.
   Toivakka, Martti
   Alam, Parvez
TI On the non-linear attachment characteristics of blood to bacterial
   cellulose/kaolin biomaterials
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Wound; Bacterial cellulose; Kaolin; Blood; Adhesion; Tribology
ID PROTEIN ADSORPTION; REGENERATION; BONE
AB In this communication, we report a non-linear variation in the strength of blood attachment to bacterial cellulose/kaolin biomaterials as the fractions of bacterial cellulose to kaolin are increased. The changes observed for attachment strength are elucidated following both experimental and numerical investigations on both the biomaterial and the blood-biomaterial interface. Our research reveals that the non-linear strength of attachment of blood is related to topographical characteristics on the surface of the biomaterial, the maleability of the biomaterial and the intermolecular strength of attraction between clotted blood proteins (fibrinogen) with the cellulose/kaolin components of the biomaterial. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Veliz, Diosangeles Soto; Toivakka, Martti; Alam, Parvez] Abo Akad Univ, Ctr Funct Mat, Lab Paper Coating & Converting, SF-20500 Turku, Finland.
   [Alam, Catharina; Toivola, Diana M.] Abo Akad Univ, Dept Biosci, SF-20500 Turku, Finland.
RP Alam, P (reprint author), Abo Akad Univ, Ctr Funct Mat, Lab Paper Coating & Converting, Porthaninkatu 3, SF-20500 Turku, Finland.
EM parvez.alam@abo.fi
CR Alam P, 2007, CHEM ENG SCI, V62, P3142, DOI 10.1016/j.ces.2007.03.018
   Asfa-Wossen L., 2013, MAT WORLD MAG, V7
   Cai Z, 2010, CELLULOSE, V17, P83, DOI 10.1007/s10570-009-9362-5
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Chambliss D.F., 2012, MAKING SENSE SOCIAL, P154
   Chen YM, 2009, J BIOACT COMPAT POL, V24, P137, DOI 10.1177/0883911509102710
   Ciechanska D, 2004, FIBRES TEXT EAST EUR, V12, P69
   DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001
   GEYER U, 1994, INT J BIOL MACROMOL, V16, P343, DOI 10.1016/0141-8130(94)90067-1
   HOFFMAN AS, 1982, ADV CHEM SER, P3
   Hsieh YC, 2008, CELLULOSE, V15, P507, DOI 10.1007/s10570-008-9206-8
   IWANAGA S, 1969, EUR J BIOCHEM, V8, P189, DOI 10.1111/j.1432-1033.1969.tb00514.x
   Kalaskar DM, 2008, SOFT MATTER, V4, P1059, DOI 10.1039/b719706n
   MARGOLIS J, 1958, J CLIN PATHOL, V11, P406, DOI 10.1136/jcp.11.5.406
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Ovington LG, 2007, CLIN DERMATOL, V25, P33, DOI 10.1016/j.clindermatol.2006.09.003
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Retegi A, 2010, CELLULOSE, V17, P661, DOI 10.1007/s10570-009-9389-7
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   Solway DR, 2010, WOUNDS, V22, P17
   Touaiti F., 2009, MAT SCI ENG A-STRUCT, V527, P2363
   Trabattoni D, 2012, INT J CARDIOL, V156, P53, DOI 10.1016/j.ijcard.2010.10.030
   Vaiana CA, 2011, BIOMACROMOLECULES, V12, P3139, DOI 10.1021/bm200616v
   Varley S.J., 1986, CLIN MAT, V1, P37
   Wanna D., 2013, ADV NAT SCI NANOSCI, V4
   Watson NFS, 2005, SURGERY, V23, P52
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Yang LJ, 2006, J PHYS CHEM B, V110, P13166, DOI 10.1021/jp060163v
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
NR 30
TC 3
Z9 3
U1 2
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2014
VL 116
BP 176
EP 182
DI 10.1016/j.colsurfb.2013.12.038
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AG8YZ
UT WOS:000335706100023
PM 24457185
DA 2018-10-20
ER

PT J
AU Young, TH
   Wang, IJ
   Hu, FR
   Wang, TJ
AF Young, Tai-Horng
   Wang, I-Jong
   Hu, Fung-Rong
   Wang, Tsung-Jen
TI Fabrication of a bioengineered corneal endothelial cell sheet using
   chitosan/polycaprolactone blend membranes
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Corneal endothelial cells; Chitosan; Polycaprolactone; Blends
ID CHITOSAN-POLYCAPROLACTONE BLENDS; TISSUE ENGINEERING APPLICATIONS;
   COLLAGEN PRODUCTION; IN-VITRO; EX-VIVO; TRANSPLANTATION; CARRIER;
   BIOMATERIALS; SCAFFOLD; DIFFERENTIATION
AB Our previous study has demonstrated cultivation of bovine corneal endothelial cells (BCECs) on the chitosan polycaprolactone (PCL) blends. BCECs could grow well and express physiological phenotypes after PCL was introduced into chitosan by means of blending. The feasibility of using chitosan-PCL-blended membranes as scaffold and carrier for corneal endothelial cell (CEC) transplantation is worthy of more investigation. In this work, we attempt to manufacture various blended membranes to bring BCEC cultivation into harmony by hybridizing two polymers with fine adjustment. Therefore, chitosan, which does not promote BCECs maturation, and PCL, which supports, BCEC proliferation, are combined to prepare the blends. Analyses of transmittance, proliferative, abilities, phenotypic expressions, extracellular matrix (ECM) protein production, and hemotoxylin and eosin (H&E) staining were executed step-by-step. From our observations, the blended membranes united respective characteristics. The cultured BCECs on the blends illustrated normal appearance and good proliferative abilities. Immunohistochemical staining verified physiologically phenotypic expressions of ZO-1 and Na-K ATPase. Western blot analysis also confirmed the existence of collagen type IV proteins. Furthermore, the formation of a continuous monolayer of cells attached on the blended membrane was confirmed by H&E staining. These results suggested that chitosan PCL blended membranes may be an optimized biomaterial to fabricate bioengineered corneal endothelium and show potential to facilitate CEC transplantation in the future. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Young, Tai-Horng; Wang, Tsung-Jen] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei, Taiwan.
   [Young, Tai-Horng; Wang, Tsung-Jen] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
   [Wang, I-Jong; Hu, Fung-Rong; Wang, Tsung-Jen] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.
   [Wang, I-Jong; Hu, Fung-Rong; Wang, Tsung-Jen] Coll Med, Taipei, Taiwan.
   [Wang, Tsung-Jen] Taipei Med Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.
   [Wang, Tsung-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Ophthalmol, Taipei, Taiwan.
RP Wang, TJ (reprint author), 252 Wu Hsing St, Taipei 10051, Taiwan.
EM tjw@tmu.edu.tw
OI Wang, I-Jong/0000-0002-3045-0614; HU, FUNG-RONG/0000-0002-2102-5317
FU National Science Council, Taipei, Taiwan [NCS 102-2320-B-038-012];
   Taipei Medical University [TMU101-AEI-B65]
FX The authors thank the National Science Council, Taipei, Taiwan (No. NCS
   102-2320-B-038-012) and Taipei Medical University (TMU101-AEI-B65) for
   their financial support of this research.
CR Bahar I, 2008, OPHTHALMOLOGY, V115, P1525, DOI 10.1016/j.ophtha.2008.02.010
   Chen KH, 2001, CORNEA, V20, P731, DOI 10.1097/00003226-200110000-00012
   Choi JS, 2010, BIOMATERIALS, V31, P6738, DOI 10.1016/j.biomaterials.2010.05.020
   Du LQ, 2011, BRIT J OPHTHALMOL, V95, P410, DOI 10.1136/bjo.2008.142539
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   ENGELMANN K, 1988, INVEST OPHTH VIS SCI, V29, P1656
   Engler C, 2009, CORNEA, V28, P1050, DOI 10.1097/ICO.0b013e3181a165a3
   GOSPODAROWICZ D, 1980, P NATL ACAD SCI-BIOL, V77, P4094, DOI 10.1073/pnas.77.7.4094
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Huang TW, 2010, BIOMATERIALS, V31, P6701, DOI 10.1016/j.biomaterials.2010.05.054
   Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016
   Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4
   JUMBLATT MM, 1978, INVEST OPHTH VIS SCI, V17, P1135
   Koh SWM, 2008, INVEST OPHTH VIS SCI, V49, P3491, DOI 10.1167/iovs.07-1543
   Koh SWM, 2009, INVEST OPHTH VIS SCI, V50, P1801, DOI 10.1167/iovs.08-2590
   LANGE TM, 1993, J CATARACT REFR SURG, V19, P232, DOI 10.1016/S0886-3350(13)80947-9
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126
   Lin SJ, 2006, BIOMATERIALS, V27, P5079, DOI 10.1016/j.biomaterials.2006.05.035
   Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034
   Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174
   Miyata K, 2001, CORNEA, V20, P59, DOI 10.1097/00003226-200101000-00012
   Marquez SP, 2009, ACTA BIOMATER, V5, P1839, DOI 10.1016/j.actbio.2009.02.011
   Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x
   Rasband WS, 1997, IMAGEJ
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Shao HJ, 2010, BIOMATERIALS, V31, P4695, DOI 10.1016/j.biomaterials.2010.02.037
   TSENG SCG, 1981, J BIOL CHEM, V256, P3361
   Wang TJ, 2012, MOL VIS, V18, P255
   Wang TJ, 2012, COLLOID SURFACE B, V90, P236, DOI 10.1016/j.colsurfb.2011.10.043
   Wang TJ, 2012, J BIOMED MATER RES A, V100A, P252, DOI 10.1002/jbm.a.33274
   Watanabe R, 2011, TISSUE ENG PT A, V17, P2213, DOI [10.1089/ten.TEA.2010.0568, 10.1089/ten.tea.2010.0568]
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Zhu YT, 2008, INVEST OPHTH VIS SCI, V49, P3879, DOI 10.1167/iovs.08-1693
NR 36
TC 14
Z9 16
U1 3
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2014
VL 116
BP 403
EP 410
DI 10.1016/j.colsurfb.2014.01.024
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AG8YZ
UT WOS:000335706100053
PM 24531150
DA 2018-10-20
ER

PT J
AU Kunze, A
   Hesse, C
   Svedhem, S
AF Kunze, Angelika
   Hesse, Camilla
   Svedhem, Sofia
TI Real-time monitoring of surface-confined platelet activation on TiO2
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Platelet activation; Aggregation; TiO2; QCM-D
ID QUARTZ-CRYSTAL MICROBALANCE; CELL-ADHESION; DISSIPATION; FILMS
AB For the development of advanced hemocompatible biomaterial functions, there is an unmet demand for in vitro evaluation techniques addressing platelet-surface interactions. We show that the quartz crystal microbalance with dissipation (QCM-D) monitoring technique, here combined with light microscopy, provides a surface sensitive technique that allows for real-time monitoring of the activation and aggregation of the surface-confined platelets on TiO2. The QCM-D signal monitored during adhesion and activation of platelets on TiO2 coated surfaces was found to be different in platelet-poor and platelet-rich environment although light microscopy images taken for each of the two cases looked essentially the same. Interestingly, aggregation of activated platelets was only observed in a protein-rich environment. Our results show that a layer of plasma proteins between the TiO2 surface and the platelets strongly influences the coupling between the platelets and the underlying substrate, explaining both the observed QCM-D signals and the ability of the platelets to aggregate. (C) 2014 The Authors. Published by Elsevier B.V. All rights reserved.
C1 [Kunze, Angelika; Svedhem, Sofia] Chalmers, Dept Appl Phys, S-41296 Gothenburg, Sweden.
   [Hesse, Camilla] Univ Gothenburg, Sahlgrenska Acad, S-41345 Gothenburg, Sweden.
RP Kunze, A (reprint author), Chalmers, Dept Appl Phys, S-41296 Gothenburg, Sweden.
EM angelika.kunze@chalmers.se
FU Swedish Research Council (VR); Linnaeus program SUPRA; European Union
   [NMP4-SL2009-229292]
FX Financial support was received from the Swedish Research Council (VR),
   the Linnaeus program SUPRA and the European Union Seventh Framework
   Program (FP7/2007-2013) under grant agreement no NMP4-SL2009-229292
   ("Find & Bind").
CR Fatisson J, 2008, LANGMUIR, V24, P3294, DOI 10.1021/1a7023204
   Fatisson J, 2011, J R SOC INTERFACE, V8, P988, DOI 10.1098/rsif.2010.0617
   GROTH T, 1995, BIOMATERIALS, V16, P1009, DOI 10.1016/0142-9612(95)94909-5
   Gupta S., 2012, BIOINTERPHASES, V7
   JOHANNSMANN D, 1992, PHYS REV B, V46, P7808, DOI 10.1103/PhysRevB.46.7808
   Johannsmann D, 2009, ANAL CHEM, V81, P8167, DOI 10.1021/ac901381z
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Lord MS, 2008, BIOMATERIALS, V29, P2581, DOI 10.1016/j.biomaterials.2008.03.002
   Lord MS, 2006, BIOMATERIALS, V27, P4529, DOI 10.1016/j.biomaterials.2006.04.006
   Muratsugu M, 1997, ANAL CHIM ACTA, V342, P23, DOI 10.1016/S0003-2670(96)00576-4
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   PARSEGIAN VA, 1983, J PROSTHET DENT, V49, P838, DOI 10.1016/0022-3913(83)90360-8
   Saitakis M, 2012, CELL MOL LIFE SCI, V69, P357, DOI 10.1007/s00018-011-0854-8
   Santos-Martinez MJ, 2012, INT J NANOMED, V7, P243, DOI 10.2147/IJN.S26679
   Sinn S., 2010, ANALYST, V135, P2939
   Tymchenko N., 2012, BIOINTERPHASES, P7
   Voinova MV, 2002, BIOSENS BIOELECTRON, V17, P835, DOI 10.1016/S0956-5663(02)00050-7
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Xi J., 2013, J BIOCHIPS TISSUE CH, VS5, P001, DOI 10.4172/2153-0777.S5-001
NR 19
TC 5
Z9 6
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2014
VL 116
BP 446
EP 451
DI 10.1016/j.colsurfb.2014.01.025
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AG8YZ
UT WOS:000335706100059
PM 24549046
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lee, HS
   Lee, JH
   Yang, JW
AF Lee, Hye Sook
   Lee, Ji Hyun
   Yang, Jae Wook
TI Effect of porcine chondrocyte-derived extracellular matrix on the
   pterygium in mouse model
SO GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
LA English
DT Article
DE Pterygium; Porcine chondrocyte-derived extracellular matrix (PCDECM);
   Athymic nude mouse
ID IN-VIVO; OCULAR ANGIOGENESIS; AMNIOTIC MEMBRANE; CELLS; PATHOGENESIS;
   SCAFFOLD; TISSUE; RECONSTRUCTION; INVASION; EYE
AB Purpose To investigate the effect of porcine chondrocyte-derived extracellular matrix (PCDECM) on an experimental mouse model of human pterygial epithelial cells.
   Methods Cultured human pterygial epithelial cells (hPECs) were stained with pan-cytokeratin (CK), CK3/2p, vimentin, and CK13 antibodies to characterize the cells. A pterygium mouse model was developed by injecting 1X10(4) hPECs into the nasal subconjunctival space in athymic nude mice. PCDECM (25 mg/mL, 10 mu L) was injected into the nasal subconjunctival space in the right eye 7, 10 and 14 days after the epithelial cell injection (PCDECM group). Image analysis was performed using ImageJ (R) to compare the lesion size. A histopathological analysis of the cornea was conducted to evaluate the state of the epithelium and the expression of pterygial epithelial cell markers.
   Results The isolated pterygial cells were positive for pan-CK, CK3/2p and vimentin, and they were negative for CK13 under immunofluorescence microscopy. On day 17 after epithelial cell injection, the size of the lesion compared to the entire cornea was increased to 37.1 % in the control group. However, in the PCDECM group, the lesion covered only 26.3 % of the entire cornea. The corneas of the pterygium mice showed an epithelium of irregular thickness, proliferation of the stroma, extracellular matrix breakdown and overexpression of pterygium-positive markers. However, these changes were significantly suppressed by the application of PCDEDM.
   Conclusions Our findings suggest that PCDECM seems to suppress pterygial epithelial cell growth and it could be used as a promising biomaterial for the noninvasive treatment of pterygium.
C1 [Yang, Jae Wook] Inje Univ, Coll Med, Dept Ophthalmol, Pusan 614735, South Korea.
   [Lee, Hye Sook; Lee, Ji Hyun; Yang, Jae Wook] Inje Univ, Busan Paik Hosp, Ocular Neovasc Dis Res Ctr, Pusan 614735, South Korea.
RP Yang, JW (reprint author), Inje Univ, Coll Med, Dept Ophthalmol, Pusan 614735, South Korea.
EM oculoplasty@gmail.com
FU Korea Healthcare Technology R&D Project, Ministry of Health and Welfare
   Affairs, Republic of Korea [HI12C0005]
FX This study was supported by a grant from the Korea Healthcare Technology
   R&D Project, Ministry of Health and Welfare Affairs, Republic of Korea
   (grant #: HI12C0005).
CR Ang LPK, 2007, CURR OPIN OPHTHALMOL, V18, P308, DOI 10.1097/ICU.0b013e3281a7ecbb
   AUSTIN P, 1983, OPHTHALMOLOGY, V90, P96
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   Bradley JC, 2010, BRIT J OPHTHALMOL, V94, P815, DOI 10.1136/bjo.2008.151852
   Choi KH, 2012, TISSUE ENG REGEN MED, V9, P43, DOI 10.1007/s13770-012-0043-3
   Choi KH, 2010, BIOMATERIALS, V31, P5355, DOI 10.1016/j.biomaterials.2010.03.053
   Chui J, 2011, AM J PATHOL, V78, P817
   Chui J, 2008, OCUL SURF, V6, P24, DOI 10.1016/S1542-0124(12)70103-9
   COGAN DG, 1949, ARCH OPHTHALMOL-CHIC, V41, P406, DOI 10.1001/archopht.1949.00900040416002
   Connon CJ, 2010, BRIT J OPHTHALMOL, V94, P1057, DOI 10.1136/bjo.2008.153064
   Cox CA, 2010, OPHTHALMOLOGY, V117, P1782, DOI 10.1016/j.ophtha.2010.01.037
   de Rotth A, 1940, ARCH OPHTHALMOL-CHIC, V23, P522
   Di Girolamo N, 2004, PROG RETIN EYE RES, V23, P195, DOI 10.1016/j.preteyers.2004.02.002
   Di Girolamo N, 1999, BRIT J OPHTHALMOL, V83, P1077, DOI 10.1136/bjo.83.9.1077
   Dua HS, 2010, BRIT J OPHTHALMOL, V94, P963, DOI 10.1136/bjo.2009.157941
   Dushku N, 2001, ARCH OPHTHALMOL-CHIC, V119, P695, DOI 10.1001/archopht.119.5.695
   Dushu N, 1994, CURR EYE RES, V21, P473
   Jin CZ, 2007, ARTIF ORGANS, V31, P183, DOI 10.1111/j.1525-1594.2007.00363.x
   Jin CZ, 2010, J BIOMED MATER RES A, V92A, P1567, DOI 10.1002/jbm.a.32419
   Kivela T, 1998, PROG RETIN EYE RES, V17, P385, DOI 10.1016/S1350-9462(98)00001-9
   Lippincott SW, 1943, J NATL CANCER I, V3, P545
   Livezeanu C, 2011, ROM J MORPHOL EMBRYO, V52, P837
   Montezuma SR, 2009, SEMIN OPHTHALMOL, V24, P52, DOI 10.1080/08820530902800017
   Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752
   Reid TW, 2010, EYE CONTACT LENS, V36, P290, DOI 10.1097/ICL.0b013e3181eea8fe
   SORSBY A, 1946, BRIT J OPHTHALMOL, V30, P337, DOI 10.1136/bjo.30.6.337
   WILLIAMS KA, 1985, TRANSPLANTATION, V39, P242, DOI 10.1097/00007890-198503000-00004
NR 28
TC 6
Z9 6
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0721-832X
EI 1435-702X
J9 GRAEF ARCH CLIN EXP
JI Graefes Arch. Clin. Exp. Ophthalmol.
PD APR
PY 2014
VL 252
IS 4
BP 609
EP 618
DI 10.1007/s00417-014-2592-8
PG 10
WC Ophthalmology
SC Ophthalmology
GA AG8HN
UT WOS:000335659500008
PM 24562465
DA 2018-10-20
ER

PT J
AU Wang, L
   La, DM
   Yang, B
   Jiang, ZP
   Zhang, YC
   Zhou, J
   Lai, W
   Chen, S
AF Wang, Liang
   La, Dong-ming
   Yang, Bin
   Jiang, Zhi-peng
   Zhang, Yu-chao
   Zhou, Jun
   Lai, Wei
   Chen, Shuang
TI Reconstruction of abdominal wall defects using small intestinal
   submucosa coated with gelatin hydrogel incorporating basic fibroblast
   growth factor(1)
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article
DE Abdominal Wall; Biocompatible Materials; Intestinal; Fibroblast Growth
   Factor 2; Rats
ID BONE REGENERATION; REPAIR; MODEL; MATRIX; RATS; VASCULARIZATION;
   ANGIOGENESIS; PREVENTION; RELEASE; IMPROVE
AB PURPOSE: To construct a new biomaterial-small intestinal submucosa coated with gelatin hydrogel incorporating basic fibroblast growth factor, and to evaluate the new biomaterials for the reconstruction of abdominal wall defects.
   METHODS: Thirty six Sprague-Dawley rats were used in the animal experiments and randomly divided into three groups. The new biomaterial was constructed by combining small intestinal submucosa with gelatin hydrogel for basic fibroblast growth factor release. Abdominal wall defects were created in rats, and repaired using the new biomaterials (group B), compared with small intestinal submucosa (group S) and ULTRAPRO (TM) mesh (group P). Six rats in each group were sacrificed at three and eight weeks postoperatively to examine the gross effects, inflammatory responses, collagen deposition and neovascularization.
   RESULTS: After implantation, mild adhesion was caused in groups B and S. Group B promoted more neovascularization than group S at three weeks after implantation, and induced significantly more amount of collagen deposition and better collagen organization than groups S and P at eight weeks after implantation.
   CONCLUSION: Small intestinal submucosa coated with gelatin hydrogel incorporating basic fibroblast growth factor could promote better regeneration and remodeling of host tissues for the reconstruction of abdominal wall defects.
C1 [Wang, Liang; La, Dong-ming; Yang, Bin; Jiang, Zhi-peng; Zhang, Yu-chao; Zhou, Jun; Lai, Wei; Chen, Shuang] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, South China Training Ctr Hernia Therapy, Dept Surg Disciplines, Guangzhou 510120, Guangdong, Peoples R China.
RP Chen, S (reprint author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, South China Training Ctr Hernia Therapy, Dept Surg Disciplines, Guangzhou 510120, Guangdong, Peoples R China.
EM chensh2@mail.sysu.edu.cn
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   De Coppi P, 2006, TISSUE ENG, V12, P1929, DOI 10.1089/ten.2006.12.1929
   Dubay DA, 2004, ANN SURG, V240, P179, DOI 10.1097/01.sla.0000131576.12153.ab
   Epstein SE, 2001, CARDIOVASC RES, V49, P532, DOI 10.1016/S0008-6363(00)00217-0
   FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664
   Franz MG, 2001, J SURG RES, V97, P109, DOI 10.1006/jsre.2001.6083
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Ikada Y., 1998, ADV DRUG DELIV REV, V31, P287
   Iwakura A, 2000, ANN THORAC SURG, V70, P824, DOI 10.1016/S0003-4975(00)01645-3
   Konstantinovic ML, 2005, BJOG-INT J OBSTET GY, V112, P1554, DOI 10.1111/j.1471-0528.2005.00688.x
   Krishnamoorthy L, 2001, J Wound Care, V10, P173
   MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297
   Muniruzzaman Tabata Y, 1998, J BIOMAT SCI-POLYM E, V9, P459
   Nurata H, 2009, J CLIN NEUROSCI, V16, P542, DOI 10.1016/j.jocn.2008.05.021
   Okazaki Y, 2000, ARCH ORAL BIOL, V45, P911, DOI 10.1016/S0003-9969(00)00035-2
   RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484
   Rieck P., 1993, Ophthalmologe, V90, P646
   Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4
   Stocum DL, 1997, SCIENCE, V276, P15, DOI 10.1126/science.276.5309.15
   Tabata Y, 1998, BIOMATERIALS, V19, P807, DOI 10.1016/S0142-9612(98)00233-6
   Taipale J, 1997, FASEB J, V11, P51
   Takaoka R, 2009, J BIOMAT SCI-POLYM E, V20, P1483, DOI 10.1163/092050609X12457419038465
   Unger EF, 2000, AM J CARDIOL, V85, P1414, DOI 10.1016/S0002-9149(00)00787-6
   van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017
   WALKER AP, 1993, J SURG RES, V55, P32, DOI 10.1006/jsre.1993.1104
   Wasserberg N, 2007, J SURG RES, V141, P294, DOI 10.1016/j.jss.2006.12.541
   Xie JL, 2008, WOUND REPAIR REGEN, V16, P576, DOI 10.1111/j.1524-475X.2008.00405.x
   Yamamoto M, 2000, J CONTROL RELEASE, V64, P133, DOI 10.1016/S0168-3659(99)00129-7
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Zhao WX, 2007, J BIOMED MATER RES A, V82A, P630, DOI 10.1002/bjm.a.31179
NR 33
TC 3
Z9 3
U1 1
U2 5
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
EI 1678-2674
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD APR
PY 2014
VL 29
IS 4
BP 252
EP 260
DI 10.1590/S0102-86502014000400006
PG 9
WC Surgery
SC Surgery
GA AF8WT
UT WOS:000334997000006
PM 24760026
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Rnjak-Kovacina, J
   Wray, LS
   Golinski, JM
   Kaplan, DL
AF Rnjak-Kovacina, Jelena
   Wray, Lindsay S.
   Golinski, Julianne M.
   Kaplan, David L.
TI Arrayed Hollow Channels in Silk-Based Scaffolds Provide Functional
   Outcomes for Engineering Critically Sized Tissue Constructs
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE silk; tissue engineering; oxygen; nutrient delivery; vascularization;
   porous scaffolds
ID VASCULARIZATION STRATEGIES; FIBROIN; NETWORKS; DEGRADATION; FABRICATION;
   DELIVERY; VESSELS; SYSTEM
AB In the field of regenerative medicine there is a need for scaffolds that support large, critically-sized tissue formation. Major limitations in reaching this goal are the delivery of oxygen and nutrients throughout the bulk of the engineered tissue as well as host tissue integration and vascularization upon implantation. To address these limitations, the development of a porous scaffold platform made from biodegradable silk protein that contains an array of vascular-like structures that extend through the bulk of the scaffold was previously reported. Here, the hollow channels play a pivotal role in enhancing cell infiltration, delivering oxygen and nutrients to the scaffold bulk, and promoting in vivo host tissue integration and vascularization. The unique features of this protein biomaterial system, including the vascular structures and tunable material properties, render this scaffold a robust and versatile tool for implementation in a variety of tissue engineering, regenerative medicine, and disease modeling applications.
C1 [Rnjak-Kovacina, Jelena; Wray, Lindsay S.; Golinski, Julianne M.; Kaplan, David L.] Ctr Sci & Technol, Dept Biomed Engn, Medford, MA 02155 USA.
RP Rnjak-Kovacina, J (reprint author), Ctr Sci & Technol, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH [NIH P41 EB002520, EY020856]; National Science Foundation Graduate
   Research Fellowship Program [NSF DGE 0806676]
FX J.R.-K. and L. S. W. contributed equally to this work. The authors thank
   the NIH (NIH P41 EB002520; EY020856) and the National Science Foundation
   Graduate Research Fellowship Program (NSF DGE 0806676) for support. The
   authors are grateful to Dr. Bruce Paniliatis for assistance with animal
   surgeries.
CR Bagnaninchi PO, 2007, TISSUE ENG, V13, P323, DOI 10.1089/ten.2006.0168
   Baranski JD, 2013, P NATL ACAD SCI USA, V110, P7586, DOI 10.1073/pnas.1217796110
   Bellas E, 2013, TISSUE ENG PART C-ME, V19, P745, DOI [10.1089/ten.tec.2012.0620, 10.1089/ten.TEC.2012.0620]
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Du YA, 2011, BIOTECHNOL BIOENG, V108, P1693, DOI 10.1002/bit.23102
   Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4
   Lokmic Z, 2008, TISSUE ENG PART B-RE, V14, P87, DOI 10.1089/teb.2007.0299
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Lovett M, 2010, TISSUE ENG PART C-ME, V16, P1565, DOI [10.1089/ten.tec.2010.0241, 10.1089/ten.TEC.2010.0241]
   Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]
   Maidhof R, 2010, BIOTECHNOL PROGR, V26, P565, DOI 10.1002/btpr.337
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Nazhat SN, 2007, BIOMACROMOLECULES, V8, P543, DOI 10.1021/bm060715f
   Phelps EA, 2009, REGEN MED, V4, P65, DOI 10.2217/17460751.4.1.65
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27
   Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wray LS, 2012, BIOMATERIALS, V33, P9214, DOI 10.1016/j.biomaterials.2012.09.017
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zhang WJ, 2011, BIOMATERIALS, V32, P9415, DOI 10.1016/j.biomaterials.2011.08.047
NR 33
TC 21
Z9 22
U1 0
U2 40
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD APR
PY 2014
VL 24
IS 15
BP 2188
EP 2196
DI 10.1002/adfm.201302901
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AE8VQ
UT WOS:000334281400007
PM 25395920
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Winnett, J
   Mallick, KK
AF Winnett, James
   Mallick, Kajal K.
TI Parametric Characterization of Porous 3D Bioscaffolds Fabricated by an
   Adaptive Foam Reticulation Technique
SO JOM
LA English
DT Article
ID HYDROXYAPATITE SCAFFOLDS; BONE; CHEMISTRY; CERAMICS; POROSITY
AB Commercially pure titanium (Ti) and its alloys, in particular, titanium-vanadium-aluminium (Ti-6Al-4V), have been used as biomaterials due to their mechanical similarities to bone, good biocompatibility, and inertness in vivo. The introduction of porosity to the scaffolds leads to optimized mechanical properties and enhanced biological activity. The adaptive foam reticulation (AFR) technique has been previously used to generate hydroxyapatite bio-scaffolds with enhanced cell behavior due to the generation of macroporous structures with microporous struts that provided routes for cell infiltration as well as attachment sites. Sacrificial polyurethane templates of 45 ppi and 90 ppi were coated in biomaterial-based slurries containing either Ti or Ti-6Al-4V as the biomaterial and camphene as the porogen. The resultant macropore sizes of 100-550 mu m corresponded well with the initial template pore sizes while camphene produced micropores of 1-10 mu m, with the level of microporosity related to the amount of porogen inclusion.
C1 [Winnett, James; Mallick, Kajal K.] Univ Warwick, Coventry CV4 7AL, W Midlands, England.
RP Winnett, J (reprint author), Univ Warwick, Coventry CV4 7AL, W Midlands, England.
EM j.winnett@warwick.ac.uk
FU Engineering and Physical Science Research Council (EPSRC)
FX The authors are grateful to Mr Martin Davis of the School of Engineering
   for the use of facilities and assistance, Science City Futures Project
   for use of XRD facilities, and Engineering and Physical Science Research
   Council (EPSRC) for a Doctoral Training Grant.
CR Ahmad S., 2010, INT J MECH MAT ENG, V5, P244
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chu P.K., 2008, BIOMATERIALS FABRICA, P19
   Cunningham E., 2011, SCI ENG S, V1, P1
   Dabrowski B, 2010, J BIOMED MATER RES B, V95B, P53, DOI 10.1002/jbm.b.31682
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   Fu Q, 2008, J BIOMED MATER RES B, V86B, P125, DOI 10.1002/jbm.b.30997
   Gupta R, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034005
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Jo IH, 2009, MATER LETT, V63, P1702, DOI 10.1016/j.matlet.2009.05.017
   Jones JR, 2009, J MATER SCI-MATER M, V20, P463, DOI 10.1007/s10856-008-3597-9
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Lewis JA, 2006, ADV FUNCT MATER, V16, P2193, DOI 10.1002/adfm.200600434
   Li JP, 2007, KEY ENG MATER, V330-332, P999, DOI 10.4028/www.scientific.net/KEM.330-332.999
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Mahendra A., 2009, INJURY, V38, pS7
   Mallick KK, 2012, J BIOMED MATER RES A, V100A, P2948, DOI 10.1002/jbm.a.34238
   Mallick KK, 2009, J AM CERAM SOC, V92, pS85, DOI 10.1111/j.1551-2916.2008.02784.x
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Miranda P, 2008, J BIOMED MATER RES A, V85A, P218, DOI 10.1002/jbm.a.31587
   Nan BY, 2011, J AM CERAM SOC, V94, P969, DOI 10.1111/j.1551-2916.2010.04257.x
   Soon YM, 2011, J EUR CERAM SOC, V31, P415, DOI 10.1016/j.jeurceramsoc.2010.09.019
   Vallet-Regis M., 2001, J CHEM SOC DA, V2, P97
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Yang J, 2011, J EUR CERAM SOC, V31, P2569, DOI 10.1016/j.jeurceramsoc.2010.12.035
   Yook SW, 2008, MATER LETT, V62, P4506, DOI 10.1016/j.matlet.2008.08.010
NR 27
TC 0
Z9 0
U1 1
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
EI 1543-1851
J9 JOM-US
JI JOM
PD APR
PY 2014
VL 66
IS 4
BP 590
EP 597
DI 10.1007/s11837-014-0937-8
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA AG6BM
UT WOS:000335503400007
DA 2018-10-20
ER

PT J
AU Filardo, G
   Drobnic, M
   Perdisa, F
   Kon, E
   Hribernik, M
   Marcacci, M
AF Filardo, G.
   Drobnic, M.
   Perdisa, F.
   Kon, E.
   Hribernik, M.
   Marcacci, M.
TI Fibrin glue improves osteochondral scaffold fixation: study on the human
   cadaveric knee exposed to continuous passive motion
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Article
DE Knee joint; Articular cartilage lesion; Osteochondral scaffold; Scaffold
   fixation; Post-operative rehabilitation; Fibrin glue
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; COMPOSITE MULTILAYERED BIOMATERIAL;
   ARTICULAR-CARTILAGE DEFECTS; SURGICAL-TREATMENT; SHEEP MODEL; FOLLOW-UP;
   ARTHROSCOPIES; REGENERATION; INJURIES; REPAIR
AB Objective: To evaluate stability and integrity of bi-layer and three-layer collagen-hydroxyapatite (C-HA) osteochondral scaffolds in a human cadaveric knee exposed to continuous passive motion (CPM) with and without loading and the role of added fibrin glue to improve the press-fit fixation of C-HA scaffolds.
   Design: Osteochondral lesions (2.0 x 1.5 cm) were chiseled out on both condyles and trochlea in eight human cadaveric knees. A total of 24 bi-layer (5 mm, four in each condyle) or three-layer C-HA scaffolds (8 mm, eight in the trochlea, four in each condyle) were first press-fit implanted and underwent testing with CPM, 90 cycles, 0 degrees -90 degrees. The second set of 24 scaffolds was implanted in cleaned lesions with the addition of fibrin glue. Two knees with fibrin glue fixation were additionally exposed to 15 kg loading, with 30 cycles of CPM, 0 degrees -30 degrees. Then, the knees were reopened and the scaffolds were evaluated using semi-quantitative Drobnic and modified Bekkers scores.
   Results: All but two scaffolds remained in the lesions site throughout CPM. Two implants failed: both were bi-layer osteochondral scaffolds, press-fit implanted at the lateral femoral condyle (LFC). A statistically significant difference was obtained between press-fit and fibrin glue implants with both Drobnic (2.9 +/- 0.7 vs 4.3 +/- 0.1, P < 0.0005) and Bekkers (3.3 +/- 1.0 vs 5.0 +/- 0.1, P < 0.0005) scores. Additional knee loading did not affect fibrin glue scaffold fixation or integrity.
   Conclusion: This cadaveric study showed fibrin glue notably improved bi-layer or three-layer C-HA scaffold press-fit fixation regardless of lesion location. It is therefore recommended that fibrin glue be used during surgery to improve early post-operative C-HA scaffold stability and integrity. (C) 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
C1 [Filardo, G.; Kon, E.] Rizzoli Orthopaed Inst, Nanobiotechnol Lab, Orthopaed Clin 2, I-40136 Bologna, Italy.
   [Perdisa, F.; Marcacci, M.] Rizzoli Orthopaed Inst, Biomech Lab, Orthopaed Clin 2, I-40136 Bologna, Italy.
   [Drobnic, M.] Univ Ljubljana, Fac Med, Orthopaed Clin, Ljubljana 61000, Slovenia.
   [Hribernik, M.] Univ Ljubljana, Fac Med, Inst Anat, Ljubljana 61000, Slovenia.
RP Kon, E (reprint author), Rizzoli Orthopaed Inst, Biomech Lab, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM e.kon@biomec.ior.it
OI Filardo, Giuseppe/0000-0002-8136-0977
CR Aroen A, 2004, AM J SPORT MED, V32, P211, DOI 10.1177/0363546503259345
   Bekkers JEJ, 2010, OSTEOARTHR CARTILAGE, V18, P266, DOI 10.1016/j.joca.2009.09.001
   BUCKWALTER JA, 1995, J ORTHOPAED RES, V13, P155, DOI 10.1002/jor.1100130202
   Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9
   Della Villa S, 2010, AM J SPORT MED, V38, P68, DOI 10.1177/0363546509348490
   Drobnic M, 2006, OSTEOARTHR CARTILAGE, V14, P337, DOI 10.1016/j.joca.2005.11.007
   Ebert JR, 2012, ARTHROSCOPY, V28, P952, DOI 10.1016/j.arthro.2011.12.022
   Efe T, 2012, INT ORTHOP, V36, P1315, DOI 10.1007/s00264-011-1437-x
   Elder SH, 2000, J ORTHOPAED RES, V18, P78, DOI 10.1002/jor.1100180112
   Filardo G, 2012, CARTILAGE, V3, P288, DOI 10.1177/1947603512436371
   Filardo G, 2014, AM J SPORTS MED
   Filardo G, 2013, KNEE
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P468, DOI 10.1007/s00167-011-1714-7
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P450, DOI 10.1007/s00167-011-1780-x
   Gratz KR, 2008, BIORHEOLOGY, V45, P193, DOI 10.3233/BIR-2008-0475
   HAKIM FT, 1984, ARTHRITIS RHEUM, V27, P1411, DOI 10.1002/art.1780271212
   Hambly K, 2006, AM J SPORT MED, V34, P1020, DOI 10.1177/0363546505281918
   Heijink A, 2012, KNEE SURG SPORT TR A, V20, P423, DOI 10.1007/s00167-011-1818-0
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   Kim MK, 2010, KNEE SURG SPORT TR A, V18, P528, DOI 10.1007/s00167-009-0905-y
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2012, KNEE SURG SPORT TR A, V20, P436, DOI 10.1007/s00167-011-1713-8
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-220
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Marcacci M, 2013, KNEE SURG SPORTS TRA, V21
   Marlovits S, 2005, KNEE SURG SPORT TR A, V13, P451, DOI 10.1007/s00167-004-0535-3
   Nehme A, 2005, CLIN ORTHOP RELAT R, P232, DOI 10.1097/01.blo.0000137546.14953.57
   Pape D, 2010, KNEE SURG SPORT TR A, V18, P448, DOI 10.1007/s00167-010-1052-1
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Rannou F., 2001, Annales de Readaptation et de Medecine Physique, V44, P259, DOI 10.1016/S0168-6054(01)00099-X
   Scotti C, 2010, KNEE SURG SPORT TR A, V18, P1400, DOI 10.1007/s00167-009-1014-7
   Vahdati A, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007748
   Widuchowski W, 2007, KNEE, V14, P177, DOI 10.1016/j.knee.2007.02.001
NR 38
TC 12
Z9 12
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1063-4584
EI 1522-9653
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD APR
PY 2014
VL 22
IS 4
BP 557
EP 565
DI 10.1016/j.joca.2014.01.004
PG 9
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA AG1WT
UT WOS:000335207600005
PM 24487043
OA Bronze
DA 2018-10-20
ER

PT J
AU Sun, JG
   Graeter, SV
   Tang, J
   Huang, JH
   Liu, P
   Lai, YX
   Yu, L
   Majer, G
   Spatz, JP
   Ding, JD
AF Sun JianGuo
   Graeter, Stefan, V
   Tang Jian
   Huang JingHuan
   Liu Peng
   Lai YuXiao
   Yu Lin
   Majer, Guenter
   Spatz, Joachim P.
   Ding JianDong
TI Preparation of stable micropatterns of gold on cell-adhesion-resistant
   hydrogels assisted by a hetero-bifunctional macromonomer linker
SO SCIENCE CHINA-CHEMISTRY
LA English
DT Article
DE biomaterials; hydrogels; micropattern; macromonomer; cell adhesion
ID ESCHERICHIA-COLI THIOREDOXIN; STEM-CELLS; SURFACE MODIFICATION;
   DIFFERENTIATION; MICROSTRUCTURES; REACTIVITY; PHOTOLITHOGRAPHY;
   NANOPARTICLES; LITHOGRAPHY; FABRICATION
AB Surface patterning is very useful in biomaterial studies, yet it is not easy to prepare a micropattern with cell-adhesion contrast that is stable in a wet environment. Recently, a platform technique of transfer photolithography was invented to fabricate stable metal microarrays on the surface of a cell-adhesion resistant and mechanically biomimetic poly(ethylene glycol) hydrogel; the linker is the key chemical in such a transfer strategy. This article reports the design and synthesis of a hetero-bifunctional macromonomer linker with a thiol group at one end and an acryloyl group at the other end. The bifunctional linker was characterized by GPC and H-1 NMR, and the average number of thiol groups in the bifunctional linker was detected by Ellman's reagent. The regent stability under wet conditions was also confirmed by the model reactants. The resultant micropatterned surfaces are meaningful for future studies of cell behaviors on mechanically biomimetic matrixes.
C1 [Sun JianGuo; Graeter, Stefan, V; Tang Jian; Huang JingHuan; Liu Peng; Lai YuXiao; Yu Lin; Ding JianDong] Fudan Univ, Dept Macromol Sci, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
   [Sun JianGuo] Fudan Univ, Res Ctr, Eye & ENT Hosp, Shanghai 200030, Peoples R China.
   [Graeter, Stefan, V; Majer, Guenter; Spatz, Joachim P.] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, D-370569 Stuttgart, Germany.
   [Graeter, Stefan, V; Majer, Guenter; Spatz, Joachim P.] Heidelberg Univ, Inst Phys Chem, D-25369120 Heidelberg, Germany.
RP Ding, JD (reprint author), Fudan Univ, Dept Macromol Sci, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
RI Spatz, Joachim/A-1107-2017
OI Spatz, Joachim/0000-0003-3419-9807
FU National Natural Science Foundation of China [21034002, 91127028,
   51273046]; Ministry of Science and Technology of China [2011CB606203];
   Science and Technology Development Foundation of Shanghai [13XD1401000];
   DAAD Scholarship
FX This work was financially supported by the National Natural Science
   Foundation of China (21034002, 91127028, 51273046), the Ministry of
   Science and Technology of China (2011CB606203), and the Science and
   Technology Development Foundation of Shanghai (13XD1401000). We also
   appreciate the DAAD Scholarship for Visiting Ph.D. Students (working in
   China) awarded to S. V. Graeter.
CR Aktary M, 2003, J VAC SCI TECHNOL B, V21, pL5, DOI 10.1116/1.1596216
   Chang GT, 2011, J CONTROL RELEASE, V156, P21, DOI 10.1016/j.jconrel.2011.07.008
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen W, 2010, MACROMOLECULES, V43, P201, DOI 10.1021/ma901897y
   Deng X, 2012, CHEM COMMUN, V48, P9741, DOI 10.1039/c2cc35010f
   Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a
   Escobar NI, 1996, NUCL MED BIOL, V23, P641, DOI 10.1016/0969-8051(96)00028-5
   Fu CY, 2011, TISSUE ENG PART C-ME, V17, P871, DOI [10.1089/ten.tec.2010.0690, 10.1089/ten.TEC.2010.0690]
   Gou HL, 2010, ACS APPL MATER INTER, V2, P1324, DOI 10.1021/am100196z
   Graeter SV, 2007, NANO LETT, V7, P1413, DOI 10.1021/nl070098g
   Guo LJ, 2004, J PHYS D APPL PHYS, V37, pR123, DOI 10.1088/0022-3727/37/11/R01
   He HX, 2000, LANGMUIR, V16, P3846, DOI 10.1021/la991356v
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huang JH, 2010, SOFT MATTER, V6, P3395, DOI 10.1039/b927168f
   Kruss S, 2012, LAB CHIP, V12, P3285, DOI [10.1039/c2lc40611j, 10.1039/c2lc40611]
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Lee W, 2012, ADV HEALTHC MATER, V1, P635, DOI 10.1002/adhm.201200158
   Li K, 2013, BIOMATERIALS, V34, P2834, DOI 10.1016/j.biomaterials.2013.01.013
   Liu JJ, 2012, SCI CHINA CHEM, V55, P494, DOI 10.1007/s11426-012-4538-5
   Liu P, 2010, NANOSCALE, V2, P122, DOI 10.1039/b9nr00124g
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Ma XL, 2010, ANGEW CHEM INT EDIT, V49, P5537, DOI 10.1002/anie.201000766
   Nobs L, 2003, INT J PHARM, V250, P327, DOI 10.1016/S0378-5173(02)00542-2
   Oh HH, 2012, ADV MATER, V24, P4311, DOI 10.1002/adma.201200237
   Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023
   Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Ramon-Azcon J, 2012, LAB CHIP, V12, P2959, DOI 10.1039/c2lc40213k
   Revzin A, 2003, LANGMUIR, V19, P9855, DOI 10.1021/la035129b
   Song W, 2011, LANGMUIR, V27, P6155, DOI 10.1021/la200487w
   Sun JG, 2008, BIOMACROMOLECULES, V9, P2569, DOI 10.1021/bm800477s
   Sun ZQ, 2011, SCI CHINA CHEM, V54, P275, DOI 10.1007/s11426-010-4195-5
   Takahashi N, 1996, BIOCHEMISTRY-US, V35, P8342, DOI 10.1021/bi960465v
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Tekin H, 2011, J AM CHEM SOC, V133, P12944, DOI 10.1021/ja204266a
   Wang B, 2007, MACROMOL RAPID COMM, V28, P567, DOI 10.1002/marc.200600730
   Wang X, 2013, BIOMATERIALS, V34, P2865, DOI 10.1016/j.biomaterials.2013.01.021
   Wang YZ, 2011, SCI CHINA CHEM, V54, P405, DOI 10.1007/s11426-010-4213-7
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wright SK, 1998, ANAL BIOCHEM, V265, P8, DOI 10.1006/abio.1998.2858
   Yan C, 2011, BIOMATERIALS, V32, P3931, DOI 10.1016/j.biomaterials.2011.01.078
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Yao X, 2013, BIOMATERIALS, V34, P9001, DOI 10.1016/j.biomaterials.2013.08.013
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
   Zhao YC, 2012, CHINESE J CHEM, V30, P491, DOI 10.1002/cjoc.201100252
   Zhao YC, 2012, CHINESE SCI BULL, V57, P234, DOI 10.1007/s11434-011-4904-2
NR 49
TC 10
Z9 10
U1 7
U2 74
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7291
EI 1869-1870
J9 SCI CHINA CHEM
JI Sci. China-Chem.
PD APR
PY 2014
VL 57
IS 4
SI SI
BP 645
EP 653
DI 10.1007/s11426-013-5057-8
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA AF0HP
UT WOS:000334395200019
DA 2018-10-20
ER

PT J
AU Cui, HT
   Liu, YD
   Cheng, YL
   Zhang, Z
   Zhang, PB
   Chen, XS
   Wei, Y
AF Cui, Haitao
   Liu, Yadong
   Cheng, Yilong
   Zhang, Zhe
   Zhang, Peibiao
   Chen, Xuesi
   Wei, Yen
TI In Vitro Study of Electroactive Tetraaniline-Containing Thermosensitive
   Hydrogels for Cardiac Tissue Engineering
SO BIOMACROMOLECULES
LA English
DT Article
ID INJECTABLE ACELLULAR HYDROGELS; EMBRYONIC STEM-CELLS;
   ELECTRICAL-STIMULATION; CARBON NANOTUBES; CARDIOMYOCYTE DIFFERENTIATION;
   MYOCARDIAL-INFARCTION; ANTIOXIDANT ACTIVITY; REPERFUSION INJURY; REPAIR;
   MODEL
AB Injectable hydrogels made of degradable biomaterials can function as both physical support and cell scaffold in preventing infarct expansion and promoting cardiac repair in myocardial infarction therapy. Here, we report in situ hydrogels consisting of thermosensitive PolyNIPAM-based copolymers and electroactive tetraaniline (TA). Studies showed that the addition of 2-methylene-1,3-dioxepane (MDO) provided the PolyNIPAM-based gel with biodegradability, and the introduction of tetraaniline endowed these copolymers with desirable electrical properties and antioxidant activities. The encapsulated H9c2 cells (rat cardiac myoblast) remained highly viable in the gel matrices. In vivo gel formation and histological analyses were performed in rats by subcutaneous injection and excellent biocompatibility was observed. Furthermore, the proliferation and intracellular calcium transients of H9c2 cells were also studied with (and without) electrical stimuli. Both in vitro and in vivo results demonstrated that electroactive hydrogel may be used as a promising injectable biomaterial for cardiac tissue engineering.
C1 [Cui, Haitao; Liu, Yadong; Cheng, Yilong; Zhang, Zhe; Zhang, Peibiao; Chen, Xuesi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Polymer Ecomat, Changchun 130022, Peoples R China.
   [Cui, Haitao; Cheng, Yilong] Univ Chinese Acad Sci, Beijing 100039, Peoples R China.
   [Wei, Yen] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China.
RP Chen, XS (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Polymer Ecomat, Changchun 130022, Peoples R China.
EM xschen@ciac.jl.cn; weiyen@tsinghua.edu.cn
RI Cheng, Yilong/G-3061-2017; Wei, Yen/H-5329-2012
OI Cheng, Yilong/0000-0002-4996-8456; 
FU National Natural Science Foundation of China [51233004, 50973109,
   51021003, 20111310585]; Ministry of Science and Technology of China
   (International Cooperation and Communication Program) [2010DFB50890,
   2011DFR51090]
FX This work was supported by grants from the National Natural Science
   Foundation of China (Projects 51233004, 50973109, 51021003, and
   20111310585) and the Ministry of Science and Technology of China
   (International Cooperation and Communication Program 2010DFB50890,
   2011DFR51090). We thank Dr. Pan He for help in animal experiments.
CR Annabi N, 2013, ADV FUNCT MATER, V23, P4950, DOI 10.1002/adfm.201300570
   Balint R, 2013, TISSUE ENG PART B-RE, V19, P48, DOI [10.1089/ten.TEB.2012.0183, 10.1089/ten.teb.2012.0183]
   Bidez PR, 2006, J BIOMAT SCI-POLYM E, V17, P199, DOI 10.1163/156856206774879180
   Borriello A, 2011, J MATER SCI-MATER M, V22, P1053, DOI 10.1007/s10856-011-4259-x
   Braunersreuther V, 2012, CURR PHARM BIOTECHNO, V13, P97, DOI 10.2174/138920112798868782
   Cui HT, 2013, BIOMACROMOLECULES, V14, P1904, DOI 10.1021/bm4002766
   Cui HT, 2012, BIOMACROMOLECULES, V13, P2881, DOI 10.1021/bm300897j
   Fu JD, 2006, ACTA PHARMACOL SIN, V27, P901, DOI 10.1111/j.1745-7254.2006.00380.x
   Gizdavic-Nikolaidis M, 2004, CURR APPL PHYS, V4, P347, DOI 10.1016/j.cap.2003.11.045
   Gorman RC, 2011, J CARDIOVASC TRANSL, V4, P543, DOI 10.1007/s12265-011-9297-8
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Guo B, 2011, BIOMACROMOLECULES, V12, P2601, DOI 10.1021/bm200389t
   Guo BL, 2011, CHEM MATER, V23, P1254, DOI 10.1021/cm103498s
   Guo BL, 2010, MACROMOLECULES, V43, P4472, DOI 10.1021/ma100530k
   Hsiao CW, 2013, BIOMATERIALS, V34, P1063, DOI 10.1016/j.biomaterials.2012.10.065
   Huang LH, 2008, BIOMACROMOLECULES, V9, P850, DOI 10.1021/bm7011828
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Li ZQ, 2012, ACTA BIOMATER, V8, P3586, DOI 10.1016/j.actbio.2012.06.024
   Li ZQ, 2011, BIOMATERIALS, V32, P3220, DOI 10.1016/j.biomaterials.2011.01.050
   Lorgis L, 2010, ATHEROSCLEROSIS, V213, P616, DOI 10.1016/j.atherosclerosis.2010.09.018
   Martinelli V, 2013, ACS NANO, V7, P5746, DOI 10.1021/nn4002193
   Martinelli V, 2012, NANO LETT, V12, P1831, DOI 10.1021/nl204064s
   Mihardja SS, 2008, BIOMATERIALS, V29, P4205, DOI 10.1016/j.biomaterials.2008.07.021
   Mooney E, 2012, BIOMATERIALS, V33, P6132, DOI 10.1016/j.biomaterials.2012.05.032
   Moura RM, 2011, ARTIF ORGANS, V35, P471, DOI 10.1111/j.1525-1594.2011.01257.x
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Pedrotty DM, 2005, AM J PHYSIOL-HEART C, V288, pH1620, DOI 10.1152/ajpheart.00610.2003
   Piras AM, 2011, MACROMOLECULES, V44, P848, DOI 10.1021/ma102309m
   Pok S, 2012, ACTA BIOMATER, V9, P5630
   Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200
   Prabhakaran MP, 2011, MAT SCI ENG C-MATER, V31, P503, DOI 10.1016/j.msec.2010.12.017
   Radisic M, 2005, J SERB CHEM SOC, V70, P541, DOI 10.2298/JSC0503541R
   Rahimi N, 2012, BIOMACROMOLECULES, V13, P1448, DOI 10.1021/bm300161r
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Saikia JP, 2010, COLLOID SURFACE B, V81, P158, DOI 10.1016/j.colsurfb.2010.07.005
   Sauer H, 1999, J CELL BIOCHEM, V75, P710, DOI 10.1002/(SICI)1097-4644(19991215)75:4<710::AID-JCB16>3.0.CO;2-Z
   Serena E, 2009, EXP CELL RES, V315, P3611, DOI 10.1016/j.yexcr.2009.08.015
   Shimizu T, 2002, J BIOMED MATER RES, V60, P110, DOI 10.1002/jbm.1284
   Silvestri A, 2013, MACROMOL BIOSCI, V13, P984, DOI 10.1002/mabi.201200483
   Stout DA, 2012, INT J NANOMED, V7, P5653, DOI 10.2147/IJN.S34574
   Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004
   Sundelacruz S, 2013, BIOMATERIALS, V34, P6695, DOI 10.1016/j.biomaterials.2013.05.040
   Titushkin I, 2009, BIOPHYS J, V96, P717, DOI 10.1016/j.bpj.2008.09.035
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032
   Undin J, 2012, POLYM CHEM-UK, V3, P1260, DOI 10.1039/c2py20034a
   Won YW, 2010, J CONTROL RELEASE, V144, P181, DOI 10.1016/j.jconrel.2010.02.014
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Zhang SS, 2013, BBA-MOL CELL RES, V1833, P876, DOI 10.1016/j.bbamcr.2012.10.020
NR 51
TC 49
Z9 49
U1 5
U2 150
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2014
VL 15
IS 4
BP 1115
EP 1123
DI 10.1021/bm4018963
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AF2VW
UT WOS:000334571600003
PM 24597966
DA 2018-10-20
ER

PT J
AU Yang, MY
   Shuai, YJ
   Zhang, C
   Chen, YY
   Zhu, LJ
   Mao, CB
   OuYang, HW
AF Yang, Mingying
   Shuai, Yajun
   Zhang, Can
   Chen, Yuyin
   Zhu, Liangjun
   Mao, Chuanbin
   OuYang, Hongwei
TI Biomimetic Nucleation of Hydroxyapatite Crystals Mediated by Antheraea
   pernyi Silk Sericin Promotes Osteogenic Differentiation of Human Bone
   Marrow Derived Mesenchymal Stem Cells
SO BIOMACROMOLECULES
LA English
DT Article
ID BIOLOGICAL NANOFIBERS; STRUCTURAL-CHANGES; PROTEIN SERICIN; STROMAL
   CELLS; FIBROIN; APATITE; MINERALIZATION; SCAFFOLDS; DEPOSITION;
   INTERFACE
AB Biomacromolecules have been used as templates to grow hydroxyapatite crystals (HAps) by biomineralization to fabricate mineralized materials for potential application in bone tissue engineering. Silk sericin is a protein with features desirable as a biomaterial, such as increased hydrophilicity and biodegradation. Mineralization of the silk sericin from Antheraea pernyi (A. pernyi) silkworm has rarely been reported. Here, for the first time, nucleation of HAps on A. pernyi silk sericin (AS) was attempted through a wet precipitation method and consequently the cell viability and osteogenic differentiation of BMSCs on mineralized AS were investigated. It was found that AS mediated the nucleation of HAps in the form of nanoneedles while self-assembling into beta-sheet conformation, leading to the formation of a biomineralized protein based biomaterial. The cell viability assay of BMSCs showed that the mineralization of AS stimulated cell adhesion and proliferation, showing that the resultant AS biomaterial is biocompatible. The differentiation assay confirmed that the mineralized AS significantly promoted the osteogenic differentiation of BMSCs when compared to nonmineralized AS as well as other types of sericin (B. mori sericin), suggesting that the resultant mineralized AS biomaterial has potential in promoting bone formation. This result represented the first work proving the osteogenic differentiation of BMSCs directed by silk sericin. Therefore, the biomineralization of A. pernyi silk sericin coupled with seeding BMSCs on the resultant mineralized biomaterials is a useful strategy to develop the potential application of this unexplored silk sericin in the field of bone tissue engineering. This study lays the foundation for the use of A. pernyi silk sericin as a potential scaffold for tissue engineering.
C1 [Yang, Mingying; Shuai, Yajun; Chen, Yuyin; Zhu, Liangjun] Zhejiang Univ, Coll Anim Sci, Inst Appl Bioresource Res, Hangzhou 310058, Zhejiang, Peoples R China.
   [Zhang, Can; OuYang, Hongwei] Zhejiang Univ, Sch Med, Ctr Stem Cell & Tissue Engn, Hangzhou 310058, Zhejiang, Peoples R China.
   [Mao, Chuanbin] Univ Oklahoma, Dept Chem & Biochem, Stephenson Life Sci Res Ctr, Norman, OK 73019 USA.
RP Yang, MY (reprint author), Zhejiang Univ, Coll Anim Sci, Inst Appl Bioresource Res, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.
EM yangm@zju.edu.cn; cbmao@ou.edu
OI Mao, Chuanbin/0000-0002-8142-3659
FU National High Technology Research and Development Program 863
   [2013AA102507]; Zhejiang Provincial Natural Science Foundation of China
   [LZ12C17001]; National Natural Science Foundation of China [20804037,
   21172194]; Silkworm Industry Science and Technology Innovation Team
   [2011R50028]; Projects of Zhejiang Provincial Science and Technology
   Plans [2012C12910]; National Institutes of Health [EB015190, HL092526];
   National Science Foundation [CBET-0854465, CMMI-1234957, CBET-0854414,
   DMR-0847758]; Department of Defense Peer Reviewed Medical Research
   Program [W81XWH-12-1-0384]; Oklahoma Center for Adult Stem Cell Research
   [434003]; Oklahoma Center for the Advancement of Science and Technology
   [HR11-006]
FX M.Y. acknowledges the support of National High Technology Research and
   Development Program 863 (2013AA102507), Zhejiang Provincial Natural
   Science Foundation of China (LZ12C17001), National Natural Science
   Foundation of China (20804037 and 21172194), and Silkworm Industry
   Science and Technology Innovation Team (2011R50028). Y.Y. would like to
   thank the financial support from Projects of Zhejiang Provincial Science
   and Technology Plans (2012C12910). C.B.M. would like to thank the
   financial support from National Institutes of Health (EB015190 and
   HL092526), National Science Foundation (CBET-0854465, CMMI-1234957,
   CBET-0854414, and DMR-0847758), Department of Defense Peer Reviewed
   Medical Research Program (W81XWH-12-1-0384), Oklahoma Center for Adult
   Stem Cell Research (434003), and Oklahoma Center for the Advancement of
   Science and Technology (HR11-006).
CR Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200
   Biswas A, 2010, BIOMACROMOLECULES, V11, P2545, DOI 10.1021/bm1009359
   Bourgeois B, 2003, J BIOMED MATER RES A, V65A, P402, DOI 10.1002/jbm.a.10518
   Cai YR, 2009, J MATER CHEM, V19, P5751, DOI 10.1039/b901620a
   Cheng C, 2008, ADV FUNCT MATER, V18, P2172, DOI 10.1002/adfm.200701130
   Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   He PF, 2013, J BIOMED MATER RES A, V101, P555, DOI 10.1002/jbm.a.34333
   He PF, 2012, BIOMACROMOLECULES, V13, P2692, DOI 10.1021/bm300651q
   He T, 2010, SMALL, V6, P2230, DOI 10.1002/smll.201001108
   Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016
   Kaur J, 2013, BIOMACROMOLECULES, V14, P3660, DOI 10.1021/bm401023h
   Khire TS, 2010, SOFT MATTER, V6, P2066, DOI 10.1039/b924530h
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Li ZY, 2007, BIOMATERIALS, V28, P1452, DOI 10.1016/j.biomaterials.2006.11.001
   Lin F, 2008, MATER CHEM PHYS, V111, P92, DOI 10.1016/j.matchemphys.2008.03.019
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Nishida A, 2011, INT J PHARMACEUT, V407, P44, DOI 10.1016/j.ijpharm.2011.01.006
   Padamwar Mahesh N, 2005, J Cosmet Dermatol, V4, P250, DOI 10.1111/j.1473-2165.2005.00200.x
   Rai RK, 2011, J PHYS CHEM C, V115, P14219, DOI 10.1021/jp2025768
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Rosa Adalberto Luiz, 2002, Pesqui Odontol Bras, V16, P209, DOI 10.1590/S1517-74912002000300005
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RUSSEL WB, 1981, ANNU REV FLUID MECH, V13, P425, DOI 10.1146/annurev.fl.13.010181.002233
   Shchukin DG, 2003, CHEM MATER, V15, P3947, DOI 10.1021/cm0341585
   Takeuchi A, 2005, J ROY SOC INTERFACE, V2, P373, DOI 10.1098/rsif.2005.0052
   Takeuchi A, 2003, J BIOMED MATER RES A, V65A, P283, DOI 10.1002/jbm.a.10456
   Wang FK, 2010, CHEM MATER, V22, P3630, DOI 10.1021/cm902727s
   Wang G, 2010, J BONE JOINT SURG BR, V92B, P320, DOI 10.1302/0301-620X.92B2.22602
   Wang JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01242
   Xu H, 2011, BIOMACROMOLECULES, V12, P2193, DOI 10.1021/bm200274r
   Yang MY, 2013, J POLYM SCI POL PHYS, V51, P742, DOI 10.1002/polb.23249
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhaorigetu S, 2007, J NUTR SCI VITAMINOL, V53, P297, DOI 10.3177/jnsv.53.297
   Zhu HB, 2011, BIOMATERIALS, V32, P4744, DOI 10.1016/j.biomaterials.2011.03.030
   Zou XH, 2009, CELL TRANSPLANT, V18, P433, DOI 10.3727/096368909788809839
NR 38
TC 48
Z9 52
U1 8
U2 114
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2014
VL 15
IS 4
BP 1185
EP 1193
DI 10.1021/bm401740x
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AF2VW
UT WOS:000334571600010
PM 24666022
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Hodgkinson, T
   Chen, Y
   Bayat, A
   Yuan, XF
AF Hodgkinson, Tom
   Chen, Ying
   Bayat, Ardeshir
   Yuan, Xue-Feng
TI Rheology and Electrospinning of Regenerated Bombyx mori Silk Fibroin
   Aqueous Solutions
SO BIOMACROMOLECULES
LA English
DT Article
ID POLYMER-SOLUTIONS; MOLECULAR-WEIGHT; DRUG-DELIVERY; NANOFIBERS; FIBERS;
   SCAFFOLDS; BIOMATERIALS; PARAMETERS; MATS; MORPHOLOGY
AB Bombyx mori silk fibroin (BMSF) has received considerable research interest as a potential biomaterial owing to its excellent mechanical properties and benign, versatile material fabrication options, including electrospinning. Despite this, characterizations of regenerated BMSF aqueous solutions and electrospun materials resulting from them are still very limited in the literature. This report details the theological characterization of regenerated aqueous BMSF solutions under shear and elongational deformation. Well-characterized regenerated BMSF solutions were then systematically electrospun over a range of concentrations and process parameters to determine their effects on electrospinning processing windows and fiber morphology. BMSF solutions could not be electrospun successfully if BMSF concentration was below 20 wt % or the relaxation time measured using the CaBER rheometer was below 0.001 s. Electrospun BMSF fiber diameter was found to increase with solution concentration when stable electrospinning was achieved. An upper threshold of 30 wt % BMSF solution was identified for the formation of fibers with a circular cross section. Adding small amount of high molecular weight poly(ethylene oxide) was an effective rheological modifier that greatly improved the electrospinnability of BMSF solutions. Electrospinning BMSF-PEO solutions over a range of parameters significantly altered the fiber products. Increasing voltage from 0.5 to 1 kV/cm was found to decrease fiber diameter by approximately 50% (p < 0.001). Flow rate was found to have a significant effect on fiber diameter, which decreased with spinneret height. The results presented here provide valuable guidance in the production of BMSF electrospun materials with specific properties for tissue engineering and regenerative medicine.
C1 [Hodgkinson, Tom; Chen, Ying; Bayat, Ardeshir; Yuan, Xue-Feng] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.
   [Hodgkinson, Tom; Chen, Ying; Yuan, Xue-Feng] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester, Lancs, England.
RP Yuan, XF (reprint author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.
EM xue-feng.yuan@manchester.ac.uk
RI Hodgkinson, Tom/E-5767-2016
OI Hodgkinson, Tom/0000-0002-3242-1593; BAYAT, ARDESHIR/0000-0002-4116-6491
FU University of Manchester; School of Chemical Engineering and Analytical
   Science; Biotechnology and Biological Sciences Research Council
   [BB/K011146/1]
FX The authors would like to thank the University of Manchester and the
   School of Chemical Engineering and Analytical Science for the
   scholarship awarded to Tom Hodgkinson that made this work possible.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bayram C, 2013, MACROMOL RES, V21, P339, DOI 10.1007/s13233-013-1037-2
   Berli CLA, 1999, FOOD HYDROCOLLOID, V13, P507, DOI 10.1016/S0268-005X(99)00036-3
   Bhattacharjee P., 2011, ELECTROSPINNING POLY
   Cao H, 2009, MAT SCI ENG C-MATER, V29, P2270, DOI 10.1016/j.msec.2009.05.012
   Chang CE, 2010, NANO LETT, V10, P726, DOI 10.1021/nl9040719
   CROSS MM, 1965, J COLL SCI IMP U TOK, V20, P417, DOI 10.1016/0095-8522(65)90022-X
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Ekemen Z, 2013, BIOMACROMOLECULES, V14, P1412, DOI 10.1021/bm400068k
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Hashimdeen SH, 2013, MAT SCI ENG C-MATER, V33, P3309, DOI 10.1016/j.msec.2013.04.020
   Holland C, 2007, POLYMER, V48, P3388, DOI 10.1016/j.polymer.2007.04.019
   Holland C, 2006, NAT MATER, V5, P870, DOI 10.1038/nmat1762
   Jarusuwannapoom T, 2005, EUR POLYM J, V41, P409, DOI 10.1016/j.eurpolymj.2004.10.010
   Jeong L, 2007, KEY ENG MATER, V342-343, P813, DOI 10.4028/www.scientific.net/KEM.342-343.813
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Koombhongse S, 2001, J POLYM SCI POL PHYS, V39, P2598, DOI 10.1002/polb.10015
   Koski A, 2004, MATER LETT, V58, P493, DOI 10.1016/S0167-577X(03)00532-9
   Lee JS, 2004, J APPL POLYM SCI, V93, P1638, DOI 10.1002/app.20602
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li Z, 2011, J NON-NEWTON FLUID, V166, P951, DOI 10.1016/j.jnnfm.2011.04.010
   Luo CJ, 2012, CHEM SOC REV, V41, P4708, DOI 10.1039/c2cs35083a
   Mahalingam S, 2013, MACROMOL RAPID COMM, V34, P1134, DOI 10.1002/marc.201300339
   Meechaisue C, 2007, BIOMED MATER, V2, P181, DOI 10.1088/1748-6041/2/3/003
   Mo CL, 2009, BIOMACROMOLECULES, V10, P2724, DOI 10.1021/bm900452u
   Ohgo K, 2003, POLYMER, V44, P841, DOI 10.1016/S0032-3861(02)00819-4
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sinha-Ray S, 2011, BIOMACROMOLECULES, V12, P2357, DOI 10.1021/bm200438v
   So Hyun K., 2003, POLYMER, V35, P185
   Sukigara S, 2004, POLYMER, V45, P3701, DOI 10.1016/j.polymer.2004.03.059
   Sukigara S, 2003, POLYMER, V44, P5721, DOI 10.1016/S0032-3861(03)00532-9
   Sun DH, 2006, NANO LETT, V6, P839, DOI 10.1021/nl0602701
   TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205
   Theron SA, 2004, POLYMER, V45, P2017, DOI 10.1016/j.polymer.2004.01.024
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang H, 2006, J APPL POLYM SCI, V101, P961, DOI 10.1002/app.24024
   Wang H, 2005, J MATER SCI, V40, P5359, DOI 10.1007/s10853-005-4332-2
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Yao YY, 2005, ACTA POLYM SIN, P687
   Zainuddin, 2008, BIOMATERIALS, V29, P4268, DOI 10.1016/j.biomaterials.2008.07.041
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P976, DOI 10.1002/jbm.a.32497
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhu JX, 2008, POLYMER, V49, P2880, DOI 10.1016/j.polymer.2008.04.049
   Zhu JX, 2007, INT J BIOL MACROMOL, V41, P469, DOI 10.1016/j.ijbiomac.2007.06.006
NR 53
TC 12
Z9 13
U1 9
U2 147
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2014
VL 15
IS 4
BP 1288
EP 1298
DI 10.1021/bm4018319
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AF2VW
UT WOS:000334571600021
PM 24661009
DA 2018-10-20
ER

PT J
AU Gao, A
   Hang, RQ
   Huang, XB
   Zhao, LZ
   Zhang, XY
   Wang, L
   Tang, B
   Ma, SL
   Chu, PK
AF Gao, Ang
   Hang, Ruiqiang
   Huang, Xiaobo
   Zhao, Lingzhou
   Zhang, Xiangyu
   Wang, Lin
   Tang, Bin
   Ma, Shengli
   Chu, Paul K.
TI The effects of titania nanotubes with embedded silver oxide
   nanoparticles on bacteria and osteoblasts
SO BIOMATERIALS
LA English
DT Article
DE TiO2 nanotubes; Ag2O nanoparticles; Anodization; Antibacterial activity;
   Osteoblasts
ID TIO2 NANOTUBES; ESCHERICHIA-COLI; IN-VITRO; STAPHYLOCOCCUS-AUREUS;
   OSTEOGENIC DIFFERENTIATION; SURFACES; INFECTIONS; ARRAYS; CELLS; ION
AB A versatile strategy to endow biomaterials with long-term antibacterial ability without compromising the cytocompatibility is highly desirable to combat biomaterial related infection. TiO2 nanotube (NT) arrays can significantly enhance the functions of many cell types including osteoblasts thus having promising applications in orthopedics, orthodontics, as well as other biomedical fields. In this study, TiO2 NT arrays with Ag2O nanoparticle embedded in the nanotube wall (NT-Ag2O arrays) are prepared on titanium (Ti) by TiAg magnetron sputtering and anodization. Well-defined NT arrays containing Ag concentrations in a wide range from 0 to 15 at % are formed. Ag incorporation has little influence on the NT diameter, but significantly decreases the tube length. Crystallized Ag2O nanoparticles with diameters ranging from 5 nm to 20 nm are embedded in the amorphous TiO2 nanotube wall and this unique structure leads to controlled release of Ag+ that generates adequate antibacterial activity without showing cytotoxicity. The NT-Ag2O arrays can effectively kill Escherichia coli and Staphylococcus aureus even after immersion for 28 days, demonstrating the long lasting antibacterial ability. Furthermore, the NT-Ag2O arrays have no appreciable influence on the osteoblast viability, proliferation, and differentiation compared to the Ag free TiO2 NT arrays. Ag incorporation even shows some favorable effects on promoting cell spreading. The technique reported here is a versatile approach to develop biomedical coatings with different functions. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Gao, Ang; Hang, Ruiqiang; Huang, Xiaobo; Zhang, Xiangyu; Tang, Bin] Taiyuan Univ Technol, Res Inst Surface Engn, Taiyuan 030024, Peoples R China.
   [Zhao, Lingzhou] Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol & Oral Med, Xian 710032, Peoples R China.
   [Wang, Lin] Ningbo Univ Technol, Inst Mat, Ningbo 315016, Zhejiang, Peoples R China.
   [Ma, Shengli] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
   [Chu, Paul K.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
RP Hang, RQ (reprint author), Taiyuan Univ Technol, Res Inst Surface Engn, Taiyuan 030024, Peoples R China.
EM hangruiqiang@tyut.edu.cn; zhaolingzhou1983@hotmail.com
RI Zhao, Lingzhou/B-4408-2014; Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883
FU National Natural Science Foundation of China [51171125, 31300808,
   31200716]; Specialized Research Fund for the Doctoral Program of Higher
   Education of China [20131402120006]; Natural Science Foundation of
   Shanxi Province [2013021011-1, 2012021021-7]; School Foundation of
   Taiyuan University of Technology [2013T013]; City University of Hong
   Kong Applied Research Grants (ARG) [9667066, 9667069]; Hong Kong
   Research Grants Council (RGC) General Research Funds (GRF) [112212]
FX This work is jointly supported by the National Natural Science
   Foundation of China (51171125, 31300808, 31200716), Specialized Research
   Fund for the Doctoral Program of Higher Education of China
   (20131402120006), Natural Science Foundation of Shanxi Province
   (2013021011-1, 2012021021-7), School Foundation of Taiyuan University of
   Technology (2013T013), City University of Hong Kong Applied Research
   Grants (ARG) Nos. 9667066 and 9667069, as well as Hong Kong Research
   Grants Council (RGC) General Research Funds (GRF) No. 112212.
CR Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Arnell RD, 1999, SURF COAT TECH, V112, P170, DOI 10.1016/S0257-8972(98)00749-X
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004
   Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923
   Civitelli R, 2008, ARCH BIOCHEM BIOPHYS, V473, P188, DOI 10.1016/j.abb.2008.04.005
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Greulich C, 2011, ACTA BIOMATER, V7, P347, DOI 10.1016/j.actbio.2010.08.003
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Huo KF, 2013, BIOMATERIALS, V34, P3467, DOI 10.1016/j.biomaterials.2013.01.071
   Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07
   Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q
   Klasen HJ, 2000, BURNS, V26, P131, DOI 10.1016/S0305-4179(99)00116-3
   Kumar R, 2005, J BIOMED MATER RES B, V75B, P311, DOI 10.1002/jbm.b.30306
   Li XM, 2013, J BIOMED MATER RES A, V101, P2424, DOI 10.1002/jbm.a.34539
   Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045
   Ma MH, 2012, J BIOMED MATER RES A, V100A, P278, DOI 10.1002/jbm.a.33251
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Musil J, 1999, THIN SOLID FILMS, V343, P47, DOI 10.1016/S0040-6090(98)01567-3
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Premchand YD, 2006, ELECTROCHEM COMMUN, V8, P1840, DOI 10.1016/j.elecom.2006.08.028
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Rupp ME, 2004, AM J INFECT CONTROL, V32, P445, DOI 10.1016/j.ajic.2004.05.002
   Samuel U, 2004, INT J ANTIMICROB AG, V23, pS75, DOI 10.1016/j.ijantimicag.2003.12.004
   Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Stains Joseph P, 2005, Birth Defects Res C Embryo Today, V75, P72, DOI 10.1002/bdrc.20034
   Stoimenov PK, 2002, LANGMUIR, V18, P6679, DOI 10.1021/la0202374
   Strathmann M, 2004, INT J ANTIMICROB AG, V24, P234, DOI 10.1016/j.ijantimicag.2003.03.001
   Wang N, 2011, BIOMATERIALS, V32, P6900, DOI 10.1016/j.biomaterials.2011.06.023
   Wassail M, 1998, J BIOMED MATER RES A, V36, P325
   Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005
   Yang WJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085102
   Zhao LZ, 2013, BIOMATERIALS, V34, P19, DOI 10.1016/j.biomaterials.2012.09.041
   Zhao LZ, 2012, BIOMATERIALS, V33, P2629, DOI 10.1016/j.biomaterials.2011.12.024
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 53
TC 142
Z9 143
U1 25
U2 272
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2014
VL 35
IS 13
BP 4223
EP 4235
DI 10.1016/j.biomaterials.2014.01.058
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF1NQ
UT WOS:000334481000031
PM 24529392
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Pieretti, EF
   Manhabosco, SM
   Dick, LFP
   Hinder, S
   Costa, I
AF Pieretti, Eurico F.
   Manhabosco, Sara M.
   Dick, Luis F. P.
   Hinder, Steve
   Costa, Isolda
TI Localized corrosion evaluation of the ASTM F139 stainless steel marked
   by laser using scanning vibrating electrode technique, X-ray
   photoelectron spectroscopy and Mott-Schottky techniques
SO ELECTROCHIMICA ACTA
LA English
DT Article; Proceedings Paper
CT 10th International Symposium on Electrochemical Methods in Corrosion
   Research (EMCR)
CY NOV 18-23, 2012
CL Maragogi, BRAZIL
SP CAPES, FAPESP, CNPq
DE Localized Corrosion; ASTM F139; Biomaterials; SVET; XPS; Mott-Schottky
ID PASSIVE FILMS; SEMICONDUCTING PROPERTIES; OXIDE-FILMS; BEHAVIOR;
   SURFACE; SVET
AB The effect of laser engraving on the corrosion resistance of ASTM F139 stainless steel (SS) has been investigated by electrochemical techniques. The nucleation of localized corrosion on this biomaterial was evaluated by scanning vibrating electrode technique (SVET) in a phosphate buffered saline solution (PBS) of pH 7.4. The Mott-Schottky approach was used to determine the electronic properties of the passive film, also chemically characterized by X-ray photoelectron spectroscopy (XPS). SVET allowed the identification of the anodic zones on the surface of the SS marked by laser technique that were associated with the heat-affected areas. Metallic drops solidified on the laser marked surface dissolved actively at OCP and favoured the nucleation of crevice corrosion, while at the pitting potential, pits nucleate preferentially on the laser marks. XPS results showed that laser engraving caused large chemical modification of the surface. Mott-Schottky results indicated a more defective oxide layer with a larger number of donors on the laser marked surface comparatively to that without marks. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Pieretti, Eurico F.; Costa, Isolda] Inst Pesquisas Energet & Nucl IPEN CNEN, BR-05422970 Sao Paulo, Brazil.
   [Manhabosco, Sara M.; Dick, Luis F. P.] Univ Fed Rio Grande do Sul, Lab Proc Eletroquim & Corrosao, BR-91501970 Porto Alegre, RS, Brazil.
   [Hinder, Steve] Univ Surrey, Fac Engn & Phys Sci, Guildford GU2 5XH, Surrey, England.
RP Pieretti, EF (reprint author), Inst Pesquisas Energet & Nucl IPEN CNEN, Av Prof Lineu Prestes 2242, BR-05422970 Sao Paulo, Brazil.
EM efpieretti@usp.br; lfdick@ufrgs.br; s.hinder@surrey.ac.uk;
   icosta@ipen.br
CR Amar H, 2011, CORROS SCI, V53, P3215, DOI 10.1016/j.corsci.2011.05.066
   Da Cunha Belo M, 1999, ELECTROCHIM ACTA, V44, P2473
   Feng ZC, 2010, CORROS SCI, V52, P3646, DOI 10.1016/j.corsci.2010.07.013
   Gittens RA, 2011, J DENT RES, V90, P1389, DOI 10.1177/0022034511408428
   Hakiki NE, 2000, CORROS SCI, V42, P687, DOI 10.1016/S0010-938X(99)00082-7
   HAKIKI NE, 1995, CORROS SCI, V37, P1809, DOI 10.1016/0010-938X(95)00084-W
   Hakiki NE, 1998, J ELECTROCHEM SOC, V145, P3821, DOI 10.1149/1.1838880
   ISAACS HS, 1988, CORROS SCI, V28, P547, DOI 10.1016/0010-938X(88)90023-6
   Kallip S, 2010, CORROS SCI, V52, P3146, DOI 10.1016/j.corsci.2010.05.018
   Kallip S, 2012, ELECTROCHEM COMMUN, V20, P101, DOI 10.1016/j.elecom.2012.04.007
   Lamaka SV, 2008, ELECTROCHEM COMMUN, V10, P259, DOI 10.1016/j.elecom.2007.12.003
   Lyman D. J., 1974, MAT SCI, V4, P415
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Nascente PAP, 2005, J MOL CATAL A-CHEM, V228, P145, DOI 10.1016/j.molcata.2004.09.075
   Ningshen S, 2007, CORROS SCI, V49, P481, DOI 10.1016/j.corsci.2006.05.041
   SCHMUKI P, 1995, J ELECTROCHEM SOC, V142, P1705, DOI 10.1149/1.2048644
   Shahryari A, 2008, MAT SCI ENG C-BIO S, V28, P94, DOI 10.1016/j.msec.2007.09.002
   Taveira LV, 2010, CORROS SCI, V52, P2813, DOI 10.1016/j.corsci.2010.04.021
   Taveira LV, 2005, CORROS SCI, V47, P757, DOI 10.1016/j.corsci.2004.07.012
   Vuillemin B, 2003, CORROS SCI, V45, P1143, DOI 10.1016/S0010-938X(02)00222-6
NR 20
TC 15
Z9 15
U1 1
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
EI 1873-3859
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD APR 1
PY 2014
VL 124
SI SI
BP 150
EP 155
DI 10.1016/j.electacta.2013.10.137
PG 6
WC Electrochemistry
SC Electrochemistry
GA AG0MM
UT WOS:000335109600019
DA 2018-10-20
ER

PT J
AU Mehmood, MS
   Walters, BM
   Yasin, T
   Ahmad, M
   Jahan, MS
   Mishra, SR
   Ikram, M
AF Mehmood, Malik Sajjad
   Walters, Benjamin Michael
   Yasin, Tariq
   Ahmad, Manzoor
   Jahan, Muhammad Shah
   Mishra, Sanjay R.
   Ikram, Masroor
TI Correlation of residual radical's with three phase morphology of UHMWPE:
   Analysis for the dependence on heat involved during vitamin E diffusion
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE UHMWPE; ESR analysis; Vitamin E; Three phase morphology; Raman
   spectroscopy
ID MOLECULAR-WEIGHT POLYETHYLENE; INDUCED CRYSTALLINITY CHANGES;
   ELECTRON-BEAM IRRADIATION; ALPHA-TOCOPHEROL; LINEAR POLYETHYLENE;
   CROSS-LINKING; ENVIRONMENTS; RESISTANCE; OXIDATION; POLYMER
AB Ultra-high molecular weight polyethylene (UHMWPE) is often used as a biomaterial component of hip and knee implants. Alpha-tocopherol (vitamin E) is an antioxidant that is sometimes diffused into the UHMWPE during the manufacturing process to help in eliminating free radicals and preventing these implants from oxidation. In order to diffuse vitamin E into the UHMWPE, the UHMWPE is heated while submerged in a hot bath of vitamin E. The aim of this study is to investigate the effect of this heat on polyenyl radicals (-center dot CH-[CH=CH-](m)-) with m > 3, and oxygen-centered dienyl or trienyl radicals (center dot OCH- [CH=CH-](m)-) with m = 2 or 3] and their correlation with the three phase morphology of irradiated, vitamin E-doped UHMWPE. Free radical analysis via electron spin resonance (ESR) reveal that heat involved during vitamin E diffusion is responsible for the decay of similar to 98% of the primary trapped radicals, just as in the control samples without vitamin E. However, for vitamin E-doped UHMWPE, the vitamin E is then present for subsequent protection, and control samples (heated without vitamin E) suffer more during shelf-aging of 6 months. Differential scanning calorimetry (DSC), wide angle X-ray scattering (WAXS), and Raman spectroscopic methods conclude that the % interphase contents of UHMWPE control samples are 9.70 +/- 1.00, 6.06 +/- 1.20, 2.61 +/- 0.80, and 1.50 +/- 0.71, while for vitamin E-doped samples are 15.43 +/- 1.66, 11.48 +/- 1.46, 7.74 +/- 1.54, and 5.54 +/- 1.31, for sample heated/doped for 10 min, 30 min, 1 h, and 2 h, respectively. Moreover, it is also found that the % interphase contents of UHMWPE are in direct correlation with total amount of residual radicals, arid oxygen centered di- or tri-enyl radicals regardless of samples initial treatment before the shelf aging. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Mehmood, Malik Sajjad] Univ Engn & Technol, Dept Basic Sci & Humanities, Taxila 47050, Pakistan.
   [Mehmood, Malik Sajjad; Yasin, Tariq; Ahmad, Manzoor; Ikram, Masroor] Pakistan Inst Engn & Appl Sci, Islamabad 45650, Pakistan.
   [Mehmood, Malik Sajjad; Walters, Benjamin Michael; Jahan, Muhammad Shah; Mishra, Sanjay R.] Univ Memphis, Dept Phys, Biomat Res Lab, Memphis, TN 38152 USA.
RP Mehmood, MS (reprint author), Univ Engn & Technol, Dept Basic Sci & Humanities, Taxila 47050, Pakistan.
EM msajjad.82@gmail.com
RI Malik, Sajjad Mehmood/E-5729-2015; Ikram, Masroor/G-3359-2015
OI Malik, Sajjad Mehmood/0000-0002-5026-8203; 
FU NSF/Biosurfaces center at the University of Memphis, Memphis, TN, USA
FX Dr. Malik Sajjad Mehmood would like to acknowledge Engr. Hafiz Irfan
   Arshad, and Ms. Fareeha Zaheer from UET, Taxila for their moral support
   in compiling this work. This work was also supported by NSF/Biosurfaces
   center at the University of Memphis, Memphis, TN, USA.
CR Barron D, 2008, J MATER SCI-MATER M, V19, P2293, DOI 10.1007/s10856-007-3333-x
   Barron D, 2008, POLYMER, V49, P3111, DOI 10.1016/j.polymer.2008.05.004
   BHATEJA SK, 1990, J MACROMOL SCI PHYS, VB29, P1, DOI 10.1080/00222349008212332
   BHATEJA SK, 1983, J APPL POLYM SCI, V28, P861, DOI 10.1002/app.1983.070280236
   BHATEJA SK, 1995, J MACROMOL SCI R M C, VC35, P581, DOI 10.1080/15321799508021752
   Bracco P, 2007, POLYM DEGRAD STABIL, V92, P2155, DOI 10.1016/j.polymdegradstab.2007.02.023
   Bracco P, 2011, CLIN ORTHOP RELAT R, V469, P2286, DOI 10.1007/s11999-010-1717-6
   Costa L, 2009, POLYM DEGRAD STABIL, V94, P1542, DOI 10.1016/j.polymdegradstab.2009.04.023
   James Runt IRH, 1980, THERMAL ANAL POLYM M
   Joo YL, 2000, POLYMER, V41, P1355, DOI 10.1016/S0032-3861(99)00272-4
   Joon BP, 2013, ENCY BIOMATER BIOMED, P1690
   Kelly JM, 2002, J MACROMOL SCI-POL R, VC42, P355, DOI 10.1081/MC-120006452
   Kornacka EM, 2013, RADIAT PHYS CHEM, V84, P151, DOI 10.1016/j.radphyschem.2012.06.027
   Kurtz SM, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P1
   Mehmood MS, 2012, POLYM SCI SER A+, V54, P343, DOI 10.1134/S0965545X12040062
   Mehmood MS, 2013, POLYM DEGRAD STABIL, V98, P1256, DOI 10.1016/j.polymdegradstab.2013.03.001
   Mehmood MS, 2013, APPL MAGN RESON, V44, P531, DOI 10.1007/s00723-012-0421-y
   Oral E, 2005, BIOMATERIALS, V26, P6657, DOI 10.1016/j.biomaterials.2005.04.026
   Oral E, 2004, BIOMATERIALS, V25, P5515, DOI 10.1016/j.biomaterials.2003.12.048
   Oral E, 2008, BIOMATERIALS, V29, P3557, DOI 10.1016/j.biomaterials.2008.05.004
   Oral E, 2007, NUCL INSTRUM METH B, V265, P18, DOI 10.1016/j.nimb.2007.08.022
   Oral E, 2007, BIOMATERIALS, V28, P5225, DOI 10.1016/j.biomaterials.2007.08.025
   Oral E, 2006, BIOMATERIALS, V27, P5580, DOI 10.1016/j.biomaterials.2006.07.017
   Oral E, 2011, INT ORTHOP, V35, P215, DOI 10.1007/s00264-010-1161-y
   Oral E, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P221, DOI 10.1016/B978-0-12-374721-1.00015-8
   Oral E, 2009, BIOMATERIALS, V30, P1870, DOI 10.1016/j.biomaterials.2008.12.029
   Ridley MD, 2007, NUCL INSTRUM METH B, V265, P62, DOI 10.1016/j.nimb.2007.08.026
   Ridley MD, 2009, J BIOMED MATER RES A, V88A, P1097, DOI 10.1002/jbm.a.32042
   Russell KE, 1997, POLYMER, V38, P1409, DOI 10.1016/S0032-3861(96)00643-X
   Sobieraj MC, 2009, J MECH BEHAV BIOMED, V2, P433, DOI 10.1016/j.jmbbm.2008.12.006
   Torrisi L, 2004, RADIAT EFF DEFECT S, V159, P259, DOI 10.1080/10420150410001711813
   Visco AM, 2010, INT J POLYM ANAL CH, V15, P424, DOI 10.1080/1023666X.2010.510109
   Walters BM, 2009, 4 INT UHMWPE M TOR I
   WANG LH, 1991, MACROMOLECULES, V24, P5535, DOI 10.1021/ma00020a009
NR 34
TC 8
Z9 8
U1 0
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD APR
PY 2014
VL 53
BP 13
EP 21
DI 10.1016/j.eurpolymj.2014.01.013
PG 9
WC Polymer Science
SC Polymer Science
GA AF1NT
UT WOS:000334481300002
DA 2018-10-20
ER

PT J
AU Gaur, PK
   Mishra, S
AF Gaur, Praveen Kumar
   Mishra, Shikha
TI Diclofenac Loaded Nanoparticles Fabricated with Biomaterial (Ceramide 2)
   for Transdermal Delivery
SO SCIENCE OF ADVANCED MATERIALS
LA English
DT Article
DE Biomaterial; Ceramide 2; Diclofenac; Permeation; Pharmacokinetics
ID SOLID LIPID NANOPARTICLES; IN-VITRO PERMEATION; EX-VIVO; SKIN
   PENETRATION; DRUG-DELIVERY; FORMULATION; RELEASE; GEL; MICROPARTICLES;
   LIPOSOMES
AB Objective: Solid lipid nano particles loaded with model drug Diclofenac sodium were formulated using a biomaterial (ceramide 2) and evaluated for physicochemical properties, in vitro/ex vivo permeation and pharmacokinetic/ pharmacodynamic studies. Methods: The SLNs were prepared using modified emulsion/solvent evaporation method and characterized for physical parameters, in vitro drug release, accelerated stability studies. Then SLNs were formulated into gels and compared with a commercial formulation (CEG) and carbopol gel containing plain drug (CG) for ex vivo, in vivo drug permeation and anti-inflammatory activity. Key findings: The SLNs were stable with optimum physical parameters. GN-3 and SN-3 gave highest in vitro drug release. CNG-3 has shown higher drug permeation (158.49 mu g/cm(2)) into receptor fluid in ex vivo permeation study in comparison to CEG (1.35 mu g/cm(2)). The enhancement ratio of CNG-3 was 43.249 (with respect to CG). CNG-3 has shown almost 8.5 times C-max then CEO at 4 hours. The AUC value of CNG-3 was 16 times than CEG whereas CNG-3 provided 99.81% edema inhibition in 6 hours. Conclusion: Physicochemical properties of major lipid component govern the characteristics and permeation profile of SLN. SLN made up of ceramide-2 showed good physical properties with acceptable stability. It also showed promising transdermal permeation.
C1 [Gaur, Praveen Kumar] ITS Paramed Pharm Coll, Dept Pharmaceut, Ghaziabad 201206, UP, India.
   [Mishra, Shikha] Jamia Hamdard, Dept Pharmacognosy & Phytochem, New Delhi 110062, India.
RP Gaur, PK (reprint author), ITS Paramed Pharm Coll, Dept Pharmaceut, Ghaziabad 201206, UP, India.
EM gaurmpharma@rediffmail.com
OI Gaur, Praveen/0000-0002-4221-1485
CR AGUIAR AJ, 1969, J PHARM SCI, V58, P210, DOI 10.1002/jps.2600580215
   Akhter S, 2008, CURR NANOSCI, V4, P381, DOI 10.2174/157341308786306071
   Babu R. J., 2006, FATTY ALCOHOLS FATTY, P137
   Batheja Priya, 2006, Expert Opin Drug Deliv, V3, P127
   Baydoun L, 2003, EUR J PHARM BIOPHARM, V56, P73, DOI 10.1016/S0939-6411(03)00036-5
   Bhaskar K, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-6
   Chime SA, 2013, J MICROENCAPSUL, V30, P335, DOI 10.3109/02652048.2012.726284
   Denet AR, 2004, ADV DRUG DELIVER REV, V56, P659, DOI 10.1016/j.addr.2003.10.027
   Dragicevic-Curic N, 2008, J CONTROL RELEASE, V127, P59, DOI 10.1016/j.jconrel.2007.12.013
   Dugard P. H., 1976, ADV MOD TOXICOL, P525
   DURRHEIM H, 1980, J PHARM SCI, V69, P781, DOI 10.1002/jps.2600690709
   El-Kamel Amal H, 2008, Curr Drug Deliv, V5, P20, DOI 10.2174/156720108783331014
   El-Leithy ES, 2010, AAPS PHARMSCITECH, V11, P1695, DOI 10.1208/s12249-010-9544-3
   Furuishi T, 2008, BIOL PHARM BULL, V31, P1439, DOI 10.1248/bpb.31.1439
   Gaur P. K., 2013, PHARM DEV T IN PRESS
   Gaur P. K., 2013, DRUG DEV IN IN PRESS
   Gaur PK, 2013, BIOMED RES INT, V2013, P10
   Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011
   Haigh JM, 1998, INT J PHARM, V170, P151, DOI 10.1016/S0378-5173(98)00064-7
   HIGUCHI T, 1960, J SOC COSMET CHEM, V11, P85
   Ishida T, 2002, INT J PHARM, V232, P59, DOI 10.1016/S0378-5173(01)00896-1
   Jasper AW, 2005, J PHYS CHEM B, V109, P3915, DOI 10.1021/jp044805v
   Jukanti R, 2011, J PHARM SCI-US, V100, P3208, DOI 10.1002/jps.22542
   Kitagawa S, 1995, INT J PHARM, V126, P49, DOI 10.1016/0378-5173(95)04075-7
   Kobayashi N, 1999, CHEM PHARM BULL, V47, P199
   Kwon TK, 2011, J IND ENG CHEM, V17, P10, DOI 10.1016/j.jiec.2010.10.001
   Lee JW, 2011, J CONTROL RELEASE, V154, P58, DOI 10.1016/j.jconrel.2011.05.003
   Liu CH, 2011, COLLOID SURFACE B, V82, P63, DOI 10.1016/j.colsurfb.2010.08.018
   Liu DF, 2011, J NANOPART RES, V13, P2375, DOI 10.1007/s11051-010-9998-y
   Manconi M, 2011, EUR J PHARM BIOPHARM, V78, P27, DOI 10.1016/j.ejpb.2010.12.010
   Manosroi A, 2008, INT J PHARM, V360, P156, DOI 10.1016/j.ijpharm.2008.04.033
   Mishra D, 2007, J PHARM SCI, V96, P147
   Morel S, 1996, INT J PHARM, V132, P259, DOI 10.1016/0378-5173(95)04388-8
   Patel NA, 2009, PHARM DEV TECHNOL, V14, P80, DOI 10.1080/10837450802409438
   PHILLIPS CA, 1995, J PHARM SCI, V84, P1427, DOI 10.1002/jps.2600841208
   Reithmeier H, 2001, INT J PHARM, V218, P133, DOI 10.1016/S0378-5173(01)00620-2
   SCHWARZ C, 1994, J CONTROL RELEASE, V30, P83, DOI 10.1016/0168-3659(94)90047-7
   Shekar BC, 2011, J DISPER SCI TECHNOL, V32, P1158, DOI 10.1080/01932691.2010.498248
   Touitou E, 2000, J CONTROL RELEASE, V65, P403, DOI 10.1016/S0168-3659(99)00222-9
   Vasiljevic D, 2006, INT J PHARM, V309, P171, DOI 10.1016/j.ijpharm.2005.11.034
   Walters K. A., 2002, STRUCTURE FUNCTION S
   Wartewig S, 2007, SKIN PHARMACOL PHYS, V20, P220, DOI 10.1159/00010442
   YARDLEY HJ, 1981, PHARMACOL THERAPEUT, V13, P357, DOI 10.1016/0163-7258(81)90006-1
NR 43
TC 4
Z9 4
U1 0
U2 15
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1947-2935
EI 1947-2943
J9 SCI ADV MATER
JI Sci. Adv. Mater.
PD APR
PY 2014
VL 6
IS 4
BP 736
EP 745
DI 10.1166/sam.2014.1762
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA AF0GQ
UT WOS:000334392600014
DA 2018-10-20
ER

PT J
AU Hamidi, S
   Letourneur, D
   Aid-Launais, R
   Di Stefano, A
   Vainchenker, W
   Norol, F
   Le Visage, C
AF Hamidi, Sofiane
   Letourneur, Didier
   Aid-Launais, Rachida
   Di Stefano, Antonio
   Vainchenker, William
   Norol, Francoise
   Le Visage, Catherine
TI Fucoidan Promotes Early Step of Cardiac Differentiation from Human
   Embryonic Stem Cells and Long-Term Maintenance of Beating Areas
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID PREVENTS NEOINTIMAL HYPERPLASIA; ENDOTHELIAL PROGENITOR CELLS;
   HEPARIN/HEPARAN SULFATE; IN-VITRO; GROWTH; HEART; POLYSACCHARIDE;
   EXPRESSION; SCAFFOLDS; HYDROGEL
AB Somatic stem cells require specific niches and three-dimensional scaffolds provide ways to mimic this microenvironment. Here, we studied a scaffold based on Fucoidan, a sulfated polysaccharide known to influence morphogen gradients during embryonic development, to support human embryonic stem cells (hESCs) differentiation toward the cardiac lineage. A macroporous (pore 200 mu m) Fucoidan scaffold was selected to support hESCs attachment and proliferation. Using a protocol based on the cardiogenic morphogen bone morphogenic protein 2 (BMP2) and transforming growth factor (TGF beta) followed by tumor necrosis factor (TNF alpha), an effector of cardiopoietic priming, we examined the cardiac differentiation in the scaffold compared to culture dishes and embryoid bodies (EBs). At day 8, Fucoidan scaffolds supported a significantly higher expression of the 3 genes encoding for transcription factors marking the early step of embryonic cardiac differentiation NKX2.5 (p<0.05), MEF2C (p<0.01), and GATA4 (p<0.01), confirmed by flow cytometry analysis for MEF2C and NKX2.5. The ability of Fucoidan scaffolds to locally concentrate and slowly release TGF beta and TNF alpha was confirmed by Luminex technology. We also found that Fucoidan scaffolds supported the late stage of embryonic cardiac differentiation marked by a significantly higher atrial natriuretic factor (ANF) expression (p<0.001), although only rare beating areas were observed. We postulated that absence of mechanical stress in the soft hydrogel impaired sarcomere formation, as confirmed by molecular analysis of the cardiac muscle myosin MYH6 and immunohistological staining of sarcomeric alpha-actinin. Nevertheless, Fucoidan scaffolds contributed to the development of thin filaments connecting beating areas through promotion of smooth muscle cells, thus enabling maintenance of beating areas for up to 6 months. In conclusion, Fucoidan scaffolds appear as a very promising biomaterial to control cardiac differentiation from hESCs that could be further combined with mechanical stress to promote sarcomere formation at terminal stages of differentiation.
C1 [Hamidi, Sofiane; Di Stefano, Antonio; Vainchenker, William; Norol, Francoise] Inst Gustave Roussy, INSERM, UMR 1009, F-94805 Villejuif, France.
   [Hamidi, Sofiane; Di Stefano, Antonio; Vainchenker, William] Univ Paris 11, Inst Gustave Roussy, UMR 1009, Villejuif, France.
   [Hamidi, Sofiane; Di Stefano, Antonio; Vainchenker, William] Inst Gustave Roussy, Villejuif, France.
   [Letourneur, Didier; Aid-Launais, Rachida; Le Visage, Catherine] X Bichat Hosp, INSERM, U698, F-75018 Paris, France.
   [Letourneur, Didier; Aid-Launais, Rachida; Le Visage, Catherine] Univ Paris 13, Sorbonne Paris Cite, F-93430 Villetaneuse, France.
   [Letourneur, Didier; Aid-Launais, Rachida; Le Visage, Catherine] Univ Paris Diderot, Paris, France.
   [Norol, Francoise] Hop La Pitie Salpetriere, AP HP, Serv Biotherapie, Paris, France.
RP Le Visage, C (reprint author), X Bichat Hosp, INSERM, U698, F-75018 Paris, France.
EM catherine.levisage@inserm.fr
RI Di Stefano, Antonio/M-1478-2018; Le Visage, Catherine/E-5460-2011;
   Didier, letourneur/H-5268-2012
OI Le Visage, Catherine/0000-0003-1816-1649; Didier,
   letourneur/0000-0003-2197-9468
FU Medicen Paris region (consortium Ingecell); Agence Nationale de la
   Recherche [ANR-08-BIOT-012, ANR-12-TECSAN-0011]; INSERM; University
   Paris 7; University Paris 13; StemPole Ile de France
FX This work was supported in part by grants from Medicen Paris region
   (consortium Ingecell), Agence Nationale de la Recherche
   (ANR-08-BIOT-012, ANR-12-TECSAN-0011), INSERM, and Universities Paris 7
   and Paris 13. SH was supported by a fellowship from the StemPole Ile de
   France. We are grateful for the assistance of S.M. Derkaoui (Inserm
   U698, Paris) for scaffolds preparation and characterization and S.
   Benadda (Institut Claude Bernard IFR2, Universite Paris Diderot) for
   confocal imaging.
CR Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200
   Autissier A, 2007, J BIOMED MATER RES A, V82A, P336, DOI 10.1002/jbm.a.30998
   Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539
   Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916
   Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155
   Blin G, 2010, BIOMATERIALS, V31, P1742, DOI 10.1016/j.biomaterials.2009.11.055
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Clause KC, 2009, TISSUE ENG PT A, V15, P1373, DOI 10.1089/ten.tea.2008.0169
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Deux JF, 2002, ARTERIOSCL THROM VAS, V22, P1604, DOI 10.1161/01.ATV.0000032034.91020.0A
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flaibani M, 2009, TISSUE ENG PT A, V15, P2447, DOI 10.1089/ten.tea.2008.0301
   Freguin-Bouilland C, 2007, TRANSPLANTATION, V83, P1234, DOI 10.1097/01.tp.0000261109.97928.9c
   Gomez-Lopez S, 2011, GLIA, V59, P1588, DOI 10.1002/glia.21201
   Howard D, 2008, J ANAT, V213, P66, DOI 10.1111/j.1469-7580.2008.00878.x
   Jacot JG, 2010, J BIOMECH, V43, P93, DOI 10.1016/j.jbiomech.2009.09.014
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI200112131
   Klaus A, 2009, PEDIATR CARDIOL, V30, P609, DOI 10.1007/s00246-008-9352-7
   Klump H, 2005, ANN NY ACAD SCI, V1044, P6, DOI 10.1196/annals.1349.002
   Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705
   Lake AC, 2006, J BIOL CHEM, V281, P37844, DOI 10.1074/jbc.M600686200
   Lavergne M, 2012, MACROMOL BIOSCI, V12, P901, DOI 10.1002/mabi.201100431
   Le Visage C, 2012, TISSUE ENG PT A, V18, P35, DOI [10.1089/ten.tea.2011.0053, 10.1089/ten.TEA.2011.0053]
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li SWC, 2009, CELL BIOL INT, V33, P255, DOI 10.1016/j.cellbi.2008.11.009
   Liu H, 2006, BIOMATERIALS, V27, P5978, DOI 10.1016/j.biomaterials.2006.05.053
   MCCAFFREY TA, 1994, J CELL PHYSIOL, V159, P51, DOI 10.1002/jcp.1041590108
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Nakamura S, 2008, J BIOMED MATER RES A, V85A, P619, DOI 10.1002/jbm.a.31563
   Nogami K, 2004, J BIOL CHEM, V279, P8219, DOI 10.1074/jbc.M307304200
   Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051
   Religa P, 2000, EUR J VASC ENDOVASC, V20, P419, DOI 10.1053/ejvs.2000.1220
   Russell B, 2010, J MOL CELL CARDIOL, V48, P817, DOI 10.1016/j.yjmcc.2010.02.016
   Sarlon G, 2012, J THROMB HAEMOST, V10, P38, DOI 10.1111/j.1538-7836.2011.04554.x
   Schenke-Layland K, 2011, BIOMATERIALS, V32, P2748, DOI 10.1016/j.biomaterials.2010.12.046
   Senni K, 2006, ARCH BIOCHEM BIOPHYS, V445, P56, DOI 10.1016/j.abb.2005.11.001
   Skardal A, 2010, TISSUE ENG PT A, V16, P2675, DOI [10.1089/ten.tea.2009.0798, 10.1089/ten.TEA.2009.0798]
   Small EA, 2003, DEV BIOL, V261, P116, DOI 10.1016/S0012-1606(03)00306-3
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003
   Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103
   Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902
   Votteler M, 2010, MACROMOL BIOSCI, V10, P1302, DOI 10.1002/mabi.201000102
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   White E, 2011, PFLUG ARCH EUR J PHY, V462, P177, DOI 10.1007/s00424-011-0963-0
   Zemani F, 2005, BIOCHEM PHARMACOL, V70, P1167, DOI 10.1016/j.bcp.2005.07.014
NR 48
TC 12
Z9 12
U1 1
U2 22
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR 1
PY 2014
VL 20
IS 7-8
BP 1285
EP 1294
DI 10.1089/ten.tea.2013.0149
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AE6NG
UT WOS:000334110000016
PM 24354596
OA Green Published
DA 2018-10-20
ER

PT J
AU Moghaddam, AS
   Raji, A
   Movaffagh, J
   Yazdi, AT
   Mahmoudi, M
AF Moghaddam, Atieh Seyedian
   Raji, Ahmadreza
   Movaffagh, Jebraiel
   Yazdi, Abbas Tabatabaee
   Mahmoudi, Mahmoud
TI Effects of Autologous Keratinocyte Cell Spray With and Without Chitosan
   on Third Degree Burn Healing: An Animal Experiment
SO WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE
LA English
DT Article
DE burn; cultured keratinocyte suspension; chitosan; wound healing
ID MURINE EPIDERMAL-KERATINOCYTES; LONG-TERM CULTURE; IN-VITRO;
   PHOTOCROSSLINKABLE CHITOSAN; GEL FORMULATION; CHITIN; PROLIFERATION;
   FIBROBLASTS; WOUNDS; GROWTH
AB Treatment of extensive third degree burns, especially in the case of limited skin donor sites for obtaining autologous split-thickness skin grafts (STSG), has led to in vitro expansion of keratinocytes. Cultured epidermal autograft (CEA) sheets have been used for burn treatment for several years. However, time consuming processes of isolation and Cultivation of keratinocytes, as Well as difficult procedures of detachment of CEA from cultured flask, led scientists to develop the technique of spraying cultured single :keratinocytes (CSK) instead of using CEA. Chitosan is a well-known wound dressing biomaterial that has both biological and medical applications. In this study, the application method of CSK was used to determine whether there would be any significant difference between the treatment Of burns with CSK alone in comparison to burns treated with CSK and covered with chitosan gel at a neutral pH. Materials and Methods. Thirty male,Wistar rats were selected and their keratinocytes were isolated and cultured from small skin biopsy. Rats were divided randomly into 3 equal groups and 3 full-thickness round burn wounds Were created on their backs. Rats were treated with either normal saline (control group), CSK (test group A), or CSK + neutral chitosan (CSK + NCH) (test group B). The wounds were photographed on days 0, 3, 5, 7, 10, and 14, and the percentage of wound contraction was calculated with an image analyzer. Biopsy samples were taken for histological studies. Results. The results showed faster wound contraction for test groups A and B during the 14-day period than the control group (P < 0.05). Also, more contraction was found in test groups A and B in 7 days (P < 0.05). Histological observations showed significant difference in inflammation and fibrotic tissue formation between groups, but other parameters did not show any remarkable difference. Conclusion. Based on the findings of this study, the authors concluded that chitosan can prevent cells from dripping out of the wound, speed up wound contraction, and extend fibrotic tissue formation. Chitosan did not, however, have any effect on fastening the reepithelialilation and granulation tissue formation during the first 14 days.
C1 [Moghaddam, Atieh Seyedian; Raji, Ahmadreza] Ferdowsi Univ Mashhad, Fac Vet Med, Dept Basic Sci, Mashhad, Iran.
   [Movaffagh, Jebraiel] Mashhad Univ Med Sci, Targeted Drug Delivery Res Ctr, Mashhad, Iran.
   [Movaffagh, Jebraiel] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmaceut, Mashhad, Iran.
   [Yazdi, Abbas Tabatabaee] Mashhad Univ Med Sci, Fac Med, Dept Pathol, Mashhad, Iran.
   [Mahmoudi, Mahmoud] Mashhad Univ Med Sci, Fac Med, Dept Immunol, Mashhad, Iran.
RP Moghaddam, AS (reprint author), Ferdowsi Univ Mashhad, Fac Vet Med, Dept Basic Sci, Mashhad, Iran.
EM at_se553@stu.um.ac.ir
CR Alemdaroglu C, 2006, BURNS, V32, P319, DOI 10.1016/j.burns.2005.10.015
   Alsarra IA, 2009, INT J BIOL MACROMOL, V45, P16, DOI 10.1016/j.ijbiomac.2009.03.010
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Currie LJ, 2003, BURNS, V29, P677, DOI 10.1016/S0305-4179(03)00155-4
   DESAI M H, 1991, Journal of Burn Care and Rehabilitation, V12, P540, DOI 10.1097/00004630-199111000-00009
   Fraulin FOG, 1998, J BURN CARE REHABIL, V19, P337, DOI 10.1097/00004630-199807000-00012
   Fredriksson C, 2008, BURNS, V34, P212, DOI 10.1016/j.burns.2007.03.008
   FRESHNEY RI, 2002, CULTURE EPITHELIAL C
   GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665
   Hager B, 1999, J INVEST DERMATOL, V112, P971, DOI 10.1046/j.1523-1747.1999.00605.x
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Kamolz LP, 2008, EUR SURG, V40, P19, DOI 10.1007/s10353-008-0380-6
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   NASEEMA A, 1995, CURR SCI INDIA, V69, P461
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Oloumi M. M., 2008, Iranian Journal of Veterinary Surgery, V3, P47
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Purna S K, 2000, Burns, V26, P54
   Rheinwald J G, 1980, Methods Cell Biol, V21A, P229, DOI 10.1016/S0091-679X(08)60769-4
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Suzuki Y, 2000, CARBOHYD POLYM, V42, P307, DOI 10.1016/S0144-8617(99)00161-7
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Yano S, 2005, BRIT J DERMATOL, V153, P1101, DOI 10.1111/j.1365-2133.2005.06832.x
NR 26
TC 1
Z9 1
U1 1
U2 9
PU H M P COMMUNICATIONS
PI MALVERN
PA 83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA
SN 1044-7946
J9 WOUNDS
JI Wounds-Compend. Clin. Res. Pract.
PD APR
PY 2014
VL 26
IS 4
BP 108
EP 117
PG 10
WC Dermatology; Surgery
SC Dermatology; Surgery
GA AF7NQ
UT WOS:000334902200005
DA 2018-10-20
ER

PT J
AU Manecka, GM
   Labrash, J
   Rouxel, O
   Dubot, P
   Lalevee, J
   Andaouss, SA
   Renard, E
   Langlois, V
   Versace, DL
AF Manecka, G. M.
   Labrash, J.
   Rouxel, O.
   Dubot, P.
   Lalevee, J.
   Andaouss, S. Abbad
   Renard, E.
   Langlois, V.
   Versace, D. L.
TI Green Photoinduced Modification of Natural
   Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Surface for Antibacterial
   Applications
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Photochemistry; Poly(3-hydroxybutyrate-co-3-hydroxyvalerate);
   Photografting; Antibacterial activities
ID SELF-ASSEMBLED MONOLAYERS; TRANSFER RADICAL POLYMERIZATION; TISSUE
   ENGINEERING APPLICATIONS; BIOLOGICALLY-ACTIVE POLYMERS; ANTIMICROBIAL
   ACTIVITY; QUATERNIZED CHITOSAN; ZWITTERIONIC POLYSULFOBETAINE;
   MECHANICAL-PROPERTIES; SILVER NANOPARTICLES; PROTEIN ADSORPTION
AB A green photoinduced method for the modification of a biodegradable and biocompatible polymer, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBHV), has been successfully carried out using three types of monomers with potential antibacterial effects, i.e., 2-[(methacryloyloxy)-ethyl] trimethylammonium chloride (META), 2-[(methacryloylethyl)]-dimethyl-(3-sulfopropyl) ammonium (MESA) and 2-hydroxyethyl methacrylate (HEMA). The photografting process is conducted through a photoinduced free radical process employing a ketone-based photoinitiator in an aqueous medium. Under appropriate conditions, the photogenerated radicals abstract hydrogen atoms from the PHBHV backbone, thus initiating the UV-mediated photopolymerization of derived-(meth)acrylate monomers from the surface of PHBHV film. The photochemical mechanism of the ketones photolysis is entirely described by a electron spin resonance/spin trapping technique, and the modified-PHBHV films are extensively characterized by ATR-FTIR and water contact angle and XPS measurements. Finally, a primary investigation is conducted to support the antibacterial activity of the new functionalized biomaterial against Escherichia coli and Staphylococcus aureus.
C1 [Manecka, G. M.; Labrash, J.; Rouxel, O.; Dubot, P.; Renard, E.; Langlois, V.; Versace, D. L.] Univ Paris Est Creteil Val de Marne, CNRS, Inst Chim & Mat Paris Est, UMR 7182,Equipe Syst Polymeres Complexes, F-94320 Thiais, France.
   [Lalevee, J.] Inst Sci Mat Mulhouse, IS2M LRC 7228, F-68057 Mulhouse, France.
   [Andaouss, S. Abbad] Univ Paris Est Creteil Val de Marne, CNRS, UMR 7618, Unite Bioemco,Equipe IBIOS, F-94010 Thiais, France.
RP Versace, DL (reprint author), Univ Paris Est Creteil Val de Marne, CNRS, Inst Chim & Mat Paris Est, UMR 7182,Equipe Syst Polymeres Complexes, 2-8 Rue Henri Dunant, F-94320 Thiais, France.
EM versace@icmpe.cnrs.fr
RI LANGLOIS, Valerie/C-2584-2016; Versace, Davy-Louis/D-8124-2016
FU CNRS institute; UPEC
FX The authors would like to thank the CNRS institute and UPEC for
   financial supports.
CR Al-Muaikel NS, 2000, J APPL POLYM SCI, V77, P740, DOI 10.1002/(SICI)1097-4628(20000725)77:4<740::AID-APP4>3.0.CO;2-P
   Albert M, 2003, BIOMACROMOLECULES, V4, P1811, DOI 10.1021/bm0342180
   Amarjargal A, 2012, MATER CHEM PHYS, V135, P277, DOI 10.1016/j.matchemphys.2012.05.078
   Amna T, 2012, APPL MICROBIOL BIOT, V93, P743, DOI 10.1007/s00253-011-3459-0
   Babinot J, 2012, CHEM COMMUN, V48, P5364, DOI 10.1039/c2cc30482a
   Babinot J, 2012, J COLLOID INTERF SCI, V375, P88, DOI 10.1016/j.jcis.2012.02.042
   Chang Y, 2008, LANGMUIR, V24, P5453, DOI 10.1021/la800228c
   Chang Y, 2010, BIOMACROMOLECULES, V11, P1101, DOI 10.1021/bm100093g
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Cheng ML, 2011, POLYMER, V52, P1391, DOI 10.1016/j.polymer.2011.01.039
   Chung DW, 2003, INT J FOOD SCI TECH, V38, P165, DOI 10.1046/j.1365-2621.2003.00657.x
   Decraene V, 2006, APPL ENVIRON MICROB, V72, P4436, DOI 10.1128/AEM.02945-05
   El Habnouni S, 2011, ADV FUNCT MATER, V21, P3321, DOI 10.1002/adfm.201100412
   Elzatahry AA, 2012, INT J NANOMED, V7, P2829, DOI 10.2147/IJN.S31810
   Feiertag P, 2003, MACROMOL RAPID COMM, V24, P567, DOI 10.1002/marc.200390085
   Fouassier J.-P., 1993, RAD CURING POLYM SCI
   Fouassier JP, 2013, PHOTOINITIATORS POLY
   Genzer J, 2006, BIOFOULING, V22, P339, DOI 10.1080/08927010600980223
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   Hazer DB, 2012, MAT SCI ENG C-MATER, V32, P637, DOI 10.1016/j.msec.2012.01.021
   Herold BC, 2002, J VIROL, V76, P11236, DOI 10.1128/JVI.76.22.11236-11244.2002
   Iemma F, 2010, J APPL POLYM SCI, V115, P784, DOI 10.1002/app.31067
   Ignatova M, 2007, EUR POLYM J, V43, P1112, DOI 10.1016/j.eurpolymj.2007.01.012
   Ignatova M, 2006, CARBOHYD RES, V341, P2098, DOI 10.1016/j.carres.2006.05.006
   Ignatova M, 2012, MACROMOL BIOSCI, V12, P104, DOI 10.1002/mabi.201100178
   JANZEN EG, 1973, J PHYS CHEM-US, V77, P139, DOI 10.1021/j100620a031
   Jon SY, 2003, LANGMUIR, V19, P9989, DOI 10.1021/la034839e
   Ke Y, 2007, J APPL POLYM SCI, V104, P4088, DOI 10.1002/app.25678
   Kenawy ER, 2006, REACT FUNCT POLYM, V66, P419, DOI 10.1016/j.reactfunctpolym.2005.09.002
   Kenawy ER, 2003, MACROMOL BIOSCI, V3, P107, DOI 10.1002/mabi.200390016
   Kim SH, 2003, J MEMBRANE SCI, V211, P157, DOI 10.1016/S0376-7388(02)00418-0
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Knoll H, 1981, REACT KINET CATAL LE, V15, P431
   Lao HK, 2007, BIOMACROMOLECULES, V8, P416, DOI 10.1021/bm0609700
   Lao HK, 2011, J APPL POLYM SCI, V120, P184, DOI 10.1002/app.32967
   Lao HK, 2010, J APPL POLYM SCI, V116, P288, DOI 10.1002/app.31507
   Lee SB, 2004, BIOMACROMOLECULES, V5, P877, DOI 10.1021/bm034352k
   Li LY, 2007, J BIOMAT SCI-POLYM E, V18, P1415, DOI 10.1163/156856207782246795
   Li X, 2009, ACTA BIOMATER, V5, P2002, DOI 10.1016/j.actbio.2009.01.035
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Lim KS, 2012, POLYM INT, V61, P1519, DOI 10.1002/pi.4239
   Lin J, 2002, BIOTECHNOL LETT, V24, P801, DOI 10.1023/A:1015584423358
   Linhart W, 2006, J MATER SCI, V41, P4806, DOI 10.1007/s10853-006-0023-x
   Lu J, 2001, J APPL POLYM SCI, V82, P300, DOI 10.1002/app.1852.abs
   Ma HM, 2000, MACROMOLECULES, V33, P331, DOI 10.1021/ma990821s
   MATSUNAGA T, 1988, APPL ENVIRON MICROB, V54, P1330
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Pant HR, 2011, J HAZARD MATER, V189, P465, DOI 10.1016/j.jhazmat.2011.02.062
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Perni S, 2009, BIOMATERIALS, V30, P89, DOI 10.1016/j.biomaterials.2008.09.020
   Podsiadlo P, 2005, LANGMUIR, V21, P11915, DOI 10.1021/la051284+
   Ruckh TT, 2012, J MATER SCI-MATER M, V23, P1411, DOI 10.1007/s10856-012-4609-3
   Rupp B, 2010, GREEN CHEM, V12, P1796, DOI 10.1039/c0gc00066c
   Sakuragi M, 2010, MAT SCI ENG C-MATER, V30, P316, DOI 10.1016/j.msec.2009.11.006
   Sampedro MF, 2007, INFECT DIS CLIN N AM, V21, P785, DOI 10.1016/j.idc.2007.07.001
   SCHAKENRAAD JM, 1988, BIOMATERIALS, V9, P116, DOI 10.1016/0142-9612(88)90082-8
   Schmitt MA, 2004, J AM CHEM SOC, V126, P6848, DOI 10.1021/ja048546z
   Schmitt MA, 2007, J AM CHEM SOC, V129, P417, DOI 10.1021/ja0666553
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299
   Versace DL, 2013, J MATER CHEM B, V1, P4834, DOI 10.1039/c3tb20869a
   Versace DL, 2013, ADV HEALTHC MATER, V2, P1008, DOI 10.1002/adhm.201200269
   Versace DL, 2012, GREEN CHEM, V14, P788, DOI 10.1039/c2gc16399c
   Wang HL, 2004, J POLYM SCI POL CHEM, V42, P253, DOI 10.1002/pola.11022
   Wang YY, 2011, BIOMACROMOLECULES, V12, P551, DOI 10.1021/bm100886w
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   Xing ZC, 2012, J NANOMATER, V2012, P1
   Yang W, 2008, LANGMUIR, V24, P9211, DOI 10.1021/la801487f
   Ye SH, 2010, COLLOID SURFACE B, V79, P357, DOI 10.1016/j.colsurfb.2010.04.018
   Ying TH, 2008, BIOMATERIALS, V29, P1307, DOI 10.1016/j.biomaterials.2007.11.031
   Zhao T, 2008, J APPL MICROBIOL, V104, P824, DOI 10.1111/j.1365-2672.2007.03616.x
NR 79
TC 10
Z9 10
U1 2
U2 67
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD APR
PY 2014
VL 2
IS 4
BP 996
EP 1006
DI 10.1021/sc400564r
PG 11
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA AE6IA
UT WOS:000334092600057
DA 2018-10-20
ER

PT J
AU Walters, BD
   Stegemann, JP
AF Walters, B. D.
   Stegemann, J. P.
TI Strategies for directing the structure and function of three-dimensional
   collagen biomaterials across length scales
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Collagen; Scaffold; Fabrication; Structure; Biomaterial
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING APPLICATIONS;
   SMOOTH-MUSCLE-CELLS; CROSS-LINKED COLLAGEN; BIOMIMETIC NANOFIBROUS
   SCAFFOLDS; HUMAN-SKIN FIBROBLASTS; RAT-TAIL COLLAGEN;
   MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; MIMETIC PEPTIDE
AB Collagen type I is a widely used natural biomaterial that has found utility in a variety of biological and medical applications. Its well-characterized structure and role as an extracellular matrix protein make it a highly relevant material for controlling cell function and mimicking tissue properties. Collagen type I is abundant in a number of tissues, and can be isolated as a purified protein. This review focuses on hydrogel biomaterials made by reconstituting collagen type I from a solubilized form, with an emphasis on in vitro studies in which collagen structure can be controlled. The hierarchical structure of collagen from the nanoscale to the macroscale is described, with an emphasis on how structure is related to function across scales. Methods of reconstituting collagen into hydrogel materials are presented, including molding of macroscopic constructs, creation of microscale modules and electrospinning of nanoscale fibers. The modification of collagen biomaterials to achieve the desired structures and functions is also addressed, with particular emphasis on mechanical control of collagen structure, creation of collagen composite materials and crosslinking of collagenous matrices. Biomaterials scientists have made remarkable progress in rationally designing collagen-based biomaterials and in applying them both to the study of biology and for therapeutic benefit. This broad review illustrates recent examples of techniques used to control collagen structure and thereby to direct its biological and mechanical functions. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Walters, B. D.; Stegemann, J. P.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Stegemann, JP (reprint author), Univ Michigan, Dept Biomed Engn, 1101 Beal Ave, Ann Arbor, MI 48109 USA.
EM jpsteg@umich.edu
FU National Institutes of Health [R21-AR062709]; Tissue Engineering at
   Michigan (TEAM) training grant [T32-DE007057]
FX The authors are grateful to their colleagues in the field of
   biomaterials and tissue engineering for their valuable insight and
   discussions on the topic of collagen and its biomedical applications. In
   this review, the authors have used selected examples of published
   studies to illustrate strategies to control the structure and function
   of collagen-based biomaterials. The authors apologize to those whose
   work could not be included due to space limitations. Support from the
   National Institutes of Health through grant R21-AR062709 (to JPS) and
   the Tissue Engineering at Michigan (TEAM) training grant (T32-DE007057,
   to BDW) is gratefully acknowledged.
CR Achilli M, 2010, POLYMERS-BASEL, V2, P664, DOI 10.3390/polym2040664
   Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
   Alekseeva T, 2012, EUR CELLS MATER, V23, P28, DOI 10.22203/eCM.v023a03
   Amruthwar SS, 2013, J BIOMED MATER RES A, V101, P2383, DOI 10.1002/jbm.a.34514
   Ananta M, 2009, TISSUE ENG PT A, V15, P1667, DOI 10.1089/ten.tea.2008.0194
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bai X, 2011, BIOMED MATER, P6
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072
   Batorsky A, 2005, BIOTECHNOL BIOENG, V92, P492, DOI 10.1002/bit.20614
   Baxter SC, 2008, CELL BIOCHEM BIOPHYS, V51, P33, DOI 10.1007/s12013-008-9013-8
   Bedran-Russo AKB, 2007, J BIOMED MATER RES B, V80B, P268, DOI 10.1002/jbm.b.30593
   Berglund JD, 2004, TISSUE ENG, V10, P1526, DOI 10.1089/1076327042500427
   Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9
   Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602
   Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155
   Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015
   Bitar M, 2007, J MATER SCI-MATER M, V18, P237, DOI 10.1007/s10856-006-0685-1
   BORNSTEIN MB, 1958, LAB INVEST, V7, P134
   Bornstein P, 1964, J CLIN INVEST, V43, P1812
   Bou-Akl T, 2013, J BIOMED MATER RES A, V101, P2507, DOI 10.1002/jbm.a.34549
   Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015
   Burck J, 2013, LANGMUIR, V29, P1562
   Butler MJ, 2012, TISSUE ENG PT A, V18, P1628, DOI [10.1089/ten.tea.2011.0467, 10.1089/ten.TEA.2011.0467]
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Caldwell D, 2012, ADV HLTH MAT
   Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731
   Cao Y, 2007, J NANOSCI NANOTECHNO, V7, P447, DOI 10.1166/jnn.2007.137
   Carey S, 2011, C P IEEE ENG MED BIO
   Caves JM, 2011, BIOMATERIALS, V32, P5371, DOI 10.1016/j.biomaterials.2011.04.009
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   Chamberlain MD, 2012, TISSUE ENG PT A, V18, P285, DOI [10.1089/ten.TEA.2011.0393, 10.1089/ten.tea.2011.0393]
   Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041
   Chan BP, 2005, J BIOMED MATER RES A, V75A, P689, DOI 10.1002/jbm.a.30469
   Chan BK, 2012, MACROMOL BIOSCI, V12, P1490, DOI 10.1002/mabi.201200234
   Chandran PL, 2012, CONNECT TISSUE RES, V53, P285, DOI 10.3109/03008207.2011.640760
   Chang SH, 2010, PLAST RECONSTR SURG, V125, P1393, DOI 10.1097/PRS.0b013e3181d62aab
   Cheema U., 2006, EUR CELLS MATER, V11, P32
   Chen DW, 2012, INT J PHARMACEUT, V430, P335, DOI 10.1016/j.ijpharm.2012.04.010
   Chen L, 2011, J BIOMED MATER RES A, V99A, P395, DOI 10.1002/jbm.a.33202
   Chen S, 2011, ACTA BIOMATER, V7, P644, DOI 10.1016/j.actbio.2010.09.014
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021
   Chicatun F, 2011, BIOMACROMOLECULES, V12, P2946, DOI 10.1021/bm200528z
   Chiu CT, 2007, ARTIF CELL BLOOD SUB, V35, P309, DOI 10.1080/10731190701378626
   Cirka HA, 2012, ANN BIOMED ENG, V40, P1654, DOI 10.1007/s10439-012-0532-5
   Clark GL, 1935, J AM CHEM SOC, V57, P1509, DOI 10.1021/ja01311a504
   Cliche S, 2003, POULTRY SCI, V82, P503, DOI 10.1093/ps/82.3.503
   Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893
   Crouzier T, 2008, LANGMUIR, V24, P13173, DOI 10.1021/la801999n
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   Davis GE, 2001, J CELL SCI, V114, P917
   de Jonge N., 2012, ANN BIOMED ENG, V41, P763
   Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377
   DeVolder RJ, 2012, TISSUE ENG PT A, V18, P1642, DOI [10.1089/ten.tea.2011.0547, 10.1089/ten.TEA.2011.0547]
   Dewitt DD, 2009, TISSUE ENG PT A, V15, P2785, DOI [10.1089/ten.tea.2008.0406, 10.1089/ten.TEA.2008.0406]
   Ding T, 2011, REGEN MED, V6, P437, DOI [10.2217/rme.11.39, 10.2217/RME.11.39]
   Dong B, 2009, MACROMOL RAPID COMM, V30, P539, DOI 10.1002/marc.200800634
   Drexler J, 2010, TISSUE ENG, P17
   EHRLICH HP, 1990, TISSUE CELL, V22, P407, DOI 10.1016/0040-8166(90)90070-P
   EHRMANN RL, 1956, J NATL CANCER I, V16, P1375
   Ekaputra A, 2009, TISSUE ENG, V15, P3770
   Elbjeirami WM, 2003, J BIOMED MATER RES A, V66A, P513, DOI 10.1002/jbm.a.10021
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Enea D, 2011, J MATER SCI-MATER M, V22, P1569, DOI 10.1007/s10856-011-4336-1
   Eng G, 2013, P NATL ACAD SCI USA, V110, P4551, DOI 10.1073/pnas.1300569110
   Everaerts F, 2008, J BIOMED MATER RES A, V85A, P547, DOI 10.1002/jbm.a.31524
   Fernandez P, 2009, INTEGR BIOL, V1, P252, DOI 10.1039/b822897c
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Fischer RL, 2012, J MATER SCI-MATER M, V23, P1645, DOI 10.1007/s10856-012-4641-3
   Forgacs G, 2003, BIOPHYS J, V84, P1272, DOI 10.1016/S0006-3495(03)74942-X
   FRANCIS G, 1975, BIOCHEM J, V145, P287, DOI 10.1042/bj1450287
   Francis-Sedlak ME, 2009, BIOMATERIALS, V30, P1851, DOI 10.1016/j.biomaterials.2008.12.014
   Franz S, 2013, ACTA BIOMATER, V9, P5621, DOI 10.1016/j.actbio.2012.11.016
   Galie PA, 2012, EXP CELL RES, V318, P75, DOI 10.1016/j.yexcr.2011.10.008
   Galie PA, 2011, ANN BIOMED ENG, V39, P2767, DOI 10.1007/s10439-011-0371-9
   Ghezzi CE, 2011, BIOMATERIALS, V32, P4761, DOI 10.1016/j.biomaterials.2011.03.043
   Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203
   Gillette BM, 2011, BIOMATERIALS, V32, P8067, DOI 10.1016/j.biomaterials.2011.05.043
   Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3786
   Gough J, 2002, J BIOMED MATER RES, V61, P121
   Griffith M, 2002, CORNEA, V21, pS54, DOI 10.1097/01.ICO.0000028326.06702.9C
   GRINNELL F, 1984, J CELL SCI, V66, P51
   Grover CN, 2012, J MECH BEHAV BIOMED, V10, P62, DOI 10.1016/j.jmbbm.2012.02.028
   Guarnieri D, 2007, J MATER SCI-MATER M, V18, P245, DOI 10.1007/s10856-006-0686-5
   Guo C, 2007, BIOMATERIALS, V28, P1105, DOI 10.1016/j.biomaterials.2006.10.010
   Gupta R, 2011, TISSUE ENG PT A, V17, P2005, DOI [10.1089/ten.tea.2010.0542, 10.1089/ten.TEA.2010.0542]
   Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200
   Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7
   Herchenhan A, 2012, BIOMECH MODEL MECHAN, V11, P449, DOI 10.1007/s10237-011-0324-0
   HILLIS WD, 1959, EXP CELL RES, V17, P557, DOI 10.1016/0014-4827(59)90086-2
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Hong H, 2007, BIOMATERIALS, V28, P3824, DOI 10.1016/j.biomaterials.2007.05-007
   Hong H, 2008, J BIOMAT SCI-POLYM E, V19, P1279, DOI 10.1163/156856208786052380
   Hong SM, 2012, LAB CHIP, V12, P3277, DOI 10.1039/c2lc40558j
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Huang G., 2012, BIOFABRICATION, V4, P1
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Huang Z, 2009, BIOMED MATER, P4
   Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001
   Hwang YJ, 2011, ACS APPL MATER INTER, V3, P2579, DOI 10.1021/am200416h
   Isenberg BC, 2003, ANN BIOMED ENG, V31, P937, DOI 10.1114/1.1590662
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Jeng LB, 2009, J BIOMED MATER RES A, V91A, P886, DOI 10.1002/jbm.a.32293
   Ji J, 2012, J MECH BEHAV BIOMED, V13, P185, DOI 10.1016/j.jmbbm.2012.04.016
   Jiang QR, 2013, J BIOMED MATER RES A, V101, P1237, DOI 10.1002/jbm.a.34422
   Johnson T, 2011, NANOTECHNOLOGY, V22, P1
   Kalson NS, 2010, MATRIX BIOL, V29, P678, DOI 10.1016/j.matbio.2010.08.009
   KANDA K, 1994, CELL TRANSPLANT, V3, P481, DOI 10.1177/096368979400300605
   Karamichos D, 2007, INVEST OPHTH VIS SCI, V48, P5030, DOI 10.1167/iovs.07-0443
   Khaing ZZ, 2012, NEUROSCI LETT, V519, P103, DOI 10.1016/j.neulet.2012.02.027
   Kittiphattanabawon P, 2010, EUR FOOD RES TECHNOL, V230, P475, DOI 10.1007/s00217-009-1191-0
   Koch L, 2012, BIOTECHNOL BIOENG, V109, P1855, DOI 10.1002/bit.24455
   Krishna OD, 2009, BIOMACROMOLECULES, V10, P2626, DOI 10.1021/bm900551c
   Krishnamoorthy G, 2013, J BIOMAT SCI-POLYM E, V24, P344, DOI 10.1080/09205063.2012.690280
   Lai V, 2012, J BIOMED ENG, V134, P11001
   Lee HJ, 2006, BIOMATERIALS, V27, P5268, DOI 10.1016/j.biomaterials.2006.06.001
   Lee W, 2009, BIOMATERIALS, V30, P1587, DOI 10.1016/j.biomaterials.2008.12.009
   Legant WR, 2009, P NATL ACAD SCI USA, V106, P10097, DOI 10.1073/pnas.0900174106
   Leung BM, 2010, TISSUE ENG PT A, V16, P3207, DOI [10.1089/ten.tea.2009.0746, 10.1089/ten.TEA.2009.0746]
   Li JS, 2008, J BIOMED MATER RES B, V86B, P381, DOI 10.1002/jbm.b.31031
   Liao E, 2007, TISSUE ENG, V13, P2007
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Liu DC, 2001, ASIAN AUSTRAL J ANIM, V14, P1638, DOI 10.5713/ajas.2001.1638
   Liu SQ, 2010, BIOMATERIALS, V31, P7298, DOI 10.1016/j.biomaterials.2010.06.001
   Liu T, 2012, J BIOMED MATER RES, V95, P276
   Love SA, 2012, ANNU REV ANAL CHEM, V5, P181, DOI 10.1146/annurev-anchem-062011-143134
   Lu SH, 2012, J TISSUE ENG REGEN M, V6, P786, DOI 10.1002/term.484
   Lund AW, 2008, J BIOMED MATER RES B, V87B, P213, DOI 10.1002/jbm.b.31098
   Lv Q, 2008, J BIOMED MATER RES A, V84A, P198, DOI 10.1002/jbm.a.31366
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Madhavan K, 2011, J BIOMED MATER RES A, V97A, P16, DOI 10.1002/jbm.a.33006
   Madhavan K, 2010, ACTA BIOMATER, V6, P1413, DOI 10.1016/j.actbio.2009.09.028
   Marelli B, 2011, BIOMATERIALS, V32, P8915, DOI 10.1016/j.biomaterials.2011.08.016
   Martin-Martin B, 2011, EUR J CELL BIOL, V90, P26, DOI 10.1016/j.ejcb.2010.09.008
   Matmaroh K, 2011, FOOD CHEM, V129, P1179, DOI 10.1016/j.foodchem.2011.05.099
   Matsunaga YT, 2011, ADV MATER, V23, pH90, DOI 10.1002/adma.201004375
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   McClure M, 2011, J VISUAL EXP EXP, P4
   McGuigan A, 2008, PLOS ONE, P3
   McGuigan AP, 2006, NAT PROTOC, V1, P2963, DOI 10.1038/nprot.2006.443
   McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103
   Mekhail M, 2010, J BIOMAT SCI-POLYM E, p[22, 2241]
   Moon S, 2010, TISSUE ENG PART C-ME, V16, P157, DOI [10.1089/ten.tec.2009.0179, 10.1089/ten.TEC.2009.0179]
   Morimoto Y, 2013, ADV HEALTHC MATER, V2, P261, DOI 10.1002/adhm.201200189
   Mu CD, 2013, J BIOMED MATER RES A, V101, P385, DOI 10.1002/jbm.a.34338
   Mu Z, 2013, LAB CHIP, V13, P1612
   Nagai N, 2008, J BIOMATER APPL, V23, P275, DOI 10.1177/0885328208092109
   Nakaji-Hirabayashi T, 2012, BIOCONJUGATE CHEM, V23, P212, DOI 10.1021/bc200481v
   Nalinanon S, 2007, FOOD CHEM, V104, P593, DOI 10.1016/j.foodchem.2006.12.035
   Nam K, 2008, MACROMOL BIOSCI, V8, P32, DOI 10.1002/mabi.200700206
   Nazhat SN, 2007, BIOMACROMOLECULES, V8, P543, DOI 10.1021/bm060715f
   Ng C, 2006, ANN BIOMED ENG, P34
   NG C. P., 2003, AM J PHYSIOL-HEART C, V284, P1771
   Nguyen TD, 2009, TISSUE ENG PT A, V15, P957, DOI 10.1089/ten.tea.2007.0384
   Nirmalanandhan VS, 2009, TISSUE ENG PT A, V15, P2103, DOI 10.1089/ten.tea.2008.0335
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]
   Paten JA, 2013, BIOMATERIALS, V34, P2577, DOI 10.1016/j.biomaterials.2012.12.028
   Perka C, 2000, CLIN EXP RHEUMATOL, V18, P13
   Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Powell HM, 2009, TISSUE ENG PT A, V15, P2177, DOI 10.1089/ten.tea.2008.0473
   RAMACHANDRAN GN, 1956, NATURE, V177, P710, DOI 10.1038/177710b0
   RAMACHANDRAN GN, 1954, NATURE, V174, P269, DOI 10.1038/174269c0
   Rao RR, 2013, J BIOMED MATER RES A, V101, P1531, DOI 10.1002/jbm.a.34611
   Raub CB, 2007, BIOPHYS J, V92, P2212, DOI 10.1529/biophysj.106.097998
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   ROSENBLATT J, 1994, BIOMATERIALS, V15, P985, DOI 10.1016/0142-9612(94)90079-5
   Rowe S, 2009, J BIOMECHANICAL ENG, V131
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Rowe SL, 2006, BIOMACROMOLECULES, V7, P2942, DOI 10.1021/bm0602233
   Saeidi N, 2012, BIOMATERIALS, V33, P7366, DOI 10.1016/j.biomaterials.2012.06.041
   Satyam A, 2012, J TISSUE ENG REGEN M
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Serpooshan V, 2011, J BIOMED MATER RES A, V96A, P609, DOI 10.1002/jbm.a.33008
   Shaikh FM, 2008, CELLS TISSUES ORGANS, V188, P333, DOI 10.1159/000139772
   SIMKOVIC D, 1959, EXP CELL RES, V17, P573, DOI 10.1016/0014-4827(59)90090-4
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Soares ALF, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003870
   Solorio L, 2010, J TISSUE ENG REGEN M, V4, P514, DOI 10.1002/term.267
   Somers P, 2008, J HEART VALVE DIS, V17, P682
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Stahl PJ, 2010, BIOMACROMOLECULES, V11, P2336, DOI 10.1021/bm100465q
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   Sundararaghavan HG, 2009, BIOTECHNOL BIOENG, V102, P632, DOI 10.1002/bit.22074
   Suri S, 2010, TISSUE ENG PT A, V16, P1703, DOI 10.1089/ten.tea.2009.0381
   Tang MD, 2004, ADV MATER, V16, P1345, DOI 10.1002/adma.200400766
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Tonelli FMP, 2012, INT J NANOMED, V7, P4511, DOI 10.2147/IJN.S33612
   TORBET J, 1984, BIOCHEM J, V219, P1057, DOI 10.1042/bj2191057
   Tosun Z, 2010, J NEURAL ENG, V7, P1
   Tovell VE, 2012, INVEST OPHTH VIS SCI, V53, P4682, DOI 10.1167/iovs.11-8577
   Townley WA, 2008, J HAND SURG-AM, V33A, P1608, DOI 10.1016/j.jhsa.2008.06.013
   Usha R, 2000, J APPL POLYM SCI, V75, P1577
   Vader D, 2009, PLOS ONE, V4, P35902
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Voge C, 2012, J BIOMED MATER RES, V101, P231
   Voge CM, 2008, J BIOMED MATER RES A, V86A, P269, DOI 10.1002/jbm.a.32029
   Walters VI, 2012, CONNECT TISSUE RES, V53, P255, DOI 10.3109/03008207.2011.634532
   Walton RS, 2010, J MATER SCI-MATER M, V21, P451, DOI 10.1007/s10856-009-3910-2
   Wang LM, 2013, CELLS TISSUES ORGANS, V197, P333, DOI 10.1159/000348359
   Wang LM, 2011, ACTA BIOMATER, V7, P2410, DOI 10.1016/j.actbio.2011.02.029
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Wen F, 2008, J BIOMED MATER RES B, V87B, P154, DOI [10.1002/jbm.b.31086, 10.1002/jbm.b.31080]
   White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016
   Wilson CG, 2009, BIOMATERIALS, V30, P5639, DOI 10.1016/j.biomaterials.2009.07.011
   WOODLEY DT, 1991, J INVEST DERMATOL, V97, P580, DOI 10.1111/1523-1747.ep12481920
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
   Wu XM, 2007, J BIOMED MATER RES A, V81A, P59, DOI 10.1002/jbm.a.31003
   Wyckoff R W, 1935, Science, V82, P175, DOI 10.1126/science.82.2121.175
   Xu B., 2011, INT J BIOMATER, P12, DOI [10.1155/2011/172389, DOI 10.1155/2011/172389]
   Xu T, 2013, BIOFABRICATION, V5, P1
   Xu W, 2011, ANN OTO RHINOL LARYN, V120, P123, DOI 10.1177/000348941112000209
   Yahyouche A, 2011, ACTA BIOMATER, V7, P278, DOI 10.1016/j.actbio.2010.08.005
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Yin AL, 2013, J BIOMED MATER RES A, V101, P1292, DOI 10.1002/jbm.a.34434
   Zhang XM, 2012, J BIOMED MATER RES A, V100A, P2960, DOI 10.1002/jbm.a.34243
   Zheng WF, 2010, ADV ENG MATER, V12, pB451, DOI 10.1002/adem.200980087
   Zhou JA, 2010, INT J BIOL MACROMOL, V47, P514, DOI 10.1016/j.ijbiomac.2010.07.010
   Zhou WD, 2013, J BIOMAT SCI-POLYM E, V24, P301, DOI 10.1080/09205063.2012.690277
NR 231
TC 76
Z9 77
U1 12
U2 204
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1488
EP 1501
DI 10.1016/j.actbio.2013.08.038
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700002
PM 24012608
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Brown, AC
   Barker, TH
AF Brown, Ashley C.
   Barker, Thomas H.
TI Fibrin-based biomaterials: Modulation of macroscopic properties through
   rational design at the molecular level
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Fibrin; Biomaterial design; Fibrin glue; Wound repair; Tissue
   engineering
ID MESENCHYMAL STEM-CELLS; KNOB-HOLE INTERACTIONS; ALPHA-C-DOMAINS;
   POLY(ETHYLENE GLYCOL) HYDROGELS; HEPARIN-CONJUGATED FIBRIN; ANGIOGENESIS
   IN-VITRO; LINKED GAMMA-CHAINS; B-B INTERACTIONS; MECHANICAL-PROPERTIES;
   CLOT STRUCTURE
AB Fibrinogen is one of the primary components of the coagulation cascade and rapidly forms an insoluble matrix following tissue injury. In addition to its important role in hemostasis, fibrin acts as a scaffold for tissue repair and provides important cues for directing cell phenotype following injury. Because of these properties and the ease of polymerization of the material, fibrin has been widely utilized as a biomaterial for over a century. Modifying the macroscopic properties of fibrin, such as elasticity and porosity, has been somewhat elusive until recently, yet with a molecular-level rational design approach it can now be somewhat easily modified through alterations of molecular interactions key to the protein's polymerization process. This review outlines the biochemistry of fibrin and discusses methods for modification of molecular interactions and their application to fibrin based biomaterials. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Brown, Ashley C.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   [Brown, Ashley C.; Barker, Thomas H.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Brown, Ashley C.; Barker, Thomas H.] Emory Univ, Atlanta, GA 30332 USA.
   [Barker, Thomas H.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Barker, TH (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
EM thomas.barker@bme.gatech.edu
FU NIBIB NIH HHS [R21 EB013743, R01 EB011566]
CR Ahmann KA, 2010, TISSUE ENG PT A, V16, P3261, DOI 10.1089/ten.TEA.2009.0708
   Ahmed TAE, 2007, TISSUE ENG, V13, P1469, DOI 10.1089/ten.2006.0354
   Akpalo E, 2011, ACTA BIOMATER, V7, P2418, DOI 10.1016/j.actbio.2011.03.002
   Alsberg E, 2006, TISSUE ENG, V12, P3247, DOI 10.1089/ten.2006.12.3247
   Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Averett RD, 2012, BIOPHYS J, V103, P1537, DOI 10.1016/j.bpj.2012.08.038
   Bachli EB, 2003, J THROMB HAEMOST, V1, P1935, DOI 10.1046/j.1538-7836.2003.00363.x
   Bagoly Z, 2012, THROMB RES, V129, P382, DOI 10.1016/j.thromres.2011.11.040
   BALE MD, 1988, THROMB RES, V52, P565, DOI 10.1016/0049-3848(88)90129-6
   BARADET TC, 1995, BIOPHYS J, V68, P1551, DOI 10.1016/S0006-3495(95)80327-9
   Barker TH, 2001, J BIOMED MATER RES, V56, P529, DOI 10.1002/1097-4636(20010915)56:4<529::AID-JBM1124>3.0.CO;2-2
   Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072
   Ben-David D, 2013, BIOMATERIALS, V34, P2902, DOI 10.1016/j.biomaterials.2013.01.035
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bergel S., 1909, DTSCH MED WOCHENSCHR, V35
   Bielecki T, 2012, CURR PHARM BIOTECHNO, V13, P1121, DOI 10.2174/138920112800624292
   Bootle-Wilbraham C. A., 2001, Angiogenesis, V4, P269
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Burton RA, 2007, BIOCHEMISTRY-US, V46, P8550, DOI 10.1021/bi700606v
   Carlisle CR, 2009, BIOMATERIALS, V30, P1205, DOI 10.1016/j.biomaterials.2008.11.006
   CARR ME, 1995, BLOOD COAGUL FIBRIN, V6, P567, DOI 10.1097/00001721-199509000-00011
   CARR ME, 1986, BIOCHEM J, V239, P513, DOI 10.1042/bj2390513
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   Chekanov VS, 2003, VASC MED, V8, P157, DOI 10.1191/1358863x03vm491oa
   Chen ZW, 2011, J MICROENCAPSUL, V28, P344, DOI 10.3109/02652048.2011.569764
   Chernysh IN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00879
   Chung E, 2013, INT J NANOMED, V8, P325, DOI 10.2147/IJN.S36711
   Chung W, 2009, AM J SURG, V197, P604, DOI 10.1016/j.amjsurg.2008.12.013
   COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034
   Collen A, 2000, CANCER RES, V60, P6196
   Collet JP, 2005, BLOOD, V106, P3824, DOI 10.1182/blood-2005-05-2150
   Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354
   Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392
   Cronkite EP, 1944, J AMER MED ASSOC, V124, P976, DOI 10.1001/jama.1944.02850140022006
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   Currie LJ, 2001, PLAST RECONSTR SURG, V108, P1713, DOI 10.1097/00006534-200111000-00045
   Cushman M, 2003, BLOOD, V101, P1243, DOI 10.1182/blood-2002-05-1416
   Davis HE, 2011, ACTA BIOMATER, V7, P691, DOI 10.1016/j.actbio.2010.09.007
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Doolittle RF, 2006, BIOCHEMISTRY-US, V45, P2657, DOI 10.1021/bi0524767
   Drinnan CT, 2010, J CONTROL RELEASE, V147, P180, DOI 10.1016/j.jconrel.2010.03.026
   Duong H, 2009, TISSUE ENG PT A, V15, P1865, DOI 10.1089/ten.tea.2008.0319
   Elvin CM, 2010, J BIOMED MATER RES A, V93A, P687, DOI 10.1002/jbm.a.32572
   Elvin CM, 2009, BIOMATERIALS, V30, P2059, DOI 10.1016/j.biomaterials.2008.12.059
   ERICKSON HP, 1983, ANN NY ACAD SCI, V408, P146, DOI 10.1111/j.1749-6632.1983.tb23242.x
   Everse SJ, 1998, BIOCHEMISTRY-US, V37, P8637, DOI 10.1021/bi9804129
   EVERSE SJ, 1995, PROTEIN SCI, V4, P1013
   Falvo MR, 2010, BIOPHYS CHEM, V152, P15, DOI 10.1016/j.bpc.2010.08.009
   Feng XD, 1999, J INVEST DERMATOL, V113, P913, DOI 10.1046/j.1523-1747.1999.00786.x
   Feng Xiaodong, 2013, Int J Cell Biol, V2013, P231279, DOI 10.1155/2013/231279
   Ferguson J, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P225, DOI 10.1007/978-3-7091-0286-2_15
   Ferris D, 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/691605
   FERRY JD, 1947, J AM CHEM SOC, V69, P388, DOI 10.1021/ja01194a066
   Fezza JP, 2002, PLAST RECONSTR SURG, V110, P658, DOI 10.1097/00006534-200208000-00044
   Fogelson AL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051922
   Fortelny RH, 2008, HERNIA, V12, P499, DOI 10.1007/s10029-008-0365-1
   Frisman I, 2011, BIOMATERIALS, V32, P7839, DOI 10.1016/j.biomaterials.2011.06.078
   Frisman I, 2010, J MATER SCI-MATER M, V21, P73, DOI 10.1007/s10856-009-3848-4
   FURLAN M, 1976, THROMB HAEMOSTASIS, V36, P582
   GABRIEL DA, 1992, J BIOL CHEM, V267, P24259
   Gaffney PJ, 2001, ANN NY ACAD SCI, V936, P594
   Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487
   Geer CB, 2007, J THROMB HAEMOST, V5, P2344, DOI 10.1111/j.1538-7836.2007.02774.x
   Gersh KC, 2010, J THROMB HAEMOST, V8, P2826, DOI 10.1111/j.1538-7836.2010.04118.x
   GERTH C, 1974, BIOPHYS CHEM, V2, P208, DOI 10.1016/0301-4622(74)80046-3
   Gorodetsky R, 1998, J LAB CLIN MED, V131, P269, DOI 10.1016/S0022-2143(98)90100-7
   GRAY AJ, 1990, J CELL SCI, V96, P271
   GREENBERG CS, 1985, BLOOD, V66, P466
   GREENBERG CS, 1982, J BIOL CHEM, V257, P6096
   Gross TJ, 1997, THROMB HAEMOSTASIS, V77, P894
   Gugerell A, 2012, J BIOMED MATER RES A, V100A, P1239, DOI 10.1002/jbm.a.34007
   Hanson AJ, 2002, J BIOMED MATER RES, V61, P474, DOI 10.1002/jbm.10196
   He M, 2013, J PLAST SURG HAND SU
   Helms CC, 2012, BIOPHYS J, V102, P168, DOI 10.1016/j.bpj.2011.11.4016
   HENSCHEN A, 1983, ANN NY ACAD SCI, V408, P28, DOI 10.1111/j.1749-6632.1983.tb23232.x
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Houser JR, 2010, BIOPHYS J, V99, P3038, DOI 10.1016/j.bpj.2010.08.060
   Huang NF, 2009, REGEN MED, V4, P527, DOI [10.2217/rme.09.32, 10.2217/RME.09.32]
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146
   Jiang B, 2013, TISSUE ENG PT A, V19, P224, DOI 10.1089/ten.tea.2012.0120
   Jing P, 2008, BIOMACROMOLECULES, V9, P2438, DOI 10.1021/bm800459v
   Kang H, 2009, J PHYS CHEM B, V113, P3799, DOI 10.1021/jp807749f
   Karp JM, 2004, J BIOMED MATER RES A, V71A, P162, DOI 10.1002/jbm.a.30147
   KIM JP, 1992, J CELL PHYSIOL, V151, P443, DOI 10.1002/jcp.1041510303
   Kong SW, 2011, BONE, V48, P298, DOI 10.1016/j.bone.2010.09.029
   Kubo M, 2001, J INVEST DERMATOL, V117, P1369, DOI 10.1046/j.0022-202x.2001.01551.x
   Kulltarni MM, 2011, MOL PHARMACEUT, V8, P439, DOI 10.1021/mp100295z
   KUNITADA S, 1992, BLOOD, V79, P1420
   Kupcsik L, 2009, TISSUE ENG PT A, V15, P2309, DOI 10.1089/ten.tea.2008.0400
   Lai VK, 2012, ACTA BIOMATER, V8, P4031, DOI 10.1016/j.actbio.2012.07.010
   LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085
   LAUDANO AP, 1980, BIOCHEMISTRY-US, V19, P1013, DOI 10.1021/bi00546a028
   LAUDANO AP, 1981, SCIENCE, V212, P457, DOI 10.1126/science.7209542
   LAUDANO AP, 1983, ANN NY ACAD SCI, V408, P315, DOI 10.1111/j.1749-6632.1983.tb23254.x
   Lawrie AS, 1998, J CLIN PATHOL, V51, P462, DOI 10.1136/jcp.51.6.462
   Le Guehennec L, 2004, EUROPEAN CELLS MAT, V8, P1, DOI DOI 10.22203/ECM.V008A01
   Le Nihouannen D, 2006, BIOMATERIALS, V27, P2716, DOI 10.1016/j.biomaterials.2005.11.038
   Lee CR, 2005, TISSUE ENG, V11, P1562, DOI 10.1089/ten.2005.11.1562
   Lesman A, 2011, BIOMATERIALS, V32, P7856, DOI 10.1016/j.biomaterials.2011.07.003
   LEWIS SD, 1985, J BIOL CHEM, V260, P192
   Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200
   Litvinov RI, 2005, BLOOD, V106, P2944, DOI 10.1182/blood-2005-05-2039
   Litvinov RI, 2007, BIOCHEMISTRY-US, V46, P9133, DOI 10.1021/bi700944j
   Litvinov RI, 2007, BLOOD, V109, P130, DOI 10.1182/blood-2006-07-033910
   Liu W, 2010, J THROMB HAEMOST, V8, P1030, DOI 10.1111/j.1538-7836.2010.03745.x
   Lord ST, 2011, ARTERIOSCL THROM VAS, V31, P494, DOI 10.1161/ATVBAHA.110.213389
   Lorentz KM, 2011, BIOMATERIALS, V32, P430, DOI 10.1016/j.biomaterials.2010.08.109
   Lounes KC, 2002, BIOCHEMISTRY-US, V41, P5291, DOI 10.1021/bi011988s
   Marci M, 2000, Minerva Cardioangiol, V48, P97
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   Medved L, 2003, THROMB HAEMOSTASIS, V89, P409
   MOCKROS LF, 1974, BIOPHYS CHEM, V2, P164, DOI 10.1016/0301-4622(74)80037-2
   Morin KT, 2011, BIOMATERIALS, V32, P6111, DOI 10.1016/j.biomaterials.2011.05.018
   Morris TA, 2011, AM J RESP CRIT CARE, V184, P708, DOI 10.1164/rccm.201104-0624OC
   Mosesson MW, 2004, J THROMB HAEMOST, V2, P388, DOI 10.1111/j.1538-7933.2004.00613.x
   MOSESSON MW, 1993, BLOOD, V82, P1517
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Murciano JC, 2002, AM J PHYSIOL-LUNG C, V282, pL529, DOI 10.1152/ajplung.00112.2001
   NAIR CH, 1986, THROMB RES, V42, P809, DOI 10.1016/0049-3848(86)90117-9
   Naito M, 2000, THROMB RES, V98, P165, DOI 10.1016/S0049-3848(99)00202-9
   Namani R, 2009, J BIOMECH, V42, P2047, DOI 10.1016/j.jbiomech.2009.06.007
   Neidert MR, 2006, TISSUE ENG, V12, P891, DOI 10.1089/ten.2006.12.891
   NELB GW, 1976, BIOPHYS CHEM, V5, P377, DOI 10.1016/0301-4622(76)80050-6
   NELB GW, 1981, BIOPHYS CHEM, V13, P15, DOI 10.1016/0301-4622(81)80020-8
   Nurnberger S, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P237, DOI 10.1007/978-3-7091-0286-2_16
   NUSSENZWEIG V, 1961, ANN I PASTEUR PARIS, V100, P490
   Okumura N, 2007, J THROMB HAEMOST, V5, P2352, DOI 10.1111/j.1538-7836.2007.02793.x
   Pandi L, 2009, BIOCHEMISTRY-US, V48, P7201, DOI 10.1021/bi900647g
   Ping LF, 2011, BIOCHEMISTRY-US, V50, P9066, DOI 10.1021/bi201094v
   Potier E, 2010, J MATER SCI, V45, P2494, DOI 10.1007/s10853-010-4221-1
   Rahmany MB, 2013, BIOMATERIALS, V34, P2492, DOI 10.1016/j.biomaterials.2012.12.008
   Rao RR, 2012, ANGIOGENESIS, V15, P253, DOI 10.1007/s10456-012-9257-1
   RICHARDSON DL, 1976, BRIT J HAEMATOL, V32, P507, DOI 10.1111/j.1365-2141.1976.tb00953.x
   Ricles LM, 2011, INT J NANOMED, V6, P407, DOI 10.2147/IJN.S16354
   Riedel T, 2011, BLOOD, V117, P1700, DOI 10.1182/blood-2010-08-300301
   ROBERTS W W, 1973, Biorheology, V10, P29
   ROBSON SC, 1994, BRIT J HAEMATOL, V86, P322, DOI 10.1111/j.1365-2141.1994.tb04733.x
   ROSKA FJ, 1982, BIOPOLYMERS, V21, P1811, DOI 10.1002/bip.360210910
   ROSKA FJ, 1982, BIOPOLYMERS, V21, P1833, DOI 10.1002/bip.360210911
   ROSSER RW, 1977, BIOPHYS CHEM, V7, P153, DOI 10.1016/0301-4622(77)80008-2
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Rowe SL, 2006, BIOMACROMOLECULES, V7, P2942, DOI 10.1021/bm0602233
   Rowe SL, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128673
   Ruggiero R, 2008, Minerva Chir, V63, P249
   Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4
   Ryan EA, 1999, BIOPHYS J, V77, P2827, DOI 10.1016/S0006-3495(99)77114-6
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sander EA, 2011, ANN BIOMED ENG, V39, P714, DOI 10.1007/s10439-010-0192-2
   Sawamura Y, 1999, NEUROSURGERY, V44, P332, DOI 10.1097/00006123-199902000-00048
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Seetharaman S, 2011, ACTA BIOMATER, V7, P2787, DOI 10.1016/j.actbio.2011.04.003
   Seliktar D, 2005, ANN NY ACAD SCI, V1047, P386, DOI 10.1196/annals.1341.034
   SENIOR RM, 1986, J CLIN INVEST, V77, P1014, DOI 10.1172/JCI112353
   SHAINOFF JR, 1979, SCIENCE, V204, P200, DOI 10.1126/science.155308
   Shats EA, 1997, ATHEROSCLEROSIS, V129, P9, DOI 10.1016/S0021-9150(96)06003-0
   SIEBENLIST KR, 1994, J BIOL CHEM, V269, P28414
   Soon ASC, 2011, BIOMATERIALS, V32, P4406, DOI 10.1016/j.biomaterials.2011.02.050
   Soon ASC, 2010, BIOMATERIALS, V31, P1944, DOI 10.1016/j.biomaterials.2009.10.060
   Soon AS, 2013, ADV HLTH MAT
   Sperzel M, 2007, J THROMB HAEMOST, V5, P2113, DOI 10.1111/j.1538-7836.2007.02717.x
   Spicer PP, 2010, J CONTROL RELEASE, V148, P49, DOI 10.1016/j.jconrel.2010.06.025
   SPOTNITZ WD, 1995, THROMB HAEMOSTASIS, V74, P482
   Spotnitz WD, 2005, TISSUE ADHESIVES CLI, P77
   Spotnitz WD, 2008, TRANSFUSION, V48, P1502, DOI 10.1111/j.1537-2995.2008.01703.x
   Spotnitz WD, 2010, CLIN APPL THROMB-HEM, V16, P497, DOI 10.1177/1076029610363589
   Spotnitz WD, 2010, WORLD J SURG, V34, P632, DOI 10.1007/s00268-009-0252-7
   Stabenfeldt SE, 2012, BIOMATERIALS, V33, P535, DOI 10.1016/j.biomaterials.2011.09.079
   Stabenfeldt SE, 2010, BLOOD, V116, P1352, DOI 10.1182/blood-2009-11-251801
   Stabenfeldt SE, 2011, BIOTECHNOL BIOENG
   Standeven KF, 2007, BLOOD, V110, P902, DOI 10.1182/blood-2007-01-066837
   Syedain ZH, 2008, P NATL ACAD SCI USA, V105, P6537, DOI 10.1073/pnas.0711217105
   Syedain ZH, 2009, BIOMATERIALS, V30, P6695, DOI 10.1016/j.biomaterials.2009.08.039
   TAKEI A, 1995, IN VITRO CELL DEV-AN, V31, P467
   Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   THOMPSON DF, 1988, DRUG INTEL CLIN PHAR, V22, P946, DOI 10.1177/106002808802201203
   THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109
   Tidrick RT, 1944, SURGERY, V15, P90
   Vaiman M, 2006, ANN OTO RHINOL LARYN, V115, P483, DOI 10.1177/000348940611500701
   Van Lieshout M, 2006, TISSUE ENG, V12, P481, DOI 10.1089/ten.2006.12.481
   VEKLICH YI, 1993, J BIOL CHEM, V268, P13577
   Vinatier C, 2009, J BIOMED MATER RES A, V89A, P176, DOI 10.1002/jbm.a.31988
   Voge CM, 2013, J BIOMED MATER RES A, V101, P231, DOI 10.1002/jbm.a.34310
   Wang H, 2006, MATRIX BIOL, V25, P20, DOI 10.1016/j.matbio.2005.09.004
   Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x
   Weisel J. W., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P161, DOI 10.2174/187152508784871963
   Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639
   Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029
   Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X
   WEISEL JW, 1986, BIOPHYS J, V50, P1079, DOI 10.1016/S0006-3495(86)83552-4
   Weisel JW, 2004, J THROMB HAEMOST, V2, P1467, DOI 10.1111/j.1538-7836.2004.00873.x
   Weisel JW, 2001, ANN NY ACAD SCI, V936, P312
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Xu JH, 1998, J CELL BIOL, V140, P709, DOI 10.1083/jcb.140.3.709
   Xu T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015001
   Yang HS, 2010, TISSUE ENG PT A, V16, P2113, DOI [10.1089/ten.tea.2009.0673, 10.1089/ten.TEA.2009.0673]
   Yang HS, 2010, TISSUE ENG PT A, V16, P1225, DOI [10.1089/ten.tea.2009.0390, 10.1089/ten.TEA.2009.0390]
   Yao L, 2005, TISSUE ENG, V11, P991, DOI 10.1089/ten.2005.11.991
   Yucel EA, 2003, J DENT, V31, P569, DOI 10.1016/S0300-5712(03)00113-1
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhao HG, 2009, J MATER SCI-MATER M, V20, P135, DOI 10.1007/s10856-008-3543-x
NR 208
TC 61
Z9 61
U1 4
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1502
EP 1514
DI 10.1016/j.actbio.2013.09.008
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700003
PM 24056097
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ceccarelli, J
   Putnam, AJ
AF Ceccarelli, Jacob
   Putnam, Andrew J.
TI Sculpting the blank slate: How fibrin's support of vascularization can
   inspire biomaterial design
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Fibrin; Biomaterial; Extracellular matrix; Angiogenesis
ID HUMAN-ENDOTHELIAL CELLS; ENGINEERED PEG HYDROGELS; MESENCHYMAL
   STEM-CELLS; IN-VITRO; CAPILLARY MORPHOGENESIS; EXTRACELLULAR MATRICES;
   VE-CADHERIN; 3-DIMENSIONAL CELL; STROMAL CELLS; FACTOR XIIIA
AB Fibrin is the primary extracellular constituent of blood clots, and plays an important role as a provisional matrix during wound healing and tissue remodeling. Fibrin-based biomaterials have proven their utility as hemostatic therapies, scaffolds for tissue engineering, vehicles for controlled release, and platforms for culturing and studying cells in three dimensions. Nevertheless, fibrin presents a complex milieu of signals to embedded cells, many of which are not well understood. Synthetic extracellular matrices (ECMs) provide a blank slate that can ostensibly be populated with specific bioactive cues, including growth factors, growth factor binding motifs, adhesive peptides and peptide crosslinks susceptible to proteases, thereby enabling a degree of customization for specific applications. However, the continued evolution and improvement of synthetic ECMs requires parallel efforts to deconstruct native ECMs and decipher the cues they provide to constituent cells. The objective of this review is to reintroduce fibrin, a protein with a well-characterized structure and biochemistry, and its ability to support angiogenesis specifically. Although fibrin's structure function relationships have been studied for decades, opportunities to engineer new and improved synthetic hydrogels can be realized by further exploiting fibrin's inspiring design. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ceccarelli, Jacob; Putnam, Andrew J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Putnam, AJ (reprint author), Univ Michigan, Dept Biomed Engn, 2154 Lurie Biomed Engn Bldg,1101 Beal Ave, Ann Arbor, MI 48109 USA.
EM putnam@umich.edu
RI Putnam, Andrew/E-8643-2010
OI Putnam, Andrew/0000-0002-1262-4377
FU National Institutes of Health [R01-HL085339, R21-DE021537]
FX We gratefully acknowledge financial support from the National Institutes
   of Health (R01-HL085339 and R21-DE021537). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the NIH.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Bach TL, 1998, J BIOL CHEM, V273, P30719, DOI 10.1074/jbc.273.46.30719
   Barker TH, 2001, J BIOMED MATER RES, V56, P529, DOI 10.1002/1097-4636(20010915)56:4<529::AID-JBM1124>3.0.CO;2-2
   Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Brown AEX, 2009, SCIENCE, V325, P741, DOI 10.1126/science.1172484
   Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2
   BUNCE LA, 1992, J CLIN INVEST, V89, P842, DOI 10.1172/JCI115663
   Carrion B, 2010, BIOTECHNOL BIOENG, V107, P1020, DOI 10.1002/bit.22891
   Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842
   Ceccarelli J, 2012, CELL MOL BIOENG, V5, P463, DOI 10.1007/s12195-012-0242-y
   CHALUPOWICZ DG, 1995, J CELL BIOL, V130, P207, DOI 10.1083/jcb.130.1.207
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X
   CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Clark RAF, 1996, MOL CELLULAR BIOL WO
   Cummins PM, 2007, AM J PHYSIOL-HEART C, V292, pH28, DOI 10.1152/ajpheart.00304.2006
   DIAMOND SL, 1989, SCIENCE, V243, P1483, DOI 10.1126/science.2467379
   Dunn CJ, 1999, DRUGS, V58, P863, DOI 10.2165/00003495-199958050-00010
   Ehrbar M, 2007, BIOMACROMOLECULES, V8, P3000, DOI 10.1021/bm070228f
   FERRY JD, 1952, P NATL ACAD SCI USA, V38, P566, DOI 10.1073/pnas.38.7.566
   FERRY JD, 1947, J AM CHEM SOC, V69, P388, DOI 10.1021/ja01194a066
   Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741
   Gailit J, 1997, EXP CELL RES, V232, P118, DOI 10.1006/excr.1997.3512
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013
   Gjorevski N, 2010, INTEGR BIOL-UK, V2, P424, DOI 10.1039/c0ib00040j
   GORKUN OV, 1994, BIOCHEMISTRY-US, V33, P6986, DOI 10.1021/bi00188a031
   Grainger SJ, 2013, TISSUE ENG PT A, V19, P1209, DOI [10.1089/ten.tea.2012.0281, 10.1089/ten.TEA.2012.0281]
   Griffith CK, 2005, TISSUE ENG, V11, P257, DOI 10.1089/ten.2005.11.257
   Guthold M, 2007, CELL BIOCHEM BIOPHYS, V49, P165, DOI 10.1007/s12013-007-9001-4
   Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596
   HAJJAR KA, 1986, J BIOL CHEM, V261, P1656
   Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338
   Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7
   Jackson MR, 2001, AM J SURG, V182, P1
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Kachgal S, 2012, J CELL PHYSIOL, V227, P3546, DOI 10.1002/jcp.24056
   Kachgal S, 2011, ANGIOGENESIS, V14, P47, DOI 10.1007/s10456-010-9194-9
   Kim PD, 2009, BIOMATERIALS, V30, P3854, DOI 10.1016/j.biomaterials.2009.04.013
   Kniazeva E, 2012, INTEGR BIOL-UK, V4, P431, DOI 10.1039/c2ib00120a
   Korff T, 1999, J CELL SCI, V112, P3249
   Kotlarchyk MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020201
   Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085
   Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317
   Lord ST, 2007, CURR OPIN HEMATOL, V14, P236, DOI 10.1097/MOH.0b013e3280dce58c
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MARDER VJ, 1983, ANN NY ACAD SCI, V408, P397, DOI 10.1111/j.1749-6632.1983.tb23260.x
   Martinez J, 2001, ANN NY ACAD SCI, V936, P386
   Matsumoto T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001211
   Medved L, 2003, THROMB HAEMOSTASIS, V89, P409
   Miller JS, 2010, BIOMATERIALS, V31, P3736, DOI 10.1016/j.biomaterials.2010.01.058
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Morin KT, 2011, BIOMATERIALS, V32, P6111, DOI 10.1016/j.biomaterials.2011.05.018
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   MOSESSON MW, 1995, J STRUCT BIOL, V115, P88, DOI 10.1006/jsbi.1995.1033
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Moya ML, 2013, TISSUE ENG PART C-ME, V19, P730, DOI [10.1089/ten.tec.2012.0430, 10.1089/ten.TEC.2012.0430]
   Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1
   NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061
   NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119
   Odrljin TM, 1996, ARTERIOSCL THROM VAS, V16, P1544, DOI 10.1161/01.ATV.16.12.1544
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Pechik I, 2006, BIOCHEMISTRY-US, V45, P3588, DOI 10.1021/bi0525369
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Radosevich M, 1997, VOX SANG, V72, P133, DOI 10.1046/j.1423-0410.1997.7230133.x
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Rao RR, 2012, ANGIOGENESIS, V15, P253, DOI 10.1007/s10456-012-9257-1
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   Sander EA, 2011, ANN BIOMED ENG, V39, P714, DOI 10.1007/s10439-010-0192-2
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   SHEN LL, 1975, THROMB RES, V6, P255, DOI 10.1016/0049-3848(75)90073-0
   Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206
   Sokic S, 2012, TISSUE ENG PT A, V18, P2477, DOI [10.1089/ten.tea.2012.0173, 10.1089/ten.TEA.2012.0173]
   Soon ASC, 2011, BIOMATERIALS, V32, P4406, DOI 10.1016/j.biomaterials.2011.02.050
   Soon ASC, 2010, BIOMATERIALS, V31, P1944, DOI 10.1016/j.biomaterials.2009.10.060
   Spotnitz WD, 2010, WORLD J SURG, V34, P632, DOI 10.1007/s00268-009-0252-7
   Stabenfeldt SE, 2012, BIOMATERIALS, V33, P535, DOI 10.1016/j.biomaterials.2011.09.079
   Standeven KF, 2005, BLOOD REV, V19, P275, DOI 10.1016/j.blre.2005.01.003
   Sumpio BE, 1997, AM J PHYSIOL-CELL PH, V273, pC1441
   Trkov S, 2010, J TISSUE ENG REGEN M, V4, P205, DOI 10.1002/term.231
   VERNON RB, 1992, LAB INVEST, V66, P536
   WEISEL JW, 1987, P NATL ACAD SCI USA, V84, P8991, DOI 10.1073/pnas.84.24.8991
   Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382
   Yakovlev S, 2009, BIOCHEMISTRY-US, V48, P5171, DOI 10.1021/bi900487d
   Yang HS, 2010, TISSUE ENG PT A, V16, P1225, DOI [10.1089/ten.tea.2009.0390, 10.1089/ten.TEA.2009.0390]
   Yeon JH, 2012, LAB CHIP, V12, P2815, DOI [10.1039/c2lc40131b, 10.1039/C2LC40131B]
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang G, 2010, ACTA BIOMATER, V6, P3395, DOI 10.1016/j.actbio.2010.03.019
   Zisch AH, 2004, BIOMATERIALS, V25, P3245, DOI 10.1016/j.biomaterials.2003.10.015
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 104
TC 16
Z9 16
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1515
EP 1523
DI 10.1016/j.actbio.2013.07.043
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700004
PM 23933102
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wise, SG
   Yeo, GC
   Hiob, MA
   Rnjak-Kovacina, J
   Kaplan, DL
   Ng, MKC
   Weiss, AS
AF Wise, Steven G.
   Yeo, Giselle C.
   Hiob, Matti A.
   Rnjak-Kovacina, Jelena
   Kaplan, David L.
   Ng, Martin K. C.
   Weiss, Anthony S.
TI Tropoelastin: A versatile, bioactive assembly module
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Tropoelastin; Elastin; Structure; Elasticity; Biomaterials
ID RECOMBINANT HUMAN TROPOELASTIN; ELASTIN-LIKE POLYPEPTIDES; ENGINEERED
   BLOOD-VESSELS; CROSS-LINKING DOMAIN; SOLID-STATE; CUTIS-LAXA; STRUCTURAL
   DISORDER; HYDROPHOBIC DOMAINS; SECONDARY STRUCTURE; SELF-ASSOCIATION
AB Elastin provides structural integrity, biological cues and persistent elasticity to a range of important tissues, including the vasculature and lungs. Its critical importance to normal physiology makes it a desirable component of biomaterials that seek to repair or replace these tissues. The recent availability of large quantities of the highly purified elastin monomer, tropoelastin, has allowed for a thorough characterization of the mechanical and biological mechanisms underpinning the benefits of mature elastin. While tropoelastin is a flexible molecule, a combination of optical and structural analyses has defined key regions of the molecule that directly contribute to the elastomeric properties and control the cell interactions of the protein. Insights into the structure and behavior of tropoelastin have translated into increasingly sophisticated elastin-like biomaterials, evolving from classically manufactured hydrogels and fibers to new forms, stabilized in the absence of incorporated cross-linkers. Tropoelastin is also compatible with synthetic and natural co-polymers, expanding the applications of its potential use beyond traditional elastin-rich tissues and facilitating finer control of biomaterial properties and the design of next-generation tailored bioactive materials. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wise, Steven G.; Hiob, Matti A.; Ng, Martin K. C.] Heart Res Inst, Sydney, NSW 2042, Australia.
   [Wise, Steven G.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Wise, Steven G.; Yeo, Giselle C.; Hiob, Matti A.; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
   [Rnjak-Kovacina, Jelena; Kaplan, David L.] Tufts Univ, Sch Engn, Dept Biomed Engn, Medford, MA 02155 USA.
   [Ng, Martin K. C.] Royal Prince Alfred Hosp, Dept Cardiol, Camperdown, NSW 2050, Australia.
   [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.
   [Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
RP Weiss, AS (reprint author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
EM tony.weiss@sydney.edu.au
RI Wise, Steven/G-2630-2018
OI Wise, Steven/0000-0001-7964-819X; WEISS, ANTHONY/0000-0002-8106-4836;
   Yeo, Giselle/0000-0001-6071-8899
FU Australian Research Council; Australian Defense Health Foundation;
   National Health and Medical Research Council [APP1033079, APP1039072];
   National Institutes of Health [EB014283]; IPRS/IPA
FX We acknowledge funding from the Australian Research Council (A.S.W.),
   Australian Defense Health Foundation (A.S.W.), National Health and
   Medical Research Council (APP1033079 and APP1039072; A.S.W. and
   M.K.C.N.) and National Institutes of Health (EB014283; A.S.W and D.L.K).
   A.S.W. is the Scientific Founder of Elastagen Pty Ltd. G.C.Y. is
   supported by an IPRS/IPA PhD scholarship. The authors declare no
   conflict of interest in this work.
CR Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Almine JF, 2013, FASEB J
   Annabi N, 2013, BIOMATERIALS, V34, P5496, DOI 10.1016/j.biomaterials.2013.03.076
   Annabi N, 2011, BIOMATERIALS, V32, P1517, DOI 10.1016/j.biomaterials.2010.10.024
   Annabi N, 2010, BIOMATERIALS, V31, P1655, DOI 10.1016/j.biomaterials.2009.11.051
   Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108
   Bax DV, 2011, BIOMATERIALS, V32, P5100, DOI 10.1016/j.biomaterials.2011.03.079
   Bax DV, 2009, ACTA BIOMATER, V5, P3371, DOI 10.1016/j.actbio.2009.05.016
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   BLOOD CH, 1988, J CELL BIOL, V107, P1987, DOI 10.1083/jcb.107.5.1987
   Bochicchio B, 2008, CHIRALITY, V20, P985, DOI 10.1002/chir.20541
   Bochicchio B, 2011, CHIRALITY, V23, P694, DOI 10.1002/chir.20979
   Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200
   BROWN PL, 1992, BIOCHEM BIOPH RES CO, V186, P549, DOI 10.1016/S0006-291X(05)80843-5
   BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149
   BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778
   Rodriguez-Cabello JC, 2011, NANOMEDICINE-UK, V6, P111, DOI 10.2217/NNM.10.141
   CICILA G, 1985, BIOCHEMISTRY-US, V24, P3075, DOI 10.1021/bi00334a001
   Clarke AW, 2005, BIOCHEMISTRY-US, V44, P10271, DOI 10.1021/bi050530d
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Debelle L, 1998, EUR J BIOCHEM, V258, P533, DOI 10.1046/j.1432-1327.1998.2580533.x
   DEBELLE L, 1992, EUR BIOPHYS J BIOPHY, V21, P321
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Djajamuliadi J, 2009, MATRIX BIOL, V28, P92, DOI 10.1016/j.matbio.2008.12.001
   Dyksterhuis LB, 2007, MATRIX BIOL, V26, P125, DOI 10.1016/j.matbio.2006.10.002
   Dyksterhuis LB, 2010, BIOCHEM BIOPH RES CO, V396, P870, DOI 10.1016/j.bbrc.2010.05.013
   Dyksterhuis LB, 2009, ARCH BIOCHEM BIOPHYS, V487, P79, DOI 10.1016/j.abb.2009.06.001
   Gauvin R, 2012, WIRES NANOMED NANOBI, V4, P235, DOI 10.1002/wnan.171
   Giraud MN, 2007, TISSUE ENG, V13, P1825, DOI 10.1089/ten.2006.0110
   GOSLINE JM, 1975, BIOPOLYMERS, V14, P1811, DOI 10.1002/bip.1975.360140904
   Greisler HP, 1996, BIOMATERIALS, V17, P329, DOI 10.1016/0142-9612(96)85571-2
   Gronau G, 2012, BIOMATERIALS, V33, P8240, DOI 10.1016/j.biomaterials.2012.06.054
   Hahn CN, 1997, HUM MOL GENET, V6, P205, DOI 10.1093/hmg/6.2.205
   He D, 2007, MATRIX BIOL, V26, P524, DOI 10.1016/j.matbio.2007.05.005
   He D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046130
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   HINEK A, 1994, CELL ADHES COMMUN, V2, P185, DOI 10.3109/15419069409004436
   HOEVE CAJ, 1974, BIOPOLYMERS, V13, P677, DOI 10.1002/bip.1974.360130404
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   INDIK Z, 1990, ARCH BIOCHEM BIOPHYS, V280, P80, DOI 10.1016/0003-9861(90)90521-Y
   Jensen SA, 2000, J BIOL CHEM, V275, P28449, DOI 10.1074/jbc.M004265200
   KAGAN HM, 1982, METHOD ENZYMOL, V82, P637
   Kapadia MR, 2008, CIRCULATION, V117, P1873, DOI 10.1161/CIRCULATIONAHA.107.714170
   Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546
   Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200
   Kumashiro KK, 2008, BIOPOLYMERS, V89, P668, DOI 10.1002/bip.20984
   Kumashiro KK, 2006, J BIOL CHEM, V281, P23757, DOI 10.1074/jbc.M510833200
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9
   LYERLA JR, 1975, BIOCHEMISTRY-US, V14, P5175, DOI 10.1021/bi00694a024
   Maeda I, 2011, J PEPT SCI, V17, P735, DOI 10.1002/psc.1394
   MAMMI M, 1968, NATURE, V220, P371, DOI 10.1038/220371b0
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   Martino M, 2000, INT J BIOL MACROMOL, V27, P59, DOI 10.1016/S0141-8130(99)00118-X
   McCann JT, 2005, J MATER CHEM, V15, P735, DOI 10.1039/b415094e
   McKenna KA, 2012, ACTA BIOMATER, V8, P225, DOI 10.1016/j.actbio.2011.08.001
   Mecham RP, 1991, ANN N Y ACAD SCI, V624, P137
   Megarbane H, 2009, J INVEST DERMATOL, V129, P1650, DOI 10.1038/jid.2008.450
   Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173
   Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200
   Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9
   Mithieux SM, 2005, J STRUCT BIOL, V149, P282, DOI 10.1016/j.jsb.2004.11.005
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mithieux SM, 2009, BIOMATERIALS, V30, P431, DOI 10.1016/j.biomaterials.2008.10.018
   Miyagawa S, 2011, ANN THORAC SURG, V91, P320, DOI 10.1016/j.athoracsur.2010.09.080
   Muiznieks LD, 2003, ARCH BIOCHEM BIOPHYS, V410, P317, DOI 10.1016/S0003-9861(02)00719-1
   Muiznieks LD, 2007, BIOCHEMISTRY-US, V46, P8196, DOI 10.1021/bi700139k
   Muiznieks LD, 2010, J BIOL CHEM, V285, P39779, DOI 10.1074/jbc.M110.164467
   Muiznieks LD, 2010, BIOCHEM CELL BIOL, V88, P239, DOI [10.1139/o09-161, 10.1139/O09-161]
   Naumann C, 2009, BIOPOLYMERS, V91, P321, DOI 10.1002/bip.21133
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   OLSEN DR, 1988, J BIOL CHEM, V263, P6465
   Ostuni A, 2007, BIOPHYS J, V93, P3640, DOI 10.1529/biophysj.107.110809
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Pektok E, 2008, CIRCULATION, V118, P2563, DOI 10.1161/CIRCULATIONAHA.108.795732
   Pepe A, 2005, MATRIX BIOL, V24, P96, DOI 10.1016/j.matbio.2005.01.004
   Perry A, 2002, BIOPHYS J, V82, P1086, DOI 10.1016/S0006-3495(02)75468-4
   Pometun MS, 2004, J BIOL CHEM, V279, P7982, DOI 10.1074/jbc.M310948200
   Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008
   Rauscher S, 2012, ADV EXP MED BIOL, V725, P159, DOI 10.1007/978-1-4614-0659-4_10
   Rauscher S, 2010, BIOCHEM CELL BIOL, V88, P269, DOI [10.1139/O09-169, 10.1139/o09-169]
   Rnjak J, 2009, BIOMATERIALS, V30, P6469, DOI 10.1016/j.biomaterials.2009.08.017
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022
   Rodriguez-Cabello JC, 1999, MACROMOL CHEM PHYSIC, V200, P1831, DOI 10.1002/(SICI)1521-3935(19990801)200:8<1831::AID-MACP1831>3.0.CO;2-V
   RUCKER RB, 1973, BIOCHIM BIOPHYS ACTA, V317, P193, DOI 10.1016/0005-2795(73)90212-2
   Sato F, 2007, J MOL BIOL, V369, P841, DOI 10.1016/j.jmb.2007.03.060
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   SEPHEL GC, 1989, J INVEST DERMATOL, V93, P147, DOI 10.1111/1523-1747.ep12277389
   TAMBURRO AM, 1992, J BIOMOL STRUCT DYN, V10, P441, DOI 10.1080/07391102.1992.10508661
   Tamburro AM, 2005, PATHOL BIOL, V53, P383, DOI 10.1016/j.patbio.2004.12.014
   Tamburro AM, 2003, BIOCHEMISTRY-US, V42, P13347, DOI 10.1021/bi034837t
   Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i
   Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200
   Tu YD, 2010, MICRON, V41, P268, DOI 10.1016/j.micron.2009.11.003
   Venugopal J, 2005, TISSUE ENG, V11, P847, DOI 10.1089/ten.2005.11.847
   Villani V, 1999, ANN NY ACAD SCI, V879, P284, DOI 10.1111/j.1749-6632.1999.tb10433.x
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Wilson BD, 2011, ANN BIOMED ENG, V39, P337, DOI 10.1007/s10439-010-0142-z
   Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Wise SG, 2009, ADV PROTEIN CHEM STR, V78, P1, DOI [10.1016/S1876-1623(08)78001-5, 10.1016/S1876-1623(09)78001-5]
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Yeo GC, 2012, P NATL ACAD SCI USA, V109, P2878, DOI 10.1073/pnas.1111615108
   Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003
   Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009
NR 112
TC 33
Z9 33
U1 1
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1532
EP 1541
DI 10.1016/j.actbio.2013.08.003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700006
PM 23938199
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Jiang, T
   Deng, M
   James, R
   Nair, LS
   Laurencin, CT
AF Jiang, Tao
   Deng, Meng
   James, Roshan
   Nair, Lakshmi S.
   Laurencin, Cato T.
TI Micro- and nanofabrication of chitosan structures for regenerative
   engineering
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Chitosan; Regenerative engineering; Microfabrication; Nanofabrication
ID INJECTABLE THERMOGELLING CHITOSAN; SINTERED MICROSPHERE SCAFFOLDS;
   MESENCHYMAL STEM-CELLS; BONE REGENERATION; SOFT LITHOGRAPHY;
   PHOTOCROSSLINKABLE CHITOSAN; NANOFIBROUS SCAFFOLDS; SUBCHONDRAL BONE;
   BIOMEDICAL APPLICATIONS; ANTIBACTERIAL ACTIVITY
AB Repair and regeneration of human tissues and organs using biomaterials, cells and/or growth factors is the ultimate goal of tissue engineers. One of the grand challenges in this field is to closely mimic the structures and properties of native tissues. Regenerative engineering the convergence of tissue engineering with advanced materials science, stem cell science, and developmental biology represents the next valuable tool to overcome the challenges. This article reviews the recent progress in developing advanced chitosan structures using various fabrication techniques. These chitosan structures, together with stem cells and functional biomolecules, may provide a robust platform to gain insight into cell-biomaterial interactions and may function as excellent artificial extracellular matrices to regenerate complex human tissues and biological systems. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Jiang, Tao] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA.
   [Jiang, Tao; Deng, Meng; James, Roshan; Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, Farmington, CT 06030 USA.
   [Jiang, Tao; Deng, Meng; James, Roshan; Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Raymond & Beverly Sackler Ctr Biol Phys & Engn Sc, Farmington, CT 06030 USA.
   [Deng, Meng; James, Roshan; Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.
   [Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Dept Chem Mat & Biomol Engn, Storrs, CT 06269 USA.
RP Laurencin, CT (reprint author), Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, 263 Farmington Ave, Farmington, CT 06030 USA.
EM laurencin@uchc.edu
FU National Science Foundation [INT0115595]; Presidential Award for
   Excellence in Science, Engineering, and Math Mentoring [NSF DUE0834313]
FX The authors acknowledge the funding from the National Science Foundation
   grant INT0115595 and the Presidential Award for Excellence in Science,
   Engineering, and Math Mentoring (NSF DUE0834313). C.T.L. was previously
   the recipient of a Presidential Faculty Fellow Award from the National
   Science Foundation.
CR Abdel-Fattah WI, 2007, ACTA BIOMATER, V3, P503, DOI 10.1016/j.actbio.2006.12.004
   Agarwal P, 2012, J MATER SCI, V47, P4262, DOI 10.1007/s10853-012-6276-7
   Allcock HR, 2006, POLYPHOSPHAZENES
   Almodovar J, 2013, BIOTECHNOL BIOENG, V110, P609, DOI 10.1002/bit.24710
   Almodovar J, 2011, MACROMOL BIOSCI, V11, P72, DOI 10.1002/mabi.201000261
   Almodovar J, 2010, BIOMACROMOLECULES, V11, P2629, DOI 10.1021/bm1005799
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Anton F., 1934, U.S. Patent, Patent No. [1,975,504, 1975504]
   Antunes JC, 2011, BIOMACROMOLECULES, V12, P4183, DOI 10.1021/bm2008235
   Belitsky JM, 2007, CHEM BIOL, V14, P1140, DOI 10.1016/j.chembiol.2007.09.007
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bhattacharyya S, 2009, J BIOMED NANOTECHNOL, V5, P69, DOI 10.1166/jbn.2009.032
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Bhattarai N, 2009, ADV MATER, V21, P2792, DOI 10.1002/adma.200802513
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Boddohi S, 2008, BIOMACROMOLECULES, V9, P2021, DOI 10.1021/bm8002573
   Boddohi S, 2010, COLLOID SURFACE B, V77, P60, DOI 10.1016/j.colsurfb.2010.01.006
   Boddohi S, 2009, BIOMACROMOLECULES, V10, P1402, DOI 10.1021/bm801513e
   Borden M, 2004, J BONE JOINT SURG BR, V86B, P1200, DOI 10.1302/0301-620X.86B8.14267
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   Borden M, 2002, BIOMATERIALS, V23, P551, DOI 10.1016/S0142-9612(01)00137-5
   Brown JL, 2010, J BIOMED MATER RES A, V95A, P1150, DOI 10.1002/jbm.a.32934
   Brugnerotto J, 2001, POLYMER, V42, P9921, DOI 10.1016/S0032-3861(01)00557-2
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen F, 2008, J BIOMAT SCI-POLYM E, V19, P677, DOI 10.1163/156856208784089661
   Chen JP, 2008, COLLOID SURFACE A, V313, P183, DOI 10.1016/j.colsurfa.2007.04.129
   Chen ZG, 2008, CARBOHYD POLYM, V72, P410, DOI 10.1016/j.carbpol.2007.09.018
   Chen ZG, 2007, MATER LETT, V61, P3490, DOI 10.1016/j.matlet.2006.11.104
   Chevrier A, 2007, OSTEOARTHR CARTILAGE, V15, P316, DOI 10.1016/j.joca.2006.08.007
   Cho JH, 2004, BIOMATERIALS, V25, P5743, DOI 10.1016/j.biomaterials.2004.01.051
   Cho Y, 2010, J EXP BIOL, V213, P1513, DOI 10.1242/jeb.035162
   Cooper A, 2011, PHYS CHEM CHEM PHYS, V13, P9969, DOI 10.1039/c0cp02909b
   Cooper A, 2010, J MATER CHEM, V20, P8904, DOI 10.1039/c0jm01841d
   Costa RR, 2011, SMALL, V7, P2640, DOI 10.1002/smll.201100875
   Dautzenberg H., 1994, POLYELECTROLYTES FOR
   Deng M, 2012, IEEE T NANOBIOSCI, V11, P3, DOI 10.1109/TNB.2011.2179554
   Deng M, 2011, ADV FUNCT MATER, V21, P2641, DOI 10.1002/adfm.201100275
   Du J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/12/125707
   Duan B, 2004, J BIOMAT SCI-POLYM E, V15, P797, DOI 10.1163/156856204774196171
   Duan B, 2006, EUR POLYM J, V42, P2013, DOI 10.1016/j.eurpolymj.2006.04.021
   Eser ECCI, 1998, NEUROL RES, V20, P648
   Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053
   Fernandez JG, 2009, SMALL, V5, P614, DOI 10.1002/smll.200800907
   Foley PL, 2013, BIOMATERIALS, V34, P2539, DOI 10.1016/j.biomaterials.2012.12.035
   Francis SJ, 2000, BIOMATERIALS, V21, P2589, DOI DOI 10.1016/S0142-9612(00)00126-5
   Frohbergh ME, 2012, BIOMATERIALS, V33, P9167, DOI 10.1016/j.biomaterials.2012.09.009
   Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044
   Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917
   Gerentes P, 2002, BIOMATERIALS, V23, P1295, DOI 10.1016/S0142-9612(01)00247-2
   Goh J, 2003, TISSUE ENG S1, V9, P31
   Groth T, 2004, ANGEW CHEM INT EDIT, V43, P926, DOI 10.1002/anie.200301708
   Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015
   Hoemann CD, 2010, AM J SPORT MED, V38, P1845, DOI 10.1177/0363546510369547
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Ignatova M, 2007, EUR POLYM J, V43, P1112, DOI 10.1016/j.eurpolymj.2007.01.012
   Ignatova M, 2006, CARBOHYD RES, V341, P2098, DOI 10.1016/j.carres.2006.05.006
   Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jacobs V, 2011, CURR NANOSCI, V7, P396, DOI 10.2174/157341311795542570
   James R, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025011
   James R, 2011, FRONT MATER SCI, V5, P342, DOI 10.1007/s11706-011-0151-3
   James R, 2011, METHODS MOL BIOL, V726, P243, DOI 10.1007/978-1-61779-052-2_16
   Jeong SI, 2010, TISSUE ENG PART A, V17, P59
   Jia YT, 2007, CARBOHYD POLYM, V67, P403, DOI 10.1016/j.carbpol.2006.06.010
   Jiang T, 2005, MATER RES SOC SYMP P, V845, P187
   Jiang T, 2012, CHITOSAN BASED SYSTE, P393
   Jiang T, 2008, THESIS U VIRGINIA
   Jiang T, 2008, CURR TOP MED CHEM, V8, P354
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Jiang T, 2010, ACTA BIOMATER, V6, P3457, DOI 10.1016/j.actbio.2010.03.023
   Jiang T, 2010, J BIOMED MATER RES A, V93A, P1193, DOI 10.1002/jbm.a.32615
   Jung KH, 2007, J APPL POLYM SCI, V105, P2816, DOI 10.1002/app.25594
   Karp JM, 2006, BIOMATERIALS, V27, P4755, DOI 10.1016/j.biomaterials.2006.04.028
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Koev ST, 2010, LAB CHIP, V10, P3026, DOI [10.1039/c0lc00047g, 10.1039/c01c00047g]
   Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012
   Kosaka T, 1996, J VET MED SCI, V58, P963, DOI 10.1292/jvms.58.10_963
   Kumar G, 2003, LANGMUIR, V19, P10550, DOI 10.1021/la035309l
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Kumbar SG, 2008, BIOMEDICAL NANOSTRUCTURES, P261
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Kumbar SG, 2007, J BIOMED MATER RES B, V81B, P91, DOI 10.1002/jbm.b.30641
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Laurencin C.T., 2012, SCI TRANSL MED, V4, P160
   Li L, 2006, CARBOHYD RES, V341, P374, DOI 10.1016/j.carres.2005.11.028
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liliensiek SJ, 2009, TISSUE ENG PT A, V15, P2643, DOI [10.1089/ten.tea.2008.0284, 10.1089/ten.TEA.2008.0284]
   Liu B, 2006, MACROMOL RAPID COMM, V27, P1859, DOI 10.1002/marc.200600492
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Marchand C, 2011, TISSUE ENG PART A, V18, P508
   McLaughlin SW, 2012, J MATER SCI-MATER M, V23, P2141, DOI 10.1007/s10856-012-4677-4
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Merrell JG, 2009, CLIN EXP PHARMACOL P, V36, P1149, DOI 10.1111/j.1440-1681.2009.05216.x
   Mincheva R, 2007, EUR POLYM J, V43, P2809, DOI 10.1016/j.eurpolymj.2007.04.020
   Mo Xiumei, 2007, Frontiers of Materials Science in China, V1, P20, DOI 10.1007/s11706-007-0004-2
   Mori T, 2005, J VET MED SCI, V67, P51, DOI 10.1292/jvms.67.51
   Mwale F, 2005, TISSUE ENG, V11, P130, DOI 10.1089/ten.2005.11.130
   Nair LS, 2007, BIOMACROMOLECULES, V8, P3779, DOI 10.1021/bm7006967
   Neamnark A, 2006, CARBOHYD POLYM, V66, P298, DOI 10.1016/j.carbpol.2006.03.015
   Netz RR, 2003, PHYS REP, V380, P1, DOI 10.1016/S0370-1573(03)00118-2
   Nirmala R, 2011, MACROMOL RES, V19, P345, DOI 10.1007/s13233-011-0402-2
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   Pakravan M, 2012, BIOMACROMOLECULES, V13, P412, DOI 10.1021/bm201444v
   Pangestuti R, 2010, MAR DRUGS, V8, P2117, DOI 10.3390/md8072117
   Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045
   Peach MS, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045016
   Peach MS, 2012, J BIOMED NANOTECHNOL, V8, P107, DOI 10.1166/jbn.2012.1368
   Peesan M, 2006, J BIOMAT SCI-POLYM E, V17, P547, DOI 10.1163/156856206776986251
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Prabhakaran MP, 2008, TISSUE ENG PT A, V14, P1787, DOI 10.1089/ten.tea.2007.0393
   Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   Revzin A, 2003, LANGMUIR, V19, P9855, DOI 10.1021/la035129b
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rogers JA, 2005, MATER TODAY, V8, P50, DOI 10.1016/S1369-7021(05)00702-9
   Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Schlenoff J. B., 2003, MULTILAYER THIN FILM
   Schwarz A, 1998, LANGMUIR, V14, P5526, DOI 10.1021/la980359p
   Shalumon KT, 2012, J BIOMED NANOTECHNOL, V8, P405, DOI 10.1166/jbn.2012.1395
   Shim IK, 2008, J BIOMED MATER RES A, V90, P595
   Shin DS, 2003, BIOSENS BIOELECTRON, V19, P485, DOI 10.1016/S0956-5663(03)00228-8
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Silva JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055451
   Singh A, 2006, BIOMACROMOLECULES, V7, P914, DOI 10.1021/bm050752r
   Sogias IA, 2010, MACROMOL CHEM PHYS, V211, P426, DOI 10.1002/macp.200900385
   Stephan SJ, 2010, LARYNGOSCOPE, V120, P895, DOI 10.1002/lary.20624
   Taylor ED, 2010, J BONE JOINT SURG AM, V92A, P170, DOI 10.2106/JBJS.J.01112
   Torres-Giner S, 2008, ENG LIFE SCI, V8, P303, DOI 10.1002/elsc.200700066
   Wan Y, 2008, ACTA BIOMATER, V4, P876, DOI 10.1016/j.actbio.2008.01.001
   Wang JP, 2010, J BIOMED MATER RES A, V93A, P753, DOI 10.1002/jbm.a.32591
   Wang W, 2008, J BIOMED MATER RES A, V91, P994
   Wang W, 2010, ACTA BIOMATER, V6, P4027, DOI 10.1016/j.actbio.2010.04.027
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yang DZ, 2008, MACROMOL BIOSCI, V8, P239, DOI 10.1002/mabi.200700221
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yuxi L, 2012, J COLLOID INTERF SCI, V379, P130
   Zankovych S, 2013, ACTA BIOMATER, V9, P4926, DOI 10.1016/j.actbio.2012.08.013
   Zeleny J, 1914, PHYS REV, V3, P69, DOI 10.1103/PhysRev.3.69
   Zhang Y, 2007, BIOMACROMOLECULES, V9, P136
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
   Zhang YY, 2007, COLLOID POLYM SCI, V285, P855, DOI 10.1007/s00396-006-1630-4
   Zhou Y., 2007, BIOMACROMOLECULES, V9, P349
   Zhou YS, 2006, J APPL POLYM SCI, V102, P5692, DOI 10.1002/app.25068
   Zhou ZL, 2013, BIOMACROMOLECULES, V14, P529, DOI 10.1021/bm301785b
NR 160
TC 58
Z9 61
U1 8
U2 193
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1632
EP 1645
DI 10.1016/j.actbio.2013.07.003
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700015
PM 23851172
DA 2018-10-20
ER

PT J
AU Miao, SD
   Wang, P
   Su, ZG
   Zhang, SP
AF Miao, Shida
   Wang, Ping
   Su, Zhiguo
   Zhang, Songping
TI Vegetable-oil-based polymers as future polymeric biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Vegetable-oil; Biomaterial; Polyurethane; Polyester; Polyether
ID EPOXIDIZED SOYBEAN OIL; SOY-BASED POLYOLS; STRUCTURE-PROPERTY
   RELATIONSHIPS; RENEWABLE RESOURCES; PLANT OILS; POLYURETHANE NETWORKS;
   RICINOLEIC ACID; LINSEED OIL; CHEMOENZYMATIC EPOXIDATION; POLYHYDROXY
   TRIGLYCERIDES
AB Vegetable oils are one of the most important classes of bio-resources for producing polymeric materials. The main components of vegetable oils are triglycerides - esters of glycerol with three fatty acids. Several highly reactive sites including double bonds, allylic positions and the ester groups are present in triglycerides from which a great variety of polymers with different structures and functionalities can be prepared. Vegetable-oil-based polyurethane, polyester, polyether and polyolefin are the four most important classes of polymers, many of which have excellent biocompatibilities and unique properties including shape memory. In view of these characteristics, vegetable-oil-based polymers play an important role in biomaterials and have attracted increasing attention from the polymer community. Here we comprehensively review recent developments in the preparation of vegetable-oil-based polyurethane, polyester, polyether and polyolefin, all of which have potential applications as biomaterials. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Miao, Shida; Su, Zhiguo; Zhang, Songping] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China.
   [Miao, Shida] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
   [Wang, Ping] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA.
   [Wang, Ping] Univ Minnesota, Dept Bioprod & Biosyst Engn, St Paul, MN 55108 USA.
   [Zhang, Songping] Synerget Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China.
RP Zhang, SP (reprint author), Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China.
EM spzhang@home.ipe.ac.cn
FU National Natural Science Foundation of China [20728607, 20706054,
   20976180]; 973 Program [2009CB724705]; 863 Project [2008AA10Z302]; Open
   Funding Project of the Guangxi Key Laboratory of Biorefinery, Guangxi,
   China [GXBF11-02]
FX The authors thank support from the National Natural Science Foundation
   of China (Grant Nos. 20728607, 20706054, 20976180), 973 Program
   (2009CB724705) and 863 Project (2008AA10Z302); the Open Funding Project
   of the Guangxi Key Laboratory of Biorefinery, Guangxi, China (No.
   GXBF11-02).
CR Acar M, 2013, J MACROMOL SCI A, V50, P287, DOI 10.1080/10601325.2013.755443
   Adhvaryu A, 2005, IND CROP PROD, V21, P113, DOI 10.1016/j.indcrop.2004.02.001
   Ahamad S, 1999, J APPL POLYM SCI, V72, P1679, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1679::AID-APP4>3.3.CO;2-8
   Alam M, 2011, J POLYM ENVIRON, V19, P391, DOI 10.1007/s10924-011-0281-9
   Andjelkovic DD, 2005, POLYMER, V46, P9674, DOI 10.1016/j.polymer.2005.08.022
   Bakare IO, 2006, J APPL POLYM SCI, V100, P3748
   Biermann U, 2000, ANGEW CHEM INT EDIT, V39, P2206, DOI 10.1002/1521-3773(20000703)39:13<2206::AID-ANIE2206>3.0.CO;2-P
   Biermann U, 2006, EUR J ORG CHEM, P2631, DOI 10.1002/ejoc.200500701
   Biswas A, 2009, J AGR FOOD CHEM, V57, P8136, DOI 10.1021/jf901401s
   Boquillon N, 2000, POLYMER, V41, P8603, DOI 10.1016/S0032-3861(00)00256-1
   Bunker SP, 2002, J POLYM SCI POL CHEM, V40, P451, DOI 10.1002/pola.10130
   Calderon M, 2010, ADV MATER, V22, P190, DOI 10.1002/adma.200902144
   Campanella A, 2004, GREEN CHEM, V6, P330, DOI 10.1039/b404975f
   Ronda JC, 2011, EUR J LIPID SCI TECH, V113, P46, DOI 10.1002/ejlt.201000103
   Cayli G, 2008, J APPL POLYM SCI, V109, P2948, DOI 10.1002/app.28401
   Cayli G, 2010, J APPL POLYM SCI, V116, P2433, DOI 10.1002/app.31846
   Chakrapani S, 1998, J MACROMOL SCI PURE, VA35, P691, DOI 10.1080/10601329808002006
   Chen Qizhi, 2012, PROG BIOMATER, V1, P1, DOI DOI 10.1186/2194-0517-1-2
   Chen ZG, 2010, J COAT TECHNOL RES, V7, P603, DOI 10.1007/s11998-010-9241-x
   Cho HG, 2010, J APPL POLYM SCI, V116, P736, DOI 10.1002/app.31467
   Das B, 2013, IND CROP PROD, V44, P396, DOI 10.1016/j.indcrop.2012.11.028
   de Espinosa LM, 2009, J POLYM SCI POL CHEM, V47, P1159, DOI 10.1002/pola.23225
   de Espinosa LM, 2011, EUR POLYM J, V47, P837, DOI 10.1016/j.eurpolymj.2010.11.020
   Del Rio E, 2010, J POLYM SCI POL CHEM, V48, P4995, DOI 10.1002/pola.24297
   Desroches M, 2012, POLYM REV, V52, P38, DOI 10.1080/15583724.2011.640443
   Desroches M, 2011, MACROMOLECULES, V44, P2489, DOI 10.1021/ma102884w
   Earls JD, 2007, POLYMER, V48, P712, DOI 10.1016/j.polymer.2006.11.060
   Ebata H, 2007, MACROMOL BIOSCI, V7, P798, DOI 10.1002/mabi.200700018
   Esen H, 2003, J APPL POLYM SCI, V89, P3882, DOI 10.1002/app.12594
   FEAIRHELLER SH, 1994, J AM OIL CHEM SOC, V71, P863, DOI 10.1007/BF02540463
   Frey H., 2002, REV MOL BIOTECHNOL, V90, P257, DOI DOI 10.1016/S1389-0352(01)00063-0
   Galia M, 2010, EUR J LIPID SCI TECH, V112, P87, DOI 10.1002/ejlt.200900096
   Gandini A, 2013, GREEN CHEM, V15, P1514, DOI 10.1039/c3gc40358k
   Gandini A, 2008, MACROMOLECULES, V41, P9491, DOI 10.1021/ma801735u
   Gerbase AE, 2002, J AM OIL CHEM SOC, V79, P179, DOI 10.1007/s11746-002-0455-0
   Gerbase AE, 2002, J AM OIL CHEM SOC, V79, P797, DOI 10.1007/s11746-002-0561-z
   Gonzalez-Paz RJ, 2011, J POLYM SCI POL CHEM, V49, P2407, DOI 10.1002/pola.24671
   Goud VV, 2007, CHEM ENG SCI, V62, P4065, DOI 10.1016/j.ces.2007.04.038
   Guner FS, 2006, PROG POLYM SCI, V31, P633, DOI 10.1016/j.progpolymsci.2006.07.001
   Guo A, 2000, J POLYM SCI POL CHEM, V38, P3900, DOI 10.1002/1099-0518(20001101)38:21<3900::AID-POLA70>3.0.CO;2-E
   Guo BC, 2011, BIOMACROMOLECULES, V12, P1312, DOI 10.1021/bm2000378
   Guo YZ, 2007, J AM OIL CHEM SOC, V84, P929, DOI 10.1007/s11746-007-1126-5
   Harry-O'kuru RE, 2002, IND CROP PROD, V15, P51, DOI 10.1016/S0926-6690(01)00095-4
   Harry-O'Kuru RE, 2002, J AGR FOOD CHEM, V50, P3214, DOI 10.1021/jf011464z
   Hilker I, 2001, CHEM ENG SCI, V56, P427, DOI 10.1016/S0009-2509(00)00245-1
   Hojabri L, 2010, J POLYM SCI POL CHEM, V48, P3302, DOI 10.1002/pola.24114
   Hojabri L, 2010, BIOMACROMOLECULES, V11, P911, DOI 10.1021/bm901308c
   Hojabri L, 2009, BIOMACROMOLECULES, V10, P884, DOI 10.1021/bm801411w
   Javni I, 2003, J APPL POLYM SCI, V88, P2912, DOI 10.1002/app.11966
   JIE MSFLK, 1988, LIPIDS, V23, P367, DOI 10.1007/BF02537351
   Johnson NS, 2011, J AM OIL CHEM SOC, V88, P1425, DOI 10.1007/s11746-011-1808-x
   KHOE TH, 1976, J AM OIL CHEM SOC, V53, P17, DOI 10.1007/BF02632517
   Klaas MR, 1999, IND CROP PROD, V9, P125
   Kreye O, 2013, GREEN CHEM, V15, P1431, DOI 10.1039/c3gc40440d
   Kundu PP, 2005, BIOMACROMOLECULES, V6, P797, DOI 10.1021/bm049429z
   La Scala J, 2005, POLYMER, V46, P61, DOI 10.1016/j.polymer.2004.11.002
   La Scala JJ, 2004, POLYMER, V45, P7729, DOI 10.1016/j.polymer.2004.08.056
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Li F, 2001, POLYMER, V42, P1567, DOI 10.1016/S0032-3861(00)00546-2
   Liu ZS, 2007, BIOMACROMOLECULES, V8, P233, DOI 10.1021/bm060496y
   Liu ZS, 2011, J AGR FOOD CHEM, V59, P1909, DOI 10.1021/jf1035614
   Liu ZS, 2010, J AM OIL CHEM SOC, V87, P437, DOI 10.1007/s11746-009-1514-0
   Liu ZS, 2009, GREEN CHEM, V11, P1774, DOI 10.1039/b915742p
   Liu ZX, 2013, SOFT MATTER, V9, P5609, DOI 10.1039/c3sm50271f
   Liu ZX, 2012, SOFT MATTER, V8, P5888, DOI 10.1039/c2sm25115a
   Lligadas G, 2006, J POLYM SCI POL CHEM, V44, P634, DOI 10.1002/pola.21201
   Lligadas G, 2007, BIOMACROMOLECULES, V8, P1858, DOI 10.1021/bm070157k
   Lligadas G, 2007, BIOMACROMOLECULES, V8, P686, DOI 10.1021/bm060977h
   Lligadas G, 2013, J POLYM SCI POL CHEM, V51, P2111, DOI 10.1002/pola.26620
   Lligadas G, 2013, MACROMOL CHEM PHYS, V214, P415, DOI 10.1002/macp.201200582
   Lligadas G, 2010, POLYMERS-BASEL, V2, P440, DOI 10.3390/polym2040440
   Lligadas G, 2010, BIOMACROMOLECULES, V11, P2825, DOI 10.1021/bm100839x
   lonescu M., 2007, J POLYM ENVIRON, V15, P237
   Lozada Z, 2009, J APPL POLYM SCI, V113, P2552, DOI 10.1002/app.30209
   Lu YS, 2008, BIOMACROMOLECULES, V9, P3332, DOI 10.1021/bm801030g
   Lu YS, 2009, CHEMSUSCHEM, V2, P136, DOI 10.1002/cssc.200800241
   Luo Q, 2011, MACROMOLECULES, V44, P7149, DOI 10.1021/ma201366e
   Luo XG, 2013, MACROMOL MATER ENG, V298, P412, DOI 10.1002/mame.201200030
   Mauldin TC, 2008, J POLYM SCI POL CHEM, V46, P6851, DOI 10.1002/pola.22995
   Meier MAR, 2007, CHEM SOC REV, V36, P1788, DOI 10.1039/b703294c
   Mello VM, 2013, IND CROP PROD, V43, P56, DOI 10.1016/j.indcrop.2012.07.007
   Metzger JO, 2006, APPL MICROBIOL BIOT, V71, P13, DOI 10.1007/s00253-006-0335-4
   Miao S, 2012, J APPL POLYM SCI, V127, P1929
   Miao S, 2013, BIOTECHNOL LETT
   Miao SD, 2008, J POLYM SCI POL CHEM, V46, P4243, DOI 10.1002/pola.22721
   Miao SD, 2013, J AM OIL CHEM SOC, V90, P1415, DOI 10.1007/s11746-013-2273-5
   Miao SD, 2012, EUR J LIPID SCI TECH, V114, P1345, DOI 10.1002/ejlt.201200219
   Miao SD, 2012, EUR J LIPID SCI TECH, V114, P1165, DOI [10.1002/ejlt.201200050, 10.1002/ejlt.201290028]
   Miao SD, 2010, J POLYM SCI POL CHEM, V48, P243, DOI 10.1002/pola.23759
   MOHANTY A. K., 2005, NATURAL FIBRES BIOPO, V1, P1
   Mohanty AK, 2002, J POLYM ENVIRON, V10, P19, DOI 10.1023/A:1021013921916
   More AS, 2013, EUR POLYM J, V49, P823, DOI 10.1016/j.eurpolymj.2012.12.013
   Mutlu H, 2010, EUR J LIPID SCI TECH, V112, P10, DOI 10.1002/ejlt.200900138
   Narine SS, 2007, J AM OIL CHEM SOC, V84, P55, DOI 10.1007/s11746-006-1006-4
   Nayak RR, 2004, POLYM-PLAST TECHNOL, V43, P261, DOI 10.1081/PPT-120027475
   Pan X, 2011, BIOMACROMOLECULES, V12, P2416, DOI 10.1021/bm200549c
   Petrovic ZS, 2008, POLYM REV, V48, P109, DOI 10.1080/15583720701834224
   Petrovic ZS, 2008, POLYM INT, V57, P275, DOI 10.1002/pi.2340
   Petrovic ZS, 2013, POLYMER, V54, P372, DOI 10.1016/j.polymer.2012.10.019
   Petrovic ZS, 2010, MACROMOLECULES, V43, P4120, DOI 10.1021/ma100294r
   Petrovic ZS, 2005, BIOMACROMOLECULES, V6, P713, DOI 10.1021/bm049451s
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   Rao BS, 2008, PROG ORG COAT, V63, P416, DOI 10.1016/j.porgcoat.2008.07.001
   Raquez JM, 2010, PROG POLYM SCI, V35, P487, DOI 10.1016/j.progpolymsci.2010.01.001
   Rengasamy S, 2013, PROG ORG COAT, V76, P78, DOI 10.1016/j.porgcoat.2012.08.012
   ROSCH J, 1993, POLYM BULL, V31, P679, DOI 10.1007/BF00300127
   Samuelsson J, 2004, J POLYM SCI POL CHEM, V42, P6346, DOI 10.1002/pola.20468
   Sharma BK, 2006, J AM OIL CHEM SOC, V83, P129, DOI 10.1007/s11746-006-1185-z
   Sharma BK, 2006, J AGR FOOD CHEM, V54, P9866, DOI 10.1021/jf061896f
   Sharma V, 2008, PROG POLYM SCI, V33, P1199, DOI 10.1016/j.progpolymsci.2008.07.004
   Sharmin E, 2007, EUR J LIPID SCI TECH, V109, P134, DOI 10.1002/ejlt.200600227
   Sharmin E, 2007, INT J BIOL MACROMOL, V40, P407, DOI 10.1016/j.ijbiomac.2006.10.002
   Shikanov A, 2006, BIOMACROMOLECULES, V7, P288, DOI 10.1021/bm050648
   Slivniak R, 2005, BIOMACROMOLECULES, V6, P1679, DOI 10.1021/bm049194r
   Slivniak R, 2005, MACROMOLECULES, V38, P5545, DOI 10.1021/ma0503918
   Stemmelen M, 2011, J POLYM SCI POL CHEM, V49, P2434, DOI 10.1002/pola.24674
   Sylvain C, 2012, EUR J LIPID SCI TECH, V114, P1447
   Teomim D, 1999, J BIOMED MATER RES, V45, P258, DOI 10.1002/(SICI)1097-4636(19990605)45:3<258::AID-JBM14>3.0.CO;2-W
   Tian QP, 2002, J AM OIL CHEM SOC, V79, P479, DOI 10.1007/s11746-002-0509-3
   Turunc O, 2010, MACROMOL RAPID COMM, V31, P1822, DOI 10.1002/marc.201000291
   van Beilen JB, 2007, ADV BIOCHEM ENG BIOT, V107, P133, DOI 10.1007/10_2007_056
   Vazquez B, 2002, J BIOMED MATER RES, V63, P88, DOI 10.1002/jbm.10092
   Wang CS, 2009, J APPL POLYM SCI, V114, P125, DOI 10.1002/app.30493
   Wang Z, 2012, MACROMOLECULES, V45, P9010, DOI 10.1021/ma301938a
   Warwel S, 2004, IND CROP PROD, V20, P301, DOI 10.1016/j.indcrop.2003.11.002
   Warwel S, 2001, CHEMOSPHERE, V43, P39, DOI 10.1016/S0045-6535(00)00322-2
   Warwel S, 1995, J MOL CATAL B-ENZYM, V1, P29, DOI 10.1016/1381-1177(95)00004-6
   Wool R. P., 2005, BIOBASED POLYM COMPO
   Xia Y, 2013, J RENEW MATER, V1, P3, DOI 10.7569/JRM.2012.634103
   Xia Y, 2010, GREEN CHEM, V12, P1893, DOI 10.1039/c0gc00264j
   Xu QY, 2010, BIORESOURCE TECHNOL, V101, P3711, DOI 10.1016/j.biortech.2009.12.093
   Zaikov G, 1999, INT J POLYM MATER, V44, P107
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   Zhao HP, 2008, J APPL POLYM SCI, V110, P647, DOI 10.1002/app.28711
   Zlatanic A, 2004, J POLYM SCI POL PHYS, V42, P809, DOI 10.1002/polb.10737
NR 135
TC 153
Z9 162
U1 18
U2 250
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1692
EP 1704
DI 10.1016/j.actbio.2013.08.040
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700020
PM 24012607
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Miller, T
   Goude, MC
   McDevitt, TC
   Temenoff, JS
AF Miller, Tobias
   Goude, Melissa C.
   McDevitt, Todd C.
   Temenoff, Johnna S.
TI Molecular engineering of glycosaminoglycan chemistry for biomolecule
   delivery
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Glycosaminolgycan; Chemistry; Protein binding; Growth factor; Controlled
   release
ID FIBROBLAST-GROWTH-FACTOR; HYALURONIC-ACID HYDROGELS; CHONDROITIN
   SULFATE-E; CONJUGATED POLYMERIC MICELLE; BONE MORPHOGENETIC PROTEINS;
   MESENCHYMAL STEM-CELLS; HEPARIN-BASED HYDROGEL; CROSS-LINKED COLLAGEN;
   VESSEL WALL INJURY; DERMATAN SULFATE
AB Glycosaminoglycans (GAGs) are linear, negatively charged polysaccharides that interact with a variety of positively charged growth factors. In this review article the effects of engineering GAG chemistry for molecular delivery applications in regenerative medicine are presented. Three major areas of focus at the structure-function-property interface are discussed: (1) macromolecular properties of GAGs; (2) effects of chemical modifications on protein binding; (3) degradation mechanisms of GAGs. GAG-protein interactions can be based on: (1) GAG sulfation pattern; (2) GAG carbohydrate conformation; (3) GAG polyelectrolyte behavior. Chemical modifications of GAGs, which are commonly performed to engineer molecular delivery systems, affect protein binding and are highly dependent on the site of modification on the GAG molecules. The rate and mode of degradation can determine the release of molecules as well as the length of GAG fragments to which the cargo is electrostatically coupled and eventually released from the delivery system. Overall, GAG-based polymers are a versatile biomaterial platform offering novel means to engineer molecular delivery systems with a high degree of control in order to better treat a range of degenerated or injured tissues. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Miller, Tobias; Goude, Melissa C.; McDevitt, Todd C.; Temenoff, Johnna S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Miller, Tobias; Goude, Melissa C.; McDevitt, Todd C.; Temenoff, Johnna S.] Emory Univ, Atlanta, GA 30332 USA.
   [McDevitt, Todd C.; Temenoff, Johnna S.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Temenoff, JS (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM johnna.temenoff@bme.gatech.edu
FU NIH [R01 AR062006]; NSF [DMR 1207045]
FX The authors were supported by funding from the NIH (R01 AR062006) and
   NSF (DMR 1207045).
CR Almond A, 2007, CELL MOL LIFE SCI, V64, P1591, DOI 10.1007/s00018-007-7032-z
   ARNOTT S, 1974, J MOL BIOL, V88, P175, DOI 10.1016/0022-2836(74)90303-9
   ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A
   Avci FY, 2003, CURR PHARM DESIGN, V9, P2323, DOI 10.2174/1381612033453929
   Bae KH, 2008, BIOMATERIALS, V29, P3376, DOI 10.1016/j.biomaterials.2008.04.035
   Baker JR, 2000, BIOCHEM J, V348, P465, DOI 10.1042/0264-6021:3480465
   Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311
   Bali JP, 2001, SEMIN ARTHRITIS RHEU, V31, P58, DOI 10.1053/sarh.2000.24874
   Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201
   BARZU T, 1989, J CELL PHYSIOL, V140, P538, DOI 10.1002/jcp.1041400320
   Baumann H, 1998, CARBOHYD RES, V308, P381, DOI 10.1016/S0008-6215(98)00097-4
   BENDAYAN P, 1994, THROMB HAEMOSTASIS, V71, P576
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   BIENKOWSKI MJ, 1985, J BIOL CHEM, V260, P356
   BIENKOWSKI MJ, 1985, SEMIN THROMB HEMOST, V11, P86, DOI 10.1055/s-2007-1004363
   BOEYENS JCA, 1978, J CRYST MOL STRUCT, V8, P317, DOI 10.1007/BF01200485
   Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109
   Capila I., 2002, ANGEW CHEM INT EDIT, V1, 3, p[41, 390], DOI DOI 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.C0;2-B
   Casu B, 2002, SEMIN THROMB HEMOST, V28, P335, DOI 10.1055/s-2002-34302
   Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1
   Chen AL, 2008, BIOMACROMOLECULES, V9, P2447, DOI 10.1021/bm800485x
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Choh SY, 2011, BIOMACROMOLECULES, V12, P1126, DOI 10.1021/bm101451k
   Chu HH, 2011, P NATL ACAD SCI USA, V108, P13444, DOI 10.1073/pnas.1110121108
   Crescenzi V, 2007, BIOMACROMOLECULES, V8, P1844, DOI 10.1021/bm0700800
   DANISHEFSKY I, 1972, THROMB RES, V1, P173
   Das SK, 2001, CHEM-EUR J, V7, P4821
   Das SK, 2001, ANGEW CHEM INT EDIT, V40, P1670, DOI 10.1002/1521-3773(20010504)40:9<1670::AID-ANIE16700>3.3.CO;2-H
   Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200
   DIANCOURT F, 1994, J BIOACT COMPAT POL, V9, P267, DOI 10.1177/088391159400900303
   DOL F, 1990, J LAB CLIN MED, V115, P43
   Dudhia J, 2005, CELL MOL LIFE SCI, V62, P2241, DOI 10.1007/s00018-005-5217-x
   EDWARDS HE, 1977, INT J RADIAT BIOL, V32, P351, DOI 10.1080/09553007714551101
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490
   Esko J.D., 2009, ESSENTIALS GLYCOBIOL
   FERNANDEZ F, 1986, BRIT J HAEMATOL, V64, P309, DOI 10.1111/j.1365-2141.1986.tb04124.x
   Fransson LA, 1993, DERMATAN SULPHATE PR, P11
   Fryer A, 1997, J PHARMACOL EXP THER, V282, P208
   Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951
   Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI200113713
   GALLAGHER JT, 1992, INT J BIOCHEM, V24, P553, DOI 10.1016/0020-711X(92)90326-V
   Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Gandhi NS, 2012, BBA-PROTEINS PROTEOM, V1824, P1374, DOI 10.1016/j.bbapap.2012.07.002
   Glass JR, 1996, BIOMATERIALS, V17, P1101, DOI 10.1016/0142-9612(96)85911-4
   Groffen AJA, 1998, EUR J BIOCHEM, V254, P123, DOI 10.1046/j.1432-1327.1998.2540123.x
   Guglieri S, 2008, BIOCHEMISTRY-US, V47, P13862, DOI 10.1021/bi801007p
   Hay E. D., 1981, J CELL BIOL, V91, p205s
   Hennan JK, 2002, J PHARMACOL EXP THER, V301, P1151, DOI 10.1124/jpet.301.3.1151
   Herrera AJ, 2007, CARBOHYD RES, V342, P1876, DOI 10.1016/j.carres.2007.02.025
   Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#
   Hintze V, 2012, ACTA BIOMATER, V8, P2144, DOI 10.1016/j.actbio.2012.03.021
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   HIRANO S, 1975, CONNECT TISSUE RES, V3, P73, DOI 10.3109/03008207509152343
   Hirsh J, 2001, ARTERIOSCL THROM VAS, V21, P1094, DOI 10.1161/hq0701.093686
   Hong TT, 2006, THROMB RES, V117, P333, DOI 10.1016/j.thromres.2005.03.018
   HOOK M, 1984, ANNU REV BIOCHEM, V53, P847
   HOPWOOD JJ, 1973, BIOCHEM J, V135, P631, DOI 10.1042/bj1350631
   Hricovini M, 2002, SEMIN THROMB HEMOST, V28, P325, DOI 10.1055/s-2002-34301
   Huckerby TN, 1998, EUR J BIOCHEM, V253, P499, DOI 10.1046/j.1432-1327.1998.2530499.x
   Huckerby TN, 2002, PROG NUCL MAG RES SP, V40, P35, DOI 10.1016/S0079-6565(01)00040-1
   Hughes RC, 2001, BIOCHIMIE, V83, P667
   Huskisson EC, 2008, J INT MED RES, V36, P1161, DOI 10.1177/147323000803600602
   Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019
   INOUE Y, 1976, CARBOHYD RES, V46, P87, DOI 10.1016/S0008-6215(00)83533-8
   ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P817, DOI 10.1093/glycob/4.6.817
   Iwaki J, 2008, BIOCHEM BIOPH RES CO, V373, P206, DOI 10.1016/j.bbrc.2008.05.190
   JASEJA M, 1989, CAN J CHEM, V67, P1449, DOI 10.1139/v89-221
   Jensen M, 2002, EUR J PHARM SCI, V15, P139, DOI 10.1016/S0928-0987(01)00193-2
   Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030
   Jeon O, 2007, CARBOHYD POLYM, V70, P251, DOI 10.1016/j.carbpol.2007.04.002
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   KANTOR TG, 1957, J AM CHEM SOC, V79, P152, DOI 10.1021/ja01558a040
   Kim M, 2010, TISSUE ENG PART C-ME, V16, P1, DOI [10.1089/ten.tec.2008.0548, 10.1089/ten.TEC.2008.0548]
   Knox SM, 2006, CELL MOL LIFE SCI, V63, P2435, DOI 10.1007/s00018-006-6162-z
   Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474
   Kock L, 2012, CELL TISSUE RES, V347, P613, DOI 10.1007/s00441-011-1243-1
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348
   Lallam-Laroye C, 2006, J BIOMED MATER RES A, V79A, P675, DOI 10.1002/jbm.a.30880
   Lee JS, 2008, INT J PHARM, V346, P57, DOI 10.1016/j.ijpharm.2007.06.025
   Lee JS, 2007, J CONTROL RELEASE, V117, P204, DOI 10.1016/j.jconrel.2006.11.004
   Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6
   Li BZ, 2009, BIOCHEM PHARMACOL, V78, P292, DOI 10.1016/j.bcp.2009.04.012
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Liberda J, 1997, BIOTECHNOL TECH, V11, P265, DOI 10.1023/A:1018446723616
   Lim JJ, 2011, ACTA BIOMATER, V7, P986, DOI 10.1016/j.actbio.2010.10.009
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135
   Loo BM, 2001, J BIOL CHEM, V276, P16868, DOI 10.1074/jbc.M011226200
   Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   LYONS H, 1971, J BIOL CHEM, V246, P277
   Maaroufi RM, 2007, THROMB RES, V120, P615, DOI 10.1016/j.thromres.2006.10.023
   MACCARANA M, 1993, J BIOL CHEM, V268, P23898
   Malavaki C, 2008, CONNECT TISSUE RES, V49, P133, DOI 10.1080/03008200802148546
   MALMSTROM A, 1981, BIOCHEM J, V198, P669, DOI 10.1042/bj1980669
   Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857
   Maruyama T, 1998, CARBOHYD RES, V306, P35, DOI 10.1016/S0008-6215(97)10060-X
   McNaught AD, 2008, GLYCOSCIENCE, P2727
   Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455
   MEYER K, 1953, J BIOL CHEM, V205, P611
   Miljkovic ND, 2008, OSTEOARTHR CARTILAGE, V16, P1121, DOI 10.1016/j.joca.2008.03.003
   Miyazaki T, 2008, J CELL PHYSIOL, V217, P769, DOI 10.1002/jcp.21557
   Mizumoto S, 2013, FEBS J, V280, P2462, DOI 10.1111/febs.12156
   Mobli M, 2008, GLYCOCONJUGATE J, V25, P401, DOI 10.1007/s10719-007-9081-9
   Mori H, 2005, J BIOSCI BIOENG, V100, P54, DOI 10.1263/jbb.100.54
   Moy FJ, 1997, BIOCHEMISTRY-US, V36, P4782, DOI 10.1021/bi9625455
   Mulloy B, 2012, PURE APPL CHEM, V84, P65, DOI 10.1351/PAC-CON-11-10-27
   Nader HB, 1999, BRAZ J MED BIOL RES, V32, P529, DOI 10.1590/S0100-879X1999000500005
   NAGASAWA K, 1979, J BIOCHEM-TOKYO, V86, P1323, DOI 10.1093/oxfordjournals.jbchem.a132648
   NAGASAWA K, 1986, CARBOHYD RES, V158, P183, DOI 10.1016/0008-6215(86)84016-2
   NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3
   NAGASAWA K, 1992, CARBOHYD RES, V236, P165, DOI 10.1016/0008-6215(92)85014-Q
   Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200
   Nilasaroya A, 2012, BIOMATERIALS, V33, P5534, DOI 10.1016/j.biomaterials.2012.04.022
   O'Keeffe D, 2004, J BIOL CHEM, V279, P50267, DOI 10.1074/jbc.M408774200
   OFOSU FA, 1987, BIOCHEM J, V248, P889, DOI 10.1042/bj2480889
   OGAMO A, 1989, CARBOHYD RES, V193, P165, DOI 10.1016/0008-6215(89)85116-X
   Oprea AM, 2012, CARBOHYD POLYM, V90, P127, DOI 10.1016/j.carbpol.2012.05.004
   Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2
   Pap T, 2013, NAT REV RHEUMATOL, V9, P43, DOI 10.1038/nrrheum.2012.178
   Park K, 2006, J CONTROL RELEASE, V114, P300, DOI 10.1016/j.jconrel.2006.05.017
   Parkinson RJ, 2006, NEUROSURGERY, V59, P812, DOI 10.1227/01.NEU.0000232836.66310.46
   PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257
   Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116
   Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770
   Pogany P, 2009, CARBOHYD RES, V344, P1745, DOI 10.1016/j.carres.2009.05.030
   Ponedel'kina IY, 2006, RUSS J BIOORG CHEM+, V32, P472, DOI 10.1134/S1068162006050104
   PURKERSON ML, 1988, J CLIN INVEST, V81, P69, DOI 10.1172/JCI113312
   Purushothaman A, 2012, J BIOL CHEM, V287, P2935, DOI 10.1074/jbc.R111.298430
   Quantock AJ, 2010, CELL MOL LIFE SCI, V67, P891, DOI 10.1007/s00018-009-0228-7
   Radek KA, 2009, WOUND REPAIR REGEN, V17, P118, DOI 10.1111/j.1524-475X.2008.00449.x
   RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046
   Reis AV, 2011, J APPL POLYM SCI, V121, P2726, DOI 10.1002/app.33705
   Reis AV, 2009, J ORG CHEM, V74, P3750, DOI 10.1021/jo900033c
   Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200
   Rickard SM, 2003, GLYCOBIOLOGY, V13, P419, DOI 10.1093/glycob/cwg046
   Robert L, 2010, PATHOL BIOL, V58, P187, DOI 10.1016/j.patbio.2009.09.010
   ROBERT L, 1986, ANN BIOL CLIN-PARIS, V44, P145
   ROBERTS CR, 1987, BIOCHEM J, V247, P349, DOI 10.1042/bj2470349
   ROBYT JF, 1998, ESSENTIALS CARBOHYDR
   Rodriguez E, 2006, J BIOL CHEM, V281, P18444, DOI 10.1074/jbc.M51231200
   Roughley PJ, 2006, EUR SPINE J, V15, pS326, DOI 10.1007/s00586-006-0127-7
   Rudd TR, 2008, J AM CHEM SOC, V130, P2138, DOI 10.1021/ja077675n
   Ruhaak LR, 2010, ANAL BIOANAL CHEM, V397, P3457, DOI 10.1007/s00216-010-3532-z
   Rullo A, 2010, BIOPOLYMERS, V93, P290, DOI 10.1002/bip.21339
   Sattelle BM, 2013, BIOMACROMOLECULES, V14, P1149, DOI [10.1021/bm400067g, 10.1021/bm4000679g]
   Sattelle BM, 2010, J COMPUT CHEM, V31, P2932, DOI 10.1002/jcc.21589
   Sattelle BM, 2010, CARBOHYD RES, V345, P291, DOI 10.1016/j.carres.2009.11.013
   SCHMUT O, 1994, OPHTHALMIC RES, V26, P340, DOI 10.1159/000267499
   Schwartz NB, 1996, PERSPECT DEV NEUROBI, V3, P291
   Scott JE, 2001, PATHOL BIOL, V49, P284, DOI 10.1016/S0369-8114(01)00152-3
   SCOTT JE, 1995, BIOCHEMISTRY-US, V34, P15467, DOI 10.1021/bi00047a011
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Seto SP, 2012, CELL TISSUE RES, V347, P589, DOI 10.1007/s00441-011-1265-8
   Seyrek E, 2010, ADV COLLOID INTERFAC, V158, P119, DOI 10.1016/j.cis.2010.03.001
   SHAKLEE PN, 1984, BIOCHEM J, V217, P187, DOI 10.1042/bj2170187
   SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005
   Smith RAA, 2011, BIOCHEM SOC T, V39, P383, DOI 10.1042/BST0390383
   SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9
   Stick RV, 2009, CARBOHYDRATES: THE ESSENTIAL MOLECULES OF LIFE, 2ND EDITION, P1
   Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015
   Tae G, 2007, BIOMACROMOLECULES, V8, P1979, DOI 10.1021/bm0701189
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   TANFORD C, 1964, J BIOL CHEM, V239, P4034
   Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200
   Testa G, 2009, INT J PHARMACEUT, V378, P86, DOI 10.1016/j.ijpharm.2009.05.051
   Toida T, 2009, CARBOHYD RES, V344, P888, DOI 10.1016/j.carres.2009.02.010
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Tsurkan MV, 2010, MACROMOL RAPID COMM, V31, P1529, DOI 10.1002/marc.201000155
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   URBAN JPG, 1979, BIORHEOLOGY, V16, P447
   van Wachem PB, 2001, J BIOMED MATER RES, V55, P368, DOI 10.1002/1097-4636(20010605)55:3<368::AID-JBM1025>3.0.CO;2-5
   Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057
   VOLKIN DB, 1993, ARCH BIOCHEM BIOPHYS, V300, P30, DOI 10.1006/abbi.1993.1005
   Vongchan P, 2005, BBA-GEN SUBJECTS, V1721, P1, DOI 10.1016/j.bbagen.2004.09.007
   Wang SC, 2007, INT J PHARM, V329, P103, DOI 10.1016/j.ijpharm.2006.08.041
   Wei Z, 2011, GLYCOCONJUGATE J, V28, P525, DOI 10.1007/s10719-011-9352-3
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200
   Xiao ZP, 2011, J MED CHEM, V54, P603, DOI 10.1021/jm101381k
   Xu RY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.398826
   Yong LCJ, 1997, EXP TOXICOL PATHOL, V49, P409, DOI 10.1016/S0940-2993(97)80129-7
   Yu F, 2007, J AM CHEM SOC, V129, P13288, DOI 10.1021/ja075272h
   Yung S, 2007, PERITON DIALYSIS INT, V27, pS104
   Zamfir A, 2003, GLYCOBIOLOGY, V13, P733, DOI 10.1093/glycob/cwg086
NR 188
TC 31
Z9 31
U1 4
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1705
EP 1719
DI 10.1016/j.actbio.2013.09.039
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700021
PM 24121191
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Bryksin, AV
   Brown, AC
   Baksh, MM
   Finn, MG
   Barker, TH
AF Bryksin, Anton V.
   Brown, Ashley C.
   Baksh, Michael M.
   Finn, M. G.
   Barker, Thomas H.
TI Learning from nature - Novel synthetic biology approaches for
   biomaterial design
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Synthetic biology; Biomaterials; Directed evolution; Tissue engineering;
   Virus particles
ID TOBACCO-MOSAIC-VIRUS; IMPRINTED POLYMER NANOPARTICLES; SENSITIZED
   SOLAR-CELLS; M13 THIN-FILMS; EXTRACELLULAR-MATRIX; BUILDING-BLOCKS;
   CROSS-LINKING; SUPRAMOLECULAR STRUCTURES; REGENERATIVE MEDICINE;
   DIRECTED SYNTHESIS
AB Many biomaterials constructed today are complex chemical structures that incorporate biologically active components derived from nature, but the field can still be said to be in its infancy. The need for materials that bring sophisticated properties of structure, dynamics and function to medical and nonmedical applications will only grow. Increasing appreciation of the functionality of biological systems has caused biomaterials researchers to consider nature for design inspiration, and many examples exist of the use of biomolecular motifs. Yet evolution, nature's only engine for the creation of new designs, has been largely ignored by the biomaterials community. Molecular evolution is an emerging tool that enables one to apply nature's engineering principles to non-natural situations using variation and selection. The purpose of this review is to highlight the most recent advances in the use of molecular evolution in synthetic biology applications for biomaterial engineering, and to discuss some of the areas in which this approach may be successfully applied in the future.(c) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bryksin, Anton V.; Brown, Ashley C.; Barker, Thomas H.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Bryksin, Anton V.; Brown, Ashley C.; Barker, Thomas H.] Emory Univ, Atlanta, GA 30332 USA.
   [Brown, Ashley C.; Baksh, Michael M.; Finn, M. G.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   [Brown, Ashley C.; Baksh, Michael M.; Finn, M. G.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.
RP Barker, TH (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM thomas.barker@bme.gatech.edu
FU NIH [R21EB013743, R01EB011566, R21EB015663]; Georgia Tech Center for
   Bioengineering for Soldier Survivability Seed Grant (DoD)
   [W81XWH1110306]; American Heart Association Postdoctoral Fellowship
FX This work was funded in part by the NIH (R21EB013743, R01EB011566,
   R21EB015663), the Georgia Tech Center for Bioengineering for Soldier
   Survivability Seed Grant (DoD, W81XWH1110306), and an American Heart
   Association Postdoctoral Fellowship to ACB.
CR Adamcik J, 2012, MACROMOLECULES, V45, P1137, DOI 10.1021/ma202157h
   ALAKOKKO L, 1991, J BIOL CHEM, V266, P14175
   Arnold FH, 2003, DIRECTED EVOLUTION L
   Azucena C, 2012, LANGMUIR, V28, P14867, DOI 10.1021/la302774h
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642
   Baino F, 2011, J BIOMED MATER RES A, V97A, P514, DOI 10.1002/jbm.a.33072
   Banta S, 2010, ANNU REV BIOMED ENG, V12, P167, DOI 10.1146/annurev-bioeng-070909-105334
   Barish RD, 2009, P NATL ACAD SCI USA, V106, P6054, DOI 10.1073/pnas.0808736106
   Barker TH, 2011, BIOMATERIALS, V32, P4211, DOI 10.1016/j.biomaterials.2011.02.027
   Best JP, 2013, LANGMUIR, V29, P9824, DOI 10.1021/la402146t
   Brown AC, 2011, TISSUE ENG PT A, V17, P139, DOI [10.1089/ten.tea.2010.0199, 10.1089/ten.TEA.2010.0199]
   Bundy BC, 2011, J BIOTECHNOL, V154, P230, DOI 10.1016/j.jbiotec.2011.04.011
   Carson AE, 2009, REGEN MED, V4, P593, DOI 10.2217/RME.09.30
   Chaisri P, 2013, BIOTECHNOL J, V8, P1323, DOI 10.1002/biot.201300191
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Chen PY, 2013, ACS NANO, V7, P6563, DOI 10.1021/nn4014164
   Chen PY, 2013, J MATER CHEM A, V1, P2217, DOI 10.1039/c2ta00771a
   Chung BG, 2007, EXPERT OPIN DRUG DIS, V2, P1653, DOI 10.1517/17460441.2.12.1653
   Chung WJ, 2011, NATURE, V478, P364, DOI 10.1038/nature10513
   Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Datta B, 2008, J AM CHEM SOC, V130, P2965, DOI 10.1021/ja0726106
   DiMarco RL, 2012, ADV MATER, V24, P3923, DOI 10.1002/adma.201200051
   Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016
   Edalat F, 2012, CURR OPIN BIOTECH, V23, P820, DOI 10.1016/j.copbio.2012.05.007
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Faramarzi MA, 2013, ADV COLLOID INTERFAC, V189, P1, DOI 10.1016/j.cis.2012.12.001
   FRAENKELCONRAT H, 1955, P NATL ACAD SCI USA, V41, P690, DOI 10.1073/pnas.41.10.690
   Freer AS, 2013, J COLLOID INTERF SCI, V392, P213, DOI 10.1016/j.jcis.2012.09.072
   Gartner ZJ, 2004, SCIENCE, V305, P1601, DOI 10.1126/science.1102629
   Gasiorowski JZ, 2011, BIOMACROMOLECULES, V12, P3549, DOI 10.1021/bm200763y
   Goldsmith M, 2013, METHOD ENZYMOL, V523, P257, DOI 10.1016/B978-0-12-394292-0.00012-6
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Grelet E, 2011, LANGMUIR, V27, P4334, DOI 10.1021/la200743n
   Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697
   He JB, 2009, LANGMUIR, V25, P4979, DOI 10.1021/la803533n
   Henry AA, 2005, CURR OPIN BIOTECH, V16, P370, DOI 10.1016/j.copbio.2005.06.008
   Hoshino Y, 2012, P NATL ACAD SCI USA, V109, P33, DOI 10.1073/pnas.1112828109
   Hoshino Y, 2011, J MATER CHEM, V21, P3517, DOI 10.1039/c0jm03122d
   Hoshino Y, 2010, J AM CHEM SOC, V132, P6644, DOI 10.1021/ja102148f
   Hoshino Y, 2008, J AM CHEM SOC, V130, P15242, DOI 10.1021/ja8062875
   Hosseinkhani H, 2013, CHEM REV, V113, P4837, DOI 10.1021/cr300131h
   Hsiong SX, 2008, BIOMACROMOLECULES, V9, P1843, DOI 10.1021/bm8000606
   Huang X, 2010, ANN BIOMED ENG, V38, P1965, DOI 10.1007/s10439-010-9986-5
   INDIK Z, 1990, ARCH BIOCHEM BIOPHYS, V280, P80, DOI 10.1016/0003-9861(90)90521-Y
   Ivanovska IL, 2011, P NATL ACAD SCI USA, V108, P12611, DOI 10.1073/pnas.1105586108
   Ji YS, 2009, ANAL BIOANAL CHEM, V395, P1125, DOI 10.1007/s00216-009-3020-5
   Josephson K, 2005, J AM CHEM SOC, V127, P11727, DOI 10.1021/ja0515809
   Khan AA, 2013, LANGMUIR, V29, P2094, DOI 10.1021/la3044126
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600
   Korkmaz N, 2013, MACROMOL BIOSCI, V13, P376, DOI 10.1002/mabi.201200290
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee SY, 2012, BIOTECHNOL BIOENG, V109, P16, DOI 10.1002/bit.23328
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Leitzel JC, 2001, CHEM REC, V1, P53
   Li T, 2013, ANGEW CHEM INT EDIT, V52, P6638, DOI 10.1002/anie.201209299
   Li Xiaoyu, 2002, Journal of the American Chemical Society, V124, P746, DOI 10.1021/ja017319j
   Li Y, 2006, ANAL CHEM, V78, P317, DOI 10.1021/ac050802i
   Lin Y, 2010, ANGEW CHEM INT EDIT, V49, P868, DOI 10.1002/anie.200904993
   Liu Z, 2012, CHEM SOC REV, V41, P6178, DOI 10.1039/c2cs35108k
   Maeda Y, 2012, SOFT MATTER, V8, P7533, DOI 10.1039/c2sm25352f
   Mallick Kajal K, 2013, Front Biosci (Elite Ed), V5, P341
   Manzenrieder F, 2011, ANGEW CHEM INT EDIT, V50, P2601, DOI 10.1002/anie.201006134
   Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740
   Markowski MC, 2012, J BIOMED MATER RES A, V100A, P2119, DOI 10.1002/jbm.a.34068
   Martino M. M., 2011, SCI TRANSL MED, V3, DOI DOI 10.1126/SCITRANSLMED.3002614
   McKee ML, 2012, J AM CHEM SOC, V134, P1446, DOI 10.1021/ja2101196
   Mukhatyar VJ, 2011, BIOMATERIALS, V32, P3958, DOI 10.1016/j.biomaterials.2011.02.015
   Murugesan M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01820
   Nam KT, 2008, ACS NANO, V2, P1480, DOI 10.1021/nn800018n
   NIELSEN LE, 1969, J MACROMOL SCI-REV M, VC  3, P69, DOI 10.1080/15583726908545897
   Nishino H, 2006, ANGEW CHEM INT EDIT, V45, P2392, DOI 10.1002/anie.200503760
   Niu J, 2013, NAT CHEM, V5, P282, DOI [10.1038/NCHEM.1577, 10.1038/nchem.1577]
   Okada H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037035
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Patil AJ, 2013, NANOSCALE, V5, P7161, DOI 10.1039/c3nr02796a
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Poma A, 2013, ADV FUNCT MATER, V23, P2821, DOI 10.1002/adfm.201202397
   Poma A, 2010, TRENDS BIOTECHNOL, V28, P629, DOI 10.1016/j.tibtech.2010.08.006
   Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Rego JM, 2013, BIOTECHNOL J, V8, P237, DOI 10.1002/biot.201100504
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   ROBERTSON DE, 2004, PROTEIN ENG
   Rong JH, 2008, CHEM COMMUN, P5185, DOI 10.1039/b811039e
   Ruff AJ, 2013, FEBS J, V280, P2961, DOI 10.1111/febs.12325
   Ruff Y, 2013, J AM CHEM SOC, V135, P6211, DOI 10.1021/ja4008003
   Russell JT, 2005, ANGEW CHEM INT EDIT, V44, P2420, DOI 10.1002/anie.200462653
   Schrum JP, 2009, J AM CHEM SOC, V131, P14560, DOI 10.1021/ja906557v
   Sidhu SS, 2003, CURR OPIN CHEM BIOL, V7, P97, DOI 10.1016/S1367-5931(02)00011-x
   Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07
   Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d
   Soon ASC, 2013, ADV HEALTHC MATER, V2, P1045, DOI 10.1002/adhm.201200330
   Stabenfeldt SE, 2012, BIOMATERIALS, V33, P535, DOI 10.1016/j.biomaterials.2011.09.079
   Storhoff JJ, 1999, CHEM REV, V99, P1849, DOI 10.1021/cr970071p
   Straley K, 2009, IEEE ENG MED BIO, P2101, DOI 10.1109/IEMBS.2009.5334310
   Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987
   Tseng RJ, 2006, NAT NANOTECHNOL, V1, P72, DOI 10.1038/nnano.2006.55
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121
   Turiel E, 2010, ANAL CHIM ACTA, V668, P87, DOI 10.1016/j.aca.2010.04.019
   Ura Y, 2009, SCIENCE, V325, P73, DOI 10.1126/science.1174577
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Wang GC, 2013, P NATL ACAD SCI USA, V110, P7619, DOI 10.1073/pnas.1300233110
   Wang JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01242
   Wang PY, 2013, COLLOID SURFACE B, V110, P88, DOI 10.1016/j.colsurfb.2013.04.016
   Werkmeister JA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012002
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Wu LY, 2011, LANGMUIR, V27, P9490, DOI 10.1021/la201580v
   Wu LQ, 2004, TRENDS BIOTECHNOL, V22, P593, DOI 10.1016/j.tibtech.2004.09.008
   Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389
   Yoo PJ, 2008, ACS NANO, V2, P561, DOI 10.1021/nn700404y
   Zan XJ, 2013, ACS NANO, V7, P8385, DOI 10.1021/nn403908k
   Zeng ZY, 2010, ACS NANO, V4, P199, DOI [10.1021/nn9011256s, 10.1021/nn901256s]
   Zhou K, 2013, BIOMACROMOLECULES, V14, P2593, DOI 10.1021/bm400445m
   Zimmerman SC, 2002, NATURE, V418, P399, DOI 10.1038/nature00877
   Zlotnick A, 2013, BIOPHYS J, V104, P1595, DOI 10.1016/j.bpj.2013.02.005
NR 124
TC 17
Z9 18
U1 3
U2 131
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1761
EP 1769
DI 10.1016/j.actbio.2014.01.019
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700026
PM 24463066
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Brus, VV
   Pidkamin, LJ
   Ilashchuk, MI
   Maryanchuk, PD
AF Brus, Viktor V.
   Pidkamin, Leonid J.
   Ilashchuk, Maria I.
   Maryanchuk, Pavlo D.
TI 11th International Conference " Correlation Optics": Propolis films for
   hybrid biomaterial-inorganic electronics and optoelectronics
SO APPLIED OPTICS
LA English
DT Article
ID ORGANIC SEMICONDUCTORS; SOLAR-CELLS; ELECTRICAL-PROPERTIES; BIOLOGICAL
   TISSUES; BIOELECTRONICS; HETEROJUNCTIONS; TRANSISTORS; ANISOTROPY;
   TRANSPORT; CDTE
AB We report on the analysis of optical, polarimetric, and electrical properties of propolis films and hybrid biomaterial- inorganic heterojunctions based on them. It was shown that the material of the propolis films belongs to wide- bandgap optically active substances with the light- scattering centers, which possess complex optical properties. The values of the specific resistance.rho(P) - 1.9 center dot 10(7) Omega center dot cm and dielectric constant epsilon P - 19.5 of the propolis film were determined from the spectral distribution of the real and imaginary components of its impedance at room temperature, respectively. The dominating current transport mechanisms through the hybrid bioinorganic heterojunction propolis/ p- CdTe were established to be the interface- states- assisted generation- recombination within the depletion region via deep energy levels at forward bias as well as the leakage current through the shunt resistance at reverse bias. (C) 2014 Optical Society of America
C1 [Brus, Viktor V.; Ilashchuk, Maria I.; Maryanchuk, Pavlo D.] Chernivtsi Natl Univ, Dept Elect & Energy Engn, UA-58012 Chernovtsy, Ukraine.
   [Pidkamin, Leonid J.] Chernivtsi Natl Univ, Dept Opt & Spect, UA-58012 Chernovtsy, Ukraine.
RP Brus, VV (reprint author), Chernivtsi Natl Univ, Dept Elect & Energy Engn, Kotsubinsky Str 2, UA-58012 Chernovtsy, Ukraine.
EM v.brus@chnu.edu.ua
RI Brus, Viktor/D-5739-2016; Ilashchuk, Mariya/R-8075-2016; CENAPAD-SP,
   CENAPAD/J-2963-2017; Maryanchuk, Pavlo/D-3996-2016
OI Brus, Viktor/0000-0002-8839-124X; Ilashchuk, Mariya/0000-0002-7618-0437;
   Maryanchuk, Pavlo/0000-0002-5523-4280; Maryanchuk,
   Pavlo/0000-0002-0360-8447
CR Angelsky O. V., 2002, OPTICA APPL, V32, P603
   Angelsky OV, 2002, OPT APPL, V32, P591
   Arkhelyuk A., 2003, P SOC PHOTO-OPT INS, V5227, P219
   Banskota AH, 2001, PHYTOTHER RES, V15, P561, DOI 10.1002/ptr.1029
   Berggren M, 2007, ADV MATER, V19, P3201, DOI 10.1002/adma.200700419
   Botushanov P I, 2001, Folia Med (Plovdiv), V43, P28
   Bratter C, 1999, FORSCH KOMPLEMENTMED, V6, P256, DOI 10.1159/000021260
   Brown AR, 1997, SYNTHETIC MET, V88, P37, DOI 10.1016/S0379-6779(97)80881-8
   Brus VV, 2013, ORG ELECTRON, V14, P3109, DOI 10.1016/j.orgel.2013.07.021
   Brus VV, 2012, OPT MATER, V34, P1940, DOI 10.1016/j.optmat.2012.06.007
   Brus VV, 2012, SEMICONDUCTORS+, V46, P1152, DOI 10.1134/S1063782612090059
   Brus VV, 2012, SEMICONDUCTORS+, V46, P1012, DOI 10.1134/S1063782612080040
   Brus VV, 2012, SEMICOND SCI TECH, V27, DOI 10.1088/0268-1242/27/3/035024
   Brus VV, 2011, SEMICOND SCI TECH, V26, DOI 10.1088/0268-1242/26/12/125006
   Brus V. V., 2013, SEMICOND SCI TECH, V28
   Chua LL, 2005, NATURE, V434, P194, DOI 10.1038/nature03376
   Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x
   Crone B, 2001, APPL PHYS LETT, V78, P2229, DOI 10.1063/1.1360785
   Davis JJ, 2005, J MATER CHEM, V15, P2160, DOI 10.1039/b417712f
   Drapak SI, 2006, APPL SURF SCI, V253, P279, DOI 10.1016/j.apsusc.2006.05.092
   Drapak SI, 2005, J OPTOELECTRON ADV M, V7, P801
   Drapak SI, 2004, TECH PHYS+, V49, P1529, DOI 10.1134/1.1826206
   GARNIER F, 1993, J AM CHEM SOC, V115, P8716, DOI 10.1021/ja00072a026
   Gerrard A., 1975, INTRO MATRIX METHODS
   Gorley PM, 2008, PHYS STATUS SOLIDI C, V5, P3622, DOI 10.1002/pssc.200780149
   Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z
   Kheiri F, 2011, BIOSENS BIOELECTRON, V26, P4457, DOI 10.1016/j.bios.2011.05.002
   Kyaw AKK, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3039076
   Orsi R. O., 2005, J. Venom. Anim. Toxins incl. Trop. Dis, V11, P109, DOI 10.1590/S1678-91992005000200003
   Stakhira P, 2010, THIN SOLID FILMS, V518, P7016, DOI 10.1016/j.tsf.2010.06.051
   Sze S. M., 2007, PHYS SEMICONDUCTOR D
   TOMASBARBERAN FA, 1993, PHYTOCHEMISTRY, V34, P191, DOI 10.1016/S0031-9422(00)90804-5
   Ushenko YA, 2011, OPT SPECTROSC+, V110, P814, DOI 10.1134/S0030400X11050195
   Ushenko YA, 2011, QUANTUM ELECTRON+, V41, P170, DOI 10.1070/QE2011v041n02ABEH014215
   Willner I, 2007, BIOSENS BIOELECTRON, V22, P1841, DOI 10.1016/j.bios.2006.09.018
   Wright M, 2012, SOL ENERG MAT SOL C, V107, P87, DOI 10.1016/j.solmat.2012.07.006
NR 36
TC 7
Z9 7
U1 1
U2 3
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1559-128X
EI 2155-3165
J9 APPL OPTICS
JI Appl. Optics
PD APR 1
PY 2014
VL 53
IS 10
BP B121
EP B127
DI 10.1364/AO.53.00B121
PG 7
WC Optics
SC Optics
GA AE6QC
UT WOS:000334117600018
PM 24787194
DA 2018-10-20
ER

PT J
AU Lu, W
   Ji, K
   Kirkham, J
   Yan, Y
   Boccaccini, AR
   Kellett, M
   Jin, Y
   Yang, XBB
AF Lu, Wei
   Ji, Kun
   Kirkham, Jennifer
   Yan, Yu
   Boccaccini, Aldo R.
   Kellett, Margaret
   Jin, Yan
   Yang, Xuebin B.
TI Bone tissue engineering by using a combination of polymer/Bioglass
   composites with human adipose-derived stem cells
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE Bone tissue engineering; Adipose-derived stem cells; PDLLA/Bioglass (R)
   composite; Biodegradable polymers; In vivo
ID MARROW STROMAL CELLS; BIOGLASS(R)-FILLED POLYLACTIDE FOAMS; IN-VITRO
   CHARACTERIZATION; OSTEOBLAST-LIKE CELLS; BIOACTIVE GLASS; OSTEOGENIC
   DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; MECHANICAL-PROPERTIES;
   SCAFFOLDS; VIVO
AB Translational research in bone tissue engineering is essential for "bench to bedside" patient benefit. However, the ideal combination of stem cells and biomaterial scaffolds for bone repair/regeneration is still unclear. The aim of this study is to investigate the osteogenic capacity of a combination of poly(DL-lactic acid) (PDLLA) porous foams containing 5 wt% and 40 wt% of Bioglass particles with human adipose-derived stem cells (ADSCs) in vitro and in vivo. Live/dead fluorescent markers, confocal microscopy and scanning electron microscopy showed that PDLLA/Bioglass porous scaffolds supported ADSC attachment, growth and osteogenic differentiation, as confirmed by enhanced alkaline phosphatase (ALP) activity. Higher Bioglass content of the PDLLA foams increased ALP activity compared with the PDLLA only group. Extracellular matrix deposition after 8 weeks in the in vitro cultures was evident by Alcian blue/Sirius red staining. In vivo bone formation was assessed by using scaffold/ADSC constructs in diffusion chambers transplanted intraperitoneally into nude mice and recovered after 8 weeks. Histological and immunohistochemical assays indicated significant new bone formation in the 40 wt% and 5 wt% Bioglass constructs compared with the PDLLA only group. Thus, the combination of a well-developed biodegradable bioactive porous PDLLA/Bioglass composite scaffold with a high-potential stem cell source (human ADSCs) could be a promising approach for bone regeneration in a clinical setting.
C1 [Lu, Wei; Ji, Kun; Jin, Yan] Fourth Mil Med Univ, Res & Dev Ctr Tissue Engn, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China.
   [Lu, Wei; Yang, Xuebin B.] Univ Leeds, Leeds Dent Inst, Dept Oral Biol, Biomat & Tissue Engn Grp, Leeds LS2 9LU, W Yorkshire, England.
   [Lu, Wei] PLA, Dept Dent, Hosp 461, Changchun 130021, Jilin, Peoples R China.
   [Ji, Kun] Fourth Mil Med Univ, Dept Pediat Dent, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China.
   [Kirkham, Jennifer] Univ Leeds, Leeds Dent Inst, Biomineralizat Grp, Leeds LS2 9LU, W Yorkshire, England.
   [Kirkham, Jennifer; Yang, Xuebin B.] Chapel Allerton Hosp, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds LS7 4SA, W Yorkshire, England.
   [Yan, Yu] Univ Sci & Technol Beijing, Ctr Corros & Protect, Key Lab Environm Fracture MOE, Beijing 100083, Peoples R China.
   [Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, D-91058 Erlangen, Germany.
   [Kellett, Margaret] Univ Leeds, Leeds Dent Inst, Dept Periodontol, Leeds LS2 9LU, W Yorkshire, England.
RP Jin, Y (reprint author), Fourth Mil Med Univ, Res & Dev Ctr Tissue Engn, Sch Stomatol, 145 West Changle Rd, Xian 710032, Shaanxi, Peoples R China.
EM yanjin@fmmu.edu.cn; X.B.Yang@leeds.ac.uk
RI Jin, Yan/I-4204-2013; Boccaccini, Aldo/C-7905-2013
OI Yan, Yu/0000-0003-4048-0603
FU China Scholarship Council (CSC); Worldwide Universities Network (WUN);
   NIHR LMBRU; Jilin Province Youth Foundation [20140520051JH]
FX This work was supported by grants from the China Scholarship Council
   (CSC) and Worldwide Universities Network (WUN). It was also partially
   funded by NIHR LMBRU and Jilin Province Youth Foundation
   (20140520051JH).
CR Ahsan T, 2005, Orthod Craniofac Res, V8, P134, DOI 10.1111/j.1601-6343.2005.00326.x
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02
   Blaker JJ, 2005, ACTA BIOMATER, V1, P643, DOI 10.1016/j.actbio.2005.07.003
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Boccaccini AR, 2003, J MATER SCI-MATER M, V14, P443, DOI 10.1023/A:1023266902662
   Bosetti M, 2003, J BIOMED MATER RES A, V64A, P189, DOI 10.1002/jbm.a.10415
   Buma P, 2004, BIOMATERIALS, V25, P1487, DOI 10.1016/S0142-9612(03)00492-7
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Eppley BL, 2005, J CRANIOFAC SURG, V16, P981, DOI 10.1097/01.scs.0000179662.38172.dd
   Gabbay JS, 2006, ANN PLAS SURG, V57, P89, DOI 10.1097/01.sap.0000205378.89052.d3
   GHEYSEN G, 1983, BIOMATERIALS, V4, P81, DOI 10.1016/0142-9612(83)90044-3
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Green D, 2004, J MATER CHEM, V14, P2206, DOI 10.1039/b400486h
   Hattar S., 2002, European Cells & Materials, V4, P61
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1986, CIBA F SYMP, V121, P231
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735
   Hofmann A, 2008, BONE, V42, P894, DOI 10.1016/j.bone.2008.01.013
   Horner E, 2008, ADV TISSUE ENG, P763
   Horner EA, 2010, TISSUE ENG PART B-RE, V16, P263, DOI [10.1089/ten.teb.2009.0224, 10.1089/ten.TEB.2009.0224]
   Howard D, 2002, BIOCHEM BIOPH RES CO, V299, P208, DOI 10.1016/S0006-291X(02)02561-5
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kokai LE, 2005, PLAST RECONSTR SURG, V116, P1453, DOI 10.1097/01.prs.0000182570.62814.e3
   Lalande C, 2011, EUR CELLS MATER, V21, P341, DOI 10.22203/eCM.v021a25
   Lee JA, 2003, ANN PLAS SURG, V50, P610, DOI 10.1097/01.SAP.0000069069.23266.35
   Lee SJ, 2010, BIOMATERIALS, V31, P5652, DOI 10.1016/j.biomaterials.2010.03.019
   Liao S, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025019
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Loty C, 2001, J BONE MINER RES, V16, P231, DOI 10.1359/jbmr.2001.16.2.231
   Lu W, 2012, CELLS TISSUES ORGANS, V195, P197, DOI 10.1159/000324921
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Maquet V, 2003, J BIOMED MATER RES A, V66A, P335, DOI 10.1002/jbm.a.10587
   Marolt D, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt10
   Mauney JR, 2004, CALCIFIED TISSUE INT, V74, P458, DOI 10.1007/s00223-003-0104-7
   McIntosh KR, 2009, TISSUE ENG PT A, V15, P2677, DOI 10.1089/ten.TEA.2008.0566
   Mehrkens A, 2012, EUR CELLS MATER, V24, P308, DOI 10.22203/eCM.v024a22
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114
   Parker AM, 2006, EXPERT OPIN BIOL TH, V6, P567, DOI 10.1517/14712598.6.6.567
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x
   Rada T, 2009, J TISSUE ENG REGEN M, V3, P158, DOI 10.1002/term.141
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Saha S, 2011, STEM CELL TISSUE ENG, P211
   Saha S, 2013, CELL TISSUE RES, V352, P495, DOI 10.1007/s00441-013-1586-x
   Saha S, 2010, BIOCHEM BIOPH RES CO, V401, P333, DOI 10.1016/j.bbrc.2010.09.042
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Stamboulis A, 2002, J MATER SCI-MATER M, V13, P843, DOI 10.1023/A:1016544211478
   Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028
   Tobita M, 2011, DISCOV MED, V11, P160
   Tsigkou O, 2007, J BIOMED MATER RES A, V80A, P837, DOI 10.1002/jbm.a.30910
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   Wang CZ, 2010, BIOMATERIALS, V31, P8674, DOI 10.1016/j.biomaterials.2010.07.096
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/1076327041887718
   Yang XBB, 2006, BIOCHEM BIOPH RES CO, V342, P1098, DOI 10.1016/j.bbrc.2006.02.021
   Young MF, 2003, OSTEOPOROSIS INT, V14, pS35, DOI 10.1007/s00198-002-1342-7
   Zong C, 2010, EUR CELLS MATER, V20, P109
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 68
TC 27
Z9 29
U1 1
U2 33
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD APR
PY 2014
VL 356
IS 1
BP 97
EP 107
DI 10.1007/s00441-013-1770-z
PG 11
WC Cell Biology
SC Cell Biology
GA AE7JY
UT WOS:000334175100010
PM 24408074
DA 2018-10-20
ER

PT J
AU Agathopoulos, S
   Kolettis, TM
AF Agathopoulos, Simeon
   Kolettis, Theofilos M.
TI Novel Strategies for Cardiac Repair Post-Myocardial Infarction
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Editorial Material
ID GROWTH-FACTOR-I; ACUTE MYOCARDIAL-INFARCTION; VENTRICULAR MYOCYTES;
   HORMONE; RATS; INFLAMMATION; HYPERTROPHY; CLENBUTEROL; THERAPY;
   PATHOPHYSIOLOGY
AB Myocardial infarction constitutes an important health-related problem worldwide. Despite current treatments that salvage myocardial tissue and unload the left ventricle, chronic heart failure is common and is associated with increased morbidity and mortality. During the past decade, experimental studies, using cell-based therapies and growth factor administration integrated in biomaterial scaffolds, have demonstrated the potential to reduce the infarcted area and to improve regional and global left ventricular function. Some aspects of this rapid progress are reviewed in the present 'special issue' and a number of novel approaches are being introduced. This series of articles, contributed by research groups with different expertise, is a small step towards the combined efforts required to address the challenges associated with regenerating the infarcted myocardium.
C1 [Agathopoulos, Simeon] Univ Ioannina, GR-45110 Ioannina, Greece.
   [Kolettis, Theofilos M.] Univ Ioannina, Sch Med, Dept Cardiol, GR-45110 Ioannina, Greece.
RP Agathopoulos, S (reprint author), Univ Ioannina, 1 Stavrou Niarxou Ave, GR-45110 Ioannina, Greece.
EM sagat@cc.uoi.gr; thkolet@cc.uoi.gr
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303
   Bruel A, 2005, GROWTH HORM IGF RES, V15, P256, DOI 10.1016/j.ghir.2005.04.003
   BUERKE M, 1995, P NATL ACAD SCI USA, V92, P8031, DOI 10.1073/pnas.92.17.8031
   Cavalera M, 2014, CURR PHARM DESIGN, V20, P1971, DOI 10.2174/13816128113199990449
   Chatzinikolaidou M, 2014, CURR PHARM DESIGN, V20, P2030, DOI 10.2174/13816128113199990446
   Chen J, 2014, CURR PHARM DESIGN, V20, P2023, DOI 10.2174/13816128113199990451
   Chen PS, 2001, CARDIOVASC RES, V50, P409, DOI 10.1016/S0008-6363(00)00308-4
   Cittadini A, 1997, J AM COLL CARDIOL, V29, P1109, DOI 10.1016/S0735-1097(97)00010-7
   Daskalopoulos EP, 2014, CURR PHARM DESIGN, V20, P1987, DOI 10.2174/13816128113199990452
   Daskalopoulos EP, 2012, MICROSC MICROANAL, V18, P35, DOI 10.1017/S143192761101227X
   Doyle B, 2008, STEM CELLS DEV, V17, P941, DOI 10.1089/scd.2007.0214
   Elaiopoulos DA, 2007, CLIN SCI, V112, P385, DOI 10.1042/CS20060193
   ENTMAN ML, 1991, FASEB J, V5, P2529
   Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011
   Franco-Cereceda A, 2004, SCAND CARDIOVASC J, V38, P159, DOI 10.1080/14017430410031155
   Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162
   Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292
   Friberg L, 2000, EUR HEART J, V21, P1547, DOI 10.1053/euhj.2000.2125
   Hatzistergos KE, 2008, GROWTH HORM IGF RES, V18, P157, DOI 10.1016/j.ghir.2007.08.002
   Hodonsky C, 2014, CURR PHARM DESIGN, V20, P2012, DOI 10.2174/13816128113199990448
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Kolettis TM, 2011, MINI-REV MED CHEM, V11, P263
   Kolettis TM, 2013, CURR OPIN PHARMACOL, V13, P210, DOI 10.1016/j.coph.2013.01.001
   Kolettis TM, 2006, CARDIOVASC RES, V69, P299, DOI 10.1016/j.cardiores.2005.12.007
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002
   Li M, 2014, CURR PHARM DESIGN, V20, P1950, DOI 10.2174/13816128113199990447
   Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730
   Martin K, 2014, CURR PHARM DESIGN, V20, P1930, DOI 10.2174/13816128113199990450
   Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5
   Mitsi AC, 2006, GROWTH HORM IGF RES, V16, P93, DOI 10.1016/j.ghir.2006.02.001
   Mitsi AC, 2005, MED HYPOTHESES, V64, P582, DOI 10.1016/j.mehy.2004.07.028
   O'Sullivan JF, 2011, CIRC-CARDIOVASC INTE, V4, P327, DOI 10.1161/CIRCINTERVENTIONS.110.960765
   Olsson A, 2005, EUR J CARDIO-THORAC, V28, P448, DOI 10.1016/j.ejcts.2005.05.027
   Rao C, 2014, CURR PHARM DESIGN, V20, P2048, DOI 10.2174/13816128113199990442
   REISS K, 1994, J CELL PHYSIOL, V158, P160, DOI 10.1002/jcp.1041580120
   Robbins CS, 2010, CELL MOL LIFE SCI, V67, P2685, DOI 10.1007/s00018-010-0375-x
   Sarapultsev AP, 2014, CURR PHARM DESIGN, V20, P1980, DOI 10.2174/13816128113199990492
   Schuh A, 2014, CURR PHARM DESIGN, V20, P1964, DOI 10.2174/13816128113199990443
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Siedlecka U, 2008, AM J PHYSIOL-HEART C, V295, pH1917, DOI 10.1152/ajpheart.00258.2008
   Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017
   Soppa GKR, 2005, AM J PHYSIOL-HEART C, V288, pH1468, DOI 10.1152/ajpheart.00624.2004
   Sousonis V, 2014, CURR PHARM DESIGN, V20, P2003, DOI 10.2174/13816128113199990445
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Tsoporis JN, 2014, CURR PHARM DESIGN, V20, P1941, DOI 10.2174/13816128113199990444
   Tsoporis JN, 2005, EXP CELL RES, V303, P471, DOI 10.1016/j.yexcr.2004.10.018
   van Marion MH, 2014, CURR PHARM DESIGN, V20, P2057, DOI 10.2174/13816128113199990582
   Vilaeti AD, 2013, INT J CARDIOL, V165, P278, DOI 10.1016/j.ijcard.2011.08.036
   Wong K, 1998, CARDIOVASC RES, V37, P115, DOI 10.1016/S0008-6363(97)00190-9
   Yi X, 2014, CURR PHARM DESIGN, V20, P2040, DOI 10.2174/13816128113199990453
NR 52
TC 2
Z9 2
U1 0
U2 5
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD APR
PY 2014
VL 20
IS 12
BP 1925
EP 1929
DI 10.2174/138161282012140401153832
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AE9FY
UT WOS:000334312500001
PM 23844729
DA 2018-10-20
ER

PT J
AU Chatzinikolaidou, M
   Kaliva, M
   Batsali, A
   Pontikoglou, C
   Vamvakaki, M
AF Chatzinikolaidou, Maria
   Kaliva, Maria
   Batsali, Aristea
   Pontikoglou, Charalampos
   Vamvakaki, Maria
TI Wharton's Jelly Mesenchymal Stem Cell Response on Chitosan-graft-poly
   (epsilon -caprolactone) Copolymer for Myocardium Tissue Engineering
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Wharton's jelly; chitosan grafted poly(epsilon-caprolactone); cell
   adhesion; viability; proliferation; myocardium regeneration
ID HUMAN UMBILICAL-CORD; HEART-FAILURE; IN-VITRO; INFARCTION;
   DIFFERENTIATION; TRANSPLANTATION; CARDIOMYOCYTES; SCAFFOLDS; HYDROGEL;
   OPTION
AB Cell therapy and tissue engineering attract increasing attention as a potential approach for cardiac repair. Although a plethora of interesting concepts in the emerging field of cardiac stem cell-based tissue engineering are reported, there are still challenges that this field needs to overcome to achieve therapeutic translation into the clinical praxis. Engineering biomaterial scaffolds that facilitate stem cell engraftment, survival and homing are crucial for successful cellular cardiomyoplasty after myocardial infarction (MI). In this study we investigate for the first time the cellular response of Wharton's jelly (WJ) Mesenchymal Stem Cells (MSCs) on a copolymeric material comprising chitosan (CS) and poly(epsilon-caprolactone) (PCL). First we synthesize a copolymer consisting of poly(epsilon-caprolactone) grafted on a chemically modified chitosan-backbone (CS-g-PCL). Furthermore, we investigate the morphology, viability and proliferation of WJMSCs on material coatings and examine the cellular response from different donors. Our results show strong cell adhesion on the CS-g-PCL material surface from the first hours in culture, and a proliferation increase after 3 and 7 days. These findings support the potential use of our proposed cell-material combination in myocardium tissue engineering.
C1 [Chatzinikolaidou, Maria; Kaliva, Maria; Vamvakaki, Maria] Univ Crete, Dept Mat Sci & Technol, Iraklion, Greece.
   [Batsali, Aristea; Pontikoglou, Charalampos] Univ Crete, Sch Med, Dept Hematol, Iraklion, Greece.
   [Chatzinikolaidou, Maria; Kaliva, Maria; Vamvakaki, Maria] Fdn Res & Technol Hellas FORTH, Inst Elect Struct & Laser, Hellas, Greece.
RP Chatzinikolaidou, M (reprint author), Univ Crete, Dept Mat Sci & Technol, Iraklion, Greece.
EM mchatzin@materials.uoc.gr
RI Chatzinikolaidou, Maria/H-1061-2014
OI Chatzinikolaidou, Maria/0000-0002-2749-2506
FU Special Account for Research Fund of the University of Crete
FX This work was partly funded by the Special Account for Research Fund of
   the University of Crete. We would like to thank Ms. Aleka Manousaki and
   Ms. Alexandra Siakouli for expert technical assistance with SEM.
CR Breymann C, 2006, STEM CELL REV, V2, P87
   Cai GQ, 2009, MACROMOL BIOSCI, V9, P256, DOI 10.1002/mabi.200800153
   Chachques JC, 2009, EUR J CARDIO-THORAC, V35, P201, DOI 10.1016/j.ejcts.2008.09.028
   Chatzinikolaidou M, 2003, MATERIALWISS WERKST, V34, P1106, DOI 10.1002/mawe.200300714
   Chen MY, 2009, EXP HEMATOL, V37, P629, DOI 10.1016/j.exphem.2009.02.003
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Conconi MT, 2006, INT J MOL MED, V18, P1089
   Coutu DL, 2009, J CELL BIOCHEM, V108, P537, DOI 10.1002/jcb.22296
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Eschenhagen T, 2002, TRANSPL IMMUNOL, V9, P315, DOI 10.1016/S0966-3274(02)00011-4
   Fukuda K, 2006, CIRC RES, V98, P1002, DOI 10.1161/01.RES.0000218272.18669.6e
   HIRAI A, 1991, POLYM BULL, V26, P87, DOI 10.1007/BF00299352
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hollweck T, 2011, OPEN TISSUE ENG REGE, V4, P95
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Kehat I, 2003, HEART FAIL REV, V8, P229, DOI 10.1023/A:1024709332039
   Koerner MM, 2000, CURR OPIN CARDIOL, V15, P178, DOI 10.1097/00001573-200005000-00010
   Kofidis T, 2005, J HEART LUNG TRANSPL, V24, P737, DOI 10.1016/j.healun.2004.03.023
   Kolettis TM, 2011, MINI-REV MED CHEM, V11, P263
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Martinez EC, 2011, J MOL CELL CARDIOL, V50, P312, DOI 10.1016/j.yjmcc.2010.08.009
   Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200
   Piao H, 2007, BIOMATERIALS, V28, P641, DOI 10.1016/j.biomaterials.2006.09.009
   Schmidt D, 2006, TISSUE ENG, V12, P3223, DOI 10.1089/ten.2006.12.3223
   Smith RR, 2008, HEART RHYTHM, V5, P880, DOI 10.1016/j.hrthm.2008.02.011
   Terzaki K, 2013, J BIOMEDICAL MAT R A
   Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439
   Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yang MC, 2009, BIOMATERIALS, V30, P3757, DOI 10.1016/j.biomaterials.2009.03.057
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
NR 36
TC 6
Z9 6
U1 3
U2 24
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD APR
PY 2014
VL 20
IS 12
BP 2030
EP 2039
DI 10.2174/13816128113199990446
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AE9FY
UT WOS:000334312500012
PM 23844735
DA 2018-10-20
ER

PT J
AU Yi, X
   Li, XY
   Ren, S
   He, YY
   Wan, WG
   Wen, Y
   Jiang, XJ
AF Yi, Xin
   Li, Xiaoyan
   Ren, Shan
   He, Yiyu
   Wan, Weiguo
   Wen, Ying
   Jiang, Xuejun
TI A Novel, Biodegradable, Thermoresponsive Hydrogel Attenuates Ventricular
   Remodeling and Improves Cardiac Function Following Myocardial Infarction
   - a review
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE Thermoresponsive hydrogel; ventricular remodeling; cardiac function;
   myocardial infarction; cardiac tissue engineering
ID MATRIX-METALLOPROTEINASE ACTIVITY; ISCHEMIC-HEART FAILURE; INJECTABLE
   HYDROGEL; DRUG-DELIVERY; SKELETAL MYOBLASTS; IN-VITRO; INTRACORONARY
   INJECTION; POLY(ETHYLENE GLYCOL); CULTURE SURFACES; ANGIOTENSIN-II
AB Myocardial infarction (MI) and the subsequent heart failure remain among of the leading causes of morbidity and mortality in world wide. A number of studies have demonstrated that intramyocardial biomaterials injections improve cardiac function after implantation because of their angiogenic potential. Thermoresponsive hydrogels, one member of the hydrogels family, are a kind of biomaterial whose structure is similar to that of extracellular matrix. These hydrogels have been interesting for biomedical uses as they can swell in situ under physiological conditions and provide the advantage of convenient administration. The hydrogel that our team is interested in is a novel biodegradable injectable thermoresponsive hydrogel-the copolymer dextran-poly (epsilon-caprolactone) -2-hydroxylethyl methacrylatepoly (N-isopropylacrylaminde) (Dex-PCL-HEMA/PNIPAAm). Thus, this review will focus on requirements and challenges of injectable synthetic material, and possible mechanism of thermoresponsive hydrogel in treating MI. The main emphases are on the work done and future interesting studies in our laboratory.
C1 [Yi, Xin; Li, Xiaoyan; Ren, Shan; He, Yiyu; Wan, Weiguo; Wen, Ying; Jiang, Xuejun] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430060, Peoples R China.
   [Yi, Xin; Li, Xiaoyan; Ren, Shan; He, Yiyu; Wan, Weiguo; Wen, Ying; Jiang, Xuejun] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430060, Peoples R China.
RP Jiang, XJ (reprint author), Wuhan Univ, Renmin Hosp, Cardiovasc Res Inst, Dept Cardiol, Jiefang Rd 238, Wuhan 430060, Peoples R China.
EM xjjiang@whu.edu.cn
FU National Natural Science Foundation of China [81170307]
FX This work was supported by National Natural Science Foundation of China
   Grants 81170307.
CR Adeldoew Catharina A. M., 2007, V140, P125
   Anversa P, 2006, J AM COLL CARDIOL, V47, P1769, DOI 10.1016/j.jacc.2006.02,003
   Beck JB, 2003, J AM CHEM SOC, V125, P13922, DOI 10.1021/ja038521k
   Bleeker CB, 2006, NAT CLIN PRACT CARD, V3, P213
   Bowen FW, 2001, ANN THORAC SURG, V72, P1950, DOI 10.1016/S0003-4975(01)03282-9
   Chen FM, 2007, J CONTROL RELEASE, V118, P65, DOI 10.1016/j.jconrel.2006.11.016
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Croy SR, 2006, CURR PHARM DESIGN, V12, P4669, DOI 10.2174/138161206779026245
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3
   Dib N, 2002, J ENDOVASC THER, V9, P313, DOI 10.1583/1545-1550(2002)009<0313:ETOASM>2.0.CO;2
   Dib Nabil, 2006, Journal of Pharmacological and Toxicological Methods, V54, P71, DOI 10.1016/j.vascn.2005.12.002
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Ebara M, 2004, BIOMACROMOLECULES, V5, P505, DOI 10.1021/bm0343601
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   He YY, 2012, J CARDIOVASC PHARM
   HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548
   Holland TA, 2003, J CONTROL RELEASE, V86, P1, DOI 10.1016/S0168-3659(02)00373-5
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   HUTCHINS GM, 1978, AM J CARDIOL, V41, P1127, DOI 10.1016/0002-9149(78)90869-X
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Izutsu KI, 2005, J PHARM SCI-US, V94, P709, DOI 10.1002/jps.20292
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   JEREMY RW, 1987, J AM COLL CARDIOL, V9, P989, DOI 10.1016/S0735-1097(87)80298-X
   Jiang XJ, 2008, J BIOMED MAT, V90, P472
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kaneko Y, 1999, J BIOMAT SCI-POLYM E, V10, P1079, DOI 10.1163/156856299X00757
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Kobayashi S, 2000, BIOMACROMOLECULES, V1, P3, DOI 10.1021/bm990007c
   Kofidis T, 2005, CIRCULATION, V112, P1173
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee J, 2006, BIOMACROMOLECULES, V7, P1729, DOI 10.1021/bm0600062
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li XY, 2010, CARDIOLOGY, V115, P194, DOI 10.1159/000281840
   Lima AC, 2011, PHARM RES-DORDR, V28, P1294, DOI 10.1007/s11095-011-0380-2
   Liu Y, 2007, J CONTROL RELEASE, V117, P387, DOI 10.1016/j.jconrel.2006.11.024
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutz JF, 2006, J AM CHEM SOC, V128, P13046, DOI 10.1021/ja065324n
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006
   Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Prabu P, 2006, J BIOMED MATER RES A, V79A, P153, DOI 10.1002/jbm.a.30715
   Rane AA, 2011, PLOS ONE, V6
   Ren S, 2012, J INT MED RES, V40, P2167, DOI 10.1177/030006051204000615
   Rhee SH, 2002, BIOMATERIALS, V23, P4915, DOI 10.1016/S0142-9612(02)00251-X
   Ruiz-Ortega M, 2005, ANTIOXID REDOX SIGN, V7, P1258, DOI 10.1089/ars.2005.7.1258
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Salimath AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050980
   Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017
   Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8
   Sun Y, 2002, BASIC RES CARDIOL, V97, P343, DOI 10.1007/s00395-002-0365-8
   Sun Y, 2010, J MOL CELL CARDIOL, V48, P483, DOI 10.1016/j.yjmcc.2009.08.002
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Thomas CV, 1998, CIRCULATION, V97, P1708, DOI 10.1161/01.CIR.97.17.1708
   Tsuda Y, 2004, J BIOMED MATER RES A, V69A, P70, DOI 10.1002/jbm.a.20114
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Tyagi SC, 1996, MOL CELL BIOCHEM, V155, P13, DOI 10.1007/BF00714328
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang Tao, 2010, Zhonghua Yi Xue Za Zhi, V90, P259
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Wang T, 2009, BIOMATERIALS, V30, P4161, DOI 10.1016/j.biomaterials.2009.04.033
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   WEISMAN HF, 1988, CIRCULATION, V78, P186, DOI 10.1161/01.CIR.78.1.186
   Wu De-Qun, 2009, ACS APPL MATER INTER, V2, P319
   Wu J, 2007, BIOMATERIALS, V28, P2220, DOI 10.1016/j.biomaterials.2006.12.024
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Xiao F, 2009, COLLOID SURFACE B, V71, P13, DOI 10.1016/j.colsurfb.2008.12.040
   Xie JW, 2010, CURR PHARM DESIGN, V16, P2331, DOI 10.2174/138161210791920432
   Xu QX, 2010, CURR PHARM DESIGN, V16, P2350, DOI 10.2174/138161210791920469
   Yasuhiko T., 2009, J R SOC INTERFACE, V6, pS311
   Yellepeddi VK, 2009, EXPERT OPIN DRUG DEL, V6, P835, DOI 10.1517/17425240903061251
   Yockman JW, 2008, J CONTROL RELEASE, V132, P260, DOI 10.1016/j.jconrel.2008.06.024
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Zhang XQ, 2007, BIOMACROMOLECULES, V8, P3557, DOI 10.1021/bm700729t
NR 86
TC 4
Z9 6
U1 2
U2 57
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD APR
PY 2014
VL 20
IS 12
BP 2040
EP 2047
DI 10.2174/13816128113199990453
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AE9FY
UT WOS:000334312500013
PM 23844737
DA 2018-10-20
ER

PT J
AU Vuorenpaa, H
   Ikonen, L
   Kujala, K
   Huttala, O
   Sarkanen, JR
   Ylikomi, T
   Aalto-Setala, K
   Heinonen, T
AF Vuorenpaa, Hanna
   Ikonen, Liisa
   Kujala, Kirsi
   Huttala, Outi
   Sarkanen, Jertta-Riina
   Ylikomi, Timo
   Aalto-Setala, Katriina
   Heinonen, Tuula
TI Novel in vitro cardiovascular constructs composed of vascular-like
   networks and cardiomyocytes
SO IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
LA English
DT Article
DE Angiogenesis; Primary cardiomyocytes; Human adipose stromal cells, in
   vitro cardiotoxicity
ID ADIPOSE STROMAL CELLS; ENGINEERED HUMAN MYOCARDIUM; EMBRYONIC
   STEM-CELLS; CARDIAC MYOCYTES; MICROELECTRODE ARRAYS; SCAFFOLD-FREE;
   ADULT-RAT; TISSUE; HEART; MUSCLE
AB The interaction between different cardiac cells has shown to be important for critical biological properties including cell survival, proliferation, differentiation and function. The improvement of culture conditions with different cell types and to study their effects on cardiomyocyte viability and functionality is essential. For practical applications including general toxicity testing, drug development and tissue engineering it is important to study whether co-cultures have additional advantages over cardiomyocyte monoculture. Two multicellular in vitro cardiovascular constructs devoid of added biomaterial were developed in this study. In the first construct, neonatal rat cardiomyocytes (CM) were seeded on vascular-like network formed by human umbilical vein endothelial cells (HUVEC) and human adipose stromal cells (hASC). In the second construct, CMs were seeded on vascular-like network formed by HUVECs and human foreskin fibroblasts. The ability of these two vascular-like networks to support the viability and functionality of CMs was analyzed. Different culture media compositions were evaluated to support the development of optimal cardiovascular construct. Our results demonstrate that both vascular-like networks markedly improved CM viability and functionality. In the constructs, co-localization of CMs and vascular-like networks was seen. Multicellular constructs also allowed synchronized contractility of CMs. Serum-free medium supplemented with vascular endothelial growth factor and basic fibroblast growth factor was found to provide the most optimal conditions for cardiovascular construct as an entity. In conclusion, when combining a vascular-like network with CMs, the viability and functionality of CMs was markedly improved. The results suggest that the cardiovascular constructs developed provide a promising new tool for the assessment of toxicological and safety pharmacological effects of compounds in vitro.
C1 [Vuorenpaa, Hanna; Huttala, Outi; Sarkanen, Jertta-Riina; Ylikomi, Timo; Heinonen, Tuula] Univ Tampere, FICAM, Finnish Ctr Alternat Methods, Sch Med, FIN-33101 Tampere, Finland.
   [Ikonen, Liisa; Kujala, Kirsi; Aalto-Setala, Katriina] Univ Tampere, IBT Inst Biomed Technol, Tampere 33520, Finland.
   [Ikonen, Liisa; Kujala, Kirsi; Aalto-Setala, Katriina] BioMediTech, Tampere 33520, Finland.
   [Ylikomi, Timo] Univ Tampere, Sch Med, Dept Cell Biol, Tampere 33014, Finland.
   [Ylikomi, Timo] Tampere Univ Hosp, Dept Clin Chem, Tampere 33014, Finland.
   [Aalto-Setala, Katriina] Tampere Univ Hosp, Ctr Heart, Tampere 33520, Finland.
RP Vuorenpaa, H (reprint author), Univ Tampere, FICAM, Finnish Ctr Alternat Methods, Sch Med, FIN-33101 Tampere, Finland.
EM hanna.vuorenpaa@uta.fi
FU Pirkanmaa Centers for Economic Development, Transport and the
   Environment; City of Tampere; Ministry of Education and Culture;
   Ministry of Agriculture and Forestry; Finnish Cultural Foundation;
   Academy of Finland; Tekes-the Finnish Funding Agency for Technology and
   Innovation; Paavo Nurmi Foundation; Foundation of Aarne and Aili
   Turunen; Finnish Foundation for Cardiovascular Research; FinPharma
   Doctoral Program
FX Funding for the project was provided by Pirkanmaa Centers for Economic
   Development, Transport and the Environment; City of Tampere; Ministry of
   Education and Culture; Ministry of Agriculture and Forestry; Finnish
   Cultural Foundation; Academy of Finland; Tekes-the Finnish Funding
   Agency for Technology and Innovation; Paavo Nurmi Foundation; Foundation
   of Aarne and Aili Turunen; Finnish Foundation for Cardiovascular
   Research and FinPharma Doctoral Program.
CR Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007.
   Banyasz T, 2008, EXP PHYSIOL, V93, P370, DOI 10.1113/expphysiol.2007.040659
   Bhattacharya S, 2006, CLIN SCI, V111, P35, DOI 10.1042/cs20060003
   Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002
   Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   De Siena R, 2010, EXP CELL RES, V316, P1804, DOI 10.1016/j.yexcr.2010.02.009
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   He WJ, 2012, J HEART LUNG TRANSPL, V31, P204, DOI 10.1016/j.healun.2011.11.010
   Hsieh PCH, 2006, ANNU REV PHYSIOL, V68, P51, DOI 10.1146/annurev.physiol.68.040104.124629
   Hussain A, 2013, BIOTECHNOL BIOENG, V110, P637, DOI 10.1002/bit.24727
   Iyer RK, 2011, CURR OPIN BIOTECH, V22, P706, DOI 10.1016/j.copbio.2011.04.004
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kettenhofen R., 2005, DRUG DISCOV TODAY, V13, P702
   Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068
   Kreutziger KL, 2011, TISSUE ENG PT A, V17, P1219, DOI [10.1089/ten.tea.2010.0557, 10.1089/ten.TEA.2010.0557]
   Kujala VJ, 2011, COMPUT METH PROG BIO, V104, P199, DOI 10.1016/j.cmpb.2011.04.001
   KYOSOLA K, 1983, ANN CLIN RES, V15, P156
   Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215
   Lesman A, 2010, ANN NY ACAD SCI, V1188, P46, DOI 10.1111/j.1749-6632.2009.05082.x
   Lexchin J, 2005, CAN MED ASSOC J, V172, P765, DOI 10.1503/cmaj.045021
   Li RK, 2002, HUMAN CELL CULTURE, P118
   Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0
   Montessuit C, 2004, CARDIOVASC RES, V64, P94, DOI 10.1016/j.cardiores.2004.06.005
   NAG AC, 1980, CYTOBIOS, V28, P41
   Narang Deepak, 2004, BMC Pharmacology, V4, P29, DOI 10.1186/1471-2210-4-29
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Reppel M, 2004, J ELECTROCARDIOL, V37, P104, DOI 10.1016/j.jelectrocard.2004.08.033
   Rivron NC, 2008, EUR CELLS MATER, V15, P27, DOI 10.22203/eCM.v015a03
   Rubina K, 2009, TISSUE ENG PT A, V15, P2039, DOI 10.1089/ten.tea.2008.0359
   Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058
   Sarkanen JR, 2012, CELLS TISSUES ORGANS, V196, P385, DOI 10.1159/000336679
   Sarkanen JR, 2011, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00147
   Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   UUSIMAA PA, 1992, ENDOCRINOLOGY, V130, P2455, DOI 10.1210/en.130.5.2455
   Valarmathi MT, 2010, BIOMATERIALS, V31, P3185, DOI 10.1016/j.biomaterials.2010.01.041
NR 46
TC 8
Z9 8
U1 1
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1071-2690
EI 1543-706X
J9 IN VITRO CELL DEV-AN
JI In Vitro Cell. Dev. Biol.-Anim.
PD APR
PY 2014
VL 50
IS 4
BP 275
EP 286
DI 10.1007/s11626-013-9703-4
PG 12
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA AF0NG
UT WOS:000334410700001
PM 24163159
DA 2018-10-20
ER

PT J
AU Karimi, A
   Navidbakhsh, M
   Yousefi, H
AF Karimi, Alireza
   Navidbakhsh, Mahdi
   Yousefi, Hossein
TI Mechanical properties of polyvinyl alcohol sponge under different strain
   rates
SO INTERNATIONAL JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
DE PVA sponge; Mechanical properties; Stress-strain diagram; Energy
   absorption; Tissue engineering
ID HUMAN CORONARY-ARTERIES; UNCONFINED COMPRESSION; PVA HYDROGEL;
   COMPOSITE; TISSUE; HEALTHY; DESIGN
AB Polyvinyl alcohol (PVA) is a suitable material for biomedical and pharmaceutical applications. This paper presents a scientific study on the stiffness, strength, and energy absorption characteristics of a fabricated PVA sponge under different strain rates with a view to using it as an alternative biodegradable and biocompatible material. A range of tensile tests, such as stress failure and cyclic, on PVA sponge have been carried out. The stress strain curves in all strain rates (1, 20, 100 mm min(-1)) indicated a near constant plateau stress over a long strain range, which is ideal for energy absorption applications. It was found that the PVA sponge biomaterial exhibited remarkable stiffness, strength, and energy absorption capacities that are comparable to those of some biomaterials with the same density range. PVA sponge can also bear suitable stress both at low and high strain rates which enables it to be implemented in most tissue engineering scaffolds.
C1 [Karimi, Alireza; Navidbakhsh, Mahdi] Iran Univ Sci & Technol, Sch Mech Engn, Tehran 16844, Iran.
   [Karimi, Alireza; Navidbakhsh, Mahdi] Iran Univ Sci & Technol, Sch Mech Engn, Tissue Engn & Biol Syst Res Lab, Tehran 16844, Iran.
   [Yousefi, Hossein] Univ Tehran, Fac New Sci & Technol, Tehran, Iran.
RP Navidbakhsh, M (reprint author), Iran Univ Sci & Technol, Sch Mech Engn, Tehran 16844, Iran.
EM mnavid@iust.ac.ir
RI Navidbakhsh, Mahdi/S-9351-2018
OI Yousefi, Hossein/0000-0002-6372-5127
FU Iran University of Science and Technology
FX The authors acknowledge Iran University of Science and Technology for
   funding this project.
CR Arabnejad S, 2013, INT J MECH SCI, V77, P249, DOI 10.1016/j.ijmecsci.2013.10.003
   Ashby M.F., 2000, METAL FOAMS DESIGN G
   Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726
   Cadman J, 2013, MAT SCI ENG C-MATER, V33, P3146, DOI 10.1016/j.msec.2013.03.031
   Chang SJ, 2012, CARBOHYD POLYM, V88, P684, DOI 10.1016/j.carbpol.2012.01.017
   Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02
   Davidson JP, 1998, ARCH DERMATOL RES, V290, P1
   Efron DT, 2003, METH MOLEC MED, V78, P83
   Faturechi R., 2014, TISSUE ENG, V4, P25, DOI [10.1166/jbt.2014.1156, DOI 10.1166/JBT.2014.1156]
   Gibson L. J., 2010, CELLULAR MAT NATURE, DOI [10.1038/nature09587, DOI 10.1038/NATURE09587]
   Jiang HJ, 2004, MED ENG PHYS, V26, P269, DOI 10.1016/j.medengphy.2003.10.007
   Jiang S, 2011, J MECH BEHAV BIOMED, V4, P1228, DOI 10.1016/j.jmbbm.2011.04.005
   Johnson M, 2010, ACTA BIOMATER, V6, P2181, DOI 10.1016/j.actbio.2009.12.006
   Karimi A., 2013, PERFUSION IN PRESS, DOI [10.1177/0267659113513823, DOI 10.1177/0267659113513823, 10.1177/0267659113513823.]
   Karimi A, 2014, J THERMOPLA IN PRESS, DOI [10.1177/0892705713520176, DOI 10.1177/0892705713520176]
   Karimi A., 2013, MAT TECHNOL IN PRESS
   Karimi A., 2013, PERFUSION IN PRESS, DOI [10.1177/0267659113502835, DOI 10.1177/0267659113502835]
   Karimi A, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40257
   Karimi A, 2014, TISSUE CELL, V46, P97, DOI 10.1016/j.tice.2013.12.004
   Karimi A, 2014, BIOMED ENG-APP BAS C, V26, DOI 10.4015/S1016237214500136
   Karimi A, 2014, J BIOMATER TISS ENG, V4, P46, DOI 10.1166/jbt.2014.1134
   Karimi A, 2013, P I MECH ENG H, V227, P609, DOI 10.1177/0954411913476779
   Karimi A, 2013, MAT SCI ENG C-MATER, V33, P2550, DOI 10.1016/j.msec.2013.02.016
   Karimi A, 2013, P I MECH ENG H, V227, P148, DOI 10.1177/0954411912461239
   Korteweg W., 2004, US Pat, Patent No. 6711879
   Lee CT, 2005, CARBOHYD POLYM, V61, P348, DOI 10.1016/j.carbpol.2005.06.018
   Lee SY, 2009, ACTA BIOMATER, V5, P1919, DOI 10.1016/j.actbio.2009.02.014
   Liu LF, 2012, WATER RES, V46, P1969, DOI 10.1016/j.watres.2012.01.017
   Liu YR, 2010, J MECH BEHAV BIOMED, V3, P203, DOI 10.1016/j.jmbbm.2009.07.001
   Lu G, 2003, ENERGY ABSORPTION ST
   Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2
   Moscato S, 2008, MICRON, V39, P569, DOI 10.1016/j.micron.2007.06.016
   Setiawan L, 2012, J MEMBRANE SCI, V394, P80, DOI 10.1016/j.memsci.2011.12.026
   Shen JH, 2012, J MECH BEHAV BIOMED, V15, P141, DOI 10.1016/j.jmbbm.2012.07.004
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Zhang DK, 2012, J BIONIC ENG, V9, P234, DOI 10.1016/S1672-6529(11)60116-9
   Zhang ZQ, 2011, P ROY SOC B-BIOL SCI, V278, P519, DOI 10.1098/rspb.2010.1093
NR 38
TC 33
Z9 35
U1 6
U2 38
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 1862-5282
EI 2195-8556
J9 INT J MATER RES
JI Int. J. Mater. Res.
PD APR
PY 2014
VL 105
IS 4
BP 404
EP 408
DI 10.3139/146.111036
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA AF0HK
UT WOS:000334394700013
DA 2018-10-20
ER

PT J
AU Wigton, E
   Swanner, JC
   Joiner, W
   Feldman, A
   McGwin, G
   Huisingh, C
   Curcio, CA
   Girkin, CA
AF Wigton, Eric
   Swanner, Jason C.
   Joiner, Wade
   Feldman, Alex
   McGwin, Gerald, Jr.
   Huisingh, Carrie
   Curcio, Christine A.
   Girkin, Christopher A.
TI Outcomes of Shunt Tube Coverage With Glycerol Preserved Cornea Versus
   Pericardium
SO JOURNAL OF GLAUCOMA
LA English
DT Article
DE patch graft; glaucoma drainage implant; exposure; pericardium; cornea;
   shunt tube
ID GLAUCOMA DRAINAGE DEVICE; MOLTENO IMPLANT-SURGERY; AMNIOTIC MEMBRANE;
   PATCH GRAFT; POSTOPERATIVE COMPLICATIONS; AQUEOUS SHUNTS; EXPOSURE;
   EROSION; SETONS
AB Pericardium is a biomaterial widely used for covering the outflow tubes of glaucoma drainage devices. Recently, glycerol preserved cornea has been introduced as an alternative that offers durability and improved cosmesis because of its clarity. We retrospectively reviewed 262 patients in the University of Alabama Birmingham Glaucoma Service who underwent shunt procedures using either cornea tissue or pericardium to cover the tube. The primary outcome measure was the number of erosions of the covering material. Nine out of 101 (8.9%) patients in the pericardium covered group experienced an erosion compared with 3 out of 161 (1.9%) in the cornea covered group. A significant difference was reached with P=0.0125. Median follow-up was 440 days for the cornea group and 331 days for the pericardium group. The type of glaucoma (primary open-angle glaucoma vs. secondary glaucoma) was not associated with the risk of erosion (odds ratio, 0.501; 95% confidence interval, 0.204-1.234). The median time to exposure was 252 days in the pericardium group and 440 days in the cornea group (P=0.0017).
C1 [Wigton, Eric; Swanner, Jason C.; Joiner, Wade; Feldman, Alex; McGwin, Gerald, Jr.; Huisingh, Carrie; Curcio, Christine A.; Girkin, Christopher A.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA.
RP Wigton, E (reprint author), Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA.
EM ericwigton@yahoo.com
OI Girkin, Chris/0000-0002-9676-4499; Huisingh, Carrie/0000-0002-7010-2024
FU Global Sight Network
FX C.A.C. discloses that she receives partial salary support from Global
   Sight Network, supplier of glycerol-preserved corneas. The remaining
   authors declare no conflict of interest.
CR Ainsworth G, 2006, BRIT J OPHTHALMOL, V90, P417, DOI 10.1136/bjo.2005.084905
   Anand A, 2011, OPHTHAL SURG LAS IM, V42, P184, DOI 10.3928/15428877-20110426-01
   Budenz DL, 2011, OPHTHALMOLOGY, V118, P443, DOI 10.1016/j.ophtha.2010.07.016
   Desai Manishi A, 2011, Ophthalmic Surg Lasers Imaging, V42, P202, DOI [10.3928/15428877-20110224-94, 10.3928/15428877-20110224-04]
   Feilmeier MR, 2010, MIDDLE EAST AFR J OP, V17, P38, DOI 10.4103/0974-9233.61215
   FREEDMAN J, 1987, OPHTHALMIC SURG LAS, V18, P532
   Gedde SJ, 2007, AM J OPHTHALMOL, V143, P23, DOI 10.1016/j.ajo.2006.07.022
   Gedde SJ, 2011, EXP EYE RES, V93, P284, DOI 10.1016/j.exer.2011.03.013
   Heuer DK, 2001, J GLAUCOMA, V10, P493, DOI 10.1097/00061198-200112000-00010
   Huddleston SM, 2011, J GLAUCOMA
   Irak I, 2004, OPHTHAL SURG LAS IM, V35, P189
   Kalenak JW, 2010, J GLAUCOMA, V19, P5, DOI 10.1097/IJG.0b013e31819aa593
   KREBS DB, 1992, ARCH OPHTHALMOL-CHIC, V110, P174, DOI 10.1001/archopht.1992.01080140024014
   Lama PJ, 1999, ARCH OPHTHALMOL-CHIC, V117, P1243
   Lankaranian D, 2008, J GLAUCOMA, V17, P48, DOI 10.1097/IJG.0b013e318133fc49
   LOTUFO DG, 1991, OPHTHALMIC SURG LAS, V22, P650
   MELAMED S, 1991, AM J OPHTHALMOL, V111, P319, DOI 10.1016/S0002-9394(14)72316-5
   MELAMED S, 1990, SURV OPHTHALMOL, V34, P441, DOI 10.1016/0039-6257(90)90124-E
   Minckler DS, 2008, OPHTHALMOLOGY, V115, P1089, DOI 10.1016/j.ophtha.2008.03.031
   MINCKLER DS, 1988, OPHTHALMOLOGY, V95, P1181
   Papadaki TG, 2007, J GLAUCOMA, V16, P171, DOI 10.1097/01.ijg.0000212292.93292.80
   Raviv T, 1998, J GLAUCOMA, V7, P27
   Rojanapongpun P, 1996, AM J OPHTHALMOL, V122, P424, DOI 10.1016/S0002-9394(14)72070-7
   Singh M, 2008, CORNEA, V27, P1171, DOI 10.1097/ICO.0b013e3181814d15
   Smith MF, 2002, J GLAUCOMA, V11, P143, DOI 10.1097/00061198-200204000-00010
   Stein JD, 2008, OPTHTHALMOLOGY, V115, P109
   Stewart WC, 2010, EUR J OPHTHALMOL, V20, P124
NR 27
TC 18
Z9 18
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1057-0829
EI 1536-481X
J9 J GLAUCOMA
JI J. Glaucoma
PD APR-MAY
PY 2014
VL 23
IS 4
BP 258
EP 261
DI 10.1097/IJG.0b013e31826a96e8
PG 4
WC Ophthalmology
SC Ophthalmology
GA AE8JG
UT WOS:000334245600012
PM 22955016
DA 2018-10-20
ER

PT J
AU Jiang, RJ
   Yang, B
   Yi, D
   Wang, F
   Han, B
   Zhao, YL
   Liao, XL
   Yang, J
   Gao, CZ
AF Jiang, Rui-Jian
   Yang, Bo
   Yi, Dong
   Wang, Fen
   Han, Bin
   Zhao, Yu-Lin
   Liao, Xia-Li
   Yang, Jian
   Gao, Chuan-Zhu
TI Synthesis and characterization of a series of novel amino
   beta-cyclodextrin-conjugated poly(epsilon-lysine) derivatives
SO JOURNAL OF POLYMER ENGINEERING
LA English
DT Article
DE beta-cyclodextrin; biomaterial; characterization; poly( epsilon-lysine);
   polymer.
ID BIOMEDICAL APPLICATIONS; GENE DELIVERY; PARTICLES; POLYMERS; LYSINE; DNA
AB Soluble poly(epsilon-lysine)s bearing beta-cyclodextrin (beta-CD) moieties were prepared by three amino beta-CD derivatives and N-succinylated poly(epsilon-lysine), in which the poly(e-lysine) and amino beta-CD derivatives were bonded covalently to the end carboxyl groups of succinic acid by peptide bonds. 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDCI) and N-hydroxysuccinimide (NHS) were chosen to assist the reaction. The three poly(epsilon-lysine) derivatives were characterized by H-1 nuclear magnetic resonance (H-1 NMR) and Fourier transform infrared (FT-IR). The synthesis process is simple, feasible and has strong practicability. The target polymers can serve as new polymer biomaterial for use in the biotechnology area.
C1 [Jiang, Rui-Jian; Yang, Bo; Yi, Dong; Wang, Fen; Han, Bin; Liao, Xia-Li; Yang, Jian; Gao, Chuan-Zhu] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Dept Pharmaceut Engn, Kunming 650500, Peoples R China.
   [Zhao, Yu-Lin] Kunming Univ Sci & Technol, Fac Chem Engn, Kunming 650500, Peoples R China.
RP Yang, B (reprint author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Dept Pharmaceut Engn, Kunming 650500, Peoples R China.
EM yangbo6910@sina.com
FU National Natural Science Foundation of China (NNSFC) [21062009]; Natural
   Science Foundation of Yunnan Province [2009ZC045M]
FX This work was supported by the National Natural Science Foundation of
   China (NNSFC) (No. 21062009) and the Natural Science Foundation of
   Yunnan Province (No. 2009ZC045M), which are gratefully acknowledged.
CR Bankar SB, 2013, RSC ADV, V3, P8586, DOI 10.1039/c3ra22596h
   Bellocq NC, 2003, BIOCONJUGATE CHEM, V14, P1122, DOI 10.1021/bc034125f
   Bielinska AU, 1997, BBA-GENE STRUCT EXPR, V1353, P180, DOI 10.1016/S0167-4781(97)00069-9
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Choi HS, 2005, CHEMBIOCHEM, V6, P1986, DOI 10.1002/cbic.200500242
   Davis ME, 2004, CURR MED CHEM, V11, P179, DOI 10.2174/0929867043456179
   Green NK, 2002, CANCER GENE THER, V9, P1036, DOI 10.1038/sj.cgt.7700541
   Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565
   Mishra S, 2006, J CONTROL RELEASE, V116, P179, DOI 10.1016/j.jconrel.2006.06.018
   Nielsen LL, 1998, CANCER GENE THER, V5, P52
   Pun SH, 2004, CANCER BIOL THER, V3, P641, DOI 10.4161/cbt.3.7.918
   Shih IL, 2006, BIORESOURCE TECHNOL, V97, P1148, DOI 10.1016/j.biortech.2004.08.012
   Shih IL, 2004, MINI-REV MED CHEM, V4, P179, DOI 10.2174/1389557043487420
   Singh B, 2009, J POLYM ENG, V29, P249, DOI 10.1515/POLYENG.2009.29.5.249
   UENO A, 1983, CHEM LETT, P1635, DOI 10.1246/cl.1983.1635
   Ye H, 2013, J POLYM ENG, V33, P285, DOI 10.1515/polyeng-2013-0016
   Yoshida T, 2003, APPL MICROBIOL BIOT, V62, P21, DOI 10.1007/s00253-003-1312-9
   Yu P, 2011, J CHEM RES, P703, DOI 10.3184/174751911X13230201951890
NR 18
TC 3
Z9 3
U1 1
U2 39
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-6447
EI 2191-0340
J9 J POLYM ENG
JI J. Polym. Eng.
PD APR
PY 2014
VL 34
IS 2
BP 133
EP 139
DI 10.1515/polyeng-2013-0194
PG 7
WC Polymer Science
SC Polymer Science
GA AE8XZ
UT WOS:000334287600004
DA 2018-10-20
ER

PT J
AU Xing, ZC
   Chang, KW
   Chun, S
   Kim, S
   Kang, IK
AF Xing, Zhi-Cai
   Chang, Ki-Whan
   Chun, Sungsu
   Kim, Sukyoung
   Kang, Inn-Kyu
TI Immobilization of collagen on hydroxyapatite discs by covalent bonding
   and physical adsorption and their interaction with MC3T3-E1 osteoblasts
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE hydroxyapatite; collagen type I; immobilization; osteoblasts
ID CELL-ADHESION; I COLLAGEN; SCAFFOLD; PHENOTYPE; MATRIX; GROWTH;
   DIFFERENTIATION; POLY(L-LACTIDE); NANOPARTICLES; BIOMATERIAL
AB Hydroxyapatite (HA), a type of calcium phosphate mineral, shows high biological affinity to living bone and is widely used as a substitute for filling bone defects. The purpose of this study was to immobilize collagen on HA discs via covalent bonding and physical adsorption and to evaluate their interaction with MC3T3-E1 osteoblasts. Type I collagen was immobilized on the surface of sintered HA discs in two ways. The first way was to immobilize collagen covalently on the surface of a HA disc (HA-C) through a coupling agent, 3-aminopropyltriethoxysilane. The second one was to immobilize collagen on the surface of a HA disc in the manner of physical adsorption (HAhC). The surface properties of HA immobilized with collagen were characterized and compared with non-immobilized HA (control). The potentiality of collagen-immobilized HA discs for use as bone substitutes or scaffolds were assessed by culturing MC3T3-E1 osteoblasts on the discs. The osteoblasts were cultured for 4 and 68 h on HA discs to examine cell adhesion and proliferation, respectively. Alkaline phosphatase (ALP) activity assay was used to study the in vitro differentiation of MC3T3-E1 osteoblasts when cultured on the modified HA discs. From the results, it was apparent that the osteoblasts had proliferated more on the HA-C disc than on the HA-hC disc. The better proliferation was probably attributed to the higher amount of collagen covalently immobilized than that immobilized by physical adsorption. It was found, from the ALP activity assay, that HA-C showed better osteoblastic differentiation than HA-hC. It was considered that the higher ALP activity of HA-C was mainly expressed by the larger amount of collagen immobilized on the HA surface.
C1 [Xing, Zhi-Cai; Kang, Inn-Kyu] Kyungpook Natl Univ, Dept Polymer Sci & Engn, Taegu 702701, South Korea.
   [Chang, Ki-Whan] Daegu Hlth Coll, Dept Dent Technol, Taegu 702722, South Korea.
   [Chang, Ki-Whan; Chun, Sungsu; Kim, Sukyoung] Yeungnam Univ, Sch Mat Sci & Engn, Kyongsan 712749, Gyeonbuk, South Korea.
RP Kim, S (reprint author), Yeungnam Univ, Sch Mat Sci & Engn, Kyongsan 712749, Gyeonbuk, South Korea.
EM sykim@ynu.ac.kr; ikkang@knu.ac.kr
FU Ministry of Education, Science and Technology of Korea [2013 RIA
   2005148]
FX This work was supported from the General Research Program (2013 RIA
   2005148) from the Ministry of Education, Science and Technology of
   Korea.
CR Auclair-Daigle C, 2005, J BIOMED MATER RES A, V73A, P398, DOI 10.1002/jbm.a.30284
   Brunel G, 2001, J PERIODONTOL, V72, P257, DOI 10.1902/jop.2001.72.2.257
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Chiu JB, 2007, J BIOMED MATER RES A, V83A, P1117, DOI 10.1002/jbm.a.31279
   Cirelli JA, 1997, BIOMATERIALS, V18, P1227, DOI 10.1016/S0142-9612(97)00053-7
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   Hanagata N, 2006, BIOCHEM BIOPH RES CO, V344, P1234, DOI 10.1016/j.bbrc.2006.04.021
   Isama K, 2003, BIOMATERIALS, V24, P3303, DOI 10.1016/S0142-9612(03)00216-3
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kobayashi H, 2004, MAT SCI ENG C-BIO S, V24, P729, DOI 10.1016/j.msec.2004.08.038
   Lee DW, 2008, KEY ENG MATER, V396, P41
   Li XM, 2006, MAT SCI ENG C-BIO S, V26, P716, DOI 10.1016/j.msec.2005.06.062
   Lim S, 2012, TISSUE ENG REGEN MED, V9, P51, DOI 10.1007/s13770-012-0051-3
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   MASI L, 1992, CALCIFIED TISSUE INT, V51, P202, DOI 10.1007/BF00334548
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Monkawa A, 2006, MATER LETT, V60, P3647, DOI 10.1016/j.matlet.2006.03.076
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Richard M, 1998, CALCIFIED TISSUE INT, V62, P437, DOI 10.1007/s002239900456
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Roehlecke C, 2001, CELLS TISSUES ORGANS, V168, P178, DOI 10.1159/000047833
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Wutticharoenmongkol P, 2007, BIOMACROMOLECULES, V8, P2602, DOI 10.1021/bm700451p
   Yamaura M, 2004, J MAGN MAGN MATER, V279, P210, DOI 10.1016/j.jmmm.2004.01.094
   Yunoki S, 2006, MATER LETT, V60, P999, DOI 10.1016/j.matlet.2005.10.064
NR 27
TC 1
Z9 1
U1 0
U2 19
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD APR
PY 2014
VL 11
IS 2
BP 99
EP 105
DI 10.1007/s13770-013-1107-8
PG 7
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA AE7LI
UT WOS:000334179000001
DA 2018-10-20
ER

PT J
AU Zhang, P
   Cao, MY
AF Zhang, Ping
   Cao, Moyuan
TI Preparation of a novel organo-soluble chitosan grafted polycaprolactone
   copolymer for drug delivery
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chitosan; Amphiphilic copolymer; Drug delivery system
ID CYTOTOXIC ACTIVITIES; RELEASE BEHAVIOR; MOLECULAR-WEIGHT; NANOPARTICLES;
   WATER; DEACETYLATION; DERIVATIVES; PH; TRANSFECTION; BIOMATERIAL
AB The unsatisfactory solubility of chitosan has been a key barrier to its modification and application. To improve its solubility, a novel organo-soluble glycidol grafted chitosan was developed as a potential material for bio-related applications. The hydrophilic glycidol was grafted onto the amino groups of chitosan via a facile and "green" aqueous reaction. The grafting levels of glycidol strongly influenced the organo-solubility and water-solubility of the chitosan due to the inhibition of its intermolecular interactions. The resulting glycidol grafted chitosan (Gly-HCS and Gly-LCS) was directly dissolved in dimethyl sulfoxide (DMSO) and dimethylformamide (DMF). Taking advantage of the improved organo-solubility, an amphiphilic Gly-LCS grafted polycaprolactone (GC-g-PCL) copolymer and its assembly were prepared as an efficient anti-tumour doxorubicin (DOX) carrier. The DOX loaded GC-g-PCL assembly exhibited a control release profile and anti-tumour activity. Acting as a basic substrate, this organo-soluble chitosan derivative has the potential to meet a wide range of requirements in the field of biological macromolecules. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Cao, Moyuan] Beihang Univ, Sch Chem & Environm, Beijing 100191, Peoples R China.
   [Zhang, Ping] Qingdao Municipal Hosp, Qingdao 266011, Peoples R China.
RP Cao, MY (reprint author), Beihang Univ, Sch Chem & Environm, Xueyuan Rd 37, Beijing, Peoples R China.
EM caocmy@gmail.com
RI cao, moyuan/A-4011-2015
OI cao, moyuan/0000-0002-1528-3096
FU National Natural Science Foundation of China [21074112, 20674069];
   National Basic Research Program of China [2009CB930104]
FX We wish to thank Prof. Li-Qun Wang and Prof. Hongliang Jiang for
   assisting with this work. This work was financially supported by the
   National Natural Science Foundation of China (21074112, 20674069) and
   the National Basic Research Program of China (2009CB930104).
CR Abd El-Ghaffar MA, 2012, CARBOHYD POLYM, V89, P667, DOI 10.1016/j.carbpol.2012.03.074
   Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028
   Babin M, 2012, CARBOHYD RES, V351, P87, DOI 10.1016/j.carres.2012.01.016
   Cai GQ, 2009, MACROMOL BIOSCI, V9, P256, DOI 10.1002/mabi.200800153
   Cai GQ, 2009, EUR POLYM J, V45, P1674, DOI 10.1016/j.eurpolymj.2009.03.007
   Cao MY, 2013, COLLOID SURFACE B, V109, P154, DOI 10.1016/j.colsurfb.2013.04.001
   Cao MY, 2012, J APPL POLYM SCI, V123, P3137, DOI 10.1002/app.34968
   Chang D, 2012, CARBOHYD POLYM, V88, P663, DOI 10.1016/j.carbpol.2012.01.020
   Chen C, 2011, J BIOMED MATER RES A, V96A, P116, DOI 10.1002/jbm.a.32965
   Chen HY, 2013, INT J BIOL MACROMOL, V55, P258, DOI 10.1016/j.ijbiomac.2013.01.018
   Cho J, 2006, BIOMACROMOLECULES, V7, P2845, DOI 10.1021/bm060436s
   Cui D, 2011, ADV MATER, V23, pH200, DOI 10.1002/adma.201100600
   Duan KR, 2010, CARBOHYD POLYM, V80, P498, DOI 10.1016/j.carbpol.2009.12.013
   Duan KR, 2010, COLLOID SURFACE B, V76, P475, DOI 10.1016/j.colsurfb.2009.12.007
   Honarkar H, 2009, MONATSH CHEM, V140, P1403, DOI 10.1007/s00706-009-0197-4
   JANSSEN MJH, 1985, INT J PHARM, V23, P1, DOI 10.1016/0378-5173(85)90217-0
   Je JY, 2006, BIOORG MED CHEM LETT, V16, P2122, DOI 10.1016/j.bmcl.2006.01.060
   Jiang XA, 2003, CARBOHYD POLYM, V54, P457, DOI 10.1016/j.carbpol.2003.05.004
   Kubota N, 2000, CARBOHYD RES, V324, P268, DOI 10.1016/S0008-6215(99)00263-3
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kurita K, 2002, BIOMACROMOLECULES, V3, P1, DOI 10.1021/bm0101163
   Layek B, 2012, CARBOHYD POLYM, V89, P403, DOI 10.1016/j.carbpol.2012.03.021
   Lee JK, 2002, BIOORG MED CHEM LETT, V12, P2949, DOI 10.1016/S0960-894X(02)00530-9
   Liu DZ, 2007, CARBOHYD POLYM, V68, P544, DOI 10.1016/j.carbpol.2006.10.019
   Liu L, 2004, EUR POLYM J, V40, P2739, DOI 10.1016/j.eurpolymj.2004.07.016
   Liu L, 2010, REACT FUNCT POLYM, V70, P301, DOI 10.1016/j.reactfunctpolym.2010.02.003
   Ma GP, 2009, CARBOHYD POLYM, V75, P390, DOI 10.1016/j.carbpol.2008.07.035
   Morimoto K, 2003, MOL THER, V7, P254, DOI 10.1016/S1525-0016(02)00053-9
   Nagpal K, 2013, INT J BIOL MACROMOL, V59, P20, DOI 10.1016/j.ijbiomac.2013.04.011
   Peng BL, 2010, CARBOHYD RES, V345, P101, DOI 10.1016/j.carres.2009.10.018
   Prabu P, 2008, J MATER SCI-MATER M, V19, P2157, DOI 10.1007/s10856-007-3307-z
   Qi LF, 2005, BIOORG MED CHEM LETT, V15, P1397, DOI 10.1016/j.bmcl.2005.01.010
   Qin CQ, 2002, POLYM DEGRAD STABIL, V76, P211, DOI 10.1016/S0141-3910(02)00016-2
   Rangel-Mendez JR, 2009, J HAZARD MATER, V162, P503, DOI 10.1016/j.jhazmat.2008.05.073
   Shi BY, 2012, BIOMACROMOLECULES, V13, P146, DOI 10.1021/bm201380e
   Shukla SK, 2013, INT J BIOL MACROMOL, V59, P46, DOI 10.1016/j.ijbiomac.2013.04.043
   Soo PL, 2002, LANGMUIR, V18, P9996, DOI 10.1021/la026339b
   Tan SC, 1998, TALANTA, V45, P713, DOI 10.1016/S0039-9140(97)00288-9
   Varma AJ, 2004, CARBOHYD POLYM, V55, P77, DOI 10.1016/j.carbpol.2003.08.005
   Varshosaz J, 2012, EXPERT OPIN DRUG DEL, V9, P509, DOI 10.1517/17425247.2012.673580
   Wang CQ, 2005, CHEM COMMUN, P3591, DOI 10.1039/b504428f
   Wang JT, 2011, INT J BIOL MACROMOL, V48, P523, DOI 10.1016/j.ijbiomac.2011.01.016
   Wu J, 2007, J BIOMED MATER RES A, V80A, P800, DOI 10.1002/jbm.a.30972
   Xu PS, 2007, ANGEW CHEM INT EDIT, V46, P4999, DOI 10.1002/anie.200605254
   Xu YM, 2003, BIOMATERIALS, V24, P5015, DOI 10.1016/S0142-9612(03)00408-3
   Zhang JL, 2010, MAR DRUGS, V8, P1962, DOI 10.3390/md8071962
   Zhang YQ, 2006, CARBOHYD POLYM, V65, P229, DOI 10.1016/j.carbpol.2005.08.066
   Zhou HF, 2010, BIOMACROMOLECULES, V11, P3480, DOI 10.1021/bm100989x
NR 48
TC 11
Z9 12
U1 1
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2014
VL 65
BP 21
EP 27
DI 10.1016/j.ijbiomac.2014.01.009
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AE6ID
UT WOS:000334092900004
PM 24418345
DA 2018-10-20
ER

PT J
AU Karunamoorthi, R
   Kumar, GS
   Prasad, AI
   Vatsa, RK
   Thamizhavel, A
   Girija, EK
AF Karunamoorthi, Rajavel
   Kumar, Govindan Suresh
   Prasad, Amresh Ishwar
   Vatsa, Rajesh Kumar
   Thamizhavel, Arumugum
   Girija, Easwaradas Kreedapathy
TI Fabrication of a Novel Biocompatible Magnetic Biomaterial with
   Hyperthermia Potential
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; NICKEL FERRITE; GLASS-CERAMICS; NANOCRYSTALLINE
   NICKEL; POLYETHYLENE-GLYCOL; COMPOSITE-MATERIAL; THERMAL-STABILITY;
   CANCER-TREATMENT; PARTICLE-SIZE; BONE CANCER
AB Preparation and characterization of a novel biocompatible magnetic biomaterial having hyperthermia potential is reported in this study. Fe3+ and Ni2+ (2:1) cosubstituted hydroxyapatite nanoparticles were synthesized by simple wet precipitation method followed by freeze-drying which on heat treatment at 1150 degrees C yielded the above mentioned biocompatible magnetic biomaterial composed of hydroxyapatite and -tricalcium phosphate along with nickel ferrite. The product was characterized by X-ray diffraction, Fourier transform infrared spectroscopy, and transmission electron microscope along with composition analysis. The magnetic behavior was analyzed by vibrating sample magnetometer and biocompatibility was assessed by testing the toxicity on Hela cells using MTT assay. The hyperthermia potential of the material was studied using induction heating. The prepared material has the potential to generate sufficient heat that could be easily controlled by magnetic field parameters and amount of sample. Hence, it can be a potential candidate for making implantable thermoseed for hyperthermia treatment.
C1 [Karunamoorthi, Rajavel; Kumar, Govindan Suresh; Girija, Easwaradas Kreedapathy] Periyar Univ, Dept Phys, Salem 636011, India.
   [Prasad, Amresh Ishwar; Vatsa, Rajesh Kumar] Bhabha Atom Res Ctr, Div Chem, Bombay 400085, Maharashtra, India.
   [Thamizhavel, Arumugum] Tata Inst Fundamental Res, Dept Condensed Matter Phys, Bombay 400005, Maharashtra, India.
RP Girija, EK (reprint author), Periyar Univ, Dept Phys, Salem 636011, India.
EM girijae@yahoo.com
RI Thamizhavel, Arumugam/A-1801-2011
OI Thamizhavel, Arumugam/0000-0003-1679-4370; Kumar, G.
   Suresh/0000-0003-4441-6107
FU Periyar University; CSIR, India; UGC India [41-1013/2012 SR]
FX One of the authors (RK) thanks Periyar University for providing
   fellowship under URF. Author GSK acknowledges CSIR, India for the award
   of Senior Research Fellowship. Author EKG expresses her thanks to UGC
   India (Project Ref. no. 41-1013/2012 SR) for financial support.
CR Andronescu E, 2010, J MATER SCI-MATER M, V21, P2237, DOI 10.1007/s10856-010-4076-7
   [Anonymous], 1099352009 ISO
   Ansar EB, 2012, J AM CERAM SOC, V95, P2695, DOI 10.1111/j.1551-2916.2011.05033.x
   Arcos D, 2003, J BIOMED MATER RES A, V65A, P71, DOI 10.1002/jbm.a.10445
   Bae S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2420769
   Bodhak S, 2011, MAT SCI ENG C-MATER, V31, P755, DOI 10.1016/j.msec.2011.01.003
   Cullity B. D., 2011, INTRO MAGNETIC MAT
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   Ebisawa Y, 1997, BIOMATERIALS, V18, P1277, DOI 10.1016/S0142-9612(97)00067-7
   Ergun C, 2008, J EUR CERAM SOC, V28, P2137, DOI 10.1016/j.jeurceramsoc.2008.03.007
   Fultz B, 2008, TRANSMISSION ELECT M
   Ghosh R, 2011, J MATER CHEM, V21, P13388, DOI 10.1039/c1jm10092k
   Girija EK, 2011, CERAM ENG SCI PROC, V32, P3
   Goldman A, 2006, MODERN FERRITES TECH
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Hou CH, 2009, BIOMATERIALS, V30, P4700, DOI 10.1016/j.biomaterials.2009.05.018
   Hou CH, 2009, BIOMATERIALS, V30, P3956, DOI 10.1016/j.biomaterials.2009.04.020
   Jadhav NV, 2013, COLLOID SURFACE B, V108, P158, DOI 10.1016/j.colsurfb.2013.02.035
   Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Khot VM, 2013, DALTON T, V42, P1249, DOI 10.1039/c2dt31114c
   Kobayashi H, 2010, J APPL PHYS, V107, DOI 10.1063/1.3355936
   Komath M, 2003, B MATER SCI, V26, P415, DOI 10.1007/BF02711186
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Kumar GS, 2012, MATER CHEM PHYS, V134, P1127, DOI 10.1016/j.matchemphys.2012.04.005
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Levy M, 2011, CHEM MATER, V23, P4170, DOI 10.1021/cm201078f
   Levy M, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/20/204133
   Li GD, 2010, MAT SCI ENG C-MATER, V30, P148, DOI 10.1016/j.msec.2009.09.011
   Li YQ, 2012, J MATER SCI, V47, P730, DOI 10.1007/s10853-011-5846-4
   Low HR, 2008, INORG CHEM, V47, P11774, DOI 10.1021/ic801491t
   Misra RDK, 2004, MAT SCI ENG B-SOLID, V111, P164, DOI 10.1016/j.mseb.2004.04.014
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Mostafa NY, 2005, MATER CHEM PHYS, V94, P333, DOI 10.1016/j.matchemphys.2005.05.011
   Murakami S, 2008, J CERAM SOC JPN, V116, P950, DOI 10.2109/jcersj2.116.950
   Muzquiz-Ramos EM, 2010, MATER LETT, V64, P1117, DOI 10.1016/j.matlet.2010.02.025
   Nabiyouni G, 2010, CHINESE PHYS LETT, V27, DOI 10.1088/0256-307X/27/12/126401
   Ningthoujam RS, 2012, FUNCTIONAL MATERIALS: PREPARATION, PROCESSING AND APPLICATIONS, P229, DOI 10.1016/B978-0-12-385142-0.00006-4
   OVERGAARD J, 1977, CANCER-AM CANCER SOC, V39, P2637, DOI 10.1002/1097-0142(197706)39:6<2637::AID-CNCR2820390650>3.0.CO;2-S
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Phadatare MR, 2012, J MAGN MAGN MATER, V324, P770, DOI 10.1016/j.jmmm.2011.09.020
   Prasad AI, 2013, DALTON T, V42, P4885, DOI 10.1039/c2dt32508j
   Qiang Y, 2006, J NANOPART RES, V8, P489, DOI 10.1007/s11051-005-9011-3
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Reyes-Gasga J, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/22/225407
   Salavati-Niasari M, 2009, POLYHEDRON, V28, P1455, DOI 10.1016/j.poly.2009.03.020
   Salimi MN, 2012, POWDER TECHNOL, V218, P109, DOI 10.1016/j.powtec.2011.11.049
   Schweiger C, 2011, INT J PHARMACEUT, V408, P130, DOI 10.1016/j.ijpharm.2010.12.046
   Singh RK, 2008, J MAGN MAGN MATER, V320, P1352, DOI 10.1016/j.jmmm.2007.11.007
   Sivakumar P, 2011, MATER RES BULL, V46, P2208, DOI 10.1016/j.materresbull.2011.09.009
   Sounderyal N., 2008, RECENT PAT BIOMED EN, V1, P34
   Tampieri A, 2012, ACTA BIOMATER, V8, P843, DOI 10.1016/j.actbio.2011.09.032
   Vallet-Regi M., 2008, BIOMIMETRIC NANOCERA
   WALDRON RD, 1955, PHYS REV, V99, P1727, DOI 10.1103/PhysRev.99.1727
   Wu HC, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/16/165601
   Wu SYH, 2010, J NANOPART RES, V12, P1173, DOI 10.1007/s11051-009-9734-7
   Yin H, 2005, BIOMATERIALS, V26, P5818, DOI 10.1016/j.biomaterials.2005.02.036
NR 57
TC 9
Z9 9
U1 3
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-7820
EI 1551-2916
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD APR
PY 2014
VL 97
IS 4
BP 1115
EP 1122
DI 10.1111/jace.12746
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA AD8YB
UT WOS:000333550500020
DA 2018-10-20
ER

PT J
AU Ming, JF
   Liu, Z
   Bie, SY
   Zhang, F
   Zuo, BQ
AF Ming, Jinfa
   Liu, Zhi
   Bie, Shiyu
   Zhang, Feng
   Zuo, Baoqi
TI Novel silk fibroin films prepared by formic acid/hydroxyapatite
   dissolution method
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Silk fibroin; Hydroxyapatite; Film; Mechanical property
ID PHOSPHATE DIHYDRATE CRYSTALS; BOMBYX-MORI SILKWORM; MIDDLE DIVISION;
   RHEOLOGY; GROWTH; PH; CRYSTALLIZATION; REGENERATION; SCATTERING;
   STABILITY
AB Bombyx mori silk fibroin from the silkworm was firstly found to be soluble in formic acid/hydroxyapatite system. The theological behavior of silk fibroin solution was significantly influenced by HAp contents in dissolved solution. At the same time, silk fibroin nanofibers were observed in dissolved solution with 103.6 +/- 20.4 nm in diameter. Moreover, the structure behavior of SF films prepared by formic acid/hydroxyapatite dissolution method was examined. The secondary structure of silk fibroin films was attributed to silk II structure (beta-sheet), indicating that the hydroxyapatite contents in dissolved solution were not significantly affected by the structure of silk fibroin. The X-ray diffraction results exhibited obviously hydroxyapatite crystalline nature existing in silk fibroin films; however, when the hydroxyapatite content was 5.0 wt.% in dissolved solution, some hydroxyapatite crystals were converted to calcium hydrogen phosphate dehydrate in silk fibroin dissolution process. This result was also confirmed by Fourier transform infrared analysis and DSC measurement. In addition, silk fibroin films prepared by this dissolution method had higher breaking strength and extension at break. Based on these analyses, an understanding of novel SF dissolution method may provide an additional tool for designing and synthesizing advanced materials with more complex structures, which should be helpful in different fields, including biomaterial applications. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Ming, Jinfa; Liu, Zhi; Bie, Shiyu; Zuo, Baoqi] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Ming, Jinfa; Liu, Zhi; Bie, Shiyu; Zuo, Baoqi] Soochow Univ, Coll Text & Clothing Engn, Suzhou 215021, Peoples R China.
   [Zhang, Feng] Soochow Univ, Coll Med, Jiangsu Prov Key Lab Stem Cell Res, Suzhou 215006, Peoples R China.
RP Zuo, BQ (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM jinfa.ming@gmail.com; bqzuo@suda.edu.cn
OI Ming, Jinfa/0000-0002-0791-8987
FU First Phase of Jiangsu Universities' Distinctive Discipline Development
   Program for Textile Science and Engineering of Soochow University;
   National Science Foundation of China [81271723]; Doctoral Candidate
   Academic Award Project of Soochow University [5832003611]; Jiangsu
   Province Ordinary Universities and Colleges Graduate Scientific and
   Innovation Plan [CXLX12_0815]; National Engineering Laboratory for
   Modern Silk
FX We gratefully acknowledged the support of the First Phase of Jiangsu
   Universities' Distinctive Discipline Development Program for Textile
   Science and Engineering of Soochow University, National Science
   Foundation of China (No. 81271723), Doctoral Candidate Academic Award
   Project of Soochow University (No. 5832003611), Jiangsu Province
   Ordinary Universities and Colleges Graduate Scientific and Innovation
   Plan (CXLX12_0815) and National Engineering Laboratory for Modern Silk.
CR Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Fan SN, 2013, INT J BIOL MACROMOL, V56, P83, DOI 10.1016/j.ijbiomac.2013.01.033
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Ha SW, 2003, BIOMACROMOLECULES, V4, P488, DOI 10.1021/bm0255948
   Holland C, 2007, POLYMER, V48, P3388, DOI 10.1016/j.polymer.2007.04.019
   Holland C, 2006, NAT MATER, V5, P870, DOI 10.1038/nmat1762
   Joshi VS, 2003, CRYST RES TECHNOL, V38, P817, DOI 10.1002/crat.200310100
   Madhurambal G, 2009, J THERM ANAL CALORIM, V96, P73, DOI 10.1007/s10973-008-9841-1
   Ming JF, 2012, MATER CHEM PHYS, V137, P421, DOI 10.1016/j.matchemphys.2012.10.001
   Ming JF, 2012, J APPL POLYM SCI, V125, P2148, DOI 10.1002/app.36354
   Ng SX, 2010, ACTA BIOMATER, V6, P3772, DOI 10.1016/j.actbio.2010.03.017
   Ochi A, 2002, BIOMACROMOLECULES, V3, P1187, DOI 10.1021/bm020056g
   Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f
   Rajendran K, 2010, CRYST RES TECHNOL, V45, P939, DOI 10.1002/crat.200900700
   Rajkhowa R, 2011, J BIOMED MATER RES A, V97A, P37, DOI 10.1002/jbm.a.33021
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Suguna K., 2011, J MINER MAT CHARACT, V10, P625
   Sun MJ, 2012, J MATER CHEM, V22, P18372, DOI 10.1039/c2jm32576d
   Takahashi Y, 1999, INT J BIOL MACROMOL, V24, P127, DOI 10.1016/S0141-8130(98)00080-4
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Terry AE, 2004, BIOMACROMOLECULES, V5, P768, DOI 10.1021/bm034381v
   Tsukada M, 1996, J APPL POLYM SCI, V60, P1619, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1619::AID-APP14>3.0.CO;2-#
   Um IC, 2003, INT J BIOL MACROMOL, V33, P203, DOI 10.1016/j.ijbiomac.2003.08.004
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Wang H, 2005, INT J BIOL MACROMOL, V36, P66, DOI 10.1016/j.ijbiomac.2005.03.011
   Wang Q, 2012, BIOMACROMOLECULES, V13, P1875, DOI 10.1021/bm300387z
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Zhang F, 2012, BIOMACROMOLECULES, V13, P798, DOI 10.1021/bm201719s
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhu JX, 2008, POLYMER, V49, P2880, DOI 10.1016/j.polymer.2008.04.049
NR 33
TC 13
Z9 14
U1 3
U2 62
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2014
VL 37
BP 48
EP 53
DI 10.1016/j.msec.2013.12.041
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA AE2HZ
UT WOS:000333795200007
PM 24582221
DA 2018-10-20
ER

PT J
AU Frandsen, CJ
   Brammer, KS
   Noh, K
   Johnston, G
   Jin, S
AF Frandsen, Christine J.
   Brammer, Karla S.
   Noh, Kunbae
   Johnston, Gary
   Jin, Sungho
TI Tantalum coating on TiO2 nanotubes induces superior rate of matrix
   mineralization and osteofunctionality in human osteoblasts
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE TiO2 nanotubes; Tantalum; Osteoblast; Cell adhesion; Alkaline
   phosphatase activity; Matrix mineralization
ID MESENCHYMAL STEM-CELLS; IN-VITRO; SURFACE MODIFICATION; PROTEIN
   ADSORPTION; TITANIUM SURFACES; POROUS TANTALUM; OXIDE-FILMS; BONE;
   PROLIFERATION; ADHESION
AB Nanostructured surface geometries have been the focus of a multitude of recent biomaterial research, and exciting findings have been published. However, only a few publications have directly compared nanostructures of various surface chemistries. The work herein directly compares the response of human osteoblast cells to surfaces of identical nanotube geometries with two well-known orthopedic biomaterials: titanium oxide (TiO2) and tantalum (Ta). The results reveal that the Ta surface chemistry on the nanotube architecture enhances alkaline phosphatase activity, and promotes a similar to 30% faster rate of matrix mineralization and bone-nodule formation when compared to results on bare TiO2 nanotubes. This study implies that unique combinations of surface chemistry and nanostructure may influence cell behavior due to distinctive physico-chemical properties. These findings are of paramount importance to the orthopedics field for understanding cell behavior in response to subtle alterations in nanostructure and surface chemistry, and will enable further insight into the complex manipulation of biomaterial surfaces. With increased focus in the field of orthopedic materials research on nanostructured surfaces, this study emphasizes the need for careful and systematic review of variations in surface chemistry in concurrence with nanotopographical changes. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Frandsen, Christine J.; Brammer, Karla S.; Johnston, Gary; Jin, Sungho] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Noh, Kunbae] Cheil Ind Inc, Corp Res Inst, Uiwang Si 437711, Gyeonggi Do, South Korea.
RP Jin, S (reprint author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM jin@ucsd.edu
FU K. Iwama Endowed Chair fund at UC San Diego; UC [ele08-128656/Jin]
FX This work was supported by K. Iwama Endowed Chair fund at UC San Diego
   and UC Discovery/Kinamed Grant No. ele08-128656/Jin. The authors thank
   Mr. Clyde Pratt of Kinamed, Inc. for helpful discussions.
CR Balla VK, 2010, ACTA BIOMATER, V6, P2329, DOI 10.1016/j.actbio.2009.11.021
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brammer KS, 2011, ACTA BIOMATER, V7, P2697, DOI 10.1016/j.actbio.2011.02.039
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Curtis A, 1999, BIOCHEM SOC SYMP, V65, P15
   Cyster LA, 2003, J BIOMED MATER RES A, V67A, P138, DOI 10.1002/jbm.a.10087
   Dalby MJ, 2007, INT J NANOMED, V2, P373
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2009, NANOMEDICINE-UK, V4, P247, DOI [10.2217/nnm.09.1, 10.2217/NNM.09.1]
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Di Silvio L, 2002, BIOMATERIALS, V23, P101, DOI 10.1016/S0142-9612(01)00084-9
   Dolatshahi-Pirouz A, 2010, ACS NANO, V4, P2874, DOI 10.1021/nn9017872
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Frandsen CJ, 2011, MAT SCI ENG C-MATER, V31, P1716, DOI 10.1016/j.msec.2011.07.016
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Hayashi M, 2012, ACTA BIOMATER, V8, P2411, DOI 10.1016/j.actbio.2012.03.010
   Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P459, DOI 10.1007/s11999-009-1090-5
   Kaivosoja E, 2013, J BIOMATER APPL, V27, P862, DOI 10.1177/0885328211428094
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kaysinger KK, 1998, J CELL BIOCHEM, V68, P83, DOI 10.1002/(SICI)1097-4644(19980101)68:1<83::AID-JCB8>3.0.CO;2-S
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Liang HC, 2010, SOLID STATE PHENOMEN, V162, P295, DOI 10.4028/www.scientific.net/SSP.162.295
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Lu T, 2012, INTERFACE FOCUS, V2, P325, DOI 10.1098/rsfs.2012.0003
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   McCafferty E, 1999, J ADHES SCI TECHNOL, V13, P1415, DOI 10.1163/156856199X00569
   Meirelles L, 2008, INT J ORAL MAX IMPL, V23, P641
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Miyazaki T, 2001, J SOL-GEL SCI TECHN, V21, P83, DOI 10.1023/A:1011265701447
   MOLLER K, 1994, CELL MATER, V4, P263
   Myllymaa S, 2010, J MATER SCI-MATER M, V21, P329, DOI 10.1007/s10856-009-3836-8
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   PARFITT GD, 1976, PURE APPL CHEM, V48, P415, DOI 10.1351/pac197648040415
   ROSS S, 2002, COLLOIDAL DISPERSION
   Roy M, 2010, ADV ENG MATER, V12, pB637, DOI 10.1002/adem.201080017
   Ruckh T, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/4/045102
   Sagomonyants KB, 2011, J ORTHOP RES, V29, P609, DOI 10.1002/jor.21251
   SAVIO JA, 1994, CLIN MATER, V15, P101
   Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P476, DOI 10.1097/00005131-200608000-00005
   SHARMA CP, 1992, J BIOMED MATER RES, V26, P1179, DOI 10.1002/jbm.820260908
   Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013
   Srivastav A., 2011, BIOMEDICAL ENG TREND
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602
   Sul YT, 2006, CLIN ORAL IMPLAN RES, V17, P521, DOI 10.1111/j.1600-0501.2005.01230.X
   Sul YT, 2005, BIOMATERIALS, V26, P6720, DOI 10.1016/j.biomaterials.2005.04.058
   Welldon KJ, 2008, J BIOMED MATER RES A, V84A, P691, DOI 10.1002/jbm.a.31336
   Yan X.Z., 2013, TISSUE ENG C
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
   Zeng Q, 2005, KEY ENG MAT, V288-289, P315, DOI 10.4028/www.scientific.net/KEM.288-289.315
   Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0
NR 63
TC 27
Z9 27
U1 1
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2014
VL 37
BP 332
EP 341
DI 10.1016/j.msec.2014.01.014
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AE2HZ
UT WOS:000333795200043
PM 24582257
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Frese, J
   Morgenroth, A
   Mertens, ME
   Koch, S
   Rongen, L
   Vogg, ATJ
   Zlatopolskiy, BD
   Neumaier, B
   Gesche, VN
   Lammers, T
   Schmitz-Rode, T
   Mela, P
   Jockenhoevel, S
   Mottaghy, FM
   Kiessling, F
AF Frese, Julia
   Morgenroth, Agnieszka
   Mertens, Marianne E.
   Koch, Sabine
   Rongen, Lisanne
   Vogg, Andreas T. J.
   Zlatopolskiy, Boris D.
   Neumaier, Bernd
   Gesche, Valentine N.
   Lammers, Twan
   Schmitz-Rode, Thomas
   Mela, Petra
   Jockenhoevel, Stefan
   Mottaghy, Felix M.
   Kiessling, Fabian
TI Nondestructive monitoring of tissue-engineered constructs
SO BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK
LA English
DT Article
DE extracellular matrix; imaging techniques; nondestructive analysis;
   quality management; tissue engineering
ID ENDOTHELIAL GROWTH-FACTOR; CELL-ADHESION MOLECULE-1; ED-B DOMAIN;
   IN-VIVO; EXTRACELLULAR-MATRIX; MAGNETIC-RESONANCE; MEMBRANE ANTIGEN;
   F-18-FDG PET/CT; PROSTATE-CANCER; TUMOR-DETECTION
AB Tissue engineering as a multidisciplinary field enables the development of living substitutes to replace, maintain, or restore diseased tissue and organs. Since the term was introduced in medicine in 1987, tissue engineering strategies have experienced significant progress. However, up to now, only a few substitutes were able to overcome the gap from bench to bedside and have been successfully approved for clinical use. Substantial donor variability makes it difficult to predict the quality of tissue-engineered constructs. It is essential to collect sufficient data to ensure that poor or immature constructs are not implanted into patients. The fulfillment of certain quality requirements, such as mechanical and structural properties, is crucial for a successful implantation. There is a clear need for new nondestructive and real-time online monitoring and evaluation methods for tissue-engineered constructs, which are applicable on the biomaterial, tissue, cellular, and subcellular levels. This paper reviews current established nondestructive techniques for implant monitoring including biochemical methods and noninvasive imaging.
C1 [Mertens, Marianne E.; Lammers, Twan; Kiessling, Fabian] Rhein Westfal TH Aachen, Dept Expt Mol Imaging, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany.
   [Frese, Julia; Koch, Sabine; Rongen, Lisanne; Schmitz-Rode, Thomas; Mela, Petra; Jockenhoevel, Stefan] Rhein Westfal TH Aachen, Dept Tissue Engn & Text Implants, Helmholtz Inst Biomed Engn, Inst Appl Med Engn, D-52074 Aachen, Germany.
   [Morgenroth, Agnieszka; Vogg, Andreas T. J.; Zlatopolskiy, Boris D.; Mottaghy, Felix M.] Rhein Westfal TH Aachen, Univ Hosp, Dept Nucl Med, D-52074 Aachen, Germany.
   [Zlatopolskiy, Boris D.; Neumaier, Bernd] Max Planck Inst Neurol Res, D-50931 Cologne, Germany.
   [Gesche, Valentine N.] Rhein Westfal TH Aachen, Dept Tissue Engn & Text Implants, Inst Text Tech, D-52074 Aachen, Germany.
RP Kiessling, F (reprint author), Rhein Westfal TH Aachen, Dept Expt Mol Imaging, Helmholtz Inst Biomed Engn, Pauwelsstr 30, D-52074 Aachen, Germany.
EM fkiessling@ukaachen.de
RI Zlatopolskiy, Boris/W-3521-2017
OI Zlatopolskiy, Boris/0000-0001-5818-1260; Neumaier,
   Bernd/0000-0001-5425-3116; Jockenhoevel, Stefan/0000-0003-0584-9444;
   Schmitz-Rode, Thomas/0000-0002-1181-2165
FU European Union (ERDF - European Regional Development Fund - Investing in
   your future); German federal state North Rhine-Westphalia (NRW)
FX This review is a result of a collaboration project between the
   Department of Tissue Engineering and Textile Implants, Institute of
   Applied Medical Engineering of the University Hospital Aachen,
   Department of Nuclear Medicine of the University Hospital Aachen,
   Department of Experimental Molecular Imaging of the University Hospital
   Aachen, Max Planck Institute for Neurological Research of the University
   Hospital Aachen, Department of Tissue Engineering and Textile Implants,
   Institut fur Textiltechnik, RWTH Aachen University. The project is
   cofunded by the European Union (ERDF - European Regional Development
   Fund - Investing in your future) and the German federal state North
   Rhine-Westphalia (NRW), under the operational program "Regional
   Competitiveness and Employment" 2007-2013 (EFRE).
CR Achenbach S, 2004, CIRCULATION, V109, P14, DOI 10.1161/01.CIR.0000111517.69230.0F
   Ansar Malek Masoud, 2012, Adv Biomed Res, V1, P24, DOI 10.4103/2277-9175.98145
   Arima V, 2013, LAB CHIP, V13, P2328, DOI 10.1039/c3lc00055a
   Barrett JA, 2013, J NUCL MED, V54, P380, DOI 10.2967/jnumed.112.111203
   Beckers C, 2006, EUR J NUCL MED MOL I, V33, P275, DOI 10.1007/s00259-005-1952-3
   Boerboom RA, 2007, J STRUCT BIOL, V159, P392, DOI 10.1016/j.jsb.2007.04.008
   Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437
   Brauchle E, 2013, BIOTECHNOL J, V8, P288, DOI 10.1002/biot.201200163
   Cai WB, 2006, J NUCL MED, V47, P2048
   Charrier-Hisamuddin L, 2008, FASEB J, V22, P641, DOI 10.1096/fj.07-8876rev
   Cheng HLM, 2012, NMR BIOMED, V25, P418, DOI 10.1002/nbm.1617
   Cho SY, 2012, J NUCL MED, V53, P1883, DOI 10.2967/jnumed.112.104661
   Crofford LJ, 1997, J RHEUMATOL, V24, P15
   Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733
   Demartis S, 2001, EUR J NUCL MED, V28, P534, DOI 10.1007/s002590100480
   Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027
   Fite BZ, 2011, TISSUE ENG PART C-ME, V17, P495, DOI 10.1089/ten.tec.2010.0368
   Flanagan TC, 2009, TISSUE ENG PT A, V15, P2965, DOI [10.1089/ten.tea.2009.0018, 10.1089/ten.TEA.2009.0018]
   Frese J, 2012, BIOMED TECH S, V57, P87
   Frese J, 2012, BIOMED TECHNOL BE S1, V57, P1065
   Furumoto S, 2003, NUCL MED BIOL, V30, P119, DOI 10.1016/S0969-8051(02)00393-1
   Gordon IO, 2008, MODERN PATHOL, V21, P1421, DOI 10.1038/modpathol.2008.143
   Gremse F, 2011, RADIOLOGY, V260, P709, DOI 10.1148/radiol.11110069
   Grizzle WE, 2009, BIOTECH HISTOCHEM, V84, P185, DOI 10.1080/10520290903039052
   Hagenmueller H, 2007, ANN BIOMED ENG, V35, P1657, DOI 10.1007/s10439-007-9338-2
   Haller N, 2013, ASAIO J, V59, P169, DOI 10.1097/MAT.0b013e31827db6b6
   Herzog H, 2001, RADIOCHIM ACTA, V89, P203, DOI 10.1524/ract.2001.89.4-5.203
   Jayapaul J, 2011, BIOMATERIALS, V32, P5863, DOI 10.1016/j.biomaterials.2011.04.056
   Kalliokoski T, 2005, DIABETES RES CLIN PR, V70, P217, DOI 10.1016/j.diabres.2005.04.008
   Keidar Z, 2007, J NUCL MED, V48, P1230, DOI 10.2967/junmed.107.040253
   Koch S, 2010, BIOMATERIALS, V31, P4731, DOI 10.1016/j.biomaterials.2010.02.051
   Konig K, 2005, BIOMATERIALS, V26, P495, DOI 10.1016/j.biomaterials.2004.02.059
   Kramer NA, 2010, INVEST RADIOL, V45, P477, DOI 10.1097/RLI.0b013e3181e53e38
   Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013
   Kreitz S, 2011, TISSUE ENG PART C-ME, V17, P1021, DOI [10.1089/ten.tec.2010.0669, 10.1089/ten.TEC.2010.0669]
   Lees JG, 2007, REGEN MED, V2, P289, DOI 10.2217/17460751.2.3.289
   LIBBY P, 1993, J CLIN INVEST, V92, P538, DOI 10.1172/JCI116620
   MCAFEE JG, 1976, J NUCL MED, V17, P480
   Mees G, 2012, J NUCL MED, V53, P464, DOI 10.2967/jnumed.111.095794
   Mertens M. E., 2013, ADV FUNCT M IN PRESS
   Meyer U, 2009, FUNDAMENTALS TISSUE, P5, DOI DOI 10.1007/978-3-540-77755-7
   Miyata S, 2007, J BIOMECH, V40, P2990, DOI 10.1016/j.jbiomech.2007.02.002
   Nahrendorf M, 2009, JACC-CARDIOVASC IMAG, V2, P1213, DOI 10.1016/j.jcmg.2009.04.016
   Nakamura A, 2009, TISSUE ENG PART C-ME, V15, P169, DOI 10.1089/ten.tec.2007.0334
   Nelson GN, 2008, FASEB J, V22, P3888, DOI 10.1096/fj.08-107367
   Pandit A, 2003, EUR CELLS MATER, V6, P25
   Papos M, 1996, J NUCL MED, V37, P400
   Pascali G, 2013, NUCL MED BIOL, V40, P776, DOI 10.1016/j.nucmedbio.2013.04.004
   Perea H, 2007, J TISSUE ENG REGEN M, V1, P318, DOI 10.1002/term.32
   Popp JR, 2012, J MED DEVICES, V6, DOI 10.1115/1.4006546
   Potter K, 2006, BONE, V38, P350, DOI 10.1016/j.bone.2005.08.025
   Rice MA, 2009, ACTA BIOMATER, V5, P152, DOI 10.1016/j.actbio.2008.07.036
   Russell AJ, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P15, DOI 10.1016/B978-012370615-7/50007-X
   Santimaria M, 2003, CLIN CANCER RES, V9, P571
   Schenke-Layland K, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1896966
   Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004
   SEABOLD JE, 1989, AM J ROENTGENOL, V152, P1021, DOI 10.2214/ajr.152.5.1021
   Song G, 2008, TRANSPL P, V40, P2720, DOI 10.1016/j.transproceed.2008.07.110
   Spacek M, 2009, EUR J NUCL MED MOL I, V36, P850, DOI 10.1007/s00259-008-1002-z
   Tuan HS, 2005, COMPUT AIDED DESIGN, V37, P1151, DOI 10.1016/j.cad.2005.02.006
   Tuemen M, 2013, ANN BIOMED ENG, V41, P883, DOI 10.1007/s10439-012-0734-x
   Uddin MJ, 2011, CANCER PREV RES, V4, P1536, DOI 10.1158/1940-6207.CAPR-11-0120
   Uddin MJ, 2011, ACS MED CHEM LETT, V2, P160, DOI 10.1021/ml100232q
   Uddin MJ, 2010, CANCER RES, V70, P3618, DOI 10.1158/0008-5472.CAN-09-2664
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   Wang M, 2010, OSTEOARTHR CARTILAGE, V18, P1417, DOI 10.1016/j.joca.2010.08.009
   Weinbaum JS, 2010, TISSUE ENG PART C-ME, V16, P459, DOI [10.1089/ten.tec.2009.0112, 10.1089/ten.TEC.2009.0112]
   WELLS PNT, 1977, PHYS MED BIOL, V22, P629, DOI 10.1088/0031-9155/22/4/001
   Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851
   Yang WF, 2012, EUR J NUCL MED MOL I, V39, P1289, DOI 10.1007/s00259-012-2126-8
   Zanzonico P, 2012, RADIAT RES, V177, P349, DOI 10.1667/RR2577.1
   Zhang JS, 2012, ARTERIOSCL THROM VAS, V32, P1849, DOI 10.1161/ATVBAHA.112.252510
NR 72
TC 3
Z9 3
U1 0
U2 23
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0013-5585
EI 1862-278X
J9 BIOMED ENG-BIOMED TE
JI Biomed. Eng.-Biomed. Tech.
PD APR
PY 2014
VL 59
IS 2
SI SI
BP 165
EP 175
DI 10.1515/bmt-2013-0029
PG 11
WC Engineering, Biomedical; Medical Informatics
SC Engineering; Medical Informatics
GA AE0OM
UT WOS:000333665600010
PM 24021591
DA 2018-10-20
ER

PT J
AU Bassi, G
   Guilloton, F
   Menard, C
   Di Trapani, M
   Pacelli, L
   Carusone, R
   Midolo, M
   Amati, E
   Bezier, I
   Deschaseaux, F
   Sensebe, L
   Baroth, S
   Schrezenmeier, H
   Rojewski, M
   Layrolle, P
   Giordano, R
   Lavazza, C
   Lazzari, L
   Bourin, P
   Dominici, M
   Tarte, K
   Krampera, M
AF Bassi, G.
   Guilloton, F.
   Menard, C.
   Di Trapani, M.
   Pacelli, L.
   Carusone, R.
   Midolo, M.
   Amati, E.
   Bezier, I.
   Deschaseaux, F.
   Sensebe, L.
   Baroth, S.
   Schrezenmeier, H.
   Rojewski, M.
   Layrolle, P.
   Giordano, R.
   Lavazza, C.
   Lazzari, L.
   Bourin, P.
   Dominici, M.
   Tarte, K.
   Krampera, M.
TI EFFECTS OF A NOVEL CERAMIC BIOMATERIAL ON IMMUNE MODULATORY PROPERTIES
   AND DIFFERENTIATION POTENTIAL OF MESENCHYMAL STROMAL CELLS
SO CYTOTHERAPY
LA English
DT Meeting Abstract
C1 [Bassi, G.; Di Trapani, M.; Pacelli, L.; Carusone, R.; Midolo, M.; Amati, E.; Krampera, M.] Univ Verona, Dept Med, Sect Hematol, Stem Cell Res Lab, I-37100 Verona, Veneto, Italy.
   [Guilloton, F.; Deschaseaux, F.; Sensebe, L.; Bourin, P.] Univ Toulouse 3, EFS Pyrenees Mediterranee, UMR5273, INSERM,U1031, F-31062 Toulouse, France.
   [Menard, C.; Bezier, I.; Tarte, K.] Univ Rennes 1, INSERM, U917, Rennes, France.
   [Baroth, S.] Biomatlante SAS, Vigneux De Bretagne, France.
   [Schrezenmeier, H.; Rojewski, M.] Univ Ulm, Inst Transfus Med, D-89069 Ulm, Germany.
   [Schrezenmeier, H.; Rojewski, M.] German Red Cross Blood Donor Serv Baden Wurttembe, Ulm, Germany.
   [Layrolle, P.] Fac Med, INSERM, U957, LPRO, Nantes, France.
   [Giordano, R.; Lavazza, C.; Lazzari, L.] Fdn IRCCS Ca, Milan, Italy.
   [Bourin, P.] CSA21, Toulouse, France.
   [Dominici, M.] Univ Hosp Modena & Reggio Emilia, Modena, Italy.
RI Di Trapani, Mariano/J-9877-2016; Layrolle, Pierre/K-9257-2015; Lavazza,
   Cristiana/D-5661-2013
OI Di Trapani, Mariano/0000-0002-3077-8038; Layrolle,
   Pierre/0000-0001-9800-5210; Lavazza, Cristiana/0000-0002-1167-6167;
   Rojewski, Markus/0000-0003-4265-0442
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1465-3249
EI 1477-2566
J9 CYTOTHERAPY
JI Cytotherapy
PD APR
PY 2014
VL 16
IS 4
SU S
MA 318
BP S90
EP S91
DI 10.1016/j.jcyt.2014.01.336
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Hematology; Medicine, Research & Experimental
SC Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research
   & Experimental Medicine
GA AD7IT
UT WOS:000333438100304
DA 2018-10-20
ER

PT J
AU Guarnieri, R
   Placella, R
   Testarelli, L
   Iorio-Siciliano, V
   Grande, M
AF Guarnieri, Renzo
   Placella, Roberto
   Testarelli, Luca
   Iorio-Siciliano, Vincenzo
   Grande, Maurizio
TI Clinical, Radiographic, and Esthetic Evaluation of Immediately Loaded
   Laser Microtextured Implants Placed into Fresh Extraction Sockets in the
   Anterior Maxilla: A 2-Year Retrospective Multicentric Study
SO IMPLANT DENTISTRY
LA English
DT Article
DE immediate implants; immediate loading; maxillary esthetic zone; tooth
   extraction; therapy; laser microtextured collar surface
ID SINGLE-TOOTH IMPLANTS; SOFT-TISSUE RESPONSE; DEFINED BIOMATERIAL
   SURFACES; GUIDED BONE REGENERATION; DENTAL IMPLANTS; CASE SERIES;
   HISTOLOGIC EVIDENCE; HEALED SITES; HARD; PROVISIONALIZATION
AB Objectives:To assess the clinical, radiographic, and esthetic outcomes of implants with a laser microtextured collar placed in the anterior region of the maxilla at the time of tooth extraction and immediately temporized.Methods:Forty-six Tapered Internal Laser-Lok BioHorizons implants were immediately placed and immediately restored with nonfunctional loading in 46 patients (24 men and 22 women) with a thick gingival biotype, ideal gingival level/contour, and postextraction intact walls. Survival rate, cortical bone loss, and periimplant mucosal responses were evaluated at 6, 12, and 24 months.Results:Survival rate was 95.6%. Mean mesial and distal marginal bone loss, 24 months after installation, were 0.58 mm (SD = 0.53; range, 0.17-1.15) and 0.57 mm (SD = 0.70; range, 0.42-1.10), respectively. A mesial and distal papilla regrowth mean of 1.8 and 1.5 mm, respectively, were found. The midfacial soft tissue levels showed 0.12 mm of mean recession after 24 months.Conclusion:Immediate implants with a laser microtextured surface restored at the day of surgery, may be considered as a predictable procedure in terms of implant survival and hard and soft tissue remodeling.
C1 [Testarelli, Luca] Univ Roma La Sapienza, I-00185 Rome, Italy.
   [Iorio-Siciliano, Vincenzo] Univ Naples Federico II, Dept Periodontol, Naples, Italy.
RP Guarnieri, R (reprint author), Via Paolo Emilio,7 Int 5, I-00144 Rome, Italy.
EM renzoguarnieri@gmail.com
FU Classimplant S.R.L., Rome, Italy
FX The study was supported by Classimplant S.R.L., Rome, Italy, providing
   materials and funding.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1986, DENT CLIN N AM, V30, P151
   Alexander H, 2009, J BIOMED MATER RES B, V23, P200
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P615, DOI 10.1111/j.1600-0501.2006.01317.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Barone A, 2006, J PERIODONTOL, V77, P1914, DOI 10.1902/jop.2006.060072
   Belser UC, 2009, J PERIODONTOL, V80, P140, DOI [10.1902/jop.2009.080435, 10.1902/jop.2009.080435 ]
   Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x
   Block MS, 2009, J ORAL MAXIL SURG, V67, P89, DOI 10.1016/j.joms.2009.07.009
   Botos S, 2011, INT J ORAL MAX IMPL, V26, P492
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Buser D, 2004, INT J ORAL MAX IMPL, V19, P43
   Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x
   Buser D, 2009, J PERIODONTOL, V80, P152, DOI [10.1902/jop.2009.080360, 10.1902/jop.2009.080360 ]
   Calvo Guirado JL, 2002, J IR DENT ASS, V48, P43
   Cardaropoli G, 2006, CLIN ORAL IMPLAN RES, V17, P165, DOI 10.1111/j.1600-0501.2005.01210.x
   Chaushu G, 2001, INT J ORAL MAX IMPL, V16, P267
   Chen ST, 2007, CLIN ORAL IMPLAN RES, V18, P552, DOI 10.1111/j.1600-0501.2007.01388.x
   Chen ST, 2009, J PERIODONTOL, V80, P163, DOI [10.1902/jop.2009.080243, 10.1902/jop.2009.080243 ]
   Choquet V, 2001, J PERIODONTOL, V72, P1364, DOI 10.1902/jop.2001.72.10.1364
   Cornelini R, 2005, INT J PERIODONT REST, V25, P439
   Cosyn J, 2012, CLIN IMPLANT DENT R, V14, P517, DOI 10.1111/j.1708-8208.2010.00300.x
   Cosyn J, 2011, J CLIN PERIODONTOL, V38, P746, DOI 10.1111/j.1600-051X.2011.01748.x
   De Bruyn H, 2011, CLIN IMPLANT DENT R, V13, P175, DOI 10.1111/j.1708-8208.2009.00200.x
   De Rouck T, 2008, INT J ORAL MAX IMPL, V23, P897
   De Rouck T, 2008, J CLIN PERIODONTOL, V35, P649, DOI 10.1111/j.1600-051X.2008.01235.x
   De Rouck T, 2009, CLIN ORAL IMPLAN RES, V20, P566, DOI 10.1111/j.1600-0501.2008.01674.x
   den Hartog L, 2008, J CLIN PERIODONTOL, V35, P1073, DOI 10.1111/j.1600-051X.2008.01330.x
   Eghbali A, 2012, CLIN IMPLANT DENT R, V14, P336, DOI 10.1111/j.1708-8208.2010.00283.x
   Evans CDJ, 2008, CLIN ORAL IMPLAN RES, V19, P73, DOI 10.1111/j.1600-0501.2007.01413.x
   Furhauser R, 2005, CLIN ORAL IMPLAN RES, V16, P639, DOI 10.1111/j.1600-0501.2005.01193.x
   Gelb D A, 1993, Int J Oral Maxillofac Implants, V8, P388
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Henriksson K, 2004, CLIN IMPLANT DENT R, V6, P181
   Henry P J, 1996, Int J Oral Maxillofac Implants, V11, P450
   Heydenrijk K, 2002, INT J ORAL MAX IMPL, V17, P829
   Hui E, 2001, Clin Implant Dent Relat Res, V3, P79, DOI 10.1111/j.1708-8208.2001.tb00235.x
   Jemt T, 1997, INT J PERIODONT REST, V17, P327
   Jemt T, 1990, Int J Periodontics Restorative Dent, V10, P340
   Juodzbalys G, 2007, CLIN ORAL IMPLAN RES, V18, P237, DOI 10.1111/j.1600-0501.2006.01312.x
   Kan JYK, 2007, J ORAL MAXIL SURG, V65, P13, DOI 10.1016/j.joms.2007.04.006
   Kan JYK, 2003, J PERIODONTOL, V74, P557, DOI 10.1902/jop.2003.74.4.557
   Kan JYK, 2003, INT J ORAL MAX IMPL, V18, P31
   Lai HC, 2008, CLIN ORAL IMPLAN RES, V19, P560, DOI 10.1111/j.1600-0501.2008.01522.x
   Lang NP, 2012, CLIN ORAL IMPLAN RES, V23, P39, DOI 10.1111/j.1600-0501.2011.02372.x
   Lorenzoni M, 2003, CLIN ORAL IMPLAN RES, V14, P180, DOI 10.1034/j.1600-0501.2003.140207.x
   Nevins M, 2008, INT J PERIODONT REST, V28, P111
   Nevins M, 2010, INT J PERIODONT REST, V30, P245
   Nisapakultorn K, 2010, CLIN ORAL IMPLAN RES, V21, P662, DOI 10.1111/j.1600-0501.2009.01887.x
   Nkenke E, 2006, CLIN ORAL IMPLAN RES, V17, P19, DOI 10.1111/j.1600-0501.2006.01348.x
   Norton MR, 2004, INT J ORAL MAX IMPL, V19, P274
   Ostman PO, 2008, INT J ORAL MAX IMPL, V23, P315
   Ostman PO, 2005, CLIN IMPLANT DENT R, V7, pS60, DOI 10.1111/j.1708-8208.2005.tb00076.x
   Palmer RM, 2000, CLIN ORAL IMPLAN RES, V11, P179, DOI 10.1111/j.1600-0501.2000.tb00012.x
   Pecora GE, 2009, IMPLANT DENT, V18, P57, DOI 10.1097/ID.0b013e31818c5a6d
   Raes F, 2011, J CLIN PERIODONTOL, V38, P385, DOI 10.1111/j.1600-051X.2010.01687.x
   Redemagni M, 2009, INT J ESTHET DENT, V4, P328
   Ricci J, 2000, BONE ENG, P282
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Shapoff CA, 2010, INT J PERIODONT REST, V30, P129
   Shin SY, 2010, CLIN ORAL IMPLAN RES, V21, P804, DOI 10.1111/j.1600-0501.2010.01917.x
   Studer S, 1994, Pract Periodontics Aesthet Dent, V6, P51
   Studer S, 1994, PRACT PERIODONTICS A, V6, P62
   TARNOW DP, 1992, J PERIODONTOL, V63, P995, DOI 10.1902/jop.1992.63.12.995
   Testori T, 2004, CLIN ORAL IMPLAN RES, V15, P278, DOI 10.1111/j.1600-0501.2004.01013.x
   Turkyilmaz I, 2007, CLIN IMPLANT DENT R, V9, P222, DOI 10.1111/j.1708-8208.2007.00045.x
   Wennstrom JL, 2005, J CLIN PERIODONTOL, V32, P567, DOI 10.1111/j.1600-051X.2005.00715.x
   Wohrle P S, 1998, Pract Periodontics Aesthet Dent, V10, P1107
   Wohrle PS, 1998, PRACT PERIODONTICS A, V10, P1116
NR 69
TC 9
Z9 9
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD APR
PY 2014
VL 23
IS 2
BP 144
EP 154
DI 10.1097/ID.0000000000000061
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AD9EU
UT WOS:000333568400009
PM 24637532
DA 2018-10-20
ER

PT J
AU Boccafoschi, F
   Mosca, C
   Cannas, M
AF Boccafoschi, F.
   Mosca, C.
   Cannas, M.
TI Cardiovascular biomaterials: when the inflammatory response helps to
   efficiently restore tissue functionality?
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Review
DE device implantation; inflammatory response; synthetic polymers; wound
   healing responses; cardiovascular biomaterials
ID SELF-ASSEMBLED MONOLAYERS; HUMAN-ENDOTHELIAL-CELLS; MULTINUCLEATED
   GIANT-CELLS; FLUID SHEAR-STRESS; EXPANDED MICROPOROUS
   POLYTETRAFLUOROETHYLENE; HYALURONAN-BASED SCAFFOLD; FACTOR PATHWAY
   INHIBITOR; ARTERIAL GRAFT FAILURE; MESENCHYMAL STEM-CELLS; FOREIGN-BODY
   REACTION
AB The evaluation of biological host response to implanted materials permits the determination of the safety and biocompatibility of biomedical devices, prostheses and biomaterials. Once a biomaterial is introduced into the body to a corresponding implant site, a sequence of events occurs promoting the activation of inflammatory mediators such as leukocytes and the release of signaling molecules such as cytokines and growth factors, evoking an inflammatory and wound healing process. This review examines the cellular and molecular mechanisms involved in the foreign body reaction, especially how cytokines impact the overall inflammatory response to devices. It also reviews how these events can be modulated by the physical and chemical properties of the biomaterials such as wettability, chemistry and geometry of surface. Particular attention is dedicated to the cardiovascular field, where the use of synthetic polymers has several limitations such as thrombogenicity and risk of infection. New materials and strategies to improve biomaterial characteristics are discussed. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Boccafoschi, F.; Mosca, C.; Cannas, M.] Univ Piemonte Orientale, Dept Hlth Sci, I-28100 Novara, Italy.
RP Boccafoschi, F (reprint author), Univ Piemonte Orientale, Dept Hlth Sci, I-28100 Novara, Italy.
EM francesca.boccafoschi@med.unipmn.it
OI Boccafoschi, Francesca/0000-0002-6734-5447
CR Ainslie KM, 2009, J BIOMED MATER RES A, V91A, P647, DOI 10.1002/jbm.a.32262
   Alcantara EM, 2005, APPL ENG MECH MED
   Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ANDERSON JM, 1999, TIS ENGN INTELL UNIT, V1, P197
   Anderson JM, 2004, BIOMATERIALS SCI INT, P771
   Anderson JM, 2004, BIOMATERIAL SCI INTR, P296
   Anderson JM, 2004, BIOMATERIALS SCI INT, P360
   Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Arshady R., 2003, INTRO POLYM BIOMATER, P1
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Bellon JM, 1996, J BIOMED MATER RES, V31, P1, DOI 10.1002/(SICI)1097-4636(199605)31:1<1::AID-JBM1>3.0.CO;2-S
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   BHAGYALAKSHMI A, 1989, BIOCHEM BIOPH RES CO, V158, P31, DOI 10.1016/S0006-291X(89)80172-X
   BIRK DE, 1981, EXP EYE RES, V32, P331, DOI 10.1016/0014-4835(81)90038-5
   BLUMENBERG RM, 1991, J VASC SURG, V14, P175
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   Boretos JW, 1984, CONT BIOMATERIALS MA, P232
   Brass LF, 1991, HEMATOLOGY BASIC PRI, P1176
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   BULL DA, 1995, J SURG RES, V58, P58, DOI 10.1006/jsre.1995.1010
   Burkatovskaya M, 2006, BIOMATERIALS, V27, P4157, DOI 10.1016/j.biomaterials.2006.03.028
   Butler DL, 2010, NAT PROTOC, V5, P849, DOI 10.1038/nprot.2010.14
   CAMPBELL CD, 1975, ANN SURG, V182, P138, DOI 10.1097/00000658-197508000-00010
   CAMPBELL CD, 1976, SURGERY, V79, P485
   Carletti E, 2011, METHODS MOL BIOL, V695, P17, DOI 10.1007/978-1-60761-984-0_2
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chesnutt BM, 2009, TISSUE ENG PT A, V15, P2571, DOI 10.1089/ten.tea.2008.0054
   Chlupac J, 2009, PHYSIOL RES, V58, pS119
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   Clagett GP, 1987, HEMOSTASIS THROMBOSI, P1348
   Clarke ML, 2005, J PHYS CHEM B, V109, P22027, DOI 10.1021/jp054456k
   CLOWES AW, 1986, J VASC SURG, V3, P877, DOI 10.1067/mva.1986.avs0030877
   CLOWES AW, 1985, AM J PATHOL, V118, P43
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83
   de Mel A, 2009, BIO-MED MATER ENG, V19, P317, DOI 10.3233/BME-2009-0597
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DIAMOND SL, 1989, SCIENCE, V243, P1483, DOI 10.1126/science.2467379
   Duarte ML, 2001, INT J BIOL MACROMOL, V28, P359, DOI 10.1016/S0141-8130(01)00134-9
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   Eskin S. G., 2004, BIOMATERIALS SCI INT, P237
   Evans-Nguyen KM, 2005, BIOCHEMISTRY-US, V44, P15561, DOI 10.1021/bi0514358
   FALK E, 1996, ATHEROSCLEROSIS CORO, V2, P492
   Faries PL, 2000, J VASC SURG, V32, P1080, DOI 10.1067/mva.2000.111279
   Fereol S, 2006, CELL MOTIL CYTOSKEL, V63, P321, DOI 10.1002/cm.20130
   FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488
   Galbusera M, 1997, BLOOD, V90, P1558
   Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193
   George J, 2008, J BIOMED MATER RES A, V87A, P1103, DOI 10.1002/jbm.a.32277
   Ghanbari H, 2011, INT J NANOMED, V6, P775, DOI 10.2147/IJN.S14881
   Gibbons D.F., 1992, DEGRADATION PHENOMEN, V1994, P97
   Gimbrone MA, 1986, VASCULAR ENDOTHELIUM, P1
   Giordano C, 2006, J BIOMATER APPL, V20, P237, DOI 10.1177/0885328206051811
   Girard PP, 2007, SOFT MATTER, V3, P307, DOI 10.1039/b614008d
   Grabowski EF, 2001, ARTERIOSCL THROM VAS, V21, P157, DOI 10.1161/01.ATV.21.1.157
   Greisler H P, 1990, Ann Vasc Surg, V4, P98, DOI 10.1007/BF02042699
   GUIDOIN R, 1993, BIOMATERIALS, V14, P678, DOI 10.1016/0142-9612(93)90067-C
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   HAMILTON KK, 1990, BLOOD, V76, P2572
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   Hao T, 2010, OSTEOARTHR CARTILAGE, V18, P257, DOI 10.1016/j.joca.2009.08.007
   Heden P, 2009, AESTHET PLAST SURG, V33, P274, DOI 10.1007/s00266-008-9303-y
   Helary C, 2010, BIOMATERIALS, V31, P481, DOI 10.1016/j.biomaterials.2009.09.073
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HERRING M, 1979, ARCH SURG-CHICAGO, V114, P679
   HESS F, 1992, J CARDIOVASC SURG, V33, P358
   Hezi-Yamit A, 2009, J BIOMED MATER RES A, V90A, P133, DOI 10.1002/jbm.a.32057
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   Hsu SH, 2004, J POLYM RES, V11, P141, DOI 10.1023/B:JPOL.0000031080.70010.0b
   Ikeda T, 1998, BIOCHEM BIOPH RES CO, V253, P265, DOI 10.1006/bbrc.1998.9702
   Ingram JH, 2004, BIOMATERIALS, V25, P3511, DOI 10.1016/j.biomaterials.2003.10.054
   Irwin EF, 2008, J BIOMAT SCI-POLYM E, V19, P1363, DOI 10.1163/156856208786052407
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014
   Jeschke B, 2002, BIOMATERIALS, V23, P3455, DOI 10.1016/S0142-9612(02)00052-2
   Jin XB, 2008, J BIOMED MATER RES A, V86A, P1077, DOI 10.1002/jbm.a.31656
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kenney D, 1998, ASAIO T, V34, P661
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KOGEL H, 1989, THORAC CARDIOV SURG, V37, P119, DOI 10.1055/s-2007-1020302
   KOHLER TR, 1992, SURGERY, V112, P901
   Krane SM, 2008, AMINO ACIDS, V35, P703, DOI 10.1007/s00726-008-0073-2
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   Levin EG, 1997, J CELL SCI, V110, P139
   LIBBY P, 1996, ATHEROSCLEROSIS CORO, V1, P585
   Lidington EA, 2000, BLOOD, V96, P2784
   Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026
   Lindblad M, 1997, BIOMATERIALS, V18, P1059, DOI 10.1016/S0142-9612(97)00029-X
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Lu HJ, 2009, J MATER SCI-MATER M, V20, P1937, DOI 10.1007/s10856-009-3744-y
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Maguire T, 2007, BIOTECHNOL BIOENG, V98, P631, DOI 10.1002/bit.21435
   MALEK AM, 1994, CIRC RES, V74, P852, DOI 10.1161/01.RES.74.5.852
   Manly DA, 2011, ANNU REV PHYSIOL, V73, P515, DOI 10.1146/annurev-physiol-042210-121137
   Marcacci M, 2006, OPER TECH ORTHOP, V16, P266, DOI 10.1053/j.oto.2006.08.002
   MARCUM JA, 1984, J CLIN INVEST, V74, P341, DOI 10.1172/JCI111429
   Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Maurus PB, 2004, OPER TECHN SPORT MED, V12, P158, DOI 10.1053/j.otsm.2004.07.015
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Mukaida N, 1998, CYTOKINE GROWTH F R, V9, P9, DOI 10.1016/S1359-6101(97)00022-1
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Ni RF, 2009, CARDIOVASC INTER RAD, V32, P313, DOI 10.1007/s00270-008-9426-1
   O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Pandis L, 2010, J BIOMED MATER RES A, V93A, P1289, DOI 10.1002/jbm.a.32626
   Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765
   Pate M, 2010, ADV CLIN CHEM, V52, P109, DOI 10.1016/S0065-2423(10)52004-3
   POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001
   Pompe T, 2003, J BIOMED MATER RES A, V67A, P647, DOI 10.1002/jbm.a.10130
   Purcell EK, 2009, TISSUE ENG PART C-ME, V15, P541, DOI 10.1089/ten.tec.2008.0302
   Raines EW, 1996, ATHEROSCLEROSIS CORO, V1, P539
   Ravi S, 2009, VASCULAR, V17, pS45, DOI 10.2310/6670.2008.00084
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Saha P, 2011, ARTERIOSCL THROM VAS, V31, P506, DOI 10.1161/ATVBAHA.110.213405
   Saino E, 2011, BIOMACROMOLECULES, V12, P1900, DOI 10.1021/bm200248h
   Salacinski HJ, 2002, J BIOMED MATER RES, V59, P207
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   Sanchez VC, 2009, WIRES NANOMED NANOBI, V1, P511, DOI 10.1002/wnan.41
   Schoen F. J., 2004, BIOMATERIALS SCI INT, P293
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131
   Shi Q, 1997, J VASC SURG, V25, P736, DOI 10.1016/S0741-5214(97)70303-3
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Spatz JP, 2007, METHOD CELL BIOL, V83, P89, DOI 10.1016/S0091-679X(07)83005-6
   STEWART GJ, 1975, J LAB CLIN MED, V85, P208
   STEWART GJ, 1993, HAEMOSTASIS, V23, P127
   Stone CA, 2000, BRIT J PLAST SURG, V53, P601, DOI 10.1054/bjps.2000.3412
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   TAKADA Y, 1994, BIOCHEM BIOPH RES CO, V205, P1345, DOI 10.1006/bbrc.1994.2813
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Tedesco F, 1999, MOL IMMUNOL, V36, P261, DOI 10.1016/S0161-5890(99)90054-8
   Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   VANDERWAL AC, 1989, LAB INVEST, V61, P166
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Vasita R, 2008, CURR TOP MED CHEM, V8, P341
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   WAHL SM, 1989, J CELL BIOCHEM, V40, P193, DOI 10.1002/jcb.240400208
   Ward B, 2007, J BIOMED MATER RES A, V80, P33
   Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997
   WESELOW A, 1984, VASCULAR SURG PRINCI, P93
   WESOLOWSKI S, 1964, CARDIOVASC SURG, V38, P544
   Westmuckett AD, 2000, ARTERIOSCL THROM VAS, V20, P2474, DOI 10.1161/01.ATV.20.11.2474
   Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1
   WHITTEMORE AD, 1989, J VASC SURG, V10, P299, DOI 10.1067/mva.1989.14116
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723
   Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289
   WU MHD, 1995, J VASC SURG, V21, P862, DOI 10.1016/S0741-5214(05)80019-9
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zavan B, 2008, FASEB J, V22, P2853, DOI 10.1096/fj.08-107284
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zhong SP, 2007, MAT SCI ENG C-BIO S, V27, P262, DOI 10.1016/j.msec.2006.05.010
   Zhou HY, 2008, CARBOHYD POLYM, V73, P265, DOI 10.1016/j.carbpol.2007.11.026
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
   ZIMMERMAN GA, 1990, J CELL BIOL, V110, P529, DOI 10.1083/jcb.110.2.529
NR 189
TC 11
Z9 11
U1 1
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD APR
PY 2014
VL 8
IS 4
BP 253
EP 267
DI 10.1002/term.1526
PG 15
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AD9EY
UT WOS:000333568800001
PM 22730232
DA 2018-10-20
ER

PT J
AU Kim, MS
   Kim, GH
AF Kim, Min Seong
   Kim, Geun Hyung
TI Highly porous electrospun 3D polycaprolactone/beta-TCP biocomposites for
   tissue regeneration
SO MATERIALS LETTERS
LA English
DT Article
DE Electrospun micro/nanofibers; Polycaprolactone; Tricalcium phosphate;
   Biomaterial
ID MECHANICAL-PROPERTIES; BONE SUBSTITUTES; SCAFFOLDS; FABRICATION; DESIGN;
   PORES
AB Micro/nanofibres can provide outstanding biological activity in tissue regeneration. However, their use as a biomedical scaffold has been limited due to difficulty of three-dimensional (3D) shapability, small pore size, and weak mechanical properties. In this study, we suggest a facile method of fabricating mechanically enhanced 3D polycaprolactone (PCL)/beta-TCP micro/nanofibres with homogeneous micropores using modified wet-electrospinning supplemented with a femtosecond laser. The fabricated scaffolds demonstrated improved mechanical properties and relatively high cellular activities compared to rapid-prototyped 3D PCL/beta-TCP scaffolds. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kim, Min Seong; Kim, Geun Hyung] Sungkyunkwan Univ, Dept Biomechatron Engn, Coll Biotechnol & Bioengn, Tissue Engn Lab, Suwon, South Korea.
RP Kim, GH (reprint author), Sungkyunkwan Univ, Dept Biomechatron Engn, Coll Biotechnol & Bioengn, Tissue Engn Lab, Suwon, South Korea.
EM gkimbme@skku.edu
CR Choi SW, 2010, LANGMUIR, V26, P19001, DOI 10.1021/la104206h
   Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   Cui Y, 2009, ACTA BIOMATER, V5, P2680, DOI 10.1016/j.actbio.2009.03.024
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hong S, 2011, APPL PHYS A-MATER, V103, P1009, DOI 10.1007/s00339-011-6381-5
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   Kim G, 2011, J MATER CHEM, V21, P6165, DOI 10.1039/c0jm03452e
   Kim YB, 2012, J MATER CHEM, V22, P16880, DOI 10.1039/c2jm33036a
   Lee H, 2011, J MATER CHEM, V21, P6305, DOI 10.1039/c0jm03414b
   Lee J, 2013, MATER LETT, V93, P397, DOI 10.1016/j.matlet.2012.11.124
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Moroni L, 2008, ADV FUNCT MATER, V18, P53, DOI 10.1002/adfm.200601158
   Nisbet DR, 2009, J BIOMATER APPL, V24, P7, DOI 10.1177/0885328208099086
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sachlos E, 2003, EUR CELLS MATER, V10
   Wahl DA, 2007, J MATER SCI-MATER M, V18, P201, DOI 10.1007/s10856-006-0682-9
   Wang JP, 2010, J BIOMED MATER RES A, V93A, P753, DOI 10.1002/jbm.a.32591
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yeo M, 2012, J MATER CHEM, V22, P21636, DOI 10.1039/c2jm31165h
   Yokoyama Y, 2009, MATER LETT, V63, P754, DOI 10.1016/j.matlet.2008.12.042
   Zhang Y, 2012, MACROMOL RAPID COMM, V33, P296, DOI 10.1002/marc.201100695
NR 28
TC 18
Z9 19
U1 4
U2 67
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD APR 1
PY 2014
VL 120
BP 246
EP 250
DI 10.1016/j.matlet.2014.01.083
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AE2BW
UT WOS:000333779300067
DA 2018-10-20
ER

PT J
AU Jerman, UD
   Veranic, P
   Kreft, ME
AF Jerman, Urska Dragin
   Veranic, Peter
   Kreft, Mateja Erdani
TI Amniotic Membrane Scaffolds Enable the Development of Tissue-Engineered
   Urothelium with Molecular and Ultrastructural Properties Comparable to
   that of Native Urothelium
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID OCULAR SURFACE RECONSTRUCTION; EPITHELIAL-CELLS; BASEMENT-MEMBRANES;
   REGENERATIVE MEDICINE; CULTURE; DIFFERENTIATION; TRANSPLANTATION;
   ANGIOGENESIS; EXPRESSION; SUBSTRATE
AB The amniotic membrane (AM) is a naturally derived biomaterial that possesses biological and mechanical properties of great importance for tissue engineering. The aim of our study was to determine whether the AM enables the formation of a normal urinary bladder epithelium-urothelium- and to reveal any differences in the urothelial cell (UC) growth and differentiation when using different AM scaffolds. Cryopreserved human AM was used as a scaffold in three different ways. Normal porcine UCs were seeded on the AM epithelium (eAM), denuded AM (dAM), and stromal AM (sAM) and were cultured for 3 weeks. UC growth on AM scaffolds was monitored daily. By using electron microscopy, histochemical and immunofluorescence techniques, we here provide evidence that all three AM scaffolds enable the development of the urothelium. The fastest growth and the highest differentiation of UCs were demonstrated on the sAM scaffold, which enables the development of tissue-engineered urothelium with molecular and ultrastructural properties comparable to that of the native urothelium. Most importantly, the highly differentiated urothelia on the sAM scaffolds provide important experimental models for future drug delivery studies and developing tissue engineering strategies considering that subtle differences are identified before translation to the clinical settings.
C1 [Jerman, Urska Dragin; Veranic, Peter; Kreft, Mateja Erdani] Univ Ljubljana, Inst Cell Biol, Fac Med, SI-1000 Ljubljana, Slovenia.
RP Kreft, ME (reprint author), Univ Ljubljana, Inst Cell Biol, Fac Med, Vrazov Trg 2, SI-1000 Ljubljana, Slovenia.
EM mateja.erdani@mf.uni-lj.si
FU Slovenian Research Agency [P3-0108]
FX This work was supported by the Slovenian Research Agency (Grant No.
   P3-0108). The authors would like to express their appreciation to
   Professor Dr. Kristijan Jezernik and Professor Dr. Rok Romih for their
   continuous support. We thank Professor Dr. Tung-Tien Sun (New York
   University, School of Medicine), for uroplakin antibodies, Dr. Tina
   Cirman (Blood Transfusion Centre of Slovenia, Ljubljana) for preparing
   the AM, Eva Lasic for proofreading the manuscript, and Linda Strus and
   Sanja Cabraja for technical assistance.
CR ADINOLFI M, 1982, NATURE, V295, P325, DOI 10.1038/295325a0
   Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584
   Andersson K. E., 2013, NEUROUROL URODYN, DOI 10.1002/nau.22465
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Chen YJ, 2012, BIOMATERIALS, V33, P455, DOI 10.1016/j.biomaterials.2011.09.065
   Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P5136, DOI 10.1167/iovs.03-0484
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   HOULIHAN JM, 1995, J IMMUNOL, V154, P5665
   Hsiao Y. C., 2011, BIOMATERIALS, V32, P442
   Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Koizumi N, 2007, GRAEF ARCH CLIN EXP, V245, P123, DOI 10.1007/s00417-005-0095-3
   Kreft M. E., 2012, PLOS ONE, V7
   Kreft ME, 2010, ZDR VESTN, V79, P707
   Kreft ME, 2010, PROTOPLASMA, V246, P3, DOI 10.1007/s00709-010-0112-1
   Kreft ME, 2009, ANN NY ACAD SCI, V1152, P18, DOI 10.1111/j.1749-6632.2008.04004.x
   Kreft ME, 2005, FOLIA BIOL-PRAGUE, V51, P126
   Kruse FE, 2000, GRAEF ARCH CLIN EXP, V238, P68, DOI 10.1007/s004170050012
   Liu T, 2012, MOL VIS, V18, P2137
   Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-6
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Meinert M, 2001, AM J OBSTET GYNECOL, V184, P679, DOI 10.1067/mob.2001.110294
   Meller D, 2011, DTSCH ARZTEBL INT, V108, P243, DOI 10.3238/arztebl.2011.0243
   Mermet I, 2007, WOUND REPAIR REGEN, V15, P459, DOI 10.1111/j.1524-475X.2007.00252.x
   Mikek K., 2004, ZDR VESTN, V73, P419
   Mohammadi AA, 2013, BURNS, V39, P349, DOI 10.1016/j.burns.2012.07.010
   Nakamura T, 2008, BIOMATERIALS, V29, P3729, DOI 10.1016/j.biomaterials.2008.05.023
   Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Ohshima M, 2003, J PERIODONTAL RES, V38, P175, DOI 10.1034/j.1600-0765.2003.01628.x
   Resch MD, 2006, INVEST OPHTH VIS SCI, V47, P1853, DOI 10.1167/iovs.05-0983
   Riau AK, 2010, BIOMATERIALS, V31, P216, DOI 10.1016/j.biomaterials.2009.09.034
   Romih R, 2005, CELL TISSUE RES, V320, P259, DOI 10.1007/s00441-004-1005-4
   SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577
   Sartoneva R., 2001, J R SOC INTERFACE, V58, P671
   Sarwar Iram, 2010, J Ayub Med Coll Abbottabad, V22, P7
   Seidler DG, 2005, BIOCHEM BIOPH RES CO, V332, P1162, DOI 10.1016/j.bbrc.2005.04.175
   Sharifiaghdas Farzaneh, 2007, Urol J, V4, P71
   TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D
   Tanjore H, 2006, AM J PATHOL, V168, P715, DOI 10.2353/ajpath.2006.051321
   Turner AM, 2008, EUR UROL, V54, P1423, DOI 10.1016/j.eururo.2008.03.068
   Vinjar T., 2012, HISTOCHEM CELL BIOL, V137, P177
   Yoshida T, 2010, ARTERIOSCL THROM VAS, V30, P1300, DOI 10.1161/ATVBAHA.109.198994
   YOUNG RL, 1991, FERTIL STERIL, V55, P624
   YURCHENCO PD, 1990, FASEB J, V4, P1577
NR 45
TC 16
Z9 17
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD APR 1
PY 2014
VL 20
IS 4
BP 317
EP 327
DI 10.1089/ten.tec.2013.0298
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AE0BA
UT WOS:000333627300006
PM 23947657
OA Green Published
DA 2018-10-20
ER

PT J
AU Li, Y
   Thouas, GA
   Shi, HN
   Chen, QZ
AF Li, Yuan
   Thouas, George A.
   Shi, Hanning
   Chen, Qizhi
TI Enzymatic and oxidative degradation of poly(polyol sebacate)
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE xanthine; xanthine oxidase; enzymatic degradation; esterase; Poly(polyol
   sebacate); FeSO4/H2O2
ID IN-VIVO DEGRADATION; POLY(GLYCEROL SEBACATE); FREE-RADICALS;
   BIODEGRADATION; POLYMERS; HYDROLYSIS; TISSUE; POLY(URETHANE)S;
   BIOMATERIALS; INFLAMMATION
AB Poly(glycerol sebacate) (PGS) and poly(xylitol sebacate) (PXS) are biodegradable elastomers with tremendous potential in soft tissue engineering. This study was aimed at exploring the enzymatic degradation mechanisms of these polyesters, using biochemical conditions similar to those occurring invivo. To this end, PGS and PXS (crosslinked at 130celcius for 2 or 7 (PGS)/12 days (PXS)) were incubated invitro under physiological conditions in tissue culture media supplemented with either a biodegrading enzyme (esterase), an oxidant species (FeSO4/H2O2 with 0.11 molar ratio of Fe2+/H2O2), an oxidant generating enzyme (xanthine oxidase and xanthine) or combinations of these (FeSO4/H2O2 and esterase, or (v) xanthine oxidase/xanthine and esterase), based on their independent effects on polymer degradation. Testing was performed over 35 days of continuous incubation, during which mechanical properties, mass loss, biomaterial thickness and pH value of the culture medium were determined. Degradation kinetics of both PGS and PXS samples were primarily determined by the degree of crosslink density. Esterase and FeSO4/H2O2 accelerated the degradation of both polymers, by promoting hydrolysis and free-radical degradation, although this action was not affected by the presence of xanthine oxidase and xanthine. Degradation of PGS and PXS is primarily mediated by the action of esterase, with free-radical oxidation playing a secondary role, suggesting that both could synergistically affect the biodegradability of biomaterial implants, under more complex biological conditions.
C1 [Li, Yuan; Shi, Hanning; Chen, Qizhi] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
   [Thouas, George A.] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia.
RP Chen, QZ (reprint author), Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
EM qizhi.chen@monash.edu
FU Australian Research Council [DP130101384]
FX The work was supported by Australian Research Council (to QZC,
   DP130101384).
CR ALI SAM, 1994, J APPL POLYM SCI, V51, P1389, DOI 10.1002/app.1994.070510805
   ALI SAM, 1993, J BIOMED MATER RES, V27, P1409, DOI 10.1002/jbm.820271108
   BERGMANN F, 1958, BIOCHEM J, V68, P493, DOI 10.1042/bj0680493
   Bettinger CJ, 2011, MACROMOL BIOSCI, V11, P467, DOI 10.1002/mabi.201000397
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Bruggeman JP, 2008, ADV MATER, V20, P1922, DOI 10.1002/adma.200702377
   Chapanian R, 2009, BIOMATERIALS, V30, P295, DOI 10.1016/j.biomaterials.2008.09.038
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Chen QZ, 2012, RSC ADV, V2, P4125, DOI 10.1039/c2ra20113e
   Coleman JW, 2001, INT IMMUNOPHARMACOL, V1, P1397, DOI 10.1016/S1567-5769(01)00086-8
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269
   Ivanova T, 1997, COLLOID SURFACE B, V8, P217, DOI 10.1016/S0927-7765(96)01331-8
   Labow RS, 2002, J BIOMAT SCI-POLYM E, V13, P651, DOI 10.1163/156856202320269148
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Lee KH, 1999, J POLYM SCI POL CHEM, V37, P3558, DOI 10.1002/(SICI)1099-0518(19990915)37:18<3558::AID-POLA2>3.0.CO;2-4
   Li Y, 2012, RSC ADV, V2, P8229, DOI 10.1039/c2ra20736b
   Liang SL, 2011, BIOMATERIALS, V32, P8486, DOI 10.1016/j.biomaterials.2011.07.080
   Liang SL, 2010, BIOMATERIALS, V31, P8516, DOI 10.1016/j.biomaterials.2010.07.105
   MCCORD JM, 1974, SCIENCE, V185, P529, DOI 10.1126/science.185.4150.529
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SCHAKENRAAD JM, 1990, J BIOMED MATER RES, V24, P529, DOI 10.1002/jbm.820240502
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   Stuckey DJ, 2010, TISSUE ENG PT A, V16, P3395, DOI 10.1089/ten.TEA.2010.0213
   Veress AI, 2005, J BIOMECH ENG-T ASME, V127, P1195, DOI 10.1115/1.2073677
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   WILLIAMS DF, 1977, J BIOENG, V1, P231
   WILLIAMS DF, 1994, INT BIODETER BIODEGR, V34, P95, DOI 10.1016/0964-8305(94)90002-7
   Williams DF, 1981, ENG MED, V10, P5, DOI DOI 10.1243/EMED_JOUR_1981_010_004_02
   Williams DF, 1989, COMPREHEN POLYM SCI, P6
   Yavuz Y, 2007, CHEM ENG TECHNOL, V30, P583, DOI 10.1002/ceat.200600377
NR 36
TC 5
Z9 5
U1 2
U2 35
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD APR
PY 2014
VL 28
IS 8
BP 1138
EP 1150
DI 10.1177/0885328213499195
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD6VL
UT WOS:000333399200002
PM 23904286
DA 2018-10-20
ER

PT J
AU Sukumar, N
   Ramachandran, T
   Lakshmikantha, CB
AF Sukumar, N.
   Ramachandran, T.
   Lakshmikantha, C. B.
TI Development and characterization of cactus-dextrin- recombinant human
   epidermal growth factor based silk scaffold for wound dressing
   applications
SO JOURNAL OF INDUSTRIAL TEXTILES
LA English
DT Article
DE wound healing; dextrin; EGF; cactus; silk fibroin; Silk scaffold
ID FIBROIN; DEGRADATION; BIOMATERIALS; PROTEIN; STABILITY; RELEASE;
   EXTRACT; FILMS
AB Silk fibroin (SF), a naturally occurring protein polymer, has several unique properties such as biocompatibility, biodegradability, minimal inflammatory reaction, and endowed with excellent mechanical properties and process ability. The existing scaffolds used in medical industry lack the degradation and/or slow in healing practice, so clinically there is a need for the development of efficient and reliable biomaterial scaffolds for wound healing. Silk fibroin has shown greater potential for tissue engineering applications. This work is focused on designing biomaterial with silk as raw material and wound healing effect of SF scaffolds were also tested. The silk blended scaffolds were prepared by using SF as a vehicle with dextrin, other healing agent of cactus and epidermal growth factor (rhEGF) are used as the drug releasing model. Scanning electronic microscope (SEM) was used to observe the morphology of prepared scaffolds for process versatility and the highly specific surface area. The structure was studied by Fourier transform infrared. The SF was treated at different concentrations of cactus and rhEGF, to investigate the growth inhibition effect of bacterial growth. The SF scaffolds show favorable stability by their structural integrity, morphology, mechanical properties, and powerful antibacterial efficacy up to 100% to Escherichia coli and Staphylococcus epidermidis significantly intended to provide improved environments for the zone of incubation when compared with normal scaffolds without rhEGF. Therefore, the results give the evidence for the application of SF blended scaffolds in the treatment of wound.
C1 [Sukumar, N.] KS Rangasamy Coll Technol, Dept Text Technol, Tiruchengode, India.
   [Ramachandran, T.] Karpagam Inst Technol, Coimbatore, Tamil Nadu, India.
   [Lakshmikantha, C. B.] PB Coll Engn, Madras, Tamil Nadu, India.
RP Sukumar, N (reprint author), KS Rangasamy Coll Technol, Dept Text Technol, Tiruchengode, India.
EM sugumaraan@yahoo.com
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Basal G, 2010, FIBER POLYM, V11, P21, DOI [10.1007/s1221-010-0021-0, 10.1007/s12221-010-0021-0]
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Carvalho J, 2007, EUR POLYM J, V43, P3050, DOI 10.1016/j.eurpolymj.2007.02.046
   Chen SX, 2011, J MED PLANTS RES, V5, P973
   Demidova-Rice TN, 2012, ADV WOUND CARE, V1, P17, DOI 10.1089/wound.2011.0308
   Determan AS, 2006, BIOMATERIALS, V27, P3312, DOI 10.1016/j.biomaterials.2006.01.054
   Edan I, 2010, INT J MICROBIOL, V7, P12
   Fingold SM, 1986, BAILEY SCOTTS DIAGNO
   Hardwicke JT, 2011, J CONTROL RELEASE, V152, P411, DOI 10.1016/j.jconrel.2011.03.016
   He JK, 2012, MATER LETT, V78, P102, DOI 10.1016/j.matlet.2012.03.051
   Hreczuk-Hirst D, 2001, INT J PHARM, V230, P57, DOI 10.1016/S0378-5173(01)00859-6
   Huang XJ, 2009, CELL MOL NEUROBIOL, V29, P1211, DOI 10.1007/s10571-009-9417-z
   Jagur-Grodzinski J, 2006, POLYM ADVAN TECHNOL, V17, P395, DOI 10.1002/pat.729
   Janiga P, 2011, J IND TEXT, V42, P176
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lavin JLS, 2009, J INT MED RES, V37, P1
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lopac SK, 2009, J BIOMED MATER RES B, V91B, P938, DOI 10.1002/jbm.b.31478
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mohan VK, 2007, DIABETES RES CLIN PR, V78, P405, DOI 10.1016/j.diabres.2007.06.004
   Moreira SM, 2008, BMC BIOTECHNOL, V78, P1
   Moreira S, 2010, J BIOACT COMPAT POL, V25, P141, DOI 10.1177/0883911509357865
   Noishiki Y, 2002, J APPL POLYM SCI, V86, P3425, DOI 10.1002/app.11370
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Park EH, 1998, ARCH PHARM RES, V21, P30, DOI 10.1007/BF03216749
   Schepetkin IA, 2008, INT IMMUNOPHARMACOL, V8, P1455, DOI 10.1016/j.intimp.2008.06.003
   Sciences B, 2008, J PHARM SCI, V97, P2892
   Sobajo C, 2008, EPLASTY, V8, P438
   TrejoGonzalez A, 1996, J ETHNOPHARMACOL, V55, P27, DOI 10.1016/S0378-8741(96)01467-5
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
NR 33
TC 3
Z9 4
U1 2
U2 23
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1528-0837
EI 1530-8057
J9 J IND TEXT
JI J. Ind. Text.
PD APR
PY 2014
VL 43
IS 4
BP 565
EP 576
DI 10.1177/1528083712470159
PG 12
WC Materials Science, Textiles
SC Materials Science
GA AD3MT
UT WOS:000333150900007
DA 2018-10-20
ER

PT J
AU Henstock, JR
   Ruktanonchai, UR
   Canham, LT
   Anderson, SI
AF Henstock, J. R.
   Ruktanonchai, U. R.
   Canham, L. T.
   Anderson, S. I.
TI Porous silicon confers bioactivity to polycaprolactone composites in
   vitro
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DRUG-DELIVERY; SUBSTITUTED HYDROXYAPATITE; IONIC PRODUCTS; CELLS; VIVO;
   DISSOLUTION; DIFFERENTIATION; PROLIFERATION; BIOGLASS(R); OSTEOBLASTS
AB Silicon is an essential element for healthy bone development and supplementation with its bioavailable form (silicic acid) leads to enhancement of osteogenesis both in vivo and in vitro. Porous silicon (pSi) is a novel material with emerging applications in opto-electronics and drug delivery which dissolves to yield silicic acid as the sole degradation product, allowing the specific importance of soluble silicates for biomaterials to be investigated in isolation without the elution of other ionic species. Using polycaprolactone as a bioresorbable carrier for porous silicon microparticles, we found that composites containing pSi yielded more than twice the amount of bioavailable silicic acid than composites containing the same mass of 45S5 Bioglass. When incubated in a simulated body fluid, the addition of pSi to polycaprolactone significantly increased the deposition of calcium phosphate. Interestingly, the apatites formed had a Ca:P ratio directly proportional to the silicic acid concentration, indicating that silicon-substituted hydroxyapatites were being spontaneously formed as a first order reaction. Primary human osteoblasts cultured on the surface of the composite exhibited peak alkaline phosphatase activity at day 14, with a proportional relationship between pSi content and both osteoblast proliferation and collagen production over 4 weeks. Culturing the composite with J744A.1 murine macrophages demonstrated that porous silicon does not elicit an immune response and may even inhibit it. Porous silicon may therefore be an important next generation biomaterial with unique properties for applications in orthopaedic tissue engineering.
C1 [Henstock, J. R.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England.
   [Ruktanonchai, U. R.] NSTDA, Natl Nanotechnol Ctr NANOTEC, Pathum Thani 12120, Thailand.
   [Canham, L. T.] PSiMedica Ltd, Malvern WR14 3SZ, Worcs, England.
   [Anderson, S. I.] Univ Nottingham, Sch Grad Entry Med & Hlth, Royal Derby Hosp Ctr, Derby DE22 3DT, England.
RP Henstock, JR (reprint author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England.
EM j.r.henstock@keele.ac.uk
CR Alvarez SD, 2008, BIOMATERIALS, V30, P26
   Anderson SI, 1998, J MATER SCI-MATER M, V9, P731, DOI 10.1023/A:1008955002955
   Anglin EJ, 2004, LANGMUIR, V20, P11264, DOI 10.1021/la048105t
   Anglin EJ, 2008, ADV DRUG DELIVER REV, V60, P1266, DOI 10.1016/j.addr.2008.03.017
   Arumugam MQ, 2006, KEY ENG MATER, V254, P869
   Canham LT, 1997, PROPERTIES POROUS SI
   Canham T, 1995, ADV MATER, V7, P1033
   CARLISLE EM, 1974, FED PROC, V33, P1758
   CARLISLE EM, 1988, SCI TOTAL ENVIRON, V73, P95, DOI 10.1016/0048-9697(88)90190-8
   Charnay C, 2004, EUR J PHARM BIOPHARM, V57, P533, DOI 10.1016/j.ejph.2003.12.007
   Chouzouri G, 2007, ACTA BIOMATER, V3, P745, DOI 10.1016/j.actbio.2007.01.005
   Coffer JL, 2003, PHYS STATUS SOLIDI A, V197, P336, DOI 10.1002/pssa.200306520
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Gibson IR, 2002, J AM CERAM SOC, V85, P2771
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Homaeigohar SSH, 2005, J BIOMED MATER RES A, V75A, P14, DOI 10.1002/jbm.a.30333
   Johansson F, 2008, IEEE T BIO-MED ENG, V55, P1447, DOI 10.1109/TBME.2007.912423
   Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225
   KEETING PE, 1992, J BONE MINER RES, V7, P1281, DOI 10.1002/jbmr.5650071107
   Kleveta G, 2012, J CELL BIOCHEM, V113, P80, DOI 10.1002/jcb.23330
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kubo K, 1997, J ORAL REHABIL, V24, P70, DOI 10.1046/j.1365-2842.1997.00462.x
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   Salonen J, 2008, J PHARM SCI-US, V97, P632, DOI 10.1002/jps.20999
   SAMMONS RL, 1994, BIOMATERIALS, V15, P536, DOI 10.1016/0142-9612(94)90020-5
   SCHWARZ K, 1973, P NATL ACAD SCI USA, V70, P1608, DOI 10.1073/pnas.70.5.1608
   Scotchford CA, 2003, BIOMATERIALS, V24, P4871, DOI 10.1016/S0142-9612(03)00403-4
   Serda RE, 2009, BIOMATERIALS, V30, P2440, DOI 10.1016/j.biomaterials.2009.01.019
   Sinha VR, 2008, DRUG DELIV, V15, P365, DOI 10.1080/10717540500398092 
   Sripanyakorn S, 2005, NUTR BULL, V30, P222, DOI 10.1111/j.1467-3010.2005.00507.x
   Vaccari L, 2006, MICROELECTRON ENG, V83, P1598, DOI 10.1016/j.mee.2006.01.113
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x
   Whitehead MA, 2008, TISSUE ENG PT A, V14, P195, DOI 10.1089/ten.a.2006.0370
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zhang K, 2005, CLIN CANCER RES, V11, P7532, DOI 10.1158/1078-0432.CCR-05-0400
   ZHOU H, 1994, J BONE MINER RES, V9, P1489
NR 41
TC 6
Z9 6
U1 2
U2 39
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2014
VL 25
IS 4
BP 1087
EP 1097
DI 10.1007/s10856-014-5140-5
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD2VH
UT WOS:000333093300013
PM 24398914
DA 2018-10-20
ER

PT J
AU Petreus, T
   Stoica, BA
   Petreus, O
   Goriuc, A
   Cotrutz, CE
   Antoniac, IV
   Barbu-Tudoran, L
AF Petreus, Tudor
   Stoica, Bogdan Alexandru
   Petreus, Oana
   Goriuc, Ancuta
   Cotrutz, Carmen-Elena
   Antoniac, Iulian-Vasile
   Barbu-Tudoran, Lucian
TI Preparation and cytocompatibility evaluation for hydrosoluble
   phosphorous acid-derivatized cellulose as tissue engineering scaffold
   material
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID REGENERATED CELLULOSE; PHYSICOCHEMICAL PROPERTIES; PHOSPHATES;
   BIOMATERIALS; BIOCOMPATIBILITY; PHOSPHORYLATION; HYDROGELS;
   MINERALIZATION; DISSOLUTION; MEMBRANES
AB Chemical modification of cellulose by phosphorylation enhances its bioactivity and provides new derivatives and materials with specific end uses. In the present study, cellulose derivatized with phosphorous acid was obtained using the reaction of microcrystalline cellulose with phosphorous acid-urea mixture, in molten state, in comparison with others methods that used different solvents and catalysts. Completely water soluble films with a substitution degree close to one were obtained and characterized by analytical and spectral analysis (FT-IR, P-31 NMR), contact angle, metallographic microscopy and atomic force microscopy (AFM). 31P NMR spectra of derivatized cellulose showed a signal at 2.58 ppm (assigned to P-O-C6) while the doublets at 4.99-5.29 and at 7.38 ppm were assigned to P-O-C2 and P-O-C3, respectively; thus, the formation of monosubstituted phosphorous acid esters of cellulose is advocated. Contact angle measurements showed that the work of adhesion is more important in water than in ethylene glycol, for the phosphorous acid derivatized cellulose. The cytocompatibility of this hydrosoluble derivatized cellulose was tested by direct contact and also by indirect assays on normal human dermal fibroblasts and on osteoblast-like cells (human osteosarcoma). Cell growth on phosphorylated cellulose pellicle and the results from viability assays had shown a good cytocompatibility and lack of toxicity. Phosphorous acid derivatized cellulose would offer a promising biomaterial, useful as scaffolds for new biopolymer composites, and subject for further development as an ionic crosslinker.
C1 [Petreus, Tudor; Stoica, Bogdan Alexandru; Goriuc, Ancuta; Cotrutz, Carmen-Elena] Gr T Popa Univ Med & Pharm Iasi, Iasi 700115, Romania.
   [Petreus, Oana] Petru Poni Inst Macromol Chem, Iasi 700487, Romania.
   [Antoniac, Iulian-Vasile] Univ Politehn Bucuresti, Bucharest 06004216, Romania.
   [Barbu-Tudoran, Lucian] Babes Bolyai Univ Cluj Napoca, Cluj Napoca 400084, Romania.
RP Petreus, O (reprint author), Petru Poni Inst Macromol Chem, 41A Alley Grigore Ghica Voda, Iasi 700487, Romania.
EM biotudor@gmail.com; bastoica@umfiasi.ro; opetreus@yahoo.com;
   ancuta.goriuc@yahoo.com; cotrutz@yahoo.com; antoniac.iulian@gmail.com;
   lbarbu@hasdeu.ubbcluj.ro
RI Antoniac, Iulian/D-4802-2014
OI Antoniac, Iulian/0000-0003-0112-3494; Barbu-Tudoran,
   Lucian/0000-0003-0360-016X
FU  [IDEI 2560/2008]
FX This paper was supported by the Research Grant IDEI 2560/2008.
CR BARBIE C, 1990, Clinical Materials, V5, P251, DOI 10.1016/0267-6605(90)90023-O
   Barbosa M.A., 2005, ITBM RBM, V26, P212, DOI DOI 10.1016/J.RBMRET.2005.04.006
   Bismarck A, 1999, J COLLOID INTERF SCI, V217, P377, DOI 10.1006/jcis.1999.6345
   CORY AH, 1991, CANCER COMMUN, V3, P207
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   Enderle J., 2000, INTRO BIOMEDICAL ENG
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   Gospodinova N, 2002, GREEN CHEM, V4, P220, DOI 10.1039/b200295g
   Granja P L, 2005, Eur Cell Mater, V10, P31
   Granja PL, 2006, REACT FUNCT POLYM, V66, P728, DOI 10.1016/j.reactfunctpolym.2005.10.027
   Granja PL, 2001, J MATER SCI, V36, P2163, DOI 10.1023/A:1017587815583
   Granja PL, 2001, J MATER SCI-MATER M, V12, P785, DOI 10.1023/A:1013960601330
   Granja PL, 2001, J APPL POLYM SCI, V82, P3354, DOI 10.1002/app.2194
   Granja PL, 2001, J APPL POLYM SCI, V82, P3341
   Granja PL, 2005, EUR CELLS MATER, V10, P7
   Gunnars S, 2002, CELLULOSE, V9, P239, DOI 10.1023/A:1021196914398
   INAGAKI N, 1976, J APPL POLYM SCI, V20, P2829, DOI 10.1002/app.1976.070201017
   INAGAKI N, 1978, J POLYM SCI POL CHEM, V16, P2771, DOI 10.1002/pol.1978.170161105
   Isogai A, 1998, CELLULOSE, V5, P309, DOI 10.1023/A:1009272632367
   Kennedy JF, 1989, ELLIS HORWOOD SERIES
   Kim SS, 1998, J BIOMED MATER RES, V40, P401, DOI 10.1002/(SICI)1097-4636(19980605)40:3<401::AID-JBM9>3.0.CO;2-J
   Kolowith LC, 2001, LIMNOL OCEANOGR, V46, P309, DOI 10.4319/lo.2001.46.2.0309
   Luneva NK, 2007, RUSS J APPL CHEM+, V80, P1923, DOI [10.1134/S1070427207110298, 10.1134/SI070427207110298]
   MACIEL GE, 1982, MACROMOLECULES, V15, P686, DOI 10.1021/ma00230a097
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   MCCORMICK CL, 1985, MACROMOLECULES, V18, P2394, DOI 10.1021/ma00154a010
   MERZ W, 1959, MICROCHIM ACTA, V47, P456, DOI DOI 10.1007/BF01216866
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mucalo MR, 2009, COLLOID SURFACE B, V71, P52, DOI 10.1016/j.colsurfb.2009.01.004
   Nifant'ev E. E., 1965, RUSS CHEM REV, V34, P942, DOI DOI 10.1070/RC1965V034N12ABEH001577
   Petreus O, 2003, J APPL POLYM SCI, V90, P327, DOI 10.1002/app.12532
   Petreus O, 2003, CELULOZA SI HARTIE, V52, P20
   PIMENTEL GC, 1956, J CHEM PHYS, V24, P639, DOI 10.1063/1.1742588
   Popescu CM, 2008, CELL CHEM TECHNOL, V42, P525
   Ramos LA, 2005, BIOMACROMOLECULES, V6, P2638, DOI 10.1021/bm0400776
   Rathna GVN, 2008, J MATER SCI-MATER M, V19, P2351, DOI 10.1007/s10856-007-3334-9
   Rozmarin G, 1973, CHIMIA LEMNULUI CELU, P175
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Simionescu Cr., 1973, CELLUL CHEM TECHN, V7, P153
   Suflet DM, 2006, REACT FUNCT POLYM, V66, P1240, DOI 10.1016/j.reactfunctpolym.2006.03.006
   Suzuki M, 2000, POLYMER, V41, P4531, DOI 10.1016/S0032-3861(99)00682-5
   Weil E. D., 2009, FLAME RETARDANTS PLA
   Yamane C, 2006, POLYM J, V38, P819, DOI 10.1295/polymj.PJ2005187
NR 44
TC 4
Z9 4
U1 0
U2 30
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2014
VL 25
IS 4
BP 1115
EP 1127
DI 10.1007/s10856-014-5146-z
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD2VH
UT WOS:000333093300015
PM 24481532
DA 2018-10-20
ER

PT J
AU Quinci, F
   Dressler, M
   Strickland, AM
   Limbert, G
AF Quinci, Federico
   Dressler, Matthew
   Strickland, Anthony M.
   Limbert, Georges
TI Towards an accurate understanding of UHMWPE visco-dynamic behaviour for
   numerical modelling of implants
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
ID MOLECULAR-WEIGHT POLYETHYLENE; TOTAL KNEE ARTHROPLASTY; TOTAL
   HIP-ARTHROPLASTY; CONTACT STRESSES; ACETABULAR CUPS; CREEP-BEHAVIOR;
   WEAR; REPLACEMENTS; SIMULATION; PENETRATION
AB Considerable progress has been made in understanding implant wear and developing numerical models to predict wear for new orthopaedic devices. However any model of wear could be improved through a more accurate representation of the biomaterial mechanics, including time-varying dynamic and inelastic behaviour such as viscosity and plastic deformation. In particular, most computational models of wear of UHMWPE implement a time-invariant version of Archard's law that links the volume of worn material to the contact pressure between the metal implant and the polymeric tibial insert. During in-vivo conditions, however, the contact area is a time-varying quantity and is therefore dependent upon the dynamic deformation response of the material. From this observation one can conclude that creep deformations of UHMWPE may be very important to consider when conducting computational wear analyses, in stark contrast to what can be found in the literature. In this study, different numerical modelling techniques are compared with experimental creep testing on a unicondylar knee replacement system in a physiologically representative context. Linear elastic, plastic and time-varying visco-dynamic models are benchmarked using literature data to predict contact deformations, pressures and areas. The aim of this study is to elucidate the contributions of viscoelastic and plastic effects on these surface quantities.
   It is concluded that creep deformations have a significant effect on the contact pressure measured (experiment) and calculated (computational models) at the surface of the UHMWPE unicondylar insert. The use of a purely elastoplastic constitutive model for UHMWPE lead to compressive deformations of the insert which are much smaller than those predicted by a creep-capturing viscoelastic model (and those measured experimentally). This shows again the importance of including creep behaviour into a constitutive model in order to predict the right level of surface deformation on a tibial insert. At high compressive loads, inelastic deformation mechanisms (creep and plasticity) dominate the mechanical response of UHMWPE components by altering the surface geometry (penetration depth and so contact area) and therefore the contact pressure. Although generic creep models can provide a good first approximation of material characteristics, for best accuracy both viscous and plastic effects must be captured, and model parameters must be founded upon specific experimental test data. Such high-fidelity numerical creep models will provide a better foundation for the next generation of more robust and accurate in-silico wear prediction tools. (c) 2014 Elsevier Ltd. All rights reserved.
C1 [Quinci, Federico; Limbert, Georges] Univ Southampton, Natl Ctr Adv Tribol Southampton nCATS, Fac Engn & Environm, Southampton SO17 1BJ, Hants, England.
   [Quinci, Federico; Strickland, Anthony M.; Limbert, Georges] Univ Southampton, Bioengn Sci Res Grp, Fac Engn & Environm, Southampton SO17 1BJ, Hants, England.
   [Dressler, Matthew] Depuy Synthes Joint Reconstruct, Warsaw, IN USA.
RP Limbert, G (reprint author), Univ Southampton, Natl Ctr Adv Tribol Southampton nCATS, Fac Engn & Environm, Southampton SO17 1BJ, Hants, England.
EM g.limbert@soton.ac.uk
RI Limbert, Georges/E-5658-2010
OI Limbert, Georges/0000-0002-4268-6106
FU DePuy Synthes Joint Reconstruction; Johnson & Johnson company;
   Engineering and Physical Sciences Research Council (EPSRC)
   [EP/F034296/1]; Engineering and Physical Sciences Research Council
   [EP/F034296/1]
FX Federico Quinci is financially supported by DePuy Synthes Joint
   Reconstruction, a Johnson & Johnson company. Georges Limbert is partly
   funded through an Engineering and Physical Sciences Research Council
   (EPSRC) grant [Grant EP/F034296/1]. This financial support is gratefully
   acknowledged. The authors would also like to thank Steve Leisinger, Zach
   Stookey, and Said Gomaa at DePuy Synthes Joint Reconstruction for their
   technical support.
CR Abdelgaied A, 2011, J BIOMECH, V44, P1108, DOI 10.1016/j.jbiomech.2011.01.027
   [Anonymous], 2012, ABAQUS V 6 12 1 US M
   ARCHARD JF, 1953, J APPL PHYS, V24, P981, DOI 10.1063/1.1721448
   ATKINSON JR, 1985, WEAR, V104, P225, DOI 10.1016/0043-1648(85)90050-X
   Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9
   Bergstrom J., 2011, INT J STRUCT CHANGES, V2, P31
   Bevill SL, 2005, J BIOMECH, V38, P2365, DOI 10.1016/j.jbiomech.2004.10.022
   Bitsakos C, 2005, J BIOMECH, V38, P133, DOI 10.1016/j.jbiomech.2004.03.005
   Carr BC, 2009, MATER DESIGN, V30, P398, DOI 10.1016/j.matdes.2008.03.032
   CHARNLEY J, 1973, CLIN ORTHOP RELAT R, P9
   D'Lima DD, 2008, J ORTHOP RES, V26, P1549, DOI 10.1002/jor.20670
   D'Lima DD, 2008, CLIN ORTHOP RELAT R, V466, P2605, DOI 10.1007/s11999-008-0345-x
   Deng M, 1998, J BIOMED MATER RES, V40, P214, DOI 10.1002/(SICI)1097-4636(199805)40:2<214::AID-JBM6>3.0.CO;2-O
   Dressler MR, 2011, WEAR, V271, P2879, DOI 10.1016/j.wear.2011.06.006
   Fregly BJ, 2003, J BIOMECH, V36, P1659, DOI 10.1016/S0021-9290(03)00176-3
   Godest AC, 2002, J BIOMECH, V35, P267, DOI 10.1016/S0021-9290(01)00179-8
   Gomaa S.T., 2011, ORTH RES SOC ANN M S
   HAILEY JL, 1994, MED ENG PHYS, V16, P223, DOI 10.1016/1350-4533(94)90041-8
   Isaac G H, 1996, Proc Inst Mech Eng H, V210, P209, DOI 10.1243/PIME_PROC_1996_210_414_02
   Jauffres D, 2008, J APPL POLYM SCI, V110, P2579, DOI 10.1002/app.28697
   KABO JM, 1993, J BONE JOINT SURG BR, V75, P254
   Kang L, 2008, J BIOMECH, V41, P340, DOI 10.1016/j.jbiomech.2007.09.005
   Krichen A, 2006, KNEE, V13, P226, DOI 10.1016/j.knee.2006.02.007
   Lavernia CJ, 2001, J ARTHROPLASTY, V16, P446, DOI 10.1054/arth.2001.23509
   Lee KY, 1997, WEAR, V203, P375, DOI 10.1016/S0043-1648(96)07370-X
   Liau Jiann-Jong, 2002, Clinical Biomechanics, V17, P698, DOI 10.1016/S0268-0033(02)00102-X
   Mazzucco D, 2003, WEAR, V254, P514, DOI 10.1016/S0043-1648(03)00135-2
   McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203
   Penmetsa JR, 2006, J ORTHOP RES, V24, P422, DOI 10.1002/jor.20042
   Reeves EA, 1998, P I MECH ENG H, V212, P189, DOI 10.1243/0954411981533971
   Rullkoeter P., 2000, 46 ANN M ORTH RES SO
   Strickland MA, 2012, WEAR, V274, P100, DOI 10.1016/j.wear.2011.08.020
   Strickland MA, 2009, J BIOMECH, V42, P1469, DOI 10.1016/j.jbiomech.2009.04.022
   Strickland MA, 2009, COMPUT METHOD BIOMEC, V12, P709, DOI 10.1080/10255840902895994
   Villa T, 2004, J BIOMECH, V37, P45, DOI 10.1016/S0021-9290(03)00255-0
   Willing R, 2009, J BIOMECH, V42, P2520, DOI 10.1016/j.jbiomech.2009.07.008
   Young W.C., 2002, ROARKS FORMULAS STRE
   Zdero R, 2001, J ARTHROPLASTY, V16, P367, DOI 10.1054/arth.2001.21501
NR 38
TC 3
Z9 3
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD APR
PY 2014
VL 32
BP 62
EP 75
DI 10.1016/j.jmbbm.2013.12.023
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD8AG
UT WOS:000333488300008
PM 24434602
DA 2018-10-20
ER

PT J
AU Chen, JL
   Guo, RQ
   Zhou, Q
   Wang, T
AF Chen, Jinling
   Guo, Ruiqiang
   Zhou, Qing
   Wang, Tao
TI Injection of composite with bone marrow-derived mesenchymal stem cells
   and a novel synthetic hydrogel after myocardial infarction: A protective
   role in left ventricle function
SO KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
LA English
DT Article
DE Bone marrow mesenchymal stem cells; Echocardiography; Hydrogel
   composite; Myocardial infarction
ID HEART-FAILURE; CARDIAC-FUNCTION; ISCHEMIC-HEART; IN-VITRO; DELIVERY;
   DIFFERENTIATION; CARDIOMYOCYTES; ENHANCEMENT; PHENOTYPE; MODEL
AB A number of studies have shown that the transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) into the thinned infarct wall improves regional wall motion. In this study, we hypothesized that the injection of biomaterials and MSCs into the infarcted myocardium can preserve left ventricular (LV) function. To test this hypothesis, anterior acute myocardial infarction (AMI) was induced in 34 rabbits and BMSCs with hydrogel composite were prepared. One week after inducing AMI, 28 of the 34 rabbits were divided into four groups (Groups A-D; three rabbits were used for bone marrow aspiration, and three rabbits died) and all received an epicardial injection. Group A received BMSCs with hydrogel composite marked by 5-bromodeoxyuridine (BrdU); Group B received BMSCs only marked by BrdU; Group C received hydrogel only marked by BrdU; and Group D was the control group, which received fetal bovine serum. Echocardiography was performed before AMI was induced, 1 week after AMI, and 4 weeks after the epicardial injection. The results were compared with those before AMI, and the rabbits of all the four groups had significantly larger LV end-diastolic diameter (LVDd), thinner anterior wall (AW), lower LV ejection fraction (LVEF), lower V-S and V-E (p < 0.05) 1 week after AMI, which were more significant in Group A (p < 0.05). Compared with 1 week after AMI, Group A and Group B had significantly smaller LVDd, thicker AW, larger LVEF, larger V-S and V-E (p < 0.05) 4 weeks after the epicardial injection, which were more significant in Group A (p < 0.05); however, there was no significant difference in Group C and Group D. These results suggested that BMSCs with hydrogel composite could serve as an injectable biomaterial that prevents LV remodeling and dilation, and improves local systolic and diastolic function after AMI. Copyright (C) 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
C1 [Chen, Jinling; Guo, Ruiqiang; Zhou, Qing; Wang, Tao] Wuhan Univ, Renmin Hosp, Dept Echocardiog, Wuhan 430060, Hubei Province, Peoples R China.
RP Chen, JL (reprint author), Wuhan Univ, Renmin Hosp, Dept Echocardiog, 238 Jiefang Rd, Wuhan 430060, Hubei Province, Peoples R China.
EM cjenny2774@hotmail.com
RI WANG, TAO/B-1888-2013
FU National Key Basic Research Program of China [2005CB623903]
FX This work was supported by the National Key Basic Research Program of
   China (grant no. 2005CB623903).
CR Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   Kelly D, 2008, EUR J HEART FAIL, V10, P133, DOI 10.1016/j.ejheart.2007.12.009
   Kobayashi T, 2000, J SURG RES, V89, P189, DOI 10.1006/jsre.2000.5828
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Li H, 2006, BIOMACROMOLECULES, V7, P1951, DOI 10.1021/bm060064n
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Mathieu E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051991
   Menasche P, 2008, MOL THER, V16, P1000, DOI 10.1038/mt.2008.75
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Muller-Ehmsen J, 2002, CIRCULATION, V105, P1720, DOI 10.1161/01.CIR.0000013782.76324.92
   Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016
   Park JS, 2004, MACROMOLECULES, V37, P6786, DOI 10.1021/ma049677n
   Peppas NA, 1996, BIOMATERIALS, V17, P1553, DOI 10.1016/0142-9612(95)00307-X
   Reffelmann T, 2003, CARDIOVASC RES, V58, P358, DOI 10.1016/S0008-6363(02)00739-3
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Sabbah HN, 2003, CIRC RES, V93, P1095, DOI 10.1161/01.RES.0000101932.70443.FE
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Torres-Lugo M, 1999, MACROMOLECULES, V32, P6646, DOI 10.1021/ma990541c
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Wu DQ, 2008, LANGMUIR, V24, P10306, DOI 10.1021/la8006876
   Zhang XZ, 2002, LANGMUIR, V18, P2013, DOI 10.1021/la011325b
NR 29
TC 9
Z9 9
U1 0
U2 10
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1607-551X
J9 KAOHSIUNG J MED SCI
JI Kaohsiung J. Med. Sci.
PD APR
PY 2014
VL 30
IS 4
BP 173
EP 180
DI 10.1016/j.kjms.2013.12.004
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AD6WX
UT WOS:000333403100002
PM 24656157
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zaveri, TD
   Lewis, JS
   Dolgova, NV
   Clare-Salzler, MJ
   Keselowsky, BG
AF Zaveri, Toral D.
   Lewis, Jamal S.
   Dolgova, Natalia V.
   Clare-Salzler, Michael J.
   Keselowsky, Benjamin G.
TI Integrin-directed modulation of macrophage responses to biomaterials
SO BIOMATERIALS
LA English
DT Article
DE Macrophage; Integrin; Foreign body response; Adhesion; Immunomodulation;
   Wear debris
ID FOREIGN-BODY RESPONSE; GIANT-CELL FORMATION; WEIGHT POLYETHYLENE
   PARTICLES; ACUTE INFLAMMATORY RESPONSES; PLATELET-ACTIVATING-FACTOR;
   TITANIUM PARTICLES; IN-VITRO; ADHERENT ENDOTOXIN; DENDRITIC CELLS;
   BIOLOGICAL RESPONSES
AB Macrophages are the primary mediator of chronic inflammatory responses to implanted biomaterials, in cases when the material is either in particulate or bulk form. Chronic inflammation limits the performance and functional life of numerous implanted medical devices, and modulating macrophage interactions with biomaterials to mitigate this response would be beneficial. The integrin family of cell surface receptors mediates cell adhesion through binding to adhesive proteins nonspecifically adsorbed onto biomaterial surfaces. In this work, the roles of integrin Mac-1 (alpha(M)beta(2)) and RGD-binding integrins were investigated using model systems for both particulate and bulk biomaterials. Specifically, the macrophage functions of phagocytosis and inflammatory cytokine secretion in response to a model particulate material, polystyrene microparticles were investigated. Opsonizing proteins modulated microparticle uptake, and integrin Mac-1 and RGD-binding integrins were found to control microparticle uptake in an opsonin-dependent manner. The presence of adsorbed endotoxin did not affect microparticle uptake levels, but was required for the production of inflammatory cytokines in response to microparticles. Furthermore, it was demonstrated that integrin Mac-1 and RGD-binding integrins influence the in vivo foreign body response to a bulk biomaterial, subcutaneously implanted polyethylene terephthalate. A thinner foreign body capsule was formed when integrin Mac-1 was absent (similar to 30% thinner) or when RGD-binding integrins were blocked by controlled release of a blocking peptide (similar to 45% thinner). These findings indicate integrin Mac-1 and RGD-binding integrins are involved and may serve as therapeutic targets to mitigate macrophage inflammatory responses to both particulate and bulk biomaterials. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zaveri, Toral D.; Lewis, Jamal S.; Dolgova, Natalia V.; Keselowsky, Benjamin G.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
   [Clare-Salzler, Michael J.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.
RP Keselowsky, BG (reprint author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
EM bgk@ufl.edu
RI Lewis, Jamal/B-1734-2013
OI Zaveri, Toral/0000-0003-0059-9212
FU Arthritis Foundation; National Science Foundation [CMMI-0927918];
   National Institutes of Health [R56DK091658, R01DK091658]
FX This work was supported in part by an Arthritis Investigator Award from
   the Arthritis Foundation, and by grants from the National Science
   Foundation (CMMI-0927918) and the National Institutes of Health
   (R56DK091658 and R01DK091658), to BGK.
CR Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Acharya AP, 2011, ACTA BIOMATER, V7, P180, DOI 10.1016/j.actbio.2010.08.026
   Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   ALTIERI DC, 1986, J CLIN INVEST, V78, P968, DOI 10.1172/JCI112687
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 1981, J BIOMED MATER RES, V15, P889, DOI 10.1002/jbm.820150613
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Belisario MA, 2005, EUR J CELL BIOL, V84, P833, DOI 10.1016/j.ejcb.2005.06.002
   BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000
   Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082
   Bi YM, 2002, J ORTHOPAED RES, V20, P696, DOI 10.1016/S0736-0266(01)00176-0
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   Bix GJ, 1997, J NEUROSCI METH, V77, P67, DOI 10.1016/S0165-0270(97)00113-1
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Bracco P, 2005, Hernia, V9, P51, DOI 10.1007/s10029-004-0281-y
   Brown EJ, 2003, HANDB EXP PHARM, V158, P111
   Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826
   CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795
   Choe SW, 2010, ACTA BIOMATER, V6, P3491, DOI 10.1016/j.actbio.2010.03.006
   CHU CC, 1989, SURG GYNECOL OBSTET, V168, P233
   Collier TO, 2004, J BIOMED MATER RES A, V69A, P644, DOI 10.1002/jbm.a.30030
   Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2
   Cunnick J, 2006, J IMMUNOL METHODS, V311, P96, DOI 10.1016/j.jim.2006.01.017
   Daniels AU, 2000, J BIOMED MATER RES, V49, P469, DOI 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.3.CO;2-1
   Ding HF, 2012, J MATER SCI-MATER M, V23, P1055, DOI 10.1007/s10856-012-4574-x
   Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9
   FISHER JE, 1993, ENDOCRINOLOGY, V132, P1411, DOI 10.1210/en.132.3.1411
   Flick MJ, 2004, EXP BIOL MED, V229, P1105
   Freischlag J A, 1990, Ann Vasc Surg, V4, P449, DOI 10.1016/S0890-5096(07)60069-7
   GAN ZR, 1988, J BIOL CHEM, V263, P19827
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   GILLIGAN BJ, 1994, DIABETES CARE, V17, P882, DOI 10.2337/diacare.17.8.882
   Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7
   Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665
   Hooper KA, 2000, J BIOMED MATER RES, V50, P365, DOI 10.1002/(SICI)1097-4636(20000605)50:3<365::AID-JBM10>3.0.CO;2-X
   HORIE S, 1994, J IMMUNOL, V152, P5457
   Hsu CC, 2011, J THROMB HAEMOST, V9, P593, DOI 10.1111/j.1538-7836.2010.04163.x
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035
   Ingram JH, 2004, BIOMATERIALS, V25, P3511, DOI 10.1016/j.biomaterials.2003.10.054
   Irwin EF, 2008, J BIOMAT SCI-POLYM E, V19, P1363, DOI 10.1163/156856208786052407
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kanse SM, 2004, ARTERIOSCL THROM VAS, V24, P2251, DOI 10.1161/01.ATV.0000146529.68729.8b
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Keselowsky BG, 2011, HUM VACCINES, V7, P37, DOI 10.4161/hv.7.1.12916
   Latour RA, 2005, ENCY BIOMATERIALS BI
   LEE JD, 1993, P NATL ACAD SCI USA, V90, P9930, DOI 10.1073/pnas.90.21.9930
   Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006
   Legrand AP, 2005, J MATER SCI-MATER M, V16, P477, DOI 10.1007/s10856-005-6989-0
   Lewis JS, 2012, BIOMATERIALS, V33, P7221, DOI 10.1016/j.biomaterials.2012.06.049
   Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200
   Lishko VK, 2003, EXP CELL RES, V283, P116, DOI 10.1016/S0014-4827(02)00024-1
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2
   Monick MM, 2002, AM J PHYSIOL-LUNG C, V283, pL390, DOI 10.1152/ajplung.00437.2001
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Norton LW, 2007, J BIOMED MATER RES A, V81A, P858, DOI 10.1002/jbm.a.31088
   Olivier V, 2004, COLLOID SURFACE B, V33, P23, DOI 10.1016/j.colsurfb.2003.08.008
   Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574
   Rader CP, 1999, J ARTHROPLASTY, V14, P840, DOI 10.1016/S0883-5403(99)90035-9
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Salsmann A, 2005, J BIOL CHEM, V280, P33610, DOI 10.1074/jbc.M500146200
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sivaraman B, 2011, BIOMATERIALS, V32, P5365, DOI 10.1016/j.biomaterials.2011.04.011
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Stanley E R, 1997, Methods Mol Biol, V75, P301
   Sun DH, 2003, J BIOMED MATER RES A, V65A, P290, DOI 10.1002/jbm.a.10477
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Tatro JM, 2007, J ORTHOP RES, V25, P361, DOI 10.1002/jor.20289
   TOMIDA M, 1984, J BIOL CHEM, V259, P978
   van Bilsen PHJ, 2008, COLLOID SURFACE B, V67, P46, DOI 10.1016/j.colsurfb.2008.07.013
   Vogel S, 2001, J ENDOTOXIN RES, V7, P237, DOI 10.1179/096805101101532747
   WALZOG B, 1995, EXP CELL RES, V218, P28, DOI 10.1006/excr.1995.1127
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   Xing ZQ, 2006, J ORTHOP RES, V24, P959, DOI 10.1002/jor.20038
   Yoshida M, 2006, J BIOMAT SCI-POLYM E, V17, P893, DOI 10.1163/156856206777996844
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 91
TC 32
Z9 32
U1 2
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2014
VL 35
IS 11
BP 3504
EP 3515
DI 10.1016/j.biomaterials.2014.01.007
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC4ON
UT WOS:000332500700003
PM 24462356
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Martin, JR
   Gupta, MK
   Page, JM
   Yu, F
   Davidson, JM
   Guelcher, SA
   Duvall, CL
AF Martin, John R.
   Gupta, Mukesh K.
   Page, Jonathan M.
   Yu, Fang
   Davidson, Jeffrey M.
   Guelcher, Scott A.
   Duvall, Craig L.
TI A porous tissue engineering scaffold selectively degraded by
   cell-generated reactive oxygen species
SO BIOMATERIALS
LA English
DT Article
DE Polyurethane; Oxidation; Biodegradation; Macrophage; Wound healing;
   Scaffold
ID IN-VIVO; POLYURETHANE SCAFFOLDS; POLYMERIC NANOPARTICLES;
   MECHANICAL-PROPERTIES; DEGRADATION; VITRO; REPAIR; BIOCOMPATIBILITY;
   BIODEGRADATION; RELEASE
AB Biodegradable tissue engineering scaffolds are commonly fabricated from poly(lactide-co-glycolide) (PLGA) or similar polyesters that degrade by hydrolysis. PLGA hydrolysis generates acidic breakdown products that trigger an accelerated, autocatalytic degradation mechanism that can create mismatched rates of biomaterial breakdown and tissue formation. Reactive oxygen species (ROS) are key mediators of cell function in both health and disease, especially at sites of inflammation and tissue healing, and induction of inflammation and ROS are natural components of the in vivo response to biomaterial implantation. Thus, polymeric biomaterials that are selectively degraded by cell-generated ROS may have potential for creating tissue engineering scaffolds with better matched rates of tissue in-growth and cell-mediated scaffold biodegradation. To explore this approach, a series of poly(thioketal) (PTK) urethane (PTK-UR) biomaterial scaffolds were synthesized that degrade specifically by an ROS-dependent mechanism. PTK-UR scaffolds had significantly higher compressive moduli than analogous poly(ester urethane) (PEUR) scaffolds formed from hydrolytically-degradable ester-based diols (p < 0.05). Unlike PEUR scaffolds, the PTK-UR scaffolds were stable under aqueous conditions out to 25 weeks but were selectively degraded by ROS, indicating that their biodegradation would be exclusively cell-mediated. The in vitro oxidative degradation rates of the PTK-URs followed first-order degradation kinetics, were significantly dependent on PTK composition (p < 0.05), and correlated to ROS concentration. In subcutaneous rat wounds, PTK-UR scaffolds supported cellular infiltration and granulation tissue formation, followed first-order degradation kinetics over 7 weeks, and produced significantly greater stenting of subcutaneous wounds compared to PEUR scaffolds. These combined results indicate that ROS-degradable PTK-UR tissue engineering scaffolds have significant advantages over analogous polyester-based biomaterials and provide a robust, cell-degradable substrate for guiding new tissue formation. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Martin, John R.; Gupta, Mukesh K.; Duvall, Craig L.] Vanderbilt Univ, Stevenson Ctr 5824, Nashville, TN 37235 USA.
   [Page, Jonathan M.; Guelcher, Scott A.] Vanderbilt Univ, Nashville, TN 37235 USA.
   [Yu, Fang; Davidson, Jeffrey M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.
   [Davidson, Jeffrey M.] Vet Affairs Tennessee Valley Healthcare Syst, Med Res Serv, Nashville, TN 37212 USA.
RP Duvall, CL (reprint author), Vanderbilt Univ, Stevenson Ctr 5824, PMB 351631, Nashville, TN 37235 USA.
EM craig.duvall@vanderbilt.edu
RI Gupta, Mukesh/B-4180-2016
OI Davidson, Jeffrey/0000-0002-8782-3565
FU Vanderbilt University School of Engineering, the Department of Veterans
   Affairs; NIH [R21EB012750, R01AR056138]; NSF [DMR-1006558]
FX Funding was provided by the Vanderbilt University School of Engineering,
   the Department of Veterans Affairs, the NIH through grants R21EB012750
   and R01AR056138, and the NSF through grant DMR-1006558. The authors
   confirm that there are no known conflicts of interest associated with
   this publication and there has been no significant financial support for
   these efforts that could have influenced their outcome.
CR Adolph EJ, 2012, J BIOMED MATER RES A, V100A, P450, DOI 10.1002/jbm.a.33266
   An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Antheunis H, 2010, BIOMACROMOLECULES, V11, P1118, DOI 10.1021/bm100125b
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936
   ASTM-International, 2008, E189908 ASTM INT
   BEZWADA RS, 1995, BIOMATERIALS, V16, P1141, DOI 10.1016/0142-9612(95)93577-Z
   Broaders KE, 2010, J AM CHEM SOC, V133, P756
   Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   Dang WB, 1996, PHARMACEUT RES, V13, P683, DOI 10.1023/A:1016035229961
   Dey J, 2008, BIOMATERIALS, V29, P4637, DOI 10.1016/j.biomaterials.2008.08.020
   Dumas JE, 2014, TISSUE ENG PT A, V20, P115, DOI [10.1089/ten.tea.2012.0762, 10.1089/ten.TEA.2012.0762]
   Dumas JE, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024112
   Eglin D, 2010, J BIOMAT SCI-POLYM E, V21, P477, DOI 10.1163/156856209X424404
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Gogolewski S, 2006, J BIOMED MATER RES A, V77A, P802, DOI 10.1002/jbm.a.30669
   Guelcher S, 2007, TISSUE ENG, V13, P2321, DOI 10.1089/ten.2006.0395
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Gupta MK, 2012, J CONTROL RELEASE, V162, P591, DOI 10.1016/j.jconrel.2012.07.042
   Hafeman AE, 2008, PHARM RES-DORDR, V25, P2387, DOI 10.1007/s11095-008-9618-z
   Hafeman AE, 2011, BIOMATERIALS, V32, P419, DOI 10.1016/j.biomaterials.2010.08.108
   Harbers GM, 2006, INTRO BIOMATERIALS
   Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Hua N, 2008, J MATER SCI-MATER M, V19, P3243, DOI 10.1007/s10856-008-3460-z
   Ibim SEM, 1998, J BIOMED MATER RES, V43, P374, DOI 10.1002/(SICI)1097-4636(199824)43:4<374::AID-JBM5>3.0.CO;2-5
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Jayakumar A, 2008, J PARASITOL, V94, P84, DOI 10.1645/GE-1153.1
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Ku TH, 2011, J AM CHEM SOC, V133, P8392, DOI 10.1021/ja2004736
   Laschke MW, 2009, ACTA BIOMATER, V5, P1991, DOI 10.1016/j.actbio.2009.02.006
   Lee SY, 2003, BIOMATERIALS, V24, P5049, DOI 10.1016/S0142-9612(03)00411-3
   LEONG KW, 1987, MACROMOLECULES, V20, P705, DOI 10.1021/ma00170a001
   Li HM, 2013, ADV FUNCT MATER, V23, P3040, DOI 10.1002/adfm.201202215
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   Lowry KJ, 1997, J BIOMED MATER RES, V36, P536
   lshaug-Riley SL, 1998, BIOMATERIALS, V19, P1405
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Lux CD, 2012, J AM CHEM SOC, V134, P15758, DOI 10.1021/ja303372u
   MIKOS AG, 2000, EJB ELECT J BIOTECHN, V3, P114
   Napoli A, 2004, NAT MATER, V3, P183, DOI 10.1038/nmat1081
   Nilsson A, 2005, J HAND SURG-AM, V30A, P380, DOI 10.1016/j.jhsa.2004.12.001
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006
   Page JM, 2012, ACTA BIOMATER, V8, P4405, DOI 10.1016/j.actbio.2012.07.037
   Parrott MC, 2010, J AM CHEM SOC, V132, P17928, DOI 10.1021/ja108568g
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Pike JK, 1996, CHEM MATER, V8, P856, DOI 10.1021/cm9504596
   Rockwood DN, 2008, BIOMATERIALS, V29, P4783, DOI 10.1016/j.biomaterials.2008.08.034
   Roy D, 2010, PROG POLYM SCI, V35, P278, DOI 10.1016/j.progpolymsci.2009.10.008
   Salvatore RN, 2005, TETRAHEDRON LETT, V46, P8931, DOI 10.1016/j.tetlet.2005.10.062
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   Shim MS, 2013, ANGEW CHEM INT EDIT, V52, P6926, DOI 10.1002/anie.201209633
   Stakleff KS, 2013, ACTA BIOMATER, V9, P5132, DOI 10.1016/j.actbio.2012.08.035
   Thayer AM, 2011, CHEM ENG NEWS, V89, P13
   VISSCHER GE, 1985, J BIOMED MATER RES, V19, P349, DOI 10.1002/jbm.820190315
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Wilson DS, 2010, NAT MATER, V9, P923, DOI [10.1038/NMAT2859, 10.1038/nmat2859]
   Yu SS, 2011, BIOMACROMOLECULES, V12, P4357, DOI 10.1021/bm201328k
NR 64
TC 43
Z9 46
U1 10
U2 120
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2014
VL 35
IS 12
BP 3766
EP 3776
DI 10.1016/j.biomaterials.2014.01.026
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC3OS
UT WOS:000332431700006
PM 24491510
OA Green Accepted
DA 2018-10-20
ER

EF